Date,volume,open,high,low,close,adj close,Stock_symbol,Titles_combined,label,delta_bert
2012-01-03,8177000.0,92.7699966430664,95.11000061035156,92.7699966430664,93.9800033569336,67.95301818847656,CAT,Market Update ||| Caterpillar Projects 10% Rise In China Construction Equipment Market,1,0.54981995
2012-01-04,7335200.0,93.41000366210938,95.51000213623048,93.41000366210938,94.8499984741211,68.58208465576172,CAT,"Stock Market News for January 4, 2012 - Market News ||| S&P Bullish On Select Industrials ETFs ||| A Peek Into The Market Before The Trading Starts ||| Caterpillar Expands Research and Development Center in China",1,0.5207421
2012-01-05,5555900.0,94.83999633789062,96.16000366210938,93.9000015258789,95.5199966430664,69.0665283203125,CAT,"Benzinga's M&A Chatter for Thursday January 5, 2012 ||| Caterpillar Spokesperson, Responding to Rumored Acquisition of Agco, Says 'We Do Not Comment on Speculation or Rumors Related to Any Possible Merger or Acquisition' ||| Hearing Chatter Caterpillar May Have Interest in Acquiring Agco ||| Hearing Chatter Caterpillar May Have Interest in Acquiring Agco",1,0.4963525
2012-01-06,5474100.0,96.02999877929688,96.1999969482422,95.31999969482422,95.76000213623048,69.24005126953125,CAT,5 Stocks For A Real Estate Rebound,1,0.5448969
2012-01-09,6536300.0,96.08999633789062,97.41000366210938,96.0,97.0999984741211,70.20893859863281,CAT,Joy Global to Snap Up IMM - Analyst Blog ||| Geaux Tigers/ Roll Tide: Four Stocks For The BCS Title Game,1,0.5329722
2012-01-10,9545000.0,98.4499969482422,99.9800033569336,98.27999877929688,99.95999908447266,72.27690124511719,CAT,Jeff Miller Positions For 2012: Biggest Mistake Investors Can Make Right Now Is Underweighting Stocks,0,0.49181226
2012-01-11,7226500.0,99.83000183105467,100.4499969482422,99.4000015258789,99.63999938964844,72.04552459716797,CAT,Machinery Running Smoothly - Zacks Industry Rank Analysis ||| 4 Global Industrial ETFs to Consider Now,1,0.5152973
2012-01-12,10471800.0,99.98999786376952,102.04000091552734,98.66000366210938,101.94000244140624,73.70857238769531,CAT,Zacks Industry Rank Analysis Highlights: Caterpillar and Deere - Press Releases,1,0.50669116
2012-01-13,9914300.0,100.72000122070312,102.6999969482422,100.5500030517578,102.4800033569336,74.09902954101562,CAT,What is the Largest Position in Your Portfolio? - Real Time Insight,1,0.48833486
2012-01-17,8864700.0,103.81999969482422,104.8000030517578,103.31999969482422,103.37000274658205,74.7425308227539,CAT,"Strong U.S. Jobs Growth: Will These Profitable Companies Benefit? ||| Option Alert: Caterpiller January 100 Call; Block Trade, 3X 16,400 Contracts ||| Option Alert: Caterpiller January 80 Call; Block Trade, 3X 6,390 Contracts",1,0.4817889
2012-01-18,6794400.0,102.66000366210938,104.5,102.5,104.26000213623048,75.72303009033203,CAT,PartnerRe Assesses 4Q CAT Loss - Analyst Blog ||| Finning to Acquire Portion of Bucyrus Distribution Business,1,0.5173861
2012-01-19,9464800.0,104.6500015258789,105.76000213623048,103.62999725341795,105.75,76.80518341064453,CAT,Caterpillar Trading 1.2% Higher on Heavy Volume; Currently at $105.48,0,0.48085636
2012-01-20,6601100.0,105.3499984741211,105.91999816894533,104.83999633789062,105.63999938964844,76.72531127929688,CAT,"Zacks Bull and Bear of the Day Highlights: Western Union, ICICI Bank, Caterpillar, Joy Global and CNH Global NV - Press Releases",1,0.50393826
2012-01-23,7003800.0,105.91000366210938,107.23999786376952,105.63999938964844,106.37000274658205,77.2554931640625,CAT,Earnings Expectations for the Week of January 23,0,0.48718828
2012-01-24,5577300.0,105.43000030517578,106.8000030517578,105.1500015258789,106.29000091552734,77.1973876953125,CAT,"Caterpillar, Inc. (CAT) - Bull of the Day ||| Zacks Bull and Bear of the Day Highlights: Caterpillar, NII Holdings, Lowe's Companies, Home Depot and St. Jude Medical - Press Releases ||| BAE Systems and Caterpillar Sign 20-Year Agreement to Outfit Heavy-Duty Trucks with HybriDrive Parallel Systems",1,0.4724198
2012-01-25,10649400.0,106.0,109.27999877929688,105.98999786376952,109.0500030517578,79.20195770263672,CAT,A.M. Best Wary of PartnerRe - Analyst Blog ||| Caterpillar Earnings Preview: High Expectations,1,0.5164619
2012-01-26,18539000.0,112.20999908447266,114.0,110.6999969482422,111.30999755859376,80.84335327148438,CAT,"Durable Goods Better Than Expected - Real Time Insight ||| Mid-Day Update: Stock Ease from Early Gains But Appear to Be Slowing Drop in Recent Minutes ||| S&P Trading Range 'Til April - Cook`s Kitchen ||| Good News Starts with Caterpillar - Analyst Blog ||| Opening View: DJIA Cautiously Higher Ahead of Data Deluge; CAT, NFLX in Focus ||| Ahead of Wall Street - January 26, 2012 - Ahead of Wall Street ||| Market Wrap-Up for Jan.26 (CL, TWC, CAT, SHW, T, ADP, more) ||| Caterpillar Exceeds on Record Sales - Analyst Blog ||| Stock Market News for January 26, 2012 - Market News ||| Caterpillar Trading 4.3% Higher on Heavy Volume; Currently at $113.72 ||| Caterpillar up 2.6% Pre-Market on Strong Earnings and Guidance ||| UPDATE: Caterpillar Reports 60% Surge In Q4 Earnings, Lifts Forecast ||| Caterpillar Reports Q4 EPS $2.32 vs $1.73 Est; Revenues $17.24B vs $16.05B Est ||| Earnings Scheduled For January 26",0,0.49588114
2012-01-27,7835100.0,110.52999877929688,111.9800033569336,109.66999816894533,111.27999877929688,80.82158660888672,CAT,"Largest option buying in equities so far ||| Stock Market News for January 27, 2012 - Market News ||| The Zacks Analyst Blog Highlights: Caterpillar, 3M, Eaton, AT&T and Netflix - Press Releases ||| RenaissanceRe Projects 4Q CAT Loss - Analyst Blog ||| UPDATE: Credit Suisse Raises PT to $138 on Caterpillar",0,0.49866104
2012-01-30,5968400.0,110.0199966430664,110.75,104.4499969482422,110.41000366210938,80.18970489501953,CAT,"Stronger, but Still Weak, Earnings Season - Real Time Insight ||| Stronger Earnings, but Still Weak - Analyst Blog ||| 5 Stocks that Turned a Triple Play - Investment Ideas ||| Weakest Earnings Season Since Recession - Earnings Trends",0,0.48968
2012-01-31,7608300.0,111.29000091552734,112.0,108.70999908447266,109.12000274658205,79.25279235839844,CAT,"Zacks Investment Ideas feature highlights: Arctic Cat, Caterpillar, Apple, United Rentals and CA Technologies - Press Releases",1,0.5086946
2012-02-01,6737900.0,110.75,111.38999938964844,109.94000244140624,110.5199966430664,80.26959991455078,CAT,"Caterpillar, Inc. (CAT) - Bull of the Day ||| Zacks Bull and Bear of the Day Highlights: Caterpillar, Bank of America, Cosi, Panera Bread and Starbucks - Press Releases",0,0.46770653
2012-02-02,5125400.0,110.8000030517578,111.0199966430664,109.86000061035156,110.33000183105467,80.131591796875,CAT,"Cummins Beats, Expects Higher Revenues - Analyst Blog",1,0.5218329
2012-02-03,10225500.0,112.16999816894533,114.6500015258789,111.9000015258789,113.94000244140624,82.75352478027344,CAT,Three Bullish Signs for Today's Market ||| Strong Employment Figures and Other Economic Fantasies,0,0.52787876
2012-02-06,5029600.0,113.23999786376952,114.25,112.8000030517578,113.77999877929688,82.63731384277344,CAT,"Stock Market News for February 6, 2012 - Market News ||| Caterpillar Receives Positive Mad Money/Jim Cramer Mention -CNBC ||| Finally, Good News from Citigroup",1,0.48570648
2012-02-07,5139200.0,113.0500030517578,114.0999984741211,112.48999786376952,113.80999755859376,82.65908813476562,CAT,The Value Trap of Deeply Cyclical Stocks,1,0.4958455
2012-02-08,4123800.0,113.81999969482422,114.33000183105467,113.22000122070312,114.04000091552734,82.8261489868164,CAT,"Zacks Bull and Bear of the Day Highlights: Caterpillar, CNO Financial Group, Whole Foods Market, Yum! Brands and McDonald's - Press Releases ||| Five More Stocks ETFs Need More Of ||| Joy Global Could Be Telling Us Something",0,0.48418742
2012-02-09,7566200.0,114.38999938964844,114.63999938964844,112.58999633789062,112.83000183105467,81.94732666015625,CAT,"Knowing How And When To Sell ||| Benzinga's M&A Chatter for Thursday February 9, 2012 ||| Seeking Alpha Post Sees Manitowoc and Cummins as Takeover Targets of Caterpillar and Deere",0,0.49690762
2012-02-13,5702400.0,112.6999969482422,113.86000061035156,111.68000030517578,113.6999969482422,82.5792007446289,CAT,These sectors should outperform over 2012,1,0.5223705
2012-02-15,8201900.0,114.48999786376952,114.6999969482422,111.94000244140624,112.52999877929688,81.72942352294922,CAT,Deere Starts 2012 on a Good Note - Analyst Blog,1,0.5216462
2012-02-16,5456900.0,112.72000122070312,114.0500030517578,112.38999938964844,113.95999908447266,82.76803588867188,CAT,"What Obama's Budget Means for Investors ||| Stock Market News for February 16, 2012 - Market News",0,0.5109684
2012-02-17,4296000.0,114.37999725341795,114.5,113.02999877929688,113.9499969482422,82.76078033447266,CAT,"Terex Tops Estimates - Analyst Blog ||| Five ETFs For NASCAR Season (XLP, DIA, VROM) ||| Caterpillar Expands Operations in United States; New Factory Near Athens, Georgia Expected to Employ 1,400 People",1,0.5090627
2012-02-21,7520200.0,114.5,116.44000244140624,114.38999938964844,115.0,83.52337646484375,CAT,"Now S&P Doubtful over PartnerRe - Analyst Blog ||| Astec Beats EPS, Misses Sales - Analyst Blog",1,0.52022964
2012-02-23,5064900.0,115.87999725341795,116.4499969482422,115.0,116.1999969482422,84.39493560791016,CAT,Caterpillar January Sales No Better - Analyst Blog ||| USDA Outlook for U.S. Agricultural Trade: FY 2012 Exports Fall to $131 Billion; Imports Rise to $106.5 Billion,0,0.4859471
2012-02-24,4473500.0,116.29000091552734,116.9499969482422,115.66999816894533,116.0,84.24966430664062,CAT,The Perils of Global Business Yet Local Markets,0,0.5119255
2012-02-27,4909600.0,114.83999633789062,116.5,114.5500030517578,115.62999725341795,83.98092651367188,CAT,Dallas Fed Manufacturing Index Signals a Strengthening Industrial Sector,1,0.5466512
2012-02-28,4013200.0,115.80999755859376,116.22000122070312,115.1999969482422,115.76000213623048,84.07537078857422,CAT,Durable Goods Orders Signal a Struggling Industrial Sector,0,0.51861924
2012-03-01,7465000.0,114.66999816894533,115.37999725341795,113.01000213623048,113.38999938964844,82.35404205322266,CAT,"Caterpillar to Take Over Japan JV - Analyst Blog ||| Deere Hikes Dividend - Analyst Blog ||| Global Manufacturing Suffers Uneven Recovery ||| ISM Manufacturing Worse than Expected, but Still Expanding ||| Caterpillar to Become Sole Owner of Japanese Joint Venture ||| Caterpillar Japan Acquires 100% of Caterpillar Tohoku",0,0.5015908
2012-03-02,5404800.0,113.16000366210938,113.94000244140624,111.8000030517578,112.48999786376952,81.70040130615234,CAT,"The Zacks Analyst Blog Highlights: United Continental Holdings, Deere, Caterpillar, CNH Global NV and Kubota - Press Releases ||| Caterpillar Buys Japanese Distributor - Analyst Blog ||| Deere Invests More on Tractors - Analyst Blog",0,0.54125094
2012-03-05,8392200.0,111.5500030517578,111.9000015258789,109.5199966430664,110.08999633789062,79.95728302001953,CAT,"Stock Market News for March 5, 2012 - Market News ||| Markets Dragged Lower With Key Stock Setups",0,0.49425977
2012-03-06,12630800.0,106.56999969482422,107.16000366210938,105.1999969482422,105.93000030517578,76.93592834472656,CAT,"Stock Market News for March 6, 2012 - Market News ||| Market Wrap-Up for Mar.6 (DKS, MTN, QCOM, MRK, MA, CAT, more) ||| Caterpillar Reiterates 2012 Forecast Given on Jan 26 ||| Stocks Down in Big Trade; Caterpillar Gaps Down",1,0.5049751
2012-03-07,7385800.0,106.66000366210938,108.62000274658205,106.31999969482422,108.27999877929688,78.64270782470703,CAT,"Zacks' Voice of the People highlights opportunities with The SPDR S&P 500 ETF, The PowerShares QQQ Trust, Series 1 ETF, Caterpillar, Mastercard and Microsoft - Press Releases ||| Caterpillar Sits on Record Backlog - Analyst Blog",1,0.5079072
2012-03-08,6171200.0,109.58999633789062,110.55999755859376,108.66000366210938,110.27999877929688,80.09529876708984,CAT,"The Zacks Analyst Blog Highlights: Citigroup, HSBC Holdings, ICICI Bank, HDFC Bank and Caterpillar - Press Releases",0,0.5085852
2012-03-09,6526500.0,110.87999725341795,111.08999633789062,109.8000030517578,110.22000122070312,80.05171203613281,CAT,It's Time to Load up on These Cyclical Stocks ||| Stocks Extend Gains; Herbalife Hits All-Time High,0,0.49390942
2012-03-13,8077600.0,109.7300033569336,113.37999725341795,109.30999755859376,113.3000030517578,82.28868865966797,CAT,"Industrial, Energy and Commodity Stocks Still Rule in This Market",0,0.49931034
2012-03-14,6181000.0,113.20999908447266,113.4499969482422,111.26000213623048,112.2699966430664,81.54059600830078,CAT,"Caterpillar Announces Expansion of Manufacturing Facility in Sumter, South Carolina; More Than 80 New Jobs Expected",1,0.5289753
2012-03-15,5316700.0,112.87999725341795,113.4800033569336,111.38999938964844,113.4499969482422,82.39762115478516,CAT,Empire State Manufacturing Index Signals a Strengthening Industrial Sector,1,0.5583305
2012-03-16,5776000.0,114.0199966430664,114.25,113.04000091552734,113.58000183105467,82.4920425415039,CAT,"Caterpillar Expands Sumter Plant - Analyst Blog ||| Notable Performers Since the Turn of the Year (AAPL, VVUS, BAC)",1,0.4944548
2012-03-20,8086900.0,111.98999786376952,112.0,110.51000213623048,110.76000213623048,80.44391632080078,CAT,"Market Wrap-Up for Mar.20 (TIF, DIS, CAT, BHP, JOY, more) ||| William Blair Comments on Caterpillars Worldwide Sales ||| Deere Analyst: Slowing Caterpillar Sales Growth and China Slowdown Should Not Be Important to Deere, as Agriculture More Important for the Company ||| CAT Analyst: Not Putting Major Emphasis on Today's Retail Sales, Trend is Slightly Lower but Overall Remain Favorable; Reiterates Buy ||| Caterpillar February Retail Sales of Machines Worldwide Up 21% ||| Caterpillar, Discover Financial and Other Illinois Primary Stock Picks",0,0.493233
2012-03-21,7925000.0,110.8499984741211,111.3499984741211,109.0,109.0,79.16565704345703,CAT,"Caterpillar Increases Production Capabilities in China ||| UPDATE: Raymond James Reduces Caterpillar's PT ||| From Earlier: Caterpillar Announces Excavator Capacity Expansion, Positioning the Company to Support Long-Term Growth in China; Caterpillar Also Plans to Produce Wheeled Excavators in China ||| Raymond James Maintains Caterpillar at Outperform, Lowers PT from $140 to $130",0,0.5166249
2012-03-22,9449700.0,107.27999877929688,107.94000244140624,105.6999969482422,106.43000030517578,77.29907989501953,CAT,"Zacks Bull and Bear of the Day Highlights: Macy's, RadioShack, Caterpillar, Komatsu and Volvo AB - Press Releases ||| Terex Partners with Sinomach - Analyst Blog ||| Caterpillar Expands in China - Analyst Blog ||| Global Boom Still Alive: Cyclical Stock Stories - Cook`s Kitchen ||| Global Boom Still Alive: Cyclical Stock Stories - Cook`s Kitchen ||| Global Boom Still Alive: Cyclical Stock Stories - Cook`s Kitchen",1,0.5305083
2012-03-23,6025000.0,106.58999633789062,108.61000061035156,105.8000030517578,107.83000183105467,78.31588745117188,CAT,Caterpillar Expands China Unit - Analyst Blog ||| Canadian National Buys Locomotives - Analyst Blog ||| From Earlier: Caterpillar to Expand Shandong Engineering Machinery Product Line and Increase Capacity for SEM Wheel Loaders ||| Caterpillar to Expand Shandong Engineering Machinery Product Line and Increase Capacity for SEM Wheel Loaders,1,0.49967495
2012-03-26,4570800.0,108.8000030517578,109.6999969482422,108.12000274658205,108.75,78.98403930664062,CAT,Dallas Fed Manufacturing Index Surprises to the Downside,0,0.5026503
2012-03-27,4211400.0,108.68000030517578,109.56999969482422,107.87999725341795,108.05999755859376,78.48291778564453,CAT,Return of the Mack – KKR Appoints Former Morgan Stanley CEO,0,0.5057328
2012-03-28,10244900.0,107.95999908447266,107.97000122070312,103.5500030517578,104.26000213623048,75.72303009033203,CAT,"Zacks #1 Rank Additions for Wednesday - Tale of the Tape ||| Market Wrap-Up for Mar.28 (BTU, CAT, FCX, TYC, PNR, more) ||| Durable Goods Orders Signal a Struggling Industrial Sector; Inventories at Record Highs ||| Cascade Earnings Preview: Full-Year EPS Expected to Have Doubled",1,0.4905369
2012-03-29,8316800.0,103.62000274658205,106.2699966430664,103.4800033569336,106.0199966430664,77.00130462646484,CAT,"Market Wrap-Up for Mar.29 (BBY, MOS, AXP, WFM, CAT, CLF, more) ||| Benzinga's Top Pre-Market Losers",1,0.49815294
2012-03-30,4780300.0,106.6999969482422,106.93000030517578,105.58000183105467,106.5199966430664,77.36442565917969,CAT,"Stock Market News for March 30, 2012 - Market News ||| Cummins to Launch Upgraded Engines - Analyst Blog ||| Caterpillar Announces New Facility to Employ 150 People",1,0.51282585
2012-04-02,5211700.0,105.98999786376952,107.94000244140624,105.04000091552734,107.25,77.89463806152344,CAT,Another Distribution Center for CAT - Analyst Blog ||| Construction Spending Signals Weakening Construction Sector ||| ISM Manufacturing Signals Expanding Manufacturing Sector,0,0.5210758
2012-04-03,5828000.0,107.63999938964844,108.08999633789062,105.81999969482422,106.20999908447266,77.13928985595703,CAT,Factory Orders Rise Less than Expected,1,0.52936035
2012-04-04,5583200.0,104.7699966430664,106.83999633789062,104.33999633789062,106.26000213623048,77.17562103271484,CAT,Money-Making Machines - Zacks Industry Rank Analysis,0,0.50531626
2012-04-10,9162300.0,103.54000091552734,103.66000366210938,99.8000030517578,100.43000030517578,72.94131469726562,CAT,"Market Wrap-Up for Apr.10 (BBY, CAT, FCX, COP, PFE, more) ||| 10 Year Treasury Back below 2% as Stocks Retreat for Fifth Day",1,0.49736395
2012-04-11,6178100.0,101.7699966430664,102.5,100.5,101.75,73.90003204345703,CAT,Jon Huntsman Joins Caterpillar Board,1,0.5218731
2012-04-12,8973200.0,102.16999816894533,106.5,102.12999725341795,106.44000244140624,77.30632781982422,CAT,"Dow Soars 181 Points; China and Google In the Wings ||| Market Wrap-Up for Apr.12 (FCX, CLF, CAT, T, AXP, MCD, more) ||| CAT Hives Aussie Distribution Biz - Analyst Blog ||| From Earlier: Caterpillar to Sell Part of Bucyrus Distribution Business to Cat Dealer WesTrac for $400M ||| Seven Group Buying Caterpillar Bucyrus Distribution Business",0,0.4941755
2012-04-13,6321600.0,106.16000366210938,106.91999816894533,105.23999786376952,105.88999938964844,76.9068603515625,CAT,Safe Investing and Lagging Indicators,1,0.52564263
2012-04-16,6813500.0,107.91999816894533,108.95999908447266,106.16000366210938,106.73999786376952,77.52421569824219,CAT,"The Complexity of Covered Call Return Calculations ||| Bank of America/Merrill Lynch Upgrades Caterpillar to “Buy”; Fundamentals, Valuation Attractive (CAT) ||| Zacks #1 Rank Additions for Monday - Tale of the Tape ||| Beware the Dow Jones-Led Rally - Voice of the People ||| PartnerRe Off A.M. Best Radar - Analyst Blog ||| Caterpillar Down to Neutral - Analyst Blog ||| Stick with cash generating stocks, bonds and gold ||| Are Raised Outlooks a Bullish Sign for Caterpillar? ||| Caterpillar Motors Up On Upgrade, Q1 Earnings Loom - IBD ||| Empire State Manufacturing Index Signals a Struggling Industrial Sector ||| UPDATE: Bank of America Upgrades Caterpillar to Buy ||| Financial Breakfast: Morning News Summary for April 16, 2012 ||| Bank of America Upgrades Caterpillar from Neutral to Buy, Raises PO from $127 to $135",1,0.4880046
2012-04-17,5321000.0,107.9000015258789,109.1999969482422,106.72000122070312,108.41000366210938,78.73712921142578,CAT,"Zacks' Voice of the People highlights opportunities with IBM, Chevron, Caterpillar, 3M and Exxon Mobil - Press Releases ||| CAT Sells Off Bucyrus' Peru Biz - Analyst Blog ||| Spring Pullback Over? Not So Fast - Cook`s Kitchen ||| Caterpillar Receives MOFCOM Approval for ERA Acquisition ||| Top 4 NYSE Stocks In The Farm & Construction Machinery Industry With The Highest Cash ||| Top 4 NYSE Stocks In The Farm & Construction Machinery Industry With The Highest Cash",1,0.4832937
2012-04-18,4871700.0,107.6500015258789,109.7300033569336,107.6500015258789,109.20999908447266,79.31818389892578,CAT,"The Zacks Analyst Blog Highlights: Caterpillar, Joy Global, CNH Global NV, Komatsu and Volvo AB - Press Releases",0,0.5059312
2012-04-19,5628500.0,109.20999908447266,109.7699966430664,106.37000274658205,107.36000061035156,78.30435943603516,CAT,"The Zacks Analyst Blog Highlights: IBM, Eaton, Caterpillar, BP Plc and ExxonMobil - Press Releases ||| CAT Receives Approval for ERA Buy - Analyst Blog ||| America's oil and gas boom is a big plus for manufacturing",1,0.5122623
2012-04-20,4014600.0,107.7699966430664,108.62000274658205,107.61000061035156,107.7300033569336,78.57422637939453,CAT,"Allstate Pegs 1Q CAT Loss at $260M - Analyst Blog ||| A Look Ahead: Next Week's ETFs to Watch (IYW, XLE, UGA)",0,0.49801955
2012-04-23,5462600.0,106.33000183105467,107.04000091552734,105.12000274658205,106.9000015258789,77.96881866455078,CAT,"Earnings Expectations for the Week of April 23 (AAPL, XOM, UPS)",1,0.49123582
2012-04-24,5703200.0,107.25,108.79000091552734,107.0999984741211,108.4000015258789,79.06289672851562,CAT,Caterpillar Earnings To Offer Latest Clues On China - IBD,0,0.48223466
2012-04-25,15948300.0,106.8499984741211,107.11000061035156,102.3000030517578,103.44000244140624,75.44525146484375,CAT,"Astec Falls Short of Estimates - Analyst Blog ||| Ahead of Wall Street - April 25, 2012 - Ahead of Wall Street ||| Durable Goods Down, Earnings Up - Analyst Blog ||| Market Wrap-Up for Apr.25 (AAPL, CAT, LO, BA, HOG, TUP, more) ||| Closing Update: Stocks End Higher as Fed Comments Suggest U.S. Economy Continues to Mend ||| Caterpillar Profits Soar, Boosts View - Analyst Blog ||| Caterpillar Down 5% After Q1 Earnings ||| Caterpillar Says Inventory Increase is a Function of Future Sales; Europe Did Well Despite Problems ||| Caterpillar Sees Demand for Creation of Nat Gas Products ||| UPDATE: Caterpillar Says It Will Divert Some Excavators from China to Other Countries; Seeing Improvement IN Brazil; Says China Sales Down $250-300M in Q1 from Prior Year; Global Mining Demand Remains Robust ||| Caterpillar in Earnings Call: Intends to be Leader in China, China is Major Long-Term Growth Opportunity, but Too Much Inventory in China Industry-Wide ||| Morning Social Media Outlook for Wednesday April 25 (GEOI, NOC, WAT, T) ||| Caterpillar Down 1.4% Pre-Market on Lower Than Expected Q1 Revenues ||| Durable Goods Orders Signal a Struggling Industrial Sector; Inventories at Record High ||| Caterpillar Falls 1% Pre-Market on Earnings Beat, Revenue Miss ||| Caterpillar Reports Q1 EPS $2.37 vs $2.13 Est; Revenues $15.98B vs $16.22B Est ||| US Stock Futures Up After Upbeat Apple Results ||| Earnings Scheduled For April 25 ||| Stocks To Watch For April 25",1,0.47530386
2012-04-26,7317200.0,103.97000122070312,104.5500030517578,103.0,104.38999938964844,76.13813781738281,CAT,"Company News for April 26, 2012 - Corporate Summary ||| The Zacks Analyst Blog Highlights: Apple, Boeing, Eli Lilly, Caterpillar and Sprint - Press Releases ||| Terex Ahead of Estimates - Analyst Blog ||| 3 Top Heavy Machinery Plays - Investment Ideas ||| Morning Social Media Outlook for Thursday April 26 (ACOM, ONXX, UPS, HRB)",1,0.47761425
2012-04-30,5325600.0,103.98999786376952,104.12000274658205,102.5500030517578,102.7699966430664,74.95655822753906,CAT,"Largest option buying in equities so far ||| Dow Emerges from April Unscathed; SPX, COMP Not So Lucky ||| Caterpillar Inc. - Aggressive Growth ||| Dallas Fed Manufacturing Index Surprises to the Downside ||| Chicago PMI Worse than Expected, but Still Expanding",0,0.48690978
2012-05-01,5732800.0,102.80999755859376,103.5,101.73999786376952,102.11000061035156,74.4751968383789,CAT,"Cummins Beats, EPS Up 36% - Analyst Blog ||| Construction Spending Signals Weakening Construction Sector ||| ISM Manufacturing Better than Expected, Markets Rejoice",1,0.49891454
2012-05-02,5620200.0,101.58000183105467,102.72000122070312,100.6500015258789,102.62999725341795,74.85446166992188,CAT,Factory Orders Fall Less than Expected,0,0.51453197
2012-05-03,6102000.0,102.9000015258789,103.37999725341795,100.5,100.66999816894533,73.42491149902344,CAT,"Low CAT Loss Aids RenaissanceRe's 1Q - Analyst Blog ||| Stock Market News for May 3, 2012 - Market News",0,0.5168389
2012-05-07,7245700.0,97.66999816894533,98.1999969482422,97.02999877929688,97.19000244140624,70.88672637939453,CAT,Barron's Recap (5/5/12): The Barron's 500,0,0.50296587
2012-05-09,7733500.0,94.83999633789062,97.3000030517578,94.08000183105467,95.98999786376952,70.01152038574219,CAT,Cummins Buys SCR Doser Technology - Analyst Blog,0,0.5275191
2012-05-10,4982000.0,97.1500015258789,97.38999938964844,95.18000030517578,95.44000244140624,69.61034393310547,CAT,Caterpillar to Sell Majority Interest in Third Party Logistics Business to Platinum Equity for $750M,1,0.5096493
2012-05-14,5213300.0,94.33000183105467,94.7699966430664,93.4499969482422,93.5999984741211,68.26832580566406,CAT,"Market Wrap-Up for May 14 (JPM, AVP, MS, CAT, C, TIF, more) ||| Caterpillar Kept at Neutral - Analyst Blog",0,0.49150974
2012-05-15,5304800.0,93.8499984741211,94.66000366210938,92.29000091552734,92.68000030517578,67.59732818603516,CAT,Earnings Preview: Deere - Analyst Blog ||| Empire State Manufacturing Index Signals a Strengthening Industrial Sector,0,0.51479334
2012-05-16,5803400.0,93.43000030517578,94.08000183105467,91.70999908447266,91.86000061035156,66.99922180175781,CAT,"Deere Beats, Ups Guidance - Analyst Blog",0,0.50534606
2012-05-17,12695100.0,91.0199966430664,91.63999938964844,87.5999984741211,87.80000305175781,64.03801727294922,CAT,"Dow Dives 156 Points on Domestic Data, Overseas Woes; Facebook on Deck ||| GE Expands Its Mining Presence - Analyst Blog",1,0.5220538
2012-05-18,8655900.0,88.26000213623047,89.80999755859375,88.0199966430664,88.68000030517578,64.67986297607422,CAT,Allstate's April CAT Loss Falls YoY - Analyst Blog,1,0.5221736
2012-05-21,6811300.0,89.52999877929688,92.3000030517578,89.31999969482422,91.9800033569336,67.08673858642578,CAT,"4 Shelter From The Storm ETFs (BKLN, ENGN, FUI) ||| Dow Evades Seventh Down Day With 135-Point Rally; G8 Wants Greece to Stay ||| Market Wrap-Up for May 21 (FB, LOW, CPB, BA, CAT, HON, more) ||| 4 Shelter From The Storm ETFs (BKLN, ENGN, FCQ) ||| Caterpillar Will Sell Container Generators in Japan -Nikkei",0,0.49863487
2012-05-22,7210500.0,92.76000213623048,92.9800033569336,90.88999938964844,91.48999786376952,66.72936248779297,CAT,"Stock Market News for May 22, 2012 - Market News",1,0.5066602
2012-05-24,6421600.0,92.9499969482422,92.95999908447266,90.16999816894533,91.41999816894533,66.67831420898438,CAT,Caterpillar Awarded Defense Contract at Max Value of $776M ||| Durable Goods Orders Signal a Struggling Industrial Sector,0,0.4947747
2012-05-25,4637400.0,91.38999938964844,91.66999816894533,89.62999725341797,89.94000244140625,65.59883880615234,CAT,Deere Poised at Neutral - Analyst Blog,1,0.5270612
2012-05-29,8238800.0,91.1999969482422,93.93000030517578,90.88999938964844,92.5199966430664,67.4805908203125,CAT,"ETF Trading Report: Greek, Spain ETFs In Focus - ETF News And Commentary ||| Market Wrap-Up for May 29 (COP, MTN, DIS, CAT, BHP, more) ||| Apple, Baidu, Other China Plays Rise on Stimulus Buzz - IBD ||| China Spending Boosts CAT, Other Equipment Firms - IBD ||| Dallas Fed Manufacturing Index Surprises to the Downside",0,0.48457807
2012-05-30,6350800.0,90.98999786376952,91.0,89.5,90.18000030517578,65.77387237548828,CAT,UPDATE: Caterpillar Will Prepare to Take Contingency Plan to Next Level -Bloomberg ||| Caterpillar Says Joliet Workers Rejected Modified Accord ||| Caterpillar to Sell Part of Bucyrus Distribution Business to Cat Dealer Barloworld for $115M,0,0.5016001
2012-05-31,12370400.0,88.41999816894531,88.5,86.01000213623047,87.62000274658203,63.906734466552734,CAT,"CAT Sells Bucyrus' South African Biz - Analyst Blog ||| Joy Global Beats, Outlook Guarded - Analyst Blog ||| Dow Snaps Seven-Month Winning Streak With Worst Month in Two Years ||| Treasury Yields Touch New Lows; Stocks Down Six Percent in May ||| Mining Machinery Stocks VS Joy Global Warning - IBD",0,0.50229275
2012-06-01,9572500.0,85.08000183105469,86.80000305175781,84.72000122070312,85.5199966430664,62.37507629394531,CAT,Caterpillar Wins Federal Contract - Analyst Blog,0,0.51962304
2012-06-05,9212900.0,83.0199966430664,84.80000305175781,83.0199966430664,83.6500015258789,61.01115798950195,CAT,"Westport Innovations Trading Up 21% After Caterpillar Deal ||| Clean Energy Fuels Spikes Amid CAT & WPRT Nat Gas Vehicle Deal ||| Westport Innovations Rises 10% Pre-Market on Announcement of Natural Gas Technology Deal with Caterpillar ||| Caterpillar Cocoons Westport Innovations in New Agreement ||| Financial Breakfast: Morning News Summary for June 5, 2012 ||| Westport and Caterpillar Announce Agreement to Develop Natural Gas Technology for Off-Road Equipment",1,0.4942679
2012-06-06,8464000.0,84.72000122070312,86.66000366210938,84.5199966430664,86.66000366210938,63.206539154052734,CAT,"Deere Fortifies Production Capacity - Analyst Blog ||| Caterpillar Says Seeing Slowing Demand from Coal Industry, US Coal Only Area It Sees Slowdown -Bloomberg",1,0.5092997
2012-06-07,7773300.0,88.81999969482422,89.87000274658203,86.91999816894531,87.13999938964844,63.55663299560547,CAT,Machinery Stock Outlook - June 2012 - Industry Outlook ||| Machinery Stock Outlook - June 2012 - Zacks Analyst Interviews ||| These 13 Stocks Are a Major Bargain,1,0.49811357
2012-06-13,8308300.0,86.25,87.0,84.68000030517578,85.29000091552734,62.20734786987305,CAT,UPDATE: Caterpillar Announces 13 Percent Increase in Dividend Rate ||| Caterpillar Raises Quarterly Dividend 13%,1,0.49930406
2012-06-14,6124300.0,85.30999755859375,86.25,84.5,85.88999938964844,62.64494323730469,CAT,"Terex Intros New Division - Analyst Blog ||| Solid Dividend Raises for Three Major Brands (TGT, UTX, CAT)",1,0.52061397
2012-06-15,6571800.0,86.4000015258789,86.94999694824219,85.69000244140625,86.93000030517578,63.40349578857422,CAT,"CAT, Westport Work on New Know-How - Analyst Blog",0,0.51864827
2012-06-18,4722600.0,86.3499984741211,87.08999633789062,85.66999816894531,86.73999786376953,63.26487350463867,CAT,"The Best Stocks With Dividend Growth From Last Week (June 11 - June 17, 2012) ||| Caterpillar Hikes Dividend - Analyst Blog",1,0.48643255
2012-06-19,6254700.0,87.56999969482422,89.79000091552734,87.19999694824219,88.83999633789062,64.79655456542969,CAT,AIZ Outlines 2012 CAT Program - Analyst Blog,0,0.51828563
2012-06-20,9413700.0,88.13999938964844,88.72000122070312,86.5,87.16999816894531,63.57851791381836,CAT,"Caterpillar May Retail Sales of Machines for World Up 11%, May Total Power Systems Retail Statistics Up 2% ||| Caterpillar Chairman Urges Congress to Establish Permanent Normal Trade Relations with Russia; Action Would Increase Exports and Support Jobs in the United States",0,0.49388063
2012-06-21,8578400.0,87.08999633789062,87.44999694824219,84.83999633789062,84.9800033569336,61.981201171875,CAT,Philadelphia Fed Manufacturing Index Misses Big ||| Caterpillar in Market With $1.5B Bond Deal,0,0.49739152
2012-06-22,6408200.0,85.5,86.05000305175781,84.8499984741211,84.95999908447266,61.96661376953125,CAT,Stocks End Week of Woes on Upnote: Is a Bottom in Sight?,0,0.4892328
2012-06-25,7390700.0,83.94999694824219,83.9800033569336,82.12000274658203,82.88999938964844,60.45685577392578,CAT,Barron's Recap: The World's Most Respected Companies,0,0.49540418
2012-06-29,7053400.0,84.31999969482422,84.94000244140625,83.80999755859375,84.91000366210938,61.93016052246094,CAT,"European Debt Crisis: Why It Could Clobber Your Portfolio ||| House Approves $120 Billion Highway Bill Extending Transportation Funding Through Fiscal 2014 ||| Chicago PMI Beats Expectations, Suggests Strong Industrial Sector",0,0.4909852
2012-07-02,6420600.0,85.3499984741211,85.4800033569336,83.04000091552734,83.68000030517578,61.03304672241211,CAT,"ISM Manufacturing Shows Contraction, Lowest Since 2009",1,0.5418149
2012-07-03,4357800.0,83.9000015258789,86.69999694824219,83.87999725341797,86.45999908447266,63.06068801879883,CAT,CAT in Neutral Lane - Analyst Blog ||| Bulls Claim Victory in Shortened Session; Dow Jumps 72 Points,1,0.5121201
2012-07-06,6952000.0,85.25,85.25,83.83000183105469,84.61000061035156,61.71135711669922,CAT,"Market Wrap-Up for July 6 (CAT, CMI, POT, STX, more) ||| Wells Fargo Removes Caterpillar From Priority Stock List",0,0.48393044
2012-07-09,6291200.0,83.94000244140625,84.3499984741211,82.95999908447266,83.13999938964844,60.63917922973633,CAT,Earnings Preview: Wolverine World Wide ||| Earnings Preview: Wolverine World Wide ||| 5 Industrial Goods Stocks With The Highest Revenue,0,0.5179862
2012-07-10,15154700.0,83.55999755859375,84.30000305175781,79.12000274658203,80.2699966430664,58.54590606689453,CAT,"Market Wrap-Up for July 10 (INTC, CMI, CAT, AMAT, MJN, more) ||| Caterpillar Spokesperson, Responding to Cummins Guidance, Says 'Caterpillar is Currently in the Quiet Period Leading Up to the 2nd Quarter 2012 Release' ||| Option Alert: Heavy Put Buying Caterpillar Following Cummins Lowered Guidance ||| DE, CAT Move Lower as CMI Lowers Rev Outlook",0,0.4720361
2012-07-11,8184100.0,80.5199966430664,80.73999786376953,79.25,79.73999786376953,58.15935134887695,CAT,"Stock Market News for July 11, 2012 - Market News ||| JP Morgan Maintains Caterpillar at Overweight, Lowers PT from $132 to $109",0,0.4755585
2012-07-12,8743600.0,78.9800033569336,80.33000183105469,78.25,79.63999938964844,58.08642578125,CAT,Will Carlisle See Breakout Year On Industrials?,1,0.5259198
2012-07-13,7619500.0,79.94999694824219,82.13999938964844,79.55000305175781,82.06999969482422,59.858768463134766,CAT,"What's Holding Apple Up? - Real Time Insight ||| Caterpillar’s Target, Estimates Lowered at Credit Suisse; Channel Checks Indicate Slower Growth (CAT) ||| UPDATE: Credit Suisse Reduces PT to $120 on Caterpillar on Near-Term Growth Outlook ||| Credit Suisse Maintains Caterpillar at Outperform, Lowers PT from $138 to $120",0,0.49102375
2012-07-16,4989800.0,81.8499984741211,81.8499984741211,80.19999694824219,81.1500015258789,59.18775939941406,CAT,Shares of Woodward Drop on Guidance Cut ||| Woodward Signs Long-Term Agreement With Caterpillar,1,0.5191109
2012-07-17,6462700.0,81.88999938964844,82.29000091552734,79.94999694824219,81.91000366210938,59.74208068847656,CAT,"Hartford Expects Lower 2Q CAT Loss - Analyst Blog ||| Bank of America Downgrades J.B. Hunt to Neutral; JP Morgan Lowers Price Target ||| Caterpillar CEO Douglas Oberhelman Says Looking To Natural Gas, Increased Competition From Companies In China",1,0.52872425
2012-07-18,7457800.0,80.52999877929688,83.3499984741211,80.08999633789062,82.5199966430664,60.5715217590332,CAT,"Caterpillar Downgraded to “Hold” at Jefferies on Foreign Market Weakness (CAT) ||| GE, Chevron and Other Companies Doing Business in Myanmar ||| Chinese Home Prices Show Signs of Bottom ||| Longbow Downgrades Caterpillar from Buy to Neutral ||| Benzinga's Top Downgrades ||| Jefferies & Company Downgrades Caterpillar from Buy to Hold, Lowers PT from $130 to $85",1,0.49807414
2012-07-19,5616100.0,82.95999908447266,83.4000015258789,82.05000305175781,82.62999725341797,60.65227127075195,CAT,Philadelphia Fed Manufacturing Index Misses Big,0,0.49467543
2012-07-20,5897000.0,81.93000030517578,82.56999969482422,80.66000366210938,80.94999694824219,59.41909790039063,CAT,Allstate Expects Lower 2Q CAT Loss - Analyst Blog,1,0.51891214
2012-07-23,7567700.0,79.66000366210938,82.5999984741211,78.79000091552734,81.58000183105469,59.88153076171875,CAT,"European Anxieties Persist - Analyst Blog ||| Ahead of Wall Street - July 23, 2012 - Ahead of Wall Street ||| Ahead of Wall Street - July 23, 2012 - Ahead of Wall Street ||| ETFs for This Week's Marquee Earnings Reports (IYW, XLI) ||| Caterpillar to Sell Part of Bucyrus Distribution Business to Cat Dealer Hewitt Equipment Limited and Atlantic Tractors & Equipment Ltd. ||| Caterpillar Remains in Dead-Lock with Workers ||| Earnings Expectations for the Week of July 23",0,0.49000767
2012-07-24,8780500.0,82.75,83.30000305175781,80.2699966430664,81.43000030517578,59.77145004272461,CAT,"Q2 Preview: Macro Weakness Will Weigh on Cat (CAT), But How Much is Priced Into the Stock? ||| These 2 Stocks Will Likely Benefit from our Nation's Drought",1,0.51432943
2012-07-25,19877300.0,85.12999725341797,85.44999694824219,80.29000091552734,82.5999984741211,60.63023376464844,CAT,"CAT & Others Offset Apple Miss - Analyst Blog ||| Ahead of Wall Street - July 25, 2012 - Ahead of Wall Street ||| Caterpillar’s Q2 Earnings Surge 67%, Beating View; Forecast Boosted (CAT) ||| Caterpillar Reports Stellar Quarter - Analyst Blog ||| 4 Leveraged ETFs Poised to Deliver Big Gains (TYD, SJI) ||| Social Media Outlook for Wednesday July 25 (RVBD, REGN, IGT, NFLX) ||| Caterpillar Gives Up Gains After Earnings ||| Caterpillar Comments on Conference Call ||| Caterpillar Sees Price Increases at About 2% This Year ||| UPDATE: Caterpillar Says 2 More Quarters are Needed to Get Chinese Inventory Down ||| Wednesday Market Movers ||| Caterpillar's CEO on CNBC Says Very Bullish for Long-Term ||| UPDATE: Caterpillar Says Lowering Production Levels in China ||| UPDATE: Caterpillar Sees ECB Taking More Action This Year; Sees Other LATAM Countries Besides Brazil Keeping Low Interest Rate ||| UPDATE: Caterpillar Says US Recession is Unlikely in 2012 ||| UPDATE: Caterpillar Says More Interest Rate Cuts are Likely ||| Caterpillar Says Cautiously Optimistic for 2013 World Economy ||| Caterpillar Raises 2012 Profit Outlook ||| Caterpillar Reports Q2 EPS $2.54 vs $2.28 Est; Revenues $17.37B vs $17.11B Est ||| US Stock Futures Mixed; Apple Shares Drop In Pre-Market Trading ||| Earnings Scheduled For July 25 ||| Stocks To Watch For July 25",1,0.51845294
2012-07-26,10138200.0,83.83999633789062,84.6500015258789,82.0999984741211,83.30000305175781,61.14408493041992,CAT,"Look For Equities To Rally Into Next Week ||| Barclays Maintains Caterpillar at Overweight, Lowers PT from $127 to $124 ||| Social Media Outlook for Thursday July 26 (WFM, AKAM, DOW, FB) ||| Benzinga's Top Downgrades",1,0.50182074
2012-07-27,11229000.0,83.18000030517578,86.5999984741211,82.02999877929688,86.16000366210938,63.24336624145508,CAT,"Astec Falls Short of Estimates - Analyst Blog ||| Not All Industrial ETFs Created Equal, S&P Says ||| BMO Capital Markets Initiates Coverage on Caterpillar at Market Perform, Announces PT of $92",0,0.49981704
2012-07-30,6504600.0,86.62000274658203,86.97000122070312,85.0,85.69000244140625,62.898380279541016,CAT,"Terex Results Improve in 2Q - Analyst Blog ||| Stock Market News for July 30, 2012 - Market News ||| Buyers Beware: Dividend Stocks Becoming a Crowded Trade",0,0.50194126
2012-07-31,9192500.0,85.7699966430664,86.36000061035156,84.13999938964844,84.20999908447266,61.81201553344727,CAT,"Cummins Beats EPS, Misses Sales - Analyst Blog",0,0.51894295
2012-08-01,9366200.0,85.0,85.06999969482422,82.5,82.6500015258789,60.66692733764648,CAT,Knight Capital Glitch May Have Impacted Some ETFs ||| Caterpillar Completes Sale of Third Party Logistics Business to Platinum Equity,1,0.5091363
2012-08-02,8097300.0,82.45999908447266,84.30000305175781,82.0999984741211,83.12000274658203,61.0119514465332,CAT,Wall Street Sells on the News; Dow Drops 92 Points,1,0.50902545
2012-08-07,6049800.0,87.0,88.31999969482422,86.75,87.22000122070312,64.02142333984375,CAT,"Stock Market News for August 7, 2012 - Market News",0,0.5099433
2012-08-08,6139600.0,86.48999786376953,87.87999725341797,86.3499984741211,87.22000122070312,64.02142333984375,CAT,"Dow, SPX Snag Fourth Straight Win ... But Just Barely ||| UPDATE: Caterpillar Says It Has Seen Some Customer Caution; US Customer Not Yet at Normal Replacement Level ||| UPDATE: Caterpillar Says Expecting Chinese Growth to be Better in 2013 than 2012; Thinks US Uncertainty Will be Resolved in Next 6 Months ||| Caterpillar at Jefferies Conference Says It Has Too Much Inventory; Says Building Inventory for China Before Selling Season; Will Work Down China Inventory Over the Rest of the Year",1,0.4960468
2012-08-09,6700600.0,87.41000366210938,88.79000091552734,87.25,88.4000015258789,64.8875732421875,CAT,Caterpillar to Export Chinese Goods ||| Caterpillar to Export Chinese Goods,1,0.49813673
2012-08-13,5403400.0,88.83999633789062,89.2699966430664,87.5999984741211,88.61000061035156,65.04170989990234,CAT,"Deere Earnings Preview: Double-Digit Sales, EPS Growth Expected",0,0.53726006
2012-08-14,5485600.0,89.48999786376953,89.6500015258789,87.76000213623047,87.87000274658203,64.4985580444336,CAT,Neutral on Caterpillar - Analyst Blog,0,0.51134753
2012-08-15,6345200.0,87.25,87.7300033569336,86.16000366210938,87.61000061035156,64.30767059326172,CAT,"Deere Shares Punished on Earnings Miss ||| Caterpillar Reaches Agreement with IAM ||| Caterpillar Says It Will Help Chevron, Transocean with Legal Defense -Bloomberg ||| Deere Shares Punished on Earnings Miss",1,0.49457
2012-08-17,7848500.0,89.86000061035156,90.0999984741211,89.0999984741211,90.01000213623047,66.0693588256836,CAT,"Caterpillar in Filing Says Global Machine Sales Up 14%, Rolling Power Sales Up 4%",1,0.49914354
2012-08-22,8843500.0,90.04000091552734,90.27999877929688,87.62999725341797,88.72000122070312,65.1224594116211,CAT,"Market Wrap-Up for Aug.22 (DELL, WSM, ADI, AEO, CAT, more)",0,0.4902285
2012-08-23,5469400.0,88.63999938964844,88.72000122070312,87.13999938964844,87.62999725341797,64.32234954833984,CAT,Catapillar Says Japanese Production Relocating to Texas Plant; Will Create 800 Jobs; Will Also Export Equipment ||| Benzinga's Top Initiations,0,0.5016005
2012-08-27,4273400.0,87.6500015258789,88.0,86.54000091552734,86.62999725341797,63.58834457397461,CAT,Caterpillar Announces Final Results of Exchange Offers,0,0.50826
2012-08-29,8731900.0,85.58000183105469,86.33000183105469,84.44999694824219,86.08999633789062,63.19198226928711,CAT,Latin American Markets Mixed; Brazil Stocks Slump Ahead of Expected Rate Cut Today ||| Caterpillar Feels The Pinch Of High Interest Rates In China,0,0.51458675
2012-08-30,5170100.0,85.55999755859375,85.81999969482422,84.45999908447266,84.47000122070312,62.00285720825195,CAT,"Terex to Redeem $300M Notes - Analyst Blog ||| Joy Global Lags, Lowers Guidance - Analyst Blog ||| Dow, SPX Test Round-Number Levels In Decidedly Down Day ||| What Caterpillar, Joy Global Are Saying About Risk-On",1,0.4926189
2012-08-31,5481300.0,85.18000030517578,85.94000244140625,84.25,85.33000183105469,62.63409805297852,CAT,Why We Added Baker Hughes And Caterpillar To The Portfolio,0,0.4789335
2012-09-04,11287600.0,85.02999877929688,85.12999725341797,82.20999908447266,82.66000366210938,60.67429733276367,CAT,"Dow Swings 115 on ISM Data, Euro-Zone Stimulus",1,0.5221436
2012-09-05,6234700.0,82.5999984741211,83.08000183105469,81.77999877929688,82.75,60.74034118652344,CAT,Set Long Positions Now Ahead Of ECB And FOMC Actions ||| Bell Tolls For Bellwether FedEx,1,0.5130983
2012-09-06,6982600.0,83.55000305175781,84.93000030517578,83.3499984741211,84.79000091552734,62.23774337768555,CAT,"Honeywell Still a “Buy” at Jefferies; New Turbocharger Sales to Caterpillar Could Prove Lucrative (HON, CAT)",1,0.50612116
2012-09-07,10698000.0,87.26000213623047,88.44000244140625,86.75,88.0999984741211,64.6673583984375,CAT,Materials Gain on Chinese Stimulus Plan ||| Chinese Infrastructure Investment Rallies Materials Names ||| Mining and Industrial Names Trading Higher After China Plans Infrastructure Stimulus Program,0,0.5286529
2012-09-10,5591600.0,87.94000244140625,88.62999725341797,87.08000183105469,87.0999984741211,63.933326721191406,CAT,More Golden Cross ETFs ||| More Golden Cross ETFs,1,0.51773506
2012-09-13,7836600.0,88.62999725341797,90.97000122070312,88.30000305175781,90.68000030517578,66.5611343383789,CAT,"Caterpillar Says Will Cut 760 Jobs in North Ireland, Move 70% of Output to China -Bloomberg",1,0.50269854
2012-09-14,11375700.0,92.20999908447266,94.27999877929688,91.9800033569336,93.16999816894533,68.38882446289062,CAT,"Wall Street Continues to Climb on the Fed's Stimulus Promise ||| Caterpillar at Morgan Stanley Presentation Doesn't See Margin Performance Changing Ahead, Housing Starts Still Poor, US Construction Fairly Depressed",0,0.5038538
2012-09-17,7996500.0,92.94000244140624,93.5,91.7300033569336,91.98999786376952,67.52272033691406,CAT,Caterpillar Enters Credit Pact for Up to $3B,1,0.514307
2012-09-18,6596500.0,91.7699966430664,93.06999969482422,91.7699966430664,93.06999969482422,68.31542205810547,CAT,Four Stocks Ready to Ride China’s $157 Billion Stimulus ||| Tenneco Stays at Neutral - Analyst Blog,1,0.4954253
2012-09-19,6785200.0,93.3000030517578,94.2300033569336,92.80999755859376,93.94000244140624,68.95404052734375,CAT,"Top Performing Japanese Stocks on the NYSE (NMR, MFG, KUB) ||| Top Performing Japanese Stocks on the NYSE (NMR, MFG, KUB)",0,0.49103725
2012-09-21,10786300.0,93.41999816894533,93.41999816894533,91.37000274658205,91.72000122070312,67.32452392578125,CAT,"Caterpillar Says August 3-Month Rolling Retail Sales of Machines Up 15%, Latam Machines Dealer Stats Down 5%, Rolling Power System Retail Stats Up 3%",0,0.49063694
2012-09-24,8604700.0,90.4499969482422,91.77999877929688,90.4499969482422,90.87000274658205,66.70061492919922,CAT,"CAT CEO Sees Stock Repurchase Program in Company's Future -Bloomberg ||| UPDATE: Caterpillar Says Expecting Record FY12 Revenue and Profit ||| UPDATE: Caterpillar Says Future Energy Will be from Coal ||| UPDATE: Caterpillar Says Will be Market Share Leader in China by 2015 ||| If Not GE, Then Who Buys Joy Global? ||| UPDATE: Caterpillar Says Will Maintain Dividend in Recession ||| UPDATE: Caterpillar Says It Will Remain Attractively Profitable, Maintain Dividend ||| UPDATE: Caterpillar Says Updated FY15 Guidance Based on Revenue of $80-100B ||| UPDATE: Caterpillar Says Seeing Modest Economic Growth but Recession is Possible ||| Caterpillar Cuts 2015 EPS Forecast to $12-$18; Had Seen $15-$20 -Reuters",0,0.51092386
2012-09-25,13936300.0,88.66000366210938,89.55000305175781,87.0,87.01000213623047,63.86729049682617,CAT,"Bulls Evacuate Wall Street on QE3 Comments ||| Tentative Market to Continue? - Analyst Blog ||| Stock Market News for September 25, 2012 - Market News ||| Market Wrap-Up for Sept.25 (AAPL, CAT, MTN, PAYX, EMR, more) ||| Ahead of Wall Street - September 25, 2012 - Ahead of Wall Street ||| Why Steel Stocks And ETFs Will Stay Weak In 2012 ||| Economic Woes Hurt CAT's 2015 View - Analyst Blog ||| Coal Price Decline Pressures Caterpillar ||| ISI Group Maintains Caterpillar at Hold, Lowers PT from $89 to $87 ||| Benzinga Market Primer, Tuesday September 25 ||| US Stock Futures Flat Ahead Of Economic Data ||| Stocks To Watch For September 25, 2012",0,0.4796876
2012-09-27,7585300.0,87.83999633789062,87.94999694824219,86.75,86.91999816894531,63.80122375488281,CAT,"Machinery Stock Outlook - Sept. 2012 - Industry Outlook ||| Machinery Stock Outlook - Sept. 2012 - Industry Outlook ||| Machinery Stock Outlook - Sept. 2012 - Zacks Analyst Interviews ||| These 3 Small Mining Stocks Could be GE's Next Takeover Target ||| Bank of America Reinstates Coverage on Caterpillar at Neutral, Announces PO of $95",0,0.48186105
2012-09-28,7519300.0,86.36000061035156,86.58999633789062,85.43000030517578,86.04000091552734,63.1552619934082,CAT,Citigroup Trims Caterpillar Estimates on Growth Concerns (CAT) ||| Cummins Mining Solutions at MINExpo - Analyst Blog,0,0.51306176
2012-10-01,7385000.0,86.72000122070312,87.1500015258789,85.23999786376953,85.47000122070312,62.73687744140625,CAT,Caterpillar Announces Price Hike - Analyst Blog ||| An All-Nashville ETF? Maybe,0,0.484802
2012-10-02,8819000.0,85.62999725341797,85.93000030517578,84.3499984741211,85.47000122070312,62.73687744140625,CAT,Caterpillar to Shut Decatur Plant - Analyst Blog,0,0.50479513
2012-10-03,5584500.0,85.51000213623047,85.63999938964844,84.55000305175781,85.27999877929688,62.59742736816406,CAT,We're Bullish on Industrial and Energy Stocks,1,0.501673
2012-10-05,6547700.0,86.8499984741211,87.33999633789062,85.01000213623047,85.43000030517578,62.7075424194336,CAT,Earnings Season: The Missing Piece of the Puzzle,1,0.510724
2012-10-08,4532600.0,84.94000244140625,85.80999755859375,84.43000030517578,85.44000244140625,62.71487808227539,CAT,"Piper Jaffray Initiates Coverage on Caterpillar at Neutral, Announces PT of $90 ||| Caterpillar Says Maintaining Dividend Rate",0,0.5022804
2012-10-09,5810600.0,85.72000122070312,86.1500015258789,84.5,84.75,62.20838165283203,CAT,"Stock Market News for October 9, 2012 - Market News ||| Stock Market Trends: Wall Street is Getting Shaky ||| UPDATE: Piper Jaffray Initiates Caterpillar at Neutral on Mining Overhang ||| Benzinga's Top Initiations",0,0.5039011
2012-10-10,10634900.0,83.88999938964844,84.37000274658203,82.5999984741211,83.16000366210938,61.04127883911133,CAT,"Piper Jaffray Starts Coverage on Caterpillar as a “Neutral”; Mining Segment, China Weakness are Concerns (CAT) ||| Will Bad Earnings Sink the Market?",0,0.49555618
2012-10-11,7643800.0,83.38999938964844,83.69999694824219,82.25,82.8499984741211,60.81372833251953,CAT,"Stock Market News for October 11, 2012 - Market News ||| Use an Industrial ETF for Exposure to Resurgent Real Estate Market ||| 5 Big-Name Stocks Going Ex-Dividend Next Week ||| UPDATE: Caterpillar Names Halverson CFO ||| Caterpillar Presidents Lavin and Vittecoq Will Retire ||| RBC Downgrades Caterpillar from Outperform to Sector Perform ||| Benzinga's Top Downgrades ||| A Peek Into The Market Before The Trading Starts ||| Use an Industrial ETF for Exposure to Resurgent Real Estate Market",0,0.4830337
2012-10-15,6357300.0,82.91000366210938,83.19999694824219,82.0999984741211,82.80999755859375,60.78440475463867,CAT,"Guru Stocks at 52-Week Lows: INTC, DCM, CAT, NSANY, FTE",1,0.5010896
2012-10-16,6943000.0,83.58999633789062,85.04000091552734,83.20999908447266,84.95999908447266,62.36252212524414,CAT,Fitch Lifts Cummins Ratings - Analyst Blog,1,0.530026
2012-10-17,7339000.0,85.62000274658203,86.7699966430664,85.20999908447266,86.62999725341797,63.58834457397461,CAT,How China's Economy Could Spell Trouble for America,0,0.5242906
2012-10-18,6813600.0,86.37999725341797,87.52999877929688,85.83000183105469,86.62000274658203,63.9649658203125,CAT,"Cyclical and Turnaround Stocks: There Is a Lot of Value in This Market (Part 5) ||| Barclays Maintains Caterpillar at Overweight, Lowers PT from $116 to $114",0,0.4779779
2012-10-19,9874300.0,85.33000183105469,85.4800033569336,83.48999786376953,83.86000061035156,61.926795959472656,CAT,"Cyclical and Turnaround Stocks: There Is A Lot Of Value In This Market: Part 5 ||| Market Wrap-Up for Oct.19 ||| Caterpillar September Retail Sales Up 6% for World ||| Benzinga Market Primer, Friday October 19",1,0.4868496
2012-10-22,17158300.0,82.94000244140625,86.04000091552734,82.29000091552734,85.08000183105469,62.82773971557617,CAT,"Ahead of Wall Street - October 22, 2012 - Ahead of Wall Street ||| Record EPS for CAT in 3Q, Revs Lag - Analyst Blog ||| Caterpillar (CAT) Kicks off Busy Earnings Week ||| Benzinga Mid-Morning Market Update ||| October 22: Caterpillar Issues Warning on China - Economic Highlights ||| Dow Digs Out of Triple-Digit Hole to Peek Above Breakeven ||| Gold Prices Get Support At 50-Day Avg, Stocks Weaken ||| Benzinga Mid-Afternoon Market Update ||| Canadian Stocks Lower On M&A Blocks ||| Market Wrap-Up for Oct.22 (BTU, AAPL, CAT, VFC, AAP, more) ||| Benzinga Mid-Afternoon Market Update ||| Benzinga Mid-Day Market Update ||| UPDATE: Caterpillar Says US Construction Equipment Sales Bright Spot ||| Caterpillar Begins Q3 Earnings Call ||| Benzinga Mid-Morning Market Update ||| UPDATE: Caterpillar Q3 EPS Ex-Gain $2.27, Estimate $2.23 ||| UPDATE: Caterpillar Posts 49% Rise In Q3 Profit, Lowers 2012 Forecast ||| Earnings Expectations for the Week of October 22 ||| A Look Ahead: This Week's ETFs to Watch ||| Caterpillar CEO Currently Speaking on CNBC ||| UPDATE: Caterpillar Says Some Countries Might Pull Out of Eurozone ||| UPDATE: Caterpillar Guides Chinese GDP Growth 8.5% with Added Easing; Eurozone Most Significant Risk to 2013 Outlook ||| UPDATE: Caterpillar Says Not Predicting Recession in 2013; Modest Improvements in US and China, Continued Difficulty in Europe ||| Caterpillar Guides FY12 EPS $9-9.25, Had Seen $9.60 vs $9.42 Est ||| UPDATE: Caterpillar Reports Q3 EPS $2.54 vs $2.23 Est; Revenues $16.45B vs $16.79B Est ||| A Peek Into The Market Before The Trading Starts ||| Benzinga Market Primer for Monday October 22 ||| US Stock Futures Up Ahead of Hasbro, Caterpillar Earnings ||| Earnings Scheduled For October 22, 2012 ||| Stocks To Watch For October 22, 2012",0,0.47606337
2012-10-23,7496100.0,83.9000015258789,84.13999938964844,82.9800033569336,83.58000183105469,61.72005081176758,CAT,"Credit Suisse Lowers Price Target for Caterpillar (CAT) ||| Forget CAT, Grab These Tigers By the Tail - Investment Ideas ||| Why Both Presidential Candidates are Wrong about China ||| Ahead of Wall Street - Oct. 23, 2012 - Ahead of Wall Street ||| Goldman Sachs Maintains Caterpillar at Buy, Lowers PT from $106 to $103 ||| Barclays Maintains Caterpillar at Overweight, Lowers PT from $114 to $107 ||| UPDATE: Credit Suisse Lowers PT on Caterpillar ||| Raymond James Maintains Caterpillar at Market Perform, Lowers PT from $95 to $92.50 ||| UBS Maintains Caterpillar at Neutral, Lowers PT from $95 to $92 ||| UBS Maintains Caterpillar at Neutral, Lowers PT from $95 to $92 ||| Credit Suisse Maintains Caterpillar at Outperform, Lowers PT from $117 to $108",0,0.46992072
2012-10-24,5509000.0,84.06999969482422,84.13999938964844,82.5199966430664,82.7300033569336,61.092384338378906,CAT,"Ahead of Wall Street - October 24, 2012 - Ahead of Wall Street ||| Cummins to Reduce Headcount - Analyst Blog ||| Weak Earnings: China to Blame? - Analyst Blog",1,0.47114223
2012-10-26,7165300.0,83.4800033569336,84.31999969482422,83.23999786376953,84.25,62.21481704711914,CAT,"Stock Market News for October 26, 2012 - Market News ||| Goldman Sachs Removes Caterpillar from “Conviction Buy” List (CAT)",1,0.48148185
2012-10-31,5914600.0,85.52999877929688,85.91999816894531,84.44999694824219,84.80999755859375,62.62833786010742,CAT,"Earnings Expectations for the Week of October 29 ||| Mixed Bag for Terex Corp. - Analyst Blog ||| Macquarie Infrastructure, Haverty Furniture and Others Analysts Are Bullish On ||| Market Reopens, Apple (AAPL) Shares Dip Below $600 ||| Cummins Misses Estimates - Analyst Blog",1,0.5086379
2012-11-01,8550000.0,85.22000122070312,87.86000061035156,85.0,87.6500015258789,64.72557830810547,CAT,"CNH Beats Est., Sales Up in 3Q - Analyst Blog ||| Construction Spending Edges Up",0,0.5082691
2012-11-02,6982000.0,88.48999786376953,88.5,85.69999694824219,85.79000091552734,63.35204315185547,CAT,Caterpillar Filed Automatic Mixed Securities Shelf,1,0.5087389
2012-11-06,7048900.0,87.3499984741211,88.5999984741211,87.30000305175781,88.08000183105469,65.04310607910156,CAT,"Mid-day Glance: As America Heads To Polls, Markets Head North ||| Speaking at a Baird Conference, Cat Just Reiterated the FY12 Outlook Given on Oct. 22nd",0,0.48957118
2012-11-07,8209200.0,86.7300033569336,87.2300033569336,84.83999633789062,85.0199966430664,62.783447265625,CAT,4 Dividend Picks From The Dow Jones With Strong Long-Term Earnings Growth,0,0.5269059
2012-11-08,6240600.0,85.16000366210938,85.23999786376953,83.5199966430664,83.66000366210938,61.77912521362305,CAT,Stocks James Bond Would Love ||| Stocks James Bond Would Love,1,0.4997061
2012-11-12,5800500.0,84.44000244140625,85.56999969482422,84.2300033569336,85.18000030517578,62.90157699584961,CAT,"JPMorgan Downgrades Caterpillar to “Neutral” (CAT) ||| Benzinga's Top Downgrades ||| UPDATE: JPMorgan Downgrades Caterpillar to Neutral, Lowers PT ||| Futures Rise on Greek Austerity Vote, China Trade ||| JP Morgan Downgrades Caterpillar from Overweight to Neutral, Lowers PT from $109 to $90",0,0.5029716
2012-11-13,7695300.0,84.72000122070312,85.18000030517578,83.16999816894531,83.26000213623047,61.48377227783203,CAT,"Terex Prices $850M Senior Notes - Analyst Blog ||| Cat at Lows of Day as Presentation at Goldman Industrials Conference Ends; Sees 2013 Economic Estimates Flat, Expecting New Mining Equip. Sales Lower Next Year",0,0.4987116
2012-11-14,8497000.0,83.9000015258789,83.9000015258789,80.87999725341797,81.0999984741211,59.88869857788086,CAT,Buy these 3 Stocks For a Lot Less than What Insiders Paid ||| Buy these 3 Stocks For a Lot Less than What Insiders Paid,1,0.48778084
2012-11-15,7794600.0,81.3499984741211,82.56999969482422,80.5,81.30000305175781,60.036376953125,CAT,"Dividend Yields Tempt, But That's No Reason To Buy ||| This is How Major Companies Expect 2013 to Unfold",1,0.4828717
2012-11-16,8050900.0,81.37000274658203,82.20999908447266,80.16000366210938,81.93000030517578,60.50159454345703,CAT,Sandy to Hurt Allstate's 4Q - Analyst Blog,1,0.51794606
2012-11-20,5535900.0,83.69999694824219,83.7699966430664,82.58999633789062,83.33000183105469,61.53544998168945,CAT,"CNH Receives Revised Offer from Fiat - Analyst Blog ||| Cat Global Oct. Retail Sales of Machines Up 8%, Total Power Systems Sales Up 1%, North American Machine Retail Sales Up 13%",0,0.5136823
2012-11-23,2663700.0,83.62000274658203,84.19000244140625,83.25,84.16000366210938,62.14834976196289,CAT,Neutral on Caterpillar - Analyst Blog ||| CNH Global Favors Fiat Merger - Analyst Blog,1,0.5199325
2012-11-26,4240800.0,83.80999755859375,84.80999755859375,83.80999755859375,84.6500015258789,62.51020050048828,CAT,"Barron's Recap (11/24/12): Trouble in Tea Land ||| Forget Blue Chips: This 7% Yield Could Be Safer Than You Think ||| Manitowoc Company, Inc. (MTW) Ex-Dividend Date Scheduled for November 28, 2012 ||| Hyster-Yale Materials Handling, Inc. (HY) Ex-Dividend Date Scheduled for November 28, 2012 ||| NACCO Industries, Inc. (NC) Ex-Dividend Date Scheduled for November 28, 2012 ||| Joy Global Remains Neutral - Analyst Blog",0,0.4614268
2012-11-28,4884700.0,83.62999725341797,85.08999633789062,83.0,84.94000244140625,62.72435760498047,CAT,"Stock Market News for November 28, 2012 - Market News ||| Benzinga Market Primer, Wednesday November 28",1,0.47841176
2012-11-30,5663400.0,86.33000183105469,86.3499984741211,85.02999877929688,85.23999786376953,62.94588851928711,CAT,"We Like Industrial Stocks Heading Into 2013 ||| Dow Ends Wishy-Washy Session, Week in the Black",0,0.47193626
2012-12-03,4714100.0,85.91999816894531,85.91999816894531,84.43000030517578,84.48999786376953,62.39207077026367,CAT,Allstate Oct. CAT Loss Tops $1B - Analyst Blog,0,0.5151437
2012-12-04,4468400.0,84.05000305175781,84.95999908447266,83.75,84.16000366210938,62.14834976196289,CAT,"Miller Industries, Inc. (MLR) Ex-Dividend Date Scheduled for December 06, 2012 ||| Chemtura Announces Joint Development Deal with Cat for Duracast Tech Application",1,0.5049159
2012-12-05,8604400.0,84.62000274658203,86.56999969482422,84.56999969482422,86.05000305175781,63.54403305053711,CAT,"UPDATE: Cat, Ariel JV Announce Purchase of ProSource, to Provide Complete Pressure-Pumping Solutions ||| Cat, Ariel Create JV to Buy Prosource",0,0.505557
2012-12-07,7337200.0,86.69999694824219,87.55000305175781,86.5199966430664,86.98999786376953,64.23819732666016,CAT,"Lindsay, CNH Global Lead Rising Farm Equipment Group ||| My Favorite Dividend Contender Picks For 2013",1,0.5239275
2012-12-10,4336600.0,86.80999755859375,87.44999694824219,86.37999725341797,87.2300033569336,64.41542053222656,CAT,Barron's Recap (12/8/12): Ten Stock Picks for 2013 ||| Dow Pariahs for 2013,1,0.49415758
2012-12-11,5371600.0,87.5999984741211,88.16000366210938,87.04000091552734,87.33000183105469,64.4892578125,CAT,"Hyster-Yale Materials Handling, Inc. (HY) Ex-Dividend Date Scheduled for December 13, 2012",1,0.47771046
2012-12-12,7093300.0,87.88999938964844,88.7699966430664,87.45999908447266,87.94999694824219,64.94710540771484,CAT,"Joy Global Beats, Booking Sags - Analyst Blog ||| S&P Upgrades Industrial Sector; Highlights Three ETFs ||| S&P Upgrades Industrial Sector; Highlights Three ETFs ||| Cat Accelerates $0.52/Share Qtr. Dividend Payment to Dec. 31st",1,0.4938005
2012-12-13,6100000.0,87.8499984741211,89.30999755859375,87.81999969482422,88.36000061035156,65.24987030029297,CAT,"Company News for December 13, 2012 - Corporate Summary ||| Market Close Report: NASDAQ Composite index closes at 2,992.16 down -21.65 points ||| Dow Takes a Breather, Drops 75 Points",1,0.4822398
2012-12-14,5866400.0,88.3499984741211,89.5,88.31999969482422,89.0,65.72249603271484,CAT,Cummins Boosts Share Repurchase - Analyst Blog,1,0.5393474
2012-12-17,6092800.0,89.25,89.69000244140625,88.9000015258789,89.63999938964844,66.19508361816406,CAT,"Trader remains nervous on Caterpillar ||| Douglas Dynamics, Inc. (PLOW) Ex-Dividend Date Scheduled for December 19, 2012",1,0.46717274
2012-12-18,6653300.0,89.66999816894531,91.08999633789062,89.66999816894531,90.7699966430664,67.029541015625,CAT,"Caterpillar, Inc. (CAT) Ex-Dividend Date Scheduled for December 20, 2012",1,0.44089955
2012-12-19,7065800.0,90.91000366210938,91.83000183105467,90.73999786376952,90.79000091552734,67.04434967041016,CAT,GE's Growth Strategies For 2013 And Beyond,0,0.522335
2012-12-21,10727800.0,87.5,88.18000030517578,86.4800033569336,87.9000015258789,65.28411865234375,CAT,Cummins Power Raises Prices - Analyst Blog,0,0.52823037
2012-12-26,3236100.0,87.66999816894531,88.68000030517578,87.56999969482422,87.66999816894531,65.11329650878906,CAT,The Re-building of America - Analyst Blog ||| PartnerRe Evaluates 4Q CAT Loss - Analyst Blog,0,0.5367925
2013-01-02,11590000.0,92.9499969482422,94.44000244140624,92.9499969482422,93.5,69.44324493408203,CAT,"ISI Group Upgrades Caterpillar, Inc. to Buy, Raises PT to $111.00",1,0.49682152
2013-01-09,3546100.0,94.0999984741211,94.7699966430664,94.0999984741211,94.44000244140624,70.14142608642578,CAT,"UPDATE: Bank of America Merrill Lynch Reiterates Neutral Rating, Raises PT on Caterpillar ||| Bank of America Maintains Neutral on Caterpillar, Inc., Raises PO to $100.00",1,0.48079234
2013-01-10,4596400.0,95.11000061035156,95.19000244140624,94.2300033569336,95.08000183105467,70.61674499511719,CAT,"A Peek Into The Market Before The Trading Starts ||| Benzinga Market Primer: Thursday, January 10 ||| Caterpillar Opens Two New Facilities in Tongzhou, Jiangsu Province, China",1,0.5181318
2013-01-11,4288500.0,94.55999755859376,95.38999938964844,94.12000274658205,95.19000244140624,70.69844055175781,CAT,CAT Opens Two China Facilities - Analyst Blog ||| Trimble Navigates Along Steady Growth Course,0,0.5345039
2013-01-14,3685800.0,95.31999969482422,95.4800033569336,94.1500015258789,94.62999725341795,70.28253173828125,CAT,HAL Utilizes Natural Gas for Power - Analyst Blog ||| High Paid Manufacturing Turns to U.S. - Analyst Blog,1,0.53406096
2013-01-15,4789800.0,94.20999908447266,95.83000183105467,94.18000030517578,95.66999816894533,71.0549545288086,CAT,"Credit Suisse Maintains Outperform on Caterpillar, Inc., Raises PT to $124.00",0,0.47090685
2013-01-16,3809700.0,95.0999984741211,95.66999816894533,94.83000183105467,95.19000244140624,70.69844055175781,CAT,When Natural Gas Replacing Diesel in Frac Jobs,1,0.5360186
2013-01-17,4824100.0,95.70999908447266,96.29000091552734,95.08999633789062,95.6999969482422,71.07723236083984,CAT,Is Comeback In The Cards For Caterpillar's Stock?,1,0.5136631
2013-01-18,8330900.0,96.43000030517578,97.62000274658205,96.08999633789062,97.62000274658205,72.50325012207031,CAT,"Cat Plans $580M Charge for Accounting Misconduct at Unit ||| Caterpillar's Luis de Leon, VP of Mining Products Unit, Leaving ||| Piper Jaffray Upgrades Caterpillar, Inc. to Overweight, Raises PT to $113.00",1,0.4891625
2013-01-22,8330100.0,96.38999938964844,97.7300033569336,96.0500030517578,97.72000122070312,72.57750701904297,CAT,"CAT Unearths Accounting Fraud in ERA - Analyst Blog ||| A Look Ahead: This Week's ETFs to Watch ||| Caterpillar Shares Hit on Disclosure of Accounting Misconduct ||| Benzinga's Top Pre-Market Losers ||| Benzinga Market Primer: Tuesday, January 22 ||| Stocks To Watch For January 22, 2013",0,0.515122
2013-01-24,5816300.0,96.0,97.73999786376952,96.0,96.5999984741211,71.74564361572266,CAT,Machinery Industry Stock Outlook - Jan 2013 - Industry Outlook ||| Machinery Industry Stock Outlook - Jan 2013 - Zacks Analyst Interviews,0,0.48968256
2013-01-25,8902700.0,95.91999816894533,96.27999877929688,94.66000366210938,95.58000183105467,70.98809051513672,CAT,"Dow Makes It Six in a Row, S&P Tops 1,500 ||| Pre-Market Earnings Report for January 28, 2013 : CAT, BIIB, ROP, BBD, ONB, NDZ ||| The Week Ahead: Earnings from Facebook, Ford, Caterpillar; US Jobs Report ||| Hearing Wells Fargo Cautious on Caterpillar ||| UPDATE: Cat Dec. 3-Mo. Rolling Machine Retail Sales in North America Down 6%, APAC Down 7%, EAME Up 4%, LatAm Up 14% ||| Caterpillar Offers Dec. Three-Month Rolling Machine Retail Sales Down 1%",1,0.49211186
2013-01-28,15997500.0,98.05999755859376,98.73999786376952,96.43000030517578,97.4499969482422,72.3769760131836,CAT,"Stocks To Watch For January 28, 2013 ||| Barron's Recap (1/26/12): Made in America ||| A Look Ahead: This Week's ETFs to Watch ||| Earnings Expectations for the Week of January 28 ||| Market Exuberance to Continue? - Analyst Blog ||| Record Year for CAT Despite Muted 4Q - Analyst Blog ||| Halliburton to Clean Aussie Waters - Analyst Blog ||| Mid-Morning Market Update: CAT Releases Poor Guidance, Best Buy Sees Some Relief ||| Ahead of Wall Street - January 28, 2013 - Ahead of Wall Street ||| Dow Breaks Its Winning Streak (Albeit Barely), S&P Clings to Support ||| Pre-Market Most Active for Jan 28, 2013 : BAC, FB, CAT, NOK, F, AAPL, QQQ, RIMM, MCP, UN, ASML, NFLX ||| Mid-Afternoon Market Update: Markets Mixed, Herbalife Falld on FTC Attack on Fortune High Tech Marketing ||| Mid-Day Market Update: Zynga Rides Positive Social Media Sentiment, Jos. A Bank Falls on Bad Guidance ||| Caterpillar Earnings Surprise, Shares Rise ||| Market Wrap for Monday, January 28: Dow and S&P Fall Slightly; Nasdaq Records Small Gain ||| JP Morgan Maintains Neutral on Caterpillar, Inc., Raises PT to $100.00 ||| UPDATE: Caterpillar Says Europe Isn't Bad News Anymore ||| UPDATE: Caterpillar Says Europe Isn't Bad News Anymore ||| Mid-Afternoon Market Update: Markets Mixed, Herbalife Falld on FTC Attack on Fortune High Tech Marketing ||| UPDATE: Caterpillar CEO Sees Upside if Washington Progress Made ||| UPDATE: Caterpillar Looking Ahead to US Fiscal Issues in March, April ||| Caterpillar CEO Tells Bloomberg TV Pretty Optimistic About 2013 ||| Mid-Day Market Update: Zynga Rides Positive Social Media Sentiment, Jos. A Bank Falls on Bad Guidance ||| From Cat Q4 Call: Sees Q1 Profit Lower on Declining Sales ||| Mid-Morning Market Update: CAT Releases Poor Guidance, Best Buy Sees Some Relief ||| Caterpillar Earnings Surprise, Shares Rise ||| UPDATE: Caterpillar Q4 Profit Drops 55% ||| UPDATE: Cat Expecting Q1 Sales 'Significantly Lower' Compared to Q1 2012 ||| UPDATE: Caterpillar Says 2013 Could Be Tough Year ||| Caterpillar Sees FY13 EPS $7-9 vs $8.54 Est, Sales $60-68B vs $65.2B Est ||| Cat Q4 Adj EPS $1.91 vs $1.70 Est ||| Caterpillar, Inc. Reports Q4 GAAP EPS of $1.04; Revenue of $16.08B vs $16.16B Est ||| A Peek Into The Market Before The Trading Starts ||| Benzinga Market Primer: Monday, January 28 ||| US Stock Futures Flat Ahead Of Caterpillar Earnings ||| Earnings Scheduled For January 28, 2013",1,0.48553795
2013-01-29,6961900.0,97.91999816894533,99.1999969482422,97.72000122070312,98.5999984741211,73.23108673095703,CAT,"UPDATE: BMO Capital Markets Upgrades Caterpillar to Outperform on Long-Term Upside ||| UPDATE: JP Morgan Raises PT to $100 on Caterpillar Following Q4 Conference Call ||| BMO Capital Upgrades Caterpillar, Inc. to Outperform, Raises PT to $130.00 ||| Jefferies Maintains Hold on Caterpillar, Inc., Raises PT to $95.00 ||| Credit Suisse Maintains Outperform on Caterpillar, Inc., Lowers PT to $123.00 ||| Benzinga's Top Upgrades ||| A Peek Into The Market Before The Trading Starts",1,0.5008877
2013-01-30,5681000.0,98.83000183105467,98.95999908447266,98.25,98.6500015258789,73.26820373535156,CAT,Zacks Rank #5 Additions for Wednesday - Tale of the Tape,0,0.51496285
2013-02-04,5765000.0,98.76000213623048,98.87000274658205,97.91000366210938,98.26000213623048,72.97858428955078,CAT,Reshoring Bringing Back Jobs to USA - Analyst Blog,1,0.5373953
2013-02-05,4178000.0,98.58000183105467,99.0999984741211,98.31999969482422,98.44000244140624,73.11225128173828,CAT,CalAmp Announces Deal with Cat for M2M Wireless Communications Solutions for Global Assets,0,0.5375955
2013-02-06,4489600.0,97.87000274658205,98.75,97.36000061035156,97.6999969482422,72.56265258789062,CAT,Strong 4Q for Manitowoc - Analyst Blog ||| Bear of the Day: Caterpillar (CAT) - Bear of the Day,0,0.49379578
2013-02-07,6210100.0,97.41999816894533,98.16000366210938,95.20999908447266,96.11000061035156,71.38172912597656,CAT,Earnings Season Winding Down at Par - Earnings Trends ||| Earnings Season Winding Down at Par - Earnings Outlook ||| Sour Euro Outlook Pulls Down Markets,1,0.5082964
2013-02-08,3934200.0,96.0999984741211,97.5,96.0999984741211,96.8499984741211,71.93132781982422,CAT,Earnings Season Winding Down at Par - Earnings Trends,0,0.5291211
2013-02-14,3586300.0,96.05999755859376,96.68000030517578,95.68000030517578,96.06999969482422,71.3520278930664,CAT,"Latest Picks From Bill Gates Foundation: Buys Coca-Cola, Procter & Gamble, Wal-Mart ...",0,0.5240601
2013-02-20,8570800.0,95.0,95.0999984741211,93.0500030517578,93.22000122070312,69.23531341552734,CAT,"Terex Lags Estimates - Analyst Blog ||| Caterpillar Loses $95 Support And Daily 50 EMA At $93.81 ||| Form 8-K from Cat Shows Jan. Rolling Three-Month Machine Retail Sales Fell 4%, NA Sales Were Down 11%",0,0.5035325
2013-02-22,5851800.0,91.98999786376952,92.48999786376952,91.0500030517578,91.54000091552734,67.98757934570312,CAT,"UPDATE: Raymond James Upgrades Caterpillar to Outperform on Valuation ||| Benzinga's Top Upgrades ||| Raymond James Upgrades Caterpillar, Inc. to Outperform, Maintains $105.00 PT ||| Benzinga Market Primer: Friday, February 22",0,0.46840203
2013-02-25,7540300.0,91.80999755859376,92.22000122070312,89.08000183105469,89.16000366210938,66.21994018554688,CAT,"Hyster-Yale Materials Handling, Inc. (HY) Ex-Dividend Date Scheduled for February 27, 2013 ||| NACCO Industries, Inc. (NC) Ex-Dividend Date Scheduled for February 27, 2013 ||| Catapillar Heads Lower To Test 200 SMA At $87.53 Reversing All Of 2013 Gains, MACD Cross Zero Line On Daily; Bearish",1,0.49503094
2013-02-26,7114200.0,89.58999633789062,90.1999969482422,88.5,89.94999694824219,66.80665588378906,CAT,Caterpillar Down to Underperform - Analyst Blog ||| General Cable Misses Est in 4Q - Analyst Blog ||| These Stocks are Ripe for an Oversold Bounce,1,0.49110594
2013-02-28,5446500.0,92.48999786376952,93.16000366210938,92.2300033569336,92.37000274658205,68.60399627685547,CAT,"Stock Market News for February 28, 2013 - Market News",0,0.5060335
2013-03-01,4924400.0,91.54000091552734,91.95999908447266,90.12999725341795,91.36000061035156,67.85386657714844,CAT,"Market Close Report: NASDAQ Composite index closes at 3,169.74 up 9.55 points ||| Caterpillar to Cut Jobs in Belgium - Analyst Blog ||| Terex Corp. to Snip Jobs - Analyst Blog ||| Deere Hikes Dividend - Analyst Blog",0,0.5019577
2013-03-04,6350500.0,90.61000061035156,90.75,89.19000244140625,89.75,66.65811920166016,CAT,"Market Close Report: NASDAQ Composite index closes at 3,182.03 up 12.29 points ||| Dow Shrugs Off Overseas Malaise to Build On Momentum",1,0.5392716
2013-03-06,7135900.0,90.97000122070312,91.0500030517578,89.41000366210938,89.63999938964844,66.57643127441406,CAT,"Stock Market News for March 6, 2013 - Market News ||| ETFs For High ROE Stocks ||| Hedging The Dow At Its All-Time High",1,0.49727678
2013-03-07,4738200.0,89.9000015258789,90.4000015258789,89.2699966430664,89.6500015258789,66.58380889892578,CAT,Ford to Sell Vehicles in Myanmar - Analyst Blog ||| Seven Reasons to Expect a Record-Breaking Year for Stocks ||| Astec Declares Succession Plan - Analyst Blog,1,0.5213431
2013-03-11,4846300.0,90.48999786376952,91.5199966430664,90.0999984741211,91.18000030517578,67.7201919555664,CAT,Buffett Banks on Natural Gas Trains,0,0.50798976
2013-03-12,6593300.0,91.16000366210938,91.16000366210938,89.4000015258789,89.73999786376953,66.65067291259766,CAT,"Market Close Report: NASDAQ Composite index closes at 3,242.32 down -10.55 points ||| Tigress Financial Initiates Coverage on Caterpillar, Inc. at Underperform",0,0.4899038
2013-03-13,5836100.0,89.80000305175781,89.91000366210938,89.12999725341797,89.27999877929688,66.30903625488281,CAT,"China Will Drive Caterpillar's Long-Term Growth Despite Recent Weakness ||| Douglas Dynamics, Inc. (PLOW) Ex-Dividend Date Scheduled for March 15, 2013 ||| Watch Cat, Cummins Shares Following WSJ Article 'Glut Remains in China Construction-Equipment Market' ||| Caterpillar Finding Support At $89.50, 20 EMA Recently Crossed Below 50 EMA; Bearish, Lower Support At 200 SMA $87.45",0,0.47768554
2013-03-18,7159800.0,87.88999938964844,90.0199966430664,87.66999816894531,89.36000061035156,66.36844635009766,CAT,"Caterpillar Holds Above 200 SMA Support At $87.43 50 EMA Resistance Overhead At $91.95 ||| UPDATE: ISI Group Reiterates $119 PT and Strong Buy Rating on Caterpillar on Solid Performance ||| ISI Group Maintains Strong Buy on Caterpillar, Inc., Lowers PT to $119.00",0,0.47966734
2013-03-19,7509300.0,89.4000015258789,89.4000015258789,87.44000244140625,88.2699966430664,65.55892181396484,CAT,"Market Close Report: NASDAQ Composite index closes at 3,229.10 down -8.49 points ||| Caterpillar Headed Lower To Test 200 SMA At $87.42",0,0.49877748
2013-03-20,9389000.0,87.61000061035156,87.87999725341797,86.41999816894531,86.94000244140625,64.57110595703125,CAT,"Market Close Report: NASDAQ Composite index closes at 3,254.19 up 25.09 points ||| Bank of America Reiterates Neutral on Caterpillar on Weak February Sales ||| UPDATE: Bank of America Reiterates Neutral on Caterpillar Ahead of Global Industrials Conference ||| Caterpillar Breaking Down Under 200 SMA Support At $87.43 ||| UPDATE: Cat Reports Feb. NA Retail Machine Sales Down 12%, Asia/Pacific Machine Sales Down 26%, Europe, Africa, Middle East Sales Down 9%, LatAm Sales Up 3% ||| Cat Reports Feb. 3-Month Rolling Machine Retail Sales Down 13%",0,0.5050888
2013-03-21,5449600.0,86.43000030517578,87.31999969482422,86.43000030517578,86.83000183105469,64.48938751220703,CAT,"Jobs, Housing, PMI OK; But are More Warnings Coming? - Real Time Insight ||| Downslide in Cat Sales Continue - Analyst Blog ||| Oracle Stuns Stocks, But It Is A Minor Factor On Market To New Highs",1,0.493874
2013-03-22,5115500.0,87.01000213623047,87.62999725341797,86.97000122070312,87.4800033569336,64.97216033935547,CAT,Bear of the Day: Titan International (TWI) - Bear of the Day,0,0.4924442
2013-03-26,4173000.0,87.05999755859375,87.38999938964844,86.66000366210938,87.0,64.61565399169922,CAT,"Caterpillar Wins Defense Contract - Analyst Blog ||| Caterpillar EPS Estimates Slashed Again For 2013 and 2014 ||| A Peek Into The Market Before The Trading Starts ||| Caterpillar Announces Opening of New Facility in Wuxi, China",0,0.5016363
2013-03-28,6213400.0,87.05000305175781,87.9800033569336,86.6500015258789,86.97000122070312,64.59337615966797,CAT,What Lessons Does Cyprus Teach Us? - Analyst Blog ||| Can Caterpillar Engineer a Turnaround in China?,0,0.5129817
2013-04-02,6514300.0,86.0199966430664,86.0199966430664,84.47000122070312,84.87999725341797,63.04111862182617,CAT,Caterpillar to Cut Jobs in Milwaukee - Analyst Blog,0,0.51278913
2013-04-03,9222400.0,83.91000366210938,84.62000274658203,83.5999984741211,84.12000274658203,62.476654052734375,CAT,"Benzinga Market Primer: Wednesday, April 3 ||| UPDATE: Goldman Sachs Downgrades Caterpillar to Neutral on Lack of Upside ||| Benzinga's Top Downgrades ||| A Peek Into The Market Before The Trading Starts ||| Goldman Sachs Downgrades Caterpillar, Inc. to Neutral, Lowers PT to $101.00 ||| Benzinga Market Primer: Wednesday, April 3",1,0.49526805
2013-04-05,8985600.0,83.41000366210938,85.36000061035156,83.05000305175781,84.5999984741211,62.83316421508789,CAT,Alloy Steel Soars 17% On New BHP Billiton Deal,0,0.52725315
2013-04-09,10533700.0,84.37999725341797,86.6500015258789,84.05000305175781,85.9000015258789,63.79868698120117,CAT,"Pause Or Policy, Q2s Have Been Challenging In This Recovery ||| Does This Small Cap Machinery Company Deserve A Spot In Your Portfolio?",1,0.5102247
2013-04-10,6258700.0,86.37999725341797,86.87999725341797,85.9000015258789,86.56999969482422,64.29631805419922,CAT,Layoffs Continue at Caterpillar - Analyst Blog ||| Caterpillar Maintains Qtr. Dividend Payment of $0.52/Share ||| Top 4 NYSE Stocks In The Farm & Construction Machinery Industry With The Lowest PEG Ratio,0,0.49550688
2013-04-11,6920000.0,86.88999938964844,87.0,85.30000305175781,85.69999694824219,63.65014266967773,CAT,Value Investing for Mothers-in-Law: 'Quality' Requires More than a Good Story ||| Likely Winners and Losers in Obama's 2014 Budget,0,0.51069283
2013-04-12,4934500.0,84.98999786376953,85.33000183105469,84.30000305175781,85.05000305175781,63.16738510131836,CAT,"UPDATE: Credit Suisse Lowers PT on Caterpillar Following Dealer Survey Results ||| Credit Suisse Maintains Outperform on Caterpillar, Inc., Lowers PT to $110.00",0,0.48296264
2013-04-15,10345400.0,84.23999786376953,84.33000183105469,81.91000366210938,82.2699966430664,61.1026496887207,CAT,"Market Close Report: NASDAQ Composite index closes at 3,216.49 down -78.46 points ||| Dow Plummets 266 Points, VIX Spikes 43% on Commodities Nosedive ||| Caterpillar Announces New Organization ||| Caterpillar Announces New Organization, to Combine Parts Distribution, Diversified Products, Starts Order-to-Delivery Organization",1,0.5095338
2013-04-17,9405300.0,81.54000091552734,81.62000274658203,80.62000274658203,81.47000122070312,60.508487701416016,CAT,"Stock Downgrades: Deere Not Making Dough ||| Caterpillar, Inc. (CAT) Ex-Dividend Date Scheduled for April 18, 2013 ||| Halliburton Poised To Outperform The Energy Sector (HAL) ||| UPDATE: Jefferies Lowers PT on Caterpillar on Lowered 2013/2014 Earnings Estimates ||| Jefferies Maintains Hold on Caterpillar, Inc., Lowers PT to $75.00 ||| Top 4 NYSE Stocks In The Farm & Construction Machinery Industry With The Highest Dividend Yield",0,0.47565982
2013-04-19,7009500.0,80.94999694824219,81.16000366210938,80.01000213623047,80.43000030517578,60.11979293823242,CAT,"Pre-Market Earnings Report for April 22, 2013 : CAT, HAL, CHKP, BEAV, HAS, NVR, SIX, LII, BOH, TNC, WASH, BMRC ||| Weekly Preview: Earnings Season Continues, Apple In Focus ||| Caterpillar Earnings Preview: Low Expectations for Q1",1,0.46877724
2013-04-22,18449600.0,81.23999786376953,83.12999725341797,79.48999786376953,82.70999908447266,61.82403945922852,CAT,"Focus on the Big Picture ||| Earnings Expectations for the Week of April 22 ||| Mid-Day Market Update: Halliburton Jumps On Q1 Results, Wipro Falls ||| Mid-Morning Market Update: Markets Mixed, Caterpillar Lowers 2013 View ||| Q1 Earnings Season Raises Doubts About Outlook - Ahead of Wall Street ||| Stock Downgrades: Lights Go Out on General Electric ||| Pre-Market Most Active for Apr 22, 2013 : PWER, NOK, ZNGA, SNY, BAC, CAT, GE, STM, SHPG, SIRI, QQQ, AAPL ||| Pre-Market Primer: Caterpillar Cuts Forecast; Futures, Gold Rise ||| Benzinga Market Primer: Monday, April 22 ||| Microsoft Attracts an Activist ||| Mid-Afternoon Market Update: Markets Continue to Rise, Copper Slows its Rally ||| Random Thoughts: Stocks Arrive at a Critical Juncture ||| Market Wrap for April 22: Stocks Rise Moderately to Begin Week ||| Mid-Afternoon Market Update: Markets Continue to Rise, Copper Slows its Rally ||| Caterpillar Misses on Earnings and Lowers Guidance, Inches Ahead on Stock Repurchase ||| Mid-Day Market Update: Halliburton Jumps On Q1 Results, Wipro Falls ||| Cat Shares Continue Higher After Breaking Above $81 Resistance, Up 1% Over Last 30 Mins ||| Caterpillar Conference Call Ends; Shares Currently up ~.50 Percent ||| Caterpillar (CC): Caterpillar Optimistic, but Realistic in Addressing 'Business Cycles' and ""Knows How to Handle Them."" Shares Now Green ||| Caterpillar (CC): Mining is the Primary Reason For Caterpillar's Reduced Profit and Sales Outlook; Significantly Reduced Expectations From Mining ||| April 22nd Watchlist ||| Mid-Morning Market Update: Markets Mixed, Caterpillar Lowers 2013 View ||| Caterpillar Inches Backwards ||| Mid Day Trading Update – Relief Rally ||| Benzinga's Top Pre-Market Losers ||| UPDATE: Caterpillar Posts Drop In Q1 Profit, Lowers 2013 Forecast ||| UPDATE: Cat Announced Resumption of Buyback, Extended Plan Through Dec. 2015 ||| From Q1 Earnings Release: Cat Says Becoming More Optimistic on US Housing Sector, Expecting Slow Growth in Global Economy During 2013 ||| Caterpillar, Inc. Narrows FY2013 EPS Guidance from $7.00-9.00 to $7.00 vs $7.70 Est; Lowers FY2013 Sales Guidance from $60.0B-68.0B to $57.0B-61.0B vs $62.70B Est ||| Caterpillar, Inc. Reports Q1 EPS of $1.31 vs $1.45 Est; Revenue of $13.21B vs $13.81B Est ||| US Stock Futures Up Ahead Of Existing Home Sales Data ||| Benzinga Market Primer: Monday, April 22 ||| Economic Calendar for Monday April 22, 2013 ||| Earnings Scheduled For April 22, 2013 ||| Stocks To Watch For April 22, 2013",1,0.4857271
2013-04-23,12932500.0,83.91000366210938,84.72000122070312,82.73999786376953,84.0999984741211,62.863059997558594,CAT,"Floating Rate Notes: Overpaying for Insurance That Doesn't Protect You ||| New Stock Coverage: 'Maxx' Out Your Profits With TJX Companies ||| Global Growth Worries All Over Again - Ahead of Wall Street ||| Allstate Expects Higher 1Q CAT Loss - Analyst Blog ||| Markets End Solidly Higher, Unspoiled by Fake AP Tweet ||| UPDATE: Credit Suisse Lowers PT on Caterpillar Following Earnings Miss ||| UPDATE: JP Morgan Upgrades Caterpillar to Overweight on Low Risk ||| S&P Says Cat Ratings Unaffected by Q1 Results ||| BMO Capital Maintains Outperform on Caterpillar, Inc., Lowers PT to $96.00 ||| Credit Suisse Maintains Outperform on Caterpillar, Inc., Lowers PT to $103.00 ||| Benzinga's Top Upgrades ||| A Peek Into The Market Before The Trading Starts ||| Benzinga Market Primer: Tuesday, April 23 ||| JP Morgan Upgrades Caterpillar, Inc. to Overweight, Raises PT to $100.00 ||| Citigroup Maintains Neutral on Caterpillar, Inc., Lowers PT to $92.00",0,0.49569893
2013-04-24,7022000.0,84.27999877929688,84.6500015258789,83.29000091552734,83.77999877929688,62.623870849609375,CAT,Caterpillar Looks Like a Buy After Earnings ||| Apple Announces $100 Billion Capital Return Program,1,0.49197456
2013-04-25,6556100.0,84.69999694824219,85.0199966430664,84.0199966430664,84.51000213623047,63.16951370239258,CAT,Cat Reports $1B Accelerated BUyback Plan ||| Caterpillar Spikes Higher,1,0.5186504
2013-04-26,6160700.0,84.3499984741211,85.08000183105469,84.25,84.68000030517578,63.29658889770508,CAT,"No Time to Relax, More Significant Correction May Be in the Works ||| Bear of the Day: Titan (TITN) - Bear of the Day",1,0.49185234
2013-04-29,6065100.0,85.11000061035156,85.5,84.06999969482422,84.80000305175781,63.38628768920898,CAT,"New Stock Coverage: Madison Square Garden Coming Up Roses ||| Five Reasons Why This Will Remain A Traders Market ||| Longbow Research Upgrades Caterpillar, Inc. to Buy",0,0.493427
2013-04-30,6954300.0,84.80999755859375,85.37999725341797,83.36000061035156,84.66999816894531,63.28909683227539,CAT,Top 4 NYSE Stocks In The Farm & Construction Machinery Industry With The Highest Dividend Yield,0,0.51524806
2013-05-01,11607000.0,84.06999969482422,84.3499984741211,82.66000366210938,83.08000183105469,62.10060119628906,CAT,41 Straight Years Of Larger Dividends -- And 35% Upside,1,0.53698695
2013-05-02,5798600.0,83.33999633789062,84.55999755859375,83.0999984741211,84.26000213623047,62.98263931274414,CAT,"Manitowoc's 1Q Earnings Miss Est. - Analyst Blog ||| Economic News, ECB Spark Another Record-Setting Day",1,0.5170536
2013-05-03,11890000.0,85.58999633789062,87.4800033569336,85.4800033569336,86.9800033569336,65.01581573486328,CAT,"Market Wrap for Friday, May 3: Stocks Jump on Strong Jobs Data ||| Will Illinois Businesses Head South? ||| (OPTIONS): Caterpillar May ATM 87.50 Calls Trade 19,000 Times Over an Open Interest of 10,000",1,0.4854396
2013-05-06,6381000.0,87.12999725341797,87.94999694824219,86.87999725341797,87.58999633789062,65.47172546386719,CAT,"Caterpillar (CAT), A Sleeping Monster ||| TD Ameritrade's IMX Survey Declines to 5.31 in April",1,0.49199185
2013-05-07,10406900.0,88.11000061035156,89.80999755859375,87.91000366210938,89.79000091552734,67.11620330810547,CAT,"Market Close Report: NASDAQ Composite index closes at 3,396.63 up 3.66 points ||| After Hours Most Active for May 7, 2013 : PFE, HBA^F, BAC, DVN, QQQ, WFM, MU, CVRR, CAT, INTL, EA, INTC ||| Dow Leaves 15,000 In the Dust on Its 17th Positive Tuesday",1,0.47640136
2013-05-08,7431000.0,89.76000213623047,90.4000015258789,89.18000030517578,90.30999755859376,67.50487518310547,CAT,"Astec Industries, Inc. (ASTE) Ex-Dividend Date Scheduled for May 09, 2013 ||| Benzinga Market Primer: Wednesday, May 8 ||| Benzinga Market Primer: Wednesday, May 8",0,0.43564487
2013-05-09,5166100.0,89.9800033569336,90.69000244140624,89.55000305175781,89.94999694824219,67.23579406738281,CAT,Top 4 NYSE Stocks In The Farm & Construction Machinery Industry With The Lowest PEG Ratio,0,0.51243174
2013-05-10,6967500.0,89.95999908447266,90.25,87.9000015258789,88.62000274658203,66.24166107177734,CAT,"Market Close Report: NASDAQ Composite index closes at 3,436.58 up 27.41 points ||| 5 Conglomerates Stocks With The Highest EPS",0,0.4951561
2013-05-16,8192200.0,86.55000305175781,87.6500015258789,86.0999984741211,86.77999877929688,64.86632537841797,CAT,"Caterpillar, Mining Machinery Limited Announce Settlement",1,0.4983394
2013-05-17,6690800.0,87.38999938964844,87.86000061035156,87.0999984741211,87.66999816894531,65.53152465820312,CAT,"Joy Global Poised at Neutral - Analyst Blog ||| US Stock Futures Up On Bullish Sentiments ||| Stocks To Watch For May 17, 2013",1,0.4864244
2013-05-20,5603200.0,87.56999969482422,88.75,87.2699966430664,88.33000183105469,66.02490234375,CAT,"Caterpillar Resolves ERA Issues - Analyst Blog ||| Caterpillar Announces April North American Three-Month Machine Retail Sales Down 18%, Down 9%",0,0.49167514
2013-05-22,6479100.0,88.08999633789062,89.08999633789062,87.1500015258789,87.69999694824219,65.55394744873047,CAT,Caterpillar's April Sales Down 9% - Analyst Blog ||| Buy CAT: A Global Leader Trading at a 3rd-World Discount,0,0.5135176
2013-05-23,6026800.0,86.02999877929688,87.37999725341797,85.77999877929688,86.94999694824219,64.99336242675781,CAT,A.M. Best Upgrades View on PartnerRe - Analyst Blog ||| Machinery Industry Stock Outlook - May 2013 - Industry Outlook ||| Machinery Industry Stock Outlook - May 2013 - Zacks Analyst Interviews,0,0.49322262
2013-05-28,5800400.0,87.04000091552734,87.38999938964844,85.9000015258789,86.19000244140625,64.42527770996094,CAT,"Hyster-Yale Materials Handling, Inc. (HY) Ex-Dividend Date Scheduled for May 29, 2013 ||| Deere vs. Caterpillar: Technical Street Fight",1,0.4813465
2013-05-29,5110500.0,85.7300033569336,86.66000366210938,85.33000183105469,86.48999786376953,64.6495361328125,CAT,Caterpillar Downgraded to Strong Sell - Analyst Blog,0,0.51380396
2013-05-30,3568000.0,86.47000122070312,87.0,85.98999786376953,86.41000366210938,64.58973693847656,CAT,"Joy Global Beats Earnings, Lags Y/Y - Analyst Blog",0,0.5323157
2013-06-03,6092700.0,85.91000366210938,86.30000305175781,85.73999786376953,86.12999725341797,64.38040924072266,CAT,"Stocks to Watch for the Week of June 3, 2013",0,0.482935
2013-06-04,5105500.0,85.94999694824219,86.47000122070312,85.44000244140625,85.91999816894531,64.22347259521484,CAT,"Manitowoc Reaches 52-Week High - Analyst Blog ||| XLI Just Made New all time Highs, Will it Continue?",0,0.49316302
2013-06-10,4965200.0,84.70999908447266,84.7699966430664,83.62999725341797,83.80000305175781,62.6387939453125,CAT,Caterpillar Upgraded to Neutral - Analyst Blog,0,0.5149189
2013-06-12,4748100.0,84.16999816894531,84.37999725341797,83.01000213623047,83.20999908447266,62.197784423828125,CAT,"Miller Industries, Inc. (MLR) Ex-Dividend Date Scheduled for June 13, 2013 ||| High- And Low-Quality Stocks Beat The S&P 500 ||| Caterpillar Raises Qtr. Dividend from $0.52 to $0.60/Share",1,0.46398637
2013-06-13,6352100.0,83.31999969482422,85.27999877929688,83.19000244140625,85.13999938964844,63.64042282104492,CAT,"Douglas Dynamics, Inc. (PLOW) Ex-Dividend Date Scheduled for June 14, 2013 ||| Market Close Report: NASDAQ Composite index closes at 3,445.37 up 44.94 points ||| US Markets Dismiss Overseas Peer Pressure to Move Sharply Higher",0,0.5027088
2013-06-18,3723900.0,84.08999633789062,84.87000274658203,83.95999908447266,84.55000305175781,63.19944381713867,CAT,Terex Falls on Lowered Guidance - Analyst Blog ||| Change in Total Reserves,0,0.51193637
2013-06-20,7628100.0,83.19000244140625,83.68000030517578,82.3499984741211,83.19999694824219,62.1903190612793,CAT,"Caterpillar Reports May Rolling Three-Months Global Machine Sales Down 7%, Asia/Pacific Sales Down 14%, EAME Down 2%, LatAm Up 22%, Power Systems Retail Total Down 1%",0,0.49983904
2013-06-21,9736500.0,84.0199966430664,84.0199966430664,81.93000030517578,83.12000274658203,62.13051986694336,CAT,What China's Slowdown Means For Your Portfolio ||| CAT Suffers Sixth-Straight Sales Fall - Analyst Blog ||| Allstate's CAT Loss for May Rises - Analyst Blog,0,0.50899595
2013-06-25,6249000.0,82.33999633789062,82.68000030517578,81.97000122070312,82.33000183105469,61.54002380371094,CAT,"Stocks to Watch for June 25, 2013",0,0.48325986
2013-06-26,6950600.0,82.91999816894531,83.43000030517578,81.69999694824219,82.0999984741211,61.36807632446289,CAT,"UPDATE: Caterpillar CEO Says Trans-Pacific and EU Trade Deals Will Help to Boost U.S. Exports ||| UPDATE: Caterpillar CEO Sees Opportunities In Brazil and Africa ||| Caterpillar CEO Doug Oberhelman Says World Economy Is ""Partly Sunny""",1,0.5247568
2013-06-28,8448800.0,82.76000213623047,83.19000244140625,82.30999755859375,82.48999786376953,61.65958786010742,CAT,3 Discounted Stocks On The Verge Of A Huge Rebound,1,0.5530427
2013-07-01,4676300.0,83.04000091552734,83.25,82.2699966430664,82.72000122070312,61.83151245117188,CAT,"Barron's Recap: World's Most Respected Companies ||| CHMP Positive on Dendreon's Provenge - Analyst Blog ||| SLIDESHOW: Stocks For Weak Yen at 120 ||| UPDATE: Caterpillar to Acquire Berg Propulsion ||| Caterpillar to Acquire Berg Propulsion, Significantly Expanding Customer Options for Advanced Marine Power Solutions",0,0.49077967
2013-07-02,3659900.0,82.7699966430664,83.58999633789062,82.04000091552734,82.4800033569336,61.65211486816406,CAT,AIZ Outlines 2013 CAT Reinsurance Program - Analyst Blog ||| Caterpillar to Buy Johan Walter Berg - Analyst Blog ||| Changes To This Accounting Rule Would Have Massive Repercussions,0,0.50380045
2013-07-09,7882100.0,84.06999969482422,86.25,83.72000122070312,85.33000183105469,63.78245162963867,CAT,"NASDAQ Composite Index closes up 5.45 points for the week, rising for the 3rd straight day ||| Another Day in the Black, as the Russell 2000 Hits a New All-Time High",0,0.51413196
2013-07-10,4216800.0,85.41999816894531,85.7699966430664,84.79000091552734,84.95999908447266,63.505859375,CAT,Stock Upgrades: Bubble Wrap Maker Sealed Air Corp Poised for Nice Pop,1,0.5273027
2013-07-17,15077400.0,88.44999694824219,89.0,85.87999725341797,86.66999816894531,64.78404998779297,CAT,"Some Highlights from 'Delivering Alpha' Conference: Chanos, Paulson, Cooperman, Kingdon, Hohn ||| Chanos: 'Caterpillar Still Expanding Investment in China' ||| Chanos: 'Caterpillar Earnings Estimates Could Fall to $3-$4 Area' ||| Chanos: 'Short Caterpillar'",0,0.5070815
2013-07-19,5086200.0,85.44999694824219,85.88999938964844,85.1500015258789,85.6500015258789,64.46794128417969,CAT,Weekly Preview: Earnings Season Kicks Into Hyperdrive,1,0.54757994
2013-07-22,4835000.0,85.37999725341797,86.55000305175781,85.37999725341797,86.0,64.73135375976562,CAT,"A Look Ahead: This Week's ETFs to Watch ||| Earnings Expectations for the Week of July 22 (AAPL, GM, MCD, NFLX)",0,0.49933252
2013-07-23,6891800.0,85.48999786376953,86.37999725341797,85.12000274658203,85.5199966430664,64.37007904052734,CAT,"Pre-Market Earnings Report for July 24, 2013 : PEP, BA, F, LLY, CAT, EMC, PX, TMO, GD, RAI, WLP, CVE ||| Caterpillar Reports Breakdown of Sales Figures For Second Quarter ||| Caterpillar Earnings Preview: Continued Low Expectations (CAT)",0,0.4722384
2013-07-24,16602100.0,84.58000183105469,85.27999877929688,82.63999938964844,83.44000244140625,62.80449676513672,CAT,"Caterpillar's Earnings Drop in 2Q - Analyst Blog ||| July 24: Will Investors Focus on Economic Data or Earnings? - Economic Highlights ||| Pre-Market Primer: Apple Inc., Ford Motor Company Beat Expectations; Eurozone Might Escape Recession ||| Pre-Market Most Active for Jul 24, 2013 : DELL, F, SRPT, MFB, ING, BRCM, AZN, BAC, CAT, AAPL, TTHI, QQQ ||| Astec Misses Earnings & Sales Estimates - Analyst Blog ||| Facebook Smashes Earnings, Caterpillar Misses Big ||| Market Close Report: NASDAQ Composite index closes at 3,579.60 up .33 points ||| Weak Blue-Chip Earnings Push Dow Into the Red ||| Caterpillar Call Begins ||| Benzinga's PreMarket Info Recap for July 24, 2013: Ford and General Motors Trading at 2-Year Highs! ||| UPDATE: Caterpillar Posts Drop In Q2 Profit ||| Caterpillar, Inc. Lowers FY2013 EPS Guidance from $7.00 to $6.50 vs $6.81 Est; Lowers FY2013 Sales Guidance from $57.0B-61.0B to $56.0B-58.0B vs $58.60B Est ||| Caterpillar, Inc. Reports Q2 EPS of $1.45 vs $1.70 Est; Revenue of $14.62B ||| Benzinga Market Primer: Wednesday, July 24: Apple Earnings Beat ||| Economic Calendar for Wednesday July 24, 2013 ||| US Stock Futures Rise After Upbeat Apple Results ||| Earnings Scheduled For July 24, 2013",0,0.4916182
2013-07-25,9941300.0,82.05000305175781,82.58000183105469,81.3499984741211,82.13999938964844,61.82599639892578,CAT,"Stock Market News for July 25, 2013 - Market News ||| Things Stay The Same! Nothing Much Happens! ||| Stock Downgrades: Caterpillar Inc. Is Sent to the Doghouse ||| iShares Silver Trust ETF Traders Bet on a Big Bounce ||| UBS Maintains Neutral on Caterpillar, Inc., Lowers PT to $84.00 ||| Barclays Maintains Overweight on Caterpillar, Inc., Lowers PT to $99.00 ||| Benzinga's Top Downgrades ||| BMO Capital Downgrades Caterpillar to Market Perform, Lowers PT to $86.00",0,0.4666642
2013-07-26,5727000.0,81.87999725341797,82.08000183105469,81.43000030517578,82.05999755859375,61.76577758789063,CAT,Terex's Q2 Earnings Slump Y/Y - Analyst Blog,1,0.54192144
2013-07-29,9068800.0,82.41999816894531,83.3499984741211,82.0,83.0199966430664,62.48835372924805,CAT,"Stock Upgrades: Publicis Groupe Gets Plaudits as Wall Street Goes Gaga for Madison Avenue ||| Market Close Report: NASDAQ Composite index closes at 3,599.14 down -14.02 points ||| After Hours Most Active for Jul 29, 2013 : ELN, PFE, HLF, QQQ, HAL, ZTS, CAT, MU, FB, GILD, AGNC, PDLI ||| Dow Backpedals Ahead of the Fed's Policy Meeting ||| Stocks to Watch for the Week of July 29, 2013 ||| Caterpillar Announces $1 Billion Accelerated Stock Repurchase Program",1,0.4844559
2013-07-30,5266000.0,83.47000122070312,83.75,82.66000366210938,83.19000244140625,62.61631774902344,CAT,Stock Downgrades: Frowns All Around for Colgate-Palmolive Company ||| The T3 Morning Market Call: World Markets Green Ahead of Fed Meeting ||| New Stock Coverage: Tumi Holdings Inc May Have Too Much Baggage,0,0.48348883
2013-08-05,3758400.0,84.11000061035156,84.29000091552734,83.5,83.55999755859375,62.89482879638672,CAT,"Bloomberg Reporting Caterpillar Facing Investor lawsuit Over $580 Million Writedown Following Chinese Acquisition, Board Misconduct",0,0.50289375
2013-08-06,7223600.0,83.30999755859375,83.31999969482422,82.1500015258789,82.52999877929688,62.119537353515625,CAT,"HEES Earnings Up Y/Y; At Par with Estimates - Analyst Blog ||| After Hours Most Active for Aug 6, 2013 : SIRI, CAT, FSLR, GM, IGT, QQQ, BAC, JNJ, WFC^Q, NUAN, SZYM, CTSH ||| Top 4 NYSE Stocks In The Farm & Construction Machinery Industry With The Highest Dividend Yield",0,0.4840262
2013-08-07,4292400.0,82.37999725341797,82.7699966430664,81.80000305175781,82.43000030517578,62.04426574707031,CAT,3 Income Stocks That Passed Our '2-Minute Test',1,0.5053035
2013-08-08,6400600.0,82.94999694824219,84.58999633789062,82.91999816894531,83.95999908447266,63.195892333984375,CAT,"Astec Industries, Inc. (ASTE) Ex-Dividend Date Scheduled for August 09, 2013 ||| JP Morgan Points to Caterpillar China Excavator Sales Growth for July, Believes Could Indicate Chinese Market Recovery",1,0.5163375
2013-08-09,5478600.0,83.80000305175781,84.79000091552734,83.5,84.51000213623047,63.60988235473633,CAT,"Caterpillar Down to Underperform - Analyst Blog ||| ISI Group Downgrades Caterpillar to Buy, Announces $92.00 PT",1,0.49542138
2013-08-12,8608300.0,84.19000244140625,86.44999694824219,84.05999755859375,86.31999969482422,64.97225189208984,CAT,"Dendreon Cuts Loss, Shares Fall on Weak Guidance - Analyst Blog ||| Market Close Report: NASDAQ Composite index closes at 3,669.95 up 9.84 points ||| Stocks Get China Boost From Second China Disneyland Loan ||| China Stocks Rallying On ""Stealth Stimulus"" Loan From Agricultural Bank To Shanghai ||| China Stocks Rallying on News that a State Owned Bank Will Be Giving Shanghi a Loan Equivalent to Roughly 7% of its GDP; Watch Catapillar, Deere, Mecox Lane, E-Commerce China Dang Dang; US Steel, and Freeport McMoran",1,0.49658984
2013-08-13,6710300.0,86.62000274658203,87.43000030517578,86.44999694824219,86.56999969482422,65.16040802001953,CAT,"Caterpillar Presenting at Jefferies Global Industrial Conference: Strong Cash Flow Enables Stock Buybacks, Construction is Improving and Will Stay Steady",0,0.49921346
2013-08-20,4690000.0,83.80000305175781,84.45999908447266,83.2699966430664,83.86000061035156,63.1206283569336,CAT,"Sectors That Will Struggle in a Higher Interest Rate, Higher Bond Yield Environment ||| Cat Says Officers Steve Fisher, Steve Larson, Bill Rohner Retiring ||| Cat Reports Three-Month July Machine Retail Sales Down 9%",0,0.49447548
2013-08-21,5562600.0,83.5199966430664,83.8499984741211,82.83000183105469,82.94000244140625,62.42813491821289,CAT,"Caterpillar's July Sales Dip 9%, Shares Fall - Analyst Blog ||| Nikkei Reporting Komatsu Set to Take Margin Lead over Cat ||| Daiwa Securities Downgrades Caterpillar, Inc. to Neutral",1,0.47590038
2013-08-23,4487200.0,84.37999725341797,84.4000015258789,83.4000015258789,83.88999938964844,63.14322280883789,CAT,"After Hours Most Active for Aug 23, 2013 : HAL, MSFT, QQQ, ORCL, QCOM, BMY, WFC, CSCO, VALE/P, SIRI, FB, CAT",0,0.483895
2013-08-26,4123300.0,83.9800033569336,84.77999877929688,83.5199966430664,83.55999755859375,62.89482879638672,CAT,"After Hours Most Active for Aug 26, 2013 : JCP, FTK, QQQ, HCBK, GILD, ONXX, BAC, MSFT, CDNS, RF, CAT, AMD ||| Dow, S&P 500 Erase Friday's Momentum on Lackluster Data",0,0.4832725
2013-08-27,5569900.0,82.87999725341797,83.54000091552734,82.4800033569336,82.69999694824219,62.247501373291016,CAT,"NACCO Industries, Inc. (NC) Ex-Dividend Date Scheduled for August 28, 2013 ||| Hyster-Yale Materials Handling, Inc. (HY) Ex-Dividend Date Scheduled for August 28, 2013",0,0.42185238
2013-08-28,6762900.0,81.80999755859375,82.66000366210938,81.45999908447266,82.44999694824219,62.059326171875,CAT,Joy Global Beats Earnings Estimates - Analyst Blog,1,0.53265554
2013-08-30,4425700.0,82.58999633789062,82.76000213623047,82.20999908447266,82.54000091552734,62.1270751953125,CAT,"Earnings at Record Level, But Outlook is Weak - Earnings Outlook ||| Caterpillar vs. Peers: Fundamental Analysis ||| Deere & Company: In Maintenance Mode? Earnings Analysis",0,0.4946259
2013-09-03,7544200.0,83.1500015258789,83.54000091552734,81.72000122070312,82.51000213623047,62.1044921875,CAT,"Guru Stocks at 52-Week Lows: RDS.A, IBM, T, PM, CAT",1,0.5146285
2013-09-05,3728400.0,83.37000274658203,83.5199966430664,82.70999908447266,82.94999694824219,62.43565368652344,CAT,"Why the VIX Could Stay Low for a Long Time ||| UPDATE: Morgan Stanley Initiates Coverage on Caterpillar on 2014e Outlook Skepticism ||| Morgan Stanley Initiates Coverage on Caterpillar, Inc. at Equal-weight, Announces $89.00 PT",1,0.48561105
2013-09-09,6702200.0,84.04000091552734,86.02999877929688,84.0199966430664,85.58999633789062,64.42277526855469,CAT,"NASDAQ Composite Index closes up 1.23 points for the week, rising for the 5th straight day ||| Markets Spike on Global Economic Data, Syria Optimism",1,0.5011683
2013-09-10,6298400.0,86.80999755859375,86.88999938964844,86.18000030517578,86.61000061035156,65.1905288696289,CAT,Dow Jones Industrial Average ETF Gets A Makeover,1,0.5003406
2013-09-11,4382900.0,86.5,87.12999725341797,86.26000213623047,87.12999725341797,65.58191680908203,CAT,"Miller Industries, Inc. (MLR) Ex-Dividend Date Scheduled for September 12, 2013 ||| The Fed View & Our Market Strategy - Analyst Blog",0,0.48001075
2013-09-12,3980600.0,86.94000244140625,87.22000122070312,86.62000274658203,86.83999633789062,65.36365509033203,CAT,"Mixed August Retail Sales for Deere - Analyst Blog ||| Watch Shares of Caterpillar, Deere, Devon, Merck, and Oracle to the Downside on a Bearish Article from Jim Cramer Tweeted Out by Carl Icahn ||| Scary Story on the Booming Auto Sales No One Is Talking About",1,0.5241161
2013-09-16,4866600.0,87.95999908447266,88.22000122070312,87.02999877929688,87.18000030517578,65.61956787109375,CAT,"Three Top Stocks for the Post-Summers Uptick ||| Cat Shares Open Under $88, Push Over Resistance Level, Now Nosediving as Hearing Chatter of Negative Analyst Commentary, Shares Up 0.4% at Last Check",0,0.5247882
2013-09-17,3415400.0,87.36000061035156,87.44999694824219,86.66999816894531,87.06999969482422,65.53677368164062,CAT,"Douglas Dynamics, Inc. (PLOW) Ex-Dividend Date Scheduled for September 18, 2013 ||| Jim Chanos Just Recently Speaking on Bloomberg TV, Some Highlights: He's Short Chinese Banks, Still Short on Cat, Says Has Sold Out of Microsoft Position Since Latest 13F Filing ||| Cat Reaffirms Outlook Ahead of Citi Global Industrials Conference at 8AM EDT",1,0.49767974
2013-09-18,5564700.0,86.30999755859375,88.01000213623047,86.19999694824219,87.83999633789062,66.1163330078125,CAT,"Dendreon's Provenge Cleared in the EU - Analyst Blog ||| Baird Downgrades Caterpillar, Inc. to Neutral, Maintains $90.00 PT",0,0.49969006
2013-09-20,13435200.0,87.61000061035156,87.6500015258789,84.75,84.75,63.790523529052734,CAT,"Machinery Industry Stock Outlook - Sept 2013 - Industry Outlook ||| Machinery Industry Stock Outlook - Sept 2013 - Zacks Analyst Interviews ||| Market Close Report: NASDAQ Composite index closes at 3,774.73 down -14.65 points ||| Form 8-K from Cat Shows Aug. Global Sales Down 10%, NA Sales up 1%",1,0.49483317
2013-09-23,6048400.0,85.0,85.38999938964844,84.37999725341797,85.02999877929688,64.00127410888672,CAT,"Company News for September 23, 2013 - Corporate Summary ||| PreMarket Info Recap for September 23, 2013: Which Gaps? The Witch Gaps!",1,0.4763231
2013-09-25,3824700.0,85.13999938964844,85.55000305175781,84.43000030517578,84.5,63.60232162475586,CAT,"MT Insider: Bloomberg Markets 50 Summit - Chanos Maintains Bearish Position on China, O'Neill Cites Growth in New Economy ||| Stock Market News for September 25, 2013 - Market News ||| Market Primer: Wednesday, September 25: Investors Hesitant, US In Focus",0,0.49003968
2013-09-30,5401500.0,82.94999694824219,83.83000183105469,82.83000183105469,83.4000015258789,62.77438354492188,CAT,"Barron's Recap: The Baby Boom Budget Bomb ||| Form 8-K from Cat Shows Price Action of 0-2% on Most Machines, Sees Emisions Price Action 2-6% on Most Machine Models",1,0.5042232
2013-10-03,4223500.0,83.88999938964844,84.2699966430664,83.41999816894531,83.97000122070312,63.203426361083984,CAT,"Apple, Boeing, Merck, and More: Top Stocks for the Fourth Quarter",1,0.506265
2013-10-07,3364300.0,83.45999908447266,84.16000366210938,83.30000305175781,83.52999877929688,62.87223815917969,CAT,What to Expect from Deere's Sept Sales - Analyst Blog,0,0.5034645
2013-10-09,4577500.0,83.05000305175781,83.88999938964844,82.44999694824219,83.5199966430664,62.864688873291016,CAT,Cat Maintains Dividend Rate at $0.60/Share Per Quarter,1,0.5351532
2013-10-11,4110300.0,84.63999938964844,85.8499984741211,84.3499984741211,85.61000061035156,64.4378433227539,CAT,"Stock Market News for October 11, 2013 - Market News",1,0.50496894
2013-10-14,4689600.0,85.05999755859375,86.41999816894531,84.86000061035156,86.23999786376953,64.91202545166016,CAT,"MT Insider: All Eyes On Washington As Fiscal Impasse Continues, Markets Still Taking Development in Stride",0,0.50735873
2013-10-16,3549500.0,86.05999755859375,86.48999786376953,85.5999984741211,86.2699966430664,64.93460845947266,CAT,"Caterpillar, Inc. (CAT) Ex-Dividend Date Scheduled for October 17, 2013",0,0.43136266
2013-10-18,6752700.0,86.30999755859375,87.76000213623047,86.2699966430664,87.33999633789062,66.20038604736328,CAT,"Markets Close North of Breakeven, Notch Weekly Gains ||| Trading Radar: Busiest Earnings Week of the Quarter Approaching ||| Benzinga Weekly Preview: Earnings Season Continues, Delayed US Data To Hit Markets ||| UPDATE: Longbow Research Reiterates Buy Rating on Caterpillar",1,0.51162344
2013-10-21,3883500.0,87.72000122070312,87.80000305175781,87.19000244140625,87.69999694824219,66.47325897216797,CAT,Earnings Expectations For The Week Of October 21: The Crunch Is On ||| Caterpillar Earnings Preview: Eye On China (CAT),1,0.49082693
2013-10-22,9152900.0,87.87999725341797,89.16999816894531,87.54000091552734,89.16999816894531,67.58747100830078,CAT,"Will Caterpillar (CAT) Miss Earnings Estimates? - Analyst Blog ||| Shorts Maintain Bullish History Trading Caterpillar Off Pre-Bell Earnings ||| Despite Weak Jobs Report, Stocks Hit Higher Highs ||| Pre-Market Earnings Report for October 23, 2013 : BA, BMY, CAT, LLY, TMO, GD, WLP, NSC, NOC, CP, AEP, PLD ||| UPDATE: Cat Reports Retail North America Sales Up 4%,EAME Sept. Three-Month Rolling Sales Down 11%, Asia/Pacific Sales Down 24%, LatAm Down 10% ||| Cat Issues Three-Month Rolling Retail Machine Sales, Down 9%",0,0.47929734
2013-10-23,20968800.0,84.1500015258789,84.6500015258789,83.05000305175781,83.76000213623047,63.4869270324707,CAT,"Pre-Market Most Active for Oct 23, 2013 : ARCP, GLW, COLE, FB, CCI, APOL, BAC, CAT, RDS/A, QQQ, SIRI, CREE ||| A Tale of Two Earnings Reports - Ahead of Wall Street ||| Stocks Turn Negative on Mixed Earnings ||| Stock Upgrades: Who Needs an iWatch When There's Fossil? ||| Mid-Day Market Update: Apollo Group Jumps On Upbeat Results; Cree Shares Slip ||| Mid-Day Update: Stocks Falling After Mixed Earnings, Chinese Inflation Data Spooks Markets ||| Can Caterpillar Inc. (CAT) Continue to Rise? - Tale of the Tape ||| US Stocks Seen Opening Lower as China Warns of Lower Spending ||| Mid-Afternoon Market Update: Markets Remain in the Red as Corning Recovers More of its Gains ||| US Futures Seen Following Global Markets Lower as China puts on Brakes ||| Weakness in Asian Markets Cause US Stocks to Sell Off ||| Closing Update: Stocks Finish Listless Session Lower; Equities Drop Following Downbeat Guidance ||| Stocks Falter on Earnings, Overseas Concerns ||| Market Wrap for October 23: Stocks Fall Back as Caterpillar and Cree Forecasts Dismay Traders ||| Mid-Afternoon Market Update: Markets Remain in the Red as Corning Recovers More of its Gains ||| Mid-Day Market Update: Apollo Group Jumps On Upbeat Results; Cree Shares Slip ||| From Cat Call: CEO Oberhelman Says Co. is On Cost Lockdown ||| From Cat Call: Says Outlook Indicates Drop in EPS from Q3 to Q4, Says 2014 Global Economic Growth May Be Better ||| Cat Conference Call Just Beginning: Exec Saying Mining Has Been Difficult to Forecast ||| Mid-Morning Market Update: Markets Tumble; Caterpillar Profit Misses Estimates ||| UPDATE: Caterpillar Posts Downbeat Q3 Results, Lowers FY13 Forecast ||| Caterpillar, Inc. Lowers FY2013 EPS Guidance from $6.50 to $5.50 vs $6.19 Est ||| Caterpillar, Inc. Reports Q3 EPS of $1.45 vs $1.70 Est; Revenue of $13.40B vs $14.40B Est ||| US Stock Futures Down Ahead Of Earnings ||| Market Primer: Wednesday, October 23: Fed Taper Outlook Looking Cloudy ||| Earnings Scheduled For October 23, 2013 ||| Stocks To Watch For October 23, 2013",1,0.48688447
2013-10-24,8368700.0,83.31999969482422,85.0,83.12999725341797,84.52999877929688,64.07052612304688,CAT,"Caterpillar's Earnings Highlight Mining Industry's Challenges ||| It's Decision Time for the Stock Market: Trick or Treat? ||| Stock Market News for October 24, 2013 - Market News ||| Stock Upgrades: Goldman Given a Blankfein Check ||| Into the Heart of Q3 Earnings Season - Earnings Trends ||| Have The Worries Returned To Broad and Wall? ||| What's Really Behind China's Economic Growth and Why It Won't Last ||| UPDATE: J.P. Morgan Downgrades Caterpillar on Weaker Execution, Mounting Headwinds ||| UPDATE: Raymond James Downgrades Caterpillar Following 3Q13 EPS Results Miss ||| Benzinga's Top Downgrades ||| US Stock Futures Up Ahead Of Ford Earnings, Jobless Claims Data ||| Market Primer: Thursday, October 24: Investors Switch Focus To Earnings ||| JP Morgan Downgrades Caterpillar, Inc. to Neutral, Lowers PT to $90.00 ||| Raymond James Downgrades Caterpillar, Inc. to Market Perform, Lowers PT to $89.00",1,0.49918666
2013-10-25,4886400.0,84.31999969482422,84.77999877929688,83.61000061035156,84.7699966430664,64.25242614746094,CAT,"Stock Upgrades: DuPont Regains Its Teflon Touch ||| UPDATE: Atlantic Equities Downgrades Caterpillar on Lack of Catalysts ||| Atlantic Equities Downgrades Caterpillar, Inc. to Neutral, Lowers PT to $92.00",0,0.47427687
2013-10-28,3979200.0,84.5,84.7300033569336,84.1500015258789,84.27999877929688,63.88105773925781,CAT,Manitowoc Shares Up on Earnings Beat - Analyst Blog ||| Caterpillar Downgraded to Strong Sell - Analyst Blog ||| Caterpillar is Pulling its Weight ||| What Caterpillar's Big Drop in Earnings Means for the General Stock Market,0,0.48776233
2013-10-29,5324100.0,83.91000366210938,84.0999984741211,83.29000091552734,84.06999969482422,63.72186279296875,CAT,Earnings Season in Focus: What's Next for Stocks? - Analyst Blog,0,0.51162463
2013-10-31,4651300.0,83.44000244140625,84.2699966430664,83.36000061035156,83.36000061035156,63.1837272644043,CAT,"Record Earnings, But Outlook is Uncertain - Earnings Outlook ||| Record Earnings, But Outlook is Uncertain - Earnings Trends",1,0.504374
2013-11-04,3892500.0,83.80999755859375,83.98999786376953,83.44999694824219,83.88999938964844,63.58545303344727,CAT,The Single Most Important Attribute A Business Can Have ||| DJ Reporting Cat is Closing its Mining-Equipment Facility in West Virginia,1,0.50909597
2013-11-06,3664100.0,84.30000305175781,84.36000061035156,83.8499984741211,84.22000122070312,63.835575103759766,CAT,"Astec Industries, Inc. (ASTE) Ex-Dividend Date Scheduled for November 07, 2013 ||| HEES Gains on Earnings Beat - Analyst Blog ||| Cat Shares Moving Lower as Slides for Baird Industrial Conference Released, Co. Expecting Q3 EPS ~$1.29, Affirms FY13 Outlook",0,0.48344272
2013-11-07,5431600.0,83.94999694824219,84.43000030517578,83.5,83.6500015258789,63.40351486206055,CAT,"Q3 Earnings: The Best of 2013 Thus Far - Earnings Trends ||| ISI Group Downgrades Caterpillar, Inc. to Neutral",1,0.4991013
2013-11-08,4557300.0,83.5199966430664,84.31999969482422,83.5,84.23999786376953,63.85072326660156,CAT,"#PreMarket Primer: Friday, November 8: Investors Tweet A Sigh Of Relief ||| #PreMarket Primer: Friday, November 8: Investors Tweet A Sigh Of Relief",0,0.47117805
2013-11-13,3952800.0,83.45999908447266,84.25,83.0,84.19999694824219,63.82038879394531,CAT,Caterpillar Down to Underperform - Analyst Blog,0,0.501156
2013-11-14,4496300.0,84.0,84.19999694824219,83.55999755859375,83.76000213623047,63.4869270324707,CAT,"Buy Illinois Stocks, Not Chicago Bonds",0,0.49406537
2013-11-15,4743900.0,84.0,84.11000061035156,83.5,83.73999786376953,63.47175216674805,CAT,10 Stocks Below Their 50-Day Moving Average,1,0.5377032
2013-11-18,4803100.0,84.05000305175781,84.97000122070312,83.73999786376953,84.04000091552734,63.69915008544922,CAT,Invest like Buffett to Profit from Growth in Asia,0,0.5462482
2013-11-20,7443000.0,83.18000030517578,83.70999908447266,82.45999908447266,82.68000030517578,62.66831207275391,CAT,"Caterpillar to Close Another Mine - Analyst Blog ||| Market Wrap For November 20: Inflation Data Points To ""No"" Tapering, Fed Meeting Notes Points To ""Yes"" Tapering ||| Caterpillar Shares React After 8-K Form Disclosed Dealer Retail Shares and Power System Statistics ||| Traders in Cat Responding to Form 8-K Disclosing Three-Month Global Rolling Machine Retail Sales Down 12%",0,0.49710402
2013-11-21,6208500.0,83.05000305175781,83.08999633789062,81.87000274658203,82.12000274658203,62.24386596679688,CAT,"Caterpillar Slips as Sales Drop Again - Analyst Blog ||| Dow Secures a Triple-Digit Gain, Takes Out 16,000 ||| For the Patient Investor, High-Dividend, High Beta Stocks Can Be Highly Rewarding",1,0.50051945
2013-11-22,4403800.0,82.22000122070312,82.94999694824219,82.0,82.87999725341797,62.81989669799805,CAT,"Food for Thought on Record Highs, Taper - Ahead of Wall Street ||| #PreMarket Primer: Friday, November 22: Draghi Defends ECB Rate Cut ||| Feds Investigate Caterpilliar Division for Alleged Dumping of Train Parts into Ocean ||| #PreMarket Primer: Friday, November 22: Draghi Defends ECB Rate Cut",1,0.49134898
2013-11-25,8111400.0,84.4000015258789,84.94000244140625,83.87000274658203,84.4000015258789,63.97199630737305,CAT,"Forget Bubbles -- Values Still Remain ||| NACCO Industries, Inc. (NC) Ex-Dividend Date Scheduled for November 26, 2013 ||| Hyster-Yale Materials Handling, Inc. (HY) Ex-Dividend Date Scheduled for November 26, 2013 ||| Manitowoc Company, Inc. (MTW) Ex-Dividend Date Scheduled for November 26, 2013 ||| Market Wrap For November 25: Nasdaq Breaks 4,000 Level For First Time Since 2000 ||| UPDATE: Bank of America Upgrades Caterpillar Following Visit to SOLAR Turbine Facility ||| Benzinga's Top Upgrades ||| US Stock Futures Up Ahead Of Pending Home Sales ||| Bank of America Upgrades Caterpillar, Inc. to Buy, Raises PO to $100.00",0,0.44181812
2013-11-29,2284400.0,84.63999938964844,85.18000030517578,84.52999877929688,84.5999984741211,64.12358093261719,CAT,Market Timing Report: Rough Waters Ahead,0,0.5069738
2013-12-02,4834700.0,84.69999694824219,85.08999633789062,84.02999877929688,84.25,63.85829925537109,CAT,"Twitter, Deere And Other Stocks To Unload For 2014 ||| Cat Seeking to Cancel Listing on Frankfurt Stock Exchange",0,0.4870479
2013-12-04,5246700.0,83.75,84.37999725341797,83.11000061035156,83.97000122070312,63.64608001708984,CAT,"Miller Industries, Inc. (MLR) Ex-Dividend Date Scheduled for December 05, 2013 ||| Cat Exec at Credit Suisse Industrial Conference: Mining Has Been 'Tough' to Forecast, Mgmt Surprised by Weakness in After Market in Mining Segment",1,0.4986837
2013-12-11,5624100.0,86.02999877929688,86.22000122070312,85.12000274658203,85.27999877929688,64.63897705078125,CAT,Terex to Sell Truck Biz to Volvo for $160M - Analyst Blog ||| Bear of the Day: Caterpillar (CAT) - Bear of the Day,1,0.4874095
2013-12-13,4226200.0,85.66999816894531,86.2300033569336,85.56999969482422,86.05000305175781,65.22264099121094,CAT,Will Dividend Stocks be the Big Winners in the Budget Deal?,1,0.5090671
2013-12-16,6976200.0,86.5,87.8499984741211,86.44000244140625,87.37999725341797,66.23072814941406,CAT,"Westport Innovations Spikes Higher on Shell Canada, Caterpillar Announcement ||| Shell Canada, Caterpillar Sign Agreement Exploring LNG Fuelling Options for Mining Trucks",0,0.51454425
2013-12-17,4764400.0,87.22000122070312,87.6500015258789,86.37999725341797,86.91999816894531,65.882080078125,CAT,Mixed November Retail Sales for Deere - Analyst Blog ||| Slideshow: The Top 10 'Highs & Dives' Of S&P 500 Stocks In 2013,1,0.5218831
2013-12-18,6963200.0,87.01000213623047,88.45999908447266,86.6500015258789,88.16999816894531,66.82951354980469,CAT,"Douglas Dynamics, Inc. (PLOW) Ex-Dividend Date Scheduled for December 19, 2013",0,0.45334226
2013-12-19,4299700.0,87.5,87.83999633789062,87.26000213623047,87.54000091552734,66.35199737548828,CAT,"Market Wrap For December 18: Markets Flat During Day One Post Fed Taper ||| Cat Reports Nov. Three-Month Global Machine Sales Down 12%, North American Sales Down 2%",1,0.51561755
2013-12-20,7389700.0,87.8499984741211,89.11000061035156,87.80999755859375,88.93000030517578,67.4055404663086,CAT,"Midday Update: Q3 GDP Revision to 4.1% Sends Stocks To Record Levels ||| Dow, S&P 500 End Week at Record Highs ||| Pension Costs to Hurt Q4 at Allstate - Analyst Blog",1,0.52455217
2013-12-23,5733300.0,89.30999755859375,90.06999969482422,89.2699966430664,89.95999908447266,68.18627166748047,CAT,"Form 8-K from Caterpillar Shows Co. Cutting Jobs in Gosselies, Belgium Operations, Sees Pretax Employee Separation Costs $300M in Belgium",1,0.52454746
2013-12-24,2675700.0,90.0,90.9800033569336,89.98999786376953,90.91000366210938,68.9063491821289,CAT,Is This the Top for Caterpillar Inc. (CAT)? - Tale of the Tape,1,0.48493314
2013-12-26,4790800.0,90.98999786376952,91.66999816894533,90.6999969482422,91.1500015258789,69.08821868896484,CAT,5 Conglomerates Stocks With The Highest EPS Estimates,0,0.5358831
2013-12-27,3373800.0,91.13999938964844,91.43000030517578,90.55999755859376,90.87000274658205,68.87601470947266,CAT,Four Of 2013's Most Disappointing Stocks,0,0.5163182
2013-12-30,2625000.0,90.8499984741211,91.02999877929688,90.27999877929688,90.87000274658205,68.87601470947266,CAT,Mining Weakness Could Persist To Weigh On Caterpillar's Results In 2014,0,0.51970196
2014-01-03,3722000.0,90.0,90.25,89.58999633789062,89.81999969482422,68.08015441894531,CAT,"Cat, Trimble Report Expanded Deal for Solutions, Services Offerings",0,0.51867664
2014-01-06,5233900.0,90.19000244140624,90.3000030517578,88.37999725341797,88.63999938964844,67.18576049804688,CAT,USA TD Ameritrade's Investor Movement Index for Dec 5.62 vs 5.42 Prior,1,0.5198552
2014-01-13,5213600.0,90.26000213623048,91.26000213623048,89.81999969482422,89.88999938964844,68.13319396972656,CAT,Market Wrap For January 13: Markets Showing Weakness Ahead Of Major Earning Releases,1,0.5316232
2014-01-15,10121900.0,90.87999725341795,93.1999969482422,90.87999725341795,92.41000366210938,70.04326629638672,CAT,"Caterpillar, Inc. (CAT) Ex-Dividend Date Scheduled for January 16, 2014",0,0.44724187
2014-01-16,4771000.0,91.88999938964844,92.86000061035156,91.6999969482422,92.01000213623048,70.19586944580078,CAT,Machinery Industry Stock Outlook - Jan 2014 - Industry Outlook ||| Machinery Industry Stock Outlook - Jan 2014 - Zacks Analyst Interviews,0,0.4931002
2014-01-17,6833400.0,92.1500015258789,92.26000213623048,91.01000213623048,91.44000244140624,69.76100158691406,CAT,Caterpillar Inc. (CAT): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report,0,0.48847812
2014-01-21,5544900.0,91.5999984741211,91.8499984741211,89.63999938964844,90.5999984741211,69.12014770507812,CAT,Caterpillar Upgraded to Neutral - Analyst Blog ||| Morgan Stanley Maintains on Caterpillar,0,0.49492824
2014-01-23,5014800.0,88.69999694824219,89.08000183105469,88.05000305175781,88.4800033569336,67.50274658203125,CAT,Weak Mining Demand Will Continue To Dig In To Caterpillar's Results,0,0.5110125
2014-01-24,8087400.0,87.9800033569336,87.98999786376953,85.87999725341797,86.16999816894531,65.74041748046875,CAT,"Midday Update: Stocks Down For 4th Straight Day on Emerging Market Instability ||| Stocks Fall, Caught Up In Global Currency Turmoil, Emerging-Market Exodus ||| Benzinga Weekly Preview: Tech Sector To Steal The Spotlight ||| Caterpillar Earnings Preview: Mining Slump Still a Drag ||| Is a High Yield, High Beta Stock the Best Way to Book Big Dividends? ||| Caterpillar Dealer Machinery Sales Down 9% In Latest 3 Months ||| Top 4 NYSE Stocks In The Farm & Construction Machinery Industry With The Highest Revenue",1,0.49834007
2014-01-27,22202300.0,91.7699966430664,92.30999755859376,89.06999969482422,91.29000091552734,69.64655303955078,CAT,"US Futures Point Higher After Sell-Off Even as Emerging Market Rout Continues ||| Stock Market News for January 27, 2014 - Market News ||| US Stocks Set For Rebound Amid Earnings And Deals; Investors Still Shun Emerging Markets ||| Emerging Market Weakness, Disappointing Home Sales Erases Early Gains ||| Emerging Markets Make Investors Critical - Ahead of Wall Street ||| Caterpillar Stock Surges ||| Midday Update: Wall Street Unnerved By Emerging Markets, Weak Home Sales ||| Pre-Market Most Active for Jan 27, 2014 : VOD, ARIA, CAT, BAC, MT, GERN, ALU, FB, MTU, NOK, CSCO, SPIL ||| Closing Update: Late Rally Fizzles, Leaving Stocks Lower For A Third Day ||| Market Bubble Goes Pop! ||| Caterpillar's 4Q Impressive, but an Unlucky 2013 - Analyst Blog ||| After Solid Earnings, Are You Buying Caterpillar Stock? - Real Time Insight ||| Mid-Afternoon Market Update: Markets Post Rally to Go Into the Green; Precious Metals Take a Hit ||| Sector Update: Financial ||| Dow Declines Again; VIX Pulls Back ||| History Supports Shorts Trading Caterpillar off Pre-Market Earnings ||| Moody's Says Cat's Buyback News is Credit Negative ||| Market Wrap For January 27: China Concerns, Declining Home Sales, Tomorrow's Fed Meeting and Obama's Speech Keep Markets Lower ||| Mid-Afternoon Market Update: Markets Post Rally to Go Into the Green; Precious Metals Take a Hit ||| Caterpillar Rallies - But Way Off Highs For The Day ||| Mid-Day Market Update: U.S. Stocks Tumble; Regis Shares Decline On Downbeat Results ||| Winter's Stock Knockdown May Give Way To A Spring Thaw ||| Monday's Premarket Earnings Reports ||| From Cat Call: Expecting Q1 Sales to Be Flat YoY ||| Benzinga's Volume Movers ||| Mid-Morning Market Update: Markets Mostly Higher; Caterpillar Results Beat Street View ||| Top Trending Tickers On StockTwits For January 27 ||| Benzinga's Top #PreMarket Gainers ||| UPDATE: Caterpillar Posts Higher Q4 Profit ||| US Stock Futures Gain Ahead Of Home-Sales Data ||| Caterpillar Announces $10B Buyback; May Buyback up to $1.7B in Q1 ||| Caterpillar, Inc. Sees FY2014 EPS $5.85 vs $5.78 Est; Sees Sales $56.0B vs $55.30B Est ||| Caterpillar, Inc. Reports Q4 EPS of $1.54 vs $1.28 Est; Revenue of $14.40B vs $13.64B Est; Says Could Buyback Up to $1.7B in Q1 ||| Earnings Expectations For The Week Of January 27: Facebook, Google, Apple And More ||| Earnings Scheduled For January 27, 2014 ||| Stocks To Watch For January 27, 2014",1,0.49869552
2014-01-28,9409600.0,91.4000015258789,92.66999816894533,91.3499984741211,92.47000122070312,70.54680633544922,CAT,"Company news for January 28, 2014 - Corporate Summary ||| Caterpillar Inc. (CAT) Jumps: Stock Up 5.9% - Tale of the Tape ||| S",0,0.47888193
2014-01-30,14764700.0,91.52999877929688,93.8499984741211,90.7300033569336,93.1999969482422,71.10372161865234,CAT,Caterpillar Expands in Northern Ireland - Analyst Blog ||| Cat Closes $7.5B Buyback Authorization with Citibank ||| Caterpillar Announces Completion of $7.5B Repurchase Authorization with $1.7B Accelerated Stock Repurchase Transaction,1,0.50574625
2014-01-31,9697300.0,92.16000366210938,94.69000244140624,92.01000213623048,93.91000366210938,71.64542388916016,CAT,"Dow 30 Stock Roundup: Visa Leads, Exxon Profit Slips - Analyst Blog ||| Caterpillar to Repurchase $1.7B Shares - Analyst Blog ||| Caterpillar's Results Clipped By Mining Weakness But Its Sales Will Likely Stabilize In 2014",0,0.50925994
2014-02-03,9084100.0,93.73999786376952,93.94000244140624,91.9499969482422,92.41999816894533,70.50865936279297,CAT,"One Put, One Call Option To Know About for Caterpillar ||| Caterpillar Leads the Dow - Analyst Blog ||| Manitowoc Shares Rise on Earnings Beat - Analyst Blog",1,0.48482016
2014-02-04,6839700.0,92.4800033569336,92.6500015258789,91.48999786376952,92.5,70.56967163085938,CAT,"Noteworthy ETF Inflows: IYJ, CAT, ACN, PCP",0,0.5193971
2014-02-06,6844200.0,91.94000244140624,94.2300033569336,91.79000091552734,93.83000183105467,71.5843505859375,CAT,Allstate Earnings Top on Low CAT Loss - Analyst Blog,1,0.5249382
2014-02-07,9140200.0,94.16999816894533,95.23999786376952,93.87999725341795,94.87000274658205,72.37779235839844,CAT,"Fitch Affirms Ratings on Cat, Cat Financial; Outlook Stable",0,0.50250554
2014-02-10,5933400.0,94.97000122070312,94.9800033569336,93.62999725341795,94.5,72.09552001953125,CAT,TD Ameritrade's Investor Movement Index for Jan. Edges Higher to 5.66,1,0.5030681
2014-02-11,6006100.0,94.62000274658205,95.33999633789062,94.27999877929688,94.95999908447266,72.44644927978516,CAT,"Stock Market News for February 11, 2014 - Market News ||| Energy Price Spread: Natural Gas Vs. Crude Oil In The U.S. ||| 3 Heavy Industry Stocks In The US That Will Profit From Greater Consumer Spending In China",1,0.5065908
2014-02-12,8002000.0,95.30999755859376,96.63999938964844,95.16999816894533,96.16999816894533,73.36956787109375,CAT,"After Hours Most Active for Feb 12, 2014 : VZ, CSCO, WFM, CX, INTC, HFC, WEN, BAC, ZNGA, HIMX, WMB, CAT ||| Bulls Take a Breather as Dow Ends in the Red",0,0.4732845
2014-02-13,4387000.0,95.29000091552734,96.41000366210938,95.11000061035156,96.11000061035156,73.32382202148438,CAT,China Data Lifts Construction Equipment Stocks - Analyst Blog,1,0.5251402
2014-02-18,4871700.0,95.8499984741211,96.94000244140624,95.8499984741211,96.55999755859376,73.66709899902344,CAT,"Bill Gates Foundation Buys McDonald's, Exxon Mobil, Caterpillar Inc, Sells Procter & ... ||| Caterpillar Hits 52-Week High - Analyst Blog ||| Mining Sector Trends Pointing Towards A Recovery Are Good News For Caterpillar ||| Options Outlook For The Week Of February 17: Time To Link Up With LinkedIn?",0,0.49074695
2014-02-19,5865200.0,96.19000244140624,97.66999816894533,96.11000061035156,96.20999908447266,73.40011596679688,CAT,"Notable ETF Outflow Detected - VIS, UPS, CAT, EMR",1,0.49907786
2014-02-20,7718400.0,96.51000213623048,97.5199966430664,95.3000030517578,96.91999816894533,73.94176483154297,CAT,"Terex Beats on Q4 Earnings, Shares Dip on Low Guidance - Analyst Blog ||| Cat Reports Rolling Global Three-Month Retail Sales Down 8% ||| Benzinga's Top Initiations ||| Deutsche Bank Initiates Coverage on Caterpillar, Inc. at Buy, Announces $122.00 PT",1,0.51043034
2014-02-21,5554600.0,97.11000061035156,97.9499969482422,96.91999816894533,97.5,74.38427734375,CAT,Allstate Up on Boosted Capital Plan - Analyst Blog ||| Manitowoc Hits New 52-Week High - Analyst Blog,0,0.52044314
2014-02-25,5989200.0,96.83999633789062,96.9800033569336,95.81999969482422,96.41000366210938,73.55266571044922,CAT,"NACCO Industries, Inc. (NC) Ex-Dividend Date Scheduled for February 26, 2014 ||| Hyster-Yale Materials Handling, Inc. (HY) Ex-Dividend Date Scheduled for February 26, 2014 ||| Where to Invest When Key Stock Indices Struggle to Climb Higher",1,0.4675973
2014-02-26,4753900.0,96.66000366210938,97.91000366210938,96.33999633789062,97.1999969482422,74.1553726196289,CAT,Why Charlie Sheen's Fourth Engagement Proves The Value Of Investing With Due Diligence,0,0.5218769
2014-02-27,4337700.0,97.20999908447266,97.63999938964844,96.5199966430664,96.6999969482422,73.77391815185547,CAT,"Caterpillar Becomes #4 Most Shorted Dow Stock, Replacing AT&T ||| Caterpillar vs. John Deere - Which Would You Rather Build With?",1,0.47893375
2014-03-03,4859200.0,96.31999969482422,96.66999816894533,95.5999984741211,96.30999755859376,73.47638702392578,CAT,Caterpillar Says There Has Been No Effect on Operations in Russia - Bloomberg,1,0.5333436
2014-03-04,6261300.0,97.1999969482422,97.45999908447266,96.55999755859376,97.0199966430664,74.01805114746094,CAT,"Market Wrap For March 4: Bulls Take Over As Ukraine Fears Dissipate ||| Standpoint Research Downgrades Caterpillar, Inc. to Hold",0,0.4883012
2014-03-05,5384800.0,96.54000091552734,96.9000015258789,95.87999725341795,96.37000274658205,73.52217102050781,CAT,"Terex Corporation (TEX) Ex-Dividend Date Scheduled for March 06, 2014 ||| Astec Industries, Inc. (ASTE) Ex-Dividend Date Scheduled for March 06, 2014",1,0.43813574
2014-03-06,6714300.0,96.9499969482422,98.1500015258789,96.66000366210938,97.5999984741211,74.46053314208984,CAT,"Dow Movers: HD, JPM ||| Joy Global Lags on Earnings - Analyst Blog",0,0.52025276
2014-03-07,5259200.0,97.77999877929688,97.87000274658205,96.5,97.0500030517578,74.04093933105469,CAT,Keith McCullough Tweets: 'Re-shorted $CAT for the 1st time in 2014 this morning in #RealTImeAlerts for @HedgeyeIndstrls',0,0.5003805
2014-03-10,4640300.0,96.63999938964844,96.8000030517578,95.86000061035156,96.75,73.81208801269531,CAT,"H&E Equipment Services Up on Earnings Beat - Analyst Blog ||| UPDATE: TD Ameritrade's IMX Sentiment for Feb. Gains, Now at 5.74",1,0.49528703
2014-03-11,5731200.0,97.08999633789062,97.91000366210938,96.62000274658205,96.83999633789062,73.88075256347656,CAT,"Can You Find Dow Bargains Hidden in the Dow's Record Run? ||| Balanced Risk-Reward for Caterpillar - Analyst Blog ||| Cat Exec Currently Speaking at JP Morgan's Aviation, Transportation, Industrials Conference: Targeting 15%+ Profit Growth, Sees Certain Years Below This Level, Certain Years Above ||| Cat Exec Currently Speaking at ISI Annual Industrial Conference: Says Co. Could Consider Small, Bolt-On Acquisitions, Says Optimism on North American Construction is 'Prevalant'",0,0.49804315
2014-03-12,4448600.0,96.3000030517578,97.23999786376952,96.3000030517578,96.81999969482422,73.86548614501953,CAT,"Miller Industries, Inc. (MLR) Ex-Dividend Date Scheduled for March 13, 2014",0,0.4551161
2014-03-13,8434600.0,97.1999969482422,97.7300033569336,95.05999755859376,95.61000061035156,72.9423599243164,CAT,"After Hours Most Active for Mar 13, 2014 : PHM, PBR, QQQ, VCSH, AMAT, FIG, BPO, CAT, BAC, MU, ULTA, RFMD",0,0.47457913
2014-03-17,4697200.0,95.98999786376952,96.4499969482422,95.5500030517578,95.66999816894533,72.98811340332031,CAT,"Noteworthy ETF Outflows: VTV, HON, AIG, CAT",1,0.5200667
2014-03-18,4921300.0,96.12000274658205,96.6500015258789,95.6999969482422,96.41000366210938,73.55266571044922,CAT,"Douglas Dynamics, Inc. (PLOW) Ex-Dividend Date Scheduled for March 19, 2014",0,0.45885321
2014-03-20,4396000.0,95.70999908447266,96.23999786376952,95.0999984741211,96.20999908447266,73.40011596679688,CAT,"UPDATE: Cat Reports North American Three-Month Retail Sales Growth 2%, LatAm Down 16%, EAME Down 9%, Asia/Pacific Down 17% ||| Form 8-K from Cat Shows Feb. Rolling Three-Month Worldwide Machine Sales Down 8%",1,0.53451025
2014-03-21,8339700.0,97.06999969482422,97.62999725341795,96.66999816894533,97.38999938964844,74.30033874511719,CAT,"Market Wrap For March 21: Markets End Friday On A Negative Note, But Still Positive For The Week",0,0.4943162
2014-03-24,4808600.0,97.5999984741211,97.5999984741211,96.41999816894533,96.8499984741211,73.88834381103516,CAT,Bad Times Ahead for Caterpillar? - Analyst Blog,1,0.48376268
2014-03-25,9070400.0,97.36000061035156,99.33999633789062,97.1500015258789,98.58999633789062,75.21583557128906,CAT,"After Hours Most Active for Mar 25, 2014 : INTC, QQQ, BAC, CA, CHK, YNDX, MSFT, FCEL, T, GE, CAT, TSN ||| Dow Movers: WMT, CAT ||| Stocks Hitting 52-Week Highs",0,0.4804137
2014-03-26,5610200.0,99.27999877929688,99.5999984741211,97.8000030517578,97.8000030517578,74.61314392089844,CAT,Caterpillar Hits 52-Week High - Analyst Blog,1,0.51517683
2014-03-28,5821500.0,98.91000366210938,99.62000274658205,98.77999877929688,99.38999938964844,75.826171875,CAT,"Why Can’t the Dow Make New Highs? ||| Dow 30 Stock Roundup: Pfizer Gains, Crimea, Biotech Stocks Drag Markets - Analyst Blog",0,0.4805534
2014-03-31,5772600.0,100.0,100.62999725341795,99.0500030517578,99.37000274658205,75.81090545654297,CAT,Market Wrap For March 31: Stocks Rally As Yellen Confirms Support For Economy ||| Barclays Sees 50% Upside for Caterpillar,1,0.49774224
2014-04-01,4814300.0,98.94000244140624,100.08000183105467,98.94000244140624,99.80999755859376,76.14662170410156,CAT,"#PreMarket Primer: Tuesday, April 1: Yellen Calms Rising Rate Fears ||| #PreMarket Primer: Tuesday, April 1: Yellen Calms Rising Rate Fears",1,0.50399655
2014-04-03,8230200.0,101.91999816894533,103.1999969482422,101.61000061035156,102.5500030517578,78.23699951171875,CAT,"Risk, Reward Balanced at JOY Global - Analyst Blog ||| Caterpillar Looks Positive Despite Tax Probe - Analyst Blog ||| Jim Chanos Currently Speaking on CNBC's Squawk Box, Says He is Still Short CAT",0,0.49452177
2014-04-04,4889200.0,102.88999938964844,103.37999725341795,101.91000366210938,102.16999816894533,77.94709014892578,CAT,Vanguard Industrials ETF Experiences Big Outflow ||| Cat Files Automatic Debt Securities Shelf ||| Congress Moves Tax Loophole Bill Forward,0,0.51372683
2014-04-07,5215100.0,101.61000061035156,102.06999969482422,100.41000366210938,101.11000061035156,77.13838958740234,CAT,What The Equity Bulls Need For The Next Phase ||| UPDATE: TD Ameritrade Says IMX for Mar. Up to 5.87 ||| Top 4 NYSE Stocks In The Farm & Construction Machinery Industry With The Highest Dividend Yield,1,0.4986973
2014-04-08,6626900.0,100.9800033569336,103.25,100.95999908447266,102.38999938964844,78.11492919921875,CAT,"Dow Movers: BA, NKE",1,0.5317382
2014-04-09,4062000.0,102.6500015258789,103.1999969482422,101.8499984741211,102.98999786376952,78.57266235351562,CAT,"Daily Dividend Report: EPD, MCS, CAT, WAG, ADP ||| Cat Declares $0.60/Share Qtr. Dividend",0,0.48561865
2014-04-10,4538900.0,102.91000366210938,103.72000122070312,101.98999786376952,102.26000213623048,78.0157470703125,CAT,Market Wrap For April 10: Wednesday's Rally Completely Forgotten,0,0.50578296
2014-04-14,4114100.0,102.18000030517578,102.83000183105467,100.9499969482422,102.77999877929688,78.4124526977539,CAT,Cash Dividend On The Way From Caterpillar (CAT) ||| Markets Falling? Get Your Defense Ready,0,0.49574307
2014-04-15,6317900.0,102.62999725341795,103.08999633789062,101.26000213623048,102.5,78.19884490966797,CAT,"Caterpillar, Inc. (CAT) Ex-Dividend Date Scheduled for April 16, 2014 ||| Joy Global to Buy MTI Assets - Analyst Blog",1,0.48236722
2014-04-17,3556800.0,103.0500030517578,103.44000244140624,102.5999984741211,102.83000183105467,78.91252899169922,CAT,Dow Analyst Moves: CAT ||| Morgan Stanley Feels Cautious on Caterpillar Ahead of 1Q14 Earnings,0,0.49457085
2014-04-21,3821400.0,102.9000015258789,102.9800033569336,101.5500030517578,102.63999938964844,78.76673126220703,CAT,"Benzinga Weekly Preview: Earnings Season Kicks Into High Gear ||| CNH Industrial N.V. (CNHI) Ex-Dividend Date Scheduled for April 22, 2014",1,0.4826177
2014-04-22,4528500.0,102.77999877929688,104.13999938964844,102.76000213623048,103.69000244140624,79.572509765625,CAT,"Dow Movers: MCD, HD ||| #PreMarket Primer: Tuesday, April 22: Japan Refocuses Massive Pension Fund ||| #PreMarket Primer: Tuesday, April 22: Japan Refocuses Massive Pension Fund",0,0.46834236
2014-04-23,6427400.0,103.55999755859376,104.62000274658205,103.18000030517578,103.37999725341795,79.3345947265625,CAT,"Pre-Market Earnings Report for April 24, 2014 : VZ, MMM, MO, UPS, LLY, CAT, CELG, GM, TWC, FCX, RTN, ALXN ||| Caterpillar Earnings Preview: Looking For A Turnaround ||| Stocks Hitting 52-Week Highs",1,0.4859906
2014-04-24,8849200.0,106.0199966430664,107.4000015258789,104.79000091552734,105.27999877929688,80.79265594482422,CAT,"Dow Movers: PFE, CAT ||| Positive Earnings Backdrop - Ahead of Wall Street ||| Lessons From Earnings Season: Invest In The US ||| Earnings Boost Futures With Apple and Facebook Leading ||| #PreMarket Primer: Thursday, April 24: FDA & FCC Rolling Out Key Decisions, Apple Making Moves ||| Midday Update: Stocks Regain Composure, Recouping Early Gains Lost to Ukraine Tensions ||| Caterpillar Shares Up on Healthy Earnings Beat - Analyst Blog ||| Market Wrap For April 24: Apple's Smashing Earnings Overshadowed By Ukraine Concerns ||| From Cat Earnings Conf. Call: Expecting Q2 Sales, Profit Below 2014 Average, Q3 at Lowest Level, Q4 at Highest for the Year ||| Stocks Hitting 52-Week Highs ||| UPDATE: Caterpillar Posts Better-Than-Expected Q1 Results, Lifts FY14 Earnings Outlook ||| Caterpillar, Inc. Raises FY2014 EPS Guidance from $5.85 to $6.10 vs $5.81 Est ||| Caterpillar, Inc. Reports Q1 EPS of $1.61 vs $1.23 Est; Revenue of $13.20B vs $13.24B Est ||| US Stock Futures Surge After Upbeat Apple Earnings ||| #PreMarket Primer: Thursday, April 24: FDA & FCC Rolling Out Key Decisions, Apple Making Moves ||| Earnings Scheduled For April 24, 2014 ||| Stocks To Watch For April 24, 2014",0,0.50653374
2014-04-25,5731800.0,105.02999877929688,105.27999877929688,103.29000091552734,104.69000244140624,80.33992004394531,CAT,"Stock Market News for April 25, 2014 - Market News ||| Dow 30 Stock Roundup: Boeing, CAT Beat, 3M Slips - Analyst Blog ||| Q1 Earnings: A Stronger Weakling than Originally Thought - Earnings Preview ||| #PreMarket Primer: Friday, April 25: More Sanctions On Russia Likely ||| #PreMarket Primer: Friday, April 25: More Sanctions On Russia Likely",0,0.4572196
2014-04-28,4036200.0,104.98999786376952,105.41999816894533,103.25,104.26000213623048,80.00992584228516,CAT,Traders Selling Shares Of Cummins Ahead Of Tomorrow's Q1 Earnings Report,1,0.5234356
2014-04-29,4975800.0,104.79000091552734,105.5,103.83000183105467,105.3000030517578,80.80804443359375,CAT,Caterpillar to Close South Carolina Engine Plant,1,0.49775314
2014-04-30,5199300.0,105.2300033569336,106.23999786376952,104.98999786376952,105.4000015258789,80.88478088378906,CAT,"Dow Movers: MSFT, UNH",0,0.5067213
2014-05-01,2970800.0,105.1999969482422,105.79000091552734,104.62999725341795,105.06999969482422,80.63150787353516,CAT,This Week's Aggressive Growth Stocks (CAT)(URI) - Video Blog ||| Terex Misses on Q1 Earnings & Revs - Analyst Blog,0,0.5093886
2014-05-05,3166400.0,104.66000366210938,104.8000030517578,103.80999755859376,104.5199966430664,80.20943450927734,CAT,"DigitalGlobe, Inc. (DGI) in Focus: Stock Moves 7.9% Higher - Tale of the Tape ||| 5 Top Dow Stocks With The Most Upside Potential ||| TD Ameritrade's IMX Declines: Equity Market Exposure Decreased, Net Buying Favored Tech ||| Cat Files Registration for Supplement to Two-Parts Note Offering",0,0.50460315
2014-05-06,2836300.0,104.20999908447266,104.47000122070312,103.5999984741211,103.87000274658205,79.71063232421875,CAT,"Columbus McKinnon Corporation (CMCO) Ex-Dividend Date Scheduled for May 07, 2014",1,0.4872366
2014-05-07,3399800.0,104.0999984741211,104.66000366210938,103.43000030517578,104.62000274658205,80.28619384765625,CAT,"Allstate Earnings Falter on High CAT Loss - Analyst Blog ||| Astec Industries, Inc. (ASTE) Ex-Dividend Date Scheduled for May 08, 2014 ||| Cat Offers Presentation Slides for Wells Fargo's Industrial & Construction Conference: Affirms FY14 Adj. EPS Outlook",1,0.491648
2014-05-08,3118400.0,104.5500030517578,105.0199966430664,104.1500015258789,104.94000244140624,80.53175354003906,CAT,"Noteworthy ETF Outflows: XLI, UNP, CAT, DHR ||| Weakness Seen in A. M. Castle (CAS) Estimates: Should You Stay Away? - Tale of the Tape",1,0.4581456
2014-05-13,3951500.0,106.5,108.20999908447266,105.81999969482422,107.1500015258789,82.22772979736328,CAT,"Global Machinery Stocks, Piece by Piece - Industry Outlook",0,0.502913
2014-05-14,3082300.0,106.8499984741211,107.04000091552734,106.3000030517578,106.52999877929688,81.75194549560547,CAT,The 5 Most Overvalued Dow Stocks,0,0.51712304
2014-05-15,5151000.0,106.48999786376952,106.73999786376952,104.04000091552734,104.98999786376952,80.57012176513672,CAT,"Caterpillar Moves Up In Market Cap Rank, Passing Eli Lilly ||| Market Breadth is Blowing Warning Signs",1,0.50985044
2014-05-16,4403300.0,105.0500030517578,106.0500030517578,104.16999816894533,106.02999877929688,81.36824798583984,CAT,Weakness Seen in HollySys Automation Technologies (HOLI): Stock Declines 7.8% - Tale of the Tape ||| ExOne (XONE) in Focus: Stock Tanks 17.3% - Tale of the Tape ||| Caterpillar to Grow vs. Bleak Mining Backdrop - Analyst Blog,0,0.48945606
2014-05-19,3924300.0,105.41999816894533,105.52999877929688,104.72000122070312,105.38999938964844,80.87706756591797,CAT,"Dow Movers: T, PFE ||| Stock Pick Of The Week: Caterpillar (CAT)",0,0.4906549
2014-05-20,9277600.0,104.79000091552734,104.80999755859376,100.72000122070312,101.55999755859376,77.93790435791016,CAT,"Dow Movers: CAT, HD ||| Market Wrap For May 20: Markets Sharply Lower On Fed Talk, Disappointing Earnings ||| Form 8-K from Cat Shows Apr. 3-Mo. Rolling Total Machine Sales Down 13%",1,0.511977
2014-05-21,5460200.0,101.4800033569336,103.0,101.4800033569336,102.87999725341795,78.95089721679688,CAT,"Stock Market News for May 21, 2014 - Market News ||| Caterpillar April Sales Drop 13% - Analyst Blog ||| Top 4 NYSE Stocks In The Farm & Construction Machinery Industry With The Highest Profit Margin",1,0.49111158
2014-05-22,3112300.0,102.9000015258789,103.87999725341795,102.51000213623048,103.08000183105467,79.10437774658203,CAT,Caterpillar Is Cutting Costs & Relying On Construction & Energy Businesses To Combat Mining Weakness,1,0.5139373
2014-05-23,2888600.0,103.1500015258789,104.1500015258789,103.1500015258789,104.02999877929688,79.83341217041016,CAT,"Dow Movers: JPM, NKE ||| Dow 30 Stock Roundup: AT&T Buys DIRECTV, Home Depot Earnings Surge - Analyst Blog ||| Joy Global's Shareholder Friendly Move - Analyst Blog",0,0.52153814
2014-05-27,3443400.0,104.1999969482422,104.4800033569336,103.45999908447266,103.68000030517578,79.56482696533203,CAT,Interesting November Stock Options for Caterpillar ||| Buy Deere And Watch It Run,0,0.5116763
2014-05-28,3353300.0,103.52999877929688,103.86000061035156,102.8499984741211,102.91000366210938,78.97391510009766,CAT,"Hyster-Yale Materials Handling, Inc. (HY) Ex-Dividend Date Scheduled for May 29, 2014",1,0.47306284
2014-05-29,3071200.0,103.27999877929688,103.66999816894533,102.55999755859376,103.5999984741211,79.50343322753906,CAT,"Deere Hikes Dividend by 18% - Analyst Blog ||| Stocks To Watch For May 29, 2014",0,0.4949347
2014-05-30,5939300.0,102.9000015258789,102.9800033569336,101.5500030517578,102.2300033569336,78.45208740234375,CAT,"Balanced Risk Reward for Lindsay Corporation - Analyst Blog ||| Dow Movers: CAT, INTC ||| Caterpillar Announces Officer Departure; VP Randy Krotowski Stepping Down",1,0.51126987
2014-06-02,3747000.0,102.41999816894533,103.94000244140624,102.01000213623048,103.76000213623048,79.62620544433594,CAT,"Dow Movers: GS, CAT ||| Dow, S&P 500 Continue Their (Slow) Trek Into New-High Territory",1,0.51218694
2014-06-04,2879900.0,104.41999816894533,105.0999984741211,104.06999969482422,104.30999755859376,80.04826354980469,CAT,Cat Offers Slides for Presentation at Deutsche Bank's Global Industrials Conference: Affirms FY Adj. EPS Guidance,1,0.5102463
2014-06-05,5389200.0,104.8000030517578,107.12000274658205,104.7699966430664,106.95999908447266,82.08191680908203,CAT,"Dow Movers: DD, CAT ||| Terex Corporation (TEX) Ex-Dividend Date Scheduled for June 06, 2014 ||| Dow, S&P 500 Soar to All-Time Highs After ECB Rate Cut",1,0.49978608
2014-06-10,4752700.0,108.5,109.5,108.4000015258789,109.30999755859376,83.88533020019531,CAT,Cat to Pay $46M Settlement Related to Supply Ship Fire in 2008 - Bloomberg,0,0.51181036
2014-06-11,2738800.0,108.93000030517578,108.9800033569336,108.33000183105467,108.69000244140624,83.4095458984375,CAT,"Manitowoc Affected By Weak Cranes Performance - Analyst Blog ||| Miller Industries, Inc. (MLR) Ex-Dividend Date Scheduled for June 12, 2014 ||| Daily Dividend Report: MSFT, PM, TJX, CAT, TGT ||| Cat Raises Qtr. Dividend from $0.60 to $0.70/Share",0,0.4805755
2014-06-12,3408600.0,108.47000122070312,108.5,106.44000244140624,106.6500015258789,81.84402465820312,CAT,"Dow Movers: DIS, XOM",1,0.5212774
2014-06-13,2009100.0,106.5500030517578,107.2300033569336,106.06999969482422,106.7699966430664,81.93611145019531,CAT,"Dow 30 Stock Roundup: Caterpillar Raises Dividend, Boeing Slips on Cantor Defeat - Analyst Blog",1,0.5276867
2014-06-17,2138400.0,106.51000213623048,107.0,106.0,106.66999816894533,81.85938262939453,CAT,"Douglas Dynamics, Inc. (PLOW) Ex-Dividend Date Scheduled for June 18, 2014",1,0.45146844
2014-06-18,2218700.0,106.62999725341795,107.5999984741211,106.0500030517578,107.4800033569336,82.4809799194336,CAT,"Noteworthy ETF Inflows: MGV, WMT, HON, CAT",0,0.5218808
2014-06-19,2592400.0,106.98999786376952,107.41999816894533,106.69000244140624,107.25,82.30445861816406,CAT,"Dow Movers: JPM, PG ||| Caterpillar Down On Continued Slump In Worldwide Sales ||| 8-K from Cat Shows May Three-Month Rolling Retail Machine Sales Down 12%",1,0.52114135
2014-06-20,7762900.0,108.0500030517578,109.52999877929688,107.63999938964844,109.37999725341795,83.93905639648438,CAT,Allstate Anticipates Higher Q2 CAT Loss - Analyst Blog ||| Asia Pacific Pulls Down Caterpillar's May Sales by 12% - Analyst Blog ||| Stock Worth Buying: Columbus McKinnon - Analyst Blog,0,0.5115572
2014-06-24,2864200.0,108.55999755859376,109.33999633789062,107.0,107.80999755859376,82.73421478271484,CAT,Boeing And Caterpillar's Billion Dollar Reason For Disliking The New House Majority Leader,1,0.51401365
2014-06-26,1522900.0,108.5500030517578,108.8000030517578,107.8499984741211,108.5199966430664,83.2790756225586,CAT,Lindsay Corp. Shares Drop on Dismal Earnings - Analyst Blog,1,0.51814675
2014-06-27,3632100.0,108.33999633789062,108.87999725341795,107.7300033569336,108.77999877929688,83.47859954833984,CAT,"Allstate's Organic Growth Stable, Expenses to Limit Margins - Analyst Blog",0,0.5245388
2014-07-02,1849000.0,109.31999969482422,109.9499969482422,109.3000030517578,109.55999755859376,84.0771713256836,CAT,Top Mutual Fund: Sticks To Its Contrarian Approach ||| China Yuchai to Acquire Full Control of Remanufacturing JV; Financial Terms Not Disclosed,1,0.48741284
2014-07-03,2876200.0,109.9000015258789,111.16000366210938,109.69000244140624,111.08000183105467,85.24362182617188,CAT,"Dow Movers: MSFT, GS ||| See How Caterpillar Ranks Among Analysts' Top Dow 30 Picks ||| Dow Analyst Moves: CAT",0,0.50572556
2014-07-07,2697100.0,110.18000030517578,110.4499969482422,109.56999969482422,110.16000366210938,84.5376205444336,CAT,"One Put, One Call Option To Know About for Caterpillar",0,0.5001153
2014-07-10,2303600.0,108.13999938964844,109.56999969482422,107.8000030517578,109.36000061035156,83.92369079589844,CAT,Stocks Close Lower On Economic Concerns In Europe,1,0.5392868
2014-07-14,2375100.0,110.43000030517578,111.04000091552734,110.08999633789062,110.08999633789062,84.48388671875,CAT,Why the Earnings Streak Will Continue for Caterpillar (CAT) - Tale of the Tape,0,0.4825073
2014-07-15,3212900.0,110.25,110.41999816894533,109.4000015258789,109.8499984741211,84.29971313476562,CAT,Will W.W. Grainger (GWW) Miss Earnings Estimates? - Analyst Blog ||| Will Dover Corporation (DOV) Miss Earnings Estimates? - Analyst Blog,1,0.49114275
2014-07-16,3974100.0,110.18000030517578,111.45999908447266,109.91999816894533,111.4000015258789,85.48920440673828,CAT,"Is V. F. Corp. (VFC) Likely to Beat Earnings Estimates? - Analyst Blog ||| Zacks Rank #1 Additions for Wednesday - Tale of the Tape ||| Caterpillar, Inc. (CAT) Ex-Dividend Date Scheduled for July 17, 2014 ||| Traders Watch Construction, Trucking, Railroad, Materials Names Following Lew Comments About Rebuilding Infrastructure",0,0.46922538
2014-07-17,3164700.0,110.4000015258789,110.66999816894533,108.93000030517578,109.06999969482422,84.23043823242188,CAT,Bull of the Day: Caterpillar (CAT) - Bull of the Day,1,0.49267685
2014-07-18,2424900.0,109.43000030517578,110.16999816894533,109.0500030517578,110.16999816894533,85.07992553710938,CAT,Will iRobot (IRBT) Beat Q2 Earnings Estimates? - Analyst Blog ||| Caterpillar Initiated at Outperform by First Global -DJ,1,0.5085664
2014-07-21,2075900.0,110.0,110.5500030517578,109.4499969482422,110.2300033569336,85.12625122070312,CAT,"Workers at Caterpillar Subsidiary, Progress Rail, Say Train Repairs Were Often Unnecessary ||| Dow Movers: GE, INTC ||| 2 Option Plays During Market Stalemate",0,0.49104905
2014-07-22,2879400.0,110.83999633789062,111.27999877929688,109.8000030517578,110.05999755859376,84.99494934082031,CAT,Will Terex Corp. (TEX) Miss Earnings Estimates this Quarter? - Analyst Blog ||| Is Caterpillar Inc. (CAT) Likely to Beat Earnings Estimates? - Analyst Blog,0,0.48391545
2014-07-23,4471400.0,109.79000091552734,109.9800033569336,108.20999908447266,108.37999725341795,83.69755554199219,CAT,"Astec (ASTE) Beats Q2 Earnings Estimates on Higher Sales - Analyst Blog ||| Should You Buy Caterpillar (CAT) Ahead of Earnings? - Tale of the Tape ||| EMC Insurance Expects Q2 Loss on Higher CAT Loss - Analyst Blog ||| Pre-Market Earnings Report for July 24, 2014 : MMM, UNP, BMY, LLY, CELG, F, CAT, GM, PCP, ALXN, POT, RTN ||| Markets Mostly Higher As Earnings Season Continues To Impress",0,0.4993379
2014-07-24,8690300.0,105.5999984741211,106.2300033569336,104.08999633789062,105.04000091552734,81.11820220947266,CAT,"#PreMarket Primer: Thursday, July 24: Facebook Proves Its Worth ||| Terex (TEX) Q2 Earnings Lag Estimates, Up Y/Y, Revenues Beat - Analyst Blog ||| Dow Movers: CAT, NKE ||| In the news: Earnings continues with Ford, Caterpillar, 3M and Nokia ||| Closing Update: Stocks Pare Opening Gains on Weak Home Sales, Mixed Earnings ||| Stocks Lose Footing, End Flat After Weak Home Sales, Spotty Earnings ||| Caterpillar (CAT) Raises 2014 Guidance on Q2 Earnings Beat - Analyst Blog ||| Caterpillar Sticks to Pattern of Narrowing Earnings-Driven Pre-Bell Trade in Follow-On Regular Session, Favors Shorts ||| YTD Biggest Buyback Companies Trailing S&P In Stock Appreciation ||| Thursday Morning Earnings Reports ||| UPDATE: Caterpillar Posts Upbeat Q2 Earnings, But Revenue Misses Estimates ||| Caterpillar, Inc. Raises FY2014 EPS Guidance from $6.10 to $6.20 vs $6.23 Est; Sees Sales $54.0B-56.0B vs $56.33B Est ||| Caterpillar, Inc. Reports Q2 EPS of $1.69 vs $1.50 Est; Revenue of $14.15B vs $14.44B Est, Raises Guidance ||| #PreMarket Primer: Thursday, July 24: Facebook Proves Its Worth ||| Earnings Scheduled For July 24, 2014 ||| Stocks To Watch For July 24, 2014",0,0.5160278
2014-07-25,4126200.0,104.13999938964844,105.3499984741211,104.0999984741211,104.8499984741211,80.97148132324219,CAT,"Bearish Caterpillar Q2: Red Flag to 3 Mining Stocks - Analyst Blog ||| VIS, BA, UPS, CAT: Large Inflows Detected at ETF ||| #PreMarket Primer: Friday, July 25: Russia Accused Of Actively Engaging Ukraine ||| #PreMarket Primer: Friday, July 25: Russia Accused Of Actively Engaging Ukraine",0,0.4965425
2014-07-28,4474300.0,104.77999877929688,104.9000015258789,103.16999816894533,104.1500015258789,80.430908203125,CAT,Industrial Stock Earnings Fail to Impress These ETFs - ETF News And Commentary ||| Look for CAT to stay flat ||| Tip On Trading Earnings Reports With Binary Options,1,0.50094795
2014-07-29,7947100.0,105.0,106.44000244140624,104.69000244140624,104.69000244140624,80.84791564941406,CAT,Stocks Lower As Earnings Season Takes Back Seat To Geopolitical Uncertainties ||| Caterpillar Share Repurchases Trend Lower ||| Caterpillar Announces $2.5B of Additional Buybacks,0,0.50010484
2014-07-30,5856900.0,105.08000183105467,105.31999969482422,103.02999877929688,103.37999725341795,79.83625793457031,CAT,"ETF Outlook: Industrial Select SPDR ETF (XLI) ||| Stocks Mixed Despite Better Than Expected GDP ||| Tigress Financial Upgrades Caterpillar, Inc. to Neutral",0,0.48539156
2014-07-31,6711400.0,102.23999786376952,102.69000244140624,100.73999786376952,100.75,77.8051986694336,CAT,Allstate Tops Q2 Earnings Estimate Despite CAT Loss - Analyst Blog ||| Allegion Disappoints Q2 Earnings on Weak US Housing Recovery - Analyst Blog,0,0.5285572
2014-08-01,6011900.0,100.5199966430664,100.8499984741211,99.11000061035156,100.5199966430664,77.62760162353516,CAT,Construction Machinery: Investing Essentials,1,0.5231073
2014-08-04,5183900.0,100.36000061035156,102.0500030517578,100.0999984741211,101.80999755859376,78.6238021850586,CAT,"Dow Movers: PG, DIS ||| Dow 30 Stock Roundup: AmEx, XOM, PFE Beat on Earnings, CAT to Buy Back Shares - Analyst Blog",0,0.5077093
2014-08-05,5685400.0,101.11000061035156,102.47000122070312,100.94000244140624,101.5,78.38440704345703,CAT,Dow: Investing Essentials,0,0.5044615
2014-08-06,5526900.0,100.76000213623048,101.8499984741211,100.61000061035156,101.48999786376952,78.3766860961914,CAT,"Terex Corporation (TEX) Ex-Dividend Date Scheduled for August 07, 2014",1,0.48416075
2014-08-07,5752800.0,102.66000366210938,103.47000122070312,101.87999725341795,101.94000244140624,78.72421264648438,CAT,"Dow Movers: UNH, CAT ||| Astec Industries, Inc. (ASTE) Ex-Dividend Date Scheduled for August 08, 2014 ||| After Hours Most Active for Aug 7, 2014 : ZNGA, MU, DRI, QQQ, TSL, JCI, AAPL, CAT, UMPQ, PFE, FUR, SCTY ||| S&P 500 Falls To Two-Month Low, Dow Drifts Further Away From The 17,000 Mark ||| ISI Group Comes Out Bullish On Heavy Machinery Stocks ||| ISI Group Upgrades Caterpillar, Inc. to Buy, Raises PT to $113.00",1,0.46476063
2014-08-08,4690200.0,102.01000213623048,103.44000244140624,101.77999877929688,103.27999877929688,79.75902557373047,CAT,"Kemper Misses on Q2 Earnings & Revenues, CAT Loss Rises - Analyst Blog ||| After Hours Most Active for Aug 8, 2014 : F, PPL, QQQ, PVA, CAT, ABT, CMCSA, WMB, MSFT, SIRI, AAPL, CSCO",1,0.4992857
2014-08-11,5197900.0,104.61000061035156,104.8499984741211,103.93000030517578,104.5,80.70117950439453,CAT,"Dow Movers: WMT, INTC ||| Upcoming Corporate Events/Presentations for the Week of Aug. 11-15th ||| Accenture, Caterpillar Announce Agreement on Use of Telematics",0,0.5123074
2014-08-12,4200900.0,104.58999633789062,105.16000366210938,104.12999725341795,104.33000183105467,80.56991577148438,CAT,Cat Issues Slideshow Presentation Ahead of Jefferies Global Industrials Conference: Affirms FY14 Outlook,1,0.5184349
2014-08-13,4664900.0,104.33000183105467,105.5,104.33000183105467,105.16000366210938,81.21086883544922,CAT,Deere & Company Earnings: Weak Crop Prices Starting to Bite,1,0.5208553
2014-08-14,4178800.0,105.51000213623048,106.0,104.98999786376952,105.66000366210938,81.59703063964844,CAT,"5 Things Deere's Management Wants You to Know ||| After Hours Most Active for Aug 14, 2014 : JCP, CIE, KMI, QQQ, GFI, ULTI, SIRI, KING, CAT, PTEN, GILD, GLUU",1,0.5239151
2014-08-15,4099200.0,106.01000213623048,106.41999816894533,105.12999725341795,105.73999786376952,81.65882110595703,CAT,"Noteworthy ETF Outflows: DIA, V, GS, CAT",1,0.5269503
2014-08-18,3478600.0,106.69000244140624,107.0999984741211,106.27999877929688,106.9800033569336,82.61637878417969,CAT,RLI Corp. Poised for Top-Line Growth in the Quarters Ahead - Analyst Blog,1,0.5372573
2014-08-19,3639200.0,107.26000213623048,107.6999969482422,106.87000274658205,107.3000030517578,82.86351776123047,CAT,"After Hours Most Active for Aug 19, 2014 : BAC, XOM, AAPL, QQQ, MET, MSFT, NOK, CAT, BBD, MDLZ, GILD, ACHN",1,0.48318696
2014-08-20,5341600.0,107.38999938964844,108.1500015258789,107.1999969482422,107.6999969482422,83.17245483398438,CAT,"Industrials: Investing Essentials ||| Markets Mostly Higher Despite Initial Negative Reaction From FOMC Minutes ||| Caterpillar July Sales Off 9%; Rate Of Decline Slows ||| UPDATE: Cat Reports Jul. Resource Three-Month Rolling Sales Down 33%, Construction Sales Flat ||| 8-K from Cat Shows Global Three-Month Rolling Retail Machine Sales Down 9%",1,0.53100854
2014-08-21,4118100.0,108.16999816894533,108.56999969482422,107.54000091552734,107.97000122070312,83.3809585571289,CAT,4 Reasons Why U.S. Growth Will Strengthen,0,0.5534605
2014-08-22,4603700.0,107.58000183105467,107.81999969482422,106.54000091552734,107.30999755859376,82.8712387084961,CAT,"Progressive Corp.'s Net Premium Growth Shows Consistency - Analyst Blog ||| Caterpillar (CAT) July Sales down 9% Yet Graph Crawls Up - Analyst Blog ||| After Hours Most Active for Aug 22, 2014 : AMH, QQQ, CAT, BAC, HIG, TER, VGR, MSFT, ZION, CTXS, AAPL, SIRI ||| PowerTrend Brief: How You Can Use a Technical Analysis of Earnings to Make Smarter Investments ||| Dow Movers: GE, WMT",1,0.4831522
2014-08-25,3014100.0,107.95999908447266,108.33000183105467,107.7300033569336,107.97000122070312,83.3809585571289,CAT,5 Things General Electric Company's Management Wants You to Know,1,0.54426545
2014-08-27,3281900.0,108.12999725341795,108.91999816894533,108.08000183105467,108.5500030517578,83.8288345336914,CAT,"Hyster-Yale Materials Handling, Inc. (HY) Ex-Dividend Date Scheduled for August 28, 2014",1,0.47606337
2014-08-28,3227800.0,108.0199966430664,108.81999969482422,107.8000030517578,108.6500015258789,83.90607452392578,CAT,"After Hours Most Active for Aug 28, 2014 : CTLT, HSH, QQQ, PTX, MCRL, VALE, SPLK, CAT, MRO, PFE, MSFT, HEAR ||| Caterpillar's (CAT) Cost Savings Surmount Mining Weakness - Analyst Blog",1,0.47919738
2014-08-29,4437200.0,108.9000015258789,109.0999984741211,108.25,109.06999969482422,84.23043823242188,CAT,Low-Wage Jobs Dominate: Silver Lining for Manufacturers? - Analyst Blog,0,0.5081411
2014-09-02,4040200.0,109.02999877929688,109.7300033569336,108.83000183105467,108.91999816894533,84.1146011352539,CAT,Is it Time to Buy Deere & Co.'s Stock? ||| Why Unemployment Rates in These 5 States Could Soar Next Year,0,0.4903085
2014-09-03,4669000.0,109.4499969482422,109.66000366210938,108.0500030517578,108.45999908447266,83.75935363769531,CAT,Is Deere & Company Stock Headed for a Freefall After Losing 8% This Year?,1,0.5108679
2014-09-04,4604000.0,108.3000030517578,109.48999786376952,108.16000366210938,108.81999969482422,84.037353515625,CAT,"Joy Global Misses on Fiscal Q3 Earnings, Tweaks Guidance - Analyst Blog",0,0.54057807
2014-09-10,8154700.0,105.61000061035156,106.12000274658205,105.37999725341795,105.93000030517578,81.8055191040039,CAT,"Dow Movers: CAT, AXP ||| Miller Industries, Inc. (MLR) Ex-Dividend Date Scheduled for September 11, 2014 ||| UPDATE: Bank Of America Downgrades Caterpillar Inc. ||| Bank of America Downgrades Caterpillar, Inc. to Neutral",0,0.4631962
2014-09-11,5460100.0,105.66000366210938,105.66000366210938,104.58999633789062,105.58999633789062,81.54295349121094,CAT,"Supreme Industries, Inc. (STS) Ex-Dividend Date Scheduled for September 12, 2014",0,0.44921073
2014-09-12,6904200.0,104.97000122070312,105.08999633789062,104.4000015258789,105.0199966430664,81.10277557373047,CAT,"About That Manufacturing Skills Gap: It's Complicated ||| 3 Reasons Emerson Electric Co.'s Stock Could Fall ||| After Hours Most Active for Sep 12, 2014 : MSFT, BAC, QQQ, CAT, KRFT, CSCO, YHOO, VMW, INTC, TRP, HCN, GE ||| Hearing OTR Global Lowers View on Catepillar",0,0.49521515
2014-09-15,7051900.0,104.31999969482422,104.9000015258789,103.22000122070312,104.86000061035156,80.97918701171875,CAT,"Dow Movers: CAT, TRV ||| Interesting January 2015 Stock Options for Caterpillar ||| After Hours Most Active for Sep 15, 2014 : QQQ, VMW, BAC, MACK, OXY, YOKU, SIRI, AA, CAT, MSFT, CSCO, ERIC ||| Option Alert: Caterpillar Oct 3 $107 Call; 3,006 Contracts Traded vs 169 OI; Currently $104.39",0,0.48927262
2014-09-16,5289700.0,104.20999908447266,105.83000183105467,103.7699966430664,104.86000061035156,80.97918701171875,CAT,"8-K form Cat Financial Shows Credit Pact for Up to $3.15B ||| Option Alert: Caterpillar Shares Move to High, Activity in Sep $105 Call, Currently $105.11 ||| UPDATE: Morgan Stanley Reiterates On Caterpillar Inc. Following Investor Dinner",0,0.50774544
2014-09-17,5122200.0,105.18000030517578,105.41000366210938,103.87999725341795,103.98999786376952,80.30733489990234,CAT,"Douglas Dynamics, Inc. (PLOW) Ex-Dividend Date Scheduled for September 18, 2014",1,0.45553258
2014-09-18,3915800.0,104.3000030517578,104.5500030517578,103.4000015258789,104.33999633789062,80.5776138305664,CAT,"Dow Analyst Moves: CAT ||| Dow Movers: INTC, GS ||| Bespoke Investment Group's Co-Founder Shares Stocks He Would Avoid After FOMC",0,0.49833217
2014-09-19,8285400.0,104.8499984741211,105.0,102.08000183105467,102.51000213623048,79.1644287109375,CAT,"Notable ETF Outflow Detected - DIA, V, GS, CAT ||| Market Closes Flat As Alibaba Group Holding Ltd Begins Life As A Publicly Traded Company ||| Caterpillar Inc. Shares Drop On Lower August Sales Data ||| 8-K from Cat Shows Aug. Global Total Machine Retail Sales Down 10%",0,0.49537322
2014-09-22,5093200.0,102.0999984741211,102.26000213623048,100.81999969482422,100.9000015258789,77.92107391357422,CAT,"Company News for September 22, 2014 - Corporate Summary ||| Caterpillar's August Sales Bear the Brunt of Weak Mining - Analyst Blog",0,0.5162937
2014-09-23,5710300.0,100.86000061035156,101.08999633789062,99.87999725341795,99.98999786376952,77.21829223632812,CAT,"CAT Makes Notable Cross Below Critical Moving Average ||| Terex (TEX) Hits 52-Week Low Following Trimmed Guidance - Analyst Blog ||| Cat Shares Quiet Amid Exec Comments from Citi Conference About Protecting Dividend Being a High Priority ||| Cat Exec Currently Speaking at Citi's Industrials Conference: Considering Bolt-On Deals Within the Energy, Transportation Sectors",1,0.49956036
2014-09-24,5797000.0,100.04000091552734,101.48999786376952,99.88999938964844,101.1999969482422,78.15274047851562,CAT,3 Reasons Caterpillar Inc. Stock Could Soar ||| Why Manitowoc Company Stock Has Taken a Roller-Coaster Ride in 2014,0,0.53097034
2014-09-29,3156400.0,99.3499984741211,100.0999984741211,98.26000213623048,99.83000183105467,77.09475708007812,CAT,Inflation vs. Deflation: Who’s Winning?,0,0.49793053
2014-09-30,3746100.0,100.02999877929688,100.0999984741211,98.8000030517578,99.02999877929688,76.47692108154297,CAT,"UPDATE: Cat Says Emissions Price Action Expected to be in 2-6% Range on Most Machine Models ||| 8-K from Cat Shows Price Action of 0-2% Globally on Most Machines, Effective Jan. 2015",0,0.49555627
2014-10-03,3921900.0,98.04000091552734,98.33999633789062,97.02999877929688,97.38999938964844,75.21041870117188,CAT,3 Things to Watch For When CalAmp Corp. Reports Earnings,1,0.5414966
2014-10-06,3982400.0,97.80999755859376,98.12999725341795,96.91000366210938,98.0,75.68150329589844,CAT,5 Companies That Tell Us Where the Economy's Going ||| CalAmp Corp Delivers On Second-Quarter Earnings and Improved Full-Year Guidance,0,0.5342196
2014-10-08,6214200.0,94.58000183105467,96.86000061035156,93.63999938964844,96.6500015258789,74.63894653320312,CAT,"VYM, MO, OXY, CAT: ETF Inflow Alert",0,0.5198138
2014-10-09,6414500.0,96.20999908447266,96.5199966430664,93.23999786376952,93.5,72.20632934570312,CAT,"Daily Dividend Report: PBA, POL, UTX, CAT, WAG, F, CSX, PNR ||| A Short List Of Earnings Dates To Measure The 'October Effect'",0,0.50107527
2014-10-10,6179100.0,93.23999786376952,94.56999969482422,91.61000061035156,93.12999725341795,71.92058563232422,CAT,"Sierra Wireless vs CalAmp: Which is the Best Internet of Things Stock? ||| Weekly Market Wrap: October 10, 2014 ||| Caterpillar Inc. Announces Executive Officer Retirements And Appointments",0,0.4881344
2014-10-13,5852400.0,93.29000091552734,94.05999755859376,91.62000274658205,91.68000030517578,70.80081176757812,CAT,"Barclays Sees Opportunity In U.S. Machinery ||| Markets Debut Week On Negative Note; S&P 500 Falls Through Key Level ||| Stocks To Watch For October 13, 2014",1,0.482559
2014-10-14,6791300.0,92.51000213623048,95.01000213623048,92.38999938964844,92.8000030517578,71.66576385498047,CAT,"Will W.W. Grainger (GWW) Beat Q3 Earnings Estimates? - Analyst Blog ||| Will Dover Corporation (DOV) Miss Q3 Earnings Estimates? - Analyst Blog ||| Dow Movers: JNJ, CAT",0,0.4957226
2014-10-15,9377600.0,91.43000030517578,92.75,90.05000305175781,92.58999633789062,71.50357818603516,CAT,"Caterpillar, Inc. (CAT) Ex-Dividend Date Scheduled for October 16, 2014 ||| Markets Rebound After Getting Crushed Intraday, Still Close Lower ||| UPDATE: Credit Suisse Reiterates On Caterpillar As U.S. Markets Remain Bright Spot",1,0.45529804
2014-10-17,7442600.0,94.1999969482422,95.5999984741211,93.9800033569336,95.0500030517578,73.96251678466797,CAT,4 Industrial Stocks with Surprise Potential this Season - Earnings ESP ||| Manitowoc Company Inc. Stock Crashes 24% in 4 Trading Days: Is It Time to Buy? ||| Better Dividend Stock: Caterpillar Inc. or Deere & Company? ||| Into the Heart of Q3 Earnings Season - Earnings Preview,0,0.52011615
2014-10-20,4270800.0,94.52999877929688,95.3000030517578,93.2699966430664,94.02999877929688,73.16879272460938,CAT,"Is Now the Time to Buy Caterpillar Inc. Stock? ||| Benzinga Weekly Preview: Earnings Season Is In Full Swing ||| Will Proto Labs (PRLB) Surprise this Earnings Season? - Analyst Blog ||| Will Stanley Black & Decker (SWK) Miss on Q3 Earnings? - Analyst Blog ||| Noteworthy ETF Outflows: DIA, GS, TRV, CAT ||| Will ABB Ltd. (ABB) Disappoint this Earnings Season? - Analyst Blog ||| IBM's Report Weighs On The Dow, Apple Helps Boost The Nasdaq, S&P 500 Extends Winning Streak",1,0.50487506
2014-10-21,3990500.0,95.04000091552734,96.31999969482422,95.04000091552734,95.88999938964844,74.61615753173828,CAT,"Dow Movers: KO, CAT ||| Why Earnings Season Could Be Great for Caterpillar (CAT) - Tale of the Tape ||| Will Caterpillar Inc. (CAT) Beat Q3 Earnings Estimates? - Analyst Blog ||| Will Ericsson (ERIC) Disappoint this Earnings Season? - Analyst Blog",0,0.4708377
2014-10-22,6211300.0,95.52999877929688,95.9800033569336,94.0500030517578,94.56999969482422,73.5890121459961,CAT,"Will Flowserve Corp. (FLS) Surprise This Earnings Season? - Analyst Blog ||| Pre-Market Earnings Report for October 23, 2014 : CMCSA, UNP, MMM, CELG, LLY, OXY, CAT, GM, ALXN, PCP, RTN, POT ||| Markets Reverse Early Morning Gains Following Canadian Shooting ||| Caterpillar Posts 10% Drop In Worldwide Sales ||| 8-K from Cat Shows Sept. Three-Mo. Rolling Total Global Machine Sales Down 10%",1,0.4833919
2014-10-23,11670100.0,97.5999984741211,99.94000244140624,97.33999633789062,99.2699966430664,77.24627685546875,CAT,"Stocks are trading higher with strong momentum ||| Midday Update: Stocks Rally on Strong Earnings, Upbeat Global Economic Data ||| 3M's Third-Quarter Earnings Propel Dow to Big Day ||| In the news: Lots more earnings reports, and Reynolds banning workplace smoking ||| Closing Update: Caterpillar Earnings Trigger Stock Market Rally; Dow Pushes Through Technical Resistance ||| Futures Rally on Strong Earnings ||| Taking Stock of Q3 Earnings Season - Video Blog ||| Caterpillar (CAT) Earnings Reveals 3 Troubling Trends Wall Street Didn’t Tell You About ||| Q3 Earnings: Not Great, But Not Bad Either - Earnings Trends ||| Markets Boosted From Strong Earnings Releases, Jobless Benefits ||| #Premarket Prep Technical Update - Caterpillar Trading Sharply Higher ||| Cabela's Slips On Downbeat Results; Caterpillar Shares Jump ||| From Cat Call: Exec Notes Expecting Q4 Profit to be Down Slightly ||| Morning Market Movers ||| UPDATE: Caterpillar Shares Rise On Strong Q3 Results ||| Benzinga's Top #PreMarket Gainers ||| Caterpillar, Inc. Raises FY2014 EPS Guidance from $6.20 to $6.50 vs $6.26 Est; Narrows FY2014 Sales Guidance from $54.0B-56.0B to $55.0B vs $55.06B Est ||| Caterpillar, Inc. Reports Q3 EPS of $1.72 vs $1.36 Est; Revenue of $13.55B vs $13.27B Est. Raise FY Guidance ||| Earnings Scheduled For October 23, 2014 ||| 10 Stocks You Should Be Watching Today",1,0.4959055
2014-10-24,4133800.0,99.51000213623048,99.68000030517578,98.37000274658205,99.44000244140624,77.3785629272461,CAT,"Dow 30 Stock Roundup: Boeing, Caterpillar Beat, IBM Misses - Analyst Blog ||| Chubb Beats Q3 Earnings on Low CAT Loss; Raises Guidance - Analyst Blog ||| Stock Market News for October 24, 2014 - Market News ||| Markets End Hectic Week On Positive Note ||| Caterpillar Posts Huge Gains, But Fails To Conquer Key Resistance",0,0.49503303
2014-10-27,4346100.0,98.68000030517578,98.7699966430664,97.1500015258789,98.54000091552734,76.67823028564453,CAT,"Strong Industrial Stock Earnings Put These ETFs in Focus - ETF News And Commentary ||| Dow Movers: CVX, WMT ||| Stocks End Mixed Owed to Late Move; Energy Sector Weighs on S&P 500 ||| Closing Update: Stocks Mixed Ahead of Mid-Week Fed Meeting; S&P Hit By Rout in Energy Sector",1,0.51010895
2014-10-28,5069600.0,99.44000244140624,101.16000366210938,99.02999877929688,101.16000366210938,78.71699523925781,CAT,"Dow Movers: CVX, WMT",0,0.52069783
2014-10-29,4426400.0,101.52999877929688,101.83999633789062,99.83999633789062,100.19000244140624,77.96214294433594,CAT,Technology Outsourcer Epam Systems Knows The Big Deal,0,0.49152026
2014-10-30,2650900.0,99.62999725341795,100.58000183105467,99.05999755859376,100.16000366210938,77.93881225585938,CAT,Allstate Q3 Earnings Fall Y/Y on CAT Loss; Buyback Raised - Analyst Blog,1,0.51981276
2014-10-31,5367700.0,101.3499984741211,102.37000274658205,100.83999633789062,101.41000366210938,78.9114990234375,CAT,"AGCO Q3 Earnings Lag Y/Y, Shares Dip on Weak Outlook - Analyst Blog ||| Cat Recently Filed 10-Q; Shows SEC Subpoena Related to Accounting for Bucyrus Int'l, Co. Does Not See Material Adverse Impact",0,0.493844
2014-11-03,4434300.0,101.61000061035156,101.76000213623048,99.7699966430664,100.22000122070312,77.98551177978516,CAT,3 Best Performing Stocks in October - Analyst Blog ||| 3 Industries Being Overhauled by the Internet of Things ||| Top 4 NYSE Stocks In The Farm & Construction Machinery Industry With The Highest EPS,0,0.53552485
2014-11-04,4849000.0,99.75,100.0,98.04000091552734,98.61000061035156,76.7326889038086,CAT,"Columbus McKinnon Corporation (CMCO) Ex-Dividend Date Scheduled for November 05, 2014",1,0.48380026
2014-11-05,3515600.0,99.4499969482422,99.63999938964844,98.4499969482422,99.41000366210938,77.35521697998047,CAT,"Terex Corporation (TEX) Ex-Dividend Date Scheduled for November 06, 2014 ||| Option Alert: Caterpillar Jan $105 Call; 3,335 Contract Trade Above Ask @$1.16; Currently $98.72",1,0.46881774
2014-11-06,3427700.0,99.51000213623048,100.98999786376952,99.23999786376952,100.91000366210938,78.52243041992188,CAT,H&E Equipment Q3 Earnings Rise Y/Y but Lag Estimates - Analyst Blog,1,0.5355711
2014-11-07,2708200.0,101.26000213623048,101.83000183105467,100.9000015258789,101.76000213623048,79.18385314941406,CAT,"Dow Movers: DIS, XOM",1,0.5212774
2014-11-10,3308100.0,101.86000061035156,102.5500030517578,101.86000061035156,102.20999908447266,79.53401947021484,CAT,"IVE, HPQ, CAT, MDLZ: ETF Outflow Alert",1,0.5243224
2014-11-13,3924100.0,103.05999755859376,103.18000030517578,100.68000030517578,101.11000061035156,78.67804718017578,CAT,"Dow Movers: CVX, WMT",1,0.52069783
2014-11-18,2761200.0,101.6999969482422,102.4499969482422,101.30999755859376,102.04000091552734,79.40172576904297,CAT,"Caterpillar Poised for Growth in 2014, Headwinds Remain - Analyst Blog",0,0.5114381
2014-11-19,4679100.0,101.86000061035156,102.3000030517578,100.88999938964844,101.3000030517578,78.8259048461914,CAT,Alleghany (Y) Hits a 52-Week High on Solid Q3 Performance - Analyst Blog,1,0.53382856
2014-11-20,3052600.0,100.33000183105467,102.13999938964844,100.06999969482422,102.08999633789062,79.44062805175781,CAT,"Dow, S&P 500 Close At Record Highs In Another Quiet Trading Session ||| Stifel Nicolaus Initiates Coverage on Caterpillar, Inc. at Buy ||| Caterpillar Reports Machine Sales Declined 9% Through October ||| 8-K from Cat Shows Oct. Machine Sales Down 9% vs 10% Declines in Sept., Aug.",1,0.49294892
2014-11-21,8738000.0,104.3000030517578,107.12000274658205,104.1999969482422,106.4499969482422,82.8333511352539,CAT,"Dow Movers: VZ, CAT ||| Caterpillar Breaks Above 200-Day Moving Average - Bullish for CAT ||| Markets End Week On Positive Note As Investors Are Encouraged By Central Bank Developments In Europe, China ||| UPDATE: Stifel Initiates Coverage On Caterpillar On Potential Margin Upside",0,0.49737233
2014-11-25,3321500.0,106.0999984741211,106.62999725341795,105.33000183105467,106.23999786376952,82.669921875,CAT,"Hyster-Yale Materials Handling, Inc. (HY) Ex-Dividend Date Scheduled for November 26, 2014",0,0.4758582
2014-12-01,7431800.0,100.23999786376952,100.47000122070312,97.79000091552734,99.0,77.03617858886719,CAT,"What Exactly is Caterpillar (CAT) Doing With All of Its Money? ||| The Silver Lining in Caterpillar Inc.'s Dismal October Retail Statistics ||| Dow Movers: GE, CVX ||| Caterpillar Issues $500M In Medium Terms Notes",1,0.49365467
2014-12-02,3900400.0,99.4800033569336,99.95999908447266,98.72000122070312,99.51000213623048,77.43299865722656,CAT,"Stock Market News for December 02, 2014 - Market News",1,0.5068902
2014-12-03,6930700.0,100.04000091552734,101.45999908447266,99.95999908447266,100.18000030517578,77.95437622070312,CAT,"Dow Movers: VZ, UNH ||| Caterpillar CEO Doug Oberhelman Says In CNBC That Company Can Add Jobs With 3% GDP Growth",0,0.51497644
2014-12-04,3390100.0,99.69000244140624,100.87000274658205,99.51000213623048,99.66999816894533,77.55752563476562,CAT,Dow Analyst Moves: CAT ||| These 2 Stocks Could Tumble as Oil Prices Fall (Surprise: They're Not Oil Stocks),0,0.48763904
2014-12-08,7192100.0,98.66000366210938,98.76000213623048,95.1999969482422,95.25,74.11812591552734,CAT,What CEOs Are Saying About Washington Politics,1,0.5001623
2014-12-09,6562900.0,94.16999816894533,96.16999816894533,93.8000030517578,95.4499969482422,74.27375793457031,CAT,"Supreme Industries, Inc. (STS) Ex-Dividend Date Scheduled for December 10, 2014 ||| Option Alert: Caterpillar Feb $105 Call; 2,783 Contract Trade at Ask @$0.95; Currently $94.94",0,0.45401877
2014-12-11,4664900.0,93.68000030517578,94.29000091552734,92.52999877929688,92.69000244140624,72.1260986328125,CAT,Caterpillar Appoints Julie Lagacy As Chief Information Officer,0,0.50784785
2014-12-12,10327200.0,92.0,92.0,89.95999908447266,90.5,70.42195129394531,CAT,"Weekly Market Wrap: December 12, 2014 ||| Dow Movers: BA, WMT ||| A Different Kind of Yield to Consider - Investment Ideas",0,0.48107004
2014-12-16,7649500.0,89.2300033569336,92.25,89.1500015258789,89.33999633789062,69.51933288574219,CAT,"Option Alert: Caterpillar Feb $105 Call; 2,440 Contract Trade at Ask @$0.61; Currently $89.82",1,0.48802802
2014-12-17,8671600.0,89.4000015258789,90.13999938964844,88.02999877929688,89.75,69.83834838867188,CAT,"Dow Movers: CAT, XOM ||| Joy Global Beats on Earnings, Revenues in Q4, FY14 - Analyst Blog ||| Douglas Dynamics, Inc. (PLOW) Ex-Dividend Date Scheduled for December 18, 2014 ||| Is Caterpillar’s Mining Equipment Business Turnaround In Sight?",1,0.4790141
2014-12-18,8344400.0,91.88999938964844,91.88999938964844,90.5500030517578,91.69000244140624,71.34794616699219,CAT,"The Good, the Bad, and the Ugly From Caterpillar Inc.'s November Retail Sales ||| Caterpillar Reports Retail Machine Sales Fell 10% Through November ||| 8-K form Cat Shows Global Three-Month Rolling Machine Sales Down 10% for Nov.",1,0.52319235
2014-12-19,9689200.0,91.58000183105467,91.9800033569336,90.87999725341795,91.70999908447266,71.36349487304688,CAT,"Caterpillar November Sales Dip, Marks Two Years of Decline - Analyst Blog ||| Caterpillar Inc Announces Retirement Of VP Jim Johnson; Raymond Chan As Replacement",1,0.4937963
2014-12-22,4577200.0,92.45999908447266,92.80999755859376,91.8499984741211,92.31999969482422,71.83818054199219,CAT,Will CalAmp Earnings Build on Last Quarter's Success? ||| Caterpillar CEO On The Impact Of Oil,1,0.51214534
2014-12-23,3554200.0,92.98999786376952,93.94000244140624,92.6500015258789,93.5,72.75639343261719,CAT,"CalAmp Posts Better Earnings, But Weak Guidance Has Investors Scared ||| Allstate's Capital Secure; CAT Loss & Investments a Concern - Analyst Blog",1,0.5144489
2014-12-29,2390500.0,94.1999969482422,94.27999877929688,93.58999633789062,93.70999908447266,72.91979217529297,CAT,Why Internet of Things Specialist CalAmp Corp. Tumbled 36% in 2014 ||| This Move Might Just Have Crushed Caterpillar's Future,0,0.47974274
2014-12-30,3197400.0,93.5999984741211,93.62999725341795,92.51000213623048,92.58999633789062,72.04824829101562,CAT,Industrial Select Sector SPDR Fund Experiences Big Outflow,0,0.50465894
2015-01-02,3767900.0,91.7699966430664,92.37000274658205,90.66000366210938,91.87999725341795,76.28065490722656,CAT,CAT Named 'Top Dividend Stock of the Dow' at Dividend Channel With 3.1% Yield,0,0.50828594
2015-01-05,11301400.0,90.3499984741211,90.41999816894533,86.5999984741211,87.02999877929688,72.25408172607422,CAT,"Dow Movers: CAT, MRK ||| Evercore Partners Downgrades Caterpillar to Hold",0,0.49941826
2015-01-07,6511100.0,87.37000274658203,88.13999938964844,86.41999816894531,87.80999755859375,72.90166473388672,CAT,1 Stock You Might Want to Skip in 2015,1,0.5384894
2015-01-09,4857100.0,88.76000213623047,88.88999938964844,87.0199966430664,87.6500015258789,72.76882934570312,CAT,Will Clean Energy Fuels Bounce Back in 2015? ||| 2015 Dogs of the Dow: 10 Dividend Stocks You Should Watch This Year,0,0.49577767
2015-01-12,4351600.0,87.7300033569336,87.7699966430664,86.06999969482422,86.88999938964844,72.13786315917969,CAT,2015 Dogs Of The Dow,0,0.5194068
2015-01-13,5078100.0,87.68000030517578,87.9000015258789,85.19999694824219,86.37000274658203,71.70613098144531,CAT,SPDR Dow Jones Industrial Average ETF Experiences Big Outflow ||| MasTec (MTZ) Down to Strong Sell on Lower Oil Prices - Analyst Blog ||| Fitch Solutions Says Oil Price Drop Drives Caterpillar's CDS 52% Wider,0,0.5107589
2015-01-14,10366700.0,84.88999938964844,86.22000122070312,84.2699966430664,86.06999969482422,71.45707702636719,CAT,"Caterpillar, Inc. (CAT) Ex-Dividend Date Scheduled for January 15, 2015",0,0.44321826
2015-01-15,6683900.0,86.02999877929688,86.16999816894531,84.30000305175781,84.31999969482422,70.57819366455078,CAT,Jim Cramer Shares His Thoughts On Caterpillar And Oasis Petroleum,0,0.50501066
2015-01-20,5937300.0,84.41999816894531,84.5,83.19000244140625,83.97000122070312,70.28523254394531,CAT,5 Things Caterpillar Inc. Management Wants You to Know ||| Citi Slashes Caterpillar Price Target By $20,1,0.540946
2015-01-22,5567800.0,86.05000305175781,87.36000061035156,85.43000030517578,86.81999969482422,72.6707763671875,CAT,The 4 Worst Dow Stocks Of 2015,0,0.5186838
2015-01-23,5027500.0,86.79000091552734,87.0,85.19999694824219,85.61000061035156,71.65794372558594,CAT,Will Caterpillar (CAT) Disappoint Q4 Earnings Estimates? - Analyst Blog,1,0.49128565
2015-01-26,8140500.0,85.36000061035156,86.26000213623047,84.9000015258789,86.02999877929688,72.009521484375,CAT,"Options Action's Final Trade: Caterpillar Inc., Alibaba Group Holding Ltd And iShares MSCI Germany Index Fund (ETF) ||| Carter Worth And Mike Khouw's Caterpillar Inc. Trade ||| Caterpillar Inc.'s Dismal December Retail Hints at a Poor Quarter ||| Pre-Market Earnings Report for January 27, 2015 : PG, PFE, UTX, MMM, BMY, DD, LMT, DHR, CAT, NEE, AAL, ERIC ||| Caterpillar Sees Sales Declines In Asia And Latin America, Sales Down 12% Globally ||| 4 Charts That Show Why Companies Restructure ||| 8-K from Cat Shows Dec. Global Rolling Three-Month Machine Retail Sales Down 12%",0,0.45079386
2015-01-27,27489500.0,79.73999786376953,81.3499984741211,79.0999984741211,79.8499984741211,66.83668518066406,CAT,"Caterpillar Sticks to Pattern of Rewarding Shorts Trading Shares Off Pre-Market Earnings Reports ||| Midday Update: Stocks Unravel on Disappointing Earnings, Durable Goods Order Miss ||| Dow Plunges Over 300 Points as Microsoft Puts the PC Back on Death Row ||| Caterpillar Misses Q4 Earnings on Lower Commodity Prices - Analyst Blog ||| Futures Plummet on Earnings, Durable Goods Miss ||| Caterpillar (CAT) Misses Q4 Earnings on Oil Price Woes - Tale of the Tape ||| Pre-Market Most Active for Jan 27, 2015 : MSFT, SIMG, TVIX, AAPL, CAT, QQQ, XIV, BP, AZN, BAC, ALU, RDS/A ||| Is the Q4 Earnings Picture that Weak? - Earnings Trends ||| Stocks Trim Losses, But Concerns About Economy Rekindled By Missed Earnings, Weak Durable Goods Orders ||| S&P 500 Movers: MSFT, WAT ||| Dow Movers: MSFT, PFE ||| Is the Q4 Earnings Picture that Weak? - Earnings Outlook ||| Caterpillar Inc. Earnings and Outlook Indicate Big Trouble Ahead ||| Close Update: Stocks Climb Off Lows But Suffer Heavy Losses on Missed Earnings, Durable Goods ||| Caterpillar CEO: 'When It Rains, It Pours And This Is One Of Those Days' ||| Market Ignores Positive Economic News As Earnings Reports Concern Investors ||| CAT Sees Higher R&D Costs; Sees Weakness In Construction Outside U.S; Sees 2015 Sales Decline ||| Worst Performing Industries For January 27, 2015 ||| CAT Sees Forex To Be Revenue Headwind; Sees 2015 Rail Operations To Be Down; Sees 2015 China Sales Down ||| CAT Earnings Call Begins ||| Analysts React To Caterpillar's Miss, Morgan Stanley Calls It 'Very Surprising' ||| Stocks Hitting 52-Week Lows ||| Mid-Morning Market Update: Markets Open Lower; Caterpillar Issues Weak Outlook ||| Industrial Names Get Crushed Following Caterpillar's Disappointing Q4 ||| Morning Market Losers ||| One Of Wall Street's Best Minds Just Said This About The Markets (And Winter Storm Juno) ||| Tuesday Morning Movers: Microsoft, Procter & Gamble Tumble Following Earnings ||| Benzinga's Top #PreMarket Losers ||| UPDATE: Caterpillar Shares Down ~7% In Premarket Trading ||| UPDATE: Caterpillar Posts Downbeat Q4 Earnings, Issues Weak Outlook ||| UPDATE: Caterpillar 'While our market position in China has improved, 2015 expectations for the construction industry in China are lower' ||| UPDATE: Caterpillar Says 'The recent dramatic decline in the price of oil is the most significant reason for the year-over-year decline in our sales and revenues outlook' ||| UPDATE: Caterpillar Says 'The relatively slow growth in the world economy and continued weakness in commodity prices—particularly oil, copper, coal and iron ore—are expected to be negative for our sales' ||| Cat Reports Q4 Adj. EPS $1.35 vs $1.55 Est., Sales $14.24B vs $14.18B Est.; Expecting FY15 Sales ~$50B vs $55.01B Est. ||| Earnings Scheduled For January 27, 2015 ||| Top 4 NYSE Stocks In The Farm & Construction Machinery Industry With The Highest EPS ||| 10 Stocks You Should Be Watching Today",1,0.47325552
2015-01-28,14269300.0,80.4000015258789,81.19999694824219,79.95999908447266,80.01000213623047,66.97061920166016,CAT,"Caterpillar Inc. Moves 7% Lower After Disappointing Quarter. What Investors Need to Know ||| Q4 Earnings Season: The Apple Effect - Earnings Outlook ||| Q4 Earnings Season: The Apple Effect - Earnings Trends ||| Is The Dollar Really As Strong As Companies Are Suggesting? ||| Caterpillar Rises Despite Analyst Downgrades ||| Benzinga's Top Downgrades ||| Longbow Research Downgrades Caterpillar To Neutral ||| Vertical Research Downgrades Caterpillar to Hold ||| Atlantic Equities Downgrades Caterpillar to Underweight ||| NASDAQ Futures Jump After Upbeat Apple Earnings ||| Longbow Research Downgrades Caterpillar to Neutral, Removes $110.00 PT",0,0.4789007
2015-01-29,9157000.0,79.91000366210938,80.18000030517578,78.80999755859375,80.0,66.96224212646484,CAT,Dull Industrial Earnings Put These ETFs in Focus - ETF News And Commentary ||| Trading in a Treacherous Earnings Season,0,0.5303726
2015-01-30,8150700.0,79.51000213623047,80.81999969482422,79.41999816894531,79.97000122070312,66.93714141845703,CAT,Morgan Stanley: Q4 Earnings Are Coming In Line With Expectations ||| The Most Important Message Investors Need For Earnings Season,1,0.533003
2015-02-02,7149000.0,80.08000183105469,80.87999725341797,79.48999786376953,80.83999633789062,67.66533660888672,CAT,Caterpillar: A Blood In The Streets Moment?,1,0.50508845
2015-02-03,10895300.0,81.22000122070312,84.11000061035156,81.1500015258789,83.91999816894531,70.24338531494139,CAT,"Stocks Rising With Energy Sector Gains; Strong Vehicle Sales, Greek Concessions Also Contributing to Advance ||| Midday Update: Stocks Buoyed by Energy Sector Gains, Greece and Upbeat Vehicle Sales ||| Why the DJIA Rose Today – 305-Point Gain ||| Dow Movers: MRK, CAT ||| Columbus McKinnon Corporation (CMCO) Ex-Dividend Date Scheduled for February 04, 2015 ||| Argus Research Downgrades Caterpillar to Hold",0,0.49679434
2015-02-04,8806500.0,82.77999877929688,83.31999969482422,81.66000366210938,81.94999694824219,68.59443664550781,CAT,Revenue Weakness Stands Out in Q4 Earnings Season - Earnings Outlook ||| Revenue Weakness Stands Out in Q4 Earnings Season - Earnings Trends,1,0.5199733
2015-02-05,6640200.0,82.4000015258789,83.62999725341797,81.87000274658203,83.56999969482422,69.95041656494139,CAT,"Allstate Beats Earnings Estimates, Hikes Dividend & Buyback - Analyst Blog",0,0.51970965
2015-02-06,5581500.0,83.5999984741211,84.13999938964844,82.80000305175781,83.20999908447266,69.64909362792969,CAT,SPDR Dow Jones Industrial Average ETF Experiences Big Outflow ||| Jobs Report Confirms U.S. Recovery - Ahead of Wall Street,1,0.50759435
2015-02-09,7693800.0,83.05000305175781,84.87000274658203,82.94999694824219,84.66999816894531,70.87115478515625,CAT,"Oil Price Near $50: Should Dividend Investors Think Twice About Caterpillar, Inc.?",0,0.4896901
2015-02-11,5722600.0,83.55999755859375,83.66999816894531,82.23999786376953,83.41000366210938,69.81649780273439,CAT,Taking Stock of Q4 Earnings Season - Earnings Outlook ||| Taking Stock of Q4 Earnings Season - Earnings Trends ||| Top 4 NYSE Stocks In The Farm & Construction Machinery Industry With The Highest Profit Margin,1,0.51915073
2015-02-13,5645500.0,84.11000061035156,85.48999786376953,84.02999877929688,85.12999725341797,71.25619506835938,CAT,These 3 Stocks Led the S&P 500 to New All-Time Highs,1,0.5098392
2015-02-17,3924400.0,84.86000061035156,85.58000183105469,84.19999694824219,85.37999725341797,71.46544647216797,CAT,10 Stocks Retail Investors Loved Last Month (And 9 They Didn't) ||| Will Caterpillar's 2015 Revenue Break Its Great Depression Streak of Declines? ||| 10-K from Cat Shows Co. Received Grand Jury Subpoena on Jan. 8th Related to Documents on US/Non-US Units,0,0.49798554
2015-02-19,5733500.0,83.80999755859375,84.0,82.20999908447266,83.30000305175781,69.72443389892578,CAT,"Dow Movers: WMT, BA ||| Caterpillar Falls Amid News Of Sales Decline ||| 8-K from Cat Shows Jan. Total Rolling 3-Month Retail Sales Down 14%",1,0.51660216
2015-02-20,6029400.0,83.30000305175781,84.62000274658203,82.4000015258789,84.44000244140625,70.67864227294922,CAT,CNBC's Stock Pops & Drops From February 19,0,0.47280225
2015-02-23,5180000.0,83.9000015258789,83.9800033569336,83.13999938964844,83.48999786376953,69.88346862792969,CAT,A Bumpy Road Ahead for Caterpillar Inc. (CAT) in 2015 - Analyst Blog ||| How Is Caterpillar (CAT) Stock Shaping Up for 2015? ||| Evaluating the Q4 Earnings Season - Video Blog,1,0.5084148
2015-02-24,3678700.0,83.7699966430664,84.69000244140625,83.5999984741211,84.5,70.72887420654297,CAT,"Hyster-Yale Materials Handling, Inc. (HY) Ex-Dividend Date Scheduled for February 25, 2015",1,0.47581464
2015-02-25,3449500.0,84.5199966430664,85.36000061035156,84.16999816894531,85.1500015258789,71.27291870117188,CAT,Problems Mount in Caterpillar Inc.'s January Sales Results ||| Q4 Earnings Season Winding Down - Earnings Outlook,0,0.5174759
2015-02-26,4457000.0,85.0999984741211,85.0999984741211,83.55999755859375,83.80000305175781,70.14293670654297,CAT,Interesting Caterpillar Put And Call Options For April 10th,0,0.49185207
2015-02-27,4370500.0,84.18000030517578,84.18000030517578,82.88999938964844,82.9000015258789,69.38962554931639,CAT,Dow Analyst Moves: CAT ||| 3 Dividend Stocks to Buy Now for High Yields,1,0.5046858
2015-03-02,4155000.0,82.9000015258789,83.06999969482422,82.23999786376953,83.0,69.47333526611328,CAT,Internet of Things Stock CalAmp Corp. is a Tale of 2 Businesses ||| Is Caterpillar Inc. Finally a Good Buy for Value Investors?,0,0.48280668
2015-03-03,4331700.0,82.70999908447266,83.79000091552734,82.6500015258789,82.83999633789062,69.33939361572266,CAT,Will Joy Global (JOY) Earnings Disappoint Estimates in Q1? - Analyst Blog,0,0.51849216
2015-03-04,6863600.0,82.56999969482422,82.61000061035156,80.83000183105469,81.7300033569336,68.4102783203125,CAT,"Markets March Lower as Caterpillar, Wynn Resorts Lead the Downtrend",0,0.4855536
2015-03-05,7123500.0,81.7300033569336,81.7300033569336,80.05999755859375,81.51000213623047,68.22614288330078,CAT,"VIG, ABT, OXY, CAT: ETF Outflow Alert ||| Dow Movers: CAT, WMT ||| Astec Industries, Inc. (ASTE) Ex-Dividend Date Scheduled for March 06, 2015 ||| Terex Corporation (TEX) Ex-Dividend Date Scheduled for March 06, 2015 ||| Joy Global Misses on Earnings & Revenues, Lowers Guidance - Analyst Blog",0,0.46968466
2015-03-11,4612200.0,80.1500015258789,80.1500015258789,79.26000213623047,79.69999694824219,66.71113586425781,CAT,"Caterpillar Revised To $85 On Oil Prices, Continued Mining Weakness",1,0.5299733
2015-03-12,3612500.0,80.2699966430664,80.4800033569336,79.80000305175781,80.19000244140625,67.12127685546875,CAT,"Supreme Industries, Inc. (STS) Ex-Dividend Date Scheduled for March 13, 2015 ||| The Most Expensive Stock Behind the Internet of Things Worth Buying",0,0.46310547
2015-03-13,7272700.0,79.9000015258789,79.91000366210938,78.19000244140625,79.2300033569336,66.31775665283203,CAT,Closing Update: Volatile Week Ends with Equities Down For Third Straight Week Into Key Fed Meeting,1,0.52541125
2015-03-17,6979900.0,79.3499984741211,79.3499984741211,78.25,78.44999694824219,65.66484832763672,CAT,"Midday Update: Wall Street Braces for Loss of 'Patience' By FOMC ||| DuPont Could Be Just the Beginning of an Activist Investor Uprising ||| Douglas Dynamics, Inc. (PLOW) Ex-Dividend Date Scheduled for March 18, 2015 ||| Close Update: Wall Street Braces For FOMC; Nasdaq Ekes Out Gain on Biotech Strength ||| Dow Movers: CAT, KO ||| Cat Offers Slides Ahead of Presentation at BofAML's Global Industrials & EU Autos Conference: Reaffirms Outlook",1,0.46198347
2015-03-18,12154300.0,78.25,81.44000244140625,78.25,81.33000183105469,68.07549285888672,CAT,"Dow Movers: KO, CAT ||| Bank Of America Mixed On Caterpillar Amid Concerns Of Declining Demand For Construction Equipment",0,0.5046096
2015-03-19,5236200.0,80.5,80.5,79.55999755859375,80.08999633789062,67.03755950927734,CAT,"Dow Movers: CVX, CSCO ||| 8-K from Cat Shows Rolling Three-Month Global Machine Sales Down 11% in Feb.",1,0.53598505
2015-03-20,8216600.0,80.62000274658203,81.25,80.19000244140625,81.19000244140625,67.95830535888672,CAT,Caterpillar (CAT) Shares Fall on 11% Dip in February Sales - Analyst Blog ||| Caterpillar Falls Following News Of 11% Sales Decline,0,0.48784423
2015-03-24,3978700.0,81.1500015258789,81.19999694824219,80.19999694824219,80.4800033569336,67.364013671875,CAT,Is CAT On Its 9th Life?,0,0.51712394
2015-03-27,6336900.0,79.45999908447266,79.87999725341797,78.76000213623047,79.66999816894531,66.68601989746094,CAT,"Dow Movers: CVX, HD",1,0.51909643
2015-03-31,4848600.0,80.51000213623047,80.6500015258789,79.80999755859375,80.02999877929688,66.98735046386719,CAT,"Dow Movers: CAT, INTC",0,0.5136868
2015-04-01,4446200.0,80.02999877929688,80.5199966430664,79.38999938964844,79.63999938964844,66.66091918945311,CAT,3 Dividend Stocks Wall Street Is Wrong About ||| Josh Brown Is Bearish On Casinos; Stephen Weiss Doesn't Like Caterpillar,1,0.49255723
2015-04-02,3555300.0,79.5999984741211,80.5,79.4000015258789,80.23999786376953,67.16314697265625,CAT,Investment Strategies: Caterpillar Inc. vs. Deere & Company,1,0.4976453
2015-04-06,4495400.0,80.3499984741211,82.0,79.9800033569336,81.48999786376953,68.20940399169922,CAT,"One Put, One Call Option To Know About for Caterpillar ||| Jobs Data Dips: 3 Healthy Picks - Analyst Blog ||| Caterpillar Longs Hoping For Oversold Shares To Hold Support",0,0.47729135
2015-04-07,3526300.0,81.22000122070312,81.43000030517578,80.5,80.54000091552734,67.41423034667969,CAT,"Dow Movers: AXP, V ||| The Zacks Analyst Blog Highlights: Caterpillar, Procter & Gamble, Horizon Pharma, RadNet and PRA Health Sciences - Press Releases ||| How Does Union Pacific Stack Up Against the Rest of the Railroad Industry?",0,0.49470207
2015-04-09,4291900.0,80.5,81.20999908447266,80.27999877929688,80.68000030517578,67.53143310546875,CAT,Bill Nygren Comments on Caterpillar Inc,1,0.5059739
2015-04-10,6831900.0,81.0999984741211,82.80000305175781,80.73999786376953,82.5999984741211,69.13851165771484,CAT,"Weekly Market Wrap: April 10, 2015 ||| Caterpillar Announces New Analytics & Innovation Division",0,0.4989899
2015-04-13,5293900.0,82.5999984741211,82.61000061035156,81.5999984741211,82.13999938964844,68.75347137451172,CAT,"At What Price Should Caterpillar Bulls Buy Back In? ||| Dow Movers: GE, UNH ||| Caterpillar Joins the Big Data Bandwagon, Creates Unit - Analyst Blog ||| 12 Charts That May Show A Breakthrough In The Options Market",1,0.5110666
2015-04-14,5898700.0,82.55000305175781,83.23999786376953,81.54000091552734,83.0,69.47333526611328,CAT,"Bill Nygren on CNBC Selects Caterpillar, Precision Castparts",1,0.5026322
2015-04-15,9643800.0,83.29000091552734,85.7300033569336,83.0,85.16000366210938,71.28130340576172,CAT,"5 Crucial Things Caterpillar Inc. Management Wants You to Know ||| Caterpillar, Inc. (CAT) Ex-Dividend Date Scheduled for April 16, 2015",0,0.507133
2015-04-17,5314000.0,83.5,83.58999633789062,82.66000366210938,83.27999877929688,70.28541564941406,CAT,"CNH Industrial N.V. (CNHI) Ex-Dividend Date Scheduled for April 20, 2015",1,0.46641538
2015-04-20,3914600.0,83.95999908447266,84.75,83.87999725341797,84.5999984741211,71.39946746826172,CAT,Will Illinois Tool Works (ITW) Miss Q1 Earnings Estimates? - Analyst Blog,0,0.50883216
2015-04-21,5620900.0,84.66000366210938,84.97000122070312,83.61000061035156,83.91999816894531,70.8255615234375,CAT,Will Caterpillar (CAT) Beat Earnings Estimates in Q1? - Analyst Blog ||| Here's What Drove CalAmp's Record Quarter ||| Will Snap-on (SNA) Keep its Earnings Streak Alive in Q1? - Analyst Blog ||| 2 Caterpillar Charts This Pro Is Watching,1,0.48923275
2015-04-22,6520700.0,84.12999725341797,84.94000244140625,83.08999633789062,84.87000274658203,71.62732696533203,CAT,"Why CalAmp Corp. Stock Popped Today ||| Pre-Market Earnings Report for April 23, 2015 : PG, PEP, MMM, MO, ABBV, UNP, LLY, DHR, GM, DOW, CAT, ERIC ||| Caterpillar Rewards Shorts Off Both Up and Down Pre-Market Moves in Wake of Earnings ||| Cat Shares Indicated Higher Despite 8-K Showing Mar. Rolling Three-Month Global Retail Sales Down 12%",0,0.488494
2015-04-23,18917600.0,86.8499984741211,87.5,83.8499984741211,84.79000091552734,71.55979919433594,CAT,"Caterpillar (CAT) Beats Q1 Earnings, Ups 2015 EPS Outlook - Analyst Blog ||| Stocks: Welcome to the Era of ""Capital Recycling"" ||| VIG, EOG, CAT, GD: ETF Outflow Alert ||| EBAY, FB, GM, CAT, GOOG Earnings Buzz in Stock Market News Today ||| Pre-Market Most Active for Apr 23, 2015 : ERIC, PBR, ARRS, FB, CAT, GM, NOK, T, TRCO, QQQ, TXN, AAPL ||| Caterpillar Inc. Beats Estimates and Upgrades 2015 Outlook: Is the Worst Over for Investors? ||| Dow Movers: MMM, CAT ||| In the Thick of Q1 Earnings Season - Ahead of Wall Street ||| Morning Market Gainers ||| Caterpillar Posts Upbeat Q1 Earnings, Raises Earnings Forecast ||| Benzinga's Top #PreMarket Gainers ||| Cat Reported Q1 Adj. EPS $1.72 ||| Cat Raises FY EPS Outlook from ~$4.75 Previously to $5 vs $4.70 Est. ||| Caterpillar Reports Q1 EPS $1.86 vs. Est. $1.35, Rev. $12.702B vs. Est. $12.38B; EPS Estimate May Not Compare ||| 10 Stocks To Watch For April 23, 2015 ||| Earnings Scheduled For April 23, 2015",0,0.49268073
2015-04-24,5848100.0,84.69999694824219,85.16999816894531,84.0199966430664,84.5999984741211,71.39946746826172,CAT,"Halliburton Assets Up for Grabs, Who Will Buy? - Analyst Blog ||| Caterpillar CEO Says Oil Price has been a Headwind and Will be in 2015",1,0.49707052
2015-04-27,5912000.0,84.7699966430664,85.94000244140625,84.4000015258789,85.33000183105469,72.01554870605469,CAT,"After Crushing First-Quarter Estimates, Is Caterpillar Inc. Finally a Buy?",1,0.49011245
2015-04-29,7021800.0,85.69000244140625,87.91999816894531,85.45999908447266,87.5,73.84696197509766,CAT,"AGCO Beats Q1 Earnings, Lags Y/Y on Production Cuts - Analyst Blog ||| 3 ETFs in Focus on Mixed Q1 Industrial Results - ETF News And Commentary",0,0.5304676
2015-04-30,5460100.0,86.8499984741211,87.30000305175781,86.2300033569336,86.87999725341797,73.32369995117188,CAT,PREVIEW: First Solar to Resume Trading at 5:20 PM ET ||| Watch for Action in Solar Sector Following Deal Between Caterpillar and First Solar ||| UPDATE: Cat Announces Strategic Alliance to Develop PV Solar Solutions for Microgrid Apps with First Solar ||| Cat Announces Strategic Alliance to Develop PV Solar Solutions for Microgrid Apps with First Solar,1,0.5324944
2015-05-01,4850100.0,87.69000244140625,88.27999877929688,86.76000213623047,87.37000274658203,73.73723602294922,CAT,"Forget What Wall Street Says -- First Solar, Inc. Had a Great Quarter ||| Caterpillar Reporting Reception Of Additional Subpoena Related To Resale Of Replacement Parts",0,0.49735987
2015-05-04,2754500.0,87.7300033569336,87.95999908447266,87.16999816894531,87.30000305175781,73.67818450927734,CAT,This Struggling Industrial Giant is Gearing up to be the Next Technology Star ||| 3 Best Performing Stocks in April - Analyst Blog,0,0.5023744
2015-05-06,4464700.0,87.75,87.94000244140625,86.41999816894531,86.98999786376953,73.41654205322266,CAT,5 Solar Stocks That Should Be On Your Radar,0,0.5228457
2015-05-07,3892800.0,86.6500015258789,86.87999725341797,85.88999938964844,86.43000030517578,72.94391632080078,CAT,"Dow Movers: XOM, INTC ||| Astec Industries, Inc. (ASTE) Ex-Dividend Date Scheduled for May 08, 2015",1,0.4542472
2015-05-11,6882600.0,88.4000015258789,89.44000244140625,88.08999633789062,88.7699966430664,74.91878509521484,CAT,"One Put, One Call Option To Know About for Caterpillar ||| These 3 Stocks Should Raise Their Dividend Soon ||| Dow Movers: TRV, CAT ||| Why CalAmp Jumped 17% in April ||| Benzinga's Top Upgrades ||| Baird Upgrades Caterpillar To Outperform ||| US Stock Futures Edge Higher ||| Baird Upgrades Caterpillar to Outperform, Raises PT to $101.00",0,0.50043076
2015-05-12,4066400.0,88.19000244140625,88.33999633789062,87.26000213623047,88.16000366210938,74.40398406982422,CAT,Buy Caterpillar? This Expert Answers In 2 Charts,1,0.5045835
2015-05-14,3228400.0,88.77999877929688,89.58999633789062,88.6500015258789,88.73999786376953,74.89347839355469,CAT,Dow Analyst Moves: CAT,0,0.51468444
2015-05-15,3205000.0,88.5,88.55999755859375,87.5999984741211,88.43000030517578,74.6318359375,CAT,"Dow Movers: CAT, CSCO",0,0.51160264
2015-05-18,3074400.0,88.38999938964844,88.5,87.6500015258789,88.29000091552734,74.51371002197266,CAT,The 30 Dow Jones Stocks,0,0.5119628
2015-05-19,5676800.0,87.88999938964844,87.91000366210938,86.51000213623047,87.23999786376953,73.62753295898438,CAT,"Dow Movers: WMT, AXP",1,0.5136733
2015-05-20,3841500.0,87.62999725341797,88.12999725341797,87.12999725341797,87.93000030517578,74.20985412597656,CAT,"Caterpillar 3-Mth North America Machine Sales Up 5%, LatAm Sales Down 44% ||| Top 4 NYSE Stocks In The Farm & Construction Machinery Industry With The Highest Revenue",1,0.50817585
2015-05-21,8155500.0,88.2300033569336,89.62000274658203,87.94000244140625,89.33000183105469,75.39141845703125,CAT,"Supreme Industries, Inc. (STS) Ex-Dividend Date Scheduled for May 22, 2015 ||| After Hours Most Active for May 21, 2015 : ESRX, CAT, GE, DAL, CVC, NOV, PH, SGYP, QCOM, MSFT, QQQ, NSTG ||| Caterpillar (CAT) Monthly Sales Decline for the 29th Time - Analyst Blog ||| Did You See Caterpillar's Latest April Sales Number?",0,0.4650595
2015-05-22,3483800.0,89.18000030517578,89.5,88.62999725341797,88.62999725341797,74.8006362915039,CAT,"Expert: How To Play Caterpillar, In 2 Charts",0,0.5161002
2015-05-26,3149600.0,88.12999725341797,88.1500015258789,87.29000091552734,87.83999633789062,74.13390350341797,CAT,"Why Lower Iron Ore Prices Could Hit Caterpillar Stock Hard ||| Is The Mining Industry At A Bottom? No, Says Longbow Research ||| Caterpillar Vs. Deere: Who Wins?",1,0.4709777
2015-05-27,4517100.0,87.98999786376953,88.81999969482422,87.6500015258789,87.91999816894531,74.20143127441406,CAT,"Bill Nygren Buys 3 New Stocks in Q1 ||| Hyster-Yale Materials Handling, Inc. (HY) Ex-Dividend Date Scheduled for May 28, 2015 ||| After Hours Most Active for May 27, 2015 : ABBV, INTC, T, QQQ, NRG, CAT, MSFT, BMY, AIG, CMCSA, QCOM, AAPL",0,0.47450814
2015-05-28,5899100.0,87.33000183105469,87.44999694824219,85.7300033569336,86.01000213623047,72.58946228027344,CAT,"Dow Movers: CAT, INTC ||| What the Stock Market Did Today",0,0.4962388
2015-05-29,4685700.0,85.73999786376953,86.33000183105469,85.11000061035156,85.31999969482422,72.00711059570312,CAT,"Stock Market News for May 29, 2015 - Market News",1,0.50648725
2015-06-01,3976900.0,86.05999755859375,86.37000274658203,84.69999694824219,85.52999877929688,72.1843490600586,CAT,Vanguard Dividend Appreciation ETF Experiences Big Outflow ||| 20 Questions With Bill Nygren - Part I,1,0.4977756
2015-06-02,2817800.0,85.20999908447266,86.68000030517578,85.06999969482422,86.16999816894531,72.7244873046875,CAT,"Dow Movers: INTC, CAT ||| Stock Market News for June 02, 2015 - Market News ||| SocGen Initiates Coverage on Caterpillar at Buy, Announces $110.00 PT",1,0.497786
2015-06-03,2841800.0,86.5999984741211,87.05999755859375,85.80999755859375,86.2300033569336,72.77515411376953,CAT,"Societe Generale Initiates Coverage on Caterpillar at Buy, Announces $110.00 PT",0,0.5167855
2015-06-04,3775200.0,85.5,86.4000015258789,85.31999969482422,85.47000122070312,72.13370513916016,CAT,"Joy Global Beats Q2 Earnings Estimates, Bookings Drop - Analyst Blog",1,0.5317416
2015-06-05,3937600.0,85.01000213623047,86.5,84.91000366210938,86.05000305175781,72.62319946289062,CAT,"Terex Corporation (TEX) Ex-Dividend Date Scheduled for June 08, 2015",1,0.4800669
2015-06-08,3355800.0,85.80000305175781,86.4800033569336,85.77999877929688,86.1500015258789,72.70759582519531,CAT,"If You're in Your 70s, Consider Buying These 5 Stocks",1,0.47595128
2015-06-09,3984900.0,86.45999908447266,87.62000274658203,86.41999816894531,86.7300033569336,73.1971206665039,CAT,"Dow Movers: AAPL, CAT",1,0.51030123
2015-06-10,4717100.0,87.44999694824219,88.70999908447266,87.36000061035156,88.4800033569336,74.67403411865234,CAT,"Daily Dividend Report: CAT, TGT, MSFT, MA, PDCO, PEB ||| Miller Industries, Inc. (MLR) Ex-Dividend Date Scheduled for June 11, 2015 ||| Midday Update: Stocks Gaining Altitude As Dollar Falls, Lifting Prospects for Exports ||| Thrifty Miners Killed Caterpillar and Joy Global's Sales: Are their Parts Businesses Next? ||| Will Lower Oil Prices & Weak Mining Impact Caterpillar? - Analyst Blog ||| Caterpillar Boosts Quarterly Dividend By 10 Percent ||| Caterpillar Increases Qtr. Dividend From $0.70 To $0.77/Share ||| ~34% Of Caterpillar Holders Said To Oppose Executive Pay Plans",0,0.51785165
2015-06-11,2872900.0,88.62000274658203,88.76000213623047,87.91999816894531,88.16999816894531,74.41241455078125,CAT,"Stocks to Watch in Construction Machinery: Caterpillar Inc. and Terex Corporation ||| Caterpillar Raises Quarterly Dividend by 10%, Shares Up - Analyst Blog ||| Cat Announces Mary Bell, VP of Building Construction Products Unit to Retire, Ken Hoefling to Replace; Mark Sweeney, VP of Europe South American Operations to Retire; William Finerty, VP of Diversified Products to Leave Co.",0,0.4926214
2015-06-12,2212800.0,87.94999694824219,88.41000366210938,87.56999969482422,87.8499984741211,74.14234924316406,CAT,"Dow Movers: CSCO, CAT ||| Weekly Market Wrap: June 12, 2015",0,0.4919273
2015-06-15,2721000.0,87.13999938964844,87.38999938964844,86.3499984741211,87.12999725341797,73.53469848632812,CAT,"Is Shareholder Dissent With Caterpillar, Inc.'s Executive Compensation Justified?",0,0.51301104
2015-06-16,2895000.0,86.79000091552734,87.0199966430664,86.23999786376953,86.58999633789062,73.07894897460938,CAT,"Dow Movers: CAT, UNH ||| Douglas Dynamics, Inc. (PLOW) Ex-Dividend Date Scheduled for June 17, 2015 ||| How Investors Can Determine if Caterpillar, Inc.'s Dividend Is Valuable and Sustainable ||| These Stocks Just Raised Their Dividends",1,0.46114635
2015-06-18,3372600.0,86.83000183105469,87.73999786376953,86.83000183105469,87.44000244140625,73.79631042480469,CAT,"UPDATE: Cat Latin America Retail Sales Down 50% in May, EAME Down 7% ||| UPDATE: Cat North American Retail Sales Up 1% in May, Down 14% in Asia, Pacific Region ||| 8-K from Cat Shows Retail Three-Month Rolling Machine Sales Down 12% in May ||| Caterpillar and Modustri to Collaborate on Equipment Monitoring Technology",1,0.56124896
2015-06-19,3910900.0,87.2699966430664,87.95999908447266,87.1500015258789,87.5199966430664,73.86385345458984,CAT,"Caterpillar's (CAT) Monthly Sales Continue to Go Downhill - Analyst Blog ||| Stifel Believes 'Currency, Commodities, Global GDP Now Favor CAT Stock'",1,0.4884216
2015-06-22,3648600.0,87.97000122070312,88.31999969482422,87.70999908447266,88.2699966430664,74.4968032836914,CAT,"Caterpillar, Modustri Partner to Boost Equipment Monitoring - Analyst Blog",1,0.5177045
2015-06-23,2539000.0,88.41999816894531,88.62000274658203,88.01000213623047,88.44999694824219,74.64871215820312,CAT,Caterpillar Retrenches 50 Workers Owing to Mining Slump - Analyst Blog,0,0.52488714
2015-06-24,3413600.0,88.79000091552734,88.80999755859375,88.06999969482422,88.16999816894531,74.41241455078125,CAT,Top 4 NYSE Stocks In The Farm & Construction Machinery Industry With The Lowest PEG Ratio,0,0.51243174
2015-06-25,3239100.0,88.22000122070312,88.33000183105469,86.66000366210938,86.72000122070312,73.18866729736328,CAT,"Notable ETF Outflow Detected - UDOW, CAT, DD, MCD ||| Dow Movers: NKE, VZ",1,0.5034035
2015-06-26,4387300.0,86.5,86.94999694824219,85.80999755859375,86.81999969482422,73.2730712890625,CAT,"Dow Movers: INTC, NKE",0,0.51728976
2015-06-30,4077900.0,86.08999633789062,86.25,84.80000305175781,84.81999969482422,71.58513641357422,CAT,CalAmp Corp. Communicates Another Solid Quarter,0,0.5124167
2015-07-06,4896600.0,83.6500015258789,84.1500015258789,82.7300033569336,83.1500015258789,70.17571258544922,CAT,Why Caterpillar Stock Has Gone Nowhere So Far in 2015,1,0.4896885
2015-07-08,4325100.0,83.05000305175781,83.2300033569336,81.76000213623047,82.2699966430664,69.43300628662111,CAT,"Dow Movers: CAT, KO",0,0.50943977
2015-07-10,3495000.0,82.63999938964844,82.91000366210938,81.87000274658203,82.1500015258789,69.33175659179689,CAT,"Dow Movers: CC, VZ",1,0.5264865
2015-07-13,4228500.0,82.87000274658203,84.02999877929688,82.68000030517578,83.63999938964844,70.58924865722656,CAT,Interesting August Stock Options for Caterpillar ||| 11 Stocks With Near-Term Catalysts,1,0.5064309
2015-07-14,3797700.0,83.52999877929688,84.68000030517578,83.5199966430664,84.45999908447266,71.28129577636719,CAT,Caterpillar Upgraded to Strong Buy on Construction Growth - Analyst Blog,0,0.5284673
2015-07-15,3661700.0,84.55000305175781,84.86000061035156,83.75,84.16000366210938,71.02812957763672,CAT,"Caterpillar, Inc. (CAT) Ex-Dividend Date Scheduled for July 16, 2015 ||| Caterpillar Earnings Preview: Will the Equipment Giant Bounce Back?",0,0.46735755
2015-07-16,3686000.0,84.75,84.88999938964844,83.41000366210938,83.76000213623047,71.34326171875,CAT,Will Grainger Q2 Earnings Suffer on Canadian Dollar Slump? - Analyst Blog ||| U.S. Concrete (USCR) Rises: Stock Adds 6.1% in Session - Tale of the Tape,0,0.50422794
2015-07-20,4291400.0,83.05999755859375,83.29000091552734,82.13999938964844,82.25,70.05712127685547,CAT,"3 Reasons Caterpillar Inc. Stock Could Tumble ||| Apple Earnings Not The Only Huge Story This Week: Watch GM, Boeing, Coke, Amazon, Microsoft & Others ||| Tractor Supply (TSCO) Looks Firm from Earnings Perspective - Analyst Blog ||| Is FEMSA (FMX) Positioned to Beat Q2 Earnings Estimates? - Analyst Blog ||| One Put, One Call Option To Know About for Caterpillar ||| Will Pentair (PNR) Report Dismal Earnings Yet Again in Q2? - Analyst Blog ||| Can Amphenol (APH) Pull a Surprise with Q2 Earnings? - Analyst Blog ||| New Strong Buy Stocks for July 20th - Tale of the Tape ||| What's in Store for Dover (DOV) This Earnings Season? - Analyst Blog ||| Notable ETF Outflow Detected - VIG, QCOM, CAT, FDX",0,0.523838
2015-07-21,4691900.0,81.80000305175781,82.88999938964844,81.25,82.22000122070312,70.03156280517578,CAT,Can Skyworks (SWKS) Beat Q3 Earnings on Organic Growth? - Analyst Blog ||| Is Republic Services (RSG) Poised to Beat Q2 Earnings? - Analyst Blog ||| Can Stericycle (SRCL) Beat Earnings on Inorganic Growth? - Analyst Blog ||| Will Currency Woes Drag 3M Company's (MMM) Q2 Earnings? - Analyst Blog ||| Will Proto Labs' (PRLB) Q2 Earnings Surprise Estimates? - Analyst Blog,0,0.5144416
2015-07-22,10180700.0,81.0,81.12000274658203,79.1500015258789,79.76000213623047,67.93623352050781,CAT,"Astec's (ASTE) Q2 Earnings and Revenues Miss Estimates - Analyst Blog ||| Should You Buy Caterpillar (CAT) Ahead of Earnings? - Tale of the Tape ||| Pre-Market Earnings Report for July 23, 2015 : CMCSA, BMY, CELG, MMM, LLY, MCD, UNP, VRX, DHR, DOW, SHPG, CAT ||| Shorts Keen to Watch Caterpillar off Thursday's Pre-Market Earnings ||| Will Caterpillar (CAT) Beat Earnings Again on Cost Savings? - Analyst Blog ||| Did McDonald's, Caterpillar & Amazon Lose Sizzle To Strong Dollar? ||| CAT Goes Splat After 8-K Release ||| 8-K from Cat Shows Global Rolling 3-Month Retail Sales Down 14% in Jun.",0,0.49292687
2015-07-23,13909900.0,77.69999694824219,79.04000091552734,76.6500015258789,76.87999725341797,65.48316955566406,CAT,"Midday Update: Earnings Continue to Pressure Wall Street With Stocks Lower Third Straight Day ||| Dow Jones Industrial Average Today Moving on Earnings Disappointments from AAPL, MSFT ||| Caterpillar Q2 Earnings Beat but Fall Y/Y, Headwinds Ahead - Analyst Blog ||| Busiest Day of Q2 Earnings Season - Ahead of Wall Street ||| Caterpillar Sales Sag As Oil's Slump Weighs on Future Growth ||| Earnings Season: Hot Takes on Latest Reports ||| What the Stock Market Did Today: Dow Jones Slides 119 Points ||| US Stocks Poised For Mixed to Flat Open as Jobless Claims Plummet ||| Earnings Reaction History: Caterpillar Inc, 33.3% Follow-Through Indicator, 2.3% Sensitive ||| US Futures Modestly Higher Ahead of Weekly Jobless Claims ||| Closing Update: Stocks Slump Again: Dow Drops Triple Digits After Component Companies Go 0-for-4 With Q2 Results Today ||| Caterpillar (CAT) Shares Cross 4% Yield Mark ||| While Cramer Can't Find A 'Milligram Of Hair' That's Positive In CAT's Q2, CEO Remains Optimistic ||| Caterpillar Posts In-Line Q2 Earnings, But Sales Miss Views ||| Cat Reaffirms FY15 Adj. EPS ~$5 vs $4.97 Est. ||| Caterpillar Reports Q2 EPS $1.27 Vs Est $1.26, Sales $12.32B Vs Est $12.67B ||| Earnings Scheduled For July 23, 2015 ||| 10 Stocks To Watch For July 23, 2015",0,0.48883307
2015-07-24,9175900.0,76.91000366210938,77.08999633789062,75.8499984741211,76.0999984741211,64.81878662109375,CAT,"Stock Market News for July 24, 2015 - Market News ||| Mike Khouw Sees Unusual Options Activity In Caterpillar",0,0.49904233
2015-07-27,10269600.0,75.18000030517578,75.72000122070312,74.7699966430664,75.31999969482422,64.15442657470703,CAT,"The Zacks Analyst Blog Highlights: IBM, Verizon Communications, Apple, Microsoft and Caterpillar - Press Releases ||| Stronger Dollar Hurts Q2: 4 Safe Bets - Analyst Blog",1,0.49557692
2015-07-28,15699000.0,75.91999816894531,78.1500015258789,75.79000091552734,77.77999877929688,66.24974822998047,CAT,"Weak Industrial Earnings Drag Industrial ETFs Lower - ETF News And Commentary ||| Caterpillar Reports $1.5B Accelerated Buyback ||| International Truck To Introduce New Line Of Premium Vocational Trucks As Navistar, Caterpillar Conclude Severe Service Truck Agreement",0,0.509845
2015-07-29,13794800.0,77.30000305175781,77.45999908447266,76.51000213623047,77.33000183105469,65.86646270751953,CAT,"Dow Analyst Moves: CAT ||| Dow Movers: CAT, PFE ||| After Hours Most Active for Jul 29, 2015 : FB, BAC, T, QQQ, V, CAT, PFE, AAPL, WFM, BSX, SIRI, MU",1,0.48482347
2015-07-30,7386200.0,76.9800033569336,78.37000274658203,76.68000030517578,78.3499984741211,66.73526000976561,CAT,"After Hours Most Active for Jul 30, 2015 : CX, LNKD, FEYE, QQQ, CAT, NOK, ATR, S, EXPE, AREX, FOXA, MSFT",1,0.4936208
2015-08-03,6443300.0,78.41999816894531,78.43000030517578,76.75,77.26000213623047,65.80682373046875,CAT,Interesting November Stock Options for CAT,0,0.5153908
2015-08-04,5822300.0,77.33000183105469,77.86000061035156,76.31999969482422,76.5999984741211,65.24467468261719,CAT,World Tour: Australia's Service Economy & Commodities,1,0.53126603
2015-08-05,4581900.0,77.5,77.91999816894531,76.72000122070312,76.87999725341797,65.48316955566406,CAT,"Terex Corporation (TEX) Ex-Dividend Date Scheduled for August 06, 2015 ||| H&E Equipment Beats on Q2 Earnings Despite Bad Weather - Analyst Blog",1,0.5133069
2015-08-06,5609500.0,76.9800033569336,77.6500015258789,76.18000030517578,77.45999908447266,65.97720336914061,CAT,"Astec Industries, Inc. (ASTE) Ex-Dividend Date Scheduled for August 07, 2015",0,0.449027
2015-08-07,7851300.0,77.5199966430664,78.1500015258789,76.94000244140625,77.29000091552734,65.83238983154297,CAT,"Analyst Favorites With Strong Buyback Activity: WABCO Holdings Ranks As a Top Pick ||| Dow Movers: NKE, CAT ||| After Hours Most Active for Aug 7, 2015 : QCOM, TPH, QQQ, CAT, ESRX, EZPW, IR, ALSN, MEMP, DEPO, ZTS, MBI ||| Option Alert: Caterpillar Aug 14 $78 Call; 5000 Contracts @Ask @$0.58; Now $77.66",1,0.48339632
2015-08-10,9041600.0,78.04000091552734,80.30999755859375,77.9000015258789,80.16000366210938,68.27692413330078,CAT,"Barron's Recap: Time To Buy Commodities ||| VIG, QCOM, TXN, CAT: Large Outflows Detected at ETF ||| Dow Movers: KO, CAT ||| After Hours Most Active for Aug 10, 2015 : BAC, HOT, QQQ, KO, CAT, ODP, TXN, PG, FCAU, AAPL, MSFT, FTR ||| Close Update: Dow Ends 7-Day Losing Streak as Stocks Rally on M&A Action ||| Stocks Rally on M&A Action; Fed's Lockhart Softens September Rate Hike Warning",0,0.49166694
2015-08-11,8992500.0,78.7300033569336,78.93000030517578,77.2300033569336,78.04000091552734,66.47121429443361,CAT,"Columbus McKinnon Corporation (CMCO) Ex-Dividend Date Scheduled for August 12, 2015",1,0.48039785
2015-08-12,7236800.0,77.30999755859375,79.12000274658203,76.91999816894531,78.91999816894531,67.22075653076172,CAT,"Stock Market News for August 12, 2015 ||| Regeneron Pharmaceuticals, Oshkosh, Amgen and Caterpillar highlighted as Zacks Bull and Bear of the Day ||| After Hours Most Active for Aug 12, 2015 : CSCO, SYY, QQQ, BAC, CAT, M, HOLX, GE, SIRI, NFLX, C, MSFT ||| UPDATE: Phil Davis Following USDA Report: Likes Cat Shares at $75, Says Monsanto is 'Reasonable' at $100, Potash 'Good Gamble' at $26 ||| UPDATE: Davis Following USDA Report: '...overall, it's a pretty good time to go bargain-hunting in the space if you are a long-term investor (3 years).'",0,0.47460923
2015-08-13,5662500.0,78.55000305175781,78.58000183105469,77.69999694824219,77.76000213623047,66.23271179199219,CAT,"Don't Worry, Caterpillar's Market Share Is Stable",1,0.5143165
2015-08-14,3811500.0,77.66000366210938,78.7300033569336,77.5999984741211,78.48999786376953,66.85450744628906,CAT,"Jim Cramer Shares His Thoughts On GoPro, Marathon Oil And Caterpillar",1,0.5092172
2015-08-17,5226800.0,78.12999725341797,78.63999938964844,77.20999908447266,78.54000091552734,66.89708709716797,CAT,"Is Now the Best Time to Buy Caterpillar Inc. Stock? ||| Dow Movers: CAT, DIS ||| The Zacks Analyst Blog Highlights: Exxon Mobil, Chevron, Walt Disney, Apple, Caterpillar, Cisco Systems, General Electric, Capital One Financial, Verizon Communications, McDonald's, American Express and Intel",1,0.4944628
2015-08-19,5862700.0,78.25,78.54000091552734,77.05000305175781,77.41000366210938,65.93460083007811,CAT,"Supreme Industries, Inc. (STS) Ex-Dividend Date Scheduled for August 20, 2015",0,0.44521868
2015-08-20,7767300.0,77.27999877929688,77.83000183105469,76.41000366210938,76.41000366210938,65.08282470703125,CAT,"8-K from Cat Shows Global Rolling 3-Month Retail Sales for Jul. Down 11%, vs 14% Decline in Jun., 12% Decline in May",0,0.51470035
2015-08-21,11805500.0,75.94000244140625,76.30000305175781,74.95999908447266,75.0,63.8818473815918,CAT,"Dow Jones Industrial Average Falls 531 Points on Huge Two-Day Sell-Off ||| Caterpillar Shares Approaching Morning Lows, Jim Chanos Revealed Short Position On CNBC",0,0.50040734
2015-08-25,9427200.0,75.22000122070312,75.48999786376953,72.02999877929688,72.05999755859375,61.37769317626953,CAT,Boeing's (BA) Satellite Business to Reduce Employee Count,1,0.52523154
2015-08-26,8288100.0,73.81999969482422,74.08000183105469,72.52999877929688,73.87000274658203,62.91939163208008,CAT,Lowest 5-Day Losses on the Dow ||| Is There Danger Lurking in Caterpillar Inc.’s Dividend?,1,0.49946463
2015-08-27,8537700.0,75.04000091552734,76.22000122070312,74.2300033569336,75.66000366210938,64.44402313232422,CAT,"2 Dividend Stocks to Buy and 1 to Avoid ||| The Zacks Analyst Blog Highlights: 3M Company, Home Depot, Coca-Cola and Caterpillar ||| Hyster-Yale Materials Handling, Inc. (HY) Ex-Dividend Date Scheduled for August 28, 2015 ||| Dow Jones Industrial Average Rises 369 Points on Second-Quarter GDP",1,0.48575848
2015-08-31,7019600.0,75.31999969482422,76.7699966430664,74.9000015258789,76.44000244140625,65.1083984375,CAT,"One Put, One Call Option To Know About for Caterpillar ||| Dallas to Lose Out on GE Headquarters over Ex-Im Bank",0,0.48228922
2015-09-01,9053100.0,74.5,75.94000244140625,74.45999908447266,74.9000015258789,63.79670333862305,CAT,"Dow Movers: XOM, CAT ||| It's Not Shopping, It's Market Research: Talking Investing Trends With TD Ameritrade's Nicole Sherrod",1,0.49324122
2015-09-03,11077100.0,75.94999694824219,76.01000213623047,73.77999877929688,74.44999694824219,63.41338729858398,CAT,"Dow Movers: CAT, CVX ||| Joy Global Lags Q3 Earnings & Revenues, Trims Guidance ||| Dow Jones Industrial Average Adds 23 Points in a Mostly Flat Session ||| 5 Things Caterpillar's Management Wants You to Know ||| Trial Date Set For Traders Accused Of $100 Million Hacking Scheme",0,0.49011746
2015-09-04,12007300.0,73.0,73.66000366210938,72.3499984741211,73.0999984741211,62.26351547241211,CAT,"Dow Movers: CAT, AAPL ||| Benzinga's Top Downgrades ||| Bull Thesis Losing Ground At Caterpillar ||| US Stock Futures Tumble; Jobs Report In Focus ||| Baird Downgrades Caterpillar to Neutral, Lowers PT to $77.00",1,0.48889795
2015-09-09,5859200.0,75.0,75.19999694824219,72.77999877929688,72.95999908447266,62.144287109375,CAT,"Miller Industries, Inc. (MLR) Ex-Dividend Date Scheduled for September 10, 2015",0,0.44706473
2015-09-10,6109100.0,72.88999938964844,73.30999755859375,72.02999877929688,72.41999816894531,61.6843147277832,CAT,"Better Buy Now: Caterpillar Inc. or Cummins Inc.? ||| Industrial ETFs Are Still Scuffling ||| Industrial ETFs Are Still Scuffling ||| Option Alert: $CAT Sep $75 Call; 10,000 Contracts @Ask @$0.47; Now $72.73",1,0.48227063
2015-09-11,4413800.0,72.2300033569336,72.91999816894531,71.87999725341797,72.62999725341797,61.86319351196289,CAT,The Dow Stocks Investors Are Most Pessimistic About,1,0.4915445
2015-09-14,4231800.0,72.3499984741211,72.88999938964844,72.01000213623047,72.7699966430664,61.98244094848633,CAT,"Bill Nygren Increases Position in Caterpillar ||| Notable Monday Option Activity: CAT, HPQ, AET ||| The Only U.S. Dollar Move That Matters Now ||| Interesting October Stock Options for CAT",1,0.5012767
2015-09-16,5225800.0,74.8499984741211,75.87000274658203,74.58000183105469,75.63999938964844,64.42697143554689,CAT,"Midday Update: Stocks Advance After Benign Inflation Data Soothes Interest Rate Jitters ||| Stock Market News for September 16, 2015 ||| Douglas Dynamics, Inc. (PLOW) Ex-Dividend Date Scheduled for September 17, 2015 ||| Why Options Trading Is the Best Risk Management Strategy ||| Top 4 NYSE Stocks In The Farm & Construction Machinery Industry With The Highest EPS Growth Forecast For Next 5 Years",0,0.47987744
2015-09-17,7745000.0,75.4000015258789,75.68000030517578,73.91000366210938,74.05999755859375,63.08120346069336,CAT,JC Parets On Caterpillar: Be A Seller Of Strength,0,0.51206803
2015-09-21,7594900.0,72.30000305175781,72.83999633789062,71.91000366210938,72.16000366210938,61.46287155151367,CAT,Interesting May 2016 Stock Options for Caterpillar ||| 5 Fascinating Facts About Caterpillar You Probably Didn't Know ||| 8-K from Cat Shows Global Rolling 3-Month Retail Sales for Aug. Down 14%,0,0.5008454
2015-09-22,5717300.0,71.12000274658203,71.80000305175781,70.63999938964844,71.68000030517578,61.05402374267578,CAT,Caterpillar: 6 Things You Need to Know ||| Societe Generale: Caterpillar's Low Expectations May Be Blessing In Disguise,0,0.47878295
2015-09-23,4754300.0,71.66999816894531,71.80999755859375,70.16000366210939,70.19999694824219,59.79342269897461,CAT,"Dow Movers: CAT, INTC",0,0.5136868
2015-09-24,22589600.0,66.19999694824219,66.69999694824219,64.65000152587889,65.80000305175781,56.045692443847656,CAT,"Midday Update: Stocks Extend Slide For Third Day After Slumping Durable Goods, Caterpillar Stoke Growth Worries ||| Stocks Capitulate to More Worries Over Global Growth; Caterpillar Weighs on Dow ||| S&P 500 Movers: CAT, NEM ||| Dow Movers: CAT, KO ||| Dow Jones Industrial Average Slumps 78 Points Ahead of Yellen's Statements ||| Closing Update: Late Rebound Stops Short of Ending Week-Long Slide For Stocks Since Fed Rate Decision ||| Worst Performing Industries For September 24, 2015 ||| Mid-Morning Market Update: Markets Tumble; Accenture Tops Q4 Estimates ||| Morning Market Losers ||| Cat Shares Trading Down Another Nearly $3 Following Restructuring News, Concerning Outlook; Shares Now Trading Down Nearly 7% from Yesterday's Close ||| UPDATE: Caterpillar Announces New Organizational Structure for Mining and Customer and Dealer-Facing Divisions; Focus on Innovation and Data Analytics Remains a Key Priority ||| UPDATE: Caterpillar Says Most Salaried, MGMT Job Cuts Will Happen in 2015, See Consolidation And Closure Of Manufacturing Plants Through 2018 ||| UPDATE: Cat Planning to Permanently Reduce Workforce by 4-5K Employees ||| UPDATE: Cat Sees FY16 Sales Down ~5% ||| UPDATE: Cat's Restructuring, Cost Reduction Plans Expected to Lower Operating Costs by ~$1.5B Annually ||| UPDATE: Cat Cuts FY15 Sales Outlook from ~$49B to ~$48B vs $48.82B Est. ||| Cat Reports Restructuring, Cost Reductions Plan ||| Benzinga's Top Initiations ||| Axiom's Gordon Johnson Starts Caterpillar With A Sell, Sees 60% Downside ||| UPDATE: Axiom's Gordon Johnson on New Sell Rating for Cat: Notes Two of Co.'s Three Core Businesses 'Struggling,' Sees 60% Downside in Stock ||| Axiom Initiates Coverage on Caterpillar at Sell, Announces $28.00 PT",0,0.4974794
2015-09-25,12365100.0,65.0,65.76999664306639,64.73999786376953,64.98000335693361,55.34724807739258,CAT,"Dow Movers: CAT, NKE ||| Dow Futures Move Ahead of Q2 GDP Report ||| Caterpillar Stuck, Buy These 6 Industrial Stocks Instead ||| 5 Industrial Stocks to Avoid After Caterpillar Report ||| 4 Mining Stocks to Dump on Caterpillar's News ||| Dow 30 Stock Roundup: Boeing Receives Orders Worth $38B From China Cos, Caterpillar to Cut 5K Jobs ||| 5 Small Caps That Could Get Bulldozed By Caterpillar Inc. (NYSE: CAT) ||| United Rentals Upgrade: Bank Of America Thinks Bearish Thesis Has Come To A Close ||| Blair Downgrades Caterpillar, Notes 'Too Many Headwinds To Ignore' ||| Benzinga's Top Downgrades ||| The 'Fog Of War' Is Thickening At Caterpillar ||| Jim Cramer Gives His Opinion On Caterpillar, KB Home, Lennar, Kansas City Southern And General Electric ||| William Blair Downgrades Caterpillar to Market Perform",0,0.4881651
2015-09-28,12572000.0,64.23999786376953,64.31999969482422,62.9900016784668,63.790000915527344,54.33365631103516,CAT,"The Worst Stock Ideas Of The Past Month ||| Weighing The Week Ahead: Will Global Weakness Drag Down The U.S. Economy? ||| Parets: Caterpillar Will Continue To Be One Of Dow's Worst Stocks ||| ETF Outlook: More Biotech Blunders Or A Biotech Bounce? ||| Crush Caterpillar Woes with This Industrial ETF ||| FDL, T, MO, CAT: Large Outflows Detected at ETF ||| How the Global Commodities Crash Continue to Crush Caterpillar ||| The Zacks Analyst Blog Highlights: Caterpillar, Thompson Creek Metals, Silver Standard Resources, Randgold Resources and Sandstorm Gold ||| The Zacks Analyst Blog Highlights: Volkswagen, Exxon Mobil, Chevron, Caterpillar and Boeing ||| The Contrarian Case For Caterpillar: Don't Freak Out, Investors ||| Week Ahead: Budget Battle, Fedspeak, Jobs Data Divert Street Focus To D.C.",1,0.4718549
2015-09-29,8784400.0,63.6500015258789,65.38999938964844,63.59999847412109,64.30999755859375,54.77656555175781,CAT,"Halliburton, Baker Hughes to Sell More Assets for Merger ||| How To Deal With Continued Volatility ||| Caterpillar (CAT) Hits Rough Waters; Takes Peers Along",1,0.48739746
2015-09-30,7850300.0,64.94999694824219,65.63999938964844,64.15000152587889,65.36000061035156,55.67091751098633,CAT,"Just How Bad Are Things at Caterpillar, Inc.? ||| UPDATE: Cat Said Price Action Related to 'current industry factors as well as general economic conditions.' ||| 8-K from Cat Shows Price Action of 0-2% on Most Machines",0,0.4769306
2015-10-01,7933000.0,65.62999725341797,66.09999847412111,63.61000061035156,64.38999938964844,54.84471130371094,CAT,5 Best Performing Stocks in September ||| Optimistic Narrative for China? ||| Close Update: Stocks Trim Early Losses Tied to ISM,1,0.53412116
2015-10-02,8782700.0,63.790000915527344,65.73000335693361,63.09999847412109,65.69999694824219,55.96050262451172,CAT,"Dow 30 Stock Roundup: NIKE Beats Estimates, Pfizer Ups 2015 Outlook, Microsoft Changes Reporting Structure ||| 5 Things CalAmp Corp. Management Wants You to Know ||| The Dow's 3 Worst Stocks This Summer ||| 5 U.S. Stocks Cashing In On This Downturn ||| 6 U.S. Stocks With A High Dividend Yield, Low Beta",1,0.48526955
2015-10-05,10661900.0,66.69000244140625,69.48000335693361,66.51999664306639,69.18000030517578,58.92462539672852,CAT,Why Greenbrier Companies Decoupled in September,1,0.49209446
2015-10-06,9664100.0,69.54000091552734,71.1500015258789,69.08000183105469,70.81999969482422,60.3215217590332,CAT,"Why Caterpillar Inc.'s Shares Plunged 15% in September ||| Hearing Jeffrey Ubben's ValueAct Capital Mgmt Has Taken Stake in Caterpillar, Chatter ValueAct To Seek Board Seats And Operational Plan",0,0.48770738
2015-10-07,8307700.0,71.36000061035156,72.70999908447266,69.15000152587889,70.37999725341797,59.946739196777344,CAT,"With a Great Management Team on Your Side, Time Is Your Friend ||| Five Super Reads to Help You Calmly Navigate Choppy Markets",1,0.5341535
2015-10-08,6091600.0,70.31999969482422,72.18000030517578,69.84999847412111,71.83999633789062,61.19031143188477,CAT,Option Alert: $CAT Nov $72.5 Call; 5400 Contracts above Ask @$2.38; Now $71.78,0,0.49226034
2015-10-09,5573500.0,71.83999633789062,72.48999786376953,70.86000061035156,71.30000305175781,60.73036956787109,CAT,"Dow Movers: MSFT, UNH ||| China Shadows Q3 Earnings ||| Zacks Earnings Trends Highlights: General Electric, Caterpillar, Deere and Joy Global",0,0.49921566
2015-10-12,4643500.0,71.51000213623047,71.52999877929688,70.31999969482422,70.5,60.04895401000977,CAT,"Caterpillar Inc. Slashes Its Outlook -- Could These 4 Companies Be Next? ||| One Put, One Call Option To Know About for Caterpillar",0,0.45917636
2015-10-13,4724800.0,69.95999908447266,71.02999877929688,69.26000213623047,70.16999816894531,59.76786422729492,CAT,"Jim Cramer Gives His Opinion On SPDR Gold Trust, Randgold Resources, Chevron And Caterpillar",1,0.50323594
2015-10-15,4547900.0,70.47000122070312,70.91999816894531,69.76000213623047,70.83000183105469,60.33003616333008,CAT,"Daily Dividend Report: AMGN, WBA, UTX, CAT, AON, WY, CF",0,0.50918204
2015-10-16,8310000.0,70.62000274658203,70.83000183105469,69.11000061035156,69.68000030517578,59.35051345825195,CAT,"Dow Movers: CAT, GE",0,0.50812477
2015-10-19,5712000.0,69.25,69.47000122070311,68.80000305175781,69.26999664306639,59.00128936767578,CAT,"3 Things You Can't Miss in Caterpillar Inc.'s Upcoming Earnings Report ||| Were the Dow Jones, WSJ Hacked by Russians? ||| Will Mining Spell Doom for Caterpillar's (CAT) Q3 Earnings? ||| New Strong Sell Stocks for October 19th ||| Caterpillar Investors: Get Ready for Another Ugly Quarter",1,0.51905787
2015-10-20,6385800.0,68.86000061035156,71.19000244140625,68.51000213623047,70.26999664306639,59.85304260253906,CAT,"Is Caterpillar ready for a bounce? ||| The Zacks Analyst Blog Highlights: News Corp., Berkshire Hathaway, Caterpillar, Oracle and Panera Bread ||| Doug Kass: I'll Reload My Tesla Short If This Happens",0,0.48251396
2015-10-21,8679400.0,70.58999633789062,71.9000015258789,69.58000183105469,69.66999816894531,59.34199905395508,CAT,"Caterpillar, Inc. (CAT) Ex-Dividend Date Scheduled for October 22, 2015 ||| Pre-Market Earnings Report for October 22, 2015 : MCD, MMM, LLY, UNP, DHR, DOW, CAT, RTN, PCP, AEP, LUV, PRGO ||| Caterpillar Consistently Offers Shorts Better Trading History off Pre-Market Earnings Moves ||| Manitowoc (MTW) Shares Fall on Dismal Q3 & 2015 Outlook ||| Global Growth Temperature Likely Captured In Caterpillar, McDonald's And Under Armour Earnings ||| UPDATE: Axiom's Johnson Still Sees Cat as 'Among the better Shorts in the Market,' But Warns 'Don't Expect Any Fireworks' on Thurs. ||| Axiom's Gordon Johnson on Cat Following Three-Month Rolling Machine Sales Data: Mgmt Will Not Update Next Year's Guidance Until Jan. ||| 8-K from Cat Shows Rolling Three-Month Retail Machines Sales Down 11% Globally ||| Mike Khouw Sees Unusual Options Activity In Caterpillar",1,0.436471
2015-10-22,13909200.0,67.91999816894531,72.83000183105469,67.80999755859375,70.87999725341797,61.04730987548828,CAT,"How Q3 Earnings Season Is Unfolding ||| Noteworthy ETF Outflows: VIG, ABT, MON, CAT ||| Financial Sector Update for 10/22/2015: TROW, JNS ||| Earnings Reaction History: Caterpillar Inc, 44.4% Follow-Through Indicator, 2.4% Sensitive ||| U.S. Stock Futures Buoyed by Bullish McDonald's Earnings ||| Caterpillar Q3 Earnings Lag Y/Y, Cuts 2015 EPS Guidance ||| Singer Meghan Trainor Knows, It's All About That Central Bank Stimulus ||| Caterpillar Rallies Despite Q3 Miss ||| 11 Large-Caps Trading At Bargain Bin Prices ||| Stocks Headed Higher As Blue-Chip Earnings Paint Mixed Picture ||| Benzinga's Top #PreMarket Losers ||| Cat Sees FY15 Adj. EPS ~$4.60 vs $4.60 Est., Sales ~$48B vs $47.8B Est.; Sees FY16 Sales Down 5% YoY ||| Cat Reports Q3 Sales $11B vs $11.25B Est. ||| Cat Reports Q3 Adj. EPS $0.75 vs $0.78 Est. ||| 10 Stocks You Should Be Watching Today ||| Earnings Scheduled For October 22, 2015",1,0.50022984
2015-10-23,7942500.0,71.70999908447266,72.43000030517578,70.66000366210938,71.75,61.79662704467773,CAT,"Better-than-Expected Q3 Earnings Lift Industrial ETFs ||| Stock Market News for October 23, 2015 ||| The Zacks Analyst Blog Highlights: McDonald, Dow Chemicals and Caterpillar ||| Despite a Small Thursday Rally, Caterpillar Inc. Remains in the Struggle Zone",0,0.483652
2015-10-26,6254500.0,71.79000091552734,72.30000305175781,71.41999816894531,71.5199966430664,61.59854125976562,CAT,"Caterpillar's Metamorphosis Still on Hold as Sales, Profit Plunge ||| Terex Q3 Earnings Miss; Expects '15 EPS at Low End of View ||| 5 Stocks to Ride October's Rebound",0,0.48977783
2015-10-27,8280500.0,70.18000030517578,71.08000183105469,68.33999633789061,70.38999938964844,60.62528991699219,CAT,"Dow Movers: CAT, PFE ||| Cummins Restructures, Cuts Outlook on Weak Demand",1,0.50650775
2015-10-28,5486900.0,70.75,72.11000061035156,70.4800033569336,71.97000122070312,61.986122131347656,CAT,Huaiji Dengyun Auto-Parts Announces Master Purchase Agreement With Caterpillar Valued at 207.4M Yuan -Reuters,0,0.5058396
2015-10-29,4321300.0,71.48999786376953,72.56999969482422,71.27999877929688,71.97000122070312,61.986122131347656,CAT,"Dow Movers: INTC, UNH",1,0.50866616
2015-11-02,5876500.0,73.0,74.63999938964844,72.83000183105469,74.33999633789062,64.02733612060547,CAT,3 Unfairly Beaten-Down Manufacturing Stocks,1,0.5385717
2015-11-03,5006100.0,74.44000244140625,75.31999969482422,74.19999694824219,74.75,64.38047027587889,CAT,"5 Dow Jones Titans Perking Up ||| UPDATE: Axiom's Johnson Sees Negative Implications for US Steel, Cliffs, Joy Global, Cat Following Corrosion-Resistant Steel Case ||| UPDATE: Axiom's Johnson Notes High Prelim. Duties on China Were 'No Surprise,' But Was Surprised on Korea, Italy ||| Axiom's Gordon Johnson Highlights Corrosion-Resistant Steel Case Prelim. Margins Released, Questions 'Buy the Rumor, Sell the News?'",0,0.5106833
2015-11-05,6238900.0,74.6500015258789,75.55999755859375,73.20999908447266,74.22000122070312,63.92398834228516,CAT,"Terex Corporation (TEX) Ex-Dividend Date Scheduled for November 06, 2015 ||| Astec Industries, Inc. (ASTE) Ex-Dividend Date Scheduled for November 06, 2015",0,0.43221894
2015-11-06,5538600.0,73.41999816894531,73.8499984741211,72.33000183105469,73.83999633789062,63.5967025756836,CAT,"Dow Movers: CAT, JPM",0,0.49990785
2015-11-09,5914800.0,73.43000030517578,73.61000061035156,71.4800033569336,71.88999938964844,61.9172248840332,CAT,"Best Stock Buy Now: Caterpillar, Inc. General Electric, or United Parcel Service, Inc? ||| The Best Stocks in Construction Machinery ||| One Put, One Call Option To Know About for Caterpillar",1,0.4724675
2015-11-10,4373800.0,71.79000091552734,72.58000183105469,71.62999725341797,72.43000030517578,62.3823127746582,CAT,"Stock Market News for November 10, 2015",0,0.48326635
2015-11-12,8731700.0,70.81999969482422,70.98999786376953,68.41000366210939,68.66000366210939,59.13530349731445,CAT,"Dow Movers: CAT, UTX ||| Notable Thursday Option Activity: CAT, FOSL, YUM ||| Deutsche Bank Analyzes Industrials Heading Into The Winter Months",1,0.50596863
2015-11-13,6429600.0,68.69999694824219,70.12999725341797,68.5,69.62999725341797,59.97071838378906,CAT,"Dow Movers: CSCO, MRK",1,0.51897
2015-11-16,5167600.0,69.48000335693361,70.62000274658203,69.23000335693361,70.38999938964844,60.62528991699219,CAT,The Week Ahead: Further Weakness Looks Likely,0,0.49804872
2015-11-17,4812000.0,70.12999725341797,70.36000061035156,69.05000305175781,69.38999938964844,59.76400756835938,CAT,"Dow Movers: NKE, WMT",1,0.52700937
2015-11-19,6296000.0,69.5,70.11000061035156,68.59999847412111,70.01999664306639,60.30662155151367,CAT,"Gold Prices Dip on Fed Minutes: 4 Stocks to Buy Right Now ||| Dow Movers: UNH, PG ||| Following Caterpillar's Oct. Retail Sales Results, Axiom's Gordon Johnson Says 'it doesn't look pretty out there,' Highlights Weakness in Every Region; Reiterates Sell Rating, $28 Target ||| BZ NOTE: Decline in Cat Global Machine Sales Has Accelerated for Oct., Co. Reported 11% Declines in Both Sept., Aug. ||| 8-K from Cat Shows Global Rolling 3-Month Machine Sales Down 16% for Oct.",1,0.49002686
2015-11-20,6495100.0,70.4800033569336,71.20999908447266,70.16000366210939,71.13999938964844,61.27125930786133,CAT,"Considering Buying Caterpillar, Inc.? Why Investors Should Think Twice ||| Caterpillar's October Sales Drop of 16% Worst in 5 Years",0,0.48974407
2015-11-23,3847600.0,70.9800033569336,71.9000015258789,70.88999938964844,71.0199966430664,61.16790008544922,CAT,"3 Stocks Retirees Should Avoid ||| One Put, One Call Option To Know About for Caterpillar ||| Manitowoc Company, Inc. (MTW) Ex-Dividend Date Scheduled for November 24, 2015",1,0.49559057
2015-11-25,3493000.0,71.73999786376953,71.88999938964844,70.72000122070312,71.48999786376953,61.57270431518555,CAT,"When Will Caterpillar's End Markets Recover? ||| Hyster-Yale Materials Handling, Inc. (HY) Ex-Dividend Date Scheduled for November 27, 2015",0,0.4422444
2015-12-01,6578400.0,72.33000183105469,72.63999938964844,70.8499984741211,71.55999755859375,61.63298797607422,CAT,"Dow Movers: CAT, BA ||| Why the Yuan's Elevated Status is Good News for U.S. Investors ||| 6 Dividend Stocks Every Retiree Should Consider Owning ||| Axiom's Gordon Johnson on Sell-Rated Cat, United Rentals: Oct. Used Equipment Values Down Six Consecutive Months, Auction Values Down Seven Months In A Row; 'This Isn't a Good Trend'",0,0.48909318
2015-12-02,5068200.0,71.19999694824219,72.12999725341797,70.62000274658203,71.02999877929688,61.1765022277832,CAT,"Miller Industries, Inc. (MLR) Ex-Dividend Date Scheduled for December 03, 2015",0,0.45004687
2015-12-03,8130800.0,71.1500015258789,71.22000122070312,69.37000274658203,69.63999938964844,59.97933578491211,CAT,Teck Resources Geared Up to Face Bleak Coal Fundamentals,1,0.5203771
2015-12-07,6805900.0,68.68000030517578,68.73000335693361,67.72000122070311,68.36000061035156,58.87690734863281,CAT,"4 Reasons Why Falling Oil Prices Are Worse Than You Think ||| Dow Movers: CVX, WMT ||| Goldman Remains Cautious On Construction Machinery Names ||| Goldman Sachs Maintains Neutral on Caterpillar, Lowers PT to $67.00",0,0.5093052
2015-12-08,6866300.0,66.98999786376953,67.16000366210939,66.18000030517578,66.54000091552734,57.30937957763672,CAT,"Stocks Still Under Pressure as Oil Drops Under $37 Per Barrel ||| The Story of Caterpillar's Dramatic Stock Price Increase ||| Dow Movers: XOM, NKE ||| Industrial ETFs Look For Better Things In 2016",0,0.4869181
2015-12-10,5768700.0,65.98000335693361,67.08999633789061,65.91000366210939,66.37999725341797,57.17157363891602,CAT,"Dow Movers: UTX, CAT",0,0.5073801
2015-12-11,7572600.0,65.37999725341797,66.09999847412111,64.48000335693361,65.43000030517578,56.35336303710938,CAT,FundStrat's Tom Lee Lists 9 Stocks That May Outperform In 2016 ||| Cat Reports Pres Ed Rapp to Retire,1,0.49570593
2015-12-14,7371100.0,65.62999725341797,66.18000030517578,64.73000335693361,66.12000274658203,56.94764709472656,CAT,"5 Stocks That Could Dip on China Woes ||| One Put, One Call Option To Know About for Caterpillar ||| Caterpillar in 2015: Why It's Fallen 25% ||| Are Analog Devices' Numbers A Bad Omen For The Global Economy?",1,0.48332173
2015-12-16,6747600.0,66.22000122070311,67.87999725341797,66.13999938964844,67.72000122070311,58.32569122314453,CAT,"Joy Global (JOY) Beats on Earnings and Revenues in Q4 ||| Dow Movers: XOM, MRK ||| Douglas Dynamics, Inc. (PLOW) Ex-Dividend Date Scheduled for December 17, 2015 ||| Deutsche Bank Downgrades Caterpillar to Hold, Lowers PT to $60.00",0,0.49191177
2015-12-17,6800000.0,67.18000030517578,67.51000213623047,64.87999725341797,64.90000152587889,55.89689254760742,CAT,"Post-Fed Rally Extinguished by Another Sell-Off for Oil, Energy Stocks ||| Dow Movers: CAT, MSFT ||| Close Update: Wall Street Losses Accelerate As Oil Rout Extinguishes 3-Day Winning Streak ||| Stocks Turn Defensive as Oil Sells Off ||| Midday Update: Post-Fed Rally Extinguished by Another Sell-Off for Oil, Energy Stocks ||| Stocks Turn Negative After Oil Slips Below $35 Per Barrel ||| Cramer Advises His Viewers On Energy Transfer Partners LP And Caterpillar",1,0.51321673
2015-12-18,13490900.0,64.59999847412111,65.87000274658203,64.09999847412111,65.11000061035156,56.07775115966797,CAT,"7 Best Cheap Stocks to Buy for 2016 ||| Dow Movers: BA, CAT ||| 8-K from Cat Shows Rolling 3-Month Total Machine Retail Sales Down 7%",1,0.5262903
2015-12-21,5311500.0,65.58999633789061,65.81999969482422,64.37999725341797,65.23999786376953,56.18971633911133,CAT,Will Caterpillar Inc. Raise Its Dividend in 2016? ||| 3 Important Things Manitowoc Company Inc. Management Wants You to Know ||| Caterpillar a Top Socially Responsible Dividend Stock With 4.7% Yield (CAT) ||| Good News for These 2 Dividend Stalwarts ||| Caterpillar Loses $74M Verdict-Dow Jones,1,0.48403913
2015-12-22,9697200.0,66.25,68.79000091552734,66.11000061035156,68.41000366210939,58.91996765136719,CAT,"Caterpillar (CAT) to Pay $73.6 M In Trade Secret Suit ||| Market Close Report: NASDAQ Composite Index closes above 5000; up 32.19 points at 5,001.11 ||| Dow Jones Industrial Average Adds 165 Points as CAT Surges ||| Dow Movers: MRK, CAT ||| Joy Global Smarting from an Oversupplied Commodity Market",1,0.48602128
2015-12-23,7586300.0,69.58999633789061,70.48999786376953,68.98999786376953,69.88999938964844,60.19464874267578,CAT,"Caterpillar Inc.'s Best Segment in 2015 ||| Fast Money Halftime Report Traders Share Their Thoughts On ConAgra Foods, Starbucks, McDonald's And Caterpillar",0,0.47398224
2015-12-24,2322100.0,69.75,69.90000152587889,69.05999755859375,69.37999725341797,59.75539779663086,CAT,Option Alert: CAT Mar16 65.0 Puts Sweep: 963 @ ASK $2.19: 997 traded vs 244 OI: Earnings 1/26 $69.42 Ref,0,0.47480094
2015-12-28,3884000.0,69.12000274658203,69.18000030517578,68.02999877929689,68.58000183105469,59.0663948059082,CAT,"CalAmp Corp. Delivers an (Even) Better-Than-Expected Quarter ||| The Best Caterpillar Inc. Headlines in 2015 ||| Will Caterpillar Inc. Stock Recoup This Year's Losses in 2016? ||| Dow Movers: CVX, DIS",1,0.4850569
2015-12-29,3539500.0,69.22000122070311,69.56999969482422,68.62000274658203,69.19000244140625,59.59177780151367,CAT,"Caterpillar Inc.'s Worst Segment in 2015 ||| UBS Says 5 Most Shorted Stocks On Monday Were TSLA, CAT, NFLX, AA, & BABA According To Client Concentration",0,0.46881023
2015-12-30,3158500.0,68.66000366210939,69.62999725341797,68.56999969482422,68.69000244140625,59.16113662719727,CAT,"Dow Movers: AAPL, CAT",0,0.51030123
2015-12-31,4356400.0,68.44999694824219,69.09999847412111,67.94000244140625,67.95999908447266,58.53240203857422,CAT,"Dow Analyst Moves: CAT ||| Zacks Industry Outlook Highlights: Pentair, Lincoln Electric Holdings, Caterpillar and Illinois Tool Works ||| The Worst Industrial Stocks for 2016",1,0.48237732
2016-01-04,8586900.0,66.87999725341797,68.08000183105469,65.72000122070311,67.98999786376953,58.55823516845703,CAT,Will 2016 Be Caterpillar Inc.'s Best Year Yet? ||| The Dow Jones 2016: What to Expect,0,0.45127434
2016-01-05,6139100.0,68.37999725341797,68.44000244140625,66.41999816894531,67.27999877929689,57.94673156738281,CAT,Which of These 2 Dow Dogs Can Bounce Back in 2016?,0,0.501956
2016-01-06,6639300.0,65.98000335693361,66.84999847412111,65.62000274658203,66.22000122070311,57.03377532958984,CAT,Why Does Macquarie Hate Caterpillar Stock?,0,0.49628127
2016-01-07,8601500.0,65.08000183105469,65.51999664306639,63.65999984741211,63.93999862670898,55.07006072998047,CAT,Why George Soros Is Wrong When He Says This Is Like 2008,0,0.49737352
2016-01-11,9669400.0,63.66999816894531,63.70000076293945,60.84999847412109,61.47000122070313,52.94270706176758,CAT,Will Cummins Inc. Stock Make a Comeback in 2016? ||| Carter Worth And Mike Khouw's Caterpillar Trade ||| Interesting January 2017 Stock Options for CAT ||| Caterpillar (CAT) Slips to a 52-Week Low on Weak Sales Data ||| Aerospace ETFs Try To Take Flight,1,0.49400383
2016-01-12,8593100.0,62.43999862670898,62.5,60.38999938964844,61.59999847412109,53.054664611816406,CAT,"Kevin Kelly's Caterpillar Trade ||| Caterpillar Continues Lower For Sixth Day In A Row ||| Macquarie Negative On CAT Citing Weak Global Growth Outlook, Sees 'corrosive competition' Driving Pricing Pressures",0,0.5104042
2016-01-14,9241800.0,61.2400016784668,62.97000122070313,60.38000106811523,62.27000045776367,53.63173294067383,CAT,Better Buy: Caterpillar Inc. or Deere & Co.? ||| 4 China-Linked Stocks to Avoid (and 1 to Buy) ||| Dump Caterpillar and 3 Peers on Looming China Fears ||| Granite Construction Inc. Poised to Benefit From FAST Act,0,0.49874783
2016-01-15,12674500.0,59.52000045776367,60.09000015258789,58.75,59.86999893188477,52.21026229858398,CAT,"Dow Movers: INTC, MCD ||| Caterpillar Announces Denise Johnson As New Group President Of Resources Industries",0,0.50100964
2016-01-19,8501100.0,60.2599983215332,60.540000915527344,58.47999954223633,59.02999877929688,52.1484260559082,CAT,"The 5 Worst Stocks in the Dow Jones in 2015 ||| Miners Go Secondhand; Machinery Makers Continue to Feel the Heat ||| The Worst Caterpillar Inc. Headlines in 2015 ||| Dow Movers: CVX, PG",0,0.49616086
2016-01-20,10857700.0,58.08000183105469,59.38000106811523,56.36000061035156,58.81000137329102,51.95408248901367,CAT,"Better Buy: Joy Global, Inc. or Caterpillar Inc.? ||| Over 1,000 Stocks On The NYSE Just Hit 52-Week Lows ||| Vetr Top Raters Downgrade Caterpillar, But Why?",1,0.47780824
2016-01-21,8798300.0,59.0,60.41999816894531,58.25,59.68999862670898,52.73147964477539,CAT,New Strong Sell Stocks for January 21st,1,0.5018756
2016-01-22,7815600.0,61.22999954223633,62.56000137329102,60.59999847412109,60.97999954223633,53.87109756469727,CAT,"The 3 Biggest Challenges Facing Caterpillar Inc. in 2016 ||| Will Caterpillar Earnings Look Better in 2016? ||| Dow Movers: AXP, AAPL",0,0.49168333
2016-01-25,10971500.0,58.959999084472656,59.34999847412109,57.7599983215332,57.90999984741211,51.15899276733398,CAT,"The 3 Biggest Hurdles to Cummins Inc.'s Growth in 2016 ||| Interesting August Stock Options for CAT ||| Is Goldman Sachs Right About Caterpillar? ||| Dow Movers: CAT, MCD ||| Following Goldman Sachs' Downgrade, Caterpillar Drops 4.3% ||| Caterpillar Lower After Goldman Sachs Downgrade ||| Stock Marquee Crowded With Oil, Apple, And The Fed ||| Benzinga's Top Downgrades ||| Goldman Downgrades Caterpillar To Sell ||| 10 Stocks Moving In Monday's Pre-Market Session ||| UPDATE: Goldman Downgrades Cat; Sees 'sustained lower returns on capital in this cycle driven by an extended rationalization in global infrastructure capex, excess machinery capacity.' ||| Goldman Sachs Downgrades Caterpillar to Sell",1,0.5251809
2016-01-26,8141900.0,58.4000015258789,59.65999984741211,58.09000015258789,59.15999984741211,52.26327514648438,CAT,"Why I'm Still Not Interested in Buying Caterpillar Inc. ||| Deere, Caterpillar Spiking In Sympathy To Terex and Manitowoc; Continue To Monitor Heavy Machinery & Vehicle Following Zoomlion Proposal For Terex",0,0.4727604
2016-01-27,11013800.0,58.43000030517578,59.88999938964844,57.459999084472656,58.31999969482422,51.52119064331055,CAT,"Caterpillar Historically Digs in for Shorts Trading Shares Off Earnings-Driven Pre-Market Moves ||| Caterpillar's (CAT) Q4 Earnings: Will China Woes Hit Results? ||| Here's What Caterpillar Said In Its Rolling 3-Month Sales Report ||| Will China's Woes Emerge In Amazon, Alibaba Earnings Commentary? ||| 8-K from Cat Shows Global Rolling 3 Month Retail Sales Down 16% in Dec.",1,0.49214193
2016-01-28,13567000.0,62.0099983215332,62.45000076293945,58.56999969482422,61.08000183105469,53.959449768066406,CAT,"Close Update: Stocks Regain Momentum as Earnings, Oil Offsets Economic Shocks ||| Dow Jones Industrial Average Moving Today after Fed's Dovish Statement ||| Dow Movers: AXP, CVX ||| Caterpillar Climbs on Earnings Beat but Still Faces a Tough Road Ahead ||| Earnings Reaction History: Caterpillar Inc, 44.4% Follow-Through Indicator, 2.5% Sensitive ||| Stock Futures Bounce Back After Durable Goods Orders Shock ||| Stock Futures Bounce Back on Earnings, Stable Oil Prices ||| Caterpillar Q4 Earnings Lag Y/Y, Issues 2016 Guidance ||| Fed in ""Wait & See,"" Q4 Earnings Grind On ||| Earnings Recap For January 28 ||| Caterpillar Beats On EPS, But Slumps Slightly In Sales ||| Caterpillar Sees FY16 Rev. $40-$44B vs. Est. $43.33B, EPS $3.50 vs. Est. $3.48 ||| Caterpillar Reports Q4 EPS $0.74 vs. Est. $0.69, Rev. $11.03B vs. Est. $11.43B ||| Cat Financial Reports Q4 Rev. $2.67B ||| 12 Stocks To Watch For January 28, 2016 ||| Earnings Scheduled For January 28, 2016",1,0.5077918
2016-01-29,8221000.0,61.68999862670898,62.290000915527344,60.7599983215332,62.2400016784668,54.98421478271485,CAT,"Company News for January 29, 2016 ||| It Might Finally Be Time For Industrial ETFs ||| German Federal Cartel Office Says Investigating Possible Cartel Agreements In Sale of Agricultural Machinery, Particularly Tractors -Reuters ||| Credit Suisse Sees Downside In Ford, Prefers...Caterpillar?",1,0.48312086
2016-02-01,5955700.0,61.97000122070313,63.08000183105469,61.38000106811523,62.70000076293945,55.39059448242188,CAT,"What We Can Learn From Energy Earnings This Quarter ||| Interesting May Stock Options for CAT ||| The Zacks Analyst Blog Highlights: Caterpillar, McDonald's, 3M, Procter & Gamble and Johnson & Johnson ||| Can Cummins Avoid an Engine Failure in 2016? ||| Vetr Top Raters Downgrade Caterpillar To 3-Star Stock",0,0.5031727
2016-02-02,6282300.0,61.27999877929688,61.54999923706055,60.47999954223633,60.66999816894531,53.59724044799805,CAT,CAT Named Top 25 SAFE Dividend Stock Increasing Payments For Decades,1,0.5111602
2016-02-03,8332100.0,61.47000122070313,63.59999847412109,59.79999923706055,63.27000045776367,55.89414978027344,CAT,"Is This The Sign Of Caterpillar Inc's Rebound? ||| Market Close Report: NASDAQ Composite index closes at 4,504.24 down -12.71 points",1,0.5079083
2016-02-04,12598000.0,63.59999847412109,66.98999786376953,63.59999847412109,65.95999908447266,58.27055358886719,CAT,"Cummins' Earnings Slump Continues as Light-Duty Engines Sputter ||| Dow Movers: NKE, IBM ||| Midday Update: Wall Street Flip-Flops as Equities Track Oil",1,0.52084786
2016-02-05,7463700.0,65.66999816894531,66.76000213623047,65.18000030517578,66.12000274658203,58.41189575195313,CAT,"Market Close Report: NASDAQ Composite index closes at 4,509.56 up 5.32 points ||| Can A Healthcare Alliance Bring Down Healthcare Costs To Employers?",0,0.50440717
2016-02-08,6315500.0,65.41999816894531,65.63999938964844,63.65999984741211,64.58000183105469,57.05142593383789,CAT,"3 Reasons Deere & Company's Stock Could Fall in 2016 ||| One Put, One Call Option To Know About for Caterpillar ||| Most Of Credit Suisse's Top Investment Ideas For 2016...In One Place",0,0.52704245
2016-02-09,5638500.0,63.9000015258789,64.41000366210939,63.11999893188477,63.93000030517578,56.47719955444336,CAT,"Columbus McKinnon Corporation (CMCO) Ex-Dividend Date Scheduled for February 10, 2016",0,0.48635444
2016-02-16,4819400.0,64.16000366210939,65.55000305175781,63.5099983215332,65.20999908447266,57.60798645019531,CAT,"Axiom Capital's Gordon Johnson Sees 'Outsized Risk For Iron Ore Prices', Says Fortescue Metals Of Australia Share Of Port Hedland Exports Declined 13.4% M/M ||| Could These Dow Stocks Save You From a Bear Market? ||| The Stocks That Moved The S&P, Dow And Nasdaq Today",1,0.4969495
2016-02-17,7373800.0,66.0,67.79000091552734,65.72000122070311,67.26000213623047,59.41899871826172,CAT,"Terex Q4 Earnings Miss Estimates, Fall Y/Y; Revenues Beat ||| Dow Movers: MCD, CAT ||| 7 Stocks to Sell as the Market Bounces ||| Caterpillar Has Various Levers To Pull If Demand Falls Further, Says Credit Suisse",0,0.5021831
2016-02-18,6175500.0,67.15000152587889,67.59999847412111,65.13999938964844,66.12000274658203,58.41189575195313,CAT,"ETFs & Stocks Set to Surge on Solid Industrial Data ||| This Week's Top Value Picks: (MAN) (CAT) ||| SocGen Says CAT PT Is $77 ||| Gordon Johnson On Caterpillar: 'Macro Backdrop Is Worsening, Not Getting Better' ||| Axiom's Gordon Johnson on Cat Following Barclay's Industrial Select Conference Slideshow: 'we feel the company will have to cut its earnings guidance multiple times this year.' ||| 8-K from Caterpillar Shows Jan. Global 3-Month Retail Sales for Machines Down 15%",0,0.48707506
2016-02-19,4994900.0,64.91999816894531,65.51999664306639,64.08000183105469,65.41999816894531,57.79349136352539,CAT,"Dow Movers: CAT, AXP",1,0.5104634
2016-02-22,5787700.0,65.41999816894531,67.51999664306639,65.41999816894531,67.30999755859375,59.46316146850586,CAT,"Interesting April Stock Options for CAT ||| Dow Movers: JNJ, CAT",0,0.51264435
2016-02-23,5599400.0,67.11000061035156,67.23999786376953,65.69999694824219,65.77999877929689,58.11153793334961,CAT,"FDL, CAT, PPL, XEL: ETF Inflow Alert",1,0.5296066
2016-02-24,6439200.0,64.69999694824219,65.97000122070311,63.06999969482422,65.87999725341797,58.19985580444336,CAT,"Dow Movers: CAT, UTX ||| Caterpillar Officer Retires, Co. Consolidates Divisions ||| Cat Reports Will Consolidate Electric Power and Marine & Petroleum Power Units Into New Electric Power, Marine and O&G Division",1,0.5169305
2016-02-25,4277200.0,65.88999938964844,66.47000122070311,64.83999633789061,66.47000122070311,58.72108840942383,CAT,"Hyster-Yale Materials Handling, Inc. (HY) Ex-Dividend Date Scheduled for February 26, 2016 ||| Caterpillar to Merge Energy Units, Electric Power VP to Retire ||| Astec (ASTE) Misses on Q4 Earnings & Revenue Estimates",1,0.50152916
2016-02-26,4149800.0,67.38999938964844,68.0,66.44999694824219,66.87000274658203,59.07445526123047,CAT,"TriMas (TRS) Beats on Q4 Earnings, Revenues Lag Estimates ||| Caterpillar Shares Gain Over 2% Off The Open ||| Caterpillar To End Production of On-Highway Vocational Trucks, Reductions To Begin In March",1,0.5068599
2016-02-29,8643200.0,67.13999938964844,68.58000183105469,66.48999786376953,67.69999694824219,59.80770111083984,CAT,"Better Buy: Caterpillar Inc. vs. Deere ||| Windstream (WIN) Looks Good: Stock Jumps 7.6% in Session ||| Caterpillar to Exit On-Highway Vocational Truck Business ||| Instant Analysis: Caterpillar Releases World's First Smartphone With Thermal Imaging ||| The Stocks That Moved The S&P, Dow And Nasdaq Today",1,0.50181186
2016-03-01,4451600.0,68.44000244140625,69.48999786376953,67.33999633789061,69.08999633789061,61.0356674194336,CAT,3 Stocks With Better Dividends Than Caterpillar Inc.,1,0.5178951
2016-03-02,4801300.0,68.75,69.93000030517578,68.20999908447266,69.37999725341797,61.29184341430664,CAT,"Here's Why Astec (ASTE) is Worth Adding to Your Portfolio ||| Gordon Johnson: Start Shorting Joy Global ||| Joy Global 'Fails' Stress Test, Not The First Industrial Stock To Face Wall Street Trouble ||| Axiom Capital's Gordon Johnson Coming on Benzinga's PreMarket Prep Morning Show Right Now! We'll Be Chatting SCTY, SUNE, JOY, CAT",1,0.49406156
2016-03-03,7172700.0,69.62000274658203,72.08000183105469,69.38999938964844,71.75,63.38557052612305,CAT,"Joy Global Slips into Loss in Q4, Revenues Beat Estimates ||| Dow Movers: MCD, CAT ||| The Stocks That Moved The S&P, Dow And Nasdaq Today",1,0.5089874
2016-03-04,9521500.0,72.08999633789062,73.95999908447266,71.54000091552734,72.83999633789062,64.34848022460939,CAT,"3 Reasons to Love Caterpillar ||| Dow Movers: MSFT, CAT ||| Caterpillar Inc.: CAT Stock Is Growling Once More ||| The Stocks That Moved The S&P, Dow And Nasdaq Today",1,0.5239472
2016-03-07,10740400.0,72.80000305175781,75.7300033569336,72.80000305175781,74.7699966430664,66.05350494384766,CAT,"3 Reasons Cummins Stock Could Rise ||| The 5 Best Stocks in the Dow in February ||| Dow Movers: V, DD ||| Astec Industries, Inc. (ASTE) Ex-Dividend Date Scheduled for March 08, 2016 ||| Caterpillar (CAT) Shares March Higher, Can It Continue? ||| Terex Corporation (TEX) Ex-Dividend Date Scheduled for March 08, 2016 ||| Wall Street Mostly Higher as Oil Leads Dow to Fifth Consecutive Positive Close ||| The Stocks That Moved The S&P, Dow And Nasdaq Today ||| Caterpillar To Present At JPMorgan Conference Tuesday: What To Expect",0,0.50373524
2016-03-08,8748400.0,73.77999877929688,74.11000061035156,71.5199966430664,71.7300033569336,63.36789321899414,CAT,"Midday Update: Stocks Turn Negative on China Trade Data, Weak Oil ||| Dow Movers: CAT, HD ||| Manitowoc (MTW) Completes Foodservice Business Spin-off ||| Close Update: Stocks Close Lower as Chinese Trade Data and Falling Oil Snap Winning Streak ||| The Stocks That Moved The S&P, Dow And Nasdaq Today",1,0.53069544
2016-03-09,4907900.0,72.33000183105469,72.69999694824219,71.26000213623047,71.87000274658203,63.49156951904297,CAT,"Deere & Company Still Isn't Attractive ||| 3 Big Stock Charts for Wednesday: Bank of America Corp (BAC), Caterpillar Inc. (CAT) and SPDR S&P Oil & Gas Explore & Prod. (ETF) (XOP)",0,0.48019877
2016-03-10,6352400.0,72.02999877929688,72.02999877929688,70.48999786376953,71.36000061035156,63.0410270690918,CAT,"Dow Movers: XOM, GS",1,0.5098017
2016-03-11,4787000.0,72.36000061035156,73.0999984741211,72.27999877929688,72.80000305175781,64.31316375732422,CAT,"Dow Movers: PG, CAT ||| Deere (DE) to Lay off 125 Employees Owing to Weak Demand ||| What Joy Global's Results Mean to Caterpillar Investors",0,0.4934677
2016-03-14,5060000.0,72.7300033569336,73.44000244140625,72.12999725341797,72.7300033569336,64.25131225585939,CAT,"Caterpillar Inc.: The Bull Case for 2016 ||| UDOW, TRV, CAT, AXP: Large Outflows Detected at ETF",0,0.49997815
2016-03-15,4674400.0,71.44000244140625,72.47000122070312,70.86000061035156,72.44000244140625,63.99514389038086,CAT,"Dow Movers: CAT, AAPL ||| The 5-Minute Guide to Deere & Company's Stock ||| Will Caterpillar's Big Buybacks Continue in 2016?",1,0.5083359
2016-03-16,6641200.0,72.58999633789062,74.51000213623047,72.19999694824219,74.33999633789062,65.67362213134766,CAT,"Douglas Dynamics, Inc. (PLOW) Ex-Dividend Date Scheduled for March 17, 2016 ||| Cummins Inc.: The Bear Case for 2016 ||| Kevin Kelly Keeps Bearish View On Caterpillar",1,0.47297704
2016-03-17,13316000.0,74.19999694824219,76.30000305175781,73.5199966430664,75.9000015258789,67.05176544189453,CAT,"US Stocks Eye Modestly Lower Open After Fed Meeting; Jobless Claims, Philadelphia Fed Index Beat Views ||| 4 Out-of-the-Box Dividend Stocks With Growth Potential ||| Caterpillar Warns on Its Weak Start to 2016 ||| Why Banco Bradesco SA (ADR) (BBD), Caterpillar Inc. (CAT) and FedEx Corporation (FDX) Are 3 of Today’s Best Stocks ||| 3 ETFs to Buy for the Dividend Aristocrats! ||| US Equities Futures Edge Lower as Investors Digest Monetary Policy Makers' Outlook on Economy ||| Watch Industrial Sector Following Caterpillar's Disappointing Q1 Outlook ||| Questions Remain For Caterpillar, JPMorgan Says ||| The Market In 5 Minutes: Thursday, March 17, 2016 ||| JP Morgan Negative On Caterpillar, Sees NT Risks Skewed To Downside, Says Co's US Outlook Remains Negative ||| 10 Stocks Moving In Thursday's Pre-Market Session ||| Caterpillar -3% Premarket @$71.99 on Weak Guidance ||| Caterpillar Sees Q1 Revenue $9.3B-$9.4B vs $10.36B Est ||| Caterpillar Sees Q1 Adj EPS $0.65-$0.70 vs $0.97 Est",0,0.47734255
2016-03-18,13750200.0,76.08000183105469,76.94000244140625,74.63999938964844,75.47000122070312,66.67190551757811,CAT,"6 Stocks Leading the Dow Back to Green in 2016 ||| How Caterpillar Inc. Ranks Among the Dow’s Top Picks (CAT) ||| Caterpillar's (CAT) Q1 Guidance Falls Short of Expectations ||| Markets Back to Breakeven Thanks to 5 Large Caps ||| Jefferies Lowers Caterpillar Estimates Because Of Depressed End Markets ||| A Muddled Outlook For Industrial ETFs ||| Jefferies Maintains Hold on Caterpillar, Raises PT to $69.00",1,0.528872
2016-03-21,4315700.0,75.52999877929688,76.3499984741211,75.04000091552734,75.88999938964844,67.04293823242189,CAT,"The Zacks Analyst Blog Highlights: Baker Hughes, Exxon Mobil, Chevron, Verizon Communications, Caterpillar and 3M ||| Axiom Capital's Gordon Johnson Suspects We've Yet To Reach A Bottom In The Steel Sector Fundamentals",0,0.48770303
2016-03-22,3625600.0,75.58999633789062,76.08000183105469,75.23999786376953,75.55000305175781,66.74256896972656,CAT,BMO Cuts Caterpillar EPS Estimate 32%,0,0.49548277
2016-03-23,5352900.0,74.97000122070312,75.12000274658203,73.56999969482422,73.68000030517578,65.09056091308594,CAT,"Better Buy: Caterpillar Inc. vs. United Technologies ||| The Stocks That Moved The S&P, Dow And Nasdaq Today",1,0.50101167
2016-03-24,7036100.0,72.93000030517578,75.3499984741211,72.7300033569336,75.29000091552734,66.51287078857422,CAT,Celebrate Your Retirement by Purchasing These 3 Stocks ||| 23 Ways To Say 'I'm A Contrarian Investor' ||| OTR Global Upgrades Caterpillar to Positive,1,0.502933
2016-03-28,3425400.0,75.1500015258789,75.55000305175781,74.45999908447266,75.31999969482422,66.53939819335939,CAT,"Interesting August Stock Options for CAT ||| Goldman On Industrials: Continues To Prefer Construction Products Over E&C, Machinery",1,0.5124133
2016-03-29,4085000.0,74.97000122070312,76.05000305175781,74.19000244140625,76.01000213623047,67.14894866943361,CAT,"First Trust Morningstar Dividend Leaders Index Fund Experiences Big Inflow ||| 1 Stock I'm Watching, but Won't Buy Yet",1,0.51377094
2016-03-30,4886800.0,76.94000244140625,77.25,76.01000213623047,76.51000213623047,67.59065246582031,CAT,3 High-Yield Dividend Stocks Wealthy Investors Should Buy ||| 3 Reasons Why the Caterpillar Stock Rally Can Continue,1,0.5411078
2016-03-31,4348700.0,76.30000305175781,77.12999725341797,76.23999786376953,76.54000091552734,67.61715698242189,CAT,5 Contrarian Stock Ideas to Consider Today,1,0.5274616
2016-04-01,4878300.0,75.6500015258789,76.87000274658203,74.66999816894531,76.79000091552734,67.83802032470703,CAT,"Dow Movers: CAT, MCD",0,0.50860476
2016-04-04,4349500.0,76.55999755859375,77.04000091552734,75.41999816894531,75.72000122070312,66.89276123046875,CAT,"New Caterpillar Dealer Survey Means Stock Is Worth Almost $90 ||| Credit Suisse Maintains Outperform on Caterpillar, Raises PT to $87.00",0,0.4889188
2016-04-05,4386800.0,75.31999969482422,75.8499984741211,74.5999984741211,75.23999786376953,66.46869659423828,CAT,Better Buy: Caterpillar Inc. vs. ABB Ltd.,0,0.5033525
2016-04-06,4929800.0,75.5199966430664,75.56999969482422,73.69999694824219,75.22000122070312,66.45105743408203,CAT,"4 Important Things Cummins Inc.'s CEO Wants You to Know ||| Notable ETF Inflow Detected - FDL, DUK, CAT, D ||| Dow Movers: CAT, PFE ||| Avoid Caterpillar And John Deere ||| CIBC Says Machinery & Equipment Investment Is The 'Achilles heel' In Canada, Says Growth Has Disappointed In Absolute Terms As Well As Relative To US",0,0.5132089
2016-04-08,4911000.0,75.02999877929688,75.25,74.0,74.3499984741211,65.68245697021484,CAT,"Here's Why Caterpillar Inc., Joy Global Inc., and Westinghouse Air Brake Technologies Corp Stocks We",1,0.49714234
2016-04-11,3904800.0,74.61000061035156,75.77999877929688,74.61000061035156,74.62999725341797,65.9298095703125,CAT,"Dow Movers: NKE, CAT ||| 3 Stocks to Avoid at All Costs ||| In Case You Didn't Know, Axiom's Gordon Johnson Is Selling Iron Ore And Steel Stocks",1,0.5130039
2016-04-12,5129600.0,75.05999755859375,76.73999786376953,74.47000122070312,76.0999984741211,67.22843933105469,CAT,"Implications For Caterpillar Amid Continued Strength In Chinese Excavator Industry ||| Notable Imbalances Before Tuesday's Open Led By Under Armour, Boeing, Caterpillar",1,0.49700156
2016-04-13,9365700.0,76.87000274658203,79.16000366210938,76.55999755859375,79.12999725341797,69.90521240234375,CAT,"Daily Dividend Report: HPT, GEL, WBA, CAT, MCO, SNH ||| After-Hours Recap: Energy XXI, Seagate & More ||| Jefferies Looking For 'Green Shoots' In Machinery Stocks: What That Means ||| Caterpillar Maintains Quarterly Cash Dividend",0,0.48651466
2016-04-14,5372300.0,79.44000244140625,79.72000122070312,78.37000274658203,79.05000305175781,69.83454895019531,CAT,Caterpillar a Top 25 Dividend Giant With 3.89% Yield (CAT),1,0.49905506
2016-04-15,5508500.0,79.37999725341797,79.77999877929688,78.7300033569336,79.16999816894531,69.94056701660156,CAT,Stocks to Buy and Sell If Bernie Sanders Is Elected ||| Benzinga's Top Upgrades ||| Vertical Research Upgrades Caterpillar to Buy,1,0.49483147
2016-04-18,4822200.0,78.47000122070312,79.87000274658203,78.13999938964844,79.25,70.01122283935547,CAT,"Interesting May Stock Options for CAT ||| ""Earnings Potpourri"" Ahead, as Report Season Shifts Into Full Gear",1,0.5223473
2016-04-19,6283500.0,79.98999786376953,80.88999938964844,79.45999908447266,80.38999938964844,71.01834106445312,CAT,"CalAmp Corp. Loses Its (Satellite) Signal ||| Caterpillar Will Take 'Axe' To 2016 Guidance, Axiom's Gordon Johnson Warns",0,0.5027871
2016-04-20,5356800.0,80.25,80.5999984741211,79.30000305175781,79.73999786376953,70.44412231445312,CAT,"3 ‘Golden Cross’ Standouts Ready to Break Out ||| SDY, CAT, HCP, STR: Large Inflows Detected at ETF ||| Caterpillar Inc. Earnings: 3 Key Things to Watch ||| After Alcoa Inc.’s Earnings, These 4 Industrials Could Disappoint ||| Caterpillar, Inc. (CAT) Ex-Dividend Date Scheduled for April 21, 2016 ||| Option Alert: CAT Jun16 80.0 Puts Sweep: 1991 @ ASK $3.40: 1991 traded vs 1743 OI: Earnings 4/22 Before Open $80.26 Ref",0,0.5455234
2016-04-21,6509100.0,78.75,79.58000183105469,78.19000244140625,78.66000366210938,70.16757965087889,CAT,"Shorts Historically Get the Better Play off Caterpillar's Earnings-Driven Pre-Market Moves ||| Pre-Market Earnings Report for April 22, 2016 : GE, MCD, HON, KMB, CAT, LYB, SYF, AAL, STI, IPG, WBC, AN ||| Earnings: What's Up with the Economy? MCD, MSFT, GE and CAT Might Know ||| Eyes on ECB: Draghi Press Conference Grabs Attention Early On ||| The Market In 5 Minutes: ECB Leaves Rates Unchanged, Under Armour And GM Lead Today's Earnings ||| UPDATE: Caterpillar Total Energy And Transportation Retail Sales Down 41% In March 2016 ||| Caterpillar Reports March Total Machine Sales Down 13%, Resource Industries Down 25%, Construction Industries Down 8% March 2016",0,0.47093678
2016-04-22,10099600.0,78.93000030517578,79.18000030517578,77.19999694824219,78.31999969482422,69.86427307128906,CAT,"Close Update: Nasdaq Undermined by Tech Sector Meltdown, But Dow and S&P Close Higher ||| Caterpillar (CAT) Stock Slips on Profit Miss, Outlook ||| Caterpillar CEO: We're Near Bottom ||| Big Three: GE, Caterpillar And McDonald's Earnings Set Tone ||| Jim Cramer: No Tech Company 'Has Blown It Away Yet,' Highlights Caterpillar's 'Very Enthusiastic' Earnings ||| The Market In 5 Minutes: Sometimes It Snows In April ||| Caterpillar Reports Q1 Beat But Cuts 2016 Guidance, Shares Dip 2% ||| 12 Stocks Moving In Friday's Pre-Market Session ||| Cat Cuts High End of FY16 Sales Outlook from $40B-$44B to $40B-$42B vs $40.6B Est., Adj. EPS Outlook from ~$4 to ~$3.70 vs $3.59 Est. ||| Cat Reports Q1 EPS $0.67 vs $0.58 Est., Sales $9.46B vs $9.4B Est. ||| 10 Stocks To Watch For April 22, 2016 ||| Earnings Scheduled For April 22, 2016",0,0.4730579
2016-04-25,8079800.0,78.5,78.86000061035156,76.19999694824219,76.79000091552734,68.49948120117189,CAT,"McDonald's Easterbrook For CEO Of The Year? La Monica Believes He Could Make It ||| After-Hours Recap: Index Movers, Earnings And Charter-Time Warner Cable Deal ||| Goldman Upgrades Machinery Sector From Cautious To Neutral ||| Searching for a Catalyst As Earnings Continue ||| The Market In 5 Minutes: Monday, April 25, 2016 ||| Benzinga's Top Upgrades ||| Goldman Sachs Upgrades Caterpillar, Joy Global ||| Goldman Sachs Upgrades Caterpillar to Neutral, Raises PT to $78.00",1,0.5234752
2016-04-26,6085900.0,77.1500015258789,77.73999786376953,76.47000122070312,77.6500015258789,69.26661682128906,CAT,Argus: Caterpillar Has 20% Upside Even If It Can't Hit Cyclical Highs ||| The Market In 5 Minutes: Are You Tempted To Bite The Apple? ||| Benzinga's Top Upgrades ||| UPDATE: Argus Announced $92 PT On Caterpillar ||| Argus Research Upgrades Caterpillar to Buy,1,0.5361548
2016-05-04,6938100.0,76.18000030517578,76.30999755859375,73.9000015258789,74.23999786376953,66.22476959228516,CAT,"A Quick-And-Easy Guide To All The Calls At Ira Sohn 2016 ||| Caterpillar Shares Down ~1.8% After Einhorn Short Thesis At Sohn ||| Einhorn: Caterpillar Will Trade At Half Current Price ||| Einhorn: We Don't Think Caterpillar Will Hit Bottom Until 2018, Foresees $2.00 Annual EPS Then ||| Einhorn Highlights Caterpillar Rail Business, Says It's 20% Of Revenue And Has More Downside ||| Einhorn Says Some Caterpillar Equipment Standing Idle Due To Low Oil Prices ||| Einhorn On Caterpillar, Believes Resource Rev. Will Fall Further And Recover Less Than Wall St. Expects ||| Caterpillar Shares Volatile Amid Einhorn Presentation, Down ~1.3% After-Hours ||| Einhorn Discussing Caterpillar, Says Coal Industry Faces Bankruptcy ||| Einhorn: Market Thinks Caterpillar Business Is At A Bottom; Presentation Language Suggests May Be Short, Not Confirmed ||| David Einhorn Discussing Caterpillar ||| Ira Sohn Conference 2016: The Live Blog",0,0.47709975
2016-05-09,9405000.0,72.33000183105469,72.62999725341797,70.56999969482422,70.77999877929688,63.1383285522461,CAT,"Bank Of America Upgrades PACCAR To Buy, Labels It 'Best In Breed'",1,0.5323755
2016-05-10,6507300.0,70.77999877929688,72.70999908447266,70.58999633789062,72.51000213623047,64.68155670166016,CAT,What Do the Markets Need to Hang Their Hats On? Conviction?,0,0.49517098
2016-05-11,4691900.0,72.8499984741211,73.61000061035156,72.36000061035156,72.43000030517578,64.61019897460939,CAT,"Caterpillar Says FY16 Energy, Transportation To Decline 15% vs. Prior Forecast Of 10%",0,0.48115543
2016-05-13,6417200.0,71.62999725341797,71.77999877929688,70.05999755859375,70.06999969482422,62.50498580932617,CAT,"Axiom's Gordon Johnson Says 'A Significant Slowdown In China Is Coming' ||| Gordon Johnson Bearish On Caterpillar, 'Aggressively' Short U.S. Steel ||| Axiom's Johnson on Caterpillar: 'A Joy Global-Like Moment is Coming for Caterpillar - And We Think It's Going to Happen This Year' ||| Axiom's Johnson Highlighting His $33 Price Target on Cat, Co. 'Operating in a Number of Segments Which Are in A Structural Decline' ||| Axiom's Johnson Now Talk His Short Thesis on Caterpillar",1,0.49335426
2016-05-19,6137100.0,69.93000030517578,70.12000274658203,69.04000091552734,69.43000030517578,61.93408584594727,CAT,"Credit Remains Positive On Caterpillar, Says April's Dealer Statistics Were Inline With Expectations ||| Caterpillar Shares Down 1+% Ahead of Open; Co. Reported Global Rolling 3-Month Retail Sales Down 12% in Apr, vs Down 13% in Mar., Down 21% in Feb. ||| Axiom Capital's Gordon Johnson Says Caterpillar's Guidance 'seems to be a bad start for a company guiding to a back-end loaded rebound in 2016 sales', Maintains Sell",1,0.5004539
2016-05-20,5731600.0,70.0,70.77999877929688,69.75,69.87000274658203,62.32657241821289,CAT,"After Three-Straight Lower Weeks, Can Market Break Out of the Friday Blues?",1,0.5135143
2016-05-23,4002000.0,69.80000305175781,70.94999694824219,69.58999633789061,70.4000015258789,62.799354553222656,CAT,Axiom: Stay Away From Mining Stocks,1,0.50884306
2016-05-26,4146400.0,73.23999786376953,73.58999633789062,72.05999755859375,72.08000183105469,64.2979736328125,CAT,Joy Global's Negative Earnings Trend May Not Dictate Stock Movement,0,0.496402
2016-05-31,4072600.0,72.02999877929688,73.16999816894531,71.94999694824219,72.51000213623047,64.68155670166016,CAT,Citi Meets With Caterpillar's CFO: Cautious China Outlook And 'Stepped Up' Price Competition,0,0.5090214
2016-06-10,4879500.0,76.31999969482422,76.55999755859375,75.37999725341797,76.02999877929688,67.82151794433594,CAT,"Flight to Safety: Bond Rally Puts Pressure on Stocks Ahead of Fed Mtg, Brexit ||| Option Alert: CAT Jan17 77.5 Calls Sweep: 1022 @ ASK $4.45: 1066 traded vs 2466 OI: Earnings 7/28 $75.88 Ref",0,0.46774748
2016-06-13,4086700.0,75.69999694824219,76.33999633789062,75.2300033569336,75.2300033569336,67.10789489746094,CAT,Watch These 5 Huge Call Purchases In Monday Trade,0,0.53486645
2016-06-14,4058400.0,75.05999755859375,75.55000305175781,73.94999694824219,74.86000061035156,66.77783203125,CAT,"Caterpillar Says New Demand For Locomotives, ""Very Weak And Likely To Stay There For Awhile"", Expects To Ship Tier 4 Locomotives in 2H 2016 ||| Cat VP of Finance Says 'We Are Cautiously Optimistic Around Growth in China' ||| Cat VP of Finance Says 'Not Much New Demand for Mining Equipment,' Highlights Market Share in China 'Steadily Increasing' ||| Cat Shares Quiet Following Reuters Headlines Suggesting Co.'s Finance VP Has Said #1 Priority is Growing Co., Does Not Have 'Big Need' for CapEx Right Now ||| February 27 Earnings Update",1,0.47109482
2016-06-20,4090800.0,76.91000366210938,77.3499984741211,76.38999938964844,76.43000030517578,68.17832946777344,CAT,8-K from Cat Shows Rolling 3-Month Retail Sales for May Down 12% Globally,1,0.52171516
2016-06-21,3292100.0,76.44999694824219,76.9000015258789,76.01000213623047,76.48999786376953,68.23184967041016,CAT,Option Alert: CAT Aug16 72.5 Puts Sweep: 829 @ ASK $2.00: 905 traded vs 3565 OI: Earnings 7/28 $76.42 Ref,0,0.47230035
2016-06-22,3056800.0,76.88999938964844,77.08999633789062,76.18000030517578,76.43000030517578,68.17832946777344,CAT,Watch These 8 Huge Put Purchases In Wednesday Trade,1,0.5346428
2016-07-01,4630100.0,75.37999725341797,76.98999786376953,75.31999969482422,76.44999694824219,68.19618988037111,CAT,"Axiom's Johnson Concludes Interview on Benzinga's PreMarket Prep; Finishes with Comments He'd Be Shorting Both Caterpillar, Joy Global ||| Axiom Capital's Gordon Johnson Coming on Benzinga's PreMarket Prep in Minutes! Tune In at premarket.benzinga.com",0,0.48359057
2016-07-05,4776300.0,75.66000366210938,75.94999694824219,73.69999694824219,74.37999725341797,66.34966278076172,CAT,Option Alert: CAT Jan17 65.0 Puts Sweep: 1991 @ ASK $3.35: 2004 traded vs 11k OI: Earnings 7/26 Before Open $73.91 Ref ||| Option Alert: CAT Sep16 72.5 Puts Sweep: 2638 @ Above Ask! $3.20: 2661 traded vs 1181 OI: Earnings 7/26 Before Open $74.33 Ref ||| Option Alert: CAT Jul16 74.0 Puts Sweep: 2990 @ ASK $0.99: 3002 traded vs 912 OI: Earnings 7/26 Before Open $74.88 Ref,1,0.48020044
2016-07-06,3740500.0,74.58999633789062,74.87000274658203,73.45999908447266,74.83000183105469,66.75108337402344,CAT,Watch These 7 Huge Put Purchases In Wednesday Trade,1,0.53379714
2016-07-11,4511300.0,78.0,78.54000091552734,77.31999969482422,77.80000305175781,69.40042877197266,CAT,Barclays Warns Investors To Stay Out Of U.S. Machinery This Summer,1,0.5360869
2016-07-21,6472300.0,80.44999694824219,81.37999725341797,79.73999786376953,80.01000213623047,72.05937194824219,CAT,Option Alert: CAT Oct16 80.0 Puts Sweep: 1797 @ ASK $3.75: 1827 traded vs 91 OI: Earnings 7/26 Before Open $80.68 Ref,0,0.46490285
2016-07-22,4133800.0,79.77999877929688,79.79000091552734,78.86000061035156,79.37999725341797,71.49198150634766,CAT,Earnings Momentum Continues To Support Stocks Despite Weak Oil ||| Watch These 7 Huge Put Purchases In Friday Trade,0,0.51577526
2016-07-25,5798100.0,79.1500015258789,79.19000244140625,78.33999633789062,78.69000244140625,70.87055206298828,CAT,"Can MCD Feed Higher Sales with More than Breakfast? ||| Week Ahead: It's Not Just Earnings This Time, as GDP, Fed Also on Tap",1,0.50450075
2016-07-26,11007600.0,79.04000091552734,83.0,78.73999786376953,82.75,74.527099609375,CAT,"Mid-Afternoon Market Update: Crude Oil Drops Below $43; Linear Technology Shares Spike Higher ||| Technical Alert: Caterpillar Makes New Post-Brexit High After Q2 Report ||| Mid-Day Market Update: Dow Falls 0.5%; EXACT Sciences Shares Rise Following Strong Q2 Results ||| Mid-Morning Market Update: Markets Mostly Higher; Caterpillar Tops Q2 Views ||| The Market In 5 Minutes: Apple And Twitter And McDonald's, Oh My! ||| Caterpillar's Q2 Results Top Off A Great July For The Stock ||| A Peek Into The Markets: U.S. Stock Futures Flat Ahead Of Earnings ||| Cat Sees FY16 Sales $40B-$42B vs $40.11B Est., Adj. EPS at the Midpoint $3.70 vs $3.52 Est. ||| Caterpillar Reports Q2 EPS $1.09 vs. Est. $0.96, Rev. $10.34B vs. Est. $10.11B ||| Cat Financial Reports Q2 Rev. $659M vs. Prior Year Quarter $683M ||| Earnings Scheduled For July 26, 2016 ||| Keep an Eye on These 12 Stocks for July 26, 2016",1,0.49887174
2016-07-27,8460900.0,82.72000122070312,84.29000091552734,82.72000122070312,84.0999984741211,75.74296569824219,CAT,"Caterpillar CEO Comes Under Fire Amid Reductions, Tough Industrial Markets ||| Jim Cramer Shares His Thoughts On ConocoPhillips And Caterpillar",0,0.4861998
2016-07-29,4274200.0,82.80000305175781,83.13999938964844,82.12999725341797,82.76000213623047,74.53611755371094,CAT,Option Alert: CAT Fri 8/5 86.0 Calls (Wkly) Sweep: 893 @ ASK $0.09: 1019 traded vs 110 OI: $82.65 Ref,0,0.47305006
2016-08-01,3377100.0,82.76000213623047,82.87999725341797,81.52999877929688,81.94999694824219,73.80660247802734,CAT,"Barron's Picks And Pans: Wells Fargo, General Dynamics, Harman International And More",0,0.5062696
2016-08-03,3101700.0,81.1500015258789,82.30000305175781,80.93000030517578,82.02999877929688,73.8786392211914,CAT,Terms Of The Trade: Dogs Of The Dow Investing Strategy ||| Fantastic Yields And Where To Find Them: Top 3 Yields From The Dow 30,0,0.49910694
2016-08-05,3286100.0,82.22000122070312,82.95999908447266,82.0,82.55999755859375,74.35598754882812,CAT,"Are Caterpillar Shares Digging Their Way Up From A Bottom? ||| Cheap Oil Is Being Blamed For 200,000 Job Cuts",1,0.48726752
2016-08-16,3161800.0,84.20999908447266,84.36000061035156,83.63999938964844,84.29000091552734,75.9140853881836,CAT,"Seeing A Recovery Already Priced In, Citi Remains Neutral On Caterpillar Stock",1,0.53191453
2016-08-18,5003100.0,83.41000366210938,83.61000061035156,82.51000213623047,83.37999725341797,75.0945053100586,CAT,"UPDATE: Caterpillar Estimates Workforce Impact Reduction To Be Up To 155 Positions ||| UPDATE: Caterpillar Production Of Track Drills To Be Discontinued, No New Orders Taken ||| Caterpillar to Explore Strategic Alternatives for Certain Mining Products, Including Possible Divesture For Room And Pillar Products ||| As Trump Has Fallen In The Polls, So Has His Stock Index ||| Cat Announces Will Form Single Research, Technology, Product Development Unit ||| Decline In Caterpillar's Machine Sales Intensifies During July ||| 8-K from Cat Shows Rolling 3 Month Retail Sales Down 19% Globally in Jul.",1,0.5236331
2016-08-19,3823900.0,83.05999755859375,84.37999725341797,82.76000213623047,83.83999633789062,75.50879669189453,CAT,Are Monthly Machine Retail Sales The Most Important Metric For Caterpillar Investors?,0,0.5204316
2016-08-31,4041700.0,82.05999755859375,82.33999633789062,81.61000061035156,81.94999694824219,73.80660247802734,CAT,"Ritchie Bros.' IronPlanet Deal Has A Compelling Case To The Upside, According To Baird",0,0.4997525
2016-09-02,2449400.0,82.19000244140625,82.37000274658203,81.47000122070312,81.69000244140625,73.57243347167969,CAT,"Caterpillar Contemplates Allocation of Production from Gosselies, Belgium, to Other Manufacturing Facilities as Part of Global Restructuring",1,0.5383658
2016-09-07,3996700.0,82.5,83.7300033569336,82.41000366210938,83.72000122070312,75.40072631835938,CAT,"Deutsche Bank Initiates Coverage On 17 U.S. Machinery Stocks ||| Gordon Johnson On Sell-Rated Caterpillar: You Can't Fool All The People All The Time ||| Deutsche Bank Is Cautious On U.S. Machinery, But Loves Caterpillar",0,0.45868123
2016-09-08,3400500.0,83.5,83.95999908447266,83.08000183105469,83.54000091552734,75.23860168457031,CAT,"7 Stocks Net Sold In August, According To The IMX ||| Deutsche Bank Is Cautious On U.S. Machinery Sector, Sees 'No Recovery In Sight'",0,0.48406622
2016-09-14,5324800.0,80.37999725341797,81.62000274658203,80.2300033569336,81.0199966430664,72.96900177001953,CAT,Caterpillar 8-K Shows Company Agrees To Unsecured Revolving Credit Facility Of $3.05B Which Expires Sept. 7th 2017,1,0.49050933
2016-09-19,4351200.0,82.18000030517578,82.3499984741211,81.3499984741211,81.87999725341797,73.74356842041016,CAT,OTR Global Downgrades Caterpillar to Mixed,0,0.5120729
2016-09-21,4264300.0,82.30000305175781,83.48999786376953,82.01000213623047,83.47000122070312,75.1755599975586,CAT,CORRECTION: 8-K from Cat Shows Aug. Global Rolling 3-Month Retail Sales Down 17% ||| 8-K from Cat Shows Aug. Global Rolling 3-Month Retail Sales Down 17%,1,0.5255655
2016-09-23,3031500.0,83.51000213623047,83.58000183105469,82.38999938964844,82.44000244140625,74.2479248046875,CAT,Oshkosh Investors Disappointed By Outlook; Watch For Pressure In Other Construction Stocks,0,0.4832878
2016-09-26,3340800.0,82.19999694824219,82.68000030517578,82.01000213623047,82.37000274658203,74.18487548828125,CAT,"Barron's Picks And Pans: CBS, Capital One, Spirit Airlines And More",1,0.5102291
2016-09-29,10616400.0,86.27999877929688,88.8499984741211,86.27999877929688,87.47000122070312,78.77808380126953,CAT,"Caterpillar Announces Pricing Flat To Up 4% On Most Machines, Effective Jan 2017 ||| The Most Consistent Dividend Payers ||| Stocks Hitting 52-Week Highs",1,0.49727833
2016-10-03,4294600.0,88.2300033569336,89.19000244140625,88.16999816894531,88.27999877929688,79.50759887695312,CAT,"UPDATE: Ritchie Bros. Shares Now Up 5.6% Since News Friday Morning of Co.'s Largest-Ever Auction; BZ NOTE: Some Traders Attributing Strength in Cat, Deere to Ritchie Bros. News as Possibly Signal Improvement in Machine Sales ||| Pre-Market Prep Host Dennis Dick Tweets: Notable opening imbalances: $TWTR +351K, $BABA +59K, $PFE -146K, $GE -288K, $PG -155K, $VZ -53K, $CAT -52K, $XOM -90K, $CVX -56K",0,0.49115345
2016-10-10,3785700.0,89.0999984741211,89.5,88.13999938964844,88.22000122070312,79.45355987548828,CAT,Carter Worth And Mike Khouw's Caterpillar Trade,0,0.5120069
2016-10-11,6471900.0,89.0999984741211,89.31999969482422,87.26000213623047,87.47000122070312,78.77808380126953,CAT,"Goldman Sachs Downgrades Trio Of Construction Product Stocks ||| 8 Biggest Price Target Changes For Tuesday ||| Benzinga's Top Upgrades ||| Goldman Upgrades Caterpillar, Cummins To Buy; Adds Cummins To 'Conviction Buy' List ||| Goldman Sachs Upgrades Caterpillar, Inc. to Buy, Raises Target to $112.00",1,0.5080394
2016-10-12,3950000.0,87.5,87.75,87.0199966430664,87.58000183105469,78.87714385986328,CAT,"Option Alert: CAT May '17 $80 Call Sweep: Volume of 9,603 vs Open Interest of 142",0,0.50091815
2016-10-13,5677000.0,86.9000015258789,87.06999969482422,86.26000213623047,86.97000122070312,78.32777404785156,CAT,Watch These Huge Call Purchases In Thursday Trade,1,0.5335973
2016-10-14,3601000.0,87.83000183105469,88.41999816894531,87.55999755859375,87.66999816894531,78.95820617675781,CAT,Option Alert: CAT Feb $77.5 Put; 3000 @Bid @$2.15; Ref=$87.75,0,0.4890329
2016-10-17,4479700.0,87.37999725341797,87.72000122070312,86.9000015258789,87.29000091552734,78.615966796875,CAT,"Caterpillar CEO Doug Oberhelman To Retire In 2017, Names Jim Umpleby Next CEO ||| Barron's Big Money Poll: The Bulls Rule",0,0.5037149
2016-10-18,3715700.0,88.11000061035156,88.19999694824219,86.7699966430664,87.22000122070312,78.55292510986328,CAT,"Should Investors Be Worried About Caterpillar's CEO Resignation? ||| The Market In 5 Minutes: Netflix Dominates, Goldman Sachs Keeps Banks Flowing ||| Can You Guess This Chart? ||| Rich Ross Weighs In On Chevron, Caterpillar And McDonald's",1,0.4862303
2016-10-19,5943900.0,87.30999755859375,88.27999877929688,86.86000061035156,88.0,79.25541687011719,CAT,"Jim Chanos Is Still Bearish On Caterpillar ||| Jim Chanos On CNBC Says He Is Still Short Caterpillar ||| Kynikos Associates Jim Chanos On CNBC, Talking Caterpillar ||| 10 Notable Stocks Trading Ex-Dividend Thursday, October 20",0,0.46699136
2016-10-24,5096500.0,86.12000274658203,87.12999725341797,85.54000091552734,85.98999786376953,78.12876892089844,CAT,"Here's How the Economy Is Faring According to Caterpillar, General Motors And Under Armour ||| Caterpillar Reports Asia/Pacific Dealer Reports Retail Statistics Of Machines For 3-Month Rolling Period Up 3%, North America Retail Statistics Of Machines Ended Down 23%",0,0.47850782
2016-10-25,11639200.0,85.86000061035156,87.6500015258789,83.87999725341797,84.4800033569336,76.7568130493164,CAT,"Caterpillar On Conf. Call Says They See Q4 Falling A Bit ||| Epic Earnings: Many US Companies Beating Expectations As Season Continues ||| Caterpillar Says ON Conf. Call That They See Weakness In North American Construction, See Increase In Q4 Seasonal Cost ||| Caterpillar's (CAT) Q3 Revenue Falls Short ||| Caterpillar Q3 EPS $0.85 vs $0.76 est, Revenue $9.16B vs $9.87B est ||| 12 Stocks You Should Be Watching Today ||| Earnings Scheduled For October 25, 2016",0,0.48045728
2016-10-26,6582100.0,83.80999755859375,84.38999938964844,82.87999725341797,84.12999725341797,76.4388198852539,CAT,Caterpillar's Margins Should Be Quite Good ... Whenever Revenues Decide To Come Back ||| Caterpillar Hopes To Emerge From Its Cocoon In 2017 ||| United Technologies Among The Few Industrial Companies That Impressed Investors ||| Fast Money Traders Weigh In On Caterpillar And United Rentals,0,0.47272894
2016-10-27,5003200.0,84.27999877929688,84.33999633789062,82.70999908447266,83.01000213623047,75.42121124267578,CAT,Trump Or Clinton: Who Would Create More Jobs?,1,0.5121175
2016-11-03,3859000.0,81.63999938964844,81.66999816894531,80.68000030517578,81.2699966430664,73.84026336669922,CAT,"Goldman Sachs Industrials Conference Today; Presenters Include L-3, GM, And Caterpillar",1,0.49903807
2016-11-08,3407700.0,83.7699966430664,85.0,83.05999755859375,84.68000030517578,76.93855285644531,CAT,TD Ameritrade's IMX Index Rose 6% In October,1,0.5396602
2016-11-09,19281900.0,89.77999877929688,93.1999969482422,89.36000061035156,91.1999969482422,82.86246490478516,CAT,Stocks Hitting 52-Week Highs,1,0.5411546
2016-11-10,14174400.0,92.04000091552734,94.9499969482422,91.83999633789062,93.4499969482422,84.90678405761719,CAT,"Caterpillar Shares Jump To High Of Day, Up 2.6% At $93.59/Share",0,0.48756328
2016-11-18,4715900.0,93.01000213623048,93.4000015258789,91.9000015258789,92.33999633789062,83.89827728271484,CAT,8-K from Cat Shows Global Rolling 3-Month Total Machine Retail Sales Down 12% for Oct.,1,0.5306386
2016-11-23,6535900.0,94.80999755859376,96.41999816894533,94.22000122070312,96.18000030517578,87.38719177246094,CAT,Why Trump's $1 Trillion 10-Year Infrastructure Plan Will Only Provide $200 Billion In Stimulus,0,0.5212595
2016-11-25,2006900.0,95.95999908447266,96.44000244140624,95.20999908447266,95.80999755859376,87.05101776123047,CAT,Fast Money Traders Share Their Trades In Current Market Environment,0,0.5094592
2016-11-30,4641900.0,95.75,95.9000015258789,94.3499984741211,95.55999755859376,86.8238754272461,CAT,Oil Blowout Fuels Early Gains As Hopes Rise For OPEC Deal; Energy Sector Jumps,1,0.5115547
2016-12-01,9361600.0,96.0,97.38999938964844,94.0500030517578,96.23999786376952,87.44172668457031,CAT,"Caterpillar's Warning Moves Industrial Stocks ||| UPDATE: Cat Shares Fall ~1.5% Upon Resumption ||| Cat Shares Sink Upon Resumption ||| Caterpillar 8-K Shows Company Believes $38B Revenue Consensus Estimate Is 'A Reasonable Midpoint Expectation' ||| Cat Shares Indicated Between $96-$96.50 on 40K Shares ||| BZ NOTE: Analysts Had Been Expecting Cat's FY17 EPS $3.25 on Sales of $38.13B ||| Caterpillar 8-K Shows Co. Belief FY17 EPS Of $3.25 'Too Optimistic' Considering Expected Headwinds ||| CNH Industrial, Agco Shares Spike Lower, Likely Related to Cat's Slideshow Presentation Ahead of Credit Suisse conference ||| Terex Shares Spike Lower; BZ NOTE: Co. Had Previously Cancelled Out of Credit Suisse Conference Which Cat Just Offered Slideshow Presentation For ||| UPDATE: Cat Slideshow Presentation Shows Co. On Track for Over $2B in Cost Reductions During FY16 ||| 8-K from Cat Shows Slideshow Presentation Ahead of Credit Suisse Conference ||| Deere Shares Spike ~0.7% Higher as Cat Shares Halted with Code News Pending ||| Cat Shares Halted News Pending ||| Even After The Election Rally, Caterpillar Remains Deutsche Bank's Top Pick",0,0.4871996
2016-12-02,5038300.0,95.36000061035156,96.1500015258789,94.93000030517578,95.13999938964844,86.44227600097656,CAT,Caterpillar: Why No One Cares About 2017,0,0.48722517
2016-12-05,4980300.0,95.87000274658205,95.98999786376952,94.1500015258789,94.4499969482422,85.81536865234375,CAT,"Another Election, Another Rapid Boom In Infrastructure",1,0.55092937
2016-12-06,3663100.0,94.0999984741211,95.30999755859376,94.06999969482422,95.22000122070312,86.51496124267578,CAT,"Cleveland Research Out Positive On Caterpillar, Says International Survey Highlights 2017 Optimism ||| Cleveland Research Says International Survey Highlights Optimism For Caterpillar In 2017",1,0.50429773
2016-12-08,3861600.0,97.26000213623048,97.4000015258789,96.12999725341795,96.2699966430664,87.4689712524414,CAT,"Fitch Affirms Ratings on Cat; Outlook Lowered to Negative; Believes Credit Metrics Will Not Improve Until After '17, a Year Later Than Previously Expected ||| Technical Alert: Catepillar Lower",0,0.49700645
2016-12-13,3803300.0,95.73999786376952,96.5,95.18000030517578,96.0199966430664,87.2418212890625,CAT,How Green Are These Top Corporate Execs?,0,0.50230646
2016-12-19,3856300.0,91.93000030517578,92.77999877929688,91.0,92.70999908447266,84.23442077636719,CAT,Option Alert: CAT Fri 12/23 92.0 Puts (Wkly) Sweep: 869 @ ASK $1.18: 1663 traded vs 753 OI: Earnings 1/26 Before Open (est) $91.72 Ref,1,0.4603748
2016-12-20,4302400.0,93.63999938964844,94.83000183105467,93.3000030517578,94.33999633789062,85.71540069580078,CAT,"Caterpillar Reports Asia/Pacific Dealer Reports Retail Sales Statistics Of Machines For 3-Month Rolling Period Ended Nov. 2016 Up 11% ||| Caterpillar Says Rolling 3 Mo. Retail Sales Statistics Of Machines For Period Ended Nov. 2016 Down 17%, North America Reported Retail Sales Statistics Of Machines For 3 Mo. Rolling Period Ended Nov. 2016 Down 19% ||| Watch These 4 Huge Put Purchases In Tuesday Trade",0,0.51459384
2016-12-22,2534900.0,93.77999877929688,94.4499969482422,93.72000122070312,94.12000274658205,85.51553344726562,CAT,"Meet The New Dogs: 2017's Dogs Of The Dow Include Coca-Cola, Boeing",1,0.50783736
2016-12-29,2387200.0,93.27999877929688,93.8499984741211,93.0,93.29000091552734,84.76140594482422,CAT,The Most Overpaid And Underpaid CEOs In The Dow 30 This Year,0,0.49707544
2016-12-30,3471200.0,93.04000091552734,93.25,92.33000183105467,92.73999786376952,84.26168823242188,CAT,"Pre-Market Prep Host Dennis Dick Tweets: Some huge sell imbalances this morning: $PG -151K, $VZ -242K, $XOM -183K, $WMT -127K, $CVX -117K, $GE -471K, $CAT -95K, $PFE -373K",1,0.49302587
2017-01-03,5054900.0,94.0,95.19000244140624,93.25,93.98999786376952,85.39741516113281,CAT,"Dow Under 19,000 Or Dow At 20,000: What Happens First?",0,0.48321173
2017-01-13,2609500.0,94.06999969482422,94.62999725341795,93.68000030517578,94.4800033569336,85.84262084960938,CAT,"Jim Cramer Gives His Opinion On McCormick, RR Donnelley & Sons And New Relic",0,0.506258
2017-01-17,5040300.0,94.23999786376952,94.29000091552734,93.22000122070312,93.56999969482422,85.01580047607422,CAT,"Einhorn Goes Short On Caterpillar ||| Technical Alert: Caterpillar Lower Off Negative Einhorn Comments ||| BZ NOTE: David Einhorn Negative on Cat is Not a New Thing; Einhorn Made Negative Comments on Cat at the Ira Sohn Conference Back in May 2016; At That Time, It Was Not Confirmed Einhorn Was Short Cat ||| Deere Shares Appear to Move Lower In Sympathy with Cat as Traders Learn David Einhorn is Shorting Cat ||| Hearing David Einhorn is Shorting Cat",0,0.48739478
2017-01-25,7557900.0,97.81999969482422,98.58999633789062,97.31999969482422,98.1500015258789,89.91705322265625,CAT,"UPDATE: Axiom's Johnson Believes Cat Investors Are Too Focused on US, Believes 'China is much more important when trying to predict global mining CAPEX' ||| Axiom's Gordon Johnson Issues Mid-Day Note Suggesting to Short Cat Shares Into Thursday's Earnings Report; Believes 'the real negative catalyst will be 2017 guidance' ||| Technical Alert: Catepillar At Highest Level Since December 2014 ||| Trump Helps Send Markets To New Highs With Keystone Pipeline Order ||| Caterpillar North America Dealer Reported Retail Statistics For 3-MOnth Rolling Period Down 14%, CAT Asia/Pacific Up 19%",0,0.48915416
2017-01-26,9097300.0,98.4499969482422,98.9800033569336,96.0199966430664,97.22000122070312,89.0650634765625,CAT,"Mid-Afternoon Market Update: World Acceptance Falls On Earnings Miss; CARBO Ceramics Shares Spike Higher ||| Mid-Day Market Update: Crude Oil Up Over 2%; Mattel Shares Drop On Downbeat Results ||| Q4 2016 Real-Time Call Brief ||| In Lockstep: Dow 20,000 Significance Magnified By Record Highs For SPX ||| Mid-Morning Market Update: Markets Edge Higher; Caterpillar Issues Weak 2017 Forecast ||| Standpoint Research Downgrades Caterpillar From Hold To Sell ||| Caterpillar December Sales: Not So Much 'Good' As They Are 'Less-Bad' ||| UPDATE: Cat Sees FY17 Adj. EPS $2.90 vs $3.26 Est. ||| UPDATE: Cat Sees FY17 Sales $36B-$39B vs $38.9B Est. ||| Cat Sees FY17 Sales 'slightly lower due to the strengthening of the U.S. dollar over the past two months' ||| Cat Reports Q4 Adj. EPS $0.83 vs $0.66 Est., Sales $9.574B vs $9.84B Est. ||| A Peek Into The Markets: U.S. Stock Futures Up Ahead Of Earnings ||| 15 Stocks To Watch For January 26, 2017 ||| Earnings Scheduled For January 26, 2017",1,0.5155009
2017-01-27,6371400.0,97.69000244140624,99.45999908447266,97.5,98.98999786376952,90.68659210205078,CAT,"A CEO Who's Who Of Trump's Manufacturing Council ||| The Other Dow ETF Is Winning, Too ||| Benzinga's Top Upgrades, Downgrades For January 27, 2017 ||| Axiom's Gordon Johnson Discussing Cat's FY Outlook: Guidance is Weak Due to Inventory Overhang As Well As Weakening Trends in China Which Will Reverberate Around the World ||| The Market In 5 Minutes: Google And Microsoft And Intel, Oh My! ||| Axiom's Gordon Johnson Currently Speaking on Benzinga's PreMarket Prep Show, Discussing His Cat Call ||| Wells Fargo Upgrades Caterpillar To Outperform",0,0.49718493
2017-01-30,5221800.0,98.4000015258789,98.58999633789062,96.56999969482422,96.79000091552734,88.67112731933594,CAT,"Mixing It Up: Markets Await Host Of Economic Data, Key Earnings, And Fed Meeting",0,0.5162105
2017-01-31,5724700.0,96.58999633789062,96.62999725341795,94.58999633789062,95.66000366210938,87.63591766357422,CAT,#AdiosProductosGringos: Border Wall Backlash Leads Mexicans To Boycott American Products,0,0.5285436
2017-02-01,3582500.0,95.80999755859376,96.5199966430664,94.4000015258789,95.11000061035156,87.13204956054688,CAT,"Meet Uptake Technologies, The New Startup Run By Groupon's Founders",0,0.51162136
2017-02-07,4995600.0,94.31999969482422,94.91999816894533,93.0199966430664,93.30999755859376,85.4830322265625,CAT,"This Might Be The Best Time To Buy Caterpillar ||| Benzinga's Top Upgrades, Downgrades For February 7, 2017 ||| The Market In 5 Minutes: GM And Gap Earnings, Retail Sales Data ||| Barclays Upgrades Caterpillar To Overweight",0,0.48976448
2017-02-10,5600200.0,94.87000274658205,96.62000274658205,94.5,96.30999755859376,88.23138427734375,CAT,Hearing Evercore ISI Upgraded Caterpillar,1,0.50458115
2017-02-21,3916600.0,98.87000274658205,99.1999969482422,97.91999816894533,98.0999984741211,89.8712387084961,CAT,"Boeing, Pfizer And Others Band Together To Ask Congress For More Taxes",1,0.5125564
2017-02-23,6024800.0,98.44000244140624,98.5,95.12000274658205,95.5500030517578,87.5351333618164,CAT,Benzinga's Option Alert Recap From February 23 ||| Option Alert: Caterpillar Feb 24th 96.5 Calls Sweep: 1500 @ ASK $0.13: 1562 traded vs 271 OI: Earnings 4/25 Before Open (est) $95.30 Ref,0,0.47246367
2017-02-24,5018200.0,94.86000061035156,95.5,93.5,95.4800033569336,87.47101593017578,CAT,Watch These 8 Huge Call Purchases In Friday Trade,1,0.5314702
2017-03-02,23059200.0,98.48999786376952,98.7300033569336,92.83999633789062,94.36000061035156,86.44495391845703,CAT,"UPDATE: Caterpillar Says Warrant Is Focused On Collection Of Documents And Electronic Info ||| UPDATE: Caterpillar Says Warrant Is 'Broadly Drafted,' Believes It's Regarding Export Filings RElated To The CSARL Matter Disclosed In CAT's February 2015 10-K SEC Filing ||| Caterpillar Issues Statement, Says It Continues To Cooperate With Law Enforcement ||| Journal Star Reporter Chris Kaergard Tweets, Regarding Caterpillar: Multiple agencies involved, including IRS, FDIC and a commerce agency with an absurdly long name. ||| 3 Federal Agencies Raid Caterpillar Offices ||| UPDATE: Peoria Journal Star Article Cites Source Indicating Caterpillar Tax And Accounting Division Employees, Those From Executive Offices Among Employees Sequestered By Federal Agents ||| UPDATE: Agents From IRS, FDIC, Commerce Dept. Participated In Caterpillar Office Searches ||| Hearing Federal Agents Have Searched Caterpillar Office ||| Gordon Johnson: An Imminent End To An Epic Restock Suggests Iron Ore Prices May 'Snap' Back Toward Fundamentals",1,0.51120865
2017-03-03,8163300.0,94.36000061035156,95.9000015258789,94.20999908447266,95.12000274658205,87.14120483398438,CAT,"Caterpillar Tells Benzinga 'We Are Back To Work,' Will Continue To Operate Throughout Course Of Ongoing Investigation, ConExpo 2017 Still Planned For Next Week ||| Caterpillar Spokesperson Regarding Federal Raid Of Headquarters Tells Benzinga 'Federal authorities are concluding the on-site investigation that began yesterday,' Co. Has Been In Full Cooperation, Says Caterpillar is Company With The Highest Integrity ||| Caterpillar: Big Trouble In Little Peoria ||| Caterpillar Attempts To Stabilize After Thursday's Plunge ||| The Market In 5 Minutes ||| U.S. Coomerce Secretary Wilbur Ross on CNBC Says Caterpillar Action was Part of Ongoing Probe ||| Najarian Brothers See Unusual Options Activity In Caterpillar, Healthcare ETF And Financial Select Sector SPDR Fund ||| Caterpillar CEO Apologizes to Employees Regarding Raid; Says was Surprised by Actions after Cooperating with Authorities -Wall Street Journal",1,0.49354944
2017-03-07,4683100.0,95.6500015258789,96.2300033569336,94.76000213623048,95.93000030517578,87.8832778930664,CAT,"Cat CEO Issues Statement on Raid: '...we were surprised by actions of last week, because we have been cooperating with authorities - we are cooperating...we are an honorable company...we live by a code of conduct...' ||| Evercore Out Positive On Caterpillar Guidance, Believes Co. May Raise Guidance Next Month ||| Caterpillar Shares Spiking Higher",0,0.48300642
2017-03-08,9370400.0,94.0999984741211,95.4800033569336,92.86000061035156,93.2300033569336,85.40972900390625,CAT,"Did Axiom's Gordon Johnson Call Caterpillar's Accounting Woes 2 Years Ago? ||| Caterpillar Range Bound Since Tax Fraud Investigation Exposed ||| Caterpillar Showing Weakness Despite Evercore Boost ||| Cat Shares Down 2%; Some Traders Attributing Weakness to Earlier NY Times Report 'Caterpillar Is Accused in Report to Federal Investigators of Tax Fraud' ||| Doug Kass Tweets: Why, despite the optimism on Fast $, $CAT is my fav large cap short for 2017. nytimes.com/2017/03/07/bus… More on RealMoneyPro. ||| Trimble and Caterpillar to Partners on Telematics for Construction Operations",0,0.49355847
2017-03-10,7169000.0,91.88999938964844,93.0999984741211,90.80999755859376,92.30999755859376,84.56692504882812,CAT,"Cat Has Said IRS Has Challenged Co.'s Taxes for 2007-2012 Periods, 'We Believe We Are Compliant with Tax Laws, Stand By Our Financial Reporting' ||| Week After IRS Raid, Vetr Upgrades Caterpillar To Hold",1,0.5202832
2017-03-14,5781100.0,91.22000122070312,92.0,90.62000274658205,91.86000061035156,84.1546630859375,CAT,"Gordon Johnson Sends Another Warning Shot On Steel Following MSCI Data ||| PreMarket Prep Host Dennis Dick Tweets: Notable opening imbalances: $CAT -197K, $GE -156K, $BABA -46K, $CL -44K, $PFE -92K, $XOM -30K, $CVX -26K",1,0.49275017
2017-03-15,6434600.0,92.37000274658205,93.79000091552734,92.05999755859376,93.36000061035156,85.52883911132812,CAT,United Automobile Workers Says Caterpillar UAW Bargaining Team Has Reached Tentative Agreement ||| Caterpillar Presenting At J.P. Morgan Conf. Says Co. Backs FY17 North American Sales Guidance Being Flattish,0,0.4845328
2017-03-16,3717900.0,93.97000122070312,94.08999633789062,92.63999938964844,92.8499984741211,85.06161499023438,CAT,"Caterpillar Hires Former U.S. Atty General As Outside Counsel In Matters Related To Search Warrants, Govt. Investigation Recently Conducted At Caterpillar Headquarters ||| Both Opportunity And Uncertainty Surround Caterpillar ||| Tigress Financial Upgrades Caterpillar to Neutral",1,0.5071979
2017-03-20,6516200.0,93.12999725341795,95.4800033569336,92.88999938964844,95.4000015258789,87.39772033691406,CAT,"Cat Shares Tick Lower Following Machine Sales Data, Down ~0.4%; BZ NOTE: Cat Reported 8% Decline in Rolling 3-Month Retail Sales During Jan., 12% Decline During Dec. ||| 8-K from Cat Shows Rolling 3-Month Retail Sales for Feb. Down 1%",0,0.5009756
2017-03-31,4020600.0,92.62999725341795,93.23999786376952,92.0199966430664,92.76000213623048,84.97916412353516,CAT,Jim Cramer's 2 Picks For Trump's Infrastructure Project,0,0.51029277
2017-04-03,3685800.0,92.43000030517578,92.83999633789062,91.0,92.2699966430664,84.5302734375,CAT,"Barron's Picks And Pans: Under Armour, CarMax, Lowe's And More ||| Benzinga Premarket Prep Host Dennis Dick Tweets: Notable opening imbalances: $PFE -243K, $MRK -93K, $BABA +115K, $KO +104K, $T +111K, $CAT -55K, $IBM -42K",1,0.49276292
2017-04-04,5797500.0,93.88999938964844,94.77999877929688,93.05999755859376,94.12999725341795,86.23424530029297,CAT,Trump's China Summit Has Market Looking Cautious Amid Lack Of Other Catalysts,1,0.52720696
2017-04-05,6061300.0,94.91999816894533,96.7300033569336,93.95999908447266,94.23999786376952,86.33501434326172,CAT,"Waiting Game: Trump Meeting With China, Fed Minutes, Taxes All In Focus",1,0.50961906
2017-04-10,5168300.0,96.30999755859376,97.88999938964844,96.0999984741211,97.13999938964844,88.99176025390625,CAT,Investor Movement Index (IMX) for March 2017,0,0.47955143
2017-04-11,4250400.0,97.3000030517578,97.30999755859376,95.66999816894533,97.0999984741211,88.95511627197266,CAT,Net-Sold Stocks In Record-Setting March,0,0.5270744
2017-04-12,4773900.0,96.69000244140624,96.7699966430664,94.66000366210938,94.86000061035156,86.90300750732422,CAT,"Caterpillar Investors Expecting A 'Beat-And-Raise' Print ||| Caterpillar Inc. Maintains Dividend Rate Of $0.77/Share, Says Dividend Reflects Confidence That They Are Well-Positioned For Future",0,0.4787859
2017-04-13,4706000.0,94.5999984741211,94.86000061035156,93.08999633789062,93.0999984741211,85.29064178466797,CAT,Watch These 6 Huge Put Purchases In Thursday Trade,1,0.53349644
2017-04-19,5550400.0,94.86000061035156,95.97000122070312,93.29000091552734,93.47000122070312,85.6296157836914,CAT,Earnings: Ebay And Verizon Set To Report Q1,1,0.51878846
2017-04-24,6739400.0,95.83999633789062,97.05999755859376,95.8000030517578,96.80999755859376,89.42613220214844,CAT,"Earnings: Caterpillar, Lockheed Martin, and Eli Lilly Report Tomorrow ||| Spell Out Relief: French Vote As Expected, So Attention Turns To Earnings, Tax Reform ||| Cat Shares Higher Pre Market, Up ~1.6%; 8-K Filing Just Out Showed Global Rolling 3 Month Retail Sales Up 1% for Mar.",1,0.52985626
2017-04-25,18383500.0,102.87999725341795,104.88999938964844,102.0,104.41999816894533,96.45570373535156,CAT,"20 Biggest Mid-Day Gainers For Tuesday ||| From Cat's Q1 Earnings Conference Call: 'Nothing More to Report Related to Search Warrant Executed' at 3 Facilities in Mar. ||| Caterpillar On Conf. Call Says Nothing More To Report Related To Executed Search Warrant At 3 Illinois Facilities ||| 8 Technical Levels From Tuesday's PreMarket Prep ||| From Cat Q1 Earnings Conference Call: Sees Strong Market in China Continuing At Least Through Mid 2017 If Policy Remains Supportive ||| Caterpillar Back At November 2014 Levels Following Q1 Report ||| Eying 6,000: Nasdaq Close To New Big Number As Relief Rally Seen Continuing ||| Before-The-Open Imbalance Update: BofA 254K Shares to Buy, Ford 129K to Buy, Cat 109K to Buy, HP 103K Shares to Sell, Nike 89K to Sell, Alibaba 77K to Buy, Wells Fargo 69K to Buy, Verizon 43K to Sell, AT&T 36K to Buy ||| 22 Stocks Moving In Tuesday's Pre-Market Session ||| A Peek Into The Markets: U.S. Stock Futures Rise Ahead Of Earnings ||| UPDATE: Cat Raises FY17 Adj. EPS Outlook from ~$2.90 to ~$3.75 vs $3.25 Est., Sales $38B-$41B vs $38.3B Est. ||| Cat Raises FY17 Outlook ||| Cat Reports Q1 Adj. EPS $1.28 May Not Compare to $0.62 Est. vs $0.64 in Same Qtr. Last Year, Sales $9.822B vs $9.26B Est. ||| 15 Stocks To Watch For April 25, 2017 ||| Earnings Scheduled For April 25, 2017",1,0.51856244
2017-04-26,9856100.0,103.8000030517578,105.9800033569336,103.63999938964844,104.66000366210938,96.67740631103516,CAT,"Pre-Market Imbalance Update: US Steel 147K Shares to Sell, Twitter 113K Shares to Buy, Cat 103K to Sell, BofA 88K to Buy, Visa 57K to Sell, McDonald's 48K to Sell",0,0.49134684
2017-04-27,6727400.0,104.0500030517578,104.23999786376952,102.55999755859376,102.68000030517578,94.8484344482422,CAT,"Pre-Market Imbalance Update: US Steel 298K Shares to Sell, AT&T 118K to Sell, Nike 79K to Sell, Cat 52K to Sell",0,0.50192815
2017-05-01,4512100.0,102.6500015258789,102.98999786376952,101.41000366210938,102.0,94.22028350830078,CAT,"Barron's Picks And Pans: Caterpillar, NextEra, Chipotle And More",0,0.49955255
2017-05-03,4278400.0,101.04000091552734,102.16999816894533,100.77999877929688,101.54000091552734,93.79537200927734,CAT,"Cat Shares Spiked to Session Highs, Pared Gains, Stock Now Unch for Session; 10-Q Filing Showed Comment Co. was Notified on Feb. 17, 2017 SEC Concluded Investigation Into Bucyrus Deal and Said Did Not Intend to Recommend Enforcement Action Against Co. ||| UPDATE: Cat 10-Q Out ||| Cat Shares Volatile Over Last Min as Co.'s 10-Q Hit Just A Few Mins Ago",0,0.47971776
2017-05-04,7271600.0,101.44000244140624,101.5,98.63999938964844,99.38999938964844,91.8093719482422,CAT,"Gordon Johnson On Caterpillar: 'Probably One Of The Most Overvalued Stocks We've Ever Seen' ||| Axiom's Gordon Johnson Says Warning Signs Suggest Credit Event In China Is Closer Than It Appears, Ominous Signs For Commodity Complex ||| Axiom's Johnson Highlights Cat Peak Earnings Previously Achieved 'Because China Was Stimulating Like They Never Did Before,' Suggests He Doesn't Understand Why Sell-Side Peers are Currently Still Using Mid-Cycle Earnings Models for Cat ||| Axiom's Johnson on Cat: Using Peak Earnings, Sees Cat Share's Fair Value at $98 ||| Axiom's Johnson on Cat's Recent Earnings Report: Says Co. 'Wanted to Show the SEC They Could Put Up Good Numbers Ahead of Investigation' ||| Axiom's Johnson on Caterpillar: Stock 'is Probably One of the Most Overvalued Stocks We've Ever Seen'",1,0.48817703
2017-05-08,5094600.0,99.4800033569336,100.0999984741211,98.94000244140624,99.37000274658205,91.79088592529295,CAT,One Year Later: A Look At The 2016 Ira Sohn Conference Picks,0,0.52413327
2017-05-09,9742000.0,99.72000122070312,100.20999908447266,99.25,99.29000091552734,91.71697998046876,CAT,A Look At David Einhorn's Recent Short Calls,1,0.52285445
2017-05-10,4696700.0,99.72000122070312,100.70999908447266,99.3000030517578,100.36000061035156,92.70535278320312,CAT,How I learned To Trade Penny Stocks,1,0.53263277
2017-05-11,5220300.0,101.9000015258789,101.91999816894533,100.1500015258789,100.98999786376952,93.28732299804688,CAT,"8 Biggest Price Target Changes For Thursday ||| Benzinga's Top Upgrades, Downgrades For May 11, 2017 ||| Bank of America Upgrades Caterpillar To Buy, Raises Price Target To $120",0,0.5209916
2017-05-17,4618500.0,102.33999633789062,102.33999633789062,99.88999938964844,100.13999938964844,92.50214385986328,CAT,Looking At Drivers For Industrial ETFs,1,0.5429859
2017-05-18,5931500.0,99.13999938964844,100.66999816894533,97.73999786376952,100.22000122070312,92.57605743408205,CAT,Checking In On Global Agriculture With Deere & Company Earnings ||| 8-K from Cat Shows Global Rolling 3-Month Retail Sales Up 1% in Apr.,1,0.55823743
2017-05-19,4636500.0,101.56999969482422,102.86000061035156,101.2699966430664,102.43000030517578,94.61749267578124,CAT,Deere Delivers Welcome Distraction From Politics With Strong Earnings Data,0,0.5402863
2017-06-01,4211300.0,105.7699966430664,106.43000030517578,105.16000366210938,105.6500015258789,97.5918960571289,CAT,The Market In 5 Minutes,1,0.5408694
2017-06-05,4319500.0,105.58000183105467,107.16999816894533,105.13999938964844,105.1999969482422,97.17620849609376,CAT,"UPDATE: Axiom's Johnson Highlights Expectation for Elevated Q2 Earnings Risk in Industrial Complex ||| Axiom's Gordon Johnson Earlier Issued Mid-Day Note Justifying United Rentals, Cat Share Weakness in Otherwise Up Market: Highlighted All 7 Non-Residential US Data Points Firm Tracks as 'incrementally weaker' ||| How Ridiculous Can ETFs Get? A Fictional Cat-Themed Product Makes Insane ROI",0,0.49740878
2017-06-06,3800200.0,104.79000091552734,105.5199966430664,104.05999755859376,104.5500030517578,96.57579803466795,CAT,Industrials Complexity Has Elevated Q2 Earnings Risk: Here's Why,0,0.50207204
2017-06-08,4649300.0,103.51000213623048,105.38999938964844,103.51000213623048,105.01000213623048,97.00070190429688,CAT,"Top Ranked Momentum Stocks to Buy for June 8th ||| Top Ranked Income Stocks to Buy for June 8th ||| MRC Global (MRC) Extends PVF Deal with Chevron Corporation ||| Deutsche Bank Global Industrials & Materials Summit 2017 Concludes Today, Presenters Include: Caterpillar, Coeur Mining, L3 Technologies, JELD-WEN Holding, Trinseo, and Curtiss-Wright",1,0.48382613
2017-06-09,3881000.0,105.08999633789062,107.0199966430664,105.02999877929688,105.91999816894533,97.84129333496094,CAT,Actuant (ATU) Trims Q3 EPS Outlook on Energy Market Woes,1,0.51072896
2017-06-12,4167400.0,105.91999816894533,106.3499984741211,104.9000015258789,106.06999969482422,97.9798583984375,CAT,"Actuant (ATU) Downgraded to Sell, Q3 EPS Guidance Trimmed",0,0.49470487
2017-06-13,3522700.0,106.18000030517578,106.66000366210938,105.51000213623048,105.75,97.68426513671876,CAT,Market DeFANGed?,0,0.49466568
2017-06-14,4100200.0,105.8000030517578,105.98999786376952,103.98999786376952,104.70999908447266,96.7235870361328,CAT,"Benzinga's Option Alert Recap From June 14 ||| 5 Large Cap Stocks to Buy Now ||| Option Alert: Caterpillar Jun 104 Puts Sweep: 2030 @ ASK $0.40: 3773 traded vs 1518 OI: Earnings 7/25 Before Open (est) $104.82 Ref ||| Cat Raises Qtr. Dividend From $0.77 To $0.78/Share ||| Iron Ore Pricing 201: Current Spot Pricing Suggests Further Downside ||| Companies Holding Shareholder Meetings Today Include: Achaogen, American Airlines, ARMOUR Residential REIT, Autodesk, Bellicum Pharmaceuticals, Caterpillar, Celgene, Impinj, LendingTree, SeaWorld, Square, Stamps.com, Target, and Toyota Motor",1,0.49715367
2017-06-15,5974100.0,103.8000030517578,106.63999938964844,103.8000030517578,106.4000015258789,98.28469848632812,CAT,"Benzinga's Option Alert Recap From June 15 ||| Top Research Reports for Verizon, Alibaba & Wells Fargo ||| Option Alert: Caterpillar Jul 110 Calls Sweep: 5620 @ ASK $0.76: 7331 traded vs 3301 OI: Earnings 7/25 Before Open (est) $105.25 Ref ||| Caterpillar (CAT) Hikes Dividend After a Gap of 2 Years ||| Watch These 7 Huge Put Purchases In Thursday Trade",1,0.50888014
2017-06-16,7350400.0,106.76000213623048,107.91000366210938,106.4000015258789,107.5999984741211,99.39314270019533,CAT,"Dow 30 Stock Roundup: GE Appoints Flannery as CEO; UTX, CAT Hike Dividends ||| Watch These 8 Huge Call Purchases In Friday Trade ||| Caterpillar Announces Retirement of Three VPs",0,0.49708655
2017-06-19,4347600.0,107.9499969482422,108.04000091552734,106.66999816894533,107.48999786376952,99.29154205322266,CAT,Caterpillar vs. Deere: Which Is the Better Strong-Buy Rated Stock?,0,0.48891538
2017-06-20,5314100.0,108.05999755859376,108.18000030517578,106.91999816894533,107.04000091552734,98.8758773803711,CAT,5 Industrial Stocks to Add to Your Portfolio Right Now ||| Top Ranked Income Stocks to Buy for June 20th ||| 8-K From Cat Shows Rolling 3-Month Retail Sales For May Up 8%,0,0.51081055
2017-06-21,6274100.0,106.62999725341795,106.76000213623048,103.1500015258789,103.47000122070312,95.57818603515624,CAT,"Will Earnings Growth Continue in Q2? ||| Top Analyst Reports for Caterpillar, Intel & Monsanto ||| Caterpillar's (CAT) May Sales Rise 8%: Good Times Ahead?",1,0.49591154
2017-06-22,3652500.0,103.56999969482422,104.66000366210938,103.48999786376952,103.83999633789062,95.91995239257812,CAT,Top Ranked Momentum Stocks to Buy for June 22nd,1,0.5243626
2017-06-23,12089800.0,102.5,104.2699966430664,102.3000030517578,104.11000061035156,96.16934204101562,CAT,"Deutsche Bank: Caterpillar's Consensus Has Undergone Metamorphosis ||| Benzinga's Top Upgrades, Downgrades For June 23, 2017 ||| Deutsche Bank Downgrades Caterpillar to Hold",1,0.5026231
2017-06-26,2857700.0,104.66000366210938,105.62999725341795,103.44000244140624,104.25,96.29867553710938,CAT,"Benzinga's Bulls & Bears For The Past Week: Netflix, AMD, Colgate And More ||| Top Ranked Momentum Stocks to Buy for June 26th ||| Top Ranked Momentum Stocks to Buy for June 26th ||| Top Ranked Income Stocks to Buy for June 26th ||| Tech Strikes Back",0,0.5028518
2017-06-27,3380700.0,104.5,105.2300033569336,103.69000244140624,103.93000030517578,96.00308227539062,CAT,Dow Snaps Quiet Skid,1,0.5251254
2017-07-20,3759700.0,107.87999725341795,108.1500015258789,107.05999755859376,107.31999969482422,99.85009765625,CAT,Benzinga's Option Alert Recap From July 20 ||| These Non-Tech Companies Are Investing In An AI Future ||| Caterillar Option Alert: Fri $108 Puts at the Ask: 4096 @ $0.47 vs 1324 OI; Ref=$107.97,0,0.4899353
2017-07-21,4258100.0,106.70999908447266,106.9499969482422,105.11000061035156,106.58999633789062,99.17090606689452,CAT,Benzinga's Option Alert Recap From July 21 ||| Caterpillar Option Alert: Jul 28 $99.5 Calls Sweep (32) at the Ask: 1784 @ $6.85 vs 1 OI; Ref=$106.11 ||| Watch These 5 Huge Put Purchases In Friday Trade,1,0.52262104
2017-07-24,5980400.0,107.86000061035156,108.5,107.29000091552734,108.18000030517578,100.65023803710938,CAT,"Benzinga's Option Alert Recap From July 24 ||| What You Need To Know About Dow Components Reporting This Week ||| Latest Rally In Chinese Commodity Prices Could Be Largely Rooted In Speculation ||| Caterpillar Option Alert: Aug 18 $115 Calls Sweep (30) at the Bid: 5070 @ $0.53 vs 2634 OI; Ref=$107.92 ||| Caterpillar Is 'A Whole Different Animal,' Upgraded To Outperform ||| Benzinga's Top Upgrades, Downgrades For July 24, 2017 ||| BMO Capital Upgrades Caterpillar to Outperform ||| Watch These 5 Huge Call Purchases In Monday Trade",1,0.51511145
2017-07-25,14264600.0,113.23999786376952,114.88999938964844,111.8000030517578,114.54000091552734,106.56754302978516,CAT,"Caterpillar Says It's Seeing Healthy Demand For Mining Equipment, But Off A Very Low Level ||| Cramer: The Title For 'Most Serious' Beat And Raise This Quarter Goes To Caterpillar ||| Caterpillar Says It Expects Some Headwinds To Profitability In 2H Of 2017 ||| 25 Stocks Moving In Tuesday's Pre-Market Session ||| Cat Raises FY17 Sales Outlook From $38B-$41B To $42B-$44B vs $40.54B Est. ||| A Peek Into The Markets: U.S. Stock Futures Gain Ahead Of Earnings ||| Caterpillar Reports Q2 Adj. EPS $1.49 vs $1.26 Est., Sales $11.331B vs $10.93B Est. ||| Watch These 5 Huge Call Purchases In Tuesday Trade ||| 12 Stocks To Watch For July 25, 2017 ||| Earnings Scheduled For July 25, 2017",0,0.50938874
2017-07-26,5741200.0,114.25,114.54000091552734,113.08000183105467,113.5199966430664,105.6185531616211,CAT,5 Undervalued Stocks That Could Trade 20% Higher ||| 5 Biggest Price Target Changes For Wednesday,1,0.52231103
2017-07-31,4477200.0,114.5,114.66000366210938,113.69000244140624,113.9499969482422,106.01862335205078,CAT,Tigress Financial Upgrades Caterpillar to Buy,0,0.5176802
2017-08-01,3683700.0,114.2699966430664,114.43000030517578,112.5199966430664,113.0999984741211,105.22777557373048,CAT,"Caterpillar CFO Brad Halverson To Retire 2018, Co. To Start External Search For New CFO",0,0.4900337
2017-08-03,2438900.0,112.8499984741211,113.72000122070312,112.8499984741211,113.55999755859376,105.65576171875,CAT,"Benzinga's Top Upgrades, Downgrades For August 3, 2017 ||| The Market In 5 Minutes ||| Atlantic Equities Upgrades Caterpillar to Neutral",1,0.5148439
2017-08-07,2269400.0,114.4800033569336,114.98999786376952,114.3000030517578,114.70999908447266,106.72572326660156,CAT,These Were The Most Bought And Sold Stocks In July ||| TD Ameritrade Investor Movement Index: Bullish Retail Investors Push IMX Above 7.0 For First Time,0,0.5074251
2017-08-09,3170100.0,114.38999938964844,115.45999908447266,114.11000061035156,114.33999633789062,106.38146209716795,CAT,"Manitowoc Touches a New 52-Week High on Upbeat Q2 Results ||| Positive Trends in Q3 Estimate Revisions ||| Positive Trends in Q3 Estimate Revisions ||| Caterpillar Scales 52-Week High: What's Driving the Stock? ||| Zacks.com featured highlights: Owens Corning, Dana, Pilgrim's Pride, Caterpillar and Viad",0,0.49185422
2017-08-10,3186700.0,113.88999938964844,114.12999725341795,112.86000061035156,113.1500015258789,105.27430725097656,CAT,See Which Of The Latest 13F Filers Holds Caterpillar ||| Bemis (BMS) Plunges to 52-Week Low: What's Pulling it Down? ||| The Pullback Just Made These 3 Winners More Affordable,0,0.490756
2017-08-11,2130300.0,113.06999969482422,113.66999816894533,112.75,112.8499984741211,104.99518585205078,CAT,"3 Top Dividend Stocks in Infrastructure Spending ||| Will Ball Corp (BLL) be Affected by Dismal Can Business? ||| Why Avery Dennison (AVY) is a Must-Add to Your Portfolio ||| Top Analyst Reports for Disney, Amgen & Caterpillar",1,0.5592448
2017-08-14,1968900.0,113.45999908447266,114.37000274658205,113.2699966430664,113.70999908447266,105.79533386230467,CAT,"Caterpillar Poised to Ride on Asia, Cost Cuts & Construction ||| How Caterpillar Makes Its Money ||| Merck CEO Quits Manufacturing Council To Stand Against Violence; Trump Promptly Calls Him Out About Drug Pricing",0,0.49034405
2017-08-16,2268600.0,113.80999755859376,114.51000213623048,113.62999725341795,114.12000274658205,106.17678833007812,CAT,6 Reasons to Steer Clear from Bemis (BMS) Stock for Now,0,0.5290178
2017-08-18,3875700.0,112.98999786376952,114.63999938964844,112.69000244140624,113.91999816894533,105.99070739746094,CAT,"Deere (DE) Beats on Q3 Earnings, Misses Sales, Raises View ||| Notable Friday Option Activity: HD, NBL, CAT ||| Why Caterpillar (CAT) is a Must-Add Stock to Your Portfolio ||| Market Close Report: NASDAQ Composite index closes at 6,216.53 down -5.38 points",0,0.4970274
2017-08-21,3137400.0,113.75,114.08999633789062,113.2699966430664,113.5999984741211,105.69297790527344,CAT,"Terex (TEX) Poised to Benefit from Portfolio Restructuring ||| Interesting February 2018 Stock Options for CAT ||| Caterpillar's (CAT) Monthly Sales Growth Peaks 12% in July ||| Notable ETF Outflow Detected - VTV, IBM, HON, CAT ||| Carter Worth And Mike Khouw's Caterpillar Trade",1,0.49613225
2017-08-22,3881100.0,114.20999908447266,115.86000061035156,114.0,115.81999969482422,107.75845336914062,CAT,"Dow Movers: PG, BA ||| The Zacks Analyst Blog Highlights: Wal-Mart, Caterpillar, Mondelez, Est??e Lauder and Deere ||| Deere (DE) Poised on Farm Income Growth Amid Rising Expenses ||| Market Close Report: NASDAQ Composite index closes at 6,297.48 up 84.35 points ||| Big Daily Gain for Dow as Defense, Tech Stocks Rally",0,0.48538163
2017-08-23,2447600.0,115.0,115.37999725341795,114.75,114.75,106.76293182373048,CAT,"Surging Earnings Estimates Signal Good News for Caterpillar (CAT) ||| Domestic Political Scenario Continues to be Unsettling ||| 7 of the Strongest Stocks to Buy Right Now ||| Caterpillar Hits 52-Week High on Upbeat Sales Growth Figures ||| Wednesday’s Vital Data: Lowe’s Companies, Inc. (LOW), Salesforce.com, Inc. (CRM) and Snap Inc (SNAP) ||| Drive Tesla Inc (TSLA) Stock to Big, Safe Profits ||| Weak Small Cap Earnings Results ||| Will Trump Shut Down the Government to Get the Wall Built? ||| Large-Cap Stocks Lower on Wednesday ||| Will Trump Shut Down the Government to Get the Wall Built? ||| Weak Small Cap Earnings Results ||| Caterpillar Inc. (CAT) Stock Is a Lion. Here’s How to Tame It. ||| Packaging Corporation of America to Buy Assets for $265M",1,0.49067622
2017-08-24,1861200.0,115.0,115.0500030517578,114.38999938964844,114.77999877929688,106.79084777832033,CAT,"AGCO (AGCO) Collaborates With CPF to Form Manufacturing JV ||| Apogee Tweaks FY18 Guidance for EFCO Buy, FY19 View Positive ||| Heritage-Crystal (HCCI) Looks Good: Stock Adds 5.5% in Session ||| Zacks Earnings Trends Highlights: Caterpillar, Facebook and Intel",1,0.52136046
2017-08-25,3282200.0,115.47000122070312,116.63999938964844,115.1500015258789,115.3499984741211,107.3211669921875,CAT,"General Electric Becomes #13 Most Shorted Dow Stock, Replacing Caterpillar ||| Dow Movers: BA, CSCO ||| Caterpillar (CAT) Up 5.4% Since Earnings Report: Can It Continue? ||| Caterpillar Becomes #1 Most Shorted Dow Stock, Replacing Wal-Mart Stores",0,0.4623154
2017-08-28,2011000.0,115.76000213623048,116.05999755859376,114.66000366210938,115.06999969482422,107.06067657470705,CAT,Why Is Caterpillar Soaring in 2017?,1,0.48005703
2017-08-29,4355700.0,114.37999725341795,116.5999984741211,114.3000030517578,116.01000213623048,107.93524169921876,CAT,"8 Reasons to Add Terex (TEX) to Your Portfolio Right Now ||| Hyster-Yale Materials Handling, Inc. (HY) Ex-Dividend Date Scheduled for August 30, 2017 ||| AGCO (AGCO) Expands Parts Distribution Center in Regina",1,0.5228725
2017-08-30,3401000.0,116.12000274658205,117.69000244140624,115.87999725341795,117.5500030517578,109.36805725097656,CAT,Caterpillar Inc. (CAT) Lands $663 Million Pentagon Deal ||| Top Ranked Income Stocks to Buy for August 30th ||| 7 Buy-Ranked Stocks That Just Touched New All-Time Highs ||| Caterpillar Awarded $663 U.S. Defense Dept Contract,0,0.46925104
2017-08-31,3357700.0,117.9499969482422,118.83000183105467,117.3499984741211,117.48999786376952,109.31221771240234,CAT,"Greif (GEF) Tops Q3 Earnings & Sales, Trims FY17 EPS View ||| Ball Corp. (BLL) Set to Cease Production at 3 Facilities ||| The Zacks Analyst Blog Highlights: Alarm.com, Arista Networks, Aerovironment, Alteryx and Caterpillar ||| Caterpillar Up on DoD Deal, Good Times for Industrial Stocks? ||| Top Stock Reports for Merck, Caterpillar & Intel",1,0.4938351
2017-09-01,2992200.0,117.48999786376952,118.81999969482422,117.4000015258789,118.27999877929688,110.04723358154295,CAT,"The Zacks Analyst Blog Highlights: Merck, Caterpillar, Intel, Analog Devices and Best Buy",1,0.50455016
2017-09-05,3826800.0,118.13999938964844,119.12999725341795,117.81999969482422,118.3000030517578,110.06585693359376,CAT,6 Reasons to Add AGCO Stock to Your Portfolio Now ||| 5 of the Best Manufacturing Stocks Right Now ||| 12 Strategies to Generate Income in Retirement ||| Why You Must Add Owens-Illinois (OI) Stock to Your Portfolio ||| 5 Dividend Champions to Counter an Awful September,0,0.5113348
2017-09-06,4292600.0,118.75,119.19000244140624,116.9800033569336,116.9800033569336,108.83773803710938,CAT,"Coupa (COUP) Q2 Loss Narrower Than Expected, '18 Guidance Up ||| The Zacks Analyst Blog Highlights: Caterpillar, Principal Financial Group, First American Financial, Gap and TELUS ||| Ball Corp's (BLL) Unit Delivers JPSS-1 Weather Satellite ||| Dow Analyst Moves: CAT ||| Another Buying Opportunity? ||| Terex (TEX) Sells Remaining Shares in Konecranes for $224M ||| 6 Industrial Stocks Near 52-Week Highs That Are Must-Buys ||| AGCO Corp (AGCO) Unveils IDEAL, Boosts Agricultural Platform ||| Benzinga's Top Upgrades, Downgrades For September 6, 2017 ||| Seaport Global Initiates Coverage On Caterpillar with Neutral Rating",1,0.5127861
2017-09-07,3270100.0,117.37999725341795,117.93000030517578,116.5,117.7699966430664,109.57271575927734,CAT,"Deere to Buy Blue River Technology, Adds Competitive Edge ||| These Jaw-Dropping Facts Will Change Your Mind About the Internet of Things ||| Sealed Air Divests Diversey for $3.2B to Simplify Structure ||| Favorable Earnings Trend Expected to Continue ||| Miller Industries, Inc. (MLR) Ex-Dividend Date Scheduled for September 08, 2017",1,0.5050593
2017-09-08,2787000.0,117.2300033569336,118.8499984741211,117.0,117.81999969482422,109.61924743652344,CAT,"Donaldson's (DCI) Q4 Earnings Miss, Revenues Beat Estimates ||| 7 Reasons to Dump Astec Industries (ASTE) Stock Right Now ||| Noteworthy Friday Option Activity: BA, CAT, GTLS",1,0.510411
2017-09-11,3527500.0,118.81999969482422,118.91999816894533,117.47000122070312,118.87000274658205,110.59617614746094,CAT,Greif (GEF) Poised to Grow Despite Hurricane Harvey Impact ||| Reliance Steel (RS) Provides Operational Update Post Harvey ||| Manufacturing Expands in August: 4 Industrial Stocks to Buy ||| Crown Holdings to Build New Beverage Can Plant in Spain ||| 4 Big-Brand Stocks to Buy for an Edgy Wall Street,1,0.50841445
2017-09-12,5554000.0,119.19000244140624,121.38999938964844,119.05999755859376,120.94000244140624,112.52210235595705,CAT,"Sealed Air's (SEE) Fagerdala Buyout to Boost Asian Presence ||| Close Update: Wall Street Hits Record Highs as Telecoms, Financials Lead ||| Is Tesla Inc (TSLA) Stock Billionaire Einhorn’s Best (or Worst) Short? ||| From Cat Investor Day: Sees FY17 Adj. Operating Margin 10.9% ||| Companies Holding Analyst/Investor Days Today Include Sun Hydraulics, Performance Food Group, Equifax, and Caterpillar",0,0.4937867
2017-09-13,2532200.0,120.5,121.0,119.41000366210938,119.62999725341795,111.30326080322266,CAT,"Market Close Report: Historical high reached as NASDAQ Composite Index closes at 6,460.19. ||| 3 Stocks Going Up That Should Be Going Down ||| Deere Grows in Precision Agriculture With Blue River Buy",1,0.528299
2017-09-14,2904900.0,119.79000091552734,120.79000091552734,119.20999908447266,120.4800033569336,112.09410858154295,CAT,"S&P 500 Nears 2,500: 5 Stock Picks for Big Profits ||| Rockwell Automation Hits 52-Week High: What's Driving It? ||| Can Caterpillar (CAT) Keep the Earnings Streak Alive This Quarter? ||| AGCO or Terex: Which Stock Should You Buy? ||| 3 Promising Machinery Growth Stocks to Invest in Right Now",1,0.4906508
2017-09-15,4610100.0,121.01000213623048,121.56999969482422,120.30999755859376,121.37000274658205,112.92215728759766,CAT,"Manitowoc (MTW) Announces Plans for Reverse Stock Split ||| Douglas Dynamics, Inc. (PLOW) Ex-Dividend Date Scheduled for September 18, 2017 ||| Dow 30,000 or Bitcoin $30,000: Who Will Win the Race? ||| Reasons to Hold on to Crown Holdings (CCK) Stock for Now ||| 7 S&P 500 Leaders That Don’t Know HOW to Quit",1,0.46878338
2017-09-18,4349000.0,123.62000274658205,124.43000030517578,122.8499984741211,123.83000183105467,115.21092987060548,CAT,"Barron's Spots 5 Genuine Earnings Winners ||| Morning Movers: Caterpillar Gains on Upgrade; Orbital ATK Surges on Northrop Acquisition ||| Noteworthy Monday Option Activity: NOW, CAT, BA ||| Dow Movers: INTC, CAT ||| S&P 500 Makes History, Steers Past 2500: Top 5 Gainers ||| The Zacks Analyst Blog Highlights: Boeing, Caterpillar, Home Depot and Intel ||| Midday Update: Wall Street Sets New Record as Risk Appetite Resumes ||| Monday’s Tech Selloff Can’t Stop the Dow Jones’ Record Climb ||| Close Update: Risk Appetite Keeps Stocks Afloat as Focus Shifts to FOMC ||| Caterpillar (CAT) Stock Hits All-Time High: Should You Buy? ||| 5 Biggest Price Target Changes For Monday ||| Benzinga's Top Upgrades, Downgrades For September 18, 2017 ||| The Market In 5 Minutes ||| This Cat's Got Claws; Caterpillar Upgraded To Buy ||| A Peek Into The Markets: U.S. Stock Futures Signal Higher Start On Wall Street ||| UBS Upgrades Caterpillar to Buy",1,0.49918962
2017-09-19,3050000.0,123.95999908447266,124.93000030517578,123.76000213623048,124.73999786376952,116.05758666992188,CAT,"Caterpillar Inc. (CAT) Stock Has Catalysts Aplenty — Stay With It ||| Stock Market News For Sep 19, 2017 ||| 6 Reasons to Dump Ball Corporation (BLL) Stock Right Now ||| The Zacks Analyst Blog Highlights: Genworth Financial, Signet Jewelers, Boeing, Abercrombie & Fitch and Caterpillar",1,0.464443
2017-09-20,3151600.0,124.97000122070312,125.27999877929688,124.18000030517578,124.8499984741211,116.15992736816406,CAT,"Trimble Hits 52-Week High on Buyouts, Expanding Portfolio ||| Caterpillar's Rally Brings Focus Back on Machinery Stocks ||| Apogee (APOG) Misses Q2 Earnings & Sales, Affirms FY18 View ||| This Week's Top Growth & Income Stocks",0,0.5171813
2017-09-21,2615400.0,124.5199966430664,125.04000091552734,123.81999969482422,124.79000091552734,116.10411834716795,CAT,8-K From Cat Shows Global Rolling 3-Month Retail Sales Stats For Aug. Up 11% ||| Mike Khouw Sees Unusual Options Activity In Caterpillar,0,0.5020402
2017-09-22,2616700.0,124.58000183105467,125.41999816894533,124.3499984741211,124.43000030517578,115.7691650390625,CAT,"AGCO (AGCO) Scales 52-Week High on Strategic Initiatives ||| Caterpillar (CAT) on Growth Path, August Sales Rise 11% ||| Calgon Carbon (CCC), Kuraray Ink Definitive Merger Deal ||| Top Stock Reports for Caterpillar, Texas Instruments & Alphabet ||| Benzinga's Option Alert Recap From September 22 ||| Caterpillar Option Alert: Oct 20 $121 Puts Sweep (22) at the Bid: 501 at $1.011 vs 88 OI; Ref=$125.16",0,0.47916907
2017-09-25,3268500.0,124.37000274658205,124.77999877929688,123.6500015258789,124.31999969482422,115.66683959960938,CAT,"The Zacks Analyst Blog Highlights: Caterpillar, Texas Instruments, Alphabet, Adobe and Anthem ||| Caterpillar (CAT) or Deere (DE): Which Is the Better Stock? ||| Top Stock Picks for the Week of September 25th ||| Notable Monday Option Activity: CAT, MSFT, BA ||| Watch These 2 Huge Put Purchases In Monday Trade",1,0.48797777
2017-09-26,2301900.0,124.6999969482422,125.06999969482422,124.31999969482422,124.51000213623048,115.8436050415039,CAT,S&P Slips Below 2500,1,0.52069044
2017-09-27,2140600.0,125.20999908447266,125.41999816894533,124.33999633789062,124.5199966430664,115.8529052734375,CAT,10 Best Dow Jones Stocks to Buy for the Rest of 2017,1,0.523667
2017-09-29,2273500.0,125.3499984741211,125.5500030517578,124.51000213623048,124.70999908447266,116.02969360351562,CAT,"Seeking Income: 5 Better Options Than Caterpillar ||| Axiom's Gordon Johnson Says He Would Be Aggressively Adding To Short Positions In Caterpillar As The China Growth Engine Has Begun To Slow; Also, Mentions That There Still Has Been No Outcome From The FBI Raid Of Caterpillar's Facilities",1,0.50174147
2017-10-02,2502600.0,124.4000015258789,124.83000183105467,123.9499969482422,124.72000122070312,116.03898620605467,CAT,"5 Things CalAmp Corp. Management Wants You to Know ||| Starbucks Corporation (SBUX) Stock Is Brewing Free Profits ||| After Making New Highs, Caterpillar Inc. (CAT) Stock Is Priced For Purrfection ||| Notable Monday Option Activity: CAT, UPS, SPGI ||| Great Week, Great Month, Great Quarter",1,0.52070546
2017-10-03,2166100.0,124.9800033569336,125.52999877929688,124.3499984741211,125.51000213623048,116.77399444580078,CAT,"IYJ, CAT, CSX, ADP: Large Inflows Detected at ETF ||| Wabash National Corporation (WNC) Ex-Dividend Date Scheduled for October 04, 2017",1,0.47284338
2017-10-04,2792300.0,125.69000244140624,127.08999633789062,125.5999984741211,126.73999786376952,117.91837310791016,CAT,Stock Indexes Turn Narrowly Positive; Shopify Falls 6%,0,0.48442537
2017-10-05,2496200.0,126.8000030517578,126.91000366210938,126.01000213623048,126.4000015258789,117.60205841064452,CAT,"Stock Market News For Oct 5, 2017",1,0.47807556
2017-10-09,1979600.0,126.91999816894533,126.93000030517578,125.94000244140624,126.87999725341795,118.04864501953124,CAT,"These 3 Stocks Powered the Dow Higher in the Third Quarter ||| Caterpillar: Buy at the High? ||| Mutual Fund Managers Like U.S. Small Caps, Foreign Stocks",1,0.47704974
2017-10-10,4414300.0,127.5199966430664,128.28999328613278,127.2699966430664,128.19000244140622,119.2674789428711,CAT,"Noteworthy Tuesday Option Activity: CAT, MAC, DISH ||| Benzinga's Option Alert Recap From October 10 ||| Caterpillar Option Alert: Oct 20 $126 Calls Sweep (39) at the Ask: 2860 @ $2.651 vs 1201 OI; Ref=$128.02 ||| 5 Biggest Price Target Changes For Tuesday ||| Cat To Report Q3 Results On Tues., Oct. 24 Before Market Open",1,0.4972228
2017-10-11,2177800.0,128.16999816894528,128.85000610351562,127.66999816894533,128.60000610351562,119.64893341064452,CAT,US Market Indexes Higher on Tuesday ||| 5 Can’t-Miss Dow Jones Stocks to Buy Today ||| Watch These 8 Huge Call Purchases In Wednesday Trade,1,0.4929774
2017-10-12,3372300.0,128.39999389648438,130.16000366210938,128.3800048828125,129.99000549316406,120.94217681884766,CAT,"Waiting for a Boeing Co (BA) Stock Pullback Is the Best Play ||| 6 Machinery Stocks Poised to Beat Estimates in Q3 Earnings ||| Market Close Report: NASDAQ Composite index closes at 6,591.51 down -12.04 points ||| Stocks Back Down from Record Highs as Earnings Roll In",1,0.5034775
2017-10-16,2914200.0,131.25,132.1199951171875,130.94000244140622,131.47000122070312,122.31915283203124,CAT,Interesting January 2020 Stock Options for CAT ||| How Self-Driving Technology Will Benefit Industries,0,0.5041413
2017-10-17,2380300.0,131.13999938964844,131.47000122070312,130.32000732421878,130.53999328613278,121.4538803100586,CAT,7 Dow Jones Stocks That Pack a Growthy Punch ||| Caterpillar (CAT) Q3 Earnings: Another Beat in the Offing? ||| Top Ranked Momentum Stocks to Buy for October 17th ||| Profit From U.S. Manufacturing With These 5 Terrific Stocks,1,0.512423
2017-10-18,2511400.0,130.5,131.64999389648438,130.5,131.28999328613278,122.15170288085938,CAT,4 Blue Chip Stocks to Buy Ahead of Q3 Earnings ||| Can Pentair (PNR) Beat Q3 Earnings on Segmental Growth?,1,0.52182895
2017-10-19,4837600.0,131.0,131.6300048828125,129.39999389648438,131.55000305175778,122.3936004638672,CAT,Coupa's Latest Buyout Enhances Fraud Detection Capabilities,0,0.534398
2017-10-20,3086800.0,131.33999633789062,131.91000366210938,130.47999572753906,131.36000061035156,122.94580078125,CAT,"China's Take on the Petrodollar to Boost US Jobs: 5 Top Stocks ||| Q&A: Northern Trust Stockpicker Bangs the Drum for One Belt, One Road Stocks ||| Avery Dennison (AVY) to Report Q3 Earnings: What's in Store? ||| Noteworthy ETF Inflows: IYJ, UNP, UPS, CAT ||| Stock Exchange: Are Momentum Trades Better Than Dip Buying? ||| Upcoming Earnings: Heavy-Equipment Maker Caterpillar And Pharma Giant Eli Lilly Report On Tuesday",1,0.47612968
2017-10-23,5549500.0,131.94999694824222,132.33999633789062,131.16000366210938,131.67999267578122,123.24530029296876,CAT,"Caterpillar reports October 24 ||| A Preview Of Next Week's Blue-Chip Earnings ||| Key Predictions for Q3 Earnings Reports of CAT, PNR & SWK ||| Low Cabinets Sales to Hurt Fortune Brands (FBHS) Q3 Earnings? ||| Why Caterpillar (CAT) Might Surprise This Earnings Season ||| Caterpillar Posts the Better History on Short Side off Pre-Market Earnings Moves ||| 3 Things to Look Out For When Caterpillar Reports Earnings ||| What's in the Cards for Milacron (MCRN) in Q3 Earnings? ||| McDonald's, GM, Lockheed, Caterpillar, United Tech: Investing Action Plan ||| Jim Cramer Shares His Thoughts On Caterpillar, Coca-Cola And More ||| The Week Ahead: Earnings Season Starts In Earnest",1,0.47463536
2017-10-24,18886700.0,140.05999755859378,140.44000244140622,136.6300048828125,138.24000549316406,129.38511657714844,CAT,"Caterpillar Inc. Is Still Plowing Ahead — Stick With It ||| US Stock Market in Green on Tuesday ||| Dow Industrials Lead Stocks Up; This Finance Leader Breaks Out Again ||| Boeing Co Stock Continues to Be Propelled by Multiple Tailwinds ||| Caterpillar Inc. (CAT) Stock Surges on Stellar Earnings ||| Here’s How Far a Vulnerable Dow Jones Industrial Average Could Tumble ||| Several Oddities Persist as Stocks Surge on Blue-Chip Earnings ||| Caterpillar (CAT) Surges on Q3 Earnings Beat & Guidance Hike ||| Bet on Whirlpool Corporation While It’s In a Spin Cycle ||| Big Hitters Boost Blue-Chip Dow; 2 Near Entries ||| S&P 500 Movers: WHR, GLW ||| Dow Movers: JNJ, CAT ||| Caterpillar (CAT) and Halliburton (HAL): A Tale of Two Beats ||| Earnings Fuel Triple-Digit Gain for Dow Futures ||| Morning Movers: More Cuts For GE…and More Earnings Than You Can Shake a Stick At ||| Caterpillar's (CAT) Cost Discipline Drives Q3 Earnings Beat ||| After Hours Most Active for Oct 24, 2017 : T, BAC, CMCSA, GE, PG, HAL, CAT, FWONK, MDLZ, MSFT, CSCO, FITB ||| Earnings Fuel Dow To New Record High; 2 FANG Plays In Buy Zone ||| Caterpillar Soars On Blowout Q3 Earnings, Raised Guidance ||| Proto Labs (PRLB) to Post Q3 Earnings: What's in the Cards? ||| Dow Jones Soars Almost 200 Points to New Intraday High ||| Close Update: Dow Posts Industrial-Sized Gains on Upbeat Earnings ||| Earnings Reaction History: Caterpillar Inc, 60.0% Follow-Through Indicator, 3.4% Sensitive ||| Pre-Market Most Active for Oct 24, 2017 : REVG, CAT, GM, DB, BAC, FCAU, TVIX, AAPL, QQQ, YNDX, XIV, IONS ||| Dow Sets the Pace for a Winning Day on Wall Street ||| Dow Sets the Pace for a Winning Day on Wall Street ||| A Hot Dow Closes At New High; CAT, 3M, Polaris Score Big Gains ||| Notable Tuesday Option Activity: CAT, TLRD, DDD ||| Dow Storms Higher Led By 3M, Caterpillar; ATV Maker Blasts Off ||| Einhorn's Positions In HPE, Micron, Tempur Sealy Create Curious Volatility ||| 33 Stocks Moving In Tuesday's Mid-Day Session ||| From Cat Conference Call: Sees FY17 Sales $44B vs $42.94B Est. ||| Caterpillar On Conf. Call Says It Expects Material Costs To Put Pressure Moving Forward ||| Caterpillar Crushes Estimates With Q3 Beat And Raise ||| 14 Technical Levels Discussed On Tuesday's PreMarket Prep ||| Pre-Market Imbalance Update: GE 561K Shares To Sell, Ford 86K To Sell, Square 84K To Buy, BofA, AT&T 75K To Buy, GM 43K To Buy, Cat 33K To Buy ||| 30 Stocks Moving In Tuesday's Pre-Market Session ||| PreMarket Prep Outlook For Tuesday, Oct. 24 ||| Caterpillar Q3 Adj. EPS $1.95 vs $1.27 Est., Sales $11.41B vs $10.63B Est. ||| A Peek Into The Markets: U.S. Stock Futures Gain; McDonald's, General Motors Earnings In Focus ||| 12 Stocks To Watch For October 24, 2017 ||| Earnings Scheduled For October 24, 2017",0,0.4616057
2017-10-25,7438600.0,137.21000671386722,137.83000183105472,134.78999328613278,136.83999633789062,128.07476806640622,CAT,"Freeport-McMoRan Earnings Beat, But Stock Reverses ||| Top-Rated Stocks: Caterpillar Sees Composite Rating Climb To 98 ||| Astec (ASTE) Incurs Q3 Loss Due to Pellet Plant Charges ||| Dow Sells Off As Boeing, GE Weigh; Chance To Buy Small Caps? ||| Wednesday’s Vital Data: Advanced Micro Devices, Inc. (AMD), Sprint Corp (S) and Caterpillar Inc. (CAT) ||| Trade of the Day: Caterpillar Inc. Has Jumped Too Far ||| Why 2 Dow Stocks Shot Higher Tuesday ||| CAT Just Landed On Its Feet With An Across-The-Board Q3 Beat ||| 40 Biggest Movers From Yesterday",1,0.5041162
2017-10-26,5745400.0,136.8800048828125,138.24000549316406,136.85000610351562,136.94000244140622,128.16836547851562,CAT,"Blue Chips Stay Strong; Trucker At New High ||| Silgan (SLGN) Q3 Earnings Miss Estimates, Trims '17 Guidance ||| S&P Affirms Ratings On Cat; Raises Outlook From Negative To Stable ||| Pre-Market Imbalance Update: GE 365K Shares To Sell, AT&T 329K To Buy, Twitter 164K To Buy, Cat 78K To Sell, Square 63K To Buy, Bristol-Myers 49K To Sell, GM 38K To Sell, Alibaba 26K To Buy",1,0.48707336
2017-10-27,4064600.0,136.91999816894528,138.39999389648438,136.89999389648438,137.80999755859378,128.98263549804688,CAT,"S&P 500, Nasdaq Hit Highs As Amazon, Alphabet, Microsoft, 3M Jump, Celgene, Boeing Falter: Weekly Review",0,0.50091726
2017-10-30,3044500.0,137.30000305175778,137.80999755859378,136.47999572753906,136.49000549316406,127.74720764160156,CAT,"Why Caterpillar's Q3 Earnings Beat Was Just the Start of the Good News ||| Q3 Earnings Season: What We Know So Far ||| Bitcoin's Market Cap Is Larger Than These 5 Dow Components ||| US GDP Hits 3% Despite Twin Hurricanes: 5 Top Gainers ||| Top 3 Stocks for Retirees to Consider ||| Benzinga's Bulls And Bears Of The Past Week: Apple, Caterpillar, Tesla And More",0,0.49619266
2017-10-31,3988300.0,136.5,136.6199951171875,135.08000183105472,135.80000305175778,127.10139465332033,CAT,"TriMas (TRS) Meets Q3 Earnings, Beats Sales, Updates View ||| These 7 Dow Jones Stocks Could Sink the Index",1,0.4899451
2017-11-01,3629000.0,135.66999816894528,137.30000305175778,135.42999267578122,136.28999328613278,127.55999755859376,CAT,"Stevens Capital Management Lp Buys Boeing Co, Johnson & Johnson, TJX Inc, Sells Thermo ... ||| AGCO's Q3 Earnings Beat, Sales View Up on Solid Volumes ||| Terex (TEX) Beats Q3 Earnings by Wide Margin, Ups '17 View ||| Rockwell Automation (ROK) Shares Up on Emerson Bid Rejection ||| Notable Wednesday Option Activity: ETN, CAT, GWR",1,0.4896452
2017-11-02,2722600.0,136.41999816894528,136.99000549316406,135.69000244140622,136.47000122070312,127.72848510742188,CAT,"How to Play Advanced Micro Devices, Inc. Stock After Meltdown",1,0.51661
2017-11-03,2105400.0,136.47999572753906,136.94999694824222,136.36000061035156,136.6300048828125,127.8782196044922,CAT,"Mutual Fund Managers Like Foreign Stocks, U.S. Stocks If Taxes Are Cut ||| Top Ranked Momentum Stocks to Buy for November 3rd",1,0.4926714
2017-11-06,2780900.0,136.80000305175778,138.44999694824222,136.78999328613278,137.71000671386722,128.88905334472656,CAT,"Will Manitowoc Company Earnings Surprise the Markets the Way Caterpillar Did? ||| Boeing Co Stock Has Enough Oomph to Keep Rolling Higher ||| Manitowoc Co. Stock Popped 5.8% in October: What You Need to Know ||| One Put, One Call Option To Know About for Caterpillar ||| Caterpillar Inc. Stock Surged 8.9% in October: Here's What You Should Do",1,0.47919625
2017-11-07,3222100.0,137.80000305175778,138.89999389648438,136.66000366210938,138.80999755859378,129.91860961914062,CAT,"Small Caps Sag, But One Sector Shows Strength ||| Manitowoc's (MTW) Q3 Earnings Beat on Improved U.S Markets ||| Terex Corporation (TEX) Ex-Dividend Date Scheduled for November 08, 2017",0,0.44289863
2017-11-08,1933300.0,138.39999389648438,138.75,137.17999267578122,137.28999328613278,128.49594116210938,CAT,"Sealed Air (SEE) Q3 Earnings In Line, Maintains '17 EPS View ||| Columbus McKinnon Corporation (CMCO) Ex-Dividend Date Scheduled for November 09, 2017 ||| Calgon Carbon (CCC) Q3 Earnings Miss Estimates, Sales Beat",0,0.50676453
2017-11-09,2940300.0,136.44000244140622,136.75,134.64999389648438,135.33999633789062,126.6708755493164,CAT,"Industrial Giants Scored Big On Trump's China Visit — Or Did They? ||| Astec Industries, Inc. (ASTE) Ex-Dividend Date Scheduled for November 10, 2017 ||| Nasdaq Leads Early Dive, Intel Drags On Dow; This IPO Blasts Off ||| Tech-Heavy Asia Stocks Fall as Qualcomm Signs China Deal ||| Stocks Hit Hard, But Tech Leaders Steady; 5 Reasons To Keep Holding Apple",1,0.51363885
2017-11-10,2016900.0,135.08999633789062,136.88999938964844,135.07000732421878,136.47999572753906,127.73782348632812,CAT,"7 Reasons to Add Caterpillar (CAT) to Your Portfolio Now ||| Top Research Reports for Merck, UPS & Caterpillar",1,0.5215067
2017-11-13,1894100.0,135.52999877929688,136.55000305175778,134.8699951171875,136.52999877929688,127.7846450805664,CAT,"GE's New Dividend Yield Bodes Ill for Buyers ||| San Francisco Sentry Investment Group (ca) Buys Vulcan Materials Co, DowDuPont Inc, The Home ... ||| UPDATE: Caterpillar Says North America Machines Retail Sales For Period Ended Oct. Up 7% ||| Caterpillar Says World Machines Retail Sales For 3-Month Rolling Period Ended Oct. Up 19% ||| Retail Investors Keep Buying This Market",1,0.49232987
2017-11-14,3041300.0,138.0,138.1199951171875,136.47000122070312,137.53999328613278,128.72993469238278,CAT,"Dow Movers: GE, CAT ||| S&P 500 Leads Stocks Lower; Buffalo Wild, Advanced Auto Spike ||| Caterpillar October Sales Rise 19%: Machinery Stocks in Focus",0,0.49987692
2017-11-15,3746200.0,136.47999572753906,136.75999450683594,133.80999755859378,134.10000610351562,125.5102996826172,CAT,"Dow Movers: CAT, NKE ||| Manitowoc to Drive Margin Expansion on Strategic Initiatives ||| Ball Corporation (BLL) Down to Strong Sell on Dismal Trends ||| Terex (TEX) Taps Growth With Product & Backlog Strength ||| US Market Indexes Continue Losses on Wednesday ||| Market Close Report: NASDAQ Composite index closes at 6,706.21 down -31.66 points ||| Notable Wednesday Option Activity: DUK, CAT, CRM ||| Crude, Caterpillar Stock Send Dow Down Triple Digits ||| Nasdaq Down; Apple Back In Buy Zone; These 5 Top Stocks Thumb Nose At Dip",1,0.50045085
2017-11-16,2812900.0,135.47000122070312,137.41000366210938,135.10000610351562,136.36000061035156,127.6255111694336,CAT,"Caterpillar, Avon Products, JA Solar Holdings, Mesoblast and 21Vianet Group highlighted as Zacks Bull and Bear of the Day ||| Stock Market News For Nov 16, 2017 ||| How Caterpillar (CAT) Stock Stands Out in a Strong Industry ||| Reasons Why You Should Sell Astec (ASTE) Stock Right Now ||| Bull of the Day: Caterpillar (CAT) ||| Small Caps Up Big On Tax Plan; Can Cisco Follow Apple As A New Turnaround Play? ||| Can Caterpillar's Stock Continue to Soar?",0,0.47452247
2017-11-17,2312700.0,135.80000305175778,136.36000061035156,135.02000427246094,136.1300048828125,127.41024780273438,CAT,"Can Emerson's Latest Sweetened Takeover Bid Tempt Rockwell? ||| Why Caterpillar (CAT) Might Be a Diamond in the Rough ||| Dow Leads Early Losses; Nike, Tesla Rise; Foot Locker, Ross Stores Spike ||| Rockwell Automation (ROK) Stock Up on Emerson's Raised Offer ||| Bemis Rides on Restructuring Plan, Hurricane Effect a Woe",1,0.47886425
2017-11-20,2124000.0,136.44000244140622,137.80999755859378,136.25,136.91000366210938,128.14027404785156,CAT,Interesting May 2018 Stock Options for CAT,1,0.5143272
2017-11-21,2221400.0,137.77000427246094,138.0,137.16999816894528,137.60000610351562,128.78610229492188,CAT,Dow Analyst Moves: CAT,1,0.51468444
2017-11-22,4887500.0,138.22000122070312,138.41999816894528,137.19999694824222,138.00999450683594,129.16981506347656,CAT,Deere (DE) Tops Q4 Earnings & Sales on Rising Farm Market ||| Will Caterpillar Raise Its Dividend in 2018? ||| U.S. International Trade Commission Says It'll Investigate Allegations By Caterpillar That Wirtgen And Joseph Vogele AG Infringe On Its Patents,0,0.5089422
2017-11-24,944400.0,138.10000610351562,138.41999816894528,137.33999633789062,137.38999938964844,128.58953857421878,CAT,"Here's Why H&E Equipment (HEES) is a Solid Investment Choice ||| Tetra Tech vs. Donaldson: Facts, Figures & Growth Prospects ||| 5 Stocks to Buy Post-Machinery Industry's Solid Show in Q3 ||| Market Close Report: Historical high reached as NASDAQ Composite Index closes at 6,889.16. ||| Black Friday Headlines Help Stocks Cap Off Thanksgiving Week with a Win",0,0.5057536
2017-11-27,2585400.0,137.47000122070312,138.27000427246094,136.88999938964844,137.19000244140622,128.40237426757812,CAT,"Here's How Caterpillar Inc. Crushed It in 2017 ||| Caterpillar Inc. Is Ready to Roar Once More ||| Why Rockwell is Right to Reject Emerson's Takeover Attempts ||| The Zacks Analyst Blog Highlights: Avery Dennison, H&E Equipment Services, Terex, Caterpillar and Manitowoc Company ||| Why You Should Put Microsoft, 3M, CAT On Your Watch List Now",1,0.4865158
2017-11-28,2592700.0,137.50999450683594,139.0,137.27000427246094,138.99000549316406,130.08706665039062,CAT,Avery Dennison (AVY) Hits 52-Week High: What's Driving It? ||| Deere (DE) Hits 52-Week High on Strong Q4 & Upbeat FY18 View,0,0.49301454
2017-11-29,3098200.0,138.16999816894528,139.21000671386722,137.19999694824222,138.05999755859378,129.21662902832028,CAT,"6 Reasons to Add Terex (TEX) Stock to Your Portfolio Now ||| Hyster-Yale Materials Handling, Inc. (HY) Ex-Dividend Date Scheduled for November 30, 2017 ||| 3 Industrial Stocks to Buy As Tech Dips",1,0.5169272
2017-11-30,7507800.0,138.89999389648438,141.3300018310547,137.11000061035156,141.14999389648438,132.10870361328122,CAT,"The Zacks Analyst Blog Highlights: Caterpillar, Deere & Company, Manitowoc Company and Terex ||| Miller Industries, Inc. (MLR) Ex-Dividend Date Scheduled for December 01, 2017 ||| 3 Top Construction Machinery Stocks You Should Consider Buying Now ||| Axiom's Gordon Johnson Comments On Cat Following Report Exec At Industrials Conference Highlighted Caution On China: 'we think China slows though this year, and throughout 2018...CAT may already be seeing this' ||| Hearing Cat Exec At Credit Suisse Industrials Conference Highlighting Caution On Chinese Growth Heading Into '18",1,0.47926646
2017-12-01,5481600.0,141.60000610351562,142.39999389648438,138.3800048828125,141.52000427246094,132.45501708984378,CAT,Dover (DOV) Hits 52-Week High: What's Fueling the Stock?,0,0.4813358
2017-12-04,4922300.0,144.25,145.19000244140625,141.44000244140625,141.5,132.436279296875,CAT,"Better Buy: CalAmp Corp. vs. Cisco ||| These 3 Dow Stocks Have Entered Buy Zones ||| Noteworthy ETF Inflows: DVY, CME, CAT, ETR ||| Rockwell Automation (ROK) Buys Odos Imaging to Fortify CE ||| Deere (DE) Reinforces Construction Business with Wirtgen Buy ||| Zacks Industry Outlook Highlights: Caterpillar, Stanley Black & Decker, Deere, Roper Technologies and Rockwell Automation ||| Sonoco (SON) Maintains 2017 Outlook, Issues 2018 View ||| Premarket NYSE Opening Imbalance Update: Alibaba 113k Shares To Buy; BofA 406k To Buy; JP Morgan 64k To Buy; Goldman Sachs 25k To Buy; General Electric 80k To Buy; Caterpillar 50k To Buy; Square 28k To Buy; CVS 89K To Buy",0,0.48835602
2017-12-05,3884100.0,141.75,142.19000244140625,139.72999572753906,140.13999938964844,131.16340637207028,CAT,"Owens-Illinois (OI) Awarded Multi-Year Contract by Reed's ||| Deere (DE) Hits 52-Week High: What's Driving the Stock? ||| Coupa (COUP) Q3 Loss Narrower Than Expected, '18 Guidance Up ||| Emerson Fortifies Oil & Gas Foothold With Paradigm Buyout",1,0.4994751
2017-12-06,2881400.0,140.14999389648438,141.13999938964844,139.5,140.33999633789062,131.35057067871094,CAT,Sealed Air Hikes Prices in EMEA to Combat Escalating Costs ||| How and Why Deere & Company Stock Crushed It in November,1,0.52173305
2017-12-07,2977100.0,139.77999877929688,143.0,139.19000244140622,142.88999938964844,133.73725891113278,CAT,"Greif (GEF) Beats on Q4 Earnings & Sales, Issues FY18 View ||| Market Close Report: NASDAQ Composite index closes at 6,812.84 up 36.46 points ||| Tech Rally Drives Stocks Higher ||| Wall Street Advances With S&P 500 Snapping Four-Day Losing Skid",1,0.5036658
2017-12-08,2490100.0,143.8699951171875,144.32000732421875,142.92999267578125,143.86000061035156,134.64512634277344,CAT,CAT Crosses Above Average Analyst Target ||| Why the Dogs of the Dow Look Doomed for 2017,0,0.48554254
2017-12-11,1913500.0,144.6300048828125,144.7100067138672,143.47999572753906,143.77000427246094,134.56089782714844,CAT,Caterpillar Guilty of False Rail Repairs to Lift Revenues ||| Top-Performing Dow Stock Boeing Unloads Billions More On Investors,0,0.49194786
2017-12-12,3397100.0,144.0399932861328,144.8000030517578,143.2100067138672,143.4199981689453,134.23329162597656,CAT,"IWF, PEP, CELG, CAT: ETF Outflow Alert",1,0.52558756
2017-12-13,6486500.0,144.17999267578125,149.0500030517578,144.07000732421875,148.57000732421875,139.05342102050778,CAT,"Apple, Caterpillar Fuel Dow To Record; Bitcoin Euphoria Fading? ||| Wednesday's ETF with Unusual Volume: IWY ||| Small Caps And Dow Advance; Fed Decision Awaited ||| Dow Movers: AXP, CAT ||| CAT, Apple Drive Dow; Nasdaq Gets Traction Ahead Of Fed ||| Market Close Report: NASDAQ Composite index closes at 6,875.80 up 13.48 points ||| Close Update: Wall Street Advances With Dow Up Fifth Straight Day After Rate Hike ||| Caterpillar, Nike Lead Dow; Fed Raises Rates; 10-Year Treasury Yield Falls ||| Federal Reserve Gives Trump Tax Cuts A Green Light ||| Apple Up, This Bank Breaks Out; Take Some Profits In This Bitcoin ETF? ||| Dow Rides Fed Rate Hike to Fourth Straight Record Close ||| Caterpillar Inc. Maintains Dividend Rate At $0.78/Share ||| Hearing Goldman Raises Caterpillar To Street High Of $196/Share ||| Oppenheimer Out Positive On Cummins Via Caterpillar Sales Data Readout, Says Sales Trend Indicates Cont. growth Off Multi-Year Lows, Says Trend Remains Positive For Cummins ||| Cat 8-K Shows Global Rolling 3-Month Retail Sales Up 26% In Nov. ||| Barclays Initiates Coverage On Caterpillar with Overweight Rating ||| Benzinga's Top Upgrades, Downgrades For December 13, 2017 ||| Jim Cramer Shares His Thoughts On Johnson Controls And DR Horton",0,0.48395494
2017-12-14,4616900.0,148.85000610351562,149.0,145.8800048828125,146.27999877929688,136.91009521484378,CAT,"Daily Dividend Report: CNP, PK, PIR, CAT, EOG, XEL ||| Tax Bill: Corporate Winners and Losers ||| 3 Tech Giants to Trade With Complete Confidence into 2018 ||| The Vision Used by Self-Driving Cars Just Got a Major Upgrade ||| Greif (GEF) Poised to Benefit From Transformation Initiative ||| Caterpillar November Sales up 26%, Will the Momentum Sustain? ||| Play Earnings Beat With These 5 Top Stocks ||| Dow Snaps Winning Streak, Stocks Lower Amid Tax Bill Worries ||| Notable Thursday Option Activity: CAT, GS, SYMC ||| Barclays Constructs A Bullish Call On Caterpillar, CNH Industrial And Others ||| Caterpillar November Sales Up 26%, Will The Momentum Sustain?",1,0.537632
2017-12-15,7931700.0,147.35000610351562,147.83999633789062,145.49000549316406,146.69000244140625,137.29383850097656,CAT,"Zacks.com featured highlights: Caterpillar, Oshkosh, Arista Networks, NVIDIA and H&E Equipment Services ||| Douglas Dynamics, Inc. (PLOW) Ex-Dividend Date Scheduled for December 18, 2017",1,0.43987593
2017-12-18,3534800.0,147.75,149.80999755859375,146.8000030517578,149.77000427246094,140.17655944824222,CAT,"Benzinga's Weekly Bulls & Bears: Bitcoin, Ford, Lululemon, Nike And More ||| Here???s Why You Should Add Deere (DE) to Your Portfolio Now ||| Why Home Depot Inc Stock Is Finally Too Expensive ||| Greif Up 12% Post Q4 Earnings: Will the Trend Continue? ||| One Put, One Call Option To Know About for Caterpillar ||| US Market Indexes Gain on Monday ||| Hearing OTR Global Downgraded Caterpillar to Mixed",1,0.4930469
2017-12-19,3554100.0,149.89999389648438,151.08999633789062,148.52999877929688,150.91000366210938,141.24354553222656,CAT,"Caterpillar (CAT) Rides on Strong End Markets & Cost Control ||| AGCO Corp Scales 52-Week High: What's Driving the Stock? ||| Dow Gains 5,000 Points in 2017: 5 Stocks Leading the Rally ||| The Zacks Analyst Blog Highlights: Disney, Kraft Heinz, Caterpillar, Humana and Regeneron ||| 5 Top Ranked Machinery Stocks that More than Doubled the S&P",1,0.49910718
2017-12-20,3076000.0,151.92999267578125,152.60000610351562,150.6999969482422,152.52000427246094,142.7504119873047,CAT,"The Zacks Analyst Blog Highlights: Caterpillar, H&E Equipment Services, Komatsu, Manitowoc and Terex ||| 5 Industrial Stocks That Popped More Than 50% in 2017",1,0.50537527
2017-12-21,4017400.0,152.69000244140625,155.10000610351562,151.80999755859375,154.63999938964844,144.7345733642578,CAT,"Notable Thursday Option Activity: CAT, FDC, BOOT ||| 5 Dow Titans Going Vertical ||| CalAmp Delivers a Quarterly Beat on Telematics Strength ||| 5 Biggest Price Target Changes For Thursday",1,0.5073068
2017-12-22,2486400.0,154.77000427246094,155.8000030517578,153.9499969482422,155.75,145.77349853515625,CAT,"Lindsay's (LNN) Q1 Earnings Miss, Revenues Beat Estimates ||| 3 Top Infrastructure Stocks to Buy for Trump's 2018 $1 Trillion Plan ||| Market Close Report: NASDAQ Composite index closes at 6,959.96 down -5.40 points",1,0.5085856
2017-12-26,1870600.0,156.0399932861328,156.97999572753906,155.66000366210938,156.44000244140625,146.41932678222656,CAT,5 Top-Ranked Dow Stocks to Buy for 2018,1,0.554508
2017-12-27,2520500.0,156.94000244140625,157.69000244140625,156.30999755859375,157.52000427246094,147.43014526367188,CAT,Is General Electric Company Stock Finally Ready to Run MUCH Higher? ||| Alamo's Investment Appeal Rises on Solid Growth Potential ||| Implied Volatility Surging for Caterpillar (CAT) Stock Options,1,0.4912593
2017-12-28,4064000.0,157.94000244140625,158.64999389648438,157.22999572753906,158.4199981689453,148.27247619628906,CAT,"Terex (TEX) Scales 52-Week High: What's Driving the Stock? ||| Lindsay Rides on Irrigation Business, Commodity Prices Ail",0,0.50731933
2017-12-29,2616100.0,158.0500030517578,158.5,157.50999450683594,157.5800018310547,147.4862823486328,CAT,"Boeing, Caterpillar, Apple Lead The Top 5 Dow Stocks In 2017 ||| Industrial Select Sector SPDR Fund Experiences Big Outflow ||| Stocks Open To Tight Gains; This Dow Leader Up More Than 90% In 2017 ||| Lindsay (LNN) Secures Alex Fraser Bridge Contract Worth $14M",0,0.4936432
2018-01-02,5108400.0,158.3000030517578,159.38999938964844,156.02999877929688,157.0399932861328,146.9808807373047,CAT,"Where Will CalAmp Corp. Be in 5 Years? ||| 3 Top Dow Stocks of 2017: Are They Still Buys? ||| The Dow's 3 Best Stocks in 2017 ||| Wabash National Corporation (WNC) Ex-Dividend Date Scheduled for January 03, 2018 ||| Get Sweet Earnings Surprises With 5 Top Stocks ||| The Market In 5 Minutes: Oil's Strong Open, Cohen's Comeback, And A Look Back At 2017's Best And Worst Stocks",1,0.45555434
2018-01-03,4146100.0,157.0399932861328,157.49000549316406,155.39999389648438,157.27999877929688,147.20547485351562,CAT,"Zacks.com highlights: Caterpillar, Deckers Outdoor, HubSpot, Pioneer Natural Resources and Legg Mason ||| 5 Hot Big-Brand American Stocks to Buy in 2018 ||| Caterpillar Inc. Has Finally Reached a Top ||| iRobot Corp (IRBT) Poised to Grow on Solid Growth Drivers",1,0.47788507
2018-01-04,4865800.0,157.88999938964844,159.5800018310547,157.02000427246094,159.44000244140625,149.22714233398438,CAT,"The Zacks Analyst Blog Highlights: Caterpillar, Facebook, Morgan Stanley, Wal-Mart Stores and McDonald's ||| Dow 25,000: Chalk It Up to These 4 Stocks ||| The Benefits And Challenges Of Trading An IRA",1,0.48071593
2018-01-05,3945400.0,160.25999450683594,162.0500030517578,159.63999938964844,161.9600067138672,151.58572387695312,CAT,Manufacturing Activity on a High: 4 Industrial Stocks to Buy,1,0.53598356
2018-01-08,5929200.0,164.11000061035156,166.42999267578125,162.5500030517578,166.02999877929688,155.39501953125,CAT,"Barron's Picks And Pans: FedEx, Intel, Caterpillar And More ||| There Was More to Caterpillar Inc. Stock's 11.6% Jump in December Than You Might Know ||| Stock Indexes Calm, But Tesla Thrusts Higher ||| Tax Cuts Will Give This Dow Industrial 'Significant Upside': JPMorgan ||| Apogee Plans Restructuring, To Shut Down Viracon Glass Plant ||| Dow Movers: DIS, CAT ||| Will Strong Order Activity at Astec Offset Headwinds in Q4? ||| Notable ETF Inflow Detected - XLI, MMM, HON, CAT ||| Market Close Report: Historical high reached as NASDAQ Composite Index closes at 7,157.39. ||| Noteworthy Monday Option Activity: VZ, CAT, INTU ||| Indexes Bide Time Ahead Of Financial Earnings; FANGs Outperform ||| Dow Ends Lower; S&P, Nasdaq Still Perfect in 2018 ||| Caterpillar Stock Upgraded: What You Need to Know ||| 5 Top-Performing Blue-Chip Stocks to Buy in 2018 ||| 5 Biggest Price Target Changes For Monday ||| Caterpillar Remains 'Undervalued' After 75% Gain In 2017, Says JPMorgan ||| Benzinga's Top Upgrades, Downgrades For January 8, 2018 ||| The Market In 5 Minutes: Bitcoin ETFs, GoPro Downgrade, Nvidia Partners With Uber And Volkswagen ||| JP Morgan Upgrades Caterpillar to Overweight ||| JP Morgan Upgrades Caterpillar to Overweight from Neutral; Raises PT to $200 from $144 -Reuters",1,0.5005317
2018-01-09,4522900.0,166.3300018310547,167.41000366210938,165.08999633789062,166.42999267578125,155.76939392089844,CAT,"The Zacks Analyst Blog Highlights: 3M, Caterpillar, McDonald's, Procter & Gamble and Microsoft ||| Caterpillar at All-Time High, Spotlight on Industrial Stocks",0,0.47772366
2018-01-10,5478600.0,165.89999389648438,167.52999877929688,164.5,165.8699951171875,155.2452850341797,CAT,"Apogee (APOG) Hikes Dividend, Share Repurchase Authorization ||| 5 Best Stocks to Buy Ahead of Q4 Earnings Season ||| 2 Industries These Fools Are Watching for 2018 ||| Stocks Stumble As China Shift Rattles Global Markets; These 2 Airlines Jump ||| The 5 Best Dow Jones Stocks to Buy for 2018 ||| 5 Best Stocks to Buy Ahead of Q4 Earnings Season",1,0.5037289
2018-01-11,4199000.0,166.89999389648438,169.52999877929688,165.63999938964844,169.1999969482422,158.3619842529297,CAT,"Emerson's (EMR) Outlook Robust on Recent Acquisition Spree ||| The Zacks Analyst Blog Highlights: Denbury Resources, ProPetro, Texas Instruments, Caterpillar and Huntsman ||| Bulls In Charge As Indexes Head Higher; Small Caps, Oil Names Lead ||| Avery Dennison (AVY) Grows on Acquisitions as Costs Flare Up ||| Caterpillar (CAT) and Chevron (CVX): This Week's Growth and Income Stocks ||| A Strategy That Beat The S&P 500: Here Are Your 2018 'Dogs Of The Dow'",1,0.50846064
2018-01-12,4127900.0,169.99000549316406,170.6699981689453,169.22999572753906,170.3000030517578,159.3915252685547,CAT,"Caterpillar Forged Ahead in 2017: Can It Sustain the Thrust? ||| Stocks Up, Paycom Breaks Out; Time To Buy This Bitcoin ETF Again? ||| Big Banks Fire First Salvos Of Earnings Season, And Most Results Look Good ||| PreMarket Opening NYSE Imbalance Update: General Electric 553k Shares To Buy; Alibaba 89k Shares To Buy; Twitter 21k Shares To Buy; Ford 111k Shares To Sell ; Caterpillar 199k Shares To Buy; Verizon 50k Shares To Sell",0,0.47965726
2018-01-16,8530600.0,172.89999389648438,173.24000549316406,167.57000732421875,169.30999755859375,158.46493530273438,CAT,"Will Caterpillar (CAT) Crush Estimates at Its Next Earnings Report? ||| DVY, LMT, CME, CAT: ETF Outflow Alert ||| Manitowoc (MTW) Plans to Relocate Corporate Headquarters ||| 4 Blue-Chip Stocks to Buy in Q4 Earnings ||| 4 Blue-Chip Stocks to Buy in Q4 Earnings ||| 6 Dow Stocks That Should Drive These ETFs Higher ||| Notable Tuesday Option Activity: VLO, CAT, LOW ||| Greenlight's Q4 Letter Reveals Another Tough Quarter For David Einhorn ||| Dow Earnings: Analysts Expect Goldman Sachs Revenue Decline ||| The Breakout In Steel Stocks Were Forecasted In November ||| Upcoming Earnings: Bank Of America, Goldman Sachs And Morgan Stanley To Report This Week",0,0.4883908
2018-01-17,5571400.0,169.32000732421875,170.11000061035156,168.5,168.5,157.70680236816406,CAT,"Reminder - Caterpillar (CAT) Goes Ex-Dividend Soon ||| The Zacks Analyst Blog Highlights: Wells Fargo &, 3M, Caterpillar, McDonald's and Procter & Gamble ||| Earnings Preview: IBM to Report on Thursday, Strategic Imperatives in Focus",1,0.4884528
2018-01-18,4668800.0,169.3300018310547,170.75999450683594,168.08999633789062,168.8300018310547,158.01568603515625,CAT,"Caterpillar, Inc. (CAT) Ex-Dividend Date Scheduled for January 19, 2018 ||| Is the Options Market Predicting a Spike in Caterpillar (CAT) Stock? ||| 3 Growth Stocks That Could Put Facebook's Returns to Shame ||| 5 Top Stocks Powered by Beat Potential This Earnings Season ||| 6 Industrial Stocks Likely to Beat Estimates in Q4 ||| Benzinga's Top Upgrades, Downgrades For January 18, 2018 ||| Berenberg Initiates Coverage On Caterpillar with Buy Rating, Announces $200.00 Price Target",1,0.48890075
2018-01-19,5796700.0,169.6300048828125,170.4499969482422,168.61000061035156,170.41000366210938,160.2347412109375,CAT,Upcoming Netflix Earnings: Subscriber Growth And Price Hikes In Focus ||| 5 Biggest Price Target Changes For Friday,1,0.5306058
2018-01-22,3540900.0,170.32000732421875,170.91000366210938,168.47999572753906,170.88999938964844,160.68609619140625,CAT,"Dow Earnings: Big Expectations For Caterpillar And 3M ||| Why These 3 Winners Are Triggering This Sell Signal, But Not These Two ||| Will Improving End-Markets Aid Caterpillar's Q4 Earnings? ||| 5 Top Blue-Chip Earnings Charts to Watch ||| The Week Ahead: IPOs, Earnings, And FDA Actions Provide Catalysts ||| Upcoming Earnings: Verizon To Report Q4 Results Tomorrow Morning ||| How High And Long Can This CAT Jump? ||| Washington Shutdown Takes Center Stage, But Market Impact Only Slight So Far",0,0.5153501
2018-01-23,5036500.0,172.0,172.0500030517578,169.1999969482422,169.42999267578125,159.31326293945312,CAT,"How Caterpillar (CAT) Stock Stands Out in a Strong Industry ||| Factors That Are Likely to Impact Intel's (INTC) Q4 Earnings ||| Caterpillar Historically Favors Short Play off Earnings-Driven Pre-Market Moves ||| Notable Tuesday Option Activity: DPZ, CAT, ROK ||| Caterpillar Stock Upgraded: What You Need to Know ||| Earnings Preview: Dow Components General Electric And Caterpillar Take The Stage This Week",0,0.48985484
2018-01-24,8241000.0,171.39999389648438,172.4499969482422,167.6699981689453,168.33999633789062,158.28834533691406,CAT,"Pre-Market Earnings Report for January 25, 2018 : MMM, UNP, CAT, CELG, BIIB, RTN, NOC, PX, SHW, LUV, FCAU, AEP ||| Grainger (GWW) Q4 Earnings, Revenues Beat on Higher Volumes ||| Why Earnings Season Could Be Great for Caterpillar (CAT) ||| Intel, Starbucks, Biotechs Lead Earnings Rush: Investing Action Plan ||| Dow Leader Caterpillar Just Steamrolled Estimates Again ||| 3 Construction Stocks to Buy As U.S. Building Heats Up ||| Industrial Select Sector SPDR Fund Experiences Big Inflow ||| Like Old Times: GE And Ford Step Onto Stage While Dollar Looks Back To 2014 ||| Cat 8-K Shows Rolling 3-Month Retail Sales Up 34% Globally",1,0.5043854
2018-01-25,16937100.0,173.10000610351562,173.10000610351562,162.4600067138672,169.3699951171875,159.2568359375,CAT,"Stocks Inch Higher Amid Currency Volatility ||| Update: Wall Street Ends Mostly Higher as Dow Climbs Fourth Day in Five ||| Dow Up, Nasdaq Stalls, Chip Stocks Reverse Badly; Sell Apple Now? ||| Stocks Finished Mixed as Trump Defends Dollar ||| Mid-Afternoon Market Update: Key Technology Gains On Acquisition News; Newell Brands Shares Drop ||| Dow Leads On These Stocks; This New Breakout Comes With Caveats ||| Mid-Afternoon Market Update: Key Technology Gains On Acquisition News; Newell Brands Shares Drop ||| A Look At Caterpillar's Odd Volatility Thursday ||| Mid-Day Market Update: Dow Surges Over 100 Points; Horizon Global Shares Plunge ||| Caterpillar CFO Says They Expect Slightly Favorable Price Realization To Be Mostly Offset By Unfavorable Material Costs Driven By Higher Commodity Prices ||| Mid-Morning Market Update: Markets Mostly Higher; Caterpillar Earnings Beat Expectations ||| 26 Stocks Moving In Thursday's Pre-Market Session ||| Cat Financial Reports Q4 Sales $678M vs $642M In Prior Year Period, Profit Before Income Taxes Of $133M ||| Caterpillar Sees FY18 Adj. EPS $8.25-$9.25 vs $8.19 Est. ||| Caterpillar Reports Q4 Adj. EPS $2.16 vs $1.79 Est., Sales $12.9B vs $11.98B Est. ||| A Peek Into The Markets: U.S. Stock Futures Gain Ahead Of Earnings, Economic Data ||| 12 Stocks To Watch For January 25, 2018 ||| Earnings Scheduled For January 25, 2018",0,0.48836127
2018-01-26,9045300.0,168.80999755859375,169.0,164.5500030517578,167.05999755859375,157.08477783203125,CAT,Slowing Down? Economy Brakes Slightly In Q4 But Earnings Keep Impressing,0,0.50900465
2018-01-29,9496800.0,165.5800018310547,165.8800048828125,159.4199981689453,162.5800018310547,152.87229919433594,CAT,"Is CalAmp Corp. a Buy? ||| AGCO Rewards Shareholders With 7% Quarterly Dividend Hike ||| Midday Update: Wall Street Weighed By Apple, Lack of Progress on NAFTA ||| Top Stock Picks for the Week of Jan 29, 2018 ||| Bull of the Day: Caterpillar (CAT) ||| Market Close Report: NASDAQ Composite index closes at 7,466.51 down -39.26 points ||| Close Update: Wall Street Retreats With Dow Halting Three-Day Winning Streak",1,0.47806218
2018-01-30,8694800.0,160.3300018310547,164.7100067138672,159.80999755859375,163.75999450683594,153.9818115234375,CAT,"Caterpillar Gets a Leg or Two Up With a Winning Quarter ||| Pentair (PNR) Q4 Earnings Meet Estimates, Provides '18 View ||| Market Close Report: NASDAQ Composite index closes at 7,402.48 down -64.03 points ||| Dow Suffers Worst Day Since May ||| 5 Dividend Aristocrats Where Analysts See Capital Gains",0,0.47239104
2018-01-31,7014000.0,164.6999969482422,165.7899932861328,161.88999938964844,162.77999877929688,153.06036376953125,CAT,"A Very Strong Earnings Picture ||| What to Expect From Caterpillar Inc. in 2018 ||| Notable Wednesday Option Activity: TXT, NVDA, CAT ||| A Very Strong Earnings Picture ||| The Case for Investing in Industrial Stocks",0,0.49781808
2018-02-01,4323600.0,161.24000549316406,163.74000549316406,160.17999267578125,162.24000549316406,152.55259704589844,CAT,"Zacks Earnings Trends Highlights: Citigroup, Caterpillar, Apple and General Electric ||| Caterpillar (CAT) & Air Products (APD): Growth and Income Stocks ||| There's a Big Problem with ""Synchronized Global Growth"" ||| Argus Maintains Buy on Caterpillar, Raises Price Target to $185.00",0,0.49072278
2018-02-02,7602800.0,160.77000427246094,160.8000030517578,156.52999877929688,157.49000549316406,148.0862274169922,CAT,"Bemis (BMS) Q4 Earnings Top, Agility Plan to Drive Growth ||| The Zacks Industry Rank Highlights: Caterpillar and H&E Equipment Services",0,0.5030474
2018-02-05,11390500.0,154.92999267578125,158.92999267578125,142.85000610351562,151.0800018310547,142.0589599609375,CAT,"Dover (DOV) Rides on Acquisitions, Leaner Portfolio Strategy",1,0.51001227
2018-02-06,13908700.0,148.07000732421875,156.55999755859375,146.80999755859375,156.41000366210938,147.0706787109375,CAT,3 Growth Stocks for Forward-Looking Investors ||| TD Ameritrade Investors Had A Record-Breaking January ||| Investor Movement Index January Summary,0,0.5297061
2018-02-07,7156500.0,155.36000061035156,158.08999633789062,154.27999877929688,154.33999633789062,145.12429809570312,CAT,"Micron Technology, Inc. Stock Is Still Undervalued ||| Dow Analyst Moves: CAT ||| Columbus McKinnon Corporation (CMCO) Ex-Dividend Date Scheduled for February 08, 2018 ||| The Math Shows EDOW Can Go To $24 ||| Standout Features of the Q4 Earnings Season ||| Standout Features of the Q4 Earnings Season ||| Noteworthy Wednesday Option Activity: CAT, BG, IRBT",0,0.48278698
2018-02-08,9101900.0,153.85000610351562,154.19000244140625,145.9199981689453,145.99000549316406,137.27290344238278,CAT,"The Zacks Analyst Blog Highlights: Wells Fargo, Caterpillar, Schlumberger, Vertex and Republic Services",1,0.50666356
2018-02-09,9528100.0,148.7100067138672,150.88999938964844,142.8800048828125,149.2100067138672,140.30059814453122,CAT,"Industrial Select Sector SPDR Fund Experiences Big Outflow ||| Zacks Earnings Trends Highlights: Citigroup, Caterpillar and General Electric",1,0.50521713
2018-02-12,5756800.0,151.8699951171875,153.4499969482422,150.25,152.2899932861328,143.1967010498047,CAT,Deere & Co. reports first-quarter numbers February 16 ||| Bemis Poised to Benefit From U.S. Tax Reform & Agility Plan ||| 15 Industrial Stocks That Can Manufacture Gains in 2018 ||| Terex Pleases Investors With 25% Quarterly Dividend Hike ||| Trump's Infrastructure Plan: What You Should Know,1,0.50044084
2018-02-13,5512100.0,151.25,155.1999969482422,151.0,153.97000122070312,144.77638244628906,CAT,Caterpillar 8-K Shows Global Rolling 3-Month Retail Sales Up 34% In Jan.,1,0.5334776
2018-02-14,5560100.0,152.38999938964844,158.58999633789062,152.33999633789062,158.05999755859375,148.62217712402344,CAT,"Terex's (TEX) Q4 Earnings & Revenues Top Estimates, Up Y/Y ||| Caterpillar January Sales up 34%: Will the Momentum Sustain? ||| Q4 Earnings Season Scorecard ||| Q4 Earnings Season Scorecard ||| Top Research Reports for ExxonMobil, Caterpillar & Union Pacific ||| Cramer Looks At The Dow's Biggest Losers",1,0.5088047
2018-02-15,4914500.0,159.8000030517578,160.33999633789062,157.47999572753906,159.97999572753906,150.4275360107422,CAT,"Zacks Earnings Trends Highlights: Citigroup, Caterpillar and General Electric ||| Notable Thursday Option Activity: CAT, RHT, EQIX ||| Caterpillar Is 'Vigorously Contesting' Proposed Increasese To Tax, Penalties For Audit Period Of ~$2.3B ||| Caterpillar Filing Shows On Jan. 31st, Co. Received Agent's Report From IRS Indicating End Of Field Exam Of U.S. Incom3 Tax Returns For 2010-2012",0,0.50754917
2018-02-16,5991600.0,160.1300048828125,161.0,156.08999633789062,156.2899932861328,146.9578399658203,CAT,"Close Update: Wall Street Pares Gains But Markets Post First Weekly Advance in Three ||| Nibble on Caterpillar Inc. Stock While the Market Frowns ||| Deere Earnings Top Views, Sales Fall Short ||| Dow 30 Stock Roundup: Cisco Beats, Caterpillar January Sales up 34% ||| Stocks Wrap Up Best Week in Years ||| 5 Hot Stocks Leading the Dow ETF Rebound ||| Market Close Report: NASDAQ Composite index closes at 7,239.47 down -16.96 points",0,0.48720947
2018-02-20,5094600.0,155.1699981689453,158.25,154.27000427246094,155.55999755859375,146.2714385986328,CAT,"Deere & Company Reaps the Harvest of Growing Demand ||| XLI, CAT, LMT, UPS: Large Outflows Detected at ETF ||| Terex (TEX) Poised Well on Segment Growth & Backlog Strength",0,0.51343936
2018-02-21,4179400.0,155.6999969482422,158.39999389648438,155.0399932861328,155.22999572753906,145.96115112304688,CAT,"Dow Movers: GE, MCD ||| Astec's (ASTE) Q4 Earnings Miss Estimates, Revenues Beat ||| Milacron (MCRN) Q4 Earnings, Revenues Top on Strong Orders ||| Lincoln Electric Rides on Strong Markets, Welding Automation",1,0.5067153
2018-02-22,4723300.0,156.41000366210938,159.77999877929688,156.1999969482422,158.86000061035156,149.37440490722656,CAT,"Dow Movers: V, UTX ||| There's One Big Problem with 'Synchronized Global Growth'",1,0.5188318
2018-02-23,4450800.0,159.39999389648438,162.47999572753906,159.22000122070312,162.41000366210938,152.7124481201172,CAT,Is Caterpillar Inc. (CAT) a Buy? ||| The Key Takeaway From Caterpillar's Earnings ||| Milacron (MCRN) Rides on Rising Demand Despite Rising Costs ||| Podcast: There's One Big Problem With 'Synchronized Global Growth',1,0.5128191
2018-02-26,6254400.0,163.0500030517578,164.0500030517578,161.5500030517578,163.69000244140625,153.91600036621094,CAT,7 Reasons that Make Grainger (GWW) a Solid Investment Choice ||| Why Is Caterpillar (CAT) Down 4.1% Since its Last Earnings Report?,0,0.5079111
2018-02-28,7298600.0,161.5,162.33999633789062,154.1699981689453,154.6300048828125,145.39697265625,CAT,"Best Earnings Season in Years ||| Best Earnings Season in Years ||| Market Close Report: NASDAQ Composite index closes at 7,273.01 down -57.34 points ||| Dow, S&P Snap Longest Monthly Win Streak in Decades",0,0.5128127
2018-03-01,9434800.0,153.6699981689453,156.19000244140625,148.50999450683594,150.22999572753906,141.2596893310547,CAT,"3 Naked Puts on Blue-Chip Stocks ||| 9 Stocks to Buy Instead of Bitcoin ||| Dow Movers: CAT, XOM ||| Close Update: Wall Street Skids to Third Day of Losses as Trump Tariffs Spark Trade Fears ||| Zacks Earnings Trends Highlights: Citigroup and Caterpillar ||| 5 Mega-Cap Put Option Plays to Consider Now ||| Caterpillar Poised For a Better 2018 on Rising Mining Spend",0,0.5106391
2018-03-02,9509400.0,149.1300048828125,149.8800048828125,145.86000061035156,146.3800048828125,137.63958740234378,CAT,"Dow Opens 200 Points Lower, McDonald's (MCD) Leads Early Losses ||| Stocks Suffer Weekly Losses Amid Trade War Speculation ||| Trump to Slap Tariffs on Steel Imports, Trade War Fears Loom ||| Noteworthy Friday Option Activity: TWX, CAT, GS ||| Midday Update: Wall Street Rattled By Risks of Trade War ||| Analyst Picks: 2 Heavy Industry Stocks to Buy, and 1 to Sell ||| Vetr Crowd Upgrades Caterpillar ||| Morgan Stanley Overweight On WABCO, Deere, Caterpillar, United Rentals Among Machinery Stocks ||| Benzinga's Top Upgrades, Downgrades For March 2, 2018 ||| Morgan Stanley Initiates Coverage On Caterpillar with Overweight Rating, Announces $185.00 Price Target",1,0.4952722
2018-03-05,8453000.0,145.14999389648438,151.86000061035156,144.00999450683594,151.1199951171875,142.09654235839844,CAT,"Close Update: Wall Street Surges With Dow Snapping Four-Day Slide as Trade War Fears Ebb ||| Market Close Report: NASDAQ Composite index closes at 7,330.70 up 72.83 points ||| Wall Street Surges With Dow Snapping Four-Day Slide as Trade War Fears Ebb ||| Dow Snaps Four-Day Slide, Finishes Over 330 Points Higher",1,0.5063163
2018-03-06,5795600.0,152.63999938964844,154.97999572753906,151.6699981689453,153.75,144.5695343017578,CAT,"Stock Market News For Mar 6, 2018 ||| Reasons to Add Milacron (MCRN) Stock to Your Portfolio Now ||| Notable Tuesday Option Activity: GOOG, CAT, C",0,0.48002762
2018-03-07,5491000.0,150.0,152.27000427246094,148.80999755859375,151.50999450683594,142.46327209472656,CAT,"A Very Positive Earnings Picture ||| A Very Positive Earnings Picture ||| Terex Corporation (TEX) Ex-Dividend Date Scheduled for March 08, 2018 ||| Cash In On Earnings Beat With These 5 Top Stocks",1,0.48604205
2018-03-08,4105000.0,151.72999572753906,153.97000122070312,150.2899932861328,153.58999633789062,144.41908264160156,CAT,"Industrial Select Sector SPDR Fund Experiences Big Outflow ||| Astec Industries, Inc. (ASTE) Ex-Dividend Date Scheduled for March 09, 2018 ||| Zacks.com featured highlights include: Caterpillar, Cinemark, Healthways, Boeing and Concho",1,0.4768996
2018-03-09,4576700.0,155.1199951171875,158.4199981689453,154.3300018310547,158.25,148.8008270263672,CAT,"Dow Movers: VZ, CAT ||| CAT or DE: Which Industrial Stock to Bet on Post Earnings? ||| Steel Stocks Slide as Trump Softens Tariff Stance Amid Criticism",0,0.51941776
2018-03-12,4880400.0,158.24000549316406,159.33999633789062,153.85000610351562,154.5,145.2747344970703,CAT,Markets Now: Dow Drops 150 Points But Thankfully It's Not the Market ||| Astec (ASTE) Rides on Solid Backlog Despite Recent Headwinds ||| Close Update: Dow Slides as Industrials Face Impact of Higher Steel ||| Manitowoc's (MTW) Results to Bear the Brunt of Steel Tariff ||| Dow Surrenders Opening Gains as Boeing and Caterpillar Undermined by Steel Tariffs,0,0.4898241
2018-03-13,4819100.0,156.3000030517578,157.8699951171875,153.1999969482422,153.69000244140625,144.51312255859375,CAT,"Dow Movers: GE, INTC ||| Machinery Stocks to Bear the Brunt of Trump's Tariff Plan",0,0.49171022
2018-03-14,4873600.0,154.8000030517578,155.25,151.30999755859375,152.5399932861328,143.43177795410156,CAT,6 Cheap Blue-Chip Stocks to Buy Now,1,0.5446997
2018-03-15,5268800.0,153.17999267578125,155.58999633789062,151.64999389648438,154.57000732421875,145.34056091308594,CAT,"Miller Industries, Inc. (MLR) Ex-Dividend Date Scheduled for March 16, 2018",1,0.44495842
2018-03-16,10897600.0,154.32000732421875,157.4499969482422,153.30999755859375,156.4600067138672,147.1177215576172,CAT,"XLI, MMM, UNP, CAT: ETF Inflow Alert ||| U.S. Manufacturing Activity Holds Up Well: 5 Solid Buys ||| Stock Market News for March 16, 2018 ||| Midday Update: Strong Consumer Confidence Overshadows Political Turmoil",0,0.5080339
2018-03-19,5479200.0,154.24000549316406,154.8300018310547,150.82000732421875,152.14999389648438,143.06504821777344,CAT,"Dow Movers: CAT, NKE ||| Actuant (ATU) to Post Q2 Earnings: What's in the Offing? ||| Caterpillar to Shut Facilities, Layoff 880 Jobs to Cut Costs ||| Bemis Inks Agreement With Starboard to Appoint New Directors ||| Market Close Report: NASDAQ Composite index closes at 7,344.24 down -137.75 points ||| Dow Drops 335 Points, VIX Soars as Facebook Leads Tech Nosedive",1,0.52448237
2018-03-20,3557600.0,153.0,155.1999969482422,152.5399932861328,154.05999755859375,144.8610076904297,CAT,"Dow Movers: GE, CAT ||| Douglas Dynamics, Inc. (PLOW) Ex-Dividend Date Scheduled for March 21, 2018 ||| Battered Facebook Inc Drags Down the Nasdaq Composite ||| Close Update: Stocks Bounce Back as Energy and Industrials Buoy Wall Street",1,0.47719938
2018-03-22,8225600.0,152.8699951171875,153.5,146.25,146.89999389648438,138.12850952148438,CAT,"Dow Movers: BA, KO ||| 5 Top Stocks to Tap Earnings Beat Potential ||| Market Close Report: NASDAQ Composite index closes at 7,166.68 down -178.61 points ||| Stocks Crater Amid Trade War Tensions, Tech Sell-Off ||| Close Update: Stocks Plunge as Tariff Turmoil Sends Dow Skidding to Six-Week Lows",0,0.48746055
2018-03-23,6533100.0,147.6999969482422,148.57000732421875,143.7899932861328,144.2899932861328,135.67436218261722,CAT,"Zacks.com featured highlights include: Caterpillar, athenahealth, Antero, Pioneer and Concho",1,0.4939423
2018-03-26,5454900.0,147.82000732421875,149.55999755859375,145.25999450683594,149.19000244140625,140.28181457519528,CAT,"Why Manufacturing Stocks Soared During Trump's First Year in Office ||| Stock Market News For Mar 26, 2018 ||| Trade War Averted? Talks Between China And U.S. Raise Hopes",0,0.49366987
2018-03-29,4209400.0,146.2100067138672,148.77000427246094,145.57000732421875,147.3800048828125,138.57992553710938,CAT,"The Zacks Analyst Blog Highlights: Johnson & Johnson, Intel, Procter & Gamble, Caterpillar and Halliburton ||| Noteworthy Thursday Option Activity: JPM, CAT, REGN",0,0.49220157
2018-04-02,5397500.0,146.44000244140625,147.35000610351562,141.75999450683594,143.88999938964844,135.29826354980472,CAT,February construction spending to impact Caterpillar ||| Midday Update: Wall Street Carnage Triggered by Chinese Trade Tariffs; S&P 500 Breaches Key Support ||| 5 Dividend Aristocrats Where Analysts See Capital Gains ||| 10 Stocks at Serious Risk of a Meltdown ||| The Best Sector ETFs For April: Looking For A Rebound,1,0.50107986
2018-04-03,4845700.0,144.8000030517578,145.64999389648438,142.3800048828125,145.05999755859375,136.39842224121094,CAT,"Is Deere & Company Stock a Buy Now? 3 Pros, 3 Cons ||| Bullish on Caterpillar? You'll Love These 2 Stocks ||| Wabash National Corporation (WNC) Ex-Dividend Date Scheduled for April 04, 2018 ||| 4 Dow Titans That Could Slap the Mat",1,0.48474878
2018-04-04,6188200.0,139.8800048828125,145.4600067138672,138.05000305175778,145.17999267578125,136.51123046875,CAT,"IYJ, UTX, ACN, CAT: ETF Outflow Alert ||| Why the Best Is Yet to Come for Caterpillar ||| Close Update: Wall Street Rallies Back as Trade War Fears Subside",1,0.492601
2018-04-05,4584800.0,146.50999450683594,148.8800048828125,146.47000122070312,148.1300048828125,139.28512573242188,CAT,"Markets Now: Stocks Trim Their Gains, Still Up Solidly ||| Zacks Industry Outlook Highlights: Caterpillar, ABB, Illinois Tool Works, Deere and Stanley Black & Decker ||| 7 Stocks to Buy That Are Leading the Way Higher",0,0.48326078
2018-04-06,5707400.0,145.77000427246094,147.0,140.82000732421875,142.99000549316406,134.45204162597656,CAT,"Dow Movers: CAT, PG ||| Market Close Report: NASDAQ Composite index closes at 6,915.11 down -161.44 points ||| All 30 Dow Stocks End Lower on China Trade Turmoil ||| Close Update: Wall Street Snaps Three-Day Winning Streak as Trade Woes Resurface ||| 7 Reasons Why a U.S.-China Trade War Is Unlikely ||| 10 Stocks to Buy on Any Trade War Dip ||| Notable Friday Option Activity: BA, CAT, WYNN",1,0.49508798
2018-04-09,4050800.0,144.8000030517578,146.7899932861328,142.8000030517578,143.0800018310547,134.53662109375,CAT,"A Little (Much-Needed) Perspective on China, Tariffs and Trade War Mania ||| Stock Market News For Apr 9, 2018 ||| Worried About A Trade War? Consider Cramer's Hedge Trades",1,0.4910003
2018-04-10,3991600.0,146.75,149.00999450683594,145.6199951171875,148.08999633789062,139.24746704101562,CAT,Futures Rally As China's Xi Pledges More Open Economy,0,0.5109551
2018-04-11,3218900.0,146.67999267578125,148.35000610351562,146.32000732421875,146.7899932861328,138.02510070800778,CAT,"Benzinga's Top Analyst Calls From April 11, 2018 ||| Buckingham: Caterpillar Set To Deliver 30% EPS Growth This Year ||| Caterpillar Inc. Maintains Dividend Rate At $0.78/Share ||| Benzinga's Top Upgrades, Downgrades For April 11, 2018 ||| Buckingham Initiates Coverage On Caterpillar with Buy Rating, Announces $170.00 Price Target",1,0.5176014
2018-04-12,3958000.0,147.63999938964844,151.16000366210938,147.63999938964844,150.13999938964844,141.17510986328125,CAT,Analysts See 15% Gains Ahead For The Holdings of JKF,1,0.528015
2018-04-13,3603200.0,151.75,152.91000366210938,148.99000549316406,150.22999572753906,141.2596893310547,CAT,"Dow Movers: BA, GE ||| Better Buy: CalAmp Corp. vs. General Electric ||| An Early Preview of Caterpillar's (CAT) Q1 Earnings Outlook ||| Notable Friday Option Activity: GTES, CAT, DVMT",1,0.49185872
2018-04-16,3055600.0,151.74000549316406,153.4199981689453,150.27999877929688,152.13999938964844,143.05564880371094,CAT,"VYM, QCOM, CAT, LLY: Large Outflows Detected at ETF ||| What's in the Cards for Pentair (PNR) This Earnings Season? ||| Upcoming Earnings: Johnson & Johnson And IBM Are Scheduled To Report This Week ||| Benzinga's Bulls & Bears Of The Week: Caterpillar, Facebook, Starbucks, Tesla And More",1,0.50087416
2018-04-18,3087100.0,155.19000244140625,157.1199951171875,154.57000732421875,155.9499969482422,146.63815307617188,CAT,Cash Dividend On The Way From Caterpillar (CAT) ||| Markets Now: Dow Dips 15 Points as S&P 500 Looks to Go 3 for 3,0,0.48606172
2018-04-19,4013200.0,155.38999938964844,156.32000732421875,153.9600067138672,155.6999969482422,146.40310668945312,CAT,"Caterpillar, Inc. (CAT) Ex-Dividend Date Scheduled for April 20, 2018 ||| The Zacks Analyst Blog Highlights: UnitedHealth, Netflix, Caterpillar, M&T Bank and Infosys ||| Can Caterpillar (CAT) Retain Its Beat Streak in Q1 Earnings? ||| Valmont's (VMI) Q1 Earnings and Revenues Beat Estimates ||| Upcoming Earnings: Industrial Conglomerate GE Reports Friday Morning",0,0.44549525
2018-04-20,4057800.0,155.25,156.13999938964844,152.3699951171875,153.25,144.82489013671875,CAT,"Will iRobot (IRBT) Beat Q1 Earnings on Strong Robotic Sales? ||| Crown Holdings' (CCK) Q1 Earnings & Revenues Beat, View Up ||| 5 Big-Brand American Stocks to Sail Through an Edgy Market ||| 5 Big-Brand American Stocks to Sail Through an Edgy Market",1,0.5095736
2018-04-23,5350300.0,154.64999389648438,155.74000549316406,152.17999267578125,153.99000549316406,145.52423095703125,CAT,"Morgan Stanley: 11 High-Conviction Stocks To Watch This Earnings Season ||| Shorts See Better History Trading Caterpillar in Wake of Pre-Bell Earnings Moves ||| Can Higher Climate Revenues Buoy Ingersoll (IR) Q1 Earnings? ||| Machinery Stocks' Apr 24 Earnings Roster: CAT, IRBT & More ||| Q1 Earnings, 10-Year Yield Heating Up ||| Sonoco (SON) Tops Q1 Earnings & Sales Estimates, Lifts View ||| 10-Year Treasury Yield is Around 3%: Should You Care? ||| Will Solid Order Levels Drive Milacron's (MCRN) Q1 Earnings? ||| Alphabet, Caterpillar, Facebook, Amazon and Exxon are part of Zacks Earnings Preview ||| Why Caterpillar (CAT) Might Surprise This Earnings Season ||| The Zacks Analyst Blog Highlights: Caterpillar, Mastercard, Goldman, Boeing and Amazon.com ||| Should You Buy Caterpillar (CAT) Stock Ahead of Q1 Earnings? ||| Stocks Finish Lower as Treasury Yield Edges Near 3% ||| Pre-Market Earnings Report for April 24, 2018 : VZ, KO, MMM, LMT, UTX, CAT, LLY, NEE, BIIB, TRV, SHW, FCX ||| Notable Monday Option Activity: CAT, HAS, DHI ||| Cat 8-K Shows Global Rolling 3-Month Retail Sales For Mar. Up 26% ||| Earnings Preview: Verizon And AT&T Report Q1 Results This Week ||| Upcoming Earnings: CAT, LLY And BA Report This Week ||| The Week Ahead: Sohn Conference, FANG Earnings, DocuSign IPO ||| Benchmark Nears Benchmark: 10-Year Close To 3% Ahead Of Earnings Deluge ||| Benzinga's Top Upgrades, Downgrades For April 23, 2018 ||| Citigroup Upgrades Caterpillar to Buy",0,0.51510954
2018-04-24,24122300.0,159.75,161.10000610351562,143.36000061035156,144.44000244140625,136.49925231933594,CAT,"Midday Update: U.S. Stocks Losing Ground as Yields Resume March Higher ||| Caterpillar Inc. Management Confirmed Its Outlook — Build Your Profits ||| Owens-Illinois (OI) Beats on Q1 Earnings & Sales, Keeps View ||| Caterpillar Inc. Stock Up on Q1 Earnings Beat ||| Caterpillar (CAT) Gains on Q1 Earnings Beat, Hikes '18 View ||| Will Labor Shortages Mar Fortune Brands' (FBHS) Q1 Earnings? ||| Zacks.com featured highlights include: Caterpillar, Boeing, WellCare, BlackBerry and Amazon ||| Wall Street Rebounds as Treasury Yields Recede, Earnings Top Estimates ||| Caterpillar Beats Earnings, Stock Gets Pummeled. Why? ||| Pre-Market Most Active for Apr 24, 2018 : TVIX, QQQ, WFT, TRN, LYG, BP, SHPG, CAT, SNE, ERIC, AAPL, SQQQ ||| Caterpillar (CAT) Beats on Q1 Earnings & Revenues Estimates ||| Markets Now: Dow Drops 481 Points as Market Searches for Meaning ||| Earnings Reaction History: Caterpillar Inc, 54.5% Follow-Through Indicator, 3.5% Sensitive ||| What Happened in the Stock Market Today ||| Dow Logs Longest Losing Streak in a Year ||| Close Update: Wall Street Sinks With Dow at Two-Week Low on Downbeat Earnings, Rising Yields ||| Benzinga Pro's Most-Searched Tickers For Afternoon Of Tues., Apr. 24, 2018 ||| 32 Stocks Moving In Tuesday's Mid-Day Session ||| Cat Shares Now Down 4.5% For Session; Had Traded Up As Much As 4.6% Earlier ||| From Cat Q1 Earnings Conference Call: Expecting Q1 To Be The 'High Water Mark' For This Year ||| Cat Shares Drop To Intraday Lows, Up 0.3% For Session; Shares Down 2.3% Since Start Of Conference Call At 11 a.m. EDT ||| From Cat Q1 Earnings Call: Sees Material Cost Increases This Year Higher Than Est. In Dec. Qtr. Outlook, Cites Higher Steel Prices ||| Caterpillar Says it Sees $1B to $1.5B of CAPEX for the Foreseeable Future ||| Bond Yield Rise Pauses, Dow Futures Get A Bit of Help From Some Earnings ||| 28 Stocks Moving In Tuesday's Pre-Market Session ||| Cat Raises FY18 Adj. EPS Outlook From $8.25-$9.25 as Of Jan. 25, '18 To $10.25-$11.25 vs $9.17 Est. ||| Cat Q1 Adj. EPS $2.82 Beats $2.08 Est., Sales $12.86B Beats $11.98B Est. ||| 12 Stocks To Watch For April 24, 2018 ||| Earnings Scheduled For April 24, 2018",1,0.47590736
2018-04-25,9963700.0,143.8300018310547,147.60000610351562,142.16000366210938,145.19000244140625,137.20799255371094,CAT,"Boeing’s Pricing Power Outweighs the China Risk ||| AT&T, eBay, & Visa All Set to Top Earnings Estimates Today ||| Midday Update: Dow on Course For Longest Losing Streak in a Year as Investors Rotate Into Bonds ||| SPDR KBW Regional Banking (ETF) Is Soaring as the 10-Tear Taps 3% ||| 3 Picks for A Stock Picker's Market ||| Dow Analyst Moves: CAT ||| U.S. Market Averages Mixed as Earnings Take Center Stage; S&P 500 Flirts With 200-Day MA ||| Q1 Earnings: BA, NOC & More ||| Rockwell Automation (ROK) Tops on Q2 Earnings, Hikes Outlook ||| Avery Dennison (AVY) Q1 Earnings & Sales Beat Estimates ||| Astec (ASTE) Beats on Q1 Earnings, Misses Sales Estimates ||| Wednesday’s Vital Data: Freeport-McMoRan Inc. (FCX), Twitter Inc. (TWTR) and Caterpillar Inc (CAT) ||| Industrials, Tech Take It On the Chin as Earnings Roll On ||| The Not-Good-Enough Earnings Season ||| Close Update: Boeing Floats Dow as Treasury Yields Continue to Dampen Demand For Equities ||| A Funny Thing Happened on the Way to Q1 Earnings... ||| Benzinga's Top Analyst Calls From April 25, 2018 ||| Benzinga Pro's Most-Searched Tickers For Morning Of Wed., Apr. 25, 2018 ||| 7 Biggest Price Target Changes For Wednesday ||| Baird Says Buybacks Is A Much Needed Catalyst At This Point For Caterpillar, Says Recent Conf. Call Didn't Provide Any Insight Into Pace Or Amount That The Co. Would Deploy, But Thinks That At Least ~$5B Could Be Feasible ||| More Big Companies Beat Projections, But Wall Street Appears To Still Struggle ||| Daiwa Capital Downgrades Caterpillar to Neutral ||| Baird Maintains Neutral on Caterpillar, Lowers Price Target to $158.00",1,0.48340395
2018-04-26,6558900.0,145.32000732421875,147.39999389648438,144.00999450683594,146.30999755859375,138.26643371582028,CAT,Caterpillar Inc. Is a Value Stock in a Booming Economy ||| Investors Are Selling Into Earnings Strength ||| Zacks: The Not-Good-Enough Earnings Season,0,0.47148922
2018-04-27,3860600.0,145.6699981689453,146.60000610351562,144.16000366210938,144.72000122070312,136.76385498046878,CAT,Upgraded Broker Ratings Make These 5 Stocks Worth Buying Now ||| Xylem (XYL) to Report Q1 Earnings: What's in the Cards?,0,0.48346657
2018-04-30,4764800.0,145.2100067138672,146.1999969482422,143.60000610351562,144.36000061035156,136.42364501953122,CAT,"cc ||| Stay Put on Caterpillar Inc. Stock While the Market Shudders ||| Notable ETF Outflow Detected - DIA, GS, MCD, CAT ||| Rates, Rates, Rates: Global Week Ahead ||| Morning Movers: McDonald's Happy Meal, Sprint's Bad Connection, Altria's Upgrade ||| Notable Monday Option Activity: AKRX, VRNS, CAT ||| Stock Market News For Apr 30, 2018",1,0.48719093
2018-05-01,5004400.0,143.0800018310547,144.42999267578125,140.30000305175778,144.4199981689453,136.48033142089844,CAT,"Yes, ‘Irrational Volatility’ in Caterpillar Inc. Stock Should Concern You ||| Zacks.com highlights: CBRE Group, Microchip Technology, AMC Networks, Caterpillar and Celanese ||| 5 Top Stock Trades for Wednesday Morning",0,0.47990218
2018-05-02,4637600.0,143.99000549316406,146.64999389648438,143.47999572753906,143.86000061035156,135.95114135742188,CAT,"Columbus McKinnon Corporation (CMCO) Ex-Dividend Date Scheduled for May 03, 2018 ||| 3 Stocks I Own in My IRA -- and May Buy Even More Of ||| Ooooh Snap! That Was A Bad Quarter for Snap Inc, But There’s Still Easy Money Here. ||| Analyst: Cummins' Earnings Visibility Clouded By Overhang, Peaking End Markets",0,0.46682924
2018-05-03,7703200.0,141.69000244140625,145.14999389648438,138.14999389648438,143.77999877929688,135.87551879882812,CAT,"3 Top Value Stocks to Buy Now ||| 3 Top Value Stocks to Buy Now ||| Dow Movers: CAT, PG ||| Bank Of America Lowers Industrial Machinery Price Targets Across The Board ||| Benzinga's Top Upgrades, Downgrades For May 3, 2018 ||| Bank of America Downgrades Caterpillar to Neutral",1,0.4990294
2018-05-04,4678400.0,142.24000549316406,147.19000244140625,141.0500030517578,146.3699951171875,138.32315063476562,CAT,"Dow 30 Stock Roundup: AAPL, DWDP, CVX, MRK, MCD, PFE Beat on Earnings ||| Caterpillar Names Andrew Bonfield CFO ||| Todd Gordon Likes Caterpillar, Home Depot And Boeing",1,0.48120162
2018-05-07,6844600.0,148.17999267578125,151.4600067138672,148.0,149.82000732421875,141.58348083496094,CAT,"Dow Movers: TRV, CAT ||| Pentair Riddled by Cost Inflation, Post Separation Concerns",1,0.49869996
2018-05-08,3853600.0,150.64999389648438,151.07000732421875,148.57000732421875,149.92999267578125,141.6874237060547,CAT,"Notable ETF Outflow Detected - DIA, GS, MCD, CAT ||| Noteworthy Tuesday Option Activity: BCOR, CAT, IAC ||| 5 Top Stocks Showing Promise of an Earnings Beat ||| Manitowoc's (MTW) Loss Narrows in Q1, Revenues Top Estimates",1,0.5153274
2018-05-09,4668200.0,150.75,153.35000610351562,150.5,152.61000061035156,144.22007751464844,CAT,"Pentair (PNR) Maintains '18 View, Announces Long-Term Goals ||| No Deal? No Problem for the Market",1,0.5062147
2018-05-10,3911000.0,153.1999969482422,155.44000244140625,152.80999755859375,153.97000122070312,145.50531005859375,CAT,"Astec Industries, Inc. (ASTE) Ex-Dividend Date Scheduled for May 11, 2018 ||| The Zacks Analyst Blog Highlights: Disney, Caterpillar, General Motors, Capital One and Cognizant ||| Improving Demand & Cost Cuts Fuel Caterpillar's (CAT) Growth ||| Silgan Holdings to Grow on Dispensing Systems Acquisition",1,0.46673122
2018-05-11,3507900.0,154.25,156.74000549316406,153.77000427246094,154.86000061035156,146.34640502929688,CAT,"Bemis Banks on Agility Plan, Expenses Continue to Mount ||| Why CalAmp Corp. Stock Fell 13.7% in April ||| Caterpillar 8-K Shows Global Rolling 3-Month Retail Sales Up 28%",1,0.52389246
2018-05-14,3563900.0,155.61000061035156,156.39999389648438,154.38999938964844,155.27999877929688,146.7432861328125,CAT,"Deere & Co. reports earnings May 18 ||| The Implied Analyst 12-Month Target For VIG ||| Stifel Nicolaus Maintains Hold on Caterpillar, Lowers Price Target to $174 ||| 5 Biggest Price Target Changes For Monday",0,0.49009952
2018-05-15,4127200.0,153.82000732421875,154.39999389648438,151.7100067138672,152.58999633789062,144.20118713378906,CAT,7 Reasons to Add Caterpillar (CAT) to Your Portfolio Now,1,0.53675824
2018-05-16,2693400.0,152.5500030517578,153.8699951171875,152.35000610351562,153.8000030517578,145.34469604492188,CAT,"Notable ETF Inflow Detected - DIA, GS, MCD, CAT ||| Only Six Dow Components With Recent Insider Buying, CAT is One of Them ||| Wednesday 5/16 Insider Buying Report: CAT, SSNC ||| Terex Banks on Execute to Win Plan and Backlog Strength",0,0.49992248
2018-05-17,2885800.0,153.6999969482422,155.25,152.75999450683594,153.69000244140625,145.24073791503906,CAT,The Upside Remains Huge for Caterpillar Inc. ||| 5 Manufacturing Stocks to Buy as Industrial Production Rises ||| 6 Reasons to Add Rockwell Automation to Your Portfolio Now,1,0.5085821
2018-05-18,3889300.0,154.14999389648438,156.83999633789062,154.00999450683594,155.7100067138672,147.14967346191406,CAT,"Dow Movers: INTC, CAT ||| Go Long Deere & Company As Wall Street Frets One Tepid Earnings Report ||| Deere (DE) Q2 Earnings Lag, Sales Meet Estimates, View Up ||| Caterpillar Inc. Becomes a Proxy for Trump Disquiet ||| Close Update: Wall Street Defensive as Trade Talks Continue, Dow Buoyed by Industrials ||| Noteworthy Friday Option Activity: CAT, PYPL, RL ||| A Tale of Two Earnings Reports, Deere Misses and Rallies Anyway ||| Philly Fed Factory Orders Hit 45-Year High: 5 Solid Picks ||| Deere In Headlights: Earnings Miss, China Trade Talk Share Center Stage Friday",1,0.48203802
2018-05-21,5849700.0,159.25999450683594,161.60000610351562,158.6999969482422,158.9199981689453,150.1831817626953,CAT,"12 Dow 30 Companies With Above-Average Salaries ||| Dow Movers: MRK, INTC ||| Grab 5 Cheap Large-Cap Stocks on Eased US-China Trade Fear ||| Rockwell Automation (ROK) to Grow on Manufacturing Strength ||| Manitex (MNTX) Up 63% in a Year: What's Driving the Stock? ||| Here's Why Pentair (PNR) Stock is Out of Investors' Favor ||| Close Update: Wall Street Rallies on Cooling Trade War Rhetoric, M&A Cheer ||| Wall Street Rallies on Cooling Trade War Rhetoric, M&A Cheer ||| Here's Why You Should Hold onto Bemis (BMS) Stock for Now",0,0.5294049
2018-05-22,3512400.0,159.02999877929688,159.35000610351562,156.13999938964844,156.1999969482422,147.61273193359375,CAT,"Is Caterpillar (CAT) Stock Outpacing Its Industrial Products Peers This Year? ||| 4 Blue-Chip Stocks Rallying on a U.S.-China Trade Deal ||| Industrials Set to Gain as Trade War Fears Ease: 5 Picks ||| The Zacks Analyst Blog Highlights: Western Digital, Magna International, Nucor, Sony and Caterpillar",1,0.5021088
2018-05-23,4010000.0,154.64999389648438,158.0,153.72000122070312,157.74000549316406,149.06805419921875,CAT,"3 Stocks to Play Trump’s Trade Talks with China ||| Here's Why You Should Hold on to TriMas (TRS) Stock for Now ||| The Zacks Analyst Blog Highlights: Boeing, Caterpillar, Diodes, Texas Instruments and CNOOC ||| 5 Top-Ranked Stocks Gearing Up for an Earnings Beat ||| Geopolitics Back In Town, And It Looks Like They Might Weigh On Market",0,0.48531112
2018-05-24,2891000.0,157.2100067138672,158.39999389648438,156.02999877929688,157.6999969482422,149.0302734375,CAT,"OEF, ABT, UTX, CAT: ETF Outflow Alert ||| Why Is Caterpillar (CAT) Up 8.1% Since Its Last Earnings Report? ||| Caterpillar and 4 Other Stocks with Relative Price Strength",0,0.4773063
2018-05-25,2359700.0,156.9199981689453,157.57000732421875,155.22999572753906,155.85000610351562,147.281982421875,CAT,"Zacks.com featured highlights include: Caterpillar, Nine Energy, E*TRADE, PGT and Landstar ||| Deere (DE) Banks on Wirtgen Acquisition, Expenses Flare Up ||| These 3 Stocks Should Boost Their Dividends Within a Month ||| Noteworthy Friday Option Activity: CAT, WIFI, SLCA ||| Caterpillar, Tupperware, Nvidia, Texas Instruments and Intel as Zacks Bull and Bear of the Day ||| Armstrong World Up 47% in a Year: What's Behind the Rally? ||| Bull of the Day:Caterpillar (CAT)",0,0.4780119
2018-05-29,3795800.0,154.25999450683594,155.72000122070312,152.63999938964844,153.6199951171875,145.17457580566406,CAT,Expansion in Emerging Markets to Aid Milacron Amid Inflation ||| Here's Why You Should Hold on to Deere (DE) Stock for Now ||| Chasing Yield: Where to Find the Top Dividend Stocks,1,0.502686
2018-05-30,2688200.0,154.60000610351562,155.97999572753906,153.83999633789062,155.4600067138672,146.9134063720703,CAT,"5 Reasons to Retain AptarGroup (ATR) in Your Portfolio ||| Hyster-Yale Materials Handling, Inc. (HY) Ex-Dividend Date Scheduled for May 31, 2018",0,0.48875973
2018-05-31,4546000.0,155.3000030517578,155.30999755859375,151.5,151.91000366210938,143.55857849121094,CAT,"Tariff Merry-Go-Round Sinks Stocks ||| Deere Rewards Investors With 15% Quarterly Dividend Hike ||| Close Update: Wall Street Sinks as U.S. Aluminum, Steel Tariffs Bring Retaliations ||| 5 Manufacturing Stocks to Buy as Industrial Production Rises ||| Wall Street Sinks as U.S. Aluminum, Steel Tariffs Bring Retaliations",1,0.50704616
2018-06-01,2755500.0,153.3000030517578,154.19000244140625,152.25999450683594,153.52000427246094,145.0800323486328,CAT,"US Pushes Ahead With Steel Tariffs, Reignites Trade War Fears ||| Improving Crane Markets Aid Manitowoc, Higher Costs Ail ||| Jobs Party: Gains Outpace Estimates But Inflationary Signs Lacking",0,0.49650124
2018-06-04,2470900.0,154.7899932861328,154.92999267578125,152.0800018310547,152.5,144.11614990234375,CAT,"Strong Jobs Data Ends Short but Crazy Week ||| U.S. Manufacturing Gathers Steam Under Trump: 5 Top Picks ||| 5 Manufacturing Stocks to Grab on Blockbuster Jobs Report ||| Notable Monday Option Activity: CAT, EBAY, SJM ||| 5 Manufacturing Stocks to Grab After Blockbuster Jobs Report",1,0.5144194
2018-06-05,2916600.0,152.39999389648438,153.10000610351562,152.02000427246094,153.00999450683594,144.5980987548828,CAT,"The Zacks Analyst Blog Highlights: Caterpillar, Regal Beloit, Zebra Technologies, Kaman and EnerSys ||| Trump Tariffs Continue to Rattle Markets, But Investors Should Stay Calm",1,0.49438304
2018-06-06,3689300.0,153.64999389648438,156.5399932861328,153.00999450683594,156.50999450683594,147.90565490722656,CAT,"Sealed Air Teams Up With Kuraray for Plantic Food Packaging ||| Terex Corporation (TEX) Ex-Dividend Date Scheduled for June 07, 2018 ||| Three Industries Already Using Self-Driving Vehicles",0,0.5065178
2018-06-07,3149100.0,157.11000061035156,157.92999267578125,155.52999877929688,156.2899932861328,147.69776916503906,CAT,"Miller Industries, Inc. (MLR) Ex-Dividend Date Scheduled for June 08, 2018 ||| Zebra Technologies (ZBRA) Soars to a 52-Week High, Time to Cash Out? ||| TriMas (TRS) Gains 35% in a Year: What's Driving the Stock? ||| Greif (GEF) Misses on Q2 Earnings & Revenues, Lifts EPS View ||| Caterpillar Presentation At Deutsche Bank Global Industrials Summit Began at 11am; Watching CAT Shares After Hearing Co. At Conf. Says Margins Are Going to Be 'Impressive' This Year, Unconfirmed",0,0.45258114
2018-06-08,3254100.0,156.19000244140625,156.64999389648438,155.0399932861328,155.32000732421875,146.78111267089844,CAT,Time to Get Greedy With Deere & Company Stock ||| Why You Should Invest in Rockwell Automation (ROK) Stock Now ||| Reasons to Retain Lincoln Electric (LECO) in Your Portfolio,1,0.5041885
2018-06-11,2758300.0,155.19000244140625,157.0800018310547,154.72000122070312,156.3000030517578,147.70724487304688,CAT,"Top Research Reports for Disney, Caterpillar & MetLife ||| Zacks.com highlights: Caterpillar, Boeing, J.Jill, Weight Watchers International and Xcerra ||| Sealed Air Grows on Product Innovation, Near-Term Risks Stay ||| Ball Corp (BLL) Rides on Expansion, Domestic Beer Markets Ail ||| 10 Big-Cap Turnaround Stocks for Value-Hunting Investors",1,0.49329537
2018-06-12,2595600.0,156.4499969482422,159.19000244140625,156.38999938964844,157.49000549316406,148.83181762695312,CAT,"The Zacks Analyst Blog Highlights: Disney, Caterpillar, MetLife, Celgene and Northrop Grumman ||| Rockwell Automation-PTC Alliance to Enhance IoT Platform ||| The 10 Stocks That Will Push the Dow Over 30K",0,0.48340353
2018-06-13,4189300.0,157.17999267578125,157.35000610351562,154.50999450683594,154.7100067138672,146.20465087890625,CAT,"Dow Movers: VZ, DIS ||| Here's Why You Must Add Caterpillar (CAT) to Your Portfolio ||| Close Update: Wall Street Roiled By FOMC, Flatter Yield Curve ||| Daily Dividend Report: CAT, TGT, HRB, UTX, JCI ||| Mid-Day Update: Wall Street Stalls as FOMC Decision Looms ||| Cat 8-K Shows Raised Qtr. Dividend From $0.78 To $0.86/Share ||| Caterpillar 8-K Shows Global Rolling 3-Month Retail Sales Up 24%",0,0.48917967
2018-06-14,3967600.0,155.6999969482422,157.36000061035156,152.75999450683594,153.13999938964844,144.720947265625,CAT,"SPDR S&P 500 ETF Experiences Big Outflow ||| U.S. Manufacturing Gathers Steam Under Trump: 5 Top Picks ||| Why the Fed Rate Hike Probably Won’t Affect Capital Spending ||| Analysts Expect EQWL Will Reach $60 ||| Caterpillar (CAT) May Sales Surge 24%, Raises Dividend ||| Why Investors Should Add Tetra Tech to Their Portfolio Now ||| 10 Biggest Price Target Changes For Thursday ||| UBS Maintains Buy on Caterpillar, Raises Price Target to $185",0,0.49396175
2018-06-15,8852500.0,150.85000610351562,151.0,148.42999267578125,150.02000427246094,141.77247619628906,CAT,"Douglas Dynamics, Inc. (PLOW) Ex-Dividend Date Scheduled for June 18, 2018 ||| The Zacks Analyst Blog Highlights: CSX, Eni, Kimberly-Clark, Caterpillar and Check Point Software ||| Stocks Slump Amid Renewed Trade War Tensions",0,0.48403487
2018-06-18,3651600.0,148.4199981689453,149.4600067138672,147.72000122070312,148.67999267578125,140.50614929199222,CAT,"Grainger Rides on Improving Markets & Growing E-commerce ||| Ensign Group, Big Lots, Caterpillar, United Rentals and Terex highlighted as Zacks Bull and Bear of the Day ||| Stock Market News For Jun 18, 2018 ||| 3 Construction Stocks to Buy Right Now",0,0.4900495
2018-06-19,6792000.0,146.0,146.3000030517578,142.32000732421875,143.3000030517578,135.42190551757812,CAT,"Stock Market News For Jun 19, 2018 ||| CAT Crosses Below Key Moving Average Level ||| Close Update: Wall Street Sinks as Dow Turns Negative for 2018 on Trade War Jitters ||| Markets Now: Blame Boeing---and Caterpillar and 3M---for the Dow's 287-Point Drop ||| Russian Economic Development Minister Oreshkin Says Russia May Impose Tariffs On Imports Of U.S. Road-Building Machinery, Says Russia Won't Impose Tariffs On Imports Of Medicine From U.S. ||| Pressure Mounts: President Doubles Down On Tariff Threat To China",0,0.48257798
2018-06-20,4128300.0,144.22000122070312,144.69000244140625,141.82000732421875,143.1300048828125,135.26127624511722,CAT,"Stock Market News For Jun 20, 2018 ||| Selling Pressure Seems Ready To Ebb A Bit, But Trade Fears Haven't Vanished",0,0.47784293
2018-06-21,5914900.0,142.25,142.38999938964844,139.1199951171875,139.52999877929688,131.85916137695312,CAT,5 Solid Reasons to Retain Deere (DE) in Your Portfolio Now ||| Dow Extends Slide As VIX Spikes ||| Relative Strength Alert For Caterpillar ||| Analysts: Caterpillar's Stock Could Be Front And Center In A Trade War,1,0.52705544
2018-06-22,5114700.0,140.89999389648438,142.5,139.77000427246094,139.94000244140622,132.24662780761722,CAT,"Why Tesla Shorts Are Doomed ||| Mid-Morning Market Update: Markets Mostly Higher; BlackBerry Beats Q1 Estimates ||| Caterpillar Stock Is Ready to Pounce Again After the Tariff Takedown ||| Caterpillar Enters Oversold Territory ||| 5 Top Stock Trades for Monday Morning ||| Mid-Morning Market Update: Markets Mostly Higher; BlackBerry Beats Q1 Estimates ||| OPEC Meeting Front And Center As DJIA Enters Session Down Eight-Straight Days ||| BlackBerry Beats Q1 Earnings Estimates, Announces Bullitt Partnership",0,0.48259833
2018-06-25,6078200.0,138.86000061035156,138.97999572753906,135.17999267578122,136.58000183105472,129.07138061523438,CAT,"Should You Buy Caterpillar (CAT) Stock Right Now? ||| Boeing Is Still Soaring In Spite of Today’s Air Pocket — Get On Board ||| Dow Movers: CAT, WMT ||| Beat the Market With 5 Stocks Likely to Beat Estimates ||| 3 Big Stock Charts for Monday: Caterpillar, PPL Corp and Iron Mountain ||| Zacks Investment Ideas feature highlights: Tesla, Alphabet, Caterpillar, Deere and Goodyear Tire ||| CAT Named Top 25 SAFE Dividend Stock Increasing Payments For Decades ||| Close Update: Wall Street Skids on Trade Jitters With Tech Stocks Leading Losses",0,0.45849195
2018-06-27,5665000.0,136.77000427246094,139.46000671386722,134.58000183105472,134.61000061035156,127.20965576171876,CAT,"Notable Wednesday Option Activity: CAT, LEG, CAG",1,0.5232576
2018-07-02,3172600.0,133.80000305175778,136.42999267578122,133.19999694824222,136.28999328613278,128.79728698730472,CAT,"Caterpillar could rebound on construction spending report ||| Wabash National Corporation (WNC) Ex-Dividend Date Scheduled for July 03, 2018 ||| 7 Stocks at Risk as Trump’s Trade War Heats Up",0,0.48162207
2018-07-05,3366300.0,135.00999450683594,136.08999633789062,134.08999633789062,135.80999755859378,128.34368896484378,CAT,"Stock Market News For Jul 5, 2018 ||| Is Nucor Corporation a Buy? ||| Noteworthy Thursday Option Activity: CAT, KMB, BIG",0,0.48033434
2018-07-06,3179600.0,135.11000061035156,135.86000061035156,133.32000732421878,135.41000366210938,127.96568298339844,CAT,"How Much Will Construction & Forestry Segment Contribute To Deere's Top Line Growth? ||| Dow Movers: CAT, MCD",1,0.509808
2018-07-09,5562300.0,136.22000122070312,141.0500030517578,136.10000610351562,140.97000122070312,133.22001647949222,CAT,"Close Update: Wall Street Buoyed By Pause in US/China Trade Tensions ||| Market Close Report: NASDAQ Composite index closes at 7,756.20 up 67.81 points ||| Bank Stocks Boost Dow to Third Straight Win ||| Caterpillar (CAT) or Deere (DE): Which Is the Better Stock? ||| Monday Sector Leaders: Industrial, Energy ||| What Trade War? Positive Sentiment Seems To Continue From Friday",1,0.48875764
2018-07-10,3761700.0,141.61000061035156,141.86000061035156,140.13999938964844,141.25,133.48460388183594,CAT,5 Top Stock Trades for Wednesday Morning,0,0.5354747
2018-07-11,5231700.0,138.1300048828125,139.38999938964844,135.83999633789062,136.75999450683594,129.24143981933594,CAT,"Dow Movers: UTX, V ||| Markets Now: Dow Drops 207 Points as Caterpillar, Chevron Slide ||| Stocks Snap Win Streak as Oil Prices Plunge",1,0.51842546
2018-07-12,4250800.0,138.5,139.72999572753906,136.83000183105472,139.41999816894528,131.75518798828122,CAT,iShares U.S. Industrials ETF Experiences Big Outflow ||| Take Advantage of the Selloff in Caterpillar Stock — But Not Yet,1,0.49744532
2018-07-13,2838700.0,139.53999328613278,141.25,139.07000732421878,140.75,133.01211547851562,CAT,"Noteworthy Friday Option Activity: BBY, CAT, DLR ||| Big Banks Deliver Mixed Results, But JP Morgan Stands Out With Strong Quarter",0,0.51314676
2018-07-16,3723100.0,140.8800048828125,140.8800048828125,137.89999389648438,138.08000183105472,130.4888916015625,CAT,"Market Close Report: NASDAQ Composite index closes at 7,805.72 down -20.26 points ||| Buy Caterpillar While Trade War Talks Subside ||| Caterpillar Inc. Stock Has Lost 13.9% in 2018 So Far: Should You Be Worried?",1,0.46093595
2018-07-17,3306000.0,136.97999572753906,139.33000183105472,136.52999877929688,138.94999694824222,131.31106567382812,CAT,"Stock Market News For July 17, 2018 ||| Ex-Dividend Reminder: Caterpillar, EMCOR Group and AAR ||| Morning Movers: Johnson & Johnson Gains; Deere, Caterpillar Slip ||| Goldman Sachs Turns Cautious On Machinery Stocks ||| Goldman Removes Caterpillar And Deere From Conviction Buy List",1,0.4707666
2018-07-18,4394800.0,139.0,141.5,138.33000183105472,141.1199951171875,133.36175537109378,CAT,"Caterpillar, Inc. (CAT) Ex-Dividend Date Scheduled for July 19, 2018",0,0.43072987
2018-07-19,3576700.0,139.57000732421878,140.53999328613278,139.05000305175778,139.41999816894528,132.56306457519528,CAT,Whether You Should Invest in Boeing Depends on Two Key Questions ||| Dover Corporation: Buy the Dip?,0,0.5009145
2018-07-20,5247000.0,138.36000061035156,138.58000183105472,136.63999938964844,136.82000732421878,130.09095764160156,CAT,"Weekly Jobless Claims Plunge to 48-Year Low: 5 Top Picks ||| Dow Movers: CAT, MSFT ||| Stanley Black (SWK) Tops Q2 Earnings & Sales, Reiterates View ||| Philly Fed Manufacturing Index Remains Robust: 4 Great Picks ||| Noteworthy Friday Option Activity: CAT, CONN, AXDX",0,0.51378256
2018-07-23,3542300.0,136.6199951171875,136.80000305175778,135.60000610351562,136.27999877929688,129.5775146484375,CAT,"Barron's Picks And Pans: Autoliv, BlackRock, Boeing, Netflix And More ||| Bet on the Upside in Lockheed Martin Stock Before It’s Too Late ||| The 5 Best Stocks to Buy This Earnings Season ||| The Zacks Analyst Blog Highlights: Graco, Caterpillar, Terex and American Axle & Manufacturing Holdings",1,0.4998865
2018-07-24,5064700.0,138.89999389648438,140.60000610351562,137.36000061035156,137.97000122070312,131.18437194824222,CAT,"Dow Movers: MMM, CAT ||| Broad Blue-Chip Rally Boosts Dow Triple Digits ||| Earnings Preview: Boeing, GM And Ford To Report Q2 Earnings This Week ||| 'White House readies plan to extend about $12 billion in emergency aid to farmers caught in Trump's escalating trade war' -Washington Post ||| Watching Deere, Cat Shares As Traders Circulate 'Trump to announce trade aid for farmers' -Politico",1,0.52805847
2018-07-25,5041800.0,138.0,141.0500030517578,136.66999816894528,140.47999572753906,133.57093811035156,CAT,"Will $12B Emergency Relief Help U.S. Agricultural Sector? ||| BlackBerry Investors Are Panicking Needlessly ||| Deere, Caterpillar Shares Volatile Following Recent Headlines Of EU Concessions To U.S. To Avoid Trade War",1,0.51492405
2018-07-26,5385600.0,140.75,143.5500030517578,140.07000732421878,142.5800018310547,135.56767272949222,CAT,"Can Caterpillar (CAT) Retain Its Beat Streak in Q2 Earnings? ||| Upcoming Earnings: Oil Supermajors Chevron And ExxonMobil To Report Friday Morning ||| Intel Earnings Preview: High Expectations, Still No CEO",0,0.48136684
2018-07-27,4649400.0,143.9499969482422,143.9499969482422,140.77999877929688,142.55999755859375,135.54864501953122,CAT,"Pre-Market Earnings Report for July 30, 2018 : CAT, SPG, STX, L, CNA, FDC, ON, AER, AMG, BAH, EXP, VET ||| Can Construction Industry, Resource Industry, Energy & Transportation Drive Growth For Caterpillar In Q2? ||| Caterpillar (CAT) Stock Flat Ahead of Earnings: What To Expect ||| Caterpillar Earnings Preview: Economic Outlook Seems Good, Tariffs Adding Uncertainty ||| Economic Growth Hits Best Level Since 2014 As Earnings Season Keeps Rolling",0,0.50071615
2018-07-30,13837700.0,145.7100067138672,146.6999969482422,139.05999755859378,139.75,132.87684631347656,CAT,"Caterpillar reports earnings July 30 ||| IOO, CAT, AMT, FOXA: ETF Outflow Alert ||| Mid-Morning Market Update: Markets Down; Caterpillar Tops Q2 Expectations ||| Why It’s Time to Dig Into Caterpillar Stock on This Earnings Report ||| Markets Now: As S&P 500 Slips, Value Stocks Shine ||| Caterpillar (CAT) Gains on Q2 Earnings Beat, Hikes '18 View ||| Caterpillar Earnings Confirm Last Quarter Was Not the ‘High-Water Mark’ ||| Morning Movers: Caterpillar Gives the Dow Wings ||| Align, AngioDynamics and Caterpillar highlighted as Zacks Bull and Bear of the Day ||| Earnings Reaction History: Caterpillar Inc, 45.5% Follow-Through Indicator, 3.8% Sensitive ||| Caterpillar (CAT) Beats on Q2 Earnings & Revenues Estimates ||| CAT Earnings, Bearish TSLA Analysts, MoviePass, & Sports Gambling | Free Lunch ||| Notable Monday Option Activity: BKNG, CAT, RL ||| Caterpillar Historically Favors Short Play off Earnings-Driven Pre-Market Moves ||| Close Update: Stocks Slide With Tech-Sector Selloff Handing Nasdaq Third Straight Loss ||| What Happened in the Stock Market Today ||| How Will Tariffs Impact Caterpillar (CAT) Following Strong Q2 Earnings? ||| Mid-Afternoon Market Update: Crude Oil Up Over 2%; RLJ Entertainment Shares Spike Higher ||| The Week Ahead: Apple And Tesla Earnings, FOMC Meeting, Sonos IPO ||| Mid-Day Market Update: NASDAQ Down Over 1%; Sohu.com Shares Plummet ||| From Cat Q2 Earnings Conference Call: Co. Will Start To See Price Realization Turn Positive In Q4 For Construction Industries ||| From Cat Q2 Earnings Conference Call: Mining Is Improving But Is Still Well Below Normal Levels ||| From Cat Q2 Earnings Conference Call: 'Our Business In China Continues To Be Strong,' Sees 2H'18 Operating Margin Similar To 1H'18 Level ||| Caterpillar Says Mining Customers Are Placing Orders on New Equipment But Have Not Begun Full Scale Fleet Replacement ||| Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Mon., Jul. 30, 2018 ||| CAT Climbs Into Driver's Seat To Start Earnings Parade, With Fed Meeting Ahead ||| Mid-Morning Market Update: Markets Down; Caterpillar Tops Q2 Expectations ||| Benzinga Pro's 5 Stocks To Watch Today ||| Caterpillar Raises FY2018 EPS Guidance from $10.25-11.25 to $11.00-12.00 vs $10.87 Est ||| Caterpillar Q2 EPS $2.97 Beats $2.73 Estimate, Sales $14.011B Beat $13.88B Estimate ||| 7 Stocks To Watch For July 30, 2018 ||| Earnings Scheduled For July 30, 2018",1,0.47132567
2018-07-31,7608700.0,141.97000122070312,144.77999877929688,140.16999816894528,143.8000030517578,136.72767639160156,CAT,"Dow Movers: WBA, MMM ||| 5 Top Stock Trades for Wednesday — Is Procter Finally a Buy? ||| Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Tues., Jul. 31, 2018 ||| 'Caterpillar weakness yesterday was all about No China Truce. Today's talk is of China Truce...'-Jim Cramer Tweets ||| Barclays Steps To The Sidelines On Caterpillar ||| Bank of America Maintains Neutral on Caterpillar, Lowers Price Target to $155 ||| Morgan Stanley Maintains Overweight on Caterpillar, Raises Price Target to $187 ||| Benzinga's Top Upgrades, Downgrades For July 31, 2018 ||| BMO Capital Maintains Outperform on Caterpillar, Lowers Price Target to $185 ||| Barclays Downgrades Caterpillar to Equal-Weight",0,0.48546803
2018-08-01,6364500.0,142.97000122070312,143.07000732421875,138.11000061035156,138.53999328613278,131.72634887695312,CAT,"Market Close Report: NASDAQ Composite index closes at 7,707.29 up 35.50 points ||| Fed Leaves Rates Unchanged; Apple Earnings Send Nasdaq Higher ||| Stock Market News For Aug 1, 2018 ||| Dow Movers: CAT, AAPL ||| Trade of the Day: Caterpillar Is a Short ||| Apple, Caterpillar, CBS, Pfizer: 'Fast Money' Picks For August 1",0,0.49015814
2018-08-02,4195000.0,137.07000732421878,138.71000671386722,135.69000244140622,138.00999450683594,131.222412109375,CAT,"Stock Market News For Aug 2, 2018",1,0.4847833
2018-08-03,3594100.0,138.19999694824222,138.60000610351562,137.07000732421878,138.50999450683594,131.69784545898438,CAT,"Caterpillar (CAT), Boeing (BA), Others Sink Despite??Strong??Economy??as??Trade War Escalates ||| Caterpillar (CAT), Boeing (BA), Others Sink Despite Strong Economy as Trade War Escalates ||| Emerson (EMR) to Report Q3 Earnings: What's in the Cards? ||| Dow 30 Stock Roundup: Apple, DowDuPont, Caterpillar, Pfizer Earnings Impress",1,0.4767565
2018-08-06,3125200.0,138.52000427246094,140.66999816894528,137.97000122070312,139.47999572753906,132.62013244628906,CAT,"Benzinga's Bulls & Bears Of The Week: AT&T, Caterpillar, Nike, Tesla And More ||| Unemployment Nears 50-Year Low: 5 Top-Ranked Picks ||| Big Oil and Big Trucks",1,0.5079453
2018-08-07,4813000.0,140.61000061035156,143.32000732421875,140.30000305175778,142.3800048828125,135.37750244140622,CAT,"The Zacks Analyst Blog Highlights: Caterpillar, BHP Billiton and Celgene ||| TriMas (TRS) Q2 Earnings & Sales Top Estimates, View Up ||| Terex Corporation (TEX) Ex-Dividend Date Scheduled for August 08, 2018 ||| Manitowoc (MTW) Beats on Q2 Earnings & Revenues, Revises View ||| Notable Tuesday Option Activity: FOXA, CAT, DVA ||| Dow Movers: PG, CAT ||| Nasdaq Nabs Longest Win Streak Since March ||| Manufacturing - Construction and Mining Stock Outlook: Solid Prospects ||| Market Close Report: NASDAQ Composite index closes at 7,883.66 up 23.98 points ||| What's Powering Caterpillar's Fresh Surge? ||| 10 Biggest Price Target Changes For Tuesday ||| Stifel Nicolaus Maintains Hold on Caterpillar, Lowers Price Target to $168",0,0.45633003
2018-08-08,3435100.0,142.32000732421875,142.39999389648438,139.25999450683594,139.71000671386722,132.83882141113278,CAT,"Caterpillar: Buy, Sell, or Hold? ||| Columbus McKinnon Corporation (CMCO) Ex-Dividend Date Scheduled for August 09, 2018 ||| 6 Top Picks as S&P 500 Dashes Toward New Record-High ||| Terex (TEX) Beats on Q2 Earnings & Revenues, Raises '18 View",0,0.47265223
2018-08-09,3338500.0,140.10000610351562,140.89999389648438,138.25,138.52000427246094,131.70735168457028,CAT,"DIA, GS, MCD, CAT: Large Outflows Detected at ETF ||| Astec Industries, Inc. (ASTE) Ex-Dividend Date Scheduled for August 10, 2018 ||| Two Major Mergers Fall Through, A Reminder That Deals Don't Always Work Out",0,0.48653
2018-08-10,6268600.0,137.52000427246094,137.52000427246094,134.72999572753906,135.91999816894528,129.23521423339844,CAT,Bet on 5 Stocks With Strong Earnings Beat Prospects ||| Is Caterpillar (CAT) Stock a Solid Choice Right Now?,0,0.48528758
2018-08-13,3879400.0,135.91999816894528,136.72999572753906,134.72000122070312,135.02000427246094,128.37948608398438,CAT,"Zacks.com featured highlights include: Molina, Caterpillar, Fortinet and GATX ||| 10 Biggest Price Target Changes For Monday ||| Argus Maintains Buy on Caterpillar, Lowers Price Target to $165",0,0.47629407
2018-08-14,3537900.0,135.60000610351562,136.44999694824222,134.66999816894528,134.91999816894528,128.28440856933594,CAT,"Caterpillar's July Sales Up 24%, Clocks Average YTD of 28% ||| Why Caterpillar (CAT) is a Top Dividend Stock",0,0.48105952
2018-08-15,5682200.0,133.25,133.25,129.42999267578122,132.02000427246094,125.52702331542967,CAT,"Wall Street Unnerved By Turkey; Market Averages Suffer Largest Daily Loss in a Month ||| Only Eight Dow Components With Recent Insider Buying, CAT is One of Them ||| Dow Movers: CAT, MRK ||| Manitowoc Rides on Backlog Strength & Product Introduction ||| The Correction Has Started: 6 Charts Explain Why ||| Should You Buy Deere (DE) Stock Ahead of Earnings? ||| Noteworthy Wednesday Option Activity: A, CAT, WYNN ||| Caterpillar is on Sale",1,0.4861343
2018-08-16,5539400.0,133.72000122070312,136.55000305175778,133.64999389648438,136.25999450683594,129.5584716796875,CAT,"How Will Caterpillar Perform In Second Half Of 2018 After Strong Q2 Growth? ||| Zacks Investment Ideas feature highlights: Caterpillar ||| The Zacks Analyst Blog Highlights: Caterpillar, Morgan Stanley, Walmart, Phillips 66 and Marriott ||| The 3 Cheapest Dow Stocks ||| Will Renewed Talks Ease U.S-China Trade War Tensions? ||| Close Update: Wall Street Rally Fueled by Renewed U.S./China Trade Talks ||| Mid-Day Update: Wall Street Rallies As US/China Trade Talks Back On",1,0.47516233
2018-08-17,6611700.0,135.64999389648438,140.21000671386722,135.44000244140622,139.33999633789062,132.48703002929688,CAT,"4 Stocks to Buy as Industrial Production Edges Up in July ||| Stock Market News For Aug 17, 2018 ||| Caterpillar Moves Up In Market Cap Rank, Passing NextEra Energy ||| Market Close Report: NASDAQ Composite index closes at 7,816.33 up 9.81 points ||| Why Is Deere (DE) Stock Up Despite Missing Earnings? ||| Dow Adds Triple Digits on China Trade Hopes ||| Podcast: 6 Charts Explain Why The Correction Has Started ||| Headlights On Deere: Mixed Results As Company Cites Higher Costs",0,0.49817625
2018-08-20,3311100.0,139.82000732421878,140.55000305175778,138.55999755859378,138.66999816894528,131.84996032714844,CAT,"Crown Holdings (CCK) Down 27% YTD: What's Pulling it Down? ||| New Strong Buy Stocks for August 20th ||| US, China Look to Mend Trade Relations: 5 Winning Picks ||| The Zacks Analyst Blog Highlights: Meritor, Actuant, Cleveland-Cliffs and Caterpillar ||| AptarGroup Rides on Business Transformation Amid Inflation",1,0.49542
2018-08-21,3021400.0,139.07000732421878,140.9600067138672,139.07000732421878,139.99000549316406,133.10504150390622,CAT,"Dow Movers: JNJ, INTC ||| The Zacks Analyst Blog Highlights: Caterpillar, Celanese, Micron Technology, QUALCOMM and Skyworks Solutions ||| Jim Cramer Shares His Thoughts On Twitter, Caterpillar And Dominion Energy",0,0.47690168
2018-08-22,2209500.0,140.32000732421878,140.69999694824222,139.36000061035156,139.6300048828125,132.76274108886722,CAT,"Noteworthy Wednesday Option Activity: CAT, KR, AGN",0,0.52334094
2018-08-23,3905300.0,139.05000305175778,139.16999816894528,136.41999816894528,136.78999328613278,130.06242370605472,CAT,"3 Manufacturing Stocks to Buy Despite Trade War Concerns ||| Market Close Report: NASDAQ Composite index closes at 7,878.46 down -10.64 points ||| Trump Drama, Trade Tensions Drag Stocks Lower ||| Close Update: Wall Street Retreats as U.S.-China Trade Dispute Deepens ||| Caterpillar (CAT) & Sony (SNE): Dividend-Paying Stocks to Watch ||| Dow Movers: CAT, MSFT ||| Rockwell Automation (ROK) Wins $50M Contract From Codelco ||| Fed On Center Stage As Jackson Hole Meeting Starts, With Powell Speech Friday",1,0.5060053
2018-08-24,2565400.0,137.82000732421878,138.55000305175778,136.88999938964844,138.21000671386722,131.41259765625,CAT,3 Manufacturing Stocks to Buy Despite Trade War Concerns ||| Caterpillar (CAT) Outpaces Stock Market Gains: What You Should Know ||| 4 Dow Titans Ready to Topple Over At Any Moment,1,0.4930509
2018-08-27,4770900.0,139.39999389648438,142.3800048828125,139.30000305175778,142.0399932861328,135.05419921875,CAT,"Dow Movers: PFE, CAT ||| Why the Best Is Yet to Come for Deere ||| In Your 60s? 3 Stocks You Should Consider Buying ||| Powell Sees No Signs Of Economy Overheating, But Key Data On Way This Week",0,0.48369902
2018-08-28,3234000.0,143.4199981689453,143.77000427246094,141.49000549316406,142.0,135.01618957519528,CAT,"5 Top Stocks Likely to Beat Earnings Estimates ||| 7 Reasons to Add Caterpillar (CAT) to Your Portfolio Now ||| Dow Out of Its Second Longest Correction Territory: 5 Picks ||| What the ""New"" NAFTA Means for U.S. Companies",0,0.5365844
2018-08-29,3369900.0,142.42999267578125,142.58999633789062,141.2899932861328,141.86000061035156,134.88308715820312,CAT,"Why Is Caterpillar (CAT) Down 1.3% Since Last Earnings Report? ||| Hyster-Yale Materials Handling, Inc. (HY) Ex-Dividend Date Scheduled for August 30, 2018 ||| Zacks.com featured highlights include: Columbia Sportswear, Illumina, WellCare, athenahealth and Caterpillar",0,0.47155562
2018-08-30,4773300.0,141.02999877929688,141.47000122070312,138.44999694824222,139.05999755859378,132.22077941894528,CAT,"7 Dow Stocks to Buy at a Reasonable Price ||| Dow Movers: DWDP, PFE ||| Zebra (ZBRA) Hits Fresh High: Is There Still Room to Run? ||| Market Close Report: NASDAQ Composite index closes at 8,088.36 down -21.33 points ||| U.S. Stocks Snap Four-Day Win Streak on Renewed China Trade Concerns ||| Close Update: Wall Street Snaps Four-Day Winning Streak as Trade Worries Grow",0,0.48930162
2018-08-31,4552200.0,138.52000427246094,140.22000122070312,138.3800048828125,138.85000610351562,132.0211181640625,CAT,Is Caterpillar (CAT) a Great Dividend Play? ||| Why Caterpillar (CAT) is a Top Dividend Stock ||| Caterpillar (CAT) Stock Sinks As Market Gains: What You Should Know,0,0.4636208
2018-09-04,3955600.0,137.86000061035156,139.0,136.92999267578122,138.24000549316406,131.44111633300778,CAT,"Wall Street Looks Stunning: A Bumpy Road Ahead? ||| Noteworthy ETF Inflows: DIA, GS, AAPL, CAT ||| Stock Market News For Sept 4, 2018",1,0.4595934
2018-09-05,4579400.0,138.33000183105472,141.10000610351562,137.67999267578122,140.58999633789062,133.675537109375,CAT,"Dow Movers: V, CAT ||| ISM Manufacturing Index Hits 14-Year High: 5 Picks ||| Stocks Struggle Again as Tech Gets Crushed ||| Buy CAT Stock Because It's Cheap & Caterpillar Is Set to Grow ||| Deutsche Bank Reinstates Buy on Caterpillar, Announces $177 Price Target",1,0.48505342
2018-09-06,4588100.0,140.33999633789062,141.8699951171875,140.05999755859378,141.57000732421875,134.60736083984378,CAT,"September Bogging You? Look at the Best 9-Month Run Instead ||| Miller Industries, Inc. (MLR) Ex-Dividend Date Scheduled for September 07, 2018 ||| Why Fluor Corporation Soared in August",0,0.4993856
2018-09-07,4173400.0,140.72999572753906,142.13999938964844,140.05000305175778,141.32000732421875,134.36962890625,CAT,"The Zacks Analyst Blog Highlights: Caterpillar, D.R. Horton, Bristol-Myers Squibb, athenahealth and BJ's Restaurants ||| Caterpillar (CAT) Stock Moves -0.18%: What You Should Know ||| Oppenheimer Initiates Coverage On Caterpillar with Perform Rating ||| Solid Employment Report, But Tech Selloff Enters Fourth Day ||| Benzinga's Top Upgrades, Downgrades For September 7, 2018",1,0.50301117
2018-09-12,5630600.0,141.5800018310547,144.75,140.6199951171875,144.27999877929688,137.18403625488278,CAT,"New Strong Buy Stocks for September 12th ||| 5 Best Bargain PEG Stocks for Value Investors ||| Dow Within Striking Distance of Record High Level: 4 Picks ||| The Zacks Analyst Blog Highlights: Caterpillar, Amazon.com, Berkshire Hathaway and Microsoft ||| Why Caterpillar is a Top Socially Responsible Dividend Stock (CAT) ||| Close Update: Wall Street Wobbles Into Close as Dow Lifted by Trade Hopes, Tech Dents Nasdaq",1,0.47913378
2018-09-13,3670700.0,145.0500030517578,146.4600067138672,144.52000427246094,145.5399932861328,138.382080078125,CAT,"3 Top Gold Stocks to Watch in September ||| Air Of Cautious Optimism To Start Day On Positive China Talk, Easing Price Fears",0,0.5435067
2018-09-14,4699600.0,145.6300048828125,147.1999969482422,143.22999572753906,144.89999389648438,137.77357482910156,CAT,"Notable ETF Inflow Detected - XLI, BA, CAT, LMT ||| Lehman Brothers' Collapse: Did the Markets Learn Any Lesson? ||| Douglas Dynamics, Inc. (PLOW) Ex-Dividend Date Scheduled for September 17, 2018 ||| What's in Store for Apogee (APOG) Stock in Q2 Earnings? ||| Cat 8-K Shows Rolling 3-Month Retail Machine Sales For Aug. Up 23% Year Over Year",1,0.44172058
2018-09-17,3827100.0,144.85000610351562,148.05999755859375,144.5500030517578,146.22000122070312,139.02864074707028,CAT,"Caterpillar's August Sales Up 23%, Clocks Average YTD of 28% ||| Dow Movers: MCD, CAT ||| Why Caterpillar (CAT) is a Top Dividend Stock ||| Zebra (ZBRA) Hits Fresh High: Is There Still Room to Run? ||| Auto Sector Powers U.S. Industrial Production: 5 Great Picks ||| Why Caterpillar (CAT) is a Great Dividend Stock ||| Market Close Report: NASDAQ Composite index closes at 7,895.79 down -114.25 points ||| Stocks Sell Off Ahead of Trump Trade Announcement",1,0.4914878
2018-09-18,4496400.0,147.0,149.27999877929688,146.27000427246094,149.07000732421875,141.7384796142578,CAT,"Dow Movers: DIS, AAPL ||| Manitowoc Taps Growth With Product Innovation, Risks Remain ||| CAT Makes Bullish Cross Above Critical Moving Average ||| 3 Trade War Stocks to Buy (and 3 to Sell)",1,0.49939215
2018-09-19,6000100.0,149.75999450683594,153.11000061035156,149.3699951171875,152.75999450683594,145.2469940185547,CAT,"Apogee (APOG) Q2 Earnings Miss, Sales Top Estimates, View Cut ||| Stock Market News For Sep 19, 2018 ||| Dow Movers: MSFT, CAT ||| How The Pieces Add Up: IWX Headed For $59 ||| Wall Street Resilient to Trade Jitters: Top 5 Gainers ||| Stock Market Appears To Focus On US-China Tariff News As US, Canada Continue Talks",1,0.49423218
2018-09-20,6774100.0,155.41000366210938,157.72000122070312,154.4600067138672,156.0,148.32765197753906,CAT,"Major Stock Indexes Approaching Record Highs: 5 Top Picks ||| 1 Investment Banker Offers Up 3 Industrials Stocks to Buy ||| Dow Movers: WMT, CAT ||| New Strong Buy Stocks for September 20th ||| The Zacks Analyst Blog Highlights: American Woodmark, Guess', Rocky Brands, W.W. Grainger and Caterpillar ||| Another Big Day Sends Dow to Record High ||| 5 Excellent PEG Stocks Suitable for GARP Investors ||| Benzinga's Top Upgrades, Downgrades For September 20, 2018 ||| Baird Upgrades Caterpillar to Outperform",1,0.49349022
2018-09-21,5932100.0,156.6300048828125,157.2899932861328,154.8000030517578,156.3800048828125,148.68894958496094,CAT,"Stock Market News For Sep 21, 2018 ||| Market Rallies Despite Trade Worries: 5 Blue-Chip Picks ||| The Recent Rally in Caterpillar Stock Has Reached an Extreme ||| Zacks.com highlights: Caterpillar, Tailored Brands, United Rentals, DXC Technology and Perspecta ||| 4 Stocks to Play as U.S. Manufacturing Remains Robust ||| Baird Turns Positive On Machinery Stocks, Upgrades Caterpillar, Manitowoc, Sun Hydraulics",0,0.4888864
2018-09-24,3844500.0,156.0,156.10000610351562,153.77000427246094,154.0,146.42601013183594,CAT,"Benzinga's Bulls & Bears Of The Week: Amazon, Caterpillar, Costco, Netflix, More ||| Caterpillar Stock Is in the Right Industry at the Right Time",1,0.50449544
2018-09-25,3454600.0,154.1199951171875,154.5,152.80999755859375,154.08999633789062,146.51158142089844,CAT,"The Zacks Analyst Blog Highlights: Caterpillar, Atkore, Global Brass and Meritor ||| Vigo System Signs Deal With Caterpillar Unit to Sell Infrared Detectors Worth €2.1M",0,0.5076327
2018-09-26,3096100.0,153.9499969482422,155.14999389648438,152.88999938964844,153.1699981689453,145.63682556152344,CAT,BlackBerry (BB) to Report Q2 Earnings: What's in the Offing? ||| Avery Dennison Poised on Pricing Actions Amid Rising Costs,0,0.500549
2018-09-27,2674100.0,153.02000427246094,154.0500030517578,151.1999969482422,152.47000122070312,144.97125244140625,CAT,First Session After Rate Hike Seems To Have Investors Mulling Fed Comments,1,0.51859814
2018-09-28,3599900.0,152.0,152.91000366210938,150.55999755859375,152.49000549316406,144.9902801513672,CAT,"Dow Movers: GS, MCD ||| Lindsay's Prospects Bleak on Dismal Agricultural Market ||| Looking for Earnings Beat? Play These Top 5 Stocks",0,0.48247084
2018-10-01,3736300.0,153.61000061035156,154.5,151.67999267578125,152.27999877929688,144.7906036376953,CAT,"7 Stocks to Buy Thanks to Trump’s New Trade Deal ||| Notable Monday Option Activity: CAT, WHR, SWKS",1,0.51060885
2018-10-02,4344000.0,152.2899932861328,155.3800048828125,151.5,154.82000732421875,147.2056884765625,CAT,"The 5 Best Dow Jones Stocks to Buy Now ||| Dow Analyst Moves: CAT ||| Why the Earnings Surprise Streak Could Continue for Caterpillar (CAT) ||| ISM Manufacturing Index Gains for 113th Month: 4 Top Picks ||| Wabash National Corporation (WNC) Ex-Dividend Date Scheduled for October 03, 2018 ||| Apogee's Performance to be Marred by View Cut & Inflation ||| Close Update: Dow Climbs to Record, Outpaces Other Indexes; S&P 500, Nasdaq Slip",1,0.508359
2018-10-03,6043300.0,156.0,159.3699951171875,155.7899932861328,158.22000122070312,150.43846130371094,CAT,"The Zacks Analyst Blog Highlights: Atkore International Group, Global Brass and Copper Holdings, Caterpillar and DXP Enterprises ||| Mid-Day Update: Dow Breaks Record As Italy Concedes and ISM Sets 13-Year High ||| Industrial Select Sector SPDR Fund Experiences Big Outflow ||| Stock Market News For Oct 3, 2018 ||| Upbeat Economic Data Sends Nasdaq to Positive Finish ||| Dow Attains All-Time High Level: 5 Terrific Picks ||| Buy Caterpillar (CAT) Stock As It Cuts Costs To Counter Tariffs ||| Correction: Mid-Day Update: Dow Breaks Record As Italy Concedes and ISM Sets 21-Year High ||| Market Close Report: NASDAQ Composite Index closes above 8000; up 25.54 points at 8,025.09 ||| Caterpillar, Denbury, Northrop Grumman, Ross Stores, XLE: 'Halftime Report' Final Trades For Oct. 3",0,0.502869
2018-10-04,4130800.0,158.02999877929688,158.5500030517578,155.1999969482422,156.75,149.04074096679688,CAT,"The Zacks Analyst Blog Highlights: General Motors, Tyson Foods, Boeing, Caterpillar and 3M ||| Why Caterpillar (CAT) is a Great Dividend Stock Right Now ||| These 7 Stocks Will Push the Dow to 27,000 ||| Champions Oncology, Actuant, Caterpillar and Boeing highlighted as Zacks Bull and Bear of the Day ||| Is Caterpillar (CAT) Stock Outpacing Its Industrial Products Peers This Year?",0,0.48360988
2018-10-05,4955100.0,156.50999450683594,156.80999755859375,151.61000061035156,153.30999755859375,145.7699432373047,CAT,Here's Why You Should Buy Caterpillar (CAT) Stock Right Now ||| Close Update: U.S. Stocks Sink for Second Day as Bond Yields Jump After Jobs Data,1,0.49146542
2018-10-08,3463200.0,151.9499969482422,153.66000366210938,150.8800048828125,153.35000610351562,145.80795288085938,CAT,"Top Stock Reports for Apple, Microsoft & Pfizer ||| 5 Dividend Growth Stocks With Upside To Analyst Targets ||| Caterpillar (CAT) Gains As Market Dips: What You Should Know ||| Notable Monday Option Activity: HELE, OMCL, CAT",0,0.48736072
2018-10-09,4996900.0,152.61000061035156,152.61000061035156,149.0800018310547,149.4600067138672,142.10931396484375,CAT,"Dow Movers: CAT, WMT ||| 5 Blue-Chip Stocks to Keep an Eye On",0,0.50544584
2018-10-10,9419300.0,148.6999969482422,149.1699981689453,143.72000122070312,143.72000122070312,136.65159606933594,CAT,"Daily Dividend Report: UTX, FAST, CMI, CAT, SIRI, AOS",0,0.49738654
2018-10-11,7608300.0,142.9499969482422,145.88999938964844,139.83999633789062,140.97000122070312,134.03683471679688,CAT,"Jim Cramer Shares His Thoughts On Alibaba, Caterpillar And More",1,0.5044946
2018-10-12,5596200.0,144.02000427246094,144.39999389648438,139.75,142.07000732421875,135.082763671875,CAT,What To Expect From Caterpillar's Q3 Earnings,0,0.49527863
2018-10-15,3741700.0,142.0,143.17999267578125,141.1199951171875,141.8000030517578,134.8260498046875,CAT,5 Blue Chip Stocks to Watch ||| Caterpillar (CAT) Stock Moves -0.19%: What You Should Know,1,0.51163244
2018-10-16,3573400.0,143.35000610351562,143.88999938964844,141.27000427246094,143.7100067138672,136.64208984375,CAT,Caterpillar Named Top Dividend Stock With Insider Buying and 2.43% Yield (CAT) ||| Caterpillar (CAT) Stock Looks Like A Strong Buy Ahead of Q3 Earnings ||| Surverying The Q3 Earnings Heat Map,0,0.48598385
2018-10-17,4807500.0,143.0800018310547,143.52000427246094,141.11000061035156,141.33999633789062,134.38864135742188,CAT,"Ex-Dividend Reminder: Hormel Foods, Hollysys Automation Technologies and Caterpillar ||| Caterpillar (CAT) to Report Q3 Earnings: What's in the Offing?",0,0.48309
2018-10-18,10250200.0,140.16000366210938,140.8000030517578,134.47000122070312,135.80000305175778,129.12112426757812,CAT,"Dow Movers: CAT, NKE ||| Market Close Report: NASDAQ Composite index closes at 7,485.14 down -157.56 points ||| S&P Holds Key Moving Average Amid Sell-Off ||| Caterpillar, Inc. (CAT) Ex-Dividend Date Scheduled for October 19, 2018 ||| Stocks That Will Be Trading Ex Dividend Fri., Oct. 19, 2018",0,0.46669334
2018-10-19,7055100.0,136.19000244140622,136.92999267578122,131.27000427246094,131.32000732421878,125.6572265625,CAT,"Resource Industries to Aid Caterpillar's (CAT) Q3 Earnings ||| Industrial Earnings Haven't Been Able to Lift the Market. Can Consumer Stocks Save the Day? ||| Market Close Report: NASDAQ Composite index closes at 7,449.03 down -36.11 points ||| Caterpillar is Oversold ||| Stocks Trading Ex Dividend For Fri., Oct. 19, 2018",0,0.4755763
2018-10-22,7858900.0,132.67999267578122,133.1300048828125,128.66000366210938,128.71000671386722,123.15975952148438,CAT,"Caterpillar Stock Is a Strong Buy Ahead of Earnings Tomorrow ||| Halliburton, Schlumberger, Caterpillar and Twitter are part of Zacks Earnings Preview ||| Pre-Market Earnings Report for October 23, 2018 : VZ, MCD, MMM, UTX, LMT, NEE, CAT, BIIB, CNC, GLW, PCAR, RF ||| 5 Top Stock Trades for Tuesday Morning: Trading the Earnings Deluge ||| Caterpillar Holds Post-Earnings Trading Pattern Favoring Downside ||| China's Stock Market Rally & Earnings Previews for CAT, MCD, and LMT ||| Caterpillar 8-K Shows Rolling 3-Month Machine Sales Up 21% For September ||| Caterpillar Q3 Earnings Preview ||| Checking In On The Global Economy With Caterpillar Earnings ||| Benzinga's Week Ahead: Can Tech Earnings Restore The Rally? Amazon, Google To Report ||| Tug-of-War: Volatile October Continues As Bulls, Bears Duke It Out",0,0.46852323
2018-10-23,24113300.0,119.68000030517578,122.5,115.62000274658205,118.9800033569336,113.8493423461914,CAT,"Dow Movers: CAT, MCD ||| Mid-Day Update: Wall Street Dumps Equities as Growth Forecasts Disappoint, Geopolitical Tensions Rise ||| S&P 500 Movers: WAT, CDNS ||| Why the Market Is So Scared by Mixed Results From 3 Dow Stocks ||| US Stock Futures Unhinged by Disappointing Guidance, Asian Market Rout ||| Caterpillar (CAT) Surpasses Q3 Earnings and Revenue Estimates ||| Pre-Market Most Active for Oct 23, 2018 : QQQ, AMD, MCHI, SQQQ, TVIX, CAT, TOT, BP, BAC, LYG, BABA, TQQQ ||| Earnings Reaction History: Caterpillar Inc, 45.5% Follow-Through Indicator, 3.8% Sensitive ||| Tuesday Sector Laggards: Energy, Industrial ||| What Happened in the Stock Market Today ||| Market Close Report: NASDAQ Composite index closes at 7,437.54 down -31.09 points ||| Stocks, Oil Slump in Risk-Off Session ||| Caterpillar Inc (CAT) Q3 2018 Earnings Conference Call Transcript ||| Noteworthy Tuesday Option Activity: CAT, CRR, LVS ||| Why Caterpillar Stock Plunged 10% This Morning ||| Stocks Rally from Session Lows: 3 Great Earnings Reports to Thank ||| Cramer: 3M's Q3 Showed Deterioration, Not Improvement ||| 44 Stocks Moving In Tuesday's Mid-Day Session ||| From Caterpillar Conference Call: Co. Says Has Not Updated 2018 Adjusted Profit Outlook Because Nothing Material Has Changed Since Outlook Was Updated In July ||| Caterpillar Says China Accounts For 5%-10% Of Total Company Sales From Revenues ||| From Caterpillar Conference Call: Co. Says Continues To Expect Industry Sales In China For 10-Ton-And-Above Excavators To Be Up About 40% For The Full Year ||| From Caterpillar Conference Call: Co. Says Recovery In Global Mining Sales Is Still In Early Stages But Expects Higher Demand For New Equipment Moving Forward. ||| From Caterpillar Conference Call: Co. Says For Remainder Of 2018, Expects Normal Seasonal Trends For China ||| From Caterpillar Conference Call: Co. Says Continues To Monitor Construction Equipment Demand In China To Determine Trajectory Of Future Sales In Asia-Pacific ||| Will Tariffs Weigh On Boeing and Ford Earnings? Analysts Don't Seem Too Worried ||| Caterpillar shares are down 9.1% following Q3 earnings; Though the company beat consensus estimates, it reported higher manufacturing costs in the quarter due to tariffs and said freight costs were unfavorable due to increases in steel prices. ||| Wall Street Starts The Day In Risk-off Mood As Global Sentiment Weakens ||| Stocks Which Set New 52-Week Low Yesterday, October 22nd ||| Caterpillar Tumbles After Q3 Earnings Release, Sees Higher Costs Ahead Due To Tariffs ||| Caterpillar Reaffirms FY18 Adj. EPS $11-$12 vs $11.66 Estimate ||| Caterpillar, Inc. Q3 EPS $2.86 Beats $2.83 Estimate, Sales $13.5B Beat $13.18B Estimate ||| 12 Stocks To Watch For October 23, 2018 ||| Earnings Scheduled For October 23, 2018",0,0.4816592
2018-10-24,15304200.0,120.0,121.63999938964844,112.25,112.33999633789062,107.49565887451172,CAT,"The Zacks Analyst Blog Highlights: Microsoft, Caterpillar, Amazon, Walmart and Coca-Cola ||| Wall Street Sacrifices Boeing-Fueled Gains as Chipmakers and Industrials Weigh ||| There’s so Much to like About GOOG Stock Ahead of Earnings ||| Wednesday’s Vital Data: McDonald’s, Caterpillar and Verizon ||| Keep Caterpillar’s Q3 Report in Perspective (Even If Nobody Else Is) ||| Strong Comeback Saves Market From Another Plunge ||| Mid-Day Update: Boeing-Fueled Rally Extinguished As Chipmakers and Industrials Resume Slide ||| Weak Spots in the Earnings Picture ||| Analysts Say The Market Is Getting Caterpillar Earnings Wrong ||| Credit Suisse Maintains Outperform on Caterpillar, Lowers Price Target to $183 ||| Citigroup Maintains Buy on Caterpillar, Lowers Price Target to $160 ||| Stocks Which Set New 52-Week Low Yesterday, October 23rd ||| Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Wed., Oct. 24, 2018 ||| 56 Biggest Movers From Yesterday",1,0.4816306
2018-10-25,13568900.0,114.83000183105467,117.08999633789062,112.5,115.62999725341795,110.64379119873048,CAT,"3 ‘Bounce-Back’ Stocks to Sell Into the False Rally ||| Key Takeaways From Caterpillar's Q3 ||| Zacks Earnings Trends Highlights: Illinois Tool Works, Caterpillar, 3M and Avery Dennison ||| 3 Stocks to Buy and Hold Through the Panic Selling ||| 8 Biggest Price Target Changes For Thursday ||| Snapping Back, But Can Rally Attempt Last? Strong Earnings Might Power Market ||| Benzinga's Top Upgrades, Downgrades For October 25, 2018 ||| DZ Bank Upgrades Caterpillar to Hold, Lowers Price Target to $119",0,0.49132666
2018-10-26,10820400.0,114.0999984741211,116.43000030517578,112.36000061035156,115.0500030517578,110.08880615234376,CAT,"Top Research Reports for McDonald's, Thermo Fisher & Caterpillar ||| 5 Top Stock Trades for Monday: Trading Alphabet, Snap Earnings ||| The Market's Exaggerated Earnings Worries",0,0.50270385
2018-10-29,8069600.0,116.87999725341795,118.3499984741211,112.05999755859376,113.9800033569336,109.06495666503906,CAT,"Bulls & Bears Of The Week: Caterpillar, eBay, Intel, Morgan Stanley And More ||| Barron's Picks And Pans: Bank Of America, Caterpillar, Sensata And More ||| The Zacks Analyst Blog Highlights: McDonald's, Thermo Fisher, Caterpillar, CSX and Celgene ||| Caterpillar (CAT) Dips More Than Broader Markets: What You Should Know ||| These Are The Biggest Stocks Reporting Earnings This Week, And Their Recent Track Records",1,0.47827184
2018-10-30,8057600.0,114.0,117.73999786376952,113.0999984741211,117.45999908447266,112.39488983154295,CAT,"Has Earnings Growth Peaked Already? ||| See Which Of The Latest 13F Filers Holds Caterpillar ||| Stock Market News For Oct 30, 2018 ||| Stocks Which Set New 52-Week Low Yesterday, October 29th ||| Wild Times: Market Seems To Seek Solid Ground After Monday's Manic",1,0.4951333
2018-10-31,10341300.0,119.41000366210938,122.88999938964844,119.26000213623048,121.31999969482422,116.08843231201172,CAT,"3 Takeaways from the Q3 Earnings Season ||| Top Buys by Top Brass: Group President De Lange's $124.8K Bet on CAT ||| Trader looks for Caterpillar to dig out ||| Noteworthy Wednesday Option Activity: AZO, CAT, ALB",1,0.54764307
2018-11-01,10138900.0,122.58999633789062,125.2300033569336,120.94000244140624,124.6999969482422,119.32268524169922,CAT,"Zacks Earnings Trends Highlights: Amazon, Alphabet, Facebook, Caterpillar and 3M ||| Close Update: Stocks Surge as Encouraging Corporate Earnings, Trump Tweet on China Boosts Market ||| Mid-Day Update: Wall Street Perks Up After Trump Talks Trade With Xi ||| This ETF Holds Stocks Insiders Want to Own ||| Caterpillar Files Registration For A Mixed Securities Offering, No Size Disclosed",1,0.5238139
2018-11-02,7683900.0,127.0500030517578,128.30000305175778,124.26000213623048,125.79000091552734,120.36568450927734,CAT,"5 of the Best Blue-Chip Stocks to Ride the Dow Rally ||| Dow Movers: AAPL, CVX ||| Caterpillar Stock Looks Attractive After Pullback",1,0.52850354
2018-11-05,4844200.0,126.08999633789062,126.9499969482422,124.5500030517578,126.41000366210938,120.95895385742188,CAT,Caterpillar (CAT) Gains But Lags Market: What You Should Know ||| A Foolish Take: The Biggest Losers in the Dow's October Swoon ||| 3 Weakening Stocks to Short Today ||| How Alcoa Fell 13.4% in October on Fears Over China,1,0.48627594
2018-11-06,4728200.0,126.4000015258789,129.5,126.30999755859376,129.33000183105472,123.75302124023438,CAT,Stock Futures Defensive as Mid-Term Election Results Loom ||| Dow Gains Ahead of Election Results ||| Close Update: Buying Erupts Into The Close as Wall Street Positions For Mid-Term Results,1,0.49528658
2018-11-07,7551900.0,133.52000427246094,135.22000122070312,130.8800048828125,135.10000610351562,129.27421569824222,CAT,"Wednesday's ETF with Unusual Volume: FXR ||| Terex Corporation (TEX) Ex-Dividend Date Scheduled for November 08, 2018 ||| Market Close Report: NASDAQ Composite index closes at 7,570.75 up 194.79 points ||| Columbus McKinnon Corporation (CMCO) Ex-Dividend Date Scheduled for November 08, 2018 ||| CAT Stock Is Primed for a Big Comeback, Despite Trade War ||| Dow Jumps 545 Points After Midterms ||| Noteworthy Wednesday Option Activity: COL, CAT, CMG",0,0.4863388
2018-11-08,6269400.0,133.83000183105472,134.69999694824222,130.89999389648438,131.38999938964844,125.72421264648438,CAT,"Notable ETF Outflow Detected - SPTM, LMT, BMY, CAT ||| Dow Movers: CAT, GS ||| Zacks Earnings Trends Highlights: Amazon, Alphabet, Facebook, Caterpillar and 3M ||| Astec Industries, Inc. (ASTE) Ex-Dividend Date Scheduled for November 09, 2018 ||| Recession Watch: 5 Charts You Need to See ||| Market Close Report: NASDAQ Composite index closes at 7,530.89 down -39.86 points ||| Dow Ekes Out a Gain After Fed Surprises No One ||| Hearing CAT IR Says Co. Will Buy Back More Shares In Q4 Than Q3 ||| CAT Shares Spike Higher From Session Lows, Hearing Co. Spokesperson Says Was Positively Surprised By October China Sales",0,0.4700981
2018-11-09,7248400.0,129.58999633789062,129.60000610351562,125.7300033569336,126.91000366210938,121.43739318847656,CAT,"Wall Street Spooked by Inflation Data, Sluggish Chinese Growth ||| Dow Movers: CAT, DIS",0,0.4878346
2018-11-12,5870100.0,127.18000030517578,128.41000366210938,124.58999633789062,125.0,119.6097412109375,CAT,"Stock Market News For Nov 12, 2018 ||| Caterpillar (CAT) Stock Moves -1.51%: What You Should Know ||| Why Caterpillar Inc. Stock Cratered 20.4% in October",1,0.48417827
2018-11-13,5820200.0,125.5,129.78999328613278,125.27999877929688,125.95999908447266,120.52835083007812,CAT,"3 Post-Midterm Buys for 6.5% Dividends and 240% Payout Growth ||| Mid-Day Update: Wall Street Bounces Back as Trade Talks Seen Back On, Tech Recovers ||| Dow Movers: BA, INTC ||| Caterpillar Reports Asia/Pacific Machines Retail Sales For 3 Month Rolling Period Ended Oct 20 Up 20%, North America Up 21%, Latin America Up 23% ||| The Simply Good Foods Company Reports $50M Buyback",0,0.53003484
2018-11-14,5516300.0,127.2699966430664,129.0,123.7300033569336,125.0999984741211,119.70542907714844,CAT,"Dow Movers: UNH, NKE ||| Caterpillar's Retail Sales Growth Continues to Decelerate",1,0.51805985
2018-11-15,5815200.0,124.31999969482422,130.27999877929688,123.12999725341795,129.41999816894528,123.83914184570312,CAT,"Zacks Earnings Trends Highlights: Macy???s, Amazon, Alphabet, Facebook and Caterpillar",1,0.5070981
2018-11-19,5385600.0,129.14999389648438,129.49000549316406,125.5999984741211,125.9800033569336,120.5474853515625,CAT,"Stock Market News For Nov 19, 2018",0,0.4689309
2018-11-21,4759500.0,122.81999969482422,126.22000122070312,122.51000213623048,123.87000274658205,118.52848052978516,CAT,"Dow Movers: JNJ, CAT ||| Caterpillar (CAT) Outpaces Stock Market Gains: What You Should Know",0,0.47349438
2018-11-23,3130100.0,121.95999908447266,124.0500030517578,121.56999969482422,122.31999969482422,117.0453109741211,CAT,Caterpillar (CAT) Up 10.3% Since Last Earnings Report: Can It Continue?,1,0.4806499
2018-11-26,4696600.0,123.6500015258789,125.79000091552734,123.16000366210938,124.8000030517578,119.41837310791016,CAT,"Data Dive, Trade Talks And Powell: Busy Post-Holiday Week On The Way",0,0.50183755
2018-11-27,4049400.0,124.0,124.5999984741211,122.38999938964844,124.5999984741211,119.22698974609376,CAT,"Caterpillar (CAT) Stock Sinks As Market Gains: What You Should Know ||| 3 Stocks to Trade This Week: GM, NVDA, CAT",1,0.47703528
2018-11-28,5745200.0,125.3000030517578,130.77999877929688,123.83999633789062,130.77000427246094,125.13094329833984,CAT,"Hyster-Yale Materials Handling, Inc. (HY) Ex-Dividend Date Scheduled for November 29, 2018 ||| NASDAQ Composite Index closes up .85 points for the week, rising for the 3rd straight day ||| Dow Has Best Day Since March After Fed Speech ||| Noteworthy Wednesday Option Activity: PDFS, CELG, CAT",0,0.47982183
2018-11-29,4999600.0,130.80000305175778,130.91000366210938,127.58999633789062,130.22999572753906,124.6142120361328,CAT,"Stock Market News For Nov 29, 2018 ||| Powell Pop: After Sharp Rally On Fed Speech, Nerves Still Seem Frayed",1,0.48981786
2018-11-30,8458200.0,130.05000305175778,135.97000122070312,129.83999633789062,135.66999816894528,129.81962585449222,CAT,"Market Close Report: NASDAQ Composite index closes at 7,330.54 up 57.46 points ||| Close Update: Trump Reassurances on Trade Meeting Fuels Rally ||| S&P, Nasdaq Log Best Week Since 2011 ||| Friday Sector Leaders: Utilities, Industrial",1,0.4963863
2018-12-03,9365800.0,141.8800048828125,142.41000366210938,138.52999877929688,138.94999694824222,132.95819091796878,CAT,"7 Blue-Chip Stocks for the Market Comeback ||| Stock Market News For Dec 3, 2018 ||| Monday’s Vital Data: Pfizer, Goldman Sachs and Caterpillar ||| Time to Buy Caterpillar (CAT) Stock After U.S.-China Trade Ceasefire? ||| 10 Stocks to Buy With The Trade War on Pause ||| Big Deal Or Little Deal? What's The Deal With Trump's Trade Truce? ||| Bank Of America Sees 20% Upside In Caterpillar ||| Shares of Caterpillar and sector-related stocks are moving higher after analysts at Bank of America upgraded Caterpillar shares from Neutral to Buy, citing last week's 'less-hawkish' Fed meeting and a temporary tariff truce between the US and China. ||| 10 Biggest Price Target Changes For Monday ||| Trade Truce: Market Appears To Get A Big Lift As Tariff Fears Retreat After G20 ||| Benzinga's Top Upgrades, Downgrades For December 3, 2018 ||| Bank of America Upgrades Caterpillar to Buy, Raises Price Target to $163",0,0.51530206
2018-12-04,8113400.0,138.08000183105472,138.08000183105472,129.03999328613278,129.32000732421878,123.74346923828124,CAT,"Dow Movers: CAT, VZ ||| Manchester United, Big Five Sporting, Caterpillar, Terex and Deere highlighted as Zacks Bull and Bear of the Day ||| Market Close Report: NASDAQ Composite index closes at 7,158.43 down -283.08 points ||| Stocks Pummeled on Trade Fears, Bond Yields ||| Ahead Of Mid-Week Pause, Investors Fret Over Trade Pact Details",0,0.48348433
2018-12-07,6413700.0,129.10000610351562,129.97999572753906,122.75,123.5500030517578,118.2222671508789,CAT,Starbucks Stock Is Worth Trading With This Out-of-the-Box Pairs Partner ||| The 5 Things I Look For In A Potential Trade,0,0.4896321
2018-12-10,5970900.0,122.41000366210938,124.37000274658205,121.16000366210938,123.38999938964844,118.06917572021484,CAT,"Barron's Picks And Pans: Apple, Caterpillar, Lennar And More ||| Caterpillar (CAT) Stock Sinks As Market Gains: What You Should Know ||| Here’s Why Caterpillar Stock Jumped 11.8% in November but Is Plunging in December",0,0.47847292
2018-12-12,5544100.0,125.73999786376952,127.97000122070312,125.0999984741211,125.37000274658205,119.96379089355467,CAT,"Dow Movers: VZ, MMM ||| Better Buy Heading into 2019: Boeing (BA) vs. Caterpillar (CAT) Stock ||| Daily Dividend Report: BEN, MO, CAT, XEL, ZBH",1,0.4860471
2018-12-13,4544100.0,126.4499969482422,129.11000061035156,125.04000091552734,125.9000015258789,120.47093963623048,CAT,"Dow Movers: CVX, PG ||| Zacks Earnings Trends Highlights: Caterpillar, Honeywell and 3M ||| Caterpillar Names CEO Jim Umpleby Chair",1,0.49275255
2018-12-14,4483300.0,123.41999816894533,127.73999786376952,123.1500015258789,126.7699966430664,121.3034210205078,CAT,"Dow Movers: JNJ, JPM ||| Stock Market News For Dec 14, 2018 ||| Caterpillar November Sales Up 16%, Lowest So Far This Year ||| Market Close Report: NASDAQ Composite index closes at 6,910.67 down -159.66 points ||| Dow Drops Nearly 500 Points; S&P Marks Lowest Close in Months ||| Caterpillar Option Alert: Dec 21 $126 Calls Sweep (34) near the Ask: 502 @ $3.6 vs 1568 OI; Earnings 1/28 Before Open Ref=$127.1699 ||| Caterpillar 8-K Shows Chief Accounting Officer Jananne Copeland To Retire ||| Caterpillar 8-K Thurs. Showed Rolling 3-Month Machine Retail Sales Up 16% Year Over Year",0,0.4695635
2018-12-17,5662300.0,126.8000030517578,127.6500015258789,123.68000030517578,124.47000122070312,119.10260009765624,CAT,Caterpillar (CAT) Stock Moves -1.81%: What You Should Know,0,0.46623743
2018-12-18,5377900.0,125.87000274658205,128.75,123.5999984741211,124.2699966430664,118.91121673583984,CAT,15 Stocks Facing Big Political Risk in 2019 ||| Dow Analyst Moves: CAT ||| Fed Meeting Starts With Market Off To Worst December Start in 38 Years,0,0.5024347
2018-12-19,6416500.0,125.06999969482422,128.94999694824222,120.8000030517578,122.33000183105467,117.0548858642578,CAT,"Dow Movers: AXP, CAT ||| Douglas Dynamics, Inc. (PLOW) Ex-Dividend Date Scheduled for December 20, 2018",0,0.45444208
2018-12-21,10034100.0,121.7300033569336,123.7300033569336,119.56999969482422,120.06999969482422,114.892333984375,CAT,"DIA, GS, CAT, TRV: Large Outflows Detected at ETF",0,0.5248006
2018-12-24,2986600.0,118.16999816894533,119.58999633789062,116.66999816894533,116.9499969482422,111.90686798095705,CAT,What's in Store for Caterpillar in 2019? ||| Countdown to 2019: Lessons From the Dow's Painful Year ||| Losing Its FAANG: Market Struggles In 2018 As Tech Rally Slows ||| Manufacturing - Construction & Mining Industry: Prospects Dim,1,0.48137125
2018-12-26,5093700.0,118.0,124.7699966430664,116.08999633789062,124.76000213623048,119.38011169433594,CAT,"Stock Market News For Dec 26, 2018 ||| Benzinga's Top Upgrades, Downgrades For December 26, 2018",1,0.47991303
2018-12-28,3813500.0,127.12999725341795,128.25,125.0500030517578,125.61000061035156,120.19343566894533,CAT,"Caterpillar (CAT) Dips More Than Broader Markets: What You Should Know ||| Noteworthy Friday Option Activity: CRC, SNBR, CAT",1,0.47894853
2018-12-31,3455200.0,126.5999984741211,128.11000061035156,124.5,127.06999969482422,121.59048461914062,CAT,"DIA, CAT, TRV, UTX: ETF Outflow Alert ||| Stock Market News For Dec 31, 2018 ||| Wabash National Corporation (WNC) Ex-Dividend Date Scheduled for January 02, 2019 ||| Caterpillar Option Alert: Jan 18 $135 Calls at the Ask: 900 @ $1.301 vs 6782 OI; Earnings 1/28 Before Open Ref=$125.75",0,0.47203162
2019-01-02,4783200.0,124.02999877929688,127.87999725341795,123.0,126.37999725341795,120.93022918701172,CAT,"Previewing the Q4 Earnings Season ||| Previewing the Q4 Earnings Season ||| Stock Market News For Jan 2, 2019",0,0.49723026
2019-01-03,6165800.0,125.30999755859376,125.5,120.44000244140624,121.51000213623048,116.2702407836914,CAT,"Zacks Earnings Trends Highlights: FedEx, Caterpillar, Honeywell and 3M ||| Better Buy for 2019: Caterpillar vs. Deere ||| Alcoa Stock Has Been Decimated, But There Is Light Ahead ||| Shares of several tech stocks are trading down after Apple cut Q1 sales guidance.",1,0.5087877
2019-01-04,5456600.0,124.16999816894533,128.58999633789062,123.6999969482422,128.14999389648438,122.62390899658205,CAT,"Dow Movers: WMT, INTC",1,0.51758707
2019-01-07,4653400.0,128.58999633789062,129.60000610351562,126.6999969482422,128.22999572753906,122.7004623413086,CAT,"Will Caterpillar Raise Its Dividend in 2019? ||| The Zacks Analyst Blog Highlights: Bank of America, PepsiCo, Union Pacific, Caterpillar and Mondelez ||| Improving Demand to Drive Caterpillar Despite Higher Costs ||| Caterpillar (CAT) Gains But Lags Market: What You Should Know",1,0.46853852
2019-01-08,4202600.0,129.89999389648438,131.5,128.22999572753906,129.77000427246094,124.1740493774414,CAT,"Why Caterpillar Lost 19.4% in 2018 ||| Dow Movers: GS, CAT ||| 200 Million Reasons Why 3M's Latest Buy Is a Smart Move",1,0.49038616
2019-01-09,4865600.0,131.08999633789062,132.22000122070312,129.91000366210938,130.27000427246094,124.65250396728516,CAT,"SPDR Dow Jones Industrial Average ETF Experiences Big Outflow ||| Watching The Clock: Trade Talks End With Optimism, But Deadline Draws Closer",1,0.50666964
2019-01-10,3418500.0,128.61000061035156,133.1199951171875,127.25,132.96000671386722,127.22649383544922,CAT,Trump's attorney general nominee to recuse from AT&T-Time Warner appeal ||| 5 Dividend Aristocrats Where Analysts See Capital Gains,0,0.49712384
2019-01-11,2908600.0,131.08000183105472,132.32000732421878,130.05000305175778,132.10000610351562,126.4035873413086,CAT,"Dow Movers: CAT, INTC",0,0.5136868
2019-01-14,4482300.0,130.30999755859378,132.38999938964844,129.1300048828125,131.80000305175778,126.11652374267578,CAT,"Why Fluor Slumped in 2018 ||| Stock Market News for Jan 14, 2019 ||| Dow Movers: CAT, GS",0,0.47985384
2019-01-16,3636900.0,130.75999450683594,132.52000427246094,130.24000549316406,131.66000366210938,125.9825668334961,CAT,Reminder - Caterpillar (CAT) Goes Ex-Dividend Soon,1,0.49106365
2019-01-17,6878500.0,130.47000122070312,135.89999389648438,129.16000366210938,134.53999328613278,128.73834228515622,CAT,"DIA, GS, CAT, TRV: Large Inflows Detected at ETF ||| Can Caterpillar (CAT) Keep the Earnings Surprise Streak Alive? ||| Caterpillar, Inc. (CAT) Ex-Dividend Date Scheduled for January 18, 2019 ||| Close Update: Wall Street Heads For The Exits With Solid Gains as Friendly Trade Headlines Trigger Late Rally ||| Bank Season Hits Roadblock As Morgan Stanley Earnings Appear To Disappoint",1,0.4589668
2019-01-18,6122400.0,135.10000610351562,137.72000122070312,133.66000366210938,136.60000610351562,131.55043029785156,CAT,Will Caterpillar (CAT) Retain Earnings Beat Trend in Q4? ||| Stocks Score Big Win Ahead of Holiday Weekend ||| Hope Takes Flight: China Optimism Has Markets Looking Strong Ahead of Weekend,0,0.49641106
2019-01-22,5188700.0,134.92999267578122,134.94000244140622,131.16999816894528,132.24000549316406,127.35159301757812,CAT,"Caterpillar (CAT) Earnings Expected to Grow: Should You Buy? ||| Stock Market News For Jan 21, 2019 ||| Market Close Report: NASDAQ Composite index closes at 7,020.36 down -136.87 points ||| 3 Top Mining Stocks to Watch Now ||| Dow Drops 300 Points on Troubling China Headlines ||| Stock Market News For Jan 22, 2019 ||| Close Update: Economic Anxiety Sends US Stock Indexes Tumbling to Kick Off Shortened Trading Week ||| US Agriculture Department Says All Farm Service Agency Offices Will Soon Re-Open Despite Partial Government Shutdown ||| Shares of several petroleum companies are trading lower after crude oil prices drop over 3% on concerns of an economic slowdown in China.",0,0.4911783
2019-01-23,3123600.0,133.03999328613278,133.49000549316406,130.14999389648438,131.82000732421878,126.94713592529295,CAT,"Geopolitics Aside, How About Those Earnings? Investors Appear To Switch Focus",1,0.5201927
2019-01-24,3943600.0,131.41000366210938,132.99000549316406,131.19999694824222,132.72999572753906,127.823486328125,CAT,"Avery Dennison (AVY) to Report Q4 Earnings: What to Expect? ||| Will GPU Product Introduction Benefit AMD's Q4 Earnings? ||| Factors Expected to Influence Microsoft's (MSFT) Q2 Earnings ||| Noteworthy Thursday Option Activity: VMC, CAT, AMAT ||| Jim Cramer Shares His Thoughts On PG&E, Tenneco And More ||| Amarin, Caterpillar, McDonald's, Xilinx: 'Fast Money' Picks For January 24",1,0.511971
2019-01-25,6417400.0,134.77000427246094,136.88999938964844,133.88999938964844,136.86000061035156,131.80081176757812,CAT,"Is a Surprise Coming for Caterpillar (CAT) This Earnings Season? ||| Ball Corporation (BLL) to Post Q4 Earnings: What to Expect? ||| Upcoming Earnings Reports to Watch: CAT, AAPL, FB ||| 5 Machinery Stocks Likely to Surpass Q4 Earnings Estimates ||| Positive EPS & Revenue Surprises Hard to Come By ||| Notable ETF Outflow Detected - DIA, GS, CAT, TRV ||| Pre-Market Earnings Report for January 28, 2019 : CAT, BOH, ARLP, CADE, OPB, BMRC, SALT, PROV ||| Pentair (PNR) to Report Q4 Earnings: What's in the Offing? ||| Caterpillar Looks Good Ahead of Q4 Earnings ||| Stock Market Gets Lift On Deal To Reopen Govt.; Positive Trade, Fed News Also Help",0,0.47592768
2019-01-28,17421400.0,126.98999786376952,127.8000030517578,123.1500015258789,124.37000274658205,119.77252197265624,CAT,"Is Fluor a Buy? ||| Barron's Picks And Pans: Caterpillar, Dell, Intel And More ||| Caterpillar, Apple, Facebook and Microsoft are part of Zacks Earnings Preview ||| Mid-Morning Market Update: Markets Open Lower; Caterpillar Profit Misses Expectations ||| Why Caterpillar Stock Crashed 9% Today ||| Caterpillar Earnings: CAT Stock Slides Lower on Big Miss ||| Mid-Day Market Update: Crude Oil Down Over 3%; Trevena Shares Spike Higher ||| Major Averages Posting Steep Losses In Mid-Day Trading - U.S. Commentary ||| Stocks Show Significant Move To The Downside - U.S. Commentary ||| Caterpillar (CAT) Q4 Earnings, Revenues Lag Estimates, Up Y/Y ||| Caterpillar (CAT) Misses Q4 Earnings and Revenue Estimates ||| Spirit, Red Robin, Caterpillar, Apple and FedEx highlighted as Zacks Bull and Bear of the Day ||| US STOCKS-Wall Street drops more than 1 pct on Caterpillar, Nvidia warnings ||| Wall Street drops more than 1 pct on Caterpillar, Nvidia warnings ||| Dow Movers: CAT, PG ||| Should You Buy Caterpillar Stock on This Downdraft? ||| Wall Street Tips Lower as Busy Earnings Week Kicks Off With Disappointing Caterpillar Earnings ||| Stocks May Open Lower On Disappointing Caterpillar Earnings - U.S. Commentary ||| Caterpillar forecasts 2019 profit below estimates ||| Wall Street To Open In The Red ||| Pre-Market Most Active for Jan 28, 2019 : VALE, TWTR, PCG, AMD, SQQQ, CAT, NFLX, ERIC, QQQ, NOK, CHK, TVIX ||| Mid-Day Update: Wall Street Bloodied By Warnings From Caterpillar and Nvidia ||| Soft Start Predicted For China Stock Market ||| Why Boeing Is a Strong Buy Stock and News from CAT, NVDA, & VALE ||| Dow, NASDAQ Rise Just Enough for a 5-Week Rally ||| Whirlpool says costs, strong dollar to hit 2019 profit, shares fall ||| Caterpillar stock slides on profit miss, China sales forecast ||| Caterpillar 4th-qtr profit misses estimate badly, shares slide ||| Dow Futures Drop 93 Points Because the Market's Waiting For Wednesday's Fed Meeting ||| More Pain Predicted For Singapore Stock Market ||| Earnings Reaction History: Caterpillar Inc, 45.5% Follow-Through Indicator, 4.0% Sensitive ||| What Happened in the Stock Market Today ||| Caterpillar Q4 18 Earnings Conference Call At 11:00 AM ET ||| Market Close Report: NASDAQ Composite index closes at 7,085.69 down -79.17 points ||| Dow Falls 208 Points on China Slowdown Fears ||| Stocks Move Significantly Lower On Disappointing Earnings News - U.S. Commentary ||| C$ reverses from 2-week high on global growth worries ||| Wall Street ends lower as Caterpillar, Nvidia warnings weigh ||| US STOCKS SNAPSHOT-Wall Street ends lower as Caterpillar, Nvidia warnings weigh ||| Bond prices rise after strong demand at $162 billion auctions ||| Caterpillar Q4 Profit Misses View; Stock Down ||| Mid-Afternoon Market Update: Dow Falls 280 Points; Avalon GloboCare Shares Surge ||| 36 Stocks Moving In Monday's Mid-Day Session ||| Mid-Day Market Update: Crude Oil Down Over 3%; Trevena Shares Spike Higher ||| From Caterpillar Conference Call; Co. Says In A Much ""Better"" Position To Generate Cash If There Is A Market Downturn ||| From Caterpillar Conference Call: Co. Says Expect Construction Industries Sales In China To Be Flat After 40% Increase In Industry Sales In 2018 ||| Caterpillar Says Tariffs Cost the Company $100M in 2018 ||| Caterpillar Says Better Than Expected Product Pricing was Offset By Higher Material and Freight Costs ||| Deal To Reopen Govt. Boosts Wall Street As Trade, Fed News Also Help ||| Mid-Morning Market Update: Markets Open Lower; Caterpillar Profit Misses Expectations ||| Nvidia Cuts Q4 Sales Guidance, Chips Stocks Tumble ||| Caterpillar shares are trading lower after the company missed Q4 EPS and sales estimates. Stocks in the farm and construction equipment space are trading down in sympathy. ||| Benzinga Pro's Top 7 Most-Searched Tickers For Morning Of Mon., Jan. 28, 2019 ||| Caterpillar shares are trading lower after the company reported Q4 EPS of $2.55 versus the $2.99 analyst estimate. ||| Caterpillar Sinks On Q4 Earnings Miss ||| Caterpillar Sees FY19 EPS $11.75-$12.75 vs $12.64 Est. ||| Caterpillar Q4 Adj. EPS $2.55 Misses $2.99 Estimate, Sales $14.3B Miss $14.33B Estimate ||| A Peek Into The Markets: US Stock Futures Down, Caterpillar Earnings In Focus ||| 8 Stocks To Watch For January 28, 2019 ||| Earnings Scheduled For January 28, 2019",1,0.47614762
2019-01-29,8550800.0,125.61000061035156,128.38999938964844,125.61000061035156,126.52999877929688,121.85266876220705,CAT,"The One Big Concern This Earnings Season ||| Caterpillar Inc. (CAT) Q4 2018 Earnings Conference Call Transcript ||| Tuesday’s Vital Data: Caterpillar, Cronos Group, Nvidia ||| Gold hits eight-month peak on U.S.-China trade woes; focus on Fed ||| Q1 Earnings Growth Turns Negative ||| European Shares Set To Fall On US-China Trade Worries ||| PRECIOUS-Gold hits eight-month peak on U.S.-China trade woes; focus on Fed ||| The Street Reacts To Caterpillar's First Notable Miss In Years ||| Apple Today, Powell Tomorrow: Busy Earnings And Fed Week Continues ||| Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Tues., Jan. 29, 2019 ||| 50 Biggest Movers From Yesterday",1,0.5056413
2019-01-30,7181600.0,127.93000030517578,131.35000610351562,126.30999755859376,130.11000061035156,125.30032348632812,CAT,"Today, Companies Blame China. Tomorrow, They'll Blame the Shutdown ||| Columbus McKinnon Corporation (CMCO) Ex-Dividend Date Scheduled for January 31, 2019 ||| Zacks Earnings Trends Highlights: Apple, Caterpillar and Nvidia ||| Apple, Boeing And The Fed: A Full Day Ahead As Earnings Help Recharge Wall Street",1,0.47871774
2019-01-31,6643300.0,130.32000732421878,133.33999633789062,129.03999328613278,133.16000366210938,128.23759460449222,CAT,"Why Caterpillar's Quarterly Miss Isn't as Bad as It Looks ||| Here’s Why Boeing Stock Will Run Up To All-Time Highs In 2019 ||| Market Close Report: NASDAQ trading volume joins the top ten ranking for the year. NASDAQ Composite Index closes at 7,281.74 ||| January Markets: Fed Stays ""Patient"" And Earnings Brew ||| Earnings, Volatility, Brexit Are Key Topics Heading Into February ||| 'Caterpillar unveils an all-electric 26-ton excavator with a giant 300 kWh battery pack' -Earlier Electrek Article",0,0.4748518
2019-02-01,5646700.0,133.02999877929688,133.86000061035156,130.11000061035156,130.91000366210938,126.07077026367188,CAT,Caterpillar (CAT) Stock Sinks As Market Gains: What You Should Know,0,0.47007698
2019-02-04,4541700.0,130.8800048828125,131.30999755859378,130.10000610351562,130.8800048828125,126.0418701171875,CAT,"Time to Buy Caterpillar Stock? ||| Were Rockwell Automation's Earnings Enough to Refute the Doubters? ||| DIA, CAT, TRV, WMT: Large Outflows Detected at ETF ||| It’s Time to Short the Dead Cat Bounce in Caterpillar Stock ||| Week in Review: Easy Fed Helps S&P 500 Cap Best January Since 1987",1,0.47827137
2019-02-05,3614500.0,130.6300048828125,132.10000610351562,130.60000610351562,132.0,127.12046813964844,CAT,Caterpillar Option Alert: Mar 15 $135 Calls Sweep (6) near the Ask: 500 @ $2.771 vs 2815 OI; Ref=$130.88,0,0.46595958
2019-02-06,3098200.0,131.27000427246094,132.10000610351562,130.36000061035156,130.53999328613278,125.71443176269533,CAT,Engine maker Cummins reports 12 percent rise in quarterly sales ||| Slowing Earnings Growth Ahead ||| Slowing Earnings Growth Ahead,0,0.5562556
2019-02-07,3682100.0,129.28999328613278,130.44000244140622,127.36000061035156,128.77999877929688,124.01950073242188,CAT,"57 Best Dividend Stocks You Can Count On in 2019 ||| Close Update: Global Economic Slowdown, Stalled Trade Talks Roil Wall Street",0,0.5068351
2019-02-08,3135000.0,127.4800033569336,128.60000610351562,126.5500030517578,128.60000610351562,123.84616088867188,CAT,"Stock Market News For Feb 8, 2019 ||| Mid-Day Update: Global Growth Gloom and Trade Tensions Drive Dow To Weekly Loss ||| Noteworthy Friday Option Activity: MTB, GE, CAT ||| Dow 30 Stock Roundup: Disney Earnings Impress, Pfizer's Cancer Drug Gets CHMP Nod",1,0.48545253
2019-02-11,2648100.0,128.94999694824222,130.07000732421878,128.69000244140622,128.92999267578122,124.16394805908205,CAT,5 Dividend Growth Stocks With Upside To Analyst Targets,1,0.5329772
2019-02-12,4505600.0,130.25999450683594,133.55999755859378,130.0,132.66999816894528,127.76570892333984,CAT,"Dow Movers: PG, MRK ||| As Multinationals Flounder, Two Small Caps Can Bring Big Gains ||| NASDAQ Composite Index closes up 9.71 points for the week, rising for the 3rd straight day ||| Dow Shoots Higher as Shutdown Fears Ease ||| Stock Market News: Aurora Opens Marijuana Earnings Season While Caterpillar Celebrates Trade Talks ||| Only Six Dow Components With Recent Insider Buying, CAT is One of Them",1,0.5393003
2019-02-13,3189600.0,134.19999694824222,134.30999755859378,132.44999694824222,133.10000610351562,128.1798095703125,CAT,Q4 2018 Earnings Season Scorecard ||| Q4 2018 Earnings Season Scorecard ||| Deere Stock Dips on Downgrade ||| Bank Of America Downgrades Deere After Big Run ||| Caterpillar 8-K Shows Rolling 3-Month Retail Total Machine Sales Up 9% Year Over Year In Jan.,0,0.5170476
2019-02-14,2877500.0,131.77999877929688,133.25,131.27000427246094,132.6199951171875,127.717529296875,CAT,"Will Deere (DE) Stock Continue to Climb After Q1 Earnings? ||| Zacks Earnings Trends Highlights: Apple, Caterpillar and Nvidia ||| Stock Market News For Feb 14, 2019 ||| Caterpillar Says Have About 104,000 Employees At Dec 31, 2018, Up About 5.7 Percent From At Dec 31, 2017 ||| Valentine's Card From The Market: Trade Optimism Continues, Cisco Posts Strong Quarter",1,0.4642228
2019-02-15,5217500.0,134.10000610351562,136.25,133.67999267578122,136.19999694824222,131.16520690917972,CAT,"The Zacks Analyst Blog Highlights: Caterpillar, Netflix, Philip Morris International, Altria and Verizon ||| Notable Friday Option Activity: CFR, CAT, UPLD",0,0.49281108
2019-02-20,6199000.0,136.38999938964844,140.69000244140622,136.33999633789062,140.30999755859378,135.12326049804688,CAT,"Dow Movers: WBA, CAT ||| CAT Completed a Bullish Inverted Head-and-Shoulders Pattern ||| Q4 Earnings Season Winding Down ||| Q4 Earnings Season Winding Down ||| Market Close Report: NASDAQ Composite index closes at 7,489.07 up 2.30 points ||| Dow Pops After Fed Minutes ||| Caterpillar Breaks Above 200-Day Moving Average - Bullish for CAT ||| Caterpillar Exec Speaking At Barclays Global Industrials Conference: Price Increases Will Offset Inflation Headwinds, Sees Some Dealer Inventory Growth Ahead Of Spring 2019 ||| UPDATE From Earlier China Demand Headline: Caterpillar Exec At Barclays Global Industrials Conference Says Seeing 'Very Strong' Chinese Demand In 2019 ||| Caterpillar Shares Make Near-Term Parabolic Move, Spike To Session High, Now Selling Off As Apparent Confusion On Recent Headlines From Co. ||| Caterpillar Shares Spike To Session High Over $139 As Traders Circulate Comment About China Demand In 2019; Shares Up 2.6% For Session ||| Caterpillar Option Alert: Fri $140 Calls Sweep (20) near the Ask: 1747 @ $0.35 vs 4858 OI; Ref=$137.58",0,0.4883272
2019-02-21,4051100.0,139.75,140.97999572753906,138.41000366210938,138.8800048828125,133.74613952636722,CAT,"Dow Movers: WBA, MCD ||| Stock Market News For Feb 21, 2019 ||| Are We Heading into an Earnings Recession?",0,0.4866843
2019-02-22,3485000.0,138.77999877929688,139.69000244140622,137.92999267578122,138.67999267578122,133.55352783203122,CAT,"Mid-Day Update: Dow Hits Highest Level in 2019 as Trade Optimism Overshadows Growth Concerns ||| Trump Says We Are Doing Well For Farmers, It Will Be The Biggest Farm Deal Ever Made ||| Market Appears Hopeful On Trade Deal As Trump Meets With Chinese Negotiator ||| Watching Caterpillar, Xerox Shares Amid Headline EU Said Its Ready To Target Cat, Xerox If Pres Trump Targets Auto Tariffs ||| EU Said Ready To Target Caterpillar, Xerox If Trump Hits Cars",1,0.50614995
2019-02-25,4444100.0,140.99000549316406,142.5500030517578,140.17999267578122,141.41000366210938,136.1826171875,CAT,"Dow Movers: PG, GS ||| 3 Risky but Potentially High-Reward Stocks ||| Stocks Rise on China Trade Negotiations ||| Surprising Analyst 12-Month Target For OEW ||| Notable Monday Option Activity: COG, XLNX, CAT ||| As Trade Optimism Grows, Markets Turn Green and Boeing, Caterpillar Among Leaders",0,0.53279394
2019-02-26,7275600.0,136.52999877929688,139.02999877929688,135.27000427246094,137.97999572753906,132.87940979003906,CAT,"Mid-Day Update: Stocks Hover Near Unchanged As Wall Street Digests Soft Housing Data, Upbeat Consumer Confidence and Fed's Powell ||| Caterpillar's Crushing Downgrade: What You Need to Know ||| Stocks Struggle to Stay Positive As Upbeat Consumer Confidence Overshadowed by Powell ||| Caterpillar News: Why CAT Stock Is Crumbling Today ||| Stock Market News: Aurora Buys Portuguese Pot, Caterpillar Comes Down ||| Dow Movers: HD, NKE ||| Home Depot, Caterpillar weigh on futures; Fed testimony awaited ||| US STOCKS-Home Depot, Caterpillar weigh on futures; Fed testimony awaited ||| Wall St edges lower in choppy session ||| US STOCKS-Wall St edges lower in choppy session ||| Stocks End Seesaw Session Lower with Powell, Data In Focus ||| Close Update: US Stocks Slip Late to Post Fractional Losses in Choppy Session ||| US Stocks Managing Fractional Gains Late in Choppy Session ||| 5 Must-See Stock Trades for Wednesday: HD, CAT, SHAK, HTZ ||| US STOCKS-S&P swivels on mixed data, Fed comments help steady nerves ||| The Double Downgrade Hurting Caterpillar's Stock ||| Soft Touch: Home Depot's Earnings Miss, Caterpillar Downgrade Both Appear To Weigh ||| 10 Biggest Price Target Changes For Tuesday ||| Benzinga's Top Upgrades, Downgrades For February 26, 2019 ||| UPDATE: UBS On Caterpillar Also Expects Co's ''2020 EPS to decline ~8% YoY, as continued growth in mining and buybacks will not be enough to offset headwinds in construction and oil & gas' ||| UPDATE: UBS Downgrades Caterpillar From Buy To Sell As Firm Believes '~55% of CAT's end markets will peak in 2019, pressuring revenue and margins in 2020 as demand declines' ||| 25 Stocks Moving In Tuesday's Pre-Market Session ||| Caterpillar shares are trading lower after UBS downgraded the stock from Buy to Sell and announced a $125 price target. ||| A Peek Into The Markets: US Stock Futures Drop Ahead Of Fed Chairman's Testimony ||| UBS Downgrades Caterpillar to Sell, Lowers Price Target to $125",1,0.50783634
2019-02-27,3441000.0,137.86000061035156,139.63999938964844,137.13999938964844,139.58000183105472,134.42027282714844,CAT,"Hyster-Yale Materials Handling, Inc. (HY) Ex-Dividend Date Scheduled for February 28, 2019 ||| 9 Best Stocks to Buy on U.S.-China Trade Optimism",0,0.49149534
2019-02-28,4024000.0,138.55000305175778,139.0,137.13999938964844,137.33999633789062,132.26307678222656,CAT,"Dow Movers: DWDP, PFE",1,0.5171863
2019-03-01,3811000.0,138.86000061035156,139.5,136.94000244140622,137.47000122070312,132.38825988769528,CAT,"Notable ETF Inflow Detected - DIA, GS, MCD, CAT",1,0.5032375
2019-03-04,3859800.0,138.80000305175778,139.77000427246094,137.10000610351562,138.35000610351562,133.23574829101562,CAT,"Dow Movers: WBA, CAT ||| Noteworthy Monday Option Activity: ANF, CAT, KSS",0,0.49850395
2019-03-05,3122900.0,138.05999755859378,138.46000671386722,137.0,137.13999938964844,132.07046508789062,CAT,4 Best Stocks to Gain on U.S.-China Trade Optimism ||| 4 Large-Cap Stocks Ready to Rebound ||| CAT CFO Says China And North America Sales Remain Strong,0,0.51057833
2019-03-06,3886000.0,137.53999328613278,137.66000366210938,134.72999572753906,134.83000183105472,129.84585571289062,CAT,"Dow Analyst Moves: CAT ||| The Zacks Analyst Blog Highlights: Boeing, Abbott, PayPal, Caterpillar and Anthem ||| Terex Corporation (TEX) Ex-Dividend Date Scheduled for March 07, 2019",0,0.43635824
2019-03-07,4290800.0,134.3800048828125,134.80999755859378,131.6199951171875,132.80000305175778,127.89089965820312,CAT,"Dow Movers: GS, VZ",0,0.5253867
2019-03-08,4238000.0,130.5,132.1300048828125,130.22999572753906,131.35000610351562,126.49449157714844,CAT,"Astec Industries, Inc. (ASTE) Ex-Dividend Date Scheduled for March 11, 2019",1,0.44977137
2019-03-12,4208800.0,133.24000549316406,133.3800048828125,131.91999816894528,132.47999572753906,127.58271026611328,CAT,"Dow Movers: BA, AXP",1,0.5205826
2019-03-13,4285200.0,133.97999572753906,134.30999755859378,132.69000244140622,133.5,128.56501770019528,CAT,"Why Caterpillar is a Top Socially Responsible Dividend Stock (CAT) ||| Notable Wednesday Option Activity: WMT, MEI, CAT ||| Caterpillar 8-K Shows Global Rolling 3-Month Retail Machine Sales Up 7% Year Over Year In Feb.",1,0.49463984
2019-03-14,3742200.0,132.83999633789062,134.07000732421878,132.02000427246094,133.69000244140622,128.74800109863278,CAT,"Miller Industries, Inc. (MLR) Ex-Dividend Date Scheduled for March 15, 2019 ||| 5 Dividend Aristocrats Where Analysts See Capital Gains",0,0.47305903
2019-03-15,7049900.0,133.8699951171875,134.52999877929688,131.97999572753906,132.66999816894528,127.76570892333984,CAT,"Douglas Dynamics, Inc. (PLOW) Ex-Dividend Date Scheduled for March 18, 2019",1,0.45450163
2019-03-18,4095400.0,132.69999694824222,134.19999694824222,132.52999877929688,134.10000610351562,129.14285278320312,CAT,Caterpillar (CAT) Outpaces Stock Market Gains: What You Should Know,1,0.46742803
2019-03-20,3522100.0,133.83000183105472,134.14999389648438,132.05999755859378,133.00999450683594,128.09312438964844,CAT,"Doves Fly On Street: Stocks Jump After Fed Keeps Rates Unchanged, Signals Easy Policy ||| Fed And FedEx: While Fed Meeting Dominates News, Don't Forget Trade Situation",1,0.48362586
2019-03-21,2635700.0,132.16000366210938,134.60000610351562,132.00999450683594,134.05999755859378,129.10432434082028,CAT,Financial Sector Takes A Dive Along With Treasury Yields After Fed Announcement,0,0.50504696
2019-03-22,5745800.0,132.99000549316406,133.30000305175778,129.49000549316406,129.77000427246094,124.972900390625,CAT,Shares of the overall market are trading lower after the yield curve inverted for the first time since 2007; some attribute this as a sign of the economy slowing.,1,0.5400106
2019-03-25,3199800.0,129.58999633789062,132.0,129.22999572753906,131.3800048828125,126.52338409423828,CAT,"Barron's Picks And Pans: Caterpillar, GM, Lyft And More ||| 3 Stocks to Trade as Fears of a Recession Return ||| Caterpillar (CAT) Gains As Market Dips: What You Should Know",1,0.46611953
2019-03-28,2487200.0,131.89999389648438,132.80000305175778,131.16000366210938,132.3699951171875,127.4767837524414,CAT,"Wall St muted as growth worries weigh; trade talks in focus ||| US STOCKS-Wall St muted as growth worries weigh; trade talks in focus ||| Agree To Purchase Caterpillar At $80, Earn 3.7% Using Options ||| US STOCKS-Wall St treads water as growth worries weigh; trade in focus ||| April's Markets Face Global Issues, Quarterly Earnings Season",1,0.4992582
2019-03-29,4681600.0,134.0,136.27999877929688,133.6199951171875,135.49000549316406,130.48146057128906,CAT,"Noteworthy Friday Option Activity: USCR, FDX, CAT ||| Dow Movers: DWDP, CAT ||| Daimler buys Torc Robotics stake for self-driving trucks ||| Daimler buys Torc Robotics stake in self-driving trucks push ||| Market Close Report: NASDAQ Composite index closes at 7,729.32 up 60.15 points ||| Noteworthy Friday Option Activity: USCR, FDX, CAT",1,0.49452952
2019-04-01,5081500.0,137.69000244140622,140.3699951171875,136.32000732421878,140.25,135.06549072265622,CAT,"NASDAQ Composite Index closes up 60.16 points for the week, rising for the 3rd straight day ||| Tech, Financials Lead Stock Market Rally ||| Shares of several industrial and construction stocks are trading higher following strong US construction spending numbers. ||| China Strength Appears To Give Markets An Early Boost Despite Weak Retail Sales Data",0,0.49627241
2019-04-02,2529000.0,140.14999389648438,140.69000244140622,139.22999572753906,140.19000244140622,135.00770568847656,CAT,"Wabash National Corporation (WNC) Ex-Dividend Date Scheduled for April 03, 2019 ||| Caterpillar (CAT) Stock Moves -0.04%: What You Should Know ||| Brexit Concerns, Walgreens Earnings, Rising Bonds All Could Be Possible Rally Barriers",0,0.47929725
2019-04-03,4821800.0,139.85000610351562,140.55000305175778,138.41000366210938,139.25999450683594,134.11209106445312,CAT,"Stock Market News: Netflix's Oscar Hopes Rise; Caterpillar's Naysayers Speak Up ||| Analyst Says It's 'Becoming Increasingly Clear' Caterpillar Is Approaching A Negative Earnings Cycle ||| Benzinga's Top Upgrades, Downgrades For April 3, 2019 ||| Deutsche Bank Downgrades Caterpillar to Hold",1,0.51449615
2019-04-04,2988900.0,139.13999938964844,140.8699951171875,139.0,140.1300048828125,134.94993591308594,CAT,Vanguard Dividend Appreciation ETF Experiences Big Inflow,1,0.5220681
2019-04-05,2812300.0,141.10000610351562,141.14999389648438,139.91999816894528,140.36000061035156,135.17144775390622,CAT,"Hearing Citi Positive On Caterpillar, Says Co. To Benefit From Improving China",0,0.5228532
2019-04-09,3316500.0,138.64999389648438,138.91000366210938,136.07000732421878,136.35000610351562,131.30967712402344,CAT,"Dow Movers: CAT, DIS ||| Market Close Report: NASDAQ Composite index closes at 7,909.28 down -44.60 points ||| Tariff Troubles Drag Dow; S&P Snaps Win Streak ||| Shares of several stocks in the industrial and farm & construction equipment sector are trading lower after Lindsay Corp reported significantly worse-than-expected Q2 financial results. Some US industrials may also be affected by the EU and China agreeing to discuss an investment treaty and the issue of industrial subsidies",1,0.49919873
2019-04-10,3310600.0,137.16000366210938,138.21000671386722,136.27999877929688,137.52999877929688,132.44602966308594,CAT,"Daily Dividend Report: WAB, CAT, SKIS, LKFN, CLDT ||| Caterpillar (CAT) Outpaces Stock Market Gains: What You Should Know",1,0.4676433
2019-04-11,2762900.0,137.58999633789062,139.58999633789062,136.97999572753906,138.8699951171875,133.73649597167972,CAT,"Market Digests Trade, Brexit News Ahead Of Bank Earnings Reports",1,0.52877724
2019-04-12,4383000.0,141.0,141.9199981689453,139.80999755859378,141.1999969482422,135.98037719726562,CAT,"SPYV, CAT, ANTM, MDLZ: Large Inflows Detected at ETF ||| 3 Big Stock Charts for Friday: ConocoPhillips, Caterpillar and Morgan Stanley",0,0.4799187
2019-04-16,2672800.0,140.55999755859378,142.2100067138672,139.58999633789062,142.02999877929688,136.77969360351562,CAT,10 Dividend Growth Stocks You Can’t Miss ||| Cash Dividend On The Way From Caterpillar (CAT),1,0.50079715
2019-04-17,3469400.0,143.0,144.5,142.4600067138672,142.74000549316406,137.46347045898438,CAT,Caterpillar (CAT) Gains As Market Dips: What You Should Know,1,0.4745692
2019-04-18,4504500.0,142.8000030517578,144.77000427246094,142.4199981689453,143.36000061035156,138.89738464355472,CAT,4 Stocks Surging on China’s Turnaround ||| 4 Stocks Surging on China’s Turnaround,0,0.50714606
2019-04-22,3637500.0,142.9499969482422,143.17999267578125,141.42999267578125,142.3800048828125,137.94789123535156,CAT,"3 Big Stock Charts for Monday: Caterpillar, Lamb Weston and CF Industries ||| Noteworthy ETF Outflows: XLI, UNP, HON, CAT ||| 9 Best Stocks to Buy on U.S.-China Trade Optimism",0,0.50177807
2019-04-23,5930500.0,142.0,143.1300048828125,141.44000244140625,142.02999877929688,137.60877990722656,CAT,"Notable Tuesday Option Activity: GD, HAS, CAT ||| Caterpillar Consistently Rewards Shorts of Pre-Bell Earnings Moves ||| Earnings Beats Keep Coming, With Verizon, CocaCola, Twitter, Procter & Gamble All Solid",0,0.49135712
2019-04-24,8694400.0,139.75,140.30000305175778,136.55999755859378,137.72999572753906,133.44264221191406,CAT,"Nasdaq Retreats from Record High as Stocks Slip ||| Caterpillar Earnings: CAT Stock Falls on Weakening Sales ||| Dow Movers: CAT, WBA ||| Earnings Reaction History: Caterpillar Inc, 54.5% Follow-Through Indicator, 4.8% Sensitive ||| Caterpillar Raises FY19 Earnings Outlook - Quick Facts ||| Caterpillar Inc. Earnings Advance In Q1 ||| Strength In Mining Business Powers Caterpillar First-Quarter Results To Record ||| Caterpillar Says Expect To Repurchase Another $750M Of Company Stock In Q2 2019; Says Any Additional Share Repurchases Will Depend Upon Cash Generation And Alignment For Capital Allocation Priorities ||| Caterpillar Says, In Resource Industries, Expects Demand For Heavy Construction And Quarrying Aggregate Equipment To Remain Strong ||| After Hitting Highest Close Ever, Market Starts Day Off With Weak Boeing Results ||| Caterpillar Earlier Reaffirmed FY19 Adj. EPS Guidance $11.75-$12.75 vs $12.30 Estimate ||| Caterpillar shares are trading lower, reversing course after earlier strength. The company reported better-than-expected Q1 EPS and sales and reaffirmed its FY19 adjusted EPS guidance. ||| Caterpillar Raises FY19 GAAP EPS Guidance From $11.75-$12.75 To $12.06-$13.06 vs $12.30 Estimate ||| Caterpillar Q1 EPS $3.25 Beats $2.86 Estimate, Sales $13.466B Beat $13.38B Estimate ||| 16 Stocks To Watch For April 24, 2019 ||| Earnings Scheduled For April 24, 2019",0,0.48675746
2019-04-25,5094700.0,137.05000305175778,137.46000671386722,134.08999633789062,136.1300048828125,131.89244079589844,CAT,CAT Crosses Below Key Moving Average Level ||| Disappointing 3M Results Weigh On Dow Futures As Earnings Season Marches On,1,0.5104878
2019-04-29,3374300.0,139.5,140.44999694824222,138.82000732421878,139.02000427246094,134.69247436523438,CAT,Add Up The Pieces: DTN Could Be Worth $96,1,0.49901894
2019-04-30,3862000.0,139.99000549316406,140.0,137.58000183105472,139.41999816894528,135.08001708984378,CAT,"Notable Tuesday Option Activity: CAT, IDCC, SFLY ||| Notable ETF Inflow Detected - DIA, AAPL, GS, CAT ||| Headline Edge: Is The Surge In Oil Price Revving Up or Running On Empty?",0,0.48849246
2019-05-01,3652000.0,139.58000183105472,139.92999267578122,137.63999938964844,138.14999389648438,133.84956359863278,CAT,"Fed Day Underway, But Focus Might Be On Apple As Results Get Positive Read",0,0.502157
2019-05-02,5405700.0,138.52000427246094,138.53999328613278,134.3800048828125,135.16999816894528,130.96232604980472,CAT,"Caterpillar News: Why CAT Stock Is Falling Lower Today ||| Caterpillar Lifts Dividend By 20%; Expects To Double ME&T Services Sales By 2026 ||| 2 New ETFS For 'Biblically Responsible Investing' ||| Caterpillar CFO Says Tariffs Will Cost Company $250 Million To $350M In 2019, If No Relief; Says 'We Generally See More Demand Opportunities Than Negatives Out There At The Moment' ||| Caterpillar Sees Doubling Machine, Energy & Transportation Sales To $28B By 2026, Sees Higher Adj. Operating Margins Through Cycles Of 3-6% Above Historical Performance ||| Caterpillar Says 'Company plans to return substantially all Machine, Energy & Transportation (ME&T) free cash flow to shareholders through continued dividend growth and more consistent share repurchases' ||| Caterpillar Raises Qtr. Dividend From $0.86 To $1.03/Share",1,0.48839658
2019-05-06,4866500.0,134.77999877929688,137.49000549316406,134.30999755859378,136.75999450683594,132.50282287597656,CAT,"Why Caterpillar Stock Is a Tasty Treat for Income Investors Now ||| Dow Movers: CAT, CVX ||| Boeing, Caterpillar, Chipmakers Retreat After Trump Threats To Raise China Tariffs",0,0.49743074
2019-05-07,5622900.0,135.19999694824222,136.0,132.05999755859378,133.66999816894528,129.50901794433594,CAT,"Tariff-Related Losses Put Pressure On Multinationals, FAANGs, Semiconductors",0,0.5050877
2019-05-08,4140500.0,133.02000427246094,134.41999816894528,131.78999328613278,131.94999694824222,127.84255981445312,CAT,"Noteworthy Wednesday Option Activity: CAT, ALB, QRVO ||| Hitting A Wall: More Red Ink Appears Ready To Spill As New Tariffs Loom",0,0.5320491
2019-05-09,5906200.0,130.22000122070312,131.67999267578122,128.17999267578122,131.19999694824222,127.11590576171876,CAT,Caterpillar Shares Unaffected As Co. Issues Press Release Highlighting Sustainability Report With Details Of Co.'s Progress On Executing Enterprise Strategy ||| Key Day Shapes Up For Trade Talks But Earnings Also In Focus As Disney Results Gleaned,1,0.5244931
2019-05-10,5240600.0,130.52999877929688,131.72999572753906,127.91999816894533,131.33999633789062,127.25154876708984,CAT,"Dow Movers: CAT, WMT",0,0.51608366
2019-05-13,8580700.0,127.51000213623048,127.5199966430664,124.08000183105467,125.3000030517578,121.39957427978516,CAT,"Dow Movers: AAPL, VZ ||| Is Caterpillar Stock a Buy? ||| 5 Popular Stocks That Are Crashing Hard Now ||| Trump Says Portion Of Funds US Takes In From Tariffs On Chinese Imports Will Go To US Farmers ||| Why Boeing Could Be A Big Loser In US-China Trade War ||| Trade War Heats Up As China Retaliates With Raised Tariffs Of Its Own ||| Caterpillar 8-K Shows Global Rolling-3 Month Retail Sales Up 7% Year Over Year ||| Shares of automotive and industrial companies are trading lower amid revamped US-China trade tensions. New tariffs between the two nations could increase input and materials costs for companies in these sectors and harm their overseas operations.",1,0.48165876
2019-05-14,4019100.0,126.5,128.55999755859378,125.6999969482422,127.47000122070312,123.50202941894533,CAT,"Dow Rallies Amid Ebbing Fears Over Trade War ||| Shares of several companies in the industrial sector are trading slightly higher, rebounding from recent weakness amid renewed cautious optimism surrounding US-China trade talks. ||| As Trade Tensions Ease Slightly, Tech, Industrial Shares In Focus",0,0.4921572
2019-05-15,2875900.0,125.91000366210938,127.95999908447266,124.9800033569336,127.3000030517578,123.33731079101562,CAT,"Dow Movers: CAT, KO ||| Emerging & Frontier Markets: Going Abroad Without Leaving The Office ||| Alibaba, Macy's Report Solid Results but Chinese, U.S. Retail Sales Disappoint",0,0.49963656
2019-05-23,4964900.0,122.0999984741211,123.76000213623048,121.41000366210938,122.26000213623048,118.45420837402344,CAT,Dow Analyst Moves: CAT,1,0.51468444
2019-05-24,3802500.0,123.5199966430664,124.08000183105467,122.20999908447266,122.9000015258789,119.07427215576172,CAT,"Top 10 Most Overbought Stocks Via Benzinga Pro's Radar Tool For Fri., May 24, 2019",0,0.466298
2019-05-28,4889400.0,122.9000015258789,123.45999908447266,121.51000213623048,121.58999633789062,117.80504608154295,CAT,"Carter Worth And Mike Khouw's Caterpillar Trade ||| Notable Tuesday Option Activity: PLAN, HD, CAT ||| Top 10 Most Oversold Stocks Via Benzinga Pro's Radar Tool For Tue., May 28, 2019",0,0.46411687
2019-06-03,4161800.0,119.91000366210938,121.69000244140624,119.76000213623048,120.6500015258789,116.8943099975586,CAT,Dow Jones Today: 4 Big Stocks That Could Be in Big Trouble,1,0.48863256
2019-06-04,4060400.0,121.80999755859376,122.7699966430664,120.75,122.08000183105467,118.2798080444336,CAT,"Vanguard Industrials ETF Experiences Big Inflow ||| Shares of several industrial companies are trading higher amid eased trade tensions after China's Commerce Ministry stated they are open to dialogue to resolve trade tensions; Mexico trade concerns also eased after Mexican officials said they could find c ||| UBS Maintains Sell on Caterpillar, Lowers Price Target to $115",1,0.5147403
2019-06-05,3598400.0,123.4000015258789,123.63999938964844,121.95999908447266,123.12000274658205,119.28743743896484,CAT,"Boomerang Seems To Continue As Caterpillar, Nvidia, Apple Among Early Gainers",1,0.49499494
2019-06-07,2547500.0,124.37999725341795,125.62999725341795,124.08000183105467,124.45999908447266,120.5857162475586,CAT,"Why Stanley Black & Decker Stock Is Having a Wild Year ||| Notable Friday Option Activity: NCR, CAT, FSLR",1,0.50278175
2019-06-10,3705000.0,125.47000122070312,127.27999877929688,125.23999786376952,125.73999786376952,121.82585906982422,CAT,Why Caterpillar Shares Fell 14.1% in May,1,0.49169877
2019-06-11,4516200.0,129.0,129.60000610351562,126.95999908447266,127.27999877929688,123.31793212890624,CAT,"Dow Jones Today: It Should Have Been Better ||| Shares of several iron ore, metal, and industrial companies are trading higher after China's iron ore futures rose on expectations that mining production will not be able to meet high demand.",0,0.5251496
2019-06-12,3034600.0,126.75,127.5199966430664,126.08000183105467,127.0999984741211,123.14353942871094,CAT,"As Solid as It Is, Looming Fears Will Hold Back Caterpillar Stock",1,0.5159192
2019-06-13,3495200.0,127.3499984741211,128.39999389648438,126.76000213623048,127.16999816894533,123.21135711669922,CAT,Caterpillar Reports 6% Year-Over-Year Sales Increase ||| Caterpillar 8-K Shows Rolling 3-Month Global Retail Sales Up 6% Year Over Year,1,0.51189935
2019-06-14,2530100.0,126.61000061035156,127.6500015258789,125.5,127.2300033569336,123.26949310302734,CAT,"Why Caterpillar is a Top 25 Dividend Giant (CAT) ||| Wall Street Under Pressure From Faltering Chipmakers, Weak China Industrial Production Data",1,0.48426113
2019-06-18,4756100.0,128.39999389648438,131.35000610351562,128.21000671386722,130.33000183105472,126.2729949951172,CAT,"7 Value Stocks to Buy for the Second Half ||| Notable Tuesday Option Activity: CAT, HSY, MSFT",1,0.49486315
2019-06-19,3847200.0,130.32000732421878,131.53999328613278,129.8699951171875,130.61000061035156,126.54426574707033,CAT,"Noteworthy ETF Outflows: XLI, MMM, GE, CAT ||| Fed Alert: All Eyes Focused On Powell And Company As Markets Await Decision",1,0.5212096
2019-06-21,5742500.0,133.35000610351562,135.25,132.55000305175778,133.88999938964844,129.72218322753906,CAT,"Caterpillar CEO Tells Cramer Trade Tensions 'Not New For Us' ||| Caterpillar Option Alert: Jul 26 $142 Calls Sweep (34) near the Ask: 542 @ $1.48 vs 13 OI; Earnings 7/24 Before Open Ref=$134.035 ||| Middle East Tensions Gave Aerospace Stocks A Lift On Thursday, But Volatility Now Easing",1,0.48958683
2019-06-24,3197700.0,133.63999938964844,134.94999694824222,133.55000305175778,134.3699951171875,130.18722534179688,CAT,CAT Named Top 25 SAFE Dividend Stock Increasing Payments For Decades,0,0.5111602
2019-06-25,3751800.0,134.58000183105472,134.91000366210938,132.6300048828125,133.71000671386722,129.54777526855472,CAT,Dow Stock Should Be Cheap – But Not This Cheap,1,0.49800476
2019-06-27,3594400.0,135.69999694824222,136.00999450683594,133.97000122070312,135.5,131.28205871582028,CAT,"Commit To Purchase Caterpillar At $85, Earn 3.8% Using Options ||| As Goes the Economy, So Goes Caterpillar Stock",1,0.5138204
2019-06-28,10469400.0,136.0,137.27000427246094,136.0,136.28999328613278,132.04745483398438,CAT,"Top 10 Most Overbought Stocks Via Benzinga Pro's Radar Tool For Friday, June 28, 2019 ||| Top 10 Most Overbought Stocks Via Benzinga Pro's Radar Tool For Fri., June 28, 2019",1,0.45137653
2019-07-01,4846200.0,139.30000305175778,140.16999816894528,134.97000122070312,136.60000610351562,132.34782409667972,CAT,"3 Top Infrastructure Stocks to Watch This Month ||| Ceasefire: Tariff Tailwind Injects Early Euphoria, With New Record Highs In Sight",0,0.5406235
2019-07-02,3204900.0,136.60000610351562,136.99000549316406,135.07000732421878,135.85000610351562,131.62115478515622,CAT,"Top 10 Most Overbought Stocks Via Benzinga Pro's Radar Tool For Tue., July 02, 2019 ||| With Jobs Report Ahead, Focus Turns To Economic Data, Auto Sales, Tesla Output",0,0.49957475
2019-07-05,3071800.0,134.42999267578122,135.58999633789062,133.22000122070312,135.49000549316406,131.27236938476562,CAT,Why Caterpillar Stock Soared 13.8% in June,0,0.49173164
2019-07-08,2742100.0,135.14999389648438,136.1300048828125,134.42999267578122,134.83999633789062,130.64259338378906,CAT,"Dow Jones Today: Why These Big Names Got Drubbed ||| Top 10 Most Overbought Stocks Via Benzinga Pro's Radar Tool For Mon., July 08, 2019",0,0.46189478
2019-07-10,3933300.0,134.72999572753906,135.49000549316406,132.55000305175778,132.63999938964844,128.51107788085938,CAT,3 Technically Fragile Dow Stocks to Short,1,0.53815573
2019-07-12,4149800.0,134.71000671386722,138.3800048828125,134.60000610351562,138.36000061035156,134.05302429199222,CAT,"Dow Jones Today: A Fantastic Friday ||| Notable Friday Option Activity: JNJ, NLSN, CAT",1,0.5095134
2019-07-15,4498700.0,138.3800048828125,139.99000549316406,138.25999450683594,139.63999938964844,135.29318237304688,CAT,These 3 Value Stocks Are Absurdly Cheap Right Now ||| 5 Dow Jones Stocks to Buy Now,0,0.48522997
2019-07-16,4051600.0,139.41000366210938,140.6199951171875,138.16000366210938,139.08999633789062,134.76029968261722,CAT,"These 2 Companies Just Set the Tone for Industrial Earnings Season ||| XLI, HON, UTX, CAT: ETF Outflow Alert",0,0.5126367
2019-07-17,3750200.0,138.19999694824222,138.50999450683594,135.72999572753906,135.72999572753906,131.5048828125,CAT,"Dow Jones Today: A Lackluster Showing ||| Ex-Dividend Reminder: Caterpillar, AZZ and Graco",0,0.49557346
2019-07-19,4837100.0,134.22000122070312,137.05000305175778,134.22000122070312,136.22999572753906,133.00494384765622,CAT,"Noteworthy Friday Option Activity: CAT, QEP, BEAT ||| Investing in Chicago Stocks",0,0.5172697
2019-07-23,4122200.0,135.92999267578122,138.22999572753906,135.52999877929688,138.10000610351562,134.83067321777344,CAT,"Caterpillar, Qudian And More 'Fast Money' Picks From July 23 ||| Budget Deal, Earnings Strength From Lockheed, CocaCola, United Technologies Lift Spirits",0,0.47462955
2019-07-24,12664900.0,130.97999572753906,134.30999755859378,128.44999694824222,131.91000366210938,128.78721618652344,CAT,"Caterpillar Earnings: CAT Stock Down on Q2 Miss ||| What Happened in the Stock Market Today ||| Chip Stock Strength Sends Nasdaq, S&P to Record Closes ||| Dow Jones Today: The Dow Has a Caterpillar Problem ||| 3 Retail Home Suppliers to Trade Now ||| Caterpillar Q2 19 Earnings Conference Call At 11:00 AM ET ||| Noteworthy ETF Outflows: XLI, HON, UTX, CAT ||| Cat Financial Q2 Profit Up 11% - Quick Facts ||| Caterpillar Inc. Q2 adjusted earnings Miss Estimates ||| Caterpillar Q2 19 Earnings Conference Call At 11:00 AM ET ||| Differing Reactions To 2 Big Earnings Misses Contain Lesson For Investors ||| Caterpillar Earnings Disappoint Due To Weaker China Sales And Higher Production Costs ||| Mid-Afternoon Market Update: Snap Rises After Strong Q2 Results; Healthcare Services Shares Plummet ||| Mid-Day Market Update: Tupperware Falls On Downbeat Earnings; Teradyne Shares Gain ||| Caterpillar Inc Says Still Expect Tariffs To Cost $250M-$350M In 2019 ||| Mid-Morning Market Update: Markets Mixed; Caterpillar Earnings Miss Views ||| Analyst Discusses Caterpillar's Earnings Miss ||| Weak Boeing, Caterpillar Q2, Rate Pressure On Banks, All Weigh ||| Caterpillar Falls After Q2 Earnings Miss ||| Caterpillar shares are trading lower after the company reported worse-than-expected Q2 EPS and sales. The company also said it expects FY19 EPS to be at the lower end of the guidance rance. ||| Cat Sees FY19 EPS Guidance $12.06-$13.06 At Lower End Of Range ||| Caterpillar Q2 EPS $2.83 Misses $3.12 Estimate, Sales $14.432B Miss $14.44B Estimate ||| 14 Stocks To Watch For July 24, 2019 ||| Earnings Scheduled For July 24, 2019",1,0.50788987
2019-07-25,4823200.0,131.08000183105472,134.89999389648438,131.00999450683594,134.71000671386722,131.52091979980472,CAT,"3 Stocks to Trade After Earnings ||| 4 Blue-Chip Stocks Under Pressure on Earnings ||| Caterpillar Option Alert: Aug 9 $139 Calls Sweep (38) near the Ask: 613 @ $0.84 vs 224 OI; Ref=$134.64 ||| ECB Chimes In: Hints Of Rate Cut Could Support Ahead Of Amazon, Alphabet ||| UPDATE: Buckingham Downgrades Caterpillar To Neutral, Lowers Target To $140 As Firm Notes 'we are struggling to identify a catalyst to drive the stock significantly higher from current levels in the near term' ||| Benzinga's Top Upgrades, Downgrades For July 25, 2019 ||| Morgan Stanley Maintains Overweight on Caterpillar, Lowers Price Target to $155 ||| Buckingham Research Downgrades Caterpillar to Neutral",0,0.4835032
2019-07-29,2715600.0,133.49000549316406,134.64999389648438,132.85000610351562,134.46000671386722,131.27685546875,CAT,"Host Of Earnings Loom With Beyond Meat, Apple Among Highlights Ahead Of Fed, Payrolls",0,0.49465692
2019-07-30,3257200.0,133.32000732421878,133.57000732421878,131.49000549316406,132.94999694824222,129.80258178710938,CAT,"Why Did Caterpillar Stock Rise 2X in 3 Years? ||| Caterpillar Option Alert: Aug 23 $146 Calls Sweep (47) near the Ask: 1012 @ $0.22 vs 49 OI; Ref=$132.76 ||| Caterpillar Option Alert: Aug 23 $147 Calls Sweep (48) near the Ask: 1500 @ $0.18 vs 41 OI; Ref=$132.57 ||| 'Watch $CAT, that needs to go back up..' -CNBC's Jim Cramer Tweets",0,0.47856486
2019-07-31,4322000.0,132.89999389648438,134.3699951171875,131.00999450683594,131.66999816894528,128.55288696289062,CAT,"Easing Up: Fed Expected To Cut Rates, But Apple's Strong Results Front And Center Early",0,0.5129646
2019-08-05,5482500.0,122.11000061035156,122.80999755859376,120.33000183105467,121.6500015258789,118.77009582519533,CAT,"5 Top Blue Chip Stocks to Buy Now ||| Amid Trade War Flare, Earnings Continue With Disney And Uber This Week",1,0.5395057
2019-08-06,3713900.0,122.77999877929688,123.6500015258789,120.63999938964844,122.08000183105467,119.1899185180664,CAT,Relative Strength Alert For Caterpillar,0,0.50186795
2019-08-07,5048700.0,120.0,121.1999969482422,118.6500015258789,120.77999877929688,117.92069244384766,CAT,"Noteworthy Wednesday Option Activity: REGN, CAT, MMM ||| Caterpillar Stock Gives Income Investors a Feast on Agriculture’s Problems ||| Shares of several large-cap companies are trading lower in sympathy with the overall market ||| 8 Industrials Stocks Moving In Today's Pre-Market Session",1,0.5046435
2019-08-08,3734800.0,121.0,122.0999984741211,120.37000274658205,122.0199966430664,119.13134002685548,CAT,"Dow Jones Today: China Provides a Calming Influence ||| Dow Analyst Moves: CAT ||| See How Caterpillar Ranks Among Analysts' Top Dow 30 Picks ||| All 30 Dow Stocks Ranked: The Analysts Weigh In ||| Trump Again Calls For 'Substantial Fed Cuts' In Series Of Tweets ||| Benzinga's Top Upgrades, Downgrades For August 8, 2019 ||| Goldman Sachs Downgrades Caterpillar to Neutral, Lowers Price Target to $130",0,0.5118121
2019-08-09,3805600.0,121.51000213623048,121.6999969482422,118.80999755859376,119.37999725341795,116.5538330078125,CAT,"Dow Jones Today: We’ve Seen This Movie Before ||| Twists And Turns: This Week's Wild Ride Swings Through U.K., Italy, China",0,0.50901765
2019-08-12,4321500.0,118.9499969482422,119.02999877929688,116.06999969482422,116.72000122070312,113.95681762695312,CAT,Machine Learning Engine Says S&P 500 Is 8 Times More Likely To Drop 5% In A Month Than To Rise 10%,1,0.4946434
2019-08-13,4331900.0,116.94000244140624,122.0,116.79000091552734,119.01000213623048,116.19259643554688,CAT,"Dow Movers: CVX, CAT ||| 50 Stocks Moving In Tuesday's Mid-Day Session ||| Caterpillar's Global Machine Sales For July Rise 4% ||| Caterpillar shares are trading higher after the company reported rolling 3-month retail shares for July are up 4% year-over-year. ||| Caterpillar 8-K Shows Global Rolling 3-Month Retail Sales For Jul. Up 4% Year Over Year",0,0.48358956
2019-08-14,5543100.0,116.58000183105467,116.9000015258789,115.04000091552734,115.20999908447266,112.48255157470705,CAT,"Notable Wednesday Option Activity: CAT, PRO, STC ||| 9 Industrials Stocks Moving In Wednesday's Pre-Market Session",1,0.5102057
2019-08-15,4171900.0,115.08000183105467,115.5999984741211,113.97000122070312,115.25,112.5216064453125,CAT,"Benzinga's Top Upgrades, Downgrades For August 15, 2019 ||| Stephens & Co. Initiates Coverage On Caterpillar with Underweight Rating, Announces $100 Price Target",1,0.5152069
2019-08-16,3551900.0,116.25,117.87000274658205,115.91999816894533,116.43000030517578,113.67366790771484,CAT,Dow Jones Today: A Fantastic Friday ||| Investors Should Buy General Electric Stock on Its Latest Decline,1,0.49711958
2019-08-19,2630900.0,118.22000122070312,118.48999786376952,116.70999908447266,117.36000061035156,114.58165740966795,CAT,12 Industrials Stocks Moving In Monday's Pre-Market Session,0,0.5304065
2019-08-20,2402000.0,117.58999633789062,117.79000091552734,116.47000122070312,116.66999816894533,113.90798950195312,CAT,Cummins's Guidance Raises Red Flags for Caterpillar ||| Cummins' Guidance Raises Red Flags for Caterpillar,1,0.51182675
2019-08-21,2783000.0,118.0,119.31999969482422,117.54000091552734,117.68000030517578,114.89408111572266,CAT,"DIA, GS, TRV, CAT: ETF Outflow Alert",1,0.53663754
2019-08-23,6102000.0,116.25,116.9000015258789,113.31999969482422,114.05999755859376,111.35977935791016,CAT,"Dow Movers: CAT, BA ||| Shares of several industrial companies are trading lower on escalated trade tensions after China announced it plans to impose a 5% to 10% tariff rate on $75 billion worth of U.S. goods. Trump announced he will respond to China's tariffs this afternoon.",1,0.5305125
2019-08-26,5200400.0,115.05999755859376,115.66999816894533,113.83999633789062,114.41999816894533,111.71125030517578,CAT,"Dow Movers: HD, AAPL ||| 3 Casualties of China's New Tariffs ||| 10 Industrials Stocks Moving In Monday's Pre-Market Session",0,0.51545954
2019-08-27,3160700.0,115.16000366210938,115.45999908447266,113.1500015258789,113.37999725341795,110.69587707519533,CAT,"Caterpillar is Oversold ||| Neutral Zone: Stocks, Bonds Both Up As Next Moves In Trade War Anxiously Awaited",1,0.49065402
2019-08-28,3187900.0,112.86000061035156,114.9499969482422,111.75,114.86000061035156,112.14083862304688,CAT,Stocks That Hit 52-Week Lows On Wednesday,1,0.50929344
2019-08-29,3442900.0,116.62000274658205,118.12999725341795,116.48999786376952,117.7699966430664,114.98194122314452,CAT,"Dow Jones Today: China Confirmation Proves Meaningful ||| 3 Left-for-Dead Stocks to Buy As They Come Back to Life ||| Dow Movers: KO, INTC ||| Shares of agricultural and industrial companies are trading higher after China said it would try to resolve US trade conflicts and would not immediately respond to tariff hikes. Note: China previously announced it would not buy US agriculture products. ||| 10 Industrials Stocks Moving In Thursday's Pre-Market Session",1,0.50815016
2019-08-30,2912000.0,119.0199966430664,119.58999633789062,118.4499969482422,119.0,116.18283081054688,CAT,"Noteworthy Friday Option Activity: CAT, AN, ISRG ||| Follow Through: Trade Optimism Keeps Wall Street's Spirits High",0,0.5142636
2019-09-03,3780600.0,117.9000015258789,117.9000015258789,115.4000015258789,117.02999877929688,114.2594757080078,CAT,"Better Buy: Boeing vs. Caterpillar ||| Dow Jones Today: Not the Way to Start September ||| 3 Under-the-Radar Stocks Ready to Bounce ||| Shares of several iron ore companies are trading lower as global shipments of iron rose. With the abundance of iron supply, consumers can get the commodity at a lower price. Iron ore prices fell 27% by the end of August, the most since October 2011.",1,0.49608025
2019-09-04,3688400.0,118.41999816894533,119.23999786376952,118.26000213623048,119.0999984741211,116.2804718017578,CAT,"Stocks Have Positive Tone As Overseas Tension Eases, With Positive United News Helping",1,0.5256825
2019-09-05,5355100.0,120.5,124.23999786376952,120.5,122.98999786376952,120.078369140625,CAT,"Stocks Surge on U.S.-China Trade Optimism ||| Dow Jones Today: Finally, Some Relief on the Trade Front ||| 4 Top Industrial Stocks to Watch in September ||| Shares of several large-cap companies are trading higher with the broader stock market after the Chinese Minister of Commerce said the leaders of the U.S. and China are set to meet in Washington D.C in early October. ||| Investors Optimistic On News Of US-China Trade Talks Set For October ||| 7 Industrials Stocks Moving In Thursday's Pre-Market Session",0,0.5203957
2019-09-06,3315700.0,123.70999908447266,124.33999633789062,122.45999908447266,122.6999969482422,119.79524230957033,CAT,"Caterpillar, Wells Fargo And More 'Fast Money' Picks For September 6 ||| 6 Industrials Stocks Moving In Friday's Pre-Market Session",1,0.4973675
2019-09-09,4433300.0,123.38999938964844,127.38999938964844,123.1999969482422,127.25,124.2375259399414,CAT,"Why Mining Stock Prices Crashed in August ||| Dow Jones Today: Looking for Direction ||| Noteworthy Monday Option Activity: BIIB, CAT, MKTX ||| UPDATE: Bank Of America On Caterpillar Also Notes Co's 'share price is baking in $6 of trough EPS, but the real figure could be closer to $8' As Firm Doesn't See A Repeat Of Co's 2012-2016 Earnings Downturn That Was Driven By Miners ||| UPDATE: Bank Of America Reiterates Buy On Caterpillar, Lowers Target To $145 As Firm Notes Co. 'could face another 1-2 quarters of negative EPS revisions due to dealer destocking in construction and weakness in upstream oil and gas' ||| Caterpillar shares are trading higher after Bank of America reiterated a Buy rating on the stock. ||| Bank of America Reiterates Buy on Caterpillar, Lowers Price Target to $145",1,0.49604216
2019-09-10,8479700.0,127.26000213623048,130.28999328613278,127.22000122070312,130.28999328613278,127.20555114746094,CAT,"Notable ETF Outflow Detected - UDOW, MMM, CAT, WBA ||| CAT Named A Top Socially Responsible Dividend Stock ||| Shares of several agricultural companies are trading higher in sympathy with the broader market after several reports suggested China would consider buying U.S. agriculture again.",1,0.53381276
2019-09-11,7592600.0,130.85000610351562,133.19000244140622,129.47000122070312,133.08999633789062,129.93927001953122,CAT,3 Beaten-Down Industrials Worth Considering Now,0,0.53337383
2019-09-12,5594600.0,132.0,132.69000244140622,130.07000732421878,131.75,128.63099670410156,CAT,"Dow Jones Today: Maybe We’re Getting Somewhere ||| 3 Stocks to Buy As Sector Rotation Heats Up ||| Wells Fargo Downgrades Deere And Caterpillar, Sees 'Likely Need To Cut Production Soon' ||| UPDATE: Wells Fargo On Caterpillar And Deere Also Notes 'other businesses within each company's portfolio will remain flat as a potential 2020 US construction equipment demand drop will put downward pressure on earnings power' ||| UPDATE: Wells Fargo Downgrades Caterpillar And Deere To Market Perform Due To Firm's Perception That 'US construction equipment demand is at or near peak and likely will decline during 2020 due to flattening activity and a shift to equipment rental' ||| Deere and Caterpillar shares are trading lower after Wells Fargo downgraded both stocks on weak construction channel check data. ||| Benzinga's Top Upgrades, Downgrades For September 12, 2019 ||| 'Fast Money' Traders Advise Their Viewers On Mastercard, Caterpillar And More ||| Wells Fargo Downgrades Caterpillar to Market Perform, Announces $143 Price Target",1,0.48696828
2019-09-13,3704900.0,132.80000305175778,133.99000549316406,131.1300048828125,133.77999877929688,130.61294555664062,CAT,14 Stocks Already Hurt by President Trump's Tariffs ||| Caterpillar 8-K Shows Global Rolling 3-Month Retail Sales For Aug. Up 4%,0,0.49500632
2019-09-16,2876500.0,132.99000549316406,133.80000305175778,131.99000549316406,133.14999389648438,129.99786376953122,CAT,"What Is a Dividend Aristocrat? ||| Bulls And Bears Of The Week: Altria, Apple, Caterpillar, Ford, Oracle And More ||| 3 Industries Suffering Due to the Trade War ||| 7 Dow Titans Breaking Higher",0,0.4847113
2019-09-17,2888900.0,132.58999633789062,132.75999450683594,131.19000244140622,132.16999816894528,129.04104614257812,CAT,"Dow Jones Today: Oil Slides, Investors Wait on Fed ||| Dow Jones Today: Oil Slides, Investors Wait on Fed ||| Notable Tuesday Option Activity: CAT, CME, REGI",0,0.48361123
2019-09-19,2725700.0,131.47000122070312,132.02999877929688,129.8699951171875,130.1199951171875,127.0395736694336,CAT,"Noteworthy ETF Outflows: VIS, CAT, NOC, CSX ||| Dow Movers: CAT, MSFT ||| After Jumping 2X In 3 Years, Does Deere's Stock Still Have Room For Growth? ||| 7 Industrials Stocks Moving In Thursday's Pre-Market Session",0,0.49865612
2019-09-24,3370700.0,128.74000549316406,129.0,125.56999969482422,125.98999786376952,123.0073471069336,CAT,"Deutsche Bank Turns Bullish On Transports For 2020 ||| Boeing, Caterpillar, Other Trade-Sensitive Stocks Get Boost Amid Market Optimism ||| Citigroup Maintains Buy on Caterpillar, Lowers Price Target to $145 ||| 10 Biggest Price Target Changes For Tuesday ||| Citi Maintains Buy on Caterpillar, Lowers Price Target to $145",1,0.47123304
2019-09-25,2354100.0,125.8499984741211,126.81999969482422,125.0199966430664,126.61000061035156,123.61267852783205,CAT,"Commit To Purchase Caterpillar At $80, Earn 7.2% Using Options",0,0.5169652
2019-09-26,2227400.0,126.79000091552734,126.91999816894533,125.6500015258789,126.38999938964844,123.39788818359376,CAT,"CalAmp Inches Toward Growth on SaaS Strength ||| Despite Washington Turmoil, Market Aims Higher As Optimism Over Trade Climbs",1,0.5374517
2019-09-30,2795300.0,126.33999633789062,127.0999984741211,125.87999725341795,126.30999755859376,123.31977081298828,CAT,"'@CaterpillarInc and continue our Administration's fight for a free and fair trade deal. While the Democrats are focused on Presidential harassment, we will continue to fight for what matters most to the American people.' -VP Pence",0,0.4715744
2019-10-01,3718200.0,127.4000015258789,128.5,122.3000030517578,122.37000274658205,119.47305297851562,CAT,"Notable Tuesday Option Activity: REGN, CAT, GPC ||| Shares of several industrial companies are trading lower after worse-than-expected PMI results.",0,0.5180053
2019-10-02,4255800.0,121.1500015258789,121.8499984741211,119.33999633789062,119.95999908447266,117.12010192871094,CAT,Shares of several industrial companies are trading lower on continued fears of a recession following weak ADP jobs report. There is also uncertainty in the market over the upcoming U.S.-China meeting next week. ||| 8 Industrials Stocks Moving In Wednesday's Pre-Market Session,1,0.49480772
2019-10-03,3110200.0,119.33999633789062,120.05999755859376,117.25,120.04000091552734,117.19821166992188,CAT,Analysts Anticipate DJD To Hit $41,1,0.5076396
2019-10-07,2334500.0,120.8499984741211,121.6999969482422,119.75,120.25,117.40324401855467,CAT,3 Top U.S. Stocks to Watch in October ||| Dan Nathan's Caterpillar Options Trade ||| IBM or GPRO — Which Tech Stock Looks Better to Buy? ||| Caterpillar Stock Is Ready to Start Purring,0,0.52579796
2019-10-08,3530000.0,118.79000091552734,119.1999969482422,117.69000244140624,117.97000122070312,115.17721557617188,CAT,"Caterpillar or Deere: Which Heavy-Equipment Manufacturer Is A Better Bet? ||| As Trade Talks Approach, ""Barometer"" Stocks Like Apple And Boeing Could Be In Focus ||| UBS Maintains Sell on Caterpillar, Lowers Price Target to $117",1,0.4673019
2019-10-09,2557300.0,119.48999786376952,120.05999755859376,118.0,119.44000244140624,116.61241912841795,CAT,"Daily Dividend Report: IP, PG, CAT, EPD, AON ||| Caterpillar Investors Should Prepare for a Difficult Quarter ||| Increased Optimism On The Tariff Front Could Help Trade-Sensitive Stocks Like Chipmakers ||| Morgan Stanley Maintains Overweight on Caterpillar, Lowers Price Target to $150",1,0.48048627
2019-10-10,3242900.0,120.04000091552734,123.02999877929688,119.76000213623048,122.69000244140624,119.78548431396484,CAT,Why We Think GE's Stock Is Worth $12 ||| Caterpillar shares trading higher but not seeing company-specific news. Shares rebounded over the $120 level today.,1,0.48799863
2019-10-11,6747800.0,125.61000061035156,130.3800048828125,125.4000015258789,128.39999389648438,125.36029815673828,CAT,"Shares of several industrial companies are trading higher after President Trump made positive remarks on the U.S.-China trade talks as traders grew more optimistic over the possibility of a limited trade deal. Trump is scheduled to meet with Chinese Vice Premier Liu He at the White House today. ||| Credit Suisse Maintains Outperform on Caterpillar, Lowers Price Target to $149 ||| 18 Industrials Stocks Moving In Friday's Pre-Market Session",0,0.48763433
2019-10-14,2851500.0,126.80999755859376,128.55999755859378,126.01000213623048,128.3800048828125,125.3407745361328,CAT,"Dow Movers: DOW, NKE ||| 'Fast Money Halftime Report' Picks From October 14 ||| 'China has the market demand to buy $40B-$50B worth of US farm products. China won't make a commitment that it can't honor; once it promises, it will fulfill it' -Tweet From Global Times Editor ||| Banks In Focus This Week As JPMorgan , Goldman Sachs, Others Report Tuesday",1,0.47753042
2019-10-15,3289000.0,127.98999786376952,131.67999267578122,127.6500015258789,131.02999877929688,127.92803955078124,CAT,"Caterpillar (CAT) Shares Cross Above 200 DMA ||| Caterpillar shares are trading higher in sympathy with the overall market after multiple companies reported earnings that topped expectations, bringing the whole market higher on positive sentiment. ||| Unit Was Issued Imminent Danger Order By US Department Of Labor, Mine Safety & Health Administration At Its Mine At Carlsbad, New Mexico; Order Was Issued Upon Observing A Mechanic Working Under Raised Forks Of A Cat Forklift",0,0.47985712
2019-10-16,3038300.0,131.0,132.80999755859378,130.11000061035156,130.19000244140622,127.1079330444336,CAT,"Notable Wednesday Option Activity: CAT, CBB, PYPL ||| VIG, ADP, CAT, SPGI: Large Inflows Detected at ETF ||| CAT Ex-Dividend Reminder - 10/18/19 ||| Can Caterpillar Continue Its Strong Revenue Run Rate In 2019?",1,0.5219232
2019-10-18,4329200.0,130.14999389648438,132.02999877929688,129.99000549316406,130.71000671386722,128.61869812011722,CAT,"Coca-Cola, Schlumberger Earnings Help Boost Investor Morale Despite China Data ||| Benzinga's Top Upgrades, Downgrades For October 18, 2019 ||| Caterpillar shares are trading lower after Morgan Stanley downgraded the stock from Overweight to Equal-Weight and lowered the price target $150 to $145 per share. ||| UPDATE: Morgan Stanley On Caterpillar Also Notes 'We believe that the US Construction Equipment market peaked in 2019 and that E&T markets will fail to re-accelerate in 2020' ||| UPDATE: Morgan Stanley Downgrades Caterpillar To Equal-Weight, Lowers Target To $145 As Firm Notes 'We see increasing downside risks to CAT's Construction and Energy & Transportation segments' ||| 13 Industrials Stocks Moving In Friday's Pre-Market Session ||| Morgan Stanley Downgrades Caterpillar to Equal-Weight, Lowers Price Target to $145",1,0.51691043
2019-10-21,4225200.0,131.94999694824222,133.44999694824222,131.5,132.22999572753906,130.1143798828125,CAT,"Dow Movers: BA, CAT ||| Earnings Season Kicks Into Full Gear In Round 3 Of The WeTrader Competition ||| Earnings Roll On With Light Schedule Today But McDonald's, Biogen On Tuesday Calendar",1,0.4889475
2019-10-22,4681600.0,132.58999633789062,134.25999450683594,130.94000244140622,133.69000244140622,131.551025390625,CAT,"Mixed Bag: Better Outlooks From Lockheed, United Technologies, But McDonald's Misses",1,0.50791293
2019-10-23,11295900.0,134.22999572753906,135.99000549316406,130.69999694824222,135.33999633789062,133.17462158203122,CAT,"What Happened in the Stock Market Today ||| Dow Jones Today: It Definitely Could’ve Been Worse ||| Stock Market News: Caterpillar Hits a Speed Bump; Nike Switches CEOs ||| Daily Markets: Caterpillar, Boeing Earnings Set Today's Tone ||| Caterpillar Q3 19 Earnings Conference Call At 8:30 AM ET ||| Caterpillar Cuts Full-year Earnings Forecast - Quick Facts ||| Wall Street Looks For Direction Amid Mixed Earnings Results ||| Wednesday's Market Minute: Are You Frightened? ||| From Cat Q3 Earnings Conference Call: Co. Committed To High Single Digit Dividend Increase Over The Years ||| From Cat Q3 Earnings Conference Call: Sees Pricing To Be 'Moderate' Next Year ||| Caterpillar Inc Says Expects $900M Inventory Reduction In Q4 2019 ||| Catepillar Says 'See Flat End User Demand In Q4 2019 vs Expectation Of A Rise Earlier' ||| Caterpillar Inc Says 'Customers Are Delaying Capital Spending In Light Of Global Economic Uncertainity' ||| From Cat Q3 Earnings Conference Call: Sees Chinese Dealers Increasing Inventories In View Of Earlier Chinese New Year ||| Caterpillar Reports Q3 Earnings Miss, Cuts Guidance ||| Caterpillar shares are trading lower after the company reported worse-than-expected Q3 results and cut FY19 guidance. ||| Caterpillar Cuts FY19 EPS Guidance From $12.06-$13.06 To $10.90 To $11.40 vs $11.70 Est. ||| Caterpillar Q3 EPS $2.66 Misses $2.89 Estimate, Sales $12.8B Miss $13.49B Estimate ||| 12 Stocks To Watch For October 23, 2019 ||| Earnings Scheduled For October 23, 2019",0,0.47844076
2019-10-24,3916200.0,135.08999633789062,135.28999328613278,132.3800048828125,133.85000610351562,131.70846557617188,CAT,"Dow Jones Today: Another Sluggish Day Despite Earnings Avalanche ||| UPDATE: Bank Of America Maintains Buy On Caterpillar, Raises Target To $154 As Firm Notes 'We see an improving set-up into 2020 as CAT is curtailing production aggressively in Q4 when end-user demand is still positive' ||| CORRECTION: BofA Raised Price Target On Caterpillar From $145 To $154, Maintained Buy Rating ||| Bank of America Earlier Maintained Buy on Caterpillar, Raised Price Target From $145 To $154 ||| Deutsche Bank Maintains Hold on Caterpillar, Raises Price Target to $123 ||| Earnings Deluge As Twitter, Ford, 3M Fall While Tesla, Microsoft Rise; Amazon Later ||| 10 Biggest Price Target Changes For Thursday ||| Thursday's Market Minute: Will Housing Defend Its Title? ||| Morgan Stanley Maintains Equal-Weight on Caterpillar, Lowers Price Target to $132 ||| Baird Maintains Outperform on Caterpillar, Raises Price Target to $150 ||| Credit Suisse Maintains Outperform on Caterpillar, Raises Price Target to $150",1,0.5139698
2019-10-25,8319500.0,135.0,139.97999572753906,134.85000610351562,139.72999572753906,137.494384765625,CAT,Dow Jones Today: Trade Talks Have Stocks Flirting With Records ||| WeTrader Competition: Round Three Wrap-up ||| Caterpillar shares are trading higher despite no company-specific news. The stock has rallied approximately 16% over the past 14 trading sessions.,1,0.50879383
2019-10-28,6173800.0,139.97000122070312,141.6300048828125,138.8699951171875,140.05999755859378,137.819091796875,CAT,"Another Bonanza Earnings Week As Apple Looms, With Fed, Payrolls Also On Weekly Agenda",1,0.52355856
2019-10-29,4427900.0,139.3800048828125,141.4499969482422,138.77000427246094,141.3300018310547,139.06878662109378,CAT,Caterpillar Stock Looks Like a Viable Option for Dividend Investors ||| Navistar Expands TRATON Partnership With Canadian Mining Deal,0,0.49646866
2019-10-30,3947900.0,141.0,141.0,139.61000061035156,140.33999633789062,138.09461975097656,CAT,"Three Times A Charm? Rate Cut Comes As No Surprise, But Pause May Be Ahead ||| November Outlook: From Jobs To Fed to China, This Month Has it All ||| Caterpillar Shares Relatively Quiet As Hearing David Einhorn's Greenlight Capital Exited Short Position In Cat At A Loss",0,0.5043101
2019-10-31,4037500.0,139.3699951171875,140.33999633789062,136.38999938964844,137.80000305175778,135.59526062011722,CAT,"Dow Jones Today: China Trade, Impeachment Drive Return of Headline Risk ||| Dow Movers: CAT, AAPL ||| Caterpillar shares are trading lower in sympathy with Alamo Group after the company reported Q3 EPS down from last year. ||| 3 ETFs To Consider For The Next 6 Months ||| With China Trade Back In Focus, Strong Earnings From Apple, Facebook Blunt The Blow",1,0.5023471
2019-11-01,6220200.0,139.3699951171875,144.61000061035156,139.22999572753906,144.49000549316406,142.17823791503906,CAT,3 New and Superior Long-Term Stocks to Buy ||| 3 New and Superior Long-Term Stocks to Buy ||| Caterpillar shares are trading higher. Not seeing any news to justify the price action. ||| A Pair Of Super Cyclical ETFs For November,1,0.52311283
2019-11-04,5437800.0,145.35000610351562,147.0,145.02000427246094,146.9199981689453,144.56935119628906,CAT,3 Industrial Breakout Stocks to Buy ||| Caterpillar Lays Off 120 Temporary Workers In Texas ||| Stocks That Hit 52-Week Highs On Monday ||| Caterpillar Inc. Announces Layoffs At Plant In South Texas,0,0.53235424
2019-11-05,4516500.0,146.86000061035156,148.0,145.6699981689453,146.3699951171875,144.0281524658203,CAT,"Stocks That Hit 52-Week Highs On Tuesday ||| Uber Shares Hit The Curb After Earnings, But Trade Optimism Continues To Lift Market",0,0.47546026
2019-11-06,3736600.0,146.47000122070312,146.47000122070312,144.66000366210938,145.49000549316406,143.1622314453125,CAT,"Bank of America Reiterates Buy on Caterpillar, Raises Price Target to $165",1,0.49539456
2019-11-07,3816700.0,147.38999938964844,148.41000366210938,146.75,147.00999450683594,144.6579132080078,CAT,Stocks That Hit 52-Week Highs On Thursday ||| 5 Industrials Stocks Moving In Thursday's Pre-Market Session,1,0.48358694
2019-11-12,2843100.0,148.11000061035156,148.47000122070312,146.02000427246094,146.33999633789062,143.9986114501953,CAT,Stocks That Hit 52-Week Highs On Tuesday,0,0.5111693
2019-11-13,3194400.0,144.36000061035156,145.86000061035156,143.69000244140625,144.49000549316406,142.17823791503906,CAT,Abbott CEO Miles White Steps Down ||| Caterpillar 8-K Shows Rolling 3-Month Retail Sales For Oct. Up 3%,0,0.49546173
2019-11-14,2581700.0,144.2100067138672,145.33999633789062,143.2100067138672,143.44000244140625,141.14501953125,CAT,3 Industrial Stocks to Buy ||| 3 Top Industrial Stocks to Watch in November,1,0.52310896
2019-11-15,2827400.0,144.55999755859375,145.8800048828125,144.50999450683594,145.30999755859375,142.985107421875,CAT,"Notable Friday Option Activity: CIEN, RTN, CAT",0,0.5190699
2019-11-18,2638600.0,144.24000549316406,144.77999877929688,143.02000427246094,143.58999633789062,141.29263305664062,CAT,"Dow Movers: CAT, UNH ||| NOBL, WBA, APD, CAT: ETF Inflow Alert",0,0.50774604
2019-11-19,2085100.0,144.35000610351562,144.75999450683594,142.75999450683594,143.17999267578125,140.88917541503906,CAT,Explaining The Rally In United Rentals Stock,0,0.52638066
2019-11-20,3484700.0,142.4499969482422,142.6999969482422,140.10000610351562,141.52000427246094,139.25575256347656,CAT,Should the World’s Problems Stop You from Buying Caterpillar Stock?,1,0.5166997
2019-11-21,3297700.0,141.5500030517578,143.94000244140625,140.9499969482422,143.36000061035156,141.06631469726562,CAT,3 of the Best Stock Dips to Buy ||| Bank of America Stock Needs Help to Jump Start Its Rally ||| Does Parker-Hannifin's Guidance Signal a Turnaround for Industrial Companies?,1,0.50647044
2019-11-22,2258300.0,143.9199981689453,144.4600067138672,143.02999877929688,143.8800048828125,141.57798767089844,CAT,Why Oshkosh Stock Is Up 18% Over The Last Month,1,0.49923587
2019-11-25,3085200.0,144.75,146.57000732421875,143.8000030517578,146.4199981689453,144.0773468017578,CAT,"Noteworthy Monday Option Activity: CPRI, JEC, CAT",0,0.5277349
2019-11-27,2660200.0,145.02000427246094,145.72000122070312,143.6999969482422,145.69000244140625,143.35902404785156,CAT,Dow Jones News: Apple Ramps Up AirPods Pro Production; Caterpillar Down on Weak Deere Forecast,0,0.5076041
2019-11-29,1652500.0,144.19000244140625,145.4600067138672,143.7899932861328,144.72999572753906,142.4143829345703,CAT,Alamo Group Seeds Future Growth in Forestry,0,0.5582466
2019-12-02,2896200.0,145.1999969482422,146.0399932861328,142.83999633789062,142.9600067138672,140.67269897460938,CAT,"'Fast Money Halftime Report' Traders Give Their Take On JPMorgan, EA And More",0,0.49565405
2019-12-03,3839600.0,140.05000305175778,140.42999267578122,138.55999755859378,140.05999755859378,137.819091796875,CAT,"Machine Learning Answers: If Caterpillar Stock Drops 10% A Week, What’s The Chance It’ll Recoup Its Losses In A Month? ||| Cramer Weighs In On Biogen, Caterpillar And More ||| Shares of several industrial companies are trading lower on global macro concerns after Trump implied a US-China trade deal may not occur until 2020.",1,0.5075576
2019-12-04,2484600.0,140.97999572753906,142.27999877929688,140.0,140.1199951171875,137.87814331054688,CAT,3 Dow Stocks to Buy in the Selloff ||| 6 Manufacturing Stocks to Buy as the Economy Recovers ||| 3 Dividend Stocks Ideal for Retirees,1,0.5049128
2019-12-05,2277700.0,140.58000183105472,141.1199951171875,139.52999877929688,141.0500030517578,138.79325866699222,CAT,7 Stocks Still at Risk From Trade-War Shenanigans,1,0.52624637
2019-12-10,1888900.0,142.69000244140625,143.58999633789062,141.75,142.8699951171875,140.58413696289062,CAT,"Notable Tuesday Option Activity: ADI, MU, CAT ||| Investor Movement Index: November 2019",1,0.51111054
2019-12-11,2265700.0,143.77000427246094,144.6199951171875,143.2899932861328,144.0,141.69607543945312,CAT,"Daily Dividend Report: MAA, DHR, MO, CAT, EOG",1,0.51550955
2019-12-12,3714100.0,143.5399932861328,147.39999389648438,143.0,146.77999877929688,144.4315948486328,CAT,Standpoint Research Downgrades Caterpillar to Hold ||| Hearing Standpoint Downgrading Caterpillar From Buy To Hold; Unconfirmed ||| Caterpillar 8-K Shows Nov. Global Rolling 3-Month Retail Sales Unchanged Year Over Year,0,0.4956374
2019-12-13,3311700.0,146.8000030517578,148.39999389648438,145.14999389648438,145.52999877929688,143.2015838623047,CAT,"Benzinga's Top Upgrades, Downgrades For December 13, 2019",0,0.5198404
2019-12-16,2414800.0,147.7100067138672,148.3000030517578,145.22999572753906,145.36000061035156,143.03431701660156,CAT,"3 Top Dividend Aristocrat Stocks to Buy Now ||| Will Caterpillar Raise Its Dividend in 2020? ||| IVE, CAT, MDLZ, TFC: ETF Inflow Alert ||| Morgan Stanley Maintains Equal-Weight on Caterpillar, Raises Price Target to $137",1,0.51873237
2019-12-17,2850800.0,145.5,146.99000549316406,145.4600067138672,146.3699951171875,144.0281524658203,CAT,"Noteworthy Tuesday Option Activity: CAT, PVH, QRVO",1,0.51579714
2019-12-18,2629500.0,146.5,147.3000030517578,145.60000610351562,147.1199951171875,144.76614379882812,CAT,"Deutsche Bank Maintains Hold on Caterpillar, Raises Price Target to $147",0,0.48939395
2019-12-20,6805400.0,147.3800048828125,147.77000427246094,145.24000549316406,147.57000732421875,145.20895385742188,CAT,"Dow Movers: NKE, WBA ||| JP Morgan Maintains Overweight on Caterpillar, Raises Price Target to $178",1,0.49599504
2019-12-23,2346500.0,147.67999267578125,148.52999877929688,146.77999877929688,148.5,146.1240692138672,CAT,These 3 Value Stocks Are Absurdly Cheap Right Now ||| 3 Top Infrastructure Stocks to Watch in 2020 ||| How The Dow Jones Industrial Average Changed Over The Past Decade ||| CAT Named Top 25 SAFE Dividend Stock Increasing Payments For Decades ||| Navistar Rebuilds Share As Products And Service Grow Customer Base,0,0.5070372
2019-12-24,966200.0,148.6999969482422,148.8000030517578,147.2899932861328,147.47999572753906,145.12037658691406,CAT,"Noteworthy ETF Inflows: IVE, HD, CAT, MDLZ",1,0.52470535
2019-12-27,1544500.0,148.63999938964844,148.92999267578125,147.99000549316406,148.27999877929688,145.9075927734375,CAT,3 Doggish Dow Stocks With Big Income and Upside Potential ||| Why Your 2020 Resolution Should Be to Buy More Industrial Stocks ||| CAT Stock Will Continue to Underperform in 2020 ||| Stocks That Hit 52-Week Highs On Friday,0,0.5113297
2019-12-30,1789200.0,148.4199981689453,148.47000122070312,147.00999450683594,147.52000427246094,145.15975952148438,CAT,5 Stocks to Buy in January,1,0.5286715
2020-01-02,3311900.0,149.0,150.5500030517578,147.97999572753906,150.52999877929688,148.12159729003906,CAT,Caterpillar Stock Will Be Boosted by Multiple Macro Trends in 2020,0,0.5067067
2020-01-03,3100600.0,148.77000427246094,149.9600067138672,147.4499969482422,148.44000244140625,146.06503295898438,CAT,"Progress Rail Sells Its Leasing Segment To Paceline Equity Partners ||| Gold, Bonds, Crude All On The Rise After US Strike In Middle East Sparks Fears",0,0.49273458
2020-01-06,2549600.0,147.27000427246094,148.55999755859375,146.5399932861328,148.33999633789062,145.96661376953125,CAT,A 2019 Review of Dow Jones Stocks (And What 2020 May Bring),0,0.5124484
2020-01-07,2841900.0,147.35000610351562,147.57000732421875,145.50999450683594,146.3800048828125,144.03799438476562,CAT,"Dow Jones Today: Middle East Focus Factors Into The Equation Again ||| 3 Dow Jones Stocks That Are Ready to Pop ||| DIA, GS, MCD, CAT: ETF Outflow Alert ||| These 25 Companies Laid Off Workers in 2019",1,0.49717155
2020-01-09,2272500.0,147.80999755859375,147.97000122070312,146.50999450683594,147.30999755859375,144.95310974121094,CAT,"3 Big Stock Charts for Thursday: Home Depot, Lennar, and Roper Technologies",0,0.51575685
2020-01-10,2393700.0,147.4499969482422,147.72000122070312,145.8300018310547,146.1300048828125,143.7919921875,CAT,Dow Analyst Moves: CAT ||| The Challenges Boeing's New CEO Is Facing,1,0.518861
2020-01-13,3355200.0,146.52999877929688,146.8300018310547,145.5500030517578,146.82000732421875,144.470947265625,CAT,Where To Invest In The 2020s,0,0.5193714
2020-01-15,2640500.0,146.22000122070312,146.74000549316406,145.1999969482422,145.57000732421875,143.24095153808594,CAT,"Trinity Industries Names New Chief Executive Officer ||| Trade Deal Signing Today Represents A Landmark, But Plenty Of Questions Still Remain",1,0.5108888
2020-01-17,3331500.0,147.2100067138672,148.27000427246094,146.60000610351562,147.77999877929688,146.4355926513672,CAT,"10 Biggest Price Target Changes For Friday ||| Credit Suisse Maintains Outperform on Caterpillar, Raises Price Target to $173 ||| Citigroup Maintains Buy on Caterpillar, Raises Price Target to $170",0,0.51635617
2020-01-21,2476700.0,147.1999969482422,147.8699951171875,145.69000244140625,145.85000610351562,144.52316284179688,CAT,"10 Stocks to Buy as the 2020 Presidential Election Approaches ||| What to Expect From the Manufacturing Sector This Earnings Season ||| Benzinga Pro's Top 5 Stocks To Watch For Tues., Jan. 21, 2020: HAL, LB, NVAX, CAT, TCOM ||| 10 Biggest Price Target Changes For Tuesday ||| Daiwa Capital Upgrades Caterpillar to Outperform, Raises Price Target to $165",0,0.49807575
2020-01-22,3602400.0,146.25,146.55999755859375,142.52000427246094,142.6300048828125,141.33245849609375,CAT,Dow Jones Today: Stocks Still Rise Despite Mixed Bag With Earnings,1,0.4982637
2020-01-23,3182700.0,141.80999755859375,143.2100067138672,139.80000305175778,142.75,141.45135498046875,CAT,Is Deere's Stock Overvalued?,0,0.52905434
2020-01-24,2526200.0,142.5500030517578,142.6999969482422,139.25999450683594,140.3800048828125,139.10292053222656,CAT,"Dow Jones Today: Coronavirus Vexes Stocks ||| Dow Movers: DOW, INTC ||| Cancellations And Delays: Boeing Set To Report Q4 Earnings",0,0.5076575
2020-01-27,2920500.0,136.89999389648438,137.80999755859378,135.57000732421878,135.72999572753906,134.49520874023438,CAT,"Dow Jones Today: Virus Spreads, Impeachment Proceedings Infect Stocks ||| Going Viral: Stocks On Their Back As Virus Spreads Heading Into Key Earnings, Fed Week ||| Shares of multiple farm and construction equipment companies are trading lower as the Wuhan coronavirus continues to spread, causing global economic concerns and clouding the demand outlook for these products.",1,0.5191719
2020-01-30,3862600.0,134.75999450683594,135.97000122070312,132.91000366210938,135.3699951171875,134.13848876953122,CAT,Focus On Small Caps: What Is The Russell 2000 Index? ||| Q4 Earnings Outlook For Caterpillar,0,0.5033379
2020-01-31,6785700.0,133.82000732421878,134.99000549316406,130.53999328613278,131.35000610351562,130.15507507324222,CAT,"Caterpillar Q4 Profit Tops View, But Sales Miss ||| Caterpillar Inc. Q4 adjusted earnings Beat Estimates ||| 5 Top Stock Trades for Monday: SPY, FB, LK, CAT, NVDA ||| Caterpillar Q4 19 Earnings Conference Call At 8:30 AM ET ||| Sour Finish: Stocks Dive, Led By Hotels, Airlines, As Fears Of Coronavirus Impact Increase ||| Caterpillar shares are trading lower after the company reported worse-than-expected Q4 sales results. The company issued FY20 EPS guidance below analyst estimates. CFRA downgraded the stock from Hold to Sell and lowered the price target from $156 to $120. ||| Mid-Afternoon Market Update: Dow Tumbles More Than 500 Points; World Wrestling Entertainment Shares Plummet ||| Mid-Day Market Update: Crude Oil Down 1.5%; Navistar Shares Spike Higher ||| CFRA Downgrades Caterpillar to Sell, Lowers Price Target to $120 ||| Mid-Morning Market Update: Markets Open Lower; Caterpillar Posts Mixed Q4 Results ||| Position Scrimmage: Coronavirus, End-Of-Month Profit Taking Influencing Markets ||| From Cat Earnings Conference Call: Sees Chian Sales Flat To Down In 2020 ||| Caterpillar Inc Says Slowing Demand For Reciprocating Engines In North America And Lower Turbine Project Deliveries Contributed To 11% Decrease In Oil & Gas Sale ||| From Caterpillar's Conference Call: Says Dealer Inventory For The Quarter Decreased $700 Million Compared To Increase Of $200 Million In Prior Year's Quarter ||| Caterpillar Reports Mixed Q4 Earnings ||| Cat Sees FY20 EPS $8.50-$10 vs $10.63 Estimate ||| Caterpillar Q4 Adj. EPS $2.63 Beats $2.37 Estimate, Sales $13.1B Miss $13.41B Estimate ||| A Peek Into The Markets: US Stock Futures Drop Ahead Of Earnings, Economic Data ||| 12 Stocks To Watch For January 31, 2020 ||| Earnings Scheduled For January 31, 2020",0,0.49552643
2020-02-03,4385300.0,131.44000244140622,133.16000366210938,129.30000305175778,129.77000427246094,128.58944702148438,CAT,"Earnings Preview: Is It Time to Avoid Buying Google Stock? ||| RBC Capital Maintains Sector Perform on Caterpillar, Lowers Price Target to $145 ||| Surprise, Surprise: Stocks Wearing Their Rally Hats Despite China Market Tanking ||| Morgan Stanley Maintains Equal-Weight on Caterpillar, Lowers Price Target to $126 ||| Credit Suisse Maintains Outperform on Caterpillar, Raises Price Target to $173",1,0.4917365
2020-02-04,3501600.0,133.0,134.77999877929688,132.67999267578122,133.50999450683594,132.29541015625,CAT,"Dow Movers: VZ, NKE ||| Caterpillar Looks Ready to Increase Its Dividend Early in 2020 ||| Shares of several industrial companies are trading higher in sympathy with the overall market on a continued rebound after increased fear of the Wuhan coronavirus' impact on the economy dropped the Dow roughly 600 points on Friday. ||| Citigroup Maintains Buy on Caterpillar, Lowers Price Target to $160",1,0.56815726
2020-02-05,4448100.0,135.55000305175778,137.47000122070312,135.44000244140622,137.44000244140622,136.18966674804688,CAT,Caterpillar's China Manufacturing Plants Shut Until Feb. 10 ||| Shares of several industrial companies are trading higher as unconfirmed reports of progress towards a coronavirus treatment raise investor sentiment amid the virus outbreak. NOTE: The WHO played down these reports and said there are no known treatments.,0,0.5199099
2020-02-07,3812300.0,136.03999328613278,136.49000549316406,133.0,133.3699951171875,132.15667724609378,CAT,"Dow Movers: DOW, VZ",1,0.5210771
2020-02-10,2331600.0,133.03999328613278,134.33000183105472,132.77999877929688,134.32000732421878,133.09805297851562,CAT,"Dow Jones Today: Stocks Shrug Off Q1 GDP Warning ||| Why Cummins Stock Tumbled 10.6% in January ||| 2 Alarming Reasons Caterpillar Stock Tumbled 11.1% in January ||| Caterpillar's Share Price Dip May Attract Dividend Investors ||| 3 Big Stock Charts for Monday: Johnson Controls, Hanes, and Mohawk Industries ||| Caterpillar Says Most Of Its Chinese Facilities Reopened On Feb. 10; Co. To Continue To Follow Local Government Direction On Remaining Openings",1,0.5082178
2020-02-11,2381900.0,135.49000549316406,137.22999572753906,135.05999755859378,136.19000244140622,134.95103454589844,CAT,3 Dividend Stocks to Buy for the Long Haul ||| Daily Markets: Are Coronavirus Worries Behind Us? What This Means For Investors,1,0.5045232
2020-02-12,3222000.0,138.39999389648438,139.94000244140622,138.08999633789062,139.58999633789062,138.32009887695312,CAT,Dow Jones Today: Easing Coronavirus Concerns Propel Stocks Higher,1,0.534425
2020-02-13,3318800.0,140.0,140.5,138.42999267578122,139.72000122070312,138.44891357421878,CAT,"Dow Jones Today: Coronavirus Controversy Reemerges ||| Caterpillar's Risk-Reward Is Attractive, Goldman Sachs Says In Upgrade ||| Coronavirus Fears Back On Big Earnings Day As Alibaba, PepsiCo, Nvidia All Report ||| Benzinga's Top Upgrades, Downgrades For February 13, 2020 ||| Caterpillar 8-K Shows Global Rolling 3-Month Retail Sales For Jan. Down 7% Year Over Year ||| Benzinga Pro's Top 5 Stocks To Watch For Thurs., Feb. 13, 2020: FXI, TSLA, BABA, NIO, CAT ||| A Peek Into The Markets: US Stock Futures Tumble Over 200 Points As New Coronavirus Cases Surge ||| Goldman Sachs Upgrades Caterpillar to Buy",0,0.49846402
2020-02-14,2813400.0,139.49000549316406,139.6199951171875,136.88999938964844,137.99000549316406,136.73466491699222,CAT,"3 Top Value Stocks to Buy Right Now ||| Why Caterpillar's Stock Is Like The 'Unloved Stepchild' Of This Market ||| After Years Of High Growth, Daseke Finds Itself In Need Of A Tune-Up ||| Industrials Ended 2019 On A Strong Note, But Are Some Segments In Better Shape Than Others?",0,0.525564
2020-02-18,3869700.0,137.46000671386722,138.57000732421878,135.08000183105472,136.58000183105472,135.33749389648438,CAT,Caterpillar Announces That Pam Heminger Is The New Company's Vice President,1,0.5146077
2020-02-19,2134900.0,136.78999328613278,137.21000671386722,136.05999755859378,136.86000061035156,135.61494445800778,CAT,"Goldman Sachs: 2 Industrial Stocks to Snap Up, 1 to Avoid",1,0.5089167
2020-02-20,2678200.0,136.25999450683594,138.88999938964844,136.19999694824222,136.92999267578122,135.68429565429688,CAT,"Dow Movers: INTC, DOW ||| Trinity Industries' Quarterly Profit Falls But Revenues Rise",1,0.51773745
2020-02-21,2855600.0,136.5,137.44000244140622,135.11000061035156,137.21000671386722,135.96176147460938,CAT,"Dow Jones Today: Flight to Safety Dings Stocks ||| Trinity ""Right-Sizing"" Production Capacity With Market Demand",0,0.5079503
2020-02-24,4964800.0,132.52999877929688,133.86000061035156,132.05000305175778,132.16999816894528,130.96760559082028,CAT,"Barron's Picks And Pans: AT&T, Kroger, Virgin Galactic And More ||| Dow Jones Today: Monday, Bloody Monday ||| Shares of several industrial and shipping companies are trading lower amid continued spread of coronavirus including notable upticks in Iran and Italy. NOTE: The virus has raised fear of a global economic slowdown.",0,0.50095135
2020-02-25,4840200.0,132.97000122070312,133.13999938964844,128.25,129.0,127.82644653320312,CAT,"Dow Jones Today: CDC Warning Is a Red Flag for Stocks ||| Acquisitions and a Pop in Gold Mean NEM Stock Will Continue to Sparkle ||| 3 Big Stock Charts for Tuesday: Apple, Starbucks and Caterpillar",0,0.48580763
2020-03-04,5074700.0,126.06999969482422,127.44000244140624,124.30999755859376,127.4000015258789,126.24099731445312,CAT,"Railroads Signal a Tough Year Ahead for This Industry ||| As Market Stays Choppy, Investors Watch Big Tech Companies Apple, Microsoft For Clues ||| Shares of several industrial companies are trading higher after Joe Biden took the delegate lead on Super Tuesday. Biden's more 'moderate' economic policies have been seen as more favorable for growth.",0,0.4910965
2020-03-05,6015300.0,123.1500015258789,124.8499984741211,121.23999786376952,121.97000122070312,120.8603973388672,CAT,3 Bearish Options Trades to Play Market Volatility ||| Shares of several industrial companies are trading lower as global markets continue to experience volatility amid the coronavirus spread.,0,0.5243317
2020-03-06,5767900.0,119.0,121.8499984741211,118.83000183105467,121.41000366210938,120.30549621582033,CAT,"Shares of several companies in the broader industrial sector are trading lower amid the global coronavirus outbreak, which has hampered global economic outlook for the sector.",0,0.5350344
2020-03-09,8636200.0,112.98999786376952,112.98999786376952,104.02999877929688,104.06999969482422,103.12323760986328,CAT,Shares of several industrial companies are trading lower as US equities crash amid coronavirus fears and OPEC failing to reach a production agreement.,1,0.53073364
2020-03-10,8293200.0,108.63999938964844,109.05999755859376,99.11000061035156,106.48999786376952,105.52122497558594,CAT,Dow Jones News: Microsoft Top Cloud Pick; Caterpillar Could Suffer From Oil Market Chaos ||| Validea Peter Lynch Strategy Daily Upgrade Report - 3/10/2020 ||| Shares of several industrial companies are trading higher as markets rebound following Monday's selloff. US President Trump on Monday suggested the US is considering a payroll tax cut to relieve the negative economic effects of the coronavirus.,0,0.49343362
2020-03-11,6543600.0,103.8000030517578,104.75,100.06999969482422,100.69000244140624,99.77399444580078,CAT,"Caterpillar CFO At Conexpo Says Co. Has Not Seen Impact Of Coronavirus On Its Supply Chain ||| B of A Securities Reiterates Buy on Caterpillar, Lowers Price Target to $123 ||| Shares of several companies in the broader industrial sector are trading lower as equities sell off. The global coronavirus outbreak has weakened economic outlook and negatively impacted industrials.",0,0.4877095
2020-03-12,10285900.0,93.5,94.27999877929688,87.5,92.26000213623048,91.42068481445312,CAT,"Caterpillar Cracks Under Coronavirus Pressure: Retail Machine Sales Tumble ||| Stocks That Hit 52-Week Lows On Thursday ||| Shares of several companies in the broader industrial sector including construction, shipping, defense and others, are trading lower as equities sell off. The global coronavirus outbreak has weakened economic outlook and negatively impacted industrials.",1,0.5005032
2020-03-13,8718600.0,98.38999938964844,99.91000366210938,90.13999938964844,99.63999938964844,98.7335433959961,CAT,"Baird Maintains Outperform on Caterpillar, Lowers Price Target to $157 ||| Citigroup Maintains Buy on Caterpillar, Lowers Price Target to $130",0,0.48190135
2020-03-16,9899000.0,89.0,105.8499984741211,88.5,93.41000366210938,92.56021881103516,CAT,"Dow Jones Today: Terrible Teens as 6 Dow Stocks Slide 13% or More ||| Analyst Upgrades Caterpillar Stock to Buy Despite Coronavirus Fears ||| Dow Movers: BA, JNJ ||| 2 Dow Stocks Surviving The Coronavirus Carnage ||| Caterpillar shares are trading higher despite overall market weakness after analysts at Stifel upgraded the stock from Hold to Buy. ||| Caterpillar shares are trading lower despite an analyst at Stifel upgrading the company's stock from Hold to Buy. NOTE: Several shares in the industrial sector are trading lower amid continued coronavirus outbreak concerns. UPDATE: Shares have since reversed, now higher. ||| Stifel Upgrades Caterpillar to Buy, Lowers Price Target to $137",1,0.48082247
2020-03-17,7206100.0,96.01000213623048,100.44000244140624,92.97000122070312,100.1999969482422,99.28844451904295,CAT,"Shares of several industrial companies are trading higher rebounding from Monday's crash. Stocks may also potentially be getting a boost from expectations of a further $850 billion stimulus proposal. ||| Morgan Stanley Maintains Equal-Weight on Caterpillar, Lowers Price Target to $115",0,0.47722602
2020-03-18,6995100.0,93.98999786376952,102.9499969482422,93.11000061035156,100.12000274658205,99.20917510986328,CAT,"3 High-Yield Stocks at Rock-Bottom Prices ||| Benzinga's Top Upgrades, Downgrades For March 18, 2020 ||| UBS Upgrades Caterpillar to Neutral, Lowers Price Target to $100",1,0.53434706
2020-03-23,6737500.0,93.9000015258789,96.23999786376952,90.63999938964844,91.8499984741211,91.014404296875,CAT,Zuora: Is This the Top Stock for the Subscription Economy?,1,0.52659315
2020-03-24,7417100.0,96.05999755859376,102.02999877929688,95.16999816894533,101.33999633789062,100.41807556152344,CAT,Shares of several industrial companies are trading higher amid hopes of Congress passing a US economic stimulus package agreement. The sector has been impacted by economic disruption caused by the coronavirus.,1,0.53702766
2020-03-26,6059600.0,104.8499984741211,110.97000122070312,102.88999938964844,110.5,109.49474334716795,CAT,"Caterpillar Withdraws 2020 Outlook ||| Dow Analyst Moves: CAT ||| Dow Jones News: iPhone Trouble for Apple; Caterpillar Pulls Guidance ||| Dow Movers: TRV, BA ||| Caterpillar Withdraws 2020 Outlook as Coronavirus Hits Supply Chain ||| Despite 'Once In A Lifetime Opportunity,' Investors Still Need To Do Their Homework ||| Pandemic Leads Caterpillar To Withdraw 2020 Guidance ||| Caterpillar Withdraws FY20 Guidance ||| Caterpillar Says Ended 2019 With $8.3B In Cash And Avialable Global Credit Facilities Of $10.5B",0,0.4891197
2020-03-27,5746500.0,104.43000030517578,109.63999938964844,103.4000015258789,105.44000244140624,104.48078155517578,CAT,"BofA Downgrades Caterpillar, Strengths Not Enough To Offset Energy Exposure ||| Shares of several companies in the broader industrial sector are trading lower as markets sell off following this week's strength. Despite US stimulus efforts, macro concerns still persist due to the coronavirus. ||| Morgan Stanley Maintains Equal-Weight on Caterpillar, Lowers Price Target to $109",1,0.4904669
2020-03-30,5725600.0,106.33000183105467,112.83999633789062,104.93000030517578,111.70999908447266,110.69373321533205,CAT,"Benzinga's Bulls And Bears Of The Week: Boeing, Netflix, Nike, Target And More ||| 7 Stocks to Buy for a Dovish Federal Reserve ||| Shares of several industrial companies are trading higher as equities rebound following recent US stimulus efforts. The sector has been hit my macro disruption amid the coronavirus pandemic.",1,0.5030718
2020-03-31,8970800.0,110.7300033569336,116.91000366210938,110.26000213623048,116.04000091552734,114.98434448242188,CAT,"Dow Jones Today: A Tough but Calm End to a Turbulent Quarter ||| Why Caterpillar's Stock Is Trading Higher Today ||| Caterpillar shares are trading higher after Citigroup maintained its Buy rating on the stock. NOTE: Potentially rebounding from this quarter's weakness due to Coronavirus. ||| Citigroup Maintains Buy on Caterpillar, Lowers Price Target to $125",0,0.49481812
2020-04-03,5036400.0,115.5,116.83999633789062,112.12000274658205,114.66999816894533,113.6268081665039,CAT,"Shares of several industrial companies are trading lower amid overall market weakness. The coronavirus has caused global macro disruption, which has been a negative catalyst for the sector as output and investment outlook is hampered.",1,0.5328928
2020-04-06,5785600.0,120.04000091552734,121.7300033569336,118.12999725341795,120.43000030517578,119.33441162109376,CAT,"3 Top Infrastructure Stocks to Watch in April ||| Shares of several industrial companies are trading higher with the broader market on optimism that coronavirus cases in several US hotspots appear to be reaching their peak. ||| Caterpillar Filing Shows Registration For 2 Senior Notes Offerings, Due 2030, Due 2050, No Size Disclosed",1,0.5316919
2020-04-07,8489900.0,122.88999938964844,128.80000305175778,120.51000213623048,121.91999816894533,120.81085205078124,CAT,Shares of several industrial companies are trading higher amid optimism that coronavirus cases in Asia are potentially easing. Strength may also be attributed to optimism that coronavirus cases in several US hotspots appear to be reaching their peak.,1,0.53888476
2020-04-08,4686100.0,122.98999786376952,128.17999267578122,121.04000091552734,127.4000015258789,126.24099731445312,CAT,"Daily Dividend Report: CAT,ROK,LEN,UNF,KNOP ||| Cramer Shares His Thoughts On IBM, Enphase And More",0,0.49661726
2020-04-09,4753500.0,128.64999389648438,129.60000610351562,123.1500015258789,125.02999877929688,123.8925552368164,CAT,"Goldman Sachs: These Are the 5 Best Stocks for an Economic Recovery ||| Dow Jones Today: Lowered Fatality Forecasts Sent Stocks Higher ||| Caterpillar seeks $3 bln loan from banks to boost liquidity - Bloomberg ||| Caterpillar seeks $3 bln loan from banks to boost liquidity - Bloomberg ||| Caterpillar Seeking $3B Loan From Banks To Boost Liquidity ||| Credit Suisse Maintains Outperform on Caterpillar, Lowers Price Target to $148 ||| 10 Biggest Price Target Changes For Thursday ||| Cramer Weighs In On Uber, Yelp And More ||| Stephens & Co. Maintains Underweight on Caterpillar, Lowers Price Target to $80",0,0.46744728
2020-04-13,10519600.0,119.9499969482422,120.0500030517578,113.58000183105467,114.13999938964844,113.10163116455078,CAT,"BUZZ-U.S. STOCKS ON THE MOVE-Netflix, Amazon.com, Dish Network, GE, AMC Entertainment, Aurora Cannabis ||| Wall Street slides as investors brace for dour earnings ||| Dow Jones News: Iger Reportedly Running Disney; Caterpillar Downgraded ||| Wall Street slides as investors brace for dour earnings ||| Dow Movers: CAT, WMT ||| Dow Jones Today: Stocks Decline Anticipating Q1 Earnings ||| Wall Street slides as focus shifts to earnings ||| BofA Downgrades Caterpillar, Says Energy Problem Is Here To Stay ||| Morgan Stanley Maintains Equal-Weight on Caterpillar, Lowers Price Target to $107 ||| Caterpillar shares are trading lower after analysts at Bank of America downgraded the company's stock from Neutral to Underperform. ||| B of A Securities Downgrades Caterpillar to Underperform ||| Hearing Caterpillar Shares Were Downgraded by Bank of America",1,0.5114757
2020-04-14,7166300.0,116.5,117.83999633789062,114.51000213623048,116.4800033569336,115.42034912109376,CAT,"Pandemic survival plans: U.S. businesses scramble to conserve cash, boost liquidity ||| Shares of several industrial companies are trading higher as markets gain on positive coronavirus outlook. Optimism surrounding the virus has led to hopes of an upcoming return to economic activity, which would benefit the sector. ||| JPMorgan, Wells Fargo Earnings Lower Than Expected, But Positive Tone Helps Shares ||| Caterpillar To Report Q1 Earnings Tues., Apr. 28 Before Market Open",0,0.5392771
2020-04-15,5652800.0,112.95999908447266,113.0999984741211,109.8000030517578,111.52999877929688,110.51537322998048,CAT,"Cash Dividend On The Way From Caterpillar (CAT) ||| Every Member Of Trump's 'Great American Economic Revival' Industry Groups ||| Shares of several industrial companies are trading lower as equities fall amid mixed earnings results from banks, a significant decline in the price of oil and worse than expected retail sales in March.",1,0.50724065
2020-04-16,5926400.0,111.8499984741211,113.47000122070312,108.86000061035156,113.22000122070312,112.19000244140624,CAT,Validea Peter Lynch Strategy Daily Upgrade Report - 4/16/2020 ||| S&P 500 Futures Up 3.2% After Hours; Many Other Stocks Moving Higher With Futures; Investors Reacting Favorably To White Phase Guidelines On Reopening Economy,1,0.49749205
2020-04-20,4083800.0,114.44000244140624,117.06999969482422,112.12000274658205,114.5999984741211,114.5999984741211,CAT,"Bulls And Bears Of The Week: Caterpillar, Facebook, Microsoft And More",0,0.50498885
2020-04-21,5743300.0,111.04000091552734,111.04000091552734,108.5999984741211,109.8499984741211,109.8499984741211,CAT,"Dow Movers: IBM, WMT ||| Shares of several industrial companies are trading lower as markets dip after oil prices fell to historic lows, partially stemming from weak demand caused by the coronavirus pandemic. ||| 14 Industrials Stocks Moving In Tuesday's Pre-Market Session",1,0.50573623
2020-04-22,3795100.0,112.02999877929688,112.0999984741211,109.20999908447266,110.63999938964844,110.63999938964844,CAT,"Stock Alert: Caterpillar Edges Up ||| Dow Movers: WMT, INTC ||| Caterpillar Shares Tick Lower From Open; Hearing Cleveland Research Out Cautious On Stock/Co.",1,0.51060265
2020-04-23,3545400.0,111.33000183105467,115.2300033569336,110.9499969482422,112.91000366210938,112.91000366210938,CAT,Shares of several industrial companies are trading higher. Movement appears market-related as equities gain amid a rebound in oil prices.,1,0.51573575
2020-04-27,5344800.0,110.8499984741211,116.12999725341795,109.7300033569336,115.1999969482422,115.1999969482422,CAT,"GLOBAL MARKETS-Asia shares gain as BOJ eases further; U.S. crude slips ||| Investors Should Not Buy Caterpillar Ahead of Its Earnings ||| Wall Street gains as some U.S. states reopen for business ||| BUZZ-U.S. STOCKS ON THE MOVE-Kohl's, tanker operators, oil and gas companies, U.S. casinos ||| BUZZ-U.S. STOCKS ON THE MOVE-Tanker operators, oil and gas companies, Caterpillar ||| Wall Street gathers steam as U.S. states prepare to reopen ||| Wall Street gains as U.S. states start to reopen ||| Wall St set to rise as U.S. starts to reopen, Boeing gains ||| GLOBAL MARKETS-Asia shares rally as BOJ buys more bonds; U.S. crude skids ||| 3 Sector ETFs For This Week's Earnings Parade ||| Morgan Stanley On Caterpillar And United Rental's Stock: 'Time To Leave' ||| UPDATE: Morgan Stanley Downgrades Caterpillar And United Rentals As Firm Sees 'growing headwinds from a multi-year downturn in Non-Resi Construction, combined with historically weak oil prices and declining mining commodity price' ||| Apple And Amazon Earnings, Fed Meeting Among Highlights In Busy Week Ahead ||| Benzinga's Top Upgrades, Downgrades For April 27, 2020 ||| Morgan Stanley Downgrades Caterpillar to Underweight",1,0.5030104
2020-04-28,5604600.0,117.86000061035156,118.0,113.37000274658205,115.45999908447266,115.45999908447266,CAT,"Caterpillar Q1 20 Earnings Conference Call At 8:30 AM ET ||| Dow Jones Today: Stocks Sag Under Predictions Q2 Will Be Worst of 2020 ||| S&P 500 gains modestly, warning of higher COVID-19 deaths curb recovery hopes ||| Caterpillar Q1 20 Earnings Conference Call At 8:30 AM ET ||| Caterpillar Inc (CAT) Q1 2020 Earnings Call Transcript ||| Caterpillar reports 46% profit fall, give no 2020 outlook ||| Caterpillar Inc. Q1 adjusted earnings Miss Estimates ||| CFRA Maintains Sell on Caterpillar, Lowers Price Target to $101 ||| Morning Market Stats in 5 Minutes ||| Earnings Feast: Bring a Plate With Healthcare and Caterpillar in Morning, GOOGL And AMD Later ||| From Caterpillar Earnings Conference Call: Impact Of Coronavirus Pandemic Has Been Significantly More Severe, More Chaotic Than Expected ||| From Caterpillar Q1 Earnings Conference Call: Will Temporarily Suspend Buyback ||| Caterpillar Q1 Adj. EPS $1.600 Misses $1.690 Estimate, Sales $10.600B Miss $10.920B Estimate ||| A Peek Into The Markets: US Stock Futures Up Ahead Of Earnings, Economic Reports ||| Earnings Scheduled For April 28, 2020 ||| 10 Stocks To Watch For April 28, 2020",1,0.48018315
2020-04-29,4261100.0,116.95999908447266,120.81999969482422,116.52999877929688,120.05999755859376,120.05999755859376,CAT,"B of A Securities Maintains Underperform on Caterpillar, Lowers Price Target to $100 ||| UBS Maintains Neutral on Caterpillar, Raises Price Target to $112 ||| Morgan Stanley Maintains Underweight on Caterpillar, Raises Price Target to $95",0,0.4791911
2020-04-30,4039100.0,118.0,118.25,115.33000183105467,116.37999725341795,116.37999725341795,CAT,3 Stocks to Buy for Fundamental Strength After Earnings ||| Trump's tariffs add to pandemic-induced turmoil of U.S. manufacturers ||| Shares of several industrial companies are trading lower amid market weakness following US jobless claims and consumer spending data.,0,0.5013963
2020-05-01,3960400.0,114.0,114.58999633789062,110.56999969482422,110.87999725341795,110.87999725341795,CAT,"BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Medigus, Aemetis ||| 3 Dividend Stocks That Should Pay You For the Rest of Your Life ||| BUZZ-U.S. STOCKS ON THE MOVE-Medigus Ltd, Western Digital Corp, Aemetis Inc ||| Shares of several industrial companies are trading lower on market weakness as investor uncertainty grows following quarterly earnings results from multiple companies.",0,0.47211966
2020-05-04,4500700.0,110.0199966430664,110.27999877929688,106.58000183105467,107.72000122070312,107.72000122070312,CAT,"Is Caterpillar's Dividend Sustainable? ||| Benzinga's Bulls And Bears Of The Week: Ford, Gilead, Microsoft, Intel And More ||| Stock Alert: Caterpillar Shares Slide",1,0.50395876
2020-05-05,3477400.0,109.23999786376952,111.08999633789062,108.73999786376952,108.91000366210938,108.91000366210938,CAT,3 Top Industrial Stocks to Watch in May ||| Stock Alert: Caterpillar Drops Again ||| Shares of several industrial companies are trading higher amid positive investor sentiment as some US states begin to reopen their economies and as oil prices gain for the session.,0,0.5376297
2020-05-07,4377900.0,109.0199966430664,110.0500030517578,106.77999877929688,107.29000091552734,107.29000091552734,CAT,"How Deere, Caterpillar kept plants running during the coronavirus outbreak ||| How Deere, Caterpillar kept plants running during the coronavirus outbreak",1,0.5119672
2020-05-08,3913400.0,108.97000122070312,112.1999969482422,108.3000030517578,112.11000061035156,112.11000061035156,CAT,Shares of several industrial companies are trading higher after US unemployment figures came in below consensus estimates. Equities have been strong this week amid a rebound in oil prices and some US states easing lockdown restrictions.,0,0.5212512
2020-05-11,4205600.0,110.16000366210938,110.7699966430664,108.18000030517578,108.61000061035156,108.61000061035156,CAT,"Stock Alert: Caterpillar Slides ||| 3 Big Stock Charts for Monday: Boeing, Procter & Gamble, and Caterpillar",0,0.4965637
2020-05-12,3874100.0,109.11000061035156,109.33000183105467,105.0,105.0,105.0,CAT,"""Stay at Home"" Stocks Still Rule the Roost as Nvidia, Microsoft, Apple Start Week Firmly",0,0.49971557
2020-05-13,5376100.0,105.13999938964844,105.29000091552734,102.5500030517578,104.4800033569336,104.4800033569336,CAT,Caterpillar Feels COVID-19 Pinch: Retail Machine Sales Tank ||| Caterpillar 8-K Shows Global Rolling 3-Month Retail Sales Down 22% In Apr.,1,0.5240181
2020-05-15,6583100.0,105.18000030517578,107.98999786376952,104.27999877929688,107.91999816894533,107.91999816894533,CAT,Dow Jones Today: Another Data Defying Day As Retail Spend Plummeted,1,0.52255386
2020-05-18,5604400.0,112.22000122070312,115.66000366210938,112.01000213623048,115.0199966430664,115.0199966430664,CAT,"Cramer Shares His Thoughts On Inovio, Raytheon And More ||| Stock Alert: Caterpillar Gains Nearly 5% ||| Vanguard Dividend Appreciation ETF Experiences Big Inflow ||| Shares of several industrial companies are trading higher amid market strength as news from a Moderna trial stoked optimism about a potential coronavirus vaccine, which has raised hopes of an economic rebound.",0,0.517066
2020-05-19,3404900.0,114.9499969482422,115.44000244140624,112.01000213623048,112.08000183105467,112.08000183105467,CAT,3 Top Industrial Stocks to Buy Right Now ||| Short Setup Watch-List of Stocks That Just Can't Do Anything Right,1,0.5436154
2020-05-20,3735700.0,113.30999755859376,117.4800033569336,113.0500030517578,115.69000244140624,115.69000244140624,CAT,"Dow Movers: MRK, DOW ||| Shares of several industrial companies are trading higher amid strength in oil, strong earnings from Lowe's and optimism towards a U.S. economic rebound. ||| Advisors Asset Management, Inc. Buys Walgreens Boots Alliance Inc, Brookfield Real Assets ...",0,0.4776779
2020-05-21,2342300.0,114.9499969482422,115.68000030517578,113.81999969482422,114.05999755859376,114.05999755859376,CAT,The Biggest Drops In The History Of The Dow Jones Industrial Average,0,0.5137688
2020-05-22,2735100.0,114.12999725341795,114.16000366210938,111.47000122070312,112.47000122070312,112.47000122070312,CAT,"Dow Movers: XOM, PG",1,0.50886065
2020-05-26,4185100.0,115.9800033569336,118.55999755859376,115.9800033569336,117.41000366210938,117.41000366210938,CAT,Caterpillar Option Alert: Jun 5 $121 Calls Sweep (3) near the Ask: 1000 @ $1.444 vs 34 OI; Earnings 7/22 Before Open [est] Ref=$117.73 ||| Shares of several industrial companies are trading higher in sympathy with the overall market as equities rally on coronavirus vaccine hopes as well as a pickup in economic activity as some US states reopen businesses.,1,0.49689513
2020-05-27,4462700.0,119.72000122070312,122.48999786376952,119.52999877929688,122.41999816894533,122.41999816894533,CAT,"Shares of several industrial companies are trading higher amid economic optimism, stemming from some US states reopening businesses, an increase in mortgage demand figures and positive vaccine sentiment.",0,0.5332085
2020-05-28,3743700.0,124.75,124.83000183105467,120.27999877929688,120.73999786376952,120.73999786376952,CAT,3 Top Industrial Stocks Still Down More Than 20% in 2020 ||| Caterpillar (CAT) Dips More Than Broader Markets: What You Should Know ||| Caterpillar (CAT) Up 2% Since Last Earnings Report: Can It Continue? ||| New Strong Sell Stocks for May 28th,0,0.5361892
2020-05-29,4278100.0,119.62999725341795,120.70999908447266,117.56999969482422,120.12999725341795,120.12999725341795,CAT,"DIA, GS, WMT, CAT: ETF Inflow Alert",1,0.54192835
2020-06-01,2131300.0,119.86000061035156,121.1999969482422,117.61000061035156,120.5,120.5,CAT,Is Deere's Stock Set for Recovery?,1,0.52177846
2020-06-02,2977500.0,121.83999633789062,123.81999969482422,121.27999877929688,123.31999969482422,123.31999969482422,CAT,Stock Market Today: Upbeat Economic Data Cheers Investors,1,0.5192292
2020-06-03,3712600.0,125.4499969482422,127.3499984741211,125.01000213623048,127.08999633789062,127.08999633789062,CAT,Shares of several industrial companies are trading higher after as equities continue to gain on optimism over an economic reopening which could potentially increase consumer spending and sales demand as well as a smaller-than-expected drop in nonfarm payrolls. ||| Zoom Stock Rises Then Falls After Blockbuster Earnings,1,0.49585938
2020-06-05,5591900.0,137.85000610351562,139.3699951171875,133.38999938964844,135.1199951171875,135.1199951171875,CAT,3 Top Infrastructure Stocks to Watch in June ||| Shares of several industrial companies are trading higher following strong US jobs numbers and continued optimism surrounding the reopening of the US economy. These have lead to hopes of an economic rebound and an uptick in production/shipping activity.,1,0.5574597
2020-06-08,4139200.0,135.32000732421878,139.94000244140622,135.32000732421878,137.72000122070312,137.72000122070312,CAT,"Shares of several industrial companies are trading higher on continued upward momentum surrounding the economy reopening, which would increase consumer spending and economic activity. New York City moved into phase one of its reopening plan on Monday.",0,0.49946186
2020-06-11,5969300.0,126.41000366210938,126.83999633789062,121.5199966430664,121.5500030517578,121.5500030517578,CAT,"Nikola Hires Industry Executives to Lead Energy and Manufacturing ||| The Top 3 Infrastructure Stocks to Help Build Your Portfolio ||| Daily Dividend Report: TGT,CAT,NLY,CSCO,ZBH",1,0.5116734
2020-06-12,4489000.0,124.4000015258789,125.16999816894533,119.3499984741211,123.1500015258789,123.1500015258789,CAT,"Dow Jones Rebounds as Caterpillar Reports Awful Sales Figures, Microsoft in Trump's Crosshairs ||| Dow Analyst Moves: CAT",1,0.5043654
2020-06-16,6892400.0,131.3699951171875,132.44000244140622,126.38999938964844,130.11000061035156,130.11000061035156,CAT,"Notable ETF Inflow Detected - DIA, GS, BA, CAT ||| Wall Street jumps as May retail sales boost hopes of swift recovery ||| Wall Street jumps on glimmers of economic recovery ||| Wall Street set to jump after record rise in May retail sales ||| Wall Street surges after record rise in May retail sales ||| Dow Movers: PFE, BA",0,0.48455748
2020-06-19,6488000.0,130.0,130.0,125.7300033569336,127.45999908447266,127.45999908447266,CAT,3 Dow Jones Stocks Primed for Trading Today,0,0.52202487
2020-06-22,2806300.0,126.36000061035156,126.4800033569336,124.5999984741211,125.79000091552734,125.79000091552734,CAT,"Dow Movers: WBA, AAPL",1,0.5142129
2020-06-23,2357100.0,127.38999938964844,127.56999969482422,125.83000183105467,126.25,126.25,CAT,3 Infrastructure Stocks That Will Benefit From Trump’s Proposal,0,0.5358171
2020-06-24,3766500.0,124.79000091552734,124.83999633789062,121.83000183105467,122.05999755859376,122.05999755859376,CAT,"DIA, GS, BA, CAT: ETF Inflow Alert",1,0.54063636
2020-06-25,2903400.0,121.61000061035156,124.83000183105467,120.8000030517578,124.70999908447266,124.70999908447266,CAT,Do Caterpillar's Horrible Sales Figures Point to Long-Term Trouble?,0,0.5166981
2020-07-06,2491900.0,130.1300048828125,130.5,128.1699981689453,129.42999267578125,119.7510223388672,CAT,3 Top Industrial Stocks to Watch in July,0,0.5502545
2020-07-08,2279500.0,129.3300018310547,129.3300018310547,126.47000122070312,128.1300048828125,118.54823303222656,CAT,"UDOW, MMM, CAT, TRV: Large Outflows Detected at ETF",0,0.51751274
2020-07-09,2663500.0,127.54000091552734,128.35000610351562,125.12000274658205,125.7300033569336,116.32769775390624,CAT,"If You Like Dividends, You Should Love These 3 Stocks",1,0.49124452
2020-07-14,6540800.0,130.32000732421875,137.30999755859375,129.22999572753906,136.8800048828125,126.6439208984375,CAT,Dow Nabs Third Straight on 556-Point Pop ||| 8 Presidential Election Stocks to Buy in Case Trump Wins Again,1,0.5143735
2020-07-15,4915200.0,140.1699981689453,140.1699981689453,137.11000061035156,138.36000061035156,128.01324462890625,CAT,"4 Machinery Stocks That Are Ready To Move Higher ||| Ex-Dividend Reminder: Graco, AZZ and Caterpillar",1,0.5004196
2020-07-16,3621500.0,138.3000030517578,140.99000549316406,137.60000610351562,138.55999755859375,128.19827270507812,CAT,"Noteworthy ETF Outflows: XLI, HON, RTX, CAT",0,0.51866007
2020-07-23,1613700.0,136.89999389648438,137.52000427246094,135.7100067138672,136.60000610351562,127.3313980102539,CAT,5 Top Dividend Aristocrats to Buy and Hold Forever,1,0.55606693
2020-07-24,2036300.0,137.1999969482422,138.69000244140625,136.85000610351562,137.5800018310547,128.24485778808594,CAT,Here Are 2 Top Ways to Play Caterpillar Stock,1,0.52563494
2020-07-28,2029900.0,138.94000244140625,139.99000549316406,137.9199981689453,138.02999877929688,128.66436767578125,CAT,PREVIEW-Caterpillar results likely to shed light on strength of economic recovery,1,0.51943433
2020-07-30,3063500.0,139.0800018310547,139.10000610351562,135.97000122070312,136.72999572753906,127.45254516601562,CAT,"Pre-Market Earnings Report for July 31, 2020 : MRK, XOM, CVX, ABBV, CHTR, CAT, D, CL, ITW, AON, LHX, IDXX ||| BUZZ-U.S. STOCKS ON THE MOVE-Caterpillar, Textron, Kellogg Co",0,0.452257
2020-07-31,6780900.0,132.42999267578125,135.14999389648438,130.2100067138672,132.8800048828125,123.86378479003906,CAT,"Caterpillar (CAT) Q2 2020 Earnings Call Transcript ||| Nasdaq surges on megacap earnings but U.S. fiscal uncertainty nags ||| Nasdaq surges on megacap earnings but fiscal uncertainty lingers ||| Dow Jones Slumps Despite Apple's Blockbuster Earnings; Caterpillar Stock Sinks on Weak Demand ||| Megacap earnings lift Nasdaq but fiscal uncertainty weighs ||| Wall Street weighed down by fiscal aid uncertainty as tech boost fades ||| Dow Movers: CAT, AAPL ||| BUZZ-U.S. STOCKS ON THE MOVE-Caterpillar, Under Armour, Merck & Co, L3Harris Tech ||| S&P 500, Dow slide as pandemic nerves offset tech euphoria ||| Pandemic boost for Big Tech set to drive Wall St higher ||| Coronavirus hits Caterpillar's quarterly earnings ||| Cat Financial Q2 Profit Down 25% - Quick Facts ||| Caterpillar Q2 Profit Plunges, But Results Top Estimates - Quick Facts ||| Caterpillar Inc. Q2 Profit Retreats ||| Caterpillar Q2 20 Earnings Conference Call At 8:30 AM ET",0,0.4931967
2020-08-03,2851100.0,132.3000030517578,133.0,131.10000610351562,131.77999877929688,122.8384017944336,CAT,U.S. manufacturing activity near 1-1/2-year high; construction spending extends drop ||| U.S. manufacturing activity near 1-1/2-year high -ISM ||| These 2 Stock Market Sectors Are Buys if Biden Beats Trump in November ||| European stocks grind higher as euro zone data offsets HSBC warning ||| UK aerospace supplier Senior Plc posts half-year loss,0,0.48351738
2020-08-05,2767800.0,132.77999877929688,135.94000244140625,132.61000061035156,134.97000122070312,125.8119659423828,CAT,"Dow Movers: WMT, DIS",0,0.5185916
2020-08-07,2223700.0,134.0,135.11000061035156,132.52000427246094,134.9199981689453,125.7653579711914,CAT,All of Caterpillar’s Segments Are Hurting -- Here Are the Details ||| Is Caterpillar Stock a Buy?,1,0.48688155
2020-08-12,2541200.0,143.9499969482422,144.1699981689453,141.3300018310547,142.57000732421875,132.8962860107422,CAT,"UDOW, CAT, TRV, AXP: Large Outflows Detected at ETF ||| Dow Movers: BA, GS",0,0.5101493
2020-08-14,2038500.0,139.4499969482422,140.88999938964844,138.77000427246094,139.9600067138672,130.46339416503906,CAT,"Dow Jones Little Changed as Apple Bans Fortnite, Caterpillar Reports Rough July Sales ||| Caterpillar's Coronavirus Woes Continue: Retail Machine Sales Tumble",0,0.50687265
2020-08-21,2524600.0,136.8000030517578,139.0,136.8000030517578,138.42999267578125,129.0371856689453,CAT,Vanguard Industrials ETF Experiences Big Outflow ||| 9 Top Stocks to Buy for a Weakened Dollar,1,0.50591224
2020-08-25,2467500.0,142.6699981689453,144.92999267578125,140.5399932861328,141.14999389648438,131.57264709472656,CAT,"Dow Movers: AAPL, CAT",1,0.51030123
2020-08-26,2379900.0,140.47999572753906,142.44000244140625,139.80999755859375,141.8300018310547,132.20651245117188,CAT,Honeywell Is Even More of a Screaming Buy After Being Added to the Dow Jones,1,0.5041921
2020-08-27,3010300.0,142.1300048828125,144.33999633789062,141.27999877929688,143.3699951171875,133.64202880859375,CAT,Dow Analyst Moves: CAT,1,0.51468444
2020-08-31,2886500.0,143.5,143.60000610351562,142.27000427246094,142.30999755859375,132.65391540527344,CAT,"DGRW, QCOM, CAT, RTX: ETF Inflow Alert",1,0.525702
2020-09-01,2673900.0,141.6699981689453,146.1199951171875,140.91000366210938,146.0500030517578,136.14013671875,CAT,Despite 90% Move Deere Stock Has More Room To Grow,1,0.5530384
2020-09-08,4775200.0,147.0,150.75999450683594,145.72000122070312,148.52000427246094,138.44259643554688,CAT,S&P 500 Sell-Off Deepens: Tech and Energy Stocks Get Crushed,1,0.5205941
2020-09-11,3237100.0,150.47999572753906,154.39999389648438,150.24000549316406,153.8300018310547,143.39224243164062,CAT,Dow ends higher but Wall Street posts 2nd straight weekly drop on tech slide ||| Wall Street posts 2nd straight weekly drop on tech slide,0,0.49948427
2020-09-15,4092400.0,154.1999969482422,154.47000122070312,148.36000061035156,148.60000610351562,138.51715087890625,CAT,"BUZZ-U.S. STOCKS ON THE MOVE-General Motors Co, Ocwen Financial Corp, Centrus Energy Corp, Comcast Corp ||| Dow Jones Rises 100 Points; Caterpillar Stock Down on Sales Slump; Walmart Launches Subscription Service; Microsoft Rolls Out Mobile Cloud Gaming",1,0.5067945
2020-09-16,3302000.0,150.0,151.97999572753906,148.3699951171875,151.11000061035156,140.85684204101562,CAT,"Rexnord, Kennametal, Heico: Industrial Stocks Poised To Gain As The Economy Recovers",1,0.5168652
2020-09-17,4487000.0,149.85000610351562,156.25,149.14999389648438,153.8699951171875,143.42958068847656,CAT,"Where to Invest $5,000 Right Now ||| Is Navistar Stock Fully Priced At $43?",0,0.47928265
2020-09-21,4278200.0,148.55999755859375,149.5,143.8699951171875,145.3300018310547,135.46900939941406,CAT,3 Best Dividend Stocks to Buy During a Stock Market Crash,1,0.5445831
2020-09-22,2579500.0,145.00999450683594,147.5,144.5,147.14999389648438,137.16552734375,CAT,Are We Headed for Another Stock Market Crash?,0,0.50169146
2020-09-29,1605600.0,148.3699951171875,148.97000122070312,146.2100067138672,147.41000366210938,137.40789794921875,CAT,7 Manufacturing Stocks to Buy for a Solid Foundation,1,0.5566251
2020-09-30,3642800.0,148.0,150.9499969482422,147.74000549316406,149.14999389648438,139.02980041503906,CAT,7 Boring Infrastructure Stocks With Beautiful Upside Potential,0,0.51813596
2020-10-05,2597700.0,152.1699981689453,154.4499969482422,151.6199951171875,153.49000549316406,143.07533264160156,CAT,"We Ask Successful Investors: What Are Your 3 Favorite Stocks if Biden Wins the Election? ||| Dealmaking, Trump's health update boost European stocks ||| Caterpillar Finds Opportunity in a Weak Oil Market ||| Dealmaking, Trump's health update boost European stocks ||| Weir Group to sell oil & gas division to Caterpillar for $405 million ||| Weir Group to sell oil & gas division to Caterpillar for $405 million ||| Caterpillar To Buy Weir Oil & Gas For $405 Mln",0,0.5001133
2020-10-06,2559800.0,154.0,155.4499969482422,151.27999877929688,151.52999877929688,141.2483367919922,CAT,Here's Why CalAmp Stock Tanked in September,1,0.5287683
2020-10-09,4084200.0,157.8699951171875,159.38999938964844,157.39999389648438,158.94000244140625,148.15553283691406,CAT,More Stimulus Hopes As Stocks Rise,1,0.53507096
2020-10-12,4279800.0,159.97000122070312,163.1999969482422,159.52000427246094,162.61000061035156,151.5765380859375,CAT,Oil Investment Hits a Multi-Year Low: What It Means for Energy Stocks ||| Caterpillar Agrees to Acquire Weir Oil & Gas: What it Means for Investors ||| FOCUS-Caterpillar bets on self-driving machines impervious to pandemics,0,0.48393646
2020-10-14,4087100.0,162.66000366210938,164.82000732421875,162.5,163.61000061035156,152.50868225097656,CAT,"BUZZ-U.S. STOCKS ON THE MOVE-Twitter, Caterpillar, Wells Fargo, Restaurant Brands ||| BUZZ-U.S. STOCKS ON THE MOVE-Abercrombie & Fitch, Boeing, Wells Fargo, Goldman Sachs",1,0.48820293
2020-10-15,2958500.0,160.27000427246094,165.77999877929688,160.14999389648438,165.0399932861328,153.84164428710938,CAT,Time To Sell Deere Stock After 2x Rally?,1,0.51656616
2020-10-22,2356800.0,167.97999572753906,169.85000610351562,166.88999938964844,169.66000366210938,158.14816284179688,CAT,"Caterpillar, Inc. (CAT) Ex-Dividend Date Scheduled for October 23, 2020",0,0.433761
2020-10-23,2857300.0,169.3699951171875,170.64999389648438,167.55999755859375,168.58999633789062,158.11065673828125,CAT,Caterpillar: An Attractive Opportunity Compared To Deere?,0,0.4996961
2020-10-26,4506600.0,166.63999938964844,166.63999938964844,160.8300018310547,163.1999969482422,153.0556640625,CAT,"Ignore Trump and Biden, These 3 Stocks Are Buys No Matter Who Wins ||| 4 Top Stock Trades for Tuesday: SAP, CAT, HAS, MMM ||| What Should Investors Do If Biden Wins The Election? Or Trump?",0,0.47612956
2020-10-27,4857900.0,160.9600067138672,161.85000610351562,157.00999450683594,157.91000366210938,148.0945281982422,CAT,"GLOBAL MARKETS-Stocks wobble on COVID-19, US election uncertainty; dollar slips ||| Caterpillar reports 54% drop in quarterly earnings ||| GLOBAL MARKETS-Stocks stumble, dollar dips on COVID-19, U.S. election anxiety ||| S&P 500, Dow slip on earnings worries, stimulus uncertainty ||| Dow Jones Doesn't Get Lift From Merck, Caterpillar, and 3M Earnings Beats ||| US STOCKS-S&P 500, Dow slip on earnings worries, stimulus uncertainty ||| US STOCKS-S&P 500, Dow slip on earnings worries, stimulus uncertainty ||| Cat Financial Q3 Profit Drops ||| Caterpillar reports lower Q3 earnings ||| Caterpillar Inc. Q3 adjusted earnings Beat Estimates ||| Caterpillar Q3 20 Earnings Conference Call At 8:30 AM ET ||| US STOCKS-S&P 500 flat after Monday's selloff as focus turns to corporate earnings ||| US STOCKS-Futures rebound from Monday's selloff as earnings take center stage",0,0.4799789
2020-10-28,5645100.0,153.8000030517578,155.42999267578125,150.52000427246094,151.16000366210938,141.7640838623047,CAT,Is Plug Power Ready to be Played as a Buy?,1,0.518166
2020-10-29,3867200.0,150.60000610351562,155.50999450683594,149.6300048828125,154.6699981689453,145.05587768554688,CAT,Caterpillar Inc. (NYSE:CAT) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year,1,0.47272485
2020-10-30,4373500.0,153.9600067138672,157.2899932861328,153.0399932861328,157.0500030517578,147.28797912597656,CAT,7 Industrial Stocks to Reconstruct Your Portfolio for 2021 ,1,0.53973156
2020-11-02,4072400.0,159.1999969482422,163.85000610351562,157.64999389648438,163.27000427246094,153.12135314941406,CAT,This Insider Has Just Sold Shares In Caterpillar Inc. (NYSE:CAT) ||| Is Caterpillar Stock Safe for Dividend Investors? ||| Must-Watch Trends for Investors in the Q3 Earnings Season ||| Potential stock winners and losers from Tuesday's U.S. election,1,0.47761613
2020-11-03,4843600.0,165.0,169.0,163.07000732421875,167.69000244140625,157.26661682128906,CAT,"US STOCKS-Wall St jumps 2% as Americans head to polls ||| US STOCKS-Wall Street closes sharply higher on U.S. Election Day stimulus hopes ||| US STOCKS-Wall Street rallies with Election Day underway ||| US STOCKS-Wall St jumps on bets of Biden victory, stimulus hopes ||| US STOCKS-Wall St set to jump on Biden victory bets, stimulus hopes ||| US STOCKS-Wall Street jumps as Americans head to polls",0,0.5032106
2020-11-04,9081700.0,159.17999267578125,162.3800048828125,155.22999572753906,155.22999572753906,145.58108520507812,CAT,Market Outlook: The Important Post-Election Statement ||| Dow Jones Surges 750 Points After Election; UnitedHealth and Tech Giants Rally; Caterpillar Stock Sinks ||| Wall St seeks safety of Big Tech as election hangs in the balance ||| Stock Alert: Caterpillar Down 6%,1,0.48267528
2020-11-05,4821600.0,157.6699981689453,164.9600067138672,157.60000610351562,163.08999633789062,152.95252990722656,CAT,"Dow Movers: UNH, CAT",0,0.500451
2020-11-09,5969600.0,174.02999877929688,176.3699951171875,170.1199951171875,170.82000732421875,160.20204162597656,CAT,Is Honeywell Stock a Buy Near Its 52-Week High? ||| Caterpillar or Nikola: Which Is the Better Buy Heading Into 2021? ||| Stock Alert: Caterpillar Rises To New 52-week High ||| US STOCKS-Wall Street set to jump after Biden election win,1,0.49294516
2020-11-11,2345500.0,172.3800048828125,172.74000549316406,167.47000122070312,169.4600067138672,158.92657470703125,CAT,"Dow Movers: AXP, CRM",0,0.51554304
2020-11-12,2185500.0,168.8300018310547,171.10000610351562,167.64999389648438,169.1300048828125,158.61708068847656,CAT,Dow Analyst Moves: CAT ||| After A 2x Rally Deere & Company Stock Looks Expensive,1,0.5013629
2020-11-13,2120200.0,170.3000030517578,172.22000122070312,169.19000244140625,171.7100067138672,161.03672790527344,CAT,The 3 Safest Industrial Dividends Right Now ||| Why a Coronavirus Vaccine Could Send Shares of Caterpillar to a New All-Time High,1,0.5099799
2020-11-17,2110800.0,172.1699981689453,172.47999572753906,170.19000244140625,171.91000366210938,161.22427368164062,CAT,5 Transport Infrastructure Stocks to Buy on Bets U.S. Builds Back Better,1,0.5442116
2020-11-18,3165100.0,172.0399932861328,175.3800048828125,172.0399932861328,172.74000549316406,162.00271606445312,CAT,"EXCLUSIVE-U.S. investigators were told to take 'no further action' on Caterpillar, ex-client of Barr ||| Noteworthy ETF Inflows: VYM, LMT, RTX, CAT",1,0.5001276
2020-11-23,2403500.0,173.75999450683594,175.5,173.24000549316406,174.77999877929688,163.91587829589844,CAT,7 Value Stocks That May Come Back into Style After the Pandemic,1,0.51128674
2020-11-24,3447000.0,176.25,178.32000732421875,175.27000427246094,176.89999389648438,165.90411376953125,CAT,China construction machinery industry cheers strong 2020 sales but outlook uncertain ||| What To Expect From Deere Stock In Q4? ||| Mining industry making headway on zero emissions truck fleet-ICMM,0,0.48528787
2020-11-25,2506400.0,176.4600067138672,176.47999572753906,172.77999877929688,174.6300048828125,163.77520751953125,CAT,General Electric Stock Can See Higher Levels Led By Aviation Growth,1,0.5435233
2020-11-27,976900.0,174.41000366210938,175.9199981689453,173.8800048828125,175.0800018310547,164.19725036621094,CAT,3 Top Dividend Aristocrat Stocks to Buy Now,0,0.54932463
2020-11-30,2382600.0,173.61000061035156,174.8800048828125,172.42999267578125,173.58999633789062,162.79986572265625,CAT,Caterpillar's Sales Just Bottomed: Time to Buy?,0,0.48668215
2020-12-01,2710200.0,175.38999938964844,176.57000732421875,172.94000244140625,173.25999450683594,162.49037170410156,CAT,Is Caterpillar Stock a Buy?,1,0.4938387
2020-12-03,2903900.0,173.8699951171875,175.0800018310547,173.27999877929688,174.6300048828125,163.77520751953125,CAT,Why Shares in Caterpillar Soared in November,1,0.50042987
2020-12-04,6086200.0,175.9199981689453,183.8099975585937,175.6199951171875,182.2100067138672,170.88404846191406,CAT,"Major Benchmarks Log Record Closes, Weekly Wins ||| Dow Movers: AAPL, CVX",0,0.50915647
2020-12-07,4587400.0,180.38999938964844,180.38999938964844,176.55999755859375,178.7100067138672,167.6016082763672,CAT,"Notable ETF Inflow Detected - DIA, GS, BA, CAT",1,0.505711
2020-12-09,2915500.0,179.6199951171875,180.47999572753903,177.0,180.07000732421875,168.87709045410156,CAT,"Daily Dividend Report: MA,TJX,DHR,CAT,O",0,0.49808082
2020-12-10,3109400.0,179.24000549316406,179.52999877929688,177.13999938964844,178.85000610351562,167.73291015625,CAT,"Dow Movers: VZ, CVX",1,0.52075
2020-12-11,2673400.0,176.99000549316406,179.77999877929688,176.22999572753906,179.2899932861328,168.1455535888672,CAT,8 Infrastructure Stocks That Will Shine In The 2021 Spotlight,0,0.5385762
2020-12-15,2360300.0,179.92999267578125,182.759994506836,179.02000427246094,181.7400054931641,170.44325256347656,CAT,"China's Xugong Group set to get $2.3 bln from GIC, others in SOE mixed-owner reform -sources",0,0.4767982
2020-12-16,2031800.0,180.8500061035156,181.2700042724609,178.36000061035156,179.5,168.34249877929688,CAT,"Dow Movers: CVX, MCD ||| China's Xugong Group set to get $2.3 bln from GIC, others in SOE mixed-owner reform -sources",0,0.46305117
2020-12-21,2071000.0,176.94000244140625,180.88999938964844,176.32000732421875,180.1600036621093,168.9614715576172,CAT,3 Surprising Value Stocks That Reached All-Time Highs in 2020,0,0.5383621
2020-12-28,1508800.0,180.47999572753903,181.1199951171875,178.30999755859375,178.3699951171875,167.28273010253906,CAT,Is Caterpillar Stock Worth Buying for 2021?,0,0.4963116
2020-12-29,1490300.0,179.1699981689453,179.3800048828125,175.11000061035156,176.64999389648438,165.6696319580078,CAT,"Dow Movers: CAT, AMGN",1,0.5102382
2020-12-30,2720600.0,179.77000427246094,182.22999572753903,178.69000244140625,180.0399932861328,168.84893798828125,CAT,"Dow Jones Rises as Caterpillar Stock Is Boosted, Nike Stock Slumps ||| Dow Movers: INTC, CAT",1,0.49528462
2021-01-06,8034700.0,187.1499938964844,197.27999877929688,186.1499938964844,193.8600006103516,181.80987548828125,CAT,"Dow Movers: KO, CAT ||| BUZZ-U.S. STOCKS ON THE MOVE-Imara Inc, DraftKings Inc, 500.Com Ltd ||| Stock Alert: Caterpillar Touches New 52-week High ||| US STOCKS-Nasdaq set to slump on prospects of Democrat-controlled Senate ||| US STOCKS-Nasdaq futures slump 2% on prospects of Democrat-controlled Senate ||| US STOCKS-Nasdaq futures sink 2% as investors brace for possible Blue Wave",1,0.49149722
2021-01-07,5297500.0,196.8500061035156,197.3699951171875,192.1999969482422,194.22999572753903,182.15689086914065,CAT,5 Big Reasons Caterpillar Stock Jumped 23% in 2020 and Continues to Rally,1,0.5208401
2021-01-08,3186600.0,193.8500061035156,195.259994506836,191.32000732421875,194.259994506836,182.18502807617188,CAT,Motley Fool Money: 2021 Preview Show,0,0.5036427
2021-01-12,2466100.0,194.67999267578125,198.0,193.3099975585937,197.5399932861328,185.2611694335937,CAT,"BUZZ-U.S. STOCKS ON THE MOVE-fuboTV, ArcLight, Liminal BioSciences, Biomerica ||| BUZZ-U.S. STOCKS ON THE MOVE-Tencent Music, Xpeng, VOXX International",0,0.47633758
2021-01-13,3154700.0,198.7899932861328,200.1699981689453,195.8000030517578,195.88999938964844,183.7137145996093,CAT,Here's What We Like About Caterpillar's (NYSE:CAT) Upcoming Dividend,1,0.4788985
2021-01-14,2486600.0,196.1000061035156,197.9100036621093,195.3600006103516,197.3999938964844,185.1298828125,CAT,My Best Dividend Stock to Buy Right Now,0,0.49964872
2021-01-15,3317100.0,195.6600036621093,195.7100067138672,190.8800048828125,194.6199951171875,182.52264404296875,CAT,"Ex-Dividend Reminder: Quest Diagnostics, Acuity Brands and Caterpillar ||| Caterpillar, Inc. (CAT) Ex-Dividend Date Scheduled for January 19, 2021",0,0.44649053
2021-01-19,2361200.0,194.2899932861328,196.1100006103516,193.44000244140625,194.0599975585937,182.96578979492188,CAT,3 Dividend Stocks to Buy for a 2021 Bull Market,0,0.522607
2021-01-20,2501100.0,192.6600036621093,193.8999938964844,190.4199981689453,192.33999633789065,181.3441467285156,CAT,Caterpillar Stock Looks Expensive: Here Are 3 Reasons It's Still Cheap ||| Caterpillar Keeps Building Reasons for Investors to Stick Around,0,0.49205005
2021-01-25,3837100.0,190.5599975585937,191.3699951171875,186.97000122070312,187.33999633789065,176.6299591064453,CAT,The Smartest People on Wall Street Are Buying These 3 Stocks -- Should You Follow? ||| 3 Successful Investors Share Their First Stock Buys of 2021,0,0.47514167
2021-01-27,4095300.0,184.1999969482422,185.5500030517578,179.33999633789062,180.6300048828125,170.30357360839844,CAT,Dow Analyst Moves: CAT,1,0.51468444
2021-01-28,3445400.0,182.259994506836,187.6100006103516,181.3099975585937,184.33999633789065,173.80148315429688,CAT,"5 Top Stock Trades for Friday: GM, CAT, SHOP, MA, TWLO ||| Pre-Market Earnings Report for January 29, 2021 : LLY, CVX, HON, CHTR, CAT, CL, ROP, ERIC, LHX, JCI, PSX, LYB ||| 7 Stock Predictions For Biden’s First Year ||| Here's Why Amazon Will Never Be a Dow Jones Industrials Stock",0,0.52019846
2021-01-29,4541400.0,183.5,188.82000732421875,180.72999572753903,182.83999633789065,172.38723754882812,CAT,"Cat Financial Q4 Profit Down 8% - Quick Facts ||| Caterpillar posts smaller-than-expected fall in quarterly earnings ||| Caterpillar Q4 Profit Falls, But Beats Estimates - Quick Facts ||| Caterpillar Inc. Q4 adjusted earnings of $2.12 per share ||| Caterpillar Q4 20 Earnings Conference Call At 8:30 AM ET ||| Caterpillar reports lower fourth-quarter earnings",1,0.5059675
2021-02-01,2738200.0,185.9600067138672,186.8000030517578,182.0200042724609,184.72000122070312,174.1597442626953,CAT,Watch Out! 3 Reasons the Stock Market Could Be Overvalued,1,0.501323
2021-02-03,2979000.0,190.9100036621093,191.52999877929688,189.0599975585937,191.4499969482422,180.50498962402344,CAT,"Dow Movers: AMGN, BA",1,0.5118687
2021-02-05,2240000.0,192.5200042724609,194.3300018310547,190.009994506836,193.0,181.96636962890625,CAT,"Caterpillar Looks Poised for a Recovery in 2021 ||| Dow Movers: MSFT, JNJ",1,0.4995692
2021-02-18,2345800.0,201.5500030517578,202.8800048828125,198.5800018310547,199.9199981689453,188.49078369140625,CAT,"XLI, BA, RTX, CAT: ETF Outflow Alert ||| Automakers, medical device firms ask Biden for U.S. chip factory subsidies",1,0.52677584
2021-02-19,4937300.0,203.25,211.4600067138672,202.6999969482422,209.9100036621093,197.90963745117188,CAT,"What To Expect From Deere Stock In Q1? ||| US STOCKS-Wall Street closes flat as cyclicals shine, big tech falls ||| Caterpillar Takes Over #65 Spot From ServiceNow ||| US STOCKS-Wall Street supported by rise in cyclical stocks ||| US STOCKS-Wall Street little changed as cyclicals shine, big tech falls",1,0.48886228
2021-02-22,4578300.0,209.6300048828125,218.8699951171875,209.33999633789065,218.0599975585937,205.59375,CAT,Oil Is Surging: These 3 Stocks Would Be Big Winners in an Oil Boom ||| Bill Gates Owns These 3 Stocks: Should You?,1,0.49661502
2021-02-23,4125100.0,219.52999877929688,220.7400054931641,213.27999877929688,220.17999267578125,207.5925445556641,CAT,"These 3 Blue Chip Stocks Set Record Highs to Help the Stock Market Recover Tuesday ||| Dow Movers: NKE, DIS",1,0.49957645
2021-02-24,4925000.0,220.4100036621093,226.6699981689453,219.8800048828125,222.47000122070312,209.7516021728516,CAT,US STOCKS-Wall Street set to open higher as tech sell-off cools,0,0.5038789
2021-02-26,4461300.0,220.75,222.3999938964844,215.82000732421875,215.8800048828125,203.53836059570312,CAT,4 Stocks to Invest Your Stimulus Check In,1,0.5244352
2021-03-01,2871200.0,219.3099975585937,222.5800018310547,218.8999938964844,219.759994506836,207.196533203125,CAT,"XLI, HON, UNP, CAT: Large Inflows Detected at ETF",0,0.52807426
2021-03-02,2854300.0,218.69000244140625,219.33999633789065,215.009994506836,215.82000732421875,203.4817810058593,CAT,"Is Caterpillar Stock a Buy? ||| Dow Movers: MSFT, DOW",0,0.49470252
2021-03-04,3568400.0,214.47999572753903,216.6699981689453,208.47000122070312,212.7700042724609,200.6061553955078,CAT,3 Dividend Stocks for a 2021 Economic Recovery,1,0.5542091
2021-03-05,3602300.0,214.33999633789065,220.77999877929688,211.5,220.1600036621093,207.57369995117188,CAT,3 Industrial Stocks That Are Ignoring the Sell-Off,1,0.5116131
2021-03-08,3048700.0,220.97000122070312,224.3000030517578,218.2100067138672,221.5800018310547,208.91249084472656,CAT,4 Reasons Caterpillar Stock Shot Up 18.1% to an All-Time High in February,0,0.52393776
2021-03-09,2902400.0,221.3800048828125,222.3300018310547,216.13999938964844,216.8000030517578,204.40577697753903,CAT,"Noteworthy ETF Inflows: XLI, HON, UNP, CAT",1,0.51809883
2021-03-11,2960000.0,223.0,223.6000061035156,219.1499938964844,219.759994506836,207.196533203125,CAT,"Pre-Market Most Active for Mar 11, 2021 : OGI, SQQQ, SPPI, RBLX, AMC, GE, NIO, PLTR, AAPL, SOS, QQQ, CATB",1,0.4791378
2021-03-15,4215300.0,228.8699951171875,231.8000030517578,225.8300018310547,230.7400054931641,217.54884338378903,CAT,7 Infrastructure Stocks to Buy for Warren’s Wealth Tax,0,0.536324
2021-03-17,3518500.0,228.1300048828125,234.3000030517578,227.1300048828125,233.6300048828125,220.2736053466797,CAT,"XLI, HON, UNP, CAT: ETF Inflow Alert",0,0.531117
2021-03-18,4336200.0,234.0,237.77999877929688,229.7400054931641,230.67999267578125,217.4922790527344,CAT,Is General Electric Stock Headed Lower After The AerCap Deal?,0,0.51069057
2021-03-22,2211600.0,226.6199951171875,227.17999267578125,223.57000732421875,226.0200042724609,213.0986785888672,CAT,3 Infrastructure Stocks to Buy for Biden's Next Big Plan,0,0.5192887
2021-03-24,4258000.0,220.509994506836,227.1100006103516,220.509994506836,221.22999572753903,208.5825042724609,CAT,"Dow Movers: CRM, CVX",1,0.5181759
2021-03-25,2901800.0,219.22999572753903,224.97000122070312,216.0399932861328,224.25,211.42987060546875,CAT,After A Massive 3.4x Rise Has Deere & Company Stock Run Ahead Of Its Valuation?,1,0.50865394
2021-03-29,3003200.0,228.1000061035156,231.8500061035156,227.7100067138672,230.22000122070312,217.0585784912109,CAT,"Cathie Wood Owns These 3 Infrastructure Stocks: Should You? ||| Noteworthy ETF Inflows: DIA, GS, BA, CAT",1,0.51120263
2021-03-30,3139100.0,231.1999969482422,234.72000122070312,231.13999938964844,233.0800018310547,219.7550506591797,CAT,7 Infrastructure Stocks Ready for the Looming Supercycle ||| Best Industrial Stocks To Buy This Week? 4 In Focus,0,0.5346146
2021-04-05,2323400.0,235.0,235.6600036621093,232.3699951171875,233.7100067138672,220.3490447998047,CAT,7 Stocks To Buy for April As Momentum Builds for a Bullish Run,0,0.50469136
2021-04-06,2614500.0,232.5,236.67999267578125,230.22999572753903,230.63999938964844,217.45455932617188,CAT,"Notable ETF Inflow Detected - DIA, GS, AMGN, CAT",0,0.5023305
2021-04-07,2449600.0,231.9600067138672,234.19000244140625,229.3500061035156,230.4100036621093,217.2377014160156,CAT,"Next Stop, More Capital Gains for General Electric Investors",1,0.528218
2021-04-09,2482900.0,231.3000030517578,232.1999969482422,227.5399932861328,230.75,217.55828857421875,CAT,7 Infrastructure Stocks Excited For The $2 Trillion Biden Plan ||| 7 Safe Stocks to Buy for Uncertain Times,1,0.5266975
2021-04-12,1688200.0,230.3000030517578,231.3000030517578,228.92999267578125,230.92999267578125,217.7279510498047,CAT,Does Caterpillar (NYSE:CAT) Have A Healthy Balance Sheet? ||| Top Stocks To Buy This Week? 4 Industrial Stocks To Watch,0,0.49349117
2021-04-14,2491000.0,229.6000061035156,234.22000122070312,229.5500030517578,232.5800018310547,219.28366088867188,CAT,"Blue-Collar Technology ||| Dow Movers: JPM, GS",0,0.50939655
2021-04-15,1860200.0,233.1499938964844,233.44000244140625,230.7400054931641,232.5200042724609,219.22708129882807,CAT,Dow Analyst Moves: CAT,1,0.51468444
2021-04-19,1712600.0,232.8999938964844,233.1000061035156,229.9100036621093,232.38999938964844,219.10452270507807,CAT,"IWD, CAT, BLK, GE: ETF Outflow Alert ||| Cathie Wood's ARK Invest Only Owns 4 Dow Stocks, and They Aren't What You Think",0,0.4768969
2021-04-21,1977700.0,227.32000732421875,232.6100006103516,226.0200042724609,232.4600067138672,219.1705017089844,CAT,"Ex-Dividend Reminder: Simulations Plus, Caterpillar and Celanese",0,0.49071786
2021-04-22,2410700.0,233.25,233.42999267578125,228.7700042724609,228.88999938964844,215.80458068847656,CAT,"Caterpillar, Inc. (CAT) Ex-Dividend Date Scheduled for April 23, 2021",1,0.43798774
2021-04-28,2965300.0,230.0500030517578,233.72000122070312,229.3800048828125,232.3000030517578,220.0096893310547,CAT,"Pre-Market Earnings Report for April 29, 2021 : MA, CMCSA, MRK, TMO, MCD, BMY, CAT, AMT, SPGI, MO, SO, NOC ||| How to Pick Up Fisker Shares at a Discount ||| 8 Stocks That Could Crash if Infrastructure Spending Falls Through ||| US STOCKS-Dow, Nasdaq set to open lower after tech, Boeing results; Fed in focus ||| 3 AI Stocks to Buy to Future-Proof Your Portfolio",0,0.46395385
2021-04-29,5442400.0,235.0,235.1999969482422,223.1999969482422,227.47000122070312,215.43521118164065,CAT,"5 Top Stock Trades for Friday: F, MCD, QCOM, CAT, LYFT ||| US STOCKS-Apple, Facebook drive Nasdaq futures higher as earnings roll in ||| Facebook fuels S&P 500 to record high close ||| US STOCKS-S&P 500 near record high on Facebook boost, Nasdaq eases ||| Here's What McDonald's and Caterpillar Just Said About the Stock Market Boom ||| US STOCKS-S&P 500, Nasdaq hit record highs on tech earnings boost, upbeat data ||| Cat Financial Q1 Profit Rises ||| What President Biden's Big Speech Means for Investors ||| US STOCKS-Apple, Facebook set to boost Wall Street after strong earnings ||| US STOCKS-Facebook fuels S&P 500 to record high close ||| Caterpillar Inc. Q1 Income Climbs ||| Caterpillar Q1 21 Earnings Conference Call At 8:30 AM ET ||| Biden's EU trade dilemma: more pain for Harley, distillers or back off metals tariffs?",1,0.5302577
2021-04-30,3953500.0,225.5200042724609,228.38999938964844,224.8800048828125,228.1100006103516,216.0413818359375,CAT,Caterpillar Delivers Blowout Quarter In 1Q,1,0.5098687
2021-05-03,3182900.0,230.0,230.92999267578125,227.2100067138672,228.1699981689453,216.09820556640625,CAT,"Top Industrial Stocks To Buy In May 2021? 4 Names To Watch ||| Caterpillar Steamrolls Past Expectations, so Why Is This Dividend Stock Falling Now? ||| How Much Of Caterpillar Inc. (NYSE:CAT) Do Institutions Own?",1,0.46832973
2021-05-05,3690600.0,234.6199951171875,239.3300018310547,231.8500061035156,237.8800048828125,225.29443359375,CAT,"US STOCKS-Dow ends at record high, Nasdaq falls as tech slides ||| SKLZ Alert: Why Is Skillz Stock Dropping Today? ||| ATVI Alert: 15 Reasons Why Popular Reddit Stock Activision Blizzard Is Trending Today ||| US STOCKS-Wall St set to rise on growth stocks bounce, strong ADP data ||| US STOCKS-Futures rise as growth stocks bounce, economic data eyed",0,0.48250282
2021-05-06,4527000.0,238.0,240.97999572753903,236.0,237.07000732421875,224.5273284912109,CAT,Is Now a Good Time to Buy Cyclical Stocks?,1,0.5108645
2021-05-07,3327900.0,235.63999938964844,241.88999938964844,233.1600036621093,240.9900054931641,228.23992919921875,CAT,3 Most-Shorted Stocks to Trade,1,0.54599476
2021-05-10,3752900.0,243.5,245.77999877929688,242.58999633789065,242.6100006103516,229.7742156982422,CAT,"These 2 Winners Shot the Stock Market Through Dow 35,000",0,0.49398613
2021-05-12,3668500.0,241.2700042724609,243.22999572753903,236.44000244140625,237.32000732421875,224.7641143798828,CAT,"Why C3.ai Stock Does Not Compute ||| Dow Hits $35,000, Crushing the Nasdaq. What Does That Mean for Retirees?",1,0.47525072
2021-05-17,1998400.0,242.7400054931641,245.4499969482422,241.1199951171875,244.7899932861328,231.83888244628903,CAT,These Stocks Could Be the Biggest Winners of the Stock Market Sell-Off,0,0.50201416
2021-05-18,2436200.0,244.7899932861328,245.5399932861328,239.4100036621093,239.47000122070312,226.80035400390625,CAT,"VTV, PM, CAT, RTX: Large Inflows Detected at ETF ||| After A Large 3x Rise Has Caterpillar Stock Run Ahead Of Its Valuation?",0,0.49344307
2021-05-20,3339200.0,237.47999572753903,237.6000061035156,232.58999633789065,234.9900054931641,222.5573883056641,CAT,What To Expect From Deere's Q2?,1,0.5105917
2021-05-21,2479100.0,236.6000061035156,239.3999938964844,235.009994506836,237.2400054931641,224.68833923339844,CAT,US STOCKS-U.S. stocks end mixed as Dow recovers on strong economic data ||| Inflation is Here: 3 Stocks That Can Benefit,1,0.49136853
2021-05-26,2070000.0,237.4100036621093,239.5,236.6199951171875,237.7100067138672,225.1334686279297,CAT,3 Dividend Stocks to Celebrate the 125-Year Anniversary of the Dow Jones Industrial Average ||| Deere Stock Set To Rise After A 5% Drop Over The Last Week,1,0.50253564
2021-05-27,3594700.0,241.5,243.3699951171875,238.92999267578125,241.27999877929688,228.5145721435547,CAT,"Dow Movers: CRM, BA ||| Better Buy: Boeing vs. Caterpillar",0,0.49673414
2021-05-28,2290700.0,241.9100036621093,242.259994506836,238.7899932861328,241.0800018310547,228.3251495361328,CAT,"DIA, AMGN, CAT, V: Large Outflows Detected at ETF",1,0.5246492
2021-06-01,2476000.0,244.009994506836,244.92999267578125,241.8099975585937,242.759994506836,229.91629028320312,CAT,Carmakers in 'India's Detroit' allowed to operate as workers protest COVID risk ||| Is Caterpillar Inc.'s (NYSE:CAT) ROE Of 21% Impressive?,1,0.49501076
2021-06-02,2348500.0,243.07000732421875,245.1000061035156,240.6999969482422,243.4600067138672,230.5792388916016,CAT,Engine No. 1 to win third seat on Exxon board based on preliminary results,1,0.5192172
2021-06-03,1923200.0,242.42999267578125,246.44000244140625,240.8699951171875,243.83999633789065,230.9391326904297,CAT,Stocks That Should Benefit As Capex Cycle Picks Up,1,0.501363
2021-06-04,1837900.0,245.1199951171875,246.69000244140625,242.32000732421875,244.0200042724609,231.1096343994141,CAT,Norway wealth fund to vote for shareholder climate policy initiative at Caterpillar AGM ||| What's Next For General Electric Stock After A 7% Rise? ||| 7 Best Manufacturing Stocks to Buy on Record-High Growth Data,0,0.51175153
2021-06-07,2330700.0,244.0500030517578,244.3300018310547,238.6199951171875,239.759994506836,227.07501220703125,CAT,Is Caterpillar Stock a Buy? ||| 5 Potential Winners from Biden's Infrastructure Plan ||| 5 Non-Tech Stocks Getting Hit by the Chip Shortage ||| Company Of The Day: Caterpillar,1,0.48596787
2021-06-08,2212300.0,239.3999938964844,241.2100067138672,236.0599975585937,240.1600036621093,227.453842163086,CAT,"Noteworthy ETF Outflows: UPRO, PM, MS, CAT",0,0.5195807
2021-06-09,2919600.0,239.0,239.19000244140625,234.4499969482422,234.6499938964844,222.2353363037109,CAT,This Blue Chip Dividend Aristocrat Just Boosted Its Payout by 8%,0,0.49513718
2021-06-10,6281800.0,236.13999938964844,236.6499938964844,225.5800018310547,225.72999572753903,213.7872772216797,CAT,"Daily Dividend Report: CAT,NLY,JCI,ROP,CARR ||| Sandvik expects bigger market for battery-driven mining gear in 2-3 years ||| Caterpillar Bumps Up Quarterly Dividend by 8%",0,0.49526832
2021-06-15,5055900.0,219.88999938964844,220.77999877929688,216.259994506836,219.4600067138672,207.84901428222656,CAT,Despite A 7% Fall This Week Caterpillar Stock May Have More Downside ||| 3 Construction Stocks Getting Hammered by Material Price Spikes ||| After An 11% Fall Deere Stock Looks Undervalued,0,0.46836877
2021-06-17,7995300.0,216.97000122070312,218.2700042724609,207.8800048828125,209.4499969482422,198.3685913085937,CAT,"Dow Movers: DOW, CRM",0,0.5101648
2021-06-18,7156400.0,206.17999267578125,211.8099975585937,205.5,208.8600006103516,197.8098297119141,CAT,"Dow Movers: INTC, CAT ||| AGCO Stock Likely To Rebound After A 7% Drop In A Week",1,0.5040339
2021-06-21,5633900.0,211.5500030517578,215.22999572753903,211.3999938964844,213.2100067138672,201.92970275878903,CAT,"Why We're Not Concerned About Caterpillar Inc.'s (NYSE:CAT) Share Price ||| What's Next For Terex Stock After An 11% Fall In 5 Days? ||| Dow Movers: CRM, DOW ||| 8 Blue-Chip Stocks to Buy to Fortify Your Portfolio ||| Final Exxon AGM tally lifts ex-MetLife chairman to board, seals activist win ||| Noteworthy ETF Inflows: VIS, CAT, DE, FDX ||| Final Exxon AGM tally lifts ex-MetLife chairman to board, seals activist win",0,0.47586495
2021-06-24,6827600.0,216.5399932861328,221.92999267578125,215.3300018310547,219.33999633789065,207.7353515625,CAT,Nasdaq and S&P 500 end at record highs; Dow rallies ||| US STOCKS-Nasdaq and S&P 500 end at record highs; Dow rallies ||| US STOCKS-Nasdaq and S&P 500 scale new peaks; Dow rallies,0,0.4599343
2021-06-25,11274200.0,221.17999267578125,221.75,215.2700042724609,216.3099975585937,204.86569213867188,CAT,"3 Top Infrastructure Stocks To Watch With The New Infrastructure Deal In Place ||| US STOCKS-S&P 500, Nasdaq set for record open after May inflation data misses estimates",0,0.5397452
2021-06-29,3443400.0,218.0399932861328,218.6999969482422,214.58999633789065,215.1000061035156,203.71969604492188,CAT,Here Are 3 Top Stock Trades This Week,1,0.5095543
2021-06-30,3249500.0,214.6199951171875,217.9499969482422,214.0599975585937,217.6300048828125,206.1158142089844,CAT,3 Industrial Stocks To Watch In July 2021,0,0.5416143
2021-07-01,2426300.0,219.1600036621093,219.7899932861328,216.1499938964844,216.7100067138672,205.2445068359375,CAT,The Top 3 Stocks to Own on Potential Passage of Infrastructure Bill ||| Dow Analyst Moves: CAT,1,0.5072148
2021-07-06,4348100.0,217.4100036621093,217.5599975585937,211.33999633789065,213.5200042724609,202.22329711914065,CAT,"Is It Time to Buy the Dow Jones' 3 Worst-Performing June Stocks? ||| EXCLUSIVE-Biden plans steps to help farmers deal with meat processors, tractor makers ||| EXCLUSIVE-Biden sides with farmers over 'Right to Repair' tractor software battle ||| EXCLUSIVE-Biden sides with farmers over 'Right to Repair' tractor software battle",1,0.48140293
2021-07-09,3163800.0,215.8999938964844,218.58999633789065,214.3999938964844,217.4199981689453,205.9169464111328,CAT,"Dow Movers: MSFT, CAT ||| UK engineer Senior lifts forecast on recovery in aerospace, oil & gas",1,0.50751156
2021-07-12,2509000.0,216.0200042724609,218.9499969482422,214.8500061035156,218.5800018310547,207.0155639648437,CAT,3 Stocks to Load Up on When the Stock Market Crashes ||| 3 Infrastructure Stocks for Growth and Dividends,0,0.5257489
2021-07-13,2373300.0,218.9600067138672,219.0500030517578,214.6999969482422,215.19000244140625,203.804916381836,CAT,"Notable ETF Outflow Detected - UPRO, NEE, LOW, CAT",0,0.49533364
2021-07-14,3185200.0,215.259994506836,215.63999938964844,211.22000122070312,211.63999938964844,200.44273376464844,CAT,Here's Why General Electric Stock Has More Upside,0,0.5056568
2021-07-15,2737500.0,210.27999877929688,213.38999938964844,210.1199951171875,211.4100036621093,200.2248992919922,CAT,Should You Buy Caterpillar Inc. (NYSE:CAT) For Its Upcoming Dividend?,0,0.48419136
2021-07-16,4368800.0,212.4600067138672,212.6999969482422,207.009994506836,207.9499969482422,196.9479522705078,CAT,"Caterpillar, Inc. (CAT) Ex-Dividend Date Scheduled for July 19, 2021",0,0.43403745
2021-07-19,5391100.0,202.2700042724609,203.75,199.22999572753903,203.0800018310547,193.3677978515625,CAT,4 Cyclical Stocks To Watch This Week,1,0.5146313
2021-07-21,3407300.0,208.72000122070312,210.9600067138672,207.5800018310547,210.72999572753903,200.6519317626953,CAT,"Noteworthy ETF Inflows: ESGV, CAT, DE, CVS",0,0.52371126
2021-07-22,1931500.0,211.0,211.3800048828125,208.5399932861328,209.1600036621093,199.1570281982422,CAT,Big Tech Headlines Another Major Week for Earnings,1,0.5276505
2021-07-23,2302600.0,209.5,210.3699951171875,207.8600006103516,209.52999877929688,199.50933837890625,CAT,"US STOCKS-Wall Street surges to all-time closing high on earnings, economic revival ||| US STOCKS-Wall Street notches record closing high on earnings, economic strength ||| Wall Street extends rally, S&P, Nasdaq on course for record closing highs",1,0.4875746
2021-07-29,3419700.0,214.0,214.509994506836,209.69000244140625,212.5599975585937,202.3944091796875,CAT,"Dow Movers: MRK, CVX ||| 3 Top Infrastructure Stocks To Watch As Biden’s Infrastructure Bill Advances ||| Pre-Market Earnings Report for July 30, 2021 : PG, XOM, ABBV, CVX, LIN, CHTR, CAT, ENB, ITW, CL, IDXX, AON ||| US STOCKS-Dow, S&P futures rise as Fed stays dovish course; Ford jumps ||| US STOCKS-S&P 500, Dow set to rise as economic growth heats up ||| US STOCKS-S&P 500, Dow scale all-time highs as economy picks up pace",0,0.49859077
2021-07-30,5834900.0,207.8999938964844,208.6699981689453,203.1499938964844,206.75,196.8622894287109,CAT,"US STOCKS-Wall Street falls with Amazon; S&P 500 posts sixth straight month of gains ||| US STOCKS-Wall Street declines with Amazon; S&P 500 posts gains for month ||| 4 Top Stock Trades for Monday: AAPL, CAT, CVX, RIDE ||| US STOCKS-Wall Street falls as Amazon earnings disappoint ||| Dow Movers: CAT, PG ||| US STOCKS-Nasdaq, S&P 500 fall as Amazon earnings disappoint ||| US STOCKS-Glum Amazon earnings set to weigh on Nasdaq, S&P 500 ||| Glum Amazon earnings drag Nasdaq futures down 1% ahead of inflation data ||| Caterpillar adjusted profit rises as economic growth drives demand ||| Caterpillar Q2 21 Earnings Conference Call At 8:30 AM ET",0,0.48475432
2021-08-02,3977100.0,208.0,210.8999938964844,204.9499969482422,205.1600036621093,195.3483123779297,CAT,US STOCKS-Stimulus hopes set to lift S&P 500 to near record highs ||| 3 Stocks to Sell after Disappointing Earnings ||| 5 Top Infrastructure Stocks To Watch In August 2021 ||| US STOCKS-Stimulus hopes lift Wall St futures ahead of manufacturing PMIs ||| 7 Infrastructure Stocks to Buy as America Rebuilds ||| Parts supplier Senior reports first-half profit as markets recover ||| Aerospace supplier Senior posts first-half profit as markets recover,1,0.510108
2021-08-04,2948700.0,208.22000122070312,209.58999633789065,204.3699951171875,204.5200042724609,194.73892211914065,CAT,Caterpillar (NYSE:CAT) Is Looking To Continue Growing Its Returns On Capital,1,0.50317985
2021-08-05,2685800.0,205.25,207.6600036621093,204.6999969482422,207.19000244140625,197.28125,CAT,"Deere, Caterpillar reinstate mask mandates ||| Noteworthy ETF Inflows: DIA, GS, V, CAT ||| Is It Time to Buy the Dow Jones' 3 Worst-Performing July Stocks?",1,0.49251637
2021-08-09,2747200.0,207.2899932861328,209.8800048828125,206.1199951171875,208.88999938964844,198.89993286132807,CAT,"Trade Alert: The Independent Director Of Caterpillar Inc. (NYSE:CAT), David MacLennan, Has Just Spent US$103k Buying 56% More Shares",1,0.49494612
2021-08-10,4193600.0,210.0,214.8999938964844,208.9600067138672,214.07000732421875,203.83221435546875,CAT,"US STOCKS-Dow, S&P 500 close up as U.S. infrastructure bill clears Senate ||| US STOCKS-Dow, S&P 500 hit records as infrastructure bill passes Senate ||| US STOCKS-Dow, S&P 500 close at records as U.S. infrastructure bill clears Senate",1,0.48391557
2021-08-11,7794100.0,215.72999572753903,222.57000732421875,214.57000732421875,221.6600036621093,211.0592041015625,CAT,"Slowing inflation growth lifts Dow, S&P to records ||| 4 Top Infrastructure Stocks To Watch As Senate Passes $1 Trillion Infrastructure Bill ||| US STOCKS-Dow, S&P 500 hit records as inflation growth slows ||| Economy-linked stocks boost Dow to new highs as inflation growth slows ||| Dow Movers: V, HD ||| US STOCKS-Wall St set to rise as inflation growth slows ||| Here's Why Caterpillar Stock Fell in the Last 3 Months ||| US STOCKS-Nasdaq futures dip after infrastructure bill clears Senate ||| Caterpillar, Home Depot, and Walgreens Lift Dow Jones to Record Even as Visa Stock Falls ||| US STOCKS-Slowing inflation growth lifts Dow, S&P to records",0,0.519131
2021-08-12,4444500.0,222.2400054931641,223.759994506836,218.47000122070312,220.2400054931641,209.7071075439453,CAT,"US STOCKS-Dow futures hit record high ahead of jobless claims, Disney earnings",0,0.48827186
2021-08-13,2049400.0,219.8800048828125,220.5500030517578,217.72999572753903,218.57000732421875,208.11700439453125,CAT,"Notable ETF Inflow Detected - DIA, GS, CAT, NKE",0,0.50123215
2021-08-16,3132500.0,217.3600006103516,218.0,214.33999633789065,217.7100067138672,207.2981414794922,CAT,3 High-Yield Dividend Stocks That Just Went on Sale ||| 7 Infrastructure Stocks to Buy Before They Get a Biden Bill Boost ||| Caterpillar (NYSE:CAT) is Positioned to Benefit from the Massive Infrastructure Bill,0,0.5345855
2021-08-17,4022800.0,216.22000122070312,216.38999938964844,210.5800018310547,213.44000244140625,203.23231506347656,CAT,"Caterpillar, Rockwell Automation: Stocks To Pick As Capex Cycle Takes Hold",0,0.4970652
2021-08-18,2947700.0,212.5,213.5500030517578,209.72000122070312,209.8099975585937,199.77593994140625,CAT,Dow set to open lower on recovery fears as focus turns to Fed ||| Dow futures slip on recovery fears as focus turns to Fed,0,0.5077331
2021-08-20,2765500.0,205.4199981689453,207.259994506836,203.58999633789065,204.94000244140625,195.13885498046875,CAT,"US STOCKS-S&P 500, Dow on track for worst week in 2 months on recovery, taper fears ||| Will General Electric Stock Rebound After A 4% Fall In A Week?",1,0.48603678
2021-08-24,2485900.0,209.75,213.2700042724609,209.52999877929688,212.58999633789065,202.42300415039065,CAT,"XLI, RTX, CAT, LMT: ETF Outflow Alert",1,0.52566
2021-08-25,2599800.0,213.1699981689453,215.6999969482422,212.1499938964844,214.759994506836,204.4891967773437,CAT,"US STOCKS-Futures muted after record close for S&P 500, Nasdaq ||| US STOCKS-Futures flat after record close for S&P 500, Nasdaq",0,0.47041255
2021-08-26,2513900.0,214.509994506836,214.509994506836,210.47999572753903,211.2400054931641,201.1375732421875,CAT,Should You Buy Deere Stock At $360 Levels?,1,0.5004945
2021-08-30,1922100.0,213.22000122070312,213.7400054931641,210.8000030517578,211.4499969482422,201.33750915527344,CAT,Tech Stocks Are Too Expensive. Try These 3 Cheap Stocks Instead,0,0.4747754
2021-08-31,2857900.0,211.27999877929688,212.3000030517578,210.4199981689453,210.8699951171875,200.7852478027344,CAT,7 Dividend Aristocrat Stocks to Buy in September for Gains and Stability,0,0.5297529
2021-09-01,4122900.0,210.8699951171875,210.9900054931641,206.6100006103516,207.9600067138672,198.014404296875,CAT,"Dow Movers: WBA, AAPL",1,0.5142129
2021-09-02,2921600.0,208.9199981689453,212.9499969482422,208.9199981689453,211.77999877929688,201.65171813964844,CAT,3 Stocks to Buy That Wall Street Has Discarded,0,0.5043142
2021-09-03,2512000.0,211.1499938964844,212.8000030517578,210.0,210.3699951171875,200.3091583251953,CAT,"Noteworthy ETF Inflows: UDOW, BA, CAT, MMM ||| Dow Movers: AXP, CVX ||| US STOCKS-Futures fall as monthly jobs growth slows sharply",0,0.54366505
2021-09-07,2641100.0,210.0399932861328,210.33999633789065,207.8500061035156,208.22999572753903,198.27149963378903,CAT,Is Now An Opportune Moment To Examine Caterpillar Inc. (NYSE:CAT)?,0,0.4952242
2021-09-10,2551200.0,207.1000061035156,207.8800048828125,204.82000732421875,205.009994506836,195.2055053710937,CAT,"Energy Sector Update for 09/10/2021: AEP,CGRN,CAT,NFE ||| Energy Sector Update for 09/10/2021: CGRN,CAT,NFE",1,0.46766108
2021-09-13,2699100.0,207.1600036621093,207.8600006103516,203.92999267578125,206.1999969482422,196.3385772705078,CAT,"3 Dow Jones Stocks to Buy Hand Over Fist Right Now ||| FOCUS-From zippers to glass, shortages of basic goods hobble U.S. economy",0,0.51719743
2021-09-14,3757600.0,206.0399932861328,206.1000061035156,201.63999938964844,202.3300018310547,192.6536560058593,CAT,"3 Sinking Industrial Stocks to Sell ||| DIA, BA, CAT, MMM: ETF Inflow Alert ||| Dow Movers: NKE, GS",1,0.5252216
2021-09-20,9151100.0,193.0599975585937,193.9900054931641,188.47999572753903,190.82000732421875,181.6941375732422,CAT,"Dow Movers: CAT, MRK ||| Wall St set to drop at open on growth worries; focus turns to Fed ||| US STOCKS-Futures drop over 1% on growth worries; focus turns to Fed ||| US STOCKS-Futures fall over 1% on growth worries, focus turns to Fed",0,0.4774838
2021-09-21,5699900.0,192.0,192.7100067138672,186.97999572753903,189.83999633789065,180.760971069336,CAT,"Dow Movers: MMM, DIS",1,0.51297003
2021-09-22,3924400.0,192.0,194.5,191.1600036621093,191.3500061035156,182.1987762451172,CAT,"XLI, BA, CAT, MMM: Large Outflows Detected at ETF",1,0.52470535
2021-09-23,3367800.0,192.9100036621093,197.6000061035156,192.8500061035156,196.6199951171875,187.2167510986328,CAT,Best Stocks To Watch Today? 4 Industrial Stocks To Know,1,0.48774603
2021-09-24,2199500.0,195.6499938964844,197.7899932861328,194.92999267578125,196.82000732421875,187.40719604492188,CAT,September Sell-Off: How to Navigate the Market ||| Will Caterpillar Stock Rebound After A 6% Fall In A Week?,1,0.5068295
2021-09-27,3033100.0,197.6000061035156,201.9900054931641,197.6000061035156,200.0,190.43511962890625,CAT,"Are Investors Undervaluing Caterpillar Inc. (NYSE:CAT) By 31%? ||| The Smartest Dividend Aristocrats to Buy With $500 Right Now ||| US STOCKS-Dow, S&P futures inch higher as banks, energy stocks jump ||| Here's Why Deere Stock Is Likely To See Higher Levels After A 5% Fall In A Week ||| US STOCKS-Tech megacaps, chipmakers set to drag Nasdaq lower at open",1,0.48089096
2021-09-30,4978100.0,198.6199951171875,198.8699951171875,191.6300048828125,191.97000122070312,182.78912353515625,CAT,"DIA, UNH, BA, CAT: ETF Outflow Alert",1,0.5300121
2021-10-04,2864600.0,194.7400054931641,195.9100036621093,192.4100036621093,193.1300048828125,183.8936462402344,CAT,Will General Electric Stock Continue To Rise After An 8% Move Last Week?,0,0.5124441
2021-10-05,3074600.0,192.759994506836,194.3999938964844,190.72999572753903,192.5,183.2937927246093,CAT,"5 Industrial Stocks to Buy for October ||| Dow Movers: CAT, CVX",0,0.5140799
2021-10-06,3777700.0,190.0,192.38999938964844,187.8000030517578,191.8600006103516,182.68438720703125,CAT,US STOCKS-Futures slide on inflation worries; ADP jobs beat sparks taper fears ||| US STOCKS-Futures tumble as soaring energy prices fuel inflation worries,1,0.49083093
2021-10-11,2015200.0,196.33999633789065,197.1699981689453,192.67999267578125,192.88999938964844,183.6651153564453,CAT,3 Growth Stocks Perfect for New Investors,0,0.541211
2021-10-13,3253200.0,190.5,191.25,187.72000122070312,188.94000244140625,179.90403747558594,CAT,"Daily Dividend Report: QCOM,CAT,IP,CMI,CMC ||| My 3 Biggest Stock Market Predictions for October",1,0.4977697
2021-10-14,5212900.0,193.5500030517578,194.8000030517578,192.6100006103516,194.3300018310547,185.0362701416016,CAT,"Dow Movers: WBA, UNH",1,0.510844
2021-10-15,4736300.0,195.9600067138672,199.4499969482422,195.3000030517578,199.0200042724609,189.501953125,CAT,What You Need To Know About Caterpillar Inc.'s (NYSE:CAT) Investor Composition,0,0.4898505
2021-10-18,2809400.0,197.3800048828125,198.67999267578125,195.5500030517578,198.17999267578125,188.70211791992188,CAT,7 Stocks to Buy on the Debt-Ceiling Standoff Slump ||| 3 Infrastructure Stocks You Can Buy and Hold for the Next Decade ||| Be Sure To Check Out Caterpillar Inc. (NYSE:CAT) Before It Goes Ex-Dividend,1,0.49076104
2021-10-20,2936000.0,201.1600036621093,205.17999267578125,200.52999877929688,204.19000244140625,194.42469787597656,CAT,"Ex-Dividend Reminder: Caterpillar, Pembina Pipeline and SM Energy",0,0.490147
2021-10-21,3071300.0,201.6000061035156,202.3000030517578,199.7400054931641,202.13999938964844,192.4727478027344,CAT,"ANALYSIS-U.S. company results in industrial, materials sectors could shed light on inflation woes ||| ANALYSIS-U.S. company results in industrial, materials sectors could shed light on inflation woes ||| Caterpillar, Inc. (CAT) Ex-Dividend Date Scheduled for October 22, 2021",0,0.4660905
2021-10-22,2632400.0,200.63999938964844,202.3500061035156,199.1999969482422,200.6499938964844,192.10890197753903,CAT,How Will General Electric Stock Trend Following Q3 Earnings?,1,0.51555103
2021-10-25,3294700.0,201.27999877929688,203.3099975585937,200.509994506836,202.2100067138672,193.6025390625,CAT,"S&P 500, Dow hit new highs; Big Tech struggles ahead of earnings ||| Caterpillar's (NYSE:CAT) Rising Efficiency Should Provide some Peace of Mind",0,0.48809445
2021-10-26,2933600.0,202.75,202.7899932861328,199.47000122070312,199.63999938964844,191.1419372558593,CAT,"US STOCKS-S&P 500, Dow set for record open as investors eye tech earnings",0,0.4996974
2021-10-27,3406700.0,200.25,200.42999267578125,195.9199981689453,196.1300048828125,187.78135681152344,CAT,"Pre-Market Earnings Report for October 28, 2021 : MA, CMCSA, MRK, LIN, SHOP, AMT, SNY, CAT, MO, MCO, ITW, NOC ||| Pre-Market Earnings Report for October 28, 2021 : MA, CMCSA, MRK, LIN, SHOP, AMT, SNY, CAT, MO, MCO, ITW, NOC ||| 3 Industrial Stocks For Your November 2021 Watchlist ||| 5 Potential Winning Stocks from Biden's Infrastructure Plan",1,0.4764392
2021-10-28,4462700.0,197.3600006103516,204.5,197.0500030517578,204.08999633789065,195.40249633789065,CAT,"US STOCKS-S&P, Nasdaq hit record closing highs on earnings bullishness ||| US STOCKS-Solid earnings lift mood on Wall Street ahead of Apple, Amazon results ||| Caterpillar Financial Q3 Profit Surges ||| US STOCKS-S&P, Nasdaq hit record closing highs on earnings bullishness ||| US STOCKS-Nasdaq hits record high with Apple, Amazon results on deck ||| Dow Movers: MSFT, MRK ||| US STOCKS-Nasdaq scales record peak ahead of Apple, Amazon results ||| US STOCKS-Wall Street set to rise on positive earnings, Big Tech strength ||| US STOCKS-S&P, Nasdaq hit record closing highs on earnings bullishness ||| US STOCKS-Futures rise on positive earnings; GDP data awaited ||| Caterpillar Inc. Q3 Income Rises ||| Caterpillar Q3 21 Earnings Conference Call At 8:30 AM ET ||| ProShares ProShares UltraPro Dow30 Experiences Big Outflow",0,0.46987373
2021-10-29,4292200.0,207.9900054931641,209.75,203.2400054931641,204.009994506836,195.325912475586,CAT,"Caterpillar Jumps 4% on Q3 Outperformance ||| Dow Movers: AAPL, CAT ||| How Will Caterpillar Stock Trend Following Q3 Earnings? ||| US STOCKS-Apple, Amazon set to knock S&P 500, Nasdaq off record peak ||| 3 Stocks to Buy as the Market Reaches All-Time High ||| US STOCKS-Microsoft brings S&P 500, Nasdaq back into record territory",1,0.4940193
2021-11-03,3137000.0,206.259994506836,206.5800018310547,201.82000732421875,203.5500030517578,194.885498046875,CAT,"3 Cyclical Stocks To Watch Ahead Of The Fed’s Latest Policy Update ||| Dow Movers: CAT, NKE",1,0.5337708
2021-11-05,2591300.0,205.47999572753903,208.8800048828125,205.22999572753903,205.8800048828125,197.1162872314453,CAT,"US STOCKS-Wall St eyes record open on strong jobs report, Pfizer COVID-19 pill cheer",1,0.48128775
2021-11-08,5944700.0,215.88999938964844,216.47000122070312,211.25,214.25,205.1300201416016,CAT,"Caterpillar Leads Dow Jones Up 116 Points on $1 Trillion Infrastructure Deal ||| US STOCKS-Wall Street closes up on infrastructure gains but Tesla weighs ||| US STOCKS-Wall Street closes up on infrastructure gains but Tesla weighs ||| US STOCKS-Wall Street edges higher on U.S. infrastructure bill; Tesla drags ||| Dow Movers: NKE, CAT ||| 5 Infrastructure Stocks To Watch As The $1 Trillion Infrastructure Bill Advances ||| US STOCKS-Futures tick higher after Congress clears infrastructure bill; Tesla falls",0,0.50222427
2021-11-09,3310300.0,215.17999267578125,215.57000732421875,208.9600067138672,209.8099975585937,200.8790283203125,CAT,Deere Is Likely To Outperform This Stock Amid A Rebound In Construction Demand,0,0.5521288
2021-11-10,3261800.0,209.2700042724609,209.9499969482422,206.42999267578125,206.6699981689453,197.8726806640625,CAT,Wall Street set to open lower as surge in consumer prices fans inflation fears ||| U.S. stock futures tick lower as inflation worries take hold ahead of CPI data ||| Stocks To Pick Following The Passage Of The U.S. Infrastructure Bill,1,0.5037778
2021-11-11,4819800.0,207.8800048828125,210.44000244140625,207.8800048828125,208.52999877929688,199.65350341796875,CAT,"Dow Movers: DIS, BA ||| Caterpillar: A Beneficiary of Infrastructure Spending ||| U.S. stock futures rise after inflation-driven rout, Disney shares tumble ||| Wall Street set to rise after inflation-driven rout; Disney shares tumble",1,0.4859811
2021-11-12,2018000.0,209.3500061035156,210.69000244140625,208.3000030517578,209.2700042724609,200.3620147705078,CAT,"3 Infrastructure Stocks to Benefit From the New Law ||| After Raising Their Dividends, These 3 Blue Chip Stocks Are Great Buys Now",0,0.5201817
2021-11-15,2392600.0,210.0,210.69000244140625,206.759994506836,207.7100067138672,198.8684234619141,CAT,Should You Be Excited About Caterpillar Inc.'s (NYSE:CAT) 31% Return On Equity?,0,0.4790055
2021-11-16,2138000.0,208.0,208.17999267578125,205.259994506836,205.42999267578125,196.68544006347656,CAT,Why This Nonsense-Named Basket of Stocks Could Pay Serious Dividends,0,0.48945516
2021-11-17,3135700.0,205.0,205.19000244140625,200.8500061035156,202.97999572753903,194.3397521972656,CAT,"Just How Bad is America's Infrastructure, and How Can Investors Benefit from the New Infrastructure Bill? ||| Which Stocks To Buy Now? 3 Industrial Stocks To Know ||| DIA, GS, AMGN, CAT: ETF Outflow Alert",0,0.47859696
2021-11-22,2596500.0,201.4900054931641,204.52999877929688,200.08999633789065,202.3800048828125,193.7653045654297,CAT,7 Stocks to Buy if the DWAC Trump SPAC Succeeds,1,0.49993515
2021-11-24,3880500.0,203.6600036621093,208.259994506836,203.0800018310547,207.07000732421875,198.25564575195312,CAT,How Will Deere Stock Trend Following Q4 Earnings?,0,0.5214285
2021-11-29,4559900.0,201.22999572753903,201.5,193.27999877929688,195.9199981689453,187.58029174804688,CAT,3 Infrastructure Stocks To Watch This Week ||| Will Deere Stock See Higher Levels After An Upbeat Q4?,0,0.5223444
2021-12-01,3425300.0,197.5800018310547,198.42999267578125,191.3600006103516,191.47000122070312,183.3197021484375,CAT,"REUTERS NEXT-As Freeport converts mining trucks to green power, costs unclear",1,0.5241209
2021-12-02,3445700.0,192.3099975585937,197.6199951171875,191.8099975585937,196.7899932861328,188.4132232666016,CAT,"Omicron What? Dow Jones Shakes Off Fears, Surges 680 Points on Boeing, Visa, AmEx Gains ||| Dow Analyst Moves: CAT",1,0.49205294
2021-12-03,3250900.0,197.6699981689453,199.38999938964844,195.7400054931641,197.8000030517578,189.38026428222656,CAT,5 Best Dividend Stocks For Your Late 2021 List,1,0.5393803
2021-12-06,2838400.0,199.5800018310547,203.259994506836,198.33999633789065,201.27999877929688,192.712142944336,CAT,Does Caterpillar (NYSE:CAT) Have A Healthy Balance Sheet? ||| This Transmissions Company Is Likely To Offer Better Returns Over Caterpillar Stock ||| 3 Bargain-Bin Value Stocks That Are Too Cheap to Ignore,1,0.46954572
2021-12-07,2818000.0,203.2899932861328,206.2100067138672,203.07000732421875,204.4900054931641,195.7854766845703,CAT,From PayPal to MercadoLibre: 3 Blue-Chip Stocks That Just Went On Sale,0,0.5011368
2021-12-08,2341200.0,204.4100036621093,206.1999969482422,203.6100006103516,204.19000244140625,195.49826049804688,CAT,"Daily Dividend Report: KDP,MSFT,DHR,CAT,MAA",0,0.50492525
2021-12-14,2248800.0,200.0,203.97999572753903,199.8000030517578,201.63999938964844,193.0567626953125,CAT,"Energy Sector Update for 12/14/2021: PRM,CAT,CVX,BRK.A,BRK.B,ALTO,NM ||| UDOW, GS, BA, CAT: ETF Outflow Alert",1,0.48218837
2021-12-15,2193700.0,201.0,202.6000061035156,198.63999938964844,202.5500030517578,193.9280548095703,CAT,Will Honeywell Stock Rise Following A 9% Fall In A Month?,1,0.5257568
2021-12-16,2856800.0,205.0,208.22999572753903,204.6499938964844,206.1699981689453,197.3939514160156,CAT,"Dow Movers: HD, IBM ||| 3 Dividend Stocks That Will Pay You Forever",0,0.49356762
2021-12-20,3605100.0,197.5500030517578,197.5500030517578,193.0599975585937,195.4600067138672,187.13986206054688,CAT,Wall St set to open lower as Omicron's spread stokes fears of tighter curbs ||| US STOCKS-Futures tumble on fears of tighter curbs to combat Omicron's spread,1,0.51447594
2021-12-22,3558700.0,200.97999572753903,203.3999938964844,200.8300018310547,202.1499938964844,193.5450592041016,CAT,"Wall St climbs on positive economic data, Omicron update ||| US STOCKS-Wall Street subdued as Omicron concerns linger",1,0.5103732
2021-12-23,2669600.0,203.4199981689453,207.3000030517578,203.2899932861328,206.1999969482422,197.42266845703125,CAT,"Dow Movers: CRM, DOW",1,0.514926
2021-12-27,1711200.0,205.94000244140625,206.8999938964844,205.13999938964844,206.3800048828125,197.5950164794922,CAT,"Is Caterpillar Setting Up for a Cyclical Upswing? ||| Investing in Caterpillar (NYSE:CAT) five years ago would have delivered you a 152% gain ||| 3 Top Stocks to Buy Before 2021 Ends ||| Investing $50,000 in This Basket of Dividend Stocks Could Give You $1,500 in 2022 Income ||| Catepillar, Applied Materials: Capex Stocks Had A Good 2021. Will 2022 Be Better?",1,0.48780563
2021-12-29,1334900.0,206.2700042724609,208.5500030517578,206.0800018310547,207.3300018310547,198.50457763671875,CAT,Best Stocks To Buy Today? 4 Cyclical Stocks To Know ||| These 3 Dow Stocks Are Set To Soar in 2022's First Half and Beyond,0,0.4675473
2021-12-30,1465900.0,207.3300018310547,208.9100036621093,205.92999267578125,206.0800018310547,197.3077850341797,CAT,5 Dividend Stocks To Watch In 2022,1,0.5417464
2022-01-03,2055600.0,207.3300018310547,208.6000061035156,205.8000030517578,207.0,198.1885986328125,CAT,7 of the Best Infrastructure Stocks for 2022 to Buy Now,1,0.548802
2022-01-04,5242300.0,208.27999877929688,218.9199981689453,207.94000244140625,218.0800018310547,208.7969970703125,CAT,"7 Best Industrial Stocks to Buy for America’s Manufacturing Renaissance ||| Tuesday's ETF with Unusual Volume: EDOW ||| Dow Movers: KD, GS",1,0.51782936
2022-01-06,3913200.0,221.4900054931641,222.7100067138672,218.0599975585937,221.9900054931641,212.54054260253903,CAT,"Notable ETF Outflow Detected - UDOW, AMGN, CAT, BA",1,0.4962056
2022-01-10,3734900.0,224.9499969482422,225.75,220.6100006103516,221.63999938964844,212.20542907714844,CAT,My 3 Biggest Stock Market Predictions for January,0,0.5059624
2022-01-11,2944300.0,222.0,222.08999633789065,216.58999633789065,219.9499969482422,210.5873870849609,CAT,Worried About Missing Your 2022 Financial Goals? Consider These Three Blue Chip Dividend Stocks ||| Should You Buy Caterpillar Stock Over This Industrial Company?,1,0.49805728
2022-01-13,5002300.0,222.88999938964844,227.8800048828125,222.63999938964844,227.0,217.3372802734375,CAT,Caterpillar (NYSE:CAT) Is Experiencing Growth In Returns On Capital ||| Hitachi to sell about half its stake in construction unit - NHK ||| Are Capex Cycle Stocks Poised To Outperform This Year?,1,0.48051807
2022-01-14,3970600.0,224.72000122070312,229.63999938964844,223.5800018310547,228.94000244140625,219.19471740722656,CAT,"SUSL, TXN, AMGN, CAT: Large Outflows Detected at ETF ||| This Healthcare Company Is A Better Pick Over Honeywell Stock ||| Japan's Hitachi to sell about 50% stake in construction unit for $1.6 bln",1,0.508442
2022-01-18,5411900.0,227.7100067138672,230.42999267578125,226.8600006103516,229.8699951171875,220.08511352539065,CAT,"BHP Group joins Australia's big miners in electric trains purchase to transport iron ore ||| Caterpillar Inc. (NYSE:CAT) Passed Our Checks, And It's About To Pay A US$1.11 Dividend ||| Top Industrial Stocks To Watch This Week ||| Ex-Dividend Reminder: Acuity Brands, Pentair and Caterpillar",0,0.5001703
2022-01-20,3545600.0,221.0800018310547,221.8699951171875,216.0399932861328,216.6300048828125,208.4151153564453,CAT,"Dow Movers: DOW, TRV ||| 5 Blue-Chip Stocks Likely to Gain on Earnings Next Week",0,0.50023025
2022-01-21,3754700.0,217.509994506836,217.509994506836,212.4199981689453,214.08999633789065,205.971420288086,CAT,"Caterpillar (CAT) Stock Moves -1.17%: What You Should Know ||| Caterpillar (CAT) Earnings Expected to Grow: Should You Buy? ||| The Zacks Analyst Blog Highlights: American Express Co., Apple Inc., The Boeing Co., Caterpillar Inc. and Chevron Corp",1,0.46349537
2022-01-24,5107300.0,211.1600036621093,214.97000122070312,206.6600036621093,214.3300018310547,206.20236206054688,CAT,"Value Investing Is Back in Style! 3 Reasons That's Great for Most Investors ||| GLOBAL MARKETS-Asia shares tense as Fed looms, Ukraine a concern ||| Caterpillar (CAT) Gears Up For Q4 Earnings: What to Expect? ||| Earnings Growth & Price Strength Make Caterpillar (CAT) a Stock to Watch ||| How Will General Electric Stock Trend Following Q4 Earnings?",0,0.4960345
2022-01-25,4554300.0,212.0800018310547,216.8300018310547,207.1000061035156,214.3099975585937,206.1830902099609,CAT,"S&P 500 Corrects Ahead Of Fed Meeting: Let's Check The Technicals ||| Notable ETF Outflow Detected - SSO, ABT, T, CAT",0,0.5028734
2022-01-26,3558500.0,215.0,218.8800048828125,212.2400054931641,214.2899932861328,206.16384887695312,CAT,What's in Store for Juniper (JNPR) This Earnings Season?,0,0.47603762
2022-01-27,3678100.0,215.2100067138672,217.8999938964844,210.1499938964844,212.1699981689453,204.12423706054688,CAT,"Pre-Market Earnings Report for January 28, 2022 : CVX, CAT, CHTR, CL, PSX, LYB, WY, VFC, SYF, CHD, BAH, ALV ||| 7 Top Stocks With 10X Potential in 2022 For Your Portfolio ||| Why Caterpillar (CAT) Might Surprise This Earnings Season",0,0.4754077
2022-01-28,10747300.0,205.58999633789065,208.0,196.8000030517578,201.1600036621093,193.53173828125,CAT,"US STOCKS-Apple, Visa power Wall St higher as roller-coaster week winds down ||| US STOCKS-S&P 500 flirts with correction for fifth time on rate hike worries ||| US STOCKS-S&P 500 gains near the end of frenetic week ||| Caterpillar (CAT) Q4 Earnings and Revenues Surpass Estimates ||| US STOCKS-Wall Street ends frenetic week with gains ||| Caterpillar Q4 Results Top Estimates - Quick Facts ||| Caterpillar (CAT) Q4 Earnings & Sales Beat Estimates, Up Y/Y ||| US STOCKS-Wall Street rallies, capping frenetic week with best day of the year ||| US STOCKS-Nasdaq set for higher open after Apple results, inflation data ||| Caterpillar Q4 21 Earnings Conference Call At 8:30 AM ET ||| Will Caterpillar Stock Rise Following Its Q4 Earnings? ||| Will These Cyclical Stocks Outperform As The Markets Sell Off? ||| Best Value Stocks To Buy For 2022? 4 Industrial Stocks In Focus ||| Caterpillar beats quarterly revenue estimates ||| Dow Movers: CAT, V ||| Caterpillar Inc. Q4 Profit Increases, beats estimates",1,0.48817238
2022-01-31,6179000.0,199.4499969482422,201.6000061035156,194.67999267578125,201.5599975585937,193.9165802001953,CAT,"Why Caterpillar (CAT) is a Great Dividend Stock Right Now ||| Dow Movers: DOW, AAPL",1,0.47439858
2022-02-01,4026400.0,200.8000030517578,205.7899932861328,200.5399932861328,205.3500061035156,197.5628662109375,CAT,"Unusual Options Activity in Fluor (FLR), Caterpillar (CAT), and General Motors (GM) ||| Uncertainty Demands Defensive Stocks, and Caterpillar Inc. (NYSE:CAT) Might be one of Them",0,0.4705556
2022-02-02,3492300.0,203.1999969482422,205.8000030517578,201.3999938964844,204.94000244140625,197.1684112548828,CAT,"5 Top Value Stocks To Watch In February 2022 ||| Notable ETF Inflow Detected - IOO, ABT, RTX, CAT ||| Dow Movers: JPM, MSFT ||| What to Expect From Caterpillar in 2022",0,0.50602454
2022-02-07,2402000.0,198.83999633789065,201.52999877929688,198.02999877929688,199.82000732421875,192.2425537109375,CAT,Should You Buy Caterpillar Stock After Its Upbeat Q4 Results? ||| 3 Wildly Undervalued Dividend Stocks to Buy in February,1,0.49089012
2022-02-10,3538500.0,202.57000732421875,206.75,201.5599975585937,203.07000732421875,195.36932373046875,CAT,$90 Oil: 3 Dividend-Paying Companies Set to Thrive,0,0.51912516
2022-02-11,3826700.0,203.4199981689453,204.6499938964844,200.1300048828125,201.2400054931641,193.6087188720703,CAT,"DGRW, MSFT, BX, CAT: Large Inflows Detected at ETF ||| $90 Oil: Chevron and Caterpillar's 2020 Acquisitions Are Paying Off Big Time",0,0.4873922
2022-02-14,2730500.0,200.9499969482422,201.6999969482422,198.1100006103516,199.88999938964844,192.30992126464844,CAT,Insider Buying: The Caterpillar Inc. (NYSE:CAT) Independent Director Just Bought 34% More Shares ||| 7 Dividend Aristocrats That Could Outpace This Volatile Market ||| US STOCKS-Futures fall on fears of potential Russian attack on Ukraine ||| US STOCKS-Futures slide on fears of potential Russian attack on Ukraine,1,0.47764865
2022-02-17,4699600.0,201.0,201.759994506836,194.44000244140625,194.7400054931641,187.355209350586,CAT,Dow Analyst Moves: CAT ||| Can Caterpillar Support Its Dividend? ||| 3 Machinery Stocks Set to Beat Earnings Estimates in Q4 ||| Will Deere Stock See Higher Levels Following Its Q1 Results?,0,0.5068047
2022-02-18,4385200.0,193.3600006103516,195.6199951171875,191.17999267578125,191.9499969482422,184.67100524902344,CAT,"Dow Movers: INTC, JPM ||| The Zacks Analyst Blog Highlights: Caterpillar Inc., Deere & Company, The Middleby Corp. and Chart Industries",0,0.4843046
2022-02-22,3488000.0,191.9499969482422,194.8999938964844,190.5500030517578,191.2100067138672,183.9590606689453,CAT,"Got $500? 2 Dividend Stocks Down 19% and 32% to Buy Now ||| Notable ETF Outflow Detected - XLI, BA, DE, CAT",0,0.47627473
2022-02-25,3594600.0,184.94000244140625,187.92999267578125,184.1199951171875,187.0599975585937,179.9664306640625,CAT,Should You Buy Deere Stock After A 6% Fall Last Week?,1,0.50577044
2022-03-01,5110600.0,187.7700042724609,188.22000122070312,180.63999938964844,182.8300018310547,175.8968505859375,CAT,5 Stocks to Buy to Protect Against Rising Sea Levels ||| Will Caterpillar Stock Continue To See Lower Levels Or Is A Rise Imminent?,1,0.5073929
2022-03-04,4334700.0,191.1000061035156,196.009994506836,190.3099975585937,195.6600036621093,188.24029541015625,CAT,"Why Caterpillar (CAT) is a Top Dividend Stock for Your Portfolio ||| Noteworthy ETF Inflows: DIA, CAT, AXP, TRV",1,0.47218558
2022-03-07,6912300.0,194.7899932861328,203.5,193.6199951171875,196.6999969482422,189.2408905029297,CAT,"Dow Movers: AXP, CAT",1,0.51300144
2022-03-08,9318600.0,203.8699951171875,214.88999938964844,203.0,210.0,202.0365447998047,CAT,"Wall St ends down in rocky session as U.S. bans Russian oil imports ||| US STOCKS-S&P 500 drops in rocky session as U.S. bans Russian oil imports ||| S&P 500 little changed in rocky session as U.S. bans Russian oil imports ||| US STOCKS-Wall St bounces in choppy session as U.S. bans Russian oil imports ||| Dow Movers: PG, CAT ||| US STOCKS-Wall Street slips on concerns about Russia oil ban",0,0.47693038
2022-03-09,4798300.0,212.57000732421875,213.6000061035156,207.4499969482422,209.77999877929688,201.82485961914065,CAT,7 Dividend Stocks to Finance Your Golden Years ||| Caterpillar (CAT) Soars 6.8%: Is Further Upside Left in the Stock? ||| Caterpillar (CAT) Stock Sinks As Market Gains: What You Should Know,1,0.48116812
2022-03-10,4886300.0,209.38999938964844,217.5200042724609,208.17999267578125,211.7899932861328,203.7586212158203,CAT,"Top Stock Reports for Bank of America, Qualcomm & ConocoPhillips ||| Caterpillar (CAT) & Other Industrials Suspend Operations in Russia ||| Rio first big miner to cut Russia ties; Sony, Nintendo halt console sales",1,0.49656639
2022-03-11,4045500.0,212.3000030517578,217.7700042724609,212.3000030517578,214.8300018310547,206.68338012695312,CAT,"International Paper to consider stake sale in Russia's Ilim Group ||| The Zacks Analyst Blog Highlights Bank of America, Qualcomm ConocoPhillips, Target and Caterpillar",1,0.50249153
2022-03-14,3530700.0,216.3000030517578,218.47999572753903,212.92999267578125,215.44000244140625,207.270248413086,CAT,"DIA, AMGN, CAT, HON: Large Outflows Detected at ETF",1,0.5224803
2022-03-15,4364200.0,216.1199951171875,217.3800048828125,210.509994506836,216.4600067138672,208.25157165527344,CAT,Caterpillar (CAT) Gains But Lags Market: What You Should Know ||| Caterpillar continues to use Russian rail for shipments - Bloomberg News ||| This Industrial Company Is A Better Bet Over General Electric Stock,0,0.47378728
2022-03-17,3600400.0,215.32000732421875,221.77999877929688,214.33999633789065,221.6999969482422,213.29283142089844,CAT,10 Smart Stocks to Buy on the Recent Market Correction,0,0.5145734
2022-03-21,2902200.0,221.0,227.0500030517578,220.9900054931641,223.7100067138672,215.2266387939453,CAT,3 Unstoppable Dividend Stocks That Benefit From Higher Oil and Commodity Prices ||| Are You Looking for a High-Growth Dividend Stock? Caterpillar (CAT) Could Be a Great Choice,0,0.49442232
2022-03-22,2461500.0,224.4600067138672,225.8500061035156,221.33999633789065,222.7100067138672,214.2645568847656,CAT,"Notable ETF Inflow Detected - DIA, AMGN, CAT, HON",0,0.49028957
2022-03-25,1581100.0,222.08999633789065,223.8000030517578,221.13999938964844,223.3600006103516,214.889892578125,CAT,Caterpillar Inc: Current Conditions Point to Further Growth ||| New to Investing? This 1 Industrial Products Stock Could Be the Perfect Starting Point ||| 2 Non-Oil Dividend Stocks That Are Crushing the Market in 2022,0,0.47799695
2022-03-28,3072500.0,222.33999633789065,222.67999267578125,219.0399932861328,221.8500061035156,213.4371795654297,CAT,Caterpillar (CAT) Stock Sinks As Market Gains: What You Should Know,0,0.47007698
2022-03-29,3667800.0,220.8000030517578,221.42999267578125,216.5399932861328,221.0399932861328,212.6578521728516,CAT,"Ball Corp (BLL) Cuts Plants Operations in Russia, Plans to Exit ||| Got $500? Consider These 3 Cathie Wood Bargain Stocks",1,0.49449837
2022-03-30,2507400.0,222.0,225.8800048828125,220.6999969482422,223.0800018310547,214.6205139160156,CAT,Wall Street slips as optimism over Russia-Ukraine peace talks ebbs,0,0.5057744
2022-03-31,3152100.0,223.2100067138672,225.19000244140625,222.42999267578125,222.82000732421875,214.3703765869141,CAT,"DIA, GS, CAT, HON: ETF Outflow Alert ||| This Unstoppable Dividend Aristocrat Might Be the Safest Stock on the Planet ||| Up 19% In A Month, Will Caterpillar Stock Continue To See Higher Levels?",0,0.50669324
2022-04-04,2181300.0,219.1600036621093,221.3500061035156,216.6000061035156,220.8099975585937,212.43658447265625,CAT,"Why Caterpillar Stock Soared in March ||| Why Shares of Stanley Black & Decker Slumped in March ||| Manitowoc (MTW) Cuts Operations in Russia, Halts Crane Orders",0,0.496986
2022-04-05,3582100.0,220.0,222.3699951171875,215.13999938964844,216.0200042724609,207.8282470703125,CAT,Caterpillar Stock: A Bargain or Dead “CAT” Bounce? ||| Why Caterpillar (CAT) is a Top Stock for the Long-Term,1,0.5032904
2022-04-06,2783300.0,215.1199951171875,217.1300048828125,213.5500030517578,216.2100067138672,208.0110321044922,CAT,Why Caterpillar (CAT) is a Great Dividend Stock Right Now ||| Caterpillar (CAT) Gains As Market Dips: What You Should Know ||| Fed Turns Tougher Than Expected: Buy These 5 Blue-Chip Stocks ||| 6 Stocks That Moved the Market in March,0,0.47485518
2022-04-07,2253600.0,215.4600067138672,216.3099975585937,213.5599975585937,215.8999938964844,207.71278381347656,CAT,"Dow Movers: AXP, MRK",1,0.52058166
2022-04-11,2494700.0,217.02999877929688,218.759994506836,215.75,216.0500030517578,207.85711669921875,CAT,3 Infrastructure Stocks You Can Buy and Hold for the Next Decade,1,0.5214243
2022-04-12,2508200.0,215.4499969482422,219.47999572753903,214.97999572753903,216.6999969482422,208.48245239257807,CAT,"Noteworthy ETF Outflows: XLI, UNP, HON, CAT",1,0.51706654
2022-04-13,1898900.0,216.92999267578125,219.67999267578125,216.3999938964844,218.2700042724609,209.992919921875,CAT,"Daily Dividend Report: QCOM,CAT,O,CTAS,FAST ||| Is There A Better Pick Over Deere Stock?",1,0.5027068
2022-04-18,3644000.0,228.0,234.3800048828125,228.0,229.9199981689453,221.20114135742188,CAT,Brazil's Tupy to acquire Traton-owned motor maker MWM in $184 mln deal ||| 3 Large-Cap Stocks to Add to Your April Buy List ||| Strong Revenue Trends And Better Prospects Make Caterpillar Stock A Good Pick,1,0.49630728
2022-04-20,2907700.0,233.5500030517578,236.3699951171875,232.5800018310547,235.0800018310547,226.1654815673828,CAT,"Top Analyst Reports for Oracle, Linde & Caterpillar ||| Ex-Dividend Reminder: Caterpillar, Kaiser Aluminum and Pembina Pipeline ||| New to Investing? This 1 Industrial Products Stock Could Be the Perfect Starting Point ||| 3 Undervalued Blue-Chip Stocks to Buy Now",0,0.52693695
2022-04-21,3571400.0,237.2400054931641,237.8999938964844,231.6499938964844,232.57000732421875,223.7506561279297,CAT,"Caterpillar (CAT) Stock Moves -1.07%: What You Should Know ||| Earnings Preview: Caterpillar (CAT) Q1 Earnings Expected to Decline ||| The Zacks Analyst Blog Highlights Oracle, Linde, Caterpillar, Salesforce and Vale",0,0.47160727
2022-04-22,5053700.0,228.3999938964844,229.7899932861328,215.6000061035156,216.3000030517578,209.09559631347656,CAT,Starbucks Has Less International Exposure Than You May Think,1,0.5283928
2022-04-25,4145500.0,215.3099975585937,217.0,209.57000732421875,216.6999969482422,209.4822692871093,CAT,"3 Unstoppable Dow Dividend Aristocrats That Are Passive Income Machines ||| Down More Than 23%, This Year's 2 Worst-Performing Dow Stocks Look Like Monster Buys Right Now ||| This Unstoppable Dividend Aristocrat Is 2022's Best-Performing Dow Stock (and It's Not Even Close) ||| 10 Unstoppable Stocks You'll Want in Your Corner if the Market Crashes ||| 3 Dirt Cheap Dividend Stocks You Can Buy and Hold Forever ||| Caterpillar (CAT) is a Top Dividend Stock Right Now: Should You Buy? ||| Stock Market News for Apr 25, 2022",0,0.5211967
2022-04-26,4176700.0,216.1300048828125,218.1999969482422,209.3500061035156,210.3000030517578,203.2954559326172,CAT,"PREVIEW-Caterpillar sales seen lifted by oil, commodity prices",1,0.5128264
2022-04-27,3358300.0,211.1100006103516,215.5500030517578,207.3000030517578,213.9600067138672,206.8335418701172,CAT,"Pre-Market Earnings Report for April 28, 2022 : MA, LLY, MRK, TMO, CMCSA, MCD, LIN, SNY, CAT, MO, SO, NOC",0,0.48034286
2022-04-28,6092800.0,207.42999267578125,212.9600067138672,202.0,212.44000244140625,205.3641357421875,CAT,"US STOCKS-Wall Street ends sharply higher, lifted by Meta and Apple ||| US STOCKS-Wall Street ends sharply higher, lifted by Meta and Apple ||| US STOCKS-Wall Street surges as Meta Platforms lifts techs, growth stocks ||| Dow Movers: CAT, MRK ||| Caterpillar (CAT) Q1 Earnings Beat Estimates on Strong Demand ||| Q1 GDP Negative; Q1 Earnings Beats from CAT, LLY, MCD ||| US STOCKS-Wall St inches higher as Meta earnings offset GDP gloom ||| US STOCKS-Wall St set for higher open as Meta earnings offset GDP gloom ||| US STOCKS-Wall St rises as Meta earnings offset GDP worries ||| Caterpillar (CAT) Q1 Earnings and Revenues Surpass Estimates ||| US STOCKS-Nasdaq futures jump after strong Meta results; GDP data awaited ||| Caterpillar Inc. Q1 Profit Increases, beats estimates ||| Caterpillar first-quarter sales rise 14% ||| Caterpillar Q1 22 Earnings Conference Call At 8:30 AM ET ||| PREVIEW-Caterpillar sales seen lifted by oil, commodity prices",0,0.50147915
2022-04-29,3404000.0,212.6999969482422,217.2100067138672,210.1600036621093,210.5399932861328,203.5274353027344,CAT,2 Shocking Dow Charts That Illustrate the Power of Long-Term Investing ||| Is First Trust Value Line Dividend ETF (FVD) a Strong ETF Right Now? ||| China April factory activity contracts at steeper pace as lockdowns bite,1,0.5117108
2022-05-02,2639500.0,210.0,212.7700042724609,207.6600036621093,212.07000732421875,205.00650024414065,CAT,China April factory activity contracts at steeper pace as lockdowns bite ||| Some CNH Industrial workers in U.S. start strike -UAW union statement ||| Here's What Caterpillar Just Told Us About the Economy (and It's Not Good),1,0.4792205
2022-05-04,3023700.0,214.9499969482422,223.2899932861328,213.8300018310547,222.58999633789065,215.17608642578125,CAT,"Dow Movers: UNH, CAT",0,0.500451
2022-05-05,3005600.0,222.3999938964844,223.1499938964844,213.7700042724609,215.92999267578125,208.73789978027344,CAT,Dow Analyst Moves: CAT,0,0.51468444
2022-05-09,2929900.0,212.02999877929688,212.0500030517578,205.44000244140625,206.2899932861328,199.4189910888672,CAT,Good Stocks To Buy Right Now? 3 Industrial Stocks To Watch,0,0.4972016
2022-05-11,2552400.0,205.5599975585937,209.7100067138672,203.58999633789065,205.2100067138672,198.3749542236328,CAT,Agriculture Stocks are Rising; These 3 Could Harvest Healthy Returns ||| Why Caterpillar (CAT) is a Top Dividend Stock for Your Portfolio,0,0.5004379
2022-05-13,2323800.0,205.1499938964844,206.4600067138672,202.9199981689453,204.3300018310547,197.52427673339844,CAT,"Top Stock Reports for Walmart, Chevron & Mastercard ||| Notable ETF Inflow Detected - IWF, NVDA, DE, CAT",1,0.5007556
2022-05-16,2540800.0,205.0200042724609,209.2100067138672,203.67999267578125,207.19000244140625,200.28903198242188,CAT,"The Zacks Analyst Blog Highlights Walmart, Chevron, Mastercard, Honeywell International, and Caterpillar",1,0.50205344
2022-05-17,2275900.0,212.8000030517578,213.7700042724609,209.13999938964844,213.08999633789065,205.9925079345703,CAT,Caterpillar eyes energy transition as growth driver for mining business,0,0.5178678
2022-05-18,4723300.0,213.83999633789065,217.8999938964844,207.5200042724609,207.94000244140625,201.0140380859375,CAT,"Dow Movers: WBA, CAT",0,0.5156925
2022-05-19,2887700.0,205.8600006103516,209.27999877929688,201.7100067138672,206.759994506836,199.8733367919922,CAT,The 5 Best Long-Term Stocks Every 30-Year-Old Should Buy and Hold,0,0.526611
2022-05-20,5404500.0,206.4499969482422,206.6300048828125,194.0399932861328,197.82000732421875,191.2311248779297,CAT,"Here's Why You Should Retain Caterpillar (CAT) Stock Now ||| Dow Movers: BA, NKE ||| Should First Trust Value Line Dividend ETF (FVD) Be on Your Investing Radar?",1,0.4668525
2022-05-23,3246600.0,199.92999267578125,205.4900054931641,199.1600036621093,204.1499938964844,197.35025024414065,CAT,Best Stocks To Invest In Right Now? 5 Value Stocks To Watch This Week,1,0.48403445
2022-05-25,3080200.0,205.0,210.08999633789065,204.82000732421875,209.3099975585937,202.33839416503903,CAT,"Down 24% In 1 Month, This Dirt Cheap Dividend Stock Looks Like a Great Value",1,0.5012808
2022-05-27,2020400.0,215.0,217.6300048828125,214.1600036621093,217.13999938964844,209.9075927734375,CAT,Caterpillar (CAT) is a Top Dividend Stock Right Now: Should You Buy? ||| SPDR Dow Jones Industrial Average ETF Trust Experiences Big Inflow,0,0.47038385
2022-05-31,3773500.0,214.7899932861328,218.08999633789065,213.4900054931641,215.8500061035156,208.6605834960937,CAT,Why This 1 Industrial Products Stock Could Be a Great Addition to Your Portfolio,1,0.503579
2022-06-01,2314000.0,218.4600067138672,219.0,214.3000030517578,217.57000732421875,210.32330322265625,CAT,Caterpillar CEO doesn't see slowdown in demand despite recession fears ||| Caterpillar (CAT) to Showcase Hydrogen-Fueled CHP System ||| Caterpillar To Participate At Bernstein''s 38th Annual Conference At 11:00 AM ET,1,0.49472788
2022-06-06,1565400.0,222.8999938964844,224.759994506836,222.25,223.6300048828125,216.1814422607422,CAT,"3 Powerhouse Passive-Income Stocks to Buy This Summer ||| DIA, CAT, TRV, AXP: ETF Inflow Alert",1,0.5142968
2022-06-07,1799000.0,222.0,227.2700042724609,221.6499938964844,227.1000061035156,219.53585815429688,CAT,Caterpillar (CAT) Outpaces Stock Market Gains: What You Should Know,1,0.46742803
2022-06-08,4171300.0,225.2899932861328,232.3500061035156,224.6199951171875,229.8000030517578,222.1459503173828,CAT,"Daily Dividend Report: CAT,RCII,DELL,ACM,GEF ||| 7 Dividend Stocks to Buy for a Rich Retirement",0,0.49683517
2022-06-09,3045700.0,227.42999267578125,228.2100067138672,223.6199951171875,223.6699981689453,216.22010803222656,CAT,"7 Blue-Chip Stocks With Strong Dividend Yields ||| 3 Dividend Aristocrats Suited Perfectly for Income Investors ||| Caterpillar (CAT) Rewards Shareholders With 8% Dividend Hike ||| Dow Movers: BA, HD ||| 4 Infrastructure Stocks to Buy in June",0,0.521331
2022-06-13,3559400.0,209.5800018310547,209.8699951171875,204.8999938964844,206.8800048828125,199.9893341064453,CAT,Why the Dow Jones Industrial Average Has Avoided the Bear So Far,0,0.49761584
2022-06-14,2359000.0,208.0599975585937,209.72999572753903,205.2700042724609,206.69000244140625,199.80567932128903,CAT,"Caterpillar To Move Its Headquarters To Texas From Illinois ||| Caterpillar to move global headquarters to Texas ||| Caterpillar to move global headquarters to Texas ||| Noteworthy ETF Outflows: DIA, GS, AMGN, CAT",0,0.48230755
2022-06-15,2343100.0,207.47999572753903,208.6499938964844,203.1300048828125,206.0,199.1386566162109,CAT,"Top Stock Reports for Oracle, Texas Instruments & Caterpillar ||| New to Investing? This 1 Industrial Products Stock Could Be the Perfect Starting Point",0,0.48794535
2022-06-16,4789900.0,201.07000732421875,201.25,193.25,194.7899932861328,188.3020172119141,CAT,"6 Low-Tech Stocks That Are Ideal for Value Investors ||| The Zacks Analyst Blog Highlights Oracle, Texas Instruments, Caterpillar, Lowe's Companies and Enbridge",0,0.51188505
2022-06-21,2755400.0,197.1000061035156,198.4199981689453,193.8699951171875,196.3699951171875,189.8293914794922,CAT,"Caterpillar (CAT) Gains But Lags Market: What You Should Know ||| Top Analyst Reports for Alphabet, Bank of America & Charles Schwab ||| Quant Ratings Updated on 62 Stocks ||| FOCUS-U.S. factories pop up to make medical gloves, spurred by pandemic",0,0.50328416
2022-06-22,4008700.0,190.0,192.7899932861328,187.7100067138672,187.8300018310547,181.5738677978516,CAT,"Should You Buy Deere Stock At $320? ||| DIA, GS, AMGN, CAT: Large Inflows Detected at ETF ||| Rio Tinto (RIO) Officially Opens Its High-Tech Gudai Darri Mine ||| What A Recession Would Mean For Caterpillar Stock?",0,0.4691754
2022-06-23,6667900.0,186.5800018310547,187.22999572753903,176.02000427246094,178.6699981689453,172.71893310546875,CAT,"Hedge fund Citadel to move headquarters to Miami from Chicago ||| Dow Movers: BA, MRK",1,0.5146608
2022-06-27,3061100.0,188.0800018310547,190.0800018310547,185.82000732421875,187.58999633789065,181.34185791015625,CAT,"Should You Buy General Electric Stock At $65? ||| 3 Dividend Aristocrats That Income Investors Can't Ignore ||| Still Think Tesla Is Expensive? This Stat Will Change Your Mind ||| Caterpillar: Strong Results, but Mixed Investment Case",0,0.48001468
2022-06-28,3327200.0,189.97000122070312,193.1000061035156,187.42999267578125,187.44000244140625,181.1968536376953,CAT,Caterpillar (CAT) Stock Moves -0.08%: What You Should Know,0,0.46721622
2022-06-29,2436900.0,187.32000732421875,187.57000732421875,182.1300048828125,183.47999572753903,177.36874389648438,CAT,Why Caterpillar (CAT) is a Great Dividend Stock Right Now ||| Reasons to Retain Caterpillar (CAT) Stock in Your Portfolio ||| 7 Best Infrastructure Stocks to Buy Now,0,0.47635487
2022-06-30,4197100.0,180.259994506836,182.13999938964844,177.1199951171875,178.75999450683594,172.80593872070312,CAT,"Is First Trust Value Line Dividend ETF (FVD) a Strong ETF Right Now? ||| Top Research Reports for Amazon, Accenture & Comcast ||| SPDR Dow Jones Industrial Average ETF Trust Experiences Big Outflow",0,0.49038085
2022-07-01,3423100.0,179.30999755859375,181.32000732421875,173.72000122070312,178.2899932861328,172.3516082763672,CAT,"The Zacks Analyst Blog Highlights Amazon, Accenture, Comcast, Morgan Stanley, and Caterpillar",0,0.49956268
2022-07-05,3724900.0,173.77000427246094,174.4199981689453,170.60000610351562,173.75999450683594,167.97250366210938,CAT,Why Shares of Caterpillar Slumped in June ||| 6 Low-Tech Stocks With Good Yields and Buybacks,0,0.4872809
2022-07-06,3190600.0,173.47999572753906,174.6699981689453,169.2899932861328,172.30999755859375,166.57078552246094,CAT,Is It Time to Buy the Dow Jones' 3 Worst-Performing June Stocks?,1,0.50402427
2022-07-07,4677600.0,182.5,182.5,176.3300018310547,180.27999877929688,174.2753143310547,CAT,"U.S. EXIM Bank chief plans 'aggressive' marketing push, eyes steady volume growth ||| Dow Movers: VZ, BA",0,0.4990946
2022-07-08,2491100.0,180.22999572753903,181.2400054931641,176.38999938964844,179.10000610351562,173.13462829589844,CAT,"10 Best Dividend Stocks to Buy Now in July ||| Caterpillar (CAT) Dips More Than Broader Markets: What You Should Know ||| Stock Market News for Jul 8, 2022",0,0.5019463
2022-07-11,2773300.0,177.41000366210938,179.77000427246094,174.6199951171875,175.02000427246094,169.19053649902344,CAT,7 Overlooked Blue-Chip Stocks to Add to Your Buy List ||| 7 Best Dow Stocks to Buy in July,0,0.51263905
2022-07-13,2389000.0,172.25,175.25,171.86000061035156,173.8699951171875,168.07882690429688,CAT,Is Most-Watched Stock Caterpillar Inc. (CAT) Worth Betting on Now?,0,0.4810265
2022-07-14,2531200.0,169.75,170.6999969482422,167.0800018310547,169.94000244140625,164.27972412109375,CAT,"Zacks Industry Outlook Highlights Caterpillar, Komatsu and Terex",1,0.51148677
2022-07-15,2282100.0,172.25,173.3800048828125,169.1999969482422,173.3800048828125,167.6051483154297,CAT,Are You Looking for a High-Growth Dividend Stock? ||| Caterpillar About To Put More Money In Your Pocket (CAT),1,0.47492388
2022-07-18,2476400.0,176.1300048828125,176.6999969482422,172.7100067138672,173.49000549316406,167.7114715576172,CAT,"3 Dividend Aristocrats to Boost Your Passive Income Stream This Summer ||| Caterpillar (CAT) Gains As Market Dips: What You Should Know ||| Pre-Market Earnings Report for July 19, 2022 : JNJ, LMT, TFC, HAL, NVS, CFG, SBNY, ALLY, HAS, MAN, SI, CATC ||| Pre-Market Earnings Report for July 19, 2022 : JNJ, LMT, TFC, HAL, NVS, CFG, SBNY, ALLY, HAS, MAN, SI, CATC",1,0.50300175
2022-07-19,2671400.0,173.89999389648438,179.6999969482422,172.8800048828125,179.49000549316406,174.72015380859375,CAT,Is Caterpillar (CAT) a Good Pick for Value Investors?,1,0.49215657
2022-07-20,2175900.0,178.77999877929688,180.8000030517578,177.07000732421875,179.97000122070312,175.18739318847656,CAT,"DIA, AMGN, CAT, HON: ETF Outflow Alert",1,0.52354014
2022-07-21,2214500.0,178.4199981689453,181.07000732421875,176.47999572753906,180.9900054931641,176.18028259277344,CAT,Dow Analyst Moves: CAT ||| 3 No-Brainer Dividend Stocks to Hold for Retirement ||| Should First Trust Value Line Dividend ETF (FVD) Be on Your Investing Radar?,0,0.47824332
2022-07-22,1961500.0,181.4900054931641,182.8000030517578,177.33999633789062,178.6199951171875,173.87326049804688,CAT,7 Seriously Undervalued Retirement Stocks to Buy Now ||| My Top Dividend Aristocrat for the Second Half of 2022,1,0.5293023
2022-07-26,1767700.0,181.1600036621093,183.6499938964844,180.5800018310547,181.22999572753903,176.41390991210938,CAT,Caterpillar (CAT) Reports Next Week: Wall Street Expects Earnings Growth ||| The 7 Best Industrial Stocks to Buy Now ||| America’s Infrastructure Might Have to Wait Longer to Improve,1,0.5250851
2022-07-27,1856500.0,182.9199981689453,186.17999267578125,180.32000732421875,185.25,180.3270721435547,CAT,Is Trending Stock Caterpillar Inc. (CAT) a Buy Now?,1,0.48356435
2022-07-28,2229200.0,186.8500061035156,189.5200042724609,184.1999969482422,187.83999633789065,182.8482360839844,CAT,"Caterpillar (CAT) to Post Q2 Earnings: What's in the Offing? ||| XLI, CAT, DE, BA: ETF Outflow Alert ||| Earnings Preview: The Manitowoc Company, Inc. (MTW) Q2 Earnings Expected to Decline",1,0.4817729
2022-08-01,3185100.0,195.0800018310547,197.19000244140625,193.3999938964844,194.8600006103516,189.6816864013672,CAT,"More money in the bank for insiders who divested US$3.5m worth of Caterpillar Inc. (NYSE:CAT) shares last year ||| Pre-Market Earnings Report for August 2, 2022 : SPGI, CAT, ITW, ETN, MAR, MPC, UBER, RACE, IDXX, MPLX, KKR, PEG ||| Pre-Market Earnings Report for August 2, 2022 : SPGI, CAT, ITW, ETN, MAR, MPC, UBER, RACE, IDXX, MPLX, KKR, PEG ||| Will Caterpillar Stock Rise Post Q2 Results? ||| Caterpillar (CAT) Could Be a Great Choice ||| Dow Movers: DOW, BA",0,0.4776352
2022-08-02,8193100.0,188.0,189.47000122070312,183.1600036621093,183.509994506836,178.63328552246094,CAT,"Choppy trading on Wall Street as Pelosi visits Taiwan ||| Dow Movers: CAT, AMGN ||| S&P 500 ends see-saw session lower as Pelosi visits Taiwan ||| S&P 500 ends see-saw session lower as Pelosi visits Taiwan ||| Best Dividend Stocks To Buy Now? 5 For Your List ||| Why Caterpillar Stock Is Down Today ||| Wall Street falls on rising U.S.-China tensions, Caterpillar shares weigh ||| US STOCKS-Futures fall as U.S.-China tensions grow ||| Pre-markets Down on Tension Between U.S. And China ||| Caterpillar (CAT) Q2 Earnings Surpass Estimates ||| Wall Street set to open lower as U.S.-China tensions grow ||| Caterpillar Q2 22 Earnings Conference Call At 8:30 AM ET ||| Stock Futures Dip, Geopolitical Conflict and Q2 Earnings in Focus ||| Caterpillar adjusted profit rises on higher equipment prices",0,0.49112144
2022-08-05,1908500.0,183.5800018310547,186.1000061035156,183.22999572753903,185.38999938964844,180.46334838867188,CAT,3 Blue-Chip Stocks With Rock-Solid Dividends,1,0.54390085
2022-08-09,2460000.0,185.9499969482422,187.8800048828125,185.1600036621093,186.02999877929688,181.0863647460937,CAT,"SPDR Dow Jones Industrial Average ETF Trust Experiences Big Inflow ||| Checking In on Caterpillar, Arista Networks, and Pinterest",1,0.50583225
2022-08-11,2538900.0,192.8300018310547,195.5800018310547,191.9100036621093,194.0,188.8445587158203,CAT,Heavy-duty truck group drops lawsuit against California air regulators ||| What's Next For Caterpillar Stock After A Mixed Q2?,1,0.5033116
2022-08-15,1752400.0,193.3999938964844,196.5,193.07000732421875,195.9499969482422,190.74273681640625,CAT,What To Expect From Deere's Q3?,1,0.51210207
2022-08-16,1959300.0,195.32000732421875,198.3999938964844,194.9499969482422,197.5200042724609,192.27099609375,CAT,"The ""Death of Globalization"" Is Here (Let's Tap It for 100%+ Dividend Growth)",0,0.5063009
2022-08-17,1576200.0,195.0,196.8999938964844,193.8699951171875,195.92999267578125,190.7232360839844,CAT,"At US$198, Is It Time To Put Caterpillar Inc. (NYSE:CAT) On Your Watch List?",1,0.49777618
2022-08-18,1750900.0,197.0500030517578,197.6300048828125,195.25,197.3500061035156,192.1055145263672,CAT,"Top Analyst Reports for JPMorgan Chase, AbbVie & Abbott",0,0.4995521
2022-08-19,2003600.0,195.2700042724609,197.22000122070312,193.8099975585937,195.6000061035156,190.40203857421875,CAT,"Why Is Everyone Talking About Caterpillar Stock? ||| Reasons to Hold Caterpillar (CAT) Stock in Your Portfolio ||| VIS, CAT, DE, GE: Large Outflows Detected at ETF ||| The Zacks Analyst Blog Highlights JPMorgan Chase, AbbVie, Abbott Laboratories, Intuit and Caterpillar",0,0.4721645
2022-08-22,2008900.0,193.1100006103516,193.92999267578125,191.5500030517578,191.759994506836,186.6640625,CAT,"Up 20% In A Month, Will General Electric Stock See More Gains? ||| 3 Reliable Dividend Aristocrats to Help Supplement Income in Retirement",1,0.5177621
2022-08-24,2503200.0,197.5599975585937,198.67999267578125,193.4499969482422,194.1600036621093,189.0002899169922,CAT,These 3 Blue-Chip Stocks Are Great Shields Against Volatility ||| 3 Popular Stocks With Recent Price Target Cuts,1,0.49292773
2022-08-29,1996600.0,190.0,193.1699981689453,189.0,191.77999877929688,186.6835327148437,CAT,"Up 19% In A Month, Can Deere Stock Continue Its Run?",0,0.52422893
2022-08-30,2691200.0,191.5,191.9600067138672,184.58999633789065,186.94000244140625,181.97216796875,CAT,"Dow Movers: CVX, BA",0,0.5149559
2022-08-31,2656600.0,186.6300048828125,188.0599975585937,184.5,184.7100067138672,179.80142211914062,CAT,"BHP Group (BHP), Caterpillar to Refurbish Escondida Truck Fleet ||| 3 S&P 500 Companies With Insider Buys in 2022",0,0.5012764
2022-09-01,2686200.0,182.2700042724609,183.2100067138672,180.10000610351562,182.44000244140625,177.59176635742188,CAT,"Got $5,000? 2 Top Industrial Stocks to Buy for the Long Term",0,0.50220555
2022-09-02,2185400.0,184.8500061035156,185.7400054931641,179.85000610351562,180.8300018310547,176.02452087402344,CAT,Caterpillar (CAT) Stock Moves -0.88%: What You Should Know ||| Caterpillar (CAT) is a Top Dividend Stock Right Now: Should You Buy?,0,0.46526927
2022-09-06,2141700.0,182.8999938964844,183.6600036621093,179.58999633789062,180.6600036621093,175.85906982421875,CAT,"3 Stocks Bulls and Bears Can't Stop Fighting Over ||| Caterpillar Inc. (NYSE:CAT) Shares Could Be 23% Below Their Intrinsic Value Estimate ||| 7 Dow Stocks With Superior Fundamentals ||| Dow Movers: WMT, CAT",1,0.5046471
2022-09-07,2166900.0,179.11000061035156,181.83999633789065,178.19000244140625,180.8600006103516,176.05374145507812,CAT,This Dow Jones Stock Is a More Recession-Proof Than You Think,1,0.5060977
2022-09-08,2245700.0,179.67999267578125,183.27999877929688,178.0800018310547,183.1499938964844,178.28286743164062,CAT,Caterpillar (CAT) Outpaces Stock Market Gains: What You Should Know,1,0.46742803
2022-09-09,2279600.0,187.5500030517578,189.759994506836,187.22000122070312,189.4900054931641,184.4543914794922,CAT,"Dow Movers: UNH, CAT ||| US STOCKS-Tech stocks drive gains in futures ||| Down Between 18% and 37%: 3 Top Dividend Stocks That Are Passive Income Machines",1,0.4782415
2022-09-13,2207500.0,187.8500061035156,190.0500030517578,183.5,184.3099975585937,179.4120635986328,CAT,SPDR Portfolio S&P 500 Value ETF Experiences Big Outflow,1,0.5132982
2022-09-14,2295000.0,183.9199981689453,185.13999938964844,181.8699951171875,184.6499938964844,179.74302673339844,CAT,7 Best Infrastructure Stocks to Buy Now ||| Here's Why Genuine Parts Is a No-Brainer Dividend Stock ||| Is Caterpillar Stock A Better Pick Over Its Competitor?,0,0.49316385
2022-09-15,1933100.0,184.6699981689453,186.5399932861328,181.67999267578125,182.4900054931641,177.6404266357422,CAT,These 3 Dow Stocks Are Set to Soar in 2022's Second Half and Beyond,0,0.4967848
2022-09-19,2923700.0,177.25,182.72999572753903,176.8000030517578,182.1100006103516,177.27052307128906,CAT,Defense Wins Ballgames; 3 Blue-Chip Stocks To Consider ||| Why Caterpillar (CAT) is a Top Dividend Stock for Your Portfolio ||| New to Investing? This 1 Industrial Products Stock Could Be the Perfect Starting Point,0,0.47904444
2022-09-20,2512400.0,180.58999633789065,180.72000122070312,176.30999755859375,177.99000549316406,173.260009765625,CAT,"Dow Movers: NKE, AAPL",0,0.5140634
2022-09-21,4061900.0,179.27999877929688,180.4900054931641,171.8800048828125,171.9499969482422,167.38052368164062,CAT,EXCLUSIVE-U.S. EPA to consider tougher emissions rules for heavy trucks,0,0.5107394
2022-09-22,2508400.0,172.6999969482422,174.6199951171875,170.2899932861328,170.5500030517578,166.01773071289062,CAT,Pick Either General Electric Stock Or Its Sector Peer – Both Are Likely To Offer Similar Returns ||| Caterpillar (CAT) Stock Moves -0.81%: What You Should Know,0,0.46999928
2022-09-23,4047200.0,168.66000366210938,169.44000244140625,161.72999572753906,164.24000549316406,159.8754119873047,CAT,Should You Be Adding Caterpillar (NYSE:CAT) To Your Watchlist Today?,0,0.48978558
2022-09-26,3213400.0,164.0,165.85000610351562,162.22000122070312,162.6199951171875,158.2984619140625,CAT,"7 Stocks That Could Explode After the 2022 Midterm Elections ||| 3 Large-Cap Stocks Seeing Insider Activity in 2022 ||| US STOCKS-Futures shackled by rate-hike, recession worries ||| US STOCKS-Wall Street eyes lower open on rate hike, recession worries",0,0.4879712
2022-09-29,3518100.0,165.6999969482422,166.58999633789062,163.5399932861328,165.89999389648438,161.4912872314453,CAT,Caterpillar (CAT) Stock Moves -1.11%: What You Should Know,0,0.46671477
2022-10-03,3444700.0,167.42999267578125,173.3699951171875,166.0500030517578,171.22999572753906,166.67965698242188,CAT,"3 Recession-Resistant Agriculture Dividend Stocks That Can Steer Your Portfolio Toward Greener Pastures ||| Dow Movers: JNJ, CVX",1,0.5521966
2022-10-04,4008200.0,174.3000030517578,180.19000244140625,174.2100067138672,179.6300048828125,174.85641479492188,CAT,Top Stocks To Buy Now? 3 Industrial Stocks To Check Out ||| Down Between 19% and 40%: 3 Passive-Income Powerhouse Stocks to Buy in October,0,0.48730224
2022-10-05,3067400.0,177.14999389648438,180.259994506836,176.69000244140625,178.3800048828125,173.63963317871094,CAT,Solid Growth Prospects Make Deere Stock A Better Pick Over This Industrial Company ||| Tyson Foods moves corporate jobs to Arkansas in latest blow to Chicago ||| Tyson Foods moves corporate jobs to Arkansas in latest blow to Chicago ||| Deere (DE) Rides on Strong Agriculture & Construction Markets,1,0.5036272
2022-10-06,2415000.0,177.41000366210938,180.97999572753903,176.88999938964844,178.80999755859375,174.0582275390625,CAT,Caterpillar (CAT) to Unveil Four Battery Electric Machines ||| Dow Analyst Moves: CAT,0,0.49895895
2022-10-07,2759200.0,176.72000122070312,178.9600067138672,175.13999938964844,177.5500030517578,172.83169555664062,CAT,"DIA, GS, CAT, HON: Large Inflows Detected at ETF ||| Down Between 25% and 33%: 3 Dividend Stocks to Buy and Hold in October",1,0.51353365
2022-10-10,2633900.0,179.80999755859375,181.1600036621093,176.07000732421875,178.6699981689453,173.9219512939453,CAT,Will Caterpillar (CAT) Beat Estimates Again in Its Next Earnings Report?,1,0.4933327
2022-10-11,2542400.0,176.82000732421875,183.0800018310547,176.6699981689453,179.75,174.97323608398438,CAT,Caterpillar (CAT) Gains As Market Dips: What You Should Know,0,0.4745692
2022-10-12,2260800.0,179.47999572753906,181.1199951171875,178.77999877929688,179.5,174.72988891601562,CAT,2 Cathie Wood Investments That Could Deliver Superior Returns,1,0.5405809
2022-10-13,3745900.0,173.75,184.9499969482422,172.7100067138672,183.13999938964844,178.2731475830078,CAT,Caterpillar CEO to continue in post after company waives retirement policy ||| Caterpillar CEO Jim Umpleby To Continue As CEO,0,0.48329073
2022-10-14,2830200.0,183.75,184.3300018310547,177.52999877929688,178.19000244140625,173.45468139648438,CAT,"Is Caterpillar Stock (NYSE:CAT) a Buy? ||| Dow Movers: CAT, UNH ||| Unusual Options Activity and Flow in Caterpillar Inc. (CAT)",1,0.47208425
2022-10-17,2940000.0,182.3000030517578,184.3099975585937,179.1999969482422,180.8000030517578,175.99533081054688,CAT,Caterpillar (CAT) Gains But Lags Market: What You Should Know,1,0.47749946
2022-10-18,2674000.0,184.8999938964844,185.52999877929688,180.9100036621093,183.5500030517578,178.67225646972656,CAT,"How Will General Electric Stock Trend Following Q3 Earnings? ||| Noteworthy ETF Outflows: DIA, GS, CAT, TRV",1,0.4956927
2022-10-20,2953900.0,184.5399932861328,185.7400054931641,180.4600067138672,180.5399932861328,175.7422332763672,CAT,"Caterpillar (CAT) Earnings Expected to Grow: Should You Buy? ||| Ex-Dividend Reminder: Service Properties Trust, Lakeland Financial Corp and Caterpillar",1,0.47906685
2022-10-21,3483800.0,179.72999572753906,190.4100036621093,179.2100067138672,190.22000122070312,186.4039764404297,CAT,"New to Investing? This 1 Industrial Products Stock Could Be the Perfect Starting Point ||| Top Stock Reports for AstraZeneca, Caterpillar & Crown Castle ||| Dow Movers: VZ, CAT",1,0.48231947
2022-10-24,2919500.0,188.6499938964844,192.13999938964844,188.4499969482422,191.3000030517578,187.4623260498047,CAT,"The Zacks Analyst Blog Highlights AstraZeneca, Caterpillar, Crown Castle, Nasdaq and American Water Works ||| Earn Passive Income for Years With This Dividend Aristocrat ||| PREVIEW-Strong equipment, parts demand expected to lift Caterpillar sales",1,0.49785548
2022-10-25,2545000.0,190.2899932861328,195.6699981689453,188.9199981689453,194.83999633789065,190.9312896728516,CAT,4 Stocks to Watch From the Construction & Mining Equipment Industry,1,0.55347717
2022-10-26,3546000.0,198.3000030517578,199.5800018310547,194.57000732421875,196.9600067138672,193.00875854492188,CAT,"5 Intriguing Earnings Charts ||| Pre-Market Earnings Report for October 27, 2022 : MA, MRK, MCD, LIN, CMCSA, HON, SPGI, CAT, AMT, MO, NOC, SO ||| DIA, GS, CAT, TRV: ETF Outflow Alert ||| Caterpillar Q3 Preview: Can Shares Uphold Strength? ||| Zacks Industry Outlook Highlights Caterpillar, Hitachi Construction Machinery, H&E Equipment Services, and Terex",1,0.5356002
2022-10-27,7872200.0,210.1499938964844,217.1300048828125,207.3699951171875,212.13999938964844,207.8842315673828,CAT,"US STOCKS-Dow jumps on earnings boost; Meta weighs on Nasdaq ||| Caterpillar (CAT) Q3 Earnings & Sales Top Estimates, Rise Y/Y ||| US STOCKS-S&P 500, Nasdaq slide, while Dow ends higher on mixed earnings picture ||| GLOBAL MARKETS-Wall Street mixed, European shares end nearly flat; sterling, euro fall ||| US STOCKS-S&P 500, Nasdaq slide, but Dow ends higher on mixed earnings picture ||| US STOCKS-S&P 500, Nasdaq end lower but the Dow jumps as earnings bifurcate ||| US STOCKS-Dow jumps, Nasdaq sinks on mixed earnings ||| GLOBAL MARKETS-Wall Street mixed, European shares end nearly flat; British pound eases ||| US STOCKS-Dow jumps on earnings boost, Meta drags Nasdaq lower ||| These 2 Dow Jones Stocks Are Riding Out the Bear Market Well ||| US STOCKS-Nasdaq futures fall as Meta plummets on dismal outlook ||| Caterpillar (CAT) Beats Q3 Earnings and Revenue Estimates ||| Cat Financial Q3 Profit Rises ||| Caterpillar posts higher adjusted profit on strong equipment demand ||| Caterpillar Inc. Q3 Profit Increases, beats estimates ||| Caterpillar reports higher adjusted profit on strong demand ||| Dow Movers: AAPL, CAT ||| US STOCKS-Dow, S&P 500 eye higher open after GDP data",1,0.49254477
2022-10-28,5161000.0,212.5,219.5,211.2100067138672,219.33999633789065,214.93980407714844,CAT,Stocks Still Eye Weekly Wins Despite Big Tech Bust ||| Why Caterpillar Stock Is Crushing the Market This Week,0,0.49885723
2022-10-31,3786100.0,215.33999633789065,218.8699951171875,215.009994506836,216.4600067138672,212.1175842285156,CAT,"Company Report Roundup: Tesla, Tractor Supply, American Express, and More ||| Is Caterpillar (CAT) Outperforming Other Industrial Products Stocks This Year? ||| Take the Zacks Approach to Beat the Market: Caterpillar, Amgen, Inventiva in Focus",1,0.48499653
2022-11-01,2717500.0,218.6300048828125,219.47000122070312,216.7100067138672,218.5,214.11666870117188,CAT,4 Blue-Chip Stocks to Buy as Dow Seals Record October Gains,0,0.5239971
2022-11-02,3150000.0,217.6000061035156,221.6999969482422,213.92999267578125,214.5399932861328,210.2360992431641,CAT,"The Zacks Analyst Blog Highlights Caterpillar, JPMorgan Chase, Home Depot and Merck & Co",1,0.50188726
2022-11-03,3570400.0,211.5399932861328,221.7899932861328,211.3600006103516,219.259994506836,214.86138916015625,CAT,U.S. EPA to set tougher heavy duty emissions rules in 2023 ||| US STOCKS-Wall St down for fourth straight day on Fed rate hike worry ||| US STOCKS-U.S. stocks close lower on Fed rate hike worry ||| US STOCKS-Wall St falls on concerns over Fed interest rate path ||| US STOCKS-Wall St slides as Fed signals more interest rate hikes,1,0.4835046
2022-11-04,4973800.0,224.0200042724609,229.72999572753903,223.6000061035156,227.8500061035156,223.27908325195312,CAT,3 Reliable Dividend Stocks That Are Coiled Springs for Economic Growth,1,0.5500484
2022-11-07,3405600.0,228.0,229.1300048828125,222.6699981689453,228.6100006103516,224.0238342285156,CAT,What's Next For Caterpillar Stock After A 19% Rise In A Month?,1,0.5054253
2022-11-08,3676600.0,228.6100006103516,232.6300048828125,226.6699981689453,229.8099975585937,225.1997528076172,CAT,5 Stocks that Moved the Market in October,0,0.5298709
2022-11-11,3585400.0,233.0,238.3999938964844,232.0,236.4900054931641,231.7457733154297,CAT,3 Top-Ranked Stocks up More Than 25% The Past Month ||| Are You Looking for a Top Momentum Pick? Why Caterpillar (CAT) is a Great Choice ||| October CPI Data Raises Hope for a Soft Landing: 5 Top Picks,1,0.5410523
2022-11-14,3217700.0,236.0,239.8500061035156,234.5,236.5,231.7555389404297,CAT,"URTH, GS, CAT, NKE: ETF Inflow Alert ||| The Top Dividend Stocks to Prepare for Retirement – And How to Choose Them ||| Caterpillar Inc. (CAT) Hit a 52 Week High, Can the Run Continue? ||| 3 Dow Dividend Stocks That Are Too Cheap to Ignore ||| Beat the Market Like Zacks: JPMorgan, Berkshire Hathaway, Amgen in Focus ||| e.l.f. Beauty and Ally Financial have been highlighted as Zacks Bull and Bear of the Day",0,0.49089935
2022-11-15,3371000.0,237.1000061035156,239.3999938964844,232.75,234.58999633789065,229.88385009765625,CAT,The 1 Key Metric Investors Should Watch for Every Stock,0,0.5018418
2022-11-16,3062000.0,234.0,234.6600036621093,230.83999633789065,232.4199981689453,227.7574005126953,CAT,"3 Stocks Seeing Insider Activity in 2022 ||| Is Caterpillar (CAT) Stock Outpacing Its Industrial Products Peers This Year? ||| Up 30% in 1 Month, Does This Dividend Aristocrat Have More Room to Run?",0,0.49344346
2022-11-21,2522600.0,231.5500030517578,233.6699981689453,228.2700042724609,232.1699981689453,227.5124053955078,CAT,Is Your Investment Portfolio Down Big? Consider This Timeless Investing Strategy ||| Is Caterpillar (CAT) Stock a Solid Choice Right Now?,1,0.4928806
2022-11-22,2523300.0,234.0,237.47999572753903,233.3600006103516,237.259994506836,232.50030517578125,CAT,"Why Caterpillar (CAT) is a Top Value Stock for the Long-Term ||| Caterpillar Inc. Shares Near 52-Week High - Market Mover ||| Keep Close Tabs on These 3 New Dividend Aristocrats ||| New to Investing? This 1 Industrial Products Stock Could Be the Perfect Starting Point ||| Top Stock Reports for AbbVie, PepsiCo & Walt Disney",0,0.47604337
2022-11-28,2862100.0,233.94000244140625,234.9600067138672,231.57000732421875,232.3000030517578,227.63980102539065,CAT,My Top Wildly Undervalued Dividend King to Buy In 2023 ||| What's Next For Deere Stock After A Solid Q4? ||| This Dividend Aristocrat Is Pushing All-Time Highs ||| Reasons to Add Caterpillar (CAT) Stock to Your Portfolio ||| Caterpillar (CAT) Is Up 1.85% in One Week: What You Should Know,1,0.4859568
2022-11-29,2277900.0,233.3000030517578,235.72999572753903,231.5500030517578,235.1199951171875,230.4032287597656,CAT,US STOCKS-Wall Street mixed as Apple dips and traders eye Powell speech ||| Should You Buy Caterpillar (CAT) After Golden Cross?,1,0.48638496
2022-11-30,3850000.0,235.8999938964844,236.759994506836,230.7899932861328,236.4100036621093,231.6673583984375,CAT,Buy Caterpillar (CAT) Stock for Solid Growth,0,0.50472856
2022-12-01,2504700.0,236.8999938964844,237.0,231.94000244140625,235.69000244140625,230.96180725097656,CAT,December is Usually a Good Time for Wall Street: 5 Growth Picks,1,0.5079874
2022-12-02,2218300.0,233.88999938964844,238.47000122070312,233.58999633789065,236.1300048828125,231.3929748535156,CAT,"Is Axon Enterprise (AXON) Stock Outpacing Its Industrial Products Peers This Year? ||| Dow Movers: INTC, KO ||| The Zacks Analyst Blog Highlights AMark Precious Metals, Barings BDC, Caterpillar, Chico's FAS and J & J Snack Foods ||| Noteworthy ETF Inflows: IWB, GS, CAT, DE ||| Top 4 Blue-Chip Stocks to Enhance Your Portfolio in December",0,0.49618894
2022-12-05,2064500.0,234.8000030517578,235.9100036621093,232.259994506836,232.57000732421875,227.90440368652344,CAT,"Caterpillar (CAT) Stock Moves -1.51%: What You Should Know ||| Beat the Market Like Zacks: Novo Nordisk, Axon, General Mills in Focus ||| The Zacks Analyst Blog Highlights Caterpillar, Merck, UnitedHealth Group and Walmart ||| Komatsu CEO: no immediate plan to withdraw from Russia",0,0.46276465
2022-12-06,3633800.0,232.58999633789065,233.0500030517578,225.5599975585937,228.2899932861328,223.7102508544922,CAT,The China Crisis Could Send These Dividends Soaring 300%,1,0.5432357
2022-12-08,2189400.0,230.9100036621093,232.5,229.5399932861328,230.9199981689453,226.28749084472656,CAT,CNH Industrial's CEO sees lack of growth in China's construction market,0,0.54486233
2022-12-09,2257000.0,232.0,232.8099975585937,227.19000244140625,227.2899932861328,222.7303161621093,CAT,Better Buy: Caterpillar vs. Stanley Black & Decker,1,0.5008354
2022-12-12,2709200.0,227.5500030517578,233.3999938964844,227.0200042724609,233.0599975585937,228.3845672607422,CAT,"Why Should You Invest in Blue Chip Stocks? ||| Dow Jones Bear Market: 3 No-Brainer Stocks for Market Growth ||| IWB, SCHW, GS, CAT: ETF Inflow Alert",1,0.48874527
2022-12-13,2945200.0,237.82000732421875,237.9199981689453,232.1300048828125,235.4900054931641,230.7658233642578,CAT,What's Driving Growth For General Electric Stock? ||| Buy These 2 Industrial Products Stocks ||| Caterpillar (CAT) Outpaces Stock Market Gains: What You Should Know,0,0.47010294
2022-12-14,3513800.0,236.0599975585937,238.22000122070312,233.1199951171875,234.47999572753903,229.7760772705078,CAT,3 Top Stocks With Solid Earnings Growth to Buy Ahead of 2023,0,0.54137224
2022-12-15,2953200.0,232.1600036621093,232.92999267578125,227.72000122070312,230.6600036621093,226.03271484375,CAT,"5 Momentum Stocks for Keeping Your Portfolio Warm This Winter ||| Caterpillar Stock Is A Better Pick Over This Relatively Small Industry Peer ||| Like Dividends? 3 Aristocrats Worthy of Consideration ||| Top 5 High-Yield S&P 500 Stocks to Buy for 2023 ||| Daily Dividend Report: FMC,CVS,XEL,CAT,PNW",1,0.54573673
2022-12-16,7610700.0,228.6300048828125,233.22000122070312,228.0500030517578,232.72000122070312,228.0513916015625,CAT,Surviving Market Volatility: 3 Low Beta Stocks to Consider,0,0.5248193
2022-12-19,2622400.0,233.8999938964844,236.92999267578125,230.92999267578125,232.2899932861328,227.6300048828125,CAT,"Caterpillar Inc. Shares Near 52-Week High - Market Mover ||| Caterpillar (CAT) Stock Moves -0.18%: What You Should Know ||| Dow Movers: DIS, BA ||| Beat the Market Like Zacks: Vivint, Caterpillar, Oracle in Focus",1,0.47731856
2022-12-20,2649900.0,232.44000244140625,235.72000122070312,231.8600006103516,235.13999938964844,230.4228515625,CAT,"Caterpillar Inc. Shares Climb 0.8% Past Previous 52-Week High - Market Mover ||| U.S. business equipment borrowings rise 9% in November - report ||| IWF, DE, CAT, ZTS: ETF Inflow Alert ||| Are Industrial Products Stocks Lagging Caterpillar (CAT) This Year?",1,0.48927057
2022-12-21,4143600.0,237.6600036621093,241.9100036621093,237.6600036621093,241.72999572753903,236.8806304931641,CAT,Caterpillar Inc. Shares Close in on 52-Week High - Market Mover ||| 3 Stocks Seeing Insider Activity in 2022 ||| TEX vs. CAT: Which Stock Is the Better Value Option? ||| Best Momentum Stocks to Buy for December 21st ||| New Strong Buy Stocks for December 21st ||| Best Income Stocks to Buy for December 21st ||| Is There A Better Pick Over Honeywell Stock?,0,0.4727899
2022-12-22,3129900.0,240.1499938964844,240.8000030517578,233.0399932861328,237.5399932861328,232.7746734619141,CAT,"Caterpillar Inc. (CAT) Hits Fresh High: Is There Still Room to Run? ||| Caterpillar Inc. Shares Near 52-Week High - Market Mover ||| Dow Analyst Moves: CAT ||| Investors Heavily Search Caterpillar Inc. (CAT): Here is What You Need to Know ||| Top 5 Momentum Stocks to Gain From a Possible Santa Rally ||| Zacks Investment Ideas feature highlights: Caterpillar, Enterprise Product Partners and United Air Lines",1,0.47135785
2022-12-23,1959900.0,236.9499969482422,240.5399932861328,236.5,239.8699951171875,235.0579376220703,CAT,"The Zacks Analyst Blog Highlights Veritiv, Caterpillar, Arista Networks, First Financial Bancorp and WhiteHorse Finance",1,0.5155088
2022-12-27,3381500.0,240.69000244140625,245.0500030517578,239.72000122070312,243.13999938964844,238.2623443603516,CAT,"Dow Jones Bear Market: The Smartest Investors Are Buying These Beaten-Down Stocks ||| 7 Industrial Stocks to Buy for 2023 ||| Bull of the Day: Caterpillar Inc. (CAT) ||| Dow Movers: DIS, CVX ||| Top Stock Picks for Week of December 26, 2022 ||| Caterpillar and Cracker Barrel Old Country Store have been highlighted as Zacks Bull and Bear of the Day ||| Reasons Why You Should Avoid Betting on Greif (GEF) Now",0,0.49136564
2022-12-28,2270000.0,243.13999938964844,243.82000732421875,238.27999877929688,239.3800048828125,234.57778930664065,CAT,Caterpillar (CAT) Dips More Than Broader Markets: What You Should Know ||| 3 Top Performing Blue-Chips of 2022 ||| The Zacks Analyst Blog Highlights Archer Daniels Midland and Caterpillar,1,0.48202083
2022-12-29,1652500.0,241.2100067138672,241.6100006103516,238.2700042724609,240.1999969482422,235.38131713867188,CAT,"3 Top Stocks With Dividend Yields Above 10% ||| Reasons to Add Titan International (TWI) to Your Portfolio ||| O-I Glass (OI) Up 37% YTD: Will the Momentum Continue in 2023? ||| Zacks Investment Ideas feature highlights: Caterpillar, Chevron and Amgen",0,0.5252013
2022-12-30,1521100.0,239.38999938964844,240.1600036621093,237.6999969482422,239.5599975585937,234.7541656494141,CAT,SPDR Dow Jones Industrial Average ETF Trust Experiences Big Inflow ||| Dow Jones Beats S&P 500 in 2022: 5 Hot Stocks,0,0.50189894
2012-01-05,18431800.0,21.020000457763672,21.48500061035156,21.0,21.26000022888184,18.288637161254883,GILD,"Take a Look at My ""Cheat Sheet"" of Undervalued Stocks",1,0.49478552
2012-01-09,16801200.0,21.2450008392334,21.4950008392334,21.174999237060547,21.364999771118164,18.378963470458984,GILD,"BMY Kicks Off 2012 Pharma Deals - Analyst Blog ||| Just What The Doctor Ordered: 4 ETFs For Biotech M&A ||| Forget Dendreon, Inhibitex is the New Biotech Success Story",1,0.50978905
2012-01-10,30110000.0,21.549999237060547,22.520000457763672,21.46999931335449,22.125,19.032745361328125,GILD,"The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, Sanofi, Inhibitex, Gilead Sciences and Pharmasset - Press Releases ||| Going Nuc-lear on Hepatitis C -- Is Idenix the Next Target?",1,0.5006742
2012-01-17,24215200.0,22.5,23.25,22.434999465942383,23.1299991607666,19.89728355407715,GILD,"6 Stocks that worth watching ||| Gilead Enters into $1.25B, 5 Year Credit Pact; Funds Will Partially Cover Pharmasset Acquisition ||| Gilead Sciences Hits 52-Week High of $45.05",1,0.4991563
2012-01-18,26292400.0,23.15999984741211,23.77499961853028,23.049999237060547,23.7549991607666,20.4349308013916,GILD,J.P. Morgan Gives Gilead Sciences HIV Monthly Rx Update ||| Gilead Sciences Hits 52-Week High of $46.51,0,0.49879777
2012-01-19,24058000.0,23.63999938964844,23.739999771118164,23.395000457763672,23.604999542236328,20.305891036987305,GILD,Gilead Clinches Pharmasset Buy - Analyst Blog ||| Achillion's Hep C Pipeline Likely Can't Compete ||| From Earlier: Gilead Sciences Announces U.S. Food and Drug Administration Approves New Formulations of Viread® for Use by Children Living With HIV,1,0.53501385
2012-01-20,14076000.0,23.56999969482422,23.729999542236328,23.415000915527344,23.71999931335449,20.40482711791992,GILD,"The Zacks Analyst Blog Highlights: Gilead Sciences, Bristol-Myers Squibb, Inhibitex, Vertex Pharmaceuticals and Merck - Press Releases",0,0.50818795
2012-01-24,15147400.0,23.65999984741211,23.93000030517578,23.53499984741211,23.834999084472656,20.503751754760746,GILD,"Gilead Initiates Phase 2 Clinical Trial Evaluating GS-7340, A Low-Dose Novel Prodrug of Tenofovir for the Treatment of HIV ||| BioLineRx Surges after Hep C License Agreement ||| Gilead Sciences Hits 52-Week High of $47.56",1,0.50685745
2012-01-25,15804800.0,23.71500015258789,24.239999771118164,23.71500015258789,24.145000457763672,20.77042579650879,GILD,Gilead Sciences Hits 52-Week High of $47.87,1,0.5146759
2012-01-26,18193200.0,24.28499984741211,24.38999938964844,23.924999237060547,24.295000076293945,20.899459838867188,GILD,Brean Murray Carret & Co. Raises Gilead Sciences PT To $60,1,0.5133976
2012-02-01,19617600.0,24.52499961853028,24.700000762939453,24.434999465942383,24.575000762939453,21.14032554626465,GILD,Gilead Sciences Hits 52-Week High of $49.06,1,0.5135892
2012-02-02,17363600.0,24.559999465942383,24.815000534057617,24.184999465942383,24.655000686645508,21.20914649963379,GILD,Gilead Guides 2012 Product Sales $8.6-8.8B ||| Gilead Sciences Reports Q4 EPS $0.97 vs $1.05 Est; Revenues $2.20B vs $2.18B Est ||| Gilead Sciences Hits 52-Week High of $49.40,1,0.50909156
2012-02-03,75343200.0,26.70499992370605,27.450000762939453,26.5,27.350000381469727,23.527484893798828,GILD,"Gilead Misses EPS Ests, Sales Up - Analyst Blog ||| Gilead Sciences Soars On ""Striking"" Clinical Trial Data ||| Gilead Sciences Surging on Clinical Trial Data ||| UPDATE: JP Morgan Raises Target to $65 on Gilead Sciences ||| Gilead Sciences Hits 52-Week High of $53.42 ||| Gilead Sciences up 10% Despite Lower Than Expected Q4 Profit ||| Brean Murray Maintains Sell on Idenix ||| UPDATE: Deutsche Bank Raises Target to $66 on Gilead Sciences ||| JP Morgan Raises PT on Gilead Sciences to $65",1,0.50691015
2012-02-06,37824600.0,27.14999961853028,28.25,27.1200008392334,28.01499938964844,24.09954071044922,GILD,"Company News for February 6, 2012 - Corporate Summary ||| Gilead Sciences Hits 52-Week High of $54.90",0,0.48252505
2012-02-08,23592000.0,27.280000686645508,27.450000762939453,26.915000915527344,27.13500022888184,23.342533111572266,GILD,Generic Challenge for UTHR's Remodulin - Analyst Blog,0,0.5170907
2012-02-10,14493000.0,26.795000076293945,26.979999542236328,26.709999084472656,26.875,23.11886978149414,GILD,"Morgan Stanley Initiates Coverage on Gilead Sciences at Overweight, Announces PT of $65",1,0.504123
2012-02-14,14643000.0,27.13500022888184,27.450000762939453,27.07999992370605,27.280000686645508,23.467267990112305,GILD,From Earlier: U.S. FDA Grants Priority Review for Truvada for Reducing the Risk of Acquiring HIV Infection,1,0.53828824
2012-02-15,12190800.0,27.450000762939453,27.45499992370605,27.03499984741211,27.40999984741211,23.57910346984864,GILD,Weak Revenues Pull Down Actelion - Analyst Blog,0,0.5284821
2012-02-17,124983800.0,23.0,23.940000534057617,22.799999237060547,23.5,20.21556854248047,GILD,"Gilead Remains Neutral - Analyst Blog ||| Friday Slide: Opportunity Or Red Flag For Biotech ETFs? (GILD, IBB, XBI) ||| Gilead Analyst: The Gilead News is Positive for Vertex Investor Sentiment. It Casts Doubt Over the Thesis That Invicek's Market Share Will Go to Zero in 2014. ||| Gilead Falls On Disappointing Hep C Drug Data; Analysts Remain Bullish ||| UPDATE: Analyst Mark Schoenebaum Discusses Gilead Sciences on CNBC ||| Gilead Sciences Negative Data Ripples through Biotech Field, Boosting Vertex, Achillion; Knocking Idenix ||| Achillion Pharmaceuticals Spiking Higher on Gilead Hep C Data ||| Deutsche Bank Sees Buying Opportunity on Gilead Share Weakess ||| Vertex Pharmaceuticals Seeing Strength this Morning after Gilead's Negative Results ||| Idenix Pharmaceuticals Seeing Weakness this Morning on Gilead's Negative Results ||| Gilead Sciences Falls 23% Pre-Market on Disappointing Hep C Data ||| Gilead Announces Data for Genotype 1 Null Responder Hepatitis C Patients Enrolled in ELECTRON Study; Viral Relapse Seen Post Treatment with GS-7977 Plus Ribavirin",0,0.48800635
2012-02-21,38854000.0,23.27499961853028,23.375,22.295000076293945,22.34499931335449,19.221996307373047,GILD,Gilead's HCV Drug Suffers Setback - Analyst Blog,0,0.52722687
2012-02-22,36038400.0,22.104999542236328,22.51000022888184,21.905000686645508,22.26499938964844,19.15317916870117,GILD,Hearing Deutsche Bank Making Negative Comments on Gilead Sciences,1,0.52793854
2012-02-23,22631200.0,22.45499992370605,22.65999984741211,22.184999465942383,22.575000762939453,19.41985321044922,GILD,JP Morgan Remains Bullish on Gilead Sciences,1,0.51171345
2012-02-24,13753400.0,22.700000762939453,22.75,22.32999992370605,22.6299991607666,19.46717071533203,GILD,Action Date for UTHR Candidate - Analyst Blog ||| UPDATE: Deutsche Bank Cuts Target to $57 on Gilead Sciences,0,0.51974744
2012-02-27,15203600.0,22.5,22.655000686645508,22.38500022888184,22.59499931335449,19.43705368041992,GILD,"Deutsche Bank Reiterates Buy, $57 PT on Gilead Sciences ||| Morgan Stanley: 7977 Will Be Vital in All-Oral HCV Therapy",1,0.53490597
2012-02-28,17867800.0,22.64999961853028,23.20499992370605,22.565000534057617,23.0,19.78545379638672,GILD,Largest option buying in equities so far,0,0.5245229
2012-03-02,15709000.0,23.3700008392334,23.63999938964844,23.13999938964844,23.4950008392334,20.21126747131348,GILD,"Option Alert: Gilead Sciences April 50 Call; Block Trade, 3,835 Contracts",0,0.5164171
2012-03-05,13825600.0,23.479999542236328,23.56999969482422,22.975000381469727,23.114999771118164,19.884376525878903,GILD,"Hearing Goldman Sachs Reiterating Gilead Sciences as Top Pick for 2012, Making Positive Comments",0,0.52079356
2012-03-06,18648000.0,22.790000915527344,23.084999084472656,22.690000534057617,22.940000534057617,19.73383522033692,GILD,"Researcher Says 8 Of The 9 ""null"" Hepatitis C Patients Who Have Reached 4 Weeks Post-Treatment In Trial Of Gilead's GS-7977 Have Relapsed -Reuters",0,0.49497932
2012-03-07,15951600.0,22.934999465942383,22.959999084472656,22.39999961853028,22.739999771118164,19.561782836914062,GILD,"3 Nasdaq Stocks for Active Investors ||| Gilead Analyst: The Abstract Stated That Total Cholesterol and LDL Increases Are Significantly Lower for Quad. Some HIV Medicines Have Been Linked to an Increase in Cholesterol, Which Can Lead to Heart Attacks. ||| Gilead's Quad Single Tablet Regimen for HIV Non-Inferior to Atripla in Pivotal Phase 3 Study ||| Morgan Stanley Updates Gilead Sciences Model",1,0.5298645
2012-03-09,11584000.0,23.295000076293945,23.30500030517578,22.959999084472656,23.045000076293945,19.824159622192383,GILD,Gilead Launching New Single Tablet AIDS Drug This Year,1,0.5400466
2012-03-13,14249800.0,23.170000076293945,23.415000915527344,22.815000534057617,23.405000686645508,20.13385009765625,GILD,Idenix Pharmaceuticals Spokesperson Says Resolution in Patent Interference Claim Against Gilead Could Take Up to 2 Years ||| Hearing Leering Says Gilead Will Have to Pay Licensing Fee to Idenix ||| The Portfolio Bids Adieu to Gilead and Banco Itau,0,0.5063247
2012-03-15,12254600.0,23.46500015258789,23.600000381469727,23.31999969482422,23.57999992370605,20.28438949584961,GILD,"UPDATE: Stifel Nicolaus Resumes Buy, $57 PT on Gilead Sciences",0,0.5090732
2012-03-21,8691600.0,23.520000457763672,23.520000457763672,23.09000015258789,23.14999961853028,19.91448783874512,GILD,Vertex' HCV-HIV Treatment Impresses - Analyst Blog,1,0.5414278
2012-04-03,17569600.0,24.270000457763672,24.43000030517578,23.73500061035156,24.049999237060547,20.688701629638672,GILD,Brean Murray Carret Discusses Gilead's Potential Competitor,0,0.531103
2012-04-04,35547200.0,23.94499969482422,23.94499969482422,22.77499961853028,23.59499931335449,20.297292709350582,GILD,Hearing UBS Positive on Gilead Sciences,1,0.5255738
2012-04-05,16543000.0,23.51499938964844,23.940000534057617,23.5,23.8799991607666,20.542461395263672,GILD,"After Hours Most Active for Apr 5, 2012 : QQQ, FTR, DDD, STD, BAC, EXC, GILD, CSCO, TLEO, MDAS, SYK, MSFT",0,0.4872322
2012-04-19,72033400.0,27.225000381469727,27.375,25.799999237060547,26.125,22.473691940307617,GILD,"Pre-Market Most Active for Apr 19, 2012 : BAC, HGSI, GILD, MS, CVI, QQQ, NOK, EBAY, TOT, EMC, VOD, AAPL ||| Hedge Fund Shkreli Making Negative Comments on Gilead Sciences, Shorting Shares ||| Notable Options Activity in Gilead Sciences Inc ||| Benzinga's Top Pre-Market Gainers ||| Financial Breakfast: Morning News Summary for April 19, 2012 ||| Gilead Sciences Rises 15% on Release of Phase 2 Hepatitis C Data ||| From Earlier: Gilead Announces Early Sustained Virologic Response Rates for GS-7977 Plus Ribavirin in Genotype 1 Treatment-Naïve Hepatitis C Patients",0,0.48986012
2012-04-20,29794800.0,26.114999771118164,26.26499938964844,25.21500015258789,25.5,21.936044692993164,GILD,Vertex Reports Positive Data on Incivek - Analyst Blog,1,0.5430676
2012-04-24,14329600.0,25.709999084472656,26.18000030517578,25.65999984741211,26.18000030517578,22.5210075378418,GILD,Earnings Preview: Celgene - Analyst Blog,1,0.5329461
2012-04-26,13356800.0,26.13500022888184,26.395000457763672,26.020000457763672,26.36000061035156,22.67584800720215,GILD,Pharma & Biotech Stock Outlook - April 2012 - Industry Outlook ||| Gilead Sciences Reports Q1 EPS $0.91 vs $0.94 Est; Revenues $2.21B vs $2.20B Est,0,0.4849589
2012-04-27,11804600.0,26.25,26.625,25.854999542236328,26.07999992370605,22.43498611450196,GILD,Higher Costs Hurt Gilead - Analyst Blog,0,0.53266996
2012-05-01,12372600.0,25.975000381469727,25.989999771118164,25.645000457763672,25.71999931335449,22.12529945373535,GILD,Gilead Initiates Phase 3 Clinical Trial of GS-1101 for the Treatment of Chronic Lymphocytic Leukemia,1,0.53425723
2012-05-04,12764800.0,25.43000030517578,25.545000076293945,25.09499931335449,25.13500022888184,21.622058868408203,GILD,"After Hours Most Active for May 4, 2012 : QQQ, BAC, STD, STJ, NEM, GILD, GGC, TOT, SPPI, MSFT, FNFG, INTC",0,0.48414275
2012-05-09,17594000.0,25.0,25.395000457763672,24.64999961853028,25.31999969482422,21.78120231628418,GILD,FDA Staff Saying Research Shows Gilead's Quad to Be Non-Inferior to Comparator Groups with Respect to Efficacy -Reuters ||| UPDATE: Gilead's HIV Quad Drug Faces FDA Panel Review Friday,1,0.5376971
2012-05-11,19139800.0,26.1200008392334,26.1200008392334,25.59499931335449,25.920000076293945,22.297348022460938,GILD,UPDATE: FDA Advisory Committee Supports Approval of Gilead's Once-Daily Quad Single Tablet Regimen for HIV ||| FDA Advisory Panel Votes 13-1 to Recommend Gilead's Quad ||| From Earlier: FDA Advisory Committee Supports Approval of Gilead's Truvada® for Reducing the Risk of Acquiring HIV,1,0.54639894
2012-05-14,18509400.0,25.825000762939453,26.530000686645508,25.625,26.229999542236328,22.56401634216309,GILD,Good News for Gilead - Analyst Blog ||| HIV Drug Maker Gilead Sciences Scores Two Wins,0,0.5196955
2012-05-15,12099400.0,26.155000686645508,26.18000030517578,25.834999084472656,25.934999465942383,22.31024932861328,GILD,"The Zacks Analyst Blog Highlights: Gilead Sciences, Abbott Labs, Alliance Data Systems Corporation, Blue Nile and Bristol-Myers Squibb - Press Releases ||| Third Point Initiates Stake in Gilead Sciences, Hollyfrontier, Newell Rubbermaid, Potash ||| S&P Bullish On Biotech ETFs (FBT, IBB, XBI)",0,0.48218128
2012-05-16,13440000.0,25.924999237060547,26.05500030517578,25.78499984741211,25.790000915527344,22.185518264770508,GILD,"J.P. Morgan Reiterates Overweight Rating, $65 PT for Gilead Sciences",0,0.50808245
2012-05-21,11385800.0,25.01499938964844,25.459999084472656,25.0,25.44499969482422,21.888731002807617,GILD,"The Definitive Biotech ETF Guide (IBB, XBI, FBT)",0,0.509021
2012-05-24,5950000.0,25.065000534057617,25.354999542236328,25.01000022888184,25.309999465942383,21.772594451904297,GILD,FDA Nod for Merck Drug Label Update - Analyst Blog ||| Gilead Drug Up for European Review - Analyst Blog,0,0.53166175
2012-06-08,7522000.0,24.450000762939453,24.90999984741211,24.40999984741211,24.81999969482422,21.351083755493164,GILD,FDA Delays Decision on Gilead's Truvada to Prevent HIV -Bloomberg,0,0.5194242
2012-06-13,9520400.0,24.7450008392334,25.125,24.545000076293945,24.559999465942383,21.12742042541504,GILD,"Gilead Sciences Says Very Robust Pipeline in Phase 2, Phase 3 ||| Gilead Sciences Presentation Begins at William Blair Growth Stock Conference ||| PREVIEW: Gilead Sciences, Scotts Miracle-Gro to Present at William Blair Growth Stock Conference at 9:00am",1,0.4852287
2012-06-18,8566000.0,25.174999237060547,25.239999771118164,24.96500015258789,25.104999542236328,21.596254348754883,GILD,European Medicines Agency Validates Gilead's Marketing Application for Elvitegravir for Treatment of HIV Infection,1,0.53221035
2012-06-20,8195000.0,25.424999237060547,25.604999542236328,25.184999465942383,25.38999938964844,21.841421127319336,GILD,EMA Validates Gilead's Drug - Analyst Blog,0,0.532492
2012-06-27,6772800.0,25.18000030517578,25.670000076293945,25.18000030517578,25.625,22.043575286865234,GILD,Gilead Submits New Drug Application to U.S. FDA for HIV Integrase Inhibitor Elvitegravir for Treatment-Experienced Patients,0,0.52807266
2012-06-28,10368000.0,25.57999992370605,25.600000381469727,24.8700008392334,25.020000457763672,21.52313232421875,GILD,Gilead Seeks FDA Approval - Analyst Blog ||| Gilead Submits New Drug Application to U.S. FDA for Boosting Agent Cobicistat,1,0.5260485
2012-06-29,10835600.0,25.56999969482422,25.68000030517578,25.21500015258789,25.63999938964844,22.05648231506348,GILD,Heating Positive Chatter in Achillion Pharmaceuticals,1,0.53642946
2012-07-02,7177800.0,25.59499931335449,25.834999084472656,25.4950008392334,25.815000534057617,22.20702171325684,GILD,Gilead Seeks FDA OK for Cobicistat - Analyst Blog,1,0.54939514
2012-07-05,6372600.0,26.01499938964844,26.075000762939453,25.670000076293945,25.729999542236328,22.133899688720703,GILD,Small-Cap Corner: A Forgotten Biotech ETF,0,0.5039447
2012-07-11,18216400.0,25.200000762939453,25.424999237060547,25.02499961853028,25.334999084472656,21.79410743713379,GILD,Glaxo HIV Drug Beats Gilead's Atripla In Study -IBD,0,0.49737746
2012-07-16,7247600.0,25.59499931335449,25.96999931335449,25.44499969482422,25.96999931335449,22.34035301208496,GILD,UPDATE: U.S. Food and Drug Administration Approves Gilead's Truvada® for Reducing the Risk of Acquiring HIV ||| Gilead Wins FDA Approval for Truvada to Prevent HIV Risk,1,0.53610706
2012-07-23,8093000.0,26.19499969482422,26.19499969482422,25.834999084472656,25.94499969482422,22.31885528564453,GILD,FDA Nod for Gilead's Truvada - Analyst Blog ||| FDA Nod for Gilead's Truvada - Analyst Blog,0,0.5306431
2012-07-24,13031000.0,25.975000381469727,25.989999771118164,25.46999931335449,25.549999237060547,21.97905731201172,GILD,Earnings Preview: Celgene - Analyst Blog ||| Earnings Preview: Celgene - Analyst Blog ||| Gilead's Once-Daily Single Tablet Regimen Complera® Maintains HIV Suppression Among Patients Switching From Protease Inhibitor-Based Regimens ||| Gilead's Boosting Agent Cobicistat for HIV Therapy as Effective as Ritonavir in Pivotal Phase 3 Study,1,0.5206526
2012-07-26,10841200.0,25.96999931335449,26.07999992370605,25.520000457763672,25.84000015258789,22.22852897644043,GILD,Gilead Sciences Reports Q2 EPS $0.99 vs $0.95 Est; Revenues $2.41B vs $2.29B Est,1,0.5223533
2012-07-27,28110600.0,26.979999542236328,27.795000076293945,26.809999465942383,27.75,23.871580123901367,GILD,"Gilead Beats Zacks Estimates - Analyst Blog ||| UPDATE: Jefferies Raises PT on Gilead Science from $48 to $53 ||| Stifel Nicolaus Maintains Gilead Sciences at Buy, Raises PT from $55 to $60 ||| Jefferies & Company Maintains Gilead Sciences at Hold, Raises PT from $48 to $53",1,0.4899536
2012-07-30,14145800.0,27.75,28.020000457763672,27.71500015258789,27.80500030517578,23.918895721435547,GILD,Possible Hepatitis C Outbreak Could Lift This ETF,0,0.53583455
2012-08-02,58864400.0,28.950000762939453,29.420000076293945,28.01499938964844,28.645000457763672,24.641489028930664,GILD,"Pre-Market Most Active for Aug 2, 2012 : KCG, NOK, BAC, GILD, SIRI, CAJ, GMCR, FSLR, NAV, QQQ, IDIX, BMY ||| Top-Performing Funds Latch On To Biotech And Discount Retail Stocks ||| Barclays Upgrades Gilead Sciences from Equal-weight to Overweight ||| Mylan Signs Agreement with Gilead to Accelerate Access to Generic Single and Fixed-Dose Combination ARVs Containing Emtricitabine ||| Gilead Sciences Announces New Collaboration with Indian Partners to Reduce Manufacturing Cost and Improve Availability of Emtricitabine-Based Antiretroviral Therapy in Developing Countries ||| Deutsche Bank Maintains Gilead Sciences at Buy, Raises PT from $57 to $65",0,0.5058367
2012-08-09,7932200.0,28.290000915527344,28.63999938964844,28.2549991607666,28.450000762939453,24.47374725341797,GILD,Pharma & Biotech Stock Outlook - Aug. 2012 - Industry Outlook ||| Pharma & Biotech Stock Outlook - Aug. 2012 - Industry Outlook ||| Pharma & Biotech Stock Outlook - Aug. 2012 - Zacks Analyst Interviews,0,0.47237456
2012-08-13,6270600.0,28.209999084472656,28.334999084472656,28.155000686645508,28.315000534057617,24.357616424560547,GILD,Short Sellers Shy Away from Biotech Firms,1,0.49351072
2012-08-15,8732200.0,28.82999992370605,29.05500030517578,28.64999961853028,28.98500061035156,24.933971405029297,GILD,"Deutsche Bank Maintains Gilead Sciences at Buy, Raises PT from $65 to $68",0,0.48877975
2012-08-17,13487200.0,28.46500015258789,28.625,28.07999992370605,28.375,24.409229278564453,GILD,Idenix Shares Plunge After Hepatitis Drug Study Put on Hold,0,0.50415415
2012-08-24,12176600.0,28.13999938964844,28.799999237060547,28.06999969482422,28.645000457763672,24.641489028930664,GILD,Bristol-Myers' Trash is Gilead Sciences' Treasure,0,0.4976643
2012-08-27,6233600.0,28.684999465942383,28.739999771118164,28.170000076293945,28.59499931335449,24.598482131958008,GILD,Gilead Quad Pill Wins FDA Approval to Treat Patients with HIV -Bloomberg ||| Short Interest in Biotech Firms on the Rise,1,0.5412511
2012-08-28,10713400.0,28.78499984741211,29.125,28.76499938964844,28.815000534057617,24.787729263305664,GILD,"UPDATE: Stifel Nicolaus Raises PT to $68 on Gilead Sciences ||| Stifel Nicolaus Maintains Gilead Sciences at Buy, Raises PT from $65 to $68 ||| Jefferies & Company Maintains Gilead Sciences at Hold, Raises PT from $53 to $55",1,0.48662165
2012-08-29,8791400.0,28.825000762939453,29.0049991607666,28.68000030517578,28.8799991607666,24.843645095825195,GILD,Gilead's Stribild Gets FDA Nod - Analyst Blog,0,0.53111726
2012-08-30,7308600.0,28.834999084472656,28.95499992370605,28.614999771118164,28.7549991607666,24.73611831665039,GILD,"UBS Maintains Gilead Sciences at Buy, Raises PT from $61 to $65",1,0.492274
2012-09-05,16491600.0,28.940000534057617,29.549999237060547,28.850000381469727,29.21999931335449,25.136125564575195,GILD,"Three Biotech Stocks Analysts Are Keen On (MDVN, GEVA, OPTR)",1,0.50944436
2012-09-11,7886800.0,29.75,29.950000762939453,29.584999084472656,29.655000686645508,25.510330200195312,GILD,Cost Cutting at Actelion - Analyst Blog,1,0.53674316
2012-09-12,11742200.0,29.770000457763672,29.950000762939453,29.725000381469727,29.875,25.699583053588867,GILD,Gilead Receives Positive Mad Money/Jim Cramer Mention -CNBC ||| Gilead Reiterates Its FY12 Forecast for Net Product Sales $8.8-9B ||| Gilead Sciences Begins Presentation at Morgan Stanley Conference,1,0.5124437
2012-09-13,11020200.0,29.84499931335449,30.28499984741211,29.76000022888184,30.1200008392334,25.91033935546875,GILD,Short Sellers Shy Away from Biotech Firms,1,0.49351072
2012-09-14,29969600.0,30.084999084472656,31.32999992370605,30.0,31.01000022888184,26.675954818725582,GILD,Gilead Accelerates Expiration of Rights Pact,1,0.53421384
2012-09-17,42983200.0,30.959999084472656,33.1349983215332,30.95499992370605,32.900001525878906,28.30179977416992,GILD,"Top Narrow Based Indexes For September 17 ||| Stocks Hitting 52-Week Highs ||| JP Morgan Maintains Gilead Sciences at Overweight, Raises PT from $70 to $75",1,0.4903056
2012-09-19,25121800.0,33.599998474121094,33.64500045776367,33.32500076293945,33.60499954223633,28.908266067504883,GILD,"UPDATE: Deutsche Bank Reiterates Buy Rating, Raises PT on Gilead Sciences ||| Long set-ups for Wednesday ||| Deutsche Bank Maintains Gilead Sciences at Buy, Raises PT from $68 to $75",1,0.4888811
2012-09-24,10118600.0,33.349998474121094,33.744998931884766,33.290000915527344,33.58000183105469,28.88675880432129,GILD,"Weekly CFO Sells Highlight: ASGN, COF, AKRX, MCRS, GILD, ROP, PLL",1,0.5091858
2012-09-26,16877000.0,33.52000045776367,33.935001373291016,32.88999938964844,33.029998779296875,28.413631439208984,GILD,"Mixed Results from Vertex Studies - Analyst Blog ||| Short Interest in Biotech Firms Resumes (BIIB, GILD, ILMN, REGN)",1,0.52310157
2012-09-27,16017800.0,33.060001373291016,33.54499816894531,32.93000030517578,33.31999969482422,28.663095474243164,GILD,"Bank of America Maintains Gilead Sciences at Buy, Raises PO from $64 to $86",0,0.4927502
2012-10-01,15170200.0,33.744998931884766,34.13999938964844,33.43000030517578,33.720001220703125,29.007190704345703,GILD,Bernstein Upgraded Gilead Sciences from Market Perform to Outperform,1,0.54297936
2012-10-03,24339800.0,34.80500030517578,35.19499969482422,34.685001373291016,35.0,30.108295440673828,GILD,"Three Biotech Stocks Analysts Are Keen On (ARIA, MACK, GEVA) ||| Three Biotech Stocks Analysts Are Keen On (ARIA, MACK, GEVA) ||| UBS Maintains Gilead Sciences at Buy, Raises PT from $65 to $80",0,0.50159895
2012-10-08,9106000.0,34.849998474121094,35.154998779296875,34.79999923706055,34.904998779296875,30.026567459106445,GILD,"Piper Jaffray Maintains Gilead Sciences at Overweight, Raises PT from $69 to $85",0,0.49850917
2012-10-11,10018000.0,33.91999816894531,34.38999938964844,33.880001068115234,33.935001373291016,29.1921443939209,GILD,"After Hours Most Active for Oct 11, 2012 : QQQ, AMD, BAC, ETP, LOPE, CLWR, S, WCRX, SAN, GILD, PPL, MSFT",1,0.49036852
2012-10-15,27701200.0,34.16999816894531,34.595001220703125,33.189998626708984,33.65999984741211,28.95557403564453,GILD,"Arena Pharma Initiates PAH Study - Analyst Blog ||| Barclays Maintains Gilead Sciences at Overweight, Raises PT from $65 to $73 ||| Short Interest Swings in Biotech Stocks (BIIB, CELG, GILD)",1,0.49675244
2012-10-19,13346200.0,34.13999938964844,34.314998626708984,33.18000030517578,33.29499816894531,28.641586303710938,GILD,Actelion Beats; Maintains View - Analyst Blog,0,0.508392
2012-10-23,16187000.0,32.935001373291016,33.2400016784668,32.20000076293945,32.45500183105469,27.91899871826172,GILD,Gilead Sciences Reports Q3 EPS $1 vs $0.94 Est; Revenues $2.43B vs $2.34B Est,1,0.527537
2012-10-24,24662000.0,34.345001220703125,34.79999923706055,33.779998779296875,34.16999816894531,29.3942985534668,GILD,"Pre-Market Most Active for Oct 24, 2012 : FB, SIRI, EMC, BAC, QQQ, GILD, DOW, ZNGA, MM, BP, SEH, AMRN ||| S&P Likes a Trio of Biotech ETFs ||| S&P Likes a Trio of Biotech ETFs ||| UPDATE: Credit Suisse Reiterates Neutral Rating, Raises PT on Gilead Sciences ||| UPDATE: Jefferies & Company Reiterates Hold Rating, Raises PT on Gilead Sciences ||| BMO Capital Markets Maintains Gilead Sciences at Outperform, raises PT from $67 to $89 ||| Credit Suisse Maintains Gilead Sciences at Neutral, Raises PT from $54 to $65 ||| Jefferies & Company Maintains Gilead Sciences at Hold, Raises PT from $55 to $59",0,0.47535378
2012-10-25,11959600.0,34.25,34.6150016784668,33.665000915527344,33.689998626708984,28.98138236999512,GILD,"Short Interest Swings in Biotech Stocks (BIIB, GILD, VVUS)",0,0.52167726
2012-10-31,10130400.0,33.84000015258789,34.369998931884766,33.334999084472656,33.59000015258789,28.89536476135254,GILD,Actelion Files NDA for Macitentan - Analyst Blog ||| Gilead's Once-Daily Novel Prodrug for the Treatment of HIV Meets 24-Week Primary Objective in Phase 2 Study,1,0.5304195
2012-11-01,8702600.0,33.849998474121094,34.17499923706055,33.53499984741211,33.75,29.033002853393555,GILD,Edward Owens' Vanguard Health Care Fund Does More Shedding Than Adding in Third Quarter,0,0.519217
2012-11-08,18285600.0,32.59000015258789,32.7400016784668,32.06999969482422,32.42499923706055,27.893186569213867,GILD,"After Hours Most Active for Nov 8, 2012 : PDLI, QQQ, AVP, ETP, PFE, GRPN, MRK, BAC, SD, NVDA, GILD, MSFT",1,0.48614097
2012-11-12,61555000.0,36.15499877929688,37.16999816894531,35.790000915527344,36.96500015258789,31.79866981506348,GILD,"Pre-Market Most Active for Nov 12, 2012 : TIE, UN, BAC, GILD, MT, CLVS, FB, JEF, GRPN, DCM, NKTR, QQQ ||| Mid-Day Market Update: Markets Slow Their Rally; JC Penney Spikes Lower ||| Mid-Morning Market Update: Markets Continue Cautious Rally; Jefferies Acquired by Leucadia ||| After Hours Most Active for Nov 12, 2012 : MET, PGR, QQQ, PRU, GILD, EVER, CIM, MSFT, C, QCOM, NVDA, INTC ||| Mid-Afternoon Market Update: Markets Near Flat; J.C. Penney Falling Further ||| Gilead Sciences And Celgene Liven Up Biotech ETFs ||| Mid-Afternoon Market Update: Markets Near Flat; J.C. Penney Falling Further ||| Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX) ||| Mid-Day Market Update: Markets Slow Their Rally; JC Penney Spikes Lower ||| Stocks Hitting 52-Week Highs ||| Mid-Morning Market Update: Markets Continue Cautious Rally; Jefferies Acquired by Leucadia ||| Benzinga's Top Pre-Market Gainers ||| Gilead Sciences Rises 10% Pre-Market on Positive Hepatitis C Data ||| Gilead Announces Positive Hepatitis C Data",0,0.45727196
2012-11-13,37446600.0,37.1349983215332,37.7400016784668,36.275001525878906,36.345001220703125,31.265321731567383,GILD,"UPDATE: Deutsche Bank Raises PT to $95 on Gilead Sciences on Latest Data ||| UPDATE: Stifel Nicolaus Raises PT to $85 on Gilead Sciences on HCV Data ||| Stocks Hitting 52-Week Highs ||| Stifel Nicolaus Maintains Gilead Sciences at Buy, Raises PT from $80 to $85 ||| Deutsche Bank Maintains Gilead Sciences at Buy, Raises PT from $75 to $95",0,0.50360024
2012-11-14,23384000.0,36.28499984741211,36.959999084472656,36.0,36.14500045776367,31.093265533447266,GILD,Abbott's Phase III Plans for HCV - Analyst Blog ||| UPDATE: BMO Capital Markets Reiterates Gilead Sciences at Outperform on Positive ELECTRON Data Results,1,0.5242558
2012-11-15,16891800.0,36.025001525878906,36.53499984741211,35.55500030517578,36.44499969482422,31.351337432861328,GILD,Gilead Announces Results from Two Phase 3 Stribild HIV Studies,1,0.54493517
2012-11-16,26510400.0,36.51499938964844,37.459999084472656,36.40999984741211,37.20000076293945,32.00082015991211,GILD,Biotech ETFs: A Fiscal Cliff Safe Haven? - ETF News And Commentary ||| Gilead Presents Encouraging Data - Analyst Blog,1,0.5318929
2012-11-19,18330000.0,37.36000061035156,37.619998931884766,36.880001068115234,37.40999984741211,32.18146514892578,GILD,"Weekly Top Insider Sells? AAPL, GILD, BMRN, and PCLN",1,0.51675385
2012-11-26,10464400.0,37.81999969482422,37.92499923706055,37.34000015258789,37.73500061035156,32.46104049682617,GILD,Actelion Drug to be Reviewed in EU - Analyst Blog,0,0.5328162
2012-11-27,11027400.0,37.30500030517578,37.915000915527344,37.05500030517578,37.32500076293945,32.10834884643555,GILD,"EC Approves Gilead's Viread for HIV-1 Infection in Children, Adolescents ||| Gilead Shares Continuing Higher After Teva Says Won't Offer Gilead Generics Til June 1st or Court Ruling ||| Gilead Announces Sustained Virologic Response Rate of 78% from Phase 3 Study of Sofosbuvir",1,0.5432099
2012-11-29,7691600.0,37.625,37.8849983215332,37.275001525878906,37.650001525878906,32.38792419433594,GILD,Gilead Reports Positive HCV Data - Analyst Blog,0,0.5278632
2012-11-30,8630200.0,37.68999862670898,37.78499984741211,37.30500030517578,37.5,32.258888244628906,GILD,Top ETF Winners And Losers In November,0,0.5176867
2012-12-03,9308600.0,37.48500061035156,37.86000061035156,37.22499847412109,37.30500030517578,32.091148376464844,GILD,"RIM, Green Mountain and Other Top Performing Nasdaq Stocks in November ||| BioMarin, Prestige Brands and Other Top Performing Health Care Stocks in November ||| PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for December 05, 2012 ||| Encouraging News for Gilead - Analyst Blog",0,0.4654922
2012-12-04,10630800.0,37.630001068115234,37.92499923706055,37.05500030517578,37.08000183105469,31.897594451904297,GILD,"Enzon Pharmaceuticals, Inc. (ENZN) Ex-Dividend Date Scheduled for December 06, 2012 ||| Barclays Maintains Overweight on Gilead Sciences, Inc., Raises PT to $76.00",1,0.47246155
2012-12-06,12606000.0,37.415000915527344,37.45000076293945,36.834999084472656,36.90499877929688,31.74706077575684,GILD,Pharma & Biotech Stock Outlook - Dec 2012 - Industry Outlook ||| Pharma & Biotech Stock Outlook - Dec 2012 - Zacks Analyst Interviews,1,0.4884324
2012-12-10,8242000.0,37.125,37.35499954223633,36.9900016784668,37.125,31.936309814453125,GILD,"A Look at Fortune's Health Care Picks for 2013 (ALGN, FMS, GILD) ||| Gilead Board Approves Two-for-One Stock Split",1,0.5107078
2012-12-11,18427200.0,37.36000061035156,38.380001068115234,37.26499938964844,38.16999816894531,32.835243225097656,GILD,Gilead Plans to Split Stock 2-for-1 - Analyst Blog,0,0.52834904
2012-12-12,11670200.0,38.185001373291016,38.560001373291016,38.03499984741211,38.1150016784668,32.78793716430664,GILD,"Benzinga's M&A Chatter for Wednesday December 12, 2012 ||| J.P. Morgan Reiterates Overweight Rating on Gilead Sciences ||| These ETFs Are Awash in 2013 Takeover Targets ||| Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS) ||| Morning Market Movers ||| UPDATE: Gilead to Buy YM BioSciences for $2.95/Share in Cash ||| Gilead Sciences to Buy YM Biosciences for $2.95/Share in Cash",0,0.49917135
2012-12-13,11188000.0,37.9900016784668,38.21500015258789,37.2400016784668,37.3849983215332,32.15995407104492,GILD,"Gilead to Buy YM BioSciences - Analyst Blog ||| Goldman Sachs Reinstates Neutral on Gilead Sciences, Inc., Announces $81.00 PT",0,0.5008072
2012-12-14,9999400.0,37.34999847412109,37.34999847412109,36.72999954223633,37.119998931884766,31.932003021240234,GILD,"Piper Jaffray Maintains Overweight on Gilead Sciences, Inc., Raises PT to $88.00",1,0.4982625
2012-12-17,10991000.0,37.244998931884766,37.73500061035156,36.744998931884766,37.72999954223633,32.45674514770508,GILD,UPDATE: Bloom Burton Downgrades YM BioSciences to Hold Post Gilead Acquisition,1,0.52792513
2012-12-18,8140600.0,37.8849983215332,38.310001373291016,37.58000183105469,37.92499923706055,32.62449264526367,GILD,"Actelion Drug Accepted for Review - Analyst Blog ||| UBS Maintains Buy on Gilead Sciences, Inc., Raises PT to $87.00",0,0.5005503
2012-12-24,2914400.0,36.27000045776367,36.4900016784668,36.220001220703125,36.33000183105469,31.252416610717773,GILD,Roche's Tamiflu Label Expanded - Analyst Blog,0,0.53467
2012-12-28,6763800.0,36.03499984741211,36.48500061035156,35.88999938964844,36.18999862670898,31.13198471069336,GILD,"Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)",1,0.525526
2013-01-03,5965400.0,37.55500030517578,37.92499923706055,37.369998931884766,37.47499847412109,32.23738479614258,GILD,"Baird Initiates Coverage on Gilead Sciences, Inc. at Outperform, Announces $86.00 PT",1,0.5260653
2013-01-07,7948400.0,38.44499969482422,38.540000915527344,38.09999847412109,38.43999862670898,33.0675163269043,GILD,4 Health Care ETFs Your Broker Forgot to Mention ||| Gilead Offers Update on Hep C Development Plans ||| MacroGenics Enters License Agreement with Gilead Sciences to Develop and Commercialize Four DART Products,1,0.51578784
2013-01-08,13371400.0,38.40999984741211,39.20500183105469,38.40499877929688,38.70000076293945,33.291168212890625,GILD,"This Stock Could be Perfect for the ""Dividend Decade""",1,0.51893574
2013-01-14,9162200.0,39.220001220703125,39.25,38.744998931884766,38.8849983215332,33.450313568115234,GILD,The Smart Money Loves These 10 Stocks ||| Update on HCV Pipeline from Gilead - Analyst Blog,0,0.49922398
2013-01-15,9326800.0,38.70500183105469,39.17499923706055,38.540000915527344,38.68000030517578,33.27397155761719,GILD,One Biotech Stock Investors are Unfairly Ignoring ||| One Biotech Stock Investors are Unfairly Ignoring,0,0.49444056
2013-01-22,8020800.0,39.290000915527344,39.34000015258789,38.744998931884766,38.95500183105469,33.51054000854492,GILD,"Morgan Stanley Sees Possible Near-Term Increase in M&A, Unveils 'Acquisition Likelihood Estimate Ranking Tool'",0,0.51149243
2013-01-24,11185800.0,38.650001525878906,39.375,38.54499816894531,39.20000076293945,33.72129440307617,GILD,Friday January 25th Watchlist,1,0.508236
2013-01-25,18244800.0,39.20000076293945,39.685001373291016,39.185001373291016,39.68000030517578,34.13420867919922,GILD,Safest Way to Play Biotech - Cook`s Kitchen ||| Gilead's HIV Candidate Advances - Analyst Blog,0,0.50958186
2013-01-28,5978900.0,40.060001373291016,40.18999862670898,39.209999084472656,39.43999862670898,33.92774963378906,GILD,"Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)",1,0.5295738
2013-01-29,8439600.0,39.34000015258789,40.02000045776367,39.290000915527344,39.900001525878906,34.323455810546875,GILD,MedTech Industry Stock Outlook - Jan 2013 - Industry Outlook ||| MedTech Industry Stock Outlook - Jan 2013 - Zacks Analyst Interviews,0,0.48986155
2013-01-30,7279700.0,39.970001220703125,40.38999938964844,39.650001525878906,39.84999847412109,34.28044509887695,GILD,"UPDATE: Deutsche Bank Reiterates Buy Rating, Lowers PT on Gilead Sciences ||| UBS Maintains Buy on Gilead Sciences, Inc., Raises PT to $47.00 ||| Deutsche Bank Maintains Buy on Gilead Sciences, Inc., Lowers PT to $48.00",0,0.46394092
2013-02-04,12765200.0,40.709999084472656,40.900001525878906,39.5099983215332,39.59000015258789,34.056793212890625,GILD,"After-Hours Earnings Report for February 4, 2013 : GILD, APC, YUM, BIDU, GGP, BAP, LIFE, HIG, EW, AXS, LEG, SWI ||| Gilead Sciences, Inc. Reports Q4 EPS of $0.50 vs $0.48 Est; Revenue of $2.59B vs $2.43B Est ||| Morgan Stanley Reiterates Overweight Rating on Gilead Sciences on Phase III Data ||| Piper Jaffray Reiterates Overweight Rating, $44 PT on Gilead Sciences ||| Gilead Announces Sustained Virologic Response Rates from Two Phase 3 Studies of Sofosbuvir ||| US Stock Futures Flat Ahead Of Factory-Orders Data ||| Earnings Scheduled For February 4, 2013",1,0.47999048
2013-02-05,11527200.0,40.150001525878906,41.34000015258789,40.150001525878906,40.540000915527344,34.87401580810547,GILD,"Gilead Beats Estimates in 4Q - Analyst Blog ||| UBS Maintains Buy on Gilead Sciences, Inc., Raises PT to $48.00 ||| Atlantic Equities Downgraded Gilead Sciences, Inc. to Neutral, Raised PT to $41.00 ||| YM Biosciences Wins Final Court Order Approving Plan of Arrangement with Gilead ||| Stocks Hitting 52-Week Highs ||| Jefferies Maintains Hold on Gilead Sciences, Inc., Raises PT to $40.00 ||| Stifel Nicolaus Maintains Buy on Gilead Sciences, Inc., Raises PT to $49.00 ||| UPDATE: Gilead Posts Upbeat Q4 Results",0,0.48340413
2013-02-07,11699400.0,39.77999877929688,40.459999084472656,39.47999954223633,40.36000061035156,34.71916580200195,GILD,"Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 11, 2013",1,0.44740185
2013-02-11,11061800.0,40.900001525878906,41.0099983215332,40.15999984741211,40.400001525878906,34.75357437133789,GILD,"Techne Corporation (TECH) Ex-Dividend Date Scheduled for February 13, 2013 ||| Gilead Closes YM Biosciences Buyout - Analyst Blog ||| After Hours Most Active for Feb 11, 2013 : BAC, FB, GILD, UAL, TTWO, FE, WFR, AMGN, TLM, ATVI, KORS, SQNM",1,0.478841
2013-02-12,9791000.0,40.459999084472656,40.95000076293945,40.29999923706055,40.83000183105469,35.123477935791016,GILD,"Bayer Seeks Riociguat Approval - Analyst Blog ||| Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)",1,0.5181837
2013-02-19,11548300.0,42.25,43.040000915527344,42.060001373291016,42.27999877929688,36.37081527709961,GILD,"Gilead's Sofosbuvir Meets Primary Endpoint in Fourth Pivotal Phase 3 Study ||| Credit Suisse Upgrades Gilead Sciences, Inc. to Outperform, Raises PT to $55.00",0,0.4976907
2013-02-20,9391800.0,42.5099983215332,42.84000015258789,41.880001068115234,41.880001068115234,36.0267333984375,GILD,March Action Date for UTHR Candidate - Analyst Blog,0,0.51764846
2013-02-21,9769500.0,41.81999969482422,41.84999847412109,41.18000030517578,41.540000915527344,35.7342529296875,GILD,Gilead and Teva Bury the Hatchet - Analyst Blog,1,0.5224683
2013-02-25,9560900.0,42.77000045776367,43.34999847412109,42.060001373291016,42.09000015258789,36.2073860168457,GILD,Gilead Shares Moving Higher as BofA Merrill Added to 'US 1 List',1,0.53224033
2013-02-27,7986000.0,42.38999938964844,43.290000915527344,42.08000183105469,42.88999938964844,36.89557266235352,GILD,"PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for March 01, 2013",0,0.45668986
2013-02-28,10104200.0,43.02999877929688,43.18000030517578,42.709999084472656,42.720001220703125,36.74932861328125,GILD,"Short Interest Swings in Biotech Stocks (ALXN, AMGN, CELG)",1,0.5240682
2013-03-04,8814000.0,43.52999877929688,43.880001068115234,43.18000030517578,43.869998931884766,37.73859786987305,GILD,HIV Infected Baby 'Cured' with Aggressive Drug Treatment -NYT ||| An HIV Cure Is Great News For These Drug Manufacturers,1,0.5213316
2013-03-05,15086800.0,44.34999847412109,45.58000183105469,44.34999847412109,45.02000045776367,38.72787094116211,GILD,"UPDATE: Piper Jaffray Raises PT to $50 on Gilead Sciences on Positive Data ||| Gilead Reports Full 24-Week Phase 2 Results for Once-Daily Single Tablet HIV Regimen Containing Novel TAF ||| Piper Jaffray Maintains Overweight on Gilead Sciences, Inc., Raises PT to $50.00 ||| AHF Seeking FDA Reversal on Gilead's HIV Prevention Pill for Women",1,0.5167242
2013-03-07,9176500.0,45.09999847412109,45.20000076293945,44.5099983215332,44.95000076293945,38.66765594482422,GILD,Good News for Gilead's HIV Pipeline - Analyst Blog,1,0.5425342
2013-03-08,6885100.0,45.2400016784668,45.54999923706055,44.5099983215332,45.43000030517578,39.08057403564453,GILD,"If Stocks Keep Soaring, Get to Know These Leveraged ETFs",1,0.5069201
2013-03-11,7298000.0,45.4900016784668,45.95000076293945,45.18000030517578,45.93999862670898,39.519290924072266,GILD,"Study Shows Gilead's Ranexa Reduces Angina Frequency in Chronic Angina Patients With Type 2 Diabetes ||| Gilead Puts Biotech ETFs in Focus - ETF News And Commentary ||| Deutsche Bank Reiterates Buy Rating, $48 PT on Gilead Sciences on IMS Weekly Script Analysis ||| A Look Ahead: This Week's ETFs to Watch",1,0.50906014
2013-03-12,9915900.0,45.970001220703125,46.369998931884766,45.52999877929688,46.18000030517578,39.72574234008789,GILD,"Encouraging Data Presented by Gilead - Analyst Blog ||| Short Interest Swings in Biotech Stocks (AMGN, CELG, PCYC)",0,0.5014748
2013-03-13,6112100.0,46.150001525878906,46.150001525878906,45.61000061035156,45.869998931884766,39.45907211303711,GILD,Gilead Hits 52-Week High - Analyst Blog,1,0.5369678
2013-03-14,8979700.0,45.900001525878906,46.13999938964844,45.68000030517578,45.880001068115234,39.46767044067383,GILD,"Pre-Market Most Active for Mar 14, 2013 : BBRY, VOD, SLCA, BAC, ETFC, GILD, NOK, QQQ, TSM, SD, ERIC, MT ||| UPDATE: Oppenheimer Raises Gilead PT on Promising Oncology Pipeline ||| Oppenheimer Maintains Outperform on Gilead Sciences, Inc., Raises PT to $50.00",0,0.5086053
2013-03-15,14207400.0,45.810001373291016,46.0,44.959999084472656,45.16999816894531,38.85690307617188,GILD,Exploring No Man's Land ETFs ||| Report of 14 Adults 'Cured' of HIV -NewScientist,0,0.50648326
2013-03-18,9084200.0,44.7400016784668,45.0099983215332,44.09999847412109,44.79999923706055,38.53861618041992,GILD,"Three Top Performing BRIC Stocks (CBPO, GSH, VIPS) ||| Citigroup Maintains Buy on Gilead Sciences, Inc., Raises PT to $60.00",0,0.5285786
2013-03-22,8290600.0,45.130001068115234,45.560001373291016,44.84000015258789,45.5099983215332,39.14939498901367,GILD,"Gilead Confirms Positive CHMP Opinion for Stribild ||| EMA Gives Positive Opinion's on Baxter's Hyqvia, ARIAD Pharma's Iclusig, Gilead's Stribild",0,0.49589598
2013-03-25,12174000.0,46.0099983215332,46.130001068115234,44.7599983215332,44.97999954223633,38.69346237182617,GILD,"Mid-Morning Market Update: Markets Rise On Cyprus Deal, Dollar General Posts Higher Profit ||| Gilead's Stribild Backed by CHMP - Analyst Blog ||| Mid-Afternoon Market Update: VrinetX Falls as Veeco Continues to Boost ||| Mid-Day Market Update: Markets Turn Red, Apollo Group Surges On Upbeat Results ||| Moving Averages Indicate These Sector ETFs Could be Stretched ||| Mid-Afternoon Market Update: VrinetX Falls as Veeco Continues to Boost ||| Mid-Day Market Update: Markets Turn Red, Apollo Group Surges On Upbeat Results ||| Mid-Morning Market Update: Markets Rise On Cyprus Deal, Dollar General Posts Higher Profit ||| Morning Market Losers ||| Benzinga's Top Pre-Market Losers",1,0.5114924
2013-03-26,7122900.0,45.150001525878906,45.88999938964844,45.11000061035156,45.7599983215332,39.36445617675781,GILD,"After Hours Most Active for Mar 26, 2013 : TWX, HAL, RF, WFC, HPQ, NEM, MDLZ, QCOM, INTC, ORCL, QQQ, GILD ||| Gilead Announces Update on Phase 3 Study of Oral Fixed-Dose Combination of Sofosbuvir and Ledipasvir for Genotype 1 Hepatitis C Patients",1,0.5084144
2013-03-27,18418400.0,46.20000076293945,47.83000183105469,45.91999816894531,47.720001220703125,41.050514221191406,GILD,"Market Close Report: NASDAQ Composite index closes at 3,256.52 up 4.04 points ||| Benzinga's Top Pre-Market Gainers",1,0.51192874
2013-03-28,18502100.0,47.86000061035156,49.47999954223633,47.84999847412109,48.93999862670898,42.09999465942383,GILD,"Balanced View on Gilead Sciences - Analyst Blog ||| Biotech Breakout Boosting ETFs ||| Stocks Hitting 52-Week Highs ||| Short Sellers Dump Amgen, Focus on Celgene, Gilead Sciences",0,0.48360112
2013-04-01,14403100.0,49.0099983215332,49.16999816894531,47.90999984741211,47.97999954223633,41.27416610717773,GILD,"WEEKLY CFO SELLS HIGHLIGHT: ANIK, GILD, PETM, NKE, ADBE ||| Gilead's HCV Study to Continue - Analyst Blog ||| After Hours Most Active for Apr 1, 2013 : BAC, FCX, QQQ, CPNO, PNG, INTC, VCSH, HUM, GILD, MS, VCIT, AER",1,0.49192506
2013-04-04,10050300.0,47.90999984741211,48.34999847412109,47.560001373291016,47.7400016784668,41.067718505859375,GILD,"Pharma & Biotech Stock Outlook - Apr 2013 - Zacks Analyst Interviews ||| Pharma & Biotech Stock Outlook - Apr 2013 - Industry Outlook ||| Benzinga's M&A Chatter for Thursday April 4, 2013 ||| Credit Suisse Maintains Outperform on Gilead Sciences, Inc., Raises PT to $60.00 ||| Hearing Chatter Dan Loeb Has Taken Significant Stake in Gilead",0,0.50578946
2013-04-05,10958000.0,46.900001525878906,47.45000076293945,46.52999877929688,47.369998931884766,40.74942779541016,GILD,Generics: The Way Forward in India? - Analyst Blog ||| Some Companies Aren't Evil... And Some Even Save Lives,0,0.50958997
2013-04-08,9538000.0,47.25,47.61000061035156,46.84999847412109,47.20000076293945,40.60318756103516,GILD,These Are the 100 Highest-Paid CEOs in Business Today ||| Gilead Submits NDA to FDA for Sofosbuvir for Hep C,1,0.5208156
2013-04-09,13126300.0,48.09000015258789,48.810001373291016,47.9900016784668,48.29999923706055,41.549442291259766,GILD,Gilead Seeks FDA Approval - Analyst Blog ||| Priority Review for Bayer's Riociguat - Analyst Blog ||| Gilead Hep C Drug Likely to be Launched in Q1 2014,1,0.53347975
2013-04-10,10084900.0,48.52000045776367,49.84999847412109,48.5,49.72999954223633,42.77959060668945,GILD,"Pre-Market Most Active for Apr 10, 2013 : RSO, BAC, HMA, FSLR, GILD, ERIC, NOK, FB, BHP, NJ, SIRI, BBRY ||| Data on ArQule's ARQ 092 - Analyst Blog ||| Short Sellers Move Out of Amgen, Celgene, Pharmacyclics",1,0.50229895
2013-04-11,15567100.0,50.20000076293945,51.970001220703125,50.18000030517578,51.650001525878906,44.431243896484375,GILD,ETF Showdown: A Pharma Fight ||| Under The Hood: An Unheralded Biotech ETF,1,0.5007295
2013-04-12,10697000.0,51.65999984741211,52.43000030517578,51.38999938964844,51.93000030517578,44.67211532592773,GILD,"UBS Maintains Buy on Gilead Sciences, Inc., Raises PT to $59.00",0,0.48250064
2013-04-15,13210200.0,52.25,52.36000061035156,50.619998931884766,50.68000030517578,43.59681701660156,GILD,"A Look Ahead: This Week's ETFs to Watch ||| Will JNJ Miss on Earnings? - Analyst Blog ||| Leerink Swann Maintains Outperform on Gilead Sciences, Inc., Raises PT to $70.00",1,0.48908478
2013-04-16,13561900.0,51.27000045776367,52.04999923706055,51.060001373291016,52.0099983215332,44.74092483520508,GILD,"UPDATE: Deutsche Bank Raises PT on Gilead Sciences on Monthly HCV Market Model ||| Deutsche Bank Maintains Buy on Gilead Sciences, Inc., Raises PT to $69.00",0,0.48813814
2013-04-18,9391500.0,51.880001068115234,52.060001373291016,50.52999877929688,50.86000061035156,43.75165939331055,GILD,FDA Panel Backs GSK/THRX's Drug - Analyst Blog,1,0.53478503
2013-04-19,20436500.0,50.65999984741211,53.97999954223633,50.65999984741211,53.16999816894531,45.73880386352539,GILD,"Vertex News Lifts Biotech ETFs ||| Waters 1Q Earnings Expected to Miss - Analyst Blog ||| BMY, Santaris Pharma Team Up - Analyst Blog ||| Weekly Preview: Earnings Season Continues, Apple In Focus ||| Vertex News Lifts Biotech ETFs",1,0.5133318
2013-04-22,15188600.0,54.119998931884766,54.2400016784668,53.290000915527344,54.04999923706055,46.49581909179688,GILD,"A Look Ahead: This Week's ETFs to Watch ||| Forest Labs Likely to Miss 4Q Earnings - Analyst Blog ||| Biogen: Will it Miss Earnings Again? - Analyst Blog ||| Will Amgen Beat Earnings? - Analyst Blog ||| Bristol-Myers Likely to Report In Line Earnings - Analyst Blog ||| Gilead Sciences Target Boosted Sharply from $48 to $97 at Maxim ||| Biotech Mutual Funds Show ETFs Are The Place to Be ||| UPDATE: Morgan Stanley Raises PT on Gilead Sciences on Multiple Positive Factors ||| Morgan Stanley Maintains Overweight on Gilead Sciences, Inc., Raises PT to $65.00",0,0.4989448
2013-04-23,13828200.0,54.400001525878906,55.15999984741211,52.58000183105469,53.33000183105469,45.87644958496094,GILD,"Will Eli Lilly Beat Earnings in 1Q? - Analyst Blog ||| Piper Jaffray Maintains Overweight on Gilead Sciences, Inc., Raises PT to $63.00 ||| Gilead, Bristol Hepatitis-C Drug Combination Suppresses Virus in Study, Helps Those Who Fail Other Drugs ||| Gildead Presents Data from Phase 3 Studies of Sofosbuvir for Hepatitis C",0,0.50988734
2013-04-25,10862700.0,51.29999923706055,51.84000015258789,50.90999984741211,51.43000030517578,44.24198532104492,GILD,"Is the Biotech Sector Still a Market Leader? - Real Time Insight ||| Gilead Hep-C Combo Cures 100% of Patients in Study, Results Presented in Amsterdam",0,0.49412894
2013-04-26,9678600.0,51.4900016784668,52.25,51.290000915527344,51.380001068115234,44.19898223876953,GILD,"After Hours Most Active for Apr 26, 2013 : STX, CMCSA, BAC, NTAP, VZ, QQQ, GILD, INTC, APC, GE, AXP, PFE ||| Buzz on the Street: Apple Earnings, a Hijacked AP, and the Telltale VIX Make for One Wacky Week ||| Weekly Preview: Focus Shifts from Earnings to Economy ||| Short Sellers Move into Celgene, Regeneron",0,0.4729816
2013-04-29,10806000.0,51.36000061035156,51.630001068115234,50.77000045776367,51.09000015258789,43.94950485229492,GILD,"A Look Ahead: This Week's ETFs to Watch ||| Earnings Expectations for the Week of April 29 ||| A Look Ahead: This Week's ETFs to Watch ||| Gilead Receives CRL from FDA for Elvitegravir, Cobicistat",0,0.50794953
2013-04-30,13550600.0,50.75,50.88999938964844,49.43000030517578,50.63999938964844,43.56240463256836,GILD,Double Setback for Gilead - Analyst Blog,0,0.51892525
2013-05-01,9679100.0,50.45000076293945,50.650001525878906,49.86000061035156,50.13999938964844,43.13228225708008,GILD,Illumina and Other Bargain Biotech Stocks Worth a Look Now,1,0.5003088
2013-05-02,16602700.0,52.75,53.209999084472656,51.95000076293945,52.18000030517578,44.88717269897461,GILD,"After-Hours Earnings Report for May 2, 2013 : GILD, AIG, CNQ, LNKD, MYL, WFT, FLR, XL, TDC, MHK, MCHP, CPT ||| The Markets Now: Stocks Climb Higher After ECB Rate Cut, Jobless Claims Report ||| Gilead Sciences, Inc. Reports Q1 EPS of $0.48 vs $0.50 Est; Revenue of $2.53B vs $2.58B Est ||| Benzinga Market Primer: Thursday, May 2",1,0.49607992
2013-05-03,17089300.0,54.54999923706055,56.34999847412109,54.52000045776367,55.150001525878906,47.44207763671875,GILD,"The Markets Now: Dow, S&P Hit New Highs on Employment Report ||| Gilead Misses on Earnings, Sales in 1Q - Analyst Blog ||| Market Wrap for Friday, May 3: Stocks Jump on Strong Jobs Data ||| Three Sector ETFs Up 20% or More YTD",0,0.5137141
2013-05-07,14096100.0,54.369998931884766,54.59999847412109,52.81999969482422,53.130001068115234,45.70439910888672,GILD,"Techne Corporation (TECH) Ex-Dividend Date Scheduled for May 08, 2013",0,0.46711564
2013-05-08,12612500.0,53.130001068115234,53.40999984741211,51.9900016784668,52.380001068115234,45.059226989746094,GILD,"In Danish Laboratories, Hope Looms Large for a Permanent HIV Cure",1,0.5592153
2013-05-10,12752600.0,52.77000045776367,53.150001525878906,52.18999862670898,52.880001068115234,45.48934555053711,GILD,S&P Highlights Biotech ETFs,1,0.52303374
2013-05-13,14485400.0,53.119998931884766,55.09000015258789,52.93000030517578,54.470001220703125,46.857120513916016,GILD,"Short Interest in Vertex Rises, in Celgene Falls ||| Stock Market News for May 13, 2013 - Market News ||| Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 14, 2013",1,0.45212054
2013-05-15,16779100.0,56.34000015258789,57.09999847412109,55.09000015258789,56.36000061035156,48.48296737670898,GILD,Gilead Offers Response Data from Phase 2 Study of Idelalisib,0,0.5279429
2013-05-16,15554100.0,56.59999847412109,56.63999938964844,54.20000076293945,54.959999084472656,47.27863311767578,GILD,Pipeline Progress at Gilead - Analyst Blog,1,0.52880216
2013-05-21,10085900.0,56.13999938964844,56.84999847412109,55.7599983215332,56.470001220703125,48.57759094238281,GILD,Gilead Receives MAA for Hep C Treatment,0,0.5293924
2013-05-22,12765800.0,57.0,58.060001373291016,55.619998931884766,55.93000030517578,48.11306381225586,GILD,"Pre-Market Most Active for May 22, 2013 : NTAP, PFE, NMR, RDS/A, RDS/B, NOK, SNE, PGTI, IRWD, GILD, VOD, ZNGA ||| Gilead's Sofosbuvir under European Review - Analyst Blog",0,0.4850449
2013-05-28,8669400.0,56.68000030517578,56.81999969482422,55.61000061035156,56.18000030517578,48.328125,GILD,"European Commission Approves Stribild®, a New Single Tablet Regimen for the Treatment of HIV-1 Infection",0,0.5212961
2013-05-29,9677700.0,55.93999862670898,56.18999862670898,54.84999847412109,55.630001068115234,47.85498428344727,GILD,"Short Interest in Vertex Rises, in Biogen Idec Falls",1,0.54719746
2013-05-31,11526200.0,56.209999084472656,56.209999084472656,54.47999954223633,54.47999954223633,46.86572647094727,GILD,"PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for June 03, 2013",0,0.44915646
2013-06-03,15319800.0,54.560001373291016,54.63999938964844,51.34999847412109,53.119998931884766,45.69579315185547,GILD,"Stock Market News for June 3, 2013 - Market News",0,0.50696284
2013-06-04,11367200.0,53.130001068115234,53.68999862670898,51.91999816894531,52.31999969482422,45.00760269165039,GILD,"Enzon Pharmaceuticals, Inc. (ENZN) Ex-Dividend Date Scheduled for June 05, 2013",0,0.4531163
2013-06-07,12883500.0,51.880001068115234,53.40999984741211,51.810001373291016,52.88999938964844,45.49794006347656,GILD,"Gilead Gets FDA Priority Review for Sofosbuvir for Hep C, Says PDUFA Date Dec. 8th",0,0.5073334
2013-06-10,8744200.0,53.54999923706055,53.560001373291016,52.11000061035156,52.43999862670898,45.11082077026367,GILD,Priority Review for Gilead Drug - Analyst Blog ||| Benzinga's Top Pre-Market Gainers,0,0.5160096
2013-06-11,7277900.0,51.900001525878906,52.97999954223633,51.38999938964844,52.43999862670898,45.11082077026367,GILD,3 Impressive Biotech ETFs Crushing the Market - ETF News And Commentary,0,0.54404414
2013-06-12,9707600.0,52.83000183105469,53.060001373291016,51.13999938964844,51.16999816894531,44.018333435058594,GILD,"Gilead Shares Unaffected Following Headlines Viread Study Shows Reduced HIV Risk Among 49% of Patients ||| Short Interest Falls in Vertex, Rises in Biogen Idec (VRTX, BIIB)",1,0.5196617
2013-06-13,9292700.0,51.25,52.09999847412109,50.68000030517578,51.95000076293945,44.68931579589844,GILD,"Argus Research Upgrades Gilead Sciences, Inc. to Buy, Announces $62.00 PT",1,0.52394474
2013-06-17,10079200.0,52.77000045776367,53.2599983215332,50.81999969482422,51.02999877929688,43.897891998291016,GILD,Oppenheimer Reiterates Outperform Rating on Gilead Sciences Following Initial Idelalisib Ph.II Results ||| Gilead Interim Phase 2 Data for Idelalisib Shows Response in Refractory Indolent Non-Hodgkin's Lymphoma,1,0.5331439
2013-06-19,6406800.0,51.81999969482422,52.04999923706055,50.56999969482422,50.59999847412109,43.52799224853516,GILD,Gilead Presents Idelalisib Data - Analyst Blog,0,0.52624804
2013-06-25,12879000.0,49.40999984741211,50.880001068115234,49.310001373291016,49.77999877929688,42.82260513305664,GILD,Gilead Retained at Neutral - Analyst Blog,1,0.53127944
2013-06-26,9904400.0,50.41999816894531,51.630001068115234,50.29999923706055,51.310001373291016,44.13875961303711,GILD,"Short Interest in Biogen Idec and Vertex Shrinks (BIIB, CELG, VRTX)",0,0.54089373
2013-07-01,9472900.0,51.970001220703125,52.79999923706055,51.52999877929688,51.650001525878906,44.431243896484375,GILD,ETFs For an Onyx Takeover Battle,1,0.54035044
2013-07-08,10022700.0,53.59999847412109,53.959999084472656,53.209999084472656,53.31999969482422,45.86783981323242,GILD,"After Hours Most Active for Jul 8, 2013 : S, NLSN, INTC, FB, ORCL, NOK, AA, CSCO, MSFT, GILD, IGT, JNPR",1,0.4794213
2013-07-11,11373200.0,56.02999877929688,56.25,55.38999938964844,55.84999847412109,48.04423904418945,GILD,"Biogen Idec Inc. (BIIB): Today's Most Compelling Stock Buy ||| Short Interest Rises in Gilead Sciences, Onyx Pharmaceuticals (BIIB, GILD, ONXX)",1,0.49426067
2013-07-15,7637500.0,57.20000076293945,57.720001220703125,56.81999969482422,57.65999984741211,49.60126876831055,GILD,Health Care ETFs Looking Healthy Ahead of Earnings,0,0.48855057
2013-07-16,8831400.0,57.54999923706055,57.77000045776367,56.77999877929688,57.13999938964844,49.15394592285156,GILD,"Benzinga's M&A Chatter for Tuesday July 16, 2013 ||| Gilead Not Commenting on Potential Bid for Onyx ||| UPDATE: Amgen, Pfizer, Bristol-Myers Squibb, Gilead Among Companies that May Submit Bids for Onyx, According to Sources",1,0.47742966
2013-07-17,9123400.0,57.369998931884766,57.77000045776367,57.11000061035156,57.75,49.67869567871094,GILD,"Kris Jenner of Rock Springs Capital Mentioning Vertex, Gilead, Pharmacyclics",1,0.5066619
2013-07-22,12171600.0,59.709999084472656,60.459999084472656,58.61000061035156,59.709999084472656,51.36475372314453,GILD,Benzinga's Top Pre-Market Losers,0,0.5231748
2013-07-25,11325400.0,60.119998931884766,61.13999938964844,58.810001373291016,60.86000061035156,52.35403060913086,GILD,"After-Hours Earnings Report for July 25, 2013 : AMZN, GILD, SBUX, MCK, CB, CERN, NEM, RSG, PFG, KLAC, BMRN, CBG ||| Gilead Sciences Rises After Q2 Report (GILD) ||| Gilead Sciences, Inc. Reports Q2 EPS of $0.50, Inline; Revenue of $2.66B vs $2.66B Est ||| Economic Calendar for Thursday July 25, 2013",1,0.48647928
2013-07-26,14716300.0,63.81999969482422,64.04000091552734,61.58000183105469,62.56999969482422,53.82503128051758,GILD,"Short Interest in Pharmacyclics Plunges (AMGN, ONXX, PCYC) ||| Baird Downgrades Gilead Sciences, Inc. to Neutral ||| Atlantic Equities Upgrades Gilead Sciences to Overweight",0,0.49099615
2013-07-29,10264600.0,62.59999847412109,62.81999969482422,61.56999969482422,62.02000045776367,53.35190963745117,GILD,"Can the Recent Uptrend Continue for Gilead Sciences, Inc. (GILD)? - Tale of the Tape ||| After Hours Most Active for Jul 29, 2013 : ELN, PFE, HLF, QQQ, HAL, ZTS, CAT, MU, FB, GILD, AGNC, PDLI",0,0.4882538
2013-07-30,11134400.0,62.0,62.27999877929688,61.459999084472656,61.72999954223633,53.10243225097656,GILD,Zacks #1 Rank Additions for Tuesday - Tale of the Tape ||| Three ETFs That Have Blown Past Their 200-Day Lines,0,0.503235
2013-07-31,8423200.0,62.09999847412109,62.20000076293945,61.36000061035156,61.400001525878906,52.81856155395508,GILD,"Cubist Pharma Announces Acquisition Deals - Analyst Blog ||| Earnings Beat at Hospira in 2Q, Sales In Line - Analyst Blog ||| Amgen Beats on Earnings & Revs in Q2 - Analyst Blog",1,0.53517723
2013-08-01,7726300.0,62.04999923706055,62.20000076293945,60.970001220703125,62.0,53.33469772338867,GILD,"Earnings Increase at Bayer in 2Q - Analyst Blog ||| PCYC Reports Earnings in Q2, Revs Surge - Analyst Blog",0,0.5445618
2013-08-02,5614300.0,61.86000061035156,61.95000076293945,61.27999877929688,61.75,53.11963653564453,GILD,"Earnings Beat at AstraZeneca in 2Q - Analyst Blog ||| Three Soaring, But Overlooked Health Care ETFs",0,0.50887823
2013-08-05,6105100.0,61.75,61.900001525878906,60.43000030517578,60.95000076293945,52.43144607543945,GILD,Anika Soars on Strong Q2 Results - Analyst Blog,0,0.5222391
2013-08-06,8579000.0,60.91999816894531,60.91999816894531,59.18000030517578,59.97999954223633,51.59701919555664,GILD,Earnings Beat at Regeneron in Q2 - Analyst Blog ||| Zoetis Reports In-Line Earnings in Q2 - Analyst Blog,1,0.5434106
2013-08-07,9417900.0,60.130001068115234,60.470001220703125,59.20000076293945,60.220001220703125,51.80347442626953,GILD,Endo Health Beats on Earnings & Revs. in Q2 - Analyst Blog ||| Sanofi's Vaccine Progresses - Analyst Blog ||| Affymetrix Rise on Turnaround 2Q Earnings - Analyst Blog ||| Rigel Pharma Narrows Q2 Loss - Analyst Blog ||| AHF Wins Major Ruling against FDA on Gilead Prevention Pill,0,0.5187707
2013-08-08,8283700.0,60.5,60.77999877929688,59.290000915527344,59.29999923706055,51.01205825805664,GILD,"Glaxo Seeks Votrient Label Expansion in EU - Analyst Blog ||| Jazz Pharma Posts Higher Earnings & Revs - Analyst Blog ||| Wider-than-Expected Loss at Spectrum Pharma - Analyst Blog ||| After Hours Most Active for Aug 8, 2013 : BAC, QQQ, MACK, ONNN, CTL, GILD, DNDN, FIG, TSM, WMGI, RAX, KEY",0,0.5081285
2013-08-09,5666200.0,58.81999969482422,60.22999954223633,58.56999969482422,59.209999084472656,50.93463897705078,GILD,Bristol-Myers Downgraded to Underperform - Analyst Blog ||| FDA Panel to Review THRX/GSK Candidate - Analyst Blog,0,0.524556
2013-08-12,6263600.0,58.86000061035156,59.13999938964844,58.31999969482422,58.900001525878906,50.66797256469727,GILD,Glaxo Seeks Vaccine Approval - Analyst Blog,1,0.5456211
2013-08-13,4565900.0,59.09999847412109,59.45000076293945,58.220001220703125,58.93000030517578,50.69376754760742,GILD,"Wider Y/Y Loss at Ariad - Analyst Blog ||| Major Setback for Vical - Analyst Blog ||| Impax Surpasses Earnings Estimates - Analyst Blog ||| Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for August 14, 2013 ||| Techne Corporation (TECH) Ex-Dividend Date Scheduled for August 14, 2013",0,0.47215208
2013-08-14,5155200.0,59.11000061035156,59.560001373291016,58.13999938964844,58.16999816894531,50.03998947143555,GILD,ENDP to Offload Anatomical Pathology Unit - Analyst Blog ||| Myriad Outstrips Q4 and FY Earnings Estimates - Analyst Blog ||| How Much Does It Cost To Develop A New Drug?,0,0.5112618
2013-08-15,7345200.0,57.369998931884766,57.650001525878906,55.959999084472656,56.88999938964844,48.93889617919922,GILD,"Progenics' Loss Narrows Y/Y - Analyst Blog ||| Earnings Beat at Perrigo in Q4, Sales Dip - Analyst Blog",1,0.5354094
2013-08-16,7598300.0,56.7599983215332,57.72999954223633,56.25,56.90999984741211,48.95609664916992,GILD,"Integra Receives Go-Ahead in N.J. - Analyst Blog ||| Wider-than-Expected Loss at Biodel - Analyst Blog ||| Apricus' Loss Narrows Y/Y - Analyst Blog ||| After Hours Most Active for Aug 16, 2013 : BAC, SNV, QQQ, QCOM, PGR, SE, RSG, FE, VRTX, DELL, GILD, CA ||| Glaxo's Tivicay Gets Approval - Analyst Blog",1,0.49598157
2013-08-19,5518000.0,56.84000015258789,58.130001068115234,56.75,57.34000015258789,49.32598876953125,GILD,Narrower-than-Expected Loss at Athersys - Analyst Blog ||| Update on Chelsea's Northera - Analyst Blog ||| Glaxo's Tyverb Gets EU Approval - Analyst Blog,1,0.530886
2013-08-20,5349400.0,57.310001373291016,58.54999923706055,57.310001373291016,58.0,49.89376068115234,GILD,"Medtronic Posts In-Line Q1 Earnings, Misses Revs - Analyst Blog ||| Encouraging News for Peregrine Pharma - Analyst Blog ||| Lannett, Jerome Stevens Extend Contract - Analyst Blog ||| Still Neutral on Cubist Pharma - Analyst Blog ||| New Reagent Kits from Illumina - Analyst Blog",1,0.52701175
2013-08-21,10075700.0,57.70000076293945,59.540000915527344,57.43000030517578,58.68999862670898,50.4873161315918,GILD,"Voluntary Recall at Alexion - Analyst Blog ||| XOMA Prices Offering - Analyst Blog ||| LIFE Remains at Neutral - Analyst Blog ||| After Hours Most Active for Aug 21, 2013 : HPQ, LIFE, MSFT, GMCR, GILD, GE, TWC, PHM, QQQ, XOM, VNDA, EMC ||| Boston Scientific Upgraded to Buy - Analyst Blog ||| Pipeline Setback for GTx - Analyst Blog",1,0.49311382
2013-08-22,4750500.0,58.75,59.97999954223633,58.70000076293945,59.93000030517578,51.55401611328125,GILD,Positive Results from Fibrocell Science - Analyst Blog ||| Epizyme Wins Orphan Drug Status - Analyst Blog,0,0.53272605
2013-08-23,6215500.0,59.9900016784668,60.119998931884766,59.470001220703125,59.63999938964844,51.30453109741211,GILD,"Cytokinetics' Tirasemtiv Data Published - Analyst Blog ||| Pound For Pound, Are Biotechs Still Worth Their Salt? ||| Merrimack Study Data Published - Analyst Blog ||| Omnicell Held at Neutral - Analyst Blog ||| Good News for RedHill Biopharma - Analyst Blog",1,0.49391648
2013-08-26,6619100.0,59.81999969482422,60.9900016784668,59.59999847412109,60.41999816894531,51.97551727294922,GILD,"XOMA Raises Funds - Analyst Blog ||| Actelion Inches Close to Ceptaris - Analyst Blog ||| Amgen to Acquire Onyx Pharma - Analyst Blog ||| Pipeline Setback for Glaxo - Analyst Blog ||| After Hours Most Active for Aug 26, 2013 : JCP, FTK, QQQ, HCBK, GILD, ONXX, BAC, MSFT, CDNS, RF, CAT, AMD ||| Horizon Pharma Settles with Par Pharma - Analyst Blog",0,0.4844614
2013-08-27,6127400.0,59.79999923706055,59.83000183105469,58.56999969482422,58.7400016784668,50.53032684326172,GILD,"Rigel Down on Phase II Setback - Analyst Blog ||| Short Interest In Celgene, Onyx Continues To Shrink (CELG, ONXX, VRTX)",1,0.5215252
2013-08-28,8862800.0,58.83000183105469,61.040000915527344,58.5,60.43999862670898,51.99273300170898,GILD,Orexigen Provides Contrave Update - Analyst Blog ||| Pharmacyclics' Ibrutinib Data Published - Analyst Blog ||| Akorn to Buy Hi-Tech Pharma - Analyst Blog,1,0.5276417
2013-08-29,5500100.0,60.130001068115234,61.27999877929688,59.90999984741211,60.93000030517578,52.41424560546875,GILD,Merrimack Progresses With MM-398 - Analyst Blog ||| Topline Data on Astex Candidate - Analyst Blog ||| Sanofi Reports Positive Vaccine Data - Analyst Blog ||| Good News for Regeneron on Eylea - Analyst Blog,0,0.5279386
2013-08-30,5545400.0,61.15999984741211,61.15999984741211,59.959999084472656,60.27000045776367,51.846492767333984,GILD,"PCYC's Ibrutinib Under FDA Review - Analyst Blog ||| Affymetrix Upped to Outperform - Analyst Blog ||| Voluntary Recall at Cubist Pharma - Analyst Blog ||| PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for September 03, 2013 ||| Data on Actelion's Opsumit Published - Analyst Blog ||| Opko Acquires Prolor Biotech - Analyst Blog ||| Swissmedic Negative on Apricus' Vitaros - Analyst Blog",1,0.49199206
2013-09-03,7068700.0,60.900001525878906,61.59999847412109,60.25,60.91999816894531,52.4056396484375,GILD,"Data Presented on Eliquis - Analyst Blog ||| Interim Phase II Data on Isis Candidate - Analyst Blog ||| Additional Funds for Galectin - Analyst Blog ||| Aradigm, Grifols Collaborate - Analyst Blog",1,0.51948714
2013-09-04,7264000.0,60.79999923706055,61.459999084472656,60.36000061035156,61.11000061035156,52.569095611572266,GILD,Gilead Sciences: A Biotech Powerhouse ||| Sanofi Unveils Bond Issue Pricing - Analyst Blog ||| Spectrum Pharma Launches Marqibo - Analyst Blog,0,0.5173651
2013-09-05,4951900.0,61.18999862670898,61.29999923706055,60.5099983215332,61.06999969482422,52.53467559814453,GILD,Pipeline Progress at Tetraphase - Analyst Blog ||| Amgen/Cytokinetics Drug Misses Primary Endpoint - Analyst Blog ||| Encouraging News from THRX's TD-4208 - Analyst Blog ||| Data on MDCO's Cangrelor - Analyst Blog ||| Good News for Chelsea Therapeutics - Analyst Blog ||| Priority Review for Takeda Candidate - Analyst Blog ||| New U.S. Patent for BiolineRx's BL-8040 - Analyst Blog ||| Biotech Breakout Highlights Flawed ETF Thinking,1,0.53112876
2013-09-06,8284700.0,61.34999847412109,61.47999954223633,59.41999816894531,61.119998931884766,52.57768630981445,GILD,Data on Pomalyst Published - Analyst Blog ||| FDA Licensure for Merck Facility - Analyst Blog,1,0.5384851
2013-09-09,5751200.0,61.08000183105469,62.65999984741211,61.08000183105469,62.65999984741211,53.90245056152344,GILD,Target Date for Endo Health's Aveed - Analyst Blog ||| Illumina Inks Supply Deal in NIPT - Analyst Blog ||| FDA Expands Celgene's Abraxane Label - Analyst Blog ||| Pipeline Progress at AstraZeneca - Analyst Blog ||| Bayer Looking to Expand in Russia - Analyst Blog,1,0.5327974
2013-09-10,4835000.0,63.15999984741211,63.560001373291016,62.45000076293945,62.86000061035156,54.07449722290039,GILD,Biogen-Isis Team Up Again - Analyst Blog ||| Rigel Pharma Trims Workforce - Analyst Blog ||| Cubist Pharma Prices Senior Notes - Analyst Blog ||| Data on Biodel's BIOD-123 - Analyst Blog ||| Encouraging Data on Oncolytics' Reolysin - Analyst Blog ||| Orphan Status for BioLineRx' Candidate - Analyst Blog,1,0.51272416
2013-09-11,5462000.0,63.119998931884766,63.29999923706055,62.18000030517578,62.93000030517578,54.13471603393555,GILD,Biogen-Amicus in Parkinson's Deal - Analyst Blog ||| Lannett Beats Q4 Earnings Estimates - Analyst Blog ||| Catalyst Pharma Raises Funds - Analyst Blog ||| UPDATE: Gilead Says Will File for EU Approval of Idelalisib in Q4 ||| Gilead Submits NDA to FDA for Idealalisib for Treatment of NHL,1,0.542902
2013-09-12,4853700.0,63.0,63.4900016784668,62.27999877929688,63.18999862670898,54.358375549316406,GILD,"Gilead Seeks FDA Approval for Idelalisib - Analyst Blog ||| Positive Results on Ventrus' Candidate, Shares Up - Analyst Blog ||| Data on Actelion's Opsumit - Analyst Blog ||| Some New ETFs Off To Impressive Starts ||| Some New ETFs Off To Impressive Starts",1,0.5274562
2013-09-13,3839800.0,63.52999877929688,63.619998931884766,62.720001220703125,63.52999877929688,54.6508674621582,GILD,New Phase I data on Omeros' OMS824 - Analyst Blog ||| United Therapeutics NDA Accepted - Analyst Blog ||| Good News for Perrigo - Analyst Blog ||| Zacks #1 Rank Additions for Friday - Tale of the Tape ||| Protalix Prices Notes - Analyst Blog ||| Biotech Alexion: A Giant In The Tiny Orphan Market,0,0.50830925
2013-09-16,7037400.0,64.08000183105469,64.20999908447266,62.58000183105469,63.02000045776367,54.21214294433594,GILD,"Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, CELG, PCYC) ||| Pipeline Progress at Gilead - Analyst Blog ||| New Patents for Insmed's Arikace - Analyst Blog",0,0.50866634
2013-09-17,5631400.0,62.900001525878906,63.380001068115234,62.36000061035156,62.68999862670898,53.928260803222656,GILD,Encouraging Data on Kythera's ATX-101 - Analyst Blog ||| EU Approval for Raptor Pharma's Procysbi - Analyst Blog,1,0.5473779
2013-09-18,7916500.0,62.83000183105469,64.5199966430664,62.58000183105469,64.27999877929688,55.29605102539063,GILD,Pipeline Update from BioMarin - Analyst Blog ||| Kythera Biopharmaceuticals (KYTH) in Focus: Stock Surges 25.1% - Analyst Blog ||| Clovis Oncology (CLVS) Surges: Stock Gains 7.3% in Session - Analyst Blog,1,0.51613414
2013-09-19,5450300.0,64.62000274658203,64.73999786376953,63.63999938964844,64.31999969482422,55.33045196533203,GILD,"Sangamo Prices Shares - Analyst Blog ||| Biogen Upped to Outperform - Analyst Blog ||| BioCryst, NIAID Collaborate for BCX4430 - Analyst Blog ||| Protalix Raises Funds - Analyst Blog ||| Still Neutral on Perrigo - Analyst Blog ||| U.S. Patent Allowance for BioLineRx' BL-8020 - Analyst Blog",0,0.5094699
2013-09-20,9073800.0,64.41000366210938,64.4800033569336,63.79999923706055,63.86000061035156,54.93474197387695,GILD,Actelion Acquires Ceptaris - Analyst Blog ||| CHMP Positive on GSK/THRX candidate - Analyst Blog ||| Pipeline Progress at Omeros - Analyst Blog ||| Positive Data on Pacira's Exparel - Analyst Blog ||| Data on KaloBios' KB001 Published - Analyst Blog,0,0.5075149
2013-09-23,5998800.0,63.43000030517578,63.70000076293945,62.33000183105469,62.58000183105469,53.833641052246094,GILD,Japanese Approval for Theravance/Glaxo Drug - Analyst Blog ||| Pipeline Progress at Alexion - Analyst Blog ||| Sarepta Therapeutics (SRPT) Worth Considering: Stock Surges 18.0% - Analyst Blog ||| Data on Cytori's Cell Therapy - Analyst Blog,1,0.5298138
2013-09-24,5175000.0,62.630001068115234,63.15999984741211,62.36000061035156,62.7400016784668,53.97127914428711,GILD,Pipeline Progress at Agios Pharma - Analyst Blog ||| Pipeline Progress at BioMarin - Analyst Blog ||| Good News for Perrigo's Generic Unit - Analyst Blog ||| Sativex Pricing Agreement for GW Pharma - Analyst Blog,0,0.52574974
2013-09-25,5358300.0,62.630001068115234,62.7400016784668,61.709999084472656,61.72999954223633,53.10243225097656,GILD,"European Commission Gives Okay on Gilead's Tybost for HIV Therapy ||| BioMarin, Celgene Lead Trend in Biotech Short Interest (BRMN, CELG, REGN)",1,0.5184741
2013-09-27,5632700.0,62.36000061035156,63.93000030517578,62.150001525878906,63.540000915527344,54.65946578979492,GILD,"Health Care Stocks Gurus Investors Are Buying Ahead of Obamacare ||| Update on Gilead's Portfolio - Analyst Blog ||| Threats of a Government Shutdown Weigh on the Dow, S&P 500 ||| Gilead Wins Orphan Drug Status for Lymphoma Treatment",0,0.5137795
2013-09-30,7887300.0,62.150001525878906,63.70000076293945,62.0,62.869998931884766,54.08310317993164,GILD,Gilead Back to Neutral - Analyst Blog,0,0.5199546
2013-10-07,8070600.0,62.150001525878906,62.54999923706055,61.65999984741211,61.77000045776367,53.136837005615234,GILD,"Weekly CFO Sells Highlight: FWLT, DOOR, NKE, MGAM, GILD ||| After Hours Most Active for Oct 7, 2013 : AAT, MU, QCOM, AMD, GILD, QQQ, AAXJ, RENN, FOXA, XOM, PBR/A, MLU ||| Playing Momentum With ETFs (PDP, PIE, MTUM) ||| Playing Momentum With ETFs (PDP, PIE, MTUM) ||| Shares of Gilead Bouncing Off Lows; Several Analysts Making Reassuring Comments",0,0.48221925
2013-10-08,9671000.0,61.84000015258789,61.880001068115234,59.29999923706055,59.380001068115234,51.08087158203125,GILD,"Biotech ETFs Plummeting (XBI, IBB, BBH)",0,0.50048786
2013-10-09,15313300.0,59.810001373291016,60.2400016784668,58.810001373291016,58.900001525878906,50.66797256469727,GILD,"UPDATE: Gilead to Stop Phase 3 Study 116 of Idelalisib in Chronic Lymphocytic Leukemia Early Because of Positive Risk-Benefit ||| UPDATE: Gilead Says Planning to File Idelaisib in EU Later This Year ||| Gilead Says Will Stop Phase 3 Study 116 of Idelalisib in CLL, Says Will Engage in Dialogue with FDA",1,0.52210456
2013-10-10,15240300.0,61.630001068115234,62.79999923706055,61.150001525878906,62.7400016784668,53.97127914428711,GILD,Bayer's Adempas Cleared in the U.S. - Analyst Blog ||| J&J Gains Marginally on HCV Deal - Analyst Blog,0,0.5386087
2013-10-11,8092400.0,62.93999862670898,63.47999954223633,62.380001068115234,62.68999862670898,53.928260803222656,GILD,"Short Sellers Move On Amgen, Vertex (AMGN, PCYC, VRTX)",1,0.521097
2013-10-15,8003800.0,63.45000076293945,64.72000122070312,63.43000030517578,63.59999847412109,54.71107482910156,GILD,"Stock Market News for October 15, 2013 - Market News ||| FDA Reporting Gilead Wins Orphan Drug Designation for Idealalisib",1,0.5323559
2013-10-16,8336700.0,64.05999755859375,65.73999786376953,63.84999847412109,65.6500015258789,56.47456359863281,GILD,Gilead's Stribild Demonstrates Durable Viral Suppression in Two Phase 3 Studies,1,0.54637814
2013-10-17,7651400.0,65.69999694824219,67.37999725341797,65.26000213623047,67.36000061035156,57.945560455322266,GILD,Bullish on Gilead's Stribild - Analyst Blog,1,0.5120553
2013-10-21,9685200.0,68.11000061035156,68.3499984741211,66.62999725341797,66.98999786376953,57.62726593017578,GILD,Actelion's Opsumit Cleared in the U.S. - Analyst Blog,1,0.5325851
2013-10-22,6873000.0,67.01000213623047,68.25,66.63999938964844,68.08999633789062,58.573543548583984,GILD,Inside Biotech ETFs: Can the Run Continue? - ETF News And Commentary ||| United Therapeutics Aims For A Cardiovascular Drug OK,1,0.5334166
2013-10-24,10476900.0,69.44000244140625,70.13999938964844,68.94999694824219,69.83000183105469,60.07035827636719,GILD,"Top Ranked Biotech ETF in Focus: BBH - ETF News And Commentary ||| After Hours Most Active for Oct 24, 2013 : ZNGA, MSFT, CSCO, ABV, AMZN, GILD, BAC, QQQ, KO, CRM, TSM, OZM",0,0.48420376
2013-10-25,9458300.0,70.12000274658203,70.30000305175781,68.19999694824219,69.68000030517578,59.94132995605469,GILD,"Short Sellers Retreat From Biogen Idec, Move On Pharmacyclics (BIIB, BMRN, PCYC)",0,0.50615615
2013-10-28,7013300.0,70.0,70.4000015258789,68.61000061035156,68.7300033569336,59.124122619628906,GILD,Glaxo Seeks EU Approval for HIV Drug - Analyst Blog ||| Positive CHMP Opinion for Actelion's Opsumit - Analyst Blog,1,0.55193377
2013-10-29,6255900.0,68.79000091552734,69.55999755859375,68.2300033569336,69.5,59.78647994995117,GILD,"After-Hours Earnings Report for October 29, 2013 : GILD, BIDU, AFL, LNKD, AMP, VRTX, BXP, EIX, FISV, RRC, WU, KIM ||| Gilead Sciences, Inc. Reports Q3 EPS of $0.52 vs $0.48 Est; Revenue of $2.78B vs $2.72B Est",1,0.509436
2013-10-30,16630600.0,71.88999938964844,73.19999694824219,71.43000030517578,72.66999816894531,62.513427734375,GILD,"Antiviral Franchise Powers Earnings Beat at Gilead - Analyst Blog ||| Market Wrap for October 30: Fed Worries Push Stocks Lower, Facebook Earnings Raise Concerns ||| Deutsche Bank Adds Gilead Sciences to 'Short-Term Buy' List ||| UPDATE: BMO Capital Markets Reiterates on Gilead Sciences Following Solid 3Q13 Results",0,0.5062688
2013-11-01,9395500.0,71.38999938964844,71.48999786376953,70.41999816894531,70.97000122070312,61.05102157592773,GILD,Argus' Market Digest Summary,0,0.516435
2013-11-04,9332700.0,71.12999725341797,71.25,69.31999969482422,69.33999633789062,59.64883804321289,GILD,"Gilead Announces Positive Phase 3 HCV Treatment Results in Patients Co-Infected With HIV ||| Gilead Announces Promising Phase 2 HCV Treatment Results in Liver Transplant Patients ||| Bristol-Myers Seeks Japanese Approval - Analyst Blog ||| J&J, Gilead Report HCV Combo Shows 93% SVR12 Rate Prior Null Responders, Says Medivir Showed No Benefit from Ribavirin, 12-Week Regimen Similar to 24 ||| Benzinga's Top #PreMarket Losers",1,0.51564914
2013-11-05,7102200.0,69.48999786376953,70.04000091552734,69.25,69.54000091552734,59.82088851928711,GILD,U.S. Launch of Actelion's Opsumit - Analyst Blog,0,0.52754956
2013-11-06,11095700.0,69.66000366210938,69.95999908447266,67.20999908447266,67.36000061035156,57.945560455322266,GILD,"Techne Corporation (TECH) Ex-Dividend Date Scheduled for November 07, 2013",0,0.4649536
2013-11-12,8446100.0,67.18000030517578,67.83999633789062,67.16000366210938,67.61000061035156,58.1606330871582,GILD,Gilead Sciences Leads In Rising Short Interest Among Biotechs,1,0.51781416
2013-11-18,8781100.0,70.52999877929688,70.73999786376953,68.75,68.97000122070312,59.33054733276367,GILD,"Gilead Says Idelalisib Significantly Reduced Rate of Disease Progression or Death in Phase 3 Trial, Met Primary, Secondary Endpoints ||| UPDATE: Gilead Says Working on Resubmitting Vitekta to FDA as Single Agent ||| European Commission Approves Gilead's Vitekta, HIV-1 Infection Treatment",1,0.5174938
2013-11-19,7336500.0,68.80000305175781,69.86000061035156,68.3499984741211,69.66000366210938,59.92412185668945,GILD,European Approval for Gilead's Vitekta - Analyst Blog ||| Synta Pharmaceuticals (SNTA) Catches Eye: Stock Surges 15.2% - Tale of the Tape,1,0.52612454
2013-11-20,10245300.0,70.19000244140625,71.47000122070312,69.8499984741211,71.08000183105469,61.14564895629883,GILD,"UPDATE: Citigroup Reiterates on Gilead Sciences on Positive Outlook ||| Citigroup Maintains Buy on Gilead Sciences, Inc., Raises PT to $87.00",1,0.4874198
2013-11-22,18519700.0,72.86000061035156,75.20999908447266,72.8499984741211,74.2699966430664,63.88980102539063,GILD,Recent Cloud IPO Veeva Systems Scores In Health Biz ||| UPDATE: Bank of America Increased Gilead Sciences PT ||| EMA Says Gilead Sciences Granted Marketing Authorization for Sofosbuvir,1,0.5274287
2013-11-25,12257400.0,75.41999816894531,75.43000030517578,74.44000244140625,74.5999984741211,64.1736831665039,GILD,"Sector Update: Biotech Select Index Achieves All-Time High; UBS Reportedly Positive ||| Gilead Soars on Positive CHMP Opinion - Analyst Blog ||| Stock Market News for November 25, 2013 - Market News ||| Glaxo Shares Rise on Tivicay News - Analyst Blog",0,0.5042403
2013-11-26,9030800.0,74.83000183105469,75.05999755859375,74.11000061035156,74.37000274658203,63.9758186340332,GILD,"Piper Jaffray Reinstates Overweight on Gilead Sciences, Inc.",1,0.53042936
2013-11-27,8228900.0,74.75,75.30000305175781,74.16999816894531,74.62999725341797,64.19947814941406,GILD,UPDATE: Piper Jaffray Initiates Coverage on Gilead Sciences on Expected Attractive Returns ||| 10 Stocks To Be Thankful For This Thanksgiving,1,0.53290665
2013-11-29,4900300.0,75.0,75.25,74.7699966430664,74.80999755859375,64.35432434082031,GILD,3 Invesco Funds Delivering Great Returns (revised) - Analyst Blog,0,0.5375668
2013-12-02,11734800.0,74.83999633789062,74.97000122070312,73.61000061035156,74.5199966430664,64.10485076904297,GILD,"PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for December 03, 2013 ||| Gilead Sciences can fix what's ailing your portfolio ||| Idenix Pharmaceuticals Files Patent Infringement, Interference Lawsuits Against Gilead Sciences",0,0.47134107
2013-12-03,12863900.0,73.91999816894531,74.05999755859375,72.36000061035156,72.41999816894531,62.29837417602539,GILD,"Medidata, CaesarStone Among New Buys Of Top Funds",1,0.51724255
2013-12-04,11241700.0,72.0199966430664,72.88999938964844,71.5,72.47000122070312,62.34137725830078,GILD,"Are Biotech ETFs Back on Track? - ETF News And Commentary ||| Update on Gilead's Legal Troubles - Analyst Blog ||| Biotech Stock Roundup: CBST Hits 52-Week High, OREX Lights Up - Analyst Blog",1,0.49168223
2013-12-06,11554900.0,74.05999755859375,74.12999725341797,73.08000183105469,73.98999786376953,63.64891815185547,GILD,Bloomberg First Word Reporting Gilead Has Won FDA Approval for Sofosbuvir,1,0.5424782
2013-12-09,17248700.0,76.06999969482422,76.11000061035156,74.2300033569336,75.19000244140625,64.68120574951172,GILD,"Gilead Reports Positive Data from Interim Phase 2 Results for GS-9973 in Previously Treated Chronic Lymphocytic Leukemia ||| Gilead Announces Phase 2 Study Results for Idelalisib in Refractory Indolent Non-Hodgkin's Lymphoma at ASH ||| Pre-Market Most Active for Dec 9, 2013 : GIVN, SYY, INFI, NOK, ALU, JCP, GILD, AAXJ, FB, BAC, CRNT, NJ ||| FDA Clears Gilead's Sovaldi - Analyst Blog ||| Market Wrap For December 9: Investors Digest Further Clues Hinting at An Upcoming Taper ||| Moody's Revises Gilead Outlook to Positive on Sovaldi Approval ||| USA TD Ameritrade's Investor Movement Index for Nov 5.42 vs 5.07 Prior ||| Benzinga's Top #PreMarket Gainers",0,0.5268236
2013-12-10,25872900.0,75.0,75.0999984741211,70.2300033569336,72.80999755859375,62.63386917114258,GILD,"Bloomberg Reporting Express Scripts' Miller in Phone Interview Said Aiming to Cut Costs for Hep C Drugs, Planning to Pit Gilead Against Other Drugmakers ||| Stocks to Watch for December 10, 2013",0,0.4733075
2013-12-11,16840400.0,72.95999908447266,73.06999969482422,70.4800033569336,70.61000061035156,60.74134826660156,GILD,The One True Sector Bubble: Profits Here When It Crashes Soon,0,0.51183605
2013-12-13,11343000.0,71.20999908447266,71.61000061035156,70.13999938964844,71.4000015258789,61.4209213256836,GILD,Buzz on the Street: Naughty Bears May Keep Santa Away ||| FDA Approves Gilead's Once-Daily Single Tablet HIV-1 Regimen Complera® for Patients Switching from a Stable Regimen; Also Approved by European Comission,1,0.51404107
2013-12-16,12025400.0,72.02999877929688,72.36000061035156,71.33999633789062,71.41999816894531,61.438133239746094,GILD,"Label of Gilead's Complera Expanded - Analyst Blog ||| After Hours Most Active for Dec 16, 2013 : JPM, BAC, BRY, QQQ, MSFT, GILD, PFE, GM, EMC, INTC, CSCO, MU ||| Market Wrap For December 16: Dow Posts Triple Point Gain Ahead of Fed Meeting ||| Gilead Announces Health Canada Notice of Compliance for Sovaldi for Treatment of Chronic Hepatitis C",0,0.50771224
2013-12-17,12247500.0,71.72000122070312,71.73999786376953,69.05000305175781,70.08000183105469,60.28543472290039,GILD,Slideshow: The Top 10 'Highs & Dives' Of S&P 500 Stocks In 2013,1,0.5165424
2013-12-18,17907500.0,72.27999877929688,73.68000030517578,70.62000274658203,73.58999633789062,63.30482864379883,GILD,"Gilead's Sovaldi Holds Promise - Analyst Blog ||| Market Wrap For December 18: Markets Surge Following the Fed's Taper Announcement ||| JP Morgan Lifts Target on Gilead from $85 to $100, Maintains Overweight ||| Gilead Sciences Says High Cure Rates Observed With Single Tablet Regimen May Eliminate Interferon And Ribavirin From Hcv Therapy For Genotype 1 Patients ||| Gilead Issues SVR12 Rates from Three Phase 3 STudies, Says Ion-1 Rate 97.7%, NDA Submission Planned for Q1'14",0,0.5061862
2013-12-19,10040500.0,73.02999877929688,74.87999725341797,73.0,73.43000030517578,63.167213439941406,GILD,"Stock Market News for December 19, 2013 - Market News ||| Positive Data on Gilead's Sovaldi - Analyst Blog",1,0.51516074
2013-12-23,7545000.0,75.3499984741211,75.80000305175781,74.68000030517578,74.98999786376953,64.50917053222656,GILD,"Enzon Pharmaceuticals, Inc. (ENZN) Ex-Dividend Date Scheduled for December 24, 2013",0,0.45819163
2013-12-24,4530700.0,74.98999786376953,75.02999877929688,74.20999908447266,74.95999908447266,64.48335266113281,GILD,UPDATE: Idenix Pharmaceuticals Spokesperson Says IDX20963 Still on Hold; Preclinical Work is Ongoing to Characterize the Genotoxicity Signal in Single Ames in vitro Test; No Update on Litigation,1,0.49717993
2013-12-26,4852200.0,74.97000122070312,75.3499984741211,74.66999816894531,75.19999694824219,64.6898193359375,GILD,"Rising Short Interest In Pharmacyclics, Other Biotechs (AMGN, GILD, PCYC)",0,0.5219086
2013-12-27,4913900.0,75.36000061035156,75.36000061035156,74.25,74.44999694824219,64.0446548461914,GILD,Genomic Health Remains Neutral - Analyst Blog,1,0.5268077
2013-12-30,5899800.0,74.66999816894531,75.25,74.22000122070312,75.08000183105469,64.58661651611328,GILD,"Weekly CFO Sells Highlight: Facebook Inc., Google Inc., Verisk Analytics Inc., Gilead Sciences Inc. ||| Update on RedHill Biopharma's Pipeline - Analyst Blog",1,0.51677305
2013-12-31,6679700.0,75.06999969482422,75.25,74.16000366210938,75.0999984741211,64.60379791259766,GILD,Gilead Sciences Inc. (GILD): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report,1,0.49733493
2014-01-02,8279300.0,75.20999908447266,75.58999633789062,74.38999938964844,75.20999908447266,64.69842529296875,GILD,Bullish on Gilead - Analyst Blog,0,0.50855285
2014-01-06,8346000.0,74.58000183105469,74.69000244140625,72.7300033569336,73.23999786376953,63.0037727355957,GILD,"Targets on Gilead Raised from $87 to $96 at Citi, from $80 to $102 at UBS",0,0.5067765
2014-01-08,11063200.0,73.16999816894531,74.37999725341797,72.52999877929688,73.45999908447266,63.19300842285156,GILD,"Nomura Initiates Coverage on Gilead Sciences, Inc. at Buy, Announces $118.00 PT",1,0.52063835
2014-01-10,8471300.0,75.0,75.04000091552734,73.5199966430664,74.87000274658203,64.40594482421875,GILD,"Stock Market News for January 10, 2014 - Corporate Summary",0,0.4931412
2014-01-13,9130400.0,75.1500015258789,75.27999877929688,72.5999984741211,73.13999938964844,62.91775131225586,GILD,FDA Accepts NDA for Gilead's Idelalisib for Treatment of Refractory Indolent Non-Hodgkin's Lymphoma,1,0.5385969
2014-01-14,11265200.0,73.55000305175781,75.16999816894531,72.81999969482422,74.98999786376953,64.50917053222656,GILD,Can Biotech Repeat in 2014?,1,0.5377225
2014-01-16,20728500.0,75.38999938964844,79.0199966430664,75.30000305175781,77.9000015258789,67.01245880126953,GILD,Stocks 2014: Investing For Growth - The Power And Protection Of High Compounding Earnings Growth - Part 2 ||| Is The Market On Drugs?,1,0.49311954
2014-01-17,11843300.0,77.88999938964844,79.05999755859375,77.44000244140625,78.4000015258789,67.44258880615234,GILD,Gilead Announces EC Has Granted Marketing Authorization for Sovaldi,1,0.5411771
2014-01-21,13026200.0,79.75,81.58000183105469,79.41999816894531,81.58000183105469,70.17813110351562,GILD,"Bayer's Adempas Gets Japanese Approval - Analyst Blog ||| European Approval for Gilead Drug - Analyst Blog ||| Weekly CFO Sells Highlight: Gilead Sciences Inc., Micron Technology Inc., Adobe Systems Inc.",1,0.51181763
2014-01-22,17385400.0,83.72000122070312,84.4000015258789,81.88999938964844,82.18000030517578,70.69429016113281,GILD,"Pre-Market Most Active for Jan 22, 2014 : PBR/A, VALE, AMD, BBD, CX, COH, NUAN, BBRY, FB, GILD, GRPN, TSLA ||| After Hours Most Active for Jan 22, 2014 : EBAY, QQQ, NFLX, BAC, EXEL, AVP, AA, FCX, COLE, MSFT, XOM, GILD",0,0.45185143
2014-01-23,10756500.0,81.80000305175781,82.27999877929688,80.91000366210938,82.1500015258789,70.6684799194336,GILD,Deutsche Bank Adds Gilead to 'Short-Term Buy' List,0,0.5153171
2014-01-27,13638100.0,80.76000213623047,80.76000213623047,77.58999633789062,78.86000061035156,67.83829498291016,GILD,CHMP Positive on Bayer's Riociguat - Analyst Blog,1,0.53964055
2014-01-28,10284700.0,80.5999984741211,81.16999816894531,79.81999969482422,80.66999816894531,69.39531707763672,GILD,"Deutsche Bank Boosts Target on Gilead to $132, on Celgene to $190, on Biogen to $415, Says We Would Be Buyers on Weakness",0,0.486252
2014-01-29,10140000.0,80.01000213623047,81.08999633789062,78.95999908447266,79.8499984741211,68.68992614746094,GILD,Idenix to Challenge Decision by USPTO Patent Trial and Appeal Board in First Patent Interference ||| Ian Estepan Tweet: Patent Office Website Indicates That $GILD Has Prevailed In Interference Proceeding Between '572 Patent And $IDIX '868 Application,1,0.50525814
2014-01-31,10819500.0,79.97000122070312,81.75,79.3499984741211,80.6500015258789,69.37812042236328,GILD,Mylan Selected as Gilead's Exclusive Branded Medicines Business Partner for India,0,0.5196787
2014-02-03,14336700.0,81.7699966430664,81.86000061035156,78.58999633789062,78.83000183105469,67.81248474121094,GILD,"Weekly CFO Sells Highlight: Google Inc, Forest Laboratories Inc, Facebook Inc, Gilead Sciences Inc. ||| Mylan Rolls out Herceptin Biosimilar in India - Analyst Blog ||| Will Gilead (GILD) Disappoint This Earnings Season? - Analyst Blog ||| 3 Reasons For Biotech Stock Advance To Continue",1,0.49500322
2014-02-04,15478300.0,80.18000030517578,82.05999755859375,79.8499984741211,82.0199966430664,70.556640625,GILD,"After-Hours Earnings Report for February 4, 2014 : GILD, AFL, EQR, AMP, CERN, CHRW, UNM, MAC, GNW, GAS, CVD, AXS ||| Gilead Sciences Falls Ever-So-Slightly After Q4 Earnings Beat ||| Market Wrap For February 4: Investors And Traders Go Bargain Hunting ||| From Gilead Call: CEO Martin Highlighting FDA Priority Review for Idelalisib in CLL ||| Gilead Sciences, Inc. Sees FY2014 Product Sales $11.30B-11.50B ||| Gilead Sciences, Inc. Reports Q4 EPS of $0.55 vs $0.50 Est; Revenue of $3.12B vs $2.85B Est ||| Baird Upgrades Gilead Sciences, Inc. to Outperform ||| Nomura Maintains Buy on Gilead Sciences, Inc., Raises PT to $119.00 ||| #PreMarket Primer for Tuesday, February 4: Will The Plunge Continue?",0,0.505733
2014-02-05,23469100.0,81.9800033569336,82.0,76.70999908447266,78.1500015258789,67.2275161743164,GILD,"Gilead Beats on Earnings & Revs, Sovaldi off to a Flier - Analyst Blog ||| Market Wrap For February 5: Markets Unsure Of Which Direction To Take ||| Stifel Nicolaus Maintains Buy on Gilead Sciences, Inc., Raises PT to $92.00",0,0.4765753
2014-02-06,17193800.0,78.5,79.5,76.26000213623047,76.5,65.80815124511719,GILD,Zacks Rank #1 Additions for Thursday - Tale of the Tape,1,0.51489204
2014-02-10,10487600.0,79.33999633789062,81.12999725341797,78.80000305175781,80.9800033569336,69.66201782226562,GILD,"Gilead Files for US Approval of Ledipasivr/Sofosbuvir Fixed-Dose Combo ||| Three ETFs To Buy On The Pullback (PJP, SKYY, SPY)",1,0.5271669
2014-02-11,12608600.0,81.12000274658203,82.04000091552734,80.88999938964844,81.80000305175781,70.36739349365234,GILD,"IBB, GILD, BIIB, AMGN: Large Inflows Detected at ETF ||| Gilead Seeks U.S. Approval - Analyst Blog",1,0.5279803
2014-02-12,9490300.0,82.25,82.93000030517578,81.61000061035156,82.0,70.53942108154297,GILD,"Stock Market News for February 12, 2014 - Market News",1,0.5088183
2014-02-19,9752400.0,83.6500015258789,83.80000305175781,82.30000305175781,82.69999694824219,71.14158630371094,GILD,"Gilead Sciences VP Bischofberger Sells 90,000 Shares -Form 4 ||| A High Expected Return Watch List",1,0.520676
2014-02-20,8962700.0,82.69999694824219,83.19999694824219,81.87999725341797,82.80999755859375,71.23622131347656,GILD,Pipeline Progress at Regulus - Analyst Blog,0,0.5310989
2014-02-21,11015000.0,83.54000091552734,83.62000274658203,82.58000183105469,82.58999633789062,71.04698181152344,GILD,BioMarin Rises on Favorable CHMP Opinion - Analyst Blog,1,0.5238146
2014-02-24,9098200.0,82.98999786376953,84.05999755859375,82.80000305175781,83.56999969482422,71.89000701904297,GILD,Pharmacyclics Attains 52-Week High - Analyst Blog ||| S&P 500 Analyst Moves: GILD ||| Constructing A Hedged Portfolio Around A Position In Priceline.com,1,0.51642734
2014-02-25,8351300.0,84.13999938964844,84.87999725341797,83.06999969482422,83.94999694824219,72.2168960571289,GILD,No Looking Back for Regeneron's Eylea - Analyst Blog,0,0.5141748
2014-02-26,11908500.0,84.05000305175781,84.5,83.30999755859375,83.80999755859375,72.09647369384766,GILD,Top 4 Large-Cap Stocks In The Biotechnology Industry With The Lowest PEG Ratio,0,0.51795727
2014-02-27,11003900.0,83.6500015258789,84.0,82.5,83.6500015258789,71.95883178710938,GILD,Mylan Beats on Q4 Earnings & Revenues - Analyst Blog,0,0.5350959
2014-02-28,12503600.0,83.79000091552734,84.19999694824219,81.80000305175781,82.79000091552734,71.21903228759766,GILD,"Earnings Decline YoY at Alkermes - Analyst Blog ||| Noteworthy ETF Inflows: IBB, BIIB, GILD, AMGN ||| Cara Therapeutics (CARA) Zooms: Stock Up 12.4% - Tale of the Tape ||| PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for March 03, 2014 ||| bluebird bio (BLUE) Zooms: Stock Up 7.2% - Tale of the Tape",0,0.512298
2014-03-03,12024000.0,82.79000091552734,82.9000015258789,81.0,81.44999694824219,70.06629943847656,GILD,Are These Biotechs Part of Your Portfolio? - Analyst Blog ||| EU Review for The Medicines Co.'s Oritavancin - Analyst Blog ||| Actelion Gains on QIDP and Fast Track Status - Analyst Blog ||| Update on Anacor's AN2728 - Analyst Blog,1,0.51337355
2014-03-04,8220800.0,82.86000061035156,83.36000061035156,82.55999755859375,82.94000244140625,71.34807586669922,GILD,AbbVie HCV Combination Therapy Data Looks Good - Analyst Blog ||| Theravance to Split in Q2 - Analyst Blog ||| Celldex Posts Narrower-Than-Expected Loss in Q4 - Analyst Blog ||| Isis Pharma Slips on Wider-Than-Expected Q4 Loss - Analyst Blog ||| Narrower-than-Expected Loss at Dendreon Drives Shares Up - Analyst Blog,0,0.49725166
2014-03-05,6590400.0,83.0199966430664,83.44000244140625,82.7300033569336,82.87000274658203,71.28784942626953,GILD,Dynavax Receives Milestone Payments from AstraZeneca - Analyst Blog ||| Pipeline Setback Overshadows XOMA's Q4 - Analyst Blog ||| Narrower-than-Expected Q4 Loss at GTx - Analyst Blog ||| Sunesis (SNSS) Jumps: Stock Moves 6.8% Higher - Tale of the Tape ||| Acorda Therapeutics (ACOR) Jumps: Stock Rises 7.5% - Tale of the Tape,0,0.5165213
2014-03-06,21950000.0,83.22000122070312,83.41999816894531,78.5,79.91999816894531,68.75013732910156,GILD,Rigel Rises on Narrower Q4 Loss - Analyst Blog ||| Osiris Misses on Q4 Earnings - Analyst Blog ||| Biogen-Eisai Ink Alzheimer's Deal - Analyst Blog ||| Pipeline Progress at Bristol-Myers - Analyst Blog ||| Oncothyreon (ONTY) Jumps: Stock Moves 9.9% Higher - Tale of the Tape ||| Market Wrap For March 6: Investors Find Positives In Jobless Claims,0,0.50105894
2014-03-07,20459900.0,81.20999908447266,81.3499984741211,77.80999755859375,79.58000183105469,68.45765686035156,GILD,Alcobra Gains IND Clearance for MDX - Analyst Blog ||| Friday's ETF with Unusual Volume: IBB,1,0.52981555
2014-03-10,8661900.0,79.4000015258789,80.30000305175781,78.3499984741211,80.2300033569336,69.01683044433594,GILD,"OEF, GILD, HD, UTX: ETF Inflow Alert ||| Salesforce (CRM) & MacroGenics (MGNX): The Relative Value of Potential ||| Additional Positive Data on Omeros Treatment - Analyst Blog ||| NewLink Genetics' Shares Sink - Analyst Blog ||| UPDATE: TD Ameritrade's IMX Sentiment for Feb. Gains, Now at 5.74",0,0.4982185
2014-03-11,10569900.0,80.3499984741211,80.56999969482422,79.31999969482422,79.83999633789062,68.68133544921875,GILD,"Is Gilead Sciences (GILD) a Great Growth Stock? - Tale of the Tape ||| Focus on Regulus' Pipeline - Analyst Blog ||| Alexion Lifts 2014 View, Shares Up - Analyst Blog",0,0.50646067
2014-03-12,9671400.0,79.36000061035156,80.30000305175781,78.62000274658203,79.72000122070312,68.57808685302734,GILD,"Sanofi, UCB Ink Deal - Analyst Blog ||| Phase I Data on Rexahn's Supinoxin - Analyst Blog",0,0.5185987
2014-03-13,10600700.0,80.26000213623047,80.47000122070312,77.55999755859375,78.01000213623047,67.10710144042969,GILD,AstraZeneca to Sell Cheshire Research Site - Analyst Blog ||| Bright Outlook at Bayer - Analyst Blog ||| Unfavorable Ruling for Pfizer - Analyst Blog ||| Wider Q4 Loss at Keryx - Analyst Blog ||| Geron Plunges on FDA Clinical Hold - Analyst Blog,0,0.4987791
2014-03-14,18775000.0,76.98999786376953,77.0999984741211,74.55000305175781,75.05000305175781,64.56079864501953,GILD,"S&P 500 Movers: CELG, COH ||| Raptor Pharma Posts Wider-Than-Expected Q4 Loss - Analyst Blog ||| Anacor Reports Narrower Q4 Loss - Analyst Blog ||| Narrower-than-Expected Q4 Loss at Repros - Analyst Blog ||| Vanda Pharmaceuticals (VNDA) Soars: Stock Adds 9.6% in Session - Tale of the Tape ||| Sector Update: Health Care ||| Market Wrap For March 14: Ukraine Tension Drag Markets Lower ||| US Stock Futures Edge Higher Ahead Of Consumer Sentiment Report ||| Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe",1,0.51086825
2014-03-17,14099000.0,75.95999908447266,76.86000061035156,75.08000183105469,75.44999694824219,64.90489196777344,GILD,Novartis' Bexsero Recommended in Australia - Analyst Blog,1,0.53598255
2014-03-18,10327000.0,75.54000091552734,78.05999755859375,75.51000213623047,77.7699966430664,66.90062713623047,GILD,Narrower-Than-Expected Loss at Relypsa - Analyst Blog ||| Intercept Sees Weakness in Earnings Result - Analyst Blog ||| Repros Provides Proellex Update - Analyst Blog ||| Amgen Scores Again with PCSK9 Inhibitor - Analyst Blog ||| Actelion's Tracleer Misses Primary Endpoint - Analyst Blog ||| Biogen to be added to S&P100 - Analyst Blog,0,0.50437635
2014-03-19,11155700.0,78.19999694824219,78.5999984741211,76.01000213623047,76.54000091552734,65.8425521850586,GILD,"Stock Market News for March 19, 2014 - Market News ||| Strength Seen in GTX (GTXI): Stock Moves 8.8% Higher - Tale of the Tape ||| Idenix Files Lawsuit vs. Gilead Again - Analyst Blog ||| After Hours Most Active for Mar 19, 2014 : BTU, JPM, QQQ, WFC, BPO, STAG, MET, GILD, HZNP, ADSK, CSCO, MSFT ||| Biogen Faces Delay in FDA Action Date - Analyst Blog",0,0.44531846
2014-03-20,12148300.0,76.5,76.6500015258789,74.86000061035156,75.52999877929688,64.97370910644531,GILD,"Nasdaq 100 Movers: GILD, AKAM ||| Health Care Select Sector SPDR Fund Experiences Big Inflow ||| Palatin Technologies (PTN) Worth Watching: Stock Soars 15.6% - Tale of the Tape ||| Why ANI Pharmaceuticals (ANIP) Has a Bright Short-Term Future? - Tale of the Tape",0,0.48228338
2014-03-21,36979700.0,75.66999816894531,76.19999694824219,70.8499984741211,72.06999969482422,61.99728012084961,GILD,"Nasdaq 100 Movers: SYMC, VIP ||| Trial Protocol Submission Lifts Heat Biologics - Analyst Blog ||| Good News for Johnson & Johnson - Analyst Blog ||| Healthcare Stocks Undercut Earlier Market Advance; Gilead Sciences Sinks After Congress Questions Drug Price ||| Sector Update: Healthcare ||| Favorable Data for Myriad Genetics - Analyst Blog ||| Market Wrap For March 21: Markets End Friday On A Negative Note, But Still Positive For The Week ||| U.S. Lawmakers Ask For Briefing From Gilead Sciences onn Price Of New Hepatitis C Drug Sovaldi",1,0.5022036
2014-03-24,29285300.0,72.54000091552734,72.88999938964844,68.80999755859375,72.12999725341797,62.04890441894531,GILD,"Gilead (GILD) is now in Oversold Territory - Tale of the Tape ||| Breakthrough Therapy Status for Pfizer's Drug - Analyst Blog ||| Biotech Continues Friday Sell-Off On Drug Pricing Concerns ||| Closing Update: Stocks Decline on Below-Consensus Manufacturing Index, Biotech Selling Blitz ||| Are Biotech Stocks Oversold? - Analyst Blog ||| Gilead Down on Sovaldi Price Issue - Analyst Blog ||| Have We Seen The Top Of The Market? ||| Idenix to Appeal Norway District Court Decision Regarding Patent Invalidity Case",1,0.5057482
2014-03-25,19176900.0,72.5999984741211,74.30000305175781,71.9000015258789,73.02999877929688,62.82311248779297,GILD,Update on Celgene's Product Portfolio - Analyst Blog,0,0.5166793
2014-03-26,15708700.0,73.72000122070312,75.01000213623047,72.7699966430664,72.77999877929688,62.608055114746094,GILD,Retrophin (RTRX) Catches Eye: Stock Moves 7.9% Higher - Tale of the Tape ||| Positive Data on Halozyme Candidate - Analyst Blog ||| Morgan Stanley Starts Gilead Sciences With Equal-Weight; $75 PT,0,0.47617432
2014-03-27,17749700.0,72.37999725341797,73.33999633789062,70.58999633789062,71.41000366210938,61.42953109741211,GILD,"Glaxo's Eperzan Approved in EU - Analyst Blog ||| Insmed Down on Disappointing Arikayce Results - Analyst Blog ||| Market Wrap For March 27: Markets Lower Following Mixed Economic Data ||| UPDATE: Gilead Sciences' LDV/SOF Receives Accelerated Assessment ||| EMA Validates Gilead's Marketing Application for Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Genotype 1 Chronic Hepatitis C Infection ||| Morgan Stanley's Top Biotech Pick is Biogen ||| Morgan Stanley Initiates Coverage on Gilead Sciences, Inc. at Equal-weight, Announces $75.00 PT",0,0.5152929
2014-03-28,29246100.0,70.62000274658203,71.11000061035156,67.62999725341797,68.55000305175781,58.96925735473633,GILD,"Gilead's HCV Candidate Under Review in the EU - Analyst Blog ||| Sector Update: Healthcare ||| Nasdaq 100 Movers: GILD, CTSH ||| Update on Glaxo's Mekinist-Tafinlar - Analyst Blog ||| Moderate Gains for Healthcare Stocks; Gilead Sciences Slips After Reported Sales Dip for HCV Drug ||| Gilead Sciences Breaks Below 200-Day Moving Average - Notable for GILD",1,0.5088704
2014-03-31,18594900.0,69.16999816894531,71.0,69.16999816894531,70.86000061035156,60.95640182495117,GILD,"Biotechnology Shares Rebound 2.4% on Monday, But Still on Track to End March Lower ||| Pre-Market Most Active for Mar 31, 2014 : RIO, BBRY, QQQ, BAC, NOK, FB, GILD, TVIX, TWTR, MNKD, MT, ALSN ||| Idera Soars on Phase II Drug Data - Analyst Blog ||| Gilead Sciences Now #33 Largest Company, Surpassing Visa ||| Any Survivors from the Biotech ETF Meltdown? - ETF News And Commentary ||| FDA Nod for Biogen's Alprolix - Analyst Blog",1,0.4770477
2014-04-01,19497100.0,73.33999633789062,73.87999725341797,72.13999938964844,73.63999938964844,63.34786224365234,GILD,"iShares Russell 1000 Growth ETF Experiences Big Outflow ||| Momenta Pharmaceuticals Slumps: MNTA Falls 16.9% in Session - Tale of the Tape ||| Stock Market News for April 01, 2014 - Market News ||| Ultragenyx (RARE) Jumps: Stock Rises 7.0% - Tale of the Tape ||| Despite S&P 500's New High, Stocks Face Challenges",1,0.50657886
2014-04-02,15992800.0,75.16000366210938,75.25,73.33999633789062,73.95999908447266,63.62312316894531,GILD,"Gilead Says Results of Phase 3 Study of Sofosbuvir Confirm Efficacy, Safety ||| Gilead's HepC Drug Sales May Be More Resilient Than Feared",1,0.5195061
2014-04-03,15989400.0,75.16000366210938,75.18000030517578,72.29000091552734,74.0,63.65754699707031,GILD,Encouraging Results on Gilead's Sovaldi - Analyst Blog,0,0.53718567
2014-04-07,16037200.0,71.91999816894531,73.7300033569336,70.72000122070312,72.2300033569336,62.13494491577149,GILD,"FDA News Lifts Dyax Slightly - Analyst Blog ||| Amgen's Oncology Candidate Disappoints - Analyst Blog ||| UPDATE: TD Ameritrade Says IMX for Mar. Up to 5.87 ||| Gilead Sets US FDA Priority Review Designation for Ledipasvir/Sofosbuvir Fixed-Dose Combo Tablet, Sets PDUFA Date for Oct. 10th",0,0.5302134
2014-04-08,25269000.0,71.70999908447266,71.70999908447266,69.27999877929688,70.01000213623047,60.225196838378906,GILD,"Nasdaq 100 Movers: MYL, BIDU ||| FDA Target Date for Gilead's HCV Candidate - Analyst Blog ||| Encouraging Results from Pfizer's Palbociclib - Analyst Blog ||| Pipeline Update from Idenix - Analyst Blog ||| Biotechs Struggling To Find A Bottom ||| Morning Market Losers ||| Benzinga's Top #PreMarket Losers ||| Express Scripts Reports Spending on Hepatitis C Medications in US to Rise 1,800% by 2016",1,0.50850785
2014-04-09,20688600.0,70.5,71.29000091552734,69.86000061035156,70.6500015258789,60.77573776245117,GILD,"VUG, GILD, HD, AXP: Large Inflows Detected at ETF",0,0.5217175
2014-04-10,43152600.0,70.80000305175781,71.2300033569336,64.80999755859375,65.4800033569336,56.328311920166016,GILD,"3 Top-Ranked Biotech Stocks on the Rebound - Analyst Blog ||| After Hours Most Active for Apr 10, 2014 : CWH^D, HBAN, QQQ, MSFT, GE, VZ, EMC, MO, D, LRCX, FB, GILD ||| Gilead Announces Encouraging Sovaldi Data - Analyst Blog ||| Market Wrap For April 10: Wednesday's Rally Completely Forgotten ||| Five Star Stock Watch: Gilead Sciences ||| Natco Pharma Files to Block Grant Of India Patent On Gilead's Hepatitis C Drug Sovaldi -Reuters ||| Nomura Maintains Buy on Gilead Sciences, Inc., Raises PT to $121.00 ||| Gilead Announces Phase 2 Results for Investigational All-Oral Sofosbuvir-Based Regimens for Treatment of Chronic Hepatitis C",1,0.54104894
2014-04-11,35988700.0,64.19000244140625,68.94000244140625,63.5,66.02999877929688,56.80144500732422,GILD,Encouraging Results on Gilead's Sovaldi - Analyst Blog ||| Sector Update: Healthcare Shares Lower in Pre-Market Trade ||| Gilead Sciences (GILD) Falls: Stock Goes Down 7.3% - Tale of the Tape ||| 3 Pharma Mutual Funds Beating the S&P 500 - Best of Funds ||| Encouraging Data from Bristol-Myers - Analyst Blog ||| Sector Update: Healthcare Mixed in Late Session; Gilead Sciences Turns Higher ||| Sector Update: Healthcare ||| US Stock Futures Slip Ahead Of Consumer Sentiment Report ||| Gilead Announces Sovaldi Demonstrates Efficacy and Safety Among Chronic Hepatitis C Patients with Advanced Liver Disease,1,0.5276932
2014-04-14,17988000.0,67.79000091552734,68.38999938964844,65.73999786376953,66.79000091552734,57.45523452758789,GILD,"Gilead Bucks Biotech Trend Thanks to Sovaldi News - Analyst Blog ||| Pre-Market Most Active for Apr 14, 2014 : C, ING, BAC, FB, QQQ, ALU, TVIX, BCS, NBG, XIV, ASML, GILD ||| Hard-to-Cure Patients May Benefit from Merck's HCV Drug - Analyst Blog ||| Positive Data on AbbVie's HCV Program - Analyst Blog ||| Markets Falling? Get Your Defense Ready",1,0.4886741
2014-04-15,21802600.0,67.55000305175781,69.13999938964844,65.58999633789062,68.16999816894531,58.642364501953125,GILD,"S&P 500 Movers: NEM, TRIP ||| Gilead Receives FDA Orphan Status for Chronic Lymphocytic Leukemia - Bloomberg",1,0.5254342
2014-04-17,17546400.0,69.37000274658203,70.63999938964844,69.08999633789062,70.0,60.216590881347656,GILD,"Noteworthy ETF Outflows: VHT, GILD, MDT, ESRX ||| Has A Streamlined FDA Raised The Value Of Drug Stocks?",1,0.52948153
2014-04-21,17973500.0,70.37999725341797,71.98999786376953,69.4000015258789,71.5999984741211,61.59297180175781,GILD,"Weekly CFO Sells Highlight: AthenaHealth Inc, Gilead Sciences Inc, JPMorgan Chase & Co. ||| Will Gilead (GILD) Beat Q1 Earnings? - Analyst Blog ||| After Hours Most Active for Apr 21, 2014 : BAC, C, NFLX, GS^I, AGN, FB, AMD, PT, QQQ, MSFT, GILD, WEN ||| Gilead Sciences' New Drug Applications for Cobicistat and Elvitegravir for HIV Therapy Accepted by U.S. FDA ||| Bloomberg Report Says CVS May Try to Slow the Uptake of Gilead's New Drug; Says CVS Wants Price Competition to Gilead's Hepatitis C Drug",1,0.5004244
2014-04-22,29207300.0,72.86000061035156,73.26000213623047,71.8499984741211,72.86000061035156,62.6768798828125,GILD,"Keep an Eye on these 3 Biotech Stocks - Earnings ESP ||| Synageva Heading For Big Disappointment ||| After-Hours Earnings Report for April 22, 2014 : T, GILD, AMGN, CNI, YUM, DFS, ILMN, ISRG, VMW, FTI, JNPR, BCR ||| Gilead Crushes On Earnings, Quickly Gives Up Gains ||| Market Wrap For April 22: S&P Rises For Sixth Straight Day, Dow & Nasdaq Also Positive ||| Gilead Beats Q1 Estimates, Stock Halted Briefly ||| Gilead Sciences Shares Resume Trade, Up 5% ||| Gilead Sciences Shares to Resume Trade at 4:30PM EDt ||| Gilead Sciences, Inc. Reports Q1 EPS of $1.48 vs $0.92 Est; Revenue of $5.0B, Up 98% YOY ||| Gilead Sciences Halted Ahead of Earnings ||| CAFC Says Gilead Has Lost Appeals Court Ruling Related to Patent Over TAmiflu ||| Earnings Scheduled For April 22, 2014",1,0.48477367
2014-04-23,35411800.0,75.7300033569336,75.87999725341797,73.76000213623047,73.86000061035156,63.53711700439453,GILD,"Strong Q1 Earnings at Gilead on Stellar Sovaldi Sales - Analyst Blog ||| Nasdaq 100 Movers: ISRG, GILD ||| Cubist Pharma Posts Weak Earnings on Soft Cubicin Sales - Analyst Blog ||| Stock Market News for April 23, 2014 - Market News ||| Amgen's Q1 Earnings Decline Y/Y - Analyst Blog ||| US Futures Mixed Amid Earnings Deluge; Apple, Facebook Set to Report After Close ||| US Futures Edge Lower Amid Mixed Earnings Bag, Markets Eye Apple, Facebook After Close ||| An Improving, But Still Weak Earnings Picture - Earnings Trends ||| An Improving, But Still Weak Earnings Picture - Earnings Outlook ||| AbbVie Files for HCV Combination Therapy in U.S. - Analyst Blog ||| Biogen's Q1 Earnings Soar Y/Y on Tecfidera Sales - Analyst Blog ||| Market Wrap For April 23: S&P 500 Ends Winning Streak, Apple Announces 7-for-1 Stock Split ||| #Premarket Technical Update - Gilead Sciences Trading Higher ||| Morning Market Movers ||| How Did Analysts Get Gilead's Earnings Completely Wrong? ||| Benzinga's Top #PreMarket Gainers ||| ETF Outlook For Wednesday, April 23, 2014 (MGC, IYZ, TAN, BBH, GILD, T) ||| Nomura Maintains Buy on Gilead Sciences, Inc., Raises PT to $130.00",1,0.51600343
2014-04-24,22098100.0,74.93000030517578,75.0,71.62999725341797,74.08000183105469,63.72636795043945,GILD,"Alexion Posts Strong Earnings in Q1 - Analyst Blog ||| Biogen Raises Full-Year Earnings, But Is That The Entire Picture?",0,0.49569792
2014-04-25,22726800.0,74.0199966430664,74.87999725341797,73.43000030517578,73.9000015258789,63.5715217590332,GILD,"AbbVie Beats on Q1 Earnings, Humira Soars - Analyst Blog ||| U.S.-Russia Tensions Over Ukraine Could Make This An Interesting Weekend",1,0.5431213
2014-04-28,22497800.0,74.8499984741211,76.80000305175781,72.7699966430664,74.08000183105469,63.72636795043945,GILD,3 Pharma Mutual Funds Beating the S&P 500 - Best of Funds,1,0.55037034
2014-04-29,15865700.0,74.66999816894531,76.37999725341797,74.0,76.23999786376953,65.58448791503906,GILD,"VUG, QCOM, HD, GILD: Large Outflows Detected at ETF ||| OncoGenex's Custirsen Misses Primary Endpoint - Analyst Blog ||| Can Affymetrix (AFFX) Surprise This Earnings Season? - Analyst Blog ||| Hyperion Set to Acquire Andromeda - Analyst Blog",1,0.5022381
2014-04-30,20165300.0,76.1500015258789,78.66999816894531,75.48999786376953,78.48999786376953,67.52002716064453,GILD,Q2 Earnings Estimates Coming Down - Earnings Outlook ||| Amicus Up on Positive Data - Analyst Blog,1,0.5225104
2014-05-01,15970200.0,78.62000274658203,79.88999938964844,77.83000183105469,79.0199966430664,67.97593688964844,GILD,"3 Biotech Beats this Earnings Season - Earnings ESP ||| Wider-than-expected Loss at Alkermes, Revenues Slip - Analyst Blog ||| OncoGenex Posts Wider Loss, Beats Revenues - Analyst Blog ||| Synageva's Q1 Loss Narrower than Expected - Analyst Blog ||| Merck (MRK) Earnings Beat Puts Healthcare ETFs in Focus - ETF News And Commentary ||| United Therapeutics Gains on Q1 Earnings - Analyst Blog",0,0.5370898
2014-05-02,16772700.0,79.30000305175781,79.5,76.6500015258789,77.70999908447266,66.8490219116211,GILD,"Novo Nordisk Beats Earnings Ests, Misses Revs - Analyst Blog ||| Wider-than-Expected Q1 Loss at Incyte - Analyst Blog ||| Can the Rally in Gilead (GILD) Shares Continue? - Tale of the Tape ||| Earnings Estimates Moving Higher for Gilead (GILD): Time to Buy? - Tale of the Tape ||| Loss at BioMarin Narrower Than Expected - Analyst Blog ||| Shire Beats on Earnings in Q1 - Analyst Blog",1,0.5198364
2014-05-05,14085700.0,76.7300033569336,79.91000366210938,76.62999725341797,79.83000183105469,68.6727294921875,GILD,"Nasdaq 100 Movers: WYNN, GILD ||| Narrower-than-Expected Loss at Seattle Genetics - Analyst Blog ||| Vertex Down on Wider-than-Expected Loss - Analyst Blog ||| InterMune Up on Narrower-than-Expected Q1 Loss - Analyst Blog ||| Celldex's Q1 Loss Widens - Analyst Blog ||| Pfizer Tops on Q1 Earnings, Generics Hit Revs - Analyst Blog ||| Idenix's Q1 Loss Widens - Analyst Blog ||| Geron Reports In-Line Q1 Loss - Analyst Blog ||| AstraZeneca Rejects Pfizer's Latest Offer - Analyst Blog ||| Bull of the Day: Gilead Sciences (GILD) - Bull of the Day",0,0.49328873
2014-05-06,10990500.0,79.73999786376953,79.91999816894531,78.2300033569336,78.31999969482422,67.37376403808594,GILD,"Dynavax Reports In Line Q1 Results - Analyst Blog ||| Marginal Earnings Beat at Zoetis, View Maintained - Analyst Blog ||| Techne Corporation (TECH) Ex-Dividend Date Scheduled for May 07, 2014 ||| Endocyte, Inc. (ECYT) in Focus: Stock Rises 5.6% - Tale of the Tape ||| Regeneron Inks Ophthalmology Deal - Analyst Blog ||| Vical Narrows Q1 Loss - Analyst Blog",1,0.4807289
2014-05-07,14664700.0,79.0,79.2300033569336,76.80000305175781,78.7699966430664,67.7608871459961,GILD,"Narrower-than-Expected Loss at Momenta - Analyst Blog ||| Split Update Overshadows Wider Q1 Loss at Theravance - Analyst Blog ||| IYH, GILD, BMY, ABBV: ETF Outflow Alert ||| Wider-than-Expected Loss at Aegerion - Analyst Blog ||| Gilead Announces $5B Buyback Plan",0,0.48908666
2014-05-08,13777000.0,78.87999725341797,80.27999877929688,78.19999694824219,78.7300033569336,67.72647094726562,GILD,"Avanir Loss In Line with Ests, Revs Up - Analyst Blog ||| J&J /Gilead HCV Combo Drug Filed - Analyst Blog ||| Q1 Earnings Season in Final Stretch - Earnings Outlook ||| Q1 Earnings Season in Final Stretch - Earnings Trends",1,0.51167756
2014-05-09,9017400.0,78.80999755859375,79.79000091552734,78.0,79.76000213623047,68.61251831054688,GILD,"Medivation Q1 Loss Wider Than Expected - Analyst Blog ||| Earnings Up at Jazz Pharma, Guidance Reiterated - Analyst Blog ||| XOMA Posts Wider Q1 Loss - Analyst Blog ||| Anacor Reports Wider-than-Expected Q1 Loss - Analyst Blog ||| Salix Q1 Earnings Boosted by Santarus Acquisition - Analyst Blog ||| Gilead Announces Phase 1 Data For Investigation Therapy",1,0.51318496
2014-05-12,11254300.0,80.2300033569336,80.7300033569336,79.16999816894531,80.3499984741211,69.12003326416016,GILD,Gilead Phase 2 Study Shows Reduction in Atrial Fibrillation Burden with Investigational Combination of Ranolazine and Low-Dose Dronedarone ||| Loss Widens at Achillion - Analyst Blog ||| Shares Continue to fall on Emergent BioSolutions' Wider Loss - Analyst Blog ||| RadNet Touches New 52-Week High - Analyst Blog ||| Dendreon Falls on Q1 Loss - Analyst Blog ||| Strength Seen in Medivation (MDVN): Stock Up 8.5% - Tale of the Tape ||| Spectrum Pharma Up on Q1 Earnings - Analyst Blog ||| Illumina Upgraded to Strong Buy - Analyst Blog ||| Amgen-AstraZeneca Psoriasis Drug Scores - Analyst Blog ||| Breaking Biotech: Gilead's Phase 2 Study Results,0,0.50392383
2014-05-13,8515500.0,80.48999786376953,80.70999908447266,80.01000213623047,80.30000305175781,69.07704162597656,GILD,"Osiris Therapeutics Q1 Loss Narrower-Than-Expected - Analyst Blog ||| PDL BioPharma Misses on Q1 Earnings - Analyst Blog ||| Halozyme's Q1 Loss Widens - Analyst Blog ||| Tesaro, Inc. (TSRO) Looks Strong as Stock Rallies 21% - Tale of the Tape ||| Insys in Focus on Subsys Worries - Analyst Blog ||| Gilead Shows More Pipeline Progress - Analyst Blog ||| Shire to Acquire Lumena - Analyst Blog",1,0.4997142
2014-05-14,10735800.0,80.4000015258789,81.61000061035156,79.61000061035156,80.97000122070312,69.65339660644531,GILD,"Athersys Reports Wider-than-Expected Q1 Loss - Analyst Blog ||| Oragenics (OGEN) Catches Eye: Stock Rises 9.7% - Tale of the Tape ||| Halozyme Therapeutics, Inc. (HALO) in Focus: Stock Up 6.9% - Tale of the Tape ||| XenoPort's Q1 Loss Narrows - Analyst Blog",0,0.49148485
2014-05-15,12705000.0,81.0199966430664,81.41999816894531,79.45999908447266,80.0999984741211,68.90498352050781,GILD,"Arena Slides on Wider Q1 Loss, Misses Ests - Analyst Blog ||| Novartis Settles Gleevec Patent Litigation - Analyst Blog ||| Progenics' Q1 Loss Narrows - Analyst Blog ||| Q1 Earnings Season Coming to an End - Earnings Outlook ||| Q1 Earnings Season Coming to an End - Earnings Trends ||| Incyte to Collaborate with AstraZeneca - Analyst Blog",1,0.51549065
2014-05-16,10525700.0,80.30000305175781,80.83999633789062,79.22000122070312,80.80000305175781,69.50714874267578,GILD,"XenoPort - Reckitt Benckiser Pharma Collaborate - Analyst Blog ||| Clovis Oncology, Inc. (CLVS) in Focus: Stock Surges 16 % - Tale of the Tape ||| Data on Novo Nordisk's NovoEight - Analyst Blog ||| Update on Glaxo's Darapladib - Analyst Blog",1,0.5064098
2014-05-19,10159200.0,80.70999908447266,82.0999984741211,80.5,82.05000305175781,70.58245086669922,GILD,"AstraZeneca Rejects Pfizer's Final Offer - Analyst Blog ||| After Hours Most Active for May 19, 2014 : MTCN, CAM, MSFT, MO, NXPI, JNJ, ARCP, FITB, DTV, GILD ||| Ligand-AstraZeneca Collaborate - Analyst Blog ||| Shire Meets FDA for Lifitegrast - Analyst Blog",0,0.46831667
2014-05-20,10553900.0,82.04000091552734,82.47000122070312,80.72000122070312,81.13999938964844,69.79963684082031,GILD,"Glaxo-Genmab's Arzerra Disappoints - Analyst Blog ||| InterMune Up on Esbriet Data Presentation - Analyst Blog ||| UPDATE: Gilead Reports Investigational GS-5806 Reduces Viral Load, Clinical Syptoms in Phase 2 RSV Study, Says Study Reached Primary, Secondary Endpoints ||| Gilead Reports Investigational GS-5806 Reduces Viral Load, Clinical Syptoms in Phase 2 RSV Study, Says Study Reached Primary, Secondary Endpoints",1,0.51822174
2014-05-21,9042000.0,81.26000213623047,81.9800033569336,80.68000030517578,81.80999755859375,70.3759994506836,GILD,Data on Novartis' Ultibro Breezhaler - Analyst Blog ||| Celgene Inks Licensing Deal with AADi - Analyst Blog ||| Insmed (INSM) in Focus: Stock Moves 6.7% Higher - Tale of the Tape ||| Gilead's GS-5806 Encourages - Analyst Blog ||| Auspex Pharmaceuticals (ASPX) Jumps: Stock Rises 9.5% - Tale of the Tape ||| Additional Data on InterMune's Esbriet - Analyst Blog ||| Dendreon Up on Provenge Data - Analyst Blog ||| Intercept Sinks on Cholesterol Issue - Analyst Blog ||| AbbVie's Humira Gets Orphan Drug Designation - Analyst Blog ||| Myriad Genetics Unveils Positive Prolaris Data - Analyst Blog,1,0.50369143
2014-05-22,10879000.0,81.62999725341797,83.69999694824219,81.55999755859375,82.9000015258789,71.31365203857422,GILD,Clovis Gets Breakthrough Therapy Designation - Analyst Blog ||| Data on Insmed's Arikayce - Analyst Blog ||| Another Weak Earnings Season Coming to an End - Earnings Outlook ||| Another Weak Earnings Season Coming to an End - Earnings Trends,0,0.49607518
2014-05-23,13588000.0,82.43000030517578,82.5,80.75,80.94000244140625,69.62757873535156,GILD,"Nasdaq 100 Movers: GILD, VIP ||| Stock Market News for May 23, 2014 - Market News ||| Pipeline Progress at RedHill Biopharma - Analyst Blog ||| ZIOPHARM Presents Encouraging Data - Analyst Blog ||| Update on Celsion's ThermoDox - Analyst Blog ||| Sarepta to Acquire Manufacturing Facility - Analyst Blog ||| Celgene Gains Slightly on Management Changes - Analyst Blog",1,0.49996045
2014-05-27,10994500.0,82.08000183105469,82.94999694824219,81.12000274658203,82.16000366210938,70.67707824707031,GILD,Pfizer Pulls Out of AstraZeneca Deal - Analyst Blog ||| Ambit Biosciences (AMBI) in Focus: Stock Jumps 10.0% - Tale of the Tape ||| Amgen's Vectibix Label Expanded - Analyst Blog ||| CHMP Negative on Novartis' RLX030 - Analyst Blog ||| CHMP Positive on Roche's Gazyvaro - Analyst Blog ||| Durata Therapeutics' Skin Drug Gets FDA Nod - Analyst Blog ||| PTC Therapeutics Up on Positive CHMP Opinion - Analyst Blog,0,0.45079583
2014-05-28,8522900.0,82.0199966430664,82.87000274658203,81.75,81.86000061035156,70.41899871826172,GILD,"InterMune Resubmits Esbriet NDA - Analyst Blog ||| Verastem (VSTM) in Focus: Stock Adds 14% in Session - Tale of the Tape ||| Valeant Selling Product Rights to Nestle - Analyst Blog ||| Isis Pharmaceuticals, Inc. (ISIS) in Focus: Stock Rises 9.21% - Tale of the Tape ||| Incyte Joins Forces with Bristol-Myers - Analyst Blog ||| Option Alert: Gilead Jun $87.5 Call; 7,432 Contracts Traded vs 3.026 OI; Currently $82.41",1,0.50543916
2014-05-29,7904300.0,82.01000213623047,82.6500015258789,81.80999755859375,82.08000183105469,70.6082763671875,GILD,"Array BioPharma Collaborates with Biogen - Analyst Blog ||| Intercept's Obeticholic Acid Gets Fast Track Status - Analyst Blog ||| BioMarin's Pipeline Advances - Analyst Blog ||| Valeant Ups Offer for Allergan - Analyst Blog ||| Xenoport, Inc. (XNPT) Soars: Stock Up 5.9% - Tale of the Tape ||| GTX Inc. (GTXI) Soars: Stock Up 9.7% - Tale of the Tape ||| Orexigen (OREX) in Focus: Stock Moves 6.1% Higher - Tale of the Tape",0,0.4985191
2014-05-30,11058500.0,81.7699966430664,82.0999984741211,80.47000122070312,81.20999908447266,69.85984802246094,GILD,Update on Bayer's Xarelto - Analyst Blog ||| Oncothyreon Collaborates with Celldex - Analyst Blog,1,0.5398257
2014-06-02,7598000.0,81.31999969482422,81.80000305175781,80.75,81.55000305175781,70.1523208618164,GILD,"Retrophin (RTRX) Jumps: Stock Adds 13.5% in Session - Tale of the Tape ||| Encouraging Data on Pharmacyclics/J&J Drug - Analyst Blog ||| Stock Market News for June 02, 2014 - Market News ||| PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for June 03, 2014 ||| Roche Acquires Genia Technologies - Analyst Blog ||| Merck Presents Positive Trial Results For Cancer Drug ||| Myriad Genetics to Unveil BRACAnalysis, HRD Data - Analyst Blog ||| Allergan Inc. (AGN) in Focus: Stock Rises 5.65% - Tale of the Tape ||| Value Of U.S. Equity Buybacks In May Drops",1,0.49128798
2014-06-03,8249600.0,81.2699966430664,82.81999969482422,81.20999908447266,82.55000305175781,71.0125732421875,GILD,"Applied Genetic (AGTC) Soars: Stock Up 44.1% - Tale of the Tape ||| Data on Incyte's Jakafi - Analyst Blog ||| Data on Bristol-Myers' Yervoy - Analyst Blog ||| Puma Biotech Crashes on PB272 Study News - Analyst Blog ||| Myriad Genetics Posts Key myPath Melanoma Data - Analyst Blog ||| Valeant Relentless on Acquiring Allergan - Analyst Blog ||| UPDATE: Gilead Reports Updated Phase 2 Results for Investigational GS-9973, Showed 49% Overall Response Rate with Est. Progression-Free Survival Rate at 24 Weeks 70% ||| Gilead Reports Updated Phase 2 Results for Investigational GS-9973, Showed 49% Overall Response Rate with Est. Progression-Free Survival Rate at 24 Weeks 70%",1,0.5025385
2014-06-04,9055500.0,82.26000213623047,83.29000091552734,82.0199966430664,83.0199966430664,71.4168701171875,GILD,"Biotech Stock Roundup: Gilead, Pharmacyclics Impress at ASCO - Analyst Blog",0,0.50998104
2014-06-05,8423500.0,83.45999908447266,83.45999908447266,82.44999694824219,82.80000305175781,71.2276382446289,GILD,MannKind Corp. (MNKD) Soars: Stock Adds 10.8% in Session - Tale of the Tape ||| Halozyme Study Clinical Hold Lifted by FDA - Analyst Blog ||| Roche's Ventana Collaborates with AstraZeneca's MedImmune - Analyst Blog ||| Bristol-Myers Focuses on India - Analyst Blog ||| Vanda Up on EU News - Analyst Blog ||| Positive Data on Vertex Pharma's Kalydeco - Analyst Blog,0,0.5003936
2014-06-06,9104500.0,83.23999786376953,83.23999786376953,81.72000122070312,82.38999938964844,70.87493896484375,GILD,"Affymetrix, BioDiscovery Launch Cancer Research Software - Analyst Blog ||| Pipeline Progress at GlaxoSmithKline - Analyst Blog ||| Clovis Oncology (CLVS) Jumps: Stock Rises 6.2% - Tale of the Tape ||| Celldex Therapeutics (CLDX) Soars: Stock Adds 12.6% in Session - Tale of the Tape ||| Curis Re-Initiates Dosing for CUDC-427 - Analyst Blog ||| MannKind Hits 52-Week High - Analyst Blog ||| Alkermes' Pipeline Holds Promise - Analyst Blog",0,0.5005051
2014-06-09,23319200.0,81.38999938964844,81.5,78.5,79.01000213623047,67.96732330322266,GILD,"Aerie Pharmaceuticals, Inc. (AERI) in Focus: Stock Rises 5.71% - Tale of the Tape ||| Mid-Morning Market Update: Markets Edge Higher; Tyson Wins Bidding Battle To Buy Hillshire Brands For $63/Share ||| Novavax (NVAX) Crumbles: Stock Tumbles by 7.7% - Tale of the Tape ||| Pre-Market Most Active for Jun 9, 2014 : HSH, IDIX, WU, ACHN, AAPL, FDO, RIO, YELP, DG, FB, MNKD, GILD ||| BioDelivery Sciences' Bunavail Gets FDA Nod - Analyst Blog ||| GW Pharma Gets Fast-Track Designation for Epidiolex - Analyst Blog ||| Orexigen's Upcoming Pipeline Catalyst - Analyst Blog ||| Pipeline Progress at Momenta - Analyst Blog ||| Are Gilead Shares Overreacting To Merck's Idenix Acquisition? ||| Mid-Morning Market Update: Markets Edge Higher; Tyson Wins Bidding Battle To Buy Hillshire Brands For $63/Share ||| Hepatitis C Stocks Move After Idenix Rockets Up 235% ||| Benzinga's Top #PreMarket Losers",1,0.49116707
2014-06-10,11293800.0,79.27999877929688,79.94000244140625,78.73999786376953,79.54000091552734,68.42327117919922,GILD,"Closing the Books on Q1 Earnings Season - Earnings Trends ||| AVEO Pharmaceuticals, Inc. (AVEO) in Focus: Stock Rises 7.8% - Tale of the Tape ||| Strength Seen in Inovio (INO): Stock Rises 9.4% - Tale of the Tape ||| Why Puma Biotechnology (PBYI) Could Be Positioned for a Slump - Tale of the Tape ||| Idenix Pharmaceuticals (IDIX) Soars: Stock Rises 229.1% - Tale of the Tape ||| Pharmacyclics' Imbruvica Under FDA Priority Review - Analyst Blog ||| Achillion Pharmaceuticals (ACHN) in Focus: Stock Rises 47.6% - Tale of the Tape ||| Agios Initiates Trial on AG-348 - Analyst Blog ||| Closing the Books on Q1 Earnings Season - Earnings Outlook ||| Integra Lifesciences Down to Sell on Poor Q1 Segment Show - Analyst Blog ||| Idenix Skyrockets on Merck Acquisition Deal, Focus on HCV - Analyst Blog ||| Immunomedics' IMMU-132 Gets Orphan Drug Status - Analyst Blog ||| Cubist Pharma's Antibiotics Portfolio Holds Promise - Analyst Blog",1,0.51089346
2014-06-11,11865400.0,79.36000061035156,81.80000305175781,79.30999755859375,80.81999969482422,69.52435302734375,GILD,"Bristol-Myers' RA Drug Orencia Encouraging - Analyst Blog ||| Strength Seen in Receptos, Inc. (RCPT) as Stock Shoots up 36.78% - Tale of the Tape ||| Allergan Rejects Valeant's Proposal Yet Again - Analyst Blog ||| Achillion Surges Two Days in a Row, HCV in Focus - Analyst Blog ||| Merck KGaA/Auxogyn's Eeva System Gets FDA Clearance - Analyst Blog ||| Centene Dodges Bullets In Changing Medicaid Landscape ||| Alkermes Progresses with its Late Stage Candidate - Analyst Blog ||| NPS Pharma's Natpara Likely to be Reviewed in September - Analyst Blog",0,0.47729772
2014-06-12,7080000.0,80.80000305175781,81.56999969482422,80.33000183105469,80.58000183105469,69.31790161132812,GILD,Orexigen Therapeutics (OREX) in Focus: Stock Tumbles 14.7% - Tale of the Tape ||| Avanir Gains - AVP-825 Hits Phase III Primary Endpoint - Analyst Blog ||| Roche's HPV Test Approved in Canada - Analyst Blog ||| Encouraging Long-Term Data on Celgene's Otezla - Analyst Blog ||| Geron Corp. (GERN) Soars: Stock Up 10.6% - Tale of the Tape ||| Vital Therapies (VTL) Catches Eye: Stock Surges 20.7% - Tale of the Tape ||| Genomic Health's Oncotype DX Redefines Breast Cancer Therapy - Analyst Blog ||| Auxilium Pharma Launches Authorized Generic Testim - Analyst Blog ||| Ocera Therapeutics (OCRX) Soars: Stock Adds 11.8% in Session - Tale of the Tape ||| Orexigen Slumps as Obesity Drug Approval Delayed - Analyst Blog ||| Eli Lilly's Cyramza Misses Primary Goal in Liver Cancer Study - Analyst Blog ||| Amgen-AstraZeneca Psoriatic Arthritis Drug Shows Improvement - Analyst Blog ||| Achillion Pharmaceuticals (ACHN) in Focus: Stock Falls 6.4% - Tale of the Tape,1,0.5266364
2014-06-13,7695100.0,80.68000030517578,81.0999984741211,79.87000274658203,80.72000122070312,69.4383316040039,GILD,"Shire to Conduct Trials on Vyvanse on FDA's Request - Analyst Blog ||| Bristol-Myers Suffers a Legal Setback - Analyst Blog ||| BIND Therapeutics (BIND) Soars: Stock Up 6.8% - Tale of the Tape ||| Progenics Pharmaceuticals, Inc. (PGNX) in Focus: Stock Rises 9.23% - Tale of the Tape ||| AstraZeneca Boosts Pipeline with $232 Million Synairgen Deal - Analyst Blog ||| Sanofi/ Regeneron Present Postive Data on Sarilumab - Analyst Blog ||| J&J, ViiV Healthcare Tie Up for Single-Tablet HIV Treatment - Analyst Blog ||| Vertex Pharmaceuticals' New Kalydeco Data Out - Analyst Blog ||| Relief for Nektar after AADPAC Voting - Analyst Blog",1,0.5220165
2014-06-16,7356500.0,80.87000274658203,81.38999938964844,80.41000366210938,80.7699966430664,69.48135375976562,GILD,"Gilead Phase 3 Data Show Fixed-Dose Combination of Ledipasvir/Sofosbuvir Achieved 100 Percent Sustained Virologic Response Among Patients with Chronic Hepatitis C in Japan ||| Actelion's Selexipag Meets Primary Endpoint - Analyst Blog ||| Gilead's HCV Combination Therapy Data Looks Promising - Analyst Blog ||| Celgene's Vidaza Disappoints in Phase III Study - Analyst Blog ||| Sector Update: Shares Mixed Pre-Market; Gilead Lifts on Phase 3 Results for Hepatitis C Treatment ||| Sector Update: Healthcare ||| What Falling Estimates & Price Mean for Rexahn Pharmaceuticals (RNN) - Tale of the Tape ||| Sanofi's Diabetes Portfolio in Focus at American Diabetes Association Sessions - Analyst Blog ||| Novo Nordisk's Victoza 3 mg Positive in Phase III - Analyst Blog ||| OncoMed's OMP-18R5 On Clinical Hold, Shares Down - Analyst Blog ||| Integra LifeSciences, Premier Ink 3-Year Purchase Deal - Analyst Blog ||| AbbVie Gets Priority Review from FDA for HCV Treatment - Analyst Blog ||| Karyopharm Therapeutics Skyrockets on Drug Trial News - Analyst Blog ||| Benzinga's M&A Chatter for Monday June 16, 2014",0,0.5171688
2014-06-17,11141300.0,80.7300033569336,80.87000274658203,79.55999755859375,79.79000091552734,68.6383056640625,GILD,"Vertex Pharmaceuticals Crumbles on Analyst Worries - Analyst Blog ||| Orexigen (OREX) in Focus: Stock Moves 7.5% Higher - Tale of the Tape ||| Sequenom Inc. (SQNM) Soars: Stock Rises 9.2% - Tale of the Tape ||| J&J's Velcade in Focus at the European Hematology Association - Analyst Blog ||| Ligand Pharma's LGD-6972 Positive in Phase I Study - Analyst Blog ||| Strength Seen in bluebird bio, Inc. (BLUE) as Stock Shoots up 32.08% - Tale of the Tape ||| Glaxo's Promacta Holds Promise - Analyst Blog ||| Valeant Receives FDA's Clearance for Restylane - Analyst Blog ||| Novartis Submits Bexsero to FDA for Marketing Approval - Analyst Blog",0,0.49775922
2014-06-18,10436400.0,79.8499984741211,79.98999786376953,78.83000183105469,79.47000122070312,68.36304473876953,GILD,"Alexion's Soliris Gets Orphan Drug Status for New Indication - Analyst Blog ||| Pfizer Ties Up with Cellectis for Cancer Immunotherapy - Analyst Blog ||| AVEO Pharmaceuticals (AVEO) Catches Eye: Stock Up 11.4% - Tale of the Tape ||| Merck KGaA-Ono Pharma Deal Ends - Analyst Blog ||| Advances In HIV, Hep C Treatments Could Spark Renewed Interest In Biotech Stocks",1,0.5158771
2014-06-19,10967200.0,79.47000122070312,80.5,78.87999725341797,79.77999877929688,68.62970733642578,GILD,"Intra-Cellular Therapies, Inc. (ITCI) in Focus: Stock Rises 8.74% - Tale of the Tape ||| Applied Genetic Technologies (AGTC) Jumps: Stock Up 6.1% - Tale of the Tape ||| Ultragenyx Pharmaceutical (RARE) Jumps: Stock Up 6.5% - Tale of the Tape ||| Insmed Incorporated (INSM) Catches Eye: Stock Surges 42.6% - Tale of the Tape ||| Alkermes' Aripiprazole Lauroxil Looks Promising - Analyst Blog ||| Valeant Launches Hostile Bid for Allergan - Analyst Blog ||| Acorda Therapeutics (ACOR) in Focus: Stock Moves 7.8% Higher - Tale of the Tape ||| Protalix Drug in Phase IIa Study for Gaucher Disease - Analyst Blog ||| Vertex Pharmaceuticals-Johnson & Johnson Collaborate on Flu Drug - Analyst Blog ||| Forest Laboratories Nabs Pediatric Exclusivity for Namenda - Analyst Blog ||| BioLineRx to Commence BL-8040 Study - Analyst Blog ||| Gilead Shares Spiker Lower; May be Attributed to Congressional Probe into Sovaldi Pricing",1,0.4937237
2014-06-20,14042000.0,80.13999938964844,81.55000305175781,79.68000030517578,81.19999694824219,69.85124206542969,GILD,Celgene Rises on Yet Another Stock Split - Analyst Blog ||| AstraZeneca's Naloxegol Data Published - Analyst Blog ||| OncoMed's OMP-54F28 on Partial Clinical Hold - Analyst Blog ||| Merge Healthcare: Updated Research Report - Analyst Blog ||| Illumina: Updated Research Report - Analyst Blog,0,0.49768332
2014-06-23,7481800.0,81.2699966430664,82.2300033569336,80.58000183105469,80.80000305175781,69.50714874267578,GILD,Novo Nordisk Reveals Positive Data on Victoza 3 mg - Analyst Blog ||| RegeneRx and Lee's Pharmaceutical Dry Eye Drug Progresses - Analyst Blog ||| Cubist Gains FDA Approval for Sivextro - Analyst Blog ||| Strength Seen in Cara Therapeutics Inc. (CARA) as Stock Rallies 19.60% - Tale of the Tape ||| Merrimack Falls Steeply as Sanofi Returns Oncology Drug Rights - Analyst Blog ||| Alkermes plc (ALKS) Jumps: Stock Rises 5.7% - Tale of the Tape,1,0.50470364
2014-06-27,10397800.0,82.22000122070312,83.37999725341797,81.6500015258789,82.94000244140625,71.34807586669922,GILD,Gilead Submits NDA to Japan's Pharmaceutical and Medical Devices Agency for Sofosbuvir for Chronic Hepatitis C,0,0.51706123
2014-06-30,10882500.0,82.8499984741211,84.44999694824219,82.62999725341797,82.91000366210938,71.32225036621094,GILD,"IYH, PFE, GILD, ABT: Large Inflows Detected at ETF ||| Gilead Seeks Japanese Approval for Sovaldi - Analyst Blog ||| UPDATE: Morgan Stanley Reiterates On Gilead Sciences On EM Sovaldi",1,0.49789563
2014-07-02,13949300.0,85.55000305175781,87.87999725341797,85.37999725341797,87.0999984741211,74.9266586303711,GILD,"Nasdaq 100 Movers: PAYX, LMCA ||| Biotech Stock Roundup: Vertex Jumps on Phase III Data, MannKind Scores FDA Approval - Analyst Blog ||| Option Alert: Gilead Aug $95 Call; 9,227 Contracts Traded vs 3,595 OI; Currently $87.67",1,0.49216717
2014-07-03,9126100.0,87.69999694824219,88.4000015258789,87.05000305175781,87.9000015258789,75.6148452758789,GILD,"Merck, Gilead Lead Race To Eradicate Hepatitis C ||| Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector",0,0.5017033
2014-07-07,11474000.0,88.05999755859375,88.5999984741211,86.98999786376953,87.20999908447266,75.02127075195312,GILD,FDA Warns Gilead on Marketing oF Hepatitis B Drug Viread,0,0.51021117
2014-07-08,11727100.0,86.83999633789062,87.5199966430664,86.02999877929688,87.11000061035156,74.93524932861328,GILD,Bristol-Myers Gains Japanese Approval for HCV Combo Drug - Analyst Blog ||| Alexion Pharma Looks To Life Beyond Its Blockbuster,1,0.5351625
2014-07-10,9521200.0,87.18000030517578,89.25,86.30999755859375,88.94000244140625,76.50949096679688,GILD,J.P. Morgan: Johnson & Johnson's Drug Segment May Beat Q2 Street Views,0,0.50387794
2014-07-11,11268700.0,88.9000015258789,89.9800033569336,88.25,88.7300033569336,76.32882690429688,GILD,Sector Update: Health Care Stocks Ending Mixed; Achillion Pharmaceutical Easing From M&A-Fueled Afternoon Rally ||| Sector Update: Health Care ||| Markets Close Higher Ahead Of Busy Earnings Season ||| Stocks Hitting 52-Week Highs ||| Wyden and Grassley Seek Details on Gilead's Solvaldi Pricing,1,0.5152747
2014-07-14,10729000.0,89.12999725341797,90.2699966430664,88.83999633789062,89.8499984741211,77.29229736328125,GILD,Hefty Price Tag of Gilead's Sovaldi Questioned Again - Analyst Blog ||| 2 Biotech Stocks That Crushed On Earnings,0,0.4944916
2014-07-16,14259700.0,89.4000015258789,89.44000244140625,85.81999969482422,87.0,74.84062194824219,GILD,"Biotech Stock Roundup: AbbVie Woos Shire with Revised Offer, Sarepta Slips on Eteplirsen Data - Analyst Blog",0,0.50406307
2014-07-18,13236100.0,85.7300033569336,89.75,85.30000305175781,89.19000244140625,76.72454833984375,GILD,"Nasdaq 100 Movers: NVDA, AVGO ||| Investors Focus On Earnings Rather Than Geopolitical Tensions ||| Biotech Enters Reporting Season With Large Caps Central To Sector Performance",0,0.50204694
2014-07-21,13822000.0,89.80000305175781,90.9800033569336,88.80999755859375,88.86000061035156,76.440673828125,GILD,Biogen Shares Rebound As Street Has A Change Of Heart,1,0.5134229
2014-07-22,12302900.0,89.31999969482422,89.9000015258789,88.58000183105469,89.33000183105469,76.84497833251953,GILD,Will Gilead (GILD) Earnings Disappoint in Q2 as Costs Rise? - Analyst Blog,1,0.5140482
2014-07-23,17694800.0,90.0999984741211,90.7300033569336,89.29000091552734,90.33999633789062,77.71380615234375,GILD,"After Hours Most Active for Jul 23, 2014 : FB, MDAS, QQQ, GILD, QCOM, F, ARIA, T, XRX, CX, BID, ABBV ||| Biotech Stock Roundup: AbbVie's Tax Inversion, Amgen Drug Scores in Phase 3 - Analyst Blog ||| Markets Mostly Higher As Earnings Season Continues To Impress ||| Shares of Gilead Resume Trade, Trading Very Slightly Lower, Down ~0.5% from Close ||| Gilead Reports Q2 Sovaldi Sales $3.48B ||| PREVIEW: Gilead Sciences to Resume Trading at 4:30 PM ET ||| Gilead Sciences, Inc. Sees FY2014 Sales $21.0B-23.0B vs $22.63B Est ||| Gilead Sciences, Inc. Reports Q2 EPS of $2.36 vs $1.79 Est; Revenue of $6.53B vs $5.86B Est ||| Gilead Halted Ahead of Earnings ||| Statement from FDA Confirms Approval of Gilead's Zydelig ||| FDA Statement Shows Approval for Gilead's Zydelig - Bloomberg ||| Earnings Scheduled For July 23, 2014",1,0.48842892
2014-07-24,23546700.0,91.55999755859376,92.97000122070312,89.88999938964844,90.54000091552734,77.88585662841797,GILD,Gilead Crushes Q2 Earnings Estimates as Sovaldi Sales Soar - Analyst Blog ||| Alexion Pharmaceuticals Q2 Earnings In Line; Revises View - Analyst Blog ||| Healthcare Spending to Trend Up in 2015: 3 Healthcare Fund Picks - Best of Funds ||| Gilead Beats Q2 Views On Revenue Growth Lead By Sovaldi Drug,0,0.49471036
2014-07-25,13059400.0,90.68000030517578,90.77999877929688,88.69999694824219,89.83999633789062,77.28368377685547,GILD,"Noteworthy ETF Inflows: XLV, MRK, GILD, CELG ||| EU Medicines Agency Recommends Gilead Leukemia Drug Idelalisib",1,0.52637017
2014-07-28,14066500.0,90.0999984741211,91.7300033569336,89.93000030517578,91.45999908447266,78.67727661132812,GILD,"#PreMarket Primer: Monday, July 28: Tension Between U.S. And Israel On The Rise ||| Biotech ETF Price Swings May Signal Need For Caution ||| Pharmacyclics/Johnson & Johnson Drug Backed for EU Approval - Analyst Blog ||| #PreMarket Primer: Monday, July 28: Tension Between U.S. And Israel On The Rise",1,0.5065063
2014-07-30,10753800.0,94.3000030517578,94.33999633789062,93.55999755859376,93.79000091552734,80.681640625,GILD,"Biotech Stock Roundup: Gilead's Sovaldi & Biogen's Tecfidera Impressive Run Continues - Analyst Blog ||| Merck, J&J, Baxter Provide Healthy Dividend Stream",0,0.47794458
2014-07-31,13429400.0,93.0,93.37000274658205,91.25,91.5500030517578,78.75472259521484,GILD,Can the Earnings Rebound be Sustained? - Earnings Trends ||| Can the Earnings Rebound be Sustained? - Earnings Outlook,0,0.4843171
2014-08-04,11030000.0,92.0,92.88999938964844,91.5199966430664,92.18000030517578,79.29663848876953,GILD,"XLV, MRK, GILD, UNH: Large Outflows Detected at ETF ||| TD Ameritrade Client Activity Jumped In July, Back To March Levels",1,0.5067527
2014-08-06,11016200.0,91.5,93.0199966430664,91.08999633789062,92.79000091552734,79.82141876220703,GILD,Q3 Earnings Estimates Not Falling As Much - Earnings Trends ||| Why Investors Should Closely Watch Celgene,0,0.503818
2014-08-07,8804600.0,93.5500030517578,93.63999938964844,91.66000366210938,92.0500030517578,79.18482971191406,GILD,"#PreMarket Primer: Thursday, August 7: Russia Set To Release A List Of Banned Goods ||| #PreMarket Primer: Thursday, August 7: Russia Set To Release A List Of Banned Goods ||| Top 4 Stocks In The Biotechnology Industry With The Highest Revenue",1,0.51239806
2014-08-08,9820800.0,91.83999633789062,92.54000091552734,90.81999969482422,92.4499969482422,79.52890014648438,GILD,Market Strategy: Play Energy & IT - Analyst Blog,1,0.53467417
2014-08-11,8575000.0,93.13999938964844,93.30999755859376,92.5199966430664,92.91999816894533,79.93323516845703,GILD,"Alnylam's Q2 Loss Wider-than-Expected, Pipeline in Focus - Analyst Blog ||| Medivation Jumps on Q2 Earnings Beat, Outlook Encourages - Analyst Blog ||| Emergent BioSolutions Misses on Earnings, Ups Revenue View - Analyst Blog ||| Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for August 12, 2014 ||| MannKind Enters into a Global Deal with Sanofi for Afrezza - Analyst Blog ||| After Hours Most Active for Aug 11, 2014 : KMI, QQQ, MU, SQNM, GILD, NUAN, AMKR ||| Tekmira Pharma Soars on FDA Announcement over Ebola Drug - Analyst Blog",1,0.5069035
2014-08-12,10587800.0,92.6999969482422,93.37999725341795,92.51000213623048,93.36000061035156,80.31171417236328,GILD,"After Hours Most Active for Aug 12, 2014 : KING, QQQ, RAD, XRX, NVDA, TD, KMI, CAT, EA, GILD, MSFT, MRVL ||| Spectrum Pharmaceuticals (SPPI) Posts Strong Earnings in Q2 - Analyst Blog ||| MannKind Posts Wider Q2 Loss, Up on Sanofi Deal for Afrezza - Analyst Blog ||| Anacor's Q2 Loss Narrower than Expected, Kerydin in Focus - Analyst Blog ||| OvaScience (OVAS) Shows Strength: Stock Up 7% - Tale of the Tape ||| Tekmira Shares Continue to Rise in the Search for Ebola Cure - Analyst Blog ||| What is Your Stock's Earnings Yield? - Screen of the Week ||| Sarepta Therapeutics Reports Wider Y/Y Loss, Revenues Miss - Analyst Blog ||| Five Prime Therapeutics (FPRX) Jumps: Stock Adds 10.3% in Session - Tale of the Tape",1,0.5061461
2014-08-13,13027400.0,93.5,94.61000061035156,93.33999633789062,93.9800033569336,80.8450698852539,GILD,"IWF, KO, GILD, ORCL: Large Inflows Detected at ETF ||| Intercept Pharmaceuticals Posts Earnings, Pipeline in Focus - Analyst Blog ||| ETF Outlook: SPDR S&P Biotech ETF (XBI) ||| Dendreon Down on Default Risk, Reports Narrower Q2 Loss - Analyst Blog ||| BioDelivery Sciences Q2 Loss Narrows, Up on Solid Revenues - Analyst Blog",1,0.5001979
2014-08-14,12344200.0,94.58000183105467,96.37000274658205,94.23999786376952,96.36000061035156,82.89244079589844,GILD,"Gilead Sciences (GILD): Plenty Of Room To Run ||| After Hours Most Active for Aug 14, 2014 : JCP, CIE, KMI, QQQ, GFI, ULTI, SIRI, KING, CAT, PTEN, GILD, GLUU ||| Strong Earnings Season Winding Down - Earnings Trends ||| Strong Earnings Season Winding Down - Earnings Outlook ||| Should Gilead Sciences (GILD) Be in Your Portfolio? - Stocks in the News ||| Shares of Intercept Moving Higher; Report of Tweet Mentioning Potential Deal by Gilead being Passed Around, Totally Unconfirmed",1,0.5020904
2014-08-15,19714200.0,98.41999816894533,99.48999786376952,97.0199966430664,99.48999786376952,85.58497619628906,GILD,"Array BioPharma Falls Despite Narrower-than-Expected Q4 Loss - Analyst Blog ||| Closing Update: Nasdaq Closes Higher in Afternoon Rebound But Dow, S&P 500 Finish in the Red on Russia-Ukraine Worries ||| A Double Dose of Good News for Gilead Sciences, Inc. ||| Sector Update: Health Care Stocks Turn Mixed at Close; Achillion Pharma Spikes After Hep C Drug Candidate Performs Well in Phase II Testing ||| Sector Update: Health Care ||| Why Achillion Pharmaceuticals, Inc. Stock Soared ||| Markets Close The Week On Negative Note As Ukraine Worries Mount ||| Gilead Shares Rise in Premarket as UK's National Institute for Health and Care Excellence Recommends English Health System Pays for Sovaldi, Also Gets Favorable Ruling vs Roche in Arbitration",1,0.49221814
2014-08-18,14755700.0,100.44000244140624,101.5,100.08000183105467,100.72000122070312,86.6430892944336,GILD,"CNBC's Stock Pops & Drops From August 15 ||| Techne Corporation (TECH) Ex-Dividend Date Scheduled for August 19, 2014 ||| #PreMarket Primer: Monday, August 18: Jackson Hole Draws Market Attention ||| Achillion Pharmaceuticals Soars on Mid-Stage HCV Study Data - Analyst Blog ||| Should Achillion Pharma (ACHN) Be In Your Portfolio Now? - Stocks in the News ||| #PreMarket Primer: Monday, August 18: Jackson Hole Draws Market Attention",1,0.49509686
2014-08-19,16300900.0,101.43000030517578,101.6500015258789,99.33000183105467,101.27999877929688,87.12480926513672,GILD,"Celladon Corp. (CLDN) Jumps: Stock Adds 11.3% in Session - Tale of the Tape ||| PDL BioPharma Misses on Q2 Earnings due to Higher Expenses - Analyst Blog ||| Will Roche (RHHBY) Buy the Remaining Stake in Chugai? - Analyst Blog ||| After Hours Most Active for Aug 19, 2014 : BAC, XOM, AAPL, QQQ, MET, MSFT, NOK, CAT, BBD, MDLZ, GILD, ACHN ||| Biogen Strengthens MS Portfolio with Plegridy FDA Approval - Analyst Blog ||| Pfizer Submits Palbociclib Marketing Application to the FDA - Analyst Blog",0,0.4728478
2014-08-20,12590600.0,100.70999908447266,102.56999969482422,100.61000061035156,100.79000091552734,86.70327758789062,GILD,"Emergent BioSolutions, MorphoSys Tie Up on Cancer Candidate - Analyst Blog ||| 3 Reasons Gilead Science, Inc.’s Stock Could Rise ||| Healthcare Enjoys Growth Trends: 3 Medical Stocks to Buy - Analyst Blog ||| Record Earnings & Stronger Growth in Q2 - Earnings Trends ||| Record Earnings & Stronger Growth in Q2 - Earnings Outlook ||| Oncothyreon (ONTY) Slumps, Tecemotide Fails Phase I/II Study - Analyst Blog",1,0.53278375
2014-08-21,9799500.0,101.0,102.30999755859376,100.86000061035156,102.2699966430664,87.9764633178711,GILD,"Discovery Laboratories (DSCO) Worth Watching: Stock Up 6.9% - Tale of the Tape ||| VTI, MRK, KO, GILD: Large Inflows Detected at ETF ||| Amicus Therapeutics (FOLD) Worth Watching: Stock Rises 20.4% - Tale of the Tape ||| Bristol-Myers, Celgene Pair Up for Oncology Combo Treatments - Analyst Blog ||| Nasdaq 100 Movers: SPLS, GILD ||| Achillion Attains 52-Week High on ACH-3102 Patent Protection - Analyst Blog ||| Amicus Therapeutics (FOLD) Soars on Fabry Drug Trial Results - Analyst Blog",1,0.5067745
2014-08-22,13255900.0,103.0199966430664,105.16000366210938,102.61000061035156,103.95999908447266,89.43025970458984,GILD,Why Gilead Sciences (GILD) Could Beat Earnings Estimates Again - Tale of the Tape ||| Bristol-Myers/Pfizer's Eliquis Gets Yet Another FDA Nod - Analyst Blog ||| Data on Celgene's Revlimid Published in Oncology Journal - Analyst Blog ||| 3 Reasons Bristol-Myers Squibb's Stock Could Rise ||| Amgen Upgraded to Strong Buy - Analyst Blog,1,0.50163394
2014-08-25,19882000.0,105.11000061035156,107.52999877929688,105.11000061035156,107.4499969482422,92.43245697021484,GILD,"CNBC's Stock Pops & Drops From August 22 ||| OncoMed Pharmaceuticals (OMED) in Focus: Stock Rises 5.1% - Tale of the Tape ||| Nasdaq 100 Movers: INTU, GILD ||| S&P 500 Movers: STZ, GILD ||| 3 Reasons Johnson & Johnson's Stock Could Fall ||| More Biotech Mergers: Roche to Acquire InterMune (ITMN) - Stocks in the News ||| Cubist Pharmaceuticals' Antibiotic Accepted for EU Review - Analyst Blog ||| InterMune's Roche Deal Sends Peer Group Up",0,0.47169927
2014-08-26,18799900.0,108.05999755859376,108.72000122070312,104.7699966430664,106.2699966430664,91.41739654541016,GILD,"Cardiome Pharma Signs Agreement with Eurolab for Brinavess - Analyst Blog ||| TrovaGene (TROV) Jumps: Stock Rises 9.2% - Tale of the Tape ||| Gilead (GILD) Shares March Higher, Can It Continue? - Tale of the Tape ||| InterMune (ITMN) Worth Watching: Stock Rises 35.4% - Tale of the Tape ||| Nasdaq 100 Movers: GILD, TSCO ||| Kite Pharma Drug Fares Well in Non-Hodgkin's Lymphoma Study - Analyst Blog ||| VIVUS Acquires Certain Topamax Related Patents from J&J - Analyst Blog ||| Alkermes Gains on Aripiprazole Lauroxil NDA Submission - Analyst Blog ||| #PreMarket Primer: Tuesday, August 26: US Gathers Intelligence In Syria ||| Deutsche Bank Has Added Gilead, Celgene to 'Short-Term Buy' List - Bloomberg ||| #PreMarket Primer: Tuesday, August 26: US Gathers Intelligence In Syria",1,0.5016978
2014-08-27,16164800.0,106.5500030517578,108.7699966430664,105.76000213623048,107.41000366210938,92.3980712890625,GILD,"Is It Time to Buy AbbVie Stock? ||| Amicus Therapeutics Hits 52-Week High on Migalastat Data - Analyst Blog ||| 3 Reasons Pfizer Inc.'s Stock Could Fall ||| Isis Pharmaceuticals, Inc. (ISIS) Surges: Stock Moves 10.8% Higher - Tale of the Tape ||| Celldex Therapeutics (CLDX) Worth Watching: Stock Rises 9.1% - Tale of the Tape ||| #PreMarket Primer: Wednesday, August 27: Israel And Hamas To Resume Peace Talks In Cairo ||| Biotech ETFs Hitting New Highs On Takeover News (FBT, PBE, ITMN) ||| Seeing Very High Social Activity on Gilead Shares as Stock Crosses $108 Level, Shares Up 2% ||| #PreMarket Primer: Wednesday, August 27: Israel And Hamas To Resume Peace Talks In Cairo",1,0.51536983
2014-08-28,10301600.0,107.0,108.11000061035156,106.73999786376952,107.51000213623048,92.48410034179688,GILD,"Q2 Earnings Season in Rearview Mirror - Earnings Outlook ||| Guggenheim S&P 500 Equal Weight ETF Experiences Big Inflow ||| Has Gilead Sciences, Inc.'s Star Drug Already Peaked? ||| Bristol-Myers' Oral HCV Treatment Daklinza Gets EU Clearance - Analyst Blog ||| Amgen's Chronic Heart Failure Drug Gets Priority Review - Analyst Blog ||| Bristol-Myers Squibb's Daklinza Threatens Johnson & Johnson More Than Gilead Sciences ||| MediciNova Rises on FDA's Nod on MN-166 Study Initiation - Analyst Blog ||| Allergan Seeks Court Order to Stop Valeant, Affiliates - Analyst Blog ||| Q2 Earnings Season in Rearview Mirror - Earnings Trends ||| BioTime's AST-OPC1 Cleared by FDA for Phase I/IIa Study - Analyst Blog ||| Aegerion Resolves FDA's Warning on Juxtapid, Lifts Overhang - Analyst Blog",1,0.54213357
2014-08-29,11318200.0,107.9000015258789,108.23999786376952,106.77999877929688,107.55999755859376,92.527099609375,GILD,"Protalix BioTherapeutics, Inc. (PLX) Jumps: Stock Adds 8.3% in Session - Tale of the Tape ||| OncoMed Pharmaceuticals (OMED) in Focus: Stock Up 9.9% - Tale of the Tape ||| Why Gilead Sciences (GILD) Could Be Positioned for a Surge? - Tale of the Tape ||| Regeneron Pharmaceuticals' Pipeline Progress Raises Costs - Analyst Blog ||| Pfizer's C. Difficile Vaccine Gets Fast Track Status - Analyst Blog ||| Protalix/Pfizer's Elelyso Approved in Pediatric Patients - Analyst Blog ||| Momenta-Sandoz's Generic Copaxone Accepted for Review by FDA - Analyst Blog ||| Isis Pharmaceuticals Starts Phase III Study on ISIS-APOCIIIRx - Analyst Blog ||| What You Need to Know About the Roche-InterMune Deal",1,0.47068954
2014-09-02,15275700.0,108.16999816894533,109.5,107.61000061035156,109.36000061035156,94.07553100585938,GILD,"3 Simple Ways to Invest Like George Soros ||| Mike Khouw's Gilead Sciences Trade ||| Ambit Biosciences (AMBI) Jumps: Stock Up 6.6% - Tale of the Tape ||| PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for September 03, 2014 ||| Bristol-Myers/Pfizer's Eliquis Encourages in VTE Analysis - Analyst Blog ||| AstraZeneca Reports Data on Brilinta from ATLANTIC Study - Analyst Blog ||| Bayer/Johnson & Johnson to Expand Xarelto Label Further - Analyst Blog ||| United Therapeutics Soars on Remodulin Patent Case Win - Analyst Blog ||| Novartis Releases Positive Data on LCZ696 for Heart Failure - Analyst Blog ||| BioCryst's Ebola Candidate Moving to Efficacy Study Soon - Analyst Blog ||| Biotechnology, Oil And Brazil ETFs To Watch This Week",1,0.520635
2014-09-03,14388400.0,110.0,110.63999938964844,108.33999633789062,109.43000030517578,94.1357421875,GILD,"Sanofi Reports Positive Phase III Data on Dengue Vaccine - Analyst Blog ||| Bristol-Myers Returns Clazakizumab Rights, Alder Sinks - Analyst Blog ||| Biotech Stock Roundup: United Therapeutics Up on Court Ruling, Amgen Files PCSK9 Inhibitor - Analyst Blog ||| Infinity Pharma (INFI) Shares Skyrocket on Cancer Drug Partnership - Stocks in the News ||| Alder Biopharmaceuticals Slumps: ALDR Tanks 13.2% in Session - Tale of the Tape ||| Arena Pharmaceuticals' APD811 Gets Orphan Drug Status - Analyst Blog ||| New Managers Revive Thrivent Large Cap Growth Fund ||| Bayer Discloses Encouraging Data on Anticoagulant Xarelto - Analyst Blog ||| ETF Insider: Q&A with Kevin Kelly of Recon Capital Partners ||| Three Stocks Top-Performing Funds Like: Facebook Baidu Gilead",0,0.49154893
2014-09-04,13757500.0,109.80999755859376,110.0,106.2699966430664,106.86000061035156,91.9249267578125,GILD,"Rexahn Pharmaceuticals (RNN) Jumps: Stock Rises 9.6% - Tale of the Tape ||| 3 Reasons Gilead Sciences, Inc.’s Stock Could Fall ||| Alkermes Completes Enrolment for Phase II ALKS 3831 Study - Analyst Blog ||| 3 Reasons Bristol-Myers Squibb's Stock Could Fall ||| J&J Ebola Vaccine Gets Funding, Development to Pick Pace - Analyst Blog",0,0.49906415
2014-09-05,36078400.0,106.4000015258789,106.5,97.54000091552734,105.36000061035156,90.63457489013672,GILD,"XOMA Corporation (XOMA) Jumps: Stock Rises 6.2% - Tale of the Tape ||| Markets Edge Lower; Zumiez Issues Weak Outlook ||| iShares Russell 1000 Growth ETF Experiences Big Inflow ||| Celgene's Revlimid Impresses in Phase III NDMM Study - Analyst Blog ||| Mallinckrodt's Pain Therapy Hits Phase III Primary Endpoint - Analyst Blog ||| Abbott Labs' FreeStyle Libre Flash Glucose Gets CE Mark - Analyst Blog ||| A Word On Healthcare Mutual Funds, And One Sector's 'Fittest' Segment ||| Markets Edge Lower; Zumiez Issues Weak Outlook ||| Why Gilead Sciences, Inc. Is A Top Mutual Fund Holding",1,0.49847433
2014-09-08,11930900.0,104.9499969482422,106.8499984741211,104.73999786376952,106.52999877929688,91.64103698730467,GILD,"CNBC's Stock Pops & Drops From September 5: Control4 Corp, Priceline Group Inc & More ||| Allianz's Analyst Likes Biogen Idec Inc, Celgene Corporation & Gilead ||| Fast Money Halftime Report Final Trade From September 5: American Eagle Outfitters, Delta Air Lines, Inc. & More ||| Is a Cheap Hepatitis C Cure About to Go Global? ||| BioDelivery Sciences (BDSI) Jumps: Stock Rises 8.9% - Tale of the Tape ||| Stock of the Week: Express Scripts (ESRX) ||| OncoMed's Shares Gain on Lifting of Partial Clinical Hold - Analyst Blog ||| Prana Biotechnology Up on Orphan Drug Status for PBT2 - Analyst Blog ||| Novartis (NVS) Presents Positive Data on Ultibro Breezhaler - Analyst Blog ||| Bayer/Regeneron Looking for Eylea Label Expansion in Japan - Analyst Blog ||| Bristol-Myers Sues Merck of Patent Infringement on Keytruda - Analyst Blog ||| Gilead Down on Likely Sovaldi Generic Deal in Poor Nations - Analyst Blog ||| ZIOPHARM Oncology (ZIOP) in Focus: Stock Rises 10.4% - Tale of the Tape ||| Keryx Biopharmaceuticals (KERX) Crumbles: Stock Falls by 5.5% - Tale of the Tape ||| Gilead Reports First-Line Combo Study of Ambrisentan, Tadalafil Met Primary Endpoint, Expecting to Submit Ambition Data by End of 2014",0,0.4695824
2014-09-09,14085700.0,106.9000015258789,106.9800033569336,104.31999969482422,105.88999938964844,91.09049987792967,GILD,Hospira Down on Legal Blow; Court Allows Generic Precedex - Analyst Blog ||| Glaxo (GSK) Updates on Asthma Candidate Mepolizumab - Analyst Blog ||| Pluristem & United Therapeutics Progress with Phase I Study - Analyst Blog ||| Have We Seen The Market's Top? ||| Hearing Cleveland Research Says Gilead Recently Started Cutting Pricing 8% for Sovaldi,1,0.52869207
2014-09-10,11246400.0,106.1999969482422,108.2300033569336,105.76000213623048,108.22000122070312,93.0948486328125,GILD,"Biotech ETFs Slip on Gilead Weakness; Buying Opportunity Now? - ETF News And Commentary ||| Stemline Therapeutics (STML) in Focus: Stock Up 12.3% - Tale of the Tape ||| PDL BioPharma Sees Higher-than-Expected Revenues in Q3 - Analyst Blog ||| Spectrum Pharmaceuticals to Advance Neutropenia Drug - Analyst Blog ||| Auxilium Pharmaceuticals to Restructure, Cut Jobs by 30% - Analyst Blog ||| Emergent BioSolutions Wins $29M Anthrax Vaccine Deal - Analyst Blog ||| Myriad Genetics Posts Encouraging myPath Melanoma Data - Analyst Blog ||| Biotech Stock Roundup: AbbVie Ties Up with Infinity, Keryx Slips on FDA Approval - Analyst Blog ||| Peregrine Pharmaceuticals' Q1 Loss Wider than Expected - Analyst Blog ||| Gilead Sciences, Inc. Could Be Taking A Break Before Even More Upside",0,0.49093768
2014-09-11,10470000.0,108.0,108.48999786376952,105.8000030517578,106.38999938964844,91.52062225341795,GILD,Why Gilead Sciences Stock Is Up 40% in 2014 ||| Momenta Gains on Purchase of Autoimmune Antibodies - Analyst Blog ||| Novartis Presents Data on Multiple Sclerosis Drug Gilenya - Analyst Blog ||| Mylan to Acquire U.S. Rights to Arixtra for up to $300M - Analyst Blog ||| Medivation Eyes Blockbuster As Cancer Drug Gets An OK,0,0.5078836
2014-09-12,15843400.0,106.16999816894533,106.9000015258789,102.9000015258789,103.66000366210938,89.17218780517578,GILD,"#PreMarket Primer: Friday, September 12: US Allies Vague About Participation In Syrian Airstrikes ||| Will Allergan's Board Be Revamped to Aid Valeant Buyout? - Analyst Blog ||| Abbott Labs (ABT) to Repurchase Shares for $3B - Analyst Blog ||| Biogen Reports Positive Two-Year Data on MS Drug Plegridy - Analyst Blog ||| #PreMarket Primer: Friday, September 12: US Allies Vague About Participation In Syrian Airstrikes",0,0.503676
2014-09-15,18163900.0,101.9000015258789,102.0999984741211,99.33000183105467,100.98999786376952,86.87532806396484,GILD,"Alnylam Expands Pipeline with Preeclampsia Drug ALN-AGT - Analyst Blog ||| Why Is Gilead Sciences, Inc. Stock Offering This Drug for Cheap? ||| Sector Update: Health-Care Shares Flat Pre-Market ||| Sector Update: Health Care ||| NPS Pharmaceuticals' Natpara Gets Positive FDA Panel Vote - Analyst Blog ||| Abbott Labs Presents Positive One-Year Data on Absorb - Analyst Blog ||| Eli Lilly's Cyramza Scores in Colorectal Cancer Study - Analyst Blog ||| Genomic Health Reveals Positive Oncotype DX Test Results - Analyst Blog ||| 3 Reasons McKesson Corporation's Stock Could Rise ||| Novartis Presents Positive Data on Lucentis and Jetrea - Analyst Blog ||| Morning Market Losers ||| Benzinga's Top #PreMarket Losers ||| #PreMarket Primer: Monday, September 15: Cameron Vows To Destroy ISIS ||| UPDATE: Gilead Announces Licensing Agreements for Generic Sovaldi ||| Mylan In Pact With Gilead To Accelerate Access To Hepatitis C ||| UPDATE: Gilead Says Licensees to Set Prices for Generic Version of Sovaldi, Will Pay Gilead a Royalty on Sales ||| Gilead Licenses Hep C Drug Sovaldi to 7 Companies Including Mylan, Ranbaxy",1,0.519566
2014-09-16,14933000.0,99.8499984741211,104.97000122070312,99.2300033569336,104.76000213623048,90.1184539794922,GILD,"AstraZeneca and Eli Lilly Collaborate for Alzheimer's Drug - Analyst Blog ||| Synthetic Biologics' SYN-005 Gets Orphan Drug Designation - Analyst Blog ||| Gilead (GILD) Slips on Generic Sovaldi Licensing Deals - Analyst Blog ||| Is Illumina (ILMN) a Buy on Solid Q2, Strategic Road Map? - Analyst Blog ||| Deutsche Bank Is Bullish On Gilead Sciences, Inc. And Other Biotech Stocks ||| Benzinga's Top #PreMarket Losers",0,0.48535323
2014-09-17,18455700.0,104.56999969482422,105.79000091552734,101.9000015258789,103.83999633789062,89.3270034790039,GILD,"3 Hot Ways to Play the Biotechnology Bonanza ||| Sector Update: Health Care ||| Sector Update: Health-Care Shares Mixed Pre-Market ||| Merck Posts Positive Data on Osteoporosis Drug Odanacatib - Analyst Blog ||| Shire's Vyvanse Accepted for FDA Review for Binge Eating - Analyst Blog ||| AstraZeneca's Constipation Drug Movantik Gets FDA Nod - Analyst Blog ||| Biotech Stock Roundup: Avanir Soars on Phase II Data, Orexigen's Contrave Approved - Analyst Blog ||| Regeneron Gets Breakthrough Therapy Status for Eylea - Analyst Blog ||| This Top Growth Fund Leans Heavily On Large-Cap Tech ||| Gilead Says Addition of Simtuzumab to Gemcitabine Didn't Significantly Increase Progression-Free Survival",1,0.5470775
2014-09-18,16347900.0,104.62999725341795,106.5,104.0999984741211,105.93000030517578,91.12492370605467,GILD,"Is It Time to Buy Dividend Stock Bristol-Myers Squibb Co? ||| ImmunoCellular Therapeutics (IMUC) Jumps: Stock Up 9% - Tale of the Tape ||| Halozyme Therapeutics (HALO) Jumps: Stock Up 9.3% - Tale of the Tape ||| Repros Therapeutics (RPRX) Crumbles: Stock Falls by 10.5% - Tale of the Tape ||| Gilead Sciences, inc. Stock's Incoming Game Changer ||| 3 Best Stocks for Investing in Biotech ||| Sanofi & MyoKardia Ink Deal to Develop Cardiomyopathies - Analyst Blog ||| Alnylam (ALNY) to File Clinical Trial Application for ALN-CC5 - Analyst Blog ||| Gilead Down on Weak Simtuzumab Data and Sovaldi News - Analyst Blog ||| 2 Columbia Growth Funds Notch Impressive Three-Month Performance",1,0.5010335
2014-09-19,22238400.0,107.75,107.88999938964844,105.51000213623048,105.95999908447266,91.15071868896484,GILD,"VIVUS and Auxilium Announce Stendra Label Expansion - Analyst Blog ||| 5 Things Gilead Sciences, Inc. Management Wants You to Know ||| VIVUS Inc. (VVUS) Rises: Stock Adds 12.4% in Session - Tale of the Tape ||| Sector Update: Health Care ||| Dividend Aristocrats: Time to Buy AbbVie Inc Stock? ||| Bayer to Shed MaterialScience Business, Shares Rise - Analyst Blog ||| Spectrum Pharmaceuticals Out-Licenses Products in China - Analyst Blog ||| Bristol-Myers' (BMY) Yervoy Label Expanded in Canada - Analyst Blog ||| Eli Lilly's Trulicity Approved by FDA for Type II Diabetes - Analyst Blog ||| Is Merck KGaA on Track with its ""Fit for 2018"" Program? - Analyst Blog ||| US Stock Futures Signal Higher Start On Wall Street ||| Gilead Gets EC Approval for Zydelig in Chronic Lymphocytic Leukemia, Follicular Lymphoma",0,0.5100233
2014-09-22,12319400.0,106.01000213623048,107.56999969482422,104.62000274658205,105.47000122070312,90.72921752929688,GILD,"Dynavax (DVAX) Jumps: Stock Moves 6.7% Higher - Tale of the Tape ||| Cytori Therapeutics (CYTX) Jumps: Stock Rises 6.4% - Tale of the Tape ||| Vertex Pharmaceuticals (VRTX) Jumps: Stock Rises 6.6% - Tale of the Tape ||| Isis Pharmaceuticals Up on $4M Milestone Payment - Analyst Blog ||| Gilead's (GILD) Zydelig Gets EU Clearance for Blood Cancer - Analyst Blog ||| Flexion Continues to Fall Post Clinical Hold on FX006 - Analyst Blog ||| Surprising Silver Lining for Gilead Sciences, inc. Stock",0,0.49061805
2014-09-23,10700400.0,104.70999908447266,106.20999908447266,104.5500030517578,105.38999938964844,90.66038513183594,GILD,"Integra Freedom Wrist's Commercial Availability Falls Flat - Analyst Blog ||| Amgen Files Blinatumomab Marketing Application in U.S. - Analyst Blog ||| IWF, IBM, VZ, GILD: Large Inflows Detected at ETF ||| Bayer/Regeneron Successfully Expand Eylea Label in Japan - Analyst Blog ||| AstraZeneca Posts Positive Data on its Type II Diabetes Drug - Analyst Blog ||| Gilead Submits NDA in Japan for Fixed-Dose Combination of Ledipasvir/Sofosbuvir for Chronic Hepatitis C Genotype 1 Infection",1,0.51986605
2014-09-24,14781400.0,106.25,108.80999755859376,106.0199966430664,108.70999908447266,93.5163803100586,GILD,"Sangamo Biosciences (SGMO) Jumps: Stock Rises 5.4% - Tale of the Tape ||| The Next Blue Chip Stocks: Gilead Sciences, Inc. ||| Novavax's Influenza Vaccine Study Shows Adjuvant Efficiency - Analyst Blog ||| Gilead (GILD) Seeks Japanese Approval for HCV Combo Drug - Analyst Blog ||| Celgene's Otezla Label Expanded to Include Plaque Psoriasis - Analyst Blog ||| Emergent BioSolutions Initiates Pivotal Study on BioThrax - Analyst Blog ||| Gilead's Investigational Tenofovir Alafenamide (TAF)-Based Single Tablet HIV Regimen Meets 48-Week Primary Objective in Two Phase 3 Studies",0,0.4988853
2014-09-25,15402400.0,108.91999816894533,110.58999633789062,106.41000366210938,107.33999633789062,92.33785247802734,GILD,"Seattle Genetics' Adcetris Positive in Durability Analysis - Analyst Blog ||| ETF Outlook: S&P Health Care Select SPDR ETF (XLV) ||| This Switch Could Make Gilead Sciences, Inc. Stock Billions ||| Gilead Scores with TAF-based HIV Regimen, Shares Up - Analyst Blog ||| The Best Biotech Stock for Your Growth Portfolio ||| Genomic Health Upbeat on Strong International Performance - Analyst Blog ||| Acorda Skyrockets on $525M Civitas Therapeutics Deal - Analyst Blog ||| Gilead Shares Volatile This Morning Following FDA Approval of VITEKTA in HIV",1,0.5073279
2014-09-26,10856700.0,108.9000015258789,109.01000213623048,106.76000213623048,108.37999725341795,93.23248291015624,GILD,"Rexahn Pharmaceuticals (RNN) Jumps: Stock Gains 10.2% - Tale of the Tape ||| The 5 Best Biotech Stocks in 2014...so far ||| Celldex (CLDX) Up on Pilot Study Initiation on CDX-301 - Analyst Blog ||| Alnylam Starts New Study on Cardiac Amyloidosis Patients - Analyst Blog ||| MannKind and Sanofi Complete Afrezza Collaboration Deal - Analyst Blog ||| Gilead's HIV Drugs Tybost and Vitekta Get FDA Clearance - Analyst Blog ||| Myriad Genetics Poised on Strong myRisk, Overseas Results - Analyst Blog ||| Gilead Release Confirms European CHMP Positive Opinion for Harvoni for Treatment of Chronic Hep C Infection in Adults ||| EMA Announces Positive Recommendation for Gilead's Harvoni -DJ",0,0.48649567
2014-09-29,8072100.0,107.58999633789062,108.68000030517578,106.4499969482422,107.51000213623048,92.48410034179688,GILD,"What This Huge George Soros Mistake Can Teach You ||| Agios Pharmaceuticals Inc, Altria Group Inc Highlight CNBC's Stock Pops & Drops From September 26 ||| Gilead Sciences, Inc. Takes Aim at Bristol-Myers Squibb ||| Bristol-Myers' Opdivo Under Review in US, EU for Cancer Treatment - Analyst Blog ||| Alimera/pSivida's Iluvien Receives FDA Approval for DME - Analyst Blog ||| Agios to Present Data on AG-120 in November, Shares Rises - Analyst Blog ||| Gilead's HCV Combo Drug Harvoni Secures CHMP Backing - Analyst Blog ||| Nektar/AstraZeneca's Moventig a Step Closer to EU Approval - Analyst Blog ||| Gilead Sciences, Inc. Consolidating Gains?",0,0.47942916
2014-09-30,11622700.0,107.4800033569336,108.0,105.86000061035156,106.4499969482422,91.5722198486328,GILD,"Ambit Biosciences (AMBI) Soars: Stock Adds 87.1% - Tale of the Tape ||| Immunomedics (IMMU) Jumps: Stock Adds 9.1% is Session - Tale of the Tape ||| Gilead Sciences, Inc. Stock's Stunning New Opportunity ||| Raptor Pharmaceuticals (RPTP) Crumbles: Stock Falls by 7.2% - Tale of the Tape ||| CorMedix Files IND Application for Neutrolin in the US - Analyst Blog ||| AMAG Up on Roughly $1B deal with Lumara to Widen Portfolio - Analyst Blog ||| Regado Trims Workforce, Revamps Strategy on Trial Halt - Analyst Blog ||| AIFA, Gilead Have Agreed to Reimburse Sovaldi for Hep C Treatment",0,0.46947762
2014-10-01,11659400.0,106.98999786376952,107.58999633789062,105.19000244140624,105.58999633789062,90.83243560791016,GILD,"Did Achillion Pharmaceuticals, Inc. Get Left Out in the M&A Cold? ||| Round 2 of Gilead Sciences, Inc.'s Offensive Begins ||| #PreMarket Primer: Wednesday, October 1: First Case Of Ebola In The US Confirmed ||| Seattle Genetics-Takeda Reveal Impressive Adcetris Data - Analyst Blog ||| #PreMarket Primer: Wednesday, October 1: First Case Of Ebola In The US Confirmed",0,0.48627436
2014-10-02,11527500.0,105.0,105.91000366210938,103.61000061035156,104.55999755859376,89.9463882446289,GILD,Progenics/Salix's Relistor Label Expanded in the U.S. - Analyst Blog ||| AbbVie's (ABBV) Humira Gains Yet Another FDA Approval - Analyst Blog ||| AVEO-Biodesix Reveal Lung Cancer Study Exploratory Data - Analyst Blog,1,0.51310825
2014-10-03,10294700.0,105.5500030517578,107.3499984741211,104.70999908447266,106.5199966430664,91.63245391845705,GILD,MannKind Receives $150 Million Upfront Payment from Sanofi - Analyst Blog ||| Regeneron-Sanofi's Dupilumab Meets All Endpoints - Analyst Blog,0,0.5182729
2014-10-06,11278300.0,107.22000122070312,107.4499969482422,104.81999969482422,105.12999725341795,90.43672943115234,GILD,"Gilead Sciences, Inc. Got 2 Drugs Approved, and Didn't Bother to Tell Anyone ||| Better Dividend Stock: Merck & Co. Inc. or Bristol-Myers Squibb Co.? ||| The Biggest Threat Facing Johnson & Johnson ||| Gilead Sciences' Other Important New Drug ||| After Hours Most Active for Oct 6, 2014 : ITUB, BAC, CX, PUK, HSBC, FTR, JDSU, HBAN, BID, GILD, SYMC, FITB",0,0.4615438
2014-10-07,9757300.0,104.8499984741211,105.3000030517578,102.54000091552734,104.29000091552734,89.71412658691406,GILD,The Most Important Number You Need to Know Before Buying Gilead Sciences Inc. Stock,1,0.5075538
2014-10-08,16545000.0,104.3000030517578,108.97000122070312,104.04000091552734,108.87000274658205,93.65402221679688,GILD,"Bristol-Myers Tells Gilead Sciences, Inc. ""You Win"" ||| ETF Outlook: Health Care Select Sector SPDR ETF (XLV) ||| Biotech Stock Roundup: Sunesis Tanks on Study Results, Chimerix Up on Ebola Update - Analyst Blog ||| Bristol-Myers Gives Up on US Approval of 2-Drug HCV Combo - Analyst Blog ||| After Hours Most Active for Oct 8, 2014 : AA, REXX, QQQ, CS, GPS, CX, ABB, KMI, ZNGA, GILD, SIRI, MSFT ||| Shares of Achillion Pharma at Session Highs as Traders Passing Around Mid-Day Note from FBR Showing Indication from Co. (via Abstract) of '100% of Patients Dosed for Eight Weeks Remained Cured'",0,0.49417716
2014-10-09,13174600.0,108.41999816894533,108.62000274658205,105.72000122070312,105.8499984741211,91.05609130859376,GILD,"iShares U.S. Healthcare ETF Experiences Big Inflow ||| Bristol-Myers Co Regroups; Hepatitis C Fight With Gilead Sciences Not Over ||| After Hours Most Active for Oct 9, 2014 : SIRI, SVU, BNDX, BRK/B, BAC, SYF, COG, CS, QQQ, AAPL, MSFT, GILD ||| 3 Stocks to Buy if the Market Crashes",0,0.4913519
2014-10-10,19704500.0,105.38999938964844,107.5,103.0,103.7300033569336,89.23237609863281,GILD,Gilead Sciences Inc. Gets First Hepatitis C Cocktail Drug Approved ||| Release Confirms Gilead's Approval For Combination Hep C Product ||| Gilead Has Won US Approval for Combination Hep C Product,0,0.5187309
2014-10-13,14578900.0,104.48999786376952,104.56999969482422,101.36000061035156,101.44000244140624,87.26245880126953,GILD,"Gilead Sciences, inc. Stock's Green Light Sparks Offensive ||| Gilead's All-Oral Combo HCV Drug Harvoni Cleared by FDA - Analyst Blog ||| Markets Debut Week On Negative Note; S&P 500 Falls Through Key Level ||| FBR Capital Maintains Outperform on Gilead Sciences, Inc., Raises PT to $133.00 ||| Big Swings in Biotech Short Interest ||| 5 Companies That Could Develop An Enterovirus Treatment",0,0.50417787
2014-10-14,27245100.0,102.0,102.87999725341795,94.2699966430664,97.18000030517578,83.59783935546875,GILD,"S&P 500 Movers: GILD, CCI ||| Gilead Sciences president and COO sells 146,895 shares ||| Deutsche Bank Says Gilead Sciences Stock Reaction Is Overdone ||| Deutsche Bank Just Out with Mid-Day Defense on Gilead, 'weakness on Irish tax, JNJ comments is overdone'",0,0.47823587
2014-10-15,23835100.0,95.0,97.7699966430664,91.7300033569336,96.16000366210938,82.72039794921875,GILD,"Novavax Begins Mid-Stage Study on RSV Vaccine in Elders - Analyst Blog ||| Biotech Stock Roundup: Gilead Nabs FDA Nod for Combo HCV Drug, Auxilium Accepts Endo Offer - Analyst Blog ||| Should Gilead Sciences, inc. Fear Incoming Competition? ||| Healthcare ETFs in Focus on JNJ Earnings Beat - ETF News And Commentary ||| Barclays: Johnson & Johnson's Q3 Could Be 'High Water Mark'",1,0.5022877
2014-10-16,19881400.0,94.38999938964844,100.0,93.27999877929688,96.87999725341795,83.33976745605469,GILD,3 Reasons AbbVie's Stock Could Rise ||| Gilead Announces Health Canada Has Issued Notice of Compliance Related to Harvoni for Genotype 1 Chronic Hep C,1,0.5277988
2014-10-17,17539000.0,98.62000274658205,102.31999969482422,98.62000274658205,100.75,86.66888427734375,GILD,"IYH, GILD, TMO, COV: Large Outflows Detected at ETF ||| Gilead's Harvoni Receives Notice of Compliance from Canada - Analyst Blog",1,0.52546453
2014-10-20,11887100.0,101.1500015258789,103.58999633789062,100.81999969482422,102.20999908447266,87.92484283447266,GILD,"Could This Game-Changing Drug Deliver $10 Billion in Sales Within Its First Year? ||| This Drug Could Outsell Medical Marijuana ||| 180 Million People Have This Disease, Yet Few Are Aware of It ||| What Johnson & Johnson Can Tell Us about Gilead Sciences, inc. Stock ||| 3 Stocks I'll Buy if the Market Crashes ||| #PreMarket Primer: Monday, October 20: Fed To Tread Softly At October Meeting",1,0.49818128
2014-10-21,12267900.0,104.0500030517578,106.66999816894533,103.45999908447266,106.66999816894533,91.76148986816406,GILD,3 Drugs Critical to Johnson & Johnson's Future,0,0.54633975
2014-10-22,13763100.0,106.51000213623048,107.0,104.08000183105467,106.08999633789062,91.26254272460938,GILD,Is Johnson & Johnson's Worst Nightmare Becoming Reality? ||| Gilead's Hep C Dream Drug Faces Demanding Investors ||| Why Regulus Therapeutics Inc. Stock More Than Doubled,1,0.5170077
2014-10-24,15125700.0,107.52999877929688,111.47000122070312,106.5999984741211,110.70999908447266,95.2368621826172,GILD,Bristol-Myers Squibb Co's Third-Quarter Earnings Beat the Street ||| Will Gilead (GILD) Miss Earnings on High Operating Costs? - Analyst Blog ||| Stocks Trade Higher Ahead of News-Heavy Weekend ||| Friday's ETF with Unusual Volume: BBH,1,0.51502055
2014-10-27,11505500.0,110.7699966430664,112.98999786376952,108.87000274658205,112.58999633789062,96.85408020019533,GILD,"How Gilead Sciences Inc. Isn't Gouging Hepatitis C Patients, in 1 Simple Infographic ||| Will Marijuana-Based Pharmaceuticals Make Drugs More Affordable? ||| IYH, GILD, ABT, AGN: Large Inflows Detected at ETF ||| A safe route into the biotech sector ||| Stock of the Week: Gilead Sciences (GILD) ||| 3 Biotech Stocks Growing Faster Than Gilead Sciences Inc. ||| Merck & Co., Inc. Earnings: Patent Losses and Competition Weigh on Sales ||| #PreMarket Primer: Monday, October 27: ECB Stress Tests In-Line With Expectations",1,0.5096942
2014-10-28,16128700.0,113.25,114.12999725341795,112.26000213623048,113.4499969482422,97.59390258789062,GILD,"Amgen Beats Earnings Estimates, What's Next for AMGN? - Stocks in the News ||| Gilead (GILD) Posts Weak Earnings; Stock Falls 4% After-Hours - Stocks in the News ||| 3 Ways You'll Know Gilead Sciences, Inc. Stock Is Still On Track ||| What to Make of Gilead Sciences Inc.'s Third-Quarter Earnings Miss ||| After Hours Most Active for Oct 28, 2014 : FB, QQQ, BAC, JNJ, BSBR, EMC, AAPL, SAN, KMI, GPOR, YHOO, GILD ||| Gilead Sciences Reports Softer Sovaldi Revenues ||| Gilead Boosts FY14 Product Sales Guidance from $21-$23B Previously to $22-$23B ||| Gilead Sciences, Inc. Reports Q3 EPS of $1.84 vs $1.92 Est; Revenue of $6.04B vs $6.06B Est; Narrowing Guidance ||| Gilead Earnings Implied Volatility ~70%; Expecting $6.30 Move ||| #PreMarket Primer: Tuesday, October 28: CDC Warns That Involuntary Quarantines Could Discourage Progress On Ebola ||| Earnings Scheduled For October 28, 2014",0,0.4698257
2014-10-29,21151500.0,109.8499984741211,113.43000030517578,108.0,110.72000122070312,95.24545288085938,GILD,"Gilead Beats on Q3 Earnings, Sovaldi Sales Fall Sequentially - Analyst Blog ||| In the news: Facebook earnings, AT&T facing a lawsuit over throttling and more ||| Fast Money Traders Comment On Stocks Making Headlines On Wednesday: Panera Bread, Hershey And More ||| Express Scripts Says May Change Drug Formulary in Mid-2015 to Favor Less Expensive Hepatitis C Drugs vs Gilead's Sovaldi -Reuters ||| #PreMarket Primer: Wednesday, October 29: Fed Likely To End Bond Purchases",1,0.50945604
2014-10-30,13796700.0,110.72000122070312,114.3499984741211,110.5999984741211,114.22000122070312,98.25627899169922,GILD,"5 Things Bristol-Myers Squibb Co.'s Management Wants You to Know ||| Why You Shouldn't Worry About Gilead Sciences, Inc.",0,0.5301505
2014-10-31,22070000.0,115.9000015258789,116.83000183105467,110.76000213623048,112.0,96.3465576171875,GILD,"Edward Jones Initiates Coverage on Gilead Sciences, Inc. at Hold",0,0.49898252
2014-11-03,15356600.0,112.30999755859376,112.8000030517578,108.80999755859376,109.9800033569336,94.60888671875,GILD,"5 Staggering Statistics About the Fastest Growing Drug in the World ||| Seattle Genetics Gains on Narrower-than-Expected Q3 Loss - Analyst Blog ||| Novo Nordisk's Earnings Rise in Q3, 2014 Outlook Narrowed - Analyst Blog ||| Noteworthy ETF Inflows: XLV, GILD, MRK, UNH ||| 2 More Gilead Sciences, Inc. Blockbusters You Ought to Know About ||| CNBC's Stock Pops & Drops From November 3: GoPro, Gilead Sciences And More ||| #PreMarket Primer: Monday, November 3: Commercial Space Travel Questioned After Failed Flights",0,0.5371337
2014-11-05,15459500.0,110.87000274658205,110.91000366210938,105.75,106.0500030517578,91.2281494140625,GILD,"Is This Trend Making Gilead Sciences, Inc. Worry?",1,0.5015141
2014-11-06,13149400.0,106.94000244140624,108.4499969482422,106.0999984741211,106.94000244140624,91.99375915527344,GILD,"5 Things AbbVie Inc.'s Management Wants You to Know ||| Why Achillion Pharmaceuticals, Inc. Stock Launched 18% Higher in October ||| ETF Outlook: First Trust Amex Biotech Index Fund ETF (FBT) ||| Gilead Submits New Drug Application To FDA For Tenofovir Alafenamide",0,0.52475965
2014-11-07,12663700.0,108.9000015258789,108.9499969482422,106.33000183105467,106.4499969482422,91.5722198486328,GILD,"Why AbbVie Inc.'s Game-Changing New Drug Could Be a Serious Threat to Gilead Sciences Inc. ||| Gilead (GILD) Submits HIV Combination Drug for FDA Review - Analyst Blog ||| Pharmacyclics, Inc.'s Imbruvica Holds Its Own Against Gilead Sciences, Inc.'s Zydelig",1,0.5059205
2014-11-10,21412900.0,109.06999969482422,109.37000274658205,106.66000366210938,107.0199966430664,92.06258392333984,GILD,"3 Biotech Stocks to Watch in November ||| 5 Prescription Drugs Selling Like Hot Cakes ||| Stocks Quietly Grind Higher, But Stifled By Lack of Fresh Catalysts ||| Pre-Market Most Active for Nov 10, 2014 : BABA, ALU, MTU, GILD, GPRO, PBR, QQQ, NVO, ACHN, TVIX, NMR, AAPL ||| 3 Drugs That Make Gilead Sciences' Harvoni Look Cheap ||| Merck Reports Interim Data on Hepatitis C Virus Drug - Analyst Blog ||| RBC Sees Weak Merck Data As Positive For Gilead",1,0.4952719
2014-11-11,12206500.0,107.4800033569336,108.72000122070312,106.66999816894533,108.01000213623048,92.91419982910156,GILD,"Notable ETF Inflow Detected - XLV, MRK, GILD, UNH ||| Stock Market News for November 11, 2014 - Market News ||| Gilead Sciences Inc. Breathes a Sigh of Relief -- Hepatitis C Patients, Not So Much ||| Bristol-Myers Gives Updates on HCV Candidate Daclatasvir - Analyst Blog ||| Conatus Pharmaceuticals (CNAT): Will Loss Narrow in Q3? - Analyst Blog ||| Gilead Reports Phase 2 Data for Investigational All-Oral Regimen of Sofosbuvir Plus GS-5816 for Treatment of Chronic Hep C ||| Gilead Announces Phase 2 Data For Investigational All-Oral Regimen Of Sofosbuvir Plus GS-5816 For The Treatment Of Chronic Hepatitis C",0,0.4767081
2014-11-12,12802200.0,107.76000213623048,107.80999755859376,105.6999969482422,106.9000015258789,91.9593505859375,GILD,"Biotech Stock Roundup: Gilead, AbbVie Score at Liver Meeting, Dendreon Files for Bankruptcy - Analyst Blog ||| This Tiny Biotech Is Piggybacking on Gilead Sciences, Inc.'s Success ||| Gilead Reports Promising Data on its HCV Drug Harvoni - Analyst Blog ||| Gilead Prices $4B Offering Of Senior Unsecured Notes ||| Fast Money Halftime Report Final Trade From November 12: Twitter, Dunkin Brands, Gilead Sciences ||| #PreMarket Primer: Wednesday, November 12: Banks Fined More Than $3 Billion For Role In Forex Manipulation",0,0.50731134
2014-11-13,20880400.0,106.95999908447266,107.0500030517578,103.51000213623048,104.1999969482422,89.6366958618164,GILD,"Nasdaq 100 Movers: NTAP, VIAB ||| Gilead Sciences In Correction Mode ||| The Top 25 Analysts On Wall Street ||| Hearing Cleveland Research Cautious on Gilead",0,0.5010475
2014-11-14,23553400.0,103.5,103.79000091552734,100.0,102.05999755859376,87.79578399658203,GILD,"Nasdaq 100 Movers: GILD, NTAP ||| S&P 500 Movers: GILD, HAL ||| Tiger Management's Julian Robertson Buys Alibaba, eBay, MasTec, Sells Tableau Software, ... ||| Biotech: And Yet We've Just Begun... ||| CNBC's Stock Pops & Drops From November 13: King Digital, Alibaba, SanDisk, Gilead Sciences ||| #PreMarket Primer: Friday, November 14: Tensions At All-Time High For G20 Summit",0,0.47063944
2014-11-17,17100900.0,101.0999984741211,102.16000366210938,100.3000030517578,100.44000244140624,86.4021987915039,GILD,Julian Robertson's Tiger Management 13F Reveals Huge Alibaba Stake ||| 3 Stocks the Smartest Investors Are Buying Right Now ||| Incyte Building Blockbuster Drug One Disease At A Time,1,0.5176208
2014-11-18,20163300.0,101.69000244140624,103.97000122070312,100.81999969482422,103.70999908447266,89.21520233154297,GILD,Gilead Sciences Announces That The European Commission Has Granted Marketing Authorization for Gilead's Harvoni,0,0.5182652
2014-11-19,13864200.0,103.1999969482422,103.31999969482422,101.01000213623048,102.33999633789062,88.03666687011719,GILD,"Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blog ||| Stock Market News for November 19, 2014 - Market News ||| Nasdaq 100 Movers: TSLA, SPLS",0,0.4940373
2014-11-20,20027500.0,101.9499969482422,103.37999725341795,100.3000030517578,100.58999633789062,86.53125,GILD,"Notable ETF Inflow Detected - VTI, BAC, GILD, INTC ||| Biotech's 3 Most Influential CEOs ||| Gilead to Buy Knight Therapeutics' Priority Review Voucher - Analyst Blog ||| Hearing Unconfirmed Market Chatter of Icahn Stake in Gilead ||| CNBC's Stock Pops & Drops From November 19 ||| French Ministry of Health Announces Final Negotiated Price for Gilead's Sovaldi is €41,000 for 12 Weeks -Reuters",0,0.4978951
2014-11-24,17111100.0,101.11000061035156,102.3000030517578,99.44000244140624,100.5999984741211,86.53984069824219,GILD,This May Be the Fastest Growing Big Biotech Stock Next Year (Hint: It's Not Gilead Sciences) ||| Gilead Sciences Inc. Just Paid $125 Million for Something It Can't Use for a Year ||| AbbVie's HCV Cocktail Treatment Closer to EU Approval - Analyst Blog ||| Can Partnering To Fight Hepatitis C Pay At Enanta? ||| 3 Biotech Stocks That Could Soar Even Higher,1,0.5175126
2014-11-25,20640200.0,100.9499969482422,101.37999725341795,98.37000274658205,101.11000061035156,86.97856140136719,GILD,Why You Shouldn't Bet Against Gilead Sciences (GILD) Stock - Tale of the Tape ||| 3 Biotech Growth Stocks You Can Buy Right Now ||| AbbVie Takes Aim at Gilead Sciences,0,0.474597
2014-11-26,11536500.0,101.25,101.5500030517578,99.83000183105467,100.3000030517578,86.28179931640625,GILD,"Should Gilead Sciences, Inc. Pay a Dividend? ||| #PreMarket Primer: Wednesday, November 26: Big Retailers Gear Up For Black Friday",1,0.47876966
2014-11-28,7552700.0,100.98999786376952,101.33000183105467,99.6999969482422,100.31999969482422,86.29898834228516,GILD,Johnson & Johnson's Rezolsta Approved in the EU for HIV-1 - Analyst Blog,1,0.5502235
2014-12-01,14516100.0,100.0,101.98999786376952,99.7699966430664,100.5500030517578,86.49684143066406,GILD,"Bristol-Myers Squibb Co's Hep C Drug Denied; Gilead Sciences Inc. Smiling (for Now) ||| 5 Drug Classes Where Prescription Spending Could Grow the Quickest ||| Nasdaq 100 Movers: VIP, GILD ||| 3 Healthcare Stocks to Hold Forever ||| 8-K from Gilead Sciences Shows UK Court Invalidated Idenix 489 Patent, Trials Will Be Held on Merck's Idenix Patents in Canada in Jan. ||| Mylan Reports Deal with Gilead for Enhancement of Access to TAF-Based HIV Treatments in Developing Countires",1,0.5160567
2014-12-02,15568200.0,101.16999816894533,102.77999877929688,101.0199966430664,102.19000244140624,87.90763092041016,GILD,"The Most Important FDA Decision We're Watching This Month ||| PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for December 03, 2014 ||| Mylan, Gilead Ink Deal for TAF-based HIV Drugs - Analyst Blog",0,0.5170352
2014-12-03,17620800.0,103.04000091552734,103.08000183105467,99.86000061035156,100.87999725341795,86.78072357177734,GILD,"Great News For Biogen, But What's Next For The Stock?",1,0.5077395
2014-12-04,12052800.0,100.7699966430664,102.02999877929688,99.86000061035156,101.81999969482422,87.58934020996094,GILD,Johnson & Johnson Bought Alios for Hepatitis C ||| 3 Cheap Growth Stocks You Can Buy Right Now ||| 25 Best Stocks for 2015 ||| Why Biotech Stocks Don't Pay Dividends ||| 1 Big FDA Decision I'm Watching This Month ||| Earnings Season In Review: Who's Winning?,1,0.5160745
2014-12-05,18127600.0,102.29000091552734,105.4499969482422,102.1500015258789,104.58999633789062,89.9721908569336,GILD,Gilead Sciences Spikes Higher As Barron's Suggests Looking Beyond Hepatitis-C,1,0.5340858
2014-12-08,13754200.0,105.0500030517578,107.58000183105467,104.91999816894533,105.55999755859376,90.8066177368164,GILD,"3 Top Large-Cap Biotech Stocks for 2015 ||| 3 Reasons Gilead Sciences Could Soar in 2015 ||| 3 Large Cap Biotech Stocks That Could Pay Dividends, But Won't ||| George Soros Is Dumping These 3 Dividend Stocks: Should You? ||| 3 Biotech Companies That Are Making Incredibly Smart Moves ||| Time to Buy This Dip in Gilead Sciences, Inc. Stock? ||| 3 Biotech ETFs Rally On Merger News ||| Gilead Presents Follow-up Data from Zydelig Registrational Studies At 56th American Society of Hematology Annual Meeting",1,0.51740474
2014-12-09,11330900.0,103.80999755859376,106.0,102.22000122070312,105.91000366210938,91.10772705078124,GILD,"5 Biotech Stocks to Buy for 2015 ||| UPDATE: Morgan Stanley Raises PT on Gilead Sciences Following AlphaWise Survey ||| Morgan Stanley Maintains Equal-weight on Gilead Sciences, Inc., Raises PT to $100.00",0,0.5213857
2014-12-10,11903000.0,105.88999938964844,106.76000213623048,104.47000122070312,104.83999633789062,90.18724060058594,GILD,"Cheap Stocks for 2015: The Best Buys in Healthcare ||| Septa Lawsuit Seeks Class-Action Status, Monetary Damages From Gilead for Price Gouging on Sovaldi -DJ",0,0.48227394
2014-12-11,10962200.0,105.2300033569336,106.9000015258789,104.0,104.30999755859376,89.73131561279297,GILD,Why Gilead Sciences and AbbVie Care About This Tiny Company ||| Gilead Sciences Bucks Trend In Biotech Short Interest ||| 6 Strong Analyst Recommendations That You Should Know,0,0.48831022
2014-12-12,11245100.0,103.47000122070312,106.4000015258789,103.33999633789062,104.12999725341795,89.57647705078125,GILD,These 2 Biotech Stocks Are Set To Split The $15 Billion Hepatitis C Market,0,0.50815266
2014-12-15,16206000.0,105.23999786376952,105.94000244140624,102.37000274658205,103.16000366210938,88.74207305908203,GILD,"Why I'm Not Short Gilead Sciences, Inc. ||| Can These Top Dividend-Paying Stocks Soar in 2015? ||| 3 Healthcare Stocks to Watch in 2015 ||| Could the World's Top-Selling Drug Be Toppled? ||| Gilead Sciences Announces Philippe Bishop, MD Will Join Gilead As SVP Hematology, Oncology Therapeutics",0,0.47779715
2014-12-16,13047100.0,102.63999938964844,102.91000366210938,100.38999938964844,100.45999908447266,86.41942596435547,GILD,The 3 Most Exceptional CEOs of 2014,1,0.5360491
2014-12-17,13557600.0,100.47000122070312,102.73999786376952,99.55999755859376,102.4000015258789,88.08826446533203,GILD,"Noteworthy ETF Outflows: OEF, GILD, GOOG, PM ||| Pfizer, Inc. Invests in Growth... Literally",1,0.5174228
2014-12-19,21210300.0,105.88999938964844,109.48999786376952,104.63999938964844,108.4499969482422,93.29270935058594,GILD,"3 Pharma Giants Growing Significantly Faster Than Pfizer, Inc. ||| United Therapeutics Lung Drug Keeps Going And Going ||| ONO, Gilead Announce Exclusive License Agreement to Develop ONO-4059 for Treatment of B-cell Malignancies and Other Diseases",0,0.524742
2014-12-22,72464200.0,96.7300033569336,98.06999969482422,92.4499969482422,92.9000015258789,79.916015625,GILD,"These Biotech Stocks Are Growing Even Faster Than Gilead Sciences ||| Gilead Sciences, Inc. Gets Some Competition (but Not Really) ||| AbbVie's All-Oral, Interferon-Free HCV Treatment Approved - Analyst Blog ||| S&P 500 Movers: GILD, LM ||| Nasdaq 100 Movers: GILD, VIP ||| Mid-Morning Market Update: Markets Open Higher; Caesars Entertainment To Buy Caesars Acquisition ||| Pre-Market Most Active for Dec 22, 2014 : ACHN, GILD, CHL, TVIX, ABBV, FB, RAD, ALU, PBR, ALLY, XIV, QQQ ||| U.S. Stocks Set to Mostly Continue Post-Fed Rally in Light Holiday Trading; Chicago Fed Activity Index Surges ||| Could Gilead Sciences, Inc. Be a Top Stock in 2015? ||| Why Gilead Sciences Shares Tumbled Today ||| Gilead/Ono Pharmaceutical Ink Deal for Blood Cancer Drug - Analyst Blog ||| Monday's ETF Movers: EEM, BBH ||| U.S. Stock Futures Gain In Pre-Christmas Rally ||| AbbVie Takes A Bite Out Of Gilead Sciences' Hepatitis C Market Share ||| Bank Of America Downgrades Gilead Sciences, Sees Possible Pricing War ||| Option Alert: GIlead Jan $105 Call; 4,504 Contract Trade Above Ask @$1.45; Currently $94.64 ||| Bank of America Downgrades Gilead Sciences to Underperform, Lowers PT to $87.00 ||| Mid-Day Losers From December 22: Gilead, Ocwen Financial And More ||| Mid-Morning Market Update: Markets Open Higher; Caesars Entertainment To Buy Caesars Acquisition ||| Monday's Biggest Social Media Movers ||| Morning Market Losers ||| Gilead Sciences Plummets Amid AbbVie Deal With Express Scripts ||| Monday's #PreMarket Movers: Caesars, Enta, Twitter And More ||| Benzinga's Top #PreMarket Losers ||| Express Scripts to Cover AbbVie Hepatitis C Drug Viekira Pak, Drops Coverage on Gilead's Sovaldi Due to Significantly Lower Price of AbbVie Treatment -CNBC",0,0.47850472
2014-12-23,61035200.0,93.41000366210938,93.5,85.94999694824219,89.44999694824219,76.94818878173828,GILD,"Top-Rated Stock Picks and Most-Read Stories of the Week of December 15 for Nasdaq.com ||| GILD Makes Notable Cross Below Critical Moving Average ||| Gilead Falls on AbbVie and Express Scripts Deal: 3 Biotech ETFs to Watch - ETF News And Commentary ||| AbbVie Inc. Throws First Punch in Hep C Price War With Gilead Sciences, Inc. ||| What the World's Biggest Hedge Fund Has Been Selling ||| Gilead Sciences Slumps: GILD Tumbles 14.3% in Session - Tale of the Tape ||| Express Scripts Hates Gilead Sciences, Loves AbbVie ||| Achillion Gains on Positive Results from its HCV Candidates - Analyst Blog ||| Express Scripts (ESRX) Picks AbbVie's Hepatitis C Drug - Analyst Blog ||| Why Achillion Pharmaceuticals Shares Collapsed by 25% Today ||| Pre-Market Most Active for Dec 23, 2014 : ALU, VALE/P, NQ, RAD, RIG, GPRO, ARIA, BAC, JRJC, QQQ, GILD, TVIX ||| 3 Charts That Show Why There's Gilead Sciences...And Then There's Everybody Else ||| Evercore ISI Analyst: 160,000 Patients Affected by AbbVie Hepatitis Pact ||| Health Care And Biotech Sector Looking Sick ||| #Premarket Prep Technical Update - Gilead Sciences Continues Lower ||| CNBC's Meg Tirrell Breaks Down The AbbVie/Express Scripts Deal ||| Deutsche Bank Analyst Sees Gilead Sciences Vs. AbbVie 'Price War' ||| Fast Money Picks For December 23: Gilead Sciences, Starbucks, CVS Health",1,0.5252879
2014-12-24,21196200.0,88.9800033569336,92.66999816894533,88.86000061035156,91.29000091552734,78.53105926513672,GILD,"Nasdaq 100 Movers: VIP, CELG ||| Biotech Stock Roundup: AbbVie's HCV Treatment Approved, ImmunoGen Plunges on Data - Analyst Blog ||| The Hepatitis C Drug Developer That Crushed Gilead Sciences, Inc. in 2014 (Hint: It's Not AbbVie) ||| Pre-Market Most Active for Dec 24, 2014 : RIG, GPRO, SNN, ARCP, FB, SMFG, ACHN, BAC, FCAU, TVIX, CRH, GILD ||| Biotech Booms Amid Pre-Christmas Snoozefest ||| Could Express Scripts Holding Company's Gilead Gamble Backfire? ||| How Gilead And Johnson & Johnson's Tumble Could've Burned These Hedge Funds ||| Benzinga's Top #PreMarket Losers",1,0.5051934
2014-12-26,17649600.0,92.76000213623048,94.36000061035156,92.30999755859376,93.79000091552734,80.681640625,GILD,"S&P 500 Movers: EQT, GILD ||| Nasdaq 100 Movers: VIP, GILD ||| Stock Market News for December 26, 2014 - Market News ||| Pre-Market Most Active for Dec 26, 2014 : GPRO, FB, TVIX, BAC, GILD, QQQ, PBR, VALE, RAD, AAPL, BABA, AUY ||| #Premarket Prep Technical Update - Gilead Sciences Higher ||| Morning Market Movers ||| Why Shares Of Gilead Sciences Are Trading Higher ||| RBC: Gilead could launch $10B+ accelerated buyback",1,0.49699995
2014-12-29,20634000.0,96.06999969482422,97.41999816894533,95.4000015258789,97.3000030517578,83.70106506347656,GILD,"3 Stocks Poised for Eye-Popping Gains in 2015 ||| CNBC's Stock Pops & Drops From December 26 ||| Should AbbVie Inc. and Gilead Sciences, Inc. Fear This Biotech Instead of Each Other? ||| Pharma Stocks Could Be in Deep Trouble in 2015. Here's Why. ||| Health Care Sector Update for 12/29/2014: POZN, AEZS, GILD ||| Nasdaq 100 Movers: REGN, GILD ||| IBB, GILD, REGN, BMRN: Large Inflows Detected at ETF ||| Is Gilead Sciences, Inc. a Value Stock Following Its Tumble? ||| Mid-Afternoon Market Update: Crude Oil Slides 3%; Gilead Sciences Shares Spike Higher ||| Pre-Market Most Active for Dec 29, 2014 : RIO, TVIX, ALU, FCAU, GILD, XIV, JUNO, AAPL, PBR, BAC, GPRO, MTW ||| Mid-Afternoon Market Update: Crude Oil Slides 3%; Gilead Sciences Shares Spike Higher ||| Morgan Stanley Upgrades Gilead Sciences, Says It Will Maintain 75% Market Share ||| Morning Market Movers ||| Benzinga's Top Upgrades ||| #PreMarket Primer: Monday, December 29: Controversial Film 'The Interview' Makes Millions Online ||| Gilead Reports Amended Deals with J&J's Janssen to Develop PREZISTA-Based Single-Tablet Regimen for Treatment of People Living with HIV ||| Benzinga's Top #PreMarket Gainers ||| Morgan Stanley Upgrades Gilead Sciences To Overweight, Shares Rise ||| UPDATE: Gilead Shares Rise ~2% Premarket Follwing Morgan Stanley Upgrade to Overweight ||| US Stock Futures Down; Crude Oil Rises ||| Morgan Stanley Upgrades Gilead Sciences to Overweight",0,0.48629478
2014-12-30,18488400.0,97.73999786376952,98.23999786376952,95.06999969482422,95.27999877929688,81.96339416503906,GILD,"3 Biotech Stocks That Soared Past Gilead in 2014 - Analyst Blog ||| Start the New Year Off Right With the 3 Best Biotech Stocks ||| DoctoRx Positions For 2015: I Have Cut Back On My Exposure To All Biotech Substantially ||| Gilead/J&J Expand TAF-based HIV Drugs Related Agreement - Analyst Blog ||| Gilead Spokesperson Says GoodRx Coupon for Harvoni Tablets Was Not Sponsored by Gilead and Co Cannot Comment on Pricing, As they do Not Sell Directly to Consumers ||| Discount Coupon for Gilead's Harvoni from GoodRx",0,0.5135947
2014-12-31,13879000.0,96.0,96.75,94.23999786376952,94.26000213623048,81.0859375,GILD,Interesting GILD Put And Call Options For February 2015 ||| These 3 Biotechs Are Looking at a Happy New Year ||| The Struggles Of Gilead Sciences,1,0.5081896
2015-01-02,12340200.0,95.13999938964844,96.6500015258789,94.5199966430664,94.91000366210938,81.64511108398438,GILD,"How 1 Tiny Hepatitis C Drug Developer Trounced Gilead Sciences, Inc. in 2014",1,0.5340245
2015-01-05,27530400.0,95.23999786376952,98.7300033569336,93.18000030517578,96.79000091552734,83.26233673095703,GILD,"3 Biotech Stocks With a Higher Profit Margin Than Gilead Sciences, Inc. ||| The 3 Underlying Reasons Why Gilead Sciences, Inc. Could Remain Wildly Successful ||| These Were The 10 Most Traded Stocks Of 2014 ||| Prospects For 2014's Best and Worst Performing Sectors ||| Why Gilead Sciences, Inc. Stock Plunged as Much as 14% in December ||| CNBC's Stock Pops & Drops From January 5 ||| Gilead Sciences Spikes Amid CVS Formulary Status ||| CVS Health Corp. Gives Preferred Formulary Status to Gilead Sciences' Drugs Harvoni and Sovaldi",1,0.51595724
2015-01-06,22363800.0,98.47000122070312,99.33999633789062,96.08999633789062,97.6500015258789,84.00215911865234,GILD,"J.P Morgan Just Chimed In With Ratings On Biotech Stocks ||| Barclays Analyst Sees Biotech FY15 EPS Growth Outstripping Market ||| UPDATE: Barclays Initiates Coverage On Gilead Sciences, 'Should Remain Ahead Of Its Peers' ||| Gilead Sciences Announces Purchase of Phenex Pharma's Development Program for NASH ||| Barclays Initiates Coverage on Gilead Sciences at Overweight, Announces $125.00 PT",1,0.5080839
2015-01-07,16373700.0,99.30999755859376,99.9000015258789,98.44000244140624,99.4800033569336,85.57638549804688,GILD,"VV, C, GILD, PEP: ETF Inflow Alert ||| 3 Biotech Stocks That Could Trounce Gilead Sciences, Inc. in 2015 ||| Enzon Pharmaceuticals, Inc. (ENZN) Ex-Dividend Date Scheduled for January 08, 2015 ||| The Biggest Surprise in the Battle Between AbbVie and Gilead Sciences ||| Gilead to Purchase Liver Disease Program from Phenex - Analyst Blog ||| Gilead Sciences Just Received Orphan Drug Status For Liver Treatment ||| Gilead Receives Orphan Drug Status For Simtuzumab",1,0.4760076
2015-01-08,18902300.0,100.8000030517578,102.4499969482422,100.29000091552734,102.3000030517578,88.00225067138672,GILD,"Why Medivation Inc. Stock Sank 14% in December ||| 1 Amazing Chart Shows Why Gilead Sciences, Inc.'s Stock Still Belongs in Your Portfolio ||| Anthem, Gilead Sign Deal For Hep. C Drug",0,0.4927912
2015-01-09,14738100.0,103.5199966430664,103.83000183105467,101.75,102.20999908447266,87.92484283447266,GILD,Is Gilead Sciences Inc. Now a Takeover Target? ||| Adam Feuerstein @adamfeuerstein Tweet: $GILD Buying $VRTX Among Bold Biotech Stock Predictions for 2015 thestreet.com/story/13006004… @dsobek peers into his Cajun crystal ball...,0,0.48280647
2015-01-12,12746000.0,102.83999633789062,103.33999633789062,100.76000213623048,101.20999908447266,87.06458282470703,GILD,"The Dark Secret in the AbbVie-Gilead Sciences Hepatitis C Drug War ||| Did Gilead Sciences Just Buy Its Next Blockbuster Drug? ||| Should AbbVie Inc. Or Gilead Sciences Buy These Tiny Biotech Stocks? ||| Better Healthcare Buy: Big or Little Biotechs ||| 3 Ways Gilead Sciences, Inc. Could Still Be in Big Trouble ||| 1 Big Loser in the Slugfest Between AbbVie and Gilead Sciences ||| Which Big Biotech Will Soar in 2015? ||| Is Celgene Corporation a Takeover Target in 2015? ||| A Look At 3 Biotech Stocks With Upside Potential ||| Prime Therapeutics Enters Agreements With AbbVie, Gilead ||| Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2",0,0.49778715
2015-01-13,27030600.0,101.8499984741211,101.87999725341795,95.25,97.20999908447266,83.62364959716797,GILD,"Nasdaq 100 Movers: GILD, CELG ||| Did Gilead Sciences' Sales Soar in Q4? ||| Why Pharmacyclics Inc. Skyrocketed Higher Today ||| Aetna CEO Bertolini Says Co Has Not Made Decision Regarding Gilead's, Abbvie's Hepatitis C Drugs -Reuters ||| Gilead Begins Presentation At JPM Conference",1,0.50019884
2015-01-14,16183700.0,96.0,100.08999633789062,95.70999908447266,99.26000213623048,85.38715362548828,GILD,3 Stocks to Buy When the Market Crashes ||| How Much Could AbbVie Inc. Make Selling Its Hepatitis C Drug This Year? ||| Gilead Sciences' Sovaldi Patent Application Rejected In India ||| 'India Rejects Gildead Patent Request For Hep C Drug',0,0.50713706
2015-01-15,11442200.0,99.3000030517578,100.38999938964844,97.2300033569336,97.4000015258789,83.78709411621094,GILD,"QUAL, GILD, HD, ORCL: ETF Inflow Alert ||| Kite CEO Says Learning from Gilead's Pricing Playbook for their Own Experimental Cancer Treatment -Reuters",1,0.51744574
2015-01-16,14097700.0,97.41999816894533,100.88999938964844,97.06999969482422,100.70999908447266,86.63448333740234,GILD,Understanding Stock Dilution -- and Why You Should Care About It ||| Will Organovo Holdings Inc. be Bought Out in 2015? ||| From Aetna Newsroom: 'Aetna and Gilead agree to discount pricing for hepatitis C drugs' ||| Aetna Says Gilead's Harvoni And Sovaldi Are Preferred Treatment For Its 20 Mln Commercial Customers ||| Nomura's Takeaways From Meeting With Gilead Sciences' Management,1,0.5053533
2015-01-20,18838100.0,101.13999938964844,104.0500030517578,100.1500015258789,103.77999877929688,89.27542114257812,GILD,"3 Big Pharma Stocks With More Free Cash Flow Than Gilead Sciences Inc. ||| Is 1 Drug Really Outselling Legalized Marijuana? ||| After Hours Most Active for Jan 20, 2015 : BAC, PFE, EMC, AAPL, QQQ, NFLX, FCX, INTC, JPM, IBM, GILD, MACK ||| Johnson & Johnson Overcomes Threats from Competitors, Delivers Solid Quarterly Results ||| The 5 Biggest Biotech Stocks ||| Why Drug Pricing Could Bring Volatility To The Biotech Sector This Year",0,0.5152436
2015-01-21,12312500.0,103.04000091552734,105.06999969482422,102.56999969482422,103.58000183105467,89.1033706665039,GILD,"Why Johnson & Johnson's Stock Could Crater in 2015 ||| Biotech Stock Roundup: EU Approvals for AbbVie & Celgene Drugs, CytRx Partial Clinical Hold Lifted - Analyst Blog ||| Healthcare ETFs in Focus on Mixed JNJ Results - ETF News And Commentary ||| Deutsche Bank Comments On Concerns Over Consensus Estimates For AbbVie And Gilead Sciences",1,0.49613056
2015-01-23,9593500.0,104.4000015258789,106.11000061035156,103.8000030517578,105.54000091552734,90.78943634033205,GILD,"IWF, GILD, PEP, ORCL: Large Outflows Detected at ETF",1,0.5219842
2015-01-26,10307500.0,104.87000274658205,107.7699966430664,104.87000274658205,107.11000061035156,92.13999938964844,GILD,Here's Why This Year's Flu Vaccine Isn't Working ||| Alibaba Is A Favorite Holding Even For U.S.-Focused Funds ||| US Stock Futures Signal Lower Start On Wall Street ||| Gilead Expands Hepatitis C Generic Licensing Agreements to Include GS-5816,0,0.5015579
2015-01-27,10341100.0,105.94000244140624,107.0199966430664,104.86000061035156,105.02999877929688,90.35069274902344,GILD,This Telling Figure Insinuates Big Pharma Could Be in Big Trouble,0,0.4906871
2015-01-28,11554500.0,105.31999969482422,105.5,102.3499984741211,102.4499969482422,88.13128662109375,GILD,"Is AbbVie (ABBV) Set to Beat 4Q Earnings on Humira Sales? - Analyst Blog ||| Cancer biotech Kolltan Pharmaceuticals withdraws $86 million IPO ||| Gilead Promotes Andrew Cheng To EVP HIV Therapeutics and Development Operations; Taiyin Yang To EVP, President Pharmaceutical Development and Manufacturing",1,0.519796
2015-01-29,8410500.0,102.5,104.51000213623048,101.06999969482422,104.18000030517578,89.61949157714844,GILD,Baird Remains Buyers Of Gilead Before Earnings Release,1,0.5453019
2015-01-30,13608200.0,104.33000183105467,106.2699966430664,103.7300033569336,104.83000183105467,90.17865753173828,GILD,"AbbVie (ABBV) Tops 4Q Earnings Estimates, Affirms View - Tale of the Tape ||| What Investors Are Watching For In Regulus Therapeutics' Next Data Release",1,0.5149626
2015-02-02,13965600.0,106.0999984741211,107.19000244140624,104.43000030517578,106.19000244140624,91.34856414794922,GILD,"Gilead Sciences' Future in 3 Simple Slides ||| 3 Biotech Giants That Shouldn't Pay a Dividend ||| Fast Money Halftime Report Final Trade From January 30 ||| Can Biotech Duplicate Its 2014 Performance, or Is It Time to Jump Ship? ||| Biotech Breakdown: Market Breaks...Gilead, Kite Pharma & Biogen Idec Worth Watching ||| Earnings Expectations For The Week Of February 2: Disney, Exxon, GM And More ||| Why The Biotech Boom Is Still In The 1st Inning ||| Will Gilead (GILD) Miss Q4 Earnings on Low HCV Drug Sales? - Analyst Blog ||| 3 Things to Watch With Gilead Sciences, Inc. Q4 Results ||| Why Gilead Sciences, Inc. Shares Roared Higher By 11% in January ||| Gilead Could Miss Earnings (Hint: Watch Drug Sales) ||| Energy, TIPs And Biotechnology ETFs To Watch This Week",1,0.51299596
2015-02-03,19849900.0,106.70999908447266,107.30999755859376,104.0999984741211,107.18000030517578,92.20021057128906,GILD,"IYH, GILD, AMGN, ABBV: ETF Outflow Alert ||| Gilead Sciences, Inc. Earnings: We'll Make Up for It in Volume ||| Gilead Sciences Beats Q4 Earnings Estimates, GILD Falls on Revenue Outlook - Stocks in the News ||| What's Behind Gilead Sciences' Strong Q4 but Weak 2015 Outlook? ||| After Hours Most Active for Feb 3, 2015 : FNFG, COST, GILD, QQQ, BK, AAXJ, DIS, COP, BAC, ESRX, STT, ALLY^A ||| Earnings Reaction History: Gilead Sciences Inc., 44.4% Follow-Through Indicator, 3.0% Sensitive ||| After-Hours Earnings Report for February 3, 2015 : GILD, DIS, EQR, AFL, CMG, FISV, WYNN, EW, ITUB, CHRW, UNM, AJG ||| Tuesday's After-Hours Movers: Gilead, Wynn Resorts And Chipotle Fall Following Earnings ||| Gilead Sciences Beats Q4 Views But Outlook Disappoints, Shares Fall ||| Gilead Sciences conference call ends. ||| Company has never been in better shape and will continue to look forward and invest in share buybacks, dividends and continued product strength. ||| Gilead has a large, sustainable market in Europe that will continue with healthy growth in the coming years. ||| The timing of our dividend reflects our confidence in our cash flow and balance sheet. Does not in any way prevent the company from investing in its business pipeline or M&A. We do not feel constrained in any way by issuing this dividend. ||| Gilead sales team has been a lot of time securing access in 2014 and will shift to drive demand in 2015. ||| Harvoni has proven to be effective on a much wider range of patients than previously thought, we are not concerned about future competition and this represents a very strong category for Gilead based on this profile. ||| 70% of patients in 2014 came from the private sector ||| We are confident that we will see a large increase in patients across the US based on our goals to achieve greater accessibility. ||| Intentions for dividend are to grow over time, but at the moment they will still use share repurchases as the larger portion of the share returns in the near future. ||| Gilead conference call Q&A begins ||| CFO Washington: Expecting 2015 product sales to be $26-27B, increase of 6-10% over 2014 ||| CFO Washington: Repaid $1B in outstanding debt in Q4 ||| CFO Washington: HCV product sales $12.4B for 2014, helped by continued launches of Sovaldi and Harvoni and geographic expansion ||| Gilead Estimates 2015 Gross to Net Hepatitis C Drug Adjustments at 46% vs 22% at End of 2014 ||| CFO Washington: Cash flow will keep company strong and well positioned for any forthcoming M&A opportunities ||| CFO Washington: Annual yield of 1.6%, based on Monday's closing stock price ||| EVP Carter: HIV: In 2014, Gilead continues clinical and commercial success, $1.9B in sales in the Q4 and $6.3B in sales for the whole year, lead by Complera and Stribild ||| EVP Carter: 80% of new HIV patients started treament on a Gilead product, 70% of which were on Truvada ||| EVP Carter: We aim to streamline the process of access to treatment and therapy to at least 250,000 patients across all genotypes ||| EVP Carter: We expect 2015 gross to net adjustments in product in the US to be 46%, over double in 2014 which was 22% ||| EVP Carter: Sovaldi contributed $1.5B to European sales in 2014 ||| EVP Carter: 140,000 have started HCV therapy on a Gilead product in the United States. ||| CEO Martin: Board has approved quarterly cash dividend program and $15B, 5-year repurchase. 2015 will be as busy as 2014, and will continue to provide collaboration and medication to those in need. I am proud of our progress thus far. ||| CEO Martin: GS-57945 Phase 2 studies are planned in Crohn's disease ||| CEO Martin: Progress continues in oncology and inflammation. Additional hires have been made to oncology, respiratory and inflammatory studies and departments. ||| CEO John Martin: Sovaldi has been approved in India and currently has 15,000 under treatment ||| Gilead Sciences Announces Initial Dividend Of $0.43/share ||| Gilead Sciences Announces $15B Buyback Program ||| Gilead Reports Q4 Adj. EPS $2.43 vs $2.21 Est., Sales $7.31B vs $6.74B Est. ||| Gilead Sciences Q4 Conference Call Play-By-Play Recap ||| Notable Earnings After The Close: GILD, DIS, CMG ||| Gilead Sciences Earnings Preview: Hepatitis C Guidance Is Key ||| Catamaran Corp Says Gilead's Hepatitis C Treatments, Harvoni, Sovaldi Are Exclusive Options on Cos National, Value Formularies ||| Why This Analyst Thinks Gilead Sciences Will 'Handily' Beat Q4 Expectations ||| The Key Level In Gilead Sciences You Need To Watch For ||| Here's What To Watch At Gilead Sciences, Chipotle & Twitter ||| From Conf Call: Aetna CFO Says Part of Increase in 2015 Earnings Outlook Based on Lower Price on Gilead's Hepatitis C Drugs ||| Earning & Economic Calendar for Tuesday February 3, 2015 ||| Earnings Scheduled For February 3, 2015 ||| Must Watch Stocks for Today",0,0.47464505
2015-02-04,59415800.0,98.93000030517578,100.20999908447266,95.80999755859376,98.43000030517578,84.67314147949219,GILD,"AbbVie Inc. Earnings: After a Strong Year, Eyes Shift to 2015 ||| Why Achillion Pharmaceuticals, Inc. Stock Is Crashing Today ||| Biotech Stock Roundup: Biogen Impresses with 4Q Results, Gilead & AbbVie HCV Drugs in Focus - Analyst Blog ||| Nasdaq 100 Movers: GILD, CTSH ||| Why Gilead Sciences Shares Crashed Today ||| Pre-Market Most Active for Feb 4, 2015 : ODP, SPLS, PBR, VIV, GILD, GM, GSK, PHG, AZN, TVIX, PEGI, QQQ ||| Gilead Tops Q4 Earnings Estimates, 2015 Outlook Disappoints - Analyst Blog ||| Dow Jones Ends Choppy Trading Session with 6-Point Gain ||| Merck & Co., Inc. Earnings: 1 Sentence That Changed Everything ||| S&P 500 Movers: RL, SJM ||| The S&P 500 Got A Boost From These Earnings ||| Cigna Signs Agreement with Gilead to Include Harvoni as Only Preferred Brand for Customers with Hep C Genotype 1 ||| UBS Just Boosted Aetna By 8% Because Of This ||| J.P. Morgan Is Watching This 'Curve Ball' At Gilead ||| Gilead Sciences Getting Crushed On Mixed Results ||| 5 Reasons Deutsche Bank Still Likes Gilead Stock ||| Morgan Stanley On Gilead: 'It's All About Price (Again)' ||| Nomura Just Cut Its Price Target On Gilead ||| Morning Market Losers ||| Wednesday Morning Movers: Gilead Sciences, Myriad Genetics Tumble Following Earnings ||| Benzinga's Top #PreMarket Losers",1,0.50731033
2015-02-06,21546300.0,99.7300033569336,100.58000183105467,97.1500015258789,97.4800033569336,83.85591125488281,GILD,"3 Things You Ought to Know About Gilead's Tumble ||| Gilead, Amgen Q4 Earnings & Weak Outlook Affect Biotech ETFs - ETF News And Commentary ||| Credit Suisse Downgrades Gilead Sciences, Sees Declining HCV Revenues ||| Benzinga's Top Downgrades ||| Credit Suisse Downgrades Gilead Sciences To Neutral ||| Credit Suisse Downgrades Gilead Sciences to Neutral, Lowers PT to $115.00",0,0.526239
2015-02-09,12668500.0,97.01000213623048,98.66999816894533,96.62999725341795,96.9000015258789,83.35697937011719,GILD,"What's Bad For Gilead Sciences and Merck Is a Good Sign for Patients ||| 5 Key Findings After 1 Full Year of Obamacare ||| Can You Guess the Stock Putting Gilead Sciences to Shame? (Hint: It's Not AbbVie) ||| Why Shares of Regulus Therapeutics Inc. Crashed ||| Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 10, 2015 ||| Achillion Soars on 6 Week HCV Cure When Used with Gilead's Sofosbuvir - Stocks in the News ||| Dividend Investing News: GM, GILD, and 29 More Increases ||| Gilead's Sofosbuvir Just Made Achillion Investors Very Happy ||| Jefferies Analyst Says AbbVie Hepatitis C Price-War Fears Overblown ||| Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest Profit Margin",1,0.48328516
2015-02-10,11495100.0,97.75,98.75,97.12000274658205,98.31999969482422,84.57849884033203,GILD,"Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for February 11, 2015 ||| Obama Just Created New Questions For Drug Makers",1,0.5188786
2015-02-11,14529600.0,98.62999725341795,101.26000213623048,98.41999816894533,99.9800033569336,86.0064926147461,GILD,"Wednesday 2/11 Insider Buying Report: GILD, YHOO ||| Biotech Stock Roundup: Achillion Impresses with HCV Data, Regeneron 4Q Results Top Estimates - Analyst Blog ||| OEF, GILD, C, DIS: ETF Outflow Alert ||| Gilead Sciences Shares Rise Amid Insider Buy, Conference Presentation Broadcast - Stocks in the News ||| Gilead Shares Near High; Presenting at Leerink Conference ||| Adam F Says AbbVie Deal with Express Scripts has Backfired ||| From Conf Call: Wellcare Says in Last Few Weeks have Reaffirmed Alignment With Gilead as Clinical Choice for Hep C Treatment ||| JMP Securities Covers Mostly Good News From Pharma Pending More Visibility",1,0.4996226
2015-02-12,10659900.0,100.62000274658205,101.6999969482422,99.5999984741211,100.8000030517578,86.7118911743164,GILD,"AbbVie Seeks Japanese Approval for HCV Cocktail Treatment - Analyst Blog ||| Gilead, Beryllium Publish Structural Basis for HCV RNA Replication in Science",1,0.53885895
2015-02-13,11084700.0,101.26000213623048,101.9000015258789,100.83000183105467,101.9000015258789,87.65815734863281,GILD,1 Sentence That Tells You Everything You Need to Know About Each of These 10 Big Pharma Earnings Rep ||| 5 Things CVS Health's Management Wants You to Know,1,0.52294433
2015-02-17,10789900.0,102.05999755859376,103.8499984741211,101.91000366210938,103.83999633789062,89.3270034790039,GILD,"3 Biotech Stocks I Love ||| 1 Number Shows Why Gilead Sciences, Inc. Shareholders Should Be Thrilled Right Now ||| In Case You Missed It, There's a New Fastest Growing Drug in the World ||| Gilead Sciences, Atlas Energy And Others Insiders Have Been Buying ||| Obamacare Could Soon Make These Stocks Soar ||| Was Gilead Sciences Inc.'s Dividend a Good Idea? ||| Could This Be The Biggest Advance in Hepatitis C since Gilead Sciences' Sovaldi? ||| 4 Stocks Wall Street Loves This Year...And 4 It Doesn't ||| Tiger Management's Julian Robertson Buys Apple, Netflix, Illumina, Sells Alibaba, EBay, MasTec ||| Not Too Late to Ride on Q4 Earnings: 3 Biotech Picks - Earnings ESP ||| Surprise! We Still Need Drugmakers to Develop Revolutionary Hepatitis C Drugs ||| Leon Cooperman's Omega Advisors Bought Gilead, Boosted Groupon & Liquidated Alibaba Last Quarter ||| 13F: Omega Advisors Reports New Position In Gilead Sciences Totaling 612,500 Shares ||| Biotech Performance 'Particularly Impressive,' Says JP Morgan ||| Top 5 Biotech Stocks That The Smart Money Doesn't Like",1,0.51826817
2015-02-18,7459400.0,103.76000213623048,104.13999938964844,103.01000213623048,103.94000244140624,89.4130630493164,GILD,Is Gilead Sciences Inc. Stock Cheap Now? ||| What Steven Cohen Is Doing With His Personal Wealth ||| Hearing Unconfirmed Market Chatter of Potential Gilead Bid for Juno,0,0.49607682
2015-02-19,9203800.0,103.4000015258789,104.30999755859376,102.5500030517578,102.7300033569336,88.37214660644531,GILD,"XLV, PFE, MRK, GILD: Large Inflows Detected at ETF ||| 11.7 Billion Reasons Gilead Sciences, Inc. Should Keep Winning",0,0.47636735
2015-02-20,9965400.0,102.41999816894533,102.98999786376952,101.91999816894533,102.61000061035156,88.26891326904297,GILD,"Gilead Insider buys 10,000 shares ||| New Potential HIV Vaccine Drug 'Absolutely 100% Effective' In Monkeys",1,0.53270346
2015-02-23,8926900.0,102.95999908447266,104.98999786376952,102.9499969482422,104.51000213623048,89.90337371826172,GILD,"3 Biotech Stocks I'd Love to Stash Away in My Portfolio Forever ||| Did Researchers Just Discover a Cure for HIV/AIDS? ||| 3 Tiny Biotech Stocks That I'm Paying Attention to in 2015 ||| The Nasdaq-100 Turns 30: Tracking Innovation in Large Cap Growth ||| 3 Stocks Pre-Retirees Can Buy and Hold for the Next 20 Years ||| Mylan Reports Signing of Exclusive Deal with Gilead Related to Distribution of Sovaldi, Harvoni in India ||| Mylan Signs Exclusive Agreement with Gilead Sciences to Distribute Sovaldi, Harvoni in India",1,0.52878904
2015-02-24,7830300.0,104.58999633789062,105.41999816894533,104.01000213623048,104.6999969482422,90.06681823730469,GILD,"Top-Rated Stock Picks and Most-Read Stories at Nasdaq.com: Feb. 15-21, 2015",0,0.4932974
2015-02-25,7270200.0,104.83999633789062,105.0,103.9000015258789,104.43000030517578,89.83455657958984,GILD,"These Pharmaceutical Stocks Let You Tap into a $402 Billion Trend ||| Why Pharmacyclics, Inc. Soared Higher Today ||| Gilead Says Watson Alleges Patent Associated with Ambrisentan Tablets Is Invalid; Gilead to File Patent Infringement Suit as Necessary -DJ ||| UPDATE: Gilead Reports Preclinical Data ||| Gilead Announces Preclinical Data for an Investigational TLR7 Agonist in SIV-Infected, Virally Suppressed Monkeys",0,0.48326764
2015-02-26,6698000.0,104.3000030517578,104.8499984741211,103.3000030517578,104.19000244140624,89.62812042236328,GILD,Biotech Head-to-Head: Gilead vs. Celgene ||| Gilead Offers Phase 3 Results for Investigational Once-Daily Single Tablet HIV Regimen Containing TAF ||| UPDATE: Gilead Press Release Regarding Phase 3 Harvoni Study ||| Gilead Announces SVR12 Rates From Phase 3 Study Evaluating Harvoni® for Treatment of Chronic Hepatitis C in Patients Co-Infected With HIV ||| Bloomberg Reporting Gilead Will Avoid Billions in Taxes From Its Hep. C Drug By Booking Profits Overseas,0,0.4859808
2015-02-27,7940000.0,104.27999877929688,104.33999633789062,102.70999908447266,103.52999877929688,89.06034088134766,GILD,"Noteworthy ETF Inflows: IYH, MRK, GILD, AMGN ||| Gilead Confirms Immunovaccine Deal PR Was Fake ||| Immunovaccine CEO Says PR on Immunovaccine Signing Deal With Gilead Was a Hoax -Reuters ||| Bloomberg Reporting Globe Newswire Confirms Earlier Immunovaccine Release Was Hoax ||| Immunovaccine Disclaims Hoax Press Release ||| ImmunoVaccine Up 24% On Deal With Gilead Sciences ||| Gilead Booking Profits Overseas On A $1,000 Pill: Hard To Swallow ||| Gilead Partners Immunovaccine Announces Fast Track, Phase I Trial Approval for Ebola, Anthrax Vaccine Programs",1,0.5036159
2015-03-02,7672800.0,104.3000030517578,104.3000030517578,102.8000030517578,103.83000183105467,89.31840515136719,GILD,"This Breakthrough Study May Allow Researchers to Tackle the Root Cause of Heart Disease ||| 3 Big Cap Biotechs That Could Trounce Gilead Sciences This Year ||| Why Don't These Winning Stocks Pay Dividends? ||| PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for March 03, 2015 ||| Gilead's (GILD) HIV Drug Positive in 2 Phase III Studies - Analyst Blog",0,0.47197965
2015-03-03,8348500.0,103.83999633789062,103.9000015258789,102.1500015258789,102.79000091552734,88.42376708984375,GILD,Pioneer Fundamental Growth Fund: Why Is It Revving Up?,1,0.5053503
2015-03-04,8884500.0,102.08999633789062,104.08000183105467,101.66000366210938,103.05999755859376,88.65601348876953,GILD,"Top-Rated Stock Picks and Most-Read Stories at Nasdaq.com: Feb. 22-28, 2015",1,0.49562874
2015-03-05,8650700.0,103.43000030517578,104.4499969482422,102.72000122070312,103.41999816894533,88.96570587158203,GILD,"After Hours Most Active for Mar 5, 2015 : EMC, BAC, GRMN, RIO, GE, QQQ, KLAC, MU, DNR, MS, GILD, AAPL ||| Bristol-Myers' Drug Shows Impressive Data, Inks Deal - Analyst Blog",0,0.4948831
2015-03-06,8658900.0,103.0,103.75,101.70999908447266,101.80999755859376,87.58075714111328,GILD,"Forget Gilead Sciences (GILD), Buy These Biotech Stocks Instead - Stocks in the News",0,0.47060803
2015-03-09,9335900.0,101.54000091552734,101.9800033569336,100.19000244140624,101.37000274658205,87.20223999023438,GILD,Copy of Gilead's Sovaldi Appears in Bangladesh for $10/Pill,0,0.50437546
2015-03-10,12728900.0,99.87000274658205,100.5500030517578,98.6999969482422,98.83000183105467,85.0172348022461,GILD,"In Case You Missed It, Gilead Sciences, Inc.’s “Bad” News Is Actually Great ||| TD Ameritrade's IMX for Feb. Showed ~3% Decline to 4.7 Reading",1,0.51216346
2015-03-11,9006400.0,99.12999725341795,100.13999938964844,98.76000213623048,98.97000122070312,85.13765716552734,GILD,"Biotech Stock Roundup: AbbVie to Buy Pharmacyclics, FDA Approves First Biosimilar - Analyst Blog ||| Express Scripts Issues Report on Prescription Drug Spending - Analyst Blog ||| The 4 Biggest Biotech Stocks In The Market",1,0.49330577
2015-03-12,8356800.0,99.62999725341795,100.5500030517578,98.87999725341795,99.93000030517578,85.96349334716797,GILD,"Hetero Receives Approval for Generic Sofosbuvir Tablets, 400 Mg in India -Reuters",0,0.5229274
2015-03-13,7810200.0,99.58999633789062,100.9800033569336,98.87999725341795,99.61000061035156,85.68821716308594,GILD,Bristol-Myers Seeks Daclatasvir Approval in the U.S. - Analyst Blog ||| Analyst Sees Upside To Outlook At 4 Biotechs,1,0.5100547
2015-03-16,10524200.0,100.0,101.5999984741211,99.7699966430664,101.3000030517578,87.14201354980469,GILD,Should Gilead Sciences Inc.’s Slowing Growth Concern Investors? ||| Is This Number the Scariest Healthcare Statistic Out There? ||| 3 Biotech Stocks Wall Street Loves,0,0.4809707
2015-03-17,9906300.0,100.8000030517578,101.75,99.61000061035156,100.44000244140624,86.4021987915039,GILD,Bristol-Myers Squibb Co. Is Back in the Hepatitis C Race ||| 3 Stocks Benefiting From Jaw-Dropping Growth in Specialty Drug Spending,0,0.5134977
2015-03-18,12992200.0,100.27999877929688,100.58999633789062,98.54000091552734,100.27999877929688,86.26456451416016,GILD,"Biotech Stock Roundup: Amgen & Regeneron Shine at ACC, Nektar Drug Disappoints - Analyst Blog ||| Why I'm Not Giving Up on This Tiny Biotech Stock (Yet) ||| Gilead Sciences Stuck In Trading Range: A Technical Look",1,0.49321425
2015-03-20,17162200.0,102.01000213623048,102.70999908447266,101.6999969482422,102.29000091552734,87.99363708496094,GILD,The Top 5 Trading Ideas Of The Week By Traffic ||| Biotech Stocks Soar Amid Positive News ||| Argus Sees 'Strong Prospects' For Gilead Sciences,0,0.50897765
2015-03-23,17983700.0,99.77999877929688,101.19000244140624,99.25,100.26000213623048,86.24736785888672,GILD,"Dividend Stocks: 2 to Avoid, 1 to Buy ||| Drug Spending Is Soaring: 3 Takeaways You Can't Miss ||| 1 Biotech Stock You Can Buy and Hold for the Next 20 Years ||| Pre-Market Most Active for Mar 23, 2015 : STO, GSK, GILD, AAPL, VRTX, IMGN, RDS/B, QQQ, FB, RDS/A, SDRL, NVS ||| Better Dividend Stock: AbbVie or Gilead Sciences, Inc.? ||| After Hours Most Active for Mar 23, 2015 : BAC, OPK, CSCO, GE, QQQ, ZTS, OCN, MSFT, GILD, MDLZ, AAPL, WFC ||| Previewing the Q1 Earnings Season - Video Blog ||| ICYMI: Pharmaceutical Stocks Are Moving Big On Monday ||| Gilead Shares Reacting To Death Of Patient ||| Why This Analyst Thinks Gilead's Technicals Are Setting Up For A Break ||| Morning Market Losers ||| Gilead Shares Tumble On Drug Warning; Baird Says Buy ||| Benzinga's Top #PreMarket Losers ||| Gilead Shares Fall 2.7% Premarket Following Bloomberg Report of Death of Hepatitis Patient on Heart Drug",1,0.4902981
2015-03-24,11784800.0,100.48999786376952,102.8499984741211,100.06999969482422,101.41000366210938,87.23665618896484,GILD,"Company News for March 24, 2015 - Corporate Summary ||| FDA Recommends Health Care Professionals Not Prescribe Either Harvoni or Sovaldi Combined With Another Direct Acting Antiviral With Amiodarone ||| Gilead Safety Warning? No Problem, Says Wall Street ||| Gilead Canada Says Multiple Provinces to Provide Public Access to Harvoni for Chronic Hepatitis C Virus Genotype 1 Infection In Adults; Sovaldi Also Listed for Public Reimbursement for Chronic HCV Genotypes 1, 2,3 Infection in Multiple Provinces",0,0.48414567
2015-03-25,15629300.0,101.98999786376952,103.11000061035156,99.77999877929688,99.86000061035156,85.90326690673828,GILD,"Biotech Stock Roundup: Biogen Soars on Alzheimer's Data, Gilead HCV Drugs Label Update - Analyst Blog ||| Bubble Bursting? 3 Top Stock Biotech Stocks to Buy",1,0.49513972
2015-03-26,10928000.0,99.12999725341795,101.81999969482422,98.58999633789062,101.08000183105467,86.95277404785156,GILD,"iShares S&P 100 ETF Experiences Big Outflow ||| Stock Market News for March 26, 2015 - Market News ||| Is It Closing Time At The Biotech Bar? ||| Japan's MHLW Approves Gilead's Sovaldi for Treatment of Genotype 2 Chronic Hepatitis C",0,0.5031851
2015-03-27,8815900.0,101.0,102.0999984741211,100.9000015258789,101.0,86.88395690917969,GILD,"Investors Might Want To Stay Away From This Biotech ETF ||| Gilead's Hepatitis C Drug Sovaldi Gets Approval in Japan - Analyst Blog ||| Investors Might Want To Stay Away From This Biotech ETF ||| Experts Talking Gilead, Not Bubbles At Detroit's Engage Conference",0,0.48395765
2015-03-30,9968200.0,101.12000274658205,101.66000366210938,99.56999969482422,100.69000244140624,86.61727142333984,GILD,"The Biggest Red Flag for Biotech Investors ||| Could These Experimental Drugs Eclipse Harvoni's Historic Launch? ||| 3 Best Dividend Stocks for 2015 ||| The Best Dividend-Paying Healthcare Stocks ||| The Zacks Analyst Blog Highlights: Gilead Sciences, Bristol-Myers Squibb, Achillion Pharmaceuticals and Cambrex - Press Releases ||| 3 Triple-Digit Stocks With Upside Potential of At Least 40%",0,0.5027972
2015-03-31,13559900.0,100.01000213623048,100.1999969482422,98.06999969482422,98.12999725341795,84.41503143310547,GILD,"Post-UNH Deal, Spotlight on Pharmacy Benefit Stocks - Analyst Blog ||| What to Look for This Earnings Season - Earnings Outlook ||| What to Look for This Earnings Season - Earnings Trends ||| Doctor Says Sovaldi Could br Cardiotoxic -Medscape ||| Gilead Sciences Hovering Above Major Support Level ||| Is Gilead's Latest Japan Win Good News For Shareholders?",0,0.49995813
2015-04-01,15134200.0,98.16000366210938,98.16000366210938,95.37999725341795,97.72000122070312,84.06237030029297,GILD,"Zacks Earnings Trends Highlights: Bank of America, Gilead Sciences and Apple - Press Releases ||| After Hours Most Active for Apr 1, 2015 : AA, MU, PFE, ACWI, MYL, JNJ, MRK, AVIV, QQQ, PAGP, THRM, GILD",1,0.49103698
2015-04-02,10727300.0,97.98999786376952,99.5,97.01000213623048,98.43000030517578,84.67314147949219,GILD,Is AbbVie Inc. Stock About to Crash? ||| Q1 Earnings Season is Spotlight as Alcoa (AA) Reports Results - Earnings Preview,0,0.48744014
2015-04-06,9697300.0,97.91999816894533,98.73999786376952,97.19000244140624,97.79000091552734,84.12259674072266,GILD,"Actavis Confirms it Filed NDA To Market Letairis Generic ||| Following Gilead Sciences, Inc., Which Biotech Will Pay a Dividend Next? ||| The Safest Biotech Bet on the Market ||| Why Smart Money Loves This Biotech Stock ||| 5 Big Losers if the Supreme Court Strikes Down Federal Obamacare Subsidies ||| The One Biotech Stock That Looks Like a Bargain These Days ||| Notable ETF Inflow Detected - XLV, MRK, GILD, UNH ||| Actavis in Patent Infringement Lawsuit for Gilead's Letairis - Analyst Blog ||| After Hours Most Active for Apr 6, 2015 : WIN, O, IGT, DEI, CNO, SIRI, KKR, KO, QQQ, CSCO, FOXA, GILD ||| What RBC Is Saying About MannKind And Gilead ||| Gilead Alert: What Deutsche Bank Is Saying",1,0.48844793
2015-04-07,8264700.0,98.27999877929688,99.73999786376952,98.01000213623048,98.69000244140624,84.89678955078125,GILD,Gilead Submits New Drug Application to U.S. FDA for Fixed-Dose Combo of Emtricitabine/Tenofovir Alafenamide for HIV Treatment,1,0.5394229
2015-04-08,10967100.0,98.6999969482422,100.9000015258789,98.55999755859376,99.87000274658205,85.91188049316406,GILD,"Gilead Submits Regulatory Application for HIV Drug in U.S. - Analyst Blog ||| Biotech Stock Roundup: Alkermes Drug Fares Well, Targacept Slides on Deal Termination - Analyst Blog ||| This Data Offers Insight Into Gilead Sales ||| US Stock Futures Edge Higher Ahead Of Fed Minutes, Alcoa Earnings",1,0.51716286
2015-04-09,9178100.0,100.16999816894533,101.18000030517578,99.91999816894533,101.16000366210938,87.02159881591797,GILD,"The Zacks Analyst Blog Highlights: Alkermes, Regulus, Juno Therapeutics, Targacept and Gilead - Press Releases ||| Merck's HCV Combo Drug Gets Two Breakthrough Status - Analyst Blog ||| The Biotech Stocks JMP Is Watching",1,0.5022592
2015-04-10,9257600.0,101.75,102.4499969482422,101.05999755859376,101.7699966430664,87.54632568359375,GILD,Biotech Investors: Nomura Says To Watch These Dates ||| Gilead Shares Pulling Back; May be Attributed to Barron's Blog Post Mentioning Nomura Analyst Concern Regarding Harvoni Pricing,1,0.5023521
2015-04-13,10648400.0,102.01000213623048,103.81999969482422,102.0,102.27999877929688,87.98504638671875,GILD,The 3 Best Stocks to Invest in Biotechnology ||| Q1 Earnings Season Ramps Up - Earnings Preview ||| 3 Stocks You Absolutely Must Watch This Earnings Season ||| 5 Companies The Crowd Is Betting On To Beat Wall Street ||| 7 Trends Drug Investors Should Know,0,0.50215566
2015-04-14,7224700.0,102.33999633789062,102.66000366210938,101.47000122070312,102.20999908447266,87.92484283447266,GILD,"XLV, MRK, GILD, UNH: ETF Outflow Alert ||| J.P. Morgan, Bank of America, Gilead Sciences and Actavis are part of Zacks Earnings Preview: - Press Releases ||| Analyst Wants Proof On Arrowhead Research's Hepatitis B Drug",1,0.50728995
2015-04-15,12899700.0,102.38999938964844,104.36000061035156,102.33000183105467,104.02999877929688,89.49047088623047,GILD,3 Biotech Stocks Under $10 with Amazing Growth Prospects - Analyst Blog,0,0.5386832
2015-04-16,6670400.0,103.9499969482422,104.72000122070312,103.11000061035156,103.33999633789062,88.89688873291016,GILD,"Johnson & Johnson's Earnings: The Good, The Bad and The Ugly ||| The Best Stock to Invest in Hep C",0,0.4942062
2015-04-17,9896500.0,102.3499984741211,102.80999755859376,100.61000061035156,101.37999725341795,87.2108383178711,GILD,Gilead Sciences (GILD) Shares Cross Below 200 DMA,0,0.5077581
2015-04-20,8752000.0,102.27999877929688,102.27999877929688,100.41000366210938,100.66000366210938,86.59146881103516,GILD,What Could Possibly Go Wrong With Gilead Sciences Inc. Stock? ||| 3 Drug Stocks Leading the Charge Against Infectious Diseases ||| Morningstar: Gilead Sciences To Grow Its Hepatitis C Market ||| These Companies Probably Won't Be Acquiring Ariad Pharmaceuticals ||| 3 Biotech Stocks That Could Be Developing Billion Dollar Drugs ||| How to Invest Money in Biotech ||| Why This Trader Likes Gilead Better Than Biogen,1,0.49954656
2015-04-21,19722700.0,101.41999816894533,105.70999908447266,100.88999938964844,105.1999969482422,90.4969482421875,GILD,"Benzinga's M&A Chatter for Tuesday April 21, 2015 ||| Gilead-Vertex Deal Has 'Low Probability' Of Happening, RBC Capital Says ||| Adam Feuerstein @adamfeuerstein Tweet: Ackman could be interviewed on @CNBC multiple times across many shows to promote/pump his $GILD position. ||| Should Gilead Buy Vertex? ||| Hearing RBC Says Probability of Gilead Buying Vertex is Low ||| RBC Analyst Saying Gilead and Vertex Deal Is A 'pretty low probability' ||| Tweet, Rumor And Bernstein Fueling Rallies In Gilead Sciences, Vertex Pharmaceuticals ||| Hearing Unconfirmed Market Chatter of Ackman $2B Stake in Gilead; Ackman Said to Push for Acquisition of Vertex ||| Bernstein: It's Time For Gilead To Pull The Trigger On This Acquisition ||| Adam Feuerstein @adamfeuerstein Tweet: $GILD Should Buy $VRTX for $45B Now, Analyst Says thestreet.com/story/13119465… via @TheStreet",0,0.49715438
2015-04-22,8267300.0,105.23999786376952,105.41999816894533,103.83000183105467,104.18000030517578,89.61949157714844,GILD,"Notable ETF Outflow Detected - XLV, GILD, UNH, ESRX ||| The Zacks Analyst Blog Highlights: Gilead Sciences, Biogen, Geron, Johnson & Johnson and Anthera Pharmaceuticals - Press Releases ||| Biotech Stock Roundup: Amgen Starts Earnings Season on Strong Note, Setbacks for Ampio & Athersys - Analyst Blog",1,0.48491734
2015-04-23,8071800.0,104.63999938964844,105.75,104.01000213623048,105.20999908447266,90.50554656982422,GILD,"Is Amgen Inc.'s Dividend Sustainable? ||| Gilead (GILD) Announces Encouraging Data on its HCV Drugs - Analyst Blog ||| Gilead Announces Data for Investigational, All-Oral, Pan-Genotypic Three-Drug Regimen of Sofosbuvir, GS-5816 and GS-9857 for Chronic Hepatitis C ||| Gilead Says Harvoni. Sovaldi Demonstrate Efficacy, Safety Among Chronic Hepatitis C Patients with Advanced Liver Disease",0,0.5056998
2015-04-24,9734400.0,104.63999938964844,105.68000030517578,103.5999984741211,103.6999969482422,89.20657348632812,GILD,Merck Reports Encouraging Data on HCV Combo Candidate - Analyst Blog ||| AbbVie's HCV Cocktail Treatment Under FDA Priority Review - Analyst Blog ||| 142 HIV Cases Linked to Indiana Outbreak -DJ ||| Morgan Stanley Alert: Gilead Investors Don't Have The Whole Story ||| Analyst: Biogen Will Miss On Tecfidera Sales; No Threat To Gilead's Harvoni,0,0.49854255
2015-04-27,10829200.0,104.18000030517578,104.52999877929688,102.01000213623048,102.94000244140624,88.55281066894531,GILD,"Gilead Says Sovaldi in Combination with RBV or with PEG/RBV Demonstrated High Cure Rates across all Patients with Genotypes 2, 3 ||| Why Healthcare is the Best Sector For Your Money ||| Can You Guess Which State Won't Pay for Hepatitis C Drugs? ||| Gilead and Bristol-Myers Reveal Positive Data on HCV Drugs - Analyst Blog ||| Will Express Scripts (ESRX) Disappoint Earnings in Q1? - Analyst Blog ||| Biotech Bubble Bursting? 3 Stocks I Want to Buy ||| All-Star Analysts Discuss GoPro, Apple & Gilead Before They Make Headlines ||| This Underrated Twitter Account Is Crushing The Market ||| Oppenheimer Assumes Gilead Sciences at Outperform",1,0.5247763
2015-04-28,9793700.0,103.12000274658205,103.83000183105467,101.13999938964844,103.72000122070312,89.22379302978516,GILD,Bristol-Myers Squibb Crushes First-Quarter Earnings: Here's Why ||| 3 Things to Watch with Gilead Sciences Inc.'s Q1 Earnings ||| 5 Biotech Stocks to Avoid After Monday's Slump - Analyst Blog ||| 10 Most Profitable Businesses in Biotech,0,0.51825446
2015-04-29,8932200.0,103.12000274658205,103.9000015258789,101.62000274658205,102.31999969482422,88.01944732666016,GILD,What's Behind Vertex Pharmaceuticals Incorporated's Disappointing Q1 ||| Can Gilead Really Post EPS Growth Above 50%? ||| What's Wall Street Been Saying About Gilead Lately?,0,0.4832549
2015-04-30,14009500.0,102.1500015258789,102.6999969482422,99.8000030517578,100.51000213623048,86.46241760253906,GILD,"Agree To Buy Gilead Sciences At $70, Earn 5.4% Using Options ||| The Zacks Analyst Blog Highlights: Amgen, Celladon, Biogen, Celgene and Gilead - Press Releases ||| Q1 Earnings Scorecard - The Dollar Impact - Earnings Outlook ||| After Hours Most Active for Apr 30, 2015 : LNKD, QQQ, MSFT, GILD, AAPL, LOW, HD, NVAX, CY, NRZ, BAC, GE ||| Earnings Reaction History: Gilead Sciences Inc., 55.6% Follow-Through Indicator, 3.7% Sensitive ||| After-Hours Earnings Report for April 30, 2015 : GILD, V, AIG, PSA, LNKD, BMRN, SWKS, FLT, EMN, EXPE, WU, FMX ||| Gilead Sciences Beats Q1 Views, Shares Rise ||| Gilead Reports Q1 EPS $2.94 vs. Est. $2.32, Rev. $7.59B vs. Est. $6.92B ||| Is Gilead Sciences About To Buy Vertex For $45 Billion? ||| Earning & Economic Calendar for Thursday April 30, 2015 ||| Earnings Scheduled For April 30, 2015",1,0.51580137
2015-05-01,22306500.0,103.1999969482422,106.33999633789062,102.5,105.01000213623048,90.33351135253906,GILD,"Gilead Sciences, Inc. Earnings: Hepatitis C Market by the Numbers ||| Midday Update: Wall Street Mostly Ignores Weak Manufacturing Data, Starts May in Buying Mood Buy ||| QUAL, GILD, V, MA: ETF Outflow Alert ||| Daily Dividend Report: LM, KO, GILD, AIG, VFC, PAYX ||| Gilead Tops Q1 Earnings Estimates, 2015 Outlook Revised - Analyst Blog ||| Gilead Soothes Price War Worry With Q1 Results ||| Gilead Sciences Rallying Off Q1 Beat: A Technical Look ||| Does Anyone Care About Gilead's Beat, Guidance Boost? ||| Bank Of America Reviews Gilead Earnings ||| Morgan Stanley On What 'Should Be Rewarded' At Gilead ||| Gilead Still A 'Top Pick' For Barclays ||| Keep an Eye on These 10 Stocks for May 1, 2015",1,0.4878269
2015-05-04,13215600.0,105.6500015258789,107.5,105.22000122070312,105.66000366210938,90.89265441894533,GILD,"Stock Market News for May 04, 2015 - Market News ||| How These 2 Industries Helped Save the Stock Market This Earnings Season ||| Biotech's Blue Chip Stocks ||| Gilead Sciences Remains Popular Post-Earnings ||| Mylan Launches Gilead Sciences' Sovaldi Tablets in India",0,0.5013531
2015-05-05,15046500.0,105.3000030517578,105.7300033569336,102.7300033569336,102.98999786376952,88.59581756591797,GILD,"Top-Rated Stock Picks and Most-Read Stories at Nasdaq.com: April 26 to May 2, 2015 ||| Beyond Pharma: 3 Healthcare Choices - Analyst Blog ||| Is This Why the Street Keeps Doubting Gilead Sciences, Inc.? ||| Conatus Pharmaceuticals (CNAT): What's Up this Earnings? - Analyst Blog",0,0.48130506
2015-05-06,10065200.0,103.4499969482422,103.83000183105467,101.5199966430664,102.2699966430664,87.9764633178711,GILD,Gilead Announces Purchase of EpiTherapeutics for $65M,0,0.52364635
2015-05-07,13878300.0,102.16999816894533,102.3499984741211,99.66000366210938,101.79000091552734,87.56352996826172,GILD,"Glaxo's (GSK) Q1 Earnings Fall Y/Y; Gives Five-Year View - Analyst Blog ||| After Hours Most Active for May 7, 2015 : VALE/P, VALE, RIG, EMC, GILD, MSFT, AAPL, PFE, CX, ODP, MRVL, QQQ ||| Big Pharma Giant AbbVie Inc. Took Off in April -- Here's Why ||| 10 Most Profitable Companies in Healthcare ||| Standout Sectors of Q1 Earnings Season - Earnings Outlook ||| Alexion to Buy Synageva for $8.4B: Alexion Down, Synageva Up - Analyst Blog ||| Standout Sectors of Q1 Earnings Season - Earnings Trends ||| Deutsche Sees Cancer Treatment Home Run At Infinity Pharmaceuticals",1,0.4999185
2015-05-08,9651700.0,103.0,103.95999908447266,102.87999725341795,103.8499984741211,89.3355941772461,GILD,"MannKind's (MNKD) Q1 Loss In Line with Expectation - Analyst Blog ||| iShares Rolls Out New Smart Beta ETFs ||| Emergent BioSolutions (EBS) Loss Wider than Expectations - Analyst Blog ||| Sarepta Posts Wider-than-Expected Loss, Eteplirsen in Focus - Analyst Blog ||| Medivation (MDVN) Misses on Q1 Earnings, Revenues - Analyst Blog ||| Corcept Therapeutics Reports Wider Q1 Loss, Revenue Miss - Analyst Blog ||| Zacks Earnings Trends Highlights: Walgreen Boots, Amazon and Gilead Sciences - Press Releases ||| 3 Value Stocks You Can Buy Right Now ||| iShares Rolls Out New Smart Beta ETFs ||| WHO Says Lower Prices for Hepatitis C Drugs Needed to Make them Affordable in Poorer Countries -Reuters",1,0.49618238
2015-05-11,9956100.0,104.19000244140624,105.36000061035156,104.0,104.7300033569336,90.0926284790039,GILD,"The Best And Worst ETFs Of The Week Amid Biotech Rebound ||| A Stock Market Bubble in Biotech Stocks? ||| The Best And Worst ETFs Of The Week Amid Biotech Rebound ||| Actavis Tops 1Q Earnings by Wide Margin, Provides Outlook - Analyst Blog ||| Osiris Therapeutics Q1 Earnings & Revenues Grow Y/Y - Analyst Blog ||| ETFs in Focus on Impressive Q1 Biotech Earnings - ETF News And Commentary ||| Bio-Techne Lags on Q3 Earnings, Revenues; Expenses Rise - Analyst Blog ||| IWB, MRK, GILD, V: Large Inflows Detected at ETF ||| Novartis' Zykadia Approved in the EU for Lung Cancer - Analyst Blog ||| Myriad Genetics Q3 Test Growth Impresses Yet Revenues Fall - Analyst Blog ||| NxStage Medical Loss Narrower than Expected, Revenues Up - Analyst Blog ||| Seattle Genetics (SGEN) in Focus: Stock Up 8.1% - Tale of the Tape ||| Endo (ENDP) Beats on Q1 Earnings, 2015 Guidance Upped - Analyst Blog",1,0.5031407
2015-05-12,9552600.0,104.20999908447266,106.1500015258789,103.4499969482422,105.55999755859376,90.8066177368164,GILD,"Mettler-Toledo (MTD) Beats on Q1 Earnings, Sales; Stock Up - Analyst Blog ||| 5 Largest Markets for Pharmaceuticals ||| TrovaGene (TROV) in Focus: Stock Rises 7.1% - Tale of the Tape ||| Inovio Narrows Q1 Loss Y/Y, Misses Earnings Estimates - Analyst Blog ||| Arena Pharmaceuticals 1Q Loss Narrower-Than-Expected - Analyst Blog ||| Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for May 13, 2015 ||| Forget Gilead Sciences, Inc. -- This Tiny Biotech Offers A Much Richer Opportunity ||| Fluidigm Q1 Revenues Lower than Expected, Stock Down - Analyst Blog",1,0.4867701
2015-05-13,10814500.0,105.97000122070312,107.43000030517578,105.9499969482422,106.38999938964844,91.52062225341795,GILD,"McKesson Beats on Q4 Earnings & Revenues, Guides Strong - Analyst Blog ||| Vertex Pharmaceuticals' Orkambi Wins FDA Panel Backing - Analyst Blog ||| Zacks.com featured expert Kevin Matras highlights: Gilead Sciences, Citigroup and Barclays - Press Releases ||| Biotech Stock Roundup: Alexion to Buy Synageva, FDA Panel Backs Vertex's Orkambi - Analyst Blog ||| Retail Sector in the Spotlight - Earnings Outlook ||| Falling Earnings Estimates Signal Weakness Ahead for Compugen (CGEN) - Tale of the Tape ||| Retail Sector in the Spotlight - Earnings Trends ||| Why ANI Pharmaceuticals (ANIP) Could Be Positioned for a Slump - Tale of the Tape ||| Senator Sanders Asks VA to Break Patent on Gilead's Sovaldi -Firece Pharma",1,0.5203792
2015-05-14,12761300.0,107.2699966430664,108.8499984741211,106.66000366210938,108.73999786376952,93.54217529296876,GILD,"Emergent BioSolutions, Glaxo Initiate Ebola Vaccine Study - Analyst Blog ||| Sanofi (SNY) Exercises Celiac Disease Program Option - Analyst Blog ||| Roche Reports Encouraging Data on Lung Cancer Drugs - Analyst Blog ||| RXi (RXII) Q1 Loss Wider-Than-Expected, Pipeline in Focus - Analyst Blog",1,0.50603384
2015-05-15,13419600.0,109.0500030517578,110.23999786376952,108.29000091552734,109.3000030517578,94.02391815185548,GILD,"Eli Lilly, Sanford-Burnham Ink Deal for Immunotherapies - Analyst Blog ||| Prestige Brands Holdings Beats on Q4 Earnings, Revenues - Analyst Blog ||| Amgen Announces Positive Results on Migraine Candidate - Analyst Blog ||| Agenus (AGEN) Provides Update on its Brain Cancer Vaccine - Analyst Blog ||| Endo/BioDelivery Reveal Encouraging Data on Pain Drug - Analyst Blog ||| Teva Presents Encouraging Data from Chronic Migraine Study - Analyst Blog ||| Leon Cooperman's Omega Advisors Sells Apple, Gilead; Buys Humana, GM And IBM ||| Omega Advisors 13-F Shows Cooperman Sold Out Of Gilead Stake",1,0.5011892
2015-05-18,13716000.0,109.58999633789062,111.33000183105467,109.36000061035156,111.0,95.48632049560548,GILD,"Could an HIV/AIDS Vaccine Be a Reality By the End of the Decade? ||| Could This Tiny Biotech Be on Gilead Sciences’ M&A Radar? ||| Is Gilead Sciences Its Own Worst Enemy? ||| 3 Types of Risks Facing Biotech Stocks ||| Kite Pharma Narrows Q1 Loss, Misses Estimates; Gives View - Analyst Blog ||| Gilead Sciences (GILD) Stock: 3 Reasons Why It Is a Top Choice for Growth Investors - Tale of the Tape ||| Why Achillion Pharmaceuticals, Inc. Shares Soared Today ||| This Experimental Drug Could Finally Cure HIV ||| Alnylam Files Clinical Trial Application for ALN-AAT - Analyst Blog ||| The Best Blue Chips to Own Forever ||| Gilead Press Release Confirms Will Present at UBS '15 Global Healthcare Conference Tomorrow (Tues, May 19) ||| Top Street Analysts Like Gilead Sciences",0,0.5015758
2015-05-19,8676900.0,111.12000274658205,111.5500030517578,110.0500030517578,110.55999755859376,95.10781860351562,GILD,"Stock Market News for May 19, 2015 - Market News ||| Eleven Biotherapeutics Tanks after Eye Drug Fails Study - Analyst Blog ||| Regeneron/Sanofi Announce Positive Data on Dupilumab - Analyst Blog ||| Theravance Biopharma Posts Positive Data on Velusetrag - Analyst Blog ||| Genomic Health's Loss Lingers, Profits Expected in 4Q15 - Analyst Blog ||| XBiotech's Xilonix Recommended for Colorectal Cancer Study - Analyst Blog ||| Lannett (LCI) Signs Deal to Acquire Silarx Pharmaceuticals - Analyst Blog ||| Celgene/Accelreon's Luspatercept Granted Fast Track Status - Analyst Blog ||| Merck KGaA Q1 Earnings Fall Y/Y, 2015 Sales View Retained - Analyst Blog ||| Eleven Biotherapeutics (EBIO) in Focus: Stock Tanks 69.2% - Tale of the Tape",0,0.49276343
2015-05-20,10335100.0,110.08999633789062,110.91000366210938,108.1500015258789,110.16999816894533,94.7723159790039,GILD,"Zacks.com featured expert Kevin Matras highlights: Outerwall, Gilead Sciences, Lionbridge Technologies, Silicon Motion Technology and Wabash National - Press Releases ||| IWF, GILD, V, SLB: Large Inflows Detected at ETF ||| Why Achillion Pharmaceuticals, Inc. Shares Are Collapsing ||| SWOT Analysis of Gilead Sciences Inc. Stock ||| Johnson & Johnson Takes On Gilead Sciences in Hep C... Again ||| Intercept Pharmaceuticals Reveals Phase III OCA Study Plan - Analyst Blog ||| How Celgene Stock Is Breaking All the Rules ||| Achillion and Johnson & Johnson in $1.1B HCV Tie-Up - Analyst Blog ||| Option Alert: Gilead Jun 5 $108 Call; 1274 Contract Trade above Ask @$2.33; Now $108.57 ||| 5 NASDAQ Healthcare Stocks With The Highest EPS ||| Gilead Just Presented 'Interesting' Data, Analysts Say ||| Patent Challenges In 5 Countries Dispute Validity Of Gilead's Claims To Hep C Drug Patents That Prevent Treatment For Up To 59 Million People",1,0.49014854
2015-05-21,8374000.0,109.9000015258789,111.47000122070312,109.80999755859376,111.22000122070312,95.6755828857422,GILD,"MannKind, Front and Center: The Best Product Doesn’t Always Equal the Best Stock ||| Johnson & Johnson Just Stepped Up Its Hepatitis C Game ||| J&J (JNJ) to File for More than 10 New Products by 2019 - Analyst Blog ||| Bristol-Myers' HCV Combination Designation Amended by FDA - Analyst Blog ||| What Does The Johnson & Johnson/Achillion Deal Mean For HCV Competitors?",1,0.48799086
2015-05-22,12079000.0,110.6999969482422,112.66000366210938,110.6999969482422,111.70999908447266,96.09708404541016,GILD,Should You Get Rid of CytRx Corporation (CYTR) Now? - Tale of the Tape ||| Novartis Announces Positive Data on Oncology Drug Afinitor - Analyst Blog ||| Kite Pharma Starts Dosing in Phase I/II Study on KTE-C19 - Analyst Blog,0,0.49422455
2015-05-26,16006900.0,111.48999786376952,111.52999877929688,109.54000091552734,109.7699966430664,94.42821502685548,GILD,"Healthcare Investment Opportunities for the Long Term ||| Warren Buffett's Portfolio: 3 Biotech Stocks the Oracle of Omaha Could Love ||| Amgen's PCSK9 Inhibitor a Step Closer to EU Approval - Analyst Blog ||| The Best Business Model in Biotech ||| AstraZeneca, Amgen End Psoriasis Drug Brodalumab Deal - Analyst Blog ||| Actavis to Continue Selling Namenda IR under Court Ruling - Analyst Blog ||| Pop! 3 To Buy If Biotech Stocks Burst ||| Pharmacyclics' Imbruvica Gets CHMP's Nod for Full Approval - Analyst Blog ||| Merck's (MRK) Keytruda a Step Closer to European Approval - Analyst Blog",1,0.5134614
2015-05-27,11722000.0,110.33999633789062,112.5999984741211,109.9800033569336,112.45999908447266,96.74224853515624,GILD,"Synageva BioPharma Files for Kanuma's Approval in Japan - Analyst Blog ||| Genomic's Prostate Cancer Test Recommended by Palmetto - Analyst Blog ||| The 7 Best ETFs to Buy for June ||| Merck/J&J Get CHMP Backing for Simponi's Expanded Use - Analyst Blog ||| Health Care Sector Update for 05/27/2015: GBIM,GILD,GBSN,NURO ||| Aegerion's Juxtapid Successful in Phase III Japanese Study - Analyst Blog ||| Gilead's Alberta ULC Unit Announces 'cuts ribbon on innovative new laboratory, announces additional $100m investment in Edmonton'",1,0.5220784
2015-05-28,8252400.0,112.01000213623048,113.43000030517578,111.81999969482422,112.8499984741211,97.07775115966795,GILD,"GlobeImmune-Gilead's Hepatitis B Drug Fails in Phase II - Analyst Blog ||| Gilead's Sustainable Competitive Advantage ||| Undervalued Stocks in Biotech Worth Buying ||| IWF, GILD, V, CMCSA: Large Inflows Detected at ETF ||| Qiagen Launches Clinical Insight Bioinformatics Platform - Analyst Blog ||| Retrophin Soars on $245M Priority Review Voucher Sale - Analyst Blog ||| Actavis' Viberzi Gets FDA Nod for Irritable Bowel Syndrome - Analyst Blog ||| European Medicines Agency Validates Gilead's Marketing Application for Fixed-Dose Combination of Emtricitabine and Tenofovir Alafenamide for HIV Treatment",0,0.50597197
2015-05-29,11343500.0,113.1500015258789,113.37000274658205,111.8499984741211,112.2699966430664,96.57882690429688,GILD,Teva Settles Provigil Drug Delay Charge with FTC for $1.2B - Analyst Blog ||| Is CVS Health (CVS) Worth Adding to Your Portfolio Now? - Analyst Blog ||| Gilead's New HIV Combination Drug under Review in the EU - Analyst Blog ||| Does This Data Show 2015 Is Finally The Year To 'Sell In May?',1,0.54854286
2015-06-01,11417600.0,113.16999816894533,114.76000213623048,112.6500015258789,114.08000183105467,98.1358413696289,GILD,"Investing for Beginners: How to Start in Biotech ||| Leading Health Insurers in These 4 States Just Proposed 25% to 52% Premium Price Hikes ||| 3 Best of Breed Biotech Stocks ||| Time to Take Profits in Gilead Sciences Inc. Stock? ||| Why AbbVie, Inc. Is a Better Long-Term Buy Than Gilead Sciences, Inc. ||| Stocks To Watch in Biotech ||| Gilead Announces Zydelig in Combination With Ofatumumab Improves Progression-Free Survival in Previously-Treated Patients With CLL ||| Bristol-Myers Slumps: BMY Falls 6.6% in Session - Tale of the Tape ||| Are Celgene Corp.'s Shares About to Get Hammered? ||| Why I'm Buying Gilead Sciences Stock ||| Your Best Investing Questions ||| Gilead Reveals Encouraging Data from Leukemia Study - Analyst Blog ||| Bristol-Myers' Opdivo Superior to Standard-of-Care Therapies - Analyst Blog ||| AbbVie Presents Positive Data from Multiple Studies at ASCO - Analyst Blog",0,0.5058588
2015-06-02,10189800.0,113.8499984741211,114.1999969482422,113.13999938964844,113.94000244140624,98.0154266357422,GILD,"3 Bargain Stocks to Beat the Market ||| Why Gilead Sciences, Inc. Catapulted Higher in May ||| Merck's Keytruda under Priority Review for Lung Cancer - Analyst Blog ||| PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for June 03, 2015 ||| Celldex Glioblastoma Vaccine Hits Phase II Primary Endpoint - Analyst Blog ||| Roche Collaborates with Amgen for Immuno-Oncology - Analyst Blog",1,0.5250182
2015-06-03,7413400.0,114.2699966430664,114.93000030517578,113.87000274658205,114.6500015258789,98.62618255615234,GILD,"Zacks.com featured expert Kevin Matras highlights: Gilead Sciences, Goodyear Tire, Kraton, Aecom and Teekay Tankers - Press Releases ||| Ultragenyx KRN23 Positive in Children, to be Studied in Adults - Analyst Blog ||| Biotech Stock Roundup: ImmunoGen Soars on ASCO Data, Amgen Collaborates with Roche - Analyst Blog",0,0.5002915
2015-06-04,8637600.0,113.9000015258789,114.58000183105467,113.26000213623048,113.93000030517578,98.00682067871094,GILD,Ardelyx Regains Product Portfolio Rights from AstraZeneca - Analyst Blog ||| bluebird Amends Collaboration Agreement with Celgene - Analyst Blog ||| CVS Health-HHS to Endorse Preventive Health Services Online - Analyst Blog ||| Merge's New Cloud-based Mobile App to Aid Clinical Research - Analyst Blog,1,0.5174767
2015-06-05,8435700.0,113.81999969482422,114.27999877929688,112.5199966430664,113.95999908447266,98.0326156616211,GILD,5 Stocks to Buy for June ||| Retrophin's Neurodegenerative Drug Gets Fast Track Status - Analyst Blog,0,0.50326186
2015-06-08,10742900.0,113.95999908447266,114.7699966430664,113.52999877929688,113.6999969482422,97.8089599609375,GILD,"Bad News for Obamacare: Insurance Rates Could Rise By Double-Digits in 2016 ||| Is Gilead Sciences Inc.'s Moat Filling Up With Sand? ||| Are Biotech Stocks Really Overvalued? ||| Problems With Obamacare That Could Prove Difficult to Fix ||| Gilead Sciences (GILD) Stock: Moving Average Crossover Alert - Tale of the Tape ||| Horizon Pharma (HNZP) Starts Phase III Study on Actimmune - Analyst Blog ||| Regeneron/Sanofi's PCSK9 Drug Praluent Set for FDA Panel - Analyst Blog ||| After Hours Most Active for Jun 8, 2015 : PFE, CMCSA, FTR, BAC, HTZ, CX, VSH, QQQ, GNW, HBAN, GILD, QVCA ||| Bio-Techne to Buy Cliniqa, Boost Clinical Controls Portfolio - Analyst Blog ||| Eli Lilly (LLY) Presents Encouraging Data on Diabetes Drugs - Analyst Blog ||| Vertex Pharmaceuticals Will Outperform, Has 'Competitive Edge,' JMP Says",1,0.5147852
2015-06-09,9566700.0,113.22000122070312,115.3000030517578,113.1500015258789,114.75,98.71219635009766,GILD,"Repros' Enclomiphene to Face FDA Advisory Panel in November - Analyst Blog ||| Jazz Pharmaceuticals' Sleep Disorder Drug Enters Phase III - Analyst Blog ||| Roche to Develop Diagnostic Test for Cardiovascular Disease - Analyst Blog ||| Renaissance Technologies: Here’s What this Huge Hedge Fund Company Has Been Buying ||| Seattle Genetics-Unum Therapeutics Tie Up for Cancer Drugs - Analyst Blog ||| Intrexon, Fibrocell Announce Positive Pre-Clinical Data - Analyst Blog ||| BioMarin Seeks EU Approval for DMD Drug Drisapersen - Analyst Blog ||| 10 Most Profitable Businesses in San Francisco ||| Chimerix Enrolls for Trial on Cytomegalovirus Infection Drug - Analyst Blog ||| Benzinga's M&A Chatter for Tuesday June 9, 2015",1,0.49394122
2015-06-10,11986000.0,115.0199966430664,117.93000030517578,114.80999755859376,117.66999816894533,101.22409057617188,GILD,"7 Things to Know About Gilead Sciences - Stocks in the News ||| TrovaGene Hits 52-Week High, PCM Continues to Impress - Analyst Blog ||| Roche's Actemra Gets Breakthrough Therapy Designation - Analyst Blog ||| Celgene and Lycera Collaborate, Acquisition Option Included - Analyst Blog",1,0.5317309
2015-06-11,14474700.0,118.08000183105467,119.6999969482422,117.9000015258789,119.12999725341795,102.48004150390624,GILD,"Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for June 12, 2015 ||| 3 Things AbbVie Inc.'s Management Wants You to Know ||| After Hours Most Active for Jun 11, 2015 : QRVO, TWTR, WETF, QCOM, LO, GM, FOXA, GILD, AA, RAI, QQQ, AMH ||| Bayer (BAYRY) Up on Deal to Sell Diabetes Care Business - Analyst Blog ||| Illumina Partners in China to Develop NGS Diagnostic Solution - Analyst Blog ||| Agios Gets Orphan Drug Designation from FDA for AG-120 - Analyst Blog ||| Gilead's President Spoke At Goldman Sachs' Global Healthcare Conference This Week: Here Are The Highlights",0,0.46451396
2015-06-12,9266000.0,118.58999633789062,118.75,116.76000213623048,117.66000366210938,101.58216094970705,GILD,Novartis' (NVS) Promacta's Label Expansion Approved in U.S. - Analyst Blog ||| Pfizer's Pristiq Fails in First Phase III Pediatric Study - Analyst Blog ||| Isis Pharmaceuticals Up on Positive Data on ISIS-SMNRx - Analyst Blog ||| Big Biotech Stocks See Declining Short Interest,1,0.49552205
2015-06-15,9605800.0,116.72000122070312,118.38999938964844,116.4000015258789,118.16000366210938,102.01382446289062,GILD,"Gilead Sciences' Next Growth Market ||| iShares U.S. Healthcare ETF Experiences Big Outflow ||| Stock Market News for June 15, 2015 - Market News ||| Agios Reports New Data on Hematologic Malignancy Drugs - Analyst Blog ||| AstraZeneca Presents Phase III Data on Gout Drug Lesinurad - Analyst Blog ||| Celgene Presents Positive SPRINT Study Data on Revlimid - Analyst Blog ||| Alnylam Reveals Positive Initial Data on RNAi Drug ALN-CC5 - Analyst Blog ||| Novartis Presents Data on Leukemia, Dermatology Drugs - Analyst Blog",1,0.5123084
2015-06-16,8447800.0,118.2699966430664,119.4499969482422,117.41999816894533,119.06999969482422,102.79949188232422,GILD,United Therapeutics Faces Patent Challenge for Tyvaso - Analyst Blog ||| RedHill Biopharma Surges on Encouraging Data on RHB-105 - Analyst Blog ||| Shire to Make Milestone Payment to ArmaGen for AGT-182 - Analyst Blog ||| Avalanche Biotechnologies Slips on Weak AVA-101 Data - Analyst Blog ||| bluebird bio Reports Encouraging Data on Thalassemia Drug - Analyst Blog ||| Sanofi Starts Dosing in Phase I/II Study on Olipudase Alfa - Analyst Blog,0,0.50449175
2015-06-17,12078300.0,119.08999633789062,119.4499969482422,117.86000061035156,118.87999725341795,102.63542938232422,GILD,"The Ensign Group Hits 52-Week High, Acquisitions Hold Key - Analyst Blog ||| 3 Good Stocks to Buy for Their Earnings Growth ||| 5 Healthcare Stocks for Dividend Lovers ||| Acorda Gains on Positive Parkinson's Disease Study Data - Analyst Blog ||| Genomic Health Liquid Biopsy Test Fit for Bladder Cancer - Analyst Blog",1,0.5251622
2015-06-18,13653000.0,119.18000030517578,121.77999877929688,119.0199966430664,121.20999908447266,104.64705657958984,GILD,Better Buy: Gilead Sciences Inc. or Celgene Corporation? ||| Qiagen's New Genetic Fingerprint Kits to Aid DNA Analysis - Analyst Blog ||| Lion Biotechnologies (LBIO) Falls: Stock Goes Down 9.1% - Tale of the Tape ||| Masimo (MASI) Upped to Strong Buy on a Slew of Positives - Analyst Blog ||| Synergy Pharmaceuticals Soars on Constipation Drug Data - Analyst Blog ||| Biotech ETFs Hit New 2015 Highs ||| Eli Lilly Reports Data on Migraine Drug; Inks Oncology Deals - Analyst Blog ||| Biotech ETFs Hit New 2015 Highs ||| Option Alert: Gilead Jul $115 Call; 1001 Contract Trade at Ask @$7.05; Now $121,0,0.5065664
2015-06-19,21020000.0,120.47000122070312,121.0,119.5500030517578,119.8000030517578,103.4297332763672,GILD,"Stock Market News for June 19, 2015 - Market News ||| BioMarin Pharmaceutical Surges on Price Target Increase - Analyst Blog ||| Qiagen, Hitachi High-Technologies Ink Molecular Testing Deal - Analyst Blog ||| Nasdaq Composite's New High Built On Solid Growth",1,0.51507926
2015-06-22,8040700.0,120.7699966430664,121.87000274658205,120.55999755859376,121.48999786376952,104.88880920410156,GILD,"China Rejects Gilead's Sovaldi Patent Application ||| Did China Just Crush Gilead Sciences' Dreams? ||| Epizyme Lead Candidate Effective in Ongoing Cancer Study - Analyst Blog ||| Bristol-Myers' (BMY) Melanoma Drug Opdivo Gets EU Nod - Analyst Blog ||| Gilead Patent for Sovaldi Rejected in China, Shares Down - Analyst Blog ||| Where Can Mega-Drug Stock Gilead Sciences Go Now?",1,0.513161
2015-06-23,8429200.0,121.81999969482422,122.4000015258789,121.0999984741211,122.20999908447266,105.5103988647461,GILD,"Stock Market News for June 23, 2015 - Market News ||| Kite Pharma and Bluebird Tie Up for HPV Cancer Targets - Analyst Blog ||| Can a Growth Stock Also Be a Value Stock? ||| Pfizer to Buy Two Meningitis Vaccines from Glaxo for $130M - Analyst Blog ||| The Medicines Co. Antiplatelet Drug Kengreal Wins FDA Nod - Analyst Blog ||| Isis Pharmaceuticals Up on Spinal Muscular Atrophy Data - Analyst Blog ||| ProShares Releases 2 New Leveraged Biotech ETFs ||| ProShares Releases 2 New Leveraged Biotech ETFs",0,0.49206245
2015-06-24,8354800.0,121.88999938964844,123.37000274658205,121.6500015258789,122.01000213623048,105.33773040771484,GILD,"Vanda Pharmaceuticals' Schizophrenia Drug Shows Success - Analyst Blog ||| Pfizer Starts Phase III Rivipansel Study, GlycoMimetics Up - Analyst Blog ||| Macrocure (MCUR) Falls: Stock Goes Down 10% - Tale of the Tape ||| Alnylam Reports Encouraging New Data on Hemophilia Drug - Analyst Blog",0,0.48930258
2015-06-25,8575000.0,122.4800033569336,122.61000061035156,119.80999755859376,120.2300033569336,103.80097198486328,GILD,"Glaxo, Pfizer Meningitis B Vaccines Get ACIP's Category B - Analyst Blog ||| Agios Doses First Patient with AG-881 in Early-Stage Study - Analyst Blog ||| Transition Therapeutics Tanks on Alzheimer's Disease Data - Analyst Blog ||| Genomic's Oncotype DCIS Score Betters Treatment Guidance - Analyst Blog",0,0.49850026
2015-06-26,9730800.0,120.3000030517578,120.61000061035156,118.88999938964844,119.5,103.17072296142578,GILD,"BioMarin DMD Drug Drisapersen Validated for EU Review - Analyst Blog ||| Eli Lilly Wins Alimta Patent Lawsuit in the UK, Shares Up - Analyst Blog ||| Option Alert: Gilead Jul $120 Call; 2050 Contract Trade at Ask @$2.40; Now $119.96",0,0.49428925
2015-06-29,12491100.0,117.87999725341795,119.13999938964844,115.3000030517578,115.45999908447266,99.6827621459961,GILD,Biotech Short-Sellers Prefer Amgen To Gilead Sciences ||| 3 Stocks to Buy if Biotech Crashes ||| Better Dividend Stock: AbbVie or Johnson & Johnson? ||| Biogen/Sobi's Hemophilia B Drug Alprolix under EU Review - Analyst Blog,1,0.50871783
2015-06-30,11345200.0,117.29000091552734,118.3000030517578,116.77999877929688,117.08000183105467,101.0813980102539,GILD,"Stock Market News for June 30, 2015 - Market News ||| Juno-Celgene in Immunotherapy Deal, Initial Deal Value $1B - Analyst Blog ||| Gilead Sciences (GILD): An Ideal Buy the Dip Candidate ||| Celldex's Rintega Phase III Study Recommended to Continue - Analyst Blog ||| BioMarin's NDA for DMD Drug Drisapersen Accepted by FDA - Analyst Blog ||| Intercept Pharmaceuticals Files for OCA in U.S. and Europe - Analyst Blog ||| Integra to Acquire TEI, Expand in Regenerative Wound Care - Analyst Blog",0,0.48377514
2015-07-01,10248500.0,118.11000061035156,118.5999984741211,115.4000015258789,116.01000213623048,100.15763854980467,GILD,"Stock Market News for July 01, 2015 - Market News ||| What Is Beyond Vision-Loss Blockbuster For Regeneron? ||| Gilead Submits New Drug Application to U.S. Food and Drug Administration for Single Tablet Regimen for HIV Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide ||| Fast Money Picks For July 1",0,0.5066911
2015-07-02,8832000.0,116.33000183105467,116.48999786376952,114.91000366210938,115.04000091552734,99.32018280029295,GILD,"Noteworthy ETF Inflows: IWB, DIS, GILD, AMZN ||| Express Scripts Reports Public Exchange Pharmacy Trends - Analyst Blog",1,0.5209089
2015-07-06,13543300.0,114.45999908447266,116.44000244140624,114.12000274658205,115.66000366210938,99.8554458618164,GILD,"Japan's Ministry of Health, Labour and Welfare Approves Gilead's Harvoni ||| The Competitive Advantage of the Best Biotech Stocks ||| After Hours Most Active for Jul 6, 2015 : ABBV, INFY, RAD, CAG, GILD, INTC, SFM, SFUN, BNDX, PPC, MBI, MU ||| Gilead's (GILD) HCV Drug Harvoni Gets Approval in Japan - Analyst Blog ||| Gilead Sciences Spent $125 Million to Get This Drug on the Market 4 Months Early ||| Gilead Still A 'Buy' After Harvoni Approval In Japan, Maxim Proclaims",0,0.48656672
2015-07-07,10183000.0,115.9499969482422,116.41999816894533,113.12999725341795,115.12999725341795,99.39785766601562,GILD,"Gilead Sciences Gets Another Green Light in Japan ||| After Hours Most Active for Jul 7, 2015 : BAC, WMB, WRE, ALU, WRI, HLF, FTR, GILD, AAPL, QQQ, MSFT, USLV ||| Keep An Eye On These 8 After-Hours Movers",0,0.4879871
2015-07-08,9238800.0,114.25,114.41000366210938,112.41000366210938,112.94000244140624,97.50714111328124,GILD,"3 Stocks to Buy in a Market Crash ||| Biotech Stock Roundup: Vertex CF Drug Approved, Biogen Strikes Deal for Gene Therapy - Analyst Blog",1,0.50285196
2015-07-09,9007800.0,114.4000015258789,114.75,113.33000183105467,113.36000061035156,97.86970520019533,GILD,"The Zacks Analyst Blog Highlights: Vertex, Biogen, Applied Genetic, Gilead and Alexion - Press Releases ||| What Is the Potential Impact of Gilead's Harvoni Launching in Japan? ||| Large-Cap Biotechs Poised For Second-Half Rally, RBC Says",1,0.501676
2015-07-10,9703400.0,114.87999725341795,115.0,113.1999969482422,113.73999786376952,98.19780731201172,GILD,S&P 500 Analyst Moves: GILD ||| CNBC's Meg Tirrel Speculates About Gilead's New Acquisiton,1,0.5143974
2015-07-13,9632800.0,115.0,115.11000061035156,114.30999755859376,114.5500030517578,98.89714813232422,GILD,iShares Russell 1000 ETF Experiences Big Inflow ||| 5 Drugs That Investors May Be Undervaluing ||| Short Sellers Shy Away From Biotech Stocks,1,0.48708025
2015-07-14,11295900.0,115.22000122070312,117.80999755859376,114.87000274658205,117.36000061035156,101.32316589355467,GILD,"Stock Market News for July 14, 2015 - Market News ||| 3 Biotech Stocks That Could Soon Rocket Higher ||| Option Alert: Gilead Jul 24 $115 Call Sweep 1437 Contracts at Ask @$3.15; Now $117.34 ||| Fast Money Picks For July 14",1,0.45786375
2015-07-15,10479200.0,119.05999755859376,119.72000122070312,117.20999908447266,117.38999938964844,101.34902954101562,GILD,"Are Gilead Sciences, Inc.'s Expectations Too High for This Drug?",1,0.51089764
2015-07-16,7514600.0,118.33000183105467,119.4000015258789,118.05999755859376,118.8499984741211,102.60954284667967,GILD,8 Biotech Stocks to Buy ||| Manager Of Hot New Biotech ETFs Explains The Strategy ||| Option Alert: Gilead Jul $121 Call Sweep; 1479 Contracts @Ask @$0.23; Now $119.22 ||| Bristol-Myers' HIV-1 Drug Approved In Europe,0,0.5056995
2015-07-17,8170100.0,118.75,118.8499984741211,117.22000122070312,118.26000213623048,102.10016632080078,GILD,Bristol-Myers' HIV-1 Drug Evotaz Gets European Approval - Analyst Blog ||| Why Big Biotech Could Have Another Leg Up,0,0.5091587
2015-07-20,7218700.0,118.8000030517578,118.9499969482422,117.83999633789062,118.1999969482422,102.04837036132812,GILD,Oppenheimer's 10 'Best Of The Best' Technical Buy Ideas,0,0.5113637
2015-07-21,6489100.0,118.20999908447266,118.9800033569336,116.91999816894533,117.77999877929688,101.68575286865234,GILD,"The Best Deals in Value Stocks ||| New Alzheimer's Trials Could Produce The Most Important Drugs In History ||| Gilead Reports Phase 3 Results From the First Study to Evaluate Switching From TDF-Based Regimens to a TAF-Based Regimen Containing Elvitegravir, Cobicistat, Emtricitabine and Tenofovir Alafenamide",0,0.48956287
2015-07-22,6977100.0,116.81999969482422,118.4000015258789,116.55999755859376,117.44000244140624,101.3922119140625,GILD,"XLV, GILD, AGN, BMY: Large Inflows Detected at ETF ||| Gilead Sciences' Next Big Move May Not Be What You're Thinking ||| Gilead (GILD) Presents Encouraging Data on HIV Candidate - Analyst Blog",1,0.5171147
2015-07-23,6110300.0,117.86000061035156,118.5999984741211,117.41999816894533,117.66000366210938,101.58216094970705,GILD,Bristol-Myers Squibb Gets a Mixed Message From Investors,0,0.49110916
2015-07-24,15067600.0,116.13999938964844,117.1500015258789,112.66000366210938,112.83000183105467,97.41217041015624,GILD,What to Expect From Gilead Sciences Inc.'s Q2 Results ||| Gilead (GILD) to Report Q2 Earnings: Surprise in the Cards? - Analyst Blog,0,0.4793337
2015-07-27,14883600.0,112.62999725341795,112.87999725341795,108.0,110.54000091552734,95.4350814819336,GILD,"1 ETF That’s Crushing Even Warren Buffett ||| Stock Market News for July 27, 2015 - Market News ||| 3 Stocks for Retirees to Buy ||| Wall Street's Best Think Gilead Will Continue To Outperform The Market ||| A Big Day For Biotech And It's Not Going So Well",1,0.52502674
2015-07-28,16439700.0,112.5199966430664,113.4000015258789,110.73999786376952,113.06999969482422,97.61934661865234,GILD,"Great Stocks for Baby Boomers ||| EWG, DWAQ: Big ETF Inflows ||| The Zacks Analyst Blog Highlights: Gilead Sciences, AbbVie, Merck, Achillion Pharmaceuticals and Express Scripts - Press Releases ||| Are These 2 Big Pharmas Really Buyout Candidates? ||| 3 Big Biotech Buybacks That Investors Should Love ||| Gilead Sciences Inc. Posts Q2 Results, Able to Beat Earnings, Revenue Estimates - Stocks in the News ||| Gilead Sciences Inc. Q2 Earnings: Harvoni Delivers Again ||| After Hours Most Active for Jul 28, 2015 : TWTR, SIG, JD, PRXL, ACWI, T, ABEV, MRK, BAC, GILD, UTIW, FB ||| Earnings Reaction History: Gilead Sciences Inc., 55.6% Follow-Through Indicator, 3.5% Sensitive ||| After-Hours Earnings Report for July 28, 2015 : GILD, ESRX, APC, EQR, AFL, TWTR, EW, AKAM, VRSK, CTXS, KIM, CHRW ||| Tuesday's After-Hours Movers: Twitter, Gilead, Yelp And Buffalo Wild Wings ||| Gilead Sciences Q2 Profit Beats Views, Shares Rise ||| Gilead Raises FY15 Sales Guidance from $26B-$27B to $29B-$30B vs $30.36B Est. ||| Gilead Sciences Reports Q2 EPS $3.15 Vs Exp $2.64 ||| Options Strategist Discusses Activity In Gilead And Wynn Ahead Of Earnings ||| Is More M&A On The Way For Large-Cap Biotechs? ||| Earnings Scheduled For July 28, 2015 ||| 10 Stocks You Should Be Watching Today",1,0.4897064
2015-07-29,23144800.0,118.37999725341795,119.45999908447266,115.11000061035156,115.70999908447266,99.89861297607422,GILD,"Amp Up Your Portfolio With These Biotech Stocks ||| Stock Market News for July 29, 2015 - Market News ||| YieldBoost Gilead Sciences From 0.4% To 5.4% Using Options ||| Daily Dividend Report: MPC, HLT, CG, XOM, WFC, GILD, AMGN, SYK, PX, BDX ||| Pre-Market Most Active for Jul 29, 2015 : CFG, TWTR, GSK, SIRI, YELP, FB, FCAU, STO, GILD, QQQ, BLDR, AAPL ||| Gilead (GILD) Beats on Q2 Earnings, Raises 2015 Outlook - Analyst Blog ||| Gilead Sciences: Here's What A Bull And A Bear Are Saying ||| Morning Market Gainers ||| Benzinga's Top #PreMarket Gainers ||| Gilead Worth $125 After Earnings: Morgan Stanley ||| Fast Money Picks For July 29 ||| Deutsche Bank Maintains Buy on Gilead Sciences, Raises PT to $135.00 ||| Keep an Eye on These 10 Stocks for July 29, 2015",1,0.4925153
2015-07-30,11977200.0,116.11000061035156,118.25,114.75,117.9000015258789,101.78934478759766,GILD,"Notable ETF Outflow Detected - XLV, GILD, AGN, BMY ||| Gilead's Hepatitis C Dominance Unchecked By AbbVie ||| A Pharma ETF Focused On Quality, Fast-Growing Stocks ||| Even With Recent Declines, Investors Still Love Biotech ETFs ||| Even With Recent Declines, Investors Still Love Biotech ETFs",0,0.48303702
2015-08-03,11660000.0,118.5,120.16999816894533,118.18000030517578,119.5999984741211,103.25706481933594,GILD,"5 Can't-Miss Quotes From Gilead Sciences Management ||| A Look Ahead: Consumer Discretionary And Greek ETFs To Watch This Week ||| Integra Tops Earnings & Revenues, Guides Low on Spine Sale - Analyst Blog ||| 4 Stocks Set to Crush Their 52-Week Highs Soon - Analyst Blog ||| What's in Store for Conatus (CNAT) This Earnings Season? - Analyst Blog",0,0.50633734
2015-08-04,7876400.0,119.5999984741211,120.37000274658205,118.55999755859376,118.87000274658205,102.6268310546875,GILD,"The Zacks Analyst Blog Highlights: BJ's Restaurants, Gilead Sciences, Scorpio Tankers and Teekay Tankers - Press Releases ||| Mixed Biotech Earnings put These ETFs in Focus - ETF News And Commentary",0,0.5138397
2015-08-05,8071000.0,119.6999969482422,120.06999969482422,118.37999725341795,118.66000366210938,102.4455108642578,GILD,What Company Will Be Fastest Growing Big-Cap Biotech?,0,0.5101258
2015-08-06,10755300.0,119.4499969482422,119.48999786376952,114.80999755859376,115.3000030517578,99.5446319580078,GILD,"Geron Q2 Loss Narrower-than-Expected, Imetelstat in Focus - Analyst Blog ||| Arena Pharmaceuticals 2Q Loss Narrower-Than-Expected - Analyst Blog ||| Ronald Muhlenkamp Makes Small Changes in Composition of His Top 10 Stakes ||| Jazz Pharmaceuticals Misses on Q2 Earnings, Affirms View - Analyst Blog ||| Osiris Therapeutics' Q2 Earnings & Revenues Grow Y/Y - Analyst Blog ||| Allergan's (AGN) 2Q Earnings & Revenues Shoot Up Y/Y - Analyst Blog",0,0.49775758
2015-08-07,9670200.0,115.27999877929688,115.3000030517578,113.12999725341795,114.44000244140624,98.80215454101562,GILD,"What Does the Social Media Crowd Think About Gilead Sciences (GILD) Stock? - Tale of the Tape ||| Sarepta Posts Narrower-than-Expected Loss in Q2, Shares Up - Analyst Blog ||| iShares Core S&P 500 ETF Experiences Big Inflow ||| Top Biotech Stocks to Buy on Sale ||| The Historical Correlation Between Biotech Stocks And Interest Rates",1,0.49362463
2015-08-10,7776200.0,115.7300033569336,117.12000274658205,115.51000213623048,116.58000183105467,100.64974975585938,GILD,"Did Gilead Sciences Just Give Wall Street a Huge Head Fake? ||| 3 Biotech Stocks to Buy in August ||| Sanofi Inks Deals, Diabetes and Immuno-Oncology in Focus - Analyst Blog",0,0.5094266
2015-08-11,6567700.0,115.12000274658205,116.8499984741211,114.68000030517578,115.61000061035156,99.81228637695312,GILD,"Kite Pharma 2Q Loss Wider Than Expected, Pipeline in Focus - Analyst Blog ||| Repros Incurs Narrower Y/Y Loss in Q2, Pipeline in Focus - Analyst Blog ||| Celldex Q2 Loss Narrower than Expected, Pipeline in Focus - Analyst Blog ||| BioDelivery Incurs Wider Loss in Q2, Revenues Fall Y/Y - Analyst Blog ||| TrovaGene Q2 Loss Widens on Higher Expenses, Shares Fall - Analyst Blog ||| What TD Ameritrade Investors Bought And Sold Last Month",1,0.50928664
2015-08-12,6999600.0,114.8499984741211,116.45999908447266,113.5500030517578,116.25,100.36482238769533,GILD,"Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for August 13, 2015 ||| Myriad Genetics Posts In-Line Earnings in Q4, Margins Suffer ||| Enzon Pharmaceuticals, Inc. (ENZN) Ex-Dividend Date Scheduled for August 13, 2015 ||| Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for August 13, 2015 ||| Clovis Oncology Strikes Deal with Roche for Rociletinib ||| Pluristem (PSTI) Provides Update on PLX-PAD Cells in Japan ||| BioScrip's Strategic Plans Offer Hope, Margin Concerns Stay ||| Should You Get Rid of ANI Pharmaceuticals (ANIP) Now?",0,0.44492897
2015-08-13,6337400.0,116.25,116.70999908447266,115.18000030517578,115.1999969482422,99.4582977294922,GILD,"Juno Therapeutics Posts In-Line 2Q Loss, Pipeline in Focus ||| Myriad Genetics (MYGN) Jumps: Stock Moves 6.8% Higher ||| Should You Get Rid of Five Prime Therapeutics (FPRX) Now? ||| Is Gilead Sciences Biotech's Biggest Bargain? ||| Teva's Chorea in Huntington Disease Treatment under Review ||| What Are Payors Saying About Managed Care Giants?",1,0.49718976
2015-08-14,5533400.0,114.66000366210938,115.87000274658205,114.5500030517578,115.5999984741211,99.80363464355467,GILD,"What Falling Estimates & Price Mean for bluebird bio (BLUE) ||| John Buckingham Buys 10 New Stakes in Second Quarter ||| Why ACADIA Pharmaceuticals (ACAD) Could Be Positioned for a Slump ||| Emergent BioSolutions Gets $44M CDC Contract for VIGIV ||| AMGN vs. GILD: The Battle of the Large Cap Biotech Stock ||| Myriad: Medicare Coverage for Prolaris Prostrate Cancer Test ||| BioDelivery's New Onsolis Formulation Gains FDA Approval ||| Integra's Acquisitions to Buoy Growth in '15, Currency Woes Stay",1,0.5271199
2015-08-17,7126700.0,115.08000183105467,116.88999938964844,115.01000213623048,116.41999816894533,100.51158905029295,GILD,"3 Numbers Show Why Gilead Sciences Inc. Is in a Great Position Today ||| iShares Core S&P 500 ETF Experiences Big Inflow ||| Onconova Files IND Application for Rigosertib, Shares Jump",1,0.52499115
2015-08-18,5934000.0,116.52999877929688,117.6999969482422,115.98999786376952,117.05999755859376,101.06415557861328,GILD,"3 Dividend-Paying Healthcare Stocks to Buy and Hold Forever ||| Achillion Pharmaceuticals (ACHN) Jumps: Stock Gains 16.7% ||| Kite Pharma Provides Update, Death Not Related to KTE-C19 ||| BioLineRx Up on Phase IIb Study Initiation on Leukemia Drug ||| Myriad Genetics: myRisk Offers Strength, Currency Woes Linger ||| Genomic Health Prostate Cancer Test Wins Medicare Coverage",0,0.52375627
2015-08-19,7504800.0,116.6500015258789,117.1999969482422,115.4000015258789,116.20999908447266,100.3302993774414,GILD,Insys Files CP; Dronabinol Oral Solution under FDA Review ||| Merck's Keytruda under FDA Review for First-Line Melanoma ||| Option Alert: Gilead Aug $115 Call Sweep; 1008 Contracts @Ask @$1.75,0,0.49741113
2015-08-20,9200200.0,114.86000061035156,116.08999633789062,112.3499984741211,112.38999938964844,97.03228759765624,GILD,"Weakness Seen in TrovaGene (TROV) Estimates: Should You Stay Away? ||| 3 Biotech Stocks We Love ||| United Therapeutics to Sell Priority Review Voucher to AbbVie ||| Vical's Antifungal Candidate VL-2397 Receives QIDP Status ||| BioMarin's Drisapersen Gets Rare Pediatric Disease Status ||| Illumina (ILMN) Creates Helix to Encourage Genomics Startups ||| European Medicines Agency Validates Gilead's Marketing Application for Single Tablet Regimen Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide for HIV Treatment",0,0.49901748
2015-08-21,22739400.0,110.54000091552734,111.22000122070312,105.33000183105467,105.33000183105467,90.93699645996094,GILD,"Friday's ETF with Unusual Volume: PJP ||| Vascular (VBLT) Starts Patient Dosing in Glioblastoma Study ||| Raptor (RPTP) to Buy Quinsair, Boost Rare Disease Portfolio ||| Notable Two Hundred Day Moving Average Cross - GILD ||| Is Valeant's (VRX) $1B Buy of Addyi Maker a Prudent Move? ||| Gilead's EU Regulatory Application for HIV Drug Validated ||| Why Eli Lilly (LLY) was a Bright Spot in the Market on Thursday ||| Argos Therapeutics (ARGS) Jumps: Stock Moves Up 12% ||| Falling Earnings Estimates Signal Weakness Ahead for Alexion Pharmaceuticals (ALXN) ||| The Other Bearish Biotech ETF Is Looking Groovy, Too",0,0.48636967
2015-08-24,25731800.0,97.30999755859376,101.0,86.0,100.66000366210938,86.90514373779297,GILD,Bad News for Hepatitis C Patients: Your Treatment Costs May Be Higher Than Expected ||| Stock Futures Plunge: 4 Value Stocks Brokers Love Right Now ||| 6 Things You Should Know About a Stock Market Correction ||| Raptor Pharmaceuticals (RPTP) in Focus: Stock Adds 5.8% ||| Seres (MCRB) Up on Orphan Drug Status for Lead Candidate ||| Alkermes' (ALKS) Aristada Review Date Postponed by FDA ||| Avoid The Temptation To Buy Calls On Anything 'Options' This Week ||| Morgan Stanley Lists Stocks With $5B in Market Cap Possessing Best 1 Year Opportunity,1,0.5036546
2015-08-25,18482500.0,105.43000030517578,107.9000015258789,102.55999755859376,102.55999755859376,88.54551696777344,GILD,"XLV, GILD, AGN, AMGN: Large Outflows Detected at ETF ||| Bouncing Biotech? 3 Stocks To Buy ||| Epizyme (EPZM) Shows Strength: Stock Adds 9.6% in Session ||| 4 Notable Stocks Still Green After Late Tuesday Sell-Off ||| Nasdaq Slips into Correction: 4 Stocks Stand Tall ||| AstraZeneca, Peregrine Team Up for Immuno-Oncology Study ||| Medivation to Gain Global Rights to BioMarin's Talazoparib",1,0.477857
2015-08-26,15627600.0,105.91999816894533,107.0999984741211,102.45999908447266,106.95999908447266,92.34427642822266,GILD,Celldex (CLDX) Shows Strength: Stock Adds 8.2% in Session ||| What Makes CoLucid Pharmaceuticals (CLCD) a Strong Sell? ||| J&J to Sell Sugar Substitute Splenda to Heartland Food ||| Novartis' (NVS) Promacta Label Further Expanded in U.S. ||| Eli Lilly's Alimta Patent Upheld by U.S. District Court ||| Sarepta's DMD Drug Eteplirsen Gains FDA Priority Review ||| Results From the AMBITION Study of First-Line Treatment With Letairis and Tadalafil in Pulmonary Arterial Hypertension Published in The New England Journal of Medicine,1,0.4901625
2015-08-27,14610300.0,108.43000030517578,109.5999984741211,105.66999816894533,107.98999786376952,93.2335205078125,GILD,"12 Attractive Fast-Growing Dividend Growth Stocks For High Total Return ||| Benzinga's M&A Chatter for Thursday August 27, 2015 ||| Biogen And Gilead Sciences Catch The Eye Of Short Sellers ||| Hearing Unconfirmed Market Chatter of Gilead Deal to Acquire BMY",0,0.52678293
2015-08-28,10755900.0,106.95999908447266,108.79000091552734,106.77999877929688,107.77999877929688,93.05221557617188,GILD,Pfizer (PFE) Gains on Label Expansion Efforts for Ibrance ||| Exelixis Up on Swiss Approval of Advanced Melanoma Drug ||| Eli Lilly's (LLY) Diabetes Drug Synjardy Gets U.S. Approval,0,0.46431336
2015-08-31,11736900.0,107.41999816894533,108.33000183105467,104.62999725341795,105.06999969482422,90.71253204345705,GILD,4 Not-Too-Scary Ways to Make Money on Biotech Stocks ||| ARIAD Skyrockets More than 40% Following Buyout Rumors ||| Alnylam Presents Positive Data on PCSK9 Synthesis Inhibitor,0,0.5050687
2015-09-01,13548000.0,102.22000122070312,104.63999938964844,101.0,101.48999786376952,87.62171936035156,GILD,"Stock Market News for September 01, 2015 ||| Cytori Therapeutics (CYTX) in Focus: Stock Rises 15% ||| PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for September 02, 2015 ||| 5 Top Stocks to Buy in September ||| Intercept's (ICPT) OCA Under Priority Review in the U.S. ||| Amicus (FOLD) Signs Agreement to Acquire Scioderm ||| Trevena's Postoperative Pain Drug Positive in Phase IIb Study ||| Sanofi Teams Up with Google Life Sciences for Diabetes ||| Allergan Buys Naurex, Boosts Mental Health Portfolio ||| It's Not Shopping, It's Market Research: Talking Investing Trends With TD Ameritrade's Nicole Sherrod",1,0.5020956
2015-09-02,11509300.0,103.44000244140624,104.3000030517578,101.0199966430664,104.2699966430664,90.02185821533203,GILD,"Biotech Stock Roundup: Amgen in the News, ARIAD a Takeover Target? ||| Notable ETF Outflow Detected - XLV, GILD, AGN, AMGN ||| 4 Google-Beating Stocks that Still Hold Promise ||| AstraZeneca Strikes Deal with Valeant for Psoriasis Drug ||| Illumina Acquires GenoLogics, Boosts Genomic Sequencing ||| Meet The Manager Of A Top Performing Mutual Fund ||| Gilead's Investigational Fixed-Dose Combination of Emtricitabine/Tenofovir Alafenamide Meets Primary 48-Week Objective in Phase 3 Study",0,0.49066114
2015-09-03,9928100.0,104.91999816894533,105.0,101.69000244140624,101.91000366210938,87.98433685302734,GILD,"AstraZeneca Ties Up for FluMist, CAZ-AVI Scores; Shares Up ||| Nektar Receives $40M Milestone Payment from AstraZeneca ||| The Zacks Analyst Blog Highlights: Google, Gilead Sciences, Regeneron Pharmaceuticals, Intuitive Surgical and Amazon.com ||| Gilead Sciences' 11% Drop in August Could Make It a Steal ||| Incyte & Hengrui to Develop Anti-PD-1 Monoclonal Antibody",1,0.50336796
2015-09-04,10336500.0,101.02999877929688,103.23999786376952,100.5500030517578,102.05999755859376,88.11383056640625,GILD,"Roche's Hemophilia A Drug Gets Breakthrough Status in U.S. ||| Value Stocks: 2 to Buy, 1 to Avoid ||| 4 Low-Volatility Stocks to Sail Through Market Mayhem ||| AstraZeneca's Brilinta Gains FDA Nod for Label Expansion ||| Allergan (AGN) to Buy Eye Care Device Company AqueSys ||| Dicerna Files IND Application for Primary Hyperoxaluria Drug",1,0.5256558
2015-09-08,9992600.0,103.83999633789062,104.9499969482422,102.91000366210938,104.9000015258789,90.56575012207033,GILD,"Alexion's Kanuma FDA Action Date Delayed by Three Months ||| AstraZeneca, Starpharma Ink Drug Delivery Technology Deal ||| Bursting Biotechs -- Are These Stocks Buys? ||| Bristol-Myers' Opdivo Encourages in Lung Cancer Study ||| Is Another Amendment of QLT-InSite Vision Deal Coming Up? ||| Whipsaw the Market Right Back with These Three Tech Investing Plays ||| Healthcare Boom a Bubble? 4 Stocks to Buy Anyway ||| Perigon Wealth Management's Largest Buys in Second Quarter ||| UBS: Biotech Will Continue To Outperform In 2015",0,0.51494634
2015-09-09,7896500.0,106.1999969482422,106.4499969482422,103.54000091552734,103.81999969482422,89.63333892822266,GILD,"Does Achillion's 13% Slump in August Make It a Bargain? ||| The Zacks Analyst Blog Highlights: Gilead, Regeneron Pharmaceuticals, Thermo Fisher Scientific and Cyberonics ||| Mirati Therapeutics (MRTX) Looks Good: Stock Gains 8.3% ||| BioDelivery Up on Striking Deal with TennCare for Bunavail ||| Immunomedics (IMMU) Worth Watching: Stock Rises 8.4% ||| Impax Hayward Facility Gets FDA Clearance, Shares Rise ||| Theravance, Glaxo SUMMIT Study Misses Primary Endpoint ||| Hearing Gilead Sciences Announcing $10B Six-Part Bond Offering",1,0.5399337
2015-09-10,10368500.0,104.0,108.5,103.87000274658205,107.25,92.59465026855467,GILD,"Noteworthy ETF Outflows: XLV, JNJ, GILD, MRK ||| VBI Vaccines (VBIV) Worth a Look: Stock Adds 8% in Session ||| Clovis Oncology (CLVS) Jumps: Stock Adds 13.8% in Session ||| VIVUS (VVUS) in Focus: Stock Moves 12.5% Higher in Session ||| Marinus' End-of-Phase II Meeting Positive for Ganaxolone ||| Protalix's Phase I/II Fabry Disease Study Interim Data Positive ||| Integra Faces Multiple Headwinds, SeaSpine Spin-off Strong ||| Notable Thursday Option Activity: BRCM, CVC, GILD ||| Gilead Prices $10B of Senior Unsecured Notes",1,0.48452675
2015-09-11,9387600.0,106.86000061035156,109.69000244140624,106.25,109.62999725341795,94.6494140625,GILD,"Why is Gilead (GILD) Raising a Whopping $10 Billion? ||| Health Care Sector Update for 09/11/2015: AKBA,BIIB,GILD,ARWR,NWBO ||| AbbVie's Humira Gains FDA Approval for Label Expansion ||| Genomic Health: Test Volume Impresses, Margin Woes Persist ||| Revance's Botulinum Toxin Type A Gel in Phase II Study ||| Aduro-Incyte in Clinical Trial Agreement for Ovarian Cancer",0,0.5088449
2015-09-14,7505800.0,109.47000122070312,109.62999725341795,108.4000015258789,109.3499984741211,94.77942657470705,GILD,"4 Ways to Protect Yourself From a Biotech Meltdown ||| Weekly CFO Sells Highlight: Gilead Sciences, DexCom, and Palo Alto Networks ||| Collegium's Xtampza Supported for Approval by FDA Panels ||| Sanofi's (SNY) LixiLan Positive in Phase III Diabetes Study ||| Better Buy: Biogen vs. Gilead Sciences ||| Will Kite (KITE) Get Orphan Status Again in EU for KTE-C19? ||| Company News for September 14, 2015 ||| Which Biotech Blue-Chip Stock Is the Best Buy? ||| Amgen And Biogen Lead Short Interest Surge In Biotechs ||| Biotechs Coming Off One Of The Busiest Weeks In Recent Memory ||| Barclays Favorite Biotech Names For Year End Balance Are Gilead, Vertex, Medivation ||| JMP Analyst Says He Believes Biotech Megacaps Appear To Be Generating A Shopping List After Raising Cash; Implying Possible M&A Activity In Biotech Space After Recent Investor Conference Activity",1,0.5064359
2015-09-15,7944100.0,109.45999908447266,111.80999755859376,108.8499984741211,111.0500030517578,96.2529067993164,GILD,"Raptor Pharmaceuticals (RPTP) in Focus: Stock Plunges 37.5% ||| Medivation Upgraded to Strong Buy, Perfect for Your Portfolio ||| Trevena (TRVN) Catches Eye: Stock Adds 15.5% in Session ||| Raptor Crushed by Liver Disease Data, Hits 52-Week Low ||| Did Gilead Sciences Just Commit a Cardinal Sin? ||| Top Weekly Insider Sells Highlights ||| AbbVie Seeks FDA Approval for Imbruvica's Label Expansion",0,0.4971035
2015-09-16,8116000.0,110.72000122070312,111.75,109.4800033569336,111.02999877929688,96.23558044433594,GILD,"The Zacks Analyst Blog Highlights: VIVUS, Regeneron Pharmaceuticals, Gilead Sciences, Repligen and Affymetrix ||| 5 Reasons I'm Buying More Gilead Sciences Inc. ||| Alnylam Reports Positive Initial Phase I Data on ALN-AS1 ||| InSite Vision Terminates QLT Deal in Favor of Sun Pharma ||| Baxalta Seeks FDA Nod for Primary Immunodeficiency Disorder",1,0.53260696
2015-09-17,9858400.0,110.87999725341795,113.30999755859376,109.75,111.61000061035156,96.7383041381836,GILD,"Aerie Reported Positive Phase III Data on Rhopressa ||| Intra-Cellular Therapies (ITCI) Jumps: Stock Rises 86.9% ||| Could These 2 Biopharmas Be the Real Apples of Gilead Sciences' Eye? ||| Novo Nordisk's Victoza Fares Better than Sanofi's Lyxumia ||| Intra-Cellular Up on Positive Data from Schizophrenia Study ||| Bristol-Myers Up, Opdivo Gets Breakthrough Therapy Status ||| Amgen to Acquire Dezima Pharma, Strikes Deal with Xencor ||| XenoPort Hits 52-Week Low on Preliminary Psoriasis Data",0,0.49518135
2015-09-18,13156900.0,109.62000274658205,110.87000274658205,108.20999908447266,108.44000244140624,93.9906997680664,GILD,"Notable ETF Inflow Detected - XLV, JNJ, GILD, MRK ||| Yellen Doesn't Raise Rates: 4 Biotech Stocks to Buy ||| Allergan/Gedeon's Vraylar Gets FDA Nod for Mental Disorders ||| Friday's ETF with Unusual Volume: XBI ||| 3 Biotech Stocks That Can Upgrade Your Portfolio",0,0.49545836
2015-09-21,15141600.0,109.12000274658205,109.37000274658205,104.58999633789062,105.73999786376952,91.65047454833984,GILD,"3 Triple-Digit Biotech Stocks That Are Worth Every Penny ||| Dicerna Pharmaceuticals (DRNA) Rises: Stock Gains 7.8% ||| 10 Super-High-Growth Stocks to Buy Now ||| Organovo Holdings (ONVO) In Focus: Stock Jumps 6.7% ||| Flex Pharma (FLKS) in Focus; Stock Tumbles 8.9% ||| The Zacks Analyst Blog Highlights: Medivation, Gilead Sciences, Regeneron Pharmaceuticals and Anthera Pharmaceuticals ||| Here's Why Gilead Sciences Is a Buy (Hint: It's Not Hepatitis C) ||| TRACON Skyrockets on Positive Choriocarcinoma Study Data ||| Amgen's Kyprolis Label Expansion Under Priority Review ||| GILD Crosses Below Key Moving Average Level ||| Trevena Hits a 52-Week High on Positive Phase II Data ||| Neogenomics Hits a 52-Week High on Cancer-Testing Deal ||| To Test or Retest? ||| Adam Feuerstein Agrees With Interviewee That Big Biotech Companies Could Be Shielded From Drug Pricing Issues, ""Yea, To Some Extent They Are A Bit Shielded As Long As They Continue To Innovate"" ||| Adam Feuerstein Believes Turing Pharma. Simply Raising Price Of Older Drug, Whereas Gilead Attempting To Cure Via Research To Develop Drug ||| UPDATE: Gilead Says 98% of Patients Achieved Primary Efficacy Endpoint, 13 Patients Showed Virologic Failure, 7 Could Not Complete Visit ||| Gilead Reports SVR12 Rates from Four Phase 3 Studies Evaluating a Once-Daily, Fixed-Dose Combination of Sofosbuvir, Velpatasvir for the Treatment of All Six Hepatitis C Genotypes",1,0.53502417
2015-09-22,14843500.0,103.98999786376952,107.04000091552734,102.86000061035156,106.51000213623048,92.31787109375,GILD,"Weekly Insider Sells Highlight: Flowers Foods, Gilead Sciences, Cigna, HanesBrands ||| Pfizer's Xeljanz Tops Phase III Ulcerative Colitis Studies ||| Gilead Unveils Encouraging HCV Data on Sovaldi/Velpatasvir ||| 5 Biotech Stocks Hit Hard by Hillary Clinton's Tweet ||| PEG Ratio vs. the P/E Ratio",0,0.50595266
2015-09-23,7973100.0,106.47000122070312,106.8499984741211,104.6999969482422,105.48999786376952,91.43376922607422,GILD,"Zacks.com featured expert Kevin Matras highlights: Cal-Maine Foods, Express, Tesoro, Build-A-Bear Workshop and Gilead Sciences ||| Biotech Stock Roundup: Clinton's Tweet Shakes Biotech Stocks, Amgen In Pipeline-Boosting Deals ||| $24.7 Billion Says Gilead Is Up to Something ||| ANI Pharmaceuticals (ANIP) Falls: Stock Goes Down 15.8% ||| AcelRx's Pain Treatment Drug Zalviso Approved in Europe ||| KYTHERA Files IND Application for Male Hair Loss Treatment ||| Heron's (HRTX) Post-Operative Pain Candidate Encourages ||| Strength Seen in Vascular Biogenics (VBLT): Stock Up 22% ||| Adam Feuerstein And The Price Blowup: Turing Pharmaceuticals' Daraprim Decision",0,0.50943875
2015-09-24,13464100.0,104.38999938964844,105.1500015258789,101.51000213623048,102.51000213623048,88.85084533691406,GILD,"The Zacks Analyst Blog Highlights: Juno, Amgen, Gilead, Intra-Cellular and TRACONThe Zacks Analyst Blog Highlights: Juno, Amgen, Gilead, Intra-Cellular and TRACON ||| Conatus Reports Promising Phase II Data on Emricasan ||| Amgen, Allergan's Biosimilar of Avastin Tops Phase III Study ||| PDL BioPharma Concludes Financing Agreement with Avinger ||| Myriad Genetics: Study Results Impress, Currency Woes Stay ||| Keep The Quality And The Large Caps With This New ETF ||| Fast Money Traders Share Their Must-Buy Stocks",0,0.5026006
2015-09-25,15998900.0,104.02999877929688,104.19000244140624,99.19000244140624,100.13999938964844,86.79663848876953,GILD,"Aduro (ADRO) to Acquire BioNovion in Cash and Stock Deal ||| Bellerophon Presents Positive Interim Data on INOpulse ||| Friday's ETF with Unusual Volume: XBI ||| Myriad Genetics Posts Positive Data on Oncology Tests ||| Stock Market News for September 25, 2015 ||| KemPharm (KMPH) Updates on Abuse-Deterrent Opioid Drug",0,0.48608786
2015-09-28,23907400.0,99.05999755859376,99.26000213623048,94.56999969482422,94.8000030517578,82.16818237304688,GILD,"Genomic Health Posts Positive Breast Cancer Trial Results ||| Charlie Munger's Six Filters for Investing Successfully ||| Regeneron/Sanofi's PCSK9 Inhibitor Praluent Approved in EU ||| In Volatile Markets, Short Sellers Head For Biotechs",1,0.5109028
2015-09-29,18416500.0,95.08000183105467,97.73999786376952,93.19000244140624,96.0,83.2082748413086,GILD,Buy 3 Compelling Biotech Stocks at Bargain Prices ||| Is Gilead Sciences' Dominance in Hepatitis C Unstoppable? ||| John Buckingham's Interview With Barron's,1,0.5037635
2015-09-30,15811800.0,98.44000244140624,99.72000122070312,96.91999816894533,98.19000244140624,85.1064682006836,GILD,"Biotech Stock Roundup: Pricing Concerns Hit Biotech Stocks, EU Nod for Regeneron's Praluent",1,0.5014596
2015-10-01,13403600.0,98.54000091552734,98.79000091552734,96.3499984741211,98.2699966430664,85.1758041381836,GILD,"iShares MSCI USA Quality Factor ETF Experiences Big Inflow ||| Stock Market News for October 01, 2015 ||| The Zacks Analyst Blog Highlights: Regeneron, Vertex, Gilead, Biogen and Celgene ||| 3 Companies That Could Beat Apple to a $1 Trillion Valuation ||| Fast Money Traders Share The Stocks They Would Buy In Fourth Quarter",1,0.523936
2015-10-02,19143500.0,95.54000091552734,98.30999755859376,94.37000274658205,98.27999877929688,85.18448638916016,GILD,"Morning Market Losers ||| Benzinga's Top Downgrades ||| Morgan Stanley On Big Biotech: Upgrades, Pfizer, Vertex, Alexion, Cuts Gilead, Valeant ||| Benzinga's Top #PreMarket Losers ||| Morgan Stanley Downgrades Gilead Sciences to Equal-weight, Maintains $127.00 PT",1,0.51174605
2015-10-05,14536000.0,99.98999786376952,101.3000030517578,97.66000366210938,99.26000213623048,86.03389739990234,GILD,"5 Stocks We Bought Recently ||| Tweet This Hillary: Pros See Biotech ETFs As A Buy ||| ContraVir Soars 150% as New HBV Drug is 60x More Active than Gilead's Viread ||| Health Care Sector Update for 10/05/2015: ONCE,CTRV,SIEN ||| Health Care Sector Update for 10/05/2015: ATRC,CTRV,GILD,SIEN ||| 3 Biotech Bargains to Buy ||| UPDATE: ContraVir +100% on Positive CMX157 Hepatitis B Data ||| ContraVir +30% Premarket as Co Says Data Demonstrate CMX157 to be 60-Fold More Potent vs Hepatitis B Virus than Gilead's Viread",0,0.4842516
2015-10-06,14842700.0,98.81999969482422,98.9000015258789,95.0500030517578,97.54000091552734,84.5430908203125,GILD,"3 Biotech Stocks That Have Been Unfairly Beaten Down ||| Merck's (MRK) All-Oral Ribavirin-Free HCV Data Published ||| Notable Tuesday Option Activity: GILD, HP, T ||| Why AbbVie Inc.'s Shares Slumped 13% in September ||| Biotech Bears Spark Good Vibes For These ETFs ||| Social Media Beat: The Three Gs -- GE, Google And Gilead ||| Singapore Ministry of Health Convenes Independent Review Committee on Report of Cluster of 22 Acute Cases of Hepatitis C Among Kidney Patients -Reuters",1,0.52181345
2015-10-07,12457700.0,97.98999786376952,100.79000091552734,97.5,100.2699966430664,86.90930938720703,GILD,"Stock Market News for October 07, 2015 ||| Biotech's Bloodbath Is Ridiculous; Here's Why ||| Bristol-Myers Gets Priority Review for HCV Drug Daklinza",1,0.49912584
2015-10-08,11833100.0,100.02999877929688,101.16000366210938,98.06999969482422,100.80999755859376,87.37737274169922,GILD,"Gilead Is About to Disappoint Investors -- but for All the Right Reasons ||| 3 Pharma Stocks With Big Margins of Safety ||| Stock Market News for October 08, 2015",0,0.46385258
2015-10-09,8622200.0,101.2699966430664,101.8000030517578,99.4499969482422,100.6500015258789,87.23867797851562,GILD,"Build Your Long-Term Investment Portfolio ||| Noteworthy ETF Inflows: QUAL, AAPL, GILD, COST ||| 4 Biotech Stocks Now at Bargain Prices",0,0.4853679
2015-10-12,8863800.0,101.08000183105467,101.22000122070312,99.37999725341795,99.51000213623048,86.25059509277344,GILD,"When These 3 Healthcare CEOs Speak, We Listen ||| Watching Volatility In Other Big Pharma Names Amid Eli Lilly Halt",0,0.50390667
2015-10-13,9411200.0,98.91000366210938,99.81999969482422,98.0,98.19000244140624,85.1064682006836,GILD,"3 Biotech Stocks With Astonishingly Low P/E Ratios ||| Osiris Therapeutics, Inc. (OSIR) Ex-Dividend Date Scheduled for October 14, 2015 ||| Want Lower Drug Prices? These 3 Proposals Won't Help You!",1,0.49244812
2015-10-14,9575800.0,98.37000274658205,99.94000244140624,98.11000061035156,98.38999938964844,85.27983093261719,GILD,J&J Posts Mixed Q3 Bag: ETFs in Focus,1,0.52124
2015-10-15,9462400.0,98.08999633789062,101.69000244140624,97.5999984741211,101.63999938964844,88.0967788696289,GILD,Breaking Down Biotech's Bloodbath: Which Companies to Buy,1,0.5249696
2015-10-16,9975800.0,101.9499969482422,103.37000274658205,101.51000213623048,102.83000183105467,89.12821960449219,GILD,Bristol-Myers' (BMY) Daklinza Gets NICE Recommendation,1,0.50037044
2015-10-19,7636900.0,102.63999938964844,103.83999633789062,101.83999633789062,103.61000061035156,89.80426788330078,GILD,"Gilead Sciences: Stagnation Directly Ahead? ||| The 5 Best Bargains in the Stock Market ||| Noteworthy ETF Inflows: QUAL, AAPL, GILD, COST ||| Cowen: In Biotech Earnings We Trust",0,0.48636213
2015-10-20,10164800.0,103.43000030517578,103.9499969482422,101.12999725341795,101.66000366210938,88.1141128540039,GILD,"Stock Market News for October 20, 2015 ||| Johnson & Johnson Tells Gilead Sciences ""Game On"" ||| Oppenheimer Incrementally More Bullish on Gilead, Remains Cautious On Vertex",1,0.48852232
2015-10-21,9837500.0,102.79000091552734,102.91999816894533,99.37000274658205,101.7300033569336,88.17479705810547,GILD,"Stock Market News for October 21, 2015 ||| Battle Royale: Gilead Sciences Inc vs Celgene Corporation ||| UPDATE: Gilead Said GS-5734 Currently Being Provided to Female Patient in UK ||| Gilead Offers Update on GS-5734 for Treatment of Ebola: Fulfilled Request for Compassionate Access",1,0.5020677
2015-10-22,24746600.0,102.0,109.41999816894533,100.4000015258789,107.5999984741211,93.26261138916016,GILD,"Shares of AbbVie Inc Plummeted Today. Here's Why. ||| Achillion, J&J's HCV Combo Drug Phase IIa Study Started ||| Bullish Two Hundred Day Moving Average Cross - GILD ||| FDA Ruling Shakes Up Biotech: Gilead, AbbVie And More ||| Morgan Stanley Says Viekira Unlikely To Be Pulled From Market, Gilead May Gain Market Share But Not All Of Viekira's Market Share ||| UPDATE: FDA Requires Abbvie to Add New Information About Safety Risk To Drug Labels ||| UPDATE: FDA Warns Hepatitis C Treatments Viekira Pak And Technivie Can Cause Serious Liver Injury -Reuters ||| FDA Warns Of Potential Injury To Livers When Using Viekira Pak, Will Require Manufacture To Include Additional Safety Risk Info ||| Hearing FDA warns of serious liver injury risk w/HCV treatment v-pak ||| Gilead Spikes Higher ||| UPDATE: GIlead's Phase 3 Genvoya Study Found To Be Non-Inferior To Stribild With Improved Renal, Bone Parameters ||| Gilead Reports Phase 3 Results for Genvoya an Investigational Once-Daily Single Tablet Regimen for HIV",1,0.5038848
2015-10-23,15001300.0,108.45999908447266,109.6500015258789,105.5,107.98999786376952,93.60064697265624,GILD,"AbbVie Slumps, FDA Issues Warning Related to 2 HCV Drugs ||| Gilead Sciences (GILD) Jumps: Stock Adds 5.8% in Session ||| What's in Store for Gilead (GILD) this Earnings Season? ||| Gilead Sciences Finds Resistance",1,0.50464576
2015-10-26,10906500.0,108.6500015258789,110.36000061035156,107.44000244140624,108.62999725341795,94.15538024902344,GILD,"Specialty Drug Classes That Are Costing Consumers an Arm and a Leg ||| High Hopes For Apple, Alibaba, Other Earnings This Week",1,0.49357077
2015-10-27,15787000.0,109.38999938964844,111.11000061035156,108.69000244140624,110.95999908447266,96.17489624023438,GILD,"Top-Rated Stock Picks and Most-Read Stories at Nasdaq.com: October 18 - 24 ||| Here's Why Wall Street May Be Dead Wrong About AbbVie ||| Gilead Sciences (GILD) Stock Rising On Q3 Earnings and Revenue Estimates ||| After Hours Most Active for Oct 27, 2015 : TWTR, AAPL, GE, ABX, QQQ, MSFT, CSCO, PPS, NRG, HCC, GILD, FB ||| Earnings Reaction History: Gilead Sciences Inc., 44.4% Follow-Through Indicator, 3.2% Sensitive ||| After-Hours Earnings Report for October 27, 2015 : AAPL, GILD, ESRX, CNI, APC, AFL, FISV, EIX, TWTR, VRSK, AKAM, MAC ||| Tuesday's After-Hours Movers: Apple And Twitter Lead The Way ||| Gilead Sciences Posts Upbeat Q3 Earnings, Lifts Outlook ||| Gilead shares down ~2% following earnings release ||| UPDATE: Gilead Raises FY15 Net Product Sales Guidance from $29B-$30B to $30B-$31B vs $31.5B Est. ||| Gilead Raises FY15 Net Product Sales Guidance ||| Gilead Reports Product Sales $8.2B; Revises FY15 Net Product Sales Outlook ||| Gilead Reports Q3 Adj. EPS $3.22 vs $2.89 Est. ||| Gilead +1.5% Ahead of Earnings After the Close ||| Biotech ETFs: Buy, Buy, Buy? ||| Earnings Scheduled For October 27, 2015",0,0.47766277
2015-10-28,17795600.0,109.0,109.20999908447266,105.94000244140624,108.12999725341795,93.72201538085938,GILD,"This Company's 31-Year Adjusted EPS Growth Streak Will Likely End in 2015 ||| Commit To Purchase Gilead Sciences At $60, Earn 5.1% Using Options ||| Daily Dividend Report: AFL, SXI, AAPL, WFC, GILD, MET, ICE, GWW, CHD ||| Gilead (GILD) Beats on Q3 Earnings, HCV Drugs Lose Shine ||| Biotech Stock Roundup: Biogen Tops Estimates, FDA Approves Alexion's Strensiq ||| Gilead Submits New Drug Application to U.S. Food and Drug Administration for Fixed-Dose Combination of Sofosbuvir/Velpatasvir for Treatment of All Six Genotypes of Hepatitis C ||| Gilead Stock Whiffs, But One Pro Remains Bullish ||| Fast Money Picks For October 28 ||| Keep an Eye on These 10 Stocks for October 28, 2015",1,0.5056089
2015-10-29,10783300.0,108.18000030517578,110.7699966430664,107.69000244140624,109.20999908447266,94.6580810546875,GILD,Will AbbVie (ABBV) Surprise on Earnings Again in Q3?,0,0.5082979
2015-10-30,8545000.0,109.5199966430664,109.86000061035156,108.08000183105467,108.12999725341795,93.72201538085938,GILD,"Health Care Sector Update for 10/30/2015: GILD, SGEN ||| Gilead Sciences, WuXi PharmaTech to Collaborate on Dedicated Analytical and Stability Testing Facility",1,0.52340776
2015-11-02,8362000.0,108.76000213623048,109.9499969482422,108.31999969482422,109.5999984741211,94.9961166381836,GILD,Gilead Sciences Is Shrugging Off Its Competitors ||| Make Gilead part of your biotech portfolio ||| Which Dividends Would Be Safest If Drug Prices Were Slashed Tomorrow? ||| What's in Store for Conatus (CNAT) this Earnings Season? ||| 5 Best Dividend Stocks To Buy In November ||| 10 Stocks with 10% Plus Gains in October,0,0.46864375
2015-11-03,7458600.0,109.4000015258789,109.54000091552734,108.31999969482422,109.0999984741211,94.56275177001952,GILD,"5 Exciting Biotech Stocks to Buy on November Upswing ||| Vanguard Growth ETF Experiences Big Inflow ||| ViiV Healthcare Attacking, but Gilead Prepares to Strike Back",0,0.5101004
2015-11-04,8081800.0,109.5999984741211,109.7300033569336,107.3000030517578,108.9800033569336,94.458740234375,GILD,"Biotech Stock Roundup: AbbVie's Humira Remains Strong, Shire to Buy Dyax ||| Meg Tirrell @megtirrell Tweet: In drug price task force hearing, House Dems take aim at Sovaldi",0,0.47723883
2015-11-05,10182100.0,108.33000183105467,108.38999938964844,106.0500030517578,107.83000183105467,93.46197509765624,GILD,"The Zacks Analyst Blog Highlights: AbbVie, Amgen, Dyax, Repros and Gilead ||| Does AbbVie's Viekira Pak Warning Land Express Scripts in the Penalty Box? ||| Gilead's Sovaldi in Focus on Bradyarrhythmia Concerns ||| UPDATE: Gilead's Genvoya Is First TAF-Based Regimen To Receive FDA Approval ||| U.S. Food and Drug Administration Approves Gilead's Single Tablet Regimen Genvoya for Treatment of HIV-1 Infection ||| FDA Approves Gilead'S Single Tablet Regimen Genvoya for Treatment Of Hiv-1 Infection -Reuters ||| ISIS Pharma Called A 'Sleeper Awakening' At Piper Jaffray ||| Fast Money Picks For November 5",1,0.50413156
2015-11-06,8565900.0,107.0,108.33999633789062,106.36000061035156,108.33999633789062,93.9040069580078,GILD,Biotech Sees Better-than-Expected Earnings: ETFs in Focus ||| Marijuana and Hepatitis C: What to Watch in 2016 ||| Gilead's (GILD) Cocktail HIV Drug Genvoya Gets FDA Nod,0,0.524212
2015-11-09,8142200.0,108.0,108.52999877929688,107.08000183105467,108.11000061035156,93.70465850830078,GILD,"Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for November 10, 2015 ||| 5 Picks on Strongest Jobs Gains of 2015 ||| Three Rules for Options Trading Success ||| What Does 2016 Hold for This Closely-Watched Biotech ETF? ||| Early Global News: New Alibaba Chatter, Tesla-GM Size Comparison & What Pamela Anderson And Gilead May Have In Common ||| Pamela Anderson And Hepatitis C: Which Drug Makers Are Working On A Cure?",1,0.49092218
2015-11-10,8571300.0,108.0999984741211,109.37000274658205,107.94000244140624,108.8499984741211,94.34605407714844,GILD,5 Biotech Stocks with Good Growth Prospects,0,0.5345164
2015-11-11,6056800.0,108.91000366210938,109.2300033569336,107.02999877929688,107.19000244140624,92.90724182128906,GILD,"IWF, AAPL, GILD, CMCSA: ETF Inflow Alert ||| The Zacks Analyst Blog Highlights: Gilead Sciences, Retrophin, Exelixis, Actelion and Enzo Biochem ||| A Trio of Catalysts Lift Merck Higher in October ||| Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for November 12, 2015 ||| X-RX Reports Autotaxin Inhibitor Partnership With Gilead",0,0.5125296
2015-11-12,8010900.0,106.94000244140624,107.0999984741211,104.16000366210938,104.2300033569336,90.3416519165039,GILD,"U.S. FDA Approves New Indications for Harvoni, Gilead's Once-Daily Single Tablet Regimen for Chronic Hepatitis C",0,0.5149827
2015-11-13,10848400.0,104.08999633789062,104.18000030517578,102.12000274658205,102.56999969482422,88.9028549194336,GILD,"Tyco Q4 Earnings In Line with Estimates, Revenues Lag ||| Hepatitis C Treatment in 2016: Will Gilead Sciences or AbbVie Win? ||| Gilead's (GILD) HCV Drug Harvoni's Label Expanded in U.S.",1,0.56047213
2015-11-16,7344200.0,102.9000015258789,104.0,101.63999938964844,103.80999755859376,89.97762298583984,GILD,5 Drugs That Are the Face of Prescription Drug Reform ||| Multiple Scientific Presentations at The Liver Meeting 2015 Further Highlight the Utility of Sofosbuvir-Based Hepatitis C Therapies ||| Better Dividend Stock: Gilead Sciences Inc. vs. Teva Pharmaceutical Industries ||| AbbVie Reports Encouraging Data on HCV Drug Viekira Pak ||| Gilead's Zydelig® Combined with Bendamustine and Rituximab Shows Superior Efficacy to Bendamustine/Rituximab in Phase 3 Study of Patients with Relapsed Chronic Lymphocytic Leukemia,1,0.53175104
2015-11-17,6921800.0,104.4499969482422,104.88999938964844,103.5,104.52999877929688,90.6016845703125,GILD,3 Biotech Stocks You Don't Have to Babysit ||| Gilead's Leukemia Study Unblinded Early on Positive Data ||| Bristol-Myers' Opdivo Gets Priority Review from the FDA ||| Bristol-Myers Squibb Spokesperson Declines Comment on Earlier Chatter of Gilead Interest in Co. ||| Hearing Unconfirmed Market Chatter of Gilead Deal to Acquire BMY,1,0.5241811
2015-11-18,8246800.0,104.48999786376952,108.22000122070312,104.4499969482422,108.12999725341795,93.72201538085938,GILD,Zoetis' (ZTS) Antiparasitic Simparica Gets EU Approval ||| Infinity (INFI) Completes Enrollment in Phase III DUO Study ||| This Just In: Upgrades and Downgrades ||| GILD Makes Bullish Cross Above Critical Moving Average,0,0.504211
2015-11-19,7019600.0,108.0,108.0500030517578,106.20999908447266,106.51000213623048,92.31787109375,GILD,"Notable ETF Inflow Detected - VUG, GILD, MA, ABBV ||| The Zacks Analyst Blog Highlights: Clovis Oncology, Gilead, AbbVie and Medicines Company",1,0.48907894
2015-11-23,5481700.0,106.6999969482422,107.6500015258789,105.93000030517578,106.36000061035156,92.18785095214844,GILD,Gilead Sciences Inc. Has Plenty of Room to Run in Hepatitis C ||| Biogen's (BIIB) Biosimilar of Pfizer's Enbrel Gets CHMP Nod ||| Can Merck & Co. Take Down Gilead Sciences?,1,0.47843423
2015-11-24,6547100.0,105.75,106.8000030517578,105.5,106.56999969482422,92.3698501586914,GILD,"Gilead's (GILD) Cocktail HIV Drug Genvoya Approved in EU ||| 5 Cheap Health Care Stocks that Promise Healthy Returns ||| Zacks Industry Outlook Highlights: Valeant, Pfizer, Allergan, AbbVie and Gilead ||| Healthcare's Greatest Dividend Stocks",1,0.4863113
2015-11-25,5720500.0,106.56999969482422,108.06999969482422,106.30999755859376,107.77999877929688,93.41861724853516,GILD,"The Zacks Analyst Blog Highlights: Gilead Sciences, Mylan, Indivior, OmniComm Systems and Air Methods ||| Early Global News: Ebola In Liberia, Boeing To Roll Out 737 MAX Next Month, Google Testing SMS Alerts",1,0.51427406
2015-11-27,2749200.0,108.13999938964844,108.62999725341795,107.62000274658205,108.0,93.60931396484376,GILD,"Gilead Sciences Grabs 4 Regulatory Wins -- but Does It Matter? ||| 5 Dividend Stocks to Buy in December ||| Giving Thanks, Healthcare Style ||| The Zacks Analyst Blog Highlights: BioMarin, Amgen, Vertex, Gilead, Biogen and Repros",0,0.49240166
2015-11-30,9837800.0,108.20999908447266,108.30999755859376,105.69000244140624,105.95999908447266,91.84114074707033,GILD,The Most Important Message From Charlie Sheen's Recent HIV Admission ||| 3 Healthcare Stocks With Massive Buyback Programs ||| There's a 0.0000000000028% Chance This Drug Doesn't Work,0,0.51292115
2015-12-01,10659500.0,106.3499984741211,107.37999725341795,104.6500015258789,105.8499984741211,91.7458038330078,GILD,"Stock Market News for December 01, 2015 ||| PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for December 02, 2015 ||| Curing the World: A Shout Out to Healthcare Innovators ||| 15 Biotechs Making Announcements At The 2015 Piper Jaffray Healthcare Conference ||| Gilead Selling Off; CNBC Reports Senate Investigating Co Over Drug Pricing",0,0.47880104
2015-12-02,8850500.0,105.0,105.56999969482422,104.3000030517578,104.44000244140624,90.523681640625,GILD,"3 Global Infectious Diseases That May Soon Have Cures ||| Can Under Armour Inc Shareholders Find a Blueprint in Nike Inc? ||| Gilead's High-Priced HCV Drugs in Focus on Senate Report ||| Biotech Stock Roundup: Repros Tanks on CRL, AbbVie Multiple Myeloma Drug Approved ||| 5 Things To Consider When Preparing For A Santa Claus Rally ||| High Drug Prices Put Gilead Under Fire From Senate Committee ||| Early Global News: Instagram Seeing Fast Growth Among U.S. Companies, Cabelas Explores Strategic Options",0,0.52485496
2015-12-03,13772400.0,104.31999969482422,104.58999633789062,100.5,101.37999725341795,87.87139892578125,GILD,"AbbVie's NDA for Once-Daily Viekira Pak Accepted by FDA ||| The Zacks Analyst Blog Highlights: Repros Therapeutics, AbbVie, Amgen, XOMA and Gilead ||| Why Achillion Pharmaceuticals Shot 30% Higher in November ||| After Hours Most Active for Dec 3, 2015 : PAH, QQQ, MDLZ, HPE, PFE, FCX, AAPL, WEN, BAC, ORCL, GILD, CSCO",1,0.532941
2015-12-04,8738300.0,101.44000244140624,104.16000366210938,101.25,104.06999969482422,90.20298767089844,GILD,EMA Validates Gilead's Marketing Application for Fixed-Dose Combination of Sofosbuvir/Velpatasvir for Treatment of Hep C,0,0.53050673
2015-12-07,5956100.0,104.11000061035156,104.1500015258789,102.25,102.91000366210938,89.19754028320312,GILD,"The 3 Most Important Drugs in Gilead Sciences' Pipeline ||| Gilead's HCV Drug's Regulatory Application Validated in EU ||| Bristol-Myers/AbbVie Report Long-Term Data on Empliciti ||| Achillion Spikes to High; May be Attributed to FT Article on Gilead Seeking Hep C Deal ||| Early Global News: PlayStation 4 Sets Records, New Weight Watchers App, And More ||| Gilead Canada Reports Health Canada Has Issued Notice of Compliance of Co.'s Single Tablet Regimen Genvoya for Treatment of HIV-1 Infection",1,0.5001845
2015-12-08,6675600.0,102.06999969482422,104.06999969482422,101.7300033569336,103.52999877929688,89.73493194580078,GILD,"Phase 3 Results for Zydelig With Bendamustine, Rituximab for Relapsed Chronic Lymphocytic Leukemia Presented at American Society of Hematology Annual Meeting, Study Found 67% Reduction In Disease Progress Or Death",0,0.5113536
2015-12-10,7653300.0,102.4499969482422,103.05999755859376,101.55999755859376,102.62000274658205,88.94618225097656,GILD,Will This Study Finally Catapult Gilead Sciences Into a Cancer Powerhouse?,0,0.5274737
2015-12-11,9518900.0,101.3499984741211,102.47000122070312,99.66999816894533,100.02999877929688,86.7012939453125,GILD,"Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for December 14, 2015 ||| Balance Sheet Brawl: Pfizer Vs. Bristol-Myers Squibb",1,0.4551783
2015-12-14,10251300.0,99.97000122070312,100.93000030517578,98.66000366210938,100.48999786376952,87.47602844238281,GILD,"3 Small-Cap Biotech Stocks With Big News Coming in 2016 ||| The Average American Spends This Much on Prescription Drugs Each Year ||| Weekly CFO Sells Highlight: Tyson Foods, Alexion Pharmaceuticals, Gilead Sciences ||| This May Be The Fastest-Growing Biotech Stock Next Year (Hint: It's Not Gilead Sciences) ||| M&A In Small-, Mid-Cap Biotechs Isn't Slowing Down",1,0.52690804
2015-12-15,11740300.0,101.73999786376952,103.0,101.44000244140624,101.97000122070312,88.7643814086914,GILD,"IUSG, GILD, BMY, MCD: ETF Inflow Alert",1,0.5204952
2015-12-16,10950300.0,103.18000030517578,103.48999786376952,101.63999938964844,103.33999633789062,89.95693969726562,GILD,"Is There Any Value Left in Healthcare? This Top Investing Firm Seems to Think Not ||| Amgen Returns More to Shareholders, Hikes Dividend by 27%",0,0.4991031
2015-12-17,7614400.0,104.25,104.79000091552734,102.33000183105467,102.36000061035156,89.1038589477539,GILD,"U.S. Stock Futures Extend Post-Fed Gains ||| Instant Analysis: Amgen Cranks Dividend 27% Higher ||| CT Order Filing from Gilead Shows Co.'s App Under Rule 24b-2 Was Determined (by Division of Corporation Finance) Not to Publicly Disclose ||| Benzinga's Volume Movers ||| Benzinga's Top #PreMarket Gainers ||| Galapagos, Gilead Announce Global Partnership to Develop Filgotinib to Treat Rheumatoid Arthritis, Other Inflammatory Diseases",0,0.49794456
2015-12-18,15768500.0,101.68000030517578,101.98999786376952,100.91999816894533,101.5999984741211,88.44229125976562,GILD,"Ackman, Sequoia Stock Valeant Changes Course ||| Gilead (GILD) Collaborates with Galapagos for Filgotinib ||| Option Alert: GILD Jan16 105 Calls Sweep: 10002 @ ASK $1.54: 11k traded vs 19k OI: Earnings 2/2 $101.64 Ref ||| Piper Jaffray Makes 15 'Provocative' Predictions For Biopharma Sector In 2016 ||| Atlantic Equities Initiates Coverage on Gilead Sciences at Neutral, Announces $111.00 PT",1,0.49680212
2015-12-21,8306500.0,102.20999908447266,103.26000213623048,101.62999725341795,102.62999725341795,89.33889770507812,GILD,"This Revolutionary FDA Approval Showcases an Important Trend ||| After Hours Most Active for Dec 21, 2015 : HST, GM, AAPL, EMC, C, CSCO, KR, PFE, QCOM, FB, XIV, GILD ||| GILD Fri 1/29 110 Calls (Wkly): 5200 @ ASK $0.89: 5200 traded vs 108 OI: Earnings 2/2 $102.04 Ref",1,0.50232255
2015-12-22,7151200.0,102.98999786376952,103.54000091552734,102.48999786376952,102.86000061035156,89.53912353515625,GILD,"After Hours Most Active for Dec 22, 2015 : BK, PFE, ETE, MU, AAPL, GILD, ABEV, NKE, QQQ, YHOO, HPE, UBNT ||| Is Merck & Co. About to Derail Gilead Sciences? ||| Argus Like Gilead's Filgotnib Drug, Call It A 'blockbuster product', Says Galapagos 'warrants attention'",1,0.47489434
2015-12-23,7279900.0,103.58999633789062,103.58999633789062,102.69000244140624,103.13999938964844,89.7828598022461,GILD,"Noteworthy ETF Inflows: XLV, JNJ, GILD, BMY ||| Don't Sell Gilead Sciences; Try This Instead ||| Biotech Stock Roundup: KaloBios Removes CEO Shkreli, Actelion PAH Drug Approved ||| Peering Through The Fog To Find The Best Sectors Into Year End ||| An Award-Winning Debut For This Goldman ETF",1,0.50820214
2015-12-24,2656900.0,103.3499984741211,103.9000015258789,103.1500015258789,103.58000183105467,90.1658706665039,GILD,"Biotech Industry Could Offer Early Profit in 2016 ||| The Zacks Analyst Blog Highlights: Actelion, Amgen, Gilead, AbbVie and BioMarin",0,0.4830484
2015-12-28,5270900.0,103.0,103.30999755859376,101.51000213623048,101.68000030517578,88.51193237304688,GILD,3 New Drugs Ready to Explode in 2016 ||| The Worst Johnson & Johnson Headlines in 2015 ||| 5 Play-It-Safe Stocks for 2016 ||| What Happened in Biotech in 2015?,1,0.49824086
2015-12-29,7647300.0,102.25,103.5500030517578,101.56999969482422,103.36000061035156,89.97435760498047,GILD,"Irony of Ironies: Gilead Sciences Is Licensing AbbVie's Rejected Drug ||| Enzon Pharmaceuticals, Inc. (ENZN) Ex-Dividend Date Scheduled for December 30, 2015",0,0.46249905
2015-12-30,4876300.0,102.83999633789062,103.0500030517578,102.02999877929688,102.16000366210938,88.92977142333984,GILD,Drugmaker Returns on R&D Are Shrinking ||| Option Alert: GILD Feb16 105 Calls: 2000 @ Above Ask! $2.77: 2056 traded vs 9762 OI: Earnings 2/2 $102.16 Ref,0,0.4728594
2015-12-31,6245200.0,102.36000061035156,102.41999816894533,101.16999816894533,101.19000244140624,88.08540344238281,GILD,Can Gilead Sciences Score With AbbVie's Dropped Ball? ||| Looking To Q4 Earnings Season In 6 Charts ||| Roth Capital's Joseph Pantginis Reiterates Buy on Ligand Following Captisol Supply Deal with Gilead; 'We believe Ligand is strongly positioned for continued growth.' ||| 8-K from Ligand Pharma Shows Co. Entered Supply Deal with Gilead for Captisol,0,0.51153105
2016-01-04,14904400.0,99.7699966430664,100.0,97.01000213623048,98.01000213623048,85.31721496582031,GILD,"Why Did Gilead Sciences, Inc. Take on a Mountain of Debt? ||| What Makes a Stock ""Cheap""? ||| What Does 2016 Hold for Biotech Stocks? ||| 3 Stocks To Buy In A Market Crash ||| Gilead Reports U.S. FDA Priority Review Designation for Sofosbuvir/Velpatasvir for Treatment of All Genotypes of Chronic Hepatitis C Infection, Final FDA Decision Anticipated By June 28th ||| Gilead, Other Biotechs Selling Off On Market Weakness",1,0.5067787
2016-01-05,9260800.0,99.69000244140624,99.8499984741211,98.6999969482422,99.26000213623048,86.40533447265625,GILD,"Why the Dow Jones Industrial Average Is Falling Today ||| Gilead's (GILD) HCV Drug Gets Priority Review Status in U.S. ||| How to Pick an Undervalued Stock Before It Picks Up Steam ||| Gilead Reports Termination of Phase 3 Study of Simtuzumab in Patients with Idiopathic Pulmonary Fibrosis ||| UPDATE: Gilead To Submit Regulatory Applications For TAF For Chronic HBV In U.S. And EU In Q1 2016 ||| Gilead Reports Top-Line Results From Phase 3 Studies With Chonic Hepatits B Infection, TAF Demonstrated Improved Renal And Bone Safety Parameters Compared To Viread",1,0.50038683
2016-01-06,12540700.0,97.56999969482422,100.68000030517578,97.5199966430664,100.3000030517578,87.31065368652344,GILD,"Company News for January 06, 2016 ||| Biotech Stock Roundup: MannKind Tanks on Deal Termination, Speedy Review for Gilead Drug ||| Gilead Up on Encouraging Data on Tenofovir Alafenamide",0,0.50260043
2016-01-07,12944600.0,98.05999755859376,99.0,96.02999877929688,96.25,83.78514862060547,GILD,"The Zacks Analyst Blog Highlights: Gilead, MannKind, VIVUS and Baxalta ||| Why Gilead Is 'The Apple Of Biotech' ||| Jim Cramer Gives His Opinion On Lockheed Martin And Gilead Sciences",1,0.49711946
2016-01-08,11976000.0,96.9000015258789,97.98999786376952,96.41000366210938,96.4499969482422,83.95923614501953,GILD,AbbVie's Viekira Pak sNDA Accepted with Priority Review,1,0.52995336
2016-01-11,12322500.0,97.22000122070312,97.22000122070312,94.29000091552734,96.5,84.00276184082031,GILD,5 Commonly Prescribed Drugs With Six-Digit Annual Price Tags ||| 3 Healthcare Stocks to Buy on Sale ||| 1 George Soros Quote to Keep in Mind in 2016 ||| Celldex Therapeutics Drops 10% as Biotech Heads South ||| Integra Strong on International Growth; US Spine Bothers ||| 3 Healthcare Stocks to Buy in a Market Meltdown ||| 5 Biotech Stocks Ready to Crush the Market in 2016,1,0.5382532
2016-01-12,9830100.0,96.9000015258789,98.48999786376952,95.20999908447266,97.0999984741211,84.52505493164062,GILD,"3 Things You Absolutely Must Know About Merck ||| 3 Slides Suggesting Gilead Sciences May Be Unstoppable ||| Noteworthy ETF Outflows: XLV, PFE, GILD, BMY ||| Invest in San Francisco with These 3 Stocks! ||| Aegerion Provides Preliminary Sales View & Pipeline Updates ||| The Zacks Analyst Blog Highlights: Gilead, Horizon Pharma, AVEO Pharmaceuticals, Achillion Pharmaceuticals and Inovio Pharmaceuticals ||| Gilead Reports FDA Submission of NDA for TAF for Treatment of Chronic Hep B ||| Moving To Momentum With ETFs",0,0.5014524
2016-01-13,12135700.0,97.25,98.02999877929688,92.12000274658205,92.54000091552734,80.55562591552734,GILD,"Gilead Sciences Takes 2 Steps Forward and 1 Step Back ||| Galapagos, Gilead Cleared FTC to Close Global Partnership on Filgotinib",1,0.52699596
2016-01-14,16303200.0,92.72000122070312,94.87999725341795,90.79000091552734,93.0199966430664,80.97344207763672,GILD,5 Good Stocks to Buy While They Are Cheap ||| Why Galapagos NV's Shares Bolted Higher in 2015 ||| Pluristem (PSTI) Gets FDA Approval for Phase I PLX-R18 Trial,0,0.514342
2016-01-15,18108300.0,90.37000274658205,92.77999877929688,89.68000030517578,91.83999633789062,79.94625854492188,GILD,4 Biotech Stocks Looking Good this Earnings Season ||| 5 Strong Growth S&P 500 Stocks to Buy on the Sell-off ||| Gilead Sciences' Galapagos Deal Advances It Toward a Multibillion-Dollar Market ||| Rethink U.S. Large-Cap Exposure With This ETF ||| Write A Prescription For This Healthcare ETF ||| Bank of America Upgrades Gilead Sciences to Neutral,0,0.5493233
2016-01-19,14373700.0,93.13999938964844,93.22000122070312,88.8499984741211,89.9000015258789,78.25751495361328,GILD,"The Zacks Analyst Blog Highlights: Gilead Sciences, Biogen, Cytokinetics and Bristol-Myers Squibb ||| 3 Stocks We're Watching in the First Quarter ||| 5 Nasdaq Value Stocks to Buy Cheap ||| The Zacks Analyst Blog Highlights: Amazon.com, Delta Air Lines, Gilead Sciences, Citrix Systems and Motorola Solutions ||| The Zacks Analyst Blog Highlights: Gilead Sciences, Hawaiian Holdings, Central Garden & Pet, Photronics and Exactech ||| 3 Slides That Perfectly Sum Up Where AbbVie Is Headed Next ||| Heron (HRTX) Down, Sustol Review Period Extended by FDA ||| What's in Store for Maxim Integrated (MXIM) in Q2 Earnings? ||| Galapagos, Gilead Complete Global filgotinib Collaboration Deal; Triggers $300M Fee Payment To Galapagos; Gilead Also Now Owns 14.75% Of Galapagos ||| Credit Suisse Initiates Coverage on Gilead Sciences at Outperform, Announces $125.00 PT",1,0.48414305
2016-01-20,19676300.0,88.0,91.83000183105467,86.27999877929688,90.5500030517578,78.82331848144531,GILD,"Zacks Investment Ideas feature highlights: Gilead Sciences, Qorvo, Essex Property Trust and Facebook ||| Merrimack Reports Positive Onivyde Data in Pancreatic Cancer ||| Dynavax, AstraZeneca Amend Deal for Asthma Candidate ||| The Weekly Play: Sell Calls on This Sector (IBB) ||| Gilead Sciences Tumbles; Unconfirmed Reports Of Drug Pricing Changes In Japan ||| Credit Suisse Bullish On Most Big Pharma Names ||| Gilead Shares Down Over 2.75%, Pharma Japan Reporting Possible Drug Repricing For Sovaldi, Harvoni, Avastin, And Plavix ||| Credit Suisse Sets Outperform Rating, $125 Target On Gilead Story ||| Credit Suisse Initiates GILD At Outperform, Believes Franchise Is Sustainable And Says 'this value stock is no trap'",0,0.49332482
2016-01-21,12158300.0,90.37000274658205,90.5999984741211,88.70999908447266,88.87000274658203,77.36089324951172,GILD,What's in Store for Corning (GLW) This Earnings Season? ||| 5 Dividend Stocks to Buy in January ||| Looking To Healthcare ETFs For Earnings Growth,1,0.51429385
2016-01-22,9160700.0,90.4000015258789,92.06999969482422,89.70999908447266,91.83000183105467,79.93755340576172,GILD,What's in Store for Teradyne (TER) this Earnings Season?,0,0.46946886
2016-01-25,10188400.0,91.52999877929688,93.54000091552734,90.43000030517578,90.61000061035156,78.87554931640625,GILD,"Gilead Takes a Page Out of Celgene's Playbook ||| Jim Cramer Dishes On Microsoft, Gilead, TG Therapeutics & NY Community Bancorp ||| After Hours Most Active for Jan 25, 2016 : BAC, FCAU, QQQ, HLF, MSFT, SCHW, HPE, SIRI, AAPL, HES, GILD, CSCO ||| Will Currency and Generics Hit J&J's (JNJ) Q4 Earnings? ||| Oil Short Covering Isn't A Share Price Bottom - Global Week Ahead ||| The Stock Sell-Off: What Should You Do Now? ||| Will Biogen (BIIB) Beat 4Q Earnings on MS Franchise Sales? ||| Forget Johnson & Johnson: Here Are 2 Better Dividend Stocks ||| Will Zimmer Biomet (ZBH) Beat Earnings Again in Q4? ||| See Which Of The Latest 13F Filers Holds Gilead Sciences ||| Why Q4 Earnings Beat is Dicey at Quest Diagnostics (DGX) ||| What to Expect from Lam Research's (LRCX) Q2 Earnings? ||| What's in Store for Texas Instruments' (TXN) Q4 Earnings? ||| Will Higher Expenses Hurt Vertex's (VRTX) 4Q Earnings? ||| Gilead Sciences Now Holds 14.75% of Galapagos Shares",1,0.48489425
2016-01-26,6889200.0,90.72000122070312,92.83000183105467,90.25,92.20999908447266,80.26834106445312,GILD,"Can QLogic (QLGC) Keep the Earnings Streak Alive in Q3? ||| Will Lilly (LLY) Keep the Earnings Streak Alive in Q4? ||| What to Expect from InvenSense (INVN) in Q3 Earnings? ||| J&J's Q4 Results Mixed with Earnings Beat, Revenue Miss ||| Will Amgen (AMGN) Continue with the Earnings Streak in Q4? ||| Celgene (CELG) to Report Q4 Earnings: What to Expect? ||| The Zacks Analyst Blog Highlights: Gilead Sciences, Horizon Pharma, NXP Semiconductor and TDK",0,0.4872784
2016-01-27,12520300.0,91.83999633789062,92.0999984741211,89.0,89.62999725341797,78.02246856689453,GILD,"ImmunoGen (IMGN) Q2 Earnings Preview: What to Expect? ||| Will Alibaba Group (BABA) Beat Earnings Estimates in Q3? ||| Biogen Tops on Q4 Earnings by a Wide Margin, Provides View ||| Will 2016 Be BioMarin Pharmaceutical's Best Year Yet? ||| Will AbbVie (ABBV) Keep the Earnings Streak Alive in Q4? ||| Will Currency Volatility Keep Hurting Abbott's (ABT) Earnings? ||| Will Myriad Genetics Q2 Earnings (MYGN) Surprise Investors? ||| Option Alert: GILD Fri 1/29 91.0 Calls (Wkly) Sweep: 4000 @ ASK $0.58: 4849 traded vs 1183 OI: Earnings 2/2 After Close $89.61 Ref ||| Massachusetts Attorney General To Gilead Sciences: Cost Of Harvoni & Sovaldi Drugs 'May Constitute An Unfair Trade Practice In Violation Of Massachusetts Law' ||| Massachusetts AG Tells Gilead to Lower Prices on Hep C Drugs -Boston Globe",0,0.4979672
2016-01-28,14168300.0,90.0,90.22000122070312,86.86000061035156,87.52999877929688,76.1944351196289,GILD,"Gilead Sciences (GILD) Looks Cheap at these Levels ||| Abbott Labs (ABT) Beats on Q4 Earnings, Lags on Revenues ||| Celgene Misses on Q4 Earnings, Reiterates 2016 Guidance ||| 3 Things to Watch in Gilead Sciences' Q4 Results ||| XLV, PFE, GILD, AGN: Large Inflows Detected at ETF ||| Vertex (VRTX) Posts Narrower 4Q Loss, Maintains Outlook ||| Bristol-Myers Beats on Q4 Earnings, Provides 2016 Guidance ||| 7 Biotech Traders Pick Their Favorite Stocks For 2016 ||| Stocks To Play In A Zika Virus Pandemic",0,0.487452
2016-01-29,37029000.0,84.27999877929688,85.30000305175781,82.33000183105469,83.0,72.25108337402344,GILD,"What's in Store for Nivalis (NVLS) this Earnings Season? ||| Why is Gilead (GILD) Stock Falling Today? ||| Instant Analysis: Gilead Sciences Inc.'s Longtime CEO Steps Down ||| Merck's Hepatitis C Doublet Wins FDA Approval and Unveils Its Secret Weapon ||| Should You Buy Gilead Sciences (GILD) Ahead of Earnings? ||| Amgen Tops on Q4 Earnings & Revenues, Ups 2016 Outlook ||| Pre-Market Most Active for Jan 29, 2016 : CBX, GILD, TAP, TVIX, UBS, MSFT, INO, QQQ, BAC, FB, NOK, XRX ||| Merck's HCV Drug Zepatier Gets FDA Nod; Sets Lower Price ||| Bristol-Myers' Daklinza-Sovaldi Label Expanded in the EU ||| Corcept Reports Preliminary Q4 Earnings, Revenues in Line ||| What's in the Cards for Yahoo! (YHOO) this Earnings Season? ||| Roche's (RHHBY) Earnings Miss Estimates, Revenues Beat ||| Edwards Lifesciences (EW) Likely to Top Earnings Again in Q4 ||| AbbVie Posts In-Line Earnings, Maintains 2016 Outlook ||| Instant Analysis: Can Merck Make Waves In the Crowded Hepatitis C Space? ||| Gilead Hits New 52-Week Low; Here Are Two Reasons Why ||| Worst Performing Industries For January 29, 2016 ||| Stocks Hitting 52-Week Lows ||| EXCLUSIVE: Colombian Health Minister Says Country Has 16,490 Confirmed Zika Cases, Likely More Unreported ||| Maybe Some Good News For A Big Biotech ETF ||| 10 Stocks Moving In Friday's Pre-Market Session ||| Gilead Names Chair, CEO John Martin Exec Chair; Pres, COO, John Milligan, Promoted to CEO",1,0.5022607
2016-02-01,17943600.0,82.31999969482422,84.5199966430664,82.27999877929688,84.05000305175781,73.16510772705078,GILD,"Here's Why Johnson & Johnson's Sales Fell Last Year ||| Johnson & Johnson Wants Investors to Ignore Falling Hepatitis C Drug Sales ||| 3 Surprisingly Controversial Stocks in Donald Trump's Portfolio ||| Will Mallinckrodt (MNK) Earnings Disappoint Investors in Q1? ||| Will 2016 Be Merck & Co. Inc.'s Best Year Yet? ||| Gilead (GILD) Is in Oversold Territory: What's Next? ||| 3 Biotech Stocks You Don't Have to Babysit ||| GW Pharmaceuticals (GWPH): What Awaits in Q1 Earnings? ||| Accuray (ARAY) Q2 Loss Wider than Estimate, Shares Fall ||| Is Alexion (ALXN) Likely to Disappoint this Earnings Season? ||| Is Illumina (ILMN) Poised to Beat Earnings Estimates in Q4? ||| Can Microchip (MCHP) Keep the Earnings Streak Alive in Q3? ||| From GoPro To Gilead: The Week's Most Important Earnings Calls After Google ||| UPDATE: STAT News on Gilead Cites Filing Posted on AIDSHealth.org ||| Gilead Accused of Manipulating HIV Patents Story, AIDS Healthcare Foundation Files Lawsuit Against Gilead-STAT News ||| European Medicines Agency Validates Gilead's Type II Variation Application for Truvada for Reducing the Risk of Sexually Acquired HIV",0,0.49162343
2016-02-02,16895600.0,84.18000030517578,84.22000122070312,81.88999938964844,82.70999908447266,71.99864196777344,GILD,"After Hours Most Active for Feb 2, 2016 : FCAU, QQQ, MRVL, HPE, MSFT, GILD, T, DFT, AAPL, FUEL, AKR, GE ||| Gilead Sciences (GILD) Beats Earnings and Revenue Estimates ||| Why Gilead Sciences Shares Tumbled 18% in January ||| 4 Top-Ranked Biotech Stocks on Sale ||| 5 Top-Rated S&P 500 Dividend Stocks to Buy in February ||| Start the New Year off Right with 3 Best Biotech Stocks ||| What's in Store for Stericycle (SRCL) this Earnings? ||| Will Qorvo (QRVO) Miss Q3 Earnings on Expected Low Sales? ||| Earnings Reaction History: Gilead Sciences Inc., 50.0% Follow-Through Indicator, 3.1% Sensitive ||| Ametek (AME) to Report Q4 Earnings: Will it Beat or Miss? ||| How to Benefit from Daily Trading Order Flow ||| Abbott Labs to Boost Diagnostics Business with Alere Buyout ||| Gilead Trounces Hep C Estimates; Harvoni International Footprint Nearly Equals U.S. ||| Earnings Recap For February 2 ||| Gilead To Increase Qtr. Dividend From $0.43 To $0.47/Share ||| Gilead Reports $12B Additional Buyback ||| Gilead Sees FY16 Rev. $30B-$31B v.s Est. $32.26B ||| Gilead Sciences Reports Q4 EPS $3.32 Vs Est $2.99, Sales $8.51B Vs Est $8.13B ||| Gilead Faces Its Great Hep C Threat: Will It Change Earnings? ||| Hearing Intercept Pharma hires JPM to Handle Interest from Pfizer, Gilead, BristolMyers -Daily Mail ||| Must Watch Stocks for Today ||| Earnings Scheduled For February 2, 2016",1,0.49768287
2016-02-03,24497700.0,84.91000366210938,86.98999786376953,83.87000274658203,86.38999938964844,75.20205688476562,GILD,"The Zacks Analyst Blog Highlights: Gilead Sciences, Mylan, United Therapeutics and INSYS Therapeutics ||| Qiagen Q4 Earnings Miss, Molecular Diagnostics Disappoints ||| Alexion Misses on Earnings and Revenues in Q4, Gives View ||| Merck Tops on Q4 Earnings, Revenue Outlook Falls Short ||| The Zacks Analyst Blog Highlights: Darden Restaurants, KLA-Tencor, Motorola Solutions, Gilead Sciences and NVIDIA ||| The Zacks Analyst Blog Highlights: Yahoo, Chipotle, Gilead Sciences and Match Group ||| Gilead (GILD) Beats Q4 Earnings Estimates, Gives 2016 View ||| Forget Gilead Sciences: These Stocks Doubled Last Year ||| Instant Analysis: Gilead Sciences Raises Its Dividend 10% ||| Myriad Genetics Tops Q2 Earnings; myRisk Conversion Over ||| Market Close Report: NASDAQ Composite index closes at 4,504.24 down -12.71 points ||| Gilead Sciences Rallies Off Q4 Report ||| Zika-Related Social Media Chatter Is Picking Up ||| Is Big Pharma Hinting At A SMID-Cap Biotech Rally? ||| Joe McCann: Here's How To Play Biotech Market In Earnings Season ||| Ronnie Moas Initiates Gilead At Buy; Models Show It's A Top 10 S&P Stock ||| Benzinga's Top Initiations ||| Credit Suisse Not Expecting GILD To Face Significantly Lower HCV Discounts From New Competitor ||| Credit Suisse Maintains Outperform on Gilead Sciences, Lowers PT to $118.00 ||| Standpoint Research Initiates Coverage on Gilead Sciences at Buy, Announces $110.00 PT ||| Keep an Eye on These 10 Stocks for February 3, 2016",1,0.49807224
2016-02-04,14538700.0,86.0199966430664,87.44999694824219,85.61000061035156,86.68000030517578,75.4544906616211,GILD,"The Zacks Analyst Blog Highlights: Biogen, Gilead, AbbVie, Intrexon and NewLink ||| Why Did Biotech Fall Off a Cliff in January? ||| 4 Can't-Miss Numbers From GlaxoSmithKline's Fourth-Quarter Results ||| Why Achillion Pharmaceuticals Shares Crashed 37% in January ||| 25 Companies That Could Still Buy Back Mountains Of Stock",0,0.49479795
2016-02-05,15732800.0,86.68000030517578,88.0199966430664,84.44999694824219,85.13999938964844,74.11393737792969,GILD,5 Stocks We're Buying Again ||| Gilead Sciences 2016 Guidance: Sandbagging Wall Street Again? ||| Leerink Is Back On Board The Biotech Train ||| Leerink Swann Initiates Coverage on Gilead Sciences at Outperform,1,0.49949884
2016-02-08,19111300.0,84.19000244140625,86.6500015258789,83.86000061035156,85.26000213623047,74.21839904785156,GILD,"Grading Gilead Sciences' Performance in 2015 ||| 1 Company Gilead Sciences Should Consider Buying Right Now ||| Is Gilead Sciences Finally Nearing a Bottom? ||| Barron's: Here Comes $20 Oil ||| Barron's Picks And Pans: Kinder Morgan, Gilead Sciences And More ||| Bristol-Myers' Daklinza-Sovaldi Label Expanded by the FDA ||| Will Gilead Sciences, Inc. Continue to Dominate HIV Treatment? ||| Most Of Credit Suisse's Top Investment Ideas For 2016...In One Place ||| Schoenebaum: Biotech P/Es Show 'Buying Signal' With Caveat; Amgen, Biogen, Celgene & Gilead Have Catalysts ||| How To Invest In An Aging World With The 'Live Long & Prosper' ETF",1,0.5077948
2016-02-09,14322700.0,84.19999694824219,88.4800033569336,84.0999984741211,87.25,75.95069122314453,GILD,"3 Biotech Stocks to Buy in a Market Crash ||| Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for February 10, 2016 ||| The Agony of High Returns ||| Biotech ETFs Slide as Stocks Report Mixed Q4 Results ||| Icahn, Gilead, GE Lead Top Insider Trades Of The Week ||| Celgene, Gilead Spike to Highs; May be Attributed to CMS Memo ||| Rebound For Big Biotech ETF Will Require Some Patience ||| Cramer Shares His Thoughts On Chipotle Mexican Grill, Inc. And Gilead Sciences, Inc.",1,0.5041371
2016-02-10,13462300.0,88.69000244140625,89.8499984741211,87.54000091552734,87.80000305175781,76.42945861816406,GILD,"Biotech Stock Roundup: Alexion, Regeneron Miss Estimates; Setback for CTI BioPharma ||| Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 11, 2016 ||| Pfizer's Biosimilar of Remicade Recommended for Approval ||| CTI BioPharma's Myelofibrosis Drug on Full Clinical Hold ||| Gilead Sciences Inc.'s Outlook For 2016: What Investors Need to Know ||| Zika Virus Spreading: Here's How To Play It Again",0,0.4693095
2016-02-11,13013400.0,86.5,88.44999694824219,86.01000213623047,87.36000061035156,76.04644775390625,GILD,"Genomic Health Q4 Loss Wider than Expected, Revenues Up ||| GW Pharmaceuticals Up on Narrower-than-Expected Q1 Loss ||| Benzinga's Top Initiations ||| Oppenheimer Initiates Coverage on Gilead Sciences at Outperform, Abb $120.00 PT",1,0.51057446
2016-02-12,11311700.0,88.66000366210938,89.87999725341797,86.68000030517578,89.44000244140625,77.8570556640625,GILD,"Why Intercept Pharmaceuticals Inc is Skyrocketing Today ||| These 7 Single-Digit P/E Stocks Could Collectively Deliver $600 Billion in Free Cash Flow by 2020 ||| Novartis Filing for Neulasta Biosimilar Accepted in the EU ||| Acorda Q4 Earnings Decline Y/Y, Ampyra & Pipeline in Focus ||| Achillion Begins Study on First Complement Factor D Inhibitor",1,0.50851506
2016-02-16,12278000.0,90.72000122070312,91.27999877929688,89.88999938964844,91.1500015258789,79.34561920166016,GILD,"Gilead Sciences Wants to Make Being a Shareholder Worth It ||| Schroer: Biotech Will Turn Around ||| Noteworthy ETF Inflows: QUAL, MSFT, AAPL, GILD ||| Intercept Pharmaceuticals (ICPT) Soars on Buyout Rumors ||| Novartis Acquires Rights to Biosimilar of Remicade from Pfizer ||| 7 Words That Could Have Biotech and Big Pharma Very Worried ||| Zoetis Tops Q4 Earnings and Revenues, Updates Guidance ||| Gilead Reports FDA Has Approved Two Supplemental Indications for Harvoni in Chronic Hep C Patients with Advanced Liver Disease",0,0.49567443
2016-02-17,22772800.0,91.08999633789062,91.5,88.66000366210938,89.36000061035156,77.78743743896484,GILD,"Why Shares of Regulus Therapeutics Skyrocketed Higher Today ||| Nasdaq 100 Movers: CERN, PCLN ||| Biotech Stock Roundup: Incyte Down on Jakafi Update, Is Intercept a Buyout Target? ||| Express Scripts Tops Earnings in Q4, Misses on Revenues ||| Pre-Market Most Active for Feb 17, 2016 : ASX, BAC, KMI, NJ, GRPN, RGLS, MFG, NOK, AAPL, TVIX, XIV, GILD ||| 3 Quotes Show Gilead Sciences' New CEO Is Ready to Deal ||| Gilead's HCV Drug Harvoni Approved in Two More Indications ||| The Stocks That Moved The S&P, Dow And Nasdaq Today",0,0.5012006
2016-02-18,11427500.0,89.5999984741211,90.9499969482422,88.93000030517578,88.98999786376953,77.46533966064453,GILD,"Why You Shouldn't Care If Your Portfolio Is Up Today ||| The Zacks Analyst Blog Highlights: Incyte, Intercept Pharma, Gilead, Aegerion and Clovis ||| Forget AbbVie Inc.: Here Are 2 Better Dividend Stocks",0,0.46332338
2016-02-19,12897800.0,88.19999694824219,88.9800033569336,87.12000274658203,87.44000244140625,76.1160888671875,GILD,"Agios' (AGIO) Q4 Loss Wider than Expected, Pipeline in Focus ||| Can Biotech Stocks Bounce Back?",1,0.4962482
2016-02-22,9749400.0,88.3499984741211,89.5,88.05000305175781,89.0999984741211,77.56110382080078,GILD,The Simple Way I Search for the Next Hit Stock ||| Is This the Company Gilead Sciences Should Fear Most? (Hint: It's Not Merck or AbbVie) ||| 5 Ways to Spot Awe-Inspiring Growth Stocks ||| Better Buy: Gilead Sciences Inc. vs. Amgen Inc. ||| A Look Back at 2 Successful Biotech Buyouts ||| Do Sky-High Drug Prices Turn Biotech Companies Into Bad Guys? ||| Gilead Launches New Grants Program to Support HIV Cure,0,0.47239006
2016-02-23,8394500.0,89.0999984741211,89.4000015258789,87.9000015258789,88.3499984741211,76.90824127197266,GILD,"Will Merck Encroach On Gilead's Harvoni Territory? ||| 8,383 Patients Contacted to Arrange Blood Test Following Possible Exposure to ex-NHS Worker with Hepatitis C -Sky News",1,0.5044142
2016-02-24,8338400.0,87.41000366210938,89.54000091552734,86.79000091552734,89.36000061035156,77.78743743896484,GILD,"Noteworthy ETF Inflows: XLV, PFE, GILD, AGN ||| How to Find Ethical Investments in the Pharmaceutical Industry ||| Gilead Offers New Preclinical Study Data Evaluating Investigational TLR7 Agonist in SIV-Infected Monkeys ||| Biotech Investors Shouldn't Fear Legislation, Even If Hillary Is President And Dems Win Senate Majority",1,0.50006956
2016-02-25,9171500.0,90.0,90.48999786376952,89.55000305175781,90.16000366210938,78.48382568359375,GILD,"Citi: Buy Celgene, Gilead, Biogen And Regeneron As Biotechs Recover ||| Citigroup Initiates Coverage on Gilead Sciences at Buy",0,0.50607777
2016-02-26,13349700.0,90.61000061035156,90.91999816894533,87.88999938964844,88.0999984741211,76.69062805175781,GILD,"Geron Q4 Loss In-Line with Estimates, Imetelstat in Focus ||| United Therapeutics Tops on 4Q Revenues, Earnings Up Y/Y ||| European CHMP Adopts Positive Opinion for Gilead's Fixed-Dose Combination Descovy for the Treatment of HIV",0,0.52057767
2016-02-29,12732500.0,87.87000274658203,89.13999938964844,87.25,87.25,75.95069122314453,GILD,Worry More or Worry Less? Global Week Ahead ||| 2 Drug Stocks To Buy For Safe Dividends And 20% Gains ||| 3 Mega Biotechs Leerink Loves ||| Health Canada Issues Notice Of Compliance for Gilead's Truvada for Reducing Risk of Sexually Acquired HIV Infection,1,0.497215
2016-03-01,11746100.0,87.9000015258789,89.72000122070312,87.30000305175781,89.69000244140625,78.07469177246094,GILD,"The Zacks Analyst Blog Highlights: Petrobras, Korea Electric Power, Taiwan's Chungwa Telecom, Gilead Sciences and Celgene ||| PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for March 02, 2016 ||| Forget Eli Lilly and Co: Here Are 2 Better Dividend Stocks ||| Gilead Reports FDA Approval of Second TAF-Based Single Tablet Regimen Odefsey for Treatment of HIV-1 Infection ||| Gilead's 'R&D Day' Points To Upside For Shareholders",0,0.45629153
2016-03-02,10557200.0,89.5999984741211,89.68000030517578,87.95999908447266,88.80000305175781,77.29996490478516,GILD,"Biotech Stock Roundup: Gilead HIV Drug Approved, Baxalta in Immuno-Oncology Deal",0,0.5077766
2016-03-03,12374600.0,89.12999725341797,89.30999755859375,87.4800033569336,87.83000183105469,76.45557403564453,GILD,"The Zacks Analyst Blog Highlights: Gilead, Amgen, Baxalta, PTC Therapeutics and Cara Therapeutics ||| Gilead Shares Fall to Low of $87.65 on Volume; May be Attributed to Insider Sales Filings ||| Leerink Positive On GILD Outlook, Likes Co's Substantial Cash Generation, Maintains Outperform And $125 PT ||| NY State AG Subpoenas Health Insurers Requesting Documents Explaining How Decide Which Hep C Drugs to Cover -Bloomberg",0,0.4943192
2016-03-04,21201900.0,88.30000305175781,89.0999984741211,86.8499984741211,87.20999908447266,75.9158706665039,GILD,"What Does Trump's Healthcare Plan Mean for Investors? ||| Gilead Sciences, Inc.: Short the Looming Value Trap in GILD Stock",1,0.4907234
2016-03-07,13100600.0,87.11000061035156,90.04000091552734,86.87999725341797,89.6500015258789,78.03987121582031,GILD,"Last Month's Best Healthcare ETF ||| Better Buy: Celgene Corporation vs. Gilead Sciences ||| Can Conatus (CNAT) Surprise Estimates in Q4 Earnings? ||| After Hours Most Active for Mar 7, 2016 : NJR, SDRL, FTSM, CLF, MOS, HBI, V, AMAT, BJRI, MSFT, GILD, QQQ ||| The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, Gilead Sciences, Biogen, Amgen and Regeneron Pharmaceuticals ||| Gilead Vs. Merck: What To Know ||| The 5 Most Notable Insider Sells Of The Week",0,0.48910442
2016-03-08,11056800.0,89.6500015258789,90.4000015258789,88.3499984741211,88.66000366210938,77.17808532714844,GILD,"3 Value Stocks Near 52-Week Lows Worth Buying ||| 3 Stocks to Hold Forever ||| Celldex Advised to Discontinue Phase III Study on Rintega ||| The Market In 5 Minutes: Tuesday, March 8, 2016 ||| Leerink Raises Gilead Target To $130 On New HIV Outlook",0,0.49552953
2016-03-09,10428100.0,88.94000244140625,89.25,87.43000030517578,87.83000183105469,76.45557403564453,GILD,"Sucampo Beats Earnings & Revenues on Strong Amitiza Sales ||| Merck KGaA's Q4 Earnings Down Y/Y, Offers 2016 Outlook ||| Is U.S. Demand for New Hepatitis C Drugs About to Explode?",1,0.50482976
2016-03-10,10884500.0,88.30000305175781,89.9000015258789,87.81999969482422,88.63999938964844,77.1606674194336,GILD,AbbVie Inc (ABBV) Is About to Steamroll the Competition ||| Factor Fun With This ETF,1,0.50474364
2016-03-11,10581000.0,89.97000122070312,89.9800033569336,88.80000305175781,89.6500015258789,78.03987121582031,GILD,"Biotech Investing Guide: 3 Stocks to Buy and 3 to Avoid ||| Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for March 14, 2016",1,0.4591575
2016-03-14,11004900.0,90.0,91.20999908447266,89.33999633789062,90.45999908447266,79.12448120117188,GILD,Gilead's Zydelig under EU Review amid Safety Concerns,0,0.53646207
2016-03-15,10265100.0,89.91999816894531,90.06999969482422,89.02999877929688,89.44000244140625,78.2322998046875,GILD,"Why Investors Should Sell These Biotech Stocks & Buy Gilead Instead ||| The Zacks Analyst Blog Highlights: Celgene, Gilead Sciences and Logitech International ||| Better To Short Biotech ETF Or To Invest In Inverse Counterpart? ||| 4 Large Caps to Navigate an Erratic Market ||| Gilead Shares Down 0.7% @$89.90 Pre-Market After Gilead Decided To Stop Zydelig Trials Due To Serious Adverse Events",1,0.48968434
2016-03-16,8860200.0,88.95999908447266,90.87999725341795,88.91000366210938,90.27999877929688,78.96703338623047,GILD,"Biotech Stock Roundup: GW Pharma Soars on Epidiolex Data, Gilead's Zydelig in Trouble? ||| Stock Market News for March 16, 2016",0,0.46180162
2016-03-17,10549300.0,89.79000091552734,90.37000274658205,88.80999755859375,89.52999877929688,78.31102752685547,GILD,"The Zacks Analyst Blog Highlights: GW Pharma, Orexigen, Gilead and Regeneron ||| A Rare Opportunity With A Biotechnology ETF",1,0.5259052
2016-03-18,16824300.0,90.0199966430664,90.7300033569336,89.54000091552734,90.2699966430664,78.95829772949219,GILD,"Do You Own Any Of These Top Sector Funds? ||| Gilead, Expedia Are Greatly Undervalued ||| Potent Value In This Large-Cap ETF",1,0.5070321
2016-03-21,9816900.0,90.0,93.01000213623048,90.0,92.66999816894533,81.05755615234375,GILD,3 Large-Cap Stocks With the Highest Net Profit Margins ||| Forget CVS Health Corp.: Here Are 2 Better Dividend Stocks,1,0.5118889
2016-03-22,9830800.0,92.13999938964844,93.95999908447266,92.0500030517578,93.72000122070312,81.97599792480469,GILD,"Wedbush Downgrades Infinity Pharma To Underperform, Slashes Target To $3",0,0.5057329
2016-03-23,13891900.0,90.95999908447266,92.22000122070312,89.97000122070312,90.08000183105467,78.7921142578125,GILD,"Jury Rules Merck Patents Valid…Bad For Gilead? ||| Gilead -2.5% Premarket Following Verdict Tuesday Validating Merck's Hep C Patents ||| Credit Suisse Maintains Outperform on Gilead Sciences, Lowers PT to $116.00",1,0.49310315
2016-03-24,14396500.0,89.61000061035156,92.81999969482422,89.44000244140625,91.31999969482422,79.87672424316406,GILD,"AbbVie Inc.'s Big Win Over Gilead Sciences Wasn't in Hepatitis C ||| After Hours Most Active for Mar 24, 2016 : BXLT, SPN, GE, QQQ, MSFT, SAN, AES, JD, PFE, QCOM, ATML, GILD ||| Gilead & Biogen's Patent Woes, Amgen Scores Win in Patent Litigation ||| An Attempt to Value Valeant Just for Fun ||| Patent Expert: It's Not Over For Gilead, Still Has Strong Defense Against Merck ||| Gilead, FedEx And Other Fast Money Picks For March 24",1,0.48594615
2016-03-28,9606800.0,92.06999969482422,94.30999755859376,91.94000244140624,92.45999908447266,80.87386322021484,GILD,"Patent Payoff? Merck's and Ionis Pharmaceuticals' Take Could Be Tiny ||| Gilead to Pay $200 Million to Merck for HCV Patent Dispute ||| Nasdaq 100 Movers: MU, MAR ||| A Snapshot of the 6 Cheapest Megacap Stocks ||| Buy These 5 Large Caps for Incredible ROI Potential ||| Data Shows Gilead's HCV Franchise Is Surviving New Competition",0,0.48881984
2016-03-29,8664500.0,92.19000244140624,92.23999786376952,90.61000061035156,92.1999969482422,80.6464614868164,GILD,"Markets Reverse Earlier Declines as Consumer, Tech Stocks Lead Gains But Falling Oil Price, Yellen Speech Limits Advance ||| The Zacks Analyst Blog Highlights: Accenture, Broadcom, Gilead Sciences, ULTA Salon, Cosmetics & Fragrance, and NetEase ||| 3 Biotech Stocks You Don't Have to Babysit ||| Close Update: Wall Street Gives Yellen's Speech Thumbs-Up ||| Health Care Sector Update for 03/29/2016: NVTA,CTRV,BPMX ||| Health Care Sector Update for 03/29/2016: PBYI,CTRV,GILD,BPMX ||| ContraVir Pharma Says Its CMX157 Outperformed Gilead's Drug in Trial",0,0.48297545
2016-03-30,8125200.0,92.47000122070312,93.56999969482422,91.55999755859376,91.97000122070312,80.44528198242188,GILD,3 Biotech Stocks That Make the Grade for Investors ||| 4 Value Stocks to Buy Now ||| 5 Value Stocks to Buy Now,0,0.52549297
2016-03-31,13656300.0,91.9000015258789,92.75,91.54000091552734,91.86000061035156,80.34904479980469,GILD,"Buying These 2 Drug Developers Would Make a Lot of Sense for Johnson & Johnson ||| Why Speculation Has Medivation Inc.'s Shares Soaring 20% Today ||| Health Care Sector Update for 03/31/2016: MDVN,AZN,GILD,AMGN,SNY,GNVA,LIFE ||| After Hours Most Active for Mar 31, 2016 : BAC, VG, GE, MSFT, GILD, QQQ, GRUB, FCX, PFE, AAPL, CSCO, INTC ||| IBM, Micron, Gilead: Fast Money Picks For March 31 ||| Gilead Submits NDA to Japan's Pharmaceutical and Medical Devices Agency for Tenofovir Alafenamide for Patients with Chronic Hepatitis B Infection",1,0.48344842
2016-04-01,11423000.0,91.33999633789062,94.37999725341795,91.04000091552734,94.12000274658205,82.32587432861328,GILD,"4 Best Biotech Stocks of the First Quarter of 2016 ||| The Zacks Analyst Blog Highlights: Gilead Sciences, Hewlett Packard Enterprise, Michael Kors Holdings, Xerox and Zimmer Biomet Holdings ||| Will Walgreens Boots (WBA) Q2 Earnings Surprise Investors? ||| Gilead Seeks Approval for Tenofovir Alafenamide in Japan ||| How Big of a Deal Are Gilead Sciences Patent Woes?",1,0.52443933
2016-04-04,8804800.0,94.3499984741211,95.0,93.75,94.23999786376952,82.4308090209961,GILD,"Patent Palooza: One Patent Battle in Hep C, And Another Patent Brawl Brewing On Capitol Hill ||| Gilead Sciences, Inc. (GILD) Buys Nimbus Therapeutics Subsidiary for $1.2B ||| Commit To Buy Gilead Sciences At $47.50, Earn 3.6% Using Options ||| 3 Biotech Stocks on the Verge of an Overdue Run (AMGN, GILD, REGN) ||| Better Buy: Gilead Sciences Inc. vs. Biogen Inc. ||| Gilead Sciences Acquires Nimbus Apollo for $400M ||| Gilead Announces FDA Has Approved Descovy ||| Gilead Reports Purchase of Nimbus Therapeutics' ACC Program for NAS, Other Liver Diseases; Made $400M Upfront Payment, Potential to Receive Added $800M in Development-Related Milestones Over Time",1,0.49668932
2016-04-05,11808600.0,93.5500030517578,96.69000244140624,93.5,95.56999969482422,83.59415435791016,GILD,"Forget Regeneron Pharmaceuticals, Inc.: These 2 Stocks Are Better Buys ||| 4 Great Stocks to Ride the IBB Rebound ||| Why Is Gilead Sciences (GILD) A Zacks Rank #1 Stock Right Now? ||| Gilead Descovy Wins FDA Nod, To Buy Nimbus Liver Program ||| BMO Capital Initiates Coverage on Gilead Sciences at Market Perform, Announces $102.00 PT",1,0.52314544
2016-04-06,11118800.0,95.48999786376952,97.5,95.4800033569336,97.44000244140624,85.2298355102539,GILD,"Gilead (GILD) is a Cheap Growth Stock Worth Buying Now ||| Notable ETF Outflow Detected - IWB, GILD, AMGN, SBUX ||| 5 Dividend Stocks Starting a Multi-Decade Bull Market ||| The Zacks Analyst Blog Highlights: Edwards Lifesciences, PRA Health Sciences, Gilead Sciences, AMAG Pharmaceuticals and Horizon Pharma ||| Biotech Stock Roundup: Gilead's HIV Drug Approved, Regeneron Up on Positive Data",0,0.4898891
2016-04-07,13333100.0,97.20999908447266,97.62999725341795,95.08999633789062,95.56999969482422,83.59415435791016,GILD,"3M (MMM): A Likely Winner Among Losers This Earnings Season? ||| The Zacks Analyst Blog Highlights: Gilead, Regeneron, Medivation and Intercept ||| How One Analyst Is Playing The Biotech Rebound This Week",1,0.5098307
2016-04-08,9722900.0,96.20999908447266,97.4499969482422,95.58000183105467,96.08999633789062,84.04898834228516,GILD,"Edwards Lifesciences Corp: EW Stock Is at the Heart of Innovation ||| The Zacks Analyst Blog Highlights: 3M, Canadian Pacific Railway, Edison International, CGI Group and Gilead Sciences ||| After Hours Most Active for Apr 8, 2016 : RIG, CIT, GE, SYMC, ESRX, INTC, GLW, PFE, GILD, CSCO, BRCD, WMT",0,0.4926563
2016-04-11,8796300.0,96.41000366210938,97.0500030517578,95.73999786376952,95.83000183105467,83.82158660888672,GILD,"After Nearly 39 Million Deaths, a Cure for HIV Could Be Just 3 Years Away ||| Weekly CEO Sells Highlight: Gilead Sciences, Boston Scientific, Sonic, HealthEquity",1,0.5050863
2016-04-12,9224800.0,96.0,97.4000015258789,95.5,97.23999786376952,85.05488586425781,GILD,"3 Biotech Stocks to Buy in April ||| TrovaGene Inks Strategic Partnership with Stratose, Stock Up ||| Cancer Drug Stocks Are The Picture Of Health ||| Baird: Gilead Set For Q1 EPS Miss, But Hep C Trends Still Good Long Term",0,0.50363046
2016-04-13,9299000.0,97.83999633789062,97.97000122070312,96.6500015258789,97.19000244140624,85.01116180419922,GILD,"Horizon Pharma Plunges on Bleak Q1 and 1H16 Guidance ||| Nasdaq 100 Movers: STX, JD ||| CorMedix (CRMD) Worth Watching: Stock Soars 19.9% ||| How ROE Can Ensure Big Gains While Picking Cash-Rich Stocks ||| Clovis Drops, FDA Panel Seeks More Data on Rociletinib ||| AbbVie's Venclexta Notches FDA Win, But Investors Might Want To Temper Enthusiasm ||| SunTrust: Medivation M&A Chatter Highlights Value, Company's 'Unique' Industry Position",1,0.5053412
2016-04-14,8743400.0,97.01000213623048,98.7699966430664,96.9000015258789,98.19000244140624,85.8858413696289,GILD,AbbVie Reveals Positive Data on Combination HCV Therapy ||| Merck Offers Positive Data from Comparative Trial on Zepatier ||| SPDR S&P 500 Growth ETF Experiences Big Inflow ||| Better Buy: Inovio Pharmaceuticals or Arrowhead Research Corp.?,1,0.50820476
2016-04-15,8910600.0,98.52999877929688,98.9800033569336,97.62000274658205,98.29000091552734,85.97331237792969,GILD,"Better Buy: Gilead Sciences Inc. vs. Celgene Corporation ||| Why Regulus Therapeutics Is Slumping 14% Today ||| Friday's ETF with Unusual Volume: IYH ||| Adam Feuerstein @adamfeuersteinTweet: Investor source (long $GILD) at EASL: ""$RGLS isn't going anywhere. This is the $GILD show. Literally half the posters are abt GILD's drugs."" ||| Gilead Sciences' Two Phase Three Trials Meet Primary Endpoints ||| Gilead Announces Two Phase 3 Studies Evaluating Tenofovir Alafenamide for Patients With Chronic Hep B Infection Both Met their Primary Endpoints of Non-inferiority to Gilead's Viread",1,0.48354033
2016-04-18,8067800.0,98.16999816894533,99.7300033569336,98.11000061035156,99.1999969482422,86.7692642211914,GILD,The Big Downside to Better Medicine? Higher Prices ||| Gilead Announces Multiple Scientific Presentations Demonstrating Broad Utility of Sofosbuvir-Based Hep C Therapies at ILC ||| Gilead Presents New Data Highlighting Progress in Liver Fibrosis at ILC ||| Will MS Franchise Sales Boost Biogen's (BIIB) 1Q Earnings? ||| What's in Store for Lam Research (LRCX) in Q3 Earnings? ||| Will Currency Woes Hurt Abbott Labs' (ABT) Q1 Earnings? ||| Top 4 Sales Growth Stocks ||| Gilead Presents Multiple HCV and HBV Data at Liver Congress ||| Illumina (ILMN): Stock Poised to Beat Q1 Earnings,1,0.4948317
2016-04-19,9811700.0,99.76000213623048,100.7300033569336,99.23999786376952,99.44000244140624,86.9792251586914,GILD,3 Biotech Stocks That Could Endure Hillary Clinton,1,0.540043
2016-04-20,8864100.0,99.3499984741211,100.95999908447266,99.3499984741211,100.11000061035156,87.56526184082031,GILD,"Healthcare ETFs to Buy on Blockbuster J&J Q1 Results ||| Biotech Stock Roundup: Medivation Buyout Rumors Resurface, Synta Up on Merger Deal",1,0.49096906
2016-04-21,9038200.0,99.9000015258789,101.83999633789062,99.9000015258789,101.73999786376952,88.9909896850586,GILD,"GILD Makes Bullish Cross Above Critical Moving Average ||| What Awaits Edwards Lifesciences (EW) in Q1 Earnings? ||| The Zacks Analyst Blog Highlights: Medivation, Synta, AbbVie, Gilead and Orexigen ||| Express Scripts (ESRX) Q1 Earnings: Stock to Disappoint? ||| 5 Stocks That Could Hike Their Dividends 20% ||| Epizyme (EPZM) Q1 Earnings: Can the Stock Surprise?",1,0.48422825
2016-04-22,10301900.0,101.55999755859376,102.4499969482422,100.5,101.93000030517578,89.15718078613281,GILD,"Will GNC Holdings' (GNC) Q1 Earnings Surprise Investors? ||| Can Hologic (HOLX) Pull a Surprise in Q2 Earnings? ||| After Hours Most Active for Apr 22, 2016 : GPN, GME, MSFT, BAC, HPY, GE, KO, PNK, QLIK, QCOM, GILD, INTC ||| 3 Stocks to Buy in a Crashing Market ||| Will Thermo Fisher (TMO) Exceed Q1 Earnings Expectations?",1,0.48638052
2016-04-25,8292300.0,101.83999633789062,102.37999725341795,101.5,102.29000091552734,89.4720687866211,GILD,"3 Things to Watch in Gilead Sciences, Inc.'s First-Quarter Results ||| 87% of Americans Want Medicare to Have This Power, but the Federal Government Disagrees ||| Are These 3 Biotechs Destined to Be Bought Out? ||| Healthcare Q1 Earnings Look Solid: ETFs to Benefit ||| Will Ametek (AME) Earnings Surpass Estimates in Q1? ||| Texas Instruments (TXN) Q1 Earnings: What Lies in Store? ||| Amgen (AMGN) May Beat Q1 Earnings: Will the Stock Gain? ||| Can Arrowhead Do For Hep B What Gilead Sciences Did For Hep C? ||| 5 Biotech Stocks to Bet on This Earnings Season ||| Sustainable Investing With A New ETF ||| Gilead Gets European Commission Marketing Authorization For HIV-1 Infection Drug ||| Gilead Announces European Commission Grants Marketing Authorization For 2 Doses Of Descovy For HIV Treatment",0,0.53405225
2016-04-26,9342600.0,102.0199966430664,103.0999984741211,101.01000213623048,101.33000183105467,88.63239288330078,GILD,"Henry Schein (HSIC) Q1 Earnings: Can the Stock Surprise? ||| Can athenahealth (ATHN) Pull a Surprise in Q1 Earnings? ||| UCB (UCBJF) Posts Q1 Results, Reiterates 2016 Guidance ||| Biotech Stock Gilead (GILD) Likely to Beat in Q1 Earnings ||| Myriad Genetics (MYGN) Q3 Earnings: A Beat in the Cards? ||| 7 Dividend Stocks With “Hidden” Yields ||| Perrigo's CEO Resigns, Trims 2016 Outlook, Stock Tumbles ||| Express Scripts (ESRX) Misses on Q1 Earnings, Lifts Outlook ||| Health Care Select Sector SPDR Fund Experiences Big Inflow ||| Credit Suisse Maintains Outperform on Gilead Sciences, Raises PT to $120.00 ||| Big Biotech In The Earnings Spotlight",0,0.4849091
2016-04-27,8585800.0,101.3000030517578,101.77999877929688,100.1500015258789,100.72000122070312,88.09881591796875,GILD,"4 Biotech Stocks Reporting on Apr 28: AMGN, GILD, ALXN, CELG ||| Aegerion (AEGR): Can the Stock Surprise in Q1 Earnings? ||| Aerie (AERI): Can the Stock Pull a Surprise in Q1 Earnings? ||| Biotech Stock Roundup: Biogen Tops on Q1 Earnings, Sarepta, Catalyst Plunge on Regulatory News ||| Amazon Earnings, GDP And Other Key Market Data For Thursday",0,0.51338387
2016-04-28,15680300.0,100.41000366210938,100.75,96.8000030517578,97.0,84.84495544433594,GILD,"Gilead Sciences (GILD) Stock Slumps on Q1 Earnings, Revenue Miss ||| 9 Figures That Sum Up Gilead Sciences' First Quarter ||| Q1 Earnings Reports Continue the Deluge: AMZN, GILD, AMGN ||| The Zacks Analyst Blog Highlights: Biogen, Sarepta, Catalyst Pharmaceuticals, AbbVie and Gilead ||| AbbVie (ABBV) Beats on 1Q Earnings, Lowers View on Deal ||| Will Vertex (VRTX) Stock Decline on 1Q Earnings Miss? ||| After-Hours Earnings Report for April 28, 2016 : AMZN, GILD, AMGN, BIDU, HIG, RSG, EXPE, ESS, BMRN, LNKD, SWKS, DLR ||| Earnings Reaction History: Gilead Sciences Inc., 50.0% Follow-Through Indicator, 3.3% Sensitive ||| After Hours Most Active for Apr 28, 2016 : QQQ, RSE, MSFT, AMZN, YHOO, AMX, AAPL, GILD, PHM, BAC, LNKD, XOM ||| LNKD Stock: STELLAR Q1 Earnings Redeem LinkedIn Corp ||| Sanofi's Bid for Medivation Is Too Low ||| 5 Best ROE Stocks to Beat Earnings Blues ||| Gilead Reaffirms FY16 Sales $30B-$31B vs $31.8B Est. ||| Gilead Sciences Reports Q1 Adj EPS $3.03 Vs Est $3.14, Sales $7.79B Vs Est $8.11B ||| Biotech Boom May Continue Through Earnings Season ||| Earnings Scheduled For April 28, 2016",0,0.50273544
2016-04-29,33629200.0,91.19000244140624,92.52999877929688,87.80000305175781,88.20999908447266,77.15644836425781,GILD,"RPT: U.S. Stocks Slump, Led by Healthcare and Technology ||| Chevron Corporation Continues Chasing a Moving Target in Oil (CVX) ||| Gilead Sciences, Inc. Reports Disappointing Q1 Harvoni Sales ||| 3 Drug Stocks Reporting Early Next Week: PFE, MYL, MNK ||| 2 Bullish Bets for Alibaba Group Holding Ltd (BABA) ||| The Zacks Analyst Blog Highlights: Broadcom, Kellogg, Altria Group, Gilead Sciences and Braskem ||| 3 Megatrends Powering the Growth Machine at Facebook Inc (FB) ||| The Motley Fool’s 10 Best Stock Calls of the Last 10 Years ||| 3 Stocks to Watch on Friday: Amgen, Inc. (AMGN), Gilead Sciences, Inc. (GILD) and TiVo, Inc. (TIVO) ||| Why Gilead Sciences, Inc. (GILD), Stericycle Inc (SRCL) and Western Digital Corp (WDC) Are 3 of Today’s Worst Stocks ||| Close Update: U.S. Stocks Head for Weekly Loss Amid Apple's Woes ||| U.S. Stocks Head for Weekly Loss Amid Apple's Woes ||| Daily Dividend Report: GILD, PFG, OXY, PX, K, HCN, PAYX ||| RPT - Mid-Day Update: U.S. Stocks Decline, Led by Technology and Healthcare Sectors After Weak Earnings ||| After-Hours Recap: April In Review, Friday Index Movers & After-Hours Runners ||| Gilead Says European CHMP Adopts Positive Opinion For Its Odefsey For Treating HIV ||| European CHMP Adopts Positive Opinion for Gilead's TAF-Based Single Tablet Regimen Odefsey for Treatment of HIV ||| 15 Stocks Moving In Friday's Pre-Market Session ||| Maxim Group Downgrades Gilead Sciences to Hold ||| 10 Stocks You Should Be Watching Today",1,0.49991345
2016-05-02,13524000.0,88.69999694824219,89.44999694824219,86.75,89.0,77.84746551513672,GILD,"3 Key Pipeline Developments for Gilead Investors to Watch ||| Barron's 500: America's Top Companies ||| Biotech ETFs Sink on Mixed Q1 Results ||| Novo Nordisk (NVO) Beats on Q1 Earnings, Retains Outlook ||| Stock Market News for May 02, 2016 ||| Good News: Gilead Sciences Discounted Its Drugs Again ||| ImmunoGen (IMGN) Posts Wider-than-Expected Q3 Loss ||| Trade of the Day: IBB Breaking Down ||| Shire (SHPG) Tops Q1 Earnings, Baxalta Buyout Set for June",0,0.52999413
2016-05-03,9881800.0,88.66999816894531,89.12000274658203,87.0,87.16999816894531,76.24676513671875,GILD,"This New Stock Market Trend Is Catching Investors By Surprise (but It Shouldn't) ||| Mallinckrodt (MNK) Tops Q2 Earnings and Sales, Ups View ||| Merrimack (MACK) Posts Narrower-than-Expected Loss in Q1 ||| Mylan Beats on Q1 Earnings, Revenues Lag, 2016 View Intact ||| Gilead Sciences Is Cannibalizing Its Own Sales, and Management Loves It ||| Aerie (AERI) Q1 Loss Wider than Expected, Pipeline in Focus ||| What Sent Medivation, Inc.'s Shares Soaring 25.1% In April ||| 5 Data Points Wall Street Is Anxiously Awaiting in Merck's Q1 Report ||| SurModics (SRDX) Beats Q2 Earnings & Revenues Estimates ||| The Next Sector Rotation Will Be To Biotechs",0,0.46915054
2016-05-04,12187800.0,86.66000366210938,86.98999786376953,85.41000366210938,85.5999984741211,74.87348175048828,GILD,"Better Buy: Gilead Sciences vs. Biogen ||| Drug Stocks Earnings Preview: GERN, RPRX, ICPT, AGIO & More ||| Health Care Select Sector SPDR Fund Experiences Big Inflow ||| Biotech Stock Roundup: Amgen Impresses, Gilead Disappoints in Q1, Biogen to Spin Off Hemophilia ||| 3 Dirt-Cheap Biotech Stocks To Buy ||| Jim Cramer Advises Viewers On Schlumberger, Gilead Sciences And Disney",1,0.49586573
2016-05-05,8035800.0,86.3499984741211,86.4000015258789,85.19999694824219,85.86000061035156,75.10091400146484,GILD,7 Figures That Sum Up Merck & Co.'s First Quarter,0,0.5187084
2016-05-06,9271300.0,85.66999816894531,85.83999633789062,84.04000091552734,84.68000030517578,74.06876373291016,GILD,"Drug Stocks' Earnings Previews: FGEN, IRWD, ENTA, FLML",1,0.49963188
2016-05-09,8469000.0,84.98999786376953,86.45999908447266,84.69999694824219,85.66999816894531,74.9347152709961,GILD,"Walt Disney Co (DIS) Stock: Short the Short-Term ||| Should You Buy Or Sell Gilead (GILD) Stock? 3 Pros, 3 Cons",1,0.48977295
2016-05-10,6840000.0,86.41000366210938,86.4800033569336,84.88999938964844,86.18000030517578,75.38081359863281,GILD,"Biotech Giant Gilead Sciences Goes on Sale ||| Drug Stocks Q1 Earnings Slated on May 11: ACRS, EARS & More ||| Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for May 11, 2016",0,0.44170636
2016-05-11,8445700.0,86.38999938964844,86.4000015258789,83.80999755859375,83.9000015258789,73.38653564453125,GILD,"Noteworthy ETF Outflows: XLV, UNH, GILD, AMGN",0,0.5088568
2016-05-12,12095700.0,84.0999984741211,84.30000305175781,81.69999694824219,82.76000213623047,72.3893814086914,GILD,"Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 13, 2016",0,0.44691432
2016-05-16,6508100.0,82.69999694824219,83.83000183105469,82.5,83.61000061035156,73.13285827636719,GILD,"13F From George Soros Shows New Stake In Gilead Sciences ||| Leon Cooperman Buys 227,000 Apple Shares, Adds More Microsoft",0,0.52059484
2016-05-17,8379200.0,83.5,83.73999786376953,82.44999694824219,82.76000213623047,72.3893814086914,GILD,Has A Biotech Recovery Started Yet?,1,0.53833747
2016-05-19,9272400.0,82.30999755859375,82.58999633789062,81.27999877929688,82.13999938964844,71.84705352783203,GILD,"XLV, UNH, GILD, AMGN: ETF Outflow Alert ||| 5 Reasons Arrowhead Pharma Is A Hepatitis B Leader",1,0.50309896
2016-05-20,7953000.0,82.16999816894531,83.08000183105469,82.06999969482422,82.63999938964844,72.28441619873047,GILD,"These 4 Value Stocks Are Collectively Generating $114 Billion in Free Cash Flow a Year ||| Friday's ETF with Unusual Volume: PBE ||| Biotech Stocks Show Signs Of Revival, But Beware Of Side Effects ||| Low Volatility ETFs For The Impatient Investor Are Latest Hot Trend",1,0.47368354
2016-05-23,7782700.0,83.0199966430664,84.02999877929688,82.25,83.33000183105469,72.887939453125,GILD,"Your 2016 Guide to Investing in Gilead Sciences Stock ||| Gilead Sciences, Inc. (GILD): Grab This Bargain While You Can",1,0.49286023
2016-05-24,13171300.0,83.77999877929688,86.44000244140625,83.70999908447266,86.22000122070312,75.41580963134766,GILD,"Notable Tuesday Option Activity: CYTR, GILD, CKEC ||| Gilead Names Kevin Young CBE COO",1,0.5090986
2016-05-25,11621400.0,86.80000305175781,87.0,85.69999694824219,86.51000213623047,75.66946411132812,GILD,"Billionaires Are Bailing on Gilead Sciences -- Should You, Too? ||| 3 Stocks the Market Loves to Hate, but You Should Love ||| After Hours Most Active for May 25, 2016 : FCX, YHOO, ETE, QQQ, JPM, SYMC, MCD, DOW, WFC, INTC, GILD, AAPL ||| Galapagos' RA Drug Filgotinib to Enter Phase III in 3Q16 ||| Benzinga's M&A Chatter for Wednesday May 25, 2016 ||| Celgene, Gilead Said to Bid for Medivation -Bloomberg",0,0.46145153
2016-05-26,8126000.0,86.44000244140625,86.5,85.05000305175781,85.29000091552734,74.60234832763672,GILD,Could Rally Cool Off Ahead Of Friday's GDP Data and Yellen Speech?,1,0.5336326
2016-05-27,6125900.0,85.81999969482422,86.0199966430664,85.19999694824219,85.81999969482422,75.06592559814453,GILD,"Notable ETF Inflow Detected - XLV, UNH, BMY, GILD ||| Interested in Medivation? Take a Number! ||| 3 Retirement Stocks to Buy in June ||| Gilead Gets European CHMP's Positive Opinion For Epclusa For All Genotypes of Chronic Hepatitis C Treatment ||| European CHMP Adopts Positive Opinion for Gilead's Epclusa for the Treatment of All Genotypes of Chronic Hepatitis C, Expects Target Action Date Under PDUFA Of June 28th, 2016",1,0.50054795
2016-05-31,12517800.0,86.4000015258789,87.2300033569336,86.05000305175781,87.05999755859375,76.15052795410156,GILD,3 Perfect Stocks for Baby Boomers in Their 50s to Consider Buying ||| Gilead's (GILD) New HCV Drug Epclusa Wins CHMP Backing ||| 5 Dividend Stocks to Buy in June ||| 10 Biotech Stocks With Symptoms of Strong Growth ||| Solid Potential For Gilead To Beat Estimates And Raise Guidance: Here's How,0,0.5450881
2016-06-01,7451800.0,87.2300033569336,87.30000305175781,86.30999755859375,86.58000183105469,75.730712890625,GILD,"PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for June 02, 2016 ||| Benzinga's Top Initiations ||| Gabelli & Co Initiates Coverage on Gilead Sciences at Buy",1,0.49473688
2016-06-06,8596700.0,86.16999816894531,87.87000274658203,86.0999984741211,87.5999984741211,76.62288665771484,GILD,"Is AbbVie's Stock Too Risky? ||| GuruFocus Best Idea Contest —…–6: Who Is Beating the Market ||| What's The Single Best $10,000 Investment To Hold For The Next 25 Years? ||| 7 Stocks to Buy in June ||| Forget Biogen: These 3 Stocks Are Better Buys ||| 3 Cheap Biotech Stocks You Can Buy Now ||| After Hours Most Active for Jun 6, 2016 : BAX, AMAT, WPX, SPLS, BABA, S, CSCO, STJ, GILD, PHM, TVIX, CMCSA ||| US Judge Rules Gilead Won't have to Pay $200M Jury Verdict to Merck in Hepatitis C Patent Dispute -Reuters ||| TD Ameritrade's IMX Growth Hits Record High In May: Check Out Clients' Picks & Pans ||| Gilead Shares Trading HOD, Seeing Sweep Action In The Weekly 87.5 Calls Expiring July 1",0,0.5006326
2016-06-07,7923800.0,87.54000091552734,88.23999786376953,86.9000015258789,87.5,76.53541564941406,GILD,"Legal Dispute Puts Ionis Pharmaceuticals' Payday on Hold ||| Merck Says Ruling Reversal in Gilead Case 'Doesn't Reflect the Facts,' Co. Will Appeal Ruling Overturn",0,0.50013316
2016-06-08,7331600.0,87.5199966430664,88.08999633789062,86.81999969482422,87.41999816894531,76.46542358398438,GILD,"Acadia Pharmaceuticals Inc.: 7 Companies That Could Buy ACAD ||| Gilead Shares Spiking, Traders Passing Around Comments Of Possible ValueAct Stake",0,0.49385637
2016-06-09,8083700.0,86.91999816894531,87.25,85.6500015258789,85.7699966430664,75.0221939086914,GILD,Why Galapagos NV Shares Soared 30.5% in May ||| Hold The Phone On Biotech,0,0.49994203
2016-06-13,8194100.0,84.02999877929688,84.80999755859375,83.9000015258789,83.9800033569336,73.45649719238281,GILD,"My Favorite Clinical-Stage Biotech Stocks to Buy ||| 3 Stocks That Are Ridiculously Cheap Right Now ||| Dividend Stocks Retirees Can Buy ||| Biogen And Gilead Sciences Buck Biotech Short Interest Trend ||| Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for June 14, 2016 ||| Gilead's HCV Franchise Erosion Here To Stay; Leerink Cuts Price Target",0,0.47312975
2016-06-14,7488700.0,83.5,84.55999755859375,82.7699966430664,83.56999969482422,73.50926971435547,GILD,"Noteworthy ETF Inflows: XLV, UNH, BMY, GILD ||| At William Blair Growth Conference, Gilead Says They Cured 2 People With Ebola Treated With GS-5734",0,0.51450634
2016-06-16,6172200.0,82.77999877929688,83.69999694824219,82.2300033569336,83.51000213623047,73.45650482177734,GILD,Arbutus Biopharma Taken Off Of Chardan's Sell List,0,0.49820238
2016-06-17,15951300.0,83.68000030517578,84.16999816894531,82.52999877929688,82.6500015258789,72.70002746582031,GILD,New Strong Sell Stocks for June 17th ||| ABBV Named A Top Socially Responsible Dividend Stock ||| 3 Reasons Gilead Sciences Is a Buy,1,0.49287778
2016-06-20,6951800.0,83.26000213623047,84.12000274658203,82.9000015258789,82.98999786376953,72.99910736083984,GILD,"2 Biotech Stocks That Could Raise Their Dividends -- and 1 That Won't ||| Gilead Sciences: Where's the Value? ||| The 3 Best Dividend Stocks for Beginning Investors ||| Gilead Reports Prelim. Data on Bictegravir, Says Now Being Evaluated in Phase 3 Studies",0,0.5088889
2016-06-21,8412000.0,83.3499984741211,83.44000244140625,81.43000030517578,81.79000091552734,71.94356536865234,GILD,Gilead Presents Favorable Preliminary Bictegravir HIV Data ||| New Strong Sell Stocks for June 21st ||| These 5 Biotech Stocks Are Ridiculously Cheap ||| Gilead Sciences Approaches Major Support Level,1,0.5239537
2016-06-22,10069600.0,81.55999755859375,83.79000091552734,81.55999755859375,82.44999694824219,72.52409362792969,GILD,"Corporate Share Buybacks Rise to Record Level in First Quarter ||| Noteworthy ETF Outflows: XLV, UNH, BMY, GILD ||| Can These Upstarts Knock Gilead Sciences Off Its Perch? ||| Biotechs Are Ripping Following IPAB Ruling",1,0.51734024
2016-06-23,5844000.0,83.29000091552734,83.58000183105469,82.54000091552734,83.37000274658203,73.33334350585938,GILD,"The 3 Most Important Data Releases and FDA Decisions in the Second Half of 2016 ||| Gilead Sciences Get European Commission Grant For Marketing Authorization Of Its Single Tablet Regimen Odefsey ||| As Buybacks Soar, Buyback ETF Tries To Get Its Groove Back ||| European Commission Grants Marketing Authorization for Gilead's Single Tablet Regimen Odefsey for the Treatment of HIV",0,0.52980876
2016-06-24,12438000.0,81.16999816894531,82.25,80.22000122070312,80.47000122070312,70.78247833251953,GILD,The iShares NASDAQ Biotechnology Index (IBB): Biotech Stocks Are Pushing for Recovery ||| Option Alert: SWEEP (BUY) - GILD July 8 $81 Call - 739 @ 1.559 in 18 orders. 753 traded. OI: 11,0,0.484275
2016-06-27,11724000.0,79.9000015258789,80.47000122070312,77.91999816894531,78.25,68.82974243164062,GILD,"Can Gilead Sciences Rebound in the Second Half of 2016? ||| 3 Biotech Stocks to Buy Now for the Long Haul ||| Regulus Therapeutics Inc. Clinical Hold: Should Investors Be Yellow-Bellied? ||| When Will Gilead Sciences, Celgene, and CVS Health Hit $100 Again?",1,0.4920971
2016-06-28,14751000.0,79.66999816894531,82.41999816894531,79.44999694824219,82.30999755859375,72.40097045898438,GILD,"Why Is Gilead Sciences (GILD) Stock Gaining Today? ||| This Leading Indicator Suggests the Stock Market May Be on the Precipice of Tumbling ||| The FDA Unsurprisingly Approves Gilead's New Hepatitis C Drug. Now What? ||| GILD Stock: FDA Greenlights Gilead Sciences, Inc. Hep-C Drug Epclusa ||| Instant Analysis: Gilead Sciences Wins an Important FDA Approval ||| Jefferies Sees Limited Impact To Gilead From Regulus' HCV Candidate's Clinical Hold ||| Gilead Shares Still Up Nearly 4% On News Of FDA Approval For Hepatitis C Drug ||| Gilead Rallies Off Epclusa Approval ||| Gilead Gets FDA Approval For Epclusa (Sofosbuvir/Velpatasvir) for All Genotypes Of Chronic Hepatitis C Treatment ||| Adam Feuerstein @adamfeuerstein Tweet: $GILD I'm surprised at the Epclusa WAC price of $74,760 — a lot lower than I expected. ||| FDA Approves Gilead's Epclusa for Treatment of Chronic Hepatitis C Virus Infection",0,0.4850463
2016-06-29,10452600.0,83.38999938964844,83.45999908447266,81.75,82.2699966430664,72.36576843261719,GILD,"How Much Will the Elections Affect Healthcare Stocks? ||| 3 Biotech Stocks to Buy on Sale Right Now ||| Top 6 Research Reports for June 29, 2016 ||| Biotech Stock Roundup: Gilead Gets FDA Nod for HCV Drug, Regulus Hit by Clinical Hold ||| Buying Nike, Gilead And PayPal: Fast Money Picks For June 29",1,0.49361154
2016-06-30,9706500.0,82.2699966430664,83.41999816894531,81.52999877929688,83.41999816894531,73.37733459472656,GILD,"Health Insurers: a Surprising Key to Drugmakers' Sucess ||| The Zacks Analyst Blog Highlights: Gilead, Regulus, AbbVie, The Medicines and GW Pharma ||| 3 Dividend Growth Stocks to Buy in July",1,0.51009786
2016-07-01,8336300.0,83.1500015258789,85.30000305175781,82.75,84.86000061035156,74.64397430419922,GILD,"10 Biotech And Specialty Pharma Bargains - Do You Have The Guts To Speculate? ||| Jim Cramer Shares His Thoughts On Gilead Sciences, Inc. And Citigroup Inc ||| Fast Money Traders Share Their Biotech Picks",0,0.5094491
2016-07-05,7621700.0,84.68000030517578,85.16000366210938,83.51000213623047,83.88999938964844,73.790771484375,GILD,"3 Issues That Every Healthcare Investor Should Consider ||| The Big Loser After Gilead's Latest Approval May Not Be Who You Think (Hint: It's not AbbVie, Inc.) ||| Gilead Sciences Stock Is Stupid Cheap ||| Agree To Purchase Gilead Sciences At $47.50, Earn 4.4% Using Options ||| These 3 Biotech Stocks Are Ridiculously Cheap Now",1,0.5299102
2016-07-07,6764500.0,85.9000015258789,86.26000213623047,84.7699966430664,85.47000122070312,75.1805419921875,GILD,"Stock Market News for July 07, 2016 ||| Non-GAAP Earnings Aren't The Solution",1,0.47499263
2016-07-08,7628800.0,85.95999908447266,86.94000244140625,85.7300033569336,86.55000305175781,76.1305160522461,GILD,Attention Investors: The P/E Ratio Revisited ||| Health Care Select Sector SPDR Fund Experiences Big Outflow ||| Ligand Reaches OmniAb Platform License Agreement with Gilead ||| Gilead Receives European Commission Marketing Authorization For Epclusa ||| Ligand Enters into OmniAb Platform License Agreement with Gilead Sciences ||| Gilead Announces European Commission Marketing Authorization For Epclusa For Hepatitis C,0,0.5277699
2016-07-11,7453900.0,86.55999755859375,87.2300033569336,86.08999633789062,86.25,75.86663818359375,GILD,"Like Conscious Capitalism? You'll Love These 3 Stocks ||| Ligand (LGND) Signs Deal with Gilead for OmniAb Technology ||| Gilead's Pan-Genotypic HCV Drug Epclusa Gains EU Approval ||| 3 Stocks With 50% More Post-Brexit Upside (BP, GSK, RBS) ||| Implied RDVY Analyst Target Price: $23",1,0.48627114
2016-07-12,7857700.0,86.81999969482422,87.30999755859375,86.4800033569336,86.62999725341797,76.20088195800781,GILD,Gilead Sciences' Latest Approval Is a Big Deal ||| 10 Stocks Cramer's Watching To See If The Market Rebound Is Sustainable,0,0.5065793
2016-07-13,8334400.0,86.70999908447266,87.08000183105469,85.72000122070312,85.75,75.42683410644531,GILD,"Why Investors Are Underestimating Gilead Sciences ||| Biotech Stock Roundup: Juno In and Out of Clinical Hold, Amgen Biosimilar Gets Panel Backing",0,0.48051512
2016-07-14,8104400.0,86.43000030517578,86.51000213623047,85.2699966430664,85.54000091552734,75.2420883178711,GILD,"How Much Do Stock Prices Matter in Biotech? ||| The Zacks Analyst Blog Highlights: Juno, Amgen, AbbVie, Gilead and CytRx ||| Gilead Receives Approval in Canada for Epclusa for Treatment of Chronic Hepatitis C",1,0.49945593
2016-07-15,11483300.0,85.66999816894531,87.95999908447266,85.54000091552734,86.66999816894531,76.23606872558594,GILD,Novartis (NVS) Likely to Beat Q2 Earnings: Stock to Gain? ||| Will UnitedHealth (UNH) Continue to Beat on Earnings in Q2? ||| Gilead's HCV Drug Epclusa Gets Regulatory Nod in Canada ||| Biogen (BIIB) Q2 Earnings: Will the Stock Disappoint? ||| J&J (JNJ) May Beat Q2 Earnings: Will the Stock Gain? ||| SWEEP (SELL) - GILD Sep $87.5 Put - 842 @ 3.801 in 37 orders. 907 traded. OI: 449,1,0.5101741
2016-07-18,6788300.0,86.94000244140625,87.33999633789062,86.47000122070312,86.93000030517578,76.46477508544922,GILD,"Barron's Picks And Pans: Madison Square Garden, Cigna, Kennedy-Wilson And More ||| Abbott Labs (ABT) Q2 Earnings: Will the Stock Surprise? ||| Is This Gilead Sciences' Most Underappreciated Drug Candidate? ||| Roche's Gazyva Fails in Phase III B-cell Lymphoma Study ||| TE Connectivity (TEL) Q3 Earnings: What's in the Cards?",0,0.4878099
2016-07-19,9832800.0,86.5,86.95999908447266,85.27999877929688,85.44000244140625,75.1541519165039,GILD,iShares Edge MSCI USA Quality Factor ETF Experiences Big Inflow ||| 5 Stocks with High ROE to Buy as Earnings Bells Chime ||| 3 Biotech Stocks to Buy and Hold ||| 5 Best Stocks For Value Investors This Week ||| Earnings Estimates for These 3 Biotech Giants Should Be Heading Lower -- Here's Why ||| Here Are The 14 Stocks Morgan Stanley Wants You To Focus On During Q2 Earnings,1,0.49533498
2016-07-20,9055900.0,85.45999908447266,87.12000274658203,85.0999984741211,86.66000366210938,76.2272720336914,GILD,"Can Stryker (SYK) Pull an Earnings Surprise this Season? ||| Better Buy: Gilead Sciences Inc. vs. Amgen Inc. ||| Biotech Stock Roundup: Celgene in Immuno-Oncology Deal, Zafgen Drops Lead Drug ||| Abbott (ABT) Beats on Earnings & Sales in Q2, Maintains View ||| Will Honeywell (HON) Pull a Surprise this Earnings Season? ||| Why Gilead Sciences (GILD) Might Surprise This Earnings Season",1,0.4895077
2016-07-21,9453400.0,87.16000366210938,87.83000183105469,86.30000305175781,87.23999786376953,76.73745727539062,GILD,"What's in Store for TransUnion (TRU) This Earnings Season? ||| Gilead Sciences, Inc.: 2 GILD Stock Trades for Earnings ||| Express Scripts (ESRX) Q2 Earnings: Stock to Disappoint? ||| Biogen (BIIB) Stock Up on Q2 Earnings Beat, Raised Outlook ||| Gilead (GILD) Stock Likely to Beat This Earnings Season ||| 3 Healthcare ETFs to Buy as JNJ Beats Q2 Earnings ||| Eli Lilly (LLY) May Beat Q2 Earnings: Will the Stock Gain? ||| Gilead's Odefsey Meets Primary 48-Week Objective in Two Phase 3b Studies",0,0.46554828
2016-07-22,7374700.0,87.31999969482422,87.44000244140625,86.31999969482422,86.55000305175781,76.1305160522461,GILD,"Medical Stocks Reporting Early Next Week: GILD, LLY & More ||| Can GoPro (GPRO) Spring a Surprise this Earnings Season? ||| Gilead Gets European CHMP's Positive Opinion On Its Type II Variation Application For Truvada ||| Gilead Sciences Reports Position Opinion from CHMP Related to Type II Variation App for Truvada for Reducing Risk of Sexually-Acquired HIV",1,0.50718844
2016-07-25,15718500.0,86.56999969482422,88.8499984741211,86.27999877929688,88.55000305175781,77.88973999023438,GILD,"I Just Bought These 4 Fast-Growing Biotech Stocks ||| 3 Stocks That Turned $10,000 Into $1 Million ||| 5 Reasons Biotech Stocks Are Smart Investments ||| Biotech In The Earnings Spotlight: Amgen, Celgene, Gilead Sciences ||| Scott Bauer's Gilead Sciences Trade ||| Gilead (GILD) Stock Falls on Sales Miss and Lower 2016 Revenues Guidance ||| Q2 Earnings After the Bell Monday: TXN, GILD, LVS ||| Roche (RHHBY) Misses on Q2 Revenues, New Launches in Focus ||| This Week Could Decide Whether Biotech ETFs' Rally Sizzles Or Fizzles ||| Why Gilead Sciences, Inc. (GILD), Netflix, Inc. (NFLX) and Sprint Corp (S) Are 3 of Today’s Best Stocks ||| After Hours Most Active for Jul 25, 2016 : GE, GILD, MDLZ, AA, AAPL, PFE, BAC, MSFT, AER, QQQ, FOXA, XOM ||| Earnings Reaction History: Gilead Sciences Inc., 60.0% Follow-Through Indicator, 3.9% Sensitive ||| Biotech Earnings Battle: Gilead (GILD) vs. Amgen (AMGN) ||| 4 Stocks Moving In Monday's After-Hours Session ||| After-Hours Losers: CRME down 14.91%, SANM 9.06%, GBR 4.50%, CMP 2.75%, GILD 3.67, CDNS 2.45%, FCCY 2.50% ||| Gilead Misses Revenue Estimates, Cuts Guidance ||| Gilead Shares Down 4.5% ||| Gilead Cuts FY16 Rev. From $30-$31B To $29.5-$30.5B ||| Gilead Sciences Cuts Sales Guidance ||| Gilead Reports Q2 EPS $3.08 vs. Est. $3.02, Rev. $7.776B vs. Est. $7.79B ||| Technical Alert - Gilead Sciences Testing Major Resistance Ahead Of Q2 Report ||| The Market In 5 Minutes: Yahoo, Outerwall Highlight Merger Monday ||| Earnings Scheduled For July 25, 2016 ||| 8 Stocks You Should Be Watching Today",0,0.4836366
2016-07-26,47371900.0,84.05000305175781,84.1500015258789,80.51000213623047,81.05000305175781,71.29264831542969,GILD,"Gilead Sciences, Inc. (GILD): Catch This Falling Knife NOW ||| Tuesday's ETF with Unusual Volume: DLN ||| Tuesday's ETF Movers: XME, BBH ||| iShares Silver Trust (ETF): A Golden Opportunity Beckons in SLV ||| S&P 500 Movers: CNC, TXN ||| Nasdaq 100 Movers: GILD, TXN ||| Gilead (GILD) Beats on Q2 Earnings, Cuts 2016 Sales View ||| The Zacks Analyst Blog Highlights: Texas Instruments, Gilead Sciences and Las Vegas Sands ||| Why Gilead Sciences, Inc. (GILD), Mobileye NV (MBLY) and Under Armour Inc (UA) Are 3 of Today’s Worst Stocks ||| Pre-Market Most Active for Jul 26, 2016 : SIRI, RDS/B, MBLY, AZN, FCX, NFLX, MCD, S, GILD, XIV, TXN, AAPL ||| 3 Stocks to Watch on Tuesday: Express Scripts Holding Company (ESRX), Las Vegas Sands Corp. (LVS) and Gilead Sciences, Inc. (GILD) ||| Jerome Dodson Comments on Gilead ||| After GILD Earnings, Which Biomed Stock is Best Right Now? ||| Harvoni Sales Declines Hurt Gilead Sciences Inc. in Q2 ||| Daily Dividend Report: IBM, GILD, COST, AEP, EXC, ETN, FIS ||| 3 Big Stock Charts for Tuesday: AbbVie Inc (ABBV), Gilead Sciences, Inc. (GILD) and Sprint Corp (S) ||| 15 Biggest Mid-Day Losers For Tuesday ||| Technical Alert - Gilead Sciences Falls Into Limited Support Zone After Q2 Report ||| Benzinga's Top Downgrades ||| The Market In 5 Minutes: Apple And Twitter And McDonald's, Oh My! ||| 15 Stocks Moving In Tuesday's Pre-Market Session ||| Needham Downgrades Gilead Sciences to Hold ||| Wait On The DNC Before Going Long Biotech ETFs ||| Keep an Eye on These 12 Stocks for July 26, 2016",1,0.48012984
2016-07-27,14103800.0,81.33999633789062,81.9800033569336,81.05999755859375,81.79000091552734,71.94356536865234,GILD,"The Drug-Price War Just Took a Big New Twist ||| Express Scripts (ESRX) Posts In-Line Earnings, Lags Revenues (Revised) ||| Biotech Stock Roundup: Biogen Q2 Results Impress, Gilead HCV Franchise Under Pressure ||| Wednesday’s Vital Data: Apple Inc. (AAPL), Twitter Inc (TWTR) and Gilead Sciences, Inc. (GILD) ||| Barclays Shares Its Thoughts On Gilead Sciences Post-Earnings",0,0.47926793
2016-07-28,13011000.0,81.94999694824219,81.9800033569336,80.62000274658203,81.23999786376953,71.45976257324219,GILD,"QUAL, GILD, MMM, PEG: ETF Outflow Alert ||| The Zacks Analyst Blog Highlights: Biogen, Gilead, AbbVie, Amgen and Celgene ||| Research Reports for Facebook, DuPont, Gilead & Others",0,0.4944375
2016-07-29,19465700.0,80.5999984741211,80.83999633789062,79.37000274658203,79.47000122070312,69.90284729003906,GILD,What Awaits ACUR & Other Drug Stocks this Earnings Season? ||| The Market In 5 Minutes: Amazon And Google Continue To Dominate ||| Argus Research Downgrades Gilead Sciences to Hold,1,0.50008565
2016-08-01,14758000.0,79.80999755859375,81.20999908447266,79.51000213623047,80.45999908447266,70.77366638183594,GILD,"Rapidly Rising Prescription Drug Costs Could Put Medicare on Life Support ||| 12 Big Pharma Stats That Will Blow You Away ||| Celgene Corporation: Why CELG Stock Could Top $200/Share ||| UPDATE: Free Cash-Flow For Bristol-Myers Squibb Has Been Negative For 2 Straight Quarters ||| UPDATE: In Early July Citigroup Said Gilead Would Not Seek Mega-Merger, Said Co Was Comfortable With 'their lean size' ||| Gilead Spikes to High; Hearing Unconfirmed Market Chatter Co Talking With BMY Regarding Merger ||| Jefferies Ponders Whether Gilead Sciences Should Experiment With An HCV Spinoff",0,0.510995
2016-08-02,13408200.0,80.9800033569336,81.19000244140625,79.44999694824219,79.56999969482422,69.9908218383789,GILD,"Drug Stocks to Watch for Earnings on Aug 3: ZTS, EXEL & More",1,0.504966
2016-08-04,9738300.0,80.20999908447266,80.62999725341797,79.55000305175781,79.7699966430664,70.16673278808594,GILD,"Drug Stocks' Earnings to Watch on Aug 5: PETX, DVAX & More",1,0.51039934
2016-08-05,10692300.0,80.19999694824219,80.66000366210938,79.86000061035156,80.41000366210938,70.72969818115234,GILD,"Ligand (LGND) Q2 Earnings Decline Y/Y, Maintains View ||| After Hours Most Active for Aug 5, 2016 : AAPL, BAC, MSFT, QQQ, GILD, FCX, NVDA, VZ, AAL, MRK, GM, PFE ||| Gilead Shares Indicated Higher, Up ~0.4%; BZ NOTE: Co. Was Discussed as a Possible Takeover Candidate for Bristol-Myers, as Recently as Aug. 1",0,0.4881523
2016-08-08,9511600.0,80.45999908447266,80.79000091552734,79.01000213623047,79.73999786376953,70.1403579711914,GILD,"Are Gilead Sciences' Best Days Behind It? ||| Noteworthy ETF Outflows: OEF, GILD, AGN, CELG ||| Licensing Agreements Drive Ligand Pharmaceuticals Inc. 13% Higher in July",0,0.49945167
2016-08-09,9578200.0,79.86000061035156,79.9000015258789,79.01000213623047,79.33000183105469,69.77972412109375,GILD,ETFs to Watch as Nasdaq Hits All-Time High,0,0.52000976
2016-08-10,12022200.0,79.43000030517578,79.58999633789062,78.44999694824219,78.9000015258789,69.40147399902344,GILD,"Gilead Sciences, Inc.: A Breakdown Looms for GILD Stock",1,0.50946224
2016-08-11,8454700.0,79.1500015258789,79.9800033569336,78.80000305175781,79.56999969482422,69.9908218383789,GILD,"The Implied Analyst 12-Month Target For QQXT ||| Gilead Shares Tick Lower; Traders Circulating Stat News Article ""IRS is urged to investigate Gilead for 'dodging' US taxes""",1,0.5120978
2016-08-12,8434000.0,79.33999633789062,79.7699966430664,78.87000274658203,79.66000366210938,70.06999969482422,GILD,"Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for August 15, 2016",0,0.44415948
2016-08-15,7464800.0,79.87999725341797,80.08999633789062,79.43000030517578,79.6500015258789,70.06118774414062,GILD,"Could Gilead Sciences Face an Unexpected $10 Billion Tax Bill? ||| 7 Battered Biotech Stocks to Buy ||| These 3 Hated Dividend Stocks Look Like Buys ||| 13F from Soros' Soros Fund Mgmt Shows Liquidated Positions in Apple, Netflix, Gilead, Gap, Synchrony Financial, United Continental ||| 13F from Cooperman's Omega Shows Liquidated Stake in Gilead",0,0.4949188
2016-08-16,7969900.0,79.56999969482422,79.80000305175781,79.23999786376953,79.25,69.70934295654297,GILD,4 Top Biotech Stocks That Can Be Purchased on the Cheap This Summer ||| The Least Popular Stocks This 13F Season,1,0.54007447
2016-08-17,10583800.0,79.45999908447266,80.87000274658203,79.30000305175781,80.69999694824219,70.98477935791016,GILD,"3 Cheap Stocks for Rookie Investors to Start With ||| UPDATE: Reuters Says Merck, Sanofi, Pfizer, Gilead, Celgene Have Each Submitted Expressions of Interest for Medivation",0,0.5258722
2016-08-19,8227900.0,80.55999755859375,81.18000030517578,80.2300033569336,81.0,71.2486572265625,GILD,"Noteworthy ETF Outflows: TQQQ, GILD, QCOM, CELG",0,0.51645815
2016-08-22,7522000.0,80.88999938964844,81.52999877929688,80.5999984741211,80.91999816894531,71.17829895019531,GILD,"3 Reasons Medivation Is the Juiciest Target in Biotech ||| Top Undervalued Stocks to Buy in 2016 ||| Benzinga's Weekend M&A Chatter ||| ETFs in Focus on Pfizer's Medivation Acquisition ||| Wall Street Breakfast: Pfizer To Buy Medivation For $14B ||| Here's Why a Gilead Stock Split Is Unlikely ||| Galapagos NV Reports Initiation of Global Phase 3 Program Investigating filgotinib In Rheumatoid Arthritis ||| European Commission Grants Marketing Authorization For Once-Daily Truvada To Reduce Risk Of Sexually Acquired HIV-1 ||| Must Watch Stocks for August 22, 2016",1,0.5100752
2016-08-23,8279400.0,81.45999908447266,81.63999938964844,81.0199966430664,81.47000122070312,71.6620864868164,GILD,Gilead (GILD) Truvada Gets EU Approval for Label Expansion ||| Galapagos (GLPG) Advances RA Drug Filgotinib to Phase III,0,0.5138449
2016-08-24,9699600.0,81.47000122070312,82.0999984741211,80.18000030517578,80.5,70.8088607788086,GILD,"Biotech Stock Roundup: Medivation to Pfizer, Clovis Priority Review ||| Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for August 25, 2016 ||| Why You Should (and Shouldn't) Buy Gilead Sciences, Inc.",0,0.48488754
2016-08-25,9220100.0,80.44999694824219,81.0,79.30000305175781,80.08000183105469,70.4394302368164,GILD,"After Hours Most Active for Aug 25, 2016 : ENS, MSFT, BAC, CLF, LMT, WNC, QQQ, WLL, FITB, GILD, URBN, EA ||| Mylan NV (MYL): Stop Rewarding Big Pharma Greed! ||| 3 Reasons Gilead Sciences Inc. Stock Could Fall",0,0.48022997
2016-08-26,8928000.0,80.11000061035156,80.33000183105469,79.2699966430664,79.7699966430664,70.16673278808594,GILD,3 Top Stocks to Buy for Your Children ||| 6 More Pharma Companies Selling Overpriced Drugs,0,0.52490544
2016-08-29,15383500.0,79.6500015258789,79.69999694824219,77.62999725341797,78.16999816894531,68.75935363769531,GILD,"Here Are All The Big Biotech Mergers In 2016 ||| Billionaire George Soros' Fund Dumped These 3 Biotech Holdings. Should You? ||| Noteworthy ETF Outflows: TQQQ, AMGN, KHC, GILD ||| Nasdaq 100 Movers: GILD, TMUS ||| Why Gilead Sciences, Inc. (GILD), Valeant Pharmaceuticals Intl Inc (VRX) and Core-Mark Holding Company, Inc. (CORE) Are 3 of Today’s Worst Stocks ||| Technical Alert: Gilead Sciences Makes New Low For Move And Attempts To Rebound",0,0.47281164
2016-08-30,9174200.0,78.05000305175781,78.38999938964844,77.66000366210938,77.91999816894531,68.5394515991211,GILD,"There’s More to Johnson & Johnson (JNJ) Than Meets the Eye ||| 2 Clinical-Stage Biotech Stocks to Buy ||| Looking Beyond Hepatitis C: Here's How Gilead Could Make Another $10 Billion Annually ||| Janney Initiates Galapagos At Buy, Sees Fair Value Of Shares At $64",1,0.5096489
2016-08-31,9758500.0,77.73999786376953,78.5999984741211,77.58000183105469,78.37999725341797,68.94408416748047,GILD,3 Beaten-Up Biotech Stocks: Are They Bargains?,0,0.51654214
2016-09-01,12403900.0,78.43000030517578,78.45999908447266,76.94000244140625,77.41999816894531,68.09965515136719,GILD,"Biotech Stock Roundup: Gilead in Patent Infringement Lawsuit, Enbrel Biosimilar Approved ||| Noteworthy Thursday Option Activity: MRK, GPS, GILD ||| 7 Deeply Underloved Blue-Chip Stocks to Buy Now",0,0.48035994
2016-09-02,7956200.0,77.62000274658203,77.76000213623047,76.66999816894531,76.88999938964844,67.63345336914062,GILD,"4 Cheap Dividend Growth Stocks to Buy (AVB, CMI, GILD, PSA)",1,0.511472
2016-09-06,11648400.0,77.77999877929688,78.29000091552734,77.25,77.87999725341797,68.50428009033203,GILD,3 Reasons Gilead Sciences Inc. Stock Could Rise ||| Drug Stocks Remain in Focus as Pricing Debate Continues ||| Gilead Sciences Inc.'s 5 Best Moves in 2016 So Far ||| Forget CVS Health Corporation: Here Are 3 Better Dividend Stocks ||| Dividends & Income Digest: Are You An 'Essentialist' Investor? ||| Benzinga's Top Upgrades ||| The Market In 5 Minutes: Stocks Return Higher From Three-Day Weekend ||| Jefferies Upgrades Gilead To Buy Citing Bullish Prospects For HIV Franchise ||| Jefferies Upgrades Gilead Sciences to Buy,1,0.51943827
2016-09-07,8232700.0,78.37999725341797,78.80999755859375,77.91999816894531,78.22000122070312,68.8033447265625,GILD,"Gilead Sciences, Inc. (GILD): Cheap Dividend Growth or Value Trap?",1,0.48414442
2016-09-08,8549600.0,78.33000183105469,79.13999938964844,77.5999984741211,78.98999786376953,69.48064422607422,GILD,"7 Good Stocks to Buy While They Are Down ||| Better Buy: Biogen Inc. vs. Gilead Sciences ||| 2 Stocks With Better Dividends Than CVS Health Corporation ||| Zeke Ashton Invests in –… New Holdings ||| Traders Attributing Strength in TESARO Shares to Comment from Gilead Exec Mgmt is 'Absolutely Willing' to Take Risk with Right PARP Product ||| Hearing Gilead Exec at Wells Fargo Healthcare Conference Has Said Mgmt is Feeling 'an Urgency to Do Deals,' But is Not Desperate",0,0.5088955
2016-09-09,10415200.0,78.45999908447266,79.0,78.05000305175781,78.05000305175781,68.65380096435547,GILD,The Perfect Defensive Stock For This ‘Joyless’ Bull Market (JNJ) ||| Hillary Clinton's New Prescription Drug Proposal Takes Aim at Valeant Pharmaceuticals and Mylan,1,0.5004966
2016-09-12,8896100.0,77.69000244140625,79.02999877929688,77.69000244140625,78.8499984741211,69.35749816894531,GILD,"Two Things You Must Understand About Biotech Investing ||| Is Clovis Oncology Still a Strong Buy? ||| Gilead Sciencs, Inc. a Takeover Target? It's Not as Crazy As It Sounds ||| Buy Gilead Sciences for a 42% Profit? What You Need to Know ||| Benzinga's Top Initiations ||| The Market In 5 Minutes: Hillary Clinton Falls Ill With The Global Stock Markets ||| Berenberg Initiates Coverage on Gilead Sciences at Buy",0,0.47542396
2016-09-13,9389600.0,78.66000366210938,78.66000366210938,77.5,78.05999755859375,68.66259002685547,GILD,"J&J Files for Single-Tablet Regimen of HIV Drug Prezista in EU ||| Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for September 14, 2016 ||| Billionaire Battleground: Is It Time to Buy or Sell Gilead Sciences? ||| Option Alert: GILD Jun 16 $72.5 Puts at the bid: 2000 @ 5.651 vs. Open Interest 136 ||| Recent Strength In TESARO Being Attributed To Gabelli Research Report Of Potential Gilead Interest In TESARO",0,0.50759953
2016-09-14,8311200.0,77.94000244140625,78.4000015258789,77.44000244140625,77.62000274658203,68.68916320800781,GILD,"New Oracle, Gilead Sciences & TOTAL Research Reports ||| Biotech Stock Roundup: Horizon-Raptor Acquisition Deal, Geron Down on Pipeline News ||| Inside the Recent Surge in Biotech ETFs ||| Credit Suisse Cuts Gilead Price Target To $95 ||| 7 Biggest Price Target Changes For Wednesday ||| The Market In 5 Minutes: Huge FDA News, Major Mid-Week M&A ||| Can You Guess This Chart? ||| Watch These 7 Huge Put Purchases In Wednesday Trade",1,0.50172573
2016-09-15,10112800.0,77.75,79.19999694824219,77.2699966430664,78.83999633789062,69.76876831054688,GILD,"The Zacks Analyst Blog Highlights: TOTAL, Oracle and Gilead Sciences ||| Adam Feuerstein @adamfeuerstein $GILD Drug Pipeline, Maligned by Investors is Still Packed with Q4 Clinical Trial Readouts thestreet.com/story/13741594… 9 clinical trials in Q4. ||| Adam Feuerstein Tweets: $GILD Drug Pipeline, Maligned by Investors, is Still Packed with Q4 Clinical Trial Readouts thestreet.com/story/13741594… 9 clinical trials in Q4.",0,0.4842806
2016-09-16,10307900.0,78.8499984741211,79.19000244140625,78.41000366210938,78.80000305175781,69.73338317871094,GILD,5 Undervalued Stocks to Buy for Enterprising Value Investors ||| TESARO Shares Trading Up ~2% in Otherwise Down Tape on No News; Some Traders Getting Anxious Following News of Gilead $5B Senior Notes Offering Announced Thurs. Evening,1,0.5125881
2016-09-19,7234200.0,78.91999816894531,79.51000213623047,78.80999755859375,78.98999786376953,69.90151977539062,GILD,"How Risky Is Gilead Sciences Inc.? ||| Noteworthy ETF Outflows: XLV, MDT, GILD, ABBV",1,0.48450565
2016-09-20,17560700.0,79.63999938964844,82.06999969482422,79.62999725341797,81.77999877929688,72.37051391601562,GILD,"How Safe Is Gilead Sciences Inc. and Its Dividend? ||| After Hours Most Active for Sep 20, 2016 : GILD, HPQ, QQQ, CSCO, SYMC, INTC, YHOO, VZ, HES, EVHC, BAC, POT ||| After Hours Most Active for Sep 20, 2016 : GILD, HPQ, QQQ, CSCO, SYMC, INTC, VZ, YHOO, HES, EVHC, POT, PG ||| Technical Alert: Gilead Sciences Tests Resistance At $82 Area ||| NASH Sympathy Plays On Tobira Therapeutics Deal ||| The 5 Top-Selling Drugs In The World",0,0.47173005
2016-09-21,13628800.0,82.02999877929688,82.05000305175781,80.66000366210938,81.69999694824219,72.2997055053711,GILD,"Stock Market News for September 21, 2016 ||| Trade of the Day: iShares Nasdaq Biotechnology Index (ETF) (IBB) Is Turning Things Around ||| Allergan Buys NASH Therapy Maker Tobira at Huge Premium ||| Gilead Reports Termination of Phase 2/3 Study of GS-5745 in Patients Ulcerative Colitis ||| The Street's Adam Feuerstein Tweets: $AGN ($94B) is not buying $GILD ($107B) Please shut up. ||| Allergan Going After Gilead? Gabelli Says CEO 'Playing Chess While The Market Is Playing Checkers' ||| Traders Highlighting Barron's Article On Gabelli Note Speculating Allergan Possibly Preparing Bid For Gilead ||| Allergan's Tobira Acquisition Represents The Highest Premium Ever Paid In Biopharma",0,0.4951324
2016-09-22,8213800.0,81.97000122070312,82.0,80.9000015258789,81.5199966430664,72.14042663574219,GILD,The Pros and Cons of Buying Gilead Sciences Stock ||| Is Galectin The Next Takeover Target for the Biotech World? ||| Gilead Sciences Inc.'s Biggest Win in 2016 So Far ||| Gilead Valuation Only Minimally Effected By Drug Trial Stoppage ||| Will Allergan Buy Gilead? Don't Count On 'The Mother Of All Blockbusters' ||| Benzinga's Top Initiations ||| The Market In 5 Minutes: No Interest Rate Hike...Yet ||| Berenberg Initiates Coverage on Gilead Sciences at Buy ||| Can You Guess This Chart?,0,0.50820595
2016-09-23,7534500.0,81.55000305175781,82.0,81.22000122070312,81.37000274658203,72.0076904296875,GILD,"The Cheapest Stocks in Biotech ||| Sell Twitter, Buy Gilead And More Fast Money Picks For September 23 ||| Cramer Advises His Viewers On Gilead Sciences And Monsanto",0,0.48234802
2016-09-26,9036000.0,81.0,81.12999725341797,79.91999816894531,80.62000274658203,71.34398651123047,GILD,"Is This Tiny Company the Best Pharmacy Stock to Buy? ||| 3 Dirt-Cheap Dividend Stocks You Can Buy Right Now ||| The Zacks Analyst Blog Highlights: Deutsche Bank, Apple, Therapeutics, Allergan and Gilead Sciences ||| Incyte Could Be A Takeover Target, Argus Lifts Price Target To $98",0,0.5078885
2016-09-27,13214300.0,79.31999969482422,79.9000015258789,78.63999938964844,79.25,70.1316146850586,GILD,"XLV, AMGN, MDT, GILD: ETF Inflow Alert ||| Why Cash Is King for Biotech Stocks ||| Nasdaq 100 Movers: GILD, NCLH ||| 5 Safe Stocks to Buy Today ||| Tuesday's ETF with Unusual Volume: IWY ||| Gilead Sciences, WHO Report 5 Year Leishmaniasis Partnership ||| Galapagos Reports Successful Completion Of Discussions With US And European Authorities To Initiate Phase 3 Crohn's Disease Study ||| 15 Biggest Mid-Day Losers For Tuesday ||| The Drug Price Increase Debate: Separating The Winners From The Losers ||| The Market In 5 Minutes: Debates, Oil Keep Stocks Mixed ||| Benzinga's Top Downgrades ||| Leerink Swann Downgrades Gilead Sciences to Market Perform",0,0.47702065
2016-09-28,6854100.0,79.12000274658203,79.5,78.51000213623047,78.97000122070312,69.88384246826172,GILD,"Biotech Stock Roundup: Amgen's Kyprolis Disappoints, Array Up on Cancer Data ||| Gilead, Bank Of America, Costco: Fast Money Picks For September 28",0,0.45574802
2016-09-29,7618600.0,79.16000366210938,79.33999633789062,77.75,77.86000061035156,68.90155792236328,GILD,Nonalcoholic Steatohepatitis: What's The Market Opportunity And Who Are The Major Players? ||| Nonalcoholic Steatohepatitis (NASH): What's The Market Opportunity And Who Are The Major Players?,1,0.4877436
2016-09-30,11031500.0,78.05999755859375,79.62999725341797,78.05000305175781,79.12000274658203,70.01657104492188,GILD,"Hey Gilead, It's Time to Start Looking Over Your Shoulder in Hepatitis C",0,0.5098932
2016-10-03,10626200.0,78.62999725341797,78.97000122070312,77.25,78.02999877929688,69.0519790649414,GILD,"Nasdaq 100 Movers: NTAP, CTSH ||| Gilead Sciences' Pain Is Celgene's Gain ||| 7 Stocks That Could Be Bought Next",0,0.47663942
2016-10-04,8219400.0,77.5999984741211,78.41999816894531,77.12000274658203,77.23999786376953,68.35287475585938,GILD,"How To YieldBoost GILD To 8.2% Using Options ||| Nope, Gilead Sciences Won’t Get Bought out",1,0.4923719
2016-10-05,7910200.0,77.3499984741211,78.0,77.19999694824219,77.56999969482422,68.6448974609375,GILD,"Biotech Stock Roundup: Summit Soars on Sarepta Deal, Regeneron Presents Data ||| FDA Issues Warning on Hepatitis C Drugs",0,0.50491565
2016-10-07,11149200.0,76.44999694824219,76.4800033569336,74.91999816894531,75.23999786376953,66.58299255371094,GILD,Steven Cohen Increases Position in Dynavax ||| Technical Alert: Gilead Sciences Makes New Low For Move,1,0.5177512
2016-10-10,7161100.0,75.5,75.97000122070312,75.26000213623047,75.48999786376953,66.80422973632812,GILD,"The Big Reason You Shouldn't Give Up on Big-Cap Biotech ||| Will Gilead Sciences Inc. Set Its Sights on Incyte? ||| After Hours Most Active for Oct 10, 2016 : MU, PG, QQQ, TWTR, FB, YHOO, QCOM, CPN, GILD, KO, OLN, MTG",0,0.48499203
2016-10-11,11910000.0,75.13999938964844,75.27999877929688,73.55999755859375,73.81999969482422,65.32637023925781,GILD,Merck's New Products and Solid Pipeline As Growth Drivers ||| 7 Stocks the 2016 Presidential Candidates Have Called Out By Name ||| Technical Alert: Gilead Sciences Lower For Fourth Day In A Row,0,0.48800653
2016-10-12,10014500.0,74.18000030517578,74.20999908447266,72.91999816894531,73.02999877929688,64.62728118896484,GILD,"Gilead Sciences, Inc. Is More Than an HCV Play (GILD) ||| Theravance Biopharma's Valuation Has Gotten A Little Carried Away ||| Analysts Share Their Low Forward P/E Picks",1,0.4866517
2016-10-13,10586100.0,72.29000091552734,73.93000030517578,72.20999908447266,73.05999755859375,64.65381622314453,GILD,ContraVir Pharmaceuticals Stock Jumps on Positive Results From Hepatitis B-Drug Trial,0,0.52475244
2016-10-14,7359100.0,73.2699966430664,73.5,72.7300033569336,72.75,64.37950134277344,GILD,Any Bank Stocks You Can Trust? ||| Option Alert: GILD May $65 Put; 1100 @Bid @$3.40 vs 275 OI,0,0.47338447
2016-10-17,8181400.0,72.54000091552734,73.45999908447266,72.30999755859375,72.63999938964844,64.2821273803711,GILD,"3 Top Bargain Stocks to Buy Today ||| Notable ETF Inflow Detected - IVW, DIS, GILD, MA ||| 3 Top Stocks to Buy for Your Grandchildren's Benefit ||| 20-Week Data From Filogtinib Phase 2 ""Fitzroy"" STudy In Crohn's Disease Expected To Be Presented During United European Gastroenterology Week ||| Watch These 5 Huge Put Purchases In Monday Trade",1,0.53344315
2016-10-18,6353500.0,73.4000015258789,73.83000183105469,72.91000366210938,73.41000366210938,64.96356201171875,GILD,"Better Buy: Biogen Inc. vs. Gilead Sciences, Inc. ||| Exclusive: SunTrust Top Analysts Explain Fatty Liver Diseases, Galmed's Potential In The Space",0,0.51242673
2016-10-19,6326400.0,73.5,73.91999816894531,73.30999755859375,73.33999633789062,64.90159606933594,GILD,41 Billion Reasons Why Gilead Sciences Might Need New Management,1,0.5180611
2016-10-20,10351400.0,73.13999938964844,74.80999755859375,73.0999984741211,74.30999755859375,65.76000213623047,GILD,"Nothing Can Stop Merck & Co., Inc. (MRK) Stock Now ||| Better Buy: Pfizer Inc. vs. GlaxoSmithKline plc ||| Gilead Announces SVR12 Rates From Four Phase 3 Studies of a Once-Daily, Fixed-Dose Combination of Sofosbuvir, Velpatasvir and Voxilaprevir in Treatment-Naïve and Treatment-Experienced Genotype 1-6 Chronic HCV-Infected Patients ||| UPDATE: Gilead Says Separate Phase 2 Study of Selonsertib Did Not Meet Primary Endpoint for PAH or DKD; Gilead Will Not Pursue Phase 3 Studies for PAH or DKD at This Time ||| UPDATE: Gilead Says Selonsertib Showed 'Anti-Fibrotic Activity in Open-Label Phase 2 NASH Study; Data Support Plans to Advance GS-4997 into Phase 3 Clinical Trials' ||| Gilead Reports Top-Line Phase 2 Results from Selonsertib in NASH, PAH, DKD",0,0.50522137
2016-10-21,8256500.0,74.0999984741211,74.94000244140625,73.77999877929688,74.29000091552734,65.7423095703125,GILD,Best And Worst Biotech ETFs Of 2016 Tell A Tale About This Industry,0,0.49766785
2016-10-24,7404000.0,74.51000213623047,74.77999877929688,73.73999786376953,74.1500015258789,65.618408203125,GILD,Healthcare ETFs: Gain or Pain Ahead in Q3 Earnings? ||| Gilead Reports FTC/TAF-Based Regimens Demonstrate Comparable Efficacy and Improved Renal and Bone Laboratory Parameters Compared to Truvada,1,0.5192019
2016-10-25,6140800.0,74.04000091552734,74.68000030517578,73.91000366210938,74.41000366210938,65.8484878540039,GILD,"IVW, DIS, MA, GILD: ETF Inflow Alert ||| 4 Top Drug Stocks That Can Be Purchased on the Cheap This Fall ||| Jefferies Says Gilead's 4997 Data Is Impressive, Underappreciated",1,0.49743015
2016-10-26,8333000.0,74.51000213623047,75.80000305175781,74.26000213623047,75.37999725341797,66.7068862915039,GILD,"Global Blood Therapeutics: Incredible Value At This Price ||| Biotech Stock Roundup: Clinical Holds Hit Inovio & Aduro, Vertex Q3 Results Miss Estimates ||| 3 Key Questions for Gilead Sciences, Inc. in Q3 ||| Option Alert: GILD Feb17 82.5 Calls: 3530 @ Above Ask! $2.00: 4948 traded vs 774 OI: Earnings 11/1 After Close $75.25 Ref",1,0.5076091
2016-10-27,9596400.0,75.93000030517578,76.36000061035156,75.63999938964844,75.83000183105469,67.1051025390625,GILD,"Which Of The Latest 13F Filers Holds Gilead Sciences? ||| Better Buy: Gilead Sciences Inc. vs. Johnson & Johnson ||| Noteworthy Thursday Option Activity: GILD, JPM, HD",0,0.4794214
2016-10-28,13160000.0,74.75,74.77999877929688,73.2300033569336,73.87999725341797,65.37947845458984,GILD,2 Reasons Celgene Corporation's Future Just Got Brighter ||| AbbVie's Viekira Pak Sales Plummet in Q3,0,0.5262237
2016-10-31,8457000.0,74.08999633789062,74.44000244140625,73.55000305175781,73.62999725341797,65.15824127197266,GILD,"Unfazed by FDA Warning, Gilead Sciences' Stock Could Be Turning a Corner ||| 3 Things AbbVie's Management Said While Its Stock Got Hammered ||| These Companies Make Millions Per Employee — And Yield Up To 13% ||| $40 Billion Opportunity: 3 Biotechs Poised to Dominate ||| Genetic Stocks to Watch for Earnings on Nov 1: GILD & More ||| Your Two Minute Earnings Preview for Gilead (GILD) Stock ||| 9 Shiny New Dividend Stocks You Can Trust in the Long Run",1,0.503715
2016-11-01,10741600.0,73.62999725341797,74.29000091552734,73.05999755859375,74.06999969482422,65.54761505126953,GILD,"AbbVie's Stock Is Suffering From a Lack of Diversification ||| Why We're Right to Invest in Gilead Sciences Stock ||| Gilead (GILD) Misses Q3 Earnings, Reiterates 2016 Guidance ||| After Hours Most Active for Nov 1, 2016 : YUMC, QCP, AA, GES, BAC, CSCO, PFE, AAPL, INTC, MENT, MSFT, GILD ||| The 3 Best Stocks to Buy Before Nov. 8 ||| Earnings Reaction History: Gilead Sciences Inc., 60.0% Follow-Through Indicator, 4.2% Sensitive ||| After-Hours Earnings Report for November 1, 2016 : GILD, PXD, EIX, EA, ILMN, DVN, CERN, ES, FLT, NBL, SBAC, VRSK ||| Adam Feuerstein @adamfeuerstein Tweet: Summary of analyst reaction to $GILD quarter: ""Whew, they didn't guide down again."" Sad to say, but that is a positive. ||| Gilead Ticks Lower On Earnings Miss ||| Gilead Reports Q3 Adj. EPS $2.75 vs $2.86 Est., Sales $7.5B vs $7.45B Est. ||| ContraVir CEO Talks Hep. B Treatment's Future ||| Nerves Start To Fray Ahead Of Election As Investors Scramble For Protection ||| The Election Can't Come Soon Enough For Biotechs ||| Earnings Scheduled For November 1, 2016 ||| Keep an Eye on These 10 Stocks for November 1, 2016",0,0.47838148
2016-11-02,14620000.0,74.0,74.3499984741211,72.44999694824219,72.51000213623047,64.1671142578125,GILD,"Gilead (GILD) Misses Q3 Earnings Estimates, Retains View ||| 3 Stocks to Watch on Wednesday: Square Inc (SQ), Gilead Sciences, Inc. (GILD) and Electronic Arts Inc. (EA) ||| Gilead Sciences Inc. Hepatitis C Sales Sink Again in Q3 ||| Drug Stocks Q3 Earnings Roster for Nov 3; ICPT, EXEL, AKRX ||| Gilead's Q3 Bombshell: No More Hepatitis C R&D ||| Near-Term Headwinds And Long-Term Promise For Gilead Sciences ||| Gilead Sciences Price Target Trimmed Following A Sobering Q3 ||| Benzinga's Top Upgrades ||| The Market In 5 Minutes: Alibaba, Brocade And A Game 6 ||| BMO Capital Upgrades Gilead Sciences, Inc. - Common Stock to Outperform ||| 12 Stocks You Should Be Watching Today",0,0.49918896
2016-11-03,9286200.0,72.33000183105469,72.93000030517578,71.68000030517578,71.76000213623047,63.50337600708008,GILD,"Noteworthy ETF Inflows: VUG, PM, ORCL, GILD ||| Company News for November 03, 2016 ||| Drug Stocks to Watch for Earnings on Nov 4; REGN & More ||| Thursday’s Vital Data: Facebook Inc (FB), Alibaba Group Holdings Ltd (BABA) and Gilead Sciences, Inc. (GILD) ||| 5 Things Gilead Sciences' Management Said After Its Earnings Plummet ||| Why Celgene Corp Is a Better Buy Than Gilead Sciences",1,0.4768936
2016-11-04,11779500.0,71.5199966430664,73.29000091552734,71.38999938964844,72.43000030517578,64.09629821777344,GILD,"Drug Stocks Earnings Roster for Nov 7: HZNP, ACAD & More ||| After Hours Most Active for Nov 4, 2016 : GLW, BAC, BHI, AKS, EVDY, GE, MSFT, CTSH, TXN, AAPL, QCOM, GILD ||| Friday's ETF with Unusual Volume: BBH ||| Gilead Shares Spike to Session Highs as Traders Passing Around Vague, Unconfirmed Chatter in Name; Shares Up 2% for Session",1,0.47448197
2016-11-07,9513500.0,73.4800033569336,74.70999908447266,73.05000305175781,74.0,65.48567199707031,GILD,"3 Best Biotech Stocks of the 21st Century (So Far) ||| Zacks Industry Outlook Highlights: Amgen, Vertex, Valeant Pharmaceuticals International, Mylan N.V. and Gilead Sciences ||| Top Research Reports for Exxon, Duke & Gilead ||| 2 Reasons Why the iShares NASDAQ Biotechnology Index (ETF) Tumbled 11% in October ||| 3 Best Healthcare Stocks to Buy Now",1,0.5202304
2016-11-08,7449600.0,73.93000030517578,74.66000366210938,73.29000091552734,74.04000091552734,65.52107238769531,GILD,"The Zacks Analyst Blog Highlights: ExxonMobil, Gilead, Duke Energy, NVIDIA and Monster Beverage ||| Why Gilead Sciences Shares Fell 7% in October ||| Biotech ETFs Slumping on Q3 Results ||| UPDATE: Jefferies Comments on Gilead: 'ALXN's actions interpreted by some as suggesting they are in play.'; BZ NOTE: Note is Focused on Gilead, Not Necessarily Alexion; Jefferies Maintains Gilead is 'Undervalued' ||| UPDATE: Jefferies Note Highlighting Gilead for Alexion Titled 'Another Look At Our Hypothetical M&A Scenario Analysis' ||| Hearing Jefferies Defending Alexion, Says Gilead Could Buy Co. ||| The Market In 5 Minutes: Election Day Has Finally Arrived ||| Mizuho Initiates Coverage On Gilead Sciences, Inc. - Common Stock at Buy, Announces $88.00",1,0.50504947
2016-11-09,26693700.0,76.80000305175781,80.0,76.75,78.47000122070312,69.44135284423828,GILD,"How a Donald Trump Presidency Could Affect Biotech Stocks ||| Is a Donald Trump Presidency a Black Swan Event for Pharma Stocks? ||| Drug Stocks Q3 Earnings Roster for Nov 10: AVXS, GBT & BPMC ||| Biotech Stock Roundup: Ionis Soars on Spinraza Data, Regeneron's Q3 Results Mixed ||| Better Buy: Gilead Sciences Inc. vs. Pfizer Inc. ||| Wednesday's Loser: Hospital Stocks ||| Biotech Is Getting A Big Boost Following Clinton's Loss",0,0.5017612
2016-11-10,16651800.0,79.66000366210938,80.0,76.94000244140625,77.83999633789062,68.88383483886719,GILD,"XLV, JNJ, GILD, BIIB: ETF Inflow Alert ||| Peek Into Drug Stocks' Q3 Earnings on Nov 11: XBIT & REPH ||| U.S. Food and Drug Administration Approves Gilead's Vemlidy for the Treatment of Chronic Hepatitis B Virus Infection",0,0.5105852
2016-11-11,12949600.0,77.4800033569336,77.51000213623047,75.29000091552734,76.41999816894531,67.6272201538086,GILD,"Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for November 14, 2016 ||| Drug Stocks' Q3 Earnings to Watch on Nov 14: ARGS, AST ||| Technical Alert: Gilead Sciences Lower Despite Favorable EU Ruling ||| EU Medicines Agency Announces Positive Opinion from CHMP for Gilead's Chronic Hep B Treatment, Vemlidy",1,0.49455318
2016-11-14,8832800.0,77.04000091552734,77.12999725341797,76.06999969482422,76.75,67.91926574707031,GILD,"Should Biopharma Companies Buy Innovation? ||| 3 Drugmakers That Probably Have Lower Tax Rates Than You Do ||| 4 Biotech Stocks to Buy After Clinton’s Defeat ||| Merck's Triple Combination HCV Therapy Positive in Phase III ||| Gilead (GILD) HBV Drug Vemlidy Gets Positive CHMP Opinion ||| Gilead Responds To CMS Blog Highlighting High Cost Of Harvoni: Most Payers Receive Substantial Discounts Off The List Price ||| Gilead Reports Phase 2 Data for Selonsertib in NASH Showed Results Demonstrate Improvement in Fibrosis Stage among NASH Patients with Moderate to Severe Fibrosis ||| Gilead Responding To CMS Blog Post Highlighting The Cost Increase For Hep-C Treatment Harvoni Tells Benzinga The VA And Medicaid Currently Receive Discounts Of 50%+ On Harvoni ||| Several Key Catalysts Lay Ahead For Gilead Sciences In The Next Year ||| CMS Criticizes Gilead's Harvoni Price Increases ||| Benzinga's Top Initiations ||| The Market In 5 Minutes: A Couple Of Pharma Stocks Move 70% In Opposite Directions ||| Stifel Nicolaus Initiates Coverage On Gilead Sciences, Inc. - Common Stock at Buy, Announces $100.00",0,0.49249455
2016-11-15,8560100.0,77.02999877929688,77.11000061035156,75.0,76.3499984741211,67.56529235839844,GILD,3 Biotech ETFs for Decades of Big Returns,0,0.5458286
2016-11-16,8415000.0,76.08000183105469,76.87999725341797,75.56999969482422,76.0,67.25555419921875,GILD,"Biotech Stock Roundup: Biotech Stocks Soar on Election Results, Gilead HBV Drug Approved ||| 3 Potential Acquisition Targets for Gilead Sciences, Inc. ||| Gilead's Full Top-Line Results From Two Phase 3 Studies ||| Gilead Announces SIMPLIFY-1 Study Achieved Its Primary Endpoint In Phase 3 Study ||| Gilead Announces SIMPLIFY-2 Did Not Achieve Its Primary Endpoint In Phase 3 Study",0,0.49241796
2016-11-17,9413500.0,75.72000122070312,76.0199966430664,74.8499984741211,75.58000183105469,66.88388061523438,GILD,"Gilead Reports Phase III Myelofibrosis Data on Momelotinib ||| 3 Beaten-Down Biotech Stocks to Buy for Huge Gains ||| Bad News for Gilead Sciences Is Good News for Incyte ||| How Incyte Just Became A Major M&A Target ||| Incyte Shares Trading Up 5.3%, Traders Attributing Strength To Multiple Analyst Notes Highlighting Gilead's Unlikely Approval Of SIMPLIFY-1 and SIMPLIFY-II, Combined With Repatriation Holiday, Make Incyte More Attractive As M&A Target",0,0.51105285
2016-11-18,8194300.0,75.58999633789062,75.73999786376953,74.25,74.62000274658203,66.03433990478516,GILD,3 Embarrassingly Cheap Dividend Stocks ||| Assessing The Legitimacy Of The Biotech ETF Bounce,1,0.50781494
2016-11-21,6810600.0,74.66000366210938,75.19000244140625,74.44999694824219,74.9800033569336,66.35291290283203,GILD,"The No. 1 Healthcare Concern Americans Want Donald Trump to Fix -- and It's Not Obamacare ||| 5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them ||| Attention, Biotech Investors: Black Friday Is Already Here",0,0.48933575
2016-11-22,6019600.0,75.05999755859375,75.44000244140625,74.0199966430664,74.45999908447266,65.89274597167969,GILD,Are Biogen and Gilead Sciences in Denial? ||| What Happened in Biotech in 2016? ||| UPDATE: Galapagos Says Start of DIVERSITY Study Triggers $50M Milestone Payment from Gilead,1,0.5381319
2016-11-23,6849200.0,73.8499984741211,75.3499984741211,73.76000213623047,75.30000305175781,66.63609313964844,GILD,"The Worst Growth Dividend Stocks of 2016 ||| 3 Inexpensive Top Stocks You've Overlooked This Fall ||| Galapagos (GLPG) Filgotinib in Phase III for Crohn's Disease ||| Biotech Stock Roundup: Acorda Stops Ampyra PSWD Development, CRL for Spectrum's Qapzola",1,0.5026576
2016-11-25,3068600.0,75.47000122070312,75.55000305175781,74.87000274658203,75.44000244140625,66.75997161865234,GILD,J&J (JNJ) Reportedly Approaches Actelion for Acquisition,0,0.5256471
2016-11-28,9338900.0,75.30000305175781,75.44000244140625,74.22000122070312,74.54000091552734,65.9635238647461,GILD,—‘ Questions With Gabriele Grego,1,0.51471394
2016-11-29,7160700.0,74.69000244140625,75.4000015258789,74.29000091552734,74.87000274658203,66.25557708740234,GILD,"PiperJaffray Healthcare Conference Begins Today, Day 1 of 2; Presenters Include NantKwest, Ignyta, Gilead Sciences, DexCom, Incyte, bluebird bio",0,0.4888935
2016-11-30,10627300.0,75.0,75.08000183105469,73.58999633789062,73.69999694824219,65.22018432617188,GILD,"Trade of the Day: Gilead Sciences, Inc. (GILD) Stock Looks Like a Bargain ||| 5 Things Gilead Sciences' CEO Just Said That You Need to Know",0,0.46585888
2016-12-01,8270200.0,73.97000122070312,74.02999877929688,72.72000122070312,72.83999633789062,64.4591293334961,GILD,"Gilead Sciences, Inc.'s $10 Billion Mistake",0,0.5059742
2016-12-02,9227900.0,73.04000091552734,73.5999984741211,72.16000366210938,72.41999816894531,64.08746337890625,GILD,PRAC Warns Of Risk Of Hepatitis B Re-activation With Direct-acting Antivirals For Hepatitis C,0,0.5153474
2016-12-06,8723900.0,72.66999816894531,72.66999816894531,71.94999694824219,72.47000122070312,64.13172149658203,GILD,"Noteworthy ETF Inflows: XLV, MRK, AMGN, GILD ||| Gilead Sciences Inc.'s Worst Moves in 2016",1,0.49100503
2016-12-07,13061000.0,71.77999877929688,72.9000015258789,71.55000305175781,72.77999877929688,64.40603637695312,GILD,"Gilead Sciences Nears 30-Month Low, Attempts To Rebound",0,0.5233715
2016-12-08,12333500.0,72.45999908447266,72.5999984741211,70.83000183105469,72.0199966430664,63.733489990234375,GILD,Stocks Hitting 52-Week Lows ||| Endeavor Funds' Jerome Dodson Defends 3 Stocks Beaten Down In 2016 ||| Gilead Submits NDA to FDA for Sofosbuvir,1,0.50687987
2016-12-09,9936300.0,72.33999633789062,73.12999725341797,71.94999694824219,72.69999694824219,64.33525085449219,GILD,"After Hours Most Active for Dec 9, 2016 : V, PBCT, HPE, IFGL, FOSL, PCAR, CAT, BAC, MT, SXL, MSFT, GILD ||| Top Research Reports for NVIDIA, Medtronic & Gilead Sciences",1,0.4937882
2016-12-12,9475900.0,72.55999755859375,73.68000030517578,72.12999725341797,73.47000122070312,65.01665496826172,GILD,"How Gilead Sciences Inc. Could Pay You $30,000 a Year in Retirement ||| 3 Cheap Healthcare Stocks You Can Buy Right Now ||| The Zacks Analyst Blog Highlights: Gilead Sciences, Medtronic, NVIDIA, Accenture and Simon Property ||| The 3 Most Profit-Friendly Biotech Stocks ||| 10 Notable Stocks Trading Ex-Dividend Tuesday, December 13 ||| Express Scripts Hep. C Cure Program Expands To Cover Treatments To Include Viekira Pak, Harvoni In 2017",1,0.49467924
2016-12-13,12693000.0,73.41000366210938,75.87000274658203,73.4000015258789,74.83999633789062,66.6554183959961,GILD,Trade Valeant Pharmaceuticals Intl Inc (VRX) Stock for Free Profits ||| These 3 Dividend Stocks Are Ridiculously Cheap ||| 3 Beaten-Up Cheap Stocks: Are They Bargains? ||| 3 Top Biotech Stocks to Buy on Sale ||| Better Buy: Gilead Sciences Inc. vs. Amgen Inc.,1,0.503801
2016-12-14,11822800.0,74.86000061035156,76.31999969482422,74.86000061035156,75.70999908447266,67.43028259277344,GILD,"XLV, AMGN, ABBV, GILD: ETF Outflow Alert ||| Najarian Brothers See Unusually High Options Activity In KeyCorp, Gilead Sciences",0,0.48670024
2016-12-15,9448800.0,75.80000305175781,75.98999786376953,74.91000366210938,75.55000305175781,67.28778839111328,GILD,"Gilead Sciences Inc.'s Best Moves in 2016 ||| How Risky Is Gilead Sciences Inc.? ||| CNBC Meg Tirrell Tweets: $GILD says it plans to ""vigorously challenge"" verdict ordering it to pay $MRK $2.54B in hepatitis C royalties ||| Gilead To Pay Merck $2.54B In Hep. C Royalties ||| Galapagos Reports Publication of Phase 2 Study with Filgotinib in Crohn's Disease in The Lancet",0,0.4892677
2016-12-16,14437500.0,74.43000030517578,74.95999908447266,73.94000244140625,74.0999984741211,65.9963607788086,GILD,"Is This Gilead Sciences' Biggest Mistake in 2016? ||| Gilead to Pay Merck $2.5B in HCV Patent Dispute, Stock Falls ||| Why AbbVie Inc (ABBV) Stock Is Still a Long-Term Winner ||| Gilead Sciences' Year Officially Becomes Superbad",1,0.48246253
2016-12-19,8212200.0,73.61000061035156,75.30000305175781,73.55000305175781,74.4000015258789,66.2635498046875,GILD,"The 12 Greatest Medical Breakthroughs of 2016 ||| The Most Expensive Drugs of 2016 ||| 3 Small Biotech Stocks That Big Biotechs Like ||| Could Gilead Sciences' Game-Changing HIV Pill Solve Its Growth Problem? ||| Japan to Review Drug Prices Each Year vs Every Two Years Previously -Reuters ||| Japan's Ministry of Health, Labour and Welfare Approves Gilead's Vemlidy for Patients With Chronic Hepatitis B Virus Infection",0,0.5147787
2016-12-20,8452000.0,74.51000213623047,74.62999725341797,73.43000030517578,74.05000305175781,65.95181274414062,GILD,"Nasdaq 100 Movers: GILD, TRIP ||| Gilead Sciences Has Bought Back $10 Billion of Stock in 2016. Should Investors Be Happy? ||| 3 Incredibly Cheap Biotech Stocks",0,0.4809693
2016-12-21,7018700.0,74.02999877929688,74.83000183105469,73.55999755859375,73.95999908447266,65.87165832519531,GILD,"Biotech Stock Roundup: Conatus Soars on Novartis Deal, Early FDA Nod for Clovis Drug ||| 5 Steps To Buying Biotech Stocks ||| Health Care Sector Update for 12/21/2016: ALXN,GILD,MRUS,INCY,MACK ||| Forget Gilead Sciences Inc.: These 3 Stocks Are Better Buys",0,0.47492573
2016-12-22,8413800.0,73.68000030517578,73.75,72.91999816894531,73.30000305175781,65.28385162353516,GILD,"10 Best Stocks for Retirement Investors ||| Noteworthy ETF Outflows: TQQQ, AMGN, KHC, GILD ||| Will 2017 Be Gilead Sciences Inc.'s Worst Year Yet?",1,0.5192328
2016-12-27,6632900.0,73.5199966430664,74.80000305175781,73.51000213623047,73.7300033569336,65.66682434082031,GILD,3 Great Income Stocks That Could Double Their Dividends ||| Will 2017 Be Gilead Sciences Inc.'s Worst Year Yet?,0,0.51236284
2016-12-28,6387600.0,73.61000061035156,73.69999694824219,72.62000274658203,72.7699966430664,64.81180572509766,GILD,2 Incredibly Cheap Dividend Stocks,0,0.5432361
2016-12-29,7533600.0,72.7699966430664,72.8499984741211,71.94000244140625,72.12999725341797,64.24179077148438,GILD,"United Therapeutics' PAH Suite Bodes Well, Competition Rife",0,0.5004279
2016-12-30,9220900.0,72.02999877929688,72.26000213623047,71.30000305175781,71.61000061035156,63.778656005859375,GILD,January Will Feature Some Of The Market's Most Influential Events,1,0.5274218
2017-01-03,10953700.0,72.33999633789062,74.2300033569336,72.18000030517578,74.16000366210938,66.04979705810547,GILD,Biotech Stocks: What to Watch in 2017 ||| Forget Gilead Sciences Inc.: These 2 Stocks Doubled Last Year,1,0.48073027
2017-01-04,14914200.0,74.52999877929688,76.9800033569336,74.37999725341797,76.37999725341797,68.02699279785156,GILD,Is Biogen Playing With Fire? ||| Jim Cramer Gives His Opinion On SYSCO And Gilead,0,0.48994792
2017-01-05,9413100.0,76.83999633789062,76.8499984741211,75.56999969482422,76.01000213623047,67.69747924804688,GILD,Gilead Sciences Must Answer to Investors After a Disappointing 2016 ||| Gilead Sciences Inc.'s Biggest Failure in 2016 ||| 5 Stocks to Buy for Enterprise Investors ||| Why Gilead Sciences Lost a Staggering 29.2% In 2016 ||| Jefferies' Picks For 2017's Most And Least Likely Biotech M&A Targets,0,0.47213158
2017-01-06,8980000.0,76.44999694824219,76.5,75.41000366210938,75.48999786376953,67.23433685302734,GILD,"Biotech Investing: 3 Bold Predictions for 2017 ||| Noteworthy Friday Option Activity: APC, KITE, GILD ||| Hearing Carl Icahn Considering Activist Stake In Gilead",1,0.5243891
2017-01-09,10165300.0,75.93000030517578,76.08999633789062,75.2699966430664,75.83999633789062,67.5460433959961,GILD,"What If You Considered Gilead Sciences a Start-Up? ||| Why Ariad Pharmaceuticals Stock Soared Today ||| Top Biotech Resolutions for 2017 ||| Notable ETF Outflow Detected - TQQQ, AMGN, KHC, GILD ||| The Zacks Analyst Blog Highlights: Gilead Sciences, Pepsi, United Parcel Services, Twitter and Stanley Black & Decker ||| 2017 J.P. Morgan Healthcare Conference Roundup ||| The 10 Worst Stocks in the Nasdaq in 2016 ||| 4 Things Gilead Sciences' CEO Says to Expect in 2017 ||| Gilead Says Slowdown In Patients Starting Hepatitis C Therapies To Continue Into 2017 ||| Adam Feuerstein Tweets: $GILD breakout. The full force of co.'s HIV power is being applied to bictegravir pgm. They sound really confident about this drug. #JPM17 ||| Gilead CEO Says Planning Phase 3 Trials Of Nash Drug In Patients With Advanced Fibrosis ||| The Year's Biggest Healthcare Conference Commences This Week; Here's What You Need To Know",0,0.4877352
2017-01-11,14165700.0,75.5199966430664,75.55000305175781,73.01000213623047,73.7699966430664,65.70243835449219,GILD,"Should You Buy Amgen Inc. (AMGN) Stock? 3 Pros, 3 Cons ||| Stock Market Roundup Jan. 11: Health Sector Lower on Trump ""Murder"" Comment ||| This Stumbling Biotech Stock Still Has a Lot of Promise ||| Adam Feuerstein Tweets: $GILD told analysts at mtg today they might separate out HCV and/or HIV product guidance for 2017 on upcoming earnings call. ||| Watching Weakness In Amgen,Biogen, Gilead, Mylan, Pfizer And Other Biotechs After Pres. Elect Trump Negative Statement On Drug Pricing ||| Gilead Granted Marketing Authorization From European Commission for Vemlidy ||| GM, Gilead, Barracuda And Freeport-McMoRan: Fast Money Picks For January 11",0,0.47421488
2017-01-12,7057700.0,73.52999877929688,73.68000030517578,72.93000030517578,73.36000061035156,65.33727264404297,GILD,"Is the Options Market Predicting a Spike in Gilead Sciences (GILD) Stock? ||| Stock Market News for January 12, 2017 ||| Waverton Investment Management Ltd Buys Wells Fargo & Co, US Bancorp, Baidu Inc, Sells ... ||| Gilead (GILD) HBV Drug Vemlidy Receives European Approval",0,0.4723946
2017-01-17,11706600.0,72.91999816894531,72.91999816894531,71.7300033569336,71.91000366210938,64.04585266113281,GILD,"Should Investors Bet on Gilead Sciences Version 3.0? ||| Is Donald Trump Big Pharma's Worst Nightmare? ||| Agree To Buy Gilead Sciences At $55, Earn 4.4% Using Options ||| 3 Bargain Stocks to Buy Now ||| Notable Tuesday Option Activity: GILD, Q, AXP",1,0.481187
2017-01-18,9910000.0,72.23999786376953,72.47000122070312,71.5,72.12999725341797,64.24179077148438,GILD,"These 3 Healthcare Stocks Are Ridiculously Cheap ||| Value Investing 2017: 3 Stocks to Put on Your Radar ||| BZ NOTE: Gilead Has Been Mentioned as a Rumor Stock by Traders At Least Twice Over the Last 2 Months ||| Hearing Gilead, Pfizer CEOs Currently Meeting At Davos, Traders Speculating M&A Talks ||| Orphan Drugs Among 2015's Top 10 Best-Selling Medications",0,0.47650787
2017-01-19,9810900.0,71.81999969482422,72.25,71.2300033569336,71.56999969482422,63.74303436279297,GILD,"Noteworthy ETF Inflows: VLUE, GM, GILD, F ||| Verastem's CEO Talks DYNAMO Study, The Competitive Landscape And Pitch To Investors",0,0.4941178
2017-01-20,10270300.0,71.97000122070312,72.0,70.58000183105469,71.01000213623047,63.244285583496094,GILD,"Incyte Has Insight Into Market With Potential Blockbuster Drugs ||| Is Gilead Sciences (GILD) a Great Stock for Value Investors? ||| The Zacks Analyst Blog Highlights: Gilead Sciences, Las Vegas Sands, Illinois Tool Works, Pfizer and Lockheed Martin ||| Are You Undervaluing These 3 Biopharmas' Pipelines? ||| Technical Alert: Gilead Sciences Makes New For Move ||| EMA Validates Gilead's Marketing Authorization Application for Investigational Chronic Hepatitis C Therapy Sofosbuvir/Velpatasvir/Voxilaprevir",0,0.4771971
2017-01-23,9657600.0,70.87000274658203,71.29000091552734,70.30000305175781,70.69000244140625,62.95927429199219,GILD,"How Will Gilead Sciences Fare Under President Trump? ||| 3 Incredibly Cheap High-Yield Dividend Stocks ||| Can Q4 Earnings Revitalize Healthcare ETFs? ||| Has Gilead Sciences' Cash Cow Finally Hit Bottom? ||| Is Gilead Sciences, Inc. (GILD) Stock Great for Value Investors? ||| Gilead (GILD) HCV Therapy Application Validated in Europe ||| Incyte Has Insight Into Market With Potential Blockbuster Drugs",0,0.47429037
2017-01-24,10912800.0,70.5999984741211,70.9800033569336,69.77999877929688,70.25,62.5673828125,GILD,Better Buy: Biogen Inc. vs. Gilead Sciences Inc. ||| Gilead Sciences Stock: What Could Go Wrong? ||| Benzinga's Option Alert Recap From January 24 ||| Option Alert: Gilead May 70.0 Calls Sweep: 2173 @ ASK $3.953: 12k traded vs 1798 OI: Earnings 2/7 After Close $70.12 Ref,1,0.49250638
2017-01-25,14001600.0,70.81999969482422,72.33999633789062,70.72000122070312,71.91000366210938,64.04585266113281,GILD,"3 Top Stocks You Can Buy on Sale ||| Forget Incyte: Gilead Sciences Would Be Better Off Buying This Company ||| Biotech Stock Roundup: Synergy Drug Gets FDA Nod, AbbVie, GILD HCV Drugs under EU Review ||| 3 Top Biotech Stocks to Buy Now ||| Notable Wednesday Option Activity: MTB, CMA, GILD ||| Gilead Responds to Report Of Lack Of Efficacy From Harvoni Treatment, Points to Extensive Data Showing Failure Rates 'low but given large numbers of patients treated...not unexpected to see reports of some patients failing these treatments' ||| UPDATE: Gilead Says It Has Worked Closely With FDA To Share Data On Liver Failure Cases, Has Found No Suggestion Of Causal Relationship Between Harvoni And Liver Failure, No Product Updates Deemed Necessary ||| Gilead Responds To Reports Of Side Effects From Harvoni Hepatitis Treatment, Tells Benzinga Safety Is Highest Priority, Co. Continuously Monitors Safey Information To Inform Appropriate Use ||| Traders Circulating Stat News Report Posted 5 Hrs Ago Suggesting Safety Concerns In Gilead's Hepatitis Drugs ||| Watch These 10 Huge Call Purchases In Wednesday Trade",0,0.5270144
2017-01-26,8580100.0,71.77999877929688,71.8499984741211,71.1500015258789,71.22000122070312,63.43131256103516,GILD,3 Reasons Gilead Sciences Inc. Stock Could Rise ||| Gilead Defends Hepatitis C Treatments On Reports Of Side Effects,1,0.5298418
2017-01-27,6939700.0,71.43000030517578,72.16999816894531,71.16000366210938,71.26000213623047,63.466941833496094,GILD,"3 Companies Putting the Squeeze on Bristol-Myers Squibb ||| 3 Healthcare Stocks to Buy Despite Trump’s Bluster ||| JJ Kinahan Walks Us Through The Most Traded Stocks Among TDA Clients In 2016: Apple, Bank of America & More",1,0.50949687
2017-01-30,7242500.0,71.0,71.66999816894531,70.75,71.51000213623047,63.68960571289063,GILD,The Single Most Important Number for Gilead Sciences ||| Key Takeaways from AbbVie's Q4 Call: Humira and the Pipeline ||| Why You're Right to Invest in Gilead Sciences Stock,1,0.511926
2017-01-31,10365500.0,71.12999725341797,72.58000183105469,70.98999786376953,72.44999694824219,64.52680969238281,GILD,"Gilead Sciences a Top 25 Dividend Giant With 2.63% Yield (GILD) ||| This Was, Unquestionably, the Most Disappointing Drug Launch of 2016 ||| 3 Critical Things to Watch in Gilead Sciences' Q4 Results",1,0.5014899
2017-02-01,7441800.0,72.72000122070312,72.87999725341797,72.05999755859375,72.81999969482422,64.85631561279297,GILD,These 3 Biotech Stocks Are Ridiculously Cheap,0,0.48328966
2017-02-02,8814200.0,72.61000061035156,72.83000183105469,71.77999877929688,72.25,64.34866333007812,GILD,"8 Value Stocks to Buy In The S&P 500 ||| 3 Dividend Stocks With the Biggest Revenue Growth Over the Past 10 Years ||| Jim Cramer Gives His Opinion On CSX, JetBlue, Gilead And Burlington Stores",1,0.4896492
2017-02-03,8034300.0,72.73999786376953,72.75,71.7699966430664,72.33999633789062,64.42882537841797,GILD,Gilead Sciences (GILD) Q4 Earnings: What's in the Cards?,1,0.4927971
2017-02-06,7635000.0,72.0199966430664,72.66999816894531,71.44000244140625,72.38999938964844,64.47335815429688,GILD,"3 Crucial Questions Gilead Sciences Should Answer Tuesday ||| 3 Healthcare Tickers That Will Return Profits in 3 Months ||| Drug Stocks Reporting Earnings on Feb 7: GILD, MNK & More ||| Q4 2016 Real-Time Call Brief",1,0.5163202
2017-02-07,13325400.0,72.55999755859375,73.30000305175781,72.41000366210938,73.12999725341797,65.13243865966797,GILD,"Healthcare Stocks: The Buying Opportunity of the Year? ||| 3 Attractive Income Stocks Whose Dividends Could Double ||| Gilead Sciences Inc. Reports Q4 Earnings Decline and Worsening Outlook for 2017 ||| Gilead Sciences Posts Q4 Earnings Beat, Slumps on Weak Guidance ||| After Hours Most Active for Feb 7, 2017 : BAC, FCX, GILD, SCOR, GE, MSFT, QQQ, TEVA, HBAN, T, TWLO, MTCH ||| Spot Trading L.L.C Buys Gilead Sciences, Allergan PLC, Bristol-Myers Squibb Company, Sells SPDR ... ||| After-Hours Earnings Report for February 7, 2017 : DIS, GILD, MDLZ, PXD, ORLY, MCHP, PAA, AKAM, ATO, CPT, JKHY, DEI ||| Gilead Touches Lowest Level Since 2014 Following Q4 Report ||| Adam Feuerstein @adamfeuerstein Tweet: $GILD Just Kitchen-Sinked 2017 Guidance, Worse Than Anyone Expected —> thestreet.com/story/13993572 ||| Gilead Raises Qtr Dividend From $0.47/Share To $0.52/Share ||| Gilead Science Sees FY17 Product Sales $22.5B-$24.5B ||| Gilead Sciences Reports Q4 Adj EPS $2.70 vs $2.61 Est, Revenus $7.32B vs $7.15B Est ||| Keep an Eye on These 12 Stocks for February 7, 2017 ||| Earnings Scheduled For February 7, 2017",0,0.4950138
2017-02-08,51547400.0,67.2699966430664,67.2699966430664,65.75,66.83000183105469,59.52141189575195,GILD,"Nasdaq 100 Movers: AKAM, MCHP ||| Gilead Sciences Just Lost $9 Billion in Market Value -- Here's Why ||| S&P 500 Movers: AKAM, MCHP ||| Gilead Sciences, Inc. (GILD) Stock Tumbles on Dismal Guidance ||| 3 Big Stock Charts for Wednesday: Gilead Sciences, Inc. (GILD), AK Steel Holding Corporation (AKS) and Sysco Corporation (SYY) ||| Pre-Market Most Active for Feb 8, 2017 : PE, GILD, AMC, TWTR, FCAU, BAC, TVIX, RIO, QQQ, CTSH, MCHP, GMLP ||| Biotech Stock Roundup: Amgen, Gilead Report 4Q Results, ARIAD Seeks EU Nod for Brigatinib ||| Gilead (GILD) Beats Q4 Earnings & Sales, View Disappoints ||| Why Gilead Sciences Stock Slumped Today ||| Daily Dividend Report: MMM, GILD, ALK, TWX, SYK, PSX, IR, RCL, CLX ||| Why Gilead Sciences, Zillow Group, and Parsley Energy Slumped Today ||| 5 Things Gilead Sciences' Management Said as Its Stock Slumped ||| Why Gilead Sciences, Inc. (GILD), Zillow Group, Inc. (Z) and Akamai Technologies, Inc. (AKAM) Are 3 of Today’s Worst Stocks ||| 20 Biggest Mid-Day Losers For Wednesday ||| Oil Weakness A Possible Drag On Market As Earnings Season Keeps Rolling ||| 8 Biggest Price Target Changes For Wednesday ||| Gilead's 2017 Guidance Sank Shares To A New Bottom ||| Martin Shkreli: I Would Buy Gilead Shares ||| Benzinga's Top Upgrades, Downgrades For February 8, 2017 ||| The Market In 5 Minutes: Disney, Gilead Investors Not Too Pleased ||| Yesterday Night, Martin Shrkeli Said He Would Be A Buyer Of Gilead On Weak Quarter Results, Believes Stock Is Worth $125/Share ||| 25 Stocks Moving In Wednesday's Pre-Market Session ||| Citigroup Downgrades Gilead Sciences To Neutral, Lowers Price Target To $76 ||| 12 Stocks You Should Be Watching Today",0,0.4661621
2017-02-09,23070600.0,66.33999633789062,66.79000091552734,65.37999725341797,65.58999633789062,58.41701126098633,GILD,"Don't Panic: Gilead Sciences Really Isn't a Value Trap ||| Thursday's ETF with Unusual Volume: LRGF ||| Nasdaq 100 Movers: MCHP, VIAB ||| Zacks Market Edge Highlights: Health Care SPDR ETF, iShares NASDAQ Biotechnology ETF, Acadia, Aetna and Gilead ||| Thursday’s Vital Data: Apple Inc. (AAPL), Gilead Sciences, Inc. (GILD) and Advanced Micro Devices, Inc. (AMD) ||| Holowesko Partners Ltd. Buys Wells Fargo, Gilead Sciences, PulteGroup, Sells Citizens Financial ...",1,0.49432915
2017-02-10,16208400.0,65.8499984741211,66.77999877929688,65.43000030517578,66.36000061035156,59.102806091308594,GILD,"Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 13, 2017 ||| Biotech ETFs Powered by Q4 Earnings",1,0.47005886
2017-02-13,15885100.0,66.80999755859375,67.79000091552734,66.5,67.6500015258789,60.251739501953125,GILD,"Is Gilead Sciences Getting Ready for a Massive Acquisition? ||| Gilead Sciences, Fossil Reach 3-Year Low Prices ||| Drug Stocks Earnings Slated for Feb 14: INCY, PRTA & More ||| Forget Gilead, Buy These 5 Biotech Stocks Instead ||| Notable Monday Option Activity: GS, GILD, DE ||| Better Buy: Illumina or Gilead Sciences? ||| Gilead Sciences Says Bictegravir in Combination With FTC/TAF Showed 97% Rates of Virologic Suppression in Phase 2 Study ||| Hearing Carl Icahn Has Taken Stake In Gilead",0,0.47690287
2017-02-14,14972600.0,68.5999984741211,68.66999816894531,67.33000183105469,67.55000305175781,60.16266250610352,GILD,"Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for February 15, 2017 ||| Tuesday’s Vital Data: Tesla Inc (TSLA), Gilead Sciences, Inc. (GILD) and Microsoft Corporation (MSFT) ||| The Zacks Analyst Blog Highlights: Gilead Sciences, Celgene, Fate Therapeutics, Exelixis and Akebia Therapeutics ||| North Tide Capital, Llc Buys Impax Laboratories, Allergan PLC, Accuray, Sells Community Health ... ||| Could A Blockbuster Cannabis Drug Be On The Way? (GILD, GWPH) ||| Gilead (GILD) Announces Data on Combination Therapy for HIV ||| Why I Just Bought More Shares of Gilead Sciences, Inc. ||| Hearing Gilead Will Face New Patent Challenges Related to Hep C Drugs In India; Shares Unaffected ||| Curing Disease Is Bad For Business: How Do Big Pharma Companies Continue Their Growth? ||| Wall Street's M&A Chatter From February 13",1,0.49478874
2017-02-15,16656600.0,67.69999694824219,69.9800033569336,67.66000366210938,69.80000305175781,62.166603088378906,GILD,"Falling Earnings Estimates Signal Weakness Ahead for Gilead Sciences (GILD) ||| Drug Stocks Q4 Earnings Slated for Feb 16: ALXN, ZTS & More ||| Biotech Stock Roundup: Regeneron's Praluent to Remain on Market for Now, GILD Presents HIV Data ||| Deutsche Bank Casts Doubt On Pfizer's Rumored Takeover Approach To Bristol-Myers ||| Gilead Announces Higher Rates of Virologic Suppression in 144-Week Data Evaluating Safety and Efficacy of Genvoya® for Treatment of HIV-1 in Treatment-Naïve Adults",1,0.48281977
2017-02-16,10965500.0,70.0,70.66999816894531,69.26000213623047,70.30999755859375,62.62082290649414,GILD,"Should You Buy Amgen, Inc. (AMGN) Stock? 3 Pros, 3 Cons ||| Why It's a Colossal Mistake to Sell Gilead Sciences Stock Now ||| Gilead Sciences (GILD) Shares Cross 3% Yield Mark ||| Gilead Receives Canada Approval For Odefsey For Treatment Of HIV-1 Infection",0,0.4940307
2017-02-17,11186900.0,70.18000030517578,70.79000091552734,69.70999908447266,69.8499984741211,62.21112823486328,GILD,"Thanks, Martin Shkreli, for the Dumbest Advice Ever on Drug Pricing ||| Five Major Myths about Options Trading ||| Why President Trump Should Buy Gilead Sciences",0,0.5177043
2017-02-21,11190400.0,70.0,70.0,68.83000183105469,69.29000091552734,61.71237564086914,GILD,"Better Buy: Gilead Sciences, Inc. vs. Pfizer Inc. ||| Why Gilead Sciences Is a Buy ||| 7 Ultra-Cheap Value Stocks to Buy Now ||| Gilead Sciences, Inc. (GILD) Stock Has Caught a Cold ||| Zacks Investment Ideas feature highlights: Tesla, Volatility Index and Gilead ||| Icahn Takes Bristol-Myers Stake With M&A In Mind; Who Could Be The Acquirer?",0,0.4709731
2017-02-22,10073400.0,69.11000061035156,69.7300033569336,68.66000366210938,68.83000183105469,61.30268096923828,GILD,"3 Beaten-Up Dividend Stocks: Are They Bargains? ||| Biotech Stock Roundup: Alexion Reports 4Q Results, Celgene MS Drug Looks Promising ||| North Tide Capital, Llc Buys Impax Laboratories, Allergan PLC, Accuray, Sells Community Health ... ||| 3 Things Gilead Sciences' CEO Just Said That You'll Want to Know ||| Gilead Sciences Canada To List Epclusa On Public Drug Plan To Treat All 6 Genotypes Of Hep. C Infection ||| RBC Capital Markets Healthcare Conference Begins Today, Day 1 Of 2; Presenters Include Tesaro, Axovant, Gilead, And Puma Biotechnology",1,0.5234021
2017-02-23,7529100.0,68.73999786376953,69.52999877929688,68.43000030517578,69.37000274658203,61.78363800048828,GILD,United Therapeutics (UTHR) Down on Q4 Earnings & Sales Miss,1,0.5211106
2017-02-24,7382400.0,69.31999969482422,70.06999969482422,69.05000305175781,69.94000244140625,62.291290283203125,GILD,"VOO, GILD, HON, UNP: Large Inflows Detected at ETF ||| 3 Incredibly Cheap Biotech Stocks ||| EU Medicines Agency Recommends Approval of Gilead's Descovy For HIV Treatment",1,0.53881204
2017-02-27,6354200.0,69.81999969482422,70.54000091552734,69.80000305175781,70.5,62.7900505065918,GILD,"These 3 Big Pharma Stocks Are Ridiculously Cheap ||| 3 Top Healthcare Stocks to Buy Now ||| Numeric Investors Llc Buys Gilead Sciences, Microsoft, Baxter International, Sells Facebook, ... ||| Better Buy: Biogen Inc. vs. Gilead Sciences Inc. ||| North Tide Capital, Llc Buys Impax Laboratories, Allergan PLC, Accuray, Sells Community Health ...",0,0.4818643
2017-02-28,8828800.0,70.37000274658203,70.94000244140625,70.01000213623047,70.4800033569336,62.77223587036133,GILD,Hearing Starboard Has Built $2.6B Activist Stake In Gilead,0,0.529732
2017-03-01,9629400.0,70.81999969482422,70.98999786376953,70.0199966430664,70.19000244140625,62.51396560668945,GILD,"Sarepta (SRPT) Q4 Loss Widens; Sales of Duchenne Drug Slow ||| Biotech Stock Roundup: Kite Soars on CAR-T Data, EXEL in Immuno-Oncology Deals ||| Pricing to Remain Pharma Headline Risk in 2017 ||| Jerome Dodson Adds to 9 Positions in 4th Quarter",1,0.5145898
2017-03-02,8672900.0,70.0,70.88999938964844,70.0,70.52999877929688,62.8167724609375,GILD,"Zacks Industry Outlook Highlights: Sanofi, AstraZeneca, Novo Nordisk, Gilead Sciences and Valeant Pharmaceuticals International ||| Biotech ETF (BBH) Hits New 52-Week High ||| North Tide Capital, Llc Buys Impax Laboratories, Allergan PLC, Accuray, Sells Community Health ... ||| After Hours Most Active for Mar 2, 2017 : FTR, V, GE, FIG, XRX, HST, LOW, GILD, DISCA, YHOO, QCOM, CMCSA ||| Traders Circulating Rumor Of Icahn Involvement In Gilead",1,0.5040767
2017-03-03,6620900.0,70.66999816894531,70.80999755859375,70.22000122070312,70.73999786376953,63.00380325317383,GILD,"Should You Buy General Motors Company (GM) Stock? 3 Pros, 3 Cons ||| 2 Reasons Behind Sarepta Therapeutics Inc.'s 6.9% February Jump",0,0.48722225
2017-03-06,7335900.0,70.55999755859375,70.5999984741211,69.69999694824219,70.12000274658203,62.45160675048828,GILD,RBC Hints At Potential M&A For Kite Pharma,0,0.51846033
2017-03-07,9044200.0,69.58999633789062,69.95999908447266,68.77999877929688,69.0199966430664,61.471900939941406,GILD,"Is This the Right Time to Invest in Biotech Stocks? ||| Here's Why the Best Is Yet to Come for Gilead Sciences, Inc. ||| North Tide Capital, Llc Buys Impax Laboratories, Allergan PLC, Accuray, Sells Community Health ... ||| Notable ETF Inflow Detected - IYH, GILD, AGN, BIIB ||| 3 Biotech Stocks You Don't Have to Babysit",1,0.51765597
2017-03-08,7377200.0,69.0199966430664,70.0,68.87999725341797,69.69999694824219,62.07754135131836,GILD,"Biotech Stock Roundup: Trump Tweet Hits Biotech Stocks, Concert Gains on Vertex Deal",0,0.49876377
2017-03-09,13597000.0,69.20999908447266,69.25,67.80999755859375,68.38999938964844,60.91079330444336,GILD,"Will Gilead Sciences Net a $270 Million Windfall? ||| Benzinga's Top Upgrades, Downgrades For March 9, 2017 ||| UBS Downgrades Gilead Sciences To Neutral",0,0.50674886
2017-03-10,14480500.0,68.56999969482422,68.61000061035156,67.44999694824219,68.19000244140625,60.7326774597168,GILD,"Ex-Dividend Reminder: Gilead Sciences, T Rowe Price Group and Redwood Trust ||| North Tide Capital, Llc Buys Impax Laboratories, Allergan PLC, Accuray, Sells Community Health ... ||| AbbVie Stock Upgraded: What You Need to Know ||| Incyte Spikes to High of $149.28 ||| Hearing Unconfirmed Chatter Gilead Near Bid for Incyte ||| Adam Feuerstein Weighs In On Novo-GBT Rumors, Undue Sarepta Volatility, Unprofitable Business Of Curing Disease ||| Adam Feuerstein Talks Vulnerable Pharmaceuticals, Drug Pricing Under Trump ||| Barclays Analyst Pens Open Letter To Gilead Board And Management ||| Feuerstein Highlighting Several Points Why Gilead Has Been Struggling Recently ||| Feuerstein on Benzinga's PreMarket Prep Discussing Stocks Which Could Be Impacted by Drug Pricing Changes: Believes Worst Case Scenario Would Create Vulnerabilities for Drugs with High Levels of Competition ||| Galapagos Announces New Phase 2 Studies with Filgotinib in Small Bowel and Fistulizing Crohn's Disease",0,0.49542388
2017-03-13,8493500.0,68.31999969482422,68.3499984741211,67.52999877929688,68.0999984741211,60.65251541137695,GILD,"Which Biotech Is the Best Dividend Stock? ||| 3 Healthcare Stocks That Are Looking Cheap ||| Sarepta's DMD Drug Launch Slow; What's in Store for 2017? ||| Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for March 14, 2017 ||| Adam Feuerstein Tweets: Barclays Healthcare Conference: $GILD CEO John Milligan 9 am Tues. $INCY CEO Herve Hoppenot 2:30 pm Weds. Both STILL ON SCHEDULE. ||| Wall Street's M&A Chatter From March 10-12",0,0.46660972
2017-03-14,6109500.0,67.41000366210938,68.0999984741211,67.4000015258789,67.7699966430664,60.82303237915039,GILD,"Gilead Looking To Buy Incyte? It Makes Sense ||| Barclays Global Healthcare Conference Begins Today; Presenters Include Johnson & Johnson, Alnylam, Axovant, Paraxel, Gilead, bluebird bio, Envision Healthcare, & Tenet Healthcare",1,0.48878905
2017-03-15,8312600.0,67.97000122070312,68.77999877929688,67.61000061035156,68.47000122070312,61.4512939453125,GILD,"The Beginning of a Stock Portfolio Experiment ||| 3 Reasons Why Gilead Sciences Will Buy Incyte -- and 1 Reason Why It Won't ||| Forget Gilead, Buy These Small-Cap Biotech Stocks Instead",1,0.48994982
2017-03-16,6855000.0,68.73999786376953,68.77999877929688,68.20999908447266,68.54000091552734,61.51411056518555,GILD,"Camber Capital Management LLC Buys Allergan PLC, Myriad Genetics, Vertex Pharmaceuticals, Sells ... ||| IWF, CELG, BMY, GILD: ETF Inflow Alert ||| Biotech Stock Roundup: Amgen's Data on Repatha, Catalyst Soars on Firdapse Data ||| 3 Numbers That Make Gilead Sciences, Inc. Look Cheaper Than It Really Is ||| Incyte Shares Spike Over $148 Level as Hearing Traders Circulating Unconfirmed Chatter of Gilead Interest",1,0.50647473
2017-03-17,18241000.0,68.76000213623047,69.87999725341797,68.25,69.05999755859375,61.98081207275391,GILD,3 Drug Stocks With Some of the Highest Profit Margins,0,0.53184795
2017-03-20,6287400.0,68.94000244140625,69.20999908447266,68.63999938964844,68.70999908447266,61.66669845581055,GILD,"Why Biotech Stock Gilead (GILD) Could Be a Value Trap ||| Look Under The Hood: BBH Has 12% Upside ||| 3 Stocks That Are Ridiculously Cheap Right Now ||| Jefferies Says Gilead's GS-0976 Novel Mechanism Has Good Scientific Rationale, May Likely Be Playing Out In Phase 2 Study",0,0.46934456
2017-03-21,8691500.0,68.80000305175781,69.08000183105469,67.43000030517578,67.73999786376953,60.79610824584961,GILD,Is Valeant Pharmaceuticals Intl Inc (VRX) Stock Worth the Risk? ||| Biotech Bull Making a Comeback ||| Mylan Receives Tentative Approval from FDA for HIV Therapy,1,0.5481299
2017-03-22,5402800.0,67.80000305175781,68.05000305175781,67.51000213623047,67.83000183105469,60.87688446044922,GILD,"Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valeant Pharma, Celgene and Amgen ||| Biotech Stock Roundup: Amgen Down on Repatha Data, Nektar Surges on Pain Results",0,0.49579343
2017-03-23,6174900.0,67.61000061035156,67.91999816894531,67.26000213623047,67.48999786376953,60.571739196777344,GILD,Why Teva Pharmaceutical Industries Ltd (ADR) Stock Has Staying Power,1,0.5182338
2017-03-24,6037800.0,67.56999969482422,67.87000274658203,67.19999694824219,67.51000213623047,60.58970260620117,GILD,"The Best-Case Scenario for Gilead Sciences, Inc.",0,0.5024172
2017-03-27,5455300.0,67.11000061035156,67.81999969482422,66.97000122070312,67.5,60.58071517944336,GILD,"Better Buy: Celgene Corporation vs. Gilead Sciences ||| 3 Top Dividend Stocks Selling for a Discount This Spring ||| IVW, HD, CMCSA, GILD: Large Inflows Detected at ETF ||| STAT News Reporting Gilead Faces European Hepatitis C Drug Patent Challenge Filed By Medecins du Monde and Doctors Without Borders",0,0.50307256
2017-03-28,8509100.0,67.44999694824219,67.4800033569336,66.80000305175781,67.0999984741211,60.221717834472656,GILD,3 Least Risky Biotech Stocks on the Market,1,0.54394835
2017-03-29,7224700.0,67.0999984741211,67.56999969482422,66.91000366210938,67.26000213623047,60.365333557128906,GILD,"Four Magic Formula Picks For a Richly Valued Market ||| Biotech Stock Roundup: Regeneron, Tesaro Drugs Approved, Vertex Scores Big in Study ||| 3 Drugmakers With Boatloads of Cash to Spend ||| Option Alert: Gilead May 67.5 Calls: 1500 @ ASK $2.38: 1955 traded vs 4929 OI: Earnings 4/27 After Close (est) $67.38 Ref",1,0.51350117
2017-03-30,5198700.0,67.36000061035156,67.77999877929688,67.0999984741211,67.52999877929688,60.60764694213867,GILD,Has Gilead Sciences Lost Its Way? ||| Here's What You Missed On PreMarket Prep Today ||| Galectin Shares Upgraded To Buy; NASH-CX Results In December A 'Major Stock Catalyst',1,0.5121984
2017-03-31,8876500.0,67.37000274658203,68.33000183105469,67.37000274658203,67.91999816894531,60.95766830444336,GILD,New Strong Sell Stocks for March 31st ||| Option Alert: Gilead Apr 69.5 Calls: 1500 @ ASK $0.58: 1520 traded vs 942 OI: Earnings 4/27 After Close (est) $68.22 Ref,0,0.46524888
2017-04-03,8446700.0,67.8499984741211,68.0199966430664,66.75,67.0999984741211,60.221717834472656,GILD,"The Worst-Case Scenario for Gilead Sciences, Inc. ||| 3 Biotech Trades for the Faux Doomsday Scenario ||| 3 Lowest P/E Stocks Today",0,0.494179
2017-04-04,5895000.0,67.04000091552734,67.13999938964844,66.6500015258789,66.9800033569336,60.11402893066406,GILD,"VHT, GILD, TMO, DHR: ETF Outflow Alert ||| Galapagos Initiates 3 Phase II Studies for Filgotinib ||| Galapagos Announces Three New Phase 2 Proof-of-Concept Studies Investigating Filgotinib in Sjögren's Syndrome with Collaboration Partner Gilead",0,0.5147785
2017-04-05,7113600.0,66.9800033569336,67.12999725341797,66.4000015258789,66.47000122070312,59.65630722045898,GILD,"Health Care Sector Update for 04/05/2017: SRPT,GILD,NEOT,UNIS ||| Biotech Stock Roundup: Acorda Down on Court Ruling, Patent Challenge for CELG Drug ||| Gilead (GILD) Up 4.3% Since Earnings Report: Can It Continue? ||| Feuerstein Throws BioMarin Into Gilead Takeover Speculation ||| Feuerstein on Possibilities of Gilead Takeover Interest: Notes A Lot of Sources Have Talked About TESARO as Target, But Feels BioMarin is a Co. Which Has Better Chance to Move the Needle at Gilead ||| Feuerstein on Possibilities of Gilead Takeover Interest: Likes BioMarin as a Target",1,0.49341294
2017-04-06,8716000.0,66.43000030517578,66.80000305175781,66.2300033569336,66.4800033569336,59.665283203125,GILD,"Can This Fallen Biotech Be Revived? ||| Gilead Sciences: The Bull, the Bear and the Fence-Sitter ||| KMG Chemicals, Gilead Sciences, STMicroelectronics NV, Lockheed Martin and AeroVironment highlighted as Zacks Bull and Bear of the Day ||| Bear of the Day: Gilead Sciences (GILD) ||| Anthrax And Government Contracts: PharmAthene And Altimmune Ahead Of Merger ||| Your Cheat Sheet For Q1 Biotech Earnings",1,0.48964828
2017-04-07,7618900.0,66.41999816894531,66.83999633789062,66.2699966430664,66.58000183105469,59.75503540039063,GILD,"Would Gilead Sciences Make This Staggeringly Audacious Move? ||| Gilead Announces FDA Has Approved New Indications for Harvoni, Sovaldi in Patients 12 Years, Older with Chronic Hep C Infection",0,0.52213216
2017-04-10,6549600.0,66.55999755859375,67.23999786376953,66.38999938964844,66.41999816894531,59.61141586303711,GILD,The 3 Best HIV Drug Stocks to Buy in 2017 ||| Gilead (GILD) HCV Drugs Gets FDA Nod for Label Expansion,0,0.54221517
2017-04-11,7329400.0,66.43000030517578,66.52999877929688,65.83000183105469,66.0199966430664,59.25243377685547,GILD,"ANTIPODES PARTNERS Ltd Buys United States Natural Gas Fund LP, Gilead Sciences, Baidu ||| 3 Fire-Sale Stocks: Will They Bounce Back or Burn You? ||| Watch These 6 Huge Put Purchases In Tuesday Trade",1,0.50456226
2017-04-12,7819100.0,66.33000183105469,66.37000274658203,65.79000091552734,66.22000122070312,59.43192672729492,GILD,"VOO, BMY, GILD, AGN: Large Inflows Detected at ETF ||| Biotech Stock Roundup: Geron Gains on Interim Data, OncoMed Slumps on Pipeline Setback ||| Apple Team Working on Secret Diabetes Treatment -CNBC",1,0.49723646
2017-04-17,5684300.0,66.80999755859375,67.1500015258789,66.5999984741211,66.69999694824219,59.86271667480469,GILD,3 Biotech Stocks to Buy on Sale ||| Why Gilead Sciences Could Be a Gold Mine for Value Investors,0,0.5109268
2017-04-18,7358100.0,66.58999633789062,66.87000274658203,65.69999694824219,66.05999755859375,59.288330078125,GILD,"Here's The Real Reason Gilead Sciences Is So Incredibly Cheap ||| Did Pharma & Biotech M&As Pick Pace in Q1? ||| Commit To Buy Gilead Sciences At $35, Earn 2.7% Using Options ||| Gilead Shares Turn Positive Over Last Few Mins, Now Up 0.1% as Traders Circulating Rumor Mentioning JANA",1,0.49819905
2017-04-19,5343100.0,66.19000244140625,66.4000015258789,65.88999938964844,66.27999877929688,59.48577880859375,GILD,Looking for a Smart Way to Use Your Tax Refund? Buy These 3 Stocks,1,0.5075074
2017-04-20,6380400.0,66.36000061035156,66.66999816894531,66.16000366210938,66.5,59.6832275390625,GILD,"Novartis (NVS) Q1 Earnings: Will the Stock Disappoint? ||| Health Care Sector Update for 04/20/2017: GILD,IMNP,SKLN ||| Peek Under The Hood: IYH Has 11% Upside ||| Benzinga's Option Alert Recap From April 20 ||| Option Alert: Gilead May 65.0 Calls: 979 @ Above Ask! $2.65: 1086 traded vs 3760 OI: Earnings 5/2 After Close $66.29 Ref",0,0.49542055
2017-04-21,7241800.0,66.54000091552734,66.68000030517578,65.75,65.93000030517578,59.17164993286133,GILD,"Should Gilead Sciences Acquire NewLink Genetics? ||| What's in Store for GlaxoSmithKline (GSK) in Q1 Earnings? ||| Amgen (AMGN) to Report Q1 Earnings: Will it Beat Again? ||| Alexion (ALXN) Q1 Earnings: Can the Stock Pull a Surprise? ||| 10 Reasons Merck Could Be the World's Most Perfect Stock ||| Health Care Sector Update for 04/21/2017: GILD,AUPH,XBIT ||| Watch These 10 Huge Call Purchases In Friday Trade",1,0.4857063
2017-04-24,9117100.0,66.48999786376953,66.48999786376953,65.70999908447266,66.25,59.4588508605957,GILD,Why Now Is Not the Time to Buy Valeant Pharmaceuticals ||| Should Gilead Sciences Be Worried About Allergan? ||| What's in Store for Agenus (AGEN) this Earnings Season? ||| Celgene (CELG) to Post Q1 Earnings: What's in the Cards?,1,0.4868318
2017-04-25,9007000.0,66.5999984741211,67.52999877929688,66.55999755859375,67.12000274658203,60.23967361450195,GILD,"Noteworthy Tuesday Option Activity: ETSY, GILD, UAL ||| Jerome Dodson Keeps Buying McKesson, Axalta, Pentair ||| Gilead (GILD) Q1 Earnings: Stock Likely to Beat Estimates? ||| Bristol-Myers (BMY) to Post Q1 Earnings: What's in Store? ||| Exelixis (EXEL) Q1 Earnings: Will the Stock Disappoint?",1,0.49127853
2017-04-26,15156300.0,67.41000366210938,68.5999984741211,67.2699966430664,68.22000122070312,61.2269172668457,GILD,"What's in Store for Merck (MRK) this Earnings Season? ||| Pfizer (PFE) Q1 Earnings: Will it Pull Off a Surprise? ||| What Awaits Aerie Pharmaceuticals (AERI) in Q1 Earnings? ||| Biotech Stock Roundup: Biogen Gains on Strong Q1, NASH Data on Gilead Drug ||| Extreme Leverage? Extreme Valuations? Big-Time Short Sellers Must Be Thinking About It ||| After Hours Most Active for Apr 26, 2017 : BAC, QQQ, NRG, MPW, GE, PFE, GM, MCHI, GILD, SIRI, MU, MSFT ||| What to Expect from Prothena (PRTA) This Earnings Season? ||| Benzinga's Option Alert Recap From April 26 ||| Option Alert: Gilead May 69.0 Calls Sweep: 1000 @ ASK $1.57: 2284 traded vs 196 OI: Earnings 5/2 After Close $68.48 Ref",1,0.48940846
2017-04-27,6734700.0,68.16999816894531,68.76000213623047,68.05000305175781,68.58000183105469,61.55001831054688,GILD,"BioMarin (BMRN) Q1 Earnings: Will it Beat Estimates Again? ||| United Therapeutics (UTHR) Q1 Earnings Beat, Sales Miss",0,0.50452673
2017-04-28,6257500.0,68.83000183105469,68.95999908447266,68.23999786376953,68.55000305175781,61.52308654785156,GILD,"IUSG, GILD, QCOM, TWX: ETF Inflow Alert ||| Sarepta (SRPT) Q1 Loss Narrows, Exondys 51 Sales Pick Up ||| General American Investors Co Inc Buys Ensco PLC, Johnson Controls International PLC, Liberty ... ||| Is Intercept (ICPT) Poised for a Beat This Earnings Season? ||| What to Expect from Keryx (KERX) Stock This Earnings Season? ||| Regeneron (REGN) to Post Q1 Earnings: What's in the Cards? ||| The Tech Sector's Strong Earnings Power",0,0.5049064
2017-05-01,5372600.0,68.54000091552734,68.80999755859375,68.05000305175781,68.11000061035156,61.12819290161133,GILD,"3 Things to Watch With Gilead Sciences, Inc. Q1 Results ||| What's in Store for Zoetis (ZTS) Stock This Earnings Season? ||| 3 Big Drugmakers That Could Make Billions Under Trump's Tax Plan ||| Geron (GERN) Q1 Earnings: What's in Store for the Stock? ||| Gilead Sciences, Inc. (GILD) Stock Still Looks Sick ||| Apple, Facebook and Gilead Sciences are part of Zacks Earnings Preview ||| What to Expect from Endocyte (ECYT) Stock for Q1 Earnings? ||| Spot Trading L.L.C Buys Walt Disney Co, Johnson & Johnson, Mastercard, Sells SPDR S&P ... ||| Earnings Preview: Q1 Results From Pfizer, Merck, And Gilead Sciences This Week",1,0.51743644
2017-05-02,12987200.0,68.29000091552734,69.16000366210938,68.16000366210938,68.58999633789062,61.55898666381836,GILD,"After-Hours Earnings Report for May 2, 2017 : AAPL, GILD, MDLZ, APC, ALL, DVN, VRSK, DVA, OKE, OKS, AKAM, WGP ||| Gilead (GILD) Misses Q1 Earnings and Revenue Estimates, Stock Drops ||| Gilead Sciences Inc.'s Revenue and Earnings Continue to Fall on Declining HCV Sales ||| Earnings Reaction History: Gilead Sciences Inc., 72.7% Follow-Through Indicator, 4.9% Sensitive ||| This Week's Must See Earnings Charts ||| Meg Tirrell Tweets: $GILD CEOs says a number of partnerships, acquisitions could play out this year ||| Gilead Reaffirms FY17 Outlook ||| Gilead Reports Q1 Adj. EPS $2.23 vs $2.28 Est., Sales $6.505B vs $6.62B Est. ||| 12 Stocks To Watch For May 2, 2017 ||| Earnings Scheduled For May 2, 2017",0,0.49742982
2017-05-03,13591200.0,67.11000061035156,67.58000183105469,66.2699966430664,67.20999908447266,60.32044219970703,GILD,"Notable Wednesday Option Activity: GRA, AERI, GILD ||| How to Trade Gilead Sciences, Inc. (GILD) Stock After Its Q1 Miss ||| Gilead (GILD) Beats on Q1 Earnings, Revenues Miss Estimates ||| Amazon: Love The Company, Hate The Stock Price ||| Gilead Sciences Posts Mixed Q1 Results: ETFs in Focus ||| After Gilead Earnings, Buy These Biotech Stocks ||| Gilead Sciences' 5-Point Plan to Turn Things Around ||| Daily Dividend Report: AAPL, PEP, EXPD, MAN, WIN, GILD, SYK ||| Walt Disney Co (DIS) Stock Cracks, And It Could Get Worse ||| Gilead's Q1 Fails To Impress, But Strength Of Pipeline Not Reflected In Current Share Price ||| In Light Of Negative Sentiment, Gilead's Q1 Results Weren't So Bad ||| Adam Feuerstein Tweets: No $GILD M&A Yet, but CEO Offers Hint of Deals to Come —> thestreet.com/story/14116282… ||| 25 Stocks Moving In Wednesday's Pre-Market Session ||| 15 Stocks To Watch For May 3, 2017",1,0.48984042
2017-05-04,8702900.0,67.41999816894531,68.56999969482422,67.33000183105469,68.08000183105469,61.10126876831055,GILD,"A Big, New Threat to Gilead Sciences Is Coming ||| Analysts On Gilead: We Think They're Mobilizing For A Deal",0,0.5056087
2017-05-05,5788800.0,68.0999984741211,68.44999694824219,67.51000213623047,67.80000305175781,60.84996795654297,GILD,"Better Buy: Gilead Sciences, Inc. vs. Johnson & Johnson ||| Intercept (ICPT) Q1 Loss Narrower than Expected, Sales Beat ||| Top Research Reports for Today: GILD, DOW, MET & More",0,0.48385128
2017-05-08,7126900.0,67.77999877929688,67.81999969482422,67.08000183105469,67.20999908447266,60.32044219970703,GILD,ProShares UltraPro S&P500 Experiences Big Outflow,1,0.5057931
2017-05-09,5557400.0,67.22000122070312,67.75,67.0999984741211,67.61000061035156,60.679447174072266,GILD,"I Still Can't Believe Gilead Sciences, Inc. Spent $14.8 Billion on Shareholder Rewards ||| 3 Stocks That Generate Tons of Cash ||| Here's Why Diplomat Pharmacy Inc. Is Rising Today",0,0.4893843
2017-05-10,7190500.0,67.69000244140625,67.80000305175781,66.70999908447266,66.91999816894531,60.06016159057617,GILD,Better Buy: GlaxoSmithKline vs. Johnson & Johnson ||| Why Gilead Sciences Stock Lagged Behind Other Biotechs in April,0,0.51230323
2017-05-11,8055500.0,66.7699966430664,66.83999633789062,66.05999755859375,66.70999908447266,59.871707916259766,GILD,"3 Top Biotech Stocks For May ||| U.S. Health Officials Say New Cases Of Hep. C Rose ~300% From 2010 to 2015, Fueled By Spike In Heroin and Other Injection Drugs",0,0.5486957
2017-05-12,8091200.0,66.87000274658203,66.9000015258789,65.73999786376953,66.05999755859375,59.288330078125,GILD,"Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 15, 2017 ||| Why Gilead Sciences is the 'Top Dividend Stock of the Nasdaq 100' With 3.1% Yield (GILD)",0,0.45768622
2017-05-15,6202500.0,66.08000183105469,66.16999816894531,65.7300033569336,65.94999694824219,59.18960571289063,GILD,"Stocks That Fell to 3-Year Lows in the Week of May 12 ||| Better Buy: Gilead Sciences, Inc. vs. Amgen Inc.",0,0.47728527
2017-05-16,5961000.0,65.73999786376953,66.02999877929688,65.4800033569336,65.72000122070312,58.98318099975586,GILD,"VYM, BMY, GILD, QCOM: ETF Inflow Alert ||| Want to Get in on Biotech? Check Out These 3 Stocks ||| 3 Best Dividend Stocks in Biotech",0,0.48975435
2017-05-17,8976100.0,65.37000274658203,65.62000274658203,64.45999908447266,64.51000213623047,57.897216796875,GILD,Value Stock or Value Trap?,0,0.48760942
2017-05-18,7926000.0,64.44999694824219,64.66999816894531,63.880001068115234,64.43000030517578,57.82542037963867,GILD,"Gilead Sciences Enters Oversold Territory ||| A Doomed Trump Presidency Would Be a Terrifying Development for Pharmaceutical Stocks ||| Alcentra Capital: Selling Stock Or Selling Out? ||| Bank Of America Health Care Conference Concludes Today; Presenters Include Boston Scientific, Humana, Universal Health, Chemed, Community Health, Eagle Pharma, Alnylam, Gilead, & Illumina",0,0.49681807
2017-05-19,8429400.0,64.37999725341797,64.80000305175781,64.08000183105469,64.2300033569336,57.64592742919922,GILD,"Zacks Value Investor Highlights: Avis Budget Group, General Motors, Gilead Sciences, LGI Homes and Micron",1,0.50870544
2017-05-22,7162900.0,64.23999786376953,64.63999938964844,64.12000274658203,64.36000061035156,57.76259231567383,GILD,"Merck's HIV Drug Gets Positive CHMP Opinion for Higher Dose ||| Woodford Investment Management LLP Buys Gilead Sciences Inc, Bioverativ Inc, Biogen Inc, Sells ...",1,0.5326828
2017-05-23,5094600.0,64.36000061035156,64.80000305175781,64.30000305175781,64.69000244140625,58.05877304077149,GILD,Valeant and Gilead: Beaten Down Bargains or Truly Terrible?,0,0.4962472
2017-05-24,5926700.0,64.7300033569336,64.79000091552734,64.2300033569336,64.30999755859375,57.717716217041016,GILD,"3 Reasons Gilead Sciences, Inc. Is a Better Dividend Stock Than Amgen, Inc. ||| Inovio Pharmaceuticals Stock Soars on Encouraging HIV Vaccine Readout ||| Is The Worst Behind Gilead Sciences?",1,0.5247076
2017-05-25,5659000.0,64.5,64.83000183105469,64.20999908447266,64.55999755859375,57.94209289550781,GILD,Federal Reserve Reluctant to Let Go,0,0.49494407
2017-05-26,4021900.0,64.37000274658203,64.75,64.30999755859375,64.5,57.88824462890625,GILD,These Are the 10 Lowest P/E Stocks Today ||| 3 Value Stocks for Daring Investors ||| Benzinga's Option Alert Recap From May 26 ||| Option Alert: Gilead Jan18 75.0 Calls: 2233 @ ASK $1.30: 5722 traded vs 17k OI: Earnings 7/25 After Close (est) $64.57 Ref,0,0.49337193
2017-05-30,6979900.0,64.47000122070312,64.7699966430664,64.30000305175781,64.48999786376953,57.87926483154297,GILD,"7 Things You Didn't Know About Gilead Sciences, Inc. ||| Intercept's (ICPT) Liver Drug Ocaliva Approved in Canada ||| Meet the Cancer Therapy that Could Become the Second Best-Selling Drug in the World by Year's End ||| Gilead Sciences Fixed-Dose Combination of Bictegravir, Emtricitabine and Tenofovir Alafenamide for the Treatment of HIV-1 Meets Primary Endpoint in Four Phase 3 Studies; U.S. NDA Submission Planned For Q2 ||| Watch These 8 Huge Call Purchases In Tuesday Trade",1,0.5253917
2017-05-31,9190200.0,64.47000122070312,64.91999816894531,64.18000030517578,64.88999938964844,58.2382698059082,GILD,Merck's HIV Drug Isentress Gets FDA Approval for Higher Dose ||| Gilead Single Tablet Regiment for HIV Good in Phase III ||| Better Buy: Biogen Inc. vs. Gilead Sciences Inc.,0,0.5150353
2017-06-01,9316300.0,65.01000213623047,65.70999908447266,64.51000213623047,64.62000274658203,57.995941162109375,GILD,"Noteworthy Thursday Option Activity: TUP, RH, GILD",1,0.5198261
2017-06-02,6459300.0,64.9000015258789,65.55000305175781,64.76000213623047,65.4000015258789,58.695987701416016,GILD,"Notable ETF Inflow Detected - IVW, SBUX, QCOM, GILD",1,0.5026218
2017-06-05,6184800.0,65.58999633789062,65.79000091552734,65.04000091552734,65.4800033569336,58.76778793334961,GILD,3 History-Making Stocks ||| 3 Great Dividend Stocks to Buy That You Might Not Know Are Dividend Stocks ||| 3 Dividend Stocks for Daring Investors ||| 3 Stocks Baby Boomers Are Buying That Millennials Aren't,0,0.5170162
2017-06-06,7282800.0,65.19000244140625,65.37999725341797,64.63999938964844,64.8499984741211,58.20235824584961,GILD,"Why Gilead Sciences Stock Slumped in May ||| 3 Value Stocks Perfect for Retirement ||| Gilead, Roche Shares Largely Unimpacted Following Headlines the World Health Organization Expert Committee Said Could Delete Oseltamivir from Next List of Recommended Medicines as General Treatment for Flu Pandemics",0,0.50231165
2017-06-07,7790400.0,65.02999877929688,65.16999816894531,64.19999694824219,64.31999969482422,57.7266960144043,GILD,"The Zacks Analyst Blog Highlights: Gilead, BP, Dow Chemical, America Movil and MetLife ||| Spring Bank Pharmaceuticals' Hepatitis B Results in Context",0,0.5038432
2017-06-08,8744900.0,64.16000366210938,64.58000183105469,64.05999755859375,64.12000274658203,57.54719161987305,GILD,The Best Hep C Drug Stock to Buy in 2017,1,0.5250844
2017-06-09,9338900.0,64.11000061035156,64.94000244140625,63.95000076293945,64.69999694824219,58.06773376464844,GILD,"The 3 Best Value Stocks You Can Buy Right Now ||| Gilead Sciences, Inc.: The Bear Case From a Bull ||| Why GlaxoSmithKline Stock Had a Breakout May ||| What Traders Can Learn From Professional Horse Betting",1,0.49327782
2017-06-12,10459200.0,64.5999984741211,66.69999694824219,64.55000305175781,65.43000030517578,58.72290802001953,GILD,"Notable Monday Option Activity: GE, GILD, ADBE ||| Noteworthy ETF Outflows: OEF, BA, GILD, USB ||| Ex-Dividend Reminder: Analogic, Gilead Sciences and Hill-Rom Holdings ||| 3 Beaten-Up Biotech Stocks: Are They Bargains? ||| Gilead Reports Submission Of NDA For Fixed-Dose Combo Of Bictegravir, Emtricitabine, Tenofovir Alafenamide For HIV ||| What Do To With Starbucks, Amgen, Costco, Twilio, Gilead and Kroger?",0,0.5015834
2017-06-13,8185300.0,65.61000061035156,65.6500015258789,65.01000213623047,65.1500015258789,58.47161102294922,GILD,"Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for June 14, 2017 ||| 3 Dividend Stocks to Buy on Sale ||| Gilead (GILD) Submits NDA for HIV Combination Therapy Regimen ||| Tesaro Is A Top Rumor Mill Stock Right Now; Here Is A Timeline Of The Chatter ||| Wall Street's M&A Chatter From June 12: Neuroderm, Penn Virginia, Tesaro, Synaptics-Conexant",0,0.49459362
2017-06-14,6795700.0,64.91999816894531,65.36000061035156,64.54000091552734,64.98999786376953,58.79730987548828,GILD,"Wall Street's M&A Chatter From June 13: Brookdale, Etsy, Roche-Tesaro",0,0.4705137
2017-06-15,6858100.0,64.70999908447266,65.16000366210938,64.0999984741211,64.80999755859375,58.63445281982422,GILD,"Will These Cutting-Edge Cancer Killers Reignite The Biotech Rally? ||| 3 Stocks With Better Dividends Than CVS Health Corporation ||| Epizyme Provides Positive Interim Data on EZH2 Inhibitor ||| Biotech Stock Roundup: Management Changes at Biogen, Alexion, GILD Files HIV Drug ||| Epizyme Provides Positive Interim Data on EZH2 Inhibitor ||| Goldman Sachs Global Healthcare Conference Concludes Today, Presenters Include: Gilead, Tesaro, Ironwood Pharmaceuticals and Alkermes ||| Biotech Stock Roundup: Management Changes at Biogen, Alexion, GILD Files HIV Drug",0,0.4917684
2017-06-16,10246600.0,64.79000091552734,64.83999633789062,63.7599983215332,64.12000274658203,58.01020431518555,GILD,Is Gilead Sciences a Great Stock for Value Investors? ||| 3 Beaten-Down Stocks Ready to Bounce Back ||| Is Gilead Sciences a Great Stock for Value Investors?,1,0.49923497
2017-06-19,7900100.0,64.19000244140625,64.97000122070312,64.08000183105469,64.80999755859375,58.63445281982422,GILD,5 Answers to Questions Gilead Sciences' Investors Probably Have ||| Gilead Sciences Receives FDA Orphan Designation for Tybost in Treatment of HIV-1 Infection in Pediatric Patients ||| Why Tesaro Inc. Stock Briefly Dipped Today ||| A Peek Into The Markets: U.S. Stock Futures Signal Higher Start On Wall Street ||| Gilead Receives Approval in Canada for VEMLIDY for the Treatment of Chronic Hepatitis B Virus Infection,1,0.5305396
2017-06-20,13114600.0,64.88999938964844,66.0,64.0199966430664,65.58999633789062,59.34013366699219,GILD,"ProShares UltraPro QQQ Experiences Big Inflow ||| Why This Billionaire Just Bought Gilead Sciences, Synergy, and Valeant Stock ||| Gilead's (GILD) HBV Drug Vemlidy Receives Approval in Canada ||| Gilead's (GILD) HBV Drug Vemlidy Receives Approval in Canada ||| Gilead Shares Spike ~$0.45 Off Session Lows As Traders Circulating Takeover Chatter",1,0.50549835
2017-06-21,13981300.0,65.81999969482422,67.69000244140625,65.61000061035156,67.5,61.068138122558594,GILD,"How to Find the Best Value Stocks ||| 5 Biotech Stocks That Are Roaring Back to Life ||| Wednesday's ETF with Unusual Volume: IBB ||| Biotech Stock Roundup: Clovis Soars on Rubraca Data, Seattle Hit by Study Halt ||| Wall Street's M&A Chatter From June 20: Calpine, Parexel, Gilead, Spherix-Hoth Therapeutics, Norsat-Hytera",1,0.48485357
2017-06-22,28962900.0,68.31999969482422,71.44000244140625,68.29000091552734,70.4800033569336,63.764190673828125,GILD,"Nasdaq 100 Movers: CA, REGN ||| Market Close Report: NASDAQ Composite index closes at 6,236.69 up 2.74 points ||| Thursday Sector Leaders: Healthcare, Energy",1,0.4940868
2017-06-23,22911200.0,71.23999786376953,71.37000274658203,69.83999633789062,70.5199966430664,63.800384521484375,GILD,"Stock Market News for June 23, 2017 ||| Deutsche Bank's Take On Big Pharma: 3 Buys And A Hold ||| Benzinga's Top Upgrades, Downgrades For June 23, 2017 ||| Gilead Reports European CHMP Adopted Positive Opinion For Co.'s Vosevi For Treatment Of All Chronic Hep C Genotypes ||| Deutsche Bank Initiates Coverage On Gilead Sciences with Buy Rating, Announces $79.00 Price Target",1,0.5129188
2017-06-26,14129100.0,71.25,71.76000213623047,70.72000122070312,71.23999786376953,64.45176696777344,GILD,"2 Top Biotech Stocks to Buy on Sale ||| Barron's Picks And Pans: Canadian Stocks, NCR, Gilead And More ||| How We Earn $5,300 In Dividends From A $10,000 Investment (VZ, PSX, GILD)",0,0.51311725
2017-06-27,10768700.0,71.4000015258789,71.9000015258789,70.63999938964844,70.6500015258789,63.91796875,GILD,Gilead's (GILD) HCV Drug Application Accepted in the EU ||| 2 Pharma Buyout Targets That May Surprise You,1,0.51274633
2017-06-28,10606200.0,70.97000122070312,72.08999633789062,70.83000183105469,71.91999816894531,65.06696319580078,GILD,"Notable ETF Inflow Detected - VHT, GILD, LLY, AGN ||| FBT's Underlying Holdings Could Mean 11% Gain Potential",0,0.5027826
2017-06-29,11437400.0,72.0,72.16999816894531,70.0199966430664,70.86000061035156,64.10797882080078,GILD,"3 Big Stock Charts for Thursday: Merck & Co., Inc. (MRK), Gilead Sciences, Inc. (GILD) and Valeant Pharmaceuticals Intl Inc (VRX) ||| Trade of the Day: Gilead Sciences, Inc. (GILD) ||| Biotech Stock Roundup: EU Nod for Regeneron RA Drug, Portola Soars on FDA Nod ||| Biotechs Soared In June; Japan, Small Caps Also Outperformed",0,0.4909904
2017-07-03,3453000.0,71.11000061035156,71.5999984741211,70.55999755859375,70.69999694824219,63.96321487426758,GILD,3 Charts That Show Why to Buy Gilead Sciences Stock Now ||| 3 Top High-Yield Pharmaceutical Stocks to Buy Now ||| 3 Reasons Why Gilead Sciences Shouldn't Buy Vertex Pharmaceuticals,1,0.5248521
2017-07-05,7219600.0,70.83000183105469,71.29000091552734,70.16000366210938,70.86000061035156,64.10797882080078,GILD,"Chevron Corporation (CVX) Is Stabilizing — Fill Up ||| Bank on Gilead Sciences, Inc. (GILD) Stock Getting Its Mojo Back ||| Galapagos-Gilead Begin Phase II Study on Uveitis Candidate",0,0.49575865
2017-07-06,7989000.0,70.66000366210938,70.73999786376953,69.19000244140625,69.4800033569336,62.85947036743164,GILD,GILD Dividend Yield Pushes Past 3%,0,0.51127905
2017-07-07,6535800.0,69.69000244140625,69.69000244140625,68.54000091552734,69.25,62.651397705078125,GILD,"Will Gilead's Dividend Keep Climbing? ||| What's Behind Gilead Sciences, Inc.'s 9.5% Rally in June",1,0.5001964
2017-07-10,6485900.0,69.23999786376953,69.73999786376953,69.12000274658203,69.29000091552734,62.68757247924805,GILD,"How Shrewd of a Dealmaker Is Gilead Sciences? Just Look at Its Last 7 Acquisitions ||| 3 Dividend Stocks for Long-Term Investors ||| Top Stock Reports for Wells Fargo, Broadcom & Gilead ||| Spring Bank Pharma Reports Collaboration With Gilead For Hep B Phase 2 Study Exploring Combo Treatment Of SB 9200, Vemlidy",1,0.5023451
2017-07-11,6442700.0,68.98999786376953,69.5,68.61000061035156,69.3499984741211,62.74186706542969,GILD,"The Zacks Analyst Blog Highlights: Wells Fargo, Broadcom, Gilead, NextEra Energy and Emerson Electric ||| Benzinga's Top Upgrades, Downgrades For July 11, 2017 ||| Jefferies Assumes Gilead Sciences at Hold, Announces price target $80.00",1,0.4858994
2017-07-12,5585200.0,69.7699966430664,70.12999725341797,69.61000061035156,69.80000305175781,63.14897537231445,GILD,J&J (JNJ) to Commence Pharma Q2 Earnings Season: What's Up? ||| J&J To Commence Pharma Q2 Earnings Season: What's Up?,1,0.49005038
2017-07-13,7533900.0,69.98999786376953,70.9800033569336,69.5199966430664,70.58000183105469,63.85465240478516,GILD,"The Zacks Analyst Blog Highlights: Merck, Eli Lilly, Celgene, Gilead Sciences and Shire ||| 3 Dividend Stocks That Are Minting Money ||| 3 Value Stocks for Discriminating Investors ||| 5 Pharma & Biotech Stocks That Could Be Big Winners in Q2 Earnings ||| How Biogen Inc. Makes Most of Its Money ||| 5 Drug Stocks Well Poised to Beat Q2 Earnings Estimates ||| Shares of Eli Lilly, AstraZeneca, Merck, Gilead, Abbvie, Other Large Cap Biotech Spiking Higher ||| EMA Validates Gilead's Marketing Application for Fixed-Dose Combination of Bictegravir, Emtricitabine and Tenofovir Alafenamide for Treatment of HIV",0,0.50377965
2017-07-14,5234600.0,70.73999786376953,71.02999877929688,70.41999816894531,70.56999969482422,63.84561538696289,GILD,"Gilead (GILD) Application for HIV Drug Validated in EU ||| Jim Cramer Advises His Viewers On Seagate, Centurylink And Gilead",1,0.52365786
2017-07-17,7612400.0,70.58000183105469,71.86000061035156,70.4000015258789,71.1500015258789,64.37034606933594,GILD,"Gilead (GILD) Application for HIV Drug Validated in EU ||| These 3 Charts Don't Lie: Gilead Sciences Needs an Acquisition ||| Will the Drug Pricing Executive Order Help Big Pharma? ||| VLUE, WMT, GILD, NSC: ETF Outflow Alert ||| Exclusive: Verastem CEO Talks Duvelisib, Pipeline Data, And Further Upside For The Stock",1,0.5149422
2017-07-18,6096700.0,71.30000305175781,71.7300033569336,70.72000122070312,71.69000244140625,64.85889434814453,GILD,"5 Big Pharma Stocks With the Best Drug Pipelines ||| 5 Ways Gilead Sciences Could Spend Its Cash Hoard ||| Health Care Sector Update for 07/18/2017: GILD,CAPR,IMUC ||| Gilead Reports FDA Approved Vosevi For Re-Treatment Of Adults With Chronic Hep C",1,0.5566227
2017-07-19,8312400.0,72.0,72.73999786376953,71.7699966430664,72.72000122070312,65.79074096679688,GILD,"Gilead's HCV Portfolio Receives a Boost With Vosevi Approval ||| Exane Asset Management Buys Monsanto Co, Biogen Inc, Qiagen NV, Sells Citigroup Inc, W R Grace, ... ||| Why Vertex Pharmaceuticals Incorporated Stock Is Soaring Today ||| Biotech Stock Roundup: Vertex Boosted by CF Data, FDA Nod for Gilead, Puma Drugs",1,0.52027833
2017-07-20,9271400.0,72.86000061035156,73.73999786376953,72.7699966430664,73.41999816894531,66.4240493774414,GILD,"Is a Beat in Store for Alexion (ALXN) this Earnings Season? ||| Is Gilead (GILD) Poised for a Beat This Earnings Season? ||| Health Care Sector Update for 07/20/2017: SBPH,GILD,SRPT,CFRX",1,0.47676656
2017-07-21,8874000.0,73.31999969482422,74.41000366210938,73.27999877929688,73.76000213623047,66.73164367675781,GILD,"What to Expect from Keryx (KERX) this Earnings Season? ||| What's in the Offing for Bristol-Myers (BMY) in Q2 Earnings? ||| HCA Healthcare (HCA) Q2 Earnings: Will it Beat Estimates? ||| Amgen (AMGN) to Report Q2 Earnings: What's in the Cards? ||| Warren Buffett's Net Worth Would Be $100 Billion Right Now if Not for This ||| Better Buy: Valeant Pharmaceuticals International, Inc. vs. Gilead Sciences ||| Is a Beat in the Cards for Vertex (VRTX) in Q2 Earnings?",1,0.4905886
2017-07-24,8943200.0,73.69999694824219,74.41999816894531,73.19000244140625,74.38999938964844,67.3016128540039,GILD,"Better Buy: Celgene Corporation vs. Gilead Sciences, Inc. ||| 3 Things You Can Expect in Gilead Sciences' Q2 Update ||| Gilead Sciences, Inc. (GILD) Stock Is a 2-for-1 Deal ||| Is a Beat in Store for Agenus (AGEN) this Earnings Season? ||| 2 Ways To Trade This Week's Healthcare Earnings ||| Adam Feuerstein Tweets: $GILD — HIV is the new (old) profit driver, which is why bictegravir (new data today) is so important. —> statnews.com/2017/07/24/hiv… ||| Gilead Presenting Phase 3 Bictegravir Data At Int'l AIDS Society Conf. Today",0,0.49164793
2017-07-25,9061200.0,74.72000122070312,75.29000091552734,73.62000274658203,73.73999786376953,66.71353912353516,GILD,Will Radius Health (RDUS) Disappoint this Earnings Season? ||| Is a Surprise Coming for Gilead Sciences (GILD) This Earnings Season? ||| 3 Dividend Stocks That Thrive in Bear Markets,1,0.49201247
2017-07-26,10695300.0,74.0999984741211,74.2699966430664,73.62000274658203,74.19000244140625,67.12068176269531,GILD,"VOO, MDT, GILD, BMY: Large Outflows Detected at ETF ||| Biotech Stock Roundup: Amgen, Biogen Top Q2 Estimates, Update on Incyte RA Drug ||| Gilead Sciences Has 3 Available Options, but Only 1 Makes Sense ||| Gilead Sciences, Inc. Boosts Its Full-Year Outlook Thanks to Stronger-Than-Expected Hep C Sales ||| Gilead (GILD) Shares Pop on Q2 Earnings and Revenue Beats ||| Earnings Reaction History: Gilead Sciences Inc., 72.7% Follow-Through Indicator, 5.1% Sensitive ||| After-Hours Earnings Report for July 26, 2017 : FB, GILD, PYPL, SU, LVS, VRTX, PSA, LRCX, EW, DFS, ABX, NOW ||| Gilead Sciences, Inc. Reports Q2 Adj. EPS $2.56 vs $2.15 Est., Sales $7.141B vs $6.35B Est. ||| Gilead Sciences, Verizon Communications, And MGM Resorts Report Q2 Results This Week ||| Redburn Initiates Coverage On Gilead Sciences with Buy Rating ||| 12 Stocks To Watch For July 26, 2017 ||| Earnings Scheduled For July 26, 2017",1,0.50310117
2017-07-27,13871000.0,75.43000030517578,75.98999786376953,74.44999694824219,74.95999908447266,67.8172836303711,GILD,"Validea Benjamin Graham Strategy Daily Upgrade Report - 7/27/2017 ||| Whoops! Twitter Inc (TWTR) Stock Tanks as User Growth Vanishes ||| Gilead (GILD) Tops Q2 Earnings& Revenue Estimates, Stock Up ||| 3 Stocks to Watch on Thursday: Buffalo Wild Wings (BWLD), Gilead Sciences, Inc. (GILD) and PayPal Holdings Inc (PYPL) ||| Score Hot Profits on a Netflix, Inc. (NFLX) Stock Cooldown ||| Gilead Sciences, Inc. (GILD) Stock Has Tremendous Potential Even Post-Rally ||| Wall Street's M&A Chatter From July 26: Biomarin, Sigma Designs, Colgate-Palmolive, Markel-State National ||| Gilead, Juniper, United, Wynn: Fast Money Picks For July 27 ||| 15 Stocks To Watch For July 17, 2017",1,0.48418456
2017-07-28,8954600.0,75.01000213623047,76.02999877929688,74.75,75.94000244140625,68.70391845703125,GILD,4 Drug Stocks in Focus this World Hepatitis Day ||| EC Grants Marketing Authorization for Gilead's Vosevi for the Treatment of All Genotyes of Chronic Hepaptitis C,1,0.55012906
2017-07-31,7994100.0,76.0,76.48999786376953,75.83000183105469,76.08999633789062,68.8396224975586,GILD,5 Things Gilead Sciences' Q2 Earnings Numbers Didn't Tell You,0,0.5320002
2017-08-01,7296600.0,76.3499984741211,76.36000061035156,75.5199966430664,75.69999694824219,68.48678588867188,GILD,"3 ETFs to Watch Out for on Biotech Earnings ||| General American Investors Co Inc Buys Oracle Corp, NOW Inc, eBay Inc, Sells Imax Corp, ... ||| Intercept (ICPT) Posts Narrower-than-Expected Loss in Q2 ||| Gilead Sciences a Top 25 Dividend Giant With 2.74% Yield (GILD) ||| FDA Approves Expanded Labeling For Gilead's Epclusa ||| 3 ETFs To Watch Out For On Biotech Earnings ||| August PDUFA Dates: Biotech Investors Stay Tuned To A Month Of Plenty",1,0.52265614
2017-08-02,7086200.0,75.54000091552734,75.9000015258789,75.16999816894531,75.83999633789062,68.61344146728516,GILD,"Top Ranked Income Stocks to Buy for August 2nd ||| Biotech Stock Roundup: Q2 Earnings from Gilead, CELG & More, Dynavax Up on Panel Vote",0,0.48757932
2017-08-03,11161100.0,75.7699966430664,76.0,74.30000305175781,74.37000274658203,67.28352355957031,GILD,"ITOT, MDT, GILD, SLB: Large Inflows Detected at ETF ||| Should You Buy Vertex Pharmaceuticals Incorporated (VRTX) Stock? 3 Pros, 3 Cons ||| Regeneron (REGN) Beats on Q2 Earnings & Sales, Raises View ||| 3 “Strong Buy” High-Yield Dividend Stocks",0,0.50303715
2017-08-04,14960900.0,73.7300033569336,73.76000213623047,72.58000183105469,73.16000366210938,66.18882751464844,GILD,"Domini Social Investments LLC Buys First Solar Inc, SunPower Corp, Sells Sunrun Inc, Fitbit Inc ||| Infinity (INFI) Q2 Loss Wider than Expected, View Intact ||| Radius (RDUS) Q2 Loss Wider than Expected on Higher Expenses ||| United Therapeutics Shares Up 7.7% On M&A Chatter; GSK, Gilead, Novartis Said To Be Possibly Considering Deal For Co. ||| UK Evening Standard Reports GSK, Gilead, Novartis Could Pay Up to $200/Share for United Therapeutics",1,0.49787468
2017-08-07,7556500.0,72.80000305175781,73.5,72.27999877929688,73.44000244140625,66.442138671875,GILD,"Is AbbVie About to Deliver a Blow to Gilead Sciences' Guidance? ||| 10 Reasons Cancer Drugs Usually Cost $100,000 or More a Year ||| Drug Stocks Q2 Earnings Roster for Aug 8: ACAD, JAZZ & More ||| These 3 Biotechs Just Crushed Analyst Expectations ||| Top Ranked Momentum Stocks to Buy for August 7th ||| Wall Street's M&A Chatter From August 4-7: Acadia Pharma, United Technologies-Rockwell Collins, United Therapeutics",0,0.48342946
2017-08-08,7943900.0,73.41999816894531,73.66999816894531,72.80999755859375,73.2699966430664,66.28834533691406,GILD,"Pioneer Investments Buys Citigroup, Berkshire, Gilead ||| Mallinckrodt (MNK) Tops Q2 Earnings, Generics Segment Weak",1,0.51580465
2017-08-09,12054600.0,72.83000183105469,74.68000030517578,72.83000183105469,73.9000015258789,66.85830688476562,GILD,"Prothena (PRTA) Q2 Loss Narrows as Roche Makes $30M Payment ||| After Hours Most Active for Aug 9, 2017 : VG, ABEV, GGB, T, COR, QQQ, BRCD, MOMO, ODP, ADP, NEE, GILD ||| Validea David Dreman Strategy Daily Upgrade Report - 8/9/2017 ||| Valeant (VRX) Beats Q2 Earnings, Sales in Line, Trims View ||| Mylan (MYL) Misses on Q2 Earnings & Sales, Lowers View ||| Gilead Shares Up ~$0.40 Over Last Min. As Traders Circulating Chatter Of Activist Interest",0,0.4798557
2017-08-10,8813000.0,73.5199966430664,73.77999877929688,72.52999877929688,72.69999694824219,65.77264404296875,GILD,"Alnylam (ALNY) Q2 Loss Narrower than Expected, Sales Miss ||| Gilead Reports FDA Priority Review Designation For Fixed-Dose Combo Of Bictegravir, Emtricitabine, Tenofovir Alafenamide For Treatment Of HIV ||| Morgan Stanley Expects Galapagos Shares To Rise 10%",0,0.5158243
2017-08-11,7029700.0,72.5199966430664,72.68000030517578,71.81999969482422,72.4000015258789,65.5012435913086,GILD,"iShares Edge MSCI USA Value Factor ETF Experiences Big Inflow ||| Forget Teva (TEVA), Buy These 4 Drug Stocks Instead ||| Bb Biotech Ag Buys AveXis Inc, Sells Regeneron Pharmaceuticals Inc, Puma Biotechnology Inc, PTC ...",1,0.5084577
2017-08-14,4952800.0,72.87000274658203,73.11000061035156,72.55999755859375,72.80999755859375,65.87216186523438,GILD,"Why Has 2017 Been a Horrible Year So Far for Biotech Acquisitions? ||| Gilead (GILD) NDA for HIV Combo Regimen Gets Priority Review ||| 3 Healthcare Stocks That Are Looking Cheap Right Now ||| 5 Discounted PEG Stocks for GARP Investors ||| Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for August 15, 2017",1,0.4806511
2017-08-15,5212100.0,73.0,73.37999725341797,72.7300033569336,73.12000274658203,66.15264129638672,GILD,"Chiron Investment Management, LLC Buys iShares iBoxx $ Investment Grade Corporate Bond, Gilead ... ||| Zacks.com featured highlights: Coca-Cola FEMSA, Banco Bilbao Vizcaya Argentaria, Lantheus Holdings, Gilead Sciences and Lam Research ||| Mallinckrodt (MNK) Looks Strong on Acthar, Generics Weak ||| Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for August 16, 2017",1,0.51462686
2017-08-16,5237300.0,73.19000244140625,73.7699966430664,73.12000274658203,73.3499984741211,66.36071014404297,GILD,"Sterneck Capital Management, LLC Buys CorEnergy Infrastructure Trust Inc, Chicago Bridge & ... ||| Biotech Stock Roundup: Regeneron Drops RSV Antibody, Gilead HIV Drug Gets Priority Review ||| Regeneron's (REGN) RSV Drug Suptavumab Fails NURSERY Trial",0,0.49738085
2017-08-17,9065400.0,73.08999633789062,73.41000366210938,72.27999877929688,72.33999633789062,65.44696044921875,GILD,"Is Regeneron Pharmaceuticals the Best Biotech Stock to Buy? ||| 3 Value Stocks for Retirees ||| A Peek Into The Markets: U.S. Stock Futures Down Ahead Of Wal-Mart, Alibaba Earnings ||| Gilead Receives Approval For Vosevi",0,0.51775974
2017-08-18,6052600.0,72.31999969482422,72.62999725341797,71.83000183105469,72.11000061035156,65.23885345458984,GILD,AbbVie's HCV Combo Drug Mavyret Clinches Approval in Canada ||| Gilead (GILD) HCV Drug Vosevi Receives Approval in Canada ||| Pfizer's (PFE) Besponsa Gets FDA Nod with a Boxed Warning ||| Mylan Finalizes Settlement Agreement with DOJ for $465M ||| 5 Biggest Price Target Changes For Friday,1,0.52767336
2017-08-21,5531800.0,72.08000183105469,72.95999908447266,72.08000183105469,72.5999984741211,65.68217468261719,GILD,Monday's ETF with Unusual Volume: BBH,1,0.51938826
2017-08-22,4729300.0,72.66000366210938,73.76000213623047,72.6500015258789,73.33999633789062,66.35166931152344,GILD,"Noteworthy ETF Outflows: FXH, ALGN, CNC, GILD ||| Alkermes Initiates Rolling Submission of Depression Drug ||| 4 Biotech Stocks to Add to your Portfolio Post Q2 Earnings ||| Alexion's (ALXN) Soliris' Label Expansion Approved in Europe",1,0.4943879
2017-08-23,6499300.0,73.2699966430664,74.19999694824219,73.05999755859375,73.73999786376953,66.71353912353516,GILD,Pfizer's Ibrance in First-Line Combo Breast Cancer Study ||| Are Glaxo's Successful New Drugs Enough to Drive Growth? ||| 3 Reasons AbbVie Is a Better Dividend Stock Than Gilead Sciences,1,0.4773056
2017-08-24,4929300.0,73.80999755859375,74.30000305175781,73.6500015258789,74.0199966430664,66.96685791015625,GILD,Why I'm Hanging On to a Loser ||| Roche (RHHBY) Hemophilia A Drug Granted Priority Review,0,0.48933014
2017-08-25,3729000.0,74.2300033569336,74.43000030517578,73.69000244140625,73.79000091552734,66.7587890625,GILD,Novartis (NVS) Receives EC Approval for Breast Cancer Drug ||| Will Endo (ENDP) Continue to Disappoint Investors in 2017?,1,0.5169447
2017-08-28,18800000.0,74.9000015258789,75.94000244140625,74.19999694824219,74.69000244140625,67.57302856445312,GILD,"Why I Love AbbVie Inc. ||| UQM Technologies, Kite Pharma Jump on Monday ||| Midday Update: Sectors Split As Hurricane Harvey's Impact Spreads Through Wall Street ||| Gilead Sciences to Buy Kite Pharma for $11.9 Billion: Is It Enough to Move the Needle? ||| 3 Reasons to Applaud Gilead Sciences' Acquisition of Kite Pharma ||| Stock Futures Perk Up Despite Potential Economic Damage From Hurricane ||| Health Care Sector Update for 08/28/2017: JNJ, PFE, ABT, MRK, AMGN, KITE, GILD, AVEO, NVS ||| Pre-Market Most Active for Aug 28, 2017 : KITE, WFM, GILD, JUNO, TVIX, MYCC, QQQ, FCAU, BHP, Q, DB, BABA ||| Roche's Gazyva Gets Priority Review for Follicular Lymphoma ||| AstraZeneca's Faslodex Gets FDA Nod in First-Line Setting ||| Close Update: Shares Mixed As Hurricane Batters Energy Sector, Underpins Construction, Home Improvement Stocks ||| Novartis Announces Positive Data on Cardiovascular Drug ||| Why Thor Industries, IXYS Corporation, and Kite Pharma Jumped Today ||| Mid-Afternoon Market Update: IXYS Surges On Acquisition News; Uni-Pixel Shares Plunge ||| Why Did Kite Pharma (KITE) Stock Skyrocket Today? ||| Gilead's Plan? Cash In on CAR-T ||| Mid-Afternoon Market Update: IXYS Surges On Acquisition News; Uni-Pixel Shares Plunge ||| Adam Feuerstein Tweets: $GILD should be more worried about $NVS undercutting CAR-T pricing than any NIH-loving ninny. ||| 18 Biggest Mid-Day Gainers For Monday ||| Mid-Day Market Update: Crude Oil Down 2.5%; MaxPoint Interactive Shares Spike Higher ||| Juno Therapeutics Jumps 17% After Gilead's Purchase Of Kite Pharma ||| Mid-Morning Market Update: Markets Mostly Higher; Gilead Sciences To Buy Kite Pharma ||| Gilead Option Alert: Sep 29 $76 Calls Sweep (34) at the Ask: 1751 @ $1.353 vs 389 OI; Ref=$75.15 ||| Gilead Seeks Diversification Into Immuno-oncology Space With $11.9 Billion Kite Pharma Acquisition ||| Gilead CEO On Conf. Call Says Co. Is Not Going Quiet After This Deal, Will Search For More Opportunities ||| 25 Stocks Moving In Monday's Pre-Market Session ||| A Peek Into The Markets: U.S. Stock Futures Edge Lower Ahead Of International Trade Data ||| Gilead to Acquire Kite Pharma for $11.9B Cash, $180/Share ||| Gilead to Acquire Kite Pharma for $180/Share According to Dow Jones ||| Gilead to Buy Kite Pharma for ~$11B in Cash -DJ",1,0.492792
2017-08-29,10688600.0,74.29000091552734,75.80000305175781,74.22000122070312,75.73999786376953,68.52297973632812,GILD,"Here's What Else Gilead Sciences Gets by Buying Kite Pharma ||| Amgen Presents New Repatha Analysis from FOURIER Study ||| Company News For August 29, 2017 ||| 5 Top ROE Stocks to Buy as Hurricane Harvey Wreaks Havoc ||| Gilead to Fly High with Kite Pharma Acquisition for $11.9B ||| Can Gilead Sciences Squeeze $12 Billion From Kite Pharma? ||| Get Ready for More Acquisitions by Gilead Sciences ||| Why Juno Therapeutics Stock Is Blasting Off Today ||| Indecision Won't Kill You, But It Will Take Your Money ||| Analysts Weigh In On Gilead-Kite Pharma Deal ||| Juno Therapeutics Adds To Monday's Gain After Wedbush Upgrade ||| 5 Biggest Price Target Changes For Tuesday ||| Wall Street's M&A Chatter From August 28: Gilead-Kite Pharma, Enzymotec-Frutarom, MaxPoint-Valassis ||| Watch These 8 Huge Call Purchases In Tuesday Trade",1,0.49444702
2017-08-30,35927100.0,75.81999969482422,81.44000244140625,75.73999786376953,81.2300033569336,73.48985290527344,GILD,"Wednesday's ETF with Unusual Volume: PKW ||| Zacks.com featured highlights Broadcom, CBRE Group, Sandvik, Applied Materials and Gilead Sciences ||| The Zacks Analyst Blog Highlights: Gilead Sciences, Kite Pharma, AbbVie's and Novartis AG ||| Gilead (GILD) Up 2.1% Since Earnings Report: Can It Continue? ||| Has Gilead Sciences' Big Bounce Begun With the Kite Pharma Buyout? ||| Why Analog Devices, Gilead Sciences, and Universal Display Jumped Today ||| 5 Biotech Stocks That Are Breaking Higher ||| Why Novatis' $475K CAR-T Cancer Treatment Is Actually Cheap ||| Benzinga's Option Alert Recap From August 30 ||| Gilead Option Alert: Sep 8 $81 Calls Sweep (12) at the Ask: 502 @ $1.221 vs 20 OI; Ref=$80.93 ||| Gilead Option Alert: Sep 15 $77 Puts Sweep (30) at the Ask: 514 @ $1.078 vs 92 OI; Ref=$78.11 ||| The Market In 5 Minutes ||| Brian Stutland Sees Unusual Options Activity In Juno Therapeutics",1,0.5002184
2017-08-31,30895700.0,81.5,84.12999725341797,81.47000122070312,83.70999908447266,75.73353576660156,GILD,"Novartis (NVS) CAR-T Therapy Kymriah Receives FDA Approval ||| Thursday's ETF with Unusual Volume: BBH ||| Novartis $475,000 Price Tag Sets the Stage for a Price War With Gilead Sciences ||| Biotech Stock Roundup: CAR-T in Focus on Gilead-Kite Deal, Incyte Up on Baricitinib Update ||| After Hours Most Active for Aug 31, 2017 : DOW, DD, SBAC, BAC, QQQ, MSFT, TEVA, PFE, GE, AMAT, GILD, INTC ||| Could Gilead Sciences Stock Skyrocket 25%? 1 Analyst Thinks So ||| Why bluebird bio Inc Continued Its March Higher Again Today ||| A Sign Of Things To Come? Traders Are Betting On More Biotech Mergers ||| S-3 From Gilead Shows Registration For Mixed Securities Shelf Offering ||| Benzinga's Option Alert Recap From August 31 ||| Gilead Option Alert: Feb 16 $80 Puts Sweep (2) at the Bid: 1000 @ $3.9 vs 111 OI; Ref=$83.870 ||| iShares NASDAQ Biotech ETF At Highest Since Level Since December 2015 ||| Street Puts Stamp Of Approval On Gilead's Kite Pharma Takeover ||| 18 Biggest Mid-Day Gainers For Thursday ||| Gilead Gets An Upgrade Amid 'Game-Changing' Kite Deal ||| Benzinga's Top Upgrades, Downgrades For August 31, 2017 ||| Argus Upgrades Gilead Sciences to Buy ||| Watch These 7 Huge Put Purchases In Thursday Trade ||| Watch These 7 Huge Call Purchases In Thursday Trade",1,0.5064416
2017-09-01,14311600.0,83.36000061035156,84.0999984741211,82.25,83.75,75.76972198486328,GILD,"Gilead Buys Kite, the Future of CAR-T, and A Visit to the New Whole Foods ||| Friday’s Vital Data: Apple Inc. (AAPL), Advanced Micro Devices, Inc. (AMD) and Gilead Sciences, Inc. (GILD) ||| 5 Winning Stocks to Beat September Blues ||| Valeant (VRX) Continues to Lose Ground: Can It Bounce Back? ||| Gilead Sciences’ Oncology M&A Strategy Explained ||| You Reached Retirement: 3 Stocks to Consider Today ||| Wonder Why Gilead Sciences Bought Kite Pharma? Here’s the Answer! ||| Attention Biotech Investors: September Ushers In Another Slew Of PDUFA Catalysts ||| Sell In May And Go Away? Doing So With These Stocks Was A Mistake ||| Watch These 5 Huge Put Purchases In Friday Trade",0,0.46799102
2017-09-05,13491900.0,83.23999786376953,83.62000274658203,81.3499984741211,82.55999755859375,74.693115234375,GILD,"3 Biotech Stocks That Skyrocketed This Week ||| Vetr Urges Hold On Gilead After Kite Merger ||| Here's the Best Dividend Stock in Big Pharma ||| Why Gilead Sciences Shares Soared 10.6% in August ||| Better Buy: Gilead Sciences, Inc. vs. Johnson & Johnson ||| The Only 2 Biotech Stocks With a Higher Dividend Yield Than the S&P 500 ||| The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Activision Blizzard, Intuit, Alexion Pharmaceuticals and Gilead Sciences ||| Gilead Sciences Couldn't Have Timed its Splash Into CAR-T Better ||| Biotech Stocks Back in Favor: Will the Rally Continue? ||| Why Juno Therapeutics Shares Vaulted 46% Higher in August ||| Why It's Useful To Know A Company's Competitors When Trading",1,0.5138387
2017-09-06,10694600.0,82.8499984741211,83.43000030517578,82.51000213623047,82.94999694824219,75.04595184326172,GILD,"Mallinckrodt Down as District Court Invalidates Inomax Patents ||| Here's What Lifted bluebird bio Inc. Stock 40% Higher in August ||| Why Kite Pharma Soared 64.8% in August ||| Citi Biotech Conference Begins Today, Presenters Include: Gilead, Ligand, Puma Biotech, and Bioverativ",1,0.5024656
2017-09-07,13147800.0,83.12000274658203,85.62000274658203,82.9000015258789,85.47000122070312,77.3258285522461,GILD,"5 Things You'll Want to Know From Celgene Corporation's Latest Presentation ||| Are These Healthcare Stocks Top Takeover Targets? ||| Are You Buying Gilead Sciences, Inc. for the Wrong Reason? ||| 5 Things Gilead Sciences' Management Just Said That You'll Want to Know ||| Kymriah, First CAR-T Therapy Approved: 4 Pharma Stocks in Focus ||| Najarian Brothers See Unusual Options Activity In Tripadvisor And Gilead ||| Pro: Biotech Is The Hottest ETF Of 2017 With Plenty Of Upside Ahead",0,0.5133427
2017-09-08,11611100.0,85.29000091552734,86.2699966430664,84.9000015258789,85.0999984741211,76.9910888671875,GILD,"Noteworthy ETF Outflows: ITOT, GILD, SLB, CVS ||| GILD Crosses Above Average Analyst Target ||| After Hours Most Active for Sep 8, 2017 : KNX, AAPL, IUSG, IUSV, QQQ, VIPS, ITUB, CHK, GILD, JBLU, T, XOM ||| 4 Biotech Stocks to Improve Your Portfolio’s Health",0,0.49089718
2017-09-11,10125200.0,85.68000030517578,86.0,84.13999938964844,84.5199966430664,76.46635437011719,GILD,"Why Exelixis, Inc. Could Be a Gold Mine for Growth Investors ||| CAR-T Mania: Could Juno Therapeutics Get Acquired Next? ||| 5 Tough Questions for Gilead Sciences About the Kite Pharma Acquisition ||| Top Stock Reports for Gilead, Oracle & Morgan Stanley ||| The Move in SPDR S&P Biotech (ETF) (XBI) ETF Is Coming — Get on Board ||| Morgan Stanley Healthcare Conference Begins Today, Presenters Include: Veeva Systems, Quorum Health, Neurocrine Biosciences, Vertex Pharma, Merck, Ocular Therapeutix, Biogen, Gilead, and Bristol-Myers",0,0.4839826
2017-09-12,8907900.0,84.1500015258789,84.75,83.80000305175781,84.51000213623047,76.45730590820312,GILD,"Ex-Dividend Reminder: Gilead Sciences, Hill-Rom Holdings and Owens & Minor ||| The Zacks Analyst Blog Highlights: Gilead, Oracle, Morgan Stanley, Expedia and Kroger ||| 3 Stocks for Future Millionaires",0,0.4791308
2017-09-13,7594800.0,84.5,84.51000213623047,83.37000274658203,83.68000030517578,75.70639038085938,GILD,"Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for September 14, 2017 ||| 3 Biotech Stocks That Have Already Quadrupled in 2017 ||| Is the Sell-Off of Intercept Pharmaceuticals Stock Overblown? ||| Gilead Sciences, Inc.'s Best Investment of 2017 (Hint: It Wasn't Kite Pharmaceuticals)",0,0.45700732
2017-09-14,9605400.0,83.13999938964844,83.13999938964844,81.56999969482422,82.29000091552734,74.91438293457031,GILD,"Nasdaq 100 Movers: HSIC, CTRP ||| CAR-T Therapy FDA Approved - Slingshot Insights' Idea Of The Month ||| 4 Biotech Stocks That Show Promise on Sustainable Growth ||| Options Traders Expect Huge Moves in Gilead Sciences (GILD) Stock",1,0.5109632
2017-09-15,12401900.0,82.79000091552734,83.5,82.30999755859375,82.36000061035156,74.97811126708984,GILD,3 Reasons Why Gilead Sciences Stock Is a Buy Now ||| Validea Joel Greenblatt Strategy Daily Upgrade Report - 9/15/2017 ||| 3 Dividend Healthcare Stocks ||| RBC Initiated Coverage On 33 Pharma/Biotech Cos.,1,0.53638846
2017-09-18,7886500.0,82.52999877929688,83.5,81.54000091552734,82.97000122070312,75.5334243774414,GILD,"3 Great Income Stocks That Could Double Their Dividends ||| 3 Biotech Stocks That Are Just Getting Started ||| Notable ETF Inflow Detected - MOAT, GILD, GWRE, VFC ||| 3 Value Stocks for Smart Investors ||| Why Bellicum Pharmaceuticals Stock Is Rising Today",0,0.50697166
2017-09-19,6310500.0,83.38999938964844,83.38999938964844,82.12999725341797,82.29000091552734,74.91438293457031,GILD,"Yes, Juno Therapeutics (JUNO) Just Became a Great CAR-T Trade ||| Gilead Sciences' Kite Pharma Deal Has Already Paid for Itself -- for Investors ||| AMD, Bank Of America, Gilead, Intel: Fast Money Picks For September 19",1,0.4679673
2017-09-21,6194700.0,82.7300033569336,83.41000366210938,82.2300033569336,82.62000274658203,75.21479034423828,GILD,4 Sell-Ranked Biotech Stocks with Falling Estimates to Avoid ||| Immunize Juno Therapeutics Inc (JUNO) Stock With This Trade ||| 3 Biotech Stocks With Major Catalysts Incoming,1,0.5133401
2017-09-22,5654700.0,82.47000122070312,83.37000274658203,82.01000213623047,83.2699966430664,75.80653381347656,GILD,"3 Big Biotech Stocks to Buy This Fall ||| Juno Therapeutics Inc (JUNO) Stock: To Buy or Not to Buy? ||| Oddly, Juno Therapeutics Is Jumping 11.3% Today ||| Gilead's (GILD) Epclusa Receives Label Expansion in Canada",1,0.5578201
2017-09-25,8473400.0,83.41000366210938,84.27999877929688,82.86000061035156,83.61000061035156,76.1160659790039,GILD,3 Sector-Specific Trades to Start the Week Off Right ||| First Week of May 2018 Options Trading For Gilead Sciences (GILD) ||| Gilead's Sovaldi Approved by the China FDA for Treatment of Chronic Hepatitis C Virus Infection,1,0.5476796
2017-09-26,7900000.0,83.66999816894531,84.7300033569336,83.55000305175781,83.76000213623047,76.25260925292969,GILD,"Noteworthy ETF Outflows: FTA, GPS, GILD, LEA ||| Kite Pharma Triples So Far in 2017: What's Driving the Rally? ||| Biotech Stock Roundup: Amgen Reiterates 2017 Outlook, Intercept Hit by Ocaliva Safety Issues ||| FDA Chief Gottlieb Addresses Opioids, Cancer, New Therapies ||| Gilead, Kite Pharma Report Expiration Of HSR Waiting Period",1,0.49003142
2017-09-27,6818500.0,83.9800033569336,84.55000305175781,83.45999908447266,83.86000061035156,76.34366607666016,GILD,"If Familiarity Breeds Contempt, What Do Debt And Complacency Breed? ||| Gilead Sciences COO Kevin YOung CBE To Retire Effective Early 2018",0,0.49700138
2017-09-28,17739900.0,83.51000213623047,83.5999984741211,79.20999908447266,80.91000366210938,73.65807342529297,GILD,"Market Close Report: NASDAQ Composite index closes at 6,453.45 up .19 points ||| Why Gilead Sciences, Pier 1 Imports, and PetMed Express Slumped Today ||| Novartis Could Acquire This Biotech — Why A Deal Is 'Very Logical' ||| Gilead (GILD) Gets Approval for HCV Drug Sovaldi in China ||| Biotech Stocks To Watch And Pharma Industry News ||| Gilead Tumbles On Report HIV-Drug Whistleblower Case Reopened ||| Noteworthy Thursday Option Activity: GILD, BMY, XOM ||| Biotechs Beating The Market, But Are They In Buy Range? ||| Indexes Mixed, Apple And Gilead Down; Here Is The Threat To Autohome Stock",1,0.49264556
2017-09-29,13301300.0,81.19999694824219,81.95999908447266,79.30999755859375,81.0199966430664,73.75821685791016,GILD,"Keep Riding the GoPro Inc (GPRO) Stock Wave! ||| How Will Trump’s Proposed Tax Reform Impact Drug Companies? ||| Go Long Costco Wholesale Corporation (COST) Stock for Big-Time Gains ||| Gilead Sciences, Inc. (GILD) Stock Got Its Mojo Back",1,0.47969452
2017-10-02,9805400.0,81.20999908447266,83.62999725341797,81.18000030517578,83.5199966430664,76.03412628173828,GILD,"Best Buy: Johnson & Johnson, Pfizer, or Gilead Sciences? ||| Merck Drops Two HCV Combination Programs Amid Competition ||| Here's Why Bluebird Bio (BLUE) Stock Is Falling Today ||| Better Buy: Gilead Sciences, Inc. vs. Pfizer",0,0.458386
2017-10-03,6513200.0,83.5,84.2300033569336,82.12999725341797,83.19000244140625,75.73371124267578,GILD,"Why bluebird bio, Inc. Stock Gained 10% in September ||| Will Gilead & AbbVie Benefit from Merck's Decision to Drop Two HCV Programs? ||| The 5 Best M&A Deals of 2017 (So Far!) ||| Good News and Bad News for Gilead Sciences: Which Carries More Weight?",0,0.49547356
2017-10-04,6711400.0,83.2300033569336,83.26000213623047,82.06999969482422,82.41999816894531,75.03271484375,GILD,"FXH, ALNY, ALGN, GILD: Large Inflows Detected at ETF ||| Biotech Stock Roundup: Endocyte Shoots up on Deal, Amgen-AbbVie Settle Humira Litigation ||| Gilead Report No Patients In bictegravir Treatment Arm Demonstrated Treatment-Emergent Resistance Through 48 Weeks, Was Found To Be Non-Inferior To Boosted Protease Inhibitor Based Regiments ||| Jefferies Reinstates Hold on Gilead Sciences, Announces $93.00 Price Target ||| Gilead Announces New License Agreement With UN-Backed Medicines Patent Pool for Access to Bictegravir",1,0.52556086
2017-10-05,6717100.0,82.22000122070312,83.52999877929688,82.12999725341797,83.51000213623047,76.0250244140625,GILD,"5 Undervalued Stocks With Free Cash Flow to Burn ||| Benzinga's Top Upgrades, Downgrades For October 5, 2017 ||| Oppenheimer Initiates Coverage On Gilead Sciences with Perform Rating",0,0.5185178
2017-10-06,5797000.0,82.94000244140625,83.22000122070312,81.94999694824219,82.13999938964844,74.77781677246094,GILD,Everything Is Going Right for AbbVie: Is It the Best Biotech Stock to Buy Right Now? ||| Here's What's Has Happened in the HCV Space Lately ||| Intercept Dives Along With Ocaliva Prescriptions On FDA Warning ||| 5 Stocks the Bull Market Left Behind ||| Gilead Option Alert: Oct 20 $81.5 Puts Sweep (23) at the Ask: 507 @ $1.191 vs 329 OI; Ref=$82.05 ||| Life (Science) Lessons: The Hows And Whos To Play Biotech,0,0.49818745
2017-10-09,3959800.0,82.36000061035156,82.76000213623047,81.55999755859375,81.9800033569336,74.63216400146484,GILD,This Dirt-Cheap Biotech Stock Is a Bargain to Buy ||| Bitcoin vs. Biotech: Which Is the Smarter Investment? ||| AbbVie's Fast Becoming a Top Stock to Buy Now ||| Health Care Sector Back In Focus In Congress Ahead Of Q3 Earnings Result ||| Watch These 7 Huge Put Purchases In Monday Trade,1,0.5140029
2017-10-10,5750100.0,81.9000015258789,83.05999755859375,81.86000061035156,83.04000091552734,75.59716033935547,GILD,"Going Long Pfizer Inc. (PFE) Stock Is an Easy Pill to Swallow ||| $50,000 Per Year in Prescription Drugs? You Likely Know Someone Who Used at Least That Much ||| Horan Capital Management Buys TJX Inc, Chipotle Mexican Grill Inc, Nike Inc, Sells Berkshire ... ||| Healthcare: Are These the Best Dividend Stocks to Buy Now? ||| These Were The Most Bought And Sold Stocks In September ||| 5 Pharma & Biotech Stocks That Could Be Big Winners in Q3 Earnings",0,0.46141052
2017-10-11,6770200.0,83.05999755859375,83.29000091552734,82.30999755859375,82.56999969482422,75.16927337646484,GILD,"Barclays Reinstates Overweight on Gilead Sciences, Announces $90.00",0,0.48478845
2017-10-12,6763600.0,82.56999969482422,82.81999969482422,81.0199966430664,81.30000305175781,74.01311492919922,GILD,"ANTIPODES PARTNERS Ltd Buys KT Corp, Michael Kors Holdings, Oracle Corp, Sells Dynegy Inc, ... ||| This No. 1-Ranked Medical Stock Is Breaking Out With Q3 Earnings Due ||| Non-Alcoholic Steatohepatitis 2017 Progress Update ||| 5 Game-Changing Cancer Drug Innovations Being Developed Right Now ||| How To Use Options During Earnings Season",0,0.4837785
2017-10-13,5682900.0,81.2699966430664,81.58000183105469,80.6500015258789,81.16999816894531,73.89476013183594,GILD,"Exane Asset Management Buys AT&T Inc, Verizon Communications Inc, CNH Industrial NV, Sells ... ||| It’s Time to Start Buying Beaten-Up Gilead Sciences, Inc. (GILD) Stock ||| Gilead Sciences, Inc. (GILD) Stock Is Primed After Kite Pharma Buy ||| 3 Healthcare Value Stocks ||| Why These Biotech Players Look Poised To Crush Earnings Views",0,0.46309927
2017-10-16,7377600.0,81.12999725341797,81.20999908447266,79.55000305175781,79.94999694824219,72.78411102294922,GILD,"IBD Biotech Innovator Awards ||| Kite Pharma Cancer Treatment Stands Out In Hot CAR-T Field ||| Notable Monday Option Activity: TGTX, GILD, RT ||| Trump Likely To Sign Executive Order On Drug Pricing 'Any Day'",1,0.5007635
2017-10-17,7041800.0,80.0,80.70999908447266,79.55999755859375,80.23999786376953,73.0481185913086,GILD,"Zacks Industry Outlook Highlights: Gilead, Teva, Pfizer and Amgen ||| Better Buy: Ziopharm Oncology, Inc. vs. Celldex Therapeutics",0,0.48988396
2017-10-18,7181900.0,80.26000213623047,80.83999633789062,79.76000213623047,80.01000213623047,72.83873748779297,GILD,"S&P 500 Futures: These 5 Top Stocks Are Big Overnight Movers ||| Top Stock Reports for IBM, Celgene and Procter & Gamble ||| Gilead Subsidiary Kite Announces FDA Approval For Yescarta ||| 13 Stocks Moving In Wednesday's After-Hours Session",1,0.5040473
2017-10-19,15565200.0,81.52999877929688,82.47000122070312,80.51000213623047,81.58999633789062,74.2771224975586,GILD,"Sellers Come Into Nasdaq As Apple Lags; Another IPO Soars ||| iShares Edge MSCI USA Value Factor ETF Experiences Big Inflow ||| Does Gilead Now Have A New Multi-Billion-Dollar Franchise? ||| Zacks Market Edge Highlights: Gilead, Biogen, Teva, AbbVie and Aetna ||| Gilead Slaps Mega-Price on Its Newly Approved CAR-T ||| After Hours Most Active for Oct 19, 2017 : V, AAPL, CMCSA, BABA, PYPL, PFE, T, KW, GE, QQQ, ADBE, GILD ||| Senator Bernie Sanders Tweets: Gilead, one of the greediest pharmaceutical corporations in the world, is once again gouging people dealing with life-threatening illness. ||| 32 Stocks Moving In Thursday's Mid-Day Session ||| Gilead's Yescarta Cancer Treatment Approved, Some Analysts Shrug ||| Gilead Volatile After Kite Pharma's Yescarta Gets FDA Approval ||| 22 Stocks Moving In Thursday's Pre-Market Session",0,0.4937824
2017-10-20,9188300.0,81.94999694824219,81.94999694824219,80.44999694824219,81.20999908447266,73.9311752319336,GILD,"Celgene Could Be the Best CAR-T Stock to Buy, Not Gilead Sciences ||| Gilead (GILD) CAR-T Therapy Yescarta Clinches FDA Approval ||| Gilead Sciences Shows Rising Relative Price Performance; Still Shy Of Key Threshold ||| Gilead Sciences Reports Phase 2 And 3 Studies Of Its Approved HCV And HBV Medicines At The 2017 Liver Meeting",0,0.4944719
2017-10-23,6803400.0,81.25,81.31999969482422,80.08999633789062,80.16999816894531,72.98439025878906,GILD,Why Agenus Inc. Stock Briefly Popped Today ||| Is Gilead (GILD) Poised for a Beat This Earnings Season? ||| Gilead Drug Approval Fuels Interest in CAR-T Space: 3 Stocks to Consider ||| 3 Gene Therapy Stocks That Could Make You Rich ||| IBD's No. 1 Group Under Pressure; These 6 Key Earnings Loom; S&P 500 Futures ||| What's in Store for BioMarin (BMRN) This Earnings Season? ||| The Week Ahead: Earnings Season Starts In Earnest ||| Alpine Immune Sciences and Kite Extend Research Term of Collaboration for CAR-T and TCRs,0,0.4889173
2017-10-24,7300300.0,80.18000030517578,80.37999725341797,78.80000305175781,80.0999984741211,72.92066192626953,GILD,"Better Buy: Gilead Sciences, Inc. vs. Amgen ||| 3 Healthcare Value Stocks ||| Is a Beat in Store for Alexion (ALXN) This Earnings Season? ||| Healthcare ETFs Set To Soar As Q3 Earnings Unfold ||| Gilead Announces GS-0976 In Phase 2 Study Showed Statistically Significant Efficacy Compared To Placebo",0,0.4951801
2017-10-25,9571700.0,80.08000183105469,80.08000183105469,78.69000244140625,79.88999938964844,72.72947692871094,GILD,"Is a Surprise Coming for Gilead Sciences (GILD) This Earnings Season? ||| Biotech Stock Roundup: Biogen Tops Q3 Earnings, Gilead's CAR T Drug Gets FDA Nod ||| Is a Beat in Store for Agenus (AGEN) This Earnings Season?",0,0.4804575
2017-10-26,12451300.0,78.29000091552734,79.5,77.0,77.87999725341797,70.89965057373047,GILD,"Gilead Sciences, Inc. Stock Looks Good Regardless of Quarterly Earnings Report ||| Gilead Sciences Inc. Still Singing the HCV Blues in the 3rd Quarter ||| Gilead (GILD) Q3 Earnings and Revenues Sink ||| Gilead Tops Sales, Profit Views But Misses On Hep C; Shares Fall ||| 5 Biotech Stocks That Are Getting Battered Too Hard for Comfort ||| Earnings Reaction History: Gilead Sciences Inc., 66.7% Follow-Through Indicator, 4.8% Sensitive ||| After-Hours Earnings Report for October 26, 2017 : MSFT, AMZN, GOOGL, INTC, GILD, BIDU, CB, SYK, WDC, FTV, CERN, EXPE ||| 14 Stocks Moving In Thursday's After-Hours Session ||| Gilead Sciences Reports Q3 Adj. EPS $2.27 vs $2.13 Est., Sales $6.512B vs $6.39B Est. ||| It's A Bad Day For Biotechs ||| Earnings Scheduled For October 26, 2017",0,0.47260773
2017-10-27,22760700.0,75.01000213623047,77.19999694824219,72.76000213623047,77.06999969482422,70.16223907470703,GILD,"Dow Stock Merck, AbbVie Top Earnings Views, Light On Sales ||| 3 Stocks to Watch on Friday: Baidu Inc (ADR) (BIDU), Gilead Sciences, Inc. (GILD) and Mattel, Inc. (MAT) ||| Daily Dividend Report: SPG, PFG, GILD, AGN, ITW ||| Gilead Sciences, Inc. Stock Is a Buy When It Seems Like It Shouldn’t Be ||| 45 Stocks Moving In Friday's Mid-Day Session ||| 32 Stocks Moving In Friday's Pre-Market Session",0,0.47214985
2017-10-30,11277000.0,76.0999984741211,76.93000030517578,75.25,75.98999786376953,69.1790542602539,GILD,"Validea Benjamin Graham Strategy Daily Upgrade Report - 10/28/2017 ||| 3 ETFs to Watch on Biotech Earnings ||| Gilead Sciences, Inc. (GILD) Stock Isn’t Worth It Here ||| 5 Things You Need to Know From Gilead Sciences' Q3 Update ||| iShares Edge MSCI USA Value Factor ETF Experiences Big Inflow ||| What's in the Cards for PFE, INCY and ACOR in Q3 Earnings? ||| Company News For Oct 30, 2017 ||| How Celgene, Gilead's Pricing Woes Continue To Haunt Biotech Stocks ||| Top Research Reports for JPMorgan Chase, Gilead & ConocoPhillips",0,0.4688808
2017-10-31,8796600.0,75.83000183105469,76.38999938964844,74.72000122070312,74.95999908447266,68.24134826660156,GILD,"The Zacks Analyst Blog Highlights: JPMorgan Chase, Gilead, ConocoPhillips, General Electric and Walgreens ||| Ionis Down Big on Analyst Miss",0,0.4942951
2017-11-01,8776400.0,74.69000244140625,75.8499984741211,74.22000122070312,74.83000183105469,68.1230239868164,GILD,How Blood-Disease Data Sent These 2 Biotech Stocks Flying ||| Can Juno Therapeutics Outmaneuver Its CAR-T Competitors? ||| See Which Of The Latest 13F Filers Holds Gilead Sciences ||| The Health Care Episode: Reviewing Earnings Season And A CVS/Aetna Merger,0,0.48478466
2017-11-02,7464400.0,74.72000122070312,74.80000305175781,73.55000305175781,73.80999755859375,67.1944351196289,GILD,"Intercept (ICPT) Q3 Loss Narrower Than Expected, Sales Beat ||| 5 Biotech and Pharma Stocks with Key FDA Catalysts this November ||| Sharp Drop Celgene Corporation Stock May Have Just Created an Entry Point ||| Notable Thursday Option Activity: VMC, GILD, MIC ||| What's Behind Gilead Sciences Inc.'s $7.8 Billion Slide in October?",0,0.4924048
2017-11-03,7648600.0,73.58999633789062,73.8499984741211,72.83000183105469,73.45999908447266,66.87579345703125,GILD,"3 Reasons It's Smart to Buy Celgene's Stock Now ||| WestEnd Advisors, LLC Buys Bank of America Corporation, SPDR Portfolio Short Term Corporate ...",0,0.54469085
2017-11-06,8268200.0,73.29000091552734,73.5,72.11000061035156,72.37999725341797,65.89260864257812,GILD,"3 Stocks Changing the Future of Healthcare ||| 3 ETFs to Watch on Biotech Earnings ||| FDA Commissioner Tweets: Today, #FDA finalized guidance to help bring more Hepatitis C treatments to the market https://go.usa.gov/xnbNg ||| Federal Register Issues Guidance: Chronic Hepatitis C Virus Infection; Developing Direct-Acting Antiviral Drugs for Treatment",1,0.5261138
2017-11-07,7824400.0,72.41000366210938,73.33999633789062,72.31999969482422,73.20999908447266,66.64822387695312,GILD,"Credit Suisse Healthcare Conference Continues Today, Presenters Include: Walgreens, Vertex Pharmaceuticals, Laboratory Corp, Puma Biotech, Anthem, Alexion Pharma, Celgene, and Gilead ||| Gilead Sciences Says In Sept 2017, Post-Trial Motions Judge Denied Idenix's Motion for Enhanced Damages, Attorney's; Says Expects Judge to Rule On Outstanding Motions With Relation to Idenix in Late 2017, Early 2018‍ -10Q",0,0.48694053
2017-11-08,8095400.0,73.31999969482422,73.37000274658203,72.72000122070312,73.0999984741211,66.5480728149414,GILD,"Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for November 09, 2017 ||| A Big Biotech ETF Is About To Get Cheaper",0,0.4999182
2017-11-09,5817800.0,73.04000091552734,73.41999816894531,72.62000274658203,73.0199966430664,66.4752426147461,GILD,"You'll Be Stunned by Gilead Sciences CEO's Prediction for 2018 ||| Biotech Stock Roundup: Regeneron Delivers Strong Q3 Results, Cellectis Clinical Hold Lifted ||| Sphera Funds Management Ltd. Buys Cellcom Israel, Allergan PLC, Teva Pharmaceutical Industries, ... ||| Lightning Round: Jim Cramer Advises His Viewers On Gilead, Exxon Mobil And More",1,0.48705173
2017-11-10,7698200.0,72.95999908447266,74.08000183105469,72.19999694824219,73.7699966430664,67.15802001953125,GILD,"Notable Friday Option Activity: ICPT, GILD, CLVS",0,0.50886506
2017-11-13,8735300.0,73.25,73.38999938964844,72.51000213623047,72.8499984741211,66.32046508789062,GILD,"What Investors Need to Know About Investing in Low PE Stocks ||| As Gilead's Outlook Dims, Argus Downgrades ||| Argus Downgrades Gilead Sciences to Hold",0,0.4906772
2017-11-14,10925600.0,72.69999694824219,72.72000122070312,70.05000305175781,71.1500015258789,64.7728500366211,GILD,"GILD Makes Notable Cross Below Critical Moving Average ||| Temasek Holdings (private) Ltd Buys Visa Inc, Virtu Financial Inc, Ctrip. ... ||| Biotechs Sell Off In Droves — Are Investors Seeking Mergers? ||| 7 Life Science Stocks to Buy Today",1,0.49937782
2017-11-15,8539300.0,70.62999725341797,72.0999984741211,70.52999877929688,71.80999755859375,65.37369537353516,GILD,"Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for November 16, 2017 ||| Gilead Sciences Inc (GILD) President and CEO John F Milligan Sold $16 million of Shares ||| Portfolio Manager Says Now Is A Great Time To Buy Biotech",1,0.48496073
2017-11-16,7535900.0,71.75,72.5999984741211,71.25,72.41000366210938,65.91992950439453,GILD,"Summit Street Capital Management, LLC Buys Fluor Corp, Hawaiian Holdings Inc, Kulicke & ... ||| Biotech Industry: Small Innovators Outflank Big Caps As Blockbuster Drug Patent Cliff Looms",1,0.5273855
2017-11-17,5719100.0,72.2699966430664,72.62000274658203,72.12000274658203,72.44000244140625,65.94723510742188,GILD,"Celgene CAR-T Therapy Gets Breakthrough Therapy Designation ||| Biotechs Trading Lower in Q4 on Macro Uncertainty, Tepid Q3",0,0.5012377
2017-11-20,6452500.0,72.41000366210938,72.61000061035156,71.55000305175781,72.12999725341797,65.66500854492188,GILD,"Better Buy: Biogen Inc. vs. Gilead Sciences ||| Gilead Sciences Enters Oversold Territory ||| After Hours Most Active for Nov 20, 2017 : ACM, QQQ, BAC, LC, EUFN, PFE, WFC, T, URBN, FITB, GILD, AAPL",1,0.4913713
2017-11-21,6473500.0,72.06999969482422,72.83999633789062,71.81999969482422,72.51000213623047,66.01095581054688,GILD,The 1 Thing Missing From Gilead Sciences' 2018 Priority List,1,0.51452893
2017-11-22,4369000.0,72.4800033569336,73.08999633789062,72.3499984741211,72.81999969482422,66.29316711425781,GILD,J&J & Glaxo Get FDA Approval for First Two-Drug HIV Regimen,0,0.53647506
2017-11-24,2335900.0,72.76000213623047,72.91999816894531,72.2300033569336,72.45999908447266,65.9654312133789,GILD,CAR-T Therapy Space 2017 Progress Report ||| Biotech Poised for Growth: 3 Healthy Fund Choices ||| J&J & Glaxo's Jucala Approval Puts Spotlight on HIV Space,0,0.5270999
2017-11-27,4907500.0,72.51000213623047,72.5999984741211,71.5199966430664,71.69999694824219,65.2735595703125,GILD,"Sphera Funds Management Ltd. Buys Cellcom Israel, Allergan PLC, Teva Pharmaceutical Industries, ... ||| Hedge Funds Are Snapping Up These 3 ‘Strong Buy’ Stocks",1,0.49490342
2017-11-28,5971200.0,72.16000366210938,72.68000030517578,71.4000015258789,72.58999633789062,66.08378601074219,GILD,"Health Care Sector Update for 11/28/2017: COOL,PZRX,PETX, MDT,GILD,PFE ||| Glaxo, Pfizer's ViiV Healthcare Begins HIV Drug Combo Study ||| X-Chem, Gilead Report Drug Discovery Collaboration To Screen Proprietary Dex Libraries To Discover Therapeutic Leads Against Targets In Antiviral, Added Therapeutic Areas ||| Amazon, Gilead, Nordstrom: Fast Money Picks For November 28",1,0.4776262
2017-11-29,9913400.0,72.83999633789062,74.19999694824219,72.56999969482422,73.66999816894531,67.06698608398438,GILD,"Notable ETF Inflow Detected - QUAL, BLK, MMC, GILD ||| 3 Dividend Stocks With Better Yields Than McDonald's ||| How Will U.S. Tax Reform Impact Pharma/Biotech Industry?",1,0.4978871
2017-11-30,11766900.0,74.48999786376953,75.0999984741211,73.75,74.77999877929688,68.07749938964844,GILD,"10 Blockbuster Drugs of the Future for Big Pharma Stocks ||| No. 1-Ranked Medical Stock Tests Support In New Base ||| Does Gilead's Kite Acquisition Offer A New Buying Opportunity? ||| Gilead Sciences Stock Upgraded: This Is the Power of Free ||| Better Buy: Ziopharm Oncology Inc. vs. Celldex Therapeutics, Inc. ||| Morning Movers: Sears Soars on Earnings; Kroger Gains ||| CMS Head Verma Says Agency Considering Ways To Curb Costs For Expensive New Medications ||| Maxim Explains Why Gilead Sciences Is A Now A Buy ||| Benzinga's Top Upgrades, Downgrades For November 30, 2017 ||| Maxim Group Upgrades Gilead Sciences to Buy",1,0.521731
2017-12-01,8425000.0,74.44000244140625,75.61000061035156,73.5,75.33999633789062,68.58728790283203,GILD,Gilead & 3 Other Drug Stocks in Focus this World AIDS Day ||| Glaxo Begins Phase III Study on Injection to Prevent HIV ||| GlaxoSmithKline Begins Phase III Study On Injection To Prevent HIV ||| Maim Upgrades Gilead Sciences to Buy from Hold -Reuters,0,0.5144178
2017-12-04,8617600.0,75.45999908447266,75.58000183105469,72.91000366210938,73.08999633789062,66.53897094726562,GILD,5 Top Biotech Stocks to Buy Now ||| Gilead Sciences Announces a $100M Commitment to Fight HIV/AIDS in Southern US,1,0.5483389
2017-12-06,6097900.0,73.72000122070312,74.3499984741211,72.83999633789062,73.29000091552734,66.7210464477539,GILD,Why Gilead Could Have 'Greatest' Ever In HIV Drug Launches ||| Can Drug/Biotech M&A Rebound Next Year After Bleak 2017?,0,0.5029503
2017-12-07,6172700.0,73.19999694824219,73.25,72.20999908447266,72.72000122070312,66.20213317871094,GILD,"Notable Two Hundred Day Moving Average Cross - GILD ||| Notable ETF Inflow Detected - VLUE, GILD, F, NSC ||| UPDATE: Gilead Says Deal For Cell Design Labs Made Up Of Initial Upfront Payment Of ~$175M, Added Payments Of Up To $322M 'upon the occurrence of certain events, including the achievement of development and approval milestones' ||| Gilead Sciences Reports Deal With Subsidiary Kite To Acquire Cell Design Labs For ~$567M",1,0.5268142
2017-12-08,7906900.0,73.4000015258789,74.37999725341797,72.51000213623047,74.22000122070312,67.56768035888672,GILD,"Why Biotech Stocks May Wait A While Before Feeling The Love ||| Gilead Sciences to Acquire Cell Design Labs for $567 Million ||| Noteworthy Friday Option Activity: UAL, GILD, ABBV ||| Gilead Option Alert: Dec 15 $71.5 Calls Sweep (19) at the Ask: 500 @ $2.281 vs 99 OI; Ref=$73.62 Signals ||| Wall Street's M&A Chatter From December 7: Entellus Medical-Stryker, Sucampo, Silicon Labs-Sigma Designs",1,0.4929055
2017-12-11,9179900.0,74.5999984741211,76.2699966430664,74.38999938964844,75.87999725341797,69.07889556884766,GILD,"Is Gilead Sciences, Inc. a Buy? ||| Is Now the Perfect Time to Buy Juno Therapeutics Stock? ||| Gilead's Kite Announces Long-Term Data From Pivotal ZUMA-1 Study of Yescarta in Patients With Refractory Large B-cell Lymphoma at #ASH2017 ||| Health Care Sector Update for 12/11/2017: VSTM, MRK, IONS, GILD, IMGN, JUNO, CELG, REGN, BIVV ||| Here's Why Bluebird Bio (BLUE) Stock Skyrocketed Today ||| 3 Stocks in Focus as Biotech M&A Hopes for 2018 Rise ||| What's Causing Juno Therapeutics Shares to Tumble 11.9% Today ||| Gilead (GILD) Posts Updated Data on CAR-T Therapy Yescarta ||| Novartis Reports Updated Results from Kymriah's JULIET Study ||| 3 Stocks In Focus As Biotech M&A Hopes For 2018 Rise",1,0.51806647
2017-12-12,9281600.0,76.05000305175781,76.16000366210938,74.25,76.08999633789062,69.27008056640625,GILD,"Ex-Dividend Reminder: Conmed, Merck and Gilead Sciences ||| Bluebird's Shares Jump on Strong Data for CAR-T Therapy ||| ASH 2017: CAR-T Wallops Blood Cancer ||| Juno Reports Additional Data on CAR-T Therapy, Shares Drop ||| Jim Simons: Pioneer Quant Manager ||| Kite Announces Data from ZUMA-3 Study of KTE-C19 in Adult Patients with Relapsed or Refractory ALL at #ASH2017",1,0.5048619
2017-12-13,9968800.0,76.30999755859375,77.1500015258789,76.2699966430664,76.58000183105469,69.7161636352539,GILD,"Biotech Stock Roundup: ASH Data in Focus, Gilead to Buy Cell Design Labs ||| ASH 2017 Highlights: Gilead, Novartis, Juno, Bluebird Bio And More ||| Analyst Doubts Bluebird Bio Shares — Up 200% In 2017 — Can Fly Much Higher",0,0.5059726
2017-12-14,9055400.0,76.0,76.47000122070312,74.06999969482422,74.33999633789062,68.13961029052734,GILD,"Thursday’s Vital Data: JD.com Inc(ADR) (JD), Time Warner Inc. (TWX) and Gilead Sciences, Inc. (GILD) ||| Galapagos Exercises Co-promotion Option for Filgotinib with Collaboration Partner Gilead Sciences in Eight European Countries ||| Gilead Sciences Reports Executive Chair John Martin Will Transition To Chair Of Board",1,0.5114207
2017-12-15,15367200.0,75.0,75.7300033569336,74.0999984741211,75.56999969482422,69.26702880859375,GILD,"Notable Friday Option Activity: INTC, LMT, GILD ||| Galapagos Cozies Up Closer to Gilead Sciences ||| Noteworthy ETF Inflows: VYM, ABBV, GILD, LLY ||| Can Teva Jump-Start Its Restructuring By Swiping Some Of Gilead's Sales? ||| CAR T Stocks in Focus with ASH 2017 Meet: GILD, JUNO & More",0,0.5259062
2017-12-18,9986600.0,76.02999877929688,76.4800033569336,75.01000213623047,75.12999725341797,68.86372375488281,GILD,"Even in This Rich Market, Gilead Sciences, Inc. Is Offering Investors Value ||| After Hours Most Active for Dec 18, 2017 : EPD, GM, INTC, BP, ETE, QQQ, LC, AAPL, MPLX, GILD, CMCSA, AKAM ||| Why No Large-Cap Biotech Franchise Is Safe From Threats In 2018 ||| Galapagos Announced Earlier Receipt Of Transparency Notification From Gilead Sciences",0,0.48153555
2017-12-19,6737600.0,75.05999755859375,75.33999633789062,74.26000213623047,74.3499984741211,68.14878845214844,GILD,"3 Questions Keeping Juno Therapeutics' Investors Up at Night ||| Why These Biotech Stocks Could Be Taken Over In 2018 ||| Galapagos Shares Briefly Spike Higher, Turn Positive As Traders Circulate Report Gilead Could Be Interested In Co.",0,0.5005561
2017-12-20,7349500.0,73.52999877929688,74.7300033569336,73.41999816894531,74.01000213623047,67.83714294433594,GILD,"Biotechs: Not So 'Darn Scary' After All ||| Biotechs: Not So 'Darn Scary' After All - An SA Marketplace Roundtable ||| 3 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2018 ||| 3 Biotech Pipeline Areas To Keep An Eye On In 2018 ||| Credit Suisse: Street Expectations 'Too High' For Gilead's Hep C Therapy ||| Benzinga's Top Upgrades, Downgrades For December 20, 2017 ||| The Market In 5 Minutes: Historic Tax Bill Looms Large, Bitcoin Cash, Amazon Boxes, And More ||| Credit Suisse Downgrades Gilead Sciences to Neutral ||| Credit Suisse Downgrades Gilead to Neutral from Outperform; Lowers PT to $80 from $82 -Reuters",0,0.4876464
2017-12-21,7196100.0,73.7300033569336,74.37000274658203,72.93000030517578,73.0199966430664,66.9297103881836,GILD,Gilead: Maybe 2018 Won't Be Its Year Either,0,0.49562702
2017-12-22,6560200.0,72.80000305175781,73.3499984741211,72.37000274658203,72.70999908447266,66.64556121826172,GILD,Q&A: Vertex Chief Talks About Company's 'Transformational Year' ||| Better Buy: GlaxoSmithKline plc vs. Bristol-Myers Squibb,0,0.49240905
2017-12-27,3933900.0,72.7300033569336,73.43000030517578,72.55999755859375,72.9800033569336,66.89305114746094,GILD,"4 Biotech Stocks Ready to Crush the Market in 2018 ||| Notable Wednesday Option Activity: RL, WBA, GILD ||| Noteworthy ETF Outflows: XLV, GILD, LLY, BIIB ||| 4 Biotech Stocks Ready To Crush The Market In 2018 ||| Gilead Option Alert: Jan 19 $73 Calls Sweep (12) at the Ask: 522 @ $1.68 vs 267 OI; Ref=$73.13",0,0.5041303
2017-12-28,4624200.0,73.02999877929688,73.16999816894531,72.04000091552734,72.4800033569336,66.43475341796875,GILD,5 of the Best-Performing Biotech Stocks of 2017,0,0.5321256
2017-12-29,7370700.0,72.30999755859375,72.75,71.61000061035156,71.63999938964844,65.6648178100586,GILD,Intercept (ICPT) Stock Loses Sheen in 2017: What Lies Ahead? ||| Celgene (CELG) in Troubled Waters in '17: What Does 2018 Hold?,1,0.46245697
2018-01-02,7905100.0,72.19000244140625,74.2699966430664,71.72000122070312,74.0999984741211,67.91962432861328,GILD,"3 Biggest Breakthroughs in Cancer Treatment in 2017 ||| 3 Biotech and Pharma Stocks with FDA Catalysts this January ||| Here's How bluebird bio, Inc. Crushed It in 2017 ||| Why 2017 Was a Year to Remember for Juno Therapeutics ||| Why These 2 Biotechs Could Outperform Amid 'Hyper-Competition' ||| Gilead Shares Spike Higher Over $72, $73 Levels; Stock Up 2.5%",1,0.54976016
2018-01-03,6640000.0,74.05000305175781,74.83999633789062,73.33000183105469,74.66000366210938,68.43293762207031,GILD,Why This Is the Perfect Level to Buy Celgene Corporation Stock,0,0.50826645
2018-01-04,5074600.0,75.0,75.06999969482422,73.55999755859375,73.9000015258789,67.73631286621094,GILD,"Why Juno Therapeutics Stock Cooled Off in December ||| XLV, AMGN, GILD, LLY: Large Outflows Detected at ETF ||| 18 Reasons I Like Biotech Stocks in 2018",1,0.4782216
2018-01-05,7901100.0,74.16999816894531,74.54000091552734,73.02999877929688,74.5199966430664,68.30461120605469,GILD,"Biotech: The Tide Is Turning ||| Noteworthy Friday Option Activity: GILD, AVXS, UAA ||| Dynavax To Launch Hepatitis B Vaccine — Is An Acquisition Coming? ||| BofA: The Biotech Sector Is In A 'Perfect Storm' For M&A",0,0.5209792
2018-01-08,5858500.0,74.33999633789062,74.72000122070312,73.44000244140625,74.4000015258789,68.19461059570312,GILD,"5 Biggest New Drugs of 2018 -- and How You Can Profit From Their Makers ||| Galapagos Reports Topline Data From Osteoarthritis Study ||| Celgene to Acquire Impact Biomedicines to Boost Pipeline ||| JP Morgan Healthcare Conference Begins Today, Presenters Include: Gilead, Illumina, Seattle Genetics, Biogen, Incyte, Baxter, Regeneron, Walgreens, Alnylam, Edwards Lifesciences, Molina, Alexion, Celgene, Pfizer, Neurocrine Biosciences, and Jazz Pharma",1,0.5230389
2018-01-09,14824100.0,74.61000061035156,78.68000030517578,74.56999969482422,78.0999984741211,71.58599853515625,GILD,3 Top Healthcare Stocks to Buy in January ||| 5 Ways Gilead Sciences Plans to Return to Growth ||| Pete Najarian Sees Unusual Options Activity In Gilead And KKR & Co.,1,0.50811553
2018-01-10,10150400.0,78.0999984741211,78.87000274658203,77.01000213623047,78.70999908447266,72.1451416015625,GILD,"Biotech Stock Roundup: Celgene to Acquire Impact, J.P. Morgan Healthcare Conference in Focus",1,0.49783486
2018-01-11,7872900.0,78.69999694824219,79.68000030517578,77.87000274658203,79.05999755859375,72.4659423828125,GILD,Can Biotech Keep Last Year's Momentum Alive in 2018? ||| Big Pharma CEOs Speak About Impact of Tax Reform on M&A ||| Valeant Pharmaceuticals Intl Inc Stock Is Worth the Risk,0,0.48868507
2018-01-12,6366200.0,79.33999633789062,79.4000015258789,78.6500015258789,79.0199966430664,72.42927551269531,GILD,"10 Value Stocks to Buy for 2018 and Beyond ||| 3 Reasons Dividend-Monster Pfizer Inc. Could Explode Higher ||| XLV, MRK, AMGN, GILD: ETF Outflow Alert ||| 2017 Was a Year to Forget for Gilead Sciences, Inc., but This Year Could Be Better",1,0.48758814
2018-01-16,11750200.0,79.75,81.58999633789062,79.5199966430664,80.25,73.55669403076172,GILD,"Noteworthy Tuesday Option Activity: GILD, WDC, BMY ||| 5 Biggest Price Target Changes For Tuesday ||| Benzinga's Top Upgrades, Downgrades For January 16, 2018 ||| The Market In 5 Minutes: Auto Show Highlights, Bitcoin Tumbles, Northrop Vs. Lockheed ||| Wells Fargo Upgrades Gilead Sciences to Outperform ||| Wells Fargo Upgrades Gilead Sciences to Outperform; Raises PT to $96 from $84 -Reuters",1,0.49715215
2018-01-17,11162800.0,80.70999908447266,82.06999969482422,80.20999908447266,81.73999786376953,74.92240905761719,GILD,"Why Celgene's Rumored Acquisition Of Juno Actually Makes Sense ||| Why Juno Therapeutics Stock Is Soaring Today ||| What's Juno Therapeutics Worth to Celgene? ||| Is Celgene (CELG) Looking to Take Over Juno Therapeutics? ||| Is Gilead Sciences, Inc. a Buy in 2018? ||| Biotech Stock Roundup: Juno Surges on Acquisition Rumor, Concert Down on Patent News",0,0.4988
2018-01-18,8527500.0,81.47000122070312,81.6500015258789,80.7699966430664,81.16999816894531,74.39996337890625,GILD,"Merck & Co., Inc. Stock Could Still Soar Another 10% From Here ||| 3 Top-Ranked Drug Stocks That Are Broker Favorites ||| Novartis sBLA for CAR-T Therapy Kymriah Accepted by FDA ||| No Reason To Rush Into Juno Therapeutics Inc Stock After This Big Pop ||| 3 Top-Ranked Drug Stocks that are Broker Favorites ||| Healthcare: Is Celgene Going to Buy Juno Therapeutics? ||| Juno Hits 52-Week High on Celgene's Rumored Buyout Interest ||| Gilead's Kite Pharma Reports Clinical Collaboration To Evaluate Investigational Combo Of Yescarta, Pfizer's Utomilumab In Large B-Cell Lymphoma",0,0.4969542
2018-01-19,7920900.0,81.30000305175781,81.52999877929688,80.37000274658203,80.9800033569336,74.22581481933594,GILD,"The Zacks Analyst Blog Highlights: Apple, JPMorgan, AbbVie, Gilead and Simon Property Group ||| The Top 10 Value Stocks in the S&P 500 ||| The Top 10 Value Stocks In The S&P 500",1,0.48081434
2018-01-22,7464500.0,81.30999755859375,82.05000305175781,81.05000305175781,81.41000366210938,74.61994171142578,GILD,"What to Expect From Amgen, Inc. in 2018 ||| Better Buy: GlaxoSmithKline plc vs. Eli Lilly ||| Better Buy: Gilead Sciences, Inc. vs. Pfizer Inc. ||| Celgene's $9 Billion Buyout of Juno: Is It a Good Deal for Investors? ||| 3 Stocks the World's Best Investors Are Buying Right Now ||| Noteworthy ETF Outflows: IWB, AMGN, GILD, ABT ||| 5 Stocks With Clear Technical Trading Signals Right Now",0,0.48620066
2018-01-23,7198800.0,81.2300033569336,82.18000030517578,80.91000366210938,80.94999694824219,74.19831848144531,GILD,"Bluebird Up on Buyout Speculation After Celgene/Juno Deal ||| Celgene (CELG) to Acquire Juno Therapeutics for $9 Billion ||| Gilead To Report Q4 Earnings On Tues., Feb. 6 After Market Closes ||| Pharma M&A Picks Up Momentum ||| Bluebird Bio Up On Buyout Speculation After Celgene-Juno Deal ||| Biotech M&A Off To A Strong Start In 2018: More Deals To Follow?",1,0.49741185
2018-01-25,4708000.0,81.58000183105469,81.83999633789062,80.8499984741211,81.19000244140625,74.41829681396484,GILD,"Celgene (CELG) Q4 Earnings & Sales Beat on Solid Revlimid ||| Will 2018 Be Bellicum Pharmaceuticals, Inc.'s Best Year Yet? ||| Celgene Reverses In Fourth Quarter As Otezla Sales Rebound",1,0.50979
2018-01-26,14617200.0,81.95999908447266,85.48999786376953,81.87999725341797,85.45999908447266,78.33214569091797,GILD,"Is It Finally Safe to Buy Gilead Sciences Stock? 1 Analyst Thinks So ||| Why This Biopharma 'Behemoth' Could Soon Become Acquisitive ||| 5 Biotech and Pharmaceutical Stocks Going Bonkers ||| Notable Friday Option Activity: SBUX, GILD, ITW ||| Jefferies On Gilead: 'We See Better Days Ahead' ||| Benzinga's Top Upgrades, Downgrades For January 26, 2018 ||| The Market In 5 Minutes: GDP, Intel's Beat, XFL's Return, Bitcoin And Japan ||| Jefferies Upgrades Gilead Sciences to Buy",1,0.48369142
2018-01-29,19411600.0,85.12000274658203,89.54000091552734,85.12000274658203,88.80000305175781,81.39356231689453,GILD,"3 Small Biotechs That Big Drugmakers Are Probably Drooling Over ||| US Stocks Slump as Declines in Telecom, Utilities Sectors Weigh ||| Nasdaq 100 Movers: WYNN, GILD ||| Gilead Sciences, Take-Two Interactive Hit Buys After Vertex Breakout ||| Monday Sector Leaders: Consumer Products, Healthcare",0,0.5198347
2018-01-30,14001200.0,88.0199966430664,88.33000183105469,86.2699966430664,87.29000091552734,80.009521484375,GILD,"GILD Crosses Above Average Analyst Target ||| 3 Big Biotech Stocks With Major Catalysts on the Way ||| Vetr Crowd Downgrades Gilead Sciences ||| Gilead Sciences Outlook Brightens; Citi Upgrades ||| Benzinga's Top Upgrades, Downgrades For January 30, 2018 ||| Citigroup Upgrades Gilead Sciences to Buy",0,0.5039873
2018-01-31,12790800.0,86.5999984741211,87.0999984741211,83.29000091552734,83.80000305175781,76.81060028076172,GILD,iShares Nasdaq Biotechnology ETF Experiences Big Outflow ||| Vertex (VRTX) & Other Drug Stocks with FDA Catalysts this February ||| Attention Biotech Investors: February PDUFA Catalysts Come Calling ||| FDA Watchlist: Catalysts To Look Out For This February,0,0.49601164
2018-02-01,7305100.0,83.19999694824219,84.16000366210938,81.18000030517578,83.48999786376953,76.52645111083984,GILD,"Will Gilead (GILD) Disappoint Investors in Q4 Earnings? ||| Biotech Stock Roundup: AbbVie 4Q Results Impress, Ablynx to be Acquired by Sanofi ||| Alphabet Earnings Preview: What Might Be Expected For Q4?",0,0.48329505
2018-02-02,9356300.0,82.6500015258789,83.33999633789062,81.4800033569336,81.7300033569336,74.91324615478516,GILD,3 Top Biotherapeutics Stocks to Buy Now,0,0.5507819
2018-02-05,10810400.0,81.4000015258789,82.5,78.33999633789062,78.37000274658203,71.83350372314453,GILD,"3 Headwinds in Q4 Earnings Results That Make Merck a Mediocre Stock ||| What to Expect With Gilead Sciences' Q4 Results ||| Benzinga's Weekly Bulls & Bears: AbbVie, Kinder Morgan, Paypal, Starbucks, Wynn And More ||| Noteworthy Monday Option Activity: CMI, MU, GILD ||| The Week Ahead: IPOs Ramp Up Just As Earnings Season Fades",1,0.5466201
2018-02-06,13287400.0,77.3499984741211,80.61000061035156,76.9000015258789,80.37999725341797,73.67584228515625,GILD,"Gilead (GILD) 4th Quarter Earnings: What to Expect ||| Gilead Sciences Inc. (GILD) Q4 2017 Earnings Conference Call Transcript ||| New Quarterly Earnings Results for DIS, CMG, SNAP and More ||| Gilead (GILD) Posts Earnings Beat, Total Product Sales See YoY Decline ||| Earnings Reaction History: Gilead Sciences Inc., 63.6% Follow-Through Indicator, 4.4% Sensitive ||| After-Hours Earnings Report for February 6, 2018 : DIS, GILD, APC, PXD, CERN, MCHP, MKL, PAA, AKAM, UDR, JKHY, ATO ||| TD Ameritrade Investors Had A Record-Breaking January ||| 8 Stocks Moving In Tuesday's After-Hours Session ||| Gilead Sciences Shares Up 2.4% After Hours As Company Reports Positive Q1 Earnings, 10% Q1 Dividend Increase ||| Gilead Sciences Raises Qtr. Dividend From $0.52 to $0.57/Share ||| Gilead Sciences Reports Q4 EPS $1.78 vs $1.67 Est., Sales $5.9B vs $5.73B Est. ||| Investor Movement Index January Summary ||| Earnings Outlook For Gilead Sciences ||| 12 Stocks To Watch For February 6, 2018 ||| Earnings Scheduled For February 6, 2018",1,0.49263966
2018-02-07,20315600.0,79.66999816894531,84.58000183105469,79.3499984741211,82.76000213623047,75.85735321044922,GILD,"Gilead (GILD) Beats on Q4 Earnings, 2018 View Lacks Lustre ||| The Zacks Analyst Blog Highlights: Walt Disney, Chipotle, Snap and Gilead Sciences ||| Gilead Sciences Inc. Delivers Deja Vu in the Fourth Quarter ||| Daily Dividend Report: GILD, CTSH, ICE, APC, GLW ||| 5 Things Gilead Sciences' Management Just Said That You Need to Know ||| Najarian Brothers See Unusual Options Activity In Procter & Gamble And Gilead ||| With $36.7B In Cash, Bank of America Expects Gilead To Shop For Complements To Drug Pipeline ||| Gilead Reports FDA Approved Biktarvy For Treatment Of HIV-1 Infection ||| Leerink Swann Maintains Market Perform on Gilead Sciences, Lowers price target to $83.00",0,0.4870905
2018-02-08,13853700.0,82.44000244140625,82.8499984741211,78.06999969482422,78.22000122070312,71.69601440429688,GILD,"Glaxo (GSK) Earnings and Revenues Surpass Estimates in Q4 ||| FDA Approves Gilead (GILD) HIV Triple Therapy, Stock Up ||| Here's What Gilead Sciences Just Said About Its Future ||| Is Gilead Sciences, Inc. Stock Still a Solid Value Play? ||| BMO Capital Maintains Market Perform on Gilead Sciences, Raises price target to $88.00",1,0.49186465
2018-02-09,13746400.0,78.9000015258789,79.94999694824219,76.0199966430664,79.31999969482422,72.70426177978516,GILD,Glaxo's (GSK) Begins Phase III HIV Two-Drug Regimen Study,1,0.5241823
2018-02-12,10030700.0,79.7699966430664,81.41999816894531,79.62999725341797,80.13999938964844,73.45586395263672,GILD,3 ETFs to Watch on Biotech Earnings ||| Better Buy: Pfizer Inc. vs. GlaxoSmithKline plc ||| How Huge Is the Latest HIV Drug Approval for Gilead Sciences? ||| Traders Circulating Speculation Gilead Pursuing Galapagos Takeover,1,0.5271985
2018-02-13,6596800.0,79.56999969482422,81.08999633789062,78.6500015258789,80.79000091552734,74.05166625976562,GILD,"Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 14, 2018 ||| Intercept Starts OCA Trial for NASH Patients With Cirrhosis",1,0.49918917
2018-02-14,7063300.0,80.19999694824219,82.29000091552734,79.9800033569336,81.81999969482422,74.99574279785156,GILD,"Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for February 15, 2018",0,0.46623328
2018-02-15,7159700.0,82.22000122070312,82.30000305175781,81.48999786376953,81.55000305175781,74.74826049804688,GILD,"Intercept (ICPT) Q4 Earnings & Sales Lag on Dull Ocaliva ||| 3 Great Acquisition Targets for Gilead Sciences -- and 1 Iffy Candidate ||| Gilead Shares Unaffected, AbbVie Shares Move Lower Amid Capitol Forum Report 'Rep. Khanna and Other Democrats Urge HHS to Take Patents, Pave Way for Cheaper HCV Generics'",0,0.4890411
2018-02-16,7548600.0,81.44999694824219,82.33000183105469,80.61000061035156,80.69999694824219,73.96915435791016,GILD,"Noteworthy ETF Inflows: SPYG, CRM, GILD, CHTR",1,0.5225631
2018-02-20,7229300.0,80.20999908447266,81.7300033569336,80.20999908447266,80.94000244140625,74.18914794921875,GILD,"Validea's Top Five Healthcare Stocks Based On Benjamin Graham - 2/18/2018 ||| Is AbbVie or Gilead Sciences Stock a Better Buy? ||| Gilead, Merck Quiet As Traders Circulate Reuters Article From Feb. 17th Titled 'Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict'",0,0.48381674
2018-02-21,6956900.0,80.9000015258789,81.93000030517578,80.30000305175781,80.69000244140625,73.9599838256836,GILD,"RBC Capital Global Healthcare Conference Begins Today, Presenters Include: Chemed, Revance, Eagle Pharma, Enanta, Gilead, TransEnterix, Immunogen, and Incyte",0,0.50613624
2018-02-22,8382200.0,80.7300033569336,81.12999725341797,79.18000030517578,79.4000015258789,72.77758026123047,GILD,"Health Care Sector Update for 02/22/2018: CLVS,SGMO,GILD,BKD ||| Health Care Sector Update for 02/22/2018: SGMO, GILD, CLVS, NVO, NVS, BKD ||| Why Sangamo Therapeutics Rocketed Higher Today ||| Health Care Sector Update for 02/22/2018: CLVS,SGMO,GILD,BKD ||| 5 Drugs That Are Critical for Gilead Sciences' Future ||| Gilead Form 4 Filing Late Wed. Showed Sale Of 14,435 Shares By Exec VP, Corporate & Medical Affairs, Gregg Alton, On Feb. 20 ||| Gilead's Kite, Sangamo Therapeutics Partner To Develop Generation Engineered Cell Therapies For Cancer Treatment, Sangamo To Receive Upfront Payment Of $150M With $3.01B In Potential Milestone Payments",1,0.48807985
2018-02-26,6394400.0,81.26000213623047,81.93000030517578,80.19999694824219,81.79000091552734,74.96825408935547,GILD,SPDR Portfolio S&P 500 Growth ETF Experiences Big Inflow ||| Gilead Sciences: The Oncology Company?,0,0.5033445
2018-02-27,6748100.0,81.77999877929688,82.04000091552734,80.30000305175781,80.36000061035156,73.65751647949219,GILD,"Teva Pharma and Natco Pharma Submit ANDAs to the FDA Requesting Permission to Manufacture Generic Sovaldi, Argue Gilead's Patents are Not Valid",0,0.50352275
2018-02-28,7559500.0,80.48999786376953,80.69999694824219,78.69000244140625,78.7300033569336,72.16349029541016,GILD,"Top Analyst Reports for Gilead, BNY Mellon & State Street ||| Biotech Stock Round Up: Celgene Suffers Setback, Gilead Teams Up with Sangamo ||| Health Care Sector Update for 02/28/2018: HTBX, SGYP, CODX, GILD ||| Health Care Sector Update for 02/28/2018: GILD,SGYP,CPH.TO,HTBX,CODX",0,0.46824694
2018-03-01,8267500.0,78.94000244140625,79.81999969482422,77.02999877929688,77.52999877929688,71.06356048583984,GILD,"The Zacks Analyst Blog Highlights: Gilead, BNY Mellon, State Street, Alliant Energy and Dillard's ||| Intangibles Hold the Key to Valeant Pharmaceuticals Intl Inc Stock ||| Biotech ETFs Head to Head: XBI vs. IBB. ||| Gilead Sciences' History Points to Future Success",1,0.507769
2018-03-02,6625500.0,76.83999633789062,78.88999938964844,76.4000015258789,78.69000244140625,72.12680053710938,GILD,Here’s Why Gilead Sciences' Jump Into Gene Editing Is Important,0,0.5137725
2018-03-05,10483300.0,78.22000122070312,78.68000030517578,77.13999938964844,77.91999816894531,71.42102813720703,GILD,"Here's Why Crispr Therapeutics AG Jumped Again in February ||| Gilead Announces Data Support Continued Clinical Investigation of GS-9620 and GS-9722 as Part of an HIV Eradication Strategy ||| Gilead Reports Phase 3 Study Data Evaluating Women Who Switched To Biktarvy From a Boosted Protease Inhibitor-Based Regimen or Boosted Elvitegravir-Containing Regimen ||| UPDATE: Gilead Says 'No Patients in Biktarvy Treatment Arm Demonstrated Treatment-Emergent Resistance Through 48 Weeks' ||| UPDATE: Gilead Says 'Through 48 Weeks, Biktarvy Found to Be Non-Inferior to Abacavir-Containing Regimen in Virologically Suppressed Adults Living With HIV' ||| Gilead Highlights Results From Phase 3 Study Of Patients Who Switched To Biktarvy From Abacavir, Dolutegravir, Lamivudine Regimen ||| 7 Biotech Stocks With Clinical Trial Outcomes In March",1,0.5383048
2018-03-06,7919400.0,78.5999984741211,80.02999877929688,78.47000122070312,79.31999969482422,72.70426177978516,GILD,"Gilead Announces Positive Data on New HIV Therapy Biktarvy ||| Notable Tuesday Option Activity: GILD, LE, PYPL ||| An Eventful February Took Its Toll On TD Ameritrade's Investor Index ||| Investor Movement Index February Summary",1,0.50112545
2018-03-07,6715200.0,78.73999786376953,80.1500015258789,78.12000274658203,79.98999786376953,73.3183822631836,GILD,Height Casts 65% Odds That Congress Rolls Back Pharma Discounts,1,0.52614343
2018-03-08,5707800.0,79.95999908447266,80.66999816894531,79.31999969482422,80.06999969482422,73.3917007446289,GILD,"Gilead Sciences (GILD) Down 3.4% Since Earnings Report: Can It Rebound? ||| 2 Cheap Growth Stocks to Buy Right Now ||| Biotech Stock Round Up: Regeneron Submits sBLA, Biogen to Withdraw Zinbryta",1,0.49571532
2018-03-09,7024800.0,80.5,81.05000305175781,79.98999786376953,80.72000122070312,73.98748779296875,GILD,Don't Bail On Biotech ETFs: 'There Are Several Reasons Why The Sector Took A Breather',1,0.49872822
2018-03-12,7515700.0,80.93000030517578,81.33999633789062,80.41999816894531,81.05999755859375,74.29913330078125,GILD,"How Biopharmas Battle for Billions ||| Here's What Lifted Sangamo Therapeutics Inc. in February ||| The Revolutionary New HIV Drug You've Probably Never Heard Of ||| The 1 Big Risk That Every Drugmaker Fears ||| How Pricing Can Be Vital to a Drugmaker's Profitability ||| After Hours Most Active for Mar 12, 2018 : PFE, QCOM, F, CBS, BAC, QQQ, CELG, HST, SOHU, GE, CTSH, GILD ||| Gilead Sciences Tweets: Gilead's Norbert Bischofberger to step down; John McHutchison appointed Chief Scientific Officer and Andrew Cheng appointed Chief Medical Officer",1,0.52011675
2018-03-13,7608900.0,81.12999725341797,82.72000122070312,81.12000274658203,81.72000122070312,74.90409088134766,GILD,3 Biotech Stocks With Rising Earnings Estimates Post Q4,0,0.5200772
2018-03-14,6527300.0,82.05000305175781,82.56999969482422,80.88999938964844,81.0999984741211,74.33578491210938,GILD,"Bull of the Day: Regeneron (REGN) ||| Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for March 15, 2018 ||| Is Gilead Sciences Trying to Put Itself Out of Business? ||| Notable Wednesday Option Activity: DDD, GILD, HD",0,0.4812128
2018-03-15,5946600.0,80.55999755859375,80.87999725341797,79.2699966430664,79.51000213623047,73.39424896240234,GILD,Is Gilead Sciences (GILD) a Great Stock for Value Investors?,1,0.49927914
2018-03-16,9564900.0,79.91999816894531,80.9000015258789,79.4000015258789,79.73999786376953,73.60655975341797,GILD,5 Must-See Quotes From AbbVie's Management ||| 3 Reasons CRISPR Stocks Could Keep Soaring ||| Specialty Research: What The Lucrative NASH Market Has In Store,0,0.53518707
2018-03-19,8917300.0,79.30999755859375,79.5,76.30000305175781,77.18000030517578,71.24346923828125,GILD,"3 Revolutionary Cancer Treatments ||| Top 52 Nasdaq Stocks By Yield, Upside & Gains For March ||| Validea's Top Five Healthcare Stocks Based On David Dreman - 3/18/2018 ||| Gilead Sciences' $14 Billion-Per-Year Threat ||| Tops Of 44 'Safer' Dividend Nasdaq Equities: Comcast By Gain; Vodafone By Yield For March ||| By The Numbers: Best Stocks In The Nasdaq 100 ||| Despite Struggles Celgene Corporation Stock Is Still A Buy ||| Nick's Portfolio Tournament First Round Results ||| Biotech Bio Series #2: Is Gilead Still A Growth Stock?",0,0.53276306
2018-03-20,5798300.0,77.37999725341797,77.69999694824219,76.70999908447266,76.91999816894531,71.00347137451172,GILD,Checking In On The Healthcare Sector Ahead Of Q1 Earnings Season ||| Biotechs Approaching New Waters ||| AAM S&P 500 High Dividend Value ETF SPDV: Should You Ditch The High Yield Dog For This ETF ||| JF's Core Biotech Buys Edition 1 Volume 7: Updates And Taking Advantage Of Current Weakness ||| Thor And The Cycle: An Investing Fable (Podcast With DoctoRx),0,0.50208634
2018-03-21,5826500.0,76.73999786376953,77.44000244140625,76.20999908447266,76.48999786376953,70.6065444946289,GILD,"Better Buy: Amgen Inc. vs. Gilead Sciences, Inc. ||| Notable Two Hundred Day Moving Average Cross - GILD ||| New Glaxo pharma head Miels making presence felt with 20% expense cut demand",0,0.49501842
2018-03-22,7861000.0,75.8499984741211,76.76000213623047,75.04000091552734,75.56999969482422,69.75730895996094,GILD,"Gilead Sciences (GILD) Shares Cross 3% Yield Mark ||| Powerhouse Duo Takes On Gilead, Allergan In Liver Disease, But Stocks Dip ||| 5 Undervalued Large-Cap Stocks For Value Investors - March 2018",0,0.46793178
2018-03-23,9268900.0,75.37999725341797,75.62000274658203,72.7300033569336,72.83999633789062,67.23729705810547,GILD,"Celgene Corporation Looks Cheap, Considering Its Potential ||| Stemline Therapeutics Inc Stock Investors Are Betting, Not Investing ||| Bulletproof Investing Performance: Week 17",1,0.49504355
2018-03-26,7370900.0,74.16999816894531,75.70999908447266,73.56999969482422,75.54000091552734,69.7296142578125,GILD,"Gilead Sciences' Investors Better Watch This Regeneron-Alnylam Deal ||| Better Buy: Gilead Sciences, Inc. vs. Biogen Inc. ||| JF's Core Biotech Buys #8: Taking Advantage Of Volatility And Initiating A Position In Dynavax ||| Arena's APD371 For $14 Billion Dollar Pain Market ||| Gilead: Did Biktarvy Kill The Sell Thesis?",0,0.4991339
2018-03-27,6370900.0,75.9800033569336,76.1500015258789,73.55000305175781,74.11000061035156,68.40960693359375,GILD,Is Gilead Sciences a Beaten-Up Biotech Stock to Buy? ||| 5 Biotech Stocks With Amazing Pipelines ||| ETF Month #7: An Ultra Low-Cost Healthcare ETF ||| 3 Sell-Rated Drug Stocks Investors Should Avoid for Now,1,0.48773783
2018-03-28,6487900.0,74.19000244140625,75.73999786376953,73.9000015258789,74.77999877929688,69.02806854248047,GILD,"Celgene Loses 17.8% in 3 Months: Time to Reshuffle Portfolio? ||| Nick's Portfolio Tournament Second Round Results ||| A Growing Dividend Portfolio That Will Survive Rising Interest Rates ||| Selloff continues in biotechs, XBI down 2% ||| Celgene Loses 17.8% in 3 Months: Time to Reshuffle Portfolio?",1,0.5285998
2018-03-29,5694900.0,75.13999938964844,76.19000244140625,74.61000061035156,75.38999938964844,69.59115600585938,GILD,"Gilead: With Expectations Reflecting Hepatitis-C Market Revenue Decline, Conservative Valuation And Pipeline Prospects Make Stock Attractive ||| BioSci Specialty Report On The Novel Cancer Treatment CAR-TCR",0,0.519331
2018-04-02,8234600.0,74.93000030517578,75.08999633789062,71.87000274658203,73.13999938964844,67.51422119140625,GILD,"Better Buy: Celgene Corporation vs. Gilead Sciences ||| An Integrated BioSci Report On Alpine Immune Sciences: A Stellar Next-Generation Immunotherapy Innovator ||| Top Stock Reports for United Technologies, Medtronic & Gilead",1,0.5110719
2018-04-03,5987000.0,73.44000244140625,73.95999908447266,72.02999877929688,73.75,68.07730102539062,GILD,"The Zacks Analyst Blog Highlights: United Technologies, Medtronic, Gilead, Hewlett Packard and Yum! Brands ||| JF's Core Biotech Buys #9: Shire In Play, Volatility Continues And Capitalizing On Weakness ||| Revisiting The Margin Of Safety: The IW Box",1,0.5002857
2018-04-04,7852600.0,72.94999694824219,75.68000030517578,72.80999755859375,75.4000015258789,69.60038757324219,GILD,"Which Big Pharma CEOs Least Deserved Their Big Pay Increases? ||| Confluence Investment Management Llc Buys Gilead Sciences Inc, DowDuPont Inc, Oracle Corp, ... ||| Nick's Portfolio Review Q1 2018",0,0.48281282
2018-04-05,6183000.0,75.93000030517578,75.9800033569336,74.18000030517578,74.81999969482422,69.06500244140625,GILD,"Patients receiving FDA-approved CAR-T therapies face potentially prohibitive co-payments ||| Be Ahead Of The Curve With Gilead Sciences ||| BioSci Rounds Report: Unlocking Hidden Values In Omeros, Unum, And Nektar ||| By The Numbers: Best Biotech Stocks",0,0.50594264
2018-04-06,6439500.0,74.27999877929688,75.30000305175781,72.70999908447266,73.41000366210938,67.76345825195312,GILD,Can Been-There Biotech Entrepreneur Arie Belldegrun Do It Yet Again? ||| Incyte epacadostat flop weighing on certain biotechs premarket,1,0.49947482
2018-04-09,6383600.0,73.87999725341797,75.30999755859375,73.1500015258789,73.80000305175781,68.12345123291016,GILD,"Is Cellectis SA Stock a Buy Now? ||| Biotech Fire Sale: 2 Top Stocks to Buy Next Week ||| 4 Top Stocks for Investing in Pharma's Next $35 Billion Market ||| Sangamo: 3 Waves Of Pipeline Expansion ||| The Bio-Tech 'Wreck': General, And Company-Specific Analysis ||| BioSci Research On Myovant Sciences (Part I): Is This A Big Winner In The Making?",1,0.51785594
2018-04-10,5738900.0,74.56999969482422,75.4800033569336,73.79000091552734,75.0199966430664,69.2496109008789,GILD,"Biotech Analysis Central Pharma News: Novartis's Gene Therapy Catch, AstraZeneca's NASH Move, Clovis's Expanded Rubraca Market ||| American National Bank Buys Delta Air Lines Inc, Schlumberger, Fiserv Inc, Sells Walmart Inc, ... ||| 'Safer' Dividend Healthcare Top Gainers Are AbbVie, Sanofi, Lilly, Gilead, And Novartis (All BPh) Per Broker Targets To April 2019 ||| 50 Healthcare Top Yield Equities For April ||| Novartis and Other Drug Stocks With FDA Catalysts in April ||| JF's Core Biotech Buys #10: Incyte Disappoints, Optimism Returns To Gene Therapy And A New Position",0,0.48254135
2018-04-11,7850100.0,74.69000244140625,75.20999908447266,74.20999908447266,74.33000183105469,68.6126937866211,GILD,"This Little-Known Company Should Have Gilead's and Celgene's Investors Nervous ||| Is Gilead Sciences, Inc. (GILD) a Buy? ||| Divergent Wealth Advisors, Llc Buys iShares Core S&P 5……, iShares Core S&P Total U. ... ||| Road To Financial Independence: My March 89-Stock Portfolio Review",1,0.4745677
2018-04-12,4857700.0,74.83000183105469,76.25,74.83000183105469,75.29000091552734,69.49884796142578,GILD,"IBB, GILD, BIIB, VRTX: ETF Outflow Alert ||| Why One Drug Flop Tanked Incyte's Stock ||| Rounds Report: Geron Rallied While FDA's New Guidance Created Tailwinds For Individualized Medicine Innovators ||| Verastem: A Solid Player On A Crowded Field",0,0.5124144
2018-04-13,4432100.0,75.55999755859375,75.83999633789062,74.86000061035156,75.22000122070312,69.4342269897461,GILD,"Bristol-Myers Collaborates With Harvard Fibrosis Network ||| 3 Top Healthcare Stocks to Buy in April ||| Gilead Combination Therapy Data Presented from First 12-Week Study, Says Enrollment Complete for Phase 3 STELLAR Trials of ASK1 Inhibitor Selonsertib ||| Steinberg Global Asset Management Buys Vanguard Short-Term Inflation-Protected Securities, ... ||| MorphoSys Finalizes U.S. IPO Terms ||| Bristol-Myers Collaborates With Harvard Fibrosis Network ||| Gilead combo therapy for NASH shows encouraging action in proof-of-concept study ||| ANTIPODES PARTNERS Ltd Buys Qualcomm Inc, Gilead Sciences Inc, KT Corp, Sells Michael Kors ...",0,0.5080685
2018-04-16,4720500.0,75.87000274658203,75.9800033569336,74.23999786376953,74.69000244140625,68.94498443603516,GILD,Portfolio Review: Continued Market Outperformance In Q1 2018 ||| Validea's Top Five Healthcare Stocks Based On Benjamin Graham - 4/15/2018 ||| Gilead (GILD) Presents Encouraging Data on NASH Therapies ||| Gilead (GILD) Presents Encouraging Data on NASH Therapies ||| Gilead: Yescarta Faces Unforeseen Hurdles,1,0.5047061
2018-04-17,4351900.0,74.94999694824219,75.94000244140625,74.58999633789062,75.47000122070312,69.66500854492188,GILD,"Evelo Biosciences Files For U.S. IPO ||| JF's Core Biotech Buys #11: Positive News For Several Holdings, A Change To Benchmarks And Introducing Our 17th Position ||| Why Every Investor Should Analyze Free Cash Flow",1,0.4772779
2018-04-18,3043700.0,75.63999938964844,76.06999969482422,75.25,75.68000030517578,69.85883331298828,GILD,"Big Biotech ETF Can Bounce Back ||| Biotech Stock Roundup: ALKS Up, CLDX Down, ALXN to Acquire Wilson Therapeutics ||| Gilead Subsidiary Kite Acquires Certain Facilities From Astellas, No Terms Disclosed ||| Reader Inquiry: Is Recent Weakness In Sangamo Therapeutics A Buying Opportunity? ||| Biotech Stock Roundup: ALKS Up, CLDX Down, ALXN to Acquire Wilson Therapeutics",0,0.4898413
2018-04-19,3958200.0,75.41999816894531,75.91999816894531,73.83000183105469,74.44000244140625,68.7142333984375,GILD,"4 Beaten-Down Funds Set to Soar (with dividends up to 10.9%) ||| Health Care Sector Update for 04/19/2018: NVS, DHR, ALGN, GILD, 4503.T ||| Health Care Sector Update for 04/19/2018: AGN,SHPG,GILD,NVS,DHR ||| Top Research Reports for IBM, McDonald's & Gilead ||| Top Research Reports for IBM, McDonald's & Gilead ||| Investors mull Gilead's filgotinib in wake of Eli Lilly's/Incyte's baricitinib ||| Astellas sells certain U.S. research facilities to Gilead",0,0.4854382
2018-04-20,5201700.0,74.4000015258789,74.41999816894531,73.18000030517578,73.69999694824219,68.0311508178711,GILD,"iShares Nasdaq Biotechnology ETF Experiences Big Outflow ||| The Zacks Analyst Blog Highlights: IBM, McDonald's, Gilead, Phillips 66 and Lam Research ||| Watching Gilead Shares As Traders Circulating Earlier STAT News Article 'NIH is sued for plans to award license for CAR-T therapy to Gilead' ||| The Zacks Analyst Blog Highlights: IBM, McDonald's, Gilead, Phillips 66 and Lam Research ||| Portfolio Strategy Report: Why Investors Should Build Shares In Bioscience Stocks",1,0.51264197
2018-04-23,5014300.0,74.08000183105469,74.31999969482422,73.3499984741211,74.01000213623047,68.31729125976562,GILD,"Better Buy: Gilead Sciences, Inc. (GILD) vs. Pfizer (PFE) ||| Is a Beat in Store for Bristol-Myers (BMY) in Q1 Earnings? ||| Analysts Expect 14% Gains Ahead For SPYG ||| Is a Beat in Store for Alexion (ALXN) This Earnings Season? ||| Is a Beat in Store for Alexion (ALXN) This Earnings Season? ||| Q1 Earnings Surprise Well in Cards: Healthcare ETFs to Buy ||| Is a Beat in Store for Bristol-Myers (BMY) in Q1 Earnings? ||| The More It Drops, The More I Buy - Part 3 ||| How To Retire At 65 With Only Half A Million ||| Gilead: Will Medicare Boost Yescarta Sales?",0,0.47275412
2018-04-24,5562500.0,74.08000183105469,74.30000305175781,72.26000213623047,72.72000122070312,67.12651062011719,GILD,"Is Bellicum Pharmaceuticals, Inc. a Buy? ||| Is a Beat in Store for Vertex (VRTX) This Earnings Season? ||| 3 Bargain Stocks You Can Buy Right Now ||| Your Guide to Investing in Zinc-Finger (ZFN) Gene Editing ||| Monthly Review Of DivGro: March 2018 ||| By The Numbers: Healthcare Stocks With Big Cash Distributions ||| Is a Beat in Store for Vertex (VRTX) This Earnings Season? ||| JF's Core Biotech Buys #12: Updates And Introducing Our 18th Selection",1,0.49567097
2018-04-25,6335500.0,72.79000091552734,73.55999755859375,72.47000122070312,73.25,67.61576080322266,GILD,"Interesting GILD Put And Call Options For July 20th ||| Baird: Biogen A Buy On M&A Prospects, Underappreciated Franchises ||| Gilead Sciences: Tempting In 2018 ||| A New Generation Of Novel HIV Small-Molecule Antivirals ||| Stocks Drop as 10-Year Yield Touches 3%",1,0.5392649
2018-04-26,6341200.0,73.27999877929688,74.31999969482422,72.08999633789062,73.9000015258789,68.21575927734375,GILD,"Is a Beat in the Cards for Gilead (GILD) in Q1 Earnings? ||| What's in the Cards for Immune Design (IMDZ) in Q1 Earnings? ||| What's in the Offing for Keryx (KERX) This Earnings Season? ||| Better Buy: Celgene Corporation vs. Gilead Sciences ||| An Eye On Biotech - Today's Editors' Picks ||| Notable Thursday Option Activity: MAR, GILD, ABBV ||| Essex Investment Management Co Llc Buys Schlumberger, Delta Air Lines Inc, Albemarle Corp, ... ||| Glaxo (GSK) Q1 Earnings Lag, Shingrix Vaccines Sales Solid ||| Is a Beat in the Cards for Gilead (GILD) in Q1 Earnings? ||| What's in the Cards for Immune Design (IMDZ) in Q1 Earnings? ||| What's in the Offing for Keryx (KERX) This Earnings Season? ||| Amgen's Dim Sales Outlook Looms Over Buybacks ||| We Believe Janssen Has Separated From Geron. Just Awaiting Divorce Papers ||| An Eye On Biotech - Today's Editors' Picks ||| AbbVie Is Still A One-Trick Pony",0,0.4847391
2018-04-27,5030700.0,73.91000366210938,74.19000244140625,73.0999984741211,73.86000061035156,68.17884063720703,GILD,"What's in the Cards for Conatus (CNAT) This Earnings Season? ||| 3 Things You Need to Know About AbbVie's Monster Q1 Earnings ||| Health Care Sector Update for 04/27/2018: ACAD,GILD,HRC,SNY ||| HIV Segment to Aid Gilead (GILD) Beat Q1 Earnings Estimates? ||| Health Care Sector Update for 04/27/2018: SNY,GILD,HRC ||| Gilead Sciences Reports European CHMP Adopted Positive Opinion For Co.'s Biktarvy ||| HIV Segment to Aid Gilead (GILD) Beat Q1 Earnings Estimates? ||| What's in the Cards for Conatus (CNAT) This Earnings Season? ||| Celyad up 20% on encouraging data on CAR-T candidate CYAD-01 ||| AbbVie's Q1: It May Be Biotech's Apple, Circa 2005 ||| European advisory group backs Gilead's Biktarvy for HIV-1 ||| Rounds Report: Unlocking Value Of Omeros And Intercept",0,0.4801074
2018-04-30,8268200.0,74.05999755859375,74.22000122070312,72.16999816894531,72.2300033569336,66.6742172241211,GILD,"AbbVie's First Quarter: Can We Quit Worrying About Humira Now? ||| Stocks To Watch: Apple, FOMC And China On Tap ||| What to Expect With Gilead Sciences Inc.'s Q1 Earnings Results ||| The Week Ahead In Biotech: PDUFA Dates, Clinical Trials, Merck And Pfizer Earnings On Tap ||| Is a Beat in the Cards for Agios (AGIO) in Q1 Earnings? ||| What's in Store for ImmunoGen (IMGN) This Earnings Season? ||| Will Agenus (AGEN) Disappoint Investors This Earnings Season? ||| Drug Stocks Q1 Earnings to Watch on May 1: PFE, MRK & More ||| Gilead And Verily Announce Scientific Collaboration To Identify And Understand Immunological And Molecular Drivers Of Inflammatory Diseases ||| The Week Ahead: Tesla And Apple Earnings, Dropbox Quiet Period Expires, Fed Rate Decision And More ||| Notable earnings after Tuesday's close ||| Gilead teams up with Verily to further understanding of disease profiles and responses to treatment ||| Evelo Biosciences To Raise $85 Million In IPO ||| Is a Beat in the Cards for Agios (AGIO) in Q1 Earnings? ||| What's in Store for ImmunoGen (IMGN) This Earnings Season? ||| Will Agenus (AGEN) Disappoint Investors This Earnings Season? ||| Drug Stocks Q1 Earnings to Watch on May 1: PFE, MRK & More ||| AbbVie's Mavyret Could Punish Gilead Tuesday ||| Ionis Pharmaceuticals: The Pinnacle Of RNA Therapeutic Innovation",1,0.49014527
2018-05-01,6180800.0,72.29000091552734,72.83000183105469,71.77999877929688,72.55999755859375,66.97882080078125,GILD,"After-Hours Earnings Report for May 1, 2018 : AAPL, GILD, SU, MDLZ, APC, ALL, FISV, OKE, CXO, EIX, DVN, VRSK ||| XLV, MRK, AMGN, GILD: Large Outflows Detected at ETF ||| Gilead Sciences, Inc. Stock Declined After Earnings Miss ||| Gilead Sciences, Inc. (GILD) Q1 2018 Earnings Conference Call Transcript ||| Gilead (GILD) Shares Slip on Earnings Miss, Revenues Down Over 20% ||| Earnings Reaction History: Gilead Sciences Inc., 54.5% Follow-Through Indicator, 4.3% Sensitive ||| Better Buy: Biogen Inc. vs. Gilead Sciences Inc. ||| 9 Stocks Moving In Tuesday's After-Hours Session ||| Gilead Reaffirms FY18 Outlook ||| Gilead Sciences Q1 EPS $1.48 Misses $1.64 Estimate, Sales $5.088B Miss $5.38B Estimate ||| Benzinga's Daily Biotech Pulse: Karyopharm's STORM Study, Inogen Rallies On Earnings ||| 15 Stocks To Watch For May 1, 2018 ||| Earnings Scheduled For May 1, 2018 ||| Gilead Sciences (GILD) Q1 2018 Results - Earnings Call Transcript ||| Gilead Sciences, Inc. 2018 Q1 - Results - Earnings Call Slides ||| After Hours Gainers / Losers (05/01/2018) ||| Gilead (GILD) Shares Slip on Earnings Miss, Revenues Down Over 20% ||| Gilead Sciences declares $0.57 dividend ||| Gilead Q1 top line down 22%; earnings down 43%; shares down 6% after hours ||| Gilead Sciences misses by $0.19, misses on revenue ||| AbbVie: Can Mylan Pull Off A Humira Biosimilar? ||| JF's Core Biotech Buys #13: Continued Market Headwinds And How To Respond",0,0.46925622
2018-05-02,25822600.0,68.26000213623047,68.76000213623047,66.0199966430664,66.87999725341797,61.73572540283203,GILD,"Relative Strength Alert For Gilead Sciences ||| Nasdaq 100 Movers: GILD, AAPL ||| The Zacks Analyst Blog Highlights: Apple, Snap, Gilead and T-Mobile U.S. ||| Biotech Stock Roundup: ALXN, VRTX Post Solid Results, GILD Disappoints in Q1 ||| Gilead (GILD) Q1 Earnings & Sales Miss Estimates on Weak HCV ||| Market Close Report: NASDAQ Composite index closes at 7,100.90 down -29.80 points ||| Why Molson Coors, Gilead Sciences, and Yum China Holdings Slumped Today ||| 5 Top Stock Trades for Thursday Morning ||| 43 Stocks Moving In Wednesday's Mid-Day Session ||| 21 Stocks Moving In Wednesday's Pre-Market Session ||| Benzinga's Daily Biotech Pulse: SIGA Rallies On FDA Panel Backing, Rigel And Gilead React To Earnings ||| 16 Stocks To Watch For May 2, 2018 ||| Diamond Hill Capital Management Buys Berkshire Hathaway Inc, United Continental Holdings Inc, ... ||| S&co Inc Buys GCI Liberty Inc, GCI Liberty Inc, Liberty Latin America, Sells Duke Energy ... ||| Cirius Therapeutics completes enrollment in mid-stage study of lead candidate in NASH ||| The Zacks Analyst Blog Highlights: Apple, Snap, Gilead and T-Mobile U.S. ||| Biotech Stock Roundup: ALXN, VRTX Post Solid Results, GILD Disappoints in Q1 ||| Gilead Denies It Stumbled: Is The Selling Overdone Or Just Starting? ||| The Fed Expected To Hold Steady, Apple Beats, Facebook Dates (Wall Street Breakfast Podcast)",0,0.4903136
2018-05-03,15060800.0,66.5999984741211,66.83999633789062,64.2699966430664,65.19000244140625,60.17572021484375,GILD,"Did Gilead Sciences Make a Big Mistake? ||| Company News for May 3, 2018 ||| Earnings Season Is Keeping the Markets Wobbly ||| 5 Reasons You Shouldn't Worry About Gilead Sciences' Ugly Q1 Results ||| 55 Biggest Movers From Yesterday ||| Gilead Sciences: The Sales Tell The Story ||| Company News for May 3, 2018",1,0.48326254
2018-05-04,9150500.0,65.08000183105469,65.70999908447266,64.70999908447266,65.41999816894531,60.38802719116211,GILD,"Celgene (CELG) Q1 Earnings & Sales Beat on Revlimid Strength ||| 5 Value Stocks to Book Gains Using Price-to-Book Ratio ||| Is Gilead Sciences Stock Finally a Bargain? ||| Notable Friday Option Activity: GILD, EXEL, RIG ||| Gilead Sciences, Inc. Stock Will Recover… Eventually ||| Mission Wealth Management, Llc Buys Vanguard Mortgage-Backed Securities ETF, Vanguard Total ... ||| Top Stock Reports for BP, Gilead, Enterprise Products & Colgate ||| Celgene (CELG) Q1 Earnings & Sales Beat on Revlimid Strength ||| 5 Value Stocks to Book Gains Using Price-to-Book Ratio ||| Gilead Earnings: Is There A Silver Lining Somewhere?",0,0.4847859
2018-05-07,13201100.0,65.70999908447266,65.94000244140625,64.43000030517578,64.87999725341797,59.889556884765625,GILD,"The Zacks Analyst Blog Highlights: BP, Gilead, Enterprise Products and Colgate ||| After Hours Most Active for May 7, 2018 : CMCSA, QQQ, GILD, MU, FNSR, CRZO ||| Gilead: What A Disaster ||| JF's Core Biotech Buys #14: Introducing Our Final 2 Positions & Taking Advantage Of Weakness In The I-O Space ||| 46 'Safer' Dividend Nasdaq Equities Paced By Comcast Gain And Vodafone Yield For May ||| Gilead: I'm Thankful That I Sold ||| Biotech Forum: The Week Ahead ||| The Zacks Analyst Blog Highlights: BP, Gilead, Enterprise Products and Colgate ||| Here Are 52 Top NASDAQ Stocks By Yield, Upside And Gains For May ||| Novartis Pushes To Advance Kymriah, Will A Second Indication Be Enough?",1,0.4673944
2018-05-08,8973300.0,64.98999786376953,65.66999816894531,64.54000091552734,65.22000122070312,60.20340347290039,GILD,"Intercept (ICPT) Q1 Loss Narrower Than Expected, Sales Lag ||| Intercept (ICPT) Q1 Loss Narrower Than Expected, Sales Lag",1,0.49512255
2018-05-09,7861000.0,64.97000122070312,66.08999633789062,64.62999725341797,65.69000244140625,60.63725662231445,GILD,"Why Bristol-Myers Squibb Stock Crashed in April ||| 3 Stocks That Turned $10,000 Into $1 Million ||| Lipotoxicity And NASH: Gilead's Actions Speak Louder Than Words",0,0.48091277
2018-05-10,6614200.0,66.01000213623047,66.0999984741211,65.20999908447266,65.37000274658203,60.34186935424805,GILD,"Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for May 11, 2018 ||| Rounds Report: Global Blood Therapeutics Rallied While Improving FDA Policies To Help Nektar",1,0.5196394
2018-05-11,10014100.0,65.22000122070312,66.75,64.83999633789062,66.16000366210938,61.07110977172852,GILD,"Elite Wealth Management, LLC Buys Alphabet Inc, Philip Morris International Inc, Chevron Corp, ... ||| Domini Social Investments LLC Buys DexCom Inc, Itron Inc, Atlassian Corporation PLC, Sells ... ||| Trump speech on drug prices light on specifics ||| Keeping It Simple On The Short Side ||| Trump plan on drug prices to be announced this afternoon ||| FANG Stocks Have Ignited A Rally - Cramer's Mad Money (5/10/18)",1,0.5013106
2018-05-14,6173700.0,66.36000061035156,67.68000030517578,66.19000244140625,67.05000305175781,61.89265441894531,GILD,"Get Rich (Safely) With Growth Strategies: 3 To Consider ||| DGI For The DIY: Q1 2018 Portfolio Update ||| Gilead, Match Group, Biotech, Ethereum: 'Fast Money' Picks For May 14 ||| Genomic Medicine: Catch The Gene Therapy Wave ||| Breakout Watch: Biotech Stock With 172% Growth Enters Buy Zone ||| JF's Core Biotech Buys #15: Removal Of A Key Overhang, Buying Weakness In I-O, Updates And Adding To 2 Positions",0,0.49162734
2018-05-15,7483500.0,66.80000305175781,67.55999755859375,66.63999938964844,66.98999786376953,61.83726501464844,GILD,"Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 16, 2018 ||| U.S. Food and Drug Administration Approves Expanded Indication for Truvada for Reducing the Risk of Acquiring HIV-1 in Adolescents ||| Gilead's Kite Pharma Reports New Global Facilities, Expanded Collaboration With National Cancer Institute To Support Cell Therapy Pipeline ||| 5 Low P/E Companies In The S&P 500 - May 2018 ||| Gilead Sciences: Resist Sentiment, Stop Speculating And Invest ||| FDA OKs expanded use for Gilead's Truvada ||| Kite Pharma continues buildout for cell therapy manufacture",1,0.50616235
2018-05-16,6603000.0,67.0,67.9800033569336,67.0,67.55000305175781,62.354190826416016,GILD,"Your Daily Pharma Scoop: Biohaven Updates, MEIP Offering, Kite European Expansions ||| Gilead Sciences (GILD) Presents at the Bank of America Merrill Lynch 2018 Healthcare Conference (Transcript) ||| Biotechs perk up ahead of ASCO abstract drop ||| –… Best Dividend-Paying Stocks for the Enterprising Investor - May —…–8 ||| Bluebird Bio: Gene Therapy Best In Class ||| Bellicum Pharmaceuticals: Will This CAR-TCR Innovator Deliver Robust Profits?",1,0.50993055
2018-05-17,5946200.0,67.0999984741211,68.12999725341797,67.0999984741211,67.5999984741211,62.40034103393555,GILD,"XLV, MRK, AMGN, GILD: ETF Inflow Alert ||| UPDATE: FDA Offers Guidelines, Background For Reference Listed Drug Access Inquiries, Related To Claim Of Blocking Generic Rivals ||| Gilead Option Alert: Jun 21, 2019 $75 Calls Sweep (26) at the Ask: 962 @ $4.35 vs 383 OI; Ref=$67.58 ||| Hearing FDA Names Drugmakers Accused Of Blocking Generic Rivals Including Gilead, Celgene, Novartis ||| Doheny Asset Management Buys Karyopharm Therapeutics Inc, Aimmune Therapeutics Inc, FibroGen ...",1,0.49729088
2018-05-18,6336400.0,67.58999633789062,68.48999786376953,67.33999633789062,68.0199966430664,62.78803253173828,GILD,Gilead: Where's The Next Catalyst? ||| Investors bullish on biotechs after Trump drug pricing speech ||| How To Retire Today With $1 Million,0,0.49825966
2018-05-21,6006500.0,68.1500015258789,68.56999969482422,67.25,67.62999725341797,62.42802810668945,GILD,"Should The FDA Be Shaming Drug Companies? Financial Advisors' Daily Digest ||| Cabot-Wellington, LLC Buys iShares Core MSCI EAFE, Sells JPMorgan Chase, Gilead Sciences Inc, ... ||| Should The FDA Be Shaming Drug Companies? Financial Advisors' Daily Digest ||| Cellectis: Will Focus On Universal CAR-T Payoff?",1,0.48676077
2018-05-22,6210200.0,67.97000122070312,68.69000244140625,67.51000213623047,67.83000183105469,62.61266326904297,GILD,Glaxo and J&J's Two-Drug HIV Regimen Juluca Gets EU Approval ||| 3 Biotechs on the FDA's Naughty List That Should Be on Investors' Buy Lists ||| Tesaro Shares Spike ~$0.70 Over Last Min. As Hearing Speculation Gilead Is In Advanced Talks To Buy Co. ||| Core Biotech Buys #16: Taking Advantage Of Weakness To Add To Conviction Ideas,1,0.5221248
2018-05-23,5093200.0,67.36000061035156,68.37999725341797,67.3499984741211,68.16999816894531,62.92649841308594,GILD,We Did The Math MGV Can Go To $86 ||| High Rates And Inflation Could Pose A Systemic Risk To Biotech ||| Is Celgene's Stock A Buy The Dip Opportunity?,0,0.49367616
2018-05-24,4892300.0,68.04000091552734,68.29000091552734,67.08000183105469,67.52999877929688,62.335723876953125,GILD,"bluebird's Lenti-D Gets Breakthrough Therapy Status From FDA ||| 'Safer' Dividend Healthcare Top WallStar Gainers Are Gilead, Sanofi, Amerisource, Anthem, And Johnson, Per Broker May Targets ||| Howard Capital Management Inc. Buys ProShares Ultra QQQ, Wells Fargo, Ford Motor Co, Sells ... ||| The No. 1 Stock In The World (Revisited) - Visa And Apple Up, Kinder Morgan And Gilead Down ||| Top Wall Street Healthcare Gainers For May: Allergan, CVS Health, Patterson, Sanofi, And Gilead ||| bluebird's Lenti-D Gets Breakthrough Therapy Status From FDA",0,0.50155514
2018-05-25,4864600.0,67.6500015258789,67.93000030517578,67.0,67.37999725341797,62.197265625,GILD,"Noteworthy ETF Outflows: XLV, GILD, TMO, CVS ||| Rounds Report: CryoPort Rallied While The FDA Approved Palynziq ||| Mining For ASCO 2018's Gold, Part 3: Making Money In The Brain",0,0.508313
2018-05-29,7820200.0,67.0,67.55999755859375,66.70999908447266,67.33000183105469,62.1511116027832,GILD,3 Top Value Stocks to Buy Now ||| Why It's Time That Markets Assign More Value To Celgene's Drug Pipeline,1,0.5133827
2018-05-30,5931400.0,67.66000366210938,67.79000091552734,67.30999755859375,67.69000244140625,62.483428955078125,GILD,"Read This Before You Buy Immuno-Oncology Stocks ||| Biotech Stock Roundup: GILD Epclusa's China Approval, BMRN Palynziq's FDA Nod ||| UPDATE: Galapagos Will Receive a $15M Payment from Gilead For This Progression of Filgotinib From Phase 2 to a Phase 2b/3 SELECTION Study ||| Gilead and Galapagos Announce Filgotinib in Phase 2 EQUATOR Study Met Primary Edpoint ||| Benzinga's Daily Biotech Pulse: Chinese Cheer For Gilead, Immutep Presents Positive Phase 1 Data, FDA Accepts Exelixis sNDA ||| Gilead Announces China Drug Administration Approves Epclusa for Chronic Hepatitis C Virus Infection ||| Gilead and Galapagos' filgotinib successful in mid-stage psoriatic arthritis study ||| The Kite Killer - TapImmune And Marker Merger Challenges Gilead ||| Gilead's Epclusa OK'd in China; shares up 1% premarket",0,0.518535
2018-05-31,12447300.0,68.0999984741211,68.1500015258789,67.20999908447266,67.4000015258789,62.215728759765625,GILD,"2018 ASCO Conference Roundup ||| Gilead & Galapagos Announce Positive Data on Filgotinib ||| Why Is Gilead Sciences (GILD) Down 7.2% Since Its Last Earnings Report? ||| Here's Why Madrigal Pharmaceuticals Is Skyrocketing Today ||| ASCO Conference Preview: Here's What Biotech Investors Need to Watch ||| Benzinga's Daily Biotech Pulse: Clinical Hold For Crispr, Gilead Study Meets Endpoint, Akers Gets Grace Time ||| PiperJaffray Assumes Gilead Sciences at Overweight, Announces Price Target $85 ||| Your Daily Pharma Scoop: Crispr On Hold, AstraZeneca Stumbles Again, TherapeuticsMD Receives FDA Approval ||| Core Biotech Buys #17: Positive Commentary For Gene Therapy And Our First Swap ||| Gilead & Galapagos Announce Positive Data on Filgotinib ||| Why Is Gilead Sciences (GILD) Down 7.2% Since Its Last Earnings Report? ||| Mining ASCO 2018's Gold, Part 7: Digest This News And Get Valuable Information ||| Road To Financial Independence: My April 91-Stock Portfolio Review",1,0.51066893
2018-06-01,5128600.0,67.62000274658203,68.43000030517578,67.5199966430664,68.30000305175781,63.046504974365234,GILD,"Has the Gilead Sciences Buy Argument Collapsed? ||| Better Know Biotech: 2 Stocks You've Got to Know About ||| Madrigal's NASH Study Data Encouraging, Stock Skyrockets ||| 5 Top Stocks to Buy in June ||| Cramer: Gilead Is Dead Money ||| Reader Inquiry: Is MorphoSys A Core Buy In Biotech? ||| ASCO wary of Trump plan to lower drug prices ||| Top Holdings Of Dividend ETFs (June 2018 Edition) ||| Madrigal's NASH Study Data Encouraging, Stock Skyrockets",1,0.4831837
2018-06-04,11726900.0,68.19000244140625,70.80000305175781,67.94999694824219,70.20999908447266,64.8095932006836,GILD,"Venture Capital Deals Of The Week: Goldman Bets On Supply Chain, Mobile Games ||| 3 Reasons Gilead Sciences Is a Better Value Stock Than Amgen ||| Gilead Sciences Leads Its First Step Toward Pipeline Recovery With Clinical Candidate Filgotinib ||| Conatus Pharmaceuticals: What Investors Can Expect From This Interesting NASH Innovator? ||| Noteworthy Monday Option Activity: MA, GILD, WDC ||| Gilead Option Alert: Jul 20 $70 Calls Sweep (24) near the Ask: 827 @ $2.05 vs 4507 OI; Earnings 7/25 After Close [est] Ref=$69.86 ||| Gilead Shares Spike Higher After the Company Says a Study of an Experimental Therapy Eliminated Eliminated Woman's Breast Cancer ||| Gilead's Kite Rports ZUMA-1 Data Suggest Patient Response To Yescarta At 3 Months Could Be Predictive Of Longer-Term Response In refractory B-Cell Lymphoma ||| Gilead's Kite Reports Initial Results From Phase 1 Study Of T-Cell Receptor Cell Therapy In HPV-16-Positive Solid Tumors: NCI Study Shows Investigational Therapy Induces Response In Patients with Epithelial Cancers ||| Crispr On Hold While Sangamo Accelerates ||| By The Numbers: Investing Ideas Based On Profitability, Value, And Momentum ||| Gilead up 1% on reported settlement with Mylan over Tybost, encouraging news on new cancer treatment ||| Biotech Bio Series #3: Should You Buy The Dip On AbbVie?",0,0.4910098
2018-06-05,7821200.0,70.25,70.7300033569336,69.2699966430664,70.05999755859375,64.67112731933594,GILD,My 30 Stock Portfolio +3 Adds,1,0.51134586
2018-06-06,12376600.0,70.16999816894531,71.97000122070312,69.69000244140625,71.97000122070312,66.43421173095703,GILD,"2 Cheap Dividend Stocks You Can Buy Right Now ||| iShares Nasdaq Biotechnology ETF Experiences Big Inflow ||| Biotech Stock Roundup: Regeneron, Celgene, Amgen Impress at ASCO ||| Jefferies 2018 Global Healthcare Conference Continues Today, Presenters Include: TherapeuticsMD, Charles River, OSI Systems, Odonate Therapeutics, Syros, Alnylam, Gilead, and Celgene ||| Gilead Collaborates with Hookipa for HBV and HIV Therapies ||| Woodford Investment Management LLP Buys Evofem Biosciences Inc, Sells Alkermes PLC, Gilead ... ||| PBMs one-up drug makers on drug copay assistance schemes ||| Mining ASCO 2018's Gold, Part 12: Let's Talk About Blood, Baby ||| Biotech Stock Roundup: Regeneron, Celgene, Amgen Impress at ASCO ||| Your Daily Pharma Scoop: Iovance Zooms Ahead, Palatin Surges And Deciphera Moves Up ||| Biotech Analysis Central Pharma News: Roche Abandons Drug, Gilead's Early Stage Bet, Vaxart's Phase 2 Failure",0,0.4993915
2018-06-07,7604900.0,71.87999725341797,71.94999694824219,71.0999984741211,71.9000015258789,66.3696060180664,GILD,"Should You Stick With Gilead Sciences? ||| Alpine Immune Sciences: What The Q1 2018 Earnings Foretell? ||| Core Biotech Buys #18: Thoughts On ASCO And The End Of Core Biotech ||| Galectin Therapeutics's Market Value Should Soar In The Coming Months ||| This One Study Could Radically Change The Cancer Immunotherapy Market ||| An Integrated BioSci Research On Madrigal: What The Stellar Data Reporting For MGL-3196 Foretells ||| Gilead's Evolution In Oncology, With Comments On Valuation",1,0.5207998
2018-06-08,5843100.0,71.44999694824219,72.27999877929688,71.3499984741211,71.91000366210938,66.37883758544922,GILD,NASH players in spotlight on Bristol-Myers Squibb interest ||| Using Ratios To Identify Stocks Set To Outperform Their Peers: Introducing My Research,0,0.49424937
2018-06-11,5425500.0,71.79000091552734,72.0,71.11000061035156,71.83000183105469,66.30496978759766,GILD,"Your 52 Top Yield, Upside And Gains Nasdaq Index Stocks For June ||| Retirement: The Future-Proof Portfolio For Young Investors, Bought At A Market High, Is Reducing Its Losses ||| JAK Inhibitors' Prospects Strong: 4 Stocks Ruling the Space ||| Gilead Sciences a Top Socially Responsible Dividend Stock With 3.2% Yield (GILD) ||| A Conservative Investment Strategy To Achieve 10%-12%+ Annual Cash Flow Returns ||| JAK Inhibitors' Prospects Strong: 4 Stocks Ruling the Space",0,0.49218965
2018-06-12,6977500.0,71.76000213623047,71.9800033569336,70.98999786376953,71.68000030517578,66.16651916503906,GILD,"After Hours Most Active for Jun 12, 2018 : CMCSA, F, EDR, MU, KNX, WMB, GE, MGM, AMAT, INTC, GILD, AGNC ||| Galmed Shares More Than Double As It Hits Bullseye With Fatty Liver Candidate",0,0.4930404
2018-06-13,5077000.0,71.9000015258789,71.9800033569336,71.0,71.29000091552734,65.8065185546875,GILD,"Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for June 14, 2018 ||| Galmed (GLMD) Soars on Positive NASH Data on Aramchol ||| Noteworthy Wednesday Option Activity: ANET, TPX, GILD ||| Drug Stocks: The Next Hot Industry or Value Traps? ||| Drug Stocks: The Next Hot Industry or Value Traps? ||| Gilead Sciences, Inc. (GILD) Presents at Goldman Sachs 39th Annual Global Healthcare Conference (Transcript) ||| Apple: Can Shares Double Again In 2 Years? ||| Viking Therapeutics: Hallmark Moment ||| Galmed (GLMD) Soars on Positive NASH Data on Aramchol ||| Sangamo Therapeutics: Investability Outlook",0,0.46047136
2018-06-14,5226300.0,71.0,71.62000274658203,70.51000213623047,71.1500015258789,66.2066421508789,GILD,NASH Space in Focus as Galmed (GLMD) Posts Positive Data ||| Autolus Therapeutics Readies $125 Million U.S. IPO ||| ContraVir on go to start clinical development of HBV candidate CRV431 in U.S.; shares up 14% premarket,0,0.49887893
2018-06-15,11518000.0,71.0999984741211,71.41000366210938,69.91000366210938,70.2300033569336,65.35054779052734,GILD,"Noteworthy ETF Outflows: IBB, BIIB, GILD, CELG ||| Zacks Value Investor Highlights: Gilead Sciences, Biogen, Celgene, Lannett and Valeant ||| Avoiding The 'Black Hole' Of Disease Development ||| Brief Mid-Year Update On 2018 Global Asset Allocation ||| Zacks Value Investor Highlights: Gilead Sciences, Biogen, Celgene, Lannett and Valeant ||| Gilead: Growth Pick For Your Portfolio",0,0.50050294
2018-06-18,6565300.0,69.7699966430664,69.94000244140625,68.91999816894531,69.05999755859375,64.26184844970703,GILD,"Validea's Top Five Healthcare Stocks Based On Benjamin Graham - 6/17/2018 ||| Novartis Announces Positive Data on CAR-T Therapy, Kymriah ||| Gilead Oncology CAR T-Cell Therapies Outlook Compelling ||| Novartis Announces Positive Data on CAR-T Therapy, Kymriah ||| Dividend Portfolio Review: New Dividend Record",1,0.4919743
2018-06-19,8634000.0,68.45999908447266,70.98999786376953,68.16000366210938,70.94000244140625,66.01122283935547,GILD,3 Great Reasons to Buy Gilead Sciences ||| A Look Back At What's Happened To Each Sector Through The First Half Of 2018 (Part 1) ||| Does Gilead's Have A HBV Blockbuster Drug In The Works?,1,0.529863
2018-06-20,6010600.0,70.95999908447266,71.56999969482422,70.3499984741211,71.45999908447266,66.49510192871094,GILD,"2 High-Flying Biotech Stocks With Even More Room to Grow ||| CRISPR Science and Stocks: Knowing Enough to Invest ||| Small-Cap Biotechs Developing Novel Gene Therapies Could Become Targets of Big Pharma ||| CRISPR Science and Stocks: Knowing Enough to Invest ||| 3 Things In Biotech, June 19: Geron Just Can't Win, Verastem Breaks Out",1,0.5150848
2018-06-21,6548400.0,71.47000122070312,71.69000244140625,70.77999877929688,71.5199966430664,66.5509262084961,GILD,"Johnson & Johnson: Strong Company, But Won't Fit In Most Portfolios ||| 1 High-Yield Blue Chip Set To Soar And 1 You Should Ignore",0,0.4829782
2018-06-22,6118900.0,71.69000244140625,71.76000213623047,70.83000183105469,71.06999969482422,66.13220977783203,GILD,Arbutus Biopharma: The Next Big Breakout Biotech?,1,0.51014817
2018-06-25,6019500.0,70.72000122070312,71.63999938964844,70.55000305175781,71.13999938964844,66.19732666015625,GILD,"What Does Breakthrough Therapy Designation Really Mean For My Company? ||| 2018 Call Portfolio ||| Health Care Sector Update for 06/25/2018: DRIO, SYBX, GILD ||| IBB, GILD, BIIB, CELG: ETF Inflow Alert ||| Health Care Sector Update for 06/25/2018: VLRX,GILD,SYBX ||| Health Care Sector Update for 06/25/2018: DRIO,VLRX,GILD,SYBX ||| European Commission Grants Marketing Authorization for Gilead's Biktarvy ||| Genomic Medicine: Is The Platform The FDA Product? ||| Gilead Sciences Is Too Cheap To Ignore - Cramer's Lightning Round (6/22/18)",0,0.49466372
2018-06-26,6538300.0,71.26000213623047,72.06999969482422,69.70999908447266,70.25,65.36917114257812,GILD,"Gilead's (GILD) Biktarvy Gets EC Nod for HIV- 1 Infection ||| After Hours Most Active for Jun 26, 2018 : PFE, F, QQQ, MSFT, FLNT, ON, BWP, TEVA, GILD, T, INTC, MDT ||| Here Are 43 Of 84 'Safer' Healthcare High Yield Dividend Equities For June ||| Gilead's (GILD) Biktarvy Gets EC Nod for HIV- 1 Infection ||| 59 Top-Yield Healthcare Equities For June",0,0.504423
2018-06-27,5818600.0,70.33999633789062,70.77999877929688,68.5999984741211,68.63999938964844,63.87102890014648,GILD,"Biotech Stock Roundup: PBYI Soars, MACK Crashes, GILD's Biktarvy Gets EC Nod ||| Big Biotechs May Lose Ground To Smaller Upstarts This Year ||| Biotech Stock Roundup: PBYI Soars, MACK Crashes, GILD's Biktarvy Gets EC Nod",1,0.4700117
2018-06-28,7977100.0,69.8499984741211,70.5,69.08000183105469,70.33000183105469,65.44361877441406,GILD,"Raymond James Reviews Gilead Pipelines, Takes Bullish Stance On Pharma Stock ||| Benzinga's Top Upgrades, Downgrades For June 28, 2018 ||| Raymond James Initiates Coverage On Gilead Sciences with Strong Buy Rating, Announces $93 Price Target ||| 5 Undervalued Large-Cap Stocks For Value Investors - June 2018 ||| Raymond James initiates Gilead at 35% upside",1,0.5107115
2018-06-29,6215700.0,70.4800033569336,71.5,70.29000091552734,70.83999633789062,65.91817474365234,GILD,"4 Biotech Stocks to Bet on in the Second Half of 2018 ||| EU Recommends Approval Of Novartis Kymriah, Recommends Approval Of Utlragenyx Drug For Treatment Of Sly Syndrome, Recommends Approval Of Yescarta ||| Rival Novartis, Gilead CAR-T therapies win CHMP recommendations",1,0.5353069
2018-07-02,4086700.0,70.69999694824219,71.37999725341797,70.30000305175781,71.27999877929688,66.32760620117188,GILD,"Venture Capital Deals Of The Week: SoftBank Leads $200M Into Indian Insurance ||| Novartis to Spin-Off Alcon as Separate Trading Company ||| –… Undervalued Stocks for the Enterprising Investor - July —…–8 ||| Gemphire's Positive Phase 2b Results Reignites The NASH Market Yet Again ||| Gilead's (GILD) CAR T Therapy Gets Positive CHMP Opinion ||| Your Daily Pharma Scoop: Spectrum Trial Proceeds, AzurRx Moves To Phase 3, Aptose Jumps",1,0.5044907
2018-07-03,3147700.0,71.4000015258789,71.94000244140625,71.0999984741211,71.33000183105469,66.37413024902344,GILD,"IBB, GILD, AMGN, BIIB: Large Outflows Detected at ETF ||| Is Gilead Sciences a Great Stock for Value Investors? ||| Liquidia Technologies Starts IPO Process ||| Pfizer boosts prices of certain drugs by almost 10% ||| Is Gilead Sciences a Great Stock for Value Investors?",1,0.5146138
2018-07-05,5755400.0,71.33999633789062,72.88999938964844,71.29000091552734,72.80999755859375,67.75130462646484,GILD,"Biotech Stock Roundup: GILD's Positive CHMP Nod, Regulatory Updates & More ||| A Look At Biotech In 2018 And The Biggest Catalysts Coming Up In The Second Half Of The Year ||| Biotech Stock Roundup: GILD's Positive CHMP Nod, Regulatory Updates & More ||| Galectin Therapeutics IPF Patent Solidifies Platform Technology Status ||| Insurers making headway on corralling drug costs with copay accumulators",1,0.48664337
2018-07-06,8859800.0,73.19999694824219,75.44000244140625,73.0,75.20999908447266,69.98455047607422,GILD,"Why Biotech Stocks Rallied on Biogen's Alzheimer's Test ||| Noteworthy Friday Option Activity: GILD, OMC, ADSK ||| Gilead Sciences Option Alert: Jul 20 $74.5 Calls Sweep (5) near the Ask: 500 @ $1.371 vs 81 OI; Earnings 7/25 After Close Ref=$74.4 ||| Stonebridge Capital Management Inc Buys Apple Inc, Starbucks Corp, International Business ... ||| Carlton Hofferkamp & Jenks Wealth Management, LLC Buys PIMCO Enhanced Short Maturity Active ... ||| Why Biotech Stocks Rallied on Biogen's Alzheimer's Test ||| Biogen leads biotechs into positive territory",1,0.49123347
2018-07-09,8546500.0,75.44999694824219,77.19000244140625,75.20999908447266,76.63999938964844,71.3152084350586,GILD,"Ariel Investments on the Future of Health Care ||| Bullish Two Hundred Day Moving Average Cross - GILD ||| Biotech ETFs Surge on Biogen's Positive Drug Trial Result ||| Health Care Sector Outlook: Checking In Ahead Of Q2 Earnings Reports ||| Biotechs give up gains after Trump tweet on prices ||| Top Research Reports for Mastercard, Gilead & Goldman Sachs ||| Biotech ETFs Surge on Biogen's Positive Drug Trial Result ||| Gilead Sciences Near-Term Data Release For Rheumatoid Arthritis Is An Important Event ||| Using Ratios To Identify Stocks Set To Outperform Their Peers: Pharmaceutical Rankings Update ||| Gilead Q2 Results Could Initiate A Rally ||| Learn How To Invest Against Acute Myeloid Leukemia, One Of The Fastest-Growing Cancer Markets ||| Dividend Income Update: June 2018",1,0.51955736
2018-07-10,8380800.0,77.02999877929688,77.44000244140625,76.23999786376953,76.75,71.41756439208984,GILD,"The Zacks Analyst Blog Highlights: Mastercard, Gilead, Goldman Sachs, PepsiCo and Aetna ||| Trade of the Day: Gilead Sciences (GILD) ||| Is Invesco Zacks Multi-Asset Income ETF (CVY) a Hot ETF Right Now? ||| Novartis, Roche, Gilead Have Cancelled Some Drug Price Increases ||| Gilead: Laddered Calls ||| Pricing transparency law in California having effect, drug makers nix planned increases ||| Celgene: Fears Are Overplayed ||| Is Invesco Zacks Multi-Asset Income ETF (CVY) a Hot ETF Right Now? ||| Dividend Portfolio Review: Top 2 Dividend Income For June",0,0.4645479
2018-07-11,6138800.0,76.5,76.66000366210938,75.69000244140625,76.0199966430664,70.73828887939453,GILD,"Noteworthy ETF Inflows: IBB, GILD, AMGN, BIIB ||| 3 Huge Biotech Winners in 2018 (So Far) ||| Gilead Sciences (GILD) Shares Cross 3% Yield Mark ||| 3 Stocks With Bullish Setups For The Rest Of The Week ||| Big Pharma in the red after Pfizer backs away from price hikes ||| Monthly Review Of DivGro: June 2018",1,0.4780811
2018-07-12,8955900.0,76.55999755859375,78.16999816894531,75.93000030517578,77.5999984741211,72.20851135253906,GILD,"If You're Thinking About Buying Gilead Sciences Stock, Now's the Time to Do It ||| Gilead Reports Received Approval In Canada For BIKTARVY For Treatment Of HIV-1 Infection ||| Gilead: Cheap Valuation For Great Pipeline ||| Drug prices still marching upward - Bloomberg",0,0.51637506
2018-07-16,3093500.0,77.58000183105469,77.8499984741211,76.7300033569336,77.26000213623047,71.89214324951172,GILD,"Stocks To Watch: Prime Time In Retail ||| Validea's Top Five Healthcare Stocks Based On Benjamin Graham - 7/15/2018 ||| 3 Best Big Pharma Stocks to Buy for the 2nd Half of 2018 ||| 4 Biggest HIV Drugs of 2024: Which Stocks Are Poised to Profit? ||| 46 Nasdaq 'Safer' Dividend Net Gains Led By Lam, Western, Broadcom, Vodafone, And KLA-Tencor, Per Broker July Targets ||| Your 52 Top Yield, Upside, And Net Gain Nasdaq Stocks For July ||| CVS responds to Trump Administration's request for info on now to lower drug prices",0,0.48088714
2018-07-17,4424700.0,77.11000061035156,77.76000213623047,76.93000030517578,77.19999694824219,71.8363037109375,GILD,Gilead's HIV Franchise Under Assault As It Stares Down Paradigm-Changing Drug ||| My Top 5 Undervalued DGI Stocks,0,0.51430154
2018-07-18,5186600.0,77.08999633789062,77.77999877929688,76.81999969482422,77.12000274658203,71.76187133789062,GILD,"J&J's Darunavir-Based Single-Tablet HIV Regimen Gets FDA Nod ||| Benzinga's Daily Biotech Pulse: Novartis Earnings, J&J's HIV Combo Clears FDA Hurdle, Cara To Offer Shares ||| Madrigal Is Unreasonably Priced For Perfection And Limited Competition ||| FDA committed to easing approval path for biosimilars ||| You Can't Go Wrong Buying Netflix On Dips - Cramer's Mad Money (7/17/18) ||| FDA OKs J&J's single tablet darunavir-based regimen for HIV-1",0,0.5044959
2018-07-19,6488400.0,76.98999786376953,77.7300033569336,76.08000183105469,77.05000305175781,71.69671630859375,GILD,"Noteworthy ETF Outflows: IBB, BIIB, GILD, AMGN ||| 5 Biotech Stocks Well Poised to Beat Q2 Earnings Estimates ||| Gilead Reports Kite Pharma And Gadeta Entered Strategic Collaboration To Develop Novel Gamma Delta TCR Therapies In Various Cancers ||| Gilead's Kite, Gadeta Report Strategic Partnership to Advance Gamma Delta T Cell Receptor Technology for Solid Tumors ||| 5 Biotech Stocks Well Poised to Beat Q2 Earnings Estimates ||| Liquidia Technologies Readies $50 Million IPO ||| Big Pharma in the red on ramped up pressure on drug prices",1,0.5365885
2018-07-20,5656000.0,76.36000061035156,77.69999694824219,76.36000061035156,77.37000274658203,71.99449920654297,GILD,4 Biotech Bets to Watch as Industry Rebounds in a Month ||| Will HIV Sales Drive Gilead (GILD) to Beat in Q2 Earnings? ||| Celgene Shares Spike ~0.6% Following Trader Circulation Of Questionable Chatter Of Interest From Gilead ||| Quarterly Review Of DivGro: Q2 2018 ||| Will HIV Sales Drive Gilead (GILD) to Beat in Q2 Earnings? ||| 4 Biotech Bets to Watch as Industry Rebounds in a Month ||| Mustang Bio: A Differentiated CAR-T Innovator With Multiple Unlocking Catalysts,1,0.52093136
2018-07-23,5119800.0,77.08999633789062,77.94000244140625,76.95999908447266,77.37999725341797,72.0037841796875,GILD,"Stocks To Watch: FANGs Out In Tech ||| 3 Key Things to Watch in Gilead Sciences' Q2 Earnings Report ||| The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results, Earnings And IPOs ||| Why I Finally Sold my Gilead Sciences Stock Position ||| Better Buy: Gilead Sciences, Inc. vs. Celgene ||| Amgen (AMGN) to Report Q2 Earnings: Will it Beat Again? ||| Will Strong HIV Sales Fuel Gilead (GILD) In Q2 Earnings? ||| 3 Big Stock Charts for Monday: Wells Fargo, Philip Morris and Gilead Sciences ||| The Week Ahead: FANG Earnings Continue, Fox Vote On Disney Deal, More IPOs ||| Sangamo's Acquisition Of TxCell Is A Double Edged Sword ||| J&J Wants A Piece Of Gilead's HIV Market ||| Will Strong HIV Sales Fuel Gilead (GILD) In Q2 Earnings? ||| Healthcare ETFs to Buy on Solid Q2 Earnings Expectations ||| Amgen (AMGN) to Report Q2 Earnings: Will it Beat Again? ||| Biotech Stocks Are Tariff-Safe And Building Momentum",1,0.49622032
2018-07-24,8686500.0,77.75,78.58999633789062,77.4000015258789,77.6500015258789,72.25503540039062,GILD,Is a Beat in the Cards for AbbVie (ABBV) in Q2 Earnings? ||| Is a Beat in Store for Keryx (KERX) This Earnings Season? ||| Gilead Highlights New Data On Impact Of Truvada For Pre-Exposure Prophylaxis on the Number of HIV Diagnoses in the United States At Int'l. AIDS Conference: Prevalence Increased From 7 To 68.5 Per 1K People ||| Notable earnings after Wednesday's close ||| Gilead's Truvada used for pre-exposure prophylaxis lowered new HIV infection rates in U.S. ||| Gilead's Truvada used for pre-exposure prophylaxis lowered new HIV infection rates in U.S. ||| Is a Beat in Store for Keryx (KERX) This Earnings Season? ||| 4 Members Of The $800+ Billion Market Cap Club,1,0.5272889
2018-07-25,7968400.0,77.47000122070312,79.0,77.29000091552734,78.91999816894531,73.4367904663086,GILD,"Biotech Stock Roundup: Biogen Gains on Q2 Results, Agios Gets FDA Nod For Leukemia Drug ||| Facebook Misses 1st Time in 11 Quarters; Plus GILD, QCOM ||| Gilead Sciences (GILD) Q2 Earnings and Revenues Surpass Estimates ||| Notable Wednesday Option Activity: GRPN, GILD, SPWR ||| After-Hours Earnings Report for July 25, 2018 : FB, V, PYPL, GILD, QCOM, SU, MDLZ, LVS, VRTX, F, NOW, ALGN ||| Gilead Reaffirms FY18 Net Product Sales Guidance $20B-$21B vs $20.81B Estimate ||| UPDATE: Gilead Raises FY18 GAAP EPS From $1.41-$1.51 To $1.50-$1.60 ||| Gilead Raises FY18 Outlook ||| Gilead Sciences Q2 Adj. EPS $1.91 Beats $1.56 Estimate, Sales $5.5B Beat $5.21B Estimate ||| Gilead Sciences Announces CEO John F. Milligan to Step Down ||| Benzinga's Daily Biotech Pulse: Merck's Keytruda Found Effective, Nabriva To Acquire Zavante, FDA Denies Agile ||| Gilead Sciences Q2 Earnings Preview ||| Earnings Scheduled For July 25, 2018 ||| Gilead Sciences (GILD) Q2 2018 Results - Earnings Call Transcript ||| Facebook Misses 1st Time in 11 Quarters; Plus GILD, QCOM ||| 'End of era' for Gilead as CEO and Chairman set exit ||| Gilead Sciences declares $0.57 dividend ||| Gilead chief Milligan to step down at year-end ||| Gilead Q2 revenues down 21%; earnings down 41%; shares down 2% after hours ||| Gilead Sciences beats by $0.35, beats on revenue ||| 5 Health Care Stocks Gurus Are Buying ||| What We Can Expect From Gilead ||| Biotech Stock Roundup: Biogen Gains on Q2 Results, Agios Gets FDA Nod For Leukemia Drug ||| GlaxoSmithKline Achieves Successful 2-Drug Regimen Studies For HIV, Gilead Might Have Met Its Match",0,0.48847175
2018-07-26,14492500.0,77.7699966430664,79.04000091552734,76.0999984741211,78.16000366210938,72.72959899902344,GILD,"Gilead (GILD) Q2 Earnings & Sales Beat Eclipsed by CEO Exit ||| AstraZeneca's (AZN) Q2 Earnings and Sales Beat, Stock Up ||| Allergan (AGN) Beats on Q2 Earnings, Unveils Buyback Plan ||| Alexion's (ALXN) Earnings Beat Estimates in Q2, Guidance Up ||| CEO Departure at Gilead Sciences Upstages Good Second-Quarter Results ||| Microsoft, H&R Block, Facebook, Qualcomm and Gilead highlighted as Zacks Bull and Bear of the Day ||| Daily Dividend Report: SCHW, MCK, CVX, CMCSA, GILD ||| Gilead Sciences Option Alert: Sep 21 $82.5 Calls Sweep (32) near the Ask: 863 @ $1.15 vs 3235 OI; Ref=$77.79 ||| Benzinga's Top Upgrades, Downgrades For July 26, 2018 ||| Benzinga's Daily Biotech Pulse: Biogen, AC Immune Slip Despite Positive Trials, Sarepta Slapped With Clinical Hold ||| Morgan Stanley Maintains Equal-Weight on Gilead Sciences, Raises Price Target to $85 ||| Baird Downgrades Gilead Sciences to Neutral ||| Allergan (AGN) Beats on Q2 Earnings, Unveils Buyback Plan ||| AstraZeneca's (AZN) Q2 Earnings and Sales Beat, Stock Up ||| Alexion's (ALXN) Earnings Beat Estimates in Q2, Guidance Up ||| Microsoft, H&R Block, Facebook, Qualcomm and Gilead highlighted as Zacks Bull and Bear of the Day ||| Gilead (GILD) Q2 Earnings & Sales Beat Eclipsed by CEO Exit ||| Facebook Takes The FANGs Out (Wall Street Breakfast Podcast) ||| Wall Street Breakfast: Facebook Takes The FANGs Out",0,0.4962648
2018-07-27,9455900.0,78.12999725341797,78.94999694824219,76.62999725341797,76.80999755859375,71.47339630126953,GILD,"iShares Nasdaq Biotechnology ETF Experiences Big Inflow ||| Forget Gilead Sciences' CEO Departure -- This Was the Biotech's Big News ||| After Hours Most Active for Jul 27, 2018 : QQQ, WFC, CSCO, MS, DB, NOK, CZR, MO, KO, GILD, SOXX, SYMC ||| Stifel Doubles Down On MEI Pharma, Considers ME-401 'Best-In-Class' ||| Gilead Sciences: Stabilisation In Sight",0,0.46839148
2018-07-30,5720900.0,76.47000122070312,76.95999908447266,75.83999633789062,76.31999969482422,71.01744079589844,GILD,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs ||| Gilead Sciences: Insight Into The Kite And Gadeta Partnership For CAR-TCR Targeting Solid Tumors ||| 3 Cheap Big Pharma Dividend Stocks That You Can Buy Now and Hold for Years ||| Is Gilead Sciences' Sudden Change in Leadership a Good Thing? ||| Celyad Looks To Take The Cake In Speculative Biotech ||| Gilead's Stock Price Is Ready To Soar",1,0.51216674
2018-07-31,6615100.0,76.58999633789062,78.08000183105469,76.19000244140625,77.83000183105469,72.42253112792969,GILD,"Sanofi's (SNY) Q2 Earnings Surpass Estimates, Sales Miss ||| Better Buy: Biogen Inc. vs. Gilead Sciences, Inc. ||| Gilead: Is The Drama Over? ||| Tiziana Life Sciences Files For Small IPO ||| Pfizer's Read thinks drug rebates going bye-bye in U.S. ||| U.S. healthcare spending nearing 20% of GDP ||| AbbVie: Undervalued And Strong Growth On The Horizon ||| Sanofi's (SNY) Q2 Earnings Surpass Estimates, Sales Miss ||| Is Gilead Sciences (GILD) Outperforming Other Medical Stocks This Year? ||| Sickle Cell Disease Breakthrough: Global Blood Therapeutics' Antisickling Agent Voxelotor",1,0.5159103
2018-08-01,4246200.0,77.5,78.3499984741211,77.37999725341797,77.9000015258789,72.4876708984375,GILD,"Shire's (SHPG) Earnings and Revenues Beat Estimates in Q2 ||| Endocyte (ECYT) Posts Narrower-Than-Expected Loss in Q2 ||| Meet The 'Safer' 35 Healthcare High Yield WallStars For July ||| Shire's (SHPG) Earnings and Revenues Beat Estimates in Q2 ||| Endocyte (ECYT) Posts Narrower-Than-Expected Loss in Q2 ||| Biotech Stock Roundup: Celgene, Amgen, Vertex Impress in Q2, Gilead's CEO to Exit ||| Wall Street Favorite Healthcare Equities For July Topped By CVS Health",0,0.48827
2018-08-02,5629200.0,77.69000244140625,78.16000366210938,76.86000061035156,77.62999725341797,72.23641967773438,GILD,"5 Cheap PEG Stocks Suitable for GARP Investors ||| Zoetis (ZTS) Beats on Q2 Earnings & Sales, Updates '18 View ||| The 5 Best Dividend Stocks to Buy, Hands Down ||| Zoetis (ZTS) Beats on Q2 Earnings & Sales, Updates '18 View ||| 5 Cheap PEG Stocks Suitable for GARP Investors",1,0.51892716
2018-08-03,4628600.0,77.68000030517578,77.94999694824219,77.16999816894531,77.93000030517578,72.51557159423828,GILD,"bluebird (BLUE) Q2 Loss Wider Than Expected, Revenues Miss ||| Acorda (ACOR) Q2 Earnings and Revenues Surpass Estimates ||| Intercept (ICPT) Gains on Solid Q2 Results, Ocaliva Recovers ||| Ultragenyx (RARE) Posts Narrower-than-Expected Loss in Q2 ||| Epizyme (EPZM) Q2 Loss Narrows, Shares Crash 24% on Setbacks ||| Ultragenyx (RARE) Posts Narrower-than-Expected Loss in Q2 ||| Epizyme (EPZM) Q2 Loss Narrows, Shares Crash 24% on Setbacks ||| bluebird (BLUE) Q2 Loss Wider Than Expected, Revenues Miss ||| Zacks.com featured highlights include: Biogen, Thermo Fisher, HCA, Gilead and QUALCOMM",0,0.4881928
2018-08-06,3955100.0,77.83999633789062,78.23999786376953,77.26000213623047,77.87000274658203,72.45973205566406,GILD,"Gilead Sciences Is A Solid Buy In 2018 ||| Q2 Scorecard & Research Reports for Gilead, American Tower & Others ||| Alnylam's (ALNY) Q2 Loss Wider Than Expected, Sales Beat ||| iShares Nasdaq Biotechnology ETF Experiences Big Outflow ||| Gilead Sciences' Genvoya for the Treatment of HIV-1 is Approved by the China National Drug Administration ||| Q2 Scorecard & Research Reports for Gilead, American Tower & Others ||| Tom Gayner Exits Flowserve, Gilead, IBM ||| Alnylam's (ALNY) Q2 Loss Wider Than Expected, Sales Beat ||| Stocks Showing Improved Relative Strength: Gilead Sciences ||| Gilead's Genvoya OK'd in China ||| Gilead's Genvoya approved in China for the treatment of HIV-1 infection ||| Gilead: A Bell Tolls, And A Window Of Opportunity Opens",1,0.500112
2018-08-07,5759100.0,77.94000244140625,78.55000305175781,77.5199966430664,78.37999725341797,72.93431854248047,GILD,"Radius (RDUS) Q2 Loss Narrower Than Expected, Tymlos Sales Up ||| The Highs And Lows Of Earnings Season Dominate July's IMX Results ||| Investor Movement Index July Summary ||| Diamond Hill Capital Management Buys Facebook Inc, Bank OZK, Brighthouse Financial Inc, Sells ... ||| AbbVie and Enanta down on loss of preferred status in HCV with Express Scripts ||| Biopharma 2018: Growth At A Reasonable Cost (GARC) ||| Johnson & Johnson: Headline Risk But Business Solid ||| Dividend Portfolio Review: Busy Earnings Season, Heavy Buying, Growing Dividends",0,0.495641
2018-08-08,4400600.0,78.19000244140625,78.37999725341797,76.83000183105469,76.91000366210938,71.56645202636719,GILD,"AVEO Pharmaceuticals (AVEO) Q2 Loss In Line, Revenues Miss ||| Inovio (INO) Q2 Loss Narrows, Revenues Surpass Estimates ||| Better Buy: Gilead Sciences, Inc. vs. Amgen Inc. ||| Merrimack (MACK) Suffers Wider-Than-Expected Loss in Q2 ||| VIVUS (VVUS) Q2 Loss Wider Than Expected, Revenues Up Y/Y ||| Biotech Stock Roundup: Regeneron Shines, BLUE Surges, ONCE Plunges ||| Prothena (PRTA) Q2 Earnings Lag Estimates, Pipeline in Focus ||| AVEO Pharmaceuticals (AVEO) Q2 Loss In Line, Revenues Miss ||| Merrimack (MACK) Suffers Wider-Than-Expected Loss in Q2 ||| VIVUS (VVUS) Q2 Loss Wider Than Expected, Revenues Up Y/Y ||| Your Daily Pharma Scoop: Foundation Promising, Paratek Moves Up, Ovid Down",1,0.4907213
2018-08-09,5835400.0,77.02999877929688,78.62000274658203,76.91999816894531,78.04000091552734,72.6179428100586,GILD,"Keryx's (KERX) Loss Wider Than Expected in Q2, Sales Lag ||| PDL BioPharma (PDLI) Q2 Earnings Top, Revenues Slump Y/Y ||| Is Crispr Therapeutics Stock Grossly Overvalued? ||| Aerie (AERI) Earnings Miss in Q2, Rhopressa Performs Well ||| Horizon Pharma (HZNP) Q2 Earnings & Sales Beat, Shares Rise ||| Noteworthy Thursday Option Activity: PRGO, OXY, GILD ||| Tiger Management's Top Growth Picks ||| Sangamo: First Look At June 2018 Results ||| Aerie (AERI) Earnings Miss in Q2, Rhopressa Performs Well ||| Horizon Pharma (HZNP) Q2 Earnings & Sales Beat, Shares Rise",0,0.5137593
2018-08-10,5564100.0,77.5199966430664,77.95999908447266,76.30000305175781,76.7300033569336,71.39895629882812,GILD,"Puma Biotech (PBYI) Q2 Loss Narrows, Nerlynx Drives Sales ||| Agenus' (AGEN) Q2 Loss Narrower Than Expected, Revenues Beat ||| Biotech ETFs in Focus on String of Q2 Earnings Beat ||| Biotech ETFs in Focus on String of Q2 Earnings Beat ||| Puma Biotech (PBYI) Q2 Loss Narrows, Nerlynx Drives Sales ||| Agenus' (AGEN) Q2 Loss Narrower Than Expected, Revenues Beat",1,0.4988081
2018-08-13,4903400.0,76.87000274658203,77.4800033569336,76.52999877929688,77.16999816894531,71.80838012695312,GILD,"Stocks To Watch: Any Privacy For Tesla? ||| Ligand (LGND) Proposes to Buy U.K.'s Drug Discovery Biotech ||| Shire, Shionogi File NDA for Intuniv for Adults in Japan ||| Amicus (FOLD) Gets FDA Nod for Fabry Disease Drug Galafold ||| Alnylam (ALNY) Gets FDA Nod for First-Ever RNAi Therapeutic ||| Ronald Muhlenkamp Dumps One Pharmaceutical Company in Favor of Another ||| Alnylam (ALNY) Gets FDA Nod for First-Ever RNAi Therapeutic ||| –… Undervalued Stocks for the Enterprising Investor - August —…–8",1,0.51828486
2018-08-14,4399800.0,77.11000061035156,77.81999969482422,77.11000061035156,77.30999755859375,71.93865966796875,GILD,"Bayer Plunges as Monsanto Fined $289M in Roundup Lawsuit ||| CI Global Investments Inc. Buys Cboe Global Markets Inc, Anthem Inc, Jacobs Engineering Group ... ||| One Year Later: Lessons Learned In CAR-T ||| Duquesne Capital Management, LLC Buys Facebook Inc, Gilead Sciences Inc, Microsoft Corp, Sells ... ||| Spark Therapeutics: This Appears To Be A Dip Worth Buying ||| Is Cocrystal Beating The Dead Hepatitis C Horse?",0,0.49807632
2018-08-15,11810000.0,76.4000015258789,76.47000122070312,74.25,74.83999633789062,69.64027404785156,GILD,"GILD Makes Notable Cross Below Critical Moving Average ||| Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for August 16, 2018 ||| Investors shun healthcare stocks in broad market selloff",1,0.4922029
2018-08-16,8742100.0,75.16000366210938,75.68000030517578,74.68000030517578,75.58999633789062,70.33815002441406,GILD,Inovio Pharmaceuticals Initiates Dosing in HIV Vaccine Study ||| Lessons from a Legendary Value Investor ||| Vertex's Cystic Fibrosis Drug Gets FDA Nod for Children ||| Should Gilead Be Worried About This New Monthly HIV Medication? ||| A Synopsis Of The HIV Market ||| Inovio Pharmaceuticals Initiates Dosing in HIV Vaccine Study ||| Lessons from a Legendary Value Investor ||| Vertex's Cystic Fibrosis Drug Gets FDA Nod for Children ||| PepsiCo And Gilead: 2 Very Different CEO Departures,0,0.5056076
2018-08-17,13337900.0,75.41000366210938,75.55000305175781,72.05999755859375,72.91999816894531,67.8536605834961,GILD,"Regeneron, Teva Announce Positive Data on Osteoarthritis Drug ||| Has Gilead Sciences (GILD) Outpaced Other Medical Stocks This Year? ||| Zacks Value Trader Highlights: Sony, Carrizo Oil & Gas, Intel, United Rentals and Gilead ||| Has Gilead Sciences (GILD) Outpaced Other Medical Stocks This Year? ||| Notable Friday Option Activity: ADBE, FB, GILD ||| Stanley Druckenmiller Bets on Facebook and Oil ||| Benchmark Indexes Mixed Friday ||| Gilead continues selloff, down 3% ||| Has Gilead Sciences (GILD) Outpaced Other Medical Stocks This Year? ||| Has Gilead Sciences (GILD) Outpaced Other Medical Stocks This Year? ||| Regeneron, Teva Announce Positive Data on Osteoarthritis Drug ||| Zacks Value Trader Highlights: Sony, Carrizo Oil & Gas, Intel, United Rentals and Gilead ||| Glaxo, J&J's Dual Drug HIV Regimen Succeeds in Phase III Study",0,0.4998997
2018-08-20,9137800.0,72.94000244140625,73.37000274658203,71.9000015258789,72.36000061035156,67.33257293701172,GILD,"Sangamo Therapeutics: More Catalysts Powering A Gene-Based Innovator ||| Is Viking Therapeutics, Inc. a Buy? ||| 8 Undervalued Biotech Stocks to Watch ||| Novo Nordisk Buys Ziylo to Develop Glucose Responsive Insulin ||| Time for Jackson Hole: Global Week Ahead ||| Gilead Sciences, Inc. 2018 Q2 - Results - Earnings Call Slides ||| Time for Jackson Hole: Global Week Ahead ||| Gilead Sciences: Still My Top Biotech Pick For The Next Decade ||| Biotech Analysis Central Pharma News: Gilead's Hope Dashed, Pfizer's Vaccine Deal, Eisai And Merck FDA Approval",1,0.5192454
2018-08-21,9139900.0,72.37000274658203,73.4800033569336,72.37000274658203,73.31999969482422,68.22586822509766,GILD,"Alexion's BLA for ALXN1210 Gets Priority Review From FDA ||| China Biologic Products (CBPO) Looks Good: Stock Adds 8.7% in Session ||| The Zacks Analyst Blog Highlights: Amazon, Petroleo Brazileiro, Gilead Sciences and KLA-Tencor ||| The Cost of Cures: How Investing in Biotech Stocks Could Soon Be Radically Changed ||| Japan Nods to AstraZeneca's Tagrisso for First-Line NSCLC ||| Jane's July Dividend Increases And Income Tracker - Retirement Accounts ||| Alexion's BLA for ALXN1210 Gets Priority Review From FDA ||| China Biologic Products (CBPO) Looks Good: Stock Adds 8.7% in Session",1,0.50852704
2018-08-22,5083500.0,73.44999694824219,74.3499984741211,73.20999908447266,73.81999969482422,68.69113159179688,GILD,"Pacira (PCRX) Rides High on Robust Exparel Performance ||| Allergan Falls on FDA's Rejection of Uterine Fibroids Drug ||| Infinity Focuses on Developing IPI-549 for Solid Tumors ||| 5 Drug Stocks to Buy While the Pharma Sector Is on Sale ||| Sierra Oncology Acquires Momelotinib, Will Pay Gilead $3M Upfront With Potential Milestone Payments Of Up To $195M ||| Here's 53 Nasdaq Top Yield, Upside, And Net Gain Stocks For August ||| Alnylam Completes Enrollment in Phase III Givosiran Study ||| bluebird bio: Heading To $200 On Pipeline Progress And Potential M&A ||| Pacira (PCRX) Rides High on Robust Exparel Performance ||| Allergan Falls on FDA's Rejection of Uterine Fibroids Drug ||| Gilead Debate Focused On Threat Of GSK In HIV And On Management Departures ||| Infinity Focuses on Developing IPI-549 for Solid Tumors ||| Outperforming The Market By Following Earnings Revisions ||| Market Caution Amid Political Worries (Wall Street Breakfast Podcast) ||| Sierra Oncology acquires late-stage candidate from Gilead for up to $198M; shares up 20% premarket ||| Wall Street Breakfast: Market Caution Amid Political Worries ||| Congo clears more experimental Ebola treatments",0,0.5192111
2018-08-23,4737500.0,73.54000091552734,73.76000213623047,72.75,73.33999633789062,68.24449157714844,GILD,Exact Sciences Inks Cologuard Co-Promotion Deal With Pfizer ||| 4 Biotech Stocks Investors Can Bet on Post Solid Q2 Earnings ||| Mallinckrodt's Stannsoporfin Gets Complete Response Letter ||| Don't Worry About An Inverted Yield Curve...YET ||| Your 47 Nasdaq 'Safer' Dividend Equities For August ||| Don't Worry About An Inverted Yield Curve...YET ||| AbbVie Posts Positive Data on Elagolix for Uterine Fibroids ||| Oklahoma first state to negotiate efficacy-based drug prices ||| 4 Biotech Stocks Investors Can Bet on Post Solid Q2 Earnings ||| Mallinckrodt's Stannsoporfin Gets Complete Response Letter,1,0.4945467
2018-08-24,4767100.0,73.5199966430664,74.01000213623047,73.20999908447266,73.58999633789062,68.47711181640625,GILD,Why Is Gilead (GILD) Down 6.2% Since Last Earnings Report? ||| Shire's Takhzyro Gets FDA Nod for Hereditary Angioedema ||| Roche (RHHBY) Gets FDA Approval for Cobas EFGR Mutation Test ||| 3 Big Drug Stocks With Big Cash Stockpiles: Should You Spend Your Cash Buying Them? ||| 23andMe cuts off app developers from raw genetic data ||| Why Is Gilead (GILD) Down 6.2% Since Last Earnings Report? ||| Shire's Takhzyro Gets FDA Nod for Hereditary Angioedema ||| Roche (RHHBY) Gets FDA Approval for Cobas EFGR Mutation Test ||| 2018 Call Portfolio Update,1,0.50464433
2018-08-27,5355500.0,74.0,74.91000366210938,73.83999633789062,74.81999969482422,69.62165832519531,GILD,"Play The Future of Gene Therapy With These 5 Biotech Stocks ||| Novartis' CAR-T Therapy Kymriah Gets Approval in Europe ||| Novo Nordisk's Ozempic Lowers Risk of Cardiovascular Events ||| Bausch (BHC) Gets FDA Approval for Altreno for Acne Vulgaris ||| Gilead's Yescarta Resceives European Marketing Authorization ||| Bausch (BHC) Gets FDA Approval for Altreno for Acne Vulgaris ||| Is It Time To Take Profits On Merck? ||| Seattle Genetics Is A Solid Buy In 2018 ||| Biotech Analysis Central Pharma News: J&J And Bayer Failure, Gilead Sciences Unloads Cancer Drug, Mallinckrodt Fails To Get Green Light ||| Money flow stays positive in biotechs, XBI up 6% since last week ||| Novartis' CAR-T Therapy Kymriah Gets Approval in Europe ||| Genfit And Elafibranor In NASH Fibrosis: A Revisit Of The FDA Guidelines ||| Yescarta receives marketing authorization in Europe for the treatment of relapsed or refractory DLBCL and PMBCL",1,0.52853304
2018-08-28,4737600.0,74.80000305175781,75.47000122070312,74.61000061035156,74.93000030517578,69.72400665283203,GILD,"Amgen Files for Once-Weekly Regimen for Myeloma Drug Kyprolis ||| Ultragenyx's Rare Disease Drug Mepsevii Gets EU Approval ||| Gilead's CAR-T Therapy Yescarta Gets Approval in Europe ||| 3 Top Healthcare Stocks to Buy This Week ||| Bayer's Blood Thinner Xarelto Fails in Line Extension Studies ||| Ultragenyx's Rare Disease Drug Mepsevii Gets EU Approval ||| Bayer's Blood Thinner Xarelto Fails in Line Extension Studies ||| NASH Cirrhosis: The Real NASH Epidemic ||| 30 Stock Portfolio Summer Review ||| Amgen Files for Once-Weekly Regimen for Myeloma Drug Kyprolis ||| Your Cancer Highlight: Novartis Gets Another CAR-T Approval, But Manufacturing Is A Drag ||| Gilead's CAR-T Therapy Yescarta Gets Approval in Europe ||| UK's NICE not on board with Gilead's Yescarta",1,0.51631296
2018-08-29,4570500.0,74.9000015258789,75.80999755859375,74.36000061035156,75.62000274658203,70.3660888671875,GILD,"Affimed (AFMD) Surges On Collaboration Contract With Roche ||| Biotech Stock Roundup: GILD Gets EC Nod for Yescarta, AMGN Submits Kyprolis sNDA ||| Time to Take Some Profits in Sarepta Therapeutics Stock ||| Retirement: The Future-Proof Portfolio For Young Investors Becomes 7 Months Old, New Position Opened ||| Your Daily Pharma Scoop: ESPR Phase 3 Positive, FDA Rejects Volanesorsen, Ozempic Succeeds ||| Biotech Stock Roundup: GILD Gets EC Nod for Yescarta, AMGN Submits Kyprolis sNDA ||| Gilead Sciences appoints Laura Hamill as Executive VP, Worldwide Commercial Operations",1,0.4945667
2018-08-30,4459100.0,75.73999786376953,76.3499984741211,75.5,76.29000091552734,70.98951721191406,GILD,"Ultragenyx to File NDA for LC-FAOD Candidate on Existing Data ||| Gilead Sciences (GILD) Gains As Market Dips: What You Should Know ||| Gilead Sciences (GILD) Gains As Market Dips: What You Should Know ||| Affimed (AFMD) Surges on Collaboration Contract with Roche (revised) ||| Bausch (BHC) Resubmits NDA for Duobrii for Plaque Psoriasis ||| Gilead Sciences (GILD) Gains As Market Dips: What You Should Know ||| FDA OKs two new HIV treatments from Merck ||| Affimed (AFMD) Surges on Collaboration Contract with Roche (revised) ||| A Middle-Class Millennial's Personal Investment Portfolio And Rationale ||| Et Tu, Bruton? ||| By The Numbers: Is Biogen A Buy?",0,0.47890064
2018-08-31,4311900.0,76.31999969482422,76.58999633789062,75.51000213623047,75.7300033569336,70.46842956542969,GILD,Bayer's (BAYRY) Jivi Gets FDA Approval to Treat Hemophilia A ||| Glaxo's Asthma Drug Gets EU Nod for Pediatric Population ||| Vertex Inks Deal With Genomics to Make Serious Disease Drugs ||| Merck (MRK) Receives FDA Approval for Two HIV Medicines ||| Bristol-Myers' Sprycel Seeks Label Expansion in the U.S. ||| Alnylam Gets European Nod for First-Ever RNAi Therapeutic ||| Bayer's (BAYRY) Jivi Gets FDA Approval to Treat Hemophilia A ||| Bristol-Myers' Sprycel Seeks Label Expansion in the U.S. ||| Glaxo's Asthma Drug Gets EU Nod for Pediatric Population ||| Vertex Inks Deal With Genomics to Make Serious Disease Drugs,0,0.5221794
2018-09-04,4842300.0,75.36000061035156,75.72000122070312,73.6500015258789,74.29000091552734,69.12847900390625,GILD,"Better Buy: Amgen Inc. vs. Gilead Sciences, Inc. ||| The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings ||| Gilead And NASH: New Heydays Are Ahead ||| AstraZeneca's Lupus Drug Misses Primary Endpoint in Study ||| Road To Financial Independence: Growing Dividends, Endless Opportunities But Limited Capital ||| Inovio (INO) Initiates Phase I Study on Hepatitis C Vaccine ||| Is Now a Good Time to Buy Gilead Sciences? ||| Alnylam's Shares Up as Onpattro Gets FDA and EU Approvals ||| Novo Nordisk's Ozempic Lowers Risk of Cardiovascular Events (revised) ||| UPDATE: Terms Of Gilead Licensing Deal For Trianni Not Disclosed ||| Gilead Reports Licensing Deal With Trianni For Use Of Trianni Transgenic Human Monoclonal Antibody Discovery Platform ||| Biotech Analysis Central Pharma News: Pfizer Axes Drug, Merck's Approvals, Bayer's Green Light ||| Gilead in-licenses Trianni antibody discovery platform ||| Novo Nordisk's Ozempic Lowers Risk of Cardiovascular Events (revised) ||| Inovio (INO) Initiates Phase I Study on Hepatitis C Vaccine",1,0.49184072
2018-09-05,5069400.0,74.18000030517578,74.66000366210938,73.91000366210938,74.52999877929688,69.35179901123047,GILD,"MannKind Stock Up on Licensing Deal With United Therapeutics ||| Horizon Pharma Completes Enrollment in Eye Disease Study ||| Bayer (BAYRY) Misses on Q2 Earnings, Closes Monsanto Buyout ||| Horizon Pharma Completes Enrollment in Eye Disease Study ||| Bayer (BAYRY) Misses on Q2 Earnings, Closes Monsanto Buyout ||| Abivax UC candidate shows positive action in mid-stage study",0,0.49261174
2018-09-06,5404900.0,74.37000274658203,74.63999938964844,72.61000061035156,72.87999725341797,67.81643676757812,GILD,"Puma Biotech Gets EU Nod for Breast Cancer Drug Nerlynx ||| ProQR Up More Than 120% on Favorable Eye Disorder Study Data ||| IBB, GILD, CELG, REGN: Large Outflows Detected at ETF ||| bluebird (BLUE) Reports Updated Data on Lenti-D Gene Therapy ||| 3 Top Big Pharma Stocks to Buy Now ||| The Daily Biotech Pulse: Novartis Divestment, Eyepoint's Drug Gets Coverage, Spectrum's Robust Data ||| Gilead, Galapagos Announce Tortuga Phase 2 Study of Filgotinib in Ankylosing Spondylitis Achieves Primary Endpoint ||| Biotechs and biopharmas in the red ||| ProQR Up More Than 120% on Favorable Eye Disorder Study Data ||| Puma Biotech Gets EU Nod for Breast Cancer Drug Nerlynx ||| Gilead and Galapagos' TORTUGA Phase 2 study of filgotinib in AS achieves primary endpoint",0,0.4968213
2018-09-07,6891900.0,72.7300033569336,72.80000305175781,71.48999786376953,72.22000122070312,67.2022933959961,GILD,"Inovio Initiates Dosing in Phase I/IIa Study on MERS Vaccine ||| Noteworthy Friday Option Activity: UBNT, ROKU, GILD ||| Arrowhead Stock Is Not Done Rallying After Its 38% Jump ||| Top Research Reports for Abbott, Gilead & FedEx ||| Arrowhead Pharmaceuticals Could Become The Next Gilead ||| Inovio Initiates Dosing in Phase I/IIa Study on MERS Vaccine ||| Jobs Report Expected To Be Strong (Wall Street Breakfast Podcast) ||| Wall Street Breakfast: Jobs Report Steals The Spotlight ||| Ebola outbreak spreading in Congo",1,0.50812745
2018-09-10,5009600.0,72.58000183105469,73.16999816894531,72.3499984741211,72.51000213623047,67.47215270996094,GILD,"The Week Ahead In Biotech: Conferences, Clinical Trial Results, Earnings And IPOs ||| Inovio's Early/Mid-Stage Vaccine Pipeline Exhibits Growth ||| The Zacks Analyst Blog Highlights: Abbott, Gilead, FedEx, Archer Daniels and CBRE ||| Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know ||| Shire's ADHD Portfolio Remains Strong Amid Competition ||| Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know ||| Shire's ADHD Portfolio Remains Strong Amid Competition ||| Gilead Sciences Is On The Right Trajectory Path For Autoimmune Disorders ||| Inovio's Early/Mid-Stage Vaccine Pipeline Exhibits Growth ||| My Quarterly Non-Taxable Portfolio Update ||| Breaking Down The NASH Fibrosis Market - Intercept, Genfit Primed For Potential Market Dominance ||| The Zacks Analyst Blog Highlights: Abbott, Gilead, FedEx, Archer Daniels and CBRE",0,0.5100455
2018-09-11,5265100.0,72.5999984741211,72.69000244140625,71.7699966430664,72.2300033569336,67.21160888671875,GILD,"Endocyte Announces FDA's Acceptance of Trial Endpoint Change ||| Ex-Dividend Reminder: El Paso Electric, DTE Energy and Gilead Sciences ||| Gilead and Galapagos Announce Filgotinib Meets Primary and 'All Key Secondary' Endpoints In Phase 3 Study In Rheumatoid Arthritis ||| Gilead Sciences Brings Strong Rheumatoid Arthritis Data, This Train Keeps Rolling ||| After Hours Gainers / Losers (09/11/2018) ||| Gilead's filgotinib successful in late-stage study in treatment-resistant rheumatoid arthritis ||| HQL: A Top-Notch Biotech CEF ||| Endocyte Announces FDA's Acceptance of Trial Endpoint Change ||| Sangamo (Part V): Assessing The Prospects Of SB-913",1,0.51753855
2018-09-12,9589000.0,75.05999755859375,75.18000030517578,73.4000015258789,73.97000122070312,68.83072662353516,GILD,"Gilead Sciences Reports Market-Moving News ||| Here's Why Galapagos NV Is Skyrocketing 18.3% Today ||| Merck's Antibacterial Drug Succeeds in Label Expansion Study ||| Regeneron/Sanofi's sBLA for Praluent to be Reviewed by FDA ||| Biotech Stock Roundup: GILD's Arthritis Drug Successful in Phase III, PRQR Soars ||| Incyte, Foundation Medicine Partner for Companion Diagnostics ||| Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for September 13, 2018 ||| Why Altria Group, Galapagos, and Laredo Petroleum Jumped Today ||| 3 Top Stocks for Investing in Pharma's Next $35 Billion Market ||| Why Gilead, Galapagos Shares Are Trading Higher ||| Fast Money Picks For September 12 ||| Gilead Reports Collaboration With Precision BioSciences For Development Of Therapies Against Hep B Virus Using ARCUS Genome Editing ||| The Daily Biotech Pulse: Foamix Jumps on Data, Positive Results for Galapagos-Gilead's Rheumatoid Arthritis Drug, Bausch Health Trims Debt ||| 30 Stocks Moving In Wednesday's Pre-Market Session ||| 36 'Safer' Dividend Healthcare WallStars For September ||| US Stocks Lower on Wednesday ||| Gilead's Rheumatoid Arthritis Drug Successful in Phase III ||| Gilead Sciences, Inc. (GILD) CEO John Milligan at the Morgan Stanley 16th Annual Global Healthcare Conference (Transcript) ||| Aceto 72% Target Net Gain Tops WallStar Healthcare Equities For September ||| Biotech Stock Roundup: GILD's Arthritis Drug Successful in Phase III, PRQR Soars ||| Incyte, Foundation Medicine Partner for Companion Diagnostics ||| Gilead teams up with Precision BioSciences in HBV ||| Stock Futures Flat As Chips Weigh, Oil Rises, But This Pot Stock Soars",1,0.5099867
2018-09-13,5607200.0,73.75,74.25,72.9000015258789,74.12000274658203,69.50589752197266,GILD,"Gilead Inks Gene Editing Collaboration Deal for HBV Infection ||| What's Next for Gilead Sciences After Its Latest Clinical Success ||| Company News For Sep 13, 2018 ||| Better Buy: Gilead Sciences, Inc. vs. Biogen ||| Stocks Trading Ex Dividend For Thurs., Sep. 13, 2018 ||| Your Daily Scoop: Foamix Zooms, Pfizer And Merck Report Positive ||| Gilead Inks Gene Editing Collaboration Deal for HBV Infection",0,0.491954
2018-09-14,4959800.0,74.20999908447266,74.55000305175781,73.20999908447266,73.37999725341797,68.81195068359375,GILD,"IBB, BIIB, GILD, CELG: Large Outflows Detected at ETF ||| A Brawl Is Brewing Between AbbVie and Gilead Sciences in Arthritis ||| Stocks Trading Ex Dividend For Thurs., Sep. 13, 2018 ||| Gilead Is On Hold For Now ||| Unity (UBX) Catches Eye: Stock Jumps 8.8% ||| General Electric Is A Wait And Watch Story - Cramer's Lightning Round (9/13/18)",0,0.48485127
2018-09-17,5757200.0,73.5,73.52999877929688,72.61000061035156,72.77999877929688,68.24931335449219,GILD,"Validea's Top Five Healthcare Stocks Based On Benjamin Graham - 9/16/2018 ||| Should Value Investors Pick Gilead Sciences (GILD) Stock? ||| Why Gilead Stock Is a Sleepy Giant Waiting to Break Out ||| Can The Hepatitis B Market Become The Next Growth Story For Gilead Sciences? ||| ' High-Quality Biotech Companies for 4th Quarter ||| My Anniversary: One Year Later, My Articles Outperform The S&P By 50% ||| GSK's 2-Drug Combo For HIV Could Threaten Gilead",1,0.5158385
2018-09-18,7251800.0,72.77999877929688,74.01000213623047,72.18000030517578,73.66999816894531,69.08390045166016,GILD,"Theravance, Mylan Report Positive Data on COPD Drug Yupelri ||| Is Galapagos NV a Buy Now? ||| After Hours Most Active for Sep 18, 2018 : F, T, ABEV, SYMC, QQQ, MO, NLY, INTC, GILD, FE, FOXA, GRPN ||| Viking Therapeutics and Madrigal Pharmaceuticals Are Racing to the Finish Line in NASH ||| Theravance, Mylan Report Positive Data on COPD Drug Yupelri ||| Agenus Receives Milestone Payment of $5 Million from Incyte ||| AbbVie used kickbacks to boost Humira sales - CA insurance commissioner ||| For Investors Seeking Exposure To Biotech, BB Biotech AG Might Be An Interesting Alternative To Funds ||| Gilead: Forming A Base?",1,0.48272276
2018-09-19,3662800.0,73.47000122070312,74.31999969482422,73.30000305175781,73.87999725341797,69.28083038330078,GILD,"Biotech Stock Roundup: CELG, REGN Present Data, VKTX Soars on Drug's Success ||| Viking Therapeutics Liver Candidate Passes Test, Shares Soar ||| Dr. Reddy's (RDY) Presence in Generics Market Remains Strong ||| Is Gilead (GILD) a Suitable Stock for Value Investors Now? ||| Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know ||| Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know ||| Biotech Stock Roundup: CELG, REGN Present Data, VKTX Soars on Drug's Success ||| My Quarterly Global Portfolio Update ||| Dr. Reddy's (RDY) Presence in Generics Market Remains Strong ||| Is Gilead (GILD) a Suitable Stock for Value Investors Now?",1,0.51305735
2018-09-20,5883700.0,73.95999908447266,74.95999908447266,73.83999633789062,74.83000183105469,70.17168426513672,GILD,"Molecular Templates Surges 50%, Inks Cancer Deal With Takeda ||| The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Celgene, Sanofi and Gilead Sciences ||| Ultragenyx's Shares Surge More Than 80% in the Year So Far ||| Ultragenyx's Shares Surge More Than 80% in the Year So Far ||| Molecular Templates Surges 50%, Inks Cancer Deal With Takeda ||| The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Celgene, Sanofi and Gilead Sciences",1,0.53650343
2018-09-21,9578700.0,74.79000091552734,75.93000030517578,74.75,75.51000213623047,70.80935668945312,GILD,"How Do Drugs Compete Against Each Other? ||| FDA Confirms Positive Safety Profile of Acadia's Nuplazid ||| Is iShares Nasdaq Biotechnology ETF a Buy? ||| Feds looking into free services from drug makers - WSJ ||| What's Next For Gilead? ||| Breaking Down The NASH Cirrhosis Market - Gilead Poised For Success, But Is It Enough To Boost Stock Price?",1,0.5034911
2018-09-24,4926300.0,75.29000091552734,76.20999908447266,75.23999786376953,75.62000274658203,70.91252899169922,GILD,"3 Top Biotech Stocks to Buy Right Now ||| 3 Ways to Unpack Some Hidden Treasure in Tesaro Stock ||| CHMP Reconfirms Negative Opinion for Sarepta's Exondys ||| Gilead Subsidiary to Launch Authorized Generics of Epclusa and Harvoni for the Treatment of Chronic Hepatitis C ||| Exelixis, Ipsen Receive Positive CHMP Opinion for Cabometyx ||| CHMP Reconfirms Negative Opinion for Sarepta's Exondys ||| Can Biogen Continue to Be a Top Performer in the Biotech Space? ||| Express Scripts taking credit for Gilead's planned launch of generic HCV meds ||| Expected Value Investing: Diving Deeper On Conatus ||| Gilead to launch generic versions of Epclusa and Harvoni ||| Rubius (RUBY) in Focus: Stock Moves 8.7% Higher",0,0.5499285
2018-09-25,5926500.0,75.69999694824219,75.98999786376953,74.91999816894531,74.98999786376953,70.32173156738281,GILD,Gilead (GILD) to Launch Generics for Leading HCV Treatments ||| Pfizer facing difficult path to ramp up biosimilar business ||| Fracking Business Is Slowing - Cramer's Lightning Round (9/24/18),1,0.49622577
2018-09-26,7527500.0,75.11000061035156,76.41000366210938,74.8499984741211,75.6500015258789,70.94063568115234,GILD,"IBB, BIIB, GILD, CELG: ETF Inflow Alert ||| Gilead Sciences' Latest Tactic? Go Generic ||| Gilead Sciences (GILD) Gains As Market Dips: What You Should Know ||| Notable Wednesday Option Activity: ISRG, CELG, GILD ||| Gilead Is Undercutting Its Own Drugs: Here's Why ||| 5 Biotech Stocks to Play the Sector’s Next Big Trend: NASH ||| Traders Circulating FDA.gov Adverse Event Reporting System Doc Showing Case For Multiple Instances Of Co.'s HIV Treatment Potentially Causing Transplacental Defects; Gilead Shares Move Lower ||| Gilead Sciences (GILD) Gains As Market Dips: What You Should Know ||| Biotech Analysis Central Pharma News: Gilead's New Move, Sarepta's Hold Removal, Alexion's Plan ||| Verastem Declines On Its Much-Touted Catalyst, Is It Worth Buying Now? ||| Biotech Stock Roundup: ALXN Soliris Successful, Respite For Sarepta, AMRN Soars",1,0.4935086
2018-09-27,5451000.0,75.6500015258789,77.0999984741211,75.56999969482422,76.58000183105469,71.81275177001953,GILD,"Alexion (ALXN) to Acquire Biotech Syntimmune for $1.2 Billion ||| Look Under The Hood: SPYV Has 11% Upside ||| Guide to CRISPR Stocks & Latest Apple, Fed, GDP News | Free Lunch ||| On The Nasdaq Bandwagon, Top Yield, Upside, And Net Gain Stocks For September ||| HighTide's HTD1801 Fast Track'd for PSC ||| Guide to CRISPR Stocks & Latest Apple, Fed, GDP News | Free Lunch ||| Tiziana Life Sciences Plans To Raise $16 Million In U.S. IPO ||| Generic HCV Could Benefit Gilead ||| Alexion (ALXN) to Acquire Biotech Syntimmune for $1.2 Billion ||| Best And Worst-Performing Stocks In The S&P 500 Over The Last 20 Years And How They Have Performed In 2018",1,0.4906239
2018-09-28,7604800.0,76.58000183105469,77.23999786376953,76.12999725341797,77.20999908447266,72.40352630615234,GILD,Better Buy: Vertex Pharmaceuticals Incorporated vs. Galapagos NV ||| Can Biotech Stocks Power Ahead? ||| Jane's August Dividend Increases And Income Tracker - Retirement Accounts ||| 47 Nasdaq 'Safer' Dividend Dogs For September 2019 ||| 3 Biotech Stocks With Rising Estimates in the Past Month,1,0.4981053
2018-10-01,7820400.0,77.31999969482422,78.58999633789062,77.04000091552734,77.95999908447266,73.10684204101562,GILD,"5 Reasons to Buy Gilead Stock Today ||| Cantor Fitzgerald Initiates Coverage On Gilead Sciences with Overweight Rating, Announces $87 Price Target ||| 5 Best Biotech Stocks to Buy In October",1,0.5025068
2018-10-02,7468700.0,78.02999877929688,78.75,77.69000244140625,78.66999816894531,73.77265167236328,GILD,"3 Reasons Why Buying Viking Therapeutics on the Dip Could Pay Off Big ||| Gilead Subsidiary, Kite, And HiFiBiO Therapeutics Announce Research Collaboration o Develop Technology For The Potential Discovery Of Neoantigen-Reactive T Cell Receptors (TCRs) Cancer Treatment; HiFiBio Will Receive $10M Upfront Payment ||| NASH players under pressure following Liver Meeting abstract drop ||| FDA issues new draft guidance aimed at speedier generic approvals ||| 5 Top Healthcare Mutual Funds to Buy in October ||| Kite Pharma teams up with HiFiBiO to develop T cell receptors for cancer ||| ContraVir: A Speculative Contrarian Bet With Lots Of Upside Potential Part II",1,0.5377655
2018-10-03,6560100.0,78.8499984741211,79.61000061035156,78.4800033569336,79.0,74.08209991455078,GILD,"Biotech Stock Roundup: ALXN on Acquisition Spree, FDA Nod for REGN, AMGN Drugs ||| Gilead, HiFiBiO Collaborate to Develop T-Cell Receptors ||| Gilead Reports 96-Week Results From Phase 3 Study Of Biktarvy For Treatment Of HIV-1 In Adults New To HIV Therapy: 'Showed High Efficacy and a Demonstrated Tolerability Profile' ||| Gilead, HiFiBiO Collaborate to Develop T-Cell Receptors ||| Biotech Stock Roundup: ALXN on Acquisition Spree, FDA Nod for REGN, AMGN Drugs ||| Gilead Sciences' Biktarvy(R) gets approval in Hong Kong",0,0.50912976
2018-10-04,7705500.0,78.68000030517578,78.94999694824219,75.83000183105469,76.55999755859375,71.79399108886719,GILD,"Notable ETF Outflow Detected - IBB, GILD, BIIB, CELG ||| J&J's Phase III Data Shows Switch to its HIV Drug Beneficial ||| Better Buy: Gilead Sciences, Inc. vs. Pfizer ||| Noteworthy Thursday Option Activity: CBLK, GILD, AMTD ||| 7 Healthcare Stocks to Buy Right Now ||| Gilead Sciences Option Alert: Oct 19 $77.5 Calls Sweep (19) near the Ask: 539 @ $0.986 vs 4073 OI; Earnings 10/25 After Close Ref=$76.18 ||| Steven Cohen Plunges Into Nevro ||| Merck's Delstrigo shows sustained treatment effect in late-stage HIV study ||| J&J's Phase III Data Shows Switch to its HIV Drug Beneficial ||| Monthly Review Of DivGro: September 2018",0,0.49005666
2018-10-05,6083400.0,76.7699966430664,77.55999755859375,75.1500015258789,76.23999786376953,71.49391174316406,GILD,Gilead Announces Positive Data From Ongoing Biktarvy Study ||| Gilead Sciences (GILD) Stock Moves -0.24%: What You Should Know ||| Gilead Sciences (GILD) Stock Moves -0.24%: What You Should Know ||| Merck Reports Positive Efficacy Data from Phase III HIV Study ||| The Biotech Conundrum ||| Gilead Announces Positive Data From Ongoing Biktarvy Study ||| England's NHS to offer Gilead's Yescarta through Cancer Drugs Fund,1,0.49485993
2018-10-08,4507100.0,76.30000305175781,76.6500015258789,75.51000213623047,76.4000015258789,71.64395904541016,GILD,"Gilead Sciences: We're Not In Bull Territory Yet ||| Road To Financial Independence: Best September Ever, Investing Into Technology Stocks Amid Mounting Trade Woes ||| Arrowhead Surges Forward With Major Deal And Its Intentions Were Highly Misunderstood ||| Atara: Forecasting The Upcoming Clinical Binary Of Tab-Cel",1,0.49962112
2018-10-09,5367800.0,76.19999694824219,77.38999938964844,75.83000183105469,76.54000091552734,71.7752456665039,GILD,"Better Buy: Crispr Therapeutics AG vs. Editas ||| Arbutus Biopharma: The Good, The Bad, And The Ugly ||| Quarterly Review Of DivGro: Q3 2018 ||| Dividend Income Update September 2018",0,0.48831534
2018-10-10,6719900.0,76.22000122070312,77.05999755859375,74.75,74.77999877929688,70.12480163574219,GILD,"Biotech Stock Roundup: GILD, BIIB Present Data, VTGN Gains on Fast Track Status ||| The 5 Best Dividend Stocks to Buy, Hands Down ||| Arbutus (ABUS) Plunges on Disappointing HBV Pipeline Updates ||| Arbutus (ABUS) Plunges on Disappointing HBV Pipeline Updates ||| Biotech Stock Roundup: GILD, BIIB Present Data, VTGN Gains on Fast Track Status",0,0.46519643
2018-10-11,8486100.0,74.9000015258789,75.19000244140625,71.80000305175781,72.5,67.98673248291016,GILD,The October Pause That Refreshes ||| Alpine Immune Sciences: Digging Into A Recent Newcomer Onto The Immunotherapy Scene ||| All Signs Pointing To Trouble At Cambrex - What Happened In Korea Is A Precursor,1,0.4988469
2018-10-12,5638400.0,73.19999694824219,73.9000015258789,72.26000213623047,73.58999633789062,69.00888061523438,GILD,"Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know ||| Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know ||| Parnassus Fund Buys Trimble Inc, Nielsen Holdings PLC, Sells C.H. ...",0,0.5009053
2018-10-15,5198600.0,73.30999755859375,73.7699966430664,72.70999908447266,72.77999877929688,68.24931335449219,GILD,"Protect Your Portfolio And Increase Returns By Focusing On Earnings Trends ||| 2 Pharmaceutical Stocks to Buy With Dividends of 3% or Better ||| Broderick Brian C Buys SPDR Portfolio Total Stock Market, PayPal Holdings Inc, Deere, Sells ... ||| FDA issues new guidance aimed at more efficient drug development ||| Gilead In PBC: The Clinical Pursuit For Dominance ||| Healthcare 16-24% Target Net Gains Pace WallStars For October",1,0.51254743
2018-10-16,7455100.0,73.30000305175781,76.44000244140625,73.04000091552734,76.30999755859375,71.55956268310547,GILD,"Forget Gilead Sciences: Intercept Pharmaceuticals, Inc. Is a Better Growth Stock ||| Gilead Sciences Breaks Above 200-Day Moving Average - Bullish for GILD ||| Can This Tiny Biotech Revolutionize a $35 Billion Market? ||| Notable Tuesday Option Activity: GS, CMG, GILD ||| 10 'Safer' Dividend Healthcare WallStars Gain 12-23% Per Broker October Targets And Dividends",0,0.48998234
2018-10-18,6185300.0,75.55999755859375,75.5999984741211,73.31999969482422,74.16999816894531,69.55277252197266,GILD,Is Sangamo Therapeutics Inc. a Buy? ||| Gilead Sciences (GILD) Dips More Than Broader Markets: What You Should Know ||| Risk-Reward With Gilead Sciences ||| Marker Therapeutics: A Safer And Potentially More Effective CAR-T Alternative ||| Gilead Sciences Is Bottoming - Cramer's Lightning Round (10/17/18),0,0.5008996
2018-10-19,5036500.0,74.1500015258789,74.80000305175781,73.1500015258789,73.2699966430664,68.70880889892578,GILD,Biotech Stocks Bloodied But Can Now Drive M&A ||| Assembly Biosciences: A Horseman Of The HBV Core-Pocalypse?,0,0.4944659
2018-10-22,5351400.0,73.45999908447266,73.69999694824219,72.18000030517578,72.33999633789062,67.8366928100586,GILD,"Gilead, Galapagos Announce FINCH 2 Study Results Demonstrate Significant Improvement in Rheumatoid Arthritis Signs, Symptoms and Health-Related Quality of Life ||| Stocks To Watch: Tech Earnings Bellwethers Set To Test Rally ||| The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results, Large-Cap Pharma Earnings And IPOs ||| iShares Nasdaq Biotechnology ETF Experiences Big Outflow ||| Will Gilead (GILD) HIV Sales Offset HCV Sales Decline in Q3? ||| Will Gilead (GILD) HIV Sales Offset HCV Sales Decline in Q3?",0,0.4975867
2018-10-23,5738500.0,71.54000091552734,72.30999755859375,70.69999694824219,71.66999816894531,67.20841217041016,GILD,"Why CASI Pharmaceuticals Inc. Is Rocketing Higher Today ||| Alkermes (ALKS) Exceeds Q3 Earnings Estimates, Raises Outlook ||| The Zacks Analyst Blog Highlights: Roche, Gilead and Bristol Myers ||| Alkermes (ALKS) Exceeds Q3 Earnings Estimates, Raises Outlook ||| Biotechs set for down gap at open ||| The Zacks Analyst Blog Highlights: Roche, Gilead and Bristol Myers",0,0.4879646
2018-10-24,8949100.0,71.2300033569336,72.05999755859375,67.87999725341797,68.01000213623047,63.776248931884766,GILD,"Investors Are Underestimating Gilead Sciences Stock ||| 3 Top Healthcare Stocks to Buy Right Now ||| Noteworthy Wednesday Option Activity: GILD, WING, VEEV ||| Notable earnings after Thursday's close ||| Biotechs in a rout, XBI down 6% ||| Healthcare ETFs to Buy Ahead of Q3 Earnings ||| Biogen: Examining The Upside Potential ||| Alexion's (ALXN) Earnings Beat Estimates in Q3, Guidance Up ||| Drug Stocks' Earnings Due on Oct 25: MRK, BMY, GILD & CELG",1,0.5156388
2018-10-25,9388600.0,68.27999877929688,70.0199966430664,67.25,68.62000274658203,64.34827423095703,GILD,"Vertex (VRTX) Q3 Earnings and Revenues Surpass Estimates ||| Bristol-Myers (BMY) Beats on Q3 Earnings, Raises EPS View ||| Sarepta (SRPT) Q3 Earnings & Sales Miss, Exondys 51 Sales Up ||| New Batch of Q3 Earnings: AMZN, GOOGL, INTC & More ||| Earnings Reaction History: Gilead Sciences Inc., 58.3% Follow-Through Indicator, 4.5% Sensitive ||| After-Hours Earnings Report for October 25, 2018 : AMZN, GOOGL, INTC, GILD, SYK, FTV, DFS, DLR, RSG, CERN, FE, BMRN ||| Gilead Sciences Raises FY18 Sales Guidance From $20B-$21B To $20.8B-$21.3B vs $21.43B Est. ||| Gilead Sciences, Inc. Q3 Adj. EPS $1.84 Beats $1.63 Estimate, Sales $5.5B Beat $5.38B Estimate ||| A Preview Of Gilead's Q3 Earnings ||| The Daily Biotech Pulse: AbbVie Takes Full Control Of Cystic Fibrosis Program, Amgen Slashes Cholesterol Drug Price ||| Earnings Scheduled For October 25, 2018 ||| Gilead Sciences (GILD) Q3 2018 Results - Earnings Call Transcript ||| Gilead Sciences, Inc. 2018 Q3 - Results - Earnings Call Slides ||| New Batch of Q3 Earnings: AMZN, GOOGL, INTC & More ||| Gilead Sciences declares $0.57 dividend ||| Gilead Sciences Q3 revenue off 14%; earnings down 23%; shares up 1% after hours on consensus beat ||| More Revenue Declines For Gilead? ||| Vertex (VRTX) Q3 Earnings and Revenues Surpass Estimates ||| Sarepta (SRPT) Q3 Earnings & Sales Miss, Exondys 51 Sales Up ||| Platinum Asset Management Quarterly Report September 30, 2018",1,0.5101473
2018-10-26,11006100.0,66.79000091552734,70.27999877929688,66.5,69.73999786376953,65.39855194091797,GILD,"Daily Dividend Report: MAC, COG, GILD, AGN, DUK ||| Gilead (GILD) Beats on Q3 Earnings & Sales, Updates View ||| Gilead Sciences' 3rd Quarter: Good News Gets Better, Bad News Gets Worse ||| Gilead Sciences Stock Is Back to Base — Go Long ||| Raymond James Maintains Strong Buy on Gilead Sciences, Lowers Price Target to $94 ||| Cantor Fitzgerald Maintains Overweight on Gilead Sciences, Raises Price Target to $88 ||| 10 Biggest Price Target Changes For Friday ||| Benzinga's Top Upgrades, Downgrades For October 26, 2018 ||| The Daily Biotech Pulse: Gilead's Q2, Syndax Breast Cancer Drug Setback, Synergy Pharma On Brink Of Default ||| PiperJaffray Downgrades Gilead Sciences to Neutral, Lowers Price Target to $75 ||| Gilead (GILD) Beats on Q3 Earnings & Sales, Updates View ||| Trump mulling tieing U.S. drug prices to Europe's ||| Wild Ride Ahead Of GDP Data (Wall Street Breakfast Podcast) ||| Premarket analyst action - healthcare, Piper softens view on Gilead Sciences, shares down 3% premarket ||| Wall Street Breakfast: Wild Ride Ahead Of GDP Data",1,0.4905883
2018-10-29,9183400.0,70.80000305175781,71.98999786376953,69.47000122070312,70.9000015258789,66.48634338378906,GILD,"AbbVie Takes Aim at Vertex Pharmaceuticals Incorporated ||| Where Will Gilead Sciences, Inc. Be in 5 Years? ||| 7 Rising Healthcare Stocks to Consider ||| Analysts See 18% Upside For The Holdings of JKF ||| The Zacks Analyst Blog Highlights: Roche, Gilead and Bristol Myers (Revised) ||| Dr. Reddy's (RDY) Earnings and Revenues Improve Y/Y in Q2 ||| Gilead Sciences (GILD) Gains As Market Dips: What You Should Know ||| This Stock Reset Requires Patience ||| Gilead: The Good, The 'Meh' And The Ugly ||| Dr. Reddy's (RDY) Earnings and Revenues Improve Y/Y in Q2 ||| Top Analyst Reports for Johnson & Johnson, UnitedHealth, AT&T & Intel ||| Vertex: Great Company But Too Pricey ||| Equity Investing In This Rate-Hiking Environment ||| ViiV Healthcare's cabotegravir and rilpivirine regimen shows durable treatment effect in mid-stage HIV study ||| The Zacks Analyst Blog Highlights: Roche, Gilead and Bristol Myers (Revised) ||| Gilead: More Of The Same",1,0.49282023
2018-10-30,6632500.0,71.23999786376953,72.62000274658203,71.04000091552734,72.04000091552734,67.55537414550781,GILD,Better Buy: Celgene Corporation vs. Gilead Sciences ||| Can the Strong Economy Save the Stock Market? ||| Gilead Reports 96-Week Results From Phase 3 Study Of Biktarvy For Treatment Of HIV-1 In Adults New To HIV Therapy: 'Showed High Efficacy and High Barrier to Resistance' ||| Can the Strong Economy Save the Stock Market? ||| Gilead Remains A Sell ||| Gilead's Biktarvy on par with DTG+FTC/TAF in late-stage HIV study,0,0.51888484
2018-10-31,17316000.0,72.41000366210938,72.5,67.2300033569336,68.18000030517578,63.93566131591797,GILD,"Aduro (ADRO) Q3 Loss Narrower Than Expected, Revenues Lag ||| SPTM, TXN, GILD, LMT: Large Inflows Detected at ETF ||| Market Close Report: NASDAQ Composite index closes at 7,305.90 up 144.25 points ||| Biotech Stock Roundup: Celgene, Amgen, Vertex Impress in Q3, DRNA Soars on LLY Deal ||| Gilead Sciences shares are down 6.0% after the company announced partnership with Tango Therapeutics; Gildead will pay $50M upfront. ||| Gilead Sciences and Tango Therapeutics Announce Collaboration to Develop Immuno-Oncology Therapies, Gilead to Make a $50M Upfront Payment ||| Jerome Dodson Comments on Gilead Sciences ||| US Stock Market Advances Wednesday ||| Gilead down 6% as investors unmoved with Tango deal ||| Aduro (ADRO) Q3 Loss Narrower Than Expected, Revenues Lag ||| Gilead teams up with Tango Therapeutics in cancer",1,0.48350632
2018-11-01,8060600.0,68.19999694824219,70.41999816894531,68.0,70.30999755859375,65.93306732177734,GILD,"Acorda (ACOR) Q3 Earnings Top Estimates, Ampyra Sales View Up ||| 3 Big Stock Charts for Thursday: Walmart, Prologis and Incyte ||| The Zacks Analyst Blog Highlights: Gilead Sciences, Amgen, Vertex Pharmaceuticals, Celgene and Regeneron Pharmaceuticals ||| Intercept (ICPT) Gains on Earnings and Revenue Beat in Q3 ||| Evaluating Pfizer's Growth Plans And Valuation ||| Parallel Advisors, LLC Buys Apple Inc, Vanguard Short-Term Bond, Invesco S&P 5…… Equal ... ||| Biotech ETFs in Focus on String of Q3 Earnings Beat ||| Acorda (ACOR) Q3 Earnings Top Estimates, Ampyra Sales View Up ||| Money flow returns to biotechs, XBI up 4% ||| Jane's September Dividend Increases And Income Tracker - Retirement Accounts ||| FDA OKs genetic test to inform on drug metabolism ||| A Safe, Simple Means To Earn 3% To 6% On Your Cash Reserves: Part II",0,0.4904893
2018-11-02,6061200.0,70.97000122070312,71.56999969482422,68.88999938964844,69.44000244140625,65.11723327636719,GILD,"Conatus' (CNAT) Q3 Loss In Line, Revenues Lag Estimates ||| Emergent (EBS) Q3 Earnings and Revenues Fall Shy of Estimates ||| Agios (AGIO) Q3 Earnings Beat, Tibsovo Sales Drive Stock ||| bluebird (BLUE) Q3 Loss Narrower Than Expected, Revenues Beat ||| Street Fighting Man: Buying More AbbVie ||| Radius Health (RDUS) Posts Narrower-Than-Expected Q3 Loss ||| Conatus' (CNAT) Q3 Loss In Line, Revenues Lag Estimates ||| bluebird (BLUE) Q3 Loss Narrower Than Expected, Revenues Beat ||| Key events next week - healthcare ||| Economy Is Cooling - Cramer's Mad Money (11/1/18)",1,0.49321774
2018-11-05,6087800.0,69.87999725341797,70.16999816894531,68.95999908447266,69.58000183105469,65.24851989746094,GILD,"3 Top Biotech Stocks With P/Es Below 14 ||| November 2018 Stock Considerations ||| Pacira (PCRX) Q3 Earnings and Revenues Surpass Estimates ||| Why Gilead Sciences, Inc. Stock Broke Down in October ||| Puma Biotech (PBYI) Q3 Loss Narrows, Nerlynx Pulls Stock Down ||| CAR-T Cell Therapy: Will First To Market Mean First To Disappoint? ||| Pacira (PCRX) Q3 Earnings and Revenues Surpass Estimates ||| Puma Biotech (PBYI) Q3 Loss Narrows, Nerlynx Pulls Stock Down ||| How To Retire In 2018 Facing An Uphill Battle",1,0.5448705
2018-11-06,5699000.0,69.75,70.4000015258789,69.55000305175781,70.3499984741211,65.97057342529297,GILD,"IMX Dips In October, But Investors Remain Bullish ||| Investor Movement Index October Summary ||| Why We Pass On Amgen ||| A Migrating Biotech Bear",1,0.5126201
2018-11-07,8635900.0,71.01000213623047,72.80000305175781,70.36000061035156,72.4800033569336,67.96798706054688,GILD,"Honeywell International Inc Buys Alibaba Group Holding, DowDuPont Inc, Knight-Swift ... ||| Biotech Analysis Central Pharma News: Gilead's Push, AcelRx's Approval, Trevena's Rejection",0,0.49452505
2018-11-08,5007100.0,72.25,72.66000366210938,71.61000061035156,71.87999725341797,67.40532684326172,GILD,"PDL BioPharma (PDLI) Q3 Earnings Top, Revenues Rise, Stock Up ||| Prothena (PRTA) Reports Narrower-Than-Expected Loss in Q3 ||| Validea Benjamin Graham Strategy Daily Upgrade Report - 11/8/2018 ||| Aerie (AERI) Q3 Earnings Miss, Rhopressa Gains Traction ||| Lessons From My Biggest Seeking Alpha Mistakes ||| PDL BioPharma (PDLI) Q3 Earnings Top, Revenues Rise, Stock Up",0,0.4769213
2018-11-09,4568000.0,71.47000122070312,71.91000366210938,70.68000030517578,71.18000030517578,66.74891662597656,GILD,Arena Pharmaceuticals (ARNA) Beats on Q3 Earnings and Sales ||| Endo (ENDP) Stock Declines Despite Q3 Earnings & Revenue Beat ||| Gilead Reports Phase 2 Results For GS-9674 In Primary Sclerosing Cholangitis At The Liver Meeting ||| Endo (ENDP) Stock Declines Despite Q3 Earnings & Revenue Beat ||| Gilead's GS-9674 shows positive effect in mid-stage PSC study ||| Gilead's GS-9674 shows positive action in mid-stage NASH study ||| How To Retire With Safe And Quality High Yields,0,0.50600123
2018-11-12,5300800.0,71.06999969482422,71.47000122070312,70.05999755859375,70.48999786376953,66.10187530517578,GILD,"Biotech Bear Market: But Is It Time to Start Trading? ||| Medicines Company (MDCO) Q3 Loss Widens, Inclisiran in Focus ||| Tilray (TLRY) to Report Q3 Earnings: What's in the Cards? ||| Cronos (CRON) to Report Q3 Earnings: What's in the Offing? ||| Tilray (TLRY) to Report Q3 Earnings: What's in the Cards? ||| Biotechs getting slammed again, XBI down almost 4% ||| Medicines Company (MDCO) Q3 Loss Widens, Inclisiran in Focus",1,0.47737476
2018-11-13,4437600.0,70.5999984741211,72.55000305175781,70.30999755859375,70.91999816894531,66.5051040649414,GILD,"Amarin's Vascepa Cuts Heart Risk in Outcomes Test, Stock Down ||| The Acquirer's Portfolio - A Year In Review ||| Amarin's Vascepa Cuts Heart Risk in Outcomes Test, Stock Down ||| Can-Fite Biopharma And Namodenoson In NAFLD/NASH: A Targeted Therapeutic Approach ||| Amazon Selects New York And Virginia Locations For HQ2 And 3 ||| Wall Street Breakfast: Amazon Finds Homes For New Headquarters ||| Ebola clinical trial to begin in DRC",0,0.49764985
2018-11-14,4397200.0,71.36000061035156,71.70999908447266,70.1500015258789,70.55000305175781,66.15814208984375,GILD,"Biotech Stock Roundup: Gilead, Regeneron Present Data, Cocrystal Pharma Surges ||| Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for November 15, 2018 ||| Roche's Tecentriq Gets Priority Review for Breast Cancer ||| Biotech Bio Series #4: Regeneron Is Not Done ||| Biotech Stock Roundup: Gilead, Regeneron Present Data, Cocrystal Pharma Surges ||| Road To Financial Independence: Growing Dividends, Endless Opportunities But Limited Capital ||| Roche's Tecentriq Gets Priority Review for Breast Cancer",0,0.4825355
2018-11-15,9249300.0,70.22000122070312,70.56999969482422,68.44000244140625,69.77999877929688,65.43606567382812,GILD,"Sangamo's Shares Drop on Rating Downgrade, Pipeline Woes ||| Acorda Down More Than 30% in the Past 3 Months: Here's Why ||| Gilead And GS-9674 In PSC And NASH: To Itch Or Not To Itch ||| Sangamo's Shares Drop on Rating Downgrade, Pipeline Woes ||| Acorda Down More Than 30% in the Past 3 Months: Here's Why ||| Biotech Giant Should Deliver Mid-Teens Total Returns ||| BeiGene (BGNE) Catches Eye: Stock Jumps 8.3%",0,0.4919998
2018-11-16,8059100.0,69.44999694824219,69.69999694824219,68.93000030517578,69.19999694824219,64.89216613769531,GILD,"IBB, GILD, CELG, ILMN: ETF Outflow Alert",0,0.5275438
2018-11-19,8814700.0,69.06999969482422,69.23999786376953,67.6500015258789,68.01000213623047,63.776248931884766,GILD,5% Income Strategy For 2019 And Beyond ||| Validea's Top Five Healthcare Stocks Based On Benjamin Graham - 11/18/2018 ||| Tesaro Stock Sinks in Aftermath of Sale Rumors ||| Amgen's Blincyto Gets Positive CHMP Opinion for Line Extension ||| Novartis (NVS) Gets FDA Nod for Label Expansion of Promacta ||| Gilead Announces China National Medical Products Administration (NMPA) Approves Vemlidy for Chronic Hepatitis B Virus Infection ||| NGM Biopharmaceuticals And NASH: Making Progress ||| Novartis (NVS) Gets FDA Nod for Label Expansion of Promacta ||| Amgen's Blincyto Gets Positive CHMP Opinion for Line Extension ||| CytoDyn Unveils Pipeline Growth In Coming Year At Annual Shareholder Meeting ||| Gilead's Vemlidy for chronic hepatitis B virus approved in China,0,0.51448685
2018-11-20,8511000.0,68.4000015258789,69.45999908447266,67.54000091552734,67.56999969482422,63.3636360168457,GILD,Emergent's (EBS) Zika Vaccine Candidate Meets Study Endpoint ||| Gilead's Vemlidy Gets Approval in China for HBV Infection ||| Gilead's Vemlidy Gets Approval in China for HBV Infection ||| Jeff Auxier Picks Up ' Stocks in 'rd Quarter ||| Will —…–9 Be Gilead's Turnaround Year? ||| The Future-Proof Portfolio For Young Investors: Stability In A Volatile Period ||| Emergent's (EBS) Zika Vaccine Candidate Meets Study Endpoint,0,0.49868187
2018-11-21,8866000.0,67.56999969482422,67.69000244140625,66.55000305175781,66.73999786376953,62.58530807495117,GILD,"Biotech Stock Roundup: GILD's Drug Wins Nod in China, Arena Up On Licensing Deal ||| Nasdaq 100 Movers: TSLA, ADSK ||| Should Value Investors Consider Gilead (GILD) Stock Now? ||| Tesaro Is Now An Attractive Acquisition Target",0,0.4974966
2018-11-23,3072800.0,66.37999725341797,67.04000091552734,66.05999755859375,66.58999633789062,62.444637298583984,GILD,Novartis Gets Approval for Gene Therapy Luxturna in Europe ||| CAR-T Cells In The Real World ||| Novartis Gets Approval for Gene Therapy Luxturna in Europe,1,0.5283374
2018-11-26,9451000.0,67.37000274658203,68.05999755859375,66.05999755859375,66.94000244140625,62.77286529541016,GILD,"Week In Review: Alphamab Closes $100 Million Series A For Oncology Candidates ||| Better Buy: Gilead Sciences vs. Celgene ||| 9 Policy Catalysts For Health Care Investors To Watch Before Year's End ||| Bloomberg 2019 Watchlist: 50 Dividend Dogs Show Target Gains And Losses ||| Stocks That Fell to '-Year Lows in the Week of Nov. —' ||| Gilead's HIV Franchise, CAR T Therapy Likely to Propel Growth ||| After Hours Most Active for Nov 26, 2018 : CTL, GE, QQQ, RF, TEVA, HAL, BAC, INTC, AAPL, GILD, XEL, STLD ||| Gilead's HIV Franchise, CAR T Therapy Likely to Propel Growth ||| Viking Therapeutics Won't Live Up To The Hype",1,0.5004103
2018-11-27,8001500.0,66.48999786376953,67.44999694824219,65.80999755859375,67.44000244140625,63.24174118041992,GILD,"5 Biotech Stocks to Scoop Up for Big Dividends ||| Eyenovia Initiates Phase III Study for Mydriasis Candidate ||| Bayer's TRK Inhibitor Gets FDA Nod for Advanced Solid Tumors ||| Zafgen (ZFGN) Plunges as FDA Puts Hold on Diabetes Drug Trial ||| Bristol-Myers' Opdivo-Yervoy Combo Fails in Lung Cancer Trial ||| Jane's October Dividend Increases And Income Tracker - Retirement Accounts ||| Gilead Sciences, Inc. (GILD) Management At The Evercore ISI HealthCONx Conference 2018 - Brokers Conference Transcript ||| Eyenovia Initiates Phase III Study for Mydriasis Candidate ||| Bayer's TRK Inhibitor Gets FDA Nod for Advanced Solid Tumors ||| 17 'Safer' Dividend Bloomberg 2019 Watchlist Picks Per Broker Nov. Targets And Financials",1,0.5377147
2018-11-28,6463100.0,67.48999786376953,69.20999908447266,66.91000366210938,69.19000244140625,64.8827896118164,GILD,Celgene & Bluebird's CAR T Therapy Study Completes Enrollment ||| Novartis (NVS) Receives EC Approval for Neulasta Biosimilar ||| Pfizer's Epilepsy Drug Lyrica Gets Pediatric Exclusivity ||| Novartis (NVS) Receives EC Approval for Neulasta Biosimilar ||| Celgene & Bluebird's CAR T Therapy Study Completes Enrollment ||| December 2018 Stock Considerations,1,0.49329227
2018-11-29,6468000.0,68.80000305175781,70.27999877929688,68.72000122070312,69.69000244140625,65.35166931152344,GILD,How Google Is Helping Make Advances In Medical Technology ||| Catalyst's Firdapse Receives FDA Approval for Rare Disease ||| How The Parts Add Up: RNDV Targets $24 ||| Merck (MRK) Receives Approval for 2 HIV Medicines in EU ||| Japan Tobacco Terminates Agreements With Gilead Sciences Under Which Gilead Grants An Exclusive License To JT To Develop And Commercialize Six Anti-HIV Drugs In Japan,1,0.53772616
2018-11-30,8673300.0,69.7300033569336,72.19999694824219,69.44999694824219,71.94000244140625,67.46160888671875,GILD,"Key Pharma Players With HIV Focus Ahead of World Aids Day ||| 3 Top Dividend Stocks With Yields Over 3% ||| Gilead Sciences shares are trading higher amid reports of an Ebola outbreak in The Congo; Gilead developed the Remdesivir antiviral which is undergoing clinical trials to treat Ebola. ||| The Oil Turn, Soaring Goose, And Value Traps ||| Healthcare Yields Of 3% To 4.8% From Top 10 WallStars In November ||| World Economy On Display At G20 Summit (Wall Street Breakfast Podcast) ||| Wall Street Breakfast: World Economy On Display At G20 Summit ||| Congo Ebola outbreak second largest in history",0,0.51897776
2018-12-03,11239300.0,72.73999786376953,72.9000015258789,70.51000213623047,70.86000061035156,66.4488296508789,GILD,"Gilead's Kite Announces Two-Year Data for Yescarta in Patients With Refractory Large B-Cell Lymphoma at ASH 2018; Median Duration Of Complete Response Was Not Reached; Median Overall Survival Was Not Reached ||| The Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials And IPOs ||| Gilead's CAR-T Yescarta shows long-term benefit in lymphoma study ||| Shire's Takhzyro Gets European Nod for Hereditary Angioedema ||| FDA Committee to Review Amgen's (AMGN) Osteoporosis Candidate ||| Monday's ETF Movers: XBI, XLV ||| Kite Announces Encouraging Updated Data From ZUMA-3 Study of KTE-X19 in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia at ASH 2018 ||| Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know ||| 41 'Safer' Dividend Healthcare Pre-December WallStars From Dividend Dogcatcher ||| Shire's Takhzyro Gets European Nod for Hereditary Angioedema ||| FDA Committee to Review Amgen's (AMGN) Osteoporosis Candidate",0,0.5021072
2018-12-04,9935000.0,70.80000305175781,72.62999725341797,69.31999969482422,69.55000305175781,65.22039031982422,GILD,"Amgen's BiTE Immunotherapies Show Promise in Early Studies ||| Gilead (GILD) Announces Data on CAR T Therapy Candidate ||| Gilead Reports China National Medical Products Administration Approved Harvoni As Hepatitis C Treatment ||| Gilead Reports China National Medical Products Administration Approved Descovy As HIV Treatment ||| The Daily Biotech Pulse: ASH Presentations Take The Spotlight, Eiger Gets A New CFO ||| Gilead's Kite Announces Updated Data From ZUMA-3 Study of KTE-X19 in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia at ASH 2018 ||| Gilead (GILD) Announces Data on CAR T Therapy Candidate ||| Performance Review: Stocks That Topped My Factor-Based Quality Ranking Model ||| Gilead CAR-T therapy shows sustained benefit in treatment-resistant ALL patients",1,0.5109475
2018-12-06,8099400.0,68.70999908447266,70.20999908447266,68.11000061035156,70.19000244140625,65.82054138183594,GILD,"Gilead's (GILD) Harvoni and Descovy Get Approval in China ||| Gilead's (GILD) Harvoni and Descovy Get Approval in China ||| Biotech Stock Roundup: ASH Meet in Focus, Gilead's Drugs Get Approval in China ||| Celgene Doesn't Want To Be Left Out, Posts Promising JCAR017 Data ||| Gilead Sciences Gets A Much Needed Confirmation Boost For Yescarta",0,0.48613235
2018-12-07,5657500.0,69.77999877929688,70.0,67.88999938964844,68.1500015258789,63.90753555297852,GILD,"VLUE, GM, MU, GILD: ETF Outflow Alert ||| Biogen (BIIB) In-Licenses ALS Candidate BIIB067 From Ionis ||| Biogen (BIIB) In-Licenses ALS Candidate BIIB067 From Ionis",0,0.47097555
2018-12-10,8927200.0,69.22000122070312,69.87000274658203,65.9000015258789,67.48999786376953,63.28862380981445,GILD,"How To Retire At 62 With Just Half A Million ||| Roche Executive Daniel O'Day to Succeed John Milligan as Gilead CEO ||| WSJ: Gilead Sciences to hire Roche exec O'Day as its next CEO ||| Don’t Punish Gilead Stock for Doing Its Job ||| Roche's Tecentriq Gets FDA Approval for First-Line NSCLC ||| Why CRSP Stock Has Added Layers of Risk ||| Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know ||| Gilead Shares Down 1.7% To Below $68 Level Mon.; Co. Announced Late Sun. Roche Exec Daniel O'Day Will Replace John Milligan As CEO, Also Be Named Chair ||| Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know ||| Challenges For Gilead's 2 New CEOs ||| New chief at Gilead an ""incremental positive"" - Jefferies ||| Roche's Tecentriq Gets FDA Approval for First-Line NSCLC ||| Stock Futures Mixed, Nasdaq Leads Dow Jones; This Defense Stock Jumps ||| Trade Truce Shot Clock Keeps Ticking (Wall Street Breakfast Podcast) ||| Wall Street Breakfast: Trade Truce Shot Clock Keeps Ticking ||| It's official! O'Day takes top job at Gilead",1,0.48337162
2018-12-11,5867000.0,68.12999725341797,69.16999816894531,67.19999694824219,67.72000122070312,63.50429534912109,GILD,"Ex-Dividend Reminder: New Jersey Resources, Conmed and Gilead Sciences ||| 4 Biotech Stocks Investors Can Add to Their Portfolio in 2019 ||| Gilead Sciences (GILD) Appoints Daniel O'Day as New CEO ||| New Gilead Sciences CEO Has 'Breadth Of Experience' From Time At Roche, Says Bullish Raymond James ||| Gilead Sciences (GILD) Appoints Daniel O'Day as New CEO ||| Portfolio Update: Stocks Getting Slammed As Dividends Shine Bright ||| 4 Biotech Stocks Investors Can Add to Their Portfolio in 2019 ||| Traders Are Confused- Cramer's Mad Money (12/10/18)",1,0.505533
2018-12-12,6447900.0,68.58000183105469,69.31999969482422,68.05999755859375,68.13999938964844,63.89815902709961,GILD,"Biotech Stock Roundup: Gilead to Get New CEO, Biogen In-Licenses Candidate ||| Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for December 13, 2018 ||| Notable Wednesday Option Activity: NDSN, GILD, TLRD ||| Gilead Sciences Option Alert: Jan 18 $50 Calls Sweep (2) near the Ask: 700 @ $19.076 vs 2396 OI; Earnings 2/5 After Close [est] Ref=$69.07 ||| Stocks That Will Be Trading Ex Dividend Thurs., Dec. 13, 2018 ||| Gilead: The New CEO Will Need More Time ||| The Zacks Analyst Blog Highlights: Gilead Sciences, Alexion Pharmaceuticals, Regeneron Pharmaceutical and Biogen ||| Marker Therapeutics Exits ASH An Optimist. Should That Be Enough For You?",0,0.4883626
2018-12-13,6198200.0,68.0999984741211,68.29000091552734,66.70999908447266,67.3499984741211,63.69011688232422,GILD,"Gilead Sciences a Top Socially Responsible Dividend Stock With 3.4% Yield (GILD) ||| The Zacks Analyst Blog Highlights: Gilead Sciences, Conatus Pharmaceuticals, Biogen, Ionis Pharmaceuticals and Exelixis ||| Bausch (BHC) Bids for Assets of Synergy Pharmaceuticals ||| Senate Dems introduce bill to block ""excessive"" increases in drug prices ||| Why Biotech Asset Managers Can (Should?) Make Money In Any Markets ||| Bausch (BHC) Bids for Assets of Synergy Pharmaceuticals ||| December Call Expirations",0,0.4790416
2018-12-14,8253600.0,66.80000305175781,67.16999816894531,65.37999725341797,65.56999969482422,62.0068473815918,GILD,AMAG to Acquire Ciraparantag Maker Perosphere Pharmaceuticals ||| Mylan (MYL) Gets Favorable Ruling Against Sanofi's Lantus ||| J&J weighing on big biopharma players ||| AMAG to Acquire Ciraparantag Maker Perosphere Pharmaceuticals ||| 5 Biotech Stocks Set to Bounce Back in '19 After a Rough Ride ||| Has Celgene Entered Bargain Territory?,0,0.49632016
2018-12-17,11671600.0,65.37999725341797,67.0999984741211,64.55999755859375,65.12000274658203,61.58129501342773,GILD,"3 Biotechs Gilead Sciences Could Buy in March ||| Stocks That Fell to '-Year Lows in the Week of Dec. –4 ||| Validea's Top Five Healthcare Stocks Based On Benjamin Graham - 12/16/2018 ||| 2 Sets of Disasters Biotech Will Pay For in 2019 ||| Why Dova Pharmaceuticals Is Nosediving Today ||| Gilead Sciences (GILD) Stock Moves -0.69%: What You Should Know ||| Gilead Sciences Option Alert: Jan 18 $75 Calls at the Ask: 600 @ $0.37 vs 25755 OI; Earnings 2/5 After Close [est] Ref=$66.87 ||| 'Safer' Dividend NASDAQ Dogs Hunt 26.5%-59.4% Net Gains Per Broker December Targets ||| Gilead Sciences (GILD) Stock Moves -0.69%: What You Should Know ||| Zymeworks: Updates To Thesis And 2019 Outlook ||| Jane's November Dividend Increases And Income Tracker - Retirement Accounts ||| 54 Top Nasdaq December Dividend Dears By Yield, Upside, And Net Gains",0,0.5127547
2018-12-18,9325600.0,65.4800033569336,66.73999786376953,64.30000305175781,64.83999633789062,61.316505432128906,GILD,"Puma Biotech's Nerlynx Ups Survival in Third-Line Breast Cancer ||| What Happened With CAR-T Stocks in 2018 ||| 3 Biotechs With Potential Blockbusters Near the Finish Line ||| Evofem Shares Up as Birth Control Gel Succeeds in Phase III ||| Guggenheim Reinstates Buy on Gilead Sciences, Announces $86 ||| Bristol-Myers' Label Expansion of Sprycel Gets CHMP Nod ||| Evofem Shares Up as Birth Control Gel Succeeds in Phase III ||| The New Generex: Unlocking The Value ||| Puma Biotech's Nerlynx Ups Survival in Third-Line Breast Cancer ||| Liver Therapy Forum: A Specialized Marketplace Service For Liver Therapeutics Investment Opportunities ||| Credit Suisse sees 18% upside in Abbott in premarket analyst action ||| The First Ever Alphies (Podcast)",0,0.53780335
2018-12-19,9488300.0,65.11000061035156,66.79000091552734,63.47999954223633,64.19999694824219,60.71128082275391,GILD,"Vertex's (VRTX) 3rd Study on Pain Drug Meets Primary Endpoint ||| Forget bluebird bio, Amgen Is a Better Biotech Stock ||| Gilead Sciences, Scholar Collaborate On Novel Therapies For Fibrotic Diseases ||| Morgan Stanley Maintains Equal-Weight on Gilead Sciences, Raises Price Target to $86 ||| Gilead Sciences And Scholar Rock Announce Collaboration To Develop Novel Therapies For Fibrotic Diseases; Scholar Rock Will Receive $80M Upfront As Well As Up To $1.425B In Potential Milestones ||| Vertex's (VRTX) 3rd Study on Pain Drug Meets Primary Endpoint ||| Scholar Rock teams up with Gilead in fibrotic diseases in partnership valued as high as $1.5B",1,0.51304114
2018-12-20,10462600.0,64.12999725341797,65.3499984741211,63.34999847412109,64.30000305175781,60.805850982666016,GILD,"Why Agenus Stock Is Soaring Today ||| Wall Street Sees Cautiously Higher Open After Fed Move ||| US Futures Inch Higher After Fed Move ||| 3 Top Healthcare Stocks to Buy in December ||| Gilead Partners with Scholar Rock for Fibrotic Disease Drugs ||| Raymond James: Gilead In NASH For The Long Haul ||| The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum ||| Gilead, Agenus Report Collaboration Deal To Develop Immuno-Oncology Therapies; Agenus To Receive $150M ||| Bristol-Myers to Sell French Consumer Health Unit for $1.6B ||| Gilead Partners with Scholar Rock for Fibrotic Disease Drugs ||| Agenus teams up with Gilead to develop five I-O therapies; shares up 72% premarket",0,0.50156957
2018-12-21,17586200.0,64.75,66.08999633789062,62.25,62.619998931884766,59.21714782714844,GILD,iShares Nasdaq Biotechnology ETF Experiences Big Outflow ||| Agenus' Stock Up 23% on Immuno-Oncology Deal With Gilead ||| Novartis (NVS) Offers to Buy French Gene Therapy Manufacturer ||| Novartis (NVS) Offers to Buy French Gene Therapy Manufacturer,0,0.4981245
2018-12-24,6162600.0,62.470001220703125,62.83000183105469,60.470001220703125,60.540000915527344,57.25017929077149,GILD,2 Beaten-Down Biotech Stocks That Look Like Bargains Now ||| The Week Ahead In Biotech: Focus Shifts To Year-End Clinical Trial Results ||| Mallinckrodt's Inhaled Xenon Gas Therapy Enters Phase III ||| Alexion's Ultomiris Gets Early FDA Nod for Rare Blood Disorder ||| 28 Stocks Moving In Monday's Pre-Market Session ||| Acorda Gets FDA Approval for Parkinson's Disease Drug Inbrija ||| Immunomedics (IMMU) in Focus: Stock Moves 6.1% Higher,1,0.5386077
2018-12-26,8824400.0,60.650001525878906,63.22999954223633,60.31999969482422,63.220001220703125,59.784549713134766,GILD,"3 Biotech Stocks That Are Too Cheap to Ignore ||| Biotech Stock Roundup: ALXN, ACOR Drugs' Get FDA Nod, AGEN up on GILD Deal ||| Gilead Doubles Down On Its NASH Pipeline With $1.5B Deal ||| Agenus Gets Hail Mary Cash Infusion From Gilead Sciences ||| Agenus Wins $1.85 Billion Deal, But Market Cap Is Just $266 Million ||| Biotech Stock Roundup: ALXN, ACOR Drugs' Get FDA Nod, AGEN up on GILD Deal",0,0.5027754
2018-12-27,9548200.0,62.400001525878906,63.02000045776367,60.470001220703125,62.93999862670898,59.51975631713867,GILD,Share In Healthcare And Biotech Gains With 12% Yield From This Tekla Fund,0,0.53532225
2018-12-28,6785400.0,62.810001373291016,63.040000915527344,61.66999816894531,61.880001068115234,58.51736068725586,GILD,Gilead Sciences (GILD) Dips More Than Broader Markets: What You Should Know ||| Intercept (ICPT) Benefits from Ocaliva's Recovery in 2018 ||| Gilead Sciences (GILD) Dips More Than Broader Markets: What You Should Know ||| Intercept (ICPT) Benefits from Ocaliva's Recovery in 2018,1,0.4889407
2018-12-31,7584000.0,62.0,63.06999969482422,61.58000183105469,62.54999923706055,59.15094757080078,GILD,Five Stocks To Add In 2019 ||| January 2019 Stock Considerations ||| Updated Lists Of Stocks Topping Our Ranking Model ||| CNBC article highlights $35B market opportunity of NASH drugs,1,0.4973489
2019-01-02,7839400.0,61.7599983215332,64.01000213623047,61.5,63.43999862670898,59.99258804321289,GILD,3 Pharma Stocks Revving for Growth ||| Gilead Sciences Option Alert: Feb 15 $65 Calls Sweep (27) near the Ask: 536 @ $2.739 vs 4625 OI; Earnings 2/5 After Close [est] Ref=$63.63 ||| Gilead Sciences Option Alert: Mar 15 $65 Calls Sweep (17) near the Ask: 590 @ $3.25 vs 329 OI; Earnings 2/5 After Close [est] Ref=$63.4 ||| Gilead Sciences Option Alert: Mar 15 $65 Calls Sweep (28) near the Ask: 508 @ $3.151 vs 329 OI; Earnings 2/5 After Close [est] Ref=$63.43 ||| Drug makers OK with price inclusion in TV ads if done fairly,1,0.5266075
2019-01-03,14631300.0,66.29000091552734,67.25,65.13999938964844,65.25,61.70423126220703,GILD,Oppenheimer Upgrades Gilead Sciences to Outperform ||| 26 Stocks Moving In Thursday's Pre-Market Session ||| Gilead shares are trading up on news that Bristol-Myers will acquire Celgene in a $74 billion deal. ||| Genomic Medicine 2019: Sangamo Assay Kicks Off A Pivotal Year ||| Wall Street Retreats Thursday ||| Needham sees 27% upside in Thermo Fisher in today's analyst action ||| 5 Health Care Stocks Gurus Are Buying ||| Gilead Sciences: Top Biotech Pick For The Next Decade With An Options Play ||| Stock Futures Tumble As Apple Cripples Global Tech Stocks ||| BMY/Celgene tie-up buoys Gilead and Vertex premarket,1,0.4944961
2019-01-04,9639500.0,66.25,68.43000030517578,66.04000091552734,68.25,64.54120635986328,GILD,"Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? ||| Merck Doesn't Want To Be Left Out Of The NASH Race Either, Uses Option Agreement ||| Biotechs lead broad market advance, XBI up 5% ||| Performance Review: 2018's Realized Returns ||| Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? ||| 3 Reasons Biotech Should Rally In 2019",1,0.5043277
2019-01-07,10504100.0,68.0999984741211,68.93000030517578,67.37000274658203,68.55999755859375,64.83435821533203,GILD,"AskSlim Market Week - Saturday, Jan. 5 ||| Stocks To Watch: CES Headlines Action-Packed Week ||| 2019 J.P. Morgan Healthcare Conference Roundup ||| Better Buy: Gilead Sciences vs. Amgen ||| Gilead. Yuhan Announce Collaboration and License Agreement to Develop Novel Investigational Treatments for Advanced Fibrosis Due to Nonalcoholic Steatohepatitis ||| CES Headlines Action-Packed Week (Stocks To Watch Podcast) ||| Why Agenus Stock Is Spiking Today ||| Merck loses bid to revive $200 mln Gilead verdict at U.S. high court ||| Gilead (GILD) Collaborates With Yuhan for NASH Candidates ||| Gilead Sciences (GILD) Gains But Lags Market: What You Should Know ||| After Hours Most Active for Jan 7, 2019 : CMCSA, ABEV, BAC, AMAT, GILD, FDC, MSFT, CTL, SYMC, QQQ, EXC, EMR ||| 5 Top-Selling Drugs With Growth Potential In 2019 ||| Gilead Sciences at JP Morgan Conference Says To Focus On HIV In 2019 ||| Gilead Sciences (GILD) Gains But Lags Market: What You Should Know ||| 2018 Q4 Non-Taxable Portfolio Update ||| Gilead (GILD) Collaborates With Yuhan for NASH Candidates ||| Gilead teams up with Yuhan in NASH",0,0.4982033
2019-01-08,7527400.0,68.8499984741211,69.1500015258789,67.08999633789062,68.08999633789062,64.389892578125,GILD,"7 Things to Expect for Gilead Sciences in 2019 ||| Japan Okays Approves Gilead Sciences' Epclusa ||| UPDATE: Nektar Says Gilead Will Be Responsible For Preclinical Studies, Costs ||| UPDATE: Nektar Research Collab With Gilead Will Be For Exploration Of Combo Between Co.'s NKTR-225 And Gilead's Effector-Memory T Cells With Antiretroviral Therapies ||| Nektar Therapeutics 8-K Shows Pres, CEO Will Make Presentation At JP Morgan Healthcare Conference; Will Outline Research Collab With Gilead; Will Show $1.92B In Cash, Equivalents as Of Dec. 31, 2018 ||| Gilead Received Approval for Epclusa in Japan ||| Dividend Income Update December 2018 ||| Nektar teams up with Gilead in combination virology therapies ||| Gilead's Epclusa OK'd in Japan",0,0.517285
2019-01-09,5770000.0,68.19999694824219,68.66000366210938,67.54000091552734,67.94000244140625,64.24805450439453,GILD,"Value Added: 7 Top Stocks for 2019 ||| Biotech Stock Roundup: LOXO, CELG Gain, J.P. Morgan Healthcare Conference in Focus ||| Road To Financial Independence: My December 100-Stock Portfolio Review ||| Gilead Is Gearing Release Of NASH Results Soon, But Other Deals Are Still Rolling In ||| Biotech Stock Roundup: LOXO, CELG Gain, J.P. Morgan Healthcare Conference in Focus ||| Where Will M&A Strike Next Across Biotech?",1,0.5066699
2019-01-10,5715900.0,67.73999786376953,68.2699966430664,67.08999633789062,68.04000091552734,64.34261322021484,GILD,Will Investors Find A Nektar Balm In Gilead? ||| Drug applications take back seat to safety surveillance at FDA during shutdown ||| Monthly Review Of DivGro: December 2018,1,0.49392533
2019-01-11,5663100.0,67.80000305175781,68.4000015258789,67.44000244140625,68.16000366210938,64.45609283447266,GILD,Here's Why Verastem Tumbled 34.1% in December ||| NASH Space in Focus in 2019 as Firms Look to Diversify ||| Agenus Gets A Grant: A Good Opportunity To Buy ||| Dem lawmakers introduce bill to lower U.S. drug prices,0,0.49647418
2019-01-14,9172500.0,67.7699966430664,67.94000244140625,67.11000061035156,67.25,63.595550537109375,GILD,Average American Retirement Portfolio - Twenty Percent Better Than The Average Retiree ||| A Planned Spinoff Of Cancer Vaccines At Generex ||| Is 2019 The Turnaround Year For Gilead Sciences?,1,0.51230884
2019-01-15,7199500.0,67.19000244140625,68.70999908447266,67.02999877929688,68.5199966430664,64.7965316772461,GILD,FDA to beef up cell and gene therapy staff ||| FDA Commish touts advances/successes ||| Why AbbVie Believes In Life After (Humira's) Death ||| Cirius Therapeutics Seeks $86 Million IPO ||| Rowan Street Capital Q3'18 Letter: Exploiting The Market's Fear And Greed,0,0.51300186
2019-01-16,6142300.0,68.2699966430664,68.87000274658203,67.55000305175781,67.63999938964844,63.96435546875,GILD,Will Dividend Stocks be the Hot Stocks of 2019? ||| Hospitals squeezed by high drug costs ||| Biopharma firms under pressure on Brexit uncertainty ||| Shionogi's Strong Core Offers More Capital Return Possibilities,1,0.5106235
2019-01-17,5224500.0,67.54000091552734,68.95999908447266,67.45999908447266,68.6500015258789,64.91947937011719,GILD,"Why Gilead Sciences Stock Sank by 12.7% in 2018 ||| Zacks Market Edge Highlights: Occidental, Gilead, AbbVie, AT&T and Verizon ||| A Real Dividend Growth Machine: 2018 Portfolio Review ||| Zacks Market Edge Highlights: Occidental, Gilead, AbbVie, AT&T and Verizon ||| Jane's FY-2018 Dividend Income Totals - Why Being Patient Pays",1,0.4905107
2019-01-18,8358800.0,69.23999786376953,69.58000183105469,68.51000213623047,69.18000030517578,65.42066955566406,GILD,"Notable Friday Option Activity: WYNN, GS, GILD ||| Searching For A Treatment: NASH Investigational Drugs With Catalysts This Year ||| The Week That Was In San Francisco: 2019 Should Be A Great Year For Healthcare Stocks",0,0.47977126
2019-01-22,9827000.0,68.73999786376953,68.81999969482422,68.0199966430664,68.55000305175781,64.82490539550781,GILD,"Better Buy: Biogen vs. Gilead Sciences ||| Retirement: 2018 Performance Of The Future-Proof Portfolio For Young Investors ||| 7 Stupidly Cheap Stocks to Buy Now ||| After Hours Most Active for Jan 22, 2019 : GRPN, QQQ, INTC, XEL, GILD, AMD ||| Nicholas Ward's Dividend Growth Portfolio: 2018 Review ||| Editas and CRISPR weigh on biotechs, XBI down 3%",0,0.48485568
2019-01-23,6952600.0,68.5199966430664,69.51000213623047,67.81999969482422,68.25,64.54120635986328,GILD,"3 Upcoming Readouts for Gilead Sciences You Don't Want to Miss ||| 3 Top Healthcare Stocks to Buy in January ||| Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know ||| Jefferies bearish on biotechs, sees 6% near-term downside",0,0.53301287
2019-01-24,7750900.0,68.43000030517578,68.45999908447266,67.5199966430664,67.86000061035156,64.17239379882812,GILD,"iShares U.S. Healthcare ETF Experiences Big Inflow ||| Does Johnson & Johnson's Grim Outlook Spell Trouble for Big Pharma Stocks? ||| Agenus Closes $150 Million Immuno-oncology Transaction With Gilead ||| Update On NASH Antifibrotics: Allergan, Gilead, Conatus, Galectin ||| Healthcare ETFs in Focus Ahead of Q4 Earnings",1,0.48921764
2019-01-25,8809600.0,68.16999816894531,69.27999877929688,68.0999984741211,68.9000015258789,65.1558837890625,GILD,The Economics Of Cures - Gilead At A Turning Point ||| Healthcare Winners And Losers If This Shutdown Is Prolonged,0,0.5016301
2019-01-28,7120000.0,68.41999816894531,69.0,67.36000061035156,67.91000366210938,64.21968078613281,GILD,CEOs Aren't Worried About The Shutdown - Yet ||| Stocks To Watch: Tech Giants Step To The Plate ||| BMS Reports Q4: Analysis Of Its Stock And Of Celgene ||| 13 Monster Stock Market Predictions For The Week Of January 28 ||| Gilead And Selonsertib In NASH Fibrosis And Compensated Cirrhosis: The FDA Guidelines For Conditional Approval ||| Tech Giants Step To The Plate (Stocks To Watch Podcast) ||| Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for ||| Analysts Cut AbbVie Price Targets After Earnings Miss ||| Barron's 2019 Roundtable Picks 48 Scrappy Dog Stocks,1,0.48525003
2019-01-29,6989300.0,68.06999969482422,69.95999908447266,68.04000091552734,69.58999633789062,65.80838775634766,GILD,"Avalon GloboCare Stock Is an Expensive Mystery ||| Nasdaq 100 Movers: AMD, PCAR ||| The Biggest Biotech Binary Event in 2019 Is Just Around the Corner ||| Tiny Israeli firm touts cancer cure ||| 3 Top-Notch Healthcare Names I Just Added To My Portfolio ||| Large Cap Growth Strategy Q4 2018 Commentary ||| All Cap Growth Q4 2018 Commentary",1,0.49771628
2019-01-30,5113400.0,69.41999816894531,70.30000305175781,68.5999984741211,69.83000183105469,66.03534698486328,GILD,A Cure for Cancer Next Year? The Stock Market Says Don't Believe the Hype ||| Gilead Sciences (GILD) Gains But Lags Market: What You Should Know,1,0.4968163
2019-01-31,8343700.0,69.80999755859375,70.31999969482422,69.08000183105469,70.01000213623047,66.20556640625,GILD,3 Top Large-Cap Stocks to Buy in February ||| Will Gilead (GILD) Q4 Earnings Disappoint on Weak HCV Sales? ||| Will Gilead (GILD) Q4 Earnings Disappoint on Weak HCV Sales?,1,0.54199344
2019-02-01,6502100.0,70.0,70.5,69.36000061035156,70.05000305175781,66.24339294433594,GILD,Novartis's cancer therapy wins UK backing after initial lymphoma snub,0,0.53852594
2019-02-04,6913800.0,69.86000061035156,70.26000213623047,69.22000122070312,70.05000305175781,66.24339294433594,GILD,"VC Deals: Go-Jek Closes Half Of $2B Goal ||| Stocks To Watch: Disney, Alphabet And Super Bowl Players ||| The Week Ahead In Biotech: Conferences, Clinical Trials, Earnings And IPOs ||| Gilead Sciences Q4 Earnings Preview ||| Notable earnings after Monday's close ||| Disney, Alphabet And Super Bowl Players (Stocks To Watch Podcast) ||| Midday Stock Market News: Alphabet, Gilead Earnings on Tap ||| Gilead (GILD) 4th Quarter Earnings: What to Expect ||| Gilead Sciences, Inc. (GILD) Q4 2018 Earnings Conference Call Transcript ||| Gilead Sciences Q4 18 Earnings Conference Call At 4:30 PM ET ||| Gilead Sciences Earnings: GILD Stock Dips on Q4 EPS Miss, Revenue Beat ||| Gilead 4th-qtr profit misses Wall Street estimate, shares fall ||| Alphabet (GOOGL) Outperforms Estimates, Gilead (GILD) Mixed ||| Gilead fourth-quarter profit misses Wall Street estimate, shares fall ||| Notable Monday Option Activity: BABY, GILD, VRNT ||| After-Hours Earnings Report for February 4, 2019 : GOOGL, GILD, AVB, HIG, ITUB, ARE, STX, QGEN, AIV, KRC, LEG, OLN ||| '$GILD's comment on M&A: late stage opportunities are few and far between.' -Tweet From Notable Biotech Investor Brad Loncar ||| Gilead Sciences shares are trading lower after the company reported Q4 EPS of $1.44 versus the $1.70 estimate. ||| Gilead Raises Qtr. Dividend From $0.57 To $0.63/Share ||| Gilead Sees FY19 GAAP EPS $1.40-$1.50, Product Sales $21.3B-$21.8B ||| Gilead Sciences Q4 EPS $1.44 May Not Compare To $1.70 Estimate, Sales $5.795B Beat $5.48B Estimate ||| Q4 Earnings Preview For Gilead Sciences ||| 8 Stocks To Watch For February 4, 2019 ||| Earnings Scheduled For February 4, 2019 ||| Gilead Sciences'(GILD) CEO Gregg Alton on Q4 2018 Results - Earnings Call Transcript ||| Gilead Sciences, Inc. 2018 Q4 - Results - Earnings Call Slides ||| Alphabet (GOOGL) Outperforms Estimates, Gilead (GILD) Mixed ||| Gilead down 3% after hours on Q4 results, growth remains elusive ||| Gilead Sciences declares $0.63 dividend ||| Gilead Sciences misses by $0.26, beats on revenue ||| 8 Monster Earnings Predictions For The Week of Feb. 4",0,0.5040614
2019-02-05,14500600.0,67.75,69.0199966430664,66.75,67.68000030517578,64.00218963623047,GILD,"Gilead (GILD) Q4 Earnings Miss Estimates, Revenues Beat ||| Is Gilead Sciences a Bad News Buy? ||| Nasdaq 100 Movers: GILD, JD ||| Health Care Sector Update for 02/05/2019: OPGN, CNC, GILD, JNJ, PFE, ABT, MRK, AMGN ||| Daily Dividend Report: GILD, EXC, AVB, CHD, UTX ||| UnitedHealth, MercadoLibre, Alphabet and Gilead highlighted as Zacks Bull and Bear of the Day ||| Gilead Sciences' HCV Albatross Weighs on Its Results Yet Again ||| Stock Market Today: Alphabet Grows While Gilead Sciences Shrinks ||| 5 Top Stock Trades for Wednesday: GOOGL, GILD, EL, BA ||| January's Market Bounce Resulted In Some Unexpected Retail Trading Trends ||| Analysts Focus On Gilead's Late-Stage Data Readouts Following Mixed Q4 ||| Investor Movement Index January Summary ||| 42 Stocks Moving In Tuesday's Mid-Day Session ||| Gilead Sciences shares are trading lower after the company reported Q4 EPS of $1.44 versus $1.70 estimate; sales declined 3.8% year over year due to weakness in its hepatitis C segment. ||| 32 Stocks Moving In Tuesday's Pre-Market Session ||| The Daily Biotech Pulse: Gilead Earnings, Codexis Sings Pact With Merck, Eli Lilly Reports Positive Trial Results ||| 12 Stocks To Watch For February 5, 2019 ||| Gilead Sciences: Stable But Non-Inspiring ||| — Large-Cap Companies Report Earnings ||| Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments ||| UnitedHealth, MercadoLibre, Alphabet and Gilead highlighted as Zacks Bull and Bear of the Day ||| Gilead down 3% premarket after Q4 results, $820M impairment charge to R&D ||| Stocks Are Poised To Rise On Feb. 5 As Global Rally Marches On ||| Europe Stocks Rise, U.S. Set To Open In The Green ||| Wall Street Breakfast: Europe Stocks Rise, U.S. Set To Open In The Green ||| 2018 Drug Approvals: A Closer Look ||| Dividend Portfolio Review: 22% Y/Y Growth In January",1,0.48618442
2019-02-06,7580200.0,67.58000183105469,69.30999755859375,67.2699966430664,68.75,65.01403045654297,GILD,"Amgen a Top Socially Responsible Dividend Stock With 3.1% Yield (AMGN) ||| Biotech Stock Roundup: Celgene Tops in Q4, Gilead Disappoints, ALKS & AVEO Sink ||| Wednesday Sector Leaders: Healthcare, Technology & Communications ||| Gilead's Kite Failure Shows Dangers of Speculation Even at the Top Tier ||| Using Ratios To Identify Stocks Set To Outperform Their Peers: Statistical Summary Of 2 Years Of Research ||| Biotech Stock Roundup: Celgene Tops in Q4, Gilead Disappoints, ALKS & AVEO Sink",0,0.5039624
2019-02-07,6643400.0,68.43000030517578,68.7699966430664,66.91999816894531,67.27999877929688,63.62391662597656,GILD,"The Zacks Analyst Blog Highlights: Gilead, Vertex, Celgene, Alkermes and AVEO ||| For Sale: Performance Stocks, Slightly Worn ||| Vertex: Shareholders Might Have Reason To Breathe More Easily ||| In A World Full Of Numbers, These Non-Numeric Factors That Matter More ||| What Gilead's Fourth Quarter Call Told Us About Their Core Business ||| 10 Dividend Growth Stocks For February 2019 ||| Gilead: What A Difference An O'Day Can Make",1,0.473314
2019-02-08,5522200.0,66.91999816894531,67.61000061035156,66.33999633789062,67.47000122070312,63.8035888671875,GILD,Why Agenus Inc. Stock Took Flight in January ||| After Humira: AbbVie's Upa Vs. Gilead's Filgo,1,0.48767653
2019-02-11,5505500.0,67.62000274658203,67.97000122070312,67.29000091552734,67.62000274658203,63.94544219970703,GILD,"Why Gilead Sciences Stock Perked Up in January ||| Gilead misses key goal in NASH liver disease trial, shares sink ||| 7 Stocks Moving In Monday's After-Hours Session ||| Gilead Sciences shares are trading lower after the company reported the topline data from its STELLAR-4 Phase 3 study did not meet its primary endpoint. ||| Gilead Reports Topline Data From Phase 3 STELLAR-4 Study of Selonsertib in Compensated Cirrhosis Due To NASH Did Not Meet Primary Endpoint ||| Viking Therapeutics, Madrigal move up as Gilead liver drug fails to meet goals ||| Gilead's selonsertib flunks late-stage NASH study",0,0.5018581
2019-02-12,15927900.0,64.77999877929688,65.44000244140625,63.959999084472656,65.4000015258789,61.8460807800293,GILD,"5 Must-See Stock Charts for Wednesday: GILD, NFLX, EA ||| Nasdaq 100 Movers: GILD, EA ||| Health Care Sector Update for 02/12/2019: KMDA, GILD, MDGS, JNJ, PFE, MRK, ABT, AMGN ||| Better Buy: Gilead Sciences vs. Pfizer ||| Health Care Sector Update for 02/12/2019: GILD,KMDA,OHI ||| Gilead's (GILD) Late-Stage Study on Liver Disease Drug Fails ||| Notable Tuesday Option Activity: EA, GILD, NKE ||| Gilead Sciences Stock Slides Lower on NASH Drug Failure ||| Here's Why Viking Therapeutics Rose as Much as 13.9% Today ||| 44 Stocks Moving In Tuesday's Mid-Day Session ||| Gilead Analysts React To Failed NASH Trial: Citigroup, Wells Fargo Downgrade Biotech ||| 8 Biggest Price Target Changes For Tuesday ||| UPDATE: Raymond James Lowers Gilead Target From $90 To $85 As Firm Notes 'Gilead's Phase 3 trial in F4 NASH patients (STELLAR4) failed' And Firm Has 'very little reason to suspect STELLAR3 in F3 NASH (data 2Q19E) will be any different' ||| Gilead's Failed NASH Drug Trial Drags Stock Lower ||| Benzinga's Top Upgrades, Downgrades For February 12, 2019 ||| 26 Stocks Moving In Tuesday's Pre-Market Session ||| Shares of Gilead Sciences are trading lower after the company announced its Phase 3 STELLAR-4 study did not meet its primary endpoint. The stock was subsequently downgraded by several banks. ||| The Daily Biotech Pulse: NASH Disappointment For Gilead, Xeris To Offer Shares ||| Raymond James Maintains Strong Buy on Gilead Sciences, Lowers Price Target to $85 ||| A Peek Into The Markets: US Stock Futures Point To Higher Wall Street Open ||| Citigroup Downgrades Gilead Sciences to Neutral, Lowers Price Target to $75 ||| Wells Fargo Downgrades Gilead Sciences to Market Perform, Lowers Price Target to $68 ||| 2 Dividend Blue-Chips Set To Soar And 1 You Should Ignore ||| Gilead's (GILD) Late-Stage Study on Liver Disease Drug Fails ||| Boehringer Ingelheim teams up with IBM to explore use of blockchain in clinical trials ||| Gilead Sciences: Reaching An Inflection Point",1,0.5203301
2019-02-13,9047500.0,65.56999969482422,66.66999816894531,65.48999786376953,65.94000244140625,62.35673141479492,GILD,"Celgene vs. Gilead Stock: What’s the Better Biotech Buy? ||| Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 14, 2019 ||| Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for February 14, 2019 ||| Biotech Stock Roundup: Regeneron Impresses in Q4, Gilead Slumps, MacroGenics Soars ||| Analyst: Intercept's NASH Drug Could Launch Sans Competition After Gilead Trial Failure ||| Biotech Stock Roundup: Regeneron Impresses in Q4, Gilead Slumps, MacroGenics Soars ||| Biotech Bonanza: The Mergers And Acquisitions Theme ||| 3 Biotech Stocks With Strong Quantitative Drivers",1,0.4268717
2019-02-14,5737100.0,66.12999725341797,66.79000091552734,65.68000030517578,66.37000274658203,62.76336669921875,GILD,"Should You Buy Viking Therapeutics After Gilead Drug Failure? ||| Despite M&A Spree, Biotech ETFs Slide on Mixed Earnings ||| Gilead: What Just Happened? ||| Gilead Could Be The Winner From Washington State's Winner-Take-All Hep C Proposal ||| Despite M&A Spree, Biotech ETFs Slide on Mixed Earnings ||| Estimating The Potential Success Of Late Clinical Stage NASH Treatments ||| Is Gilead Science A Potential Buy?",1,0.49616525
2019-02-15,6214200.0,66.70999908447266,67.69000244140625,66.5,67.58999633789062,63.91706848144531,GILD,"U.S. Medicare plans to track CAR-T cancer therapy outcomes ||| The Week Ahead In Biotech: Conferences, Clinical Trials And Earnings ||| Centers For Medicaid, Medicare Has Proposed Coverage With Evidence Development For CAR-T Therapy, Decision Would Provide Nationwide Consistency In CMS Coverage ||| Ci Investments Inc. Buys CSX Corp, Athene Holding, Verizon Communications Inc, Sells Micron ... ||| FDA finalizes guidance for expedited review of cell and gene therapy applications ||| FDA creates new accelerated review pathway for generic drug applications ||| Gilead's Mousetrap",0,0.53029215
2019-02-19,6396200.0,67.33999633789062,67.7699966430664,66.6500015258789,66.76000213623047,63.13217544555664,GILD,"Better Buy: Celgene vs. Gilead Sciences ||| How To Retire: Kill The TV ||| 3 Biotech Stocks With Strong Quantitative Drivers ||| Intercept's fatty liver drug meets late-stage main goal, shares soar ||| Tuesday's ETF with Unusual Volume: PBE ||| Intercept Shares Soar To Multimonth High After NASH Drug Aces Late-Stage Trial ||| Gilead Reports Received Approval In Canada For YESCARTA CAR T Therapy For Adults With Relapsed or Refractory Large B-cell Lymphoma After Two or More Lines of Systemic Therapy ||| 5 Undervalued Companies For The Defensive Investor Nearest 52 Week Lows – February 2019 ||| Can Gilead Recover After Latest Earnings Downfall? ||| Gilead's Recent NASH Trial Failure Represents Opportunity For Galectin ||| Maryland strikes out in reviving drug price-gouging law ||| Teva: Reasons To Avoid It In Favor Of Innovative Biotechs",1,0.49267837
2019-02-20,5679800.0,66.66999816894531,67.29000091552734,66.5199966430664,66.9800033569336,63.3402214050293,GILD,"Intercept Pharmaceuticals Investors Strap In for a Wild Ride ||| Biotech Stock Roundup: ICPT Strong on NASH Drug Data, Collaborations & More ||| Biotech Stock Roundup: ICPT Strong on NASH Drug Data, Collaborations & More ||| Intercept Reports Positive Top-Line Data for NASH, Shares Up",0,0.5181075
2019-02-21,5607900.0,66.93000030517578,66.95999908447266,65.23999786376953,65.55000305175781,61.9879264831543,GILD,"2 Frustrating Flops, Plus Welcome to the Wrinkle Wars ||| The Zacks Analyst Blog Highlights: Intercept, Gilead, Vertex, Alkermes and Clovis ||| What Pharma Investors Need to Know About Pfizer's Latest Disaster ||| Jane's January Retirement Account Update - Pay Attention To The P/E Ratio ||| Jane's January Retirement Account Update - Pay Attention To The P/E Ratio ||| Biotechs under pressure, XBI down 1.4% ||| The Zacks Analyst Blog Highlights: Intercept, Gilead, Vertex, Alkermes and Clovis ||| U.S. healthcare spending to rise 5.5% per annum over next decade",1,0.5082787
2019-02-22,4925500.0,65.61000061035156,65.95999908447266,65.33000183105469,65.73999786376953,62.167598724365234,GILD,"Sofinnova Ventures Inc Buys NuCana PLC, Gilead Sciences Inc, Incyte Corp, Sells Ascendis Pharma ...",0,0.5129613
2019-02-25,7090500.0,66.05999755859375,66.05999755859375,65.2300033569336,65.3499984741211,61.79879379272461,GILD,Better Buy: bluebird bio vs. Gilead Sciences,0,0.51220316
2019-02-27,7645100.0,65.11000061035156,66.11000061035156,65.01000213623047,65.56999969482422,62.0068473815918,GILD,Is Viking Therapeutics a Buy?,0,0.51428294
2019-02-28,7227300.0,65.19999694824219,65.66000366210938,64.7300033569336,65.0199966430664,61.486724853515625,GILD,Recent Stock Purchase February 2019 ||| Genfit Seeks $100 Million Global IPO ||| Intercept And The Clinical Reality Of Treating NASH Fibrosis,1,0.52020675
2019-03-01,6002500.0,65.62000274658203,66.27999877929688,65.4000015258789,66.01000213623047,62.42293548583984,GILD,"Intercept (ICPT) Up on Q4 Revenue Beat, NASH Study in Focus ||| 10 Undervalued Companies For The Defensive Investor – March 2019 ||| Intercept (ICPT) Up on Q4 Revenue Beat, NASH Study in Focus ||| Nektar (NKTR) Q4 Earnings Beat, NKTR-181 Review Extended ||| European advisory group backs expanded labeling for Gilead's Viread",0,0.47810987
2019-03-04,8409600.0,66.19999694824219,66.47000122070312,64.9000015258789,65.44999694824219,61.89336013793945,GILD,"The 3 Oldest Members of Biotech's Billion-Burned Club ||| Why Sangamo Therapeutics Lost 22.9% of Its Value in February ||| Sum Up The Pieces: QQXT Could Be Worth $58 ||| Eli Lilly seeks to quell drug price anger with cheaper insulin ||| After Hours Most Active for Mar 4, 2019 : LTHM, LLY, ATVI, BAC, S, OHI, GE, GILD, CMCSA, IMGN, AAPL, SGMS ||| Road To Financial Independence: Rising Dividends And Endless Opportunities ||| Here's 68 Top S&P 500 Stocks For Yield, Gains & Upside In March ||| Monthly Review Of DivGro: February 2019 ||| March 2019 Stock Considerations",0,0.5253838
2019-03-05,7405400.0,65.2300033569336,65.6500015258789,64.3499984741211,64.38999938964844,60.89096832275391,GILD,"If The Celgene Deal Fails, Who Would Buy Bristol-Myers Squibb?",0,0.4998135
2019-03-06,9442500.0,64.44999694824219,64.58999633789062,62.7599983215332,62.91999816894531,59.5008430480957,GILD,"World's second man cleared of AIDS virus invigorates quest for cure ||| Why Is Gilead (GILD) Down 4.9% Since Last Earnings Report? ||| Gilead Sciences (GILD) Shares Cross 4% Yield Mark ||| UPDATE: Gilead Says Biktarvy Showed No Treatment-Emergent Resistance ||| Gilead Reports Presented New Data On Biktarvy, TAF-Based Regimens For Treatment Of HIV-1: Through Week 48, Biktarvy Maintained High Rates Of Virologic Suppression With Low Incidence Of Study Drug-Related Adverse Events, ||| Gilead Announces Its DISCOVER Trial Meets Primary And Secondary Endpoints And Will Support Supplemental Regulatory Filing For Descovy For Pre-Exposure Prophylaxis ||| Sangamo 2018: Coming Up Short ||| Gilead's Descovy on par with Truvada for preventing HIV infection ||| Biotechs remain under pressure on Gottlieb exit ||| Why Is Gilead (GILD) Down 4.9% Since Last Earnings Report?",0,0.4943111
2019-03-07,7618500.0,62.93000030517578,63.18999862670898,61.959999084472656,62.52999877929688,59.13203430175781,GILD,"2 Biotech Stocks With Major Incoming Catalysts ||| Gilead Reports Positive Data on HIV Drugs Biktarvy & Descovy ||| Gilead Highlights Data From Two Studies Supporting Further Development Of GS-6207, A Novel, Investigational HIV-1 Capsid Inhibitor As A Component Of Future Long-Acting HIV Therapies ||| Gilead's GS-6207 shows encouraging action in early-stage studies ||| Gilead Reports Positive Data on HIV Drugs Biktarvy & Descovy ||| Your 55 March Quarter NASDAQ Dividend Dogs By Yield, Upside And Net Gains",1,0.540226
2019-03-08,7639700.0,62.22999954223633,63.40999984741211,62.0,63.22999954223633,59.79399871826172,GILD,Don’t Abandon Gilead Stock After Weak Q4 Results ||| Gilead Reports Positive Data on HIV Drugs Biktarvy & Descovy ||| Stocks That Fell to '-Year Lows in the Week of March 8 ||| US Markets Decline on Friday,1,0.5052553
2019-03-11,5207900.0,63.369998931884766,64.54000091552734,63.06999969482422,64.33999633789062,60.84368133544922,GILD,"3 Top Biotech Stocks to Buy in March ||| Precision Sets Itself Up For An IPO, With An Already Impressive Partnership On The Table ||| Biotech Stocks Hold After After Brief Sell-Off Last Week…Updates",1,0.5189554
2019-03-12,5235600.0,64.54000091552734,65.27999877929688,64.16000366210938,64.83000183105469,61.30705261230469,GILD,"Gilead Sciences, Inc. (GILD) Presents at Barclays Global Healthcare Conference (Transcript) ||| Trump 2020 drug pricing initiatives - part 2 ||| Biotechs (mostly) in the green on Sharpless nod to head FDA",1,0.49127644
2019-03-13,6276300.0,65.19000244140625,65.94999694824219,64.87999725341797,65.75,62.177059173583984,GILD,"Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for March 14, 2019 ||| Gilead Sciences Option Alert: Apr 18 $70 Calls Sweep (33) near the Ask: 991 @ $0.301 vs 5924 OI; Earnings 4/30 After Close [est] Ref=$65.63 ||| Agenus Reports Acceptance Of Co.'s IND Filing For AGEN1423 Partnership With Gilead, Triggering Cash Payment Of $7.5M ||| Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know ||| Conatus up 22% ahead of Emricasan data presentation",0,0.46081436
2019-03-14,7958500.0,65.04000091552734,65.30000305175781,64.3499984741211,64.79000091552734,61.86196899414063,GILD,"Agenus Wins $7.5M Milestone Payment From Gilead, Stock Up ||| IBB, CELG, BIIB, GILD: Large Inflows Detected at ETF ||| Agenus Wins $7.5M Milestone Payment From Gilead, Stock Up",1,0.48226917
2019-03-15,11976800.0,64.7300033569336,65.79000091552734,64.7300033569336,65.62999725341797,62.66400909423828,GILD,"Benzinga's Top Upgrades, Downgrades For March 15, 2019 ||| BMO Capital Initiates Coverage On Gilead Sciences with Outperform Rating, Announces $78 Price Target ||| BMO bullish on Gilead, sees 20% upside ||| BMO likes Amgen and Gilead in premarket analyst action",0,0.4972276
2019-03-18,8066900.0,65.79000091552734,65.9000015258789,64.83000183105469,65.0199966430664,62.081573486328125,GILD,"Better Buy: Amgen vs. Gilead Sciences ||| YETI, Gilead, Dick's, FedEx and Amazon highlighted as Zacks Bull and Bear of the Day ||| Bear of the Day: Gilead Sciences (GILD) ||| After Hours Most Active for Mar 18, 2019 : ELAN, LLY, BAC, MRK, HPQ, WMB, QCOM, GILD, CMCSA, PEP, EBAY, ATVI ||| Bear of the Day: Gilead Sciences (GILD)",1,0.46878856
2019-03-19,6860800.0,65.0,66.0999984741211,64.9000015258789,65.48999786376953,62.53033447265625,GILD,Gilead Sciences (GILD) Gains As Market Dips: What You Should Know ||| GSK Prescribes A US$3.5bn Bond In Three Parts ||| IPO Update: Precision BioSciences Readies Plan For IPO ||| IPO Update: Genfit Files Proposed Terms For IPO And Private Placement,0,0.48509157
2019-03-20,8408200.0,65.06999969482422,65.25,64.37999725341797,64.5999984741211,61.68055725097656,GILD,Undervalued Growth and Dividend Growth in Health Technology ||| Jane's February Retirement Account Update - Why You Should Consider Capital Recycling,1,0.5232088
2019-03-21,9069500.0,64.13999938964844,65.0199966430664,63.0,64.91999816894531,61.9860954284668,GILD,"Does Recent AbbVie Stock Weakness Make It A Buy? 3 Pros, 3 Cons ||| Some Thoughts On Biogen's Drop ||| GSK Prescribes A $3.5bn Bond In 3 Parts",0,0.50057787
2019-03-22,5911900.0,64.86000061035156,65.0999984741211,63.70000076293945,63.77000045776367,60.88806915283203,GILD,Conatus (CNAT) Declines on Failure of NASH Fibrosis Study ||| iShares Nasdaq Biotechnology ETF Experiences Big Inflow ||| Biogen Stock Fell Too Far on Unfortunate News ||| Conatus Shares Fall By More Than 50% After Midstage Study Shows NASH Candidate Lagged Placebo ||| Conatus (CNAT) Declines on Failure of NASH Fibrosis Study ||| Conatus flop fails to move NASH players,1,0.49087492
2019-03-25,7686800.0,63.79999923706055,63.9900016784668,62.93000030517578,63.790000915527344,60.90716552734375,GILD,Hookipa Pharma on deck for IPO ||| Why 1 Top Analyst Thinks Gilead Sciences Will Soar More Than 25% ||| Gilead Sciences (GILD) Gains As Market Dips: What You Should Know ||| Gilead Sciences (GILD) Gains As Market Dips: What You Should Know ||| What Will Provide Gilead The Growth Needed For Multiple Expansion?,1,0.4876576
2019-03-26,6332400.0,64.05000305175781,64.94999694824219,63.95000076293945,64.23999786376953,61.33682632446289,GILD,"Gilead Reports Japan's Ministry of Health, Labour, Welfare Approves Co.'s Biktarvy For Treatment Of HIV-1 Infection ||| Gilead's Biktarvy OK'd in Japan",0,0.50784695
2019-03-27,5919600.0,64.13999938964844,64.55999755859375,63.459999084472656,63.65999984741211,60.78304290771485,GILD,"3 Top Dividend Stocks to Add to Your Watchlist ||| The Precision Biosciences IPO: What You Need To Know ||| 6 Gene Therapy M&A Targets On The Radar ||| Gilead to Present New Data From Multiple Liver Disease Research and Development Programs at The International Liver Congress 2019 ||| –… Stocks for Using a Benjamin Graham Value Investing Strategy ||| Using Ratios To Identify Stocks Set To Outperform Their Peers: Pharmaceutical Rankings Update ||| 10 Stocks For Using A Benjamin Graham Value Investing Strategy – March 2019 ||| Biotech Stock Roundup: BIIB & CNAT Crash on Study Failures, LXRX Gets CRL",1,0.552289
2019-03-28,5256000.0,63.91999816894531,63.93999862670898,63.16999816894531,63.68999862670898,60.81167984008789,GILD,Gilead And Galapagos Announce Filgotinib Meets Primary And Key Secondary Endpoints In The Phase 3 Finch 1 Rheumatoid Arthritis Study,1,0.52637696
2019-03-29,9601400.0,64.9000015258789,65.62999725341797,64.6500015258789,65.01000213623047,62.07202911376953,GILD,"Why BlackBerry, Galapagos, and Progress Software Jumped Today ||| Health Care Sector Update for 03/29/2019: GLPG,GILD,FTSV,SEEL,AZN,AZN.L ||| Why Galapagos Stock Is Crushing It Today ||| Shares in Galapagos jump 15 pct after arthritis drug results ||| Why BlackBerry, Galapagos, and Progress Software Jumped Today ||| Health Care Sector Update for 03/29/2019: GLPG,GILD,FTSV,SEEL,AZN,AZN.L ||| Congo Health Ministry Says Has Recorded 15 New Confirmed Cases Of Ebola ||| Gilead Sciences shares are trading higher after the company's filgotinib met its primary and key secondary endpoints in a phase 3 Finch 1 rheumatoid arthritis study. ||| The Daily Biotech Pulse: Safety Board Clears Eisai's Alzheimer's Study, Positive Trial Results For Galapagos-Gilead ||| Wall Street Ends the Week Higher ||| –… Low Price-Earnings Stocks for the Defensive Investor ||| IMF March Buys: The 18 Stocks Added To My Fund ||| 10 Low PE Stock Picks For The Defensive Investor – March 2019 ||| NASH Scorecard So Far This Year: A Look at the Hits & Misses ||| Stock Futures Climb, China Markets Rally; Dow Jones Reaches For Q1 Record ||| Filgotinib worth as much as $6/share to Gilead - Leerink ||| Gilead and Galapagos up premarket on positive filgotinib data",1,0.48974952
2019-04-01,5757300.0,65.54000091552734,66.23999786376953,65.25,65.87999725341797,62.9027099609375,GILD,"How To Retire: Don't Go To College ||| Dividend Champions For April 2019 ||| IBB, GILD, CELG, VRTX: Large Outflows Detected at ETF ||| Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know ||| Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know",1,0.46700612
2019-04-02,6932100.0,65.69000244140625,66.77999877929688,65.69000244140625,66.23999786376953,63.24643707275391,GILD,Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences ||| Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences ||| Gilead Has A Shot To Regain Investor Confidence With Inflammatory Disorder Drug Filgotinib ||| 6 Stocks Growing Earnings ||| 5%+ Dividend Yield Portfolio: Improvements Years In The Making (Mar 2019 Review) ||| Total USD Portfolio Review - March And Q1 2019,1,0.5123359
2019-04-05,5401100.0,67.19999694824219,68.06999969482422,66.91000366210938,67.54000091552734,64.48770141601562,GILD,"Gilead Sciences Option Alert: May 17 $70 Calls Sweep (35) near the Ask: 534 @ $1.309 vs 7580 OI; Earnings 4/30 After Close [est] Ref=$67.56 ||| Gilead Reports Submission Of Supplemental New Drug Application To FDA For Once-Daily Descovy For HIV Pre-Exposure Prophylaxis ||| Genfit And The NASH Education Program: The Race To Inform ||| Underhill Investment Management Llc Buys Watsco Inc, D.R. ... ||| Gilead files U.S. application HIV prevention claim for Descovy ||| Key events next week - healthcare",0,0.5331386
2019-04-08,5308400.0,67.38999938964844,67.80999755859375,66.9000015258789,67.37999725341797,64.33492279052734,GILD,Where Will Gilead Sciences Be in 5 Years? ||| Divorce: The Forced Portfolio Colonoscopy And The Lessons I Learned ||| Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know ||| Gilead Files sNDA for Label Expansion of HIV Therapy Descovy ||| Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know ||| Gilead Files sNDA for Label Expansion of HIV Therapy Descovy ||| Don't Be A Worrywart (My Little Conglomerate Q1 2019 Update) ||| Road To Financial Independence: New Dividend Record In March,0,0.53442734
2019-04-09,5908000.0,67.2699966430664,67.62000274658203,65.94000244140625,66.08999633789062,63.10321807861328,GILD,"3 Dividend Stocks Perfect for Retirees ||| Factory Mutual Insurance Co Buys iShares MSCI ACWI ex US Index Fund, iShares MSCI Emerging ... ||| Glaxo's Dovato Gets FDA Nod for Treatment-Naive HIV Patients",1,0.5561739
2019-04-10,7451400.0,67.2300033569336,67.56999969482422,66.77999877929688,67.4000015258789,64.35401916503906,GILD,"'Gilead Sciences to lay off one-fifth of sales force as financial pressures build' -STAT ||| UBS Upgrades Gilead, Sees EPS Upside In 2019 ||| Gilead Sciences shares are trading higher after UBS upgraded the stock from Neutral to Buy and raised the price target from $75 to $77. ||| 10 Biggest Price Target Changes For Wednesday ||| Benzinga's Top Upgrades, Downgrades For April 10, 2019 ||| A Peek Into The Markets: US Stock Futures Climb Ahead Of CPI, Fed Minutes ||| UBS Upgrades Gilead Sciences to Buy, Raises Price Target to $77 ||| Gilead to cut 150 sales reps ||| Stocks Are Pointing To a Higher Opening On April 10 ||| UBS likes Gilead in premarket analyst action",0,0.49897492
2019-04-11,5994400.0,67.83999633789062,68.0,66.02999877929688,66.30999755859375,63.31328201293945,GILD,"Noteworthy Thursday Option Activity: ADSK, GILD, HUM ||| Noteworthy Thursday Option Activity: ADSK, GILD, HUM ||| Gilead Highlights Will Present New Data On HBV, Hep C Medicines At The International Liver Congress Thurs. ||| The Daily Biotech Pulse: NASH Cheer For Intercept, Gilead Layoffs, BioDelivery Licenses Constipation Drug ||| Gilead Presents New Data in NASH at the International Liver Congress 2019 ||| Gilead Sciences: Hitting Bottom ||| NASH players in the red as EASL announcements fail to excite investors ||| Intercept Reports Additional Positive Data From NASH Study ||| Gilead's GS-9674/GS-0976 shows positive action in POC NASH study",0,0.48966733
2019-04-12,6975400.0,66.76000213623047,66.83999633789062,65.08000183105469,65.27999877929688,62.32982635498047,GILD,"Novo Nordisk and Gilead team up to test fatty liver disease treatment ||| Gilead Sciences, Novo Nordisk Announce Intent to Initiate a Clinical Collaboration in NASH ||| DeDora Capital, Inc. Buys Alphabet Inc, Linde PLC, Microsoft Corp, Sells Thermo Fisher ... ||| 5 Companies That Will Raise Earnings ||| Gilead Sciences to collaborate with Novo Nordisk for clinical trial in NASH",1,0.514963
2019-04-15,4766400.0,65.4000015258789,65.95999908447266,64.5,65.43000030517578,62.47304916381836,GILD,Better Buy: Amgen vs. Gilead Sciences ||| Better Buy: Gilead Sciences vs. Biogen ||| Weighing The Week Ahead: What Will Q1 Earnings Reveal About Economic Strength? ||| Gilead Sciences (GILD) Gains As Market Dips: What You Should Know ||| Gilead to Collaborate with Novo Nordisk for NASH Treatment ||| Gilead Sciences (GILD) Gains As Market Dips: What You Should Know,0,0.48880172
2019-04-16,5820700.0,65.8499984741211,66.1500015258789,64.3499984741211,64.54000091552734,61.62327194213867,GILD,Is TG Therapeutics a Buy? ||| Why Amgen Stock Could Break Out to New Highs ||| Gilead teams up with insitro for experimental NASH treatments ||| Gilead Sciences Enters Strategic Collaboration With Insitro - Quick Facts ||| Shares of several drug companies are trading lower. Weakness may be tied to uncertainty over healthcare policy going into the 2020 primaries and Washington's recent efforts to curb prescription drug prices. ||| Gilead And Insitro Announce Strategic Collaboration To Discover And Develop Novel Therapies For Nonalcoholic Steatohepatitis ||| 5 Health Care Stocks in Gurus' Portfolios ||| Gilead And The Pain Ahead ||| Gilead teams up with insitro in NASH; shares up 1% premarket,0,0.5042749
2019-04-17,7888400.0,64.58000183105469,64.69999694824219,63.150001525878906,63.25,60.39157104492188,GILD,"Noteworthy ETF Inflows: VLUE, GM, GILD, EXC ||| Shares of several drug companies are trading lower amid continued efforts from Washington to curb prescription drug prices. The overall healthcare sector has seen weakness recently due to uncertainty over the future of healthcare policy. ||| Gilead Sciences Wants To Reignite Its NASH Portfolio With 2 Advancements ||| Axcella Health Files For U.S. IPO ||| Merck's Keytruda + Galectin's Belapectin (GR-MD-02): Thoughts On The Evidence ||| Drugmaker selloff intensifies on D.C. pricing headwinds ||| Gilead Collaborates With Insitro to Develop NASH Therapies ||| Biotech Stock Roundup: GILD Collaborates on NASH, FCSC Surges on Deal",0,0.49716282
2019-04-18,11552900.0,63.61000061035156,63.61000061035156,61.560001373291016,62.95000076293945,60.105125427246094,GILD,"Noteworthy Thursday Option Activity: GM, GILD, ICPT ||| Noteworthy Thursday Option Activity: GM, GILD, ICPT ||| Shares of several drug companies are trading lower amid continued efforts from Washington to curb prescription drug prices. The overall healthcare sector has seen weakness recently due to uncertainty over the future of healthcare policy. ||| Jim Cramer Shares His Thoughts On AMD, Gilead, Nvidia And More ||| Peoples Financial Services Corp. Buys Berkshire Hills Bancorp Inc, ESSA Bancorp Inc, Charter ... ||| Novo Nordisk's (NVO) Share Price Rises YTD on Strong Pipeline ||| Novo Nordisk's (NVO) Share Price Rises YTD on Strong Pipeline ||| Is Healthcare Berning?",0,0.5244314
2019-04-22,11480600.0,62.77999877929688,63.33000183105469,61.54999923706055,61.869998931884766,59.07393264770508,GILD,"Regions Financial Corp Buys DowDuPont Inc, Watsco Inc, TE Connectivity, Sells Pfizer Inc, ... ||| Stocks That Fell to '-Year Lows in the Week of April –9 ||| Quarterly Review Of DivGro: Q1-2019 ||| 5 Top Stock Trades for Tuesday: TSLA, TWTR, TTD, O ||| Re-engineered CAR-T eliminates dangerous side effect in lymphoma study",1,0.49545875
2019-04-23,10286600.0,62.06999969482422,63.34999847412109,61.88999938964844,63.040000915527344,60.19105911254883,GILD,"2 Best Biotech Buyout Plays ||| Shares of several healthcare stocks are trading higher in a potential rebound from last week's selloff. In an upgrade of HCA Healthcare, Raymond James analysts noted the selloff was 'based on legislation that has almost no chance of passing' ||| Milestone Pharmaceuticals: At Phase 3 Of Development ||| 6 Poorly Performing Stocks in Gurus' Portfolios ||| The Biotech Sector Is On Sale; Time To Buy ||| What's in the Cards for AstraZeneca (AZN) in Q1 Earnings?",0,0.5233085
2019-04-24,6130200.0,63.15999984741211,63.18999862670898,62.20000076293945,62.79999923706055,59.9619026184082,GILD,"'Gilead defied a government HIV patent. The Justice Department has opened a review.' -Washington Post ||| Gilead Reports Its Kite Pharma Co. Planning New Facility In Frederick County On 20-Acre Site, Maryland To Produce Cell Therapies For People With Cancer ||| 5 Stocks To Own As Healthcare Bottoms ||| Clean Yield Group Buys Vodafone Group PLC, Highwoods Properties Inc, Hingham Institution for ... ||| Gilead Sciences Isn't Satisfied With Only A Few NASH Deals, Presses On With More ||| DOJ to review government patent related to Gilead's Truvada ||| DOJ to review government patent related to Gilead's Truvada ||| What's in the Cards for Amarin (AMRN) This Earnings Season?",1,0.5205536
2019-04-25,7944700.0,62.470001220703125,64.33000183105469,62.04999923706055,64.13999938964844,61.24134826660156,GILD,"Notable ETF Inflow Detected - IBB, CELG, GILD, BIIB ||| Gilead Reiterates Faith In NASH Combination Approach After Another Trial Disappointment ||| Gilead Announces Phase 3 STELLAR-3 Study Of Selonsertib In Bridging Fibrosis Due To NASH Did Not MEet PRe-Specified Week 48 Endpoint ||| GILD vs. ALKS: Which Stock Is the Better Value Option? ||| Gilead's selonsertib flunks another NASH study; shares down 1% premarket",1,0.52768874
2019-04-26,8144600.0,64.43000030517578,65.31999969482422,64.30999755859375,65.1500015258789,62.20570373535156,GILD,"Bernstein Initiates Coverage On Gilead Sciences, Inc. - Common Stock with Outperform Rating ||| Bernstein Initiates Coverage On Gilead Sciences, Inc. - Common Stock with Outperform Rating, Announces $82 Price Target ||| Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know ||| Biotech News Recap: Gilead Sciences' STELLAR Data Falls Short ||| European advisory group back's Mylan's generic version of Glaxo's Volibris ||| Bernstein likes Gilead in premarket analyst action ||| Sector Study: Healthcare Vs. Technology Dividend Dogs, Which To Buy?",0,0.48063174
2019-04-29,5252500.0,65.05999755859375,65.5999984741211,64.80999755859375,64.91999816894531,61.9860954284668,GILD,"2 Reasons Gilead Sciences' NASH Program Could Bounce Back ||| How a Medicare Rule Change Could Bring CAR-T Stocks Back to Life ||| Stocks To Watch: Eyes On Apple, Uber, F8 And Avengers ||| Stocks To Watch: Eyes On Apple, Uber, F8 And Avengers ||| Sangamo (SGMO) Q1 Earnings: What's in Store for the Stock? ||| 2 Quality Dividend Stocks Trading Near 52-Week Lows ||| Fibrocell (FCSC) Q1 Earnings: What's in Store for the Stock? ||| 5 Drug/Biotech Stocks Poised to Beat Q1 Earnings Estimates ||| Eyes On Apple, Uber, F8 And Avengers (Stocks To Watch Podcast) ||| Is a Beat in the Cards for Incyte (INCY) in Q1 Earnings? ||| Market At New Highs, But Healthcare And Biotechs Feel The Heat ||| The U.S. Week Ahead (Apr 29-May 3), Financial Market Frenzy: Fed, Jobs, Earnings",1,0.53559875
2019-04-30,7164900.0,64.94999694824219,65.26000213623047,63.95000076293945,65.04000091552734,62.10067367553711,GILD,"Will Gilead Stock Get A Needed Boost From This Week’s Earnings Report? ||| Gilead Reports CFO Robin Washington To Step Down; Was Named To Alphabet's Board ||| AVEO Pharmaceuticals (AVEO) to Post Q1 Earnings: What's Up? ||| What's in Store for ANI Pharmaceuticals (ANIP) Q1 Earnings? ||| What's in the Cards for Bausch Health (BHC) Q1 Earnings? ||| AbbVie: Value Trap? Maybe, But Here's Why It Can Revive",0,0.48743874
2019-05-01,5779700.0,64.81999969482422,65.61000061035156,64.45999908447266,64.87000274658203,61.938358306884766,GILD,"3 Things You Can Expect in Gilead Sciences' Q1 Earnings Update ||| Alphabet's Eric Schmidt, Diane Greene To Leave Board This June ||| The Daily Biotech Pulse: Nabriva Stumbles At FDA Hurdle, Gilead CFO To Retire, Eisai Ends Collaboration With Purdue ||| Is a Beat in the Cards for Mallinckrodt (MNK) Q1 Earnings? ||| Parnassus Investments Buys Gilead Sciences Inc, AbbVie Inc, Thomson Reuters Corp, Sells ... ||| Teva launches generic Letairis in U.S. ||| Wall Street's Top Stories At Midday, May 1st ||| The Retiree's Dividend Portfolio - Jane's March Update - Dividend Increases Galore ||| Gilead finance chief to retire next year",1,0.5331851
2019-05-02,5735800.0,64.70999908447266,65.38999938964844,64.19999694824219,65.30000305175781,62.348934173583984,GILD,"Better Buy: Vertex Pharmaceuticals vs. Galapagos ||| Daily Dividend Report: EOG, GILD, DUK, ECL, ICE ||| Gilead Sciences Inc. Q1 adjusted earnings Beat Estimates ||| Gilead (GILD) 1st Quarter Earnings: What to Expect ||| June 14th Options Now Available For Gilead Sciences (GILD) ||| Gilead Reaffirms FY19 Guidance ||| Gilead Sciences Q1 Adj. EPS $1.76 Beats $1.61 Estimate, Sales $5.258B Miss $5.31B Estimate ||| What's The Buzz Around Novartis' Gene Therapy Zolgensma? ||| The Daily Biotech Pulse: FDA Nod For Sanofi's Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data ||| Earnings Scheduled For May 2, 2019 ||| Gilead Sciences, Inc. (GILD) CEO Daniel O'Day on Q1 2019 Results - Earnings Call Transcript ||| Gilead Sciences (GILD) Q1 Earnings Top Estimates ||| Gilead Sciences declares $0.63 dividend ||| Gilead turning the corner, Q1 earnings up 28% ||| IPO Update: Axcella Health Readies Plan For $75 Million IPO ||| May 2019 Stock Considerations",1,0.49362475
2019-05-03,8822500.0,65.97000122070312,67.73999786376953,65.9000015258789,67.12999725341797,64.09622192382812,GILD,"VTV, MO, GILD, AXP: ETF Inflow Alert ||| Gilead Sciences Returns to Growth in the First Quarter ||| Gilead Sciences Inc (GILD) Q1 2019 Earnings Call Transcript ||| Gilead Sciences shares are trading higher after the company reported better-than-expected Q1 EPS and reaffirmed 2019 guidance. ||| The Daily Biotech Pulse: Obseva Reports Positive Endometriosis Drug Trial, Assembly Biosciences Execs Depart, Coherus Settles With Amgen ||| Gilead Sciences Rises on –st-Quarter Results ||| Novo Nordisk (NVO) Q1 Earnings and Revenues Miss Estimates ||| Gilead (GILD) Earnings Beat, Revenues Miss Estimates in Q1 ||| AbbVie: No Reason To Throw In The Towel ||| Gilead advancing U.S. application for Kite cell therapy for mantle cell lymphoma ||| O'Day: The Man Of The Hour For Gilead ||| It's Jobs Day (Wall Street Breakfast Podcast) ||| Wall Street Breakfast: It's Jobs Day",1,0.5147235
2019-05-06,6304700.0,66.33000183105469,67.80000305175781,66.04000091552734,67.69000244140625,64.63092041015625,GILD,5 Things You Can Expect for Gilead Sciences With Its New CEO at the Helm ||| 5%+ Dividend Yield Portfolio: The Number Of Stocks To Own (Apr 2019 Review) ||| Analysts Expect VOOV To Hit $124,0,0.54140997
2019-05-07,7281300.0,67.05000305175781,67.5,65.93000030517578,66.4000015258789,63.399208068847656,GILD,Where Will Gilead Sciences Spend Its Cash? ||| Biotech ETFs in Focus on String of Q1 Earnings Beats ||| Road To Financial Independence: 107 Stocks April Update ||| AstraZeneca's Calquence successful in late-stage leukemia study,0,0.5045701
2019-05-08,6509500.0,66.18000030517578,66.44000244140625,65.20999908447266,66.06999969482422,63.084129333496094,GILD,"Goldfinch Bio Partners With Gilead Sciences - Quick Facts ||| Gilead To Invest $109M In Goldfinch Bio For Kidney Drug Collaboration ||| UPDATE: Goldfinch To Receive $55M In Upfront Payments From Gilead, Added $54M To Support Development Of KGA Platform For Diabetic Kidney Disease ||| Gilead Sciences Reports Strategic Collaboration With Goldfinch Bio To Develop Novel Therapies For Kidney Disease ||| Biotech News Recap: Merck Announces Yet Another Successful Readout For A Key Asset ||| Gilead's Earnings Might Point To A Potential Turnaround In Coming Year ||| Fragasso Group Inc. Buys iShares Core S&P 5……, Vanguard Mid-Cap, Hilton Worldwide ... ||| CryoPort: Powerful Industry Tailwind Signals Robust Growth Ahead ||| Drug makers to face added pricing pressure in Canada under new proposal - Reuters ||| Drug makers to disclose prices in TV ads as early as this summer ||| Gilead teams up with Goldfinch Bio in kidney diseases",1,0.51291704
2019-05-09,6116700.0,65.56999969482422,66.48999786376953,64.76000213623047,66.12999725341797,63.14140701293945,GILD,"Horizon Therapeutics' (HZNP) Q1 Earnings Beat Estimates ||| Amicus' (FOLD) Earnings & Revenues Miss Estimates in Q1 ||| Noesis Capital Mangement Corp Buys Amphenol Corp, Nielsen Holdings PLC, Gilead Sciences Inc, ... ||| Nektar (NKTR) Q1 Earnings & Revenues Beat, Decline Y/Y ||| Gilead Sciences At The Filgotinib And Selonsertib Crossroads ||| Is Gilead Sciences (GILD) Stock Outpacing Its Medical Peers This Year?",0,0.4961907
2019-05-10,5953400.0,66.04000091552734,66.27999877929688,64.12000274658203,65.56999969482422,62.606727600097656,GILD,"Shares of several healthcare companies are trading lower in sympathy with the overall market. The S&P 500 is trading lower 1% ||| 'Drugmaker Gilead reaches multiyear agreement with White House to donate HIV prevention med PrEP' -CNBC ||| Oak Grove Capital LLC Buys Advanced Micro Devices Inc, The Home Depot Inc, Constellation Brands ... ||| Factorial Partners, LLC Buys Biogen Inc, Canadian Pacific Railway, Zions Bancorp NA, Sells Bank ... ||| Global Blood (GBT) Reports Narrower-Than-Expected Loss in Q1 ||| Agenus (AGEN) Q1 Earnings Beat Estimates, Revenues Miss ||| PDL BioPharma (PDLI) Q1 Earnings Top Mark, Revenues Rise Y/Y ||| Gilead to donate Truvada to help prevent HIV",0,0.51217604
2019-05-13,8146000.0,64.41999816894531,64.52999877929688,63.15999984741211,64.16999816894531,61.26999282836914,GILD,"Is It Finally Time to Buy Gilead Sciences? ||| Shares of several healthcare companies are trading lower amid continued trade dispute between the US and China. Also, the United States filed a lawsuit against drug manufacturers alleging price fixing. ||| GILD vs. ILMN: Which Stock Is the Better Value Option? ||| FDA finalizes guidance on interchangeable biosimilars",1,0.4867972
2019-05-14,6810900.0,64.23999786376953,65.61000061035156,64.0999984741211,65.08000183105469,62.13886642456055,GILD,"Shares of several healthcare companies are trading higher as the US market rebounds from recent weakness, driven by renewed cautious optimism surrounding US-China trade talks. ||| Healthcare Value Capital, LLC Buys Gilead Sciences Inc, Viking Therapeutics Inc, Allergan PLC, ... ||| Gilead Has Levers To Pull",1,0.50020653
2019-05-15,5381500.0,64.66999816894531,65.77999877929688,64.38999938964844,65.30000305175781,62.348934173583984,GILD,"IBB, GILD, CELG, BIIB: ETF Outflow Alert ||| Temasek Liquidates Positions In Boeing, Tencent Music, Gilead, Takes Small Stake In Microsoft ||| Gilead Sciences Is A Good Long-Term Investment Without A Moat ||| Galectin Therapeutics: Primed For Takeoff After The Rights Offering And New Clinical Evidence ||| Mallinckrodt Ends Enrollment in Phase III for Terlipressin ||| Biotech Stock Roundup: FDA Nod for REGN's Eylea in DR, Tie-Ups & Other Updates ||| Vertex One Asset Management Inc. Buys L' Technologies Inc, First Data Corp, Celgene Corp, ...",1,0.49638584
2019-05-16,7535400.0,65.58999633789062,66.70999908447266,65.48999786376953,65.77999877929688,62.807228088378906,GILD,"Agios' Tibsovo Meets Endpoint in Cholangiocarcinoma Study ||| AbbVie Grabs FDA Approval In HCV, Faces Several Risks ||| D. E. Shaw & Co., Inc. Buys Pfizer Inc, AbbVie Inc, Johnson & Johnson, Sells ...",1,0.49043018
2019-05-17,6660900.0,65.7699966430664,67.22000122070312,65.5999984741211,66.36000061035156,63.36101913452149,GILD,"GILD, NVO, ZYNE and NOG among notable after hour movers ||| Gilead chief defends hefty Truvada price at government hearing",0,0.5059815
2019-05-20,4473900.0,65.98999786376953,66.2300033569336,65.56999969482422,65.86000061035156,62.88361740112305,GILD,"Enanta And EDP-305 In NASH: An Update ||| Better Buy: Vertex Pharmaceuticals vs. Galapagos ||| Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences ||| Hearing Credit Suisse Initiates Coverage On Gilead With Neutral Rating, $70 Price Target ||| Gilead Sciences: Still A Good Pick Despite Risks",1,0.5240017
2019-05-21,5118200.0,66.22000122070312,66.72000122070312,65.80999755859375,66.5199966430664,63.513790130615234,GILD,"Credit Suisse Initiates Coverage On Gilead Sciences, Inc. - Common Stock with Neutral Rating, Announces $70 Price Target ||| Top Stock Reports for Disney, Coca-Cola & Gilead ||| Credit Suisse likes Amgen in premarket analyst action ||| Alexion (ALXN) Stock Up 30.7% YTD: Will the Momentum Stay?",0,0.47846735
2019-05-22,5764800.0,66.26000213623047,66.80000305175781,65.7300033569336,66.5,63.49469375610352,GILD,"High Short Interest, Strong Performance Stocks: May 2019 ||| Lilly's Crohn's Disease Candidate Meets Phase II Study Goals ||| The Zacks Analyst Blog Highlights: Disney, Coca-Cola, Gilead, CME and Entergy",1,0.5060163
2019-05-23,6707200.0,66.75,67.45999908447266,66.37000274658203,67.16999816894531,64.13440704345703,GILD,"IBB, CELG, GILD, AMGN: ETF Inflow Alert ||| 3 Top Biotech Stocks to Buy Right Now ||| Gilead And Kratos Defense: 'Fast Money Halftime Report' Picks From May 23 ||| Benzinga's Top Upgrades, Downgrades For May 23, 2019 ||| Citigroup Upgrades Gilead Sciences, Inc. - Common Stock to Buy",0,0.49780315
2019-05-24,4197900.0,67.30000305175781,67.47000122070312,66.44999694824219,66.88999938964844,63.86706161499024,GILD,"Alpine Immune Sciences 8-K Shows Gilead's Kite Pharma Provided Co. Notice Of Termination Of License, Research Deal ||| The Retiree's Dividend Portfolio - Jane's April Update: Why You Should Consider Canadian Banks ||| 5 Best PEG Stocks Suitable for GARP Investors ||| Kite exits research collaboration with Alpine",0,0.48935643
2019-05-28,9821600.0,65.30999755859375,65.79000091552734,63.95000076293945,63.970001220703125,61.07903289794922,GILD,"Is Gilead Sciences (GILD) Outperforming Other Medical Stocks This Year? ||| Noteworthy Tuesday Option Activity: UAL, GILD, HP ||| Nasdaq 100 Movers: MYL, AMD ||| 10 Top Pot Stocks to Buy ||| Goldman Downgrades Gilead Sciences: 'We Find It Difficult To See The Stock's Multiple Expanding' ||| UPDATE: Goldman Downgrades Gilead To Sell, Lowers Target To $60 As Firm Notes 'Nearer-term we expect the company's top line growth to decelerate' ||| 10 Biggest Price Target Changes For Tuesday ||| Gilead Sciences shares are trading lower after Goldman Sachs downgraded the stock from Neutral to Sell and lowered the price target from $70 to $60. ||| Benzinga's Top Upgrades, Downgrades For May 28, 2019 ||| A Peek Into The Markets: US Stock Futures Edge Lower Ahead Of Economic Data ||| Goldman Sachs Downgrades Gilead Sciences to Sell, Lowers Price Target to $60 Price Target ||| Using Market Sentiment To Grab A Yield-Hunting Edge ||| Gilead Gains 6.8% YTD as HIV Franchise Maintains Momentum ||| Teva launches generic Ranexa in U.S. ||| Goldman bearish on Gilead, sees 10% downside risk; shares slip 2% premarket",0,0.49188864
2019-05-29,7193700.0,63.61000061035156,63.72999954223633,62.84000015258789,63.369998931884766,60.50614547729492,GILD,"Gilead, Galapagos Highlights Will Present Latest Data From Filgotinib At EULAR 2019 ||| GILD or ILMN: Which Is the Better Value Stock Right Now? ||| New commercial chief at Gilead",0,0.5083147
2019-05-30,4311900.0,63.459999084472656,63.63999938964844,62.810001373291016,63.34000015258789,60.477500915527344,GILD,Recent Stock Purchase May 2019 ||| Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know,0,0.47545052
2019-05-31,4871900.0,62.77000045776367,63.060001373291016,62.16999816894531,62.25,59.43675994873047,GILD,Kite And Humanigen Collaborate To Conduct Clinical Study On Relapsed/DLBCL ||| Gilead's Kite Reports Clinical Collaboration With Humanigen To Evaluate Investigational Combination of Yescarta® with Lenzilumab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma ||| Gilead: The Next Shoe To Drop ||| Kite and Humanigen Announce Clinical Collaboration to Evaluate Investigational Combination of ... ||| Gilead teams up with Humanigen in study of combo therapy for DLBCL,1,0.5224796
2019-06-03,9150900.0,62.5,64.44000244140625,62.18000030517578,63.630001068115234,60.75439834594727,GILD,"Biocartis, Kite Sign Agreement for Development of Assays Supporting Kite's Therapies; Financial Terms Not Disclosed ||| Why Is Gilead (GILD) Down 3% Since Last Earnings Report? ||| Stocks That Fell to '-Year Lows in the Week of May '– ||| Gilead Sciences shares are trading higher after Kite, a Gilead company, announced positive data from the ZUMA-1 trial of Yescarta. ||| Gilead's Kite Highlights New Yescarta Data From ZUMA-1, Showed 'High Rates of Durable Response and Overall Survival Regardless of Age at Two Years Post-Treatment' ||| Dividend Portfolio Review: New Dividend Record For May ||| Gilead Presents Data on CAR T Cell Therapy Candidate at ASCO ||| Gilead's CAR T KTE-X19 shows positive action in early-stage ALL study",1,0.51186556
2019-06-04,5647800.0,63.970001220703125,64.72000122070312,63.65999984741211,64.31999969482422,61.41321563720703,GILD,3 Cancer Stocks Given a Lift by Amgen ||| Shares of several healthcare companies are trading higher with the overall US market. Recent comments out of China and Mexico has renewed trade optimism and lifted economic outlook. ||| 5 Biotech Stocks to Buy Right Now,1,0.5239527
2019-06-05,5226500.0,64.80000305175781,64.83999633789062,63.59999847412109,64.44000244140625,61.52779006958008,GILD,"Vanguard Total World Stock ETF Experiences Big Outflow ||| Gilead Sciences, Inc. (GILD) CEO Daniel O'Day presents at Jefferies 2019 Global Healthcare Brokers Conference (Transcript) ||| 5%+ Dividend Yield Portfolio: Coping With Existential Dread (May 2019 Review) ||| The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Gilead Sciences, Repligen, Illumina and Bio-Techne ||| Total USD Portfolio Monthly Review - May 2019",0,0.4738546
2019-06-06,4982500.0,64.44999694824219,64.80000305175781,63.56999969482422,63.72999954223633,60.849876403808594,GILD,How The Pieces Add Up: RNDV Targets $25 ||| ContraVir Rallies As NASH Drug Shows Efficacy In Preclinical Study ||| Biotech Stocks Tumble As FDA Doubts Method Of Testing Drugs ||| 5 Stocks Boosting Book Value,1,0.5106864
2019-06-07,6255100.0,64.13999938964844,65.62999725341797,63.470001220703125,65.3499984741211,62.39666366577149,GILD,"Many US-traded stocks are trading higher as recent economic signals have raised the potential for a Federal Reserve rate cut. ||| Agenus Is A Buy Long Term, Despite Short Interest ||| Key events next week - healthcare",1,0.4827165
2019-06-10,5942700.0,65.4000015258789,66.2699966430664,65.27999877929688,66.12000274658203,63.13187026977539,GILD,"The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts ||| Is Gilead Sciences Worth the Wait? ||| How To Find Undervalued Stocks In The Healthcare Sector ||| How To Find Undervalued Stocks In The Healthcare Sector ||| Dividend Challenger Highlights: Week Of June 9",0,0.51478046
2019-06-11,5144600.0,66.12999725341797,66.83000183105469,65.94999694824219,66.0999984741211,63.11276626586914,GILD,"Is the Newest Gene Editing Stock a Buy? ||| Why Low-Float, Thinly Traded ContraVir Pharma's Rally Is Continuing ||| Gilead Hopes To Continue Sales Expansion Of Yescarta - Results From KTE-X19 Step In The Right Direction",1,0.50947374
2019-06-12,6406800.0,66.37999725341797,67.45999908447266,66.20999908447266,66.77999877929688,63.76203918457031,GILD,"Notable Wednesday Option Activity: EXAS, GILD, PSTG ||| WHO Emergency Committee Meeting To Decide If Ebola Outbreak Constitutes An Int'l. Emergency Will Begin Jun. 14, 2019 ||| Gilead Sciences Option Alert: Jun 28 $66 Calls Sweep (3) near the Ask: 500 @ $1.301 vs 838 OI; Earnings 7/24 After Close [est] Ref=$66.67 ||| The Daily Biotech Pulse: Nuvectra Files For Expanded Label For Algovita SCS, Axovant Earnings, FDA Nod For Aratana ||| BIIB Is For Buy-O-Gen ||| June 2019 Stock Considerations",1,0.49347553
2019-06-13,4452900.0,66.30999755859375,67.25,66.30000305175781,66.98999786376953,64.57171630859375,GILD,"Abcellera Reports Therapeutic Antibody Discovery Collaboration With Gilead, Will Receive Upfront, Research Payments ||| 5 Companies Raising Earnings ||| Akero Therapeutics Readies $75 Million IPO",0,0.52060926
2019-06-14,5333800.0,66.91000366210938,66.9800033569336,66.19999694824219,66.36000061035156,63.96445846557617,GILD,GILD vs. ILMN: Which Stock Is the Better Value Option?,1,0.49289778
2019-06-17,5287300.0,66.47000122070312,67.44999694824219,66.06999969482422,67.0999984741211,64.67774200439453,GILD,"Better Buy: Aurora Cannabis vs. Gilead Sciences ||| 5 Top Stock Trades for Tuesday: FB, NFLX, GILD, TSLA ||| Notable ETF Outflow Detected - IBB, GILD, BIIB, VRTX ||| 5 Undervalued Stocks Growing Earnings ||| AstraZeneca Gives Detailed Data From Calquence Leukemia Study",1,0.48669377
2019-06-18,7385700.0,67.6500015258789,68.9000015258789,67.37999725341797,68.19999694824219,65.73802947998047,GILD,"GILD Crosses Above Key Moving Average Level ||| 3 Big Stock Charts for Tuesday: McKesson, Dish Network and Gilead Sciences ||| 3 Big Drugmakers Most Likely to Make Acquisitions After Pfizer's Surprise Deal ||| Uganda clears three experimental Ebola treatments",1,0.5274363
2019-06-19,4643100.0,68.02999877929688,68.4000015258789,67.6500015258789,68.26000213623047,65.7958755493164,GILD,"3 Large-Cap Biotech Stocks to Buy for Massive Gains ||| Gilead Reports Strategic Collaboration With Nurix To Develop Novel Therapies For Cancer, Other Diseases ||| Marker Therapeutics: A Cell Therapy Biotech Thinking Outside Of The Box ||| Gilead and Nurix Establish Strategic Collaboration to Develop Novel Therapies for Cancer and ... ||| The Retiree's Dividend Portfolio - Jane's May Update: Women And The Challenge Of Retirement",1,0.5381004
2019-06-20,4968300.0,68.79000091552734,69.31999969482422,67.70999908447266,68.56999969482422,66.09468078613281,GILD,Gilead (GILD) Teams Up With Nurix for Cancer and Other Drugs,1,0.53120387
2019-06-21,8718500.0,68.52999877929688,69.47000122070312,68.2699966430664,69.37999725341797,66.87543487548828,GILD,"Gilead Sciences (GILD) Gains As Market Dips: What You Should Know ||| Intercept: Amid The FDA Draft Guidance, OCA Will Be Approved ||| Arbutus Gets Clearance to Initiate Hepatitis Study, Stock Up",0,0.5139039
2019-06-24,4013700.0,69.12999725341797,69.4800033569336,68.69999694824219,68.83999633789062,66.35493469238281,GILD,"Dividend Challenger Highlights: Week Of June 23 ||| Gilead, Carna Biosciences Announce Research and Development Collaboration to Develop Novel Immuno-Oncology Therapies ||| Gilead And Cilofexor In Phase 3 Primary Sclerosing Cholangitis: Making Progress",0,0.49808785
2019-06-25,6293200.0,68.75,69.9800033569336,68.12999725341797,68.4800033569336,66.00792694091797,GILD,"iShares Nasdaq Biotechnology ETF Experiences Big Outflow ||| The 10 Biggest Biotech Stocks ||| The Daily Biotech Pulse: Genfit NASH Drug In China, Conatus Explores Sale, Gilead Stitches Up Immuno-Oncology Partnership ||| Gilead's Latest Bolt-On Buys Point To A New Way Of Approaching Drug Development ||| Ziopharm: Awakening The Sleeping Beauty CAR-T ||| Pharma players in green on AbbVie/Allergan deal ||| Gilead inks deal with Carna Bio for immuno-oncology therapies",0,0.4863279
2019-06-26,9479000.0,68.5,68.54000091552734,66.58000183105469,66.68000030517578,64.27291107177734,GILD,"5 Game Changing M&A Deals of the Last Decade ||| Healthcare stocks under pressure ahead of Dem debate ||| Biotech Stock Roundup: Vertex, AMAG Drugs Get FDA Nod, Conatus Study Fails & More ||| 'Play Money' High Yield Portfolio Revisited ||| Gilead Inks Deal With Carna Biosciences for Immuno-Oncology",1,0.53651786
2019-06-27,5996900.0,66.63999938964844,67.38999938964844,66.26000213623047,67.08000183105469,64.65847778320312,GILD,"First Week of February 2020 Options Trading For Gilead Sciences (GILD) ||| 5 Reasons Why You Should Be Interested In Gilead Sciences ||| Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know ||| Zacks Market Edge Highlights: Facebook, Gilead, Disney, Grubhub and Microsoft",1,0.48909494
2019-06-28,19742500.0,67.1500015258789,68.0199966430664,66.86000061035156,67.55999755859375,65.12113952636719,GILD,Has Gilead Sciences (GILD) Outpaced Other Medical Stocks This Year? ||| Alexion Receives FDA Approval for Label Expansion of Soliris,1,0.5227153
2019-07-01,6014500.0,68.0,68.86000061035156,67.27999877929688,67.83000183105469,65.38139343261719,GILD,"The Week Ahead In Biotech: Pending Clinical Readouts In Focus ||| AbbVie And Gilead - 2 Different Strategies To Improve Growth ||| After Hours: Sarin Scare at Facebook, Gilead to Make Arthritis Drug Submission Soon ||| Gilead Announces Intent to Submit NDA to FDA for Filgotinib This Year ||| Regeneron/Sanofi's Dupixent Gets Positive CHMP Recommendation",1,0.521779
2019-07-02,6010200.0,68.63999938964844,68.94000244140625,67.95999908447266,68.83999633789062,66.35493469238281,GILD,"The Daily Biotech Pulse: Celyad To Advance Leukemia Drug To Clinical Trial, Positive Data For Teva's Migraine Drug ||| U.S. drugmakers institute new round of increases ||| Gilead to Submit NDA for Inflammation Drug Filgotinib in '19 ||| Stock Futures Trim Losses; Goldman Sachs Weighs On Dow Jones ||| Regeneron/Sanofi's Libtayo Gets EU Approval for Skin Cancer ||| Gilead intends to submit filgotinib NDA for rheumatoid arthritis",1,0.5212532
2019-07-03,2906000.0,69.06999969482422,69.06999969482422,68.31999969482422,69.0,66.50916290283203,GILD,"VTI, C, GE, GILD: ETF Inflow Alert ||| Gilead Sciences (GILD) Gains But Lags Market: What You Should Know ||| Why These 4 Biotech Leaders Could Rebound On Strong Earnings ||| Silverleafe Capital Partners, LLC Buys Anthem Inc, SPDR S&P Health Care Equipment, The Walt ...",0,0.4887608
2019-07-05,4118300.0,68.55999755859375,69.3499984741211,68.3499984741211,68.52999877929688,66.05611419677734,GILD,Gilead Sciences Option Alert: Jul 26 $71.5 Calls Sweep (28) near the Ask: 596 @ $0.339 vs 1144 OI; Earnings 7/24 After Close [est] Ref=$68.65,0,0.47126278
2019-07-08,7191900.0,68.2699966430664,68.47000122070312,66.36000061035156,67.4800033569336,65.04402160644531,GILD,"Dividend Income Update: June 2019 ||| We Did The Math OVLU Can Go To $30 ||| Are Natural Killer Cells the Next Big Thing in Immunotherapy? ||| Shares of several healthcare companies are trading lower after Trump on Friday said he was preparing an executive order declaring a 'favored nations clause' for drug prices, lowering the price that consumers will pay prescription drugs. ||| Biotechs and biopharmas under pressure ahead of Trump order on drug prices ||| Gilead And The Status Of My Model Portfolio ||| 5%+ Dividend Yield Portfolio: Slowly Achieving The Dream (June 2019 Review)",1,0.49858868
2019-07-09,5201400.0,67.18000030517578,68.18000030517578,66.75,67.75,65.30427551269531,GILD,"Gilead, Lyndra Therapeutics Partner On Ultra-Long-Acting HIV Drugs ||| Lyndra Therapeutics, Gilead Sciences to Collaborate on Development of Ultra-Long-Acting HIV Therapeutics ||| Rowland & Co Investment Counsel Buys Alphabet Inc, The Walt Disney Co, Gilead Sciences Inc, ... ||| Mirati Therapeutics Still Has Room To Grow ||| Drug makers perk up on block of price disclosures in TV ads ||| Glaxo's Long-Acting HIV Regimen Gets FDA's Priority Status ||| My Road To Financial Independence: 103-Stocks Portfolio June Review",0,0.5071429
2019-07-10,4072300.0,68.0,68.52999877929688,66.9000015258789,67.45999908447266,65.02474975585938,GILD,"Court Ruling Topples Trump Order, No Price Display in TV Ads ||| Will Patent Woes Boost Pharma Stock Megamergers Further?",0,0.5011627
2019-07-11,5833100.0,67.01000213623047,67.38999938964844,65.54000091552734,66.19000244140625,63.80059814453125,GILD,"IBB, GILD, CELG, ILMN: Large Outflows Detected at ETF ||| Shares of several drug manufacturing companies are trading lower. The Trump Administration earlier rolled back a proposal to eliminate rebates from government drug plans and commented on continued efforts to lower drug prices. ||| Gilead Reports Strategic Collaboration With Renown Institute For Health Innovation For Collection, Analyzing Of Genetic, Electronic Health Data ||| Trump Drops Drug Rebate Proposal: What's Next and What Stocks to Play ||| Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know ||| Gilead picks site for western China operations",1,0.5291869
2019-07-12,4740700.0,66.16999816894531,66.68000030517578,65.88999938964844,66.26000213623047,63.868072509765625,GILD,New CEO at Kite,1,0.5166292
2019-07-15,7495100.0,66.9800033569336,68.25,66.83999633789062,68.06999969482422,65.61273193359375,GILD,"Week In Review: SinoMab To IPO On Hong Kong Exchange ||| Gilead, Galapagos Announce 10-year Global R&D Collaboration ||| Gilead to boost Galapagos stake in $5.1B deal ||| GILD Crosses Above Key Moving Average Level ||| What Happened in the Stock Market Today ||| Nasdaq Today: Bitcoin & Libra; What’s Broadcom Doing? ||| Health Care Sector Update for 07/15/2019: CAPR,GLPG,GILD,OMCL,TEVA ||| Galapagos Deal: GLPG Stock Rockets Higher on Gilead Stake ||| Nasdaq 100 Movers: SYMC, GILD ||| Health Care Sector Update for 07/15/2019: CAPR, GLPG, GILD, NTGN, JNJ, PFE, ABT, MRK, AMGN ||| Why Galapagos NV Stock Is Soaring Today ||| Health Care Sector Update for 07/15/2019: GLPG,GILD,OMCL,TEVA ||| Mid-Afternoon Market Update: Carolina Trust BancShares Rises On Acquisition News; Callon Petroleum Shares Tumble ||| Mid-Day Market Update: Crude Oil Down 1%; Galapagos Shares Spike Higher ||| 42 Stocks Moving In Monday's Mid-Day Session ||| Mid-Morning Market Update: Markets Edge Lower; Citigroup Beats Q2 Estimates ||| Galapagos Notches $3.95B Upfront Investment From Gilead ||| Gilead Sciences shares are trading higher after Wells Fargo upgraded the stock from Market Perform to Outperform and raised the price target from $68 to $88. ||| 10 Biggest Price Target Changes For Monday ||| Benzinga's Top Upgrades, Downgrades For July 15, 2019 ||| Wells Fargo Upgrades Gilead Sciences to Outperform, Raises Price Target to $88 ||| Galapagos Shares RIse $23 Premarket Following Announcement of $1.1B Equity Investment from Gilead ||| First Hawaiian Bank Buys Vanguard Large-Cap, The Walt Disney Co, Jack Henry & Associates ... ||| Wall Street Mixed on Monday ||| Gilead Buys More Galapagos, Callon Acquires Carrizo; Confirming XBI And XOP ETF Strategies ||| High-Quality Dividend Growth Stocks With Higher Yields ||| Stock Futures Rise; Boeing Hampers Dow Jones, Citigroup Earnings Beat ||| Gilead-Galapagos Ink $5.1B Deal for Additional Compounds ||| Wells sees 33% upside in Gilead in premarket analyst action ||| Revenues From New Drugs - And Thoughts On Chance ||| Wall Street Breakfast: China GDP, Earnings Season, Prime Day",0,0.54162294
2019-07-16,5573200.0,68.06999969482422,68.19999694824219,66.51000213623047,66.94000244140625,64.52351379394531,GILD,"3 Soaring Biotech Stocks With More Fuel in the Tank ||| Gilead To Report Q2 Earnings On Tue., Jul. 30, 2019 After Market Close ||| 52 Biggest Movers From Yesterday ||| NGM Biopharmaceuticals And NGM282 In Primary Biliary Cirrhosis: A Rapid Clinical Benefit ||| Behind Gilead's Big Move On Galapagos ||| Recent Progress With Filgotinib Plus Latest Partnership Expansion Points To Gilead's New Solid Path ||| Company News for Jul 16, 2019",0,0.5312313
2019-07-17,4858500.0,67.12999725341797,67.41999816894531,66.80999755859375,66.91999816894531,64.50424194335938,GILD,"The Multibillion-Dollar Race for Gene Therapy Manufacturing Is On ||| Gilead's Galapagos Deal: What It Means for Investors ||| Gilead Sciences (GILD) Stock Moves -0.03%: What You Should Know ||| Mirum Pharmaceuticals IPO: At Phase 3 Of Development ||| Galapagos: Our Predictive Tools See Upside Despite Surge ||| Biotech Stock Roundup: Galapagos & Hookipa Surge, AMGN Shelves Alzheimer's Study ||| Gilead Sciences changes senior leadership team",1,0.50670236
2019-07-18,4002500.0,66.62999725341797,67.5999984741211,66.30000305175781,67.20999908447266,64.78377532958984,GILD,3 Top Healthcare Stocks to Buy Right Now,0,0.55247885
2019-07-19,8876400.0,67.5199966430664,67.52999877929688,64.91000366210938,65.04000091552734,62.69211196899414,GILD,"Friday Sector Laggards: Utilities, Healthcare ||| Notable ETF Inflow Detected - IBB, GILD, CELG, VRTX ||| Gilead Will Buy Exclusive Global Rights To Develop, Commercialize Novel Small Molecules Against 3 Undisclosed Targets From Novartis, Novartis Will Receive Upfront Payment, Eligible For Added $291M ||| Intercept, Intercepted Before The NASH Goal Line ||| Key events next week - healthcare ||| Gilead in-licenses antiviral programs from Novartis",0,0.4998367
2019-07-22,6302600.0,65.30000305175781,65.81999969482422,64.75,64.91000366210938,62.566802978515625,GILD,8 More Big Pharma Events in 2019 You Don't Want to Miss ||| Gilead Presents New Data On Biktarvy For The Treatment Of HIV In Women And In Virologically Suppressed Patients With Known Resistance ||| STAT News Article Highlights CAR-T Therapy Innovations ||| Gilead Highlights Presentation Of Proof-Of-Concept Data For GS-6207 Capsid Inhibitor In People Living With HIV ||| DURECT Soars On Out-Licensing Deal With Gilead For Up To $170M ||| DURECT And Gilead Enter Into License Agreement For Long-Acting Injectable HIV Investigational Product; DURECT To Receive Upfront Payment Of $25M With Potential For Up To $75M In Development And Regulatory Milestones ||| Gilead announces new late-stage data on HIV med Biktarvy ||| Gilead's GS-6207 shows encouraging action in early-stage HIV study ||| What's in Store for Anika Therapeutics' (ANIK) Q2 Earnings? ||| Alexion (ALXN) to Report Q2 Earnings: What's in the Cards? ||| Durect up 39% premarket on Gilead deal,1,0.549739
2019-07-23,7854200.0,65.06999969482422,66.44000244140625,64.68000030517578,66.4000015258789,64.00301361083984,GILD,"5 Biotech Stocks to Buy for a Strong Growth Prognosis ||| Gilead Highlights Presentation Of Data In Ongoing HIV Cure Research Program ||| Gilead Reports Presented Added Results From DISCOVER Trial Of Descovy At International AIDS Society Conference on HIV Science ||| Parsec Financial Management, Inc. Buys Gilead Sciences Inc, UnitedHealth Group Inc, Broadcom ... ||| Gilead's TLR7 agonists show encouraging action in early studies ||| The Retiree's Dividend Portfolio - Jane's June Update: The Stock Market Climbs While Jane's Cost Basis Drops ||| Is a Beat in Store for Repligen (RGEN) This Earnings Season? ||| Gilead Sciences (GILD) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release ||| AMAG (AMAG) to Report Q2 Earnings: What's in the Cards? ||| Norsk Hydro: Digesting A Weak First Quarter",1,0.54271466
2019-07-24,4592400.0,66.4800033569336,66.81999969482422,65.83000183105469,66.63999938964844,64.23435974121094,GILD,"Health Care Sector Update for 07/24/2019: GILD,GHDX,EFII,EW,SGEN ||| Wolff Financial Management LLC Buys Vanguard Mid-Cap, Vanguard Tax-Exempt Bond, Vanguard ... ||| Gilead Sciences (GILD) Gains But Lags Market: What You Should Know ||| DURECT's Deal With Gilead: An Unexpected Bonus For Shareholders ||| Eli Lilly (LLY) to Report Q2 Earnings: What's in Store? ||| What's in the Cards for Zynerba (ZYNE) This Earnings Season?",0,0.48223543
2019-07-25,4061200.0,66.56999969482422,67.06999969482422,66.19999694824219,66.31999969482422,63.925907135009766,GILD,"3 'Perfect 10' Biotech Companies to Buy ||| Acorda (ACOR) to Post Q2 Earnings: What's in the Cards? ||| Discovery Value Fund Buys Tencent Music Entertainment Group, PPDAI Group Inc, Sells JinkoSolar ... ||| Intercept: Ocaliva Woes Extend Far Beyond Itching And Blackbox Warnings ||| What's in the Cards for AcelRx (ACRX) This Earnings Season?",1,0.51159877
2019-07-26,4790600.0,66.3499984741211,67.04000091552734,65.91999816894531,66.91999816894531,64.50424194335938,GILD,"BTC Capital Management, Inc. Buys Gilead Sciences Inc, PacWest Bancorp, Teledyne Technologies ... ||| What's in the Cards for Pfizer (PFE) This Earnings Season? ||| Will Strong HIV Sales Drive Gilead's (GILD) Q2 Earnings? ||| What's in the Cards for Amarin (AMRN) This Earnings Season? ||| Vertex (VRTX) to Post Q2 Earnings: What's in the Cards? ||| Can Newer Drugs Help Amgen (AMGN) Beat on Earnings in Q2? ||| Drug pricing bill passes Senate committee ||| Will Strong Jakafi Sales Drive Incyte (INCY) Q2 Earnings?",1,0.48922548
2019-07-29,5571700.0,68.08999633789062,68.4000015258789,67.30000305175781,67.87000274658203,65.4199447631836,GILD,"The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate ||| Weekly Market Preview: Six Stocks To Watch For the Coming Week (BYND, GILD, AAPL, AMD, QCOM, SQ) ||| Gilead Through The Eyes Of A Dividend Growth Investor ||| Marijuana Stock Cann('t)Trust, and What's Behind Gilead's Latest Megadeal ||| RBC On Gilead: 'A Compelling Opportunity To Build A Long-Term Position' ||| UPDATE: RBC On Gilead Also Notes 'high conviction that with new leadership and many overhangs out of the way, shares will begin to better reflect the value of future cash flows from their marketed products and pipeline, which we believe is worth $91' ||| UPDATE: RBC Upgrades Gilead To Top Pick, Announces $91 Target As Firm Notes 'We have increasingly high confidence GILD's HIV franchise will provide steady annual revenues of ~$16B/year over the medium term' ||| Benzinga's Top Upgrades, Downgrades For July 29, 2019 ||| RBC Capital Upgrades Gilead Sciences to Top Pick ||| Notable earnings after Tuesday's close ||| Zoetis (ZTS) to Report Q2 Earnings: What's in the Cards? ||| Axovant (AXGT) to Post Q1 Earnings: What's in the Cards? ||| What's in Store for Array BioPharma (ARRY) in Q4 Earnings? ||| DivGro Stocks Ranked By Quality Score ||| What's in the Cards for Sarepta (SRPT) This Earnings Season? ||| RBC sees 36% upside in Gilead in premarket analyst action",0,0.5119257
2019-07-30,6694500.0,67.80000305175781,67.83000183105469,66.66000366210938,67.08999633789062,64.6681137084961,GILD,"After Hours: Apple, Mastercard, and Gilead Sciences Report Earnings ||| Gilead Sciences Inc. Q2 adjusted earnings Beat Estimates ||| Noteworthy Tuesday Option Activity: GRMN, GILD, MCD ||| Gilead (GILD) 2nd Quarter Earnings: What to Expect ||| Gilead Sciences Q2 19 Earnings Conference Call At 4:30 PM ET ||| Gilead Ticks Higher After Q2 Earnings Beat ||| Gilead Raises FY19 Product Sales Guidance From $21.3B-$21.8B To $21.6B-$22.1B ||| Gilead Sciences Q2 Adj. EPS $1.82 Beats $1.72 Estimate, Sales $5.685B Beat $5.51B Estimate ||| The Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On Earnings ||| 15 Stocks To Watch For July 30, 2019 ||| Earnings Scheduled For July 30, 2019 ||| Gilead Sciences, Inc. (GILD) CEO Daniel O'Day on Q2 2019 Results - Earnings Call Transcript ||| Gilead Sciences (GILD) Beats Q2 Earnings and Revenue Estimates ||| Gilead Sciences, Inc. 2019 Q2 - Results - Earnings Call Slides ||| Gilead Q2 revenues flat; earnings up 3.5%; guidance raised ||| Gilead Sciences declares $0.63 dividend ||| Professional Advisory Services Inc Buys Zebra Technologies Corp, Analog Devices Inc, Sells ... ||| Trump readies plan allow drug imports from Canada ||| Gilead Earnings Preview ||| Buy 6 Top Stocks Set to Beat on Earnings in Q2 Today",0,0.4753564
2019-07-31,10366300.0,65.6500015258789,66.72000122070312,64.16000366210938,65.5199966430664,63.154781341552734,GILD,"Gilead Sciences Reports Improving Revenue in the 2nd Quarter ||| Gilead Sciences Option Alert: Aug 9 $67.5 Calls Sweep (2) near the Ask: 700 @ $0.401 vs 536 OI; Ref=$65.71 ||| Gilead Sciences shares are trading lower despite better-than-expected Q2 results and raised guidance. ||| Credit Suisse Maintains Neutral on Gilead Sciences, Lowers Price Target to $67 ||| Raymond James Maintains Strong Buy on Gilead Sciences, Raises Price Target to $86 ||| Durect's Latest Progress Between Liver Disease Drug And Partnership Launches It Forward ||| Gilead At An Inflection Point: Examining The HIV Market ||| Hookipa Gains FDA Signal To Begin HPV-Cancer Drug; Allows For Catalyst In Late 2020 ||| Biotech Stock Roundup: Celgene, Amgen, Gilead Impress in Q2, Other Pipeline Updates ||| Gilead (GILD) Q2 Earnings & Sales Beat, Sales Guidance Raised ||| Wall Street Breakfast: First Rate Cut Since The Financial Crisis",0,0.4836384
2019-08-01,8259800.0,65.66000366210938,66.77999877929688,65.08000183105469,65.47000122070312,63.106590270996094,GILD,"2 Small-Cap Stocks That Could Make You Rich ||| How To Be A Great Investor, Part 2: Understand Value",0,0.48871267
2019-08-02,6753100.0,65.19000244140625,65.45999908447266,64.25,64.94999694824219,62.6053581237793,GILD,"Cpcm, Llc Buys JPMorgan Ultra-Short Income ETF, Gilead Sciences Inc, iShares Edge MSCI Min ... ||| Key events next week - healthcare ||| Gilead Sciences: A Very Core Holding",0,0.47807506
2019-08-05,7230000.0,64.30000305175781,64.62000274658203,62.869998931884766,63.36000061035156,61.07275390625,GILD,Stocks To Watch: Trading Tariff Turbulence ||| 5%+ Dividend Yield Portfolio: Grinding Along In 2019 (July 2019 Review) ||| Trading Tariff Turbulence (Stocks To Watch Podcast) ||| Here's Why Galapagos NV Rose 34.5% in July ||| Shares of several drug/pharma/medical equipment companies trading lower given weakness in broader stock market following concerns with China trade tensions. ||| Will Cost Control Help Teva (TEVA) Beat on Q2 Earnings? ||| Ad Com Wednesday for Gilead's Descovy for prevention of HIV infection,1,0.49546424
2019-08-06,7052100.0,63.459999084472656,64.1500015258789,62.63999938964844,63.97999954223633,61.67037963867188,GILD,"GILD Crosses Above 4% Yield Territory ||| Notable ETF Outflow Detected - IBB, GILD, CELG, ILMN ||| Notable Tuesday Option Activity: GILD, EVRI, PLT ||| Gilead Sciences Option Alert: Sep 20 $65 Calls Sweep (2) near the Ask: 527 @ $1.5 vs 3258 OI; Ref=$63.23 ||| Gilead's Sciences Canada Unit Highlights Ontario Drug Benefit Program Will Provide Eligible Patients With Access To Biktarvy Tablets ||| Biotech ETFs in Focus on Impressive Q2 Earnings Results ||| How to Be a Great Investor, Part Two: Understand Value",0,0.5056522
2019-08-07,5450400.0,63.34000015258789,64.19999694824219,62.540000915527344,63.880001068115234,61.57398223876953,GILD,"Gilead Sciences Statement on FDA Advisory Committee's Recommendation on Descovy for PrEP ||| Gilead Shares Unaffected As FDA Panel Has Voted 16-2 In Favor Of co.'s Descovy For Pre-Exposure Prep Of HIV In Men, Transgender Women ||| The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout ||| FDA advisory committee backs Gilead's Descovy for PrEP ||| Cincinnati Financial Corp Buys Valero Energy Corp, TJX Inc, Snap-on Inc, Sells Polaris Inc",1,0.50719
2019-08-08,5188900.0,63.720001220703125,64.9000015258789,63.61000061035156,64.81999969482422,62.48005294799805,GILD,"DERM On Watchlist, FDA Panel Nod For GILD, So Long, CVRS And AVDR ||| Fidelity National Information Services Achieves #72 Analyst Rank, Surpassing Gilead Sciences ||| Gilead Sciences a Top 25 Dividend Giant With 3.94% Yield ||| Agenus Reports $7.5M Payment Triggered Following Acceptance Of Investigational New Drug Application Filing For AGEN2373 ||| The Daily Biotech Pulse: Glaukos To Buy Avedro, Mixed Adcom Vote For Gilead, Dynavax Offering ||| Highland Associates Inc Buys Alphabet Inc, Gilead Sciences Inc, Mastercard Inc, Sells ... ||| Highland Associates Inc Buys Alphabet Inc, Gilead Sciences Inc, Mastercard Inc, Sells ... ||| Agenus up 8% on AGEN2373 IND, milestone payment ||| Intercept (ICPT) Q2 Earnings & Sales Beat, NASH in Focus",1,0.49855438
2019-08-09,5233000.0,64.69999694824219,65.72000122070312,64.36000061035156,65.23999786376953,62.884883880615234,GILD,"Gilead Reports China National Medical Products Admin. Approved Biktarvy For Treatment Of HIV-1 Infection ||| Agenus (AGEN) Q2 Earnings Miss Estimates, Revenues Beat",0,0.5290316
2019-08-12,5703200.0,64.93000030517578,65.47000122070312,63.4900016784668,63.97999954223633,61.67037963867188,GILD,"Week In Review: Nanjing King-Friend Invests $95 Million In US Partner, Meitheal Pharma ||| 3 Embarrassingly Cheap Dividend Stocks ||| Week In Review: Nanjing King-Friend Invests $95 Million In U.S. Partner, Meitheal Pharma ||| 3 Big Stock Charts for Monday: Xilinx, News Corp and Gilead Sciences ||| The Future Of HCV Market Duopoly ||| Regeneron's REGN-EB3 shows positive effect in Ebola study ||| Gilead Chugs Along ||| Q2 Biotech Updates",1,0.495692
2019-08-13,4779600.0,63.720001220703125,64.98999786376953,63.720001220703125,64.30000305175781,61.97882843017578,GILD,"Shares of several healthcare companies are trading higher with the overall market after the U.S. announced it is excluding and delaying the additional 10% tariff on certain products. ||| Pictet Asset Management Ltd Buys Intel Corp, Southern Co, Altair Engineering Inc, Sells Hologic ... ||| Sangamo: Lead Gene Therapy Program Moving Into Phase 3 ||| Mergers & Acquisitions Take Center Stage in Biotech Industry ||| Holowesko Partners Ltd. Buys Gilead Sciences Inc, Alphabet Inc, SK Telecom Co, Sells D.R. ...",0,0.51580095
2019-08-14,6382100.0,63.68999862670898,63.79999923706055,62.91999816894531,63.119998931884766,60.8414192199707,GILD,"Road To Financial Independence: Highlights Of July 2019 ||| Biotech Stock Roundup: Amgen's Enbrel Patent Win, AMRN's Setback & More ||| Zacks Industry Outlook Highlights: Gilead Sciences, Regeneron Pharmaceuticals, Amgen, Vertex Pharmaceuticals and Alexion Pharmaceuticals",0,0.48845586
2019-08-15,4490800.0,63.27999877929688,63.810001373291016,62.84000015258789,62.869998931884766,60.60044479370117,GILD,"Gilead Reports EMA Validated Marketing Application For Filgotinib For Treatment Of RA ||| Gilead Reports Its Canada Unit Reported Quebec Public Drug Insurance Plan Will Be Provided For Eligible Patients With Access To Biktarvy Tablets ||| ANTIPODES PARTNERS Ltd Buys Sprott Physical Gold and Silver Trust, Merck Inc, FedEx Corp, Sells ... ||| DIAM Co., Ltd. Buys SPDR Gold Trust, Alibaba Group Holding, Corteva Inc, Sells DuPont de ... ||| EMA accepts Gilead's filgotinib application for rheumatoid arthritis",1,0.5139468
2019-08-16,6967500.0,63.40999984741211,63.5099983215332,62.84000015258789,63.13999938964844,60.86069869995117,GILD,"VTV, GE, MO, GILD: ETF Outflow Alert ||| FDA OKs AbbVie's Rinvoq rheumatoid arthritis; shares up 2% ||| Gilead's (GILD) Filgotinib MAA for RA Accepted in Europe",1,0.51126206
2019-08-19,6163200.0,63.68999862670898,64.41999816894531,63.68999862670898,64.11000061035156,61.79568099975586,GILD,"Stocks That Fell to '-Year Lows in the Week of Aug. –6 ||| Goodbye To Gilead As ViiV, Merck Besiege Its HIV Citadel ||| 5 Top ESG Stocks on RBC Capital's 'Best Ideas' List",0,0.47386748
2019-08-21,4493700.0,64.04000091552734,64.26000213623047,63.66999816894531,64.12999725341797,61.81495666503906,GILD,"Gilead Sciences Says ""Strongly Believe"" That The Patents Granted To Hhs Since 2015 For Prep And Pep Are Not Valid ||| Gilead Statement On Petitions To U.S. Patent And Trademark Office On Hiv Prep Patents; Will Continue To Invest In Programs To Accelerate Access To Prep ||| American Century Companies Inc Buys iShares Russell –……… Value ETF, Gilead Sciences ... ||| Elkhorn Partners Limited Partnership Buys Occidental Petroleum Corp, Gilead Sciences Inc, ... ||| Biotech Stock Roundup: CELG's Inrebic Gets FDA Nod, SRPT Suffers Setback & More",1,0.523088
2019-08-22,5084900.0,64.30999755859375,64.69999694824219,63.540000915527344,64.22000122070312,61.90171432495117,GILD,"Novo Nordisk: A Secular Growth Engine ||| Novo Nordisk's Fiasp Gets EC Approval for Label Expansion ||| Top Research Reports for Union Pacific, Lowe's & Gilead ||| The Zacks Analyst Blog Highlights: Celgene, Gilead, Vertex, Sarepta and Regeneron",0,0.5051954
2019-08-23,7488300.0,64.06999969482422,64.66999816894531,62.18999862670898,62.5099983215332,60.25343704223633,GILD,"Gilead And Galapagos Complete Closing Of Transformative Research And Development Collaboration ||| Gilead and Galapagos consummate R&D partnership ||| Keudell Buys The Kraft Heinz Co, Enbridge Inc, iShares Core MSCI EAFE ETF, Sells L' ... ||| The Zacks Analyst Blog Highlights: Union Pacific, Lowe's, Gilead, Target and Emerson",1,0.51202554
2019-08-26,4053200.0,63.29999923706055,63.33000183105469,62.33000183105469,63.0,60.72575378417969,GILD,"3 Big Stock Charts for Monday: Intuit, Gilead Sciences and Nike ||| Alberta Provides Access To Biktarvy For The Treatment Of HIV ||| Galapagos NV Osteoarthritis Drug Candidate Has Vast Potential Value ||| Gilead & Galapagos Close Research & Development Agreement",1,0.5206611
2019-08-28,5441100.0,63.040000915527344,64.19000244140625,62.72999954223633,63.63999938964844,61.34264373779297,GILD,"Noteworthy ETF Outflows: IBB, GILD, CELG, VRTX ||| Tracking Earnings Estimates/Revisions For 30 Nasdaq Stocks ||| FDA warns on rare liver injury with leading HCV meds",1,0.5090614
2019-08-29,4758500.0,64.2699966430664,64.41999816894531,63.290000915527344,63.75,61.44867706298828,GILD,Why Is Gilead (GILD) Down 2.9% Since Last Earnings Report?,0,0.49027047
2019-08-30,5301200.0,63.9900016784668,64.01000213623047,62.84999847412109,63.540000915527344,61.24625778198242,GILD,Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know,0,0.48349074
2019-09-03,4909200.0,63.150001525878906,63.34000015258789,62.27000045776367,62.970001220703125,60.69683837890625,GILD,3 High-Yield Dividend Stocks to Buy on Sale ||| Better Buy: Gilead Sciences vs. Biogen ||| 10 Good Companies To Own For The Next 10 Years (Or Longer) ||| Gilead Sciences Deal With Galapagos NV Should Be A Winner ||| The Retiree's Dividend Portfolio - Jane's July Update: What Does Volatility Look Like In Your Portfolio?,1,0.5400491
2019-09-04,5898200.0,63.36000061035156,63.66999816894531,62.38999938964844,63.27000045776367,60.98600769042969,GILD,'Serving on a Board Made Me a Better CFO' ||| Genomic Medicine: Fall 2019 Tracking Update,1,0.51637954
2019-09-05,6011100.0,63.43999862670898,64.5,63.33000183105469,64.05999755859375,61.74748611450195,GILD,Avalon: Poised For Market Conquest,1,0.5237484
2019-09-09,8701000.0,64.6500015258789,66.56999969482422,64.62999725341797,66.33000183105469,63.935543060302734,GILD,"88 Firms Going Ex-Dividend Next Week, Including Coca-Cola, Merck And Public Storage ||| Dividend Challenger Highlights: Week Of September 8 ||| Stocks To Watch: Apple, IPOs And German Auto ||| 5%+ Dividend Yield Portfolio: Defensively Doubling My Cash Cushion (Aug 2019 Review) ||| Apple, IPOs And German Auto (Stocks To Watch Podcast) ||| Gilead Sciences Breaks Above 200-Day Moving Average - Bullish for GILD ||| IVE, COST, MDLZ, GILD: ETF Outflow Alert ||| Gilead Sciences and Elton John AIDS Foundation to Partner to Positively Impact People Affected with HIV ||| Biotech (Top 30 Weights) 2019 Earnings Estimates Up 8.58% In Last 2 Months ||| 100-Stock Dividend Portfolio Update For August 2019 ||| Durect earns $10M milestone from Gilead under SABER license deal ||| Bellicum: Moving Toward MAA Submission For Rivo-Cel",1,0.51435393
2019-09-10,7419700.0,66.08000183105469,67.18000030517578,65.7699966430664,67.08000183105469,64.65847778320312,GILD,"Ex-Dividend Reminder: Gilead Sciences, Conmed and Crown Castle International ||| Gilead Sciences, Inc. (GILD) CEO Daniel O'Day presents at Morgan Stanley Global Healthcare Conference (Transcript)",1,0.48709795
2019-09-11,8853300.0,66.98999786376953,68.16000366210938,66.98999786376953,68.08000183105469,65.62236785888672,GILD,"Notable Wednesday Option Activity: AXDX, GILD, MDB ||| 4 Key Questions for Gilead Sciences' New CEO ||| Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know",0,0.46481577
2019-09-12,6495500.0,67.5,67.54000091552734,66.26000213623047,66.36000061035156,64.56190490722656,GILD,Interesting GILD Put And Call Options For November 1st ||| Vir Biotechnology Files U.S. IPO Plan ||| 5 Companies Growing Earnings,1,0.5060773
2019-09-16,4644100.0,66.29000091552734,66.43000030517578,65.66000366210938,65.87999725341797,64.09490203857422,GILD,Better Buy: Celgene vs. Gilead Sciences ||| Is iShares Nasdaq Biotechnology Index Fund a Buy? ||| Retirement: Future-Proof Portfolio For Young Investors Is Even More Relevant With Negative Interest Rates,1,0.49753624
2019-09-17,4819800.0,65.9000015258789,66.23999786376953,65.27999877929688,66.16999816894531,64.37704467773438,GILD,"PBE, GILD, ALXN, INCY: Large Outflows Detected at ETF ||| The Retiree's Dividend Portfolio - Jane's August Update: Price Targets ||| S&P 500 Top Return Dividend Dogs Save September",0,0.49770695
2019-09-18,4295400.0,66.01000213623047,66.1500015258789,65.11000061035156,65.72000122070312,63.939247131347656,GILD,An Investor's Guide to Disrupting Drugmakers ||| 5 Predictable Guru Stocks ||| Healthcare And Biotechnology Dashboard - Update,1,0.5273254
2019-09-20,9700400.0,65.88999938964844,67.0199966430664,65.88999938964844,66.41999816894531,64.62026977539062,GILD,"3 Biotechs With the Biggest Cash Stockpiles ||| Shares of several drug companies are trading higher after Senate Majority Leader McConnell suggested a new Democratic drug price reform proposal would be dead on arrival. ||| Gilead, AbbVie Are Innovative, but May Be Underappreciated ||| Drug makers up after McConnell thumbs down on Pelosi price pricing plan",0,0.51856613
2019-09-23,5259100.0,66.25,66.33000183105469,64.87999725341797,65.7300033569336,63.94897079467773,GILD,Dividend Challenger Highlights: Week Of September 22 ||| Better Buy: Vertex Pharmaceuticals vs. Galapagos ||| Meet the Revolutionary New Diabetes Drug You've Probably Never Heard Of ||| Novo Nordisk's Semaglutide in Tablet Form Gets FDA Approval ||| Merck's Two HIV Drugs Get FDA Approval for Expanded Use,0,0.52177787
2019-09-24,5823400.0,65.98999786376953,66.02999877929688,64.23999786376953,64.55999755859375,62.81067657470703,GILD,"3 Big Stock Charts for Tuesday: Baker Hughes, Gilead Sciences and Jefferies Financial Group ||| Retirement: Buying More Stocks For The Future-Proof Portfolio For Young Investors",0,0.52123266
2019-09-25,4914500.0,64.5,64.83999633789062,64.0199966430664,64.19999694824219,62.46043014526367,GILD,"OEF, GILD, AXP, MS: ETF Outflow Alert ||| OEF, GILD, AXP, MS: ETF Outflow Alert ||| GlaxoSmithKline Makes A Bold Statement With Latest HIV Data",0,0.5036224
2019-09-26,6398400.0,64.41999816894531,64.41999816894531,63.09000015258789,63.29999923706055,61.58481597900391,GILD,"Notable Thursday Option Activity: CALM, GILD, EPAY ||| 'Fast Money Halftime Report' Picks For September 26 ||| Enanta's Stock Down Despite NASH Drug Meeting Goal in Study",0,0.5032881
2019-09-27,7410900.0,63.56999969482422,63.91999816894531,62.56999969482422,62.900001525878906,61.19565582275391,GILD,Is GlaxoSmithKline a Buy? ||| AbbVie (ABBV) Gets FDA Nod for Label Expansion of HCV Drug,1,0.5198471
2019-09-30,8291400.0,63.0,63.810001373291016,62.86000061035156,63.380001068115234,61.66265106201172,GILD,"Better Buy: Gilead Sciences vs. Pfizer ||| The Week Ahead In Biotech (Sept. 29-Oct. 5): Conference Presentations, IPOs Hit Top Gear ||| Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates",0,0.48557478
2019-10-01,4899200.0,63.59999847412109,64.33000183105469,62.959999084472656,63.220001220703125,61.50698852539063,GILD,IPO Update: Vir Biotechnology Proposes IPO Terms,0,0.51581675
2019-10-02,6409700.0,62.93999862670898,62.93999862670898,61.52000045776367,61.619998931884766,59.95033645629883,GILD,Forget Vertex Pharmaceuticals; CRISPR Therapeutics Is a Better Biotech Growth Stock ||| Shares of several healthcare companies are trading lower in sympathy with the overall market on continued fears of a recession amid a weak ADP jobs report. There is also uncertainty in the market over the upcoming U.S.-China meeting next week.,1,0.52582484
2019-10-03,6325200.0,61.7400016784668,62.34000015258789,60.88999938964844,62.22999954223633,60.54380798339844,GILD,Gilead Receives FDA Approval For Descovy In HIV Pre-Exposure Prophylaxis ||| Gilead's Descovy gains PrEP indication,1,0.5382837
2019-10-04,5138700.0,62.45000076293945,62.720001220703125,61.91999816894531,62.560001373291016,60.8648681640625,GILD,"FDA Approves Descovy, Second Drug To Prevent HIV Infection ||| Gilead Highlights New Data From HIV Clinical Development Program At IDWeek ||| Keytruda on path to become world's no. 1 selling drug, research firm says ||| 5%+ Dividend Yield Portfolio: Defensive Positioning Paying Off (Sep 2019 Review) ||| Gilead's Descovy HIV Regimen Gets FDA Nod for Label Expansion ||| Q3 2019 Dividend Portfolio Update: New September Dividend Record ||| Gilead reports new data from Discover trial",1,0.53001773
2019-10-07,5980700.0,62.54999923706055,63.58000183105469,62.27999877929688,62.72999954223633,61.03025817871094,GILD,"Dogs Of The S&P 500 Light Up October ||| Noteworthy ETF Outflows: IBB, CELG, GILD, ILMN ||| Galapagos: A Rare De-Risked Biotech Opportunity ||| Gilead's Yescarta gets thumbs up in Scotland ||| Novo Nordisk Focuses on Pipeline Development Amid Competition",0,0.499803
2019-10-08,4559800.0,62.33000183105469,62.4900016784668,61.369998931884766,61.68999862670898,60.018436431884766,GILD,"Gilead Announces NDA Submission For Filgotinib In Japan - Quick Facts ||| Shares of several healthcare companies are trading lower with the broader market after the US expanded its trade blacklist to include China's top AI firms. The US also will increase its tariffs on $250 billion worth of goods from 25% to 30% on Oct 15. ||| The Daily Biotech Pulse: D-Day For Clinuvel, Qiagen Warns Of Q3 Shortfall, Prevail Announces Gene Therapy Collaboration ||| Gilead Submits NDA for Filgotinib for the Treatment of Adults With Rheumatoid Arthritis in Japan ||| Sustainable Green Finance May Be The Next Big Thing ||| Gilead Sciences submits NDA for filgotinib in Japan ||| Gilead Sciences submits NDA for filgotinib in Japan",1,0.55975884
2019-10-09,3516200.0,62.290000915527344,62.43000030517578,61.7599983215332,61.97999954223633,60.30058288574219,GILD,"3 Companies To Watch For At November’s Society for Immunotherapy of Cancer Meeting ||| Jim Cramer Shares His Thoughts On Roku, Gilead And More ||| Biotech Stock Roundup: GILD's Descovy Label Expansion Gets FDA Nod & Other Updates ||| Gilead (GILD) Files NDA for RA Candidate Filgotinib in Japan",1,0.54526925
2019-10-10,5718400.0,62.119998931884766,63.40999984741211,62.0,63.2599983215332,61.5458984375,GILD,"Notable Thursday Option Activity: ABBV, GILD, SWKS ||| 3 Big Pharma Companies Driving Price Inflation ||| Gilead, Galapagos Report Efficacy, Safety Results Of Filgotinib Through 52 Weeks In FINCH 1, 3 Studies In RA ||| Gilead To Report Q3 Earnings On Thurs., Oct. 24, 2019 After Market Close ||| Gilead Sciences Option Alert: Fri $62.5 Calls Sweep (91) near the Ask: 983 @ $0.391 vs 359 OI; Earnings 10/24 After Close Ref=$62.4786 ||| Enrollment underway in mid-stage study of Jazz Pharma's defibrotide ||| Monthly Review Of DivGro: September 2019",1,0.50855905
2019-10-11,5598100.0,63.95000076293945,64.48999786376953,63.66999816894531,63.9900016784668,62.25612258911133,GILD,"Health Care Sector Update for 10/11/2019: ACRS, GERN, GILD, GLPG, JNJ, PFE, ABT, MRK, AMGN ||| Shares of several healthcare companies are trading higher after President Trump made positive remarks on the U.S.-China trade talks as traders grew more optimistic over the possibility of a limited trade deal. Trump is scheduled to meet with Chinese Vice Premier Liu He at the White House today. ||| The Daily Biotech Pulse: Therapix Extends Merger Deadline, Five Prime Restructures, Gilead-Galapagos Rheumatism Drug Readout ||| Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know ||| Jazz Starts CAR T-cell Linked Neurotoxicity Study Enrollment ||| Why Gilead (GILD) Could Beat Earnings Estimates Again ||| Town & Country Bank & Trust CO dba First Bankers T Buys United Parcel Service Inc, ... ||| Gilead-Galapagos Report Efficacy & Safety Results on RA Drug ||| Gilead and Galapagos' filgotinib shows durable effect in late-stage RA studies",1,0.525758
2019-10-14,4354500.0,63.83000183105469,65.0199966430664,63.83000183105469,64.51000213623047,62.76203155517578,GILD,Better Buy: Gilead Sciences vs. Johnson & Johnson ||| 3 Top Healthcare Dividend Stocks That Are Great Picks for Retirees ||| 89bio Files Initial Registration Statement For U.S. IPO ||| Interview: Ariel Investments' Rupal Bhansali Taking GuruFocus Reader Questions ||| Ariel Investments' Rupal Bhansali Taking GuruFocus Reader Questions ||| Healthcare And Biotechnology Dashboard - Update ||| Bernstein sees 19% upside in Amgen in premarket analyst action,1,0.50604814
2019-10-15,5675700.0,64.83000183105469,65.73999786376953,64.61000061035156,65.30000305175781,63.53062438964844,GILD,"TQQQ, COST, CHTR, GILD: ETF Outflow Alert ||| Gilead Sciences Names Andrew Dickinson CFO - Quick Facts ||| Gilead Sciences Appoints Andrew Dickinson As CEO Effective November 1, 2019 ||| Summit X, LLC Buys Gilead Sciences Inc, iShares Edge MSCI Min Volatility USA ETF, Nuveen Global ... ||| Pelosi drug bill would save $345B - CBO ||| YHB Investment Advisors, Inc. Buys Pfizer Inc, General Electric Co, Chipotle Mexican Grill Inc, ... ||| New finance chief at Gilead",1,0.49789712
2019-10-16,4854900.0,65.05999755859375,65.87999725341797,65.0,65.3499984741211,63.57926177978516,GILD,"BofA Merrill Lynch sees 25% upside in Vertex in after-hours analyst action ||| Osborn Rohs Williams & Donohoe Ltd Buys Comcast Corp, CURO Group Holdings Corp, Ameriprise ... ||| Mission Wealth Management, Llc Buys iShares Core U.S. ... ||| Hamlin Capital Management, LLC Buys Gilead Sciences Inc, NetApp Inc, Royal Dutch Shell PLC, ... ||| Biogen (BIIB) to Report Q3 Earnings: What's in the Cards?",0,0.4908209
2019-10-17,4682600.0,65.30000305175781,65.69000244140625,64.77999877929688,65.2300033569336,63.462528228759766,GILD,"Bank of America Reinstates Neutral on Gilead Sciences, Announces $70 Price Target ||| Cambiar Investors Llc Buys Skyworks Solutions Inc, Corteva Inc, Gilead Sciences Inc, Sells ... ||| Pelosi drug bill passes first House committee ||| Can New Drugs Help Lilly (LLY) to Deliver Solid Q3 Earnings?",0,0.4951873
2019-10-18,8805600.0,65.4000015258789,65.44999694824219,64.19999694824219,64.91000366210938,63.15119171142578,GILD,"Stephens Inc Buys iShares –-' Year Credit Bond ETF, SPDR Barclays Short Term Corporate ... ||| Bailard, Inc. Buys iShares iBoxx $ Investment Grade Corporate Bond ET, iShares —…+ Year ... ||| Will Soliris Aid Growth for Alexion (ALXN) in Q3 Earnings? ||| New Gilead CFO: Let's Make A Deal ||| Factors Setting the Tone for Novartis' (NVS) Q3 Earnings ||| The Retiree's Dividend Portfolio - Jane's September Update: Adding Vermilion Energy",1,0.5008424
2019-10-21,3737000.0,64.94000244140625,65.37000274658203,64.80000305175781,65.20999908447266,63.44306182861328,GILD,"The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict ||| Ariel Investments' Rupal Bhansali Taking GuruFocus Reader Questions ||| Earnings Season Kicks Into Full Gear In Round 3 Of The WeTrader Competition ||| Edge Wealth Management LLC Buys DocuSign Inc, Gilead Sciences Inc, Kayne Anderson MLP/Midstream ... ||| Exact Sciences (EXAS) to Post Q3 Earnings: What's in Store? ||| What's in Store for Healthcare ETFs in Q3 Earnings?",1,0.5305336
2019-10-22,5881800.0,65.70999908447266,66.58999633789062,65.66999816894531,65.86000061035156,64.07544708251953,GILD,"Noteworthy Tuesday Option Activity: GILD, APLS, MAT ||| Chowder's 'Lost Works' - Part 3: Portfolio Construction And The Valuation Scam ||| Top Stock Reports for U.S. Bancorp, Bristol-Myers Squibb & Morgan Stanley",1,0.4817597
2019-10-23,6056100.0,65.72000122070312,66.6500015258789,65.52999877929688,66.58000183105469,64.77594757080078,GILD,"Foundry Partners, LLC Buys Altria Group Inc, The AES Corp, Synovus Financial Corp, Sells ... ||| The Zacks Analyst Blog Highlights: U.S. Bancorp, Bristol-Myers Squibb, Morgan Stanley, Bank of America and Gilead Sciences ||| Will Strong Jakafi Sales Drive Incyte's (INCY) Q3 Earnings?",0,0.5000411
2019-10-24,5555400.0,66.75,66.75,65.62999725341797,66.0,64.21165466308594,GILD,"Gilead Sciences Inc (GILD) Q3 2019 Earnings Call Transcript ||| Gilead Sciences Inc. Q3 adjusted earnings Beat Estimates ||| Gilead Sciences shares are trading lower after the company reported worse-than-expected Q3 sales results. The company also narrowed its FY19 sales guidance below analyst estimates. ||| Gilead Narrows FY19 Sales Guidance From $21.6B-$22.1B To $21.8B-$22.1B vs $22.32B Estimate, Reaffirms EPS At $3.90-$4 ||| Gilead Sciences Q3 Adj. EPS $1.75 Beats $1.74 Estimate, Sales $5.604B Miss $5.61B Estimate ||| The Daily Biotech Pulse: Acorda To Trim Jobs, GlaxoSmithKline Gets FDA Nod, Edward Lifesciences Posts Q3 Beat-And-Raise ||| Earnings Scheduled For October 24, 2019 ||| Gilead Sciences, Inc. (GILD) CEO Daniel O'Day on Q3 2019 Results - Earnings Call Transcript ||| Gilead Earnings, Revenue In Line ||| Q3 Earnings Frenzy: Amazon (AMZN), Intel (INTC) & More ||| Gilead Sciences, Inc. 2019 Q3 - Results - Earnings Call Presentation ||| Gilead Sciences declares $0.63 dividend ||| Gilead Q3 revenues flat, non-GAAP EPS off 5%; shares down 2% after hours ||| Gilead Sciences EPS beats by $0.02, revenue in-line ||| 6 High-Yielding Dividend Stocks ||| Railway Pension Investments Ltd Buys Bristol-Myers Squibb Company, Amgen Inc, Goldman Sachs ... ||| Gilead Will Pull Levers Thursday",0,0.50775206
2019-10-25,12014700.0,63.0,64.2699966430664,62.52000045776367,63.31999969482422,61.60427474975586,GILD,"4 Top Stock Trades for Monday: TSLA, GILD, GLD, VZ ||| Gilead Sciences Q3 Revenue Is Flat, and R&D Hits Earnings ||| Daily Dividend Report: VFC, BRO, COG, GRC, GILD ||| 5 Biotech Stocks to Buy for a Strong Growth Prognosis ||| What's Behind Gilead Sciences' Lackluster Q3 Earnings Results ||| Benzinga's Top Upgrades, Downgrades For October 25, 2019 ||| Gilead Falls On Uninspiring Q3 Print: 3 Analyst Takes ||| UPDATE: Raymond James On Gilead Notes 'therefore filgotinib and M&A will need to be the main growth drivers going forward';'both can be and while the base business doesn't look like a major growth business to us anymore on net, it is still stable', Huge ||| UPDATE: Raymond James Maintains Strong Buy On Gilead, Lowers Target To $81 Notes 'our investment thesis is admittedly drifting'; Doesn't 'think Biktarvy + PrEP + Yescarta are enough anymore to drive growth in the face of continued pressure on HCV' ||| Hearing Dealreporter Says Gilead Could Be Eyeing Intercept Pharma ||| Oppenheimer Maintains Outperform on Gilead Sciences, Lowers Price Target to $80 ||| 10 Biggest Price Target Changes For Friday ||| Maxim Group Downgrades Gilead Sciences to Hold ||| BMO Capital Maintains Outperform on Gilead Sciences, Lowers Price Target to $81 ||| Gilead Sciences shares are trading lower after the company reported worse-than-expected Q3 sales results. The company also narrowed its FY19 sales guidance below analyst estimates. ||| Raymond James Maintains Strong Buy on Gilead Sciences, Lowers Price Target to $81 ||| Maxim Downgrades Gilead To Hold, Lowers Price Target To $66 ||| The Daily Biotech Pulse: Melinta Crosses FDA Hurdle But Sees Liquidity Pushback, Positive Readout For Aclaris Wart Drug ||| Agenus -2.1% on Gilead filing to offer up to 11.1M shares ||| Gilead Sciences' Turnaround Is Here ||| — Large-Cap Stocks Issue Quarterly Figures ||| And the Winner for the Worst Corporate Deal is Bayer ||| Callaway Golf, FedEx, Amazon, Intel and Gilead highlighted as Zacks Bull and Bear of the Day ||| Gilead's (GILD) Earnings Miss Estimates in Q3, Sales Beat ||| BioLife Gives Another Opportunity To Investors ||| Wall Street Breakfast: China Seeks Removal Of U.S. Tariffs In Return For Ag Buys",1,0.5259405
2019-10-28,7854600.0,63.630001068115234,63.95000076293945,62.77999877929688,63.72999954223633,62.00316619873047,GILD,"Stocks To Watch: FOMC, Streaming Wars And JEDI In Focus ||| Better Buy: Abbott Laboratories vs. Novo Nordisk ||| Gilead Sciences: Soft, Yet Solid Enough ||| Stocks That Fell to '-Year Lows in the Week of Oct. —5 ||| FOMC, Streaming Wars And JEDI In Focus (Stocks To Watch Podcast) ||| IBB, CELG, GILD, ILMN: ETF Outflow Alert ||| Gilead Sciences Option Alert: Jan 17 $65 Calls Sweep (22) near the Ask: 12532 @ $1.638 vs 31930 OI; Ref=$63.015 ||| Gilead and Glympse Bio Announce the Companies Enter Strategic Collaboration for Use of Biomarker Technology in NASH Clinical Development ||| Drug/Biotech Stock Q3 Earnings Due on Oct 29: MRK, PFE & More ||| As The Street Sours On Gilead, The Stock Looks Sweeter ||| Gilead teams up with Glympse Bio in NASH program",0,0.4840649
2019-10-29,5534100.0,64.0,64.0,63.25,63.45000076293945,61.73075485229492,GILD,The 3 Best Sectors for Long-Term Earnings ||| Can New Drugs Help Gilead Sciences Rebound? ||| Galapagos' Quarterly Results: Gilead Profit Recognition And Important Catalysts For 2020 ||| Allogene Therapeutics: Stay On The Sidelines On This Until 2020,0,0.5172745
2019-10-30,6289200.0,63.45000076293945,63.59999847412109,62.66999816894531,63.150001525878906,61.43888473510742,GILD,"3 Reasons CRISPR Therapeutics Stock Can Reach Record Highs Again ||| US Appeals Court Upholds Lower Court Ruling That Tossed $2.54B Jury Verdict For Merck In Patent Case Against Gilead ||| Allergan's Near Billion-Dollar Charge, And Other News: The Good, Bad And Ugly Of Biopharma ||| Merck strikes out in bid to reverse adverse ruling in Hep C patent fight with Gilead ||| Merck strikes out in bid to reverse adverse ruling in Hep C patent fight with Gilead",1,0.5099211
2019-10-31,6438100.0,62.90999984741211,63.81999969482422,62.7400016784668,63.709999084472656,61.98370742797852,GILD,"The Zacks Analyst Blog Highlights: Alexion, Amgen, Gilead and AMAG",1,0.5060696
2019-11-01,4956800.0,63.970001220703125,64.98999786376953,63.7599983215332,64.66000366210938,62.9079704284668,GILD,"Notable Friday Option Activity: GILD, AMED, TGT ||| November 2019 Stock Considerations ||| Gilead to up stake in Galapagos to 25.1% ||| Key events next week - healthcare",1,0.49333334
2019-11-04,7008700.0,65.16000366210938,65.4800033569336,64.02999877929688,65.20999908447266,63.44306182861328,GILD,"Noteworthy ETF Outflows: IBB, CELG, GILD, VRTX ||| Biotech ETFs in Focus on Impressive Q3 Earnings Results ||| Boston nonprofit playing big role in drug pricing ||| Boston nonprofit playing big role in drug pricing ||| Boston nonprofit playing big role in drug pricing ||| Boston nonprofit playing big role in drug pricing ||| Swapping Apple For Apple - October Dividend Portfolio Update ||| Incyte: An Undervalued Biotech With Catalysts ||| Incyte: An Undervalued Biotech With Catalysts",1,0.49887723
2019-11-05,6599100.0,65.41000366210938,66.2699966430664,65.19000244140625,65.38999938964844,63.61819076538086,GILD,"Agenus (AGEN) Q3 Earnings Beat Estimates, Revenues Up Y/Y",1,0.50129485
2019-11-06,6010500.0,65.62999725341797,66.16999816894531,65.06999969482422,65.41000366210938,63.63764953613281,GILD,"Up 19.2%, Is Viking Therapeutics Stock Still a Buy? ||| These 3 European Biotechs Can Help Recession-Proof Your Portfolio ||| Gilead Therapeutics Exercises Warrants for 2.62M Shares of Galapagos ||| Gilead Presents 96-Week Discover Trial Data Supporting Non-inferior Efficacy And Key Safety Differences Of Descovy For PrEP Compared With Truvada For PrEP ||| Trillium Asset Management, Llc Buys New York Times Co, AstraZeneca PLC, Gilead Sciences Inc, ... ||| Prentiss Smith & Co Inc Buys Verizon Communications Inc, Unilever PLC, Gilead Sciences Inc, ... ||| Gilead HIV meds show sustained benefit in late-stage studies",0,0.5015691
2019-11-07,7746000.0,65.0199966430664,65.16999816894531,63.43999862670898,63.959999084472656,62.226932525634766,GILD,"Here's Why Galapagos Stock Rose 20.5% in October ||| Former Google, Pharma Execs Start Ritual-Based Cannabis Company ||| Gilead Sciences shares are trading lower after the company exercised warrants for 2.62 million shares of Galapagos. ||| 5%+ Dividend Yield Portfolio: Winning With A Defensive Tilt (October 2019 Review) ||| Feds sue Gilead over patents in HIV pre-exposure prophylaxis",1,0.51016
2019-11-08,4953100.0,63.52999877929688,65.5199966430664,63.52000045776367,65.37999725341797,63.60845947265625,GILD,"US Files Complaint Against Gilead Sciences For Patent Infringement ||| Is The Future Finally Looking Up For Gilead Sciences? ||| Gilead Highlights Presentation Of Data On GS-6207 As Potential Component Of Long-Acting HIV Therapy ||| Gilead To Present New Data From Viral Hepatitis Research Programs At The Liver Meeting 2019 ||| First Financial Holdings, Inc. Buys iShares –-' Year Treasury Bond ETF, Salesforce. ... ||| Mandatum Life Insurance Co Ltd Buys Caterpillar Inc, Activision Blizzard Inc, F5 Networks Inc, ...",0,0.53679657
2019-11-11,3696400.0,65.0199966430664,65.1500015258789,64.33000183105469,64.63999938964844,62.88850402832031,GILD,"Gilead, Galapagos Announce New Data on Filgotinib in Rheumatoid Arthritis Demonstrate Durable Efficacy and Safety Profile ||| Will Its HIV Lineup Save Gilead Sciences? ||| Reverse Brain Drain, Commercial-Espionage And Patent Infringements: The Good, Bad And Ugly Of Biopharma ||| Silver Ring Value Partners Q3 2019 Letter",0,0.49694893
2019-11-12,4243200.0,64.55999755859375,64.86000061035156,64.1500015258789,64.31999969482422,62.57717514038086,GILD,"iShares Nasdaq Biotechnology ETF Experiences Big Outflow ||| Benzinga's Top Upgrades, Downgrades For November 12, 2019 ||| SunTrust Robinson Humphrey Initiates Coverage On Gilead Sciences with Hold Rating, Announces $70 Price Target ||| Reasonably Valued, High Quality, High Yield Dividend Growth Stocks ||| AlphaCrest Capital Management LLC Buys Cognizant Technology Solutions Corp, Starbucks Corp, ... ||| Argent Trust Co Buys Morgan Stanley, SPDR S&P 5…… ETF Trust, Vulcan Materials Co, Sells ... ||| SunTrust sees 16% upside in Amgen in premarket analyst action",0,0.4967212
2019-11-13,4482600.0,64.1500015258789,64.1500015258789,63.09999847412109,63.33000183105469,61.6140022277832,GILD,"Bell Asset Management Ltd Buys The Kroger Co, Genpact, 'M Co, Sells McKesson Corp, Sealed Air ... ||| Woodley Farra Manion Portfolio Management Inc Buys Bristol-Myers Squibb Company, Sells Gilead ...",1,0.5141794
2019-11-14,7548200.0,63.22999954223633,64.0,62.380001068115234,63.810001373291016,62.080997467041016,GILD,"Notable Thursday Option Activity: GILD, GEO, TTWO ||| Gilead Sciences (GILD) Shares Cross 4% Yield Mark ||| 3 Big Stock Charts for Thursday: Gilead Sciences, DocuSign and Western Digital ||| Gilead Sciences Option Alert: Jan 17 $65 Calls Sweep (87) near the Ask: 4354 @ $1.248 vs 47976 OI; Ref=$62.565 ||| Galapagos Says Received Transparency Notice from Gilead; Gilead Holds 25.10% of Galapagos Shares ||| Sand Hill Global Advisors, LLC Buys Gilead Sciences Inc, Vanguard S&P 5…… ETF, Vanguard ... ||| Walleye Trading Advisors, LLC Buys Netfin Acquisition Corp, Facebook Inc, Baidu Inc, Sells ... ||| Pioneer Investment Management Inc Buys Molson Coors Brewing Co, AmerisourceBergen Corp, ... ||| Franklin Resources Inc Buys Schlumberger, Occidental Petroleum Corp, Barrick Gold Corp, Sells ... ||| Bruderman Asset Management, LLC Buys TELUS Corp, Gilead Sciences Inc, Bristol-Myers Squibb ... ||| Leuthold Weeden Capital Management Buys Amazon. ... ||| Sphera Funds Management Ltd. Buys Gilead Sciences Inc, Sanofi SA, Novo Nordisk A/S, Sells ...",1,0.4895243
2019-11-19,6135100.0,64.7300033569336,65.05000305175781,64.5,65.0,63.2387580871582,GILD,"Agenus On A Roll With More Catalysts Ahead ||| Ccm Investment Advisers Llc Buys MDU Resources Group Inc, Gilead Sciences Inc, Automatic Data ... ||| Drug Legislation Likely to Dry Up Biotech Funding ||| Why I'm A Bad Investor (Podcast)",0,0.46336085
2019-11-20,7633900.0,64.77999877929688,65.30000305175781,64.4800033569336,64.87999725341797,63.12200164794922,GILD,"3 Recovering Healthcare Stocks to Buy That Already Escaped Flu Season ||| Gilead Sciences Inc (GILD) EVP,Corp Affairs & Gen Counsel Brett A Pletcher Sold $–. ... ||| Launch of new generic drugs in U.S. still lags - WSJ ||| Why I'm A Bad Investor (Podcast Transcript)",1,0.5282022
2019-11-21,5392000.0,65.0999984741211,65.80000305175781,64.51000213623047,65.7300033569336,63.94897079467773,GILD,January 2020 Options Now Available For Gilead Sciences (GILD) ||| Galapagos And Its Partnership With Gilead: A Study ||| Biotech ETF (BBH) Hits New 52-Week High,0,0.5044051
2019-11-22,4589300.0,65.79000091552734,65.94000244140625,65.19000244140625,65.26000213623047,63.49170684814453,GILD,Enanta Pharmaceuticals' Q4 Results Pulled Down by AbbVie's Sinking HCV Sales ||| Investing In The Holy Grail Of Cancer Treatment: Immunotherapy,1,0.515366
2019-11-25,7492900.0,65.55000305175781,67.27999877929688,65.48999786376953,67.22000122070312,65.39859771728516,GILD,"Does Amarin Have a Dark Horse Suitor? ||| 3 Dividend Stocks to Buy on Sale ||| 5 Top Stock Trades for Tuesday: NVDA, TSLA, GILD ||| Gilead Sciences shares are trading higher. Currently not seeing any news to justify the price action. ||| The Retiree's Dividend Portfolio - Jane's October Update: Taking Advantage Of Zero Cost Trading",1,0.49385276
2019-11-26,6923500.0,66.97000122070312,67.6500015258789,66.68000030517578,67.27999877929688,65.45697021484375,GILD,"Better Buy: Editas Medicine or Sangamo Therapeutics? ||| Gilead Sciences Inc (GILD) EVP,Corp Affairs & Gen Counsel Brett A Pletcher Sold $– ... ||| Voya Financial Advisors, Inc. Buys iShares iBoxx $ High Yield Corporate Bond ETF, iShares Core ... ||| Stocks Are Mixed Overseas, But Will Try To Push Higher in The US",0,0.49804726
2019-11-27,4980300.0,67.27999877929688,67.48999786376953,66.69999694824219,67.12000274658203,65.30131530761719,GILD,"IBB, GILD, VRTX, ILMN: Large Outflows Detected at ETF ||| Stocks Are Pointing To More Gains For November 27",1,0.49513578
2019-11-29,2658800.0,67.04000091552734,67.36000061035156,66.80999755859375,67.23999786376953,65.41806030273438,GILD,Iovance Biotherapeutics: Solving The Solid Tumors Conundrum,0,0.5101951
2019-12-02,7642100.0,67.25,67.5199966430664,65.94000244140625,66.12000274658203,64.32840728759766,GILD,"The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More ||| Interview With Galapagos CEO Onno Van De Stolpe: Partnerships, Pipeline And Potential ||| Galapagos: Banking On Steady Growth ||| Intercept (ICPT) Gains 7.5% YTD on Progress in NASH Space",0,0.4959805
2019-12-03,5333300.0,65.79000091552734,66.19999694824219,65.16999816894531,66.06999969482422,64.2797622680664,GILD,5%+ Dividend Yield Portfolio: Staying In The Game (November 2019 Review),1,0.5142549
2019-12-04,5093400.0,66.30000305175781,67.22000122070312,66.05999755859375,66.75,64.94133758544922,GILD,CHNA: You're Missing Out On This Huge Opportunity In Biopharma ||| Bayer and Teva Double Down on Worst M&A Deals of Decade,0,0.50203234
2019-12-05,5847800.0,66.9000015258789,66.94999694824219,65.4000015258789,65.93000030517578,64.14356231689453,GILD,"Thursday Sector Laggards: Energy, Healthcare ||| IBB Is Positioned For Outperformance ||| The Solution To High Drug Prices In The U.S. Is Mass Importation ||| Acadia Presents More Positive Data, Outlook Grows Stronger",1,0.52212936
2019-12-09,5983700.0,67.18000030517578,67.87999725341797,66.83000183105469,66.93000030517578,65.116455078125,GILD,"Kite Announces Long-term Data From ZUMA-1 Showing Approximately Half of Refractory Large B-cell Lymphoma Patients Were Alive Three Years After Yescarta Treatment at ASH 2019 ||| Dividend Challenger Highlights: Week Of December 8 ||| Stocks To Watch: Netflix, Cisco And Chewy On The Marquee ||| November 2019 Dividend Portfolio Update ||| 7 Monster Stock Market Predictions For The Week of December 9th ||| Netflix, Cisco And Chewy On The Marquee (Stocks To Watch Podcast) ||| No CRISPR Required: This Forgotten Gene Editing Stock Is Up 50% in 5 Weeks ||| Gilead's Kite Presents Results From Pivotal ZUMA-2 Trial In Relapsed Or Refractory Mantle Cell Lymphoma; Results Showed 93 Percent of Patients Treated With Investigational KTE-X19 Achieved Response ||| Gildead's Kite Presents Findings From Real-World Use Of Yescarta Study ||| Gilead Shares Unaffected Following Earlier Article From UK's Guardian 'Sanders and Ocasio-Cortez say company seeking HIV patent extension 'deceitful and immoral''",1,0.52344656
2019-12-10,4272900.0,66.8499984741211,67.18000030517578,66.12999725341797,67.08000183105469,65.26239776611328,GILD,"APTO On The Move, PLX To Effect Reverse Split, SCYX Plunges ||| Gilead Sciences (GILD) Gains As Market Dips: What You Should Know ||| Genfit Hopes to Buck the Odds With NASH Drug ||| Top Stock Reports for Toyota, CVS Health & 3M",1,0.4945624
2019-12-11,5589800.0,67.36000061035156,67.98999786376953,67.11000061035156,67.77999877929688,65.94342803955078,GILD,"GILD's KTE-X19 To Face FDA, NTEC Drops As NVS Walks Away, KZIA On Watch ||| Noteworthy Wednesday Option Activity: GILD, GKOS, DERM ||| GILD Named A Top Socially Responsible Dividend Stock ||| Kite Submits Biologics License Application to U.S. Food and Drug Administration for Company's Second CAR T Cell Therapy ||| Gilead's Kite And Kiniksa Pharmaceuticals Announce Clinical Collaboration Evaluating Investigational Combination Of Yescarta And Mavrilimumab In Relapsed Or Refractory Large B-Cell Lymphoma ||| Pura Vida Investments, Llc Buys Grifols SA, Intersect ENT Inc, Regeneron Pharmaceuticals Inc, ... ||| Hot Options Report For End Of Day - Wednesday, Dec. 11 ||| Gilead files U.S. application for CAR T for mantle cell lymphoma ||| Kiniksa Pharma up 7% premarket on Kite collaboration ||| The Zacks Analyst Blog Highlights: Toyota, CVS, 3M, Gilead and Goldman",0,0.5049158
2019-12-12,5732200.0,67.16000366210938,68.16000366210938,67.0199966430664,67.62999725341797,66.41480255126953,GILD,"Gilead Sciences Option Alert: Jan 17 $70 Calls Sweep (41) above Ask!: 864 @ $1.087 vs 44382 OI; Earnings 2/3 After Close [est] Ref=$67.575 ||| Gilead Sciences Option Alert: Jan 17 $70 Calls Sweep (21) near the Ask: 608 @ $1.048 vs 44382 OI; Earnings 2/3 After Close [est] Ref=$67.535 ||| 'Activists Say A Patent Office Lawyer's Tweets Showed 'Bias' In Favor Of Gilead In HIV Drug Case' - STAT ||| Gilead Sciences Option Alert: Feb 21 $70 Calls at the Ask: 4230 @ $2.351 vs 10716 OI; Earnings 2/3 After Close [est] Ref=$67.6259 ||| The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win ||| A Quantitative Risk And Dividend Model ||| House passes drug pricing bill, Senate unlikely to support ||| An Important Warning After This Record Year ||| Gilead Teams Up With Kiniksa, Submits BLA for CAR T Therapy",0,0.47427797
2019-12-13,8198900.0,66.25,66.80999755859375,65.45999908447266,65.7699966430664,64.58821868896484,GILD,"IBB, GILD, VRTX, ILMN: ETF Outflow Alert ||| Bristol-Myers Squibb Wins Patent Royalty Fight Against Gilead; Co. Awarded $585M In Damages Plus Royalty ||| Gilead Sciences shares are trading lower after Credit Suisse downgraded the stock from Neutral to Underperform and lowered the price target from $67 to $63. ||| Credit Suisse Downgrades Gilead Sciences to Underperform, Lowers Price Target to $63 ||| Merger Mating Dance: We Explore Who Gets The Rose Next - Sectors And Targets, Part I ||| Pura Vida Investments, Llc Buys Grifols SA, Intersect ENT Inc, Regeneron Pharmaceuticals Inc, ... ||| Genfit Hopes to Buck the Odds With NASH Drug ||| Credit Suisse cuts view on Gilead in premarket analyst action",1,0.5028796
2019-12-16,11647500.0,66.25,66.79000091552734,66.08999633789062,66.12000274658203,64.93193817138672,GILD,"Bristol-Myers Wins $752 Mln In US Patent Case Against Gilead Sciences ||| Bernie Sanders Tweet: We could eradicate HIV/AIDS in America. What's standing in the way? The greed of the pharmaceutical industry. An $8 HIV drug in Australia costs $2,000 in America. That is immoral. We need affordable, generic HIV medicine. Now ||| Better Buy: Gilead Sciences vs. Amgen ||| Amarin’s Vascepa Approval Seems Fishy for Patients and AMRN Investors ||| Gilead: Phase 2 ATLAS Data Shows Consistent Improvements In Liver Histology ||| Gilead Sciences Option Alert: Jan 17 $70 Calls Sweep (21) near the Ask: 514 @ $0.693 vs 65480 OI; Earnings 2/3 After Close [est] Ref=$66.4952 ||| Gilead's Phase 2 ATLAS Study in Patients with Bridging Fibrosis and Compensated Cirrhosis Missed its Primary Endpoint ||| Gilead Sciences (GILD) Gains But Lags Market: What You Should Know",1,0.54688364
2019-12-17,7881300.0,66.18000030517578,66.41000366210938,65.79000091552734,66.19999694824219,65.01049041748047,GILD,7 Biotech Stocks to Buy and Hold in 2020 ||| Drugs That Missed Key Goals In Phase III Trials ||| Gilead (GILD) Announces Top-Line Results From NASH Study,0,0.5062823
2019-12-18,10105600.0,66.30999755859375,66.5,65.26000213623047,65.68000030517578,64.49983978271484,GILD,"5 Biotech Stocks to Buy for a Strong Growth Prognosis ||| Biotech Stock Roundup: AMRN Stock Up, Pipeline Updates from GILD, BIIB, AMGN & More",0,0.495805
2019-12-19,9495300.0,65.91000366210938,65.91000366210938,65.16000366210938,65.29000091552734,64.1168441772461,GILD,"2 Must-Own Dividend Growth Stocks in 2020 ||| Gilead Reports Submission Of Filgotinib New Drug Application Under Priority Review For Rheumatoid Arthritis Treatment ||| Micron Yesterday, Nike Today: Earnings Keep Rolling In As Week Winds Down ||| The Zacks Analyst Blog Highlights: Amarin, Amgen, Gilead Sciences, Biogen and Kiniksa Pharmaceuticals",1,0.5308308
2019-12-20,23440000.0,65.58999633789062,67.0,65.16999816894531,66.8499984741211,65.64881134033203,GILD,"Health Care Sector Update for 12/20/2019: GILD,TXG,BIO,NLNK,MRK,ABEO ||| Noteworthy Friday Option Activity: GILD, MET, PYPL ||| Gilead Reports China's National Medical Products Admin. Approved Vosevi For Treatment Of Chronic Hep C Infection Who Require Re-Treatment ||| The Daily Biotech Pulse: Axovant Surges On Gene Therapy Study Results, FDA Approves Merck's Ebola Vaccine, Abeona Announces Offering ||| Gilead (GILD) Files NDA With FDA for RA Candidate Filgotinib",0,0.4783473
2019-12-23,7038200.0,66.69999694824219,67.4000015258789,66.54000091552734,66.75,65.55061340332031,GILD,20 High-Yield Dividend Stocks to Buy in 2020 ||| Biotech Stocks Make Q4 Comeback in 2019: Our Calls Were Excellent ||| Did Cellectis Just Provide a Glimpse of the Future of Cellular Medicine? ||| iShares Russell 1000 Value ETF Experiences Big Outflow ||| GlaxoSmithKline's Long-Acting HIV Regimen Gets CRL From FDA,0,0.49081436
2019-12-24,1965800.0,66.80999755859375,66.94000244140625,66.29000091552734,66.72000122070312,65.52114868164062,GILD,"Interesting GILD Put And Call Options For August 2020 ||| Gilead's Japan Unit In Deal With Eisai To Co-Promote RA Drug Filgotinib ||| The Daily Biotech Pulse: NewLink Genetics Licenses Ovarian Cancer Dug, Correvio Awaits FDA Verdict ||| Gilead and Eisai Enter Into Agreement in Japan for the Co-Promotion of the Investigational Rheumatoid Arthritis Therapy Filgotinib, Pending Regulatory Approval ||| Gilead Sciences (GILD) Dips More Than Broader Markets: What You Should Know",0,0.5137324
2019-12-26,3527400.0,66.70999908447266,66.91000366210938,66.1500015258789,66.38999938964844,65.19707489013672,GILD,Gilead (GILD) Partners With Eisai for RA Candidate in Japan,0,0.5182873
2019-12-27,4463900.0,66.37999725341797,66.48999786376953,65.70999908447266,65.94999694824219,64.76498413085938,GILD,"Better Buy: Editas Medicine vs. CRISPR Therapeutics ||| Spring Bank (SBPH) Stops Dosing in HBV Studies, Stock Down",0,0.5095326
2019-12-30,5864300.0,65.7300033569336,66.0999984741211,64.80999755859375,64.93000030517578,63.7633171081543,GILD,"3 Dividend Stocks to Buy for 2020 ||| Week Ahead In Biotech: PDUFA Date Ahead For Astra Zeneca, Merck's Lynparza, Pending Clinical Readouts In Focus ||| Notable Two Hundred Day Moving Average Cross - GILD",1,0.508536
2019-12-31,6984700.0,64.66000366210938,65.05999755859375,64.3499984741211,64.9800033569336,63.81241607666016,GILD,"Vascepa’s Future Looks Rosy, But It Could Still Be Fishy for Amarin Stock ||| Gilead Sciences Option Alert: Feb 21 $70 Calls at the Ask: 5863 @ $0.761 vs 14359 OI; Earnings 2/3 After Close [est] Ref=$64.5295",1,0.4884266
2020-01-02,5038200.0,65.52999877929688,65.73999786376953,65.04000091552734,65.2300033569336,64.05792999267578,GILD,"Bristol-Myers Squibb, Gilead Sciences, Biogen Raised U.S. List Prices on 50+ Drugs on Wednesday an Average of 5% ||| GILD vs. TECH: Which Stock Should Value Investors Buy Now? ||| Drugmakers Kick Off 2020 With Margin-Expanding Price Hikes",0,0.5164704
2020-01-03,4689700.0,64.62999725341797,65.37000274658203,64.55999755859375,65.06999969482422,63.90079498291016,GILD,"IBB, GILD, VRTX, BIIB: ETF Outflow Alert ||| Biotech's Most Volatile Binary Events for Q1 ||| Gilead Sciences Option Alert: Jan 17 $65 Calls at the Ask: 1500 @ $1.311 vs 32458 OI; Earnings 2/3 After Close [est] Ref=$65.1002 ||| Benzinga's Top Upgrades, Downgrades For January 3, 2020",1,0.50738955
2020-01-06,8248700.0,64.66999816894531,65.83000183105469,64.66000366210938,65.6500015258789,64.47037506103516,GILD,Better Buy: Gilead Sciences vs. Biogen ||| HOOKIPA Says it has Made Strong Progress in its Collaboration with Gilead for Cures to Hepatitis B and HIV,0,0.51524293
2020-01-07,8082600.0,65.26000213623047,65.29000091552734,64.16999816894531,65.12000274658203,63.94990158081055,GILD,Investor Movement Index Summary: December 2019,1,0.50348514
2020-01-08,6607300.0,65.11000061035156,66.23999786376953,64.80999755859375,65.80000305175781,64.61768341064453,GILD,Xencor And Gilead Enter License Agreement For Use Of XmAb Antibody Technologies In Investigational Agents For HIV,1,0.5417361
2020-01-09,5942300.0,65.80999755859375,66.06999969482422,65.30000305175781,65.83999633789062,64.6569595336914,GILD,Gilead Sciences Licenses Portfolio Of HIV Antibodies From Rockefeller ||| Gilead Sciences Licenses Portfolio Of HIV Antibodies From The Rockefeller University ||| Gilead (GILD) Inks License Deal with Xencor for HIV Candidate ||| Agenus Initiates Phase I Study on Oncology Candidate AGEN1223,0,0.5141354
2020-01-10,5153900.0,66.0,66.08999633789062,64.9800033569336,65.02999877929688,63.861515045166016,GILD,"7 Healthcare Stocks to Buy or Sell As Pricing Pressures Mount ||| A Preview Of JPMorgan's Healthcare Conference: Focus On Value-Creating Themes, 2020 Expectations ||| Stock Research Reports for Chevron, Accenture, Adobe & Others",0,0.5029086
2020-01-13,6868900.0,65.05000305175781,65.26000213623047,64.08000183105469,64.30999755859375,63.15444946289063,GILD,"Market Briefing For Jan. 13, 2020 ||| Notable Monday Option Activity: AIMT, NKE, GILD ||| Gilead Sciences To Present At J.P. Morgan Conference; Webcast At 12:30 PM ET ||| IBB, GILD, VRTX, BIIB: Large Inflows Detected at ETF ||| Gilead Invests In Kyverna Therapeutics, Enters License Agreement - Quick Facts ||| Gilead Sciences CEO Says To Focus On Small To Medium Sized Bolt-On Acquisitions ||| Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know ||| The Zacks Analyst Blog Highlights: Chevron, Accenture, Adobe Systems, Gilead Sciences and Honda Motor",0,0.47052482
2020-01-14,9929700.0,64.41000366210938,64.55999755859375,63.90999984741211,64.19999694824219,63.046424865722656,GILD,PJP's Underlying Holdings Could Mean 14% Gain Potential,0,0.5073131
2020-01-15,7080600.0,64.06999969482422,64.93000030517578,63.97999954223633,64.0999984741211,62.94822692871094,GILD,"Wedge Capital Management L L P Buys US Foods Holding Corp, Apple Inc, Skyworks Solutions Inc, ... ||| Parnassus Endeavor Fund Adds to Cisco, Alphabet ||| Parnassus Endeavor Fund Invests in Insurance and Logistics in 4th Quarter ||| Performance Review of Our Annual Stock Picks",0,0.48369098
2020-01-16,10633900.0,64.29000091552734,64.37999725341797,63.119998931884766,63.20000076293945,62.06439971923828,GILD,"Stocks Rise Yet Again, But Signs Of A Pullback Are Still On The Horizon",0,0.49833992
2020-01-17,13457600.0,63.5,63.5,62.56999969482422,62.97999954223633,61.84835052490234,GILD,"Gilead Sciences Option Alert: Fri $63 Calls Sweep (52) above Ask!: 1040 @ $0.3 vs 232 OI; Earnings 2/3 After Close [est] Ref=$63.09 ||| Ackerman Capital Advisors, LLC Buys Occidental Petroleum Corp, Intercontinental Exchange Inc, ... ||| Hamilton Wealth, LLC Buys Vanguard Total World Stock Index Fund, Pfizer Inc, Gilead Sciences ... ||| Zeke Capital Advisors, Llc Buys iShares National Muni Bond ETF, iShares Short-Term National ... ||| Novo Nordisk's Ozempic Gets FDA Nod for CV Risk Reduction ||| Mirador Capital Partners LP Buys ProShares Short S&P5……, iShares Nasdaq Biotechnology ...",0,0.50383276
2020-01-21,12261100.0,62.90999984741211,62.91999816894531,62.22999954223633,62.630001068115234,61.504642486572266,GILD,"Stocks That Fell to '-Year Lows in the Week of Jan. –7 ||| 7 Blockbuster Drugs Expected To Be Launched In 2020 ||| 5 Monster Stocks To Watch For The January 21 Trading Session ||| iShares Nasdaq Biotechnology ETF Experiences Big Outflow ||| Guggenheim Securities Downgrades Gilead Sciences to Neutral ||| Empire Life Investments Inc. Buys Gilead Sciences Inc, Philip Morris International Inc, Johnson ... ||| Decatur Capital Management, Inc. Buys Merck Inc, Costco Wholesale Corp, NVIDIA Corp, Sells The ...",1,0.46734038
2020-01-22,7906100.0,62.79999923706055,63.43000030517578,62.59999847412109,63.400001525878906,62.26080703735352,GILD,"Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know ||| Truewealth Llc Buys Gilead Sciences Inc, Truist Financial Corp, Vanguard Total Stock Market ... ||| High-Yield Stocks for the Dividend Investor",1,0.47995466
2020-01-23,14648700.0,63.25,64.05999755859375,62.7400016784668,63.93999862670898,62.79109954833984,GILD,"2 Small-Cap Biotech Stocks to Watch in 2020 ||| Gilead Considering Ebola Drug as Potential Coronavirus Treatment ||| 2 Dividend-Paying Biotech Stocks Worth Owning in 2020 ||| Gilead Says There Are Currently No Antiviral Data For Remdesivir That Show Activity Against Wuhan Coronavirus ||| Gilead Says Co Is In Discussions Regarding Potential Use Of Remdesivir As An Investigational Treatment For Ongoing Wuhan Coronavirus Outbreak ||| Gilead Says Co Is In Active Discussions With Researchers, Clinicians In U.S. And China Regarding Ongoing Wuhan Coronavirus Outbreak ||| Gilead Shares Spike To Session High Hearing Company Assessing Its Ebola Drug As A Coronavirus Treatment ||| Gilead, Bristol-Myers Pumped More Into R&D Than Shareholder Enrichments ||| New Potomac Partners, LLC Buys Gilead Sciences Inc, AbbVie Inc, Invesco Preferred ETF, Sells ...",0,0.50387347
2020-01-24,18685100.0,64.06999969482422,64.19999694824219,62.84000015258789,63.150001525878906,62.01530075073242,GILD,"An Emboldened Bristol-Myers Squibb Wants $1.5 Billion From Gilead Sciences ||| Better Buy: Amgen vs. Gilead Sciences ||| Autus Asset Management, LLC Buys iShares Core U.S. ... ||| Bourne Lent Asset Management Inc Buys Bristol-Myers Squibb Company, Enbridge Inc, L'Harris ... ||| What Lies Ahead for Healthcare ETFs in Q4 Earnings?",1,0.4945292
2020-01-27,10421600.0,63.0,64.27999877929688,62.79999923706055,63.83000183105469,62.68307876586914,GILD,"Better Buy: Vertex Pharmaceuticals vs. Galapagos ||| 5 Biotech Stocks to Watch With the Coronavirus Scare ||| Which Big Biotech Has the Safer Dividend -- Amgen or Gilead Sciences? ||| Gilead Sciences Option Alert: Mar 20 $62.5 Calls Sweep (50) near the Ask: 984 @ $3.051 vs 1043 OI; Earnings 2/4 After Close Ref=$63.61 ||| Gilead Sciences Option Alert: Fri $64.5 Calls Sweep (15) near the Ask: 505 @ $0.461 vs 3302 OI; Earnings 2/4 After Close Ref=$63.69 ||| Will Soliris, Ultomiris Drive Alexion's (ALXN) Q4 Earnings? ||| Amgen (AMGN) to Report Q4 Earnings: What's in the Cards? ||| Can Biogen (BIIB) Keep the Earnings Streak Alive in Q4? ||| Oakwood Capital Management Llc Buys Truist Financial Corp, Verizon Communications Inc, ...",1,0.5133729
2020-01-28,10241100.0,64.25,64.87999725341797,64.08999633789062,64.36000061035156,63.203556060791016,GILD,Gilead Sciences Option Alert: Fri $64.5 Calls at the Ask: 3770 @ $0.451 vs 6889 OI; Earnings 2/4 After Close Ref=$64.205 ||| Gilead Sciences (GILD) Gains But Lags Market: What You Should Know ||| Wining & Losing ETF Areas on Coronavirus Outbreak,0,0.46990752
2020-01-29,7071000.0,64.41999816894531,65.13999938964844,64.22000122070312,64.30000305175781,63.14463424682617,GILD,"Noteworthy ETF Outflows: IBB, GILD, VRTX, BIIB ||| Near a 7-Year Low, Is Gilead Sciences a Buy? ||| North Star Investment Management Corp. Buys Truist Financial Corp, ViacomCBS Inc, Vanguard ... ||| Gilead's Mantle Cell Lymphoma Drug MAA Gets EMA Validation ||| Biotech Stock Roundup: EPZM Drug Gets FDA Nod, XLRN & HEPA Surge on Study Data",0,0.5057289
2020-01-30,8771800.0,63.900001525878906,64.0999984741211,63.02999877929688,64.02999877929688,62.87948226928711,GILD,Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences ||| J&J (JNJ) Plans to Develop Vaccine for New Coronavirus ||| J&J (JNJ) Plans to Develop Vaccine for New Coronavirus ||| These 4 Biotech Stocks Are the Silver Lining on the Wuhan Coronavirus,0,0.49820942
2020-01-31,11416800.0,63.79999923706055,63.93000030517578,62.59999847412109,63.20000076293945,62.06439971923828,GILD,"Hearing Gilead Working with China to Determine if its Remdesivir Can be Used to Treat Corona Virus ||| Martin Capital Partners, LLC Buys Kellogg Co, Merck Inc, Gilead Sciences Inc, Sells Westpac ... ||| Camarda Wealth Advisory Group, LLLP Buys SFL Corp, Halliburton Co, Exxon Mobil Corp, Sells ... ||| Biotech (Top Weights) Earnings Estimates And Revisions",1,0.51165766
2020-02-03,35562000.0,67.73999786376953,68.68000030517578,65.48999786376953,66.36000061035156,65.16761779785156,GILD,"Stocks That Fell to '-Year Lows in the Week of Jan. '– ||| Where Will Vertex Pharmaceuticals Be in 10 Years? ||| The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus ||| Beijing's China-Japan Friendship Hospital will Lead a Clinical Trial on the Treatment of Coronavirus Gilead's Remdesivir in Wuhan ||| Coronavirus Case Treated With Gilead Drug May Spur Wider Tests ||| Daily Markets: Coronavirus Delivers Sharp Shift To The Markets ||| Gilead's Ebola Drug Shows Positive Signs in Treating Coronavirus ||| Gilead's Ebola Drug Shows Positive Signs in Treating Coronavirus ||| Here's Why Inovio Pharmaceuticals and Vir Biotechnology Shares Have Fallen Today ||| 3 Big Drugmakers Are Taking On the Coronavirus ||| GILD Crosses Above Key Moving Average Level ||| Why Gilead Sciences Stock Is Up 13% Today ||| Gilead Sciences Option Alert: Mar 20 $67.5 Calls Sweep (35) near the Ask: 692 @ $2.297 vs 11796 OI; Earnings 2/4 After Close Ref=$66.66 ||| Gilead Sciences Option Alert: Mar 20 $75 Calls Sweep (35) near the Ask: 719 @ $0.5 vs 244 OI; Earnings 2/4 After Close Ref=$66.8 ||| PreMarket Prep Recap: Bulls Regain Early Control Of The Markets ||| 61 Stocks Moving In Monday's Mid-Day Session ||| 'Gilead Sciences says remdesivir not yet approved to treat coronavirus' -China's Global Times ||| Gilead Sciences Option Alert: May 15 $75 Calls at the Ask: 500 @ $0.761 vs 914 OI; Earnings 2/4 After Close Ref=$65.7449 ||| Gilead Sciences Option Alert: Feb 21 $70 Calls Sweep (4) near the Ask: 721 @ $1.061 vs 27477 OI; Earnings 2/4 After Close Ref=$67.245 ||| Gilead Sciences Option Alert: Feb 21 $70 Calls Sweep (119) above Ask!: 1094 @ $0.594 vs 27477 OI; Earnings 2/4 After Close Ref=$68.2778 ||| Gilead's Experimental Antiviral Drug To Be Screened In Human Trials In China For Coronavirus ||| 18 Healthcare Stocks Moving In Monday's Pre-Market Session ||| 30 Stocks Moving in Monday's Pre-Market Session ||| Gilead Sciences shares are trading higher following reports the company's Remdesivir will undergo a trial for treatment of Coronavirus. ||| Gilead Shares Selling Off Over the Last 30 Minutes, the Stock Traded Higher Early Monday Following a Weekend Report the Company's Remdesivir Would Undergo a Trial for Coronavirus ||| Fort Point Capital Partners, LLC Buys Alerian MLP ETF, Cadence Design Systems Inc, Everbridge ... ||| Hyman Charles D Buys Truist Financial Corp, General Motors Co, Vanguard Information Technology ... ||| US Markets Advance on Monday ||| Arrowhead (ARWR) to Report Q1 Earnings: What's in the Cards? ||| Most Active Equity Options For Midday - Friday, Feb. 3 ||| Most Active Equity Options For Midday - Monday, Feb. 3 ||| Merck (MRK) to Report Q4 Earnings: Is a Beat in the Offing?",1,0.49195307
2020-02-04,15904100.0,68.0,68.01000213623047,66.87999725341797,67.4000015258789,66.18893432617188,GILD,"Gilead Announces Q4 Financial Results, Misses EPS Target ||| Gilead Sciences Q4 Profit Misses Estimates ||| Gilead Sciences Inc (GILD) Q4 2019 Earnings Call Transcript ||| FDA Approves Emergency Use of Coronavirus Test ||| Gilead Sciences Q4 19 Earnings Conference Call At 4:30 PM ET ||| FDA Approves Emergency Use of Coronavirus Test ||| Momentum Stocks To Watch: Gilead Sciences Inc. (GILD) ||| Gilead Sciences Inc. Q4 adjusted earnings Miss Estimates ||| Here's a Better Reason to Buy Gilead Sciences Stock Than a Possible Coronavirus Treatment ||| Remdesivir & Chloroquine were Found Effective in Inhibiting Recently Emerged Coronavirus (2019-nCoV) in Vitro; Result was Published in Cell Research, said Wuhan Institute of Virology on its website Tue ||| '$GILD on call: No knowledge of additional #coronavirus responses to remdesivir. Waiting for clinical data. On manufacturing capacity: ""We are investing heavily to be prepared as best we can.""' -Tweet From STAT's Adam Feuerstein ||| Gilead Raises Quarterly Dividend From $0.63 To $0.68/Share ||| Gilead Sees FY20 Product Sales $21.8B-$22.2B, Adj. EPS $6.05-$6.45 vs $7.01 Estimate ||| Gilead Sciences Q4 Adj. EPS $1.3 Misses $1.67 Estimate, Sales $5.796B Beat $5.71B Estimate ||| Gilead Sciences Option Alert: Feb 21 $72.5 Calls Sweep (37) near the Ask: 531 @ $0.513 vs 10294 OI; Earnings 2/4 After Close Ref=$67.39 ||| The Daily Biotech Pulse: EyePoint In-Licenses Eye Disorder Drug, BioMarin CFO Quits, Rockwell Medical To Offer Shares ||| First Shipment of Gildead's Remdesivir May Arrive in China on Tuesday ||| 85 Biggest Movers From Yesterday ||| Earnings Scheduled For February 4, 2020 ||| Disney, Gilead & Snap Post Mixed Quarters, Chipotle Beats ||| WealthTrust Axiom LLC Buys Gilead Sciences Inc, ViacomCBS Inc, Evolution Petroleum Corp, Sells ... ||| A Pick and Shovel Strategy to Avoid Competition and Speculation",0,0.5062557
2020-02-05,21184500.0,66.22000122070312,66.55000305175781,64.06999969482422,65.87000274658203,64.6864242553711,GILD,"3 Important Things to Know About Gilead Sciences' Q4 Results ||| WHO Confirms 3,100 New Confirmed Coronavirus Infections Yesterday ||| Health Care Sector Update for 02/05/2020: CERN,AIMT,GILD ||| Health Care Sector Update for 02/05/2020: VVUS,CERN,AIMT,GILD ||| Notable Wednesday Option Activity: IBM, MSFT, GILD ||| Daily Dividend Report: MMM, GILD, CG, PSX, SYK ||| Health Care Sector Update for 02/05/2020: CERN,AIMT,GILD ||| 13 Key NASH Drug Candidates To Watch For In A Potential $30-Billion Market ||| 'We are aware of reports of the Wuhan Institute for Virology's patent application. Our focus at this time, is on rapidly determining the potential for remdesivir as a treatment for 2019-nCoV and accelerating manufacturing' ||| UPDATE: B of A Maintains Neutral On Gilead, Raises Target To $72 Notes 'Overall, we believe that 2020 guidance looks conservative, but we remain concerned over the lack of clear growth drivers that could meaningfully accelerate product sales' ||| Benzinga's Top Upgrades, Downgrades For February 5, 2020 ||| Gilead shares are trading lower after the company reported worse-than-expected Q4 EPS and issued soft FY20 guidance. ||| Credit Suisse Maintains Underperform on Gilead Sciences, Raises Price Target to $60 ||| B of A Securities Maintains Neutral on Gilead Sciences, Raises Price Target to $72 ||| The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data ||| Raymond James Downgrades Gilead Sciences to Outperform, Lowers Price Target to $80 ||| Nbt Bank N A Buys iShares MSCI EAFE Growth ETF, Caterpillar Inc, Vanguard REIT ETF, Sells ... ||| Regeneron Expands Agreement to Develop Coronavirus Therapy ||| Biotech Stock Roundup: Earnings Updates From VRTX, AMGN, GILD; AIMT Gains FDA Nod ||| Morgan Dempsey Capital Management Llc Buys HP Inc, Molson Coors Beverage Co, Gilead Sciences ... ||| Most Active Equity Options For Midday - Wednesday, Feb. 5 ||| The Zacks Analyst Blog Highlights: Disney, Chipotle, Ford, Gilead and Snap",1,0.50890785
2020-02-06,28805500.0,67.29000091552734,69.9000015258789,66.05000305175781,68.20999908447266,66.984375,GILD,"Multiple Positive Catalysts Make JD.com Stock Worth Buying ||| 74 Stocks Moving In Thursday's Mid-Day Session ||| Gilead Sciences shares are trading higher after Chinese scientists applied to patent the company's remdesivir to help treat the coronavirus. ||| Benzinga's Top Upgrades, Downgrades For February 6, 2020 ||| Bernstein Downgrades Gilead Sciences to Market Perform, Lowers Price Target to $70 ||| Moloney Securities Asset Management, LLC Buys SPDR® Nuveen Bloomberg Barclays High Yield ... ||| Can Biotech ETFs Continue to Soar in 2020? ||| Zevin Asset Management Llc Buys Healthpeak Properties Inc, Gilead Sciences Inc, Marriott ... ||| Coronavirus Starting to Weigh on 2020 Q1 Earnings Estimates ||| Hot Options Report For End Of Day - Thursday, Feb. 6 ||| Royal Bank Of Scotland Group Plc Buys Ross Stores Inc, TechnipFMC PLC, Vanguard FTSE Europe ... ||| Company News for Feb 6, 2020 ||| Most Active Equity Options For Midday - Wednesday, Feb. 6",1,0.5157404
2020-02-07,27320100.0,69.9800033569336,71.19000244140625,68.38999938964844,68.87000274658203,67.63252258300781,GILD,"Health Officials Say U.S. Coronavirus Vaccine is Making Good Progress ||| 4 Internet Stocks to Buy That Are Surging Higher ||| Gilead Sciences shares are trading higher on reports suggesting China has started enrolling coronavirus patients in a clinical trial of the company's Remdesivir. ||| GileadSciences Said it Will make Remdesivir Available to More 2019nCoV Patients via Proper Channels if Drug Proves Potentially Safe and Effective in Preliminary Trials ||| China Began Enrolling CoronavirusPatients in Clinical Trial of Remdesivir on Thursday ||| Hot Options Report For End Of Day - Friday, Feb. 7 ||| Most Active Equity Options For Midday - Friday, Feb. 7 ||| Intercontinental Wealth Advisors, LLC Buys MSCI United Kingdom Index Fund, PJSC Lukoil, Truist ... ||| The Zacks Analyst Blog Highlights: Exxon Mobil, Chevron, IBM, Gilead and Edwards Lifesciences",1,0.52121574
2020-02-10,24347800.0,69.31999969482422,69.4000015258789,67.61000061035156,68.98999786376953,67.75035858154297,GILD,"Gilead Sciences: Still on the Path to Recovery ||| Week In Review: AkesoBio Files For $300 Million Hong Kong IPO ||| 1 Big Question to Ask Yourself Before Buying Gilead Sciences Stock ||| The Week Ahead In Biotech: SMID-Cap Earnings In The Spotlight ||| Could These 5 Stocks Benefit From the Coronavirus Outbreak? ||| 3 Pros and 3 Cons For INO Stock Amid Chinese Coronavirus Outbreak ||| FDA Grants a Priority Review To Gilead Sciences' Cancer Therapy ||| FDA Grants Priority Review For Kite's KTE-X19 BLA - Quick Facts ||| iShares Nasdaq Biotechnology ETF Experiences Big Outflow ||| U.S. FDA Grants Priority Review For Kite's KTE-X19 Biologics License Application In Relapsed Or Refractory Mantle Cell Lymphoma; NOTE: Kite Is A Gilead Co. ||| New Strong Sell Stocks for February 10th ||| Most Active Equity Options For Midday - Monday, Feb. 10",0,0.51604015
2020-02-11,12858700.0,68.93000030517578,68.98999786376953,67.5,67.76000213623047,66.54246520996094,GILD,"Johnson & Johnson Announces Partnership With U.S. government to Accelerate Coronavirus Vaccine Development ||| Coronavirus Gets an Official Name From the WHO ||| Johnson & Johnson Is Racing Against Time to Develop the First Coronavirus Vaccine ||| Is Gilead Sciences an Acquisition Target? ||| The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology ||| ARGI Investment Services, LLC Buys SPDR Barclays Short Term Treasury ETF, iShares —…+ Year ... ||| Can Biotech ETFs Gain on Mixed Q4 Earnings Results? ||| Diodes (DIOD) Q4 Earnings and Revenues Top Estimates ||| VAREX IMAGING (VREX) Q1 Earnings Miss Estimates ||| Western Union (WU) Q4 Earnings and Revenues Lag Estimates ||| Enlightenment Research, LLC Buys Micron Technology Inc, Netflix Inc, Qualcomm Inc, Sells ... ||| Gilead's BLA for CAR T Cell Therapy Gets FDA Acceptance",0,0.5093446
2020-02-12,13927100.0,67.5,67.81999969482422,66.31999969482422,66.94999694824219,65.74701690673828,GILD,"Is Moderna a Buy? ||| Nasdaq 100 Movers: CERN, CSGP ||| Pandemic Fears Not Enough to Buy Inovio Stock ||| Notable Wednesday Option Activity: EGLE, GILD, SEAS ||| Better Buy: bluebird bio vs. Gilead Sciences ||| Gilead Sciences Option Alert: Feb 21 $72.5 Calls Sweep (47) near the Ask: 970 @ $0.242 vs 13430 OI; Ref=$66.425 ||| Valueworks Llc Buys Qualcomm Inc, Comcast Corp, Amgen Inc, Sells United Natural Foods Inc, ... ||| J&J (JNJ) Signs Deal With HHS to Develop Coronavirus Vaccine",0,0.49133718
2020-02-13,8031000.0,67.12999725341797,67.7699966430664,66.5199966430664,66.80000305175781,65.59971618652344,GILD,"Inovio’s Surge on a Coronavirus Vaccine Was Just Speculation ||| 3 Biotech Stocks That Made Early Shareholders Millionaires ||| White House Claims Other Countries Are ""Free-Riding"" on U.S. Drug Development ||| Greenwood Capital Associates Llc Buys iShares Core MSCI Emerging Markets, Vanguard ... ||| Horiko Capital Management LLC Buys Boeing Co, Raytheon Co, Sells Altice USA Inc, Gilead ... ||| Van Hulzen Asset Management, LLC Buys Starbucks Corp, Schlumberger, Coca-Cola Co, Sells CVS ...",1,0.5146688
2020-02-14,9109100.0,67.41000366210938,67.66000366210938,67.04000091552734,67.55999755859375,66.34605407714844,GILD,"Mint Tower Capital Management B.V. Buys Alphabet Inc, Broadcom Inc, Amazon. ... ||| Platinum Investment Management Ltd Buys Trip.com Group, 58. ...",0,0.50992393
2020-02-18,9904700.0,67.55999755859375,67.80000305175781,66.70999908447266,67.01000213623047,65.80593872070312,GILD,"3 High-Yielding U.S. Pharmaceutical Companies to Consider ||| Week In Review: Bio-Thera Raises $241 Million In Shanghai STAR IPO For Antibody Portfolio ||| Better Buy: AbbVie vs. Gilead Sciences ||| Healthcare (Top 30 Weights) Earnings Estimates And Revisions ||| The FDA Has a Plan to Deal With the Coronavirus ||| Capital Markets Trading UK LLP Buys Petroleo Brasileiro SA Petrobras, Gilead Sciences Inc, ... ||| Permit Capital, LLC Buys ViacomCBS Inc, Qurate Retail Inc, Sells Viacom Inc, Goldman Sachs ... ||| Camber Capital Management LLC Buys Gilead Sciences Inc, Global Blood Therapeutics Inc, Ventas ... ||| Valueworks Llc Buys Mammoth Energy Services Inc, Cheniere Energy Inc, Gilead Sciences Inc, ... ||| Half-Inflated Bubbles Are A Buy ||| Report: Gilead Struggling to Find Subjects for COVID-19 Drug Trial ||| 2 Reasons to Be Optimistic About Gilead Sciences’ Future ||| IBB, GILD, VRTX, BIIB: ETF Outflow Alert ||| Is Viking Therapeutics' Stock a Buy? ||| Moderna Will Rebound, But Wait for a Dip Lower to Buy Shares ||| The Wuhan Virus and Research-Focused Biotech Companies ||| Your Dirty Dozen",1,0.5372318
2020-02-19,7754000.0,67.19999694824219,67.54000091552734,66.81999969482422,67.3499984741211,66.13982391357422,GILD,"3 Contrarian Stocks to Buy Now for Absolute Returns ||| Where Will Gilead Sciences Be in 10 Years? ||| Gilead Sciences Option Alert: Mar 20 $75 Calls Sweep (28) near the Ask: 500 @ $0.52 vs 14425 OI; Ref=$67.3588 ||| Gilead to Present at the Cowen and Company 40th Annual Health Care Conference on Monday, March 2, 2020",0,0.4925065
2020-02-20,8697200.0,67.26000213623047,67.36000061035156,66.0999984741211,67.0,65.7961196899414,GILD,"Notable Thursday Option Activity: STX, UNP, GILD ||| Why Wells Fargo Stock Looks Poised to Rebound",1,0.515366
2020-02-21,22478200.0,67.18000030517578,69.77999877929688,66.80999755859375,69.69999694824219,68.44760131835938,GILD,"A Plan to Use Blockchain to Stop Counterfeit Drugs Moves Forward ||| Nasdaq 100 Movers: ALGN, BMRN ||| Gilead Sciences Option Alert: Mar 20 $80 Calls Sweep (44) near the Ask: 528 @ $0.62 vs 23628 OI; Ref=$69.25 ||| Gilead shares are trading higher. The company's collaboration partner Galapagos said it expects Filgotinib approval in the US, Europe and Japan. ||| Gilead Sciences Option Alert: Mar 20 $65 Calls Sweep (2) near the Ask: 1014 @ $4.5 vs 8617 OI; Ref=$68.6795 ||| Gilead Sciences Option Alert: Mar 20 $70 Calls Sweep (3) near the Ask: 500 @ $1.861 vs 14420 OI; Ref=$68.63 ||| Gilead Shares Rise 1.5% Premarket; Galapagos Announced Co, Gilead Expect Approval of First Product Candidate, Filgotinib, in RA in the U.s., Europe, and Japan ||| Most Active Equity Options For Midday - Friday, Feb. 21",1,0.49488446
2020-02-24,42905000.0,73.88999938964844,74.5199966430664,71.58999633789062,72.9000015258789,71.59010314941406,GILD,"3 Dividend Stocks That Raised Their Payouts in February ||| Biotech Stocks Mixed But Outperform The Market On A Down Day ||| Market Briefing for Monday, February 24 ||| Health Care Sector Update for 02/24/2020: NGM,UTHR,GILD,EPZM ||| Gilead Antiviral Drug Shows the Most Potential for COVID-19, Says WHO Official ||| Health Care Sector Update for 02/24/2020: UTHR,GILD,EPZM ||| Stock Market News: Berkshire Sinks Despite Buffett Optimism; Gilead Rises on Coronavirus Hopes ||| Nasdaq 100 Movers: AAL, GILD ||| S&P 500 Movers: AAL, GILD ||| Chip Stocks, Apple, Airlines Among Hardest Hit As Stocks Plunge On Coronavirus Spread ||| PreMarket Prep Stock Of The Day: Gilead Sciences ||| Gilead Sciences Option Alert: Jan, 2022 $100 Calls Sweep (2) near the Ask: 500 @ $2.8 vs 4912 OI; Ref=$72.95 ||| Gilead Sciences Option Alert: Mar 20 $70 Calls Sweep (2) near the Ask: 500 @ $4.5 vs 18026 OI; Ref=$72.8664 ||| Gilead Sciences Option Alert: Mar 20 $80 Calls at the Ask: 1000 @ $1.4 vs 20677 OI; Ref=$73.93 ||| Shares of Gilead Sciences are trading higher amid the non-Chinese spread of coronavirus due to the company's ongoing trial to treat coronavirus. ||| Market Briefing for Tuesday, February 25 ||| TrueNorth, Inc. Buys Invesco BulletShares —…—– High Yield Corporate Bon, Micron ...",0,0.49190724
2020-02-25,39199200.0,73.7300033569336,73.8499984741211,69.0199966430664,70.0999984741211,68.84041595458984,GILD,"8 of the Best Stocks to Buy for ESG Investors ||| U.S. Health Official Warns: COVID-19 Will Hit the United States ||| U.S. Health Officials Start First Clinical Trial With Gilead Sciences' Experimental Coronavirus Treatment ||| NIO Stock Will Sustain Momentum in 2020 Despite Coronavirus Concerns ||| 11 Best Stocks to Ride Out the Coronavirus Outbreak ||| Nasdaq 100 Movers: GILD, REGN ||| Is It Too Late to Buy High-Flying Galapagos? ||| NIAID's Fauci Says The Earliest A Coronavirus Vaccine Could Be Tested And Available To Public Would Be A Year Or A Year And A Half ||| Gilead Shares On Watch As NIAID's Fauci Discusses Trials For Co.'s Candidate ||| National Institutes Of Health Says Those With Confirmed Coronavirus Infection With Mild, Cold-Like Symptoms Or No Apparent Symptoms Will Not Be Included In Remdesivir Trial; Must Have Laboratory-Confirmed Coronavirus Infection ||| Clinical Trial of Remdesivir To Treat Coronavirus Begins Study; Enrolling Hospitalized Adults With Coronavirus In Nebraska ||| Gilead Sciences shares are trading lower, potentially selling off from Monday strength. Shares gained on Monday after the WHO said the company's experimental drug may be a coronavirus treatment candidate. ||| Gilead Sciences Option Alert: Mar 20 $70 Calls Sweep (3) near the Ask: 506 @ $4.394 vs 19554 OI; Ref=$73.0738 ||| Hearing US Will Start Testing Gilead's Remedesivir To Treat Coronavirus ||| Gilead Shares Volatile But Largely Unaffected Following Earlier Bloomberg Article 'Gilead's Drug Leads Global Race for Coronavirus Treatment' ||| The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement ||| Investing in Biotech Stocks the Right Way During an Epidemic ||| Four Stocks to Watch as the Race for a Coronavirus Vaccine Picks Up",1,0.5221004
2020-02-26,35000500.0,71.31999969482422,75.47000122070312,70.72000122070312,74.69999694824219,73.35775756835938,GILD,"Noteworthy ETF Inflows: IBB, GILD, VRTX, BIIB ||| Resilience to Coronavirus Concern Is a Bullish Sign for Alibaba Stock ||| Novavax to Begin Clinical Testing of Coronavirus Vaccine by Late Spring ||| 7 Safe Stocks to Buy on the Coronavirus Dip ||| Airport Screeners Are Likely Missing 2 Out of 3 COVID-19 Carriers, Researchers Warn ||| Gilead’s Coronavirus Drug Could Propel GILD Stock Much Higher ||| Should You Buy Inovio Pharmaceuticals Stock Right Now? ||| Gilead Reports Initiation Of 2 Phase 3 Studies Of Remdesivir For Coronavirus ||| Shares of several healthcare and biotech companies are trading higher. Not seeing any news to justify the price action. ||| Gilead Sciences Option Alert: Mar 20 $80 Calls Sweep (9) near the Ask: 1000 @ $1.301 vs 23681 OI; Ref=$72.32 ||| Gilead Sciences Option Alert: Mar 20 $72.5 Calls Sweep (78) near the Ask: 1382 @ $3.116 vs 9226 OI; Ref=$72.16 ||| Shares of several healthcare and biotech companies are trading higher. Movement appears market related as equities have rebounded this session following recent selloffs. ||| 24 Healthcare Stocks Moving In Wednesday's Pre-Market Session ||| Special Issue: Coronavirus, Amarin, The WHO And Pandemic Bonds. ||| Ronald Muhlenkamp's Firm Exits Celgene, Trims Gilead Position ||| Special Issue: Coronavirus, Amarin, The WHO And Pandemic Bonds ||| Most Active Equity Options For Midday - Wednesday, Feb. 26",0,0.5030101
2020-02-27,51442400.0,78.30999755859375,78.87999725341797,72.26000213623047,72.66000366210938,71.35442352294922,GILD,"Nasdaq 100 Movers: AAL, GILD ||| S&P 500 Movers: FLIR, PWR ||| Stock Alert: GILD Gains After Initiating Phase 3 Studies For COVID-19 Treatment ||| Momentum Stocks Benefitting From Coronavirus ||| Why Inovio Pharmaceuticals, Gilead Sciences, Moderna, and Novavax Are All Jumping Today ||| Fighting The Deadly Coronavirus ||| Buy Microsoft Stock On The Dip Over Coronavirus ||| Noteworthy Thursday Option Activity: SAIA, GILD, MA ||| April 9th Options Now Available For Gilead Sciences (GILD) ||| Forty Seven Shares Spike Sharply Higher After Hours As Hearing Co. Had Discussions About Various Options With Gilead ||| Stocks That Hit 52-Week Highs On Thursday ||| Benzinga's Top Upgrades, Downgrades For February 27, 2020 ||| Barclays Initiates Coverage On Gilead Sciences with Underweight Rating, Announces $62 Price Target ||| 28 Healthcare Stocks Moving In Thursday's Pre-Market Session ||| The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy ||| Gilead Sciences shares are trading higher after the company announced it has initiated 2 Phase 3 studies of remdesivir in adults diagnosed with the Coronavirus. ||| Gilead to Widen Testing of Antiviral Drug in Hong Kong, South Korea, other Asian Markets ||| Dow Plunges 1,200 Points As Stock Market Melts Down Again On Coronavirus Fears ||| Just Four S&P 500 Stocks Up This Week ||| Gilead Sciences Clears Key Benchmark, Hitting 80-Plus RS Rating ||| Dow Jones Plunges 650 Points On Rapidly Spreading Coronavirus; Microsoft Plunges On Revenue Warning ||| Ariel Investments Bobrinskoy Isn't Panicking Over Covid-–9 ||| Ariel Investments' Bobrinskoy Isn't Panicking Over Covid-–9 ||| Gilead Sciences (GILD) Surges: Stock Moves 6.6% Higher ||| Most Active Equity Options For Midday - Thursday, Feb. 27",0,0.4936474
2020-02-28,33804800.0,70.16999816894531,71.08000183105469,66.62999725341797,69.36000061035156,68.11370849609375,GILD,"Gilead Sciences (GILD) Shares Cross 4% Yield Mark ||| Health Care Sector Update for 02/28/2020: ALT,FTSV,GILD,CLSN ||| 3 Small-Caps That Are Soaring Because of Coronavirus Panic ||| Gilead Reportedly in Talks to Acquire Cancer Biotech Forty Seven ||| Health Care Sector Update for 02/28/2020: DNLI,ALT,FTSV,GILD,CLSN ||| Stock Alert: Forty Seven Surges 30% ||| Dow Falls Another 350 Points on Coronavirus Concerns, Worst Week Since 2008 ||| How Gilead Sciences Is Driving Forty Seven and Trillium Therapeutics Higher Today ||| Forty Seven (FTSV) Soars On Reports Of Takeover Interest ||| This Under-the-Radar Stock Is the Biggest Winner From the Coronavirus Outbreak ||| Health Care Sector Update for 02/28/2020: FTSV, GILD, SGMO, BHVN, JNJ, PFE, ABT, MRK, AMGN ||| Gilead Sciences shares are trading lower after DZ Bank downgraded the stock from Buy to Hold. NOTE: Many stocks in the healthcare sector are trading lower with the overall market amid continued coronavirus fears. ||| Gilead Sciences Option Alert: Jun 19 $80 Calls Sweep (4) near the Ask: 1000 @ $2.5 vs 8423 OI; Ref=$68.2 ||| Gilead Eyes Takeover Of Cancer Biotech Forty Seven: Report ||| The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO ||| DZ Bank Downgrades Gilead Sciences to Hold ||| Coronavirus News: As Covid-19 Infects Stock Market, Economy And Business Face Test ||| Stocks Pare Losses As Some Techs, Key ETF Show A Possible Low ||| Week In Review: Bulls Get Sick ||| Most Active Equity Options For Midday - Friday, Feb. 28",1,0.49996486
2020-03-02,31113000.0,70.31999969482422,75.41000366210938,70.08000183105469,75.4000015258789,74.0451889038086,GILD,"FDA Approves Coronavirus Tests in Academic Laboratories Across U.S. ||| Coronavirus: Emerging Numbers Provide Reasons for Calm ||| Here's Why Hype Around Companies Working on Coronavirus Treatments Is Overblown ||| Week In Review: CICC Capital Closes $229 Million China Fund For Biologics ||| All the Stocks I'm Selling If the Coronavirus Keeps Spreading ||| 2 Stocks That Can Help You Protect Your Wealth From a Coronavirus Pandemic ||| 2 Biotech Stocks Winning the Coronavirus Race ||| 7 Stocks to Buy as a Hedge Against The Coronavirus Threat ||| Better Buy: Gilead Sciences vs. Pfizer ||| Barron's Picks And Pans: COVID-19 Stocks, Intel, Tesla And More ||| Information And Panic In The Digital Age ||| Daily Markets: Investors Hoping Central Banks Will Relieve Coronavirus Pressures ||| Now Is the Time to Buy the Dip in Amazon Stock for the Long Term ||| Dow Jones Recovers 1,300 Points Despite Increase in U.S. Coronavirus Deaths ||| Gilead Sciences Acquiring Cancer-Focused Biotech Forty Seven for $4.9 Billion ||| Health Care Sector Update for 03/02/2020: CODX,FTSV,GILD,APDN,UMRX ||| Health Care Sector Update for 03/02/2020: FTSV, GILD, KPTI, CODX, JNJ, PFE, ABT, MRK, AMGN ||| Why Gilead Sciences, Forty Seven, and Trillium Therapeutics Are Moving Higher Today ||| Forty Seven's Stock Surges As Gilead Sciences To Buy Company In $4.9 Bln Deal ||| 3 Top Biotech Stocks to Buy in March ||| How The COVID-19 Outbreak Is Benefiting Biotech Investors ||| Mid-Afternoon Market Update: Dow Jumps 800 Points; China Pharma Shares Spike Higher ||| How To Approach The Market This Week: PreMarket Prep Recap For March 2, 2020 ||| Mid-Day Market Update: Crude Oil Rises Over 3%; Novavax Shares Plunge ||| Shares of several healthcare companies are trading higher in sympathy with the overall market as it rebounds from a selloff caused by coronavirus fears. ||| Mid-Morning Market Update: Markets Open Higher; Gilead To Buy Forty Seven For $4.9B ||| Gilead Confirms Deal To Buy Biotech Forty Seven For $4.9B ||| Benzinga Pro's Top 5 Stocks To Watch For Mon., Mar. 2, 2020: GILD, BIDU, CODX, MRKR, APDN ||| Gilead to Acquire Forty Seven for $95.50/Share Cash ||| Gilead's $4.9 Bln Deal Shows Regular Death Goes On ||| The Supply Chain Problem: How a Coronavirus-Driven Recession Would Present Unique Challenges ||| 5 Biotechs That Escaped the Coronavirus Onslaught Last Week",0,0.5260139
2020-03-03,24482000.0,74.2699966430664,74.81999969482422,71.51000213623047,74.20999908447266,72.8765640258789,GILD,"Trump Administration Considers Reimbursing Hospitals to Treat Uninsured Coronavirus Patients ||| Kids May Be the Hidden Carriers of COVID-19 ||| Inovio Has Potential Beyond Its Speculative Coronavirus Vaccine ||| Nasdaq 100 Movers: ADSK, TSLA ||| Nasdaq CEO Says Capital Is Part of Curing the Coronavirus ||| National Institutes For Health Head Fauci Says We Should Know Within Several Months Whether Gilead's Antiviral Coronavirus Treatment Works, Sees Implementation 'Imminent' Afterward ||| Gilead Sciences shares are trading lower. NOTE: The company on Monday announced it will acquire Immuno-oncology therapy developer Forty Seven for $95.50/share in cash, or around $4.9 billion total. ||| The Daily Biotech Pulse: GenMark Diagnostics Ships COVID-19 Test Kits, Karyopharm To Offer Shares, And More ||| Pfizer Works On Compounds That May Help Stop Coronaviruses ||| Gilead Sciences Inc (GILD) EVP,Corp Affairs & Gen Counsel Brett A Pletcher Sold ... ||| Gilead to Buy Immuno-Oncology Company Forty Seven for $4.9B ||| Trump Asks Pharma Firms to Step Up Coronavirus Vaccine Work ||| Pfizer Plans Coronavirus Therapy, Progresses With Tanezumab BLA",1,0.51680017
2020-03-04,23741700.0,74.9000015258789,76.01000213623047,72.58999633789062,76.01000213623047,74.64422607421875,GILD,"Buy Regeneron Stock for Coronavirus 2.0 and Beyond ||| China Approves a Treatment for COVID-19 Complications ||| Why It’s Probably Safe to Start Buying AMD Stock on Weakness ||| Wednesday's ETF with Unusual Volume: MDIV ||| Why Forty Seven Stock Soared 57% in February ||| Barrick Gold Isn’t the Best Hedge Against the Coronavirus ||| Is Gilead Sciences the Best Buy in the Coronavirus Sell-Off? ||| Gilead Sciences Option Alert: May 15 $80 Calls Sweep (2) near the Ask: 503 @ $4.0 vs 12396 OI; Earnings 4/30 After Close [est] Ref=$75.56 ||| Biotech Stock Roundup: GILD to Buy Forty Seven, Pipeline Updates From BIIB & More ||| Are Options Traders Betting on a Big Move in Gilead (GILD) Stock?",1,0.51875347
2020-03-05,22727600.0,75.0,77.5,74.52999877929688,76.12999725341797,74.7620620727539,GILD,"Inovio Pharmaceuticals Rapidly Becoming The Premier Coronavirus Play ||| Is iShares Nasdaq Biotechnology Index Fund a Buy? ||| Nasdaq 100 Movers: AAL, NTES ||| Is Inovio Stock a Buy on Coronavirus Cure Potential? ||| Up 2000% on Coronavirus Worries, CODX Stock Is a Short-Term Buy ||| 3 Biotech Stocks That Are Coronavirus Safe Havens ||| Is Inovio Stock Still a Buy After Its Massive 150% Leap This Year? ||| Gilead Sciences Option Alert: Jan 15 $110 Calls Sweep (18) near the Ask: 535 @ $2.08 vs 2732 OI; Earnings 4/30 After Close [est] Ref=$76.93 ||| How To Trade Stocks: Do You Know The Seven Most Important Words On Wall Street? ||| Regeneron (REGN) Gains from Focus on Coronavirus Treatments ||| Why Is Gilead (GILD) Up 15.4% Since Last Earnings Report? ||| Alnylam, Vir Collaborate on RNAi Therapy for Coronavirus ||| Most Active Equity Options For Midday - Thursday, March 5",1,0.50365055
2020-03-06,31704700.0,75.31999969482422,80.4000015258789,75.0999984741211,80.22000122070312,78.77857971191406,GILD,"Amid the Coronavirus Frenzy, Novavax Remains a Risky Bet ||| 4 Top Stock Trades for Monday: AMD, WMT, CRM, GILD ||| Is There a Cure for the SARS-CoV-2 Coronavirus? ||| 3 Top U.S. Stocks to Watch in March ||| Here's My Top Stock to Buy in March ||| EPA Releases List of Disinfectants to Protect Against Coronavirus ||| Gilead Sciences Option Alert: May 15 $90 Calls Sweep (66) near the Ask: 1794 @ $4.846 vs 7861 OI; Earnings 4/30 After Close [est] Ref=$79.01 ||| Gilead Sciences Option Alert: Mar 20 $79 Calls Sweep (25) near the Ask: 1668 @ $3.937 vs 599 OI; Earnings 4/30 After Close [est] Ref=$79.175 ||| Gilead Sciences shares are trading higher after hearing that Evercore said data from Gilead China on the coronavirus could arrive this month. ||| Hearing Evercore Saying Data From Gilead China On Coronavirus Could Arrive This Month ||| Can-Fite (CANF) to Explore RA Drug for Coronavirus Treatment",0,0.52001
2020-03-09,32839400.0,77.91999816894531,78.19000244140625,73.08999633789062,73.5199966430664,72.19895935058594,GILD,"Gilead Sciences Could Be the First to Beat the Coronavirus ||| 3 Stocks That Are Actually Up Because of the Coronavirus ||| Is The Stock Market About To Crash: Should I Sell My Stocks Now Or Is It Still Overvalued? ||| Is Inovio Pharmaceuticals Stock the Cure for Your Portfolio? ||| FDA Warns Companies Selling Fraudulent COVID-19 Products ||| Moderna Stock’s Winning Streak Seems Likely to End ||| Will Gilead Sciences Make a Fortune Off Its Coronavirus Drug? ||| GILD Crosses Above Average Analyst Target ||| Better Buy: Amgen vs. Gilead Sciences ||| CDC Says Coronavirus Spread to Continue Into 2021 ||| Study Warns Number of U.S. COVID-19 Cases Much Higher Than Reported ||| Gilead Shares Unaffected Amid Co. Press Release Highlighting New Data On Biktarvy Presented At CROI 2020 ||| TD Ameritrade Index Shows Retail Investors Were Pessimistic In February ||| Investor Movement Index Summary: February 2020 ||| Gilead Sciences shares are trading lower after RBC Capital downgraded the stock from Top Pick to Outperform. ||| Benzinga's Top Upgrades, Downgrades For March 9, 2020 ||| RBC Capital Downgrades Gilead Sciences to Outperform, Announces $86 Price Target ||| Stocks To Watch: Gilead Sciences Sees RS Rating Rise To 93 ||| Most Active Equity Options For Midday - Monday, March 9",0,0.49570602
2020-03-10,27660000.0,75.51000213623047,75.55999755859375,68.77999877929688,72.33999633789062,71.04016876220703,GILD,"COVID-19 Nearing Pandemic Level, WHO Warns ||| Nasdaq 100 Movers: GILD, TSLA ||| IBB, GILD, VRTX, BIIB: Large Outflows Detected at ETF ||| FDA Postpones All Foreign Inspections Over Coronavirus ||| The Gates Foundation and Friends Launch COVID-19 Treatment Accelerator ||| 7 Big Pharma Companies Trump Asked to Fight the Coronavirus Outbreak ||| AbbVie to Test HIV Drug as a Potential Coronavirus Treatment ||| GILD Stock Looks Poised for a Serious Coronavirus Bump ||| How to Be Greedy When Others Are Fearful ||| 3 Profitable Healthcare Stocks That Are Trouncing the Market During the Coronavirus Correction ||| How Close Are Biotechs To Bringing A COVID-19 Treatment To Market? ||| Treatment With Gilead's Vesatolimod Is Evaluated For Safety And Virologic And Immunologic Response Versus Placebo In Phase 1B HIV Functional Cure Study ||| Gilead Presents 96-Week DISCOVER Trial Data Demonstrating 'Favorable Renal and Bone Safety Profile of Descovy for HIV PrEP in At-Risk Populations' ||| Gilead Sciences shares are trading lower, not currently seeing company-specific news. Weakness potentially related to profit taking, as the company is working on a coronavirus treatment and has performed well amid the outbreak. ||| ' Sectors Holding Up Well Despite Market Selloffs ||| Most Active Equity Options For Midday - Tuesday, March 10",1,0.5312402
2020-03-11,32018600.0,73.9000015258789,75.37999725341797,72.77999877929688,73.69999694824219,72.375732421875,GILD,"CDC: Gilead Sciences' Remdesivir Is Being Used to Treat Coronavirus Patients ||| World Health Organization: Coronavirus Disease COVID-19 Now a Pandemic ||| Nasdaq 100 Movers: WDC, NTES ||| S&P 500 Movers: WCG, DXC ||| Better Coronavirus Stock: Gilead Sciences vs. Inovio Pharmaceuticals ||| 5 Biotech Stocks to Buy for a Strong Growth Prognosis ||| Gilead Highlights New Clinical Study Data For GS-6207 Presented At CROI 2020 ||| Gilead (GILD) Announces Positive Long-Term Results on Descovy ||| Pharma M&A Has Slowed to a Crawl",0,0.49262765
2020-03-12,26364600.0,70.44000244140625,72.86000061035156,67.87999725341797,68.58000183105469,67.97490692138672,GILD,CDC Releases List of Conditions That Increase the Risk of Severe Coronavirus Illness ||| 10 Health and Pharmaceutical Companies Fighting the Coronavirus ||| Why iBio Pharma Stock Is Not for Timid Investors Despite Great Potential ||| Shares of several healthcare companies are trading lower as equities sell off amid continued global coronavirus concerns. The virus has caused global economic disruption and negatively impacted stocks across sectors. ||| 4 Sectors in Focus Following Coronavirus-Induced Selloff ||| Stocks To Watch: Gilead Sciences Sees Relative Strength Rating Rise To 92,1,0.53452265
2020-03-13,30116100.0,71.93000030517578,72.0,67.5,70.75,70.12576293945312,GILD,Eli Lilly Joins the Hunt for a Coronavirus Treatment ||| Shares of several healthcare companies are trading higher as the market rebounds following Thursday's selloff. NOTE: Since the coronavirus outbreak the healthcare sector has been extremely volatile. ||| Coronavirus and Pharma: Will Emergency Approvals Help or Hurt? ||| Stocks Trade Near Lowest Levels Of Session As Gains Thin Out ||| Coronavirus Drug Development Efforts Pick Up Amid Sell-Off ||| Roche's (RHHBY) Coronavirus Test Achieves EUA From the FDA ||| How Investors Made $5 Billion From The Coronavirus Panic ||| Last Stocks Above Their Moving Averages,0,0.5130197
2020-03-16,26764600.0,67.23999786376953,72.80000305175781,64.41000366210938,68.9000015258789,68.29208374023438,GILD,"Early Results Dampen Outlook for Experimental COVID-19 Treatment ||| Why This Coronavirus Stock Will Keep Growing Long After the Outbreak is Over ||| When Will the Coronavirus Market Crash Be Over? Watch These 3 Stocks ||| Will Your Elective Surgery Be Delayed by Coronavirus? ||| As the Coronavirus Worsens, INO Stock Gets More Interesting ||| 7 Biotech Stocks to Buy and Hold in 2020 ||| Can This American Biotech Company Save the Global Economy? ||| Gilead Up as Remdesivir Shows Promise in Treating Coronavirus ||| Hyman Charles D Buys Truist Financial Corp, General Motors Co, Vanguard Information Tech, Sells ... ||| 4 Big Drug/Biotech Stocks Up in Coronavirus-Hit Economy",1,0.51695883
2020-03-17,28823700.0,70.0,76.08000183105469,69.0,74.5199966430664,73.86249542236328,GILD,3 Cloud Computing Stocks That Are Winning From the Coronavirus ||| Coronavirus Correction: 3 Must-Own Dividend Stocks ||| 8 Best Performing Stocks During the 2020’s Market Meltdown ||| Why Regeneron Pharmaceuticals Stock Is Bolting Higher Today ||| This IBD Stock Of The Day Plans To Test A Coronavirus Drug This Summer ||| Top Companies Racing to Prevent the Spread of Coronavirus Fear,1,0.5127962
2020-03-18,34965900.0,73.61000061035156,80.0,72.97000122070312,79.41999816894531,78.7192611694336,GILD,"Bayer Is Donating Its Malaria Drug That Could Help Coronavirus Patients In The U.S. ||| Trump Signs Coronavirus Relief Bill Into Law ||| How to Survive the Economic Fallout from COVID-19 ||| Why Is Everyone Talking About Gilead Sciences? ||| Tweet From STAT News' Adam Feuerstein Includes Some Details Of Piper Sandler Note On Gilead's Remdesivir Potentially Being Approved For Broad Use In 'Coming Months' ||| Hearing Piper Analyst Suggesting Gilead's Remdesivir Could Be Approved For Coronavirus Infection 'Very Soon' ||| DZ Bank Upgrades Gilead Sciences to Buy ||| Gilead Sciences shares are trading higher amid continued global coronavirus concerns, as the company's experimental drug remdesivir is being evaluated as a potential coronavirus treatment candidate. ||| 3 Hot Biotech Coronavirus Stocks Breaking Out Now ||| Stock Charts To Watch - Wednesday, March 18 ||| Pharmaceutical Companies Gain in the Fight Against Covid-–9 ||| Hot Options Report For End Of Day - Wednesday, March 18 ||| The Zacks Analyst Blog Highlights: REGN, SNY, GILD and MRNA ||| Pfizer, Regeneron Give Update on Coronavirus Drug Development ||| Mallinckrodt Completes NDA Submission for Kidney Failure Drug ||| Most Active Equity Options For Midday - Wednesday, March 18",0,0.49985877
2020-03-19,46268200.0,80.9800033569336,85.97000122070312,78.29000091552734,78.55000305175781,77.85694122314453,GILD,"Mylan Ramps Up Production of Hydroxychloroquine as a Potential COVID-19 Treatment ||| China Reports No New Coronavirus Outbreaks, First Time Since Outbreak Began ||| Coronavirus-Fighting Tech Makes iBio Stock an Interesting Play ||| Japanese-Developed Flu Drug Avigan Seems Effective Against COVID-19 ||| Noteworthy ETF Inflows: ESGU, NEE, ADBE, GILD ||| Big Pharma's Fight Against the Coronavirus Pandemic: Good News and Bad News ||| Better Coronavirus Stock: Gilead Sciences or Regeneron Pharmaceuticals? ||| '250 patients have received $GILD's remdesivir through expanded access, new FDA info says' -Tweet From Pharma Pink Sheet Reporter ||| FDA Approves EPCLUSA For Pediatric Patients With Any Strain Of Hepatitis C ||| UPDATE: Jefferies Notes Trumps Public Announcement Of Fast Track Potential For New Coronavirus Therapies For Compassionate Use Only, Calls 'Not Material,' And 'A Relatively Minor Disappointment Vs Growing Investor Expectations' For Gilead ||| Hearing Jefferies Has Called Trump's Coronavirus Fast Track 'Somewhat Disappointing' For Gilead ||| Gilead Sciences Option Alert: Apr 17 $82.5 Calls Sweep (25) near the Ask: 331 @ $8.643 vs 1043 OI; Earnings 4/30 After Close [est] Ref=$81.9 ||| FDA's Hahn Clarifies Remdesivir Is Going Through Normal FDA Process ||| Gilead shares are trading higher amid continued coronavirus concerns, as the company's drug remdesivir is being evaluated as a potential coronavirus treatment candidate. Piper Sandler analysts said they believe the drug could soon receive approval. ||| Analyst Says Gilead's Remdesivir Could Be Approved 'Within Months' For COVID-19 Treatment ||| Is It Safe To Enter Downtrodden Stocks? ||| Even With This Crisis It's a Market of Stocks ||| Kyle Bass: You Can Be a Value Investor Again ||| The Stalwarts ||| Most Active Equity Options For Midday - Thursday, March 19",0,0.5076694
2020-03-20,35110200.0,79.5,81.5999984741211,72.16999816894531,73.26000213623047,72.61361694335938,GILD,"Gilead’s Coronavirus Vaccine Candidate Shows Promise, Says Cowen ||| These 4 Top Stocks Are Bear-Market Tested ||| Is It Too Late to Buy Coronavirus Biotech Stocks? ||| Trump’s Coronavirus News Conference on Thursday: 3 Key Things That Investors Should Know ||| 3 of the Strongest Stocks to Buy ||| Why BofA Has Low Expectations For Gilead's Remdesivir As Potential Coronavirus Treatment ||| The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company ||| Piper Sandler Upgrades Gilead Sciences to Overweight ||| Gilead's HCV Drug Epclusa Gets FDA Nod for Expanded Age Group ||| Most Active Equity Options For Midday - Friday, March 20 ||| Biotechs Offer a Glimmer of Hope Amid the Deadly COVID-19 Outbreak ||| 5 Biotechs In Search Of A Coronavirus Vaccine ||| It's Time To Pull The Plug On The Shorter's Or Raging Bearish Market-Maker(s)",0,0.4945035
2020-03-23,19875200.0,75.30000305175781,75.30000305175781,68.86000061035156,72.61000061035156,71.96935272216797,GILD,"All the Drugs Proving Anecdotally Effective Against COVID-19, and the Companies That Make Them ||| Coronavirus Crisis: 3 Biotech Stocks to Buy Right Now ||| Gilead Stock Flies High With a Potential Coronavirus Treatment ||| Gilead Sciences Stops Accepting Emergency-Use Applications for Remdesivir ||| Don’t Forget About Stocks to Buy During the Coronavirus Crisis ||| 3 Things To Watch In The Coronavirus Bear Market This Week ||| 5 Stocks Moving In Monday's After-Hours Session ||| Gilead Sciences shares are trading higher as traders circulate word the company received FDA Orphan Drug Designation for Remdesivir as a treatment for the coronavirus. ||| Traders Circulate Word Gilead Receives FDA Orphan Drug Designation For Remdesivir As Treatment For Coronavirus ||| Shares of several healthcare companies are trading lower amid market volatility. Sunday's fiscal stimulus bill failed a procedural senate vote while the Fed Monday morning announced further stimulus measures to support liquidity. ||| Gilead shares are trading higher amid continued coronavirus concerns, as the company's drug remdesivir is being evaluated as a potential coronavirus treatment candidate. UPDAE Shares have since reversed and are now trading lower. ||| Glaxo's Long-Acting HIV Regimen Cabenuva Gets Canada's Nod ||| Most Active Equity Options For Midday - Monday, March 23 ||| Dow Jones Today, Futures Up: Stimulus Impasse; New York, California Lockdown; NYSE Floor Closes",1,0.5039522
2020-03-24,20608100.0,75.12999725341797,75.83000183105469,72.11000061035156,73.95999908447266,73.30744171142578,GILD,"10 Stocks to Buy as They Ride a Coronavirus Tailwind ||| Top-Notch Vaccine Technology Makes iBio Stock a Smart Bet ||| Inovio Could Be a Bargain Using Probability Analysis ||| 3 Biotech Stocks Fighting the Coronavirus; Here’s What to Expect ||| Why Consider These 2 Stocks When Markets Are Crashing? ||| US Indexes Regain Some Ground Tuesday ||| Lilly Halts Enrollment, Biotechs Focus to Find Coronavirus Cure",0,0.4855849
2020-03-25,24138100.0,73.87000274658203,74.48999786376953,69.33999633789062,69.66000366210938,69.04537963867188,GILD,"Gilead Asks the FDA to Rescind Orphan Drug Designation for Remdesivir as a Treatment for COVID-19 ||| Health Care Sector Update for 03/25/2020: GILD,ASTC,VTGN,ALLK ||| A COVID-19 Immunity Test Is on the Way ||| How Are Market Caps Doing in a Downturn ||| Moderna CEO Says a Coronavirus Vaccine Could Be Available in Emergencies This Fall ||| Coronavirus Drugs Already in the Pipeline ||| 5 Stocks to Buy in the Coronavirus Bear Market ||| 4 Reasons Biotech Stocks Are a Buy Right Now ||| Gilead Asks FDA To Rescind Orphan Drug Designation For Remdesivir, Says It Is Confident It Can Maintain Expedited Timeline ||| Zoom Video, Teladoc Lead The Coronavirus Short Squeeze Candidates ||| Gilead Sciences shares are trading lower, not currently seeing company-specific news. Movement appears market related as equities experience volatility amid US stimulus progress. ||| Top 5 Drug Stocks To Stop The Coronavirus Pandemic ||| Coronavirus Drug Development Race to Boost These 4 Stocks ||| Biotech Stock Roundup: HOTH & IMV to Develop Coronavirus Vaccines, & More",1,0.5197374
2020-03-26,18351900.0,69.9000015258789,73.91000366210938,69.75,73.86000061035156,73.20832061767578,GILD,"7 U.S. Stocks to Buy on Coronavirus Weakness ||| This PR Nightmare for GILD Stock Will Eventually Fade ||| May 8th Options Now Available For Gilead Sciences (GILD) ||| 1 Safe-Haven Stock for the Near Term ||| GILD Seeks To Revoke Coveted Status, ELOX Pauses Trial, PRQR On Watch ||| Gilead shares are trading higher as the global coronavirus outbreak continues. The company's drug remdesivir is being evaluated as a potential coronavirus treatment candidate. ||| Gilead Asks FDA to Withdraw Orphan Drug Tag for Remdesivir ||| Biotech Stocks Accelerate Efforts for Coronavirus Treatments ||| The Zacks Analyst Blog Highlights: Gilead Sciences, Regeneron, Sanofi, Moderna and Inovio Pharmaceuticals ||| Drug Developers Increasing Hope in Fight Against Coronavirus with Potential New Treatments ||| Markets Stop Short Of A Third Straight Day Of Gains",0,0.5033213
2020-03-27,16521600.0,73.70999908447266,75.38999938964844,71.91000366210938,72.8499984741211,72.20722961425781,GILD,"Noteworthy ETF Outflows: RSP, REGN, GILD, AMD ||| Nasdaq 100 Movers: EXPE, GILD ||| For Gilead, Its Coronavirus Treatment Is Icing on the Cake ||| 3 Things to Know if Chloroquine Wins the COVID-19 Treatment Race ||| Veeva Systems' CRM Product Is Seeing Ten Times More Usage During Coronavirus Pandemic",1,0.49232817
2020-03-30,15929400.0,75.3499984741211,76.41999816894531,73.88999938964844,75.93000030517578,75.26005554199219,GILD,"The 3 Most Resilient Stocks in the Bear Market Today ||| AskSlim Market - Friday, March 27 ||| Gilead Sciences Expands Access to Experimental COVID-19 Treatment ||| 3 Coronavirus-Proof Dividend Stocks That Are Perfect for Retirees ||| 2 Biotech Stocks in the Hunt for New Coronavirus Drugs; Oppenheimer Weighs In ||| Ex-FDA Chief Gottlieb Expects Coronavirus Therapeutic Option By Summer ||| Barron's Picks And Pans: Tech Picks, SoftBank, REITs, Tesla And More ||| 4 Reasons Drug Stocks Are a Buy Right Now ||| Is It Time To Buy Stocks Or Is The Market Heading Even Lower? ||| Gilead Expands Access To Investigational Anti-coronavirus Drug ||| Gilead shares are trading higher after the company said it would expand access to its experimental coronavirus treatment, Remdesivir. ||| Gilead Reports HSR Waiting Period For Forty Seven Deal Expired; Sees Tender Offer Closing Beginning In Apr. 2020 ||| COVID-19 Claiming Lives But Therapeutics Could Be on the Way ||| Sanofi Begins Kevzara Study for Severe Coronavirus Infection",0,0.5064511
2020-03-31,12111900.0,75.94999694824219,76.33000183105469,73.79000091552734,74.76000213623047,74.10037994384766,GILD,Is iBio Stock Worth the Risk as Coronavirus Continues to Spread? ||| 5 Hot Stocks for 2020 That Are Soaring While the Market Plunges ||| Gilead’s Cash and the Coronavirus Make GILD Stock Look Cheap ||| Gilead Sciences Option Alert: Apr 9 $85 Calls Sweep (24) near the Ask: 1031 @ $0.653 vs 571 OI; Earnings 4/30 After Close [est] Ref=$75.37 ||| Gilead Sciences (GILD) Stock Moves -1.54%: What You Should Know ||| Gilead Expands Access to Experimental Coronavirus Treatment ||| Drugmakers Test New Ways to Fight Coronavirus: 3 Stocks To Pick Up Now,0,0.49786755
2020-04-01,12177600.0,74.31999969482422,74.38999938964844,72.0,72.51000213623047,71.87023162841797,GILD,"Gilead Initiates Two Phase 3 Randomised Studies To Evaluate The Safety And Efficacy Of Its Investigational Treatment Remdesivir For Coronavirus ||| '$GILD says it's starting two more remdesivir studies vs Covid-19, in 15 UK hospitals.' -Jacob Plieth ||| Cullinan Associates Inc Buys Truist Financial Corp, Procter & Gamble Co, Gilead Sciences ... ||| First Financial Bank, N.A. - Trust Division Buys iShares Core MSCI EAFE, Gilead Sciences Inc, ... ||| No Foolin': ADP Report Better than Expected ||| Most Active Equity Options For Midday - Wednesday, April 1",1,0.50713164
2020-04-02,20482100.0,71.80999755859375,77.4800033569336,71.37999725341797,76.9800033569336,76.30079650878906,GILD,"GILD Stock Remains a Smart Play Now and in the Future ||| Top 3 Healthcare Stocks to Buy Right Now ||| Better Coronavirus Stock: Abbott Labs vs. Gilead Sciences ||| My Top Pharma Stocks to Buy in the Market Crash ||| Gilead Sciences Option Alert: Fri $81 Calls Sweep (16) near the Ask: 356 @ $0.283 vs 9594 OI; Earnings 4/30 After Close [est] Ref=$75.59 ||| Gilead Sciences shares are trading higher. The company on Wednesday announced it is initiating two phase 3 randomized studies as a potential coronavirus treatment. ||| Coronavirus Outbreak Updated: Keep Up With The Latest Headlines ||| RNC Genter Capital CEO Likes Tech, Health Care, Financials In Volatile Market ||| The Best and Worst-Performing S&P 5…… Stocks of the –st Quarter ||| Can Buffett-Style Investing Succeed Today? Stocks & ETFs to Consider ||| Recovering From the Coma ||| Acceptable Longs",1,0.5035597
2020-04-03,19421800.0,77.41000366210938,79.47000122070312,76.36000061035156,78.20999908447266,77.51994323730469,GILD,"EMA Recommends Remdesivir for Treatment of COVID-19 Under Compassionate-Use Rules ||| Noteworthy Friday Option Activity: MTSI, GILD, WYNN ||| Gilead Sciences’ Coronavirus Treatment Has Big-Time Potential ||| Why Gilead Sciences Shares Rose 7.79% in March ||| Better Buy: Gilead Sciences vs. Biogen ||| EMA recommends compassionate use of Gilead's remdesivir for COVID-19 ||| What's The Difference Between Coronavirus, SARS-CoV-2 and COVID-19? ||| UPDATE: EMA Gives Recommendations On Compassionate Use Of Gilead's Remdesivir For COVID-19 Coronavirus Infection ||| European Medicines Agency (European Equivalent Of FDA) Says Gilead's Remdesivir Shown To Be Active Against COVID-19, 2 SARS-, MERS-Coronavirus Infections, But Notes 'Currently Only Limited Data On Use' in COVID-19 Patients ||| Pharma Coronavirus Efforts Continue, Amgen & Incyte Join In ||| Incyte to Evaluate Lead Drug Jakafi for COVID-19 Infection ||| Most Active Equity Options For Midday - Friday, April 3",0,0.48441333
2020-04-06,19101100.0,79.23999786376953,79.6500015258789,75.87999725341797,77.7300033569336,77.04418182373047,GILD,"Should You Buy Forty Seven Before Gilead Sciences' Acquisition Closes? ||| Why Gilead Sciences Is the Hottest Stock to Buy Today ||| Barron's Picks And Pans: Post-Pandemic Ideas, Safe Dividends And More ||| Volatile Coronavirus Biotech Stock Plays ||| Gilead Has Treated More Than 1,700 COVID-19 Patients With Remdesivir ||| The 5 Best Coronavirus Stocks To Buy Right Now ||| Should You Buy Gilead Sciences Stock Right Now? ||| Yes, the Stock Market Will Probably Go Lower. Here's Why You Should Invest Anyway. ||| 3 Coronavirus Stocks That Could Lead the Market to Recovery ||| Gilead To Donate 1.5M Doses Of Experimental Coronavirus Treatment: 'The Right Thing To Do' ||| BUZZ-U.S. STOCKS ON THE MOVE-Kohl's, Carnival Corp, Akers Bioscience, Immunomedics ||| Gilead To Donate 1.5 Mln Doses Of Investigational COVID-19 Drug Remdesivir ||| Nasdaq 100 Movers: CTXS, ULTA ||| Coronavirus Fighter Gilead Sciences Might Be Expensive, but It’s Still Worth Owning ||| BUZZ-U.S. STOCKS ON THE MOVE-Carnival Corp, Capri Holdings, Kohl's, Immunomedics ||| Monday Sector Laggards: Healthcare, Energy ||| BUZZ-U.S. STOCKS ON THE MOVE-Borr Drillng, Millendo Therapeutics, Menlo Therapeutics, Immunomedics Inc ||| It’s Tough to Admit, but Our New Normal Might Justify Buying IBIO Stock ||| GSK to partner with Vir for potential COVID-19 treatments, invest $250 mln ||| Doctors embrace drug touted by Trump for COVID-19, without hard evidence it works ||| Gilead, Second Genome Enter Four-year Strategic Collaboration - Quick Facts ||| BUZZ-U.S. STOCKS ON THE MOVE-Gilead Sciences, Wayfair, Immunomedics, Akers Bioscience ||| Trump Says Spoke With Pharmaceutical Companies; Says 10 Different Therapeutic Agents Are In Active Trials, Says Will Be 'Fairly Quick Process' And Says A Second Company Was Approved To Start Vaccine Trials ||| STAT News Reporter Says CEOs Of Amgen, Genentech, Gilead And Regeneron Were Involved In Call With Trump ||| Gilead Analyst Sees Catalyst Ahead In Data Readout For Potential Coronavirus Treatment ||| 'Data for Gilead's potential coronavirus therapy are coming soon. Here's what you need to know' -Article From STAT News ||| Gilead Sciences and Second Genome Announce Strategic Collaboration in Biomarker and Inflammatory Bowel Disease Drug Discovery ||| How Will 'Virus Stocks' Fare After the Coronavirus? ||| Trinity Legacy Partners LLC Buys Gilead Sciences Inc, Verizon Communications Inc, Costco ...",0,0.49010447
2020-04-07,19917900.0,77.30000305175781,77.68000030517578,72.5,74.66999816894531,74.01116943359375,GILD,"BUZZ-U.S. STOCKS ON THE MOVE-Royal Caribbean, Kohl's, Gilead Sciences, Electronic Arts ||| Investors await data on coronavirus drugs as market rally builds ||| Is Inovio Pharmaceuticals a Good Buy on Coronavirus Potential? ||| BUZZ-U.S. STOCKS ON THE MOVE-Activision Blizzard, Gilead Sciences, Royal Caribbean, Kohl's ||| Tuesday Sector Laggards: Utilities, Healthcare ||| Here Are All the Companies Working on COVID-19 Vaccines, Treatments, and Testing ||| My Top Biotech Stocks to Buy in the Market Crash ||| Gilead Sciences Pins Its Hopes on Remdesivir ||| Gilead Unit Completes Acquisition Of Forty Seven - Quick Facts ||| BUZZ-U.S. STOCKS ON THE MOVE-Roadrunner Transportation, Gannett Co, Liminal BioSciences ||| Gilead Analyst Sees Over 50% Chance Of Success For Remdesivir In Mild-To-Moderate COVID-19 ||| 10 Short Squeeze Candidates If The Market Rally Continues ||| Gilead Sees Volume Spike As Traders Circulate German Website Suggesting Spokesperson For Federal Institute For Drugs And Medical Devices Confirmed 'Corona patients who are particularly seriously ill may...be treated with not yet approved remdesivir' ||| Jim Cramer, On CNBC's 'Squawk On The Street,' Says He Is More Bullish On Regeneron Than Gilead ||| Cantor Fitzgerald Reiterates Overweight on Gilead Sciences, Raises Price Target to $86 ||| Spirit Of America Management Corp Buys Hess Midstream Operations LP, Blackstone Group Inc, TC ... ||| Biotech Stocks, ETFs to Gain on COVID-19 Vaccine & Drug Progress ||| F&V Capital Management, LLC Buys FedEx Corp, Gilead Sciences Inc, PowerShares QQQ Trust Ser ... ||| Is Pharma the Sector to Bet on in 2020? 2 Big Stocks to Buy",1,0.50779414
2020-04-08,12215400.0,74.7300033569336,75.12999725341797,73.56999969482422,74.98999786376953,74.3283462524414,GILD,"Why Forty Seven Stock Skyrocketed 64.5% in March ||| Good News for Remdesivir Is Good News for Gilead Sciences Stock ||| Better Coronavirus Stock: Emergent BioSolutions vs. Gilead Sciences ||| Novavax to start human trial for novel coronavirus vaccine ||| UPDATE: RBC Issues Report On Gilead: 'New Remdesivir Trial Changes Aim To Maximize Odds, Though Suggests Dramatic Effects Unlikely' ||| Gilead Shares Tick Lower As Traders Circulate Comment From RBC Suggesting co. Updated Its ClinicalTrials.gov Listing For 2 Trials For Remdesivir For Coronavirus Treatment To Increase Enrollment, Revise Primary, Secondary Endpoints ||| Cardinal Capital Management, Inc. Buys TC Energy Corp, Pembina Pipeline Corp, Granite Real ... ||| Biotech Stock Roundup: AMGN & INCY Focus on Coronavirus Treatments, & More ||| ESG: Nature's Solutions Overshadowed By Vaccine Push",0,0.49620217
2020-04-09,12821100.0,74.37000274658203,74.5999984741211,72.94999694824219,73.51000213623047,72.86141204833984,GILD,"Bristol-Myers' win in U.S. patent case against Gilead boosted to $1.2 bln ||| Health Care Sector Update for 04/09/2020: BIOC,BHC,BHC.TO,RTIX,GILD ||| GILD May 29th Options Begin Trading ||| Nasdaq 100 Movers: CTXS, UAL ||| Gilead Canada Submits SNDS To Health Canada For Descovy - Quick Facts ||| Gilead Canada Reports Submission Of Supplemental New Drug Submission To Health Canada For Descovy For HIV Pre-Exposure Prophylaxis ||| Covid Report: Pfizer Selects Lead Coronavirus Drug; Gilead Updates Tests ||| Coronavirus Testing, Vaccines & Treatments: What You Should Know ||| Verity & Verity, LLC Buys Truist Financial Corp, Gilead Sciences Inc, JM Smucker Co, Sells ...",1,0.50830746
2020-04-13,16255600.0,75.80000305175781,76.0,73.72000122070312,75.27999877929688,74.61579132080078,GILD,"Lantz Financial LLC Buys Snap-on Inc, Abbott Laboratories, AbbVie Inc, Sells iShares Core ... ||| Johanson Financial Advisors, Inc. Buys Synopsys Inc, Gilead Sciences Inc, MFA Financial Inc, ... ||| Early Look at Gilead Sciences' Experimental Coronavirus Treatment Disappoints ||| 5 Biotech Stocks Winning the Coronavirus Race ||| Eli Lilly Starts Clinical Trial for Potential COVID-19 Treatment ||| Bloomberg Praises ""Uninterpretable"" Gilead Study While Bashing Trump ""Miracle Drug"" Hydroxychloroquine ||| Queen Elizabeth's Speech, Markets Look To Recover, And Pharma Works For A Vaccine ||| 3 Top Biotech Stocks to Buy in April ||| Is Galapagos Stock a Buy? ||| The Week Ahead In Biotech: Urogen FDA Decision, Amarin, J&J Earnings And More COVID-19 Updates ||| Dow Jones Futures: Coronavirus Stock Market Rally Awaits OPEC+ Production Deal; Microsoft, Netflix, Nvidia, Veeva, MSCI, Gilead, Apple Supplier Lumentum In FocusS ||| The Week Ahead In Biotech: Urogen FDA Decision, Amarin, J&J Earnings And More COVID-19 Updates ||| Gilead Says Remdesivir Improved 68% Of COVID-19 Patients In 53-Person Study ||| AMRN Chugs Along, ATHX To Initiate Pivotal COVID-19 Trial, WORX Soars 550% ||| Health Care Sector Update for 04/13/2020: PSTI,WORX,GILD,CANF ||| Health Care Sector Update for 04/13/2020: WORX,GILD,CANF ||| BUZZ-U.S. STOCKS ON THE MOVE-Netflix, Amazon.com, Dish Network, GE, AMC Entertainment, Aurora Cannabis ||| BUZZ-U.S. STOCKS ON THE MOVE-Amazon.com, Netflix, Royal Caribbean Cruises, Sabre Corp, Pluristem Therapeutics ||| Wall Street Week Ahead-Health, tech, staples could shine through earnings gloom ||| Wall Street set to dip as focus turns to earnings ||| Health Care Sector Update for 04/13/2020: CANF, CTSO, GILD, JNJ, PFE, ABT, MRK, AMGN ||| BUZZ-U.S. STOCKS ON THE MOVE-Carnival Corp, Gilead Sciencs, Pluristem Therapeutics, Dropbox, Scworx, Quintana Energy ||| Gilead Analysts Break Down Remdesivir Data Readout From Compassionate Use ||| Gilead Sciences Option Alert: Fri $71 Calls Sweep (9) near the Ask: 384 @ $3.9 vs 337 OI; Earnings 4/30 After Close [est] Ref=$74.39 ||| Gilead Sciences Option Alert: Fri $85 Calls Sweep (3) near the Ask: 7494 @ $0.12 vs 15594 OI; Earnings 4/30 After Close [est] Ref=$74.42 ||| India Today Journalist Tweets: '2 out of 3 #COVID19 patients have benefitted from Remdesivir drug - an observational study has found @ICMRDELHI director Dr Raman GangaKhedkar,' Says Need For Ventilator/Oxygen Was Found To Have Reduced After Administration ||| Gilead shares are trading higher after the company said its coronavirus treatment showed an improvement in 68% of cases. ||| Dow Jones Leads Market Lower, But This Top Coronavirus Stock Breaks Out ||| Coronavirus Stock Market Rally: Dow Jones Falls 350 Points, As Covid-19 Cases Continue To Rise; Amazon, Gilead Key Movers ||| Gilead Reports Promising Data on Experimental Coronavirus Drug ||| Dow Jones Today, Futures Slip; Earnings Season Looms, OPEC Deal Lifts Oil Stocks, Gilead Jumps On Coronavirus News",1,0.49768674
2020-04-14,14379300.0,75.9800033569336,77.8499984741211,75.33999633789062,77.75,77.06400299072266,GILD,"Three Reasons to Consider Buying Regeneron Stock ||| How Good Is Gilead's Latest News for Coronavirus Drug Remdesivir? ||| Gilead Shares Spike To Session High, Quickly Pare Gain, Following Comment From Trump Co.'s Remdesivir Is Showing 'Good Progress' ||| Gilead Sciences Option Alert: Jun 19 $90 Calls Sweep (2) near the Ask: 344 @ $2.42 vs 5076 OI; Earnings 4/30 After Close [est] Ref=$76.3 ||| ETFs to Rise as Gilead Drug Shows Promise in Coronavirus Cure ||| First Bank & Trust Buys Cisco Systems Inc, Mastercard Inc, Merck Inc, Sells Visa Inc, ... ||| Will Stem Cell Therapies Aid in Fight Against Coronavirus?",0,0.5035776
2020-04-15,11397400.0,76.16000366210938,76.58999633789062,74.47000122070312,74.62999725341797,73.97152709960938,GILD,"AstraZeneca to Test Blood Cancer Drug for COVID-19 Treatment ||| Chinese Researchers Suspend Trial of Experimental Coronavirus Treatment ||| BUZZ-U.S. STOCKS ON THE MOVE-U.S. oil stocks, retailers, restaurants, BofA, J.C. Penny, IBM, Gilead, LyondellBasell ||| Initial Coronavirus Treatment Trials Look Good for Gilead Stock ||| Gilead Stock Could Get a Lift From a Coronavirus Treatment ||| Is Moderna a Good Coronavirus Stock To Buy? ||| Arcus Bio Shares Volatile After Hours Amid Report Gilead To Hold Talks To Take Stake In Co. ||| Why Gilead's Stock Is Trading Lower Today ||| Gilead's Spokesperson Confirms Remdesivir Trial In China In Patients With Severe Disease Was 'Terminated Early Due To Low Enrollment'; Trial In China In Patients With Moderate Disease Now Listed On Clinicaltrials.gov As Suspended ||| Every Member Of Trump's 'Great American Economic Revival' Industry Groups ||| Gilead Sciences shares are trading lower after trials of the company's potential coronavirus candidate Remdesivir were suspended in China due to low enrollment. ||| Gilead Shares Fall To Pre-Market Low As Hearing Co. Trial For Remdesivir In China Has Been Suspended",1,0.492512
2020-04-16,20935400.0,74.83999633789062,76.95999908447266,74.44999694824219,76.54000091552734,75.86467742919922,GILD,"Is Exelixis a Buy? ||| GLOBAL MARKETS-Asian stocks set to rise as markets brace for China GDP data ||| Dollar wobbles as fresh hopes for virus treatment prop up risk appetite ||| Report says COVID-19 patients respond to Gilead's remdesivir, shares surge ||| U.S. stock futures jump late following data on potential virus treatment, Trump guidelines ||| Gilead surges after report suggests COVID-19 patients responding to remdesivir ||| Health Care Sector Update for 04/16/2020: SNGX, GILD, RCUS, RAD, JNJ, PFE, ABT, MRK, AMGN ||| Why Arcus Biosciences Stock Is Skyrocketing Today ||| Gilead Sciences’ Remdesivir Data Release Brings Much Needed Relief for Patients and Investors ||| Why Gilead Sciences Stock Is on Fire Today ||| Gilead Sciences Drug Shows Promising Results In Covid-19 Patients; Stock Up 14% ||| Gilead Says Expect Data From Phase 3 Study in Patients With Severe Covid-19 Infection to Be Available at End of April ||| Gilead Says Understand the Urgent Need for a Covid-19 Treatment and the Resulting Interest in Data on Our Investigational Antiviral Drug Remdesivir; Says Anecdotal Reports Do Not Provide Statistical Power Necessary to Determine Safety, Efficacy Profile of Remdesivir as Treatment for Covid-19 ||| Big Stocks Moving After Hours As Market Cheers Gilead, 'Reopening' Updates ||| Gilead's Encouraging Remdesivir Data: Rapid Reaction On The Stock ||| 7 Stocks Moving In Thursday's After-Hours Session ||| Gilead Sciences shares are trading higher after a report noted that data from a clinical trial on the company's remdesivir drug suggests coronavirus patients are responding to treatment. ||| 'Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment' -STAT News ||| Gilead Sciences Option Alert: Aug 21 $110 Calls Sweep (7) near the Ask: 321 @ $1.772 vs 10932 OI; Earnings 4/30 After Close [est] Ref=$76.2501 ||| Gilead Sciences Option Alert: Aug 21 $80 Calls Sweep (33) near the Ask: 530 @ $5.947 vs 6241 OI; Earnings 4/30 After Close [est] Ref=$74.66 ||| Market Briefing for Friday, April 17 ||| Mechanics Bank Trust Department Buys PowerShares QQQ Trust Ser –, VanEck Vectors ... ||| US Indexes Close Higher Thursday ||| Dow Jones Futures Jump On Gilead, Boeing News: Ride The Coronavirus Stock Market Rally Wave With These Eight Sectors ||| Jag Capital Management, Llc Buys Akamai Technologies Inc, Gilead Sciences Inc, Vertex ... ||| Gilead Down on Suspension of Coronavirus Study in China ||| Most Active Equity Options For Midday - Thursday, April 16 ||| Which Stocks Will Be The Big COVID-19 Winners?",1,0.5080966
2020-04-17,94348500.0,85.16999816894531,85.79000091552734,81.01000213623047,83.98999786376953,83.24893951416016,GILD,"Gilead's Remdesivir Shows Promise Against COVID-19 in Sneak Peek at Clinical Trial Data ||| EMERGING MARKETS-Mexican peso rises on stimulus, Latam FX ends week in losses ||| Wall Street gains on Boeing surge and coronavirus drug hopes ||| GLOBAL MARKETS-Stocks rally as investors take heart on U.S. economic reopening plan ||| Health Care Sector Update for 04/17/2020: GENE,GILD,WORX ||| Wall Street gains on Boeing news, Trump's reopening plan ||| Gilead Stock Isn’t Worth Chasing Now Despite Recent Remdesivir Success ||| Why Shares of AMC, Cinemark, Live Nation, and Planet Fitness Popped Today ||| Why Restaurant Stocks Jumped Today ||| 4 Top Stock Trades for Monday: BA, MRNA, SLB, KSU ||| Wall St gains on Boeing, Trump's restart plan ||| Whether or Not Gilead Sciences Produces a Successful COVID-19 Therapeutic, It's a Bargain ||| Stock Market News: Coronavirus Hopes Boost These 2 Stocks ||| Here's Why JPMorgan Chase and Other Bank Stocks Are Up on Friday ||| Boeing, Trump's restart plan boost Wall Street ||| GLOBAL MARKETS-Stocks race toward second weekly gain ||| Gilead's shares rise on report of experimental drug's promise in COVID-19 ||| BUZZ-U.S. STOCKS ON THE MOVE-Schlumberger, Biohaven Pharmaceutical, Spirit AeroSystems ||| Health Care Sector Update for 04/17/2020: GENE,GILD,WORX ||| Wall St climbs on Boeing, Trump's reopening plan ||| Don't Waste Your Money on Penny Stocks, These 2 Stocks Are Better Buys ||| U.S. stocks futures jump on Trump's restart plan, coronavirus drug hopes ||| Gilead's shares rise on report of experimental drug's promise in COVID-19 ||| BUZZ-U.S. STOCKS ON THE MOVE-Schlumberger, Banks, Spirit AeroSystems, State Street ||| Boeing, lockdown easing hopes set to lift Wall Street ||| BUZZ-U.S. STOCKS ON THE MOVE-Pulmatrix, Cutera, Moderna, Spirit AeroSystems ||| Coronavirus Drug Results Send Gilead Sciences Stock Flying; JPMorgan Weighs In ||| GLOBAL MARKETS-Super-charged stocks race towards second weekly gain ||| Daily Markets: Investors Cheer Gilead Results and Reopening Roadmap ||| Nasdaq 100 Movers: CTXS, GILD ||| Health Care Sector Update for 04/17/2020: MRNA, GILD, WORX ||| US STOCKS-Futures jump on Trump's restart plan, coronavirus drug hopes ||| GLOBAL MARKETS-Asian stocks rise as re-open of U.S economy offsets China GDP slump ||| GLOBAL MARKETS-Super-charged stocks race toward second best week ever ||| Hopes for virus treatment, U.S. reopening snuff out dollar rally ||| Nikkei scales 6-week high on hopes for virus treatment, U.S. plan to reopen ||| U.S. housing secretary says Gilead's remdesivir appears promising for COVID-19 -Fox Business ||| Lonza focuses on coronavirus projects as epidemic brings in new business ||| EMERGING MARKETS-Equities buoyed by U.S. optimism as currencies dip ||| South African rand stronger at end of torrid week ||| Why Peloton Stock Lost Ground Friday ||| Ross Gerber Says Tesla Is Pushing Ahead Of Competitors During COVID-19 Pandemic ||| National Institutes Of Health Gives Formal Statement On Gilead's Remdesivir In Monkeys ||| Gilead Shares Relatively Quiet As Hearing National Institutes For Health Suggest Co.'s Remdesivir Coronavirus Anti-Viral Treatment Prevent COVID-19 Progression In Monkeys ||| A Strong But Cautious Start To The Second Quarter ||| CFRA Downgrades Gilead Sciences to Sell ||| Why Amazon Is Trading Down Friday ||| Gilead Analysts Tackle Early Results From Remdesivir Study In COVID-19, Morgan Stanley Says Stock Move Looks Overdone ||| 58 Stocks Moving In Friday's Mid-Day Session ||| Big Earnings Day As Honeywell, Procter & Gamble, Schlumberger Among Those Reporting ||| Gilead Sciences Option Alert: May 15 $80 Puts Sweep (6) near the Bid: 577 @ $4.542 vs 1435 OI; Earnings 4/30 After Close Ref=$84.38 ||| Former FDA Commissioner Says Gilead's Remdesivir Could Have Enough Data For Emergency Use Authorization ||| Benzinga Pro's Top 5 Stocks To Watch For Fri., Apr. 17, 2020: GILD, NOK, INVH, THMO, LOGM ||| The Daily Biotech Pulse: Moderna Secures $483M In BARDA Funding, Gilead Remdesivir Data, Veracyte's Positive Pre-Announcement ||| Gilead Sciences shares are trading higher after a report noted that data from a clinical trial on the company's remdesivir drug suggests coronavirus patients are responding to treatment. ||| '""My hunch is that it's going to work earlier in the disease so if it's introduced early in the disease it can be an effective drug. It's not a slam dunk by any means. I don't think it's a cure for the virus,"" says @ScottGottliebMD...' ||| Hearing Raymond James Downplaying Gilead Data On Remdesivir, Says Recent Comments On Data Congruent With Prior New England Journal Of Medicine Cohort Which Implied Potential Modest To No Benefit Compared Historically ||| 36 Stocks Moving in Friday's Pre-Market Session ||| S&P Futures Rise 2.5%; Report Suggests Gilead's Remdesivir Shows Promise in Treating Covid-19; President Trump Unveils Plan for U.S. Economy Restart; Boeing to Reopen Next Week ||| Versant Capital Management, Inc Buys iShares J.P. ... ||| US Indexes Close Higher Friday and for the April –7 Week ||| Steven Cohen Beefs Up Immune System With Immunomedics ||| Keeler Thomas Management LLC Buys Vanguard Total Stock Market, Vanguard Growth, Cisco Systems ... ||| Dow Jones Races Higher, Helped By Surging Boeing Stock; 3 Coronavirus Stocks Lead Nasdaq 100 ||| Dow Jones Races Higher, Helped By Surging Boeing Stock; 3 Coronavirus Stocks Lead Nasdaq 100 ||| Week In Review: The Bulls Are Running ||| The Dollar And Equities Are Finishing The Week On Firm Footing ||| Dow Jones Leads Stock Market Rally Fueled By Hopes A Coronavirus Drug Is Near ||| Bourne Lent Asset Management Inc Buys L'Harris Technologies Inc, Pacific Biosciences of ... ||| Central Trust & Investment Co Buys Schwab Short-Term U.S. ... ||| Stocks Spike On April 16 In Hopes Of COVID-19 Treatment ||| Coronavirus Stock Market Rally Gets Postive Treatment News; Dow Jones Surges 600 Points As Boeing Soars On Production Restart ||| Markets Up on COVID-19 Treatment Data ||| Futures Up on Coronavirus Treatment Data ||| US Dollar Dips To Find Support, NZD/USD Surges - US Market Open ||| Gilead's (GILD) Coronavirus Drug Shows Promise, Shares Gain ||| Five Stock Picks From The Hedge Fund Manager Who Saw The Pandemic Coming ||| Dow Jones Today Leads Early Futures Rally, Gilead's Covid Treatment Tests Positive: Boeing, Disney Spike ||| Wall Street to Get Its Mojo Back: Here're the Big Winners ||| Buy 5 Top Medical Stocks on Coronavirus Drug Trial Results ||| Gilead Brings Likely Coronavirus Cure, Pharma Rallies on R&D ||| Stock Futures Jump On Covid-19 Treatment Hopes",0,0.5128244
2020-04-20,31003600.0,82.98999786376953,85.18000030517578,80.6500015258789,81.26000213623047,80.54302978515625,GILD,"Indexes End Week Higher As White House Rolls Out State-By-State Coronavirus Strategy, Investors Digest First Round Of Earnings Reports ||| The Stock Market Has Gone Insane ||| Market Briefing For Monday, April 20 ||| Stock market gains alongside economic pain; some worry about over-optimism ||| 2 Best Stocks to Buy Now ||| Can Gilead Sciences’ Coronavirus Gains Continue? ||| The Week Ahead In Biotech (April 19-25): Eli Lilly, Biogen Earnings On Tap, Sanofi Awaits FDA Decision ||| Nasdaq 100 Forecast: Threatening 9000 ||| Bulls Hiding In Large-Caps And In Just A Few Names Within Large-Caps – Conviction Lacking ||| Bulls Hiding In Large-Caps (In Just A Few Names); Conviction Lacking ||| Banking & Finance Expected To Get Crushed ||| Why Peloton Stock Lost Ground Friday ||| Covid-–9 Shines Spotlight on Clarivate ||| New Zealand Dollar Gained With Dow Jones, Traders Await Earnings ||| Forex Forecast: Pairs In Focus - Sunday, April 19 ||| Weekly Market Digest: What Does the S&P Tell Us About The Market? ||| Weighing The Week Ahead: Curb Your Enthusiasm ||| Gilead Sciences: Possible COVID-19 Treatment Already Priced in the Stock, Says Analyst ||| BUZZ-U.S. STOCKS ON THE MOVE-Co-Diagnostics, Xeris Pharma, Cyclacel Pharma ||| Notable ETF Inflow Detected - VYM, GILD, CME, USB ||| Gilead Sciences Reaches Analyst Target Price ||| Stock market gains alongside economic pain; some worry about over-optimism ||| Novartis, U.S. drug regulator agree to malaria drug trial against COVID-19 ||| Novartis, U.S. regulators agree to malaria drug trial against COVID-19 ||| Why These COVID-19 Vaccine Stocks Soared Today ||| Alexion Pharmaceuticals to Initiate Phase 3 Study for Ultomiris as a Potential Coronavirus Treatment ||| How The COVID-19 Pandemic Could End ||| Gilead Sciences Option Alert: Fri $90 Calls Sweep (6) near the Ask: 428 @ $1.85 vs 7491 OI; Earnings 4/30 After Close Ref=$84.33 ||| Gilead Sciences Option Alert: May 15 $90 Calls at the Ask: 398 @ $4.201 vs 10729 OI; Earnings 4/30 After Close Ref=$83.15 ||| Benzinga's Top Upgrades, Downgrades For April 20, 2020 ||| A Peek Into The Markets: US Stock Futures Down Ahead Of Earnings ||| Wells Fargo Downgrades Gilead Sciences to Equal-Weight, Announces $87 Price Target ||| BMO Capital Downgrades Gilead Sciences to Market Perform, Announces $79 Price Target ||| 95 Biggest Movers From Friday ||| Altman Advisors, Inc. Buys Gilead Sciences Inc, Zoom Video Communications Inc, Costco Wholesale ... ||| Penn Davis Mcfarland Inc Buys Gilead Sciences Inc, Spirit AeroSystems Holdings Inc, ... ||| Earnings In The Time Of Corona: Why Gilead, Vertex Could Outperform ||| 4 Top Sectors of Last Week & Their Winning ETFs ||| Earnings Scorecard and Top Stock Reports for Alphabet, Gilead & Starbucks ||| 5 Best Sector ETFs Halfway Through April ||| Biotech ETF (BBH) Hits New 52-Week High ||| Stock Market News for Apr 20, 2020 ||| Biogen (BIIB) to Report Q1 Earnings: What's in the Cards? ||| Gilead (GILD) in Focus: Stock Moves 9.7% Higher ||| Market Logic Can Be Confusing ||| Gilead Increases Enrollment Target, Pharma Rally Continues ||| Back-to-Back Weekly Gains as Stocks Continue to Recover",0,0.48861304
2020-04-21,19989400.0,80.25,82.23999786376953,78.26000213623047,78.52999877929688,77.83712005615234,GILD,"Gilead, ONKo-innate Announce Research Collaboration For Cancer Therapy ||| Gilead, Kite And oNKo-innate Announce Research Collaboration To Discover Cancer Immunotherapies Focused On Natural Killer (NK) Cells ||| Biotech ETFs Gaining on Progress in Coronavirus Treatment ||| Hamilton Wealth, LLC Buys Vanguard Financials, Microsoft Corp, ProShares Short S&P5……, ... ||| Investors Asset Management Of Georgia Inc Buys Truist Financial Corp, First Defiance Financial ... ||| Lawson Kroeker Investment Management Inc Buys Brookfield Asset Management Inc, Keysight ... ||| The Zacks Analyst Blog Highlights: Alphabet, Gilead Sciences, Starbucks, Tesla and Intuit",1,0.5205042
2020-04-22,13988600.0,79.58000183105469,81.55999755859375,78.80999755859375,81.30999755859375,80.59259033203125,GILD,"How Banks Have Prepared for a Slowdown ||| Artificial Intelligence and Drug Discovery: The Companies Leading The Way ||| The 10 Best Dividend Stocks for 2020 ||| Gilead Sciences Races to Manufacture Remdesivir, but Chemistry Has Speed Limits ||| 4 Reasons Why Chesapeake Energy Stock Can Survive ||| 3 Great Reasons to Buy Gilead Sciences Stock ||| Gilead Sciences Option Alert: Jun 19 $110 Calls Sweep (27) near the Ask: 1095 @ $2.046 vs 2252 OI; Earnings 4/30 After Close Ref=$81.06 ||| The Daily Biotech Pulse: Immunic To Develop COVID Treatment, Gilead Strikes IO Partnership ||| Market Briefing for Thursday, April 23 ||| Biotech Stock Roundup: ALXN, MRNA Up on Coronavirus Treatment Updates, & More ||| These 'Healthy' Stocks Tip The Coronavirus Market In Your Favor ||| Rnc Capital Management Llc Buys The Travelers Inc, Gilead Sciences Inc, Tyson Foods Inc, Sells ... ||| Stocks Slip Again on Oil Prices",0,0.488772
2020-04-23,65439700.0,82.16999816894531,84.0,74.4000015258789,77.77999877929688,77.09373474121094,GILD,"Gilead Sciences Rebuts Report Claiming Covid-19 Drug Remdesivir Trial Failed ||| Gilead's Remdesivir Reportedly Flopped in Chinese COVID-19 Study ||| Wall Street trims gains after report on coronavirus drug trial ||| GLOBAL MARKETS-Asian shares fall on coronavirus drug, economic damage concerns ||| GLOBAL MARKETS-Asian stocks poised to rise after Wall Street gains slip away ||| S&P 500 slips after report on coronavirus drug trial ||| Jobs Data, Treatment Buzz Keep Stock Gains in Check ||| 5 Top Stock Trades for Friday: GILD, INO, LVS, DPZ, LLY ||| WHO to launch initiative to share COVID-19 drugs, tests and vaccines-statement ||| S&P 500 slips after report on coronavirus drug trial ||| Buy the Dip in Gilead Stock Because Remdesivir May Not Be a Flop ||| Gilead's coronavirus drug flops in first trial - FT ||| Wall St rises on hopes worst for labor market is over ||| First Week of GILD July 17th Options Trading ||| Foreigners remain net sellers of Japan stocks for 10th week ||| BUZZ-U.S. STOCKS ON THE MOVE-Expedia Group, Crocs, Enzo Biochem ||| Notable Thursday Option Activity: COF, GILD, WYNN ||| Wall Street pares gains on report of potential coronavirus drug failing trial ||| Is It Too Late to Buy Gilead Sciences? ||| 7 Safe Stocks to Buy on the Coronavirus Dip ||| Better Buy: AbbVie vs. Gilead Sciences ||| BUZZ-U.S. STOCKS ON THE MOVE-Aytu BioScience, QEP Resources, Immunomedics ||| Why Gilead Stock Is Trading Lower Today ||| Gilead Sciences Option Alert: May 1 $64 Puts Sweep (7) near the Bid: 350 @ $0.585 vs 61 OI; Earnings 4/30 After Close Ref=$75.99 ||| Hearing SunTrust Defending Gilead, Says Remdesivir Could Still Work In Patients With Moderate Severity Coronavirus Infection ||| Hearing Author Of Gilead Study Disputes Characterization Drug 'Flopped' ||| WHO Says Draft Document On Gilead's Remdesivir Was Inadvertently Posted On Website, Says Manuscript Undergoing Peer Review, WHO Is Waiting For Final Version Before Commenting ||| Gilead Sciences Option Alert: Fri $85 Calls Sweep (11) near the Ask: 969 @ $0.29 vs 4919 OI; Earnings 4/30 After Close Ref=$75.9249 ||| Gilead shares are trading lower after the company reportedly ended its Remdesivir study due to low enrollment and said study results were inconclusive. ||| UPDATE: Gilead Calls Study Results 'Inconclusive,' Says Trends In Data Suggest Potential Benefit Via Remdesivir ||| UPDATE: Gilead Says Remdesivir Study Was 'Underpowered' To Enable Statistically Meaningful Conclusions ||| UPDATE: Gilead Says Investigators In Remdesivir Study Did Not Provide Permission For Publication Of Results, Confirms Study Terminated Early Due To Low Enrollment ||| Gilead Confirms Remdesivir Data Was Prematurely Posted, Says Has Been REmoved ||| Gilead Sciences Option Alert: Jun 19 $110 Calls Sweep (4) near the Ask: 863 @ $1.601 vs 14400 OI; Earnings 4/30 After Close Ref=$78.0397 ||| Gilead Sciences Option Alert: May 15 $80 Calls Sweep (11) near the Ask: 550 @ $5.0 vs 15829 OI; Earnings 4/30 After Close Ref=$77.81 ||| 'I do not believe this gilead news. It is from the chinese trials ...This is not from Gilead' -Tweet From CNBC's Jim Cramer ||| Gilead Shares Resume Following Circuit Breaker Halt, Shares Have Rebounded ~4.6% From Session Low, Down 1.9% For Session ||| 'Data on Gilead's remdesivir, released by accident, show no benefit for coronavirus patients' -STAT News ||| UPDATE: FT Report On Gilead's Remdesivir Says Study Was Ended Due To Low Enrollment, Results Didn't Given Meaningful Conclusions ||| S&P 500 Futures Plunge ~30 Points Following Report Gilead's Remdesivir 'Flops' In First Trial ||| Gilead Shares Plunge As Hearing Co.'s Remdesivir 'Flops' In First Trial ||| Gilead Sciences Option Alert: Fri $80 Calls Sweep (6) near the Ask: 500 @ $3.0 vs 3935 OI; Earnings 4/30 After Close Ref=$82.365 ||| KEYWISE CAPITAL MANAGEMENT (HK) Ltd Buys Gilead Sciences Inc, Micron Technology Inc, Bilibili ... ||| Dow Jones Futures: Coronavirus Stock Market Rally Stalls On Gilead Remdesivir News; Intel, Google News Hits These Tech Titans ||| US Indexes End Flat on Thursday ||| Ride Out the Coronavirus Mayhem With These ETF Areas ||| G&S Capital LLC Buys Johnson & Johnson, SPDR Bloomberg Barclays –-' Month T-Bill, ... ||| 30 S&P 500 Stocks That Rose In The Crisis: It's A Market Of Stocks ||| Stocks Tumble, Gilead Crashes After FT Reports Gilead's Remdesivir ""Flops"" In First Clinical Trial",1,0.51574004
2020-04-24,24441000.0,77.0999984741211,80.1500015258789,76.25,79.63999938964844,78.93732452392578,GILD,"Gilead Sciences Disputes Claim That Remdesivir Failed in a COVID-19 Trial ||| Sanofi confirms targets, strong demand for pain killers lifts Q1 ||| The Coronavirus Makes iBio Finally Relevant ||| EXCLUSIVE-Trial of Gilead's potential coronavirus treatment running ahead of schedule -researcher ||| Oil selloff weighs on FTSE as retail sales sink ||| GLOBAL MARKETS-Stocks struggle with muddled government pandemic response ||| Why Remdesivir Clinical Studies Will Lift Gilead Sciences ||| 3 Top Stocks Under $5 to Buy Now ||| European shares slide as EU stimulus fails to impress ||| EXCLUSIVE-Trial of Gilead's potential coronavirus treatment running ahead of schedule -researcher ||| EMERGING MARKETS-Set for weekly losses as doubts arise over COVID-19 drug efficacy ||| FTSE 100 tracks global mood lower as retail sales sink ||| European shares slide as pandemic jitters return ||| EXCLUSIVE-Trial of Gilead's potential coronavirus treatment running ahead of schedule -researcher ||| GLOBAL MARKETS-Asian stocks fall, Europe set to follow on doubts over coronavirus drug ||| SE Asia Stocks-Most slide on lockdown extension in parts of region, weak global data ||| GLOBAL MARKETS-Stocks fall on worries over EU stimulus details, coronavirus drug ||| CORRECTION: Lead Researcher For Gilead Remdesivir Trial Says Sees Trial Results Possibly By Mid May; Initial Headline Incorrectly Suggested 'Mid Day' ||| Gilead Sciences Option Alert: Fri $76.5 Calls at the Ask: 994 @ $2.701 vs 218 OI; Earnings 4/30 After Close Ref=$79.12 ||| UPDATE: Lead Researcher For Gilead Remdesivir Trial Says Sees Trial Results Possibly By Mid May, Prelim. Results Could Come Earlier ||| Gilead Shares Spike To Session High; Report A Lead Researcher Has Said US Gov't. Trial Of Remdesivr Is 'Running Ahead Of Schedule' ||| Crude Oil Bounce Gives Energy Stock A Lift As Market Volatility Ebbs ||| Baird Analyst Says 'Don't Give Up' Yet On Gilead's Remdesivir ||| Benzinga Pro's Top 5 Stocks To Watch For Fri., Apr. 24, 2020: GILD, DKNG, FFIV, ADC, SGMS ||| Cordasco Financial Network Buys Prologis Inc, Truist Financial Corp, Essential Utilities Inc, ... ||| Private Wealth Partners, LLC Buys Vertex Pharmaceuticals Inc, Qualcomm Inc, Gilead Sciences ... ||| Bill Gates' Coronavirus Manifesto Reveals 5 Forecasts For Investors ||| American Assets Investment Management, LLC Buys Gilead Sciences Inc, International Business ... ||| Cairn Investment Group, Inc. Buys SPDR Bloomberg Barclays –-' Month T-Bill, 'M Co, ... ||| Week In Review: Strong Weekly Close ||| Acorda (ACOR) to Report Q1 Earnings: What's in the Cards? ||| Can Vertex (VRTX) Withstand the Coronavirus Impact on Q1 Earnings? ||| Stock Market News for Apr 24, 2020 ||| The Week In Charts: Can You Time With Volatility? Blood In The Streets-Time To Buy? ||| Ropes Wealth Advisors LLC Buys iShares Core S&P 5……, Vanguard Total Stock Market, ... ||| Most Active Equity Options For Midday - Friday, April 24 ||| Markets Flat And Bitcoin Climbs As Coronavirus Treatment Flops",1,0.5178642
2020-04-27,14640700.0,79.9000015258789,80.4000015258789,78.23999786376953,79.9000015258789,79.19503021240234,GILD,"Bulls And Bears Of The Week: Amazon, Boeing, Disney, Netflix And More ||| Stock Market Update: Get A Handle On The Coronavirus Bull Market ||| ANALYSIS-Investors bet on testing, treatments for restart of U.S. economy ||| Why Is the Stock Market Hanging Its Hopes on Gilead's Remdesivir? ||| Gilead Sues U.S., Claiming It Secretly Obtained Patents on HIV Research That Led to Truvada ||| The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight ||| China Tried to Patent Potential Coronavirus Drug Remsvidir the Day After Beijing Confirmed Virus Was Transmissable Between Humans ||| Another Good Week for Biopharma and Diagnostics Stocks: Innovation is Driving Gains ||| BUZZ-U.S. STOCKS ON THE MOVE-Regeneron, Zoom Video, U.S. oil companies, Apple, U.S. insurers ||| Pfizer Stock Is Much More Than Just a Coronavirus Play ||| BUZZ-U.S. STOCKS ON THE MOVE-Kohl's, tanker operators, oil and gas companies, U.S. casinos ||| Don’t Let Negative Data Dissuade You from Gilead Sciences ||| Besides Remdesivir, These 2 COVID-19 Treatments Could Have Promise ||| Here's What to Expect With Gilead Sciences' Q1 Earnings Update ||| ANALYSIS-Investors bet on testing, treatments for restart of U.S. economy ||| Moderna Scores Huge Grant, Leads Charge Toward Coronavirus Vaccine ||| 'Experts worry next studies of Gilead Covid-19 drug may add uncertainty' -STAT ||| Japan PM Abe Says Approval For Remdesivir Expected 'Soon' ||| UPDATE: UBS Downgrades Gilead Sciences To Neutral, Raises Price Target From $77 To $80 'on valuation & as risk/reward into remdesivir (RDV) phase 3 readout appears balanced' ||| Benzinga's Top Upgrades, Downgrades For April 27, 2020 ||| UBS Downgrades Gilead Sciences to Neutral ||| Hearing Japan May Approve Gilead's Remdesivir for Coronavirus in May ||| Japan PM Abe Says Gilead's Coronavirus Drug Candidate Remdesivir May Soon Get Approval ||| Bbva Compass Bancshares, Inc Buys Vanguard Mega Cap Growth, iShares U.S. ... ||| Beacon Harbor Wealth Advisors, Inc. Buys Regeneron Pharmaceuticals Inc, iShares Core MSCI ... ||| Santori & Peters, Inc. Buys iShares iBoxx $ Investment Grade Corporate Bond, Gilead ... ||| Focus on Coronavirus Treatments to Boost Biotech Stocks ||| Should Franklin LibertyQ U.S. Equity ETF (FLQL) Be on Your Investing Radar?",0,0.4800637
2020-04-28,9778200.0,79.88999938964844,80.06999969482422,78.08000183105469,78.66999816894531,77.97588348388672,GILD,"Gilead Sciences' (GILD) Remdesivir Sparks Market Hope With Trial Success ||| 10 Stocks to Buy for an Aging Population ||| The AbbVie Buyout is Not a Sure Thing for Allergan Stock Investors ||| Gilead Sciences Option Alert: Aug 21 $115 Calls Sweep (55) near the Ask: 320 @ $2.074 vs 8159 OI; Earnings 4/30 After Close Ref=$79.3902 ||| Jerome Dodson Comments on Gilead Sciences ||| Jerome Dodson's Parnassus Endeavor Fund –st-Quarter Commentary ||| North Point Portfolio Managers Corp Buys MarketAxess Holdings Inc, Sysco Corp, Primo Water ... ||| Texas Capital Bancshares Inc Buys Vanguard FTSE Developed Markets, iShares Russell ... ||| First American Trust Co Buys Activision Blizzard Inc, Gilead Sciences Inc, PayPal Holdings Inc, ... ||| Exchange Capital Management, Inc. Buys Vanguard Financials, Gilead Sciences Inc, Emerson ... ||| First-Mover Pandemic Disease Fight ETF On The Way ||| Will Strong HIV Sales Drive Gilead's (GILD) Q1 Earnings? ||| As Pandemic Progresses, Promising Projects Thrive or Fail in Rally for Effective Coronavirus Treatment",1,0.48891908
2020-04-29,78230200.0,83.97000122070312,85.01000213623047,80.05000305175781,83.13999938964844,82.40644073486328,GILD,"The Dow Surged 532 Points Because We're Closer to a Covid-19 Drug ||| Why Novavax Stock Slumped Today ||| GLOBAL MARKETS-Stocks rally on treatment hopes, currencies await ECB ||| GLOBAL MARKETS-Asian stocks set to track U.S. gains as virus treatment hopes lift confidence ||| Why Discover Financial Stock Jumped 15% Today ||| Breakingviews - Corona Capital: U.S. GDP, Gilead’s drug, Spotify ||| Dow Jones Today: Vaccine Hopes Overcame Contracting GDP ||| Dow, Oil Close With Strong Wins ||| Wall Street rallies on promising coronavirus drug ||| This News Has Foot Locker Stock Running Higher Today ||| GLOBAL MARKETS-Shares jump on coronavirus treatment hopes, oil soars ||| U.S. stocks rally on coronavirus drug hopes ||| Why Hotel Stocks Are Surging Today ||| Restaurant Stocks Soar Wednesday on Positive COVID-19 Developments ||| Here's Why Visa, Mastercard, and American Express Are Higher on Wednesday ||| American Airlines Stock Is Still a Long-Term Winner ||| FOREX-Dollar drops as Fed repeats vow to support economy ||| COVID-19 complication seen in children is ""rare"", WHO says ||| Amazon is Wall St's biggest winner from coronavirus ||| Wall Street jumps on coronavirus drug hopes; Fed in focus ||| Better Buy: Cara Therapeutics vs. Sangamo Therapeutics ||| What to Expect from Gilead Earnings ||| Yields down ahead of Fed meeting wrap-up ||| Buy Gilead Stock Because Remdesivir Is a Covid-19 Game-Changer ||| Stock Market News: Mastercard Charges Ahead; Alphabet Spells Ad Success ||| BUZZ-U.S. STOCKS ON THE MOVE-Liberty Oilfield, MRC Global, Capricor Therapeutics ||| Stock Alert: Gilead Sciences Up 4% On Positive Data On COVID-19 Drug ||| Gilead Sciences Says Remdesivir Hit the Mark in COVID-19 Trial ||| Wall Street jumps on hopes of potential coronavirus drug ||| Gold falls as equities drift higher ahead of Fed statement ||| Wall St set to jump at open on hopes of potential coronavirus drug ||| US STOCKS SNAPSHOT-Futures jump after Gilead's COVID-19 drug meets main goal ||| Dollar drops as Coronavirus treatment hopes boosts risk sentiment ||| European shares rise on COVID-19 drug hopes, upbeat outlook from corporates ||| Gilead's remdesivir meets main goal of trial in COVID-19 patients ||| BUZZ-U.S. STOCKS ON THE MOVE-Capricor Therapeutics, Liberty Oilfield, Blue Apron ||| Gilead says remdesivir shows improvement in COVID-19 patients when used early ||| Gilead Sciences Records Positive Data From 10-day Covid-19 Trial Of Remdesivir ||| BUZZ-U.S. STOCKS ON THE MOVE-Alphabet, Spotify, Blue Apron ||| Trump Says He Wants FDA To Go As Quickly As Possible To Approve Gilead's Remdesivir ||| Fed Has Market's Back As It Pledges To Keep Rates Low Until Economy Can Swim On Its Own ||| FDA Announcement Allowing Emergency Use Of Gilead's Experimental Coronavirus Drug Remdesivir Could Come As Soon As Wednesday ||| CFRA Maintains Sell on Gilead Sciences, Raises Price Target to $74 ||| NIH Reports Median Time To Recovery Was 11 Days For Patients Treated With Remdesivir Compared With 15 Days For Those Who Received Placebo ||| NIH Reports Prelim Results Suggested A Survival Benefit, With A Mortality Rate Of 8.0% For Group Receiving Remdesivir Versus 11.6% For Placebo Group ||| NIH Clinical Trial Shows Remdesivir Accelerates Recovery From Advanced Coronavirus; Preliminary Results Indicate That Patients Who Received Remdesivir Had A 31% Faster Time To Recovery Than Those Who Received Placebo ||| Fauci: FDA 'Working As We Speak' To Get Remdesivir To Market ||| Fauci Says China Study On Remdesivir Was Not Adequate, Underpowered ||| Here's How Much Investing $100 In Gilead Sciences Stock Back In 2010 Would Be Worth Today ||| Fauci Says Has No Timeline On Gilead Working With FDA For Remdesivir Approval ||| 'Fauci says Gilead reports the anti-viral reduced duration of COVID-19 from 15 to 11 days. ""A drug can block this virus,"" said Fauci about the results of the drug trial. He says the mortality rate also fell from 11% to 8%' -Tweet From CBS White House ||| 'Fauci says Gilead reports the anti-viral reduced duration of COVID-19 from 15 to 11 days. ""A drug can block this virus,"" said Fauci about the results of the drug trial. He says the mortality rate also fell from 11% to 8%' -Tweet From CBS White House ||| Fauci: Data Shows Remdesivir 'Clear Cut' Positive Effect ||| SVBLeerink On Gilead Expects 'to learn more about these results during Gilead's earnings call tomorrow and we believe the focus of the discussion with primarily revolve around timelines for further clinical readouts as well as supply and manufacturing' ||| SVBLeerink Maintains Market Perform, $68 Target On Gilead Notes 'We remain optimistic about the potential for remdesivir to provide meaningful clinical benefit across a relatively broad spectrum of moderate to severe COVID-19 illness' ||| Why Gilead Stock Is Trading Higher Today ||| STAT News Reporter Adam Feuerstein Responds To Tweet On Lancet Report On Remdesivir Trial, Says 'This Is The Negative China Study...We Reported On Last Week;' Lancet Study Suggests Drug Not Associated With Significant Clinical Benefits ||| UPDATE: JMP Reiterates Market Outperform Rating, $10 Price Target On BioCryst Pharma; BZ NOTE: BioCryst Shares Currently Trading At $3.72 ||| BioCryst Pharma Shares At Intraday High As Traders Circulate JMP Research Note Highlighting 'expect BCRX shares to trade up on [remdesivir] news' ||| Hearing Gilead Drug Results Will Likely Be Discussed At White House Coronavirus Briefing, National Institutes For Health Will Release Results Later Today ||| P/E Ratio Insights for Gilead Sciences ||| Alphabet, Boeing Shares Get A Lift Following Earnings, While GE Falls Short ||| Gilead Sciences Option Alert: Fri $80 Calls at the Ask: 1000 @ $3.32 vs 6362 OI; Earnings 4/30 After Close Ref=$81.245 ||| UPDATE: Jefferies Says While Gilead Data Positive 'on balance there are a couple of factors to fill out the picture that are important to know in detail' ||| Jefferies Says Gilead News On Remdesivir Will Be Taken As Good News Over Short Term, Sees FDA Probably Accelerating Some Sort Of Approval, Expanded Use For Drug ||| Gilead shares are trading higher after a study of the company's remdesivir by the National Institute of Allergy and Infectious Diseases met its primary endpoint. Remdesivir is being evaluated as a potential coronavirus treatment candidate. ||| Gilead's Remdesivir Reaches Goal In NIAID-Sponsored Coronavirus Trial ||| 'Today, the world gets the first real sign that a new medicine, remdesivir from Gilead Sciences, will help the world emerge from the Covid-19 pandemic...' -Tweet From STAT News' Adam Feuerstein ||| UPDATE: Gilead Says 'At Day 14, 64.5% (n=129/200) of patients in the 5-day treatment group and 53.8% (n=106/197) of patients in the 10-day treatment group achieved clinical recovery' ||| Gilead Says Plans To Submit Full Data For Remdesivir In Peer-Reviewed Journal In Coming Weeks ||| UPDATE: Gilead Says No New Safety Signals Were Identified With Remdesivir ||| UPDATE: Gilead Says Phase 3 Trial Of Remdesivir Showed Patients Receiving 10-Day Treatment Course Achieved Similar Improvement In Clinical Status vs Those Taking 5-Day Treatment Course ||| Gilead Shares To Resume Trade At 9 a.m. EDT ||| S&P 500 Futures Spike ~15 Points Following Positive Gilead Data On Remdesivir ||| Gilead Reports Data From National Institute of Allergy and Infectious Diseases, Says 'We understand that the trial has met its primary endpoint and that NIAID will provide detailed information at an upcoming briefing' ||| REMINDER: Results From Gilead's Coronavirus Anti-Viral, Remdesivir, Expected This Week ||| Gilead Shares Halted News Pending ||| Market Briefing for Thursday, April 30 ||| Dow Jones Futures: Tesla Leads Tech Titans In Buy Zones As Coronavirus Stock Market Rally Roars ||| Qp Wealth Management, Llc Buys First Trust North American Energy Infrastructure F, Gilead ... ||| Stocks Surge On Coronavirus Drug News; Key ETF Breaks Out As Small Caps Lead ||| Iowa State Bank Buys Gilead Sciences Inc, iShares Core S&P Mid-Cap, SPDR MSCI ACWI ex-US, ... ||| Dow Jones Surges 600 Points On Coronavirus Drug News, Despite Gloomy U.S. Data ||| Gilead's Coronavirus Drug Shows Positive Data ||| Biotech Stocks Earnings Roster for Apr 30: AMGN, GILD & More ||| Full On FOMO ||| Gilead Rises, Boosts Market As Remdesivir COVID-19 Trial Meets Primary Target ||| Armstrong Shaw Associates Inc Buys Gilead Sciences Inc, Brookfield Asset Management Inc, Sells ...",1,0.49432817
2020-04-30,39199900.0,85.47000122070312,85.66999816894531,81.33000183105469,84.0,83.25885772705078,GILD,"Yields fall, two-year note touches lowest level since 2011 ||| Wall St set to slide at open after jobless claims data ||| 7 U.S. Stocks to Buy on Coronavirus Weakness ||| Notable Thursday Option Activity: MDB, CASA, GILD ||| Gilead Beats Earnings Estimates, but the Stock Falls ||| GLOBAL MARKETS-Global equities dip at end of best month since '09 ||| GLOBAL MARKETS-Stocks head for best month on record ahead of ECB ||| EMERGING MARKETS-Stocks extend gains, Hungary outperforms on reopening plans ||| Is Gilead Sciences Stock a Buy Right Now? This Is What You Need to Know ||| U.S. FDA moving with 'lightning speed' on Gilead's COVID-19 drug - Bloomberg ||| GLOBAL MARKETS-Global equities dip; remain on pace for best month on record ||| Gilead Awaits FDA Approval on Remdesivir to Treat Covid-19 ||| PayPal Is the Elixir We Need in This Awful Earnings Season ||| IBB, GILD, VRTX, BIIB: ETF Inflow Alert ||| Gilead (GILD) 1st Quarter Earnings: What to Expect ||| Gilead Sciences Inc. Q1 adjusted earnings of $1.68 per share ||| 3 Big Stock Charts for Thursday: Gilead Sciences, Boeing, and Nio ||| China stocks log best month in five on virus drug trial, policy hopes ||| China stocks touch seven-week high on coronavirus treatment, policy hopes ||| Dow, S&P 500 futures dip at end of strong month; jobless data awaited ||| Have $3,000 to Invest? Here Are 3 Top Coronavirus Stocks to Buy Right Now. ||| Moderna Stock Is Near Highs, But Faces Risk ||| Gilead Sciences Q1 20 Earnings Conference Call At 4:30 PM ET ||| European Stocks Pause After Big Asia and Wall Street Rally ||| London stocks hit by Shell's historic dividend cut ||| Gilead aims to expand remdesivir output for COVID-19, posts flat 1st-qtr results ||| Dow, S&P 500 futures dip at end of strong month; jobless data eyed ||| Tokyo shares end near 8-week high, track Wall Street gains on virus drug hopes ||| EM ASIA FX-Indonesian rupiah jumps about 3% on higher bond inflows expectation ||| Indian shares soar on COVID-19 drug hopes, set for best month since 2009 ||| GLOBAL MARKETS-Stocks rally on treatment hopes, currencies await ECB ||| London stocks rise on optimism around virus drug, upbeat earnings ||| Gilead Sciences Announces Plans To Be Able To Produce Several Million Remdesivir Treatment Courses In 2021 ||| Gilead Announced Number Of Treatment Courses Expected To Be Available May Actually Be Higher Based On Recent Topline Results From First Simple Study ||| Gilead Announced It Anticipates More Than 1M Treatment Courses Will Be Manufactured By December 2020; Treatment Courses Projections Assume A 10-day Dosing Duration ||| Gilead Sciences Commits ~$50M Of Spending To Combat Coronavirus ||| Gilead Reports Q1 Earnings Beat, Anticipates Short-Term Impact From Coronavirus ||| After Hours Stocks We're Watching: AMZN, WDC, AMGN, GILD, V, SKY, LOCO ||| Gilead Says While Coronavirus Did Not Impact Its First Quarter Results in It Anticipates That Its Business In The Short Term Will Be Impacted Due To Fewer Patients Accessing Treatment For Conditions Such As HIV And HCV ||| Gilead Sciences Q1 EPS $1.680 Beats $1.570 Estimate, Sales $5.548B Beat $5.450B Estimate ||| Gilead Sciences Option Alert: May 15 $70 Puts at the Bid: 2500 @ $0.521 vs 15919 OI; Earnings 4/30 After Close Ref=$81.95 ||| UK's Vallance: Remdesivir Has Shown Promise In Studies, Says Total Number Of Infections Coming Down ||| Gilead Sciences Option Alert: Jun 19 $95 Calls at the Bid: 1500 @ $3.17 vs 7992 OI; Earnings 4/30 After Close Ref=$82.61 ||| Apple And Amazon Up To Bat this Afternoon As Investors Ponder Microsoft, Facebook Results ||| FDA Commissioner Hahn Says Is Moving At 'Lightning Speed' On Gilead's Remdesivir, Says Wants To Have 'Totality Of Data' To Target Drug ||| The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1 ||| Earnings Scheduled For April 30, 2020 ||| Dow Jones Futures: Apple, Amazon, Atlassian Test Buy Points On Earnings As Coronavirus Stock Market Rally, Tesla Hit Brakes; Amgen, Gilead Near Breakouts ||| Carnick & Kubik Group, LLC Buys iShares Short Treasury Bond ETF, Gilead Sciences Inc, ... ||| Gilead, Takeda Rumored to Have Sights on Iovance ||| Gilead Sciences (GILD) Q1 Earnings and Revenues Beat Estimates ||| Gilead Reports Q1 Adjusted EPS $1.68, Consensus $1.57 ||| Stock Market News for Apr 30, 2020 ||| Can The Dow Jones Today Nail Its Best Month In 45 Years? Nasdaq Up Ahead Of Jobless Data: Tesla, Facebook, Spike ||| Remdesivir Progresses on Coronavirus Trial: Pharma Upbeat ||| 5 Small-Cap ETFs Beating S&P 500 in April ||| Leveraged Small-Cap and Inverse Leveraged Gold Miners: 2 ETFs to Watch on Outsized Volume ||| Approval Of Gilead's Remdesivir 'All But Final,' Says Piper Sandler ||| Stocks Jump over 2% on Coronavirus Treatment, Tech Earnings ||| Shell Cuts Dividend For First Time Since WWII",0,0.4935406
2020-05-01,34498100.0,81.19999694824219,81.4000015258789,77.62000274658203,79.94999694824219,79.24458312988281,GILD,"Why Foot Locker, Callaway Golf, and Newell Brands Plunged 10% Early Friday ||| U.S. FDA authorizes remdesivir drug as emergency treatment for COVID-19 ||| Gilead's Remdesivir Becomes 1st Drug Allowed For Emergency Use For COVID-19 ||| 3 Big Stories in Gilead Sciences' Q1 Results ||| FDA Allows Emergency Use of Gilead's Covid-19 Drug ||| U.S. FDA authorizes remdesivir drug as emergency treatment for COVID-19 ||| Gilead Aims to Get Its Potential COVID-19 Drug to as Many Patients as Possible ||| Trump: FDA authorizes Remdesivir drug for COVID-19 ||| BUZZ-U.S. STOCKS ON THE MOVE-Medigus Ltd, Western Digital Corp, Aemetis Inc ||| Coronavirus trial drug remdesivir's maker aims for wide distribution -Gilead CEO ||| Coronavirus trial drug Redesivir's maker hopes for swift FDA approval -interview ||| Gilead Stock Drops on Wave of Downgrades ||| What Does Remdesivir's Promising Study Mean for Gilead's Stock? ||| BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Medigus, Aemetis ||| Inovio Is in a Race to Develop a COVID-19 Vaccine, but Can It Possibly Win? ||| Reuters Issues Correction: Says Vice President Pence Says The 1.5 Million (Not 1 Million) Vials Of Remdesivir Will Start Being Distributed To Hospitals On Monday ||| Markets Have Best Month Since 1987, But End Week On Low Note ||| Gilead's Remdesivir Granted FDA Emergency Use To Treat COVID-19 ||| Gilead Says Set A Goal Of Producing At Least 500,000 Treatment Courses By October, 1M Treatment Courses By December 2020 And 'Millions More In 2021' ||| Gilead Says Authorization Allows 5-Day And 10-Day Treatment Durations ||| Gilead Clarifies: 'Remdesivir remains an investigational drug and has not been approved by FDA'; Notes 'The authorization is temporary and does not take the place of the formal new drug application submission, review and approval process' ||| Gilead PR Highlights FDA Emergency Authorization For Remdesivir; Says 'Authorization Enables Broader Use of Remdesivir to Treat Hospitalized Patients with Severe COVID-19 Disease in the United States' ||| Vice President Pence Says 1M Vials Of Remdesivir Will Start Being Distributed To Hospitals On Monday ||| FDA Letter To Gilead Authorizing Emergency Use For Remdesivir (Full Letter) ||| (PDF) FDA Fact Sheet For Remdesivir ||| Gilead Shares Spike On Reports Of FDA Emergency Use Authorization For Remdesivir; Down ~4.3% For The Session ||| FDA's Hahn Says 'This Is An Important Clinical Advance' ||| FDA Commissioner Hahn: Gilead Drug Authorized For Use In Hospitalized Patients ||| Trump Says Gilead CEO Calls It An Important First Step And Is Donating 1 Million Vials Of Remdesivir ||| Trump Says Gilead Has Emergency Use Authorization From FDA ||| Gilead Analysts See Questionable Commercial Opportunity For Coronavirus Candidate Remdesivir ||| UPDATE: Morgan Stanley Maintains Equal-Weight On Gilead Sciences, Raises Target To $77 Notes 'Base business stable, we continue to expect near-term updates on remdesivir' ||| UPDATE: SunTrust Robinson Humphrey Downgrades Gilead Sciences To Sell, Maintains $70 Target On 'Lack of visibility to growth'; Notes 'We don't know what a sustainable revenue stream from remdesivir will look like' ||| UPDATE: Raymond James Downgrades Gilead Sciences To Market Perform 'Because We Aren't Going to Wild Guess Remdesivir NPV' ||| Benzinga's Top Upgrades, Downgrades For May 1, 2020 ||| SVB Leerink Maintains Market Perform on Gilead Sciences, Raises Price Target to $85 ||| Oppenheimer Maintains Outperform on Gilead Sciences, Raises Price Target to $90 ||| Morgan Stanley Maintains Equal-Weight on Gilead Sciences, Raises Price Target to $77 ||| The Daily Biotech Pulse: Gilead Slips Despite Forecast-Beating Q1, Moderna Partners With Lonza For Coronavirus Vaccine Production, Lyra Therapeutics IPO ||| Gilead CEO Says Company Will Continue to Try to Make New Drug Accessible and Affordable to Patients Around the World ||| 20 Healthcare Stocks Moving In Friday's Pre-Market Session ||| Gilead Sciences shares are trading lower after several firms downgraded the company's stock following the company's Q1 earnings results. The company also sees its business in the short term will be impacted by coronavirus due to fewer patients accessing treatment. ||| Gilead Says It Will Produce 1M Courses Of Coronavirus Experimental Drug 'Remdesivir' By December ||| JP Morgan Downgrades Gilead Sciences to Neutral ||| SunTrust Robinson Humphrey Downgrades Gilead Sciences to Sell ||| Raymond James Downgrades Gilead Sciences to Market Perform ||| Prudential Plc Buys Vanguard Intermediate-Term Corporate Bond ETF, iShares iBoxx $ Investment ... ||| Main Street Research LLC Buys Gilead Sciences Inc, General Mills Inc, Dollar General Corp, ... ||| What The Heck & What Now? ||| Week In Review: Sellers Show Up After Long Hiatus ||| Dow Jones Today, Futures Fade On Earnings News, Trump Trade Threat; Amazon, Apple Backtrack ||| The Zacks Analyst Blog Highlights: Gilead Sciences, Pfizer, Sanofi, GlaxoSmithKline and Moderna ||| The Zacks Analyst Blog Highlights: Amazon, Apple, Gilead Sciences, Amgen and Visa ||| ETF Asset Report of Coronavirus-Inflicted April",1,0.51297736
2020-05-04,19203000.0,81.62000274658203,81.76000213623047,79.19000244140625,80.25,79.54193878173828,GILD,"5 Top Coronavirus Stocks to Buy in May ||| Japan aims to fast-track review of anti-viral drug remdesivir ||| What Should Investors Make Of Conflicting Results Surrounding Gilead's Remdesivir? ||| Barron's Picks And Pans: Berkshire Hathaway, Carvana, Madison Square Garden And More ||| Market Briefing For Monday, May 4 ||| Week In Review: How Trump's Policies Moved Stocks - Saturday, May 2 ||| Gold gains as rising U.S.-China tensions dent risk sentiment ||| Remdesivir To Be Available For Coronavirus Patients This Week, Gilead CEO Says ||| Trump Says Gilead is Pushing Fast on Coronavirus Drug ||| Gilead CEO O'Day Says Co Has Donated Its Remdesivir Supplies to Federal Government' Says Government to Determine Where Treatments Go, Based on Need ||| Benzinga's Bulls And Bears Of The Week: Ford, Gilead, Microsoft, Intel And More ||| Pricing of Covid-–9 Products Will Face Public Scrutiny ||| Gilead CEO Says Remdesivir Will Get To Patients Early This Week ||| ""Remdesivir Is Probably Worthless"" - A Trauma Surgeon Exposes ""Drug Company's Shenanigans"" ||| Weekly Market Digest: U.S. Stocks Have Their Best Month In 30 Years ||| JPMorgan’s Bullish Stance on Gilead Sciences (GILD) Stock Comes to an End ||| Forget Gilead, These 2 Pharma Dividends Pay up to 10% ||| Apps cannot replace ""boots-on-the-ground"" in virus fight - WHO ||| What Might Gilead's Covid-19 Drug Cost, $10 or $4,500? ||| BUZZ-U.S. STOCKS ON THE MOVE-Airlines, banks, insurers, PG&E ||| Earnings Preview: Is SQ Stock a Buy Before Wednesday? ||| Despite Gains, Threat, Gilead Is Still Attractive ||| Vir, Alnylam identify COVID-19 therapy candidate, plan human trials by year end ||| The Dow Rose 26 Points Because an Oil Rebound Lifted Stocks ||| European stock futures drop as U.S., China spar over virus origin ||| Foreigners remain net sellers of Japan stocks for 11th straight week ||| The 3 Best Stocks to Buy in May ||| WHO Expert Says It Has Not Received Any Data From The US Relevant To The Purported Origin Of The Virus, Need To Understand More About Virus ||| WHO Says We Welcome The Recent Data From Randomized Control Trial Done In US With Gileads Remdesivir Says 'There Are Signals Of Hope There For The Potential Use Of The Drug' ||| 4 Sector ETFs For May: 2 To Buy, 2 To Avoid ||| A Peek Into The Markets: US Stock Futures Down; Dow Futures Fall Over 300 Points ||| 7 Stocks To Watch For May 4, 2020 ||| Alpine Woods Capital Investors, Llc Buys Cigna Corp, SPDR Select Sector Fund - Technology, SPDR ... ||| David Carlson's Elfun Trusts Cuts Visa, Apple, Microsoft ||| Elfun Trust Cuts Visa, Apple, Microsoft ||| Top ETF Stories of April Likely to Hit Headlines Again in May ||| Dow Jones Today Leads Futures Lower As Boeing, Airlines Suffer A Buffett Hit; Marijuana Stock Canopy Growth Spikes ||| Remdesivir Gets Emergency Approval: What's In Store for Gilead? ||| 4 Sector ETFs For May: 2 To Buy, 2 To Avoid ||| Assuming Away The Can And...",0,0.5299367
2020-05-05,14925900.0,79.33000183105469,79.83000183105469,78.51000213623047,79.13999938964844,78.44173431396484,GILD,"Gilead in talks to expand global supply of COVID-19 drug remdesivir ||| Gilead in talks to expand global supply of COVID-19 drug remdesivir ||| Gilead Sciences Plans to Expand Global Supply of Remdesivir ||| How Can The Stock Market Soar With Rising Unemployment? ||| Regeneron Says Its COVID-19 Combo Treatment Could Be Ready for People This Fall ||| Gilead Sciences Is a Strong Buy Despite What Its Detractors Might Say ||| Could This Under-the-Radar Biotech Piggyback on Gilead's Remdesivir Success? ||| Finding a Coronavirus Cure: 5 Companies Making Moves ||| EXCLUSIVE-Bangladesh's Beximco to begin producing COVID-19 drug remdesivir-COO ||| Gilead In Talks With Some Chemicals, Pharma Companies About Ability To Produce Remdesivir For Europea, Asia, Developing World Through At Least 2022 ||| UPDATE: Gilead Negotiating Long-Term Voluntary Licenses With Several Generic Drugmakers In India, Pakistan To Produce Remdesivir For Developing Countries ||| Gilead Will Further Accelerate, Maximize Access To Remdesivir, Negotiating On Long-Term Voluntary Licenses With Drugmakers ||| Japanise Health Minister Says Gilead's Remdesivir May Be Approved In Japan On Thursday ||| 'With remdesivir, Gilead finds itself at strategic crossroads, with its reputation (and far more) at stake' -STAT News $ ||| Bp Plc Buys Netflix Inc, Union Pacific Corp, Exelon Corp, Sells PNC Financial Services Group ... ||| What the Heck & What Now? ||| 3 Sector ETFs Gaining Momentum in May ||| Harfst & Associates, Inc. Buys Gilead Sciences Inc, Caterpillar Inc, Lithia Motors Inc, ...",0,0.5050658
2020-05-06,12591900.0,78.9000015258789,79.36000061035156,77.26000213623047,77.47000122070312,76.78646850585938,GILD,"Will Gilead price its coronavirus drug for public good or company profit? ||| How Will Double-Digit Unemployment Affect Your Stock Portfolio? ||| 4 Safe Stocks That Can Make You Rich in This Economy ||| Inovio Pharmaceuticals Is Hurting From Remdesivir but It’s Still Standing ||| Israel Reports a ""Breakthrough"" Coronavirus Antibody Treatment ||| EXPLAINER-Who can make Gilead's coronavirus drug, licence free? ||| Is This Coronavirus Drug Authorization Really Good News for Gilead? ||| EXUMA Biotech Is 'Revolutionizing CAR-T Therapy,' Increasing Patient Access, CEO Says ||| Gilead Works To 'Maximize Global Supply' Of Coronavirus Candidate Remdesivir Amid Threat Of Patent Loss ||| Gilead Says Possibility That Co May Experience Delays With NDA for Filgotinib for Treatment of RA Filed With FDA and With NDA, MAA for Kte-x19 for Treatment of Relapsed or Refractory Mantle Cell Lymphoma ||| Gilead Says Anticipate Accelerating Remdesivir Investments in Future Quarters ||| Gilead Sciences Says Incurred ~$50M of Manufacturing Scale-up, Clinical Trial Costs for Remdesivir During Q1 ||| Coronavirus Has Been Circulating Since Late 2019, UK Research Says ||| Intrust Bank Na Buys iShares Core S&P 5……, SPDR Series Trust Portfolio S&P 5…… ... ||| Biotech ETFs Poised to Benefit From Coronavirus ||| GILD vs. ILMN: Which Stock Should Value Investors Buy Now? ||| 5 Stocks to Buy as Coronavirus Vaccine in Human Trails Ramp Up ||| Markets Level Off As Trade Talks Commence",1,0.4964341
2020-05-07,13491700.0,77.9000015258789,78.43000030517578,76.80999755859375,77.61000061035156,76.92523193359375,GILD,"U.S. Doctors want details on federal distribution of Gilead coronavirus drug ||| Doctors want details on federal distribution of Gilead coronavirus drug ||| June 26th Options Now Available For Gilead Sciences (GILD) ||| The Best Thing Happening During These ‘Worst of Times’ ||| Japan approves Gilead Sciences' remdesivir as COVID-19 drug ||| Japan approves Gilead Sciences' remdesivir as COVID-19 drug ||| Gilead Issues Press Release Highlighting Approval Of Veklury In Japan For Patients With Severe Coronavirus Infection ||| 3 Biotech ETFs Up 10% Or More Over The Last Month ||| Gilead Sciences Option Alert: May 15 $80 Calls Sweep (4) near the Ask: 725 @ $0.96 vs 14381 OI; Ref=$77.35 ||| Japan Health Ministry Official: Remdesivir Will Be Used For Coronavirus/Covid-19 Patients With Severe Conditions ||| Japan Approves Gilead Sciences' Drug Remdesivir As Coronavirus/COVID-19 Treatment ||| Gilead Sciences Inc (GILD) EVP,Corp Affairs & Gen Counsel Brett A Pletcher Sold $– ... ||| Bourgeon Capital Management Llc Buys The Walt Disney Co, ishares Gold Trust, Rockwell ...",0,0.48710698
2020-05-08,10554700.0,77.76000213623047,78.44000244140625,76.87000274658203,77.48999786376953,76.80628967285156,GILD,"The Dow Rose 455 Points Because Job Losses Can't Get Any Worse ||| NIH begins study of remdesivir with anti-inflammatory drug to treat COVID-19 ||| EXCLUSIVE-Iran-linked hackers recently targeted coronavirus drugmaker Gilead -sources ||| Is Gilead Sciences Stock a Buy? ||| UPDATE: NIAID Says Investigators Currently Expect Enrolling 1K+ Patients In Remdesivir Plus Baricitinib Trial ||| UPDATE: NIH's National Institute Of Allergy And Infectious Diseases Says Remdesivir Trial Is Expected To Open At ~100 US, Int'l. Sites ||| US National Health Institutes Clinical Trial Testing Remdesivir Plus Anti-Inflammatory Adults With Coronavirus In US ||| Iranian Linked Hackers Attacked Gilead ||| White House Says Task Force's Birx Will Offer Consultation Regarding Gilead's Coronavirus Drug ||| Continental Advisors Llc Buys SPDR Select Sector Fund - Energy Select Sector, iShares Inc MSCI ... ||| Are Biotech ETFs in Trouble as Coronavirus Dims Guidance? ||| Dai-Ichi Life Insurance Company, Ltd Buys Lockheed Martin Corp, Bright Horizons Family ... ||| CapWealth Advisors, LLC Buys Gilead Sciences Inc, CenturyLink Inc, National Health Investors ... ||| Boston Common Asset Management, LLC Buys GlaxoSmithKline PLC, Gilead Sciences Inc, Cerner Corp, ... ||| 6 ETF Areas Beating S&P 500 in 2020 ||| 3 Industries Investors Should Avoid In A Post-COVID World",1,0.51752526
2020-05-11,13340500.0,77.7699966430664,80.91999816894531,77.62000274658203,80.80000305175781,80.08708953857422,GILD,"U.S. to allow states to distribute Gilead's remdesivir to fight COVID-19 ||| HHS Announces Shipments of Donated Remdesivir for Hospitalized Patients With Covid-19 from a Donation by Gilead Sciences to the U.S. Which Was Finalized on May 3, 2020 ||| 3 Top Biotech Stocks to Buy in May ||| What Investors Are Missing About Gilead Sciences ||| The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight ||| NYC Mayor Bill de Blasio Tweets: This week the FDA approved the use of Remdesivir to treat severely ill COVID-19 patients. The initial clinical trials shows it decreased hospital stays from 15 to 11 days. That's promising. ||| Gilead's Remdesivir Supply Won't Meet U.S. Need, Analyst Says ||| EMA recommends expanding compassionate use of Gilead's COVID-19 drug ||| The Government Will Distribute Gilead's Remdesivir. This Could Be Bad News for Investors ||| EMA recommends expanding compassionate use of Gilead's COVID-19 drug ||| MOAT, NOW, PFE, GILD: ETF Inflow Alert ||| Co-Diagnostics Is a Smart Way to Play Coronavirus Testing ||| Despite Challenges, GE Is a Long-Term Winner ||| UPDATE: European Medicines Authority Says Has Added Treatment Duration Of 5 Days For Gilead's Remdesivir Alongside 10-Day Course ||| European Medicine Authority Recommends Expanding Gilead's Remdesivir Compassionate Use To Patients Not On Mechanical Ventilation ||| Gilead shares are trading higher. Strength potentially due to optimism surrounding the company's Remdesivir, which is being evaluated as a potential coronavirus treatment candidate. ||| Biotech Stock Rally Is Crushing Short Sellers ||| Dean Capital Investments Management, LLC Buys Gilead Sciences Inc, The Chemours Co, ... ||| Ensign Peak Advisors, Inc Buys ServiceNow Inc, Honeywell International Inc, EPAM Systems Inc, ... ||| US Indexes Post Some Gains Monday ||| Sitrin Capital Management LLC Buys Gilead Sciences Inc, Salesforce. ... ||| Pekin Singer Strauss Asset Management Buys Evercore Inc, Ituran Location and Control, TPI ... ||| Private Harbour Investment Management & Counsel, L Buys Gilead Sciences Inc, Exxon Mobil ... ||| Banco Santander, S.A. Buys Microsoft Corp, Pampa Energia SA, Intel Corp, Sells McDonald's Corp, ... ||| Biotech Stock Rally Is Crushing Short Sellers",0,0.52133983
2020-05-12,12140800.0,80.20999908447266,80.4800033569336,77.91000366210938,77.94999694824219,77.2622299194336,GILD,"Gilead Strikes Deal With Mylan to Supply Remdesivir Internationally ||| India's Jubilant signs licensing deal for Gilead's potential COVID-19 drug ||| 9 Enduring Stocks That You Shouldn’t Sell in May ||| UPDATE: Under The Terms Of The License Agreement Signed With Gilead, Mylan Has Rights To Manufacture And Distribute Remdesivir In 127 Low- And Middle-Income Countries, Including India. ||| Mylan To Supply Investigational Antiviral Remdesivir For The Potential Treatment Of Coronavirus/COVID-19 ||| Gilead Confirms Non-Exclusive Voluntary License Deal For Distribution Of Remdesivir With 5 Generic Makers In 127 Countries ||| Here's A Bullish Options Play On Gilead ||| 'Gilead strikes licensing agreements w 5 cos (Cipla Ltd., Ferozsons Laboratories, Hetero Labs Ltd., Jubilant Lifesciences and Mylan) to manufacture remdesivir in 127 countries, royalty-free until WHO declares end of global public health emergency' -Tweet ||| Jubilant Life Sciences Signs Non-Exclusive License Deal For Selling Gilead's Remdesivir In 127 Countries Including India; BZ NOTE: Jubilant Not Publicly Traded In US ||| FDA Commissioner: We've Learned A Lot Of Lessons From The 'Remdesivir Situation' ||| Fauci: Remdesivir Study Was Statistically Significant But Modest Success ||| 'Distribution of Key Drug Was Flawed, Says White House Official' -Yesterday WSJ Report ||| Symons Capital Management Inc Buys Gilead Sciences Inc, Agnico Eagle Mines, Telefonaktiebolaget ... ||| Jackson, Grant Investment Advisers, Inc. Buys ProShares S&P 5…… Dividend Aristocrats, ... ||| Birchview Capital, LP Buys ACADIA Pharmaceuticals Inc, Biogen Inc, Neurocrine Biosciences Inc, ...",0,0.49873835
2020-05-13,11166300.0,79.30000305175781,79.3499984741211,76.9000015258789,77.05999755859375,76.38008880615234,GILD,"Takeda says coronavirus treatment trial using recovered patients' blood could start in July ||| Gilead's Remdesivir Isn't Enough to Drive Its Stock Higher ||| Gilead In Deal With 5 Cos. To Make And Sell Remdesivir In 127 Countries ||| U.S. accuses China-linked hackers of stealing coronavirus research ||| Where Will Gilead Sciences Be in 1 Year? ||| U.S. stock futures climb ahead of Fed Chair Powell's address ||| Is AbbVie a Buy Now That the Allergan Deal Is Done? ||| Gilead Stock Still Looks Poised to Prove the Bears Wrong ||| Gilead, Co.'s Kite Pharma Highlight Acceptance Of 9 Abstracts During ASCO 2020 ||| Gilead Sees Some Results On Remdesivir In 'Few Weeks' ||| Hetero Enters Into a Licensing Agreement With Gilead Sciences, Inc. for the Manufacturing and Distribution of ""Remdesivir"" in 127 Countries, Including India, for COVID-19 ||| Roivant Sciences Says Breathe Trial Participants Will Be Permitted To Use Investigational Antivirals Including Remdesivir ||| The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter ||| 4 Key Takeaways From Senate's Online Hearing On US Coronavirus Strategy, Reopening Economy ||| Gilead Shares Drop As It Agrees To 'Royalty-Free' Coronavirus Drug Licence With Generic Drugmakers In 127 Countries ||| Healthcare Of Ontario Pension Plan Trust Fund Buys Allergan PLC, Mastercard Inc, Apple Inc, ... ||| Elkhorn Partners Limited Partnership Buys Cadiz Inc, ViacomCBS Inc, Nucor Corp, Sells Gilead ... ||| Hudson Canyon Investment Counselors Llc Buys NVIDIA Corp, Microchip Technology Inc, Raytheon ... ||| Vantis Investment Advisers L.P. Buys Gilead Sciences Inc, Uber Technologies Inc, Target Corp, ... ||| Stonehage Fleming Financial Services Holdings Ltd Buys Colgate-Palmolive Co, Edwards ... ||| Biotech Companies Lead Search for Coronavirus Vaccine: 4 Winners ||| SeaCrest Wealth Management, LLC Buys CVS Health Corp, Netflix Inc, Gilead Sciences Inc, Sells ...",1,0.51314557
2020-05-14,10711900.0,76.55000305175781,77.80999755859375,75.83000183105469,77.2300033569336,76.54859161376953,GILD,"France says any Sanofi COVID-19 vaccine for the world, no favourites ||| Part of Gilead's coronavirus drug donation allocated to Japan ||| Health groups ask India to rescind Gilead's patents for COVID-19 drug remdesivir ||| Japan says drugmaker Gilead's COVID-19 treatment remdesivir now in use in hospitals ||| Health groups ask India to rescind Gilead's patents for COVID-19 drug remdesivir ||| 2 Recession-Proof Healthcare Stocks to Buy in 2020 ||| VBI Vaccines Shares At Session Highs; 'Why Big Investors Aren't Betting It All on a Coronavirus Cure' -WSJ Article; Mentions Gilead, VBI Vaccines, INOVIO ||| '#COVID19 No data disclosed for #remdesivir #hydroxychroloquine in the DISCOVERY trial in France.' -Tweet From Andy Biotech. BZ NOTE: Content In Tweet From ~2 Hours Ago ||| IMC-Chicago, LLC Buys iShares Russell —………, Mastercard Inc, iShares Core S&P ... ||| Green Square Asset Management, LLC Buys Cisco Systems Inc, Amgen Inc, International Business ... ||| German American Bancorp, Inc. Buys Cisco Systems Inc, SPDR Select Sector Fund - Energy Select ... ||| After Drug Failure, Genfit's Cupboard Is Nearly Bare ||| Fairpointe Capital LLC Buys Hexcel Corp, Check Point Software Technologies, Waters Corp, Sells ...",0,0.5237745
2020-05-15,12350800.0,76.47000122070312,76.8499984741211,75.44999694824219,76.26000213623047,75.58715057373047,GILD,"Gilead to end coronavirus drug trials, adding to access worry -researchers ||| Pakistan's Ferozsons to begin producing COVID-19 drug remdesivir ||| Gilead Sciences Option Alert: Jan 15 $90 Calls Sweep (3) near the Ask: 350 @ $4.651 vs 8065 OI; Ref=$75.96 ||| L— Asset Management, LLC Buys Schwab U.S. ... ||| Walled Lake Planning & Wealth Management, Llc Buys Gilead Sciences Inc, Juniper Networks ... ||| PointState Capital LP Buys Microsoft Corp, SPDR Select Sector Fund - Health Care, UnitedHealth ... ||| Capital World Investors Buys Gilead Sciences Inc, Johnson & Johnson, Philip Morris ... ||| Capital International Investors Buys Gilead Sciences Inc, Netflix Inc, Truist Financial Corp, ... ||| Casdin Capital, LLC Buys Blueprint Medicines Corp, Twist Bioscience Corp, Gilead Sciences Inc, ... ||| Great Valley Advisor Group, Inc. Buys Goldman Sachs ActiveBeta U.S. ... ||| swisspartners Advisors Ltd Buys Alaska Air Group Inc, Marathon Petroleum Corp, iShares MSCI All ...",0,0.50215954
2020-05-18,16609100.0,76.45999908447266,76.5,73.86000061035156,74.76000213623047,74.10037994384766,GILD,"Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences ||| Could Veeva Systems Be a Millionaire-Maker Stock? ||| How Trump's Policies Moved Stocks ||| Is Gilead Sciences a Great Dividend Stock? ||| Why Gilead's Remdesivir Might Not Be the Mega-Moneymaker Some Think It Will Be ||| Barron's Picks And Pans: Cisco, Gilead, Netflix, Wayfair And More ||| Nasdaq 100 Movers: GILD, EXPE ||| BUZZ-U.S. STOCKS ON THE MOVE-Oasis Midstream, L Brands, Diffusion Pharma ||| GSK's long-acting injection beats Truvada in HIV prevention trial ||| GSK's long-acting injection beats Truvada in HIV prevention trial ||| RBC Analyst Earlier Warned Gilead's Remdesivir Is Unlikely To Yield Monetary Results Co. Hoped, Notes Co. Planning To Give Away 1.5M Doses For Free ||| Gilead Sciences Option Alert: Jan 15 $125 Calls Sweep (26) above Ask!: 300 @ $0.686 vs 2223 OI; Ref=$74.881 ||| Lake Point Wealth Management Buys iShares Core S&P Total U.S. ... ||| Markets Go Manic Thanks To Money-Printing, Moderna, & Merkel ||| The Zacks Analyst Blog Highlights: JPMorgan Chase, AbbVie, Royal Dutch Shell, Gilead Sciences and Anthem ||| Adalta Capital Management LLC Buys Verizon Communications Inc, Brookfield Asset Management Inc, ...",0,0.48371744
2020-05-19,14152000.0,73.66999816894531,74.8499984741211,72.30000305175781,72.33999633789062,71.70172882080078,GILD,"GlaxoSmithKline, Pfizer, and Shionogi's HIV Prevention Candidate Outperforms Gilead's Truvada ||| How The Parts Add Up: SCIU Targets $33 ||| Where Will Adaptimmune Be in 5 Years? ||| In The Midst Of Pandemic, Traders Pin Their Hopes On These Healthcare ETFs",1,0.49657768
2020-05-20,13429500.0,72.80999755859375,74.08999633789062,72.70999908447266,73.88999938964844,73.2380599975586,GILD,"Gilead-Galapagos's drug meets main goals of ulcerative colitis study ||| Health Care Sector Update for 05/20/2020: HOTH,ALDX,GILD,INO,BDX ||| Noteworthy Wednesday Option Activity: GILD, ILMN, ATVI ||| Health Care Sector Update for 05/20/2020: ALDX,GILD,INO,BDX ||| Why the Next Month Will Determine the Rest of the Year for Gilead's Stock ||| Gilead Still Holds the Winning Hand, Says 5-Star Analyst ||| Higher dose of Gilead-Galapagos drug meets ulcerative colitis study goals ||| Gilead, Galapagos Report Topline Results From Phase 2b/3 Trial Of Filgotinib In Moderate To Severe Active Ulcerative Colitis ||| Gilead Sciences Option Alert: Jul 17 $80 Calls Sweep (32) near the Ask: 508 @ $2.09 vs 5144 OI; Ref=$73.8899 ||| Gilead Sciences Option Alert: May 29 $75 Calls Sweep (2) near the Ask: 300 @ $1.45 vs 2555 OI; Ref=$73.31 ||| 'Gov. Abbott announced El Paso hospitals would receive 12 cases of Remdesivir...' -Tweet From El Paso, Texas' KVIA ABC 7 News ||| These Biotech Microcaps Have Gained Strong Momentum ||| These 4 High Earnings Yield Stocks are Hot Investment Picks",0,0.49142835
2020-05-21,7193500.0,73.47000122070312,73.93000030517578,72.88999938964844,73.5,72.85150146484375,GILD,"U.S. doctors call for remdesivir data to guide coronavirus treatment ||| Galapagos and Gilead Sciences Post Successful Yet Disappointing Filgotinib Results ||| How a Coronavirus Vaccine Might Move the Stock Market ||| ATRA Abuzz, ATOS' COVID-19 Med Effective, INO And VXRT On Track ||| The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive",0,0.5016458
2020-05-22,6268500.0,73.08999633789062,73.48999786376953,72.70999908447266,73.33999633789062,72.69290924072266,GILD,"Peer-reviewed data shows Gilead's drug effective against COVID-19 -NIH ||| Remdesivir Can’t Cure Covid, But Good Luck Telling Gilead Stock ||| Before You Buy Gilead Sciences Stock, Read This ||| Gilead Stock Is Worth Owning With or Without a Coronavirus Cure ||| Investigators Found Remdesivir Was Most Beneficial for Hospitalized Patients With Severe Disease Requiring Supplemental Oxygen; Findings Less Conclusive in Other Patient Subgroups ||| NIH Says Peer-reviewed Data Shows Gilead''s Remdesivir for Covid-19 Improves Time to Recovery; Says Remdesivir is Superior to Standard of Care for Treatment of Covid-19, According to Report Published in New England Journal of Medicine ||| Fauci On Remdesivir Study: Study Showed Advantage Of Diminishing Time Of Recovering From COVID-19 ||| Gilead Sciences Option Alert: Jun 19 $75 Calls Sweep (39) near the Ask: 854 @ $2.185 vs 17286 OI; Ref=$72.88",0,0.48470172
2020-05-26,12308100.0,73.9800033569336,74.30000305175781,72.41000366210938,73.18000030517578,72.5343246459961,GILD,"Mixed Results for Gilead Sciences' COVID-19 Treatment ||| Better Coronavirus Stock: Gilead Sciences or Vir Biotechnology? ||| 3 Large-Cap Coronavirus Stocks Still Worth Buying ||| Market Briefing For Monday, May 25 ||| 8 Monster Stocks To Watch For The Week Of May 25 ||| What's Next For The Biotech Bull Market? Are you a Trader or an Investor? ||| 10 Stocks to Buy as They Ride a Coronavirus Tailwind ||| WHO expects hydroxychloroquine safety findings by mid-June ||| BUZZ-U.S. STOCKS ON THE MOVE-IZEA Worldwide, Diffusion Pharma, DouYu International ||| Lilly, Junshi Biosciences plan to start human trials of COVID-19 antibody in Q2 ||| Merck leaps into COVID-19 development fray with vaccine, drug deals ||| BUZZ-U.S. STOCKS ON THE MOVE-Novavax, Tuesday Morning, HPE ||| Britain to provide anti-viral drug remdesivir to some COVID-19 patients ||| Merck leaps into COVID-19 development fray with vaccine, drug deals ||| UK Clears Gilead's Remdesivir For Some Coronavirus Patients ||| CORRECTION: UK Health Minister Hancock Says Anti-Viral Drug Remdesivir Is Probably Biggest Step Forward In Treatment Since Crisis Began; Prior Headline Named Hancock US Health Minister, This Was Incorrect ||| 'Gilead Could Sell $1.1 Billion of Remdesivir This Year, Analyst Writes' -Barrons Report ||| UK Health Minister Hancock Says Anti-Viral Drug Remdesivir Is Probably Biggest Step Forward In Treatment Since Crisis Began ||| Benzinga's Top Upgrades, Downgrades For May 26, 2020 ||| 10 Biggest Price Target Changes For Tuesday ||| SunTrust Robinson Humphrey Upgrades Gilead Sciences to Hold, Raises Price Target of $73 ||| UK Health Ministry Says Selected NHS Patients to Access Gilead's Coronavirus Treatment Remdesivir",1,0.50598836
2020-05-27,11752300.0,72.37999725341797,74.9800033569336,72.37999725341797,74.9000015258789,74.23914337158203,GILD,"Gilead study shows shorter 5-day course of remdesivir works as well as 10-day one ||| Gilead’s Remdesivir May Be a Coronavirus Silver Bullet — But It’s Already Baked in the Stock Price ||| Here's Why Arcus Biosciences Is Losing Ground Today ||| Gilead, Arcus Biosciences Ink 10-year Deal To Co-develop Cancer Immunotherapies ||| BUZZ-U.S. STOCKS ON THE MOVE-StoneCo, Tuesday Morning, Zynerba Pharma ||| AstraZeneca tests diabetes drug for COVID-19 despite risk seen by doctors ||| Gilead And Arcus Biosciences Establish 10-Year Partnership To Co-Develop And Co-Commercialize Next-Generation Cancer Immunotherapies; Arcus To Receive $175M Up Front And $200M Equity Investment Plus Up To $1.6B In Potential R&D Funding+Milestones ||| Monday Challenge - Stock Market Commentary ||| The Losers",1,0.48002106
2020-05-28,10511700.0,74.98999786376953,76.16999816894531,74.91000366210938,75.31999969482422,74.65544128417969,GILD,"July 10th Options Now Available For Gilead Sciences (GILD) ||| Don't Waste Your Money on Penny Stocks; These 3 Are Better Buys ||| Roche mixes Actemra with Gilead's remdesivir in COVID-19 trial ||| Genentech Initiates Phase III Trial Of Actemra Plus Remdesivir On Severe COVID-19 Pneumonia ||| PHAS To Begin COVID-19 Drug Trial In June, MRSN Hits New High, LJPC Plunges, RCUS On Watch ||| Roche to study remdesivir/Actemra cocktail against severe COVID-19 pneumonia ||| Tigress Financial's Ivan Feinseth Notes Many Co.'s Working To Produce Coronavirus Vaccines/Treatments; Says If Remdesivir Is Ramped Up, Gilead May Need To Work With Others To License And Produce It, And It May Not Be As Profitable ||| The Daily Biotech Pulse: PhaseBio To Start Potential Pivotal COVID-19 Trial, Immunomedics CEO Quits, Tetraphase Receives Sweetened Offer ||| BDR Pharmaceuticals Sought India Approval to Manufacture Remdesivir Without Gilead Agreement ||| Roche Initiates Phase III Clinical Trial of Actemra/Roactemra Plus Remdesivir in Hospitalised Patients With Severe Covid-19 Pneumonia in collaboration with Gilead ||| Zacks.com featured highlights include: TakeTwo Interactive Software, Gilead Sciences and Regeneron Pharmaceuticals ||| Gilead Inks 10-Year Deal With Arcus for Immuno-oncology Drugs",1,0.51127106
2020-05-29,24381900.0,75.7699966430664,78.12000274658203,74.61000061035156,77.83000183105469,77.14329528808594,GILD,"EU regulator promises speedy review of potential COVID-19 drug remdesivir ||| Here's Why Arcus Biosciences Stock Gained as Much as 15.9% Today ||| At The ASCO: ONCY, IMV, CRDF, GILD, TAK… ||| S.Korea seeks to import anti-viral remdesivir as new coronavirus cases emerge ||| EU regulator promises speedy review of potential COVID-19 drug remdesivir ||| Gilead Seeks Marketing Authorization From India ||| Gilead's Kite Pharma Reports Yescarta Data Showing Response Rates In Relapsed, Refractory Indolent Non-Hodgkin Lymphoma To Be Presented At ASCO ||| Gilead Reports Updated Results From Single-Arm, Open-Label Phase 1b Trial Of Magrolimab In Combo With Azacitidine In Previously Untreated Patients With Higher-Risk Myelodysplastic Syndrome ||| Gilead Continues to Build Cancer Franchise ||| US Indexes Close Mostly Higher on the Last Trading Day of May",0,0.5027708
2020-06-01,14665300.0,75.47000122070312,76.9000015258789,74.37999725341797,75.16000366210938,74.49685668945312,GILD,"The Week That Was: MRK Enters COVID Space, GSK's 1Bln Dose Target, Roche, GILD Team Up For REMDACTA ||| How One Hedge Fund Billionaire Is Battling to Bring Down Drug Prices in America ||| Mylan's Pakistan Partner AGP to Sell Remdesivir to Treat Covid-19 Within Two Months ||| Health Care Sector Update for 06/01/2020: ABIO,EBS,GILD,OCGN ||| Health Care Sector Update for 06/01/2020: EBS,GILD,OCGN ||| INSIGHT-Scientists hunt pandemic hotspots in race to test vaccines ||| BUZZ-U.S. STOCKS ON THE MOVE-Coty, Tesla, Zoom Video, Zynga ||| U.S. stocks gain as signs of recovery offset protests, economic worries ||| Gold edges lower as economies open up ||| Why Carnival, Royal Caribbean, and Norwegian Cruise Line Stocks Rose Today ||| GLOBAL MARKETS-Stocks under pressure as Trump vows to end violent protests ||| Stock Alert: Gilead Down 4% On Remdesivir Trial Data ||| Vir Biotechnology Is Bucking The Biotech COVID-19 Trends, And Stands To Win ||| Wall St gains as recovery hopes overshadow U.S. protests ||| Wall Street closes higher as recovery signs soothe protest, pandemic worries ||| Gilead says remdesivir helped moderate COVID-19 patients improve ||| INSIGHT-Scientists hunt pandemic hotspots in race to test vaccines ||| BUZZ-U.S. STOCKS ON THE MOVE-Gilead, Virgin Galactic, General Electric ||| Gilead Gets a Boost From Positive Coronavirus Research ||| Gilead trades that made millions on COVID-19 drug news raise eyebrows ||| EXCLUSIVE-Russia to roll out its first approved COVID-19 drug next week ||| Nasdaq 100 Movers: GILD, ZM ||| Gilead Reports Positive Late-Stage Study Results for Remdesivir in Patients With Moderate COVID-19 ||| TQQQ, CHTR, GILD, QCOM: Large Outflows Detected at ETF ||| Wall St rises as recovery hopes offset U.S. protests, China tensions ||| Gilead says remdesivir helped moderate COVID-19 patients improve ||| 3 Biotech Quick Picks to Invest $5,000 This Week ||| Mark Genovese Joins Gilead to Lead Clinical Development of Company's Inflammation Programs ||| BioSig Shares Spike To Session High On Volume; 8-K Filing Shows Co. Subsidiary ViralClear Filed Protocol Of Planned Study To Evaluate Safety, Efficacy Of Merimepodib In Combo With Remdesivir For Patients With Advanced Coronavirus To ClinicalTrials.gov ||| Gilead Falls On Mixed Results From Late-Stage Remdesivir Study In Moderate COVID-19 ||| Gilead shares are trading lower after the company reported data from its Phase 3 Trial of Remdesivir showing odds of improvement in clinical status with 10-day course were trending toward but not reaching statistical significance. ||| 'Gilead study of remdesivir in moderate #COVID19 patients out: patients on 5-day course were 65% more likely to have clinical improvement at Day 11 vs standard of care, but effect for those on 10-day course was not statistically significant' -Tweet ||| Gilead Says Odds Of Improvement In Clinical Status With 10-day Course Of Remdesivir Were Trending Toward But Not Reaching Statistical Significance ||| UPDATE: Gilead Study Demonstrated That Patients In The 5-day Remdesivir Treatment Group Were 65 Percent More Likely To Have Clinical Improvement At Day 11 Compared With Those In The Standard Of Care Group ||| Gilead Announces Results From Phase 3 Trial of Remdesivir in Patients With Moderate COVID-19; Study Demonstrates 5-Day Treatment Course of Remdesivir Resulted in Significantly Greater Clinical Improvement Versus Treatment with Standard of Care Alone ||| The COVID Comeback ||| The 5 Most-Sold Guru Stocks of the –st Quarter ||| Gilead Falls After Phase 3 Remdesivir 10-Day Trial Failed To Reach Significance",0,0.5099572
2020-06-02,16897900.0,74.37000274658203,74.63999938964844,72.95999908447266,73.26000213623047,72.61361694335938,GILD,"S.Korea approves import of anti-viral drug remdesivir for coronavirus treatment ||| AbbVie Will Be in Big Trouble When Its Patent Cliff Arrives ||| Tuesday Sector Laggards: Healthcare, Technology & Communications ||| India approves emergency use of remdesivir to treat COVID-19 patients ||| Better Coronavirus Stock: Gilead Sciences or Novavax? ||| India approves emergency use of remdesivir to treat COVID-19 patients ||| NTLA Gains On Amended REGN Deal, GILD Reports SIMPLE Results, MYOV On Watch, NVUS Slumps ||| Gilead shares are trading lower on continued momentum after the company reported data from its Phase 3 Trial of Remdesivir showing odds of improvement in clinical status with 10-day course were trending toward but not reaching statistical significance. ||| 'Gilead Drug Remdesivir's Use Against Coronavirus Could Become Obsolete, Analyst Says' -Barrons Report ||| 'Gilead's next step on coronavirus: inhaled remdesivir, other easier-to-use versions' -Reuters ||| Gilead's Remdesivir Cleared for Use in India for Severe Covid Cases ||| AstraZeneca Ranked Most Inventive, Roche Most Innovative",1,0.5168798
2020-06-03,12654500.0,74.37999725341797,74.55000305175781,73.36000061035156,74.4000015258789,73.74356079101562,GILD,"BUZZ-U.S. STOCKS ON THE MOVE-Glu Mobile, Boeing, American Eagle ||| Wait for More Clarity Before Buying Gilead Stock, Says Analyst ||| BUZZ-U.S. STOCKS ON THE MOVE-Warner Music, Boeing, Pliant Therapeutics ||| Eli Lilly Leaps Past Regeneron's COVID-19 Treatment Candidate ||| Abbvie Stock is Offering Investors an Oil Yield Without Oil’s Risk ||| Gilead's remdesivir could see $7 bln in annual sales on stockpiling boost – analyst ||| Gilead Analyst: Coronavirus Drug, Arcus Collaboration Make Biopharma A Buy",1,0.4866471
2020-06-04,14740900.0,74.12000274658203,78.18000030517578,73.94000244140625,77.54000091552734,76.85585021972656,GILD,"What Are the Implications of Gilead’s Increased Focus on Oncology? 5-Star Analyst Weights In ||| Noteworthy Thursday Option Activity: GILD, NSSC, LB ||| Co-Diagnostics Could Be a Prudent Coronavirus Play ||| Is Remdesivir a Disappointment? ||| Better Buy: Bristol Myers Squibb vs. Gilead Sciences ||| Lyft Looks Poised to Rally Over the Next Few Months ||| Air Travel’s Comeback Looks Poised to Lift GE Stock ||| Gilead Sciences : Filgotinib Shows Sustained Efficacy In Studies On Rheumatoid Arthritis ||| Roche test receives FDA emergency use approval for COVID-19 patients",0,0.4943268
2020-06-08,17973400.0,79.30000305175781,79.30999755859375,76.7300033569336,76.97000122070312,76.29088592529297,GILD,"AstraZeneca Proposes a Merger With Gilead Sciences ||| AstraZeneca contacted Gilead over potential megamerger -Bloomberg News ||| Fujifilm says COVID-19 drug research may drag on into July ||| BUZZ-U.S. STOCKS ON THE MOVE-Sino-Global Shipping, Michaels Companies, Applied DNA ||| EU watchdog aims for speedy approval of remdesivir as COVID-19 treatment ||| BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Carnival Corp, Opiant Pharmaceuticals ||| Wall Street set to rise on swift economic rebound hopes ||| Breakingviews - AstraZeneca M&A puzzle sends shareholder warning ||| BUZZ-U.S. STOCKS ON THE MOVE-Gilead, Cisco ||| U.S. stock futures rise on optimism over economic revival ||| London's FTSE 100 falls as AstraZeneca drops on megamerger report ||| European stock rally takes step back as tech, healthcare drag ||| AstraZeneca shares down 2% after report it approached Gilead over tie-up ||| London's FTSE 100 opens lower as AstraZeneca weighs ||| European shares pull back from 3-month highs after rally ||| 4 Analysts On Why The Rumored AstraZeneca-Gilead Deal Is Unlikely To Materialize ||| Astrazeneca CEO Soriot Said To Have Called Gilead CEO On May 9; Proposed Exploring Merger On A Call ||| PreMarket Prep Stock Of The Day: Gilead Sciences ||| 3 Gilead-Heavy ETFs To Watch Amid The AstraZeneca-Gilead Rumor",1,0.50216186
2020-06-09,7804300.0,77.0,78.12999725341797,76.69000244140625,77.58999633789062,76.90541076660156,GILD,"Gilead's remdesivir slows progression of COVID-19 in monkeys - study ||| Aggressive Investors Can Do Much Better Than Merck Stock ||| Gilead's remdesivir slows disease progression in monkeys with COVID-19 ||| AstraZeneca's Acquisition of Gilead Would Create a COVID-19 Colossus -- but Don't Bet on Seeing It Happen ||| Ex-Dividend Reminder: SpartanNash, STERIS and Gilead Sciences ||| What Would a Merger Mean for Gilead? Top Analyst Weighs In ||| A Look Into Gilead Sciences' Price Over Earnings ||| Gilead's Remdesivir Slows Disease Progression in Monkeys with COVID-19",0,0.50451326
2020-06-10,7790800.0,77.80000305175781,78.38999938964844,76.87999725341797,77.06999969482422,76.38999938964844,GILD,"U.S. FDA Commissioner says agency seeks fast review of COVID-19 products ||| Gilead Merger Unlikely at This Point, Says 5-Star Analyst ||| Study: Remdesivir Prevented Lung Damage In Monkeys Infected With COVID-19 ||| Is Aprea Therapeutics Stock a Buy? ||| GILD Named A Top Socially Responsible Dividend Stock ||| Singapore approves Gilead's remdesivir for COVID-19 treatment ||| Gilead Sciences: Co. Said To Refinance $2.5B Loan Facility ||| Gilead Sciences Option Alert: Jun 19 $80 Calls Sweep (2) near the Ask: 300 @ $1.121 vs 22172 OI; Earnings 7/28 After Close [est] Ref=$78.32 ||| A Peek Into The Markets: US Stock Futures Mixed; All Eyes On Fed Decision ||| Singapore Approves Gilead's Remdesivir as COVID-19 Treatment",0,0.5094616
2020-06-11,12098200.0,75.94000244140625,76.20999908447266,72.75,72.83999633789062,72.83999633789062,GILD,Regeneron Begins Human Trials of a Potential COVID-19 Treatment ||| Better Buy: bluebird bio vs. Gilead Sciences,1,0.5164938
2020-06-12,8357900.0,73.33000183105469,73.72000122070312,71.91000366210938,73.19999694824219,73.19999694824219,GILD,India's Zydus Cadila signs pact with Gilead to make remdesivir ||| India's Zydus Cadila to make Gilead's potential COVID-19 drug remdesivir ||| Kite To Manufacture CAR T Cell Therapies In Europe - Quick Facts ||| Is Adaptimmune Therapeutics a Buy? ||| American Airlines Stock Surely Will Be Back After Yesterday’s Beating,1,0.5264989
2020-06-15,6411800.0,73.26000213623047,74.47000122070312,72.41000366210938,73.97000122070312,73.97000122070312,GILD,Where Will AbbVie Be in 5 Years? ||| Dr. Reddy's Laboratories Enters Licensing Deal With Gilead Sciences For Remdesivir ||| Why Is Everyone Talking About Gilead Sciences Stock? ||| Better Buy: Moderna vs. Gilead Sciences ||| Should Sorrento Therapeutics Be Your Next Coronavirus Buy? ||| Is Now Still a Good Time to Buy Gilead Sciences (GILD) Stock? Oppenheimer Says ‘Yes’ ||| Eli Lilly starts trial of rheumatoid arthritis drug in COVID-19 patients,1,0.5022713
2020-06-16,9619700.0,74.58999633789062,75.66000366210938,73.69999694824219,74.62000274658203,74.62000274658203,GILD,AstraZeneca's Potential Vaccine Likely To Protect Against Covid-19 For A Year : Report ||| Early Shareholders Can Win If iBio Gets a Vaccine Contract ||| Israel approves remdesivir drug for COVID-19 treatment,0,0.5173969
2020-06-17,7528400.0,74.52999877929688,74.80999755859375,73.6500015258789,73.76000213623047,73.76000213623047,GILD,"Gilead to enroll pediatric patients for late-stage remdesivir study ||| Roche rheumatoid arthritis drug fails to help COVID-19 patients in Italian study ||| As Biogen Stock Struggles, Look Elsewhere for Biotech Exposure ||| Better Coronavirus Stock: Regeneron or Gilead Sciences? ||| Is Dexamethasone the Best Treatment for COVID-19? ||| 2 Pros, 2 Cons for Buying AIM ImmunoTech",1,0.50762916
2020-06-18,5516100.0,73.38999938964844,74.18000030517578,73.01000213623047,74.04000091552734,74.04000091552734,GILD,"Roche's Rheumatoid Arthritis Drug Actemra Fails to Help COVID-19 Patients With Pneumonia ||| Notable ETF Outflow Detected - IVE, C, WFC, GILD",1,0.5013873
2020-06-19,19322700.0,74.5199966430664,78.0,74.0999984741211,77.47000122070312,77.47000122070312,GILD,Novartis halts malaria drug trial against COVID-19 amid participant shortfall ||| U.S. hospitals in hard hit regions step up use of steroids on sickest COVID-19 patients ||| Research Indicates Blood Type Could Influence COVID-19 Severity ||| Is Eli Lilly Stock a Buy? ||| Is GlaxoSmithKline a Great Dividend Stock? ||| U.S. hospitals in hard hit regions step up use of steroids on sickest patients,0,0.50357705
2020-06-22,8943000.0,76.4800033569336,76.75,75.04000091552734,75.66999816894531,75.66999816894531,GILD,Is Hydroxychloroquine a Cure for COVID-19? ||| The 3 Best Coronavirus Stocks to Buy for Long-Term Investors ||| What's the Outlook for Gilead Sciences? ||| India gives Hetero Labs and Cipla approval to make Gilead's COVID-19 drug ||| Does Gilead Have a Cure for the Coronavirus? ||| Gilead to Test an Inhaled Version of Remdesivir ||| Gilead targets remdesivir supply for 2 mln COVID-19 patients by year-end ||| Gilead to test inhaled version of remdesivir on COVID-19 patients in August ||| Gilead To Trial Inhaled Version Of Remdesivir On Covid-19 Patients,0,0.5264383
2020-06-23,7117100.0,75.66999816894531,76.06999969482422,74.80999755859375,75.05000305175781,75.05000305175781,GILD,"Gilead to buy 49.9% stake in cancer drug developer Pionyr for $275 mln ||| Gilead Sciences To Acquire 49.9% Stake In Pionyr Immunotherapeutics For $275 Mln - Quick Facts ||| India's Cipla to price remdesivir version for COVID-19 under $66 ||| Better Coronavirus Stock: Gilead Sciences vs. Sorrento Therapeutics ||| Meet the Pharma Company That Just Had a Bigger IPO Than Moderna's ||| MYOV To Report SPIRIT 1 Data, EVLO Joins COVID-19 Drug Race, NVTA Loosens Purse Strings ||| 10 Stocks Riding on the Covid-19 Recovery ||| Gilead Sciences Bets $275 Million on an Oncology Start-Up",1,0.50734013
2020-06-24,7982000.0,74.9000015258789,76.05000305175781,74.7300033569336,75.93000030517578,75.93000030517578,GILD,Why Is Everyone Talking About Bristol Myers Squibb Stock? ||| India's Hetero prices experimental COVID-19 drug remdesivir at $71 per 100 mg vial ||| Drug pricing review group raises recommended price for Gilead's remdesivir,0,0.48116076
2020-06-25,7172900.0,75.80000305175781,75.87999725341797,74.33000183105469,75.48999786376953,75.48999786376953,GILD,Gilead's remdesivir endorsed as first COVID-19 treatment in Europe ||| 5 of the Best Pharmaceutical Stocks to Buy Right Now ||| Interesting GILD Put And Call Options For August 7th ||| EU Experts Recommend Approval of Gilead's COVID-19 Drug ||| Egypt's Rameda gets requests to export COVID-19 drug -CEO ||| A Certain Type of Investor Should Buy LOW Stock at Current Levels ||| Is Wall Street Wrong About Mesoblast? ||| EU drug regulator endorses Gilead's remdesivir as COVID-19 treatment,0,0.5187837
2020-06-26,10389200.0,75.0999984741211,75.37000274658203,73.7300033569336,74.56999969482422,74.56999969482422,GILD,"7 U.S. Stocks to Buy on Renewed Coronavirus Weakness ||| Key U.S. medical group adds steroids to COVID-19 treatment guidelines ||| SPECIAL REPORT-As world approaches 10 million coronavirus cases, doctors see hope in new treatments, lessons learned ||| South Korea backs remdesivir for COVID-19, urges caution with dexamethasone",0,0.53815573
2020-06-29,8775300.0,76.52999877929688,76.55999755859375,74.13999938964844,74.55999755859375,74.55999755859375,GILD,"3 Biotech Stocks I’d Buy Right Now ||| Big tobacco, big oil and Buffett join Fed's portfolio ||| BUZZ-U.S. STOCKS ON THE MOVE-Intercept Pharma, China Jo-Jo, Tortoise Acquisition ||| Gilead Fixes the Price of COVID-19 Drug Remdesivir; the Government Secures the Bulk of Its Supply ||| Notable Monday Option Activity: MYOK, GILD, OSIS ||| Breakingviews - Gilead gives glimpse into feverish drug market ||| Wall Street ends higher on Boeing bump, stimulus eyed ||| Wall Street gains on Boeing bump, remdesivir hopes ||| Wall St ends higher on Boeing bump, stimulus eyed ||| Gilead prices COVID-19 drug candidate remdesivir at $2,340 per patient ||| Wall Street gains as investors pin hope on stimulus-powered rebound ||| Wall Street set to open higher on hopes of stimulus, rebound ||| Gilead Prices Remdesivir At $390 Per Vial; 5-day Treatment To Cost $2,340 Per Patient ||| Gilead prices COVID-19 drug candidate remdesivir at $2,340 per patient in U.S. ||| U.S. FDA declines to approve first drug for obesity-linked liver disease ||| BUZZ-U.S. STOCKS ON THE MOVE-Intercept Pharma, Landcadia, Kiniksa Pharma",1,0.5020198
2020-06-30,9402600.0,74.33999633789062,77.16000366210938,73.91000366210938,76.94000244140625,76.94000244140625,GILD,"COVID-19 Research Companies Spur Interest in Biotech ETFs ||| S.Korea says to begin talks to purchase COVID-19 drug remdesivir in August ||| Noteworthy ETF Inflows: IBB, VRTX, GILD, REGN ||| Scottish firm to trial T cells as possible COVID-19 treatment",0,0.5085048
2020-07-01,7786900.0,77.0999984741211,77.2300033569336,75.9000015258789,76.05999755859375,76.05999755859375,GILD,"UK emergency remdesivir supplies adequate to treat COVID-19, official says ||| UK emergency remdesivir supplies adequate to treat COVID-19, official says ||| Gilead To Present New Data From Its HIV Research & Development Program - Quick Facts",1,0.51663184
2020-07-02,6374400.0,76.30999755859375,77.08999633789062,75.6500015258789,76.3499984741211,76.3499984741211,GILD,"Keep an Eye on Royalty Pharma Stock, 2020’s Biggest IPO ||| Better Buy: Vertex Pharmaceuticals vs. Galapagos ||| After Gilead Reveals Remdesivir Pricing, Analyst Sees Significant Revenue Upside ||| Indonesia seeking its own COVID-19 vaccine amid worry about access",1,0.5280408
2020-07-06,7056600.0,77.51000213623047,77.66000366210938,76.06999969482422,76.76000213623047,66.3308334350586,GILD,"Gilead Sciences' COVID-19 Treatment Earns Conditional Approval in Europe ||| Gilead's COVID-19 antiviral remdesivir gets conditional EU clearance ||| EU Approves Gilead's Remdesivir To Treat COVID-19 ||| EU grants conditional clearance to COVID-19 antiviral remdesivir ||| WHO halts hydroxychloroquine, HIV drugs in COVID trials after failure to reduce death ||| Shares of Gilead Have Cooled Off: Is Now the Time to Buy? ||| Mylan prices its generic remdesivir in India at $64 per 100 mg vial ||| Daily Markets: Market Rally Continues Despite Escalating Covid-19 Cases ||| Mylan to launch generic remdesivir version in India at $64 per 100 mg vial ||| Mylan: India Approves Remdesivir For Restricted Emergency Use In COVID-19 Patients",0,0.52284133
2020-07-07,5055700.0,76.48999786376953,76.95999908447266,76.30999755859375,76.41999816894531,66.03702545166016,GILD,GSK to develop plant-based COVID-19 vaccine with Canada's Medicago ||| India's Sovereign Pharma dispatches first batch of remdesivir to Cipla ||| Here's the Surprising Coronavirus Stock You'll Really Want to Own,0,0.50515544
2020-07-08,6293500.0,76.69999694824219,77.0,74.93000030517578,75.61000061035156,65.33708190917969,GILD,"India's Cipla set to undercut rivals with generic remdesivir -sources ||| EXCLUSIVE-EU secures potential COVID-19 drugs from Roche, Germany's Merck - source ||| South Korea seeks remdesivir to treat over 5,000 COVID patients -lawmaker ||| EXCLUSIVE-EU reaches deals with Roche, Merck for supply of COVID-19 drugs - source ||| Gilead begins testing inhalable form of remdisivir for COVID-19 ||| India's Cipla prices its generic remdesivir at $53.34 per vial, below rivals",0,0.5106198
2020-07-09,5199800.0,75.11000061035156,75.83999633789062,73.94999694824219,74.70999908447266,64.55937194824219,GILD,"Gilead to deliver more remdesivir to Europe from autumn - WiWo ||| Gilead to deliver more remdesivir to Germany, Europe from the Fall - WiWo",1,0.49885905
2020-07-10,9553800.0,76.0999984741211,76.8499984741211,75.5199966430664,76.31999969482422,65.95061492919922,GILD,"U.S. dollar slides as vaccine news offsets surge in virus cases ||| S&P 500 Shoots Up 33 Points: Banks, Airlines, and Cruise Line Stocks Brush Off Record COVID-19 Cases on Gilead Treatment Update ||| Why Farfetch Stock Slid Today ||| Wall St jumps with financials; Gilead data offsets virus fears ||| Stock Market Today: Gilead Gives Stocks a Booster Shot ||| Stocks Lock in Weekly Wins, Nasdaq Captures More Highs ||| Gilead's Remdesivir Cuts Risk of COVID-19 Death by 62% -- Maybe ||| Canadian dollar recovers from 10-day low after record jobs gain ||| Wall Street climbs as Gilead data offsets virus fears; Nasdaq hits another record high close ||| Why JPMorgan, Bank of America, Citigroup, and Wells Fargo Stocks Jumped on Friday ||| Health Care Sector Update for 07/10/2020: VCNX, UMRX, GILD, CRVS ||| Sum Up The Pieces: IYH Could Be Worth $241 ||| Wall Street gains as Gilead data offsets virus fears; Dow leads gains ||| BUZZ-U.S. STOCKS ON THE MOVE-Banks, Netflix, Beyond Meat, American Airlines ||| Financials lift S&P 500, Dow despite record U.S. virus cases ||| Stock Markets Open Mixed Friday as Netflix Gets Upgraded, Gilead Reports Positive Coronavirus Treatment Results ||| Gilead's New Analysis On Remdesivir Shows Improved Clinical Recovery And Reduced Risk Of Death ||| Yen rises on renewed surge in virus cases; dollar index falls ||| BUZZ-COMMENT-U.S. coronavirus damage puts dollar on precipice vs yen ||| Gilead says additional data on remdesivir shows improved clinical recovery ||| Potential Alzheimer’s Drug Not Enough to Excite Biogen Stock Investors ||| Health Care Sector Update for 07/10/2020: UMRX,GILD,CRVS",1,0.5055079
2020-07-13,9626600.0,76.5199966430664,78.33999633789062,75.94999694824219,76.68000030517578,66.26170349121094,GILD,"After Remdesivir Trials, Is It Too Late to Buy Gilead Stock? ||| Why Gilead Sciences' Successful COVID-19 Results Fell Flat ||| Is Gilead Sciences a Good Coronavirus Stock to Buy? ||| EMERGING MARKETS-Assets start week on strong note; Polish zloty up after presidential results ||| Delta Air Lines Will Survive Just Fine Long-Term ||| JGBs slip as stronger equities dent safe-haven demand ||| Stock Market Today: This Is Your Market on (Coronavirus) Drugs ||| One in three South Korean COVID-19 patients improve with remdesivir",1,0.5022112
2020-07-14,6904200.0,76.20999908447266,77.3499984741211,75.44000244140625,77.19000244140625,66.70240783691406,GILD,Here's Gilead Sciences' Great COVID-19 Opportunity That You'll Really Want to Watch,0,0.50414133
2020-07-15,6018800.0,76.98999786376953,77.29000091552734,76.23999786376953,76.6500015258789,66.23578643798828,GILD,Why Casual Dining Restaurant Stocks Were Gaining Today ||| Better Buy: Moderna vs. BioCryst Pharmaceuticals ||| Why Gilead Sciences Is the Front-Runner in the COVID-19 Treatment Race,0,0.49373674
2020-07-16,4862200.0,76.5999984741211,76.75,75.62999725341797,76.63999938964844,66.22714233398438,GILD,Foreign investors net buyers of Japan stocks for first time in five weeks,1,0.5320356
2020-07-17,6940100.0,76.52999877929688,77.6500015258789,76.20999908447266,77.51000213623047,66.97893524169922,GILD,"Notable Friday Option Activity: IBP, GILD, IRTC ||| Hong Kong gives conditional nod to Gilead COVID-19 drug Remdesivir ||| Hong Kong gives conditional greenlight to Gilead COVID-19 drug containing Remdesivir ||| 4 Coronavirus Stocks to Watch This Summer ||| South Korea approves human trials of Celltrion's COVID-19 antibody drug ||| India's Cadila aims to complete trial of coronavirus vaccine by March",1,0.51137435
2020-07-20,6974400.0,77.75,78.94000244140625,77.27999877929688,78.08000183105469,67.47150421142578,GILD,"Remdesivir Seems Effective Against Coronavirus, But Does It Make Gilead a Buy? ||| Better Buy: Novavax vs. Roche ||| 3 Top Coronavirus Stocks to Buy Right Now ||| If You Invested $1,000 in Gilead Sciences During the Last Recession, This Is How Much You Would Have Today",0,0.49313796
2020-07-21,5636600.0,77.3499984741211,77.98999786376953,76.5999984741211,76.77999877929688,66.3481216430664,GILD,"Japan approves dexamethasone as coronavirus treatment ||| Gilead Sciences Invests $300 Million in an Immuno-Oncology Startup ||| BUZZ-U.S. STOCKS ON THE MOVE-Tailored Brands, Philip Morris, JanOne Inc ||| Gilead To Acquire 49.9% Equity Interest In Tizona - Quick Facts ||| Better Coronavirus Stock: Gilead Sciences or Novavax? ||| Better Buy: Amgen vs. Gilead Sciences",0,0.50337124
2020-07-23,5854400.0,76.43000030517578,76.80000305175781,75.37000274658203,75.55999755859375,65.29386138916016,GILD,You Could Retire in Your 40s By Following the FIRE Movement,0,0.52901053
2020-07-24,8149000.0,75.47000122070312,75.6500015258789,73.12000274658203,73.63999938964844,63.634742736816406,GILD,"IBB, VRTX, GILD, REGN: ETF Outflow Alert ||| These 5 Stocks Save Lives, Fund Retirements ||| EMA to review results from study testing common steroid drug against COVID-19 ||| Gilead: CHMP Adopts Positive Opinion For Jyseleca In Treatment Of Rheumatoid Arthritis",1,0.49316692
2020-07-27,7678500.0,73.88999938964844,74.58999633789062,73.31999969482422,74.54000091552734,64.4124526977539,GILD,"Is This Dark-Horse Coronavirus Stock a Threat to Gilead Sciences? ||| 3 Biotech Stocks With Big Incoming Catalysts ||| FDA Approves Kite's Tecartus For Relapsed Or Refractory Mantle Cell Lymphoma Treatment ||| Noteworthy Monday Option Activity: GILD, AAPL, NFLX ||| PREVIEW-U.S. drugmaker earnings heat up this week with spotlight on vaccine news ||| iBio Stock Has Tripled in a Few Weeks. Here’s What’s Next ||| By boat and on foot, Indian state hunts for plasma for COVID patients",0,0.4935276
2020-07-28,5484400.0,74.66999816894531,75.04000091552734,73.61000061035156,73.7300033569336,63.712520599365234,GILD,Sintx Joins List of Highly Speculative Covid-19 Plays ||| Speculative Investors Should Buy Sorrento Stock,0,0.48804808
2020-07-29,8345200.0,73.8499984741211,73.8499984741211,72.52999877929688,73.01000213623047,63.0903434753418,GILD,"FDA could soon authorize COVID-19 treatment with antibody plasma - WSJ ||| 4 Companies That Could Upend the Pharma Industry ||| EU buys limited supply of COVID drug remdesivir, seeks more ||| EU executive signs remdesivir deal with Gilead ||| Roche attempt to retool arthritis drug for COVID-19 pneumonia fails trial",0,0.5206661
2020-07-30,9274100.0,72.55000305175781,72.5999984741211,71.70999908447266,72.33000183105469,62.50273895263672,GILD,"Gilead Sciences Posts Q2 Loss, Lifts FY Outlook ||| Gilead Sciences' Revenue and Earnings Slip in Second Quarter ||| Gilead posts weaker-than-expected quarterly results as sales lag during pandemic ||| Gilead Sciences Inc. Q2 adjusted earnings of $1.11 per share ||| Gilead (GILD) 2nd Quarter Earnings: What to Expect ||| EXCLUSIVE-Chinese-backed hackers targeted COVID-19 vaccine firm Moderna ||| Foreigners net buyers of Japanese stocks for third straight week ||| Gilead reports quarterly loss on acquisition costs",0,0.49573994
2020-07-31,20551100.0,69.7300033569336,70.83000183105469,68.5199966430664,69.52999877929688,60.08315658569336,GILD,"Remdesivir Maker Gilead Sciences Declares Dividend; Yield Is 3.9% ||| BUZZ-U.S. STOCKS ON THE MOVE-AbbVie, Xilinx, Pinterest, Expedia Group ||| Gilead Sciences Breaks Below 200-Day Moving Average - Notable for GILD ||| Tech Giants Send Nasdaq Up 150+, but Coronavirus Vaccine Stocks Suffer on Gilead Earnings, Moderna Hack Attack ||| Gilead Sciences Enters Oversold Territory ||| Health Care Sector Update for 07/31/2020: ECOR,TLSA,GILD ||| BUZZ-U.S. STOCKS ON THE MOVE-Electronic Arts, Spartan Energy, Phillips 66 ||| BUZZ-U.S. STOCKS ON THE MOVE-Alphabet, Chevron, Applied DNA, Under Armour ||| BUZZ-U.S. STOCKS ON THE MOVE-Caterpillar, Under Armour, Merck & Co, L3Harris Tech ||| Pandemic boost for Big Tech set to drive Wall St higher ||| Nasdaq futures jump as Big Tech booms during pandemic ||| EXCLUSIVE-China-backed hackers 'targeted COVID-19 vaccine firm Moderna' ||| Merck to Begin Pivotal COVID-19 Antiviral Studies in September",1,0.50010467
2020-08-03,9671800.0,69.72000122070312,72.1500015258789,69.61000061035156,71.7300033569336,61.98424911499024,GILD,"Better Buy: Gilead Sciences vs. Pfizer ||| Gilead Sciences (GILD) Q2 2020 Earnings Call Transcript ||| Notable Monday Option Activity: WKHS, GILD, KSU ||| Ligand Trounces Q2 Estimates by Helping Companies Make COVID-19 Drug Remdesivir ||| Is BioCryst Pharmaceuticals Stock a Buy? ||| Rival drugmakers launch joint trial of medicines for COVID-19",0,0.48185077
2020-08-04,9799700.0,72.0199966430664,72.30999755859375,70.47000122070312,70.87999725341797,61.249732971191406,GILD,"NIH to launch trials to test antibody drugs for COVID-19 ||| State attorneys general urge U.S. govt to increase supply, lower price of remdesivir ||| Is Gilead Sciences a Buy After Its Disappointing Q2 Results? ||| Sun Pharma latest to sell COVID-19 drug favipiravir in India ||| 3 Key Questions to Answer Before Buying Sorrento Therapeutics Stock ||| Taiwan provisionally approves dexamethasone as coronavirus treatment",0,0.5118257
2020-08-05,12271400.0,70.63999938964844,70.80999755859375,68.9800033569336,69.0,59.62515640258789,GILD,Zydus Cadila's COVID-19 vaccine candidate found safe in early-stage human trial,0,0.52143663
2020-08-06,8318000.0,69.0199966430664,69.62999725341797,68.62000274658203,68.80999755859375,59.460968017578125,GILD,Mylan narrows full-year revenue estimates on COVID-19 pressure ||| Interesting GILD Put And Call Options For September 25th ||| Foreigners' selling of Japanese stocks hits highest since mid-March last week ||| Better Coronavirus Stock: Gilead Sciences or Pfizer?,1,0.4691293
2020-08-07,8069000.0,69.36000061035156,69.7300033569336,68.80999755859375,69.3499984741211,59.92760848999024,GILD,"Pfizer to Co-Manufacture Coronavirus Drug Remdesivir ||| Pfizer signs deal to supply Gilead's remdesivir for COVID-19 ||| 2 Coronavirus Stocks Robinhood Investors Love. Should You? ||| UK's Hikma making Gilead's COVID-19 drug remdesivir to increase supply ||| European stocks end week with gains on telecoms, tech boost ||| Pfizer Signs Deal To Boost Supply Of Gilead's Remdesivir For COVID-19 Patients ||| Pfizer signs deal to manufacture Gilead's remdesivir for COVID-19",0,0.45257056
2020-08-10,10278000.0,69.1500015258789,69.25,67.95999908447266,68.51000213623047,59.201751708984375,GILD,Gilead files U.S. marketing application for remdesivir ||| GILD Dividend Yield Pushes Past 4% ||| Gilead Sciences Submits New Drug Application for Remdesivir as a COVID-19 Treatment ||| The Implied Analyst 12-Month Target For HDV ||| Gilead Files NDA For Remdesivir For Treatment Of COVID-19 ||| Gilead files U.S. marketing application for remdesivir ||| GILD Named 'Top Dividend Stock of the Nasdaq 100' at Dividend Channel With 3.9% Yield,0,0.5171006
2020-08-11,10236900.0,68.44999694824219,69.18000030517578,67.91999816894531,68.0999984741211,58.84745407104492,GILD,"Notable ETF Outflow Detected - IYH, GILD, CVS, ANTM ||| India's shortage of remdesivir is easing, says producer Cipla ||| Should Pfizer Be Your Next Coronavirus Buy?",1,0.47917378
2020-08-13,7468100.0,68.97000122070312,69.19000244140625,67.98999786376953,68.18000030517578,58.91658020019531,GILD,Zydus Cadila launches India's cheapest remdesivir version at $37 per vial,1,0.52518904
2020-08-14,9169200.0,68.08999633789062,68.81999969482422,68.0,68.5,59.193092346191406,GILD,Foreigners turn net buyers of Japanese stocks in week ended August 7,1,0.491966
2020-08-17,6848800.0,68.31999969482422,69.3499984741211,68.30999755859375,69.1500015258789,59.75479507446289,GILD,Should You Buy Gilead Sciences Stock on the Dip? ||| Is Gilead Sciences Stock a Buy?,0,0.48629814
2020-08-18,6327500.0,69.2300033569336,69.75,68.9800033569336,69.05999755859375,59.67700958251953,GILD,"Gilead Gets CRL For Filgotinib For Moderately To Severely Active Rheumatoid Arthritis Treatment ||| Noteworthy Tuesday Option Activity: BE, GILD, SPG",0,0.50181603
2020-08-19,19680300.0,66.19000244140625,67.47000122070312,65.5,65.69999694824219,56.77352523803711,GILD,"ALBO Drops NASH Drug Development, FDA Says No To Filgotinib, SUPN On Watch, Vanda & ODYSSEY ||| Drug costs for COVID-19 patients plunge at U.S. hospitals, but may rise ||| Wednesday's ETF with Unusual Volume: DLN ||| S&P 500, Nasdaq hit record highs as Apple crosses $2 trillion mark ||| S&P 500, Nasdaq hit record highs as Apple tops $2 trillion in market value ||| Why Galapagos Stock Is Crashing Today ||| S&P 500 notches record high for second day after Target, Lowe's results beat ||| Pre-market Movers In Healthcare Sector: NMTR, VRNA, AXDX, GLPG... ||| Health Care Sector Update for 08/19/2020: MNTA, JNJ, GILD, GLPG, ALC, XLV, IBB ||| FDA Denies Approval for Gilead Sciences' Potential Blockbuster Arthritis Drug ||| Wednesday Sector Laggards: Energy, Healthcare ||| Wall Street set to open higher after solid results from Lowe's, Target",1,0.5169303
2020-08-20,8339300.0,65.83999633789062,66.16000366210938,65.55000305175781,66.05000305175781,57.07598114013672,GILD,"Breakingviews - Corona Capital: Nvidia, Air conditioners",1,0.51100814
2020-08-21,9898000.0,65.77999877929688,66.87000274658203,65.41000366210938,66.5,57.46482849121094,GILD,CDC: U.S. Coronavirus-Related Deaths to Start Falling Next Week ||| Gilead study: remdesivir has marginal benefit for moderate COVID patients ||| Eli Lilly (Still) Looks Like the Best Buy in Large-Cap Pharma ||| Gilead remdesivir study finds only marginal benefit for moderate COVID-19 patients,0,0.4873591
2020-08-24,8566200.0,66.36000061035156,66.95999908447266,65.55000305175781,66.08000183105469,57.10189056396485,GILD,Who Said the Nasdaq Doesn't Have Dividend Stocks?,0,0.49575427
2020-08-26,7522600.0,65.87999725341797,65.87999725341797,65.16000366210938,65.5999984741211,56.687103271484375,GILD,Is Gilead Sciences a Buy After Its Most Recent Roadblock?,0,0.503674
2020-08-27,7919600.0,65.58999633789062,65.8499984741211,65.31999969482422,65.55000305175781,56.64391326904297,GILD,"After a 30% Surge, Is It Time to Buy iBio Stock Again? ",0,0.50765926
2020-08-28,6821000.0,65.22000122070312,65.75,64.9800033569336,65.26000213623047,56.393310546875,GILD,"FDA expands emergency use of Gilead's remdesivir in hospitalized COVID-19 patients ||| FDA approves expanded emergency use of remdesivir in moderate COVID-19 patients ||| Noteworthy ETF Outflows: TQQQ, GILD, ISRG, JD ||| Remdesivir Data Leaves Gilead Stock Well-Positioned to Rally ||| Why I Gave Up on Gilead ||| Vaccine Race Also-ran iBio Stock Won’t See Earlier Highs Anytime Soon",1,0.5271624
2020-08-31,9083900.0,65.45999908447266,66.88999938964844,65.41999816894531,66.75,57.68087387084961,GILD,Why Gilead Sciences' Stock Could Be Heading Even Lower ||| Better Coronavirus Stock: Gilead Sciences or Abbott Laboratories? ||| What Happened to Gilead Sciences and Is the Stock Still a Buy?,0,0.48169297
2020-09-01,8348000.0,66.33000183105469,66.47000122070312,64.91000366210938,65.83000183105469,56.8858642578125,GILD,"Stock Alert: Jounce Therapeutics Surges 50% After Inking Oncology Deal With Gilead Sciences ||| Sorrento Is Only for Thrill Seekers, But the Payoff Could Be Huge ||| Gilead, Jounce Agree To License JTX-1811 Program ||| 2 Embarrassingly Cheap Dividend Stocks",1,0.5276261
2020-09-02,8334700.0,65.31999969482422,66.95999908447266,65.31999969482422,66.79000091552734,57.715423583984375,GILD,"Steroids cut death rates among critically ill COVID-19 patients, major study finds ||| Steroids cut death rates among critically ill COVID-19 patients, major study finds",0,0.49702406
2020-09-03,10457400.0,66.80999755859375,67.43000030517578,65.4800033569336,65.91000366210938,56.95499801635742,GILD,"Merck CEO sees human trials for COVID-19 vaccine candidate 'fairly soon' ||| Pfizer targets end of next month for COVID-19 vaccine update ||| Pfizer targets end of October for COVID-19 vaccine update ||| Kite, HiFiBiO Join To Develop Antibodies Against Acute Myeloid Leukemia ||| These 3 Value Stocks Are Absurdly Cheap Right Now",1,0.5057469
2020-09-08,10729400.0,65.12000274658203,65.37000274658203,63.95000076293945,64.13999938964844,55.42548370361328,GILD,Lonza says first lymphoma patient dosed with CAR-T made in 'Cocoon' system ||| Lonza says first lymphoma patient dosed with CAR-T made in 'Cocoon' system,1,0.5090744
2020-09-09,9309700.0,64.27999877929688,65.08000183105469,63.61000061035156,64.51000213623047,55.74520492553711,GILD,Understand the Science Before Deciding on Sorrento Therapeutics ||| Why Trillium Therapeutics Stock Is on Fire Today ||| Could Vertex Pharmaceuticals Be a Millionaire-Maker Stock? ||| 2 Healthcare Stocks That Are Better Value Buys Than Apple,0,0.49745193
2020-09-10,8420600.0,64.69000244140625,65.04000091552734,63.54999923706055,63.77000045776367,55.10575866699219,GILD,5 of the Best Pharmaceutical Stocks to Buy Right Now,1,0.54353404
2020-09-11,10213000.0,64.37000274658203,65.91000366210938,64.22000122070312,65.58000183105469,56.66983795166016,GILD,"EXCLUSIVE-U.S. hospitals turn down remdesivir, limit use to sickest COVID-19 patients ||| EXCLUSIVE-U.S. hospitals turn down remdesivir supplies, limit use to sickest COVID-19 patients ||| Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for September 14, 2020",1,0.4857188
2020-09-14,18854200.0,64.44000244140625,67.91999816894531,64.30999755859375,66.33999633789062,57.92721557617188,GILD,"The 1 Most Important Lesson From AstraZeneca's Halted Coronavirus Vaccine Trial ||| Gilead Sciences To Buy Immunomedics In $21 Bln Deal ||| Gilead to buy cancer drugmaker Immunomedics for $21 bln ||| 2 Biotech Stocks with Jaw-Dropping Growth Potential ||| Wildcard: Three Med-Tech Stocks to Watch ||| Wall Street closes broadly higher on deal news, vaccine hopes ||| COVID SCIENCE-Flu outbreaks may be linked to COVID-19; arthritis drug benefit seen ||| Wall Street gains 1% on deal news, vaccine hopes ||| BUZZ-U.S. STOCKS ON THE MOVE-Adobe Systems, DraftKings Inc, Newmont Corp, Photronics Inc ||| GRAPHIC-Tech leads crisis-driven M&A boom with $350 billion deal rush ||| Wall Street climbs on mega mergers, vaccine hopes ||| Why Sea Limited Stock Was Climbing Today ||| Gilead's shares rise after $21 bln deal for Immunomedics ||| Wall Street climbs on mega mergers, vaccine hopes ||| Wall Street climbs on merger deals, vaccine hopes ||| Nasdaq Set to Open Higher; NVIDIA, Gilead Deals Drive M&A ||| Gilead's shares fall on concerns over high premium cancer deal ||| Wall Street set for higher open on M&A activity, vaccine hopes ||| BUZZ-U.S. STOCKS ON THE MOVE-Oracle Corp, J.Jill, Nvidia Corp, Boeing Co ||| Eli Lilly's rheumatoid arthritis drug helps recovery in COVID-19 patients ||| US STOCKS-Futures lifted by M&A activity, vaccine hopes ||| Gilead to buy cancer drugmaker Immunomedics for $21 bln ||| Vaccine hopes, global M&A boost European stocks ||| Vaccine hopes, global M&A boost European stocks ||| Five Takeaways from Gilead's (GILD) Acquisition of Immunomedics",0,0.5189898
2020-09-15,8327700.0,67.04000091552734,67.12999725341797,65.91999816894531,66.19999694824219,57.804969787597656,GILD,"Tech, healthcare mega deals boost virus-stricken M&A market ||| iBio Takes Swings, But Hasn’t Found a Pitch It Can Hit ||| Should You Buy Vir Biotechnology Stock on the Dip? ||| Should You Buy Gilead Now That It's Acquiring Immunomedics? ||| GRAPHIC-Tech leads crisis-driven M&A boom with $350 billion deal rush ||| MRNS Catches Eye, SAVA Soars On Alzheimer's Study, ETNB Abuzz Over NASH Trial, GILD Snaps Up IMMU",0,0.50517607
2020-09-16,7563600.0,66.31999969482422,66.55000305175781,65.61000061035156,65.6500015258789,57.32472610473633,GILD,Where Will Gilead Sciences Be in 5 Years?,0,0.511988
2020-09-17,8498300.0,64.81999969482422,65.54000091552734,64.4000015258789,65.04000091552734,56.79207611083984,GILD,3 Trends Robinhood Investors Can't Stop Buying Into,1,0.5437207
2020-09-18,14256900.0,64.94999694824219,65.16999816894531,64.05000305175781,65.05000305175781,56.800811767578125,GILD,3 Biotech Stocks That Surged Last Week ||| Merger and Acquisition Monday ||| Immunomedics' cancer drug helps reduce tumor size in early-stage study ||| Immunomedics reports promising early-stage data from cancer drug study ||| 2 Great Pharma Stocks to Buy in the Next Market Crash,0,0.5272291
2020-09-21,8575200.0,64.80999755859375,64.97000122070312,63.459999084472656,64.20999908447266,56.06732940673828,GILD,Immunomedics drug Trodelvy extends survival in breast cancer patients,0,0.5293212
2020-09-22,7228200.0,64.08000183105469,64.58000183105469,63.290000915527344,63.400001525878906,55.36005401611328,GILD,"Canada at 'crossroads' with COVID-19 case numbers rising ||| Canada warns of rising COVID-19 case numbers, signs new agreements for vaccines",0,0.5127752
2020-09-23,8520200.0,63.5099983215332,64.08000183105469,63.0,63.09000015258789,55.0893669128418,GILD,Gilead to pay $97 million to settle U.S. kickback probe ||| Gilead to pay $97 million to resolve kickback claims -U.S. Justice Department ||| Gilead's seven-part M&A bond attracts heavy demand,0,0.50395226
2020-09-24,9004600.0,62.70000076293945,62.84000015258789,61.650001525878906,62.25,54.35589218139648,GILD,Pfizer partner BioNTech sees no role for its vaccine in UK challenge trial ||| Gilead Sciences To Settle Alleged False Claims Act,0,0.4719812
2020-09-25,7142800.0,62.09999847412109,62.5099983215332,61.77000045776367,62.25,54.35589218139648,GILD,Better Coronavirus Stock: Gilead Sciences vs. Moderna ||| Gilead's M&A bond creates chemistry ||| Gilead Sciences' Jyseleca Approved In Japan For Rheumatoid Arthritis Treatment,1,0.5326496
2020-09-29,8657900.0,62.959999084472656,63.02999877929688,61.95000076293945,62.09999847412109,54.22490310668945,GILD,Better Buy: Gilead Sciences vs. Amgen ||| Can Gilead Stock Decline Further From $60?,1,0.50743765
2020-09-30,10072600.0,62.34999847412109,63.43000030517578,62.11000061035156,63.18999862670898,55.17668533325195,GILD,Pfizer Stock Is Flirting with Another Breakdown ||| Oxford to study anti-inflammatory drug Humira as potential COVID-19 treatment,1,0.46556526
2020-10-01,8356500.0,63.33000183105469,63.709999084472656,62.709999084472656,63.31999969482422,55.29019546508789,GILD,"5 Top Stock Trades for Friday: PINS, CROX, STZ, CAG, GILD ||| HHS says Gilead, distributor can directly sell COVID-19 drug in U.S. ||| European Regulators Begin Accelerated Review of AstraZeneca's COVID-19 Vaccine Candidate, but FDA Widens Its Investigation Into Clinical Trial Illness",0,0.5356783
2020-10-02,7796600.0,63.29999923706055,63.84000015258789,62.150001525878906,62.16999816894531,54.28603744506836,GILD,EMA committee probes possible kidney injury from Gilead's remdesivir ||| Want to Invest in Biotech? This ETF Is Crushing Biogen and Gilead,1,0.5190997
2020-10-05,10193900.0,63.709999084472656,64.08999633789062,63.09999847412109,63.59999847412109,55.53468704223633,GILD,"President Trump Begins Treatment With Remdesivir from Gilead Sciences ||| Is Fujifilm's Avigan a Game-Changing Coronavirus Drug? ||| Experts raise questions about severity of Trump's COVID-19 ||| Why Regeneron Pharmaceuticals Shot 7% Higher on Monday ||| The 6 Degrees of Separating Coronavirus from President Trump ||| Stock Markets Soar as Coronavirus Stocks Stay in the Spotlight ||| Got $5,000? These 2 Dividend Stocks Are Cheap Buys Today ||| GLOBAL MARKETS-Stocks rise on White House reports of Trump's improving health ||| Gilead, Regeneron, Amgen: Covid Treatment Stocks Still Worth Looking At As Vaccine Nears?",0,0.5200913
2020-10-06,8398100.0,63.790000915527344,63.790000915527344,62.34999847412109,62.52000045776367,54.591644287109375,GILD,Trump administration will cease federal funding to hospitals that do not report COVID-19 data ||| European countries face shortages of COVID-19 drug remdesivir ||| Trump's COVID-19 Treatment: Here Are the Stocks of All the Drugmakers Involved,1,0.50399
2020-10-07,6351400.0,62.72999954223633,63.16999816894531,62.290000915527344,62.84000015258789,54.87106704711914,GILD,"Pipeline is bare: more funding needed to develop new COVID-19 drugs - Wellcome ||| EU buys more Remdesivir to treat 3,400 patients amid shortages ||| EU has agreed supply of 20,000 additional doses of Remdesivir",1,0.5196497
2020-10-08,6434900.0,63.33000183105469,64.05000305175781,63.02000045776367,63.31999969482422,55.29019546508789,GILD,"Takeda-led COVID-19 plasma treatment enters clinical trial with first patient ||| Is Gilead Stock a Buy Right Now? This Is What You Need to Know ||| Gilead's remdesivir shaved 5 days off COVID-19 recovery time, reduced risk of death in some ||| Gilead's remdesivir shaved 5 days off COVID-19 recovery time, reduced risk of death in some ||| BUZZ-U.S. STOCKS ON THE MOVE-Occidental Petroleum, Oxbridge Re Holdings, Roku, fuboTV, Beyond Meat ||| Lilly's rheumatoid arthritis drug cuts COVID-19 deaths in trial, data shows ||| BUZZ-U.S. STOCKS ON THE MOVE-Corteva, Martin Marietta Materials, Tesla, Acuity Brands, Dana Inc ||| BUZZ-U.S. STOCKS ON THE MOVE-Medtronic, Carnival, JetBlue Airways, Bausch Health, Gilead, Cytokinetics ||| BUZZ-U.S. STOCKS ON THE MOVE-Eaton Vance, IBM, Domino's Pizza, Jazz Pharma, Moderna, American Airlines ||| Gilead, European Commission Enter Joint Procurement Agreement For Remdesivir",1,0.49684444
2020-10-09,9364500.0,64.61000061035156,64.69000244140625,63.720001220703125,63.84000015258789,55.74424743652344,GILD,"US expects over 1 mln antibody doses from Regeneron, Lilly in 2020 ||| Trump says he is pushing to get Regeneron's COVID-19 treatment approved quickly ||| HHS expects over 1 mln antibody doses from Regeneron, Lilly in 2020 ||| Pfizer Is a Value Play in the Covid-19 Frenzy ||| US STOCKS-S&P 500 set for second straight weekly gain on stimulus hopes",1,0.49103925
2020-10-12,7750200.0,64.06999969482422,64.98999786376953,63.54999923706055,64.55000305175781,56.36421585083008,GILD,"Better Coronavirus Stock: Gilead Sciences or Abbott Laboratories? ||| If You Invested $1,000 in Gilead Sciences' IPO, This Is How Much Money You'd Have Now ||| Is Gilead Sciences a Buy? ||| Takeda group begins manufacturing COVID-19 plasma treatment ahead of approval ||| COVID SCIENCE-COVID-19 antibodies last at least 3 months; so do symptoms for many ||| Gilead: Phase 2b/3 Trial Shows Efficacy Of Filgotinib - Quick Facts",0,0.505239
2020-10-13,6450200.0,64.55000305175781,64.98999786376953,64.0,64.48999786376953,56.31181716918945,GILD,"EU makes 1 bln-euro bet on Gilead's COVID drug before trial results ||| NIH starts clinical trial testing antibody treatments in COVID-19 patients ||| EU makes 1 bln-euro bet on Gilead's COVID drug before trial results ||| Is Gilead Sciences a Good Coronavirus Stock to Buy? ||| ATXI Plunges On Thumbs-down, VYGR's Huntington's Disease Trial On Hold, Deal Or No Deal For SURF?",0,0.50022924
2020-10-14,7138900.0,64.41000366210938,64.58999633789062,63.43999862670898,64.05000305175781,55.92761993408203,GILD,Late-Stage Study of Lilly's COVID-19 Antibody Therapy Paused: Buy the Stock on the Dip? ||| Eli Lilly Coronavirus Antibody Drug Trial Paused ||| Eli Lilly's COVID-19 Treatment Candidate Has a Manufacturing Site Problem ||| Gilead Says HSR Waiting Period For Immunomedics Tender Offer Expires - Quick Facts ||| Eli Lilly to continue other COVID-19 antibody drug trials after pausing one on safety concerns,0,0.4996995
2020-10-15,9630700.0,63.47999954223633,63.54999923706055,62.650001525878906,62.959999084472656,54.97584533691406,GILD,WHO study says remdesivir did not cut hospital stay or mortality in COVID-19 patients - FT ||| WHO study says remdesivir did not reduce mortality in COVID-19 patients - FT ||| Biopharma Firm Incyte's Stock Jumped 10% – Time To Get In?,0,0.5404858
2020-10-16,12307200.0,62.400001525878906,62.86000061035156,61.83000183105469,62.0,54.13758850097656,GILD,"GSK-J&J's long-acting HIV injection gets EU panel endorsement ||| US STOCKS-Futures climb on vaccine hopes, upbeat retail sales data ||| COVID SCIENCE-Remdesivir questioned by WHO trial; women take virus more seriously than men ||| Can Cytonics Pivot Successfully to Covid-19 Therapeutics? ||| BUZZ-U.S. STOCKS ON THE MOVE-Navistar, Boeing, Regeneron, Pfizer ||| BUZZ-U.S. STOCKS ON THE MOVE-Pfizer, Hewlett Packard, BioNTech, Amarin ||| US STOCKS-Futures perk up on vaccine hopes as stimulus stand-off weighs ||| BUZZ-U.S. STOCKS ON THE MOVE-Coffee Holding, Boeing, Hertz, Pfizer ||| BUZZ-U.S. STOCKS ON THE MOVE-Gilead, Pfizer, Chewy, MMTEC ||| Get Ready To Bull Trade Novavax Stock For A Second Wave ||| ANALYSIS- Sales of first big COVID-19 drug, remdesivir, may disappoint ||| Kite: European CHMP Adopts Positive Opinion For KTE-X19 ||| NIH tests therapies to help cut hospital stays for COVID-19 patients",0,0.51003623
2020-10-19,9643600.0,62.0,62.09999847412109,60.209999084472656,60.56999969482422,52.88893127441406,GILD,"How Could Recent COVID-19 Vaccine News Impact Stocks Like Boeing or DocuSign? ||| Here Are the Treatments President Trump Received for COVID-19, None of Which Are FDA ""Approved"" ||| Validea's Top Five Healthcare Stocks Based On Benjamin Graham - 10/18/2020 ||| Does This Metric Tell Investors All They Need to Know About Gilead Sciences? ||| 2 Top Robinhood Stocks to Sell Before the Next Market Crash ||| Can Gilead Make Money From Its COVID-19 Treatment Remdesivir?",0,0.48604497
2020-10-20,9208000.0,60.59000015258789,60.900001525878906,59.86000061035156,60.54999923706055,52.87146759033203,GILD,"Is Gilead Sciences a Good Coronavirus Stock? ||| The 1 Stock Most Likely to Win From a Potentially Game-Changing Coronavirus Discovery ||| UK plans COVID-19 ""challenge"" trials that deliberately infect volunteers",0,0.4957423
2020-10-21,7493700.0,60.2400016784668,60.5,59.900001525878906,60.209999084472656,52.57458114624024,GILD,CRISPR Therapeutics Reports Mixed Cancer Trial Results ||| ANALYSIS-Lack of antidotes adds to ethical dilemmas for UK COVID-19 challenge trials ||| Better Buy: Moderna vs. Gilead Sciences,1,0.5085065
2020-10-22,17061800.0,59.91999816894531,60.900001525878906,59.650001525878906,60.66999816894531,52.97624969482422,GILD,"Gilead's Remdesivir First Drug to Win FDA Approval for Coronavirus ||| FDA Approves Gilead's Antiviral Remdesivir For Treatment Of COVID-19 - Quick Facts ||| US STOCKS-Wall Street closes higher, trade choppy as U.S. stimulus talks eyed ||| Gilead's remdesivir gets U.S. FDA approval ||| Gilead's remdesivir gets U.S. FDA approval ||| India's Dr Reddy's isolates data center services after cyberattack",1,0.51004136
2020-10-23,30965400.0,63.380001068115234,63.63999938964844,60.7599983215332,60.790000915527344,53.08103942871094,GILD,"BUZZ-U.S. STOCKS ON THE MOVE-Socket Mobile, Gilead, Intel ||| US STOCKS-S&P 500, Dow edge higher on hopes of progress in stimulus talks ||| BUZZ-U.S. STOCKS ON THE MOVE-Intel, Mattel Inc, American Express ||| US STOCKS-Wall Street subdued as wait for stimulus continues ||| BUZZ-U.S. STOCKS ON THE MOVE-Socket Mobile Inc, Iterum Therapeutics, American Express ||| US STOCKS-S&P, Nasdaq close higher as investors focus on stimulus talks ||| US STOCKS-Dow slips, S&P flat as stimulus stalemate weighs ||| US STOCKS-S&P, Nasdaq close higher as stimulus talks in spotlight ||| WHO says it will have advice on remdesivir in 3-4 weeks ||| US STOCKS-Wall Street slips as stimulus deadlock weighs ||| Pre-Market Most Active for Oct 23, 2020 : EVK, GILD, CLPS, INTC, FE, SLDB, DOGZ, GE, TJX, SNAP, NIO, BEST ||| Pre-market Movers In Healthcare Sector: SAVA, KTOV, PRVL, IMMP, GILD, ITRM, BBI… ||| Gilead Completes Transaction To Acquire Immunomedics - Quick Facts ||| US STOCKS-Dow, S&P futures gain on hopes of progress in stimulus talks ||| BUZZ-U.S. STOCKS ON THE MOVE-Gilead, Intel Corp, Socket Mobile ||| Gilead shares rise after United States approves remdesivir as COVID-19 drug ||| Daily Markets: Stocks Could Hinge On News From Washington On Stimulus - Or Lack Thereof ||| FDA OKs Gilead's Remdesivir As First COVID-19 Treatment Despite WHO Findings ||| BUZZ-U.S. STOCKS ON THE MOVE-American Express, Gilead, Socket Mobile, Uber ||| Why Gilead Sciences Stock Is on the Move Today",0,0.49569005
2020-10-26,10256300.0,60.36000061035156,60.68999862670898,59.400001525878906,59.959999084472656,52.35628128051758,GILD,"Where Things Stand in the Coronavirus Vaccine Race ||| 2 Coronavirus Stocks to Avoid This Month ||| Here's the Biggest Misconception About Coronavirus Vaccines ||| Is Sorrento Therapeutics Stock a Buy? ||| Eli Lilly Ends Late-stage Covid-19 Antibody Trial In U.S. Due To Insufficient Data ||| Good Entry Point for Gilead Sciences (GILD)? Not Just Yet, Says Analyst ||| Don’t Get Swept Up In the Unproven Promise of Aptorum Group ||| IBB, GILD, ILMN, BIIB: ETF Outflow Alert ||| Biotech Stocks Facing FDA Decision In November 2020",1,0.50242066
2020-10-27,7699900.0,59.810001373291016,60.209999084472656,59.43999862670898,60.0099983215332,52.399940490722656,GILD,NIH Ends Clinical Trial of Eli Lily's Coronavirus Antibody Therapy Candidate,0,0.5350086
2020-10-28,12150800.0,59.310001373291016,59.56999969482422,58.060001373291016,58.720001220703125,51.27354049682617,GILD,"Gilead Sciences Q3 20 Earnings Conference Call At 4:30 PM ET ||| Gilead Sciences Inc. Q3 adjusted earnings of $2.11 per share ||| Gilead Sciences Swings To Q3 Profit ||| Gilead quarterly revenue rises 17% on remdesivir sales ||| Gilead Sales Up 18% in Q3, Thanks to Coronavirus Treatment Remdesivir ||| Here's Why Gilead Sciences Is More Than Just a COVID-19 Play ||| Gilead quarterly revenue rises 17% on remdesivir sales ||| After-Hours Earnings Report for October 28, 2020 : V, AMGN, NOW, GILD, EQIX, CTSH, EBAY, ORLY, F, KLAC, WCN, PINS ||| Should You Buy Immunomedics Before the Gilead Sciences Acquisition Closes? ||| Got $5,000? These 2 Robinhood Stocks Could Make You Rich! ||| What's Next for Eli Lilly's COVID-19 Antibodies?",0,0.5112986
2020-10-29,12529400.0,57.79999923706055,58.88999938964844,57.040000915527344,58.52999877929688,51.10763168334961,GILD,"BUZZ-U.S. STOCKS ON THE MOVE-Tricida, Cancer Genetics, Penumbra Inc ||| BUZZ-U.S. STOCKS ON THE MOVE-Cancer Genetics, Tricida, Pinterest ||| BUZZ-U.S. STOCKS ON THE MOVE-Tricida, Pinterest, Blue Apron Holdings ||| Why the Luster of Gilead's Strong Q3 Results Isn't as Bright as It Seems ||| US STOCKS-Futures higher after steep selloff with eyes on Big Tech earnings ||| Is Gilead Sciences a Great Dividend Stock?",0,0.4650538
2020-10-30,11869100.0,57.790000915527344,58.58000183105469,57.18000030517578,58.150001525878906,50.775821685791016,GILD,2 No-Brainer Dividend Stocks Yielding More Than 4%,1,0.53762287
2020-11-02,9352600.0,58.77999877929688,59.150001525878906,57.83000183105469,58.52999877929688,51.10763168334961,GILD,"As Coronavirus Cases Climb, Here's 1 Stock to Buy and 1 to Avoid ||| 2 Rock-Solid Coronavirus Treatment Stocks to Buy Right Now ||| What's Driving Gilead Sciences' Growth-Through-Acquisition Strategy ||| Germany requests 5% of EU supply of remdesivir ||| Despite Pandemic Catalysts, Tread Carefully With Sorrento Stock ||| Russian firm seeks to produce COVID-19 drug remdesivir without patent ||| 3 Top Stocks With High Dividend Yields",1,0.51710916
2020-11-03,6599700.0,58.81999969482422,59.38999938964844,58.400001525878906,58.83000183105469,51.36958694458008,GILD,"BUZZ-U.S. STOCKS ON THE MOVE-U.S. banks, Plug Power, Spirit AeroSystems, Gartner, Solaredge ||| BUZZ-U.S. STOCKS ON THE MOVE-U.S. bank stocks, Alibaba, Ferrari, health insurers ||| 4 Top Biotech Stocks to Buy for Operation Warp Speed ||| Which Biotech Stocks Are a Buy on Earnings? ||| Germany says remdesivir useful for some COVID-19 patients",1,0.4949243
2020-11-04,12935200.0,59.38999938964844,61.18999862670898,59.369998931884766,59.869998931884766,52.2776985168457,GILD,Will Gilead's Remdesivir Only Be a Short-Lived Success Story? ||| Here's What's Behind Bristol Myers Squibb's Huge Acquisitions,0,0.48382565
2020-11-05,7519800.0,60.34000015258789,60.470001220703125,59.20000076293945,59.630001068115234,52.068138122558594,GILD,"EXCLUSIVE-WHO-led COVID drug scheme doubles down on antibodies, steroids and shuns remdesivir",0,0.49775347
2020-11-09,10807100.0,59.400001525878906,60.369998931884766,58.9900016784668,59.04999923706055,51.56169128417969,GILD,Better Coronavirus Stock: Gilead Sciences or Abbott Laboratories? ||| 2020 Will Be a Year to Remember for These 3 Healthcare Stocks ||| Lilly's COVID-19 Antibody Drug Gets FDA Emergency Use Authorization For Non-hospitalized Patients ||| Indian demand for COVID-19 drug remdesivir rising sharply - Cipla,1,0.5166769
2020-11-10,10524400.0,58.43999862670898,61.45000076293945,58.18000030517578,60.619998931884766,52.93259048461914,GILD,U.S. to start distributing Lilly COVID-19 antibody this week ||| These 3 Value Stocks are Absurdly Cheap Right Now,0,0.48744982
2020-11-13,6740800.0,59.959999084472656,60.97999954223633,59.77000045776367,60.59000015258789,52.906394958496094,GILD,Analysts See 10% Gains Ahead For JKF ||| World's top intensive care body advises against remdesivir for sickest COVID patients,1,0.508694
2020-11-16,6969300.0,60.2599983215332,61.29999923706055,60.25,61.09000015258789,53.34298706054688,GILD,New Drugs Approved In October,0,0.53156763
2020-11-17,5488400.0,60.79999923706055,61.04999923706055,60.369998931884766,60.970001220703125,53.23820877075195,GILD,"Eli Lilly, Regeneron, Gilead: What The Vaccine Means For Covid-19 Treatment Stocks",0,0.5064096
2020-11-18,8884200.0,61.040000915527344,61.63999938964844,60.560001373291016,60.900001525878906,53.17708206176758,GILD,Is Moderna Still a Compelling Growth Play? ||| Gilead Sciences' Lenacapavir Meets Primary Endpoint In Phase 2/3 HIV Study,0,0.52288157
2020-11-19,7525100.0,60.5,60.959999084472656,59.900001525878906,60.630001068115234,52.94132232666016,GILD,WHO advises against Gilead's remdesivir for all hospitalised COVID-19 patients ||| Sorrento CEO Henry Ji on How the Company Got Its Start ||| FDA Issues Emergency Approval To Lilly's Arthritis Drug With Remdesivir For COVID-19 Treatment,0,0.5164794
2020-11-20,9440800.0,59.59999847412109,60.2599983215332,59.47999954223633,60.11000061035156,52.487266540527344,GILD,"US STOCKS-Wall Street closes lower as surging COVID-19 cases offset vaccine hopes ||| WHO Recommends Against Using Gilead's Remdesivir for COVID-19 ||| US STOCKS-Wall Street closes lower as surging COVID-19 cases offset vaccine hopes ||| US STOCKS-S&P 500, Dow dip as spiking COVID-19 infections eclipse vaccine hopes ||| US STOCKS-Wall St dips on concerns over fading stimulus, virus fears ||| US STOCKS-S&P 500, Dow set for muted open on concerns over fading stimulus ||| Is Sorrento Therapeutics Stock a Buy? ||| WHO Recommends Against Using Gilead Sciences' Remdesivir For Covid ||| AZN's Covid Jab & Immunosenescence, PFE/BNTX To Seek Emergency Nod For Vaccine, QURE Aces HOPE-B",0,0.49666083
2020-11-23,8684000.0,60.06999969482422,60.290000915527344,59.369998931884766,59.88999938964844,52.29515838623047,GILD,"Is There Room for Latecomers to the COVID-19 Party? ||| Could Sorrento Therapeutics Be a Millionaire-Maker Stock? ||| This Company's New Approach Could Slash Gilead's Profit From HIV Drugs ||| Canada could approve COVID-19 vaccines early next year -regulator ||| Noteworthy Monday Option Activity: GILD, CBRL, VMW",1,0.5317477
2020-11-25,8336100.0,60.18000030517578,60.43999862670898,59.470001220703125,59.5,51.95462417602539,GILD,EU seeks to bypass patents to boost drugs access in crises ||| 3 High-Yield Stocks at Rock-Bottom Prices,1,0.54327226
2020-11-27,5040700.0,59.63999938964844,60.060001373291016,59.27999877929688,60.02999877929688,52.41741180419922,GILD,"This Biotech Is Up 1,500% This Year. Can It Make You Rich in 2021? ||| Is This Coronavirus Treatment Setting Investors Up for Failure?",1,0.5049554
2020-11-30,16315700.0,59.7599983215332,60.790000915527344,59.63999938964844,60.66999816894531,52.97624969482422,GILD,"Gilead's New CEO Is Going All-In on Acquisitions ||| Is Gilead Sciences a Great Dividend Stock? ||| IBB, GILD, AMGN, VRTX: ETF Outflow Alert",1,0.494337
2020-12-01,9620100.0,60.81999969482422,61.97999954223633,60.79999923706055,61.119998931884766,53.36918258666992,GILD,3 Pharma Stocks With Dividends Above 4% to Buy Now ||| Canada Approves Gilead Sciences' Descovy For HIV Pre-exposure Prophylaxis,1,0.5475143
2020-12-02,6470300.0,61.06999969482422,61.869998931884766,60.959999084472656,61.130001068115234,53.37791442871094,GILD,Medical journal editorial refutes WHO finding on Gilead's remdesivir for COVID-19 ||| Despite A 65% Rally AbbVie Stock Looks Like It Can Gain More,0,0.49700966
2020-12-08,6185000.0,60.560001373291016,61.25,60.52999877929688,61.16999816894531,53.412841796875,GILD,Did You Miss Out on a 5000% Gain With Trillium Stock?,0,0.5040725
2020-12-09,7231600.0,61.16999816894531,61.400001525878906,60.470001220703125,60.81999969482422,53.10723114013672,GILD,"Hackers steal Pfizer/BioNTech COVID-19 vaccine data in Europe, companies say ||| Dividend Investors: Don't Be Too Quick To Buy Gilead Sciences, Inc. (NASDAQ:GILD) For Its Upcoming Dividend",0,0.47279227
2020-12-10,7239500.0,60.65999984741211,60.900001525878906,60.130001068115234,60.45000076293945,52.78414535522461,GILD,Gilead to acquire German biotech firm MYR for about 1.15 bln euros ||| Gilead to acquire German biotech firm MYR for about 1.15 bln euros ||| Investors: How Would You Grade Gilead Sciences' CEO? ||| Gilead Sciences To Buy Hepatitis Drug Maker MYR GmbH For Up To EUR 1.45 Bln ||| Gilead Sciences Buys a New Hepatitis Delta Virus Treatment,1,0.49173847
2020-12-11,7845100.0,60.220001220703125,60.810001373291016,60.09000015258789,60.7599983215332,53.054832458496094,GILD,"Notable Friday Option Activity: EXPE, ULTA, GILD ||| Five key genes linked to severe COVID-19 found, suggesting drug targets ||| Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for December 14, 2020 ||| EU drugs regulator endorses changes to remdesivir marketing for COVID-19 use ||| EU drug regulator endorses changes to remdesivir marketing for COVID-19 use",0,0.4773622
2020-12-14,12233000.0,60.38999938964844,60.41999816894531,59.75,59.84000015258789,52.8428955078125,GILD,3 Stocks That Are Giving Their Investors Coal in Their Stockings ||| The Most Popular Coronavirus Stock May Lose Half Its Value by 2023,0,0.48378706
2020-12-15,8073900.0,59.81999969482422,60.06999969482422,59.27000045776367,59.43000030517578,52.48084259033203,GILD,Gilead Says Not To Pursue FDA Approval Of Filgotinib For Rheumatoid Arthritis Treatment ||| Gilead says not to pursue U.S. approval for rheumatoid arthritis drug ||| Gilead abandons filgotinib for rheumatoid arthritis in U.S.,0,0.51268625
2020-12-16,8786400.0,59.310001373291016,59.470001220703125,58.68999862670898,58.93999862670898,52.048133850097656,GILD,"BUZZ-U.S. STOCKS ON THE MOVE-Penumbra, NeuBase, Good Times Restaurants ||| IBB, GILD, MRNA, VRTX: ETF Outflow Alert ||| Kite: European Commission Grants Conditional Marketing Authorization For Tecartus ||| European shares hit 10-month peak on upbeat business activity, vaccine hopes",1,0.5212641
2020-12-17,9469000.0,58.93000030517578,59.27999877929688,58.61000061035156,59.06999969482422,52.162933349609375,GILD,"Down 9% in 2020, Is Biogen Now a Buy?",1,0.51235795
2020-12-18,22195800.0,59.18000030517578,59.18000030517578,58.52999877929688,59.08000183105469,52.17176818847656,GILD,2 Best Biotech Stocks to Buy in December,0,0.5092757
2020-12-21,12141900.0,58.45000076293945,58.61000061035156,57.70000076293945,58.540000915527344,51.69490814208984,GILD,"After Hours Most Active for Dec 21, 2020 : ET, PAA, BAC, AAPL, TJX, BMY, MSFT, VIAC, MPLX, IBN, GILD, UNIT ||| Should Investors Consider This Biotech Takeover Target?",0,0.48481125
2020-12-22,14964000.0,58.220001220703125,58.31999969482422,56.810001373291016,57.0,50.33497619628906,GILD,"Noteworthy Tuesday Option Activity: BJRI, AXSM, GILD",1,0.514897
2020-12-23,8495900.0,56.900001525878906,57.619998931884766,56.900001525878906,57.380001068115234,50.67055130004883,GILD,2 Ultra-High-Growth Healthcare Stocks That Are Just Getting Started ||| Where Will Gilead Sciences Be in 1 Year?,0,0.50904816
2020-12-31,10870500.0,56.59999847412109,58.36000061035156,56.560001373291016,58.2599983215332,51.44765472412109,GILD,"5 Undervalued Dividend Stocks to Buy ||| Noteworthy Thursday Option Activity: GILD, K, ABBV ||| 3 Bargain Stocks You Can Buy Today",1,0.5306565
2021-01-04,15520000.0,58.66999816894531,60.15999984741211,57.93000030517578,60.11000061035156,53.08133316040039,GILD,3 Great Income Stocks to Buy Right Now ||| Gilead Sciences or Biogen: Which Biotech Stock is a Better Pick for 2021? ||| 3 Stocks Trading at Rock-Bottom Prices; Analysts Say ‘Buy’ ||| My Favorite Biotech Stock for 2021,0,0.49953622
2021-01-06,12222500.0,59.70000076293945,62.08000183105469,59.70000076293945,61.95000076293945,54.706172943115234,GILD,2 Top Value Stocks to Own in 2021 ||| Kite Announces Research Collaboration With Oxford BioTherapeutics - Quick Facts,1,0.5142931
2021-01-07,10614700.0,61.900001525878906,63.2400016784668,61.52000045776367,62.52000045776367,55.20952224731445,GILD,"Moderna Is An Example of Why You Should Buy Systems, Not Drugs ||| Roche, Sanofi arthritis drugs reduce death rates among sickest COVID-19 patients",1,0.5015129
2021-01-08,8389800.0,62.61000061035156,63.40999984741211,62.5099983215332,63.040000915527344,55.66871643066406,GILD,"Notable Friday Option Activity: PYPL, ANET, GILD",0,0.5041831
2021-01-11,11316700.0,63.75,64.18000030517578,62.27000045776367,62.5099983215332,55.2006950378418,GILD,"Gilead Lifts 2020 Guidance Driven By Remdesivir Demand; Shares Gain ||| Health Care Sector Update for 01/11/2021: LLY, MESO, GILD, XLV, IBB ||| Gilead raises 2020 profit forecast ||| Gilead Sciences Revises FY20 Guidance - Quick Facts",0,0.4961028
2021-01-12,9115100.0,62.65999984741211,62.790000915527344,61.470001220703125,62.08000183105469,54.82098007202149,GILD,1 Big Reason Trillium Therapeutics Stock's Hot Streak Will Continue in 2021 ||| Why Vir Biotechnology Stock Vaulted Higher Today ||| Gilead & Vir Announce Collaboration To Find Cure For Hepatitis B Virus - Quick Facts,0,0.52033406
2021-01-13,6822600.0,61.81999969482422,62.150001525878906,61.43999862670898,61.540000915527344,54.344120025634766,GILD,3 Top Biotech Picks for January ||| Is Gilead Sciences a Good Coronavirus Stock to Buy?,1,0.53563833
2021-01-14,8694800.0,61.63999938964844,63.130001068115234,61.459999084472656,62.400001525878906,55.10356521606445,GILD,"BUZZ-U.S. STOCKS ON THE MOVE-Poshmark Inc, Twist Bioscience, Affirm Holdings, Johnson & Johnson",1,0.51121736
2021-01-15,9361900.0,62.29999923706055,63.59999847412109,62.130001068115234,63.33000183105469,55.9248161315918,GILD,Is Novavax's Growth Story Over?,1,0.5291854
2021-01-19,18395900.0,64.7300033569336,68.16000366210938,64.5999984741211,67.06999969482422,59.22749328613281,GILD,"3 Biotech Stocks To Watch This Week ||| Notable Tuesday Option Activity: GM, GILD, TWTR ||| Why Gilead Sciences Stock Is Jumping Today ||| Nasdaq 100 Movers: PTON, GILD ||| U.S. Supreme Court rebuffs Merck appeal in hepatitis C patent fight with Gilead",1,0.5143298
2021-01-20,10131300.0,67.0,68.08999633789062,66.69999694824219,67.98999786376953,60.0399169921875,GILD,My Best SaaS Stock for 2021,0,0.5042876
2021-01-21,8141800.0,67.73999786376953,67.73999786376953,66.58000183105469,66.9800033569336,59.14802169799805,GILD,GILD March 5th Options Begin Trading ||| 3 Top Stocks for Retirees,0,0.5050393
2021-01-22,4914400.0,66.52999877929688,67.47000122070312,66.23999786376953,66.94000244140625,59.112701416015625,GILD,Where Will Sorrento Therapeutics Be in 1 Year?,1,0.5135044
2021-01-25,8443900.0,66.70999908447266,68.26000213623047,66.4000015258789,68.16000366210938,60.190040588378906,GILD,Better Buy: Gilead Sciences vs. Pfizer ||| 3 Reasons This Hot Stock May Not Survive 2021 ||| 3 Blockbuster Drug Launches to Watch This Year ||| Top 5 Healthcare Stocks of 2020: Are They Buys Now? ||| GILD Makes Bullish Cross Above Critical Moving Average,0,0.4850405
2021-01-26,7125200.0,67.72000122070312,68.37999725341797,66.55999755859375,66.69999694824219,58.900760650634766,GILD,Gilead Sciences (GILD) Shares Cross 4% Yield Mark ||| These 2 Coronavirus Stocks Could Soar in the First Half of 2021,0,0.49557886
2021-01-27,9908200.0,65.75,66.91999816894531,65.08000183105469,65.4800033569336,57.82341003417969,GILD,Is Gilead Sciences Stock a Buy?,0,0.50321114
2021-01-29,11724100.0,64.19999694824219,66.2300033569336,64.04000091552734,65.5999984741211,57.92937469482422,GILD,"Danger Lurks for These 3 High-Yield Dividend Stocks ||| Without a Vaccine, Is Merck Still a Hot COVID Stock? ||| Why the Market Is So Bullish About Trillium Therapeutics",0,0.49815997
2021-02-01,6270200.0,66.02999877929688,66.2699966430664,65.05999755859375,65.0999984741211,57.48785018920898,GILD,Implied XLV Analyst Target Price: $126 ||| Gilead & Gritstone Partner To Develop HIV-specific Therapeutic Vaccine - Quick Facts,1,0.53042656
2021-02-02,7749300.0,65.08999633789062,65.97000122070312,64.20999908447266,65.12999725341797,57.51433944702149,GILD,"GILD a Top 25 Dividend Giant With $11.11B Held By ETFs ||| Noteworthy ETF Inflows: IBB, AMGN, GILD, MRNA ||| 7 Pharmaceutical Stocks With Compelling Pipelines ||| India's demand for COVID-19 drug remdesivir to fall, says Cipla",0,0.51272154
2021-02-04,7400400.0,64.88999938964844,65.98999786376953,64.44000244140625,65.83000183105469,58.13248443603516,GILD,"Gilead quarterly revenue rises 26% on remdesivir sales ||| Gilead Sciences Inc. Q4 adjusted earnings of $2.19 per share ||| Gilead quarterly revenue rises 26% on remdesivir sales ||| After-Hours Earnings Report for February 4, 2021 : TMUS, GILD, SNAP, ATVI, F, PINS, PTON, MCHP, PRU, MSI, MTD, FTNT ||| 1 Major Problem for the Healthcare Industry",1,0.4765078
2021-02-05,15068200.0,67.25,69.36000061035156,66.70999908447266,68.45999908447266,60.4549674987793,GILD,"Why Gilead Sciences Stock Jumped Today ||| Notable Friday Option Activity: NKE, GILD, GS ||| Daily Dividend Report: MDLZ,CHRW,PEP,UNP,GILD,COF ||| Gilead Revenues Increase 26% In Fourth Quarter Driven By Remdesivir Sales ||| Gilead Sciences (GILD) Q4 2020 Earnings Call Transcript",0,0.5021583
2021-02-09,6620400.0,67.7699966430664,67.83999633789062,66.8499984741211,67.30000305175781,59.43059539794922,GILD,"Jaguar Health Isn’t a Healthy Investment, but It Could Be a Profitable One ||| Forget Gamestop! This Highly Shorted Stock Is a Strong Buy Now",0,0.4881278
2021-02-10,7667900.0,67.26000213623047,68.31999969482422,67.0999984741211,67.29000091552734,59.42177581787109,GILD,"What Are Pfizer's Prospects in 2021 and Beyond? ||| Notable ETF Outflow Detected - IBB, GILD, MRNA, ILMN ||| Gilead Sciences and Galapagos Shutter Their Pulmonary Fibrosis Program ||| 3 Best Biotech Stocks to Buy Now ||| Galapagos and Gilead to end late-stage studies of lung disease drug",0,0.48953262
2021-02-11,6029100.0,67.19999694824219,67.19999694824219,66.05000305175781,66.91999816894531,59.09503555297852,GILD,"4 Top COVID Stocks to Buy in February ||| 3 Reasons Pfizer's Failures Could Lead to a Big Acquisition ||| BPTH On Steady Path, CGIX On Watch, GLPG/GILD Scrap IPF Drug, REGN's Libtayo Gets FDA Nod",0,0.53252965
2021-02-12,3977700.0,66.77999877929688,67.2699966430664,66.36000061035156,66.88999938964844,59.06855010986328,GILD,See Which Of The Latest 13F Filers Holds Gilead Sciences ||| Remdesivir not associated with kidney problems - EU drugs regulator,0,0.48828998
2021-02-16,9757000.0,66.41000366210938,66.5999984741211,64.5199966430664,64.80000305175781,57.22292709350586,GILD,"Notable Tuesday Option Activity: GTHX, EXPI, GILD ||| Tuesday Sector Laggards: Healthcare, Utilities",1,0.49516132
2021-02-17,7725400.0,64.33000183105469,65.13999938964844,63.84000015258789,65.0999984741211,57.48785018920898,GILD,Vir Biotechnology and GlaxoSmithKline Expand Their Partnership ||| Here's What Caused Royalty Pharma's Mixed Results in Q4,1,0.5182571
2021-02-18,6144600.0,64.86000061035156,65.45999908447266,64.33000183105469,65.2300033569336,57.60265350341797,GILD,3 Biotech Stocks to Buy As Things Heat Up for the Sector,0,0.5197766
2021-02-22,6597700.0,63.93000030517578,64.47000122070312,63.52999877929688,64.11000061035156,56.61360549926758,GILD,Your 2 Best Profit Opportunities in 2021,0,0.53368855
2021-02-23,8714600.0,63.84999847412109,64.16000366210938,62.77999877929688,63.68000030517578,56.23388671875,GILD,Is Galapagos Stock a Bad-News Buy Right Now? ||| EU drug watchdog to weigh in on extended use for remdesivir by summer ||| EU drugs regulator studying expanded use of COVID-19 drug remdesivir,1,0.5064002
2021-02-25,7685300.0,63.77000045776367,63.970001220703125,62.5099983215332,62.790000915527344,55.44795608520508,GILD,"UK's Hikma posts increase in FY profit, sees higher 2021 sales",0,0.5122395
2021-03-04,15847200.0,62.79999923706055,64.54000091552734,62.52999877929688,63.22999954223633,55.83650588989258,GILD,"Noteworthy Thursday Option Activity: GILD, ADI, IBM ||| Implied QQXT Analyst Target Price: $87",1,0.49688977
2021-03-08,10646900.0,64.51000213623047,66.66000366210938,63.959999084472656,64.75,57.17877197265625,GILD,After 2 Licensing Deals Will GlaxoSmithKline Acquire Vir?,0,0.52519757
2021-03-10,7595500.0,64.68000030517578,64.80000305175781,63.59999847412109,63.90999984741211,56.43698501586914,GILD,"Ex-Dividend Reminder: CONMED, Atrion and Gilead Sciences",0,0.5044038
2021-03-11,9940600.0,63.5099983215332,64.04000091552734,63.0099983215332,63.09000015258789,55.7128791809082,GILD,"Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for March 12, 2021 ||| GILD April 30th Options Begin Trading ||| 3 Deep Value Stocks for Income and High Total Returns ||| Roche says adding Actemra to Gilead's remdesivir didn't cut COVID patient hospital stays ||| Roche: REMDACTA Trial Fails To Meet Endpoints In Patients With Severe COVID-19 Pneumonia ||| Roche's Actemra drug continues mixed COVID-19 run after failing trial with Gilead's remdesivir",0,0.47610128
2021-03-15,8780200.0,62.34999847412109,63.16999816894531,61.869998931884766,63.06999969482422,56.32912826538086,GILD,"Here Are the Most Exciting Vaccines in Moderna's Pipeline ||| 2 Top Stocks to Buy on the Dip ||| Best Stocks To Buy Right Now? 4 Health Care Stocks To Know ||| 7 High-Yield Stocks for Your Retirement Nest Egg ||| Gilead And Merck Agree To Joint Development Of Long-acting Treatments In HIV ||| Gilead, Merck collaborate to develop HIV treatment - WSJ ||| FOCUS-Money, talent flowing into mRNA sector after COVID-19 success",1,0.5283179
2021-03-18,7442600.0,63.619998931884766,64.9800033569336,63.619998931884766,64.08000183105469,57.23118209838867,GILD,"Nasdaq 100 Movers: PDD, EBAY ||| Gilead, Novo Nordisk Expand NASH Collaboration ||| Gilead Sciences, Novo Collaborate To Study Efficacy Of Cilofexor, Firsocostat In NASH Patients",1,0.50839746
2021-03-22,6769200.0,64.05000305175781,65.66000366210938,63.86000061035156,65.52999877929688,58.52620697021485,GILD,The 3 Most Fascinating Stocks to Buy Now ||| This Company Will Fix the Hidden COVID Danger to Come,0,0.5123784
2021-03-24,7472800.0,64.36000061035156,65.05999755859375,64.0,64.3499984741211,57.47232055664063,GILD,7 Value Stocks Everyone Is Ignoring,0,0.49061802
2021-03-25,7391000.0,64.77999877929688,64.87999725341797,63.540000915527344,63.9900016784668,57.15079879760742,GILD,3 Top Biotech Stocks for Spring 2021,1,0.5501648
2021-03-26,6017100.0,64.02999877929688,65.29000091552734,63.900001525878906,65.23999786376953,58.267189025878906,GILD,"7 Big Pharmaceutical Stocks for Bigger Income ||| Noteworthy ETF Outflows: IXJ, JNJ, ABT, GILD ||| The Promises Behind Terns' Multi-Pronged Pipeline",1,0.5158832
2021-03-29,7902600.0,65.0,66.44000244140625,64.87999725341797,66.19000244140625,59.11567306518555,GILD,Best Stocks To Buy In April 2021? 4 Biotech Stocks To Watch This Week ||| Humanigen says drug improves ventilator-free survival in COVID-19 patients ||| Humanigen: Lenzilumab Improves Survival Without Need For Mechanical Ventilation In COVID-19 Patients ||| Humanigen says drug improves ventilator-free survival in COVID-19 patients,0,0.48900506
2021-03-31,8817200.0,65.33999633789062,65.33999633789062,64.45999908447266,64.62999725341797,57.72239685058594,GILD,Could Regeneron's Antibody Therapy Be as Important as Vaccines in Fighting COVID?,1,0.54626733
2021-04-01,10514200.0,65.75,66.83999633789062,65.43000030517578,66.44000244140625,59.33895111083984,GILD,7 Healthcare Stocks to Buy to Prepare Your Portfolio For The Next Pandemic ||| This Big Leap in Cancer Treatment Could Change the Landscape,0,0.49870834
2021-04-05,6071200.0,66.19999694824219,66.5199966430664,65.52999877929688,66.33999633789062,59.249629974365234,GILD,"Wall Street Has Given Up on These 3 Stocks, and That's a Huge Mistake ||| 3 Dependable Dividend Stocks to Buy in April ||| Analysts Predict 10% Upside For The Holdings of QQXT ||| Better Buy for 2021: Pfizer or Gilead?",0,0.45454815
2021-04-07,5188700.0,66.08000183105469,66.33000183105469,65.22000122070312,65.5999984741211,58.58872222900391,GILD,FDA Approves Gilead's Trodelvy To Treat Metastatic Triple-Negative Breast Cancer ||| Biotech startup Vaccitech confidentially files for U.S. IPO - FT,0,0.51097655
2021-04-08,6778500.0,66.0999984741211,66.25,64.83000183105469,65.0199966430664,58.07071304321289,GILD,Gilead Sciences (GILD) Shares Cross Below 200 DMA ||| Is Gilead Sciences Stock a Buy?,1,0.4976397
2021-04-12,4909100.0,65.05999755859375,65.11000061035156,64.3499984741211,64.66000366210938,57.74919509887695,GILD,"India bans exports of anti-viral drug Remdesivir as COVID-19 cases surge ||| India bans Remdesivir exports as coronavirus rages on; rallies continue ||| Notable Monday Option Activity: FAST, GILD, WMT",1,0.5084012
2021-04-13,6143400.0,64.44999694824219,65.22000122070312,64.1500015258789,64.88999938964844,57.9546012878418,GILD,FDA Grants Accelerated Approval To Gilead Sciences' Trodelvy For Treatment Of Urothelial Cancer ||| A Short Delay Is Still Bad News for AbbVie ||| India's Cipla doubles remdesivir production to meet 'unprecedented' demand,1,0.5371137
2021-04-14,5654100.0,64.97000122070312,66.16999816894531,64.83000183105469,65.30000305175781,58.3207893371582,GILD,"Drugmakers Are Vying for a Multibillion-Dollar Market ||| Gilead’s Bladder Cancer Drug Trodelvy Gets FDA Nod ||| IBB, AMGN, GILD, ILMN: Large Outflows Detected at ETF",1,0.5166731
2021-04-15,5635000.0,64.69999694824219,66.37999725341797,64.69999694824219,65.7699966430664,58.74055099487305,GILD,3 Top Healthcare Stocks to Buy Right Now,1,0.55247885
2021-04-19,7204100.0,66.69999694824219,67.0,65.58999633789062,65.94999694824219,58.90131759643555,GILD,"Why Tonix Pharmaceuticals Stock Is Jumping Today ||| Should You Review Recent Insider Transactions At Gilead Sciences, Inc. (NASDAQ:GILD)?",1,0.49131215
2021-04-20,4989400.0,65.80000305175781,66.61000061035156,65.30999755859375,66.37999725341797,59.28535842895508,GILD,India waives import duty on COVID-19 drug Remdesivir,1,0.52072644
2021-04-21,5581000.0,66.54000091552734,66.91000366210938,66.37999725341797,66.79000091552734,59.65153503417969,GILD,COVID SCIENCE-Remdesivir appears safe for seriously ill children; patients may not pose highest risk to hospital staff ||| Should You Buy Gilead Sciences in April? ||| Roche looking for new place to test COVID-19 pill after cases plummet in UK,0,0.49793825
2021-04-22,6488700.0,66.4800033569336,66.51000213623047,65.52999877929688,65.63999938964844,58.62443923950195,GILD,3 Signs the Ligand Short Squeeze Is Over,0,0.5358138
2021-04-26,6868400.0,65.44999694824219,65.87999725341797,65.04000091552734,65.76000213623047,58.731632232666016,GILD,"Gilead to help India boost remdesivir production, to give at least 450,000 vials ||| Gilead to help India increase production of remdesivir ||| The Smartest Stocks to Buy With $1,000 Right Now ||| 7 Healthcare Stocks for a Reopening World ||| Oxford COVID-19 vaccine tech maker Vaccitech targets $613 mln valuation in U.S. IPO",0,0.5080514
2021-04-27,7278300.0,65.94000244140625,66.0,64.62000274658203,64.66999816894531,57.75812530517578,GILD,Merck taps five Indian drugmakers to expand COVID-19 drug production ||| Gilead To Scale Up Remdesivir Availablity In India,0,0.5186566
2021-04-28,7861300.0,64.69000244140625,64.69999694824219,63.86000061035156,64.44000244140625,57.55270767211914,GILD,"COVID SCIENCE-Placental infection may be more likely early in pregnancy; COVID-19 may cause heart failure in some patients ||| 7 Pharmaceutical Stocks With Dividends in Hand ||| Syngene targets delivering 500,000 vials of remdesivir in India as COVID-19 surges ||| Syngene targets delivering 500,000 vials of remdesivir in India in May - executive ||| 3 Biotech Stocks That Could Be Millionaire-Makers",0,0.5092361
2021-04-29,9238800.0,64.62999725341797,64.62999725341797,63.33000183105469,63.84000015258789,57.01683807373047,GILD,"Notable Thursday Option Activity: GILD, APLS, ESI ||| Gilead 1st-quarter profit rises despite lower HIV drug sales ||| After-Hours Earnings Report for April 29, 2021 : AMZN, GILD, VRTX, TWTR, KLAC, DLR, DXCM, SWKS, FTNT, TEAM, RMD, AJG ||| Gilead Science Q1 Profit Rises, Updates FY21 EPS Outlook ||| US STOCKS-S&P 500 near record high on Facebook boost, Nasdaq eases ||| Gilead Sciences Inc. Q1 adjusted earnings Miss Estimates ||| Gilead HIV, hepatitis C sales dip, shares down 2.3% ||| EMA to quickly review Eli Lilly, Incyte arthritis drug for COVID-19 use ||| Facebook fuels S&P 500 to record high close ||| US STOCKS-Apple, Facebook set to boost Wall Street after strong earnings ||| Gilead Sciences Q1 21 Earnings Conference Call At 4:30 PM ET ||| US STOCKS-Apple, Facebook drive Nasdaq futures higher as earnings roll in ||| First Week of August 20th Options Trading For Gilead Sciences (GILD) ||| 2 Must-Own Biotech Stocks to Buy in May ||| US STOCKS-S&P 500, Nasdaq hit record highs on tech earnings boost, upbeat data",0,0.48152754
2021-04-30,12993900.0,62.459999084472656,64.0999984741211,61.95000076293945,63.470001220703125,56.68637466430664,GILD,"Daily Dividend Report: K,GILD,KMB,FIS,PLD ||| Vaccitech, startup behind Oxford COVID-19 vaccine tech, falls 20% in Nasdaq debut ||| US STOCKS-Wall Street set to take a breather; on track for weekly gains ||| US STOCKS-Futures retreat; main indexes on track for weekly gains ||| Gilead Sciences (GILD) Q1 2021 Earnings Call Transcript",1,0.491911
2021-05-03,9500200.0,63.91999816894531,65.9000015258789,63.77000045776367,65.80000305175781,58.767356872558594,GILD,"The Pfizer CEO Prediction That Could Mean Total COVID Market Dominance in 2022 ||| Here's a Popular Robinhood Penny Stock You'll Want to Have on Your Radar ||| Gilead Sciences, Inc. Just Missed EPS By 22%: Here's What Analysts Think Will Happen Next",0,0.4631979
2021-05-04,9933300.0,65.79000091552734,66.62999725341797,65.37000274658203,65.63999938964844,58.62443923950195,GILD,"iShares Nasdaq Biotechnology ETF Experiences Big Inflow ||| Nasdaq 100 Movers: OKTA, GILD ||| Eli Lilly to supply 400,000 tablets of its COVID-19 treatment to India ||| Ligand's Revenue Soars in Q1 Thanks to Gilead's COVID Drug",1,0.5314363
2021-05-05,6911200.0,65.73999786376953,67.0,65.5199966430664,66.51000213623047,59.40147018432617,GILD,Why Humanigen Stock Vaulted Higher Today ||| India approves Roche/Regeneron antibody cocktail to treat COVID-19,1,0.5070275
2021-05-07,5849300.0,66.47000122070312,67.54000091552734,66.30000305175781,66.54000091552734,59.42826843261719,GILD,3 Global Value Stocks to Buy Now,1,0.54118615
2021-05-10,8646700.0,66.95999908447266,68.4000015258789,66.7699966430664,67.4800033569336,60.26779556274414,GILD,"COVID SCIENCE-New antibody drug helps patients breathe; virus may insert genetic fragments into genetic code ||| Nasdaq 100 Movers: PDD, GILD ||| Egypt's Eva Pharma to export COVID-19 drug remdesivir to India",0,0.5047517
2021-05-11,6412000.0,67.06999969482422,68.08000183105469,66.77999877929688,67.22000122070312,60.03557205200195,GILD,The Implied Analyst 12-Month Target For OEF,1,0.5194867
2021-05-13,7186800.0,67.75,68.9800033569336,67.44000244140625,68.91000366210938,61.544960021972656,GILD,See Which Of The Latest 13F Filers Holds Gilead Sciences ||| iShares Nasdaq Biotechnology ETF Experiences Big Outflow,0,0.48735768
2021-05-14,7079200.0,68.91000366210938,69.18000030517578,68.38999938964844,68.52999877929688,61.20556640625,GILD,"Notable Friday Option Activity: ELY, GILD, OLED",1,0.5024089
2021-05-17,6214100.0,68.4800033569336,69.6500015258789,68.44999694824219,69.06999969482422,61.68785095214844,GILD,Interesting GILD Put And Call Options For May 21st,0,0.50000066
2021-05-20,6540900.0,68.66000366210938,69.9800033569336,68.37000274658203,69.3499984741211,61.93792724609375,GILD,This Top Healthcare Dividend Stock Is a Bargain Right Now ||| GILD Named 'Top Dividend Stock of the Nasdaq 100' at Dividend Channel With 4.2% Yield ||| 2 High-Yield Dividend Stocks to Buy Now,0,0.48785067
2021-05-21,6478700.0,69.7699966430664,70.11000061035156,68.70999908447266,68.75,61.40205764770508,GILD,EU regulator backs extending approval for remdesivir for another year ||| EMA backs renewing conditional marketing approval for remdesivir in COVID-19 patients,0,0.5146569
2021-05-25,9357400.0,67.30000305175781,67.4000015258789,66.0,66.2300033569336,59.1513900756836,GILD,Can This Forgotten Coronavirus Stock Make You Rich?,1,0.5270527
2021-05-27,8047700.0,66.56999969482422,67.12999725341797,65.80999755859375,65.9000015258789,58.856666564941406,GILD,Interesting GILD Put And Call Options For July 9th ||| Russian court rejects U.S firm's lawsuit over COVID-19 drug remdesivir ||| Russian Supreme Court rejects Gilead lawsuit over COVID-19 drug,1,0.48982847
2021-05-28,5937700.0,66.05000305175781,66.69000244140625,65.80000305175781,66.11000061035156,59.044219970703125,GILD,Is It Too Late to Buy the Most Promising Pipeline in the Pharma Industry?,0,0.5180517
2021-06-01,6573100.0,66.44000244140625,66.55000305175781,65.12000274658203,65.31999969482422,58.33864974975586,GILD,Could Nano-X Be a Millionaire-Maker Stock?,1,0.5344687
2021-06-03,6755400.0,65.95999908447266,66.5999984741211,65.79000091552734,66.4800033569336,59.37467956542969,GILD,"Interesting GILD Put And Call Options For July 23rd ||| Europe secures 55,000 doses of Roche-Regeneron COVID drug hope",1,0.5167188
2021-06-07,7863300.0,67.61000061035156,67.95999908447266,67.11000061035156,67.41999816894531,60.21420669555664,GILD,"Should We Be Cautious About Gilead Sciences, Inc.'s (NASDAQ:GILD) ROE Of 1.4%? ||| S.Korean stocks trade flat on caution ahead of U.S. inflation data ||| After Hours Most Active for Jun 7, 2021 : PBR, IBN, CLOV, KO, SU, CSCO, TSM, AAPL, GLW, GILD, SESN, INTC",1,0.46752185
2021-06-08,5489200.0,67.44000244140625,67.61000061035156,66.98999786376953,67.51000213623047,60.29458236694336,GILD,What's Behind This Wild-Card Coronavirus Stock?,1,0.5130324
2021-06-10,8678400.0,68.98999786376953,69.70999908447266,68.47000122070312,69.29000091552734,61.88433456420898,GILD,"GILD July 30th Options Begin Trading ||| Ex-Dividend Reminder: Owens & Minor, Merck and Gilead Sciences ||| The Nasdaq Biotechnology Index: A True Benchmark for Technology-Driven Healthcare Innovation",0,0.50400954
2021-06-11,6928000.0,69.13999938964844,69.25,68.6500015258789,68.7699966430664,61.41991424560547,GILD,"Noteworthy ETF Inflows: IBB, MRNA, GILD, ILMN ||| Invesco and Nasdaq Expand Partnership with 2 New Thematic ETFs ||| Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for June 14, 2021 ||| Gilead’s Oral Epclusa Formulation Receives FDA Approval to Treat Hepatitis C in Children Aged 3 and Above",0,0.4613247
2021-06-14,5319500.0,68.01000213623047,68.33000183105469,67.47000122070312,68.1500015258789,61.50114440917969,GILD,"3 Biotech ETFs That Could Double Your Money by 2025 With Zero Effort ||| Notable Monday Option Activity: TDG, DXCM, GILD ||| Gilead’s Yescarta Shows Significant Improvement in Survival in Follicular Lymphoma",0,0.5284387
2021-06-18,11464500.0,67.0,67.18000030517578,65.88999938964844,66.61000061035156,60.11138153076172,GILD,Interesting GILD Put And Call Options For February 2022,1,0.49571887
2021-06-21,5310400.0,66.98999786376953,67.56999969482422,66.7699966430664,67.3499984741211,60.7791748046875,GILD,"3 Top Biotech Picks for June ||| Why Enochian BioSciences Was a Winner on Monday ||| IBB, GILD, MRNA, ILMN: ETF Outflow Alert",0,0.5333317
2021-06-23,4246800.0,67.20999908447266,67.25,66.55999755859375,66.6500015258789,60.1474838256836,GILD,Unauthorized COVID-19 drugs bound for Mexico seized by U.S. authorities - WSJ ||| Unauthorized COVID-19 drugs bound for Mexico seized by U.S. authorities - WSJ,1,0.5014323
2021-06-24,5054000.0,66.7699966430664,68.23999786376953,66.6500015258789,67.18000030517578,60.62577438354492,GILD,Roche's Actemra gets U.S. FDA approval for hospitalized COVID-19 patients ||| Here's Why Arcus Biosciences Stock Is Rising Today,1,0.5260083
2021-06-25,8078100.0,67.13999938964844,68.0,66.87999725341797,67.87999725341797,61.25747680664063,GILD,Why Arcus Biosciences' Big Reveal Wasn't Very Exciting,0,0.48021352
2021-06-29,4348100.0,67.66999816894531,68.02999877929688,67.5,67.93000030517578,61.30260848999024,GILD,Will This 2020 Biotech IPO Crush the Market This Year?,1,0.5347733
2021-06-30,6010400.0,68.29000091552734,68.94000244140625,68.01000213623047,68.86000061035156,62.14185333251953,GILD,"Noteworthy ETF Inflows: IBB, GILD, MRNA, ILMN",1,0.51782405
2021-07-07,6092500.0,68.4000015258789,68.43000030517578,67.80000305175781,68.36000061035156,61.69064712524414,GILD,"After Hours Most Active for Jul 7, 2021 : AAPL, F, KO, CSCO, KHC, T, GE, BAC, GILD, KNL, MSFT, USIG",0,0.46406004
2021-07-08,4982600.0,68.05999755859375,68.31999969482422,67.41999816894531,67.69000244140625,61.08601760864258,GILD,August 27th Options Now Available For Gilead Sciences (GILD) ||| 2 Top Global Value Stocks to Buy Now,1,0.50778264
2021-07-09,6419600.0,67.58999633789062,68.41000366210938,67.44999694824219,68.22000122070312,61.56430435180664,GILD,"Notable ETF Outflow Detected - IBB, GILD, MRNA, ILMN",0,0.49863482
2021-07-12,7322400.0,68.2300033569336,69.05999755859375,67.75,68.06999969482422,61.42895126342773,GILD,"Can Gilead Beat Bristol Myers Squibb With Its Cancer CAR-T Therapy? ||| After Hours Most Active for Jul 12, 2021 : EDU, IBN, XOM, PFE, KO, ITUB, AAPL, CSCO, MSFT, GILD, QQQ, IQ",0,0.4946909
2021-07-13,4518400.0,67.83000183105469,68.5199966430664,67.83000183105469,68.01000213623047,61.37480163574219,GILD,March 2022 Options Now Available For Gilead Sciences ||| If You Had Bought Gilead Sciences' (NASDAQ:GILD) Shares Five Years Ago You Would Be Down 22%,0,0.49539703
2021-07-14,5949800.0,68.06999969482422,68.11000061035156,67.43000030517578,67.93000030517578,61.30260848999024,GILD,"Investing $72,036 Into These 3 Stocks Can Generate $300 in Monthly Income for Your Portfolio ||| 5 Stocks to Own for the Surge in Coronavirus Variants",1,0.54435045
2021-07-19,6054400.0,68.61000061035156,69.06999969482422,67.66999816894531,68.2300033569336,61.573341369628906,GILD,BioNTech strengthens cancer therapy expertise with U.S. acquisition,1,0.5518996
2021-07-20,9332500.0,68.31999969482422,69.7699966430664,68.2699966430664,69.16000366210938,62.4126091003418,GILD,"Noteworthy Tuesday Option Activity: HUM, DISH, GILD ||| Gilead Sells Kite’s R&D Platform to BioNTech",0,0.5241974
2021-07-22,2901500.0,68.01000213623047,68.80999755859375,67.81999969482422,68.6500015258789,61.95235824584961,GILD,Peek Under The Hood: SPXE Has 10% Upside ||| 3 Biotechs That Could Make Big Acquisitions This Year,1,0.5008833
2021-07-23,3524200.0,68.87999725341797,69.33999633789062,68.63999938964844,69.0199966430664,62.2862548828125,GILD,iShares Biotechnology ETF Experiences Big Inflow ||| Why This Company’s Covid-19 Vaccine Is Just the Beginning,0,0.5029693
2021-07-29,7597500.0,70.25,70.4000015258789,69.7699966430664,69.83000183105469,63.01723861694336,GILD,"After-Hours Earnings Report for July 29, 2021 : AMZN, TMUS, GILD, EW, TWLO, VRTX, KLAC, DXCM, FTNT, DLR, PINS, RSG ||| Gilead Sciences Updates FY Outlook ||| Gilead Sciences Inc. Q2 adjusted earnings Beat Estimates ||| Strong COVID-19 drug sales help boost Gilead second-quarter results ||| U.S. FDA allows Lilly's COVID-19 drug to be taken without remdesivir ||| This Biotech Stock Is Too Cheap to Ignore ||| Gilead Sciences Q2 21 Earnings Conference Call At 4:30 PM ET ||| Noteworthy Thursday Option Activity: NUE, CZR, GILD",0,0.48423162
2021-07-30,9619700.0,68.69999694824219,69.0,68.0,68.29000091552734,61.62748336791992,GILD,Validea Joel Greenblatt Strategy Daily Upgrade Report - 7/30/2021 ||| Gilead Sciences (GILD) Q2 2021 Earnings Call Transcript ||| This 1 Thing in Pfizer's Earnings Report May be a Coronavirus Game Changer,1,0.47604993
2021-08-02,4242800.0,68.33999633789062,68.6500015258789,67.83000183105469,68.3499984741211,61.68163299560547,GILD,Why Investors Should Like BioNTech's Latest Deal With Gilead,1,0.49960616
2021-08-03,5128400.0,68.6500015258789,69.83999633789062,68.20999908447266,69.83000183105469,63.01723861694336,GILD,Gilead Sciences a Top 25 Dividend Giant With 4.16% Yield (GILD) ||| Vietnam to approve remdesivir for COVID-19 treatment-state media,0,0.47975695
2021-08-04,6846300.0,69.48999786376953,69.98999786376953,69.02999877929688,69.23999786376953,62.48479843139648,GILD,"This High-Risk, High-Reward Biotech Could Make COVID Less Deadly -- and Make Investors Money ||| $5,000 Invested in These 3 Healthcare Stocks Could Make You Rich Over the Next 10 Years",1,0.5046687
2021-08-05,5532300.0,69.23999786376953,69.33000183105469,68.51000213623047,69.30000305175781,62.538944244384766,GILD,"Interesting GILD Put And Call Options For September 24th ||| Gilead says aware of counterfeit HIV medicines being distributed in U.S. ||| 3 Biotech Stocks That Could Make You Richer in August (and Beyond) ||| Gilead's Unit Kite, And Appia Bio Join For Stem Cell Therapy Research",0,0.50408584
2021-08-09,5160100.0,68.77999877929688,69.2699966430664,68.11000061035156,68.45999908447266,61.780887603759766,GILD,Gilead to require U.S. workers receive COVID-19 vaccine,1,0.525463
2021-08-12,5907000.0,70.25,71.0,69.73999786376953,70.87999725341797,63.964786529541016,GILD,"IBB, GILD, ILMN, BNTX: Large Inflows Detected at ETF",1,0.518528
2021-08-16,8874400.0,71.2699966430664,71.8499984741211,71.05000305175781,71.70999908447266,64.71380615234375,GILD,"My 2019 Report Card: Up 319% ||| 4 Pharma Stocks You Can Buy and Hold for 20 Years ||| After Hours Most Active for Aug 16, 2021 : CVE, CL, AMAT, AAPL, INTC, GNW, F, IBN, CMCSA, GILD, CNHI, MDLZ ||| EU evaluates Roche arthritis drug as COVID-19 treatment ||| Cassava Sciences Stock Is a Buy on the Strength of a Promising Alzheimer’s Drug",1,0.4834193
2021-08-17,9000100.0,71.2699966430664,73.08999633789062,71.01000213623047,73.02999877929688,65.905029296875,GILD,"After Hours Most Active for Aug 17, 2021 : AAPL, CTVA, VIPS, AXP, GILD, OSH, V, TLRY, CAG, ABNB, QQQ, CSCO",0,0.46685016
2021-08-18,8135300.0,72.62000274658203,73.33999633789062,71.9000015258789,71.95999908447266,64.93941497802734,GILD,"Why NRx Pharmaceuticals Stock Jumped 11.8% Today ||| Notable Wednesday Option Activity: SHAK, GILD, KSS",0,0.4844847
2021-08-19,5209500.0,71.61000061035156,72.33000183105469,71.51000213623047,71.66999816894531,64.6777114868164,GILD,"What Kind Of Shareholders Hold The Majority In Gilead Sciences, Inc.'s (NASDAQ:GILD) Shares?",1,0.4837648
2021-08-20,5646500.0,71.66999816894531,72.88999938964844,71.44000244140625,72.44000244140625,65.37261199951172,GILD,Why Fate Therapeutics Stock Is Sliding Today,1,0.49808413
2021-08-23,5356200.0,72.68000030517578,73.04000091552734,72.45999908447266,72.55000305175781,65.47186279296875,GILD,Why Trillium Therapeutics Stock Is Skyrocketing Today,0,0.49441817
2021-08-25,4988900.0,71.94999694824219,71.95999908447266,70.91999816894531,71.41000366210938,64.4430923461914,GILD,Is It Too Late to Buy Moderna Stock?,1,0.51376915
2021-08-26,6566900.0,71.54000091552734,72.36000061035156,71.13999938964844,71.43000030517578,64.46113586425781,GILD,Interesting GILD Put And Call Options For October 8th ||| Gilead Sciences wins reversal of $1.2 bln fine against Bristol Myers in patent case,0,0.50005084
2021-08-27,5493100.0,71.30999755859375,72.44999694824219,71.16000366210938,71.27999877929688,64.32576751708984,GILD,The 3 Best Biotech Stocks to Buy Right Now,1,0.5375049
2021-08-30,4494100.0,71.30000305175781,72.19999694824219,71.1500015258789,72.01000213623047,64.98455810546875,GILD,Could Moderna Take Down Gilead Sciences?,1,0.5256036
2021-08-31,7564600.0,72.19000244140625,72.83000183105469,71.83999633789062,72.77999877929688,65.67942810058594,GILD,"COVID 19 Stocks -- Vaccines, Diagnostics, or Treatments?",0,0.51349646
2021-09-01,5970700.0,72.68000030517578,72.72000122070312,71.3499984741211,71.87000274658203,64.85821533203125,GILD,"11 Top Healthcare ETFs to Buy Now ||| Pfizer, Merck launch new trials of oral COVID-19 drugs ||| Pfizer starts dosing patients in oral COVID-19 drug trial",1,0.5248639
2021-09-07,6775400.0,71.08000183105469,71.30000305175781,70.33000183105469,71.19000244140625,64.24455261230469,GILD,Why Investors Should Love Pfizer's Acquisition of Trillium,1,0.4917105
2021-09-08,4510000.0,71.19000244140625,71.91000366210938,71.12000274658203,71.87999725341797,64.86722564697266,GILD,Should You Buy AbbVie Stock After The Recent 7% Fall?,0,0.5055049
2021-09-09,7013600.0,71.63999938964844,71.68000030517578,70.58000183105469,70.61000061035156,63.721134185791016,GILD,Contrarian Signs Point to Possible AT&T Bull Case,1,0.5140714
2021-09-13,11048100.0,71.23999786376953,71.9000015258789,70.81999969482422,71.1500015258789,64.20845794677734,GILD,"After Hours Most Active for Sep 13, 2021 : VOD, GSK, RIO, AAPL, VEON, KO, CCJ, TAL, LFST, VZ, GILD, KBWB ||| IBB, AMGN, GILD, REGN: ETF Outflow Alert ||| Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for September 14, 2021",0,0.4765342
2021-09-14,5490000.0,70.7699966430664,71.06999969482422,70.11000061035156,70.44999694824219,64.21755981445312,GILD,Interesting GILD Put And Call Options For January 2024,1,0.4959696
2021-09-17,10888000.0,70.83000183105469,71.76000213623047,70.44000244140625,71.61000061035156,65.27493286132812,GILD,First Week of GILD May 2022 Options Trading,0,0.5228063
2021-09-20,9594900.0,70.93000030517578,71.91999816894531,70.33000183105469,70.95999908447266,64.68244934082031,GILD,3 Value Stocks to Buy While You Still Can,1,0.5134582
2021-09-21,5896000.0,71.27999877929688,72.05999755859375,71.11000061035156,71.7300033569336,65.38432312011719,GILD,"Notable Tuesday Option Activity: ATVI, CVS, GILD",0,0.51121116
2021-09-22,6557000.0,72.06999969482422,72.18000030517578,71.08000183105469,71.37999725341797,65.06527709960938,GILD,"Gilead Says Veklury Significantly Reduced Risk Of Hospitalization In High-Risk Patients With COVID ||| Pre-Market Most Active for Sep 22, 2021 : MRIN, LCID, CRVS, GILD, SQQQ, SOFI, AMC, RIG, NEM, SWN, PLTR, RIO",1,0.4935952
2021-09-23,5263500.0,71.4800033569336,72.11000061035156,71.30000305175781,71.69000244140625,65.34786224365234,GILD,3 Relatively Safe Pharma Stocks You Can Buy Right Now,0,0.540292
2021-09-24,5023400.0,71.62999725341797,71.87000274658203,71.18000030517578,71.19000244140625,64.89209747314453,GILD,"Are Investors Undervaluing Gilead Sciences, Inc. (NASDAQ:GILD) By 48%?",0,0.49311155
2021-09-27,5560500.0,71.11000061035156,71.29000091552734,70.29000091552734,70.41000366210938,64.18109893798828,GILD,3 COVID Stocks Ready to Take On the Delta Variant,0,0.5416518
2021-09-28,6392300.0,70.0,70.80000305175781,69.66999816894531,69.97000122070312,63.78001403808594,GILD,"GSK to develop longer-acting therapy for HIV with Japan's Shionogi ||| FOCUS-COVID-19 pill developers aim to top Merck, Pfizer efforts",1,0.48740515
2021-09-29,5436800.0,70.16000366210938,71.4000015258789,69.94999694824219,70.94000244140625,64.66421508789062,GILD,"After Hours Most Active for Sep 29, 2021 : COG, BAC, TLT, ABEV, IBN, UNM, KR, MSFT, AAPL, GILD, USIG, TRIP",0,0.4674834
2021-09-30,6049400.0,71.20999908447266,71.56999969482422,69.80000305175781,69.8499984741211,63.670631408691406,GILD,3 Top Dividend Stocks Yielding More Than 4% ||| Biotech Stocks Facing FDA Decision In October 2021,0,0.53496754
2021-10-01,9343700.0,68.5999984741211,69.41000366210938,67.63999938964844,68.55999755859375,62.494754791259766,GILD,Merck's $15 billion gain is stingy,0,0.48838076
2021-10-04,7560200.0,68.19999694824219,69.02999877929688,67.30000305175781,67.55999755859375,61.58322143554688,GILD,This Healthcare Company Is Using AI to Develop Drugs ||| 4 Top Health Care Stocks To Watch After Merck’s COVID-19 Pill Breakthrough,0,0.5213243
2021-10-05,7236700.0,67.44999694824219,68.12999725341797,67.23999786376953,67.4000015258789,61.43738555908203,GILD,"9 Big Pharmaceutical Stocks Sporting Stellar Yields ||| Notable Tuesday Option Activity: AZO, UHS, GILD",1,0.5291792
2021-10-06,6398600.0,67.38999938964844,67.70999908447266,66.87999725341797,67.4800033569336,61.51031494140625,GILD,Merck May Beat Pfizer to the COVID Pill Market. Does It Matter? ||| Why Gilead Sciences Investors Shouldn't Give Up on Remdesivir Just Yet ||| Could Pfizer's COVID Pill Be Better Than Merck's?,1,0.47993818
2021-10-11,3315600.0,68.2300033569336,68.44999694824219,67.8499984741211,68.08000183105469,62.057220458984375,GILD,EU assesses Regeneron/Roche COVID-19 antibody cocktail for authorisation ||| Merck seeks first U.S. FDA authorization for COVID-19 tablet,0,0.5245335
2021-10-12,8856000.0,68.19000244140625,68.33999633789062,67.29000091552734,67.37000274658203,61.41004180908203,GILD,"After Hours Most Active for Oct 12, 2021 : AAPL, GILD, X, QQQ, VZ, KMI, KO, CMCSA, PROG, SQQQ, BAC, BBD",1,0.4613671
2021-10-13,4760700.0,67.58000183105469,67.95999908447266,67.19999694824219,67.62999725341797,61.64704513549805,GILD,CRSP Stock: The Cancer Study News Sending Crispr Therapeutics Lower Today ||| Why CRISPR Therapeutics Stock Is Sinking Today,1,0.51112133
2021-10-14,7165600.0,68.20999908447266,68.7300033569336,68.0,68.1500015258789,62.12104415893555,GILD,"Noteworthy ETF Outflows: IBB, GILD, REGN, ILMN",0,0.510893
2021-10-15,4327100.0,68.30000305175781,68.5999984741211,67.5999984741211,67.62999725341797,61.64704513549805,GILD,GILD : Sacituzumab Govitecan Gets Positive CHMP Opinion For Triple-Negative Breast Cancer Treatment,0,0.5243993
2021-10-18,7576400.0,67.5,67.58000183105469,65.77999877929688,65.9000015258789,60.07008743286133,GILD,"Gilead Sciences (GILD) Shares Cross Below 200 DMA ||| Gilead Sciences: FDA Approves Low-dose Tablet Dosage Form Of Biktarvy For Pediatric
patients ||| 2 Tricks and a Treat for Gene Therapy Investors",1,0.5040585
2021-10-19,5889700.0,66.0,66.98999786376953,65.86000061035156,66.9000015258789,60.98161697387695,GILD,Gilead To Donate Remdesivir To Help Address COVID-19 Crisis In Indonesia And Armenia,0,0.5206587
2021-10-20,4878200.0,66.91000366210938,67.30999755859375,66.80000305175781,66.86000061035156,60.945159912109375,GILD,3 Under-the-Radar COVID Stocks,1,0.5517177
2021-10-21,5013700.0,67.08999633789062,67.19000244140625,66.5199966430664,66.98999786376953,61.06365585327149,GILD,Interesting GILD Put And Call Options For December 3rd,1,0.49407068
2021-10-22,4501200.0,67.12000274658203,67.2699966430664,66.51000213623047,67.23999786376953,61.291542053222656,GILD,"Notable ETF Outflow Detected - IBB, GILD, REGN, ILMN",1,0.49456915
2021-10-25,6069800.0,67.23999786376953,67.97000122070312,66.75,67.66999816894531,61.68349838256836,GILD,"2 High-Yielding Stocks You Can Buy and Hold for Years ||| Are Atea Pharmaceuticals, Agenus, Novavax, and Ocular Therapeutix Bad News Buy? ||| Notable Monday Option Activity: GILD, MRNA, ALB",1,0.50912076
2021-10-27,4887700.0,67.95999908447266,67.97000122070312,66.5999984741211,66.7699966430664,60.86311721801758,GILD,2 Beaten-Down Biotech Stocks That Could Be Great Long-Term Plays ||| 1 Small-Cap Stock With 10X Potential,1,0.5213499
2021-10-28,5884800.0,66.69999694824219,67.66000366210938,66.66999816894531,67.33999633789062,61.38268661499024,GILD,"Gilead Sciences Q3 21 Earnings Conference Call At 4:30 PM ET ||| Gilead Sciences Inc. Q3 adjusted earnings Beat Estimates ||| Gilead Sciences Lifts FY21 Outlook ||| After-Hours Earnings Report for October 28, 2021 : AAPL, AMZN, SBUX, SYK, GILD, TEAM, DXCM, RSG, RMD, AJG, SGEN, FTV ||| Gilead cuts 2021 sales forecast for non-COVID products",0,0.48055282
2021-10-29,14181100.0,65.9000015258789,65.9000015258789,64.05999755859375,64.87999725341797,59.14031219482422,GILD,Gilead Sciences Becomes Oversold ||| Gilead Sciences (GILD) Q3 2021 Earnings Call Transcript ||| Gilead Sciences : Study Data Of Biktarvy In People Living With HIV Show High Effectiveness ||| Gilead Slips 2.3% Despite Outstanding Q3 Results,1,0.53032255
2021-11-01,7254000.0,64.81999969482422,65.94000244140625,64.68000030517578,65.63999938964844,59.83308029174805,GILD,Best Stocks To Buy This Week? 3 Biotech Names To Know,1,0.4945604
2021-11-04,6522900.0,67.12000274658203,67.1500015258789,65.97000122070312,66.47000122070312,60.589656829833984,GILD,Interesting GILD Put And Call Options For December 23rd ||| The Implied Analyst 12-Month Target For FTA ||| Is There Any Hope for Atea Pharmaceuticals Stock?,0,0.4940516
2021-11-08,5217800.0,65.97000122070312,66.41999816894531,65.51000213623047,65.97000122070312,60.13389205932617,GILD,GILD Named 'Top Dividend Stock of the Nasdaq 100' at Dividend Channel With 4.3% Yield ||| 5 Buy-Rated Biotech Stocks to Bolster Your Portfolio,1,0.50397915
2021-11-09,5401500.0,66.08999633789062,66.8499984741211,65.88999938964844,66.1500015258789,60.2979621887207,GILD,"EXCLUSIVE-Amid spike in cases, EU to shortly approve first COVID antibody drugs - sources ||| Better COVID Stock: Merck vs. Pfizer",1,0.48664674
2021-11-10,6888100.0,66.55999755859375,67.88999938964844,66.55999755859375,67.31999969482422,61.36447143554688,GILD,Gilead : Phase 2b Study Of Sacituzumab Govitecan On Aggressive Type Of Breast Cancer Meets Main Goal ||| Gilead Sciences Breaks Above 200-Day Moving Average - Bullish for GILD,1,0.5038308
2021-11-11,3513600.0,67.0,67.48999786376953,66.75,67.43000030517578,61.46473693847656,GILD,"GILD December 31st Options Begin Trading ||| EU regulator endorses COVID-19 drugs from Regeneron-Roche, Celltrion",1,0.4976336
2021-11-12,8214800.0,67.66000366210938,67.7699966430664,67.19999694824219,67.4800033569336,61.51031494140625,GILD,"Pre-Market Most Active for Nov 12, 2021 : RLX, MQ, CG, PSFE, GILD, RIVN, MSFT, KO, DOCS, LCID, BEKE, JNJ",0,0.47810078
2021-11-15,4911000.0,67.47000122070312,67.83000183105469,67.01000213623047,67.19999694824219,61.25507736206055,GILD,2 High-Yield Dividend Stocks That Can Safeguard Your Portfolio Against a Market Crash,0,0.54018664
2021-11-18,8873600.0,67.54000091552734,68.27999877929688,67.36000061035156,67.79000091552734,61.79288482666016,GILD,Life sciences software startup Benchling files for U.S. listing -sources ||| Why Arcus Biosciences Stock Is On Fire Today,1,0.49824077
2021-11-19,8628800.0,68.19000244140625,68.9000015258789,67.77999877929688,68.69000244140625,62.613258361816406,GILD,"Gilead Sciences: Great Yield, but Has Patent Concerns ||| Gilead Files BLA For Bulevirtide To Treat Chronic HDV Infection",1,0.51574546
2021-11-22,8951100.0,68.69999694824219,70.36000061035156,67.94999694824219,69.97000122070312,63.78001403808594,GILD,"Better Buy: Vertex Pharmaceuticals vs. CRISPR ||| Is Merck Stock a Buy? ||| 1 Cancer Stock on Buyout Watch in 2022 ||| Noteworthy Monday Option Activity: GILD, FCX, GM",1,0.5047873
2021-11-23,7100400.0,69.87000274658203,70.87000274658203,69.70999908447266,70.62999725341797,64.38164520263672,GILD,Gilead Sciences: European Commission Grants Marketing Authorization For Trodelvy,0,0.53125983
2021-11-24,6737500.0,70.73999786376953,71.02999877929688,69.51000213623047,70.06999969482422,63.87117385864258,GILD,Gilead Bags Marketing Authorization for Cancer Drug,1,0.5475328
2021-11-26,5659500.0,69.69999694824219,70.73999786376953,69.69999694824219,70.2699966430664,64.05347442626953,GILD,3 Dividend Stocks That Are Dirt Cheap Right Now,1,0.50777864
2021-11-29,8902200.0,70.4000015258789,71.31999969482422,70.20999908447266,70.6500015258789,64.39987182617188,GILD,"Why NRx Pharmaceuticals Stock Soared Today ||| After Hours Most Active for Nov 29, 2021 : CPIX, QQQ, EBS, AAPL, BTRS, INFY, KO, MS, GILD, DRNA, C, SO ||| Gilead Sciences (NASDAQ:GILD) Has A Rock Solid Balance Sheet",0,0.4718406
2021-12-02,9411700.0,69.16999816894531,70.29000091552734,68.83000183105469,69.66999816894531,63.50656509399414,GILD,Former Immunomedics CFO charged with tipping girlfriend about cancer drug trial,0,0.513875
2021-12-03,8328200.0,70.0,70.45999908447266,69.30999755859375,69.55999755859375,63.40629959106445,GILD,"Got $1,000? Check Out These 3 Top Biotech Stocks",0,0.47791275
2021-12-06,7049400.0,69.45999908447266,70.80000305175781,69.41999816894531,69.5,63.35160827636719,GILD,Gilead Sciences a Top Socially Responsible Dividend Stock With 4.1% Yield (GILD),1,0.51034397
2021-12-07,6438000.0,69.5999984741211,69.9000015258789,68.91000366210938,69.6500015258789,63.48834228515625,GILD,"Nasdaq 100 Movers: AZN, PDD ||| Is Gilead Sciences Stock a Buy Now?",1,0.49525574
2021-12-09,5829300.0,69.88999938964844,70.7300033569336,69.23999786376953,70.30000305175781,64.0808334350586,GILD,GILD January 2022 Options Begin Trading ||| Why Arcus Biosciences Stock Vaulted Higher in November,0,0.51294255
2021-12-10,5352500.0,70.18000030517578,70.94000244140625,69.5999984741211,70.25,64.03524780273438,GILD,"Ex-Dividend Reminder: Hill-Rom Holdings, Owens & Minor and Gilead Sciences",1,0.50955397
2021-12-13,6883600.0,70.12000274658203,70.87999725341797,69.5999984741211,70.61000061035156,64.36341094970703,GILD,"Kite : Yescarta Quadruples Median Event-Free Survival Duration In Refractory Large B-Cell Lymphoma ||| U.S. FDA puts Merck's HIV drug trials on hold ||| Notable Monday Option Activity: PANW, NEO, GILD ||| Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for December 14, 2021",0,0.53242934
2021-12-14,7244900.0,69.87000274658203,70.80000305175781,69.76000213623047,70.5199966430664,64.93428802490234,GILD,"Merck's HIV Trials Put On Clinical Hold, Vifor Gets A Suitor, VERU Scores FDA Nod...",1,0.54506606
2021-12-16,10530000.0,71.3499984741211,72.83000183105469,71.05999755859375,72.30999755859375,66.58251190185547,GILD,Understanding Gilead Sciences’ Newly Added Risk Factor,0,0.5111027
2021-12-17,12226000.0,72.22000122070312,72.69000244140625,71.6500015258789,72.20999908447266,66.49043273925781,GILD,EU drug regulator won't rule on Merck COVID-19 pill before Christmas - source,1,0.48720637
2021-12-20,7616900.0,72.0,72.5199966430664,71.44999694824219,72.47000122070312,66.7298355102539,GILD,Validea's Top Five Healthcare Stocks Based On David Dreman - 12/19/2021 ||| FDA approves injectable form of GSK HIV prevention drug,0,0.5243157
2021-12-21,8786700.0,72.47000122070312,72.58999633789062,71.62999725341797,71.83999633789062,66.14974212646484,GILD,Gilead: FDA Places Clinical Hold On Studies Of Injectable Lenacapavir For HIV Treatment & Prevention ||| iShares Core High Dividend ETF Experiences Big Outflow ||| Gilead Sciences: EC Approves Variation To Conditional Marketing Authorization For Veklury,1,0.5356311
2021-12-22,6015400.0,71.58999633789062,72.45999908447266,70.66000366210938,72.43000030517578,66.69302368164062,GILD,Gilead' Veklury Reduces Risk Of Hospitalization In High-risk Patients With COVID-19 In Phase 3 Study ||| FDA Puts Gilead’s Lenacapavir Injection on Clinical Hold,1,0.5179477
2021-12-23,5096300.0,72.56999969482422,72.81999969482422,72.18000030517578,72.4800033569336,66.73906707763672,GILD,Top 10 Blockbuster Drugs In 2021,1,0.5397286
2021-12-27,4298800.0,72.27999877929688,72.87999725341797,71.91999816894531,72.87000274658203,67.09815979003906,GILD,"Good Stocks To Buy Right Now? 4 Vaccine Stocks To Check Out ||| Got $5,000? Buy and Hold These 3 Value Stocks for Years",1,0.48016647
2021-12-29,5893900.0,73.0,73.7300033569336,72.61000061035156,73.63999938964844,67.80717468261719,GILD,"NRXP Stock Alert: What Is Going on With NRx Pharmaceuticals Today? ||| Is Gilead Sciences, Inc.'s (NASDAQ:GILD) 34% ROE Better Than Average?",0,0.49192017
2021-12-30,3238700.0,73.66000366210938,74.12000274658203,73.26000213623047,73.36000061035156,67.54934692382812,GILD,Interesting GILD Put And Call Options For February 2022 ||| Russia extends production of COVID-19 drug remdesivir without patent for a year,0,0.51399493
2021-12-31,5736800.0,73.25,73.4800033569336,72.44999694824219,72.61000061035156,66.85875701904297,GILD,"After Hours Most Active for Dec 31, 2021 : FRC^N, AAPL, SOFI, CPOP, QQQ, MSFT, GFI, GILD, PFE, PSFE, CIG, BEPI ||| 3 Biotech Stocks To Watch In 2022",0,0.49476245
2022-01-03,6622500.0,72.2699966430664,72.69000244140625,71.61000061035156,72.58000183105469,66.83113861083984,GILD,3 Biotech Stocks That Could Double in 2022,0,0.5439347
2022-01-04,6784100.0,72.61000061035156,73.4000015258789,72.18000030517578,72.20999908447266,66.49043273925781,GILD,"Notable Tuesday Option Activity: HELE, TMO, GILD",0,0.506675
2022-01-05,7799500.0,72.44000244140625,73.05000305175781,71.97000122070312,72.18000030517578,66.46281433105469,GILD,2 Top Dividend Stocks That Are Yielding More Than 3%,0,0.54872406
2022-01-06,7368200.0,71.68000030517578,72.08999633789062,71.33999633789062,71.58999633789062,65.91954040527344,GILD,7 Pharmaceutical Stocks That Could Make You Rich,0,0.52873456
2022-01-07,7119600.0,71.37999725341797,71.75,70.83000183105469,71.26000213623047,65.61569213867188,GILD,"7 Safe Stocks for Your Retirement ||| PJP, GILD, EBS, PCRX: ETF Outflow Alert",1,0.5065649
2022-01-10,10362300.0,71.98999786376953,72.25,71.41999816894531,72.08999633789062,66.37995147705078,GILD,Gilead Sciences: Attractive Dividend Yield and Improving Financials ||| Gilead Announces Clinical Trial Collaborations With Merck - Quick Facts,1,0.5292441
2022-01-12,7206200.0,71.95999908447266,72.5199966430664,71.66000366210938,72.25,66.52728271484375,GILD,"Notable Wednesday Option Activity: AMAT, DIS, GILD",0,0.50346637
2022-01-13,6711300.0,71.98999786376953,72.45999908447266,71.44999694824219,71.87999725341797,66.18656921386719,GILD,Biotech Firms Partner to Advance Therapeutic Medicine,0,0.5189985
2022-01-14,8344800.0,72.06999969482422,72.13999938964844,71.16000366210938,71.7699966430664,66.0853042602539,GILD,Gilead withdraws use of Zydelig to treat two types of cancer ||| 4 Biotech Acquisitions We'd Like to See in 2022,0,0.5041352
2022-01-18,8986600.0,71.41999816894531,71.5199966430664,70.06999969482422,70.43000030517578,64.85143280029297,GILD,3 Pharma Stocks With Especially Juicy Dividends ||| Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know ||| Gilead says counterfeit versions of its HIV drugs ended up with patients ||| Gilead says counterfeiting network sold $250 mln worth of its HIV drugs,0,0.53599095
2022-01-19,8217700.0,70.27999877929688,70.6500015258789,69.01000213623047,69.06999969482422,63.5991439819336,GILD,"VONV, GILD, GM, CME: Large Outflows Detected at ETF ||| Nasdaq 100 Movers: GILD, PDD",0,0.4992019
2022-01-20,8639700.0,69.06999969482422,69.30999755859375,67.7699966430664,67.80999755859375,62.43894958496094,GILD,Gilead Sciences is Now Oversold (GILD) ||| Gilead Sciences Breaks Below 200-Day Moving Average - Notable for GILD,1,0.5015216
2022-01-21,14843200.0,68.12000274658203,69.06999969482422,67.69000244140625,68.51000213623047,63.08351516723633,GILD,FDA expands use of remdesivir to patients with high risk of hospitalization ||| First Week of GILD April 14th Options Trading,1,0.5403123
2022-01-24,12909000.0,68.54000091552734,69.33999633789062,66.77999877929688,68.56999969482422,63.13875961303711,GILD,"Gilead Sciences (GILD) Gains But Lags Market: What You Should Know ||| Gilead (GILD) Drug Gets FDA Nod for Non-Hospitalized COVID Patients ||| Vertex (VRTX) to Report Q4 Earnings: What's in the Cards? ||| FDA Expands EUA Of Veklury For Non-hospitalized Adults, Pediatric Patients With COVID-19",1,0.49160564
2022-01-25,9239400.0,68.05000305175781,69.37000274658203,67.88999938964844,68.83999633789062,63.38736724853516,GILD,"Gilead: FDA Places Partial Clinical Hold On Studies Evaluating Magrolimab - Azacitidine Combination ||| Gilead Sciences (GILD) Expected to Beat Earnings Estimates: Can the Stock Move Higher? ||| Large Cap Pharma, Biotech Stocks Down on Regulatory Updates ||| Why Sierra Oncology Stock Is On Fire Today ||| Sierra Oncology's bone marrow cancer drug meets study main goal ||| Biotech Stocks Facing FDA Decision In February 2022",0,0.51627547
2022-01-26,11280400.0,67.30999755859375,68.55999755859375,66.95999908447266,67.33999633789062,62.00617218017578,GILD,"Nasdaq 100 Movers: ADP, DDOG",0,0.5057804
2022-01-27,9323200.0,67.41000366210938,68.69000244140625,67.22000122070312,67.2699966430664,61.94171524047852,GILD,"Notable ETF Inflow Detected - HDV, BMY, GILD, LMT ||| Biotech Stock Roundup: VRTX Q4 Earnings, GILD, INCYs Regulatory Updates & More ||| Gilead's (GILD) Magrolimab Studies Put on Hold by the FDA",1,0.4962808
2022-01-28,11514100.0,67.37000274658203,68.87000274658203,67.0199966430664,68.86000061035156,63.40578079223633,GILD,5 Corporate Giants Likely to Gain From Q4 Earnings Next Week ||| Pfizer (PFE) Gets CHMP Recommendation for COVID Pill Paxlovid ||| Gilead (GILD) to Report Q4 Earnings: Is a Beat in the Cards?,0,0.50687706
2022-01-31,9252700.0,68.63999938964844,68.8499984741211,68.19000244140625,68.68000030517578,63.24003982543945,GILD,"3 Growth ETFs to Consider Buying During This Correction ||| How to Invest in Biotech When Deep Value Has no Discernible Meaning ||| Gilead : FDA Okays New Label Update For CAR T-Cell Therapy Yescarta ||| Gilead Sciences a Top 25 Dividend Giant With 4.12% Yield (GILD) ||| INSIGHT-Merck's COVID pill is last choice for U.S. patients, global use varies ||| Is Gilead Sciences Stock a Buy Now? ||| EXPLAINER-How does Merck's COVID-19 pill compare to Pfizer's?",0,0.54761523
2022-02-01,10463700.0,68.79000091552734,68.80000305175781,67.91000366210938,68.47000122070312,63.04668426513672,GILD,"GlaxoSmithKline Says Gilead, ViiV Healthcare Settle Patent Dispute Over HIV Drug ||| Gilead Sciences FY22 Outlook Below Street View ||| Wall Street Waits for Major Economic Data This Week ||| Gilead earnings dip due to legal settlement, other charges ||| Gilead earnings hurt by legal settlement, other charges ||| Gilead Sciences Inc. Q4 Profit Decreases, misses estimates ||| Gilead Sciences (GILD) Q4 Earnings Miss Estimates ||| After-Hours Earnings Report for February 1, 2022 : GOOG, GOOGL, PYPL, AMD, SBUX, GILD, CB, GM, EA, EQR, MTCH, PKI ||| Gilead COVID drug takes top spot for U.S. hospital spending -report ||| Is AbbVie Stock a Buy Now? ||| Should Value Investors Pick Gilead Sciences (GILD) Stock? ||| Big Data for Q4, Econ to Start a New Month ||| What This FDA News Could Mean for Pfizer",0,0.5058362
2022-02-02,18365000.0,65.5,66.01000213623047,64.0199966430664,65.81999969482422,60.60657501220703,GILD,"Notable Wednesday Option Activity: PYPL, GILD, MCK ||| Daily Dividend Report: GILD,SYK,ROK,EA,GLW ||| Biotech Stock Roundup: GILD Q4 Earnings, REGN, MRNA's Regulatory Updates & More ||| Nasdaq 100 Movers: PYPL, AMD ||| Gilead (GILD) Q4 Earnings Miss on Legal Settlement Charges ||| Gilead Sciences (GILD) Q4 2021 Earnings Call Transcript",0,0.5031578
2022-02-03,12479500.0,65.58000183105469,66.37999725341797,65.06999969482422,65.38999938964844,60.21062850952149,GILD,How Big Are Gilead's Latest COVID Wins?,0,0.50669765
2022-02-04,12392800.0,64.94999694824219,65.61000061035156,63.869998931884766,63.900001525878906,58.83865737915039,GILD,5 Biotech Stocks to Buy to Benefit From Biden’s New Cancer Cabinet,0,0.5186917
2022-02-09,13164800.0,63.88999938964844,63.97999954223633,63.29999923706055,63.380001068115234,58.35984420776367,GILD,"EU ramps up collection of public health data to improve drug reviews ||| See Which Of The Latest 13F Filers Holds Gilead Sciences ||| The 7 Highest Dividend Stocks for Income Investors ||| GSK logs nearly $2 bln in COVID-related sales, but profit boost to wane in 2022 ||| GSK's COVID-related sales close to $2 bln, profit boost to wane in 2022 ||| EU ramps up efforts to gather public-health data to improve drug reviews",0,0.51079357
2022-02-10,14978000.0,63.11000061035156,63.11000061035156,61.709999084472656,61.790000915527344,56.89578628540039,GILD,"HDV, GILD, MMM, DUK: Large Inflows Detected at ETF ||| Analysts Predict 10% Upside For MGV ||| How Are Biotech ETFs Reacting to These Q4 Earnings Releases? ||| April 1st Options Now Available For Gilead Sciences (GILD)",1,0.49405098
2022-02-11,13195400.0,62.040000915527344,62.880001068115234,61.7599983215332,62.06999969482422,57.153602600097656,GILD,"2 Green Flags For Gilead Sciences' Future ||| Gilead says COVID drug remdesivir shows antiviral activity against Omicron, other variants ||| Gilead: Laboratory Results Show Veklury Remains Active Against All Major SARS-CoV-2 Variants",0,0.5217045
2022-02-14,11343500.0,62.09000015258789,62.150001525878906,60.81999969482422,61.11000061035156,56.26963806152344,GILD,Is the FDA's Partial Hold Bad News for Gilead Investors? ||| Gilead Sciences' (NASDAQ:GILD) Upcoming Dividend Will Be Larger Than Last Year's ||| Gilead (GILD) Veklury Retains Activity Against Omicron Variant,1,0.52308655
2022-02-15,10515300.0,61.119998931884766,61.52000045776367,60.970001220703125,61.33000183105469,56.47221755981445,GILD,Tracking Gilead's 4 Big Stories and a Lawsuit in 2022,1,0.5238971
2022-02-16,21855900.0,61.20000076293945,62.25,61.15999984741211,61.900001525878906,56.99706268310547,GILD,"Health Care Sector Update for 02/16/2022: ALKS,ATXI,MASI,HOOK,GILD ||| Health Care Sector Update for 02/16/2022: ATXI,MASI,HOOK,GILD ||| Biotech Stock Roundup: BDSI Surges on Merger Deal, SGEN Down on Outlook & More ||| Inside Gilead's Lackluster $7.2 Billion Q4 Earnings ||| 3 Biotech Stocks to Buy in February",0,0.4746751
2022-02-18,11930700.0,61.400001525878906,61.65999984741211,60.97999954223633,61.04999923706055,56.21438980102539,GILD,"Ligand (LGND) Q4 Earnings Beat, OmniAb Spin-Off in 1H22 ||| Want To Collect $200 Every Month? Invest $49,334 in These 3 Stocks ||| These 3 Stocks Just Declared Dividend Raises",0,0.47536
2022-02-22,10781500.0,60.88999938964844,61.290000915527344,60.68999862670898,60.97999954223633,56.149940490722656,GILD,Is Moderna the Next Gilead or the Next Regeneron?,1,0.538556
2022-02-25,13133000.0,60.88999938964844,61.68000030517578,60.77999877929688,61.119998931884766,56.27885055541992,GILD,VIR Q4 Earnings Beat on Higher Revenues From Covid Treatment ||| 3 Moonshot Stocks Insiders Are Buying. What Do They Know?,0,0.48026517
2022-03-01,10694900.0,59.93999862670898,60.86000061035156,59.869998931884766,60.2599983215332,55.48696899414063,GILD,Gilead Sciences Gets CRL From FDA For Investigational Lenacapavir Due To Vial Compatability Issues ||| U.S. FDA declines to approve Gilead's HIV treatment on glass vial concerns ||| U.S. FDA declines to approve Gilead's HIV treatment,1,0.5423171
2022-03-03,13023100.0,61.540000915527344,62.0,61.34999847412109,61.709999084472656,56.82212066650391,GILD,April 22nd Options Now Available For Gilead Sciences (GILD) ||| Gilead (GILD) Down 7% Since Last Earnings Report: Can It Rebound? ||| Arthritis drug shown to reduce risk of COVID death in large UK trial ||| Should You Invest in the iShares Biotechnology ETF (IBB)?,1,0.51087373
2022-03-04,9383400.0,61.08000183105469,62.22999954223633,61.0,61.86000061035156,56.960235595703125,GILD,"Interesting GILD Put And Call Options For September 16th ||| The Zacks Analyst Blog Highlights Moderna, Gilead Sciences, Kodiak Sciences and Lexicon Pharmaceuticals",0,0.5007075
2022-03-07,18455200.0,58.970001220703125,62.25,58.900001525878906,60.2599983215332,55.48696899414063,GILD,Gilead: Phase 3 TROPiCS-02 Study Meets Primary Endpoint ||| Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?,0,0.49438816
2022-03-08,13889700.0,60.22999954223633,60.650001525878906,59.040000915527344,59.540000915527344,54.823997497558594,GILD,Gilead's (GILD) Trodelvy Late-Line Breast Cancer Study Meets Goal,0,0.5114421
2022-03-09,13682000.0,60.0099983215332,60.29999923706055,58.91999816894531,59.0,54.32676696777344,GILD,"Biotech Stock Roundup: OCGN Down on Update, VYGR Surges on Deal & Other Updates",0,0.5032426
2022-03-10,13243700.0,58.59000015258789,58.70000076293945,57.31999969482422,57.91999816894531,53.33230209350586,GILD,"April 29th Options Now Available For Gilead Sciences (GILD) ||| The Zacks Analyst Blog Highlights Ocugen, Voyager Therapeutics, BioNTech, Regeneron and Gilead Sciences ||| Noteworthy ETF Inflows: HDV, DUK, GILD, MMM ||| Ex-Dividend Reminder: Merck, Gilead Sciences and Banc Of California",1,0.50287694
2022-03-11,13007600.0,58.310001373291016,59.18999862670898,57.959999084472656,58.0,53.40597152709961,GILD,Gilead Sciences (GILD) Gains As Market Dips: What You Should Know,1,0.49328962
2022-03-15,10794600.0,58.43000030517578,58.790000915527344,57.65999984741211,58.31999969482422,54.3851318359375,GILD,Should You Invest in the VanEck Biotech ETF (BBH)?,0,0.51344
2022-03-16,13871600.0,58.66999816894531,58.66999816894531,57.18999862670898,57.970001220703125,54.05875015258789,GILD,Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know,1,0.48349074
2022-03-18,18199300.0,59.220001220703125,59.54999923706055,58.47999954223633,59.41999816894531,55.41091537475586,GILD,Bristol-Myers sues AstraZeneca over cancer-treatment patents,1,0.51722795
2022-03-21,8060600.0,59.34000015258789,60.52000045776367,59.27000045776367,59.65999984741211,55.634727478027344,GILD,"iShares Core High Dividend ETF Experiences Big Outflow ||| Atea Pharmaceuticals, Inc. (AVIR) Surges 7.4%: Is This an Indication of Further Gains?",1,0.51626164
2022-03-22,8847700.0,59.959999084472656,60.119998931884766,59.29999923706055,59.97999954223633,55.933135986328125,GILD,Gilead Sciences (GILD) Gains But Lags Market: What You Should Know,0,0.4859545
2022-03-23,9088900.0,60.0,60.29999923706055,58.79999923706055,58.84999847412109,54.87937545776367,GILD,2 High-Yielding Stocks Trading Near Multiyear Lows,1,0.5214075
2022-03-24,7939900.0,58.970001220703125,59.540000915527344,58.77000045776367,59.13999938964844,55.149810791015625,GILD,Interesting GILD Put And Call Options For May 6th,0,0.494237
2022-03-29,8051100.0,59.70000076293945,60.560001373291016,59.59999847412109,60.52999877929688,56.446022033691406,GILD,Investors Seek Second Act with Moderna Stock,0,0.5183415
2022-03-30,8614000.0,60.41999816894531,60.7400016784668,59.40999984741211,59.65999984741211,55.634727478027344,GILD,5 Charts That Show Why Bristol-Myers Squibb Is a No-Brainer Buy,0,0.5219788
2022-03-31,8226300.0,59.970001220703125,60.02000045776367,59.41999816894531,59.45000076293945,55.43889236450195,GILD,VIR Stock Gains on News of Inclusion in the S&P SmallCap 600,1,0.52842057
2022-04-01,8551000.0,59.43999862670898,59.68999862670898,58.58000183105469,59.66999816894531,55.64405059814453,GILD,U.S. FDA approves Gilead cell therapy for earlier lymphoma ||| U.S. FDA approves Gilead cell therapy for earlier lymphoma,1,0.5351348
2022-04-04,9040600.0,59.68000030517578,60.84999847412109,59.2400016784668,60.66999816894531,56.57658004760742,GILD,2 Drugmakers Set for Explosive Revenue This Decade ||| COVID SCIENCE-Gilead's remdesivir fails to show benefit in European trial; no fetus risk seen with first trimester vaccination,0,0.52418685
2022-04-05,7067200.0,60.34999847412109,61.18999862670898,59.68999862670898,59.75,55.71865081787109,GILD,Roche (RHHBY) Actemra Application Receives Priority Review ||| Precigen (PGEN) Up on FDA Fast Track Tag for CAR-T Candidate,1,0.5139246
2022-04-07,9370100.0,60.79999923706055,61.54999923706055,60.52000045776367,60.9900016784668,56.87499237060547,GILD,"Biotech Stock Roundup: VIR Down on Regulatory News, BMY Offers Updates & More",1,0.4982443
2022-04-08,10653600.0,61.27999877929688,62.81999969482422,61.22999954223633,62.29999923706055,58.09660339355469,GILD,"The Zacks Analyst Blog Highlights Bristol Myers, Vir Biotechnology, Gilead Sciences, and Vertex Pharmaceuticals ||| Here's Why a Drop in Moderna's Revenue Wouldn't Be Catastrophic",0,0.4910557
2022-04-11,8094200.0,62.81999969482422,63.060001373291016,61.84000015258789,61.88999938964844,57.714263916015625,GILD,FDA lifts partial clinical hold on Gilead's blood cancer drug trials ||| FDA Lifts Partial Clinical Hold On Gilead Sciences' MDS And AML Magrolimab Studies ||| COVID SCIENCE-RedHill pill shows promise vs Omicron; mRNA vaccines appear effective in those with well-controlled HIV,0,0.50833666
2022-04-12,7750400.0,62.380001068115234,62.470001220703125,61.209999084472656,61.630001068115234,57.4718132019043,GILD,Will AbbVie Stock Continue To Make New Highs?,1,0.52718246
2022-04-13,6879600.0,61.619998931884766,62.11000061035156,61.290000915527344,62.060001373291016,57.87279891967773,GILD,Gilead Sciences (GILD) Gains But Lags Market: What You Should Know ||| Why Is Sierra Oncology (SRRA) Stock Up Today? ||| Why Sierra Oncology Stock Is Soaring Today,0,0.48549348
2022-04-14,9750000.0,62.06999969482422,62.36000061035156,61.5,61.81999969482422,57.64898300170898,GILD,"Biotech Stock Roundup: SRRA Surges on GSK Buyout, HALO Offers Update & More ||| 2 Unstoppable Green Flags for AbbVie",0,0.49831557
2022-04-19,6178900.0,61.59999847412109,63.0,61.58000183105469,62.77999877929688,58.544219970703125,GILD,First Week of GILD July 15th Options Trading ||| ANALYSIS-Demand for Pfizer's COVID pills lags around the world,1,0.50361675
2022-04-21,6673900.0,63.54999923706055,64.27999877929688,63.16999816894531,63.75,59.448768615722656,GILD,Pfizer: What Comes After the Covid-19 Fire? ||| WHO backs Pfizer's oral COVID therapy for high-risk patients ||| Gilead Sciences (GILD) Gains As Market Dips: What You Should Know ||| Gilead Sciences (GILD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?,0,0.44422174
2022-04-25,7457900.0,62.47999954223633,62.7400016784668,61.33000183105469,62.650001525878906,58.4229850769043,GILD,Gilead Science Says Several Studies Confirm Remdesivir Activity In Treating COVID-19 ||| FDA Approves Gilead's Remdesivir To Treat Young Children With COVID-19 ||| U.S. FDA approves Gilead's COVID-19 drug for young children ||| Gilead (GILD) to Report Q1 Earnings: Is a Beat in the Cards? ||| Glaxo (GSK) to Report Q1 Earnings: What's in the Cards?,0,0.5110121
2022-04-26,6926400.0,62.400001525878906,62.869998931884766,61.75,61.77000045776367,57.60235977172852,GILD,J&J sues to block sales of 'dangerous' counterfeit HIV drugs ||| Healthcare ETFs in Focus Ahead of Q1 Earnings ||| U.S. to widen COVID antiviral pill distribution ||| 7 Dividend Stocks Paying Over 5% to Buy Now,0,0.51051664
2022-04-27,7863200.0,61.790000915527344,62.04999923706055,61.16999816894531,61.59000015258789,57.43450927734375,GILD,"Drug/Biotech Stocks Q1 Earnings Due on Apr 28: MRK, LLY & More ||| Biotech Stock Roundup: GILD's COVID-19 Drug Update, AXSM Down on Regulatory News ||| 3 Things to Know About Amazon Ahead of Its Stock Split",0,0.49868467
2022-04-28,10787500.0,61.43999862670898,61.63999938964844,60.61000061035156,61.560001373291016,57.406532287597656,GILD,"Gilead Sciences (GILD) Beats Q1 Earnings and Revenue Estimates ||| Gilead Sciences Inc. Q1 Profit Increases, beats estimates ||| After-Hours Earnings Report for April 28, 2022 : AAPL, AMZN, INTC, SYK, GILD, KLAC, LHX, DLR, DXCM, AJG, TEAM, RMD ||| Thursday's ETF with Unusual Volume: IDNA ||| Gilead first quarter sales, earnings beat Street estimates ||| Is the S&P 500 All You Need to Retire a Millionaire? ||| Gilead Sciences Q1 22 Earnings Conference Call At 4:30 PM ET",0,0.47799924
2022-04-29,10455800.0,61.560001373291016,62.060001373291016,59.27000045776367,59.34000015258789,55.33631896972656,GILD,Gilead (GILD) Q1 Earnings Beat on Solid COVID Treatment Sales ||| Gilead Sciences (GILD) Q1 2022 Earnings Call Transcript,1,0.5012348
2022-05-02,9474000.0,59.54999923706055,60.43000030517578,59.150001525878906,60.310001373291016,56.240867614746094,GILD,Top Pharmaceutical Stocks To Watch In May 2022,1,0.50924045
2022-05-04,8087800.0,60.650001525878906,62.310001373291016,60.27000045776367,62.08000183105469,57.891448974609375,GILD,"Biotech Stock Roundup: BIIB & GILD's Earnings Update, VRTX Down on Regulatory News ||| Should You Invest in the iShares Biotechnology ETF (IBB)?",0,0.5089744
2022-05-05,8767300.0,61.75,62.380001068115234,60.720001220703125,61.34999847412109,57.210697174072266,GILD,"GILD June 24th Options Begin Trading ||| Ligand (LGND) Q1 Earnings Beat, OmniAb Spin-Off on Track",0,0.50330126
2022-05-06,7468200.0,61.130001068115234,61.400001525878906,60.38999938964844,61.18000030517578,57.05216979980469,GILD,Gilead Sciences Now the Most Expensive vs. Cardano This Year,1,0.52318716
2022-05-09,9294000.0,60.79999923706055,62.38999938964844,60.72999954223633,61.68000030517578,57.5184326171875,GILD,Is Gilead Sciences Too Dependent On These 2 Areas of Its Business?,1,0.5174367
2022-05-10,9721600.0,61.880001068115234,62.540000915527344,61.560001373291016,61.77999877929688,57.6116828918457,GILD,"How Are Biotech ETFs Reacting to These Q1 Earnings Releases? ||| Noteworthy ETF Outflows: RDIV, MMM, GILD, PRU ||| Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?",0,0.4858481
2022-05-11,10224000.0,60.310001373291016,61.56999969482422,60.290000915527344,60.560001373291016,56.4739990234375,GILD,"New class of cancer drugs down, not out, after Roche trial setback - analysts ||| 2 Red Flags for Gilead Sciences' Future",1,0.5136447
2022-05-12,9727900.0,60.70000076293945,62.5,60.630001068115234,62.47999954223633,58.264461517333984,GILD,"Roche (RHHBY) Phase III NSCLC Study Disappoints, Stock Down ||| New class of cancer drugs down, not out, after Roche trial setback - analysts",0,0.49285918
2022-05-13,9515200.0,62.59999847412109,62.61000061035156,61.560001373291016,62.369998931884766,58.16188049316406,GILD,"Nasdaq 100 Movers: GILD, LCID",0,0.49437213
2022-05-16,6157500.0,62.369998931884766,62.7400016784668,61.93999862670898,62.2400016784668,58.0406494140625,GILD,FDA Lifts Clinical Hold On Gilead's Investigational Lenacapavir For Treatment & Prevention Of HIV ||| Should You Invest in the VanEck Biotech ETF (BBH)?,1,0.53016376
2022-05-18,9583900.0,63.13999938964844,63.93000030517578,62.68999862670898,63.220001220703125,58.95452880859375,GILD,"Wednesday Sector Leaders: Utilities, Healthcare ||| Biotech Stock Roundup: BBIO Up on BMY Deal, GILD & CMRX Offer Updates ||| Noteworthy ETF Outflows: IVE, MMM, CI, GILD ||| China Junshi's potential COVID drug shows promise in small trial",1,0.50810075
2022-05-20,6814600.0,63.369998931884766,63.900001525878906,62.72999954223633,63.84000015258789,59.53269958496094,GILD,"Interesting GILD Put And Call Options For June 2023 ||| Top Research Reports for JPMorgan, Gilead Sciences & CSX",0,0.5046474
2022-05-23,7256800.0,64.38999938964844,64.83000183105469,63.59000015258789,63.65999984741211,59.36484146118164,GILD,3 Biotech Stocks With a Cash Pile Higher Than Their Valuations,1,0.49758613
2022-05-26,5730800.0,65.16000366210938,65.45999908447266,64.45999908447266,64.47000122070312,60.12019348144531,GILD,First Trust Morningstar Dividend Leaders Index Fund Experiences Big Inflow,1,0.52263886
2022-05-31,13781900.0,64.5,65.02999877929688,63.66999816894531,64.8499984741211,60.474552154541016,GILD,Validea Joel Greenblatt Strategy Daily Upgrade Report - 5/28/2022 ||| Novartis (NVS) Wins FDA Nod for Label Expansion of Kymriah ||| 7 Safe Dividend Stocks With High Yields to Buy Now,0,0.50784725
2022-06-02,7860000.0,64.63999938964844,64.72000122070312,62.310001373291016,63.459999084472656,59.1783332824707,GILD,GILD July 22nd Options Begin Trading ||| Biogen Inc. (BIIB) Down 4.8% Since Last Earnings Report: Can It Rebound? ||| Biogen Inc. (BIIB) Down 4.8% Since Last Earnings Report: Can It Rebound?,0,0.46371576
2022-06-06,7865800.0,62.58000183105469,63.02000045776367,61.650001525878906,62.02999877929688,57.844818115234375,GILD,"Gilead drug modestly delays breast cancer progression in late-stage trial ||| Monday Sector Laggards: Healthcare, Utilities ||| Gilead: Trodelvy Extends Overall Survival In Second-Line Metastatic TNBC - Quick Facts ||| Gilead Sciences a Top Socially Responsible Dividend Stock With 4.6% Yield (GILD)",1,0.52137864
2022-06-08,7248200.0,62.2400016784668,62.9900016784668,62.11000061035156,62.380001068115234,58.17120742797852,GILD,"Pre-Market Most Active for Jun 8, 2022 : RDBX, DIDI, TQQQ, NIO, SQQQ, NVAX, VZ, CCL, MRK, BABA, GILD, BILI ||| 7 Oversold Stocks to Buy Right Now",0,0.48559
2022-06-09,5242200.0,62.2599983215332,62.66999816894531,61.150001525878906,61.18000030517578,57.05216979980469,GILD,GILD July 29th Options Begin Trading,0,0.5113531
2022-06-10,8155600.0,60.58000183105469,61.18000030517578,60.310001373291016,60.7400016784668,56.64185333251953,GILD,Gilead Sciences (GILD) Stock Moves -0.72%: What You Should Know ||| ASCO 2022: Surprising News in Cancer Research,0,0.5050185
2022-06-14,10073800.0,58.369998931884766,59.84000015258789,57.16999816894531,57.790000915527344,54.56429672241211,GILD,"Noteworthy Tuesday Option Activity: GILD, CMI, AR ||| Gilead Sciences Enters Oversold Territory",1,0.5155024
2022-06-15,6498100.0,57.9900016784668,58.970001220703125,57.709999084472656,58.38999938964844,55.13080978393555,GILD,"Pfizer (PFE) COVID Pill Ineffective in Standard Risk Patients ||| FDL, MO, BX, GILD: Large Inflows Detected at ETF",0,0.45967463
2022-06-16,9482200.0,57.65999984741211,58.13999938964844,57.20000076293945,57.720001220703125,54.49820327758789,GILD,Analysts Predict 17% Gains Ahead For HDV,1,0.51322216
2022-06-17,13726500.0,57.369998931884766,58.790000915527344,57.290000915527344,58.52999877929688,55.26299285888672,GILD,1 of the Safest Dividend Stocks on Earth,1,0.5366894
2022-06-21,9173000.0,59.2599983215332,60.58000183105469,58.90999984741211,60.5099983215332,57.132469177246094,GILD,Why Eli Lilly's Immunology Prospects Look Promising,1,0.5080422
2022-06-22,9045300.0,60.130001068115234,62.04999923706055,60.09000015258789,61.5099983215332,58.07665252685547,GILD,Gilead Sciences (GILD) Gains As Market Dips: What You Should Know ||| Ex-girlfriend of biotech CFO pleads guilty to insider trading,1,0.49604654
2022-06-23,6992900.0,61.88999938964844,62.650001525878906,61.75,62.58000183105469,59.08693313598633,GILD,"2 Beaten-Down Dividend Stocks That Are Now Yielding 5% ||| Gilead: Week 48 Findings Underscore Efficacy Of Bulevirtide For Treatment Of Chronic HDV ||| Top Stock Reports for Tesla, Broadcom & Anthem",1,0.52936274
2022-06-24,9207500.0,62.810001373291016,63.130001068115234,61.84999847412109,63.08000183105469,59.559024810791016,GILD,Gilead (GILD) Announces Positive Data on Hepcludex for HDV ||| Gilead: CHMP Adopts Positive Opinion For Lenacapavir To Treat People With Multi-Drug Resistant HIV,0,0.5310909
2022-06-27,6586900.0,62.93000030517578,63.52999877929688,62.630001068115234,62.83000183105469,59.32297897338867,GILD,"3 Top Dividend Stocks for Generating Passive Income ||| Gilead (GILD) HIV Candidate Gets Positive CHMP Recommendation ||| Bristol Myers (BMY) Breyanzi Gets FDA Nod for Label Expansion ||| DVY, IBM, GILD, OKE: Large Outflows Detected at ETF ||| 7 Biotech Stocks With Key Catalysts Coming in July",0,0.53706515
2022-06-28,6165300.0,62.83000183105469,63.4900016784668,62.130001068115234,62.209999084472656,58.73758316040039,GILD,"Gilead Sciences (GILD) Stock Moves -0.99%: What You Should Know ||| MOAT, IBBQ: Big ETF Outflows ||| Gilead (GILD) Resubmits NDA for HIV Inhibitor to the FDA",1,0.51641184
2022-06-29,5800400.0,62.310001373291016,62.970001220703125,61.91999816894531,62.47999954223633,58.99251174926758,GILD,"Biotech Stock Roundup: EPZM Soars on IPSEY Offer, KZR Up on Study Data & More ||| Gilead's (GILD) Yescarta Gets EC Nod for Follicular Lymphoma ||| Which Biotech Stock is the Street More Bullish on?",0,0.4850878
2022-07-01,5207600.0,61.470001220703125,62.43000030517578,61.27000045776367,62.36000061035156,58.87921142578125,GILD,Pfizer (PFE) Seeks FDA Nod for Its Oral Antiviral COVID Pill,0,0.47846463
2022-07-05,5215900.0,61.900001525878906,62.470001220703125,61.36000061035156,62.34000015258789,58.86032104492188,GILD,Is Gilead Sciences' Dividend Safe? ||| Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know ||| What Stocks To Buy Today? 5 Health Care Stocks To Know ||| GSK’s bid to dominate longer-life HIV drugs: podcast,1,0.5178012
2022-07-06,5888200.0,62.619998931884766,62.880001068115234,62.15999984741211,62.72999954223633,59.22855758666992,GILD,Q2 Earnings: Energy and What Else? ||| China allows AstraZeneca's COVID preventive drug in southern city ||| China allows AstraZeneca's COVID preventive drug in southern city,0,0.49234423
2022-07-08,4161900.0,62.560001373291016,63.20000076293945,62.400001525878906,62.84000015258789,59.33242034912109,GILD,VERU's Shares Jump on Successful COVID-19 Study Results,0,0.5262919
2022-07-11,3478600.0,62.790000915527344,63.040000915527344,62.52999877929688,62.65999984741211,59.16246795654297,GILD,"This Company Could Ease the Pain in a Bear Market ||| What's Driving AbbVie Stock Higher? ||| How to Earn $10,000 a Year in Passive Retirement Income ||| Notable ETF Outflow Detected - MOAT, K, VEEV, GILD",0,0.4963547
2022-07-12,6098300.0,62.4900016784668,62.79999923706055,62.0099983215332,62.34000015258789,58.86032104492188,GILD,Gilead Sciences (GILD) Stock Moves -0.51%: What You Should Know,1,0.47432396
2022-07-13,6162900.0,61.91999816894531,62.72999954223633,61.59999847412109,62.459999084472656,58.97362518310547,GILD,Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?,0,0.50792456
2022-07-14,4969500.0,61.83000183105469,61.90999984741211,61.27000045776367,61.810001373291016,58.35991668701172,GILD,Humanigen (HGEN) Plunges as COVID Study Fails to Meet Goal,1,0.5032442
2022-07-15,5908900.0,62.130001068115234,62.619998931884766,61.68000030517578,62.59999847412109,59.10581588745117,GILD,First Week of October 21st Options Trading For Gilead Sciences (GILD) ||| This New Regulation Could Juice Pfizer Stock Even More,0,0.49402484
2022-07-18,5608300.0,62.68000030517578,62.68000030517578,60.63999938964844,60.900001525878906,57.50070571899414,GILD,"Notable Monday Option Activity: LLY, MA, GILD",1,0.5122081
2022-07-19,6080600.0,61.65999984741211,62.27000045776367,61.27999877929688,62.119998931884766,58.65260696411133,GILD,"Gilead Renews Deal With EC To Procure Remdesivir For Member States In EU, EEA ||| EU signs COVID-19 drug procurement deal with Gilead ||| Should You Invest in the VanEck Biotech ETF (BBH)? ||| EU signs COVID-19 therapeutic procurement deal with Gilead",0,0.519988
2022-07-20,5378500.0,62.18000030517578,62.18000030517578,60.83000183105469,61.54999923706055,58.11442184448242,GILD,Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know ||| Building the Optimal Post-Pandemic Workplace,0,0.5005914
2022-07-22,4588800.0,61.27000045776367,61.79999923706055,60.58000183105469,60.79999923706055,57.40629196166992,GILD,Kite's CAR T-cell Therapy Tecartus Gets Positive CHMP Opinion In Acute Lymphoblastic Leukemia ||| Gilead Sciences: CHMP Recommends Full Marketing Authorization For Veklury To Treat COVID-19,0,0.52003026
2022-07-25,4990000.0,61.22999954223633,61.25,60.34999847412109,60.75,57.35907745361328,GILD,"Gilead (GILD) Gets Positive CHMP Opinion for Veklury & Tecartus ||| Notable ETF Outflow Detected - QQQ, CHTR, GILD, ISRG",0,0.49385986
2022-07-26,5597200.0,60.70000076293945,61.25,60.31999969482422,60.619998931884766,57.23633193969727,GILD,Gilead Sciences (GILD) Stock Moves -0.21%: What You Should Know ||| Should You Buy Beaten-Down Biotech Stocks & ETFs?,1,0.48014104
2022-07-27,7935600.0,60.380001068115234,61.369998931884766,59.68999862670898,60.900001525878906,57.50070571899414,GILD,"Will AstraZeneca (AZN) Deliver a Beat This Earnings Season? ||| Earnings Preview: Bionano Genomics, Inc. (BNGO) Q2 Earnings Expected to Decline ||| Biotech Stock Roundup: BMY, BIIB's Q2 Earnings, GILD's Updates & More",0,0.48870027
2022-07-28,6815000.0,61.0,61.11000061035156,59.619998931884766,60.400001525878906,57.02861785888672,GILD,Gilead's Biktarvy Shows High Efficacy For Broad Range Of People Initiating Treatment For HIV ||| These 4 Measures Indicate That Gilead Sciences (NASDAQ:GILD) Is Using Debt Reasonably Well ||| Is a Beat in Store for Gilead (GILD) in This Earnings Season? ||| Cheap copies of GSK's HIV prevention drug could be ready in 2026,0,0.5027564
2022-07-29,10063700.0,60.33000183105469,60.52999877929688,59.5099983215332,59.75,56.41489410400391,GILD,What is in Store for Regeneron (REGN) This Earnings Season?,0,0.47734427
2022-08-01,6742400.0,59.77000045776367,60.18000030517578,59.27000045776367,59.59999847412109,56.27326583862305,GILD,"2 Cheap Dividend Stocks Yielding More Than 4% ||| Drug, Biotech Stocks' Q2 Earnings on Aug 2: GILD, INCY & More ||| Exelixis (EXEL) to Post Q2 Earnings: What is in the Cards? ||| Novo Nordisk (NVO) to Report Q2 Earnings: What's in the Cards? ||| Is a Surprise Coming for Gilead Sciences (GILD) This Earnings Season?",0,0.514625
2022-08-02,5981600.0,59.7400016784668,60.31999969482422,59.290000915527344,59.540000915527344,56.21661376953125,GILD,"Gilead Sciences (GILD) Beats Q2 Earnings and Revenue Estimates ||| Gilead quarterly profit falls as COVID antiviral sales decrease ||| Gilead Sciences Q2 Profit Down; Lifts FY Adj. Profit, Total Product Sales Outlook ||| Gilead Sciences (GILD) Q2 2022 Earnings Call Transcript ||| Notable ETF Inflow Detected - RDIV, GILD, WBA, PRU ||| After-Hours Earnings Report for August 2, 2022 : AMD, PYPL, SBUX, GILD, OXY, PXD, ABNB, MCHP, PRU, EA, WCN, VRSK ||| Gilead Sciences Q2 22 Earnings Conference Call At 4:30 PM ET ||| Is a Beat in Store for BioNTech (BNTX) This Earnings Season?",1,0.47530717
2022-08-03,10066700.0,60.869998931884766,63.650001525878906,60.63999938964844,62.27000045776367,58.79423904418945,GILD,"Noteworthy Wednesday Option Activity: GILD, NLOK, APD ||| Why Gilead Sciences Stock Is Jumping Today ||| Gilead (GILD) Q2 Earnings & Sales Top, Revenue Outlook Upped ||| Should VanEck Morningstar Wide Moat ETF (MOAT) Be on Your Investing Radar?",0,0.48497918
2022-08-04,5520500.0,62.13999938964844,62.9900016784668,61.83000183105469,61.90999984741211,58.45433044433594,GILD,Gilead Sciences To Buy Clinical-stage Private Biotechnology Firm MiroBio For $405 Mln In Cash ||| What's Happening With AbbVie Stock?,0,0.4927152
2022-08-08,5857600.0,61.0,61.709999084472656,60.810001373291016,61.59999847412109,58.1616325378418,GILD,2 Reasons This Beaten-Down Stock Could Be About to Rebound,1,0.5327482
2022-08-09,5153400.0,61.58000183105469,62.04999923706055,61.380001068115234,62.0,58.539306640625,GILD,"Few U.S. patients with hepatitis C get timely treatment, CDC says ||| Drugmaker Gilead to help fund monkeypox education for LGBTQ+ groups",1,0.5287314
2022-08-10,8275000.0,62.4900016784668,63.18999862670898,62.11000061035156,63.13999938964844,59.61567306518555,GILD,3 Healthcare Stocks With High Profit Margins,0,0.5144066
2022-08-11,5216500.0,62.77999877929688,63.40999984741211,62.369998931884766,62.45000076293945,58.96418762207031,GILD,Why Gilead Sciences is a Top 25 Dividend Giant (GILD),1,0.49829587
2022-08-15,12381000.0,63.84999847412109,66.30000305175781,63.65999984741211,66.20999908447266,62.51431274414063,GILD,"Gilead Sciences To Buy Remaining Worldwide Rights Of Trodelvy ||| Why Gilead Sciences Stock Was a 5% Winner Today ||| Noteworthy Monday Option Activity: PEP, WBA, GILD ||| Monday's ETF Movers: TQQQ, OIH ||| GILD Makes Bullish Cross Above Critical Moving Average ||| 7 Growth Stocks to Buy After a 20% Correction",1,0.5168794
2022-08-16,7067800.0,66.16000366210938,66.41999816894531,65.6500015258789,66.33000183105469,62.62760925292969,GILD,Gilead (GILD) Announces Positive Data on Breast Cancer Drug ||| December 16th Options Now Available For Gilead Sciences (GILD),0,0.50651973
2022-08-17,6515300.0,65.97000122070312,66.9000015258789,65.81999969482422,66.0199966430664,62.334922790527344,GILD,"Biotech Stock Roundup: GILD's Drug News, NVAX & MRNA COVID-19 Vaccine Updates",0,0.51017976
2022-08-18,5178100.0,65.95999908447266,66.0,64.70999908447266,65.18000030517578,61.54180145263672,GILD,How Are Biotech ETFs Reacting to Q2 Earnings Releases?,1,0.51680416
2022-08-19,5258900.0,65.0199966430664,65.80000305175781,64.91999816894531,65.33999633789062,61.69287109375,GILD,Peek Under The Hood: SSO Has 10% Upside,0,0.50313514
2022-08-22,5224800.0,65.20999908447266,65.25,64.2300033569336,64.36000061035156,60.767574310302734,GILD,Gilead (GILD) Twice-Yearly HIV Treatment Gets EC Approval ||| Gilead's Twice-yearly HIV Drug Sunlenca Gets European Commission Approval,0,0.53061116
2022-08-23,4723700.0,64.36000061035156,64.37000274658203,63.470001220703125,63.68000030517578,60.12553787231445,GILD,Should Invesco S&P Ultra Dividend Revenue ETF (RDIV) Be on Your Investing Radar?,0,0.49388635
2022-08-24,3808000.0,63.70000076293945,63.810001373291016,63.20000076293945,63.619998931884766,60.06888198852539,GILD,"Biotech Stock Roundup: GILD, BLUE, AXSM's Drug Approvals, FHTX Study Update & More",0,0.49910706
2022-08-26,5501300.0,63.59000015258789,63.619998931884766,62.34999847412109,62.369998931884766,58.88865280151367,GILD,The Top 10 Constituents of the Nasdaq-100 Index,1,0.51503086
2022-08-29,5220000.0,62.130001068115234,62.86000061035156,61.47999954223633,62.45000076293945,58.96418762207031,GILD,Is Franklin U.S. Low Volatility High Dividend Index ETF (LVHD) a Strong ETF Right Now?,1,0.50001353
2022-08-30,5584600.0,62.5099983215332,62.68999862670898,61.790000915527344,62.5,59.01139450073242,GILD,Gilead (GILD) Outpaces Industry in Six Months: What Lies Ahead?,1,0.49496266
2022-08-31,8341600.0,62.70000076293945,63.970001220703125,62.70000076293945,63.470001220703125,59.92725372314453,GILD,"Jounce (JNCE) SELECT Study Fails to Meet Goal, Stock Down",1,0.49800444
2022-09-01,6269600.0,63.40999984741211,65.0,63.31999969482422,64.94999694824219,61.32464218139648,GILD,What's Happening With Gilead Sciences Stock? ||| Gilead (GILD) Up 1.9% Since Last Earnings Report: Can It Continue? ||| Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?,0,0.4967116
2022-09-02,6737300.0,65.04000091552734,65.29000091552734,63.369998931884766,63.81999969482422,60.257720947265625,GILD,"Gilead Sciences (GILD) Dips More Than Broader Markets: What You Should Know ||| With 81% institutional ownership, Gilead Sciences, Inc. (NASDAQ:GILD) is a favorite amongst the big guns",0,0.47858998
2022-09-06,7377500.0,63.77999877929688,63.84000015258789,62.79999923706055,63.38999938964844,59.85172271728516,GILD,3 Great Dividend Stocks to Buy in September ||| Gilead (GILD) Announces Positive New Data on Breast Cancer Drug,1,0.54113656
2022-09-07,9626600.0,63.66999816894531,64.95999908447266,63.560001373291016,64.79000091552734,61.17357635498047,GILD,Gilead's Trodelvy extends breast cancer survival by 3.2 months -study ||| Gilead's (GILD) Tecartus Gets EC Nod for New Cancer Indication ||| Gilead Sciences (GILD) Shares Cross Above 200 DMA ||| Clovis (CLVS) Down 12.6% Since Last Earnings Report: Can It Rebound? ||| Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?,1,0.503779
2022-09-08,8278400.0,65.41000366210938,65.6500015258789,64.69000244140625,65.0999984741211,61.46627426147461,GILD,GILD October 28th Options Begin Trading ||| Gilead (GILD) Breast Cancer Drug Trodelvy Improves Survival ||| Halozyme Therapeutics (HALO) Down 10.6% Since Last Earnings Report: Can It Rebound? ||| Should You Invest in the iShares Biotechnology ETF (IBB)? ||| Is First Trust Large Cap Core AlphaDEX ETF (FEX) a Strong ETF Right Now?,1,0.512733
2022-09-09,6497000.0,64.9800033569336,65.7699966430664,64.88999938964844,65.27999877929688,61.63622283935547,GILD,Gilead Sciences (GILD) Gains But Lags Market: What You Should Know,1,0.4859545
2022-09-12,18777900.0,68.43000030517578,68.87999725341797,67.4800033569336,68.01000213623047,64.21383666992188,GILD,"Ex-Dividend Reminder: Thermo Fisher Scientific, KBR and Gilead Sciences ||| IXJ, BMY, GILD, ZTS: ETF Outflow Alert ||| Gilead Sciences Gains On Agreement With Generic Manufacturers ||| Pre-Market Most Active for Sep 12, 2022 : TQQQ, HAL, SQQQ, GILD, VTYX, KR, CSX, META, KO, NIO, AMC, BSX ||| Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? ||| Should First Trust Large Cap Core AlphaDEX ETF (FEX) Be on Your Investing Radar?",0,0.48059595
2022-09-13,11799400.0,67.4000015258789,67.4000015258789,64.93000030517578,65.0999984741211,61.46627426147461,GILD,"Gilead (GILD) Up on Settling HIV Drug Suit With Generic Players ||| Company News for Sep 13, 2022 ||| 3 Unstoppable Dividend Stocks to Buy in September",1,0.5103301
2022-09-14,9113200.0,64.41000366210938,65.45999908447266,64.41000366210938,65.18000030517578,62.23973083496094,GILD,My Biggest Worry About Gilead Sciences,0,0.4824796
2022-09-15,7088500.0,65.5,65.69999694824219,64.70999908447266,65.0,62.06785583496094,GILD,Gilead Sciences : WHO Expands Recommendation For Veklury To Patients With Severe COVID-19 ||| WHO 'strongly advises against' use of two COVID treatments ||| Gilead Sciences (GILD) Stock Moves -0.28%: What You Should Know,1,0.47609887
2022-09-16,11766000.0,65.08000183105469,65.93000030517578,64.80999755859375,65.5999984741211,62.64078903198242,GILD,"Health Care Sector Update for 09/16/2022: AZN, GILD, REGN, SNY, XLV, IBB ||| Gilead: Kite's CAR T-cell Therapy Yescarta Gets Positive Opinion From CHMP In EU ||| WHO Recommends Gilead's (GILD) Veklury for Severe COVID-19",1,0.49708638
2022-09-19,6162700.0,65.3499984741211,65.86000061035156,64.5999984741211,65.81999969482422,62.85086441040039,GILD,"""The Era of the Gene-Edited Human Is Here"" ||| Gilead (GILD) Drugs Get Positive CHMP Opinion for Label Expansion ||| Should You Invest in the VanEck Biotech ETF (BBH)?",0,0.51998293
2022-09-20,6958900.0,65.41000366210938,65.4800033569336,63.88999938964844,64.58000183105469,61.66679763793945,GILD,Merck to start studying lower dose of HIV drug after FDA hold,0,0.5370782
2022-09-21,8776600.0,64.58000183105469,65.52999877929688,63.459999084472656,63.5,60.63551712036133,GILD,Gilead Sciences (GILD) Stock Moves -1.67%: What You Should Know ||| Merck (MRK) Resumes HIV Studies on Islatravir With Lower Dose,1,0.52498144
2022-09-22,6111800.0,63.34999847412109,64.31999969482422,62.93000030517578,63.77000045776367,60.89333724975586,GILD,"Biotech Stock Roundup: GILD, BMY's Regulatory News, BLUE's Therapy Approval & More ||| HDV, AVGO, BMY, GILD: Large Inflows Detected at ETF ||| Should Franklin U.S. Low Volatility High Dividend Index ETF (LVHD) Be on Your Investing Radar?",0,0.48416778
2022-09-23,7603800.0,63.4900016784668,63.790000915527344,62.29999923706055,62.86000061035156,60.024391174316406,GILD,"Got $1,000? 2 Stocks That Could Be Bargain Buys For 2022 and Beyond ||| Analysts Expect HUSV To Hit $36",0,0.46919614
2022-09-26,6141300.0,62.5099983215332,62.93999862670898,62.16999816894531,62.34000015258789,59.52783966064453,GILD,"The Zacks Analyst Blog Highlights Union Pacific, AT&T, Blackstone, Gilead Sciences and Waste Management",1,0.50159234
2022-09-27,7125900.0,62.43000030517578,63.52000045776367,62.27999877929688,62.630001068115234,59.80476379394531,GILD,Gilead Sciences (GILD) Gains As Market Dips: What You Should Know,1,0.49328962
2022-09-28,7567500.0,63.0,64.37000274658203,62.709999084472656,63.93000030517578,61.046119689941406,GILD,Gilead widens battle against alleged counterfeit HIV drug ring ||| Gilead Sciences (GILD) Shares Cross Above 200 DMA,0,0.51392233
2022-09-29,8431200.0,63.83000183105469,64.22000122070312,62.5099983215332,63.06999969482422,60.22491836547852,GILD,7 Monthly Dividend Stocks to Buy for Safety,0,0.54975677
2022-10-03,8094100.0,62.400001525878906,62.56999969482422,61.45000076293945,62.31999969482422,59.50874328613281,GILD,2 Top Biotech Stocks to Buy for the Long Haul ||| Gilead Sciences (GILD) Gains But Lags Market: What You Should Know ||| Is Invesco Dynamic Pharmaceuticals ETF (PJP) a Strong ETF Right Now?,1,0.52789056
2022-10-04,11966000.0,64.08999633789062,65.36000061035156,63.59999847412109,65.30999755859375,62.363861083984375,GILD,Validea Joel Greenblatt Strategy Daily Upgrade Report - 10/4/2022,1,0.50289613
2022-10-07,6723200.0,64.63999938964844,65.0999984741211,63.959999084472656,64.29000091552734,61.3898811340332,GILD,"SPLV, GILD, HSY, DTE: Large Outflows Detected at ETF",1,0.52013475
2022-10-10,4328500.0,64.56999969482422,64.8499984741211,64.11000061035156,64.45999908447266,61.552207946777344,GILD,Gilead Sciences (GILD) Gains As Market Dips: What You Should Know ||| Gilead (GILD) Up 2.6% in 3 Months: Will the Momentum Continue?,1,0.52011424
2022-10-11,7154500.0,64.5,66.04000091552734,64.4800033569336,65.66999816894531,62.70762252807617,GILD,Gilead Sciences: FDA Accepts For Priority Review SBLA For Trodelvy - Quick Facts,0,0.5067555
2022-10-12,6406000.0,65.8499984741211,66.37000274658203,65.30999755859375,65.38999938964844,62.44025802612305,GILD,"Biotech Stock Roundup: DICE Up on Study Data, GILD, BIIB's Updates & More ||| 4 Biotech Stocks With Huge Incoming Catalysts ||| These 2 Growth Stocks Have Potential Catalysts on the Way ||| Gilead (GILD) Trodelvy Label Expansion sBLA Gets Priority Review",1,0.48044583
2022-10-13,7690100.0,64.45999908447266,66.94999694824219,64.0999984741211,66.45999908447266,63.46199035644531,GILD,"Gilead Sciences (GILD) Gains But Lags Market: What You Should Know ||| Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know",0,0.4718226
2022-10-14,7892200.0,66.62999725341797,67.0,66.0199966430664,66.16999816894531,63.18507385253906,GILD,"Why Cash Rich Companies, ETFs are Beating the Market",1,0.49705112
2022-10-17,5799600.0,66.83999633789062,66.93000030517578,65.94000244140625,66.37999725341797,63.38560104370117,GILD,"3 Supercharged Dividend Stocks to Buy if There's a Stock Market Sell-Off ||| SPLV, GILD, HSY, GD: ETF Outflow Alert",1,0.5047271
2022-10-18,6802300.0,66.54000091552734,67.08000183105469,66.44000244140625,66.87000274658203,63.85349655151367,GILD,"U.S. sends experimental antibody, antiviral drug to Uganda for Ebola outbreak ||| Gilead's (GILD) Yescarta Gets EC Nod for New Cancer Indication",0,0.51696694
2022-10-19,7058600.0,66.8499984741211,66.97000122070312,65.8499984741211,66.19000244140625,63.20418167114258,GILD,Gilead Sciences (GILD) Dips More Than Broader Markets: What You Should Know,0,0.48663038
2022-10-20,6384200.0,66.16000366210938,66.54000091552734,65.69999694824219,66.16000366210938,63.17552185058594,GILD,"Noteworthy Thursday Option Activity: T, GILD, ALL ||| Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for",1,0.48736286
2022-10-21,7814600.0,66.18000030517578,67.94000244140625,66.11000061035156,67.79000091552734,64.73200225830078,GILD,Gilead (GILD) Inks Deal for Gene Platform in Blood Cancers,1,0.5242483
2022-10-24,7133100.0,68.11000061035156,69.37000274658203,68.08999633789062,69.0,65.88742065429688,GILD,Gilead : Data Reinforce Use Of Biktarvy For HIV Treatment With Range Of Comorbidities,1,0.5326595
2022-10-25,6711800.0,68.83999633789062,69.70999908447266,68.4800033569336,69.5999984741211,66.4603500366211,GILD,What's in Store for Gilead (GILD) This Earnings Season? ||| Exelixis (EXEL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release,1,0.4886373
2022-10-26,8763100.0,70.0,71.41000366210938,69.87999725341797,70.81999969482422,67.62531280517578,GILD,"Will Gilead Sciences Stock Climb After Q3 Earnings? ||| Top Stock Reports for The Home Depot, Elevance Health & BP ||| Drug/Biotech Stocks' Q3 Earnings on Oct 27: MRK, GILD & More ||| Why Gilead (GILD) Could Beat Earnings Estimates Again",0,0.48323974
2022-10-27,8881200.0,70.8499984741211,71.26000213623047,70.13999938964844,70.19999694824219,67.03327941894531,GILD,"Gilead Sciences (GILD) Q3 2022 Earnings Call Transcript ||| Gilead Sciences Inc. Q3 Profit Decreases, but beats estimates ||| Gilead Sciences (GILD) Q3 Earnings and Revenues Top Estimates ||| Gilead profit tops expectations despite lower COVID drug sales, shares rise ||| Gilead reports lower 3rd-quarter profit as COVID drug sales slow ||| After-Hours Earnings Report for October 27, 2022 : AAPL, AMZN, TMUS, INTC, GILD, VRTX, PXD, EW, LHX, RSG, DXCM, COF ||| The Zacks Analyst Blog Highlights The Home Depot, Elevance Health, BP, Gilead Sciences and ServiceNow",1,0.50895107
2022-10-28,27665700.0,74.36000061035156,79.61000061035156,73.98999786376953,79.2699966430664,75.69413757324219,GILD,"Health Care Sector Update for 10/28/2022: DXCM,NUVL,GILD,DVA ||| These 2 Stock Winners Topped Apple's Big Gains Friday ||| Health Care Sector Update for 10/28/2022: NUVL,GILD,DVA ||| Friday's ETF with Unusual Volume: DEF ||| Gilead (GILD) Q3 Earnings & Sales Top, Guidance Raised ||| Notable Friday Option Activity: GILD, DVA, ALGN",0,0.4589377
2022-10-31,14674300.0,78.05999755859375,79.37000274658203,77.52999877929688,78.45999908447266,74.92066955566406,GILD,$10K to $100K in 10 Years? Build Your Own ETF with Undervalued Dividend Stocks,1,0.51381063
2022-11-01,10553100.0,78.26000213623047,79.55000305175781,77.66000366210938,79.33999633789062,75.76097106933594,GILD,"Lilly (LLY) Beats on Q3 Earnings & Sales, Lowers '22 View",0,0.51305324
2022-11-02,9785000.0,78.18000030517578,80.0,77.80999755859375,77.87999725341797,74.36683654785156,GILD,"Esperion (ESPR) Q3 Earnings Beat Estimates, Revenues Miss",1,0.5145554
2022-11-03,8261100.0,77.33000183105469,79.56999969482422,77.16000366210938,79.45999908447266,75.87556457519531,GILD,"Moderna's (MRNA) Lags on Q3 Earnings, Lowers '22 Sales Outlook ||| Sarepta (SRPT) Q3 Loss Wider-Than-Expected, Sales Lag Estimates ||| Allogene (ALLO) Reports Narrower-Than-Expected Loss in Q3 ||| Is Franklin U.S. Low Volatility High Dividend Index ETF (LVHD) a Strong ETF Right Now?",1,0.49242827
2022-11-04,9103300.0,79.13999938964844,81.31999969482422,78.38999938964844,80.33999633789062,76.71585845947266,GILD,"Nektar's (NKTR) Q3 Earnings and Revenues Beat Estimates ||| Karuna Therapeutics (KRTX) Posts Wider-Than-Expected Q3 Loss ||| TEVA Misses on Q3 Earnings, Cuts 2022 Sales View, Stock Down",1,0.5076397
2022-11-07,8989300.0,79.55999755859375,81.55999755859375,79.51000213623047,81.45999908447266,77.78534698486328,GILD,"3 No-Brainer Dividend Stocks to Buy in November ||| Stellantis pauses paid ads on Twitter after Musk takes over ||| Gilead, Kite in process of pausing Twitter advertising ||| U.S. Supreme Court rejects Bristol Myers cancer-drug patent fight with Gilead ||| U.S. Supreme Court rejects Bristol Myers cancer-drug patent fight with Gilead",1,0.5289456
2022-11-08,9344400.0,80.5999984741211,83.80000305175781,80.08000183105469,82.2300033569336,78.5206069946289,GILD,"Perrigo (PRGO) Lags on Q3 Earnings & Sales, Lowers '22 EPS View",1,0.5134503
2022-11-09,10316500.0,82.5,83.55000305175781,82.18000030517578,82.31999969482422,78.60655212402344,GILD,"U.S. FDA panel votes against Veru's COVID-19 pill ||| Reata (RETA) Q3 Earnings Beat, Stock Up on Pipeline Updates ||| Notable ETF Inflow Detected - USMV, VRTX, TMUS, GILD ||| See Which Of The Latest 13F Filers Holds Gilead Sciences ||| How Are Biotech ETFs Reacting to Q3 Earnings Releases? ||| Should You Invest in the iShares Biotechnology ETF (IBB)?",1,0.51689565
2022-11-10,9397300.0,83.5,83.80000305175781,81.55999755859375,82.5999984741211,78.87391662597656,GILD,"Jazz's (JAZZ) Q3 Earnings Beat Estimates, New Drugs Drive Sales",0,0.5215471
2022-11-11,11413200.0,81.41000366210938,81.9800033569336,80.06999969482422,81.81999969482422,78.12910461425781,GILD,"Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know",1,0.4753871
2022-11-14,7665200.0,81.6500015258789,84.13999938964844,81.2300033569336,82.8499984741211,79.11264038085938,GILD,2 Top Biotech Stocks to Buy in November,1,0.52070814
2022-11-15,7121000.0,83.13999938964844,83.63999938964844,81.9800033569336,83.0,79.25587463378906,GILD,Britain's NICE recommends against NHS use of 5 COVID treatments as not cost-effective ||| Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? ||| Should You Invest in the Invesco Dynamic Pharmaceuticals ETF (PJP)?,0,0.50926393
2022-11-17,5757500.0,82.55000305175781,83.83000183105469,82.47000122070312,83.62000274658203,79.84791564941406,GILD,Is Gilead Sciences (GILD) Outperforming Other Medical Stocks This Year?,0,0.50008154
2022-11-18,7276400.0,83.62999725341797,84.05999755859375,82.98999786376953,83.62000274658203,79.84791564941406,GILD,"Top Analyst Reports for Lowe's, Gilead Sciences & Intuitive Surgical ||| Gilead (GILD) Outperforms YTD: Will It Retain the Momentum? ||| Sanofi's (SNY) Rare Anemia Drug Enjaymo Gets EU Approval ||| SPYD, KTEC: Big ETF Outflows",1,0.5456964
2022-11-21,6347900.0,83.76000213623047,85.16999816894531,83.63999938964844,84.3499984741211,80.54498291015625,GILD,"Bristol Myers (BMY) Gains 24.2% YTD: What's in Store for 2023? ||| The Zacks Analyst Blog Highlights Lowe's, Gilead Sciences, Intuitive Surgical, Valero Energy and MercadoLibre",1,0.48195243
2022-11-22,7357700.0,84.6500015258789,86.1500015258789,84.54000091552734,85.2300033569336,81.3852767944336,GILD,"SPLV, GILD, AFL, GD: Large Inflows Detected at ETF ||| Buy this Medical Sector Pioneer Stock ||| GILD vs. HALO: Which Stock Is the Better Value Option? ||| 2 Reasons to Buy AbbVie Stock and 1 Reason to Sell ||| Should You Invest in the VanEck Biotech ETF (BBH)?",1,0.49875373
2022-11-23,4680500.0,85.05999755859375,85.94000244140625,85.01000213623047,85.41999816894531,81.56671142578125,GILD,"GSK to Withdraw Blenrep From U.S. Market on FDA Request ||| Is Most-Watched Stock Gilead Sciences, Inc. (GILD) Worth Betting on Now?",1,0.5073666
2022-11-25,4028700.0,85.04000091552734,86.41000366210938,84.76000213623047,86.26000213623047,82.36881256103516,GILD,AbbVie's (ABBV) Skyrizi Gets EU Nod for Crohn's Disease ||| Pick These 4 Stocks With Exciting Interest Coverage Ratio,0,0.4995032
2022-11-28,9253800.0,86.91999816894531,88.19999694824219,85.08000183105469,85.20999908447266,81.36618041992188,GILD,"Spectrum's (SPPI) NDA for NSCLC Candidate Gets CRL From FDA ||| Arcus Climbs On Positive Results In Joint TIGIT Program In ARC-7 Study ||| Gilead, Arcus Announce Positive Update On Joint TIGIT Program In ARC-7 Study ||| Biotech Stocks Facing FDA Decision In December 2022",1,0.49481982
2022-11-29,6155600.0,85.5,85.87000274658203,84.70999908447266,85.76000213623047,81.89137268066406,GILD,"Gilead (GILD), RCUS Announce Positive Data From NSCLC Study ||| Gilead Granted Expanded Marketing Authorization For Biktarvy In The European Union",1,0.5341396
2022-11-30,14657500.0,85.76000213623047,88.1500015258789,85.01000213623047,87.83000183105469,83.86798858642578,GILD,FDA pulls U.S. authorization for Eli Lilly's COVID drug bebtelovimab ||| 2 Reasons This Stock Could Outperform in 2023 ||| AstraZeneca (AZN) Boosts Cell Therapies With Neogene Deal ||| Gilead (GILD) Gets EC Approval for Biktarvy Label Expansion ||| These 3 Stocks Are Rallying While the Rest of the Market Plunges,1,0.51181906
2022-12-01,8220500.0,88.19999694824219,88.97000122070312,87.72000122070312,87.9000015258789,83.9348373413086,GILD,"RSP, BIIB, ABMD, GILD: ETF Inflow Alert ||| The Top Healthcare Stocks to Buy With $100",1,0.49971348
2022-12-02,6730400.0,86.69999694824219,89.06999969482422,86.55000305175781,89.02999877929688,85.01385498046875,GILD,"Allogene Therapeutics (ALLO) Down 1.6% Since Last Earnings Report: Can It Rebound? ||| Roivant (ROIV), Pfizer Form Vant for Inflammatory Disease Drug",0,0.48981148
2022-12-05,6811400.0,87.83999633789062,89.0999984741211,87.47000122070312,87.9800033569336,84.01123046875,GILD,Is Gilead Sciences (GILD) Stock Outpacing Its Medical Peers This Year? ||| GSK's Myelofibrosis Candidate MAA Gets Accepted in Europe ||| Is Gilead Sciences (GILD) Stock Outpacing Its Medical Peers This Year?,0,0.48579562
2022-12-06,6760500.0,87.98999786376953,88.66999816894531,87.13999938964844,87.95999908447266,83.99212646484375,GILD,5 Dividend Stocks to Allay Fears of a More-Aggressive Fed ||| Why Gilead Sciences is a Top Socially Responsible Dividend Stock (GILD),0,0.49202505
2022-12-07,8861700.0,88.02999877929688,88.55000305175781,87.37000274658203,87.79000091552734,83.82978820800781,GILD,"Daiichi Sankyo To Transfer Yescarta Marketing Authorization In Japan To Gilead Sciences ||| First Week of GILD January 2025 Options Trading ||| Biogen (BIIB), Sage Finish Zuranolone NDA Filing for Depression ||| Wall Street Bulls Look Optimistic About Gilead (GILD): Should You Buy? ||| Pre-Market Most Active for Dec 7, 2022 : TQQQ, SMMT, SQQQ, CVNA, ESPR, RXDX, GILD, GSK, NIO, XPEV, MOS, RLX ||| The Zacks Analyst Blog Highlights Exxon Mobil, WesBanco, S&T Bancorp, Gilead Sciences and Conagra Brands",1,0.49970356
2022-12-08,6392200.0,87.87000274658203,89.61000061035156,87.55999755859375,89.47000122070312,85.43401336669922,GILD,Esperion (ESPR) Reports Positive Data From CLEAR Study ||| Is Gilead Sciences Stock Still a Buy After Soaring in 2022?,0,0.4964539
2022-12-09,8276300.0,89.2699966430664,89.2699966430664,87.79000091552734,87.97000122070312,84.00167846679688,GILD,"EU watchdog warns on waning effectiveness of antibody COVID drugs ||| Entrada (TRDA) Surges on Collaboration With Vertex for DMI ||| Kodiak Sciences Inc. (KOD) Up 1% Since Last Earnings Report: Can It Continue? ||| Is Invesco Dynamic Pharmaceuticals ETF (PJP) a Strong ETF Right Now? ||| Kite, Arcellx To Co-develop, Co-commercialize Arcellx's Lead Product Candidate, CART-ddBCMA ||| ImmunoGen, Gilead To Evaluate Pivekimab With Magrolimab In R/R CD123-positive Acute Myeloid Leukemia",1,0.49882388
2022-12-12,5968400.0,87.8499984741211,88.55999755859375,87.43000030517578,88.54000091552734,84.54596710205078,GILD,"Gilead (GILD) Partners With Arcellx, ImmunoGen in Oncology ||| Beat the Dow Jones With This Unstoppable Dividend Stock ||| Ex-Dividend Reminder: NorthWestern, Gilead Sciences and Thermo Fisher Scientific",1,0.49790746
2022-12-13,8462200.0,89.62999725341797,89.73999786376953,87.94000244140625,88.75,84.74649810791016,GILD,"Noteworthy Tuesday Option Activity: QTRX, ICUI, GILD ||| bluebird (BLUE) Up on Positive Data on Gene Therapies at ASH",0,0.5289175
2022-12-14,8643500.0,88.0,89.29000091552734,87.5199966430664,88.4000015258789,85.11235809326172,GILD,"Gilead Sciences (GILD) Stock Moves -0.39%: What You Should Know ||| Biotech Stock Roundup: HZNP Surges on AMGN Offer, TRDA Gains on VRTX Deal & More",0,0.4825318
2022-12-15,9898600.0,88.05000305175781,88.0999984741211,85.38999938964844,86.58000183105469,83.36004638671875,GILD,"GILD vs. AMGN: Two Splendid Dividend Stocks, but One Looks Better ||| Cytokinetics (CYTK) Up Despite Unfavorable FDA Committee Voting",1,0.52401394
2022-12-16,28313000.0,86.33999633789062,87.12000274658203,85.80000305175781,86.76000213623047,83.53335571289062,GILD,BioCryst (BCRX) Down as it Discontinues Developing PNH Drug,0,0.51459277
2022-12-19,5834800.0,86.0,86.62000274658203,85.43000030517578,86.41999816894531,83.20599365234375,GILD,"AbbVie (ABBV) Vraylar Gets FDA Nod for Major Depressive Disorder ||| Unusual Options Activity in Apple, Home Depot and 8 Other Stocks ||| Roche's (RHHBY) Hemophilia A Drug Gets Positive CHMP Opinion",0,0.4997775
2022-12-20,10999000.0,83.63999938964844,85.26000213623047,81.80999755859375,84.7699966430664,81.61736297607422,GILD,"SSO, GS, MS, GILD: ETF Outflow Alert ||| US STOCKS-Energy, financial stocks lift Wall St after BOJ policy surprise ||| Gilead Sciences Slips After Kite's Acquisition Of Tmunity ||| Entrada (TRDA) Down on Regulatory Update for DMD Candidate ||| US STOCKS-Wall Street set for mixed open after BOJ's policy surprise ||| bluebird's (BLUE) SCD Studies Clinical Hold Lifted by the FDA ||| Kite To Acquire Tmunity - Quick Facts ||| Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know ||| S&P 500 Movers: GILD, NEM",1,0.49681717
2022-12-21,5320700.0,85.25,85.91000366210938,84.86000061035156,85.2699966430664,82.09876251220703,GILD,"Merck (MRK), Seagen Keytruda-Padcev sBLAs Get FDA Priority Tag ||| Are Medical Stocks Lagging Gilead Sciences (GILD) This Year?",1,0.5004551
2022-12-22,4698800.0,85.25,85.47000122070312,84.37000274658203,85.27999877929688,82.1083984375,GILD,"Kite Pharma : Yescarta Approved In Japan For Initial Treatment Relapsed Large B-Cell Lymphoma ||| U.S. FDA approves Gilead's long-acting HIV drug Sunlenca ||| U.S. FDA approves Gilead's long-acting HIV drug Sunlenca ||| Roche (RHHBY) Actemra Gets FDA Nod for Adults With COVID-19 ||| Biotech Stock Roundup: MDGL Surges on NASH Data, TRDA, RCUS Down on Updates & More",0,0.52848244
2022-12-23,3955400.0,85.22000122070312,85.25,84.27999877929688,84.75,81.59811401367188,GILD,Gilead (GILD) Gets FDA Nod for Twice-Yearly HIV Treatment ||| 3 Nasdaq Stocks That Are Up 25% in 3 Months ||| Biotech is Set for a Blockbuster 2023: Here's Why ||| U.S. FDA approves Roche's lymphoma therapy,1,0.5254651
2022-12-27,3455900.0,85.25,85.47000122070312,84.69000244140625,85.01000213623047,81.84844207763672,GILD,3 Stocks That Could Soar in a Santa Claus Rally ||| Gilead Sciences (GILD) Gains As Market Dips: What You Should Know ||| Gilead buys out rights to cancer therapy from Jounce for $67 mln ||| Gilead To Acquire Remaining Rights To Immunotherapy GS-1811 From Jounce Therapeutics ||| 4 Top Biotech Stocks Worth Adding to Your Portfolio in 2023,0,0.50210834
2022-12-28,3285900.0,85.4000015258789,85.83000183105469,84.44999694824219,84.56999969482422,81.42479705810547,GILD,"Health Care Sector Update for 12/28/2022: LUCY,KALA,UTRS,JNCE,GILD ||| Health Care Sector Update for 12/28/2022: KALA, UTRS, JNCE, GILD ||| Gilead (GILD) To Get Full Rights for Jounce's Immunotherapy ||| Health Care Sector Update for 12/28/2022: XLV, VHT, GILD, UTRS, JNCE, KALA ||| Zacks Industry Outlook Highlights Gilead Sciences, GSK, Immunocore and Syndax Pharmaceuticals",1,0.47989005
2022-12-29,3464100.0,84.91000366210938,85.56999969482422,84.61000061035156,85.26000213623047,82.08914947509766,GILD,"Gilead Sciences (GILD) Gains But Lags Market: What You Should Know ||| Notable ETF Outflow Detected - SPYD, GILD, CAH, PFG ||| Biotech Stock Roundup: GILD's HIV Drug Approval, PRQR Surges on LLY Deal & More ||| This New Drug Could Be Gilead Sciences' Growth Catalyst ||| 3 High-Yielding Dividend Stocks That Could See Hikes in January",1,0.5351425
2016-01-25,5051700.0,156.39999389648438,156.52999877929688,151.1199951171875,151.1199951171875,140.2908477783203,GS,"Is Goldman Sachs Right About Caterpillar? ||| Dow Movers: CAT, MCD",1,0.49004373
2016-01-26,5237700.0,151.1199951171875,156.10000610351562,151.1199951171875,154.4499969482422,143.3822784423828,GS,"JMP Group LLC (JMP) Ex-Dividend Date Scheduled for January 27, 2016 ||| Morgan Stanley (MS) Ex-Dividend Date Scheduled for January 27, 2016",0,0.44565976
2016-01-27,5153100.0,153.58999633789062,158.42999267578125,153.19000244140625,153.72000122070312,142.70455932617188,GS,Dow Jones Industrial Average Falling Today Ahead of Fed Statement,1,0.51667905
2016-01-28,4292900.0,155.00999450683594,158.0500030517578,152.52999877929688,157.05999755859375,145.80519104003906,GS,3 Dow Jones Stocks to Buy While They're Cheap,1,0.521875
2016-01-29,4887900.0,158.63999938964844,161.58999633789062,157.77999877929688,161.55999755859375,149.98275756835938,GS,"TD Ameritrade Holding Corporation (AMTD) Ex-Dividend Date Scheduled for February 01, 2016",0,0.4781012
2016-02-01,2963500.0,160.41000366210938,161.0,158.4499969482422,159.64999389648438,148.20956420898438,GS,3 Reasons Goldman Sachs Stock Could Fall ||| Why Are These 8 Banks Too Big To Fail?,0,0.50920457
2016-02-02,6316200.0,157.0,157.0,150.16000366210938,151.6999969482422,140.82928466796875,GS,"Dow Movers: CVX, DD ||| Market Close Report: NASDAQ Composite index closes at 4,516.95 down -103.42 points ||| Close Update: Wall Street Losses Accelerate as Sell-Off in Oil Continues ||| Stocks to Buy Before the 2016 Presidential Election ||| Why Is Goldman Sachs (GS) Stock Falling Today?",1,0.50263685
2016-02-03,5893200.0,152.5,153.83999633789062,147.00999450683594,152.67999267578125,141.7390899658203,GS,"Goldman Asia Unit Faces Hong Kong SFC Wrath, Shares Fall",1,0.516904
2016-02-04,4573100.0,152.3000030517578,157.9499969482422,152.00999450683594,156.49000549316406,145.2760467529297,GS,Checking Our Mail: Financials Edition,0,0.5053987
2016-02-05,4596100.0,157.57000732421875,159.6999969482422,155.69000244140625,156.47000122070312,145.25750732421875,GS,"This Just In: UBS Falls in Love With JP Morgan and Goldman Sachs ||| Dow Movers: JNJ, WMT ||| State Street in Talks to Acquire GE's Asset Management Unit ||| Will 2016 Be Goldman Sachs' Best Year Yet? ||| Why LinkedIn (LNKD) Stock is Tumbling Today",0,0.48159343
2016-02-08,8680000.0,153.8300018310547,153.8300018310547,145.25,149.25,138.5548553466797,GS,"Dow Movers: GS, JNJ ||| The Zacks Analyst Blog Highlights: State Street, General Electric, Goldman Sachs Group and BlackRock ||| MarketAxess Holdings, Inc. (MKTX) Ex-Dividend Date Scheduled for February 09, 2016",0,0.43852928
2016-02-09,6919400.0,145.52000427246094,149.9499969482422,145.10000610351562,148.25,137.62652587890625,GS,"Stock Market News for February 09, 2016 ||| Morgan Stanley (MWR) Ex-Dividend Date Scheduled for February 10, 2016 ||| The Charles Schwab Corporation (SCHW) Ex-Dividend Date Scheduled for February 10, 2016 ||| Consumer Sector Update for 02/09/2016: CMI, WYN ||| How One Simple Hedge Could Actually Give the Biggest Profits of the 21st Century",0,0.45064485
2016-02-10,7609600.0,150.0,153.3800048828125,147.2100067138672,147.22999572753906,136.67962646484375,GS,"DIA, GS, BA, UNH: Large Inflows Detected at ETF ||| Goldman Fears Sub-$20 Oil: Who Gains, Who Loses? ||| Why Do Stocks Get Added and Removed From the S&P 500? ||| See Which Of The Latest 13F Filers Holds Goldman Sachs Group",0,0.48634103
2016-02-11,10252200.0,143.41000366210938,144.41000366210938,139.0500030517578,140.69000244140625,130.60826110839844,GS,"5 Wild Inverse ETFs Betting Against the Market ||| The Zacks Analyst Blog Highlights: Goldman Sachs Group, Chevron, PetroChina Co., Murphy USA and Valero Energy",1,0.5333355
2016-02-12,9009300.0,143.75,146.50999450683594,143.6999969482422,146.1300048828125,135.65843200683594,GS,"Stocks Bounce Back on Gains in Oil and Banking ||| Stocks Rally on Rebound in Oil and Banking Stocks ||| Dow Movers: BA, JPM ||| Stock Market News for February 12, 2016 ||| Close Update: Stocks Rally as Gains in Oil and Banks Snap 5-Day Losing Streak ||| Rally in Oil and Banking Sector Snaps Five-Day Losing Streak",1,0.5207475
2016-02-16,10198000.0,149.60000610351562,150.47999572753906,147.4499969482422,149.02000427246094,138.34140014648438,GS,"Stock Market News for February 16, 2016 ||| BofA CEO Gets Pay Raise; Record Earnings Responsible?",1,0.48295012
2016-02-17,5578800.0,150.8000030517578,151.8699951171875,150.30999755859375,150.94000244140625,140.123779296875,GS,"FBR & Co (FBRC) Ex-Dividend Date Scheduled for February 18, 2016 ||| Calamos Asset Management, Inc. (CLMS) Ex-Dividend Date Scheduled for February 18, 2016",0,0.43082622
2016-02-18,5895500.0,151.25,152.0,147.3699951171875,147.72999572753906,137.143798828125,GS,"The Gold Monster Awakens ||| HEZU, IAI: Big ETF Outflows ||| Notable ETF Outflow Detected - DIA, GS, IBM, UNH",0,0.49896753
2016-02-19,5257300.0,147.0,147.72999572753906,145.42999267578125,146.91000366210938,136.38253784179688,GS,Yahoo! to Form Independent Committee for Improvements ||| 5 Value Picks to Smartly Play a Recovering U.S. ||| Banks' Declines Give an Opportunity to Trade the Traders,1,0.48254758
2016-02-23,4249600.0,148.0,148.0500030517578,144.0500030517578,144.91000366210938,134.52589416503906,GS,"Dow Movers: JPM, HD ||| Goldman (GS) Cuts Legal Loss Estimates by 62% to $2B ||| HSBC's Hiring Practices in Asia-Pacific under SEC Probe?",1,0.5120477
2016-02-24,5714700.0,143.0800018310547,145.63999938964844,140.25999450683594,145.55999755859375,135.12928771972656,GS,"Dow Movers: CAT, UTX ||| JMP Group LLC (JMP) Ex-Dividend Date Scheduled for February 25, 2016",1,0.47297734
2016-02-25,4299600.0,146.0,149.07000732421875,145.22999572753906,148.25,137.62652587890625,GS,"Interactive Brokers Group, Inc. (IBKR) Ex-Dividend Date Scheduled for February 26, 2016",1,0.45246682
2016-02-26,5924500.0,149.72000122070312,151.97000122070312,149.00999450683594,150.25,139.4832305908203,GS,"DIA, GS, IBM, UNH: Large Outflows Detected at ETF ||| Dow Movers: IBM, GS ||| Greenhill & Co., Inc. (GHL) Ex-Dividend Date Scheduled for February 29, 2016 ||| Goldman Sachs Group, Inc. (GS) Ex-Dividend Date Scheduled for February 29, 2016 ||| BGC Partners, Inc. (BGCP) Ex-Dividend Date Scheduled for February 29, 2016",0,0.4807654
2016-02-29,5506400.0,149.75,150.2899932861328,148.32000732421875,149.52999877929688,139.41795349121094,GS,"How to Calculate Price-Weighted Average for Stocks ||| For Some Producers, $10 Oil Is Already a Reality",1,0.4839887
2016-03-01,6490400.0,150.9499969482422,154.77000427246094,150.67999267578125,154.64999389648438,144.19171142578125,GS,"Investment Technology Group, Inc. (ITG) Ex-Dividend Date Scheduled for March 02, 2016 ||| LPL Financial Holdings Inc. (LPLA) Ex-Dividend Date Scheduled for March 02, 2016 ||| CBOE Holdings, Inc. (CBOE) Ex-Dividend Date Scheduled for March 02, 2016 ||| Navient Corporation (NAVI) Ex-Dividend Date Scheduled for March 02, 2016 ||| Citigroup to Exit 20% Stake in China Guangfa Bank for $3B",0,0.43664378
2016-03-02,5047500.0,154.75,155.41000366210938,153.4499969482422,154.1999969482422,143.77215576171875,GS,"BlackRock, Inc. (BLK) Ex-Dividend Date Scheduled for March 03, 2016",1,0.44902948
2016-03-03,3615800.0,154.0,155.66000366210938,153.36000061035156,155.3300018310547,144.82574462890625,GS,"Bill Gross: Sunshine, Lollipops And... ||| 3 Reasons Goldman Sachs Stock Could Rise",1,0.5208906
2016-03-04,5256700.0,156.3699951171875,158.85000610351562,155.2899932861328,156.83999633789062,146.2335968017578,GS,Goldman Begins First Round of Layoffs; Cuts 43 Jobs ||| 10 Companies Screwing Over Their Customers ||| 3 BDC Stocks to Capitalize Long Term,0,0.5036401
2016-03-07,2771900.0,156.0,156.3699951171875,154.41000366210938,155.35000610351562,144.8443603515625,GS,The 5 Worst Stocks in the Dow in February ||| Goldman Sachs Stock in 4 Charts,0,0.5159919
2016-03-09,3250900.0,152.11000061035156,152.5,149.17999267578125,149.91000366210938,139.77224731445312,GS,"U.S. Bancorp CEO Richard Davis' 2015 Pay Slashed 40% ||| Dow Movers: NKE, CVX ||| Stock Market News for March 09, 2016 ||| 5 Smart Ways to Profit From a Stock Market Correction ||| Raymond James Financial, Inc. (RJD) Ex-Dividend Date Scheduled for March 10, 2016 ||| Nasdaq, Inc. (NDAQ) Ex-Dividend Date Scheduled for March 10, 2016 ||| 5 Oil Exploration Stocks to Buy After Yesterday's Slump",1,0.47610548
2016-03-10,4631800.0,150.41000366210938,153.60000610351562,148.83999633789062,151.02000427246094,140.80718994140625,GS,"The 4 Cheapest Big Bank Stocks Right Now ||| Dow Movers: XOM, GS",1,0.50326306
2016-03-11,4058700.0,153.27999877929688,154.16000366210938,152.3699951171875,153.94000244140625,143.5297088623047,GS,"Citi (C) Focused on Expanding Credit Derivatives Business ||| T. Rowe Price Group, Inc. (TROW) Ex-Dividend Date Scheduled for March 14, 2016 ||| Intercontinental Exchange Inc. (ICE) Ex-Dividend Date Scheduled for March 14, 2016 ||| 3 Top Stocks That EVERY Trader Should Follow – FB TSLA GS",0,0.4574184
2016-03-14,3317900.0,153.66000366210938,154.4499969482422,152.1300048828125,153.49000549316406,143.11019897460938,GS,"3 Ways to Profit From Battered and Beaten BDCs ||| Stock Market News for March 14, 2016 ||| 4 Dividend-Yielding Oil Stocks to Buy as Prices Rise",0,0.52086145
2016-03-15,3731400.0,152.64999389648438,152.74000549316406,150.89999389648438,152.02999877929688,141.74888610839844,GS,BofA Lays off Senior Bankers at Asia Investment-Banking Unit,0,0.52312183
2016-03-16,4310300.0,150.9199981689453,152.85000610351562,149.7100067138672,150.5399932861328,140.359619140625,GS,"Notable ETF Inflow Detected - DIA, GS, IBM, WMT ||| Why Goldman is Set to Acquire Startup Firm Honest Dollar",1,0.49910662
2016-03-17,4431700.0,150.38999938964844,153.97999572753906,148.75,152.91000366210938,142.5693817138672,GS,"Wells Fargo CEO to be Paid $19.3M for Fourth Year in a Row ||| Notable Thursday Option Activity: RSTI, AMC, GS",1,0.49285376
2016-03-18,7413200.0,153.91000366210938,158.17999267578125,153.8699951171875,157.60000610351562,146.9422149658203,GS,"Institutional Financial Markets, Inc. (IFMI) Ex-Dividend Date Scheduled for March 21, 2016",0,0.44378465
2016-03-21,4410200.0,157.24000549316406,158.89999389648438,155.75,156.2899932861328,145.72079467773438,GS,"3 Reasons Warren Buffett Would Dump a Stock ||| Sales Growth Masks Problems At Zillow Group ||| S&P 500 Turns Green: 5 Solid Picks ||| 3 China Stocks to Sell NOW: More RMB Weakness Ahead (BABA, BIDU, CEA) ||| GAIN Capital Holdings, Inc. (GCAP) Ex-Dividend Date Scheduled for March 22, 2016 ||| Ameriprise CEO Cracchiolo's 2015 Pay Slashed 15%",0,0.49671844
2016-03-22,3521500.0,155.5,155.58999633789062,153.36000061035156,154.1999969482422,143.77215576171875,GS,5 Oil Field Stocks That Shouldn't Be In Your Portfolio Now ||| Dow Jones Winning Streak Threatened by Terrorist Attacks ||| Goldman's Acquisition of GE's $17B Deposits Gets Fed Nod,0,0.5060039
2016-03-23,3633400.0,154.25,155.5500030517578,153.58999633789062,154.0800018310547,143.66024780273438,GS,BNY Mellon Settles Probe over Technical Glitch for $3M,0,0.5070949
2016-03-24,3693400.0,152.39999389648438,153.0399932861328,150.1300048828125,153.0,142.65328979492188,GS,"Dow Movers: GS, CAT ||| Instant Analysis: Fed Approves Goldman's $17 Billion GE Capital Bank Online Deposits Buy ||| Citigroup's German Unit Under Review for Dividend Stripping",1,0.5041736
2016-03-28,2308600.0,153.13999938964844,154.63999938964844,152.3800048828125,153.83999633789062,143.4364776611328,GS,"Stock Market News for March 28, 2016 ||| The Zacks Analyst Blog Highlights: Citigroup, JPMorgan Chase, Blackstone Group, Goldman Sachs Group and Bank of New York Mellon ||| Morgan Stanley (MSK) Ex-Dividend Date Scheduled for March 29, 2016 ||| JMP Group LLC (JMP) Ex-Dividend Date Scheduled for March 29, 2016 ||| Morgan Stanley (MWO) Ex-Dividend Date Scheduled for March 29, 2016 ||| Goldman Sachs Amends 'Warn Notice' With Higher Job Cuts",1,0.45987895
2016-03-29,2919500.0,152.8699951171875,155.35000610351562,151.5,155.02999877929688,144.5460205078125,GS,"JMP Group LLC (JMPB) Ex-Dividend Date Scheduled for March 30, 2016 ||| Stifel Financial Corporation (SFN) Ex-Dividend Date Scheduled for March 30, 2016 ||| Raymond James Financial, Inc. (RJF) Ex-Dividend Date Scheduled for March 30, 2016 ||| JMP Group LLC (JMPC) Ex-Dividend Date Scheduled for March 30, 2016 ||| Investment Banking Revenues Lowest Since Crisis",1,0.4465874
2016-03-30,3130600.0,156.1300048828125,158.02000427246094,154.88999938964844,156.5,145.91661071777344,GS,Dow Analyst Moves: GS,1,0.512465
2016-03-31,2927300.0,156.17999267578125,157.47999572753906,156.05999755859375,156.97999572753906,146.36415100097656,GS,BlackRock Mulling 400 Layoffs to Focus on Growth Areas ||| 3 Bank Stocks to Buy in April,1,0.5101386
2016-04-01,3373400.0,156.4600067138672,160.00999450683594,155.08999633789062,159.82000732421875,149.0120849609375,GS,SPDR Dow Jones Industrial Average ETF Experiences Big Inflow,0,0.5076797
2016-04-04,2478100.0,159.97000122070312,160.0,157.38999938964844,157.77000427246094,147.10072326660156,GS,"Your Instant 5-Stock Dividend-Growth Portfolio ||| U.S. Factory Activity Rebounds: 3 Mutual Fund Picks ||| Stock Market News for April 04, 2016",0,0.47629976
2016-04-05,2822700.0,156.44000244140625,156.52999877929688,154.5500030517578,155.35000610351562,144.8443603515625,GS,"Dow Movers: CSCO, PFE ||| General Electric: We're No Longer Too Big to Fail ||| Trade of the Day: GS Stock Nearing a Good Entry Point",0,0.49441612
2016-04-06,2927400.0,155.25999450683594,156.27000427246094,153.9199981689453,155.19000244140625,144.69522094726562,GS,Goldman (GS) Continues to Face Headwinds: Time to Sell? ||| 3 Stocks Goldman Sachs Group Inc (GS) LOVES Right Now – AMZN JNPR MYL ||| Barclays-Circle Partnership to Facilitate App Launch in UK,0,0.49273053
2016-04-07,4786800.0,153.64999389648438,154.02999877929688,149.3699951171875,150.41000366210938,140.2384490966797,GS,"Wow! EP Energy Corp Soared 130% in March ||| Goldman Sachs and 3 Other Broker Stocks to Avoid ||| Citi Revises Executive Pay Plan, Proxy Advisors Unsatisfied ||| Close Update: Stocks Sharply Lower on Global Growth Worries",0,0.518459
2016-04-08,3122200.0,152.07000732421875,152.8699951171875,150.00999450683594,150.27999877929688,140.11721801757812,GS,"Stock Market News for April 08, 2016 ||| 2 Forgotten Dividend Stock Growers Ready to Rally ||| The Zacks Analyst Blog Highlights: Goldman Sachs Group, Morgan Stanley, Raymond James Financial and Stifel Financial ||| 2016 IPO Prospects: SecureWorks Is Ready To List ||| Is JPMorgan Chase Stock a Buy?",1,0.5203141
2016-04-11,3464300.0,151.17999267578125,153.89999389648438,150.41000366210938,152.1999969482422,141.90737915039062,GS,"Forget Goldman Sachs (GS), Buy these Financial Stocks Instead ||| How Has The Total Size Of M&A Deals Closed By Major U.S. Investment Banks Changed In The Last 5 Quarters?",1,0.5106317
2016-04-12,2732900.0,152.6699981689453,155.08999633789062,151.3000030517578,154.30999755859375,143.87464904785156,GS,Juniper Networks Earnings: Playing the Expectations Game ||| Q1 Earnings Trend Spells Trouble for Bank ETFs ||| Goldman (GS) Admits Facts Related to RMBS in $5.1B Accord ||| 3 Stocks That Could Really Use an Earnings Beat,1,0.51085186
2016-04-13,5151100.0,156.52999877929688,159.99000549316406,156.3800048828125,159.85000610351562,149.04006958007812,GS,"S&P 500, Dow ETFs Hit Fresh ’16 Highs On China Data, JPMorgan Results ||| Apple Inc.: Goldman Sachs Is Right About AAPL Stock … For the Wrong Reason ||| Will Wingstop Provide Tasty Returns? ||| Dow Movers: VZ, JPM ||| What Investors Can Learn From the Masters ||| The 3 Best Deals In The Dow (GS, JPM, IBM) ||| Dismal Earnings Outlook Projected for 1st Quarter ||| What's Behind JPMorgan (JPM) Q1 Earnings Results?",1,0.5087567
2016-04-14,3067100.0,159.52999877929688,162.27000427246094,159.14999389648438,160.91000366210938,150.0283660888672,GS,Stocks Turn Positive as Inflation Data Offsets Downbeat Banking Results ||| The Winner of the VR Wars Needs to Dominate This Key Vertical,0,0.5029899
2016-04-15,3467900.0,161.22999572753906,161.77999877929688,158.1999969482422,158.52000427246094,147.80001831054688,GS,"Dow 30 Stock Roundup: JPMorgan Beats, P&G Hikes Dividend, Boeing Secures $992.63M Army Contract ||| Stocks Paring Losses After New Data Puts June Interest Rate Increase in Question ||| Will Goldman (GS) Disappoint Q1 Earnings on Trading Slump? ||| Stock Market News for April 15, 2016 ||| Midday Update: Wall Street Paring Earlier Losses as Bearish Economic Data Dims Rate Increase Outlook ||| Another Day, Another Fine for Bank Stocks (GS)",1,0.48352343
2016-04-18,3031500.0,157.61000061035156,160.0,157.14999389648438,159.02000427246094,148.2661590576172,GS,"Goldman Sachs reports earnings April 19 ||| Entering the Heart of Q1 Earnings Season ||| How GS, CMA, NTRS, DFS will Perform this Earnings Season?",1,0.5006636
2016-04-19,5832200.0,157.75,163.6999969482422,157.0,162.64999389648438,151.65066528320312,GS,"Early Markets Shrug Off Housing Starts, Q1 Earnings ||| Key Morning Earnings for April 19: GS, HOG, JNJ, PM, UNH ||| The Zacks Analyst Blog Highlights: Goldman Sachs Group, Comerica Incorporated, Northern Trust and Discover Financial Services ||| Goldman (GS) Q1 Earnings Beat on Effective Cost Control ||| Goldman Sachs Group Inc (GS) Reports Q1 Earnings ||| Should You Buy Or Sell Bank of America (BAC) Stock? 3 Pros, 3 Cons ||| US Stocks Eye Higher Open Even as Housing Data Miss Views ||| Earnings Reaction History: Goldman Sachs Group Inc., 20.0% Follow-Through Indicator, 1.4% Sensitive ||| Midday Update: Stocks Drift Near Negative Turf as Techs Lag, S&P 500 Faces 2,100 Resistance ||| US Equities Futures Follow World Markets Higher as Oil Gains",1,0.48008183
2016-04-20,4802200.0,162.0,167.4499969482422,161.94000244140625,166.97999572753906,155.68788146972656,GS,"Goldman Sachs Group, Inc. (GSJ) Ex-Dividend Date Scheduled for April 21, 2016 ||| Goldman Sachs Group Non-Cumulative Preferred Stock, Series B Goes Ex-Dividend Soon ||| Here's Why Morgan Stanley (MS) Stock is a Strong Sell",0,0.4469717
2016-04-21,4165100.0,166.5500030517578,168.89999389648438,165.00999450683594,165.32000732421875,154.14013671875,GS,Lexmark Stock Soars Following Announcement of Its Buyout,1,0.5140945
2016-04-22,2680300.0,165.7899932861328,167.49000549316406,165.66000366210938,166.75,155.47341918945312,GS,3 Sky High Dividend Stocks to Buy Ahead of Earnings,0,0.5537954
2016-04-25,2473000.0,166.0,167.38999938964844,164.05999755859375,165.08999633789062,153.92567443847656,GS,"The Zacks Analyst Blog Highlights: Walt Disney, Goldman Sachs Group, Johnson & Johnson and International Business Machines",1,0.510637
2016-04-26,2251600.0,165.3800048828125,166.0,164.22000122070312,165.83999633789062,154.62498474121094,GS,"Morgan Stanley (MS) Ex-Dividend Date Scheduled for April 27, 2016 ||| JMP Group LLC (JMP) Ex-Dividend Date Scheduled for April 27, 2016",1,0.44704294
2016-04-27,3323600.0,165.8300018310547,168.66000366210938,164.92999267578125,166.9199981689453,155.63194274902344,GS,"Tupperware, Goldman Sachs and Apple highlighted as Zacks Bull and Bear of the Day",0,0.48217702
2016-04-28,2528000.0,165.35000610351562,167.32000732421875,164.00999450683594,164.2899932861328,153.17982482910156,GS,"Noteworthy ETF Inflows: DIA, GS, TRV, DIS ||| TD Ameritrade Holding Corporation (AMTD) Ex-Dividend Date Scheduled for April 29, 2016",0,0.44894245
2016-04-29,2890800.0,163.8000030517578,164.67999267578125,162.55999755859375,164.11000061035156,153.01197814941406,GS,"Notable Friday Option Activity: MET, GS, IMGN",1,0.5154375
2016-05-02,1998400.0,165.0800018310547,167.19000244140625,163.99000549316406,166.17999267578125,154.94198608398438,GS,Healthcare accountability goes public: Cotiviti files for an IPO that could raise $500 million ||| Goldman Eyes New Lending Strategy Amid Revenue Pressure,0,0.53160787
2016-05-03,2777000.0,163.66000366210938,164.11000061035156,161.3699951171875,163.13999938964844,152.1075439453125,GS,"Dow Movers: GS, PFE",0,0.5195635
2016-05-04,3203900.0,161.1999969482422,162.60000610351562,159.08999633789062,160.07000732421875,149.2451934814453,GS,"Stock Market News for May 04, 2016 ||| Goldman's $272M RMBS Settlement Receives Judge Approval",0,0.5135282
2016-05-05,2366200.0,160.77999877929688,160.82000732421875,158.5,159.52999877929688,148.74168395996094,GS,"Calamos Asset Management, Inc. (CLMS) Ex-Dividend Date Scheduled for May 06, 2016 ||| Ackman Defends Valeant From Buffett, Munger Criticism",0,0.4781128
2016-05-09,2097900.0,158.1999969482422,159.85000610351562,156.7899932861328,157.50999450683594,146.85830688476562,GS,"""Sheik""-Up in Saudi Oil Leadership ||| Credit Suisse Group (CS) Ex-Dividend Date Scheduled for May 10, 2016 ||| MarketAxess Holdings, Inc. (MKTX) Ex-Dividend Date Scheduled for May 10, 2016",1,0.43508086
2016-05-10,2379600.0,158.6699981689453,161.5,158.38999938964844,161.4199981689453,150.50389099121094,GS,"Dow Movers: PFE, BA ||| Oppenheimer Holdings, Inc. (OPY) Ex-Dividend Date Scheduled for May 11, 2016 ||| The Charles Schwab Corporation (SCHW) Ex-Dividend Date Scheduled for May 11, 2016",0,0.4263079
2016-05-11,2096900.0,161.36000061035156,162.52999877929688,159.27999877929688,159.4199981689453,148.63912963867188,GS,"BGC Partners, Inc. (BGCP) Ex-Dividend Date Scheduled for May 12, 2016",0,0.4574043
2016-05-12,2448100.0,160.32000732421875,161.47000122070312,157.30999755859375,158.07000732421875,147.3804473876953,GS,How The Parts Add Up: RYF Headed For $47 ||| Which Of The Latest 13F Filers Holds Goldman Sachs Group? ||| Goldman Faces Regulatory Probe Linked to Panama Papers,0,0.4915085
2016-05-16,3177700.0,155.33999633789062,156.89999389648438,154.60000610351562,155.3800048828125,144.87234497070312,GS,Vanguard Large-Cap ETF Experiences Big Inflow ||| Goldman Sees Oil Deficit: What This Means for Energy Players,0,0.50759774
2016-05-17,2701500.0,154.74000549316406,157.11000061035156,153.77000427246094,154.64999389648438,144.19171142578125,GS,"Institutional Financial Markets, Inc. (IFMI) Ex-Dividend Date Scheduled for May 18, 2016 ||| LPL Financial Holdings Inc. (LPLA) Ex-Dividend Date Scheduled for May 18, 2016 ||| Noteworthy Tuesday Option Activity: WBMD, GS, SCOR ||| LendingClub Corp (LC) Still Can’t Get Any Credit",1,0.4626778
2016-05-18,3653300.0,154.80999755859375,160.0,154.64999389648438,159.94000244140625,149.12399291992188,GS,"Close Update: Wall Street Bounces Back From FOMC Minutes ||| U.S. stocks Turn Positive as Gains in Financials Offsets Retail-Led Losses ||| U. S. Stocks Cover Early Losses As Banking Sector Outperforms Ahead of FOMC Minutes ||| Stocks Retreat on Hawkish FOMC Minutes ||| Dow Movers: WMT, JPM",0,0.495676
2016-05-19,4712000.0,158.67999267578125,159.9499969482422,154.52000427246094,154.6999969482422,144.23829650878906,GS,"Dow Movers: GS, WMT ||| Confused About Market Trend? Buy These Balanced Funds",0,0.49052316
2016-05-20,3247800.0,155.75999450683594,156.41000366210938,153.9199981689453,154.50999450683594,144.06118774414062,GS,Goldman Upgrade Of Tesla Motors Inc Sticks Out Like A Sore Thumb ||| What Are The Current Price-to-Book Ratios For The Largest U.S. Banks?,1,0.50550497
2016-05-23,2767600.0,154.44000244140625,156.08999633789062,153.74000549316406,155.4499969482422,144.93760681152344,GS,"Stock Market News for May 23, 2016 ||| Morgan Stanley to Shift 75 Shanghai Jobs to Cheaper Sites ||| Warren Buffett’s Worst Stocks of 2016 So Far ||| The Zacks Analyst Blog Highlights: Apple, Goldman Sachs Group, Berkshire Hathaway, Wal-Mart Stores and Cisco Systems",1,0.47613516
2016-05-24,3038800.0,156.6699981689453,158.5500030517578,156.44000244140625,157.58999633789062,146.9329071044922,GS,American Capital to Sell Operations; Moody's Upgrade Likely ||| Crude Heading Toward $50: Buy 5 Low-Levered Oil Stocks,1,0.5152086
2016-05-25,3259900.0,158.05999755859375,162.2899932861328,158.02999877929688,161.25,150.34536743164062,GS,"Midday Update: Wall Street Gains Fueled by Oil, Rally in Europe on Greek Deal ||| Noteworthy Wednesday Option Activity: BREW, TSLA, GS ||| JPMorgan Said to Cut 100 Staff to Condense its Private Bank ||| Dow Movers: NKE, GS ||| Stock Market News for May 25, 2016 ||| JMP Group LLC (JMP) Ex-Dividend Date Scheduled for May 26, 2016 ||| Goldman Eyes Private-Equity Firms; May Launch a New Fund",0,0.48648953
2016-05-26,2576100.0,161.16000366210938,161.3300018310547,159.1699981689453,159.22000122070312,148.45266723632812,GS,"Dow Movers: MSFT, WMT ||| BGC Partners, Inc. (BGCA) Ex-Dividend Date Scheduled for May 27, 2016 ||| Interactive Brokers Group, Inc. (IBKR) Ex-Dividend Date Scheduled for May 27, 2016",1,0.42956883
2016-05-27,2157000.0,158.6999969482422,160.39999389648438,158.32000732421875,159.52999877929688,149.3513946533203,GS,"IYF, USB, AIG, GS: ETF Inflow Alert ||| LendingClub in Discussion with Citigroup for Loan Financing ||| How Much Did The 5 Largest U.S. Investment Banks Make Through Equity Trading In Q1 2016?",0,0.5032165
2016-05-31,2916100.0,160.39999389648438,161.64999389648438,158.5500030517578,159.47999572753906,149.3046112060547,GS,"China's Markets Achieve ""Flash Crash"" Status ||| Two Ways to Tap Rising Oil Prices with ETFs ||| Dow Movers: DIS, CAT ||| Stock Market News for May 31, 2016 ||| Navient Corporation (NAVI) Ex-Dividend Date Scheduled for June 01, 2016 ||| Best 4 Inflation-Protected Bond Mutual Funds for Your Portfolio",1,0.48081207
2016-06-01,2581600.0,157.89999389648438,160.5500030517578,156.0,159.97000122070312,149.7633056640625,GS,"Dow Movers: GS, PG ||| The Zacks Analyst Blog Highlights: Goldman Sachs, ProShares Ultra Bloomberg Crude Oil ETF and VelocityShares 3x Long Crude Oil ETN ||| BlackRock, Inc. (BLK) Ex-Dividend Date Scheduled for June 02, 2016",0,0.4505002
2016-06-02,2257100.0,160.13999938964844,160.3300018310547,158.4600067138672,159.27999877929688,149.1173553466797,GS,"Commit To Buy Goldman Sachs Group At $85, Earn 2.2% Using Options ||| Goldman (GS) Lays off Executives in Investment Banking Unit ||| JPMorgan Expects Mid-Teens Increase in Q2 Trading Revenue",0,0.50993276
2016-06-03,4329300.0,155.86000061035156,156.5399932861328,153.86000061035156,155.6699981689453,145.7376708984375,GS,"Stocks React Negatively To Anemic Jobs Data ||| Dow Movers: GS, PG ||| The Zacks Analyst Blog Highlights: JinkoSolar Holding, Alibaba Group Holding, Goldman Sachs Group, JA Solar Holdings and JD.com ||| Greenhill & Co., Inc. (GHL) Ex-Dividend Date Scheduled for June 06, 2016 ||| Don't Blame Dodd-Frank for Weak Bank Profits",1,0.48447415
2016-06-06,2540400.0,156.25,157.91000366210938,155.77000427246094,157.05999755859375,147.0389862060547,GS,"Better Buy: Bank of America Corporation vs. Goldman Sachs Corporation ||| Stock Market News for June 06, 2016 ||| The AV Club goes public: PSAV sets terms for $250 million IPO ||| Financial Sector Update for 06/06/2016: CHMG,AMG,JGW",0,0.47679543
2016-06-07,2489700.0,157.1999969482422,157.47000122070312,155.1699981689453,155.1699981689453,145.26959228515625,GS,"iShares U.S. Financials ETF Experiences Big Inflow ||| Dow Movers: GS, AAPL ||| Morgan Stanley Solicits SEC Consent to Enter ETF Market ||| Nasdaq, Inc. (NDAQ) Ex-Dividend Date Scheduled for June 08, 2016 ||| CME Group Inc. (CME) Ex-Dividend Date Scheduled for June 08, 2016 ||| Affiliated Managers to Buy Minority Stake in 5 Hedge Funds ||| Rising Trading Activity Could Boost These Financial ETFs",0,0.4763641
2016-06-08,2426800.0,155.1999969482422,156.5800018310547,153.91000366210938,154.63999938964844,144.77342224121094,GS,F5 Networks (FFIV) Stock Up on Reports of Acquisition Offer ||| This Goldman Sachs Chart Shows Why Diversification Doesn't Work Anymore,0,0.48825017
2016-06-09,2711700.0,153.7899932861328,154.2899932861328,152.4600067138672,153.1699981689453,143.3971710205078,GS,"Raymond James Financial, Inc. (RJD) Ex-Dividend Date Scheduled for June 10, 2016 ||| Goldman (GS) Cuts Jobs in Russia on Lower Profits & Deals ||| How Do The Largest U.S. Banks Fare In Terms Of Meeting Core Capital Ratio Targets? ||| Associated Capital Group, Inc. (AC) Ex-Dividend Date Scheduled for June 10, 2016",0,0.48541328
2016-06-10,4335700.0,151.35000610351562,151.66000366210938,149.57000732421875,149.88999938964844,140.32644653320312,GS,"Microsoft Attracts Growth Mutual Funds, While Apple Is Shunned (MSFT, AAPL) ||| Dow Movers: GS, NKE ||| T. Rowe Price Group, Inc. (TROW) Ex-Dividend Date Scheduled for June 13, 2016",0,0.43942702
2016-06-13,3385800.0,149.0,151.32000732421875,148.58999633789062,148.6300048828125,139.1468505859375,GS,"Stock Market News for June 13, 2016 ||| Morgan Stanley (MWG) Ex-Dividend Date Scheduled for June 14, 2016 ||| Intercontinental Exchange Inc. (ICE) Ex-Dividend Date Scheduled for June 14, 2016",0,0.41689253
2016-06-14,5069600.0,148.22000122070312,149.0500030517578,145.4499969482422,146.19000244140625,136.862548828125,GS,"Goldman Sachs (GS) Expands Consumer Banking Business ||| Goldman's Tussle with Libyan Fund Escalates as Trial Begins ||| Morgan Stanley (MS): A Winner in Microsoft-LinkedIn Deal ||| Why Match Group Inc. Stock Jumped 11.5% Today ||| 3 Stocks to Watch Ahead of the Fed Meeting (BAC F GS) ||| Health Care Sector Update for 06/14/2016: ZBH,KKR,GS,AKAO,KMPH ||| Stock Market Today: Stocks Drip Lower as Fed Meeting Begins",0,0.5034175
2016-06-15,2981400.0,147.16000366210938,148.6999969482422,145.89999389648438,146.16000366210938,136.83445739746094,GS,Morgan Stanley Emphasizing on FICC & Wealth Management ||| Stock Market Today: Stocks Enter 5-Day Selloff After FOMC Meeting ||| Dow Analyst Moves: GS ||| Goldman Settles Mortgage Suit with Australian Hedge Fund,1,0.5145807
2016-06-16,3499200.0,145.0,146.99000549316406,143.52999877929688,146.6300048828125,137.27447509765625,GS,"What Investors Need to Know About the PSAV IPO ||| Stock Market Today: Stocks Rebound, But Volatility Remains",0,0.48220474
2016-06-17,4296500.0,146.6300048828125,148.22999572753906,145.4600067138672,145.63999938964844,136.34764099121094,GS,"Dow Movers: AAPL, CAT ||| Was Salesforce Eyeing LinkedIn Before Microsoft Scooped It? ||| The Only ETF You Need to Own for the Next Decade",1,0.49920568
2016-06-20,3338900.0,148.5,150.5,147.5800018310547,147.75,138.32302856445312,GS,"Dow Movers: VZ, GS ||| At Risk Sector ETFs in a Brexit Vote",1,0.50759065
2016-06-21,2424600.0,148.5,148.8300018310547,147.1199951171875,148.35000610351562,138.88473510742188,GS,BofA's Instinct Loans Aims to Transfer Leveraged Loans ||| Market Indexes Higher Monday ||| 2 Banks that Would Feel the Most Pain From a Brexit,0,0.50605124
2016-06-22,2487600.0,148.00999450683594,150.1199951171875,147.99000549316406,148.13999938964844,138.68812561035156,GS,The Dow's 3 Cheapest Stocks Based on the PEG Ratio,1,0.51009566
2016-06-23,2940500.0,150.55999755859375,152.8000030517578,150.13999938964844,152.66000366210938,142.91973876953125,GS,Good News for This Wall Street ETF? ||| BofA Nears Accord with SEC Over Client Accounts Case ||| Goldman (GS) Third Round Layoffs: 98 in New York,0,0.49106362
2016-06-24,9442200.0,143.02999877929688,146.4199981689453,140.9199981689453,141.86000061035156,132.8087921142578,GS,"Brexit Hammers Goldman Sachs Shares ||| 3 Banking Stocks Pummeled by the Brexit Vote ||| VV, USB, GS, AXP: Large Outflows Detected at ETF ||| Are U.S. Bank Stocks Fated for a Huge Fall Post Brexit? ||| Brexit Is Pummeling These 3 Stocks in Pre-Market ||| Dow 30 Stock Roundup: Boeing Nears $4B Deal, Coke Revises Q2 Guidance ||| Global Markets Plunge Following the Brexit Vote: Here's What You Need to Know ||| After Brexit, 2 Banks to Sell and 1 to Buy ||| What Happened in the Stock Market Today ||| What The Brexit-Fed Firestorm Means For Your Bank And Your Portfolio ||| Retailers Respond to Changing Digital Shopping Habits",0,0.49104485
2016-06-27,7381000.0,140.07000732421875,141.22999572753906,138.1999969482422,139.50999450683594,130.60873413085938,GS,"BofA's Merrill Lynch Agreed to a $415M Settlement with SEC ||| What Investors Need to Know About the LINE Corporation IPO ||| Financial Sector Update for 06/27/2016: JPM, BAC, WFC, C, USB, AV, GS ||| Apple Inc. (AAPL), Goldman Sachs Group Inc (GS) and Southern Co (SO): 3 Big Stock Charts for Monday ||| Morgan Stanley (MSK) Ex-Dividend Date Scheduled for June 28, 2016 ||| Morgan Stanley (MWO) Ex-Dividend Date Scheduled for June 28, 2016 ||| U.S. Banks Clear Stress Test: Financial ETFs in Focus ||| New Stock Research Reports for June 27, 2016",1,0.4873778
2016-06-28,5041500.0,142.2100067138672,142.6199951171875,139.82000732421875,142.41000366210938,133.32373046875,GS,"JMP Group LLC (JMPB) Ex-Dividend Date Scheduled for June 29, 2016 ||| The Zacks Analyst Blog Highlights: Morgan Stanley, Citigroup, Goldman Sachs Group, Bank of America and JPMorgan Chase ||| Stifel Financial Corporation (SFN) Ex-Dividend Date Scheduled for June 29, 2016 ||| Raymond James Financial, Inc. (RJF) Ex-Dividend Date Scheduled for June 29, 2016",1,0.47407183
2016-06-29,3804100.0,143.60000610351562,145.5500030517578,142.92999267578125,145.5,136.21656799316406,GS,"Moody's Negative Outlook on U.K. Banking System Post-Brexit ||| U.S. Economy Up 1% in Q1: Will Brexit Derail Growth? ||| The Interns Ask -- What Is a Financial Stock Anyway? ||| Financial Sector Update for 06/29/2016: GS,MS,NOAH,CM,PVTB",1,0.4927585
2016-06-30,4528600.0,146.6699981689453,148.8800048828125,145.3699951171875,148.5800018310547,139.10003662109375,GS,"Top 6 Research Reports for June 30, 2016",0,0.4921586
2016-07-01,3096800.0,148.49000549316406,150.6999969482422,148.07000732421875,148.25,138.7910919189453,GS,"Financial Sector Update for 07/01/2016: JPM, BAC, WFC, C, USB, GS, BCS, LYG ||| How Did Gold Gain 25% in the First Half of 2016?",0,0.5044185
2016-07-05,3943000.0,146.72000122070312,146.94000244140625,143.3300018310547,144.4499969482422,135.2335205078125,GS,"Buffett Seeks Fed Approval for Increased Stake in Wells Fargo ||| Dow 30 Stock Roundup: Nike Beats on Earnings, AmEx Raises Dividend ||| Building On Munger's 2-Track Analysis ||| Dow Movers: JPM, JNJ ||| 3 Stocks to Watch on Tuesday: Bank of America Corp (BAC), Netflix, Inc. (NFLX) and Illumina, Inc. (ILMN) ||| Technology Sector Update for 07/05/2016: CYBR,GS,HIMX,CRUS",1,0.49940082
2016-07-06,2941800.0,142.94000244140625,145.94000244140625,142.6199951171875,145.5800018310547,136.29144287109375,GS,"Waddell & Reed Financial, Inc. (WDR) Ex-Dividend Date Scheduled for July 07, 2016 ||| Passing the Stress Test is Worth Billions to These 3 Banks",1,0.4802172
2016-07-07,2578300.0,146.0,148.08999633789062,145.36000061035156,147.0,137.62088012695312,GS,"Dow Movers: VZ, INTC ||| Why This Lending Club Co-Founder Thinks the Market Is Wrong About Online Lenders",1,0.49457395
2016-07-08,3281400.0,149.36000061035156,150.9199981689453,148.30999755859375,150.3800048828125,140.78518676757812,GS,"Why Burlington Stores, Inc. Shares Jumped 11% Last Month ||| What Was The Total Size Of M&A Deals In Q2 For Major U.S. Investment Banks?",1,0.49406546
2016-07-12,5110800.0,154.0,157.25,153.9199981689453,156.9199981689453,146.9078826904297,GS,"Dow Jones ETF: 2 Ways to Buy the Dow ||| Dow Movers: KO, GS ||| Stock Market News for July 12, 2016 ||| Close Update: U.S. Stocks Touch New Record Highs as Risk-On Sentiment Emerges ||| U.S. Stocks Touch New Record Highs as Oil Prices Rally",1,0.49395245
2016-07-13,4276400.0,157.0,158.27000427246094,156.14999389648438,157.9199981689453,147.8441162109375,GS,Stop the Presses! ||| Leon Cooperman Buys Stake in Lionbridge Technologies ||| 4 Stocks That Will Benefit from a Weaker Yen,1,0.48707628
2016-07-14,5087700.0,160.2899932861328,163.24000549316406,160.00999450683594,162.5399932861328,152.1693572998047,GS,"Dow Movers: VZ, JPM ||| Apple Inc. (AAPL) Stock Will Stay Range-Bound Until iPhone 7’s Release ||| Early Read on the Q2 Earnings Season ||| Close Update: Financials Lead U.S. Stocks Higher as Benchmarks Continue Rally ||| Financials Lead U.S. Stocks Higher as Benchmarks Continue Rally ||| Financial Sector ETFs Lead Market After J.P. Morgan Earnings Beat",0,0.5114805
2016-07-15,3078400.0,162.86000061035156,163.13999938964844,160.6999969482422,161.63999938964844,151.32676696777344,GS,"Dow Movers: IBM, UNH ||| Zacks Earnings Trends Highlights: J.P. Morgan, Yum Brands, Alcoa and Goldman Sachs ||| What's in Store for Goldman (GS) this Earnings Season? ||| Reassuring Start to Q2 Earnings Season ||| How to Trade Goldman Sachs (GS) Ahead of Earnings",1,0.51208913
2016-07-18,4734500.0,162.36000061035156,164.08999633789062,162.00999450683594,163.3300018310547,152.90896606445312,GS,"Oil and Gas Stock Roundup: Deal News Drives Big Gains This Week (PAGP, KMI, WMB) ||| Goldman Sachs reports second-quarter results July 19 ||| Stock Market News for July 18, 2016 ||| Week Ahead: Why I'm Watching Oil, Not Earnings ||| Dow Movers: CAT, GS ||| Citigroup, Bank of America, Goldman Sachs, Wells Fargo and Apple are part of Zacks Earnings Preview: ||| Close Update: U.S. Stocks Push to New Highs as Earnings Season Heats Up ||| Earnings Preview: Morgan Stanley (MS) vs. Goldman Sachs (GS) ||| Pre-Market Earnings Report for July 19, 2016 : JNJ, PM, UNH, LMT, GS, PLD, NVS, ERIC, AMTD, GPC, GWW, RF ||| How to Trade Goldman Sachs (GS) Ahead of Earnings",0,0.4603226
2016-07-19,5399700.0,162.02000427246094,164.0800018310547,160.72999572753906,161.41000366210938,151.1114501953125,GS,"Stock Futures Mixed With Dow Taking The Lead on Upbeat Component Earnings ||| U.S. Market Indexes Reach New Highs ||| Goldman Sachs Group Inc (GS): Trading Gains, Cost Cuts Can’t Propel GS ||| Dow Movers: GS, JNJ ||| Market Rally Takes Breather Despite Q2 Earnings, June Housing Starts ||| Prudent Cost Management Drives Goldman (GS) Q2 Earnings ||| The Zacks Analyst Blog Highlights: Goldman Sachs Group, Interactive Brokers Group and TD Ameritrade Holding ||| Microsoft Corporation Earnings Preview: A Cloudy Outlook (MSFT) ||| Goldman Sachs Earnings: Strong Numbers Despite Challenging Environment ||| This Bull Market Still Has More Room to Advance ||| Stocks Mixed Into Close With Dow Holding Fragile Gain ||| Financial Sector Update for 07/19/2016: GS,MTG,GOV ||| Goldman Sachs (GS) Q2 Earnings Beat; Costs Falls",1,0.50059986
2016-07-20,3547800.0,162.5500030517578,162.88999938964844,159.22000122070312,161.77000427246094,151.44845581054688,GS,"How To Outperform Any Hedge Fund (Podcast With Ian Bezek) ||| Investment Firm Pimco Taps MAN's Roman to Take Helm as Outflows Reach 37th Straight Month ||| iShares S&P 100 ETF Experiences Big Outflow ||| Cash Dividend On The Way From Goldman Sachs Group Non-Cumulative Preferred Stock, Series B ||| Goldman Sachs Group, Inc. (GSJ) Ex-Dividend Date Scheduled for July 21, 2016",0,0.48935768
2016-07-21,2855500.0,161.7100067138672,161.89999389648438,159.77000427246094,160.0500030517578,149.83822631835938,GS,Facebook Inc (FB) Earnings Preview: Pricing May Drive Upside,1,0.50117284
2016-07-22,1811700.0,160.2899932861328,160.72999572753906,159.86000061035156,160.41000366210938,150.17527770996094,GS,"Tale Of 2 Chip Makers: Intel Corporation vs Qualcomm, Inc. (INTC, QCOM)",1,0.5089516
2016-07-25,1956100.0,159.63999938964844,161.3300018310547,159.61000061035156,160.50999450683594,150.26890563964844,GS,"12 Reasons to Hate Bank Stocks ||| Amazon.com, Inc. Price Target Upped Ahead Of Earnings (AMZN) ||| Bear of the Day: Interactive Brokers Group (IBKR)",1,0.50490916
2016-07-26,2150100.0,160.67999267578125,161.5,159.4199981689453,161.16000366210938,150.87741088867188,GS,"Morgan Stanley (MS) Ex-Dividend Date Scheduled for July 27, 2016 ||| FBR & Co (FBRC) Ex-Dividend Date Scheduled for July 27, 2016 ||| JMP Group LLC (JMP) Ex-Dividend Date Scheduled for July 27, 2016",0,0.4335723
2016-07-27,2317200.0,161.1999969482422,162.1699981689453,160.41000366210938,160.99000549316406,150.71824645996094,GS,4 Financial Mutual Funds to Buy On 4-Week Market Rally,0,0.5455971
2016-07-28,2047400.0,160.17999267578125,160.9600067138672,158.83999633789062,160.52999877929688,150.28761291503906,GS,"As Fed Leaves Rates Unchanged, Big Bank ETFs Celebrate",0,0.50531805
2016-07-29,2388200.0,159.50999450683594,160.19000244140625,158.64999389648438,158.80999755859375,148.67735290527344,GS,"3 Big Stock Charts for Friday: CVS Health Corp (CVS), Goldman Sachs Group Inc (GS) and Microsoft Corporation (MSFT) ||| NEE Stock: NextEra Energy Inc Pays $18B for North Texas Electricity Market",0,0.515167
2016-08-01,2316300.0,158.80999755859375,159.9199981689453,157.92999267578125,158.17999267578125,148.0875244140625,GS,"Everything You Need to Know About How America’s Biggest Banks Are Faring in Q2 2016 ||| Dodge & Cox Comments on Goldman Sachs ||| TD Ameritrade Holding Corporation (AMTD) Ex-Dividend Date Scheduled for August 02, 2016",0,0.46432582
2016-08-02,3182800.0,157.64999389648438,158.4600067138672,155.3699951171875,156.05999755859375,146.10279846191406,GS,Is Goldman Sachs Right on Crude?,1,0.5158505
2016-08-03,2284700.0,156.4499969482422,158.9499969482422,156.17999267578125,158.33999633789062,148.2373046875,GS,"Dow Movers: PFE, DIS ||| Goldman Sachs (GS) to Pay $36.3 Million for Using Confidential Data ||| Close Update: Stocks Gain With Dow Halting Seven-Day Slide as Oil Prices Rally ||| 7 Big Banks at Risk During the Oil Selloff",0,0.4901274
2016-08-04,2005700.0,158.22000122070312,158.89999389648438,157.41000366210938,158.0500030517578,147.9658660888672,GS,"Calamos Asset Management, Inc. (CLMS) Ex-Dividend Date Scheduled for August 05, 2016",1,0.4591723
2016-08-08,2266600.0,162.10000610351562,163.97999572753906,162.00999450683594,162.8300018310547,152.44082641601562,GS,"Gen Y Fact or Fiction: Are Millennials Really … Bad With Money? ||| U.S. Market Indexes Higher After Positive Jobs Report ||| Stock Market News for August 08, 2016 ||| MarketAxess Holdings, Inc. (MKTX) Ex-Dividend Date Scheduled for August 09, 2016",1,0.47425422
2016-08-09,1957400.0,162.5,164.5800018310547,162.5,163.44000244140625,153.01193237304688,GS,"U.S. Steel Corp. To Tap Into Equity Market, Capitalize on Share Price Tripling In 2016 With Public Offering Worth $439 Million ||| Dow Movers: MRK, GS ||| The Charles Schwab Corporation (SCHW) Ex-Dividend Date Scheduled for August 10, 2016 ||| Oppenheimer Holdings, Inc. (OPY) Ex-Dividend Date Scheduled for August 10, 2016",0,0.4686626
2016-08-10,1656100.0,163.4499969482422,163.60000610351562,162.00999450683594,162.19000244140625,151.84169006347656,GS,Here’s Why Whiting Petroleum Corp’s Stock Crashed 23.7% in July,1,0.52520996
2016-08-12,1440800.0,162.6699981689453,163.3699951171875,162.07000732421875,163.25,152.8340606689453,GS,"Dow Movers: MSFT, XOM ||| See Which Of The Latest 13F Filers Holds Goldman Sachs ||| How Have Total M&A Deals Closed By Major U.S. Investment Banks Trended In The Last 5 Quarters?",1,0.51514465
2016-08-15,2222200.0,163.8699951171875,165.83999633789062,163.8000030517578,165.5500030517578,154.9873046875,GS,"BGC Partners, Inc. (BGCP) Ex-Dividend Date Scheduled for August 16, 2016 ||| Institutional Financial Markets, Inc. (IFMI) Ex-Dividend Date Scheduled for August 16, 2016 ||| How Much In M&A Advisory Fees Did The 5 Largest U.S. Investment Banks Generate In Q2?",1,0.4682617
2016-08-16,2523800.0,164.99000549316406,166.75999450683594,164.72000122070312,165.64999389648438,155.08090209960938,GS,"Noteworthy ETF Outflows: PRF, AIG, GS, MET ||| Stocks Gain with Positive Outlook",1,0.5069535
2016-08-17,2061700.0,165.94000244140625,166.32000732421875,164.74000549316406,165.6699981689453,155.09962463378906,GS,"3 Big Bank Stocks That Are Ready to Pop ||| How Have Equity Underwriting Deals Closed By U.S. Investment Banks Trended In The Last 5 Quarters? ||| Investment Technology Group, Inc. (ITG) Ex-Dividend Date Scheduled for August 18, 2016",1,0.4936094
2016-08-18,1750500.0,165.33999633789062,166.55999755859375,164.6300048828125,166.05999755859375,155.4647674560547,GS,"Financial Stocks Paint a Murky Picture: GS, MS, SCHW ||| How Have Equity Underwriting Fees For The Largest U.S. Investment Banks Changed In The Last 5 Quarters? ||| How Much In Equity Underwriting Fees Did The 5 Largest U.S. Investment Banks Generate In Q1 2016?",1,0.49826953
2016-08-22,1448100.0,166.0,166.91000366210938,164.88999938964844,166.25999450683594,155.6520233154297,GS,"Financial Sector Update for 08/22/2016: CIFC,DB,GS,KNSL,JRJC",0,0.4892912
2016-08-23,1965500.0,167.0,167.85000610351562,165.97999572753906,166.0800018310547,155.48350524902344,GS,Morgan Stanley Doubtful Over OPEC Production Cut: 4 Picks ||| Apple Inc. Not Very Optimistic About iPhone 7 (AAPL),0,0.49582523
2016-08-24,2035300.0,165.77999877929688,166.6999969482422,164.85000610351562,165.3000030517578,154.75326538085938,GS,Goldman to Cut More Investment Banking Jobs in New York,1,0.5329067
2016-08-25,1441400.0,165.0800018310547,166.0399932861328,164.61000061035156,165.89999389648438,155.31497192382812,GS,"3 Big Stock Charts: Mylan NV (MYL), GoPro Inc (GPRO) and Goldman Sachs Group Inc (GS) ||| Morgan Stanley Fined $2.4M on Internal Control Failures",1,0.515214
2016-08-26,2402200.0,166.75999450683594,168.07000732421875,165.36000061035156,165.97000122070312,155.38047790527344,GS,"JMP Group LLC (JMP) Ex-Dividend Date Scheduled for August 29, 2016",1,0.46339116
2016-08-29,2620900.0,166.60000610351562,167.86000061035156,166.14999389648438,166.8699951171875,156.2230682373047,GS,"Noteworthy ETF Outflows: DIA, GS, UNH, BA ||| Interactive Brokers Group, Inc. (IBKR) Ex-Dividend Date Scheduled for August 30, 2016 ||| Virtu Financial, Inc. (VIRT) Ex-Dividend Date Scheduled for August 30, 2016 ||| BGC Partners, Inc. (BGCA) Ex-Dividend Date Scheduled for August 30, 2016 ||| Goldman Sachs Group, Inc. (GS) Ex-Dividend Date Scheduled for August 30, 2016 ||| What Are The Current Price-to-Book Ratios For The Largest U.S. Banks?",1,0.44098264
2016-08-30,2934100.0,166.22000122070312,169.50999450683594,166.22000122070312,169.3699951171875,159.18359375,GS,"Dow Movers: BA, GS ||| BlackRock, Inc. (BLK) Ex-Dividend Date Scheduled for August 31, 2016 ||| CBOE Holdings, Inc. (CBOE) Ex-Dividend Date Scheduled for August 31, 2016 ||| Navient Corporation (NAVI) Ex-Dividend Date Scheduled for August 31, 2016 ||| $1 Billion Says Microsoft Corporation Has Run Its Course (MSFT) ||| How Did The Largest U.S. Banks Fare In Terms Of Meeting Core Capital Ratio Targets At The End Of Q2 2016?",1,0.46886173
2016-08-31,3688200.0,169.25,170.24000549316406,167.47000122070312,169.4600067138672,159.2681884765625,GS,Dow Analyst Moves: GS,0,0.512465
2016-09-01,2843300.0,170.0,170.07000732421875,166.66000366210938,168.50999450683594,158.37533569335938,GS,"Agree To Purchase Goldman Sachs Group At $80, Earn 1.8% Using Options ||| How Goldman Sachs Group Inc Ranks Among Analysts’ Top Picks (GS) ||| How Have Advisory & Underwriting Fees For The Largest U.S. Investment Banks Changed In The Last Five Quarters?",1,0.52198863
2016-09-06,2034900.0,168.72000122070312,169.7899932861328,167.47000122070312,169.3300018310547,159.14605712890625,GS,"DIA, MMM, GS, UNH: ETF Inflow Alert ||| CME Group Inc. (CME) Ex-Dividend Date Scheduled for September 07, 2016 ||| Volatile September Likely After August Losses",1,0.4892307
2016-09-07,1584300.0,168.6999969482422,170.2100067138672,168.64999389648438,169.6699981689453,159.465576171875,GS,"Why Sprouts Farmers Market Inc. Stock Tumbled Wednesday ||| Noteworthy Wednesday Option Activity: FRAN, CELG, GS",1,0.4958489
2016-09-08,3031600.0,169.35000610351562,171.8800048828125,168.7100067138672,171.66000366210938,161.3359375,GS,Stocks Lower Despite Crude Bounce ||| 3 Wall Street Titans That Are Ready to Rock,0,0.4824014
2016-09-09,3411800.0,170.8300018310547,172.4199981689453,168.50999450683594,168.57000732421875,158.4317626953125,GS,"Dow Movers: BA, JPM ||| Raymond James Financial, Inc. (RJD) Ex-Dividend Date Scheduled for September 12, 2016",1,0.4589269
2016-09-12,2647900.0,167.00999450683594,171.6699981689453,166.22999572753906,171.05999755859375,160.77200317382812,GS,"Will Lexmark Buyout be Followed by its Software Unit Sale? ||| Dow Movers: AXP, WMT ||| Forget the S&P 500, Buy These 3 High Growth Healthcare Stocks Instead ||| Deutsche Bank (DB) Nearing $2.4B Pact to Settle RMBS Case ||| 5 Stocks Ready to Climb This Fall",0,0.49128798
2016-09-13,2788200.0,168.5399932861328,169.97000122070312,166.3800048828125,167.0,156.95614624023438,GS,"US Market Indexes Lower on Tuesday ||| Intercontinental Exchange Inc. (ICE) Ex-Dividend Date Scheduled for September 14, 2016 ||| Nasdaq, Inc. (NDAQ) Ex-Dividend Date Scheduled for September 14, 2016",0,0.42153415
2016-09-14,1995900.0,167.0,167.86000061035156,165.58999633789062,166.16000366210938,156.16668701171875,GS,Facebook Inc Is a Goldman Sachs “Focus” Stock (FB),1,0.5020226
2016-09-15,1645200.0,165.77999877929688,168.75999450683594,165.75999450683594,168.0800018310547,157.97122192382812,GS,"Noteworthy Thursday Option Activity: APOG, GS, HZO",0,0.51813596
2016-09-16,4534900.0,167.85000610351562,168.0500030517578,165.61000061035156,166.0,156.0163116455078,GS,3 Top Bank Stocks to Add to Your Portfolio ||| Deutsche Bank (DB) Shares Crumble on DoJ's $14B Claim ||| Here Are the 3 Bank Stocks on the Dow Jones Industrial Average,1,0.508907
2016-09-19,2030700.0,167.33999633789062,168.30999755859375,165.67999267578125,166.2100067138672,156.21368408203125,GS,"Stock Market News for September 19, 2016",1,0.48362797
2016-09-21,2333600.0,167.4199981689453,168.27999877929688,165.92999267578125,167.02999877929688,156.98440551757812,GS,"The Zacks Analyst Blog Highlights: Abbott Labs, Comcast, Goldman Sachs, Microsoft and Philip Morris ||| Here is Why Shares of Equinix (EQIX) Tumbled on Tuesday ||| 4 Gold Stocks to Buy with Prices Set to Surge",1,0.4941414
2016-09-22,2467700.0,168.4499969482422,169.3300018310547,167.6999969482422,168.02000427246094,157.9148406982422,GS,"4 Things Frontier Communications CEO Wants Investors to Know ||| Dow Movers: V, UTX",0,0.52678627
2016-09-23,3421200.0,167.75,168.10000610351562,165.0500030517578,165.1300048828125,155.19863891601562,GS,"DIA, GS, UNH, BA: ETF Inflow Alert ||| Market Close Report: NASDAQ Composite index closes at 5,305.75 down -33.77 points ||| 5 Most Shocking Congressional Testimonies by CEOs",0,0.48121595
2016-09-26,2772200.0,163.8300018310547,163.97000122070312,161.0,161.47999572753906,151.76815795898438,GS,"Dow Movers: PFE, AAPL ||| Market Close Report: NASDAQ Composite index closes at 5,257.49 down -48.26 points ||| Stocks Retreat as Election Debate Anticipation Weighs, Financials Lose Ground ||| Goldman to Trim 30% Investment Banking Staff in Asia",1,0.5270035
2016-09-27,2602700.0,160.72000122070312,163.4499969482422,159.82000732421875,162.88999938964844,153.09336853027344,GS,"Stock Market News for September 27, 2016 ||| JMP Group LLC (JMP) Ex-Dividend Date Scheduled for September 28, 2016 ||| JMP Group LLC (JMPB) Ex-Dividend Date Scheduled for September 28, 2016 ||| JMP Group LLC (JMPC) Ex-Dividend Date Scheduled for September 28, 2016 ||| Avoid Wells Fargo & Co (WFC) Stock and Sleep Better at Night ||| Federal Reserve Plans to Curb Banks' Commodity Holdings",1,0.43938076
2016-09-28,1678100.0,163.33999633789062,163.7899932861328,161.67999267578125,163.4499969482422,153.61964416503906,GS,"Raymond James Financial, Inc. (RJF) Ex-Dividend Date Scheduled for September 29, 2016 ||| 3 Big Moves That Warren Buffett Could Make Next",0,0.48023483
2016-09-29,3733800.0,163.3800048828125,163.9600067138672,157.77000427246094,158.9499969482422,149.39031982421875,GS,"Deutsche Bank's Losses Affecting the Market on Thursday ||| Market Close Report: NASDAQ Composite index closes at 5,269.15 down -49.40 points ||| Notable Two Hundred Day Moving Average Cross - GS ||| Thursday Sector Laggards: Healthcare, Financial",1,0.4888037
2016-09-30,4497200.0,159.9499969482422,162.41000366210938,157.8000030517578,161.27000427246094,151.57078552246094,GS,"Goldman Sachs Group Inc (GS): Are We Entering the Next Recession? ||| Dow Movers: GS, WMT ||| Stock Market News for September 30, 2016 ||| Analysts Anticipate 10% Gains Ahead For VIXH",0,0.481748
2016-10-03,2444700.0,160.5,161.72000122070312,160.25,161.07000732421875,151.38284301757812,GS,"Stock Market News for October 03, 2016 ||| Lexmark's Buyout by Chinese Consortium Gets CFIUS Approval ||| How Did Major U.S. Investment Banks Fare In The Global Debt Origination Industry Over Q3?",1,0.5218959
2016-10-04,2469900.0,161.24000549316406,164.14999389648438,161.22999572753906,162.27000427246094,152.51065063476562,GS,"Dow Movers: MMM, AAPL ||| Market Close Report: NASDAQ Composite index closes at 5,289.66 down -11.21 points ||| How Have Debt Origination Deal Volumes For U.S. Investment Banks Changed In The Last 5 Quarters?",1,0.5359477
2016-10-05,2548200.0,163.32000732421875,166.57000732421875,163.00999450683594,166.39999389648438,156.3922576904297,GS,"5 Best Value Stocks for a Tricky October ||| Waddell & Reed Financial, Inc. (WDR) Ex-Dividend Date Scheduled for October 06, 2016 ||| Market Close Report: NASDAQ Composite index closes at 5,316.02 up 26.36 points ||| What Was The Share Of Major U.S. Investment Banks In The Global M&A Industry For Q3?",1,0.5246469
2016-10-06,2858000.0,167.17999267578125,167.2899932861328,164.82000732421875,167.14999389648438,157.09715270996094,GS,"Wall Street Titan Goldman Sachs Voices Its Opinion on Oil: What You Need to Know ||| Stock Market News for October 06, 2016 ||| Goldman, JPM, Glencore Aluminum Price-Fixing Suit Tossed ||| How Have Total M&A Deals Closed By Major U.S. Investment Banks Trended In The Last 5 Quarters? ||| Warren Buffett's 2 Worst Stocks of 2016 So Far",1,0.48050448
2016-10-07,3390200.0,167.5,169.97999572753906,166.24000549316406,169.8300018310547,159.615966796875,GS,"3 Stocks to Watch on Friday: Gap Inc (GPS), Honeywell International Inc (HON) and Ruby Tuesday, Inc. (RT) ||| Market Close Report: NASDAQ Composite index closes at 5,292.41 down -14.44 points",1,0.5060999
2016-10-10,2532000.0,170.52000427246094,171.75,170.10000610351562,171.0399932861328,160.753173828125,GS,Deutsche Bank Explores Capital-Raising Options with Banks,0,0.5076219
2016-10-11,2680000.0,169.83999633789062,170.8699951171875,167.91000366210938,169.0399932861328,158.8734893798828,GS,"Notable ETF Outflow Detected - DIA, GS, UNH, TRV ||| Trade of the Day: Global X Lithium ETF (NYSEARCA:LIT) ||| 3 Deeply Discounted Value Stocks on Sale This Fall",1,0.4872715
2016-10-12,2404000.0,169.0399932861328,169.99000549316406,168.3000030517578,169.3000030517578,159.11782836914062,GS,"Company News for October 12, 2016",0,0.4929035
2016-10-13,2713700.0,167.60000610351562,167.6300048828125,165.50999450683594,167.4199981689453,157.35092163085938,GS,"Dow Movers: GS, MRK ||| Will BofA (BAC) Stock Continue to Rise Post Q3 Earnings?",1,0.5129003
2016-10-14,5282300.0,171.60000610351562,172.9499969482422,169.11000061035156,170.52000427246094,160.2644805908203,GS,"Dow Movers: MCD, GS ||| Market Close Report: NASDAQ Composite index closes at 5,214.16 up .83 points ||| Bank Earnings Help Stocks on Friday ||| Reassuring Start to Q3 Earnings Season ||| Stock Market News for October 14, 2016 ||| Close Update: Dow Leads U.S. Stocks Just Higher as Financials Gain",0,0.48293906
2016-10-17,3061400.0,170.5,171.27000427246094,168.4499969482422,169.0,158.8358917236328,GS,"Earnings Results For Banks Look More Mixed Than Is Obvious ||| 3 Investment Managers' Q3 Earnings Preview: BLK, IBKR, GS ||| Goldman Sachs Earnings Preview: Improved Security Valuation, Strong Investment Banking Fees To Drive Q3 Profits ||| Will Goldman (GS) Stock Continue to Rise Post Q3 Earnings?",1,0.50749546
2016-10-18,4482500.0,172.00999450683594,173.47000122070312,171.10000610351562,172.6300048828125,162.24757385253906,GS,"Go Long Alphabet Inc (GOOG, GOOGL) Stock For the Best Price — Free ||| The Sony Corp (ADR) (SNE) Comeback Looks Real ||| Stock ETFs Rise As Investors Cheer Slew Of Upbeat Earnings ||| Twitter Inc May Have Found Its Saving Grace (TWTR) ||| Dow Movers: IBM, UNH ||| Big Q3 Earnings Checklist, Plus Latest CPI ||| Goldman Sachs Group Inc (GS) Stock Looks a Heckuva Lot Brighter ||| 3 Leaders In A Booming $182 Billion Market (GPRO, AMD, NVDA) ||| Close Update: Wall Street Heads Higher as Earnings Bolster Stocks ||| Wall Street Set for Higher Close as Earnings Bolster Stocks ||| Goldman (GS) Q3 Earnings Soar as Trading Revenues Surge",1,0.49881533
2016-10-19,3676000.0,173.3699951171875,175.67999267578125,173.17999267578125,174.50999450683594,164.01451110839844,GS,"Dow Movers: INTC, GS ||| XLF, JPM, GS, AIG: ETF Inflow Alert ||| Stock Market News for October 19, 2016 ||| Is the Earnings Improvement for Real? ||| Is the Earnings Improvement for Real? ||| Is This a New Era for Morgan Stanley (MS) Stock?",0,0.48156083
2016-10-20,2471100.0,174.0,175.7899932861328,173.8000030517578,174.50999450683594,164.01451110839844,GS,"Stock Market News for October 20, 2016 ||| Zacks Earnings Trends Highlights: J.P. Morgan, Citigroup, Bank of America and Goldman Sachs ||| Earnings Quality Signaling Good Things For Stocks ||| Ocwen Financial: Detailed History, Valuation, And The Road To Profitability",1,0.48941904
2016-10-21,2004400.0,172.83999633789062,174.89999389648438,172.50999450683594,174.6699981689453,164.1648712158203,GS,The 3 Best Female-Led Stocks to Buy Now,1,0.5427713
2016-10-24,1943200.0,175.5,175.7899932861328,174.35000610351562,175.1199951171875,164.58778381347656,GS,"Stock Market News for October 24, 2016 ||| The Zacks Analyst Blog Highlights: Abbott, Goldman Sachs, Verizon and Union Pacific ||| Tom Steyer's Investment Style: How This Hedge Fund Investor Became a Billionaire ||| Bank Stocks Are Better Off If Hillary Clinton Beats Donald Trump",1,0.4714041
2016-10-25,2423300.0,175.0399932861328,175.9600067138672,174.63999938964844,175.5500030517578,164.99195861816406,GS,"Goldman Sachs Group's Preferred Stock, Series C Crosses Above 4.5% Yield Territory",1,0.50667727
2016-10-26,2533800.0,174.7899932861328,177.89999389648438,173.92999267578125,177.07000732421875,166.4205322265625,GS,Q3 Earnings Season: Best Growth in 6 Quarters ||| Q3 Earnings Season: Best Growth in 6 Quarters,1,0.5364471
2016-10-27,3021900.0,178.19000244140625,178.85000610351562,176.57000732421875,177.75,167.0596160888672,GS,"Zacks Earnings Trends Highlights: J.P. Morgan, Citigroup, Bank of America and Goldman Sachs",0,0.5007836
2016-10-28,2042800.0,178.50999450683594,178.50999450683594,175.4600067138672,177.13999938964844,166.48631286621094,GS,"DIA, GS, TRV, AXP: ETF Inflow Alert ||| Semiconductor Stocks Earnings on Oct 31: AMKR, IDTI & MPWR",1,0.5083726
2016-11-01,2900600.0,179.0,179.17999267578125,176.61000061035156,178.05999755859375,167.3509979248047,GS,"Notable Tuesday Option Activity: GS, EVC, O",0,0.5082494
2016-11-02,2104800.0,177.07000732421875,177.5,176.07000732421875,176.5800018310547,165.95997619628906,GS,How Much In M&A Advisory Fees Did The 5 Largest U.S. Investment Banks Generate In Q3?,0,0.51653415
2016-11-03,1972700.0,176.77000427246094,177.97000122070312,176.2100067138672,176.2100067138672,165.6122589111328,GS,"Will First Solar, Inc. (FSLR) Stock Ever Really Bounce Back? ||| Calamos Asset Management, Inc. (CLMS) Ex-Dividend Date Scheduled for November 04, 2016 ||| TD Ameritrade Holding Corporation (AMTD) Ex-Dividend Date Scheduled for November 04, 2016 ||| How Much In Total Investment Banking Fees Did The Largest U.S. Investment Banks Earn In Q3? ||| How Much In Equity Underwriting Fees Did The 5 Largest U.S. Investment Banks Generate In Q3 2016?",0,0.46256799
2016-11-07,3338800.0,179.0,181.5,179.0,181.47999572753903,170.5653076171875,GS,"Here's How You Know the Coal Industry Is All but Dead ||| Dow Movers: VZ, MSFT ||| Oppenheimer Holdings, Inc. (OPY) Ex-Dividend Date Scheduled for November 08, 2016 ||| Goldman in Hot Water? Libyan Fund May Appeal Ruling",1,0.48121005
2016-11-08,2646200.0,180.11000061035156,182.67999267578125,178.4600067138672,181.9199981689453,170.97882080078125,GS,"Notable ETF Inflow Detected - IYG, WFC, USB, GS ||| Stock ETFs Post Gains On Election Day; TIPS See Record Inflow ||| Dow Movers: GS, NKE ||| Grab Some Clinton Cash With Goldman Sachs (GS) Stock ||| FBR & Co (FBRC) Ex-Dividend Date Scheduled for November 09, 2016 ||| The Charles Schwab Corporation (SCHW) Ex-Dividend Date Scheduled for November 09, 2016",1,0.5024382
2016-11-09,7823800.0,185.0,193.5399932861328,183.4499969482422,192.6300048828125,181.04473876953125,GS,How a Donald Trump Presidency Could Affect Bank Stocks,1,0.50709236
2016-11-10,11345400.0,194.52999877929688,204.6699981689453,194.0,200.8699951171875,188.7891082763672,GS,Why You Should Bet on Raymond James' (RJF) Growth Potential ||| 3 Reasons Why President Trump Sounds Good to Banks ||| How Much In Total Trading Revenues Did The 5 Largest U.S. Investment Banks Make In Q3?,1,0.5062167
2016-11-11,6290200.0,198.25,205.0,198.25,203.94000244140625,191.67446899414065,GS,"Institutional Financial Markets, Inc. (IFMI) Ex-Dividend Date Scheduled for November 14, 2016 ||| LPL Financial Holdings Inc. (LPLA) Ex-Dividend Date Scheduled for November 14, 2016 ||| Goldman (GS) to Shift to Frankfurt, Retain Passporting Right ||| Consumer Sector Update for 11/11/2016: LOCK,GS,VDTH,DISH,DDS ||| Goldman Sachs Group's Preferred Stock, Series A Shares Cross 4.5% Yield Mark",1,0.506125
2016-11-14,8248100.0,204.1499938964844,211.7700042724609,204.1499938964844,209.17999267578125,196.5993194580078,GS,"How Will a Trump Presidency Affect Solar Stocks? ||| How Do The Largest U.S. Banks Stack Up In Terms Of Their Core Capital Ratio? ||| Better Buy: Bank of America Corporation vs. Goldman Sachs ||| Stock Market News for November 14, 2016 ||| Which Of The Latest 13F Filers Holds Goldman Sachs? ||| Dow Movers: AAPL, JPM",1,0.4768925
2016-11-15,4893800.0,206.5599975585937,211.1999969482422,205.1699981689453,211.19000244140625,198.4884796142578,GS,"The Zacks Analyst Blog Highlights: UnitedHealth Group, Merck, JPMorgan Chase, Goldman Sachs Group and Cisco Systems ||| P/B Ratios For Largest U.S. Banks Soar In Response To Trump's Victory ||| P/B Ratios For Largest U.S. Banks Soar In Response To Trump's Victory",0,0.5032857
2016-11-16,5276200.0,207.3500061035156,208.0800018310547,204.8300018310547,206.259994506836,193.85494995117188,GS,"Is Symantec (SYMC) Mulling Over the Buyout of LifeLock? ||| Dow Movers: GS, VZ ||| Dow Analyst Moves: GS ||| iShares U.S. Financials ETF Experiences Big Inflow ||| Close Update: Wall Street Ends Mostly Lower as Dow Snaps Winning Streak",1,0.48473832
2016-11-17,3572400.0,206.259994506836,209.69000244140625,205.6699981689453,209.6300048828125,197.02227783203125,GS,"Stock Market News for November 17, 2016 ||| Close Update: Stocks Regain Upward Momentum as Dec Rate Hike Buoys Banking Sector",1,0.49340585
2016-11-18,4278200.0,209.8699951171875,212.07000732421875,209.72000122070312,210.3500061035156,197.698974609375,GS,"5 Overhyped Dividend Stocks You Must Avoid Now ||| BGC Partners, Inc. (BGCP) Ex-Dividend Date Scheduled for November 21, 2016",1,0.5091513
2016-11-21,2860200.0,211.4600067138672,211.69000244140625,209.17999267578125,211.0800018310547,198.38511657714844,GS,WisdomTree Invests $20M in AdvisorEngine to Expedite B2B ||| 4 Asian Stocks to Buy on Encouraging Economic Data ||| Symantec Confirms Buying ID Protector LifeLock for $2.3B,1,0.5245047
2016-11-22,2945700.0,211.3600006103516,211.9499969482422,209.88999938964844,211.1100006103516,198.4132537841797,GS,Here’s Why Steel and Metals Stocks Were Red Hot Tuesday,1,0.51397264
2016-11-23,3717400.0,211.5,213.4100036621093,209.3699951171875,212.3099975585937,199.5411071777344,GS,Ireland Hesitant to be Center of Risky Trading Post Brexit,0,0.49952793
2016-11-25,1974000.0,211.3600006103516,212.75,211.0,211.3800048828125,198.6670379638672,GS,"Investment Technology Group, Inc. (ITG) Ex-Dividend Date Scheduled for November 25, 2016 ||| Will Goldman Sachs Group (GS) Continue to Surge Higher? ||| JMP Group LLC (JMP) Ex-Dividend Date Scheduled for November 28, 2016",0,0.41933754
2016-11-28,3297400.0,210.0,211.759994506836,209.6000061035156,210.3500061035156,197.698974609375,GS,"SPDR Dow Jones Industrial Average ETF Experiences Big Inflow ||| Stock Market News for November 28, 2016",1,0.49424437
2016-11-29,2577600.0,209.9900054931641,212.9199981689453,209.9199981689453,211.75,199.63165283203125,GS,"E*TRADE Financial Poised for Growth, Peer Pressure Lingers ||| Navient Corporation (NAVI) Ex-Dividend Date Scheduled for November 30, 2016 ||| Will Goldman Sachs (GS) Crush Estimates at Its Next Earnings Report? ||| 6 Reasons to Add Goldman Sachs (GS) to Your Portfolio Now ||| CBOE Holdings, Inc. (CBOE) Ex-Dividend Date Scheduled for November 30, 2016",1,0.4735397
2016-11-30,6507900.0,215.1999969482422,220.7700042724609,214.97000122070312,219.2899932861328,206.74012756347656,GS,"Financial Sector Update for 11/30/2016: FBP,FSAM,GS,FBP ||| YieldBoost Goldman Sachs Group To 5.9% Using Options ||| Lexmark's Buyout by Chinese Consortium Completed ||| Dow Movers: VZ, GS ||| Baker Hughes (BHI) to Create New Fracturing Joint Venture ||| Market Close Report: NASDAQ Composite index closes at 5,323.68 down -56.24 points ||| OPEC Drives Dow Jones Industrial Average, S&P to Record Highs ||| 3 Regional Bank Stocks the Treasury Will Launch Into Orbit ||| Financial Sector Update for 11/30/2016: RBS,GS,FBP ||| Noteworthy Wednesday Option Activity: WBMD, LE, GS",1,0.4821613
2016-12-01,7606500.0,220.92999267578125,227.1600036621093,220.3500061035156,226.6300048828125,213.6600646972656,GS,"Dow Movers: IBM, NKE ||| What To Know About Steven Mnuchin, Trump's Treasury Secretary ||| Dow Jones Industrial Average Scores Record Close; Nasdaq Slumps ||| 5 Top Performing S&P 500 Stocks of November",0,0.48823124
2016-12-02,5297400.0,226.0,226.25,221.22000122070312,223.3600006103516,210.57720947265625,GS,Warren Buffett's Best Performing Stocks of 2016 ||| Dow Jones Industrial Average Hangs On For 4th Straight Weekly Win,1,0.4966235
2016-12-05,4599300.0,225.5200042724609,229.1999969482422,225.2400054931641,228.5500030517578,215.4701995849609,GS,"Stock ETFs Rise With Blue Chips, Small Caps And Banks In The Lead",1,0.51136893
2016-12-06,5259300.0,230.17999267578125,232.6699981689453,227.8999938964844,231.3800048828125,218.1382751464844,GS,"Notable ETF Inflow Detected - DIA, GS, IBM, UNH ||| Stock Market News for December 06, 2016 ||| CME Group Inc. (CME) Ex-Dividend Date Scheduled for December 07, 2016 ||| Oil & Gas Stock Roundup: OPEC Deal, Approvals for BP and Kinder Morgan Projects and More ||| Market Close Report: NASDAQ Composite index closes at 5,333 up 24.11 points ||| Dow Jones Industrial Average Settles at New High; Oil Snaps Win Streak",1,0.48693788
2016-12-07,6595200.0,230.3999938964844,236.08999633789065,230.3999938964844,235.5599975585937,222.0790100097656,GS,"Bank of America Corp (BAC) Stock Is on Fire. Short It for Free! ||| Stock Market News for December 07, 2016 ||| 8 Stocks to Benefit from Rising Interest Rates ||| Apple Inc. Stock Rides On iPhone 7 Demand (AAPL) ||| GAIN Capital Holdings, Inc. (GCAP) Ex-Dividend Date Scheduled for December 08, 2016 ||| The Biggest S&P 500 Question Is What to Buy",1,0.4855322
2016-12-08,7343700.0,236.8800048828125,242.4199981689453,236.0,241.4499969482422,227.6319274902344,GS,"Dow Movers: PFE, GS ||| Stock Market Roundup Dec. 8: Wall Street Hits 13th Record Close Since Election ||| Market Close Report: Historical high reached as NASDAQ Composite Index closes at 5,417.36. ||| Dow Jones Industrial Average Rolls to New High as Trump Rally Continues",1,0.49134046
2016-12-09,5456000.0,240.6100006103516,242.0,238.8800048828125,241.8500061035156,228.00906372070312,GS,"The Zacks Analyst Blog Highlights: Goldman Sachs Group, JPMorgan, 3M and IBM ||| 3 Stocks to Watch on Friday: Broadcom Ltd (AVGO), Wynn Resorts, Limited (WYNN) and Restoration Hardware Holdings Inc (RH) ||| Goldman Sachs Group Inc (GS) Stock Is an Insane Roller Coaster ||| 5 Stocks That Got Run Over By the Trump Train ||| Make a Smart Bet on Las Vegas Sands Corp. (LVS) Stock ||| Stock Market News for December 09, 2016",0,0.4582076
2016-12-12,5022000.0,240.5,242.8300018310547,236.3699951171875,237.1699981689453,223.5968780517578,GS,"Dow Jones Industrial Average Hangs On Amid Oil Rally; S&P, Nasdaq Fall ||| 5 Dow Stocks Leading the Way to 20,000 ||| Market Close Report: NASDAQ Composite index closes at 5,412.54 down -31.96 points",1,0.48645288
2016-12-13,4680500.0,239.0,240.17999267578125,235.509994506836,238.5500030517578,224.89791870117188,GS,"Zacks Investment Ideas feature highlights: Goldman Sachs, Untied Health, Caterpillar, JPMorgan and McDonalds ||| Nasdaq, Inc. (NDAQ) Ex-Dividend Date Scheduled for December 14, 2016",1,0.44443154
2016-12-14,6172400.0,235.6699981689453,243.1199951171875,235.3699951171875,239.92999267578125,226.19894409179688,GS,"Why Investors Aren’t Flocking To China ||| Notable ETF Inflow Detected - DIA, GS, IBM, UNH ||| Yellen, Trump and Tech: Will They Help Dow Hit 20K? ||| Yellen, Trump and Tech: Will They Help Dow Hit 20K? ||| New Strong Buy Stocks for December 14th ||| What Makes Patriot National (PN) a Strong Sell? ||| Fed Dooms Dow Jones Industrial Average Win Streak",1,0.49136132
2016-12-15,4829700.0,242.4900054931641,245.57000732421875,241.6199951171875,243.0,229.0932464599609,GS,Best Stocks for 2017: Citigroup Inc (C) Stock Is Undervalued ||| 3 Bank Stocks Better Than Bank of America ||| How Will These 3 Miners Deal With the Coming Collapse in Iron Ore? ||| Yesterday's Fed Decision Is Another Plus For Big Banks ||| How Goldman Sachs (GS) Stock Stands Out in a Strong Industry ||| Bank Stocks Lift Dow Jones Industrial Average,0,0.4853335
2016-12-16,6876400.0,242.8000030517578,243.19000244140625,238.3999938964844,238.8999938964844,225.2278747558593,GS,"Close Update: Stocks End Lower as Financials Weaken, Retailers Slide ||| Here Are the 8 U.S.-Based Global Systemically Important Banks ||| Stocks Poised to End Lower as Financials Weaken, Retailers Slide",1,0.5206389
2016-12-19,3743300.0,238.33999633789065,239.7400054931641,236.259994506836,239.07000732421875,225.38815307617188,GS,"Top Ranked Momentum Stocks to Buy for December 19th ||| Will The Goldman Sachs (GS) Crush Estimates at Its Next Earnings Report? ||| Stocks Most Likely to Beat Earnings for the week of December 19th ||| Financial Sector Update for 12/19/2016: GS, BCS, JPM, BAC, WFC, C, USB ||| China’s Fake Goldman Sachs is a Perfect Example of Why Investors Fear its Markets",1,0.48296997
2016-12-21,3277800.0,242.2400054931641,242.3999938964844,240.0800018310547,241.44000244140625,227.6225128173828,GS,"JNUG, UDOW: Big ETF Inflows ||| Dow Movers: GS, BA ||| Stock Market News for December 21, 2016 ||| Will WeWork Be 2017's First Unicorn IPO? ||| 5 Top-Ranked Stocks Crushing the Dow in 2016",0,0.489353
2016-12-22,2636500.0,241.22999572753903,242.8600006103516,239.5500030517578,240.1199951171875,226.3780517578125,GS,3 Reasons Why Goldman Sachs (GS) is a Great Momentum Stock ||| Top Ranked Momentum Stocks to Buy for December 22nd ||| 3 STOCKing Stuffers for 2017 ||| 7 Hot Momentum Stocks to Watch in 2017 ||| 10 Popular Bank Stocks Ranked by Stock Price,1,0.50804955
2016-12-23,2187500.0,239.5399932861328,241.8999938964844,238.9100036621093,240.97000122070312,227.1793975830078,GS,"The 3 Best Dow Jones Stocks to Buy Now ||| At an Almost 8-Year Low, Is Deutsche Bank a Buy? ||| IUSV, PM, GS, UTX: ETF Inflow Alert ||| Why Morgan Stanley (MS) Stock has Plenty of Upside Left ||| Deutsche Bank (DB) to Settle RMBS Probe with DoJ for $7.2B ||| 4 Large-Cap Financial Stocks that Crushed the Market in 2016",1,0.5004246
2016-12-27,1998200.0,241.9499969482422,242.58999633789065,240.3999938964844,241.5599975585937,227.73562622070312,GS,"Top Ranked Momentum Stocks to Buy for December 27th ||| Zacks Investment Ideas feature highlights: S&P 500 ETF, Western Digital, E*Trade Financial and Goldman Sachs ||| JMP Group LLC (JMP) Ex-Dividend Date Scheduled for December 28, 2016 ||| Should You Hold on to Hancock Holdings (HBHC) Stock Now? ||| Will Blackstone (BX) Stock Witness a Turnaround in 2017?",0,0.48366114
2016-12-28,3053000.0,243.69000244140625,244.5,240.44000244140625,240.6499938964844,226.87774658203125,GS,"Dow Movers: MRK, GS ||| Inside the 5 Top Performing Stocks of the Dow ETF ||| Goldman Sachs, Six Flags Entertainment and Marcus highlighted as Zacks Bull and Bear of the Day ||| Bull of the Day: Goldman Sachs (GS) ||| Close Update: Profit-Taking Accelerates as Year-End Comes Into Focus",0,0.46816403
2016-12-29,2619000.0,240.75,241.07000732421875,236.63999938964844,238.17999267578125,224.54910278320312,GS,"5 Mega Stocks Poised to Deliver Mega Returns in 2017 ||| Dow Movers: GS, KO ||| Regions (RF) Reflects Mixed Revenue Picture & Cost Control ||| Why First Horizon (FHN) is a Must Buy for Investors Now? ||| Dow Jones Industrial Average Stumbles Yet Again ||| Stocks Set for Marginal Losses in Second Day of Declines ||| Notable Thursday Option Activity: XPO, RCII, GS ||| Close Update: Stocks Post Marginal Losses in Second Day of Declines",1,0.5196087
2016-12-30,2355500.0,238.509994506836,240.5,237.3999938964844,239.4499969482422,225.7464294433593,GS,"Stock Market News for December 30, 2016 ||| Understanding The Italian Banking Crisis, A New Lead Domino? ||| Warren Buffett's Best-Performing Bank Stocks in 2016 ||| Market Close Report: NASDAQ Composite index closes at 5,383.12 down -48.97 points ||| Dow Jones Industrial Average Ends Epic Year On a Down Day",1,0.46867463
2017-01-03,4384200.0,242.6999969482422,244.97000122070312,237.97000122070312,241.57000732421875,227.74508666992188,GS,The 5 Best Stocks in the Dow Jones in 2016 ||| What Does 2017 Hold for the S&P 500? Here's Why That's the Wrong Question ||| People's United (PBCT) on Expansion Mode: Time to Buy? ||| Will Goldman and JPMorgan Dominate Once Again in 2017? ||| 6 Reasons to Add People's United (PBCT) to Your Portfolio ||| TD Ameritrade (AMTD) Poised for Growth; Should You Buy? ||| Can Caterpillar (CAT) Lead the Dow Rally in 2017? ||| Goldman Sachs Stock Split: Will 2017 Finally Be the Year the Wall Street Giant Splits Its Shares?,1,0.50095975
2017-01-04,2728700.0,241.44000244140625,243.32000732421875,240.02999877929688,243.1300048828125,229.21578979492188,GS,"Ares Capital Completes Acquisition of American Capital ||| 5 Stocks to Buy as Dollar Hits 14-Year High ||| Energy Sector Update for 01/04/2017: SNP,C,GS,MS,SXE,DPM,PSX,SE ||| 6 Reasons to Add Cullen/Frost (CFR) to Your Portfolio Now",0,0.5003316
2017-01-05,3562600.0,242.72000122070312,243.22999572753903,236.77999877929688,241.32000732421875,227.50938415527344,GS,Here's Why Goldman Sachs Soared 33% in 2016,1,0.52136195
2017-01-06,3591100.0,242.2899932861328,246.1999969482422,241.3699951171875,244.8999938964844,230.88449096679688,GS,"Waddell & Reed Financial, Inc. (WDR) Ex-Dividend Date Scheduled for January 09, 2017 ||| Associated Capital Group, Inc. (AC) Ex-Dividend Date Scheduled for January 09, 2017 ||| US Market Indexes Higher With Positive Jobs Report ||| 5 Sinfully Good Stocks to Buy in 2017 ||| The 5 Best Dow Jones Stocks in 2016 ||| Notable Friday Option Activity: GS, ABT, ULTA",0,0.4777207
2017-01-10,3432900.0,240.8699951171875,243.44000244140625,239.0500030517578,242.57000732421875,228.68785095214844,GS,"Notable ETF Outflow Detected - IWD, PM, GS, UTX ||| Dow Movers: GS, AXP ||| Will Goldman Sachs (GS) Crush Estimates at Its Next Earnings Report?",1,0.49351817
2017-01-11,3532600.0,242.7700042724609,245.83999633789065,242.0,245.759994506836,231.6952972412109,GS,Is a Beat in Store for PNC Financial (PNC) in Q4 Earnings? ||| Biogen Inc (BIIB) Stock Should Move Higher in 2017 ||| US Market Indexes Higher After Trump Press Conference ||| Will Goldman Sachs Raise Its Dividend in 2017?,0,0.49187228
2017-01-12,4022300.0,245.0599975585937,245.47000122070312,241.57000732421875,243.83999633789065,229.88514709472656,GS,"BDCs Did Worse and Tried to Be Responsible in 2016 ||| Top Research Reports for January 12, 2017",1,0.4684716
2017-01-13,4186100.0,245.42999267578125,247.7700042724609,242.9100036621093,244.3000030517578,230.31881713867188,GS,"Noteworthy Friday Option Activity: GS, WFC, MAC ||| Will Goldman (GS) Q4 Earnings Beat on Market Volatility? ||| Dow Movers: DIS, JPM ||| Solid Start to Q4 Earnings Season ||| Will Q4 Earnings Support Morgan Stanley (MS) Stock Rally?",0,0.5091335
2017-01-17,6277200.0,242.94000244140625,243.0599975585937,235.6100006103516,235.7400054931641,222.2487030029297,GS,"Chill Out Before Earnings Season Heats Up ||| JPMorgan, Bank of America, Goldman Sachs, Morgan Stanley and AIG are part of Zacks Earnings Preview ||| Week Ahead: Earnings in Focus ||| What's In Store for Dow ETF in Q4 Earnings? ||| Bull of the Day: Charles Schwab (SCHW) ||| Dow Jones Industrial Average Down as Trump Drops Dollar, Bank Stocks Struggle ||| Pre-Market Earnings Report for January 18, 2017 : C, GS, USB, ASML, AMTD, NTRS, FAST, CBSH ||| 5 Blue-Chip Stocks That Just Got Slammed by Trump",0,0.5003608
2017-01-18,7590500.0,236.0,237.69000244140625,231.5200042724609,234.2899932861328,220.8817138671875,GS,"‘Trump Bump’ Stimulates Trading Activity, Broker Dealer ETF ||| Mid-Morning Market Update: Markets Mixed; Goldman Sachs Profit Beats Views ||| Mid-Day Market Update: CoLucid Jumps On Acquisition News; Pearson Shares Tumble ||| Goldman Sachs Group Inc (GS) Beats Q4 Earnings Estimates ||| Goldman (GS) Tops Q4 Earnings Estimates on Solid Revenues ||| Netflix, Inc. Earnings Earn Upgrades and Target Price Hikes for NFLX Stock ||| Midday Update: Retailers Keep Pressure on Dow ||| Goldman (GS) Q4 Earnings Beat on Higher Revenues ||| Earnings Reaction History: Goldman Sachs Group Inc., 36.4% Follow-Through Indicator, 1.3% Sensitive ||| Close Update: Wall Street Ends Mostly Stronger After Yellen Speech ||| Stock Market Roundup Jan. 18: TGT Down, Financial Stocks (GS, C) in Focus ||| Goldman Sachs (GS) Crushes Q4 Earnings, Revenue Estimates ||| Citigroup (C) Q4 Earnings Beat Driven by Higher Trading, Lower Costs",0,0.48950854
2017-01-19,4561800.0,234.07000732421875,234.75,230.6199951171875,231.4100036621093,218.16651916503903,GS,"Vanguard Financials ETF Experiences Big Inflow ||| Stock Market News for January 19, 2017 ||| Dow Movers: XOM, NKE",1,0.50296736
2017-01-20,5211800.0,231.6199951171875,233.22999572753903,230.5399932861328,232.1999969482422,218.91128540039065,GS,"Donald Trump Inauguration: Stocks To Buy, Sell For The Next Four Years ||| The Zacks Stocks in the News Blog Highlights: Blaze Pizza, Bank Stocks, Target, Netflix ||| Ex-Div Reminder for Goldman Sachs Group Non-Cumulative Preferred Stock, Series N ||| Dow 30 Stock Roundup: JPMorgan, Goldman Sachs, UnitedHealth Beat",1,0.48878372
2017-01-23,3136200.0,231.8600006103516,233.75,230.75,232.6699981689453,219.3544311523437,GS,"JPMorgan, Goldman Sachs, Morgan Stanley, McDonalds and Halliburton are part of Zacks Earnings Preview: ||| Deep Water Under an Agitated Surface: Global Week Ahead",1,0.4938586
2017-01-24,4448200.0,231.8600006103516,236.0599975585937,230.83999633789065,233.67999267578125,220.3065795898437,GS,"Fairmount Santrol Holdings, StoneMor Partners, Goldman Sachs, Honda Motor and Posco highlighted as Zacks Bull and Bear of the Day ||| The Zacks Analyst Blog Highlights: Goldman Sachs, DuPont, Johnson & Johnson, Verizon Communications and Travelers Companies ||| 5 Momentum Stocks Following Driehaus' Rule ||| The Trump Effect on Corporate Earnings ||| The Trump Effect on Corporate Earnings",1,0.49804258
2017-01-25,3716800.0,235.52999877929688,237.3300018310547,234.4900054931641,237.25,223.6722869873047,GS,"The Dow Jones Industrial Average Hits 20,000. So What? Now What? ||| Intuitive Surgical (ISRG) Beats on Q4 Earnings & Revenues ||| How to Find Value Stocks Using the Price-to-Book Ratio",1,0.5116328
2017-01-26,4195600.0,237.47000122070312,240.7899932861328,237.47000122070312,239.5800018310547,225.8689422607422,GS,"Stock Market News for January 26, 2017 ||| Bank of America Corp (BAC) Stock Is STILL Too Cheap to Ignore ||| Morgan Stanley (MS) Ex-Dividend Date Scheduled for January 27, 2017 ||| JMP Group LLC (JMP) Ex-Dividend Date Scheduled for January 27, 2017",0,0.44991186
2017-01-27,3253100.0,236.8999938964844,237.97000122070312,236.009994506836,236.9499969482422,223.3894500732422,GS,"Stock Market News for January 27, 2017 ||| 10 Stocks to Buy That Already Make America Great ||| Dow Jones Stays Above 20,000 on Thursday ||| Dow Movers: CVX, INTC ||| TD Ameritrade Holding Corporation (AMTD) Ex-Dividend Date Scheduled for January 30, 2017 ||| Zacks Value Investor Highlights: Bank of America, Copa Holdings, Goldman Sachs, Group 1 Automotive and Western DigitalZacks Value Investor Highlights: Bank of America, Copa Holdings, Goldman Sachs, Group 1 Automotive and Western Digital ||| Noteworthy Friday Option Activity: AFSI, GS, ASGN",0,0.4664727
2017-01-30,3803300.0,235.5800018310547,236.2899932861328,231.5200042724609,233.8999938964844,220.5140075683593,GS,"US Market Indexes Higher for the Week ||| Dow Movers: BA, WMT ||| 5 GARP Stocks with Impressive Prospects ||| 3 Stocks to Buy for Better Deals Than the Great Recession",0,0.49756208
2017-01-31,5156400.0,232.8500061035156,234.3500061035156,228.1600036621093,229.32000732421875,216.1961212158203,GS,"Market Close Report: NASDAQ trading volume joins the top ten ranking for the year. NASDAQ Composite Index closes at 5,614.79 ||| Dow Jones Industrial Average Nabs Monthly Win ||| The Deleveraging Myth And The Revival Of U.S. Real Estate Concerns",1,0.5122374
2017-02-01,4024500.0,230.509994506836,232.8600006103516,229.5200042724609,230.6699981689453,217.4688720703125,GS,Dow Analyst Moves: GS ||| US Market Indexes Mixed on Tuesday,0,0.4950568
2017-02-02,2775700.0,228.509994506836,232.3300018310547,227.0500030517578,230.4100036621093,217.22373962402344,GS,Alibaba Group Holding Ltd (BABA) Stock Has a Secret Weapon ||| Make Bank of America Corp (BAC) Stock a Great Trade Again,1,0.50659156
2017-02-03,7381000.0,234.5200042724609,241.1100006103516,234.1999969482422,240.9499969482422,227.1605529785156,GS,"Dow Movers: MRK, V ||| Trump's Executive Actions Targets Dodd-Frank, Investor Protections Rule ||| Wall Street Rallies After Payrolls Surge With Nasdaq Poised for Record High ||| Close Update: Wall Street Rallies After Payrolls Surge With Nasdaq at Record High",0,0.47556454
2017-02-06,4639200.0,239.6000061035156,243.6499938964844,239.1699981689453,239.97999572753903,226.2460479736328,GS,"3 Bank Stocks to Buy for a Big Financial Sector Breakout ||| iShares Russell 1000 Value ETF Experiences Big Inflow ||| Dow Movers: CVX, UTX ||| Stock Market News for February 06, 2017 ||| MarketAxess Holdings, Inc. (MKTX) Ex-Dividend Date Scheduled for February 07, 2017 ||| Top Stock Picks for the Week of February 6th",0,0.5016192
2017-02-07,2660200.0,241.1499938964844,241.44000244140625,239.38999938964844,239.6199951171875,225.9066925048828,GS,"Markets Exhale, Pre-Market Buoys Upward ||| Goldman Sachs, Shutterfly, Alibaba Group, Daimler AG and Texas Instruments highlighted as Zacks Bull and Bear of the Day ||| Oppenheimer Holdings, Inc. (OPY) Ex-Dividend Date Scheduled for February 08, 2017 ||| The Charles Schwab Corporation (SCHW) Ex-Dividend Date Scheduled for February 08, 2017 ||| Bull of the Day: Goldman Sachs (GS)",0,0.45145366
2017-02-08,2744700.0,238.3000030517578,238.94000244140625,236.3099975585937,237.72999572753903,224.12481689453125,GS,"Seaboard Corporation (SEB) Ex-Dividend Date Scheduled for February 09, 2017 ||| Midday Update: Dow and S&P 500 Struggle to Stay Positive as Banking Shares Trade Lower ||| Dow Movers: JPM, DIS ||| Banking Sector Weighs on Dow; Nasdaq Flirts With Another Record High ||| How Much In Total Advisory & Underwriting Fees Did The 5 Largest U.S. Banks Earn In 2016? ||| GAIN Capital (GCAP) Worth Watching: Stock Moves 5.4% Higher",1,0.46247378
2017-02-09,3550800.0,237.72999572753903,243.2899932861328,237.4199981689453,241.5500030517578,227.7262115478516,GS,5 Incredible Bank Stocks to Buy on the Dip ||| Moelis & Company (MC) Looks Good: Stock Adds 5.4% in Session ||| 3 Warren Buffett Stocks to Buy in the Trump Era ||| How Much Did The 5 Largest U.S. Investment Banks Make Through Equity Trading Activities In 2016?,1,0.52963823
2017-02-10,3072800.0,243.3699951171875,244.1600036621093,241.22999572753903,242.72000122070312,228.82925415039065,GS,"Mead Johnson Nutrition CO (MJN) Stocks Jumps on $16.6B Reckitt Deal ||| Stock Futures Build on Gains After Trump Promises ""Phenomenal"" Tax Plan",1,0.48824888
2017-02-13,2998200.0,244.4900054931641,247.47999572753903,244.4900054931641,246.2700042724609,232.1761016845703,GS,"RPG Investment Advisory, LLC Buys T. Rowe Price Group, AT&T, Under Armour, Sells Icahn ... ||| Apple Inc. Hits New All-Time Highs. What’s Next? ||| Q4 Scorecard & Analyst Reports for Pfizer, Boeing & Goldman Sachs ||| Notable Monday Option Activity: GS, GILD, DE",1,0.47163254
2017-02-14,4141500.0,246.009994506836,250.0,245.69000244140625,249.4600067138672,235.1835327148437,GS,"Stock Market News for February 14, 2017 ||| 3 Big Stock Charts for Tuesday: Nvidia Corporation (NVDA), 3M Co (MMM) and Goldman Sachs Group Inc (GS) ||| 11 Dow Stocks Owned by Warren Buffett ||| FBR & Co (FBRC) Ex-Dividend Date Scheduled for February 15, 2017 ||| Close Update: Stocks Set Record Highs as Banking Shares Rally on Yellen's Testimony ||| The Zacks Analyst Blog Highlights: Boeing, Pfizer, Goldman Sachs, NVIDIA and Twitter ||| Piper Jaffray Companies (PJC) Ex-Dividend Date Scheduled for February 15, 2017 ||| Company News for February 14, 2017 ||| Banking Sector Fuels Record Highs on Wall Street as Yellen Discusses Rate Hikes",1,0.45779184
2017-02-15,4296600.0,250.5800018310547,251.9499969482422,248.509994506836,250.5399932861328,236.2017364501953,GS,"Why MDC Partners Stock Soared Today ||| Is Goldman Sachs (GS) Stock a Solid Choice Right Now? ||| Apple Inc. Stock Keeps Rising, Putting A Chokehold On Short-Sellers (AAPL) ||| Consumer Sector Update for 02/15/2017: MDCA,GS,CIDM,FOSL ||| How Much Did FICC Trading Contribute To The Top Line Of The 5 Largest U.S. Investment Banks In 2015?",0,0.4548224
2017-02-16,2286300.0,250.3000030517578,250.77999877929688,248.44000244140625,249.44000244140625,235.16465759277344,GS,"DIA, DUG: Big ETF Outflows ||| TD Ameritrade (AMTD) Displays Solid Trading: Time to Hold? ||| Goldman Sachs Group's Preferred Stock, Series D Crosses Above 4.5% Yield Territory",1,0.49843594
2017-02-21,2794900.0,251.0,252.6499938964844,250.7100067138672,251.759994506836,237.3518981933593,GS,"Warren Buffett's 5 Best-Performing Stocks of the Past Year ||| 4 Blue Chip Stocks to Ride the Stellar Dow Jones Rally ||| Goldman Sachs (GS) Up 7.8% Since Earnings Report: Can It Continue? ||| Goldman Sachs Group Floating Rate Non-Cumulative Preferred Stock, Series C Shares Cross 4.5% Yield Mark",0,0.47485796
2017-02-22,2378800.0,250.0599975585937,252.3500061035156,250.0,251.72999572753903,237.32362365722656,GS,"Index Investing Is a Delusion ||| VFH, USB, GS, AIG: ETF Inflow Alert ||| The Zacks Analyst Blog Highlights: Goldman Sachs Group, JPMorgan Chase, American Express and Visa ||| Investment Technology Group, Inc. (ITG) Ex-Dividend Date Scheduled for February 23, 2017",0,0.4658206
2017-02-23,2594700.0,251.3099975585937,251.8999938964844,249.32000732421875,251.19000244140625,236.8145294189453,GS,"Dow Movers: GS, CVX ||| JMP Group LLC (JMP) Ex-Dividend Date Scheduled for February 24, 2017 ||| BGC Partners, Inc. (BGCP) Ex-Dividend Date Scheduled for February 24, 2017",0,0.42534983
2017-02-24,3565400.0,247.6999969482422,248.8800048828125,246.1000061035156,247.3500061035156,233.1942901611328,GS,"Dow Movers: CAT, NKE ||| Ex-Dividend Reminder: Goldman Sachs Group, Progress Software Corp. and Jack Henry & Associates ||| Interactive Brokers Group, Inc. (IBKR) Ex-Dividend Date Scheduled for February 27, 2017 ||| Virtu Financial, Inc. (VIRT) Ex-Dividend Date Scheduled for February 27, 2017 ||| Market Close Report: NASDAQ Composite index closes at 5,845.31 up 9.80 points ||| Late-Session Burst Brings Dow Jones Industrial Average Win Streak to 11 ||| Will Morgan Stanley's Plan to Move 300 U.K Jobs Materialize?",1,0.46632054
2017-02-27,2372600.0,247.2100067138672,249.759994506836,246.6100006103516,249.3300018310547,235.0609741210937,GS,"Warren Buffett's Advice for a Stock Market Crash in 2017 ||| Here's Why Tesla (TSLA) is Tumbling Today ||| Catch Tesla Inc (TSLA) Stock While It’s Under Pressure ||| Goldman Sachs Group, Inc. (GS) Ex-Dividend Date Scheduled for February 28, 2017 ||| Which Bank Has the Best Dividend Stock? ||| Investors Call Trump's Plans into Question: 5 Utility Picks ||| Numeric Investors Llc Buys Gilead Sciences, Microsoft, Baxter International, Sells Facebook, ... ||| Is Nvidia Corporation (NVDA) Stock Back on Track? ||| Is Bitcoin Finally a Serious Currency -- or Maybe Even a Solid Investment Vehicle?",0,0.45687082
2017-02-28,3627100.0,248.0,249.0,245.6100006103516,248.0599975585937,234.47491455078125,GS,"CBOE Holdings, Inc. (CBOE) Ex-Dividend Date Scheduled for March 01, 2017 ||| Navient Corporation (NAVI) Ex-Dividend Date Scheduled for March 01, 2017 ||| Dow CEOs Make Millions: 2 Financial Blue Chips to Buy ||| Dow Jones Closes at 20,837.44 ||| Dow Jones Hits 12th Session of Record High: ETFs in Focus",1,0.47257265
2017-03-01,5218300.0,253.7100067138672,255.1499938964844,251.259994506836,252.7100067138672,238.8702850341797,GS,"Stocks Rally As Trump Address to Congress Gets Positive Reception ||| Dow Movers: INTC, JPM ||| The Zacks Analyst Blog Highlights: Goldman Sachs Group, JPMorgan Chase, Apple, American Express' and Boeing's ||| BlackRock, Inc. (BLK) Ex-Dividend Date Scheduled for March 02, 2017 ||| 'Diamonds' ETF Shines Bright: 3 Ways To Play The Dow Renaissance ||| 'Diamonds' ETF Shines Bright: 3 Ways To Play The Dow Renaissance ||| Close Update: Indices Set All-Time Highs as Wall Street Applauds Trump's Pro-Growth Policies",0,0.48075956
2017-03-02,3020000.0,253.5200042724609,254.2400054931641,250.97000122070312,251.0599975585937,237.3106231689453,GS,"3 Stocks the Smartest Investors are Buying Right Now ||| Why Tesla Inc (TSLA) Needs to Sell More Stock ||| Stock Market News for March 02, 2017 ||| 5 New Warren Buffett Quotes That Can Help You Invest Better",1,0.48461846
2017-03-03,3163700.0,251.0599975585937,254.75,251.0599975585937,252.88999938964844,239.0404052734375,GS,"Dow Movers: NKE, CAT ||| The Zacks Analyst Blog Highlights: Goldman Sachs Group, Alaska Air Group, Seagate Technology, PulteGroup and ON Semiconductor ||| Dow Sails Above 21,000 Level: Buy 4 Mutual Funds ||| Greenhill & Co., Inc. (GHL) Ex-Dividend Date Scheduled for March 06, 2017",0,0.47562826
2017-03-06,2467000.0,252.1699981689453,252.72999572753903,250.5,252.009994506836,238.2085876464844,GS,"GoPro Crashes 8% After Goldman Sachs Downgrade ||| The Next Stock Warren Buffett May Sell ||| Deutsche Bank (DB) to Raise $8.5B Capital, Sets New Targets",0,0.48943308
2017-03-07,2497300.0,252.4900054931641,253.0,250.3099975585937,250.8999938964844,237.159408569336,GS,"The Zacks Analyst Blog Highlights: Berkshire Hathaway, General Motors, Goldman Sachs Group, Restaurant Brands International and VeriSign ||| LPL Financial Holdings Inc. (LPLA) Ex-Dividend Date Scheduled for March 08, 2017 ||| Urban Outfitters, Inc. (URBN) Q4 Earnings Raise Some Red Flags",0,0.44610748
2017-03-08,3574400.0,253.6199951171875,254.7700042724609,249.6100006103516,250.2400054931641,236.5355529785156,GS,"Dow Movers: CAT, JPM ||| Why Nvidia Corporation (NVDA) Is Becoming a ‘Battleground Stock’ ||| Bank of America Corp (BAC) Stock Still Has Plenty of Oomph ||| The Real Winner in Snap’s IPO... Wall Street ||| Do We Advise Adding Goldman (GS) to Your Portfolio Now? ||| Noteworthy Wednesday Option Activity: GS, SPG, BAC",0,0.5043385
2017-03-09,3061500.0,251.22000122070312,252.7400054931641,249.5200042724609,250.17999267578125,236.47882080078125,GS,"Bill Nygren Sells Bank of America, T. Rowe Price, Goldman Sachs ||| China Cutbacks Do Not Make Alcoa Corp a Buy, Just Ask Teck Resources Ltd ||| Dow Movers: IBM, JPM",0,0.48589724
2017-03-10,3365900.0,251.83999633789065,251.8999938964844,246.8699951171875,248.3800048828125,234.77745056152344,GS,"Notable ETF Inflow Detected - VFH, USB, GS, SCHW ||| Dow Movers: XOM, IBM ||| Why Washington Federal (WAFD) Stock is an Attractive Pick Now ||| Ionis Pharmaceuticals Inc (IONS) Stock Dips on Goldman Sachs Downgrade",0,0.4779073
2017-03-13,1801100.0,249.32000732421875,249.32000732421875,247.2100067138672,248.1600036621093,234.56944274902344,GS,"T. Rowe Price Group, Inc. (TROW) Ex-Dividend Date Scheduled for March 14, 2017 ||| Intercontinental Exchange Inc. (ICE) Ex-Dividend Date Scheduled for March 14, 2017 ||| GoPro Stock Collapses to New All-Time Lows (GPRO)",0,0.46579018
2017-03-14,2144200.0,246.8099975585937,247.8300018310547,245.4100036621093,247.72000122070312,234.15353393554688,GS,"Tesla: Trade TSLA With Less Risk ||| The Zacks Analyst Blog Highlights: Goldman Sachs Group, Primerica, Health Insurance Innovations, NewStar Financial and OM Asset Management ||| Nasdaq, Inc. (NDAQ) Ex-Dividend Date Scheduled for March 15, 2017",0,0.45512074
2017-03-15,3427000.0,248.3500061035156,250.27999877929688,245.5599975585937,246.77999877929688,233.26502990722656,GS,"Why Warren Buffett Loves Fed Rate Hikes ||| 5 Top Insurance Stocks to Buy on an Imminent Rate Hike ||| Lazard Riding High on Strong Fundamentals: Time to Buy? ||| S&P 500 Surges After Federal Reserve Hikes Interest Rates ||| Noteworthy Wednesday Option Activity: MON, GS, COH",1,0.4867383
2017-03-16,2940600.0,247.8500061035156,250.1999969482422,247.3099975585937,248.22000122070312,234.6261749267578,GS,Sallie Mae Prospects Look Bright: Time to Buy the Stock? ||| 5 Biggest Winners from the Fed Rate Hike ||| Goldman Sachs Redeems Itself Somewhat With Tesla Objectivity,0,0.48956883
2017-03-17,5438100.0,249.67999267578125,249.67999267578125,243.8600006103516,243.94000244140625,230.58053588867188,GS,"Market Close Report: NASDAQ trading volume joins the top ten ranking for the year. NASDAQ Composite Index closes at 5,901",0,0.49230257
2017-03-20,2759100.0,243.32000732421875,244.92999267578125,241.5200042724609,242.13999938964844,228.87911987304688,GS,"PRF, C, GS, PRU: Large Inflows Detected at ETF ||| The Zacks Analyst Blog Highlights: Boeing, Goldman Sachs, Oracle, Dollar General and Magna International ||| Yintech Investment Holdings Limited (YIN) Ex-Dividend Date Scheduled for March 21, 2017 ||| Deutsche Bank (DB) Raises $8.6B Capital at 35% Discount ||| US Market Indexes Mostly Lower",0,0.45850265
2017-03-21,5660900.0,243.3099975585937,243.3099975585937,232.7899932861328,233.0,220.2396850585937,GS,"Goldman Sachs (GS) Reduces CEO's Salary by 27% for 2016 ||| Can Nvidia Corporation Stock Reclaim All-Time Highs? ||| Dow Movers: CAT, AAPL ||| Market Close Report: NASDAQ Composite index closes at 5,793.83 down -107.70 points ||| Financial Sector Update for 03/21/2017: GS,DB,PPBI",0,0.48325935
2017-03-22,6291300.0,231.22000122070312,232.9199981689453,229.1600036621093,231.07000732421875,218.41542053222656,GS,"Top Research Reports for Netflix, Goldman Sachs & Kinder Morgan ||| Are Investors Wrong to Be Selling Bank of America Stock Now? ||| 5 Blue-Chip Stocks That Will Get the Worst of the Selloff ||| Notable Wednesday Option Activity: GS, WWE, TSLA",1,0.49877
2017-03-23,4770700.0,230.75,234.6300048828125,229.9499969482422,231.8999938964844,219.199935913086,GS,"GAIN Capital Holdings, Inc. (GCAP) Ex-Dividend Date Scheduled for March 24, 2017 ||| Midday Update: Wall Street Gains as Banking Stocks Recover ||| Market Averages Building on Wednesday's Gains on Strength in Banking, Consumer Stocks ||| 2 Stocks Hedge Funds Love ||| Dow Movers: UNH, NKE ||| Institutional Financial Markets, Inc. (IFMI) Ex-Dividend Date Scheduled for March 24, 2017 ||| U.S. Banks Stock Outlook - March 2017 ||| Why FireEye, Penn National Gaming, and SUPERVALU Jumped Today ||| The Zacks Analyst Blog Highlights: Netflix, Kinder Morgan, Goldman Sachs Group, U.S. Bancorp and Colgate-Palmolive",0,0.48385492
2017-03-24,6387300.0,233.0,233.6999969482422,226.97000122070312,228.4100036621093,215.90106201171875,GS,"Oversold Conditions For Goldman Sachs Group (GS) ||| Goldman (GS) Displays Bright Prospects: Should You Hold? ||| Market Close Report: NASDAQ Composite index closes at 5,828.74 up 11.05 points ||| Close Update: Wall Street Swings as Health Care Bill Pulled ||| Wall Street Swings as Vote on Health Care Bill Pulled ||| Goldman Sachs Projects Another Crude Glut, Refiners to Gain?",0,0.49914652
2017-03-27,9194800.0,223.3000030517578,227.07000732421875,220.8500061035156,225.47999572753903,213.13156127929688,GS,"Snap Stock Soars 6.9% after Bullish Ratings from Wall Street ||| US Large Cap Stocks Mostly Lower on Monday ||| 3 Big Stock Charts for Monday: Goldman Sachs Group Inc (GS), Micron Technology, Inc. (MU) and Darden Restaurants, Inc. (DRI) ||| Goldman (GS) May File for Equities License in Saudi Arabia ||| 3 Bank Stocks to Buy on the Dip ||| Close Update: Dow Slides for Eighth Straight Day Even as Wall Street Pares Losses ||| Dow Set for Eighth Day of Declines Even as Wall Street Pares Losses",1,0.45765612
2017-03-28,4471200.0,225.5800018310547,229.75,225.1000061035156,229.3300018310547,216.77069091796875,GS,"Snap Inc Stock (SNAP) and The Running Of The Bulls ||| Stock Market News for March 28, 2017 ||| JMP Group LLC (JMP) Ex-Dividend Date Scheduled for March 29, 2017 ||| Snapchat Parent (SNAP) Debuts as a Zacks Rank #3 (Hold) ||| Close Update: Wall Street Rallies With Dow Snapping 8-Day Losing Streak as Apple Hits Record ||| Why the Oil Markets Dropped 4.5% in 1 Day ||| Dow Movers: VZ, GS",0,0.49854156
2017-03-29,2636000.0,229.38999938964844,229.97000122070312,227.5200042724609,228.4499969482422,215.93885803222656,GS,"Dow Jones Up More Than 150 Points ||| Raymond James Financial, Inc. (RJF) Ex-Dividend Date Scheduled for March 30, 2017 ||| Morgan Stanley Sells Australian Diesel Terminal to BB Energy ||| The 7 Best Stocks to Buy for an Income-Rich Retirement",1,0.47312522
2017-03-30,3156800.0,229.47999572753903,232.0,229.3800048828125,231.22000122070312,218.5571746826172,GS,"Notable Thursday Option Activity: TSLA, NLNK, GS ||| Amazon Enters Middle Eastern Markets ||| Are Canadian Energy Stocks Your Best Bet Right Now? ||| Why Is Goodyear Tire (GT) Stock Down Today?",0,0.48663345
2017-03-31,2858400.0,230.52999877929688,230.8000030517578,228.72999572753903,229.72000122070312,217.13931274414065,GS,"Where Does Snapchat Stand from a Fundamental Perspective? ||| 3 Big Stock Charts for Friday: Bank of America Corp (BAC), Goldman Sachs Group Inc (GS) and JPMorgan Chase & Co. (JPM) ||| The Zacks Analyst Blog Highlights: Goodyear Tire & Rubber and Goldman Sachs ||| Will Tesla Inc (TSLA) Stock Defy Financial Gravity Forever?",0,0.48882166
2017-04-03,3735600.0,230.0,230.1000061035156,225.57000732421875,228.9600067138672,216.42091369628903,GS,Which Bank Stocks Does Warren Buffett Own?,1,0.49858075
2017-04-04,3042700.0,227.72000122070312,230.69000244140625,227.27999877929688,229.259994506836,216.7044982910156,GS,"Dow Movers: NKE, CAT ||| Apple & These 3 Stocks Were Best Performers of Q1",0,0.49005222
2017-04-05,5286900.0,232.1499938964844,232.88999938964844,227.3099975585937,227.6600036621093,215.19216918945312,GS,"Waddell & Reed Financial, Inc. (WDR) Ex-Dividend Date Scheduled for April 06, 2017 ||| Bridges Investment Management Inc Buys iShares Core S&P Small-Cap, Vanguard FTSE All World ... ||| Close Update: Stocks Give Back Gains After Minutes Show Fed Considering Balance Sheet Unwinding",1,0.47072086
2017-04-06,2927200.0,227.08999633789065,230.1199951171875,225.7100067138672,228.63999938964844,216.1184539794922,GS,"US Market Indexes Gain on Thursday ||| Noteworthy Thursday Option Activity: DVN, GS, AMD",0,0.494247
2017-04-07,2853300.0,226.6000061035156,228.8300018310547,226.22999572753903,227.8800048828125,215.4001007080078,GS,3 Bank Stocks to Trade Without Spending a Dime ||| Will a Tax Cut Take the Shine Off Muni Bond Funds?,1,0.506151
2017-04-10,2653900.0,228.0,229.7899932861328,226.9499969482422,228.88999938964844,216.3547821044922,GS,"Better Buy: Himax Technologies Inc. vs NVIDIA ||| The $10 Trillion Baby Boomer Problem That Could Sink Wall Street ||| Deutsche Bank Closes $8.6B Capital Raise, Focused on Growth",0,0.50557524
2017-04-11,3374700.0,227.77999877929688,229.3999938964844,225.38999938964844,227.7400054931641,215.2677459716797,GS,Does Trump Want to Break Up These 3 Big Banks? ||| JPMorgan vs. Wells Fargo: Which Is Better Ahead of Earnings?,0,0.48809645
2017-04-12,2947500.0,227.6499938964844,228.25,225.22999572753903,225.75,213.38671875,GS,"Chesapeake Energy Corporation (CHK) Stock Is Still a HUGE Risk at $6 ||| Top Research Reports for April 12, 2017: GM, PG, GS ||| Trade Goldman Sachs Group Inc (GS) Stock and Win No Matter What ||| JPM vs Wells Fargo: Which is the Better Bank Stock Ahead of Earnings? (Revised) ||| Buy This Dip in Bank of America Corp (BAC) Stock",0,0.47170392
2017-04-13,3653700.0,225.17999267578125,228.1699981689453,223.0800018310547,223.32000732421875,211.0898284912109,GS,"Bank of America Closed Most M&A Deals In Q1 Despite Sluggish Industry Conditions ||| The Zacks Analyst Blog Highlights: General Motors, Procter & Gamble, Goldman Sachs, Kimberly-Clark and General Dynamics ||| Noteworthy Thursday Option Activity: GS, ODFL, AAOI",1,0.48996675
2017-04-17,4190900.0,223.8999938964844,226.8800048828125,223.0200042724609,226.259994506836,213.86880493164065,GS,"Should You Sell The Goldman Sachs (GS) Before Earnings? ||| Goldman Sachs Stock History: How the Investment Bank Came to Rule Wall Street ||| Company News for April 17, 2017 ||| US Market Indexes Higher on Monday ||| Pre-Market Earnings Report for April 18, 2017 : JNJ, BAC, UNH, GS, SCHW, PLD, OMC, RF, GWW, CMA, HOG, LECO ||| The Value of Cash as a Position Cannot Be Overstated ||| Dividend Growers To The Rescue As Stocks Retreat And Volatility Ticks Up ||| 5 Hot Earnings Charts to Start the Week",0,0.44052747
2017-04-18,12464000.0,219.32000732421875,219.88999938964844,213.17999267578125,215.58999633789065,203.78317260742188,GS,"3 Big Stock Charts for Tuesday: Progressive Corp (PGR), Johnson & Johnson (JNJ) and Goldman Sachs Group Inc (GS) ||| Goldman Sachs (GS) Q1 Earnings Lag on Higher Expenses ||| Mid-Day Market Update: Dow Drops Over 100 Points; Arena Pharmaceuticals Shares Plummet ||| Goldman Sachs Group is Now Oversold (GS) ||| Goldman Sachs Earnings: A Disappointing Quarter, but There Was Some Good News ||| United Continental Holdings Inc (UAL) Stock Is Good … For Dividends? ||| Dow ETF Falls On A Big Earnings Day For Blue-Chip Stocks ||| Q1 Earnings In Focus ||| What Does the Goldman Sachs Group Inc (GS) Miss Mean? ||| Dow Movers: GS, UNH ||| Mid-Morning Market Update: Markets Open Lower; Goldman Sachs Earnings Miss Estimates ||| Goldman (GS) Q1 Earnings Disappoint on Rise in Expenses ||| Will TD Ameritrade (AMTD) Stock Disappoint in Q2 Earnings? ||| Earnings Reaction History: Goldman Sachs Group Inc., 36.4% Follow-Through Indicator, 1.3% Sensitive ||| Why Goldman Sachs Group Stock Slumped 5% Today ||| Why Goldman Sachs Group Inc (GS), Harley-Davidson Inc (HOG) and Cardinal Health Inc (CAH) Are 3 of Today’s Worst Stocks ||| Market Close Report: NASDAQ Composite index closes at 5,849.47 down -7.32 points ||| Why Goldman Sachs, W.W. Grainger, and Cardinal Health Slumped Today ||| Close Update: Wall Street Trades Lower As Goldman Misses Q1 Estimates, Geopolitical Pressures Resurface ||| Goldman Sachs Sends Dow Jones Industrial Average to Triple-Digit Loss ||| Financial Sector Update for 04/18/2017: CPSS,CBL,GS ||| Stocks Wilt as Goldman Misses Street Expectations, Geopolitical Tensions Resurface ||| Mid-Afternoon Market Update: GNC Gains On Upbeat Earnings; Barracuda Shares Drop ||| Still Here and Ready to Rally ||| Financial Sector Update for 04/18/2017: RF,CBL,GS ||| Stock Market Roundup, April 18: NFLX, JNJ, GS, HOG Slump on Earnings",0,0.5108172
2017-04-19,6428800.0,215.8699951171875,217.17999267578125,213.6100006103516,214.08999633789065,202.36529541015625,GS,"Midday Update: Major Indices Up, But Dow Weighed Down By IBM ||| Why Goldman's Earnings Miss Is Nothing To Worry About ||| The Zacks Analyst Blog Highlights: Goldman Sachs, Bank of America, PNC Financial, Citigroup and JPMorgan Chase ||| Dow Analyst Moves: GS ||| Earnings Season In Focus ||| Bank of America Corp (BAC) Stock Can Still Pay You Richly ||| How Tesla Inc (TSLA) Stock Can Generate 370% Returns ||| Wednesday’s Vital Data: Facebook Inc (FB), Apple Inc. (AAPL) and Goldman Sachs Group Inc (GS) ||| Ex-Div Reminder for Goldman Sachs Group Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series K ||| Bank Stocks Roundup: MS vs. GS, Which Bank Had the Better Quarter? ||| Q1 Earnings Season Off to a Solid Start ||| Q1 Earnings Season Off to a Solid Start",1,0.48910764
2017-04-20,5168200.0,215.5,218.97999572753903,215.0,218.0599975585937,206.11788940429688,GS,"Dow Movers: TRV, AXP ||| Overseas Earnings Estimated to Outdo US: Top 5 Gainers",0,0.50118285
2017-04-21,3845700.0,218.5500030517578,219.17999267578125,216.3800048828125,216.8600006103516,204.9835968017578,GS,"Ask a Fool: Should I Sell a Stock Because the Company Missed Earnings? ||| Stock Market News for April 21, 2017 ||| Dow 30 Stock Roundup: AmEx, UNH Beat; Goldman, JNJ, Verizon Disappoint ||| Stock Market Roundup, April 21: French Election, Earnings Recap ||| Financial Literacy Month: 6 Tips For Saving More, Spending Smarter ||| Noteworthy Friday Option Activity: WYNN, HUM, GS ||| Bill O'Reilly, Bank Stocks, UAL's Apology, and the Future of Netflix",1,0.4652024
2017-04-24,5353500.0,221.17999267578125,224.8099975585937,220.3000030517578,223.22000122070312,210.99530029296875,GS,"Noteworthy ETF Outflows: DIA, GS, IBM, TRV ||| Dow Movers: VZ, GS ||| Close Update: Wall Street Surges After French Polls, With Nasdaq Reaching Record High",1,0.50451267
2017-04-25,3996900.0,226.1999969482422,227.97999572753903,225.1499938964844,226.6300048828125,214.21856689453125,GS,"JMP Group LLC (JMP) Ex-Dividend Date Scheduled for April 26, 2017 ||| America's 12 Most Charitable Companies ||| A Very Positive Earnings Picture",0,0.5022007
2017-04-26,3765300.0,227.1000061035156,229.3600006103516,226.08999633789065,226.1999969482422,213.8120880126953,GS,"Dow Movers: BA, GS ||| Morgan Stanley (MS) Ex-Dividend Date Scheduled for April 27, 2017",0,0.46105626
2017-04-27,2805800.0,226.6999969482422,226.6999969482422,223.5200042724609,225.8099975585937,213.4434356689453,GS,"Greenhaven Associates Inc Buys Taylor Morrison Home ||| Gold Road Map: Investing Pros Make Bull And Bear Case For This Metal ||| The Dow Would Be More Than 300 Points Higher This Year if Not for These 3 Stocks ||| The 3 Best ETFs for the Rest of Trump’s Presidency ||| TD Ameritrade Holding Corporation (AMTD) Ex-Dividend Date Scheduled for April 28, 2017",0,0.48644888
2017-04-28,2936600.0,225.3099975585937,226.7700042724609,223.72000122070312,223.8000030517578,211.5435485839844,GS,"Notable Friday Option Activity: WYNN, MET, GS",1,0.50563115
2017-05-02,2602400.0,224.8600006103516,225.83999633789065,223.17999267578125,225.1199951171875,212.791244506836,GS,3 Proxies of the Global Banking Environment ||| 3 Financial Stocks to Short Now ||| SPDR Dow Jones Industrial Average ETF Experiences Big Inflow ||| How to Buy the Best REITs at an 18% Discount ||| Profit From JPMorgan Chase & Co. (JPM) Stock No Matter What ||| Equity Capital Market Recovery Boosts Underwriting Fees To Highest Level Since Early 2015,1,0.52677333
2017-05-03,3042200.0,224.4499969482422,226.69000244140625,224.32000732421875,226.3099975585937,213.91607666015625,GS,Lending Club Earnings Preview: What Investors Should Watch For,1,0.5144451
2017-05-05,2435800.0,226.8800048828125,227.47000122070312,225.3000030517578,226.8699951171875,214.4454040527344,GS,"Bank of America Corp (BAC) Stock: Buy, Sell or Hold? ||| Credit Suisse Group (CS) Ex-Dividend Date Scheduled for May 08, 2017 ||| Noteworthy Friday Option Activity: TDG, GS, M",0,0.48644766
2017-05-08,2316800.0,226.75,227.33999633789065,224.6000061035156,225.02999877929688,212.70616149902344,GS,"Goldman is Getting Bullish on Oil ||| 3 Bank Stocks That Can Bank You Free Profits ||| MarketAxess Holdings, Inc. (MKTX) Ex-Dividend Date Scheduled for May 09, 2017 ||| JPMorgan to Relocate London-Based Jobs to EU Due to Brexit",0,0.4843233
2017-05-11,2440300.0,224.3500061035156,225.08999633789065,222.1499938964844,224.759994506836,212.45095825195312,GS,"Kiltearn Partners LLP Buys Invesco, McKesson Corp, Polaris Industries Inc, Sells Bank of ...",0,0.50955266
2017-05-12,2166100.0,223.4900054931641,224.4900054931641,222.47999572753903,222.82000732421875,210.61721801757807,GS,"Noteworthy Friday Option Activity: MCD, PBPB, GS",1,0.51968545
2017-05-15,2468100.0,223.1300048828125,226.57000732421875,222.8500061035156,225.1199951171875,212.791244506836,GS,"New Analyst Reports for Apple, Wells Fargo, P&G and Others ||| Stock Market News for May 15, 2017 ||| Institutional Financial Markets, Inc. (IFMI) Ex-Dividend Date Scheduled for May 16, 2017 ||| Why FireEye, Patheon, and Vista Outdoor Jumped Today ||| Goldman Sachs Group's Preferred Stock, Series K Yield Pushes Past 5.5%",1,0.4623061
2017-05-16,1710700.0,225.44000244140625,226.82000732421875,224.4100036621093,225.6000061035156,213.2449493408203,GS,"Matthew 25 Management Corp Buys Range Resources Corp, Federal Agricultural Mortgage Corporation ||| JPMorgan (JPM) Buys Dublin Office to Move Jobs Post Brexit ||| The Zacks Analyst Blog Highlights: Apple, Wells Fargo, Procter & Gamble, Goldman Sachs and General Motors",0,0.50225854
2017-05-17,7525700.0,225.6000061035156,225.6000061035156,213.1199951171875,213.72000122070312,202.0155639648437,GS,"US Market Indexes Lower on Political Worries ||| Wall Street Plunges as Trump's Comey Controversy Weighs ||| KRE, UDOW: Big ETF Outflows ||| Feeding Frenzy in Stocks as Wall Street Loses Confidence in Trump ||| Buy Micron Technology, Inc. (MU) Stock While It’s on Sale! ||| 7 Big Bank Stocks Getting Clocked by Trump Chaos ||| Midday Update: Wall Street Roiled by Latest Accusations Against President ||| Market Close Report: NASDAQ Composite index closes at 6,011.24 down -158.63 points ||| Dow Movers: GS, UNH",1,0.5090776
2017-05-19,3747100.0,214.8699951171875,217.8000030517578,214.0,215.38999938964844,203.59410095214844,GS,3 Dow Jones Icons That Will Surge on the Rebound,1,0.5588233
2017-05-22,2506100.0,217.3699951171875,217.63999938964844,215.3999938964844,216.0200042724609,204.1896209716797,GS,"Notable Monday Option Activity: TWX, AAP, GS",1,0.51666564
2017-05-23,3308800.0,215.97000122070312,220.7899932861328,214.6600036621093,219.63999938964844,207.61135864257807,GS,"Piper Jaffray Companies (PJC) Ex-Dividend Date Scheduled for May 24, 2017 ||| Consumer Sector Update for 05/23/2017: H ||| Truck Drivers Stand to Lose Most From Self-Driving Vehicles: Goldman Sachs ||| Bank Stocks Lead US Indexes Higher on Tuesday ||| Dow Movers: GS, NKE ||| Close Update: Wall Street Strengthens as Financials Lead in Wake of Trump's 2018 Budget ||| Market Close Report: NASDAQ Composite index closes at 6,138.71 up 5.09 points",1,0.4920592
2017-05-24,4141600.0,220.0,224.3999938964844,219.4499969482422,223.8300018310547,211.5718994140625,GS,"Why Bank of America Corp (BAC) Stock Will Keep Leading the Pack ||| Investment Technology Group, Inc. (ITG) Ex-Dividend Date Scheduled for May 25, 2017 ||| US Market Indexes Higher on Wednesday, S&P 500 Reaches New High ||| NASDAQ Composite Index closes up 5.09 points for the week, rising for the 5th straight day",0,0.48419577
2017-05-25,2640000.0,224.4100036621093,225.4499969482422,222.3000030517578,222.47000122070312,210.2863922119141,GS,"JMP Group LLC (JMP) Ex-Dividend Date Scheduled for May 26, 2017",1,0.4564836
2017-05-26,1787100.0,222.009994506836,224.22999572753903,221.17999267578125,223.52999877929688,211.28829956054688,GS,"SPY, GS, NVDA, TWX: Large Outflows Detected at ETF ||| Ex-Dividend Reminder: FNB, Columbia Property Trust and Goldman Sachs Group ||| Interactive Brokers Group, Inc. (IBKR) Ex-Dividend Date Scheduled for May 30, 2017 ||| Virtu Financial, Inc. (VIRT) Ex-Dividend Date Scheduled for May 30, 2017",0,0.45728126
2017-05-30,3097800.0,221.8300018310547,222.44000244140625,218.009994506836,218.4199981689453,207.1532287597656,GS,"9 Stocks That Made Warren Buffett Billions Over the Past Year ||| Close Update: S&P, Nasdaq Snap 7-Day Winning Streaks as Energy and Financials Decline ||| CBOE Holdings, Inc. (CBOE) Ex-Dividend Date Scheduled for May 31, 2017 ||| Notable Tuesday Option Activity: AMBA, VOYA, GS ||| Market Close Report: NASDAQ Composite index closes at 6,203.19 down -7 points ||| Navient Corporation (NAVI) Ex-Dividend Date Scheduled for May 31, 2017",0,0.4676229
2017-05-31,8312000.0,218.2400054931641,218.3000030517578,209.6199951171875,211.259994506836,200.362548828125,GS,"Here's Why Shares of Goldman Sachs (GS) Stumbled Today ||| Oil Sinks, Gold Shines; Which Top Chip Stock Is In Buy Zone? ||| Commit To Buy Goldman Sachs Group At $130, Earn 2.5% Using Options ||| GS Makes Notable Cross Below Critical Moving Average ||| Citigroup (C) to Expand Operations in Asia-Pacific Region ||| Market Close Report: NASDAQ Composite index closes at 6,198.52 down -4.67 points ||| Wednesday Sector Laggards: Energy, Financial ||| BlackRock, Inc. (BLK) Ex-Dividend Date Scheduled for June 01, 2017 ||| Dow Jones Industrial Average Falls Amid Financial Sector Sell-Off",1,0.4911968
2017-06-01,4057900.0,212.6100006103516,215.92999267578125,210.7899932861328,215.009994506836,203.91909790039065,GS,"Stock Market News for June 01, 2017 ||| Go Long Whiting Petroleum Corp (WLL) Stock With Relative Certainty ||| Bank Stocks Down on Weak Trading Revenue Expectations in Q2 ||| US Market Indexes Regain Losses for the Week ||| Close Update: Wall Street Hits Record Highs Ahead of Key Jobs Data ||| Dow Jones Industrial Average Nabs Record Close Ahead of Jobs Report",0,0.48034337
2017-06-02,3692000.0,212.94000244140625,215.2100067138672,211.9100036621093,213.3099975585937,202.30682373046875,GS,"Greenhill & Co., Inc. (GHL) Ex-Dividend Date Scheduled for June 05, 2017 ||| Miss Thursday's Breakouts? 2 Fresh Ideas As Market Hits Highs ||| Top Stock Research Reports for Microsoft, UPS, Alibaba & Others ||| Financial Sector (Part II): Buying Opportunity Or Time To Underweight? ||| Dow Movers: GS, GE",1,0.468299
2017-06-06,2891300.0,212.509994506836,216.0200042724609,212.47999572753903,214.52999877929688,203.46389770507807,GS,"CME Group Inc. (CME) Ex-Dividend Date Scheduled for June 07, 2017 ||| Noteworthy Tuesday Option Activity: GS, DIS, WMT",1,0.4722794
2017-06-07,2679400.0,215.3699951171875,217.22999572753903,214.3099975585937,215.77999877929688,204.6494140625,GS,"Startup Spotlight: Meet Outcome Health, the $5 Billion Healthcare Tech Unicorn ||| How to Invest in Bitcoin Without Actually Buying Bitcoin",1,0.5086646
2017-06-08,3765600.0,215.77999877929688,221.0,214.6300048828125,218.759994506836,207.47569274902344,GS,"Wall Street Wobbles as Comey Testimony Raises Concerns About Russian Meddling ||| GAIN Capital Holdings, Inc. (GCAP) Ex-Dividend Date Scheduled for June 09, 2017 ||| US Market Indexes Gain ||| Midday Update: Dow, Nasdaq Set Record Highs as Wall Street Breathes Sigh of Relief After Comey's Testimony",1,0.4897795
2017-06-09,4455400.0,220.8300018310547,223.8500061035156,219.75,222.44000244140625,210.96585083007807,GS,"Dow Movers: MSFT, GS ||| Extract Value From Whiting Petroleum Corp (WLL) Stock ||| Goldman (GS) to Raise Interest Rates to Attract Depositors",0,0.4968804
2017-06-12,3388200.0,223.6300048828125,225.22999572753903,221.9100036621093,221.9100036621093,210.46319580078125,GS,"Financial Sector Update for 06/12/2017: JPM, BAC, WFC, C, USB, GS, UBA, HHC ||| T. Rowe Price Group, Inc. (TROW) Ex-Dividend Date Scheduled for June 13, 2017 ||| Financial Sector Update for 06/12/2017: JPM, BAC, WFC, C, USB, GS, UBA, HHC",1,0.4508787
2017-06-13,2767800.0,223.3500061035156,226.8000030517578,222.7700042724609,224.1999969482422,212.63507080078125,GS,"Disruptor Alert: These 2 Companies Are Changing Banking ||| 111 Actions to Take this Week ||| Dow Movers: VZ, GS ||| Nasdaq, Inc. (NDAQ) Ex-Dividend Date Scheduled for June 14, 2017 ||| Notable Tuesday Option Activity: GS, ATVI, BBBY ||| Here's Why Tableau (DATA) Stock Popped Today ||| Intercontinental Exchange Inc. (ICE) Ex-Dividend Date Scheduled for June 14, 2017",1,0.47261146
2017-06-14,3652900.0,222.9900054931641,226.94000244140625,221.759994506836,226.509994506836,214.825912475586,GS,When Will Amazon.com Split Its Stock Again?,0,0.5055223
2017-06-15,3378900.0,224.8099975585937,226.3500061035156,222.8000030517578,223.22999572753903,211.71511840820312,GS,"Stock Market News for June 15, 2017 ||| BofA (BAC) on Track to Reduce Costs, Lays Off Employees ||| Financial Sector Update for 06/15/2017: JPM, BAC, WFC, C, USB, BX, MRCC ||| 5 Top-Performing No-Load Mutual Funds Investors Will Love ||| Fed Hikes Rate, Sets Asset Plan: 5 Top Gainers",0,0.46587437
2017-06-16,3758300.0,222.6499938964844,223.6699981689453,221.1300048828125,221.8099975585937,210.36834716796875,GS,3 Long-Term Government Bond Mutual Funds for Safe Returns,1,0.5765797
2017-06-19,2900900.0,223.42999267578125,227.0399932861328,223.1100006103516,226.1300048828125,214.46554565429688,GS,"Stock Market News for June 19, 2017",0,0.46992186
2017-06-20,2264200.0,225.509994506836,226.5399932861328,224.19000244140625,225.1000061035156,213.4886474609375,GS,Foreign Stock Funds Outdo U.S. Equals: 4 Picks ||| Why Sunrun Inc's Shares Popped 11% Today,0,0.50791675
2017-06-21,3015300.0,224.5399932861328,224.92999267578125,221.92999267578125,222.4900054931641,211.0133056640625,GS,"WPP Invests $6.5 Mln in Mic Network to Expand Digital Revenue Footprint ||| DIA, GS, BA, IBM: Large Inflows Detected at ETF",0,0.51993775
2017-06-22,3344600.0,221.44000244140625,221.8999938964844,219.2899932861328,219.7700042724609,208.43359375,GS,"Consumer Sector Update for 06/22/2017: OMNT,BKS,TMHC ||| Ericsson Divests Power Module Unit as Part of Restructuring ||| Associated Capital Group, Inc. (AC) Ex-Dividend Date Scheduled for June 23, 2017 ||| Market Close Report: NASDAQ Composite index closes at 6,236.69 up 2.74 points",0,0.45001972
2017-06-23,4448700.0,220.5,220.69000244140625,216.4600067138672,217.19000244140625,205.98667907714844,GS,"Stock Market News for June 23, 2017 ||| US Market Indexes Mostly Higher on Friday With Gains for the Week",1,0.47294706
2017-06-26,2589500.0,218.259994506836,221.97000122070312,217.6999969482422,220.44000244140625,209.06903076171875,GS,"This Sector Play Is In Buy Range; Banks Rise, But Techs Fall ||| Dow Movers: UNH, GS ||| 2 Investment Banks That Could Raise Their Dividends Soon ||| Morgan Stanley to Shift Most Jobs to Frankfurt Post Brexit ||| Market Close Report: NASDAQ Composite index closes at 6,247.15 down -18.10 points ||| Close Update: S&P 500, Dow Edge Higher as Utilities Lead; Nasdaq Weighed by Tech ||| Advanced Micro Devices, Inc. (AMD) Stock Is Spunky and Resilient, But …",0,0.4794443
2017-06-27,2899400.0,221.83999633789065,222.4100036621093,219.5599975585937,220.27999877929688,208.91726684570312,GS,"Berkshire Hathaway: The Tale of Two Recent Deals ||| JMP Group LLC (JMP) Ex-Dividend Date Scheduled for June 28, 2017",1,0.46715406
2017-06-28,3482800.0,221.8699951171875,224.6300048828125,220.75,223.22000122070312,211.7056121826172,GS,"Noteworthy Wednesday Option Activity: CHRW, GS, EXPE",1,0.5278486
2017-06-29,5063400.0,228.3699951171875,228.7899932861328,223.02999877929688,224.4100036621093,212.8342437744141,GS,"De-Stress Your Portfolio by Betting on Bank ETFs ||| Banks Hold Up As Market Sells Off; Chips, Tech Get Hammered ||| Close Update: Wall Street Gives Up Gains on Reignited Tech Selloff ||| Dow Movers: MSFT, JPM",0,0.49045348
2017-06-30,3154300.0,225.3099975585937,226.0500030517578,221.5399932861328,221.8999938964844,210.4537048339844,GS,"What Are Social Impact Bonds, and Should I Invest in Them? ||| Market Close Report: NASDAQ Composite index closes at 6,140.42 down -3.93 points",1,0.4948689
2017-07-03,2846600.0,224.4600067138672,229.07000732421875,223.4199981689453,227.27999877929688,215.55618286132807,GS,HSBC Chinese Joint Venture OK'd: What About Other Banks? ||| US Market Indexes Higher on Monday ||| Oil And Financial Stocks Continue Rally; When Will This Sector Catch Up?,1,0.50795525
2017-07-05,2772000.0,228.3800048828125,228.9199981689453,225.2100067138672,228.0399932861328,216.2769775390625,GS,"See How Goldman Sachs Group Ranks Among Analysts' Top Dow 30 Picks ||| Dow Analyst Moves: GS ||| JPMorgan (JPM) and Vantiv in Race for Worldpay Takeover ||| Noteworthy Wednesday Option Activity: GOOGL, GS, LB ||| A Timeline of Warren Buffett's Bank Stock Buys",0,0.49107167
2017-07-06,3076600.0,227.97000122070312,230.0599975585937,225.25,226.69000244140625,214.99659729003903,GS,"Trade Bank of America Corp (BAC) Stock Into the Earnings Fog ||| Goldman (GS) Plans to Turn Simon into a Neutral Platform ||| Waddell & Reed Financial, Inc. (WDR) Ex-Dividend Date Scheduled for July 07, 2017 ||| Deutsche Bank (DB) to Shift Operations to Frankfurt Soon",0,0.469341
2017-07-07,2697600.0,228.22999572753903,228.4900054931641,224.4199981689453,225.27999877929688,213.6593780517578,GS,"Market Close Report: NASDAQ Composite index closes at 6,153.08 up 63.62 points ||| Takeaways From The AMZN / WFM Deal ||| DIA, GS, BA, IBM: Large Outflows Detected at ETF",1,0.50776476
2017-07-10,2357500.0,224.2700042724609,227.33999633789065,223.9600067138672,225.83999633789065,214.19046020507807,GS,"Dow Movers: INTC, GS ||| Fox Run Management, L.l.c. Buys MSCI Inc, United Continental Holdings Inc, Brooks Automation ...",1,0.51250166
2017-07-11,2742900.0,226.0399932861328,227.9499969482422,224.6699981689453,226.9499969482422,215.24322509765625,GS,"Bitcoin Prices Could Hit $5,000 Value By 2018, Experts Say ||| 3 Smart-Beta ETFs That You Must Own",1,0.48340726
2017-07-12,2567300.0,226.3999938964844,229.0200042724609,226.07000732421875,227.38999938964844,215.6605224609375,GS,"Twitter (TWTR) Concludes Search for CFO, Appoints Ned Segal ||| ABM Likely to Buy GCA Services to Boost Education Foothold ||| Noteworthy Wednesday Option Activity: GS, MBI, VEEV",1,0.49550447
2017-07-14,3703600.0,227.22000122070312,229.6100006103516,225.1000061035156,228.6000061035156,216.8081512451172,GS,"Here's Why Dow Jones ETFs are Moving North ||| Dow Shakes Off Banks; Emerging Markets Rally As China Stock Surges ||| Will Bleak Trading Revenue Hurt Goldman's (GS) Q2 Earnings? ||| Upcoming Earnings Reports to Watch: NFLX, GS, QCOM, MSFT ||| Ulta Beauty (ULTA) Stock Climbs after Goldman Sachs Upgrade ||| Dow Movers: JPM, WMT ||| US Market Indexes Higher on Thursday",1,0.5016793
2017-07-17,2551800.0,228.72999572753903,229.63999938964844,227.2100067138672,229.259994506836,217.43408203125,GS,"Goldman Sachs reports second-quarter results July 18 ||| 3 Stocks That Turned $1,000 Into at Least $2,017 in 12 Months ||| Q2 Earnings Grab Spotlight ||| The Zacks Analyst Blog Highlights: Netflix, Goldman Sachs, Qualcomm and Microsoft ||| Investment Management Earnings on Jul 18: GS, IBKR & AMTD ||| Close Update: Market Averages Flat as Investors Wait for Direction From Earnings ||| Pre-Market Earnings Report for July 18, 2017 : JNJ, BAC, UNH, GS, LMT, PLD, NVS, PGR, AMTD, ERIC, CMA, HOG ||| Should Goldman Sachs (GS) Investors Worry About Sluggish Bank Stocks?",0,0.49006432
2017-07-18,6400700.0,227.5,230.3600006103516,222.759994506836,223.3099975585937,211.79098510742188,GS,"Wall Street Sees Cautiously Lower Open Amid Corporate Earnings ||| Goldman Sachs Group Inc (GS) Stock Slips on Bond Trading Drop ||| 3 Sectors Gain As Netflix Lifts Nasdaq; Goldman Hurts Dow ||| US Futures Mostly Lower as Traders Digest Corporate Earnings ||| Goldman's (GS) Equities Revenue, Low Costs Drive Q2 Earnings ||| Wall Street Banks And Household Brands Report Earnings ||| Midday Update: Stocks Roiled By Failed Healthcare Reform, Banking Sector Quarterly Results ||| GS, NFLX Earnings Show Importance Of Homework For Traders, Investors ||| Nasdaq Heads for Record After Netflix Results While Goldman Keeps Dow Red ||| Q2 Earnings Reports Hit the Tape: GS, BAC, JNJ, LMT & UNH ||| Goldman Sachs (GS) Q2 Earnings Beat on High Equities Revenue ||| Goldman Sachs’ Stock Down Following Earnings Report ||| What Happened in the Stock Market Today ||| Earnings Reaction History: Goldman Sachs Group Inc., 45.5% Follow-Through Indicator, 1.6% Sensitive ||| Netflix Helps Nasdaq to Record High; Goldman Drags Down Dow Jones Industrial Average ||| Close Update: Nasdaq Hits Record After Netflix Results While Goldman Keeps Dow Seeing Red ||| Market Close Report: Historical high reached as NASDAQ Composite Index closes at 6,344.31.",0,0.48187855
2017-07-19,4884600.0,222.9100036621093,224.1999969482422,221.6699981689453,222.8699951171875,211.37368774414065,GS,"3 Big Stock Charts for Wednesday: International Business Machines Corp. (IBM), Netflix, Inc. (NFLX) and Goldman Sachs Group Inc (GS) ||| Stock Market News for July 19, 2017 ||| Why Twitter Inc (TWTR) Stock Desperately Needs a “Real” CEO to Back It Up ||| Is the Options Market Predicting a Spike in Goldman Sachs (GS) Stock? ||| Earnings Season Off to a Good Start ||| Earnings Season Off to a Good Start",0,0.48297903
2017-07-20,3497800.0,223.0,224.759994506836,221.6100006103516,222.3000030517578,210.83306884765625,GS,"Notable Thursday Option Activity: GILD, GS, ATHN ||| Zacks Earnings Trends Highlights: Morgan Stanley and Goldman Sachs ||| Ex-Div Reminder for Goldman Sachs Group Non-Cumulative Preferred Stock, Series N",0,0.48214522
2017-07-21,3446600.0,221.88999938964844,222.3099975585937,219.08999633789065,220.17999267578125,208.82244873046875,GS,New Strong Sell Stocks for July 21st ||| Midday Update: GE Weighs on Dow,0,0.49941164
2017-07-24,3123100.0,218.94000244140625,219.72999572753903,218.0,218.17999267578125,206.92559814453125,GS,"How Goldman Sachs Is Disrupting This $1 Trillion Industry ||| Goldman Sachs Group's Preferred Stock, Series B Shares Cross 6% Yield Mark",1,0.48894158
2017-07-26,2792500.0,222.4499969482422,223.7400054931641,221.8699951171875,222.25,210.78564453125,GS,"Morgan Stanley (MS) Ex-Dividend Date Scheduled for July 27, 2017 ||| JMP Group LLC (JMP) Ex-Dividend Date Scheduled for July 27, 2017 ||| Top Stock Reports for McDonald's, 3M & Stryker ||| Here’s Why You Need to Stay Long Bank of America Corp (BAC) Stock",0,0.45324397
2017-07-27,2812500.0,221.83999633789065,222.7100067138672,220.42999267578125,221.47999572753903,210.05538940429688,GS,"The Zacks Analyst Blog Highlights: McDonald's, 3M, Stryker, Goldman Sachs and Kinder Morgan ||| TD Ameritrade Holding Corporation (AMTD) Ex-Dividend Date Scheduled for July 28, 2017 ||| Noteworthy Thursday Option Activity: GS, CHTR, CRM",1,0.47421473
2017-07-28,2483200.0,221.7700042724609,223.6699981689453,220.8600006103516,223.6100006103516,212.0755157470703,GS,"Boeing Co (BA) Stock Is a First-Class Ride Towards $260 ||| Noteworthy ETF Outflows: DIA, GS, TRV, CAT",1,0.50366557
2017-07-31,1994900.0,223.9499969482422,225.5,223.0500030517578,225.3300018310547,213.7068023681641,GS,"Should You Buy Bank of America Corp (BAC) Stock? 3 Pros, 3 Cons ||| Here's Why Tesla (TSLA) Shares Are Falling Today",1,0.47288027
2017-08-01,2986800.0,227.08999633789065,228.6199951171875,226.72999572753903,227.0,215.29063415527344,GS,"How to Trade Tesla with ETFs Ahead of Earnings? ||| Dow Movers: MCD, JPM",0,0.49743348
2017-08-02,1863300.0,226.3999938964844,227.72999572753903,225.57000732421875,226.2700042724609,214.59829711914065,GS,"Will This Trend Weigh on Bank Profits Again This Quarter? ||| Stock Market News For August 02, 2017",0,0.47078216
2017-08-03,2106400.0,226.0,226.7400054931641,223.97000122070312,223.9900054931641,212.4359130859375,GS,"5 Blue-Chip Stocks to Buy as the Dow Breezes Past 22,000 ||| Stock Market News For August 03, 2017 ||| Validea John Neff Strategy Daily Upgrade Report - 8/3/2017",1,0.49084684
2017-08-04,3400300.0,226.0500030517578,229.7899932861328,225.0599975585937,229.7899932861328,217.9367218017578,GS,"Dow Heads For Nine As JPMorgan, Goldman Rally; Is It Still A Buy? ||| Market News For August 04, 2017 ||| How Important Is Trading Revenue to JPMorgan Chase? ||| Market Close Report: NASDAQ Composite index closes at 6,351.56 up 11.22 points",1,0.47947714
2017-08-07,3809800.0,229.8000030517578,233.1300048828125,229.2899932861328,232.9199981689453,220.9052581787109,GS,"Notable ETF Inflow Detected - DIA, GS, TRV, CAT ||| Dow Movers: UTX, MCD ||| Monday’s Vital Data: Tesla Inc (TSLA), Teva Pharmaceutical Industries Ltd (ADR) (TEVA) and Snap Inc (SNAP) ||| LPL Financial Holdings Inc. (LPLA) Ex-Dividend Date Scheduled for August 08, 2017 ||| Goldman Sachs Group Inc (GS) Stock Is a Top Breakout Pick ||| Close Update: U.S. Stocks Push on With March Higher as Dow Climbs For 10th Consecutive Day",0,0.48092633
2017-08-08,3322500.0,232.3999938964844,235.8300018310547,231.6999969482422,232.0500030517578,220.0801696777344,GS,"Stock Market News For August 08, 2017 ||| A Crash-Proof Way to Bank 13% a Year ||| The Charles Schwab Corporation (SCHW) Ex-Dividend Date Scheduled for August 09, 2017 ||| Oppenheimer Holdings, Inc. (OPY) Ex-Dividend Date Scheduled for August 09, 2017",0,0.45713687
2017-08-09,2571100.0,230.32000732421875,231.4900054931641,229.0599975585937,231.009994506836,219.0937957763672,GS,"Dow Movers: DIS, TRV ||| Snap the Market Slumber With These 5 Winning Financial Picks ||| BGC Partners, Inc. (BGCP) Ex-Dividend Date Scheduled for August 10, 2017",0,0.429536
2017-08-10,3325500.0,229.0200042724609,229.4499969482422,225.47000122070312,225.5,213.8680114746093,GS,"Midday Update: Geopolitical Risks Exacerbate Profit-Taking in Stocks ||| Dow Movers: GS, CVX ||| Goldman Sachs to Divest Remaining Stake in Rothesay Life ||| Kiltearn Partners LLP Buys Helmerich & Payne Inc, McKesson Corp, United Natural Foods Inc, ...",0,0.4914973
2017-08-11,2956600.0,225.07000732421875,226.67999267578125,222.6499938964844,224.1499938964844,212.587646484375,GS,"3 Dow Jones Stocks That Are in Trouble ||| 3 Big Stock Charts for Friday: iShares Russell 2000 Index (ETF) (IWM), Goldman Sachs Group Inc (GS) and Merck & Co., Inc. (MRK) ||| Stocks Stem Three-Day Slide as Inflation Miss Curbs Rate-Hike Expectations",1,0.5237719
2017-08-14,2266100.0,226.3699951171875,229.8300018310547,226.3000030517578,227.3600006103516,215.63204956054688,GS,"Dow Movers: HD, GS ||| US Market Indexes Start the Week Higher ||| Here Is a Crash-Proof Way You Can Bank 13% Per Year",1,0.5054398
2017-08-15,1867000.0,229.57000732421875,230.6100006103516,227.5,227.58999633789065,215.8501739501953,GS,"Real Estate Startup Redfin (RDFN) Keeps Soaring ||| IWV, PCLN, BMY, GS: ETF Outflow Alert ||| DIA, VIXM: Big ETF Inflows",0,0.49448532
2017-08-16,2393900.0,228.259994506836,229.009994506836,225.0,225.6100006103516,213.97232055664065,GS,GoPro Stock Tanks One Day After Upgrade,0,0.5225043
2017-08-17,3460300.0,224.3800048828125,225.97999572753903,221.1100006103516,221.4199981689453,209.9984436035156,GS,"Investment Technology Group, Inc. (ITG) Ex-Dividend Date Scheduled for August 18, 2017 ||| Midday Update: Washington and Walmart Weigh on Wall Street",1,0.46243906
2017-08-18,3149300.0,220.7899932861328,224.08999633789065,220.5500030517578,222.1499938964844,210.6908264160156,GS,"Noteworthy Friday Option Activity: GS, CBRL, PVH ||| Why Is Goldman Sachs (GS) Up 1.2% Since the Last Earnings Report? ||| No, Millennials Are Not Killing Craft Beer",0,0.47434378
2017-08-21,2203300.0,222.3999938964844,222.3999938964844,219.2100067138672,220.7899932861328,209.4009552001953,GS,"Goldman (GS) Gets Consent for Equity Trading in Saudi Arabia ||| Financial Sector Update for 08/21/2017: JPM, BAC, C, USB, WFC, GS, KKR ||| Financial Sector Update for 08/21/2017: TBK,HBMD,GS ||| Financial Sector Update for 08/21/2017: MTB, C, GS",1,0.47553286
2017-08-22,2021300.0,221.8600006103516,223.77999877929688,221.3300018310547,223.5800018310547,212.0470428466797,GS,"First Week of GS April 2018 Options Trading ||| Goldman Sachs (GS) to Boost Commodities Unit With New Hires ||| Financial Sector Update for 08/22/2017: JPM, BAC, WFC, C, USB, GS, KKR ||| What's Next for Bristol-Myers Squibb After Its Opdivo Setback? ||| Why Did Redfin (RDFN) Stock Sink Today?",0,0.47238263
2017-08-23,2568000.0,221.8999938964844,224.8099975585937,221.3300018310547,222.7400054931641,211.25038146972656,GS,"Income Reading List: How Investors View Venezuelan, European Debt; Companies Paying Big Dividends ||| Piper Jaffray Companies (PJC) Ex-Dividend Date Scheduled for August 24, 2017",1,0.46223122
2017-08-25,2232500.0,223.63999938964844,224.9499969482422,222.1300048828125,222.47000122070312,210.99429321289065,GS,"Goldman Sachs Group Becomes #19 Most Shorted Dow Stock, Replacing JPMorgan Chase ||| 3 Financial Stocks You Can Keep Forever",0,0.49164513
2017-08-28,2641600.0,222.9100036621093,223.08999633789065,218.8600006103516,220.3500061035156,208.98367309570312,GS,"Dow Movers: TRV, HD ||| JMP Group LLC (JMP) Ex-Dividend Date Scheduled for August 29, 2017 ||| Goldman Sachs Group, Inc. (GS) Ex-Dividend Date Scheduled for August 29, 2017",0,0.42402047
2017-08-29,2369100.0,217.2700042724609,220.1300048828125,215.75,219.9600067138672,209.3262634277344,GS,"Dow Movers: NKE, UNH ||| Navient Corporation (NAVI) Ex-Dividend Date Scheduled for August 30, 2017 ||| CBOE Holdings, Inc. (CBOE) Ex-Dividend Date Scheduled for August 30, 2017 ||| Virtu Financial, Inc. (VIRT) Ex-Dividend Date Scheduled for August 30, 2017 ||| Interactive Brokers Group, Inc. (IBKR) Ex-Dividend Date Scheduled for August 30, 2017 ||| Goldman Sachs Group's Preferred Stock, Series K Yield Pushes Past 5.5%",1,0.45386705
2017-08-30,2411400.0,220.25,224.22000122070312,220.08999633789065,222.4199981689453,211.66734313964844,GS,"Will GoM Oil Refiners, Drillers Survive the Harvey Mayhem? ||| Dow Movers: JNJ, GS ||| Financial Sector Update for 08/30/2017: JPM, BAC, WFC, C, USB, GS, GPT ||| BlackRock, Inc. (BLK) Ex-Dividend Date Scheduled for August 31, 2017",1,0.47481364
2017-09-01,2346900.0,224.5500030517578,227.5599975585937,223.52999877929688,225.8800048828125,214.9600524902344,GS,US Market Indexes Higher on Friday,0,0.5005043
2017-09-05,5646200.0,223.8500061035156,224.0,217.3000030517578,217.77999877929688,207.2516632080078,GS,"5 Dividend Champions to Counter an Awful September ||| Close Update: Wall Street Slides as Investors Seek Havens on Global and Domestic Jitters ||| Dow Movers: UTX, HD",1,0.5145151
2017-09-06,3613600.0,218.97999572753903,221.0200042724609,217.6100006103516,218.8300018310547,208.2509002685547,GS,"CME Group Inc. (CME) Ex-Dividend Date Scheduled for September 07, 2017 ||| US Market Indexes Lower With Increased Trading Volatility",0,0.47308517
2017-09-07,3594600.0,218.72999572753903,218.8099975585937,214.63999938964844,215.83999633789065,205.40542602539065,GS,"Goldman Sachs CEO Thinks Markets Are Too High ||| Health Care Sector Update for 09/07/2017: EKSO, NLNK, ALNY",1,0.47942483
2017-09-08,3120900.0,215.509994506836,219.27999877929688,215.3999938964844,217.2100067138672,206.709213256836,GS,"Go Long the Financial Select Sector SPDR Fund (XLF) ||| Dow Movers: IBM, TRV ||| Stock Market News For Sep 8, 2017 ||| GAIN Capital Holdings, Inc. (GCAP) Ex-Dividend Date Scheduled for September 11, 2017 ||| Notable Friday Option Activity: GOOG, GS, GOOGL ||| These Charts Explain Why Goldman Sachs' CEO Is Unnerved by the Markets Right Now",1,0.4842702
2017-09-11,2971500.0,220.07000732421875,221.88999938964844,218.9900054931641,221.0599975585937,210.37307739257807,GS,"Goldman Sachs (GS) to Expand Retail Banking, Moves to UK ||| 7 Preferred Stocks for High Yields and Diversified Risk",1,0.5090816
2017-09-12,3745800.0,222.5399932861328,227.69000244140625,222.0200042724609,225.9499969482422,215.0266876220703,GS,"Dow Movers: MCD, DWDP ||| Citigroup (C) Projects Weak Q3 Trading Revenues on Y/Y Basis ||| Goldman Sachs (GS) Slashes Fees for its Smart-Beta Funds ||| Goldman Sachs (GS) Invests 100 Million Pounds in Neyber ||| T. Rowe Price Group, Inc. (TROW) Ex-Dividend Date Scheduled for September 13, 2017 ||| Close Update: Wall Street Hits Record Highs as Telecoms, Financials Lead",1,0.50260824
2017-09-13,2383500.0,225.25,227.13999938964844,224.72000122070312,226.5599975585937,215.607177734375,GS,"Big Banks See Slump in Q3 Trading Revenues on Y/Y Basis ||| Quantifying Costs: Hurricanes and iPhone X ||| Is Goldman Sachs Overly Optimistic About its Revenue Growth? ||| Nasdaq, Inc. (NDAQ) Ex-Dividend Date Scheduled for September 14, 2017 ||| Intercontinental Exchange Inc. (ICE) Ex-Dividend Date Scheduled for September 14, 2017 ||| Aftermath of The Hurricanes ||| Stock Market News For Sep 13, 2017",1,0.454789
2017-09-14,1986600.0,226.1000061035156,228.1000061035156,226.0500030517578,226.8500061035156,215.8832092285156,GS,Why Buy BAC Stock After Recent Selloff?,0,0.50046873
2017-09-15,4365800.0,227.1499938964844,227.2100067138672,223.82000732421875,225.22000122070312,214.3319702148437,GS,"June 2019 Options Now Available For Goldman Sachs Group ||| Dow Movers: GS, BA ||| This Week in Solar",1,0.496216
2017-09-18,2466800.0,226.3000030517578,229.0,225.6600036621093,227.52999877929688,216.53028869628903,GS,"Will Goldman Sachs Finally Split Its Stock? ||| This Is Bad News for Third-Quarter Bank Earnings ||| Noteworthy Monday Option Activity: DRI, GS, CRM",1,0.48332968
2017-09-19,1858000.0,228.009994506836,230.13999938964844,227.3300018310547,228.9100036621093,217.8435821533203,GS,"TD Ameritrade Acquires Scottrade, Moody's Upgrades Ratings ||| Dow Analyst Moves: GS ||| 3 Big Stock Charts for Tuesday: Costco Wholesale Corporation (COST), Goldman Sachs Group Inc. (GS) and TripAdvisor Inc. (TRIP) ||| The 7 Best Dow Jones Stocks to Buy Today",1,0.49132696
2017-09-20,2682300.0,229.5,231.6499938964844,228.5,229.7899932861328,218.68101501464844,GS,"Stock Market News For Sep 20, 2017 ||| GS Crosses Above Key Moving Average Level",1,0.5094286
2017-09-21,1800800.0,229.88999938964844,232.1000061035156,229.3999938964844,231.2899932861328,220.10850524902344,GS,"Top Analyst Reports for MasterCard, Netflix & Honeywell",0,0.5102298
2017-09-22,1861800.0,230.63999938964844,231.4900054931641,228.8800048828125,231.02999877929688,219.861068725586,GS,"Dow Movers: AAPL, BA ||| Music Sales Keep Climbing on Paid Streaming: 2 Top Gainers ||| Goldman Sachs (GS) May Continue Witnessing Revenue Pressure",0,0.51455766
2017-09-25,2261800.0,230.7700042724609,231.8600006103516,228.3600006103516,230.259994506836,219.12831115722656,GS,"The Zacks Analyst Blog Highlights: Goldman Sachs, Sony, Amazon.com, Pandora Media and Nexstar Media ||| How the 4 Newest Dow Stocks Have Surprised Investors ||| Noteworthy Monday Option Activity: DRI, GS, K",0,0.492218
2017-09-26,1770000.0,230.8600006103516,231.44000244140625,229.02999877929688,229.94000244140625,218.82379150390625,GS,Buy Bank of America Corp (BAC) Stock Even After This Rally,1,0.52709085
2017-09-27,3072100.0,234.07000732421875,235.6000061035156,232.9100036621093,234.759994506836,223.4107666015625,GS,"Close Update: Equities Advance With Dow Snapping Four-Day Skid as Trump's Tax Framework Released ||| Goldman, JPMorgan Lead Dow; One Of These 2 Equity Plays Breaks Out ||| Stock Indexes Up; Trump To Unveil Tax Cut Details ||| DIA, GS, UNH, HD: ETF Inflow Alert ||| Banks And Financial Stocks: Latest News And Analysis ||| 10 Best Dow Jones Stocks to Buy for the Rest of 2017 ||| Top Stock Reports for Goldman Sachs, PepsiCo and Johnson & Johnson ||| Nasdaq Kicks Higher, Apple Up Again; Can These 5 Chip Stocks Catch Nvidia? ||| JMP Group LLC (JMP) Ex-Dividend Date Scheduled for September 28, 2017 ||| Dow Movers: NKE, GS",1,0.49703783
2017-09-28,2121800.0,235.0,236.1999969482422,233.5,235.47000122070312,224.08645629882807,GS,"Stock Market News For Sep 28, 2017 ||| Raymond James Financial, Inc. (RJF) Ex-Dividend Date Scheduled for September 29, 2017 ||| The Zacks Analyst Blog Highlights: Goldman Sachs Group, PepsiCo, Johnson & Johnson, Cummins and Fidelity National Information Services ||| The Best-Performing Big Bank Stock in September",1,0.48863673
2017-09-29,1902300.0,235.009994506836,237.6000061035156,234.57000732421875,237.19000244140625,225.72329711914065,GS,"Dow Movers: MRK, V ||| US Market Indexes Gain on Friday, Finish Higher for September",1,0.504793
2017-10-02,2501300.0,237.1999969482422,241.1000061035156,237.1000061035156,240.6499938964844,229.0160217285156,GS,"Small Caps, Dow Names Lead; Should You Buy These 5 Stocks In Bases? ||| Notable Monday Option Activity: GS, CYTK, CMPR ||| Could Goldman Sachs Be The First Bank To Offer Bitcoin Trades?",1,0.4876093
2017-10-03,2010800.0,241.07000732421875,242.7100067138672,239.69000244140625,241.6199951171875,229.9391326904297,GS,"Stock Market News For Oct 3, 2017 ||| Goldman (GS) Might Initiate Bitcoin Trading Operation Soon",0,0.485987
2017-10-04,1840400.0,241.6199951171875,242.8800048828125,240.1199951171875,240.3099975585937,228.6924591064453,GS,Wall Street's Winning Streak Pauses; Private Sector Hiring Slows,1,0.5448283
2017-10-05,3521300.0,241.0,246.32000732421875,240.1199951171875,246.0599975585937,234.1644592285156,GS,"Dow Movers: UNH, AAPL ||| Market Close Report: Historical high reached as NASDAQ Composite Index closes at 6,585.36. ||| 'Fear Index' Falls to Record Low Close; S&P Secures Longest Win Streak in 4 Years ||| Close Update: Wall Street Extends Rally on Strong Data, House Passes Budget Resolution ||| Wall Street Extends Rally on Strong Data, House Passes Budget Resolution ||| Thursday Sector Leaders: Financial, Services",0,0.47924793
2017-10-06,2396100.0,246.3000030517578,247.0800018310547,244.6100006103516,246.0200042724609,234.12643432617188,GS,"Stock Market News For Oct 6, 2017 ||| Goldman Sachs Gets Technical Rating Upgrade ||| 3 Earnings Reports to Watch Next Week",0,0.48779327
2017-10-09,2165200.0,245.1499938964844,246.3500061035156,242.0200042724609,242.8000030517578,231.0621032714844,GS,"Five Ways That You -- and Companies -- Can Maintain a Competitive Edge ||| Waddell & Reed Financial, Inc. (WDR) Ex-Dividend Date Scheduled for October 10, 2017",0,0.4590815
2017-10-10,2187100.0,242.8000030517578,243.72999572753903,241.6999969482422,242.6000061035156,230.87176513671875,GS,"Big Banks Will Win The Fintech Revolution ||| Will Dow ETFs Continue to Shine in Q3 Earnings? ||| US Market Indexes Lower on Monday ||| Should You Buy Bank ETFs Before Earnings Release? ||| Noteworthy Tuesday Option Activity: GS, MMM, GM",0,0.4831017
2017-10-11,2175700.0,242.0,243.1999969482422,241.3500061035156,242.3999938964844,230.68142700195312,GS,How Legal Is Bitcoin Anyway? ||| Why Did Kroger (KR) Stock Gain Today?,0,0.48511106
2017-10-12,2148200.0,242.3300018310547,243.4199981689453,238.75,239.8000030517578,228.20713806152344,GS,"5 Ways to Maintain a Competitive Edge, No. 5: Be Willing to Outwait Your Rivals ||| How to Go Long JPMorgan Chase & Co. (JPM) Stock With Confidence ||| JPMorgan Sees Nothing To Spark Trading As Wall St. Waits On Tax Reform ||| Bitcoin Hits Record; JPMorgan 'Open Minded' To Regulated Digital Cash",0,0.501847
2017-10-13,2491000.0,239.0,239.4499969482422,236.83999633789065,238.52999877929688,226.9985198974609,GS,"What Is Organic Growth, and When Is It a Smart Idea? ||| DIA, GS, MMM, UNH: Large Inflows Detected at ETF ||| Will Trading Weakness Impact Goldman's (GS) Q3 Earnings? ||| Global Thematic Partners, LLC Buys Edison International, Baidu Inc, Match Group Inc, Sells ...",1,0.5047551
2017-10-16,2969200.0,238.6000061035156,242.759994506836,238.3500061035156,242.4100036621093,230.69094848632807,GS,"Will Wall Street Sell the Earnings News? ||| Is PayPal a $75 Stock? ||| Buy JPMorgan Chase & Co. (JPM) as It Crushes Another Quarter ||| Midday Update: Wall Street Extends Gains, But Drug Companies Roiled by Trump's Shot Across the Bow ||| Energy, Banking Stocks Up; 4 More Reasons To Keep Holding Apple ||| Close Update: Wall Street Continues Record-Setting Run as Banking Sector Braces For Earnings ||| Stocks Up At Open; Apple Gets Upgrade; Empire State Survey Spikes ||| Goldman Sachs vs. Morgan Stanley: Which Earnings Report Will Be Best? ||| Dow Leads Stocks As Indexes Crawl To Record Highs Again ||| 4 Dow Stocks To Report Earnings Tuesday: Investing Action Plan ||| Indexes Close At New Highs, Dow Eyes 23,000 As Six Blue Chips Rally ||| Pre-Market Earnings Report for October 17, 2017 : JNJ, UNH, GS, MS, CSX, PLD, PGR, CMA, GWW, HOG, SNV, SYNT",0,0.49007216
2017-10-17,7088400.0,244.44000244140625,244.88999938964844,235.19000244140625,236.08999633789065,224.6764678955078,GS,"Stocks Rise As Dow Nears 23,000, UnitedHealth, J&J Lead Dow ||| Correction: Wall Street Sees Narrowly Mixed Open Amid Corporate Earnings, Data ||| Goldman Sachs Group Inc (GS) Stock Drops Despite Q3 Earnings Beat ||| Goldman's (GS) Q3 Earnings Encouraging, Revenues Up Y/Y ||| Goldman Sachs Earnings: A Strong Quarter After a Weak Start to 2017 ||| Market: Spectacular All Around ||| Dow Movers: GS, UNH ||| Q3 Earnings Blasting Off: GS, MS, JNJ and More ||| Midday Update: Dow Reaches 23,000 Milestone on Healthcare Gains ||| Stocks Sputter While Facebook Climbs Past Its Buy Point ||| Wall Street Sees Narrowly Mixed Open Amid Corporate Earnings, Data ||| Here's How Rivals Goldman Sachs, Morgan Stanley Are Diverging ||| Dow 23,000 Becomes Reality as Melt Up Intensifies ||| Earnings Reaction History: Goldman Sachs Group Inc., 54.5% Follow-Through Indicator, 1.8% Sensitive ||| Market Close Report: NASDAQ Composite index closes at 6,623.66 down -.35 points ||| U.S. Stocks End Mixed After a Quick Trip Up to Dow 23K ||| Goldman Sachs Earnings: Bank Combats Trading Drop With Private Equity Gain ||| Notable Tuesday Option Activity: GS, TSLA, BA ||| Goldman Sachs (GS) Beats Q3 Earnings & Revenue Estimates",1,0.48488736
2017-10-18,4235900.0,236.8699951171875,242.6499938964844,236.8699951171875,242.02999877929688,230.32931518554688,GS,"7 Reasons Bitcoin Is Barreling Toward a $100 Billion Market Cap ||| Stock Market News For Oct 18, 2017 ||| Dow Leads Indexes Up, As IBM Stuns Street ||| Is Goldman Sachs Losing Its Mojo on Wall Street? ||| Dow Leads On IBM, Goldman; New China IPO Surges ||| Close Update: Wall Street Stretches String of Record Closes With Tailwind From IBM ||| Dow Storms Past 23,000 On IBM Outlook As This Chipmaker Spikes",0,0.5069655
2017-10-19,2710900.0,240.3500061035156,240.9900054931641,238.1000061035156,239.9900054931641,228.3879547119141,GS,Next Fed Chair: Who Will Replace Janet Yellen? ||| A Great Day for a Selloff! Dow Drops 70 Points as Wall Street 'Celebrates' Black Monday ||| Goldman Sachs Sees Relative Strength Rating Climb To 72,1,0.5103704
2017-10-20,3022800.0,242.9499969482422,245.25,240.6699981689453,244.72999572753903,232.89878845214844,GS,"Stitch Fix IPO: 14 Things for Potential Investors to Know ||| E*TRADE (ETFC) Q3 Earnings & Revenues Beat, Costs Flare Up ||| Dow Gaps Up Again To Record High; JPMorgan, Goldman Lead ||| Bitcoin Price Surpasses $6,000 — the Blockchain Bubble Is Here ||| Goldman Nears Buy Point As Bank Stocks Rally On Move Toward Tax Cuts ||| Close Update: Stocks Rally as Washington Moves Closer to Tax Reform Legislation ||| Top Research Reports for UnitedHealth, Goldman Sachs & Morgan Stanley",0,0.5033571
2017-10-23,1963300.0,244.38999938964844,245.3300018310547,241.3800048828125,242.1300048828125,230.42446899414065,GS,"How Does JPMorgan Chase Make Money? ||| Goldman Sachs Group Non-Cumulative Preferred Stock, Series B About To Put More Money In Your Pocket",1,0.4902736
2017-10-24,2285300.0,243.6000061035156,246.25,243.0,244.83999633789065,233.00347900390625,GS,Big Hitters Boost Blue-Chip Dow; 2 Near Entries,0,0.5034475
2017-10-25,2904300.0,246.1600036621093,246.5,240.8000030517578,241.7100067138672,230.0247802734375,GS,"Noteworthy Wednesday Option Activity: WATT, JNPR, GS ||| Stock Action Turns Ugly; This Blue Chip Beats But Still Sinks ||| TD Ameritrade (AMTD) Q4 Earnings Beat Estimates, Stock Up ||| Greenhaven Associates Inc Buys Taylor Morrison Home Corp, Sells Boeing Co ||| Are These Dow Stocks as Cheap as They Appear? Part 5 ||| Investing in Bank Stocks: What You Need to Know",1,0.5061147
2017-10-26,1948800.0,242.6100006103516,244.0,241.52999877929688,241.72000122070312,230.0343017578125,GS,"With Yellen Out, Markets Prefer Powell As Next Federal Reserve Chief ||| T. Rowe Price's (TROW) Q3 Earnings Beat, Revenues In Line",0,0.5129238
2017-10-27,2111500.0,240.8500061035156,242.44000244140625,239.6699981689453,241.7100067138672,230.0247802734375,GS,"Top Ranked Momentum Stocks to Buy for October 27th ||| JMP Group LLC (JMP) Ex-Dividend Date Scheduled for October 30, 2017 ||| Morgan Stanley (MS) Ex-Dividend Date Scheduled for October 30, 2017",0,0.44712302
2017-10-30,1764400.0,240.1000061035156,242.58999633789065,239.52999877929688,240.88999938964844,229.24444580078125,GS,"Tech Stocks Lead; FANG's Facebook, Apple Still In Buy Range ||| Stocks Down, But Apple Thrives; Will GE Exit The Dow Industrials?",1,0.50289387
2017-10-31,2658700.0,240.67999267578125,244.17999267578125,240.6300048828125,242.47999572753903,230.757553100586,GS,"Noteworthy ETF Inflows: DIA, GS, MMM, UNH",1,0.52202624
2017-11-01,2969600.0,243.88999938964844,247.3999938964844,242.9100036621093,244.259994506836,232.4515075683593,GS,"Blue-Chip Dow Leads Upside; Stock Market Awaits Fed Pick ||| Bitcoin Rally Continues After CME Group's Embrace ||| Stocks Pare Gains From Record Highs; Fed, Facebook, Tesla On Deck ||| Dow Movers: AAPL, GE ||| Buy the General Motors Company Dip With Both Hands ||| Noteworthy Wednesday Option Activity: GS, GD, WFC",1,0.48405004
2017-11-02,2509100.0,244.69000244140625,247.7400054931641,243.3800048828125,246.8800048828125,234.94483947753903,GS,"Dow Edges Up, Nasdaq Slips As Apple, FANGs Dip, Tesla Dives ||| U.S. Banks Stock Outlook - November 2017",0,0.45860344
2017-11-03,1954600.0,245.3699951171875,246.27999877929688,243.19000244140625,244.3999938964844,232.5847320556641,GS,"Stocks Trim Gains; Apple Shares Hit New High On Blowout Earnings ||| Dow Movers: GS, AAPL ||| TD Ameritrade Holding Corporation (AMTD) Ex-Dividend Date Scheduled for November 06, 2017",0,0.45580053
2017-11-06,1744800.0,243.5,244.5800018310547,241.6699981689453,243.4900054931641,231.71875,GS,"MarketAxess Holdings, Inc. (MKTX) Ex-Dividend Date Scheduled for November 07, 2017",0,0.44812077
2017-11-07,2483900.0,243.9100036621093,244.97999572753903,238.83999633789065,239.8099975585937,228.2166442871093,GS,"Midday Update: Stocks Retreat From Record Highs as Wall Street Assess Geopolitical Risks, Tax Reform Debate ||| SPDR Dow Jones Industrial Average ETF Experiences Big Inflow ||| Why You Should Add Goldman (GS) Stock to Your Basket Now? ||| Deutsche Bank Shows Capital Strength, Legal Costs a Drag ||| LPL Financial Holdings Inc. (LPLA) Ex-Dividend Date Scheduled for November 08, 2017 ||| Blockchain 101: If Bitcoin's a Fraud, How is Ethereum Different? ||| Wall Street Winning Streak Ends as Risk Aversion Resurfaces With Saudi Purge, Tax Reform Debate",1,0.49505007
2017-11-08,2349800.0,239.1999969482422,242.32000732421875,237.5500030517578,241.25,229.58702087402344,GS,"Buy These 4 Stocks to Profit From Bitcoin's Soaring Popularity ||| Oppenheimer Holdings, Inc. (OPY) Ex-Dividend Date Scheduled for November 09, 2017 ||| Notable Wednesday Option Activity: WMT, TWX, GS",0,0.4798693
2017-11-09,2122400.0,239.509994506836,242.3699951171875,237.83999633789065,240.7899932861328,229.1492462158203,GS,"Seaboard Corporation (SEB) Ex-Dividend Date Scheduled for November 10, 2017 ||| Square Inc Stock Is Still a Shooting Star That’s Worth a Buy ||| Stocks Hit Hard, But Tech Leaders Steady; 5 Reasons To Keep Holding Apple ||| Four Reasons Why JPMorgan, Morgan Stanley, Other Bank Stocks Keep Falling",0,0.45731592
2017-11-10,1845600.0,241.69000244140625,243.32000732421875,240.0,240.1499938964844,228.54019165039065,GS,"Is Goldman Sachs' Stock Worth a Look? ||| BGC Partners, Inc. (BGCP) Ex-Dividend Date Scheduled for November 13, 2017 ||| Seeking Alpha's Weekly Media, Tech, And Finance News Roundup",1,0.48253796
2017-11-13,1953900.0,237.97000122070312,240.8999938964844,237.1600036621093,240.2700042724609,228.6544189453125,GS,"Nvidia, Goldman Are Among 5 Bitcoin Stocks To Watch As Cryptocurrency Soars ||| Bank of America Corp Stock: How to Have Your Cake and Eat It Too ||| What Investors Need to Know About Investing in Low PE Stocks ||| 8 Warren Buffett Deals That Won Big ||| Kiltearn Partners LLP Buys CVS Health Corp, General Electric Co, United Natural Foods Inc, ...",0,0.47599348
2017-11-14,3000200.0,239.6499938964844,240.8800048828125,235.6300048828125,237.2400054931641,225.77088928222656,GS,US Market Indexes Lower on Tuesday ||| See Which Of The Latest 13F Filers Holds Goldman Sachs Group,1,0.4900632
2017-11-15,2564100.0,234.97000122070312,238.1499938964844,233.5500030517578,237.6100006103516,226.12301635742188,GS,"Noteworthy ETF Inflows: IVE, MDT, ABT, GS ||| Stocks Stumble Out Of The Gate; Tech Lags Amid Apple Worries ||| Stock Market News For Nov 15, 2017 ||| Stocks Drop At Open; Foxconn Bites Apple, Target Dives",1,0.4869324
2017-11-16,2304300.0,238.3800048828125,240.69000244140625,238.1999969482422,239.3699951171875,227.79788208007807,GS,Indexes Thrust Higher; This Stock Hits 16-Year High,0,0.50850344
2017-11-17,2826400.0,238.8600006103516,239.0800018310547,237.1199951171875,238.0200042724609,226.51315307617188,GS,Wall Street Banks Held for Rigging Treasury Bond Auctions,1,0.5039701
2017-11-21,2223800.0,239.4100036621093,239.58999633789065,237.5399932861328,238.0200042724609,226.51315307617188,GS,"Financial Sector Update for 11/21/2017: JPM, BAC, WFC, C, USB, GS, HSBC ||| Goldman Sachs Names Frankfurt & Paris as EU Hubs Post Brexit ||| The 30 Dow Jones Stocks ||| JPMorgan CEO Called Bitcoin A 'Fraud'; Now His Bank May Trade Futures",0,0.45614007
2017-11-22,2177200.0,237.94000244140625,238.9499969482422,236.3600006103516,236.42999267578125,225.0000457763672,GS,"STMicroelectronics Trades At A Discount To Peers Despite Strong Fundamentals ||| Notable Wednesday Option Activity: CAT, GOOG, GS",0,0.49948594
2017-11-24,1268500.0,237.4199981689453,238.5599975585937,235.5500030517578,235.9499969482422,224.5432586669922,GS,Is Bank of America Stock a Buy Before the End of 2017?,0,0.5012194
2017-11-27,1999600.0,235.75,236.8800048828125,234.8000030517578,235.1100006103516,223.7438507080078,GS,"Bitcoin Hits New High on Wider Acceptance ||| Bitcoin Nears $10,000 Milestone; These Crypto Stock Plays Are Moving ||| Ex-Dividend Reminder: Goldman Sachs Group, Central Pacific Financial and Cullen/Frost Bankers ||| Piper Jaffray Companies (PJC) Ex-Dividend Date Scheduled for November 28, 2017 ||| Blockchain: Disruptive Technology Is Here to Stay",1,0.47821328
2017-11-28,3212900.0,236.08999633789065,240.0,234.3300018310547,239.4100036621093,227.83595275878903,GS,"Amazon Gains On Goldman Note, AWS re:Invent Heats Up ||| Goldman Sachs Group, Inc. (GS) Ex-Dividend Date Scheduled for November 29, 2017 ||| JMP Group LLC (JMP) Ex-Dividend Date Scheduled for November 29, 2017 ||| Will Goldman Sachs Raise Its Dividend in 2018? ||| Apple Off, But Stocks Up Sharply; Can These 4 Retailers Win Big In 2018?",1,0.47083932
2017-11-29,4500000.0,241.25,244.47000122070312,240.3999938964844,241.3600006103516,230.4135284423828,GS,"Midday Update: Tech Sector Takes Shellacking, Led by Chipmakers, FANG Stocks ||| Morgan Stanley Stock Is Set to Break Out Soon ||| Stifel Financial Corporation (SF) Ex-Dividend Date Scheduled for November 30, 2017 ||| Virtu Financial, Inc. (VIRT) Ex-Dividend Date Scheduled for November 30, 2017 ||| Interactive Brokers Group, Inc. (IBKR) Ex-Dividend Date Scheduled for November 30, 2017 ||| Navient Corporation (NAVI) Ex-Dividend Date Scheduled for November 30, 2017 ||| Cboe Global Markets, Inc. (CBOE) Ex-Dividend Date Scheduled for November 30, 2017 ||| Stocks Mixed As Apple, Nvidia Weigh; How High Can Bitcoin Go? ||| Dow Rallies; 3 Reasons Why The Tech-Stock Run Isn't Over ||| NYSE Indexes Hang Tough, But Nasdaq Diverges; Leaders Crushed ||| Five Reasons Why JPMorgan, Citigroup, Other Financials Are Seizing Market Leadership ||| Investors Rotate Into Bank, Retail Stocks As Techs Tumble ||| It’s Not Too Late to Go Long JPMorgan Chase & Co.",1,0.45833614
2017-11-30,6364600.0,244.07000732421875,250.7899932861328,244.0,247.63999938964844,236.4086761474609,GS,"Take a Chance, Go Long PayPal Holdings Inc ||| Dow, S&P 500 Notch Record Highs; Are Tech Leaders Done Going Down? ||| S&P 500 Futures Fall As 'Trigger' Delays Senate Tax-Cut Vote ||| Notable Thursday Option Activity: GS, DY, AET ||| Stock Indexes Roll Higher, But Bitcoin Plunges ||| Goldman Tops Dow; Apple And FANGs Lead Early Tech Bounce ||| Bitcoin Retreats As Goldman CEO, Fed's Quarles Raise Doubts ||| Warren Buffett’s Market Indicator Breaks 140% ||| BlackRock, Inc. (BLK) Ex-Dividend Date Scheduled for December 01, 2017 ||| Dow Hits 24,000; Five Below Smashes Views; Why Apple Could Win Big In 2018 ||| Nasdaq Recovers A Bit On Tax-Reform Hopes; More Breakouts Emerge ||| GOP Has Votes For Tax Bill, McConnell Says; S&P 500 Pares Flynn Losses ||| US Market Indexes Gain on Thursday ||| Why Limelight Networks, Inc. Stock Fell 10% Today ||| Bank Stocks Lift Dow to New High on Tax Bill Hopes",1,0.49190986
2017-12-01,4765400.0,249.77999877929688,250.67999267578125,244.009994506836,248.9499969482422,237.6593017578125,GS,Chipotle Up Big on CEO Departure,1,0.527257
2017-12-04,3326100.0,254.88999938964844,254.8999938964844,250.009994506836,250.6499938964844,239.2821807861328,GS,"These 3 Dow Stocks Have Entered Buy Zones ||| NYSE Indexes Hold Early Gains But Chips Sink Nasdaq ||| Bank Stocks Rise As Senators Add These Last-Minute Perks To Tax Bill ||| Noteworthy ETF Inflows: SPYV, GS, ORCL, GM ||| Dow, S&P 500 Record Highs; Bank Stocks Surge, Tech Leaders Reverse Lower ||| Top Merger Activity For Companies Not Named CVS Or Aetna ||| Why Citigroup Inc Stock Will Blast Through the $75 Level",0,0.50206697
2017-12-05,2526800.0,250.8000030517578,251.3500061035156,247.4100036621093,248.3300018310547,237.06741333007807,GS,"These 2 Financial Giants Just OK'd Higher Shareholder Returns ||| Dow Analyst Moves: GS ||| Bitcoin on Fire: What Investors Need to Know ||| The Goldman Sachs Group Inc Rally Is Due for a Rest — Profit Anyway ||| FANGs, Other Tech Leaders Snap Back; This Top Group Struggles",0,0.47473255
2017-12-06,2331400.0,246.2400054931641,248.0800018310547,245.1300048828125,245.9499969482422,234.7953338623047,GS,"CME Group Inc. (CME) Ex-Dividend Date Scheduled for December 07, 2017 ||| Wells Fargo CEO Looks Optimistic About Q4 C&I Loans Scenario ||| Will JPMorgan Chase Do a Stock Split in 2018? ||| Goldman Sachs, Standard Chartered Set to Expand in Poland",1,0.4834001
2017-12-07,2667000.0,244.6199951171875,249.47999572753903,244.3999938964844,248.5599975585937,237.28697204589844,GS,"Interesting GS Put And Call Options For January 2018 ||| GAIN Capital Holdings, Inc. (GCAP) Ex-Dividend Date Scheduled for December 08, 2017 ||| Noteworthy Thursday Option Activity: WDC, GS, CTSH",1,0.47851592
2017-12-08,1959100.0,250.5,250.67999267578125,247.1999969482422,250.3500061035156,238.9958038330078,GS,"Bitcoin Tumbles From Frenzied Run; JPMorgan's Dimon Still 'Highly Skeptical' ||| This Online Tailor Brings A Personal Touch To The Fashion Plate ||| Top Research Reports for Bank of America, Celgene & Goldman Sachs",0,0.47853938
2017-12-11,1494200.0,250.0,251.3999938964844,248.759994506836,250.1300048828125,238.78575134277344,GS,"Bitcoin Futures Surge Above $18,000 In Cboe Trading Debut ||| Bitcoin Futures Soar In Debut; These Crypto Stock Plays Jump ||| The Zacks Analyst Blog Highlights: Bank of America, Celgene, Goldman Sachs, L Brands and Quest Diagnostics",1,0.4921795
2017-12-12,3464200.0,250.8099975585937,258.20001220703125,250.69000244140625,257.67999267578125,245.9933624267578,GS,"Boeing, Goldman Lead Dow Higher; Financials Outperform Ahead Of Fed ||| Goldman Sachs and Morgan Stanley: A Closer Look Into The 2 Big Investment Banks ||| Dow Leads Upside; Fast Traders In IBD 50 Are Falling ||| Intercontinental Exchange Inc. (ICE) Ex-Dividend Date Scheduled for December 13, 2017 ||| ETFs to Gain/Lose if Fed Turns Hawkish for 2018 ||| Bank Stocks Boost Dow, S&P to Record Highs After GOP Tax Bill Update ||| Market Close Report: NASDAQ Composite index closes at 6,862.32 down -12.76 points ||| Why Goldman Sachs, Seagate Technology, and Tenet Healthcare Jumped Today ||| Tuesday Sector Leaders: Financial, Healthcare",0,0.4730759
2017-12-13,3482300.0,257.8099975585937,260.5,255.5599975585937,255.5599975585937,243.9694976806641,GS,"Follow Goldman to Invest in Commodity ETFs for 2018 ||| Notable ETF Inflow Detected - DIA, GS, MMM, HD ||| US Market Indexes Mixed on Tuesday ||| Energy Sector Update for 12/13/2017: NBLX,HTM,GS ||| Trade of the Day: Goldman Sachs Group Inc Clears the Hurdle ||| Nasdaq, Inc. (NDAQ) Ex-Dividend Date Scheduled for December 14, 2017",0,0.4959618
2017-12-14,3353200.0,257.1300048828125,259.54998779296875,255.47999572753903,255.47999572753903,243.8931427001953,GS,"Goldman Sachs' and Morgan Stanley's Big Growth Opportunities ||| How to Evaluate Investment Banking Stocks ||| How Do Investment Banks Make Money? ||| Notable Thursday Option Activity: CAT, GS, SYMC",1,0.49457437
2017-12-15,5283400.0,256.70001220703125,258.9700012207031,254.759994506836,257.1700134277344,245.5065155029297,GS,The Dow's 3 Most Pathetic Dividend Stocks,1,0.5084325
2017-12-18,2575600.0,260.0,262.0,259.1600036621094,260.0199890136719,248.2271881103516,GS,"Nasdaq Hits A Record; Apple And This Leading Defense Stock Break Out ||| Stock Market News For Dec 18, 2017 ||| Close Update: Wall Street Rallies to New Records as Tax Reform Legislation Heads to Final Vote ||| Bitcoin Futures, Spot Prices Converge After CME Trading Debut",0,0.47485808
2017-12-19,2195500.0,261.6000061035156,261.79998779296875,256.17999267578125,256.4800109863281,244.84776306152344,GS,"Dow Movers: GS, WMT ||| US Market Indexes Lower on Tuesday ||| Market Close Report: NASDAQ Composite index closes at 6,963.85 down -30.91 points ||| Close Update: Wall Street Rally Pauses as House Passes Tax Bill, Senate Debate Begins ||| Apple Stock Fine After Downgrade; 3 Reasons Why This Bitcoin ETF Hasn't Topped",0,0.49326912
2017-12-20,2052400.0,258.8699951171875,259.0899963378906,254.5500030517578,255.17999267578125,243.60671997070312,GS,"Financial Sector Update for 12/20/2017: JPM, BAC, WFC, C, USB, GS, MS, MET, HDB, KKR, TRTX",1,0.4784302
2017-12-21,3337800.0,256.6099853515625,262.0899963378906,256.2799987792969,261.010009765625,249.17233276367188,GS,"Stock Indexes Rise Moderately; Breakouts Increase ||| Apple, Banks Boost Dow Near Record; Can Bitcoin Stop Its Slump? ||| US Market Indexes Gain on Thursday ||| 5 Dow Titans Going Vertical ||| DIA, GS, MMM, HD: ETF Inflow Alert ||| These 3 Big-Name Energy Stocks Could Rebound 13% or More in 2018",0,0.50575197
2017-12-22,2100600.0,261.6600036621094,262.1400146484375,257.7200012207031,258.9700012207031,247.224838256836,GS,"Associated Capital Group, Inc. (AC) Ex-Dividend Date Scheduled for December 26, 2017 ||| Financial Sector Update for 12/22/2017: JPM, BAC, WFC, C, USB, GS, COF",0,0.44885573
2017-12-26,1289300.0,258.19000244140625,259.20001220703125,256.0,257.7200012207031,246.03152465820312,GS,"Should You Buy Lululemon Athletica Inc. Stock in 2018? 3 Pros, 3 Cons ||| CME Group Inc. (CME) Ex-Dividend Date Scheduled for December 27, 2017",0,0.44511902
2017-12-27,1567900.0,257.9800109863281,257.9800109863281,255.5200042724609,255.9499969482422,244.34181213378903,GS,"Dow Movers: NKE, GE ||| JMP Group LLC (JMP) Ex-Dividend Date Scheduled for December 28, 2017 ||| Better Buy: Bank of America Corporation vs. Goldman Sachs",1,0.47392368
2017-12-28,1301000.0,256.9800109863281,257.0,255.1000061035156,256.5,244.86688232421875,GS,"Financial Sector Update for 12/28/2017: GS, AEG, IBCP, ORIT, ITUB",0,0.48301882
2017-12-29,2519300.0,255.8699951171875,256.6499938964844,252.9100036621093,254.759994506836,243.2057647705078,GS,"SPDR Dow Jones Industrial Average ETF Experiences Big Inflow ||| Stocks Reverse Lower; Chinese IBD 50 Leader Attempts Breaks Out ||| Dow Movers: GS, KO ||| Raymond James Financial, Inc. (RJF) Ex-Dividend Date Scheduled for January 02, 2018 ||| Notable Friday Option Activity: GS, RTN, MU ||| Can JPMorgan & Goldman Regain Their Top Position in 2018?",1,0.44744068
2018-01-02,2258300.0,257.7699890136719,257.9100036621094,253.9199981689453,255.6699981689453,244.0745086669922,GS,"Goldman Expects Tax Reform to Have a One-Time $5B Impact ||| Company News For January 2, 2018 ||| 3 GOP Tax Plan Winners to Buy Now – and 1 to Watch ||| Las Vegas Sands, Genesco, Goldman Sachs and JPMorgan highlighted as Zacks Bull and Bear of the Day",0,0.4788116
2018-01-04,2583200.0,255.22999572753903,259.7200012207031,254.32000732421875,256.8299865722656,245.1819305419922,GS,"Stocks Higher For Third Straight Day; Another FANG Breaks Out ||| Dow Movers: INTC, GS",0,0.4978363
2018-01-05,2594700.0,257.17999267578125,257.489990234375,253.69000244140625,255.5200042724609,243.93130493164065,GS,"Dow Movers: DIS, CSCO ||| Stock Market News for January 05, 2018 ||| Morgan Stanley To Take $1.25 Billion Hit For U.S. Tax Revamp ||| The 2017 Industry Focus Awards: Best Fact and MVP ||| Q4 Bank Earnings Will be Messy & Noisy ||| Notable Friday Option Activity: FC, GS, HXL ||| Why Using Stock Charts Is The Way To Avoid Early 2018 Head Fakes",0,0.4989304
2018-01-08,2940500.0,254.75,255.17999267578125,251.6199951171875,251.8099975585937,240.3895721435547,GS,"7 Bargain Stocks in Today's Pricey Market ||| DIA, GS, HD, TRV: Large Inflows Detected at ETF ||| Stocks Close Mixed; How Oprah Caused A Stock To Break Out ||| Midday Update: U.S. Stocks Tread Water as Wall Street Rally Stalls",1,0.49765593
2018-01-09,2637300.0,252.8000030517578,255.6000061035156,252.6199951171875,253.94000244140625,242.42300415039065,GS,"Dow Movers: NKE, JNJ ||| Stocks Turn Mixed; This IBD 50 Name Breaks Out, But Reverses ||| Citigroup, JPMorgan, Bank of America, Goldman Sachs and Wells Fargo are part of Zacks Earnings Preview ||| Waddell & Reed Financial, Inc. (WDR) Ex-Dividend Date Scheduled for January 10, 2018 ||| 2 Warren Buffett Stocks to Buy in January ||| Nasdaq, S&P 500 Extend Win Streaks; Financials Shine, Proofpoint Up Again",1,0.49643534
2018-01-10,2927200.0,255.0,255.1499938964844,252.3500061035156,254.3300018310547,242.79527282714844,GS,"Midday Update: Wall Street Roiled By Possible Chinese Asset Reallocation, But Financial Stocks Mitigate Losses ||| Trade of the Day: Bank on Goldman Sachs Group Inc ||| Looking Past Noisy Bank Earnings ||| JPMorgan, Wells Fargo Preview: Tax Reform To Overshadow Q4 Mess",1,0.50585526
2018-01-11,2422400.0,255.75,255.88999938964844,252.97000122070312,255.1300048828125,243.5590209960937,GS,"After a Solid Start, What Awaits Dow ETF in Q4 Earnings? ||| Financial Sector Update for 01/11/2018: JPM, BAC, WFC, C, USB, HSBC, XL, GBDC, SW.PA ||| Bank Earnings Might Look Bad -- Here's Why You Shouldn't Worry",1,0.4754551
2018-01-12,2849200.0,255.75,257.29998779296875,254.08999633789065,257.0299987792969,245.37283325195312,GS,"Energy Sector Update for 01/12/2018: BHP,USEG,BP,RDS-A,GS,BHGE ||| Zacks Earnings Trends Highlights: Citigroup, JPMorgan, Bank of America, Goldman Sachs and Morgan Stanley ||| Energy Sector Update for 01/12/2018: XOM, CVX, COP, SLB, OXY, USO, UNG, RIO, BP, RDS.A ||| More Banks, More Cars, More Earnings: Investing Action Plan ||| 10 Value Stocks to Buy for 2018 and Beyond ||| 3 Best Stock Charts for Friday: Fifth Third Bancorp, Goldman Sachs and Citigroup ||| Energy Sector Update for 01/12/2018: USEG,BP,DCP,GS, RDS-A,RDS.A, RDS-A, RDS.B, RDS/B, RDS-B",1,0.44806048
2018-01-16,4445500.0,259.25,261.7699890136719,256.3999938964844,258.4599914550781,246.73797607421875,GS,"The 9 Best Dividend Growth Stocks in the Dow Jones ||| Goldman Sachs to report Q4 results January ||| Will Goldman's (GS) Q4 Earnings Overcome Trading Slump? ||| Dow Jones Hits 26,000, Then Loses It ||| The Most Important Earnings Charts This Week ||| Noteworthy ETF Inflows: DIA, GS, MMM, UNH ||| Is Morgan Stanley a Better Q4 Earnings Pick Than Goldman? ||| Weak Trading Activities to Hurt BofA (BAC) in Q4 Earnings? ||| Pre-Market Earnings Report for January 17, 2018 : BAC, GS, USB, ASML, SCHW, FAST ||| BofA, Goldman, Alcoa Pick Up Earnings Season Pace: Investing Action Plan ||| Notable Tuesday Option Activity: GS, QCOM, PX ||| Dow Touches New Intraday High, Finishes Lower",0,0.5137271
2018-01-17,8608100.0,260.9800109863281,262.0,248.83999633789065,253.6499938964844,242.1461334228516,GS,"Financial Sector Update for 01/17/2018: JPM, BAC, WFC, C, USB, GS, NRZ, ALLY, CIT, HSBC, MS, PNC, STI, PFG.L ||| Dow Movers: GE, IBM ||| Stocks Log Modest Gains As Big Banks Fall; Leading Chip Plays Rally ||| If At First You Don't Succeed... ||| Morning Movers: Juno Soars; Goldman Sachs, CSX Slide ||| Goldman (GS) Q4 Earnings Impressive, Tax Expense Recorded ||| Goldman Sachs Group Inc Stock Falls on Big Tax Loss ||| Bank of America Corp Stock Falls Despite Q4 Earnings Beat ||| Midday Update: Dow Climbs Back Above 26,000 As Banking Sector Rebounds ||| Spending Bill In Focus ||| Stocks Rally As Boeing Helps Dow Climb To Record High ||| IBM Leads Dow's Early Rally; Apple Downgraded, This Biotech Spikes ||| 4 Good Things in Goldman Sachs’ Earnings Report – and 3 That Have Me Worried ||| Financial Sector Update for 01/17/2018: NRZ,BAC,GS,USB ||| 5 Blue-Chip Stocks That Are a Threat to the Dow ||| Goldman Sachs Weighs In On Cryptocurrencies As Trading Lags Peers ||| Financial Sector Update for 01/17/2018: ICE,NRZ,BAC,GS,USB ||| Dow Jones Takes 26,000 for the First Time ||| Earnings Reaction History: Goldman Sachs Group Inc., 54.5% Follow-Through Indicator, 1.9% Sensitive ||| Dow Skyrockets 322 Points to Close North of 26,000",0,0.47103646
2018-01-18,4984500.0,254.4900054931641,254.5399932861328,250.6000061035156,250.97000122070312,239.5876922607422,GS,"You Just Can’t Bet Against Goldman Sachs Group Inc ||| Morgan Stanley Reports Q4 Earnings Beat ||| Dow Movers: BA, VZ ||| Trade of the Day: Goldman Sachs Group Inc Survives the Earnings Test ||| Why GNC Holdings, Inc. Stock Skyrocketed Nearly 50% Today",1,0.49266335
2018-01-19,4643400.0,251.0,256.1400146484375,250.259994506836,256.1199951171875,244.5041046142578,GS,"Ask a Fool: Are There Any Cheap Stocks Left? ||| Dow 30 Stock Roundup: AXP, GS, UNH IBM Q4 Earnings Impress ||| Is Citigroup Inc Stock the Best of the Bank Stocks?",1,0.46972838
2018-01-22,5264700.0,255.4499969482422,262.8699951171875,255.19000244140625,261.5199890136719,249.65919494628903,GS,"Dow Movers: UTX, VZ ||| Stock Market News For Jan 22, 2018 ||| 7 Stocks Leading the Post-Shutdown Rally ||| 14,596 Reasons to Buy Alphabet, Inc.",0,0.49499345
2018-01-24,4314000.0,260.739990234375,265.7799987792969,260.29998779296875,265.67999267578125,253.6305084228516,GS,"Dow Movers: AAPL, VZ ||| 3 Preferred Stocks That Earn You 6%-Plus ||| 3 Big Trends in Bank Earnings ||| 2 Bank Stocks to Buy for 2018 ||| The Future Looks Really Bright for TD Ameritrade Holding Corp. Stock ||| Market Close Report: NASDAQ Composite index closes at 7,415.06 down -45.23 points ||| Financial Stocks Keep Dow Afloat as S&P, Nasdaq End Lower ||| Close Update: Wall Street Mixed as Financials Lift Dow But Nasdaq Wilts Under Tech Pressure ||| Dow, S&P Recover From Earlier Losses As Airlines Sink",1,0.4992074
2018-01-25,5055000.0,266.3500061035156,270.5,265.010009765625,269.0299987792969,256.8285217285156,GS,"Stock Market News For Jan 25, 2018 ||| Goldman Sachs Teams Up With This Silicon Valley Upstart in Commercial Real Estate ||| Is Houlihan Lokey's Superb Profit Growth Coming To An End? ||| Blue Chips Advance Nicely; Street Awaits GDP Report",0,0.4828201
2018-01-26,3535400.0,267.489990234375,269.0,266.04998779296875,268.1400146484375,255.9789581298828,GS,3 Top Bank Stocks to Buy Right Now,1,0.548221
2018-01-29,3881100.0,269.0400085449219,273.7900085449219,268.8099975585937,272.4800109863281,260.1221008300781,GS,"Stocks Fall Modestly Early; This Video Game Maker Breaks Out ||| Morgan Stanley (MS) Ex-Dividend Date Scheduled for January 30, 2018 ||| JMP Group LLC (JMP) Ex-Dividend Date Scheduled for January 30, 2018 ||| Indexes Edge Lower: Dr. Pepper Surges, Goldman Leads Dow ||| Market Close Report: NASDAQ Composite index closes at 7,466.51 down -39.26 points ||| Apple, Caterpillar Send Dow Down 177 Points ||| Hudson Group IPO: What Investors Need to Know ||| It’s Time to Be Cautious on Bank of America Corporation Stock",0,0.46979168
2018-01-30,3970400.0,270.3900146484375,272.0,267.1099853515625,268.94000244140625,256.7426147460937,GS,"T. Rowe Price's (TROW) Q4 Earnings Beat Estimates, Costs Up ||| Goldman Sachs Group's Preferred Stock, Series N Shares Cross 6% Yield Mark",0,0.504781
2018-01-31,3710200.0,268.54998779296875,270.0,266.3299865722656,267.8900146484375,255.7403259277344,GS,GE Is 'Likely' To Get Booted From Dow Index; What Recent Reshuffles Say ||| 3 Top Bank Stocks to Buy Now,1,0.4886018
2018-02-01,3388200.0,266.1499938964844,272.5899963378906,266.0,272.2300109863281,259.8834228515625,GS,"A Twitter Executive's Exit Makes the Stock a No-Go ||| Goldman Sachs Group's Preferred Stock, Series A Shares Cross 4.5% Yield Mark",0,0.5002144
2018-02-02,5913900.0,270.0,271.75,259.3500061035156,260.0400085449219,248.246337890625,GS,"TD Ameritrade Holding Corporation (AMTD) Ex-Dividend Date Scheduled for February 05, 2018",0,0.46780893
2018-02-05,6528500.0,257.510009765625,263.29998779296875,241.5,249.1100006103516,237.81202697753903,GS,Why Wall Street's Angry About the Bitcoin Gold Rush ||| Citigroup Inc Stock Is a Quality Stock I Can Go Long In Today! ||| How to Wreck Your Retirement in 2 Buys,1,0.49008387
2018-02-07,4125000.0,255.8999938964844,261.95001220703125,255.6600036621093,257.1000061035156,245.43963623046875,GS,"With Twitter Inc, Earnings Are Not the Story ||| This Is When to Buy Bank of America Corporation Stock ||| The Charles Schwab Corporation (SCHW) Ex-Dividend Date Scheduled for February 08, 2018 ||| Trade of the Day: Higher Market Volatility Is Good for Goldman Sachs Group Inc ||| Financial Sector Update for 02/07/2018: ICE,CG,AINV,GS,AAPL ||| Financial Sector Update for 02/07/2018: CG,AINV,GS,AAPL",0,0.47170737
2018-02-08,4166200.0,257.92999267578125,258.7799987792969,246.0500030517578,246.3500061035156,235.1772003173828,GS,"Oppenheimer Holdings, Inc. (OPY) Ex-Dividend Date Scheduled for February 09, 2018",1,0.4496859
2018-02-09,5978600.0,249.6199951171875,251.6699981689453,239.2899932861328,249.3000030517578,237.99343872070312,GS,"SPDR Dow Jones Industrial Average ETF Experiences Big Outflow ||| TRP vs. ENB: Which Is a Better Buy Ahead of Q4 Earnings? ||| Goldman (GS) to Expand Online Lending Platform's Offerings ||| Top Analyst Reports for Merck, Goldman Sachs & Tesla",1,0.48994577
2018-02-12,3692500.0,251.1499938964844,256.1499938964844,248.82000732421875,253.1600036621093,241.6783599853516,GS,"MarketAxess Holdings, Inc. (MKTX) Ex-Dividend Date Scheduled for February 13, 2018 ||| The Zacks Analyst Blog Highlights: Merck, Goldman Sachs, Tesla, T-Mobile and Activision ||| Is Under Armour Inc Stock Finally Irrelevant?",1,0.46272123
2018-02-13,2700500.0,252.009994506836,256.3999938964844,250.5800018310547,255.52999877929688,243.9408721923828,GS,JPMorgan Chase Stock Upgraded: What You Need to Know ||| Will Russia & OPEC's Production Curb Continue?,1,0.5123504
2018-02-14,3793800.0,255.0,262.7099914550781,254.47999572753903,262.5799865722656,250.67105102539065,GS,"3 Charts Tell the Story for Bank of America Corp Stock ||| Close Update: Wall Street Extends Win Streak to Fourth Day, Powered By Financials and Tech Stocks ||| Wall Street Extends Win Streak to Fourth Day, Powered By Financials and Tech Stocks",1,0.52873456
2018-02-15,3523100.0,265.760009765625,268.0,262.9100036621094,267.67999267578125,255.539779663086,GS,"Amazon Partners With Bank Of America On Small-Business Loans ||| Noteworthy Thursday Option Activity: GS, NVDA, BMY",0,0.5299645
2018-02-16,2602500.0,265.989990234375,269.2799987792969,265.8999938964844,267.6199951171875,255.4825134277344,GS,"5 Hot Stocks Leading the Dow ETF Rebound ||| Dow 30 Stock Roundup: Cisco Beats, Caterpillar January Sales up 34% ||| 5 Hot Stocks Leading the Dow ETF Rebound",0,0.5165873
2018-02-20,2618400.0,266.8900146484375,268.8500061035156,263.3099975585937,264.8900146484375,252.87635803222656,GS,SPDR Dow Jones Industrial Average ETF Experiences Big Outflow ||| Goldman's (GS) CEO Blankfein's Pay Raised by 9% in 2017,0,0.5114373
2018-02-22,2678900.0,264.3999938964844,266.32000732421875,260.7200012207031,261.42999267578125,249.57327270507807,GS,"Dow Analyst Moves: GS ||| Noteworthy Thursday Option Activity: GS, SGMO, NVDA",1,0.5021245
2018-02-23,2507100.0,263.0,266.9800109863281,262.3999938964844,266.7699890136719,254.67108154296875,GS,"Dow 30 Stock Roundup: Walmart Disappoints, Coca-Cola Impresses ||| Investment Technology Group, Inc. (ITG) Ex-Dividend Date Scheduled for February 26, 2018 ||| BGC Partners, Inc. (BGCP) Ex-Dividend Date Scheduled for February 26, 2018",1,0.45263135
2018-02-26,2751400.0,267.5,271.7799987792969,266.7699890136719,271.260009765625,258.9574279785156,GS,JPMorgan Chase & Co. Has Upside Potential — Grab It!,0,0.4785904
2018-02-27,3140600.0,271.0,273.1199951171875,267.92999267578125,267.92999267578125,255.7784423828125,GS,"Financial Sector Update for 02/27/2018: NMI, CVBF, GS ||| Stifel Financial Corporation (SF) Ex-Dividend Date Scheduled for February 28, 2018 ||| Virtu Financial, Inc. (VIRT) Ex-Dividend Date Scheduled for February 28, 2018 ||| Interactive Brokers Group, Inc. (IBKR) Ex-Dividend Date Scheduled for February 28, 2018 ||| Goldman Sachs Group, Inc. (GS) Ex-Dividend Date Scheduled for February 28, 2018",0,0.43177179
2018-02-28,3104300.0,269.1400146484375,269.489990234375,262.57000732421875,262.92999267578125,251.70985412597656,GS,"Why BlackRock, Inc. Is the King of Investment Firms ||| XLF, GS, USB, MS: ETF Inflow Alert ||| 3 Revelations From LendingClub's Earnings Report ||| Navient Corporation (NAVI) Ex-Dividend Date Scheduled for March 01, 2018",0,0.4452936
2018-03-01,3483500.0,262.6099853515625,263.54998779296875,256.20001220703125,256.7799987792969,245.822265625,GS,"Seaboard Corporation (SEB) Ex-Dividend Date Scheduled for March 02, 2018",1,0.4746742
2018-03-02,3122800.0,255.0,259.239990234375,252.1000061035156,258.1199951171875,247.1051177978516,GS,"Bad News, and No News, for Overstock.com Inc Stock ||| Noteworthy Friday Option Activity: TWX, CAT, GS",1,0.49023944
2018-03-05,2445800.0,256.4599914550781,264.54998779296875,256.239990234375,263.1199951171875,251.8917236328125,GS,"BlackRock, Inc. (BLK) Ex-Dividend Date Scheduled for March 06, 2018",1,0.44358018
2018-03-06,2217300.0,264.7699890136719,267.8699951171875,263.2099914550781,266.92999267578125,255.5391387939453,GS,"Goldman Sachs Group's Preferred Stock, Series B Shares Cross 6% Yield Mark",0,0.503536
2018-03-07,2509400.0,262.69000244140625,266.42999267578125,260.95001220703125,265.3500061035156,254.0265655517578,GS,"Think Small as Trade War Fears Grip Market: 5 Must Buys ||| LPL Financial Holdings Inc. (LPLA) Ex-Dividend Date Scheduled for March 08, 2018 ||| These 3 Growth Stocks Can’t Be Hurt by a Trade War",1,0.4803279
2018-03-08,2565400.0,266.4800109863281,268.1000061035156,262.6300048828125,266.3399963378906,254.9743194580078,GS,"iShares U.S. Financials ETF Experiences Big Inflow ||| Goldman Sachs' Ratings Affirmed by Moody's, Outlook Stable ||| Bank Stocks Up on Expected Trading Revenues Rebound in Q1",1,0.52176857
2018-03-09,4410600.0,268.70001220703125,271.0899963378906,267.0400085449219,270.7699890136719,259.2152709960937,GS,"Buy These 4 Oil Stocks as the Sector Remains Undervalued ||| Financial Sector Update for 03/09/2018: ACGL,AIG,GS,CLDT,HFWA",1,0.46691713
2018-03-12,3065600.0,271.0,275.3099975585937,270.7699890136719,273.3800048828125,261.71392822265625,GS,"Tariffs Are Here: What's Next? ||| Morgan Stanley (MS) Ratings, Outlook Affirmed by Moody's ||| Midday Update: Dow Reverses Gains as Profit-Taking Surfaces Into 25,500 ||| David Solomon: Goldman Sachs Next CEO? ||| Close Update: Dow Slides as Industrials Face Impact of Higher Steel ||| Dow Surrenders Opening Gains as Boeing and Caterpillar Undermined by Steel Tariffs ||| Markets Now: Dow Drops 150 Points But Thankfully It's Not the Market",0,0.46393815
2018-03-13,2288100.0,274.3399963378906,275.0299987792969,267.44000244140625,268.5299987792969,257.07086181640625,GS,"Micron Technology, Inc. Is Still Cheap at All-Time Highs — But Be Cautious ||| Company News For Mar 13, 2018 ||| Ladenburg Thalmann Financial Services Inc (LTS) Ex-Dividend Date Scheduled for March 14, 2018 ||| Intercontinental Exchange Inc. (ICE) Ex-Dividend Date Scheduled for March 14, 2018 ||| T. Rowe Price Group, Inc. (TROW) Ex-Dividend Date Scheduled for March 14, 2018",0,0.45858473
2018-03-14,2478700.0,270.3999938964844,270.7799987792969,263.9100036621094,264.42999267578125,253.14581298828125,GS,"Nasdaq, Inc. (NDAQ) Ex-Dividend Date Scheduled for March 15, 2018 ||| Close Update: Wall Street Limps Into The Close as Trade-War Weighs",1,0.46673572
2018-03-15,2255200.0,265.7200012207031,269.0,265.3500061035156,266.6099853515625,255.23277282714844,GS,"Germany Sees Most Job Expansion by Foreign Banks Post Brexit ||| Markets Now: Here We Go Again ||| Validea John Neff Strategy Daily Upgrade Report - 3/15/2018 ||| U.S. Banks Stock Outlook - March 2018 ||| Top Research Report for AT&T, Goldman Sachs & Sanofi",1,0.49185115
2018-03-16,4114400.0,266.010009765625,269.8500061035156,265.3299865722656,267.6000061035156,256.1805114746094,GS,"Zacks Industry Outlook Highlights: Goldman Sachs, JPMorgan, Morgan Stanley and Bank of America ||| Notable ETF Inflow Detected - DIA, GS, GE ||| The Zacks Analyst Blog Highlights: AT&T, Goldman Sachs, Sanofi, General Mills and Discovery ||| What to Expect From Micron Technology's Q2 Earnings ||| Best Low-P/E Stocks to Buy in March ||| Cohen & Company Inc. (COHN) Ex-Dividend Date Scheduled for March 19, 2018",0,0.49025935
2018-03-20,1514800.0,263.2900085449219,264.6400146484375,261.8900146484375,263.19000244140625,251.95877075195312,GS,"Stifel (SF) Closes Acquisition of Ziegler Wealth Management ||| Tech Selloff & Fed Meeting Put These ETFs in Focus ||| Forget That Dow is in Negative Territory: Buy These 5 Winners ||| Consumer Sector Update for 03/20/2018: SNMX, WMT, FDX, PLCE, GSL",0,0.47112617
2018-03-21,2817600.0,263.010009765625,266.489990234375,260.3099975585937,261.8500061035156,250.67593383789065,GS,"BofA Plans to Offload Risky Margin Loans Post Steinhoff Loss ||| Can BlackRock Thrive Even as Fund Fees Fall? ||| The Zacks Analyst Blog Highlights: Boeing, Cisco, Intel, Visa and Goldman Sachs",0,0.49901873
2018-03-22,4489300.0,258.4200134277344,260.82000732421875,252.17999267578125,252.6000061035156,241.82066345214844,GS,Energy Sector Update for 03/22/2018: GS,0,0.48833546
2018-03-23,3634200.0,253.6300048828125,253.9900054931641,244.92999267578125,245.259994506836,234.7938690185547,GS,"SPDR Dow Jones Industrial Average ETF Experiences Big Outflow ||| GAIN Capital Holdings, Inc. (GCAP) Ex-Dividend Date Scheduled for March 26, 2018",1,0.46379414
2018-03-26,3787200.0,250.6499938964844,255.3600006103516,248.4499969482422,254.8800048828125,244.0033569335937,GS,Goldman Sachs Group Inc Stock Is Still Worth Owning Without Blankfein at the Helm,0,0.4831697
2018-03-27,2981500.0,255.88999938964844,257.0599975585937,245.6100006103516,247.259994506836,236.70851135253903,GS,"JMP Group LLC (JMP) Ex-Dividend Date Scheduled for March 28, 2018 ||| Close Update: Wall Street Sinks as Technology Stocks Face Sharp Selloff",1,0.48973295
2018-03-28,2660200.0,248.77999877929688,251.22999572753903,244.3699951171875,249.3699951171875,238.7285003662109,GS,"Raymond James Financial, Inc. (RJF) Ex-Dividend Date Scheduled for March 29, 2018 ||| Analysts Forecast 12% Gains Ahead For FNCF",1,0.46577144
2018-03-29,3073900.0,250.7899932861328,252.97999572753903,248.3300018310547,251.8600006103516,241.1122283935547,GS,"Is JPMorgan Chase & Co. Still Poised To Beat Its Rivals? ||| Noteworthy Thursday Option Activity: CMG, GS, NVDA",0,0.48897988
2018-04-02,3429900.0,251.259994506836,252.6000061035156,243.7700042724609,247.3500061035156,236.794677734375,GS,Goldman (GS) to be Sued Over Discrimination Against Women ||| 5 Juicy Dividend Stocks to Ride Out a Dicey April,1,0.49627382
2018-04-03,2488200.0,248.6100006103516,250.88999938964844,245.8999938964844,250.5800018310547,239.8868560791016,GS,Best ETFs for 2018: Energy Select Sector SPDR (ETF) Can Still Win ||| Quality Stocks Like Citigroup Inc Will Be Higher Soon — Go Long,1,0.50079954
2018-04-05,1924800.0,254.5,258.0,253.3999938964844,255.8099975585937,244.89366149902344,GS,"Goldman Sachs Group's Preferred Stock, Series C Yield Pushes Past 4.5%",0,0.48103055
2018-04-06,3621900.0,251.47999572753903,255.33999633789065,246.67999267578125,249.97000122070312,239.3029022216797,GS,"Waddell & Reed Financial, Inc. (WDR) Ex-Dividend Date Scheduled for April 09, 2018",1,0.45329174
2018-04-10,3113900.0,257.9599914550781,259.8900146484375,255.9499969482422,256.57000732421875,245.62124633789065,GS,Is Goldman Sachs (GS) Set to Beat Q1 Earnings Estimates? ||| How Vertical Integration Is Changing Financials,0,0.49003997
2018-04-11,3322000.0,252.58999633789065,254.8300018310547,249.7899932861328,252.94000244140625,242.14614868164065,GS,"Dow Movers: GS, CVX",1,0.5195594
2018-04-13,3026200.0,261.94000244140625,262.5,254.5399932861328,255.9199981689453,244.9989776611328,GS,"Bank of America Corp (BAC) Stock Looks Like a Buy Ahead of Earnings ||| Stock Market News For Apr 13, 2018 ||| USB vs. BAC: Which Bank Stock is Better Ahead of Earnings? ||| Dow Swings Lower With Big Bank Stocks ||| Noteworthy Friday Option Activity: GS, FLR, CMG",1,0.48040733
2018-04-16,3257400.0,257.1300048828125,260.6600036621094,256.6600036621094,257.8800048828125,246.87535095214844,GS,"SA Stock To Watch: Netflix To The Rescue? ||| SA Stocks To Watch: Netflix To The Rescue? ||| Goldman Sachs expected to report Q1 results April 17 ||| Should You Buy Goldman Sachs (GS) Stock Ahead of Earnings? ||| JPMorgan Chase & Co. Should Be Up on Earnings, Not Down ||| Pre-Market Earnings Report for April 17, 2018 : JNJ, UNH, GS, PGR, PLD, NTRS, CMA, OMC, MLNX, MBWM ||| Why Dean Foods Co (DF) Stock Is Falling Today",0,0.49042314
2018-04-17,10134400.0,261.6000061035156,262.25,252.33999633789065,253.6300048828125,242.8067169189453,GS,"Morning Movers: Goldman, UnitedHealth Jump on Earnings, Twitter Takes Off on Upgrade ||| Mid-Morning Market Update: Markets Open Higher; Goldman Sachs Tops Q1 Expectations ||| Mid-day Update: Earnings Steal Wall Street's Focus Away From Geopolitics, China ||| Should You Buy Morgan Stanley (MS) Stock Ahead of Earnings? ||| Goldman Sachs Earnings: 12 Things to Know About Q1 ||| Mid-Day Market Update: Netflix Surges After Strong Q1 Print; Apellis Pharmaceuticals Shares Slide ||| New Construction Data, Q1 Earnings In Focus ||| Tax Day Not So Taxing (for Corporations, Housing) ||| Pre-Market Most Active for Apr 17, 2018 : NFLX, TVIX, SQQQ, QQQ, GS, RIO, TWTR, BAC, BABA, CHK, GERN, ROKU ||| Earnings Reaction History: Goldman Sachs Group Inc., 63.6% Follow-Through Indicator, 2.1% Sensitive ||| Market Close Report: NASDAQ Composite index closes at 7,281.10 up 124.82 points ||| Netflix, Corporate Earnings Lift U.S. Stocks; VIX Suffers 6th Straight Loss ||| 5 Trades to Make First Thing Tomorrow Morning ||| Mid-Afternoon Market Update: Chinanet Gains Following Q4 Results; SeaChange Shares Fall ||| Financial Sector Update for 04/17/2018: GS, NTRS, CMA, PACW, CLNS ||| Goldman's (GS) Q1 Earnings & Revenues Beat Estimates",1,0.52369195
2018-04-18,4524800.0,254.8999938964844,257.0199890136719,252.25,254.0,243.1609039306641,GS,"6 Stocks to Watch as the Market Goes Higher ||| After Solid Q1 Earnings Beats by Goldman Sachs, J.P. and Morgan Stanley, could they be derailed by...Spotify? ||| Huge Earnings Beat Still Sends Goldman Sachs Group Inc Stock South",1,0.4847551
2018-04-19,3990000.0,254.0,256.1600036621094,252.8300018310547,254.1699981689453,243.3236541748047,GS,"Morgan Stanley Beats Big, But Market Is Unimpressed",0,0.49350387
2018-04-20,2930600.0,254.1000061035156,255.67999267578125,251.47999572753903,251.9600067138672,241.2079620361328,GS,"Rely on Driehaus Strategy and Buy These 5 Momentum Stocks ||| 3 Top Stocks on Sale This Quarter ||| Dow 30 Stock Roundup: AmEx, Goldman, IBM, JNJ, P&G, UNH Earnings Impress ||| In a Volatile 1st Quarter, CME Group Might Be the Big Winner ||| DIA, GS, TRV, AXP: Large Inflows Detected at ETF ||| 5 Big-Brand American Stocks to Sail Through an Edgy Market ||| Top Analyst Reports for Goldman Sachs, Abbott & Altria",0,0.47627905
2018-04-23,3775900.0,251.6600036621093,252.75,246.19000244140625,246.6699981689453,236.14370727539065,GS,"Zacks.com featured highlights include: ICU Medical, KAR Auction, Sony, Goldman Sachs and United Natural ||| Uncle Sam’s Favorite BDCs (with 9% to 10% Yields) ||| The Zacks Analyst Blog Highlights: Caterpillar, Mastercard, Goldman, Boeing and Amazon.com ||| The Zacks Analyst Blog Highlights: Goldman, Abbott, Altria, PayPal and Progressive ||| Market Close Report: NASDAQ Composite index closes at 7,128.60 down -17.53 points ||| Stocks Finish Lower as Treasury Yield Edges Near 3%",0,0.478038
2018-04-24,4705100.0,248.82000732421875,249.1499938964844,240.0399932861328,242.4900054931641,232.14208984375,GS,"TD Ameritrade's (AMTD) Q2 Earnings Beat on Improved Trading ||| Zacks Investment Ideas feature highlights: Goldman, Morgan Stanley, Chicago Mercantile, CBOE and Intercontinental Exchange ||| GS Crosses Below Key Moving Average Level ||| A Trio of Financial Sector Headlines",0,0.5035263
2018-04-25,5041400.0,242.19000244140625,242.4600067138672,237.509994506836,239.22999572753903,229.02120971679688,GS,"Fantastic Earnings From These Two Investment Banks ||| T. Rowe Price's (TROW) Q1 Earnings Miss, Revenues Increase",1,0.5312764
2018-04-26,2891100.0,239.2700042724609,241.6600036621093,238.009994506836,240.08999633789065,229.8444976806641,GS,"Morgan Stanley (MS) Ex-Dividend Date Scheduled for April 27, 2018",0,0.45579895
2018-04-30,2790500.0,240.97000122070312,243.07000732421875,238.22000122070312,238.3300018310547,228.1596221923828,GS,"Venture Capital Deals Of The Week: Goldman Sachs Bets On Used Cars, Telemedicine ||| cc ||| Rates, Rates, Rates: Global Week Ahead ||| Is Whirlpool Corporation Stock a Value Buy or Value Trap? ||| 5 Top Stocks to Buy Ahead of a Grueling May ||| Notable ETF Outflow Detected - DIA, GS, MCD, CAT ||| Notable Monday Option Activity: CMG, DISH, GS",0,0.49492916
2018-05-01,3269800.0,237.509994506836,237.8999938964844,233.9600067138672,236.6699981689453,226.5704498291016,GS,"Relative Strength Alert For Goldman Sachs Group ||| Lam Research, Fitbit, Texas Instruments, Goldman Sachs and Caterpillar highlighted as Zacks Bull and Bear of the Day ||| Markets Now: Dow Slumps 180 Points. Thankfully, It's Not the Market. ||| Validea Kenneth Fisher Strategy Daily Upgrade Report - 5/1/2018",0,0.48152176
2018-05-02,3710900.0,236.6000061035156,237.9100036621093,233.4199981689453,234.0500030517578,224.062255859375,GS,Goldman Sachs to Settle Improper Trading Probe for $109M ||| Validea David Dreman Strategy Daily Upgrade Report - 5/2/2018,0,0.4891086
2018-05-03,4511400.0,232.4499969482422,234.0,227.3999938964844,233.4100036621093,223.4495391845703,GS,UBS Group AG to Boost Majority Stake to 51% in China JV ||| 2 Warren Buffett Stocks to Buy in May,1,0.5098538
2018-05-04,2622300.0,232.3099975585937,236.7899932861328,232.27999877929688,234.94000244140625,224.91427612304688,GS,"TD Ameritrade Holding Corporation (AMTD) Ex-Dividend Date Scheduled for May 07, 2018",1,0.4678073
2018-05-07,1979400.0,236.0,238.1699981689453,235.27999877929688,237.1999969482422,227.07781982421875,GS,"MarketAxess Holdings, Inc. (MKTX) Ex-Dividend Date Scheduled for May 08, 2018 ||| Warren Buffett Offers Another Round of Hard Truths for Bitcoin Fans ||| Notable Monday Option Activity: GS, PLNT, DISH",0,0.45927978
2018-05-08,3267000.0,238.2400054931641,240.6600036621093,236.0,237.0,226.88633728027344,GS,"Dow Movers: VZ, GE ||| Notable ETF Outflow Detected - DIA, GS, MCD, CAT ||| GS vs. MS: Which Investment Bank to Buy Post Q1 Earnings? ||| 3 Reasons You Should Buy Bank of America Corp Stock Right Now! ||| BlackRock to Sell 40% Stake in Joint Venture With DSP Group ||| The Surprising Catalyst Behind the Sudden Resurgence in Cryptocurrencies",1,0.49201947
2018-05-09,2434000.0,237.97999572753903,242.0500030517578,237.25,241.72999572753903,231.41452026367188,GS,"Oppenheimer Holdings, Inc. (OPY) Ex-Dividend Date Scheduled for May 10, 2018 ||| The Charles Schwab Corporation (SCHW) Ex-Dividend Date Scheduled for May 10, 2018 ||| Dow Analyst Moves: GS",1,0.4511302
2018-05-10,2599000.0,242.1100006103516,245.4199981689453,240.1600036621093,243.44000244140625,233.0515594482422,GS,"Dow Movers: CSCO, XOM ||| Seaboard Corporation (SEB) Ex-Dividend Date Scheduled for May 11, 2018 ||| Still Easier Ways to Make Money Than Wells Fargo & Co Stock ||| The Real Winner in Apple's New Credit Card Deal Might Surprise You",0,0.47653922
2018-05-11,1540100.0,243.44000244140625,244.9100036621093,241.7100067138672,242.9199981689453,232.55374145507807,GS,The Bitcoin Bubble Created These 5 Dividend Growth Buys,1,0.5363601
2018-05-14,1928500.0,243.6000061035156,245.8800048828125,243.5,243.9100036621093,233.5015106201172,GS,"3 Top Bank Stocks to Buy in May ||| 3 Weak Stocks Begging for Bear Trades ||| Dow Movers: NKE, GS ||| Cohen & Company Inc. (COHN) Ex-Dividend Date Scheduled for May 15, 2018",0,0.504275
2018-05-15,2165700.0,243.0,243.9499969482422,240.6699981689453,241.5599975585937,231.2517547607422,GS,"Financial Sector Update for 05/15/2018: PPDF,CCT,GS ||| Financial Sector Update for 05/15/2018: GS, CCT, PPDF ||| JPMorgan Chase & Co. Is Wise to Plant Seeds in China ||| Notable Tuesday Option Activity: GS, M, A ||| Financial Sector Update for 05/15/2018: AHL,LYG,PPDF,CCT,GS",0,0.48266762
2018-05-16,1965200.0,241.2700042724609,241.83999633789065,240.58999633789065,240.9600067138672,230.6773681640625,GS,"Notable ETF Inflow Detected - DIA, GS, MCD, CAT ||| 5 Reasons to Include E*TRADE (ETFC) in Your Portfolio Now ||| LPL Financial Holdings Inc. (LPLA) Ex-Dividend Date Scheduled for May 17, 2018 ||| A Vicious Debt Cycle Could Send Interest Rates Much Higher ||| How Warren Buffett Decides It's Time to Sell a Stock ||| Apple Roundup: Goldman Deal, Buffett Adoration, Ireland, Green Energy",0,0.47155702
2018-05-17,2462700.0,240.4199981689453,242.44000244140625,238.77999877929688,239.1000061035156,228.89675903320312,GS,"4 Reasons to Invest in LPL Financial (LPLA) Stock Right Now ||| People's United Grows on Acquisitions, Costs Woes Linger ||| Why Is Goldman (GS) Down 4.8% Since Its Last Earnings Report? ||| Is it Advisable to Add Goldman (GS) to Your Basket Now? ||| 3 Stocks for Warren Buffett Fans",0,0.5069417
2018-05-18,2699000.0,238.1000061035156,238.7400054931641,236.8699951171875,237.0,226.88633728027344,GS,Should You Invest in the iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI)?,1,0.49986774
2018-05-21,1951700.0,239.1000061035156,240.07000732421875,237.32000732421875,237.6999969482422,227.5564880371093,GS,"Goldman's President Likely to Take Over as CEO by 2018 End ||| If You Fear Rising Interest Rates, Buy These Five Dow Stocks ||| Playing $80 Oil: Be Safe, or Be Daring",1,0.47398427
2018-05-23,3114000.0,236.8800048828125,237.8699951171875,234.3800048828125,237.8099975585937,227.66180419921875,GS,Goldman Displays Cost Control: Should You Hold the Stock?,0,0.50912166
2018-05-25,1985600.0,235.0,236.1199951171875,234.27999877929688,235.009994506836,224.9812927246093,GS,"7 Dow Titans Rolling Over ||| Investment Technology Group, Inc. (ITG) Ex-Dividend Date Scheduled for May 29, 2018 ||| 3 Stocks That Could Make Your Grandkids Rich",0,0.50857157
2018-05-29,5323600.0,231.5200042724609,232.47000122070312,225.0200042724609,227.02999877929688,217.34182739257807,GS,"Ex-Dividend Reminder: Cullen/Frost Bankers, AGNC Investment and Goldman Sachs Group ||| Dow Movers: GE, KO ||| Goldman Sachs Group, Inc. (GS) Ex-Dividend Date Scheduled for May 30, 2018 ||| JMP Group LLC (JMP) Ex-Dividend Date Scheduled for May 30, 2018 ||| Europe Drama, Big Banks Cause Stock Sell-Off; VIX Surges ||| Financial Sector Update for 05/29/2018: UNM,BNS,BNS.TO,KKR,RBS ||| Financial Sector Update for 05/29/2018: BNS,BNS.TO,KKR,RBS",1,0.45839217
2018-05-30,3348600.0,228.94000244140625,229.6699981689453,226.27999877929688,229.1600036621093,220.15670776367188,GS,"Navient Corporation (NAVI) Ex-Dividend Date Scheduled for May 31, 2018 ||| Stock Market News For May 30, 2018 ||| Virtu Financial, Inc. (VIRT) Ex-Dividend Date Scheduled for May 31, 2018 ||| Cboe Global Markets, Inc. (CBOE) Ex-Dividend Date Scheduled for May 31, 2018 ||| GS Named 'Top Dividend Stock of the Dow' at Dividend Channel With 1.4% Yield ||| Interactive Brokers Group, Inc. (IBKR) Ex-Dividend Date Scheduled for May 31, 2018 ||| Close Update: Wall Street Recovers After Selloff as Energy, Financial Stocks Surge ||| Noteworthy Wednesday Option Activity: ABBV, GS, DG ||| Stifel Financial Corporation (SF) Ex-Dividend Date Scheduled for May 31, 2018",0,0.45621982
2018-05-31,5334900.0,227.33999633789065,228.1100006103516,224.08999633789065,225.8800048828125,217.0055694580078,GS,"Stock Market News For May 31, 2018 ||| USB vs. BAC: Which Bank Stock Looks Better Post Q1 Earnings? ||| Will Softening of Volcker Rule Prove Beneficial for Banks?",1,0.5039952
2018-06-01,3330900.0,228.3999938964844,230.25,228.08999633789065,228.3500061035156,219.3785400390625,GS,"Dow Movers: UNH, INTC ||| 5 Top Stocks to Pull Through the June Swoon ||| The Zacks Analyst Blog Highlights: Bank of America and U.S. Bancorp ||| Close Update: Wall Street Buoyed After Better-Than-Expected Payrolls Report, Tech Rally",1,0.5042825
2018-06-05,1986200.0,228.94000244140625,229.33999633789065,227.2899932861328,228.33999633789065,219.3689117431641,GS,"Dow Movers: GE, DWDP ||| BlackRock, Inc. (BLK) Ex-Dividend Date Scheduled for June 06, 2018 ||| Walmart Inc Sells Walmart Brazil for $0 … And It’s a Smart Deal",1,0.469497
2018-06-06,2566400.0,229.8500061035156,232.5800018310547,229.3600006103516,232.22999572753903,223.1060791015625,GS,"Financial Select Sector SPDR Fund Experiences Big Outflow ||| CME Group Inc. (CME) Ex-Dividend Date Scheduled for June 07, 2018 ||| Notable Wednesday Option Activity: GS, SGMS, AXON ||| 3 Top Bank Stocks to Buy in June",1,0.48539323
2018-06-07,2905000.0,233.88999938964844,235.9199981689453,232.5399932861328,233.4499969482422,224.2781524658203,GS,Goldman Sachs Has Big Plans in Consumer Banking,0,0.5161478
2018-06-08,2253100.0,233.0,234.2700042724609,232.3500061035156,233.38999938964844,224.22052001953125,GS,"Goldman Sachs Group Inc Is Right. U.S. Growth Is as Good as It Gets ||| GAIN Capital Holdings, Inc. (GCAP) Ex-Dividend Date Scheduled for June 11, 2018 ||| Energy Sector Update for 06/08/2018: BHGE, XOM, CVX, RDS.A, RDS.B, BP, E, COP, TOT, PBR, PBR.A, EC, SLB, HAL, NOV, SPN",1,0.468098
2018-06-11,1936800.0,234.6199951171875,235.1600036621093,233.58999633789065,234.08999633789065,224.8930206298828,GS,"Venture Capital Deals Of The Week: Ant Financial Gets $14B Ahead Of IPO ||| Weekly Market Preview: Trump Meets Kim Jong Un, FOMC Meets On Interest Rates, Retail Sales, And More ||| Dow Movers: MCD, CSCO",0,0.4894827
2018-06-12,2080000.0,234.1199951171875,235.22999572753903,231.8600006103516,232.6300048828125,223.4903564453125,GS,"3 Low-Cost Bank Stocks Helping to Move the Market Higher ||| Intercontinental Exchange Inc. (ICE) Ex-Dividend Date Scheduled for June 13, 2018",1,0.516294
2018-06-13,3637400.0,233.6499938964844,238.22999572753903,233.1000061035156,233.8300018310547,224.64321899414065,GS,"T. Rowe Price Group, Inc. (TROW) Ex-Dividend Date Scheduled for June 14, 2018 ||| Nasdaq, Inc. (NDAQ) Ex-Dividend Date Scheduled for June 14, 2018 ||| Ladenburg Thalmann Financial Services Inc (LTS) Ex-Dividend Date Scheduled for June 14, 2018",0,0.45492476
2018-06-14,2899600.0,235.8699951171875,235.88999938964844,232.58999633789065,233.6499938964844,224.4702911376953,GS,"Associated Capital Group, Inc. (AC) Ex-Dividend Date Scheduled for June 15, 2018 ||| Noteworthy Thursday Option Activity: CMG, NBL, GS",0,0.46334434
2018-06-15,4738100.0,231.5,233.1499938964844,229.83999633789065,231.9199981689453,222.80825805664065,GS,Fed Sets Loan Exposure Limits on Major Wall Street Banks,0,0.50034904
2018-06-18,2327500.0,230.1999969482422,231.6699981689453,229.1499938964844,231.38999938964844,222.2990875244141,GS,3 Top Bank Stocks to Buy Right Now ||| Why Zillow Group Inc Stock Is Heading Lower Today,0,0.5253812
2018-06-19,3326600.0,228.22000122070312,229.0399932861328,226.1600036621093,228.32000732421875,219.34971618652344,GS,"BOK Financial Eyes Expansion, To Buy CoBiz Financial for $1B ||| JPMorgan to Pay $65 Million as Swap Rate Manipulation Charge",0,0.5114407
2018-06-21,3094600.0,226.38999938964844,228.42999267578125,224.57000732421875,226.97999572753903,218.0623474121093,GS,"Deutsche Bank to Pay $205M for Forex Trading Manipulation ||| Notable Thursday Option Activity: GS, ARNA, LFGR",0,0.49385712
2018-06-22,2731800.0,227.77999877929688,230.5,225.5800018310547,226.0200042724609,217.1400756835937,GS,"Don’t Worry About Missing Out, Ansys Stock Is Due for a Pullback",0,0.49353835
2018-06-25,3817700.0,224.5,225.13999938964844,220.38999938964844,221.5399932861328,212.8360595703125,GS,Venture Capital Deals Of The Week: Tencent Bets On Online Education ||| Goldman Sachs Group Enters Oversold Territory,1,0.52686054
2018-06-26,2692900.0,221.77999877929688,222.8000030517578,219.1199951171875,221.5800018310547,212.87451171875,GS,"Here's Why Netflix (NFLX) Stock Climbed Back Today ||| Court Annuls Nomura, RBS Plea Against Mortgage Bond Case",0,0.5032691
2018-06-27,3104200.0,221.47999572753903,225.47000122070312,220.13999938964844,220.17999267578125,211.52951049804688,GS,"Zacks Investment Ideas feature highlights: Blockchain Equity, Nvidia, Chicago Mercantile Exchange, CBOE Global Holdings and Goldman Sachs ||| Should You Buy Netflix (NFLX) Stock Right Now?",1,0.49612594
2018-06-28,3072600.0,220.25,224.6600036621093,219.5800018310547,223.4199981689453,214.6422119140625,GS,"Goldman Sachs BDC Prices $40 Mln of Convertible Notes to Pay Down Revolving Credit Facility Debt ||| Are Tesla Short Sellers In for a “Rude Awakening”? ||| Trump Waves White Flag on Trade: 4 Stocks to Make a Comeback ||| Raymond James Financial, Inc. (RJF) Ex-Dividend Date Scheduled for June 29, 2018",0,0.47803214
2018-06-29,3393700.0,224.3999938964844,225.1699981689453,220.4499969482422,220.57000732421875,211.9042205810547,GS,"Dow Pares Triple-Digit Lead, But Ends 2Q Higher ||| Stock Market News For Jun 29, 2018 ||| Financial Sector Update for 06/29/2018: AXP,ABR,MNR,BAC,WFC,C,JPM,GS,MS,STT,DB ||| JPMorgan (JPM) Launches its Online-Only Bank Nationwide ||| Financial Sector Update for 06/29/2018: EQH,AMZN,MNR,AXP,ABR,BAC,WFC,C,JPM,GS,MS,STT,DB ||| How Financial ETFs Look After Fed Stress Test ||| Noteworthy Friday Option Activity: CMG, GS, CELG ||| Financial Sector Update for 06/29/2018: PGH,EQH,AMZN,MNR,AXP,ABR,BAC,WFC,C,JPM,GS,MS,STT,DB",1,0.46306762
2018-07-02,1723200.0,219.75,223.33999633789065,218.88999938964844,223.259994506836,214.488525390625,GS,"Close Update: Wall Street Recoups Losses in Wobbly Session as Tech, Financials Advance ||| Wall Street Recoups Losses in Wobbly Session as Tech, Financials Advance",0,0.47483444
2018-07-03,1204400.0,224.4600067138672,224.63999938964844,219.9900054931641,220.3800048828125,211.7216339111328,GS,"Dow Movers: NKE, XOM ||| Goldman (GS) Signs Undertaking With ASIC Over Block Trade ||| The 2018 Bank Stress Tests: What Investors Need to Know",1,0.46483824
2018-07-05,2218200.0,221.5,222.13999938964844,219.77999877929688,220.7400054931641,212.06753540039065,GS,"GS August 24th Options Begin Trading ||| 5 Top Stock Trades for Thursday Morning ||| Bank Stress Test Winners and Losers ||| 2 Warren Buffett Stocks to Buy in July ||| Financial Sector Update for 07/05/2018: GS,PNC,WU,GZT",1,0.4786875
2018-07-06,1846400.0,220.5399932861328,223.1999969482422,219.8800048828125,221.7899932861328,213.0762634277344,GS,"JPMorgan (JPM) to Relocate Dozens of Personnel Pre-Brexit ||| Notable ETF Outflow Detected - DIA, GS, MCD, IBM ||| Noteworthy Friday Option Activity: HELE, GS, CELG",1,0.4814421
2018-07-09,2743900.0,223.3600006103516,228.1999969482422,223.0,227.9900054931641,219.0326690673828,GS,"Top Research Reports for Mastercard, Gilead & Goldman Sachs ||| Bank Stocks Boost Dow to Third Straight Win",0,0.513576
2018-07-10,2524800.0,228.0,228.8699951171875,225.8500061035156,226.8500061035156,217.93746948242188,GS,"Stock Market News For Jul 10, 2018 ||| The Zacks Analyst Blog Highlights: Mastercard, Gilead, Goldman Sachs, PepsiCo and Aetna",0,0.47212228
2018-07-11,2527000.0,225.759994506836,227.25,225.1999969482422,225.6600036621093,216.7942047119141,GS,Why Finance's New Favorite Metric Is Customer Satisfaction ||| 7 S&P 500 Stocks With Low P/E Ratios,1,0.4866166
2018-07-12,2223100.0,227.63999938964844,227.8000030517578,225.7700042724609,227.22000122070312,218.29293823242188,GS,Goldman's (GS) Credit-Portfolio Trades Benefit From ETF Boom,0,0.53588706
2018-07-13,2541500.0,226.6300048828125,228.6199951171875,223.92999267578125,226.4100036621093,217.51475524902344,GS,Will Muted Trading Business Impact Goldman (GS) Q2 Earnings? ||| 3 Cybersecurity Stock to Buy on Midterm Election Hacking ||| Market Unimpressed with Bank Earnings,1,0.49487284
2018-07-16,3271200.0,227.1999969482422,231.44000244140625,226.7400054931641,231.44000244140625,222.34716796875,GS,"Wells Fargo, JPMorgan, Bank of America, Goldman Sachs and Morgan Stanley are part of Zacks Earnings Preview ||| SPDR Dow Jones Industrial Average ETF Experiences Big Outflow ||| Close Update: Wall Street Wobbles as Oil Prices Sink, Earnings Bolster Financials ||| 10 Dow Jones Titans to Buy Now ||| Financial Sector Update for 07/16/2018: GS,BAC,KKR,RLJ,GOOG,GOOGL,RLJ,DRH ||| Pre-Market Earnings Report for July 17, 2018 : JNJ, UNH, GS, SCHW, PLD, PGR, OMC, CMA, FHN, NEOG, NSM, MBWM",0,0.50140584
2018-07-17,9280200.0,231.47999572753903,233.22999572753903,226.8699951171875,231.0200042724609,221.94363403320312,GS,"Markets Now: Dow Slips 12 Points, as UnitedHealth Slides ||| Midday Update: U.S. Stocks Reverse Early Losses as Powell Soothes Wall Street ||| Mid-Day Market Update: Avid Bioservices Surges Following Earnings Beat; Netflix Shares Plunge ||| David Solomon: 7 Things to Know About the New Goldman Sachs CEO ||| Goldman Sachs Group, Inc. (GS) Q2 2018 Earnings Conference Call Transcript ||| Goldman Sachs Earnings: Strong Profitability and Growth in Several Key Areas ||| Goldman Beats in Blankfein's Final Quarter ||| Netflix Miss Weighs on Wall Street ||| Financial Sector Update for 07/17/2018: GS, NSM, CMA ||| Financial Sector Update for 07/17/2018: PACW,GS,CMA,NSM ||| Stock Market News For July 17, 2018 ||| Why Omnicom, UnitedHealth Group, and Goldman Sachs Slumped Today ||| Close Update: Wall Street Bounces Back From Netflix Crash on Powell Assurances ||| Netflix rallies, Why? ||| Goldman Sachs Delivers Solid Earnings and New CEO ||| Mid-Afternoon Market Update: CCA Industries Falls Following Q2 Results; AMERI Holdings Shares Surge ||| Goldman Sachs (GS) Q2 Earnings Impress on Record Revenues ||| Financial Sector Update for 07/17/2018: GS,CMA,NSM ||| Goldman's (GS) Q2 Earnings & Revenues Beat Estimates",1,0.507866
2018-07-18,6149900.0,232.33999633789065,233.72000122070312,230.1499938964844,231.2400054931641,222.1549835205078,GS,"Dow Movers: CVX, WBA ||| Earnings & Economic Data Deluge ||| The Price of Bitcoin Jumped Yesterday… Is There Hope for the Bulls? ||| Validea David Dreman Strategy Daily Upgrade Report - 7/18/2018 ||| Validea Peter Lynch Strategy Daily Upgrade Report - 7/18/2018 ||| Company News For Jul 18, 2018",0,0.47819945
2018-07-19,4638500.0,231.1100006103516,231.9900054931641,228.97999572753903,229.6300048828125,220.60826110839844,GS,5 Bank Stocks to Bank On ||| Are CEOs Really Worth What They’re Paid?,1,0.50324696
2018-07-20,2683500.0,229.009994506836,232.0500030517578,228.8000030517578,231.69000244140625,222.5873107910156,GS,"Bank ETFs Rise on the Wave of Big Releases ||| Energy Sector Update for 07/20/2018: BHGE, XOM, CVX, RDS.A, RDS.B, BP, E, COP, TOT, PBR, PBR.A, EC, SLB, HAL, NOV, SPN",1,0.47954312
2018-07-23,2788500.0,231.8000030517578,234.8600006103516,231.72000122070312,233.759994506836,224.5759735107422,GS,"Dow Movers: MMM, GS ||| The Zacks Analyst Blog Highlights: Microsoft, Novartis, Goldman Sachs, Starbucks and General Motors ||| Notable Monday Option Activity: IRBT, CYH, GS ||| Stocks Nearly Breakeven to Start Earnings Season",1,0.5095879
2018-07-24,2887400.0,234.75,237.47999572753903,234.33999633789065,235.8800048828125,226.6126708984375,GS,"DIA, GS, MCD, IBM: ETF Inflow Alert ||| Here's Why Bitcoin Has Gained 15% This Week ||| Strong Second-Quarter Earnings From 2 Leading Investment Banks",1,0.5023383
2018-07-25,2181500.0,235.009994506836,236.8500061035156,233.9499969482422,236.69000244140625,227.390869140625,GS,Here’s Why Bitcoin Has Gained 15% This Week ||| 3 Warren Buffett Stocks Worth Buying Now ||| Have All Nvidia (NVDA) Rumors Already Been Priced In?,1,0.4918703
2018-07-26,1885500.0,237.0,238.33999633789065,236.42999267578125,237.1100006103516,227.7943420410156,GS,"5 Dow Jones Stocks That Are Ready to Rise Again ||| Evercore (EVR) Q2 Earnings Beat Estimates, Revenues Rise ||| Why Yum China, SUPERVALU, and Advanced Micro Devices Jumped Today",1,0.5130146
2018-07-27,1998200.0,237.9600067138672,238.8000030517578,235.9900054931641,237.63999938964844,228.3035430908203,GS,"JMP Group LLC (JMP) Ex-Dividend Date Scheduled for July 30, 2018 ||| Goldman Sachs Group's Preferred Stock, Series N Shares Cross 6% Yield Mark",1,0.4843456
2018-07-30,2454100.0,238.0,239.72999572753903,236.88999938964844,238.9499969482422,229.5620574951172,GS,Top Analyst: 3 Financial Stocks Primed to Grow More Than 13% ||| U.S. Growth Hits Best Pace Since 2014: 5 Great Picks,0,0.5183659
2018-07-31,2503700.0,239.5,239.5,236.5500030517578,237.42999267578125,228.10177612304688,GS,"The Zacks Analyst Blog Highlights: Goldman Sachs, Polaris, American Woodmark, Penn National, Funko and Johnson Outdoors",0,0.50146574
2018-08-01,2510500.0,238.5,239.3999938964844,235.77999877929688,236.0399932861328,226.7663726806641,GS,Meet the Dow's 3 Most Important Components (Hint: Apple Isn't 1 of Them) ||| Here's How Morgan Stanley's Earnings Grew 49% ||| Goldman Sachs' Excellent Second-Quarter Earnings: What You Need to Know,0,0.46954262
2018-08-03,3053100.0,234.44000244140625,235.5200042724609,233.4900054931641,234.08999633789065,224.8930206298828,GS,"Energy Sector Update for 08/03/2018: BHGE, XOM, CVX, RDS.A, RDS.B, BP, E, COP, TOT, PBR, PBR.A, EC, SLB, HAL, NOV, SPN ||| See Which Of The Latest 13F Filers Holds Goldman Sachs Group ||| TD Ameritrade Holding Corporation (AMTD) Ex-Dividend Date Scheduled for August 06, 2018",1,0.4694364
2018-08-06,2259600.0,234.13999938964844,236.97999572753903,234.02999877929688,235.92999267578125,226.66070556640625,GS,"3 Top Bank Stocks to Buy Right Now ||| Financial Sector Update for 08/06/2018: BCS, SYF, WMT, HSBC, GS ||| Why Intercept Pharmaceuticals Stock Is Moving Higher Today ||| Financial Sector Update for 08/06/2018: SYF, WMT, HSBC, GS",1,0.5158201
2018-08-07,2399500.0,237.25,239.4600067138672,236.4900054931641,237.8300018310547,228.486083984375,GS,"LPL Financial Holdings Inc. (LPLA) Ex-Dividend Date Scheduled for August 08, 2018 ||| MarketAxess Holdings, Inc. (MKTX) Ex-Dividend Date Scheduled for August 08, 2018 ||| 5 Silicon Valley Stocks to Buy as Tech Juggernauts Roll On ||| The Zacks Analyst Blog Highlights: Goldman Sachs, JP Morgan Chase and Morgan Stanley ||| How Goldman Sachs Is Finally Tackling One of Its Key Problems ||| Top Stock Picks for the Week of August 6th",0,0.46371982
2018-08-08,2522400.0,238.1199951171875,239.1600036621093,236.22999572753903,236.3699951171875,227.0834350585937,GS,"The Charles Schwab Corporation (SCHW) Ex-Dividend Date Scheduled for August 09, 2018 ||| Oppenheimer Holdings, Inc. (OPY) Ex-Dividend Date Scheduled for August 09, 2018 ||| GS vs. MS: Which Bank is a Better Choice Post Q2 Earnings? ||| Boost Portfolio Returns With These 5 Warren Buffett Picks (Revised) ||| Boost Portfolio Returns With These 5 Warren Buffet Picks ||| Boost Portfolio Returns With These 5 Warren Buffett Picks ||| Financial Sector Update for 08/08/2018: PRA,SBNY,GS,LXP",0,0.46311057
2018-08-09,2951900.0,236.3500061035156,236.8500061035156,233.38999938964844,233.77999877929688,224.5951995849609,GS,"The Zacks Analyst Blog Highlights: Berkshire Hathaway, Apple, Goldman Sachs Group, United Parcel Service, Verizon Communications and Phillips 66",0,0.48961747
2018-08-10,3863400.0,230.97000122070312,231.4600067138672,228.1100006103516,229.6100006103516,220.5890350341797,GS,"Dow Movers: INTC, WMT ||| Why You Shouldn't Bet Against Goldman Sachs (GS) Stock",0,0.48444465
2018-08-13,2662700.0,229.4900054931641,229.88999938964844,226.57000732421875,226.8600006103516,217.9470672607422,GS,Turkey Crisis Pushes Stocks Into the Red,1,0.5211787
2018-08-15,3218500.0,229.3500061035156,231.5399932861328,228.3099975585937,229.25,220.2431640625,GS,"11 Stocks Warren Buffett Is Buying or Selling ||| Dow Movers: CAT, MRK ||| Here's What Warren Buffett Is Buying and Selling Now ||| Notable Wednesday Option Activity: CMG, GS, PVH ||| Top Stocks Warren Buffett Is Buying Now",1,0.4880794
2018-08-16,2438300.0,230.6699981689453,233.2899932861328,230.4499969482422,233.0,223.8458251953125,GS,"The 3 Cheapest Dow Stocks ||| Warren Buffett Just Invested $1.2 Billion in These 3 Bank Stocks ||| BGC Partners, Inc. (BGCP) Ex-Dividend Date Scheduled for August 17, 2018 ||| Seaboard Corporation (SEB) Ex-Dividend Date Scheduled for August 17, 2018",1,0.46358496
2018-08-17,2107200.0,232.509994506836,233.72000122070312,231.63999938964844,233.3800048828125,224.21090698242188,GS,"Investment Technology Group, Inc. (ITG) Ex-Dividend Date Scheduled for August 20, 2018 ||| Goldman Sachs Might Face Class Action Lawsuit Over CDOs",1,0.45634866
2018-08-21,2437300.0,235.2899932861328,239.52999877929688,235.2899932861328,238.6499938964844,229.2738647460937,GS,"Why Tesla, Inc. Stock Jumped Tuesday",1,0.479987
2018-08-22,1870900.0,237.88999938964844,239.6699981689453,237.5800018310547,239.33999633789065,229.936752319336,GS,3 Top Dividend Stocks You Can Buy on Sale,0,0.5746821
2018-08-23,2064700.0,239.0500030517578,239.27999877929688,235.83999633789065,236.33999633789065,227.0546112060547,GS,"Financial Sector Update for 08/23/2018: LX, GS, HSBC, BCS, BOKF, COBZ, DB ||| Financial Sector Update for 08/23/2018: GS, DB, BOKF",0,0.44513944
2018-08-24,1948100.0,237.3600006103516,237.8000030517578,234.6999969482422,235.1100006103516,225.8729553222656,GS,Goldman Offering Marcus to UK Staff Before Bigger Rollout,1,0.55176073
2018-08-27,4106900.0,236.9900054931641,243.6499938964844,236.5599975585937,242.6000061035156,233.06866455078125,GS,"Dow Movers: PFE, CAT ||| Tesla to Remain a Public Company ||| AMD Stock Is Expensive, But It’s Still a Better Buy Than Intel",0,0.4759792
2018-08-28,2951000.0,243.0599975585937,245.0800018310547,241.58999633789065,242.3699951171875,232.8477020263672,GS,"Zacks Investment Ideas feature highlights: Tesla, Goldman Sachs and Morgan Stanley ||| Goldman Sachs Group, Inc. (GS) Ex-Dividend Date Scheduled for August 29, 2018 ||| Dow Out of Its Second Longest Correction Territory: 5 Picks",0,0.476402
2018-08-29,1911700.0,242.0500030517578,242.7899932861328,240.3099975585937,241.3999938964844,232.683837890625,GS,"Interactive Brokers Group, Inc. (IBKR) Ex-Dividend Date Scheduled for August 30, 2018 ||| JMP Group LLC (JMP) Ex-Dividend Date Scheduled for August 30, 2018 ||| Cboe Global Markets, Inc. (CBOE) Ex-Dividend Date Scheduled for August 30, 2018",0,0.4361479
2018-08-30,1963700.0,240.8000030517578,241.1199951171875,238.67999267578125,239.3999938964844,230.7560577392578,GS,"Stifel Financial Corporation (SF) Ex-Dividend Date Scheduled for August 31, 2018",0,0.46606448
2018-08-31,1965500.0,238.94000244140625,239.3500061035156,237.1199951171875,237.8099975585937,229.2234802246093,GS,"TSLA Stays Public, AMZN Hits $2,000, ULTA & LULU Earnings ||| Greenhill & Co., Inc. (GHL) Ex-Dividend Date Scheduled for September 04, 2018",0,0.44069976
2018-09-04,2083500.0,237.759994506836,238.1199951171875,234.58999633789065,237.6600036621093,229.0788726806641,GS,"The Really Bizarre Part of the NFL Linebacker Insider Trading Story ||| Implied VLUE Analyst Target Price: $99 ||| Noteworthy ETF Inflows: DIA, GS, AAPL, CAT ||| 5 Top Stocks to Challenge a Notorious September",0,0.49696726
2018-09-05,2092000.0,237.009994506836,239.4499969482422,236.1699981689453,237.5599975585937,228.98248291015625,GS,"Bitcoin Plunges After Goldman Sachs Scraps Its Crypto Plans ||| 5 Solid Dividend Stocks to Make Good in a Lousy September ||| Navient Corporation (NAVI) Ex-Dividend Date Scheduled for September 06, 2018",0,0.42358527
2018-09-06,2651400.0,237.0,238.6300048828125,233.8800048828125,234.5200042724609,226.05226135253903,GS,"CME Group Inc. (CME) Ex-Dividend Date Scheduled for September 07, 2018 ||| Notable Thursday Option Activity: CMG, GS, MRVL",0,0.46623403
2018-09-07,1952900.0,235.0500030517578,235.63999938964844,232.67999267578125,233.9100036621093,225.4642791748047,GS,"Bitcoin: Is This the End of Rico? ||| GAIN Capital Holdings, Inc. (GCAP) Ex-Dividend Date Scheduled for September 10, 2018 ||| Here's Why You Should Pick Goldman Stock for Your Portfolio ||| Looking Ahead to Q3 Earnings Season ||| Why Criteo SA Plunged Today",0,0.4920792
2018-09-10,1948100.0,235.009994506836,235.5,231.7400054931641,231.9100036621093,223.5364990234375,GS,"Looking Ahead to Q3 Earnings Season ||| Zacks Earnings Trends Highlights: Bank of America, Goldman Sachs and Morgan Stanley",0,0.5245882
2018-09-11,2719400.0,230.6699981689453,231.6499938964844,228.6600036621093,230.2100067138672,221.8978881835937,GS,"Dow Movers: GS, NKE ||| Close Update: Wall Street Propped Up by Oil's Rally, China's Efforts to Soothe Trade War Tensions",0,0.5140115
2018-09-12,3577700.0,230.9100036621093,231.9900054931641,227.3000030517578,228.1499938964844,219.9122467041016,GS,"Grossman Is Engineering a Real Weight Watchers Stock Turnaround ||| Top Research Reports for Oracle, Roche & Goldman Sachs ||| Noteworthy ETF Inflows: DIA, GS, AAPL, MMM ||| Apple Leads a Rebound in Tech Shares: 5 Solid Buys ||| Nasdaq, Inc. (NDAQ) Ex-Dividend Date Scheduled for September 13, 2018 ||| Ladenburg Thalmann Financial Services Inc (LTS) Ex-Dividend Date Scheduled for September 13, 2018 ||| T. Rowe Price Group, Inc. (TROW) Ex-Dividend Date Scheduled for September 13, 2018 ||| JPMorgan to Restructure Luxembourg Operation Ahead of Brexit",1,0.5028787
2018-09-13,3003600.0,229.5,229.8500061035156,227.57000732421875,228.3300018310547,220.08575439453125,GS,"Zacks Investment Ideas feature highlights: Bank of America, Wells Fargo, Goldman Sachs, JP Morgan and Deutsche Bank ||| The Zacks Analyst Blog Highlights: Oracle, Roche, Goldman Sachs, Capital One and Intercontinental Exchange",1,0.49339938
2018-09-14,2228300.0,229.0800018310547,230.5500030517578,228.759994506836,229.2400054931641,220.96290588378903,GS,"Does the iPhone XS Really Move Apple Stock Closer to $400? ||| Notable Friday Option Activity: DVN, CMG, GS ||| Financial Sector Update for 09/14/2018: COLD,WFC,NDAQ,BAC,GS",0,0.4712256
2018-09-17,1918800.0,229.3999938964844,230.1600036621093,227.3000030517578,227.88999938964844,219.6616668701172,GS,10 Years On: 9 Bizarre Facts You Forgot About Lehman Brothers' Bankruptcy,1,0.52359885
2018-09-18,2498100.0,228.3500061035156,229.3999938964844,226.57000732421875,228.88999938964844,220.6255645751953,GS,Buying Bank of America Stock: 3 Pros and 3 Cons,1,0.5323069
2018-09-19,3716500.0,229.8999938964844,236.27999877929688,229.5200042724609,235.5800018310547,227.07400512695312,GS,"5 Short-Term Investments With Less Risk Than the Stock Market ||| Safely Trade Bank of America Stock in These Uncertain Times ||| 2 Bank Stocks to Trade: Buy JPMorgan, Short Goldman Sachs ||| Market Close Report: NASDAQ Composite index closes at 7,950.04 down -6.07 points ||| Dow Spikes Again; Wall Street Watches Wild Tilray Ride ||| Close Update: Dow, S&P 500 Approaching All-Time Highs as Banks Rally While Nasdaq Slips ||| 5 Top Stock Trades for Thursday — Trading FANG Stocks and Tilray ||| 6 Big Bank Stocks Leading the Breakout ||| Financial Sector Update for 09/19/2018: GS.AEG,PRU,EVOP,MET,JPM,BCS,HSBC,CS,WFC",1,0.52978784
2018-09-20,2503000.0,237.0,238.509994506836,236.02999877929688,237.3999938964844,228.82827758789065,GS,"SPDR Dow Jones Industrial Average ETF Experiences Big Outflow ||| BofA (BAC) Charged With $30M for Interest Rate Manipulation ||| Is Goldman Sachs Mulling the Spin-Off of Fintech App Simon? ||| Repeat: Close Update: Dow, S&P Set Record Highs as Wall Street Bets on Muted Trade War",0,0.49195457
2018-09-21,3760300.0,238.0599975585937,238.5200042724609,234.8300018310547,235.33999633789065,226.8426513671875,GS,Buffett Sees a Big Consumer Banking Bargain at Goldman Sachs ||| Goldman Sachs Faces Lawsuit by 2 Leading Brokerage Firms,0,0.48093978
2018-09-24,2057000.0,234.7400054931641,235.7400054931641,232.2400054931641,232.8999938964844,224.49075317382807,GS,"Forget Penny Stocks, Your Money Is Better Off in These 3 Companies ||| 10 Years Later: Warren Buffett and the Financial Crisis ||| Zacks Investment Ideas feature highlights: Apple, Goldman, US Bancorp and Bank of New York",0,0.48111844
2018-09-26,2372700.0,232.9600067138672,233.0,228.2400054931641,228.8800048828125,220.61590576171875,GS,"JMP Group LLC (JMP) Ex-Dividend Date Scheduled for September 27, 2018 ||| 10 Dow Jones Stocks to Finish the Year Strong",0,0.4991964
2018-09-27,2451500.0,228.7700042724609,229.8500061035156,227.5200042724609,227.7400054931641,219.51705932617188,GS,"Is Bank of New York Mellon Stock Worth Banking on Today? ||| Raymond James Financial, Inc. (RJF) Ex-Dividend Date Scheduled for September 28, 2018 ||| Should You Invest in the iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI)? ||| Financial Sector Update for 09/27/2018: GS, KKR, XHR ||| Financial Sector Update for 09/27/2018: C,KKR,XHR,GS ||| Financial Sector Update for 09/27/2018: KKR, XHR, GS",0,0.46087483
2018-09-28,3097800.0,225.75,227.3999938964844,223.8000030517578,224.2400054931641,216.1434631347656,GS,"Noteworthy ETF Outflows: DIA, GS, MMM, UTX ||| Dow Movers: GS, MCD ||| Goldman Sachs (GS) Unveils Online Retail Bank Marcus in UK ||| Energy Sector Update for 09/28/2018: BHGE, GS, XOM, CVX, RDS.A, RDS.B, BP, E, COP, TOT, PBR, PBR.A, EC, SLB, HAL, NOV, SPN",1,0.48194054
2018-10-01,2451300.0,226.22000122070312,227.58999633789065,225.0,225.3300018310547,217.194091796875,GS,"Credit Suisse (CS) Agrees With $10M Settlement for U.S. Probe ||| Notable Monday Option Activity: CMG, GS, MCO ||| Is RBS Planning to Unveil a Digital Banking Platform in 2019?",1,0.49716523
2018-10-03,2573900.0,227.75,229.7700042724609,226.5800018310547,227.77999877929688,219.5556182861328,GS,"Goldman Sachs Group's Preferred Stock, Series J Shares Cross 5.5% Yield Mark",0,0.50668424
2018-10-04,2903600.0,229.259994506836,231.3999938964844,225.38999938964844,227.47999572753903,219.2664337158203,GS,"Dow Movers: PG, JPM",0,0.50144047
2018-10-05,1722400.0,228.0,228.4100036621093,224.2100067138672,225.7100067138672,217.56036376953125,GS,"Why Goldman Sachs (GS) is the Pick in A Sector Set to Rise ||| Energy Sector Update for 10/05/2018: BHGE, XOM, CVX, RDS.A, RDS.B, BP, E, COP, TOT, PBR, PBR.A, EC, SLB, HAL, NOV, SPN",0,0.46189618
2018-10-08,2522900.0,224.259994506836,226.9199981689453,222.5,225.3500061035156,217.2133636474609,GS,"Elastic IPO: Free Software Really Is Lucrative ||| Citigroup to Shift Consumer Business Headquarter to London ||| Notable Monday Option Activity: RDNT, GS, HUM",0,0.5035482
2018-10-09,1862900.0,224.9900054931641,225.1199951171875,222.52999877929688,222.9100036621093,214.8614501953125,GS,Goldman Sachs (GS) Q3 Earnings Preview: What's in the Cards? ||| 4 Top Stocks to Hedge Your Portfolio Against Rising Rates,0,0.49046093
2018-10-10,3955500.0,223.2400054931641,223.63999938964844,214.5599975585937,214.88999938964844,207.13104248046875,GS,RSI Alert: Goldman Sachs Group ||| 3 Cybersecurity Stocks for These Fearful Times,0,0.49138424
2018-10-11,6217400.0,214.1999969482422,216.02999877929688,210.9499969482422,212.97000122070312,205.2803649902344,GS,Square Stock Slides on CFO Exit,1,0.5206031
2018-10-12,4161300.0,217.0,217.97999572753903,211.4600067138672,213.8699951171875,206.1478576660156,GS,"Subdued Trading Business to Hurt Goldman (GS) Q3 Earnings? ||| PNC Financial (PNC) Q3 Earnings Beat Estimates, Revenues Up ||| First Round of Bank Earnings is Positive, What???s on Deck?",1,0.4892576
2018-10-15,3333800.0,214.4499969482422,217.13999938964844,213.0500030517578,215.22000122070312,207.4491271972656,GS,"2 Great Stocks That Just Went on Sale ||| Tech Drags Dow, Nasdaq Lower ||| 5 Top Stock Trades for Tuesday: Trading Bank Earnings",1,0.5087198
2018-10-16,5924200.0,219.3500061035156,222.0,216.3000030517578,221.6999969482422,213.6951446533203,GS,"Goldman Sachs (GS) Beats Q3 Earnings and Revenue Estimates ||| Upbeat Consumer Banking Performance Helps JPMorgan Overcome Investment Banking Weakness In Q3 ||| Q3 Earnings Reports: MSFT, NFLX, GS, MS, UNH, JNJ ||| Goldman Sachs Earnings Give Investors Much to Celebrate ||| Mid-Morning Market Update: Markets Open Higher; Goldman Sachs Profit Tops Expectations ||| Financial Sector Update for 10/16/2018: MS, BLK, GS, JPM, BAC, WFC, C, USB ||| Wall Street Bolstered by Easing Geopolitical Tensions, Rally in Italian Assets ||| Mid-Day Update: Record High Job Openings, Strong Quarterly Results Fuel Rally in Dow ||| Will Tuesday's Earnings Reports Inspire a Stock Market Rebound? ||| Dow Gains 127 Points as Stocks Try Try Again ||| Close Update: Stocks Rally as Solid Earnings Reports Help Boost Markets ||| Dow Adds 547 Points as Earnings Drive Stock Gains ||| Notable Tuesday Option Activity: GS, CMG, GILD ||| The Markets Breathe a Sigh of Relief as the Big Banks Beat Estimates ||| Financial Sector Update for 10/16/2018: BANR,MS,GS,BLK ||| Stock Futures Propped Up by Earnings, Rebound in Italy",1,0.4803515
2018-10-17,4953700.0,220.52999877929688,228.8999938964844,220.0500030517578,228.27999877929688,220.0375518798828,GS,"U.S. Bancorp (USB) Beats on Q3 Earnings, Expenses Flare Up ||| Zacks Investment Ideas feature highlights: JP Morgan, Citigroup, Bank of America, Morgan Stanley and Goldman Sachs ||| Reflecting on 5 Earnings Reports and 1 Remarkable Life ||| Validea David Dreman Strategy Daily Upgrade Report - 10/17/2018 ||| Market Close Report: NASDAQ Composite index closes at 7,642.70 down -2.79 points",0,0.49415502
2018-10-18,2995400.0,227.5,228.72999572753903,223.8600006103516,224.9499969482422,216.82778930664065,GS,Why Isn't Wall Street More Enthusiastic About Investment Bank Stocks? ||| Goldman Sachs Is Finally Getting the Respect It Deserves ||| Bear of the Day: Banco De Chile,1,0.49406794
2018-10-19,2759100.0,225.259994506836,228.3000030517578,224.19000244140625,226.9600067138672,218.7652282714844,GS,Why Marcus Isn't Goldman's Saving Grace,0,0.49648476
2018-10-23,3318200.0,216.58999633789065,219.5200042724609,214.32000732421875,218.5599975585937,210.66851806640625,GS,"Beware of the Dead Cat Bounce: 5 Safe Stocks for Now ||| Goldman Sachs’ Marcus Platform Is Ready to Take the Next Step ||| Noteworthy Tuesday Option Activity: GS, PRSC, TYL",0,0.49738634
2018-10-24,4152700.0,218.13999938964844,218.92999267578125,208.3999938964844,209.17999267578125,201.627197265625,GS,Market Chatter: WPP to Sell Majority Stake in Kantar,1,0.53391355
2018-10-25,3179700.0,211.2700042724609,215.69000244140625,210.33999633789065,214.009994506836,206.2828063964844,GS,"DIA, GS, IBM, UTX: ETF Outflow Alert",0,0.5299956
2018-10-26,3557900.0,210.72999572753903,214.8000030517578,209.52999877929688,212.3600006103516,204.6923828125,GS,This Selloff Could Be Your Best Chance to Buy Bank of America Stock ||| Goldman Sachs (GS) Stock Moves -0.77%: What You Should Know,1,0.47956526
2018-10-29,3278200.0,214.1499938964844,218.2100067138672,212.0500030517578,214.4900054931641,206.7454833984375,GS,"Morgan Stanley (MS) Ex-Dividend Date Scheduled for October 30, 2018 ||| JMP Group LLC (JMP) Ex-Dividend Date Scheduled for October 30, 2018",1,0.43485966
2018-10-31,4369600.0,221.88999938964844,229.0,221.3999938964844,225.3699951171875,217.23263549804688,GS,"Big News From the Money 20/20 Conference ||| Goldman Sachs' Marcus Platform Could Have Lots of Growth Ahead ||| Goldman Sachs Might Buy ING's Italian Real Estate Portfolio ||| Goldman Sachs Group's Preferred Stock, Series B Shares Cross 6% Yield Mark ||| Notable Wednesday Option Activity: GS, PVH, GRMN",1,0.48912442
2018-11-01,2557600.0,225.759994506836,228.8800048828125,225.47000122070312,226.97000122070312,218.77487182617188,GS,"Nvidia Stock Is Worth a Look ||| Goldman Sachs -- It's Not Just for the Wealthy Anymore ||| Goldman Sachs (GS) Outpaces Stock Market Gains: What You Should Know ||| 5 Top Stock Trades for Friday: AAPL, BABA and Fitbit Earnings",1,0.4815678
2018-11-02,3699000.0,230.0,231.69000244140625,226.2899932861328,229.69000244140625,221.3966522216797,GS,"TD Ameritrade Holding Corporation (AMTD) Ex-Dividend Date Scheduled for November 05, 2018 ||| Understanding Axos Financial's Grand Vision ||| Energy Sector Update for 11/02/2018: BHGE, XOM, CVX, RDS.A, RDS.B, BP, E, COP, TOT, PBR, PBR.A, EC, SLB, HAL, NOV, SPN",0,0.481206
2018-11-05,2565200.0,228.32000732421875,231.1000061035156,226.9499969482422,228.72000122070312,220.461654663086,GS,"Financial Sector Update for 11/05/2018: GS, L, CNA, JPM, BAC, WFC, C, USB ||| MarketAxess Holdings, Inc. (MKTX) Ex-Dividend Date Scheduled for November 06, 2018 ||| DIA, BA, GS, HD: Large Inflows Detected at ETF ||| BGC Partners, Inc. (BGCP) Ex-Dividend Date Scheduled for November 06, 2018 ||| Super-Sized Treasuries Auctions, and Goldman Says Democrats Will Win House ||| Financial Sector Update for 11/05/2018: CNA,L,GS ||| Financial Sector Update for 11/05/2018: MPW, CNA, L, GS",0,0.4519083
2018-11-06,2275600.0,228.19000244140625,229.5200042724609,227.0500030517578,228.1999969482422,219.96044921875,GS,"LPL Financial Holdings Inc. (LPLA) Ex-Dividend Date Scheduled for November 07, 2018 ||| Goldman (GS) On Track to Achieve $5B Revenue Target by 2020",1,0.49083376
2018-11-07,3514300.0,230.0500030517578,232.8000030517578,226.8999938964844,231.27999877929688,222.92922973632807,GS,"Oppenheimer Holdings, Inc. (OPY) Ex-Dividend Date Scheduled for November 08, 2018 ||| The Charles Schwab Corporation (SCHW) Ex-Dividend Date Scheduled for November 08, 2018 ||| Seaboard Corporation (SEB) Ex-Dividend Date Scheduled for November 08, 2018 ||| Goldman Sachs (GS) Gains But Lags Market: What You Should Know ||| Notable Wednesday Option Activity: GS, UPS, UNH",1,0.43822855
2018-11-08,2404800.0,231.0,234.0599975585937,230.6000061035156,231.6499938964844,223.285888671875,GS,"Dow Movers: CAT, GS ||| 5 Winners for Best Post-Midterm Rally in 36 Years ||| Stifel Financial Prepares for Brexit by Acquiring MainFirst ||| US Stocks Enjoy Highest Post-Midterm Gains Since 1982: 5 Picks",0,0.50607634
2018-11-09,3721700.0,231.69000244140625,231.69000244140625,222.3000030517578,222.6499938964844,214.61083984375,GS,"Market Close Report: NASDAQ Composite index closes at 7,406.90 down -123.99 points ||| Dow Drops With Oil, But Logs Best Week Since March",0,0.4821302
2018-11-12,11019400.0,222.0,222.3099975585937,205.1300048828125,206.0500030517578,198.6102294921875,GS,"Dow Movers: AAPL, VZ ||| Market Close Report: NASDAQ Composite index closes at 7,200.87 down -206.03 points ||| Close Update: Wall Street Limps Into the Close as Tech Meltdown Gains Momentum ||| Dow Sinks 600 Points as Apple, Goldman Stocks Plummet ||| 5 Top Stock Trades for Tuesday: Goldman, Apple, and AMD Fall Hard ||| Mid-Day Update: Wall Street Roiled by Apple, Trade War Tensions, European Banking Woes ||| Monday's ETF with Unusual Volume: IXG ||| Should You Invest in the iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI)?",0,0.49034697
2018-11-13,6984800.0,204.3999938964844,209.58999633789065,202.3300018310547,205.0500030517578,197.6463165283203,GS,"DIA, BA, GS, MCD: ETF Inflow Alert ||| Tuesday’s Vital Data: Goldman Sachs, Home Depot and Walmart ||| Stock Market News For Nov 13, 2018 ||| Goldman Sachs Group's Preferred Stock, Series D Shares Cross 5% Yield Mark ||| 6 Inverse ETF Areas to Tap in Volatile Markets",0,0.50077415
2018-11-14,5742500.0,206.2400054931641,207.33999633789065,198.44000244140625,202.4900054931641,195.1787567138672,GS,"Cohen & Company Inc. (COHN) Ex-Dividend Date Scheduled for November 15, 2018 ||| Goldman in Murky Waters, State Fund 1MDB Scandal Heightens ||| Is Goldman Sachs the Best Bank Stock to Buy? ||| Why is the Stock Market Sliding Today? ||| 7 Heavily Discounted Stocks to Buy Today ||| Close Update: Wall Street Weighed Down by Apple, Banking Sector as Dow Slips Under 200 DMA ||| Goldman Sachs Group's Preferred Stock, Series C Shares Cross 5% Yield Mark ||| The Optimism Game: Which Player Matters Most for Stocks?",1,0.47395125
2018-11-15,4260000.0,201.8000030517578,204.5,199.32000732421875,203.7400054931641,196.3836212158203,GS,"3 Ridiculously Cheap Stocks I’m Watching Right Now ||| Goldman (GS) Down 11.3% Since Last Earnings Report: Can It Rebound? ||| Goldman Sachs (GS) Gains But Lags Market: What You Should Know ||| Stock Market News For Nov 15, 2018 ||| Buffett Bets Big on Banks: Should You Tap Financial ETFs?",0,0.47218272
2018-11-16,2829600.0,202.92999267578125,204.7400054931641,200.3500061035156,202.1199951171875,194.8221130371093,GS,"Dow Movers: WMT, INTC",0,0.51758707
2018-11-19,3419100.0,201.8300018310547,202.3000030517578,197.3500061035156,198.22000122070312,191.0629272460937,GS,3 Interesting Things About Warren Buffett's Bank Stock Buys ||| Berkshire Hathaway Bought Financial Stocks in Q3 ||| Here's Why Bitcoin & Other Cryptocurrencies Are Falling Today ||| Buffett Bets Big On Banking Stocks ||| Goldman Sachs Group Becomes Oversold (GS),0,0.5111323
2018-11-20,5513800.0,195.1000061035156,195.88999938964844,190.3500061035156,191.33999633789065,184.43133544921875,GS,"Canada Goose, Western Digital, Square, Goldman Sachs and Bitcoin Investment Trust highlighted as Zacks Bull and Bear of the Day ||| Validea David Dreman Strategy Daily Upgrade Report - 11/20/2018",1,0.47441736
2018-11-21,4111700.0,192.08999633789065,195.2400054931641,191.19000244140625,192.6000061035156,185.64585876464844,GS,Financial Select Sector SPDR Fund Experiences Big Outflow,0,0.5079025
2018-11-23,1862600.0,191.6100006103516,191.8699951171875,188.94000244140625,189.1000061035156,182.2722320556641,GS,"Goldman Sachs (GS) Outpaces Stock Market Gains: What You Should Know ||| Investment Technology Group, Inc. (ITG) Ex-Dividend Date Scheduled for November 26, 2018 ||| Bitcoin (BTC): Nobody Knows You When You’re Down and Out",1,0.45755368
2018-11-27,2345400.0,193.3999938964844,194.6199951171875,191.5599975585937,193.6499938964844,186.657943725586,GS,Follow Goldman With These Commodity ETFs,1,0.520322
2018-11-28,3762900.0,194.83999633789065,198.4499969482422,192.22999572753903,198.3500061035156,191.188232421875,GS,"Virtu Financial, Inc. (VIRT) Ex-Dividend Date Scheduled for November 29, 2018 ||| Goldman Sachs Group, Inc. (GS) Ex-Dividend Date Scheduled for November 29, 2018 ||| JMP Group LLC (JMP) Ex-Dividend Date Scheduled for November 29, 2018",0,0.43068305
2018-11-29,2665700.0,196.0200042724609,197.4499969482422,193.1600036621093,194.8500061035156,188.5751953125,GS,"DIA, BA, MMM, GS: ETF Outflow Alert ||| The Zacks Analyst Blog Highlights: Johnson & Johnson, Thermo Fisher, Goldman Sachs, Oracle and Accenture",0,0.4872557
2018-11-30,6220000.0,190.57000732421875,191.4499969482422,188.1199951171875,190.69000244140625,184.5491638183593,GS,"Dow Movers: GS, HD ||| Time to Buy These 3 Stocks Flirting With 52-Week Lows? ||| Market Close Report: NASDAQ Composite index closes at 7,330.54 up 57.46 points ||| S&P, Nasdaq Log Best Week Since 2011 ||| Notable Friday Option Activity: CMG, GS, RLGY",1,0.48504642
2018-12-03,4017000.0,194.0,195.6600036621093,191.6199951171875,191.6300048828125,185.4588928222656,GS,"Forget Penny Stocks, Your Money Is Better Off in These 3 Companies ||| Goldman Faces 1MDB Speedy Scandal Inquiry by Federal Reserve ||| Hyatt Buys Two Roads Hospitality, Continues With Expansion ||| Monday’s Vital Data: Pfizer, Goldman Sachs and Caterpillar ||| 3 Hot Stocks to Buy in December ||| Greenhill & Co., Inc. (GHL) Ex-Dividend Date Scheduled for December 04, 2018 ||| 3 Financial Stocks to Buy While They’re Cheap ||| UBS Group AG Gets Nod to Boost Majority Stake in China JV",0,0.48423624
2018-12-04,5797500.0,190.69000244140625,191.1100006103516,183.6300048828125,184.3099975585937,178.37461853027344,GS,"Navient Corporation (NAVI) Ex-Dividend Date Scheduled for December 06, 2018 ||| BlackRock, Inc. (BLK) Ex-Dividend Date Scheduled for December 06, 2018 ||| Another Data Breach, the Dark Side of Cryptocurrencies, and One Big Retirement Mistake ||| Wall Street Is Souring on These 7 Stocks to Sell",0,0.44048524
2018-12-06,5275500.0,181.3300018310547,184.8800048828125,180.1499938964844,184.08999633789065,178.16168212890625,GS,"Two Bank Stocks on Our Radar Right Now ||| Stock Market News For Dec 5, 2018 ||| 3 Warren Buffett Stocks to Buy in December",0,0.48024556
2018-12-07,3921200.0,183.8500061035156,186.25,179.0,179.6699981689453,173.88401794433594,GS,"GAIN Capital Holdings, Inc. (GCAP) Ex-Dividend Date Scheduled for December 10, 2018 ||| Energy Sector Update for 12/07/2018: BHGE, XOM, CVX, RDS.A, RDS.B, BP, E, COP, TOT, PBR, PBR.A, EC, SLB, HAL, NOV, SPN",0,0.4511977
2018-12-10,4528300.0,178.60000610351562,179.83999633789062,174.67999267578125,178.8300018310547,173.07107543945312,GS,"Is Goldman Sachs a Buy? ||| Dow Movers: AAPL, INTC ||| RBS Might Transfer Assets to Netherlands in No-Deal Brexit ||| Why Goldman Sachs Shares Lost 15% in November",0,0.49518225
2018-12-11,4713900.0,182.1499938964844,184.42999267578125,175.4499969482422,176.8000030517578,171.1064453125,GS,Goldman Sachs Group is Now Oversold (GS),0,0.47942847
2018-12-13,4008600.0,177.8300018310547,178.69000244140625,175.1199951171875,175.9199981689453,170.25479125976562,GS,Goldman Sachs (GS) Dips More Than Broader Markets: What You Should Know,0,0.46554613
2018-12-14,5078300.0,174.33999633789062,176.25999450683594,172.3699951171875,172.77000427246094,167.20623779296875,GS,"Morgan Stanley to Close Moscow Equities & FX Trading Desks ||| 5 Must-See Stock Charts for Monday: COST, J&J, SBUX",0,0.4858352
2018-12-17,8395800.0,169.39999389648438,171.42999267578125,166.52999877929688,168.00999450683594,162.59951782226562,GS,"Dow Movers: NKE, CVX ||| Wall St drops 1 pct as health stocks weigh; Nasdaq erases 2018 gains ||| Will Goldman (GS) Beat Estimates Again in Its Next Earnings Report? ||| Dow Drops 35 Points as Stocks Look for Way Out ||| Dow Drops 507 Points as Sell-Off Intensifies ||| Financial Sector Update for 12/17/2018: APTS,LGI,GS,ADS ||| Financial Sector Update for 12/17/2018: LGI,GS,ADS",1,0.5148598
2018-12-18,5150800.0,169.77999877929688,173.02000427246094,169.32000732421875,171.5,165.9771270751953,GS,"Company News For Dec 18, 2018 ||| Goldman Sachs (GS) Faces Criminal Charges Over 1MDB Case ||| Robinhood's New Bank Accounts, Retirement Security, and a Fintech Insider Gives His Insight ||| Malaysia says Goldman Sachs failed to disclose key facts in 1MDB bond sales",0,0.47295693
2018-12-19,5316100.0,171.58999633789062,174.85000610351562,167.60000610351562,169.25,163.79959106445312,GS,Malaysia charges another ex-Goldman Sachs banker over 1MDB ||| Why Bank of America Stock Is a Strong Play for Contrarians Today ||| Singapore c.bank bans former Goldman Sachs' banker for life ||| Goldman Sachs (GS) Stock Moves -1.31%: What You Should Know ||| Trade of the Day: Goldman Sachs Stock Is Ripe for a Contrarian Trade,0,0.4497223
2018-12-20,6488200.0,168.38999938964844,171.64999389648438,167.16000366210938,168.41000366210938,162.9866485595703,GS,"Crocs, Trinity, Netflix, HBO and Goldman Sachs highlighted as Zacks Bull and Bear of the Day ||| Dow Movers: WBA, DWDP",0,0.4968754
2018-12-21,8960000.0,168.25,169.6300048828125,159.4199981689453,160.0500030517578,154.89585876464844,GS,"DIA, GS, CAT, TRV: Large Outflows Detected at ETF ||| The 7 Most Anticipated IPOs in 2019 ||| Financial Sector Update for 12/21/2018: GS, BMA, JPM, WFC, C, BAC, USB ||| Dow 30 Stock Roundup: Nike, Walgreens Boots Earnings Impress ||| Market Close Report: NASDAQ trading volume joins the top ten ranking for the year. NASDAQ Composite Index closes at 6,332.99 ||| Dow Suffers Worst Week Since October 2008 ||| Goldman Sachs CEO to employees: our compliance is strong",0,0.4785798
2018-12-24,3783500.0,159.0,160.0,154.30999755859375,156.35000610351562,151.31500244140625,GS,"Malaysia seeks $7.5 bln in reparations from Goldman Sachs - FT ||| Countdown to 2019: Lessons From the Dow's Painful Year ||| Goldman in More Trouble, Now Embroiled in Singapore Probe",1,0.51363844
2018-12-26,7054700.0,157.0,163.11000061035156,151.6999969482422,162.92999267578125,157.68310546875,GS,"CME Group Inc. (CME) Ex-Dividend Date Scheduled for December 27, 2018 ||| Dow Movers: GS, V ||| Why Goldman Sachs Group is a Top 25 Dividend Giant (GS)",1,0.46138668
2018-12-27,4973000.0,160.1199951171875,165.41000366210938,159.02000427246094,165.41000366210938,160.083251953125,GS,3 Bank Stocks That Look Like Death ||| Can Oil Prices Rebound in 2019? 5 Top-Ranked Picks,0,0.49499014
2018-12-28,4110500.0,165.63999938964844,165.9499969482422,162.02000427246094,163.02999877929688,157.77989196777344,GS,"Dow Movers: V, PG ||| Should You Invest in the iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI)? ||| Market Close Report: NASDAQ Composite index closes at 6,584.52 up 5.03 points ||| Dow Closes Wild Trading Week With Sharp Pivot Lower",1,0.5233315
2018-12-31,4550000.0,163.77999877929688,167.1199951171875,163.77999877929688,167.0500030517578,161.67044067382812,GS,"3 Top Crypto Stocks for 2019 ||| Forget Penny Stocks, Your Money Is Better Off in These 3 Companies ||| A Volatile Year For the Stock Market ||| Financial Sector Update for 12/31/2018: DB, GS, THG, JPM, BAC, WFC, C, USB ||| Wall Street Gets Trade-Bump As Outlook Improves For Positive Trump/Xi Talks ||| PRF, AIG, MET, GS: ETF Inflow Alert ||| How to Find the Right Bargain Stocks Amid the Market Selloff ||| Financial Sector Update for 12/31/2018: APO,ARNC,THG,GS,DB ||| NASDAQ Composite Index closes up 5.03 points for the week, rising for the 4th straight day ||| Financial Sector Update for 12/31/2018: THG,GS,DB ||| Microsoft Stock Was the Dow's Top Tech Performer in 2018 ||| Stocks Close Session Strong, But Still Log Worst Year Since 2008",1,0.5252612
2019-01-02,3999400.0,164.3300018310547,172.25,163.35000610351562,172.02999877929688,166.4900665283203,GS,"Close Update: Stocks Inch Higher to Start 2019 After Choppy Session ||| Market Close Report: NASDAQ Composite index closes at 6,665.94 up 30.66 points ||| Dow Ends Higher in Wild Start to New Year ||| Notable Wednesday Option Activity: GS, LNG, EXAS",0,0.49754873
2019-01-03,4060200.0,170.66000366210938,171.77000427246094,168.2899932861328,169.50999450683594,164.0511932373047,GS,"Incyte To Present At Goldman Sachs Conference; Webcast At 11:00 AM ET ||| Goldman Sachs (GS) Stock Moves -1.46%: What You Should Know ||| Goldman Sachs Group's Preferred Stock, Series A Shares Cross 5.5% Yield Mark",1,0.4960536
2019-01-04,3788300.0,172.99000549316406,176.0,171.10000610351562,175.0500030517578,169.41282653808594,GS,The 3 Best Stocks to Buy At the End of the Bear Market,1,0.5422905
2019-01-07,3152100.0,175.22999572753906,177.8300018310547,172.27000427246094,176.02000427246094,170.35157775878906,GS,Ex-Goldman Sachs banker denied bail in Malaysia pending extradition to U.S.,0,0.517876
2019-01-08,2692700.0,177.77999877929688,178.10000610351562,172.89999389648438,175.3699951171875,169.72250366210938,GS,"Etsy Stock’s Well-Deserved Gains Have Stretched the Valuation to the Limit ||| Bank of America Stock Should Rebound 20% in the Coming Months ||| EU Nears Imposing Stricter Rules on Investment Managers ||| Boeing, Verizon Fuel Big Gains for Dow",1,0.5074455
2019-01-09,3321400.0,176.10000610351562,177.69000244140625,174.91000366210938,176.47000122070312,170.78707885742188,GS,SPDR Dow Jones Industrial Average ETF Experiences Big Outflow ||| Goldman Sachs (GS) Earnings Expected to Grow: Should You Buy? ||| Goldman Sachs (GS) Outpaces Stock Market Gains: What You Should Know,0,0.46757242
2019-01-10,2808700.0,175.66000366210938,178.07000732421875,175.5,176.0,170.33221435546875,GS,"JPMorgan Chase boosting employee bonus pool 3 pct for 2018 ||| Notable Thursday Option Activity: PYPL, ADTN, GS",1,0.48848045
2019-01-11,3182700.0,175.10000610351562,177.0399932861328,172.4199981689453,176.92999267578125,171.2322540283203,GS,"Dow Movers: CAT, INTC ||| Financial Sector Update for 01/11/2019: VRTS, GS, WDR, JPM, WFC, BAC, C, USB ||| Slack planning to pursue direct listing ||| Can Earnings Reports Push Bank Stocks Higher? ||| Financial Sector Update for 01/11/2019: UBSH,ANCX,WDR,LM,GS",1,0.51681066
2019-01-14,3361700.0,174.52000427246094,179.5399932861328,174.10000610351562,178.72000122070312,172.96461486816406,GS,"3 Top Bank Stocks to Buy in January ||| Dow Movers: CAT, GS ||| Week Ahead: Big Bank Earnings Won't Dictate Direction Of Markets ||| Stock Market News for Jan 14, 2019 ||| Citigroup, JPMorgan, Wells Fargo, Goldman Sachs and Morgan Stanley are part of Zacks Earnings Preview ||| Muted Trading Revenues to Hurt Goldman's (GS) Q4 Earnings? ||| Are Bank ETFs Good Buys Before Earnings Release? ||| 5 Fallen-Angel Stocks That Have Been Oversold ||| Week in Review: U.S. Markets Stabilize as Government Shutdown Continues",1,0.5221859
2019-01-15,2911800.0,178.32000732421875,179.99000549316406,176.39999389648438,179.91000366210938,174.11630249023438,GS,"Now Isn’t the Time to Hit the Panic Button on JPMorgan Stock ||| Close Update: Nasdaq Leads Market Higher as Technology, Health Care Shares Rally ||| Pre-Market Earnings Report for January 16, 2019 : BAC, USB, GS, BLK, PNC, BK, CMA ||| 4 Must-See Stock Charts for Wednesday: JPM, WFC, DAL, NFLX",1,0.4824663
2019-01-16,15194200.0,187.0,198.1499938964844,185.6000061035156,197.0800018310547,190.73336791992188,GS,"What Happened in the Stock Market Today ||| Goldman Sachs reports higher fourth-quarter trading revenue ||| Goldman Sachs Turns To Profit In Q4; Stock Up ||| Pre-Market Most Active for Jan 16, 2019 : FDC, BAC, LYG, FISV, SNAP, PCG, SQQQ, GS, QQQ, APTX, AMD, FB ||| Financial Sector Update for 01/16/2019: BAC, BK, GS, JPM, WFC, C, USB ||| Mid-Morning Market Update: Markets Open Higher; Goldman Sachs Tops Q4 Expectations ||| Goldman (GS) Q4 Earnings Beat Estimates, Expenses Flare Up ||| S&P 500 Movers: FISV, UAL ||| Earnings Reaction History: Goldman Sachs Group Inc., 54.5% Follow-Through Indicator, 1.9% Sensitive ||| Import/Exports & Lots of Q4 Results ||| Dow Movers: VZ, GS ||| Q4 Earnings Continue ||| Goldman Sachs Group Inc (GS) Q4 2018 Earnings Conference Call Transcript ||| Mid-Afternoon Market Update: Dow Rises 200 Points; First Data Shares Spike Higher ||| Market Close Report: NASDAQ trading volume joins the top ten ranking for the year. NASDAQ Composite Index closes at 7,034.69 ||| Mid-Day Update: Banks Fuel Demand For Risk on Wall Street ||| Close Update: Wall Street Buoyed By Bullish Bank Earnings ||| Wednesday Sector Leaders: Paper & Forest Products, Investment Brokerages ||| Wednesday's ETF Movers: IYG, ITB ||| Goldman Sachs Earnings: GS Stock Surges on Stellar Q4 ||| Wednesday Sector Leaders: Financial, Materials ||| Is Bank of America Stock’s Earnings Beat Worth 7%? ||| 5 Top Stock Trades for Thursday: BAC, GS, SNAP, FB, F ||| Financial Sector Update for 01/16/2019: SMTA,BLK,FDC,FISV,GS",1,0.48070213
2019-01-17,8177000.0,195.9499969482422,199.8000030517578,192.8300018310547,199.08999633789065,192.6786346435547,GS,"The 1MDB Scandal Won’t Really Hurt Goldman Sachs Stock ||| Industrial and Emerging Market: 2 ETFs to Watch on Outsized Volume ||| Stock Market News For Jan 17, 2019 ||| Dow Movers: HD, NKE ||| Thursday’s Vital Data: Goldman Sachs, Morgan Stanley and Bank of America ||| Morgan Stanley's Fourth Quarter: A Disappointment Among Strong Bank Earnings ||| 5 Must-See Stock Charts for Friday: MS, GE, SQ, BA ||| Goldman Sachs: Outstanding Performance at a Ridiculously Cheap Valuation ||| Zacks Earnings Trends Highlights: Goldman Sachs and Bank of America",1,0.47637725
2019-01-18,5650900.0,200.3800048828125,203.0,196.9100036621093,202.5399932861328,196.0175170898437,GS,"Dow Movers: AXP, HD ||| People's United (PBCT) Q4 Earnings Beat Estimates, Costs Up ||| Signature Bank's (SBNY) Shares Jump 8% on Q4 Earnings Beat ||| Malaysia open to talks if Goldman pays $7.5 bln, minister says ||| Upcoming Earnings Reports to Watch: IBM, INTC, SBUX ||| Notable Friday Option Activity: WYNN, GS, GILD",0,0.48831496
2019-01-22,4648500.0,200.5,201.47000122070312,195.9199981689453,197.67999267578125,191.3140411376953,GS,"Week in Review: Stocks Ignore Political Noise and Continue Rebound ||| Top and Flop ETFs of Last Week ||| Should You Invest in the iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI)? ||| 7 Stupidly Cheap Stocks to Buy Now ||| Goldman Sachs Group's Preferred Stock, Series J Shares Cross 5.5% Yield Mark ||| If George Costanza Were A Hedge Fund Manager",0,0.4913614
2019-01-23,3410700.0,197.5500030517578,198.08999633789065,194.52999877929688,196.8999938964844,190.5591583251953,GS,Forget Penny Stocks: Your Money Is Better Off in These 3 Companies ||| 2 Rock-Solid Bank Stocks With P/E Ratios Under 12 ||| Why Bank ETFs Can Continue to Rise Despite Mixed Q4 Earnings,1,0.49901152
2019-01-25,3275000.0,199.8300018310547,201.19000244140625,199.4199981689453,200.7400054931641,194.2755126953125,GS,"4 Utilities Stocks to Counter Slowdown & Shutdown Woes ||| Goldman Sachs (GS) Outpaces Stock Market Gains: What You Should Know ||| Notable Friday Option Activity: AHL, GS, TCX ||| Goldman warns as UK lawmakers examine life after Brexit for banks",0,0.51737076
2019-01-28,2369600.0,197.9900054931641,200.07000732421875,197.1000061035156,199.72000122070312,193.28836059570312,GS,"The Zacks Analyst Blog Highlights: Goldman, American Water, ALLETE, Spire and Pinnacle West ||| Should You Buy Caterpillar Stock on This Downdraft?",1,0.49952728
2019-01-29,2694100.0,199.0,201.97000122070312,197.8699951171875,200.5,194.0432281494141,GS,"The Zacks Analyst Blog Highlights: Goldman, American Water, ALLETE, Spire and Pinnacle West ||| Morgan Stanley (MS) Ex-Dividend Date Scheduled for January 30, 2019 ||| A Big Win for Synchrony and Square’s Ecosystem That Gets a Little Stronger",1,0.49821436
2019-01-30,2773300.0,200.8999938964844,203.2899932861328,199.6499938964844,202.47999572753903,195.95947265625,GS,Goldman Sachs ditches single-use plastic products,0,0.49816787
2019-02-01,3174200.0,198.0,199.63999938964844,196.5399932861328,196.5399932861328,190.21075439453125,GS,"The Winners and Losers of Bank Earnings ||| TD Ameritrade Holding Corporation (AMTD) Ex-Dividend Date Scheduled for February 04, 2019 ||| Goldman Sachs says 1MDB scandal could hit pay for top executives",1,0.48635295
2019-02-04,2400200.0,195.8000030517578,197.759994506836,194.7899932861328,197.72000122070312,191.3527374267578,GS,"1MDB Scandal Could Hit Pay For Goldman Sachs Executives ||| Notable Monday Option Activity: GS, APTV, ETFC ||| Financial Sector Update for 02/04/2019: DB, GS, HSBC, KKR, JPM, BAC, WFC, C, USB ||| Goldman to Withhold Top Executives' Pay Until 1MBD Resolves",1,0.49010175
2019-02-05,2601000.0,198.1199951171875,199.3300018310547,196.8600006103516,198.009994506836,191.6334228515625,GS,Fire at Ocado's flagship automated site halts deliveries ||| Goldman Sachs plans cuts in commodities trading unit ||| Stock buyback ban idea is topsy-turvy,0,0.4861533
2019-02-06,2063100.0,197.17999267578125,199.0599975585937,195.8300018310547,196.6199951171875,190.2881774902344,GS,"3 Stock Market Winners From Trump’s State of the Union ||| Goldman Plans to Pull Back Commodities Trading Operations ||| Goldman Sachs Group's Preferred Stock, Series N Crosses Above 6% Yield Territory",0,0.5353189
2019-02-07,2948800.0,195.27999877929688,195.8800048828125,191.0500030517578,193.07000732421875,186.8524932861328,GS,Goldman Sachs considers Swiss mortgage market entry ||| Analysts Expect JKF To Hit $115,0,0.5001347
2019-02-08,2757500.0,191.72000122070312,192.6199951171875,188.22000122070312,191.6699981689453,185.4976043701172,GS,"Goldman Sachs (GS) Plans to Enter Swiss Mortgage Market ||| Dow 30 Stock Roundup: Disney Earnings Impress, Pfizer's Cancer Drug Gets CHMP Nod",0,0.50601405
2019-02-11,2056500.0,192.8800048828125,193.32000732421875,191.07000732421875,191.3300018310547,185.1685485839844,GS,"Why First Solar Shares Popped 19.2% Last Month ||| MarketAxess Holdings, Inc. (MKTX) Ex-Dividend Date Scheduled for February 12, 2019 ||| BofA (BAC) CEO Moynihan's 2018 Compensation Increases 15% ||| Notable Monday Option Activity: MMM, GS, AMWD",1,0.4886747
2019-02-12,2392900.0,193.0500030517578,195.6499938964844,193.0,194.4900054931641,188.226791381836,GS,"The Charles Schwab Corporation (SCHW) Ex-Dividend Date Scheduled for February 13, 2019",1,0.48975834
2019-02-13,2757300.0,195.9199981689453,198.77999877929688,194.6000061035156,194.69000244140625,188.4203491210937,GS,"Stock Market News For Feb 13, 2019 ||| Dow Movers: CSCO, GS ||| Goldman Sachs Group's Preferred Stock, Series C Crosses Above 5.5% Yield Territory ||| Oppenheimer Holdings, Inc. (OPY) Ex-Dividend Date Scheduled for February 14, 2019",0,0.45162368
2019-02-14,2865000.0,192.2100067138672,194.1300048828125,189.44000244140625,192.52999877929688,186.3298797607422,GS,JPMorgan Chase to create digital coins using blockchain for payments ||| Ex-Goldman banker plans return to U.S. to face criminal charges ||| This Are the Kind of Oil Stocks You Should Watch Right Now,1,0.47091642
2019-02-15,3065400.0,193.2100067138672,198.88999938964844,193.1000061035156,198.5,192.107650756836,GS,"Malaysian court allows ex-Goldman banker to return to U.S. to face 1MDB charges ||| NASDAQ Composite Index closes up 6.58 points for the week, rising for the 6th straight day ||| Dow Grabs 8th Straight Weekly Win on Trade-Deal Hopes ||| Close Update: US Stocks Post Weekly Advance as Trade Talk Optimism Fuels Friday Rally ||| Wall Street divided on Brexit: Goldman sees a deal, JPMorgan sees a delay ||| Energy Sector Update for 02/15/2019: BHGE, XOM, CVX, RDS.A, RDS.B, BP, E, COP, TOT, PBR, PBR.A, EC, SLB, HAL, NOV, SPN ||| Deal or delay? Wall Street divided on Brexit ||| Deal or delay? Wall Street doesn't believe no-deal Brexit threat",1,0.49198803
2019-02-19,2558200.0,196.6600036621093,199.0599975585937,195.6100006103516,198.6699981689453,192.27215576171875,GS,"Stock Market News For Feb 19, 2019 ||| Malaysia to put former Goldman Sachs banker on trial before U.S. extradition ||| Goldman Sachs Asia Pacific CEO to retire ||| Dow Movers: GS, WMT ||| Noteworthy Tuesday Option Activity: GS, WYNN, GOOG",0,0.48335588
2019-02-20,2266000.0,198.72999572753903,199.3000030517578,197.509994506836,198.6000061035156,192.2044219970703,GS,"DIA, GS, MCD, IBM: ETF Outflow Alert ||| Goldman Sachs backs U.S. construction finance tech startup Rabbet",0,0.51147896
2019-02-21,2785900.0,198.97000122070312,199.4499969482422,195.0500030517578,196.3600006103516,190.0365447998047,GS,Apple Credit Card Rumors Resurface ||| Thursday Apple Rumors: Apple Credit Card to Enter Testing,0,0.5172771
2019-02-22,2626600.0,196.6000061035156,197.75,195.1999969482422,196.0,189.68814086914065,GS,Lyft’s IPO Deal Is On the Fast Track ||| JPMorgan trades banker offices for shared desks ||| Goldman Sachs (GS) Stock Sinks As Market Gains: What You Should Know ||| U.S. seeks to recover $38 mln in assets from 1MDB case,1,0.5003448
2019-02-25,3032200.0,198.0,201.5,197.7100067138672,198.6499938964844,192.2528076171875,GS,"5 Hot Stocks in Dow ETF That Led the Market Higher ||| Dow Movers: PG, GS ||| The Zacks Analyst Blog Highlights: JPMorgan, Citigroup, Bank of America, Goldman Sachs and Wells Fargo ||| Investment Technology Group, Inc. (ITG) Ex-Dividend Date Scheduled for February 26, 2019",1,0.527505
2019-02-26,2499800.0,198.47000122070312,200.5599975585937,196.5500030517578,198.8999938964844,192.4947509765625,GS,"Goldman expects legal losses to be up to $1.9 bln more than reserve ||| Goldman Sachs Group, Inc. (GS) Ex-Dividend Date Scheduled for February 27, 2019 ||| Following Earnings Beat, Hertz Stock Still Needs One Thing ||| Noteworthy Tuesday Option Activity: FGEN, DAKT, GS",0,0.4820544
2019-02-27,1804200.0,198.5,199.88999938964844,197.1199951171875,198.1000061035156,192.4947662353516,GS,"Apple’s Upcoming Credit Card and a Major Fintech Acquisition ||| Stifel Financial Corporation (SF) Ex-Dividend Date Scheduled for February 28, 2019 ||| Warren Buffett’s $112 Billion Cash Problem -- What to Expect in 2019 ||| Goldman Expects Legal Losses to Exceed Reserves by $1.9B ||| Dow, S&P Dip as D.C. Drama Grips Wall Street ||| The Upcoming Apple Credit Card -- Will It Be a Game Changer? ||| Berkshire Stocks Up on American Banks: Here's Why ||| Navient Corporation (NAVI) Ex-Dividend Date Scheduled for February 28, 2019",0,0.49859735
2019-02-28,2964300.0,198.0399932861328,198.3999938964844,196.009994506836,196.6999969482422,191.1343688964844,GS,"EU Rolls Out Strict Rules for Foreign-based Investment Managers ||| Seaboard Corporation (SEB) Ex-Dividend Date Scheduled for March 01, 2019 ||| This Dow Component Has A 1.6% Yield And Sells For Less Than Book",1,0.5056473
2019-03-01,2580500.0,198.75,201.44000244140625,197.42999267578125,198.1999969482422,192.5919189453125,GS,"The Biggest Problem Facing OSTK Stock ||| Notable ETF Inflow Detected - DIA, GS, MCD, CAT ||| China A-Shares ETFs to Roar Higher on MSCI Move ||| The Zacks Analyst Blog Highlights: Goldman Sachs, JPMorgan, Barclays and Bank of America ||| UK data centre operator Global Switch picks banks for $1 bln HK IPO",0,0.4837313
2019-03-04,2683600.0,198.8099975585937,200.8300018310547,194.1499938964844,195.97999572753903,190.43475341796875,GS,"KKR poaches Goldman Asia investment banking chair Richdale ||| KKR poaches Goldman Asia investment banking head Richdale ||| BlackRock, Inc. (BLK) Ex-Dividend Date Scheduled for March 05, 2019 ||| Wells Fargo Executives Enter Settlement Over Fake Accounts",1,0.48456508
2019-03-05,2338600.0,195.8500061035156,196.17999267578125,193.0,196.0,190.4541778564453,GS,"Suits and ties now optional, Goldman Sachs hedges dress code",0,0.4886747
2019-03-06,2247500.0,195.8999938964844,197.5599975585937,194.52999877929688,194.7400054931641,189.22984313964844,GS,What's The Revenue Potential For Apple's Proposed Credit Card With Goldman? ||| What's The Revenue Potential For Apple's Proposed Credit Card With Goldman? ||| Goldman Sachs Dress Code: What’s Changed for 2019?,0,0.45827556
2019-03-07,3567800.0,193.1300048828125,193.4499969482422,190.0800018310547,192.7700042724609,187.31558227539065,GS,"Goldman Sachs further shrinks commodities trading ||| Goldman Sachs cuts 10 roles in its commodities trading ||| S&P, Nasdaq Log Worst Losing Streaks Since December",1,0.5042642
2019-03-08,3162700.0,190.3999938964844,195.7700042724609,189.7100067138672,195.2400054931641,189.7156982421875,GS,"The Zacks Analyst Blog Highlights: Credit Suisse, UBS, Goldman, JPMorgan and Citigroup ||| Stock Market News For Mar 8, 2019 ||| China's New Wealth Industry Regime Charges Up Global Banks ||| Goldman Reduces Headcount at Commodities Trading Division ||| Market Close Report: NASDAQ Composite index closes at 7,408.14 down -13.32 points ||| Stocks Slump to 5th Straight Loss ||| Friday Sector Leaders: Utilities, Financial",1,0.5105152
2019-03-12,1977400.0,196.0,197.3999938964844,195.69000244140625,196.6300048828125,191.0663452148437,GS,U.S. Fed sanctions former Goldman Sachs bankers over 1MDB money-laundering scandal,1,0.50722516
2019-03-13,1904500.0,197.75,198.92999267578125,196.5200042724609,197.25,191.6688232421875,GS,"Peltz is triple threat of cannabis endorsements ||| Intercontinental Exchange Inc. (ICE) Ex-Dividend Date Scheduled for March 14, 2019 ||| T. Rowe Price Group, Inc. (TROW) Ex-Dividend Date Scheduled for March 14, 2019 ||| Nasdaq, Inc. (NDAQ) Ex-Dividend Date Scheduled for March 14, 2019 ||| Ladenburg Thalmann Financial Services Inc (LTS) Ex-Dividend Date Scheduled for March 14, 2019 ||| Should You Invest in the iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI)? ||| Noteworthy Wednesday Option Activity: CARA, GS, NAV",1,0.45636487
2019-03-14,1482300.0,197.32000732421875,198.5,196.6999969482422,197.47000122070312,191.88259887695312,GS,"Dow Analyst Moves: GS ||| 3 Coiled Spring Stocks Ready to Break Out ||| Financial Sector Update for 03/14/2019: LX, GS, JPM, WFC, BAC, C, USB ||| 5 Top Stock Trades for Friday: CLDR, Snap and the Banks ||| Goldman Sachs cuts CEO job in Brazil ||| Goldman Sachs changes management structure in Brazil",1,0.48478383
2019-03-15,2985200.0,197.1600036621093,198.8500061035156,196.8500061035156,198.259994506836,192.6502380371093,GS,Will Increased Competition in China Affect Starbucks Stock? ||| Goldman Laying Off Employees in Sales and Trading Division,1,0.518464
2019-03-18,3354900.0,199.17999267578125,203.8500061035156,198.9199981689453,202.47000122070312,196.7411193847656,GS,"Tilray Stock Mania Holds Its Breath as Earnings Approach ||| Dow Movers: BA, GS ||| Dow Manages a Win Ahead of Fed ||| 3 International Funds to Take Your Portfolio Global ||| Market Close Report: NASDAQ Composite index closes at 7,714.48 up 25.95 points ||| Malaysia to summons two Goldman Sachs units ahead of 1MDB case ||| 5 Top Stock Trades for Tuesday: Facebook, Tilray, Overstock",0,0.49334532
2019-03-19,3284900.0,204.8800048828125,206.4499969482422,200.77999877929688,201.1199951171875,195.42930603027344,GS,"6 Stocks to Gain With Fed Set to Keep Rates Unchanged ||| Goldman Sachs to Acquire S&P's Investment Advisory Services ||| Invesco FTSE RAFI US 1000 ETF Experiences Big Inflow ||| 3 Video Game Stocks With Superb Growth Potential ||| Macquarie agrees sale of Poland's Gdansk port terminal ||| Macquarie agrees $1.3 billion sale of Poland's Gdansk port terminal ||| 5 Dow Jones Stocks Coming to Life ||| Financial Sector Update for 03/19/2019: DB, GS, ING, AIZ, JPM, BAC, WFC, C, USB",0,0.50826836
2019-03-20,5033500.0,200.3300018310547,200.3300018310547,193.97000122070312,194.32000732421875,188.8217163085937,GS,"Citigroup Faces $25M Penalty by OCC for Fair Lending Breach ||| Dow Movers: UNH, BA ||| Market Close Report: NASDAQ Composite index closes at 7,728.97 up 5.02 points ||| Dow Drops Triple Digits After Fed",1,0.4973574
2019-03-21,4031500.0,192.8999938964844,195.5500030517578,191.75,194.5800018310547,189.0743408203125,GS,"Dow Movers: JPM, AAPL ||| Wells Fargo in talks with ex-Goldman exec Schwartz to be its next CEO - NY Post ||| 3 Bank Stocks Whacked Down by the Fed ||| Top Research Reports for Verizon, Goldman Sachs & Kinder Morgan ||| Stock Market News For Mar 21, 2019 ||| Wells Fargo in talks with ex-Goldman exec Schwartz to be next CEO -NY Post",0,0.4918005
2019-03-22,5703100.0,192.6699981689453,193.7100067138672,187.77999877929688,188.9600067138672,183.61338806152344,GS,"Wells Fargo Mulling to Hire Ex-Goldman Executive as New CEO ||| The Zacks Analyst Blog Highlights: Verizon, Goldman Sachs, Kinder Morgan, Citigroup and Stanley Black ||| GAIN Capital Holdings, Inc. (GCAP) Ex-Dividend Date Scheduled for March 25, 2019",0,0.44809616
2019-03-25,3751000.0,189.3300018310547,191.4499969482422,186.5,188.509994506836,183.1761016845703,GS,"Carnival Earnings Will Set the Tone for the Rest of 2019 ||| Stock Market News For Mar 25, 2019 ||| Goldman Sachs UK unit reports gender pay gap of 51 percent ||| Morgan Stanley Stock Is Under Heavy Pressure Today",1,0.49747935
2019-03-26,2910100.0,190.02999877929688,192.4100036621093,188.69000244140625,190.69000244140625,185.29443359375,GS,"This Is How the Apple Card Will Impact AAPL Stock ||| Stock Market News For Mar 26, 2019 ||| Apple's New Credit Card May Be Less Rewarding Than You Think",0,0.49474785
2019-03-27,2343800.0,190.6000061035156,191.6100006103516,188.7400054931641,190.02999877929688,184.65310668945312,GS,"Goldman Sachs Group's Preferred Stock, Series D Shares Cross 5.5% Yield Mark ||| Agree To Purchase Goldman Sachs Group At $120, Earn 3.8% Using Options ||| Citigroup (C) Forays Into Digital Consumer Payments Business ||| Goldman Sachs Group's Preferred Stock, Series D Shares Cross 5.5% Yield Mark",1,0.48818976
2019-03-28,2343400.0,190.7400054931641,191.9100036621093,189.2899932861328,191.17999267578125,185.7705535888672,GS,"Notable Thursday Option Activity: SQ, GS, WMC ||| Don’t Let the Gimmicky Apple Card Turn You Away From Visa Stock ||| Don’t Let the Gimmicky Apple Card Turn You Away From Visa Stock ||| Financial Sector Update for 03/28/2019: JEF, GS, JPM, BAC, WFC, C, USB ||| Raymond James Financial, Inc. (RJF) Ex-Dividend Date Scheduled for March 29, 2019 ||| Notable Thursday Option Activity: SQ, GS, WMC",1,0.47032934
2019-03-29,2632800.0,192.67999267578125,193.1100006103516,191.13999938964844,191.9900054931641,186.55764770507807,GS,"4 Upcoming IPOs to Watch That Aren’t Named Lyft ||| 3 Stocks to Buy and Hold for Decades ||| Buy Bank of America Stock Into Earnings ||| Forex firm TransferWise to sell stake in new fundraising round ||| EU risks ""trade war"" with Malaysia over palm oil - Mahathir ||| 4 Upcoming IPOs to Watch That Aren’t Named Lyft ||| Goldman's China-backed fund bucks trade tensions to buy U.S. firm ||| 3 Stocks to Buy and Hold for Decades",1,0.54657614
2019-04-02,2247000.0,196.2400054931641,197.759994506836,195.3999938964844,197.5,191.91172790527344,GS,The Alibaba of Africa Is Going Public,1,0.52869403
2019-04-03,3227900.0,199.25,201.08999633789065,198.5399932861328,200.8600006103516,195.1766815185547,GS,Goldman seeks 'curious' engineers for digital innovation program -website,1,0.50477165
2019-04-05,2447100.0,203.3800048828125,205.5,202.0599975585937,202.3800048828125,196.6536560058593,GS,"Top 10 Fintech Stocks to Buy Now ||| Dow Movers: DOW, WBA ||| Dow Movers: DOW, WBA ||| Friday’s Vital Data: Tesla, Roku and Disney ||| Friday’s Vital Data: Tesla, Roku and Disney ||| Top 10 Fintech Stocks to Buy Now ||| Noteworthy Friday Option Activity: GS, GWW, HES",1,0.50003034
2019-04-08,1891500.0,202.7899932861328,203.6300048828125,201.17999267578125,202.5399932861328,196.80911254882807,GS,"Waddell & Reed Financial, Inc. (WDR) Ex-Dividend Date Scheduled for April 09, 2019",0,0.4552089
2019-04-09,2400900.0,201.22999572753903,201.58999633789065,198.8600006103516,200.6199951171875,194.9434356689453,GS,Warren Buffett Just Gave Wells Fargo Some Valuable Advice ||| Warren Buffett Just Gave Wells Fargo Some Valuable Advice,1,0.4930678
2019-04-10,1907100.0,201.8000030517578,203.1699981689453,200.2700042724609,202.97999572753903,197.2366943359375,GS,"Market Close Report: NASDAQ Composite index closes at 7,964.24 up 54.96 points ||| Stocks Muscle Higher on Dovish Fed ||| Buy Bank of America Stock Before Its Good Citizenship Pays Off",0,0.5033597
2019-04-11,2802100.0,204.22999572753903,205.4499969482422,201.57000732421875,202.8300018310547,197.0909118652344,GS,4 Big Bank Stocks Ready to Kick Off Earnings Season ||| Pinterest IPO: What Can We Expect As Another Unicorn Comes To Market? ||| Implied SPXT Analyst Target Price: $59 ||| 4 Big Bank Stocks Ready to Kick Off Earnings Season,1,0.49790427
2019-04-12,5096600.0,207.0,209.97000122070312,206.3699951171875,207.83999633789065,201.9591522216797,GS,"The Alibaba of Africa Just Went Public ||| Notable ETF Inflow Detected - DIA, HD, GS, MCD ||| Pre-Market Earnings Report for April 15, 2019 : C, GS, MTB, PIXY",0,0.48539734
2019-04-15,6617200.0,204.1100006103516,205.7400054931641,199.6999969482422,199.9100036621093,194.2535552978516,GS,"Goldman Sachs Pay Cut 2019: Why GS Bankers, Traders Had Pay Slashed ||| What Happened in the Stock Market Today ||| Lackluster Bank Earnings Pressure U.S. Markets ||| 5 Top Stock Trades for Tuesday: C, APHA, CZR, GOOGL, AMZN ||| Mid-Afternoon Market Update: Crude Oil Down 0.6%; Fibrocell Science Shares Spike Higher ||| Financial Sector Update for 04/15/2019: ADS, C, GS, JPM, BAC, WFC, USB ||| Monday Sector Laggards: Financial, Technology & Communications ||| Mid-Day Update: US Stocks Slump as Bank Earnings Help Drag Indexes Lower Monday ||| Financial Sector Update for 04/15/2019: RY,RY.TO,GS,ADS ||| Bank of America Will Likely Beat on Earnings Expectations ||| GS May 31st Options Begin Trading ||| Mid-Morning Market Update: Markets Open Lower; Goldman Sachs Posts Mixed Q1 Results ||| Dow Movers: GS, UNH ||| Goldman Sachs Earnings: Not a Great First Quarter, but Much to Look Forward to ||| Stock Market News: Waste Management Goes Shopping; Goldman Sachs Disappoints ||| What Happened in the Stock Market Today ||| Goldman Sachs Group Inc (GS) Q1 2019 Earnings Call Transcript ||| Goldman Sachs Group Inc. Announces Fall In Q1 Earnings ||| Mid-Afternoon Market Update: Crude Oil Down 0.6%; Fibrocell Science Shares Spike Higher ||| Goldman Sachs Group Inc (GS) Q1 2019 Earnings Call Transcript ||| Market Close Report: NASDAQ Composite index closes at 7,976.01 down -8.15 points ||| Lackluster Bank Earnings Pressure U.S. Markets ||| Earnings Reaction History: Goldman Sachs Group Inc., 54.5% Follow-Through Indicator, 2.6% Sensitive ||| Close Update: Stocks Finish Lower, Dragged Down by Goldman Sachs, Citigroup Earnings ||| Goldman Sachs Q1 Profit Declines, But Tops Estimates; Hikes Dividend ||| Financial Sector Update for 04/15/2019: MOGO,MOGO.TO,DCF.TO,RY,RY.TO,GS,ADS ||| Goldman Sachs Pay Cut 2019: Why GS Bankers, Traders Had Pay Slashed ||| Monday Sector Laggards: Financial, Technology & Communications ||| Stock Market News: Waste Management Goes Shopping; Goldman Sachs Disappoints ||| Financial Sector Update for 04/15/2019: RY,RY.TO,GS,ADS ||| Goldman Sachs profit beats estimates on lower expenses, higher advisory fees",1,0.48653513
2019-04-16,4852600.0,199.6199951171875,202.94000244140625,199.2400054931641,201.83999633789065,196.12892150878903,GS,"Tuesday’s Vital Data: Goldman Sachs, Bank of America and Citigroup ||| Tuesday’s Vital Data: Goldman Sachs, Bank of America and Citigroup ||| 10 S&P 500 Stocks to Weather the Earnings Storm ||| After Bank Earnings, Is It Time to Buy? ||| Aramco in talks for 25 pct of Reliance's refining, petrochemical units ||| 5 Top Stock Trades for Wednesday: BAC, MS, O ||| 5 Top Stock Trades for Wednesday: BAC, MS, O ||| What Will the Q1 Earnings Season Bring? ||| Mixed Start to Q1 Earnings Season",1,0.47083592
2019-04-17,4195300.0,201.9600067138672,208.5,201.77999877929688,207.8999938964844,202.01747131347656,GS,"Morgan Stanley leans on wealth management to beat estimates ||| Morgan Stanley profit beats estimates on wealth management, lower costs",0,0.4920832
2019-04-18,2874300.0,207.08999633789065,207.8600006103516,205.1499938964844,205.9100036621093,200.08377075195312,GS,"Bank of America Stock Is One Catalyst Away From Moving Higher ||| Pinterest, Zoom shares surge in market debuts after IPOs ||| Brexit inertia means London's finance workers face summer slump",0,0.48735854
2019-04-22,1591400.0,205.1199951171875,205.58999633789065,204.13999938964844,204.6000061035156,198.81085205078125,GS,"Notable Monday Option Activity: GS, GBT, PTCT ||| Buy Morgan Stanley Stock on Valuation, Not External Factors",0,0.4917655
2019-04-30,1833000.0,206.94000244140625,207.9900054931641,204.1499938964844,205.9199981689453,200.09347534179688,GS,"Notable ETF Inflow Detected - DIA, AAPL, GS, CAT",0,0.50420207
2019-05-01,1981800.0,206.3999938964844,208.4100036621093,204.02999877929688,204.72999572753903,198.93716430664065,GS,Financial Literacy Month Comes to a Close,1,0.5316923
2019-05-02,1514700.0,204.42999267578125,206.22000122070312,203.1199951171875,204.9900054931641,199.1898193359375,GS,3 Top Bank Stocks to Buy Right Now,1,0.548221
2019-05-03,1897600.0,206.009994506836,208.75,205.6699981689453,207.5200042724609,201.64822387695312,GS,"GS Makes Bullish Cross Above Critical Moving Average ||| Dow Movers: CSCO, GS",0,0.4989831
2019-05-06,1927800.0,202.8000030517578,206.97999572753903,201.7100067138672,206.42999267578125,200.58905029296875,GS,"Financial Sector Update for 05/06/2019: C, GS, WFC, JPM, BAC, USB",0,0.47929466
2019-05-07,2839500.0,203.33999633789065,204.0,201.009994506836,202.6300048828125,196.8965759277344,GS,"Notable Tuesday Option Activity: XENT, GS, CRZO",0,0.5123534
2019-05-08,1817600.0,201.3999938964844,203.1999969482422,200.8000030517578,200.9499969482422,195.2641143798828,GS,"DIA, BA, UNH, GS: ETF Inflow Alert",1,0.5403428
2019-05-10,2089400.0,200.97999572753903,202.1000061035156,198.9900054931641,202.0500030517578,196.3330078125,GS,Goldman Sachs' Shares Have Sizable Upside Potential Despite Expected Pressure On Its Top Line,0,0.49083722
2019-05-13,3605600.0,197.8999938964844,197.8999938964844,194.0,194.97000122070312,189.45333862304688,GS,"Goldman Sachs Group's Preferred Stock, Series N Crosses Above 6% Yield Territory",1,0.5010594
2019-05-15,2271100.0,194.63999938964844,197.58999633789065,193.4199981689453,196.3999938964844,190.8428497314453,GS,"Notable Wednesday Option Activity: A, GS, TDG",1,0.51880175
2019-05-16,2008100.0,196.6300048828125,200.0,196.6199951171875,199.13999938964844,193.5053253173828,GS,"Stock Market News: Walmart Stokes US Growth; Goldman Heads to Main Street ||| Notable ETF Outflow Detected - DIA, GS, AAPL, MMM",0,0.5033473
2019-05-20,2483400.0,197.08999633789065,197.77999877929688,195.57000732421875,197.2400054931641,191.6591186523437,GS,Why Apple Stock Could Fall Below $160 ||| Is Goldman Sachs a Buy?,1,0.49770483
2019-05-22,2427200.0,197.44000244140625,198.47999572753903,195.4600067138672,195.5200042724609,189.98776245117188,GS,"Noteworthy Wednesday Option Activity: GS, AXDX, EZPW",0,0.52474153
2019-05-28,3040000.0,192.0,193.3099975585937,189.38999938964844,189.44000244140625,184.0797882080078,GS,"The Apple Card May Not Be Profitable for Goldman Sachs ||| Dow Movers: INTC, V ||| Ex-Dividend Reminder: FNB, Goldman Sachs Group and RLI",0,0.48510304
2019-05-29,2815800.0,187.7400054931641,188.6499938964844,184.9199981689453,188.0500030517578,183.55270385742188,GS,Why Apple and Goldman Can Afford Apple Card (When Others Can't) ||| Tilray Stock Keeps Its Eyes on the Future,0,0.48495927
2019-05-30,1919300.0,188.08999633789065,189.3699951171875,186.009994506836,187.3699951171875,182.8889617919922,GS,"Noteworthy Thursday Option Activity: ADS, PVH, GS",0,0.51737684
2019-05-31,2640100.0,184.7700042724609,184.88999938964844,182.3099975585937,182.4900054931641,178.12570190429688,GS,Dow Analyst Moves: GS,1,0.512465
2019-06-03,2857800.0,181.6999969482422,183.4900054931641,180.72999572753903,183.19000244140625,178.8089599609375,GS,"3 Top Bank Stocks to Buy Right Now ||| DIA, GS, TRV, JNJ: Large Outflows Detected at ETF ||| 10 Top-Rated Mega-Cap Stocks to Buy Now",1,0.5274447
2019-06-04,2420800.0,186.17999267578125,189.9900054931641,185.7100067138672,189.8800048828125,185.3389587402344,GS,Stock Market News: Wall Street Talks Up Uber; Tiffany Shines ||| Better Buy: Bank of America vs. Goldman Sachs,0,0.4894485
2019-06-05,1967800.0,190.1000061035156,190.1600036621093,187.009994506836,188.44000244140625,183.93338012695312,GS,4 Big Bank Stocks Rebounding,1,0.5397669
2019-06-06,1653500.0,188.0599975585937,190.7400054931641,187.3099975585937,189.8099975585937,185.2706298828125,GS,"Notable Thursday Option Activity: GS, AMBA, DK",0,0.5215779
2019-06-10,2372000.0,191.3999938964844,197.0,191.3999938964844,194.1199951171875,189.4775390625,GS,"Dow Movers: UTX, GS",1,0.5120635
2019-06-11,1632200.0,195.3000030517578,196.1199951171875,193.509994506836,194.72999572753903,190.0729522705078,GS,"Dow Jones Today: It Should Have Been Better ||| DIA, GS, AAPL, MMM: Large Outflows Detected at ETF",0,0.50865626
2019-06-12,2058800.0,193.6100006103516,194.0500030517578,189.8300018310547,190.22000122070312,185.6708221435547,GS,"Goldman Sachs Group's Preferred Stock, Series B Shares Cross 6% Yield Mark",1,0.503536
2019-06-13,1411400.0,190.4100036621093,192.25,190.07000732421875,191.4499969482422,186.87139892578125,GS,Interesting GS Put And Call Options For August 2nd ||| Analysts Predict 20% Gains Ahead For VLUE,1,0.5068754
2019-06-14,1403900.0,191.2899932861328,192.1699981689453,189.3099975585937,191.6600036621093,187.0763702392578,GS,Dow Jones Today: Stocks Have a No-Fun Friday,0,0.4925574
2019-06-18,2363000.0,190.6699981689453,197.1300048828125,190.6699981689453,194.97999572753903,190.31695556640625,GS,Why SunPower Corporation's Shares Popped 25% Today,1,0.5221962
2019-06-19,2196800.0,195.3500061035156,197.6100006103516,194.7899932861328,195.63999938964844,190.9611968994141,GS,"DIA, BA, AAPL, GS: Large Inflows Detected at ETF",1,0.52714705
2019-06-20,2749300.0,197.5,198.19000244140625,193.6100006103516,195.6999969482422,191.01974487304688,GS,"Thursday Apple Rumors: Apple Employees Are Testing its Credit Card ||| Dow Movers: JPM, NKE",1,0.5039882
2019-06-24,2069800.0,196.52999877929688,199.3500061035156,196.02999877929688,197.4900054931641,192.7669677734375,GS,"Financial Sector Update for 06/24/2019: LYG, GS, DB, JPM, BAC, WFC, C, USB",0,0.4758519
2019-06-25,1828300.0,197.5,197.5200042724609,194.009994506836,196.0599975585937,191.37115478515625,GS,"Dow Movers: GS, JNJ",1,0.52240777
2019-06-26,1649900.0,196.5,197.8699951171875,196.1199951171875,197.009994506836,192.2984313964844,GS,"Apple, The Spotify War and the Streaming Gold Mine",1,0.51748455
2019-06-27,2239200.0,197.57000732421875,199.6100006103516,196.759994506836,199.32000732421875,194.55319213867188,GS,"DIA, BA, UNH, GS: ETF Inflow Alert",1,0.5403428
2019-06-28,4854900.0,203.5,205.83999633789065,202.94000244140625,204.6000061035156,199.7069091796875,GS,"5 Top Stock Trades for Monday: STZ, C, UBER ||| Stock Market News: Jony Ive Leaves Apple; Savings Accounts See Rate Cuts ||| Should You Buy Bank of America After Dividend and Buyback Boost?  ||| Goldman Sachs Group Breaks Above 200-Day Moving Average - Bullish for GS ||| Goldman Sachs Investors Just Got Some Good News ||| 3 Big Stock Charts for Friday: Huntington Bancshares, Centurylink and Goldman Sachs",1,0.53792506
2019-07-01,2465700.0,208.0,209.8500061035156,205.7400054931641,206.8600006103516,201.91287231445312,GS,"Warren Buffett's Berkshire Hathaway Just Got a $300 Million Raise ||| 3 Top Bank Stocks to Buy Right Now ||| How Does Goldman's Investment Banking Business Compare With Its Peers? ||| Crypto News: Twitch Enables Bitcoin Payments, Goldman Sachs Might Launch a Digital Token ||| Financial Sector Update for 07/01/2019: BX,GS,JKHY,BAP,DB ||| Notable Monday Option Activity: GS, ULTA, WDC ||| 5 Big Bank Stocks Tearing Higher",0,0.4885183
2019-07-02,1621400.0,205.3999938964844,206.3099975585937,204.1600036621093,205.97999572753903,201.05389404296875,GS,"5 Top Stock Trades for Wednesday: NKE, AMRN, GS ||| 3 Warren Buffett Stocks to Buy in July",1,0.5377862
2019-07-05,1511400.0,206.8600006103516,208.759994506836,206.1999969482422,207.8999938964844,202.9279937744141,GS,"Bank of America's Generous Capital Return Plan Indicates A Payout Ratio Exceeding 100% For 2019 ||| Dow Jones Today: What’s Good Can Sometimes Be Bad ||| Dow Movers: INTC, UNH",0,0.4954958
2019-07-08,1853900.0,206.3600006103516,207.25,204.7100067138672,205.75,200.82940673828125,GS,A Foolish Take: Bank Dividends Are Soaring ||| Fed's Growth Restrictions Force Wells Fargo To Loosen Its Purse Strings For Investors Yet Again,1,0.49332803
2019-07-09,1812100.0,203.75,207.94000244140625,203.5399932861328,207.7700042724609,202.8011169433593,GS,U.S. Bancorp's Shareholder Payout Will Cross $5 Billion For The First Time Ever This Year ||| BNY Mellon's Total Shareholder Payout In 2019 Will Be Identical To The Record Payout For 2018,0,0.47084773
2019-07-10,1779800.0,207.17999267578125,208.9900054931641,205.6499938964844,205.97000122070312,201.0441436767578,GS,Why Zoom Video Stock Gained 11% in June,1,0.5189154
2019-07-11,3691600.0,206.1999969482422,212.58999633789065,206.0,211.3500061035156,206.2954864501953,GS,"Dow Jones Today: More Fed Fun, but Healthcare Weakness Caps Gains ||| Notable ETF Outflow Detected - PRF, AIG, GS, COF ||| Dow Movers: MRK, UNH",1,0.49438307
2019-07-12,2626000.0,212.0,214.19000244140625,210.7899932861328,213.94000244140625,208.82354736328125,GS,Why Avis Budget Group Stock Jumped 56% in the First Half of the Year,0,0.50868374
2019-07-15,2600200.0,214.1100006103516,214.6000061035156,209.7899932861328,211.5800018310547,206.5199737548828,GS,"Dow Jones Today: China, Earnings Anticipation Stall Stocks on Monday ||| 5 Dow Jones Stocks to Buy Now ||| Goldman Sachs Group's Preferred Stock, Series A Shares Cross 5% Yield Mark ||| Snap Stock: The Youth Market is Back ||| Dow Movers: GS, MRK ||| 3 Reasons Why Investors Should Buy JP Morgan Stock Before JPM’s Earnings",1,0.49581757
2019-07-16,5283700.0,214.8000030517578,217.3300018310547,212.5500030517578,215.5200042724609,210.3657684326172,GS,"Dow Jones Today: Earnings Disappointments ||| Goldman Sachs Group Inc (GS) Q2 2019 Earnings Call Transcript ||| Financial Sector Update for 07/16/2019: NDAQ,FHN,GS,SFBS ||| Notable Tuesday Option Activity: GS, DISCA, UAL ||| Financial Sector Update for 07/16/2019: FHN,GS,SFBS ||| Stock Market News: JPMorgan and Goldman Sachs Deliver Solid Bank Earnings ||| Goldman Sachs: An Early Winner of Earnings Season? ||| Dow Movers: INTC, GS",0,0.48221374
2019-07-18,2859000.0,212.7100067138672,215.8300018310547,211.75,214.5200042724609,209.38967895507807,GS,AAPL Stock: Apple Software Becomes Lifestyle ||| How to Invest in E-Commerce Outside the U.S.,0,0.5233186
2019-07-23,3330600.0,214.9499969482422,220.0,214.9499969482422,219.42999267578125,214.1822509765625,GS,"6 Upcoming IPOs for July ||| Noteworthy ETF Outflows: ITOT, MO, GS, CME ||| Notable Tuesday Option Activity: BIIB, CWEN, GS",1,0.53625417
2019-07-24,3180000.0,219.25,222.08999633789065,218.6300048828125,222.02999877929688,216.7200622558593,GS,3 Top Bank Stocks to Buy Right Now,0,0.548221
2019-07-25,2776700.0,221.7700042724609,221.7700042724609,218.22999572753903,219.97999572753903,214.7190856933593,GS,"Goldman Sachs Group's Preferred Stock, Series D Crosses Above 5% Yield Territory ||| 3 Top Financial Stocks to Buy Right Now",1,0.49080068
2019-07-26,2304500.0,220.4499969482422,222.2400054931641,220.3699951171875,222.13999938964844,216.8274383544922,GS,"Goldman Sachs Group's Preferred Stock, Series C Yield Pushes Past 5% ||| A Winning Plan for the Consumer Market Is Driving Goldman Sachs Stock",0,0.49049568
2019-07-29,1372800.0,221.0,222.1300048828125,220.1999969482422,220.32000732421875,215.05096435546875,GS,Is Micron Technology Stock Really Headed to $56? ||| 3 Big Bank Stocks to Buy Today,1,0.4977607
2019-07-30,1644600.0,218.4900054931641,221.9900054931641,217.3300018310547,221.3999938964844,216.1051177978516,GS,6 Upcoming IPOs for August,0,0.52788603
2019-07-31,1991100.0,221.2400054931641,221.97999572753903,219.009994506836,220.1300048828125,214.86550903320312,GS,"Notable Wednesday Option Activity: GS, COST, ILMN ||| The Implied Analyst 12-Month Target For IAI",0,0.4969414
2019-08-07,2454200.0,201.1100006103516,205.9600067138672,199.0500030517578,205.7400054931641,200.8196563720703,GS,"Notable Wednesday Option Activity: GS, Z, XON",1,0.51539695
2019-08-08,2342200.0,207.1699981689453,207.8000030517578,203.5399932861328,207.0,202.0495147705078,GS,"DIA, BA, GS, TRV: ETF Outflow Alert",0,0.53739893
2019-08-09,1790100.0,205.6199951171875,208.3000030517578,203.8600006103516,206.8999938964844,201.951889038086,GS,Friday Apple Rumors: Apple Expands Bug Bounty Program,0,0.5159756
2019-08-12,1479300.0,203.27999877929688,204.1499938964844,200.47999572753903,201.5200042724609,196.7005615234375,GS,"Dow Movers: GS, PG",1,0.5115296
2019-08-13,2115900.0,201.509994506836,206.6000061035156,200.22999572753903,204.1100006103516,199.2286376953125,GS,Can Apple Card Really Boost iPhone Loyalty?,0,0.5289502
2019-08-14,3025100.0,199.8000030517578,199.9100036621093,195.0599975585937,195.5599975585937,190.88308715820312,GS,Goldman Sachs Might End Up Regretting Apple Card Partnership ||| Goldman Sachs Group (GS) Shares Cross Below 200 DMA ||| Last Chance to Buy Alibaba Stock Before Earnings ||| JNJ Stock Is a Way Better Investment Than Bonds or CDs,1,0.47642452
2019-08-15,1981900.0,195.9100036621093,196.97000122070312,193.7100067138672,196.17999267578125,191.48828125,GS,"Noteworthy Thursday Option Activity: GS, COST, MSFT ||| Dow Analyst Moves: GS",1,0.50799644
2019-08-16,1878700.0,197.02999877929688,200.6699981689453,197.0,199.4199981689453,194.6508026123047,GS,Investors Should Buy General Electric Stock on Its Latest Decline,1,0.53032994
2019-08-20,1545600.0,200.2100067138672,201.9900054931641,199.6999969482422,199.97999572753903,195.1974029541016,GS,"Technology Sector Update for 08/20/2019: AAPL,GS,MA,MAXR,BIDU,FN",1,0.48311135
2019-08-21,1160800.0,202.7400054931641,203.0200042724609,200.1699981689453,200.67999267578125,195.8806610107422,GS,5 Things You Should Know About Apple's New Credit Card,1,0.5387557
2019-08-22,1275900.0,202.27999877929688,203.4499969482422,200.9100036621093,202.4199981689453,197.5790252685547,GS,"Notable Thursday Option Activity: ZIOP, GS, FL ||| Financial Sector Update for 08/22/2019: CM, HSBC, GS, JPM, WFC, BAC, C, USB",0,0.4816135
2019-08-26,1441900.0,198.2700042724609,199.7100067138672,198.0,199.6499938964844,194.8752899169922,GS,"3 Top Bank Stocks to Buy Right Now ||| Dow Movers: HD, AAPL",0,0.5276341
2019-08-27,1513300.0,200.3300018310547,200.8600006103516,196.5,198.07000732421875,193.3330841064453,GS,Hands On With the New Apple Credit Card,1,0.51838756
2019-08-28,1437800.0,196.57000732421875,201.47000122070312,196.25,200.4199981689453,195.6268615722656,GS,7 Things to Know About the History of Overstock and Patrick Byrne,1,0.53430766
2019-08-30,1529600.0,204.8500061035156,205.2100067138672,203.009994506836,203.9100036621093,200.2825622558593,GS,"Notable Friday Option Activity: GS, COST, ALXN",0,0.50528944
2019-09-03,2633600.0,201.1000061035156,201.6100006103516,196.5800018310547,198.97000122070312,195.43045043945312,GS,"Dow Jones Today: Not the Way to Start September ||| Dow Movers: BA, PFE",1,0.49931833
2019-09-04,1720600.0,201.4900054931641,202.1000061035156,200.0500030517578,201.72999572753903,198.141342163086,GS,3 Dow Jones Stocks With Great Trade Setups Right Now,1,0.52666223
2019-09-05,2237900.0,205.2700042724609,208.92999267578125,205.0399932861328,207.0500030517578,203.36669921875,GS,"Dow Jones Today: Finally, Some Relief on the Trade Front ||| NextEra Energy To Sell $1.5 Bln Of Equity Units ||| Goldman Sachs Is Shrinking Partnerships: WSJ Reports",1,0.49808952
2019-09-06,1438800.0,207.0599975585937,208.25,205.57000732421875,207.2100067138672,203.5238494873047,GS,"Noteworthy Friday Option Activity: GWRE, XPO, GS ||| DIA, BA, MCD, GS: ETF Inflow Alert",1,0.5214329
2019-09-10,2615800.0,213.5,217.08999633789065,213.22000122070312,215.6300048828125,211.7940673828125,GS,"Should You Buy Bank of America Stock Today? ||| Financial Sector Update for 09/10/2019: STC, FNF, MTG, GS, JPM, BAC, WFC, C, USB ||| Goldman's H1'19 M&A Advisory Fees Jump 20% To $1.7 Billion Even As Peers Report A Decline ||| Can Bank of America's Revenues Breach The $100-Billion Mark By 2021?",1,0.49551752
2019-09-12,2913800.0,216.3800048828125,220.759994506836,215.1499938964844,218.7400054931641,214.8487548828125,GS,Should Visa Worry About Apple's New Credit Card?,1,0.5305369
2019-09-16,2205500.0,217.82000732421875,219.3300018310547,216.32000732421875,217.22000122070312,213.35577392578125,GS,"3 Reasons to Consider Owning Goldman Sachs ||| Noteworthy Monday Option Activity: GS, APA, COST ||| 7 Dow Titans Breaking Higher ||| Notable ETF Inflow Detected - DIA, BA, GS, MCD",0,0.5167921
2019-09-17,2429100.0,215.8000030517578,216.13999938964844,212.5399932861328,215.9100036621093,212.069091796875,GS,Why Goldman Sachs' Downgrade of Apple Is Totally Ridiculous ||| Visa’s Investment Shows Plaid Could Replace Libra in Fintech Space,1,0.4856971
2019-09-18,2474900.0,214.8300018310547,217.88999938964844,213.3000030517578,217.0800018310547,213.21827697753903,GS,These 2 Value Stocks Are Absurdly Cheap Right Now,0,0.4692783
2019-09-20,5458900.0,214.6600036621093,216.67999267578125,213.6300048828125,213.7400054931641,209.93768310546875,GS,How to Trade Bank of America Stock as It Approaches Resistance ,0,0.51216567
2019-09-23,1485500.0,212.8500061035156,214.1100006103516,211.5599975585937,213.4600067138672,209.6626739501953,GS,BlackRock's Revenue Growth Will Slow Down Considerably Over Coming Years,0,0.5171326
2019-09-24,2837600.0,214.0399932861328,214.1999969482422,206.8000030517578,207.75,204.0542449951172,GS,"DIA, BA, GS, MCD: Large Inflows Detected at ETF",1,0.52717483
2019-09-25,1593400.0,207.9600067138672,211.08999633789065,207.4499969482422,210.02999877929688,206.29367065429688,GS,4 Mid-Market Banks Powering Advancements In Healthcare,0,0.5521196
2019-09-30,1794500.0,209.7100067138672,209.7100067138672,206.8300018310547,207.22999572753903,203.54348754882807,GS,JPMorgan's Diversified Business Model Should Help Revenues Cross $120 Billion By 2021 ||| Better Buy: Bank of America vs. Goldman Sachs ||| 3 Top Bank Stocks to Buy Right Now,0,0.48792076
2019-10-01,3156200.0,207.009994506836,209.3800048828125,202.6100006103516,202.69000244140625,199.08425903320312,GS,"Dow Jones Today: Glum Data Strikes Again ||| Noteworthy Tuesday Option Activity: COST, ATVI, GS",0,0.50423455
2019-10-02,3386800.0,201.69000244140625,201.8800048828125,197.6000061035156,198.25,194.72325134277344,GS,"GS Crosses Below Key Moving Average Level ||| Noteworthy ETF Inflows: PFF, DB, VER, GS",0,0.5037653
2019-10-03,2914500.0,197.6100006103516,198.3699951171875,193.9900054931641,197.2400054931641,193.73123168945312,GS,Expect Sideways Trading in Bank of America Stock to Continue ||| Analysts Expect OVOL To Hit $32,1,0.5003393
2019-10-08,2654900.0,197.6000061035156,198.9499969482422,195.9199981689453,197.3699951171875,193.85888671875,GS,"Dow Movers: GS, WMT ||| Is U.S. Bancorp The New Poster Child For The U.S. Banking Industry After Wells Fargo's Fall From Grace?",0,0.4988319
2019-10-09,2443500.0,198.19000244140625,198.97999572753903,196.67999267578125,196.8500061035156,193.34815979003903,GS,Federal Agencies Finalize Revisions To Simplify Volcker Rule,1,0.53184915
2019-10-10,2108000.0,197.58999633789065,201.32000732421875,197.5399932861328,199.8699951171875,196.3144073486328,GS,"Citigroup Will Have To Bank On Its Card Business To Ensure Revenue Growth Over Coming Years ||| Notable ETF Inflow Detected - DIA, BA, MCD, GS",1,0.49634355
2019-10-11,3334300.0,203.72000122070312,207.2899932861328,203.72000122070312,204.67999267578125,201.03884887695312,GS,Will The Pace of M&A Pick Up Following The Biotech Sector’s Pounding? ||| An Apple Services Bundle Could Be as Powerful as Amazon Prime,1,0.5189358
2019-10-14,2286100.0,203.8300018310547,206.1699981689453,202.9199981689453,205.82000732421875,202.15858459472656,GS,3 Things to Watch During Earnings Season,1,0.56383765
2019-10-15,8241900.0,202.0,208.2400054931641,198.6100006103516,206.4600067138672,202.7872009277344,GS,"Dow Jones Today: Earnings Boosts Across the Board ||| 3 Solar Stocks to Buy for a New Day in Solar Energy ||| Stock Market News: Bank Earnings Send JPMorgan Higher, Goldman Lower ||| Dow Movers: GS, UNH ||| Financial Sector Update for 10/15/2019: JPM, GS, WFC, BAC, C, USB ||| Goldman Sachs Posts a Rare Earnings Miss ||| Goldman Sachs Q3 Profit Declines, Miss Estimates - Quick Facts",1,0.49055558
2019-10-16,3405800.0,206.1699981689453,208.6199951171875,206.1000061035156,207.4199981689453,203.7301177978516,GS,"7 Big Bank Stocks on the Move ||| A Tale of 2 Banks ||| Notable Wednesday Option Activity: CBRE, IP, GS",0,0.5224503
2019-10-17,2876500.0,208.2899932861328,208.92999267578125,204.38999938964844,206.4600067138672,202.7872009277344,GS,"Goldman Sachs Group's Preferred Stock, Series J Shares Cross 5% Yield Mark",1,0.503265
2019-10-21,1934900.0,208.6699981689453,210.8600006103516,207.67999267578125,209.25,205.52755737304688,GS,Facebook Moves Ahead With Libra Despite Some Major Setbacks ||| Goldman Sachs Banker Arrested Over U.S. Insider Trading Allegations : Reports ||| Why Did the Market Strike Down CrowdStrike? ||| This Dow Component Has A 2.4% Yield And Sells For Less Than Book,1,0.5012896
2019-10-22,1868000.0,209.58999633789065,211.6499938964844,208.3099975585937,209.6000061035156,205.871337890625,GS,A Rundown of Third-Quarter Bank Earnings and More,1,0.5424239
2019-10-24,1266500.0,211.6100006103516,213.1499938964844,209.77999877929688,211.0500030517578,207.2955322265625,GS,How to Make Cash Pay You,1,0.525466
2019-10-28,2707800.0,216.32000732421875,218.9199981689453,215.69000244140625,217.75,213.8763427734375,GS,"Dunkin' Is Speeding Up, and Buybacks Are Slowing Down",0,0.48998916
2019-10-29,2030400.0,217.22000122070312,219.27999877929688,216.4499969482422,217.63999938964844,213.768310546875,GS,Will JPMorgan Chase Suffer From Its WeWork Connection?,0,0.5054564
2019-10-30,1584900.0,217.0200042724609,217.0500030517578,213.8099975585937,215.8099975585937,211.97085571289065,GS,"Goldman Sachs' Top Line Likely To Shrink $1.6 Billion In 2019 ||| Goldman Sachs Group's Preferred Stock, Series N Yield Pushes Past 6% ||| Why Bank of America's Stock Looks Undervalued",0,0.47824448
2019-10-31,1876200.0,215.1499938964844,215.3600006103516,211.32000732421875,213.3800048828125,209.58409118652344,GS,"Dow Analyst Moves: GS ||| Is Citigroup's Stock Undervalued? ||| Notable Thursday Option Activity: MET, XLNX, GS",1,0.49009654
2019-11-04,2538100.0,219.6999969482422,220.69000244140625,218.57000732421875,219.8699951171875,215.9586334228516,GS,Which Custody Banking Giant Is In Better Shape: BNY Mellon or State Street?,0,0.49636093
2019-11-05,2525100.0,220.8000030517578,221.77999877929688,218.47000122070312,218.63999938964844,214.75051879882807,GS,State Street or BNY Mellon: Which Custody Banking Giant Uses Its Asset Base More Efficiently? ||| What Is The Upside Potential For Morgan Stanley's Stock? ||| What Is The Upside Potential For Morgan Stanley's Stock?,0,0.4633437
2019-11-07,3748600.0,220.7700042724609,224.7700042724609,220.4100036621093,223.2899932861328,219.3177947998047,GS,"Noteworthy Thursday Option Activity: RE, KSS, GS ||| Apple Could Help Goldman Sachs Grab a Piece of This $18.5 Billion Market",0,0.5154087
2019-11-11,2754500.0,220.8999938964844,221.4100036621093,218.5200042724609,219.02999877929688,215.13357543945312,GS,"NY Regulator Investigates Goldman Sachs' Apple Card For Alleged Gender Bias ||| Financial Sector Update for 11/11/2019: ORCC,EQIX,ICE,GS ||| Financial Sector Update for 11/11/2019: EQIX,ICE,GS ||| Apple Card Being Investigated For Alleged Gender Discrimination",1,0.46397284
2019-11-14,1483100.0,218.7899932861328,220.47000122070312,218.02999877929688,219.42999267578125,215.5264587402344,GS,"Dow Movers: CSCO, WMT",1,0.5213812
2019-11-18,1603400.0,219.72999572753903,219.9499969482422,218.0399932861328,219.72999572753903,215.8211212158203,GS,This Is When You Should Buy Bank of America Stock,1,0.5206498
2019-11-19,1817100.0,220.5599975585937,220.67999267578125,218.3099975585937,220.0399932861328,216.1256103515625,GS,Is This Stock a No-Brainer Investment?,0,0.50740933
2019-11-20,2177700.0,218.3600006103516,219.47000122070312,216.3999938964844,217.9100036621093,214.0335235595703,GS,Is Goldman Sachs' Stock a Buy?,1,0.4979102
2019-11-21,1677500.0,218.6000061035156,219.32000732421875,216.82000732421875,218.22999572753903,214.34780883789065,GS,Why Shares of E*Trade Financial Fell Today ||| Goldman Sachs CEO Denies Gender Bias In Credit Limits For Apple Card,1,0.48788208
2019-11-22,1529100.0,218.0,220.7100067138672,218.0,220.27999877929688,216.36134338378903,GS,"Noteworthy Friday Option Activity: GS, CAG, SNPS ||| Daily Markets: China, USMCA Trade Issues Will Determine How Week Finishes",1,0.52802783
2019-11-25,2181800.0,220.88999938964844,223.9499969482422,220.88999938964844,222.75,218.7873992919922,GS,"If You Invested $1,000 in Berkshire’s IPO, This Is How Much Money You'd Have Now",0,0.5239538
2019-11-26,1926300.0,222.67999267578125,222.759994506836,221.1100006103516,222.4499969482422,218.4927520751953,GS,Goldman Sachs Ordered To Pay $1 Mln Fine For Recordkeeping Violations,1,0.5108646
2019-11-27,1614600.0,223.4499969482422,224.27999877929688,221.8600006103516,222.9499969482422,218.98385620117188,GS,"Goldman Sachs Group, Inc. (GS) Ex-Dividend Date Scheduled for November 29, 2019 ||| 3 Solar Stocks to Buy for a New Day in Solar Energy",0,0.4581785
2019-11-29,770400.0,220.8800048828125,222.0,220.4100036621093,221.3500061035156,218.6381378173828,GS,Deutsche Bank Reportedly Sells $50 Bln Assets To Goldman Sachs ||| Why Goldman's M&A Advisory Fees Are Largely Level Despite 68% Spurt In Deal Value,0,0.50006676
2019-12-02,2118500.0,220.97000122070312,221.8000030517578,217.0800018310547,217.63999938964844,214.9735870361328,GS,"Goldman Sachs Group's Preferred Stock, Series C Shares Cross 4.5% Yield Mark",0,0.5072755
2019-12-03,3207100.0,215.42999267578125,215.42999267578125,210.0,212.2400054931641,209.63975524902344,GS,"Financial Sector Update for 12/03/2019: GS,RC,LCN,BMO,BMO.TO ||| Validea Joseph Piotroski Strategy Daily Upgrade Report - 12/3/2019",1,0.46707132
2019-12-04,1583600.0,213.5399932861328,216.9900054931641,212.3800048828125,215.94000244140625,213.2944183349609,GS,3 Embarrassingly Cheap Dividend Stocks,1,0.55367273
2019-12-05,1329300.0,217.1499938964844,217.6300048828125,215.4199981689453,217.13999938964844,214.479721069336,GS,Analysts Expect EQRR Will Reach $48,1,0.52227545
2019-12-06,4229400.0,219.9499969482422,225.3999938964844,218.82000732421875,224.6100006103516,221.8582000732422,GS,"4 Top Stock Trades for Monday: GS, BIG, BMY",0,0.52044386
2019-12-09,2134600.0,224.6100006103516,224.6499938964844,221.7700042724609,221.8099975585937,219.09249877929688,GS,"Dow Jones Today: The Trade Clock Ticks Away ||| Notable Monday Option Activity: COST, GS, GLW ||| The 10 Best Value Stocks to Buy for 2020",1,0.49189493
2019-12-11,1778600.0,222.25,222.8500061035156,220.83999633789065,221.19000244140625,218.4801025390625,GS,Mortgage-Backed Securities Held By U.S. Commercial Banks Surpasses $2 Trillion: Cause For Concern?,1,0.47908896
2019-12-13,1908200.0,226.72000122070312,227.9900054931641,223.6999969482422,225.0,222.243408203125,GS,"Advanced Micro Devices Stock Is a Bargain, But It Still Faces China Risks ||| Here's How Much Warren Buffett Has Made on Goldman Sachs",1,0.4884495
2019-12-16,3218400.0,228.5,230.6999969482422,227.8699951171875,228.0399932861328,225.2461700439453,GS,"Dow Movers: BA, GS ||| Financial Sector Update for 12/16/2019: GS, BXS, JPM, BAC, WFC, C, USB",1,0.48201063
2019-12-17,3590000.0,230.0,232.07000732421875,228.8000030517578,231.1499938964844,228.3180694580078,GS,"Dow Jones Today: Stocks Continue Building Momentum ||| Dow Movers: BA, GS ||| Which U.S. Bank Is The Largest Holder Of Mortgage-Backed Securities?",0,0.50028837
2019-12-18,2280800.0,231.97000122070312,232.1999969482422,229.94000244140625,230.4499969482422,227.62664794921875,GS,Dow Jones Today: Stocks Took a Pre-Holiday Breather,0,0.50495744
2019-12-19,2418100.0,230.9499969482422,231.38999938964844,228.9600067138672,229.94000244140625,227.1228942871093,GS,Goldman Sachs In Talks With U.S. To Pay $2 Bln Fine To Settle 1MDB Probe: WSJ,0,0.49522638
2019-12-20,3715500.0,230.9600067138672,231.2899932861328,228.6199951171875,228.92999267578125,226.1252593994141,GS,SPDR Dow Jones Industrial Average ETF Trust Experiences Big Outflow,1,0.5093719
2019-12-23,1670400.0,229.6600036621093,230.47999572753903,228.4100036621093,229.08999633789065,226.2832946777344,GS,"5 Reasons Warren Buffett Didn't Beat the Market Over the Last Decade ||| Netflix Stock Will Surge 25% to $420 in 2020, According to This Analyst ||| Bed Bath & Beyond Cleans House Again, Ousts 6 More Executives",1,0.50155455
2019-12-24,467700.0,228.97999572753903,229.9499969482422,228.3699951171875,229.9100036621093,227.09327697753903,GS,"Financial Sector Update for 12/24/2019: GS, TROW, BLK, FFNW, JPM, BAC, WFC, C, USB",1,0.47752097
2019-12-26,1704000.0,230.259994506836,232.1999969482422,229.9900054931641,231.2100067138672,228.37733459472656,GS,How Important Is The Loans-And-Deposits Banking Business To JPMorgan's Stock?,0,0.50791025
2019-12-30,1494500.0,231.67999267578125,231.67999267578125,229.5,229.8000030517578,226.984619140625,GS,"Financial Sector Update for 12/30/2019: MUFG, BAP, JPM, GS, BAC, WFC, C, USB ||| How Will Securities Trading Headwinds Affect Morgan Stanley's Revenues?",1,0.49443817
2020-01-02,3736300.0,231.0,234.63999938964844,230.1600036621093,234.32000732421875,231.44923400878903,GS,"Noteworthy Thursday Option Activity: DRI, GS, DVN",0,0.52491415
2020-01-06,3329300.0,229.92999267578125,234.0200042724609,229.4900054931641,233.9499969482422,231.08377075195312,GS,Is The Recent Decline In JPMorgan's Net Interest Margin Figure A Cause For Concern?,1,0.52301365
2020-01-07,5255200.0,235.0,237.7700042724609,234.759994506836,235.4900054931641,232.6049194335937,GS,"DIA, GS, MCD, CAT: ETF Outflow Alert ||| Goldman Sachs Reorganizes Business Segments ||| Dow Movers: MRK, GS ||| Everything You Need to Know About Stock Buybacks ||| Financial Sector Update for 01/07/2020: BCOR, GS, JPM, BAC, WFC, C, USB",1,0.48533145
2020-01-08,3564700.0,235.67999267578125,239.75,235.47999572753903,237.759994506836,234.8470764160156,GS,A Company That Helps Employees Navigate Their Healthcare Benefits Has Asked Wall Street for Help Going Public,1,0.5257521
2020-01-09,3980700.0,241.33999633789065,243.3999938964844,239.82000732421875,242.6000061035156,239.6278076171875,GS,Dow Jones Today: Middle East Calm Proves Meaningful for Stocks,0,0.5011569
2020-01-13,3359200.0,244.44000244140625,246.1100006103516,243.0,245.2100067138672,242.205810546875,GS,Dow Jones Today: Tech Lifts Stocks as Trade Deal Signing Nears ||| Does Infosys Have What It Takes to Reach $20? ||| 6 Mega Bank Stocks to Watch Ahead of Earnings ||| JPMorgan vs. Goldman: Who Is Winning The Tussle For Investment Banking Supremacy?,1,0.503554
2020-01-14,4302800.0,245.32000732421875,248.5200042724609,244.6000061035156,245.6600036621093,242.6502990722656,GS,Dow Analyst Moves: GS,0,0.512465
2020-01-15,5411200.0,242.0,249.5,239.1600036621093,245.2100067138672,242.205810546875,GS,"Goldman Sachs' Revenue Soars 23% -- Here's Why ||| SPDR Dow Jones Industrial Average ETF Trust Experiences Big Inflow ||| Dow Jones Today: Trade Deal’s Done, Earnings Take Focus ||| Goldman Sachs Group Inc. Earnings Decline In Q4 ||| Goldman Sachs Q4 Profit Misses View, But Revenue Beats ||| Goldman Sachs Group Q4 19 Earnings Conference Call At 9:30 AM ET",1,0.5132075
2020-01-16,3968400.0,247.009994506836,249.82000732421875,246.22999572753903,249.72000122070312,246.6605682373047,GS,Why Target’s Bad Day Rained on Hasbro ||| This Is The Real Reason Shake Shack Shares Are Surging This Week ||| Is Bank of America Stock Still a Good Long-Term Pick?,0,0.48597568
2020-01-17,3108400.0,250.22999572753903,250.4600067138672,248.0,249.4600067138672,246.4037628173828,GS,"Notable Friday Option Activity: GS, DISCA, UNH",0,0.51177746
2020-01-21,2492400.0,247.2100067138672,248.8500061035156,245.6000061035156,245.6999969482422,242.68980407714844,GS,Investing in 2020: Should Investors Ride the Wave With Bank of America? ||| Better Buy: Bank of America vs. Goldman Sachs,1,0.5243155
2020-01-22,2030900.0,246.6100006103516,248.5200042724609,246.33999633789065,247.0500030517578,244.0232849121093,GS,Here’s What a Billion Paid Subscriptions Would Mean for Apple Stock,0,0.5109813
2020-01-23,2806800.0,244.5,247.0,242.8800048828125,245.5800018310547,242.5712890625,GS,Interview With Live Oak Bank's Huntley Garriott,0,0.5060872
2020-01-27,2506200.0,236.3699951171875,238.9900054931641,235.009994506836,238.13999938964844,235.2224273681641,GS,3 Safe ETFs to Buy for an Overvalued Market ||| 3 Bank Stocks to Trade After January Earnings ||| Why Bank of America Stock Probably Won’t Outperform in 2020,1,0.5096075
2020-01-28,3123000.0,239.4900054931641,243.5800018310547,238.0500030517578,242.5800018310547,239.6080474853516,GS,"If You Invested $5,000 in Goldman Sachs' IPO, This Is How Much Money You'd Have Now",0,0.50565547
2020-01-30,3261700.0,237.69000244140625,244.33999633789065,236.72999572753903,244.1300048828125,241.1390380859375,GS,Is Groupon Stock Worth Buying After MIG Capital Acquired a 5% Stake? ||| We Did The Math JKF Can Go To $126,0,0.49377063
2020-01-31,3482800.0,241.9900054931641,242.88999938964844,236.8800048828125,237.75,234.8372039794922,GS,Daily Markets: Markets Grapple With GDP Impact Of Coronavirus,1,0.52318877
2020-02-03,2733000.0,238.3600006103516,242.38999938964844,238.0500030517578,239.009994506836,236.081771850586,GS,"Investor Beware: These 4 Economic Trends Could Cause a Market Crash in 2020 ||| Dow Jones Today: A Coronavirus Rebound in the U.S., But Not China",1,0.50439805
2020-02-05,3126600.0,244.9900054931641,245.1300048828125,243.0,244.3000030517578,241.3069763183593,GS,Visa and PayPal Show the War on Cash Is Far From Over,0,0.4986316
2020-02-06,2225600.0,245.3500061035156,245.7700042724609,241.17999267578125,241.82000732421875,238.8573455810547,GS,How Did Last Week's IPOs Perform?,0,0.5172423
2020-02-07,3006500.0,239.75,240.5200042724609,236.5500030517578,238.0,235.0841522216797,GS,Dow Jones Today: Stocks Take a Breather With Several Headwinds Looming ||| A Major Executive Leaves Goldman Sachs – Should Investors be Worried? ||| 3 Top Value Stocks to Buy in February ||| Amazon and Goldman Sachs Wade Deeper Into Financial Services,0,0.49285218
2020-02-11,2238800.0,239.0,239.5500030517578,236.22000122070312,236.4600067138672,233.56301879882807,GS,"Noteworthy Tuesday Option Activity: NUE, GS, MAS",1,0.52048045
2020-02-12,2119200.0,238.009994506836,241.17999267578125,237.72000122070312,238.6499938964844,235.72618103027344,GS,Does Goldman's Stock Have More Room To Grow?,0,0.5257523
2020-02-13,1461300.0,237.8500061035156,238.97000122070312,236.57000732421875,238.3500061035156,235.4298553466797,GS,7 Reasons to Own Taylor Morrison Stock ||| 3 Solar Stocks to Buy for a New Day in Solar Energy,0,0.5441897
2020-02-18,2736500.0,236.5500030517578,237.07000732421875,231.1999969482422,233.2100067138672,230.35284423828125,GS,"Should Bed Bath & Beyond Be on Deathwatch After Horrible Holidays? ||| Warren Buffett Just Sold These 4 Big Bank Stocks ||| 16 Stocks Warren Buffett Is Buying and Selling ||| Noteworthy Tuesday Option Activity: HLF, GS, MRTX",1,0.4731276
2020-02-20,3183700.0,236.4100036621093,236.8999938964844,231.25,232.72999572753903,229.8787078857422,GS,"Dow Movers: INTC, DOW ||| Validea John Neff Strategy Daily Upgrade Report - 2/20/2020 ||| Validea Peter Lynch Strategy Daily Upgrade Report - 2/20/2020 ||| Why Did Buffett Sell Shares of These 8 Stocks in the Fourth Quarter?",0,0.47355136
2020-02-21,3081600.0,230.9100036621093,231.8000030517578,228.3699951171875,230.6199951171875,227.7945556640625,GS,The Hidden Winners From Tesla's Stock Offering,0,0.5040263
2020-02-25,5343100.0,224.77999877929688,225.8699951171875,215.88999938964844,217.6100006103516,214.9439697265625,GS,Relative Strength Alert For Goldman Sachs Group,0,0.50380325
2020-02-26,4171100.0,218.6999969482422,220.0,214.759994506836,215.77999877929688,213.1363677978516,GS,"Can Morgan Stanley's Institutional Securities Revenue Cross $20 Billion In 2020? ||| Is Bank of America Stock Undervalued? ||| Noteworthy Wednesday Option Activity: CME, GS, NCLH ||| Investing Fundamentals Best Practices ||| Ex-Dividend Reminder: Flagstar Bancorp, M & T Bank and Goldman Sachs",0,0.48078126
2020-02-27,5845900.0,210.4900054931641,213.47999572753903,205.3699951171875,205.69000244140625,203.1699981689453,GS,Goldman Sachs Group Breaks Below 200-Day Moving Average - Notable for GS ||| 2 Top Bank Stocks to Buy Right Now,0,0.5000863
2020-02-28,6740700.0,199.08999633789065,202.25,194.8500061035156,200.7700042724609,199.5227966308593,GS,"Goldman Sachs Group's Preferred Stock, Series A Shares Cross 4.5% Yield Mark ||| June 2021 Options Now Available For Goldman Sachs Group ||| Dow Jones Today: Still Bad, But Hope Emerges",1,0.46831927
2020-03-03,5677200.0,209.0,211.7899932861328,202.1199951171875,203.42999267578125,202.166259765625,GS,"3 Dead-Cat Bounce Stocks to Sell ||| UDOW, AAPL, GS, UTX: Large Inflows Detected at ETF",1,0.5050647
2020-03-04,3520400.0,205.83999633789065,208.9199981689453,202.6999969482422,208.7400054931641,207.4432830810547,GS,"Noteworthy Wednesday Option Activity: CPB, GS, MGM",0,0.5189928
2020-03-05,4151500.0,201.3300018310547,203.47000122070312,196.9499969482422,198.7899932861328,197.5550842285156,GS,3 Dividend Stocks to Ride out the Market Volatility,0,0.51886016
2020-03-09,6443000.0,173.5800018310547,179.25,170.16000366210938,172.80999755859375,171.73648071289062,GS,"Wells Fargo Stock Now Sits at Multi-Year Support Levels ||| Goldman Sachs Group's Preferred Stock, Series C Shares Cross 4.5% Yield Mark ||| Why Goldman Sachs, Charles Schwab, and TD Ameritrade Stocks Are Plunging (Again) ||| Dow Jones Today: Another Black Monday as 7 Dow Stocks Post Double-Digit Losses",1,0.48752236
2020-03-10,6803900.0,181.6199951171875,185.3999938964844,173.2899932861328,184.3500061035156,183.20480346679688,GS,"Dow Movers: VZ, CVX ||| Monday May Have Been Warren Buffett's Worst Day Ever",0,0.48148447
2020-03-11,5314000.0,178.47999572753906,180.7700042724609,170.97000122070312,171.88999938964844,170.82220458984375,GS,ProShares UltraPro Dow30 Experiences Big Inflow,0,0.49998853
2020-03-12,8357700.0,160.0,166.75,150.0,150.67999267578125,149.74395751953125,GS,"The Dow Just Had Its Biggest Drop Since 1987: Here's Why ||| Noteworthy Thursday Option Activity: MGM, VAC, GS ||| Warren Buffett's 4 Rules for Investing in a Bear Market",1,0.49117234
2020-03-13,6368400.0,162.82000732421875,177.55999755859375,152.35000610351562,177.1699981689453,176.06939697265625,GS,Dow Jones Today: Stocks Rally as Coronavirus National Emergency Looms,0,0.52639455
2020-03-16,6888000.0,150.22999572753906,169.5399932861328,150.0,154.66000366210938,153.69923400878906,GS,JPMorgan And Other Major Banks Suspend Share Buybacks Amid Coronavirus Pandemic ||| Dow Jones Today: Terrible Teens as 6 Dow Stocks Slide 13% or More ||| Banks Band Together in Stock Buyback Freeze,1,0.5010856
2020-03-17,6876300.0,157.0,166.74000549316406,150.0,158.6699981689453,157.684326171875,GS,"JPMorgan Chase Allowing, Encouraging All Employees to Work From Home ||| Know Your Investing Time Horizon",0,0.49628937
2020-03-18,9543200.0,150.0,155.97000122070312,135.41000366210938,140.02000427246094,139.15017700195312,GS,Why Shares of Alcoa Plunged 24.7% Today,1,0.5102551
2020-03-19,6548200.0,137.3800048828125,152.49000549316406,130.85000610351562,149.49000549316406,148.5613555908203,GS,Market Volatility: Fools Answer Your Questions ||| 3 Bank Stocks to Trade After The Pandemic Crash ||| Bank of America Warns a Recession Has Already Hit ||| 2 Stocks I've Bought During the Coronavirus Market Crash,0,0.4993467
2020-03-20,7561300.0,148.99000549316406,149.19000244140625,138.2899932861328,138.41000366210938,137.55018615722656,GS,"Dow Jones Today: Small Stimulus, Big Shutdowns Drag Stocks Lower ||| Noteworthy Friday Option Activity: SQ, GS, AVGO ||| Unemployment Claims Expected to Hit Record Numbers Next Week",0,0.50118566
2020-03-23,5472600.0,136.02999877929688,141.94000244140625,133.25999450683594,134.97000122070312,134.1315460205078,GS,"Goldman Sachs CEO David Solomon Compensation Rises To $27.5 Mln In 2019 ||| Financial Sector Update for 03/23/2020: WFC, GS, BHLB, JPM, BAC, C, USB",1,0.47921354
2020-03-24,6647400.0,144.32000732421875,153.89999389648438,143.6300048828125,153.60000610351562,152.6458282470703,GS,"Why a Dividend Cut Can Be a Good Sign ||| Small Businesses Hit Hard by Coronavirus Crisis, Survey Finds",1,0.50068635
2020-03-25,8587800.0,154.60000610351562,162.2100067138672,145.32000732421875,155.1300048828125,154.16632080078125,GS,"Dividends, Banking, and REITs: Your Coronavirus Stock Market Crash Questions Answered ||| 5 Bank Stocks to Buy Now Because This Isn’t 2008 Again ||| Which Companies Will Emerge Stronger",1,0.50509864
2020-03-26,6762200.0,156.3699951171875,167.66000366210938,154.30999755859375,165.7899932861328,164.7600860595703,GS,Why Exxon Mobil Stock Resembles a Tobacco Play Now,0,0.48230323
2020-03-27,4186700.0,159.0800018310547,163.72999572753906,157.0,158.33999633789062,157.3563690185547,GS,ViacomCBS Floats $2.5 Billion in Debt Securities ||| Thinking of Investing Your Stimulus Check? Do These 3 Things First,1,0.5002692
2020-03-30,4152800.0,158.52000427246094,160.42999267578125,153.17999267578125,159.6199951171875,158.62841796875,GS,Dow Analyst Moves: GS,0,0.512465
2020-04-01,4689100.0,146.10000610351562,149.57000732421875,145.0,145.2899932861328,144.38743591308594,GS,"Dow Jones Today: No April Fool’s Joke, Stocks Sink to Start New Quarter",1,0.5038019
2020-04-02,4446900.0,143.02000427246094,150.4499969482422,141.6699981689453,149.92999267578125,148.9986114501953,GS,Apple Card and Goldman Sachs Allows Customers to Defer Payments for April Amid COVID-19 ||| Implied FTA Analyst Target Price: $56,0,0.49441752
2020-04-03,2801600.0,149.1999969482422,150.9199981689453,145.22999572753906,146.92999267578125,146.01724243164062,GS,Why Immunomedics Shares Crashed 13.5% Today ||| S&P 500 Companies Have Reduced Share Buybacks 25% From Last Year,1,0.5071866
2020-04-06,4689400.0,155.47000122070312,158.92999267578125,153.77000427246094,158.22999572753906,157.24705505371094,GS,"U.S. Banks Defend Dividend Payments During Pandemic: FT ||| U.S. banks to defend dividend payments in stress tests -FT ||| 3 Dirt-Cheap Bank Stocks to Keep an Eye On During the Coronavirus Downturn ||| BUZZ-U.S. STOCKS ON THE MOVE-Carnival Corp, Capri Holdings, Kohl's, Immunomedics ||| Here's Why JPMorgan Chase, Bank of America, and Other Bank Stocks Are Rising Today ||| BUZZ-U.S. STOCKS ON THE MOVE-Gilead Sciences, Wayfair, Immunomedics, Akers Bioscience ||| BUZZ-U.S. STOCKS ON THE MOVE-Kohl's, Carnival Corp, Akers Bioscience, Immunomedics ||| BUZZ-U.S. STOCKS ON THE MOVE-Borr Drillng, Millendo Therapeutics, Menlo Therapeutics, Immunomedics Inc ||| Futures jump on hopes of slowdown in coronavirus cases ||| Is Goldman Sachs On the Right Course? ||| Coronavirus slowdown hopes set to boost Wall Street ||| BUZZ-U.S. STOCKS ON THE MOVE-Crescent Point Energy, Millendo Therapeutics, Menlo Therapeutics",1,0.5026057
2020-04-07,4953500.0,166.0,169.13999938964844,162.4499969482422,166.02000427246094,164.98866271972656,GS,"White House to hold call with banks as hundreds struggle to access small business loans ||| BUZZ-U.S. STOCKS ON THE MOVE-Activision Blizzard, Gilead Sciences, Royal Caribbean, Kohl's ||| Goldman Sachs must face class action over conflicts of interest, risky mortgages ||| BUZZ-U.S. STOCKS ON THE MOVE-Royal Caribbean, Kohl's, Gilead Sciences, Electronic Arts ||| BUZZ-U.S. STOCKS ON THE MOVE-Roadrunner Transportation, Gannett Co, Liminal BioSciences",1,0.5009044
2020-04-08,5194800.0,168.5500030517578,178.10000610351562,168.5500030517578,176.9600067138672,175.8607177734375,GS,"EXPLAINER-Do I get more time to pay my credit-card bill? ||| Why Goldman Sachs, E*Trade, and TD Ameritrade Stocks Plunged as Much as 25% in March",1,0.50024325
2020-04-09,6449900.0,180.5800018310547,187.3300018310547,179.77000427246094,184.259994506836,183.1153564453125,GS,"Notable Thursday Option Activity: GS, FB, IRM ||| 5 Wall Street Bank Stocks Surging on Fed Stimulus ||| Stock Alert: Goldman Sachs Rises 5% ||| 3 Big Stock Charts for Thursday: Goldman Sachs, FedEx, and Biogen ||| 10 Things You Didn't Know About Warren Buffett's Company, Berkshire Hathaway",0,0.4753419
2020-04-13,4774300.0,183.8500061035156,184.97000122070312,179.1300048828125,179.17999267578125,178.06690979003906,GS,How COVID-19 Is Impacting Traditional and Digital Businesses ||| KB Financial Group acquires Prudential's S.Korean unit for $1.89 bln ||| KB Financial Group acquires Prudential Financial's S.Korean unit for $1.89 bln ||| Dow Jones Today: Stocks Decline Anticipating Q1 Earnings ||| Stock Alert: Goldman Sachs Edges Down ||| PREVIEW-Trading gains for big U.S. banks may not last past 1st quarter,0,0.5050363
2020-04-14,4149600.0,182.3500061035156,183.3800048828125,174.5399932861328,178.22999572753906,177.12281799316406,GS,"Wells Fargo Offers Great Value With Its 6.8% Dividend Yield ||| EXCLUSIVE-Stay off Zoom and Google Hangouts, Standard Chartered chief tells staff ||| Stock Market Wrap-Up: Will Banks Miss the Coronavirus Recovery? ||| 5 Top Stock Trades for Wednesday: BAC, GS, JNJ, SPCE, SHOP ||| Dow Jones Today: Earnings Split, but Signs of Virus Easing Propel Stocks ||| BUZZ-U.S. STOCKS ON THE MOVE-Wall St banks, U.S. airlines, casinos, Tesla, J&J, Apple, Roku ||| 7 Bank Stocks to Watch as Earnings Season Heats Up ||| BUZZ-U.S. STOCKS ON THE MOVE-U.S. airlines, banks, General Electric, Tesla, J&J ||| Bad Times Tend to Be Good Times for Berkshire Hathaway Stock ||| EARNINGS-JPMorgan profit plunges on coronavirus loan provisions ||| EARNINGS-JPMorgan profit plunges on coronavirus loan provisions ||| Two big U.S. banks offer glum outlook for coronavirus recession",1,0.5025722
2020-04-15,6042700.0,170.6300048828125,181.67999267578125,169.14999389648438,178.52000427246094,177.4110107421875,GS,"Wall Street tumbles on gloomy economic data, bank earnings ||| GLOBAL MARKETS-Stocks slide as dire economic outlook weighs ||| 4 Top Stock Trades for Thursday: GS, C, ROKU, UNH ||| Wall Street falls on dour economic data, corporate earnings ||| Wall Street falls on dour economic data, corporate earnings ||| Warren Buffett's Moves and Big News for Fintechs ||| BUZZ-U.S. STOCKS ON THE MOVE-U.S. oil stocks, retailers, restaurants, BofA, J.C. Penny, IBM, Gilead, LyondellBasell ||| Dow Jones News: Goldman Sachs Builds Reserves; UnitedHealth Keeps Guidance ||| BUZZ-U.S. STOCKS ON THE MOVE-Banks, Aphria, Tesla, UnitedHealth, J.C. Penney ||| BUZZ-U.S. STOCKS ON THE MOVE-Netflix, Wells Fargo, Tesla, BofA, J.C. Penny, Noble Energy ||| Wall Street set to slump after gloomy economic data, bank earnings ||| Goldman Sachs Q1 Profit Nearly Halves ||| US STOCKS-Oil slide dents futures as bank earnings get underway ||| Goldman Sachs profit halves on higher loan loss provisions, investment hit ||| US STOCKS-Oil slide dents futures ahead of bank earnings ||| U.S. returns another $300 mln of recovered 1MDB funds to Malaysia ||| Goldman Sachs Earnings Aren't as Bad as You Might Think",0,0.4746535
2020-04-16,4662200.0,177.22000122070312,178.44000244140625,172.38999938964844,177.0399932861328,175.94020080566406,GS,"Big 6 Banks' Earnings Are In: What The Results Tell Investors ||| Notable Thursday Option Activity: BHVN, GS, DIS ||| Australian companies race to raise capital, share placements top $6 bln ||| Fed's Kashkari says major U.S. banks should raise $200 bln in capital- FT ||| Verizon to buy Zoom-rival BlueJeans for less than $500 mln ||| Dow Movers: BA, UNH",1,0.5146415
2020-04-17,5426700.0,183.4900054931641,185.27999877929688,178.2899932861328,183.4900054931641,182.3501434326172,GS,"EXCLUSIVE-Norwegian Cruise taps Goldman Sachs to explore stake sale -sources ||| BUZZ-U.S. STOCKS ON THE MOVE-Netflix, Cutera, Moderna ||| U.S. banks say cost cuts mostly out of sight during coronavirus ||| NYSE and Nasdaq challenger MEMX delays launch due to coronavirus crisis ||| BUZZ-U.S. STOCKS ON THE MOVE-Schlumberger, Biohaven Pharmaceutical, Spirit AeroSystems ||| BUZZ-U.S. STOCKS ON THE MOVE-Schlumberger, Banks, Spirit AeroSystems, State Street ||| BUZZ-U.S. STOCKS ON THE MOVE-Pulmatrix, Cutera, Moderna, Spirit AeroSystems ||| Expedia Chairman Says Company to Cut Ad Spending by at Least 80%",0,0.49952003
2020-04-20,4674800.0,179.6999969482422,186.32000732421875,178.02000427246094,180.3999938964844,179.27932739257812,GS,"Private Equity Is Reportedly Circling Norwegian Cruise Lines ||| Goldman Sachs looks for good borrowers, depositors in the cracks of coronavirus ||| Goldman poaches Bank of America's Fortunati to boost industrials ranks -sources ||| Medtronic Shares Ventilator Specs Online ||| Should You Get Grocery Stocks Now? ||| Citi’s Earnings Were Weak, But the Valuation of C Stock Is Attractive",0,0.49074584
2020-04-21,3819000.0,175.44000244140625,179.1999969482422,173.66000366210938,173.80999755859375,172.7302703857422,GS,"Lawsuit claims 10 big banks rigged market for 'odd-lot' U.S. corporate bonds ||| BUZZ-U.S. STOCKS ON THE MOVE-Energous, Hertz Global, PAVmed ||| LongHorn Steakhouse Parent Darden Restaurants Announces Public Offering of 7.8 Million Shares",1,0.51972705
2020-04-22,2316600.0,177.5,178.17999267578125,174.47000122070312,175.97999572753906,174.8867950439453,GS,"How Banks Have Prepared for a Slowdown ||| BUZZ-U.S. STOCKS ON THE MOVE-Snap, Peck Company, VBI Vaccines ||| Has Goldman Sachs Rallied Too Far Too Fast?",0,0.4927644
2020-04-23,2013300.0,177.0,179.07000732421875,174.4499969482422,175.0500030517578,173.9625701904297,GS,June 5th Options Now Available For Goldman Sachs Group,1,0.5103854
2020-04-24,2024400.0,177.0,177.9499969482422,173.49000549316406,177.0,175.90045166015625,GS,U.S. SEC names former Goldman Sachs exec as adviser to coronavirus taskforce ||| Wall Street curtails corporate lending in Europe to put America first -sources ||| Wall Street backs off European corporate lending to focus on America - sources ||| Goldman CEO Solomon faces pay scrub after ISS urges vote 'against',1,0.5008471
2020-04-27,2743100.0,179.10000610351562,184.25,178.72000122070312,183.5399932861328,182.3998260498047,GS,"JPMorgan poaches Citi's Torun to build up senior Paris ranks -sources ||| BUZZ-U.S. STOCKS ON THE MOVE-Regeneron, Zoom Video, U.S. oil companies, Apple, U.S. insurers ||| BUZZ-U.S. STOCKS ON THE MOVE-Tanker operators, oil and gas companies, Caterpillar ||| BUZZ-U.S. STOCKS ON THE MOVE-Southern Co, Apple, American Express, Zoom Video, U.S. banks ||| Wall St set to rise as U.S. starts to reopen, Boeing gains",1,0.4902964
2020-04-28,3344700.0,189.1600036621093,190.4199981689453,184.8699951171875,187.009994506836,185.8482666015625,GS,JPMorgan poaches Citi's Torun to build up senior Paris ranks,1,0.52648824
2020-04-29,3086300.0,192.6100006103516,193.72000122070312,189.57000732421875,190.02999877929688,188.8495178222656,GS,"Goldman Sachs puts premium on sustainable investing with new global markets council ||| Goldman Sachs puts premium on sustainable investing with new global markets council ||| Wall Street uniform to get a new accessory - the face mask ||| Forget Goldman Sachs, SVB Financial Is a Better Bank Stock",0,0.49180886
2020-04-30,2690700.0,186.0,187.5500030517578,182.8999938964844,183.4199981689453,182.28057861328125,GS,Goldman Sachs Predicts Another $1 Trillion in Federal Fiscal Aid Is Coming ||| Buffett likely to finally address pandemic at Berkshire Hathaway meeting ||| Goldman Sachs shareholders back executive pay packages ||| Amazon Stock is Rising in the Eye of the Storm Ahead of Thursday’s Report,0,0.48524767
2020-05-01,2650200.0,179.0,179.60000610351562,176.64999389648438,177.10000610351562,175.99984741210938,GS,"BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Medigus, Aemetis ||| BUZZ-U.S. STOCKS ON THE MOVE-Medigus Ltd, Western Digital Corp, Aemetis Inc ||| Shell Shocked The Market With A Dividend Cut. Goldman Sachs Suggests A Radical Change for The Oil Majors.",0,0.47424638
2020-05-04,2990100.0,175.0,176.30999755859375,171.72000122070312,176.02999877929688,174.9364776611328,GS,"Noteworthy Monday Option Activity: MYGN, GS, BGS ||| BUZZ-U.S. STOCKS ON THE MOVE-Airlines, banks, insurers, oil stocks ||| BUZZ-U.S. STOCKS ON THE MOVE-Airlines, banks, insurers, PG&E ||| Analysts Predict 13% Upside For The Holdings of OEF ||| BUZZ-U.S. STOCKS ON THE MOVE-Airlines, banks, oil stocks, Co-Diagnostics",1,0.49800742
2020-05-05,3272600.0,179.10000610351562,182.6000061035156,178.13999938964844,178.3000030517578,177.1923828125,GS,"BUZZ-U.S. STOCKS ON THE MOVE-Oil and gas stocks, banks, Tesla, tankers ||| Goldman Sachs CEO: return to work will be gradual -memo ||| Goldman Sachs CEO says staff back at offices in Asia, but not New York, London ||| BUZZ-U.S. STOCKS ON THE MOVE-Tesla, banks, Pfizer, Regeneron ||| Algorithm usage rises in choppy currency markets - JPMorgan report ||| BUZZ-U.S. STOCKS ON THE MOVE-Tesla, banks, Pfizer, Regeneron",0,0.4850029
2020-05-06,2408700.0,179.67999267578125,181.1999969482422,175.2100067138672,176.9199981689453,175.82095336914062,GS,"Goldman Sachs looks to buy private company holdings from Invesco - Sky News ||| BUZZ-U.S. STOCKS ON THE MOVE-Disney, CVS, CPS Technologies ||| Stock Alert: Goldman Sachs",1,0.4856047
2020-05-07,2480100.0,179.17999267578125,183.3800048828125,179.17999267578125,182.32000732421875,181.1874084472656,GS,Beijing opens financial markets further amid tension with Washington ||| ANALYSIS-Coronavirus crisis threatens Deutsche Bank's 'bad bank' wind-down,1,0.5115861
2020-05-08,2282600.0,185.02999877929688,185.9100036621093,182.7400054931641,185.38999938964844,184.23834228515625,GS,"BUZZ-U.S. STOCKS ON THE MOVE-Banks, Boeing, Uber, Disney ||| BUZZ-U.S. STOCKS ON THE MOVE-Banks, Uber, Roku, Sorrento Therapeutics ||| ANALYSIS-Coronavirus crisis threatens Deutsche Bank's 'bad bank' wind-down",0,0.48122743
2020-05-11,2212200.0,182.5399932861328,184.8500061035156,181.259994506836,183.1600036621093,182.02218627929688,GS,"As COVID-19 Rocks Markets, Digital Health Start-Ups Rake In Cash ||| Why Goldman Sachs Stock Gained 19% Last Month ||| Market Experts Say Stocks Are Too Expensive. Here's How to Know if They Are. ||| BUZZ-U.S. STOCKS ON THE MOVE-Cellect Biotechnology, Quidel, AMC Entertainment",0,0.4832033
2020-05-12,3549200.0,183.88999938964844,184.3000030517578,176.75,177.2100067138672,176.10916137695312,GS,"Dow Jones Today: Dr. Fauci Says Slow Down Reopening, Stocks Slip ||| Investment banks cut jobs despite coronavirus trading surge -Coalition ||| Notable Tuesday Option Activity: BLK, GS, ILMN ||| SPDR Dow Jones Industrial Average ETF Trust Experiences Big Inflow ||| Santander hires HSBC executive as regional head of Europe",0,0.4938222
2020-05-13,3445300.0,175.66000366210938,176.8800048828125,170.75999450683594,171.8000030517578,170.73275756835938,GS,"Goldman Sachs CFO calls exposure to energy, hotel, airline firms manageable ||| 3 Market Indicators Warning Us to Sell Stocks Today ||| Goldman Sachs's CFO calls exposure to energy, hotels, airlines sectors manageable ||| BUZZ-U.S. STOCKS ON THE MOVE-Cornerstone Building, Aerpio Pharma, J.C. Penney ||| Wall Street bonuses set to fall by as much as 30% in 2020 -report",1,0.48873243
2020-05-14,4176700.0,169.0399932861328,174.77999877929688,165.36000061035156,174.4499969482422,173.3662872314453,GS,Awkward greetings and long queues as Hong Kong's financiers return to work ||| Goldman Sachs Buying Financial Services Boutique Folio Financial ||| Bank stocks push Wall St higher amid lingering economic worries ||| Goldman Sachs to buy boutique wealth management custodian Folio ||| Is Bank of America Stock a Buy? ||| ANALYSIS-Coronavirus crisis a window of opportunity for bankers to the rich,0,0.5025905
2020-05-15,2867800.0,173.47999572753906,174.08999633789062,170.5800018310547,171.8699951171875,170.8023223876953,GS,"U.S. funds rush to tech companies and battered energy stocks in Q1 ||| Britain, EU dig in their heels in trade talks ||| Dow Jones Today: Another Data Defying Day As Retail Spend Plummeted ||| Buffett's Berkshire slashes Goldman stake; exits Phillips 66, Travelers ||| INTERVIEW-Goldman pushes ahead with 1,460 India hires, internships ||| Return of the vol: FX trading boosts banks' Q1 revenues ||| Buffett's Berkshire slashes Goldman stake; exits Phillips 66, Travelers",1,0.48004386
2020-05-18,4512600.0,177.7100067138672,183.1000061035156,175.24000549316406,181.8800048828125,180.75015258789065,GS,"3 Big Revelations from Warren Buffett's Latest Investing Moves ||| Berkshire Slashes Stake In Goldman; Trims JPMorgan; Exits Phillips 66, Travelers ||| Warren Buffett Sells Majority Stake In Goldman Sachs ||| BUZZ-U.S. STOCKS ON THE MOVE-Centric Brands, Fulgent Genetics, Moderna ||| BUZZ-U.S. STOCKS ON THE MOVE-Oasis Midstream, L Brands, Diffusion Pharma ||| India to see annualised contraction of 45% in April to June - Goldman ||| BUZZ-U.S. STOCKS ON THE MOVE-Centric Brands, Fulgent Genetics, Moderna ||| FOCUS-Tech firms sweeten deals for U.S. banks cutting costs in crisis",0,0.5163065
2020-05-19,2210500.0,180.5599975585937,182.19000244140625,177.72000122070312,177.8300018310547,176.7252960205078,GS,"Noteworthy Tuesday Option Activity: MRNA, VRNT, GS ||| BUZZ-U.S. STOCKS ON THE MOVE-Xenetic Biosciences, Dycom, Dynavax Technologies ||| Warren Buffett Just Dumped Goldman Sachs -- Here's Why I'm Not Selling ||| Warren Buffett's 3 Most Surprising Moves in Q1",1,0.45971945
2020-05-20,2599900.0,180.9499969482422,183.8300018310547,180.3000030517578,181.44000244140625,180.31288146972656,GS,"Stifel taps Nasdaq to run new 'dark pool' trading platform ||| Notable ETF Outflow Detected - DIA, GS, DIS, TRV",0,0.4865425
2020-05-21,2153500.0,180.1999969482422,181.1699981689453,177.67999267578125,180.10000610351562,178.981201171875,GS,"Why Chapter 11 Is Not the End of Line ||| A Closer Look at Soaring Fintech Bill.com ||| Wow! Buffett Sold 19 Stocks in the First Quarter ||| BUZZ-U.S. STOCKS ON THE MOVE-Akorn, L Brands, Aurora Cannabis",0,0.46753943
2020-05-22,2176400.0,180.02999877929688,180.63999938964844,178.05999755859375,179.92999267578125,178.81224060058594,GS,6 Banks PNC Might Want to Buy ||| 3 Stocks the World's Best Investors Just Bought ||| Banks pursue Luckin Coffee chairman's assets after loan default,1,0.51725364
2020-05-26,5971200.0,185.6300048828125,197.1000061035156,185.22000122070312,196.0599975585937,194.8420562744141,GS,"3 Reasons Why Warren Buffett Is Fearful in Today's Market ||| 1 Thing Warren Buffett Didn't Do During the Market Crash That May Surprise You ||| BUZZ-U.S. STOCKS ON THE MOVE-IZEA Worldwide, Diffusion Pharma, DouYu International ||| Goldman Sachs to Expand Its Cash Management Business ||| BUZZ-U.S. STOCKS ON THE MOVE-Alliance Data Systems, Alibaba Group, Dexcom, Can Fite Biofarma, U.S. travel firms ||| Here's Why Wells Fargo, Bank of America, and Other Big Bank Stocks Are Higher on Tuesday ||| Here's Why Wells Fargo, Bank of America, and Other Big Bank Stocks Are Higher on Tuesday ||| 4 Factors That Affect the Future of Equity Crowdfunding",1,0.5086853
2020-05-27,8182100.0,203.0,210.7100067138672,200.009994506836,209.6600036621093,208.35757446289065,GS,"Notable Wednesday Option Activity: GS, TSCO, NOW ||| Analyst Turns More Optimistic Toward Jack in the Box ||| Here's Why Wells Fargo and Other Bank Stocks Soared Wednesday ||| Bullish Two Hundred Day Moving Average Cross - GS ||| Ex-Dividend Reminder: Flagstar Bancorp, Goldman Sachs and Columbia Property Trust ||| Goldman Sachs president says bank on track to meet growth goals ||| Goldman Sachs on target to meet medium-, long-term growth goals -executive ||| BUZZ-U.S. STOCKS ON THE MOVE-Mersana, Moderna, StoneCo",0,0.49407753
2020-05-28,4886100.0,210.83999633789065,211.3099975585937,201.2100067138672,201.22000122070312,199.97000122070312,GS,"U.S. judge orders 15 banks to face big investors' currency rigging lawsuit ||| Citigroup looks to return some staff to NY headquarters over the summer - Bloomberg News ||| Morgan Stanley not given advisory role on Aramco pipeline sale - sources ||| FXI, IAI: Big ETF Outflows ||| Stock Alert: Goldman Sachs Drops 2% ||| Citigroup looks to reopen NY headquarters to some staff in July - Bloomberg News ||| Abu Dhabi's Mubadala in talks on $1 bln stake in Reliance's Jio Platforms -sources ||| Payments startup Marqeta raises $150 million, hits $4.3 billion valuation",0,0.48057458
2020-05-29,3824500.0,197.22999572753903,200.9199981689453,194.6499938964844,196.4900054931641,196.4900054931641,GS,"DIA, GS, WMT, CAT: ETF Inflow Alert ||| BUZZ-U.S. STOCKS ON THE MOVE-Phio Pharma, Sonoma Pharma, Adaptimmune ||| Goldman Sachs Delaying Launch of Robo-Advisor ||| Fed's corporate bond facility bought 15 ETFs in first days of operations ||| Morgan Stanley not given advisory role on Aramco pipeline sale - sources",1,0.49741834
2020-06-01,2230800.0,197.3099975585937,201.7700042724609,195.1199951171875,199.92999267578125,199.92999267578125,GS,"Near Its All-Time Low, Is Norwegian Cruise Line Stock a Buy? ||| StoneCo Soars on Earnings; Real Estate Is Making a Comeback ||| Goldman Sachs Shorts the U.S. Dollar as World Economies Restart ||| FOCUS-Wall Street and Fed fly blind as coronavirus upends annual stress tests",1,0.4870317
2020-06-02,4128700.0,203.7700042724609,206.5,201.32000732421875,204.13999938964844,204.13999938964844,GS,"Goldman Sachs commits to new central Paris headquarters ||| Should You Sell Abbott Laboratories Stock? ||| Bank of America pledges $1 bln to address racial, economic inequality ||| Japan's Hoshino aims to revive virus-hobbled hotels through new investment fund ||| StartEngine Review: ‘Mr. Wonderful’ Approves This Crowdfunding Platform",1,0.5168317
2020-06-03,3471900.0,208.4900054931641,211.92999267578125,206.42999267578125,210.57000732421875,210.57000732421875,GS,"Is Bank of America Stock Finally a Buy for Investors? ||| Axos Financial: A Deep Dive Into the Innovative Online Bank ||| Goldman Sachs Group's Preferred Stock, Series N Yield Pushes Past 6% ||| Make This Biotech Play if You Like Co-Diagnostics’ Chances",1,0.49796396
2020-06-04,3522300.0,208.7899932861328,214.9900054931641,207.9600067138672,214.82000732421875,214.82000732421875,GS,"BUZZ-U.S. STOCKS ON THE MOVE- Cinedigm, Ebay Inc, Anavex ||| Goldman Sachs executive's email making plea for racial equality goes viral at firm ||| Buffett's Portfolio Hasn't Done This in 4 Years, Until Now ||| Disrupter Alert: These 2 Companies Are Changing Manufacturing",1,0.52191335
2020-06-05,4737600.0,222.0,222.97999572753903,217.6600036621093,217.9199981689453,217.9199981689453,GS,Is PNC Financial Services Group a Buy? ||| Chinese online tutor Zuoyebang seeks $600-$800mln at $6.5bln valuation -sources ||| Is Goldman Sachs a Buy?,1,0.49438033
2020-06-08,3260300.0,220.0200042724609,222.259994506836,218.2400054931641,220.8099975585937,220.8099975585937,GS,"EXCLUSIVE-Malaysia: Even $3 billion not enough to settle 1MDB case with Goldman ||| EXCLUSIVE-Malaysia: Even $3 billion not enough to settle 1MDB case with Goldman ||| 7 Ways to Invest to Support Racial Justice ||| Business analytics firm Dun & Bradstreet close to launching $1 bln IPO -sources ||| SeedInvest Review: Pioneer in Equity Crowdfunding ||| DIA, GS, BA, WMT: ETF Inflow Alert ||| Apple to Roll Out Installment Plans for Its Devices ||| Financial Sector Update for 06/08/2020: EFC, QFIN, GS, XLF, FAS, FAZ",0,0.49638626
2020-06-09,2478400.0,215.7400054931641,220.0200042724609,215.1600036621093,218.1000061035156,218.1000061035156,GS,Business analytics firm Dun & Bradstreet launches U.S. IPO ||| EXCLUSIVE-Savings surge forces Goldman to shut Marcus to new UK clients ||| EXCLUSIVE-Savings surge forces Goldman to shut Marcus to new UK clients ||| Goldman Sachs Group Reaches Analyst Target Price,0,0.508018
2020-06-10,3091200.0,217.38999938964844,219.8500061035156,212.8000030517578,213.5200042724609,213.5200042724609,GS,"Amazon, Goldman Sachs Team up to Provide Credit Lines to Small Businesses ||| ANALYSIS-A casino or stock market? Retail buying frenzy goes wild ||| Goldman Sachs employees to start returning to U.S. offices from June 22 ||| EXCLUSIVE-Savings surge forces Goldman to shut Marcus to new UK clients ||| Goldman traders gain $1 bln in commodities revenue after oil slump ||| Goldman Sachs forms fund to address racial injustice",0,0.49115682
2020-06-11,4923400.0,204.6999969482422,206.8999938964844,194.0200042724609,194.1300048828125,194.1300048828125,GS,"U.S. regulator to report on climate risks to markets in July ||| Noteworthy Thursday Option Activity: GS, CI, NKE ||| Report: Goldman Sachs Partnering with Amazon For New Small Business Credit Line Program ||| PayPal pledges over $500 mln to support minority-owned U.S. businesses ||| Financial Sector Update for 06/11/2020: CIM, GS, NLY, XLF, FAS, FAZ ||| ANALYSIS-A casino or stock market? Retail buying frenzy goes wild",1,0.5178715
2020-06-12,3379400.0,200.6199951171875,202.94000244140625,196.2100067138672,201.77999877929688,201.77999877929688,GS,"Why Tesla Stock Fell on Friday ||| BUZZ-U.S. STOCKS ON THE MOVE-Party City, Centene Corp, Hertz Global ||| Why General Motors Stock Is Up Today",1,0.48753488
2020-06-15,3467400.0,195.72999572753903,206.9900054931641,195.1499938964844,206.3099975585937,206.3099975585937,GS,"EXCLUSIVE-Mexico's oil hedge to be pricier, but government likely doing it anyway ||| Goldman Sachs Adds $250 Mln To Its Small Business Commitment ||| JPMorgan to bring back more traders to office next week -source ||| Goldman Sachs increases COVID-19 federal aid commitment by $250 mln ||| EXCLUSIVE-Mexico's oil hedge to be pricier, but government likely doing it anyway",1,0.49018133
2020-06-16,3099100.0,214.97999572753903,214.97999572753903,203.72999572753903,209.58999633789065,209.58999633789065,GS,"Financial Sector Update for 06/16/2020: STOR,RILY,SPOK,GS,MFA ||| Financial Sector Update for 06/16/2020: RILY,SPOK,GS,MFA ||| Dow Analyst Moves: GS ||| Notable ETF Inflow Detected - DIA, GS, BA, CAT",0,0.47555533
2020-06-18,2051700.0,203.9900054931641,207.259994506836,202.6699981689453,203.83999633789065,203.83999633789065,GS,The Day-Trading Boom and Why It's So Concerning ||| Thyssenkrupp's elevator division set for multi-billion euro debt issue - sources,0,0.48013824
2020-06-19,4962400.0,207.0500030517578,207.4199981689453,200.97000122070312,201.6300048828125,201.6300048828125,GS,"Dow Movers: AXP, DOW ||| Bank of America Stock Is Dirt Cheap But Lacking Catalysts ||| Remark Has the Tech to Combat Covid-19, But Is It a Buy?",1,0.47859022
2020-06-22,1806900.0,200.9900054931641,204.5800018310547,200.0,203.4199981689453,203.4199981689453,GS,Lemonade IPO: It’s All About AI (Artificial Intelligence) ||| INSIGHT-Pandemic propels old-school bond traders towards an electronic future,1,0.5295361
2020-06-23,2451800.0,206.5,207.509994506836,203.63999938964844,204.77999877929688,204.77999877929688,GS,How COVID-19 Has Changed Cybersecurity ||| Why You Must Not Ignore These Pet Retailers ||| Goldman Sachs Group Breaks Above 200-Day Moving Average - Bullish for GS,0,0.48606506
2020-06-24,2756700.0,202.33999633789065,202.6100006103516,197.3800048828125,198.0200042724609,198.0200042724609,GS,"Goldman Sachs CEO says economic recovery will be rapid at first then challenged ||| Why NIO Stock Is Dropping Today ||| DIA, GS, BA, CAT: ETF Inflow Alert ||| Wall Street set for lower open as coronavirus cases flare up ||| Wall Street futures fall as U.S. states rush to contain virus flare-ups",1,0.49296114
2020-06-25,3466500.0,197.8600006103516,207.38999938964844,197.6100006103516,207.1000061035156,207.1000061035156,GS,"Federal Reserve caps bank dividend payments after pandemic analysis ||| August 7th Options Now Available For Goldman Sachs Group ||| Either Analysts Got The Components Wrong or The Dow Headed 10% Higher ||| Get Paid While You Wait: 3 Top Dividend Stocks in the Financial Sector ||| Frustration, fear and family: lockdowns test investment bankers ||| Federal Reserve to cap bank dividend payments following pandemic analysis ||| 5 Bank Stocks to Buy Because This Isn’t the Financial Crisis Again",0,0.5022919
2020-06-26,9530700.0,199.0,200.2400054931641,188.509994506836,189.19000244140625,189.19000244140625,GS,"Friday Sector Laggards: Financial, Energy ||| Noteworthy Friday Option Activity: GS, GPS, ULTA ||| Dow Movers: GS, WMT ||| Big Bank Stress Is Crushing the Stock Market Today ||| U.S. bank shares drop as Fed sets limits following stress tests ||| BUZZ-U.S. STOCKS ON THE MOVE-Gap Inc, Asta Funding, Corelogic ||| U.S. stock futures muted after Nike's surprise loss, Fed's pandemic analysis",1,0.5222053
2020-06-29,3736000.0,191.3800048828125,193.8999938964844,188.6600036621093,193.47000122070312,193.47000122070312,GS,Chinese online tutor Zuoyebang raises $750 mln in fresh round ||| Everything You Need To Know About Zocdoc ||| Wells Fargo To Cut Dividend ||| Is Square the Best Fintech Stock? ||| What is Your (New) Ceiling for Nio Stock? ||| Chinese online tutor Zuoyebang raises $750 mln in fresh round,1,0.49010876
2020-06-30,3102800.0,193.83999633789065,198.4100036621093,193.6199951171875,197.6199951171875,197.6199951171875,GS,"Goldman's investment bank to increase Black staff hiring, recruitment ||| UBS loses Australian equities crown to Macquarie ||| Which Major Banks Will Maintain Their Dividends? ||| Dow Jones Clings to Gain as Boeing Loses Orders, Apple iPhone Shipment Estimates Cut, and Financials Maintain Dividends ||| Coronavirus strikes down global M&A as companies keep their distance ||| Unlike Its Competitors, Wells Fargo Will Cut Its Dividend in Q3 ||| Goldman Sachs says it's climbing toward Fed's capital demands ||| Etsy Stock Has Tripled Since March -- How Much Higher Can It Go?",0,0.51614195
2020-07-01,2620100.0,198.8800048828125,199.7400054931641,195.5200042724609,197.57000732421875,197.57000732421875,GS,"U.S. seeks Warhol, Monet paintings linked to 1MDB scandal ||| Dun & Bradstreet Going Public Again in Fresh IPO",0,0.49543655
2020-07-02,2698800.0,202.5,203.0,197.1300048828125,197.3999938964844,197.3999938964844,GS,"BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Xerox, U.S. banks, U.S. airlines, oil stocks, Lemonade ||| BUZZ-U.S. STOCKS ON THE MOVE-Tesla, oil stocks, U.S. banks, Lemonade ||| BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Coty, U.S. banks, U.S. airlines ||| BUZZ-U.S. STOCKS ON THE MOVE-Tesla, U.S. airlines, U.S. banks, Macy's ||| U.S. stock futures rise ahead of June jobs report ||| Wall Street set to open higher as job growth picks up pace in June",1,0.4864004
2020-07-06,3567700.0,201.33999633789065,207.7899932861328,201.1300048828125,207.3600006103516,190.25,GS,"Noteworthy Monday Option Activity: NVDA, DPZ, GS ||| Goldman Sachs Lowers Economic Outlook, Citing the Rise in COVID-19 Cases ||| Daily Markets: Market Rally Continues Despite Escalating Covid-19 Cases ||| S&P 500 Up 44 Points: Buffett Fires Berkshire's Elephant Gun, Chipotle Hits All-Time High, Goldman Sachs Bearish on Economy ||| Monday Sector Leaders: Financial, Technology & Communications",0,0.5118662
2020-07-07,2853500.0,205.5,205.7100067138672,199.19000244140625,199.3600006103516,182.9101409912109,GS,Wall Street eases after strong rally as virus cases surge ||| Wall Street struggles for direction after strong rally as virus cases surge,1,0.5286448
2020-07-08,2789700.0,199.5399932861328,203.25,199.0200042724609,202.25,185.5616455078125,GS,"KKR to take over Goldman Sachs-backed insurer Global Atlantic ||| China hires Morgan Stanley, Goldman Sachs to advise on pipeline asset transfers -sources ||| China hires Morgan Stanley, Goldman Sachs to advise on pipeline asset transfers - sources",0,0.48207065
2020-07-09,3160100.0,202.1100006103516,202.5,195.0,196.8300018310547,180.5888671875,GS,"EXCLUSIVE-Goldman Sachs-backed payments startup Marqeta prepares for IPO -sources ||| Biotech Stocks Get a Boost ||| Trading, underwriting soften profit plunge for some U.S. banks ||| Ant Group listing would be fillip for Hong Kong's flagging IPO market",1,0.49891502
2020-07-10,4414800.0,196.8699951171875,206.32000732421875,196.8300018310547,205.5599975585937,188.59852600097656,GS,"S&P 500, Dow edge higher as Gilead data offsets virus concerns ||| S&P 500 Shoots Up 33 Points: Banks, Airlines, and Cruise Line Stocks Brush Off Record COVID-19 Cases on Gilead Treatment Update ||| Wall Street gains as Gilead data offsets virus fears; Dow leads gains ||| Dow Jones Rallies Despite Possible 737 Max Order Cancellation for Boeing, Dismal Bank Earnings Expected Next Week ||| Stock Markets Open Mixed Friday as Netflix Gets Upgraded, Gilead Reports Positive Coronavirus Treatment Results ||| Wall Street climbs as Gilead data offsets virus fears; Nasdaq hits another record high close ||| Expecting Another Netflix Subscriber Growth Blowout, Analyst Hikes Price Target to $670 ||| Financials lift S&P 500, Dow despite record U.S. virus cases ||| Wall St Week Ahead-Investors await BlackRock earnings after blistering Q2 market rally",1,0.5156588
2020-07-13,4449600.0,209.0,212.97999572753903,207.0,208.8800048828125,191.64459228515625,GS,"Wall St Week Ahead-Investors await BlackRock earnings after blistering Q2 market rally ||| Notable Monday Option Activity: GS, FB, NVDA ||| Earnings Season Kicks Off Amid Pandemic as Companies Pull Guidance",1,0.5101344
2020-07-14,5202000.0,211.42999267578125,214.3000030517578,207.009994506836,214.009994506836,196.35128784179688,GS,"EARNINGS-Big U.S. banks predict more economic pain from coronavirus ||| 5 Financial Stocks to Watch Closely This Earnings Season ||| Goldman Sachs unit buys stake in Permira -sources ||| DIA, GS, BA, IBM: Large Outflows Detected at ETF ||| Wall Street banks see trading-revenue renaissance ending soon ||| Goldman Sachs Says This Simple Measure Can Save Lives and the Economy ||| U.S. stock futures rise on upbeat JPMorgan results ||| Southwest Is Waiting for the Pandemic to Be Over ||| 3 Dow Jones Stocks That Look Strong Despite Market Uncertainty",1,0.52377963
2020-07-15,12516700.0,224.3699951171875,225.2400054931641,214.69000244140625,216.8999938964844,199.00282287597656,GS,"Wall Street rallies on vaccine bets, Goldman results ||| GLOBAL MARKETS-Asian shares fall despite China GDP beat as Sino-U.S. tensions, virus fears weigh ||| GLOBAL MARKETS-Asian markets look to continue upward run on vaccine hopes ||| Major Indexes Rise on Renewed Vaccine Hopes ||| GLOBAL MARKETS-Stocks rally on vaccine hopes, crude oil gains ||| EARNINGS-Goldman profit blows past estimates on trading surge ||| Dow Jones Gains on Vaccine News; Goldman Sachs Stock Jumps on Strong Earnings, While UnitedHealth Slumps ||| Financial Sector Update for 07/15/2020: JRJC, CPTA, GS, NWS, NWSA ||| Financial Sector Update for 07/15/2020: HRB,JRJC,CPTA,GS ||| Wall Street climbs on vaccine bets, Goldman results ||| BUZZ-U.S. STOCKS ON THE MOVE-Goldman, Moderna, Gap, BNY Mellon, airlines ||| Wall St ends higher on vaccine bets, Goldman results ||| S&P 500 scales over 4-month peak on vaccine hopes, Goldman profit beat ||| Financial Sector Update for 07/15/2020: GS, USB, CPTA, XLF, FAS, FAZ ||| Wall Street rises on vaccine hopes, Goldman profit beat ||| Why You Shouldn't Dismiss PepsiCo's Online Push ||| Goldman Sachs: The Early Winner of Earnings Season ||| U.S. stock futures climb on vaccine hopes, Goldman's huge profit beat ||| Goldman Sachs Group Q2 20 Earnings Conference Call At 9:30 AM ET ||| Gold steady as U.S.-China tensions mount, stronger equities cap gains ||| U.S. stock futures gain as vaccine hopes offset U.S.-China tensions ||| Goldman Sachs Q2 Profit Beats Estimates; Net Revenues Up 41% ||| EARNINGS-Goldman Sachs profit rises on trading, underwriting boost",0,0.5168695
2020-07-16,5769600.0,213.509994506836,220.4600067138672,213.5,214.6699981689453,196.9568328857422,GS,3 Dividend Stocks to Buy for a Successful Portfolio ||| EARNINGS-Morgan Stanley profit jumps 45% on trading boom ||| Morgan Stanley profit jumps 45% on trading boom ||| Bank of America profit more than halves on pandemic woes ||| Malaysian court grants temporary freeze on $340 mln 1MDB money in UK ||| GLOBAL MARKETS-Shares fall as Sino-U.S. tensions eclipse China GDP growth,0,0.50639796
2020-07-17,3614300.0,214.8999938964844,215.1699981689453,211.25,211.4100036621093,193.96578979492188,GS,"Why Goldman Sachs Group is a Top 25 Dividend Giant (GS) ||| S&P 500 ends higher as traders weigh stimulus and virus worries ||| S&P 500 ends higher as traders weigh stimulus and virus worries ||| UBS, Morgan Stanley expected to lead Vodafone Tower IPO - sources ||| Stock Markets Close Mixed as NIO Leads Nikola, EV Stocks Lower ||| UBS, Morgan Stanley expected to lead Vodafone Tower IPO - sources ||| These 3 Bank Stocks Are Still Worth a Look ||| Strong Goldman Sachs Earnings Underscore That GS Stock Can Hit $250 ||| All Eyes Are on Bank Stocks",1,0.49638003
2020-07-20,2268700.0,210.72999572753903,213.1699981689453,210.25,211.7100067138672,194.2410888671875,GS,Goldman Sachs executives in Malaysia to discuss 1MDB - finance minister ||| How to Pick a Stock Like Warren Buffett ||| Why Peloton Interactive Stock Is Up 10% Today ||| Why Amazon Stock Jumped Monday ||| 5 Bank Stocks to Buy as the Economic Outlook Improves ||| Amazon Lifts Nasdaq 170+ Points on Earnings Hopes; Nikola Plunges as Warrants Bring Dilution ||| Goldman Sachs executives in Malaysia to discuss 1MDB - finance minister,1,0.53073573
2020-07-21,3393500.0,212.25,213.8099975585937,210.38999938964844,212.0200042724609,194.5254821777344,GS,"Dow Movers: GS, XOM ||| The Largely Ignored Albertsons IPO Presents a Great Opportunity ||| Notable Tuesday Option Activity: GOOG, GS, CVX",0,0.49754888
2020-07-22,4978400.0,210.5,211.0,205.3500061035156,206.0,189.0022125244141,GS,"Westpac taps Deutsche Bank's ANZ CEO to head institutional business ||| Westpac names Deutsche Bank's ANZ CEO as institutional banking head ||| Goldman Sachs CEO wants more diversity in bank leaders now ||| Goldman Sachs Group (GS) Shares Cross Below 200 DMA ||| Wednesday Sector Laggards: Energy, Financial ||| DIA, GS, BA, JNJ: Large Inflows Detected at ETF",0,0.49850205
2020-07-23,4088600.0,205.1000061035156,206.0200042724609,202.0500030517578,203.0200042724609,186.26808166503903,GS,"How to Detect a Scam ||| Energy Transfer Will Continue to Limp as Recovery Takes Longer Than Expected ||| NVIDIA Wants to Buy Arm, SoftBank's Semiconductor Subsidiary ||| 3 Incredibly Cheap Bank Stocks",0,0.49021026
2020-07-24,3191500.0,203.0,204.92999267578125,201.32000732421875,201.47000122070312,184.8459930419922,GS,"The Remote Work Trend Will Propel CrowdStrike Higher ||| Goldman Sachs Reaches Deal With Government Of Malaysia Relating To 1MDB - Quick Facts ||| Goldman Sachs Agrees to $3.9 Billion Settlement Over Malaysia Scandal ||| Tech titans drag Wall St lower as virus cases mount ||| Why Wells Fargo Is Rallying After Weak Earnings ||| Goldman Sachs, Malaysia agree to $3.9 billion settlement over 1MDB ||| Goldman Sachs, Malaysia reach settlement agreement over 1MDB- sources ||| Benetton family investment firm to cut stake in Cellnex to 13% ||| BUZZ-U.S. STOCKS ON THE MOVE-Intel Corp, Skechers USA, Goldman Sachs ||| BUZZ-U.S. STOCKS ON THE MOVE-ChannelAdvisor, PolarityTE, Xerox",1,0.5233479
2020-07-27,2601200.0,200.1000061035156,204.17999267578125,199.58999633789065,203.0200042724609,186.26808166503903,GS,"Why Goldman Sachs' Marcus May Have a Tough Time Continuing Its Rapid Deposit Growth ||| Which of the Large U.S. Banks Is Most Leveraged? ||| Malaysia's Najib convicted on all charges in first 1MDB graft case ||| Wells Fargo files to register exchange-traded funds ||| EXCLUSIVE-Goldman revamps employee reviews, opening door to greater job cuts ||| EXCLUSIVE-HSBC aims to double number of senior Black staff by 2025- memo ||| Bank of America Is the Most Popular Financial Stock on Robinhood. Should It Be? ||| Verdict in first 1MDB case packs risk for Malaysian government",0,0.47941315
2020-07-28,2139600.0,201.9100036621093,203.6000061035156,201.08999633789065,201.6199951171875,184.983627319336,GS,"Noteworthy Tuesday Option Activity: GS, ADP, SPPI ||| Warren Buffett Invests Almost $400 Million More in Bank of America ||| Goldman hikes 12-month gold price forecast to $2,300 ||| Malaysian court allows stay of jail sentence, fine for ex-PM Najib ||| New York concert to be investigated over 'egregious' social-distancing violations, Cuomo says",1,0.49442965
2020-07-29,2635000.0,201.6999969482422,203.88999938964844,199.6199951171875,202.5800018310547,185.8643951416016,GS,Rising Sales and a Low Price Make Nio Worth the Risk ||| Why Goldman Sachs Just Raised $700 Million for a New SPAC ||| Buffett's Latest Investment and Some Financial Sector Earnings,0,0.491671
2020-07-30,3057900.0,199.5,199.9900054931641,196.3000030517578,199.52999877929688,183.06607055664065,GS,Free lunch! Bosses lure bankers back where they can see them,0,0.5014786
2020-08-03,2294600.0,198.4900054931641,199.8800048828125,196.52999877929688,199.38999938964844,182.9376373291016,GS,Here's What Happened in the Stock Market in July -- and What to Watch in August ||| Why Is Warren Buffett So Bullish on Bank of America? ||| Trulioo Is Making the Internet Safe for Business,1,0.5009368
2020-08-04,1944700.0,199.3500061035156,201.72000122070312,198.47999572753903,201.63999938964844,185.00196838378903,GS,"Goldman Sachs names new equity capital head for Australia, New Zealand",1,0.521975
2020-08-05,2232400.0,203.1699981689453,204.8099975585937,203.009994506836,204.5200042724609,187.6443023681641,GS,"Goldman sets new goals for employing Black, Latino, female vice presidents ||| Goldman Sachs aims for 7% of staff to be black, 9% to be Latino by 2025 ||| This Amazon Rival Is Scaling Up at an Alarming Pace ||| Kobe back for more with 3yr US dollar bond",0,0.50479895
2020-08-06,1882400.0,205.0,206.2899932861328,203.8300018310547,204.25,187.3966217041016,GS,It’s Time to Play the Waiting Game With Nio Stock ||| Wells Fargo Stock Is One of the Worst Banks to Buy ||| 3 Stocks Warren Buffett Probably Sold in Q2,1,0.4947686
2020-08-07,3075000.0,203.47999572753903,208.8000030517578,202.4499969482422,208.2700042724609,191.0848999023437,GS,"Wall Street dips on slowing job growth, U.S.-China tensions ||| Wall Street set to dip on slowing job growth, U.S.-China tensions ||| Goldman Sachs cuts quarterly earnings citing legal provisions ||| Masmovil board backs private equity bid after no rival offers emerge",1,0.49378726
2020-08-10,2432800.0,209.58999633789065,210.63999938964844,208.0399932861328,209.3800048828125,192.10330200195312,GS,"Federal Reserve announces post-stress test capital ratios for large banks ||| Federal Reserve announces post-stress test capital ratios for large banks ||| BUZZ-U.S. STOCKS ON THE MOVE-Eastman Kodak, Seres Therapeutics, Trevena ||| BUZZ-U.S. STOCKS ON THE MOVE-Eastman Kodak, Twitter, Simon Property",1,0.49807397
2020-08-11,4042700.0,212.72000122070312,216.9499969482422,210.52999877929688,211.0599975585937,193.64468383789065,GS,"See Which Of The Latest 13F Filers Holds Goldman Sachs Group ||| Airbnb to confidentially file for IPO in August - WSJ ||| BUZZ-U.S. STOCKS ON THE MOVE-Eyenovia, Pacific Ethanol, Inovio Pharma ||| BUZZ-U.S. STOCKS ON THE MOVE-Eyenovia, Shutterstock, PDS Biotech ||| BUZZ-U.S. STOCKS ON THE MOVE-Immutep, Catalyst Pharma, Ideanomics ||| More cash, less buzz for 2020 investment bank interns ||| Big U.S. companies form group to boost hiring of minorities in New York",1,0.49373075
2020-08-12,2439400.0,214.6999969482422,215.9499969482422,209.2700042724609,212.1300048828125,194.6264190673828,GS,"Goldman Sachs, Barclays among bidders for GM's credit card business - WSJ ||| Noteworthy Wednesday Option Activity: REGN, ADBE, GS ||| Financial Sector Update for 08/12/2020: FCFS,IVZ,GS,BCS ||| BUZZ-U.S. STOCKS ON THE MOVE-Stein Mart, Trevena, Cellular Biomedicine ||| Financial Sector Update for 08/12/2020: AFL,FCFS,IVZ,GS,BCS ||| Alibaba-backed Best to list delivery business in Hong Kong -sources ||| Dow Movers: BA, GS ||| 7 U.S. Banks That Will Need to Hold More Regulatory Capital ||| BUZZ-U.S. STOCKS ON THE MOVE-Pacific Ethanol, Cellular Biomedicine, Covetrus ||| Goldman Sachs, Barclays among bidders for GM's credit card business - WSJ",0,0.48913756
2020-08-13,2219900.0,210.4100036621093,212.1999969482422,207.69000244140625,208.38999938964844,191.1950225830078,GS,"EXCLUSIVE-China pushes First Capital merger in drive to take on Wall St - sources ||| Is Airbnb Stock Back on Track for a 2020 IPO? ||| RWE a takeover target? Not in our control, CFO says ||| Corporate America worries WeChat ban could be bad for business- WSJ ||| EXCLUSIVE-China pushes First Capital merger in drive to take on Wall St - sources ||| EXCLUSIVE-China pushes First Capital merger in drive to take on Wall St - sources",0,0.49663484
2020-08-14,2287600.0,207.4600067138672,209.47999572753903,206.6100006103516,207.97000122070312,190.80972290039065,GS,"Buffett Didn't Buy Banks in Q2 ||| Berkshire slashes Wells Fargo, JPMorgan stakes; adds Barrick Gold ||| Berkshire reduces Wells Fargo, JPMorgan, Goldman stakes; adds Barrick Gold",0,0.46375224
2020-08-17,3922600.0,207.0,207.8500061035156,202.52999877929688,203.07000732421875,186.3140106201172,GS,"Goldman sees S&P 500 surging to 3,600 by end-2020 ||| Goldman Sachs Lifts End-Year S&P 500 Forecast by 20% ||| S&P 500 News: Buffett Sells Oil Stocks, Buys Gold Miner; GM Shares Surge on EV Spinoff Idea",0,0.4918011
2020-08-18,3067900.0,203.4499969482422,203.5800018310547,201.1000061035156,201.3099975585937,184.69923400878903,GS,"Venture investor Kevin Hartz targets tech founders with blank-check firm ||| Venture investor Kevin Hartz targets tech founders with blank-check firm ||| Here's What Warren Buffett Is Buying and Selling ||| Why JD.com Stock Was Gaining Again Today ||| VTV, MDT, CI, GS: Large Outflows Detected at ETF",1,0.48595232
2020-08-19,2458500.0,202.3999938964844,206.1000061035156,201.7700042724609,203.0200042724609,186.26808166503903,GS,"S.Korea's SK Construction preferred bidder to buy waste firm EMC ||| Brazil school chain Eleva, backed by billionaire Lemann, hires banks for IPO ||| Dow Movers: WMT, GS ||| 7 Don’ts Investors Must Know ||| Booking app Omio raises $100 mln in travel recovery bet",0,0.5011857
2020-08-20,1764200.0,200.759994506836,203.27999877929688,200.33999633789065,201.8500061035156,185.1946563720703,GS,"Goldman Sachs to offer clearing services via LCH’s ForexClear ||| BUZZ-U.S. STOCKS ON THE MOVE-Opera, L Brands, OpGen ||| Chinese insurance tech firm Waterdrop raises $230 mln, plans U.S. IPO ||| Why Warren Buffett May Already Be Feeling Better About the Banking Sector",1,0.50151515
2020-08-21,1780900.0,200.1100006103516,203.3500061035156,199.82000732421875,202.42999267578125,185.72677612304688,GS,Competition to heat up among U.S. stock exchanges with new entrants ||| Wall Street set to drop at open; business surveys on deck ||| Take-Two Grows Its Mobile Gaming Empire ||| JPMorgan to launch UK digital lender in early 2021 -Sky News ||| Is Warren Buffett Giving Up On Bank Stocks? ||| Better Buy: Berkshire Hathaway or Bank of America,1,0.4945077
2020-08-24,3097400.0,203.1100006103516,207.42999267578125,201.32000732421875,207.33999633789065,190.23165893554688,GS,The Best Bank Stock to Buy Right Now ||| 1 Dow Jones Stock to Buy,0,0.4875998
2020-08-26,2563200.0,205.88999938964844,207.27999877929688,205.02999877929688,207.22000122070312,190.12155151367188,GS,"Splits, Shorts, and Refinances: What Investors Need to Know ||| Marqeta Is Gunning for the Massive Credit Card Industry ||| Worried About Another Crash? Buy Goldman Sachs ||| EXPLAINER-Ant Group's key revenue drivers as it eyes $200 bln valuation",1,0.5015576
2020-08-27,3692400.0,206.67999267578125,213.0,206.4100036621093,210.1499938964844,192.80978393554688,GS,"Royalty Pharma Is the Left-Field Investment You’re Missing Out On ||| DIA, GS, BA, MMM: Large Outflows Detected at ETF",0,0.50831354
2020-08-28,3697400.0,211.88999938964844,212.0,207.08999633789065,207.7100067138672,190.57115173339844,GS,"Report: AT&T Renews Efforts to Sell DIRECTV ||| Billionaire Fredriksen names Svelland head of holding firm Seatankers ||| Goldman Sachs Group, Inc. (GS) Ex-Dividend Date Scheduled for August 31, 2020 ||| Banks eye layoffs as short-term crisis ends, long-term costs emerge",0,0.48756173
2020-08-31,3046200.0,205.5,206.4100036621093,203.6300048828125,204.8699951171875,189.10348510742188,GS,Should You Buy The Trade Desk Stock Right Now?,1,0.5109839
2020-09-01,2457000.0,203.6000061035156,206.7100067138672,203.009994506836,205.4600067138672,189.6480712890625,GS,Dow Analyst Moves: GS ||| Tesla to raise $5 billion through share offering,1,0.5203868
2020-09-02,3565200.0,205.7899932861328,210.92999267578125,205.3699951171875,210.0399932861328,193.8756103515625,GS,"Goldman Sachs Group's Preferred Stock, Series N Shares Cross 6% Yield Mark ||| Natwest Markets, Banco Santander sell Saudi British Bank shares -term sheet",0,0.49350807
2020-09-03,3533500.0,211.75,215.22999572753903,205.8300018310547,207.5599975585937,191.58645629882807,GS,Goldman Sachs veteran Adam Korn joins Sixth Street ||| Ex-Goldman Sachs veteran Adam Korn joins Sixth Street ||| Top EU schools see applications dip as COVID compounds Brexit delays,1,0.53124696
2020-09-04,3668900.0,210.88999938964844,213.3500061035156,205.32000732421875,210.94000244140625,194.70632934570312,GS,"Noteworthy Friday Option Activity: NVDA, GOOG, GS ||| Capital Requirements of Goldman Sachs and Morgan Stanley Slightly Lowered After Fed's Mistake ||| Goldman Sachs lowers stress capital buffer after Fed's correction ||| Malaysia drops criminal charges against Goldman Sachs over 1MDB bond sales -state media ||| Is the Worst Over for Capital One Financial? ||| DIA, MCD, GS, BA: Large Inflows Detected at ETF",0,0.50751674
2020-09-08,4574700.0,209.509994506836,209.9600067138672,201.2700042724609,202.47999572753903,186.8973999023437,GS,"Goldman Sachs joins syndicate for Ant IPO of up to $30 bln -sources ||| Goldman Sachs joins syndicate for Ant IPO of up to $30 bln -sources ||| BUZZ-U.S. STOCKS ON THE MOVE-Altice USA Inc, JPMorgan Chase & Co, Co-Diagnostics, Walt Disney Co ||| BUZZ-U.S. STOCKS ON THE MOVE-Spero Therapeutics, ExxonMobil Corp, JPMorgan Chase & Co",0,0.47440356
2020-09-09,4681400.0,204.19000244140625,204.8300018310547,202.02999877929688,202.22000122070312,186.65744018554688,GS,"Australian business leaders respond to corporate scandals, #MeToo movement",0,0.5097241
2020-09-10,2510300.0,203.72999572753903,205.3500061035156,199.5500030517578,200.009994506836,184.6174774169922,GS,"Citigroup Taps a Woman to Become New CEO ||| Up 50%, Goldman Sachs Stock Can Still Grow ||| Ex-Goldman banker seeks review of 1MDB charges in Malaysia",1,0.51705897
2020-09-11,2376400.0,200.2400054931641,201.9100036621093,198.9499969482422,200.9199981689453,185.4574584960937,GS,3 Questions for Banks in a Permanent Low-Rate Environment,1,0.54949886
2020-09-14,2756900.0,203.3000030517578,203.3000030517578,200.6699981689453,201.33999633789065,185.8451538085937,GS,Wall Street fundraisers turn into wallflowers during 2020 U.S. election ||| ANALYSIS-Gulf's fiscal diet risks deeper pain amid oil price uncertainty,0,0.49884808
2020-09-15,3717600.0,202.0,202.58999633789065,197.97999572753903,198.0,182.7621917724609,GS,"Goldman Sachs names new leaders of natural resources investment banking, memo shows ||| Goldman names Kim Posnett co-head of investment banking services -Bloomberg News ||| 3 Reasons Zoom Video Communications Stock Still Looks Like a Long-Term Winner ||| Goldman names new co-heads of EMEA investment banking division - memo",1,0.5057767
2020-09-16,3571400.0,198.4900054931641,203.8000030517578,198.07000732421875,200.67999267578125,185.23594665527344,GS,Apple Abandons Credit Card Partnership With Barclays,0,0.5309016
2020-09-17,4274800.0,198.2100067138672,199.88999938964844,194.509994506836,194.8300018310547,179.83616638183594,GS,"Unity sells shares in $1.3 bln U.S. IPO above target range ||| Goldman holds top rank in activism defense, Spotlight climbs- data ||| Snowflake IPO Goes into the Stratosphere ||| U.S. stocks futures slip with focus on jobless claims as Fed underwhelms",1,0.5089742
2020-09-18,9066300.0,195.009994506836,196.6499938964844,192.3800048828125,194.8600006103516,179.86386108398438,GS,Unity Software's shares soar 44% in NYSE debut ||| Why Investors Shouldn't Get Too Excited About Peloton's Profit Spurt,0,0.50675255
2020-09-21,4871300.0,189.8999938964844,194.1699981689453,187.47000122070312,194.0,179.0700225830078,GS,China's Guolian Securities to acquire Sinolink Securities ||| Car insurance start-up Root hires Goldman Sachs to lead IPO -sources ||| Wall Street-backed MEMX launches in challenge to NYSE and Nasdaq ||| Goldman Sachs shakes up M&A ranks with new global co-chairs - memo ||| Goldman Sachs names new co-chairs of global M&A -memo ||| INSIGHT-'Free money' for banks as investors pile into fractured gold market,0,0.499256
2020-09-22,3355800.0,194.0,196.13999938964844,188.42999267578125,191.6199951171875,176.87318420410156,GS,Goldman Sachs Is Partnering With Walmart to Expand Its Consumer Banking Business ||| Are We Headed for Another Stock Market Crash?,0,0.48952845
2020-09-23,3116100.0,192.0,192.9199981689453,185.8699951171875,186.1199951171875,171.79644775390625,GS,EXCLUSIVE-How a marked-up term sheet and messy rollout threw TikTok deal into disarray ||| Bank of East Asia to sell insurance business with Elliott backing,1,0.5289978
2020-09-24,5114600.0,188.97999572753903,197.4600067138672,187.0500030517578,195.1100006103516,180.09458923339844,GS,"Goldman Sachs finances MercadoLibre loans to Brazil small companies ||| BUZZ-U.S. STOCKS ON THE MOVE-Universal Insurance Holdings, Square Inc, Taysha Gene Therapies Inc ||| BUZZ-U.S. STOCKS ON THE MOVE-Methode Electronics, Drive Shack Inc, CarMax Inc ||| Nasdaq rises on tech boost as economic recovery cools ||| BUZZ-U.S. STOCKS ON THE MOVE-Crexendo Inc, Jabil Inc, Dynatronics Corp, AMC Entertainment Holdings ||| Wall Street set to open lower as labor market recovery cools ||| US STOCKS-Futures muted ahead of jobless claims as economic recovery slows ||| Humana’s Pretty Good Year Reflects a Surprising Side to the Health Crisis",0,0.48180735
2020-09-25,3106000.0,192.9600067138672,195.38999938964844,189.6100006103516,194.9499969482422,179.94691467285156,GS,"BUZZ-U.S. STOCKS ON THE MOVE-Prelude Therapeutics, Carnival Corp, CalAmp Corp, VIA Optronics AG ||| BUZZ-U.S. STOCKS ON THE MOVE-Marinus Pharmaceuticals, Trip.com, Schlumberger, Goldman Sachs ||| 2 Stocks to Buy With the Second Stimulus Check",1,0.48682827
2020-09-28,3280100.0,197.77999877929688,201.8699951171875,197.1499938964844,199.07000732421875,183.74986267089844,GS,"10 Traits of a Great Company Culture ||| Banks, travel stocks set to lead Wall Street higher ||| US STOCKS-Futures bounce as China industrial profits rise",0,0.5313053
2020-09-29,2400000.0,198.1600036621093,198.7700042724609,195.42999267578125,196.7899932861328,181.6453094482422,GS,"Cybersecurity Mainstay McAfee Files for IPO ||| Goldman Sachs streamlines asset, consumer, wealth management units ||| AUTO1 starts preparations for stock market float -sources ||| Hitachi plans to sell Hitachi Metals in a deal worth over $6 bln -sources ||| Hitachi plans to sell stake in Hitachi Metals, sources say ||| Battery maker Northvolt raises $600 mln in private placement",1,0.5059458
2020-09-30,3075800.0,198.67999267578125,203.0800018310547,198.3600006103516,200.97000122070312,185.5036163330078,GS,"More than 7,500 finance jobs have left Britain for Europe, EY Brexit tracker ||| A Fall Financials Check-In and an Exciting New Fool Service ||| Goldman Sachs to go ahead with ""modest"" job cuts after coronavirus pause ||| Goldman Sachs to cut about 400 jobs - Bloomberg News ||| Goldman Sachs Continues to Simplify With Personnel Moves ||| Global banks ramp up preparations for U.S. election night chaos, sources say ||| US STOCKS-Industrials, tech stocks lift Wall St at the end of choppy month ||| M&A spikes in record third quarter as boards go on pandemic deal spree ||| US STOCKS-Wall Street jumps on stimulus hopes, upbeat data ||| Wall Street jumps on stimulus hopes, upbeat data",0,0.48694828
2020-10-01,2288700.0,201.52999877929688,203.1300048828125,197.8699951171875,198.5500030517578,183.2698669433593,GS,"INSIGHT-How the year 2020 confounded Wall Street strategists ||| INSIGHT-Secrecy and speed: Inside Ant Group’s unusual IPO process ||| GLOBAL MARKETS-Asian markets mixed in early trade, Tokyo edges up after trading outage ||| GLOBAL MARKETS-Asian markets mixed in early trade, Tokyo reopens after trading glitch ||| GLOBAL MARKETS-Stimulus hopes lead markets into tough fourth quarter ||| GLOBAL MARKETS-Asian markets face mixed open as U.S. stimulus deal remains elusive ||| Goldman to buy GM's credit card unit for $2.5 bln -WSJ ||| Big U.S. banks to report profit plunge as pandemic recession takes hold ||| GLOBAL MARKETS-Stimulus hopes ease markets into eventful fourth quarter ||| BUZZ-U.S. STOCKS ON THE MOVE-XPO Logistics, VerifyMe, Workday, LogicBio Therapeutics ||| GLOBAL MARKETS-Stimulus hopes ease markets into eventful fourth quarter",1,0.50113475
2020-10-02,2541200.0,195.33999633789065,200.6999969482422,195.2899932861328,199.8999938964844,184.5159606933593,GS,"BUZZ-U.S. STOCKS ON THE MOVE-Big banks, oil majors, airlines, Tesla Inc, Bloom Energy Corp ||| Savings provider Ascensus prepares for mid-2021 IPO - sources ||| Is Phillip Morris Stock a Buy? ||| US STOCKS-Wall St set to slide after Trump's positive COVID-19 test ||| GLOBAL MARKETS-U.S. stock futures extend losses as Trump tests positive for COVID-19 ||| Goldman Sachs Launching Fresh Round of Job Cuts ||| BUZZ-U.S. STOCKS ON THE MOVE-Tesla Inc, Bank of America Corp, Twilio Inc, Citigroup Inc ||| Why JinkoSolar is Soaring and Will Jump Further Over the Longer Term ||| US STOCKS-Futures sink as Trump tests positive for COVID-19",1,0.47596955
2020-10-05,2551600.0,201.92999267578125,202.83999633789065,199.58999633789065,201.8000030517578,186.2697296142578,GS,"INSIGHT-Secrecy and speed: Inside Ant Group’s unusual IPO process ||| EXCLUSIVE-Warburg Pincus, Gavea ready IPO of Brazil facilities company GPS -sources ||| BUZZ-U.S. STOCKS ON THE MOVE-TC PipeLines, energy stocks, big banks, Plug Power ||| Goldman Sachs says buy sterling as Brexit deal likely",0,0.5039566
2020-10-06,2833100.0,204.25,206.08999633789065,199.8999938964844,201.08999633789065,185.6143951416016,GS,Goldman Sachs to not name more than 60 partners in 2020 - WSJ ||| It's Profitable To Be Patient With Citigroup Stock,1,0.4931458
2020-10-07,2326600.0,203.8999938964844,205.0,201.1699981689453,203.6000061035156,187.93121337890625,GS,"Wells Fargo cuts more jobs as part of earlier cost-cutting drive ||| Wells Fargo cuts 700 commercial banking jobs- Bloomberg News ||| FOCUS-Risk haunts Societe Generale's Oudea in elusive hunt for growth ||| Report: Goldman Sachs Reducing Its Number of Partners ||| BUZZ-U.S. STOCKS ON THE MOVE-Workday, Stable Road Acquisition, RedHill Biopharma, Fox Corp, Disney",1,0.5269433
2020-10-08,2330600.0,205.1499938964844,208.1600036621093,204.1100006103516,207.97999572753903,191.97415161132807,GS,"Mexico's Pemex plans bond to raise up to $1.5 bln to refinance debt, source says ||| If Biden Can Save General Motors for a Second Time, How About GM Stock? ||| INTERVIEW-Soccer-Barca stadium revamp urgently needed due to financial hit, says vice-president",0,0.49561056
2020-10-09,3040900.0,208.759994506836,209.8099975585937,206.07000732421875,207.5399932861328,191.5679931640625,GS,"ANALYSIS-U.S. bank stocks are fine, if you are rich in patience ||| U.S. should try to delay IPO of China's Ant Financial, Rubio says ||| FOCUS-'Treasuries on steroids': U.S. banks' mortgage bond trading bonanza ||| Goldman Sachs Will Be a Gold Medal Winner Over the Next Two Years",1,0.48818472
2020-10-12,3474200.0,207.4100036621093,214.88999938964844,207.4100036621093,214.1199951171875,197.6416015625,GS,"What You Need to Know About the Root IPO ||| GLOBAL MARKETS-Asian shares defy Wall St gains as China rally cools ||| Report: Goldman Sachs in Danger of Missing 2020 Financial Targets ||| GLOBAL MARKETS-Asian stocks set to rise as tech, stimulus hopes fuel global rally ||| S&P 500 Gains 57 Points Ahead of Earnings, Huge Apple and Amazon Events, Ford Stock Gets an Upgrade ||| Snowflake Signs Multimillion-Dollar Deal With Goldman Sachs ||| BUZZ-U.S. STOCKS ON THE MOVE-Facebook, Apple, Goldman Sachs, Amazon ||| World stocks zoom to 5-week highs on economic, stimulus hopes ||| GLOBAL MARKETS-Earnings, stimulus hopes keep U.S. stocks buoyant, oil dips ||| US STOCKS-Nasdaq leads Wall St set higher on tech boost, stimulus hopes ||| US STOCKS-Nasdaq set to lead Wall St set higher on tech boost, stimulus hopes ||| Should You Invest In State Street Stock? Ask The AI Engine ||| Stock Markets Are Up -- So When Will the Dow Jones Set a Record High?",0,0.5028529
2020-10-13,3317300.0,214.009994506836,214.1100006103516,209.17999267578125,210.8099975585937,194.5863647460937,GS,"German laboratories group Synlab hires banks for 2021 IPO - sources ||| BUZZ-U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, Apple, Moderna, J&J ||| US STOCKS-Wall St closes lower on vaccine delay, dampened stimulus hopes ||| Pre-Market Earnings Report for October 14, 2020 : UNH, BAC, WFC, GS, USB, PGR, PNC, INFY, WIT ||| US STOCKS-Wall Street dips on vaccine delay, fading stimulus optimism ||| BUZZ-U.S. STOCKS ON THE MOVE-Johnson & Johnson, Gossamer, Amazon, Citigroup ||| 5 Bank Stocks To Buy for an Earnings Bump as Reporting Season Kicks Off ||| GLOBAL MARKETS-Asian shares recover early losses on Chinese trade data ||| German laboratories group Synlab hires banks for 2021 IPO - sources ||| JPMorgan beats profit estimates as trading booms",1,0.5065453
2020-10-14,7550100.0,213.8800048828125,214.4499969482422,210.2700042724609,211.22999572753903,194.9740295410156,GS,"Goldman Sachs profit nearly doubles on trading surge ||| BUZZ-U.S. STOCKS ON THE MOVE-Twitter, Caterpillar, Wells Fargo, Restaurant Brands ||| Big U.S. banks offer muddled outlook on how bad coronavirus losses might get ||| US STOCKS-Wall St slides after Mnuchin dims stimulus hopes ||| Venmo's New Credit Card, Square's New Investment, and a Preview of Bank Earnings ||| BUZZ-U.S. STOCKS ON THE MOVE-Allscripts, Bank of America, Goldman Sachs, Interpace Biosciences ||| GLOBAL MARKETS-World stocks sag on pandemic surge, gold gains on safety bid ||| S&P 500 Slumps: Oil Stocks Say We Got This! Big Banks, Coronavirus Drugmakers Say Not So Fast ||| US STOCKS-Wall St slides as Mnuchin says stimulus difficult before election ||| The 7 Best Startups You Can Buy On SeedInvest Right Now ||| Goldman Sachs Reports Surge in Third-Quarter Earnings ||| Goldman Sachs Group Inc (GS) Q3 2020 Earnings Call Transcript ||| GLOBAL MARKETS -World stocks whipsaw on pandemic worries, gold gains ||| Goldman Sachs profit nearly doubles on trading surge ||| BUZZ-U.S. STOCKS ON THE MOVE-Wells Fargo, Interpace Biosciences, Bank of America, Novan ||| US STOCKS-Wall St ticks up in choppy trading after mixed bank results ||| GLOBAL MARKETS-Shares steady with U.S. bank earnings in sight ||| Goldman Sachs Group Q3 20 Earnings Conference Call At 9:30 AM ET ||| US STOCKS-Futures muted ahead of next batch of bank earnings ||| 4 Top Stock Trades for Thursday: NIO, UAL, BIDU, MS ||| Goldman Sachs Group Inc. Q3 Profit Climbs ||| US STOCKS-Futures subdued after mixed results from big U.S. banks ||| Goldman Sachs Q3 Results Top Estimates ||| US STOCKS-Tech stocks bolster Wall St after mixed bank results",0,0.45322618
2020-10-15,4325700.0,209.5800018310547,210.72999572753903,206.8999938964844,208.6000061035156,192.54644775390625,GS,"Morgan Stanley Q3 profit beats estimates as trading powers results ||| Unqork Stock Unleashing the No-Code Revolution ||| JinkoSolar Won the Initial Solar Market, But Is Its Future Bright?",0,0.49781698
2020-10-16,3244500.0,208.32000732421875,210.0,205.8099975585937,206.2100067138672,190.34036254882807,GS,"Despite Government Threat, General Electric Is Still Treading Water ||| Big Banks Showing Confidence in the Economy",0,0.48550573
2020-10-19,3235300.0,207.38999938964844,207.9100036621093,204.58999633789065,205.69000244140625,189.86038208007807,GS,Goldman to pay over $2 bln in DOJ's 1MDB probe - Bloomberg News ||| Goldman Sachs gives staff half-day paid leave on U.S. election day ||| Berkshire Hathaway Shows Resilience in the Corona Economy ||| Goldman Sachs expects rejection of SEC plan to raise 13F reporting threshold,1,0.4834681
2020-10-20,3335500.0,206.6999969482422,211.3800048828125,206.47000122070312,208.02999877929688,192.0203094482422,GS,"Goldman Sachs Reportedly Agrees To Pay U.S. $2.8 Bln To Settle 1MDB Probes ||| Channel Tunnel operator Getlink to issue new ""green bonds"" ||| Goldman Sachs sends some London staff home following positive tests for COVID-19 ||| BUZZ-U.S. STOCKS ON THE MOVE-IBM, Cleveland BioLabs, AMC, DraftKings",0,0.48410782
2020-10-21,3083600.0,207.38999938964844,207.9499969482422,202.009994506836,202.9100036621093,187.29432678222656,GS,"Nasdaq Notches Q3 Beats, Declares Dividend, and Names a New CFO ||| Abu Dhabi's IPIC drops lawsuit against Goldman Sachs over 1MDB scandal ||| Wall Street banks see rare payday bonanza in India despite pandemic ||| ANALYSIS-U.S. investment bankers' new pitch: Biden's tax hike ||| Goldman Sachs sends some London staff home following positive tests for COVID-19 ||| Goldman Sachs-backed ThredUp files confidentially for IPO",1,0.48149177
2020-10-22,2136900.0,203.1999969482422,206.3699951171875,202.1999969482422,205.3999938964844,189.59266662597656,GS,Goldman Sachs To Pay $2.8 Bln To Settle 1MDB Probes ||| UK fines Goldman Sachs 96.6 mln pounds in global action over 1MDB scandal ||| Big Bank Earnings Recap ||| What Does Bank of America Mean for Berkshire Hathaway's Stock? ||| Goldman Sachs U.S. settlement over Malaysia 1MDB scandal to lift dark cloud ||| Hong Kong fines Goldman Sachs Asia $350 million over 1MDB ||| Hong Kong fines Goldman unit $350 million over 1MDB,0,0.49249455
2020-10-26,3249700.0,202.4900054931641,202.8099975585937,198.509994506836,201.13999938964844,185.6605529785156,GS,"3 Reasons You Shouldn't Invest Like Warren Buffett ||| What Does Marcus Mean to Goldman Sachs' Stock? ||| Lloyd Blankfein Has Thoughts on Trump, Biden, and the Stock Market ||| GS Makes Notable Cross Below Critical Moving Average ||| Munich Leukemia Laboratory put up for sale -sources",0,0.51656026
2020-10-27,3430400.0,200.0,200.58999633789065,195.4100036621093,195.67999267578125,180.6207427978516,GS,3 Stocks To Buy For Earnings Announcement Returns,0,0.507963
2020-10-28,4214600.0,191.3099975585937,193.3699951171875,188.94000244140625,189.7700042724609,175.16558837890625,GS,"BUZZ-U.S. STOCKS ON THE MOVE-Titan Pharma, Community Health Systems, MediaAlpha ||| BUZZ-U.S. STOCKS ON THE MOVE-Chefs' Warehouse, Chewy Inc, Polaris Inc ||| BUZZ-U.S. STOCKS ON THE MOVE-Omnicom, Akerna, Mastercard, gold miners ||| BUZZ-U.S. STOCKS ON THE MOVE-Travel stocks, Bunge, AMD, Hess Corp ||| There’s More Than Just Covid to the Spectacular Quibi Failure ||| Low Interest Rates Aren't the Biggest Problem Facing Banks",1,0.49093524
2020-10-29,3581200.0,189.8000030517578,192.3500061035156,186.8999938964844,189.94000244140625,175.32244873046875,GS,"JPMorgan to halt software updates around U.S. election to minimize outages ||| JPMorgan, Goldman order halt to software updates around U.S. election - The Information",0,0.4792606
2020-10-30,3658800.0,189.509994506836,190.3999938964844,185.5200042724609,189.0399932861328,174.49172973632812,GS,"3 More Takeaways From Apple's Earnings Call ||| Jittery Wall Street banks 'war game' the election with drills, client calls, special pollsters ||| EXCLUSIVE-Goldman money funds' liquidity buffer swells before U.S. election ||| 2 Potential Suitors for Wells Fargo's Asset Management Business ||| Wells Fargo Stock Has A 65% Upside Over The Next 1-2 years",1,0.54473317
2020-11-02,2459600.0,192.0,192.6999969482422,188.22999572753903,190.1999969482422,175.56248474121094,GS,Eight big banks must face U.S. cities' allegations of municipal bond collusion ||| Eight big banks must face U.S. cities' allegations of municipal bond collusion ||| Ant's IPO pushes CICC to No 2 in global league tables for new listings ||| Must-Watch Trends for Investors in the Q3 Earnings Season,1,0.52742994
2020-11-03,4545500.0,193.94000244140625,199.0,193.22000122070312,197.92999267578125,182.69757080078125,GS,"EXCLUSIVE-Trump administration shelves bid to blacklist China's Ant Group-sources ||| BUZZ-U.S. STOCKS ON THE MOVE-U.S. banks, Plug Power, Spirit AeroSystems, Gartner, Solaredge ||| EXPLAINER-Ant juggernaut jackknifes on $37 billion road to market ||| BUZZ-U.S. STOCKS ON THE MOVE-Health insurers, Alibaba, Fox, Ferrari, Gartner ||| BUZZ-U.S. STOCKS ON THE MOVE-U.S. bank stocks, Alibaba, Ferrari, health insurers ||| US STOCKS-Wall St set to jump on Biden victory bets, stimulus hopes ||| US STOCKS-Futures rise as investors bet on Biden victory, more stimulus ||| China's Ant expected to double on debut amid pent-up retail demand - fund managers",0,0.48739225
2020-11-04,3868500.0,196.25,200.82000732421875,194.8999938964844,197.8699951171875,182.64219665527344,GS,"BUZZ-U.S. STOCKS ON THE MOVE-Big tech, solar energy, health insurers, Corecivic ||| ANALYSIS-Wall Street worries tight U.S. election clouds pandemic fight, stimulus ||| BUZZ-U.S. STOCKS ON THE MOVE-U.S. defense stocks, Uber, health insurers, big pharma ||| Wall St seeks safety of Big Tech as election hangs in the balance ||| ANALYSIS-Wall Street worries tight U.S. election clouds pandemic fight, stimulus ||| ANALYSIS-Wall Street firms crave certainty about U.S. election, hope for quick stimulus ||| BUZZ-U.S. STOCKS ON THE MOVE-Uber, Alibaba, solar energy stocks, big tech ||| 3 Dividend Stocks You Can Safely Hold for Decades ||| BUZZ-U.S. STOCKS ON THE MOVE-U.S. PE firms, defense stocks, Biogen, solar energy cos",1,0.49682584
2020-11-05,2892800.0,199.6499938964844,204.1199951171875,199.0599975585937,202.9600067138672,187.34051513671875,GS,"DIA, HD, MCD, GS: Large Inflows Detected at ETF ||| Warren Buffett and Robinhood Traders Own This Stock -- Should You?",0,0.48754793
2020-11-06,2475100.0,204.33999633789065,204.38999938964844,200.4199981689453,201.259994506836,185.7713165283203,GS,"Pre-Market Most Active for Nov 6, 2020 : NIO, ACB, XPEV, SQQQ, LI, TLRY, AAPL, COTY, QQQ, TQQQ, GE, GSX ||| Malaysia's 1MDB state fund still $7.8 bln in debt - govt report",1,0.49331936
2020-11-09,6960500.0,214.4900054931641,218.0,209.3699951171875,214.92999267578125,198.38926696777344,GS,"TD Bank says it will not finance oil and gas activities in the Arctic ||| Goldman Sachs confident of hitting strategic targets -CFO ||| 1 Cheap Stock to Buy Now ||| Goldman Sachs confident of hitting strategic targets -CFO ||| US STOCKS-S&P 500, Dow set to surge as vaccine moves step closer ||| Here's Why Goldman Sachs Is Thriving While Other Banks Are Suffering ||| Israeli ad-tech firm IronSource plans IPO for H1 next year - newspaper ||| US STOCKS-Wall Street set to jump after Biden election win",1,0.48661366
2020-11-10,4166500.0,215.25,218.3800048828125,211.17999267578125,217.47000122070312,200.7338409423828,GS,Italy's Leonardo exploring options for U.S DRS unit with Goldman Sachs - sources ||| Is Morgan Stanley a Good Value Stock? ||| Italy's Leonardo exploring options for U.S. unit DRS with Goldman - sources,1,0.4816511
2020-11-11,2680700.0,218.63999938964844,219.9199981689453,215.02999877929688,218.0500030517578,201.2691650390625,GS,"Global regulators ease capital burden on JP Morgan bank ||| BUZZ-U.S. STOCKS ON THE MOVE-Goldman Sachs, Apple, Lyft, eGain, Pacific Biosciences ||| Why AMC Entertainment Stock Was Sliding Today ||| MOVES-JPMorgan names Rita Chan as Asia head of real estate banking - memo ||| BUZZ-U.S. STOCKS ON THE MOVE-Apple, Lyft, D.R. Horton, Norwegian Cruise Line ||| Here's What Made Dada Nexus Stock Go Up on Wednesday ||| Goldman Sachs lifts S&P 500 target on vaccine hopes, Biden win",0,0.4677899
2020-11-12,3005500.0,215.22000122070312,216.8600006103516,212.3999938964844,214.509994506836,198.0015869140625,GS,"Goldman Sachs highlights diversity in new partner class ||| US STOCKS-Wall Street ends sharply lower as pandemic fears resurge ||| US STOCKS-Wall Street ends sharply lower as pandemic fears resurge ||| Noteworthy Thursday Option Activity: HD, GS, CVNA ||| Why Coronavirus Vaccine News Is Great for Bank Stocks and REITs ||| US STOCKS-Wall Street drops as pandemic fears return ||| BUZZ-U.S. STOCKS ON THE MOVE-Akers Biosciences, U.S. Energy Corp, Celsius Holdings ||| GLOBAL MARKETS-Asian stocks dip as virus spread tamps vaccine hopes ||| The 7 Best Startups You Can Buy on SeedInvest Right Now ||| BUZZ-U.S. STOCKS ON THE MOVE-Moderna, Disney, Fly Leasing, China Automotive ||| US STOCKS-Dow, S&P 500 fall as COVID-19 cases spiral ||| BUZZ-U.S. STOCKS ON THE MOVE-U.S. big banks, Southwest, Fossil, Sundial Growers ||| While JPMorgan Stock Is Lagging The S&P, It Still Has Strength ||| Goldman hires Barclays banker Bion to ride insurance deal boom -memo",1,0.5159627
2020-11-13,2832100.0,215.8500061035156,220.9600067138672,215.4100036621093,219.0800018310547,202.21987915039065,GS,Wells Fargo Rumored to Be Considering Sale of Private-Label Card Business,1,0.5124808
2020-11-16,3004700.0,223.52999877929688,224.6000061035156,220.02999877929688,222.3800048828125,205.2659606933593,GS,"5 Moves to Make if the Stock Market Soars Tomorrow ||| Goldman Sachs investment banking co-head Lemkau to retire - memo ||| BUZZ-U.S. STOCKS ON THE MOVE-Uber, Adamis Pharmaceuticals, Alterity Therapeutics, Virgin ||| Goldman Sachs investment banking co-head Lemkau to retire - memo ||| US STOCKS-S&P, Dow futures rise after Moderna says vaccine 94.5% effective ||| Dubai Aerospace Enterprise hires banks for dollar sukuk -document ||| BUZZ-U.S. STOCKS ON THE MOVE-Goldman Sachs, Moderna, Adamis Pharmaceuticals, United Airlines",1,0.5284015
2020-11-17,2722900.0,220.0200042724609,224.8500061035156,218.3300018310547,224.6499938964844,207.3612518310547,GS,"Goldman Sachs plans further job cuts -sources ||| Aramco markets five-tranche bonds, seeking cash amid cheap oil ||| Down 25% YTD, Bank of America Stock Is Pressured By Low Interest Rates ||| Goldman Sachs plans second round of job cuts after pandemic-led pause -Bloomberg News ||| Dow Analyst Moves: GS",0,0.49715394
2020-11-18,2856200.0,225.0,227.72000122070312,223.509994506836,224.3000030517578,207.03819274902344,GS,Goldman Sachs Launches More Job Cuts to Achieve Better Efficiency ||| London steps up charm offensive for $4 bln Deliveroo listing - sources ||| British insurer RSA agrees $9.6 bln takeover by overseas rivals,1,0.5097183
2020-11-19,1505200.0,224.3000030517578,224.94000244140625,222.1100006103516,224.57000732421875,207.2873992919922,GS,Why a Coronavirus Vaccine is Good News for Banks,0,0.49916553
2020-11-20,1848100.0,223.0,224.8099975585937,222.6300048828125,223.3500061035156,206.1613006591797,GS,"Noteworthy Friday Option Activity: GS, NOW, AVGO ||| Japan's ANA plans share issue after board meeting as early as next week -sources ||| Mediobanca shifts bankers from London to Milan, star dealmaker to quit - sources ||| Japan's ANA plans share issue after board meeting as early as next week, sources say ||| Apollo, Carlyle, Bain are among bidders for planned Hitachi Metals sale -sources",1,0.5140904
2020-11-23,3371300.0,226.0599975585937,230.0,225.72999572753903,228.8300018310547,211.21954345703125,GS,"Peru prepares new century bond after authorizing $4 billion in debt to confront coronavirus impact ||| Yellen Treasury Pick Lifts Stock Markets; Dow Eyes 30,000 ||| Sixth Street-backed AvePoint to go public via $2 bln merger ||| BUZZ-U.S. STOCKS ON THE MOVE-DPW, Fuel Tech, Ideanomics, Bellerophon, Niu Technologies ||| BUZZ-U.S. STOCKS ON THE MOVE-Ideanomics, DPW, Ashford Hospitality, SmileDirectClub ||| Former Goldman CIO Elisha Wiesel joins fintech startup The Floor ||| EXCLUSIVE-JPMorgan dominates gold market with record $1 bln precious metals revenue ||| Sixth Street-backed AvePoint to list via $2 bln merger with blank-check co ||| Up 80%, Credit Suisse Stock Has Limited Upside ||| BUZZ-U.S. STOCKS ON THE MOVE-Ashford Hospitality, Spring Bank Pharma, Ideanomics, China Online Education",1,0.4963862
2020-11-24,3915200.0,231.1000061035156,238.1199951171875,230.6300048828125,237.5,219.2223358154297,GS,"Venture Capitalists Discuss the Future of Gaming ||| COLUMN-Speculative heat keeps copper market bubbling: Andy Home ||| After Positive Q3 Results, Morgan Stanley Stock Is Fairly Priced ||| Goldman voices concerns about OPEC+ future as decision on output curbs nears",0,0.5109549
2020-11-25,2272800.0,235.0,237.4499969482422,232.42999267578125,236.5399932861328,218.336181640625,GS,"BUZZ-U.S. STOCKS ON THE MOVE-Anpac, Weidai, Sunnova, Gap Inc, Frontline ||| US STOCKS-S&P 500, Dow dip as labor market recovery slows ||| US STOCKS-S&P 500, Dow dip from record highs as labor market recovery slows ||| OPEC+ leaning towards oil cut extension, despite rally - sources ||| BUZZ-U.S. STOCKS ON THE MOVE-AnPac, MMTEC, Ecmoho, Nordstrom, Nikola",0,0.47961938
2020-11-27,1050400.0,237.0,237.3000030517578,233.7899932861328,235.3999938964844,217.2839508056641,GS,"Looking For Cheap Stocks To Buy On Black Friday? 3 To Watch Before The Economic Rebound ||| Spain's Sabadell gives Goldman Sachs mandate to sell its British unit TSB, source says ||| Invest In HSBC Stock For 35% Gains",0,0.4919564
2020-11-30,2705400.0,232.0500030517578,235.0,230.3600006103516,230.5800018310547,212.83485412597656,GS,"DoorDash Sets Price Range for IPO; Aims to Raise as Much as $2.8 Billion ||| Natwest, Santander to sell more shares in Saudi British Bank -document ||| Goldman Sachs Group, Inc. (GS) Ex-Dividend Date Scheduled for December 01, 2020 ||| London Stock Exchange opens Brexit trading hub in Amsterdam",1,0.43971932
2020-12-02,2136300.0,232.0800018310547,238.1300048828125,231.5800018310547,237.6499938964844,220.5564422607422,GS,Is JPMorgan Chase Eyeing a British Challenger Bank? ||| Ex-Goldman Sachs President Cohn has not returned pay after 1MDB clawbacks -Bloomberg News ||| 3 Recession-Ready Stocks to Buy Right Now,0,0.4832356
2020-12-03,2142600.0,237.2899932861328,238.8500061035156,234.63999938964844,235.47000122070312,218.53323364257807,GS,"Stripe teams up with Goldman, Citi to offer banking services",1,0.5471497
2020-12-04,2373000.0,237.6999969482422,239.75,236.9499969482422,239.5800018310547,222.3475952148437,GS,"Virgin Money among challenger banks expected to join race for TSB - sources ||| BUZZ-U.S. STOCKS ON THE MOVE-Activision Blizzard, big banks, oil stocks ||| Goldman Sachs Stock Has Limited Upside",0,0.49813288
2020-12-07,1788600.0,238.5399932861328,239.8500061035156,235.4499969482422,238.4499969482422,221.2988739013672,GS,"Virgin Money among challenger banks expected to join race for TSB - sources ||| Goldman mulls Florida base for asset management arm - Bloomberg News ||| 7 Cheap Stocks to Buy Before the Market Realizes their Worth ||| Noteworthy Monday Option Activity: HUM, GS, TTWO ||| Goldman Sachs signs pact to wholly own China joint venture ||| Goldman Sachs signs pact to own 100% of China joint venture ||| EXCLUSIVE-Online lender SoFi explores deal to go public -sources ||| Goldman Sachs Group's Preferred Stock, Series A Shares Cross 4% Yield Mark ||| Goldman Sachs' MENA CEO Younan to retire -memo ||| Goldman Sachs' MENA CEO Younan to retire -memo ||| Goldman Sachs Mulls Florida Base For Asset Management Arm: Bloomberg ||| Notable ETF Inflow Detected - DIA, GS, BA, CAT ||| US STOCKS-Futures ease as Sino-U.S. tensions heat up, fiscal deal awaited",1,0.4912786
2020-12-08,1371800.0,237.009994506836,239.19000244140625,236.5800018310547,238.83999633789065,221.66082763671875,GS,Barclays names 84 new MDs; women constitute about 27% ||| 7 Stocks to Buy While Interest Rates Rise ||| Goldman Sachs In Deal To Buy Out China Joint Venture ||| EXCLUSIVE-Trading app Robinhood hires Goldman Sachs to lead IPO -sources ||| EXCLUSIVE-Trading app Robinhood hires Goldman Sachs to lead IPO - sources,1,0.49206442
2020-12-09,3552300.0,240.0,245.3600006103516,239.52999877929688,242.82000732421875,225.3545837402344,GS,"Dow Movers: PG, GS ||| Investors push back on blank-check company insiders' payout bonanza ||| INSIGHT-Saving the City: London's finance district plots reboot as COVID compounds Brexit ||| ANALYSIS-Investors push back on blank-check company insiders' payout bonanza",1,0.4984659
2020-12-10,2541700.0,240.0,245.17999267578125,239.509994506836,244.3999938964844,226.8209381103516,GS,"Morgan Stanley to shift $120 bln to Germany in post-Brexit move - source ||| U.S. withheld evidence in ex-Goldman banker's 1MDB Malaysia corruption case, lawyer claims ||| EXCLUSIVE-Job website ZipRecruiter hires banks for IPO -sources ||| EXCLUSIVE-Goldman escalates diversity push at portfolio companies; activists want more ||| Used car platform AUTO1 drives for growth at Autohero retail arm ||| EXCLUSIVE-Goldman escalates diversity push at portfolio companies; activists want more",0,0.50734895
2020-12-11,2077300.0,240.8099975585937,241.1999969482422,237.1000061035156,239.9900054931641,222.7281494140625,GS,"U.S. Supreme Court takes up Goldman securities class action appeal ||| U.S. Supreme Court takes up Goldman securities class action appeal ||| ANALYSIS-Amateur traders' euphoria leaves red-hot U.S. IPOs with money on the table ||| Stitch Fix Is no Longer a Buy, Says Prominent Analyst ||| Why Lordstown Motors Jumped 11% Today ||| Dow Movers: GS, DIS ||| Calisen to go private in $1.9 bln deal less than a year after IPO",0,0.4740623
2020-12-15,2348000.0,239.5,243.6100006103516,237.19000244140625,242.42999267578125,224.9925994873047,GS,Citigroup appoints Peter Kimpel as head of BCMA for Germany and Austria ||| Goldman Sachs Acquiring Canadian Benefits Manager People Corporation ||| Citigroup Stock Still Has Some Potential ||| Finding Value In Today's Market: Buy Credit Where Credit's Due,1,0.5074999
2020-12-16,2400900.0,243.5599975585937,243.8999938964844,241.1199951171875,243.7700042724609,226.2362365722656,GS,"Noteworthy ETF Inflows: XLF, MS, GS, AXP ||| ANALYSIS-After COVID shock, U.S. Treasury market set for new scrutiny ||| Despite Pressure on Net Interest Spread, Barclays Stock Can Still Grow",1,0.49980277
2020-12-17,2983600.0,245.0,245.92999267578125,243.0,244.42999267578125,226.8487548828125,GS,"Goldman Sachs Group's Preferred Stock, Series J Shares Cross 5% Yield Mark ||| US STOCKS-Wall Street set to gain on stimulus bets; jobless claims rise ||| US STOCKS-Futures gain on stimulus hopes ahead of jobless claims ||| Which Major U.S. Investment Bank Stock Performed the Best in 2020? ||| Most Investors Fail at Timing the Stock Market for These 3 Reasons",0,0.48145726
2020-12-18,4088100.0,245.38999938964844,245.38999938964844,240.5599975585937,242.1300048828125,224.7142333984375,GS,Coinbase picks Goldman Sachs to lead listing plans -source,1,0.49706435
2020-12-21,7408500.0,250.2899932861328,260.8500061035156,248.759994506836,256.9800109863281,238.4960784912109,GS,"Goldman Sachs Reportedly Picked to Lead Coinbase IPO ||| Why I Didn't Go All In On the Airbnb IPO ||| Here's Why Goldman Sachs Is Rising Monday ||| Monday's ETF with Unusual Volume: SPYX ||| US STOCKS-S&P 500 pares losses as U.S. stimulus passage expected ||| Markets Are Falling Monday -- But These 5 Stocks Are Looking Up ||| Monday Sector Leaders: Financial, Services ||| US STOCKS-S&P 500 ends lower as COVID worries lightened by stimulus ||| BUZZ-U.S. STOCKS ON THE MOVE-Tesla, RealPage, Eyegate Pharmaceuticals ||| Goldman Sachs, Morgan Stanley lead U.S. bank rally after stress test ||| US STOCKS-Wall Street drops on fears over new coronavirus strain ||| 2 Financial Stocks I'd Buy Right Now ||| S&P 500 Movers: FANG, GS ||| BUZZ-U.S. STOCKS ON THE MOVE-Nike, Boeing, NantKwest Inc ||| Dow Movers: INTC, NKE ||| US STOCKS-Futures tumble on fears over new coronavirus strain ||| US STOCKS-Futures tumble on fears over new coronavirus strain ||| US STOCKS-Wall Street set to drop on fears over new coronavirus strain ||| BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Nike, Boeing, RealPage ||| 3 Stocks That Cost Investors Billions in 2020",0,0.47683907
2020-12-22,3599800.0,256.8599853515625,257.70001220703125,249.8000030517578,250.08999633789065,232.10166931152344,GS,"Goldman Sachs Group's Preferred Stock, Series N Shares Cross 6% Yield Mark ||| Noteworthy Tuesday Option Activity: DD, GS, HUM",1,0.48875767
2020-12-24,968100.0,257.0400085449219,257.6199951171875,253.75,256.1600036621094,237.73504638671875,GS,"Year-End 2020: Investors Look Back, and Forward ||| What Nike Told Investors ||| US STOCKS-Wall Street set to rise on stimulus hopes; Alibaba falls on China probe",1,0.5055122
2020-12-28,2793400.0,257.8099975585937,262.6499938964844,257.0,259.5899963378906,240.9183349609375,GS,"Here's Why Tech Companies Are Fleeing Silicon Valley ||| US STOCKS-Wall St set to open near record highs after Trump signs fiscal aid bill ||| 4 Top Stock Trades for Tuesday: GM, NVDA, TTD, GS ||| DIA, HD, GS, AMGN: Large Outflows Detected at ETF ||| Japan's Daiwa bets on securities underwriting business in China, CEO says ||| Here Is What the Upcoming Coinbase IPO Means for Bitcoin ||| ANALYSIS-New direct listings won't spell the death of IPOs ||| Despite Rate Cuts, JPMorgan Still Has a 13% Upside ||| Here’s Why Moderna Stock Could Be the Stock of the Decade",0,0.49552697
2020-12-29,1430900.0,260.260009765625,260.8599853515625,256.5,258.010009765625,239.45201110839844,GS,"Investment banking from home thrived under COVID-19, but some fear losing their touch",1,0.51604414
2020-12-30,1566500.0,258.8099975585937,260.6499938964844,257.8299865722656,259.45001220703125,240.7884216308593,GS,Financial Stocks 2020: How the Pandemic Panic Played Out,1,0.51346225
2020-12-31,2043100.0,258.79998779296875,263.92999267578125,258.0,263.7099914550781,244.74200439453125,GS,"Biden's Treasury nominee Yellen discloses paid speaking gigs for financial firms ||| Moderna Stock Is More Than The Covid-19 Vaccine ||| Tech, cross-border activities set to drive Asia M&A next year ||| Fewer companies caught the deal bug in the year of the pandemic ||| Wells Fargo Is Trading Close To Its Fair Value",1,0.5325587
2021-01-04,3572000.0,267.0,267.5799865722656,260.1600036621094,265.0,245.93923950195312,GS,"5 IPOs to Look Forward to in 2021 ||| Virtu Financial moving some workers to Florida ||| US STOCKS-S&P 500, Dow aim record open as economic rebound hopes fuel rally ||| Despite Interest Rate Headwinds, Bank of America Stock Is Still A Good Investment",1,0.5397821
2021-01-05,4207100.0,263.8800048828125,273.5,262.57000732421875,270.92999267578125,251.44265747070312,GS,"IBM names former Goldman executive Gary Cohn as vice chairman ||| Noteworthy ETF Outflows: DIA, UNH, HD, GS ||| Goldman expects staff to return to offices by year-end - Bloomberg TV ||| 3 Fintechs That Might IPO Soon ||| Citi appoints Lucy Baldwin as global head of independent research",1,0.4957559
2021-01-06,6383500.0,276.2900085449219,288.3800048828125,273.1000061035156,285.54998779296875,265.0110778808594,GS,"The Surprise Stock Market Winner in the Georgia Senate Elections ||| Here's Why JPMorgan Chase, Goldman Sachs, and Citigroup Are Rising on Wednesday ||| Noteworthy Wednesday Option Activity: GS, TGT, ADBE ||| BUZZ-U.S. STOCKS ON THE MOVE-Imara Inc, DraftKings Inc, 500.Com Ltd ||| BUZZ-U.S. STOCKS ON THE MOVE-AmerisourceBergen, ReneSola Ltd, Big Tech stocks ||| GS Crosses Above Average Analyst Target ||| Britain to name former Goldman banker Sharp as next BBC chairman -Sky News ||| Britain to name former Goldman banker Sharp as next BBC chairman -Sky News ||| Goldman says Saudi's extra oil output cuts signal demand risks",1,0.5126679
2021-01-07,4009700.0,287.7699890136719,295.8900146484375,286.67999267578125,291.6499938964844,270.6723327636719,GS,Why Goldman Sachs Stock Jumped 11.9% in December ||| Online lender SoFi to go public through merger with Palihapitiya-backed SPAC ||| Growth Stock To Watch: FUTU Stock; China’s Answer To Robinhood ||| US STOCKS-Futures grind higher as Democrats win Senate control ||| US STOCKS-Wall Street set for higher open as Democrats take control of Senate ||| Canada M&A seen picking up after hitting 9-year low in 2020 ||| 2 Dividend Stocks to Supplement Your Social Security,0,0.48352978
2021-01-08,2800800.0,292.0,292.2799987792969,285.0599975585937,290.0799865722656,269.2152709960937,GS,"US STOCKS-S&P 500, Nasdaq hit record highs as stimulus hopes outweigh dire jobs report ||| Deals for 2021 ||| Dow Movers: MMM, CRM ||| Be Patient With Credit Suisse Stock",1,0.47762138
2021-01-11,2649700.0,286.79998779296875,295.0,284.20001220703125,293.8299865722656,272.695556640625,GS,"Goldman, JPMorgan, M. Stanley to delist some Hong Kong products after U.S. ban ||| Here's the Shocking Reason for the S&P 500's Strong Gains ||| China stocks rebound, Hong Kong hovers near 1-year high ||| Oil prices sapped by rising virus cases; anticipated drop in U.S. inventory stems losses ||| Goldman, JPMorgan, Morgan Stanley To Delist 500 Hong Kong-listed Products ||| PREVIEW-U.S. bank quarterly profits expected to fall again from pre-COVID levels",1,0.48646596
2021-01-12,4814400.0,297.1400146484375,303.9800109863281,296.0199890136719,302.2099914550781,280.4727783203125,GS,"EXCLUSIVE-Beauty industry supplier Knowlton readies IPO -sources ||| ANALYSIS-The trillion dollar weapon in the U.S.-China tech stock war ||| Banking ETFs Gain as Banks Pause Their Political Donations ||| MoneyLion SPAC Merger? 9 Things to Know About GSAH Stock and the Fintech Amid the Rumors ||| EXCLUSIVE-Biden to name Gary Gensler as U.S. SEC chair, sources say ||| US STOCKS-Wall Street set to rise as focus turns to earnings season ||| UBS Stock Is Expensive At The Current Levels ||| Oil prices dip on rising virus cases; expected stock draw stems losses ||| ANALYSIS-The trillion dollar weapon in the U.S.-China tech stock war",1,0.4832618
2021-01-13,2413800.0,300.0799865722656,303.7200012207031,299.1000061035156,302.94000244140625,281.1502990722656,GS,"Technology Sector Update for 01/13/2021: WIMI,INTC,VMW,CSIQ,GS",1,0.4957637
2021-01-14,3192200.0,304.04998779296875,309.4100036621094,303.5400085449219,307.8699951171875,285.7257080078125,GS,Goldman teams up with fintech startup Marqeta to build checking accounts ||| China's Vipshop appoints banks to lead HK secondary listing - sources ||| Goldman teams up with fintech startup Marqeta to build checking accounts,0,0.5045582
2021-01-15,3863700.0,301.19000244140625,304.8599853515625,296.8800048828125,301.010009765625,279.359130859375,GS,"10 Smart Stocks to Buy With $5,000 ||| Goldman Sachs Is Planning to Build Its Credit Card Business in 2021 ||| The Beautiful, Boring Secret to Landing 7% Dividends ||| EXCLUSIVE-Goldman eyes deals to boost Marcus-sources ||| JPMorgan Likely To Surpass Q4 Revenue Expectations, But The Stock Looks Overvalued ||| Index inclusion may boost China bonds flows to $140bln in 2021-Goldman Sachs ||| EXCLUSIVE-Goldman eyes deals to boost Marcus-sources ||| JPMorgan profit jumps on trading, investment banking strength",0,0.5067954
2021-01-19,6727800.0,305.0,306.6000061035156,293.79998779296875,294.20001220703125,273.0389404296875,GS,"Why I'd Love to See a Chamath Palihapitiya SPAC Take Instacart Public ||| The 5 Most Important Dow Stocks in 2021 ||| GLOBAL MARKETS-Asia shares pare losses as China economy rebounds ||| GM Partners With Goldman, Mastercard For Credit Card Launch ||| US STOCKS-Wall St set to open higher ahead of Yellen speech; spotlight on earnings ||| Financial Sector Update for 01/19/2021: GS, LC, BAC, XLF, FAS, FAZ ||| US STOCKS-Wall St closes higher as Yellen backs more stimulus ||| 4 Top Stock Trades for Wednesday: MS, HAL, PG, CLVS ||| US STOCKS-Wall St rises as Yellen speaks; spotlight on earnings ||| Goldman Sachs Just Shattered Earnings Expectations ||| US STOCKS-Wall St opens higher ahead of Yellen speech; spotlight on earnings ||| US STOCKS-Futures rise ahead of Yellen speech; spotlight on earnings ||| US STOCKS-Wall St closes higher as Yellen backs more stimulus ||| Goldman Sachs Group Inc. Reveals Gain In Q4 Bottom Line ||| Goldman Sachs profit surges past estimates on M&A, trading boost ||| Goldman Sachs profit surges on M&A, trading boost ||| Goldman Sachs Q4 Profit More Than Doubles; Results Top Estimates ||| Goldman Sachs Group Q4 20 Earnings Conference Call At 9:30 AM ET ||| Turkish Treasury mandates banks for dollar eurobond issue",0,0.5003805
2021-01-20,4792600.0,295.82000732421875,297.45001220703125,287.4800109863281,290.4700012207031,269.5772705078125,GS,Goldman Sachs 4Q Profit More Than Doubles Fueled By Trading Boom; Shares Slip ||| Goldman and Morgan Stanley raise US$13bn in TLAC funding ||| Saudi's NCB set for Gulf's lowest coupon on perpetual bonds with $1.25 bln deal ||| Goldman and Morgan Stanley return to bond primary for TLAC funding ||| ANALYSIS-Pricey U.S. stock valuations put burden on earnings to keep rally going ||| ANALYSIS-Pricey U.S. stock valuations put burden on earnings to keep rally going ||| ANALYSIS-Europe Inc earnings in no man's land between recession and recovery,0,0.510518
2021-01-21,2516000.0,290.45001220703125,292.739990234375,288.5299987792969,289.3699951171875,268.5563049316406,GS,"2 Big Fintech Stories to Watch ||| DIA, UNH, GS, HD: ETF Inflow Alert",1,0.5197583
2021-01-22,2568800.0,286.69000244140625,290.5899963378906,285.5,289.3900146484375,268.57489013671875,GS,Swedish payments firm Trustly targets second-quarter IPO - sources ||| Swedish payments firm Trustly targets second-quarter IPO - sources ||| Payments firm Flywire plans IPO at $3 billion valuation -sources,0,0.4871113
2021-01-25,4575000.0,285.5299987792969,286.3500061035156,277.5,283.0400085449219,262.6816711425781,GS,"Here's Why This Value Stock Is Up 56% in Almost 3 Months ||| Goldman says strengthening Turkish lira may be limited by reserve building ||| 3 Explosive IPO Stocks to Buy in 2021 ||| US STOCKS-Stimulus jitters dent Wall St's early gains; Nasdaq hits record ||| Goldman Sachs-backed ON24 seeks $2.22 bln valuation in IPO ||| Dow Movers: AXP, AAPL",0,0.4940517
2021-01-26,3296800.0,283.92999267578125,285.7699890136719,280.0799865722656,281.760009765625,261.4937438964844,GS,"Warren Buffett's 3 Biggest Stock Picks for 2021 ||| Validea Peter Lynch Strategy Daily Upgrade Report - 1/26/2021 ||| Validea David Dreman Strategy Daily Upgrade Report - 1/26/2021 ||| Wall Street Banks Had a Record Year. Can the Good Times Last? ||| Goldman Sachs CEO Solomon's annual pay drops 36% ||| Validea John Neff Strategy Daily Upgrade Report - 1/26/2021 ||| Citigroup Stock Is Trading 25% Below Its Fair Value ||| Saudi Arabia sells dual-tranche dollar bonds ||| Morgan Stanley, Goldman lead bonus jump for bankers in Asia - Bloomberg News",0,0.4576806
2021-01-27,3891800.0,276.0,277.3699951171875,271.32000732421875,273.3299865722656,253.6700592041016,GS,Goldman Sachs loses legal fight against EU cartel fine ||| Goldman Sachs Cuts CEO's Pay By $10 Mln Over 1MDB Scandal ||| Saudi Arabia raises $5 billion via dual-tranche bonds,1,0.5256901
2021-01-28,3778700.0,274.6099853515625,279.8299865722656,271.3299865722656,275.0199890136719,255.238525390625,GS,Robinhood raises $1 bln from its investors- NYT ||| Why GSX Techedu Is Tumbling 33% Today ||| Here's Why Amazon Will Never Be a Dow Jones Industrials Stock ||| Blue-chip UK employers try to soothe parental lockdown pain amid fears of burnout,0,0.5207317
2021-01-29,3412000.0,274.2699890136719,277.3999938964844,270.6199951171875,271.1700134277344,251.6654052734375,GS,"Wells Fargo CEO Scharf's pay drops nearly 12% in 2020 ||| Robinhood IPO? What Experts Are Saying Now Following the Reddit Fallout ||| Notable ETF Inflow Detected - DIA, UNH, HD, GS ||| Goldman Sachs raises MONETA stake to 10.45% amid offer from PPF ||| Goldman Sachs raises MONETA stake 10.45% amid offer from PPF",1,0.50709987
2021-02-01,2324100.0,272.6600036621094,276.79998779296875,272.0,274.7300109863281,254.9693756103516,GS,Morgan Stanley Stock Has More Room For Growth ||| Why The Container Store Is Racing 12% Higher Today ||| ANALYSIS-GameStop saga may provide early test of Biden administration ethics pledges,1,0.51823676
2021-02-02,5195500.0,278.32000732421875,288.25,278.0,286.9700012207031,266.3289794921875,GS,EXCLUSIVE-USA Rare Earth to explore public offering at value above $1 billion ||| Vodafone prepares telecom towers business for March IPO -sources ||| Vodafone prepares telecom towers business for March IPO - sources ||| Dow Analyst Moves: GS ||| Bumble IPO News: When Will Bumble Go Public? What is the Bumble IPO Price Range?,1,0.4970467
2021-02-03,2712800.0,286.6099853515625,289.8099975585937,285.17999267578125,288.54998779296875,267.7952880859375,GS,"Goldman Sachs names Susie Scher as chairman of its global financing group ||| U.S. companies set to post profit growth for Q4, which would defy forecasts ||| Is Deutsche Bank Stock Likely To Beat Consensus In Q4? ||| INSIGHT-After pledging disclosure, many UK banks still silent on race diversity data ||| Payment startup Payoneer to go public via $3.3 bln merger with Cohen-backed SPAC ||| 7 Growth Stocks Ready for the Next Leg Up",1,0.489263
2021-02-04,2994700.0,290.0,295.8299865722656,289.5199890136719,293.75,272.6213073730469,GS,"Lazard restructures in Australia amid M&A sector shake-up, hands advisory business to 'affiliated' firm ||| Should Value Investors Be Watching Goldman Sachs? ||| German watchdog orders Goldman Sachs to comply with money laundering rules ||| German watchdog orders Goldman Sachs to prevent money laundering, terrorist financing",0,0.495613
2021-02-05,2938100.0,295.0,297.239990234375,292.19000244140625,293.5,272.3892822265625,GS,Morgan Stanley has a chance to raise stakes in China ventures ||| Here's Why Bank of America Is a Warren Buffett Stock ||| Lazard restructures in Australia amid M&A sector shake-up,1,0.51392615
2021-02-08,2826200.0,295.0,300.8900146484375,294.5,300.1499938964844,278.5609741210937,GS,"Validea's Top Five Financial Stocks Based On John Neff - 2/7/2021 ||| Goldman appoints Swati Bhatia, David Stark to lead roles in consumer banking ||| EXCLUSIVE-Electric truck maker Xos in deal talks to go public -sources ||| Investor Mark Ein looks to raise $600 mln through two more SPACs ||| Noteworthy ETF Inflows: DIA, UNH, GS, HD ||| EXCLUSIVE-Electric truck maker Xos in deal talks to go public -sources ||| Goldman Sachs boosts U.S. GDP estimate, sees relief bill at $1.5 trillion ||| Egypt gets $3.75 billion in three-tranche bond sale",1,0.50462747
2021-02-09,2071700.0,299.6000061035156,302.45001220703125,297.70001220703125,300.4599914550781,278.84869384765625,GS,"Goldman Sachs Raises 2021, 2022 GDP Forecasts; Predicts 2024 Rate Hike",1,0.5068717
2021-02-10,3213700.0,300.0,305.17999267578125,297.75,304.2799987792969,282.3939514160156,GS,"EXCLUSIVE-Goldman, other financial firms add China staff, eyeing growth ||| SoftBank-backed Kahoot plans $7 billion Oslo listing in coming weeks - sources ||| 3 Dow Jones Stocks That Will Rise 40% or More -- If Wall Street's Bulls Have It Right",0,0.48418373
2021-02-11,2159900.0,303.9800109863281,305.010009765625,299.1700134277344,302.32000732421875,280.5749206542969,GS,Enphase Energy: Why This Solar Stock Hit a New 52-Week High Yesterday,1,0.5166143
2021-02-12,1977300.0,301.989990234375,306.70001220703125,301.7699890136719,306.32000732421875,284.2872009277344,GS,"Noteworthy Friday Option Activity: GS, MOH, SCI ||| Alan Mnuchin-backed SPAC to take health app Sharecare public for $3.9 bln",1,0.5081961
2021-02-16,2792200.0,310.0,312.9200134277344,309.2200012207031,311.9599914550781,289.5215148925781,GS,"Carlyle to exit Portuguese packaging maker Logoplaste -sources ||| BofA tops fines blacklist with US$82bn payouts in last 20 years ||| Goldman Sachs Group Reaches Analyst Target Price ||| Should Investors Own Square or PayPal? ||| Warren Buffett Made 3 Big Mistakes Recently -- Here's the Reason They Haven't Hurt Him ||| Goldman Sachs Launches Robo-Advisor Service With Only $1,000 Minimum to Open ||| US STOCKS-Wall Street set for record open on stimulus, recovery bets ||| Italy sees record demand in first bond sale under Draghi ||| Goldman Sachs unveils Marcus Invest robo-adviser in consumer push ||| Goldman Sachs to launch digital investment platform in Marcus push",1,0.49265495
2021-02-17,2333100.0,310.0299987792969,314.9800109863281,308.760009765625,312.739990234375,290.2453918457031,GS,Why Did Boston Omaha Hit a New All-Time High on Wednesday? ||| Goldman Sachs Raises 2021 Profit Estimate for the S&P 500 Index ||| Will Robinhood's IPO Be GameStopped?,0,0.49404165
2021-02-18,2093300.0,309.2200012207031,314.5,307.5799865722656,309.8999938964844,287.60968017578125,GS,"Bain hires banks to revive IPO of French car parts group Autodis -sources ||| Bain hires banks to reignite IPO of French car parts group Autodis - sources ||| Notable ETF Inflow Detected - VFH, BAC, WFC, GS ||| Dow Movers: WMT, WBA",1,0.49785927
2021-02-19,2749500.0,310.2300109863281,316.7799987792969,310.2300109863281,315.6199951171875,292.91827392578125,GS,Blank-check firm led by ex-Goldman banker aims for $500 mln IPO,1,0.5117162
2021-02-22,3162300.0,313.0,320.5599975585937,312.2099914550781,316.8699951171875,294.07830810546875,GS,"Former Bank of England Governor Carney joins board of digital payments company Stripe ||| Noteworthy Monday Option Activity: AAL, ORCL, GS ||| U.S. bank software provider Alkami plans IPO at $3 bln valuation - sources ||| The 1 Company I'll Be Buying When It Goes Public ||| ANALYSIS-For Black founders, venture funding remains elusive despite new funds ||| Carnival Floating $1 Billion in New Stock ||| Why ExxonMobil, ConocoPhillips, and Suncor Stocks Are Surging Monday",1,0.4939601
2021-02-23,2942500.0,317.9800109863281,320.0,310.5799865722656,319.2099914550781,296.2500305175781,GS,Chinese car maintenance start-up Tuhu plans U.S. IPO after $400 mln fundraising -sources ||| Bitcoin Replaces Gold as the Global Index of Fear and Greed ||| German labs supplier Ritter Medical explores options -sources,1,0.4826338
2021-02-24,3934400.0,320.1700134277344,330.9700012207031,320.1000061035156,330.6400146484375,306.8579406738281,GS,Leonardo plans to list up to 30% of DRS in New York - sources ||| Saudi Arabia completes second foray in euro market with 1.5 bln bond deal ||| Saudi Arabia gives final price guidance for euro-denominated bonds - document ||| Goldman Sachs-backed ReNew Power to go public via $8-bln SPAC deal ||| Goldman Sachs-backed ReNew Power to go public via $8-bln SPAC deal ||| Saudi Arabia gives initial guidance for euro-denominated bonds - sources,0,0.49812725
2021-02-25,4244000.0,333.3299865722656,335.8099975585937,326.2900085449219,327.760009765625,304.18505859375,GS,"Does Collapse of CCIV Stock Foreshadow the End of the SPAC Craze? ||| Daimler picks banks to help with listing of trucks unit -sources ||| Bank of America reduces staff in investment banking and trading - Bloomberg News ||| US STOCKS-Nasdaq, S&P set to open lower as tech shares fall amid rising bond yields",0,0.47719914
2021-02-26,3732200.0,325.7699890136719,328.67999267578125,319.0400085449219,319.4800109863281,296.5006408691406,GS,"US STOCKS-S&P 500, Nasdaq set to bounce back after rout ||| Goldman Sachs Group, Inc. (GS) Ex-Dividend Date Scheduled for March 01, 2021 ||| FOCUS-Banks weigh up home working - the new normal or an aberration?",1,0.4689063
2021-03-01,2957800.0,325.0,331.0400085449219,323.3099975585937,329.9200134277344,307.39239501953125,GS,"Goldman's consumer banking head Ismail joins Walmart fintech venture- Bloomberg News ||| Goldman Sachs to Relaunch Trading in Bitcoin Futures ||| GLOBAL MARKETS-Wall Street rallies on U.S. stimulus and vaccine hopes as bond markets calm ||| Notable Monday Option Activity: GS, UNVR, ADBE ||| Walmart Recruits 2 Goldman Sachs Execs for Its Fintech Start-Up ||| EXCLUSIVE-Goldman Sachs restarts cryptocurrency desk amid bitcoin boom ||| Spanish energy companies to carry the torch for renewable deals",1,0.49991372
2021-03-02,2850300.0,330.0,336.19000244140625,329.510009765625,330.94000244140625,308.3427124023437,GS,"Loeb's Third Point hires Goldman research analyst Heath Terry ||| ANALYSIS-Fixed-income markets wary of Fed decision on bank capital relief ||| Loeb's Third Point hires Goldman research analyst Heath Terry ||| DIA, GS, AMGN, BA: Large Outflows Detected at ETF ||| DraftKings (DKNG) Vs Penn National Gaming (PENN): Which Gaming Stock Is A Better Buy? ||| Instacart valuation more than doubles to $39 bln with latest funding round ||| Sunseap, Tenaga forming venture to trial Singapore electricity imports from Malaysia",1,0.512811
2021-03-03,3606300.0,333.67999267578125,340.1000061035156,333.25,334.42999267578125,311.594482421875,GS,"China's CIC eyes U.S. investment after fund with Goldman raised $2.5 bln ||| China CIC says to seek U.S. investments after fund with Goldman raised $2.5 bln ||| US STOCKS-S&P 500 set for slightly lower open as private jobs data disappoints ||| US STOCKS-Futures advance as vaccines, stimulus boost bets on economic rebound ||| Why Is Everyone Talking About Walmart Stock? ||| Sunseap, Tenaga to bid for trial Singapore electricity imports from Malaysia",0,0.49198678
2021-03-04,3647600.0,333.1300048828125,339.760009765625,323.9200134277344,329.2900085449219,306.8053894042969,GS,"Is CRISPR Stock Heading to $160 in 2021? ||| Listings boom, trading frenzy fuel record 2020 for investment banks ||| U.S. 10-yr Treasury yield to hit 1.9%-2% by year end -analysts ||| 4 Top Stock Trades for Friday: SNOW, TSLA, KR, GS ||| Why Vir Biotechnology Stock Is Falling Today",0,0.49287373
2021-03-05,3740200.0,335.5799865722656,335.5799865722656,316.4599914550781,327.3699951171875,305.0165405273437,GS,Why Micron Technology Stock Jumped on Friday ||| Goldman Sachs Could Earn $200 Million From Polar Vortex Energy Trading ||| Goldman poised to make $200 mln profit off Texas deep freeze - Bloomberg News ||| US STOCKS-Wall St set for higher open as labor market regains momentum ||| Capital Group calls for diversity data from portfolio companies - letter,1,0.5012418
2021-03-08,2998000.0,331.3599853515625,337.5899963378906,329.1000061035156,334.19000244140625,311.3708801269531,GS,Walmart Isn’t a Super-Conservative Stock Market Play Anymore,0,0.49251923
2021-03-09,3324800.0,328.6199951171875,336.3900146484375,325.57000732421875,330.5899963378906,308.0166015625,GS,"Notable Tuesday Option Activity: GS, NOW, SYF ||| When to Buy Cardano ADA Coin ||| Dow Movers: AXP, INTC ||| US STOCKS-Nasdaq set to bounce back as tech stocks gain ground ||| Goldman-owned Japanese renewables firm JRE up for sale -sources",1,0.504254
2021-03-10,3153100.0,332.07000732421875,342.3999938964844,331.5299987792969,342.0199890136719,318.6662292480469,GS,Lufthansa to start asset disposal programme with Airplus sale in summer -sources ||| Goldman Sachs to invest $10 bln over 10 years to support Black women,1,0.5058789
2021-03-11,2756600.0,338.6600036621094,345.0,336.4599914550781,342.1000061035156,318.7407531738281,GS,"With summer in sight, Goldman Sachs starts return-to-office push ||| Payments processor Flywire files paperwork to go public ||| Language-learning app Babbel targets 1 billion Frankfurt IPO -sources ||| POLL-Norway central bank rates seen on hold next week, hike draws nearer",1,0.5030087
2021-03-12,2436700.0,345.2200012207031,350.0,343.6400146484375,348.8099975585937,324.9925231933594,GS,"Dow Movers: AAPL, GS ||| Goldman Sachs sharpens push to win Asia SPAC market share ||| With summer in sight, Goldman Sachs starts return-to-office push",0,0.49986923
2021-03-15,2276200.0,349.44000244140625,352.4200134277344,342.0,346.04998779296875,322.4209899902344,GS,"Goldman holds top rank in activism defense, Spotlight takes No. 2 spot ||| Goldman Sachs board nominates Royal Dutch Shell CFO for director role ||| EXCLUSIVE-U.S. Congress launches probe into multibillion-dollar 'clean coal' tax credit",0,0.49421632
2021-03-16,2332600.0,345.2799987792969,346.8999938964844,337.75,341.7099914550781,318.3773803710937,GS,"Greece mandates investment banks for new 30-year bond issue ||| Digital payments firm SumUp borrows 750 mln euros to fund growth ||| Pick Apple Stock for Its Stability, Not Its Staggering Gains ||| Noteworthy Tuesday Option Activity: GS, FIVE, THO",1,0.5088491
2021-03-17,2710900.0,344.6199951171875,347.0299987792969,340.3999938964844,344.95001220703125,321.3961181640625,GS,Goldman-backed ThredUp looks to raise up to $168 mln through U.S. IPO ||| Sun Country Airlines IPO: 12 Things for SNCY Stock Investors to Know as Shares Debut ||| Better Buy: Amazon vs. Walmart ||| Saudi mall operator Arabian Centres plans $500 mln sukuk - sources,1,0.5075704
2021-03-18,3713000.0,350.75,356.8500061035156,346.989990234375,348.0,324.23785400390625,GS,"US STOCKS-Nasdaq slumps as bond yield surge hurts tech valuations ||| Goldman Sachs pledges another $500 mln in funding for minority-owned businesses ||| ANALYSIS-Dealmakers in Australia scramble for talent as new entrants flex muscles ||| Dow Movers: AAPL, JPM ||| US STOCKS-Nasdaq set to slump at open as bond yields spike ||| China's DMall hires three banks for over $500m US IPO - sources ||| Norway's Kahoot to explore secondary U.S. listing -CEO ||| US STOCKS-Nasdaq futures drop about 1% as bond yields spike",0,0.49550173
2021-03-19,3513000.0,346.4200134277344,347.239990234375,340.6300048828125,344.20001220703125,320.69732666015625,GS,These 2 Government Moves Cost the Stock Market 145 Dow Points Friday ||| KKR-backed cybersecurity firm KnowBe4 files for U.S. IPO ||| Benchmarks Notch Weekly Losses; Gold Charges Higher ||| Goldman Sachs Reportedly in Talks to Take Over JetBlue's Credit Card Operations ||| Penn National Is a Blue Chip for the Bros,0,0.48879573
2021-03-22,2094500.0,341.0599975585937,342.8800048828125,336.0,339.3299865722656,316.1598815917969,GS,"Goldman CEO to junior bankers: we are sending you more resources ||| Goldman CEO to junior bankers: we are giving you more resources ||| Dow Movers: GS, DIS ||| US STOCKS-Futures point to gains for tech-related stocks as bond yields ease",0,0.49263245
2021-03-23,2457500.0,337.6199951171875,341.8900146484375,331.3299865722656,331.7699890136719,309.1160888671875,GS,"Robinhood confidentially files for U.S. stock market listing - sources ||| EXCLUSIVE-Business payments firm AvidXchange preps for IPO, eyeing $7 bln valuation - sources ||| Apple card, underwriter Goldman Sachs committed no fair lending violations ||| Apple card, underwriter Goldman Sachs committed no fair lending violations ||| ThredUp IPO: When Does ThredUp Go Public? What Is the TDUP Stock IPO Price Range? ||| SoftBank-backed Compass targets $10 bln valuation in U.S. IPO ||| Canadian oil patch braces for more deals after record start to 2021",0,0.48524332
2021-03-24,3332200.0,333.4200134277344,336.94000244140625,328.44000244140625,328.6499938964844,306.2091369628906,GS,"Noteworthy Wednesday Option Activity: ADBE, INTC, GS ||| 5 Stable Cryptocurrencies With Room to Run Higher ||| Islamic Development Bank sells $2.5 bln in sustainability sukuk ||| Buy IPOE Stock Now That It Has SoFi Squarely in Its Sights ||| Saudi mall operator Arabian Centres says it intends to issue dollar sukuk ||| Islamic Development Bank gets orders over $1.7 bln for sukuk - document",1,0.51007086
2021-03-25,2804700.0,327.3500061035156,331.3900146484375,321.9200134277344,330.54998779296875,307.9793701171875,GS,"Cricut IPO: 16 Things for Potential CRCT Stock Investors to Know as Shares Begin Trading Today ||| PREVIEW-U.S. bank profits may leap, then fade, as investors look under the hood ||| US STOCKS-Tech stocks, banks set to drag Wall St lower at open ||| US STOCKS-Futures turn lower ahead of jobless claims report ||| US STOCKS-Futures rise as jobless claims expected to edge lower",0,0.49216923
2021-03-26,3082600.0,334.510009765625,335.45001220703125,322.69000244140625,327.3900146484375,305.0351867675781,GS,"Delisting Chinese Stocks? Why BIDU, VIPS and TME Stocks Continue to Fall ||| Want to Buy the Hottest IPOs? It's About to Get Much Easier ||| Citi hires Goldman's chief diversity officer ||| TDUP Stock IPO: 17 Things for ThredUP IPO Investors to Know As Shares Begin Trading Today ||| Citi hires Goldman's chief diversity officer ||| US STOCKS-Futures rise as bank, energy stocks gain on recovery hopes",0,0.48557767
2021-03-29,4533200.0,320.3500061035156,327.760009765625,317.7200012207031,325.7300109863281,303.488525390625,GS,"Goldman sold $10.5 bln of stocks in block-trade spree- Bloomberg News ||| Large block trades tied to Archegos raise worries about trading this week ||| Large block trades tied to Archegos raise worries about trading this week ||| This Stock is the Biggest Bargain in U.S. Cannabis ||| Value vs. Growth: 3 Successful Investors Weigh In on Where the Market Is Headed ||| Noteworthy ETF Inflows: DIA, GS, BA, CAT ||| US STOCKS-Banks lead Wall Street lower on hedge fund default concerns ||| Dow Movers: GS, BA ||| Top 5 Things To Watch In The Stock Market This Week ||| US STOCKS-Wall Street set to slip as bank stocks fall on hedge fund default concerns ||| US STOCKS-Futures slip as bank stocks fall on hedge fund default concerns",1,0.48339367
2021-03-30,2717300.0,329.4100036621094,335.75,328.8500061035156,332.010009765625,309.3397216796875,GS,"Wells Fargo plans to bring workers back to office in September ||| FOCUS-In Archegos fire sale, Credit Suisse, Nomura burned by slow exit ||| Dow Movers: CSCO, GS ||| Saudi mall operator Arabian Centres gives initial guidance for dollar sukuk - document ||| At $70, Citigroup Stock Doesn't Have Much To Offer ||| British climate activists to target banks in London protest",0,0.49658203
2021-03-31,2624500.0,330.2300109863281,332.6499938964844,325.44000244140625,327.0,304.6717834472656,GS,"Global M&A sets Q1 record as dealmakers shape post-COVID world ||| Big banks win dismissal of U.S. Treasury rigging litigation ||| SoftBank-backed Compass slashes target price for U.S. listing ||| Goldman to offer investments in digital assets for wealth management clients ||| Goldman Sachs Plans to Let Wealthy Clients Invest in Bitcoin ||| Dow Movers: IBM, WBA ||| FOCUS-In Archegos fire sale, Credit Suisse, Nomura burned by slow exit",1,0.5281352
2021-04-01,2659000.0,324.29998779296875,329.6600036621094,324.1600036621094,327.6400146484375,305.26812744140625,GS,Global M&A sets Q1 record as dealmakers shape post-COVID world ||| SoftBank-backed Compass valued at $8.22 bln in NYSE debut ||| Goldman promotes a flurry of female partners to executive roles ||| Climate activists splash black dye on Bank of England ||| 3 Top Value Stocks to Buy in April,0,0.5109899
2021-04-05,3235000.0,332.8500061035156,332.8500061035156,323.04998779296875,323.5400085449219,301.44805908203125,GS,"INSIGHT-Seduced by Archegos' growth, Nomura took a chance on Hwang comeback ||| Warburg Pincus applies to set up China brokerage venture ||| This 1 Thing Will Make or Break the Stock Market Rally ||| Discussing the Archegos Capital Fallout and PayPal's Cryptocurrency Move ||| Best Fintech Stocks To To Buy In April 2021? 4 Names To Watch ||| Goldman Sachs plans to return staff to London office - Guardian ||| 8 Major Players in the SPAC Game to Watch ||| Archegos-linked stocks slide as markets eye more unwinding ||| INSIGHT-Seduced by Archegos' growth, Nomura took a chance on Hwang comeback ||| Has Oprah Winfrey’s Sale Made Discovery Stock a Bargain? ||| Capital Energy bows out of Spanish green IPO race",1,0.48663208
2021-04-06,1801700.0,324.489990234375,328.5400085449219,324.0,327.0599975585937,304.72772216796875,GS,"'Millionaires tax' threat has some NY bankers, managers eyeing exits ||| Morgan Stanley dumped $5 bln in Archegos stock night before fire sale -CNBC ||| Financial Sector Update for 04/06/2021: GS,ROO.L,ARES,PAYX,GBOX ||| Goldman Sachs Group's Preferred Stock, Series K Shares Cross 5.5% Yield Mark ||| Goldman bought 75 mln pounds of Deliveroo shares to prop up IPO price - FT ||| Is Goldman Sachs the Value Stock for You? ||| Dow Movers: IBM, GS ||| Top 10 Lessons of the Archegos Collapse ||| Credit Suisse to Take Big Loss and Cut Dividend Following Archegos Debacle ||| 3 of the Best Value Stocks You Can Buy Right Now",0,0.4759624
2021-04-07,2157300.0,327.70001220703125,329.20001220703125,323.3500061035156,326.54998779296875,304.25250244140625,GS,Deliveroo ticks up as retail investors join trading,1,0.5505572
2021-04-08,2402800.0,324.2900085449219,331.489990234375,322.9700012207031,331.1400146484375,308.52911376953125,GS,"Noteworthy Thursday Option Activity: AMD, GS, DE ||| EXCLUSIVE-Brazilian payments network Elo picks banks for IPO - sources ||| U.S. Senate Banking chair presses Wall Street banks on Archegos ties ||| Prosus nets $14.6 billion from sale of Tencent stake ||| Prosus nets $14.6 billion from sale of Tencent stake",0,0.50012076
2021-04-09,2347100.0,334.0,334.8999938964844,328.7900085449219,330.8099975585937,308.2216491699219,GS,"Bridgewater, Amundi see rise in U.S. yields continuing; banks in sweet spot ||| US STOCKS-S&P 500, Dow climb for third day and close at records ||| US STOCKS-S&P 500, Dow climb for third day and close at records ||| US STOCKS-Futures tepid after S&P 500 ends at record level ||| Select Sector SPDR’s U.S. Market Weekly Summary – April 9, 2021 ||| EXCLUSIVE-China's Didi picks Goldman, Morgan Stanley for mega U.S. IPO-sources ||| BlackRock Stock To Edge Ahead Of Consensus In Q1?",1,0.5024736
2021-04-12,2318800.0,332.6700134277344,334.4800109863281,329.94000244140625,331.8399963378906,309.18133544921875,GS,"IPO Investing Could Be About to Get Much Easier ||| US STOCKS-S&P 500, Dow ease from record levels; earnings, data in focus ||| HSBC bans customers from buying bitcoin-backer MicroStrategy shares ||| US STOCKS-Wall St ends lower as investors await earnings, inflation data ||| US STOCKS-Wall St ends lower as investors await earnings, inflation data ||| US STOCKS-S&P 500, Dow dip ahead of earnings, inflation data ||| GLOBAL MARKETS-Stocks slip from record highs before U.S. bank earnings ||| US STOCKS-S&P 500, Dow slip from record highs ahead of earnings, inflation data ||| HSBC bans customers from buying bitcoin-backer MicroStrategy shares ||| GLOBAL MARKETS-Stocks slip off record highs ahead of earnings, U.S. data ||| U.S. lab products provider Avantor to buy Germany's Ritter for $1.1 bln ||| KKR-backed cybersecurity firm KnowBe4 aims for $3 bln valuation in U.S. IPO ||| US STOCKS-Futures slip after S&P 500, Dow's record close; earnings, data in focus ||| GLOBAL MARKETS-Stocks off record highs ahead of earnings, U.S. data ||| GLOBAL MARKETS-Asia shares anxious for earnings season, U.S. data deluge ||| In surprise development, angry Peruvians propel socialist in presidential race ||| In surprise development, angry Peruvians propel socialist in presidential race",0,0.46954244
2021-04-13,3575900.0,329.510009765625,330.04998779296875,324.17999267578125,327.67999267578125,305.3053894042969,GS,"US STOCKS-S&P 500, Nasdaq up as tech stocks rise after J&J vaccine pause ||| GLOBAL MARKETS-World stocks hit record high as bond yields ease with inflation fears ||| Why Tomorrow Will Be a Day of Reckoning for the Stock Market ||| US STOCKS-Tech stocks push S&P 500 to record close, buoy Nasdaq ||| Pre-Market Earnings Report for April 14, 2021 : JPM, WFC, GS, FRC, INFY, BBBY, LOVE ||| US STOCKS-S&P 500, Nasdaq up on tech gains; unfazed by vaccine pause, inflation ||| US STOCKS-S&P 500, Nasdaq up as tech stocks rise after J&J vaccine pause ||| US STOCKS-S&P 500 set for muted open on strong inflation ||| GLOBAL MARKETS-Global shares steady as investors await U.S. inflation data ||| A Huge Week Is Looming for Financial Sector ETFs ||| US STOCKS-S&P, Dow futures edge higher ahead of inflation data ||| European shares pause near record high with eyes on U.S. inflation data ||| Goldman Sachs to open office in Birmingham in UK ||| Here's How the Banks in the Archegos Blowup Fared",1,0.4866704
2021-04-14,9876800.0,328.54998779296875,344.4700012207031,326.1499938964844,335.3500061035156,312.4515991210937,GS,"US STOCKS-Wall Street ends mixed despite bumper bank earnings ||| EMERGING MARKETS-Mexico's Televisa rockets on merger plan; Latam currencies strengthen ||| GLOBAL MARKETS-Asian shares defensive, dollar struggles near 1-mth lows ||| 4 Top Stock Trades for Thursday: GS, DOGE, MARA, PLTR ||| Goldman Sachs Group Inc (GS) Q1 2021 Earnings Call Transcript ||| GLOBAL MARKETS-World stocks dip after new highs, dollar falls ||| US STOCKS-Wall Street ends mixed despite bumper big-bank earnings ||| Dow Movers: JPM, GS ||| Why the Stock Market Made Bank Wednesday Morning ||| GLOBAL MARKETS-World stocks soar to fresh peaks, dollar slips ||| Coinbase listing marks latest step in crypto's march to the mainstream ||| Good Stocks To Invest In Right Now? 4 Bank Stocks Making Headlines ||| Financial Sector Update for 04/14/2021: GS,HALL,WETF ||| US STOCKS-S&P 500, Dow rise on boost from bank earnings ||| Spain's Acciona hires banks for IPO of $9.6 bln energy unit ||| US STOCKS-Wall Street rises as big banks kick off earnings season ||| US STOCKS-S&P 500 dips off record high, Dow rises on bank earnings ||| Goldman Sachs Just Posted Its Best Quarter Ever ||| Goldman Sachs profit jumps on record global dealmaking ||| JPMorgan profit surges on trading, investment banking boost ||| Financial Sector Update for 04/14/2021: JPM, WFC, GS, XLF, FAS, FAZ ||| US STOCKS-Wall St set to open higher as JPMorgan, Goldman kick off bank earnings ||| GLOBAL MARKETS-World stocks post record highs as bond yields ease ||| Is Silvergate Capital the Growth Stock for You? ||| Goldman Sachs profit jumps on record global dealmaking ||| GLOBAL MARKETS-World stocks hit record high as bond yields ease ||| SAP, LVMH earnings nudge European stocks higher ||| Goldman Sachs Group Q1 21 Earnings Conference Call At 9:30 AM ET ||| The Positive Message From This Morning's Bank Earnings ||| Bank of America Stock To Beat Earnings Estimates In Q1? ||| Citigroup Stock Is Expected To Deliver Mixed Q1 Results ||| Coinbase listing marks latest step in crypto's march to the mainstream ||| US STOCKS-S&P, Nasdaq futures rise as JPMorgan, Goldman set to kick off earnings season",1,0.48885223
2021-04-15,4354800.0,338.8999938964844,341.3500061035156,334.5400085449219,338.54998779296875,315.4331359863281,GS,"Dow breaks 34k, S&P hits fresh record high on tech rally ||| First Week of April 16th Options Trading For Goldman Sachs Group ||| Dow hits milestone, S&P breaks record high on tech rally ||| US STOCKS-S&P 500, Dow extend record highs on tech stock gains ||| Mornings with Maria: Tom Lydon Talks Banks Earnings and ETF Inflows ||| US STOCKS-Technology stocks lead S&P 500, Dow to record highs ||| 3 Stocks to Fade Headed into the Sell-in-May Season ||| US STOCKS-S&P 500, Dow hit record highs on upbeat earnings, strong retail sales ||| GRAPHIC-Sustainable-bond issuance reaches record high in first quarter ||| Goldman’s 1Q Results Exceed Expectations As Revenues Outperform; Shares Gain ||| GRAPHIC-Sustainable-bond issuance reaches record high in first quarter ||| GLOBAL MARKETS-World stocks stay high, Russia's rouble buckles under sanctions stress ||| Goldman Sachs, Redpoint finance new round in Brazil's Olist ||| Nikkei closes nearly unchanged as tech shares cap gains ||| Apple creates fund for 'working forests' as part of carbon-removal efforts ||| US STOCKS-Futures rise on solid corporate results, jobless claims data awaited",1,0.4903644
2021-04-16,4231900.0,340.2900085449219,343.739990234375,338.6199951171875,342.3099975585937,318.9363708496094,GS,"After seed capital, Germany's Infarm hires Goldman to root out blank check -sources ||| US STOCKS-Wall St ends week positively; S&P 500, Dow hit record highs ||| US STOCKS-Wall St closes with weekly gains, S&P 500, Dow hit record highs ||| Nasdaq Stays Flat as Workhorse Drives Higher, Editas Sinks ||| Goldman Sachs Group's Preferred Stock, Series J Yield Pushes Past 5% ||| Goldman Sachs Sees Oil Demand From Transportation Peaking Within Five Years ||| US STOCKS-S&P 500, Dow hit record highs on bank earnings boost ||| US STOCKS-Wall St set to open higher after bumper earnings from big banks ||| US STOCKS-S&P 500, Dow hit record highs as Wall St indexes eye weekly gains ||| Validea David Dreman Strategy Daily Upgrade Report - 4/16/2021 ||| US STOCKS-S&P 500, Dow hit record highs on bank earnings boost ||| Goldman Sachs communications head Jake Siewert to leave - NYT ||| Morgan Stanley profit blows past estimates on dealmaking boom ||| US STOCKS-Futures muted after S&P 500, Dow hit record closing highs ||| Validea Peter Lynch Strategy Daily Upgrade Report - 4/16/2021",1,0.514643
2021-04-19,3228200.0,340.0,344.42999267578125,336.6000061035156,343.0899963378906,319.6630859375,GS,"3 Key Takeaways From Jamie Dimon's Annual Letter ||| Goldman Sachs invests $69 million in Britain's Starling Bank ||| PREVIEW-Investors turn to growth stocks' results after strong earnings start ||| Goldman Sachs Group's Preferred Stock, Series D Yield Pushes Past 4% ||| Here's Why I Think Goldman Sachs Group (NYSE:GS) Might Deserve Your Attention Today ||| Synlab aims for market capitalisation of up to 5 bln euros in planned IPO ||| Credit Suisse serves investors thin gruel as Wall Street feasts on deals ||| Why Goldman Sachs Group is the 'Top Dividend Stock of the Dow' With 1.5% Yield (GS)",0,0.54038227
2021-04-20,3662300.0,339.9700012207031,340.4700012207031,329.3500061035156,331.8800048828125,309.2185974121094,GS,"PREVIEW-Investors turn to growth stocks' results after strong earnings start ||| Here's Why Jamie Dimon Thinks We'll Be Working in Offices After the Pandemic ||| The 7 Best Blue-Chip Stocks for the Next Decade ||| Norwegian Cruise Lines Is Now a Buy, Says Goldman Sachs Analyst ||| Goldman Sachs says Black employees make up 6.8% of U.S. workforce",1,0.50123435
2021-04-21,2733300.0,330.0,335.4700012207031,327.5599975585937,335.2699890136719,312.3770751953125,GS,"4 Things We Learned from Goldman Sachs' Record First-Quarter Earnings ||| ANALYSIS-U.S. banks' bond bonanza driven by extraordinary market conditions, regulatory decisions ||| U.S. banks' bond bonanza driven by extraordinary market conditions, regulatory decisions",0,0.505395
2021-04-22,2165200.0,334.6199951171875,336.9700012207031,330.2900085449219,330.8500061035156,308.2589111328125,GS,"Goldman Sachs replenishes top ranks of consumer bank division ||| Why Nikola Stock Popped, While Fisker and Lordstown Dropped Today ||| How Morgan Stanley Lost Almost $1 Billion Last Quarter -- on 1 Client ||| Young UK investors choose cryptocurrencies over stocks - survey ||| ]Credit Suisse boosts capital as Archegos wipes trading gains ||| Credit Suisse posts 252 mln Sfr Q1 loss as Archegos wipes trading gains",1,0.4769245
2021-04-23,2163800.0,331.25,340.6700134277344,330.7200012207031,339.3500061035156,316.1784973144531,GS,"Is Apex Technology Merging With AvePoint Too Soon? ||| Notable Friday Option Activity: KMB, GS, ADBE ||| Is the S&P 500 All You Need to Retire a Millionaire?",1,0.49545568
2021-04-26,2171500.0,341.94000244140625,345.8999938964844,340.8900146484375,343.5199890136719,320.0636901855469,GS,"It's Unlikely That The Goldman Sachs Group, Inc.'s (NYSE:GS) CEO Will See A Huge Pay Rise This Year ||| UK economy set to grow faster than the U.S. this year -Goldman ||| Goldman Sachs watching total margin loans after Archegos fund blowup -executive ||| Noteworthy ETF Inflows: DIA, UNH, GS, MCD ||| The State of Real Estate in the United States ||| U.S. bank appetite for Treasuries unfazed after Fed ends regulatory relief ||| Fisker Stock at This Point Is Real Speculation, Not Just Paper ||| German eye wear retailer Mister Spex targets July IPO -sources ||| Goldman Sachs watching total margin loans after Archegos fund blowup -executive",1,0.48831376
2021-04-27,2088600.0,344.0,347.54998779296875,343.6600036621094,346.6300048828125,322.9614562988281,GS,Nomura logs biggest quarterly loss in over a decade on Archegos hit ||| Goldman's digital hedge-fund matchmaking push boosted by lockdowns,1,0.51051974
2021-04-28,2140900.0,348.0,350.1199951171875,346.0899963378906,348.1099853515625,324.3403015136719,GS,"If You Must Invest in a Cryptocurrency, Choose Ethereum ||| EIB raises 100 million euros from two-year blockchain bond - banker ||| War-rooms and oxygen: India's IT companies scramble to handle COVID-19 surge ||| Goldman sees commodities rallying over next six months on strong demand ||| Why GSX Techedu Stock Popped Today ||| Wealthfront gives green light to investment in cryptocurrencies",1,0.48566726
2021-04-29,2584400.0,350.54998779296875,353.8299865722656,347.4800109863281,352.9700012207031,328.8685607910156,GS,"METALS-Copper stabs close to $10,000/T level on Fed stimulus pledge ||| Investindustrial gears up for possible $1.2 bln Lifebrain sale - sources ||| METALS-Copper eyes $10,000/T level as U.S. dollar softens ||| Goldman shareholders nearly approve proposal requiring mandatory arbitration report ||| METALS-Copper stabs close to $10,000/T level on Fed stimulus pledge",0,0.48412335
2021-04-30,2101100.0,351.1199951171875,352.82000732421875,347.20001220703125,348.45001220703125,324.6571960449219,GS,"Notable Friday Option Activity: GS, RAPT, AMD ||| The 5 Biggest Bank Stocks Investors Need to Know ||| Could These 2 Big Bank Stocks Produce 10X Returns? ||| Barclays, BNP Paribas see profit spike from stock trading frenzy ||| BNP Paribas beats expectations for Q1 as equity trading rebounds",1,0.51360375
2021-05-03,1871700.0,350.3399963378906,354.0599975585937,349.260009765625,350.1600036621094,326.2503967285156,GS,Ranking the Big Bank Stocks: Which Is the Best Buy Now? ||| Warren Buffett's Favorite Bank Stock ||| Castor Maritime Shares Are Headed for Choppy Waters,0,0.48596135
2021-05-04,2831400.0,348.8999938964844,351.7799987792969,342.57000732421875,349.8399963378906,325.9522399902344,GS,"Goldman Sachs employees in U.S., UK to return to office by summer ||| Big Banks Make a Big Splash in Q1 ||| Goldman readies U.S. workers for return to offices in June - Bloomberg News ||| The Great Bitcoin Debate: Warren Buffett vs. Bill Miller ||| US STOCKS-Rotation out of megacaps drags Nasdaq futures lower ||| Blackstone hires former Goldman partner for its hedge fund unit ||| VAST valuation triples to $3.7 bln after Tiger Global-led investment",1,0.4838079
2021-05-05,2786800.0,352.0,359.1400146484375,348.54998779296875,357.6199951171875,333.20098876953125,GS,"US STOCKS-Dow ends at record high, Nasdaq falls as tech slides ||| KPMG UK staff to work in offices up to four days a fortnight from June ||| 3 Banking Stocks With Earnings You Can’t Ignore ||| US STOCKS-Wall St set to rise on growth stocks bounce, strong ADP data ||| US STOCKS-Futures rise as growth stocks bounce, economic data eyed",1,0.5018282
2021-05-06,3048700.0,359.7699890136719,366.2999877929688,356.5,365.9700012207031,340.9808349609375,GS,"FOCUS-Texas freeze delivers billions in profits to gas and power sellers ||| Goldman Sachs offers bitcoin derivatives to investors- Bloomberg News ||| EXCLUSIVE-U.S. remittance processor Remitly hires advisers for IPO -sources ||| Dow Movers: WBA, GS ||| 4 Copper Stocks To Watch Right Now",1,0.49898446
2021-05-07,3378100.0,362.2999877929688,371.6499938964844,360.9299926757813,370.8900146484375,345.5648803710937,GS,"Goldman Sachs Crypto: 17 Things to Know About the New Crypto Trading Team ||| US STOCKS-Nasdaq futures jump 1%, Dow negative after weak jobs data ||| US STOCKS-Futures edge higher ahead of non-farm payrolls data ||| China's Didi Chuxing to take 3.1% of passenger ride fees as profit",0,0.4908444
2021-05-10,3396300.0,373.5,376.9800109863281,368.5,368.6799926757813,343.5057678222656,GS,"Validea's Top Five Financial Stocks Based On David Dreman - 5/9/2021 ||| Bitcoin, SPACs, and More Key Takeaways From Berkshire Hathaway's Annual Meeting ||| Notable Monday Option Activity: GS, LYV, UNP ||| Why Norwegian Cruise Lines Rose 12.5% in April ||| Digital music company Believe plans Paris stock market listing",0,0.49550176
2021-05-11,3734300.0,363.0,368.6300048828125,358.6199951171875,359.9200134277344,335.3439636230469,GS,EXCLUSIVE-Toshiba board to appoint UBS as adviser for strategic review -sources ||| U.S. companies issuing bonds in foreign markets again after pandemic drop -Goldman ||| EXCLUSIVE-Toshiba board to appoint UBS as adviser for strategic review -sources,0,0.49585035
2021-05-12,3309800.0,363.0700073242188,368.1300048828125,353.2699890136719,354.3999938964844,330.20086669921875,GS,"EXCLUSIVE-Fed privately presses big banks on risks from climate change ||| Dow Movers: HON, CVX ||| US STOCKS-Wall St set to open lower as strong inflation stokes rate hike fears ||| FOCUS-Bankers quit London as Brexit relocations to EU step up",1,0.5300544
2021-05-13,2673900.0,353.25,360.8900146484375,353.25,358.8099975585937,334.3097229003906,GS,"US STOCKS-Wall St headed higher after fewer jobless claims, inflation data ||| US STOCKS-Futures slip for fourth day with focus on inflation data ||| EXCLUSIVE-Fed privately presses big banks on risks from climate change",1,0.50220233
2021-05-14,2732300.0,362.0,369.510009765625,361.7000122070313,368.7699890136719,343.58966064453125,GS,"JPMorgan Chase hires senior executive from Goldman's Marcus business - memo ||| Eni working with Goldman Sachs, Mediobanca on retail-renewable spinoff - sources ||| British commodities broker Marex Spectron plans London float ||| At $159, JPMorgan Stock Has A Limited Upside",1,0.4902915
2021-05-17,1826100.0,367.7799987792969,370.7000122070313,364.5,369.25,344.0368347167969,GS,"Brain gain: New boutiques, deals surge lure expat bankers to Australia ||| EXCLUSIVE-Goldman to launch Marcus UK robo-adviser early next year",0,0.51988703
2021-05-18,2018600.0,371.3800048828125,373.0799865722656,364.0,364.55999755859375,339.6670837402344,GS,"Up 40% YTD, Goldman Sachs Stock Is Trading Close To Its Fair Value",0,0.5061822
2021-05-19,3696000.0,360.0,360.0,353.92999267578125,358.3800048828125,333.9091186523437,GS,"Earnings Roundup: Peloton, Activision Blizzard, Cloudflare, and More ||| Wells Fargo to onboard active cryptocurrency strategy for rich clients ||| Financial Sector Update for 05/19/2021: FUTU, GS, GBCI, ALTA, XLF, FAS, FAZ ||| Does Cryptocurrency Belong in Your Investing Portfolio?",1,0.48329112
2021-05-21,2657500.0,361.489990234375,367.1400146484375,360.510009765625,366.260009765625,341.25103759765625,GS,Here's How Much Money Warren Buffett Has Made on Bank Stocks in 2021 ||| Warren Buffett's Latest Investing Mistakes ||| Will bankers embrace sensors under their desks when they return to work?,1,0.49162322
2021-05-24,1834300.0,367.3200073242188,369.7200012207031,365.510009765625,368.2900085449219,343.1424255371094,GS,"Fintech Marqeta Files to Go Public -- Here's What You Need to Know ||| Morgan Stanley Stock Is Trading Above Its Near Term Potential ||| Bank of America Stock Is Fairly Priced ||| Goldman's new director makes its board almost half female ||| Federal Reserve To Dip Toes In The Cryptocurrency ||| Cryptocurrency Exchange Operator Coinbase Could Skyrocket by 36%, Analyst Says ||| EXCLUSIVE-HSBC CEO says Bitcoin not for us ||| Goldman's new director makes its board almost half female ||| Coinbase appoints former White House staffer as chief policy officer ||| Goldman sees oil hitting $80/bbl despite likely return of Iran supply",0,0.4948108
2021-05-25,2631000.0,369.9100036621094,373.7699890136719,364.0899963378906,364.510009765625,339.6205444335937,GS,"Wall Street bank CEOs to tout COVID relief push, diversity efforts before Congress ||| As Markets Swoon, Investors Make the Bull Case for Coinbase ||| Noteworthy Tuesday Option Activity: GOOG, APD, GS ||| IXG, C, GS, BLK: ETF Outflow Alert ||| Wall Street bank CEOs to tout COVID relief push, diversity efforts before Congress ||| ANALYSIS-U.S. companies snub SPACs amid concerns they cannot deliver ||| China approves Goldman Sachs, ICBC joint wealth management venture ||| China approves Goldman Sachs, ICBC joint wealth management venture",1,0.49516612
2021-05-26,2121200.0,365.0,368.7900085449219,361.9100036621094,367.3999938964844,342.31317138671875,GS,"U.S. Justice Department starts probe on Archegos collapse - Bloomberg News ||| Wall Street CEOs get heat from Democrats, Republicans over social justice and 'wokeism' ||| Wall Street CEOs tout COVID assistance, diversity efforts before U.S. Senate",1,0.49900085
2021-05-27,3897000.0,371.3299865722656,373.5499877929688,367.2999877929688,371.3699951171875,346.0120849609375,GS,"Wall Street bank CEOs face fee criticism in second round with Congress ||| Wall Street bank CEOs face fee criticism in second round with Congress ||| Citigroup Stock Is Trading Slightly Below Its Fair Value ||| Goldman Sachs Group, Inc. (GS) Ex-Dividend Date Scheduled for May 28, 2021",1,0.46596
2021-05-28,2169700.0,372.0,373.0700073242188,368.260009765625,372.0199890136719,347.7883605957031,GS,Morgan Stanley nears full ownership of China ventures with stake buys ||| EXCLUSIVE-China presses Ximalaya to drop U.S. for Hong Kong as listing venue-sources ||| Morgan Stanley nears full ownership of China ventures with stake buys,1,0.49804574
2021-06-01,3644000.0,377.7000122070313,383.3599853515625,376.30999755859375,382.4400024414063,357.5296630859375,GS,"3 Great Stocks You Can Buy on Sale ||| Investors Who Worry About Bitcoin Should Remember These 3 Things ||| ZipRecruiter IPO: A Reopening Play? ||| EXCLUSIVE-Qatar Petroleum hires banks to run 'jumbo' bond sale in June ||| Goldman Sachs to double property investments in Japan - source ||| COLUMN-Funds cut copper exposure as Chinese impetus fades: Andy Home ||| Goldman, Citi lift Brazil 2021 GDP growth forecasts to over 5% ||| Top Credit Suisse FIG banker in Europe to join Jefferies -sources ||| Goldman Sachs revises up Brazil 2021 GDP growth forecast to 5.5% from 4.6% ||| COLUMN-Funds cut copper exposure as Chinese impetus fades: Andy Home",1,0.49789646
2021-06-02,2809700.0,383.3299865722656,384.6700134277344,379.3699951171875,383.4400024414063,358.4645080566406,GS,Citi picks Goldman partner for healthcare and consumer M&A 'super group' ||| 4 of the Best Cheap Stocks to Buy in June ||| Citi taps Goldman exec to lead healthcare-focused dealmaking 'super group' -memo ||| Growth Investors Should Get Excited for This Upcoming Fintech IPO ||| 4 Sports Betting Stocks to Wager On Right Now,1,0.5241878
2021-06-03,3003900.0,382.25,391.25,380.1300048828125,388.7200012207031,363.400634765625,GS,FOCUS-Banks bulk up in Hong Kong as China business overshadows politics ||| 2 Sports Stocks Poised for a Bull Run ||| The 4 Biggest Crypto Trends to Watch As We Move Beyond Bitcoin ||| JPMorgan seeks regulatory approval for full ownership of Chinese joint venture,1,0.5165542
2021-06-04,2514100.0,389.6799926757813,392.0499877929688,386.3200073242188,391.4500122070313,365.9527893066406,GS,"Why MicroVision Stock Popped but Blackberry, Koss, and Naked Brand Dropped ||| GS Crosses Above Average Analyst Target ||| FOCUS-Banks bulk up in Hong Kong as China business overshadows politics",0,0.483434
2021-06-07,2188700.0,393.0,393.260009765625,387.5499877929688,388.1600036621094,362.8770751953125,GS,"Financial Sector Update for 06/07/2021: UIHC, MIC, KKR, GS, V, XLF, FAS, FAZ ||| Acciona kicks off IPO of its energy unit, names bookrunners ||| Goldman Sachs partners with Visa for corporate payments",0,0.48419026
2021-06-08,2452600.0,385.7900085449219,386.4800109863281,382.2200012207031,384.7000122070313,359.6424865722656,GS,Emirates Development Bank sells $750 mln in five-year bonds ||| Emirates Development Bank tightens guidance for 5-yr dollar bonds - document,0,0.5198935
2021-06-09,2025900.0,383.1600036621094,384.2699890136719,378.8800048828125,382.7799987792969,357.84747314453125,GS,"US STOCKS-S&P 500 flirts with record high, 'meme' rally rolls on ||| Dow Movers: JPM, MRK ||| US STOCKS-Wall Street edges higher on tech gains, 'meme' stocks rally ||| US STOCKS-Wall Street set to inch higher, 'meme' stocks extend rally ||| If You're Going to Buy Cryptocurrency, This Coin Should Be Your First Buy",0,0.47057268
2021-06-10,3900800.0,389.6400146484375,389.6400146484375,372.3500061035156,373.9400024414063,349.583251953125,GS,Inflation Is Testing the Stock Market's Resolve ||| Goldman Sachs Asks Employees To Report Vaccination Status ||| Why Cardano’s Risk-Reward Ratio Is Negative ||| Goldman Sachs asks U.S. employees about vaccination status - memo ||| Bank regulators plot toughest capital rule for bitcoin ||| Bank regulators plan 'conservative' capital rule for bitcoin,1,0.5002321
2021-06-11,2117300.0,375.7000122070313,378.75,375.1099853515625,378.0499877929688,353.42559814453125,GS,"Finding the Best Semiconductor Stocks Amidst the Chip Shortage ||| Dow Movers: PG, MCD ||| Oil rally has more room to run, Brent expected to hit $80/bbl - Goldman",0,0.49965099
2021-06-14,2560500.0,377.4299926757813,378.75,370.7000122070313,372.9200134277344,348.6297302246094,GS,Marqeta IPO: Riding the Fintech Wave ||| Morgan Stanley CEO to staff: Be back at New York headquarters by September ||| Dubai plane leasing firm DAE adds more banks to bond deal ||| German eyewear retailer plans Frankfurt IPO,0,0.4992303
2021-06-15,2302900.0,373.5,374.8399963378906,367.1600036621094,371.2999877929688,347.1152648925781,GS,Dubai plane leasing firm DAE sells $1 billion in bonds ||| Dubai plane leasing firm gives initial guidance for 3-yr bonds - document,0,0.5115037
2021-06-16,3264200.0,370.989990234375,374.0799865722656,365.25,371.0,346.8348083496094,GS,"JPMorgan, Goldman Sachs delay workers' return to U.K. offices ||| Dow Movers: DOW, MRK ||| US STOCKS-Pre-Fed jitters to keep S&P 500, Nasdaq below record highs at open ||| US STOCKS-Fed jitters keep S&P, Nasdaq futures below record highs",0,0.47157538
2021-06-17,4146300.0,373.5199890136719,373.5199890136719,356.54998779296875,361.5,337.9535522460937,GS,"Brazil's BR Distribuidora launches share offering to sell Petrobras stake ||| A Good Quarter for RH and an Upgrade for ServiceNow ||| Why Are Bank Stocks Down Today? JPM, BAC, C, WFC, GS ||| Vanguard Financials ETF Experiences Big Inflow ||| Market Down? Here's 1 Stock to Own for the Long Term ||| Goldman-backed SPAC to take Mirion Tech public in $2.6 bln deal ||| Goldman-backed SPAC to take Mirion Tech public in $2.6 bln deal",0,0.48230794
2021-06-18,6290100.0,356.5199890136719,358.3800048828125,348.1300048828125,348.8299865722656,326.1087951660156,GS,"Financial Sector Update for 06/18/2021: GS,GLXY.TO,CME,CLBK,MGI,DLO ||| EXCLUSIVE-U.S. nickel-cobalt miner Missouri Cobalt hires bank to go public through SPAC ||| EXCLUSIVE-U.S. nickel-cobalt miner Missouri Cobalt hires bank to go public through SPAC ||| EXCLUSIVE-General Atlantic-backed Hotmart hires banks for Nasdaq IPO - sources ||| Dow Movers: INTC, CAT ||| US STOCKS-Wall Street set to drop at open after hawkish Bullard remarks ||| Goldman sees Fed-driven dip in commodities as a 'buying opportunity' ||| US STOCKS-Recovery bets keep S&P, Nasdaq futures near record highs ||| India's Paytm seeks shareholder approval for $1.6 bln sale of new stock",1,0.49128327
2021-06-21,2717300.0,352.8900146484375,357.9700012207031,351.0400085449219,357.5400085449219,334.25152587890625,GS,"US STOCKS-Banks, oil stocks set Wall St for rebound after Fed-induced rout ||| CNH Industrial to Acquire Raven Industries for $2.1B ||| US STOCKS-Futures rise after Fed-induced rout ||| Goldman Launches Transaction Banking in Britain ||| Global banks in Hong Kong push to get staff back to office ||| Goldman Sachs expands transaction bank to Britain",0,0.5052279
2021-06-22,1870800.0,357.0,359.8800048828125,352.6400146484375,357.5299987792969,334.2421875,GS,"U.S. Fed bank stress tests pave way for stock buyback, dividend bonanza ||| U.S. Fed bank stress tests pave way for stock buyback, dividend bonanza ||| Analysts Expect HIPR To Hit $73 ||| Will JPMorgan Chase's Consumer Banking Foray in the U.K. Pay Off? ||| Mister Spex listing price range points to $1 bln euro Frankfurt IPO",1,0.4898411
2021-06-23,1713100.0,358.7900085449219,362.4800109863281,357.6600036621094,361.0499877929688,337.53289794921875,GS,"NFL-NFL explores strategic partnership for media assets ||| Why Orphazyme Stock Skyrocketed 24.6% Today ||| NFL exploring options for media properites, including stake sale - WSJ ||| US STOCKS-Nasdaq set to open at record high ahead of business activity data ||| Call centre software company Aircall passes $1 bln valuation ||| Auto financing startup Lendbuzz raises $360 mln in debt and equity",1,0.51406014
2021-06-24,2716600.0,363.0,370.8800048828125,362.7799987792969,368.75,344.7313842773437,GS,"Banks clear Fed stress test; paving way to boost buybacks, dividends ||| Banks clear Fed stress test, paving way to boost buybacks, dividends ||| Noteworthy Thursday Option Activity: HSY, GOOG, GS ||| GS August 6th Options Begin Trading ||| US STOCKS-Nasdaq set for record open as jobs recovery gains traction ||| US STOCKS-Nasdaq 100 futures scale new peak ahead of jobless claims data",1,0.48550215
2021-06-25,2782400.0,368.8200073242188,371.1499938964844,364.5400085449219,368.7699890136719,344.7500305175781,GS,"Doximity IPO: 16 Things to Know About DOCS Stock After Its 103% Debut ||| Spanx taps Goldman Sachs to explore options including sale - NYT ||| German fintechs Raisin and Deposit Solutions join forces ||| US STOCKS-S&P, Nasdaq futures at peaks ahead of crucial inflation report",0,0.48497862
2021-06-28,1833400.0,367.7999877929688,368.8699951171875,363.8599853515625,368.7099914550781,344.6939392089844,GS,"Juventus sounds out banks for potential capital hike - sources ||| Goldman, Blankfein, Cohn must face shareholder lawsuit over 1MDB scandal ||| Wall Street banks hike shareholder payouts after Fed gives the green light ||| Michael Burry’s Big Bet on Facebook Still Has Legs ||| Qatar Petroleum hires banks for four-tranche jumbo bond sale ||| Juventus sounds out banks for potential capital hike - sources",1,0.49744967
2021-06-29,2365900.0,374.8599853515625,378.0899963378906,370.75,372.6199951171875,348.34930419921875,GS,"4 Financial Stocks To Watch In July 2021 ||| US STOCKS-S&P, Nasdaq rise to record closes ||| US STOCKS-Tech stocks propel S&P 500, Nasdaq to fresh highs ||| US STOCKS-Tech stocks propel S&P 500, Nasdaq to fresh highs ||| Why Dividend Investors Are Sending Stock Markets Higher on Tuesday ||| Bank stocks set Dow for higher open ahead of consumer confidence data ||| Canadian HR tech firm Visier becomes unicorn after Goldman-led investment ||| US STOCKS-Dow futures inch up as banks gain ahead of consumer confidence data ||| Britain's LR to focus on shipping with sale of division to Goldman Sachs arm ||| US STOCKS-Bank, tech stocks propel S&P 500 to new highs ||| Banks, tech stocks propel S&P 500 to new highs",1,0.49668714
2021-06-30,2238400.0,370.8999938964844,380.1099853515625,370.8999938964844,379.5299987792969,354.8092041015625,GS,"My 3 Biggest Stock Market Predictions for July ||| EXCLUSIVE-Swiss telecoms group Salt targets $2.7 bln valuation in autumn float -sources ||| DIA, GS, MSFT, BA: ETF Outflow Alert ||| Qatar Petroleum grabs $12.5 bln in emerging market bonds record ||| Alpha Bank share sale oversubscribed, priced at 1.0 euro/share ||| These 5 Bank Stocks Just Increased Their Dividends ||| Has Anything Changed For Pershing Square Tontine Holdings? ||| Big Banks Launch a Flurry of Dividend Increases: Here Are the Winners and Losers ||| Goldman says more OPEC+ supply needed to balance oil market",0,0.52170044
2021-07-01,2571000.0,380.7000122070313,381.6400146484375,374.1499938964844,374.989990234375,350.5649108886719,GS,"EQT, Goldman near $9 bln deal to buy contract research firm Parexel - WSJ ||| EQT, Goldman near deal to buy contract-research firm Parexel for nearly $9 bln - WSJ ||| Notable Thursday Option Activity: GS, LMND, MEG ||| Online brokerage Robinhood makes IPO filing public ||| ANALYSIS-U.S. companies spend billions on stay-at-home tech, boding ill for office properties ||| Dow Movers: WBA, CVX ||| Abu Dhabi's ADNOC adds Goldman Sachs to lead banks on drilling IPO ||| Abu Dhabi's ADNOC adds Goldman Sachs to lead banks on drilling IPO -sources ||| SentinelOne IPO: 13 Things to Know About S Stock as the Cybersecurity Company Goes Public ||| GS August 13th Options Begin Trading",0,0.49693838
2021-07-02,1598900.0,376.30999755859375,376.6000061035156,372.4200134277344,374.1600036621094,349.7889709472656,GS,"EQT, Goldman to buy clinical research firm Parexel for $8.5 bln ||| German car part firm Autodoc plans autumn IPO at 5 bln euro valuation - sources ||| Citigroup to raise base pay for junior bankers - memo ||| Why SoFi's Leadership Is a Strength ||| EQT, Goldman to buy clinical research firm Parexel for $8.5 bln ||| Why Coupang Stock Soared This Week ||| US STOCKS-S&P futures at record high ahead of nonfarm payrolls data",0,0.49456394
2021-07-06,2162900.0,373.2300109863281,373.6300048828125,365.4100036621094,369.8599853515625,345.7689819335937,GS,"1 Thing You're Missing About Goldman Sachs ||| Wall St Week Ahead-Investors eye high-dividend stocks as Treasury yields languish ||| India's Paytm to file draft prospectus next week for $2.3 bln IPO -sources ||| Credit Suisse names Goldman's Hannaford to lead tech ops as Walker decamps to U.S. ||| With European recovery in sight, property investors bank on the office ||| Goldman sees crude oil output path uncertain as OPEC+ talks cease ||| Why Limelight Networks Stock Tanked Today ||| Dow Movers: MMM, AXP",0,0.51425475
2021-07-07,2012800.0,367.5,370.0899963378906,362.1799926757813,367.6700134277344,343.72174072265625,GS,"US STOCKS-Nasdaq futures scale new peak, all eyes on Fed minutes ||| Dow Analyst Moves: GS ||| Dow Movers: GS, AAPL ||| These 2 Dow Leaders Are Hurting the Stock Market ||| ANALYSIS-U.S. IPO market a danger zone for Chinese firms after Beijing crackdown ||| US STOCKS-Tech surge puts Nasdaq on course for record open ||| ANALYSIS-U.S. IPO market a danger zone for Chinese firms after Beijing crackdown ||| Deutsche Bank hires Goldman's Jeffrey Wong for HK banking role",0,0.47630823
2021-07-08,2940500.0,359.69000244140625,362.8900146484375,355.5899963378906,358.94000244140625,335.5603332519531,GS,"Dow Movers: GS, AMGN ||| SoFi Has a Top-Notch Leadership Team  ||| PREVIEW-U.S. banks to see big jump in 2Q profits before results return to normal ||| 4 Things to Expect from Q2 Bank Earnings ||| Younited raises $170 mln from Goldman Sachs, Bridgepoint ||| Morgan Stanley Stock To Increase Quarterly Dividend By 100% ||| ANALYSIS-U.S. IPO market a danger zone for Chinese firms after Beijing crackdown ||| 3 Blue-Chip Stocks to Trade Right Now ||| DIA, GS, MSFT, CRM: ETF Inflow Alert",1,0.48472634
2021-07-09,2641800.0,366.0,372.1499938964844,364.9500122070313,371.760009765625,347.5452880859375,GS,"Dow Movers: MSFT, CAT ||| How Big Banks Celebrated Passing Their Stress Tests ||| Wall St Week Ahead-Investors eager for earnings amid growth concerns ||| Noteworthy Friday Option Activity: GS, GOOG, ADBE ||| GRAPHIC-Take Five: Bond bulls, China's conundrums and U.S. earnings ||| GRAPHIC-Take Five: Bond bulls, China's conundrums and U.S. earnings ||| JPMorgan Stock To Edge Past Revenue Estimates in Q2, Earnings To Miss Consensus ||| US STOCKS-Wall Street set to open higher as banks, energy stocks rebound",1,0.49374473
2021-07-12,4135900.0,370.30999755859375,384.0,367.3299865722656,380.5,355.7160339355469,GS,"TA Associates makes $2.8 bln takeover approach for Smiths Group unit - Mail on Sunday ||| Wall St Week Ahead-Investors eager for earnings amid growth concerns ||| US STOCKS-Tesla lifts S&P 500 to record highs ||| Pre-Market Earnings Report for July 13, 2021 : JPM, PEP, GS, FRC, FAST, CAG, ANGO, OGI ||| Saudi Aramco drops Morgan Stanley on gas pipelines deal -sources ||| Will Earnings Keep the Bull Market Roaring? ||| Saudi Aramco drops Morgan Stanley on gas pipelines deal -sources ||| US STOCKS-Tesla lifts Wall Street to close at record highs ||| Tesla lifts Wall Street to close at record highs ||| Dow, S&P futures edge lower as focus turns to earnings, economic data ||| GLOBAL MARKETS-COVID Delta upsurge keeps stock and commodity bulls in check ||| India's Paytm seeks to raise $268 mln in pre-IPO share sale-source ||| Nasdaq, S&P 500 hit new highs as focus turns to earnings, economic data ||| GLOBAL MARKETS-COVID Delta upsurge keeps stock and commodity bulls in check ||| ANALYSIS-JPMorgan, Goldman bet on tech to crack UK consumer market ||| Wall St set for mixed open as focus turns to earnings, economic data",0,0.4832549
2021-07-13,6466800.0,381.05999755859375,385.3299865722656,372.010009765625,375.9800109863281,351.4904479980469,GS,"Apple's potential 'buy now, pay later' plan sends sector tumbling ||| Why Affirm Holdings Stock Was Sinking Today ||| Nasdaq hits record high as growth stocks rise; inflation data weighs ||| GLOBAL MARKETS-Dollar gains, stocks falter after U.S. inflation data ||| Can These 2 Big Bank Stocks Beat Inflation? ||| Dow Movers: BA, KO ||| Best Bank Stocks To Buy Now? 3 Reporting Earnings This Week ||| Apple, Goldman Sachs planning 'buy now, pay later' service - Bloomberg News ||| US STOCKS-S&P 500 and Nasdaq fall after hitting record highs ||| US STOCKS-S&P 500 and Nasdaq end down after hitting record highs ||| US STOCKS-S&P 500 and Nasdaq end down after hitting record highs ||| 4 Top Stock Trades for Wednesday: AMC, BA, GS, PEP ||| GLOBAL MARKETS-Stocks slip after U.S. inflation data ||| CHPT Stock: Why ChargePoint’s Battery Is Draining Today ||| US STOCKS-Wall Street set for lower open after inflation data; earnings limit declines ||| Financial Sector Update for 07/13/2021: FRC, JPM, GS, ING, C ||| GLOBAL MARKETS-Stocks simmer near record highs ahead of U.S. inflation data ||| GLOBAL MARKETS-Stocks edge up on China exports, U.S. inflation data awaited ||| Goldman Sachs rides global dealmaking boom to smash profit estimates ||| ANALYSIS-Digital rivals? Central bank e-cash plans prompt lenders to wade in ||| GLOBAL MARKETS-China data, tech drive Asian shares higher ||| GLOBAL MARKETS-China data, tech drive Asian shares higher ||| European shares ease from peak; banks, miners boost UK stocks ||| Goldman Sachs, Warburg Pincus-backed firm buy $488 mln of Chinese logistics assets ||| Arabian Centres looks to top up Islamic bonds deal ||| JPMorgan profit surges on investment banking boost ||| JPMorgan profit surges on investment banking boost ||| EXCLUSIVE-U.S. SEC focuses on bank fee conflicts as it steps-up SPAC inquiry -sources ||| Goldman Sachs profit soars on global dealmaking frenzy",0,0.488491
2021-07-14,3295700.0,378.75,381.7699890136719,371.3900146484375,374.3999938964844,350.0133056640625,GS,US STOCKS-S&P 500 climbs and Nasdaq dips in choppy session ||| S&P 500 ends higher after Powell lulls market ||| Citigroup Stock To Post Mixed Results In Q2 ||| Top U.S. banks smash profit estimates on rebounding economy ||| Wall Street Love Is Sending These 2 Nasdaq Stocks Higher ||| S&P 500 hits record high as Powell calms taper fears ||| Wall St eases as declines in cyclicals outweigh boost from growth stocks ||| Citigroup profit beats estimates on reserve release ||| US STOCKS-Futures edge higher as earnings reports pour in; Powell testimony eyed ||| Wells Fargo beats profit estimates on reserve release boost ||| Italy's Ali Group hungry for bigger slice of U.S. fast-food market ||| US STOCKS-Wall Street set to rise as Powell calms taper fears ||| Goldman Sachs Reports Blowout Q2 Results; Hikes Dividend by 60%,0,0.49414337
2021-07-15,2183900.0,371.239990234375,378.75,370.5700073242188,373.3500061035156,349.03173828125,GS,"Why BlackBerry, GameStop, and Kodak Stocks Got Destroyed This Week ||| Goldman Sachs Group's Preferred Stock, Series K Shares Cross 5.5% Yield Mark ||| Investors Should Wait Out The Price Volatility In Ethereum ||| Is It Game Over for Affirm? ||| Morgan Stanley beats profit estimates on capital market, deal-making boom ||| 3 Top Stocks in Fintech ||| ANALYSIS-Return to the U.S. office? Ask the CEO ||| Morgan Stanley Stock To See Mixed Results In Second Quarter ||| Company Of The Day: Goldman Sachs",0,0.47534183
2021-07-16,2583300.0,374.9299926757813,374.9299926757813,363.8299865722656,364.7999877929688,341.03857421875,GS,"Big U.S. Banks Crush Q2 Earnings, Is Loan Growth On The Cards? ||| Wall St to open higher as cyclical stocks rise after retail sales data ||| US STOCKS-Futures edge higher ahead of retails sales data ||| Stocks Struggle for Direction as Banks Jumpstart Earnings Season ||| India's Paytm files draft papers for $2.2 bln IPO",0,0.5051155
2021-07-19,4394600.0,354.0,355.19000244140625,349.0,354.7200012207031,331.6152038574219,GS,"Don't Ignore The Fact That This Insider Just Sold Some Shares In The Goldman Sachs Group, Inc. (NYSE:GS) ||| Goldman Sachs sees 'upside' to oil price forecasts from OPEC+ supply deal ||| Bank of America: Keep Riding This Winning Financial Stock ||| Why Did Wells Fargo Shut Down Personal Lines of Credit? ||| Dow Jones Tumbles 863 Points on COVID-19 Surge Fears, on Track for Worst Day in Nine Months ||| Is This the Long-Awaited Stock Market Crash? ||| Dow Movers: BA, WMT ||| Why Goldman Sachs Group is a Top 25 Dividend Giant (GS) ||| US STOCKS-Dow futures slide 1% as virus surge raises growth worries ||| INSIGHT-A scandal cost Brazil billionaire bank CEO his job, but not control ||| US STOCKS-Wall Street set to tumble at open as virus surge sparks recovery worries",1,0.49342096
2021-07-20,2937900.0,352.2699890136719,367.30999755859375,351.5400085449219,364.760009765625,341.0012512207031,GS,"Goldman cuts Q3 Brent forecast to $75 a barrel on Delta demand hit ||| Barclays appoints new co-heads of investment banking ||| Brazilian oncology chain Oncoclinicas files for $670 million IPO ||| What Crash? Dow Jones Surges 600 Points on AmEx, Goldman, Boeing Stock Gains ||| 7 Best Bank Stocks to Buy Following Q2 Earnings Headlines ||| US STOCKS-Wall St set to open higher after steep selloff, IBM gains on strong results ||| Nasdaq teams up with banks to create separate market for pre-IPO stocks ||| Indian food delivery startup Swiggy raises $1.25 bln from SoftBank, Prosus ||| UBS profit leaps 63% in Q2 amid wealth management boom ||| Nasdaq partners with major banks to spin out trading platform for pre-IPO stocks ||| Goldman Sachs Opens New Office in India, to Hire Over 2,000 Employees",1,0.5095752
2021-07-21,2398800.0,368.0400085449219,374.8999938964844,367.9299926757813,373.5,349.1719665527344,GS,"Why ConocoPhillips Stock Soared Today (It Wasn't Just Oil Prices) ||| US STOCKS-Upbeat earnings, recovery optimism set S&P 500, Dow for higher open ||| Infosys reopens offices as India Inc eyes long road back to work ||| UBS Stock To Beat The Revenues Consensus In Q2? ||| US STOCKS-Upbeat earnings, recovery optimism lift Wall St futures ||| Climate friendly cooling tech firm gets $50 mln from Goldman Sachs",0,0.48345956
2021-07-22,1887100.0,372.2999877929688,373.6900024414063,368.4500122070313,372.7099914550781,348.4334411621094,GS,Blackstone doubles second quarter earnings on surging asset sales,1,0.53734046
2021-07-23,1706900.0,374.5899963378906,378.0,371.3800048828125,374.0499877929688,349.68609619140625,GS,"Goldman Sachs settling crypto ETPs in Europe - Coindesk ||| Bitcoin Price Predictions: Despite Recent Slump, Could BTC Hit $100K by Year-End? ||| Dividends Soon to Be ""Unleashed"" for Hikes Up to 100%",1,0.51211524
2021-07-26,1559100.0,373.1799926757813,376.6799926757813,373.1099853515625,375.8999938964844,351.4156188964844,GS,"Robinhood CEO says he is considering offering U.S. retirement accounts ||| Is Live Nation Entertainment Stock Heading to $110? ||| Glencore reaches $9.85 mln zinc rigging settlement in New York ||| Noteworthy Monday Option Activity: GS, FCX, PVH ||| Goldman Sachs taps into Fiserv's clients to grow transaction banking ||| Insud Pharma to sell stake in biotech unit mAbxience - sources",0,0.508159
2021-07-27,1791800.0,372.5,375.1400146484375,369.2200012207031,374.8399963378906,350.4246826171875,GS,Big Takeaways From the Big Banks' Earnings ||| Credit Suisse investment bank set for Archegos aftershocks ||| Credit Suisse appoints Goldman Sachs' Wildermuth to lead risk turnaround ||| Credit Suisse appoints Goldman Sachs' Wildermuth to lead risk turnaround,0,0.47835314
2021-07-28,1668900.0,375.80999755859375,377.4400024414063,372.3399963378906,374.2300109863281,349.8544311523437,GS,"China's markets regulator talks to banks to calm jitters - sources ||| Robinhood, gateway to 'meme' stocks, raises $2.1 billion in IPO-source ||| Battery recycling firm Redwood raises $700 mln from big fund managers",1,0.519469
2021-07-29,1296600.0,377.0299987792969,379.510009765625,374.80999755859375,377.5499877929688,352.9580993652344,GS,China's efforts to calm investor jitters help markets rebound ||| These Stocks Are a Value Investor's Dream,0,0.4956475
2021-07-30,1474900.0,376.5700073242188,379.9500122070313,373.05999755859375,374.8800048828125,350.4620666503906,GS,"Omers Infra, Goldman to buy German labs group Amedes ||| Retail rebound spurs profit rise at France's BNP as charges drop",1,0.5213248
2021-08-02,2383200.0,376.1700134277344,386.9299926757813,375.75,378.1900024414063,353.55645751953125,GS,"Goldman Sachs to raise pay for junior investment bankers - Business Insider ||| Wall St Week Ahead-Earnings bounce, bond-yield drop help keep party going for U.S. stocks ||| Space Tourism and More Market News ||| Dow Movers: CRM, GS ||| 3 Companies That Crushed Earnings Estimates This Quarter ||| US STOCKS-Stimulus hopes lift Wall St futures ahead of manufacturing PMIs",1,0.50241
2021-08-03,1494600.0,380.25,381.30999755859375,371.7699890136719,380.3599853515625,355.58514404296875,GS,"Apple, Affirm to launch buy-now-pay-later program for Canadian purchases - Bloomberg News ||| Ottobock hires Deutsche Bank, Goldman for 2022 listing -source ||| Investment banks see chance of later rate cuts in Turkey ||| Dow Movers: AXP, HD ||| The $29 billion deal in 11 weeks: how Square bought Afterpay",0,0.50260526
2021-08-04,1460500.0,378.4800109863281,382.6499938964844,375.760009765625,377.8599853515625,353.2479248046875,GS,"Validea David Dreman Strategy Daily Upgrade Report - 8/4/2021 ||| US STOCKS-Futures tread water after S&P 500 hits record high ||| Goldman Sachs Group's (NYSE:GS) Shareholders Will Receive A Bigger Dividend Than Last Year ||| Betsy Cohen's SPAC to take tech firm Pico public in $1.75 bln deal ||| Down Almost 55%, Is This Buy Now, Pay Later Stock Worth Buying?",1,0.4940627
2021-08-05,1583800.0,380.1499938964844,384.30999755859375,379.9500122070313,384.2999877929688,359.2684936523437,GS,"Wall Street largely sticks to back-to-office plans, but cracks emerge as infections mount ||| 4 Investment Banks Benefiting from Record M&A Activity ||| Noteworthy ETF Inflows: DIA, GS, V, CAT ||| Wall Street sticks with back to office plans as Delta variant sparks fears ||| FOCUS-Return of the fat cats? Bank bonuses rise as profits rebound",1,0.48564738
2021-08-06,3655800.0,388.8800048828125,398.8599853515625,388.6400146484375,397.8900146484375,371.9734191894531,GS,"Dow Movers: AMGN, JPM ||| ANALYSIS-Where will yields go? Investors weigh U.S. jobs data against Delta fears ||| This Number Helped These 3 Stocks Push the Dow Jones to Record Levels Friday",1,0.50795436
2021-08-09,3319100.0,396.5899963378906,404.6000061035156,393.5799865722656,399.8800048828125,373.833740234375,GS,Three Old-School Companies That Could Outperform New-Tech Upstarts ||| Buffett-backed Nubank hires investment banks to lead IPO - source ||| The Best Dow Jones Stocks of 2021 Can't Keep It at Record Highs Today ||| TREASURIES-Yields edge higher on record job openings ||| Investment bank Jefferies raises pay for analysts - source ||| Wall Street investment banks cut China growth forecasts ||| Is State Street Stock Fairly Priced? ||| ANALYSIS-Where will yields go? Investors weigh U.S. jobs data against Delta fears,1,0.5020169
2021-08-10,3152300.0,400.1199951171875,410.6300048828125,399.5,407.9700012207031,381.3966979980469,GS,"BUZZ-COMMENT-EUR/USD may fall regardless of U.S. CPI results ||| Jordan Company, Goldman Sachs Asset Management And Stonepeak Sell Stake In Vertical Bridge ||| EMERGING MARKETS-Asian FX weighed down by virus concerns, Fed taper talk",1,0.488898
2021-08-11,3000500.0,408.7999877929688,414.6799926757813,407.05999755859375,413.8900146484375,386.93115234375,GS,"Goldman Sachs Group, Inc. Shares Climb 0.8% Past Previous 52-Week High - Market Mover ||| Goldman to lend 1 bln euros to CVC for LaLiga deal, sources say ||| Goldman to lend 1 bln euros to CVC for La Liga deal, source says",1,0.49574065
2021-08-12,2312800.0,414.3800048828125,418.6199951171875,410.55999755859375,415.0,387.9688720703125,GS,"Goldman Sachs Group Reaches Analyst Target Price ||| Now That Square Is Buying Afterpay, Is It Becoming a Super App? ||| Interesting GS Put And Call Options For October 1st ||| Could Affirm Be the Next Big Acquisition Target? ||| California weed supplier HERBL in talks to go public via SPAC merger - sources ||| US STOCKS-Dow futures hit record high ahead of jobless claims, Disney earnings ||| 3 Hydrogen Stocks I'd Buy Right Now",0,0.5043154
2021-08-13,1980000.0,416.0,416.8900146484375,408.1799926757813,410.7799987792969,384.0237426757813,GS,"Tencent, SoftBank-led funding pushes Argentina's Uala to $2.45 bln valuation ||| Notable ETF Inflow Detected - DIA, GS, CAT, NKE ||| OPEC+ supply boost unlikely despite call from U.S. for more oil, says Goldman",0,0.49781442
2021-08-16,1590700.0,408.989990234375,408.989990234375,402.1499938964844,408.3500061035156,381.7519836425781,GS,"Saudi Aramco aims to raise at least $17 bln from gas pipeline -sources ||| 3 Reasons to Buy Alibaba, and 1 Reason to Sell ||| Saudi Aramco aims to raise at least $17 bln from gas pipeline -sources ||| Soccer-Barca can escape financial hole in 18 months, president says ||| U.S banks walk tightrope of encouraging, but not mandating vaccines ||| ANALYSIS-Back with a bang, share buybacks offer boost for Europe Inc ||| U.S banks walk tightrope of encouraging, but not mandating vaccines ||| U.S. stock futures fall as China data sours global mood",0,0.48360297
2021-08-17,2077400.0,403.8399963378906,408.3500061035156,400.2000122070313,404.9700012207031,378.5921630859375,GS,"Validea David Dreman Strategy Daily Upgrade Report - 8/17/2021 ||| Noteworthy Tuesday Option Activity: GS, BRKS, GME ||| CVS Health's Minimum Wage News Doesn't Thrill Investors ||| Wall St set to fall from record highs after weak retail data ||| China's Baidu launches U.S. dollar bond amid regulatory uncertainty at home ||| Seoul mates: Korea retail investors are bankers' best buddies amid record IPO fees ||| US STOCKS-Futures slip ahead of retail sales data",0,0.5213801
2021-08-18,2187800.0,402.6000061035156,406.1099853515625,398.5899963378906,398.7999877929688,372.8240051269531,GS,"Dow futures slip on recovery fears as focus turns to Fed ||| Dow Movers: GS, CRM ||| China's Baidu launches U.S. dollar bond amid regulatory uncertainty at home ||| Goldman Sachs Group (NYSE:GS) Is Increasing Its Dividend To US$2.00",0,0.4998982
2021-08-19,2241500.0,394.6000061035156,397.7300109863281,390.9100036621094,393.5700073242188,367.9346923828125,GS,"Schwab to boost 'vast majority' of employees' pay by 5% ||| SoftBank sells 11.4 million shares of DoorDash - source ||| Financial Sector Update for 08/19/2021: HSBC, GS, LYG, XLF, FAS, FAZ ||| At $159, JPMorgan Stock Has Limited Growth Potential ||| Goldman Sachs To Acquire NN Investment Partners - Quick Facts ||| Goldman Sachs to buy NNIP from NN for 1.7 billion euros",1,0.48334977
2021-08-20,1612100.0,391.489990234375,396.4500122070313,391.0,395.8699951171875,370.0848388671875,GS,"Why Polkadot, Chainlink, and Polygon Are All Up Today ||| 5 Reasons Warren Buffett May Be Done Buying Banks for a While",1,0.4740015
2021-08-23,1857600.0,401.8900146484375,404.1000061035156,399.0,401.4500122070313,375.3014221191406,GS,Morgan Stanley Stock Is Trading Close To Its Fair Value ||| Citigroup Stock Has A 15% Upside,1,0.49806735
2021-08-24,1958400.0,403.5899963378906,409.6600036621094,402.7000122070313,408.55999755859375,381.9482727050781,GS,"U.S. COVID-19 vaccine approval is 'seismic' shift for legality of mandates, experts say ||| Goldman Sachs to mandate COVID vaccine for staff, visitors at U.S. offices -memo ||| Goldman Sachs to mandate vaccine for staff, visitors at U.S. offices - NYT ||| 7 Mega-Cap Stocks to Buy That Have Stable Dividends ||| PFF, QRTEA, GS, MS: Large Inflows Detected at ETF ||| Upstart Has Gained 1,100% Since the IPO -- Here's Why It Could Do It Again",1,0.50719166
2021-08-25,1845300.0,409.8999938964844,416.6799926757813,408.9400024414063,413.1199951171875,386.2113037109375,GS,"Dow Movers: MRK, JPM ||| Notable Wednesday Option Activity: GS, GOOG, ADI ||| Wall Street group to revive talks with China to find common ground- Bloomberg News ||| U.S.-China group seeking to bolster financial ties to meet in autumn- source",0,0.5005534
2021-08-26,2076500.0,415.8800048828125,420.7300109863281,411.1600036621094,412.4100036621094,385.5475463867188,GS,"Goldman Sachs Makes Vaccination Must As Delta Variant Continues To Spread ||| Wall Street closes lower, ending rally on Afghanistan, Fed concerns ||| Wall Street retreats from record highs on taper concerns ||| Wall St slips on worries over Fed tapering, banks limit losses ||| Wall St set to open lower, taper talks in focus",1,0.49748904
2021-08-27,2174500.0,412.7799987792969,419.8500061035156,412.5,419.6900024414063,392.3533630371094,GS,"Wall St Week Ahead-A blazing U.S. stock rally faces market's toughest month ||| India selects 10 banks to manage Life Insurance Corp IPO ||| FOCUS-U.S. COVID-19 tests again in short supply as infections soar, schools reopen ||| Here's What We Like About Goldman Sachs Group's (NYSE:GS) Upcoming Dividend ||| Goldman Sachs Stock Is Fairly Priced",0,0.5145482
2021-08-30,2089400.0,419.9500122070313,420.760009765625,412.7200012207031,413.6000061035156,386.6600646972656,GS,3 Top Stocks to Buy and Hold Forever,0,0.5530076
2021-09-01,1680400.0,413.1600036621094,416.1099853515625,410.30999755859375,413.6600036621094,388.59521484375,GS,"Majority of U.S. companies may mandate COVID-19 vaccine in coming months - survey ||| Noteworthy ETF Inflows: PFF, QRTEA, GS, MS ||| US STOCKS-S&P 500 poised for record open as focus turns to economic data ||| US STOCKS-Gain in futures set S&P 500 for new high ahead of data",1,0.5311327
2021-09-02,1830400.0,415.1099853515625,417.5799865722656,412.6400146484375,414.5,389.3843383789063,GS,GS October 22nd Options Begin Trading ||| US STOCKS-Futures rise as focus turns to weekly jobless claims ||| German eye care clinic chain Veonet put up for sale -sources ||| BNP Paribas in wealth management JV talks with China's AgBank -sources,0,0.49088332
2021-09-03,1373600.0,414.0,415.1199951171875,410.6000061035156,411.30999755859375,386.3876037597656,GS,"Wall St Week Ahead-Investors grow wary as stocks hit new highs ||| US STOCKS-Futures fall as monthly jobs growth slows sharply ||| US STOCKS-Futures circle record highs, eyes on jobs report for taper cues",0,0.49444377
2021-09-07,1557000.0,411.0,414.7300109863281,409.6400146484375,410.3200073242188,385.4575805664063,GS,Why Shares of SolarEdge Soared 12% in August ||| How Ethereum's Next Big Upgrade Could Boost Its Value ||| Wall St Week Ahead-Investors grow wary as stocks hit new highs ||| EXCLUSIVE-China's top property broker KE Holdings exploring Hong Kong listing - sources ||| US STOCKS-Wall Street to open flat as Delta variant weighs on recovery ||| U.S. workplaces look to college fights as return to work 'turning point' looms ||| U.S. workplaces look to college fights as return to work 'turning point' looms ||| US STOCKS-Futures lower as worries over economic recovery weigh ||| EXCLUSIVE-China's top property broker KE Holdings exploring Hong Kong listing - sources ||| 4 Best Dow Stocks To Buy for September,0,0.4994316
2021-09-08,1646200.0,409.2200012207031,410.9800109863281,404.7000122070313,405.0,380.4599609375,GS,"Brazil's Invepar looks for partner in Guarulhos airport, newspaper says ||| 4 Fintech Stocks To Watch As Paypal Acquires BNPL Startup ||| Perrigo to buy HRA Pharma in $2.1 bln deal in consumer healthcare push ||| Brazil's Invepar looks for partner in Guarulhos airport, newspaper says ||| Perrigo To Acquire HRA Pharma For Approx. $2.1 Bln - Quick Facts",0,0.5202756
2021-09-09,2424600.0,404.6700134277344,408.8800048828125,403.510009765625,404.5799865722656,380.0653991699219,GS,"COLUMN-Shanghai squeeze revitalises flagging nickel market: Andy Home ||| iShares Preferred and Income Securities ETF Experiences Big Inflow ||| British airline easyJet to raise $1.7 bln, rejected bid offer ||| FOCUS-London's financial workers flock back to office in hot commuter crush",0,0.5081812
2021-09-10,1956000.0,408.0,409.7900085449219,403.1600036621094,403.4800109863281,379.0321044921875,GS,"Bank of America appoints new CFO, three women to senior leadership roles ||| German measuring technology group Schenck Process up for sale - sources ||| Don't Wait for a Market Crash to Buy This Cheap Stock",1,0.48977026
2021-09-13,1802800.0,407.4100036621094,409.3699951171875,403.7999877929688,409.260009765625,384.4618225097656,GS,"MOVES-Citigroup hires Naysmith from Goldman Sachs -sources ||| Interesting GS Put And Call Options For January 2024 ||| Telefonica hires Goldman Sachs to sell UK mobile masts stake, El Confidencial says",0,0.51660526
2021-09-14,3263200.0,410.2999877929688,417.010009765625,402.7799987792969,403.6900024414063,379.2293395996094,GS,"Hippo Is Ready to Recover From a Chaotic Start ||| Goldman Sachs CFO Stephen Scherr To Retire; Names Denis Coleman CFO ||| Dow Movers: NKE, GS ||| Goldman Sachs appoints Coleman as new CFO, replacing Scherr",0,0.4806521
2021-09-15,3199800.0,398.0,403.6099853515625,396.2099914550781,401.9500122070313,377.59478759765625,GS,"Why GreenSky Stock Soared 53% Today ||| US STOCKS-Wall Street gains as crude price surge, strong economic data prompt broad rally ||| US STOCKS-S&P 500, Dow gain on factory data, strong oil prices ||| Financial Sector Update for 09/15/2021: HUT,GSKY,GS,BRP,GREE ||| Financial Sector Update for 09/15/2021: GSKY,GS,BRP,GREE ||| Markets Stay Mixed as Goldman Sachs Fights Back Against Fintech Disruptors ||| GSKY Stock: 9 Things to Know About Buy-Now-Pay-Later Play GreenSky Amid $2.2B GS Deal ||| US STOCKS-Wall Street rallies on crude price jump, economic data ||| Volvo Cars gears up for $20 bln IPO in coming weeks, sources say ||| US STOCKS-S&P, Dow gain as energy, financials recoup recent losses ||| Goldman Sachs To Acquire GreenSky For Approximately $2.24 Bln In Stock - Quick Facts ||| Goldman Sachs to buy lender GreenSky in $2.24 billion deal ||| Goldman Sachs to buy lender GreenSky in $2.24 billion deal",0,0.4700319
2021-09-16,2882900.0,404.5199890136719,405.9800109863281,394.8900146484375,396.6799926757813,372.6441345214844,GS,"FOCUS-Banks beware, outsiders are cracking the code for finance ||| Italy's Ariston Thermo aims for Milan IPO in November - sources ||| Nigeria to hold investor call on Friday ahead of eurobond issue ||| Goldman Sachs sees India joining major global bond indexes from end-2022",0,0.50821775
2021-09-17,3843700.0,396.3200073242188,399.1600036621094,388.8299865722656,391.4599914550781,367.7403869628906,GS,"Well-timed trades in GreenSky options ahead of Goldman deal raise eyebrows ||| Sterling steadies against euro, eyes on BoE next moves ||| METALS-Nickel nears seven-year high as market frets about supply ||| JPMorgan to launch digital bank Chase in Britain next week ||| Sterling holds below one-month highs after retail sales data ||| METALS-Copper rises as China injects cash to calm markets",0,0.5202671
2021-09-20,3834500.0,377.8200073242188,380.8599853515625,372.5,378.1300048828125,355.2181091308594,GS,"EXCLUSIVE-Didi co-founder Liu told associates she plans to leave - sources ||| Dow Movers: CAT, MRK ||| GRAPHIC-Gas price surge, just one more headwind for world economy ||| GRAPHIC-Erdogan's waning patience: Four questions for Turkey's central bank ||| Why Shares of Bank of America, Citigroup, JPMorgan, and Goldman Sachs Fell Today ||| EXCLUSIVE-Didi co-founder Liu told associates she plans to leave- sources ||| Goldman Sachs hires Barclays' executive to S.Africa unit",0,0.48709333
2021-09-21,2377300.0,380.8500061035156,381.5,374.0799865722656,375.8399963378906,353.0668334960937,GS,"Bank of America cuts China growth forecast under Evergrande shadow ||| US STOCKS-Futures bounce 1% from Evergrande-led selloff ||| Nigeria raises $4 billion Eurobond on healthy investor demand ||| AT&T plans multi-year effort to burnish its brand image ||| Dow Analyst Moves: GS ||| Nigeria opens order book for $3 billion Eurobond, investor notice says ||| US STOCKS-Futures bounce 1% after Evergrande-led selloff ||| UBS Stock Has Limited Upside ||| Goldman's Petershill sets IPO price at 320-380 pence a share ||| GRAPHIC-Gas price surge, just one more headwind for world economy ||| Goldman's Petershill sets IPO price at 320-380 pence a share",1,0.52225107
2021-09-22,2991300.0,380.7999877929688,389.2900085449219,379.7099914550781,385.4700012207031,362.11334228515625,GS,Why FibroGen Fell by More Than 9% on Wednesday ||| 3 Moonshot Stocks Hidden in Cathie Wood’s Portfolios ||| 3 Hydrogen Stocks to Buy for Long-Term Growth ||| Investing in China: What an Expert Wants You to Know ||| EXCLUSIVE-India likely to block Chinese investment in insurance giant LIC's IPO -sources ||| ANALYSIS-JPMorgan's 2021 deal spree aims to fill the few holes left in its global operations ||| 3 Reasons Goldman Sachs Is Buying GreenSky,1,0.48270386
2021-09-23,2518000.0,390.3900146484375,393.739990234375,388.1799926757813,391.8599853515625,368.1161193847656,GS,Why Altice USA Fell More Than 12% Today ||| EXCLUSIVE-India likely to block Chinese investment in insurance giant LIC's IPO -sources,0,0.49355385
2021-09-24,1789700.0,390.4700012207031,392.489990234375,388.6000061035156,390.8500061035156,367.1673583984375,GS,Will SVB Financial Stock Continue Its Growth Trajectory?,1,0.53739226
2021-09-27,2788500.0,396.5799865722656,401.0,395.1799926757813,399.80999755859375,375.5844421386719,GS,"US STOCKS-Wall Street pivots to value as Treasury yields rise ||| GRAINS-Corn futures up 2% on firm cash markets; soybeans post modest gains ||| GLOBAL-MARKETS-Rising Treasury yields hit tech stocks; oil at 3-year highs ||| US STOCKS-Tech pulls Nasdaq to lower close as Treasury yields rise ||| GLOBAL-MARKETS-Treasury yields, energy stocks rise as oil hits 3-year high ||| Nigeria considers selling additional Eurobonds after successful outing ||| Goldman expects oil prices to hit $90 by year-end as supply tightens ||| BUZZ-U.S. STOCKS ON THE MOVE-Beyond Meat, U.S. banks, U.S. insurers",0,0.4658354
2021-09-28,2609000.0,400.4500122070313,404.2099914550781,388.3900146484375,389.5,365.8991088867188,GS,"Shares in Goldman's Petershill Partners flat on London debut ||| 7 Best Stock Picks From the Coming IPO Flood You Need To Know About ||| 3 Cyclical Stocks To Watch Before October 2021 ||| LIC seeks to appoint CFO before its mega IPO planned in 2021/22 ||| Goldman's Petershill Partners to be valued at $5.6 bln in IPO ||| China energy crunch triggers alarm, pleas for more coal ||| China energy crunch triggers alarm, pleas for more coal ||| Barclays Stock Has A 15% Upside",0,0.49442464
2021-09-29,1955000.0,390.6799926757813,392.3900146484375,384.2999877929688,384.8900146484375,361.5684814453125,GS,U.S. SEC charges ex-Goldman compliance analyst with insider trading ||| Jewelry retailer Claire's revives listing plans ||| U.S. SEC charges ex-Goldman compliance analyst with insider trading ||| Jewelry retailer Claire's files for U.S. IPO ||| METALS-Copper falls as power shortages grip top consumer China,0,0.50131696
2021-09-30,2665700.0,388.0,388.0199890136719,376.6199951171875,378.0299987792969,355.1241455078125,GS,"Australia to eclipse 14-year M&A record, powered by infrastructure, resources deals ||| Saudi Arabia's wealth fund to sell part of stake in Saudi Telecom ||| Saudi Arabia's wealth fund to sell part of stake in Saudi Telecom ||| French mobile gaming unicorn Voodoo buys Israeli studio Beach Bum ||| US STOCKS-Futures rise ahead of jobless claims, GDP data ||| Pandemic recovery fuels deal craze as third-quarter M&A breaks all records ||| US STOCKS-Wall St set for strong open but track steep monthly losses",1,0.5222258
2021-10-01,2382300.0,379.4400024414063,382.7200012207031,375.8500061035156,380.0,356.9747619628906,GS,"EXPLAINER-Global energy shortage or a coincidence of regional crises? ||| Notable Friday Option Activity: ADBE, GS, GMS ||| The One Investment Bet You’d Be Crazy to Miss ||| US STOCKS-Futures slip ahead of inflation, factory activity data ||| Wall Street set to open higher on bargain hunting, Merck boost",0,0.49395475
2021-10-04,2895600.0,380.2099914550781,386.8699951171875,372.8200073242188,374.1499938964844,351.479248046875,GS,Goldman Sachs Group's (NYSE:GS) investors will be pleased with their solid 144% return over the last five years ||| How Come No One Is Talking About This Explosive Growth Stock? ||| Bank of America launches research coverage for digital assets ||| Coding platform GitLab aims for nearly $9 bln valuation in U.S. IPO ||| Latin American M&A booms to 10-year high of $105 bln so far this year,1,0.5101229
2021-10-05,2508100.0,378.1000061035156,388.2200012207031,375.5,385.80999755859375,362.4327087402344,GS,"US STOCKS-Futures up as Big Tech bounces from selloff; cyclicals rise ||| Stock Market News For Today October 5, 2021 ||| US STOCKS-Futures tick higher as tech shares recover from selloff, cyclicals rise ||| Banks make slow progress on UK gender pay, while gap widens for insurers",1,0.509017
2021-10-06,2111800.0,382.3800048828125,389.5499877929688,378.6600036621094,388.0499877929688,364.5370178222656,GS,"European stocks skid on inflation angst as oil jumps ||| Noteworthy ETF Outflows: PFF, QRTEA, GS, GS ||| ANALYSIS-Russia's Gazprom feels the heat over Europe's red-hot gas prices ||| Goldman Sachs Group Reports Before the Open on 10/15 -- Options Contracts Expire the Same Day ||| Tesla faces investor test after big jury award over racism ||| Is It Time to Buy the Dow's 3 Worst-Performing September Stocks? ||| European stocks skid on inflation angst as oil jumps",1,0.49882925
2021-10-07,2348000.0,392.9100036621094,397.8500061035156,389.760009765625,390.6199951171875,366.9512634277344,GS,"Why Nio Stock Is Surging Today ||| U.S. banks expected to report mixed Q3 results, iffy loan outlook ||| Potential U.S. strategic oil release to offer only modest relief: Goldman ||| Eneos to buy Japan Renewable Energy for $1.8 bln -Nikkei ||| ANALYSIS-Russia's Gazprom feels the heat over Europe's red-hot gas prices",1,0.49962524
2021-10-08,1446700.0,390.8299865722656,394.30999755859375,388.1799926757813,392.80999755859375,369.0085754394531,GS,"Japan's Nikkei extends rally on Wall Street gains, Toyota lifts Topix",0,0.5152749
2021-10-11,1787400.0,392.8999938964844,396.9500122070313,385.0199890136719,385.239990234375,361.897216796875,GS,"Goldman cuts forecast for U.S. economic growth in 2021 and 2022 ||| Financial Sector Update for 10/11/2021: FINV, KKR, GS, NRZ, XLF, FAS, FAZ ||| How Are Stocks Doing Today? 4 Bank Stocks In Focus Now ||| Financial Sector Update for 10/11/2021: CIGI,SOFI,AJG,NRZ,GS ||| China's bond markets slump again as new Evergrande deadline passes ||| Financial Sector Update for 10/11/2021: SOFI,AJG,NRZ,GS ||| Wall Street rises as Big Tech, financials gain ||| KKR's Bae, Nuttall succeed Kravis, Roberts as co-CEOs ||| US STOCKS-Futures dip as oil rally fuels inflation worries ||| KKR's Bae, Nuttall succeed founders as co-CEOs ||| Saudi Aramco taps banks for $12-14 bln gas pipeline loan - sources ||| Refiner Eneos to buy Japan Renewable Energy for $1.8 bln ||| Wall Street set to slide on inflation worries",1,0.48682773
2021-10-12,2088200.0,386.2200012207031,388.5899963378906,381.0199890136719,386.5299987792969,363.1091003417969,GS,"Google Gives Up on Bank Accounts ||| Coding platform GitLab raises IPO pricing range, eyes nearly $10 bln valuation ||| GRAPHIC-Money markets ramp up global rate hike bets, add pressure on central banks",0,0.48800254
2021-10-13,2391600.0,388.0,388.3800048828125,378.6300048828125,386.30999755859375,362.9024353027344,GS,"US STOCKS-Tech stocks lift Nasdaq, banks weigh on S&P 500, Dow ||| US STOCKS-Tech stocks lift Nasdaq, banks weigh on S&P 500, Dow ||| Tesla directors get softer support, shareholder proposal gains traction ||| US STOCKS-S&P 500 rises with growth stocks; JPMorgan a drag ||| Wall Street set for mixed open after strong inflation data ||| US STOCKS-S&P 500, Nasdaq rise with growth stocks; JPMorgan a drag ||| JPMorgan profit beats estimates on M&A boom, loan growth ||| UK insurance firm Howden buys broker Aston Lark ||| EXCLUSIVE-Banks prepare to scrap LME gold and silver contracts, sources say",1,0.47132176
2021-10-14,3380900.0,392.0,393.6600036621094,382.2000122070313,391.2000122070313,367.4961242675781,GS,"Coding platform GitLab valued at $13.48 bln in strong market debut ||| Pre-Market Earnings Report for October 15, 2021 : SCHW, GS, PLD, PNC, TFC, JBHT, BMI ||| U.S. banks beat profit estimates on economic rebound, red-hot markets ||| Citigroup posts 48% jump in profit on reserve release ||| Bank of America Stock To Report Mixed Results In Q3? ||| Abu Dhabi fund Mubadala unit acquires a U.S. franchisee of Taco Bell ||| Wells Fargo Stock To Edge Past The Revenue Estimates In Q3? ||| Is a Wave of Fintech Acquisitions Coming Soon?",1,0.47327617
2021-10-15,6451400.0,402.30999755859375,407.2699890136719,396.3399963378906,406.0700073242188,381.4651184082031,GS,"Financial Sector Update for 10/15/2021: XP,GS,SCHW ||| Wall Street Heads Towards Winning Week Despite Fall Volatility ||| Southwest Hits Turbulence; James Bond Is Back in Theaters ||| Wall Street ends up with Goldman; Dow posts biggest weekly rise since June ||| Wall Street ends higher as Goldman rounds out parade of strong bank results ||| Consumer Sector Update for 10/15/2021: EYE,PENN,SCR,CRSR,GS ||| Financial Sector Update for 10/15/2021: BSBR,GET,XP,GS,SCHW ||| US STOCKS-Wall St climbs after week of strong bank results; market set for weekly gains ||| Bank Earnings Push Major Benchmarks to Daily, Weekly Wins ||| Goldman Sachs Group Inc. Earnings Climb In Q3, Beats estimates ||| US STOCKS-Wall St climbs on strong Goldman earnings, retail sales data ||| US STOCKS-Wall St set for higher open on Goldman earnings, retail sales data ||| Goldman Sachs Q3 Profit Beats Estimates; Net Revenues Up 26% ||| Stock Market News For Today October 15, 2021 ||| Goldman Sachs Group Q3 21 Earnings Conference Call At 10:30 AM ET ||| GLOBAL MARKETS-Investors park inflation fears to renew bets on stocks ||| Wall Street tracks weekly gains on strong banks earnings, retail sales data ||| U.S. banks see wealth management boom on borrowing, new assets",1,0.49355096
2021-10-18,3832300.0,408.010009765625,415.9400024414063,407.6000061035156,413.6900024414063,388.6234130859375,GS,"Zero-emission vehicles, wind and solar energy seen taking off - climate report ||| Goldman Sachs gets regulator nod for full ownership of China securities JV ||| The Big Storylines Ahead of the Big Banks' Earnings ||| Goldman Sachs moves to full ownership of China securities JV ||| Goldman Sachs To Top The Revenue Expectations In Q3? ||| Dow Movers: DIS, GS ||| Invest in the Potential of Snowflake Stock ||| Don't subject stablecoins to new rules, crypto lobby tells U.S. regulators ||| Investors bet BoE's Bailey has begun countdown for rates lift-off ||| Stock Market News For Today October 18, 2021 ||| US STOCKS-Futures edge lower ahead of earnings, inflation worries persist ||| Germany's Sunfire receives fresh investment for electrolyser production",0,0.48268953
2021-10-19,2568300.0,415.1799926757813,415.8500061035156,409.6900024414063,412.1600036621094,387.1860961914063,GS,Validea Martin Zweig Strategy Daily Upgrade Report - 10/19/2021 ||| US STOCKS-Earnings whip up risk appetite as Wall St sees higher open,0,0.4987591
2021-10-20,2453400.0,411.0,414.3299865722656,406.2000122070313,407.8900146484375,383.17486572265625,GS,"For Goldman Sachs, It's Rinse and Repeat ||| Why Goldman Sachs Group Inc is the 'Top Dividend Stock of the Dow' With 1.9% Yield (GS) ||| Barclays Stock To Edge Past the Revenue Consensus In Q3?",0,0.49970147
2021-10-21,2162100.0,406.7999877929688,412.6600036621094,404.6199951171875,407.5899963378906,382.89306640625,GS,"December 3rd Options Now Available For Goldman Sachs Group (GS) ||| Checking In on the Retail Sector ||| Goldman Sachs, Freshfields working on possible Porsche IPO -Manager Magazin ||| ARKK vs. GTEK: Which Technology ETF Is Better? ||| EXCLUSIVE-Home remodeling platform Houzz hires Goldman for IPO -sources ||| 3 EV Stocks That Could Win the Electric Vehicle Revolution ||| Ride This Upsurge in Nio Stock to Profits Before It Really Catches Fire",1,0.48740157
2021-10-22,2411000.0,409.989990234375,415.3599853515625,409.1000061035156,414.3200073242188,389.21527099609375,GS,"FOCUS-In corporate crackdown, U.S. SEC takes aim at executive pay ||| Aris Water Solutions IPO: 15 Things for Potential ARIS Stock Investors to Know ||| Fitch eyes fallout from Turkey rate cut 'missteps', official says ||| Invest in a Greener Planet With the ProShares Cleantech ETF ||| GRAPHIC-Global equity funds see biggest inflows in seven weeks - Lipper ||| FOCUS-In corporate crackdown, U.S. SEC takes aim at executive pay",1,0.48786038
2021-10-25,1824700.0,416.2099914550781,419.489990234375,413.2699890136719,414.75,389.6191711425781,GS,"HSBC Stock To Top The Revenue Outlook In Q3? ||| UBS Stock To Beat Street Expectations? ||| Big Bank Earnings Breakdown: Here's What You Need to Know ||| DIA, GS, TRV, IBM: Large Outflows Detected at ETF ||| FOCUS-In Ocado's world, the rise of the machines is unstoppable ||| Goldman sees upside risks to $90/bbl Brent price forecast ||| GLOBAL MARKETS-Stocks gain as upbeat Wall St earnings lift outlook ||| Why Marqeta Stock Rocketed Higher Today",1,0.5194557
2021-10-26,1843300.0,416.3699951171875,419.80999755859375,413.760009765625,417.6099853515625,392.3058166503906,GS,"Brazil's Caixa plans IPOs of Elo, asset manager in coming months ||| Will Crypto Be a Game Changer for This Growth Stock? ||| Noteworthy Tuesday Option Activity: COP, GOOG, GS",0,0.48973003
2021-10-27,2067200.0,416.5499877929688,418.05999755859375,410.5499877929688,410.989990234375,386.0870056152344,GS,Why Microsoft Stock Just Jumped 4% ||| Rent the Runway IPO: 13 Things for Investors to Know as RENT Stock Starts Trading Today ||| Sterling recovers as budget forecasts stronger UK growth ||| Evercore appoints John Weinberg as sole CEO ||| ANALYSIS-The 1970s all over again? Stagflation debate splits Wall St ||| Sterling little changed ahead of Sunak spending plans ||| ANALYSIS-The 1970s all over again? Stagflation debate splits Wall St,1,0.4824742
2021-10-29,2061700.0,414.0199890136719,415.9599914550781,411.1799926757813,413.3500061035156,388.303955078125,GS,"How Has Goldman Sachs Stock Soared 53% This Year, But Still Costs Only $1? ||| 3 Stocks to Buy as the Market Reaches All-Time High ||| 1 Healthcare Giant to Buy After Its Earnings Beat ||| Brazil's Eletrobras preselects banks for follow-on share offering ||| GRAPHIC-Global equity funds draw biggest inflows in over 7 months - Lipper",1,0.512135
2021-11-01,1820800.0,417.0700073242188,418.7300109863281,413.25,416.7000122070313,391.4510192871094,GS,Goldman flags Archegos-related lawsuits as potential legal risks ||| Bank of America to seek approval for securities firm in China - Bloomberg News ||| Goldman Sachs brings forward U.S. rate hike projection by a year ||| Wall St eyes record open in a big week for Federal Reserve ||| EXCLUSIVE-Goldman Sachs offers new way for investors to bet on SPACs -sources,1,0.50655854
2021-11-02,3000800.0,415.1000061035156,426.1600036621094,412.7900085449219,423.8500061035156,398.1677856445313,GS,"Noteworthy Tuesday Option Activity: GOOG, GS, CACC ||| Wall Street banks step up preparations for Fed tapering volatility ||| Why This Stock May Not Be the Bargain It Seems ||| US STOCKS-Futures slip on Fed angst; Tesla slides after record run ||| China stock pickers reshape portfolios on Xi's 'common prosperity' ||| With a Little Detective Work, You Won’t Get Duped Like Goldman Sachs Almost Was ||| Goldman Sachs highlights diversity in new managing director class",0,0.49883604
2021-11-03,3542400.0,423.1199951171875,424.0,412.55999755859375,417.8999938964844,392.5783386230469,GS,"Sterling edges higher ahead of central bank meetings ||| 3 Options Trades to Play Both Sides of the Market ||| Dow Movers: CAT, NKE ||| Sterling holds around three-week lows ahead of central bank meetings",0,0.4980026
2021-11-04,3802300.0,414.6499938964844,415.989990234375,403.0299987792969,408.0700073242188,383.3439025878906,GS,"US STOCKS-Chip, growth stocks send S&P 500, Nasdaq to records as Dow lags ||| Chip, growth shares lift S&P 500, Nasdaq to record highs ||| US STOCKS-S&P 500, Nasdaq extend record streaks, with boost from chip, growth shares ||| GLOBAL MARKETS-Global stocks mixed after weak banks earnings, oil reverses gains",0,0.49206254
2021-11-05,2105600.0,411.3999938964844,414.4500122070313,406.1000061035156,407.0799865722656,382.4138488769531,GS,Private equity firm BPEA hires Goldman to sell HCP Packaging -sources ||| EXCLUSIVE-Bain Capital-owned Brillio hires banks for IPO - sources ||| 3 Stocks to Watch This Earnings Season,1,0.5221596
2021-11-08,1728400.0,409.8900146484375,413.6499938964844,407.9599914550781,408.3399963378906,383.5975646972656,GS,"China Oct exports beat forecasts, offer buffer to slowing economy ||| 2 Fintech Stocks You Can Buy Right Now ||| Why Bluebird Bio Stock Plunged Today ||| Why Nio Stock Rallied 11% in October and Isn't Stopping ||| Hertz Stock IPO: 11 Things to Know as HTZ Stock Preps for Nasdaq Uplisting ||| PayPal's Market Cap Is Almost Double Goldman Sachs; Why Wall Street Needs to Pay Attention ||| Goldman Sachs Crushes Expectations Once Again ||| Why Latch Fell 21.1% in October ||| Should You Be Adding Goldman Sachs Group (NYSE:GS) To Your Watchlist Today? ||| Morgan Stanley Stock Has Limited Upside",0,0.49149543
2021-11-09,2246900.0,406.1099853515625,407.5799865722656,400.05999755859375,405.3500061035156,380.7887573242188,GS,"EXCLUSIVE-Italy's De Nora picks Goldman, Credit Suisse to work on IPO ||| EV maker Rivian prices IPO above range to raise over $10 bln -sources ||| Sterling slightly lower, near 5-week lows ||| Could This Financial Stock Reach $1,000 Within 5 Years? ||| REUTERS EVENTS-Goldman Sachs predicts years-long commodities supercycle ||| Sterling broadly unchanged near 5-week lows",0,0.4947524
2021-11-10,2243900.0,402.3299865722656,405.5499877929688,397.25,399.1199951171875,374.936279296875,GS,Sweetgreen IPO: 11 Things for Potential SG Stock Investors to Know ||| U.S. charges McKinsey partner with insider trading in Goldman purchase of GreenSky ||| U.S. stock futures tick lower as inflation worries take hold ahead of CPI data ||| Dubai ruler investment vehicle weighs IPO of business park operator TECOM -sources ||| What To Expect From Credit Suisse Stock Over The Next One Month?,1,0.5011199
2021-11-11,1252400.0,400.1400146484375,403.760009765625,398.510009765625,402.3399963378906,377.9611206054688,GS,"GLOBAL MARKETS-Dollar hits 16-month high, stocks rebound after inflation scare ||| General Mills considers $3 bln sale of Progresso, Helper brands - Bloomberg ||| General Mills considers $3 bln sale of Progresso, Helper brands - Bloomberg ||| GLOBAL MARKETS-Dollar soars to 16-month high, stocks rebound after CPI scare ||| Japan refiner Eneos, Goldman to launch tender offer in $4.2 bln Nippo deal on Friday ||| Eneos president says its Nippo tender offer will likely start 'very soon'",1,0.5019411
2021-11-15,1436500.0,406.0,407.3399963378906,403.9100036621094,404.80999755859375,380.281494140625,GS,EXCLUSIVE-BNP hires advisers to explore $15 bln Bank of the West sale - sources ||| Citigroup Stock Is Attractive At $68 ||| Why BioXcel Therapeutics Stock Is Crashing Today,0,0.5046413
2021-11-16,1311000.0,403.9100036621094,405.8399963378906,399.0,403.0899963378906,378.6657104492188,GS,"Italy's Ariston sets IPO price range, valuing group at up to 3.9 bln euros ||| ANALYSIS-Banks that helped GE, others bulk up now profit from break-ups ||| ANALYSIS-Banks profit from building up and breaking up companies ||| Are Real Estate Prices Going Up in 2022?",0,0.4848572
2021-11-17,2927000.0,401.8500061035156,402.6499938964844,391.4700012207031,391.5499877929688,367.8248596191406,GS,"GLOBAL MARKETS-Stocks slide on rate hike fears, gold prices gain ||| DIA, GS, AMGN, CAT: ETF Outflow Alert ||| June 2023 Options Now Available For Goldman Sachs Group (GS) ||| Dow Movers: V, BA ||| Blockchain firm ConsenSys raises $200 million from HSBC, Third Point ||| Why China's Debt Crisis and Housing Concerns May Be a Problem for the U.S. ||| INSIGHT-Wall Street sees first Fed climate change review in 2023",0,0.48052135
2021-11-18,1847400.0,392.2999877929688,393.9200134277344,385.6799926757813,391.3699951171875,367.6557922363281,GS,SPVM's Holdings Imply 10% Gain Potential,0,0.5240096
2021-11-19,2610400.0,382.3800048828125,390.239990234375,381.0400085449219,387.3900146484375,363.9170227050781,GS,"Interesting GS Put And Call Options For September 2022 ||| Brazil's Eletrobras picks banks to lead privatization process ||| Top Real Estate News for Friday, Nov. 19, 2021: 2 REITs and More Fed Spending ||| Skies darken for Indian IPOs after Paytm's diappointing debut ||| Turkish lira recoups some losses after Thursday's crash ||| Turkish lira hovers near record low after latest rate cut",1,0.4950111
2021-11-22,3058700.0,393.1600036621094,402.489990234375,390.1799926757813,396.1600036621094,372.1555480957031,GS,Goldman De-Risking for a Winning Business Model ||| Credit Suisse appoints Jeroen Bos global head of sustainable investing for AM,1,0.53191584
2021-11-23,2402300.0,400.25,406.9599914550781,397.510009765625,406.3399963378906,381.7187194824219,GS,"EXCLUSIVE-Major Toshiba shareholder objects to break-up, urges board to solicit offers ||| EXCLUSIVE-Major Toshiba shareholder objects to break-up, urges board to solicit offers ||| US STOCKS-Nasdaq ends lower for second day as Big Tech loses ground ||| US STOCKS-Nasdaq ends lower for second day as Big Tech loses ground ||| Nasdaq leads losses as tech weakness dents Wall Street ||| Tech weakness keeps Wall Street under pressure ||| JPMorgan named most important bank to health of financial system ||| FOCUS-As U.S. inflation hits 31-year high, banks assess risks and opportunities ||| JP Morgan becomes world's most systemic bank ||| Citigroup to create 100 roles in digital asset push",0,0.4952307
2021-11-24,2186300.0,405.0,407.4800109863281,398.2999877929688,399.1900024414063,375.0019836425781,GS,"Notable Wednesday Option Activity: GS, GME, GOOG ||| China so far non-committal to Washington's oil release, OPEC+ unmoved ||| China so far non-committal to Washington's oil release, OPEC+ unmoved ||| Sterling hits fresh 2021 low versus dollar ||| Is Latch a Bargain After Earnings? ||| Sterling holds close to 2021 low versus dollar ||| COLUMN-Yearend stress catalyzed by a restive dollar: Mike Dolan",0,0.47955713
2021-11-26,2687900.0,384.4800109863281,391.7099914550781,382.7200012207031,389.3900146484375,365.7958068847656,GS,Fed to kick off faster tapering plan from January - Goldman Sachs ||| Fed to kick off faster tapering plan from January - Goldman Sachs ||| China says it notes JPMorgan chief's sincere regret over remark ||| These 3 Stocks Punished the Dow Friday ||| US STOCKS-Dow set for 2% fall on fears over new virus variant,0,0.46910214
2021-11-29,2883400.0,394.0,396.3699951171875,382.4500122070313,386.5400085449219,363.1184997558594,GS,"FOREX-U.S. dollar rises; yen, Swiss franc skid as Omicron worries ebb ||| Wall Street banks stick with return-to-work plans while monitoring Omicron situation ||| FOREX-U.S. dollar gains; yen, Swiss franc fall as Omicron fears ease ||| FOREX-Dollar wobbles, currencies partly pull back on Omicron shock moves ||| FOREX-Dollar edges higher, currencies pull back on Omicron-shock moves",0,0.46172392
2021-11-30,4570400.0,383.5299987792969,386.8299865722656,377.260009765625,380.989990234375,357.90478515625,GS,"LG Energy Solution receives preliminary approval for its IPO -Korea Exchange ||| Goldman Sachs Announces Major Benefit Schemes To Retain Employees ||| Goldman Sachs Group, Inc. (GS) Ex-Dividend Date Scheduled for December 01, 2021 ||| Turkey economy grew 7.4% in Q3; lira clouds outlook ||| Is Bank of America Stock Fairly Priced? ||| LG Energy Solution receives preliminary approval for its IPO -Korea Exchange",0,0.5211068
2021-12-01,2476000.0,383.8200073242188,390.1600036621094,376.2099914550781,376.4800109863281,355.5344543457031,GS,Why BioXcel Therapeutics Stock Is Slumping Today ||| GRAPHIC-COVID comeback caps a November to remember in markets,1,0.502427
2021-12-02,3343700.0,378.0,389.0899963378906,376.0299987792969,387.5400085449219,365.9790954589844,GS,"EXCLUSIVE-Goldman Sachs planning new medium-term profitability targets early next year -sources ||| Omicron What? Dow Jones Shakes Off Fears, Surges 680 Points on Boeing, Visa, AmEx Gains ||| EXCLUSIVE-Goldman Sachs planning new medium-term profitability targets early next year -sources ||| January 2022 Options Now Available For Goldman Sachs Group (GS) ||| Goldman Sachs ups diversity targets as demographic data improves",0,0.49024534
2021-12-03,2807500.0,389.8800048828125,389.8800048828125,379.0299987792969,382.7300109863281,361.4367370605469,GS,"Goldman Sachs launches green finance group with Beijing think tank ||| Sterling edges lower as dollar strengthens, eyes on BoE ||| OPEC+ output increase adds to Goldman's bullish oil market view",1,0.50927764
2021-12-06,1990200.0,388.6700134277344,393.6000061035156,383.489990234375,389.2999877929688,367.6411743164063,GS,"CVC picks Goldman Sachs for potential stock market listing - The Sunday Times ||| Saudi sovereign fund PIF selling 5.01% stake in STC in secondary offer ||| ANALYSIS-China Evergrande teeters again, but investors less fearful ||| US STOCKS-Dow leads Wall Street higher with 2% gain; cyclicals in vanguard ||| New York City expands COVID vaccine mandates for children, private sector ||| New York City mandates shots for all private businesses amid Omicron spread ||| Goldman Sachs to Invest $3B in India’s Real Estate Sector — Report ||| US STOCKS-Dow bounces back on cyclical boost; Nvidia leads tech stocks lower ||| US STOCKS-Dow, S&P 500 set to rebound on banks, energy boost ||| New York City mandates vaccines for all private businesses as Omicron spreads",1,0.48147288
2021-12-07,2441000.0,393.5799865722656,401.75,393.05999755859375,400.1099853515625,377.8497314453125,GS,"Dow Analyst Moves: GS ||| Goldman Sachs Stock Has A 15% Upside ||| Porsche, Piech families consider partial VW sale to buy Porsche stake -report ||| US STOCKS-Wall St set to open 1% higher as tech stocks roar back ||| U.S. bank executives raise concerns over inflation ||| Arnault-backed group launches second SPAC listing ||| Tech, miners lift European shares as Omicron worries fade ||| Sterling edges up amid expectations of BoE tightening in February ||| ANALYSIS-China Evergrande teeters again, but investors less fearful",0,0.48140737
2021-12-08,1635200.0,401.2300109863281,401.7099914550781,395.1400146484375,397.3200073242188,375.2149963378906,GS,JPMorgan see 10% decline in 4Q markets revenue from year-earlier record,0,0.5118175
2021-12-09,2111500.0,395.7000122070313,400.1900024414063,393.0,396.489990234375,374.4311828613281,GS,"Notable Thursday Option Activity: IGMS, GS, TWLO ||| Advent, Carlyle considering bid for DuPont's $12 bln unit - Bloomberg News ||| Concerned about Omicron variant, Wall St banks encourage COVID booster shots ||| 3 Luxury Goods Stocks to Buy to Pamper Your Portfolio in 2022 ||| January 2022 Options Now Available For Goldman Sachs Group (GS) ||| Missed Out On Roku? My Best Software Stock to Buy and Hold",0,0.501173
2021-12-10,1893800.0,398.0,398.8599853515625,388.6600036621094,391.05999755859375,369.3032531738281,GS,"Should Investors Consider Confluent Stock? ||| Sterling edges up versus dollar after U.S. data ||| Jefferies says COVID-19 spike was not caused by a specific incident ||| China's Didi plans to hire Goldman for Hong Kong listing, U.S. delisting -sources ||| Sterling edges down to near 2021 low versus dollar",0,0.5087781
2021-12-13,2313300.0,391.1900024414063,391.1900024414063,382.6600036621094,384.6400146484375,363.2404479980469,GS,Why Shopify Stock Dropped Today ||| FOREX-U.S. dollar gains as Fed seen wrapping up asset purchases earlier than expected ||| FOREX-Dollar stands tall in blockbuster week for central banks ||| Conservative Investors Will Prosper With Bank of America Stock,1,0.4936822
2021-12-14,2788500.0,383.55999755859375,392.5,383.260009765625,388.8200073242188,367.1878662109375,GS,"ANALYSIS-LG Energy Solution's IPO likely to be priced at $11 bln top end - sources ||| Goldman, JPMorgan plan bumper payout for investment bankers after deal-making boom ||| BlackRock adds diversity target for U.S. boardrooms ||| UDOW, GS, BA, CAT: ETF Outflow Alert ||| US STOCKS-S&P 500, Nasdaq slide on hot producer prices data as Fed meet looms ||| Goldman Sachs, JPMorgan plan bonus boosts after deal-making boom - Bloomberg",1,0.496047
2021-12-15,2802300.0,389.5,391.3999938964844,380.6000061035156,389.9100036621094,368.21722412109375,GS,"ANALYSIS-LG Energy Solution's IPO likely to be priced at $11 bln top end - sources ||| AS-Ex-McKinsey partner pleads guilty to insider trading charge ||| Dow Movers: AXP, CSCO ||| Is Barclays Stock Undervalued? ||| With the S&P 500 Up 25% for the Year, Is It Too Late to Buy?",1,0.50150776
2021-12-16,3578200.0,395.1300048828125,399.8399963378906,391.7999877929688,397.3699951171875,375.26214599609375,GS,"Goldman Sachs expects oil demand to hit record levels in 2022, 2023 ||| Goldman Sachs sets 2030 carbon emissions reduction targets ||| Citigroup sends New York staff home, Goldman cancels remaining holiday parties ||| TPG IPO News: 11 Things to Know as the Private Equity Firm Plans to Go Public ||| Citigroup to let NYC staff work from home through holidays -source ||| EXCLUSIVE-Shareholder group pressures U.S. banks to drop fossil fuels faster ||| FOCUS-Wall St bank analysts grapple with capital impact of new derivatives rule ||| Sterling hits December highs after BoE raises interest rates ||| EXCLUSIVE-Shareholder group pressures U.S. banks to drop fossil fuels faster ||| French unicorn Voodoo to invest $200 mln in blockchain mobile games ||| Goldman Sachs sets 2030 carbon emissions reduction targets ||| Why Coinbase Stock Popped and Dropped Today",0,0.48713276
2021-12-17,7058600.0,389.2099914550781,393.6700134277344,380.6300048828125,381.7999877929688,360.5584716796875,GS,"Manulife latest financial firm to postpone back to office plans amid COVID spread ||| These 2 Dow Stocks Smacked Down the Market Friday ||| Notable Friday Option Activity: GOOG, GS, KMX ||| Dow Movers: GS, MRK ||| Buy And Hold Alibaba Stock for the Long-Term",0,0.4841087
2021-12-20,3735600.0,375.5199890136719,375.6300048828125,366.6499938964844,371.6099853515625,350.93536376953125,GS,"4 Real Estate Trends Smart Investors Are Watching for 2022 ||| Bank of Montreal in advanced talks to buy BNP Paribas's U.S. unit - WSJ ||| With Biden spending plan blocked, economists lower 2022 growth forecasts ||| Goldman Sachs strategist Abby Joseph Cohen retiring ||| With Biden spending plan blocked, economists cut 2022 growth forecasts ||| 3 Top Stock Trades for the Week ||| Notable Two Hundred Day Moving Average Cross - GS ||| Dow Movers: KD, WMT ||| The No. 1 Reason People Aren't Saving for Retirement Doesn't Have to Hold You Back, Too ||| Goldman Sachs cuts U.S. GDP forecast after Manchin retreats on Biden's bill ||| Global M&A activity smashes all-time records to top $5 trillion in 2021 ||| Global M&A activity smashes all-time records to top $5 trillion in 2021",1,0.53435653
2021-12-21,2942800.0,376.4299926757813,382.0899963378906,374.760009765625,380.3200073242188,359.1607971191406,GS,Wells Fargo delays plans for employee return to office amid Omicron surge ||| Russia's Melon Fashion Group picks banks for IPO - sources,1,0.4896438
2021-12-22,1487900.0,380.4200134277344,384.010009765625,379.2699890136719,382.3299865722656,361.0589904785156,GS,Don’t Follow “Dumb Money” Into This Corner of the Crypto Market ||| Almost One-Third of Young Workers Are Making a Huge Retirement Mistake,1,0.5026869
2021-12-23,1624000.0,383.7900085449219,387.6099853515625,383.5700073242188,385.0400085449219,363.61822509765625,GS,"Petrobras says Goldman Sachs lowers its stake in the company to under 5% ||| FOCUS-TD on deal hunt after BancWest bid as Canadian lenders pursue U.S. growth ||| My Best No-Brainer Crypto Stock for 2022 and Beyond ||| Noteworthy ETF Outflows: XLF, BLK, GS, SCHW ||| Wall St firms grapple with return-to-office conundrum as Omicron explodes ||| ANALYSIS-How 2021 became the year of ESG investing ||| Wall St firms grapple with return-to-office conundrum as Omicron explodes",1,0.48821732
2021-12-27,1430400.0,386.989990234375,389.1099853515625,385.0,388.0400085449219,366.4513244628906,GS,"Goldman Entities No Longer A Holder Of Relevant Shareholding Position In Capital Stock Of Petrobras ||| These Are Americans' Top 3 Concerns About Their Retirement ||| Goldman Sachs will require U.S. employees to get booster shots ||| Notable Monday Option Activity: GS, LMT, TWLO ||| Goldman Sachs will require employees get booster shots -Bloomberg ||| FOCUS-TD on deal hunt after BancWest bid as Canadian lenders pursue U.S. growth",0,0.49559385
2021-12-29,1327800.0,387.9700012207031,389.4599914550781,384.4200134277344,386.2000122070313,364.7136535644531,GS,"Stock Market Crash Coming? 7 Wall Street Pros Make Their Predictions ||| China's Didi plans Hong Kong 'listing by introduction', picks banks -sources",0,0.47073188
2021-12-30,1160100.0,387.75,389.7799987792969,385.2000122070313,385.5199890136719,364.0714721679688,GS,"Goldman Sachs: Cash Cow, but Profits May Decline ||| Little Excitement Around The Goldman Sachs Group, Inc.'s (NYSE:GS) Earnings ||| IonQ Is a Risky Bet on World-Changing Quantum Computing Potential",0,0.48438856
2021-12-31,1601300.0,385.0,387.0,380.8399963378906,382.5499877929688,361.2666931152344,GS,"Morgan Stanley Stock Still Has Some Upside ||| BofA allows remote work in early January - source ||| Biden, Manchin spoke about social spending bill after Manchin's rejection - adviser ||| 7 Anti-Meme Stocks to Buy as Risk-On Sentiment Fades ||| Does CrowdStrike Deserve a Spot in Your Portfolio in 2022?",1,0.48439386
2022-01-03,3334300.0,389.0,399.2999877929688,387.3399963378906,395.3299865722656,373.3356323242188,GS,"Goldman Sachs asks U.S. employees to work from home until Jan. 18 ||| Wall Street climbs in upbeat start to 2022 ||| Financial Sector Update for 01/03/2022: MS, GS, BRO, XLF, FAS, FAZ",1,0.4761781
2022-01-04,3916400.0,402.2300109863281,410.2799987792969,401.1799926757813,407.4800109863281,384.8097534179688,GS,"US STOCKS-S&P 500, Dow eye record open; Ford shines ||| Dow Movers: KD, GS ||| Telecom Italia working on new business plan as assesses KKR offer - sources ||| Telecom Italia working on new business plan as assesses KKR offer - sources ||| Stock Futures Advance With Manufacturing Data On Tap; Apple Tops $3 Trillion Market Cap At Intraday High",0,0.48457325
2022-01-05,3469600.0,409.7999877929688,412.6600036621094,397.8900146484375,398.6300048828125,376.45208740234375,GS,"Why Charles Schwabʻs Stock Price Rose 58.6% in 2021 ||| Why Riskified Stock Crashed Down 17% in December ||| Noteworthy ETF Inflows: DIA, GS, MCD, CRM ||| US STOCKS-Futures dip as tech stocks extend fall; Fed minutes eyed ||| Goldman Sachs says bitcoin will compete with gold as ""store of value""",0,0.4763533
2022-01-06,2960900.0,401.0,401.2000122070313,386.4299926757813,396.9299926757813,374.8467102050781,GS,"Moderna CEO Bancel says people may need another booster in fall of 2022 ||| GS February 25th Options Begin Trading ||| 4 Buy Now, Pay Later Trends Smart Investors Are Watching For in 2022",1,0.5042738
2022-01-07,2360700.0,397.6700134277344,400.5499877929688,394.5299987792969,397.510009765625,375.3944091796875,GS,"Reddit tapping Goldman Sachs, Morgan Stanley for IPO - Bloomberg News ||| Bank of America to increase bonus pool for employees - Bloomberg News ||| Reddit taps Morgan Stanley, Goldman Sachs for IPO - Bloomberg News ||| Why Albemarle Stock Sank in December Despite Record Lithium Prices ||| 3 of the Biggest Questions for Fintech Stocks in 2022 ||| U.S. judge sets ex-Goldman banker's 1MDB corruption trial for February, despite Omicron",1,0.49431923
2022-01-10,3009400.0,401.3200073242188,404.3699951171875,394.2200012207031,399.1700134277344,376.9620971679688,GS,"Dow Movers: NKE, GS ||| GLOBAL MARKETS-Stocks fall further as U.S. yield climb unnerves investors ||| Wall Street banks see four U.S. hikes in 2022, but inflation is a wild card ||| FOREX-Dollar higher on interest rate hike optimism ||| FOREX-Dollar rises on U.S. interest rate hike optimism ||| Saudi National Bank plans inaugural 'sustainable' sukuk ||| GLOBAL MARKETS-Stocks fall further as U.S. yield climb unnerves investors ||| Wells Fargo shares race ahead as investors bet on turnaround story ||| Why Tesla Stock First Crashed, Then Bounced Today ||| FB, AMZN, NVDA, AAPL, COIN: Why Are Tech Stocks Down Today? ||| US STOCKS-Futures muted, banks extend gains on high yields ||| Buy This Value Stock Before Everyone Else Does ||| US STOCKS-Nasdaq set to open lower as tech stocks extend declines ||| Saudi Arabia's biggest lender hires banks for sustainable sukuk -document ||| Goldman Sachs expects four Fed rate hikes this year ||| GLOBAL MARKETS-Stocks fall further as U.S. yield climb unnerves investors ||| Big U.S. banks expected to post uptick in core Q4 revenues on economic rebound ||| Some Wall Street banks see four U.S. interest rate hikes this year",1,0.48793608
2022-01-11,1748800.0,400.25,403.3399963378906,396.30999755859375,403.0499877929688,380.6261901855469,GS,Abu Dhabi's ZMI secures up to $500 mln financing facility ||| US STOCKS-Wall Street set to open higher ahead of Powell testimony ||| US STOCKS-Futures rise ahead of Fed Chair Powell's testimony,0,0.4962316
2022-01-12,4158000.0,403.239990234375,404.1199951171875,388.55999755859375,390.30999755859375,368.5950012207031,GS,Saudi National Bank gets $750 million via debut 'sustainable' sukuk ||| Why Planet Labs Stock Is Going to the Moon Today ||| Why HubSpot Gained 66.3% in 2021 ||| US STOCKS-Wall Street closes higher as inflation data supports Fed bets ||| HR software company Justworks delays U.S. IPO plans ||| Top Stock Picks For 2022 ||| Back to Zoom: Omicron weighs on investment bankers' hustle ||| EXCLUSIVE-Morgan Stanley to award bonus rises of over 20% on Thursday to top performers -sources ||| GRAPHIC-Asian bonds see a surge in foreign inflows in Dec 2021 ||| EXCLUSIVE-Morgan Stanley to award bonus rises of over 20% on Thursday to top performers -sources ||| EXCLUSIVE-Morgan Stanley to award annual bonus rises of over 20% on Thursday to top performers ||| Robinhood to permanently shift most employees to remote working ||| Citigroup Stock To Report Mixed Results In Q4?,1,0.50517637
2022-01-13,2497800.0,394.0499877929688,396.8699951171875,389.75,390.7999877929688,369.0577697753906,GS,"US STOCKS-Wall St pressured by Big Tech declines; PPI data offers relief ||| Wall Street closes down, Fed speakers put rate hikes in focus ||| Goldman Sachs (GS) Gains As Market Dips: What You Should Know ||| Citigroup reaches 99% compliance on U.S. staff vaccine mandate ||| US STOCKS-Nasdaq, S&P fall with tech stocks out of favor ||| Bausch + Lomb to list in U.S. and Canada, discloses revenue jump ||| US STOCKS-Wall St closes down, Fed speakers put rate hikes in focus ||| LIC to open India's biggest IPO issue by mid-March - sources ||| JPMorgan Stock To Beat Consensus In Q4? ||| Goldman Sachs delays return to office for U.S. workers ||| US STOCKS-Dow higher after producer prices data; Nasdaq, S&P 500 fall ||| How Will Bank ETFs Perform in Light of Q4 Earnings? ||| US STOCKS-Futures muted ahead of data; Delta Air rises on strong earnings ||| US STOCKS-Futures gain after producer prices data eases rate hike fears ||| Goldman Sachs delays return to office for U.S. workers - Bloomberg News",0,0.49392653
2022-01-14,4685300.0,382.1300048828125,384.3900146484375,375.0,380.9400024414063,359.746337890625,GS,"Palantir Stock Is a Buy on the Dip After This Recent Selloff ||| US STOCKS-Dow closes lower after disappointing bank results ||| Bausch + Lomb to list in U.S. and Canada, discloses revenue jump ||| Pre-Market Earnings Report for January 18, 2022 : SCHW, GS, PNC, TFC, BK, SBNY, SI, ONB, FMBI, FBK, MBWM, GNTY ||| Netflix Rises on Price Increase, but Next Week Is the Market's Real Test ||| Dow closes lower after disappointing bank results ||| Goldman Sachs' Petershill nears deal for Arsenal Capital stake -sources ||| Goldman Sachs Group (GS) Shares Cross Below 200 DMA ||| Gen Z investors shift focus from 'meme-stocks' to the 'metaverse,' report shows ||| 7 Earnings Reports to Watch the Week of January 17 ||| JPMorgan profit falls on trading slowdown ||| JPMorgan profit beats estimates on M&A boost",0,0.4691327
2022-01-18,13123500.0,360.0400085449219,361.5700073242188,347.2300109863281,354.3999938964844,334.6828308105469,GS,"Bitcoin, Ethereum, Cardano Continue Positive Push This Weekend ||| Goldman Sachs Stock To Report Mixed Results In Q4? ||| GLOBAL MARKETS-Stocks mixed as Beijing adds stimulus, Brent tops 2021 high ||| GLOBAL MARKETS-Asia weighs mixed China data, Brent clears 2021 highs ||| GLOBAL MARKETS-European stocks gain ahead of earnings; China adds stimulus ||| Sterling's early gains fizzle as traders hedge bets ahead of BoE meeting ||| FOREX-Dollar edges up as traders assess Fed rate hike bets ||| ANALYSIS-China's 'zero-COVID' campaign under strain as Omicron surges ||| FOREX-Dollar steadies as traders reassess rate hike bets ||| Goldman Sachs Invests In French Robotics Firm Exotec ||| Sterling heads back towards 2-1/2 month highs on rate appeal ||| Wall Street tumbles as yield spike hits tech, banks slump after Goldman miss ||| Financial Sector Update for 01/18/2022: SI,GS,CS ||| Stock Market Today: Dow Jones, S&P 500 Tumbles Today; Activision Soars On Microsoft Acquisition; Goldman Sachs Dips On Profit Miss ||| Heavy Selling: Indexes Toward Correction Levels ||| US STOCKS-Wall St sinks as yields spike, financials fall after Goldman miss ||| Financial Sector Update for 01/18/2022: GWGH,SI,GS,CS ||| GLOBAL MARKETS-Jump in Treasury yields sink equity markets, notably tech ||| Yield on U.S. 10-Year Treasury Note Hits 2-Year High ||| Goldman Sachs (GS) Q4 Earnings Lag Estimates ||| Market Update: Why Are Stocks Down Tuesday? ||| Goldman (GS) Q4 Earnings Miss Estimates, Revenues Improves ||| Tuesday's ETF Movers: ESPO, IAI ||| Markets Down, Activision Up on Microsoft Buyout ||| Sterling hits week low as dollar strength, political risk weigh ||| Here's Why Goldman Sachs Is Plunging Today ||| Does Jefferies Financial Group Belong in Your Dividend Portfolio? ||| S&P 500 Movers: GS, ATVI ||| Dow Drops More Than 500 Points Ahead of Blue-Chip Earnings ||| Goldman Drags on Stocks, but Here's the Bank That's Truly Getting Crushed ||| Goldman Sachs sees Brent oil hitting $100/bbl in Q3 2022 ||| US STOCKS-Wall St falls on tech drag; GS results trigger more bank declines ||| The Zacks Analyst Blog Highlights: The S&P 500 Financials Index, Goldman Sachs, BNY Mellon, Bank of America and Netflix ||| US STOCKS-Tech tumble, lackluster GS earnings set to weigh on Wall Street ||| This Potential Metaverse Winner Is Down 13% in 2022, and It Is a Screaming Buy ||| Financial Sector Update for 01/18/2022: GS, PNC, SBNY, CS ||| Goldman Sachs Q4 Profit Down 13%, Misses Estimates ||| Goldman Sachs Group Inc. Profit Falls In Q4, misses estimates ||| Goldman Sachs profit misses estimates on weak equity trading ||| GLOBAL MARKETS-Stocks sink, notably tech, as Treasury yields jump ||| US STOCKS-Nasdaq futures tumble as rising yields spark tech rout ||| Petershill Partners says made $458 mln of investments in Q4 ||| Hong Kong fund to sell Japan, S.Korea Burger King business in deal over $1bln - source ||| Brent to breach $100/bbl as demand weathers virus surge- Goldman Sachs ||| EXCLUSIVE-Jefferies gives up on buyout fund manager investing business-sources ||| MORNING BID-Tech trouble ||| Goldman Sachs Group Q4 21 Earnings Conference Call At 9:30 AM ET",0,0.50767946
2022-01-19,7426100.0,358.3399963378906,359.7099914550781,346.3900146484375,347.32000732421875,327.99676513671875,GS,"Wall Street banks eye 'new normal' for trading revenue after stellar two years ||| Company News for Jan 19, 2022 ||| Big Wall Street Banks Provide Mixed Start to Q4 Earnings Season ||| Big Wall Street Banks Provide Mixed Start to Q4 Earnings Season ||| Vault NFTs Launches Digital Sneakers Ahead of Highly Anticipated StockX IPO ||| Noteworthy Wednesday Option Activity: GS, BKNG, MRNA ||| US STOCKS-S&P 500, Dow up on earnings lift, Nasdaq off session low ||| RSI Alert: Goldman Sachs Group (GS) Now Oversold ||| US STOCKS-Wall St set to open higher on earnings boost, Big Tech bounces back ||| US STOCKS-Futures gain as UnitedHealth, BofA rise on results ||| More Banks Report Mixed Results, but This Fintech Disruptor's Stock Soared Wednesday ||| Why Goldman Sachs Group is the 'Top Dividend Stock of the Dow' With 2.3% Yield (GS) ||| Wall Street banks eye 'new normal' for trading revenue ||| Britain's bank 'ring-fencing' rules need simplifying, review shows ||| MORNING BID-Goldman Sachs adds another layer of stress ||| Big U.S. banks see higher expenses from workers' rising wages ||| Retail investors show signs of fatigue after last year's trading frenzy - report ||| Morgan Stanley posts higher profit on M&A boom",1,0.48963958
2022-01-20,4599900.0,348.8999938964844,357.17999267578125,346.1400146484375,348.1000061035156,328.7333984375,GS,"EXCLUSIVE-Goldman, JPMorgan award bumper bonuses for top bankers ||| 7 Bull Market Stocks to Buy for a Continued Run Higher in 2022  ||| EXCLUSIVE-Goldman, JPMorgan award bumper bonuses for top bankers ||| Expectations for Goldman Sachs (NYSE:GS) are low, but so is the Valuation ||| What’s Next for Twilio After Inflation Sent Pandemic Star Back to Earth ||| GLOBAL MARKETS-Wall Street headed higher as tech investors lick their wounds ||| Zacks Earnings Trends Highlights: JPMorgan and Goldman Sachs ||| Banks loan growth focus could impact U.S. Treasuries - Credit Suisse",0,0.49130315
2022-01-21,4904100.0,345.5400085449219,348.989990234375,340.7200012207031,343.9100036621094,324.7764892578125,GS,"Can Bitcoin Hit $100,000 in 2022? ||| JPMorgan, Barclays join bank rush to reopen offices in England ||| Sifting Through the Bad News for Our Next Profit Opportunities ||| U.S. Markets Suffered Sharp String of Losses This Week ||| The Major Forces Affecting Corporate Profits ||| EXCLUSIVE-Chime lines up Goldman Sachs for blockbuster IPO -sources ||| Informa set to launch $1.6 bln sale of Citeline unit –sources ||| Noteworthy ETF Inflows: DIA, GS, MCD, CRM ||| 1 Growth Stock With 75% Upside in 2022, According to Wall Street ||| Should Investors Bet on Oil Hitting $100 a Barrel Soon? ||| Barclays, Deutsche join bank rush to reopen offices in England ||| Morgan Stanley expects oil at $100 a barrel in second half of year ||| South Korea's IPO boom leaves investment banks short changed ||| EXCLUSIVE-Chime lines up Goldman Sachs for blockbuster IPO - sources",0,0.50920224
2022-01-24,6569800.0,337.32000732421875,344.07000732421875,326.2300109863281,343.3900146484375,324.2854309082031,GS,"Goldman appoints Sarsfield to co-run asset management unit - Bloomberg News ||| Goldman Sachs Says We're Entering a Commodity ""Supercycle."" Here Are 3 Names to Play It. ||| Goldman appoints Sarsfield to co-run asset management unit - Bloomberg News ||| Why This Wildly Undervalued Stock Is a Good Buy for 2022 ||| Why Shares of Visa, Citigroup, and Goldman Sachs Traded With Volatility Today ||| 3 Reasons You Might Not Want To Pay Off Your Mortgage Early ||| Goldman Sachs appoints Luke Sarsfield as co-head of asset management unit",0,0.47961724
2022-01-25,3959300.0,337.8599853515625,342.92999267578125,330.9100036621094,341.54998779296875,322.5477600097656,GS,"Banking Earnings Mixed-Bag: What's in Store for ETFs? ||| Goldman Sachs Group's Preferred Stock, Series A Shares Cross 4% Yield Mark ||| Dow Movers: HD, AXP ||| 3 Best Bank Stocks to Buy Following Q4 Earnings ||| EXCLUSIVE-SoftBank-backed Gopuff hires banks for IPO -sources ||| Data centre operator IXcellerate raises $190 mln for Russia expansion ||| EXCLUSIVE-Chinese fashion retailer SHEIN revives plan for New York listing in 2022-sources",1,0.5021957
2022-01-26,3745900.0,346.6000061035156,350.4800109863281,338.4100036621094,342.67999267578125,323.61492919921875,GS,"3 Best EV Stocks to Buy as We Head Into February ||| Notable Wednesday Option Activity: GATO, GS, PACK ||| Fun With Games May be a Catalyst for Ethereum in 2022 ||| GRAPHIC-Market signals scream buy after world stocks tumble ||| EXCLUSIVE-SoftBank-backed Gopuff hires banks for IPO -sources ||| Goldman Sachs: markets have not reached ""danger zone"" levels yet",0,0.49865898
2022-01-27,2573400.0,345.6700134277344,348.7699890136719,337.7200012207031,341.0299987792969,322.0567321777344,GS,"Apple to turn iPhones into payment terminals, rival Square - Bloomberg ||| The Fed, Interest Rates, and What This Team of Investors Is Watching ||| March 2023 Options Now Available For Goldman Sachs Group (GS) ||| UBS steps into 'Gen Z' push with $1.4 bln Wealthfront buy ||| Fed Chair Powell's Wait & See Monetary Approach Is Bullish For Stocks",1,0.5077389
2022-01-28,3714600.0,337.7300109863281,347.1499938964844,333.45001220703125,347.010009765625,327.7040100097656,GS,"Goldman Sachs lifts CEO Solomon's pay to $35 million ||| Why Sea Limited Stock Dropped Before Climbing on Friday ||| Goldman Sachs Group's Preferred Stock, Series C Yield Pushes Past 4.5% ||| CVC co-founder Koltes to step down as firm gears up for bumper listing ||| Morgan Stanley's Long-Term Financial Targets Make the Stock a Buy ||| Credit Suisse changes bonus structure for senior staff -memo ||| EXCLUSIVE-China securities regulator met foreign banks to soothe economic concerns",1,0.5179967
2022-01-31,3312400.0,344.6000061035156,355.2099914550781,343.44000244140625,354.67999267578125,334.947265625,GS,"What Microsoft's Planned Acquisition Means ||| Goldman Sachs expecting five rate hikes this year ||| Noteworthy ETF Outflows: DIA, GS, MCD, CRM ||| Spain's Mecalux eyes 2 bln euro valuation in April IPO, Cinco Dias says",1,0.5083656
2022-02-01,3303700.0,356.1300048828125,364.5400085449219,354.04998779296875,364.05999755859375,343.805419921875,GS,"Goldman Sachs leads U.S. banks in return to office ||| The Mindset Behind Buying Stocks When the Market Is Falling ||| Earnings beats underwhelm as Wall Street looks for good news ||| ANALYSIS-Tech-light corporate bonds swerve worst of stock market woes ||| GLOBAL MARKETS-After volatile January, choppy start of new month for world stocks",0,0.48717847
2022-02-02,2742400.0,363.5,368.5299987792969,357.8299865722656,363.05999755859375,342.861083984375,GS,"ETFs to Join Wall Street's Latest Rebound Rally ||| US STOCKS-Wall St set for fourth day of gains on Alphabet, AMD results",0,0.4997804
2022-02-03,2372900.0,362.8200073242188,365.760009765625,358.1600036621094,358.8800048828125,338.91363525390625,GS,"ANALYSIS-OPEC+ meets quickly, sticks to script, dodges debate on geopolitics ||| EXCLUSIVE-ManTech's controlling shareholder explores sale -sources ||| EXCLUSIVE-ManTech's controlling shareholder explores sale-sources ||| Goldman Sachs Group's Preferred Stock, Series K Shares Cross 6% Yield Mark ||| Notable Thursday Option Activity: QCOM, TMUS, GS ||| Clutch of hedge funds held Meta shares, may have been punished",1,0.48989308
2022-02-04,3762300.0,362.1700134277344,370.9500122070313,361.0199890136719,367.6000061035156,347.14849853515625,GS,"Wall Street Can't Make Its Mind Up Over This Growth Stock ||| Bank of America CEO's pay rises more than 30% for 2021 ||| Hertz names ex-Goldman Sachs CFO Scherr as top boss ||| Chasing sky-high valuations, Dubai bankers switch to tech sector ||| Banks expect ECB rate at 0% by year-end after hawkish turn ||| Hertz to name ex-Goldman Sachs executive Stephen Scherr as CEO - WSJ",1,0.49335274
2022-02-07,2635600.0,365.489990234375,371.4700012207031,363.3500061035156,368.1499938964844,347.6678466796875,GS,Goldman Sachs Missed Earnings Estimates. Is This a Buying Opportunity? ||| Goldman Sachs Group's (NYSE:GS) Upcoming Dividend Will Be Larger Than Last Year's ||| See Which Of The Latest 13F Filers Holds Goldman Sachs Group ||| Jury selection underway in ex-Goldman banker's 1MDB corruption trial ||| Is It Time to Buy the Dow Jones' 3 Worst Performing January Stocks? ||| Jury selection to begin in ex-Goldman banker's 1MDB corruption trial,1,0.5021586
2022-02-08,3422300.0,371.0799865722656,372.6499938964844,366.25,370.1000061035156,349.5093688964844,GS,INSIGHT-Oil and gas bankers confront their own energy transition,1,0.51817137
2022-02-09,2250400.0,373.0,376.2799987792969,370.8999938964844,374.5299987792969,353.6929626464844,GS,"Wells Fargo asks employees to return to office in mid-March - memo ||| Got $10,000? These 2 ETFs Are Great Buys for 2022 and Beyond ||| Beyond Dogecoin -- These 3 Unique Cryptos Are Better Buys ||| METALS-Supply fears keep aluminium near 13-1/2-year highs",0,0.48802352
2022-02-10,2406200.0,371.7099914550781,377.3999938964844,368.8299865722656,370.5700073242188,349.9532775878906,GS,Peek Under The Hood: IWL Has 15% Upside ||| Rogue employee or Goldman scapegoat? Ex-banker's 1MDB corruption trial to kick off ||| StoneX joins platinum and palladium benchmark auctions,0,0.5012961
2022-02-11,3142100.0,368.5499877929688,374.8999938964844,360.7699890136719,363.05999755859375,342.861083984375,GS,Large U.S. banks to drop mask mandate in U.S. offices ||| Goldman ups Fed hike forecast to 7 rate increases in 2022 after CPI data,0,0.51771766
2022-02-14,2585600.0,363.05999755859375,364.2900085449219,357.17999267578125,360.239990234375,340.19793701171875,GS,"What to Expect From Biogen's $2.3 Billion Shopping Spree ||| India's Life Insurance Corp files $8 bln IPO papers ||| Here Is Another Stock Pick That Warren Buffett Nailed During the Pandemic ||| Regulators probe block trading at Wall Street banks, hedge funds- WSJ ||| Citigroup raises Fraser's pay by 32% after appointing her as CEO ||| Nvidia Stock Before Earnings: Sell, Hold, or Buy? ||| Ex-Goldman banker's 1MDB corruption trial under way ||| US STOCKS-Futures slide on fears of potential Russian attack on Ukraine ||| EXPLAINER-What charges does ex-Goldman banker Ng face in 1MDB corruption trial?",1,0.47920045
2022-02-15,1846400.0,364.0899963378906,365.8900146484375,361.3599853515625,363.9400024414063,343.692138671875,GS,U.S. SEC is probing Wall Street trades in large blocks of shares ||| BlackRock (BLK) Prepares to Offer Crypto Trading Services ||| Twilio’s Post-Pandemic Story Looks Good ||| MORNING BID-The work of central banks,0,0.48058215
2022-02-16,2165300.0,361.3500061035156,363.0199890136719,356.5299987792969,360.04998779296875,340.0184631347656,GS,"Why Beyond Meat Stock Stumbled on Wednesday ||| Ex-Goldman banker testifies that 1MDB deal made him a 'hero' ||| FOCUS-Goldman Sachs to refresh targets and set path to growth ||| Noteworthy ETF Outflows: DIA, GS, MCD, AMGN ||| Ex-Goldman partner testifies against former colleague in 1MDB corruption trial ||| US STOCKS-Wall Street pulls back on Fed, Ukraine jitters ||| JPMorgan (JPM) Enters Metaverse, Unveils Virtual Onyx Lounge ||| Goldman Sachs Private Wealth Management arm opens new office in Monaco ||| Ex-Goldman partner to testify against former colleague in 1MDB corruption trial",0,0.48597756
2022-02-17,3102400.0,358.7799987792969,360.9599914550781,347.8399963378906,349.0599975585937,329.6399841308594,GS,Wall Street banks cautious on inflation and economy ||| US STOCKS-Stocks drop; investors flee risk as Ukraine tensions flare ||| Why Shopify Stock Lost 12% of Its Value Today ||| Risk-off trade hits Wall St as Ukraine tensions heighten ||| US STOCKS-Stocks slide as heightened Ukraine tensions weigh ||| Goldman Sachs lifts key profit target in strategy update ||| Stocks slide as heightened Ukraine tensions weigh ||| Philippines in talks with banks on green bond issue ||| US STOCKS-Wall St slides over 1% as Ukraine tensions mount ||| Goldman (GS) Up 3.7% Since Last Earnings Report: Can It Continue? ||| COLUMN-LME warehousers slash capacity as metal stocks drain away: Andy Home,0,0.4848275
2022-02-18,2910900.0,345.57000732421875,350.0,343.3699951171875,346.0400085449219,326.7879943847656,GS,"Goldman Sachs (GS) Dips More Than Broader Markets: What You Should Know ||| Noteworthy Friday Option Activity: ABT, GS, NFLX ||| Goldman Sachs Group is Oversold ||| Exxaro, China's CNIC vie with AIIM for $2 bln African power firm Lekela - sources ||| Goldman (GS) Ups ROE Aim, Restates 60% Efficiency Ratio Goal ||| Germany's Ottobock to wait until September to list amid choppy markets - sources ||| Philippines offers at least $500 mln green bonds to European investors",0,0.5053769
2022-02-22,2590800.0,342.4599914550781,349.0,341.20001220703125,344.2699890136719,325.116455078125,GS,"How T. Rowe Price Is Poised to Outperform the Market ||| EXCLUSIVE-HSBC targets 34% cut to emissions from oil and gas clients by 2030 ||| Markets pricing some geopolitics, but risk premia can grow further -Goldman ||| US STOCKS-Futures slip as Ukraine war fears, sanctions rattle investors ||| First Week of October 21st Options Trading For Goldman Sachs Group (GS) ||| EXCLUSIVE-HSBC targets 34% oil and gas emissions cut by 2030 ||| US STOCKS-Futures slip in volatile trade as Ukraine tensions mount",0,0.4905511
2022-02-23,2217300.0,347.57000732421875,349.260009765625,339.82000732421875,341.19000244140625,322.207763671875,GS,"Dow Analyst Moves: GS ||| Hertz profit rises on ongoing travel rebound, but restructuring costs weigh ||| Hertz increases profitability as travel rebound keeps momentum ||| The Zacks Analyst Blog Highlights NVIDIA, Novartis AG, NextEra Energy, The Goldman Sachs Group and Amgen ||| Boots in store for $10 bln sale as bid deadline looms ||| Ex-Goldman banker's 1MDB corruption trial hits snag over evidence disclosure ||| Goldman Sachs seeks return of bonuses from bankers for jumping ship - Bloomberg News ||| Goldman Sachs seeks return of bonuses from bankers for jumping ship - Bloomberg News ||| Boots in store for $10-billion sale as bid deadline looms",0,0.49050814
2022-02-24,4564000.0,328.57000732421875,341.0,326.95001220703125,340.19000244140625,321.2634582519531,GS,"Morgan Stanley discloses investigation into block trading business ||| US STOCKS-Wall Street slides over 1% as Russia attacks Ukraine ||| US STOCKS-Nasdaq stares at bear market as Russia invades Ukraine ||| US STOCKS-Futures dive as Russia invades Ukraine; Nasdaq bear market in sight ||| Top Stock Market News For Today February 24, 2022 ||| Diversification Supports Goldman (GS), Cost Woes Prevail ||| Star witness against ex-Goldman banker says wives used to disguise 1MDB kickbacks",1,0.47504002
2022-02-25,2980500.0,340.19000244140625,350.70001220703125,340.19000244140625,350.1199951171875,330.6410217285156,GS,"Credit Suisse tries to aid U.S. block-trading probe of rivals -Bloomberg News ||| GRAPHIC-From euro to EM: Russia's Ukraine war upends market bets ||| Credit Suisse tries to aid U.S. block-trading probe of rivals -Bloomberg News ||| After Mixed Results In Q4, Is Morgan Stanley Stock A Buy? ||| Noteworthy Friday Option Activity: ULTA, GS, GDOT ||| Can Bitcoin Reach $100,000? ||| Is Citigroup Stock Undervalued?",0,0.48645797
2022-02-28,4245700.0,340.25,343.8399963378906,337.54998779296875,341.2900085449219,322.30224609375,GS,"Goldman sees commodities rally on Russia-Ukraine crisis, sanctions ||| Russia sanctions cause weekend compliance scramble for global banks ||| U.S. banks prepare for cyber attacks after latest Russia sanctions ||| U.S. banks' Russian investment banking fee income in doubt after Moscow sanctions ||| Should SoFi Investors Worry About Goldman Sachs Competition? ||| Dubai's RTA hires investment banks for road-toll Salik IPO - sources ||| Why Nvidia Stock Should Remain on Investors’ Radars ||| Markets Bid Up from Session Lows; ZM, HPQ Beat Earnings ||| 7 Metals Stocks to Buy to Mine Profits in 2022 ||| Markets Open in Red on Geopolitical Conflict Concerns ||| U.S. SEC investigates Citi over unapproved employee communications ||| US STOCKS-Banks weigh on Wall St after new Russia sanctions ||| 3 Value and Dividend Stocks To Invest In March Amid Russia and Ukraine Uncertainty ||| Dow Movers: JPM, CRM ||| Multi-Faceted Attack on Russian Economy Sinks Futures ||| Black Rifle Coffee Company Stock Deserves to Be on Your Watchlist but Not Your Portfolio",0,0.49978185
2022-03-01,5631500.0,337.3999938964844,338.1600036621094,327.0199890136719,328.20001220703125,311.7675170898437,GS,"Archegos in settlement talks with banks -FT ||| U.S. banks' Russia exposure unclear; risk of long-term impacts - analysts ||| Ex-Goldman banker testifies at 1MDB trial that he 'lied a lot,' misled women ||| JPMorgan (JPM) to Invest in TRM Labs, Expands Crypto Exposure ||| IYF, SCHW, MS, GS: ETF Outflow Alert",1,0.4739355
2022-03-02,3469900.0,331.6000061035156,338.0,327.3999938964844,336.3800048828125,319.5379638671875,GS,"Should SPDR Dow Jones Industrial Average ETF (DIA) Be on Your Investing Radar? ||| 5 Growth Stocks You Can Buy on Sale Today ||| IEA's reserves release won't stop oil prices rising, says Goldman",0,0.4876222
2022-03-03,2393700.0,338.8699951171875,341.5,330.1300048828125,333.4200134277344,316.72613525390625,GS,Goldman Sachs GQG fund cuts Russian exposure to $222 mln ||| 3 Undervalued Stocks You Can Buy Today ||| 7 Favorite Fintech Stocks to Buy After the Correction,0,0.5074949
2022-03-04,3293100.0,327.0,330.6600036621094,324.0,329.6700134277344,313.16387939453125,GS,EXCLUSIVE-Chelsea FC's banker says Abramovich's exit will not be rushed,0,0.50042564
2022-03-07,3689900.0,326.82000732421875,327.7900085449219,320.8500061035156,321.8900146484375,305.7734680175781,GS,"Citigroup's Long-Term Strategic Vision: Disappointing but Realistic ||| Some Goldman Sachs employees moving out of Russia to Dubai -Bloomberg News ||| Deutsche Bank Stock Lost 24% Over The Last Week, What To Expect? ||| Cybersecurity startup Snyk taps Morgan Stanley, Goldman for IPO - sources ||| GRAPHIC-Tightening financial conditions sound alarm for world economy ||| Goldman sees limited fundamental impact from potential U.S. ban on Russian oil ||| Why Nvidia Stock Tanked Today ||| Noteworthy Monday Option Activity: CVX, GD, GS ||| Kohl's says it engaged with over 20 parties regarding strategic alternatives ||| What To Expect From State Street Stock?",0,0.47707757
2022-03-08,3596400.0,322.5,330.5599975585937,318.54998779296875,321.3699951171875,305.27947998046875,GS,Goldman raises oil price forecasts on Russia supply shock ||| GRAPHIC-Tightening financial conditions sound alarm for world economy,1,0.51857525
2022-03-09,3202100.0,331.67999267578125,337.4700012207031,330.0299987792969,333.5899963378906,316.8876037597656,GS,"Why Shares of Mastercard, ING Groep, and Goldman Sachs Are Rising ||| IYG, SCHW, C, GS: ETF Outflow Alert ||| NEWSMAKER-In court, a former Goldman star recounts his lies and bribes in 1MDB deceit",0,0.47225213
2022-03-10,2232600.0,327.6300048828125,331.8399963378906,324.760009765625,329.8999938964844,313.38238525390625,GS,"Dubai a favorite destination as some Moscow-based bankers beat path to exit ||| Goldman Sachs cuts U.S. growth forecast as commodity prices bite ||| Goldman Sachs (GS) Dips More Than Broader Markets: What You Should Know ||| Wall Street closes lower as inflation hits 40-year high, inviting aggressive Fed tightening ||| Wall Street ends down as inflation hits 40-year high, inviting aggressive Fed tightening ||| US STOCKS-Wall Street slides as decades-high inflation reading invites aggressive Fed tightening ||| No breakthrough in Russia-Ukraine talks as besieged civilians endure bombardments ||| EXCLUSIVE-Deutsche Telekom launches $20 bln auction of mobile towers ||| EXCLUSIVE-Deutsche Telekom launches $20 bln auction of mobile towers unit- sources ||| Goldman Sachs to exit Russia ||| Bank of NY Mellon Corp names vice chair Vince as CEO ||| Brazil's startup Contabilizei raises $63 million investment led by Softbank ||| China bars mainland brokers from promoting SPAC deals in Hong Kong -sources ||| Wall Street slumps as spiraling inflation cements rate hike bets",0,0.49370596
2022-03-11,2613500.0,334.3699951171875,336.6099853515625,326.7099914550781,327.0,310.6275634765625,GS,"Turkish lira weakens for ninth day, data shows economic woes ||| Goldman (GS), JPMorgan (JPM) to Fold Up Russia Operations ||| Turkish lira rebounds after Putin signals progress in talks ||| BUZZ-COMMENT-EUR/USD investors prefer to play it safe ||| Deutsche Bank bucks trend as it maintains ties to Russia ||| MORNING BID-A most favoured nation no more ||| PREVIEW-Telecom Italia to give KKR bid verdict in Sunday board showdown",0,0.50196785
2022-03-14,2342200.0,329.2099914550781,331.6199951171875,322.8999938964844,324.9800109863281,308.7087097167969,GS,"Wall Street banks' staff churn to double this year after bonus payouts -experts ||| Why Shares of Deutsche Bank Are Rising Today ||| Goldman Sachs Group's Preferred Stock, Series J Shares Cross 5.5% Yield Mark ||| Notable Monday Option Activity: MSFT, PYPL, GS ||| European financial institutions turn their back on Russia ||| Deutsche Bank to wind down in Russia, reversing course after backlash ||| MORNING BID-COVID comes back",1,0.4867432
2022-03-15,2140700.0,327.07000732421875,331.8999938964844,324.8399963378906,329.1600036621094,312.679443359375,GS,"Gores Guggenheim Stock Looks Attractive as Polestar Has All Ducks in Row ||| Clipper Realty Inc. (CLPR) Q4 FFO Top Estimates ||| EXPLAINER-New EU and British sanctions target Russian energy and debt ||| Citigroup (C) to Pull the Plug on All Russia Operations ||| Coal Goal’s Not on Hold, but Peabody Energy Stock Might Get Sold ||| Credit Suisse CEO details tens of billions managed for Russian clients ||| FOCUS-U.S. banks will keep a toe in Russia despite wind-downs ||| Dubai state utility DEWA launches first of 10 planned listings ||| UniCredit considers quitting Russia as markets watch for sovereign debt payment",1,0.49646267
2022-03-16,3468500.0,335.07000732421875,341.3299865722656,334.260009765625,340.760009765625,323.6986389160156,GS,"Generali's Donnet faces internal rival to CEO crown ||| JPMorgan (JPM) on Buyout Spree Again, to Acquire Global Shares",1,0.5115165
2022-03-17,2403500.0,337.3699951171875,343.6000061035156,334.8999938964844,343.2699890136719,326.0829772949219,GS,"Tech Sell-Off: 1 Beaten-Down Growth Stock That Could Soar 210%, According to Wall Street ||| BNY Mellon expects $100-mln revenue hit in first quarter from Russia pullback ||| IXG, GS, BLK, CB: Large Outflows Detected at ETF ||| Goldman Sachs (GS) Gains But Lags Market: What You Should Know ||| Imperial Petroleum Is Making Moves in Choppy Waters ||| Dow Movers: GS, AXP ||| Austria's RBI studying possible exit from Russia",1,0.5129305
2022-03-18,5861900.0,338.8699951171875,346.7699890136719,337.29998779296875,345.3800048828125,328.0873413085937,GS,Goldman Sachs raised COO pay by 78% in 2021 ||| Goldman Sachs COO paid $33 mln in 2021 ||| UBS raises stake in China brokerage joint venture to 67%,0,0.48610318
2022-03-21,3401200.0,345.260009765625,346.29998779296875,337.1499938964844,339.0,322.0267333984375,GS,"CVC plans to list on Euronext exchange rather than London - FT ||| Why Teladoc Health Was Looking Sickly on Monday ||| BNY Mellon (BK) Pulls Back From Russia, Expects Revenue Decline ||| Philippines returns to offshore bond market with three-tranche offer",1,0.5245399
2022-03-22,2840200.0,342.20001220703125,346.239990234375,340.1199951171875,343.010009765625,325.8360290527344,GS,"Mecalux targets June for $3.3 bln Madrid IPO - sources ||| Goldman sees Fed hiking rates by 50 bps at May, June meetings ||| Powell Hints at Higher Interest Rate Hikes in Coming Months ||| Markets Fill in Gaps from Monday's Losses",0,0.48974958
2022-03-23,2196800.0,340.0,340.8299865722656,335.1300048828125,335.6099853515625,318.80645751953125,GS,Hertz adds Tesla's Model Y to its EV fleet ||| U.S. bank profits could be hit by Russia-linked asset swings,1,0.52685034
2022-03-24,1944100.0,336.44000244140625,337.5,334.29998779296875,336.2300109863281,319.3954467773437,GS,"Goldman Sachs (GS) Gains But Lags Market: What You Should Know ||| GLOBAL MARKETS-Wall Street powers stocks higher, oil lower as world leaders press Russia ||| Goldman Sachs poised to lead U.S. IPO of SoftBank's Arm -sources ||| EXCLUSIVE-Goldman Sachs pushes directors for more climate data ||| Goldman Sachs: Struggling in Key Segments ||| GS May 6th Options Begin Trading ||| Goldman Sachs Stock Posted Mixed Results In Q4, What To Expect?",1,0.4796909
2022-03-25,1580800.0,337.42999267578125,341.8299865722656,335.4800109863281,337.489990234375,320.59234619140625,GS,"BOFA: Expect two 50 bps U.S. rate hikes in June and July ||| BoFA, Citi expect multiple 50-bps Fed hikes this year as inflation bites ||| Wall Street worries that Fed was behind the curve on inflation ||| Is Bank of America Stock Undervalued?",0,0.49248686
2022-03-28,2182600.0,338.1499938964844,338.5,331.510009765625,335.29998779296875,318.5119934082031,GS,"3 Stocks Warren Buffett Dumped During the Pandemic. Where Are They Now? ||| Tap the Booming Fintech Market With These ETFs ||| Turkey's C/A deficit seen rising to 4% of GDP this year -Goldman ||| Steven Mnuchin's fund buys major stake in security startup Zimperium for $525 million ||| Ex-Goldman banker's wife testifies in husband's defense at 1MDB trial ||| Why Shares of Dogecoin, EOS, and Theta Are Rising Today ||| German first-quarter dealmaking slides to six-year low due to Ukraine war jitters",1,0.5137336
2022-03-29,2378700.0,342.4700012207031,344.0,336.7300109863281,339.6600036621094,322.6537170410156,GS,"U.S. prosecutors cast doubt on ex-Goldman banker's wife testimony at 1MDB trial ||| Bank analysts, investors antsy for spending outlook as inflation risks grow ||| 2 Top Cryptocurrencies to Buy Now and Hold for the Next Decade ||| Bank analysts, investors antsy for spending outlook as inflation risks grow ||| What To Expect From Wells Fargo Stock?",0,0.48697275
2022-03-30,2650200.0,339.0,339.8599853515625,333.6300048828125,335.5899963378906,318.7874755859375,GS,"Goldman Sachs (GS) Dips More Than Broader Markets: What You Should Know ||| Noteworthy Wednesday Option Activity: OPRX, CRSR, GS ||| GRAPHIC-Profits at large global banks set to fall sharply due to M&A slowdown ||| Goldman (GS) to Buy NextCapital in Asset Management Push ||| Goldman (GS) Closes GreenSky Buyout to Augment Retail Lending ||| Generali investor Del Vecchio backs Caltagirone's plan for insurer - Bloomberg ||| Generali investor Del Vecchio backs Caltagirone's plan for insurer - Bloomberg ||| SK Hynix considering consortium to acquire chip designer Arm -CEO to Yonhap ||| Arm plans transfer of shares in China JV to speed up U.S. IPO - FT",0,0.47991374
2022-03-31,2632000.0,336.1300048828125,336.5,330.1000061035156,330.1000061035156,313.5723571777344,GS,"Lawsuit accusing 10 banks of rigging $23 trillion U.S. Treasury market is dismissed ||| The Metrics to Watch When Researching Financial Stocks ||| Raymond James (RJF) Rides on Acquisitions, Costs Increase ||| 4 ""Stealth"" Ways to Invest in Crypto ||| Global M&A hits the skids as Ukraine war saps confidence ||| Is U.S. Bancorp Stock Undervalued?",1,0.5074286
2022-04-01,2444800.0,333.92999267578125,334.1600036621094,327.57000732421875,330.2200012207031,313.68634033203125,GS,Wall Street set to open higher as jobs data shows economic strength ||| 3 CEOs to Invest In ||| US STOCKS-S&P 500 inches up as jobs report underscores economic resilience ||| Why You Should Pay Close Attention to Jefferies Right Now ||| Greece's National Bank concludes sale of insurance unit to CVC ||| Investors Should Use Weakness in Roblox as an Opportunity ||| US STOCKS-Futures edge higher with investors on jobs report watch ||| Wall St Week Ahead-'Robust' corporate cash may buoy stocks after rocky quarter ||| DEWA's $5.7 bln Dubai IPO oversubscribed at top end of range -sources,0,0.4991238
2022-04-04,2569400.0,330.0,331.8699951171875,325.8599853515625,328.2099914550781,311.7769775390625,GS,"Why ChargePoint Charged 37% Higher in March ||| 4 Reasons Goldman Sachs Is a Buy ||| DEWA's IPO could hit $6.08 bln amid retail tranche increase ||| AMD to buy cloud startup Pensando for $1.9 bln in data center push ||| Global insurers plan to ramp up private equity investments ||| Why Workhorse Group, Lordstown Motors, and Canoo Stocks All Jumped Today ||| Closing arguments begin in ex-Goldman banker's 1MDB corruption trial ||| ANALYSIS-Most banks narrow UK gender pay gaps, UBS, Deutsche Bank go into reverse ||| Closing arguments to begin in ex-Goldman banker's 1MDB corruption trial ||| Amazon Web Services' Moat Has Become Nearly Unassailable ||| Indian Oil Corp forms joint ventures for green hydrogen, electrolyser ||| Block Becomes a Bitcoin Play ||| ANALYSIS-With capital markets jittery, private equity pounces to finance tech buyouts",0,0.49982485
2022-04-05,2573900.0,327.3599853515625,329.739990234375,323.4800109863281,323.9599914550781,307.73980712890625,GS,Franklin Resources (BEN) Completes Lexington Partners Buyout ||| 2 Cybersecurity Investments That Could Help Set You Up for Life ||| ANALYSIS-Banks tiptoe into EU tussle over reining in foreign lenders ||| Goldman Sachs (GS) Dips More Than Broader Markets: What You Should Know ||| ChargePoint: Partnering with Megabank Provides Major Advantage,0,0.49342513
2022-04-06,3151300.0,320.0,320.6199951171875,315.75,316.260009765625,300.4253234863281,GS,AMD Acquires Pensando: Is It a Perfect Match? ||| Rebel Generali investor ready for legal action in case of narrow AGM board defeat ||| Goldman Sachs Group Reports Before the Open on 4/14 -- Options Contracts Expire the Same Day ||| Dubai's DEWA to raise $6.1 billion at IPO pricing level -sources,0,0.490928
2022-04-07,3562600.0,315.0,315.8299865722656,308.20001220703125,314.1499938964844,298.4209289550781,GS,"Ex-Goldman executive banned from banking over mishandling of documents, Fed says ||| Better Buy: Goldman Sachs vs. Wells Fargo ||| US STOCKS-Wall Street slips on hawkish Fed; banks, industrials top losers ||| Apple: Skating to Where the Puck is Headed ||| KKR to list Japan's Kokusai Electric as early as June, sources say ||| Capital One (COF) Announces Additional $5B Share Buyback Plan",1,0.5097585
2022-04-08,3294200.0,313.5799865722656,323.67999267578125,313.0,321.3900146484375,305.2984924316406,GS,"U.S. jury reaches verdict in ex-Goldman banker's 1MDB corruption trial ||| 7 Financial Stocks Reporting Earnings the Week of April 11 ||| Can Bank Stocks Get Their Mojo Back with Q1 Results? ||| US STOCKS-Dow gains, S&P 500 ends lower as market weighs Fed rate hikes ||| US STOCKS-Dow gains, S&P 500 slips as market weighs Fed rate hikes ||| US STOCKS-Dow gains, S&P 500 slips as market mulls Fed rate hikes ||| Wall St Week Ahead-Beaten-down growth stocks alluring as Fed slows U.S. economy ||| Dow, S&P 500 rise as banks jump ||| Nasdaq, S&P 500 slide as higher yields hit growth stocks ||| Will Low Underwriting Volume Ail Goldman's (GS) Q1 Earnings? ||| US STOCKS-Wall St set for subdued open as yields rise again ||| Advanced Micro Devices: What’s Good Is Good ||| US STOCKS-Futures edge higher at end of roller coaster week ||| PREVIEW-U.S. bank earnings to decline in first quarter ||| KKR to list Japan's Kokusai Electric as early as June, sources say ||| GRAPHIC-Take Five: The French election and the high cost of war, rates to climb ||| U.S. jury deliberates in ex-Goldman banker's 1MDB corruption trial",0,0.48396066
2022-04-11,2747700.0,320.6099853515625,328.8999938964844,319.0299987792969,320.760009765625,304.70001220703125,GS,"Why Coupang Sank 33.3% in March ||| Goldman Sachs Could See Synergies From Recent Acquisition ||| Why Zhihu Stock Was Falling Today ||| Fintech Nubank nets $650 mln credit line for Mexico, Colombia expansion ||| U.S. banks set for better-than-expected trading revenues ||| Keep an Eye on Earnings Announcements This Week ||| Why Sea Limited Floated Above the Market on Monday ||| Buffett needed two weeks for $11.6 bln Alleghany purchase, balked at Goldman fee ||| Dow Movers: MSFT, GS ||| Financial Sector Update for 04/11/2022: GS, KKR, AIG, XLF, FAS, FAZ ||| Company News for Apr 11, 2022 ||| ANALYSIS-U.S. strategic oil sale speeds fuel-price fix, but at what cost? ||| Goldman Sachs acquires NN Investment Partners for $1.85 billion ||| Goldman pays 1.7 bln euros for Dutch-based asset manager ||| JPMorgan, Bank of America, and Goldman Sachs are part of Zacks Earnings Preview ||| ANALYSIS-U.S. strategic oil sale speeds fuel-price fix, but at what cost? ||| GRAPHIC-Take Five: The French election and the high cost of war",0,0.4929106
2022-04-12,2365200.0,321.67999267578125,327.1199951171875,318.010009765625,319.7799987792969,303.76910400390625,GS,"Hg hires Goldman Sachs to prepare sale of Germany's Transporeon - sources ||| Benetton team working on premium of around 30% to buy out Atlantia - sources ||| Notable ETF Outflow Detected - DIA, GS, AMGN, AXP ||| Can Q1 Earnings Bring Strength in Dow ETF? ||| Benettons, Blackstone working on premium of around 30% to buy Atlantia - sources ||| Will Q1 Earnings from Big Five Banks Bring Investors Pain or Relief? ||| EXCLUSIVE-Franchise Group joins bidding for Kohl's -sources ||| Deutsche Telekom reviews bids for full or partial sale of mobile towers - sources ||| What's in Store for Bank ETFs This Earnings Season? ||| Temasek-backed Zilingo suspends CEO amid accounting probe - Bloomberg News ||| Temasek-backed Zilingo suspends CEO amid accounting probe - Bloomberg News ||| Newfront Announces Investments At $2.2 Bln Valuation Towards Modernizing Platform",1,0.5058247
2022-04-13,3022900.0,315.79998779296875,322.6300048828125,314.7200012207031,321.9700012207031,305.8493957519531,GS,"Mixed Start to Q1 Earnings Season ||| Pre-Market Earnings Report for April 14, 2022 : UNH, WFC, MS, GS, TSM, C, USB, PNC, STT, ERIC, ALLY, RAD ||| Mixed Start to Q1 Earnings Season ||| US STOCKS-Wall Street surges in growth stocks rally; earnings season opens ||| US STOCKS-Wall Street jumps in growth stocks rally; earnings season commences ||| US STOCKS-Wall Street advances on growth stocks as earnings season begins ||| US STOCKS-Wall St ticks higher as recovery in growth stocks offsets mixed earnings ||| US STOCKS-S&P 500, Dow set for muted open as JPMorgan, inflation data weigh ||| US STOCKS-Futures rise ahead of JPMorgan earnings, inflation data ||| France's EDF could sell renewables to focus on nuclear - BFM ||| France's EDF could sell renewables to focus on nuclear - BFM ||| JPMorgan profit falls 42% on slowdown in deals, trading",0,0.5035177
2022-04-14,5460900.0,328.4700012207031,333.0299987792969,319.0299987792969,321.6400146484375,305.53594970703125,GS,"U.S. banks build Russia reserves; trading a bright spot in results ||| Financial Sector Update for 04/14/2022: WFC, MS, GS, XLF, FAS, FAZ ||| What Investors Can Learn from Bank Earnings So Far ||| MORNING BID-Central banks flying into storm clouds ||| US STOCKS-Nasdaq, S&P 500 fall as growth shares lose steam; banks report mixed earnings ||| Just Change GameStop to ‘GameStock’ Already ||| Goldman Sachs Trounces Earnings Projections, Now What? ||| Making Sense of Bank Earnings Amid Market and Economic Uncertainty ||| US STOCKS-S&P 500, Nasdaq dip as rising bond yields pressure growth stocks ||| Stock Market Today: Dow Jones, S&P 500 Opened Mixed; Twitter (TWTR) Gains On Musk’s Buyout Offer ||| Noteworthy Thursday Option Activity: PTGX, ALGM, GS ||| Inflation and rate hikes ahead: Bankers cautious on the economy ||| US STOCKS-S&P 500, Nasdaq lose ground as rising bond yields hit growth stocks ||| US STOCKS-Nasdaq, S&P 500 fall as growth shares lose steam; banks report mixed earnings ||| US STOCKS-U.S. stocks slide as rising bond yields hit growth stocks ||| Zacks Earnings Trends Highlights: JPMorgan, Bank of America, Wells Fargo, and Goldman Sachs ||| Morgan Stanley profit falls on trading slowdown ||| US STOCKS-S&P 500, Nasdaq set for muted open after mixed bank earnings; Twitter jumps ||| Wells Fargo Stock To Beat The Consensus In Q1? ||| Most Indexes End Shortened Week Lower; Twitter Board Meets ||| Top Stock Market News For Today April 14, 2022 ||| Goldman Sachs (GS) Q1 Earnings and Revenues Top Estimates ||| US STOCKS-Futures edge higher ahead of bank earnings; Twitter jumps on Musk's takeover offer ||| Goldman Sachs Group Q1 22 Earnings Conference Call At 9:30 AM ET ||| Goldman Sachs profit nearly halves on slowdown in dealmaking ||| Morgan Stanley profit falls on trading slowdown ||| Goldman Sachs Group Inc. Profit Retreats In Q1, but beats estimates ||| 3 Big Bank Stocks That Could Bounce on Q1 Earnings ||| Goldman Sachs Q1 Results Down, Yet Top Consensus",1,0.49072027
2022-04-18,3653400.0,320.6499938964844,332.6600036621094,320.6499938964844,329.8800048828125,313.3634033203125,GS,"Goldman Sachs Still Bullish on Twilio Despite Price Cut ||| Don’t Let Goldman Sachs’ Recession Forecast Shake You Out of SPDR S&P 500 ETF Trust ||| US STOCKS-S&P 500 inches higher as strong BofA results offset tech weakness ||| Goldman Sachs Stock: Rare Value from Financial Giant ||| Earnings Season is Kicking Off ||| US STOCKS-Wall Street set to open lower as yields continue to rise ||| US STOCKS-Wall St slips as bond yields surge, BofA gains on strong earnings ||| U.S. banks' commodity trading exposures rise on Russia conflict ||| Daily Markets: Earnings Season Gets Underway ||| Tech Correction Puts IonQ Back in the Speculative Buy Zone ||| US STOCKS-Futures slip as bond yields rise, BofA up on strong consumer lending",1,0.48517472
2022-04-19,2774800.0,330.4700012207031,337.20001220703125,330.4700012207031,335.95001220703125,319.1294860839844,GS,"EXCLUSIVE-Oil tycoon Brigham prepares rare oilfield services IPO -sources ||| Goldman CEO, top deputies to get cut of profits from bank's private investment funds - WSJ ||| Nasdaq (NDAQ) Q1 Earnings: What to Expect ||| Twilio Is Talking a Tech Turnaround ||| Though CrowdStrike Is an Obvious Buy, It’s Also a Good One",1,0.48493528
2022-04-20,3040100.0,338.1000061035156,344.8999938964844,337.5,341.0599975585937,323.983642578125,GS,"Why Volta's Stock Is Plunging Today ||| Goldman Sachs Banks on Consumers for Growth ||| This Was a Growth Stock; Now Wall Street Says, ""Dump It"" ||| Petershill Partners posts robust maiden results",0,0.4898463
2022-04-21,3097800.0,344.3299865722656,347.3500061035156,333.3599853515625,334.29998779296875,317.5620422363281,GS,"Why Block, StoneCo, and Lemonade Shares Were Plunging Today ||| The Top Reasons to Buy ChargePoint Holdings Stock Now ||| Goldman Sachs flagged Morgan Stanley block trades to Hong Kong regulator - FT",0,0.48233306
2022-04-22,3125200.0,332.3099975585937,332.5,319.4700012207031,319.7699890136719,303.75958251953125,GS,"Goldman Sachs Just Upgraded This Cybersecurity Leader ||| Notable Friday Option Activity: KMB, FANG, GS ||| Keeping Up with Earnings Season ||| EXCLUSIVE-Goldman, JPMorgan among banks left holding Russian stocks by sanctions switch ||| LME to scrap gold and silver futures by July due to thin activity",1,0.49778038
2022-04-25,3093600.0,316.3800048828125,322.1600036621094,312.739990234375,321.4200134277344,305.32696533203125,GS,"Down More Than 23%, This Year's 2 Worst-Performing Dow Stocks Look Like Monster Buys Right Now ||| This Unstoppable Dividend Aristocrat Is 2022's Best-Performing Dow Stock (and It's Not Even Close) ||| 1 Green Flag for Logitech in 2022, and 1 Red Flag ||| Here's How Goldman Sachs Can Achieve a Higher Valuation ||| FOCUS-Funding obscured: The family office behind Musk's $44 bln Twitter buyout ||| These 3 Dow Stocks Are Set to Soar in 2022's Second Half and Beyond ||| Got $100? Here's 1 Great Stock to Buy and Hold ||| RPT-EXCLUSIVE-Goldman, JPMorgan among banks left holding Russian stocks by sanctions switch",0,0.49533308
2022-04-26,2791700.0,317.95001220703125,321.6000061035156,312.79998779296875,313.1199951171875,297.4425354003906,GS,"FOCUS-Funding obscured: The family office behind Musk's $44 bln Twitter buyout ||| Buyout firm Ripplewood launches Amsterdam SPAC listing ||| Are Energy Stocks Good Buys After Crude Oil Drops? ||| Funding obscured: The family office behind Musk's $44 bln Twitter buyout ||| Goldman Says Adobe Has Pricing Power. Here’s What to Expect. ||| From weed joke to agreed deal: Inside Musk's $44 bln Twitter buyout ||| UBS posts surprise 17% Q1 profit rise ||| UBS posts surprise 17% Q1 profit rise ||| Fed up with COVID lockdown, bankers, fund managers looking to leave Shanghai ||| UBS shows signs of resilience as Q1 profit surprises with a rise",1,0.4945523
2022-04-27,2469300.0,312.1400146484375,319.239990234375,312.1400146484375,313.2300109863281,297.54705810546875,GS,"Play the EV Revolution With ChargePoint Stock ||| How Morgan Stanley's Diversified Revenue Model Helped It Overcome Slow IPO Activity ||| ChargePoint Has Two Recent Great Catalysts for Growth ||| For Goldman Sachs, It's a Tale of 2 Investment Banks ||| Americana selects banks for dual listing in Saudi Arabia and the UAE - source",1,0.5007139
2022-04-28,2176000.0,317.1199951171875,319.3599853515625,312.1499938964844,318.4100036621094,302.4677124023437,GS,"Bausch + Lomb eyes valuation of $8.4 bln in Canada, U.S. IPO ||| Is Most-Watched Stock The Goldman Sachs Group, Inc. (GS) Worth Betting on Now? ||| 1 Cryptocurrency I'd Buy Right Now ||| Lazard profit beats estimates on robust financial advisory revenue ||| Goldman Sachs Group, Inc. Shares Close in on 52-Week Low - Market Mover ||| Notable ETF Inflow Detected - DIA, GS, AMGN, AXP",0,0.46891373
2022-04-29,3129600.0,317.25,319.0799865722656,304.7099914550781,305.489990234375,290.194580078125,GS,"Noteworthy Friday Option Activity: ALXO, X, GS",1,0.52025586
2022-05-02,2968100.0,305.8099975585937,311.3699951171875,302.2099914550781,310.4200134277344,294.87774658203125,GS,"3 Top Stock Trades for the Week of May 2, 2022 ||| Goldman Sachs slashes credit exposure to Russia",1,0.554791
2022-05-03,2606200.0,311.5199890136719,319.5199890136719,311.32000732421875,314.6600036621094,298.9054260253906,GS,"Wall Street sees greater risk of default by major banks ||| Stock Market News for May 3, 2022 ||| Major Banks Gain on Soaring Yields: Will This Trend Continue?",1,0.49876818
2022-05-04,2629400.0,315.8299865722656,324.79998779296875,312.1700134277344,324.1099853515625,307.8822631835937,GS,"See Which Of The Latest 13F Filers Holds Goldman Sachs Group ||| Should SPDR Dow Jones Industrial Average ETF (DIA) Be on Your Investing Radar? ||| The Zacks Analyst Blog Highlights Bank of America, The Goldman Sachs Group, JPMorgan Chase, Morgan Stanley and Citigroup",0,0.47139165
2022-05-05,2622100.0,320.5,320.67999267578125,308.69000244140625,313.07000732421875,297.39501953125,GS,"Goldman Sachs reviews abortion benefits ahead of potential Supreme Court ruling ||| Goldman Sachs, JPM weigh abortion travel expense coverage for staff - Bloomberg News ||| Interesting GS Put And Call Options For June 24th ||| Only 1 Smartphone Brand Grew Sales Last Quarter (and It's No Surprise)",0,0.47635925
2022-05-06,2375600.0,312.2799987792969,313.7099914550781,306.0599975585937,312.9599914550781,297.2905578613281,GS,"Goldman Sachs Group's Preferred Stock, Series C Yield Pushes Past 5% ||| DIA, GS, MCD, AMGN: Large Outflows Detected at ETF ||| ANALYSIS-Banks face reversal of fortune from war and runaway inflation ||| GRAPHIC-No place to hide: Dollar's surge cuts across markets",0,0.47184345
2022-05-09,3234000.0,308.9200134277344,313.7699890136719,304.9800109863281,308.8900146484375,293.42431640625,GS,3 Oversold Bank Stocks To Buy Now ||| 3 Small-Cap Stocks to Buy for Explosive Growth ||| Comparing Litecoin Versus Goldman Sachs Group Reveals New High,0,0.49760032
2022-05-10,2798400.0,311.7200012207031,315.1499938964844,300.6499938964844,305.0599975585937,289.7860412597656,GS,"JPMorgan, Goldman pushed to name clients trading Russia debt - Bloomberg News ||| Dow Analyst Moves: GS ||| 3 Bank Stocks to Consider as Cyclical Plays ||| Pre-Market Most Active for May 10, 2022 : PTON, TQQQ, AAPL, UPST, SQQQ, QQQ, PLTR, NIO, BHC, CCL, AMC, GSK ||| US STOCKS-Futures rebound after three-day slump on Wall Street ||| MOVES-Goldman Sachs adds to China leadership team - memo ||| PE firm CVC Capital pushes back stock market debut plans- FT ||| Noteworthy Tuesday Option Activity: GS, CRM, PFE",0,0.49187246
2022-05-11,2320600.0,305.0599975585937,310.9100036621094,301.0,301.54998779296875,286.4518127441406,GS,Instacart confidentially files for U.S. IPO ||| Why Peloton Interactive Is Rising Today ||| Carsharing marketplace Getaround to go public via $1.2 bln SPAC deal ||| US STOCKS-Futures rise ahead of key inflation data,0,0.49279055
2022-05-12,3408300.0,300.0,302.8900146484375,293.8999938964844,299.4100036621094,284.4189758300781,GS,"Top Wall Street firms, Ford to disclose directors' race and gender",1,0.51146376
2022-05-13,2152500.0,303.6300048828125,309.6300048828125,303.57000732421875,306.989990234375,291.6194152832031,GS,"JPMorgan's Dimon faces shareholder advisory vote on $52.6 mln retention award ||| Goldman Sachs officials reach $79.5 mln shareholder settlement over 1MDB scandal ||| Talking About the Metaverse With Venture Capitalist and Author Matthew Ball ||| 3 Undervalued Stocks to Buy Before You Sell in May and Go Away ||| Technology Sector Update for 05/13/2022: GTLB,GS,TWTR,ASNS ||| Technology Sector Update for 05/13/2022: VZIO,GTLB,GS,TWTR,ASNS ||| EQT pushes back Galderma IPO plans amid market turmoil - sources ||| Goldman Sachs boosts recruiting team in push to meet diversity goals",0,0.48285592
2022-05-16,1568800.0,305.95001220703125,306.4700012207031,300.54998779296875,303.44000244140625,288.2471923828125,GS,"GLOBAL MARKETS-Yields slip, stocks struggle as economic fears grow ||| Implied RYF Analyst Target Price: $71 ||| 7 Undervalued Blue-Chip Stocks to Buy Now ||| China warns bankers against excessive incentives in pay curbs ||| MORNING BID-COVID lockdowns may end but China is still sneezing ||| ANALYSIS-European dealmakers face shrinking debt options as recession risk looms ||| IYG, GS, CME, PNC: ETF Inflow Alert ||| Goldman Sachs policy gives partners, managing directors flexible vacation - memo",1,0.48431775
2022-05-17,2096200.0,309.8699951171875,314.32000732421875,308.1300048828125,312.9700012207031,297.3000183105469,GS,"Notable Tuesday Option Activity: GS, PANW, BGS ||| Why Shares of Citigroup Are Rising Today ||| 6 Undervalued Stocks With Growing Earnings and Dividends ||| Bank of America Stock Has Lost 21% YTD, Is It A Buy?",0,0.48218402
2022-05-18,2033200.0,309.0,312.8599853515625,304.8800048828125,306.7300109863281,291.3724670410156,GS,"Twilio Is Still Valuable, Despite its Fall ||| Wells Fargo sees end-of-year U.S. recession, cuts GDP view ||| Mastercard to cover employee travel, lodging for out-of-state abortions",1,0.5043882
2022-05-19,2108800.0,303.82000732421875,309.989990234375,303.3900146484375,308.20001220703125,292.7688903808594,GS,"US STOCKS-S&P 500 ends lower as Cisco and Apple sink ||| GLOBAL MARKETS-Wall St bounces off lows late as growth fears persist, safe-havens gain ||| US STOCKS-Wall Street mixed as Cisco sinks and Nvidia recovers ||| Why Shares of JD.com, TAL Education Group, and Pinduoduo Are Rising Today ||| Earnings Roundup: Disney, Dutch Bros, Unity Software, and More",0,0.48304588
2022-05-20,2201100.0,311.260009765625,312.5899963378906,299.4100036621094,306.79998779296875,291.4389953613281,GS,Is JPMorgan Stock Attractive At The Current Levels?,1,0.51121813
2022-05-23,2653000.0,312.7200012207031,321.8299865722656,311.07000732421875,316.6099853515625,300.7577819824219,GS,"New York police release images of suspect in fatal subway shooting ||| Goldman Sachs Group's Preferred Stock, Series K Shares Cross 6.5% Yield Mark ||| Did Kohl's Investors Miss Their Big Opportunity? ||| Goldman CEO says 'devastated' by fatal subway shooting of employee",0,0.481328
2022-05-24,1870900.0,315.3500061035156,315.79998779296875,306.42999267578125,313.95001220703125,298.2309875488281,GS,"Manhattan return-to-office plans face persistent headwinds over COVID, safety ||| Goldman Sachs (GS) Dips More Than Broader Markets: What You Should Know ||| Why Shares of JD.com, Lufax Holding, and Dingdong Are Down Today ||| Is Barclays Stock Undervalued? ||| Austria launches its first green bond - lead manager",1,0.47868037
2022-05-25,1929500.0,311.25,317.6000061035156,309.9800109863281,314.8999938964844,299.1333923339844,GS,"Notable Wednesday Option Activity: GS, MOS, NOW",1,0.5174277
2022-05-26,2440400.0,318.29998779296875,325.5,317.9800109863281,323.6300048828125,307.4263000488281,GS,"Michael Lewis on How to Spot the Real Expert ||| Why JD.com, Zhihu, and TAL Education Group Are Up Today ||| UBS Stock Outperformed The Street Expectations In Q1, What's Next?",1,0.48108438
2022-05-27,2106700.0,326.75,328.6700134277344,323.19000244140625,328.5799865722656,312.1284484863281,GS,Why Is Evercore (EVR) Up 1% Since Last Earnings Report? ||| Is the Options Market Predicting a Spike in The Goldman Sachs (GS) Stock?,0,0.48027992
2022-05-31,2722900.0,324.010009765625,329.7200012207031,322.6600036621094,326.8500061035156,312.3865661621094,GS,"Japan's SoftBank cuts borrowing from Mizuho, Goldman Sachs ||| GRAPHIC-Peak interest rates may be lower than expected as growth slowdown looms ||| Here's a Fast-Growing Fintech You Can Buy for Under $15 Today ||| Abu Dhabi Borouge's $2 billion IPO set to be ADX's biggest ||| Goldman Sachs (GS) Stock Moves -0.53%: What You Should Know ||| Top Research Reports for IBM, Goldman Sachs & Diageo",0,0.4988855
2022-06-01,2330200.0,327.0,329.2699890136719,315.8299865722656,321.8500061035156,307.6077880859375,GS,"Rimac raises $537 mln in new funding round, CEO talks potential IPO ||| 6 Cheap Stocks To Buy Before They Take Off ||| HSBC Plans to Invest $448 Million in Its China Operations ||| The Zacks Analyst Blog Highlights IBM, Goldman Sachs, Diageo, ServiceNow and Progressive",1,0.4993551
2022-06-02,1957500.0,320.5899963378906,325.20001220703125,319.2300109863281,324.25,309.90155029296875,GS,"Goldman Sachs COO Waldron says lower valuations in wealth management open M&A opportunities ||| Block to integrate Square payments with Apple iPhone's 'Tap to Pay' feature ||| China's draft cybersecurity rules pose risks for financial firms, lobby group warns ||| Stock Market News for June 2, 2022",0,0.48442492
2022-06-03,1238900.0,320.8800048828125,322.5,317.5,318.67999267578125,304.5780334472656,GS,"Citi CEO sees Europe heading into recession more than U.S. ||| Citi CEO sees Europe heading into recession more than U.S. ||| XLF, BRK.B, MS, GS: Large Outflows Detected at ETF ||| EXCLUSIVE-Musk feels 'super bad' about economy, needs to cut 10% of Tesla jobs ||| Here's Why DigitalOcean Stock Was Up 24% in May ||| EXCLUSIVE-Musk feels 'super bad' about economy, needs to cut 10% of Tesla jobs",1,0.5048739
2022-06-06,1099700.0,323.0,325.2099914550781,319.7900085449219,320.510009765625,306.3270874023437,GS,"3 Cheap Stocks That Help You Retire Early ||| Goldman Sachs (GS) Outpaces Stock Market Gains: What You Should Know ||| Wall Street set to rebound as China ADRs, growth stocks rally ||| US STOCKS-Futures rebound as China ADRs rally; growth stocks rise",1,0.49935523
2022-06-07,2516800.0,318.2799987792969,321.8399963378906,316.6600036621094,321.510009765625,307.2828674316406,GS,"What do Higher Interest Rates Mean for My Savings? ||| Kohl’s (KSS) Stock Jumps on Talks of $8 Billion Takeover ||| Apple Pay Later Just Crushed Affirm's Dreams, but It's a Nice Win for 2 Fintech Giants",0,0.4891247
2022-06-08,1438100.0,318.3399963378906,319.54998779296875,312.79998779296875,314.67999267578125,300.75506591796875,GS,"What Do Higher Interest Rates Mean for Stocks? ||| Economic Concerns and Intel Pushed The Dow Jones Down Today ||| UniCredit executive says chances to cut Russia exposure 'limited' ||| Deloitte weighs split of auditing and consulting businesses - WSJ ||| 7 Oversold Stocks to Buy Right Now ||| Socgen CEO says to allocate more capital to east Europe, car leasing ops ||| UniCredit executive - chances to cut Russia exposure ""limited""",0,0.477376
2022-06-09,2896500.0,313.5599975585937,314.1400146484375,304.0199890136719,304.2200012207031,290.7579345703125,GS,"U.S. SEC opens probe against Ericsson over 2019 Iraq bribery report ||| Notable Thursday Option Activity: NXPI, WYNN, GS ||| Apple (AAPL) Relies on Subsidiary to Manage Apple Pay Later ||| 3 Buffett-Like Stocks to Buy on the Dip",0,0.48033988
2022-06-10,3866900.0,296.989990234375,298.6499938964844,286.8500061035156,287.0199890136719,274.31903076171875,GS,"These 3 Tech Giants Have Made Big Acquisitions in 2022 ||| New Inflation Data Hammered the Dow Friday ||| Can Elon Musk and Jamie Dimon Predict the Future? ||| If You'd Invested $5,000 in Goldman Sachs in April 2020, This Is How Much You'd Have Today ||| ANALYSIS-Global investment banking faces tougher times after blockbuster year",0,0.4767852
2022-06-13,4218100.0,279.0,286.4200134277344,278.32000732421875,283.32000732421875,270.78277587890625,GS,"Fed door open to 0.75% hike after inflation data, market moves ||| Goldman Sachs (GS) Stock Moves -1.29%: What You Should Know ||| After Hours Most Active for Jun 13, 2022 : SHV, ENIA, MSFT, CMCSA, QQQ, AMZN, INTC, BSX, NI, MRO, ORCL, GSK ||| Relative Strength Alert For Goldman Sachs Group",0,0.4954769
2022-06-14,2487700.0,284.3299865722656,289.17999267578125,281.29998779296875,282.5400085449219,270.0372619628906,GS,"PREVIEW-Sanctions-hit Kremlin stages 'Russian Davos' bereft of elite, Putin speaks Friday ||| U.S. rate markets price in aggressive 75-bps hike on Wednesday ||| West Virginia threatens to bar big banks, Blackrock over perceived fossil fuel boycotts ||| PREVIEW-Sanctions-hit Kremlin to stage annual 'Russian Davos' bereft of financial elite ||| Dow Movers: BA, CVX ||| Noteworthy ETF Outflows: DIA, GS, AMGN, CAT ||| FOREX-Dollar off lows, nears 20-year highs after historic bond rout",1,0.5207624
2022-06-15,2725800.0,287.1600036621094,294.4800109863281,284.1700134277344,290.07000732421875,277.2341003417969,GS,"Global regulators set out climate checklist for banks ||| MegaRobo raises $300 mln in Goldman Sachs-led funding round ||| US STOCKS-Growth stocks lift Wall Street ahead of Fed's rate decision ||| Dow Movers: CVX, BA ||| Consumer Sector Update for 06/15/2022: DDL, RGS, CPS, GS, XLP, XLY ||| Brazil's PetroReconcavo raises $202 mln in follow-on offering",0,0.4883062
2022-06-16,2777300.0,282.67999267578125,286.1300048828125,279.1499938964844,284.9800109863281,272.36932373046875,GS,"Targa Resources to buy natural gas processor Lucid Energy for $3.55 bln ||| Noteworthy Thursday Option Activity: GS, ROKU, NBIX ||| Market Sell-Off: These 2 Top Stocks Are on Sale ||| 7 Stocks to Buy Ahead of the June 23 Bank Stress Test Results",0,0.49124995
2022-06-17,5234400.0,282.1300048828125,286.260009765625,278.1499938964844,279.7900085449219,267.4090270996094,GS,Interesting GS Put And Call Options For August 19th ||| Market Sell-Off: 3 Stocks at Their Cheapest Valuations in Years ||| U.S. banking stress indicator could worsen after Fed hike ||| 65% of Warren Buffett's Portfolio Is Invested in These 4 Stocks,1,0.4710336
2022-06-21,2506300.0,287.7699890136719,288.07000732421875,282.9800109863281,284.8099975585937,272.20684814453125,GS,"Can Bitcoin Reach $100,000? ||| Goldman Sachs (GS) Stock Sinks As Market Gains: What You Should Know ||| Company News for Jun 20, 2022 ||| Amazon Stock Is a Buy Despite Downturn ||| U.S. banks expect a clean bill of health after Fed's stress tests ||| US STOCKS-Wall Street gains over 2% in broad rebound ||| Growing forecasts for U.S. recession may spell more trouble for stocks ||| US STOCKS-Megacap, energy shares lead broad Wall Street rebound ||| Outlook for bonds improves as recession risk rises - PIMCO",0,0.4646715
2022-06-22,2463100.0,282.2900085449219,286.010009765625,281.0400085449219,284.5400085449219,271.9487609863281,GS,"DIA, GS, AMGN, CAT: Large Inflows Detected at ETF ||| Economic Hurricane Ahead? 7 Profitable Places to Hide Your Money ||| Oman offering to buy up to $1.75 bln of outstanding bonds",1,0.5181258
2022-06-23,2547000.0,283.760009765625,286.5899963378906,278.92999267578125,286.1700134277344,273.5066833496094,GS,"Is Wells Fargo Stock Fairly Priced? ||| U.S. Fed says banks can weather severe downturn comfortably ||| U.S. Fed says banks can weather severe downturn comfortably ||| US STOCKS-Wall Street struggles for direction on growing recession fears ||| US STOCKS-Defensive stocks lead Wall Street higher amid recession fears ||| ANALYSIS-Wall Street's hiring frenzy eases as worries grow over economy, market slump",1,0.47015274
2022-06-24,3984300.0,291.0,303.1300048828125,290.0,302.75,289.3529663085937,GS,"Global M&A braces for dry spell as boardrooms put expansion on hold ||| Why Wolfspeed Was a Howler of a Stock Today ||| Celsius Network hires advisors to prepare for potential bankruptcy - WSJ ||| Noteworthy Friday Option Activity: GS, WYNN, TYL ||| Buy The Dow's 2 Top-Performing Stocks Today ||| Banks Clear 2022 Stress Test: Are Larger Payouts in Store? ||| Big Wins Can’t Trump Bigger Headwinds For PLUG Stock ||| Global M&A braces for dry spell as boardrooms put expansion on hold ||| Why Shares of Goldman Sachs Are Rising Today",0,0.49194658
2022-06-27,2091700.0,303.0599975585937,304.32000732421875,298.8800048828125,300.7799987792969,287.4701538085937,GS,"MOVES-Citi hires Deutsche Bank veteran Frowein to bolster EMEA team ||| Raft of U.S. banks raise dividends after stress tests ||| Goldman Sachs (GS) Dips More Than Broader Markets: What You Should Know ||| Blackstone, Carlyle, Apollo to cover U.S. abortion-related travel costs ||| Top Stock Market News For Today June 27, 2022 ||| Still Think Tesla Is Expensive? This Stat Will Change Your Mind ||| The Zacks Analyst Blog Highlights JPMorgan, Bank of America, Citigroup and Goldman Sachs ||| Stock Market News for Jun 27, 2022",0,0.47094977
2022-06-28,2276600.0,305.8999938964844,308.9700012207031,299.17999267578125,299.489990234375,286.2372131347656,GS,"MOVES-Goldman M&A veteran Michael Carr to retire - memo ||| US STOCKS-Wall St tumbles as weak consumer confidence stokes growth worries ||| Banorte hires Bank of America, submits non-binding offer for Citibanamex- source ||| US STOCKS-Dow, S&P boosted by banks; cautious on consumer confidence data ||| GS, BAC, WFC & Others Hike Dividends After 2022 Stress Test ||| Goldman Sachs expects over $1.2 bln losses from consumer unit this year - Bloomberg News ||| 1 Warren Buffett Stock to Buy Hand Over Fist in June ||| Spain's Santander hires Credit Suisse, Goldman to look at Citibanamex bid - source",1,0.48091385
2022-06-29,2475900.0,303.3699951171875,307.44000244140625,299.9100036621094,303.2799987792969,289.8594970703125,GS,"US STOCKS-Wall St falls in choppy trading on rate hike, growth concerns ||| US STOCKS-Wall Street seesaws, trading choppy near end of quarter ||| S&P 500 staggers to slightly lower close as quarter-end looms ||| Dow Movers: BA, GS ||| US STOCKS-Sharp rate hike bets keep Wall Street subdued, Goldman lifts Dow ||| Is Apple’s Push Into the Buy Now, Pay Later Space a Mistake?",0,0.49163005
2022-06-30,2669500.0,296.5799865722656,300.3299865722656,292.2300109863281,297.0199890136719,283.87652587890625,GS,"Why Pinterest, Roku, and Etsy Plunged Today ||| Citizens Financial (CFG) Enhances Share Buyback Program to $1B ||| SPDR Dow Jones Industrial Average ETF Trust Experiences Big Outflow ||| Financial Sector Update for 06/30/2022: UBS, GS, MORN, XLF, FAS, FAZ ||| 2 Ex-Warren Buffett Stocks Soon to Have 3% Dividend Yields ||| Goldman Sachs partners with Derivative Path to grow transaction banking ||| With IPOs on ice, banks' stock offering fees plummet",1,0.47544008
2022-07-01,1749400.0,295.2699890136719,300.3299865722656,291.7200012207031,299.2300109863281,285.9887390136719,GS,Investing in the Future of Food ||| This Dividend Beast Trades at Less Than 8 Times Earnings ||| Did This Investment Bank Just Give a Warning?,0,0.5072558
2022-07-05,2480900.0,293.0,297.3500061035156,288.3599853515625,297.20001220703125,284.0486145019531,GS,Why Kohl's Plunged 27% This Week ||| ANALYSIS-Canada's light touch regulation of ESG funds risks 'greenwashing' claims ||| 2 Bank Stocks with Great Potential to Outperform the Market ||| ANALYSIS-Canada's light touch regulation of ESG funds risks 'greenwashing' claims ||| Roblox Stock Is Still Not Cheap at Two-Thirds Off ||| Goldman Sachs (GS) Stock Sinks As Market Gains: What You Should Know ||| Should SPDR Dow Jones Industrial Average ETF (DIA) Be on Your Investing Radar?,0,0.48808464
2022-07-06,1774500.0,296.2699890136719,297.3399963378906,290.6000061035156,293.760009765625,280.76080322265625,GS,These 2 Tech Companies Have Made Significant Acquisitons in 2022 ||| Why Shares of Goldman Sachs Fell 22.4% in the First Half of This Year ||| BNY Mellon appoints Goldman Sachs veteran McDonogh as CFO ||| INSIGHT-How Republican-led states are targeting Wall Street with 'anti-woke' laws ||| Dubai road toll operator appoints first CEO ahead of flotation,1,0.49446175
2022-07-07,2046500.0,297.6600036621094,299.07000732421875,293.6000061035156,298.6000061035156,285.3866577148437,GS,US STOCKS-Wall Street rises as traders temper bets on aggressive rate hikes ||| Visa Stock Remains a Long-Term Winner,0,0.47982383
2022-07-08,1438900.0,300.5,300.8900146484375,295.07000732421875,296.4700012207031,283.3508605957031,GS,"Notable ETF Outflow Detected - DIA, GS, MCD, AMGN ||| Goldman and SocGen advising French government on EDF deal - sources",0,0.47137666
2022-07-11,1519400.0,293.20001220703125,296.5400085449219,291.8800048828125,293.17999267578125,280.2064208984375,GS,"MercadoLibre receives $233 mln from Goldman Sachs to expand loans in Brazil, Mexico ||| Goldman Sachs (GS) Stock Moves -1.11%: What You Should Know ||| EXCLUSIVE-French nationalisation of EDF set to cost more than 8 bln euros ||| What Lies Ahead for Dow ETF in Q2 Earnings? ||| Earnings Preview: Goldman Sachs (GS) Q2 Earnings Expected to Decline ||| Big U.S. banks' second quarter profits to tumble on higher bad loan reserves ||| Big U.S. banks' second quarter profits to tumble on higher bad loan reserves ||| Wall Street banks' Q2 trading revenue likely to surge, softening blow from deal slump",0,0.54239005
2022-07-12,1772600.0,289.7099914550781,299.0799865722656,289.510009765625,292.5299987792969,279.5852355957031,GS,What's in Store for Bank ETFs This Earnings Season? ||| Goldman hires Google exec to co-head applied innovation unit - memo ||| ANALYSIS-Volatile U.S. markets boost appeal of dividend stocks,0,0.4862144
2022-07-13,1884100.0,290.510009765625,291.19000244140625,285.8099975585937,290.1499938964844,277.3104858398437,GS,"Goldman Sachs Group, Inc. Shares Approach 52-Week Low - Market Mover ||| In West Virginia, banks cite Green criticism as red state credential ||| 2 Dirt-Cheap Financial Stocks You Can Buy and Hold for the Next Decade",0,0.4825539
2022-07-14,3171900.0,284.239990234375,284.239990234375,277.8399963378906,281.5899963378906,269.1293334960937,GS,"US STOCKS-Wall St set to open lower as earnings of big banks disappoint ||| 3 Dow Stocks That Fell Today on Earnings Jitters ||| Wall Street banks worry about economic storms ahead ||| JPMorgan, Morgan Stanley earnings bode badly for Wall Street dealmakers ||| Dow Movers: JPM, MCD ||| EXCLUSIVE-Barclays seeks entry into China's $4.3 tln asset management market -sources ||| JPMorgan, Morgan Stanley earnings bode badly for Wall Street dealmakers ||| Weakness in Investment Banking to Mar BofA (BAC) Q2 Earnings ||| 2 Financial Stocks You'll Be Happy You Own Now and in 2032 ||| Burned Twitter deal bankers see silver lining in Musk's startups ||| US STOCKS-Futures fall as JPMorgan, Morgan Stanley kick off earnings on sour note",1,0.49062982
2022-07-15,3457600.0,286.5,296.42999267578125,285.1499938964844,293.8699951171875,280.86590576171875,GS,"US STOCKS-Wall St gains as bets of supersized rate hike recede ||| Why Shares of JPMorgan Chase, Morgan Stanley, and Goldman Sachs Rose Today ||| Wall St Week Ahead-Recession fears loom over U.S. value stocks ||| 3 Stocks That Drove the Dow's 650-Point Gain ||| US STOCKS-Wall St ends tumultuous week with strong rally as rate hike fears wane ||| Wall St ends tumultuous week with solid rally as rate hike worries fade ||| Pre-Market Earnings Report for July 18, 2022 : BAC, SCHW, GS, PLD, SYF, GNTY ||| Citi, Goldman, BofA in talks with regulators over texting fine - Bloomberg ||| Soccer-AC Milan investor can obtain documents in bid to block Elliott sale ||| Citi, Goldman, BofA in talks with regulators over texting fine - Bloomberg ||| Why DigitalOcean Stock Was Underwater This Week ||| Goldman Sachs Stock To Beat The Consensus In Q2? ||| US STOCKS-Wall St rallies on upbeat results, ebbing rate hike fears",1,0.4833915
2022-07-18,6767900.0,305.760009765625,311.25,298.7099914550781,301.260009765625,287.9289245605469,GS,"GLOBAL MARKETS-Asia shares bounce, euro on edge for ECB and gas test ||| What To Expect From Bank of America Stock In Q2? ||| GLOBAL MARKETS-Asia tries to bounce, tense week ahead for EU ||| Wall St Week Ahead-Recession fears loom over U.S. value stocks ||| 1 Green Flag for Marqeta in 2022, and 1 Red Flag ||| GLOBAL MARKETS-Asian shares drift lower in choppy markets ||| Australian shares subdued in choppy trade; NZ down ||| US STOCKS-Goldman profit beat, easing rate-hike bets drive Wall St higher ||| Australia shares set to fall; NZ flat ||| U.S. banks take hit on leveraged loans as deals slump, rates rise ||| US STOCKS-Wall Street closes down on slide in Apple shares, bank stocks ||| GLOBAL MARKETS-Stocks edge up, dollar dips as Fed hike expectations lessened ||| Wall Street ends lower on slide in Apple shares, bank stocks ||| Financial Sector Update for 07/18/2022: PLD,AMTD,GRAB,GS ||| US STOCKS-Wall Street reverses course on slide in Apple shares ||| US STOCKS-Easing rate-hike bets, bank earnings lift Wall Street ||| Financial Sector Update for 07/18/2022: AMTD,GRAB,GS ||| Why Tesla, Rivian, and Nio Stock Popped Today ||| Pre-Markets in Green as Q2 Earnings Season Gathers Pace ||| Dow Movers: JNJ, BA ||| Pre-Markets Start Robust, Where They Left Off Friday ||| US STOCKS SNAPSHOT-Wall St opens higher on Goldman profit beat, easing rate-hike bets ||| Financial Sector Update for 07/18/2022: GNTY, GS, BAC, XLF, FAS, FAZ ||| US STOCKS-Goldman profit beat, easing rate-hike bets drive futures higher ||| Goldman Sachs (GS) Q2 Earnings and Revenues Beat Estimates ||| How The Pieces Add Up: OEF Headed For $226 ||| Goldman Sachs Q2 Profit Dips 48%, Misses Estimates ||| Goldman Sachs profit nearly halves in second quarter ||| Goldman Sachs Group Inc. Profit Retreats In Q2, but beats estimates ||| GLOBAL MARKETS-Stocks climb, euro inches higher in big week for markets ||| Goldman Sachs Group Q2 22 Earnings Conference Call At 9:30 AM ET ||| GLOBAL MARKETS-Risk appetite returns to Europe ahead of crucial week ||| GLOBAL MARKETS-Shares rally, euro on edge for ECB and gas test ||| Goldman Sachs Rises As Q2 Results Beat The Street",1,0.52141756
2022-07-19,5641100.0,303.5899963378906,319.1400146484375,303.5,318.04998779296875,303.9759216308594,GS,"Do Options Traders Know Something About Goldman (GS) Stock We Don't? ||| Notable ETF Outflow Detected - SPYG, AMD, LOW, GS ||| Noteworthy Tuesday Option Activity: GS, JBHT, LOW ||| Stock Market News for Jul 19, 2022 ||| GLOBAL MARKETS-Asian shares weaken as traders eye central banks' rate plans",1,0.46210858
2022-07-20,3489800.0,317.2799987792969,322.1700134277344,316.3099975585937,321.45001220703125,307.2254943847656,GS,"Goldman Sachs names Australia's former treasurer in Asia-Pacific adviser role ||| Top Stock Reports for Comcast, Texas Instruments & Philip Morris",1,0.51309633
2022-07-21,2518800.0,320.510009765625,327.1600036621094,319.8500061035156,326.5400085449219,312.0902709960937,GS,Interesting GS Put And Call Options For September 2nd ||| Why Goldman Sachs Could Be the Best Bank Stock to Buy Now,0,0.48810378
2022-07-22,1830300.0,327.1099853515625,329.04998779296875,322.19000244140625,323.92999267578125,309.5957336425781,GS,"Why SoFi Technologies, Upstart, and Affirm Rose This Week ||| Goldman Sachs Group (NYSE:GS) Will Pay A Larger Dividend Than Last Year At $2.50 ||| 1 Green Flag for Goldman Sachs in 2022, and 1 Red Flag",1,0.48181355
2022-07-25,4024500.0,325.9700012207031,327.2900085449219,322.6000061035156,324.1199951171875,309.7773132324219,GS,"How a Dramatic Drop in IPO Activity Is Affecting Goldman Sachs' Stock ||| 6 Growth Stocks That Are Bargains After Taking a Tumble ||| Why Diamondback Energy, Centennial Resource Development, and Transocean Rallied on Monday ||| Former Goldman banker, ex-FBI trainee charged with insider trading ||| See Which Of The Latest 13F Filers Holds Goldman Sachs Group ||| Why Bitcoin, Ethereum, and Shiba Inu Are Falling Today",0,0.49438533
2022-07-26,2054700.0,321.7699890136719,324.2900085449219,317.760009765625,318.54998779296875,304.45379638671875,GS,Goldman Sachs Stock is Looking Cheap after Q2 Earnings Beat ||| Is the U.S. Economy in a Technical Recession? We'll Find Out This Week,1,0.48582444
2022-07-27,2081900.0,320.2900085449219,326.3900146484375,318.3800048828125,324.5400085449219,310.17877197265625,GS,Banking Earnings Downbeat: What's in Store for ETFs? ||| Hong Kong set for billions in inflows from China companies' listing upgrades,1,0.5217052
2022-07-28,1820700.0,325.29998779296875,329.9800109863281,321.8900146484375,329.1099853515625,314.5465087890625,GS,West Virginia bars five financial firms for deemed fossil fuel 'boycotts',1,0.51480025
2022-07-29,2112200.0,329.5,335.17999267578125,329.5,333.3900146484375,318.6371459960937,GS,What Do Higher Interest Rates Mean for Stocks? ||| What do Higher Interest Rates Mean for My Savings? ||| ANALYSIS-Wall Street weighs job cuts as deals slide in battered markets,0,0.48218563
2022-08-01,1476500.0,331.7300109863281,334.79998779296875,329.010009765625,332.0799865722656,317.38507080078125,GS,Americana adds HSBC to list of banks for Gulf dual listing -sources,0,0.49668765
2022-08-02,1862900.0,329.5,331.8299865722656,327.2200012207031,327.8800048828125,313.3709411621094,GS,Is Goldman Sachs Undervalued Right Now?,1,0.5183239
2022-08-03,1770600.0,332.07000732421875,335.510009765625,329.6199951171875,333.1700134277344,318.4268798828125,GS,"Noteworthy Wednesday Option Activity: AVGO, ALB, GS",0,0.5240012
2022-08-04,1533400.0,333.2799987792969,334.29998779296875,330.6199951171875,331.8699951171875,317.1843566894531,GS,Goldman Sachs' US Credit Card Division Probed By CFPB ||| Why Are Offerpad and Opendoor Falling on Thursday? ||| Argentine markets tick up even as Massa plan gets lukewarm reaction ||| Goldman discloses probe into U.S. credit card division,1,0.50275135
2022-08-05,1876400.0,330.8999938964844,336.9100036621094,329.6700134277344,334.6700134277344,319.8605041503906,GS,Goldman Sachs Group (NYSE:GS) Is Paying Out A Larger Dividend Than Last Year,1,0.49418443
2022-08-08,1460000.0,337.1099853515625,338.8399963378906,334.3399963378906,334.67999267578125,319.8700561523437,GS,Could Apple Join Forces With Bitcoin? ||| Got $5000? 3 Top Financial Stocks to Buy for the Long Term ||| Why Investors Knocked Block Stock Down Today,1,0.49333572
2022-08-09,1587900.0,336.1499938964844,338.1700134277344,334.57000732421875,336.6199951171875,321.7242126464844,GS,SPDR Dow Jones Industrial Average ETF Trust Experiences Big Inflow,1,0.511246
2022-08-10,2459500.0,341.3599853515625,349.70001220703125,341.3500061035156,347.9100036621094,332.5145874023437,GS,"Wall Street rally lifts Nasdaq 20% from low as inflation fears ebb ||| US STOCKS-Wall Street rallies as cooling inflation eases rate hike fears ||| Wall Street rallies as cooling inflation eases rate hike fears ||| Wall Street rallies as cooling inflation eases rate hike fears ||| US STOCKS-S&P, Nasdaq jump 2% as cooling inflation eases rate hike bets ||| GS Makes Bullish Cross Above Critical Moving Average ||| 3 Financial Stocks With Valuations Too Cheap to Ignore ||| US STOCKS-Wall St climbs as signs of cooling inflation ease rate hike bets ||| US STOCKS-Wall St set for gains after soft inflation data eases rate-hike bets",1,0.5058986
2022-08-11,2360800.0,350.0,356.04998779296875,349.7799987792969,351.67999267578125,336.11773681640625,GS,"US STOCKS-Nasdaq, S&P 500 retreat as rate hike fears cool stock rally ||| US STOCKS-S&P 500, Nasdaq retreat despite signs of slowing inflation ||| US STOCKS-S&P 500 at three-month high on rising bets of smaller rate hikes ||| Bill George Talks About What Makes a Good CEO",1,0.4896761
2022-08-12,2369000.0,353.44000244140625,354.5599975585937,350.1499938964844,353.82000732421875,338.1630554199219,GS,"Prada seeks $1 billion valuation in Milan listing - Bloomberg News ||| Stock Market News for Aug 12, 2022 ||| COLUMN-Scarcity changes the LME warehousing game: Andy Home ||| US STOCKS-Futures rise as cooling inflation sets Wall St for weekly gains ||| US STOCKS-Futures up as easing price pressures set Wall St for weekly gains",1,0.5324228
2022-08-15,2045700.0,351.0,358.6199951171875,349.04998779296875,355.8500061035156,340.1032409667969,GS,"COLUMN-Scarcity changes the LME warehousing game: Andy Home ||| Goldman, Morgan Stanley seek to end investors' Archegos-linked lawsuits",0,0.4914841
2022-08-17,1576300.0,351.8999938964844,355.5899963378906,350.7699890136719,353.739990234375,338.0866394042969,GS,"ANALYSIS-U.S., European banks could lose over $5 bln from risky buyout loans ||| Goldman (GS) Up 11.6% Since Last Earnings Report: Can It Continue? ||| Fed Issues Guidelines for Banks Engaging in Crypto Activities ||| ANALYSIS-U.S., European banks could lose over $5 bln from risky buyout loans",1,0.50278807
2022-08-18,1102200.0,352.6600036621094,355.1000061035156,350.8599853515625,354.5199890136719,338.83209228515625,GS,"JPMorgan vs. Goldman Sachs: Which Bank Stock is Better? ||| Goldman Sachs Group's Preferred Stock, Series C Shares Cross 5% Yield Mark ||| Notable Thursday Option Activity: GS, CVS, TEL ||| Noteworthy ETF Outflows: VONV, GS, C, AXP ||| The Implied Analyst 12-Month Target For IAI",0,0.4901764
2022-08-19,1812300.0,351.0,351.8599853515625,347.5,349.2699890136719,333.8143920898437,GS,Archegos tried to lull banks before $36 bln firm collapsed - US prosecutors ||| Archegos tried to lull banks before $36 bln firm collapsed - US prosecutors ||| Goldman Sachs Group (NYSE:GS) Will Pay A Larger Dividend Than Last Year At $2.50 ||| 2 Picks from Expert Hedge Fund Manager Edgar Wachenheim’s Chest,0,0.49127644
2022-08-22,1723900.0,342.44000244140625,344.5299987792969,340.760009765625,342.4200134277344,327.2675476074219,GS,What To Expect From JPMorgan Stock? ||| Goldman Sachs' long-running gender bias lawsuit set for June 2023 trial ||| Is the Options Market Predicting a Spike in Goldman Sachs (GS) Stock? ||| FACTBOX-Big banks expected to rack up more than $1 bln in fines for WhatsApp use,0,0.47551128
2022-08-23,1538000.0,341.95001220703125,344.07000732421875,339.0299987792969,340.17999267578125,325.12664794921875,GS,"Companies facing activist investors favor Goldman in first half -Refinitiv ||| Goldman sees Powell sticking to July tightening message at Jackson Hole ||| Firms make deals to boost LNG exports 60% from U.S., Canada, Mexico ||| Goldman Sachs' long-running gender bias lawsuit set for June 2023 trial ||| EXCLUSIVE-Allianz in talks with banks for China asset management venture -sources",1,0.49962294
2022-08-24,1530800.0,339.0199890136719,344.32000732421875,338.489990234375,341.94000244140625,326.80877685546875,GS,Billionaire Och sues former firm Sculptor over escalating CEO pay ||| These U.S. Banks Are Rewriting Banking Dynamics with Blockchain Technology,1,0.5274515
2022-08-25,1763900.0,344.45001220703125,346.8599853515625,342.1099853515625,346.489990234375,331.157470703125,GS,"Why Shares of JD.Com, TAL Education Group, and Pinduoduo Are Surging This Week ||| Why Shares of Freyr Battery Are Charging Higher Today ||| US STOCKS-Wall St set to rise at open as investors focus on Jackson Hole meet ||| Chinese delivery firm ZTO Express raises $870 mln in convertible bonds",0,0.50278306
2022-08-26,1703900.0,348.3399963378906,348.739990234375,336.0,336.3999938964844,321.513916015625,GS,Cheap Stocks Are Lurking Everywhere -- Don't Fall Into Their Trap ||| Citi (C) to Incur $170M Charges on Exit From Russian Operations ||| What To Expect From HSBC Stock?,0,0.48429558
2022-08-29,1835600.0,333.9200134277344,336.3999938964844,332.010009765625,333.9200134277344,319.1436767578125,GS,"2 No-Brainer Cryptocurrencies to Buy Before the Bear Market Ends ||| Goldman slashes British growth forecast, predicts Q4 recession ||| My Top FAANG Stock to Buy for the Second Half of 2022 (and Beyond) ||| What To Expect From Goldman Sachs Stock? ||| Goldman Sachs (GS) Dips More Than Broader Markets: What You Should Know ||| GLOBAL MARKETS-Rate fever propels dollar, wallops stocks and bonds",0,0.49068388
2022-08-30,1830300.0,335.0,336.010009765625,331.17999267578125,333.6300048828125,318.86651611328125,GS,Goldman Sachs to lift COVID protocols - memo ||| 7 Hot Tech Stocks to Buy in September ||| SPDR Dow Jones Industrial Average ETF Trust Experiences Big Outflow,0,0.4898584
2022-08-31,2488000.0,331.54998779296875,335.1400146484375,329.67999267578125,332.6700134277344,320.3494873046875,GS,"Japan property lures private equity with solid yields, prospective deals ||| TREASURIES-U.S. yields mixed amid high inflation, low growth concerns",1,0.5137457
2022-09-01,1575100.0,329.8699951171875,333.69000244140625,324.6199951171875,333.5,321.14874267578125,GS,"Don't work in ""lonely home silos"", Jefferies CEO tells staff ||| GS October 14th Options Begin Trading ||| This Wall Street Bank Is Learning That Building a Fintech Is Harder Than It Looks ||| The Zacks Analyst Blog Highlights Alphabet, The Goldman Sachs, Anheuser-Busch, PayPal and Duke Energy",0,0.47416687
2022-09-02,2215400.0,334.67999267578125,340.32000732421875,329.9700012207031,331.4800109863281,319.2035522460937,GS,"Noteworthy Friday Option Activity: GS, BAC, IT ||| UBS scraps $1.4 billion deal to buy Wealthfront ||| Banks battle back-to-office fatigue with ping pong, snacks, indoor gardens ||| Citadel Securities sets sights on Treasury investors in Japan",0,0.50206786
2022-09-06,1578100.0,332.32000732421875,333.25,323.4599914550781,326.489990234375,314.3983154296875,GS,"CVS to buy Signify Health in $8 bln deal ||| Should SPDR Dow Jones Industrial Average ETF (DIA) Be on Your Investing Radar? ||| India's Bengaluru hit by flooding, traffic snarls after heavy rain ||| GRAPHIC-Go big or even bigger?: Five questions for the ECB ||| Is Morgan Stanley Stock Attractive At The Current Levels? ||| Goldman Sachs (GS) Dips More Than Broader Markets: What You Should Know ||| 5 Dow Jones Industrial Average Stocks To Watch In September 2022 ||| 6 Safe Stocks to Buy in September 2022 ||| JPMorgan (JPM) Plans Hiring in Germany Amid Retail Expansion",1,0.4848556
2022-09-07,1496600.0,324.25,332.1600036621094,323.25,330.5599975585937,318.3175964355469,GS,"Notable ETF Inflow Detected - XLF, JPM, MS, GS",1,0.5050396
2022-09-08,1755600.0,330.2900085449219,335.8099975585937,327.3599853515625,335.3800048828125,322.9590759277344,GS,Credit Suisse strikes deal to buy out China joint venture partner ||| 7 S&P 500 Stocks to Buy With Superior Fundamentals ||| MOVES-Goldman Sachs bolsters asset management unit with new adviser ||| Goldman Sachs steepens U.S. rates outlook ||| Wall St slips as Powell sticks to hawkish stance,1,0.49108937
2022-09-09,1445600.0,337.9800109863281,341.0299987792969,337.0299987792969,340.1000061035156,327.5043029785156,GS,Goldman Sachs (GS) Gains But Lags Market: What You Should Know ||| Banks see strong demand for Citrix debt after discount -sources ||| Big banks to rake in record profits from commodities this year ||| Saudi wealth fund to issue green bonds as soon as next week - sources,1,0.47392714
2022-09-12,1563200.0,341.6600036621094,344.3699951171875,340.0899963378906,342.5799865722656,329.89239501953125,GS,"GLOBAL MARKETS-Stocks creep higher as focus turns to U.S. inflation data ||| Goldman Sachs set to cut jobs this month - source ||| GS January 2025 Options Begin Trading ||| Credit Suisse (CS) to Own 100% of China Securities Joint Venture ||| Goldman Sachs set to cut jobs this month - source ||| If I Could Buy Only 1 Stock, This Would Be It",0,0.4983372
2022-09-13,2242100.0,336.0799865722656,336.5199890136719,326.8299865722656,328.3900146484375,316.2279968261719,GS,"JPMorgan and BofA cautious on job cuts as Goldman layoffs loom ||| German government sells remaining Lufthansa shares ||| German government intends to reduce Lufthansa stake further -bank ||| JPMorgan and BofA cautious on job cuts as Goldman layoffs loom ||| 1 Growth Stock Set to Soar 163% From Its 52-Week Low, According to Wall Street ||| U.S. banks' key performance metric set to turn around in second half ||| GLOBAL MARKETS-Stocks extend winning run on optimism inflation peaking ||| MORNING BID-Great expectations",0,0.4766222
2022-09-14,1953300.0,328.45001220703125,330.92999267578125,323.5,327.260009765625,315.1398010253906,GS,"In rebuff to Disney, Comcast signals Hulu will not come cheap ||| Traffic, water shortages, now floods: the slow death of India's tech hub? ||| Banks Provide Grim Q3 Fee Income View, Rising Rates to Aid ||| Walmart-backed fintech to test banking services in coming weeks - Bloomberg News ||| 3 Bank Stocks That Could Thrive as Interest Rates Rise: GS; MS; BAC ||| More Cracks Are Emerging in Goldman Sachs' Consumer Banking Division. Should Investors Be Worried?",1,0.50229514
2022-09-15,1489400.0,328.7300109863281,335.2799987792969,327.5899963378906,331.6199951171875,319.33837890625,GS,"Bankers wary of backlash if Britain ditches bonus cap to cut EU ties ||| Goldman Sachs (GS) Gains As Market Dips: What You Should Know ||| Traffic, water shortages, now floods: the slow death of India's tech hub? ||| Prada invests in Italian tannery, undecided on dual listing ||| What To Expect From Wells Fargo Stock? ||| Fortanix Reports $90 Mln In Series C Funding ||| Prada CEO says no decision yet on dual listing in Milan -report",0,0.5007163
2022-09-16,2946800.0,326.3800048828125,329.0,319.7900085449219,326.2099914550781,314.1286926269531,GS,"Recession Warning Caps Off Volatile Week on Wall Street ||| Goldman Sachs defeats employee class action over retirement plan ||| Goldman Sachs consumer banking unit under Fed scrutiny - Bloomberg Law ||| Goldman Sachs consumer banking unit under Fed scrutiny - Bloomberg Law ||| Why Western Digital Is Down 13.8% This Week ||| FOCUS-U.S. SEC's crypto guidelines push up costs for lenders, disrupting projects",1,0.5187329
2022-09-19,1652700.0,320.57000732421875,329.2900085449219,320.5400085449219,328.6600036621094,316.4879455566406,GS,"Goldman Sachs cuts 2023 U.S. GDP forecasts ||| Notable Monday Option Activity: GS, SLB, RCL",0,0.49666685
2022-09-20,1569900.0,325.70001220703125,326.79998779296875,320.010009765625,323.260009765625,311.2879638671875,GS,"Mexican used-car startup Kavak lands $810 mln in debt financing ||| Stock Market News for Sep 20, 2022 ||| Streaming Dominance May Boil Down to 1 Surprising Factor ||| The Math Shows QUS Can Go To $133 ||| Goldman Sachs lays off 25 bankers in Asia - Bloomberg ||| Goldman Sachs lays off 25 bankers in Asia - Bloomberg",0,0.49077138
2022-09-21,1796700.0,324.9200134277344,329.7900085449219,320.6300048828125,320.7099914550781,308.8324279785156,GS,Goldman Sachs (GS) Stock Moves -0.79%: What You Should Know ||| Banks close painful Citrix debt chapter with $700 mln loss -source ||| Why Sotera Health Got Slammed Again on Wednesday ||| Petershill Partners approves half year dividend amid strong cashflow,0,0.48873726
2022-09-22,2239900.0,322.32000732421875,323.3900146484375,311.20001220703125,312.9200134277344,301.3309631347656,GS,"Singapore's GIC buys into Sani/Ikos, valuing resorts group at 2.3 bln euros ||| Singapore's GIC buys into Sani/Ikos, valuing resorts group at 2.3 bln euros ||| U.S. lawmakers pile pressure on big banks over China ties, Taiwan ||| U.S. lawmakers pile pressure on big banks over China ties, Taiwan",0,0.49390006
2022-09-23,2918500.0,307.54998779296875,309.7900085449219,297.4599914550781,301.9700012207031,290.78643798828125,GS,"Why Affirm Stock Finished 3.6% Lower on Friday ||| Why Shares of Mastercard, Citigroup, and Goldman Sachs Edged Lower Today",0,0.4792838
2022-09-26,2308800.0,299.0,302.1000061035156,292.3099975585937,294.6199951171875,283.7086486816406,GS,"2 Reasons This Tiny Crypto Has Explosive Potential ||| Best Stocks To Buy Now? 2 Dow Jones Stocks To Watch This Week ||| Here's My Top Value Stock to Buy Right Now ||| Noteworthy Monday Option Activity: GS, NCR, LIVN ||| Why Roblox Stock Was Up Earlier Today",0,0.5089449
2022-09-27,2007400.0,297.5,299.1499938964844,288.6199951171875,291.3800048828125,280.5886535644531,GS,"JPMorgan doubles down on UK retail bank Chase ||| Here's How 4 Dow Finance Stocks are Holding Up in Bear Market ||| Saudi Arabia's wealth fund hires banks for debut green bonds ||| Goldman cuts 2023 oil price forecast due to weakening demand outlook ||| Goldman Sachs closes $9.7 bln private-equity fund, largest since 2007 ||| U.S. fines 16 Wall Street firms $1.1 billion over record-keeping failures ||| MOVES-HSBC hires Goldman Sach's Ma to lead North Asia global banking - memo ||| Financial Sector Update for 09/27/2022: LBAI, PFS, RY, GS, XLF, FAS, FAZ ||| Goldman Sachs closes $9.7 bln private-equity fund, largest since 2007 ||| Goldman Sachs (GS) Dips More Than Broader Markets: What You Should Know",1,0.4841359
2022-09-28,2289700.0,294.0,302.4100036621094,292.4599914550781,300.7900085449219,289.650146484375,GS,"Hong Kong's global investment summit to take place Nov 2 ||| Jefferies beats quarterly profit estimates on lift from merchant banking ||| SEC, CFTC Fine Wall Street Banks for Record-Keeping Failures ||| 3 Undervalued Bank Stocks to Buy Now ||| The Zacks Analyst Blog highlights JPMorgan, Goldman Sachs, Visa and American Express ||| JPMorgan doubles down on UK retail bank Chase ||| 7 Blue-Chip Sleeper Stocks to Buy Before Wall Street Wakes Up ||| Credit Suisse Stock Lost 21% Last Week, What's Next? ||| Arabian Drilling Co to price IPO at 90-100 riyals a share",0,0.49266472
2022-09-29,1930800.0,297.07000732421875,299.3500061035156,291.54998779296875,296.1099853515625,285.1434631347656,GS,"Fed to kick off climate scenario analysis in 2023 with six large banks ||| Wall Street banks shelve $3.9 billion debt sale for Brightspeed buyout ||| Wall Street banks set to cancel $3.9 billion Brightspeed debt sale ||| RBC cuts 1% staff in U.S. capital markets division-source ||| 1 Huge Trend That Will Drive Snowflake's Future Results ||| Noteworthy ETF Inflows: DIA, GS, HON, CAT ||| Fed announces six large banks to participate in 2023 climate scenario analysis ||| 1 Wall Street Analyst Says Salesforce Stock Will Soar 115% ||| Baring Private Equity taps Goldman to lead Tricor, Vistra merger -sources",0,0.48640478
2022-10-03,1938800.0,297.1700134277344,301.2300109863281,291.1000061035156,299.1499938964844,288.0708923339844,GS,Costco Continues to Deliver ||| Goldman says reported OPEC+ output cuts reinforce its bullish oil view ||| Credit Suisse Has the Market on Edge. What Should You Do? ||| POLL-Polish c.bank seen hiking by 25 bps as CPI keeps rising ||| Is Citigroup Stock Attractive At The Current Levels?,1,0.5067472
2022-10-04,2399500.0,306.79998779296875,315.1600036621094,305.8800048828125,314.8699951171875,303.2087097167969,GS,"Is Credit Suisse Stock Attractive At The Current Levels? ||| U.S. STOCKS-Wall St rallies as data, RBA move lifts hope of Fed easing ||| STOCKS-Wall St closes up as data, RBA move lifts hope of Fed easing ||| US STOCKS-Wall St rallies as data, RBA move lifts hope of Fed easing ||| Notable Tuesday Option Activity: GS, WDC, WELL ||| JPMorgan (JPM) Plans to Go Global With Digital Retail Bank ||| Could Freyr Battery Become the Next Tesla?",0,0.4753331
2022-10-05,1992800.0,306.5799865722656,310.2099914550781,303.6000061035156,309.0,297.5560607910156,GS,"Dow Movers: GS, V ||| Saudi Arabia's wealth fund starts selling debut green bonds",0,0.5166936
2022-10-06,1367400.0,307.3900146484375,309.0799865722656,303.4200134277344,304.6700134277344,293.3865051269531,GS,"Top Research Reports for Novartis, Lowe's & Goldman Sachs ||| Will Goldman (GS) Beat Estimates Again in Its Next Earnings Report? ||| Why Pinterest Stock Jumped Today ||| Goldman raises oil price forecasts on 'very bullish' OPEC+ cuts ||| US STOCKS-Futures pare losses as jobless claims data calms rate-hike fears ||| Investors in Goldman Sachs Group (NYSE:GS) have made a notable return of 68% over the past three years ||| Zacks Earnings ESP: A Better Way to Find Earnings Surprises for Finance",0,0.49880317
2022-10-07,1790100.0,304.0,305.1499938964844,299.1499938964844,301.0799865722656,289.92938232421875,GS,"Stocks Eye Weekly Wins Despite Rapidly Cooling Rally ||| The Zacks Analyst Blog Highlights Novartis, Lowe's, The Goldman Sachs, Twitter and Xcel Energy ||| DIA, GS, CAT, HON: Large Inflows Detected at ETF ||| PREVIEW-U.S. banks' Q3 profits set to shrink on economic risks, deal slump ||| PREVIEW-U.S. banks' Q3 profits set to shrink on economic risks, deal slump",0,0.5049727
2022-10-10,1309600.0,303.6300048828125,304.7200012207031,298.42999267578125,300.5400085449219,289.409423828125,GS,"Why Pinterest Stock Beat the Market in September ||| 2 Cheap Bank Stocks to Buy Now and Never Sell ||| BofA (BAC) Agrees to Settle Mortgage Crisis Suit With Ambac ||| Financial Sector Update for 10/10/2022: SSBK, GS, PZN, XLF, FAS, FAZ ||| PREVIEW-U.S. banks' Q3 profits set to shrink on economic risks, deal slump",0,0.48045805
2022-10-11,2392800.0,298.010009765625,302.5199890136719,293.9200134277344,294.2099914550781,283.3138122558594,GS,"Noteworthy Tuesday Option Activity: MVIS, WOR, GS ||| Arabian Drilling set to raise over $700 million in IPO ||| U.S. banks likely set aside $5 bln in Q3 reserves as recession risks grow ||| SEC scrutiny into Wall Street communications shifts to investment funds - sources ||| Dow ETFs in Focus Ahead of Q3 Earnings ||| U.S. banks seen building $5 bln in reserves as recession risks grow",1,0.51588315
2022-10-12,1763800.0,293.989990234375,299.7799987792969,291.7099914550781,295.3099975585937,284.3730773925781,GS,ANALYSIS-Worries over global financial stability mount as central banks tighten policy ||| Why Peloton Interactive Is Falling Once Again Today ||| Is a Beat in the Offing for Goldman's (GS) Q3 Earnings?,1,0.5162136
2022-10-13,2724900.0,290.4200134277344,308.760009765625,287.75,307.07000732421875,295.6975402832031,GS,"How Will Bank ETFs Perform in Light of Q3 Earnings? ||| Financial Sector Update for 10/13/2022: BFST, NVEI, NVEI.TO, GS, AAPL, PGR ||| Got $5,000? 3 Cheap Stocks to Buy Right Now",0,0.48180336
2022-10-14,2397600.0,307.4599914550781,311.6199951171875,299.07000732421875,299.989990234375,288.8797607421875,GS,"Why Cinemark Stock Tumbled by Almost 20% This Week ||| Earnings Preview: Goldman Sachs (GS) Q3 Earnings Expected to Decline ||| Company News for Oct 14, 2022 ||| Morgan Stanley profit falls as deals drought extends ||| Wells Fargo profit falls on higher loan loss reserves ||| JPMorgan profit down 17% as dealmaking slumps",1,0.50436735
2022-10-17,3118600.0,304.4100036621094,311.6199951171875,304.1400146484375,306.7099914550781,295.35089111328125,GS,"Goldman to combine investment banking and trading businesses - WSJ ||| Goldman to combine investment banking and trading businesses - WSJ ||| New UK finance minister Hunt reverses Truss's economic plan in dramatic U-turn ||| US STOCKS-Wall Street jumps as BofA results spark rally ||| US STOCKS-Wall Street rallies after BofA results, UK reversal ||| Ex Goldman banker claims he was ""fired for whistleblowing"" ||| Wall Street rally throws spotlight on reports from Tesla, Netflix ||| US STOCKS-Wall Street jumps as solid BofA results spark rally ||| US STOCKS-Wall Street rallies after BofA results, UK reversal ||| The Charles Schwab Corporation (SCHW) Tops Q3 Earnings and Revenue Estimates ||| MORNING BID-Hunt for Yield ||| US STOCKS-Wall Street set to open higher as BofA rises on earnings beat ||| GLOBAL MARKETS-Asia shares ease, major test looms for UK bonds ||| GLOBAL MARKETS-Europe rallies as UK U-turns settle nerves ||| US STOCKS-Wall Street surges as BofA gains on earnings beat ||| GLOBAL MARKETS-Europe edges higher as UK U-turns settle nerves ||| UK finance minister seeks to stem bond rout with Monday plan announcement ||| US STOCKS-Wall St futures higher with focus on earnings",1,0.5119362
2022-10-18,6428600.0,321.6700134277344,324.4800109863281,312.0,313.8500061035156,302.2264709472656,GS,"US STOCKS-Goldman, Lockheed results buoy Wall Street ||| GLOBAL MARKETS-Wall Street extends rally, Treasury yields waver after solid earnings, economic data ||| GLOBAL MARKETS-Most Asian shares extend rally, markets await UK inflation data ||| Australia shares rise as strong U.S. corporate earnings boost banks, tech stocks ||| GLOBAL MARKETS-U.S. stocks extend rally, Treasury yields dip after solid earnings, economic data ||| CANADA STOCKS-TSX touches near 2-week high on earnings optimism; Iamgold leads gains ||| FOREX-Dollar higher but gains in check as risk appetite rebounds ||| Why Twilio Stock Popped Today ||| Why Tesla Stock Was Surging at the Market Open Today ||| US STOCKS-Wall St up as Goldman results keep optimism alive, rising yields cap gains ||| FOREX-Dollar edges up but gains in check as risk appetite rebounds ||| Noteworthy ETF Outflows: DIA, GS, CAT, TRV ||| GLOBAL MARKETS-U.S. stocks extend rally, Treasury yields dip on solid earnings, economic data ||| US STOCKS-Goldman, Lockheed results buoy Wall Street ||| Why Upstart Stock Is Rocketing Higher Today ||| Goldman (GS) Q3 Earnings Top Estimates, IB Revenues Slump Y/Y ||| US STOCKS-Wall St climbs as Goldman winds up big bank earnings on upbeat note ||| US STOCKS-Wall St set to jump at open as Goldman, J&J results lift earnings mood ||| Goldman Sachs Q3 Profit Down 44%, But Results Top Estimates ||| Pre-Markets Rally on Q3 Beats from J&J, Goldman ||| Company News for Oct 18, 2022 ||| Pre-Markets in the Green on Strong Earnings Numbers ||| Goldman Sachs (GS) Surpasses Q3 Earnings and Revenue Estimates ||| US STOCKS SNAPSHOT-Wall St opens higher as Goldman, J&J results lift earnings mood ||| US STOCKS-Futures firmly up as J&J results boost earnings optimism ||| Goldman Sachs unveils revamp as third-quarter profit falls ||| MORNING BID-QTips ||| Saudi Arabia markets dollar bonds, offers to buy existing notes ||| Japanese stocks end higher as Wall Street, U.S. futures rally ||| PREVIEW-Goldman to merge investment banking, trading as Marcus takes backseat",0,0.5101963
2022-10-19,2363800.0,312.6099853515625,314.7900085449219,308.0599975585937,311.760009765625,300.2138977050781,GS,"JPMorgan launches fundraising platform to lure startups ||| ANALYSIS-Goldman Sachs' consumer pivot solves one question, but makeover raises more ||| Notable Wednesday Option Activity: GNRC, GS, WHR ||| Lessons for Investors from Bank Earnings ||| ANALYSIS-Goldman Sachs' consumer pivot solves one question, but makeover raises more ||| EMERGING MARKETS-Asian currencies muted on lingering recession risks; equities mixed ||| Is The Worst Over for This Investment Bank? ||| ANALYSIS-Goldman Sachs' consumer pivot solves one question, but makeover raises more ||| Higher Interest Rates Have Caused This Lending Market to Dry Up ||| GLOBAL MARKETS-Asian shares dragged lower by China, UK inflation on radar",0,0.47707465
2022-10-20,2382300.0,312.1000061035156,316.04998779296875,309.0,310.8099975585937,299.2990417480469,GS,"Deutsche Bank cuts investment banking jobs as M&A deals dry up ||| Why Upstart, PayPal, and SoFi Stocks Were Volatile Today ||| Deutsche Bank cuts investment banking jobs as M&A deals dry up ||| 3 Bank Stocks I'd Buy More of Right Now",1,0.4714305
2022-10-21,3545700.0,311.0,325.7699890136719,309.489990234375,325.1000061035156,313.0598449707031,GS,Busy Earnings Week Brings Big Wins to Wall Street ||| Goldman: U.S. SPR crude releases to have modest price influence ||| GRAPHIC-Global bond funds record outflows for ninth week in a row ||| Financial ETFs Up on Upbeat Earnings ||| Goldman Sachs Is Scaling Back Its Consumer Products: Should You Buy the Stock?,1,0.48960212
2022-10-24,2232600.0,328.5,331.239990234375,325.8500061035156,328.70001220703125,316.5265197753906,GS,"Why Marqeta Stock Was Up 11.7% This Week ||| Goldman Sachs Group's (NYSE:GS) Dividend Will Be Increased To $2.50 ||| Goldman, banker agree settlement terms over London dismissal lawsuit ||| ANALYSIS-Options trades, lockstep moves fuel U.S. stock swings ||| 3 Dow Jones Industrial Average Stocks To Watch Today ||| GS Crosses Above Key Moving Average Level ||| GS Named 'Top Dividend Stock of the Dow' at Dividend Channel With 3.1% Yield ||| Financial Sector Update for 10/24/2022: HBT, BOH, GS, XLF, FAS, FAZ ||| Goldman Sachs launches Chinese infrastructure real estate joint venture",1,0.47793508
2022-10-25,1837700.0,327.8599853515625,333.6000061035156,325.9200134277344,332.3999938964844,320.0894470214844,GS,Wall Street bonuses expected to slide 22% this year - NY state comptroller ||| Intel unit Mobileye prices IPO above range to raise $861 mln -source ||| UK North Sea firm Ithaca Energy presses ahead with London listing ||| Intel unit Mobileye prices IPO above range to raise $861 mln -source ||| UK North Sea firm Ithaca Energy presses ahead with London listing,1,0.48843566
2022-10-26,2176700.0,334.5199890136719,338.6700134277344,334.1400146484375,335.69000244140625,323.25762939453125,GS,"Twitter plans to close Musk deal on previously agreed terms-JPMorgan exec ||| DIA, GS, CAT, TRV: ETF Outflow Alert ||| Why Silvergate Capital Stock Had a Wacky Wednesday ||| Noteworthy Wednesday Option Activity: DOCU, TDOC, GS",1,0.48026037
2022-10-27,1998800.0,339.3099975585937,341.92999267578125,336.5299987792969,337.17999267578125,324.6924133300781,GS,Citi CEO Fraser will not attend Hong Kong summit due to COVID - source ||| Goldman Sachs Will Need to Find Another Way to Achieve a Higher Valuation ||| U.S. lawmakers slam Wall Street bankers' plan to attend Hong Kong summit,1,0.50066227
2022-10-28,1677100.0,338.5199890136719,342.5799865722656,336.0,341.82000732421875,329.1606140136719,GS,Citi to sell Russian personal installment loan portfolio to Uralsib,1,0.53597766
2022-10-31,2224000.0,341.07000732421875,346.17999267578125,340.57000732421875,344.510009765625,331.7509765625,GS,"$10K to $100K in 10 Years? Build Your Own ETF with Undervalued Dividend Stocks ||| Goldman Sachs sees Fed rates peaking at 5% in March - Bloomberg News ||| Goldman Sachs names Mehrotra, Haufrect as Americas M&A co-heads -memo ||| Goldman Sachs names new M&A heads for Americas -memo ||| Why Nu Holdings Stock Rocketed 8.8% Higher Monday ||| Hong Kong eyes return to global financial map with summit amid talent crunch, geo-tension",1,0.49277738
2022-11-01,2316600.0,345.1300048828125,348.69000244140625,343.7699890136719,348.5799865722656,335.67022705078125,GS,Hong Kong's Lee touts 'China advantage' to rebuild city's image as financial hub ||| Hong Kong's Lee pitches 'China advantage' to rebuild city's image as financial hub,1,0.50057644
2022-11-02,3221200.0,347.6199951171875,357.44000244140625,346.739990234375,349.7900085449219,336.8354187011719,GS,U.S. SEC obtained $6.4 bln from enforcement in fiscal 2022 -chair ||| Ithaca Energy breathes life into UK stock market as bookrunners eye $3.6 bln listing ||| Ithaca Energy IPO to value company up to $3.6 bln -bookrunners,0,0.4714546
2022-11-03,2515600.0,347.5,350.6700134277344,342.5899963378906,348.8699951171875,335.949462890625,GS,"Goldman Sachs cuts credit exposure to Russia ||| Goldman Sachs Group's Preferred Stock, Series K Crosses Above 6.5% Yield Territory ||| Goldman Sachs cuts credit exposure to Russia ||| EXCLUSIVE-Morgan Stanley to start layoffs in coming weeks as dealmaking slows -sources",1,0.4730953
2022-11-04,3172700.0,354.0,358.3800048828125,351.2300109863281,357.9100036621094,344.6547241210937,GS,What Bear Market? This Growth Stock Just Hit a 52-Week High,1,0.51676583
2022-11-07,2526900.0,360.010009765625,362.9599914550781,358.5199890136719,362.55999755859375,349.1324768066406,GS,"Why Appian Stock Fell Today ||| The Social Security 2023 COLA: Good, Bad, and Ugly News for Retirees",1,0.48605105
2022-11-08,3501300.0,362.2999877929688,367.1900024414063,361.4599914550781,364.0199890136719,350.53839111328125,GS,Barclays cuts investment banking jobs as deals languish - source ||| Turkey raises $1.5 billion with 5-year dollar bond ||| Should SPDR Dow Jones Industrial Average ETF (DIA) Be on Your Investing Radar?,0,0.47632718
2022-11-09,3047200.0,362.9500122070313,367.1499938964844,360.8800048828125,362.0,348.5932312011719,GS,Goldman Sachs promotes 80 people to elite partner rank,1,0.53501976
2022-11-10,3790400.0,370.0,380.4299926757813,369.739990234375,378.30999755859375,364.2991638183594,GS,Buffett's Berkshire sheds large portion of US Bancorp stake ||| Millennium hires King Street's Gmelich as co-CIO,1,0.49728048
2022-11-11,3409100.0,380.0,387.0,378.75,385.1700134277344,370.9051208496094,GS,"Ex-Goldman banker Ng, convicted in 1MDB case, sues ex-boss Leissner for $130 mln",0,0.4995165
2022-11-14,2609100.0,384.0,387.2999877929688,380.5,382.3599853515625,368.19915771484375,GS,"URTH, GS, CAT, NKE: ETF Inflow Alert ||| The CPI, Layoffs, Disney's Report, and More Top Market News ||| Chinese firms embrace Swiss listings as deal pipeline swells ||| Goldman Sachs expects ""significant"" decline in U.S. inflation in 2023",1,0.5499635
2022-11-15,3192400.0,385.9800109863281,389.5799865722656,380.6499938964844,382.8800048828125,368.699951171875,GS,"JPMorgan (JPM) to Set Up New Office, Seeks Expansion in Greece",0,0.5019214
2022-11-16,2303700.0,383.2099914550781,385.3999938964844,380.010009765625,382.3299865722656,368.1702575683594,GS,"The Zacks Analyst Blog Highlights Pfizer, Goldman Sachs, General Electric, Microchip Technology and Genuine Parts ||| Dell reaches $1 billion settlement over disputed 2018 stock swap ||| Is Goldman Sachs Stock Attractive At The Current Levels? ||| Good News for Retirees: Changes to Social Security, Medicare, and Tax Brackets Are Coming in 2023 ||| Dell reaches $1 billion lawsuit settlement ||| 2 Dirt Cheap Dividend Stocks to Buy Right Now",0,0.47343555
2022-11-17,2297600.0,377.1499938964844,381.7200012207031,375.010009765625,379.7799987792969,365.7147216796875,GS,"Goldman's JV with ICBC raises $21 mln in maiden China wealth product ||| Notable Thursday Option Activity: AMR, GS, ITRI ||| Goldman (GS) Up 22.6% Since Last Earnings Report: Can It Continue?",0,0.5072516
2022-11-18,2384500.0,381.2799987792969,382.8299865722656,377.3900146484375,379.2000122070313,365.15618896484375,GS,3 Bargain Stocks You Can Buy Today and Hold Forever ||| Why Coinbase Stock Is Down Another 7% Today,1,0.49974042
2022-11-21,1877500.0,378.8999938964844,380.7699890136719,375.4200134277344,380.2099914550781,366.1287536621094,GS,"Disney Wins at the Box Office, but Makes Investors Nervous ||| After Ditching Goldman Sachs, Warren Buffett Is Buying This Investment Bank ||| Saudi Arabia's state fund hires banks for IPO of ADES, sources say ||| Global equity bear market not over yet - Goldman Sachs ||| After Q3 Beat, Is JPMorgan Stock Fairly Priced?",1,0.48218
2022-11-22,2019400.0,381.3999938964844,385.8299865722656,381.3999938964844,383.8699951171875,369.6532287597656,GS,SEC charges Goldman Sachs Asset Management with not following ESG investments policies ||| Goldman Sachs Agrees To Pay $4 Mln Penalty In ESG Fund Case : SEC ||| Interview With Value Investor Bill Nygren of Oakmark Funds ||| Citigroup targets more deals in Gulf region ||| ANALYSIS-Kohl's snub of big sale-leaseback sets up new clash with hedge funds,1,0.52390033
2022-11-23,1865400.0,383.8999938964844,388.2000122070313,383.4100036621094,386.25,371.9451293945313,GS,Goldman Sachs (GS) Outpaces Stock Market Gains: What You Should Know ||| Goldman Sachs (GS) to Pay SEC $4M Penalty Over ESG Fund Case ||| Interesting GS Put And Call Options For January 2023,1,0.4740691
2022-11-25,1129300.0,385.760009765625,389.4400024414063,385.1799926757813,388.8599853515625,374.45843505859375,GS,"3 Dow 30 Stocks To Watch Ahead Of December 2022 ||| Wall St Week Ahead-Stocks typically rally in December, investors have some caution this year",0,0.48417607
2022-11-28,2232200.0,385.4299926757813,388.3900146484375,380.8900146484375,382.3599853515625,368.19915771484375,GS,"What To Expect From Barclays Stock? ||| Is Citigroup Stock Fairly Priced? ||| Ex-Dividend Reminder: NetSTREIT, Tradeweb Markets and Goldman Sachs Group",1,0.4831508
2022-11-29,1746900.0,381.1300048828125,384.9299926757813,379.260009765625,383.7099914550781,369.4992065429688,GS,"Abu Dhabi's ADNOC working with Goldman Sachs on gas business, sources say ||| Goldman Sachs (GS) Gains As Market Dips: What You Should Know ||| 1 Super Stock With 113% Upside, According to Wall Street",1,0.49588183
2022-12-01,1706300.0,386.5,386.5,380.4500122070313,383.80999755859375,372.019287109375,GS,"REUTERS NEXT-Morgan Stanley making 'modest' job cuts; CEO 'wouldn't bet against' Musk ||| January 2023 Options Now Available For Goldman Sachs Group (GS) ||| REUTERS NEXT-Morgan Stanley making 'modest' job cuts, CEO says ||| Goldman Sachs (GS) to Pay SEC $4M Penalty Over ESG Fund Case (Revised)",0,0.46833575
2022-12-02,1932300.0,381.5199890136719,382.5199890136719,378.3999938964844,380.5799865722656,368.8885192871094,GS,"Why BioXcel Therapeutics Stock Triumphed This Week ||| Noteworthy Friday Option Activity: GS, TOWN, MSFT ||| Noteworthy ETF Inflows: IWB, GS, CAT, DE ||| Wall Street bankers to see bonuses shrink as dealmaking sputters - Bloomberg Law ||| Goldman warns of bonus cuts for traders - Bloomberg News ||| Is Bank of America Stock Fairly Priced?",0,0.4968544
2022-12-06,3081900.0,369.4800109863281,370.3699951171875,360.3299865722656,362.9100036621094,351.7613525390625,GS,"Why Bank of America Stock Was Falling Today ||| Australian, NZ dollars wallow at one-week lows ||| FOREX-Dollar edges up as darkening growth outlook hurts sentiment ||| U.S banks warn of recession risk, inflation hurting consumers, shares hit ||| U.S banks warn of recession risk, inflation hurting consumers ||| UK's CityFibre files complaint against BT's Openreach ||| Dow Movers: BA, JPM ||| Why Lincoln National Stock Plummeted 27.7% in November ||| Where Is HSBC Stock Headed? ||| EXCLUSIVE-Goldman Sachs on hunt for bargain crypto firms after FTX fiasco ||| Financial Sector Update for 12/06/2022: WDH, GS, SPGI, XLF, FAS, FAZ",0,0.49088806
2022-12-07,2128200.0,362.489990234375,365.2999877929688,358.1499938964844,359.9200134277344,348.8632202148437,GS,"US STOCKS-Wall St wavers on rising recession worries; Apple, Tesla slump ||| FOREX-Dollar eases against major currencies amid rate, economic concerns; yuan strengthens ||| US STOCKS-Wall St ends lower after choppy trading from rising recession worries ||| US STOCKS-S&P, Nasdaq extend losing streaks amid rising recession worries ||| US STOCKS-Wall St slips in choppy trading on rising recession worries ||| Japan's Nikkei hits near one-month low on economic worries ||| Under fire for weak regulation, dLocal CEO says seeking UK license ||| FOREX-Dollar falls against major currencies amid economy concerns; yuan strengthens ||| Lazard CEO warns of more Wall Street layoffs ||| US STOCKS-Wall St extends losses as recession worries mount, Apple drops ||| US STOCKS-Wall Street set to open lower as recession worries mount ||| South African rand steady as dollar inches up ||| Bank Stocks Tumble as CEOs Warn of Looming Recession in 2023 ||| MORNING BID-Hat-trick ||| FOREX-Dollar in demand as growth outlook darkens, yuan up as China eases curbs ||| FOREX-Dollar flat as growth outlook darkens, yuan firms as China eases curbs ||| US STOCKS-Futures fall on growing fears of recession ||| FOREX-Dollar slips with economy in focus, yuan firms as China eases curbs",0,0.47441918
2022-12-08,1967800.0,362.0299987792969,362.5899963378906,356.0599975585937,358.0799865722656,347.0797424316406,GS,NEWSMAKER-Audacious BlackRock challenge is Bluebell's David vs Goliath playbook ||| ExxonMobil Boosts Its Lower-Carbon Investments to $17 Billion. Time to Buy the Oil Giant? ||| Goldman Sachs plans to cut bonuses for senior employees - report ||| NEWSMAKER-Audacious BlackRock challenge is Bluebell's David vs Goliath playbook ||| Japan's Nikkei ends at near 1-month low amid economic worries ||| METALS-Copper rises as Goldman predicts run to record highs,1,0.50331205
2022-12-09,1588800.0,356.7099914550781,361.6400146484375,356.2099914550781,359.1400146484375,348.107177734375,GS,"Why Lincoln National Stock Dropped 17.8% This Week ||| Why Signature Bank Stock Fell 11.2% This Week ||| Financial Sector Update for 12/09/2022: SAN, GS, AXS, XLF, FAS, FAZ",1,0.4806501
2022-12-12,1750400.0,358.57000732421875,364.010009765625,356.3399963378906,363.1799926757813,352.0230407714844,GS,"EXCLUSIVE-Morgan Stanley to slash 2022 banker bonuses in Asia by up to half - sources ||| Goldman Sachs Plans To Cut At Least 400 Jobs In Retail Banking Unit : Report ||| Cybersecurity startup Snyk valued at $7.4 bln after latest funding ||| Trimble to buy transport logistics firm Transporeon in $1.98 bln deal ||| Goldman Sachs to stop making unsecured consumer loans - source ||| Notable Monday Option Activity: GS, TGT, HON ||| Banks Had a Tough Year With Investment Banking, but Trading Has Shined ||| Goldman Sachs plans to cut hundreds more jobs - Bloomberg Law ||| IWB, SCHW, GS, CAT: ETF Inflow Alert",1,0.52492005
2022-12-13,3062600.0,374.6300048828125,378.55999755859375,365.510009765625,368.6900024414063,357.3638000488281,GS,Goldman Sachs (GS) Outpaces Stock Market Gains: What You Should Know ||| Abu Dhabi's ADNOC invites banks to pitch for gas business IPO -sources ||| Abu Dhabi's ADNOC invites banks to pitch for gas business IPO -sources,0,0.46194193
2022-12-14,2519700.0,367.010009765625,368.8299865722656,359.45001220703125,360.3800048828125,349.3091125488281,GS,"Goldman Sachs considers at least 40% bonus cut for investment bankers - FT ||| Goldman sees oil market surplus in early 2023, slashes price forecasts ||| Why QuantumScape Stock Plunged to All-Time Lows Today ||| Dow Movers: BA, MRK ||| 2 Bank Stocks To Watch In December 2022",0,0.4984574
2022-12-15,3163700.0,354.4800109863281,356.1099853515625,347.94000244140625,349.8299865722656,339.08319091796875,GS,"Why Western Digital Stock Crashed, and Intel and Qualcomm Followed Today ||| Stock Market News for Dec 15, 2022 ||| Barclays weighs Saudi re-entry amid capital markets boom – sources",0,0.4914119
2022-12-16,5008800.0,345.0799865722656,347.7799987792969,343.4100036621094,346.3500061035156,335.7100830078125,GS,"ANALYSIS-Deutsche Bank's rollercoaster ride towards more stability ||| Wall St Week Ahead-U.S. bank stocks falter as recession worries take hold ||| Goldman Sachs to lay off up to 4,000 people -Semafor ||| Goldman Sachs to cut thousands of employees - source",0,0.48310357
2022-12-19,1646700.0,346.2699890136719,348.3999938964844,342.6300048828125,344.6099853515625,334.0235290527344,GS,"What Does 2023 Have in Store for Growth Stocks, Electric Vehicles, and More? ||| Goldman Sachs (GS) Stock Moves -0.5%: What You Should Know ||| Noteworthy Monday Option Activity: MSFT, ZIP, GS ||| Goldman Sachs (GS) Plans to Cut Thousand Jobs Amid IB Plunge ||| Company News for Dec 19, 2022",0,0.47860846
2022-12-20,1623000.0,345.989990234375,347.4200134277344,343.489990234375,344.489990234375,333.9071960449219,GS,"SSO, GS, MS, GILD: ETF Outflow Alert",1,0.5305701
2022-12-21,1923100.0,348.260009765625,350.8800048828125,346.8900146484375,350.1600036621094,339.4030456542969,GS,"Why General Mills Stock Popped by Almost 3% Today ||| U.S. dollar likely has further upside vs yen despite BOJ move -Goldman ||| The Goldman Sachs Group, Inc. (GS) is Attracting Investor Attention: Here is What You Should Know ||| Bitcoin or Gold: Which Is the Better Buy?",0,0.47110713
2022-12-22,1528900.0,347.1600036621094,348.04998779296875,339.8800048828125,345.5799865722656,334.96368408203125,GS,Banker bonuses go from boom to bust in jarring reversal ||| Banker bonuses go from boom to bust in jarring reversal,0,0.51311046
2022-12-23,1062000.0,344.8399963378906,347.760009765625,343.1099853515625,345.510009765625,334.8959045410156,GS,This Is My Top Ultra-High-Yield Dividend Stock to Buy Ahead of 2023,0,0.49026558
2022-12-27,1035000.0,346.510009765625,347.75,341.7900085449219,341.9700012207031,331.464599609375,GS,"Goldman Sachs (GS) Dips More Than Broader Markets: What You Should Know ||| YEARENDER-U.S. finance faces ESG backlash, more to come in 2023",0,0.47706833
2022-12-29,1273600.0,342.44000244140625,344.6400146484375,341.239990234375,343.42999267578125,332.8797607421875,GS,"Goldman Sachs (GS) Gains But Lags Market: What You Should Know ||| Dow Analyst Moves: GS ||| February 2023 Options Now Available For Goldman Sachs Group (GS) ||| Financial Sector Update for 12/29/2022: FAS, XLF, FAZ, BITF, GS, JPM",0,0.48122588
2022-12-30,1031400.0,341.739990234375,343.69000244140625,339.3999938964844,343.3800048828125,332.8313293457031,GS,"Goldman Sachs Group Floating Rate Non-Cumulative Preferred Stock, Series D Crosses Above 5.5% Yield Territory ||| SPDR Dow Jones Industrial Average ETF Trust Experiences Big Inflow",0,0.48162556
2012-01-04,14239200.0,34.95500183105469,35.03499984741211,34.75,34.849998474121094,26.325082778930664,KO,Things That Warren Buffett Learned From Ted Williams,0,0.5065897
2012-01-05,14287600.0,34.880001068115234,34.935001373291016,34.67499923706055,34.685001373291016,26.20044708251953,KO,SODA Pops as Kraft gets Busy with the Fizzy,0,0.51693
2012-01-09,10522600.0,34.5,34.584999084472656,34.400001525878906,34.46500015258789,26.03426170349121,KO,Geaux Tigers/ Roll Tide: Four Stocks For The BCS Title Game,1,0.53587353
2012-01-10,12964400.0,34.73500061035156,34.7599983215332,34.55500030517578,34.66999816894531,26.189115524291992,KO,"Zacks Bull and Bear of the Day Highlights: SM Energy, ICICI Bank, The Coca-Cola Company, PepsiCo and Unilever NV - Press Releases ||| Kraft and SodaStream Ink Deal - Analyst Blog",0,0.5163226
2012-01-11,23428800.0,34.185001373291016,34.3849983215332,33.775001525878906,34.029998779296875,25.70566940307617,KO,"Novelis to Supply Cans to Coca-Cola - Analyst Blog ||| UBS Gets Less Bullish on Soft Drink Giants, Downgrades Coke and Pepsi (KO, PEP) ||| Market Wrap-Up for Jan.11 (TROW, BEN, MA, GM, KO, PEP, more) ||| Orange Juice Futures Run ||| Squeezed Oranges: Orange Juice Futures Rising on Fungicide Fears ||| UBS Downgrades Coca-Cola Company to Neutral",0,0.49686447
2012-01-12,15237000.0,34.209999084472656,34.25,33.67499923706055,33.78499984741211,25.52060317993164,KO,Racism Charges Cost Pepsi $3.13mn - Analyst Blog ||| Is Coke's Secret Ingredient Fungicide? ||| Via Motors One-Ups the Chevy Volt,0,0.5045564
2012-01-17,15577000.0,33.869998931884766,33.939998626708984,33.65999984741211,33.67499923706055,25.437515258789062,KO,Pepsi: Tropicana Not 100% Clean - Analyst Blog ||| Earnings Preview: Plexus Corp. - Analyst Blog,1,0.5156539
2012-01-24,14751200.0,34.08000183105469,34.25,33.85499954223633,33.95000076293945,25.645246505737305,KO,Anti-Obesity Ads Face Pushback - Analyst Blog ||| Sink Or Swim: Apple Earnings Could Move These ETFs,1,0.51122314
2012-01-27,16825000.0,33.95500183105469,34.06999969482422,33.6150016784668,33.720001220703125,25.47150611877441,KO,Could 2012 Be a Strong Year for National Beverage?,1,0.5357499
2012-01-30,10591600.0,33.64500045776367,33.78499984741211,33.51499938964844,33.72999954223633,25.47905731201172,KO,Orange Juice Markets' Vague Future - Analyst Blog,1,0.52246904
2012-02-01,14915000.0,33.939998626708984,34.16999816894531,33.900001525878906,33.92499923706055,25.62636375427246,KO,Facebook Picks Morgan Stanley to Lead IPO; Exchange Listing Still Up In The Air,0,0.47818324
2012-02-03,16555800.0,34.130001068115234,34.244998931884766,33.91999816894531,34.040000915527344,25.71322631835937,KO,Slow Data Week Ahead - Earnings Preview ||| Finding Value in Mega-Caps ||| Chasing the End of the Dividend Rainbow,0,0.5168029
2012-02-06,14586400.0,33.91999816894531,34.1150016784668,33.849998474121094,34.01499938964844,25.694345474243164,KO,Earnings Expectations for the Week of February 6,1,0.48757693
2012-02-07,24269600.0,34.04499816894531,34.724998474121094,33.814998626708984,34.275001525878906,25.890743255615234,KO,"Coca Cola Exceeds Estimates - Analyst Blog ||| Earnings & Bernanke Take Dimming Spotlight - Analyst Blog ||| Coca-Cola Earnings: Individual Brands, Emerging Markets Lead Growth ||| Ahead of Wall Street - February 7, 2012 - Ahead of Wall Street ||| Coca-Cola Adjusted Q4 Net Beats View; Cost Cuts Coming (KO) ||| UPDATE: Citigroup Raises PT on Coca-Cola Company to $81 ||| Coca-Cola's Earnings Slide Indicates that the US Consumer is Still Struggling ||| Earnings Roundup ||| UPDATE: Coca-Cola Reports Upbeat Q4 Earnings ||| Coca-Cola Reports Q4 EPS $0.79 vs $0.77 Est; Revenues $11.00B vs $10.99B Est ||| Seven Brazilian Stocks on a Roll ||| US Stock Futures Down; Coca-Cola Earnings In Focus ||| Earnings Scheduled For February 7 ||| Stocks To Watch For February 7",0,0.48501074
2012-02-08,16428400.0,34.41999816894531,34.42499923706055,34.099998474121094,34.165000915527344,25.807653427124023,KO,"Company News for February 8, 2012 - Corporate Summary ||| UPDATE: UBS Investment Research Raises Target to $73 on Coca-Cola ||| UBS Maintains Coca-Cola from Neutral to , Raises PT from $70 to $73 ||| UPDATE: Bank of America Raises PO to $75 on Coca Cola",0,0.4913401
2012-02-09,16311400.0,34.18000030517578,34.19499969482422,33.8849983215332,33.98500061035156,25.671674728393555,KO,"Coca-Cola Enterprises Profits Soar - Analyst Blog ||| The World Has to Have this Resource... But There Simply Isn't Enough of It ||| S&P Still Likes Staples ETFs ||| The Pepsi Challenge for 8,700 People is to Find a New Job",0,0.50449365
2012-02-10,10994600.0,33.76499938964844,33.970001220703125,33.709999084472656,33.970001220703125,25.66035842895508,KO,"If Diamond Foods Cannot Buy Pringles, Who Will?",1,0.5031934
2012-02-13,11091000.0,34.209999084472656,34.29999923706055,34.04499816894531,34.220001220703125,25.84919166564941,KO,Venezuela Takes on Pepsi - Analyst Blog,1,0.5443866
2012-02-14,12596000.0,34.23500061035156,34.46500015258789,34.04999923706055,34.45000076293945,26.022937774658203,KO,"Earnings Preview: Dr Pepper Snapple - Analyst Blog ||| Berkshire Raises Stake in Coca-Cola ||| Not The Usual Suspects: ""Other"" ETFs Benefiting From Apple's Run to $500",0,0.49934357
2012-02-15,14776800.0,34.6150016784668,34.625,34.1150016784668,34.20000076293945,25.834089279174805,KO,"Dr Pepper Beats, Guides 2012 - Analyst Blog",1,0.52195907
2012-02-16,11752000.0,34.30500030517578,34.494998931884766,34.209999084472656,34.43000030517578,26.0078239440918,KO,The Board of Directors of the Coca-Cola Company Announces 50th Consecutive Annual Dividend Increase from $0.47 to $0.51,1,0.5096959
2012-02-17,14841800.0,34.53499984741211,34.584999084472656,34.29999923706055,34.525001525878906,26.07958221435547,KO,"Coca Cola Raises Its Dividend...Again - Analyst Blog ||| Five ETFs For NASCAR Season (XLP, DIA, VROM)",0,0.5115347
2012-02-21,13424800.0,34.439998626708984,34.525001525878906,34.25,34.40999984741211,25.992713928222656,KO,Investing in the Age of the Frugal American ||| From Earlier: Coca-Cola FEMSA and The Coca-Cola Company Sign an Exclusivity Agreement to Evaluate the Potential Acquisition of a Controlling Stake of the Philippines Bottling Operations,1,0.5508645
2012-02-23,11120000.0,34.54499816894531,34.650001525878906,34.459999084472656,34.59000015258789,26.12869644165039,KO,Citi Gets Saudi Supermarket Stake - Analyst Blog,0,0.52091384
2012-02-24,12485400.0,34.67499923706055,34.75,34.415000915527344,34.5,26.06070327758789,KO,"ETF Showdown: Grasping For Growth (VUG, IVW, AAPL)",0,0.5149636
2012-02-27,12086200.0,34.345001220703125,34.5,34.2599983215332,34.415000915527344,25.99649810791016,KO,Pepsi Next Hits Shelves in March - Analyst Blog ||| 4 Stocks for the Oscars,1,0.52998877
2012-02-28,9049000.0,34.474998474121094,34.54999923706055,34.400001525878906,34.42499923706055,26.004056930541992,KO,Wikileaks' Stratfor E-Mails Reveal an Investment Plot Worthy of a Spy Novel,1,0.51473856
2012-02-29,23464400.0,34.45000076293945,34.9900016784668,34.45000076293945,34.93000030517578,26.385517120361328,KO,The Best Blue-Chip Stocks In The World,0,0.511871
2012-03-01,15294200.0,34.935001373291016,34.97999954223633,34.69499969482422,34.79999923706055,26.287317276000977,KO,Kimberly-Clark Hikes Dividend - Analyst Blog,0,0.5339174
2012-03-02,11995800.0,34.70500183105469,34.79999923706055,34.48500061035156,34.59000015258789,26.12869644165039,KO,Wal-Mart Ups Annual Dividend - Analyst Blog,1,0.53457737
2012-03-05,10338600.0,34.5099983215332,34.66999816894531,34.5,34.6150016784668,26.147573471069336,KO,"Nine ETFs Trading Near 52-Week Highs ||| The Zacks Analyst Blog Highlights: Bank of America, JP Morgan Chase, Wells Fargo, Wal-Mart Stores and The Coca Cola - Press Releases ||| Forget Coca-Cola: Buy This Stock Instead ||| Warren Buffett, SSgA Not BFFs Regarding Gold",0,0.48270813
2012-03-06,13161200.0,34.40999984741211,34.54499816894531,34.31999969482422,34.380001068115234,25.97006607055664,KO,These 4 Huge Economies are in Deep Trouble ||| Coca-Cola Bottling Earnings Preview: Double-Digit EPS Growth Expected,1,0.5252803
2012-03-08,33754800.0,34.59000015258789,34.75,34.54999923706055,34.6349983215332,26.162681579589844,KO,"After Hours Most Active for Mar 8, 2012 : AIG, MRK, MO, INTC, GMCR, KO, PFE, QQQ, GNW, BRCD, SIRI, ATML",1,0.4885873
2012-03-09,36742600.0,34.71500015258789,34.869998931884766,34.654998779296875,34.755001068115234,26.253332138061523,KO,"Pepsi Steps into US Dairy Market - Analyst Blog ||| ETFs Vs. Their Most Popular Stocks (XLP, MOO, XLE)",1,0.5125951
2012-03-12,18143600.0,34.7400016784668,35.16999816894531,34.66999816894531,35.07500076293945,26.495052337646484,KO,"Monster's Energy Drinks Seen Fueling Highest Takeover Valuation: report ||| Cola Giants in Carcinogenic Row - Analyst Blog ||| Option Alert: Heavy Volume in Coca Cola March 67.5 Call; 120,641 Contracts",1,0.49657038
2012-03-13,18068000.0,34.755001068115234,35.14500045776367,34.755001068115234,35.125,26.924304962158203,KO,Cola Giants Adjust Caramel Color (revised) - Analyst Blog,0,0.51634353
2012-03-14,12918000.0,35.130001068115234,35.310001373291016,35.04999923706055,35.11000061035156,26.91280746459961,KO,Coca-Cola Issues Notes - Analyst Blog,1,0.5216348
2012-03-19,10652400.0,35.10499954223633,35.26499938964844,35.0,35.20000076293945,26.98179054260254,KO,Why Dividend Stocks Aren't Doomed After All,1,0.47820932
2012-03-20,10180400.0,35.01499938964844,35.3849983215332,34.96500015258789,35.29499816894531,27.05460929870605,KO,Soda Sales Falling 1% in 2011 -CNBC ||| Top 4 Large-Cap Stocks In The Beverages-Soft Drinks Industry With The Highest EPS,1,0.51508784
2012-03-21,19870800.0,35.2400016784668,35.70000076293945,35.17499923706055,35.560001373291016,27.25774383544922,KO,Coca-Cola Stays Neutral - Analyst Blog,1,0.5377607
2012-03-26,11536400.0,35.869998931884766,35.95000076293945,35.79499816894531,35.95000076293945,27.55668830871582,KO,Trading the Cola Wars: Coca-Cola vs. PepsiCo,0,0.52308
2012-03-27,11430400.0,35.90999984741211,35.9900016784668,35.82500076293945,35.935001373291016,27.54519462585449,KO,Neutral on Dr Pepper Snapple - Analyst Blog,1,0.519387
2012-03-30,26555800.0,36.810001373291016,37.06999969482422,36.65499877929688,37.005001068115234,28.365373611450195,KO,Zynga Partners Martha Stewart - Analyst Blog ||| Investing With a Moral Code ||| Plexus Upgraded to Neutral - Analyst Blog,1,0.5194781
2012-04-02,14579000.0,36.915000915527344,37.09999847412109,36.81999969482422,37.06999969482422,28.41520118713379,KO,"Coca-Cola Expands in China - Analyst Blog ||| Dunkin' Adds Pop And Juice To Line With Coke Deal ||| Loving Low-Beta ETFs (XLP, XLV, VTV) ||| Dunkin' Brands, Baskin-Robbins Will Serve Coca-Cola Products",0,0.49858847
2012-04-03,12989200.0,36.834999084472656,37.040000915527344,36.72999954223633,36.880001068115234,28.269561767578125,KO,"Market Wrap-Up for Apr.3 (F, TAP, PM, KO, MS, GS, more) ||| UPDATE: Stifel Nicolaus Downgrades Coca-Cola to Hold ||| Stifel Nicolaus Downgrades Coca-Cola from Buy to Hold, Removes PT ||| Why I'm passing on Diamond Foods stock",0,0.47565642
2012-04-04,12487400.0,36.64500045776367,36.79999923706055,36.60499954223633,36.72999954223633,28.154577255249023,KO,Coffee Makers Spill All Over the Map; Tim Hortons & McDonald's Burnt by Starbucks' Success ||| Dunkin Brands Deals with Coca-Cola - Analyst Blog ||| Coffee Makers Spill All Over the Map; Tim Hortons & McDonald's Burnt by Starbucks' Success,1,0.48672026
2012-04-11,12026600.0,36.21500015258789,36.23500061035156,35.91999816894531,36.060001373291016,27.641000747680664,KO,"ETF Sleuth: Flight to Low Beta? (SPLV, XLP)",1,0.5149935
2012-04-12,10640600.0,36.07500076293945,36.130001068115234,35.90999984741211,36.11000061035156,27.67933464050293,KO,"Deutsche Bank Maintains Coca-Cola at Buy, Raises PT from $75 to $80",0,0.490624
2012-04-16,14147600.0,36.11000061035156,36.39500045776367,36.06999969482422,36.220001220703125,27.763654708862305,KO,"Earnings Expectations for the Week of April 16 (GS, MSFT, MCD) ||| Investing in the Week Ahead",1,0.5263134
2012-04-17,22614400.0,36.59000015258789,37.2400016784668,36.59000015258789,36.97499847412109,28.342384338378903,KO,"Coca-Cola Beats on Volume - Analyst Blog ||| Ahead of Wall Street - April 17, 2012 - Ahead of Wall Street ||| Earnings & Housing to Drive Market - Analyst Blog ||| Coca-Cola Reports Fizzy First Quarter Results ||| Checking In: Turn Down The ""Vol"" (LVOL, SPLV) ||| Treasuries Retreat as Worries Over Spain Ease, US Stocks Rally ||| Buffett Reveals He Has Prostate Cancer ||| Morgan Stanley: The Coca-Cola Company Produces Robust Top-line Results ||| Bank of America: The Coca Cola Company's Volume Drives 1Q Upside ||| Earnings Roundup ||| UPDATE: Coca-Cola Posts Upbeat Q1 Profit ||| Coca-Cola Reports Fizzy First Quarter Results ||| Coca-Cola Reports Q1 EPS $0.89 vs $0.87 Est; Revenues $11.14B vs $10.83B Est ||| Stocks To Watch For April 17 ||| Earnings Scheduled For April 17 ||| US Stock Futures Up Ahead Of Earnings ||| US Stock Futures Up Ahead Of Earnings ||| Earnings Scheduled For April 17 ||| Earnings Scheduled For April 17 ||| Stocks To Watch For April 17",1,0.49959707
2012-04-18,11779800.0,36.90999984741211,37.17499923706055,36.8650016784668,37.084999084472656,28.426700592041016,KO,"Company News for April 18, 2012 - Corporate Summary ||| Is Coca-Cola Taking Over the World? ||| Pepsi Inks Deal with Family Dollar - Analyst Blog ||| Spotify and Coca-Cola Partner to Share Music ||| Is Coca-Cola Taking Over the World?",0,0.48933017
2012-04-19,10731200.0,37.14500045776367,37.16999816894531,36.709999084472656,36.90999984741211,28.292558670043945,KO,"The Zacks Analyst Blog Highlights: Google, Zynga, PepsiCo, Family Dollar Stores and The Coca-Cola - Press Releases ||| Risk, Reward Balanced at AmBev - Analyst Blog ||| Plexus Tops Estimates in 2Q - Analyst Blog ||| Street Yearning For Better Earnings? ||| Why You Should Be Bullish on IBM ||| Battle of Energy Drink Brands: Coca-Cola vs. Monster",1,0.49349257
2012-04-20,13461000.0,36.97999954223633,37.17499923706055,36.869998931884766,37.06499862670898,28.41136360168457,KO,Teamsters Union Settled Strike at Coca-Cola Bottling Company,0,0.5145079
2012-04-23,10472200.0,36.9900016784668,37.03499984741211,36.665000915527344,36.845001220703125,28.242734909057617,KO,Barron's Recap (4/21/12): America's Portfolio Managers See Gains for Stocks ||| Top 4 Large-Cap Stocks In The Beverages-Soft Drinks Industry With The Highest Operating Margin,1,0.5100667
2012-04-24,10288000.0,36.959999084472656,37.17499923706055,36.85499954223633,37.060001373291016,28.40753746032715,KO,"Future of NFL Football: Scandals, Injuries Raising Concerns",1,0.52457696
2012-04-25,18596000.0,37.27000045776367,37.525001525878906,37.15499877929688,37.46500015258789,28.71798515319824,KO,"Coca-Cola Board Approves First Stock Split Since 1996 (KO) ||| Dr Pepper Misses EPS, Revs In Line - Analyst Blog ||| Cramer on Coca Cola Split: Let's Hope It's Not a Google Split ||| The Coca-Cola Company Board of Directors Recommends Two-for-One Stock Split",1,0.4963443
2012-04-26,16782000.0,37.47499847412109,37.98500061035156,37.40999984741211,37.85499954223633,29.01692581176757,KO,"Company News for April 26, 2012 - Corporate Summary ||| Coca-Cola to Buy Monster? ||| Coca-Cola Analyst Jack Russo: Look for Coke to Start Selling Bottling Assets to Raise Cash for Future M&A, Possible Targets Include Monster Energy ||| Pepsi & Dr. Pepper Spill Messy Results",1,0.4921623
2012-04-30,26517600.0,38.209999084472656,38.45000076293945,37.96500015258789,38.15999984741211,29.25071907043457,KO,"Market Wrap-Up for Apr.30 (SUN, KO, MSFT, BKS, NYX, MNST, more) ||| Benzinga's M&A Chatter for Monday April 30, 2012 ||| Coca-Cola Denies Monster Acquisition Rumors ||| The Coca-Cola Company Says Not in Discussions to Acquire Monster Beverage Corporation ||| Benzinga Reported Coke/Monster Buyout on Thursday ||| Option Alert: Coca Cola May 75 Put; Block Trade: 8,933 Contracts, Currently $76.07 on Report of Possible Monster Beverage Takeover ||| Monster Beverage Spokesperson Has No Comment on Report Coke May be Buying the Company ||| Monster Beverage Spiking on Talk of Coca-Cola Buyout ||| Monster Beverage Halted Third Time on Circuit Breaker ||| Option Alert: Monster Beverage May 80 Call Rises 3,025% on Coke Rumors ||| Coca-Cola In Talks To Buy Monster Beverage; Coca-Cola Could Sell Bottling Assets To Pay For Potential Deal -WSJ, Source",1,0.49802938
2012-05-07,8965400.0,38.48500061035156,38.72499847412109,38.42499923706055,38.63999938964844,29.61863899230957,KO,"Weekly Highlight of Top Insider Buys: GE, KO, BAC, CME, HES ||| Pepsi Cans and the King of Pop - Analyst Blog ||| Buffett's Holdings Beat the S&P 500 One Month After Meeting ||| Buffett: Agnostic on Facebook ||| Buffett: Personally I Think KO will Be Bigger and More Profitable in 10 Years",0,0.4879003
2012-05-08,10561600.0,38.505001068115234,38.63999938964844,38.310001373291016,38.56999969482422,29.564998626708984,KO,"The Zacks Analyst Blog Highlights: Dish Network, Tyson Foods, Avis Budget Group, PepsiCo and The Coca Cola - Press Releases ||| Continuing to Trade in Market Down Days - Voice of the People",0,0.46259683
2012-05-09,14070800.0,38.29499816894531,38.595001220703125,38.244998931884766,38.38999938964844,29.4270133972168,KO,"Zacks' Voice of the People highlights opportunities with Lennar, Coca Cola, Raytheon and Dollar General - Press Releases ||| iPod Owners Receive Unexpected E-mail That Could Be Worth....",1,0.53403986
2012-05-10,12659200.0,38.60499954223633,38.84999847412109,38.59999847412109,38.70500183105469,29.668472290039062,KO,Neutral on Coca-Cola - Analyst Blog ||| Stock Futures Reverse Higher; Monster Seizes Big Gain,1,0.5056166
2012-05-14,15411800.0,38.560001373291016,38.625,38.310001373291016,38.435001373291016,29.46151351928711,KO,"S&P Reiterates Bullish View On Staples ETFs (XLP, FCD, MOO)",0,0.5198546
2012-05-16,17804400.0,38.33000183105469,38.41999816894531,37.959999084472656,38.165000915527344,29.254547119140625,KO,Warren Buffett's 5 Favorite Stocks,0,0.49862164
2012-05-21,13488800.0,37.10499954223633,37.29999923706055,37.06499862670898,37.255001068115234,28.557004928588867,KO,How The Botched Facebook IPO Has Created a Short-Term Opportunity in Other Social Names,0,0.51859367
2012-05-22,15260600.0,37.290000915527344,37.290000915527344,36.95500183105469,37.095001220703125,28.434370040893555,KO,It's Time to Sell These Stocks NOW,1,0.5220705
2012-05-23,18000000.0,37.0,37.28499984741211,36.90999984741211,37.275001525878906,28.572349548339844,KO,Coca-Cola’s Estimates Cut at Barclays on Western European Market Concerns (KO),1,0.5088819
2012-05-25,8999600.0,37.810001373291016,37.845001220703125,37.505001068115234,37.6150016784668,28.832958221435547,KO,Could Sodastream Face Issues Similar to those of Green Mountain?,1,0.538337
2012-05-30,13884600.0,37.53499984741211,37.625,37.40999984741211,37.52999877929688,28.767807006835938,KO,"5 ETFs That Could Jump 10%+ Over The Next Week (EPV, DUG, INDZ)",0,0.5312619
2012-06-01,20843400.0,36.994998931884766,37.22499847412109,36.505001068115234,36.54499816894531,28.012771606445312,KO,Google Could Face Court Over Antitrust Issues ||| Google Could Face Court Over Antitrust Issues,1,0.5035455
2012-06-04,13397200.0,36.51499938964844,36.869998931884766,36.27999877929688,36.81999969482422,28.223567962646484,KO,Blind Stock Valuation #2: Wal-Mart (WMT) - 1981 ||| NYC Limits Usage of Coke & Pepsi - Analyst Blog,0,0.5096773
2012-06-05,12275200.0,36.665000915527344,36.81999969482422,36.525001525878906,36.619998931884766,28.07026481628418,KO,"Stocks Donald Yacktman and Warren Buffett Both Own: KO, WFC, AXP ||| 4 Stocks to Score at Euro 2012 ||| 4 Stocks to Score at Euro 2012",1,0.5023644
2012-06-06,12496400.0,36.69499969482422,37.30500030517578,36.650001525878906,37.30500030517578,28.595333099365234,KO,Three Keys to Finding Good Dividend Stocks,0,0.5215135
2012-06-07,14342800.0,37.494998931884766,37.52999877929688,37.09999847412109,37.13999938964844,28.46885681152344,KO,Coca-Cola’s Estimates Cut at JP Morgan on European Weakness (KO) ||| A Trader's Guide to Ancestry.com (ACOM),1,0.4966959
2012-06-08,11594200.0,37.08000183105469,37.685001373291016,37.07500076293945,37.619998931884766,28.836788177490234,KO,Coca-Cola and Mexican Bottlers Will Invest in Recycling Plant -Bloomberg ||| Triple Crown Madness: 5 Stocks to Watch After the Race,0,0.50344294
2012-06-11,10657200.0,37.86000061035156,37.88999938964844,37.310001373291016,37.33000183105469,28.614505767822266,KO,A Defensive Consumer Staples ETF For An Uncertain Economic Environment ||| Dr Pepper Snapple Poised at Neutral - Analyst Blog,1,0.5213673
2012-06-13,9376200.0,37.30500030517578,37.56499862670898,37.23500061035156,37.345001220703125,29.01961898803711,KO,"S&P Bullish On Vanguard Dividend Appreciation ETF (VIG, PEP, PG) ||| 6 ETFs For The Summer Olympics (XLP, EWU, XLI)",1,0.5046177
2012-06-14,13945400.0,37.39500045776367,38.0,37.34999847412109,37.869998931884766,29.42757225036621,KO,Six Rules to Follow When Picking Stocks,1,0.5371714
2012-06-15,19748800.0,38.060001373291016,38.09999847412109,37.709999084472656,38.04499816894531,29.563554763793945,KO,A Peek Into The Market Before The Trading Starts ||| Coca-Cola Plans Presence in Myanmar,0,0.5276277
2012-06-18,10457200.0,37.97999954223633,38.209999084472656,37.8849983215332,37.9900016784668,29.52082633972168,KO,Neutral on Coca-Cola Enterprises - Analyst Blog ||| Five Stocks That Have Boosted Dividends for Five Consecutive Years ||| Five Stocks That Have Boosted Dividends for Five Consecutive Years,0,0.5025725
2012-06-19,11115400.0,38.125,38.125,37.83000183105469,37.869998931884766,29.42757225036621,KO,Coco-Cola Adds New Flavors - Analyst Blog,0,0.53504616
2012-06-20,14706800.0,37.845001220703125,37.869998931884766,37.41999816894531,37.77999877929688,29.357637405395508,KO,4 Rules of Dividend Investing - Investment Ideas ||| Spokesperson for Coca Cola Would Not Comment on How Spiking Orange Juice Futures Would Affect their Minute Maid Pricing ||| Splitsville: 8 Stocks That Will Split This Summer ||| Orange Juice Futures Rise Another 2% Wednesday on Fears of South Florida Hurricane ||| Ford and Coke Show Facebook Some Love ||| Top 4 Large-Cap Stocks In The Beverages-Soft Drinks Industry With The Highest EPS Estimates,0,0.5226614
2012-06-21,12804000.0,37.89500045776367,37.994998931884766,37.310001373291016,37.334999084472656,29.01184463500977,KO,"Four Sector ETFs to Avoid Like The Plague (MXI, OIH, XLP) ||| Social Media Outlook for Thursday June 21 (KBALB, ONXX, BBBY, DECK) ||| Coca-Cola FEMSA, Family Dollar, Other Dividend Payers on a Roll",1,0.5160573
2012-06-22,15252800.0,37.47499847412109,37.650001525878906,37.43000030517578,37.470001220703125,29.116748809814453,KO,"UPDATE: SodaStream Says It Won't Comply with Coke's Order ||| SodaStream CEO, Daniel Birnbaum, Issues Statement Regarding Coca-Cola's Threatened Lawsuit ||| Monster Joins the S&P 500 as Sara Lee Steps Down",0,0.51076955
2012-06-25,9734200.0,37.22999954223633,37.41999816894531,37.084999084472656,37.3849983215332,29.05069732666016,KO,PepsiCo Maintained at Neutral - Analyst Blog ||| Dow Declines 138 Points; Are More Euro-Zone-Spurred Losses Ahead? ||| Saving More Vs. Seeking Higher Returns for Retirement ||| Sodastream up 1% on the Session ||| Barron's Recap: The World's Most Respected Companies ||| A Bullish Play on Monster Beverage with Options,1,0.48972622
2012-06-26,11859400.0,37.494998931884766,37.68000030517578,37.09999847412109,37.540000915527344,29.17113876342773,KO,"Warren Buffett's Stocks with the Most Insider Buying ||| Buffett, Einhorn and Loeb Have Faith in Their Largest Holdings (KO, AAPL, YHOO) ||| Coca-Cola Investing $5 Billion in India ||| Financial Breakfast: Morning News Summary for June 26, 2012 ||| A Peek Into The Market Before The Trading Starts ||| Coca-Cola Targeting Additional US$3 Billion Investment to Support Long-Term, Sustainable Growth in India",1,0.4668616
2012-06-27,13644400.0,37.619998931884766,38.2400016784668,37.619998931884766,38.16999816894531,29.660688400268555,KO,"ETFs Bill Gross Might Like (BONO, HDV, PBJ) ||| ETFs Bill Gross Might Like (BONO, HDV, PBJ)",1,0.48956966
2012-06-28,10891200.0,38.04999923706055,38.334999084472656,37.845001220703125,38.28499984741211,29.75005531311035,KO,Wal-Mart Is Laser Focused On Its Growth In China,1,0.56219214
2012-06-29,18519800.0,38.56499862670898,39.095001220703125,38.540000915527344,39.095001220703125,30.37947654724121,KO,Fat Profits Make Beverage Makers A Target ||| Stocks Other Than Ford That Could be Hurt by Woes in Europe,1,0.5116344
2012-07-02,13350200.0,39.04999923706055,39.5,39.005001068115234,39.459999084472656,30.663105010986328,KO,Valuing Donald Yacktman's Portfolio - The Peter Lynch Fair Value,1,0.5266382
2012-07-03,7335000.0,39.44499969482422,39.68000030517578,39.35499954223633,39.58000183105469,30.756362915039062,KO,General Motors to Possibly Resume Advertising on Facebook,0,0.5042426
2012-07-05,10546400.0,39.5099983215332,39.56999969482422,39.09999847412109,39.22499847412109,30.48050117492676,KO,FEMSA Stays Neutral - Analyst Blog ||| Consumer Staples Stock Outlook - July 2012 - Industry Outlook ||| Consumer Staples Stock Outlook - July 2012 - Industry Outlook ||| Consumer Staples Stock Outlook - July 2012 - Zacks Analyst Interviews,0,0.48830336
2012-07-06,10036000.0,39.0099983215332,39.14500045776367,38.91999816894531,39.07500076293945,30.36394500732422,KO,Pepsi Offers 2 New Low-Fat Lays - Analyst Blog,0,0.5276718
2012-07-09,8615600.0,39.02999877929688,39.10499954223633,38.85499954223633,38.9900016784668,30.297887802124023,KO,Should Traders Brace for a Rough Q2 Earnings Season?,0,0.52906555
2012-07-10,11583400.0,39.26499938964844,39.27000045776367,38.90999984741211,38.9900016784668,30.297887802124023,KO,"PepsiCo's Yogurt Deal with Muller - Analyst Blog ||| How Coca-Cola's Stock Split May Upset Warren Buffett ||| How Coca-Cola's Stock Split May Upset Warren Buffett ||| Immigrants: Restless Dreamers, Economic Pillars ||| Shareowners of The Coca-Cola Company Approve Two-for-One Stock Split",0,0.48892796
2012-07-11,13645600.0,38.95000076293945,38.97499847412109,38.57500076293945,38.72999954223633,30.095853805541992,KO,"Facebook App Attempts to Monetize User ""Likes"" ||| PepsiCo's New Lays Plant in China - Analyst Blog ||| Facebook App Attempts to Monetize User ""Likes""",0,0.5177825
2012-07-12,19104000.0,38.51499938964844,38.6349983215332,38.2599983215332,38.31999969482422,29.77725601196289,KO,"S&P Reiterates Favorable View of Staples ETFs (VDC, XLP, MOO)",1,0.5331504
2012-07-16,17575600.0,38.54999923706055,38.70000076293945,38.09999847412109,38.2400016784668,29.715087890625,KO,"Earnings Likely to Take Backseat to Bernanke ||| Earnings Preview: Coca-Cola - Analyst Blog ||| Buffett Raises Funds Managed by Underlings to $8 Billion ||| Social Media Outlook for Monday July 16 (HGSI, KO, QCOM, WYNN) ||| Earnings Expectations for the Week of July 16",1,0.49988794
2012-07-17,21209600.0,39.02999877929688,39.33000183105469,38.380001068115234,38.845001220703125,30.18522834777832,KO,"How to Hear What Bernanke Is Saying - Analyst Blog ||| Ahead of Wall Street - July 17, 2012 - Ahead of Wall Street ||| Coca-Cola’s Profit and Revenue Beat Expectations (KO) ||| Market Wrap-Up for July 17 (STT, KO, MOS, MAT, MTB, more) ||| Coca-Cola Takes a Slight Hit on Profit ||| Social Media Outlook for Tuesday July 17 (DGIT, KO, JBHT, GOOG) ||| Coca-Cola Reducing Exposure To Banks With Its Cash, Diversifying Risk To S-t Govt Bonds, Aaa Investments ||| Why Coca-Cola could be Destroying Teeth AND Wallets ||| Coke's Fayard Says Convenience Sales Did Not Improve With Gas Prices ||| Coca-Cola's Kent Sees Prolonged Economic Crisis In Europe ||| Coca-Cola Sees Currency Having 8-9% Negative Effect in 3Q ||| Coca-Cola Says Gross Margins Softened In May And June ||| Coca-Cola's Kent Sees Double-Digit Percentage Growth In China Long-Term ||| Coca-cola's Kent Says New Packages Sizes In China Boosting Share ||| UPDATE: Coca-Cola Posts Upbeat Q2 Profit ||| Coca-Cola Reports Q2 EPS $1.22 vs $1.19 Est; Revenues $13.09B vs $12.98B Est ||| Benzinga Market Primer, Tuesday July 17 ||| US Stock Futures Up; All Eyes On Bernanke ||| Earnings Scheduled For July 17 ||| Stocks To Watch For July 17",0,0.47217563
2012-07-18,13852000.0,38.81999969482422,38.84000015258789,38.40999984741211,38.720001220703125,30.08807373046875,KO,"Company News for July 18, 2012 - Corporate Summary ||| Coca-Cola’s Numbers Lowered by Two Major Analysts (KO) ||| Facebook Investors, Nasdaq OMX Group Attempt to Separate Lawsuits ||| Six Flags Extends and Expands Partnership with The Coca-Cola Company for Another Ten Years ||| Benzinga Market Primer, Wednesday July 18",1,0.5157402
2012-07-19,18050400.0,38.7599983215332,38.79999923706055,38.25,38.775001525878906,30.130830764770508,KO,Corn Trading Near Record Highs,0,0.5213254
2012-07-20,16436000.0,38.6349983215332,38.67499923706055,38.39500045776367,38.51499938964844,29.92878150939941,KO,Identity Crisis? The Coca-Cola Company and World Wildlife Fund,0,0.50864476
2012-07-23,10655800.0,38.275001525878906,38.5,38.185001373291016,38.43999862670898,29.87049865722656,KO,This 8% Yielder Pays Monthly Dividends ||| Barron's Recap (7/21/12): The Veggie Juice Craze,0,0.48528227
2012-07-24,10445800.0,38.45000076293945,38.47499847412109,38.04999923706055,38.33000183105469,29.78502082824707,KO,NYC Holding Hearing on Soda Ban Today,1,0.5131582
2012-07-25,9020400.0,38.47499847412109,38.61000061035156,38.3650016784668,38.5099983215332,29.92490005493164,KO,PepsiCo Beats EPS; Misses Sales - Analyst Blog,1,0.5184942
2012-07-26,14144600.0,38.84999847412109,39.45500183105469,38.84999847412109,39.42499923706055,30.63591766357422,KO,"Dr Pepper Posts Higher Profit - Analyst Blog ||| Facebook In-Line With Estimates, Investors Not Impressed",1,0.51309705
2012-07-27,17825000.0,39.525001525878906,40.119998931884766,39.45000076293945,40.005001068115234,31.08662223815918,KO,"Stock Market News for July 27, 2012 - Market News",1,0.507704
2012-07-30,15947800.0,39.8849983215332,40.584999084472656,39.78499984741211,40.560001373291016,31.517881393432617,KO,"Facebook Advertising Could be Faking Your Business Out ||| Coca-Cola Announces New Operating Structure, Company Will be Organized Around 3 Businesses",0,0.4956671
2012-07-31,16333600.0,40.34999847412109,40.665000915527344,40.19499969482422,40.400001525878906,31.393558502197266,KO,"Stock Market News for July 31, 2012 - Market News",1,0.5085887
2012-08-01,12954600.0,40.48500061035156,40.625,40.29499816894531,40.505001068115234,31.47515296936035,KO,Coca-Cola to Slim Down Divisions - Analyst Blog ||| What Are High Quality Companies to Don Yacktman ||| These ETFs Will Crush Your Spirit and Your Brokerage Account ||| Coca-Cola Said to Consider Bid for F&N Beverage Division -Bloomberg,0,0.49434522
2012-08-02,13393200.0,40.3650016784668,40.5,39.7599983215332,39.875,30.985593795776367,KO,How Many of Facebook's 955 Million Users Are Fake?,1,0.5008203
2012-08-03,11834200.0,40.095001220703125,40.494998931884766,40.005001068115234,40.415000915527344,31.40522003173828,KO,5 Familiar Stocks to Sell (or Short)! - Investment Ideas ||| Beyond SPLV: Low Volatility ETFs to Survive a Wild Market,0,0.507007
2012-08-06,9179400.0,40.505001068115234,40.625,40.310001373291016,40.31999969482422,31.331392288208008,KO,"52-Week High Companies: SHW, LMCA, UN, LLY, KO ||| Donald Yacktman Buys More Cisco, Conoco, Apollo, PG ||| The Definitive Guide to Low Volatility ETFs",0,0.48470807
2012-08-07,12782800.0,40.41999816894531,40.4900016784668,39.875,39.8849983215332,30.99336814880371,KO,Which of These 7 Stocks Will Get Kicked off the Dow?,0,0.48789778
2012-08-10,40577600.0,39.58000183105469,39.60499954223633,39.30500030517578,39.39500045776367,30.61260223388672,KO,Five Great Commission-Free ETFs on TD Ameritrade - ETF News And Commentary,0,0.5376652
2012-08-13,8898200.0,39.310001373291016,39.38999938964844,39.04999923706055,39.29999923706055,30.53877830505371,KO,"A 39% Dividend Yield From Coca-Cola? ||| Coca-Cola Cut to “Neutral” at Goldman Sachs; Valuation No Longer Attractive (KO) ||| Stocks and Sports: NFL Season Kickoff Coming Soon ||| Stocks and Sports: NFL Season Kickoff Coming Soon ||| Social Media Outlook for Monday August 13 (TSO, BAC, KO, GS) ||| Goldman Sachs Downgrades Coca-Cola from CL-Buy to Neutral ||| Benzinga's Top Pre-Market Losers",1,0.514088
2012-08-15,7692500.0,39.41999816894531,39.54999923706055,39.22999954223633,39.34999847412109,30.57762908935547,KO,Beverage Stock DC Brands (OTC: HRDN) Brings Former Coca-Cola (NYSE:KO) and Coors Veteran on Board to Drive H.A.R.D. Nutrition Brand,1,0.52160573
2012-08-16,8824100.0,39.400001525878906,39.630001068115234,39.310001373291016,39.54999923706055,30.73304748535156,KO,"Healthier, Natural Energy Drinks Expand the Demographics Beyond the 18- 30 Consumers and Lead the Sector's Growth Moving Forward",0,0.51566595
2012-08-17,10541000.0,39.65999984741211,39.72999954223633,39.27000045776367,39.52999877929688,30.717504501342773,KO,"UPDATE: Barclays Lowers PT on Coca-Cola ||| Barclays Maintains Coca-Cola at Overweight, Lowers PT from $81 to $41",0,0.4978869
2012-08-21,8329000.0,39.40999984741211,39.68999862670898,39.22999954223633,39.2599983215332,30.507699966430664,KO,"Everything You Need To Know About The Apple Dividend ||| Benzinga'a M&A Chatter for Tuesday August 21, 2012 ||| OTCBB Tuesday Morning Gainers; Beverage Stocks (OTCBB: ATTD), (OTCBB: AHFD) Make Top Volume Leaders List",0,0.48181114
2012-08-23,14973300.0,38.810001373291016,38.84000015258789,38.02000045776367,38.11000061035156,29.61407852172852,KO,S&P Reiterates Overweight Rating on Staples ETFs,1,0.5344356
2012-08-24,9317800.0,38.06999969482422,38.54999923706055,38.06999969482422,38.470001220703125,29.893823623657227,KO,Why it Pays to Invest Like a Contrarian ||| Coca-Cola Walks the Tightrope - Analyst Blog ||| A Look at Steven Mandel's Lone Pine Capital,0,0.49513385
2012-08-29,23435400.0,38.04999923706055,38.04999923706055,37.380001068115234,37.459999084472656,29.108970642089844,KO,"After Hours Most Active for Aug 29, 2012 : QQQ, KO, P, BAC, GE, MU, CSCO, PFE, WFC, HBAN, MSFT, ORCL ||| Dow Settles Wishy-Washy Wednesday with Minor Gain",0,0.48105747
2012-08-30,17041800.0,37.380001068115234,37.630001068115234,37.130001068115234,37.13999938964844,28.860313415527344,KO,"Is it Time for You to Finally Sell Coca-Cola? ||| After Hours Most Active for Aug 30, 2012 : BAC, SCS, GE, MSFT, OVTI, APO, CSCO, TWX, KO, INTC, QQQ, SIRI",1,0.4838677
2012-09-06,19851400.0,37.77999877929688,38.29999923706055,37.70000076293945,38.150001525878906,29.645153045654297,KO,Is The Fed Pushing These Stocks Higher ? ||| Suntrust Intends to Sell Approximately $200M of Affordable Housing Investments -Reuters ||| This Dividend ETF Isn't The Same Old Song,0,0.47941786
2012-09-07,16391700.0,38.380001068115234,38.5,37.7400016784668,37.900001525878906,29.45088195800781,KO,3 Small Companies With Big Dividends ||| SunTrust Re-aligns Balance Sheet - Analyst Blog ||| 3 Small Companies With Big Dividends,0,0.543651
2012-09-10,18216900.0,37.959999084472656,37.97999954223633,37.59000015258789,37.65999984741211,29.264392852783203,KO,Green Mountain Offers Antioxidant Coffees - Analyst Blog ||| These 4 Companies Have Been Increasing Their Dividends for Decades ||| Coca-Cola Says Made First Delivery to Myanmar in 60 Years,1,0.5158733
2012-09-11,16505000.0,37.630001068115234,37.83000183105469,37.560001373291016,37.77000045776367,29.3498649597168,KO,Largest option buying in equities so far,0,0.5245229
2012-09-12,14632200.0,37.790000915527344,37.83000183105469,37.5099983215332,37.54999923706055,29.377256393432617,KO,Tech Dividends Impact on ETFs Could Take a While ||| Facebook Won't Build an iPhone 5 Competitor ||| Coca-Cola Says Reiniche Will be Chairman of Europe Group,1,0.5248411
2012-09-13,23803400.0,37.72999954223633,38.4900016784668,37.61000061035156,38.34999847412109,30.00312805175781,KO,Hearing Deal Reporter Says Monster Beverage Legal Troubles Hurt Chances for Takeover Deal,0,0.50296706
2012-09-14,25087400.0,38.54999923706055,38.54999923706055,38.0099983215332,38.119998931884766,29.82318687438965,KO,Coca-Cola's Dasani Water Drops Will Expand Its Low-Calorie Offerings ||| Is Warren Buffett Becoming a Trader?,1,0.5131782
2012-09-17,23594400.0,38.15999984741211,38.380001068115234,38.02999877929688,38.34999847412109,30.00312805175781,KO,"PepsiCo Remains Neutral - Analyst Blog ||| Benzinga Market Primer, Monday September 17",1,0.48452878
2012-09-18,24373700.0,38.380001068115234,39.0,38.29999923706055,38.619998931884766,30.2143611907959,KO,"Coca-Cola Discovers a New Way to Appeal to Consumers ||| After Hours Most Active for Sep 18, 2012 : INTC, QQQ, WCRX, VRSN, SSYS, KO, DAL, HF, BAC, AA, TWX, MSFT ||| Coca-Cola Surrenders Half of its Gains From Session ||| Defensive Stocks Maintain Gains in Mixed Market ||| Coca-Cola Discovers a New Way to Appeal to Consumers",0,0.5052031
2012-09-19,26276800.0,38.65999984741211,38.810001373291016,38.40999984741211,38.52000045776367,30.136127471923828,KO,QE3 Launched: The Ever Decreasing Effects of Monetary Stimulus ||| Here's Why I Upped My Position In Berkshire Hathaway,1,0.5102318
2012-09-20,26953000.0,38.38999938964844,38.869998931884766,38.380001068115234,38.63999938964844,30.230016708374023,KO,"After Hours Most Active for Sep 20, 2012 : QQQ, BAC, ORCL, S, KO, BRCD, KORS, PBR, MSFT, NOK, SYMC, YNDX ||| Dr Pepper Snapple on a Tight Rope - Analyst Blog",0,0.5105326
2012-09-21,98967500.0,38.72999954223633,38.7400016784668,37.880001068115234,38.02999877929688,29.752779006958008,KO,"After Hours Most Active for Sep 21, 2012 : S, MSFT, KO, YHOO, WFT, VMED, VIAB, WFC, QCOM, BPO, PHM, INTC",1,0.49139053
2012-09-24,21902000.0,37.810001373291016,38.2400016784668,37.810001373291016,38.119998931884766,29.82318687438965,KO,"Dividend Tax Hike: Impact on Stocks Might be Different Than You Think ||| S&P 500 Index and Big 10 Weekly Outlook-Week of September 24, 2012 ||| The Coca-Cola Company Completes Transaction with Aujan Industries",0,0.49621615
2012-09-26,16677400.0,37.77999877929688,38.18999862670898,37.7400016784668,37.7599983215332,29.54154586791992,KO,Coca-Cola Company Acquires Aujan - Analyst Blog,1,0.5323922
2012-09-27,15176100.0,38.060001373291016,38.34999847412109,37.900001525878906,38.310001373291016,29.971832275390625,KO,"Coca-Cola Breaks Above Major Resistance ||| Coca-Cola Nears Resistance ||| UBS Maintains Coca-Cola at Neutral, Raises PT from $38 to $39",0,0.49681264
2012-09-28,22721200.0,38.16999816894531,38.220001220703125,37.900001525878906,37.93000030517578,29.674541473388672,KO,Best School Deal In America: the One That Produced Steve Jobs’ Nemesis,1,0.51896507
2012-10-01,16671400.0,38.15999984741211,38.59999847412109,38.150001525878906,38.380001068115234,30.026596069335938,KO,"These 7 Stocks Haven't Missed A Dividend Payment In 113 Years ||| Ensconced in Controversy, Staples ETFs Still Soaring",0,0.48477244
2012-10-02,10276000.0,38.560001373291016,38.68999862670898,38.11000061035156,38.34000015258789,29.995304107666016,KO,"Stock Market News for October 2, 2012 - Market News ||| S&P Index and Big 10 Weekly Outlook",0,0.5039084
2012-10-04,9654500.0,38.459999084472656,38.54999923706055,38.18999862670898,38.33000183105469,29.98748207092285,KO,Three Dividend Stocks Owned by the Smart Money,1,0.5460914
2012-10-08,9434600.0,38.540000915527344,38.68000030517578,38.43999862670898,38.58000183105469,30.183076858520508,KO,Stocks Edge Lower as Consumer Names Buck the Bearish Trend,0,0.51506186
2012-10-09,13078700.0,38.5,38.83000183105469,38.459999084472656,38.560001373291016,30.16742897033692,KO,Calorie Count Vending Units from DPS - Analyst Blog ||| The Post-Jobs Apple: Is it Still a 'Buy' One Year Later? ||| These ETFs Have Stellar Dividend Growth ||| These ETFs Have Stellar Dividend Growth ||| No Surprise as Bill Gross ETF Tops $3B in AUM,0,0.48560354
2012-10-10,13754500.0,38.650001525878906,38.72999954223633,38.04999923706055,38.09000015258789,29.799728393554688,KO,"Goldman Sachs Maintains Coca-Cola at Neutral, Raises PT from $42 to $43",1,0.5017271
2012-10-11,10843800.0,38.20000076293945,38.27999877929688,38.02000045776367,38.11000061035156,29.815372467041016,KO,Coca-Cola in Talks to Invest $10M in Spotify -Bloomberg,1,0.5215752
2012-10-12,12059700.0,38.2599983215332,38.38999938964844,38.11000061035156,38.22999954223633,29.90924453735352,KO,"Earnings Preview: Coca-Cola - Analyst Blog ||| Market Wrap-Up for Oct.12 (WFC, JPM, WMT, LOW, WDC, more) ||| McDonald's: A Perfect Hybrid Between Growth and Value?",0,0.49669826
2012-10-15,13785100.0,38.09000015258789,38.25,38.0099983215332,38.130001068115234,29.831016540527344,KO,"Earnings Preview: PepsiCo - Analyst Blog ||| Pre-Market Earnings Report for October 16, 2012 : JNJ, KO, UNH, GS, PNC, STT, GWW, OMC, MAT, FRX, CBSH, DPZ ||| Citigroup Kicks Off Busy Earnings Week ||| CLSA Downgraded Coca-Cola from Outperform to Underperform ||| Earnings Expectations for the Week of October 15",0,0.48774916
2012-10-16,25811800.0,38.18000030517578,38.220001220703125,37.43999862670898,37.900001525878906,29.65106964111328,KO,"Morning Earnings Roundup: Better Investing at Goldman Sachs ||| Coca-Cola Posts In-Line Adjusted Q3 Profit; Revenue Misses Slightly (KO) ||| Upbeat Earnings Reports Spark Triple Digit Gain in the Dow ||| Citigroup Maintains Coca-Cola at Buy, Raises PT from $45.50 to $46 ||| Coca-Cola Earnings Call Begins ||| UPDATE: Coca-Cola Q3 Profit Up 3.9% ||| Coca-Cola Reports Q3 EPS $0.50 vs $0.50 Est; Revenues $12.3B vs $12.37B Est ||| Benzinga Market Primer, Tuesday October 16 ||| US Stock Futures Up Ahead Of Earnings, Economic Data ||| Earnings Scheduled For October 16, 2012",0,0.49815223
2012-10-17,15449600.0,38.060001373291016,38.150001525878906,37.70000076293945,37.7400016784668,29.525903701782227,KO,"Coca-Cola's EPS Edges Past, Fx Hurts - Analyst Blog ||| Company News for October 17, 2012 - Corporate Summary ||| PepsiCo Posts Mixed 3Q, Keeps View - Analyst Blog ||| Earnings Analysis: Coca-Cola Co. ||| UPDATE: Deutsche Bank Reiterates Buy Rating, Raises PT on The Coca-Cola Company ||| UPDATE: Citigroup Reiterates Buy Rating, Raises PT on The Coca-Cola Company ||| Deutsche Bank Maintains Coca-Cola at Buy, Raises PT from $40 to $42",1,0.49116448
2012-10-18,23063300.0,37.7599983215332,38.06999969482422,37.459999084472656,37.84000015258789,29.604124069213867,KO,These Companies Have Raised Their Dividends for 50 Consecutive Years ||| CORRECT: Coca-Cola Will Buy Back 500M Additional Shares or $18.9B ||| Coca-Cola Says Will Buyback Up to $500M of Shares,0,0.5034831
2012-10-22,13340500.0,37.369998931884766,37.47999954223633,36.959999084472656,37.22999954223633,29.126895904541016,KO,SunTrust Misses Marginally - Analyst Blog ||| Everything Investors Need to Know About DRIPs,0,0.4969778
2012-10-23,13287300.0,36.959999084472656,36.97999954223633,36.540000915527344,36.61000061035156,28.641834259033203,KO,China’s GDP: A High-Quality Problem,1,0.5207627
2012-10-26,11896500.0,37.119998931884766,37.2599983215332,36.77999877929688,37.040000915527344,28.978256225585938,KO,FEMSA's Profit Rises in 3Q - Analyst Blog ||| 10 Best Dogs Of The Dow Jones With The Strongest 5-Year EPS Growth Forecast ||| Beating Buffett With ETFs ||| Coca-Cola Announces $300M Investment for Strong in Vietnam,1,0.53005177
2012-10-31,11643500.0,37.15999984741211,37.40999984741211,36.91999816894531,37.18000030517578,29.08778381347656,KO,Monster Beverage Stock: There are Problems Beyond the Recent Health Scare ||| Four Ways to Play Rising Food Prices with ETFs - ETF News And Commentary ||| Coca-Cola to Invest $300M in Vietnam - Analyst Blog,1,0.54443836
2012-11-01,10622300.0,37.150001525878906,37.560001373291016,37.150001525878906,37.33000183105469,29.20512962341309,KO,Monster Beverage Drops Intraday on Rumors of Police Investigation,0,0.5136248
2012-11-02,11237500.0,37.58000183105469,37.650001525878906,37.0,37.08000183105469,29.009552001953125,KO,Four Reasons to Prefer This China ETF Over FXI ||| Four Reasons to Prefer This China ETF Over FXI,0,0.5233482
2012-11-05,12139600.0,36.95000076293945,36.9900016784668,36.630001068115234,36.77000045776367,28.76701164245605,KO,Investment Style Rankings For ETFs & Mutual Funds,1,0.5107772
2012-11-08,12921700.0,36.650001525878906,37.11000061035156,36.36000061035156,36.36000061035156,28.44625663757324,KO,Stocks James Bond Would Love ||| Stocks James Bond Would Love ||| Monster Beverage Bounces Back Following Disappointing Earnings,0,0.48017678
2012-11-09,11520300.0,36.04999923706055,36.52000045776367,36.04999923706055,36.290000915527344,28.3914852142334,KO,3 Consumer Staples ETFs for the Shaky Market - ETF News And Commentary,0,0.55089015
2012-11-12,10169700.0,36.290000915527344,36.290000915527344,35.9900016784668,36.08000183105469,28.22720527648925,KO,"Futures Rise on Greek Austerity Vote, China Trade",1,0.52326274
2012-11-13,12105200.0,36.02999877929688,36.560001373291016,35.97999954223633,36.15999984741211,28.28978538513184,KO,Risk Reward Balanced at Coca-Cola - Analyst Blog,0,0.5182981
2012-11-16,15624800.0,36.4900016784668,36.650001525878906,36.27000045776367,36.560001373291016,28.602725982666016,KO,"The Shocking Advice Warren Buffett Gives about ""Forever Stocks"" ||| Coca-Cola Enterprises, Inc. (CCE) Ex-Dividend Date Scheduled for November 20, 2012",1,0.45188227
2012-11-19,14076200.0,36.84999847412109,37.290000915527344,36.810001373291016,37.2400016784668,29.13471794128418,KO,Mid-Cap Dividend Dynamos ||| Mid-Cap Dividend Dynamos ||| What is Warren Buffett Buying?,1,0.48671362
2012-11-20,12278600.0,37.22999954223633,37.27000045776367,36.84999847412109,37.25,29.142547607421875,KO,Dividend Conundrum: Leggett & Platt’s 4.4% Yield vs. Becton Dickinson’s 2.4% -- Surprise ||| Green Mountain Names New CEO,1,0.49367625
2012-11-21,8631300.0,37.33000183105469,37.470001220703125,37.220001220703125,37.38999938964844,29.252077102661133,KO,Be Thankful For New Dividend ETFs,1,0.5163426
2012-11-23,5365500.0,37.54999923706055,37.95000076293945,37.4900016784668,37.93000030517578,29.674541473388672,KO,"5 Dividend Stocks You Can Hold Forever ||| Sell-Off in Classic Buy-and-Hold Stock Could Yield 200% Profits ||| Looking Ahead: Earnings from Apparel Companies, US Durable Goods",0,0.50356424
2012-11-26,13217000.0,37.58000183105469,37.77999877929688,37.22999954223633,37.36000061035156,29.228605270385746,KO,"These Stocks Should Cut Their Dividends ||| Green Mountain Coffee Roasters Earnings Preview: Looking for Some Good News ||| Coca-Cola Company (KO) Ex-Dividend Date Scheduled for November 28, 2012 ||| Molson Coors Brewing Company (TAP) Ex-Dividend Date Scheduled for November 28, 2012 ||| Once Again, Government Has India ETFs at Crossroads ||| Market Close Report: NASDAQ Composite index closes at 2,976.78 up 9.93 points ||| SPX Snaps Winning Streak, Ends Near Bull-Bear Battleground ||| Once Again, Government Has India ETFs at Crossroads",1,0.46593267
2012-11-27,11873700.0,37.43999862670898,37.790000915527344,37.34000015258789,37.41999816894531,29.27553939819336,KO,PepsiCo Update: Company Signs Major Indian Sponsorship Deal ||| Another Staples ETF to Consider ||| Another Staples ETF to Consider,1,0.52556145
2012-11-28,14846300.0,37.060001373291016,37.56999969482422,36.79999923706055,37.560001373291016,29.58669662475586,KO,Coca-Cola Doubles Down In Chile With Andina Investment ||| Has Western Union Bottomed? ||| Has Western Union Bottomed?,1,0.5252044
2012-11-29,12433700.0,37.68000030517578,37.970001220703125,37.5,37.970001220703125,29.909648895263672,KO,"Can Procter & Gamble Save Your Retirement Portfolio? ||| Sleepy General Mills Delivers in Turbulent Environment ||| Four Latin America Stocks Worth a Look Now (AKO-B, ASR, CZZ, ICA) ||| Sleepy General Mills Delivers in Turbulent Environment ||| Bears Squeezed by Green Mountain Beat ||| Coca-Cola Presenting at CAGNY Conference: Sees 2012 Capital Spending $3-3.2B",0,0.485939
2012-11-30,13039500.0,37.93999862670898,37.97999954223633,37.65999984741211,37.91999816894531,29.87027168273925,KO,Hedge Fund Billionaires Are Hoarding These 5 Stocks ||| Case For EM Consumer Bolstered by New Statistics ||| Case For EM Consumer Bolstered by New Statistics,0,0.46726575
2012-12-03,12864900.0,37.900001525878906,37.93999862670898,37.33000183105469,37.380001068115234,29.44489288330078,KO,"Pepsico, Inc. (PEP) Ex-Dividend Date Scheduled for December 05, 2012 ||| National Beverage Corp. (FIZZ) Ex-Dividend Date Scheduled for December 05, 2012 ||| Don't Spin The Roulette Wheel on a Caesars Special Dividend",0,0.45056748
2012-12-04,11794200.0,37.310001373291016,37.4900016784668,37.13999938964844,37.150001525878906,29.263729095458984,KO,"Coca-Cola, Select Milk Producers Partner to Create Fair Oaks Farms Brands",1,0.53596485
2012-12-05,14561400.0,37.20000076293945,37.5,37.08000183105469,37.310001373291016,29.389766693115234,KO,KO & Select Buy Stake in Fair Oaks - Analyst Blog ||| JP Morgan Cuts the Estimates of the Coca-Cola Company (KO),1,0.5098796
2012-12-07,10654700.0,37.43999862670898,37.7400016784668,37.38999938964844,37.709999084472656,29.7048454284668,KO,"Are the Rich Fleeing Equities for Tax-Free Havens in the New Age of Obama? ||| HSN, Coca-Cola Partner to Create Omni-Channel Retail Experience",0,0.49376696
2012-12-10,8603200.0,37.70000076293945,37.77999877929688,37.5099983215332,37.63999938964844,29.64970588684082,KO,"The $50 Billion Tax-Free ""Giveaway"" that will Affect Every Single Investor ||| Coca Cola, HSN to Collaborate - Analyst Blog",1,0.5266592
2012-12-11,10671300.0,37.630001068115234,37.9900016784668,37.58000183105469,37.86000061035156,29.823001861572266,KO,"Dr Pepper Snapple Group, Inc (DPS) Ex-Dividend Date Scheduled for December 13, 2012 ||| Coffee Holding Co., Inc. (JVA) Ex-Dividend Date Scheduled for December 13, 2012 ||| The 'Controversial' Investing Advice That's Worked Every Time in the Past Decade... ||| Monster Pops After Stifel Nicolaus Upgrade",0,0.46159413
2012-12-12,14681700.0,37.88999938964844,37.93000030517578,37.5,37.63999938964844,29.64970588684082,KO,"This ""Coca-Cola Killer"" is a Great Holiday Growth Stock to Own ||| 5 Reasons Cisco is My Top Tech Pick for 2013 ||| 5 Reasons Cisco is My Top Tech Pick for 2013",0,0.4831213
2012-12-13,11442100.0,37.70000076293945,37.790000915527344,37.52999877929688,37.59999847412109,29.61819267272949,KO,3 High-Yield Small-Caps for Income and Growth,1,0.5698305
2012-12-14,11800900.0,37.52000045776367,37.77000045776367,37.5,37.65999984741211,29.66546058654785,KO,4 Stocks Expected to Double Sales in 2013,0,0.5200296
2012-12-17,17588900.0,37.790000915527344,37.81999969482422,37.380001068115234,37.5,29.53942108154297,KO,"Vina Concha Y Toro (VCO) Ex-Dividend Date Scheduled for December 19, 2012 ||| Take This One Simple Step NOW to Protect Yourself from the ""Fiscal Cliff"" ||| KOF to Buy Stake in Coke's Bottler - Analyst Blog ||| Take This One Simple Step NOW to Protect Yourself from the ""Fiscal Cliff""",0,0.47668695
2012-12-20,16182700.0,36.68999862670898,37.09999847412109,36.650001525878906,37.04999923706055,29.184955596923828,KO,"The Best Way To Profit From The ""Dividend Decade"" ||| PepsiCo Attempts To Revive Diet Pepsi With New Sweetener Mix",0,0.48815653
2012-12-21,27942400.0,37.0,37.18999862670898,36.52999877929688,36.88999938964844,29.058921813964844,KO,The Top 10 Mid-Cap Stocks Offering Growth and High Yields ||| How to Protect Your Portfolio from a Reversed 'January Effect' ||| More 10-Calorie Sodas from Dr Pepper - Analyst Blog ||| The 8 Most Important Facts To Know About A Company Before You Invest,0,0.51255476
2012-12-24,4851800.0,36.720001220703125,36.79999923706055,36.56999969482422,36.72999954223633,28.93288230895996,KO,"Companhia de Bebidas das Americas - AmBev (ABV) Ex-Dividend Date Scheduled for December 27, 2012",0,0.48576927
2012-12-26,9982100.0,36.70000076293945,36.79999923706055,36.2400016784668,36.41999816894531,28.688692092895508,KO,The Secret Ratio That Predicts Winning Stocks Time and Again ||| The Secret Ratio That Predicts Winning Stocks Time and Again,0,0.49119478
2012-12-28,14053400.0,36.220001220703125,36.41999816894531,35.95000076293945,35.970001220703125,28.33422470092773,KO,Coca-Cola Grants for Health Programs - Analyst Blog ||| An Easy Way to Find Stocks that Will Likely Boost Dividends ||| An Easy Way to Find Stocks that Will Likely Boost Dividends,1,0.49572232
2012-12-31,15651400.0,35.880001068115234,36.27999877929688,35.58000183105469,36.25,28.55478286743164,KO,The Top 10 Brands of 2012 ||| Sectors to Monitor While the Nation Hangs from the Fiscal Cliff,1,0.52498764
2013-01-02,21872400.0,36.9900016784668,37.59999847412109,36.65999984741211,37.59999847412109,29.61819267272949,KO,"The Top Stocks Warren Buffett and Donald Yacktman Both Own ||| After Hours Most Active for Jan 2, 2013 : QQQ, BAC, VCSH, VCIT, MSFT, CX, ATML, INTC, ES, WFC, KO, AIG ||| Coca-Cola Buying Sacramento Bottling Company",0,0.48617297
2013-01-04,15311300.0,37.650001525878906,37.869998931884766,37.52000045776367,37.65999984741211,29.66546058654785,KO,Food and Beverage Picks for 2013: Coca-Cola and Mondelez,0,0.51912326
2013-01-07,14610200.0,37.52000045776367,37.52000045776367,37.09999847412109,37.29999923706055,29.381893157958984,KO,Food and Beverage Picks for 2013: Kellogg and PepsiCo ||| The Future of Coke Tastes Funny ||| The Future of Coke Tastes Funny,0,0.48111582
2013-01-08,14324300.0,37.18999862670898,37.27999877929688,36.90999984741211,37.040000915527344,29.17708778381348,KO,Coca-Cola China Seeking Police Probe Related to Fungicide Rumor - Xinhua,0,0.48909712
2013-01-10,15603700.0,37.119998931884766,37.16999816894531,36.7599983215332,36.959999084472656,29.11406135559082,KO,McDonald's: A Value Stock with Growth Potential ||| Argus Research Downgrades Coca-Cola Company (The) to Hold,0,0.5078924
2013-01-15,12721600.0,36.9900016784668,37.43000030517578,36.79999923706055,37.31999969482422,29.39764213562012,KO,Coca-Cola's Anti-Obesity Ad on Air - Analyst Blog ||| Coca-Cola's Cahillane Comments on Obesity ||| Coke Wins Unofficial Taste Test Against Pepsi ||| Can Fast Food Lovers Cram Into Smaller Cars?,0,0.5019062
2013-01-16,9168000.0,37.209999084472656,37.41999816894531,37.119998931884766,37.31999969482422,29.39764213562012,KO,Options for Beginners: An Interview with our Top Expert ||| Exclusive Shows from Yahoo and Sony - Analyst Blog,1,0.527274
2013-01-18,14056100.0,37.4900016784668,37.709999084472656,37.310001373291016,37.70000076293945,29.69698143005371,KO,SunTrust Beats on Higher Top Line - Analyst Blog ||| Why Smart Investors Are Pouring Trillions into This Type Of Stock ||| S&P Highlights 1 ETF For Lengthy Streaks of Dividend Increases,0,0.5031448
2013-01-22,21249400.0,37.7400016784668,37.7400016784668,37.04999923706055,37.130001068115234,29.24797821044922,KO,"These 3 Unheralded Stocks Have Lengthy Dividend Increase Streaks ||| 4 Ways Income Investors Can Protect Against Inflation ||| 4 Ways Income Investors Can Protect Against Inflation ||| These 3 Unheralded Stocks Have Lengthy Dividend Increase Streaks ||| Market Close Report: NASDAQ Composite index closes at 3,143.18 up 8.47 points ||| The Dow Rallies Above 13,700 While Small-Caps Step to New Highs ||| Staples Stocks Looking Pricey, Says Koesterich",0,0.47817564
2013-01-24,13258900.0,37.20000076293945,37.25,37.0,37.11000061035156,29.23221969604492,KO,"After Hours Most Active for Jan 24, 2013 : MSFT, QQQ, AMGN, NOK, SBUX, PFE, MRK, BAC, HIG, NWSA, KO, INTC ||| Neutral on Coca-Cola Enterprises - Analyst Blog ||| Top Ranked Consumer Staples ETF in Focus - ETF News And Commentary",0,0.4893218
2013-01-28,13386500.0,37.06999969482422,37.11000061035156,36.86000061035156,37.0099983215332,29.1534423828125,KO,"Delectable Small-Cap Food And Beverage Stocks ||| KOF Closes Deal with Coke's Bottler - Analyst Blog ||| Yacktman Buys Dell, a Company that Wants to Go Private - Yacktman Fund 4th Quarter Update ||| Super Bowl Ads that May Affect Your Portfolio",1,0.4843403
2013-01-29,17705800.0,36.880001068115234,37.56999969482422,36.86000061035156,37.41999816894531,29.47641372680664,KO,"Yacktman Fund Buys Dell Inc, Stryker Corporation, Coca-cola Co, Sells H&R Block Inc, ...",1,0.52412575
2013-01-31,12969100.0,37.52999877929688,37.52999877929688,37.11000061035156,37.2400016784668,29.334630966186523,KO,"How Fantasy Baseball Taught Me Everything I Need To Know About Investing ||| Beam Inc. (BEAM) Ex-Dividend Date Scheduled for February 04, 2013",1,0.4728977
2013-02-01,11932600.0,37.540000915527344,37.709999084472656,37.369998931884766,37.540000915527344,29.570934295654297,KO,"""Retirement Savings Stocks"" Yielding Up To 14% ||| Why Warren Buffett Hates Gold ||| The Week Ahead: Earnings from Visa, Coke, Sprint; ECB Decision",0,0.48855573
2013-02-04,9456300.0,37.47999954223633,37.58000183105469,37.29999923706055,37.34999847412109,29.42127227783203,KO,Coke's Latest Super Bowl Ad is a Clever Battle for Hydration ||| Pepsi's Super Bowl 2013 Ad Fails to Convey a Tasty Message ||| Coca-Cola Enterprises' 4Q Preview - Analyst Blog ||| SodaStream Falls Despite Super Bowl Ad ||| The Best and Worst Super Bowl Ads,1,0.49298793
2013-02-05,17897300.0,37.560001373291016,38.15999984741211,37.560001373291016,38.13999938964844,30.043567657470703,KO,Green Mountain Coffee Roasters Earnings Preview: Strong Revenue Growth Expected,1,0.5464845
2013-02-06,16823700.0,38.130001068115234,38.43000030517578,38.0,38.310001373291016,30.17748069763184,KO,"Stock Market News for February 6, 2013 - Market News ||| Coca-Cola Enterprises Hikes Dividend - Analyst Blog ||| As Staples Rise, Consider Alternatives to XLP",1,0.5000137
2013-02-07,18805300.0,38.41999816894531,39.060001373291016,38.34999847412109,38.90999984741211,30.650117874145508,KO,Coca Cola Enterprises' 4Q Mixed - Analyst Blog,0,0.5300712
2013-02-08,12308000.0,38.84999847412109,38.93999862670898,38.59999847412109,38.77000045776367,30.53983688354492,KO,"Earnings Preview: Coca-Cola - Analyst Blog ||| The Week Ahead: Earnings from McGraw-Hill, Cisco, Pepsi; Chinese New Year",0,0.50042444
2013-02-11,12159900.0,38.709999084472656,38.83000183105469,38.40999984741211,38.61000061035156,30.41380500793457,KO,"Coca-Cola Earnings Preview: EPS and Revenue Growth Expected ||| Earnings Expectations for the Week of February 11 ||| Will PepsiCo Beat in 4Q? - Analyst Blog ||| A Look Ahead: This Week's ETFs to Watch ||| Pre-Market Earnings Report for February 12, 2013 : KO, TRP, RAI, HCP, MMC, OMC, MHP, KORS, FIS, AVP, FOSL, VAL ||| A Look Ahead: This Week's ETFs to Watch",0,0.47113824
2013-02-12,30700500.0,38.11000061035156,38.15999984741211,37.27999877929688,37.560001373291016,29.58669662475586,KO,"Coca-Cola EPS Beats, Sales Lag - Analyst Blog ||| The State of our Economy is Good - Ahead of Wall Street ||| Market Close Report: NASDAQ Composite index closes at 3,186.49 down -5.51 points ||| Dow Picks Up Steam, Breaks Back Through 14,000 ||| Market Wrap for Tuesday, February 12: Stocks Close Mixed as Apple Drags Down Nasdaq ||| Coca-Cola's Q4 Results Highlight Challenges; Stock Falls ||| From Coca-Cola Q4 Call: Sees 2013 In Line with Long-Term Targets ||| Muhtar Kent Criticizes Mayor Bloomberg on Obesity Policies ||| UPDATE: Coca-Cola Posts Higher Q4 Earnings ||| Coca-Cola Q4 Sales $11.46B vs $11.55B Est. ||| Coca-Cola Company (The) Reports Q4 EPS of $0.45 vs $0.44 Est ||| Benzinga Market Primer: Tuesday, February 12 ||| US Stock Futures Slightly Lower Ahead Of Economic Data, Coca-Cola Earnings ||| Earnings Scheduled For February 12, 2013 ||| Stocks To Watch For February 12, 2013",0,0.48963872
2013-02-13,19943800.0,37.66999816894531,37.93999862670898,37.0099983215332,37.209999084472656,29.31098937988281,KO,Dismal Quarter & Year for Dr Pepper - Analyst Blog ||| PepsiCo Pre-Earnings: Snacking On Emerging Markets Growth,0,0.52096534
2013-02-14,22748600.0,37.2400016784668,37.5099983215332,36.70000076293945,36.84000015258789,29.01953887939453,KO,"Latest Picks From Bill Gates Foundation: Buys Coca-Cola, Procter & Gamble, Wal-Mart ... ||| Berkshire Hathaway Buys Wells Fargo, DaVita HealthCare, Sells Kraft Foods, Johnson & Johnson ||| Dow Finishes Down But Only Barely ||| Coca-Cola Slurps Up Growth Led By Emerging Markets ||| PepsiCo Reports Strong Quarter - Analyst Blog",1,0.48612872
2013-02-15,25204300.0,36.93999862670898,37.41999816894531,36.540000915527344,37.41999816894531,29.47641372680664,KO,"Market Close Report: NASDAQ Composite index closes at 3,192.03 down -6.63 points ||| Dow Closes a Second Week in the Red, Despite Late Rally ||| Heinz $28 Bn Acquisition Price Implies Faster Global Growth And Thicker Margins Ahead ||| Coca-Cola Has Released These Snazzy Marc Jacobs-Designed Diet Coke Cans ||| Hearing Monster Beverage Denies Takeover Chatter ||| Hearing Monster Strength Attributed to Renewed Coke Takeover Chatter",1,0.5267156
2013-02-19,14850600.0,37.5099983215332,37.77000045776367,37.459999084472656,37.66999816894531,29.67334175109864,KO,"Benzinga's M&A Chatter for Friday February 15, 2013 ||| The Top Stocks Held by the Most Guru Investors ||| Low-Calorie Restaurant Offerings, a Better Bottom Line? ||| New Soft Drinks Coming in 2013 ||| Is This ETF Home to Buffett's Next Target?",1,0.49155328
2013-02-21,14135100.0,37.619998931884766,37.790000915527344,37.43000030517578,37.709999084472656,29.7048454284668,KO,Look to SodaStream for Some Pop This Earnings Season ||| Coca-Cola Raises Annual Dividend from $1.02 to $1.12/Share,1,0.506503
2013-02-22,20102800.0,37.7599983215332,38.52000045776367,37.709999084472656,38.52000045776367,30.34290313720703,KO,"Bloomberg Reporting Coca-Cola to Buy Majority of Innocent Founders' Remaining Shares ||| From Coca-Cola's CAGNY Presentation: Targeting Long-Term EPS Growth in High Single Digits, Sales Growth 5-6%",0,0.51365197
2013-02-25,15874600.0,38.560001373291016,38.720001220703125,37.720001220703125,37.720001220703125,29.71272659301757,KO,"Coca-Cola Enhances Annual Dividend - Analyst Blog ||| Pepsico, Inc. (PEP) Ex-Dividend Date Scheduled for February 27, 2013 ||| Diageo plc (DEO) Ex-Dividend Date Scheduled for February 27, 2013 ||| Tigress Financial Earlier Initiated P&G, Colgate-Palmolive, Coca-Cola, Pepsi at Neutral",1,0.46835944
2013-02-26,15770000.0,37.95000076293945,38.18999862670898,37.77999877929688,38.11000061035156,30.01994132995605,KO,PepsiCo Reaches 52-Week High - Analyst Blog ||| 3 Unstoppable Dividend Stocks - Investment Ideas,1,0.5072637
2013-02-28,19005500.0,38.470001220703125,38.970001220703125,38.41999816894531,38.720001220703125,30.500444412231445,KO,PepsiCo Launches New Flavor of Chips - Analyst Blog ||| FEMSA's 4Q Beats Estimate - Analyst Blog,0,0.53573984
2013-03-01,13724500.0,38.4900016784668,38.790000915527344,38.4900016784668,38.70000076293945,30.48468971252441,KO,"US Judge Denies Coca-Cola Bid to Dismiss Consumers' Claims Related to Labeling of Simply Orange, Minute Maid Juice ||| Buffett Says Ownership in IBM, Coke, AmEx and Wells Fargo 'Likely to Increase'",1,0.53620607
2013-03-04,9934300.0,38.59999847412109,38.81999969482422,38.45000076293945,38.81999969482422,30.579221725463867,KO,"Nordstrom Expands Buyback, Ups Div - Analyst Blog ||| Coca-Cola Prices Senior Notes - Analyst Blog ||| DPS Acquires Bottling Company - Analyst Blog ||| Coca-Cola Enterprises, Inc. (CCE) Ex-Dividend Date Scheduled for March 06, 2013 ||| Companhia de Bebidas das Americas - AmBev (ABV) Ex-Dividend Date Scheduled for March 06, 2013 ||| No Surprise: Staples ETFs Gain Bullish Analyst Views ||| Warren Buffett on CNBC Calls Wells Fargo 'Cheaper Than Coke Right Now'",0,0.45360622
2013-03-05,13240700.0,38.97999954223633,39.0,38.560001373291016,38.68000030517578,30.46894073486328,KO,"Mixed Cheetos Bag from PepsiCo - Analyst Blog ||| Warren Buffett Mentions Top 4 Companies to Shareholders ||| DPS Buys Back Rights from Mondelez - Analyst Blog ||| Gap's Q4 Earnings: Strong Results And Better Outlook ||| Market Close Report: NASDAQ Composite index closes at 3,224.13 up 42.10 points ||| Department of Energy in Deal with Coca-Cola, Dell, Facebook, Private Industry Partnerships",1,0.50442445
2013-03-06,11653900.0,38.79999923706055,39.040000915527344,38.70000076293945,39.02000045776367,30.736766815185547,KO,Overbought ETFs: Buy These Two Anyway ||| Hedging The Dow At Its All-Time High,1,0.5044549
2013-03-07,15094900.0,39.040000915527344,39.18999862670898,38.84000015258789,39.119998931884766,30.815540313720703,KO,Ford to Sell Vehicles in Myanmar - Analyst Blog ||| Femsa Spreads Through Mexico - Analyst Blog,1,0.54494345
2013-03-11,9200400.0,39.20000076293945,39.380001068115234,39.18000030517578,39.310001373291016,30.965198516845703,KO,"Barron's Recap for March 9: Wall Street's Favorite Guru ||| Is It Time For Investors to Go Greek? ||| Coca-Cola Company (KO) Ex-Dividend Date Scheduled for March 13, 2013 ||| Dr Pepper Snapple Group, Inc (DPS) Ex-Dividend Date Scheduled for March 13, 2013 ||| Golden Crosses Over The Past Trading Week (50 SMA Cross Above 200 SMA) ||| CNBC Reporting Judge Halts NYC Soda Ban ||| Judge Blocks New York City's Ban on Large-Size Sugary Drinks ||| Moody's Raises Outlook on Global Beverage Industry from Stable to Positive, Sees Emerging Middle Class Driving Demand ||| Is It Time For Investors to Go Greek?",0,0.48005185
2013-03-12,11375900.0,39.27999877929688,39.310001373291016,38.79999923706055,38.959999084472656,30.689502716064453,KO,Investors were Unfazed by NYC Soda Ban,0,0.49702153
2013-03-13,14358300.0,38.81999969482422,38.869998931884766,38.54999923706055,38.59000015258789,30.61809730529785,KO,Buffett's Most Profitable Deals Good Businesses at Fair Prices or Vice Versa?,1,0.49637508
2013-03-14,14572500.0,38.81999969482422,39.119998931884766,38.65999984741211,39.02000045776367,30.95926284790039,KO,"Warren Buffett - The Big Four, High Conviction Stocks ||| UPDATE: Bank of America Reiterates Coca-Cola at Buy on Solid Footing for 2013 ||| Benzinga's Top Upgrades ||| Credit Agricole Upgrades Coca-Cola Company (The) to Outperform, Raises PT to $43.00",0,0.51364785
2013-03-15,20781900.0,38.81999969482422,38.93999862670898,38.65999984741211,38.83000183105469,30.80852127075196,KO,What Matters More: Today's Value or Tomorrow's Returns?,0,0.50669193
2013-03-18,11479900.0,38.61000061035156,38.93999862670898,38.56999969482422,38.7599983215332,30.75297164916992,KO,Golden Crosses Over The Past Trading Week (50 SMA Cross Above 200 SMA),1,0.51488894
2013-03-19,15192000.0,38.91999816894531,39.400001525878906,38.81999969482422,39.33000183105469,31.205223083496094,KO,"2 Ways to Profit from the Next Global Economic Powerhouse ||| Vina Concha Y Toro (VCO) Ex-Dividend Date Scheduled for March 21, 2013 ||| Market Close Report: NASDAQ Composite index closes at 3,229.10 down -8.49 points ||| Coca Cola Testing $39.15 Resistance, Breakout In Play ||| Benzinga Market Primer: Tuesday, March 19",1,0.52916855
2013-03-20,19271900.0,39.400001525878906,39.91999816894531,39.36000061035156,39.869998931884766,31.63367080688477,KO,"Stock Market News for March 20, 2013 - Market News ||| Market Close Report: NASDAQ Composite index closes at 3,254.19 up 25.09 points ||| Dow Hits Another New High as Investors Digest Fed Remarks ||| Here's a Nominee For Worst Analyst Call of 2013 ||| These Four NCAA Tournament Sponsors Might Make Your Portfolio Some Serious Money",1,0.46895957
2013-03-21,23063600.0,39.84999847412109,40.43000030517578,39.7599983215332,40.06999969482422,31.7923583984375,KO,Markets Drop On European Fears ||| Coca Cola Cuts 750 Jobs in US,0,0.5113408
2013-03-25,15718400.0,40.11000061035156,40.25,39.959999084472656,40.119998931884766,31.83203125,KO,"Weekly Top Insider Sells ||| Dr Pepper Reaches 52-Week High - Analyst Blog ||| After Hours Most Active for Mar 25, 2013 : CX, FB, MSFT, AIG, KO, MS, QQQ, PHH, ORCL, BAC, INTC, CHKP ||| U.S. Staples ETFs Are Expensive, But So Are EM Equivalents",1,0.4943532
2013-03-27,14559900.0,40.45000076293945,40.540000915527344,40.060001373291016,40.220001220703125,31.9113712310791,KO,Coca-Cola Kept at Neutral - Analyst Blog ||| Keeping Coca-Cola Shares From Going Flat,1,0.51573914
2013-04-01,8200500.0,40.38999938964844,40.4900016784668,40.16999816894531,40.45000076293945,32.09385299682617,KO,"Benzinga Market Primer: Monday, April 1 ||| Dr Pepper Extends Sponsorship Deal - Analyst Blog ||| FEMSA Stays at Neutral - Analyst Blog ||| Option Alert: Coca Cola August 31 Put; 4,000 Contracts Traded vs 320 Open Interest; Currently $40.42 ||| Revisiting Beating Buffett With ETFs ||| Benzinga Market Primer: Monday, April 1",1,0.51813793
2013-04-03,13639200.0,40.77999877929688,40.81999969482422,40.08000183105469,40.16999816894531,31.8716983795166,KO,Coca-Cola Enterprises Stays Neutral - Analyst Blog,1,0.53683764
2013-04-04,11435900.0,40.27000045776367,40.59000015258789,40.20000076293945,40.540000915527344,32.165260314941406,KO,Coca-Cola Launches Bottled Green Tea in Taiwan -WantChinaTimes,0,0.51327723
2013-04-05,10729500.0,40.209999084472656,40.36000061035156,40.0099983215332,40.08000183105469,31.80029487609864,KO,"A $100 Billion Cannon Is Pointed At These Takeover Targets ||| A $100 Billion Cannon Is Pointed At These Takeover Targets ||| PepsiCo in Neutral Lane - Analyst Blog ||| Warren Buffett, Donald Yacktman and Kyle Bass All Favoring Consumer Stocks",1,0.48465616
2013-04-08,22757900.0,40.060001373291016,40.869998931884766,39.77000045776367,40.86000061035156,32.419158935546875,KO,"Sprott Asset Management - As Currency Alternative, Time For Gold Is Now ||| Coca-Cola's Valuation, Warren Buffett's 1988 Purchase ||| Earnings Expectations for the Week of April 8 ||| These Are the 100 Highest-Paid CEOs in Business Today",0,0.49033955
2013-04-09,21056100.0,40.810001373291016,41.130001068115234,40.5099983215332,40.709999084472656,32.300140380859375,KO,"Compania Cervecerias Unidas, S.A. (CCU) Ex-Dividend Date Scheduled for April 10, 2013 ||| After Hours Most Active for Apr 9, 2013 : LO, QQQ, T, MSFT, KO, ORCL, KRG, CSCO, AA, MTCN, MU, FB ||| Coca Cola Attempting A Breakout Over $40.80 Resistance",1,0.47938466
2013-04-10,9703700.0,40.77999877929688,41.16999816894531,40.709999084472656,41.06999969482422,32.58576583862305,KO,Coca-Cola Reaches 52-Week High - Analyst Blog,1,0.5419704
2013-04-11,10962500.0,41.130001068115234,41.40999984741211,41.060001373291016,41.18000030517578,32.67304992675781,KO,Dr Pepper Remains Neutral - Analyst Blog ||| Shocker: A Bullish Call on Staples ETFs,0,0.5055362
2013-04-12,10394700.0,40.90999984741211,41.11000061035156,40.68000030517578,41.08000183105469,32.59370803833008,KO,"Yacktman Fund - Texas Billionaire Guru Adds and Sells First Quarter ||| Weekly Preview: Earnings Season Kicks Into High Gear ||| Davenport Downgrades Coca-Cola Company (The) to Neutral, Removes $42.00 PT",0,0.4927336
2013-04-15,16050600.0,40.84999847412109,40.9900016784668,40.04999923706055,40.09000015258789,31.808223724365234,KO,"Earnings Expectations for the Week of April 15 ||| Pre-Market Earnings Report for April 16, 2013 : JNJ, KO, GS, USB, BLK, GWW, NTRS, AMTD, CMA, WWW, MBWM ||| Billion-Dollar Fund Managers Swear By This Investing Method ||| Stocks to Watch for the Week of April 15, 2013 ||| Deutsche Bank Maintains Buy on Coca-Cola Company (The), Raises PT to $45.00",1,0.48257113
2013-04-16,32135700.0,41.400001525878906,42.47999954223633,41.25,42.369998931884766,33.617218017578125,KO,"The Markets Now: Stocks Rebound After Yesterday's Sell-Off ||| U.S. Markets Post Sharp Gains After Monday Sell-Off; Coca-Cola Hits 52-Week Top on Earnings ||| Weekly CFO Sells Highlight: KO, KKD, PIR, NPSP, ACAD ||| Mid-Morning Market Update: Markets Surge, Goldman Sachs Profit Rises ||| Pre-Market Primer: Stocks, Gold Rebound; Housing Starts Ramp Up ||| Market Close Report: NASDAQ Composite index closes at 3,264.63 up 48.14 points ||| Stocks Bounce Back on Strong Domestic Data ||| Mid-Morning Market Update: Markets Surge, Goldman Sachs Profit Rises ||| UPDATE: Coca-Cola Q1 Profit Rises 15% ||| Coca-Cola Q1 Sales $11.05B vs $10.94B Est ||| Coca-Cola Company (The) Reports Q1 EPS of $0.46 vs $0.45 Est ||| Coca-Cola Announces Deal for New, Expanded Territories with 5 US Bottlers ||| Benzinga Market Primer: Tuesday, April 16 ||| US Stock Futures Signal Higher Start On Wall Street ||| Earnings Scheduled For April 16, 2013 ||| Stocks To Watch For April 16, 2013",1,0.49527532
2013-04-17,24208000.0,42.13999938964844,42.70000076293945,42.02999877929688,42.54999923706055,33.760040283203125,KO,"Bank of America Maintains Buy on Coca-Cola Company (The), Raises PO to $46.00 ||| Coca Cola Attempting To Breakout Over $42.50 Resistance, Bullish MACD Cross On Daily ||| Coca-Cola Returning to a Franchise Model – With Conditions ||| UPDATE: Bank of America Raises PT on The Coca-Cola Company on Good 1Q13 EPS ||| Benzinga Market Primer: Wednesday, April 17 ||| Bank of America Maintains Buy on Coca-Cola Company (The), Raises PO to $46.00 ||| Top 4 Large-Cap Stocks In The Beverages-Soft Drinks Industry With The Highest Operating Margin",0,0.5084181
2013-04-18,16034200.0,42.47999954223633,42.650001525878906,42.09000015258789,42.09999847412109,33.40298843383789,KO,Coca-Cola Offers Caffeine Free Coke - Analyst Blog ||| Yield on Cost Is Warren Buffett's Coca-Cola Magic ||| 4 Well-Known Stocks With Big-Time Dividend Growth,1,0.49776894
2013-04-19,13875800.0,42.27999877929688,42.77000045776367,42.20000076293945,42.65999984741211,33.847312927246094,KO,"SunTrust Beats on Earnings, Rev Lags - Analyst Blog ||| PepsiCo Beats Earnings in 1Q13, Up Y/Y - Analyst Blog ||| Non-Streak Dividend ETFs Impress ||| S&P Likes The Biggest Dividend ETF",1,0.50151956
2013-04-22,10544100.0,42.52000045776367,42.84999847412109,42.400001525878906,42.720001220703125,33.89491271972656,KO,"Global Investor Tom Russo's Top Six Holdings ||| Anheuser-Busch Inbev SA (BUD) Ex-Dividend Date Scheduled for April 23, 2013",0,0.4650924
2013-04-24,11368200.0,42.63999938964844,42.900001525878906,42.09999847412109,42.150001525878906,33.44267272949219,KO,"Chart of the Day: Are Defensive Stocks Enough to Carry the S&P? ||| Markets Grind Sideways Despite Volatile Earnings ||| Warren Buffett Making Special Appearance at Coca-Cola Annual Shareholder Meeting, Says He'll Never Sell a Shore of Coke",1,0.49222374
2013-04-25,10197100.0,42.2599983215332,42.540000915527344,42.08000183105469,42.34999847412109,33.601348876953125,KO,"FEMSA 1Q Earnings Lag Estimate - Analyst Blog ||| CCE Beats 1Q Earnings; Misses Rev - Analyst Blog ||| Coca Cola Femsa S.A.B. de C.V. (KOF) Ex-Dividend Date Scheduled for April 26, 2013 ||| If I Could Buy Just One Stock, It Would Be This One",0,0.48349512
2013-04-30,13432200.0,42.150001525878906,42.38999938964844,41.880001068115234,42.33000183105469,33.58548355102539,KO,"Coca-Cola Bottling Co. Consolidated (COKE) Ex-Dividend Date Scheduled for May 01, 2013",0,0.46487778
2013-05-01,8710600.0,42.150001525878906,42.560001373291016,42.13999938964844,42.209999084472656,33.49027633666992,KO,"Fomento Economico Mexicano S.A.B. de C.V. (FMX) Ex-Dividend Date Scheduled for May 02, 2013",0,0.4612771
2013-05-02,18709600.0,41.65999984741211,42.15999984741211,41.4900016784668,41.959999084472656,33.29191970825195,KO,"Market Close Report: NASDAQ Composite index closes at 3,340.62 up 41.49 points ||| Economic News, ECB Spark Another Record-Setting Day",1,0.51224214
2013-05-03,11757800.0,42.16999816894531,42.41999816894531,41.959999084472656,42.2400016784668,33.51407623291016,KO,"Texas-Sized Big Buys by Yacktman ||| Beam Inc. (BEAM) Ex-Dividend Date Scheduled for May 06, 2013 ||| Mother's Day: 9 Gifts That Are Way Cooler Than a Bouquet of Flowers ||| Three Sector ETFs Up 20% or More YTD",0,0.49927437
2013-05-06,9356100.0,42.290000915527344,42.290000915527344,41.869998931884766,42.08000183105469,33.38713073730469,KO,"Don Yacktman - ""Viewing Stocks as Bonds"" ||| Wealthtrack Interviews Financial Thought Leader Charles Ellis ||| A Look Ahead: This Week's ETFs to Watch ||| Warren Buffett Takes Center Stage Again After Shareholders' Meeting ||| Warren Buffett Takes Center Stage Again After Shareholders' Meeting ||| Warren Buffett on CNBC's Squawk Box Says IBM 'Not as Bulletproof as Coca-Cola'",1,0.4953543
2013-05-07,13785300.0,42.209999084472656,42.709999084472656,42.150001525878906,42.70000076293945,33.8790397644043,KO,"In Insider Trades, Big Sales at Moody's and Facebook, Major Purchases at Wausau Paper and Ecolab ||| PepsiCo Hikes Dividend, Yet Again - Analyst Blog",0,0.51831156
2013-05-08,12636300.0,42.540000915527344,42.68000030517578,42.15999984741211,42.459999084472656,33.688629150390625,KO,Wendy's CEO Says Company iss Adding Free Style Beverage Machines From Coca-Cola,0,0.5255043
2013-05-13,9291000.0,42.13999938964844,42.43999862670898,42.0,42.18999862670898,33.474395751953125,KO,Comparing Windows 8 to New Coke is Just Plain Mean,1,0.5042382
2013-05-14,13023900.0,42.18000030517578,42.66999816894531,42.0099983215332,42.52000045776367,33.736236572265625,KO,FEMSA Expands Drugstore Chain - Analyst Blog,1,0.5328743
2013-05-15,12306200.0,42.5,43.09999847412109,42.38999938964844,42.91999816894531,34.05359649658203,KO,"Warren Buffett Buys Wells Fargo, Chicago Bridge & Iron Co. ... ||| Summary of Jana Partners 13F: Aetna, Expedia and Kinder Morgan All Raised Among Others",1,0.49883035
2013-05-16,12330000.0,42.90999984741211,43.43000030517578,42.790000915527344,43.09000015258789,34.1884765625,KO,Some Dividend ETFs Outperforming The S&P 500 ||| Investors Are Making This Classic Mistake -- Again ||| Dr Pepper Snapple Hits 52-Week High - Analyst Blog,0,0.5086856
2013-05-20,9966000.0,42.95000076293945,42.95000076293945,42.29999923706055,42.380001068115234,33.62516021728516,KO,Molson Coors Reaches 52-Week High - Analyst Blog,0,0.5244306
2013-05-21,9148800.0,42.47999954223633,42.560001373291016,42.06999969482422,42.34000015258789,33.59341049194336,KO,BMO Capital Initiates Coverage on Coca-Cola Company (The) at Market Perform,0,0.53474444
2013-05-22,13615600.0,42.27999877929688,42.86000061035156,42.040000915527344,42.25,33.522010803222656,KO,"Hershey's First New Brand Ex U.S. - Analyst Blog ||| PepsiCo Kept at Neutral - Analyst Blog ||| New Stock Coverage: Pepsi Poised to Pop ||| Apple Tops New WisdomTree Dividend ETF ||| Apple Tops New WisdomTree Dividend ETF ||| UPDATE: BMO Capital Markets Initiates Coverage on Coca-Cola with Market Perform Rating, $45 PT on Modest Near-Term Growth Outlook",0,0.50364536
2013-05-23,10934200.0,41.93000030517578,42.06999969482422,41.560001373291016,41.93000030517578,33.26811981201172,KO,Coca-Cola FEMSA Issues Yield Bond - Analyst Blog,1,0.53436375
2013-05-28,14412100.0,42.59999847412109,43.04999923706055,42.400001525878906,42.54999923706055,33.760040283203125,KO,"Molson Coors Brewing Company (TAP) Ex-Dividend Date Scheduled for May 29, 2013 ||| Top 4 Large-Cap Stocks In The Beverages-Soft Drinks Industry With The Highest Profit Margin",0,0.48443672
2013-05-29,16986600.0,42.34000015258789,42.43000030517578,41.310001373291016,41.400001525878906,32.847599029541016,KO,"Market Close Report: NASDAQ Composite index closes at 3,467.52 down -21.37 points",0,0.507835
2013-06-04,19241000.0,41.59000015258789,41.720001220703125,40.95000076293945,41.41999816894531,32.86346435546875,KO,"The Bright Side of College Costs, Sudden Storms, and an Overweight Nation: The Market for Good News ||| Stock Market News for June 4, 2013 - Market News ||| Coca-Cola Enterprises, Inc. (CCE) Ex-Dividend Date Scheduled for June 05, 2013 ||| Pepsico, Inc. (PEP) Ex-Dividend Date Scheduled for June 05, 2013 ||| The Market's Tuesday Luck Fades, as Sellers Take the Reins ||| Benzinga's M&A Chatter for Tuesday June 4, 2013 ||| Hearing Unconfirmed Chatter of Coke Bid for SodaStream ||| With Bond Yields So Low, Reluctant Investors Are Now Making the Move into These Stocks ||| Coca-Cola Opens Bottling Plant in Myanmar",0,0.4635908
2013-06-05,16429300.0,41.400001525878906,41.400001525878906,40.59999847412109,40.650001525878906,32.252540588378906,KO,"As Consumers Demand 'Natural,' Stevia Set to Become Blockbuster Product ||| X Factor: 5 Stocks Reaching Their Ex-Dividend Date on June 12 ||| KO Opens Bottling Plant in Myanmar - Analyst Blog",1,0.535886
2013-06-06,11171600.0,40.54999923706055,40.790000915527344,40.310001373291016,40.790000915527344,32.363609313964844,KO,"Own These World's Leading Brands And Never Fear A Recession Again ||| Tiger Woods Back to World's Highest Paid Athlete, Thanks to Lucrative Nike, Electronic Arts Deals ||| Hearing JPM Morgan Says Pepsi Buyout of SodaStream Unlikely, Partneship More Likely ||| Coca-Cola Spokespersson Declines Comment on SodaStream Bid Rumor ||| Bloomberg Reporting Pepsi's Wilkinson Says SodaStream Rumor 'Completely Untrue' ||| PepsiCo Wants to Buy SodaStream ||| UPDATE: PepsiCo Reportedly in Talks to Acquire SodaStream for as Much as $95/Share -Calcalist",1,0.50696474
2013-06-07,14459600.0,41.20000076293945,41.72999954223633,40.97999954223633,41.40999984741211,32.85553359985352,KO,Key Investing Takeaways from Warren Buffett's 2013 Shareholder Meeting,0,0.51014435
2013-06-10,11247400.0,41.5,41.52000045776367,41.040000915527344,41.18000030517578,32.67304992675781,KO,KO Launches POWERADE ZERO DROPS - Analyst Blog,0,0.5240559
2013-06-11,16491600.0,40.880001068115234,40.97999954223633,40.400001525878906,40.790000915527344,32.363609313964844,KO,SodaStream Hits a 52-Week High - Analyst Blog ||| NYC Asks Appeals Panel to Reinstate Large Soda Ban,0,0.5109792
2013-06-12,11611100.0,40.790000915527344,40.93999862670898,40.27999877929688,40.38999938964844,32.26774978637695,KO,CCE's Second Quarter to be Weak - Analyst Blog,1,0.5162789
2013-06-13,17861200.0,40.310001373291016,40.47999954223633,39.68000030517578,40.40999984741211,32.28371810913086,KO,"With Clever New Ads, SodaStream International Ltd. Takes Aim at Big Soda",0,0.513234
2013-06-14,13635100.0,40.380001068115234,40.790000915527344,40.2599983215332,40.34000015258789,32.22780227661133,KO,Searching For Bargains From Warren Buffett's Portfolio Using Peter Lynch Chart ||| 10 Food Stocks With Tasty Potential,1,0.51736087
2013-06-17,12409200.0,40.540000915527344,40.90999984741211,40.400001525878906,40.68000030517578,32.49943542480469,KO,Monster Slumps on Possible AMA Ban Endorsement - Analyst Blog ||| SPX Likely Headed Higher as 'Taper Tantrum' Fades,1,0.51988643
2013-06-18,9893100.0,40.70000076293945,40.9900016784668,40.56999969482422,40.93000030517578,32.69915771484375,KO,American Medical Association Calls for Ban on Advertising Energy Drinks to Kids ||| One Simple Measure for Investing in a Volatile Market,0,0.50258976
2013-06-19,16936100.0,41.0099983215332,41.43999862670898,40.40999984741211,40.40999984741211,32.28371810913086,KO,"Labor Market's Loss = Investors' Gain: Worth it? - Analyst Blog ||| UPDATE: Credit Suisse Initiates Coca-Cola at Outperform on Positive Outlook ||| Credit Suisse Initiates Coverage on Coca-Cola Company (The) at Outperform, Announces $48.00 PT",0,0.5100805
2013-06-20,24899700.0,40.27000045776367,40.34999847412109,38.970001220703125,39.130001068115234,31.26112365722656,KO,Don't Be Fooled By The Fancy Name -- Statistical Arbitrage Is A Simple Way To Profit ||| Whirlpool's KitchenAid Inks Deal (Revised) - Analyst Blog ||| Can Dr Pepper Snapple's Spirit Airlines Deal Help The Stock?,1,0.5153256
2013-06-21,21938300.0,39.630001068115234,39.970001220703125,39.29999923706055,39.7599983215332,31.764442443847656,KO,Dr Pepper Kept at Neutral - Analyst Blog,0,0.5222135
2013-06-24,16433700.0,39.45000076293945,40.0099983215332,39.130001068115234,39.52999877929688,31.580690383911133,KO,"Stock Market News for June 24, 2013 - Market News ||| SunTrust Robinson Humphrey Initiates Coverage on Coca-Cola Company (The) at Buy, Announces $47.00 PT",1,0.48791295
2013-06-25,12942100.0,39.81999969482422,39.93000030517578,39.43999862670898,39.720001220703125,31.73248291015625,KO,"COCA COLA HELLENIC BOTTLING CO (CCH) Ex-Dividend Date Scheduled for June 26, 2013 ||| The Powerful Chart That Made Peter Lynch 29% a Year for 13 Years",1,0.504408
2013-07-01,10754300.0,40.5,40.91999816894531,40.36000061035156,40.459999084472656,32.323673248291016,KO,Barron's Recap: World's Most Respected Companies,0,0.49816266
2013-07-02,12248300.0,40.470001220703125,40.7400016784668,40.18000030517578,40.369998931884766,32.25177001953125,KO,The Comprehensive Guide to Consumer Staples ETFs - ETF News And Commentary ||| This 'Forever' Stock Could Return At Least 30%,1,0.5105052
2013-07-05,10402200.0,40.720001220703125,40.79999923706055,40.150001525878906,40.52000045776367,32.371604919433594,KO,Where to Invest Excess Money,1,0.529471
2013-07-08,9936300.0,40.650001525878906,40.7599983215332,40.41999816894531,40.540000915527344,32.38758087158203,KO,"Earnings Expectations for the Week of July 8 (AA, JPM, WFC) ||| Coca-Cola to Launch Slim Cans ??? FT - Analyst Blog ||| Three Inverse ETFs For The Second Half ||| Benzinga's Top Pre-Market Losers",1,0.51539993
2013-07-09,8760500.0,40.86000061035156,41.06999969482422,40.720001220703125,40.83000183105469,32.6192741394043,KO,"Roth Suggests Buying the Dip in SodaStream, Says Coke, Pepsi Rumors Were Never Probable",0,0.49892876
2013-07-12,10686400.0,41.02999877929688,41.130001068115234,40.72999954223633,41.02999877929688,32.77904510498047,KO,Weekly Preview: Earnings Back With A Bang,0,0.51111954
2013-07-15,11418400.0,41.04999923706055,41.25,40.93000030517578,41.0099983215332,32.7630615234375,KO,"Earnings Expectations for the Week of July 15 ||| Stocks to Watch for the Week of July 15, 2013",0,0.45969933
2013-07-16,33575600.0,39.77999877929688,40.5,39.5,40.22999954223633,32.13992691040039,KO,"Dow Finishes in the Red as Wall Street Awaits Bernanke Remarks ||| Market Wrap for Tuesday, July 16: Stocks Record Modest Losses as Dollar Falls ||| Mid-Day Market Update: US Stocks Drop; Coca-Cola Shares Fall ||| Coca-Cola's Gary Fayard Blames Weak Q2 Results On Weather (KO) ||| Mid-Morning Market Update: Markets Mostly Flat, Goldman Sachs Posts Higher Profit ||| Coca-Cola Q2 Call Beginning ||| Economic Moats, Pornography and Small Sizes ||| Benzinga's Top Pre-Market Losers ||| UPDATE: Coca-Cola CFO Fayard Says Currency Impacts Affected Q2, Sees Stronger Dollar Ahead ||| UPDATE: Coca-Cola Posts Drop In Q2 Profit ||| UPDATE: Coca-Cola CFO Fayard Says Gained Market Share In India ||| UPDATE: Coca-Cola CFO Fayard Says Optimistic On Second Half of 2013, Says Colder and Wetter Second Quarter In U.S. Impacted Sales, Says People Drink Less Cola When Its Colder ||| Coca-Cola CFO Gary Fayard In CNBC Interview Giving Concerning Comments, Saying Whole Industry Slowed Down, Says Weather Around the World Impacted Sales ||| UPDATE: Coca-Cola Saw a 2% Headwind From Currencies on Revenue and 3% Headwind From Currencies On Operating Income ||| Coca-Cola Global Brand Volume Growth 1% ||| Coca-Cola Company (The) Reports Q2 EPS of $0.63, Inline; Revenue of $12.75B vs $12.97B Est ||| Benzinga Market Primer: Tuesday, July 16: Futures Flat Ahead of Earnings ||| US Stock Futures Edge Higher; Goldman Sachs Earnings, CPI In Focus ||| Economic Calendar for Tuesday July 16, 2013 ||| Earnings Scheduled For July 16, 2013 ||| Stocks To Watch For July 16, 2013",1,0.49723542
2013-07-17,18513100.0,40.54999923706055,40.97999954223633,40.310001373291016,40.84000015258789,32.62725830078125,KO,"Benzinga Market Primer: Wednesday, July 17: Bernanke Is Back",0,0.49683625
2013-07-18,9708800.0,40.86000061035156,41.06999969482422,40.7400016784668,40.810001373291016,32.60329055786133,KO,The Board of Directors of The Coca-Cola Company Elects Brent Hastie as Vice President And Declares Quarterly Dividend of $0.255 ||| Ana Botín Elected to The Coca-Cola Company Board of Directors,1,0.5136621
2013-07-19,11401100.0,40.880001068115234,41.09999847412109,40.790000915527344,41.09000015258789,32.82698059082031,KO,Rookie ETF Offers Exposure to Rising EM Dividends ||| 'Forever' Funds: The Safest High-Yield Funds on the Planet (Part II) ||| Rookie ETF Offers Exposure to Rising EM Dividends ||| UPDATE: Davenport & Company Names $42 PT on Coca-Cola Following Mixed Q2 Results,0,0.5219569
2013-07-23,9400900.0,40.95000076293945,41.130001068115234,40.790000915527344,40.959999084472656,32.723121643066406,KO,"Coca-Cola, CPK Team Up - Analyst Blog",0,0.5273922
2013-07-24,10511000.0,41.119998931884766,41.130001068115234,40.75,40.86000061035156,32.64323425292969,KO,"Three Commodity Stocks to Sell on the Pop ||| PepsiCo Beats 2Q Earnings, Rev; Up Y/Y - Analyst Blog",0,0.51355
2013-07-25,9147300.0,40.810001373291016,40.880001068115234,40.47999954223633,40.84000015258789,32.62725830078125,KO,CCE Beats 2Q Earnings Est; Misses Rev - Analyst Blog,0,0.5174082
2013-07-26,12279600.0,40.650001525878906,40.650001525878906,40.0099983215332,40.63999938964844,32.46746826171875,KO,FEMSA Q2 Earnings Miss Estimates - Analyst Blog,0,0.5315236
2013-07-30,10769400.0,40.41999816894531,40.72999954223633,40.25,40.31999969482422,32.211814880371094,KO,"Warren Buffett Hates Dividends ||| Stock Downgrades: Frowns All Around for Colgate-Palmolive Company ||| Coca-Cola Bottling Co. Consolidated (COKE) Ex-Dividend Date Scheduled for July 31, 2013",0,0.43581694
2013-08-05,9933200.0,40.18000030517578,40.470001220703125,40.18000030517578,40.290000915527344,32.187862396240234,KO,"Coca-Cola and Pepsi: Facing Slower Sales, Big Soda Is Testing Stevia in Sample Markets",1,0.521866
2013-08-06,8645600.0,40.22999954223633,40.43000030517578,40.060001373291016,40.369998931884766,32.25177001953125,KO,How to Invest Like Warren Buffett,0,0.5214799
2013-08-07,9301800.0,40.310001373291016,40.33000183105469,40.060001373291016,40.150001525878906,32.07601547241211,KO,How to Invest Like Warren Buffett,1,0.5214799
2013-08-09,9021600.0,40.25,40.31999969482422,40.04999923706055,40.15999984741211,32.083988189697266,KO,"Beam Inc. (BEAM) Ex-Dividend Date Scheduled for August 12, 2013",0,0.446886
2013-08-13,13548700.0,39.93000030517578,40.04999923706055,39.5,39.650001525878906,31.676563262939453,KO,"Diageo plc (DEO) Ex-Dividend Date Scheduled for August 14, 2013 ||| CFTC Intensifies Aluminum Hoarding Probe - Analyst Blog",0,0.50431865
2013-08-14,13787100.0,39.59000015258789,39.68000030517578,39.34999847412109,39.52999877929688,31.580690383911133,KO,"Monster Misses Q2 Earnings Estimates; Revs - Analyst Blog ||| Is This ""Forever"" Stock The Next Berkshire?",0,0.50389206
2013-08-15,14227800.0,39.29999923706055,39.400001525878906,39.02000045776367,39.09000015258789,31.22917556762696,KO,"Why Warren Buffett Hates Gold ||| PepsiCo Targets Premium Water Category Amid CSD Woes ||| Berkshire Hathaway Buys U.S. Bancorp, Suncor Energy, General Motors, Sells Moody's Corporation, ... ||| Chris Cunningham Of appssavvy Aims To Change Online Ads ||| UPDATE: Berkshire Hathway Discloses Reduced Stakes In Coca-Cola, IBM, Kraft, Mondelez, Proctor and Gamble, USG Corp., Verisk Analytics, Wal-Mart ||| Top 4 Large-Cap Stocks In The Beverages-Soft Drinks Industry With The Lowest PEG Ratio",0,0.4762148
2013-08-16,20565200.0,39.02999877929688,39.18000030517578,38.709999084472656,39.04999923706055,31.19721221923828,KO,Forget Coca-Cola: Buy This Stock Instead ||| Coca-Cola Kept at Neutral; Volumes Weak - Analyst Blog,0,0.50190055
2013-08-19,11913000.0,39.04999923706055,39.09000015258789,38.68999862670898,38.77999877929688,30.98151016235352,KO,Microsoft Bing Is Growing Market Share (MSFT),0,0.5234801
2013-08-20,10238200.0,38.84999847412109,39.13999938964844,38.650001525878906,38.650001525878906,30.877655029296875,KO,Coca Cola Launches First Herbal Drink - Analyst Blog,0,0.5334408
2013-08-23,11302800.0,38.61000061035156,38.61000061035156,38.369998931884766,38.52000045776367,30.773801803588867,KO,Time To Buy The Dip in Stocks? Be Wary.,0,0.49325284
2013-08-26,12740600.0,38.59999847412109,38.59999847412109,38.11000061035156,38.119998931884766,30.45423126220703,KO,"The Best Way To Profit From The Supercycle Bust ||| Cott Corporation (COT) Ex-Dividend Date Scheduled for August 27, 2013",1,0.48097712
2013-08-27,16742500.0,37.97999954223633,38.2400016784668,37.79999923706055,38.150001525878906,30.47820472717285,KO,"Market Close Report: NASDAQ Composite index closes at 3,578.52 down -79.05 points ||| Molson Coors Brewing Company (TAP) Ex-Dividend Date Scheduled for August 28, 2013 ||| Dow Suffers a Triple-Digit Drop Amid Syria Headlines ||| KOF Takes Over Brazilian Bottler - Analyst Blog",1,0.5429826
2013-08-28,19245200.0,38.060001373291016,38.52999877929688,38.04999923706055,38.34999847412109,30.637977600097656,KO,Don't Be Fooled By The Fancy Name -- Statistical Arbitrage Is A Simple Way To Profit,0,0.49094024
2013-08-29,14215700.0,38.470001220703125,38.470001220703125,38.09999847412109,38.09999847412109,30.43825340270996,KO,Salesforce Soars 7% After Earnings Beat (CRM) ||| Benzinga Market Primer for August 29: Delay In Military Strikes Provides Some Relief,1,0.5258085
2013-09-03,19068500.0,38.27000045776367,38.400001525878906,37.79999923706055,37.900001525878906,30.27847480773925,KO,"Coca-Cola Enterprises, Inc. (CCE) Ex-Dividend Date Scheduled for September 04, 2013 ||| Pepsico, Inc. (PEP) Ex-Dividend Date Scheduled for September 04, 2013 ||| KOF to Take Over Spaipa for $1.9B - Analyst Blog",1,0.49912393
2013-09-04,19138600.0,37.880001068115234,38.72999954223633,37.810001373291016,38.540000915527344,30.789777755737305,KO,Why Europe May Be Your Next Buying Opportunity,0,0.4961206
2013-09-05,14290500.0,38.630001068115234,38.68999862670898,38.060001373291016,38.2400016784668,30.55009651184082,KO,Dr Pepper Stays Neutral - Analyst Blog ||| Coca-Cola Enterprises Reiterates 2013 View - Analyst Blog ||| X Factor: 5 Stocks Reaching Their Ex-Dividend Date on September 12,1,0.47380424
2013-09-09,10605500.0,38.52000045776367,38.54999923706055,38.27000045776367,38.52000045776367,30.773801803588867,KO,"Tech News: Instagram Invites Advertisers Into the Picture, and Sony Launches Competitor to Apple TV",1,0.5353976
2013-09-10,11757300.0,38.77000045776367,38.77999877929688,38.5099983215332,38.630001068115234,30.861671447753903,KO,23 Companies on Historical Low P/S ||| Get Ready To Picture Instagram Monetized ||| EXCLUSIVE: Arctic Cat CEO Claude Jordan Breaks Down Weather and Sales (ACAT),1,0.5099166
2013-09-11,11996500.0,38.68000030517578,38.77999877929688,38.52999877929688,38.77999877929688,30.98151016235352,KO,"Is It Time To Cash Out Of Vodafone? ||| Coca-Cola Company (KO) Ex-Dividend Date Scheduled for September 12, 2013 ||| Dr Pepper Snapple Group, Inc (DPS) Ex-Dividend Date Scheduled for September 12, 2013",0,0.42638424
2013-09-12,12114100.0,38.59000015258789,38.61000061035156,38.27999877929688,38.43999862670898,30.93321990966797,KO,Warren Buffett's Top Growth Stocks He Keeps Buying ||| Coca-Cola Enterprises Stays Neutral - Analyst Blog,1,0.50486284
2013-09-18,18030500.0,38.810001373291016,39.59999847412109,38.58000183105469,39.59000015258789,31.858657836914062,KO,Why You Shouldn't Count Out Coke Or Pepsi,0,0.4868023
2013-09-19,14251700.0,39.63999938964844,39.66999816894531,39.150001525878906,39.310001373291016,31.633331298828125,KO,"Vina Concha Y Toro (VCO) Ex-Dividend Date Scheduled for September 20, 2013 ||| MT Insider: Equities Rally Overnight on Federal Reserve Decision To Not Taper ||| Dividend Aristocrat Walgreen Expanding Aggressively ||| SunTrust Robinson Humphrey Maintains Buy on Coca-Cola Company (The), Lowers PT to $45.00",1,0.5026116
2013-09-20,30675300.0,39.33000183105469,39.400001525878906,38.77999877929688,39.400001525878906,31.70575904846192,KO,Coke Campaign Accidentally Insults Customers With Shocking Messages,0,0.50809205
2013-09-23,19016200.0,39.15999984741211,39.18999862670898,38.43999862670898,38.630001068115234,31.086116790771484,KO,"PreMarket Info Recap for September 23, 2013: Which Gaps? The Witch Gaps!",0,0.4848969
2013-09-24,15083300.0,38.720001220703125,38.869998931884766,38.52000045776367,38.52999877929688,31.00564765930176,KO,FEMSA Ventures into Restaurant Business - Analyst Blog,0,0.5474364
2013-09-25,11446100.0,38.650001525878906,38.68000030517578,38.29999923706055,38.33000183105469,30.844709396362305,KO,Top 4 Large-Cap Stocks In The Beverages-Soft Drinks Industry With The Highest ROA,1,0.5267444
2013-09-26,10941100.0,38.4900016784668,38.7400016784668,38.38999938964844,38.7400016784668,31.17464065551757,KO,Wal-Mart Drags Down Consumer ETFs - ETF News And Commentary,0,0.5157047
2013-09-30,18101500.0,38.18999862670898,38.29999923706055,37.75,37.880001068115234,30.48258399963379,KO,"Trading Strategies Adopted From NFL QB Peyton Manning & Coca-Cola ||| Two Retirement Strategies for Combating Ongoing QE ||| Four Weekend Apple Stories You Might Have Missed ||| Interbrand Reports Apple Now Top Global Brand, Google at Number 2 Spot, Coca-Cola Falls to Number 3 -CNET",1,0.4968228
2013-10-01,13196000.0,38.0,38.09000015258789,37.619998931884766,37.95000076293945,30.53892135620117,KO,"McCann to Boost UN Public Health Targets - Analyst Blog ||| Stock Market News for October 1, 2013 - Market News ||| Stock Downgrades: JC Penney Parties Like It's 1982",0,0.48791894
2013-10-02,25664200.0,37.810001373291016,37.810001373291016,37.209999084472656,37.43000030517578,30.12046432495117,KO,FEMSA Downgraded to Underperform - Analyst Blog,0,0.52053785
2013-10-03,14437900.0,37.459999084472656,37.459999084472656,37.130001068115234,37.15999984741211,29.90318298339844,KO,Three Warren Buffett Stocks Fall to a 52-Week Low ||| Coca Cola Femsa Down to Strong Sell - Analyst Blog ||| Pepsi Launches Zero-Calorie Drinks - Analyst Blog,1,0.53651804
2013-10-04,17217500.0,37.25,37.27000045776367,36.90999984741211,37.20000076293945,29.935380935668945,KO,"Market Primer: Friday, October 4: US Budget Battle Drags On ||| Market Primer: Friday, October 4: US Budget Battle Drags On",0,0.4905562
2013-10-07,16708600.0,37.08000183105469,37.380001068115234,36.83000183105469,37.04999923706055,29.81467056274414,KO,Earnings Expectations For The Week Of October 7: A New Earnings Season ||| Reduce your risk with consumer staples ||| Bull of the Day: Berkshire Hathaway (BRK.B) - Bull of the Day,1,0.48462492
2013-10-08,20471300.0,37.09999847412109,37.40999984741211,36.900001525878906,37.27999877929688,29.999759674072266,KO,"Shares of Consumer Staples Companies Fractionally Higher, Outpacing Broader Market ||| If Treasuries Are In Trouble, What Are Your Options?",0,0.495401
2013-10-09,18998900.0,37.380001068115234,37.41999816894531,37.0099983215332,37.08000183105469,29.83881187438965,KO,Top Five Guru-Held Consumer Defensive Stocks,1,0.5179701
2013-10-10,17174400.0,37.77000045776367,37.86000061035156,37.45000076293945,37.77999877929688,30.40211677551269,KO,Starbucks Squeezing its Way into a Larger Market Share of the Fresh Juice Craze (SBUX),0,0.5028131
2013-10-11,14266900.0,37.91999816894531,37.91999816894531,37.52000045776367,37.77000045776367,30.39407157897949,KO,Do You Own This Game-Changer's First Victim? ||| Benzinga Weekly Preview: Earnings Season Gets Into Full Swing,1,0.50823504
2013-10-14,14202900.0,37.560001373291016,37.95000076293945,37.5099983215332,37.90999984741211,30.506731033325195,KO,"Earnings Expectations For The Week Of October 14: Financials, Tech and Consumer Goods ||| A US Credit Default: Not Happening? ||| S&P 500 Index Diverging Bearishly ||| Congress Negotiates a Deal to Re-Open Government and Postpone Debt Ceiling Decision ||| Pre-Market Earnings Report for October 15, 2013 : JNJ, KO, C, SCHW, OMC, FRC, CBSH, DPZ ||| Why Crestfallen Stevia Could Soon Be Making Headlines Again",0,0.4969122
2013-10-15,21676600.0,38.18000030517578,38.369998931884766,37.59999847412109,37.65999984741211,30.3055419921875,KO,"US Futures Mixed as Possible Deal on Debt Limit Competes with Citigroup Miss ||| Coca-Cola's Earnings Meet, Sales Miss - Analyst Blog ||| Hope for a Deal today ? with a mixed set of earnings - Economic Highlights ||| Stock Downgrades: Default Lies With Dassault ||| Stocks Mixed Ahead of Open as Senate Debt Pact Isn't Done Deal; Citigroup Weighs ||| Pre-Market: Citigroup Misses Expectations; Stocks Are Higher on Hopes of a Debt Deal ||| Sector Update: Consumer ||| The Yacktman Fund's Third Quarter Largest Holdings ||| Donald Yacktman Gets New Top Holding, Buys More Dell in Q3 ||| Coca-Cola Earnings Preview: Still Beverages To Drive Growth As The Soda Slump Continues ||| PepsiCo Earnings Preview: Snacks To Drive Growth As Beverages Fizzle ||| Sector Update: Consumer Shares Higher; Coca-Cola Up on Q3 Results ||| Market Wrap For Tuesday, October 15: Earnings Reports And White House Progress Send Markets Down ||| Has Washington Kicked Consumer Confidence into the Sewer? ||| PreMarket Info Recap for October 15, 2013: Earnings Kick Off Tuesday ||| Benzinga's Top Pre-Market Gainers ||| UPDATE: Coca-Cola Posts Rise In Q3 Profit ||| Coca-Cola Company (The) Reports Q3 EPS of $0.53 vs $0.54 Est; Revenue of $12.03B vs $12.06B Est ||| Market Primer: Tuesday, October 15: Tuesday Could Be 'Deal Day' ||| Earnings Scheduled For October 15, 2013 ||| Stocks To Watch For October 15, 2013",1,0.4917244
2013-10-16,17995100.0,38.0099983215332,38.2400016784668,37.77999877929688,38.0,30.579151153564453,KO,"Yacktman Fund Buys Coca-Cola, PepsiCo, , Exxon Mobil, Sells Cisco Systems Inc, Hewlett-Packard Co ||| Dow ETF in Focus on Q3 Earnings Results - ETF News And Commentary ||| Market Primer: Wednesday, October 16: Markets Wobble On Debt Deal Setback",1,0.48792657
2013-10-17,15900200.0,38.060001373291016,38.560001373291016,38.0099983215332,38.54999923706055,31.021743774414062,KO,"Trying To Beat The Market Is A Fool's Errand ||| Coca-Cola Delivers Balanced Growth From Its Diversified Portfolio ||| Snacks Fuel Growth At PepsiCo As Beverages Continue To Fizzle ||| Beverage Names Quiet, Several Sources Reporting the NY High Court Will Hear Bloomberg's Large Soda Ban Appeal ||| Coca-Cola Earnings Analysis: Is it going better with Coke?",1,0.5052547
2013-10-18,18896600.0,38.58000183105469,38.77999877929688,38.41999816894531,38.77999877929688,31.20682716369629,KO,The Sweeter Stock: PepsiCo or Coca-Cola? ||| Mexican Govt. Looks to Pull the Nation's Sweet Tooth with a Junk-Food Tax,1,0.52149713
2013-10-22,17110200.0,38.86000061035156,39.25,38.68999862670898,39.09000015258789,31.4562931060791,KO,Dr Pepper Snapple Preview: TEN Line-Up’s Performance In Focus As The CSD Slump Continues,0,0.5220508
2013-10-23,12591800.0,39.08000183105469,39.25,38.79999923706055,39.09000015258789,31.4562931060791,KO,"Drink Wine Responsibly; Invest in Beverage Stocks Profitably ||| ETF Outlook for Wednesday October 23, 2013 ||| Top 4 Large-Cap Stocks In The Beverages-Soft Drinks Industry With The Highest Dividend Yield",0,0.49377826
2013-10-24,17143800.0,39.150001525878906,39.369998931884766,38.7599983215332,38.79999923706055,31.222925186157227,KO,"CCE Beats Q3 Earnings Estimate; Meets Rev - Analyst Blog ||| Getting Smart About So-Called Smart Beta ||| After Hours Most Active for Oct 24, 2013 : ZNGA, MSFT, CSCO, ABV, AMZN, GILD, BAC, QQQ, KO, CRM, TSM, OZM",1,0.48465666
2013-10-25,14383400.0,38.84000015258789,39.130001068115234,38.630001068115234,39.02999877929688,31.40800666809082,KO,10 Undervalued Stocks to Watch,1,0.5324458
2013-10-28,16552100.0,39.02000045776367,39.7400016784668,38.9900016784668,39.61000061035156,31.87474250793457,KO,FEMSA Beats on Q3 Earnings - Analyst Blog ||| Coca Cola Files Automatic Mixed Securities Shelf,1,0.5205701
2013-10-29,14199600.0,39.56999969482422,39.959999084472656,39.34999847412109,39.79999923706055,32.02764129638672,KO,"Coca-Cola Bottling Co. Consolidated (COKE) Ex-Dividend Date Scheduled for October 30, 2013 ||| Staple This Hot ETF to Your Buy List ||| Is a Beer Mega-Merger On Tap?",0,0.48463076
2013-10-30,12360000.0,39.880001068115234,39.88999938964844,39.5099983215332,39.619998931884766,31.882795333862305,KO,"Coca Cola Femsa S.A.B. de C.V. (KOF) Ex-Dividend Date Scheduled for October 31, 2013 ||| KOF Seals $1.9B Spaipa Deal - Analyst Blog",0,0.518925
2013-10-31,14853500.0,39.5099983215332,39.86000061035156,39.5099983215332,39.56999969482422,31.842548370361328,KO,"Stock Market News for October 31, 2013 - Market News ||| Yes, Virginia, There are High Rewards from Low Risk Stocks",1,0.47853374
2013-11-01,12430400.0,39.56999969482422,39.720001220703125,39.33000183105469,39.61000061035156,31.87474250793457,KO,"Fomento Economico Mexicano S.A.B. de C.V. (FMX) Ex-Dividend Date Scheduled for November 04, 2013 ||| Beam Inc. (BEAM) Ex-Dividend Date Scheduled for November 04, 2013 ||| The Enduring Appeal of Dividends ||| EnterpriseJungle Could Become One Of The Biggest Self-Funded Startups",0,0.4517017
2013-11-04,10252100.0,39.709999084472656,39.810001373291016,39.29999923706055,39.5099983215332,31.794273376464844,KO,Barron's Recap: How to Play Latin America ||| TD Ameritrade's October IMX Summary,0,0.52480215
2013-11-05,10575000.0,39.36000061035156,39.63999938964844,39.220001220703125,39.5,31.786226272583008,KO,Donald Yacktman's Third Quarter Portfolio Top Five ||| Why Warren Buffett Won't Buy Twitter ||| Top 4 Large-Cap Stocks In The Beverages-Soft Drinks Industry With The Highest Dividend Yield,1,0.5064621
2013-11-08,11903600.0,39.7400016784668,40.04999923706055,39.4900016784668,40.04999923706055,32.22882080078125,KO,"Monster Misses Earnings, Sales yet Again - Analyst Blog ||| Coca Cola Pushes into China - Analyst Blog ||| Buy 'Dividend Aristocrats,' not Municipal Bonds ||| Coca-Cola to Invest Over $4 Billion in China",0,0.5296299
2013-11-11,9567800.0,40.0099983215332,40.04999923706055,39.77000045776367,39.869998931884766,32.0839729309082,KO,Market Wrap For November 11: Relative Quiet as Traders and Investors Observe Holiday,1,0.5147641
2013-11-12,10509200.0,39.90999984741211,39.9900016784668,39.619998931884766,39.880001068115234,32.092018127441406,KO,PepsiCo to Invest $5.5B in India - Analyst Blog,1,0.55135095
2013-11-15,12021500.0,40.15999984741211,40.31999969482422,39.959999084472656,40.220001220703125,32.365623474121094,KO,"Warren Buffett's Berkshire Hathaway Buys Exxon Mobil, DaVita, Sells ConocoPhillips, GlaxoSmithKline ||| Investors Pour Back Into Equities After Fed Taper Fears Extinguished For Now; Indices Reach New Records ||| Inexpensive Protection For Buffett's Latest Large Position",0,0.49418446
2013-11-18,9553900.0,40.2400016784668,40.2400016784668,40.0,40.16999816894531,32.32538986206055,KO,Ford Uses Coca-Cola's PlantBottle Tech - Analyst Blog ||| Janet Yellen Remarks Highlight the Enduring Appeal of Dividends ||| Will Unilever Help You Retire in Style? ||| Top Four Overlooked Stocks for Income-Seeking Investors,0,0.5003045
2013-11-19,11014800.0,40.13999938964844,40.22999954223633,39.91999816894531,40.13999938964844,32.301246643066406,KO,"Coca-Cola Enterprises, Inc. (CCE) Ex-Dividend Date Scheduled for November 20, 2013 ||| Coca-Cola Kept at Neutral - Analyst Blog ||| 3 of 'The Dogs of the Dow' are Warren Buffett Stocks: Time to Buy?",0,0.45726678
2013-11-21,26364300.0,40.20000076293945,40.4900016784668,40.09999847412109,40.43000030517578,32.534610748291016,KO,SodaStream Launches Flavor Capsules - Analyst Blog ||| PepsiCo Kept Neutral on Mixed Q3 - Analyst Blog,0,0.5184028
2013-11-22,26396500.0,40.34000015258789,40.459999084472656,40.09000015258789,40.43000030517578,32.534610748291016,KO,Coca-Cola Acquires Outstanding Ownership Stake in ZICO,0,0.5179952
2013-11-25,14059100.0,40.47999954223633,40.880001068115234,40.33000183105469,40.369998931884766,32.486328125,KO,"Molson Coors Brewing Company (TAP) Ex-Dividend Date Scheduled for November 26, 2013 ||| RBC Capital Initiates Coverage on Coca-Cola Company (The) at Outperform, Announces $50.00 PT ||| Investing in These Collectibles a Better Bet Than Wall Street?",0,0.469417
2013-11-26,14240400.0,40.4900016784668,40.59999847412109,40.2400016784668,40.25,32.38976287841797,KO,"Dr Pepper Kept Neutral on Weak Revs - Analyst Blog ||| Cott Corporation (COT) Ex-Dividend Date Scheduled for November 27, 2013 ||| Coca-Cola Company (KO) Ex-Dividend Date Scheduled for November 27, 2013",0,0.4301735
2013-12-02,16738800.0,40.09999847412109,40.20000076293945,39.75,40.08000183105469,32.47890853881836,KO,"Strong Stuff: Diageo Holds Up Well ||| Standpoint Research Initiates Coverage on Coca-Cola Company (The) at Sell, Announces $34.00 PT",1,0.51507723
2013-12-03,16592300.0,40.04999923706055,40.38999938964844,40.0099983215332,40.34999847412109,32.69768142700195,KO,"MNST Reacts to Study on Energy Drinks - Analyst Blog ||| Pepsico, Inc. (PEP) Ex-Dividend Date Scheduled for December 04, 2013 ||| Mondelez to Invest $190M in India - Analyst Blog ||| Who Would You Rather… Coke vs. Pepsi",1,0.49651375
2013-12-04,13196100.0,40.20000076293945,40.470001220703125,39.93999862670898,40.369998931884766,32.713905334472656,KO,"#PreMarket Primer: Wednesday, December 4: Taper Talk Back On The Table",0,0.4894972
2013-12-06,12557100.0,40.04999923706055,40.5,40.04999923706055,40.459999084472656,32.78683090209961,KO,Supersize EM: Obesity Matters For Emerging-Market Investors ||| Bullish News from the Black Skies over Shanghai ||| BofA Sees Promise In Green Mountain's Upcoming 'Keurig Cold' Product; GMCR Up 3%,0,0.5083428
2013-12-09,12237100.0,40.400001525878906,40.5,40.20000076293945,40.400001525878906,32.738216400146484,KO,Low Calorie Coca-Cola Life May Make Debut in US in 2014 -NY Post,0,0.49302226
2013-12-10,15967800.0,40.2599983215332,40.290000915527344,39.75,39.84999847412109,32.29251480102539,KO,"Market Wrap For December 10: Fed Meeting One Week Away ||| Is Coca-Cola 'Faith-Based' Investing at its Finest? ||| KeyBanc Sees Increased Likelikhood For Green Mountain, Coke Deal Following Kent Comments ||| Hearing Keybanc Saying Green Mountain will Announce Single-Serve Partnership with Coca-Cola",1,0.5020826
2013-12-11,14963500.0,39.95000076293945,40.34000015258789,39.88999938964844,40.130001068115234,32.51941680908203,KO,"CCE Stays Neutral Despite Strong Q3 - Analyst Blog ||| Dr Pepper Snapple Group, Inc (DPS) Ex-Dividend Date Scheduled for December 12, 2013",0,0.46532217
2013-12-12,19817700.0,39.9900016784668,40.209999084472656,39.18000030517578,39.209999084472656,31.77389144897461,KO,"Frito-Lay Could Heal PepsiCo's Beverage Wounds In North America ||| Janney Capital Initiates Coverage on Coca-Cola Company (The) at Buy, Announces $52.00 PT ||| Buffalo Wild Wings Issues Release Announcing PepsiCo as Beverage Partner",1,0.49754888
2013-12-13,14037400.0,39.470001220703125,39.63999938964844,39.209999084472656,39.22999954223633,31.79010009765625,KO,Coca-Cola to Restructure American Biz - Analyst Blog ||| Market Wrap For December 13: Major Indices Finish The Day Flat ||| Will Dividend Stocks be the Big Winners in the Budget Deal? ||| Morgan Stanley Sees Potential Benefits of Management/Organizational Changes at The Coca-Cola Company ||| Top 4 Large-Cap Stocks In The Beverages-Soft Drinks Industry With The Highest Revenue Estimates,1,0.5287884
2013-12-16,14562100.0,39.459999084472656,39.56999969482422,39.20000076293945,39.27000045776367,31.822519302368164,KO,Flee from the Detroit Bankruptcy to the Safety of Dividend Stocks,0,0.51754373
2013-12-18,23884500.0,39.2599983215332,40.08000183105469,39.0,40.02000045776367,32.430274963378906,KO,"Vina Concha Y Toro (VCO) Ex-Dividend Date Scheduled for December 19, 2013 ||| Market Wrap For December 18: Markets Surge Following the Fed's Taper Announcement",0,0.5147202
2013-12-20,22237200.0,39.91999816894531,40.18999862670898,39.84999847412109,40.040000915527344,32.44647979736328,KO,"PowerTrend Brief: It’s Still the Economy, Stupid ||| Market Wrap For December 20: Markets Gain On GDP Data ||| Stocks that Pay Dividends are The Great Equalizers for Income Disparity",1,0.4902226
2013-12-23,10943200.0,40.09999847412109,40.2400016784668,39.869998931884766,40.15999984741211,32.54372024536133,KO,CCE Expects Weak Growth in 2014 - Analyst Blog,1,0.555431
2013-12-26,8588300.0,40.220001220703125,40.540000915527344,40.13999938964844,40.4900016784668,32.81113815307617,KO,"FEMSA Upped to Neutral - Analyst Blog ||| Form 8-K from Coca Cola Bottling Shows Co., Coca-Cola Have Entered 2014 Incidence Pricing Letter Deal",1,0.51495004
2013-12-27,6762200.0,40.68999862670898,40.790000915527344,40.52999877929688,40.65999984741211,32.94889831542969,KO,"#PreMarket Primer: Friday, December 27: Twitter's IPO Proving To Be One Of The Best This Year ||| Cola Wars In Russia (Part 2) ||| #PreMarket Primer: Friday, December 27: Twitter's IPO Proving To Be One Of The Best This Year",1,0.49410412
2013-12-30,10927500.0,40.77000045776367,41.13999938964844,40.7599983215332,41.09000015258789,33.29735565185547,KO,"Barron's Recap: Home Prices Ready To Rise ||| #PreMarket Primer for December 30: Blackstone Invests In Crocs, Google & Apple Enter Auto Industry",1,0.5103226
2014-01-02,12698600.0,41.119998931884766,41.22999954223633,40.5099983215332,40.65999984741211,32.94889831542969,KO,Apple Downgrade Keeps Lid on Tech Sector; Yingli Green Energy Gains on Joint Partnership with Coal Producer ||| Sector Update: Technology ||| Tech Stocks Falling After Apple Downgrade; ChinaCache Jumps 5% After Move to Nasdaq Global Select Market ||| Sector Update: Technology,0,0.48270896
2014-01-06,11036300.0,40.47999954223633,40.59000015258789,40.15999984741211,40.27000045776367,32.63285827636719,KO,Dr. Pepper Snapple: 2013 Year In Review ||| Top 4 Large-Cap Stocks In The Beverages-Soft Drinks Industry With The Lowest PEG Ratio,1,0.5238219
2014-01-09,14070200.0,39.95000076293945,40.0,39.52000045776367,39.72999954223633,32.19527053833008,KO,"Stock Market News for January 09, 2014 - Market News ||| Bernie Madoff Shows The Importance Of Understanding The Economic Moat Of An Investment",1,0.5109551
2014-01-10,13290000.0,39.959999084472656,40.290000915527344,39.900001525878906,40.130001068115234,32.51941680908203,KO,"Market Wrap For January 10: Job Growth Weak, But Unemployment Falls",0,0.5134094
2014-01-13,14091900.0,40.0,40.130001068115234,39.5,39.52999877929688,32.03321075439453,KO,Pepsi Snacks & Drinks to Stay Together - CNBC - Analyst Blog,1,0.514776
2014-01-14,12801100.0,39.63999938964844,39.91999816894531,39.58000183105469,39.68999862670898,32.1628532409668,KO,"Ambev S.A. (ABEV) Ex-Dividend Date Scheduled for January 15, 2014",1,0.46351358
2014-01-15,12844900.0,39.83000183105469,39.93999862670898,39.58000183105469,39.7599983215332,32.2195930480957,KO,FEMSA Reopens Note Offerings - Analyst Blog ||| Coca-Cola Eyes Growth In The Sparkling Bottled Water Market ||| 9 One-Time Penny Stocks Didn't Stay That Way,0,0.48866212
2014-01-16,11063100.0,39.77999877929688,39.81999969482422,39.58000183105469,39.709999084472656,32.17906951904297,KO,How To Invest Like Peter Lynch ||| Domino's Pizza Announces Multi-Year Deal with Coca-Cola Company,0,0.5151674
2014-01-17,13992700.0,39.720001220703125,39.75,39.27999877929688,39.27999877929688,31.830610275268555,KO,"Domino's Pizza, Coca-Cola Team Up - Analyst Blog",1,0.5177673
2014-01-21,17579000.0,39.63999938964844,39.91999816894531,39.52999877929688,39.91999816894531,32.3492431640625,KO,"Yacktman Focused Fund's Top Five Stocks ||| Donald Yacktman Changes Top Portfolio Position, Sells Out Its Spin-Off ||| Dow Drops, S&P 500 Gains as Investors Weigh Earnings Reports ||| Is Coca-Cola The Best Way To Profit From Emerging Market Growth?",0,0.48299104
2014-01-22,9841700.0,39.9900016784668,40.09000015258789,39.75,39.900001525878906,32.33304214477539,KO,Global Consumer Franchise Stocks: Have Your Cake And Eat It!,0,0.525356
2014-01-23,14828100.0,39.61000061035156,39.63999938964844,39.119998931884766,39.2400016784668,31.79819869995117,KO,The Coca-Cola Company (KO): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report ||| Drink Up The Profits From The Beverage Sector,0,0.50551975
2014-01-24,16507500.0,39.08000183105469,39.25,38.81999969482422,38.84000015258789,31.47407913208008,KO,"#PreMarket Primer: Friday, January 24: Growth Fears Drag Down Emerging Markets",0,0.5027008
2014-01-27,14601900.0,38.81999969482422,38.97999954223633,38.709999084472656,38.72999954223633,31.38492584228516,KO,"Market Wrap For January 27: China Concerns, Declining Home Sales, Tomorrow's Fed Meeting and Obama's Speech Keep Markets Lower",1,0.5122204
2014-01-28,8915500.0,38.77000045776367,39.08000183105469,38.619998931884766,38.869998931884766,31.498380661010746,KO,"Coca-Cola Bottling Co. Consolidated (COKE) Ex-Dividend Date Scheduled for January 29, 2014",0,0.47546288
2014-01-30,13662000.0,38.0,38.40999984741211,38.0,38.16999816894531,30.931123733520508,KO,"Stock Market News for January 30, 2014 - Market News ||| Societe Generale Initiates Coverage on Coca-Cola Company (The) at Buy ||| What Companies Stand To Benefit From The Super Bowl?",0,0.48694232
2014-02-03,23164900.0,38.02000045776367,38.02000045776367,37.09999847412109,37.20000076293945,30.14508628845215,KO,"Guru Stocks at 52-Week Lows: CHL, IBM, PTR, T, KO ||| Guru Donald Yacktman's Top Five Holdings ||| Coca-Cola (KO) Shares Cross 3% Yield Mark",1,0.51075226
2014-02-05,13665200.0,37.4900016784668,37.720001220703125,37.380001068115234,37.61000061035156,30.47732734680176,KO,"Coca-Cola Enterprises Beats on Q4 Earnings - Analyst Blog ||| Green Mountain Partners with Coca-Cola, Shares Explode Higher - Analyst Blog ||| Coca Cola Enterprises Ups Div by 25% - Analyst Blog ||| Benzinga's M&A Chatter for Wednesday February 5, 2014 ||| Green Mountain Shares Reach $120 After-Hours, Following Announcement of Coca-Cola 10% Stake, a Gain of almost 49% ||| Green Mountain Coffee Roasters Enters 10-Year Agreement With Coca-Cola ||| Green Mountain, Coke Currently Holding Call: Green Mountain Says Will Not Comment on Future Partners ||| PREVIEW: Green Mountain Coffee Roasters to Resume Trading at 5:00 PM ET ||| Coca Cola spikes Higher on Announcement of Green Mountain Stake; SodaStream, Monster Beverage Sharply Lower ||| UPDATE: Coca-Cola to Pay $74.98/Share for 16.68M Shares of GMCR ||| UPDATE: Green Mountain Will Use Proceeds to Buyback Shares ||| Coca-Cola to Buy 10% Minority Equity Stake in Green Mountain for $1.25B",1,0.51769805
2014-02-06,22661500.0,38.7599983215332,38.93999862670898,37.91999816894531,38.02999877929688,30.81768226623535,KO,"Midday Update: Stocks Stage Impressive Rebound on Upbeat Job Market Data; Twitter Slumps on Declining Users ||| IWB, KO, PM, SLB: ETF Outflow Alert ||| Green Mountain Stock Surges on Coca-Cola Deal ||| Green Mountain Coffee Roasters Enters Ten Year Agreement With Coca-Cola ||| Emerging Markets Rally Following ECB Rate Decision ||| Stocks Bounce Back as Economic Jitters Subside ||| Closing Update: Stocks Surge as Unemployment Claims Data Boosts Expectations For January Jobs Report ||| Consumer Shares Rise in Broader Market Rally; iRobot Cleans Up After Upside FY14 Guidance ||| Consumer Stocks Posting Big Gains; SodaStream Resists Selling Pressure Resulting From Green Mountain Coffee, Coca-Cola Partnership ||| Sector Update: Consumer ||| Green Mountain Beats on Earnings, Partners Coke - Analyst Blog ||| What Companies Stand To Benefit From The Winter Olympics In Sochi? ||| Moody's Issues Report: Coke, Green Mountain Deal Credit Positive for Both Cos. ||| Moody's Issues Report: Coke, Green Mountain Deal Credit Positive for Both Cos. ||| Mid-Afternoon Market Update: Yelp Shares Show Strength as Pandora Continues to Fall on Poor Guidance ||| Green Mountain Coffee Roasters Soars ||| David Einhorn's Greenlight Capital Declines Comment on Green Mountain/Coke Deal ||| Mid-Day Market Update: Green Mountain Coffee Shares Jump After Coca-Cola Deal; Twitter Falls ||| SodaStream Makes Positive Comments on Coke Deal with Green Mountain ||| SodaStream Shares Up 6.5%, Monster Up ~1.5% as Coke Stake in Green Mountain Has Rumor Mill Churning ||| Mid-Morning Market Update: Markets Rise; General Motors Earnings Miss Estimates ||| What Companies Stand To Benefit From The Winter Olympics In Sochi? ||| Morgan Stanley Considers Potential Impact of Coca-Cola's Agreement with GMCR ||| Stocks Hitting 52-Week Highs ||| Blame It On Coca-Cola: Green Mountain Up, SodaStream Down ||| Top Trending Tickers On StockTwits For February 6 ||| Benzinga's Top #PreMarket Gainers ||| #PreMarket Primer: Thursday, February 6: Markets Taking A Breather After Twitter Earnings ||| Stocks To Watch For February 6, 2014",0,0.49969658
2014-02-07,20389000.0,38.16999816894531,38.34999847412109,37.869998931884766,37.95000076293945,30.75285530090332,KO,"Company news for February 07, 2014 - Corporate Summary ||| Dow Continues Higher, Ends the Week in the Green ||| Was The Beverage Industry The Big Winner From The Super Bowl? ||| Herb Greenberg Thinks Green Mountain Isn't Much Without Coke",1,0.49070245
2014-02-10,20877200.0,38.06999969482422,38.619998931884766,37.84000015258789,38.56999969482422,31.255266189575195,KO,"Your Magic Number for a Comfortable Retirement ||| One Put, One Call Option To Know About for Coca-Cola ||| Will Green Mountain 'Revert to the Mean' After Its Coca-Cola Deal? ||| Wall Street Analyst: SodaStream Has No Reason To Worry Over Keurig Cold",1,0.50153136
2014-02-11,15361300.0,38.66999816894531,38.77999877929688,38.5099983215332,38.63999938964844,31.312000274658203,KO,"Will Green Mountain 'Revert to the Mean' After Its Coca-Cola Deal? ||| Green Mountain, Krispy Kreme Join Forces - Analyst Blog ||| Green Mountain Coffee Roasters Shows Value of Correlation Trading ||| 3 Reasons To Trust Dividends More Than Analysts",0,0.49517784
2014-02-12,10633400.0,38.84999847412109,38.91999816894531,38.400001525878906,38.5099983215332,31.206642150878903,KO,3 Reasons To Trust Dividends More Than Analysts ||| Why Income Investors Should Prefer “New” Coke to “Old” Coke ||| Stocks For 2014: High-Yield And Fairly Valued Dividend Stocks For High Current Income - Part 5 ||| Is The Beverage Industry Now Like The High-Tech Sector? ||| What Is The Tell From The Coca-Cola Deal With Green Mountain?,1,0.52023286
2014-02-13,10435600.0,38.130001068115234,38.7599983215332,38.130001068115234,38.650001525878906,31.32009696960449,KO,"How Coca-Cola’s GMCR Deal Changes the Beverage Industry ||| Pepsi Beats on Earnings; Raises 2014 Returns - Analyst Blog ||| Stock Market News for February 13, 2014 - Market News ||| Is Coca-Cola (KO) Ready to Breakout? - Tale of the Tape",1,0.48996896
2014-02-14,16030100.0,38.59999847412109,39.02000045776367,38.27000045776367,38.93000030517578,31.5469913482666,KO,"IWB, BRK-B, MRK, KO: Large Outflows Detected at ETF ||| Pre-Market Earnings Report for February 18, 2014 : KO, MDT, DUK, WM, GPC, NI, NCLH, XRAY, WWW, CHH, HTA, NHI ||| Benzinga Weekly Preview: Investors Get A Break As Earnings Slow",0,0.48958224
2014-02-18,46098500.0,37.97999954223633,38.11000061035156,37.2599983215332,37.470001220703125,30.36387252807617,KO,"Stock Futures Lose Ground On Weak Empire State Manufacturing Index ||| Midday Update: Stocks Capitulate to Bearish Data But Nasdaq Composite Outperforming Other Indices, Led by Biotechs ||| Stocks Lose Footing Following Weak Economic Data For Housing Market, Regional Manufacturing ||| Coca-Cola Slips After Weak Revenue ||| In-Line Earnings at Coca-Cola, Sales Missed - Analyst Blog ||| Coca-Cola Shares Fizzle After Earnings ||| Looking Past the Deep Freeze - Ahead of Wall Street ||| Closing Update: Stock Rally Stalls on Weak Economic Data ||| Mid-Day Market Update: US Stocks Mostly Higher; Forest Laboratories Shares Jump On Actavis Deal ||| Sector Update: Consumer ||| Earnings Expectations For The Week Of February 17: Coca-Cola, Hewlett-Packard, Wal-Mart & More ||| Bill Gates Foundation Buys McDonald's, Exxon Mobil, Caterpillar Inc, Sells Procter & ... ||| Dow Drops on Lackluster Earnings, Data; Tech Stocks Advance ||| Mid-Afternoon Market Update: Actavis Acquisition of Forest Labs Dominates Headlines as Markets Remain Mixed ||| Sector Update: Consumer Shares Flat Pre-Market; Coca-Cola Slides 2% on Q4 Revenue Drop ||| Coca-Cola Buys Stake In Green Mountain Coffee Roasters ||| Market Wrap For February 18: Dow Finishes Lower, Nasdaq Still Hot ||| Mid-Afternoon Market Update: Actavis Acquisition of Forest Labs Dominates Headlines as Markets Remain Mixed ||| Coca-Cola Sharply Lower Despite Matching Earnings Estimates ||| Mid-Day Market Update: US Stocks Mostly Higher; Forest Laboratories Shares Jump On Actavis Deal ||| From Coke Call: Green Mountain is Important to Serve Consumers While at Home ||| Mid-Morning Market Update: Markets Mixed; Coca-Cola Posts Decline In Profit ||| From Coke Call: Co. Will Focus More on Pricing Versus Volume in North America ||| From Coke Call: Marketing Will Combat Headwinds in Mexico ||| Coke Earnings Call Now Moving Into Q&A, Exec Recently Voiced Concern with Consumers in Southern Europe ||| From Coke Earnings Call: CFO Will Recommend 2014 Dividend Increase ||| From Coca-Cola Earnings Conference Call: Saw 6% Volume Decline in Brazil During Qtr. ||| Benzinga's Top #PreMarket Losers ||| UPDATE: Coca-Cola Posts Drop In Q4 Net Profit ||| Coca-Cola Company (The) Reports Q4 EPS of $0.46, Inline ||| US Stock Futures Flat Ahead Of Coca-Cola Earnings, Housing Data ||| Coca-Cola Earnings Preview: Looking For New Growth ||| Earnings Expectations For The Week Of February 17: Coca-Cola, Hewlett-Packard, Wal-Mart & More ||| Earnings Scheduled For February 18, 2014 ||| Stocks To Watch For February 18, 2014",0,0.48784068
2014-02-19,26645100.0,37.5,37.59999847412109,37.04999923706055,37.09999847412109,30.06405258178711,KO,"Sector Update: Technology ||| Stock Market News for February 19, 2014 - Market News ||| 3 Stock Flavors for Changing Tastes - Analyst Blog ||| Tech Stocks Ending Lower Today; Akamai Sees Prolexic Deal Adding Up to $8 Mln in Additional Q1 Revenue ||| Closing Update: Stocks Lose More Ground After Fed Minutes Show Some FOMC Members Would Speed Tapering ||| Tech Stocks Slipping Into The Red; Analog Device Climbs After Better-Than-Expected Q1 Results, Increased Price Targets ||| Dr. Pepper Earnings Review: Sugary Drinks Continue To Decline In The Domestic Market ||| Consumer ETFs Slip on Soft Coca-Cola Earnings - ETF News And Commentary ||| Sector Update: Technology ||| Coca-Cola Reports Decline In Carbonated Beverage Sales ||| #PreMarket Primer: Wednesday, February 19: Tesla Earnings Expected Today",1,0.54560363
2014-02-20,22639900.0,37.060001373291016,37.52000045776367,36.88999938964844,37.29999923706055,30.22612571716309,KO,"Daily Dividend Report: KO, TIF, HFC, VAL, LECO ||| Market Wrap For Febuary 20: S&P 500 Inches Closer To New Highs ||| 3 Reasons Small-Cap Stocks Will Prosper From The Rise Of The Global Consumer Class ||| UPDATE: Coca-Cola's Kathy Waller Named as Replacement at CFO Position ||| Coca-Cola CFOr Gary P. Fayard To Retire ||| Coke Raises Qtr. Dividend from $0.28 to $0.305/Share",0,0.48938733
2014-02-21,19419800.0,37.59000015258789,37.619998931884766,37.13999938964844,37.18000030517578,30.128887176513672,KO,"3 Reasons Investors Should Toast Small-Cap Beverage Stocks ||| Dow 30 Stock Roundup: Manufacturing Lifts, Coke Loses Fizz - Analyst Blog ||| Coca-Cola Hikes Dividend by 9% - Analyst Blog ||| Green Mountain, Lavazza Pen Keurig Deal - Analyst Blog ||| Weekly Market Wrap: February 21, 2014 ||| Market Wrap For February 21: Markets End The Week On A Negative Note ||| 3 Reasons Investors Should Toast Small-Cap Beverage Stocks ||| Coca-Cola Co. Announces Letters of Intent with Reyes Holdings, Troy Taylor",1,0.51837873
2014-02-24,24223500.0,37.29999923706055,37.59999847412109,37.220001220703125,37.5,30.3881893157959,KO,How to add some security to your growth stock portfolio ||| Market Wrap For February 24: Markets Showing Strength To Start The Week,1,0.48125052
2014-02-25,22845500.0,37.630001068115234,37.93999862670898,37.5,37.77000045776367,30.60698699951172,KO,"Notable ETF Inflow Detected - IVW, QCOM, KO, MRK ||| Diageo plc (DEO) Ex-Dividend Date Scheduled for February 26, 2014 ||| Molson Coors Brewing Company (TAP) Ex-Dividend Date Scheduled for February 26, 2014 ||| Coca-Cola on Track for New Bottling Partners - Analyst Blog ||| Coca-Cola Draws Growth From Still Beverages While Currency Translations Play Spoilsport",1,0.43293038
2014-02-26,18195100.0,37.900001525878906,37.93999862670898,37.720001220703125,37.869998931884766,30.68802261352539,KO,Wednesday 2/26 Insider Buying Report: KO ||| KO: Insiders vs. Shorts ||| Top Buys by Directors: Kent's $398.1K Bet on KO,1,0.50853735
2014-02-27,18423400.0,37.84000015258789,38.11000061035156,37.79999923706055,38.06999969482422,30.850095748901367,KO,"Stocks: Berkshire Hathaway Buys Shares of DaVita HealthCare; Coca-Cola CEO Buys Company Stock ||| The New #12 Most Shorted Dow Component: Johnson & Johnson ||| 3 Reasons To Heed Omar Little's Advice ||| The Coke Bull Story: Why Soda Sales For The Company Could Improve ||| 3 Reasons To Heed Omar Little's Advice ||| Green Mountain, Coca-Cola Close Equity Transaction, Green Mountain Sees Gross Proceeds ~$1.25B, Will Use Proceeds for Buyback, Funding Capex ||| Green Mountain Coffee Roasters, Coca-Cola Co Close On Previously Announced Equity Transaction",1,0.509149
2014-02-28,15763200.0,38.08000183105469,38.38999938964844,38.040000915527344,38.20000076293945,30.95543098449707,KO,"Dow 30 Stock Roundup: Home Depot Beats, Yellen Lifts Sentiment - Analyst Blog ||| FEMSA Reports Lackluster Q4 Earnings - Analyst Blog ||| Green Mountain-Coca Cola Close Deal - Analyst Blog ||| Companies That Blame The Weather For Earnings Misses ||| What Companies Stand To Benefit From The 86th Academy Awards?",0,0.48243564
2014-03-03,18683400.0,37.880001068115234,38.15999984741211,37.84999847412109,38.119998931884766,30.890607833862305,KO,"Interesting January 2015 Stock Options for KO ||| Warren Buffett's New Shareholder Letter: What You Need to Know ||| Green Mountain-Laura Secord Sign Deal - Analyst Blog ||| Coca-Cola and Kinder Morgan Report Big CEO Buys Over the Past Week ||| Guru Stocks at 52-Week Lows: CHL, KO, T, PBR, EC ||| Weekly CEO Buys Highlight: KMI, CLMS, RTRX, OPK, KO ||| Play Ball, Make Money ||| Morgan Stanley Sees The Coca-Cola Company's 2014 Consensus EPS As Still Too High",1,0.50079983
2014-03-04,20425200.0,38.34000015258789,38.38999938964844,38.22999954223633,38.310001373291016,31.044586181640625,KO,"Coca-Cola Enterprises, Inc. (CCE) Ex-Dividend Date Scheduled for March 05, 2014 ||| Pepsico, Inc. (PEP) Ex-Dividend Date Scheduled for March 05, 2014 ||| 3 Reasons To Invest In Small Caps That Are 'Easy To Understand' ||| Market Wrap For March 4: Bulls Take Over As Ukraine Fears Dissipate ||| UBS Sees Developed Market Challenges in Home & Personal Care, Beverages Sectors ||| UPDATE: Fitch is Concerned With Coca-Cola's High Gross Leverage That Has Been Elevated By Substantial Commercial Paper Balances ||| UPDATE: Fitch Says Coke's 10-Yr Agreement With Green Coffee Mountain Roaster's is a Positive ||| Fitch Making Cautious Comments on Coca Cola ||| UPDATE: UBS Initiates Coverage on Coca-Cola at Neutral ||| UBS Initiates Coverage on Coca-Cola at Neutral",1,0.48977253
2014-03-05,14367400.0,38.41999816894531,38.45000076293945,38.25,38.34999847412109,31.07698631286621,KO,"A Comprehensive Guide to Consumer Staples ETF - ETF News And Commentary ||| Notable ETF Inflow Detected - IVW, QCOM, KO, MRK",1,0.5110554
2014-03-06,14700000.0,38.400001525878906,38.54999923706055,38.27000045776367,38.470001220703125,31.17423439025879,KO,"Cott Corporation (COT) Ex-Dividend Date Scheduled for March 07, 2014",1,0.49494576
2014-03-07,17047600.0,38.560001373291016,38.61000061035156,38.36000061035156,38.54999923706055,31.239059448242188,KO,Warren Buffett's Simple Formula for Picking Stocks ||| 3 Of Many Reasons To Buy Stocks 'When You Have the Money' ||| #PreMarket Primer: Friday March 7: Non-Farm Payrolls Will Likely Show Improvement,1,0.49156055
2014-03-10,14540800.0,38.54999923706055,38.650001525878906,38.43999862670898,38.650001525878906,31.32009696960449,KO,"One Put, One Call Option To Know About for Coca-Cola ||| 3 Of Many Reasons To Buy Stocks 'When You Have the Money' ||| Coca-Cola Enterprises Hits 52-Week High - Analyst Blog ||| 13D Filing from Coca Cola on Keurig Green Mountain Shows 10.1% Stake ||| UPDATE: TD Ameritrade's IMX Sentiment for Feb. Gains, Now at 5.74",1,0.498748
2014-03-11,13812100.0,38.84000015258789,38.84000015258789,38.540000915527344,38.79999923706055,31.441654205322266,KO,"Can You Find Dow Bargains Hidden in the Dow's Record Run? ||| Green Mountain Renamed to Hint at Keurig Link - Analyst Blog ||| Coca-Cola to Report Q1 2014 Financial Results on Tuesday, April 15, 2014, Before the Market Open ||| #PreMarket Primer: Tuesday, March 11: BOJ Continues With Stimulus Package",0,0.4765081
2014-03-12,15673700.0,38.27000045776367,38.5,38.209999084472656,38.470001220703125,31.421232223510746,KO,"Dr Pepper Snapple Group, Inc (DPS) Ex-Dividend Date Scheduled for March 13, 2014 ||| Soda Makers Hope Sugar Substitutes Will Sweeten Sales ||| Wednesday's ETF with Unusual Volume: KXI",0,0.49920782
2014-03-13,18302800.0,38.45000076293945,38.4900016784668,37.91999816894531,37.970001220703125,31.012836456298828,KO,"Notable ETF Inflow Detected - IWB, BRK.B, MRK, KO ||| NPD Reporting At-Home Soda Machine Sales Jumped 30% in 2013, Sales of Mixes/Syrups Rose 83%",1,0.5098096
2014-03-14,14687200.0,37.95000076293945,38.31999969482422,37.880001068115234,38.16999816894531,31.17619514465332,KO,The Stocks Buffett Is Increasing His Ownership in Through Buybacks ||| Peltz Demands Changes at Pepsi - Analyst Blog,1,0.47418663
2014-03-17,19203000.0,38.16999816894531,38.369998931884766,38.04999923706055,38.27000045776367,31.257869720458984,KO,"Interesting May Stock Options for KO ||| Dow Movers: KO, MMM",1,0.50537634
2014-03-18,16880400.0,38.27000045776367,38.459999084472656,38.13999938964844,38.400001525878906,31.364063262939453,KO,Coca-Cola In Brazil: Global Events And Energy Drinks Could Drive Growth (Part 1) ||| March Madness' Top Corporate Seeds,0,0.50836974
2014-03-19,20882200.0,38.36000061035156,38.59000015258789,38.09999847412109,38.13999938964844,31.15169143676757,KO,Coca-Cola In Brazil: Global Events And Energy Drinks Could Drive Growth (Part 2),1,0.54738736
2014-03-20,13228000.0,38.11000061035156,38.470001220703125,37.95000076293945,38.45000076293945,31.404897689819336,KO,"Vina Concha Y Toro (VCO) Ex-Dividend Date Scheduled for March 21, 2014",0,0.48102468
2014-03-21,19189100.0,38.77999877929688,38.83000183105469,38.27999877929688,38.43999862670898,31.3967227935791,KO,"Notable ETF Inflow Detected - OEF, BRK.B, MRK, KO ||| PepsiCo's Bittersweet Symphony: Sugar Variants Might Save Ailing Sodas In Time",0,0.5036503
2014-03-24,15693000.0,38.47999954223633,38.52999877929688,38.209999084472656,38.400001525878906,31.364063262939453,KO,Market Wrap For March 24: Markets On Two-Day Losing Streak? ||| Google Honors Activist Dorothy Height & Her Contributions,1,0.50470936
2014-03-25,16898900.0,38.4900016784668,38.79999923706055,38.459999084472656,38.619998931884766,31.54374313354492,KO,"#PreMarket Primer: Tuesday, March 25: Group Of Seven Calls For Tougher Sanctions ||| Dow Analyst Moves: KO ||| #PreMarket Primer: Tuesday, March 25: Group Of Seven Calls For Tougher Sanctions",0,0.48140934
2014-03-26,15835500.0,38.68999862670898,38.93999862670898,38.61000061035156,38.61000061035156,31.535579681396484,KO,Dr Pepper's Margins Strong; Volumes Down - Analyst Blog ||| Coca-Cola Criticized for High Management Pay - Analyst Blog,1,0.52430975
2014-03-27,13031500.0,38.5099983215332,39.0,38.47999954223633,38.81999969482422,31.70709228515625,KO,"Dr Pepper Hits a 52-Week High - Analyst Blog ||| Challenges for Coca-Cola - Analyst Blog ||| #PreMarket Primer: Thursday, March 27: Citigroup Falls Short In Stress Tests",1,0.5078359
2014-03-31,24489800.0,38.9900016784668,39.02999877929688,38.459999084472656,38.65999984741211,31.5764102935791,KO,"iShares S&P 100 ETF Experiences Big Inflow ||| Updated Research Report on FEMSA - Analyst Blog ||| Dow Movers: KO, MSFT ||| UPDATE: Beverage Digest Report Showed US Carbonated Softdrink Volume Was Down 3% During 2013, US Liquid Refreshment Beverages Down 1.6% ||| Beverage Digest Reports Coke, Dr Pepper Snapple Gained Carbonated Soft Drink Market Share In 2013, While Pepsi Lost Market Share -Reuters",0,0.5078089
2014-04-01,20515700.0,38.52999877929688,38.88999938964844,38.310001373291016,38.40999984741211,31.372220993041992,KO,Sales In The Beverage Industry Continue To Plummet,0,0.5466638
2014-04-02,15709100.0,38.4900016784668,38.540000915527344,38.29999923706055,38.33000183105469,31.30688667297364,KO,"Ambev S.A. (ABEV) Ex-Dividend Date Scheduled for April 03, 2014 ||| UPDATE: S&P Places Coca-Cola's Ratings on CreditWatch with Positive Implications ||| S&P Affirms AA- Ratings on Coca-Cola, Outlook Raised from Stable to Positive",0,0.487046
2014-04-03,18114000.0,38.38999938964844,38.4900016784668,38.040000915527344,38.06999969482422,31.09452438354492,KO,Coke Kicks Off World Cup Campaign - Analyst Blog,1,0.5459667
2014-04-04,15453600.0,38.2400016784668,38.47999954223633,38.13999938964844,38.220001220703125,31.21703338623047,KO,Updated Research Report on Pepsi - Analyst Blog ||| Worst Session in Months for Tech; Dow Logs Triple-Digit Loss,1,0.5209799
2014-04-07,17295700.0,38.27000045776367,38.88999938964844,38.2599983215332,38.619998931884766,31.54374313354492,KO,"Guru Stocks at 52-Week Lows: HSBC, KO, HMC, LNKD, ED ||| Practical Thought About Charlie Munger's ""Practical Thought About Practical Thought"" ||| Is The Market Still Playing Defense?",1,0.4819028
2014-04-08,14769900.0,38.66999816894531,38.900001525878906,38.47999954223633,38.900001525878906,31.772443771362305,KO,"Kraft's Oscar Mayer Offers New Flavors - Analyst Blog ||| Compania Cervecerias Unidas, S.A. (CCU) Ex-Dividend Date Scheduled for April 09, 2014 ||| Coca-Cola's Brand Building Initiatives Could Shoulder Sluggish CSD Sales ||| S&P Upgrades Coca-Cola from AA- to AA; Outlook Stable ||| Morgan Stanley Sees Mixed Factors for The Coca-Cola Company",1,0.54311395
2014-04-10,21025700.0,38.97999954223633,39.400001525878906,38.81999969482422,38.88999938964844,31.7642765045166,KO,KO Makes Bullish Cross Above Critical Moving Average ||| Stocks Should Pay You To Be The Owner,0,0.49088192
2014-04-11,18084200.0,38.83000183105469,39.220001220703125,38.56999969482422,38.630001068115234,31.551916122436523,KO,"Demand Strong For Coke Zero, Energy Drinks ||| A Make or Break Week for Q1 Earnings Season - Earnings Preview ||| Benzinga Weekly Preview: Short, But Action Packed Week Ahead ||| Top 40 Upcoming Earnings Releases ||| Beverage Stocks Are A Better Way To Profit From The Restaurant Group ||| Stifel Lays Out Impact of Keurig Cold on Green Mountain, Coca-Cola, SodaStream",1,0.5231775
2014-04-14,19389800.0,38.709999084472656,38.79999923706055,38.400001525878906,38.72999954223633,31.633594512939453,KO,"Earnings Expectations For The Week Of April 14: Coca-Cola, Goldman Sachs, Google And More ||| Will Coca-Cola (KO) Disappoint This Earnings Season? - Analyst Blog ||| Pre-Market Earnings Report for April 15, 2014 : JNJ, KO, SCHW, NTRS, CMA, SXT ||| Week Ahead Market Report: April 14, 2014 ||| #PreMarket Primer: Monday, April 14: Military Action In Ukraine Looking More Likely ||| Earnings Expectations For The Week Of April 14: Coca-Cola, Goldman Sachs, Google And More",1,0.47193712
2014-04-15,47529200.0,39.83000183105469,40.470001220703125,39.5,40.18000030517578,32.81791305541992,KO,"Midday Update: Stocks Turn Negative As Housing Data, Ukraine Developments Spook Investors ||| Dow Movers: WMT, KO ||| Will Pepsi (PEP) Beat This Earnings Season? - Analyst Blog ||| Pre-Market Most Active for Apr 15, 2014 : KO, QQQ, FB, JNJ, HSBC, HMC, BAC, ZBRA, GOLD, ALU, SIRI, YHOO ||| Sector Update: Consumer Shares Higher; Coca-Cola up 1% on Q1 Results ||| Sector Update: Consumer ||| Earnings Reaction History: The Coca-Cola Company, 36.4% Follow-Through Indicator, 2.0% Sensitive ||| Bulls Claim Victory in Rocky Trading Session ||| Refreshing Sales Beat at Coca-Cola - Analyst Blog ||| Diet Soda Slump To Lower Coca-Cola's Volumes; Still Beverages Could Offset This Decline ||| Market Wrap For April 15: Who Doesn't Love A Turnaround? ||| #Premarket Prep Technical Update - Coca-Cola Sharply Higher ||| The Market Is Not Acting Right ||| Benzinga's Volume Movers ||| UPDATE: Coca-Cola Posts Drop In Q1 Earnings ||| ETF Outlook for Tuesday, April 15, 2014 (EWH, FCG, PSP, HDV) ||| UPDATE: Coca-Cola Trading Higher by 1%, Despite Missing on Bottom Line ||| Coca-Cola Expecting Unfavorable FY Currency Impact, Sees Bottling Deals Unfavorable 1% Impact on FY Sales, Income ||| Coca-Cola Expecting FY Buybacks in the Range of $2.5-3B ||| Coca-Cola Company (The) Reports Q1 EPS of $0.44 vs $0.45 Est; Revenue of $10.58B vs $10.61B Est ||| #PreMarket Primer: Tuesday, April 15: Hopes For Diplomacy In Ukraine Help Settle Markets ||| Earnings Scheduled For April 15, 2014 ||| Stocks To Watch For April 15, 2014",1,0.5003556
2014-04-16,21919900.0,40.119998931884766,40.59000015258789,40.119998931884766,40.59000015258789,33.15279006958008,KO,"PepsiCo Earnings Preview: Soft Drinks To Underperform Once Again ||| Is This the Top for Coca-Cola (KO)? - Tale of the Tape ||| Texas-Based Yacktman Fund's Top First Quarter Holdings ||| #PreMarket Primer: Wednesday, April 16: Chinese GDP Slows, But Surpasses Expectations",1,0.486227
2014-04-17,18547100.0,40.43000030517578,40.720001220703125,40.25,40.720001220703125,33.25897216796875,KO,"VYM, PG, KO, PM: Large Inflows Detected at ETF ||| Coca-Cola Now #18 Largest Company, Surpassing Oracle ||| Pepsi Begins 2014 with Strong Q1 Earnings - Analyst Blog ||| InterContinental Hotels Group Announces Strategic Alliance With The Coca-Cola Company",1,0.5204597
2014-04-21,12630900.0,40.470001220703125,40.7599983215332,40.34999847412109,40.75,33.283470153808594,KO,UPDATE: Wintergreen Says 'Implication for Investment Returns in Our Country May Be Devestating' ||| Wintergreen Advisers Sends Second Letter to Warren Buffett on Coca-Cola Equity Plan ||| Morgan Stanley Notes 'Overblown' Enthusiasm from Coca-Cola Investors,0,0.495504
2014-04-22,17404900.0,40.58000183105469,40.7599983215332,40.41999816894531,40.709999084472656,33.25079727172852,KO,Can Coca-Cola Enterprises (CCE) Keep the Earnings Streak Alive? - Analyst Blog ||| Strong Beverage Stock Earnings Lift Consumer ETFs - ETF News And Commentary ||| Kraft Recalls Oscar Mayer Wieners - Analyst Blog ||| Here's How We Value Green Mountains And Coca-Cola's Partnership ||| Mid-Afternoon Market Update: Revance Therapeutics Continues to Rally as Markets Hang onto Early Strength ||| Wintergreen Advisers Sends Letter to Coca-Cola Shareholders ||| Mid-Day Market Update: Allergan Surges On Buyout Offer; Lexmark Shares Slip,1,0.51380146
2014-04-23,12072500.0,40.70000076293945,40.810001373291016,40.560001373291016,40.72999954223633,33.267127990722656,KO,"SodaStream Might Be In Talks To Sell Stake To PepsiCo, Dr. Pepper Or Starbucks ||| CNBC's Sarah Eisen Reports Coca-Cola Has Responded to Buffett's Comments, Said 'We Greatly Respect [Buffett's] Views and Look Forward to Working with Him for Years to Come' ||| Buffett Says 'Muhtar is the Right Person' to Run Coca-Cola ||| Buffett Says He Will Not Sell Shares of Coca-Cola, Reassured He Loves the Co. ||| Buffett Says 'Something Between 8-9% of the Upside in Coca-Cola Shares is Covered by Options' ||| Warren Buffett Says He Did Not Agree with Coca-Cola's Equity Plan, Believes It Was 'Too Much,' Notes Charlie Munger Also Felt This Way ||| Coca-Cola Holders Have Voted Against Splitting Chair, CEO Role, Have Approved Slate of Directors for Board, Also 2014 Equity Plan",0,0.46750647
2014-04-24,11392600.0,40.70000076293945,40.88999938964844,40.459999084472656,40.70000076293945,33.242637634277344,KO,"Coca-Cola Enterprises Beats on Q1 Earnings; Lags Rev - Analyst Blog ||| Market Wrap For April 24: Apple's Smashing Earnings Overshadowed By Ukraine Concerns ||| CNBC's Sarah Eisen Reporting Wintergreen, Related to Yesterday's Coca-Cola Vote, Has Said Believes No Co Should Implement an Equity Plan with Support of a Majority of its Holders ||| Coca-Cola Elects Waller as CFO, Executive VP ||| 3 Small Cap Food Stocks With Big Name Brand Appeal",1,0.5159633
2014-04-25,16811400.0,40.459999084472656,41.0099983215332,40.43999862670898,41.0099983215332,33.49583053588867,KO,"XLP, PG, KO, PM: Large Inflows Detected at ETF ||| Coca Cola Femsa S.A.B. de C.V. (KOF) Ex-Dividend Date Scheduled for April 28, 2014",1,0.45849803
2014-04-28,20736700.0,40.81999969482422,41.27999877929688,40.7400016784668,41.02999877929688,33.512176513671875,KO,"One Put, One Call Option To Know About for Coca-Cola ||| Look to McDonald's for food on the go… and MCD for income! ||| 3 Ways To Profit From Consolidation In The Consumer Goods Industry",0,0.51578736
2014-04-29,18928400.0,40.970001220703125,41.02999877929688,40.52000045776367,40.56999969482422,33.13644790649414,KO,"Coca-Cola Bottling Co. Consolidated (COKE) Ex-Dividend Date Scheduled for April 30, 2014 ||| Stocks Continue to Bounce Back; Dow Approaches New-High Territory ||| Market Wrap For April 29: Dow Approaches Record Highs Despite Ongoing Ukraine Tension and Upcoming Fed Meeting ||| Nomura Initiates Coverage on Coca-Cola Company (The) at Buy, Announces $53.50 PT ||| Benzinga's Top Initiations ||| Nomura Initiates Coverage on Coca-Cola Company (The) at Buy, Announces $53.50 PT ||| Top 4 NYSE Stocks In The Beverages-Soft Drinks Industry With The Highest Revenue",1,0.48880818
2014-04-30,12362000.0,40.68999862670898,40.880001068115234,40.59000015258789,40.790000915527344,33.31613540649414,KO,"Buffett Abstained From Coke Vote, Out Of Respect",0,0.47225776
2014-05-01,15385800.0,40.790000915527344,40.79999923706055,40.2599983215332,40.77999877929688,33.30796432495117,KO,FEMSA Q1 Earnings Beat Estimates - Analyst Blog ||| SodaStream Shares Bubble And Burst Following PepsiCo And Tilson Comments,1,0.5309702
2014-05-02,14197000.0,40.790000915527344,40.959999084472656,40.630001068115234,40.95000076293945,33.44683074951172,KO,"Carl Icahn Tweets 'I've written what I believe to be an informative piece titled ""Why Buffett is Wrong on Coke,"" which will appear tomorrow in Barron's'",0,0.4980023
2014-05-05,10163500.0,40.650001525878906,40.93000030517578,40.54999923706055,40.7599983215332,33.2916374206543,KO,"Warren Buffett at Annual Meeting Says Best Results for Coca-Cola Were Achieved by Berkshire Hathaway's Abstention from Compensation Plan Vote ||| Barron's Recap: India Is Open For Business ||| IWF, KO, PM, PEP: ETF Outflow Alert ||| Coca-Cola (KO) Shares Cross 3% Yield Mark ||| Warren Buffett on CNBC Says: 'We Don't have Any Desire to Go to War With Coca-Cola",0,0.5078892
2014-05-06,9359900.0,40.52000045776367,40.65999984741211,40.45000076293945,40.4900016784668,33.07110977172852,KO,"Coca-Cola to Remove Harmful Ingredient from Drinks - Analyst Blog ||| Some Thoughts on the Berkshire Hathaway Annual Meeting ||| Market Wrap For May 6: Dow Suffers Triple-Digit Point Loss, Nasdaq Underperforms Once Again",1,0.5095325
2014-05-07,11115600.0,40.70000076293945,40.970001220703125,40.630001068115234,40.90999984741211,33.41415786743164,KO,"Wintergreen Sends Directors at Coca-Cola, Berkshire Letter",0,0.5198576
2014-05-08,8538700.0,40.84999847412109,40.959999084472656,40.650001525878906,40.72999954223633,33.267127990722656,KO,"Texas-Based Yacktman's Top First Quarter Holdings ||| Keurig Green Mountain Beats on Q2 Earnings, Revs - Analyst Blog ||| Coca-Cola Bottling Announces Agreement with The Coca-Cola Company To Expand Territory ||| Market Wrap For May 8: Tesla Helps Extend Nasdaq's Losing Streak To 3 Straight Days",1,0.53733623
2014-05-09,8516400.0,40.77999877929688,40.95000076293945,40.709999084472656,40.869998931884766,33.38148498535156,KO,Consumer Stocks Mixed; Coca-Cola Bottling Acquires New Distribution Territories,0,0.53206414
2014-05-13,11579600.0,40.83000183105469,41.220001220703125,40.81999969482422,41.11000061035156,33.5775032043457,KO,"Notable ETF Outflow Detected - XLP, PG, KO, PM ||| Futures Extend Winning Streak, But Sidetracked by Disappointing Retail Sales ||| Sector Update: Consumer ||| Coca-Cola buys and additional 6% of Keurig ||| Sector Update: Consumers ||| Energy Drinks Could Be The Growth Driver For Coca-Cola In The Domestic Market ||| Consumer Stocks Mixed in Late Trade; Corinthian Colleges Rallies After Lenders Agree to Default Waiver ||| Consumer Stocks Mixed This Afternoon; Keurig Green Mountain Jumps Nearly 10% After Coca-Cola Adds to Ownership Stake ||| Vina Concha Y Toro (VCO) Ex-Dividend Date Scheduled for May 14, 2014 ||| Sector Update: Consumer ||| Mid-Day Market Update: Rackspace Gains On Upbeat Earnings; DXP Enterprises Shares Slip ||| Coca-Cola Is Now Keurig Green Mountain's Largest Shareholder ||| Mid-Morning Market Update: Markets Gain; Elizabeth Arden To Explore Strategic Alternatives ||| Morning Market Movers ||| Benzinga's Top #PreMarket Gainers ||| Keurig Green Mountain Shares Rise 4% Premarket, as Coca Cola Raises Stake to 16% ||| Coca-Cola Reports 16% Holding In Keurig Green Mountain as of May 10 vs 10.1% as of Feb 27 -13D",0,0.5051156
2014-05-14,10036100.0,41.02000045776367,41.18000030517578,40.83000183105469,40.88999938964844,33.3978271484375,KO,Coke Takes Another Sip of Keurig - Analyst Blog ||| 2 Soft Drink Stocks with Fizz - Analyst Blog ||| The 5 Most Overvalued Dow Stocks,0,0.47569513
2014-05-15,12379200.0,40.619998931884766,40.959999084472656,40.43999862670898,40.52000045776367,33.09560775756836,KO,"Coca-Cola VP Finan Sells 194,000 Shares @$41.00/Share -Form 4 ||| Should Startups File Patents Or Stick To Trade Secrets?",1,0.5055643
2014-05-16,13823900.0,40.52000045776367,40.90999984741211,40.45000076293945,40.88999938964844,33.3978271484375,KO,"Will Coca-Cola Do Better in 2014? - Analyst Blog ||| Traders In SodaStream Digesting News Of Coca-Cola's Countertop Versions Of Freestyle ||| Coca-Cola's 'Freestyle' Manager in Interview: Will Test Product at McDonald's, Said Expecting More Beverage Purchases Amid the Product ||| Coca-Cola Announces Launch of New Countertop Versions of 'Freestyle,' Watch Shares of SodaStream",0,0.50542057
2014-05-20,9639500.0,40.79999923706055,40.93000030517578,40.56999969482422,40.58000183105469,33.14461898803711,KO,"Ball Corporation Expands in Southeast Asia - Analyst Blog ||| Facebook, Publicis Ink Deal - Analyst Blog ||| Dissecting Dividend Growth ETFs ||| Dissecting Dividend Growth ETFs ||| Top 4 Stocks In The Beverages-Soft Drinks Industry With The Highest Revenue",1,0.5346056
2014-05-21,8607300.0,40.54999923706055,40.880001068115234,40.5,40.869998931884766,33.38148498535156,KO,"XLP, CEMB: Big ETF Outflows ||| Balanced View on Pepsi - Analyst Blog ||| #PreMarket Prep Recap: Tiffany & Co. A Lone Bright Spot Among Retailers",0,0.49870858
2014-05-22,8430400.0,40.77000045776367,40.84000015258789,40.52999877929688,40.58000183105469,33.14461898803711,KO,"VIG, KO, WMT, PEP: Large Inflows Detected at ETF ||| Small-Caps Lead the Market Higher in a 'Reversal of Fortune'",0,0.5117463
2014-05-27,11282900.0,40.560001373291016,40.81999969482422,40.47999954223633,40.77000045776367,33.29981231689453,KO,"Molson Coors Brewing Company (TAP) Ex-Dividend Date Scheduled for May 28, 2014 ||| #PreMarket Primer: Tuesday, May 27: Hope Rises In Ukraine Despite Increased Fighting ||| A Closer Look At The World's 10 Most Valuable Brands ||| #PreMarket Primer: Tuesday, May 27: Hope Rises In Ukraine Despite Increased Fighting",0,0.4668415
2014-05-28,7536700.0,40.70000076293945,40.88999938964844,40.52999877929688,40.58000183105469,33.14461898803711,KO,A Closer Look At The World's 10 Most Valuable Brands,1,0.5270069
2014-05-29,9867100.0,40.68000030517578,40.869998931884766,40.59999847412109,40.65999984741211,33.20995330810547,KO,"Ball Corporation Hits 52-Week High - Analyst Blog ||| Pepsi Goes Digital With Touchscreen Soda Fountain ||| After Hours Most Active for May 29, 2014 : SIRI, QQQ, DIS, MDR, BLOX, AMAT, SPLK, T, AGN, KO, MU, OVTI",1,0.51030093
2014-05-30,10446100.0,40.540000915527344,40.91999816894531,40.4900016784668,40.90999984741211,33.41415786743164,KO,Is This The Time To Buy Dividend-Paying Stocks?,0,0.51901585
2014-06-02,7472100.0,40.75,40.88999938964844,40.68000030517578,40.86000061035156,33.373321533203125,KO,"One Put, One Call Option To Know About for Coca-Cola ||| VIG, KO, WMT, QCOM: ETF Outflow Alert",1,0.48452258
2014-06-03,10493100.0,40.720001220703125,41.0,40.709999084472656,40.880001068115234,33.389644622802734,KO,"Coca-Cola Enterprises, Inc. (CCE) Ex-Dividend Date Scheduled for June 04, 2014 ||| Cott Corporation (COT) Ex-Dividend Date Scheduled for June 04, 2014 ||| Pepsico, Inc. (PEP) Ex-Dividend Date Scheduled for June 04, 2014 ||| Top Energy Drink Stocks Recover After 'Sell In May'",0,0.4260314
2014-06-04,7864700.0,40.90999984741211,40.91999816894531,40.709999084472656,40.790000915527344,33.31613540649414,KO,"Ambev S.A. (ABEV) Ex-Dividend Date Scheduled for June 05, 2014",1,0.45603773
2014-06-09,7316400.0,40.84999847412109,41.09000015258789,40.84999847412109,40.90999984741211,33.41415786743164,KO,An easy way to become your own investing guru ||| Jefferies Initiated Coverage on Beverage Stocks: ||| What's The Deal With The Keurig Green Mountain Rally?,1,0.49049
2014-06-10,9168600.0,40.84000015258789,41.150001525878906,40.810001373291016,41.06999969482422,33.544830322265625,KO,"Noteworthy ETF Inflows: VIG, KO, WMT, QCOM ||| Jefferies Initiates Coverage Across The Beverage Sector ||| UPDATE: Jefferies Initiates Coverage On Coca-Cola, Reveals Concern Over Growth",0,0.5150439
2014-06-11,9648600.0,40.97999954223633,41.060001373291016,40.790000915527344,40.86000061035156,33.373321533203125,KO,"Dr Pepper Snapple Group, Inc (DPS) Ex-Dividend Date Scheduled for June 12, 2014 ||| Coca-Cola Company (KO) Ex-Dividend Date Scheduled for June 12, 2014 ||| FIFA Sponsors Concerned About Controversy, Demand Probe - Analyst Blog ||| Will Nike and Adidas Get a World Cup Boost? - Analyst Blog ||| Dow Analyst Moves: KO",0,0.47861424
2014-06-12,11583600.0,40.40999984741211,40.68000030517578,40.369998931884766,40.41999816894531,33.262210845947266,KO,"Benzinga's M&A Chatter for Thursday June 12, 2014 ||| Supreme Court: Yes, Pom Wonderful Can Sue Coke For False Advertising ||| US Supreme Court Rules Coca-Cola Must Face Pomegranate Drink Suit - Reuters, Bloomberg ||| Keurig Green Mountain Shares Spike Higher on Unconfirmed Market Chatter Coca Cola Offed $130/Share, GMCR Wanted $145",0,0.49642253
2014-06-16,12878200.0,40.18999862670898,40.77000045776367,40.150001525878906,40.65999984741211,33.459716796875,KO,"Coca-Cola Gets DaMarcus Beasley to Promote Soccer - Analyst Blog ||| XLP, PEK: Big ETF Outflows",1,0.5150701
2014-06-17,26926600.0,41.18000030517578,41.20000076293945,40.61000061035156,40.91999816894531,33.673683166503906,KO,"Keurig Brewers Now at Subway Restaurants - Analyst Blog ||| Benzinga's M&A Chatter for Tuesday June 17, 2014 ||| Market Wrap For June 17: Markets Higher Ahead Of Fed Decision ||| UPDATE: Keurig Green Mountain Shares Rise More than 6% to All-Time Intraday High of $127.88; Shares Traded at $131.41 in Extended Hours on February 5, 2014 ||| Activist Holder Says Warren Buffett May Support Taking Coca-Cola Private ||| Warren Buffett Comments On Taking Coca-Cola Private ||| CNBC Report Warren Buffett Has Said 'Absolutely No Change of Taking Coke Private' ||| Shares of Coca-Cola Now Up ~1.5% Following Private Talks Stemming from David Winters on FBN ||| UPDATE: Winters Says Warren Buffett May Want to Take Coke Private ||| Coca Cola Share Move Higher as Activist Investor David Winters on Fox Business Discusses Possibility of Coke Going Private ||| Coca-Cola Shares Jump Nearly $1 ||| 5 Stocks To Consider During The 2014 World Cup",1,0.52877975
2014-06-18,18518200.0,40.790000915527344,41.56999969482422,40.75,41.560001373291016,34.200347900390625,KO,"Keurig Green Mountain Hits a 52-Week High - Analyst Blog ||| In the news: Cisco buys a Swedish firm, Coke working on stevia drink and more ||| Why Coca-Cola is a Top 25 Dividend Giant (KO) ||| J&J Snack Foods Offers Minute Maid Frozen Juice Bars - Analyst Blog ||| Coca-Cola Enterprises Reaffirms FY14 Guidance - Analyst Blog ||| Several Major Companies May Be Affected By Redskins Trademark Cancellation ||| David Winters of Wintergreen Advisors on Bloomberg TV: Sees Coca-Cola as an Undermanaged Business, Believes Co. is Valuable is Managed Better",1,0.50076914
2014-06-19,13275200.0,41.540000915527344,41.869998931884766,41.52999877929688,41.790000915527344,34.38962936401367,KO,Coca-Cola Hits 52-Week High on Rumors of Going Private - Analyst Blog ||| Coca-Cola Enterprises May Be In Play For An Acquisition,0,0.5129913
2014-06-20,23402600.0,41.869998931884766,41.880001068115234,41.52999877929688,41.68999862670898,34.30732345581055,KO,New Coca-Cola Life Targets Health-Conscious Crowd ||| Keurig Green Mountain's First Cold Pod Manufacturing Unit - Analyst Blog ||| How 6 Companies Have Turned To Music For The World Cup ||| 5 Stocks To Heat Up Your Portfolio This Summer,1,0.5103374
2014-06-23,13099300.0,41.459999084472656,41.7400016784668,41.33000183105469,41.72999954223633,34.34023666381836,KO,Pepsi Hits a 52-Week High - Analyst Blog ||| Top 4 Large-Cap Stocks In The Beverages-Soft Drinks Industry With The Highest ROA,1,0.5152462
2014-06-24,14962800.0,41.52000045776367,41.88999938964844,41.470001220703125,41.84999847412109,34.4389762878418,KO,"XLP, BRXX: Big ETF Inflows ||| Keurig Green Mountain Offers Wellsley Farms Coffee in K-Cups - Analyst Blog",1,0.5199919
2014-06-25,17621800.0,41.59999847412109,41.97999954223633,41.459999084472656,41.959999084472656,34.52951431274414,KO,Ball Corporation Hits 52-Week High on Market Expansion - Analyst Blog ||| ~781K Share Block Trade in Coca Cola @$41.91 at 1:10 PM ET,1,0.52823675
2014-06-26,16903300.0,41.90999984741211,42.04999923706055,41.77999877929688,42.02999877929688,34.58711242675781,KO,"Starbucks' Student Debt Fillip: Too Little, Too Late? - Analyst Blog ||| Noteworthy ETF Inflows: IWY, AAPL, MSFT, KO ||| ~570K Share Block Trade in Coca Cola @$42.00 3:54 PM ET ||| New York State High Court Rules NYC Ban on Large Sodas Illegal",1,0.4937463
2014-06-27,18674400.0,41.9900016784668,42.290000915527344,41.90999984741211,42.18999862670898,34.718780517578125,KO,Instant Replay's Next Target? The World Cup,1,0.52166104
2014-06-30,14058700.0,41.97999954223633,42.4900016784668,41.81999969482422,42.36000061035156,34.85868453979492,KO,China's Turn For A Debt Crisis: Keep Your Eyes Open For The Unexpected,0,0.4931571
2014-07-02,6707000.0,42.310001373291016,42.40999984741211,42.150001525878906,42.290000915527344,34.80107879638672,KO,"XLP, QQQE: Big ETF Outflows ||| Keurig to Serve Nestle Coffee in K-Cups - Analyst Blog",0,0.522341
2014-07-07,8991900.0,41.959999084472656,42.20000076293945,41.93000030517578,42.13999938964844,34.67762756347656,KO,"One Put, One Call Option To Know About for Coca-Cola ||| 5 Top Dow Stocks With The Most Upside Potential",0,0.47923642
2014-07-08,10090500.0,41.970001220703125,42.25,41.90999984741211,41.93999862670898,34.5130615234375,KO,"COCA COLA HBC LTD (CCH) Ex-Dividend Date Scheduled for July 09, 2014 ||| 4 More Reasons To Use Home Equity Loans To Buy Stocks",1,0.5072415
2014-07-10,12564500.0,41.560001373291016,42.290000915527344,41.54999923706055,42.2599983215332,34.776390075683594,KO,"Dow Movers: HD, VZ ||| Monster Beverage Mentioned by Jim Cramer on Mad Money as Potential Takeover Target ||| How To Play Defensive Issues On Big Down Openings ||| #Premarket Prep Technical Update - Coca Cola Trading Higher",0,0.4819039
2014-07-15,10541900.0,42.40999984741211,42.43000030517578,41.95000076293945,42.09999847412109,34.644718170166016,KO,"Noteworthy ETF Inflows: HDV, CVX, PM, KO ||| Texas-Based Yacktman Fund Reports Second Quarter Portfolio ||| Longleaf Partners Funds 2014 Semi Annual Shareholder Letter",1,0.49166456
2014-07-16,10331400.0,42.2599983215332,42.38999938964844,42.02000045776367,42.119998931884766,34.661170959472656,KO,Will Philip Morris (PM) Surprise this Earnings Season? - Analyst Blog ||| Earnings Continue Driving Markets Higher,0,0.5053999
2014-07-17,9983500.0,41.93000030517578,42.150001525878906,41.83000183105469,42.02000045776367,34.578887939453125,KO,"Activist Investor Nelson Peltz Pursues PepsiCo ||| Keurig Brews Plan For Coffee Domination, Fizzy Profit ||| Markets Sell-Off After Malaysian Airline Crash In Ukraine",1,0.511054
2014-07-18,19272400.0,42.13999938964844,42.470001220703125,42.02000045776367,42.43000030517578,34.91627883911133,KO,Investors Focus On Earnings Rather Than Geopolitical Tensions ||| Benzinga Weekly Preview: Earnings Season Continues With Geopolitical Tensions As A Backdrop ||| SocGen Downgrades Coca-Cola Company (The) to Hold,0,0.5162069
2014-07-21,17607200.0,42.119998931884766,42.56999969482422,42.09000015258789,42.400001525878906,34.8916015625,KO,"Earnings Expectations For The Week Of July 21: Apple, Facebook, GM And Much More ||| 3 Beverage Stocks To Watch Ahead Of Earnings ||| One Put, One Call Option To Know About for Coca-Cola ||| Will Altria Group (MO) Disappoint this Earnings Season? - Analyst Blog ||| Pre-Market Earnings Report for July 22, 2014 : VZ, KO, CMCSA, UTX, MCD, MO, DD, LMT, KMB, TRV, STT, CMCSK ||| Can Pepsi (PEP) Keep the Earnings Streak Alive? - Analyst Blog ||| Will Coca-Cola (KO) Beat Earnings on Better Volumes? - Analyst Blog ||| Monday's ETF with Unusual Volume: SPLV ||| #PreMarket Primer: Monday, July 21: West Warns Russia 'For The Last Time'",0,0.49578276
2014-07-22,24706000.0,41.09999847412109,41.33000183105469,40.61000061035156,41.18999862670898,33.89585876464844,KO,"Dow Movers: TRV, INTC ||| Coca-Cola Beats Q2 Earnings, Volumes Up as Sodas Bounce Back - Analyst Blog ||| With 1/3 of the S&P 500 Having Reported Earnings… - Ahead of Wall Street ||| Sector Update: Consumer Shares Mixed in Pre-Bell Trade ||| Sector Update: Consumer ||| Will Callaway Golf (ELY) Surprise This Earnings Season? - Analyst Blog ||| Coca-Cola Pre-Earnings: Organic Brands and Brazil Investments to Bolster Growth ||| Earnings Season Boosts Confidence; S&P Trades At Record Highs ||| Coca-Cola Q2 2014 Conference Call Highlights ||| Top #PreMarket Earnings Releases From July 22, 2014 ||| Chipotle Surges On Upbeat Results; Harley-Davidson Shares Slide ||| Worst Performing Industries For July 22, 2014 ||| Markets Open Higher; McDonald's Profit Misses Estimates ||| The 10 Most-Respected Corporate Brands ||| From Coca-Cola Call: Expecting Margins During 2H to Continue as Seen in 1H, Expecting 2H to Exhibit 'Sound Financial Results' ||| From Coca-Cola Earnings Conference Call: Global Sparkling Brand Grew 2% Over Qtr. ||| UPDATE: Coca-Cola Posts Downbeat Q2 Revenue, Shares Drop ||| Premarket Movers ||| Coca-Cola Says Currency Exchange Rates Expected to Have Unfavorable Impact on Reported Results in 2014 ||| Coca-Cola Says Expects Impact of Structural Items, Including New Provision in Venezuela, to be 1-2 Point Headwind on Net FY Revenues ||| Coca-Cola Company (The) Reports Q2 EPS of $0.64 vs $0.63 Est; Revenue of $12.57B vs $12.82B Est ||| US Stock Futures Up Ahead Of McDonald's, Coca-Cola Earnings ||| #PreMarket Primer: Tuesday, July 22: Separatists Hand Over Remains From Malaysian Airlines Flight ||| Earnings Scheduled For July 22, 2014 ||| Stocks To Watch For July 22, 2014",0,0.5064935
2014-07-23,17531700.0,40.97999954223633,41.04999923706055,40.630001068115234,40.810001373291016,33.58316802978516,KO,"Pepsi Tops Q2 Earnings, Revenues on Lower Fx; Ups FY Outlook - Analyst Blog ||| Markets Mostly Higher As Earnings Season Continues To Impress ||| A Pair Trader's Nightmare: Coca-Cola Vs. PepsiCo ||| #PreMarket Primer: Wednesday, July 23: Documents Show Deutsche Bank Knew Of Reporting Problems",1,0.5072635
2014-07-24,14856000.0,40.970001220703125,41.09999847412109,40.65999984741211,40.970001220703125,33.71482849121094,KO,Coca-Cola Enterprises Beats on Q2 Earnings on Volume Growth - Analyst Blog,1,0.55416816
2014-07-25,10809900.0,40.91999816894531,41.040000915527344,40.810001373291016,41.0,33.739505767822266,KO,Coke and Pepsi Earnings Put Consumer ETFs in Focus - ETF News And Commentary ||| PowerTrend Brief: Follow The Money -- To Options ||| Consider Buying Coca-Cola On The Dip For Long-Term Gains,0,0.51743907
2014-07-28,11709100.0,40.9900016784668,41.0,40.61000061035156,40.68000030517578,33.476173400878906,KO,"Is it time to buy the world a Coke? ||| FEMSA Q2 Earnings Decline Y/Y Despite Revenue Surge - Analyst Blog ||| Ambev S.A. (ABEV) Ex-Dividend Date Scheduled for July 29, 2014 ||| Tip On Trading Earnings Reports With Binary Options",0,0.48117957
2014-07-29,10863600.0,40.75,40.77999877929688,40.34999847412109,40.34999847412109,33.20460510253906,KO,The Truth Behind Stock Prices,0,0.5025601
2014-07-30,20346200.0,40.45000076293945,40.5,39.61000061035156,39.619998931884766,32.6038932800293,KO,"Dow Movers: UNH, NKE ||| Notable Two Hundred Day Moving Average Cross - KO ||| Reasons To Buy Cracker Barrel On The Dip",0,0.49546516
2014-08-04,11012900.0,39.40999984741211,39.459999084472656,39.119998931884766,39.400001525878906,32.42285919189453,KO,Don't Make This Big Investing Mistake Once Interest Rates Start Rising ||| Will Coca-Cola Bottling Co. (COKE) Deliver Strong Earnings? - Analyst Blog ||| iShares S&P 100 ETF Experiences Big Outflow ||| Can K-Cups Drive a Keurig Green Mountain (GMCR) Earnings Beat? - Analyst Blog,0,0.49061105
2014-08-05,11639200.0,39.34000015258789,39.52999877929688,39.09999847412109,39.18000030517578,32.24181365966797,KO,Donald Yacktman's Top Five Holdings ||| Ukraine Tension Prominent As Dow Suffers Triple Digit Loss; S&P 500 & NASDAQ Also Lower ||| Coca-Cola Invests Additional $5B in Africa,1,0.5411953
2014-08-06,17567500.0,39.130001068115234,39.959999084472656,39.130001068115234,39.91999816894531,32.85076904296875,KO,"Dow Movers: VZ, WMT ||| ETF Outlook: Consumer Staples Select SPDR ETF (XLP) ||| Coca-Cola Bottling Co. (COKE) Beats on Q2 Earnings & Revenues - Analyst Blog ||| International Stocks: Investing Essentials",0,0.47550768
2014-08-07,14367400.0,39.959999084472656,40.0099983215332,39.33000183105469,39.34999847412109,32.38169860839844,KO,Could This Change Sweeten Diet Soda Sales for Coke and Pepsi?,1,0.550054
2014-08-08,13667000.0,39.34000015258789,39.58000183105469,39.2599983215332,39.45000076293945,32.46400833129883,KO,3 Best Defensive Funds to Protect Your Portfolio ||| Moody's Report on US Beverage Industry Says 'Diet Soda Sales Lose Their Fizz',1,0.5399103
2014-08-11,14102600.0,39.52000045776367,39.869998931884766,39.52000045776367,39.56999969482422,32.56273651123047,KO,"Death of Diet Sodas Makes Coke, Pepsi, and SodaStream Lose Weight ||| 4 Consumer Staples Stocks Trading Higher This Quarter ||| Stephen Powers Is Bullish On PepsiCo",1,0.51008326
2014-08-12,13297500.0,39.560001373291016,39.84000015258789,39.540000915527344,39.68000030517578,32.653263092041016,KO,"Dow Movers: CVX, MRK",1,0.51862895
2014-08-13,9638900.0,39.70000076293945,40.09999847412109,39.70000076293945,39.93999862670898,32.867210388183594,KO,"XLP, PGAL: Big ETF Inflows ||| IWF, KO, GILD, ORCL: Large Inflows Detected at ETF ||| What Russian Bans Could Mean For Corporate Profits",1,0.503277
2014-08-14,6902000.0,39.93000030517578,40.18999862670898,39.93000030517578,40.18000030517578,33.06472396850586,KO,"Benzinga's M&A Chatter for Thursday August 14, 2014 ||| From Monster Beverage Call to Discuss Coke Investment: Coca-Cola Has Option to Boost Stake to ~25% ||| Coca-Cola Enters Into Long-Term Strategic Partnership With Monster ||| #Premarket Prep Technical Update - Monster Rallly in Monster Beverage ||| Monster Beverage Says Coke Will Become Monster's Preferred Distribution Partner Globally ||| UPDATE: Coca-Cola Paid $2.15B for Monster Beverage Stake ||| Coca-Cola Buys 16.7% Equity Stake in Monster Beverage ||| The Coca-Cola Co And Monster Beverage Corp Enter Into Long-Term Strategic Partnership",1,0.5092497
2014-08-15,23221600.0,40.84999847412109,41.150001525878906,40.65999984741211,40.880001068115234,33.6407585144043,KO,"In the news: BHP plans to get smaller, Coke investing in Monster and more ||| Sector Update: Consumer ||| Dow Movers: T, KO ||| U.S. Stock Futures Underpinned by Calm in Global Markets, Tame Inflation Data ||| Sector Update: Consumer ||| Sector Update: Consumer Shares Higher Pre-Market ||| Closing Update: Nasdaq Closes Higher in Afternoon Rebound But Dow, S&P 500 Finish in the Red on Russia-Ukraine Worries ||| Sector Update: Consumer ||| Can Coca-Cola Keep the Momentum Going in the Second Half? - Analyst Blog ||| Why Monster Beverage Corp's Shares Have Gained a Monstrous 30% Today ||| Sector Update: Consumer Stocks Down With Broader Market Retreat; JC Penney Falls Despite Better-Than-Expected Q2 Results ||| Pre-Market Most Active for Aug 15, 2014 : MTU, JCP, ACHN, MNST, NQ, SMFG, NOK, JD, QQQ, AMAT, TVIX, KO ||| Markets Close The Week On Negative Note As Ukraine Worries Mount ||| #Premarket Prep Technical Update - Monster Beverage Holding Gains ||| U.S. Stocks Turn Lower; Dillard's Shares Slide On Downbeat Earnings ||| Benzinga's Volume Movers ||| Markets Gain; J.C. Penney Posts Narrower-Than-Expected Q2 Loss ||| Bank Of America Comments On Coca-Cola Amid Monster Deal ||| Stocks Hitting 52-Week Highs ||| Morning Market Movers ||| Benzinga's Top #PreMarket Gainers ||| Stocks To Watch For August 15, 2014",1,0.50299174
2014-08-18,14891500.0,40.790000915527344,41.41999816894531,40.790000915527344,41.34999847412109,34.027530670166016,KO,"CNBC's Stock Pops & Drops From August 15 ||| How to Turn $200 a Month Into $5 Million ||| Interesting September Stock Options for Coca-Cola ||| Stock Market News for August 18, 2014 - Market News ||| This Massive Hedge Fund Company Has Been Buying The Coca-Cola Company. Should You? ||| 3 Reasons Dr Pepper Snapple Group Inc.'s Stock Could Rise ||| Coca-Cola to Buy Stake in Monster; Monster Shares Rise 30% - Analyst Blog ||| CNBC's Stock Pops & Drops From August 18 ||| Jefferies Thinks Monster Looks Fully Valued Following Coca-Cola Deal ||| Monster Scaring Jefferies At These Levels ||| Credit Suisse Modestly Raises Estimates On The Coca-Cola Company To Account For Monster Beverages Transaction ||| Credit Suisse: Coke To Prove Monster 'Benefits Of Scale' ||| Stocks To Watch For August 18, 2014",0,0.4862678
2014-08-19,10260400.0,41.34999847412109,41.47999954223633,41.15999984741211,41.2599983215332,33.953468322753906,KO,"The Good, the Bad, and the Ugly of Coca-Cola's New Stake in Monster Beverage ||| 3 Hot Takeover Targets In The Food And Beverage Industry ||| 3 Analysts Updates On Monster Beverage After Coca-Cola Stake",0,0.4886064
2014-08-20,6782500.0,41.150001525878906,41.34000015258789,41.09000015258789,41.25,33.94524383544922,KO,The new blue chips: Five stocks for the next generation,1,0.5194065
2014-08-21,11951000.0,41.290000915527344,41.68999862670898,41.220001220703125,41.40999984741211,34.076908111572266,KO,"VTI, MRK, KO, GILD: Large Inflows Detected at ETF ||| 5 Things SodaStream International Ltd's Management Wants You to Know",0,0.50513613
2014-08-22,11244600.0,41.290000915527344,41.52000045776367,41.04999923706055,41.119998931884766,33.8382568359375,KO,5 Best Tech Stocks to Buy for the Dividends,1,0.5180193
2014-08-25,10229300.0,41.31999969482422,41.45000076293945,41.119998931884766,41.40999984741211,34.076908111572266,KO,"Can T-Mobile's Free High-Speed Data Be Successful? ||| Can Microsoft’s Windows 9 Succeed Where Windows 8 Failed? ||| Can Pepsi (PEP) Continue its Strong First-Half Momentum? - Analyst Blog ||| Cott Corporation (COT) Ex-Dividend Date Scheduled for August 26, 2014 ||| Soft Drinks: Investing Essentials ||| Coke, Microsoft And 3 Other Big Companies That Have Used Crowdfunding ||| S&P 500 Hits 2,000 Milestone As Bullish Momentum Continues",1,0.49197248
2014-08-26,8416500.0,41.40999984741211,41.70000076293945,41.40999984741211,41.59999847412109,34.23326110839844,KO,"How the Rising Dollar May Impact Your Portfolio - Stocks in the News ||| Molson Coors Brewing Company (TAP) Ex-Dividend Date Scheduled for August 27, 2014 ||| Dow Analyst Moves: KO",0,0.49387765
2014-08-27,7693100.0,41.52999877929688,41.709999084472656,41.43999862670898,41.59999847412109,34.23326110839844,KO,4 Things Dr. Pepper Snapple Group Inc.'s Management Wants You to Know,1,0.54049116
2014-08-28,9746400.0,41.5099983215332,41.70000076293945,41.43999862670898,41.630001068115234,34.25795364379883,KO,"Notable ETF Inflow Detected - IWF, VZ, IBM, KO ||| Option Alert: Coca-Cola Nov $42 Call; 14,266 Contracts Traded vs 11,927 OI; Currently $41.52 ||| Barron's Cover Story Possible Driver Of PepsiCo Movement",1,0.49509168
2014-08-29,7666700.0,41.59999847412109,41.75,41.470001220703125,41.720001220703125,34.3320198059082,KO,Can Dr Pepper Snapple Sustain the Solid 1H Results in 2H? - Analyst Blog ||| Will the 1H14 Fizz of Beverage Giants Go Flat in 2H? - Analyst Blog,0,0.5020296
2014-09-02,9798100.0,41.52000045776367,41.84000015258789,41.310001373291016,41.63999938964844,34.26618194580078,KO,"Pepsico, Inc. (PEP) Ex-Dividend Date Scheduled for September 03, 2014 ||| Coca-Cola Enterprises, Inc. (CCE) Ex-Dividend Date Scheduled for September 03, 2014 ||| A Sample Of Warren Buffett's Largest Profits",1,0.44476968
2014-09-03,8635400.0,41.68999862670898,41.84999847412109,41.65999984741211,41.77999877929688,34.38138198852539,KO,"Why Keurig Green Mountain Inc. Stock Has Skyrocketed 87% in 2014 ||| Coca-Cola Buys Stake In Monster Beverages ||| Coca-Cola Life To Launch In Mexico Amid Increased Soft Drink Scrutiny ||| Why the Coca-Cola Partnership Bodes Well for Monster Beverage ||| Keurig Green Mountain Inc Offering Coke Product For First Time ||| Keurig Green Mountain, Inc. And The Coca-Cola Co Expand Agreement To The Keurig Hot Brewing System",1,0.5021659
2014-09-04,16785300.0,41.79999923706055,42.16999816894531,41.72999954223633,41.869998931884766,34.455440521240234,KO,"Coca-Cola Enterprises Cuts 2014 Sales and Profit Outlook - Analyst Blog ||| After Hours Most Active for Sep 4, 2014 : XRX, IGT, EMC, CA, PFE, QQQ, EXC, XLNX, KO, INTC, LOCO, AMAT ||| Coca Cola (KO) Launches Honest Tea for Keurig Brewers - Analyst Blog ||| Top 4 Stocks In The Beverages-Soft Drinks Industry With The Highest Gross Margin",0,0.4974295
2014-09-05,12768100.0,41.86000061035156,41.86000061035156,41.61000061035156,41.84000015258789,34.430763244628906,KO,iShares Russell 1000 Growth ETF Experiences Big Inflow ||| Will Strategic Partnerships Pull Coke From Doldrums?,0,0.5021081
2014-09-08,9097700.0,41.66999816894531,41.93999862670898,41.630001068115234,41.77999877929688,34.38138198852539,KO,Should Coca-Cola Enterprises (CCE) Be in Your Portfolio? - Analyst Blog,1,0.50180286
2014-09-09,11892500.0,41.77000045776367,42.02999877929688,41.75,41.93999862670898,34.5130615234375,KO,"Dow Movers: GS, KO ||| Food Industry Launch Initiatives To Upgrade Food Safety Measures",1,0.5236652
2014-09-10,17558000.0,41.900001525878906,42.18999862670898,41.83000183105469,42.16999816894531,34.70232009887695,KO,"Dr Pepper Snapple Group, Inc (DPS) Ex-Dividend Date Scheduled for September 11, 2014 ||| Coca-Cola Company (KO) Ex-Dividend Date Scheduled for September 11, 2014 ||| Better Dividend Stock: Coca-Cola Company or PepsiCo, Inc.?",0,0.46159914
2014-09-11,19614000.0,41.68000030517578,42.060001373291016,41.65999984741211,41.95000076293945,34.77277755737305,KO,3 Warren Buffett Stocks That Dividend Investors Need to Know About ||| Latin America To Drive Volume And Margin Expansion For Anheuser-Busch InBev,0,0.5403717
2014-09-12,12966800.0,41.900001525878906,41.91999816894531,41.36000061035156,41.459999084472656,34.36661148071289,KO,5 Top Dividend Stocks,1,0.5790221
2014-09-15,12259600.0,41.45000076293945,41.58000183105469,41.33000183105469,41.5,34.39977264404297,KO,"How to Make Money in Stocks Without Taking Big Risks ||| Here’s Why Warren Buffett’s Favorite Stock Is Struggling ||| Lessons From This Huge Warren Buffett Failure ||| Noteworthy ETF Inflows: IWF, ORCL, KO, QCOM",1,0.472361
2014-09-16,15232800.0,41.290000915527344,41.79999923706055,41.18000030517578,41.63999938964844,34.51581954956055,KO,"Dow Movers: UTX, UNH ||| Walmart to Pay Penalty for Overcharging Coca-Cola Products - Analyst Blog ||| Will Coca-Cola's Relaunch of Surge on Amazon Open Doors? - Analyst Blog ||| Oprah's Wealth-Building Secret Revealed ||| Benzinga's Top Initiations ||| Cowen Initiates Coca-Cola With Market Perform ||| Cowen & Company Initiates Coverage on Coca-Cola Company (The) at Market Perform, Announces $43.00 PT",0,0.4835147
2014-09-17,16693800.0,41.77000045776367,41.77999877929688,41.31999969482422,41.61000061035156,34.4909553527832,KO,"3 Rock Solid Dividend Stocks With Upside Potential ||| Here's the Most Likely Outcome to Sodastream's Takeover Chatter ||| How Safe is Coke Stock and Its Dividend? ||| EXCLUSIVE: How Former IBM Exec Mychelle Mollot Will Help Klipfolio ||| After The Surge: 5 More Food Products Amazon Could Resurrect ||| Death Cross Stocks - The Coca-Cola Company, Crocs, Inc. & More",1,0.52653486
2014-09-18,12586400.0,41.75,41.880001068115234,41.54999923706055,41.790000915527344,34.640167236328125,KO,"3 Reasons Coca-Cola Is a Top Dividend Stock ||| Diageo plc (DEO) Ex-Dividend Date Scheduled for September 19, 2014",1,0.5185933
2014-09-19,47559700.0,41.97999954223633,42.34999847412109,41.75,42.04999923706055,34.855674743652344,KO,"After Hours Most Active for Sep 19, 2014 : MSFT, BTU, FB, URI, ARCP, AAPL, SIRI, UHS, CSCO, ORCL, KO, GGP ||| Keurig Hits New High on Cola Deal Expansion, 84% YTD Yield - Analyst Blog ||| Vina Concha Y Toro (VCO) Ex-Dividend Date Scheduled for September 22, 2014",1,0.50658256
2014-09-22,11518100.0,41.84999847412109,42.25,41.72999954223633,42.220001220703125,34.99658203125,KO,"Warren Buffett's Highest-Yielding Stocks ||| Is the Stock Market Ready to Plunge? Here Are 3 Things to Do Right Now ||| Anheuser's Domestic Beer Volumes To Remain Weak In The Near Term, ||| The Coca-Cola Company's 'Surge' Comeback Causes Social Media Stir",0,0.50584096
2014-09-23,10251300.0,42.0,42.15999984741211,41.880001068115234,41.88999938964844,34.72304916381836,KO,3 Great Stocks to Buy With No Debt and Great Prospects,1,0.5351908
2014-09-24,13540900.0,41.84999847412109,42.34000015258789,41.84999847412109,42.27000045776367,35.03804016113281,KO,Soda Giants Pledge to Reduce Calories in American Diet - Analyst Blog ||| Option Alert: Coca-Cola Shares Moving Higher; Oct $43 Call Active; Currently $42.08,0,0.4929817
2014-09-25,11076300.0,42.060001373291016,42.16999816894531,41.77000045776367,41.77999877929688,34.631866455078125,KO,3 Reasons The Coca-Cola Company's Stock May Fall,1,0.54914534
2014-09-26,9939600.0,42.0,42.25,41.709999084472656,42.20000076293945,34.980010986328125,KO,Europe Spells Trouble for America's Record Run ||| 3 Soft Drink Kings Pledge To Make Americans Healthier,1,0.5360197
2014-09-29,12441100.0,41.900001525878906,42.2599983215332,41.880001068115234,42.25,35.02145767211914,KO,The Single Biggest Risk in Retirement -- and How to Avoid It ||| Warren Buffett's Simple Formula for Picking Great Stocks ||| Dividend Aristocrats: Time to Buy The Coca-Cola Company?,1,0.50342304
2014-10-01,30409700.0,42.54999923706055,42.84999847412109,42.369998931884766,42.7400016784668,35.427616119384766,KO,Vanguard Dividend Appreciation ETF Experiences Big Outflow ||| Is The Coca-Cola Company a Good Dividend Stock to Buy Now? ||| Russia Comes Down Hard on PepsiCo: Should Investors Worry? ||| Guru Ray Dalio Followed His Own Drummer to Success ||| The Next Blue Chip Stocks: Facebook ||| 3 Companies Helping To Keep Diabetes Rates Lower ||| Wintergreen Advisers Offers Response to Coca-Cola's Statement Related to New Equity Stewardship Guidelines ||| Coca-Cola Shares Edge Lower as Bloomberg Reporting Wintergreen Has Said Co. Finally Conceded on Equity Plan,0,0.5183382
2014-10-02,16643200.0,42.59999847412109,42.77999877929688,42.41999816894531,42.65999984741211,35.36130905151367,KO,"Dow Movers: KO, HD ||| In the news: Dollar General extends offer for Family Dollar, Musk drops hints about 'the D' ||| Serge Berger, The Steady Trader Investment Strategist, Talks Facebook Inc And The Coca-Cola Company ||| UPDATE: Buffett Says Feels as Good as Ever About Coke Investment ||| Warren Buffett on CNBC Says Coca-Cola's Altered Executive Compensation Plan Makes Great Sense ||| #PreMarket Primer: Thursday, October 2: Hong Kong Protests Threaten To Escalate",1,0.47650898
2014-10-03,14046300.0,42.86000061035156,43.06999969482422,42.65999984741211,43.0,35.64313507080078,KO,Shareholder Pressure Pops at Coke ||| Is SodaStream a Short Sell?,1,0.507573
2014-10-06,20328100.0,43.02999877929688,43.68000030517578,42.970001220703125,43.59999847412109,36.14048004150391,KO,"The Skinny on Coke and Pepsi's New Lo-Cal Promise ||| The Rags-to-Riches Story of How Oprah Made Billions ||| Coca-Cola (KO) Hits 52-Week High; Trims Management Pay - Analyst Blog ||| Walmart Faces New Accusation, Agrees to Settle Lawsuit - Analyst Blog ||| Coca-Cola's Carbonates Offer Growth Despite Unfavorable Market Trends ||| Anheuser-Busch InBev: Headwinds In Russia To Lower Europe Volumes ||| Keurig Green Mountain To Expand Its Ready-To-Drink Beverage Segment With The Launch Of Honest Tea ||| Option Alert: Coca-Cola Oct $43.5 Call; 3,890 Contract Trade at Ask @$0.51; Currently $43.63 ||| UPDATE: Nomura Upgrades Coca-Cola Enterprises Inc",1,0.5158271
2014-10-07,24936600.0,43.47999954223633,44.13999938964844,43.47999954223633,43.91999816894531,36.40573501586914,KO,"Dow Movers: GS, CSCO ||| Dividend Aristocrats: Time to Buy Becton, Dickinson and Company? ||| Can Pepsi (PEP) Beat Q3 Earnings on its Snacks Strength? - Analyst Blog ||| Stocks Hitting 52-Week Highs",1,0.5095112
2014-10-08,26115600.0,43.58000183105469,44.560001373291016,43.5099983215332,44.54999923706055,36.92794799804688,KO,"XLP, BZQ: Big ETF Inflows ||| Better Dividend Stock: The Coca-Cola Company or PepsiCo, Inc.? ||| RLJ Lodging Re-opens Atlanta Hotel to Enhance Portfolio - Analyst Blog",0,0.5203383
2014-10-09,25029300.0,44.43999862670898,44.75,43.869998931884766,43.869998931884766,36.36429214477539,KO,"Noteworthy ETF Inflows: ITOT, VZ, T, KO ||| 3 Top Dividend Aristocrat Stocks for Your Portfolio ||| These Investors Are Bananas for Wanting to Buy Chiquita ||| Pepsi Q3 Earnings Beat as Emerging Market Gains, Ups View - Analyst Blog ||| Forget brand recognition, avoid these stocks",1,0.5103152
2014-10-10,25920800.0,43.880001068115234,44.869998931884766,43.84999847412109,44.470001220703125,36.861629486083984,KO,"Dow Movers: INTC, KO ||| 2 Things Coca-Cola Dividend Investors Need to Know ||| Tech, Semiconductors Among Worst Performers As Sell-Off Continues",0,0.50208455
2014-10-13,20175200.0,44.27999877929688,44.630001068115234,44.02999877929688,44.06999969482422,36.530067443847656,KO,7 Iconic Brands You’d Be Surprised to Learn Aren’t American-Owned ||| Ebola May Spike Demand for This Surprising IPO Stock ||| Will Monster Beverage (MNST) Continue to Beat Headwinds? - Analyst Blog,0,0.52609706
2014-10-14,21027400.0,44.040000915527344,44.119998931884766,43.470001220703125,43.63999938964844,36.173641204833984,KO,"How Safe is Mondelez International Inc. Stock and Its Tasty Dividend? ||| Will the End of SABMiller Deal Impact Molson Coors Canada? - Analyst Blog ||| After Hours Most Active for Oct 14, 2014 : INTC, QQQ, FB, MDR, BAC, AAPL, ONNN, MSFT, KO, T, NBR, GE",0,0.47486648
2014-10-15,22988600.0,42.70000076293945,43.52999877929688,42.70000076293945,43.22999954223633,35.83378982543945,KO,3 Smart Ways to Get Through a Market Crash ||| PepsiCo's Q3 Results Beat Expectations; Emerging Economies Fuel Growth,0,0.53110766
2014-10-16,22519200.0,42.650001525878906,42.93999862670898,42.380001068115234,42.560001373291016,35.278419494628906,KO,"XLP, XRT: Big ETF Inflows ||| Is Pandora Media's Stock a Buy Right Now? ||| 9 Wacky Wall Street Terms And Where They Came From",1,0.5012757
2014-10-17,23236000.0,42.68999862670898,43.02999877929688,42.310001373291016,42.880001068115234,35.543663024902344,KO,"Dow Movers: WMT, GE ||| IWB, VZ, KO, IBM: Large Outflows Detected at ETF ||| Into the Heart of Q3 Earnings Season - Earnings Preview ||| Will Coca-Cola (KO) Surprise Earnings this Season? - Analyst Blog ||| The Rise Of ESPN's 'College GameDay' ||| Apple, Google Lead List Of Top 10 Most Valuable Brands",1,0.4925709
2014-10-20,17647800.0,42.75,43.470001220703125,42.709999084472656,43.290000915527344,35.88352584838867,KO,"Benzinga Weekly Preview: Earnings Season Is In Full Swing ||| Can Coca-Cola Enterprises (CCE) Surprise Q3 Earnings? - Analyst Blog ||| Dow Movers: IBM, DIS ||| How Big Could the Berkshire Hathaway Brand Get? ||| Consumer Staples ETF Investing 101 - ETF News And Commentary ||| Pre-Market Earnings Report for October 21, 2014 : VZ, KO, UTX, MCD, LMT, KMB, CP, ITW, TRV, RAI, ARMH, OMC ||| The Coca-Cola Company Earnings Preview: Three Key Items to Watch ||| 3 Lessons Investors Can Learn From SodaStream Stock's Dramatic Collapse ||| Morgan Stanley Expects Muted Q3 EPS For The Coca-Cola Company ||| Coca-Cola Earnings Preview: Still Searching For Growth?",0,0.50846356
2014-10-21,55953500.0,40.79999923706055,41.18999862670898,40.2599983215332,40.68000030517578,33.720062255859375,KO,"In the news: Verizon and Coca-Cola miss, SunEdison's CEO talks growth and more ||| Stocks Extend Gains As Positive Earnings, ECB Accommodation Prospects Fuel More Bargain-Hunting ||| Midday Update: Stocks Extending Gains on Upbeat Tech Earnings, Reports ECB Looking to Add Liquitidy ||| Earnings Analysis: McDonald's, Chipotle, and Coca-Cola ||| Rally! ||| Futures Buoyed by Upbeat Tech Earnings, Rally in Europe ||| Futures Advance As Earnings and Europe Fuels More Bargain-Hunting ||| Closing Update: Earnings Fuel Rally on Wall Street; Technical Levels Compromised ||| Stocks Rally on Earnings; S&P 500 and Nasdaq Close Up for Fourth Day, Pierce Key Technical Levels ||| Why Shares of The Coca-Cola Company Went Flat Today ||| KO Dividend Yield Pushes Past 3% ||| Coca-Cola Earnings Preview: Sodas Could Surprise With Growth In Both Volumes And Margins ||| S&P 500 Movers: KO, WAT ||| The Coca-Cola Company's Q3 Earnings: Currency Woes, Revamped Plans ||| Harley-Davidson Climbs On Upbeat Earnings; Coca-Cola Shares Dip ||| Coca-Cola And Three Other Major Companies That Are Helping Entrepreneurs ||| Markets Surge; McDonald's Posts Lower Sales ||| From Coca-Cola Earnings Conference Call: Mgmt Still Expecting Long-Term High Single Digit EPS Growth ||| Morning Market Losers ||| From Coca-Cola Earnings Conference Call: Mgmt Still Expecting Long-Term High Single Digit EPS Growth ||| Coca-Cola Looking To Refocus After Earnings Miss, Lowered Guidance ||| UPDATE: Coca-Cola Posts Downbeat Q3 Revenue, Shares Fall ||| Benzinga's Top #PreMarket Losers ||| #PreMarket Primer: Tuesday, October 21: China's Third Quarter Growth Disappoints ||| Coca-Cola Now Targeting Before-Tax Profit in 6-8% Range Moving Forward, Sees Sales Target Growing in Mid Single Digit Range ||| Coke Q3 Global Unit Case Volume Up 1% ||| UPDATE: Coca-Cola Reports Streamlining of Global Supply Chain, Will Refocus on Core Model ||| Coca-Cola Reports Streamlining of Global Supply Chain, Will Refocus on Core Model ||| Coca-Cola Reports Expecting to be Below Long-Term EPS Growth Outlook in 2014 ||| Coca-Cola Company (The) Reports Q3 EPS of $0.53, Inline; Revenue of $11.98B vs $12.19B Est ||| US Stock Futures Gain After Strong Apple Results ||| Earning & Economic Calendar for Tuesday October 21, 2014 ||| Earnings Scheduled For October 21, 2014 ||| Must Watch Stocks For October 21, 2014",0,0.49671307
2014-10-22,27728200.0,40.18999862670898,41.11000061035156,40.09999847412109,40.619998931884766,33.67033004760742,KO,"The Best Warren Buffett Stocks for Dividend Investors to Buy in 2014 ||| Sector Update: Consumer Stocks Mixed Pre-Bell ||| Sector Update: Consumer ||| Dow Movers: BA, TRV ||| Markets Reverse Early Morning Gains Following Canadian Shooting ||| The Coca-Cola Company Conference Call Highlights ||| Benzinga's Top Downgrades ||| #PreMarket Primer: Wednesday, October 22: Johnson & Johnson Develops Ebola Vaccine ||| SocGen Downgrades Coca-Cola To Sell ||| SocGen Downgrades Coca-Cola Company (The) to Sell, Lowers PT to $37.50",1,0.51954263
2014-10-23,23346800.0,40.93999862670898,41.380001068115234,40.7400016784668,40.86000061035156,33.8692741394043,KO,Consumer Staples ETFs in Focus on Beverage Stock Earnings - ETF News And Commentary ||| Warren Buffett Lost Billions This Week -- Is He Losing His Touch? ||| Buy these Next Superstar Stocks - Investment Ideas ||| The Coca-Cola Company Announces Retirement of CMO/CCO Joe Tripodi; Marcos De Quinto To Become Chief Marketing Officer ||| Fast Money Halftime Report Final Trade From October 22 ||| Morgan Stanley Calls For Deeper Cuts At Coca-Cola,1,0.511271
2014-10-24,13396000.0,40.97999954223633,41.27000045776367,40.91999816894531,41.02999877929688,34.010189056396484,KO,"Why SodaStream International, Ltd. Stock Popped Today ||| XLP, SMH: Big ETF Inflows",0,0.4997128
2014-10-27,17222500.0,40.70000076293945,40.90999984741211,40.560001373291016,40.7599983215332,33.786380767822266,KO,"Warren Buffett Lost $2.5 Billion This Week, And He's Thrilled About It ||| Ambev S.A. (ABEV) Ex-Dividend Date Scheduled for October 28, 2014 ||| Why The Coca-Cola Company is One of the Biggest Warren Buffett Stocks ||| Read This Before Buying The Coca-Cola Co. Stock ||| Did PepsiCo Inc. Just Save SodaStream International? ||| Buffalo Wild Wings Investors Get Some Good News for a Change ||| Coca-Cola Earnings Review: Volatile Emerging Economies Limit Top Line Growth ||| Sector Update: Consumer ||| Coca-Cola vs. Pepsi: Which One is the Better Buy? ||| 3 Reasons Coca-Cola Can Turn It Around ||| Sector Update: Consumer Stocks Up Slightly Near Close; Coca-Cola Slips Following Buckingham Downgrade",0,0.4482582
2014-10-28,18658700.0,40.7599983215332,40.86000061035156,40.5099983215332,40.560001373291016,33.620601654052734,KO,"Noteworthy ETF Inflows: IWB, INTC, KO, IBM ||| Coca-Cola Bottling Co. Consolidated (COKE) Ex-Dividend Date Scheduled for October 29, 2014 ||| Forget the Coca-Cola Co, Dr Pepper Snapple Group is the Hot Soda Company Now ||| What SodaStream Investors Should Keep An Eye On ||| Hearing Unconfirmed Market Chatter Keuring Green Mountain CEO Going to Coca Cola; Rumor of Full Buyout by Coke",1,0.489401
2014-10-29,25761800.0,40.650001525878906,41.02999877929688,40.52000045776367,40.959999084472656,33.9521598815918,KO,"The Global Guru: Warren Buffett Stumbles ||| FEMSA Q3 Earnings Strong, Operating Income Up Double-Digits - Analyst Blog ||| Wednesday's ETF with Unusual Volume: NOBL ||| Coca-Cola Will Invest $500M Into CCA Indonesia, Will Take 29.4% Stake ||| Nomura Raises Price Target On Coca-Cola",1,0.5180199
2014-10-30,18295600.0,41.0,41.59000015258789,40.83000183105469,41.400001525878906,34.31687927246094,KO,"Will Coca-Cola Be Around 100 Years From Now? ||| Coca Cola Femsa S.A.B. de C.V. (KOF) Ex-Dividend Date Scheduled for October 31, 2014 ||| Pete Najarian Sees Unusual Options Activity In Coca-Cola",1,0.54288703
2014-10-31,18477700.0,41.83000183105469,41.88999938964844,41.400001525878906,41.880001068115234,34.71476364135742,KO,"A Beverage Company That May Have Bottomed Out ||| Option Alert: Coca-Cola Jan $44 Call; 8,964 Contract Trade at Ask @$0.36; Currently $41.64 ||| Option Alert: Coca-Cola Jan $45 Call; 3,902 Contract Trade at Ask @$0.19; Currently $41.54",0,0.48097244
2014-11-03,13230600.0,41.790000915527344,42.27999877929688,41.59000015258789,41.810001373291016,34.6567268371582,KO,You'll Never See Your Stocks the Same Way Again! ||| How Coca-Cola Is Spending $2.5 Billion to Solve Its Problems ||| Will Coca-Cola Bottling (COKE) Perform Well in Q3? - Analyst Blog,1,0.5068949
2014-11-04,10105300.0,41.77000045776367,42.04999923706055,41.65999984741211,41.81999969482422,34.66501998901367,KO,"VUG, KO, ORCL, QCOM: Large Inflows Detected at ETF ||| ""Goodbye Mr. Jones"": The End Of The Dow As An American Index ||| 3 Things to Watch When Monster Beverage Corp Reports Earnings This Week",1,0.49414715
2014-11-05,20676800.0,42.29999923706055,42.540000915527344,41.9900016784668,42.310001373291016,35.07119369506836,KO,"Dow Movers: INTC, KO ||| 4 Reasons PepsiCo Can't Save SodaStream International ||| Anheuser-Busch Inbev SA (BUD) Ex-Dividend Date Scheduled for November 06, 2014 ||| After Hours Most Active for Nov 5, 2014 : F, MRK, LBRDK, AAPL, CBS, ORCL, KO, MO, QQQ, QCOM, WFM, TSLA",0,0.47534314
2014-11-06,11528800.0,42.43000030517578,42.619998931884766,42.11000061035156,42.290000915527344,35.05461120605469,KO,"Coca-Cola Rolls Out Coca Cola Life Drink Nationwide - Analyst Blog ||| Berkeley's Soda Tax Deals a Painful Blow to Coca-Cola ||| Monster, Coca-Cola Will Amend Current Distribution Deal in US, Canada",1,0.50593644
2014-11-07,11803800.0,42.45000076293945,42.459999084472656,42.13999938964844,42.31999969482422,35.079471588134766,KO,"Monster Beverage Corp Earnings Show a Strong Leader in a Maturing Market ||| 3 Warren Buffett Secrets for a Prosperous Retirement ||| Monster Beverage (MNST) Beats on Q3 Earnings, Lags Sales - Analyst Blog",1,0.51321906
2014-11-10,9088900.0,42.25,42.56999969482422,42.09000015258789,42.38999938964844,35.13749313354492,KO,3 Steps to a Great Stock Portfolio ||| Where to find tomorrow's restaurant leaders ||| 3 Stocks for the Next 100 Years,1,0.5230098
2014-11-12,12768800.0,42.5099983215332,42.88999938964844,42.310001373291016,42.709999084472656,35.40275573730469,KO,"Notable ETF Inflow Detected - VUG, KO, GOOG, FB ||| Coca-Cola's New Plans in Focus: Should You Invest? - Analyst Blog",1,0.49776608
2014-11-13,12007700.0,42.650001525878906,43.08000183105469,42.630001068115234,42.790000915527344,35.46906661987305,KO,"How Much Does Berkshire Hathaway Like Consumer Goods? ||| Hearing Unconfirmed Chatter Coke/Keurig Machine May Not be in Stores Until Late 2016, According to Sources",0,0.48526546
2014-11-14,10939500.0,42.70000076293945,42.970001220703125,42.5,42.72999954223633,35.419334411621094,KO,U.S. Retail Offsets Eurozone Weakness - Ahead of Wall Street ||| Dow Analyst Moves: KO,1,0.52344793
2014-11-17,10664000.0,42.75,42.9900016784668,42.72999954223633,42.91999816894531,35.57682037353516,KO,"5 Companies, $1 Trillion: A Snapshot of America's Biggest Brands ||| 3 High Priced Stocks I'm Not Touching ||| 5 Ways SodaStream International, Ltd. Is Trying to Reinvent Itself ||| Events for the Week of Nov. 17-21, 2014",1,0.52635086
2014-11-18,26143000.0,42.95000076293945,43.86000061035156,42.75,43.52999877929688,36.08245468139648,KO,"Dr Pepper (DPS) Going Strong: Should You Invest in it Now? - Analyst Blog ||| Benzinga's M&A Chatter for Tuesday November 18, 2014 ||| Dow, S&P 500 Add To Gains Following Encouraging International News ||| UPDATE: Report of Potential 3G Capital Interest in Coca-Cola First Reported in June ||| Shares of Coca Cola Move Higher on Forbes Report of Potential Bid by 3G Capital",1,0.50992393
2014-11-19,25402300.0,43.66999816894531,44.43000030517578,43.560001373291016,44.220001220703125,36.65439224243164,KO,"Can $20 Million Solve Whole Foods’ Problem? ||| Dow Movers: VZ, KO ||| Fast Money Halftime Report Final Trade From November 19 ||| Notable Option Activity For November 19 ||| BTIG Analyst Says Coca-Cola Rumor is Not Legitimate ||| Option Alert: KO May 15 $49 Call; 10,182 Traded vs 192 OI; Currently $44.01 ||| Top Performing Industries For November 19, 2014 ||| Great Lakes Coca-Cola Distribution Signs Deal with Coca-Cola, No Terms Disclosed",1,0.5046739
2014-11-20,13465400.0,43.959999084472656,44.41999816894531,43.84999847412109,44.25,36.67927169799805,KO,Vanguard Growth ETF Experiences Big Inflow ||| Coca-Cola Grants Chicago Area Territories to Reyes Holdings - Analyst Blog ||| Hedge Fund Manager On Keurig Green Mountain: 'Coke Is Only Going To Buy More If The Price Falls' ||| Did Berkeley Just Start An Anti-Sugar Revolution?,1,0.52130747
2014-11-21,14382700.0,44.58000183105469,44.7400016784668,44.27999877929688,44.5,36.88650131225586,KO,3 Candidates for Warren Buffett's Portfolio ||| 3 Reasons Alcoa Inc. Stock Could Give Back Its Gains,0,0.53073573
2014-11-24,12890800.0,44.5099983215332,44.77999877929688,44.20000076293945,44.27000045776367,36.69584655761719,KO,"Believe It or Not, This Bank Has the Worst Reputation ||| Why You Should Think Buses In Brazil ||| After Hours Most Active for Nov 24, 2014 : WNR, JCP, PFE, KMI, QQQ, AAPL, SLXP, KO, SNE, NMIH, NUAN, CMCSA",1,0.49147102
2014-11-25,10741700.0,44.27000045776367,44.59000015258789,44.119998931884766,44.43000030517578,36.8284797668457,KO,"Coca-Cola Company (KO) Ex-Dividend Date Scheduled for November 26, 2014 ||| Cott Corporation (COT) Ex-Dividend Date Scheduled for November 26, 2014 ||| 2 Things PepsiCo, Inc. Investors Need to Know",0,0.4604239
2014-11-26,9199200.0,43.9900016784668,44.369998931884766,43.970001220703125,44.290000915527344,36.966190338134766,KO,Invest Like Warren Buffett With These 3 Stocks,1,0.50073546
2014-11-28,10502000.0,44.150001525878906,45.0,44.150001525878906,44.83000183105469,37.41689300537109,KO,"The Coca-Cola Company, SABMiller, Coca-Cola Sabco to Form Coca-Cola Beverages Africa ||| The Coca-Cola Company, SABMiller Ink Africa Bottling Deal - Analyst Blog ||| Warren Buffett's Favorite Stock Screen ||| After Hours Most Active for Nov 28, 2014 : CRC$, BAC, RYAM, KO, SMA, LBTYK, WFC, IFGL, INTC, MSFT, QQQ, AAPL",0,0.4899078
2014-12-01,10065700.0,44.18000030517578,44.77000045776367,44.130001068115234,44.54999923706055,37.183204650878906,KO,Coca-Cola Hits a 52-Week High on SABMiller Agreement - Analyst Blog ||| Coca-Cola's Bet on Protein Might Be Overestimating Americans' Taste for Milk,0,0.49906057
2014-12-02,9878100.0,44.369998931884766,44.66999816894531,44.22999954223633,44.540000915527344,37.17485809326172,KO,"Pepsico, Inc. (PEP) Ex-Dividend Date Scheduled for December 03, 2014 ||| FEMSA Buys Drugstore Chain, Expands in Small-box Segment - Analyst Blog ||| UPDATE: Tigress Financial Partners Upgrades Coca-Cola On Optimistic Growth Outlook ||| Tigress Financial Upgrades Coca-Cola Company (The) to Buy",0,0.48503765
2014-12-03,15246500.0,44.41999816894531,44.43999862670898,43.7599983215332,43.79999923706055,36.55721664428711,KO,"Could This Company Follow in Dendreon's Footsteps? ||| Keurig, Community Coffee Sign Distribution Deal - Analyst Blog",0,0.52994096
2014-12-05,12536900.0,43.5,43.61000061035156,43.20000076293945,43.52999877929688,36.33186721801758,KO,FDA Fat-Shames Restaurants Into Showing Nutrition Data,0,0.52909905
2014-12-08,12802300.0,43.5099983215332,43.630001068115234,43.09000015258789,43.13999938964844,36.0063591003418,KO,Coca-Cola's Next Big Drink Is... Milk? ||| Here's Why Coca-Cola Has A Great Corporate Reputation ||| Consumer Staples Select Sector SPDR Fund Experiences Big Inflow ||| Keurig Green Mountain Increases Pressure on SodaStream,0,0.50231653
2014-12-09,25714600.0,42.150001525878906,42.52999877929688,41.66999816894531,42.040000915527344,35.088253021240234,KO,Dividend Stocks: Will Craft Soda Boost PepsiCo Sales? ||| Will French Toast Crunch Relaunch Aid General Mills Sales? - Analyst Blog,0,0.50110793
2014-12-10,18324100.0,42.040000915527344,42.2400016784668,41.560001373291016,41.59999847412109,34.721004486083984,KO,"This Would Make Me Sell My Coke Stock ||| What Investors Need to Know About Amazon and Coca-Cola's Big Moves ||| Believe It Or Not, Morgan Stanley Says Buying Beer Is A Smart Investment",0,0.49703214
2014-12-11,16201500.0,41.619998931884766,42.0099983215332,41.5,41.52999877929688,34.6625862121582,KO,"Why Coca-Cola's Economic Moat Could Turn Into an Albatross ||| Benzinga's M&A Chatter for Thursday December 11, 2014",0,0.4836455
2014-12-12,18432400.0,41.38999938964844,41.61000061035156,40.869998931884766,40.90999984741211,34.145111083984375,KO,Keurig Green Mountain Expands Partnership with Caribou - Analyst Blog ||| Coke Stock Continues to Drag Down Warren Buffett's Results ||| Market Truisms and Quarterback Controversies,0,0.4929335
2014-12-15,23378500.0,41.130001068115234,41.18000030517578,40.560001373291016,40.56999969482422,33.861324310302734,KO,Bank Of America Upgrades Dr Pepper Snapple; Analysts Still Prefer Other Soft Drinks ||| Stock of the Week: Berkshire Hathaway (BRK.B) ||| UPDATE: Coca-Cola Sees A Currency Headwind On FX Of 7% ||| Coca-Cola Expects Net Repurchases Of $2B to $3B In 2015 ||| Wintergreen Advisers Issues Analysis of Coca-Cola,0,0.5005906
2014-12-16,23475400.0,40.20000076293945,41.310001373291016,39.79999923706055,40.38999938964844,33.71109390258789,KO,"Notable ETF Inflow Detected - XLP, KO, COST, WAG ||| What Pepsi Really Thinks of Its Partnership with SodaStream ||| Tuesday's ETF with Unusual Volume: DGRO ||| 3 Things SodaStream International Ltd Got Right in 2014 ||| Jefferies Lowers Coca-Cola Price Target ||| The Coca-Cola Company Appoints Julie Hamilton As Chief Customer, Commercial Leadership Officer ||| Strong Dollar Taking The Fizz Out Of Coca-Cola Profits ||| Fast Money Picks For December 16: Intersil, Toyota, Deckers Outdoor, Coca-Cola",1,0.4951968
2014-12-17,20223900.0,40.43999862670898,41.7599983215332,40.380001068115234,41.54999923706055,34.679283142089844,KO,"Dow Movers: CAT, XOM",1,0.5175244
2014-12-18,18030700.0,41.86000061035156,42.38999938964844,41.75,42.38999938964844,35.380367279052734,KO,"PowerTrend Bulletin: Tis the Season for Dividend Increases ||| Coca-Cola Bottling Reports Deal with Coca-Cola for Expansion of Franchise Territory to Louisville, Evansville, IN",0,0.5081614
2014-12-19,24009500.0,42.43999862670898,42.790000915527344,41.88999938964844,41.95000076293945,35.013126373291016,KO,Warren Buffett Doesn't Know What He's Missing with This Stock,1,0.5092881
2014-12-22,11190900.0,42.13999938964844,42.43999862670898,42.09000015258789,42.34999847412109,35.34698486328125,KO,"Mark Zuckerberg Should Heed This Warren Buffett Wisdom ||| 3 Value Stocks Senior Citizens Could Buy Right Now ||| Can Silicon Valley's Food Movement Spur Coca-Cola's Next Phase of Growth?” ||| Can Coca-Cola's Compete With Silicon Valley's Food Movement? ||| Vina Concha Y Toro (VCO) Ex-Dividend Date Scheduled for December 23, 2014 ||| Morningstar Analyst Says Coca-Cola, WhiteWave Partnership Would Make Sense ||| Argus Research Analyst John Staszak Says Coca-Cola, WhiteWave Partnership Is A 'Good Idea' ||| WhiteWave Trades Higher Amid Barron's Post On Coca-Cola Partnership ||| Barron's Blog Mentions Potential Coca-Cola Deal for WhiteWave Foods ||| UK's Competition And Markets Authority Says Relevant Merger Situation has Not Been Created in Proposed Transaction Between Coca-Cola Co and Monster Beverages",1,0.5019258
2014-12-23,13411300.0,42.540000915527344,43.13999938964844,42.470001220703125,42.970001220703125,35.86446762084961,KO,"3 Surprising Habits of Smart Investors ||| Why This Fund Manager Thinks The Coca-Cola Co Has Lost Its Way ||| Notable Option Activity For December 23 ||| UPDATE: Coca-Cola To Cut Jobs ||| Coca-Cola To Cut 1,000 To 2,000 Jobs ||| Option Alert: Coca-Cola Jan $43.5 Call; 4,337 Contract Trade at Ask @$0.32; Currently $42.66",0,0.526077
2014-12-29,8694500.0,42.79999923706055,43.060001373291016,42.4900016784668,42.86000061035156,35.77265930175781,KO,"My Biggest Investing Regret of 2014 ||| Compania Cervecerias Unidas, S.A. (CCU) Ex-Dividend Date Scheduled for December 30, 2014 ||| Sozzi Says Coca-Cola Should Imitate Pepsico, Build Snacks Division ||| Option Alert: Coca-Cola Jan $50 Call; 3,771 Contract Trade at Ask @$0.68, Currently $42.58",0,0.4829145
2014-12-30,9222000.0,42.7400016784668,42.9900016784668,42.650001525878906,42.7599983215332,35.68918991088867,KO,"Dow Movers: GE, T ||| Coca-Cola Can't Exploit This $14 Billion Opportunity Alone ||| Monster Beverage Soared 65% in 2014. What's Next?",0,0.46928132
2014-12-31,9369500.0,42.91999816894531,42.93999862670898,42.220001220703125,42.220001220703125,35.23849105834961,KO,How Keurig Green Mountain Soared 78% in 2014,0,0.53985983
2015-01-02,9921100.0,42.2599983215332,42.400001525878906,41.79999923706055,42.13999938964844,35.17171096801758,KO,"3 Dividend Aristocrats With Powerful Brands ||| Mike Khouw Sees Unusual Options Activity In Coca-Cola ||| XLP, JPP: Big ETF Outflows ||| IVW, CVS, KO, KMI: Large Inflows Detected at ETF ||| Will Keurig Green Mountain's Brewer Boost Growth in 2015? - Analyst Blog",0,0.51111186
2015-01-05,26292600.0,42.68999862670898,42.970001220703125,42.08000183105469,42.13999938964844,35.17171096801758,KO,"3 Stocks That Should Boost Their Dividends in 2015 ||| Morgan Stanley Upgrades Coca-Cola, 'Strengths Can Be Seen In Multiple Areas' ||| Hearing Unconfirmed Market Chatter of Possible 3G/Buffett Deal for Coca-Cola at $54+/Share ||| Morgan Stanley Upgrades Coca-Cola to Overweight",1,0.49793878
2015-01-06,16897500.0,42.40999984741211,42.93999862670898,42.2400016784668,42.459999084472656,35.438804626464844,KO,"The Year That Was: PepsiCo ||| Option Alert: Coca-Cola Feb $44 Call; 2,500 Contract Trade at Ask @$0.68, Currently $42.73",1,0.50257427
2015-01-07,13412300.0,42.79999923706055,43.11000061035156,42.58000183105469,42.9900016784668,35.88116455078125,KO,Keurig Cold Brewer to Offer Dr Pepper Beverages - Analyst Blog ||| Beverage Stocks That Outperformed Coca-Cola in 2014 - Analyst Blog ||| Hot Dividend Stocks: Coke Adds Fizz With Upgrade ||| 'Coca-Cola Selects PICS To Formalize Contractor Management Processes For Odwalla Brand',1,0.50870705
2015-01-08,21743600.0,43.18000030517578,43.56999969482422,43.09999847412109,43.5099983215332,36.31517028808594,KO,"Keurig Green Mountain, Dr Pepper to Make Pod Based Drinks - Analyst Blog ||| 5 Stocks to Buy for January ||| Keurig Green Mountain Has a Doctor to Treat its Cold ||| Report: Coca-Cola To Cut Up To 1,800 Jobs ||| CNBC Now Tweets: 'BREAKING: Coca-Cola eliminating 1600 to 1800 jobs as part of already announced cost-cutting plan - DJ'",0,0.5020851
2015-01-09,12733500.0,43.470001220703125,43.560001373291016,42.95000076293945,43.02999877929688,35.91454315185547,KO,"Coca-Cola (KO) Plans 1,800 Job Cuts to Reduce Expenses - Analyst Blog ||| Keurig Stock Heats Up As Its Single-Serve Machines Go Cold",0,0.5038312
2015-01-12,11415800.0,43.06999969482422,43.20000076293945,42.459999084472656,42.63999938964844,35.58903503417969,KO,"IWV, WFC, GE, KO: ETF Inflow Alert ||| 2015 Dogs Of The Dow ||| Super Bowl Marketing Campaigns Heat Up",0,0.5062457
2015-01-13,12529500.0,42.83000183105469,43.2400016784668,42.45000076293945,42.630001068115234,35.58069610595703,KO,"The Next Stock Warren Buffett May Sell ||| 8-K from Monster Beverage Shows Co. Expecting Coca-Cola Deal to Close by End of Q1, Shows Co. to Receive $2.15B Cash Payment on Deal",0,0.4880084
2015-01-15,11193100.0,42.83000183105469,42.86000061035156,42.16999816894531,42.380001068115234,35.372032165527344,KO,Is SodaStream a Top Turnaround Candidate in 2015? ||| An Interview With The CEO Of The World's Fastest-Growing Business Network,1,0.5198629
2015-01-16,15114900.0,42.36000061035156,42.59000015258789,42.2400016784668,42.52999877929688,35.49722671508789,KO,Keurig Inks Deal with GE Appliances to Offer GE Cafe Series - Analyst Blog ||| Warren Buffett And Jim Cramer See Eye-To-Eye On This Big Bank,1,0.4954572
2015-01-20,17047300.0,42.70000076293945,43.33000183105469,42.61000061035156,43.15999984741211,36.02305221557617,KO,"NFL Playoff Prediction: Buffalo Wild Wings Will Come Out on Top ||| Warren Buffett's Secret Stocks ||| 3 Reasons Keurig Green Mountain Inc.'s Stock May Fall in 2015 ||| 7 Things You Need to Know About Berkshire Hathaway ||| Pepsi Appoints Trian Nominee to Board: Truce with Peltz? - Analyst Blog ||| Dow Movers: JNJ, CSCO",1,0.5009642
2015-01-21,10720600.0,42.88999938964844,43.43000030517578,42.7599983215332,43.36000061035156,36.18997573852539,KO,"Is Coca-Cola Enterprises Stock's $1 Billion Buyback a Bright Idea? ||| After Hours Most Active for Jan 21, 2015 : CSCO, QQQ, FB, EBAY, T, GRPN, INTC, ABB, APC, SUNE, KO, PBR",1,0.4807448
2015-01-22,14709100.0,43.369998931884766,43.83000183105469,43.06999969482422,43.77999877929688,36.54053115844727,KO,Can You Name Warren Buffett's Top 5 Stock Holdings?,0,0.49561536
2015-01-23,12357700.0,43.59999847412109,43.75,43.18000030517578,43.310001373291016,36.14824295043945,KO,3 of the Best Dividend Aristocrat Stocks Money Can Buy ||| Hearing Vague Market Chatter in Keurig Green Mountain Involving Coca-Cola,0,0.5230736
2015-01-26,11151900.0,43.18000030517578,43.22999954223633,42.83000183105469,43.0,35.88950729370117,KO,Warren Buffett Bets on These Top Stocks for 2015 ||| Warren Buffett Stocks: 3 Dividend Aristocrats From Berkshire Hathaway's Portfolio,0,0.49354213
2015-01-27,15274000.0,42.540000915527344,42.63999938964844,42.150001525878906,42.38999938964844,35.380367279052734,KO,Two Yield Plays To Avoid ||| 3 Stocks to Sell as Greece Concerns Intensify Euro Slide - Analyst Blog ||| Coca-Cola New Initiatives,0,0.5118586
2015-01-28,14278500.0,42.59000015258789,42.79999923706055,41.900001525878906,41.91999816894531,34.98809051513672,KO,"XLP, KO, PM, CVS: ETF Inflow Alert ||| 10 Compelling Reasons Why Big Beverage May Want To Keep Their Eyes On Celsius Holdings ||| Pursuing Profits? Meet Margins! ||| Has Warren Buffett Lost His Touch? Not Even Close",1,0.48116598
2015-01-29,13657900.0,41.77000045776367,42.150001525878906,41.470001220703125,42.09999847412109,35.13833236694336,KO,The Coca-Cola Co. Lost to the Market in 2014. Will These Deals Help the Stock Pop in 2015?,0,0.48613092
2015-02-02,15197500.0,41.209999084472656,41.630001068115234,40.900001525878906,41.59000015258789,34.7126579284668,KO,"The Golden Age of Dividend Investing Is Dead ||| 3 Principles of Successful Dividend Investing ||| Yacktman Asset Management Buys Unilever, S&P Index in Q4 ||| Option Alert: Coca-Cola Feb $43 Call; 7155 Contract Trade at Ask @$0.28; Now $41.59",1,0.4784047
2015-02-03,13193100.0,41.75,41.84999847412109,41.369998931884766,41.630001068115234,34.746055603027344,KO,Wintergreen Says Coca-Cola 2014 Proxy Statement Did Not Adequately Disclose Secret Bonus Shares ||| 25 Stocks To Watch After Super Bowl Sunday,1,0.51933354
2015-02-04,16400000.0,41.77000045776367,42.09000015258789,41.619998931884766,41.68000030517578,34.78778839111328,KO,"Forget DIY Soda Machines, Keurig Green Mountain Inc. Needs to Buy This Company ||| 7 Top Stocks to Buy in February ||| Keurig Green Mountain Turns Cold as Results Raise New Concerns ||| Warren Buffets Says Coke Sales Up Almost Every Year Since 1896, Doesn't Worry About Coca-Cola Investment ||| The Coca-Cola Company, The Kiwanis Club of Little Havana Sign Calle Ocho Festival Beverage Agreement Through 2017",1,0.49307013
2015-02-05,11078500.0,41.79999923706055,41.81999969482422,41.5099983215332,41.790000915527344,34.879600524902344,KO,"Dow Movers: MRK, PFE ||| XLP, KO, PM, CVS: Large Inflows Detected at ETF ||| Why Keurig Green Mountain Inc Stock Went Cold Today ||| Warren Buffett Remarks On Moody's, Coca-Cola And The 'iWatch'",0,0.48881015
2015-02-06,12366400.0,41.630001068115234,41.7599983215332,41.31999969482422,41.45000076293945,34.59580612182617,KO,Will Coca-Cola's (KO) Earnings Beat Estimates this Season? - Analyst Blog,0,0.5120751
2015-02-09,13371100.0,41.380001068115234,41.45000076293945,41.040000915527344,41.22999954223633,34.412200927734375,KO,"Dear Chipotle: Please Don't Buy Back Shares ||| Carter Worth And Mike Khouw's Coca-Cola Trade ||| From Coca-Cola To Tesla, Here Are The 68 Most Important Earnings Expectations For The Week ||| Can Dick Costolo Solve Twitter’s Big Problem? ||| Pre-Market Earnings Report for February 10, 2015 : KO, CVS, REGN, RAI, PCG, HCP, OMC, HOT, TAP, KKR, WYN, SEE ||| Why Coca-Cola Shares Are Under Pressure ||| Wintergreen Urges Coca-Cola to Address Potential Approaches by Third Parties to Explore Buyout, Breakup",1,0.49550018
2015-02-10,32184200.0,42.90999984741211,43.02999877929688,42.20000076293945,42.400001525878906,35.38872146606445,KO,"Coca-Cola (KO) Beats on Earnings & Sales in Q4 - Tale of the Tape ||| Coke Climbs While Oil Stocks Fall Flat ||| Dow Movers: CVX, KO ||| Coca-Cola (KO) Beats Q4 Earnings, Revenues; Shares Rise - Analyst Blog ||| Futures Stronger Ahead of EU Finance Minister Meeting, Greek Debt Extension ||| With Soda Sales Plunging, Pepsi and Coke Turn to Nature for Help ||| Should SodaStream Investors Rule Out a Pepsi Merger? ||| The Coca-Cola Co. Earnings: Coke Revenue Stabilizes; Now for the Hard Part ||| 2 Consumer Stocks to Buy Instead of Coca-Cola in 2015 - Stocks in the News ||| Why the DJIA Rose Today – 139-Point Gain ||| Will Coca-Cola Enterprises (CCE) Disappoint this Earnings? - Analyst Blog ||| Midday Update: Stocks Resume Rally, Shrug off Losses in Energy Sector ||| Stocks Retreat Off Highs as Oil Market Slumps, Greece Still in Danger ||| Pre-Market Most Active for Feb 10, 2015 : WMGI, TVIX, BAC, BP, SAP, PBR, COUP, QCOM, KO, AAPL, XIV, QQQ ||| Mid-Afternoon Market Update: NASDAQ Gains Over 1%; Amkor Technology Shares Surge On Strong Earnings Report ||| Mid-Day Market Update: Markets Open Higher; Coca-Cola Profit Tops Views ||| From Conf Call: Coca-Cola Says China Food & Beverage Market Weakest in 10 Years ||| Morning Market Gainers ||| Morning-Market Movers Led By Aeropostale, Coca-Cola & Coupons.Com ||| UPDATE: Coca-Cola Shares Surge On Upbeat Earnings ||| 6 Things Coca-Cola Might Bring To A Store Near You ||| Coca-Cola Reports Q4 Adj. EPS $0.44 vs $0.42, Operating Sales $10.87B vs $10.76B est. ||| Earning & Economic Calendar for Tuesday February 10, 2015 ||| Earnings Scheduled For February 10, 2015 ||| Keep an Eye on These 10 Stocks for February 10, 2015",0,0.49646676
2015-02-11,20496300.0,42.09999847412109,42.4900016784668,41.70000076293945,42.369998931884766,35.363677978515625,KO,"Dow Movers: KO, BA ||| Pepsi Ends 2014 on Strong Note: Tops Q4 Earnings, Sales - Analyst Blog",0,0.5232698
2015-02-12,13818200.0,42.400001525878906,42.65999984741211,42.06999969482422,42.16999816894531,35.196754455566406,KO,"Coca Cola, PepsiCo Earnings Stir Up Consumer Staples ETFs - ETF News And Commentary ||| 3 Headwinds for Consumer Staples Stocks - Industry Outlook ||| Notable Option Activity For February 12: ZIOP, VIPS, BA, KO, CSCO, CMCSA ||| Option Alert: KO April $47 Call; 2,000 Traded vs 32 OI; Currently $42.54 ||| Fast Money Picks For February 12",0,0.49899817
2015-02-13,10792100.0,42.02000045776367,42.22999954223633,41.7599983215332,41.9900016784668,35.04652786254883,KO,"Dow Movers: AXP, CAT ||| Consumer Sector Update for 02/13/2015: GMCR, K, KO ||| 8-K: Monster Expects $280M in Costs From Transition of Distribution Agreement With Coca-Cola ||| Coca-Cola Buys 6.38 Million Shares Of Keurig Green Mountain; Stock Briefly Spikes ||| UPDATE: Keurig Green Mountain Shares Spiking On News Of Increased Stake By Coca Cola ||| Keurig Green Mountain Amended S-13d Shows Atlantic Industries Coca Cola Takes 16% Stake ||| Coca-Cola Co Buys 6,378,286 Shares Of Keurig Green Mountain Inc @$130.38/Share -Form 4",0,0.5051623
2015-02-17,12804200.0,41.810001373291016,41.880001068115234,41.63999938964844,41.810001373291016,34.89628219604492,KO,"You Should Buy This Classic Warren Buffett Stock Instead of His Used Cadillac ||| 3 Safe Stocks You Can Buy Right Now ||| Why You Can't Afford to Ignore PepsiCo Stock in 2015 ||| Think Like an Entrepreneur and Sell Your Company Stock ||| West Port Congestion to Hurt These ETFs - ETF News And Commentary ||| Coca-Cola (KO) Hikes Keurig Green Mountain Stake to 16% - Analyst Blog ||| Soros Fund Management Sells American Express & Netflix, Buys FireEye In Q4 ||| Coca-Cola Bottling Co. Consolidated Announces Agreement with The Coca-Cola Company to Expand Franchise Territory ||| Coffee: A Hot Commodity For The Next 5 Years ||| Is Dr. Pepper Snapple 'Conservative'? This Analyst Thinks So",0,0.48156515
2015-02-18,9789800.0,41.75,41.79999923706055,41.470001220703125,41.72999954223633,34.82951354980469,KO,PepsiCo Has Something Coca-Cola Doesn't and Was Wise to Keep It,1,0.53669214
2015-02-19,16578300.0,41.68000030517578,42.2400016784668,41.52999877929688,42.11000061035156,35.14667892456055,KO,"What PepsiCo Inc. Investors Should Look for in 2015 ||| KO Crosses Above Key Moving Average Level ||| PepsiCo Inc. Raises Dividends: What You Need to Know ||| James D. Robinson III, Peter Ueberroth To Retire From The Coca-Cola Company BOD ||| Coca-Cola Company Increases Qtr. Dividend From $0.305 To $0.33/share ||| Option Alert: Coca-Cola May $44 Call; 21458 Contract Trade Above Ask @$0.33; Now $41.68",0,0.51153666
2015-02-20,15982400.0,42.040000915527344,42.11000061035156,41.63999938964844,41.970001220703125,35.02982711791992,KO,"Coca-Cola CFO Speaking at CAGNY Conference Says Taking Steps to Revive Revenue, Profit Growth by Revising Incentive Metrics to Include Revenu ||| Hearing Unconfirmed Market Chatter of Coke Buying Remainder of GMCR it Doesn't Own for $140-$150/Share ||| From Coca-Cola's Presentation at CAGNY Conference: Says Confident in Mid-Single Digit Long-Term Sales Growth, High Single Digit LT Earnings Growth ||| Option Alert: Coca-Cola May $43 Call; 2690 Contract Trade Above Ask @$0.80; Now $41.84 ||| Coca-Cola Presentation Begins At Cagny Conference ||| Fast Money Halftime Report Final Trade From February 19",0,0.515315
2015-02-23,11830300.0,41.709999084472656,42.16999816894531,41.68999862670898,41.84999847412109,34.92966079711914,KO,"Can You Guess Coca-Cola Inc.'s 20 Billion-Dollar Brands? ||| Benzinga's Weekend M&A Chatter ||| Don't Trust McDonald's and Coca-Cola? You're Not Alone ||| Tigress Financial Partners' Latest Ratings On WhiteWave Foods, Coca-Cola, PepsiCo ||| Hearing Unconfirmed Market Chatter Brain Kelley to Replace Mutar Kent as Coke CEO",1,0.50450754
2015-02-24,12782700.0,41.84999847412109,42.33000183105469,41.77000045776367,42.130001068115234,35.16337585449219,KO,"Molson Coors Brewing Company (TAP) Ex-Dividend Date Scheduled for February 25, 2015 ||| Can Monster Beverage Deliver Another Monster Quarter? ||| Diageo plc (DEO) Ex-Dividend Date Scheduled for February 25, 2015 ||| Option Alert: Coca-Cola May $42 Call; 3750 Contract Trade at Ask @$0.80 ||| Option Alert: Coca-Cola May $44 Call; 3000 Contract Trade at Ask @$0.45, Now $41.90",0,0.47785985
2015-02-25,10323300.0,42.16999816894531,42.2400016784668,41.7400016784668,42.04999923706055,35.09660339355469,KO,Ball Corporation to Buy British Can Maker Rexam for $6.8B - Analyst Blog,1,0.5345299
2015-02-26,14346500.0,42.040000915527344,42.54999923706055,41.970001220703125,42.459999084472656,35.438804626464844,KO,Monster Beverage Gives Its Growth a Big Kick Higher ||| Has the Academy Awards Lost the Midas Touch? - Analyst Blog ||| Monster Beverage Beats Q4 Views; Coke Deal To Close In Q2,1,0.5102359
2015-02-27,28312800.0,42.52000045776367,43.65999984741211,42.470001220703125,43.29999923706055,36.13990020751953,KO,"Warren Buffett's Best Dividend Stocks ||| Dow Movers: AXP, KO ||| FEMSA (FMX) Q4 Earnings Miss Estimates on Currency Impact - Analyst Blog ||| Monster Beverage Beats on Q4 Earnings & Revenue Estimates - Analyst Blog ||| Ambev S.A. (ABEV) Ex-Dividend Date Scheduled for March 02, 2015 ||| DJIA Index Notches 5.6% Gain in February ||| Consumer Sector Update for 02/27/2015: WTW,MNST,CVSL ||| 3 Stocks That Could Lose You a Lot of Money ||| Consumer Sector Update for 02/27/2015: JCP, MNST, CVSL, KO ||| Stocks Hitting 52-Week Highs ||| Morning Market Gainers ||| Benzinga's Top #PreMarket Gainers ||| Fast Money Picks For February 27: Coca Cola, Google, Facebook",0,0.47267032
2015-03-02,13514600.0,43.29999923706055,43.29999923706055,43.08000183105469,43.20000076293945,36.05644226074219,KO,"These 3 Millionaire-Maker Stocks Turned $20,000 Into $1.1 Million ||| Stifel Analyst Sheds More Light On The Coke-Monster Relationship ||| 11 Key Quotes From Warren Buffett's New Shareholder Letter ||| Berkshire Hathaway Expects to Partner With 3G in More Activities ||| Warren Buffett's Simple Way to Make Money Investing ||| The 8 Words That Propelled Warren Buffett to His $71 Billion Net Worth ||| These Stocks Just Raised Their Dividends ||| Monster Beverage Hits 52-Week High on Solid Q4 Results - Analyst Blog",0,0.5058954
2015-03-03,10036300.0,43.11000061035156,43.15999984741211,42.84000015258789,42.95000076293945,35.847774505615234,KO,"Insiders Buy the Holdings of XLP ETF ||| Coca-Cola Enterprises, Inc. (CCE) Ex-Dividend Date Scheduled for March 04, 2015 ||| Pepsico, Inc. (PEP) Ex-Dividend Date Scheduled for March 04, 2015 ||| Keurig, Dunkin Brands Expand K-Cup Deal - Analyst Blog ||| Monster Beverage: Strong Buy on Solid Q4, Estimate Revision - Analyst Blog ||| Warren Buffett Keeps Buying IBM Stock: Should You Follow Him? ||| Warren Buffett: Strong Dollar Makes For 'Tough Year' In 2015 ||| Fast Money Picks For March 3: General Motors, Coca-Cola, Cisco, Bank Of America",0,0.45531526
2015-03-04,16263000.0,42.91999816894531,42.97999954223633,42.470001220703125,42.5,35.47218704223633,KO,"After Hours Most Active for Mar 4, 2015 : GM, NEE^O, QIHU, CSCO, HPQ, KO, GE, AAPL, BRCD, VIAB, BRCM, QQQ ||| Apple, 'Transformers' Lead 2015 Product Placement Award Winners",0,0.4818242
2015-03-05,9223000.0,42.560001373291016,42.61000061035156,42.25,42.400001525878906,35.38872146606445,KO,Why This Dividend Aristocrat Doesn’t Deserve Your Money ||| Consumer Staples Select Sector SPDR Fund Experiences Big Outflow ||| Keurig Green Mountain Inks K-Cup Deal with DS Services - Analyst Blog,0,0.500994
2015-03-06,18180500.0,42.119998931884766,42.20000076293945,41.33000183105469,41.52000045776367,34.654239654541016,KO,"Can United Natural (UNFI) Q2 Earnings Surprise Estimates? - Analyst Blog ||| Cott Corporation (COT) Ex-Dividend Date Scheduled for March 09, 2015 ||| Option Alert: Coca-Cola Mar $42 Call; 5971 Contract Trade at Ask @$0.28: Now $41.71",0,0.46723273
2015-03-09,10123300.0,41.52999877929688,41.54999923706055,41.31999969482422,41.38999938964844,34.54574203491211,KO,3 Stocks to Protect Investors in a Volatile Market ||| Why Procter & Gamble Co Isn't As Safe As You Think ||| Pro On Apple Watch Sell-Off: It's Only 'A Few Hours' Worth Of Trading,0,0.48988307
2015-03-10,14599100.0,41.09999847412109,41.150001525878906,40.68000030517578,40.68999862670898,33.96149444580078,KO,"Euro Pain Hits Stocks, But U.S. Multinationals Want the Last Laugh",0,0.4891688
2015-03-11,18549700.0,40.72999954223633,40.72999954223633,40.08000183105469,40.09999847412109,33.46904754638672,KO,"Dow Movers: PG, INTC ||| Dr Pepper Snapple Group, Inc (DPS) Ex-Dividend Date Scheduled for March 12, 2015 ||| Coca-Cola Company (KO) Ex-Dividend Date Scheduled for March 12, 2015 ||| Closing Update: Stocks Pare Early Gains on Lingering Concern About Higher Rates, Stronger Dollar ||| Option Alert: Coca-Cola Mar $40 Call; 2913 Contract Trade at Ask @$0.20; Now $40.13 ||| Prime Retailer Reports Coke Acquisition of GMCR in Progress",1,0.46732533
2015-03-12,17728700.0,40.09999847412109,40.56999969482422,40.02000045776367,40.56999969482422,34.14229965209961,KO,"Pre-Market Most Active for Mar 12, 2015 : BAC, LL, ACAD, HSBC, EQM, CYBR, C, AAPL, QQQ, KO, AMRN, TVIX ||| Euro Collapse No Longer a Major Concern for US Companies - Analyst Blog ||| Coca-Cola Has 'Accelerated Growth Potential,' Wells Fargo Says",0,0.48820096
2015-03-13,17438400.0,40.43999862670898,40.56999969482422,39.61000061035156,39.90999984741211,33.58687210083008,KO,"Coca-Cola CEO's 2014 Pay Rises; Skips Performance Bonus - Analyst Blog ||| XLP, KO, WMT, PM: Large Outflows Detected at ETF ||| The Zacks Analyst Blog Highlights: Coca-Cola, Kinder Morgan, Priceline Group, Berkshire Hathaway and Apple - Press Releases",1,0.48721984
2015-03-16,15238800.0,40.0,40.34999847412109,39.9900016784668,40.290000915527344,33.90666961669922,KO,Celsius Holdings Reaches Profitability: Why The Company Makes Even More Sense Now As A Future Acquisition For Big Beverage,1,0.5061322
2015-03-17,21661800.0,40.66999816894531,40.72999954223633,40.31999969482422,40.5099983215332,34.09181213378906,KO,"Why Monster Beverage Corp Stock Soared 20% in February ||| Dow Movers: CAT, KO ||| Dan Nathan Sees Unusual Options Activity In Coca-Cola",1,0.49758598
2015-03-18,26247500.0,40.47999954223633,40.790000915527344,39.79999923706055,40.59999847412109,34.16755294799805,KO,"Which American Companies Do the Most Business Abroad? ||| 5 ""Strategic Actions"" The Coca-Cola Co. Wants Investors to Know ||| Dow Movers: KO, CAT ||| Option Alert: Coca-Cola Apr $40 Call; 4357 Contract Trade at Ask @$0.81",0,0.47913295
2015-03-23,17060500.0,40.63999938964844,40.93999862670898,40.5,40.619998931884766,34.18437957763672,KO,"The Biggest Red Flag for Dividend Investors ||| When It Comes to Soda, Americans Prefer This Brand Above All Others ||| Can Coca-Cola Address Its Biggest Problem? ||| Dr Pepper (DPS): How is it Poised for 2015 after a Solid 2014? - Analyst Blog ||| The Surprising Way the Stock Market Turned Upside Down ||| MGP Ingredients, Inc. (MGPI) Ex-Dividend Date Scheduled for March 24, 2015 ||| Better Dividend Stock Buy: Procter & Gamble Co. or The Coca-Cola Co.? ||| XLP, IBCE: Big ETF Outflows",0,0.503061
2015-03-24,13485700.0,40.90999984741211,40.9900016784668,40.470001220703125,40.470001220703125,34.05815124511719,KO,"Vina Concha Y Toro (VCO) Ex-Dividend Date Scheduled for March 25, 2015 ||| 3 Warren Buffett Stocks for Retirement Investors ||| Noteworthy ETF Inflows: IWF, KO, HD, ORCL",0,0.4917178
2015-03-25,22811300.0,40.59000015258789,40.70000076293945,40.2400016784668,40.45000076293945,34.04132080078125,KO,3 Dividend Aristocrats We Wouldn't Buy ||| This Map Of Every Food Brand Will Blow Your Mind ||| Citi Talks Obesity In Massive New Report,0,0.49374318
2015-03-26,17359600.0,40.34000015258789,40.560001373291016,40.22999954223633,40.34999847412109,33.9571647644043,KO,10 Warren Buffett Stocks to Watch in 2015 ||| Pepsi-Cola Passed Diet Coke as No. 2 US Soda in 2014; Coke Remains No. 1 -Beverage Digest,0,0.5046815
2015-03-27,14384400.0,40.47999954223633,40.47999954223633,39.970001220703125,40.08000183105469,33.72993469238281,KO,"Warren Buffett's Best Dividend Stocks in 2015 ||| U.S. Sodas Fall in 2014, Pepsi Tops Diet Coke as #2 - Analyst Blog",1,0.5039513
2015-03-30,12561400.0,40.11000061035156,40.61000061035156,39.93999862670898,40.5099983215332,34.09181213378906,KO,"3 Retirement Stocks Wall Street Is Wrong About ||| The Coca-Cola Co: Why CEO Muhtar Kent Is Doubling Down on Soda ||| Warren Buffett: 3 Ways to Protect Your Savings From a Crisis ||| One Put, One Call Option To Know About for Coca-Cola ||| The Zacks Analyst Blog Highlights: PepsiCo, Coca-Cola, Dr Pepper Snapple Group and Monster Beverage - Press Releases",1,0.5251545
2015-03-31,16604800.0,40.5099983215332,40.900001525878906,40.34999847412109,40.54999923706055,34.12547302246094,KO,"After Hours Most Active for Mar 31, 2015 : QQQ, ZNGA, CSCO, WEN, RF, AAPL, MSFT, XOM, BAC, KO, GE, IGT ||| Don't Follow Warren Buffett When It Comes To Food Stocks ||| Keurig (GMCR) Boosts K-Cup Portfolio with Reily Foods Deal - Analyst Blog",1,0.46764982
2015-04-01,14300700.0,40.790000915527344,40.810001373291016,40.22999954223633,40.68000030517578,34.234886169433594,KO,"iShares Core S&P 500 ETF Experiences Big Outflow ||| Coca-Cola Company Expands in Indonesia with 2 New Plants - Analyst Blog ||| XLP, FTW: Big ETF Outflows",0,0.50293136
2015-04-02,14343100.0,40.72999954223633,40.869998931884766,40.47999954223633,40.68000030517578,34.234886169433594,KO,Three Bullish Tailwinds for These Four Dow Stocks,1,0.5475509
2015-04-06,19843400.0,40.77000045776367,41.61000061035156,40.59000015258789,41.16999816894531,34.64724349975586,KO,"Interesting May Stock Options for Coca-Cola ||| After Hours Most Active for Apr 6, 2015 : WIN, O, IGT, DEI, CNO, SIRI, KKR, KO, QQQ, CSCO, FOXA, GILD ||| Coca-Cola Shares Correcting On Long-Term Chart: A Technical Breakdown",0,0.495126
2015-04-07,9773400.0,41.04999923706055,41.369998931884766,40.970001220703125,41.0099983215332,34.51258850097656,KO,Evercore Partners Initiates Coverage on Coca-Cola at Hold,0,0.5264805
2015-04-08,8954700.0,40.97999954223633,41.09000015258789,40.7400016784668,40.88999938964844,34.41160202026367,KO,Ball Corporation Receives Query from FTC for Rexam Buy - Analyst Blog,1,0.5314029
2015-04-09,12710900.0,40.79999923706055,41.08000183105469,40.630001068115234,41.04999923706055,34.5462532043457,KO,Will Coca-Cola Enterprises (CCE) have a Tough 2015? - Analyst Blog ||| These 10 Stocks Are Likely To Beat 'Rock-Bottom' Q1 Expectations,0,0.4873048
2015-04-10,8720000.0,41.09000015258789,41.15999984741211,40.84999847412109,40.880001068115234,34.40318298339844,KO,Coca-Cola Enterprises (CCE): A Strong Sell on Weak Outlook - Analyst Blog,0,0.523731
2015-04-13,9616300.0,40.970001220703125,40.970001220703125,40.70000076293945,40.70000076293945,34.251708984375,KO,"3 Buffett-Approved Stocks to Boost Your Portfolio ||| 20 Little Known Facts About Warren Buffett ||| Susquehanna Initiates Coverage on Coca-Cola at Negative, Announces $33.00 PT ||| Pepsico, NBA Announce Announced New Multiyear Marketing Partnership ||| Wintergreen Advisers Plans Vote Vs. Coke Directors ||| Pepsico Expected to Announce NBA League Sponsorship Deal -Beverage-Digest",0,0.5305378
2015-04-14,11209700.0,40.59000015258789,40.650001525878906,40.31999969482422,40.5099983215332,34.09181213378906,KO,"Dow Movers: HD, JPM ||| Susquehanna 'Skeptical' On Monster, Initiates With Neutral Rating ||| The Susquehanna Note Moving Green Mountain Shares Up ||| Why Susquehanna Thinks Sodastream Is Worth $24/Share",0,0.48841134
2015-04-15,11189100.0,40.59000015258789,40.810001373291016,40.31999969482422,40.400001525878906,33.99924087524414,KO,3 Value Stocks Near 52-Week Lows Worth Buying ||| 3 Best Stocks to Invest in Big Brands ||| One Shareholder-Friendly Trend Every Company Should Copy ||| Hearing Renewed Unconfirmed Takeover Chatter of Coca-Cola Buyout of Keurig Green Mountain,1,0.5140415
2015-04-17,15330300.0,40.470001220703125,40.65999984741211,40.09999847412109,40.29999923706055,33.91508483886719,KO,"Dow Movers: AXP, GE ||| Dow Analyst Moves: KO ||| Consumer Sector Update for 04/17/2015: KO, FDP, WUBA ||| Will Currency Headwinds Hit Coca-Cola's (KO) Q1 Earnings? - Analyst Blog",1,0.485401
2015-04-20,13023700.0,40.41999816894531,40.900001525878906,40.40999984741211,40.65999984741211,34.21804428100586,KO,"PepsiCo Steals the NBA From Coca-Cola: What Investors Need to Know Now ||| Morgan Stanley, Facebook, Coke... Some Huge Names Report Earnings This Week ||| Can Dr Pepper (DPS) Keep the Earnings Streak Alive in Q1? - Analyst Blog ||| Interesting May Stock Options for Coca-Cola ||| Stock Market On Edge As Tech Lights Up Earnings Marquee",1,0.48934808
2015-04-21,19673100.0,40.66999816894531,40.9900016784668,40.540000915527344,40.77999877929688,34.319026947021484,KO,"Is SodaStream International Tackling Adult Beverages Next? ||| Pre-Market Earnings Report for April 22, 2015 : KO, BA, MCD, ABT, TMO, EMC, BK, TEL, TROW, STJ, APH, NLSN ||| JJ Kinahan On Coca-Cola Options Ahead Of Earnings",1,0.48022878
2015-04-22,26887200.0,41.560001373291016,41.56999969482422,41.06999969482422,41.310001373291016,34.76505279541016,KO,"Stocks: Was One Man Responsible For the 2010 ""Flash Crash""? ||| Coca-Cola (KO) Rises on Strong Q1 Earnings & Sales - Analyst Blog ||| Q1 Earnings Weakness: One-Off or Lasting? - Ahead of Wall Street ||| Coca-Cola (KO) Beats on Earnings & Sales in Q1 - Tale of the Tape ||| Dow Jones Futures Hit by Strong Dollar Earnings Challenges ||| Pre-Market Most Active for Apr 22, 2015 : NOK, ALU, NVO, KO, PKT, ASML, CHA, STM, YHOO, BRCM, FB, ANGI ||| Earnings Reaction History: The Coca-Cola Company, 30.0% Follow-Through Indicator, 2.1% Sensitive ||| Close Update: Stocks Advance as Earnings, Housing Market Data Fuels Early Rebound ||| Cramer: Coca-Cola Is The Conservative Way To Play 2 Huge Trends ||| Coca-Cola Investors: Watch These Charts ||| Coca-Cola Tops Q1 Estimates, Shares Rise ||| Coca-Cola Offers Added Letter of Intent with US Bottling Partners, Terms Not Disclosed ||| Coca-Cola Reports Q1 Operating Sales $10.711B vs $10.66B Est. ||| Coca-Cola Reports Q1 Adj. EPS $0.48 vs $0.42 Est. ||| Earning & Economic Calendar for Wednesday April 22, 2015 ||| Keep an Eye on These 10 Stocks for April 22, 2015 ||| Earnings Scheduled For April 22, 2015",0,0.474612
2015-04-23,17408800.0,41.22999954223633,41.40999984741211,40.91999816894531,40.95000076293945,34.462100982666016,KO,"Energy Drinks Fuel Monster Beverage; Coke Jolt Next ||| Stock Market News for April 23, 2015 - Market News ||| Pepsi (PEP) Tops Q1 Earnings & Sales, Expects Bigger Fx Hit - Analyst Blog ||| Excerpt From Tim Anderson's Morning Note: 'If You Want To Be Bearish, The Internals Of The Market Are Pathetic'",0,0.47720715
2015-04-24,11623300.0,41.040000915527344,41.119998931884766,40.810001373291016,40.88999938964844,34.41160202026367,KO,"Here's How PepsiCo, Inc. Satisfied Investors’ Hunger for Growth Last Quarter ||| The Soda Industry Is Undergoing 'Big Changes' ||| Analyst Sees Turnaround Pressure Building At Coca-Cola",0,0.52679104
2015-04-27,10044600.0,41.0,41.150001525878906,40.77999877929688,40.83000183105469,34.36111831665039,KO,Barrick Gold Digs Itself Into Another Hole Over Compensation ||| Does Apple Hide More Cash Abroad Than Anyone? ||| Interesting August Stock Options for Coca-Cola ||| Coca-Cola CEO Talks Strategy,0,0.5000151
2015-04-28,12174800.0,40.95000076293945,40.970001220703125,40.59999847412109,40.77000045776367,34.31061553955078,KO,"IWF, KO, HD, ORCL: ETF Outflow Alert ||| Coca-Cola Bottling Co. Consolidated (COKE) Ex-Dividend Date Scheduled for April 29, 2015 ||| Will Coca-Cola Enterprises (CCE) Disappoint on Earnings? - Analyst Blog ||| Apple Tied With Oreo Cookie-Maker For Social Media 'Likes'",0,0.47529814
2015-04-29,11371400.0,40.65999984741211,40.75,40.400001525878906,40.4900016784668,34.074981689453125,KO,"15 Things to Expect at Berkshire Hathaway's Annual Meeting This Weekend ||| A Motley Fool Obituary: Comcast-Time Warner, We Hardly Knew Ye ||| Coca Cola Femsa S.A.B. de C.V. (KOF) Ex-Dividend Date Scheduled for April 30, 2015 ||| Here's Warren Buffett Singing The Coca-Cola Song ||| Coke Shareholders Approve Pay for Top Execs With Only 80.4% Backing -Reuters",1,0.5011135
2015-05-01,10848300.0,40.58000183105469,40.93000030517578,40.5,40.90999984741211,34.428436279296875,KO,"Weekly Market Wrap: May 1, 2015 ||| Daily Dividend Report: LM, KO, GILD, AIG, VFC, PAYX ||| Cowen's Top Cigarette And Soda Stocks ||| Is Warren Buffett 'Out Of Touch' On Coca-Cola?",1,0.48269695
2015-05-04,10204800.0,40.880001068115234,41.09999847412109,40.77000045776367,40.959999084472656,34.470516204833984,KO,How's Coca-Cola Bottling Placed This Earnings Season? - Analyst Blog ||| FEMSA (FMX) Shares Gain Nearly 3% on Q1 Earnings Beat - Analyst Blog ||| Make The Most of Your 401(k) With Low-Cost Index Funds ||| Warren Buffett on CNBC Says Coca-Cola has Strong Competitive Position,0,0.4958523
2015-05-05,11721300.0,41.13999938964844,41.13999938964844,40.68000030517578,40.75,34.293792724609375,KO,"Constellation Brands Inc (STZ) Ex-Dividend Date Scheduled for May 06, 2015 ||| Monster Beverage Looks to Sustain Its Big 2015 Gains ||| Warren Buffett Is Wrong About Whole Foods",0,0.47575903
2015-05-06,11906900.0,41.040000915527344,41.09000015258789,40.38999938964844,40.65999984741211,34.21804428100586,KO,Warren Buffett Is Wrong About The Coca-Cola Co. and Whole Foods Market Inc.,1,0.49138117
2015-05-07,13834700.0,40.52999877929688,40.90999984741211,40.5099983215332,40.70000076293945,34.251708984375,KO,Monster Beverage Sees Growth Slow as Coca-Cola Deal Looms,1,0.54381555
2015-05-08,11144400.0,41.0,41.16999816894531,40.84999847412109,40.97999954223633,34.48735046386719,KO,"Monster Beverage Falls on Q1 Earnings & Revenue Miss - Analyst Blog ||| Why RBC Sees 'Short-Term Disruption, Long-Term Opportunity' At Monster Beverage",0,0.50844395
2015-05-11,10113500.0,40.97999954223633,41.38999938964844,40.880001068115234,40.93999862670898,34.45368194580078,KO,"What Is Curtis Jackson's Worth? ||| Coca-Cola (KO) Undergoing Changes: Is it for the Better? - Analyst Blog ||| How to Find the Best Stocks to Buy Now ||| Citi Upgrades Monster Beverage, Sees Pullback Offering An Opportunity ||| Top Retail Analyst: Starbucks' New 'Mini' Drinks Cuts Calories But Not Profits",0,0.49100307
2015-05-12,12384500.0,40.77000045776367,40.959999084472656,40.52000045776367,40.68999862670898,34.2432861328125,KO,"Vina Concha Y Toro (VCO) Ex-Dividend Date Scheduled for May 13, 2015 ||| Pepsi's Growth in '15 Likely to be Hit by Fx: Should You Invest? - Analyst Blog ||| Twenty-First Century Fox Cancels American Idol - Analyst Blog",1,0.50175595
2015-05-13,13183700.0,40.75,41.36000061035156,40.720001220703125,41.04999923706055,34.5462532043457,KO,"MAXIMUS, NVIDIA, PepsiCo, Coca-Cola and Dr Pepper Snapple Group Holdings highlighted as Zacks Bull and Bear of the Day - Press Releases ||| Dividend Stocks: What You Need to Know ||| Coca-Cola Discloses Letters of Intent Related to Two US Bottling Partners: Will Offer Expanded Distribution Territories to Coca-Cola Bottling Co., Clark Beverage Group",1,0.505685
2015-05-14,9961000.0,41.29999923706055,41.59999847412109,41.2599983215332,41.5,34.92495346069336,KO,"UDOW, CSCO, KO, DD: Large Outflows Detected at ETF ||| Coca-Cola Bottling to Get Additional Territories from Coca-Cola - Analyst Blog ||| The Secret to PepsiCo, Inc.'s Success ||| Coca-Cola Proceeds with Bottling Deals: Pens Letters of Intent - Analyst Blog",1,0.510023
2015-05-15,8479000.0,41.45000076293945,41.68999862670898,41.43000030517578,41.52000045776367,34.94179153442383,KO,13F Season: A Look At Warren Buffett's Q1 Moves ||| Keurig Tumbles: What Did the CEO Say About Keurig Kold?,0,0.48769778
2015-05-18,11511700.0,41.4900016784668,41.4900016784668,41.25,41.31999969482422,34.77346420288086,KO,"Everything You Need to Know About Keurig Kold ||| Keurig Green Mountain Buys SodaStream Some Time ||| Interesting January 2016 Stock Options for Coca-Cola ||| 3 Things Coca-Cola CEO Muhtar Kent Wants You to Know ||| Ray Dalio's Top 5 New Buys in Q1 ||| Bridgewater Associates, The World's Biggest Hedge Fund Firm, Is All About ETFs",0,0.49970576
2015-05-19,9072000.0,41.22999954223633,41.38999938964844,41.130001068115234,41.310001373291016,34.76505279541016,KO,Will Diet Pepsi's Switch From Aspartame To Sucralose Boost Pepsi's Stock?,1,0.5493097
2015-05-20,10965200.0,41.369998931884766,41.59000015258789,41.310001373291016,41.34999847412109,34.7987174987793,KO,Hearing Unconfirmed Market Chatter Coke to Raise Stake in GMCR,0,0.52710843
2015-05-21,9270900.0,41.2599983215332,41.31999969482422,41.06999969482422,41.22999954223633,34.69773483276367,KO,"Where Coca-Cola Co and PepsiCo, Inc. Are Going for Growth",0,0.5220476
2015-05-22,11909500.0,41.119998931884766,41.2400016784668,41.040000915527344,41.209999084472656,34.680908203125,KO,"IVV, JNJ, MRK, KO: ETF Outflow Alert ||| Lessons Learned From The Grand Canyon ||| China Haisheng Juice Holdings Co Ltd Denies Report of Coca Cola Acquisition of Shares -Reuters",0,0.50004923
2015-05-26,15194300.0,41.119998931884766,41.18000030517578,40.7400016784668,40.9900016784668,34.49576568603516,KO,"Keurig Green Mountain, Inc. Gets Frosty Reception for Pricey New Cold Beverage Machine ||| Molson Coors Brewing Company (TAP) Ex-Dividend Date Scheduled for May 27, 2015 ||| 5 Things Coca-Cola Management Wants You to Know ||| Dr Pepper (DPS): Can It Sustain the Q1 Performance in 2015? - Analyst Blog",1,0.47470525
2015-05-27,9863100.0,40.93999862670898,41.20000076293945,40.83000183105469,41.119998931884766,34.605159759521484,KO,"Is SodaStream International a Buy? ||| EMC Corp. Eyes Hybrid Cloud Market, Acquires Virtustream - Analyst Blog ||| Darren Rovell Tweets: 'FIFA partner Coca-Cola's response to FIFA indictment: ""This lengthy controversy has tarnished the mission (cont) http://tl.gd/n_1smddpm' ||| Option Alert: Coca-Cola Nov $43 Call; 4429 Contract Trade at Ask @$0.70; Now $41.15 ||| White Wave Shares Move Higher; May be Attributed to Unconfirmed Market Chatter of Bid from Coke ||| Workday Earnings Reviewed By JMP Securities",1,0.50349975
2015-05-28,9395200.0,41.20000076293945,41.29999923706055,40.880001068115234,41.13999938964844,34.62199401855469,KO,FIFA Charged of Corruption: Will Sponsors Show Red Card? - Analyst Blog ||| Fast Money Picks For May 28,0,0.48319563
2015-05-29,19628600.0,41.18000030517578,41.18000030517578,40.77000045776367,40.959999084472656,34.470516204833984,KO,"The Zacks Analyst Blog Highlights: Nike, Adidas, Anheuser-Busch InBev, Coca-Cola and Visa - Press Releases ||| FIFA Scandal Sinks Nike (NKE) and Upsets Visa (V) - Video Blog ||| FIFA Sponsors Weigh Up The Cost Of Scandal",0,0.48252606
2015-06-01,12684100.0,41.36000061035156,41.40999984741211,40.880001068115234,40.93999862670898,34.45368194580078,KO,"Sepp Blatter Retains FIFA Post; 'Not The Entire Organization' Is Guilty ||| Consumer Sector Update for 06/01/2015: BTI, KO, BYD ||| Ambev S.A. (ABEV) Ex-Dividend Date Scheduled for June 02, 2015 ||| Will Coca-Cola Enterprises (CCE) Turn Around in 2015? - Analyst Blog ||| Benzinga's Top Upgrades ||| BMO Capital Upgrades Coca-Cola To Outperform ||| BMO Capital Upgrades Coca-Cola On 2016 Forecast ||| BMO Capital Upgrades Coca-Cola to Outperform, Raises PT to $48.00",1,0.42573017
2015-06-02,11878600.0,40.84000015258789,41.15999984741211,40.68000030517578,40.9900016784668,34.49576568603516,KO,"WisdomTree LargeCap Dividend Fund Experiences Big Outflow ||| Top-Rated Stock Picks and Most-Read Stories at Nasdaq.com: May 24 - 30, 2015 ||| Coca-Cola Enterprises, Inc. (CCE) Ex-Dividend Date Scheduled for June 03, 2015 ||| Pepsico, Inc. (PEP) Ex-Dividend Date Scheduled for June 03, 2015 ||| Coca-Cola (KO) Closes Reyes Holdings & Florida Bottler Deals - Analyst Blog",0,0.43636888
2015-06-03,8153800.0,41.09999847412109,41.209999084472656,40.77999877929688,40.869998931884766,34.394779205322266,KO,Measure to Cut Costs: Banks to Turn off Voice Mail Service? - Analyst Blog ||| Exclusive: Boston Market CEO Talks 'Chicken Wars' Strategy,0,0.50712156
2015-06-04,10145800.0,40.709999084472656,40.97999954223633,40.52999877929688,40.59000015258789,34.15913009643555,KO,Can Women's World Cup Boost FIFA Sponsors Amid Scandal? - Analyst Blog ||| 10 Reasons Why Growth Stocks Can Be Appropriate For Retired Investors ||| Coca-Cola Company (KO) Unveils PlantBottle at World Expo - Analyst Blog ||| Caffeine Beats The Market,0,0.49492252
2015-06-05,15975600.0,40.47999954223633,40.52000045776367,40.08000183105469,40.09999847412109,33.74677276611328,KO,PepsiCo to Offer Craft Soda with Real Sugar: Beverage-Digest - Analyst Blog,1,0.53211504
2015-06-08,14339300.0,40.09999847412109,40.2599983215332,40.02000045776367,40.15999984741211,33.79726028442383,KO,"Warren Buffett's 3 Secrets to Success ||| Stock Market News for June 08, 2015 - Market News ||| Pre-Market Most Active for Jun 8, 2015 : SNY, PG, KO, NOK, FCAU, DEO, AAPL, BLDP, VOD, XIV, FEYE, SIRI ||| 3 Reasons SodaStream International Stock Could Fall ||| Are Orange Hibiscus and Pineapple Cream the Answer to Pepsi and Coca-Cola's Problems?",1,0.47909442
2015-06-09,10772700.0,40.16999816894531,40.41999816894531,40.11000061035156,40.20000076293945,33.8309326171875,KO,Buying Dividend Stocks to Invest Like Warren Buffett,1,0.52884305
2015-06-10,11979900.0,40.31999969482422,40.540000915527344,40.27999877929688,40.33000183105469,33.94033432006836,KO,"Point72 Asset Management: Here’s What This Infamous Outfit Has Been Buying ||| Baidu Inc (ADR) Risk Factors: Brand Strength ||| 10/19/1987: Lessons From the Stock Market's Black Monday ||| Dr Pepper Snapple Group, Inc (DPS) Ex-Dividend Date Scheduled for June 11, 2015 ||| What The Great Recession Taught Me About Dividend Growth Investing ||| Coca-Cola Company (KO) Ex-Dividend Date Scheduled for June 11, 2015 ||| Is Coca-Cola Stock a Buy? ||| Lebron's Twitter Feed Is A Slam Dunk For Investors ||| Cramer Gives His Opinion On Boeing, Exxon Mobil, Keurig And MannKind",0,0.47871742
2015-06-11,11944900.0,40.11000061035156,40.25,40.02999877929688,40.09999847412109,34.02517318725586,KO,2 Stocks to Watch in Soda ||| Second Top Firm Downgrades Colgate-Palmolive In Two Months,0,0.5099174
2015-06-12,15568600.0,40.040000915527344,40.119998931884766,39.84000015258789,39.959999084472656,33.9063835144043,KO,Will Crystal Pepsi Save PepsiCo? ||| I Wonder What Happens Next ||| UBS Just Upgraded Monster Beverage To Buy; Here's Why,0,0.4906433
2015-06-15,11364800.0,39.83000183105469,39.86000061035156,39.56999969482422,39.59000015258789,33.59244537353516,KO,"The 1 Johnson & Johnson Number You Should Know ||| Dow Movers: UTX, VZ ||| Zacks Industry Outlook Highlights: Unilever, Coca-Cola and Coca-Cola Enterprises - Press Releases ||| Coca-Cola Closes Partnership Deal with Monster Beverage - Analyst Blog ||| Keurig Green Mountain Perking Up After Making 52-Week Low",1,0.5257388
2015-06-16,12517400.0,39.630001068115234,40.15999984741211,39.59999847412109,40.08000183105469,34.00821304321289,KO,2 Stocks To Watch in Beverages ||| Monster Beverage Is Citi's Favorite Stock In US Beverage Group,1,0.4983593
2015-06-17,13898400.0,40.08000183105469,40.31999969482422,40.0099983215332,40.27000045776367,34.169429779052734,KO,"Stock Market News for June 17, 2015 - Market News",1,0.5080685
2015-06-18,16314600.0,40.15999984741211,40.7400016784668,40.15999984741211,40.650001525878906,34.49185943603516,KO,Why The Keurig Kold Is No Threat to SodaStream International Ltd ||| Coca-Cola Bottling Hits a 52-Week High; Territories Expand - Analyst Blog,0,0.5045311
2015-06-19,23550600.0,40.59000015258789,40.650001525878906,40.400001525878906,40.400001525878906,34.279747009277344,KO,"After Hours Most Active for Jun 19, 2015 : MSFT, GE, AAPL, FTR, KO, FOXA, CMCSA, C, WFC, REXX, VZ, AUY",1,0.48520535
2015-06-22,8775900.0,40.5099983215332,40.810001373291016,40.459999084472656,40.47999954223633,34.34761428833008,KO,"Is Craft Soda The Answer To Declining Soda Sales? ||| FEMSA Spreads in Mexico, Unit Seals Drugstore Chain Buyout - Analyst Blog ||| 13D Filing from Coca Cola on Monster Beverage Shows 16.7% Stake",0,0.5059606
2015-06-23,11094900.0,40.43000030517578,40.52000045776367,40.310001373291016,40.380001068115234,34.26275634765625,KO,General Mills to Stop Using Artificial Ingredients - Analyst Blog,0,0.52097535
2015-06-24,10385100.0,40.369998931884766,40.45000076293945,40.18999862670898,40.18999862670898,34.10154724121094,KO,"After Hours Most Active for Jun 24, 2015 : MSFT, C, WFC, GE, JPM, KO, VZ, CSCO, QQQ, QCOM, AAPL, MU ||| What Is an Underlying Asset? ||| Exclusive: How The Smashing Pumpkins' Billy Corgan Would Revolutionize The Music Industry",0,0.46468163
2015-06-25,10607600.0,40.27999877929688,40.34000015258789,40.02000045776367,40.02000045776367,33.95729064941406,KO,"Stifel's Mark Astrachan Believes 'Coke Energy Brands Show Path for Monster's International Expansion,' Buy Rating, $165 Price Target Maintained",0,0.51874435
2015-06-26,16215600.0,40.09999847412109,40.34999847412109,40.0,40.0,33.940330505371094,KO,"OEF, KO, CMCSA, CSCO: Large Outflows Detected at ETF ||| 3 Best Vanguard Funds for a Defensive Portfolio ||| Hearing Unconfirmed Market Chatter Monster Beverage Preparing for Coke Takeover",0,0.4946233
2015-06-29,15500800.0,39.79999923706055,39.97999954223633,39.400001525878906,39.400001525878906,33.43121719360352,KO,Interesting September Stock Options for KO,0,0.5078985
2015-07-01,11177400.0,39.380001068115234,39.59999847412109,39.27999877929688,39.5,33.51607131958008,KO,Consumer Staple ETFs Remain Steady In 2015,0,0.5314048
2015-07-02,8975900.0,39.630001068115234,39.810001373291016,39.34999847412109,39.4900016784668,33.50759506225586,KO,Dow Analyst Moves: KO,0,0.5069567
2015-07-06,10252600.0,39.31999969482422,39.59999847412109,39.220001220703125,39.41999816894531,33.44819259643555,KO,9 Top Sell Ideas From Oppenheimer's Technical Analysis Division,1,0.5485291
2015-07-07,20335000.0,39.4900016784668,40.380001068115234,39.400001525878906,40.25,34.1524543762207,KO,"Women's World Cup Final Attracts Record Viewers - Analyst Blog ||| Noteworthy ETF Inflows: XLP, PG, KO, PM",0,0.5142635
2015-07-08,11383700.0,39.9900016784668,40.22999954223633,39.84000015258789,39.86000061035156,33.821537017822266,KO,"Dow Movers: CAT, KO ||| The Zacks Analyst Blog Highlights: Twenty-First Century Fox, CBS, Walt Disney and Coca-Cola - Press Releases ||| Keurig's Troubles Linger: Faces Lawsuits and Lower Target Price - Analyst Blog ||| Option Alert: Coca-Cola July $40 Call; 2601 Contract Trade at Ask @$0.43; Now $39.98",1,0.5022381
2015-07-09,13392000.0,40.459999084472656,40.58000183105469,39.900001525878906,39.91999816894531,33.8724479675293,KO,"Pepsi Tops Earnings, Sales Again in Q2; Ups 2015 EPS View - Analyst Blog",1,0.5466879
2015-07-10,13360400.0,40.27000045776367,40.52000045776367,40.15999984741211,40.38999938964844,34.271244049072266,KO,"Noteworthy Friday Option Activity: GOOGL, BIIB, KO",1,0.5172859
2015-07-13,9854200.0,40.560001373291016,40.77000045776367,40.4900016784668,40.65999984741211,34.50034713745117,KO,"One Put, One Call Option To Know About for Coca-Cola ||| How to Invest Like Warren Buffett: Lessons From Coca-Cola and IBM",1,0.48416618
2015-07-14,19531000.0,40.900001525878906,41.2599983215332,40.84000015258789,41.16999816894531,34.933082580566406,KO,"Consumer Sector Update for 07/14/2015: KO, CCL, SBUX ||| Why Is PepsiCo Keeping This Hated Ingredient in Its Soda? ||| Option Alert: Coca-Cola July $41.5 Call Sweep; 1079 Contracts @Ask @$0.11; Now $41.19 ||| Benzinga's Top Upgrades ||| UBS Ups Coca-Cola To Buy, Says It May Finally Break Out ||| <font color=""green"">UBS Upgrades Coca-Cola to Buy, Raises PT to $48.00</font>",0,0.4622551
2015-07-15,11252100.0,41.150001525878906,41.36000061035156,41.09999847412109,41.130001068115234,34.899139404296875,KO,"XLP, PG, KO, PM: Large Inflows Detected at ETF ||| Yacktman Fund Reduces Stakes in Six of its Most Valuable Holdings ||| Can Pepsi (PEP) Maintain the Strong H1 Performance in H2? - Analyst Blog",1,0.5168931
2015-07-16,10483700.0,41.41999816894531,41.59999847412109,41.34999847412109,41.47999954223633,35.19611740112305,KO,New Feature: Stock PDF Report,0,0.5183018
2015-07-17,9608300.0,41.310001373291016,41.31999969482422,41.04999923706055,41.25,35.0009651184082,KO,Does Coca-Cola Have A Vietnam Problem?,1,0.5247063
2015-07-20,10024200.0,41.34999847412109,41.540000915527344,41.220001220703125,41.380001068115234,35.11126708984375,KO,"Apple Earnings Not The Only Huge Story This Week: Watch GM, Boeing, Coke, Amazon, Microsoft & Others ||| One Put, One Call Option To Know About for Coca-Cola ||| Can Dr Pepper (DPS) Keep the Earnings Streak Alive in Q2? - Analyst Blog ||| Will Coca-Cola's (KO) Q2 Earnings Disappoint Estimates? - Analyst Blog ||| Will Dr. Pepper Impress More Than Coke This Earnings Season?",0,0.5080868
2015-07-21,13653800.0,41.380001068115234,41.52000045776367,41.09999847412109,41.18999862670898,34.95005416870117,KO,"Why PepsiCo is a Top Socially Responsible Dividend Stock (PEP) ||| Pre-Market Earnings Report for July 22, 2015 : KO, BA, ABT, TMO, EMC, ITW, TEL, ARMH, STJ, NTRS, APH, CHKP ||| Why Coca-Cola Is a Warren Buffett Stock",0,0.48726872
2015-07-22,15528600.0,40.810001373291016,41.59000015258789,40.59000015258789,40.900001525878906,34.703983306884766,KO,"Coca-Cola Mid-Year Earnings Preview: Strong Dollar To Weigh On Results Again? ||| Earnings Highlights for July 22nd: KO Beats, QCOM to Miss? - Stocks in the News ||| Minus Apple, Tech Sector Q2 Earnings Soft - Ahead of Wall Street ||| Dow Jones Futures Today Slump 63 Points on Poor Tech Earnings ||| Consumer Sector Update for 07/22/2015: AN, KO, TUP ||| Coca-Cola (KO) Beats Q2 Earnings & Sales; US Volumes Up - Analyst Blog ||| Coca-Cola Company Earnings: Investors Get More of the Same ||| Close Update: Apple Triggers Tech-Led Rout ||| Could Monster Beverage Corp. Energize Your Portfolio with Profits? - Stocks in the News ||| Coca-Cola Flexes Its Pricing Muscle ||| Earnings Reaction History: The Coca-Cola Company, 30.0% Follow-Through Indicator, 2.2% Sensitive ||| Earlier Brian Sozzi Piece Published on TheStreet.com Shows His Belief Coca-Cola's Quarter Was 'Solid,' 'Drives Hope for Turnaround' ||| Is Social Activism And Marketing A Good Combination? ||| Hearing Unconfirmed Market Chatter Coke has Increased Stake in GMCR to 35% ||| Benzinga's Top #PreMarket Gainers ||| Coca-Cola Beats Q2 Estimates ||| Coca-Cola Reports Q2 Sales $12.156B vs $12.06B Est. ||| Coca-Cola Reports Q2 Adj. EPS $0.63 vs $0.60 Est. ||| Earnings Scheduled For July 22, 2015 ||| Keep an Eye on These 10 Stocks for July 22, 2015",0,0.4911867
2015-07-23,13522200.0,40.9900016784668,41.02000045776367,40.47999954223633,40.84000015258789,34.653076171875,KO,"Notable ETF Inflow Detected - XLP, PG, KO, PM ||| Coke Vs. Pepsi: Which Stock Tastes Better? ||| Dr Pepper (DPS) Beats Q2 Earnings, Sales In Line; Ups View - Analyst Blog",0,0.5094453
2015-07-24,10912500.0,40.7599983215332,40.83000183105469,40.40999984741211,40.43999862670898,34.313663482666016,KO,"FEMSA Misses Q2 Earnings by a Penny, Revenue Jumps 5.9% - Analyst Blog ||| Delta Names Coca-Cola's CFO Kathy Waller as New Member on Board of Directors",1,0.5160447
2015-07-28,11021800.0,40.650001525878906,40.72999954223633,40.43999862670898,40.54999923706055,34.407012939453125,KO,"Molson Coors Brewing Company (TAP) Ex-Dividend Date Scheduled for July 29, 2015 ||| Is Coca-Cola Co.'s Dividend in Trouble? ||| Coca-Cola Bottling Co. Consolidated (COKE) Ex-Dividend Date Scheduled for July 29, 2015 ||| PepsiCo a Top Ranked SAFE Dividend Stock With 2.9% Yield (PEP) ||| ABA Sues San Francisco for Health Warning on Ads Law - Analyst Blog ||| The 3 Best Stocks to Invest In Soda",1,0.44582218
2015-07-31,15309500.0,40.880001068115234,41.220001220703125,40.77000045776367,41.08000183105469,34.85671615600586,KO,"Noteworthy ETF Inflows: XLP, PG, KO, PM ||| Dow Movers: CVX, PFE ||| Revisiting Harry Potter Stocks on His 35th Birthday - Analyst Blog ||| How Is Coca-Cola Bottling Placed This Earnings Season? - Analyst Blog ||| Beverage Companies Face Watered-Down Industry Trends ||| I Like Coffee, I Like Tea, I Like What This Staples ETF Does For Me",1,0.5031128
2015-08-03,14672600.0,40.84999847412109,41.54999923706055,40.84000015258789,41.540000915527344,35.24703598022461,KO,"One Put, One Call Option To Know About for Coca-Cola ||| Will Monster Beverage (MNST) Surprise on Q2 Earnings? - Analyst Blog ||| The 'Buying Opportunity' For Monster Beverage Investors",1,0.49931675
2015-08-05,15329200.0,41.91999816894531,42.220001220703125,41.81999969482422,42.119998931884766,35.73915100097656,KO,"Tesla Drops, Keurig Flops, Hebalife Tops Earnings - Analyst Blog",0,0.5086061
2015-08-06,11378900.0,42.0,42.25,41.86000061035156,41.91999816894531,35.5694580078125,KO,"5 Things Coca-Cola Management Wants You to Know ||| Constellation Brands Inc (STZ) Ex-Dividend Date Scheduled for August 07, 2015 ||| Monster Misses on Earnings and Revenues, Stock Prices Declines Further For the Day - Stocks in the News ||| SkyWest, Medicines Co, Tesla Motors, Keurig Green Mountain and Coca Cola highlighted as Zacks Bull and Bear of the Day - Press Releases ||| Three European Coca-Cola Bottlers Agree on Merger - Stocks in the News ||| Benzinga's M&A Chatter for Thursday August 6, 2015",0,0.51266074
2015-08-07,10886700.0,41.810001373291016,41.970001220703125,41.52999877929688,41.77000045776367,35.44219207763672,KO,"Monster Beverage (MNST) Lags on Q2 Earnings and Sales - Analyst Blog ||| Consumer Sector Update for 08/07/2015: MNST,KO,BDBD,ICON ||| Coca-Cola Near Deal to Acquire Suja Life , According to Sources -Reuters ||| Barclays Reinstates Equal-weight on Coca-Cola, Announces $45.00 PT",0,0.49163657
2015-08-10,9501900.0,41.88999938964844,41.9900016784668,41.58000183105469,41.68000030517578,35.365821838378906,KO,"Notable ETF Inflow Detected - XLP, PG, KO, PM ||| Dow Movers: KO, CAT ||| Market Got You Down? Don't Bail -- Get Defensive ||| Why Monster Beverage Corporation Stock Rose 15% in July ||| After Hours Most Active for Aug 10, 2015 : BAC, HOT, QQQ, KO, CAT, ODP, TXN, PG, FCAU, AAPL, MSFT, FTR ||| Can Coca-Cola Repeat H1 Performance in H2 Amid Fx Woes? - Analyst Blog",0,0.47484276
2015-08-11,11254900.0,41.400001525878906,41.56999969482422,41.16999816894531,41.47999954223633,35.19611740112305,KO,KO Makes Notable Cross Below Critical Moving Average,0,0.5208126
2015-08-12,9602200.0,41.130001068115234,41.2599983215332,40.84999847412109,41.2599983215332,35.00944137573242,KO,LaCroix Sparkling Water Is A Billion Dollar Brand Hiding Within A Billion Dollar Market Cap Company - 45% Upside ||| Will Monster Beverage Sales Grow Post Coca-Cola Deal?,0,0.5230284
2015-08-13,10270900.0,41.27999877929688,41.380001068115234,41.0099983215332,41.09999847412109,34.87369155883789,KO,"Big Soda Giants Excel in H1; Will They Fizz On in H2? ||| Dr Pepper Invests $20M in Sports Drink Bodyarmor Owner ||| Why Monster Beverage's 10% Decline Makes It The Perfect Time To Buy ||| Coca-Cola Names James Quincey Pres, COO",1,0.49571374
2015-08-14,9904800.0,41.0099983215332,41.25,40.959999084472656,41.25,35.0009651184082,KO,"Coca-Cola Gets Quincey as COO; Will He Succeed Kent? ||| Warren Buffett Bullish On Axalta Coating Systems, Sells Out Of National-Oilwell Varco, Phillips 66 ||| Hearing Renewed Unconfirmed Market Chatter of Potential Coke Acquisition of Remaining Shares in Green Mountain it Does Not Already Own",1,0.5137788
2015-08-17,8272800.0,41.02999877929688,41.45000076293945,40.970001220703125,41.34999847412109,35.0858154296875,KO,"Sorry Coca-Cola, No One Wants To Hear Your ""Scientific Research"" ||| Coca-Cola's Management Shakeup: Bringing 'A Knife To A Gun Fight?'",0,0.5037327
2015-08-18,11199400.0,41.27999877929688,41.52999877929688,41.18999862670898,41.29999923706055,35.04338455200195,KO,"XLP, PG, KO, PM: Large Outflows Detected at ETF ||| Will Bottlers' $12.6 Billion Megamerger Help Coca-Cola Co? ||| Jeremy Grantham Reduces More Than 250 Stakes in Second Quarter ||| After Hours Most Active for Aug 18, 2015 : CSCO, T, UDR, TXN, MSFT, YHOO, PFE, KO, LOW, ADI, MAC, FTR",0,0.47546387
2015-08-19,15796500.0,41.13999938964844,41.2400016784668,40.77999877929688,40.77999877929688,34.60215759277344,KO,"2 Dividend Stocks Retirees Should Avoid ||| After Hours Most Active for Aug 19, 2015 : QQQ, HPQ, AAPL, BAX, PFE, GM, GE, KO, NTAP, BRCM, NFLX, MSFT ||| Benzinga's M&A Chatter for Wednesday August 19, 2015 ||| Suja Juice Announces Investment, Distribution Deal With Coca-Cola",0,0.5109844
2015-08-20,14218000.0,40.52000045776367,40.81999969482422,40.41999816894531,40.54999923706055,34.407012939453125,KO,Coca-Cola Acquires Minority Stake in Juice Maker Suja,0,0.5208627
2015-08-21,28036200.0,40.15999984741211,40.470001220703125,39.5099983215332,39.52999877929688,33.54152297973633,KO,"Stock Market News for August 21, 2015",0,0.48357156
2015-08-24,44065300.0,37.9900016784668,38.93999862670898,36.560001373291016,38.380001068115234,32.56574630737305,KO,"3 Dividend Stocks Retirees Should Avoid ||| How Coke Is Restructuring Its Way To Higher Profitability ||| Cott Corporation (COT) Ex-Dividend Date Scheduled for August 25, 2015",0,0.48669598
2015-08-26,23523300.0,38.75,38.83000183105469,37.88999938964844,38.72999954223633,32.86271286010742,KO,"Consumer Staples Select Sector SPDR Fund Experiences Big Outflow ||| 5 Beaten-Down Consumer Goods Stocks Still Worthy of Your Portfolio ||| Coca-Cola Enterprises Counters Weak Sales: Time to Buy? ||| Jim Cramer Gives His Opinion On Chicago Bridge & Iron, Newmont Mining And Coca-Cola",1,0.5166674
2015-08-27,18871600.0,39.060001373291016,39.380001068115234,38.59999847412109,39.27000045776367,33.3209114074707,KO,Hearing Unconfirmed Market Chatter Keurig has Unlocked 3-yr Standtill Agreement with Coke; Brought on 3G to Manage Asset for Coke,1,0.51792026
2015-08-28,14503900.0,39.11000061035156,39.470001220703125,39.04999923706055,39.45000076293945,33.47364807128906,KO,Monster Beverage's $2 Billion Question,0,0.5194201
2015-08-31,12673300.0,39.150001525878906,39.45000076293945,39.060001373291016,39.31999969482422,33.363338470458984,KO,Water Is the New Soda -- and That's a Problem for Coke and Pepsi ||| Watching Shares Of Pepsi And Coca-Cola Following Bearish Comments From Dallas Fed,0,0.50487924
2015-09-01,23703200.0,38.66999816894531,39.02999877929688,38.540000915527344,38.75,32.879695892333984,KO,"Only Nine Dow Components With Recent Insider Buying, KO is One of Them ||| Pepsico, Inc. (PEP) Ex-Dividend Date Scheduled for September 02, 2015 ||| Coca-Cola Enterprises, Inc. (CCE) Ex-Dividend Date Scheduled for September 02, 2015 ||| It's Not Shopping, It's Market Research: Talking Investing Trends With TD Ameritrade's Nicole Sherrod",1,0.4572832
2015-09-03,13311600.0,38.900001525878906,39.34000015258789,38.84000015258789,39.15999984741211,33.22758102416992,KO,"IWF, DIS, KO, CVS: Large Outflows Detected at ETF",0,0.5220982
2015-09-04,15450500.0,38.68000030517578,38.790000915527344,38.380001068115234,38.52000045776367,32.68453598022461,KO,Is The Soda Industry Doomed?,1,0.53856486
2015-09-08,15273900.0,38.869998931884766,39.02999877929688,38.59999847412109,38.900001525878906,33.0069694519043,KO,"Ambev S.A. (ABEV) Ex-Dividend Date Scheduled for September 09, 2015 ||| 12 Mutual Funds To Invest Like Warren Buffett",0,0.4710903
2015-09-09,13764600.0,39.119998931884766,39.209999084472656,38.20000076293945,38.29999923706055,32.49785614013672,KO,"Dr Pepper Snapple Group, Inc (DPS) Ex-Dividend Date Scheduled for September 10, 2015",1,0.47006953
2015-09-10,14952500.0,38.310001373291016,38.650001525878906,38.25,38.41999816894531,32.59967803955078,KO,"Invest Like Warren Buffett With These Value Stocks ||| Coca-Cola Company (KO) Ex-Dividend Date Scheduled for September 11, 2015 ||| Pre-Market Most Active for Sep 10, 2015 : CNW, DY, ENVI, XIV, QQQ, AAPL, LULU, TVIX, KO, BAC, GSK, ALU",0,0.47249505
2015-09-14,8950000.0,38.220001220703125,38.220001220703125,37.84999847412109,38.09999847412109,32.60824203491211,KO,"3 Reasons Why PepsiCo Should Buy SodaStream ||| 5 Things Investors Need to Know About Keurig Green Mountain’s Future ||| 4 Myths About Coca-Cola That Are Entirely Bogus ||| Share Repurchases: We Need Change ||| One Put, One Call Option To Know About for Coca-Cola ||| Thirsty for Solid Returns? Add Dr Pepper to Your Portfolio Now ||| Monster Beverage Okays $500M Share Buyback Program",1,0.5218688
2015-09-15,13019800.0,38.06999969482422,38.630001068115234,37.91999816894531,38.5,32.95058059692383,KO,No More Screenshots? Snapchat Introduces Three Replays For Under $1,1,0.49457562
2015-09-17,21232500.0,39.150001525878906,39.61000061035156,39.040000915527344,39.380001068115234,33.70374298095703,KO,Dow Analyst Moves: Coca-Cola ||| Coca-Cola gets show of support,0,0.5019122
2015-09-18,27527300.0,38.86000061035156,39.29999923706055,38.709999084472656,38.97999954223633,33.36139678955078,KO,"Dow Movers: XOM, PG ||| Make The World A Better Place With...Stock Picks? ||| Coca-Cola States No Penalties Were Asserted By IRS ||| Coca-Cola Receives Statutory Notice Of Deficiency From IRS For 2007-2009 Tax Years ||| Citi Analyst Becoming Encouraged By Coca-Cola, Yet Stock Remains Depressed; ""Worst May Be Behind US""",1,0.48134863
2015-09-21,12935800.0,39.04999923706055,39.310001373291016,38.93999862670898,39.18999862670898,33.54113006591797,KO,Coca-Cola (KO) Owes $3.3 Billion in Income Tax: IRS,0,0.49442434
2015-09-22,15021300.0,38.68000030517578,38.9900016784668,38.58000183105469,38.790000915527344,33.198787689208984,KO,"Notable ETF Outflow Detected - XLP, PG, KO, PM ||| Twitter Offers Custom-Emoji Ads for ''Share a Coke'' Campaign ||| Beverage Giants Are Snatching Up Drink Brands, But The Bottom Of The Barrel Isn't In Sight",0,0.48134917
2015-09-24,19385700.0,38.52000045776367,39.20000076293945,38.5099983215332,39.150001525878906,33.50690078735352,KO,"Dow Movers: CAT, KO ||| Dow Jones Industrial Average Slumps 78 Points Ahead of Yellen's Statements ||| Goldman Thinks Monster Beverage Has 23% Upside ||| UPDATE: Coca-Cola Signs Letters of Intent Related to Implementation of National Product Supply System in US ||| Coca-Cola Reports Signing of Letters of Intent for Implementation of National Product Supply System in US",1,0.507322
2015-09-25,22511300.0,39.43000030517578,40.08000183105469,39.33000183105469,39.619998931884766,33.90914535522461,KO,How to Use Orders to Target Options Trading Profits ||| Coca-Cola (KO) to Sell 9 US Plants to Independent Bottlers,0,0.5099325
2015-09-28,19323100.0,39.52000045776367,39.81999969482422,39.33000183105469,39.52999877929688,33.832115173339844,KO,Coke Stock: Still a Good Time to Bail Out of This Buffett Favorite ||| Coca-Cola Bottling Up 9% on Coca-Cola Co. Plant Buy Deal ||| Facebook Looks To Take Over TV Advertising,1,0.5162019
2015-09-29,14166900.0,39.52000045776367,39.709999084472656,39.33000183105469,39.65999984741211,33.943382263183594,KO,Is a SodaStream Killer Actually a Keurig Killer?,1,0.5252667
2015-09-30,19752600.0,39.880001068115234,40.22999954223633,39.79999923706055,40.119998931884766,34.33708572387695,KO,"XLP, PG, KO, PM: Large Inflows Detected at ETF ||| Love Soft Drinks? Make Them at Home with Keurig KOLD ||| Will Keurig Green Mountain's Kold Brewing System Be a Success?",0,0.49859455
2015-10-01,19606600.0,40.220001220703125,40.470001220703125,39.59999847412109,39.79999923706055,34.063209533691406,KO,Is This The Buying Opportunity of the Year?,1,0.52843344
2015-10-02,15537300.0,39.560001373291016,40.38999938964844,39.36000061035156,40.38999938964844,34.56816101074219,KO,"Dow Movers: JPM, PFE",1,0.51388377
2015-10-05,15664000.0,40.45000076293945,41.04999923706055,40.43000030517578,41.0099983215332,35.09879302978516,KO,My Evolution as an 'Intrinsic Value Seeker' ||| The Most Important Investing Risk ||| Why Invest? ||| Interesting December Stock Options for KO,0,0.5017687
2015-10-06,14579400.0,41.040000915527344,41.34000015258789,40.93000030517578,40.959999084472656,35.05600357055664,KO,"Consumer ETFs Preserve Gains Despite Volatile 2015 ||| Can Keurig's Kold Spark A Turnaround? ||| Pepsi Tops Q3 Sales & Earnings, Ups 2015 EPS Growth Target ||| Pepsi Hits The Spot For Dividend-Hungry Investors",1,0.5038152
2015-10-07,14329700.0,41.13999938964844,41.61000061035156,41.09999847412109,41.52000045776367,35.535282135009766,KO,"Why Should You Watch the Ball Corporation, Rexam Deal? ||| 4 Food Stocks That Could Get Gobbled Up ||| Why Pepsi Is Morgan Stanley's Top Mega-Cap Pick",1,0.50453955
2015-10-08,11960200.0,41.2599983215332,41.9900016784668,41.2599983215332,41.97999954223633,35.928985595703125,KO,"XLP, PG, KO, PM: ETF Inflow Alert ||| Vanguard Consumer Staples ETF -- Insider Buying Index Registering 13.9% ||| Coca-Cola Bottling Hits 52-Week High on Plant Buyout Deal",1,0.5156286
2015-10-09,13931200.0,41.81999969482422,42.119998931884766,41.77999877929688,42.02000045776367,35.96321487426758,KO,"Keurig Kold Receives a Lukewarm Welcome ||| Apple Pay Coming to Starbucks, KFC in 2016",0,0.52229196
2015-10-12,12299100.0,41.83000183105469,42.290000915527344,41.810001373291016,42.0,35.94609832763672,KO,"How Much Are the Richest Hedge Fund Managers Worth? ||| After Hours Most Active for Oct 12, 2015 : KO, PSTG, XIV, FOXA, NAVI, ALJ, MSFT, CVC, BEN, LNCO, SDRL, AAPL ||| Pepsi & Coca-Cola In Talks To Invest In Chobani-Reuters ||| Here's How A Company's Facebook Page Can Beat The Market",0,0.46702737
2015-10-13,12903600.0,41.79999923706055,41.90999984741211,41.540000915527344,41.650001525878906,35.64654541015625,KO,Pepsi Performs Well in '15 as Americas Improve: Is it Enough? ||| Hearing Renewed Unconfirmed Market Chatter of Increased Coke Stake in GMCR,1,0.5317313
2015-10-14,14180000.0,41.560001373291016,41.959999084472656,41.560001373291016,41.68000030517578,35.67222213745117,KO,Keurig Kold's Failure Won't Make SodaStream a Success ||| Coke and Pepsi Looking to Invest in Chobani: Who will Win? ||| Coca-Cola Enterprises' COO Damian Gamell Takes Office ||| Hearing CNBC Reporting Coca-Cola Has Said Co. Not Actively Pursuing Investment in Chobani,1,0.5078953
2015-10-15,11801600.0,41.869998931884766,42.02999877929688,41.59999847412109,41.91999816894531,35.877620697021484,KO,Did Tom Brady Just Deflate Coca-Cola and Kellogg? ||| Hearing Report Coca Cola Has Pulled Out of Talks to Purchase Interest in Chobani,1,0.5048605
2015-10-16,20384200.0,42.15999984741211,42.209999084472656,41.880001068115234,42.02000045776367,35.96321487426758,KO,"Notable ETF Inflow Detected - XLP, PG, KO, PM",0,0.49833253
2015-10-19,15553800.0,41.900001525878906,42.060001373291016,41.79999923706055,41.9900016784668,35.93754196166992,KO,"Dividend Investing 101: A Primer on Everything Dividends ||| Don't Sweat the Business Cycles With The Coca-Cola Co and Procter & Gamble Co ||| Interesting November Stock Options for KO ||| Coca-Cola (KO) to Report Q3 Earnings: What's in Store? ||| What to Watch in the Stock Market This Week ||| Coca-Cola Co. Was Smart to Avoid This Big Mistake ||| Stock Week Ahead: Housing Data, Broad-Based Earnings Line Up",1,0.48490837
2015-10-20,16199300.0,42.0,42.400001525878906,42.0,42.290000915527344,36.19430160522461,KO,"Mexico Has Some Bad News for Coke and Pepsi ||| Pre-Market Earnings Report for October 21, 2015 : KO, BA, BIIB, ABT, EMC, GM, TMO, KMB, ITW, BHI, STJ, NLSN ||| Monster Beverage Stock Soars After News of Testing At McDonald's ||| General Mills Opens Contest for Lucky Charms Marshmallow",0,0.46841
2015-10-21,19254900.0,41.93999862670898,42.52000045776367,41.709999084472656,42.18999862670898,36.10870742797852,KO,"In the Heart of Q3 Earnings Season ||| Coca-Cola (KO) Tops Q3 Earnings; Revenues Hit by Currency ||| Dow Movers: CVX, BA ||| Futures Buoyed by Upbeat Earnings, Ferrari IPO ||| The Coca-Cola Company Feels the Sting of Dollar Dominance ||| Earnings Reaction History: The Coca-Cola Company, 30.0% Follow-Through Indicator, 2.2% Sensitive ||| Coca-Cola Earnings: Cost Cutting Can't Overcome Currency Exchange ||| Coca-Cola (KO) Beats on Earnings; Misses Sales in Q3 ||| Coca-Cola Flat After Small Q3 Beat ||| Deal Buzz Tops Mixed Results From Chock-Full Earnings Calendar ||| UPDATE: Coca-Cola Says Remains on Track to Refranchise Half of Co.-Owned US Bottler-Delivered Volume by End of '17 ||| The Coca-Cola Company Reports Letters of Intent with Three U.S. Bottlers to Grant Expanded Distribution Territories in Seven States; Terms Not Disclosed ||| Coca-Cola Reports Q3 EPS $0.51 Vs Est $0.50 ||| US Stock Futures Surge Ahead Of Earnings ||| 10 Stocks To Watch For October 21, 2015 ||| Earnings Scheduled For October 21, 2015",1,0.5102512
2015-10-23,18796100.0,43.310001373291016,43.310001373291016,42.75,42.790000915527344,36.62221908569336,KO,"Retirees: I Did Not Buy IBM To Sell; It's About The Dividend Income, Stupid",0,0.48570722
2015-10-26,14788600.0,42.7599983215332,42.88999938964844,42.459999084472656,42.59000015258789,36.45104598999024,KO,"One Put, One Call Option To Know About for Coca-Cola ||| Monday's ETF with Unusual Volume: KXI ||| Problem Children Aren't Derailing Consumer Staples ETFs",1,0.48231122
2015-10-27,30166600.0,42.5,42.77000045776367,42.47999954223633,42.61000061035156,36.46817398071289,KO,"Coca-Cola Bottling Co. Consolidated (COKE) Ex-Dividend Date Scheduled for October 28, 2015 ||| Coca Cola Femsa S.A.B. de C.V. (KOF) Ex-Dividend Date Scheduled for October 28, 2015 ||| Coca-Cola Enterprises' (CCE) Q3 Earnings: What's in Store? ||| Dr Pepper Upgraded By RBC, Firm Says It Had 'Wrong Diagnosis'",1,0.48172602
2015-10-29,9427400.0,42.65999984741211,42.900001525878906,42.34000015258789,42.790000915527344,36.62221908569336,KO,"FEMSA (FMX) Posts In-Line Q3 Earnings, Revenues Strong ||| Better Buy Now: McDonald's Corporation vs. The Coca-Cola Co",0,0.5086044
2015-10-30,15356200.0,42.79999923706055,42.86000061035156,42.34999847412109,42.34999847412109,36.245643615722656,KO,"3 of the Worst Product Launches of All Time ||| Fomento Economico Mexicano S.A.B. de C.V. (FMX) Ex-Dividend Date Scheduled for November 02, 2015 ||| 4 Dividend 'Aristocrats' Outperforming The Market ||| Coca-Cola Bottling (COKE) Earnings Preview: A Sneak Peek ||| Quality And Value Meet In This Dividend ETF",0,0.5411564
2015-11-02,16252200.0,42.31999969482422,42.36000061035156,41.900001525878906,42.2400016784668,36.15149688720703,KO,"Which Of The Latest 13F Filers Holds Coca-Cola? ||| One Put, One Call Option To Know About for Coca-Cola ||| Monster Beverage (MNST) Earnings: Is a Beat in the Cards? ||| Monster Beverage Hopes to Get Its Growth Back",0,0.47814566
2015-11-03,9693100.0,42.18000030517578,42.31999969482422,41.810001373291016,42.15999984741211,36.0830307006836,KO,13 Stocks Jim Cramer Is Looking At ||| Tech Gets In On Tea Trend,0,0.48068923
2015-11-04,10488500.0,42.27000045776367,42.38999938964844,41.88999938964844,41.970001220703125,35.92042541503906,KO,"Constellation Brands Inc (STZ) Ex-Dividend Date Scheduled for November 05, 2015 ||| After Hours Most Active for Nov 4, 2015 : FB, GE, M, FEYE, CVX, WFM, HPE, KO, HPQ, FTR, SPLS, YHOO",1,0.47974437
2015-11-05,9625100.0,42.0,42.34999847412109,41.97999954223633,42.33000183105469,36.22853088378906,KO,"Anheuser-Busch Inbev SA (BUD) Ex-Dividend Date Scheduled for November 06, 2015",0,0.4628015
2015-11-06,11926700.0,41.970001220703125,42.220001220703125,41.61000061035156,41.959999084472656,35.91185760498047,KO,"Monster Beverage Beats Q3 Earnings & Sales, Shares Up 8.1% ||| Monster Beverage Roars Higher as Growth Returns to the Energy Drink Industry ||| Monster Beverage Corporation Jumps and Men's Wearhouse Inc Sinks as Stocks Extend Rally",0,0.5036165
2015-11-09,10842700.0,41.70000076293945,41.790000915527344,41.34000015258789,41.540000915527344,35.55240249633789,KO,"SodaStream International Ltd Just Reported Earnings, and Keurig Investors Should Be Scared ||| One Put, One Call Option To Know About for Coca-Cola",1,0.5153627
2015-11-10,8283100.0,41.43999862670898,41.810001373291016,41.43000030517578,41.77000045776367,35.74925231933594,KO,"Notable ETF Outflow Detected - XLP, PG, KO, PM ||| Coca-Cola's European Bottler Merger Gets EU Antitrust Nod ||| 5 Things Coca-Cola Management Wants You to Know ||| 10 S&P 500 Companies With Green Operations ||| What Rockstar Energy Drink Does To Your Body ||| Fast Money Picks For November 10",1,0.47916847
2015-11-11,9101200.0,41.93999862670898,42.20000076293945,41.91999816894531,42.040000915527344,35.9803352355957,KO,"Dow Movers: AAPL, GE ||| Coca-Cola Enterprises (CCE) Sales Remain Weak; Profits Up",0,0.49937478
2015-11-12,10725000.0,42.0099983215332,42.04999923706055,41.56999969482422,41.58000183105469,35.586639404296875,KO,"Why Dr Pepper Snapple Group Inc. Shares Rallied 13% in October ||| Have A Smile? Ackman Calls Out Buffett And Munger For Coca Cola Stake, Says Sugar Is Poison",0,0.47753996
2015-11-13,11619500.0,41.459999084472656,41.77999877929688,41.36000061035156,41.380001068115234,35.41545867919922,KO,Fatten Your Bank Account With This Junk Foods Moderate-Volatility Portfolio,1,0.5265973
2015-11-16,11244900.0,41.43000030517578,42.0,41.38999938964844,41.959999084472656,35.91185760498047,KO,3 Big-Brand Stocks to Own for the Next 20 Years ||| Better Dividend Stock: ExxonMobil vs. Coca-Cola ||| Interesting January 2017 Stock Options for KO,0,0.5130506
2015-11-17,12739400.0,41.84999847412109,42.150001525878906,41.5099983215332,41.66999816894531,35.66366195678711,KO,"Coca-Cola Enterprises, Inc. (CCE) Ex-Dividend Date Scheduled for November 18, 2015 ||| KO Named Top 25 SAFE Dividend Stock Increasing Payments For Decades ||| Is Bill Ackman Right About Warren Buffett and Coca-Cola? ||| Coca-Cola Issues Update on Q4 Currency Expectations Ahead of Morgan Stanley Consumer, Retail Conference: Sees 7 Point Headwind on Sales, 13 Point Headwind on Operating Income, 11 Point Headwind on IBT",1,0.46592757
2015-11-18,12966300.0,41.77000045776367,42.34999847412109,41.68000030517578,42.27999877929688,36.185733795166016,KO,What's Ailing Small-Cap ETFs? A Look Inside A Leader ||| Can SodaStream Survive Where Coca-Cola Failed to Thrive?,1,0.5172302
2015-11-19,24090700.0,42.31999969482422,43.29999923706055,42.31999969482422,43.11000061035156,36.89609909057617,KO,"Dow Movers: UNH, PG ||| Instant Analysis: Constellation Brands' $1 Billion Craft Beer Splurge ||| Is it the Right Time to Buy Dr Pepper Snapple (DPS) Stock? ||| Why Dr Pepper Snapple Group is a Top Socially Responsible Dividend Stock (DPS) ||| Keurig Green Mountain Soars on Strong Earnings, Dividend Hike",0,0.48759517
2015-11-20,19780800.0,43.310001373291016,43.58000183105469,42.400001525878906,42.43000030517578,36.31411743164063,KO,There's Apparently A Transformational Shift Happening In Soft Drinks Coming,1,0.55897814
2015-11-23,13338100.0,42.54999923706055,43.18000030517578,42.52999877929688,42.959999084472656,36.76771926879883,KO,"One Put, One Call Option To Know About for Coca-Cola ||| Dow Movers: PFE, HD",1,0.4918147
2015-11-24,15767200.0,42.70000076293945,43.59999847412109,42.65999984741211,43.36000061035156,37.11006546020508,KO,"Molson Coors Brewing Company (TAP) Ex-Dividend Date Scheduled for November 25, 2015",0,0.46393967
2015-11-25,10344900.0,43.31999969482422,43.5,43.2400016784668,43.36000061035156,37.11006546020508,KO,"Cott Corporation (COT) Ex-Dividend Date Scheduled for November 27, 2015 ||| How Coca-Cola Spent $46 Billion in 12 Months ||| The Coca-Cola Co. Tries a Slimming Formula ||| Keurig Debuts Keurig KOLD System in Canada; Shares Up",0,0.49005637
2015-11-30,16063000.0,43.119998931884766,43.150001525878906,42.61000061035156,42.619998931884766,36.75647735595703,KO,The Average American's Savings Account Isn't Earning Enough Annually to Buy a Latte ||| This Dow Dividend Stock Has Everything You Want ||| Monster Beverage Hits 52-Week High on Solid Q3 Results ||| Add Dr Pepper (DPS) to Your Portfolio Before it Loses Fizz ||| Monday's ETF with Unusual Volume: PEY,1,0.49624723
2015-12-01,11153000.0,42.72999954223633,43.09999847412109,42.72999954223633,42.88999938964844,36.98932266235352,KO,"Pepsico, Inc. (PEP) Ex-Dividend Date Scheduled for December 02, 2015",0,0.45088252
2015-12-02,12598500.0,42.83000183105469,42.93000030517578,42.59000015258789,42.77000045776367,36.88583755493164,KO,Challenges & Remedies for Food Stocks: 3 Choices ||| 4 Top Stocks That Pay Bigger Dividends Every Year,0,0.505643
2015-12-03,15004400.0,42.72999954223633,42.88999938964844,42.31999969482422,42.459999084472656,36.61848449707031,KO,Dow Analyst Moves: KO ||| Ball Corporation Prices Senior Notes to Fund Rexam Buyout ||| 7 Of The World's Most Famous Corporate Rivalries,1,0.49758914
2015-12-04,16488000.0,42.58000183105469,43.47999954223633,42.58000183105469,43.290000915527344,37.33428955078125,KO,"Keurig Offers K250 Brewer & Travel Mug in 2 Pantone Colors ||| Monster Brings Plenty Of Energy To Red Bull Battle ||| Why This Notable Analyst Downgraded Shares Of Coca-Cola, Left Pepsi Shares At Neutral ||| Earlier Tigress Financial Downgraded Coca-Cola to Neutral",0,0.503165
2015-12-07,12030700.0,43.310001373291016,43.43999862670898,43.0,43.20000076293945,37.25667572021485,KO,The Well-Placed Aggression of Starbucks Corporation ||| Keurig Green Mountain Just Got Bailed Out ||| Morgan Stanley Envisions Keurig's KOLD System Being De-Emphasized Over Time Without Coca-Cola's Explicit Financial Commitment To Keurig ||| Keurig Green Mountain Bought Out In $13 Billion Deal; Acquiring Firm Building Quite The Coffee Portfolio ||| Shares of Coca-Cola Trading Up 1% to $43.70 Following News of Keurig Green Mountain Go-Private Deal,0,0.50675094
2015-12-08,10736200.0,43.04999923706055,43.25,42.79999923706055,43.0099983215332,37.092811584472656,KO,Keurig (GMCR) Shares Soar as it Goes Private for $13.9B ||| How Coca-Cola Wins from JAB's $13.9 Billion Keurig Buyout,0,0.49283358
2015-12-09,12945500.0,42.77999877929688,43.27000045776367,42.5,42.65999984741211,36.79096984863281,KO,"After Keurig Buyout, What's Next for Beverage Stocks? ||| Dr Pepper Snapple Group, Inc (DPS) Ex-Dividend Date Scheduled for December 10, 2015 ||| Amazon.com Inc. Prime Video Gets an Upgrade and Keurig Green Mountain Inc Joins Global Coffee Portfo ||| Keurig Green Mountain, Coke, JAB: Win, Win, Win ||| Coca-Cola Hires Steckhan to Oversee U.S. Operations - WSJ ||| Keurig Green Mountain Inc Wins a Sky High Buyout Premium ||| Coca-Cola Signs Letter Of Intent To Expand Into South Florida ||| The Coca-Cola Announces Letters of Intent with Three US Bottlers to Grant Expanded Distribution Territories in Five States, No Terms Disclosed",1,0.49930897
2015-12-10,15483300.0,42.72999954223633,43.06999969482422,42.52999877929688,42.7599983215332,36.87720489501953,KO,"Keurig Green Mountain, Inc.'s Worst Product in 2015 ||| The Best Holiday Commercials Ever ||| Coca-Cola: 3 Important Insights From the Beverage Giant's Balance Sheet ||| The Zacks Analyst Blog Highlights: Keurig Green Mountain, Coca-Cola, Mondelez International, PepsiCo and Monster Beverage ||| Coca-Cola to Grant Expanded US Territories to Three Bottlers",0,0.4695419
2015-12-11,17313400.0,42.630001068115234,42.83000183105469,42.13999938964844,42.27000045776367,36.45462417602539,KO,Low Volatility ETFs Could Be Hot In 2016,1,0.5387144
2015-12-14,20092900.0,42.310001373291016,42.7599983215332,41.970001220703125,42.45000076293945,36.60986328125,KO,How Monster Beverage Corporation Gained 13% in November,1,0.5071694
2015-12-15,17916400.0,42.84000015258789,43.2400016784668,42.7599983215332,43.06999969482422,37.14456558227539,KO,"IWF, AAPL, KO, V: ETF Inflow Alert ||| Big Winners and Losers From the Keurig Green Mountain Inc Buyout ||| Dow Jones Industrial Average Surges 156 Points on Fed Rate Focus",1,0.5225521
2015-12-16,21868600.0,43.25,43.90999984741211,43.25,43.84000015258789,37.808624267578125,KO,Should 5 Top Buffett Stocks Be In Your Portfolio Too?,0,0.48983666
2015-12-17,14697000.0,43.810001373291016,43.88999938964844,43.41999816894531,43.4900016784668,37.50678634643555,KO,The 6 Best Dividend Stocks to Buy in 2016 ||| KO a Top 25 Dividend Giant With $5.57B Held By ETFs ||| Coca-Cola Enterprises Cuts Sales Outlook; Issues 2016 View,0,0.5123855
2015-12-18,24583700.0,43.36000061035156,43.41999816894531,42.5,42.5,36.65298461914063,KO,Todd Gordon Is Bullish On Coca-Cola,1,0.5236352
2015-12-21,10444400.0,42.81999969482422,42.93999862670898,42.459999084472656,42.77999877929688,36.89445114135742,KO,"3 Industrial Dividends That Should Be on Your Radar Now ||| Keurig Green Mountain, Inc.'s Best Product in 2015 ||| The Zacks Analyst Blog Highlights: Procter & Gamble, Coca-Cola, JPMorgan Chase, Boeing and General Electric ||| How the Coca-Cola Company Juiced Its Cash Flow by $600 Million ||| Cheap Gas Prices Pump Up Convenience Store Stocks ||| Ambev S.A. (ABEV) Ex-Dividend Date Scheduled for December 22, 2015",1,0.5390178
2015-12-22,12280800.0,42.86000061035156,43.38999938964844,42.709999084472656,43.290000915527344,37.33428955078125,KO,"Vina Concha Y Toro (VCO) Ex-Dividend Date Scheduled for December 23, 2015",1,0.47517312
2015-12-23,9092300.0,43.38999938964844,43.72999954223633,43.34999847412109,43.66999816894531,37.66200637817383,KO,"IWF, AAPL, KO, V: Large Inflows Detected at ETF ||| Important Things to Know About a Stock's Balance Sheet ||| Peering Through The Fog To Find The Best Sectors Into Year End ||| How The Keurig Deal Put Coffee Stocks On The Front Burner",0,0.5009094
2015-12-24,3036600.0,43.4900016784668,43.720001220703125,43.41999816894531,43.540000915527344,37.549896240234375,KO,"Energy Drinks, Bottled Water On Tap For Soda Giants",0,0.51565623
2015-12-28,6326100.0,43.43999862670898,43.52000045776367,43.310001373291016,43.4900016784668,37.50678634643555,KO,"Will 2016 Be Keurig Green Mountain, Inc.'s Best Year Yet? ||| Is PepsiCo, Inc. Greenwashing Its Image? ||| An ETF With A Unique View Of Low Volatility",1,0.49253243
2015-12-29,7739800.0,43.540000915527344,43.77999877929688,43.5,43.709999084472656,37.696510314941406,KO,Will Keurig's (GMCR) Decision to Go Private Aid the Stock? ||| A Look At Some Of 2015's Exciting S&P 500 ETFs,0,0.49331853
2015-12-30,5112500.0,43.75,43.77000045776367,43.45000076293945,43.56999969482422,37.57577133178711,KO,"Bernstein Highlights KO, CCE, And PEP As Company's With Relatively Attractive Valuations",0,0.5124219
2015-12-31,9727900.0,43.29999923706055,43.34000015258789,42.869998931884766,42.959999084472656,37.0496940612793,KO,These 3 Companies Doubled in 2015,0,0.5450099
2016-01-04,16084100.0,42.34000015258789,42.5,41.970001220703125,42.400001525878906,36.56674575805664,KO,"The Dow Jones 2016: What to Expect ||| Why Dividend Growth Investing Should Be Your New Year's Resolution ||| Warren Buffett's Best Dividend Stocks for 2016 ||| One Put, One Call Option To Know About for Coca-Cola",1,0.5038139
2016-01-05,15781900.0,42.310001373291016,42.630001068115234,42.16999816894531,42.54999923706055,36.696102142333984,KO,"After Hours Most Active for Jan 5, 2016 : FIG, MDLZ, ARRS, QQQ, KO, HLF, FCX, F, STOR, MU, MSFT, AAPL ||| Tuesday's ETF with Unusual Volume: KXI",0,0.4943528
2016-01-06,16245100.0,42.20000076293945,42.5099983215332,42.040000915527344,42.31999969482422,36.49773406982422,KO,3 Dividend Stocks That Will Fight Back in 2016 ||| Legg Mason Enters ETF Arena With Four Funds,0,0.50515723
2016-01-08,14645900.0,41.650001525878906,42.119998931884766,41.40999984741211,41.5099983215332,35.7991828918457,KO,This Top Mutual Fund Manager Seeks Stocks With Sharp Elbows,1,0.5183648
2016-01-11,15815200.0,41.58000183105469,41.86000061035156,41.290000915527344,41.58000183105469,35.85955047607422,KO,"Here's Why Keurig Stock Dropped 32% In 2015 ||| 4 Investing Lessons You Can Learn From the 1% ||| IWF, AAPL, KO, V: Large Outflows Detected at ETF ||| The Most Important Numbers According to Peter Lynch ||| Keurig Green Mountain, Inc. Gets the Last Laugh in 2016 ||| MKM's Jon Krinsky: Buy Low Volatility Stocks, Sell High Beta Stocks ||| The Tussle Between Two Big Consumer ETFs Is Telling ||| Fast Money Picks For January 11",1,0.50587904
2016-01-12,21814800.0,42.29999923706055,42.45000076293945,41.869998931884766,42.119998931884766,36.32524490356445,KO,"Stock Market News for January 12, 2016 ||| Walmart Rising, LinkedIn Stumbling, And Coca-Cola's Resilience...LikeFolio Top 50 Continued ||| Coca-Cola Alert: Stifel Upgrades To Buy, Sees 30% Upside ||| Stifel Upgrades Coca-Cola To Buy, Says Organic Growth Picking Up, Margins Improving ||| Stifel Nicolaus Upgrades Coca-Cola to Buy",0,0.48392257
2016-01-13,16854300.0,42.16999816894531,42.56999969482422,41.790000915527344,41.84999847412109,36.092403411865234,KO,"XLP, CHAU: Big ETF Inflows",1,0.5224204
2016-01-14,16028000.0,41.9900016784668,42.16999816894531,41.63999938964844,41.880001068115234,36.11827850341797,KO,"These 2 Bad Boy Stocks Pay Dividends In Tough Market ||| Market Close Report: NASDAQ Composite index closes at 4,615 up 88.94 points ||| Coca-Cola (KO) Signs Ad Deal with #1 Golfer Jordan Spieth",0,0.48465604
2016-01-15,21153600.0,40.95000076293945,41.59000015258789,40.93000030517578,41.5,35.79056167602539,KO,"Dow Jones Industrial Average Plunges Again: What to Do Next ||| Dow 30 Stock Roundup: JPM, Intel Beat, GE May Shift Headquarters ||| Dividend Aristocrats ETF Joins The $1 Billion Club",1,0.4919351
2016-01-19,15462200.0,41.77000045776367,42.119998931884766,41.650001525878906,41.91999816894531,36.15277862548828,KO,"The Zacks Analyst Blog Highlights: Coca-Cola, Walt Disney, Home Depot, JPMorgan Chase and Intel ||| SPDR S&P 500 ETF Experiences Big Inflow ||| Coca-Cola Still Trying To Overcome The Sugar Stigma ||| Coca-Cola Launches 'One Brand' Global Marketing Strategy",0,0.49654227
2016-01-20,19923500.0,41.45000076293945,41.619998931884766,40.75,41.380001068115234,35.68706512451172,KO,The Coca-Cola Company Starts 'Taste the Feeling' Campaign ||| Berkshire Hathaway: Estimating Earnings Power,1,0.5273167
2016-01-21,15568900.0,41.45000076293945,41.5099983215332,41.09000015258789,41.38999938964844,35.69568634033203,KO,5 Dividend Stocks to Buy in January,1,0.55057734
2016-01-22,15209200.0,41.63999938964844,42.2400016784668,41.45000076293945,42.060001373291016,36.27352142333984,KO,"After Hours Most Active for Jan 22, 2016 : BAC, BEL, SYF, ATML, OKE, KO, XOM, XIV, YHOO, MSFT, QQQ, INTC ||| CocaCola CEO Says Looking to Maintain Market Leadership in India; No Plans to Enter Snacks Business in India -ET Now",1,0.49132586
2016-01-25,12505200.0,42.2400016784668,42.5,41.93000030517578,42.15999984741211,36.3597526550293,KO,"Will 2016 Be Coca-Cola's Best Year Yet? ||| Keurig Green Mountain Stock Is Dropping, but Don't Panic",0,0.48161393
2016-01-26,13018500.0,42.15999984741211,42.5,41.93000030517578,42.08000183105469,36.29076385498047,KO,"Coca-Cola Bottling Co. Consolidated (COKE) Ex-Dividend Date Scheduled for January 27, 2016 ||| Wal-Mart, Coke And Pepsi Will Supply Flint With Water For The Rest Of The Year",1,0.5038346
2016-01-27,14167000.0,42.18000030517578,42.459999084472656,41.810001373291016,42.09000015258789,36.29938507080078,KO,8 Best Cheap Stocks Under $8 to Buy Now,1,0.5160711
2016-01-28,16622800.0,42.18000030517578,42.720001220703125,42.060001373291016,42.56999969482422,36.71334838867188,KO,"Are McDonald's, Wendy's, and Burger King Falling Into a Discount Trap? ||| PepsiCo Stock vs. Coca-Cola: Which Soda Giant Is Better Positioned to Reward Investors in 2016 ||| Arnold Van Den Berg Cuts Stake in Coca-Cola by Nearly Half ||| In A Shifting Media Landscape, One Thing Stays The Same: Super Bowl Ads",1,0.513854
2016-01-29,20457000.0,42.86000061035156,43.2599983215332,42.650001525878906,42.91999816894531,37.01519393920898,KO,"Ambev S.A. (ABEV) Ex-Dividend Date Scheduled for February 01, 2016 ||| 5 Stocks to Buy and Hold for the Next Decade ||| 8-K from Coca Cola Bottling Co. Shows Co., Coca-Cola Co. Entered Initial RMA on Jan. 29, '16",1,0.5011485
2016-02-01,17097800.0,42.59999847412109,43.150001525878906,42.56999969482422,43.0,37.08418655395508,KO,"Coca-Cola, TGI Group Announce Strategic Investment in Nigeria's Chi Limited ||| Interesting May Stock Options for KO ||| Coca-Cola Buys Stake in Nigeria's Dairy & Juice Maker Chi Ltd.",0,0.52683693
2016-02-02,12332900.0,42.70000076293945,42.790000915527344,42.40999984741211,42.43999862670898,36.60123062133789,KO,"Instant Analysis: PepsiCo, Inc. Is Opening a Restaurant in a Trendy New York Neighborhood ||| Instant Analysis: The Coca-Cola Co. Buys a Stake in a Nigerian Juice Maker",1,0.5071073
2016-02-03,15958300.0,42.79999923706055,42.93999862670898,42.27999877929688,42.720001220703125,36.842716217041016,KO,"Zacks Industry Outlook Highlights: Unilever, Coca-Cola, Procter & Gamble, Mondelez International and Altria Group ||| 3 Reasons Coca-Cola Stock Could Fall in 2016 ||| Pros Expect Smart Beta ETF Wave To Keep Swelling",0,0.49980146
2016-02-04,14413700.0,42.52000045776367,42.88999938964844,42.400001525878906,42.52999877929688,36.67885208129883,KO,"Constellation Brands Inc (STZ) Ex-Dividend Date Scheduled for February 05, 2016 ||| How To Build A Defensive Portfolio",0,0.49848378
2016-02-05,17315700.0,42.93000030517578,42.9900016784668,42.2599983215332,42.43999862670898,36.60123062133789,KO,"Consumer Sector Update for 02/05/2016: KO, PSMT ||| Coca-Cola (KO) Q4 Earnings: Will it Beat Despite Fx Woes? ||| Examining The Safety Of A Popular Staples ETF ||| Can A Healthcare Alliance Bring Down Healthcare Costs To Employers? ||| Benzinga's Top Upgrades ||| Susquehanna Upgrades Coca-Cola to Neutral, Raises PT to $40.00 ||| UBS Upgrades Coca-Cola to Buy",1,0.508828
2016-02-08,17254400.0,42.16999816894531,42.70000076293945,41.900001525878906,42.650001525878906,36.7823371887207,KO,"Donald Yacktman Trims Stake in Procter & Gamble in 4th Quarter ||| Earnings Preview: Coke Vs. Pepsi ||| Pre-Market Earnings Report for February 9, 2016 : KO, CVS, REGN, OMC, HCP, FIS, VIAB, IR, AGU, TDG, SNY, MAS ||| What Analysts Are Watching In SolarCity, FireEye And Coca-Cola This Week ||| Nomura: Mondelez's Margin Target At Risk, Sees Upside In Coke ||| Susquehanna Upgraded Coca-Cola, Could Be Eyed By Anheuser Busch",1,0.4920444
2016-02-09,24853800.0,42.2599983215332,43.4900016784668,42.2599983215332,43.29999923706055,37.34292602539063,KO,"Coca-Cola (KO) Beats Q4 Earnings & Revenues; Down Y/Y ||| Stocks Futures Endure More Selling In Sympathy With Europe, Japan ||| Coca-Cola (KO) Beats on Earnings & Sales in Q4 ||| Here's How to Think About the Stock Market Right Now ||| Earnings Reaction History: The Coca-Cola Company, 27.3% Follow-Through Indicator, 2.0% Sensitive ||| Coca-Cola's Productivity Program Boosts Earnings ||| Consumer Sector Update for 02/09/2016: LGF, KO ||| Mid-Afternoon Market Update: Crude Oil Down Over 5%; Cambrex Shares Surge Following Q4 Earnings ||| Mid-Day Market Update: US Stocks Fall; Belden Shares Gain On Earnings Beat ||| Stocks Buffeted Between Short-Term Oil Gains, Global Economic Uncertainty ||| Mid-Morning Market Update: Markets Rise; Coca-Cola Tops Q4 Expectations ||| From Conf Call: Coca-Cola CFO Says Fully Hedged on Euro, Yen, Sterling For 2016 ||| From Conf Call: Coca-Cola CEO Says With Refranchising, ""We Will Become Less Capital Intensive With Significantly Higher Margins And Returns"" ||| 10 Stocks Moving In Tuesday's Pre-Market Session ||| Coca-Cola Reports Better-Than-Expected Q4, Offers 2016 Guidance ||| The Coca-Cola Sees FY16 EPS Growth To Be 4-6%, Organic Rev. Growth 4-5%; Buybacks Of $2-$2.5B ||| Coca-Cola Q4 EPS $0.38 vs $0.37 est, Revenue $10.0B vs $9.9B est ||| Coca-Cola Bottling Signs non-binding Letter of Intent to Expand into new Ohio and West Virginia Territories, Acquisition of New Manufacturing Facility in Ohio ||| Coca Cola Announces All Remaining North American Territories Will Be Refranchised By End of 2017, Three Years Earlier Than Previously Expected ||| Company Announces Non-Binding Letter of Intent to Refranchise Company-Owned Bottling Operations in China ||| Caco Cola Announces Sale of Last 39 North American Bottling Facilities ||| 7 Stocks You Should Be Watching Today ||| Earnings Scheduled For February 9, 2016",0,0.48807162
2016-02-10,16729600.0,43.34000015258789,43.38999938964844,42.5099983215332,42.54999923706055,36.696102142333984,KO,"Dow Movers: DIS, V ||| Q4 Earnings Season: S&P 500 vs. Russell 2000 ||| Q4 Earnings Season: S&P 500 vs. Russell 2000 ||| Coca-Cola No Longer A Sell At SocGen, But Why?",0,0.48876843
2016-02-11,16825300.0,42.02999877929688,42.61000061035156,41.97999954223633,42.40999984741211,36.57535934448242,KO,"Pepsi's Q4 Earnings In Line, Sales Beat; 2016 View Downbeat",1,0.5224921
2016-02-12,15222400.0,42.720001220703125,43.13999938964844,42.560001373291016,43.11000061035156,37.17905426025391,KO,"PepsiCo, Inc. Sees Muted Growth in 2016",1,0.54233164
2016-02-16,12675900.0,43.31999969482422,43.459999084472656,43.02000045776367,43.36000061035156,37.39466094970703,KO,"Carter Worth And Mike Khouw's The Coca-Cola Co Trade ||| Can Dr Pepper (DPS) Keep the Earnings Streak Alive in Q4? ||| 11 Great Dividend Stocks for Income Investors ||| Notable ETF Outflow Detected - IVW, V, KO, MA ||| The Zacks Analyst Blog Highlights: Walt Disney, IBM, Cisco Systems, Coca-Cola and Chevron",1,0.5056336
2016-02-17,12332500.0,43.41999816894531,43.619998931884766,43.27999877929688,43.4900016784668,37.50678634643555,KO,"How Warren Buffett Chooses What to Buy, and What You Can Learn From It",1,0.5223401
2016-02-18,11170300.0,43.630001068115234,43.72999954223633,43.29999923706055,43.61000061035156,37.61026763916016,KO,3 Reasons Coca-Cola Stock Could Rise ||| Dow Analyst Moves: KO ||| Better Buy: McDonald's Corp. vs. Coca-Cola ||| Coca-Cola Raises Qtr. Dividend from $0.33 to $0.35/Share,1,0.53757405
2016-02-19,12850000.0,43.58000183105469,43.77000045776367,43.27999877929688,43.77000045776367,37.74825286865234,KO,"XLP, MYY: Big ETF Inflows ||| Instant Analysis: Coca-Cola Raises Its Dividend by 6% ||| How Risky is Sherwin-Williams Stock? ||| Coca-Cola Reports Letter of Intent to Grant Added Bottling Territory to Swire Coca-Cola USA",1,0.5305385
2016-02-22,20716100.0,43.77000045776367,44.15999984741211,43.630001068115234,43.93999862670898,37.89487075805664,KO,"Will Earnings Help Monster Beverage Bounce Back? ||| How Risky Is Coca-Cola Stock? ||| The Coca-Cola Co vs. Hard Root Beer: Warren Buffett's Economic Moat Explained ||| Dow Movers: JNJ, CAT ||| Starbucks Corporation: Give Your Portfolio a Sugar Rush (SBUX) ||| Coca-Cola to Grant Additional Bottling Territories to Swire ||| Why Low Gas Prices Are Benefitting Big Tobacco but Not Big Soda ||| Interesting April Stock Options for KO ||| Junk Food Stocks Are Winning ||| Option Alert: KO Aug16 47.0 Calls: 1200 @ ASK $0.53: 1358 traded vs 2547 OI: $43.99 Ref ||| Coca Cola Spikes to High on Volume",0,0.4933018
2016-02-23,11166400.0,43.7400016784668,44.04999923706055,43.65999984741211,43.68999862670898,37.67926025390625,KO,Consider An Equal-Weight Approach To This Hot Sector's ETFs,1,0.53620726
2016-02-24,10844200.0,43.560001373291016,43.93999862670898,43.369998931884766,43.90999984741211,37.868988037109375,KO,"IVW, V, KO, MA: Large Outflows Detected at ETF ||| Dow Movers: CAT, UTX ||| HSBC Maintains Buy on Coca-Cola, Raises PT to $50.00",1,0.50001776
2016-02-25,10903300.0,43.959999084472656,44.18000030517578,43.869998931884766,44.15999984741211,38.084598541259766,KO,"FEMSA (FMX) Down on Q4 Earnings Miss, Revenues Up Y/Y ||| Monster Beverage Suffers a Monstrous 4th Quarter ||| Monster Beverage to Acquire American Fruits & Flavors ||| Keurig-JAB Holdings Merger Receives Shareholders' Approval ||| S&P Revises Rating on Coca Cola from AA to AA-; Outlook from Negative to Stable",0,0.5083689
2016-02-26,18421000.0,44.040000915527344,44.060001373291016,43.11000061035156,43.13999938964844,37.20493316650391,KO,"These Stocks Just Raised Their Dividends ||| Monster Beverage (MNST) Stock Sinks on Earnings Miss ||| The Stocks That Moved The S&P, Dow And Nasdaq Today ||| Sterne Agee: Pepsi Should Break Up, Coke Should Accelerate Acquisitions ||| Sterne Agee CRT Cuts PEP, KO, CL, BR/B From Buy To Neutral ||| Fast Money Picks For February 26",0,0.4767858
2016-02-29,15049800.0,43.16999816894531,43.61000061035156,42.91999816894531,43.130001068115234,37.19630432128906,KO,5 of Warren Buffett’s Best Stocks to Buy and Hold ||| Facebook Inc: Genius Ad Innovation Will Move Fast and Break Things (FB) ||| Constellation Brands' Expectations Are Too Low,1,0.5180079
2016-03-01,12358300.0,43.380001068115234,43.68999862670898,43.16999816894531,43.68999862670898,37.67926025390625,KO,"Coca-Cola Enterprises, Inc. (CCE) Ex-Dividend Date Scheduled for March 02, 2016 ||| Buffett on Coca-Cola's 'Dumbest Deal' and How Berkshire Differs From 3G ||| 3 Reasons PepsiCo Inc. Stock Could Rise ||| Keurig-JAB Merger Approved by Canada's Antitrust Authority",1,0.47411948
2016-03-02,12856300.0,43.470001220703125,43.77000045776367,43.41999816894531,43.77000045776367,37.74825286865234,KO,"The 5-Minute Guide to Pepsico Inc. Stock ||| Molson Coors Brewing Company (TAP) Ex-Dividend Date Scheduled for March 03, 2016 ||| Berkshire Hathaway: Repurchase Limit to $125 Per Share",1,0.49715275
2016-03-03,13134800.0,43.61000061035156,43.97999954223633,43.540000915527344,43.959999084472656,37.91211700439453,KO,Dividends Don't Drive Total Return They Contribute To It: Part 1,1,0.4860675
2016-03-04,13691500.0,43.77999877929688,44.150001525878906,43.68000030517578,44.11000061035156,38.04147720336914,KO,"Cott Corporation (COT) Ex-Dividend Date Scheduled for March 07, 2016 ||| Is the S&P 500 Overvalued? ||| Dr Pepper Snapple (DPS) had a Strong 2015: Will it Continue? ||| UPDATE: WhiteWave Shares Continue Higher on Volume; Unconfirmed Chatter of Potential Stake from Coca-Cola",0,0.5207167
2016-03-07,10695300.0,43.90999984741211,44.13999938964844,43.86000061035156,44.0099983215332,37.95523834228516,KO,"This Is America's Favorite Soda Brand (and It's Probably Not the Brand You're Thinking Of) ||| Benzinga's Weekend M&A Chatter ||| 3 Reasons to Buy PepsiCo Inc. ||| 3 Blue-Chip Stocks Too Expensive to Consider Now ||| Have a Coke with Mr. Buffet ||| The Market In 5 Minutes: Monday, March 7, 2016",1,0.51563525
2016-03-08,18900200.0,43.91999816894531,44.470001220703125,43.810001373291016,44.31999969482422,38.22258758544922,KO,"3 Dow Jones Titans Ready to Break Out (HD, KO, MCD) ||| After Hours Most Active for Mar 8, 2016 : SYMC, F, YHOO, BAC, ODP, KO, GE, RF, NRG, MSFT, NVDA, QVCA ||| Sorry Warren Buffett, but You're Dead Wrong on These 3 Stocks ||| Paying Up To Play Defense With Staples ETFs",1,0.51662076
2016-03-09,18466600.0,44.38999938964844,44.83000183105469,44.290000915527344,44.810001373291016,38.64517593383789,KO,"Coca-Cola Launches Low Calorie Minute Maid Fizzy Juice Drink ||| Ditch The Risk, Reap Rewards With This ETF ||| Option Alert: KO Mar16 45.0 Calls Sweep: 2010 @ ASK $0.10: 2010 traded vs 21k OI: Earnings 4/27 $44.46 Ref",1,0.51751494
2016-03-10,28908600.0,44.84000015258789,45.2599983215332,44.68000030517578,45.22999954223633,39.00738906860352,KO,"Coca-Cola Company (KO) Ex-Dividend Date Scheduled for March 11, 2016 ||| Dr Pepper Snapple Group, Inc (DPS) Ex-Dividend Date Scheduled for March 11, 2016 ||| AbbVie Inc (ABBV): A Cheap Dividend Aristocrat Yielding Over 4% ||| How Has Dr Pepper Snapple’s Revenue And EBITDA Composition Changed Over 2012-2016E? ||| Cott Corporation (USA): Is COT the Canadian Coca-Cola? ||| The Market In 5 Minutes: Thursday, March 10, 2016 ||| Option Alert: KO Aug16 45.0 Calls Sweep: 2008 @ ASK $1.51: 2063 traded vs 20k OI: Earnings 4/27 $45.13 Ref ||| Stocks Hitting 52-Week Highs ||| RBC: Coca-Cola Is Our Top Mega-Cap Idea ||| RBC Capital Maintains Outperform on Coca-Cola, Raises PT to $51.00 ||| Fast Money Picks For March 10",0,0.4606168
2016-03-11,16129300.0,45.0,45.25,44.93000030517578,45.20000076293945,39.2855224609375,KO,"Coca-Cola's (KO) Initiatives Paying Off: Should You Invest Now? ||| Invest in This and You'll Always Make Money, History Shows ||| MannKind Corporation: Inhale Profits From a Short Squeeze in MNKD Stock ||| Love Dividends? 3 Stocks You Might Want to Buy ||| Freeport-McMoRan, Coca-Cola And Other Fast Money Picks For March 11",1,0.48738155
2016-03-14,13206700.0,45.040000915527344,45.41999816894531,45.040000915527344,45.290000915527344,39.363746643066406,KO,"Noteworthy ETF Inflows: VIG, KO, MMM, NKE ||| Old Reliable With This Staples ETF",0,0.51989245
2016-03-15,13686300.0,45.08000183105469,45.560001373291016,45.06999969482422,45.2400016784668,39.320289611816406,KO,"10 Stocks That Haven't Dropped in 5 Years ||| 3 Top Dividend Stocks for Retirees ||| PepsiCo, Inc. (PEP) Stock Will Stuff Your Pockets Full of Cash ||| Fitbit, Coca-Cola Lead List Of Most Notable Insider Trades Of Past Week ||| Coca-Cola Makes New All-Time High For Second Day In A Row ||| Susquehanna Maintains Neutral on Coca-Cola, Lowers PT to $39.00 ||| Fast Money Traders Share Their Strategy Ahead Of Fed Meeting",0,0.4771371
2016-03-16,15386100.0,45.04999923706055,45.16999816894531,44.54999923706055,45.04999923706055,39.15514373779297,KO,"Dow Movers: INTC, BA ||| MGP Ingredients, Inc. (MGPI) Ex-Dividend Date Scheduled for March 17, 2016 ||| Goldman Sachs Adds Monster Beverage To 'Conviction Buy' List, Removes Reynolds American",1,0.47670484
2016-03-18,23853400.0,45.84000015258789,45.869998931884766,45.38999938964844,45.59999847412109,39.633182525634766,KO,"Vina Concha Y Toro (VCO) Ex-Dividend Date Scheduled for March 21, 2016 ||| Fast Money Picks For March 18",1,0.47596574
2016-03-21,9740400.0,45.41999816894531,45.869998931884766,45.36000061035156,45.66999816894531,39.69402313232422,KO,"Warren Buffett's 10 Highest-Paying Dividend Stocks ||| One Put, One Call Option To Know About for Coca-Cola ||| 2016 Could Be the Year of the Soda Tax ||| These Are the 10 Highest-Paid Athletes in Sports ||| Warren Buffett's Advice to Investors: Purchase a Business That a Ham Sandwich Could Run",0,0.4641331
2016-03-22,13788300.0,45.54999923706055,45.72999954223633,45.38999938964844,45.5,39.5462646484375,KO,"Instant Analysis: McDonald's Corp. Releases a Happy Meal With a VR Twist ||| 3 Mexican Stocks to Have a Fiesta With ||| Should I Buy Or Sell Pepsi (PEP) Stock? 3 Pros, 3 Cons ||| Monster Beverage A 'Growth Story,' But Choppy Sales Still A Concern; BoA Goes Neutral ||| Fast Money Picks For March 22: Who WIll Benenfit From A U.S.-Cuba Relationship?",0,0.4863985
2016-03-23,9292100.0,45.400001525878906,45.709999084472656,45.34999847412109,45.459999084472656,39.51150131225586,KO,"If I Could Only Buy 1 Stock, This Would Be It ||| 3 Stocks with Better Dividends than Home Depot Inc.",1,0.48956808
2016-03-24,10890200.0,45.45000076293945,45.59999847412109,45.18999862670898,45.58000183105469,39.61580276489258,KO,Look Outside Best-Performing Sectors For Investing Success: BlackRock,1,0.525443
2016-03-28,13306600.0,45.560001373291016,45.93000030517578,45.5099983215332,45.79999923706055,39.80701446533203,KO,"One Put, One Call Option To Know About for Coca-Cola ||| Sears Holdings Corp. Is Sitting on a Ticking Time Bomb",1,0.49080446
2016-03-29,25010400.0,45.86000061035156,46.5099983215332,45.810001373291016,46.47999954223633,40.39802932739258,KO,"Stock Market News for March 29, 2016 ||| 2 Warren Buffett Stocks Retirees Can Buy Now ||| Legal Marijuana Sales Dwarf Junk Food…By A Lot ||| Target, Pepsi And Coke: Fast Money Picks For March 29",1,0.47515917
2016-03-30,14312200.0,46.630001068115234,46.72999954223633,46.33000183105469,46.58000183105469,40.48494720458984,KO,"Premium Milk Won't Be a Cash Cow for Coca-Cola Co. ||| 3 Attractive Income Stocks Whose Dividends Could Double ||| 3 Dividend Stocks That Love Janet Yellen ||| Better Buy: Philip Morris International, Inc. vs. Coca-Cola",0,0.48289692
2016-03-31,15544500.0,46.54999923706055,46.880001068115234,46.31999969482422,46.38999938964844,40.31980514526367,KO,Should PepsiCo Go 'Asset-Light' Like Coca-Cola?,1,0.52862054
2016-04-01,14922900.0,46.13999938964844,46.869998931884766,46.11000061035156,46.83000183105469,40.70223617553711,KO,Bill Ackman's 3 Worst Bets,1,0.49784955
2016-04-04,10629800.0,46.84000015258789,46.93000030517578,46.5,46.88999938964844,40.75438690185547,KO,"Pepsi Wants To Make Cola Cool Again ||| SodaStream Still Hopes to Get the Last Laugh ||| Interesting June Stock Options for KO ||| Facebook Inc: Come out on Top From Resistance in Facebook Stock (FB) ||| Can Chipotle Drink Its Way to a Turnaround? ||| Coca-Cola (KO) Shares Cross 3% Yield Mark ||| Warren Buffett’s “Big Four”: Should You Follow the Oracle of Omaha? (AXP, KO, IBM, WFC)",0,0.51954347
2016-04-05,10696700.0,46.619998931884766,46.810001373291016,46.43999862670898,46.52999877929688,40.44149017333984,KO,Does Your Dividend Fund Follow This Warren Buffett Rule? ||| Dr Pepper Increases Stake in Sports Drink Bodyarmor Owner ||| Are Investors Waiting for Earnings Season? ||| Option Alert: KO Fri 4/22 46.5 Calls (Wkly) Sweep: 7305 @ ASK $0.81: 7305 traded vs 2589 OI: Earnings 4/20 Before Open $46.68 Ref,1,0.48962376
2016-04-06,9122700.0,46.56999969482422,46.72999954223633,46.380001068115234,46.709999084472656,40.59793472290039,KO,"Why Starbucks Corporation Is Pushing Channel Development ||| Wynn Resorts, Twitter, Coca-Cola: Fast Money Picks For April 6",0,0.5018148
2016-04-07,9292000.0,46.5,46.58000183105469,46.15999984741211,46.36000061035156,40.29373550415039,KO,Will Coca-Cola's Refranchising Plans Hurt Its Dividend?,1,0.5357588
2016-04-08,11959300.0,46.43999862670898,46.97999954223633,46.43999862670898,46.869998931884766,40.73699569702149,KO,"3 Battling Beverage Stocks: KO, PEP, MNST",0,0.5324484
2016-04-11,11880100.0,46.900001525878906,47.130001068115234,46.40999984741211,46.43999862670898,40.36326599121094,KO,Could a New Drink Menu Be the Secret to Chipotle's Comeback? ||| 3 Things Warren Buffett Looks for in a Stock ||| Bank Of America Recommends Coca-Cola Ahead Of Other Beverage Stocks,1,0.5008246
2016-04-12,11219100.0,46.40999984741211,46.7599983215332,46.34999847412109,46.650001525878906,40.5457878112793,KO,"Consumer Sector Update for 04/12/2016: PERY, FAST, KO, CVS, DIS, MCD, WMT ||| Option Alert: KO May16 46.0 Calls Sweep: 2030 @ ASK $1.30: 5480 traded vs 17k OI: Earnings 4/20 Before Open $46.47 Ref ||| Notable Imbalances Before Tuesday's Open Led By Under Armour, Boeing, Caterpillar ||| Coca-Cola Enterprises Announces Coca-Cola European Partners Registration Statement Declared Effective",0,0.47891006
2016-04-13,13234100.0,46.77000045776367,46.77999877929688,45.81999969482422,46.040000915527344,40.015602111816406,KO,"Consumer Sector Update for 04/13/2016: KO, CVS, DIS, MCD, WMT, MKC, SPWH ||| Coca-Cola Enterprises (CCE) Merger Moves a Step Ahead ||| Performance vs. Outcomes ||| Notable Imbalances Before Wednesday's Open: Investors Bullish On Financials, Selling Gold Stocks",0,0.47857758
2016-04-14,12982200.0,46.060001373291016,46.220001220703125,45.75,45.83000183105469,39.83309173583984,KO,"SPLV, DRIP: Big ETF Inflows ||| How to Know When You Can Retire With Dividend Investing ||| The Coca-Cola Co. or Anheuser Busch Inbev SA (ADR): Better Dividend Investment? ||| Nike And Kobe Bryant Have Been Very Good For Each Other ||| Pepsi Lacks Catalysts; Stifel Cuts To Hold",1,0.49784794
2016-04-15,13647800.0,45.81999969482422,46.15999984741211,45.68000030517578,46.09999847412109,40.0677604675293,KO,"Taste Test: PepsiCo, Inc (PEP) Is Better Than The Coca-Cola Co. (KO) ||| OEF, KO, ORCL, BMY: ETF Outflow Alert ||| 2 Warren Buffett Stocks to Buy in April ||| Consumer Sector Update for 04/15/2016: PSG, FCAU, KO, CVS, DIS, MCD, WMT ||| 3 Steady-Eddie Dividend Stocks to Trust",1,0.45857367
2016-04-18,11538100.0,46.09999847412109,46.27999877929688,45.81999969482422,46.220001220703125,40.17205429077149,KO,"Coca-Cola and PepsiCo Have a Big Problem. So Did the Best Investment in the Past Half-Century. ||| What to Watch in the Stock Market This Week ||| Coke Versus Pepsi: Which Beats Low Q1 Earnings Expectations? ||| Interesting April Stock Options for KO ||| 3 ETFs to Help You Make More Money in Retirement ||| Consumer Sector Update for 04/18/2016: KO, CVS, DIS, MCD, WMT, PEP ||| Dr Pepper Snapple Group Inc.: Ability to ‘Know Thyself’ Makes DPS a Winner ||| Key Themes to Watch in The Coca-Cola Co.'s Upcoming Earnings Report ||| Cost Efficiency And Quality With This Dividend ETF ||| OneWeb to Build Factory in Florida Near Kennedy Space Center; Will Manufacture Satellites to Provide High-Speed Internet Access -Reuters",1,0.52531785
2016-04-19,14418300.0,46.310001373291016,46.619998931884766,46.150001525878906,46.59999847412109,40.502323150634766,KO,"T Rowe Price Adds to Energy and Industrial Holdings ||| Consumer Sector Update for 04/19/2016: HOG, PM, KO, CVS, DIS, MCD, WMT ||| Coca-Cola Zero Sugar to Replace Coke Zero ||| Do Pepsi Earnings Predict Coca-Cola Results? ||| Coca-Cola Launches 'One Brand' Packaging",0,0.50265944
2016-04-20,40360300.0,45.34000015258789,45.380001068115234,44.060001373291016,44.369998931884766,38.56412506103516,KO,"Weaker Soda Volumes Hit Coca-Cola's First-Quarter Results ||| Parade of Mixed Earnings ||| Dow Movers: KO, UNH ||| Midday Update: Stocks Regain Momentum As Oil Rebounds; Mostly Positive Earnings Also Lift Markets ||| Consumer Sector Update for 04/20/2016: BBSI, KKD, KO, PNK ||| Key Morning Earnings for April 20: ABT, DISH, KO, USB ||| Stock Futures Maintain Cautious Gains Despite Pressure on Oil ||| S&P 500 Movers: KO, DFS ||| Consumer Sector Update for 04/20/2016: DISH, KO, CVS, DIS, MCD, WMT ||| Coca-Cola (KO) Beats Q1 Earnings and Sales; Sodas Decline ||| Earnings Reaction History: The Coca-Cola Company, 20.0% Follow-Through Indicator, 1.6% Sensitive ||| Coke (KO) vs. Pepsi (PEP): The Battle of the Soda Stock ||| The Dow Jones Inches Toward Record Highs ||| Wednesday Sector Laggards: Beverages & Wineries, Drugs ||| The Coca-Cola Co: Have Consumers Lost the Thirst for Coke? (KO) ||| Consumer Sector Update for 04/20/2016: EAT,KKD,KO ||| Coca-Cola Co Drops and VMware Inc. Soars as Stocks Rise ||| Close Update: Dow Makes New 2016 High As Oil Shrugs off Supply Pressures ||| Why Check Point Software Technologies Ltd. (CHKP), The Coca-Cola Co (KO) and Office Depot Inc (ODP) Are 3 of Today’s Worst Stocks ||| Mid-Afternoon Market Update: Dow Rises 0.5%; Argos Therapeutics Shares Drop ||| Mid-Afternoon Market Update: Dow Up 0.5%; Argos Therapeutics Shares Drop ||| Coca-Cola Q1'16 Earnings Conference Call: Full Transcript ||| Mid-Day Market Update: VMware Surges On Earnings Beat; Flexsteel Shares Tumble ||| Citigroup Defending The Coca-Cola Co, Remains Confidence In Co, Reiterates Buy And $49 PT ||| Mid-Morning Market Update: Markets Mostly Flat; Coca-Cola Earnings Top Expectations ||| Notable Imbalances: Coca-Cola, Oil Stocks Under Pressure ||| The Market In 5 Minutes: Why Do We Get High On 4/20? ||| Coca-Cola Beverages Signs LOI With Coca-Cola Company To Acquire 4 Florida Production Facilities ||| Coca-Cola Affirms FY16 Comparable Currency Neutral Earnings Outlook ||| Coca-Cola Q1 EPS $0.45 vs $0.44 est, Revenue $10.28B vs $10.29B est ||| 10 Stocks To Watch For April 20, 2016 ||| Earnings Scheduled For April 20, 2016",0,0.46628967
2016-04-21,37206900.0,44.2599983215332,44.27999877929688,42.869998931884766,43.65999984741211,37.94702911376953,KO,"Dow Movers: TRV, AXP ||| Soda Stocks Fizzle Despite Earnings Beat; What About ETFs? ||| KO vs. PEP vs. DPS: Who Wins the Earnings Taste Test? ||| Coca-Cola (KO) vs. Pepsi (PEP): The Battle of the Soda Stock (Revised) ||| Don't Ditch Defensive ETFs In Q2 ||| Goldman Sachs Maintains Neutral on Coca-Cola, Raises PT to $47.00",1,0.48622283
2016-04-22,25134200.0,43.790000915527344,44.65999984741211,43.790000915527344,44.540000915527344,38.711891174316406,KO,"Coca-Cola Enterprises (CCE) Q1 Earnings: What's in Store? ||| Dow 30 Stock Roundup: IBM, AmEx, Coke, JNJ Beat, Verizon Disappoints ||| The Coca-Cola Co Vs PepsiCo, Inc: Which Sparkles More? (KO, PEP) ||| PayPal Holdings Inc: Too Expensive to Buy, Too Soon to Sell (PYPL) ||| 4 Things Warren Buffett Will Never Do ||| 3 Big Stock Charts for Friday: Boeing Co (BA), Procter & Gamble Co (PG) and The Coca-Cola Co (KO) ||| After Hours Most Active for Apr 22, 2016 : GPN, GME, MSFT, BAC, HPY, GE, KO, PNK, QLIK, QCOM, GILD, INTC ||| Warren Buffett’s 3 Safest Dividend Stocks Yielding 3% or More ||| Anheuser-Busch InBev: Future M&A Potential?",1,0.49216413
2016-04-25,11173800.0,44.5,44.720001220703125,44.380001068115234,44.709999084472656,38.85963439941406,KO,"The Biggest Problem With Coca-Cola and PepsiCo Stock ||| After-Hours Recap: The Markets' Big Week And Some After-Hours Movers ||| 3 Stocks with Better Dividends Than The Coca Cola Co ||| Notable ETF Outflow Detected - IWF, AAPL, MSFT, KO ||| These 3 Dividend Stocks Have Raised Their Dividends for 50 Consecutive Years ||| Better Buy: Altria Group Inc. vs. Coca-Cola ||| Disney World Rolls Out Its Sneakiest Price Increase Yet ||| What Awaits Monster Beverages (MNST) in Q1 Earnings? ||| Goldman Says Buy Weakness In Monster Beverage; Q1 Earnings Due Friday",0,0.48421532
2016-04-26,13935500.0,44.91999816894531,44.959999084472656,44.43000030517578,44.52999877929688,38.70318984985352,KO,"Coca-Cola Bottling Co. Consolidated (COKE) Ex-Dividend Date Scheduled for April 27, 2016 ||| Better Buy: The Walt Disney Company vs. Coca-Cola",1,0.498341
2016-04-27,11335500.0,44.63999938964844,44.86000061035156,44.25,44.68000030517578,38.83356094360352,KO,"Coca Cola Femsa S.A.B. de C.V. (KOF) Ex-Dividend Date Scheduled for April 28, 2016 ||| Anheuser-Busch Inbev SA (BUD) Ex-Dividend Date Scheduled for April 28, 2016 ||| Container Stocks' Q1 Earnings to Watch Tomorrow: BLL, SEE ||| UPDATE: Tigress Downgrades SAM To Neutral, Maintains Neutral On KO & PEP, Maintains Underperform On BUD",0,0.46458784
2016-04-28,10932500.0,44.5,44.900001525878906,44.459999084472656,44.630001068115234,38.79010772705078,KO,"NYSE:DPS – Is Dr. Pepper Snapple Stock a Buy or a Sell? ||| Consumer Staples Stocks to Post Earnings on Apr 29: MNST, NWL ||| Better Buy Now: The Coca-Cola Co. or PepsiCo Inc?",1,0.4781253
2016-04-29,11716000.0,44.52999877929688,44.86000061035156,44.5,44.79999923706055,38.93785858154297,KO,"Monster Beverage Restarts Its Growth Engines, Makes Big Buyback Offer ||| Fomento Economico Mexicano S.A.B. de C.V. (FMX) Ex-Dividend Date Scheduled for May 02, 2016 ||| Amazon.com Inc. and Monster Beverage Corporation Soar as Stocks Fall ||| Better Buy: The Coca-Cola Co vs. PepsiCo, Inc. ||| Top 10 Financial Ratios for Successful Dividend Investing ||| FEMSA (FMX) Q1 Earnings Beat, Splits Reporting Divisions ||| Why Monster Beverage Corporation Jumped 12% Today",1,0.49061647
2016-05-02,12577500.0,44.56999969482422,45.18999862670898,44.56999969482422,44.97999954223633,39.09430694580078,KO,"ETFs That Value Investors Buffett, Munger Would Approve Of ||| Buffett Responds to Criticism of Coca-Cola's Impact on Health; Calls it a Wonderful Product ||| One Put, One Call Option To Know About for Coca-Cola ||| Best of Both Worlds With This Dividend ETF ||| 4 Best Performing Stocks of April ||| How Can AB InBev's Mexico Beer Segment Grow In The Next Five Years? ||| Best (And Worst) Sector ETFs For May",0,0.4794822
2016-05-03,10420500.0,44.869998931884766,45.06999969482422,44.650001525878906,44.84000015258789,38.97262191772461,KO,3 Takeaways from Berkshire Hathaway’s Annual Meeting ||| Citi On Beverages: Weighted X-Bar Sales Not Looking Great ||| Pay Attention Investors: Millennials Just Blew Past Boomers,1,0.53658366
2016-05-04,9350500.0,44.720001220703125,45.11000061035156,44.5099983215332,44.97999954223633,39.09430694580078,KO,Dow Analyst Moves: KO ||| –…7 Profound Warren Buffett Quotes: Learn To Build Wealth ||| This Dividend ETF Has Been Winning For A Long Time,1,0.5020537
2016-05-05,8801100.0,44.93000030517578,45.4900016784668,44.869998931884766,45.060001373291016,39.163848876953125,KO,"Constellation Brands Inc (STZ) Ex-Dividend Date Scheduled for May 06, 2016",1,0.47875202
2016-05-06,8564000.0,45.060001373291016,45.40999984741211,44.91999816894531,45.31999969482422,39.38982772827149,KO,"Consumer Stocks Q1 Earnings to Watch Next Week: TSN, DIS, EA ||| 4 Metrics To Help You Profit In This Narrow Market ||| Coca-Cola Bottling (COKE) Q1 Earnings: What's in Store?",0,0.47168383
2016-05-09,8110600.0,45.31999969482422,45.5,45.16999816894531,45.2400016784668,39.320289611816406,KO,Here Is the Best Dividend ETF to Consider For Your Portfolio ||| 13 Tasty Consumer Staples ETFs to Feast On,1,0.5129528
2016-05-10,8933500.0,45.43999862670898,45.84000015258789,45.41999816894531,45.75,39.763553619384766,KO,A Trusted Dividend ETF,0,0.5329706
2016-05-11,8833100.0,45.72999954223633,45.880001068115234,45.45000076293945,45.459999084472656,39.51150131225586,KO,"Coca-Cola Bottling (COKE) Q1 Earnings & Revenues Strong ||| Vina Concha Y Toro (VCO) Ex-Dividend Date Scheduled for May 12, 2016 ||| Anheuser-Busch Inbev a Top Ranked SAFE Dividend Stock With 3.5% Yield (BUD) ||| Coca-Cola, T-Mobile And Consumer Staples: Fast Money Picks For May 11",1,0.50444263
2016-05-12,10463400.0,45.54999923706055,45.900001525878906,45.4900016784668,45.83000183105469,39.83309173583984,KO,"IWF, AMZN, FB, KO: Large Outflows Detected at ETF",0,0.51871985
2016-05-13,10341200.0,45.75,45.83000183105469,45.22999954223633,45.34999847412109,39.41588592529297,KO,"Coca-Cola (KO) Progresses with Re-franchising Initiatives ||| Dow 30 Stock Roundup: Disney's Results Disappoint, GE Plans $250M Acquisition ||| Coca-Cola Enterprises, Inc. (CCE) Ex-Dividend Date Scheduled for May 16, 2016",1,0.45677528
2016-05-16,9413600.0,45.15999984741211,45.72999954223633,45.13999938964844,45.619998931884766,39.65056228637695,KO,"XLP, EPHE: Big ETF Outflows ||| The Investment Case Against Sugar",0,0.50411564
2016-05-17,17457000.0,45.45000076293945,45.560001373291016,44.709999084472656,44.75,38.8944091796875,KO,Is it the Right Time to Invest in Coca-Cola (KO) Stock? ||| Is the Health Food Craze Impacting Food & Restaurant Stocks? ||| What's in Store for Coca-Cola Enterprises (CCE) in 2016?,0,0.477081
2016-05-18,12524300.0,44.560001373291016,44.83000183105469,44.22999954223633,44.47999954223633,38.65974426269531,KO,"Stock Market News for May 18, 2016 ||| San Francisco Not So Sweet To Beverage Investors",0,0.48233193
2016-05-19,10659500.0,44.25,44.38999938964844,44.040000915527344,44.31999969482422,38.52067184448242,KO,"EWJ, UGE: Big ETF Outflows ||| Will Monster Beverage Gain from International Expansion?",0,0.52164465
2016-05-20,12914100.0,44.5099983215332,44.540000915527344,43.93999862670898,43.95000076293945,38.19909286499024,KO,"The Zacks Analyst Blog Highlights: Monster Beverage, Coca-Cola, Primo Water and Molson Coors Brewing ||| Are Defensive Stocks Now Riskier Than The Rest Of The Market?",1,0.4983411
2016-05-23,13554700.0,44.06999969482422,44.15999984741211,43.93999862670898,43.970001220703125,38.21646499633789,KO,"Interesting November Stock Options for KO ||| SPLV, XME: Big ETF Inflows ||| After Hours Most Active for May 23, 2016 : INTC, MSFT, FCX, T, DRI, QQQ, AAPL, NVAX, KO, IILG, RIG, GE ||| Coca-Cola to Stop Production of Sugar Sweetened Beverages in Venezuela -Bloomberg",1,0.49757475
2016-05-24,12634200.0,44.09999847412109,44.41999816894531,44.0,44.369998931884766,38.56412506103516,KO,Sugar Shortage Forces The Coca-Cola Co to Stop Soda Production in Venezuela ||| 3 Stocks With a Bigger Dividend Than Coca-Cola ||| Coca-Cola Streamlines Global Structure To Align Its Operating Units ||| UPDATE: Coca-Cola Reports New Streamlined Int'l Structure ||| Coca-Cola Reports New Streamlined Int'l Structure,1,0.5167106
2016-05-25,9218100.0,44.5099983215332,44.630001068115234,44.25,44.380001068115234,38.57282638549805,KO,Coca-Cola Enterprises (CCE) Shareholders Approve Merger ||| Big Things In A Small Package For This Staples ETF,1,0.5168088
2016-05-26,8695800.0,44.52999877929688,44.77000045776367,44.43999862670898,44.68999862670898,38.84225463867188,KO,"Dow Movers: MSFT, WMT ||| Nike (NKE) is 2016's Most Valuable Apparel Brand ||| Asking the Right Questions",1,0.4946158
2016-05-31,18935200.0,44.97999954223633,44.97999954223633,44.2599983215332,44.59999847412109,38.76403045654297,KO,"SPLV, GUR: Big ETF Outflows ||| Cott Corporation (COT) Ex-Dividend Date Scheduled for June 01, 2016 ||| Midday Update: Stocks Turn Defensive After Digesting Mixed Economic Data ||| Close Update: Wall Street Spooked by Negative Consumer Confidence, Reversal in Oil ||| Why Coca-Cola Enterprises Inc. Stock Plunged Today ||| Pepsico, Inc. (PEP) Ex-Dividend Date Scheduled for June 01, 2016 ||| Did You Miss The 3-Way Coca-Cola Bottling Merger? ||| Following 3-Way Merger, Goldman Initiates Coca-Cola European Partners At Buy",1,0.48702958
2016-06-01,8916000.0,44.59999847412109,44.77999877929688,44.4900016784668,44.70000076293945,38.85094833374024,KO,"Stock Market News for June 01, 2016 ||| Molson Coors Brewing Company (TAP) Ex-Dividend Date Scheduled for June 02, 2016 ||| Benzinga's M&A Chatter for Wednesday June 1, 2016 ||| The Coca-Cola Company and Coca-Cola FEMSA to acquire AdeS soy-based beverage business from Unilever",1,0.4866659
2016-06-02,6693900.0,44.70000076293945,44.720001220703125,44.5,44.720001220703125,38.86832427978516,KO,"Unilever (UL) to Sell AdeS Unit to Coca-Cola for $575M ||| Why Coca-Cola Enterprises Inc. Fell 26% in May ||| China Stock Roundup: JinkoSolar Beats, Alibaba Announces Share Purchase Deal ||| A Low Volatility ETF With A Twist",1,0.5043809
2016-06-03,13434900.0,44.75,45.04999923706055,44.68000030517578,45.040000915527344,39.14645767211914,KO,"Dow Movers: GS, PG ||| Coca-Cola Diversifies Still Portfolio with Unilever Deal",1,0.5132655
2016-06-06,10310600.0,45.09000015258789,45.47999954223633,45.08000183105469,45.369998931884766,39.43328094482422,KO,"If You're in Your 60s, Consider Buying These 3 Stocks ||| 3 Stocks to Buy With Dividends Yielding More Than 3% ||| Interesting August Stock Options for KO",0,0.48034728
2016-06-07,9812600.0,45.34999847412109,45.47999954223633,45.20000076293945,45.31999969482422,39.38982772827149,KO,"3 Best Vanguard ETFs to Get Defensive ||| UPDATE: Beverage Digest Reporting on Keurig Kold Discontinuation, Reported in Three Recent Tweets ||| Kellogg Shares Spike to High of $74.99; Hearing Unconfirmed Market Chatter of Potential Coke Bid",1,0.53266
2016-06-08,7915400.0,45.2400016784668,45.65999984741211,45.18999862670898,45.54999923706055,39.589725494384766,KO,"If You're Retired, Consider Buying These 3 Dividend Stocks ||| Why The Coca-Cola Co (KO) Is One of Wall Street’s Most Overvalued Stocks ||| Noteworthy ETF Outflows: UPRO, BRK.B, KO, HD ||| PepsiCo, Inc.: A Dividend Machine to Hold Forever (PEP) ||| The Rise and Fall of Another SodaStream ""Killer"" ||| AMBA Stock: Why Ambarella Inc Is up 25% in 5 Days ||| Zacks Industry Outlook Highlights: Coca-Cola, McCormick, PepsiCo, Tyson Foods and Sysco ||| Celebrity-Endorsed Junk Food: What's The Cost? ||| Vernors Celebrates 150th Anniversary In Detroit Style",1,0.48744434
2016-06-09,8042900.0,45.33000183105469,45.79999923706055,45.310001373291016,45.7599983215332,39.77224349975586,KO,"Dr Pepper Snapple Group, Inc (DPS) Ex-Dividend Date Scheduled for June 10, 2016",1,0.46834096
2016-06-10,12357000.0,45.619998931884766,46.0099983215332,45.560001373291016,45.9900016784668,39.97215270996094,KO,"Dow Movers: GS, NKE",0,0.5196084
2016-06-13,10613500.0,45.47999954223633,45.66999816894531,45.09000015258789,45.119998931884766,39.516727447509766,KO,"Is The Countertop Soda Industry Dead? ||| Consumer Sector Update for 06/13/2016: WMT, MCD, KO, DIS, LB ||| Dow Movers: MSFT, INTC",0,0.48596996
2016-06-14,11298200.0,44.84999847412109,45.130001068115234,44.43999862670898,45.040000915527344,39.446659088134766,KO,"On When to Sell a Stock ||| Here’s How Enbridge Can Give Investors –—%-Plus Total Returns ||| UBS Cuts Estimates, Targets On Beverage Names Ahead Of Q2 Results ||| Option Alert: KO Jun16 45.5 Calls Sweep: 1000 @ ASK $0.12: 1286 traded vs 8158 OI: Earnings 7/27 $44.98 Ref",0,0.48976293
2016-06-15,8360400.0,45.119998931884766,45.34000015258789,44.880001068115234,45.0099983215332,39.42038345336914,KO,"10 All-American Stocks to Buy Now ||| Monster's New Soda Line Looking To Move Pepsi's Mountain ||| UPDATE: Coca-Cola Letter of Intent Includes Territory Around Memphis, TN, Plus Two Production Facilities ||| Coca-Cola Reports Will Refranchise Territory to Coca-Cola Bottling Co. Consolidated ||| Watch These 10 Huge Call Purchases In Wednesday Trade",1,0.5284326
2016-06-16,11305400.0,44.869998931884766,45.34000015258789,44.720001220703125,45.310001373291016,39.683135986328125,KO,"Coca-Cola to Re-Franchise Memphis Area to Coca-Cola Bottling ||| How New Drinks and Categories Are Making Waves in the Alcohol Industry ||| Philadelphia City Passes Soda Tax, Becomes Largest City With Sweetened Beverage Levy ||| Coca-Coal Shrugs Off Revenue Warning ||| Option Alert: KO Jun16 45.0 Puts Sweep: 1476 @ ASK $0.23: 2767 traded vs 16k OI: Earnings 7/27 $44.99 Ref ||| Associated Press Reports Philly Will Approve Sugar Tax On Sodas ||| Coca-Cola Sees 5 -6 Point Headwind on Net Revenues; 4-5 Point Headwind On Income Before Taxes In Q2 Related to Completion of Coca-Cola European Partners Combination",0,0.50533324
2016-06-17,20805400.0,45.16999816894531,45.220001220703125,44.380001068115234,44.790000915527344,39.22770309448242,KO,"IYK, PG, KO, NKE: Large Outflows Detected at ETF ||| New Philadelphia Soda Tax: Should Pepsi, Coca-Cola Worry? ||| The Coca-Cola Company (KO) Updates its Guidance for Q2 ||| American Beverage Association Calls Philly 'Sugar Tax' Regressive ||| Watch These 7 Huge Put Purchases In Friday Trade",1,0.50292534
2016-06-20,10712400.0,45.09000015258789,45.310001373291016,44.959999084472656,44.97999954223633,39.39410781860352,KO,Is Short-Term Thinking Killing the American Economy? ||| The 3 Best Dividend Stocks for Beginning Investors,1,0.50867766
2016-06-21,7919400.0,45.15999984741211,45.27999877929688,45.0,45.130001068115234,39.52547454833984,KO,"Apple Inc.: This $60 Billion Acquisition Would Set AAPL Stock Free ||| 3 Dividend Aristocrats You Shouldn't Buy in June ||| Alcoholic Sodas on the Rise? Definitely Not Your Father’s Root Beer! ||| What Makes National Beverage Different From Its Soda Peers? ||| Netflix Presents A New Application Logo ||| BZ NOTE: National Beverage Recently Unveiled (as of Early Feb.) Industry's First-Ever 'Clean Label' Soft Drink Alternative; Stock Up ~2% vs ~0.9% Increase in Pepsi, Dr Pepper Shares, 0.3% Increase in Coca-Cola ||| National Beverage Shares Outperforming Other Beverage Stocks as Traders May Be Viewing Co. as Good Alternative to Sugary-Drink Plays Amid Philly's Passing of Soda Tax ||| Forbes Reports Philly Soda Excise Tax: Will Add $2.16/12pk of Soda, Compared To $0.09 For $12pk of Beer ||| A Dividend Dynamo Ascends To New Highs",0,0.47449204
2016-06-22,10738900.0,45.25,45.33000183105469,44.810001373291016,44.86000061035156,39.28901290893555,KO,3 Reasons Pepsi Stock (PEP) is a Great Buy for Investors Now ||| Beverage Digest Recently Tweets: 'Coke just took a minority stake in Aloe Gloe. http://www.aloegloe.com/',1,0.5186382
2016-06-23,9655300.0,45.02999877929688,45.16999816894531,44.84000015258789,45.08000183105469,39.481689453125,KO,The Brexit Vote Has Big Winners and Bigger Losers ||| What Does the Canadian Warren Buffett See in Resolute Forest Products?,0,0.503926
2016-06-24,26003700.0,44.20000076293945,44.560001373291016,43.81999969482422,43.93000030517578,38.47450637817383,KO,"Dow 30 Stock Roundup: Boeing Nears $4B Deal, Coke Revises Q2 Guidance ||| New Stock Research Reports for June 24, 2016 ||| What A Boring Week In The Markets",0,0.4768867
2016-06-27,15779500.0,43.66999816894531,43.88999938964844,43.31999969482422,43.77999877929688,38.34313201904297,KO,Interesting September Stock Options for KO ||| Investors Should Get Down To (The) Business,1,0.514721
2016-06-28,16509800.0,44.060001373291016,44.18999862670898,43.66999816894531,44.18000030517578,38.69345474243164,KO,"Pepsi Bringing Back Diet Pepsi with Aspartame to U.S. Shelves ||| SPLV, KO, CHD, K: Large Inflows Detected at ETF ||| PepsiCo Going Strong Despite Adversities, 5 Reasons to Buy ||| 5 Market Cap Changes That Might Surprise You",1,0.53398824
2016-06-29,12250900.0,44.38999938964844,44.709999084472656,44.2400016784668,44.43999862670898,38.92116928100586,KO,"A Cross-Country Tour, Courtesy of Motley Fool Answers ||| Coca-Cola Scales Back On Beverages As Vermont GMO Law Takes Effect ||| No Coke... Pepsi! Goldman Sachs Agrees With The Greeks ||| Goldman Sachs Favors Pepsi Over Coca-Cola & Dr. Pepper",1,0.5127603
2016-06-30,16056500.0,44.52000045776367,45.33000183105469,44.4900016784668,45.33000183105469,39.70065307617188,KO,PepsiCo's Popular 90s Cola Crystal Pepsi is Returning ||| 3 Best Dividend Aristocrats to Buy Now ||| Crystal Pepsi Hopes to Save PepsiCo -- and Coca-Cola ||| 5 Defensive Stocks to Buy in 2016,0,0.5091498
2016-07-01,11799700.0,45.33000183105469,45.40999984741211,45.06999969482422,45.119998931884766,39.516727447509766,KO,"5 Top Made-in-America Products ||| Is Wrapping Your Product in the American Flag Good for Business? ||| Ball Corporation Completes Rexam Acquisition, Shares Rise",1,0.5487669
2016-07-05,12339100.0,45.15999984741211,45.66999816894531,45.150001525878906,45.43000030517578,39.78822326660156,KO,"The Not-So-Secret Trick That's Helped Millions of Americans Get Rich ||| Lagging Now, This Fund Has A Record Of Rebounding -- Here's How ||| Why Soda Taxes Will Help Coca-Cola",0,0.5114096
2016-07-06,10902600.0,45.5,45.54999923706055,44.91999816894531,45.27000045776367,39.64809799194336,KO,"Noteworthy ETF Outflows: SSO, KO, WMT, SLB",0,0.5138749
2016-07-07,9741100.0,45.41999816894531,45.52000045776367,44.970001220703125,45.09000015258789,39.490455627441406,KO,"Pepsi (PEP) Tops Q2 Earnings, Ups 2016 EPS Growth Target",1,0.5329929
2016-07-08,11127100.0,45.29999923706055,45.52000045776367,45.06999969482422,45.380001068115234,39.74443435668945,KO,3 American “BFGs” That Could Trip on the Brexit ||| What's Good for PepsiCo Is Good for SodaStream ||| Dig Deeper With ESG ETFs,1,0.5289118
2016-07-11,10937800.0,45.34999847412109,45.77000045776367,45.11000061035156,45.56999969482422,39.91083908081055,KO,"Better Buy: Philip Morris International, Inc. vs. Coca-Cola ||| Ambev S.A. (ABEV) Ex-Dividend Date Scheduled for July 12, 2016 ||| Coca-Cola Chief Information Officer Ed Steinike Dies After Brief Illness",1,0.4980884
2016-07-12,9739000.0,45.63999938964844,45.709999084472656,45.18000030517578,45.58000183105469,39.91960525512695,KO,"Dow Movers: KO, GS ||| Hate Risk? You'll Love These Dividend Stocks ||| 5 Dow Jones Titans Ready to Breakout This Summer ||| If This Group of Stocks Is Leading the Market Higher, a Recession Could Be Around the Corner",1,0.48777956
2016-07-13,8028400.0,45.61000061035156,45.7599983215332,45.43000030517578,45.7400016784668,40.05973052978516,KO,Why Coca-Cola May Have Interest In Taking A Stake In Hain Celestial,0,0.4923908
2016-07-14,7621200.0,45.72999954223633,45.93999862670898,45.58000183105469,45.68999862670898,40.01593780517578,KO,"SPLV, KO, CLX, HSY: Large Inflows Detected at ETF ||| Option Alert: KO 7/29 45.0 Puts (Wkly) Sweep: 3341 @ ASK $0.35: 3364 traded vs 6253 OI: Earnings 7/27 Before Open $45.93 Ref ||| Name-Brand Consumer Goods Roundup: Monster Beverage Scared Up Plenty Of Sales In Q2",0,0.4969176
2016-07-15,10621000.0,45.880001068115234,45.900001525878906,45.43999862670898,45.630001068115234,39.9633903503418,KO,"Sugary Soft Drinks Are Dead, But Coca-Cola's Future is Sweet ||| Kellogg Shares Rallying as Hearing Chatter Coke Could Be In Talks with Co. ||| Watch These 7 Huge Put Purchases In Friday Trade",0,0.49117866
2016-07-18,7958300.0,45.68999862670898,45.70000076293945,45.47999954223633,45.630001068115234,39.9633903503418,KO,"Benzinga's Weekend M&A Chatter ||| One Put, One Call Option To Know About for Coca-Cola ||| XLP, TUSA: Big ETF Outflows ||| Rodman & Renshaw Initiates Orion Energy At Buy, Attaches $2.50 Target ||| Stocks To Watch For July 18, 2016",0,0.52014595
2016-07-20,8478200.0,45.75,45.77000045776367,45.38999938964844,45.5099983215332,39.85829162597656,KO,See Which Of The Latest 13F Filers Holds Coca-Cola ||| PepsiCo a Top Socially Responsible Dividend Stock With 2.8% Yield (PEP) ||| Here's Why Olympic Advertising Will Be Totally Different This Year,0,0.47970906
2016-07-21,8045100.0,45.34000015258789,45.5099983215332,45.2599983215332,45.45000076293945,39.80574035644531,KO,"Daily Dividend Report: C, KO, MMP, TLLP, BLK ||| Dow Analyst Moves: KO ||| Can Coca-Cola (KO) Keep the Earnings Streak Alive in Q2? ||| Credit Suisse Thinks Kellogg Will Follow General Mills' Lead Into A Strategic Shift ||| Deutsche Bank Likes Consumer Staples, Stock Market Bubble Or Not",1,0.5186789
2016-07-22,8836100.0,45.5,45.84000015258789,45.459999084472656,45.83000183105469,40.13855743408203,KO,How Long Can Monster Beverage Maintain Its Caffeine High? ||| How The Coca-Cola Company Ranks Among Analysts’ Top Picks (KO) ||| 11 Big Brands Stats That Will Blow You Away ||| 5 Big Earnings Reports Next Week,0,0.49755323
2016-07-25,9134300.0,45.810001373291016,45.83000183105469,45.470001220703125,45.56999969482422,39.91083908081055,KO,"Coca-Cola will release its Q2 results July 27 ||| This Week’s Hot Earnings – AAPL BA CVX KO XOM ||| Interesting November Stock Options for KO ||| Warren Buffett’s Top 10 Pieces of Investment Advice ||| Consumer Stocks in Focus for Earnings This Week: UA, KO, MCD ||| The Mexican Template: How Coca-Cola and Pepsi Will Deal With Rising Soda Taxes ||| Week Ahead: It's Not Just Earnings This Time, as GDP, Fed Also on Tap",0,0.49271005
2016-07-26,15819900.0,45.52999877929688,45.650001525878906,44.83000183105469,44.880001068115234,39.30652618408203,KO,"Coca-Cola Bottling Co. Consolidated (COKE) Ex-Dividend Date Scheduled for July 27, 2016 ||| Pre-Market Earnings Report for July 27, 2016 : KO, CMCSA, MO, ARMH, BA, MDLZ, SPG, NEE, SO, GD, NOC, TMUS ||| How Will GMO Labeling Hurt Beverage Companies? ||| Benzinga's M&A Chatter for Tuesday July 26, 2016 ||| Could Facebook Be Berkshire's Next Tech Buy? ||| UPDATE: Coca-Cola Interest In General Mills Reignites Takeover Fever ||| General Mills Shares Moving Higher on Volume; Traders Attributing to Renewed Takeover Chatter Involving Coke",0,0.47507638
2016-07-27,37461100.0,43.900001525878906,44.060001373291016,43.09999847412109,43.400001525878906,38.01032638549805,KO,"Coca-Cola Dims 2016 Outlook on Weaker Revenue Growth ||| Stock Market Today: Apple Soars and Coca-Cola Drops to Leave the Dow Unchanged ||| Coca-Cola (KO) Beats on Q2 Earnings; Cuts Sales Forecast ||| Coca-Cola (KO) Shares Cross Below 200 DMA ||| The Coca-Cola Co's Not So Secret Formula for the Future ||| Earnings Reaction History: The Coca-Cola Company, 30.0% Follow-Through Indicator, 1.8% Sensitive ||| Dow Movers: KO, AAPL ||| 5 Blue-Chip Stocks Propelled by Earnings ||| Midday Update: Stocks Surrender Gains as Resistance, Home Sales & Oil Weigh ||| Coca-Cola (KO) Beats on Earnings in Q2; Lowers Sales View ||| The Coca-Cola Co v2.0: Smaller Company, Bigger Brand Portfolio ||| Technical Alert - Coca-Cola Revisits Post- Brexit Low After Mixed Q2 Report ||| Mid-Morning Market Update: Markets Open Higher; Apple Tops Q3 Expectations ||| From Conf Call: Coca-Cola Says Weakening Demand in Certain Large Emerging and Developing Markets Impacted Volume in Q2 ||| The Market In 5 Minutes: Apple Surprises, Twitter Disappoints And Hillary Makes History ||| A Peek Into The Markets: U.S. Stock Futures Rise; Apple Earnings Beat Estimates ||| Coca-Cola Sets The Beverage Sector Earnings Pace ||| Coca-Cola Sees FY 2016 EPS $2.00 vs $1.94 est ||| Coca-Cola Q2 EPS $0.60 vs $0.58 est, Revenue $11.54B vs $11.64B est ||| The Coca-Cola Company Announces Continued Progress with North American Refranchising Initiative ||| 12 Must Watch Stocks for July 27, 2016 ||| Earnings Scheduled For July 27, 2016",1,0.489519
2016-07-28,13077800.0,43.27000045776367,43.68999862670898,43.220001220703125,43.650001525878906,38.229286193847656,KO,"Stocks Down Slightly After Fed Keeps Rate Unchanged ||| Is It Safe to Buy Into ""Big Soda""? ||| Sorry Warren Buffett, You're Dead Wrong on These 3 Stocks ||| FEMSA (FMX) Beats on Q2 Earnings: Do You Hold the Stock? ||| Q2 Earnings Picture: Is the Worst Behind Us? ||| Dr Pepper Raises EPS Guidance On Solid Q2 Results ||| How PepsiCo Inc Has Found Success in Innovation and the Defiance of Activist Investors ||| Stock Market News for July 28, 2016 ||| Emerging Market Woes Overshadow Coca-Cola's Q2 EPS Beat ||| Wells Fargo Thinks The Street May Have Already Priced In Dr Pepper's Q2 Results ||| Coca-Cola Tasting A Little Better After Vetr Upgrade ||| Social Media Races Past Autos, Oil as Earnings Parade Continues",0,0.46544933
2016-07-29,16530500.0,43.720001220703125,43.75,43.47999954223633,43.630001068115234,38.211761474609375,KO,"Dow 30 Stock Roundup: Apple, GE, DuPont Beat, Boeing Posts Narrower-than-Expected Loss",0,0.50461936
2016-08-01,12349700.0,43.68999862670898,43.83000183105469,43.43000030517578,43.45000076293945,38.05411911010742,KO,"Monster Beverage (MNST) Q2 Earnings: What's in the Cards? ||| Beverage Stocks Earnings Releases on Aug 2: SODA, TAP & PRMW ||| One Put, One Call Option To Know About for Coca-Cola",1,0.49256527
2016-08-02,12825200.0,43.34999847412109,43.58000183105469,43.310001373291016,43.52999877929688,38.12417984008789,KO,Americans Are Finally Drinking More Water Than Soda,1,0.5181549
2016-08-03,12119100.0,43.65999984741211,43.70000076293945,43.369998931884766,43.63999938964844,38.220516204833984,KO,"Alternative Investments to Replace Bonds in Your Portfolio ||| IWF, PEP, UNH, KO: ETF Inflow Alert ||| Soft Drink Stocks Earnings Results on Aug 4: CCE, COT & MNST ||| What 2 New Warren Buffett Books Taught Me About Deep Value Investing ||| Terms Of The Trade: Dogs Of The Dow Investing Strategy ||| Fantastic Yields And Where To Find Them: Top 3 Yields From The Dow 30",0,0.47485715
2016-08-04,11244100.0,43.560001373291016,43.79999923706055,43.400001525878906,43.5099983215332,38.10665893554688,KO,"7 Olympic Sponsors: Buy or Sell? (CSCO, DOW, GE, KO) ||| Coca-Cola Bottling (COKE) Q2 Earnings: What to Expect?",0,0.5049735
2016-08-05,10398200.0,43.650001525878906,43.75,43.40999984741211,43.47999954223633,38.08039093017578,KO,"Dow 30 Stock Roundup: Merck & Pfizer Earnings Impress; Exxon & Chevron Disappoint ||| Play Rio 2016 Olympics with These Stocks & ETFs ||| Monster Beverage (MNST) Q2 Earnings Miss, Revenues Beat ||| Constellation Brands Inc (STZ) Ex-Dividend Date Scheduled for August 08, 2016 ||| Monster Beverages: An Attractive Name In One Of 2016's Best Performing Sectors",0,0.47848064
2016-08-08,8680300.0,43.43000030517578,43.52000045776367,43.220001220703125,43.43999862670898,38.04536056518555,KO,"Interesting September Stock Options for KO ||| Drinking And Driving Takes On New Meaning As Coffee May Be The Next Target For Driving Bans ||| Bernstein Gives Investors A Glimpse Of How Coca-Cola, Pepsi Are Faring In Europe This Summer",1,0.52727824
2016-08-09,7281300.0,43.5,43.63999938964844,43.380001068115234,43.470001220703125,38.07163619995117,KO,Monster Beverage Corp. Earnings: Another Rip-Roaring Growth Performance,1,0.51955634
2016-08-10,8412100.0,43.63999938964844,43.68999862670898,43.5,43.61000061035156,38.19423675537109,KO,Warren Buffett: Still Loves IBM Despite $1.5 Billion Loss as of 2nd Quarter ||| Coca-Cola Bottling (COKE) Q2 Earnings & Revenues Strong,1,0.5066583
2016-08-11,11303300.0,43.720001220703125,43.869998931884766,43.619998931884766,43.75,38.31686019897461,KO,"Trade of the Day: MNST Stock Gearing Up for a Monster Move ||| iShares Russell 1000 Growth ETF Experiences Big Outflow ||| 5 Dividend Stocks That Have Hiked Payouts 50 Years in a Row ||| The Coca-Cola Co: Here’s Where KO’s Dividend Will Go Next ||| Benzinga's M&A Chatter for Thursday August 11, 2016",1,0.48253697
2016-08-12,10928900.0,43.90999984741211,44.18999862670898,43.790000915527344,44.02999877929688,38.56208801269531,KO,Coca-Cola Set To Enter The Coffee Market In Brazil,1,0.55816364
2016-08-15,10390600.0,44.09999847412109,44.33000183105469,44.0099983215332,44.2400016784668,38.74601364135742,KO,"Interesting September Stock Options for KO ||| SPLV, SVXY: Big ETF Outflows ||| Can Coca-Cola (KO) Counter Emerging Market Headwinds?",0,0.5003063
2016-08-16,9706100.0,44.25,44.25,43.83000183105469,43.83000183105469,38.38691711425781,KO,Acquisitions Drive Berkshire Hathaway Inc. Earnings 25% Higher ||| An Outperforming Developed Markets ETF,1,0.52489966
2016-08-17,11208500.0,44.0099983215332,44.06999969482422,43.77999877929688,44.060001373291016,38.5883674621582,KO,"2 Incredibly Cheap Big Brand Stocks ||| What's the Proper Discount Rate to Use for a DCF Model? ||| Are Soda Companies Hazardous to Your Financial Health? ||| PEP Named Top 25 SAFE Dividend Stock Increasing Payments For Decades ||| After Hours Most Active for Aug 17, 2016 : ACWI, F, CSCO, SPLS, GE, WDC, ABBV, VCSH, KO, QQQ, XRX, MT ||| How To Trade Gaps In Price Action",1,0.48965684
2016-08-19,9385900.0,44.04999923706055,44.060001373291016,43.7400016784668,43.91999816894531,38.46574783325195,KO,"5 Stocks With Rising Dividends for 50 Years in a Row ||| Is Dr Pepper Snapple a Good Stock to Buy After a Strong 1H? ||| 5 Stocks That Beat The Market In A Crash (KO, SO, PG) ||| 10 Stocks Analysts Were Most Interested In During The Rio Olympics",0,0.48122397
2016-08-22,8687500.0,43.93999862670898,43.95000076293945,43.72999954223633,43.7400016784668,38.30809783935547,KO,"2 Warren Buffett Stocks to Buy in August ||| 3 Takeaways From Recent IRI Retail Data ||| Cott Corporation (COT) Ex-Dividend Date Scheduled for August 23, 2016 ||| 5 Of The Most Successful Athletes Turned Investors ||| From McMuffins To Mobile: Tracking Olympic Sponsors With TD Ameritrade's JJ Kinahan",1,0.5196995
2016-08-24,11508900.0,43.81999969482422,43.93999862670898,43.65999984741211,43.84999847412109,38.40444564819336,KO,"Utility Stocks Are About To Pull Back — Get Ready To Buy (SO, ETR) ||| Monster Beverage Gains from Strength in Energy Drinks Category ||| Build A Profitable Dividend Growth Investing Portfolio From Scratch (Podcast With Dividend House) ||| One City's 'Sugar Tax' Looks Like It's Causing Consumption To Fizzle Out",0,0.48775885
2016-08-25,9815700.0,43.84999847412109,43.93999862670898,43.630001068115234,43.66999816894531,38.24679183959961,KO,Great Stocks to Get Dividends Every Month,0,0.5177338
2016-08-26,11824900.0,43.720001220703125,43.91999816894531,43.310001373291016,43.31999969482422,37.94025421142578,KO,"Molson Coors Brewing Company (TAP) Ex-Dividend Date Scheduled for August 29, 2016 ||| Pepsico Inc Introduces New ""Craft"" Soda, but Is There Really Such a Thing? ||| Jilted Lovers: Investors Are Souring On Defensive Sector ETFs",1,0.49720466
2016-08-29,9544600.0,43.34000015258789,43.61000061035156,43.33000183105469,43.540000915527344,38.132938385009766,KO,Consumer Staples Select Sector SPDR Fund Experiences Big Outflow ||| 6 Simple Rules For Your Investment Strategy,0,0.5085233
2016-08-30,9720100.0,43.459999084472656,43.52999877929688,43.119998931884766,43.2400016784668,37.87020111083984,KO,"Top Research Reports for August 30, 2016 ||| Pepsico, Inc. (PEP) Ex-Dividend Date Scheduled for August 31, 2016 ||| How Can Dr Pepper's Latin America Segment Grow In The Next Five Years? ||| How Much Can The Coca-Cola Drink Grow In The Next Five Years? ||| How Much Was A Bottle Of Coke When Warren Buffett Was Born? ||| Warren Buffett's 86th Birthday: A Look Back At 75 Years Of Investing Genius",1,0.5129044
2016-08-31,10217900.0,43.43000030517578,43.459999084472656,43.08000183105469,43.43000030517578,38.03660202026367,KO,Better Buy: Altria Group Inc. vs. Coca-Cola ||| Workers Find Massive Amount of Cocaine at Coca-Cola Plant,0,0.49888957
2016-09-01,8457800.0,43.209999084472656,43.40999984741211,43.20000076293945,43.34999847412109,37.96653747558594,KO,"Does Netflix Have a Sustainable Competitive Advantage? ||| Impinj (PI) Beats Q2 Earnings Estimates, Raises IC Outlook ||| Coca-Cola Bottling Signs Agreements To Expand Distribution Territory, Purchase Manufacturing Facilities From Coca-Cola Subsidiary",1,0.5216849
2016-09-02,9026000.0,43.52000045776367,43.83000183105469,43.470001220703125,43.65999984741211,38.23803329467773,KO,Wintergreen Fund Dissolves — Holdings in —nd Quarter ||| Coca-Cola a Top Socially Responsible Dividend Stock With 3.2% Yield ||| Coca-Cola Bottling (COKE) to Expand Distribution Network,1,0.5332182
2016-09-06,8600400.0,43.7400016784668,43.79999923706055,43.400001525878906,43.790000915527344,38.35189056396485,KO,"XLP, PG, KO, CVS: Large Outflows Detected at ETF ||| A Response To The Economist's Hatchet Job On Warren Buffett And Berkshire Hathaway",0,0.49698123
2016-09-07,8656600.0,43.720001220703125,43.79999923706055,43.52999877929688,43.63999938964844,38.220516204833984,KO,Better Buy: Coca-Cola vs. Starbucks,0,0.5125971
2016-09-09,23624200.0,43.43000030517578,43.43000030517578,42.27000045776367,42.27000045776367,37.02064895629883,KO,3 Companies Launching Programs to Advance Working Women ||| 5 Dow Jones Titans Getting Pulled Into the Selloff ||| Better Buy: Berkshire Hathaway vs. Coke,1,0.53538835
2016-09-12,15932300.0,42.36000061035156,43.22999954223633,42.34000015258789,43.18999862670898,37.82640838623047,KO,"3 Stocks That Are Overvalued ||| Coca-Cola Company (KO) Ex-Dividend Date Scheduled for September 13, 2016 ||| 5 Blue Chip Stocks You Can Buy Today",0,0.47825864
2016-09-13,12962700.0,42.77000045776367,42.77000045776367,42.209999084472656,42.27999877929688,37.331939697265625,KO,"Better Buffett Buy: International Business Machines Corp. or Coca-Cola? ||| Olive Garden to Sell 21,000 Unlimited Pasta Passes in 2016 ||| Option Alert: KO Oct $41 Put; 4000@ Bid @$0.32; Ref =$42.65",0,0.47131357
2016-09-14,9823900.0,42.27000045776367,42.40999984741211,41.9900016784668,42.11000061035156,37.18183517456055,KO,Consumer Staples Select Sector SPDR Fund Experiences Big Inflow ||| 70% Of Americans Plan To Retire Like Red Sox Slugger David Ortiz,1,0.50632316
2016-09-15,10158500.0,42.0099983215332,42.38999938964844,41.880001068115234,42.36000061035156,37.40258026123047,KO,"Analysts Expect IWL Will Reach $54 ||| David Winters Sells Coca-Cola in —nd Quarter ||| 3 Top Consumer-Staples Stocks You Can Buy Right Now ||| Credit Suisse Initiates Coverage on Coca-Cola at Neutral, Announces $44.00 PT ||| The Beverages Strike Back; Lawsuit Filed To Block Philly's Sugar Tax",0,0.50657934
2016-09-16,16354000.0,42.16999816894531,42.2599983215332,41.970001220703125,42.13999938964844,37.20832443237305,KO,"Should You Buy PepsiCo, Coca-Cola, or Monster Beverage? 3 Things You Need to Know ||| The Zacks Analyst Blog Highlights: Coca-Cola, Schlumberger, Illinois Tool, Duke Energy and General Mills ||| 4 Stocks to Help You Make Money in Retirement ||| Credit Suisse Bullish To Neutral On Beverage/Spirit Names ||| Coca-Cola Could Remain Range-Bound For 2017; Credit Suisse Initiates At Neutral ||| National Beverage Shares 'All Fizzed Up,' Credit Suisse Initiates At Neutral ||| Credit Suisse Calls Monster Beverage An 'Unleashed Beast With Plenty Of Room To Run'",0,0.48958454
2016-09-19,7659900.0,42.15999984741211,42.369998931884766,42.08000183105469,42.09999847412109,37.17300796508789,KO,"What Is Socially Responsible Investing? ||| Apple Didn't Waste Billions on Its Buyback Program, but These Companies Did ||| Interesting May 2017 Stock Options for KO",1,0.48927423
2016-09-21,13654700.0,42.27999877929688,42.61000061035156,42.09999847412109,42.52999877929688,37.55268096923828,KO,Use These 4 Key Ingredients for Successful Dividend Investing ||| In Your 70s? Here Are 3 Stocks You May Want to Buy ||| Breaking Down Future Prospects for Chipotle and National Beverage Corp. ||| How The Coca-Cola Company Has Changed in the Last 10 Years ||| Top-Line Headwinds For Coca-Cola Likely To Fizzle Out,1,0.5004259
2016-09-22,9288300.0,42.709999084472656,43.0099983215332,42.68999862670898,42.959999084472656,37.9323616027832,KO,"XLP, PG, KO, MO: ETF Inflow Alert ||| Should Coca-Cola (KO) Stock be in Your Portfolio Now? ||| 3 Sin Stocks to Play on Smoking, Gambling and Girls, Girls, Girls!",0,0.49501073
2016-09-23,8852700.0,42.810001373291016,42.93999862670898,42.650001525878906,42.7400016784668,37.73811340332031,KO,The 5 Highest Dividend Payout Ratios on the Dow,0,0.52845126
2016-09-26,15036000.0,42.709999084472656,42.720001220703125,42.0099983215332,42.04999923706055,37.12885665893555,KO,"Cloud IPO Apptio Soars In Market Debut ||| 3 Dividend Stocks That Could Get Slammed When the Fed Raises Rates ||| Coca Cola Femsa Expands in Brazil with Vonpar Acquisition ||| 3 Things Coca-Cola Management Wants You to Know ||| One Put, One Call Option To Know About for Coca-Cola ||| Japan's Two Top Coca-Cola Bottlers to Merge -Nikkei ||| Evan G. Greenberg to Resign from The Coca-Cola Company Board of Directors ||| First Trust Gets Smart With New Sector ETFs",1,0.51875544
2016-09-27,11920400.0,42.18999862670898,42.630001068115234,42.0,42.59000015258789,37.605655670166016,KO,PepsiCo (PEP) Q3 Earnings: What's in Store for the Stock?,0,0.48734245
2016-09-28,15523800.0,42.630001068115234,42.7599983215332,42.02999877929688,42.150001525878906,37.21715927124024,KO,PepsiCo Inc.'s Stock Split History ||| 3 Stocks With Better Dividends Than Procter & Gamble ||| Here's Everything You Need To Know About Blue Chip Stocks,0,0.4714767
2016-09-29,12671700.0,42.02000045776367,42.38999938964844,41.84999847412109,42.02999877929688,37.11119842529297,KO,"4 Heavily Hyped Products That Failed ||| Dunkin’ Donuts, Coca-Cola Team Up on Bottled Coffee Drinks ||| 3 Stocks With Better Dividends Than NVIDIA Corporation ||| Tesla Motors Inc (TSLA) Is a Huge Risk for Millennials ||| The Most Consistent Dividend Payers ||| Cramer: PepsiCo Is A Snack Company, Not A Soda Seller ||| Stifel Nicolaus Downgrades Coca-Cola to Hold",1,0.51732874
2016-09-30,14375700.0,42.209999084472656,42.5,42.060001373291016,42.31999969482422,37.36725997924805,KO,"Notable ETF Inflow Detected - IWF, KO, MO, MMM ||| Dunkin' Donuts, Coca-Cola Team Up to Take On Starbucks ||| Coca-Cola Stock History: What You Need to Know ||| Coca-Cola West Co., Ltd., Coca-Cola East Japan to Merge",0,0.47998914
2016-10-03,11152800.0,42.310001373291016,42.310001373291016,41.88999938964844,42.02999877929688,37.11119842529297,KO,"One Put, One Call Option To Know About for Coca-Cola",0,0.50652075
2016-10-04,13682700.0,42.34000015258789,42.34000015258789,41.77999877929688,41.84000015258789,36.94343185424805,KO,"Coca-Cola West, East Japan to Merge in a $2.7B Stock Deal",0,0.515071
2016-10-05,9607300.0,41.93000030517578,42.06999969482422,41.66999816894531,41.810001373291016,36.91695022583008,KO,3 Stocks to Earn Dividends Every October ||| 5 Dow Jones Stocks Tripping Over Their Feet,0,0.49169597
2016-10-06,9722900.0,41.68000030517578,41.93999862670898,41.58000183105469,41.709999084472656,36.82865905761719,KO,"Dow Analyst Moves: KO ||| Even With Bottled Drinks, Dunkin' Donuts Can't Catch Starbucks ||| Better Buy: McDonald's Corp. vs. Coca-Cola ||| A Look Into Warren Buffett's Worst Investment Ever Provides A Great Lesson",1,0.4705642
2016-10-10,8983600.0,41.91999816894531,41.9900016784668,41.59999847412109,41.72999954223633,36.8463134765625,KO,"The Coca-Cola Co (KO) Stock Is a Long-Term Survivor ||| Best Stocks of 2016: Globant SA (GLOB) Emerges as Digital Transformation Leader ||| After Hours Most Active for Oct 10, 2016 : MU, PG, QQQ, TWTR, FB, YHOO, QCOM, CPN, GILD, KO, OLN, MTG ||| Consumer Staples Select Sector SPDR Fund Experiences Big Inflow ||| Coca-Cola Exercises Call Option To Acquire Anheuser-Busch InBev's Stake In Coca-Cola Beverages Africa",0,0.4933788
2016-10-11,12249100.0,41.65999984741211,41.70000076293945,41.400001525878906,41.540000915527344,36.67854690551758,KO,"After Hours Most Active for Oct 11, 2016 : BBT, BAC, QQQ, MSFT, EPD, ITW, AAPL, MAR, GE, KO, TLT, INTC ||| Exclusive: 10 Minutes With A Top Apptio Industry Peer, Digital Fuel",1,0.4897901
2016-10-12,12216300.0,41.630001068115234,41.84000015258789,41.5,41.77999877929688,36.89046096801758,KO,How PepsiCo Is Thriving in a Challenging Environment ||| Coca-Cola Company (KO) to Acquire ABI's Stake in CCBA ||| WHO Is Calling For A Global 'Sugar Tax',0,0.5170572
2016-10-13,17655600.0,41.650001525878906,41.88999938964844,41.5099983215332,41.7599983215332,36.87279891967773,KO,Coke Pops to High of $41.77 on Volume,0,0.5042258
2016-10-14,9893800.0,41.84999847412109,41.90999984741211,41.619998931884766,41.66999816894531,36.7933235168457,KO,Is PepsiCo (PEP) Mulling Over the Buyout of KeVita?,0,0.5148096
2016-10-17,10792500.0,41.72999954223633,41.86000061035156,41.56999969482422,41.59999847412109,36.73152160644531,KO,Marketplace Roundtable: Diving Into Dividend Investing ||| Interesting January 2019 Stock Options for KO ||| We Did The Math FTCS Can Go To $43,1,0.49838266
2016-10-18,11297300.0,41.810001373291016,42.0,41.72999954223633,41.970001220703125,37.05821990966797,KO,"Notable ETF Outflow Detected - XLP, KO, MO, CVS ||| Benzinga's M&A Chatter for Tuesday, October 18, 2016",1,0.4766608
2016-10-19,16367400.0,41.93000030517578,42.119998931884766,41.810001373291016,42.04999923706055,37.12885665893555,KO,"Can Apple Inc. Become a Dividend Growth Stock? (AAPL) ||| See Which Of The Latest 13F Filers Holds Coca-Cola ||| The Market In 5 Minutes: Oil Inventories, Earnings Beats And A Walgreens-Rite Aid Snag",0,0.4784245
2016-10-24,13439200.0,42.31999969482422,42.77000045776367,42.25,42.560001373291016,37.57917404174805,KO,"Coca-Cola reports Q3 earnings October 26 ||| Sure, Budweiser Is the Biggest Brand in Alcohol, but Can You Guess Who Is No. 2? ||| One Put, One Call Option To Know About for Coca-Cola ||| Can Coca-Cola (KO) Keep the Earnings Streak Alive in Q3? ||| Why Earnings Season Could Be Great for Coca Cola (KO) ||| Can Mondelez (MDLZ) Pull a Surprise This Earnings Season?",0,0.48242682
2016-10-25,16484700.0,42.63999938964844,42.880001068115234,42.43000030517578,42.540000915527344,37.5615119934082,KO,"3 Big-Brand Stocks to Buy in October ||| B&G Foods (BGS) to Report Q3 Earnings: What's in Store? ||| These Companies are Earnings All-Stars ||| Coca-Cola Earnings, Revenue May Post Decline as Emerging-Market Weakness Persists ||| Nikkei Asian Review Reports Coca-Cola, Kirin plan tie-up in Japan to slash costs ||| Epic Earnings: Many US Companies Beating Expectations As Season Continues",0,0.50777864
2016-10-26,16886200.0,43.0,43.02999877929688,42.40999984741211,42.43999862670898,37.47320938110352,KO,"Midday Update: Stocks Trim Losses on Supply-Related Bounce in Oil ||| The Morning Hype: Coke Hack, Apple Leak, and the IRS ||| iShares Russell 1000 Growth ETF Experiences Big Inflow ||| XLP, FAD: Big ETF Outflows ||| Dow Movers: AAPL, NKE ||| Q3 Earnings, Earnings, Earnings! BA, HLT, KO, MDLZ, AAPL ||| Vail Resorts, Illumina, Coca-Cola, Boston Scientific and Equifax highlighted as Zacks Bull and Bear of the Day ||| Coca-Cola (KO) Beats on Earnings & Revenues in Q3 ||| Apple Earnings Paint Mixed Picture, But Crude Weakness More Of A Drag ||| The Market In 5 Minutes: Wall Street Not Too Happy With Apple, Chipotle Or The Cubbies ||| 18 Stocks Moving In Wednesday's Pre-Market Session ||| A Peek Into The Markets: U.S. Stock Futures Down; Apple Shares Drop Following Q4 Results ||| Coca-Cola Stock Higher Following Q3 Results ||| Coca-Cola Guidance Remains Unchanged For FY16 ||| Coca Cola Q3 EPS $0.49 vs $0.48 est, Revenue $10.63B vs $10.51B est ||| Keep an Eye on These 12 Stocks for October 26, 2016 ||| Earnings Scheduled For October 26, 2016",0,0.5069149
2016-10-27,14537000.0,42.630001068115234,42.650001525878906,41.900001525878906,42.119998931884766,37.19065856933594,KO,"After Hours Most Active for Oct 27, 2016 : AAPL, F, T, PBR, QQQ, AKS, EBAY, AMZN, YHOO, BAC, KO, ADRO ||| Dow Movers: KO, DD ||| Coca-Cola's ""Core Business Model"" Shows Promise ||| Dr Pepper Snapple (DPS) Beats on Q3 Earnings; Raises View ||| 3 Internet of Things Stocks You May Be Overlooking ||| Filing from Coca-Cola Shows Registration for Mixed Securities Shelf Offering ||| The Coca-Cola Co. Names Barry Simpson Chief Information Officer",1,0.4882137
2016-10-28,13398400.0,42.2599983215332,42.470001220703125,42.09999847412109,42.22999954223633,37.28779983520508,KO,"3 Stocks to Buy With Dividends Yielding More Than 3% ||| ‘ Warren Buffett Stocks Fall to 5—-Week Lows ||| After Hours Most Active for Oct 28, 2016 : F, GE, INTC, BAC, QQQ, KO, AAPL, MSFT, RICE, ON, GXP, QVCA",1,0.49037996
2016-10-31,13327500.0,42.119998931884766,42.40999984741211,42.119998931884766,42.400001525878906,37.43790817260742,KO,"After Hours Most Active for Oct 31, 2016 : ADNT, BAC, TEVA, AAPL, MSFT, GE, CSCO, T, INTC, KO, ASNA, BEAV ||| Interesting February 2017 Stock Options for KO ||| The Coca-Cola Co (KO) Debuts Coke Ginger ||| Beverage Stock Q3 Earnings Releases on Nov 1: TAP, PRMW",0,0.46087638
2016-11-01,12223400.0,42.400001525878906,42.43000030517578,41.90999984741211,42.119998931884766,37.19065856933594,KO,"Coca-Cola, Ambev Seeking Stake in Brazil's Natural One -Reuters ||| Coca-Cola Named As Possible Suitor For Brazilian Juice Maker Natural One SA ||| Traders Turn Against This Conservative Sector ||| 4 Publicly Traded Companies More Than A Century Old",0,0.50935537
2016-11-03,11258000.0,42.220001220703125,42.220001220703125,41.959999084472656,42.02999877929688,37.11119842529297,KO,"UPRO, T, VZ, KO: Large Inflows Detected at ETF ||| The Most Valuable Companies in the World ||| Constellation Brands Inc (STZ) Ex-Dividend Date Scheduled for November 04, 2016 ||| Monster Beverage Looks Ugly as Sales, Earnings Growth Slows",0,0.50590837
2016-11-07,14038500.0,42.040000915527344,42.5,42.040000915527344,42.459999084472656,37.49087142944336,KO,What You Should Know About BlackLine's Hot IPO ||| Interesting December Stock Options for KO,1,0.49967754
2016-11-08,12036600.0,42.369998931884766,42.97999954223633,42.369998931884766,42.880001068115234,37.86171722412109,KO,"MGP Ingredients, Inc. (MGPI) Ex-Dividend Date Scheduled for November 09, 2016",0,0.44658762
2016-11-09,21351000.0,41.7599983215332,42.31999969482422,41.70000076293945,42.27000045776367,37.32310485839844,KO,"Election Chaos Sends the U.S. Stock Market Plunging: Here are 4 Things to Do Right Now ||| Soft Drink Stocks' Q3 Earnings Slated for Nov 10: CCE, COT ||| Coca-Cola Bottling (COKE) Q3 Earnings, Revenues Rise Y/Y ||| 2 Stocks to Buy and Hold in a Volatile Market",0,0.51038826
2016-11-10,33245500.0,41.86000061035156,42.2599983215332,40.84999847412109,40.93999862670898,36.14876556396485,KO,"Noteworthy ETF Outflows: VIG, PEP, KO, MMM",1,0.50962365
2016-11-11,13421000.0,40.95000076293945,41.130001068115234,40.630001068115234,41.02999877929688,36.22822952270508,KO,"Bank of America Corp (BAC) Stock Is STILL Cheap, Somehow ||| Anheuser-Busch Inbev SA (BUD) Ex-Dividend Date Scheduled for November 14, 2016",1,0.46090686
2016-11-14,19514200.0,41.130001068115234,41.41999816894531,40.84999847412109,41.16999816894531,36.35184097290039,KO,"3 Mexican Stocks to Buy, 1 to Sell in Trump’s World ||| Dr Pepper Snapple (DPS) Q3 Results Strong, View Impressive ||| One Put, One Call Option To Know About for Coca-Cola ||| Soros Fund Management initiates Coca-Cola Stake ||| Beer & Beverage: Will The Tie-Up Make Sense? ||| Coca-Cola +1.1% Premarket @$41.50 Following Sunday Telegraph Report Indicating it Could be Takeover Target of AB-Inbev ||| Coca-Cola Shares Recently Spike ~$0.85 Higher in Pre-Market Action; Some Traders Passing Around Earlier (Nov. 12) Article from UK's Telegraph Consider Possilbe AB-InBev Tie Up",1,0.5170496
2016-11-15,16554000.0,41.18000030517578,41.52000045776367,41.16999816894531,41.43999862670898,36.59025192260742,KO,"'Sugar Wars' Escalating: Beverage Companies Look To Bolster Non-Soda Portfolios ||| Morgan Stanley Global Consumer & Retail Conference Begins With Day 1 Of 3 Today Presenters Include Estee Lauder, Hanesbrands, Coca-Cola, Newell Brands, Steve Madden, Tupperware Brands, US Foods, Walgreens, Wingstop, & Weight Watchers",0,0.4831932
2016-11-16,12681400.0,41.400001525878906,41.650001525878906,41.15999984741211,41.2599983215332,36.43130874633789,KO,Anheuser Busch Inbev SA NV (ADR) (BUD) Is the King of Sin Stocks ||| SodaStream (SODA) Raised to Strong Buy: Should You? ||| What Is NAFTA And Why Does Trump Have Such A Problem With It?,0,0.48854744
2016-11-17,12398800.0,41.27999877929688,41.29999923706055,41.0,41.119998931884766,36.30769348144531,KO,Better Buy: Starbucks Corporation vs. Coca-Cola ||| Hong Kong's Swire Pacific Said to be in Talks to Buy Coca-Cola Bottling Assets in China for $1B -Bloomberg,0,0.5282086
2016-11-21,12307000.0,40.90999984741211,41.36000061035156,40.72999954223633,41.36000061035156,36.51961898803711,KO,"Soda Stocks: What to Watch in 2017 ||| The 10 Richest People in the U.S. ||| Interesting May 2017 Stock Options for KO ||| XLP, KO, MO, PEP: ETF Inflow Alert ||| DPS Named A Top Socially Responsible Dividend Stock ||| Coca-Cola (KO) to Divest Bottling Assets in China for $852M",1,0.5008255
2016-11-22,12743500.0,41.45000076293945,41.70000076293945,41.2400016784668,41.369998931884766,36.5284309387207,KO,"The Zacks Analyst Blog Highlights: Coca-Cola, Disney, Danaher, Halliburton and Time Warner ||| Cott Corporation (COT) Ex-Dividend Date Scheduled for November 23, 2016 ||| Coca-Cola (KO) Marketing Initiatives Solid, Fx Woes Stay ||| Why Building A ‘Legacy’ Portfolio Pays Off ||| 3 Stocks That Turned $8,000 Into $90,400 (or More) in 26 Years ||| Hearing Dealreporter Saying Coke 'Inching Closer' To Monster Acquisition After China Reorganization",0,0.4882594
2016-11-23,9281300.0,41.220001220703125,41.310001373291016,41.02999877929688,41.119998931884766,36.30769348144531,KO,Dr Pepper Snapple to Buy Antioxidant Drink Maker Bai Brands ||| Dr Pepper Snapple's No-Regrets Acquisition ||| Sum Up The Parts: SYG Could Be Worth $69,1,0.49946088
2016-11-25,7402300.0,41.38999938964844,41.58000183105469,41.2400016784668,41.52999877929688,36.669708251953125,KO,"Better Buy: Philip Morris International, Inc. vs. Coca-Cola ||| Molson Coors Brewing Company (TAP) Ex-Dividend Date Scheduled for November 28, 2016 ||| Pre-Market Most Active for Nov 25, 2016 : AZN, UN, VALE, FCX, KO, LN, MDLZ, CTRP, WBA, FB, KHC, XIV ||| These 4 Cities Just Raised Taxes on Soda. Will It Matter? ||| After Hours Most Active for Nov 25, 2016 : CSCO, BAC, CTSH, KO, PM, WFT, GNW, V, INTC, MSFT, QQQ, AAPL ||| Dow 30 Stock Roundup: Nike Raises Dividend, Boeing-Textron JV Bags Defense Contract",1,0.4731293
2016-11-28,19424400.0,41.5099983215332,41.790000915527344,41.27000045776367,41.75,36.86396026611328,KO,"The Zacks Analyst Blog Highlights: NIKE, Boeing, Textron, Coca-Cola and IBM",0,0.50542307
2016-11-29,11421900.0,41.52000045776367,41.52000045776367,41.13999938964844,41.150001525878906,36.641357421875,KO,"VOO, PFE, KO, PEP: Large Inflows Detected at ETF ||| Pepsico, Inc. (PEP) Ex-Dividend Date Scheduled for November 30, 2016 ||| Market Close Report: NASDAQ Composite index closes at 5,379.92 up 11.11 points ||| The Difference Between Shareholders And Stakeholders",0,0.47993356
2016-12-01,20409900.0,40.310001373291016,40.38999938964844,39.880001068115234,40.16999816894531,35.76873779296875,KO,"The Best Soda Stocks of 2016 ||| 4 Biggest Losers for the Dow in November ||| Sports Business Reporter Scott Soshnick Tweets: 'BREAKING: Coca Cola's Monster Energy replacing Sprint as sponsor of Nascar's top racing tier, source says' ||| 2 Sector ETFs Drawing Renewed Attention ||| Stocks Hitting 52-Week Lows",1,0.5131024
2016-12-05,15977800.0,40.34000015258789,40.68999862670898,40.310001373291016,40.619998931884766,36.16943740844727,KO,"One Put, One Call Option To Know About for Coca-Cola ||| Beverage Stocks Trading Up Mid Day: National Beverage 7.5%, Craft Brew Alliance 2.5%, Boston Beer 2%, Coca Cola 2%, Anheuser Busch 1.5%",0,0.49130803
2016-12-08,13077100.0,41.06999969482422,41.209999084472656,40.84999847412109,40.97999954223633,36.4899787902832,KO,"Dr Pepper Snapple Group, Inc (DPS) Ex-Dividend Date Scheduled for December 09, 2016 ||| National Beverage Corp Stock: How Sparkling Water Produced Eye-Popping Returns for Investors ||| Trying Times For Staples ETFs",1,0.5057975
2016-12-09,28125800.0,41.5,42.220001220703125,41.290000915527344,42.0,37.39822769165039,KO,"Coca-Cola (KO) Sees Leadership Shakeup ||| Dow Movers: WMT, KO ||| Market Close Report: Historical high reached as NASDAQ Composite Index closes at 5,444.50. ||| What Happened in the Stock Market Today ||| Dow Jones Industrial Average Ends Week With Record Win; S&P Nabs Best Win Streak Since '14 ||| Noteworthy Friday Option Activity: BMY, BREW, KO ||| How Buffett Made $7.5 Million From Not Buying Stock ||| Coke CEO Steps Down, Here's What To Expect From The Stock ||| Coca-Cola Currently Hosting Call to Discuss Recent Mgmt Changes, Future of Business; Shares Largely Unaffected Amid Call ||| James Quincy To Succeed Muhtar Kent As CEO in May 2017, Kent To Continue As Chairman",0,0.4827481
2016-12-12,17561900.0,42.0,42.0099983215332,41.720001220703125,41.900001525878906,37.30917739868164,KO,"Why PepsiCo, Inc. Is Still a Top Dividend Growth Stock (PEP) ||| 2 Stocks for Low-Risk Investors ||| Interesting January 2017 Stock Options for KO ||| Stock Market News for December 12, 2016",0,0.4673946
2016-12-13,18986000.0,41.720001220703125,41.959999084472656,41.540000915527344,41.7599983215332,37.18452453613281,KO,"Top Stocks to Buy in Soda ||| Deutsche Makes A Resolution To Hold Coca-Cola, Procter & Gamble In The New Year ||| Benzinga's Top Upgrades, Downgrades For December 13, 2016 ||| Jim Cramer Shares His Thoughts On Coca-Cola, Verizon, Twitter ||| Deutsche Bank Downgrades Coca-Cola to Hold",0,0.49370205
2016-12-14,17937900.0,41.88999938964844,41.9900016784668,41.060001373291016,41.209999084472656,36.69477081298828,KO,"Coca-Cola, UnitedHealth, Healthcare And Tech ETFs: Fast Money Picks For December 14",1,0.47693887
2016-12-16,19675200.0,41.61000061035156,41.7599983215332,41.47999954223633,41.7400016784668,37.16671371459961,KO,"Covered Call Writing – Stock Options Trading for Beginners ||| Dow 30 Stock Roundup: Boeing, GE Raise Dividends; ExxonMobil Gets New CEO ||| Hate Checking Your Portfolio? Try These 3 Stocks ||| The Market In 5 Minutes: Adobe, Oracle Take The Earnings Stage ||| Morgan Stanley Downgrades Coca-Cola to Equal-Weight",0,0.50128675
2016-12-19,8687300.0,41.68999862670898,41.79999923706055,41.58000183105469,41.66999816894531,37.10437774658203,KO,Better Buy: The Walt Disney Company vs. Coca-Cola ||| Interesting January 2019 Stock Options for KO ||| The Best Christmas and Holiday Commercials Ever,0,0.49695227
2016-12-20,10603500.0,41.70000076293945,41.720001220703125,41.43999862670898,41.65999984741211,37.095481872558594,KO,Coca-Cola Looks to a New Ham Sandwich for Salvation,0,0.52688324
2016-12-21,9693600.0,41.59999847412109,41.83000183105469,41.52000045776367,41.56999969482422,37.01534652709961,KO,"Stock Market News for December 21, 2016 ||| PepsiCo: A Top Dividend Growth Stock For Long-Term Investors ||| Coca-Cola (KO) to Buy AB InBev's Stake in CCBA for $3.15B ||| —‘ Questions With Fran&#231;ois Rochon of Giverny Capital ||| Soft Drink Stocks Head-to-Head: PepsiCo vs. Coca-Cola ||| After A Poor Showing In 2016, Does Nike Qualify As A 'Dog Of The Dow'? ||| Coca-Cola to Acquire AB Inbev's Interest In Bottling Operations in Zambia, Zimbabwe, Botswana, Swaziland, Lesotho, El Salvador, Honduras for Undisclosed Amount",0,0.4775966
2016-12-22,11894100.0,41.56999969482422,41.619998931884766,41.08000183105469,41.54999923706055,36.997535705566406,KO,"Broadcom, Chipotle, Coca-Cola and PepsiCo highlighted as Zacks Bull and Bear of the Day ||| Dow Analyst Moves: KO ||| 4 Dow Jones Industrial Average Laggards That Are at Risk of Falling ||| Better Buy: Altria Group Inc. vs. Coca-Cola ||| 5 Berkshire Holdings that Made 2016 Buffett's Best Year ||| US Budget Deficit Increased By 6% In November, But The Deficit Could Widen Under Trump ||| Meet The New Dogs: 2017's Dogs Of The Dow Include Coca-Cola, Boeing",1,0.48224422
2016-12-23,6436600.0,41.619998931884766,41.68999862670898,41.34999847412109,41.59999847412109,37.04205322265625,KO,"ITOT, HD, MRK, KO: Large Inflows Detected at ETF ||| Dow 30 Stock Roundup: Nike Beats, Coca-Cola to Buy AB InBev's Stake in CCBA",1,0.5039317
2016-12-27,6999200.0,41.560001373291016,41.7599983215332,41.540000915527344,41.61000061035156,37.05095672607422,KO,"How Ugly Can the Bond Rout Get? ||| Coca-Cola European Partners plc (CCE) Ex-Dividend Date Scheduled for December 28, 2016",0,0.46601757
2016-12-28,8988000.0,41.4900016784668,41.66999816894531,41.38999938964844,41.38999938964844,36.85505676269531,KO,Meet This Year's Best Consumer Staples ETF,1,0.5331533
2016-12-29,6875300.0,41.380001068115234,41.68999862670898,41.380001068115234,41.59999847412109,37.04205322265625,KO,"Dow Movers: GS, KO ||| How Coca-Cola Can Increase Its Value in 2017",0,0.5148923
2016-12-30,11470200.0,41.68999862670898,41.84000015258789,41.34999847412109,41.459999084472656,36.91739654541016,KO,"A Rare Deal On Goodyear Tire & Rubber Co Is Available Now (GT) ||| 3 Beaten-Up Dividend Aristocrats: Are They Bargains? ||| European Equity Benchmarks Close Higher, FTSE Ends 2016 at Record High ||| These Two 2016 Dow Losers Can Return 20% In 2017 ||| Doug Young Positions For 2017: A Rocky Road Ahead For China ||| Which Wall Street Firm Made The Best Stock Picks Of 2016?",1,0.4922285
2017-01-03,14711000.0,41.5,41.810001373291016,41.27999877929688,41.79999923706055,37.22013473510742,KO,"4 Stocks Reach Their ‘-Year Low Prices ||| Dow Under 19,000 Or Dow At 20,000: What Happens First? ||| Barron's Best Income Ideas For 2017 ||| Coca-Cola (KO) Underperforms: Will It Turn Around in 2017? ||| The 5 Worst Stocks in the Dow Jones in 2016",0,0.49251205
2017-01-04,9959400.0,41.880001068115234,41.970001220703125,41.59000015258789,41.650001525878906,37.08657836914063,KO,"3 New Year’s Retirement Investments: 1 Stock, 1 ETF and 1 Mutual Fund ||| FEMSA (FMX) Downgraded to Strong Sell on Dismal Trends ||| Pre-Market Prep Host Dennis Dick Tweets: Notable opening imbalances: $PG +93K, $KO +136K, $BAC +350K, $T -138K, $XRX +272K, $GM +60K, $CVX +73K, $BABA +49K, $F +441K",1,0.5402284
2017-01-05,8968300.0,41.65999984741211,41.86000061035156,41.52999877929688,41.75,37.17560958862305,KO,The 2 Best Consumer Staples Stocks to Keep an Eye On in 2017 ||| The Coca-Cola Co (KO) Stock Is Fizzing With Value ||| Coca-Cola Sued for Misleading Consumers About Health Risks,0,0.4981647
2017-01-06,10246600.0,41.70000076293945,41.810001373291016,41.540000915527344,41.7400016784668,37.16671371459961,KO,"The Worst Soda Stocks of 2016 ||| Dr Pepper Snapple Group Inc (DPS) Stock Can Punch Above Its Weight ||| Here Are the 2017 Dogs of the Dow ||| Dow 30 Stock Roundup: Boeing Wins 737 MAX 8 Order; ExxonMobil, Tillerson Agree to Cut Ties",0,0.48855692
2017-01-09,14822500.0,41.22999954223633,41.58000183105469,41.209999084472656,41.31999969482422,36.792724609375,KO,"How You Can Make Big Funds Jealous…And Beat Them, Too ||| Goldman Sachs Blasts Procter & Gamble Stock as Too ""Rich"" to Own ||| Barclays' Favorite In Big Beverage Group May Surprise You ||| Benzinga's Top Upgrades, Downgrades For January 9, 2017 ||| The Market In 5 Minutes: Earnings Results, Conferences, Trump And More ||| Goldman Sachs Downgrades Coca-Cola to Sell ||| Barclays Initiates Coverage On Coca-Cola at Equal-Weight",0,0.49876735
2017-01-10,19706800.0,41.43999862670898,41.43999862670898,40.86000061035156,41.040000915527344,36.54341506958008,KO,"ACWI, C, HD, KO: Large Inflows Detected at ETF ||| The Zacks Analyst Blog Highlights: Wal-Mart, Exxon Mobil, QUALCOMM, Coca-Cola and Monsanto",1,0.5191161
2017-01-11,9266200.0,40.84999847412109,41.119998931884766,40.83000183105469,41.04999923706055,36.55231094360352,KO,3 Companies The Coca-Cola Co (KO) Should Buy in 2017,0,0.54567283
2017-01-12,8541200.0,41.0099983215332,41.040000915527344,40.79999923706055,40.95000076293945,36.4632682800293,KO,"Should I Buy FireEye Inc (FEYE) Stock? 3 Pros, 3 Cons ||| Wells Fargo: We Share Retailer's Concerns On Monster Beverage",0,0.47287643
2017-01-13,8123500.0,41.0,41.040000915527344,40.68999862670898,40.880001068115234,36.40094757080078,KO,Are Investor Concerns On Monster Beverages Misplaced? ||| Jim Cramer On JPMorgan: Best Quarter Ever,1,0.4980568
2017-01-17,12469400.0,40.84000015258789,41.29999923706055,40.79999923706055,41.220001220703125,36.70368957519531,KO,How Vending Machine Technology Can Boost Fastenal’s Growth ||| Will Coca-Cola Raise Its Dividend in 2017? ||| The Program For Trading Like A Hedge Fund ||| Risks and Opportunities From the Donald Trump Administration ||| Winners And Losers From Trump's U.S. Dollar Comments ||| Option Alert: Coca Cola Jun 47.0 Calls Sweep: 4359 @ ASK $0.11: 4674 traded vs 7721 OI: Earnings 2/9 Before Open $41.17 Ref ||| Quality Dividends On The Cheap With This ETF,1,0.51784796
2017-01-18,10390500.0,41.25,41.380001068115234,41.13999938964844,41.290000915527344,36.76602554321289,KO,"Notable ETF Outflow Detected - IUSG, HD, MO, KO",0,0.49683747
2017-01-19,10987100.0,41.13999938964844,41.290000915527344,41.02999877929688,41.13999938964844,36.63245391845703,KO,"Benzinga's Top Upgrades, Downgrades For January 19, 2017 ||| Wells Fargo Downgrades Coca-Cola to Market Perform",1,0.52513015
2017-01-20,14695400.0,41.27000045776367,41.43999862670898,41.130001068115234,41.31999969482422,36.792724609375,KO,"XLP, DXJR: Big ETF Outflows ||| Buy the Vanguard Consumer Staples ETF (VDC) as the Economy Stabilizes ||| Option Alert: Coca Cola Feb 39.0 Puts Sweep: 706 @ ASK $0.13: 5844 traded vs 3582 OI: Earnings 2/9 Before Open $41.33 Ref",1,0.50242025
2017-01-23,11628900.0,41.310001373291016,41.5,41.209999084472656,41.43000030517578,36.89068222045898,KO,Better Buy: The Coca-Cola Co. vs. International Business Machines Corp. ||| Interesting May Stock Options for KO ||| Watch These 7 Huge Put Purchases In Monday Trade,1,0.49838042
2017-01-24,17040100.0,41.470001220703125,41.970001220703125,41.470001220703125,41.900001525878906,37.30917739868164,KO,"Coca-Cola Bottling Co. Consolidated (COKE) Ex-Dividend Date Scheduled for January 25, 2017 ||| Which Of The Latest 13F Filers Holds Coca-Cola? ||| Hearing Coca-Cola Mentioned in Takeover Chatter With Kellogg",1,0.48264575
2017-01-25,12538200.0,41.93999862670898,42.25,41.900001525878906,42.119998931884766,37.50507354736328,KO,4 Dividend Stocks That'll Likely Raise Their Payouts for a 55th Consecutive Year ||| The Market In 5 Minutes: Big Earnings And A Major IPO Acquisition ||| Wall Street's M&A Chatter From January 24,0,0.47556224
2017-01-26,8976800.0,42.02999877929688,42.11000061035156,41.790000915527344,41.810001373291016,37.22904968261719,KO,"Noteworthy ETF Outflows: VT, KO, C, IBM ||| Is LIFEWTR PepsiCo's (PEP) Answer to Coke's Smart Water? ||| Coca-Cola Hit With ""Tobacco-Style"" Lawsuit. Who Else Is at Risk? ||| Vita Coco Hires JP Morgan To Explore Sale, Could Value Co. At $1B; Coke Owns #2 Brand, Zico ||| What Do Pepsi's Super Bowl Ads For Sugar-Free Products Mean For The Soda Market? ||| Following Sprint Stake, How Does Jay Z's Tidal Investment Rank Among Hip Hop's Biggest Deals?",0,0.47449303
2017-01-27,12967400.0,41.90999984741211,41.95000076293945,41.41999816894531,41.45000076293945,36.90848922729492,KO,Why Shareholders Care About Dividends,0,0.5067382
2017-01-30,11626200.0,41.29999923706055,41.47999954223633,41.209999084472656,41.380001068115234,36.84615707397461,KO,"US Market Indexes Higher for the Week ||| Baby Boomers Love These 5 Brands ||| One Put, One Call Option To Know About for Coca-Cola ||| Cullinan Associates Inc Buys NYSE:COH, NAS:JD, NYSE:SNY, Sells BMY, XOM, AFL ||| The Importance Of Immigrants On Wall Street, In Silicon Valley And For The United States ||| Who Is Jorge Paulo Lemann, And Why Might He Be Up To Something Big In 2017?",1,0.49705258
2017-01-31,12678000.0,41.38999938964844,41.68999862670898,41.36000061035156,41.56999969482422,37.01534652709961,KO,The Top 10 Dow Dividend Stocks for February,0,0.5221219
2017-02-01,11136100.0,41.52000045776367,41.65999984741211,41.25,41.2599983215332,36.73930358886719,KO,"Rowland & Co Investment Counsel Buys WEC Energy Group, Southern, Bank of Americaoration, ... ||| 52-Week Company Lows",1,0.51823604
2017-02-03,11882400.0,41.58000183105469,41.790000915527344,41.459999084472656,41.540000915527344,36.98863220214844,KO,"OEF, HD, KO, V: ETF Outflow Alert ||| Benzinga's Option Alert Recap From February 3 ||| Option Alert: Coca Cola Feb 10th 41.5 Puts Sweep: 3121 @ ASK $0.37: 5751 traded vs 1134 OI: Earnings 2/9 Before Open $41.71 Ref",1,0.5213084
2017-02-06,15742800.0,41.52999877929688,41.66999816894531,41.400001525878906,41.560001373291016,37.00642776489258,KO,"3 Things to Watch in the Stock Market This Week ||| Constellation Brands Inc (STZ) Ex-Dividend Date Scheduled for February 07, 2017 ||| American Staples Earnings Preview: Low Expectations For Coca-Cola, Disney ||| Which Super Bowl LI Commercials Were Social Hits? ||| Jobs Report, Fed Meeting Out of the Way, So Market Seeks New Catalyst ||| The Market In 5 Minutes: One For The Thumb ||| Watch These 8 Huge Put Purchases In Monday Trade",1,0.5162523
2017-02-07,13315200.0,41.70000076293945,41.97999954223633,41.66999816894531,41.900001525878906,37.30917739868164,KO,"The Coca-Cola Co (KO) Q4 Earnings Should Scare the Bears! ||| Coca-Cola (KO) Q4 Earnings: Disappointment in the Cards? ||| SodaStream's New Foe Is an Old Friend That Was an Older Foe ||| 20 Most Talked About Super Bowl LI Commercials, Ranked ||| Benzinga's Option Alert Recap From February 7 ||| The Trump Diet: Fried Chicken, Diet Coke And Big Macs Served On A Silver Platter ||| Option Alert: Coca-Cola Feb 10th 43.0 Calls Sweep: 1575 @ ASK $0.07: 2500 traded vs 524 OI: Earnings 2/9 Before Open $41.73 Ref ||| The Market In 5 Minutes: GM And Gap Earnings, Retail Sales Data",1,0.48926222
2017-02-08,14219700.0,41.90999984741211,42.150001525878906,41.84000015258789,42.02000045776367,37.41603469848633,KO,"What Awaits Coca-Cola Enterprises (CCE) in Q4 Earnings? ||| 3 Earnings Charts You Have to See ||| Why a PepsiCo, Inc. (PEP) Split Would Unlock 20% Upside ||| Nvidia Corporation (NVDA) Q4 Earnings Preview ||| Why Coca-Cola Co (KO) Stock Is a Great Contrarian Opportunity ||| Noteworthy Wednesday Option Activity: AAN, TCS, KO ||| Expect Another Drop In Revenue In Q4 As Coca-Cola Ends Another Transition Year ||| Here’s How Coca Cola Is Gearing To Fight The “Health” War In Japan ||| Beverage Stocks to Watch for Q4 Earnings on Feb 9: KO, CCE ||| Stock Market News for February 08, 2017 ||| The Most Popular Brand On Facebook Next To, Well, Facebook, Is... ||| Watch These 8 Huge Call Purchases In Wednesday Trade",0,0.48296112
2017-02-09,27240300.0,42.02000045776367,42.02000045776367,40.720001220703125,41.25,36.73040771484375,KO,"Midday Update: Wall Street Sets New Records on Gains in Banking, Energy Shares ||| Schlumberger Limited (SLB) Stock Could Be a Gusher. Tap It! ||| Trade of the Day: Is The Coca-Cola Co (KO) Stock Ready to Bubble Up? ||| Earnings Reaction History: The Coca-Cola Company, 36.4% Follow-Through Indicator, 1.9% Sensitive ||| What Happened in the Stock Market Today ||| Wall Street Marks Record Day as Trump's Tax Talk Spurs Rally ||| Dow Movers: KO, NKE ||| Coca-Cola (KO) Beats on Earnings & Revenues in Q4 ||| Q4 2016 Real-Time Call Brief ||| Coca-Cola Smoked After Q4 Report ||| Market Points Toward Possible Test Of Record Highs Despite Twitter Results ||| The Market In 5 Minutes: Twitter Tanks, Trump Tweets, Tesla Preps ||| A Peek Into The Markets: U.S. Stock Futures Rise; Twitter Sales Miss Views ||| Coca-Cola Sees FY17 Adj. EPS Down 1-4% YoY ||| Coca-Cola Sees FY17 Organic Sales Growth ~3% ||| Coca-Cola Reports Q4 Adj. EPS $0.37, Inline, Sales $9.4B vs $9.13B Est. ||| 12 Stocks To Watch For February 9, 2017 ||| Earnings Scheduled For February 9, 2017",0,0.48485717
2017-02-10,28847300.0,41.02000045776367,41.20000076293945,40.54999923706055,40.58000183105469,36.13380432128906,KO,"Patten Group, Inc. Buys Delphi Automotive PLC, Vanguard Total Stock Market, Ventas, Sells ... ||| Dow 30 Stock Roundup: Coca-Cola, Disney, Visa Beat on Earnings ||| Market Close Report: Historical high reached as NASDAQ Composite Index closes at 5,734.13. ||| After Hours Most Active for Feb 10, 2017 : KMI, BAC, CTB, KO, WFT, KKR, FB, MENT, ARRY, MSFT, SGYP, MU ||| Dow Jones Industrial Average Enjoys Record Highs, Weekly Win ||| Synovus Financial Corp Buys iShares MSCI EAFE, Vanguard REIT ETF - DNQ, iShares Nasdaq ...",1,0.49126482
2017-02-13,23617100.0,40.77000045776367,40.83000183105469,40.5,40.619998931884766,36.16943740844727,KO,"3 Things to Watch in the Stock Market This Week ||| Coca-Cola Is Forging Ahead With Its Business Transformation ||| 3 Stocks That Turned $10,000 Into at Least $3.68 Million ||| New Strong Sell Stocks for February 13th ||| PepsiCo (PEP) Q4 Earnings: What's in Store for the Stock? ||| The Zacks Analyst Blog Highlights: Coca-Cola, Walt Disney, Visa, Boeing and Merck ||| Beverage Stocks to Report Q4 Earnings on Feb 14: TAP, DPS ||| Investors Growing Impatient With Coca-Cola's Inability To Overcome Macro Challenges",0,0.52148694
2017-02-14,32177800.0,40.380001068115234,40.59999847412109,40.220001220703125,40.52999877929688,36.08928680419922,KO,"11 Dow Stocks Owned by Warren Buffett ||| The Zacks Analyst Blog Highlights: Coca-Cola, Castle Brands, Molson Coors Brewing and Dr. Pepper Snapple Group ||| PEP Named Top 25 SAFE Dividend Stock Increasing Payments For Decades ||| Warren Buffett Buys Apple, Delta Air Lines, Southwest Airlines Co, Sells Deere, Wal-Mart ... ||| 13F Roundup: Apple, Bank Of America And Other Stocks Hedge Funds Love/Hate",0,0.50788087
2017-02-15,26600800.0,40.41999816894531,40.630001068115234,40.400001525878906,40.43999862670898,36.0091438293457,KO,"Better Buy: Altria Group Inc. vs. Coca-Cola ||| Pepsi (PEP) Tops Q4 Earnings Estimates, Guides Below Market ||| Here's What Warren Buffett's Portfolio Looked Like 25 Years Ago ||| Buffett Signals Shift on Long-Standing Tech Stance With Big 4Q Apple Bet ||| How Sweet Were The Soda Pop Quarterly Prints?",1,0.4854247
2017-02-16,22214800.0,40.54999923706055,41.27999877929688,40.5,41.20000076293945,36.68589019775391,KO,"New Strong Sell Stocks for February 16th ||| Marco Investment Management Llc Buys Johnson Controls International PLC, Amgen, AbbVie, Sells ... ||| Coca-Cola Increases Qtr Dividend From $0.35/Share To $0.37/Share ||| SodaStream Has Quietly Had A Really Nice Run",1,0.49863765
2017-02-17,15065100.0,41.130001068115234,41.36000061035156,41.04999923706055,41.22999954223633,36.71259689331055,KO,"Stock Market News for February 17, 2017 ||| Coca-Cola a Top Ranked SAFE Dividend Stock With 3.6% Yield (KO) ||| Warren Buffett’s Market Indicator Reaches 130% ||| Potential Cuts To Supplemental Nutrition Assistance Program Benefits Put These Top Lines At Risk ||| Markets Turn Lower As Long Weekend Approaches, But Optimism Seems Evident",1,0.50978106
2017-02-21,17072600.0,41.20000076293945,41.5,41.20000076293945,41.459999084472656,36.91739654541016,KO,"PepsiCo Earnings Review: 53rd Week Boosts Overall Results For 2016 ||| Why The Coca-Cola Co (KO) Dividend Star is Waning ||| Better Buy: Berkshire Hathaway vs. Coca-Cola ||| 7 Dividend Stocks Increasing Payouts – KO CSCO TROW SHW ADI LLL ABX ||| Looking to Beat Inflation? Check Out These 3 Stocks ||| Stock Market News for February 21, 2017 ||| Warren Buffett's 5 Largest Stock Holdings ||| Impinj (PI) Misses Q4 Earnings Estimates, Shares Plunge ||| Diageo plc (DEO) Ex-Dividend Date Scheduled for February 22, 2017",1,0.512109
2017-02-22,11186800.0,41.5099983215332,41.68000030517578,41.400001525878906,41.59999847412109,37.04205322265625,KO,Better Buy: Coca-Cola vs. Anheuser-Busch InBev ||| Vanguard Large-Cap ETF Experiences Big Outflow ||| Smaller Cans Won't Save Coca-Cola ||| These ETFs Could Help You Trade Short-Term Moves In Defensive Sectors,1,0.5075081
2017-02-23,12856800.0,41.66999816894531,42.0,41.619998931884766,41.65999984741211,37.095481872558594,KO,"Molson Coors Brewing Company (TAP) Ex-Dividend Date Scheduled for February 24, 2017 ||| 7 Blue-Chip Stocks That Are Flush With Cash ||| Coca-Cola Exec. At CAGNY Conf. Says Co. Will Look At Downsizing Packaging In Some Areas",1,0.47275108
2017-02-24,13215300.0,41.70000076293945,41.90999984741211,41.59999847412109,41.77999877929688,37.202335357666016,KO,"MGP Ingredients, Inc. (MGPI) Ex-Dividend Date Scheduled for February 27, 2017",0,0.44025648
2017-02-27,12186400.0,41.75,41.75,41.59000015258789,41.66999816894531,37.10437774658203,KO,"Warren Buffett Owns 133 Million Shares of Apple Inc. (AAPL) ||| Why Starbucks Corporation (SBUX) Stock Is Right for Income Hunters ||| The 3 Highest Growth Consumer Goods Stocks on the Market Today ||| Warren Buffett On Active vs. Passive Investing, Outlines 'The Bet' In Berkshire Shareholder Letter ||| Warren Buffett Doubles Apple Stake, Cheers iPhone Maker's Stickiness",1,0.45520896
2017-02-28,15946800.0,41.68000030517578,42.06999969482422,41.63999938964844,41.959999084472656,37.36260986328125,KO,"Trump Headwinds Halt Dow Jones Industrial Average Hot Streak ||| The Zacks Analyst Blog Highlights: Berkshire Hathaway, American Express, Coca-Cola, Apple and Wal-Mart ||| Market Close Report: NASDAQ Composite index closes at 5,825.44 down -36.46 points ||| 3 Dividend Stocks You Don't Have to Babysit ||| Pepsico, Inc. (PEP) Ex-Dividend Date Scheduled for March 01, 2017 ||| Walmart Launches Grocery Price War: Can It Take on Aldi?",1,0.5052957
2017-03-01,14662000.0,42.0099983215332,42.34999847412109,41.880001068115234,42.15999984741211,37.54069519042969,KO,Berkshire Hathaway: Repurchase Limit Crosses $135 Per Share ||| Coca-Cola Has a Plan to Improve Soft Drink Sales ||| Monster Beverage Powers Up to Finish 2016 Strong,1,0.5260471
2017-03-02,15507600.0,42.08000183105469,42.560001373291016,42.06999969482422,42.470001220703125,37.81673431396485,KO,"Coca-Cola a Top Socially Responsible Dividend Stock With 3.5% Yield (KO) ||| Buffett's Soda Empire: If Kraft Heinz Acquired Pepsi, What Share Of The Soda Market Would 'The Oracle' Own? ||| Casualties Of The Sugar Wars: Pepsi Announces Job Cuts As Philly Soda Tax Hits Sales",1,0.5216795
2017-03-03,11740000.0,42.470001220703125,42.4900016784668,42.25,42.47999954223633,37.82564163208008,KO,Consumer Staples Select Sector SPDR Fund Experiences Big Inflow ||| How Many Shares of Apple Does Warren Buffett's Berkshire Hathaway Own? ||| Indian Dream Fizzling Out: Indian State Pulls U.S. Soft Drinks Over Water Scarcity,0,0.4940019
2017-03-06,16307800.0,42.34000015258789,42.43000030517578,42.119998931884766,42.18000030517578,37.55850601196289,KO,"How Catalysts Can Boost Your Annual Returns ||| Could Trump Impede Michelle Obama's Health Initiatives? ||| Coca-Cola Stock Is Still a Terrible Investment ||| Do Sin Taxes Really Work? ||| After Hours Most Active for Mar 6, 2017 : HST, NRG, HPE, PM, KO, GE, MNST, STKL, AAPL, FB, QQQ, EBAY ||| Invest Like Warren Buffett with These 5 Excellent Stocks",0,0.4884278
2017-03-07,11273700.0,42.0,42.2400016784668,41.95000076293945,41.9900016784668,37.38932418823242,KO,Which Is Better: Apple vs Coke,0,0.5022925
2017-03-08,14636000.0,42.0,42.02999877929688,41.7400016784668,41.9900016784668,37.38932418823242,KO,"Caterpillar, Oil Stocks Drag Dow Jones Industrial Average Lower ||| Will Innovation and Leadership Take Center Stage at Snap Inc? ||| It's Time To Sell This Classic American Stock ||| Dr Pepper Snapple: Top Line Shows Strength, Currency a Drag ||| 3 Big Stock Charts for Wednesday: Advanced Micro Devices, Inc. (AMD), Ford Motor Company (F) and The Coca-Cola Co (KO) ||| Hershey Shares Spike As Trader Chat Rooms Revive Speculation Buffett, Kraft Heinz Could Make Acquisition Bid ||| Dan Nathan Sees Unusual Options Activity In The Coca-Cola Co",1,0.48475504
2017-03-09,14496400.0,42.09000015258789,42.11000061035156,41.91999816894531,42.02999877929688,37.4249382019043,KO,"Dow Analyst Moves: KO ||| Why You Really Need to Diversify ||| Is PepsiCo (PEP) Acquiring Brazilian Diary Company Vigor? ||| Coca-Cola (KO) and Nestle to Dissolve Tea Joint Venture ||| Dr Pepper Snapple Group, Inc (DPS) Ex-Dividend Date Scheduled for March 10, 2017 ||| Coca-Cola Bottling (COKE) Q4 Earnings, Revenues Rise Y/Y ||| Up 13% Since Its Latest Report, Monster Beverage Still Has Plenty of Room to Run ||| Competition Only Helps Apple Ripen, An Advantage Over The FANG Stocks",1,0.48528838
2017-03-10,16369700.0,42.22999954223633,42.400001525878906,42.150001525878906,42.290000915527344,37.65646362304688,KO,"The 2 Worst Dividend Aristocrats to Buy Now ||| Coca-Cola Company (KO) Ex-Dividend Date Scheduled for March 13, 2017 ||| What Percentage of Coca-Cola Does Warren Buffett Own?",0,0.4781837
2017-03-13,12831500.0,41.91999816894531,42.119998931884766,41.84000015258789,42.02999877929688,37.75526809692383,KO,"VYM, KO, MO, COP: ETF Outflow Alert ||| 7-Point Checklist For Buying Your First Stock ||| One Put, One Call Option To Know About for Coca-Cola ||| Carter Worth And Mike Khouw's Coca-Cola Trade",0,0.49825537
2017-03-14,9844500.0,41.97999954223633,42.09999847412109,41.83000183105469,41.970001220703125,37.70137023925781,KO,"Better Buy: The Coca-Cola Co vs. Reynolds American, Inc. ||| Warren Buffett's Top 10 Dividend Stocks ||| Best Performing Stocks of All Time",1,0.4934019
2017-03-15,22757800.0,41.97999954223633,42.27999877929688,41.970001220703125,42.119998931884766,37.83610916137695,KO,"Coca-Cola Bottling Hits 52-Week High, Joins S&P SmallCap 600 ||| Dunkin' Brands Long-term View Bright, Headwinds Persist",1,0.5088299
2017-03-16,16004200.0,42.02999877929688,42.38999938964844,41.900001525878906,42.25,37.952884674072266,KO,Why You Should Pay More for Quality Stocks,0,0.5129307
2017-03-17,37526500.0,42.27999877929688,42.34999847412109,42.0099983215332,42.02999877929688,37.75526809692383,KO,"WPP: Inorganic Growth on Track, Set to Expand in Europe ||| 4 Consumer Stocks to Buy Before They Move Higher ||| How to Invest in Stocks for Beginners",1,0.52320915
2017-03-20,11484200.0,42.09999847412109,42.34000015258789,42.06999969482422,42.18000030517578,37.89000701904297,KO,"Beverage Giants Continue to Shift Gears as Bottled Water Consumption Surpassed Soda in 2016 ||| Should Coke And Pepsi Move Into The Hard Soda Biz? ||| Zacks Investment Ideas feature highlights: McDonald's, Coke and Etrade ||| Benzinga's Premarket Prep Host Dennis Dick Tweets: Notable opening imbalances: $BAC -984K, $JPM -86K, $PFE +115K, $BABA +54K, $GE -88K, $KO +72K, $NKE +64K",1,0.502011
2017-03-21,17187300.0,42.310001373291016,42.630001068115234,42.209999084472656,42.5,38.177467346191406,KO,"What’s the Key to a Long-Term Competitive Advantage? ||| How to Invest in Stocks for Beginners ||| These 3 Stocks Just Raised Their Dividends ||| After Hours Most Active for Mar 21, 2017 : LYG, KBWB, KO, NOK, JPM, GPK, FTR, GE, FB, CMCSA, MSFT, EBAY ||| VT, NSRGY, NVS, KO: Large Inflows Detected at ETF ||| Market Close Report: NASDAQ Composite index closes at 5,793.83 down -107.70 points ||| Benzinga's Top Upgrades, Downgrades For March 21, 2017 ||| National Beverage Could Be A Major Beneficiary Of The Sugar Tax ||| JP Morgan Initiates Coverage On Coca-Cola With Neutral, Announces $43 Price Target",0,0.46563345
2017-03-22,11605500.0,42.560001373291016,42.70000076293945,42.25,42.380001068115234,38.06966781616211,KO,Guy Adami And David Seaburg Share Their Thoughts On Altria And Coca-Cola,0,0.52056205
2017-03-23,11503300.0,42.209999084472656,42.38999938964844,42.060001373291016,42.16999816894531,37.88102340698242,KO,US Market Indexes Lower With Losses Led by Energy Stocks ||| The Business Of Clean Water ||| The Coca-Cola Company Names Francisco Crespo Chief Growth Officer,0,0.505362
2017-03-24,13804400.0,42.22999954223633,42.25,41.90999984741211,42.119998931884766,37.83610916137695,KO,"3 Stocks You Don't Have to Babysit ||| Pioneer Investments Exits Wells Fargo, Coca-Cola, Buys Walt Disney ||| Household Names JPMorgan Initiated Ratings On This Week",1,0.5071586
2017-03-27,12387400.0,42.11000061035156,42.34000015258789,42.04999923706055,42.31999969482422,38.01576614379883,KO,"Interesting November Stock Options for KO ||| 3 Dividend Champions We Refuse to Buy ||| Dow Movers: GS, WMT ||| What Makes a Competitive Advantage Durable? ||| Here's Every Major Corporation That's Pulled Ads From YouTube",1,0.5010172
2017-03-28,14123800.0,42.2400016784668,42.560001373291016,42.2400016784668,42.43000030517578,38.11458206176758,KO,Warren Buffett on the Importance of Moats ||| Don’t Fall Into the Value Investing Trap,0,0.51164216
2017-03-29,9580100.0,42.5099983215332,42.52999877929688,42.290000915527344,42.41999816894531,38.10559844970703,KO,"Coca-Cola (KO) Diversifies with Unilever's AdeS Acquisition ||| CinemaCon Conference Continues Today; Presenters Include Regal Entertainment, Cinemark, Sony, Coca-Cola, Twentieth Century Fox, Time Warner, Imax, & Comcast",1,0.50520885
2017-03-30,11999900.0,42.34999847412109,42.619998931884766,42.2599983215332,42.59999847412109,38.26728820800781,KO,"XLP, KO, MO, WMT: Large Inflows Detected at ETF",0,0.52758306
2017-03-31,11551800.0,42.54999923706055,42.650001525878906,42.43000030517578,42.43999862670898,38.12356185913086,KO,What Is Dr Pepper Snapple's Revenue And EBITDA Breakdown? ||| What Is Dr Pepper Snapple’s Fundamental Value Based On Expected 2017 Results? ||| 5 “Dead Money” Dividend Aristocrats To Avoid ||| You Avoided Under Armour: Here's Why National Beverage Is the Next Bubble Stock to Avoid,0,0.48180836
2017-04-03,11240000.0,42.58000183105469,42.630001068115234,42.27000045776367,42.40999984741211,38.09661483764648,KO,"3 Top Dividend Stocks in Soda ||| 50 Advertisers Boycott YouTube Advertising, And It Won't Mean More Than A 1% Dip In Google's Top Line ||| AB InBev (BUD) Sells SABMiller Assets to Japan's Asahi Group ||| Here's What To Expect From This Year's World Retail Congress ||| Yahoo Finance Reporter Daniel Roberts Tweets: Coke is the new soft drink sponsor of Major League Baseball, replacing Pepsi. It had been Pepsi since 1997. $KO ||| Benzinga Premarket Prep Host Dennis Dick Tweets: Notable opening imbalances: $PFE -243K, $MRK -93K, $BABA +115K, $KO +104K, $T +111K, $CAT -55K, $IBM -42K",1,0.55967385
2017-04-04,10946200.0,42.5099983215332,42.68999862670898,42.369998931884766,42.68000030517578,38.33915328979492,KO,"Warren Buffett: Coke's New Pitchman ||| Coca-Cola Inks Deal with MLB, Becomes Official Soft Drink ||| Warren Buffett Appears on Cherry Coke Cans in China",0,0.50390565
2017-04-05,10142800.0,42.650001525878906,42.86000061035156,42.52999877929688,42.56999969482422,38.2403450012207,KO,"Coca-Cola European Partners plc (CCE) Ex-Dividend Date Scheduled for April 06, 2017 ||| Benzinga's Option Alert Recap From April 5 ||| Option Alert: Coca-Cola Apr 28th 44.0 Calls Sweep: 651 @ ASK $0.14: 651 traded vs 44 OI: Earnings 4/25 Before Open $42.83 Ref ||| World Retail Congress Continues Today; Presenters Include PVH, Estee Lauder's Jo Malone, Facebook, And Coca-Cola",1,0.49012226
2017-04-06,14597800.0,42.58000183105469,42.7599983215332,42.470001220703125,42.66999816894531,38.33018112182617,KO,"Rathbone Brothers plc Buys Sherwin-Williams Co, Alphabet, Global Payments, Sells Reynolds ... ||| After Hours Most Active for Apr 6, 2017 : SYF, V, MFC, JBL, INTC, KO, TRCO, FB, TMUS, PYPL, SPLS, AAPL ||| 4 Reasons PepsiCo Is a Better Dividend Stock Than The Coca-Cola Company ||| Watch These 8 Huge Call Purchases In Thursday Trade",0,0.4848995
2017-04-07,11028800.0,42.63999938964844,42.7400016784668,42.5099983215332,42.61000061035156,38.27627944946289,KO,Why FEMSA (FMX) Stock Should Be Part of Your Portfolio Now ||| By What Percentage Have PepsiCo’s Revenues And EBITDA Grown Over The Last Five Years?,1,0.49712545
2017-04-10,9426900.0,42.72999954223633,42.79999923706055,42.560001373291016,42.68999862670898,38.34813690185547,KO,3 Top Soda Stocks to Buy in 2017 ||| Better Buy: Berkshire Hathaway Inc. vs. The Coca-Cola Co ||| Jim Cramer Weighs In On Centurylink And Coca-Cola,0,0.52733666
2017-04-12,13417200.0,42.540000915527344,42.9900016784668,42.5099983215332,42.93999862670898,38.57270431518555,KO,"Better Buy: The Coca-Cola Co. vs. Philip Morris International ||| After Hours Most Active for Apr 12, 2017 : F, T, INTC, PFE, CSCO, GM, XOM, KO, MAT, QCOM, JD, SIRI ||| 3 Stocks You'll Want to Pass on to Your Grandkids Someday ||| Pre-Market Imbalance Update: Berkshire Hathaway 55K Shares to Buy, GE 34K Shares to Sell, Coca-Cola 20K to Sell ||| The Most Likely Targets For A Kraft Heinz Deal: Mondelez Or Pepsi ||| Watch These 5 Huge Call Purchases In Wednesday Trade",0,0.46944383
2017-04-13,9891900.0,42.869998931884766,43.08000183105469,42.77999877929688,42.790000915527344,38.43796157836914,KO,Why Charlie Munger Hates Value Investing,1,0.5015723
2017-04-17,11318100.0,42.790000915527344,43.06999969482422,42.77999877929688,43.06999969482422,38.689491271972656,KO,"Capital City Trust Co Buys Enbridge, Vanguard High Dividend Yield ETF - DNQ, iShares Core ... ||| Rating the CEOs of Warren Buffett's Stocks ||| After Hours Most Active for Apr 17, 2017 : WWE, F, BAC, NFLX, MSFT, KO, ORCL, INTC, CMCSA, GM, TRIP, ATVI",1,0.47541907
2017-04-19,13893100.0,43.7400016784668,43.790000915527344,43.18999862670898,43.22999954223633,38.83321380615234,KO,"September 15th Options Now Available For Coca-Cola (KO) ||| Coca-Cola (KO) Brings Popular ""Share a Coke"" Program Back ||| The Market In 5 Minutes ||| Benzinga's Top Upgrades, Downgrades For April 19, 2017 ||| Credit Suisse Upgrades Coca-Cola to Outperform",0,0.4842676
2017-04-21,13833800.0,42.97999954223633,43.09999847412109,42.88999938964844,43.06999969482422,38.689491271972656,KO,"Top Research Reports for Today: VZ, KO, SBUX ||| Should You Expect a Beat from Coca-Cola (KO) in Q1 Earnings ||| Why Hormel Foods Corp (HRL) Stock Is a Better Buy Than The Coca-Cola Co (KO) ||| National Beverage Valuation Has Bubbled Too High ||| Pre-Market Imbalance Update (Note These Will Be More Volatile Because Of Options Expiration): Nike 211K Shares to Sell, Coca-Cola 205K Shares to Sell",1,0.49277145
2017-04-24,16703800.0,43.2400016784668,43.43000030517578,43.150001525878906,43.27999877929688,38.87813186645508,KO,"Coca-Cola will report Q1 results ||| S&P Global (SPGI) to Post Q1 Earnings: A Beat in the Cards? ||| Vanguard Growth ETF Experiences Big Inflow ||| Dr Pepper Snapple (DPS) Q1 Earnings: A Beat in the Cards? ||| Top Ranked Momentum Stocks to Buy for April 24th ||| Will Beverage Stocks KO & AKO.B Add Fizz to Q1 Earnings? ||| The Zacks Analyst Blog Highlights: Verizon, Coca Cola, Starbucks, Danaher and Express Scripts ||| Interesting January 2019 Stock Options for KO ||| Can Procter & Gamble (PG) Spring a Surprise in Q3 Earnings? ||| Pre-Market Earnings Report for April 25, 2017 : KO, MMM, MCD, LLY, LMT, DD, BIIB, CAT, SPGI, VLO, GLW, BHI ||| The Hershey Company (HSY): Disappointment in the Cards? ||| TransUnion (TRU) Q1 Earnings: What's in Store this Time? ||| United Technologies (UTX) Q1 Earnings: What's in Store? ||| Earnings: Caterpillar, Lockheed Martin, and Eli Lilly Report Tomorrow ||| Earnings Preview: McDonald's, Coca-Cola, And Chipotle Report Q1 ||| Spell Out Relief: French Vote As Expected, So Attention Turns To Earnings, Tax Reform",0,0.49128798
2017-04-25,18745100.0,42.84999847412109,43.43000030517578,42.81999969482422,43.11000061035156,38.72542190551758,KO,"PepsiCo (PEP) Q1 Earnings: Will it Pull Off a Surprise? ||| Coca-Cola (KO) Q1 Earnings Miss, Refranchising Costs Hurt ||| Coca-Cola Bottling Co. Consolidated (COKE) Ex-Dividend Date Scheduled for April 26, 2017 ||| Earnings Reaction History: The Coca-Cola Company, 27.3% Follow-Through Indicator, 1.5% Sensitive ||| Coke Layoffs: The Coca-Cola Co (KO) to Cut 1,200 Jobs After Weak Q1 ||| Coca-Cola (KO) Misses on Q1 Earnings, Beats Revenue ||| Coca-Cola Incoming CEO On Sugar Tax, Says 'If governments need money, they should widen their tax bases'; Says Most of 1,200 Job Reductions Will Be In Atlanta ||| 8 Technical Levels From Tuesday's PreMarket Prep ||| Eying 6,000: Nasdaq Close To New Big Number As Relief Rally Seen Continuing ||| Coca-Cola's Stock Unmoved After Mixed Q1 Report ||| Coca-Cola Sees FY 2017 EPS Down 1% to 3% YoY ||| Coca-Cola Reaffirms 3% Organic Revenue Growth ||| Coca-Cola Q1 EPS $0.43 vs $0.44 Est, Sales $9.12B vs $8.89B Est ||| 15 Stocks To Watch For April 25, 2017 ||| Earnings Scheduled For April 25, 2017",1,0.47490436
2017-04-26,13626600.0,43.060001373291016,43.43000030517578,42.97999954223633,43.2400016784668,38.84220504760742,KO,"Stock Market News for April 26, 2017 ||| Top Research Reports for Today: MCD, KO, TMUS ||| Q1 Earnings Season Shows Broad-based Momentum ||| Q1 Earnings Season Shows Broad-based Momentum ||| How Ad Companies Have Responded To A Changing Media Landscape",0,0.5119893
2017-04-27,10386200.0,43.16999816894531,43.27999877929688,42.91999816894531,43.0099983215332,38.635589599609375,KO,"The Zacks Analyst Blog Highlights: McDonald's, Coca-Cola, T-Mobile, PPG Industries and Corning ||| Coca Cola Femsa S.A.B. de C.V. (KOF) Ex-Dividend Date Scheduled for April 28, 2017 ||| Coca-Cola's Structural Changes Eat Away At Profits, But Big Plans Ahead To Improve Efficiency ||| Dr Pepper Falls Short Of Revenue Estimates But Raises EPS Guidance ||| Cliffs Natural Resources Inc (CLF) Stock Digging Itself a Deep Hole ||| 3 Stocks That Could Have Doubled Your Money ||| Zacks Earnings Trends Highlights: Caterpillar, DuPont, McDonald's, Coke and Procter & Gamble",1,0.4688756
2017-04-28,10337800.0,42.959999084472656,43.20000076293945,42.84999847412109,43.150001525878906,38.761356353759766,KO,"Home Market And Healthier Options Boost PepsiCo's Q1 Results ||| Anheuser-Busch Inbev SA (BUD) Ex-Dividend Date Scheduled for May 01, 2017 ||| Dow 30 Stock Roundup: 3M, DuPont, GE Beat; Coke Disappoints ||| What Donald Trump And Warren Buffett Have In Common ||| Coca-Cola, Starbucks, Under Armour: Fast Money Picks For April 28",1,0.4790387
2017-05-01,13208200.0,43.150001525878906,43.5,43.09999847412109,43.220001220703125,38.8242301940918,KO,"Interesting September Stock Options for KO ||| The Zacks Analyst Blog Highlights: JPMorgan Chase, 3M, Boeing, Coca-Cola and DuPont ||| Fomento Economico Mexicano S.A.B. de C.V. (FMX) Ex-Dividend Date Scheduled for May 02, 2017 ||| FEMSA (FMX) Lags Earnings and Revenues in Q1, Stock Gains ||| Benzinga's Bulls And Bears For The Week: Chipotle, IBM, Under Armour And More ||| Pre-Market Imbalance Update: AT&T 397K Shares to Sell, Verizon 213K to Sell, Pfizer 152K to Sell, Twitter 145K Shares to Buy, Coca-Cola 123K to Sell",1,0.493611
2017-05-02,11823900.0,43.220001220703125,43.43999862670898,43.15999984741211,43.38999938964844,38.97694396972656,KO,"Monster (MNST) Q1 Earnings: Is Disappointment in the Cards? ||| Beverage Stocks to Report Q1 Earnings this Week: TAP, BUD ||| IVE, KO, AGN, MDLZ: Large Outflows Detected at ETF ||| Facebook Inc (FB) Stock Deserves Its Record High — And More ||| Here's Why Monster Has Little Upside Going Into Earnings",0,0.478225
2017-05-03,10389000.0,43.33000183105469,43.4900016784668,43.150001525878906,43.31999969482422,38.914058685302734,KO,"Soft Drink Stocks' Q1 Earnings Due on May 4: MNST, CCE, COT ||| Coca-Cola European Partners (CCE) Q1 Earnings: What's Up? ||| Pre-Market Imbalance Update: BofA 232K Shares to Sell, Ford 222K Shares to Buy, Twitter 145K to Buy, JP Morgan 87K to Sell, Coca-Cola 59K to Sell, ExxonMobil 35K to Buy, Chevron 14K to Buy",1,0.49347925
2017-05-04,10193100.0,43.41999816894531,43.810001373291016,43.400001525878906,43.65999984741211,39.219482421875,KO,Monster Beverage Deals With Seasonal Sluggishness,1,0.5238653
2017-05-05,8133000.0,43.790000915527344,43.84000015258789,43.560001373291016,43.68999862670898,39.24642562866211,KO,"Constellation Brands Inc (STZ) Ex-Dividend Date Scheduled for May 08, 2017 ||| 4 Tech Stock Juggernauts That Are the New ‘Nifty 50’ ||| Shares of IBM Slide After Warren Buffett Cuts Stake By a Third ||| S&P Dividend Aristocrats: Which Stocks Make the List? ||| Monster Beverage (MNST) Q1 Earnings, Revenues Top Estimates",1,0.48563606
2017-05-08,14284300.0,43.59000015258789,43.90999984741211,43.540000915527344,43.88999938964844,39.42608642578125,KO,"Uber Vs. Lyft: Most Dynamic Clash Since Pepsi And Coke ||| Trade of the Day: Monster Beverage Corporation (MNST) Can Return 17% ||| After Hours Most Active for May 8, 2017 : XRX, PFE, YHOO, SRC, DDR, KO, JNPR, AAPL, MSFT, MNST, ADI, CSX",0,0.4769885
2017-05-09,8694400.0,43.88999938964844,43.88999938964844,43.380001068115234,43.5099983215332,39.08473587036133,KO,6 Companies Paying Warren Buffett at Least $48 Million in Dividend Income Each Quarter ||| Detroit Entrepreneur Launches Superinfused Beverages As A Healthy Soft Drink Alternative,1,0.50720555
2017-05-10,7597700.0,43.47999954223633,43.619998931884766,43.36000061035156,43.56999969482422,39.13864135742188,KO,"Sodastream International Ltd (SODA) Sparkles With 141% Earnings Jump ||| Coca-Cola Bottling (COKE) Q1 Earnings Flat, Revenues Grow ||| The Market In 5 Minutes",1,0.5384044
2017-05-11,6860100.0,43.4900016784668,43.68000030517578,43.43000030517578,43.66999816894531,39.228458404541016,KO,Better Buy: International Business Machines Corporation vs. Coca-Cola,0,0.5215247
2017-05-12,7275800.0,43.63999938964844,43.68000030517578,43.459999084472656,43.59000015258789,39.15660858154297,KO,"Top Picks For The Rest Of 2017, Courtesy Of UBS",1,0.52295816
2017-05-15,8493000.0,43.459999084472656,43.7599983215332,43.459999084472656,43.72999954223633,39.28236389160156,KO,Pete Najarian Sees Unusual Options Activity In Coca-Cola,1,0.5421731
2017-05-16,10454100.0,43.869998931884766,44.11000061035156,43.77000045776367,43.84999847412109,39.3901596069336,KO,3 Top Packaged Foods Companies to Buy in 2017 ||| Where Does Apple's Stock Go From Here?,1,0.5175792
2017-05-17,14538800.0,43.84999847412109,44.16999816894531,43.709999084472656,43.93000030517578,39.4620246887207,KO,"Warren Buffett Buys Apple Inc, Bank of New York Mellon Corp, Sells International Business ... ||| Coca-Cola European Partners plc (CCE) Ex-Dividend Date Scheduled for May 18, 2017",0,0.43944138
2017-05-18,13832200.0,43.869998931884766,43.959999084472656,43.63999938964844,43.79999923706055,39.34524154663086,KO,"Better Buy: Procter & Gamble Company vs. Coca-Cola ||| Noteworthy ETF Outflows: IWF, KO, LOW, NKE",1,0.49800998
2017-05-19,11796800.0,43.84999847412109,44.0,43.7599983215332,43.900001525878906,39.43507766723633,KO,Better Buy: Coca-Cola vs. Pepsi ||| PepsiCo's (PEP) Cost-Cut Efforts to Impress Amid Macro Woes ||| 4 Stocks I'll Hold Forever ||| Why Facebook Inc (FB) Stock Will Always Be King,1,0.48071143
2017-05-22,12857900.0,43.88999938964844,44.220001220703125,43.810001373291016,44.18000030517578,39.68659591674805,KO,Putting Some Spice In The Consumer Staples Trade,1,0.5507955
2017-05-23,11996100.0,44.25,44.59999847412109,44.209999084472656,44.38999938964844,39.87524032592773,KO,"Dow Movers: GS, NKE ||| After Hours Most Active for May 23, 2017 : HPE, QQQ, WFM, GE, BAC, NLY, ODP, EXC, KO, MSFT, AAPL, CSCO",1,0.4762085
2017-05-24,12738300.0,44.5099983215332,45.09000015258789,44.5099983215332,45.02999877929688,40.45013427734375,KO,"Better Buy: PepsiCo, Inc. vs. Kimberly-Clark Corp ||| US Market Indexes Higher on Wednesday, S&P 500 Reaches New High ||| 3 Dow Jones Stocks to Buy for a 2017 Breakout ||| Coca-Cola Reports Co. is 'moving closer to completing the refranchising of its Company-owned territories in the United States'",1,0.50680745
2017-05-25,16704200.0,45.0,45.47999954223633,44.970001220703125,45.40999984741211,40.79149627685547,KO,"Dow Analyst Moves: KO ||| Molson Coors Brewing Company (TAP) Ex-Dividend Date Scheduled for May 26, 2017 ||| After Hours Most Active for May 25, 2017 : HPE, KO, OZRK, JNPR, MSFT, XOM, DFS, ALXN, BMY, CTSH, JD, CMCSA ||| Position Sizing With the Kelly Criterion ||| Benzinga's Option Alert Recap From May 25 ||| Option Alert: Coca Cola Jan18 47.0 Calls Sweep: 994 @ ASK $0.93: 5173 traded vs 11k OI: Earnings 7/25 Before Open (est) $45.04 Ref",0,0.48511687
2017-05-26,11341400.0,45.34999847412109,45.560001373291016,45.33000183105469,45.38999938964844,40.77353286743164,KO,"KO September 2018 Options Begin Trading ||| IWB, PM, KO, C: ETF Inflow Alert ||| Coca-Cola (KO) Up 4.1% Since Earnings Report: Can It Continue? ||| KO Crosses Above Average Analyst Target ||| Watch These 8 Huge Call Purchases In Friday Trade",1,0.49419254
2017-05-30,13093500.0,45.15999984741211,45.459999084472656,45.11000061035156,45.43000030517578,40.80946731567383,KO,"9 Stocks That Made Warren Buffett Billions Over the Past Year ||| 3 Top Dividend Stocks in Consumer Staples ||| Pepsico, Inc. (PEP) Ex-Dividend Date Scheduled for May 31, 2017 ||| Cott Corporation (COT) Ex-Dividend Date Scheduled for May 31, 2017 ||| How Coca-Cola Makes Most of Its Money ||| After Hours Most Active for May 30, 2017 : BRCD, GE, MAT, NBL, BAC, SYF, KO, HPQ, EXTR, CTSH, NVDA, PYPL",1,0.48479518
2017-05-31,14148000.0,45.43000030517578,45.70000076293945,45.369998931884766,45.470001220703125,40.84539031982422,KO,"Warren Buffett Buys Apple Inc, Bank of New York Mellon Corp, Sells International Business ... ||| PepsiCo (PEP) Scales a 52-Week High on Healthy Prospects ||| 2 ETFs On Breakout Watch Hold Buffett Dividend Stocks ||| Pre-Market Imbalance Update: Ford 258K Shares to Buy, BofA 198K Shares to Sell, Coca-Cola 90K to Sell, Alibaba 51K to Sell, JP Morgan 47K to Sell, Citi 46K to Sell, Twitter 29K to Sell",1,0.49720088
2017-06-01,11049300.0,45.45000076293945,45.790000915527344,45.22999954223633,45.790000915527344,41.13284683227539,KO,Monster Beverage Remains A Top Pick At Jefferies,1,0.526443
2017-06-02,9923700.0,45.83000183105469,45.88999938964844,45.61000061035156,45.88999938964844,41.22268295288086,KO,3 Dividend Aristocrats That Deserve the Title … and 2 Pretenders,1,0.5408583
2017-06-05,10015200.0,45.77999877929688,45.9900016784668,45.68999862670898,45.9900016784668,41.31250762939453,KO,"Better Buy: McDonald's Corp. vs. Coca-Cola ||| Benzinga's Bulls And Bears For The Past Week: McDonald's, Ford, BlackBerry And More ||| One Put, One Call Option To Know About for Coca-Cola ||| After Hours Most Active for Jun 5, 2017 : F, MSFT, BAC, V, JNPR, BLL, KO, PYPL, AAPL, ADSK, INTC, SBUX ||| Sugar Standoff: U.S. & Mexico Race To Ink Deal On Exports To Head Off Higher Prices ||| Height Securities Highlights Today Is Deadline For U.S. & Mexico To Announce Sugar Export Agreement Before Dept. Of Commerce Triggers Antidumping Duties Of Up To 80%",0,0.47017726
2017-06-06,9836700.0,45.900001525878906,46.060001373291016,45.77999877929688,45.97999954223633,41.30352020263672,KO,Why Monster Beverage Corporation Stock Rose 11% Last Month ||| Want Market-Beating Dividends? These 2 ETFs Own Buffett Stocks ||| Shares Of Pepsi and Coca-Cola Slightly Lower Premarket; Yesterday Seattle City Council Voted To Impose Tax On Sugary Drinks Beginning In July,0,0.48420474
2017-06-07,12776300.0,45.5,45.70000076293945,45.34999847412109,45.5099983215332,40.881324768066406,KO,"PepsiCo and Coca-Cola Downgraded: What You Need to Know ||| Dow Movers: KO, NKE ||| Market Close Report: NASDAQ Composite index closes at 6,297.38 up 22.32 points ||| Analyst: Dr. Pepper And Cott Ready To Bubble Higher, Coke And Pepsi Potential Fizzles ||| Sugar Taxes To Trade Agreements: Good News, Bad News This Week For Cola Companies ||| Benzinga's Top Upgrades, Downgrades For June 7, 2017 ||| The Market In 5 Minutes ||| Pre-Market Imbalance Update: Alibaba 114K Shares to Buy, BofA 95K Shares to Buy, Coca-Cola 91K to Sell, Twitter 21K to Sell ||| BMO Capital Downgrades Coca-Cola to Market Perform, Announces $46.00 Price Target",0,0.49260762
2017-06-08,12879000.0,45.5099983215332,45.5099983215332,45.02999877929688,45.130001068115234,40.53997039794922,KO,"5 Beverage Stocks to Stay Cool this Summer ||| 3 Stocks to Buy With Dividends Yielding 3% or More ||| A Market Foolery Picnic With Soda, Beer, and (Silicon) Chips ||| 5 Beverage Stocks to Stay Cool this Summer",1,0.5007799
2017-06-09,9358800.0,45.060001373291016,45.34999847412109,44.970001220703125,45.31999969482422,40.71065521240234,KO,"Ex-Dividend Reminder: Leggett & Platt, Coca-Cola and Altria Group ||| Dr Pepper Snapple Group, Inc (DPS) Ex-Dividend Date Scheduled for June 12, 2017 ||| Warren Buffett’s 7 Best Dividend Stocks for Retirement",1,0.46399495
2017-06-12,11228500.0,45.31999969482422,45.47999954223633,45.20000076293945,45.33000183105469,40.71963882446289,KO,"5 Lessons on Failure From Tremendously Successful CEOs ||| Interesting November Stock Options for KO ||| Coca-Cola Company (KO) Ex-Dividend Date Scheduled for June 13, 2017 ||| The Investors’ Version of the Pepsi Challenge Has a Clear Winner ||| Noteworthy Monday Option Activity: UPS, R, KO",0,0.51812667
2017-06-13,10023400.0,45.0,45.11000061035156,44.79999923706055,45.02999877929688,40.78302764892578,KO,"3 Growth Stocks You Should Consider Today ||| Traders Ditch Tech For Calmer Waters ||| Benzinga's Top Upgrades, Downgrades For June 13, 2017 ||| Daiwa Capital Initiates Coverage On Coca-Cola with Outperform Rating, Announces $48.60 Price Target",1,0.5294592
2017-06-14,11497500.0,45.18000030517578,45.470001220703125,45.15999984741211,45.29999923706055,41.027565002441406,KO,"Why Most Stocks Are Stinkers (and What You Can Do About It) ||| Goldman Sachs, Home Depot Lift Dow to New Highs ||| After Hours Most Active for Jun 14, 2017 : YHOO, ZNGA, MU, SBGL, FOXA, ETE, STLD, HLT, BABA, NRZ, KO, QQQ ||| Here are the Key Differences Between the Dow and the S&P 500",0,0.46122232
2017-06-15,9908700.0,45.18000030517578,45.34000015258789,45.040000915527344,45.25,40.98228454589844,KO,FEMSA's (FMX) Strategic Measures Drive Growth: Time to Hold? ||| Implications Of The Fed's Rate Hike And What To Do ||| Want Market-Beating Dividends? These 2 ETFs Own Buffett Stocks ||| Why The Coca-Cola Co Is a Top 25 Dividend Giant (KO) ||| FEMSA's (FMX) Strategic Measures Drive Growth: Time to Hold?,1,0.491372
2017-06-16,27025300.0,45.310001373291016,45.34999847412109,45.0099983215332,45.310001373291016,41.03662109375,KO,"Consumer Sector Update for 06/16/2017: WMT, MCD, DIS, CVS, KO, CCL, CUK, TLRD, SONC ||| 3 Vanguard ETFs to Buy for Growth, Growth, Growth! ||| Mattel Dividend Cut",1,0.4724131
2017-06-19,7624700.0,45.34999847412109,45.380001068115234,45.09999847412109,45.380001068115234,41.10002136230469,KO,"One Put, One Call Option To Know About for Coca-Cola ||| Noteworthy ETF Outflows: SSO, V, KO, BMY ||| The 7 Most Important Terms for Any Beginning Investor",1,0.49208754
2017-06-20,14920900.0,45.34999847412109,45.869998931884766,45.31999969482422,45.61000061035156,41.30833053588867,KO,"Consumer Sector Update for 06/20/2017: WMT, MCD, DIS, CVS, KO, FCAU, CMG ||| 6 Things You Didn't Know About Coca-Cola ||| UBS Is Cautious On Hain Celestial, Campbell Soup And Conagra Following Whole Foods Deal",0,0.47700638
2017-06-21,9515800.0,45.619998931884766,45.68000030517578,45.16999816894531,45.220001220703125,40.955116271972656,KO,"Monster Beverage Is 'Best In Class,' Remains A Top Pick At Credit Suisse",0,0.4990352
2017-06-22,7446300.0,45.16999816894531,45.27999877929688,45.02999877929688,45.06999969482422,40.81925964355469,KO,The Most Important Dividend Stock Charts You'll Ever See,1,0.51396245
2017-06-23,9544800.0,45.04999923706055,45.380001068115234,45.02999877929688,45.25,40.98228454589844,KO,"Dow Movers: NKE, PG ||| Consumer Sector Update for 06/23/2017: WMT, MCD, CVS, KO, DIS, FINL, MCD, HOG ||| What the Dasani Tap-Water Scandal Can Teach Investors ||| Pre-Market Imbalance Update: GE 213K Shares To Buy, Ford 127K Shares To Sell, Coca-Cola 49K To Sell, Twitter 28K To Sell, Square 13K To Buy",1,0.47539538
2017-06-26,7747100.0,45.31999969482422,45.5099983215332,45.29999923706055,45.43000030517578,41.14530944824219,KO,Interesting January 2019 Stock Options for KO ||| How Far Could LaCroix Drive National Beverage? ||| Lower For Longer: 3 Ways To Combat Low Rates ||| What Does Warren Buffett Have To Do With The Amazon-Whole Foods Merger?,0,0.48151666
2017-06-28,9218800.0,45.25,45.5,45.22999954223633,45.31999969482422,41.04568099975586,KO,"VUG, KO, DIS, MMM: ETF Inflow Alert",0,0.5280014
2017-06-29,9283500.0,45.130001068115234,45.2400016784668,44.650001525878906,44.83000183105469,40.60189437866211,KO,Coca-Cola Has Reached Deal With South African Gov't Related To A Package Of Conditions Addressing Public Interest Considerations For Deal To Buy Majority Stake In Coca-Cola Beverages South Africa ||| Coca-Cola India to Offer Cheaper Soft Drinks to Compete with Smaller Companies -Times of India,1,0.5001136
2017-06-30,9352800.0,44.88999938964844,45.119998931884766,44.84999847412109,44.84999847412109,40.62000274658203,KO,Diversification Is Becoming More Important Than Ever,0,0.50472105
2017-07-03,6434500.0,45.11000061035156,45.27000045776367,44.7599983215332,44.7599983215332,40.53849792480469,KO,I Still Can't Believe Coca-Cola Spent $2 Billion on Keurig ||| 3 Top Warren Buffett Stocks to Buy for Retirement Now ||| Buffett Uses This Simple Strategy To Boost Returns By 10 Percent ||| Buffett Uses This Simple Strategy To Boost Returns By 10% ||| These Are America's Most Patriotic Brands,1,0.49300614
2017-07-05,6853600.0,44.790000915527344,44.9900016784668,44.72999954223633,44.81999969482422,40.59284591674805,KO,"16 Stock Picks With Staying Power ||| Consumer Sector Update for 07/05/2017: WMT, MCD, DIS, CVS, KO, GM, TSLA ||| Better Buy: Altria Group Inc. vs. Coca-Cola ||| PepsiCo, Inc. Earnings Preview: Numbers and Key Themes to Watch",0,0.48193324
2017-07-06,13113000.0,44.720001220703125,44.84999847412109,44.290000915527344,44.400001525878906,40.21244430541992,KO,"Consumer Sector Update for 07/06/2017: YUMC, F, LB, KO, CVS, DIS, MCD, WMT ||| Pre-Market Imbalance Update: Sprint 84K Shares To Buy, GE 80K Shares To Sell, Twitter 41K To Sell, Coca-Cola 37K To Sell, P&G 35K To Buy, Citi 28K To Buy, BofA 26K To Buy, Wells Fargo 25K To Buy, J&J 22K To Sell",0,0.4626262
2017-07-07,9566000.0,44.470001220703125,44.52000045776367,44.2400016784668,44.38999938964844,40.203399658203125,KO,PepsiCo (PEP) Q2 Earnings: Is Disappointment in the Cards?,0,0.49271995
2017-07-10,9672000.0,44.45000076293945,44.58000183105469,44.22999954223633,44.380001068115234,40.19433975219727,KO,"Better Buy: Coca-Cola vs. Reynolds American ||| Interesting September Stock Options for KO ||| Does PepsiCo, Inc. (PEP) Still Have Its Head in the Game? ||| PEP Stock – Why Pepsico Might Surprise This Earnings Season ||| Pre-Market Imbalance Update: GE 94K Shares To Sell, Coca-Cola 37K To Sell, BP 35K To Sell, Alibaba 12K Shares To Buy",0,0.50189644
2017-07-11,10300700.0,44.31999969482422,44.47999954223633,44.150001525878906,44.33000183105469,40.14905548095703,KO,"PepsiCo (PEP) Beats on Q2 Earnings & Revenues, Guides Up",1,0.52436626
2017-07-12,7737400.0,44.59000015258789,44.77000045776367,44.43999862670898,44.5099983215332,40.31206893920898,KO,"Here's Why FEMSA (FMX) Deserves a Place in Your Portfolio ||| Burke & Herbert Bank & Trust Co Buys Procter & Gamble Co, Yum China Holdings Inc, ... ||| Attention Sports Fans: An ETF That Tracks Corporate Sponsorships Just Hit The Market",0,0.5045463
2017-07-13,6371900.0,44.4900016784668,44.52999877929688,44.369998931884766,44.43000030517578,40.2396240234375,KO,4 High Yielding Dividend Stocks in Consumer Staples Sector,1,0.57060575
2017-07-14,8558700.0,44.52000045776367,44.720001220703125,44.5,44.68000030517578,40.466041564941406,KO,"After Hours Most Active for Jul 14, 2017 : F, MU, ETE, ROST, FB, QQQ, BAC, EBAY, AGNC, KEY, KO, M",1,0.4846823
2017-07-17,7189200.0,44.65999984741211,44.790000915527344,44.61000061035156,44.72999954223633,40.51132583618164,KO,"SPY, KO, CSCO, DIS: Large Outflows Detected at ETF ||| CVS Health and Valero Look Good by This Measure",0,0.5059111
2017-07-18,9037200.0,44.77999877929688,44.84999847412109,44.619998931884766,44.66999816894531,40.45698547363281,KO,"The Best Stock in Georgia: The Coca-Cola Co. ||| After Hours Most Active for Jul 18, 2017 : CHS, JBGS, HAL, QQQ, SIRI, ODP, SQ, ESV, TLT, KO, MU, QYLD ||| The Difference Between A Good Company And A Good Stock",1,0.5039765
2017-07-19,6986900.0,44.66999816894531,44.84000015258789,44.54999923706055,44.83000183105469,40.60189437866211,KO,"After Hours Most Active for Jul 19, 2017 : INTC, PFE, QQQ, CAG, T, RF, MGM, KO, ROST, ERIC, TMUS, AAPL",0,0.47034168
2017-07-20,7430300.0,44.900001525878906,44.97999954223633,44.75,44.81999969482422,40.59284591674805,KO,"KBWB, FTXG: Big ETF Outflows ||| Watch Out Below For Coca-Cola",1,0.52436286
2017-07-21,8545600.0,44.77999877929688,45.06999969482422,44.66999816894531,45.02999877929688,40.78302764892578,KO,"Plug Power Partners with Walmart in New Fuel Cell Deal, Stock Soars ||| The Zacks Analyst Blog Highlights: Johnson & Johnson, Coca-Cola, Honeywell, Crown Castle and WEC Energy ||| National Beverage: A Great Story, But It's Run Too Far",0,0.4928575
2017-07-24,9103600.0,45.040000915527344,45.04999923706055,44.83000183105469,44.84000015258789,40.6109504699707,KO,"Chipotle Is Getting Smart About Menu Additions ||| A Foolish Take: American Soda Consumption Plunges to a 31-Year Low ||| Coca-Cola (KO) Q2 Earnings: Will it Lose Fizz This Season? ||| Daily Dividend Report: STT, SWKS, MXIM, ZION, KO, INTC ||| What You Need To Know About Dow Components Reporting This Week ||| Earnings Roundup: McDonald's, Chipotle And Coca-Cola Report Q2 Results This Week ||| Earnings Preview: Search Giant Alphabet Kicks Off A Busy Week",1,0.5084088
2017-07-25,14096300.0,45.02000045776367,45.290000915527344,44.93999862670898,45.2400016784668,40.97322463989258,KO,"Why AT&T Inc. (T) Stock Will Keep Getting Stronger ||| Notable ETF Outflow Detected - IWF, KO, DIS, AVGO ||| Coca-Cola Bottling Co. Consolidated (COKE) Ex-Dividend Date Scheduled for July 26, 2017 ||| Food & Beverage Stock Q2 Earnings Slated for Jul 26: HSY, KO ||| Pre-Market Earnings Report for July 26, 2017 : KO, BA, TMO, NEE, GD, ANTM, NOC, F, STT, BAX, NSC, WM ||| A. D. Beadell Investment Counsel, Inc. Buys Tanger Factory Outlet Centers Inc, ON Semiconductor ...",1,0.45817226
2017-07-26,13608900.0,44.54999923706055,45.790000915527344,44.310001373291016,45.7400016784668,41.42606735229492,KO,"Coca-Cola's (KO) Healthy Drive Helps Q2 Earnings to Beat ||| Q2 Earnings From Boeing And Coca Cola ||| Q2 Earnings Results Ahead of Facebook Today: BA, F, KO ||| Alphabet Inc (GOOGL) Stock Is a (Better) Buy After Earnings ||| 3 Stocks to Watch on Wednesday: Advanced Micro Devices, Inc. (AMD), The Coca-Cola Co (KO) and United States Steel Corporation (X) ||| Coca-Cola (KO) Surpasses Q2 Earnings Estimate ||| FEMSA (FMX) Stock Dips 2% on Q2 Earnings & Revenue Miss ||| Earnings Reaction History: The Coca-Cola Company, 27.3% Follow-Through Indicator, 1.6% Sensitive ||| Close Update: Dow, Nasdaq Set Record Highs While S&P 500 Flattens ||| Dow and S&P 500 Touch New Highs, Oil Prices Rising ||| Global Brands To Drive Revenue Growth For Anheuser-Busch In The Second Quarter ||| Bai Brands To Give A Boost To Dr Pepper Snapple's Earnings ||| A Peek Into The Markets: U.S. Stock Futures Up Ahead Of Earnings, Fed Decision ||| Coca-Cola Reaffirms FY 2017 Organic Revenue, Updates EPS to Flat to Down 2% YoY ||| Coca-Cola Q2 EPS $0.59 vs $0.58 Est., Sales $9.70B vs $9.65B Est. ||| 12 Stocks To Watch For July 26, 2017 ||| Earnings Scheduled For July 26, 2017",1,0.49473074
2017-07-27,15195200.0,45.79999923706055,46.43000030517578,45.70000076293945,46.119998931884766,41.77022171020508,KO,"Company News for July 27, 2017 ||| The Best Way to Reduce Risk",0,0.47320178
2017-07-28,11945300.0,46.0,46.119998931884766,45.72999954223633,46.0099983215332,41.67060089111328,KO,"Top Research Reports for Facebook, Coca-Cola & Verizon ||| After Hours Most Active for Jul 28, 2017 : LC, CDR, QQQ, BBL, ZNGA, FE, KO, F, MDLZ, WDC, INTC, MU ||| Pre-Market Imbalance Update: Square 123K Shares To Buy, Coca-Cola 108K Shares To Sell, AT&T 66K To Sell, Verizon 52K To Sell",0,0.4889233
2017-07-31,13622900.0,46.0,46.08000183105469,45.790000915527344,45.84000015258789,41.51663589477539,KO,"Buffett's Berkshire Hathaway Has Held These 2 Stocks For Decades ||| Anheuser-Busch Blends Sparkling Juice, Energy Drinks Into Beer Portfolio With Hiball Buyout ||| 3 Stocks You Can Buy and Hold Forever ||| One Put, One Call Option To Know About for Coca-Cola ||| The Zacks Analyst Blog Highlights: Facebook, Coca-Cola, Verizon, Boeing and General Dynamics ||| The 3 Best Buffett Stocks for Retirees ||| It's All About Bai In Dr Pepper Snapple's Second Quarter Results ||| Time to Cash in on Cola Earnings with These ETFs?",0,0.4845989
2017-08-01,10306800.0,45.970001220703125,46.060001373291016,45.650001525878906,45.70000076293945,41.38983917236328,KO,5 Cash-Rich Consumer Stocks You Should Consider ||| Top Stocks with Big Potential Catch-Up Moves,0,0.51860446
2017-08-02,10187900.0,45.59999847412109,46.0,45.380001068115234,45.59000015258789,41.29022216796875,KO,"Patton Albertson & Miller, LLC Buys SPDR Nuveen Bloomberg Barclays Municipal Bond, iShares ... ||| Zacks.com featured highlights: Apptio, Barnes Group, Fortive Corp., Coca-Cola Co. and Northrop Grumman ||| IWF, V, KO, MA: Large Outflows Detected at ETF ||| DuPont's Next Big Idea Could Be Huge for Coca-Cola ||| 5 Top Stocks with Big Potential Catch-Up Moves",1,0.4976737
2017-08-03,14261400.0,45.650001525878906,45.95000076293945,45.630001068115234,45.66999816894531,41.3626708984375,KO,Why You Should Toast the Bitcoin Split With a Coke Classic ||| Not Much To See With Staples ETFs,0,0.49588254
2017-08-04,9523600.0,45.66999816894531,45.7599983215332,45.470001220703125,45.5,41.20870590209961,KO,"Constellation Brands Inc (STZ) Ex-Dividend Date Scheduled for August 07, 2017",1,0.47027534
2017-08-07,6226300.0,45.52000045776367,45.7599983215332,45.5,45.63999938964844,41.33550262451172,KO,"Berkshire Hathaway Inc. (BRK.B) Stock Hit by Insurance Losses ||| Will Coca-Cola Bottling (COKE) Post Higher Earnings in Q2? ||| Monster Beverage (MNST) Q2 Earnings: What's in the Cards? ||| Unionbancal Corp Buys iShares U.S. Preferred Stock ETF, iShares Select Dividend ETF, iShares ...",0,0.4719812
2017-08-08,5747900.0,45.63999938964844,45.81999969482422,45.54999923706055,45.59999847412109,41.29927062988281,KO,"Apertura Capital, LLC Buys Twitter Inc, Las Vegas Sands Corp, Advanced Micro Devices Inc, Sells ... ||| Diageo plc (DEO) Ex-Dividend Date Scheduled for August 09, 2017 ||| Gratus Capital LLC Buys AbbVie Inc, Edwards Lifesciences Corp, Sysco Corp, Sells Schwab U.S. ... ||| Monster Beverage Falls Flat Despite Record Sales",0,0.48882693
2017-08-09,9635300.0,45.560001373291016,45.65999984741211,45.33000183105469,45.59000015258789,41.29022216796875,KO,"Coca-Cola Bottling (COKE) Earnings & Revenues Grow in Q2 ||| Monster Beverage (MNST) Earnings Miss, Sales Beat in Q2",1,0.5076466
2017-08-10,8901600.0,45.560001373291016,45.84000015258789,45.459999084472656,45.7400016784668,41.42606735229492,KO,"Dow Analyst Moves: KO ||| Noteworthy ETF Outflows: IYK, PM, KO, NKE",0,0.49974203
2017-08-11,8357600.0,45.86000061035156,45.900001525878906,45.56999969482422,45.59000015258789,41.29022216796875,KO,"Pre-Market Imbalance Update: BofA 424K Shares To Sell, Alibaba 161K To Sell, Citi 111K To Sell, Coca-Cola 107K To Sell, JP Morgan 103K To Sell",1,0.49990022
2017-08-14,8421200.0,45.66999816894531,45.93999862670898,45.619998931884766,45.79999923706055,41.480411529541016,KO,"How Safe Is Coca-Cola's Dividend? ||| Better Buy: McDonald's vs. Coca-Cola ||| Pre-Market Imbalance Update: BofA 257K Shares To Buy, Alibaba 118K To Buy, ConocoPhillips 76K To Buy, Coca-Cola 40K To Sell ||| Kraft, Coca-Cola Seen as Potential Acquirers of Danone -NY Post",1,0.4929535
2017-08-15,9638100.0,45.79999923706055,46.25,45.79999923706055,46.18999862670898,41.833621978759766,KO,"PepsiCo a Top Ranked SAFE Dividend Stock With 2.7% Yield (PEP) ||| Wall Street's M&A Chatter From August 14: Danone, Neff Corp, Huawei Technologies-Applied Optoelectronics",1,0.49903825
2017-08-16,8087300.0,46.150001525878906,46.34000015258789,46.119998931884766,46.20000076293945,41.84268951416016,KO,Coca-Cola Option Alert: Feb 16 $46 Calls Sweep (16) at the Bid: 906 @ $1.54 vs 433 OI; Ref=$46.22,0,0.48380056
2017-08-17,8477000.0,46.119998931884766,46.33000183105469,45.84999847412109,45.86000061035156,41.53475189208984,KO,"Noteworthy Thursday Option Activity: BID, LVS, KO ||| Watch These 7 Huge Call Purchases In Thursday Trade",0,0.5078866
2017-08-18,10879800.0,45.79999923706055,45.900001525878906,45.630001068115234,45.66999816894531,41.3626708984375,KO,"Cott Corporation (COT) Ex-Dividend Date Scheduled for August 21, 2017 ||| Why Coca-Cola Shareholders Have Something to Worry About",1,0.48781633
2017-08-21,9429700.0,45.66999816894531,45.79999923706055,45.560001373291016,45.68000030517578,41.371726989746094,KO,"Cramer Finds A Way To Explain Stock Diversification With Fantasy Football ||| Warren Buffett's Top 10 Stocks ||| Noteworthy ETF Outflows: VOO, C, KO, INTC ||| 4 “Safe” Dividends That are Anything But",0,0.4644651
2017-08-22,10536700.0,45.70000076293945,45.75,45.540000915527344,45.59999847412109,41.29927062988281,KO,"Consumer Sector Update for 08/22/2017: WMT, MCD, CVS, KO, RT, DSW, COTY ||| After Hours Most Active for Aug 22, 2017 : CPN, CRM, QQQ, KO, AAPL, SBUX, T, MU, TGT, XOM, CSCO, HOLX ||| Pre-Market Imbalance Update: Sprint 223K Shares To Buy, Square 139K To Buy, GE 90K To Buy, Snap 54K To Buy, Coca-Cola 53K Shares To Sell, Alibaba 53K To Buy, J&J 49K To Sell",0,0.46485692
2017-08-23,6528400.0,45.630001068115234,45.65999984741211,45.43999862670898,45.540000915527344,41.24493789672852,KO,"Consumer Sector Update for 08/23/2017: KO, CVS, DIS, MCD, WMT, LOW, EXPR, LZB ||| Coca-Cola, Pepsico & Others Agree to Limit Sugar in Products ||| Coca-Cola European Partners plc (CCE) Ex-Dividend Date Scheduled for August 24, 2017",0,0.46681634
2017-08-24,7534400.0,45.540000915527344,45.61000061035156,45.310001373291016,45.40999984741211,41.127197265625,KO,Sugar And Spite: Big Cities Taxes On Beverages Irking Big Soda,1,0.52118194
2017-08-25,8807100.0,45.59999847412109,45.7599983215332,45.560001373291016,45.56999969482422,41.27210998535156,KO,"PepsiCo vs Coca-Cola: Which Stock Should You Buy Right Now? ||| After Hours Most Active for Aug 25, 2017 : WLL, PFE, ROST, MU, EBAY, QQQ, DAL, KO, CSCO, AXL, CPN, WFM",0,0.47607774
2017-08-28,8024000.0,45.630001068115234,45.68999862670898,45.380001068115234,45.41999816894531,41.13624572753906,KO,"Why You Might Want to Avoid This Dividend Aristocrat ||| You Wouldn't Believe the Size of Coca-Cola's Advertising Budget ||| Molson Coors Brewing Company (TAP) Ex-Dividend Date Scheduled for August 29, 2017 ||| Consumer Sector Update for 08/28/2017: WMT, MCD, CVS, KO, DIS, ULTA, YUMC, ILG",1,0.46247852
2017-08-29,7762200.0,45.400001525878906,45.56999969482422,45.25,45.45000076293945,41.16342544555664,KO,"VOO, C, KO, INTC: Large Inflows Detected at ETF ||| Dow Movers: NKE, UNH ||| Why Buffett, Lynch and Pabrai Want Easy Ideas",0,0.48306525
2017-08-30,7134900.0,45.36000061035156,45.540000915527344,45.290000915527344,45.38999938964844,41.10907745361328,KO,3 Reasons Dr Pepper Snapple Group Stock Could Rise ||| 5 Reasons to Add Coca-Cola European Partners (CCE) Right Now ||| Blue Apron IPO Debacle Hasn't Killed Off Meal Kit Delivery Yet ||| Buffett On Brands: More Isn't Always Better,1,0.5218974
2017-09-01,7391200.0,45.63999938964844,45.79999923706055,45.540000915527344,45.77999877929688,41.46229934692383,KO,Is Coca-Cola Mulling Over the Buyout of Monster Beverage?,1,0.5200085
2017-09-05,9916700.0,45.75,45.93000030517578,45.650001525878906,45.91999816894531,41.58909225463867,KO,"3 Consumer-Goods Stocks to Buy With Dividends Yielding More Than 3% ||| Top Analyst Reports for Apple, Visa & Coca-Cola",1,0.512918
2017-09-06,9238900.0,45.97999954223633,46.040000915527344,45.790000915527344,45.959999084472656,41.62531661987305,KO,"The Zacks Analyst Blog Highlights: Apple, Visa, Coca-Cola, Travelers and Blackstone ||| UPRO, GOOGL, C, KO: Large Outflows Detected at ETF ||| Its Business As Usual ||| The Principle of Multitudes ||| FEMSA (FMX) Stock Immune to Earnings Slump: Find Out Why ||| A Guide to Dividend Stocks",1,0.49632385
2017-09-07,9418400.0,46.0099983215332,46.31999969482422,45.959999084472656,46.27999877929688,41.915138244628906,KO,Battle of Dividends: McDonald's vs. Coca-Cola ||| 3 High-Yield Warren Buffett Stocks ||| McDonald's Shakes Up McCafe Brand: Should Competitors Worry?,1,0.49636224
2017-09-08,10534900.0,46.18999862670898,46.369998931884766,46.02000045776367,46.29999923706055,41.933250427246094,KO,"McDonald's Corp Revitalizes McCafe: What You Need to Know ||| 3 BDCs Paying 10%+: 2 Hopefuls, 1 Hopeless Wreck ||| Warren Buffett Buys Bank of New York Mellon Corp, Synchrony Financial, STORE Capital Corp, ...",1,0.5098774
2017-09-11,10430300.0,46.34999847412109,46.59000015258789,46.220001220703125,46.52000045776367,42.13249969482422,KO,Why I Love Berkshire Hathaway,1,0.51330584
2017-09-12,8567600.0,46.5,46.75,46.45000076293945,46.720001220703125,42.31364822387695,KO,"Ex-Dividend Reminder: Teck Resources, Leggett & Platt and Coca-Cola ||| Dr Pepper Snapple Group, Inc (DPS) Ex-Dividend Date Scheduled for September 13, 2017 ||| KO Named Top 25 SAFE Dividend Stock Increasing Payments For Decades ||| A Hidden Gem Among Dividend ETFs",1,0.49623606
2017-09-13,10218000.0,46.68000030517578,46.97999954223633,46.650001525878906,46.869998931884766,42.44948959350586,KO,"Zacks Industry Outlook Highlights: Amazon.com, Unilever, Coca-Cola, Procter & Gamble and Kellogg ||| Starbucks Freshens Menu With Cold-Pressed Espresso Shot ||| Coca-Cola Company (KO) Ex-Dividend Date Scheduled for September 14, 2017 ||| Buy Microsoft Corp (NASDAQ:MSFT) On This Short-Term Weakness",0,0.47132978
2017-09-14,13768800.0,46.400001525878906,46.470001220703125,45.93999862670898,46.11000061035156,42.09346008300781,KO,"Notable ETF Inflow Detected - VT, PM, KO, DIS ||| Market Close Report: NASDAQ Composite index closes at 6,429.08 down -31.11 points ||| Green Market Report Debuts With Intentions Of Becoming The 'CNBC Or Dow Jones Of Cannabis'",1,0.5008602
2017-09-15,16141400.0,46.29999923706055,46.36000061035156,46.0,46.18000030517578,42.15736770629883,KO,Synchrony Is a Buffett Favorite: Here’s Why,0,0.4770391
2017-09-18,8535300.0,46.150001525878906,46.2400016784668,45.90999984741211,46.11000061035156,42.09346008300781,KO,"Better Buy: International Business Machines Corporation vs. Coca-Cola ||| One Put, One Call Option To Know About for Coca-Cola ||| Dow Movers: INTC, CAT ||| 10 Professional Athletes Bringing Home the Biggest Endorsement Checks ||| Could Monster's Takeover Be On The Cards For Coca-Cola?",0,0.49432817
2017-09-19,7297900.0,46.13999938964844,46.18999862670898,45.88999938964844,45.97999954223633,41.97478866577149,KO,FEMSA Cuts Stake in Heineken: Here's What Investors Must Know ||| I Still Can't Believe Coca-Cola Spent $2 Billion on Keurig,0,0.5000272
2017-09-20,11026600.0,45.7599983215332,46.150001525878906,45.54999923706055,45.77999877929688,41.79220962524414,KO,"3 Stocks That Put Coca-Cola's Returns to Shame ||| Get Ready to Rent, But Not Own, Twilio Stock for Now",0,0.5061353
2017-09-21,7555300.0,45.709999084472656,45.790000915527344,45.36000061035156,45.400001525878906,41.4453125,KO,What Can We Do Now?,1,0.522067
2017-09-22,8024800.0,45.45000076293945,45.630001068115234,45.369998931884766,45.4900016784668,41.527469635009766,KO,Bear Of The Day Cott Corp (COT),1,0.50196445
2017-09-25,9215300.0,45.5,45.7599983215332,45.34999847412109,45.68999862670898,41.71004867553711,KO,"3 Soda Stocks You May Be Overlooking ||| Best Buy: The Coca-Cola Co vs. PepsiCo, Inc. vs. Procter & Gamble Co ||| One Put, One Call Option To Know About for Coca-Cola ||| Dunkin' Donuts Beverages Now Available for Amtrak Travelers ||| The World's Most Valuable Brands In 2017: Apple, Google, Coca-Cola And More",0,0.503666
2017-09-26,6480100.0,45.68999862670898,45.869998931884766,45.560001373291016,45.56999969482422,41.60050201416016,KO,3 Stocks the Smartest Investors are Buying Right Now,0,0.49305227
2017-09-27,14816200.0,45.470001220703125,45.5,44.380001068115234,44.63999938964844,40.75151443481445,KO,"Coca-Cola To Report Q3 Earnings On Wed., Oct. 25 Before Market Open",1,0.5179226
2017-09-28,8789500.0,44.66999816894531,45.0,44.650001525878906,44.90999984741211,40.99799346923828,KO,"Kellogg CEO John Bryant to Retire ||| PepsiCo, Inc. (PEP) Stock Lost Its Fizz But Can Still Bring You Sweet Gains ||| Apple Brand Estimated At 3 Times The Value Of Amazon's",1,0.50994456
2017-09-29,10082200.0,44.86000061035156,45.11000061035156,44.790000915527344,45.0099983215332,41.08928680419922,KO,FDA Extends Deadline For Compliance With Nutrition Facts and Supplement Facts Label Final Rule From 7/26/2018 to 1/1/2020,0,0.5075305
2017-10-02,10707800.0,45.04999923706055,45.27000045776367,44.75,44.79999923706055,40.8975715637207,KO,"Why Leveraged Oil Stocks are Bad Investments ||| Better Buy: Starbucks Corporation vs. Coca-Cola ||| Dow Kicks Off 4Q With a Triple-Digit Rally ||| One Put, One Call Option To Know About for Coca-Cola ||| Market Close Report: Historical high reached as NASDAQ Composite Index closes at 6,516.72. ||| Morgan Stanley Catches Flack For Colgate-Palmolive Upgrade ||| A Global Consumer Staples Idea",1,0.5022944
2017-10-03,12038100.0,44.86000061035156,45.2599983215332,44.7599983215332,45.18999862670898,41.253604888916016,KO,PepsiCo (PEP) Gears Up for Q3 Earnings: Is a Beat in Store? ||| 5 Dividend Growth Stocks With Upside To Analyst Targets ||| Consumer Staples ETFs Face Technical Test ||| FoodBev Media Reports Coca-Cola To Acquire Topo Chico,1,0.52798146
2017-10-04,14060300.0,45.11000061035156,45.560001373291016,44.93999862670898,45.5,41.53660583496094,KO,"Pepsi's Last Straw: Takeover Next? ||| US Market Indexes Continue to Gain on Tuesday ||| Better Buy: Coca-Cola vs. Anheuser-Busch InBev ||| PepsiCo (PEP) Q3 Earnings Top on Lower Cost, Sales Let Down ||| Coca-Cola Is Trying Really Hard to Not Be a Soda Company ||| Coca-Cola and AB InBev Complete Transition of Majority Ownership in Coca-Cola Beverages Africa",1,0.51774716
2017-10-05,10215300.0,45.5099983215332,45.75,45.5,45.52000045776367,41.55485153198242,KO,What Does the Future Hold for Tiffany & Co.?,0,0.4854367
2017-10-06,5437900.0,45.38999938964844,45.52000045776367,45.27999877929688,45.4900016784668,41.527469635009766,KO,"The Most Important Dividend Stock Chart You'll Ever See ||| Patton Albertson & Miller, LLC Buys iShares J.P. ... ||| 3 Stocks That Look Just Like Coca-Cola in 1988 ||| Buffett’s Largest Stock Kraft Heinz Drops Near 52-Week Low ||| Marshwinds Advisory Co Buys DowDuPont Inc, BHP Billiton, Enbridge Inc, Sells E.I. ... ||| AB InBev (BUD) Seals Deal to Sell African Bottling Business",0,0.49587676
2017-10-09,5268300.0,45.54999923706055,45.650001525878906,45.34000015258789,45.40999984741211,41.45444107055664,KO,"3 Stable Stocks for Conservative Investors ||| Coca-Cola Flexes Its Venture Capital Muscle With Purchase of Topo Chico ||| Top Analyst Reports for Coca-Cola, BP & Alibaba ||| Lightning Round: Jim Cramer Weighs In On Monster Beverage, General Electric And More",1,0.5258689
2017-10-10,6310400.0,45.59999847412109,45.900001525878906,45.52999877929688,45.869998931884766,41.87437057495117,KO,"Noteworthy ETF Outflows: IWB, CMCSA, KO, PM ||| XLP, EVX: Big ETF Outflows ||| The Zacks Analyst Blog Highlights: Coca-Cola, BP, Alibaba Group, U.S. Bancorp and Vale",1,0.4932682
2017-10-11,6638200.0,45.880001068115234,46.09999847412109,45.869998931884766,46.09999847412109,42.08434295654297,KO,"Rowland & Co Investment Counsel Buys Bed Bath & Beyond Inc, Berkshire Hathaway Inc, ... ||| Transcript of Joel Tillinghast Podcast Interview ||| Soda Stocks Slightly Higher Today Following Chicago's 'Sugar Tax' Repeal Tuesday; Pepsi Up 0.62%, Coca-Cola +0.59%, Dr Pepper Snapple +0.41%",1,0.5061432
2017-10-12,7710200.0,45.97999954223633,46.13999938964844,45.93999862670898,46.11000061035156,42.09346008300781,KO,"Editors' Picks Daily - October 12, 2017 ||| How to Invest the Buffett Way",1,0.4823976
2017-10-13,7126000.0,46.25,46.380001068115234,46.150001525878906,46.18000030517578,42.15736770629883,KO,A New FDA Approval Sends Small Cap Flexion Soaring,1,0.545413
2017-10-16,12708600.0,46.119998931884766,46.75,46.09999847412109,46.619998931884766,42.55904006958008,KO,"McDonald's Muchies - Debra Borchardt's Idea Of The Month ||| McDonald's Munchies - Debra Borchardt's Idea Of The Month ||| One Put, One Call Option To Know About for Coca-Cola",0,0.49359328
2017-10-17,7699400.0,46.52999877929688,46.630001068115234,46.310001373291016,46.52000045776367,42.46774673461914,KO,Better Buy: Coca-Cola vs. PepsiCo,0,0.51550657
2017-10-18,6272200.0,46.40999984741211,46.540000915527344,46.2400016784668,46.400001525878906,42.35820770263672,KO,"Pre-Market Imbalance Update: IBM 219K Shares To Buy, Alibaba 133K To Buy, Coca-Cola 131K To Sell, Twitter 88K To Sell, Square 79K To Buy, AT&T 73K To Buy, Pfizer 71K To Sell, Ford 67K To Sell, J&J 55K To Sell",1,0.48961118
2017-10-19,7515500.0,46.369998931884766,46.790000915527344,46.31999969482422,46.59000015258789,42.53165054321289,KO,"Notable ETF Inflow Detected - XLP, KO, PEP, MO ||| 3 Stocks Every Retiree Should Consider Buying ||| Will Q3 Earnings Launch 'Monster' Move For This Stock? ||| Good Companies Don't Always Make Good Stocks",0,0.4696537
2017-10-23,7153600.0,46.380001068115234,46.650001525878906,46.22999954223633,46.31999969482422,42.28517150878906,KO,"What Is Warren Buffett’s Top Dividend Stock? ||| One Put, One Call Option To Know About for Coca-Cola ||| Earnings Preview: Food And Beverage Companies McDonald's, Chipotle And Coca-Cola Report This Week ||| Jim Cramer Shares His Thoughts On Caterpillar, Coca-Cola And More ||| The Week Ahead: Earnings Season Starts In Earnest",0,0.47549605
2017-10-24,9539500.0,46.2599983215332,46.290000915527344,45.95000076293945,46.18000030517578,42.15736770629883,KO,"Raymond James Trust N.a. Buys DowDuPont Inc, Facebook Inc, Alphabet Inc, Sells E.I. ... ||| Soft Drinks Stock Q3 Earnings Roster for Oct 25: KO and DPS ||| Pre-Market Earnings Report for October 25, 2017 : KO, V, BA, TMO, WBA, GD, ANTM, NOC, NSC, BAX, S, APH ||| Outside Factors To Pressure Dr Pepper Snapple's Earnings In The Third Quarter",0,0.4767702
2017-10-25,11994200.0,46.369998931884766,46.7599983215332,45.93000030517578,46.04999923706055,42.038692474365234,KO,"Q3 Earnings Bonanza, Plus Good Durable Goods ||| Earnings Reaction History: The Coca-Cola Company, 27.3% Follow-Through Indicator, 1.6% Sensitive ||| The Coca-Cola Co (KO) Reports Better-Than-Expected Earnings ||| Mid-Day Market Update: Dow Falls Over 100 Points; Chipotle Shares Drop On Earnings Miss ||| Mid-Afternoon Market Update: Acadia Healthcare Tumbles After Downbeat Results; MacroGenics Shares Surge ||| Coca-Cola (KO) Surpasses Q3 Earnings & Revenue Estimates ||| Coca-Cola Is Taking Aim at La Croix ||| Coca-Cola's (KO) Q3 Earnings Beat Estimates on Healthy Drive ||| Dow Spirals Triple Digits on Disappointing Earnings ||| Mid-Afternoon Market Update: Acadia Healthcare Tumbles After Downbeat Results; MacroGenics Shares Surge ||| Coca-Cola's Q3 Earnings Beat Estimates On Healthy Drive ||| Mid-Day Market Update: Dow Falls Over 100 Points; Chipotle Shares Drop On Earnings Miss ||| Mid-Morning Market Update: Markets Mostly Lower; Coca-Cola Tops Q3 Estimates ||| PreMarket Prep Outlook For Wednesday, Oct. 25 ||| A Peek Into The Markets: U.S. Stock Futures Mostly Flat Ahead Of Earnings ||| Coca-Cola Q3 Adj. EPS $0.50 vs $0.49 Est., Sales $9.08M vs $8.72M Est. ||| 12 Stocks To Watch For October 25, 2017 ||| Earnings Scheduled For October 25, 2017",1,0.5213234
2017-10-26,10569100.0,46.31999969482422,46.75,46.220001220703125,46.22999954223633,42.2030143737793,KO,"Dow Analyst Moves: KO ||| The Coca-Cola Co Stock Finally Hits a Headwind Despite Good Earnings ||| Not There, Yet: What Level Makes The Coca-Cola Co Stock Interesting?",0,0.48481902
2017-10-27,9988000.0,46.130001068115234,46.33000183105469,45.90999984741211,46.06999969482422,42.05694961547852,KO,"Microsoft (MSFT) Q1 Earnings Beat on Strong Azure Growth ||| XLP, PSCM: Big ETF Outflows ||| Crossmark Global Holdings, Inc. Buys Xerox Corp, ArcelorMittal SA, Hilton Worldwide Holdings ... ||| Dow 30 Stock Roundup: INTC, KO, V, MSFT, UTX, CAT, PG Beat ||| The Zacks Analyst Blog Highlights: Visa, Coca-Cola, United Technologies, AT&T and Novartis",0,0.4873099
2017-10-30,7201900.0,46.0,46.06999969482422,45.81999969482422,45.86000061035156,41.8652458190918,KO,"Super Bowl Champ Marvin Washington Talks Cannabis-Derived Therapeutics For Athletes, Isodiol's Leadership In CBD ||| ITOT, T, KO, PEP: Large Inflows Detected at ETF ||| Interesting January 2019 Stock Options for KO ||| 7 Quotes That Sum Up Buffett's Entire Strategy ||| Will FEMSA's (FMX) Upside on Sturdy Q3 Earnings Sustain? ||| Pre-Market Imbalance Update: GE 526K To Sell, Alibaba 221K To Buy, GM 183K To Sell, Square 169K To Buy, BofA 136K To Sell, Twitter 116K To Sell, AT&T 108K To Buy, Pfizer 106K To Sell, Coca-Cola 59K To Sell, Verizon 51K To Sell, Mastercard 38K To Buy",1,0.5033362
2017-11-01,7067600.0,45.75,46.09000015258789,45.630001068115234,45.79999923706055,41.81046295166016,KO,B&G Foods' (BGS) Stock Gains on Q3 Earnings & Revenue Beat,1,0.52452385
2017-11-02,8317800.0,45.810001373291016,45.95000076293945,45.75,45.880001068115234,41.88349151611328,KO,"Interesting KO Put And Call Options For December 22nd ||| Fomento Economico Mexicano S.A.B. de C.V. (FMX) Ex-Dividend Date Scheduled for November 03, 2017 ||| 5 Key Points From Dunkin' Brands' Earnings Conference Call ||| Better Buy: Coca Cola vs. National Beverage ||| After Hours Most Active for Nov 2, 2017 : INTC, F, AAPL, GE, SBUX, PFE, KO, HPQ, NAVI, GM, BTEC, QQQ",1,0.51466274
2017-11-06,7451300.0,45.90999984741211,45.91999816894531,45.41999816894531,45.470001220703125,41.50921249389648,KO,"Notable ETF Inflow Detected - XLP, KO, PEP, MO ||| Coca-Cola European Partners (CCE) Q3 Earnings: What's Up? ||| Will Coca-Cola Bottling (COKE) See Earnings Growth in Q3? ||| One Put, One Call Option To Know About for Coca-Cola",1,0.49796018
2017-11-07,9868000.0,45.40999984741211,45.95000076293945,45.310001373291016,45.93999862670898,41.93826675415039,KO,"Monster Beverage (MNST) Q3 Earnings: What's in the Cards? ||| Square, Monster Beverage, Roku, Alarm.com Lead Investing Action Plan ||| Intelsat, Coca-Cola Partner to Bring Satellite Internet Access to Africa",1,0.5271365
2017-11-08,7586900.0,45.97999954223633,46.18999862670898,45.869998931884766,46.18000030517578,42.15736770629883,KO,Here's What You Need to Know About Salesforce's Einstein ||| Coca-Cola Bottling (COKE) Earnings & Revenues Grow in Q3 ||| Investors Think Monster Beverage Still Needs an Energy Boost ||| Warren Buffett Loves These 2 Dividend Aristocrats ||| Credit Suisse Adjusts Its Top Picks List In A Record-Breaking Market,1,0.49161434
2017-11-09,6532400.0,46.119998931884766,46.38999938964844,46.02000045776367,46.22999954223633,42.2030143737793,KO,"3 Stocks to Buy With Dividends Yielding More Than 3% ||| Monster Beverage (MNST) Q3 Earnings in Line, Revenues Beat",1,0.4994145
2017-11-10,8022900.0,46.20000076293945,46.63999938964844,46.13999938964844,46.540000915527344,42.48600769042969,KO,"Lightning Round: Jim Cramer Is A Seller Of Pandora, Lost Faith In Chipotle",1,0.52347225
2017-11-13,7653600.0,46.59999847412109,46.81999969482422,46.540000915527344,46.720001220703125,42.65032958984375,KO,"One Put, One Call Option To Know About for Coca-Cola ||| Noteworthy Monday Option Activity: AFL, EXC, KO ||| Alibaba, Coca-Cola, Qualcomm: 'Fast Money' Final Trades ||| The Week Ahead For November 13: Conferences, Earnings and IPO Events To Watch",1,0.49367464
2017-11-14,17200700.0,46.709999084472656,47.47999954223633,46.619998931884766,47.43000030517578,43.298484802246094,KO,"Indexes Dip As Oil Retreats; Coke, United Tech, Home Depot Buoy Dow ||| Stocks Lower As Oil Stocks Lag, But Coca-Cola Surges To New High ||| iShares Core S&P Total U.S. Stock Market ETF Experiences Big Inflow ||| These 4 Stocks Hit Buy Points; This New IPO Soars Late: S&P 500 Futures ||| The Only High-Yield Dow Stock Making New Highs Is... ||| The Buy And Hold Case For Coca-Cola ||| 5 Biggest Price Target Changes For Tuesday ||| Benzinga's Top Upgrades, Downgrades For November 14, 2017 ||| The Market In 5 Minutes: B-Dubs, Jeff Sessions, Donald Jr., And More ||| Wells Fargo Maintains Outperform on Coca-Cola, Raises Price Target to $51.00 ||| A Peek Into The Markets: U.S. Stock Futures Flat Ahead Of Producer Price Index ||| Wells Fargo Upgrades Coca-Cola to Outperform",0,0.4888485
2017-11-15,12419100.0,47.31999969482422,47.459999084472656,46.77999877929688,46.810001373291016,42.73249053955078,KO,"Consumer Staples ETFs Head to Head: XLP vs. VDC ||| Bank Of America, Coca-Cola, Foot Locker, UPS: 'Fast Money' Picks For November 15",0,0.46459496
2017-11-16,12506400.0,46.95000076293945,46.97999954223633,46.5099983215332,46.54999923706055,42.4951400756836,KO,"5 Key Takeaways From Coca-Cola's Earnings Call ||| Marco Investment Management Llc Buys DowDuPont Inc, Apple Inc, JPMorgan Chase, Sells E.I. ... ||| Companies Holding Analyst/Investor Days Today Include: Axon Enterprise, Coca-Cola, Charter Communications, SiriusXM, and Kura Oncology ||| Coca-Cola Reaffirms Long-Term Targets Of Mid Single Digit Organic Sales Growth ||| Coca-Cola To Host Investor Day Thurs. Starting At 12:30 p.m. EST; Co. Reaffirms FY17 Outlook",0,0.5379259
2017-11-17,19720700.0,46.34000015258789,46.380001068115234,45.25,45.709999084472656,41.72830581665039,KO,"Stocks Dip; Two New Growth Stocks That Might Be Better Than Tesla ||| Dow Movers: KO, NKE ||| Indexes Retreat, But These Two Stocks Break Out",0,0.4733633
2017-11-20,19160900.0,45.650001525878906,45.880001068115234,45.41999816894531,45.459999084472656,41.50008773803711,KO,"Best Buy: Coca-Cola, McDonald's, or Verizon? ||| 3 Top Soda Stocks to Consider Buying Now ||| Interesting May 2018 Stock Options for KO ||| Noteworthy Monday Option Activity: HD, KO, MU ||| Jim Cramer And Najarian Brothers See Unusual Options Activity In Coca-Cola, Alibaba And Schlumberger",1,0.49562842
2017-11-22,8434400.0,45.88999938964844,45.93000030517578,45.540000915527344,45.84000015258789,41.84698486328125,KO,"VOO, BRK.B, VZ, KO: ETF Outflow Alert ||| Coca-Cola Tweaks Its Financial Strategy ||| The Narrative Structure Coca-Cola Is Using to Dominate Beverage Markets ||| Coca-Cola Outlines New Priorities ||| Wall Street's M&A Chatter From Nov. 21: PepsiCo, Kraft-Heinz Foods, H&E Equipment Centers, AT&T",1,0.4975584
2017-11-24,2996300.0,45.88999938964844,46.04999923706055,45.86000061035156,45.880001068115234,41.88349151611328,KO,"4 Takeaways from Coca-Cola’s Investor Day ||| Cott Corporation (COT) Ex-Dividend Date Scheduled for November 27, 2017",1,0.51670825
2017-11-27,5649200.0,45.880001068115234,45.9900016784668,45.810001373291016,45.900001525878906,41.901763916015625,KO,Interesting February 2018 Stock Options for KO ||| How Coca-Cola Is Focusing On India — Part 1,0,0.49115434
2017-11-28,8432800.0,45.9900016784668,46.150001525878906,45.77999877929688,45.83000183105469,41.83786392211914,KO,"Molson Coors Brewing Company (TAP) Ex-Dividend Date Scheduled for November 29, 2017",0,0.45925513
2017-11-29,16502100.0,45.77000045776367,45.81999969482422,45.209999084472656,45.5,41.53660583496094,KO,"Dow Movers: V, UNH ||| Pepsico, Inc. (PEP) Ex-Dividend Date Scheduled for November 30, 2017 ||| Coca-Cola Company (KO) Ex-Dividend Date Scheduled for November 30, 2017",1,0.4271625
2017-11-30,17147600.0,45.13999938964844,45.84000015258789,45.02999877929688,45.77000045776367,42.12564468383789,KO,"Top Analyst Reports for Coca-Cola, Honeywell & Chubb",1,0.51305705
2017-12-01,12468800.0,45.79999923706055,46.02000045776367,45.209999084472656,45.970001220703125,42.30971908569336,KO,"Dividend “Century Aristocrats”: Ranking 5 Buys Today ||| The Zacks Analyst Blog Highlights: Coca-Cola, Honeywell, Chubb, Statoil and Workday ||| 3 Dividend Stocks With Better Yields Than Coca-Cola",1,0.507768
2017-12-04,17523600.0,45.9900016784668,46.380001068115234,45.77000045776367,46.22999954223633,42.549015045166016,KO,"Dr Pepper Snapple Group a Top Socially Responsible Dividend Stock With 2.6% Yield (DPS) ||| After Hours Most Active for Dec 4, 2017 : CSCO, NVDA, CMCSA, KO, FHN, CAR, QQQ, DYN, NRG, HPQ, BAC, AAPL ||| Coca-Cola Shares Unresponsive Following Reveal Article Titled 'Inside a judge's rehab: Unpaid work at a local Coca-Cola plant' ||| A Post-Sneaker World: How 'Small' Footwear Brands Are Beating The Giants",1,0.4851379
2017-12-05,13670800.0,46.25,46.43999862670898,46.060001373291016,46.2599983215332,42.57662582397461,KO,"3 Stocks That Cut Bigger Checks Than PepsiCo ||| After Hours Most Active for Dec 5, 2017 : DLPH, F, FTR, QQQ, WFC, BAC, V, INTC, KO, EBAY, MSFT, AAPL ||| PreMarket Opening NYSE Imbalance Update: Alibaba 232k Shares To Sell; Citigroup 107k Shares To Sell; Coke 72k Shares To Sell; Disney 59k Shares To Sell; Ford 217k Shares To Sell; Walmart 33k Shares To Sell; Bank of America 99k Shares To Buy; AT&T 80",1,0.483941
2017-12-06,8154000.0,46.36000061035156,46.47999954223633,46.2599983215332,46.45000076293945,42.75149917602539,KO,"Will Coca-Cola Raise Its Dividend in 2018? ||| One Analyst Thinks National Beverage Can Skyrocket Another 40% ||| Report: Oklahoma Judge's Treatment Program Masked Unpaid Labor For Coca-Cola Bottler, Others",0,0.49141583
2017-12-07,9106500.0,46.290000915527344,46.31999969482422,45.720001220703125,45.77999877929688,42.13484573364258,KO,"Better Buy: The Coca-Cola Co. vs. British American Tobacco PLC (ADR) ||| Tech Rally Drives Stocks Higher ||| XLP, SPMD: Big ETF Inflows ||| Market Close Report: NASDAQ Composite index closes at 6,812.84 up 36.46 points ||| Nasdaq Leads With Facebook Back In Buy Range; Bitcoin Skyrockets",0,0.48539963
2017-12-08,13238600.0,45.70000076293945,45.72999954223633,45.04999923706055,45.310001373291016,41.702274322509766,KO,"iShares Russell 1000 ETF Experiences Big Inflow ||| Dow Movers: KO, MSFT ||| Jobs Report Beat Sparks Market Advance; This Airline Breaks Out ||| Market Close Report: NASDAQ Composite index closes at 6,840.08 up 27.24 points",1,0.5070107
2017-12-11,9698700.0,45.310001373291016,45.40999984741211,44.91999816894531,45.33000183105469,41.720680236816406,KO,"One Put, One Call Option To Know About for Coca-Cola ||| 4 Top Stocks You Can Buy on Sale for 2018",0,0.48517197
2017-12-12,13999300.0,45.25,45.52000045776367,45.060001373291016,45.290000915527344,41.68386459350586,KO,"5 Dividend Growth Stocks With Upside To Analyst Targets ||| How Dr Pepper Snapple Can Rebound in 2018 ||| Dr Pepper Snapple Group, Inc (DPS) Ex-Dividend Date Scheduled for December 13, 2017 ||| This Day In Market History: Warren Buffett Buys First Shares Of Berkshire Hathaway",1,0.5100638
2017-12-13,12418700.0,45.45000076293945,46.04999923706055,45.400001525878906,45.900001525878906,42.24529647827149,KO,"Dow Movers: AXP, CAT ||| Here's Where Things Went Wrong For Coca-Cola in 2017 ||| Patten Group, Inc. Buys DowDuPont Inc, iShares Core MSCI Emerging Markets, Hanesbrands Inc, ... ||| 3 Stocks for Warren Buffett Fans",1,0.49254355
2017-12-14,9029000.0,45.810001373291016,46.16999816894531,45.79999923706055,46.02999877929688,42.36493682861328,KO,"How Has Coca-Cola Turned Around Its Fortunes In Latin America? ||| Deutsche Bank Initiates Coverage On Coca-Cola with Buy Rating, Announces $52.00 Price Target",1,0.5390166
2017-12-18,10156800.0,46.20000076293945,46.380001068115234,45.90999984741211,45.93000030517578,42.27290344238281,KO,"Forget Coca-Cola, Altria Group Is a Better Dividend Stock ||| Stocks To Watch: Tax Reform Heads To The Finish Line ||| Danger Lurks for These 3 High-Yield Dividend Stocks ||| One Put, One Call Option To Know About for Coca-Cola ||| Can FEMSA (FMX) Sustain Recent Momentum in Q4 & in 2018? ||| The 3 Best Dow Dividend Stocks for 2018 ||| Better Buy: Philip Morris International (PM) vs. Coca-Cola (KO) ||| Market Close Report: Historical high reached as NASDAQ Composite Index closes at 6,994.76. ||| Dow Secures 70th Record Close of 2017 Amid Tax Bill Anticipation ||| August 2018 Options Now Available For Coca-Cola (KO) ||| IVE, KO, COST, GE: Large Outflows Detected at ETF ||| Coca-Cola To Report Q4 Earnings On Tues., Feb. 13 Before Market Open",1,0.49763596
2017-12-19,8253200.0,46.040000915527344,46.380001068115234,45.90999984741211,46.130001068115234,42.45698547363281,KO,"3 Buy-Ranked Stocks That Warren Buffett Loves ||| UPDATE: Maxim Believes Potential Suitors For Hain Celestial Include: Conagra, Nestle, General Mills, Kraft Heinz, Mondolez, and Coca-Cola",0,0.51110053
2017-12-20,7311000.0,46.209999084472656,46.29999923706055,45.959999084472656,46.08000183105469,42.41096496582031,KO,"Congress To Pass Massive Tax Bill ||| Tax Cuts to Boost GDP: How Much, For How Long?",0,0.50663286
2017-12-21,9657100.0,46.13999938964844,46.220001220703125,45.560001373291016,45.59999847412109,41.96917724609375,KO,Stock Indexes Rise Moderately; Breakouts Increase ||| Pre-Market Opening NYSE Imbalance Update: Snap 61k Shares To Sell; General Electric 45k Shares To Sell; Coke 88k Shares To Sell. FedEx 67k To Buy; Nike 53k To Sell; ||| PreMarket Opening NYSE Imbalance Update: General Electric 100k Shares To Sell; Coca-Cola 67K Shares To Sell; Twitter 34k Shares To Sell,0,0.47407028
2017-12-22,5406300.0,45.68999862670898,45.72999954223633,45.54999923706055,45.59000015258789,41.95997619628906,KO,Remark Shares Up 12.8% As Traders Circulate Unconfirmed Chatter Of AI Deal With Coke,1,0.50014466
2017-12-27,5660600.0,45.900001525878906,45.93999862670898,45.720001220703125,45.93000030517578,42.27290344238281,KO,Why You Should Let It Ride with Adobe Systems Incorporated Stock,0,0.5137032
2017-12-28,6538900.0,45.90999984741211,45.9900016784668,45.63999938964844,45.720001220703125,42.079627990722656,KO,"Market Close Report: NASDAQ Composite index closes at 6,950.16 up 10.82 points ||| Dow Secures Historic 71st Record Close",1,0.508832
2017-12-29,8371500.0,45.70000076293945,46.18000030517578,45.68999862670898,45.880001068115234,42.22688293457031,KO,"Stocks Take Tiny Steps, As Market Wraps Up Big Yearly Gain ||| Dow Movers: GS, KO ||| Why Boxes Are the Future ||| Indexes Ease On Final Trading Day Of Year; China Names Lead IBD 50 ||| Consumer Staples ETFs Leave Investors Hungry In 2017",0,0.48398554
2018-01-02,10872200.0,45.90999984741211,45.93999862670898,45.5099983215332,45.540000915527344,41.91396331787109,KO,"Coca-Cola Co Is a ‘Dividend Aristocrat’ Worth Holding ||| Benzinga's Bulls & Bears: Apple, GE, Starbucks, Tesla, And More ||| 27 Quotes From Investing Greats to Make You a Better Dividend Investor",0,0.49734336
2018-01-03,12635600.0,45.4900016784668,45.68999862670898,45.34000015258789,45.43999862670898,41.82191848754883,KO,"VYM, KO, PM, GE: Large Outflows Detected at ETF ||| After Hours Most Active for Jan 3, 2018 : F, CSCO, BAC, JD, QQQ, KO, TXN, INTC, WFT, NRG, MSFT, C",1,0.495701
2018-01-04,12709400.0,45.560001373291016,46.220001220703125,45.45000076293945,46.08000183105469,42.41096496582031,KO,"Can Coca-Cola Break Out of Its Trance in 2018? ||| Noteworthy Thursday Option Activity: MO, FL, KO ||| Blackhawk, Coca-Cola, JPMorgan: 'Fast Money Halftime Report' Traders Share Their Stock Picks",0,0.4734004
2018-01-05,13113100.0,46.02000045776367,46.20000076293945,45.790000915527344,46.06999969482422,42.40175247192383,KO,"3 Reasons to Be Bullish on Coca-Cola Co Stock ||| After Hours Most Active for Jan 5, 2018 : NKE, BAC, HPE, MDLZ, GE, QQQ, MSFT, KO, C, TLT, SCMP, AAPL",0,0.51019675
2018-01-08,7068600.0,45.95000076293945,46.09999847412109,45.880001068115234,46.0,42.33733367919922,KO,"3 of the Best-Performing Stocks of All Time ||| Coca-Cola Stock Offers Nothing Beyond the 3.2% Dividend ||| Coca-Cola Chilean Arm to Buy Novaverde, Diversifies Portfolio",1,0.5313065
2018-01-09,9962400.0,46.0,46.36000061035156,45.93999862670898,46.22999954223633,42.549015045166016,KO,Why Monster Beverage Corp. Stock Rose 43% in 2017,0,0.48978466
2018-01-10,10700700.0,46.22999954223633,46.2599983215332,45.93000030517578,46.06999969482422,42.40175247192383,KO,"Dow Analyst Moves: KO ||| PepsiCo Introduces MTN DEW ICE, Diversifies CSD Portfolio ||| 3 Risks That Could Take down Facebook Inc Stock",0,0.5037635
2018-01-11,7583200.0,46.22999954223633,46.22999954223633,45.86000061035156,46.040000915527344,42.3741455078125,KO,"Noteworthy ETF Inflows: SPYV, DWDP, GE, KO ||| These 3 Dividend Giants Are Safer Than You Think ||| 5 Dividend Growth Stocks With Upside To Analyst Targets ||| A Strategy That Beat The S&P 500: Here Are Your 2018 'Dogs Of The Dow'",1,0.47841394
2018-01-12,14570100.0,46.27999877929688,46.38999938964844,46.02999877929688,46.150001525878906,42.47539520263672,KO,Coca-Cola (KO) Rebrands Diet Coke Amid Sinking CSD Sales ||| 3 Dividend Stocks That Pay You More Than Coca-Cola ||| Evercore ISI Group Upgrades Coca-Cola to Outperform,1,0.53548175
2018-01-16,16459300.0,46.150001525878906,46.619998931884766,46.13999938964844,46.52999877929688,42.82513427734375,KO,"10 Things You Didn't Know About Coca-Cola ||| Can FORCE Program Drive Kimberly-Clark's (KMB) Q4 Earnings? ||| Dow Touches New Intraday High, Finishes Lower ||| 6 Dow Stocks That Should Drive These ETFs Higher ||| 6 Dow Stocks That Should Drive These ETFs Higher",1,0.50216395
2018-01-17,12143100.0,46.58000183105469,47.0,46.54999923706055,46.81999969482422,43.09203720092773,KO,The Secret to 162% Gains From Safe Blue Chip Dividends ||| PepsiCo a Top Socially Responsible Dividend Stock With 2.7% Yield (PEP),1,0.51718324
2018-01-18,11952900.0,46.75,47.06999969482422,46.61000061035156,46.880001068115234,43.14726257324219,KO,"Noteworthy Thursday Option Activity: MNST, KO, MAT",1,0.5139479
2018-01-19,16187400.0,46.9900016784668,47.25,46.869998931884766,47.15999984741211,43.40496826171875,KO,"Noteworthy ETF Inflows: VTI, VZ, CMCSA, KO ||| The Top 10 Value Stocks In The S&P 500",1,0.49356526
2018-01-22,9577400.0,47.13999938964844,47.5,47.09000015258789,47.380001068115234,43.60744857788086,KO,"Will Diet Coke's New Flavors Hit the Spot? ||| Stocks Up, As Shutdown Vote Looms; Halliburton Breaks Out ||| 3 Stocks Wall Street Hasn't Heard of Yet ||| The Market In 5 Minutes: Celgene Buys Juno, Netflix Earnings Preview, Eagles And Patriots Advance To Super Bowl ||| PreMarket Opening NYSE Imbalance Update: Morgan Stanley 345k Shares To Sell; General Electric 1.3M Shares To Sell; Coke 106k Shares To Sell; Slumberger 186k Shares To Buy; Nike 137k Shares To Sell; Alibaba 42k Shares To Buy; Square 49k Shares To Buy",1,0.50127035
2018-01-23,11463700.0,47.209999084472656,47.70000076293945,47.130001068115234,47.45000076293945,43.671875,KO,The 10 Most Expensive Stocks In The S&P 500,1,0.5199081
2018-01-24,15964500.0,47.52999877929688,47.95000076293945,47.47999954223633,47.83000183105469,44.0216178894043,KO,Can Process Equipment Unit Aid Hillenbrand (HI) Q1 Earnings?,1,0.5160105
2018-01-25,11755000.0,47.70000076293945,48.0,47.70000076293945,47.84000015258789,44.03081893920898,KO,"Will Skin Care, Makeup Fuel Estee Lauder (EL) in Q2 Earnings? ||| Benzinga Pro Morning New 52-Week High Check: Verizon, Coca-Cola, Citrix Systems, IDEXX Laboratories, Wal-Mart Stores, Dollar General, Intuitive Surgical, TransDigm Group, LyondellBasell Industries ||| PreMarket Opening NYSE Imbalance Update: Alibaba 60k Shares To Sell; Ford 157k Shares To Sell; Coca-Cola 51k Shares To Sell",1,0.49266428
2018-01-26,16671200.0,47.77999877929688,48.619998931884766,47.7400016784668,48.52999877929688,44.66588592529297,KO,"Close Update: U.S. Stocks Rally To New Records on Strength in Tech, Healthcare Stocks",0,0.4932804
2018-01-29,11662600.0,48.209999084472656,48.459999084472656,47.58000183105469,47.70000076293945,43.90196990966797,KO,"Dr. Pepper Stock Soars After Keurig Merger Announcement ||| Noteworthy ETF Outflows: VYM, INTC, VZ, KO ||| Is Coca-Cola a Buy in 2018?",0,0.5001688
2018-01-30,12404800.0,47.72999954223633,48.15999984741211,47.400001525878906,47.40999984741211,43.63505935668945,KO,"A Happy Meal Quarter Puts McDonald’s Corporation Stock On Sale ||| Dr Pepper Snapple, Keurig to Merge in a $18.7 Billion Deal ||| PreMarket Opening NYSE Imbalance Update: Coke 104k Shares To Sell; JP Morgan 111k To Sell; BofA 260k To Sell; Pfizer 361k to Sell; CVS 28k To Sell; Alibaba 86k To Sell; Juniper 33k To Sell; Twitter 95k To Buy",1,0.48982334
2018-02-01,10279400.0,47.40999984741211,47.72999954223633,47.11000061035156,47.45000076293945,43.671875,KO,"Better Buy: Procter & Gamble (PG) vs. Coca-Cola (KO) ||| PepsiCo Takes Aim at LaCroix, as Does Everyone Else ||| PreMarket Opening NYSE Imbalance Update: Square 57k Share To Sell; Alibaba 102k To Sell; General Electric 190k To Sell; Verizon 87k To Sell; Citigroup 45k To Sell; Coke 72k To Sell; MetLife 28k To Sell",0,0.49800032
2018-02-05,23261500.0,46.650001525878906,46.91999816894531,44.40999984741211,44.88999938964844,41.315711975097656,KO,"Coca-Cola (KO) Shares Cross Below 200 DMA ||| Disney Earnings Preview: Will Fox Deal Distract From Everything Else? ||| The Most Loved And Hated Super Bowl LII Commercials: Pepsi Steals The Show, Diet Coke Falls Flat",0,0.48715493
2018-02-06,25184300.0,43.869998931884766,44.7400016784668,43.43999862670898,44.66999816894531,41.11322784423828,KO,Holding Stocks In A Rising Rate Environment ||| 3 Dividend Stocks Perfect for Retirees ||| RSI Alert: Coca-Cola Now Oversold ||| What The Keurig-Dr Pepper Deal Means for SodaStream ||| iShares Core S&P Total U.S. Stock Market ETF Experiences Big Inflow,0,0.5009312
2018-02-07,18041600.0,44.58000183105469,45.5,44.27999877929688,44.560001373291016,41.011985778808594,KO,"Notable Wednesday Option Activity: RH, DNKN, KO ||| Twitter Earnings Preview: Revenue And User Growth In Focus ||| Correction Territory: Putting It Into Perspective",0,0.5013249
2018-02-08,23295300.0,44.619998931884766,44.619998931884766,43.06999969482422,43.09999847412109,39.668235778808594,KO,"Should You Buy Coca-Cola Co Stock? 3 Pros, 3 Cons ||| Earnings Preview: Activision Blizzard To Report Q4 Results After The Close ||| Pyeongchang 2018: A Winter Olympics Stock Portfolio",1,0.49072707
2018-02-09,22853100.0,43.36000061035156,43.459999084472656,42.18999862670898,43.130001068115234,39.69584274291992,KO,5 “Bond Bombed” Dividend Blue Chips to Sell ||| TRP vs. ENB: Which Is a Better Buy Ahead of Q4 Earnings? ||| Market Ignores Impressive Earnings Performance,1,0.5442421
2018-02-12,14689000.0,43.560001373291016,44.22999954223633,43.369998931884766,43.970001220703125,40.46896362304688,KO,"Coca-Cola reports Q4 numbers February 16 ||| The Zacks Analyst Blog Highlights: Alibaba, Coca-Cola, Visa, Intel and Procter and Gamble ||| PepsiCo, Inc. May Have Found a Winning Formula With Bubly ||| The Coca-Cola Co Dividend King Is Facing Turbulent Waters ||| General Electric, Pepsi, Coke, Deere and Under Amour are part of Zacks Earnings Preview ||| Surprising Analyst 12-Month Target For SPMV ||| Companies Powering the Winter Olympics: 3 Stocks to Buy Now ||| PepsiCo (PEP) 4th Quarter Earnings: What to Expect ||| The Week Ahead: Earnings, FDA Actions, And Industry Conferences To Watch ||| Wall Street Olympics: Watching To See If Stocks Can Recover Even As Yields Rise",1,0.5056342
2018-02-13,13163200.0,43.91999816894531,44.40999984741211,43.68999862670898,44.18999862670898,40.67144393920898,KO,"Earnings Reaction History: The Coca-Cola Company, 27.3% Follow-Through Indicator, 1.4% Sensitive",0,0.50811285
2018-02-14,13457900.0,44.02000045776367,44.18999862670898,43.630001068115234,44.09999847412109,40.58861541748047,KO,"Notable ETF Outflow Detected - XLP, KO, CVS, MDLZ ||| Will Cost Saving Plans Support Coca-Cola's (KO) Q4 Earnings? ||| Coca-Cola European Partners (CCE) Q4 Earnings: What's Up? ||| Why Defensive ETFs Fail in the Market Downturn? ||| Earnings Preview: How Is Coca-Cola Battling 12 Years Of Falling Soda Sales?",1,0.47848812
2018-02-15,13467300.0,44.25,44.83000183105469,44.119998931884766,44.77999877929688,41.21446990966797,KO,"Soft North American Sales to Hit Coca-Cola (KO) Q4 Earnings ||| Notable Thursday Option Activity: KO, CAI, AMKR ||| Dr Pepper's (DPS) Q4 Earnings Meet, Revenues Lag Estimates ||| Close Update: Inflation Fears Fail to Dent Wall Street's Euphoria ||| Daily Dividend Report: CSCO, KO, AMAT, ITW, SLF ||| Coca-Cola Raises Qtr. Dividend From $0.37 To $0.39/Share ||| Instant Replay? January Appears To Be Back On Wall Street Amid Fierce Rally",1,0.51430273
2018-02-16,17202300.0,45.56999969482422,45.63999938964844,44.720001220703125,44.97999954223633,41.39854049682617,KO,"Coca-Cola (KO) Shares Rally on Q4 Earnings & Revenue Beat ||| Mid-Morning Market Update: Markets Open Higher; Coca-Cola Sales Top Expectations ||| The Coca-Cola Co Beat Earnings — Go Long KO Stock Now! ||| Mid-Day Market Update: Dow Rises Over 100 Points; Apricus Biosciences Shares Plummet ||| Coca-Cola Company (KO) Q4 2017 Earnings Conference Call Transcript ||| 5 Dividend Growth Stocks Powered by Unstoppable Megatrends ||| 5 Dividend Growth Stocks Powered by Unstoppable Megatrends ||| Morning Movers: Coca-Cola Climbs, Shake Shack Sinks ||| Don't Abandon Dividend Stocks; Tweak Your Strategy Instead ||| Coca-Cola's New Drinks, Revamped Diet Sodas Boost Earnings ||| The Coca-Cola Company Beat Wall Street's Sales Targets Again ||| Pre-Market Most Active for Feb 16, 2018 : QQQ, NOK, STM, AAPL, USLV, TEVA, TVIX, FOLD, QCOM, DB, KO, VALE ||| Consumer Sector Update for 02/16/2018: KO,CPB,WEN ||| Consumer Sector Update for 02/16/2018: LOW,KO,CPB,WEN ||| Stocks Rise, Fight To Extend Rally As Apple Edges Up, Arista Dives ||| Earnings Reaction History: The Coca-Cola Company, 27.3% Follow-Through Indicator, 1.3% Sensitive ||| Coca-Cola (KO) Surpasses Q4 Earnings & Revenue Estimates ||| Mid-Afternoon Market Update: Blackline Surges After Q4 Results; Moleculin Biotech Shares Slide ||| Mid-Day Market Update: Dow Rises Over 100 Points; Apricus Biosciences Shares Plummet ||| Mid-Morning Market Update: Markets Open Higher; Coca-Cola Sales Top Expectations ||| Tractors And Beverages: Deere And Coke Highlight Earnings Data As Weekend Nears ||| Coca Cola Says They're 'Dissatisfied' They Were Not Able To Turn Around Diet Coke In 2017 ||| Benzinga Pro's 5 Stocks To Watch Today ||| PreMarket Prep Opening NYSE Imbalance Update: Bank Of America 145k Shares To Sell; Coke 65k Shares To Buy; Berkshire Hathaway B Shares 39k To Buy; JP Morgan 28k Shares To Buy; Wal-Mart 22k Shares To Buy; Boeing 45k Shares To Buy ||| Coca-Cola Sees FY18 Adj. EPS $2.06 to $2.10 vs $2.01 Est. ||| Coca-Cola Reports Q4 Adj. EPS $0.39 vs $0.39 Est., Sales $7.5B vs $7.4B Est. ||| 10 Stocks To Watch For February 16, 2018 ||| Earnings Scheduled For February 16, 2018",0,0.4922225
2018-02-20,14137300.0,44.75,44.83000183105469,43.93999862670898,43.9900016784668,40.48736572265625,KO,"6 Notable Dividend Stocks Boost Payouts, Including Coca-Cola (KO) ||| Independent Research Upgrades Coca-Cola Co to Hold from Sell, Raises Price Target to $48 from $36 -Reuters ||| DPS Misses Consensus Revenue Expectations In The Fourth Quarter ||| BMO Capital Maintains Market Perform on Coca-Cola, Raises price target to $48.00 ||| Morgan Stanley Maintains Equal-Weight on Coca-Cola, Raises price target to $49.00 ||| JP Morgan Maintains Neutral on Coca-Cola, Raises price target to $49.00 ||| Credit Suisse Maintains Outperform on Coca-Cola, Raises price target to $53.00",0,0.52844775
2018-02-21,12792900.0,44.11000061035156,44.2599983215332,43.33000183105469,43.34000015258789,39.889122009277344,KO,Better Buy: Berkshire Hathaway vs. Coke ||| Why PepsiCo Has Turned Cautious on Growth,1,0.5145687
2018-02-22,12377800.0,43.43000030517578,43.81999969482422,43.220001220703125,43.52000045776367,40.0547981262207,KO,"XLP, KO, PEP, COST: ETF Outflow Alert ||| What Campbell Soup Is Getting Right",1,0.5050057
2018-02-23,8277200.0,43.58000183105469,44.060001373291016,43.41999816894531,44.040000915527344,40.53338623046875,KO,"Who's Got the Sweeter Dividend: PepsiCo or Coca-Cola? ||| Dow 30 Stock Roundup: Walmart Disappoints, Coca-Cola Impresses ||| Coca-Cola European Partners plc (CCE) Ex-Dividend Date Scheduled for February 26, 2018",0,0.45711383
2018-02-26,12713300.0,44.22999954223633,44.38999938964844,43.810001373291016,44.02999877929688,40.52418518066406,KO,"Will Higher Costs Hit Coca-Cola Bottling (COKE) Q4 Earnings? ||| Market Close Report: NASDAQ Composite index closes at 7,421.46 up 84.07 points ||| Stocks Push Higher as Dow Adds 400 Points ||| Apple News: Buffett Buys More, iCloud Goes Google, China Woes ||| Warren Buffett Still Prefers Burgers And iPhones To Tacos And Samsungs",0,0.4939854
2018-02-27,12774400.0,44.150001525878906,44.310001373291016,43.619998931884766,43.619998931884766,40.14682769775391,KO,Monster Beverage (MNST) Q4 Earnings: Is a Beat in Store?,0,0.47944996
2018-02-28,11929400.0,43.83000183105469,43.90999984741211,43.220001220703125,43.220001220703125,39.77867889404297,KO,Afraid Market Volatility? Vanguard Consumer Staples Is Safe and Cheap ||| Monster Beverage Hits the Brakes ||| Coca-Cola a Top Socially Responsible Dividend Stock With 3.6% Yield (KO) ||| Coca-Cola Bottling (COKE) Earnings & Revenues Grow in Q4,1,0.4998604
2018-03-01,17746800.0,43.09999847412109,43.63999938964844,42.81999969482422,43.43000030517578,39.971961975097656,KO,"FEMSA (FMX) Lags Q4 Earnings & Sales Estimates, Stock Falls ||| Molson Coors Brewing Company (TAP) Ex-Dividend Date Scheduled for March 02, 2018 ||| Monster Beverage (MNST) Q4 Earnings & Revenues Lag Estimates ||| Market Close Report: NASDAQ Composite index closes at 7,180.56 down -92.45 points ||| Stocks Sink After Trump Tariff Announcement",1,0.49793765
2018-03-02,14050100.0,43.25,43.79999923706055,43.2400016784668,43.720001220703125,40.23887252807617,KO,"Notable ETF Inflow Detected - XLP, KO, PEP, COST",1,0.506117
2018-03-05,11992700.0,43.56999969482422,43.93999862670898,43.5,43.88999938964844,40.39533615112305,KO,"2 Reasons Coca-Cola Is a Better Dividend Stock than Starbucks ||| Fretting Over Trump Tariffs? Buy 5 Ultra-Safe Stocks Now ||| Monster Beverage Is A 'Compelling Growth Story,' Deutsche Bank Says In Upgrade",1,0.49614608
2018-03-06,10010500.0,43.95000076293945,44.04999923706055,43.59000015258789,43.93000030517578,40.4321517944336,KO,Coca-Cola to Launch Alcoholic Drink in Japan -FT,0,0.5039838
2018-03-07,10881700.0,43.59000015258789,43.91999816894531,43.470001220703125,43.81999969482422,40.33089828491211,KO,Monster Beverage Stumbles: Should Investors Worry?,1,0.5007525
2018-03-08,12361100.0,43.900001525878906,44.459999084472656,43.79999923706055,44.45000076293945,40.91073989868164,KO,"Goodbye, Gary Cohn. Hello, Coke Beverages With Alcohol ||| How to Invest in ETFs Backed by Women Power ||| Coca-Cola (KO) Forays Into Alcoholic Drink Space in Japan",1,0.51554537
2018-03-09,9778600.0,44.56999969482422,44.81999969482422,44.38999938964844,44.81999969482422,41.25128936767578,KO,"Cott Corporation (COT) Ex-Dividend Date Scheduled for March 12, 2018 ||| Company News For Mar 9, 2018 ||| The Coca-Cola Company Announces Letter of Intent for Acquiring And Refranchising Of Canadian Bottling Operations",0,0.5030663
2018-03-12,11857700.0,44.95000076293945,45.09000015258789,44.33000183105469,44.52999877929688,40.984375,KO,"Better Buy: Altria Group vs. Coca-Cola ||| Coca-Cola Dips a Toe Into the Alcohol Market ||| Coca-Cola Plans to Localize Two-Thirds of its Products for India Market -LiveMint ||| XLP, REW: Big ETF Inflows ||| Will Coca-Cola's (KO) Diversification Plan Rev Up Sales? ||| The Zacks Analyst Blog Highlights: Coca-Cola, Eli Lilly, Occidental Petroleum, Ross Stores and Wynn Resorts",1,0.50218326
2018-03-13,11342100.0,44.66999816894531,44.83000183105469,44.400001525878906,44.56999969482422,41.02118682861328,KO,"3 Rules You Need for Picking Dividend Stocks ||| Salesforce to Buy B2B eCommerce Software Provider CloudCraze ||| Coca-Cola Company (KO) Ex-Dividend Date Scheduled for March 14, 2018",0,0.5003886
2018-03-14,15321200.0,44.380001068115234,44.43000030517578,43.72999954223633,43.77999877929688,40.6497917175293,KO,"VUG, CMCSA, KO, PM: Large Inflows Detected at ETF",0,0.52758014
2018-03-15,12456700.0,43.880001068115234,44.0,43.54999923706055,43.66999816894531,40.54764938354492,KO,"Should You Buy Kroger Co After Its Post-Earnings Plunge? ||| Is the Dismal Surprise Trend a Grave Concern for FEMSA (FMX)? ||| Is This the Beginning of a Rough Patch for Coca-Cola Stock? ||| Analysts Predict 12% Gains Ahead For EDOW ||| How Much Money Does NCAA March Madness Make? ||| Coca-Cola's Tiny Experiment With Alcoholic Beverages ||| 3 Naked Puts to Help You Make $1,000 Monthly",0,0.48206782
2018-03-16,26603300.0,43.70000076293945,44.02000045776367,43.45000076293945,43.459999084472656,40.3526611328125,KO,"Better Buy: Coca-Cola vs. Philip Morris ||| Salesforce.com, Inc. Stock Is Firing on All Cylinders",0,0.492897
2018-03-19,12380300.0,43.459999084472656,43.709999084472656,43.18000030517578,43.2599983215332,40.16696548461914,KO,"Dow Movers: CAT, NKE ||| 10 Can’t-Miss Dividend Hikes Coming This April ||| Dr Pepper Snapple Group, Inc (DPS) Ex-Dividend Date Scheduled for March 20, 2018 ||| The Business Behind the NCAA's Money-Making March Madness Tournament",0,0.48760498
2018-03-20,13559800.0,43.31999969482422,43.47999954223633,43.0099983215332,43.15999984741211,40.07411575317383,KO,"What Is MuleSoft, and Why Does Salesforce Want to Buy It?",0,0.49337265
2018-03-21,13054000.0,43.130001068115234,43.45000076293945,42.790000915527344,43.0,39.925559997558594,KO,"Salesforce to Acquire MuleSoft, Its Biggest-Ever Buyout Deal",0,0.5170206
2018-03-22,12274100.0,42.880001068115234,43.369998931884766,42.70000076293945,42.7599983215332,39.70271682739258,KO,"Dow Movers: BA, KO ||| Market Close Report: NASDAQ Composite index closes at 7,166.68 down -178.61 points",0,0.49937087
2018-03-26,11276100.0,42.61000061035156,42.810001373291016,42.25,42.68999862670898,39.63772201538086,KO,Drink It Up: Coca-Cola Is Using Blockchain to Improve Workers' Rights ||| Which Consumer-Goods Stocks Have the Best Dividend? ||| Why Warren Buffett Uses Book Value to Measure His Performance ||| Better Buy: International Business Machines Corporation vs. Coca-Cola ||| There Still Is Some Upside Left in Dr Pepper Snapple Group Inc. Stock ||| Rise Of The Robots: 7 New AI-Powered iShares ETFs,1,0.50664324
2018-03-28,16277400.0,43.0,43.70000076293945,43.0,43.31999969482422,40.22267532348633,KO,"Dow Movers: INTC, VZ ||| Here Are 953 Million Reasons to Buy Shares of Buffett's Berkshire Hathaway",1,0.48717332
2018-04-02,14207900.0,43.43999862670898,43.5,42.470001220703125,42.66999816894531,39.61915969848633,KO,How Safe Is Coca-Cola's Stock (KO) and Dividend? ||| iShares Russell 1000 ETF Experiences Big Outflow ||| The Coca-Cola Company On Friday Recommended Shareholders Reject Mini-Tender Offer By TRC Capital Corp.,1,0.5030531
2018-04-03,15484600.0,42.97999954223633,43.540000915527344,42.84000015258789,43.380001068115234,40.27839279174805,KO,Is Coca-Cola Stock a Buy? ||| What You Need To Know About Snap Today,1,0.5013223
2018-04-04,13563300.0,43.13999938964844,44.400001525878906,43.11000061035156,44.2400016784668,41.07690048217773,KO,"Stocks Trim Losses as Kudlow Assures Wall Street About Trade War ||| GlaxoSmithKline's Horlicks Up for Grabs: Who Will Snap It Up? ||| Dow Movers: BA, KO ||| Close Update: Wall Street Rallies Back as Trade War Fears Subside",1,0.48432574
2018-04-09,11913400.0,44.02999877929688,44.310001373291016,43.77999877929688,43.83000183105469,40.69621276855469,KO,"Should Facebook, Inc. Launch a Paid Service? Absolutely!",1,0.5060463
2018-04-10,10379500.0,44.06999969482422,44.18000030517578,43.720001220703125,43.9900016784668,40.84477615356445,KO,"Top Stock Reports for Wells Fargo, Coca-Cola & Disney ||| VUG, FB, HD, KO: ETF Inflow Alert ||| 7 Stocks to Buy for Big May Dividend Hikes",0,0.50322145
2018-04-11,8424300.0,43.810001373291016,44.13999938964844,43.7599983215332,43.9900016784668,40.84477615356445,KO,"The Zacks Analyst Blog Highlights: Wells Fargo, Coca-Cola, Disney, Fiserv and Archer Daniels ||| Stocks Sink as Trump Fuels Syria Tensions",1,0.5270208
2018-04-12,8476400.0,44.08000183105469,44.40999984741211,43.95000076293945,44.02999877929688,40.88191223144531,KO,Here's How You Can Buy the Buffett Way Ahead of Q1 Earnings,1,0.5097977
2018-04-13,10774200.0,44.18999862670898,44.68999862670898,44.13999938964844,44.5099983215332,41.32759475708008,KO,"XLP, BJK: Big ETF Outflows",1,0.5260718
2018-04-16,8962100.0,44.650001525878906,44.88999938964844,44.400001525878906,44.68000030517578,41.485443115234375,KO,Here's What Makes FEMSA (FMX) a Good Investment Choice Now,1,0.5209809
2018-04-17,8406400.0,44.95000076293945,45.02999877929688,44.650001525878906,44.880001068115234,41.67113876342773,KO,"5 Dividend Aristocrats Where Analysts See Capital Gains ||| SCIU's Holdings Imply 10% Gain Potential ||| PepsiCo's Cost-Saving Plans to Spur Growth Amid Weak Sales ||| Benzinga's Top Analyst Calls From April 17, 2018 ||| Dividend Growth ETFs Stumble As Payout Growth Continues ||| Molson Coors Downgraded By Goldman Sachs On Weak Volume; Coca-Cola European Partners Upgraded On Growth Opportunity ||| A Beverage Pair Trade From Goldman Sachs: Buy Coca-Cola, Sell Pepsi ||| Benzinga's Top Upgrades, Downgrades For April 17, 2018 ||| Goldman Sachs Upgrades Coca-Cola to Neutral",0,0.5061611
2018-04-18,7429000.0,44.900001525878906,44.970001220703125,44.33000183105469,44.5099983215332,41.32759475708008,KO,General Electric Company Stock Could Get Buffett Boost ||| The 3 Most Ambitious Blockchain Projects,0,0.4896741
2018-04-20,14690700.0,44.310001373291016,44.40999984741211,43.58000183105469,43.7400016784668,40.61265563964844,KO,"ITOT, PFE, VZ, KO: Large Inflows Detected at ETF ||| Will Cost Cut, Innovations Drive Coca-Cola (KO) Q1 Earnings? ||| Markets Now: Dow Tumbles 275 Points as Earnings Aren't Enough",1,0.4997877
2018-04-23,11878500.0,43.7400016784668,43.9900016784668,43.560001373291016,43.97999954223633,40.83549118041992,KO,"Stocks To Watch: Earnings Blockbusters And Trump Talks Drug Prices ||| Better Buy: Coca-Cola vs. Anheuser Busch InBev ||| Will Hershey's (HSY) Cost-Saving Plans Drive Q1 Earnings? ||| Will North America Sales Drive Coca-Cola's (KO) Q1 Earnings? ||| KO vs. PEP: Which Stock is Poised for Better Q1 Earnings? ||| Will FEMSA (FMX) Repeat its Dismal Earnings Trend in Q1? ||| Is Colgate (CL) Poised for Another Earnings Surprise in Q1? ||| NYSE to Soon Greet The Fearless Girl Statue ||| BodyArmor Takes On Gatorade, The NBA & Twitch, & An ESPN+ Update ||| Pre-Market Earnings Report for April 24, 2018 : VZ, KO, MMM, LMT, UTX, CAT, LLY, NEE, BIIB, TRV, SHW, FCX ||| The Week Ahead: Sohn Conference, FANG Earnings, DocuSign IPO",0,0.5227986
2018-04-24,18523900.0,43.97999954223633,44.09999847412109,42.72999954223633,43.06999969482422,39.99054718017578,KO,"KO Stock Delivers Solid Q1 Amid Mounting Concerns ||| Wait for a Lower Valuation Before Buying The Coca-Cola Co Stock ||| Morning Movers: Caterpillar Climbs, Verizon Jumps, Coca-Cola Bubbles Up ||| Coca-Cola (KO) Stock Gains on Q1 Earnings & Revenue Beat ||| Mid-Day Market Update: Sanmina Surges Following Q2 Beat; Valeritas Shares Slide ||| Coca-Cola (KO) Tops Q1 Earnings & Revenue Estimates ||| Coca-Cola Company (The) (KO) Q1 2018 Earnings Conference Call Transcript ||| Consumer Sector Update for 04/24/2018: WHR, HOG, JBLU, KORS ||| Markets Now: Dow Drops 481 Points as Market Searches for Meaning ||| Consumer Sector Update for 04/24/2018: HOG,JBLU,KO ||| Earnings Reaction History: The Coca-Cola Company, 27.3% Follow-Through Indicator, 1.2% Sensitive ||| Mid-Afternoon Market Update: Dow Falls Over 500 Points; Santander Consumer USA Shares Gain On Earnings Beat ||| Mid-Day Market Update: Sanmina Surges Following Q2 Beat; Valeritas Shares Slide ||| Bond Yield Rise Pauses, Dow Futures Get A Bit of Help From Some Earnings ||| Mid-Morning Market Update: Markets Mostly Flat; Coca-Cola Beats Q1 Views ||| A Peek Into The Markets: US Stock Futures Rise Ahead Of Earnings, Economic Data ||| Coca-Cola Says Is On Track To Hit FY Targets ||| Coca-Cola Q1 Adj. EPS $0.47 Beats $0.46 Est., Sales $7.6B Beats $7.3B Est. ||| 12 Stocks To Watch For April 24, 2018 ||| Earnings Scheduled For April 24, 2018",0,0.4940296
2018-04-25,20774700.0,42.7400016784668,42.88999938964844,41.90999984741211,42.43000030517578,39.39631271362305,KO,"Midday Update: Dow on Course For Longest Losing Streak in a Year as Investors Rotate Into Bonds ||| Coca-Cola Bottling Co. Consolidated (COKE) Ex-Dividend Date Scheduled for April 26, 2018 ||| A Preview of Coca-Cola European Partners' (CCE) Q1 Earnings ||| Soft Drink Stocks' Q1 Earnings Slated on Apr 26: PEP, CCE ||| Notable Wednesday Option Activity: KO, IPI, RRC ||| A Preview Of Coca-Cola European Partners' Q1 Earnings",1,0.48545855
2018-04-26,13561000.0,42.400001525878906,43.09999847412109,42.2599983215332,42.75,39.69342422485352,KO,"Dr Pepper's (DPS) Q1 Earnings Miss, Revenues Beat Estimates ||| Top Stock Reports for JPMorgan, Coca-Cola, Comcast & United Technologies ||| Is iShares Edge MSCI USA Size Factor ETF (SIZE) a Hot ETF Right Now? ||| PepsiCo's (PEP) Shares Surge on Q1 Earnings & Revenue Beat ||| Facebook Stock Reports Its Most Important Quarter Yet and Doesn’t Disappoint",1,0.49624762
2018-04-27,9777900.0,42.72999954223633,43.34000015258789,42.709999084472656,43.310001373291016,40.2133903503418,KO,"Daily Dividend Report: TRP, IMO, APAM, KO, TXN ||| FEMSA (FMX) Stock Rises Despite Q1 Earnings & Sales Miss ||| The Zacks Analyst Blog Highlights: JPMorgan, Coca-Cola, Comcast and United Technologies ||| Consumer Staples ETFs: No Safety This Year",0,0.50221777
2018-04-30,16037700.0,43.5,43.68999862670898,42.970001220703125,43.209999084472656,40.120548248291016,KO,"Food Stocks Slated to Report Q1 Earnings on May 1: MDLZ, ADM ||| Will Weak Sales Hurt Kraft Heinz's (KHC) Earnings in Q1? ||| Anheuser-Busch Inbev SA (BUD) Ex-Dividend Date Scheduled for May 01, 2018",0,0.4682262
2018-05-01,11514200.0,42.959999084472656,42.9900016784668,42.18000030517578,42.59000015258789,39.54487228393555,KO,Consumer Staples Select Sector SPDR Fund Experiences Big Inflow ||| PreMarket Prep Opening NYSE Imbalance Update: Coca-Cola 213k Shares To Sell; AT&T 313k To Sell; ExxonMobil 114k To Sell; McDonald's 99k To Sell; Proctor & Gamble 87k To Sell; General Electric 226k To Sell,0,0.47358078
2018-05-02,13736400.0,42.400001525878906,42.59000015258789,41.93999862670898,42.060001373291016,39.052764892578125,KO,The Greatest Value Investors of All-Time,0,0.50298244
2018-05-03,18352200.0,42.220001220703125,42.400001525878906,41.52000045776367,41.88999938964844,38.89492034912109,KO,"Stocks That Made New 52-Week Lows Today Include Colgate-Palmolive, Philip Morris, Regeneron, Corning, Hanesbrands, Bed Bath & Beyond, Pepsi, Coca-Cola, Paccar, Johnson & Johnson, Mallinckrodt, CBS, DISH Network, Goodyear Tire, Chubb, Hershey, and AT&T ||| PreMarket Prep Opening NYSE Imbalance Update: Coca-Cola 155k Shares To Buy; Alibaba 87k To Buy; AT&T 46k to Buy; Pfizer 43k To Buy; General Electric 159k To Buy; Square 168k To Sell; Verizon 47k To Buy",1,0.4840256
2018-05-04,10946200.0,41.790000915527344,42.5,41.77000045776367,42.36000061035156,39.33131790161133,KO,"After Hours Most Active for May 4, 2018 : GE, KMI, BAC, UTX, KO, COG",0,0.4820663
2018-05-07,9336000.0,42.34000015258789,42.4900016784668,41.959999084472656,42.13999938964844,39.127044677734375,KO,Will Product Innovation Boost Monster's (MNST) Q1 Earnings? ||| Coca-Cola Bottling (COKE) Q1 Earnings: What's in Store?,0,0.47816804
2018-05-08,15062200.0,41.970001220703125,42.09000015258789,41.68999862670898,41.810001373291016,38.82064437866211,KO,"Has Monster Beverage's Recovery Fizzled? ||| Constellation Brands Inc (STZ) Ex-Dividend Date Scheduled for May 09, 2018",0,0.46757114
2018-05-09,9295200.0,41.970001220703125,42.22999954223633,41.66999816894531,41.77999877929688,38.79278564453125,KO,"Monster Beverage (MNST) Q1 Earnings In Line, Sales Miss ||| Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)?",1,0.5007157
2018-05-10,7924200.0,41.9900016784668,42.36000061035156,41.93999862670898,42.18000030517578,39.164188385009766,KO,"Coca-Cola Bottling (COKE) Incurs Loss in Q1, Shares Down",0,0.5201618
2018-05-14,10715500.0,42.25,42.31999969482422,41.900001525878906,42.040000915527344,39.0342025756836,KO,"Better Buy: Altria Group vs. Coca-Cola ||| HEWG, SIZE: Big ETF Outflows",0,0.5108618
2018-05-15,16449700.0,41.77999877929688,41.91999816894531,41.45000076293945,41.720001220703125,38.73707580566406,KO,"After Hours Most Active for May 15, 2018 : QQQ, PPL, GE, KO, EXC, FNSR, PFE, INTC, EPD, CELG, MSFT, FOLD ||| Jim Cramer Gives His Opinion On Wendys And Coca-Cola",0,0.50164443
2018-05-16,11590500.0,41.7400016784668,41.93999862670898,41.540000915527344,41.54999923706055,38.579227447509766,KO,Can Healthier Options Buoy the U.S. Soft Beverages Industry? ||| Buy and Hold Forever? Nah – I’d Sell If You See These 3 Signs ||| Warren Buffett Pushing More Cash To Equities; 'Big 5' Stocks Still At The Top,1,0.48342642
2018-05-17,14857400.0,42.0099983215332,42.34999847412109,41.869998931884766,42.29999923706055,39.27560424804688,KO,"Notable ETF Inflow Detected - IVW, KO, ACN, MO ||| Dow Movers: CSCO, KO ||| Stocks Fall After Trump's China Comments ||| Barclays Finds Coca-Cola's Stock Refreshing As Consumer Staples Industry Suffers ||| Benzinga's Top Upgrades, Downgrades For May 17, 2018 ||| A Peek Into The Markets: US Stock Futures Down Ahead Of JC Penney Earnings ||| Barclays Upgrades Coca-Cola to Overweight",0,0.5005624
2018-05-18,11950200.0,42.29999923706055,42.380001068115234,42.08000183105469,42.18000030517578,39.164188385009766,KO,5 Income Plays for 25 More Years of Dividend Growth,1,0.5743407
2018-05-21,9110200.0,42.310001373291016,42.52000045776367,42.27000045776367,42.40999984741211,39.377742767333984,KO,"12 Dow 30 Companies With Above-Average Salaries ||| Benzinga's Bulls & Bears Of The Week: Coca-Cola, Ford, JC Penney, Spotify And More ||| Giving Consumer Staples ETFs Another Chance",0,0.5368527
2018-05-22,8222900.0,42.5,42.59999847412109,42.209999084472656,42.25,39.22918319702149,KO,"Notable ETF Outflow Detected - XLP, KO, PM, WMT ||| Innovations & Emerging Market Presence Bode Well for PepsiCo ||| Starbucks Corporation Aims Toward Worldwide Name Recognition",1,0.53565603
2018-05-23,8971400.0,42.25,42.45000076293945,41.93000030517578,42.400001525878906,39.36845779418945,KO,7 Dividend Aristocrats That Could Outpace the Market,0,0.5303973
2018-05-24,9269600.0,42.400001525878906,42.470001220703125,42.18999862670898,42.31999969482422,39.2941780090332,KO,Coca-Cola (KO) Down 1.9% Since Earnings Report: Can It Rebound? ||| General Mills' 30% Upside Looks Appetizing,1,0.49401498
2018-05-25,8806500.0,42.34000015258789,42.58000183105469,42.20000076293945,42.400001525878906,39.36845779418945,KO,Consumer Products Aren’t Nearly as Safe as You Thought — They’re Dying,1,0.49253687
2018-05-29,14826900.0,42.119998931884766,42.84999847412109,42.09999847412109,42.68000030517578,39.62843704223633,KO,"PepsiCo to Acquire Bare Foods, Augment Organic Offerings ||| Dow Movers: GE, KO ||| Market Close Report: NASDAQ Composite index closes at 7,396.59 down -37.26 points ||| Europe Drama, Big Banks Cause Stock Sell-Off; VIX Surges ||| Magento Buy Keeps Adobe Systems Inc. Stock Expensive but Worth It ||| Coca Cola To Invest $1.2B In Argentina From 2019-2021",1,0.48776326
2018-05-30,10114200.0,42.77000045776367,43.27999877929688,42.70000076293945,43.130001068115234,40.04626083374024,KO,"Pepsico, Inc. (PEP) Ex-Dividend Date Scheduled for May 31, 2018 ||| Cott Corporation (COT) Ex-Dividend Date Scheduled for May 31, 2018 ||| Coca-Cola to Boost Investment in Argentina to $1.2 Billion",0,0.46877846
2018-05-31,15571300.0,43.20000076293945,43.209999084472656,42.68000030517578,43.0,39.925559997558594,KO,"Is the Panic Over Italy’s Political Crisis an Opportunity for Investors? ||| Consumer Staples Select Sector SPDR Fund Experiences Big Inflow ||| Monster Beverage's New Share Buyback Plan to Boost Returns ||| Molson Coors Brewing Company (TAP) Ex-Dividend Date Scheduled for June 01, 2018 ||| The Market In 5 Minutes: Right To Try, Uber, Buffett, Jobless Claims And More",1,0.49327028
2018-06-01,10664700.0,43.09999847412109,43.31999969482422,43.040000915527344,43.119998931884766,40.03697204589844,KO,PepsiCo Continues Its Push Into Healthy Snacks,1,0.5525266
2018-06-04,11727600.0,43.36000061035156,43.59000015258789,43.290000915527344,43.4900016784668,40.38052749633789,KO,Here's Why You Should Stay Away From Monster Beverage Now,0,0.49871972
2018-06-06,9202900.0,43.060001373291016,43.459999084472656,43.040000915527344,43.459999084472656,40.3526611328125,KO,"Consumer Staples Hits New Low, Mexico Tariffs Add to Woes",0,0.48265612
2018-06-07,11948100.0,43.33000183105469,43.72999954223633,43.33000183105469,43.43999862670898,40.33409881591797,KO,Here's How FIFA's World Cup Sponsors Have Performed on the Stock Market ||| Consumer Staples Don't 'Have To Come Back',1,0.50880086
2018-06-08,12078800.0,43.56999969482422,44.0,43.560001373291016,43.95000076293945,40.80763626098633,KO,"Why Investors Have Turned Cautious on Monster Beverage Shares ||| After Hours Most Active for Jun 8, 2018 : OLLI, IEF, BAC, CMCSA, QQQ, ZNGA, SWN, TWTR, FOXA, KO, XOM, BHLB ||| Why Monster Beverage Corp. Shares Sparkled On Friday",1,0.48059994
2018-06-11,7526100.0,43.95000076293945,44.25,43.88999938964844,44.130001068115234,40.97476577758789,KO,"Weekly Market Preview: Trump Meets Kim Jong Un, FOMC Meets On Interest Rates, Retail Sales, And More ||| KO, BUD & More to Score With World Cup Sponsorships ||| The Zacks Analyst Blog Highlights: Adidas, Coca-Cola, Visa, Budweiser and McDonald's ||| Adidas vs Nike: Which Sportswear Giant Will Win the FIFA World Cup? ||| Better Buy: Coca-Cola vs. Philip Morris",1,0.48981625
2018-06-12,8243300.0,44.130001068115234,44.41999816894531,44.08000183105469,44.40999984741211,41.234745025634766,KO,Can Growing Bottled Water Sales Save CSD Makers' Fortunes? ||| Coca-Cola Option Alert: Aug 17 $44 Calls Sweep (4) near the Ask: 1017 @ $1.101 vs 15799 OI; Earnings 7/25 Before Open [est] Ref=$44.375,0,0.48339573
2018-06-13,16745000.0,44.34999847412109,44.52000045776367,44.150001525878906,44.18000030517578,41.02118682861328,KO,"Dow Analyst Moves: KO ||| Coca-Cola Company (KO) Ex-Dividend Date Scheduled for June 14, 2018 ||| Implied Volatility Surging for Coca-Cola Company (KO) Stock Options ||| FEMSA (FMX) on Crossroads: Can Strategies Counter Hurdles? ||| Why Coca-Cola is a Top 25 Dividend Giant (KO) ||| After Hours Most Active for Jun 13, 2018 : CMCSA, FOXA, ATUS, MSFT, KO, TWTR, PPL, QQQ, VZ, INTC, SOXX, VSH ||| Notable Wednesday Option Activity: KO, AA, BLUE ||| Ahead Of Fed, AT&T-Time Warner Ruling Injects Some Optimism Into Market ||| Coca-Cola Reaffirms FY Guidance; Sees Currency Headwind on Q2 EPS to be ~2%; Sees FY 2018 EPS Currency Headwind of 2% to 3%.",0,0.48913884
2018-06-14,12696200.0,43.75,43.84999847412109,43.52000045776367,43.58000183105469,40.82447052001953,KO,Adidas Vs. Nike: Which Sportswear Giant Will Win The FIFA World Cup?,1,0.5204399
2018-06-15,21562500.0,43.560001373291016,44.150001525878906,43.45000076293945,44.119998931884766,41.33031845092773,KO,"Ambev S.A. (ABEV) Ex-Dividend Date Scheduled for June 18, 2018",0,0.45134374
2018-06-18,12161900.0,43.880001068115234,43.959999084472656,43.400001525878906,43.54999923706055,40.79636764526367,KO,"IWB, KO, DIS, CMCSA: Large Outflows Detected at ETF ||| XLP, RNDM: Big ETF Inflows ||| Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)?",1,0.5083694
2018-06-19,12936400.0,43.29999923706055,43.75,43.20000076293945,43.59999847412109,40.843204498291016,KO,Analysts Predict 10% Gains Ahead For RNDV ||| Will Sodastream International Ltd Stock Fizz or Fizzle Out? ||| A Look Back At What's Happened To Each Sector Through The First Half Of 2018 (Part 2),0,0.47818056
2018-06-20,10893700.0,43.619998931884766,43.77999877929688,43.22999954223633,43.2599983215332,40.524696350097656,KO,Walgreens Stock Replaces GE in the DJIA,0,0.4975588
2018-06-21,10465200.0,43.27000045776367,43.29999923706055,42.959999084472656,43.09000015258789,40.36544799804688,KO,Revival of North America Sales to Aid NIKE (NKE) Q4 Earnings,1,0.5444801
2018-06-22,14924400.0,43.150001525878906,43.40999984741211,43.08000183105469,43.25,40.51533508300781,KO,"Constellation Brands (STZ) Q1 Earnings: What's in the Cards? ||| Will CCI Plan Aid McCormick (MKC) Q2 Earnings Amid Cost Woes? ||| National Beverage: I See New Highs In The Short Term, While My 2-Year Target Moves Up To $250",1,0.5432021
2018-06-25,12092400.0,43.15999984741211,43.75,43.15999984741211,43.58000183105469,40.82447052001953,KO,"Dow Movers: CAT, WMT ||| Warren Buffett and Jamie Dimon Say You're Too Short-Sighted",0,0.49402177
2018-06-26,13974700.0,43.560001373291016,43.84000015258789,43.27999877929688,43.33000183105469,40.59027862548828,KO,"Top Stock Reports for Facebook, Amgen & Abbott ||| Notable ETF Inflow Detected - XLP, KO, PEP, MDLZ",0,0.5057325
2018-06-27,15332600.0,43.33000183105469,43.61000061035156,42.9900016784668,43.06999969482422,40.346710205078125,KO,Dr Pepper Issues Updates on Keurig Merger & Special Dividend,1,0.5169573
2018-06-28,12668900.0,43.2400016784668,43.68000030517578,43.16999816894531,43.470001220703125,40.7214241027832,KO,"Dow Movers: WBA, VZ",1,0.52183545
2018-06-29,11485600.0,43.56999969482422,44.09999847412109,43.310001373291016,43.86000061035156,41.08676528930664,KO,Dr Pepper Issues Updates on Keurig Merger & Special Dividend (revised) ||| Planters Cheez Balls Are Coming Back: Here Are 7 Other Foods We Want To Eat Again,0,0.48033217
2018-07-02,9232500.0,43.77999877929688,44.15999984741211,43.58000183105469,43.75,40.98371887207031,KO,Here's How FIFA's World Cup Sponsors Have Performed on the Stock Market ||| Trade War Tensions Re-escalate ||| Trade War Rhetoric Heats Up ||| PreMarket Prep Opening NYSE Imbalance Update: Coca-Cola 146k Shares To Sell; Pfizer 147k To Sell; IBM 76k To Sell; BofA 75K To Sell,1,0.4629495
2018-07-03,8214300.0,44.060001373291016,44.33000183105469,43.9900016784668,43.9900016784668,41.20854568481445,KO,"Dr Pepper & Keurig Merger Nears Completion, Forms Board ||| Don’t Expect Merger to Invigorate Dr Pepper Snapple Stock",1,0.51603764
2018-07-05,11653000.0,44.15999984741211,44.66999816894531,44.130001068115234,44.65999984741211,41.83617782592773,KO,4 Items to Watch When PepsiCo Reports Earnings ||| 3 Huge Reasons to Be Bullish on Coca-Cola Stock ||| Better Buy: The Coca Cola Co (KO) vs. Procter & Gamble Co (PG),0,0.52080345
2018-07-06,8733900.0,44.66999816894531,44.93999862670898,44.58000183105469,44.63999938964844,41.81744384765625,KO,Coca-Cola (KO) Shares Cross Above 200 DMA,0,0.5069939
2018-07-09,7373100.0,44.540000915527344,44.72999954223633,44.34000015258789,44.400001525878906,41.59261703491211,KO,"XLP, KO, PEP, PM: ETF Outflow Alert ||| Gatorade Rival Heats Up, Nike Loses a Star & a Publicly Traded Soccer Update",1,0.51811004
2018-07-10,10606100.0,44.5099983215332,45.0,44.5,44.970001220703125,42.126583099365234,KO,"Earnings Beat Reaffirms PepsiCo Stock — As a Dividend Play ||| 3 Companies To Make Trump’s Trade War Feel Irrelevant ||| PepsiCo (PEP) Stock Up on Q2 Earnings Beat, Revenues Lag ||| Nike Already Won the FIFA World Cup Over Adidas",0,0.5094312
2018-07-11,7715600.0,44.9900016784668,45.0,44.63999938964844,44.790000915527344,41.95795822143555,KO,"Consumer Staples ETF (XLP) Hits New 52-Week High ||| Stock Market News For Jul 11, 2018 ||| The Key Questions Facing McDonald’s Stock",0,0.47472337
2018-07-12,6331600.0,44.83000183105469,44.959999084472656,44.4900016784668,44.66999816894531,41.84554672241211,KO,5 Tips for Making Money in Penny Stocks,1,0.5629667
2018-07-16,5831400.0,44.72999954223633,44.79999923706055,44.52999877929688,44.72999954223633,41.90175247192383,KO,PreMarket Prep Opening NYSE Imbalance Update: ExxonMobil 55k Shares To Sell; Pfizer 50k To Sell; Merck 26k To Sell; Coca-Cola 54k To Sell; Johnson & Johnson 54k To Sell; Ford 103k To Sell; Kroger 90k To Sell,1,0.48288646
2018-07-18,7351600.0,45.18999862670898,45.290000915527344,44.84000015258789,45.119998931884766,42.26709365844727,KO,"KXI, KO, PEP, PM: ETF Inflow Alert ||| Factors Setting the Tone for Coca-Cola's (KO) Q2 Earnings ||| Better Buy: Philip Morris International vs. Coca-Cola ||| Why PepsiCo is a Top Socially Responsible Dividend Stock (PEP)",0,0.4996164
2018-07-19,10097500.0,44.9900016784668,45.43000030517578,44.91999816894531,45.11000061035156,42.25772857666016,KO,"3 Big Stock Charts for Thursday: McDonald’s, AbbVie and Coca-Cola ||| Should You Invest in the FID-STAPLES (FSTA)? ||| Baltimore City Ordinance Barring Restaurants From Including Sodas/Sugary Drinks on Kids Menus Went Into Effect Wednesday ||| Upcoming Earnings: GE Reports Friday Morning, Turnaround And Restructuring Rolls On",1,0.5339225
2018-07-20,8588400.0,45.02000045776367,45.27999877929688,44.900001525878906,45.27999877929688,42.416969299316406,KO,"Trade Tension Back In Town, Weighing On Sentiment Despite Strong Tech Results",0,0.51112324
2018-07-23,9055700.0,45.27999877929688,45.36000061035156,44.77000045776367,44.95000076293945,42.10784149169922,KO,"Upcoming Earnings: Alphabet's $5 Billion Fine to Weigh on Results ||| Big Week Ahead For Info Tech With Some Major Names On Tap, Along With GDP ||| The Week Ahead: FANG Earnings Continue, Fox Vote On Disney Deal, More IPOs",1,0.5157176
2018-07-24,13786100.0,44.77999877929688,45.27000045776367,44.61000061035156,45.2599983215332,42.39823913574219,KO,"Will North America Sales Fuel Coca-Cola's (KO) Q2 Earnings? ||| Coca-Cola (KO) Gains 0.7% Ahead of Earnings: What To Expect ||| After Hours Most Active for Jul 24, 2018 : WFC, FOXA, QQQ, T, KMI, KO, RWT, KR, SYMC, CMCSA, INTC, AMAT ||| Pre-Market Earnings Report for July 25, 2018 : BA, KO, TMO, NEE, UPS, ANTM, GD, GM, NOC, BSX, NSC, HCA ||| Coca-Cola Q2 Earnings Preview ||| Madison Square Garden Strikes Sponsorship Deal With Pepsi, Ending Century-Long Coke Partnership ||| Food And Beverage Earnings: Reports Coming Up From Coca-Cola And McDonald's ||| 'JUST IN: Pepsi wins pouring rights for Madison Square Garden properties, including MSG & Radio City, unseats Coca-Cola, which has had deal since 1910.' -Tweet From Darren Rovell",1,0.48768115
2018-07-25,21330600.0,46.0,46.58000183105469,45.75,46.09000015258789,43.17576217651367,KO,"Coca-Cola (KO) Beats on Q2 Earnings & Revenues, Updates View ||| Dow Movers: BA, KO ||| Coca-Cola Company (The) (KO) Q2 2018 Earnings Conference Call Transcript ||| Facebook Earnings Preview, & Today's Top Reports: BA, GM, GRUB, KO | Free Lunch ||| Understanding the Differences Between Dividends and Distributions ||| Coca-Cola Bottling Co. Consolidated (COKE) Ex-Dividend Date Scheduled for July 26, 2018 ||| Coca-Cola Earnings: KO Stock Pulls Off Surprise Q2 Beat ||| Mid-Day Market Update: Crude Oil Up Over 1%; Agile Therapeutics Shares Plunge ||| Coca-Cola (KO) Tops Q2 Earnings and Revenue Estimates ||| Consumer Sector Update for 07/25/2018: KO,GM,FCAU ||| Coca-Cola (KO) Q2 Earnings & Revenues Surpass Estimates ||| Coca-Cola (KO) Says Diet Sodas Aren't Dead Yet ||| Consumer Sector Update for 07/25/2018: IRBT,KO,GM,FCAU ||| Notable Wednesday Option Activity: T, KO, MGM ||| Earnings Reaction History: The Coca-Cola Company, 27.3% Follow-Through Indicator, 1.3% Sensitive ||| Mid-Afternoon Market Update: U.S. Stocks Turn Higher; Travelzoo Shares Slide ||| Coca-Cola CEO Talks Q2 Earnings, Downplays North American Concerns ||| Mid-Day Market Update: Crude Oil Up Over 1%; Agile Therapeutics Shares Plunge ||| Mid-Morning Market Update: Markets Mostly Lower; Coca-Cola Tops Q2 Views ||| Coca-Cola Sees FY18 Growth Of 8-10% YoY, Organic Sales Growth Of 4% ||| Coca-Cola Q2 EPS $0.61 Beats $0.60 Estimate, Sales $8.9B Beat $8.55B Estimate ||| A Peek Into The Markets: US Stock Futures Flat Ahead Of Earnings ||| 14 Stocks To Watch For July 25, 2018 ||| Earnings Scheduled For July 25, 2018",1,0.49066928
2018-07-26,12673100.0,46.36000061035156,46.59000015258789,46.20000076293945,46.2400016784668,43.31628036499024,KO,"Notable ETF Outflow Detected - IWV, VZ, PG, KO ||| Understanding Dividend Stocks and Their Benefits and Risks ||| 5 Dow Jones Stocks That Are Ready to Rise Again ||| Pepsi Stock Should Continue to Satisfy Investors ||| What It Takes To Be A Dividend King",0,0.46979836
2018-07-27,10516900.0,46.31999969482422,46.5,46.060001373291016,46.209999084472656,43.28817367553711,KO,"Dow 30 Stock Roundup: Boeing, Intel, Verizon, Visa Earnings Impress ||| Cola Earnings Add Fizz to Consumer Staples ETFs ||| After Hours Most Active for Jul 27, 2018 : QQQ, WFC, CSCO, MS, DB, NOK, CZR, MO, KO, GILD, SOXX, SYMC ||| Coca-Cola (KO) Raises Soda Prices As Trade War Tensions Heat Up ||| A Running List Of The Companies Blaming Trade Policy For Stifled Earnings, Guidance",1,0.48544848
2018-07-30,8967900.0,46.09999847412109,46.43999862670898,46.04999923706055,46.22999954223633,43.306907653808594,KO,FEMSA (FMX) Tops Q2 Earnings on Solid FEMSA Comercio Results,1,0.5261998
2018-08-02,12009700.0,46.47999954223633,46.630001068115234,46.18000030517578,46.18000030517578,43.260066986083984,KO,Apple Hits $1 Trillion – Next Stop $300?,1,0.5056209
2018-08-03,11462800.0,46.22999954223633,46.7599983215332,46.13999938964844,46.619998931884766,43.6722526550293,KO,Coca-Cola CEO James Quincey Talks Share Gains and International Growth,1,0.55502063
2018-08-06,10056100.0,46.59999847412109,46.869998931884766,46.54999923706055,46.650001525878906,43.70034790039063,KO,"DGRO, KO, PEP, MRK: ETF Inflow Alert ||| Coca-Cola Stock Is Ready to Pop ||| Dow Movers: INTC, DIS ||| The Legacy Of Outgoing PepsiCo CEO Indra Nooyi",0,0.4994002
2018-08-07,8632900.0,46.52000045776367,46.61000061035156,46.130001068115234,46.5,43.55983352661133,KO,"Dow Movers: PG, CAT",0,0.5080112
2018-08-08,6810000.0,46.4900016784668,46.560001373291016,46.119998931884766,46.150001525878906,43.231971740722656,KO,"Diageo plc (DEO) Ex-Dividend Date Scheduled for August 09, 2018 ||| What's Sapping Monster Beverage's Energy?",1,0.499842
2018-08-09,8924100.0,46.25,46.41999816894531,46.08000183105469,46.34999847412109,43.4193229675293,KO,"Monster Beverage (MNST) Q2 Earnings Top, Sales Lag Estimates ||| 15 Consumer Stocks That Deliver Dividend Growth Like Clockwork ||| Why Monster Beverage Corp. Stock Jumped as Much as 5.1% Today",0,0.4936768
2018-08-13,8143400.0,46.04999923706055,46.130001068115234,45.70000076293945,45.83000183105469,42.93220520019531,KO,"Rescue Your Retirement With High-Growth Dividend Stocks ||| Safe Investments to Regularly Earn 12%-Plus ||| Dow Movers: KO, CSCO ||| Higher Interest Rates Aren’t Always Bad for Stocks",1,0.49760106
2018-08-14,6846100.0,45.90999984741211,46.09999847412109,45.869998931884766,45.88999938964844,42.988407135009766,KO,"USMV, WM, KO, PEP: ETF Inflow Alert ||| XLP, EZJ: Big ETF Inflows ||| Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)? ||| Sports Drink Wars: Coca-Cola Acquires BodyArmor Stake In Challenge To Gatorade ||| Benzinga Pro's 5 Stocks To Watch Today ||| Coca-Cola to Acquire Minority Stake in BODYARMOR with Path to Ownership Under Defined Terms, BODYARMOR to Gain Access to U.S. Coca-Cola Bottling System with Future Potential for Global Expansion",1,0.51087177
2018-08-16,10600700.0,46.11000061035156,46.380001068115234,45.970001220703125,46.220001220703125,43.29753875732422,KO,Coca-Cola's (KO) Investment in BODYARMOR to Augment Sales,1,0.5452706
2018-08-20,6392000.0,46.68000030517578,46.869998931884766,46.59000015258789,46.72999954223633,43.77529525756836,KO,PepsiCo’s Nooyi Goes Out With a SodaStream Fizz ||| PepsiCo Acquires SodaStream For $3.2 billion ||| Pepsi (PEP) Buys SodaStream (SODA) for $144 per Share ||| Pepsi In $3.2B All-Cash Deal to Buy SodaStream,0,0.50718564
2018-08-21,13986300.0,46.72999954223633,46.75,46.209999084472656,46.220001220703125,43.29753875732422,KO,"Dow Movers: JNJ, INTC ||| PepsiCo Fortifies Sparkling Water Range With SodaStream Buyout ||| Consumer Sector Update for 08/21/2018: K,GSK,COTY,DISCA,SJM,UN,UL,KO,MDLZ ||| Financial Exchange Stock Talk: Nat Stewart On National Beverage",0,0.48503938
2018-08-22,7159100.0,46.34000015258789,46.380001068115234,45.91999816894531,45.93000030517578,43.02587890625,KO,Boost Your Portfolio’s Yield by 400% Overnight,0,0.53308475
2018-08-24,10952900.0,45.650001525878906,45.79999923706055,45.58000183105469,45.630001068115234,42.74484252929688,KO,Better Buy: International Business Machines Corporation vs. Coca-Cola,1,0.5215247
2018-08-27,9581200.0,46.04999923706055,46.04999923706055,45.560001373291016,45.68999862670898,42.801048278808594,KO,"How Synthetic Biology's ""Window of Innovation"" Is Disrupting the Chemical Industry ||| 21 Beverage Stocks to Buy for the Contrarian-Minded ||| The Pepsi Challenge: Dealing with Continued Declines in Soft Drink Consumption",0,0.5116451
2018-08-29,12410900.0,45.25,45.41999816894531,45.220001220703125,45.33000183105469,42.46381378173828,KO,"Dow Analyst Moves: KO ||| Coca-Cola a Top Socially Responsible Dividend Stock With 3.4% Yield (KO) ||| Molson Coors Brewing Company (TAP) Ex-Dividend Date Scheduled for August 30, 2018",0,0.4303054
2018-08-30,9716500.0,45.27999877929688,45.31999969482422,44.88999938964844,44.95000076293945,42.10784149169922,KO,"Notable ETF Inflow Detected - USMV, MA, KO, PEP ||| XLP, KOLD: Big ETF Outflows ||| Can Healthier Options Boost the U.S. Soft Drink Industry? ||| Implied PWV Analyst Target Price: $42",0,0.48346597
2018-08-31,19834100.0,45.0,45.06999969482422,44.38999938964844,44.56999969482422,41.75186538696289,KO,"Dunkin' Brands Continues Beverage & Digital Innovations ||| Coca Cola Agrees To Buy Costa Coffee ||| Coke Buys U.K.'s Costa Coffee Ahead of Labor Day Weekend ||| U.S. Stock Futures Remain Defensive As Fear of Trade War Roils Emerging Markets ||| Coca-Cola Buys Coffee Chain Costa in $5.1 Billion Deal ||| KO Crosses Below Key Moving Average Level ||| 4 Large-Cap Stocks Ripe for the Traders ||| Noteworthy Friday Option Activity: MEET, QDEL, KO ||| Is Coke (KO) Stock a Buy After Costa Purchase & BodyArmor Investment? ||| Consumer Sector Update for 08/31/2018: BIG,SBUX,KO,PBPB ||| Coca-Cola Enters Hot Beverage Market With $5.1B Purchase Of British Chain Costa Coffee ||| As Long Weekend Looms, Stocks Under Pressure From More Trade Concerns ||| Starbucks Shares Down 2.5% On Light Volume; Stock Price Under $53; Shares Could Be Lower Following Coca-Cola ~$5B Deal To Buy Coffee Brand Costa Limited ||| A Peek Into The Markets: US Stock Futures Fall Ahead Of Consumer Sentiment Report ||| The Coca-Cola Company to Acquire Costa for ~$5.1B",1,0.50398684
2018-09-04,11138500.0,44.59999847412109,44.900001525878906,44.5099983215332,44.7599983215332,41.92985534667969,KO,Coca-Cola (KO) to Expand in Coffee Space With Costa Buyout ||| Money 101 With The Ascent,1,0.50831443
2018-09-05,10554900.0,44.65999984741211,45.41999816894531,44.65999984741211,45.380001068115234,42.51065444946289,KO,"Coca-Cola Enters Another High-Profit Category ||| Pepsico, Inc. (PEP) Ex-Dividend Date Scheduled for September 06, 2018 ||| Coca-Cola to Acquire Costa Coffee: Consumer Staples ETFs in Focus ||| 5 Top Dividend Kings to Buy and Hold Forever",1,0.48440778
2018-09-06,11439400.0,45.400001525878906,46.0,45.29999923706055,45.77000045776367,42.87599563598633,KO,"Barclays Consumer Staples Conference Concludes Today, Presenters Include: Craft Brew Alliance, Central Garden & Pet, Procter & Gamble, Tilray, and Coca-Cola",0,0.51560926
2018-09-07,10208100.0,45.59999847412109,45.81999969482422,45.27999877929688,45.720001220703125,42.82915496826172,KO,Coca-Cola Enters Uncharted Territory With Major Coffee Deal,1,0.5390933
2018-09-10,8568900.0,45.90999984741211,46.310001373291016,45.79999923706055,46.060001373291016,43.14765548706055,KO,"What Does $5.1 Billion Get You in the Coffee Industry? ||| How Will Coca-Cola Leverage Its New Brick-and-Mortar Footprint? ||| Why the Costa Buyout Is Just One Piece of Coca-Cola's Ongoing Transformation ||| Top Analyst Reports for Berkshire Hathaway, Coca-Cola & Disney",0,0.4894466
2018-09-11,9278300.0,46.09999847412109,46.150001525878906,45.880001068115234,46.02000045776367,43.11018371582031,KO,"3 Top Dividend Stocks to Buy in September ||| Ex-Dividend Reminder: Coca-Cola, Garmin and Altria Group ||| Why Coca-Cola is a Top 25 SAFE Dividend Stock (KO) ||| Coca-Cola May Have a New Target in Its Race for Global Beverage Dominance ||| The Zacks Analyst Blog Highlights: Berkshire Hathaway, Coca-Cola, Disney, BHP and Zoetis",1,0.53585654
2018-09-12,13216400.0,46.15999984741211,46.29999923706055,46.02000045776367,46.2400016784668,43.31628036499024,KO,"Coca-Cola Company (KO) Ex-Dividend Date Scheduled for September 13, 2018",0,0.4586332
2018-09-13,8294800.0,46.0099983215332,46.119998931884766,45.709999084472656,45.83000183105469,43.2973861694336,KO,"Stocks Trading Ex Dividend For Thurs., Sep. 13, 2018",1,0.47505918
2018-09-14,7612900.0,45.91999816894531,46.02999877929688,45.61000061035156,45.9900016784668,43.44853973388672,KO,"XLP, OILD: Big ETF Inflows ||| KO Named 'Top Dividend Stock of the Dow' at Dividend Channel With 3.4% Yield ||| Benzinga's Top Upgrades, Downgrades For September 14, 2018 ||| Guggenheim Initiates Coverage On Coca-Cola with Buy Rating ||| Stocks Trading Ex Dividend For Thurs., Sep. 13, 2018",1,0.5220975
2018-09-17,8527300.0,46.0,46.33000183105469,45.90999984741211,46.31999969482422,43.76029968261719,KO,"Who Just Made the Better Deal: Coke or Pepsi? ||| What Happened in the Stock Market Today ||| Marijuana News: Coca-Cola, Aurora Cannabis Plan CBD Drinks ||| Consumer Sector Update for 09/17/2018: SAFM, KO, MDP, SHOO ||| Marijuana Stocks and ETF: What Investors Need to Know ||| New Age Beverages Stock Soars on Coca-Cola Takeover Rumors ||| Consumer Sector Update for 09/17/2018: TJX,RH,BBBY,KO,ACB.TO ||| PepsiCo Holds Ground Despite Tough Conditions, Stock Gains 9% ||| The 5 Highest-Yielding Warren Buffett Dividend Stocks ||| Marijuana ETF Pops on Speculation of a Coca-Cola, Aurora Partnership ||| Consumer Sector Update for 09/17/2018: BBBY,KO ||| Report: Coca-Cola Is Canna-Curious ||| Coca-Cola Says No Decisions Have Been Made At This Time Related To Interests In CBD Beverages ||| Coca-Cola is in Talks with Aurora Cannabis to Develop Drinks According to BNN Bloomberg",0,0.45972154
2018-09-18,9847400.0,46.38999938964844,46.52999877929688,45.93000030517578,45.93000030517578,43.3918571472168,KO,"3 Reasons Why Coca-Cola Stock Won’t Benefit from a CBD Beverage ||| Noteworthy ETF Inflows: DGRO, WFC, KO, PEP ||| Company News For Sep 18, 2018 ||| Stock Market News For Sep 18, 2018 ||| TSX up 13 Points With Healthcare, Energy, Leading Gains ||| Why Coke Just Dropped $5B on a Coffee Company ||| Marijuana ETF Boosted by Coca-Cola’s Interest in Weed Drinks ||| Update: TSX May Rise with Commodities; Aurora Cannabis, Enbridge In Focus ||| Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)? ||| Why Marijuana Stocks and ETF are Soaring ||| Is Now a Good Time to Buy Tilray Inc.? ||| The Companies That Could Benefit From An Aurora Cannabis-Coca-Cola Deal",1,0.52550626
2018-09-19,7119000.0,46.0,46.11000061035156,45.869998931884766,45.959999084472656,43.42019271850586,KO,Want Dividends and Price Upside? 7 Stocks for 162% Returns ||| 5 Dividend Stocks With 50-Plus Years of Annual Dividend Hikes ||| This Marijuana Stock Picked a Good Day to Top the News Cycle ||| When Mere Chatter Moves Big Names ||| The Other Marijuana Stock on Coca-Cola's Radar Not Named Aurora Cannabis,1,0.4929618
2018-09-20,9736700.0,46.220001220703125,46.68000030517578,46.150001525878906,46.63999938964844,44.062618255615234,KO,3 Beverage Giants That Should Be Looking for a Cannabis Partner ||| What Was Behind Tilray's Wild Ride Yesterday ||| Coca-Cola Option Alert: Oct 19 $47 Calls at the Ask: 2000 @ $0.391 vs 6350 OI; Earnings 10/24 Before Open [est] Ref=$46.475,0,0.51435184
2018-09-21,19240300.0,46.63999938964844,46.68999862670898,46.380001068115234,46.58000183105469,44.00593948364258,KO,"Why Did McDonald's (MCD) & Starbucks (SBUX) Stock Jump Friday? ||| Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",0,0.48190236
2018-09-24,10778900.0,46.4900016784668,46.52999877929688,45.84000015258789,46.06999969482422,43.52412033081055,KO,"Don’t Get Too Excited About Coca-Cola’s “Cannabis Drink” Buzz ||| The Tilray Bubble Has Popped, And TLRY Stock Still Has Further to Fall ||| Coca Cola to Acquire the French businesses of Tropico; Financial Terms Not Disclosed",0,0.4826137
2018-09-25,7919100.0,46.060001373291016,46.18000030517578,45.61000061035156,45.68000030517578,43.15566635131836,KO,More Highs Ahead for Adobe Stock ||| Navigating The Maze Of The Cannabis Market After The Daze Of Summer,1,0.5056421
2018-09-26,10162600.0,45.77000045776367,46.06999969482422,45.56999969482422,45.84999847412109,43.3162727355957,KO,"5 Blue-Chip ""Marijuana Stocks"" ||| Notable ETF Outflow Detected - OEF, KO, PEP, IBM ||| Better Dividend-Stock Buy: Verizon (VZ) vs. Coke (KO) ||| High Times Buys DOPE Magazine For $11M: Here's Why And What It Means For The Cannabis Industry",1,0.5407524
2018-09-28,9071900.0,46.0,46.18999862670898,45.970001220703125,46.18999862670898,43.63748550415039,KO,"Keurig Dr Pepper (KDP) to Acquire CORE Nutrition for $525M ||| Pot Stocks & ETF: Risks and Rewards ||| Despite Bumps, CBD Market Growing Toward Convenience Store Shelves",1,0.5239674
2018-10-01,9364700.0,46.16999816894531,46.34999847412109,46.04999923706055,46.22999954223633,43.67527770996094,KO,"Coca-Cola Is Straying From Its Strengths, but That May Be a Good Thing",1,0.5012506
2018-10-02,7462700.0,46.27999877929688,46.560001373291016,46.060001373291016,46.5099983215332,43.93980026245117,KO,"3 Top Dividend Stocks With Yields Over 3% ||| Pepsi Stock Slips on an Otherwise Impressive Q3 ||| PepsiCo (PEP) Q3 Earnings & Sales Top, Organic Sales View Up",0,0.5223469
2018-10-03,10542300.0,46.459999084472656,46.54999923706055,45.79999923706055,45.869998931884766,43.33517074584961,KO,"After Coke, It's PepsiCo's Turn to Monitor Cannabis Market ||| Keurig Dr Pepper Inc. (KDP) Ex-Dividend Date Scheduled for October 04, 2018",0,0.44502342
2018-10-04,9582300.0,45.65999984741211,45.900001525878906,45.43000030517578,45.84999847412109,43.3162727355957,KO,"Top Research Reports for Adobe, United Technologies & Lockheed Martin",1,0.5198458
2018-10-05,8734100.0,45.93999862670898,46.15999984741211,45.68999862670898,45.880001068115234,43.34462356567383,KO,"Molson Coors and HEXO Joint Venture Goes Live as ""Truss"" ||| Don’t Go Rushing Into Facebook Stock Just Yet ||| The Zacks Analyst Blog Highlights: Adobe, United Technologies, Lockheed Martin, CVS Health and Coca-Cola ||| Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week ||| Hemp Stocks: A Look At Leading Public Hemp Companies",1,0.48577642
2018-10-08,9808100.0,45.9900016784668,46.58000183105469,45.970001220703125,46.47999954223633,43.91146087646485,KO,"Dow Movers: V, WBA",0,0.52096146
2018-10-10,13917000.0,46.29999923706055,46.70000076293945,45.66999816894531,45.68000030517578,43.15566635131836,KO,Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)? ||| Could Altria Group Invest In This Pot Stock? ||| Coca-Cola (KO) Stock Moves -1.49%: What You Should Know,0,0.47484174
2018-10-11,17677900.0,45.79999923706055,45.970001220703125,44.5,44.63999938964844,42.17314147949219,KO,"PepsiCo Inks Deal With Loop for Sustainable Product Packaging ||| 3 Personal Products Stocks to Buy as the Market Dips ||| How New Age Beverages Corp. Stock More Than Tripled Last Month ||| Altria to Explore Cannabis Prospects, Eyes Stake in Aphria ||| Anaplan's IPO: What You Need To Know ||| Zydus Cadila Group Outbids Coca-Cola for Kraft Heinz Consumer Brand Business in India",1,0.5139036
2018-10-12,12420100.0,44.47999954223633,44.880001068115234,44.25,44.68000030517578,42.2109375,KO,We Did The Math RHS Can Go To $137 ||| Soft Drinks Industry Outlook: Will Healthy Options Bring Fizz Back?,1,0.506512
2018-10-16,10442500.0,45.02000045776367,45.59999847412109,44.86000061035156,45.4900016784668,42.976173400878906,KO,Speculators Should Consider Taking a Sip of New Age Beverages Stock ||| The Largest Private Employer in the World May Soon Sell Marijuana Products ||| Cannabis Market Attracts U.S. Cigarette Makers As Well ||| Amazon Adds to Its Value With Digital Ads ||| Coca-Cola (KO) Gains But Lags Market: What You Should Know,1,0.486934
2018-10-17,11055800.0,45.40999984741211,45.9900016784668,45.36000061035156,45.86000061035156,43.325721740722656,KO,"The 5 Keys to Success for Marijuana Stock Aurora Cannabis ||| The Zacks Analyst Blog Highlights: Altria, Coca-Cola, PepsiCo, Constellation and Canopy Growth",0,0.5149022
2018-10-18,12716900.0,45.900001525878906,46.08000183105469,45.459999084472656,45.61000061035156,43.08953857421875,KO,"Notable ETF Inflow Detected - USMV, WM, KO, FISV ||| Coca-Cola Says Brian Smith Appointed COO And President",1,0.5077537
2018-10-19,13989200.0,45.83000183105469,46.4900016784668,45.83000183105469,46.33000183105469,43.769752502441406,KO,"Daily Dividend Report: VFC, RCI, PNW, IDA, KO ||| Why You Should Be Careful With These Cannabis-Infused Beverage Stocks",0,0.48928145
2018-10-22,14283600.0,46.369998931884766,46.459999084472656,45.810001373291016,45.970001220703125,43.42964553833008,KO,"3 Dividend Stocks That Pay You More Than Coca-Cola Does ||| See Which Of The Latest 13F Filers Holds Coca-Cola ||| $100 Billion Pot Companies? These 3 Stocks Could Be the First ||| After Hours Most Active for Oct 22, 2018 : TWTR, BAC, QQQ, VST, KO, QCOM, CMCSA, MAS, PSX, VNQI, SIRI, AAPL",1,0.47688246
2018-10-23,17483900.0,45.619998931884766,46.459999084472656,45.45000076293945,46.36000061035156,43.79809188842773,KO,Marijuana ETF Enters Bear Territory: What Lies Ahead? ||| Marijuana Stocks Plummet to Record Low: What's Next?,1,0.48985592
2018-10-24,21626000.0,46.33000183105469,47.38999938964844,46.2400016784668,46.72999954223633,44.147647857666016,KO,"Coca-Cola Bottling Co. Consolidated (COKE) Ex-Dividend Date Scheduled for October 25, 2018 ||| The Zacks Analyst Blog Highlights: Microsoft, Caterpillar, Amazon, Walmart and Coca-Cola ||| Coca-Cola (KO) Gains As Market Dips: What You Should Know",0,0.47249544
2018-10-25,14220200.0,46.650001525878906,46.7400016784668,46.119998931884766,46.5099983215332,43.93980026245117,KO,"The Zacks Analyst Blog Highlights: Procter & Gamble, Boeing, Coca-Cola, Verizon and McDonald's",0,0.49714184
2018-10-26,21458000.0,46.369998931884766,46.47999954223633,45.43000030517578,45.91999816894531,43.38240432739258,KO,"Notable ETF Inflow Detected - USMV, WM, KO, FISV ||| Cannabis-Infused Beverages: 3 Things You May Not Realize",1,0.4832608
2018-10-29,20932200.0,46.150001525878906,46.560001373291016,46.04999923706055,46.459999084472656,43.8925666809082,KO,"Coca-Cola reports Q3 earnings October 30 ||| Pre-Market Earnings Report for October 30, 2018 : PFE, MA, KO, GE, AMT, AET, AGN, HCA, ECL, CTSH, BP, LYB ||| Calls buyers thirsty for Coca-Cola ||| 3 Aspects of Coca-Cola’s Earnings That Could Impact KO Stock ||| Benzinga's Week Ahead: Can Facebook, Apple Earnings Rescue The Stock Market? ||| Correction And Bounce: SPX Off 10% From Highs Intraday As Weak Earnings, Outlooks Crush Stocks",1,0.49550265
2018-10-30,20895400.0,46.619998931884766,47.7400016784668,46.040000915527344,47.630001068115234,44.99790573120117,KO,"Earnings Reaction History: The Coca-Cola Company, 36.4% Follow-Through Indicator, 1.5% Sensitive ||| Mid-Day Update: Wall Street Recovers as Earnings Lift Market Averages, Trade Tensions Ease ||| Coca-Cola (KO) Q3 Earnings and Revenues Surpass Estimates ||| Wall Street Bounces Back as Trump Soothes Trade-War Jitters ||| Amid Q3 Earnings Season, Fresh Jobs Numbers From ADP ||| Coca-Cola & McDonald's Looked Strong, Is Starbucks (SBUX) Next? ||| Consumer Sector Update for 10/30/2018: CHGG,KO,LL ||| What Happened in the Stock Market Today ||| Coca-Cola Co (KO) Q3 2018 Earnings Conference Call Transcript ||| Coke & Under Armour Earnings Impress As Wall Street Braces for Facebook ||| Close Update: Stocks Gain After Monday's Tumble Amid Earnings, Optimism Over US-China Trade Relations ||| Dow Jumps 431 Points as Stocks End on a High Note ||| Wild Times: Market Seems To Seek Solid Ground After Monday's Manic ||| 'Coca-Cola CEO: ""we have no plans to get into the cannabis space."" $kO' - The Street's Brian Sozzi Tweets ||| Coca-Cola Q3 EPS $0.58 Beats $0.55 Estimate, Sales $8.2B Beat $8.18B Estimate ||| A Peek Into The Markets: US Stock Futures Gain Ahead Of Earnings ||| 14 Stocks To Watch For October 30, 2018 ||| Jubilant FoodWorks Announces PepsiCo as New Beverage Partner for Domino's Pizza in India; Ends 20-Year Partnership with Coca-Cola ||| Earnings Scheduled For October 30, 2018",1,0.51484764
2018-10-31,25309400.0,47.5,48.08000183105469,47.220001220703125,47.880001068115234,45.23409652709961,KO,"Why Coca-Cola Stock Will Keep On Truckin’ In This Volatile Market ||| Facebook Stock Should Be Trading Much, Much Higher ||| Notable Wednesday Option Activity: EL, MU, KO ||| Molson Coors Expects To Launch Cannabis Beverage In 2019 ||| Morgan Stanley Maintains Equal-Weight on Coca-Cola, Raises Price Target to $51 ||| Jefferies Maintains Hold on Coca-Cola, Raises Price Target to $49 ||| From Molson Coors Q3 Earnings Conference Call: CEO Sees Canadian Cannabis Drink Market 'A Tremendous Opportunity'",0,0.4845518
2018-11-01,16494500.0,47.810001373291016,48.150001525878906,47.29999923706055,47.7400016784668,45.10183334350586,KO,"Fomento Economico Mexicano S.A.B. de C.V. (FMX) Ex-Dividend Date Scheduled for November 02, 2018 ||| Pfizer and Coca-Cola Earnings Help Safer Income Stocks Shine ||| High-Dividend, Wide Moat ETFs Debut",1,0.48384565
2018-11-02,17584900.0,47.81999969482422,48.0,47.43999862670898,48.0,45.34746170043945,KO,"7 Best Stocks to Buy as You Recalibrate Your Compass ||| Constellation Brands Inc (STZ) Ex-Dividend Date Scheduled for November 05, 2018 ||| Coca-Cola's Interest in Marijuana Has Fizzled Out",1,0.5046058
2018-11-05,16543500.0,48.0,48.77999877929688,47.91999816894531,48.68999862670898,45.99932861328125,KO,"Coca-Cola (KO) Outpaces Stock Market Gains: What You Should Know ||| USMV, MCD, KO, WM: Large Inflows Detected at ETF ||| 3 Big Stock Charts for Monday: Coca-Cola, Kinder Morgan and Adobe",1,0.48126784
2018-11-06,14373400.0,48.650001525878906,49.130001068115234,48.59999847412109,49.11000061035156,46.39612579345703,KO,"Can Low Volatility ETFs Protect Your Portfolio? ||| Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)? ||| You Can Trust Coca-Cola Stock ||| Stocks Which Set New 52-Week High Yesterday, Mon., Nov. 5, 2018",1,0.48575416
2018-11-07,12239700.0,49.38999938964844,49.54999923706055,49.02999877929688,49.369998931884766,46.64175033569336,KO,"Drink Up -- Monster Beverage Just Got Its Energy Back ||| 5 Top Stock Trades for Thursday: AMZN, Z, TWLO and Etsy ||| PreMarket Prep Opening NYSE Imbalance Update: Alibaba 62k Shares To Buy; GE 106k To Buy; Coke 85k To Sell; IBM 30k To Buy",0,0.47662035
2018-11-08,9762800.0,49.119998931884766,49.369998931884766,49.09999847412109,49.33000183105469,46.60396957397461,KO,"Monster Beverage (MNST) Q3 Earnings & Sales Top Estimates ||| Why Monster Beverage Corp. Stock Fell Today ||| What Coca-Cola's Management Wants Investors to Know ||| Stocks Which Set New 52-Week High Yesterday, Wed., Nov. 7, 2018 ||| As Coke Shakes Up Energy Drink Category, Monster Earns A Downgrade ||| PreMarket Prep Opening NYSE Imbalance Update: Twilio 85k Shares To Sell; Square 157k To Sell; General Electric 267k To Sell; Coke 164k To Sell",1,0.48092502
2018-11-09,12398100.0,49.38999938964844,49.88999938964844,49.36000061035156,49.68000030517578,46.93462753295898,KO,"Dow Movers: CAT, DIS ||| Stocks Which Set New 52-Week High Yesterday, Thurs., Nov. 8, 2018",1,0.46661818
2018-11-12,13918300.0,49.61000061035156,50.2400016784668,49.540000915527344,49.869998931884766,47.11412811279297,KO,"Time to Buy Coca-Cola (KO) Stock Near New All-Time High? ||| 3 Big Stock Charts for Monday: Coca-Cola, Ralph Lauren and Mondelez International ||| Coca-Cola (KO) Gains As Market Dips: What You Should Know ||| October's biggest Losers And Most Surprising Winners",0,0.48030043
2018-11-14,12106800.0,49.84999847412109,49.93999862670898,49.59000015258789,49.7599983215332,47.01020431518555,KO,"7 Highest-Yielding Dow Dividend Stocks ||| Dow Analyst Moves: KO ||| IWF, KO, PEP, ABBV: ETF Inflow Alert",0,0.50922054
2018-11-15,12080100.0,49.65999984741211,49.75,49.27000045776367,49.7400016784668,46.991310119628906,KO,Coca-Cola Option Alert: Jan 18 $48 Calls Sweep (2) above Ask!: 2100 @ $2.081 vs 9243 OI; Ref=$49.465 ||| Election Returns Likely To Usher In Hemp Amendment With Farm Bill,1,0.50704736
2018-11-16,13405800.0,49.65999984741211,50.25,49.630001068115234,50.16999816894531,47.39754867553711,KO,Have a Coke and a Smile: KO Stock Is Safe Haven for a Troubled Market,1,0.50257504
2018-11-19,13575800.0,50.310001373291016,50.7599983215332,50.25,50.5099983215332,47.71875762939453,KO,"Stock Market News For Nov 19, 2018 ||| Coca-Cola (KO) Chalks Out Plan for Coffee Business, Cannabis ||| Coca-Cola (KO) Gains As Market Dips: What You Should Know ||| Coca-Cola CEO Talks Coffee, Cannabis With Cramer",0,0.4784073
2018-11-20,16255300.0,50.81999969482422,50.84000015258789,49.209999084472656,49.380001068115234,46.65120697021485,KO,"Stocks Which Set New 52-Week High Yesterday, Mon., Nov. 19, 2018 ||| Coca-Cola, PayPal, Valero: 'Fast Money' Picks For November 20",0,0.46294662
2018-11-21,13559200.0,49.22999954223633,49.43999862670898,48.59000015258789,48.72999954223633,46.03712463378906,KO,"3 Big Stock Charts for Wednesday: Coca-Cola, Hologic and Applied Materials ||| Tesla Stock’s Surprising Resilience Is a Good Sign for Tesla Bulls ||| October's Biggest Losers And Most Surprising Winners ||| Stock, Oil Markets Bouncing Ahead of Thanksgiving Holiday ||| Stocks Which Set New 52-Week High Yesterday, Tues., Nov. 20, 2018",1,0.5144025
2018-11-23,4792500.0,48.75,49.22999954223633,48.54999923706055,49.02000045776367,46.31110000610352,KO,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",0,0.48148152
2018-11-26,9341900.0,49.0099983215332,49.22999954223633,48.66999816894531,48.869998931884766,46.16938400268555,KO,"Why Facebook Stock Is Compelling for Long-Term Investors ||| Interesting January 2020 Stock Options for KO ||| Dow Movers: JNJ, AXP ||| 3 Consumer Stocks to Buy for a Strong Defense",1,0.4964274
2018-11-27,9180700.0,48.880001068115234,49.40999984741211,48.72999954223633,49.369998931884766,46.64175033569336,KO,"Ex-Dividend Reminder: Tyson Foods, Coca-Cola and Flowers Foods",1,0.50413686
2018-11-28,11368700.0,49.209999084472656,49.720001220703125,49.209999084472656,49.709999084472656,46.96296691894531,KO,"Coca-Cola Company (KO) Ex-Dividend Date Scheduled for November 29, 2018 ||| Coca-Cola (KO) Gains But Lags Market: What You Should Know ||| 7 Consumer Stocks to Buy and Hold Through the New Year ||| Noteworthy Wednesday Option Activity: AMGN, V, KO ||| Molson Coors Brewing Company (TAP) Ex-Dividend Date Scheduled for November 29, 2018 ||| Cannabis-Infused Beverage Stocks Rip Higher Amid Positive Farm Bill Development ||| Stocks That Will Be Trading Ex Dividend Thurs., Nov. 29, 2018",0,0.48520902
2018-11-29,11564300.0,49.27999877929688,49.43000030517578,48.970001220703125,48.97999954223633,46.63921356201172,KO,"Coke (KO) Up 3.8% Since Last Earnings Report: Can It Continue? ||| Thursday’s Vital Data: Coca-Cola, Freeport-McMoran and Microsoft ||| Look to KO for a Solid, Safe Return ||| Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)? ||| Stocks Trading Ex Dividend For Thurs., Nov. 29, 2018",1,0.5013025
2018-11-30,25538200.0,49.0,50.4900016784668,48.9900016784668,50.400001525878906,47.99135971069336,KO,Is Coca-Cola a Buy? ||| Direxion Unveils Four Leveraged Consumer ETFs,0,0.49610624
2018-12-03,14877200.0,49.869998931884766,49.959999084472656,48.88999938964844,49.68999862670898,47.31528854370117,KO,"IWF, GOOG, GOOGL, KO: Large Inflows Detected at ETF ||| Will PepsiCo's New CEO Radically Alter Its Strategy? ||| Dow Movers: VZ, BA ||| Better Buy: IBM vs. Coca-Cola",0,0.5071525
2018-12-04,19059900.0,49.970001220703125,50.5099983215332,49.5,49.58000183105469,47.21054458618164,KO,"Pepsico, Inc. (PEP) Ex-Dividend Date Scheduled for December 06, 2018 ||| Glaxo to Sell India's Popular Horlicks Brand to Unilever ||| Coca-Cola (KO) Stock Moves -0.22%: What You Should Know",0,0.4445782
2018-12-06,17674900.0,49.5099983215332,49.630001068115234,48.65999984741211,49.380001068115234,47.02009963989258,KO,"PepsiCo (PEP) Acquires SodaStream, Expands Beverage Portfolio ||| Can You Hide in Johnson and Johnson Stock Amid the Turmoil? ||| 7 Dividend Titans Trading Like Growth Stocks ||| Better Buy: General Electric vs. Coca-Cola ||| Coca-Cola Reports Chair Muhtar Kent To Leave Co.; James Quincey Named Replacement",0,0.49326488
2018-12-07,15565700.0,49.56999969482422,49.68000030517578,48.880001068115234,49.09000015258789,46.743953704833984,KO,Make Mine Vanilla: Dull Jobs Report Might Be Just What's Needed After Wild Week,1,0.50776
2018-12-10,12331100.0,49.45000076293945,49.45000076293945,48.470001220703125,49.2400016784668,46.88679122924805,KO,"Why Monster Beverage Shares Rose 13% Last Month ||| Cushman & Wakefield Issues Release Highlighting Coca-Cola's Sale Of 711 Fifth Ave. In Manhattan, No Terms Disclosed",1,0.4859198
2018-12-11,18083600.0,49.59000015258789,50.0099983215332,49.18000030517578,49.540000915527344,47.17245864868164,KO,"Why Is Shopify Stock Holding Up While Others Can’t Handle The Turmoil? ||| IWF, MA, PEP, KO: Large Outflows Detected at ETF ||| Coca-Cola (KO) Gains As Market Dips: What You Should Know ||| Noteworthy Tuesday Option Activity: FDX, KO, BAC ||| The 2018 Farm Bill Vote: What You Need To Know ||| Coca-Cola CEO Says Somewhat Uncertain Growth May Slow Compared To FY18 ||| An Upgrade For A Defensive Sector",0,0.47154498
2018-12-12,12316900.0,49.95000076293945,50.02000045776367,49.18999862670898,49.220001220703125,46.86774826049805,KO,"Wednesday’s Vital Data: Coca-Cola, Twitter and Wells Fargo ||| Will Coca-Cola Stock Be the Next Giant to Fall? ||| HSY Stock Is Proving Chocolate Safe From the Bear ||| Keurig Dr. Pepper After the Merge -- Where Are They Now? ||| CME Group, Home Depot, Target: 'Fast Money' Picks For December 12 ||| Dan Nathan Sees Unusual Options Activity In Coca-Cola",1,0.48792997
2018-12-13,13766200.0,48.720001220703125,49.61000061035156,48.56999969482422,49.470001220703125,47.10579681396485,KO,"4 Reasons Why Pot Stocks & ETF Could Be on a High in 2019 ||| Coca-Cola Option Alert: Fri $49.5 Calls Sweep (2) near the Ask: 1216 @ $0.24 vs 2705 OI; Ref=$49.49 ||| Benzinga's Top Upgrades, Downgrades For December 13, 2018 ||| UBS Downgrades Coca-Cola to Neutral, Raises Price Target to $51 ||| Coca-Cola Reports Loan Deal With Ioniqa Technologies For Transformation Of Hard-to-Recycle Plastic Waste into High-Quality, Food-Grade PET, No Terms Disclosed",0,0.5012616
2018-12-14,13835900.0,49.22999954223633,49.52000045776367,49.02000045776367,49.34000015258789,46.98201370239258,KO,Is Coca-Cola A Growth Company?,0,0.5310323
2018-12-17,18482700.0,49.34000015258789,49.52999877929688,48.02000045776367,48.33000183105469,46.02027893066406,KO,5 Things That Defined Aurora Cannabis' 2018 ||| Why Soda's Decline Represents An Opportunity To Revolutionize The Beverage Sector,0,0.53310144
2018-12-18,14765700.0,48.61000061035156,48.83000183105469,47.84999847412109,48.31999969482422,46.01075744628906,KO,"Ambev S.A. (ABEV) Ex-Dividend Date Scheduled for December 19, 2018 ||| Macquarie: Coca-Cola A Winner With BodyArmor Investment As Pepsi's Gatorade Cedes Share ||| Which Beverages Stocks Will Pop? UBS Weigh In On The Sector",0,0.472419
2018-12-19,17903800.0,48.2400016784668,48.7599983215332,47.619998931884766,47.900001525878906,45.6108283996582,KO,"ITOT, PFE, KO, PEP: ETF Inflow Alert ||| Dow Movers: AXP, CAT ||| 5 Reasons Marijuana Stocks Could Lose You Money in 2019 ||| Coca-Cola (KO) Stock Moves -0.89%: What You Should Know",0,0.4656283
2018-12-20,21130000.0,47.810001373291016,48.130001068115234,47.09999847412109,47.540000915527344,45.26803970336914,KO,Pepsico's SodaStream to open factory in impoverished Gaza,1,0.52737534
2018-12-21,32477700.0,47.2599983215332,48.75,47.22999954223633,47.56999969482422,45.29659652709961,KO,"Dow Movers: WBA, NKE ||| Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)?",0,0.50535697
2018-12-24,10733700.0,47.619998931884766,47.869998931884766,45.83000183105469,45.959999084472656,43.76354598999024,KO,"Bulls & Bears Of The Week: Best Buy, Coca-Cola, Ford, Hilton, Netflix And More ||| Losing Its FAANG: Market Struggles In 2018 As Tech Rally Slows",1,0.53015417
2018-12-26,14342600.0,45.880001068115234,46.959999084472656,45.65999984741211,46.93999862670898,44.69670486450195,KO,Market Close Report: Record breaking 361.44 point close for the NASDAQ Composite index ||| Dow Racks Up Biggest Gain Ever in Post-Christmas Comeback,1,0.5146889
2018-12-27,16966500.0,46.7400016784668,47.54999923706055,46.02999877929688,47.52999877929688,45.25851821899414,KO,"Notable ETF Inflow Detected - XLP, KO, PEP, COST ||| Cut the CRaP: Amazon's Strategy to Grow Profits ||| Bringing Some Sexy To Consumer Staples ETFs ||| In The December Bloodbath, These Hidden Factors Might Be Prompting Traders To Buy",0,0.4879328
2018-12-28,13218200.0,47.88999938964844,48.0099983215332,47.02999877929688,47.20000076293945,44.94428634643555,KO,"Friday’s Vital Data: Coca-Cola, Intel and Ford",1,0.5053638
2018-12-31,10576300.0,47.4900016784668,47.540000915527344,46.959999084472656,47.34999847412109,45.08711624145508,KO,"Barron's Picks And Pans: Coca-Cola, Disney, McDonald's, Verizon And More ||| KO is Climbing Toward $48.50 ||| 5 Dogs of the Dow Stocks for 2019",0,0.48023105
2019-01-02,11603700.0,46.93999862670898,47.220001220703125,46.560001373291016,46.93000030517578,44.68718719482422,KO,"Keurig Dr Pepper Inc. (KDP) Ex-Dividend Date Scheduled for January 03, 2019 ||| Apple Stock Is One to Own in 2019 ||| 3 Dividend Aristocrats to Buy and Hold Forever ||| TGT is Rising, But There is Resistance at $67.50 ||| The Zacks Analyst Blog Highlights: IBM, ExxonMobil, Verizon, Chevron and Coca-Cola ||| Macquarie: Coca-Cola European Partners Faces Downside Risk From UK Plastic Regulations",0,0.4711631
2019-01-03,14714400.0,46.81999969482422,47.369998931884766,46.52999877929688,46.63999938964844,44.41104507446289,KO,"Coca-Cola Completes Acquisition Of Costa - Quick Facts ||| EU clears Coca-Cola acquisition of Costa Coffee chain ||| Coca-Cola (KO) Stock Moves -0.62%: What You Should Know ||| After Hours Most Active for Jan 3, 2019 : CTL, BAC, FRC, ET, KO, DWDP ||| EC Clears Coca Cola Acquisition of Cost Coffee",1,0.4795052
2019-01-04,13013700.0,46.75,47.56999969482422,46.63999938964844,47.56999969482422,45.29659652709961,KO,Cleveland Fed President: No Reason To Believe Recession In Sight,0,0.49889857
2019-01-07,13135500.0,47.56999969482422,47.75,46.900001525878906,46.95000076293945,44.70623397827149,KO,Will Coca-Cola Raise Its Dividend in 2019? ||| Small-Caps Outperform in Up Day for Stocks ||| Monday's ETF with Unusual Volume: DJD ||| The Top Cannabis Investing Storylines to Watch in 2019,1,0.49944338
2019-01-08,15420700.0,47.25,47.56999969482422,47.040000915527344,47.47999954223633,45.21090316772461,KO,"Why Monster Beverage Shares Jumped 6% Higher Today ||| Will Cannabis-Infused Beverage Stocks Live Up to the Hype or Fizzle Out? ||| Top Analyst Reports for Visa, Coca-Cola & AbbVie ||| Tuesday's ETF with Unusual Volume: KXI ||| SunTrust Turns Bullish On Monster Beverage",0,0.49025044
2019-01-09,18032500.0,47.08000183105469,47.27999877929688,46.43000030517578,46.56999969482422,44.34439849853516,KO,"Dow Movers: KO, CVX ||| The Zacks Analyst Blog Highlights: Visa, Coca-Cola, AbbVie, Johnson & Johnson and Duke Energy ||| Coca-Cola (KO) Stock Sinks As Market Gains: What You Should Know ||| Constellation Brands Tops Q3 Earnings, View Cut Hurts Stock ||| Wednesday's ETF with Unusual Volume: XRLV",1,0.49883953
2019-01-10,15976600.0,46.65999984741211,47.09000015258789,46.34000015258789,47.06999969482422,44.82049560546875,KO,"Dow Movers: PFE, BA ||| 3 Dividend Stocks That Pay You Better Than Coca-Cola Does ||| After Hours Most Active for Jan 10, 2019 : IEF, TAK, BAC, V, INTC, QQQ, TWTR, GIS, KO, MSFT, CMCSA, CSCO",1,0.47729662
2019-01-11,11088600.0,47.290000915527344,47.36000061035156,46.970001220703125,47.34000015258789,45.077598571777344,KO,4 Big-Brand Stocks to Sell Now (and 2 Cheap Dividends to Buy Instead),0,0.5068575
2019-01-14,11514300.0,47.25,47.400001525878906,46.9900016784668,47.150001525878906,44.89667510986328,KO,"USMV, NEM, WM, KO: Large Inflows Detected at ETF",1,0.5260488
2019-01-15,11342900.0,46.88999938964844,47.59999847412109,46.810001373291016,47.56999969482422,45.29659652709961,KO,"After Hours Most Active for Jan 15, 2019 : F, PCG, GE, QQQ, KO, BAC, FOXA, TAL, SIRI, AMD, VMBS, MU ||| My 3 Favorite “Dogs of the Dow” for 2019 ||| PepsiCo a Top Socially Responsible Dividend Stock With 3.5% Yield (PEP)",0,0.4798887
2019-01-16,16907800.0,47.400001525878906,47.470001220703125,46.86000061035156,46.91999816894531,44.67766571044922,KO,7 Stocks to Buy as the Dollar Weakens,1,0.5007541
2019-01-17,12044600.0,46.91999816894531,47.13999938964844,46.880001068115234,47.060001373291016,44.810977935791016,KO,"Whitbread Q3 Sales Rise, UK LFL Sales Down; Backs FY19 View, Says Cautious On UK",1,0.53903717
2019-01-18,12760700.0,47.25,47.68999862670898,47.119998931884766,47.61000061035156,45.33468627929688,KO,"Noteworthy Friday Option Activity: KO, OSTK, HLF",1,0.52475923
2019-01-22,11700400.0,47.70000076293945,47.790000915527344,47.209999084472656,47.720001220703125,45.43943786621094,KO,"USMV, WM, KO, NEM: ETF Inflow Alert",1,0.533859
2019-01-23,12058300.0,47.81999969482422,48.290000915527344,47.650001525878906,48.27000045776367,45.96315002441406,KO,"Coca-Cola (KO) Outpaces Stock Market Gains: What You Should Know ||| Here's Why Investing in Monster Beverage (MNST) Makes Sense ||| 5 Best Stocks to Buy and Hold for the Long Term ||| Coca-Cola Consolidated, Inc. (COKE) Ex-Dividend Date Scheduled for January 24, 2019 ||| 5 Large-Cap Stocks Blitzing Higher ||| Sink Into Staples ETFs",0,0.4663522
2019-01-25,12066500.0,47.880001068115234,48.02999877929688,47.2400016784668,47.369998931884766,45.10615539550781,KO,The 'Amazon Effect' And How Bringg Helps Companies Gain More Customers,0,0.52242637
2019-01-28,9966900.0,47.220001220703125,47.29999923706055,46.93999862670898,47.16999816894531,44.91571044921875,KO,4 Companies Join 'Dividend Aristocrats' but Lag Behind Market,1,0.53266835
2019-01-29,11998600.0,47.20000076293945,47.630001068115234,47.130001068115234,47.400001525878906,45.134727478027344,KO,"NBEV Stock Is a Plausible, If Risky, Path to CBD-Infused Gains ||| What Makes Marijuana ETF the Best Performer in January? ||| Coca-Cola (KO) Gains As Market Dips: What You Should Know",1,0.4825841
2019-01-30,12952500.0,47.25,47.88999938964844,47.18999862670898,47.86000061035156,45.57274627685547,KO,"Dow Analyst Moves: KO ||| Notable ETF Outflow Detected - IWF, BA, KO, DIS",1,0.50301254
2019-01-31,32181500.0,47.84999847412109,48.77999877929688,47.470001220703125,48.130001068115234,45.829833984375,KO,"Coca-Cola Completes Buyout of Nigeria's Dairy & Juice Maker ||| 5 Dividend Growth Stocks With Upside To Analyst Targets ||| Earnings, Volatility, Brexit Are Key Topics Heading Into February ||| How To Approach Q4 Earnings: The Analyst Perspective",1,0.51823807
2019-02-04,15105700.0,48.70000076293945,49.45000076293945,48.540000915527344,49.25,46.89631652832031,KO,Better Buy: Procter & Gamble vs. Coca-Cola,1,0.5167248
2019-02-05,12651900.0,49.33000183105469,49.470001220703125,49.09999847412109,49.2599983215332,46.90583801269531,KO,"Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)? ||| Should You Buy Cronos Group Stock Right Now? ||| Coca-Cola (KO) Gains But Lags Market: What You Should Know ||| If This Is Millennials' Favorite Stock, I Feel Sorry for Them ||| Coca-Cola Option Alert: Mar 15 $50 Calls Sweep (3) near the Ask: 606 @ $0.59 vs 17084 OI; Earnings 2/14 Before Open Ref=$49.335",0,0.46460482
2019-02-06,8689100.0,49.209999084472656,49.36000061035156,49.02000045776367,49.2599983215332,46.90583801269531,KO,Stocks Slip as Earnings Enthusiasm Fades ||| Why Monster Beverage Shares Gained 16% Last Month,1,0.5093991
2019-02-07,10047800.0,49.16999816894531,49.459999084472656,49.0,49.41999816894531,47.05818557739258,KO,Coca-Cola (KO) Earnings Expected to Grow: Should You Buy?,1,0.4929317
2019-02-08,9813300.0,49.369998931884766,49.5,49.11000061035156,49.5,47.13436508178711,KO,"Upcoming Earnings Reports to Watch: ATVI, KO, CSCO ||| Earnings Growth Deceleration Details ||| 10 Best Dividend Stocks to Buy for the Next 10 Months ||| Constellation Brands Inc (STZ) Ex-Dividend Date Scheduled for February 11, 2019",1,0.43684506
2019-02-11,9369300.0,49.56999969482422,49.880001068115234,49.47999954223633,49.61000061035156,47.23910903930664,KO,"Looking Forward to an Eventful Week; Plus L, CNA, DO ||| Notable ETF Inflow Detected - USMV, WM, KO, FISV ||| Companies From Several Industries to Report Q4 Earnings ||| Pepsi Earnings: What to Watch ||| Can Coke (KO) Keep the Earnings Surprise Streak Alive? ||| Why Newell (NWL) is Poised to Beat Earnings Estimates in Q4 ||| Earnings Potpourri: Coca-Cola, Deere, Cisco Report This Week, But Trade Talks Dominate",1,0.50377524
2019-02-12,10983300.0,49.68999862670898,49.79999923706055,49.459999084472656,49.65999984741211,47.286720275878906,KO,What to Expect From These 5 Soft Drinks Stocks' Q4 Earnings? ||| How Coca-Cola Is Thriving Despite Declining Soda Consumption,1,0.4979335
2019-02-13,12748800.0,49.61000061035156,49.93999862670898,49.560001373291016,49.790000915527344,47.4105110168457,KO,Boston Beer (SAM) to Post Q4 Earnings: What's in the Offing? ||| Coca-Cola (KO) 4th Quarter Earnings: What to Expect ||| 5 Must See Earnings Charts ||| 7 Reasons to Own Coca-Cola Stock ||| Coca-Cola's Q4 Earnings Outlook ||| What Are The Trends In 13Fs Showing Us?,0,0.49444357
2019-02-14,58905400.0,46.70000076293945,46.959999084472656,45.5,45.59000015258789,43.41122817993164,KO,"Coca-Cola (KO) Q4 2018 Earnings Conference Call Transcript ||| Coca-Cola tops sales estimates ||| Why Coca-Cola Stock Was Sliding Today ||| Coca-Cola Earnings: KO Stock Takes a Hit Following Its Q4 Report ||| Coca-Cola forecasts full-year profit below expectations ||| Consumer Sector Update for 02/14/2019: SIX, YETI, KO, WMT, MCD, DIS, CVS ||| Tilray Stock Is Off Its Highs, But a Move is Imminent ||| Higher prices dent Coca-Cola demand, forecast underwhelms ||| Coca-Cola (KO) Meets Q4 Earnings Estimates ||| Earnings Reaction History: The Coca-Cola Company, 27.3% Follow-Through Indicator, 1.5% Sensitive ||| Coca-Cola (KO) Q4 Earnings In Line, Stock Slips on Soft View ||| Why Starbucks (SBUX) Stock Looks Like a Strong Buy at New High ||| See Which Of The Latest 13F Filers Holds Coca-Cola ||| Consumer Sector Update for 02/14/2019: BLMN,GOOS,GOOS.TO,YETI,KO ||| Close Update: Stocks Roiled by Retail Sales, 'Deadlocked' Trade Negotiations ||| 5 Must-See Stock Trades for Friday, Including Coca-Cola ||| Coca-Cola Takes a Hit Following a Muted 2019 Outlook ||| Stocks Finish Mixed After National Emergency Bombshell ||| Thursday Sector Laggards: Financial, Consumer Products ||| Thursday's ETF with Unusual Volume: IWL ||| Notable Thursday Option Activity: DXC, KO, BMY ||| NASDAQ Composite Index closes up 5.76 points for the week, rising for the 5th straight day ||| Consumer Sector Update for 02/14/2019: GOOS,GOOS.TO,YETI,KO ||| 52 Stocks Moving In Thursday's Mid-Day Session ||| Valentine's Card From The Market: Trade Optimism Continues, Cisco Posts Strong Quarter ||| Coca-Cola shares are trading lower despite a Q4 sales beat, after the company provided FY19 EPS guidance of $2.01-$2.10, below the $2.22 estimate. ||| A Peek Into The Markets: US Stock Futures Up Ahead Of Earnings, Economic Data ||| Coca-Cola Sees FY19 Operating Income Growth 10-11% Year Over Year ||| Coca-Cola Sees FY19 Organic Sales Growth 4% Year Over Year ||| Coca-Cola Q4 EPS $0.43, Inline, Sales $7.1B Beat $7.03B Estimate ||| 11 Stocks To Watch For February 14, 2019 ||| Earnings Scheduled For February 14, 2019",0,0.49589944
2019-02-15,35701600.0,45.900001525878906,46.2599983215332,45.20000076293945,45.2400016784668,43.07795715332031,KO,"PepsiCo forecasts surprise drop in profit as it ramps up investments ||| 4 Reasons Why Marijuana Stocks & ETFs Could Be on a High in 2019 ||| PepsiCo says investments to drive sales will dent profit this year ||| Canopy Growth Stock Has Great Potential — Buy High And Sell Higher ||| Forget Coca-Cola: PepsiCo Is a Better Dividend Stock ||| Wall St set for higher open as U.S.-China trade talks advance ||| Stock Market News For Feb 15, 2019 ||| NASDAQ Composite Index closes up 6.58 points for the week, rising for the 6th straight day ||| PepsiCo forecast surprise drop in 2019 core profit ||| Dow Grabs 8th Straight Weekly Win on Trade-Deal Hopes ||| Sex, Coke, and Video Streaming ||| The Post-Earnings Drop of Coca-Cola Stock Is a Buying Opportunity ||| PepsiCo forecasts surprise drop in 2019 adjusted profit ||| Futures up on progress in U.S.-China trade talks ||| Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Fri., Feb. 15, 2019 ||| UPDATE: Citigroup Downgrades Coca-Cola And Lowers Price Target From $56 To $50 As Firm Notes 'we simply believe KO's shares are fully-valued given the lack of near-term EPS growth on a dollar-basis at the company' ||| Deere Valentine: Tractor Maker's Latest Results Not Exactly A Love Letter To Shareholders ||| Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Fri., Feb. 15, 2019 ||| The Street's Reaction To Coca-Cola's Dip ||| Benzinga's Top Upgrades, Downgrades For February 15, 2019 ||| PreMarket Prep Opening NYSE Imbalance Update: Bank Of America 335k Shares To Buy, JP Morgan 143k To Buy; Coca-Cola 274k To Buy, Pfizer 251k To Buy, AT&T 224K To Buy, Verizon 130k To Buy ||| A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Economic Reports ||| Citigroup Downgrades Coca-Cola to Neutral ||| 71 Biggest Movers From Yesterday",0,0.5175511
2019-02-19,25511300.0,45.31999969482422,45.59000015258789,44.77000045776367,44.83000183105469,42.68754959106445,KO,"Weekly Market Summary: Stocks Approach Overbought Levels as U.S. Government Shutdown Averted ||| Coca-Cola and PepsiCo See a Different Year Ahead ||| Bulls & Bears Of The Week: Cisco, Coca-Cola, IBM, Tesla And More ||| The Zacks Analyst Blog Highlights: Starbucks, Apple, Nestle, Dunkin' and Coca-Cola ||| 3 Things Coca-Cola's CEO Wants Investors to Know ||| PepsiCo a Top Ranked SAFE Dividend Stock With 3.2% Yield ||| How to Handle Canopy Growth Stock Post Earnings ||| Tuesday’s Vital Data: Coca-Cola, Canopy Growth Corp and Nvidia ||| Why Macquarie Prefers Pepsi Over Coca-Cola",1,0.49507755
2019-02-20,27464000.0,44.90999984741211,45.2400016784668,44.79999923706055,45.09999847412109,42.94464492797852,KO,"Why Pepsi Stock Can Rally Above $120 in 2019 ||| Noteworthy ETF Outflows: XLP, KO, PEP, WMT ||| 5 Reasons Coca-Cola's Stock Is Going Flat ||| What Pepsi Wants Investors to Know ||| Coca-Cola Option Alert: Jun 21 $42 Puts Sweep (25) near the Bid: 959 @ $0.708 vs 4850 OI; Ref=$44.915",1,0.50256073
2019-02-21,23121200.0,45.0,45.90999984741211,44.959999084472656,45.86000061035156,43.6683235168457,KO,"What Investors Need to Know About Investing in Marijuana Stocks ||| Daily Dividend Report: KO, NTES, DPZ, SCI, XEC ||| Coca-Cola Raises Dividend, Adds 150M To Share Buyback ||| Coca-Cola Adds 150M To Buyback ||| Coca-Cola Raises Qtr. Dividend From $0.39 To $0.40/Share ||| A Chat With The CEO Behind The Cannabis Company With The 'BOSS' Ticker: 'There Isn't A Single Route To Success'",0,0.49315456
2019-02-22,24728400.0,45.7599983215332,45.95000076293945,45.20000076293945,45.27999877929688,43.11603927612305,KO,"Top Research Reports for McDonald's, CVS Health & Celgene ||| Marijuana Stocks and ETFs: Risks and Rewards ||| Stocks Gain Amid Flurry of Trade News; Dow Extends Historic Streak ||| Coca-Cola Shares Volatile Following Release Of Slide Show Presentation For CAGNY Conference; Said Co. 'Committed to Margin Expansion but Due to Recent Acquisitions, the Previous 2020 Guidance of 34%+ Is No Longer the Right Reference Point, Is Withdrawn'",0,0.5182925
2019-02-25,23774400.0,45.43999862670898,45.56999969482422,44.84000015258789,44.93999862670898,42.79228973388672,KO,"The Dogs of the Dow Start 2019 Slow ||| Warren Buffett Gives Thumbs-Up To New Execs, Notes Earnings Impact From Kraft Heinz In Annual Berkshire Hathaway Letter ||| The Zacks Analyst Blog Highlights: McDonald's, CVS Health, Celgene, Coca-Cola and Agilent ||| Why Dividend Investors Have Warren Buffett All Wrong ||| Former Mexican President Vicente Fox Joins Helix TCS Board",0,0.49609205
2019-02-26,20463200.0,45.09999847412109,45.13999938964844,44.65999984741211,44.68999862670898,42.554237365722656,KO,4 Large-Cap Stocks in Trouble,1,0.55381536
2019-02-27,17827500.0,44.59999847412109,45.02000045776367,44.41999816894531,44.93999862670898,42.79228973388672,KO,"Why Coca-Cola is a Top Socially Responsible Dividend Stock (KO) ||| Pepsico, Inc. (PEP) Ex-Dividend Date Scheduled for February 28, 2019 ||| Coca-Cola Stock Primed For a Quiet Comeback As Soda Gets Its Fizz Back ||| Monster Beverage Powers Up for 2019 ||| Coca-Cola Option Alert: Jun 21 $42 Puts Sweep (47) near the Bid: 2603 @ $0.68 vs 31429 OI; Earnings 4/23 Before Open [est] Ref=$44.575 ||| Coca-Cola Option Alert: Jun 21 $42 Puts Sweep (47) near the Bid: 2603 @ $0.68 vs 31429 OI; Earnings 4/23 Before Open [est] Ref=$44.575",1,0.48303345
2019-02-28,22533900.0,45.119998931884766,45.61000061035156,45.11000061035156,45.34000015258789,43.17317581176758,KO,"FEMSA (FMX) Reports Strong Q4 Earnings, Sales Lag Estimates ||| Molson Coors Brewing Company (TAP) Ex-Dividend Date Scheduled for March 01, 2019 ||| Monster Beverage (MNST) Stock Up on Q4 Earnings & Sales Beat ||| The Perils Of Investing Idol Worship: The Kraft Heinz Lessons! ||| Monster Beverage Posts Sales, EPS Beat: 4 Sell-Side Takes",1,0.5021313
2019-03-01,16291600.0,45.470001220703125,45.63999938964844,45.20000076293945,45.380001068115234,43.21126937866211,KO,"3 Dividend Stocks That Pay You Better Than Coca-Cola Does ||| The Best Way to Profit From a Coca-Cola, Monster Beverage Pairs Trade",1,0.49224123
2019-03-04,15973800.0,45.52999877929688,45.66999816894531,45.29999923706055,45.650001525878906,43.468360900878906,KO,"XLP, USDY: Big ETF Inflows",0,0.52240616
2019-03-05,13062300.0,45.650001525878906,45.70000076293945,45.400001525878906,45.59999847412109,43.420745849609375,KO,Soft Drinks Outlook: Can Portfolio Shift Bring Back the Fizz?,0,0.5061162
2019-03-06,14232100.0,45.66999816894531,45.790000915527344,45.43999862670898,45.45000076293945,43.27791976928711,KO,PreMarket Prep Opening NYSE Imbalance Update: Conagra 133k Shares To Buy; Bank Of America 264k to Sell; Proctor & Gamble 50k to Sell; Coca-Cola 54k to Sell,0,0.4892835
2019-03-07,12084000.0,45.4900016784668,45.52999877929688,45.130001068115234,45.27999877929688,43.11603927612305,KO,"Awash with plastic bottles and lacking a law, Kenya struggles to recycle ||| A Hard Brexit Could Take a Toll on These 3 Companies ||| Benzinga's Top Upgrades, Downgrades For March 7, 2019 ||| Credit Suisse Initiates Coverage On Coca-Cola with Neutral Rating, Announces $48 Price Target",0,0.51708096
2019-03-08,15579100.0,45.150001525878906,45.25,44.61000061035156,44.84000015258789,42.69706726074219,KO,Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)? ||| The #1 Way to Invest for Retirement ||| Why Owners of Elite Dividend-Paying Businesses Don’t Worry About “The Market” ||| Coca-Cola (KO) Dips More Than Broader Markets: What You Should Know,1,0.49940303
2019-03-11,22126900.0,45.13999938964844,46.2400016784668,45.09999847412109,46.18000030517578,43.973026275634766,KO,"3 Big Stock Charts for Monday: Coca-Cola, Citrix Systems and Johnson Controls ||| 5 Top Stock Trades for Tuesday: Apple, Nvidia, Boeing",0,0.50641906
2019-03-12,19348500.0,45.95000076293945,46.25,45.900001525878906,46.04999923706055,43.849246978759766,KO,"Consumer Staples Select Sector SPDR Fund Experiences Big Inflow ||| Ex-Dividend Reminder: Garmin, Coca-Cola and Sturm, Ruger ||| Better Buy: General Electric vs. Coca-Cola ||| Activision Blizzard Is Taking Esports to the Next Level ||| BMO Downgrades Monster Beverages After Hitting 'Peak Valuation' ||| HSBC Downgrades Coke: 'If The Bottlers Aren't Happy, Nobody's Happy' ||| Benzinga's Top Upgrades, Downgrades For March 12, 2019 ||| 10 Consumer Stocks To Buy Right Now, According To Quantamize ||| HSBC Downgrades Coca-Cola to Hold",1,0.5465283
2019-03-13,16222500.0,46.130001068115234,46.34000015258789,45.90999984741211,46.220001220703125,44.01111602783203,KO,"Dow Movers: HD, UTX ||| Buy the Dip in National Beverage Because FIZZ Stock Is Ready to Pop ||| Coca-Cola Company (KO) Ex-Dividend Date Scheduled for March 14, 2019",0,0.44260788
2019-03-14,18504100.0,45.84000015258789,46.11000061035156,45.630001068115234,45.70000076293945,43.89585876464844,KO,"Here's the Real Reason Aurora Cannabis Shares Caught Fire Yesterday ||| Elite Dividend Payers: The Cure for the Biggest Mistake Income Investors Make ||| Coca-Cola (KO) Dips More Than Broader Markets: What You Should Know ||| Better Dividend Buy: IBM vs. Coca-Cola ||| Coca-Cola To Report Q1 Earnings Tues., Apr. 23, 2019 Before Market Open",0,0.4844046
2019-03-15,47254500.0,45.720001220703125,45.900001525878906,45.13999938964844,45.29999923706055,43.51165008544922,KO,"As Credit Suisse Says Pepsi Stock Could Fall 14%, Is KO Stock A Better Buy? ||| Market Close Report: NASDAQ trading volume joins the top ten ranking for the year. NASDAQ Composite Index closes at 7,688.53 ||| Trade, Tech Spark Risk-On Session for Stocks",1,0.49150634
2019-03-18,24006400.0,45.43000030517578,45.68000030517578,45.36000061035156,45.40999984741211,43.617305755615234,KO,"Coke (KO) Down 0.6% Since Last Earnings Report: Can It Rebound? ||| Bulls & Bears Of The Week: Apple, Kroger, Nike, Oracle, Tesla And More ||| Tilray Stock Mania Holds Its Breath as Earnings Approach ||| Aurora Cannabis: 4 Logical Brand-Name Partners ||| Aurora Cannabis: 4 Logical Brand-Name Partners",1,0.49602747
2019-03-20,13376100.0,45.400001525878906,45.900001525878906,45.18000030517578,45.52999877929688,43.732566833496094,KO,"XLP, KO, PEP, WMT: ETF Inflow Alert ||| PreMarket Prep Opening NYSE Imbalance Update: Walmart 113k Shares To Sell; ExxonMobil 60k To Sell; Chevron 41k To Sell; P&G 40k To Sell; Coca-Cola 52; Morgan Stanley 40k To Sell; Alibaba 49k To Sell; Disney 100k To Buy; General Electric 83k To Sell",0,0.4868384
2019-03-21,20043000.0,45.52999877929688,45.7599983215332,45.43999862670898,45.5099983215332,43.71335220336914,KO,Here's What You Must Know About Keurig Dr Pepper (KDP) Stock ||| Coca-Cola (KO) Stock Sinks As Market Gains: What You Should Know,1,0.47546265
2019-03-22,19055900.0,45.459999084472656,46.11000061035156,45.459999084472656,45.93000030517578,44.11677932739258,KO,"Dow Movers: NKE, VZ ||| Is This Why Aurora Cannabis and Coca-Cola Never Reached a Deal? ||| Beverage Stocks Unaffected Following Thurs. Afternoon NY Post Article 'Soda could cause colon cancer tumors to grow: new medical study'",1,0.5004916
2019-03-25,11668200.0,45.86000061035156,46.20000076293945,45.790000915527344,46.02999877929688,44.21282958984375,KO,3 Reasons to Add Monster Beverage (MNST) to Your Portfolio ||| Can Orange Vanilla Coke Save Coca-Cola? ||| Rates Still In Focus: Financial Stocks Might Feel Heat As Investors Concerned About Yields,1,0.5010591
2019-03-26,11434900.0,46.16999816894531,46.790000915527344,46.16999816894531,46.63999938964844,44.79874420166016,KO,KO Makes Bullish Cross Above Critical Moving Average,0,0.50998306
2019-03-27,11543600.0,46.650001525878906,46.90999984741211,46.33000183105469,46.61000061035156,44.769927978515625,KO,Coca-Cola (KO) Stock Moves -0.23%: What You Should Know,0,0.46427155
2019-03-28,11121100.0,46.68000030517578,46.91999816894531,46.47999954223633,46.58000183105469,44.741119384765625,KO,"We're At A Turning Point In The Market ||| DGRO, VZ, WFC, KO: Large Inflows Detected at ETF ||| McDonald’s Stock Pushes Onward and Upward With Menu-Tech Acquisition ||| McDonald’s Stock Pushes Onward and Upward With Menu-Tech Acquisition",1,0.480645
2019-03-29,16045600.0,46.66999816894531,46.90999984741211,46.47999954223633,46.86000061035156,45.01006317138672,KO,3 Dividend Stocks That Pay You Better Than Coca-Cola Does ||| 5 Promising Biotech Stocks That Could Be Takeover Targets ||| Insights Could Be the Next Big Thing for Alphabet Stock ||| The Sweet Dividend Alone Makes KO Stock Worth Another Look ||| We're Up 92% On This Stock -- Here's Why The Ride Isn't Over...,0,0.49095884
2019-04-01,11522700.0,46.9900016784668,47.16999816894531,46.59000015258789,46.720001220703125,44.875587463378906,KO,Quickly Spot Patterns With This Popular Charting Style ||| 5 Tips for Making Money in Penny Stocks ||| How To Give Yourself A 30% Raise,0,0.51844174
2019-04-02,8495000.0,46.75,46.93000030517578,46.56999969482422,46.56999969482422,44.73151397705078,KO,"My Trade On This ""Hated"" Stock Could Deliver 50% Gains ||| The Simplest Move To Reduce Your Tax Bill",0,0.49600065
2019-04-03,12854500.0,46.41999816894531,46.59000015258789,46.040000915527344,46.18000030517578,44.35690307617188,KO,"A Simple Yet Effective Indicator for Clear Buy/Sell Signals ||| Keurig Dr Pepper Inc. (KDP) Ex-Dividend Date Scheduled for April 04, 2019 ||| The Most Powerful (But Ignored) Sign Of A Successful Investment ||| Guggenheim Referencing Nielsen Data Notes Coca-Cola 'Total sales increased +2.5% in the 12-wks with CSD sales increasing +5.1% as the company continues to benefit from its market leadership with price / mix up +6.4%'; Maintains Buy",1,0.5003103
2019-04-04,7814900.0,46.34000015258789,46.540000915527344,46.11000061035156,46.47999954223633,44.64506530761719,KO,Want To Buy An IPO Like Lyft? Here's Why That's A Bad Idea ||| Wall Street Can Toast the Constellation Brands Report ||| Canopy Growth Is the Best Bet In an Overvalued Marijuana Space ||| Wall Street Can Toast the Constellation Brands Report ||| 5 Ways To Know When To Dump A Stock,0,0.4677343
2019-04-05,7677600.0,46.4900016784668,46.58000183105469,46.20000076293945,46.470001220703125,44.63545608520508,KO,The Bull Market Is 10 Years Old. Now What? ||| Consumer Staples Select Sector SPDR Fund Experiences Big Outflow ||| 3 Stocks With Dependable Dividends ||| The Four Red Flags Of Dividend Cuts,1,0.4894982
2019-04-08,9421300.0,46.540000915527344,46.56999969482422,46.27000045776367,46.54999923706055,44.71229934692383,KO,Why Monster Beverage Stock Dropped 15% in March ||| An Approximate Guide to Market Timing ||| Is This The First Medical Marijuana Blue Chip Stock?,1,0.4862403
2019-04-09,8641800.0,46.45000076293945,46.720001220703125,46.27000045776367,46.66999816894531,44.82756042480469,KO,"7 Catalysts That Will Send Marijuana Stocks Soaring in 2019 ||| In New York, confusion reigns in the emerging CBD edibles business ||| 4 Growth Stocks That Still Have Room To Run In This Market",0,0.52388984
2019-04-10,8059900.0,46.84000015258789,47.0,46.560001373291016,46.63999938964844,44.79874420166016,KO,The Critical Price Level You Need To Watch,1,0.5238527
2019-04-11,7352400.0,46.720001220703125,46.75,46.540000915527344,46.709999084472656,44.86598205566406,KO,3 Dividend Stocks That Pay You Better Than Coca-Cola Does ||| 3 Dividend Stocks That Pay You Better Than Coca-Cola Does ||| Coca-Cola (KO) Stock Moves 0.15%: What You Should Know ||| How I Use Buffett's Advice To Earn Huge Yields And Capital Gains,1,0.50261426
2019-04-12,10690000.0,46.66999816894531,46.93000030517578,46.56999969482422,46.7400016784668,44.894798278808594,KO,Warren Buffett’s Top 10 Stock Holdings ||| Warren Buffett’s Top 10 Stock Holdings,1,0.48025152
2019-04-15,10261300.0,46.880001068115234,47.040000915527344,46.70000076293945,47.0,45.14453506469727,KO,"Pepsi Earnings: What to Watch ||| 3 Reasons Coca-Cola Is a Buy for Conservative Investors ||| Coca-Cola, Disney Partner to Bring Custom Bottles of Coke Products for New 'Star Wars: Galaxy's Edge' Land ||| XLP, KO, PEP, WMT: Large Inflows Detected at ETF ||| Wait For This One Signal Before Going Long Monster Beverage Stock",0,0.49602196
2019-04-16,10804600.0,47.04999923706055,47.09999847412109,46.70000076293945,46.95000076293945,45.09650802612305,KO,"Pepsico Stock Is Fizzing Ahead of Earnings ||| Top Research Reports for Coca-Cola, United Technologies & Royal Dutch Shell ||| Pepsico Stock Is Fizzing Ahead of Earnings ||| Wells Fargo Maintains Outperform on Coca-Cola, Raises Price Target to $52",1,0.4940763
2019-04-17,11849300.0,47.20000076293945,47.54999923706055,47.150001525878906,47.27999877929688,45.41347503662109,KO,"Dow Analyst Moves: KO ||| It's Official! This Major Pot Stock Wants a Partner ||| Pepsi Outperforms, Can Coke Follow?",1,0.5010987
2019-04-18,12167000.0,47.33000183105469,47.58000183105469,47.27000045776367,47.47999954223633,45.60558319091797,KO,"3 Tailwinds to Consider for KO Stock Before Calling It Quits ||| Coca-Cola (KO) Outpaces Stock Market Gains: What You Should Know ||| After Hours Most Active for Apr 18, 2019 : IEF, CZR, NEM, FOLD, BAC, QCOM, PSTG, GM, IQ, KO, QQQ, EXC",0,0.4881676
2019-04-22,9834700.0,47.400001525878906,47.61000061035156,47.02000045776367,47.400001525878906,45.52874374389648,KO,"Miguel Patricio: 10 Things to Know About the New Kraft Heinz CEO ||| Great Q1 Earnings Aren’t Even the Best Reason to Buy Pepsi Stock ||| New Pressure on China Might Just Boost Applied Materials Stock ||| 'California soda tax proposal shelved while lawmaker vows to try again next year' -The Modesto Bee ||| As Earnings Season Rolls On, Many Companies Have Beaten Expectations",1,0.51006323
2019-04-23,25327800.0,48.09000015258789,48.720001220703125,47.54999923706055,48.209999084472656,46.3067626953125,KO,"Here Is How to Trade Coke Stock’s Spike on Earnings ||| Coca-Cola Co (KO) Q1 2019 Earnings Call Transcript ||| What Happened in the Stock Market Today ||| S&P, Nasdaq Secure Record Closes; Dow Powers North ||| Noteworthy ETF Outflows: XLP, PG, KO, PEP ||| Earnings Reaction History: The Coca-Cola Company, 27.3% Follow-Through Indicator, 1.9% Sensitive ||| 7 Dividend Stocks To Consider for Growth ||| The Coca-Cola Q1 19 Earnings Conference Call At 8:30 AM ET ||| Coca-Cola Earnings: KO Stock Bubbles Higher on Q1 Beat ||| Coca-Cola Company Shares Up 3% On Q1 Results; Affirms FY Guidance ||| Earnings Beats Keep Coming, With Verizon, CocaCola, Twitter, Procter & Gamble All Solid ||| Coca-Cola shares are trading higher after the company reported better-than-expected Q1 EPS and sales. The company issued FY19 guidance for organic growth up 4 percent from last year. ||| This Day In Market History: Coca-Cola Launches New Coke ||| A Peek Into The Markets: US Stock Futures Mostly Higher ||| Coca-Cola Reaffirms FY19 Guidance: Organic Sales Growth ~4% Year Over Year, EPS Down 1% To Up 1% Year Over Year ||| Coca-Cola Q1 Adj. EPS $0.48 Beats $0.46 Estimate, Sales $8B Beat $7.89B Estimate ||| 12 Stocks To Watch For April 23, 2019 ||| Earnings Scheduled For April 23, 2019",0,0.48486
2019-04-24,15997300.0,48.02999877929688,48.22999954223633,47.91999816894531,47.97999954223633,46.085845947265625,KO,"Wednesday’s Vital Data: Coca-Cola, Qualcomm and Microsoft ||| Consumer Sector Update for 04/24/2019: TUP, KO, EBAY, WMT, MCD, DISCB, CVS, KO ||| 'Coca-Cola is launching its own coffee, energy drink this year' -NY Post ||| UBS Maintains Neutral on Coca-Cola Company (The) Common Stock, Raises Price Target to $52 ||| Deutsche Bank Maintains Buy on Coca-Cola Company (The) Common Stock, Raises Price Target to $54 ||| Morgan Stanley Maintains Equal-Weight on Coca-Cola Company (The) Common Stock, Raises Price Target to $52",0,0.49983808
2019-04-25,11444400.0,47.7400016784668,47.88999938964844,47.470001220703125,47.84000015258789,45.95137023925781,KO,Coca-Cola's Outlook Has Analysts Perking Up,1,0.52878785
2019-04-26,10154300.0,47.9900016784668,48.45000076293945,47.97999954223633,48.2599983215332,46.35478973388672,KO,"Agree To Purchase Coca-Cola At $38, Earn 2.9% Using Options",1,0.5269365
2019-04-30,17912900.0,48.52999877929688,49.18000030517578,48.38999938964844,49.060001373291016,47.12321472167969,KO,5 Terrific Tech Stocks That Will Make You Forget About FANG,0,0.51164466
2019-05-01,10551200.0,48.95000076293945,49.08000183105469,48.54999923706055,48.59000015258789,46.6717643737793,KO,Consumer Staples Select Sector SPDR Fund Experiences Big Outflow ||| BlackBuck Raises $150 Million In Series D To Expand Services Across India ||| Best Sector ETFs For May: An Interesting Mix,0,0.4869303
2019-05-02,8724600.0,48.52999877929688,48.77000045776367,48.27000045776367,48.38999938964844,46.47966003417969,KO,Going Shopping With This Consumer Staples ETF ||| This Day In Market History: Bill Gates Unveils Microsoft Excel,1,0.52955127
2019-05-03,7076900.0,48.59999847412109,48.959999084472656,48.52000045776367,48.720001220703125,46.796634674072266,KO,Why Monster Beverage Shares Soared Today ||| The Street Debates Monster Beverage's Quarter ||| Which Economy? – Three Heartbeats To Monitor: The Consumer Economy,0,0.49839595
2019-05-06,8657800.0,48.33000183105469,48.61000061035156,48.2599983215332,48.470001220703125,46.55650329589844,KO,Is 'Injustice' Responsible for National Beverage's Stock Price Decline? ||| A Beginner's Guide to Value Investing,0,0.49987346
2019-05-07,12487500.0,48.22999954223633,48.290000915527344,47.77000045776367,48.0,46.10505676269531,KO,10 Great Stocks to Buy on Dips,0,0.512935
2019-05-08,9281400.0,48.04999923706055,48.22999954223633,47.81999969482422,47.84999847412109,45.96097946166992,KO,Hitting A Wall: More Red Ink Appears Ready To Spill As New Tariffs Loom ||| This Day In Market History: The First Coca-Cola Is Sold,0,0.5015058
2019-05-09,11450500.0,47.79999923706055,47.97999954223633,47.06999969482422,47.400001525878906,45.52874374389648,KO,Keurig and Anheuser-Busch Cocktail Maker Ready to Expand,1,0.5455781
2019-05-10,9653800.0,47.40999984741211,48.29999923706055,47.400001525878906,48.18999862670898,46.28755187988281,KO,"Consumer Sector Update for 05/10/2019: WMT, MCD, DIS, CVS, KO, CHS, CARS, SSP ||| Warren Buffett and Dividend Stocks: Everything Investors Need to Know",0,0.45193774
2019-05-13,11911500.0,47.90999984741211,48.130001068115234,47.72999954223633,48.04999923706055,46.15308380126953,KO,"IPO Outlook For The Week: Tech Solutions, Craft Brewery And The 'Starbucks Of China' ||| The ConversionPoint IPO: What You Need To Know",1,0.4901737
2019-05-14,16844200.0,48.52999877929688,49.31999969482422,48.34999847412109,48.68999862670898,46.7678108215332,KO,"After Hours: Tilray Tops, Agilent Whiffs, Coca-Cola Gets Some Fizz ||| 5 Consumer Stocks Ready to Push Higher ||| Dow Movers: UNH, KO ||| Getting Defensive With Sector ETFs ||| Morgan Stanley Upgrades Coca-Cola, Sees More Growth Ahead ||| Coca-Cola shares are trading higher after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised the price target from $52 to $55. ||| UPDATE: Morgan Stanley Names Coca-Cola 'our top mega-cap staples pick' ||| UPDATE: Morgan Stanley Upgrades Coca-Cola To Overweight, Raises Target To $55 As Firm Notes Co's 'NTM P/E valuation is surprisingly at a -5% discount to mega-cap peers, more than one standard deviation below its historical +2% premium' ||| Coca-Cola Shares Unaffected Amid Guardian Report 'Coca-Cola most common source of packaging pollution on UK beaches – study' ||| Benzinga's Top Upgrades, Downgrades For May 14, 2019 ||| Morgan Stanley Upgrades Coca-Cola Company (The) Common Stock to Overweight, Raises Price Target to $55",1,0.49222654
2019-05-15,11422500.0,48.66999816894531,49.380001068115234,48.59999847412109,49.18000030517578,47.238468170166016,KO,"For Aurora Stock, The Bullish Bet Is Still On ||| Dow Movers: CAT, KO",1,0.5035468
2019-05-17,11257000.0,49.27000045776367,49.54999923706055,49.16999816894531,49.20000076293945,47.25768280029297,KO,"5 Great Blue-Chip Stocks to Buy Today ||| The Bullish Thesis for Tilray Stock Is Still Alive and Well ||| XLP, IQIN: Big ETF Inflows",0,0.51184934
2019-05-20,13850500.0,49.040000915527344,49.13999938964844,48.7599983215332,48.84999847412109,46.9214973449707,KO,"3 Brand-Name Food and Beverage Companies That Want In on the Marijuana Craze ||| Berkshire Hathaway Stock Should Pay a Special Dividend ||| Warren Buffett Is the World's Biggest Investor in These 5 Stocks ||| Coca-Cola To Maintain Major Stake In Coca-Cola Beverages Africa - Quick Facts ||| A Look At This Year's Top Restaurant Trends: Cannabis, Craft And Casual ||| PreMarket Prep Opening NYSE Imbalance Update: GE 215k Shares To Sell; Alibaba 69k To Sell; Pfizer 131k To Sell; Coca-Cola 58k To Sell; J&J 32k To Sell ||| UPDATE: Coca-Cola Will Reclassify Coca-Cola Beverages Africa Into Continuing Operations ||| Coca-Cola Reports Will Maintain Majority Stake In Coca-Cola Beverages Africa For Foreseeable Future",0,0.517591
2019-05-21,10587400.0,49.0,49.02999877929688,48.45000076293945,48.59999847412109,46.68136596679688,KO,6 Top Stocks to Buy Under $50 in 2019,1,0.54652035
2019-05-22,16050400.0,48.77999877929688,49.709999084472656,48.720001220703125,49.650001525878906,47.68991470336914,KO,It’s Time to Load Up on CGC Stock Again,1,0.52770734
2019-05-23,12199400.0,49.5,49.900001525878906,49.459999084472656,49.84999847412109,47.88201522827149,KO,"Dow Movers: UTX, KO",0,0.5049629
2019-05-24,6887600.0,49.81999969482422,49.88999938964844,49.52999877929688,49.61000061035156,47.65149688720703,KO,"3 Dividend Stocks That Pay You More Than Pepsi Does ||| New Age Beverages Stock Could Surge to $6.70 ||| Dow Movers: KO, BA ||| This Day In Market History: AOL Is Founded",0,0.5004843
2019-05-28,18614000.0,49.59999847412109,49.66999816894531,49.02999877929688,49.09999847412109,47.1616325378418,KO,"Disney Dominates Media, Market Notices ||| Capitalize on Name-Brand Strength with Coca-Cola ||| TriGrow's David Kessler On The Need For Standards In Cannabis Cultivation",0,0.5207813
2019-05-29,12534600.0,48.7400016784668,49.02999877929688,48.40999984741211,48.61000061035156,46.69097518920898,KO,Tilray Stock Keeps Its Eyes on the Future,1,0.52520293
2019-05-30,9087200.0,48.720001220703125,49.310001373291016,48.66999816894531,49.25,47.30570983886719,KO,3 Warren Buffett Stocks Worth Buying Now,0,0.5321675
2019-05-31,11368600.0,49.0,49.310001373291016,48.77999877929688,49.130001068115234,47.19044876098633,KO,"Warren Buffett: His Best Investing Strategies, Stocks, and Advice",1,0.49812922
2019-06-03,14167200.0,49.15999984741211,49.97999954223633,49.02000045776367,49.97999954223633,48.00688934326172,KO,Is Coca-Cola a Buy? ||| 6 Big Dividend Stocks to Buy as Yields Plunge ||| Carter Worth And Mike Khouw's Coca-Cola Trade,1,0.5075312
2019-06-04,12010600.0,50.0,50.27999877929688,49.619998931884766,50.0,48.02609634399414,KO,"3 Small-Cap Stocks to Buy ||| Taking Advantage of an Undervalued Target ||| Morgan Stanley's Beverage Pair Trade: Overweight Coca-Cola, Underweight Keurig Dr Pepper",1,0.49604425
2019-06-05,15837600.0,50.0099983215332,51.13999938964844,49.68999862670898,50.77999877929688,48.77530670166016,KO,"5 Top Stock Trades for Thursday: SHOP, MU, KO, AEO ||| Noteworthy ETF Outflows: XLP, KO, PEP, KMB ||| Dow Jones Today: Stocks Get Some Support from the Middle",1,0.5316792
2019-06-06,15190400.0,50.90999984741211,51.540000915527344,50.59000015258789,51.400001525878906,49.37083435058594,KO,7 Stocks to Buy That Don’t Care About Tariffs ||| Thursday's ETF with Unusual Volume: RHS,1,0.50405383
2019-06-07,15293600.0,51.470001220703125,52.18999862670898,51.45000076293945,51.4900016784668,49.457279205322266,KO,"The Next GameStop? 5 Zombie Dividends Up to 13.3% (Sell Now) ||| Report: Monster Beverage Considers Expansion Into Alcohol, Cannabis ||| UPDATE: Monster CEO Said Co Is 'preparing to acquire nonalcoholic beverages outside of energy drinks when its noncompete clause with Coke expires in a year'",0,0.49132952
2019-06-10,9737400.0,51.540000915527344,51.540000915527344,51.09000015258789,51.380001068115234,49.35162353515625,KO,"Twilio Needs to Figure Out How to Land the Rocket Ship ||| KO Crosses Above Average Analyst Target ||| 3 Big Stock Charts for Monday: CenterPoint Energy, McKesson and Coca-Cola",0,0.50763893
2019-06-11,9915600.0,51.45000076293945,51.59000015258789,51.18000030517578,51.33000183105469,49.303592681884766,KO,3 Scenarios That Would Make Aurora Cannabis a Buy,1,0.5422996
2019-06-12,11087500.0,51.5,52.13999938964844,51.470001220703125,51.63999938964844,49.601356506347656,KO,"Notable Wednesday Option Activity: FB, GOOGL, KO ||| Millennial Research Firm Says Young Consumers Still Love LaCroix ||| Abbott, Coca-Cola And More: 'Fast Money Halftime Report' Picks For June 12",0,0.45893756
2019-06-13,10353600.0,51.459999084472656,51.70000076293945,50.77999877929688,51.130001068115234,49.494873046875,KO,Cronos Group Stock Is Just Getting Started ||| Interesting KO Put And Call Options For August 2nd ||| Why Coca-Cola is a Top 25 Dividend Giant (KO),1,0.5066122
2019-06-14,8694300.0,51.04999923706055,51.52999877929688,51.04999923706055,51.310001373291016,49.66911697387695,KO,The Berkshire Hathaway Portfolio: All 48 Buffett Stocks,0,0.4944349
2019-06-17,12322400.0,51.25,51.47999954223633,50.61000061035156,50.869998931884766,49.24319076538086,KO,"5 Companies Looking to Cash In on Netflix's ""Stranger Things"" ||| NBEV Stock Is More Than Just CBD — But It’s Still Not Enough",0,0.48992845
2019-06-19,9414100.0,50.540000915527344,51.2400016784668,50.470001220703125,51.119998931884766,49.48519134521485,KO,Bank Of America's Energy Drink Case Study: Early Distribution Deals Could Decide Winners In Cannabis Market,1,0.51316357
2019-06-20,10656600.0,51.5,51.790000915527344,51.34999847412109,51.65999984741211,50.0079231262207,KO,The Blue Chip of Pot: Can CGC Stock Rally 20% on Acreage Deal and Earnings?,0,0.5123075
2019-06-21,21264400.0,51.52999877929688,51.88999938964844,51.40999984741211,51.54999923706055,49.90143966674805,KO,"Which is the Better Dividend Aristocrat, McDonald’s or Coca-Cola? ||| Noteworthy ETF Inflows: XLP, PG, KO, PEP",1,0.48599938
2019-06-24,10780000.0,51.7400016784668,52.20000076293945,51.70000076293945,51.91999816894531,50.25960922241211,KO,"Dry States: The Decline of Alcohol in the U.S. ||| 3 Dividend Stocks That Pay You Better Than Coca-Cola Does ||| Organisers Of Olympic Games Sign Sponsorship Deal with Coca-Cola, China Mengniu Dairy Worth Combined $3B; Deal to Include Summer and Winter Olympics from 2021-2032",0,0.5123801
2019-06-25,11519900.0,52.0,52.09999847412109,51.63999938964844,51.7599983215332,50.1047248840332,KO,"'Fast Money' Traders Talk Gold, Defensive Stocks And More",0,0.49878657
2019-06-26,12405100.0,51.52000045776367,51.63999938964844,51.09000015258789,51.119998931884766,49.48519134521485,KO,'Coca-Cola in exclusive talks with Cafe Coffee Day for acquiring stake' -India's Economic Times,0,0.50549906
2019-06-27,12374900.0,51.290000915527344,51.400001525878906,50.970001220703125,51.08000183105469,49.446475982666016,KO,"Coca-Cola, A Shipper Of Choice That Quenches Drivers' Thirsts For Efficiency",0,0.5080905
2019-07-01,14976400.0,51.06999969482422,51.630001068115234,50.77999877929688,51.59999847412109,49.9498405456543,KO,"Dow Jones Today: Trade News Was Certainly Sold ||| Healthcare and Insurance Trends: 2 Hot Stocks to Buy ||| Notable ETF Inflow Detected - XLP, PG, KO, PEP ||| Morgan Stanley: Coca-Cola 'Clearly' Boasts Better Growth ||| Arbitration Panel OKs Coca-Cola Competition With Monster Beverage ||| UPDATE: Morgan Stanley Maintains Overweight, Raises Coca-Cola Target To $57 As Firm Believes Co. 'offers a clearly superior LT growth outlook vs. CPG peers, with stronger pricing power and favorable strategy tweaks' ||| Morgan Stanley Maintains Overweight on Coca-Cola, Raises Price Target to $57 ||| The American Arbitration Associate Rules the Introduction of Coca-Cola Energy is Allowed Under the Terms of Coca-Cola's Contract with Monster Energy",1,0.50230294
2019-07-02,8569200.0,51.77999877929688,52.04999923706055,51.54999923706055,51.97999954223633,50.31768798828125,KO,"3 Dow Jones Stocks to Buy for the Second Half ||| The Next Wave Of Canadian Cannabis ||| Fourth Of July Pop, Boom, And Sparkle: Summer Seasonal Stocks To Consider",1,0.5076928
2019-07-03,7253700.0,52.0,52.33000183105469,52.0,52.09999847412109,50.4338493347168,KO,"Dow Analyst Moves: KO ||| 3 Top Dividend Stocks to Buy Right Now ||| Flags Waving As Holiday Approaches, With Tesla Quarter Showing Unexpected Strength",1,0.5031516
2019-07-05,8916300.0,51.88999938964844,52.119998931884766,51.47999954223633,52.11000061035156,50.44353485107422,KO,"5 Companies Cashing in on the ""Stranger Things"" Craze",0,0.5291085
2019-07-08,9495100.0,52.20000076293945,52.33000183105469,51.88999938964844,52.0,50.3370475769043,KO,"Barron's Picks And Pans: Coca-Cola, Kroger, Shopify And More ||| PepsiCo Second-Quarter Earnings: What to Watch ||| Old But Gold: 3 Centenarian Stocks That Are Looking Toward the Future",0,0.4719643
2019-07-09,10584900.0,51.720001220703125,51.970001220703125,51.43000030517578,51.59000015258789,49.940162658691406,KO,The Consumer Staples Select Sector SPDR Fund Experiences Big Outflow ||| What Could Drive PepsiCo’s Earnings Decline In Q2 2019? ||| 5 Great Blue-Chip Stocks to Buy,1,0.5077602
2019-07-10,7620900.0,51.79999923706055,51.970001220703125,51.65999984741211,51.81999969482422,50.16280746459961,KO,Aurora Cannabis Stock’s Highs Are Coming,1,0.5133629
2019-07-11,10376500.0,51.9900016784668,52.060001373291016,51.65999984741211,52.040000915527344,50.37577438354492,KO,5 Artificial Intelligence Stocks to Consider ||| KO Crosses Above Average Analyst Target ||| PepsiCo's Earnings Beat In Q2 2019 Reaffirms Strong Revenue And Profitability Outlook ||| Loadsmart And Oracle Collaborate To Digitize Logistics,1,0.5087388
2019-07-12,7347400.0,52.25,52.290000915527344,51.90999984741211,52.119998931884766,50.453216552734375,KO,Why Coca-Cola Consolidated's Stock Gained 69% in the First Half of 2019,1,0.5194318
2019-07-15,5876100.0,52.27999877929688,52.290000915527344,51.869998931884766,52.130001068115234,50.46289443969727,KO,Better Buy: Procter & Gamble vs. Coca-Cola ||| How to Invest Like Warren Buffett in 2019 and Beyond,1,0.4971997
2019-07-17,8264200.0,52.220001220703125,52.2599983215332,52.0099983215332,52.18000030517578,50.51129150390625,KO,"ACWI, BABA, KO, AMGN: ETF Inflow Alert ||| XLP, BDRY: Big ETF Outflows ||| Heading Into Earnings, Coca Cola Stock Is a Buy on the Next 5% Dip",0,0.50111556
2019-07-18,11912300.0,52.040000915527344,52.16999816894531,51.66999816894531,52.02999877929688,50.366092681884766,KO,"Daily Dividend Report: C, MS, PPG, SWK, V, KO ||| The 10 Biggest Consumer Staples Stocks",0,0.4911072
2019-07-22,12090700.0,51.52000045776367,51.52000045776367,51.130001068115234,51.220001220703125,49.581993103027344,KO,"Will Coca-Cola Earnings Stay Flat in the Second Quarter? ||| 3 Things to Watch in the Stock Market This Week ||| Dow Jones Today: Waiting on the Earnings Tidal Wave ||| Notable Earnings To Watch On July 23 - AN, JBLU, BIIB, CMG, KO, HOG, HAS, TXN",1,0.4893944
2019-07-23,33417900.0,53.25,54.63999938964844,52.7599983215332,54.33000183105469,52.59253692626953,KO,"Stocks End Higher on Earnings, U.S.-China Trade Buzz ||| Dow Jones Today: Earnings Drive Stocks to Record Highs ||| 5 Top Stock Trades for Wednesday: LMT, GE, KO, T ||| Notable Tuesday Option Activity: CMG, NFLX, KO ||| Tuesday Sector Leaders: Materials, Consumer Products ||| Coca-Cola Co (KO) Q2 2019 Earnings Call Transcript ||| Coca-Cola Earnings: KO Stock Bubbles Up to an All-Time High ||| Dow Movers: TRV, KO ||| Consumer Sector Update for 07/23/2019: WMT, MCD, DIS, CVS, KO, EDU, HAS, KMB, HOG ||| Coca-Cola Q2 Results Beat Estimates; Reaffirms FY19 Earnings Outlook ||| The Coca-Cola Q2 19 Earnings Conference Call At 8:30 AM ET ||| The Coca-Cola Company Q2 adjusted earnings Beat Estimates ||| Stocks that Broke 52-Week Highs Tuesday ||| Mid-Afternoon Market Update: Dow Rises Over 150 Points; LSC Communications Shares Plunge ||| 45 Stocks Moving In Tuesday's Mid-Day Session ||| Mid-Day Market Update: Tile Shop Falls After Q2 Results; Chiasma Shares Surge ||| Mid-Morning Market Update: Markets Open Higher; Coca-Cola Tops Q2 Estimates ||| Cramer Weighs In On Coca-Cola's Earnings ||| Budget Deal, Earnings Strength From Lockheed, CocaCola, United Technologies Lift Spirits ||| Coca-Cola shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. ||| Coca-Cola CEO Says Coke Zero Sugar Is Not In Third Year Of Double-Digit Volume Growth ||| Coca-Cola CEO Says Co. Remains Fully Committed To Partnership With Monster ||| Coca-Cola Trades Higher On Q2 Earnings Beat ||| 25 Stocks Moving In Tuesday's Pre-Market Session ||| A Peek Into The Markets: US Stock Futures Gain Ahead Of Earnings ||| Coca-Cola Q2 Adj. EPS $0.63 Beats $0.61 Estimate, Sales $10B Beat $9.84B Estimate ||| 10 Stocks To Watch For July 23, 2019 ||| Earnings Scheduled For July 23, 2019",0,0.5017573
2019-07-24,15633400.0,54.119998931884766,54.81999969482422,53.619998931884766,53.77999877929688,52.06012725830078,KO,"Wednesday’s Vital Data: Coca-Cola, Bank of America and Delta Airlines ||| A Surprising Source Fuels Coca-Cola's Robust Second Quarter ||| Should You Buy Coca-Cola’s Stock at Its All-Time High? ||| Coca-Cola Is Well Positioned To Achieve Higher End Of Sales Growth Outlook, BMO Says ||| Cramer And This Technical Analyst Agree: Coca-Cola Has Room To Run ||| BMO Capital Maintains Market Perform on Coca-Cola, Raises Price Target to $52 ||| JP Morgan Maintains Neutral on Coca-Cola, Raises Price Target to $59 ||| Morgan Stanley Maintains Overweight on Coca-Cola, Raises Price Target to $60 ||| Credit Suisse Maintains Neutral on Coca-Cola, Raises Price Target to $54 ||| Deutsche Bank Maintains Buy on Coca-Cola, Raises Price Target to $60 ||| 60 Biggest Movers From Yesterday",0,0.51799625
2019-07-25,19135000.0,53.630001068115234,53.79999923706055,52.720001220703125,53.06999969482422,51.372833251953125,KO,"7 Oversold Stocks To Buy Right Now ||| Why Coca-Cola Shares Bubbled Up to a New High ||| A Conversation on ESG and Sustainability With As You Sow CEO Andrew Behar ||| XLP, PG, KO, PEP: Large Inflows Detected at ETF ||| Coca-Cola and Hasbro Shareholders Are Smiling, but Harley's Still Decelerating",1,0.504413
2019-07-26,11451900.0,53.34000015258789,54.310001373291016,53.18999862670898,54.16999816894531,52.43765258789063,KO,"Dow Jones Today: A Strong End to the Week ||| Is the Colombian Cannabis Industry Leading Latin America, Or Just Leading Investors On A Wild Goose Chase?",0,0.50422055
2019-07-29,12283900.0,54.16999816894531,54.29999923706055,53.900001525878906,53.9900016784668,52.26340866088867,KO,"3 Ways Coca-Cola Is Expanding Beyond Soda ||| Bulls And Bears Of The Week: Coca-Cola, Intel, Mattel, Starbucks And More ||| Cracking Open Another Trade on Coca-Cola ||| 3 Debt-Defying Stocks ||| Should Investors Buy Dow Stock After Dow’s Q2 Results? ||| Analyst Sees 'Merit' In Buying Coca-Cola And Pepsi, But Which Stock Has More Upside? ||| Benzinga's Top Upgrades, Downgrades For July 29, 2019 ||| Host Of Earnings Loom With Beyond Meat, Apple Among Highlights Ahead Of Fed, Payrolls ||| Atlantic Equities Initiates Coverage On Coca-Cola with Overweight Rating",0,0.5107621
2019-07-30,8127100.0,53.959999084472656,54.29999923706055,53.56999969482422,53.720001220703125,52.002044677734375,KO,"The Big Question I Want To Ask The Fed This Week... ||| Coca-Cola Shows the World How You Nurture a Big Brand ||| The Best Performing Real Estate Asset Isn't What You Might Think ||| Apple On Today's Menu, With Starring Roles From China Talks, Fed Meeting",0,0.48763716
2019-07-31,16865500.0,53.5099983215332,53.5099983215332,52.040000915527344,52.630001068115234,50.946903228759766,KO,The Single Stock Trait Warren Buffett Mentioned 20 Times ||| What Your Investment Strategy Needs Right Now ||| How Large Option Traders Are Reacting To The Interest Rate Cut,0,0.51019245
2019-08-02,13102300.0,51.90999984741211,52.72999954223633,51.90999984741211,52.33000183105469,50.656497955322266,KO,13 Best Stocks to Buy for the Next Stock Market Correction,0,0.49066186
2019-08-05,19986500.0,52.38999938964844,52.65999984741211,51.400001525878906,51.650001525878906,49.99824523925781,KO,"Dow Jones Today: Not a Case of the Monday’s, but Much, Much Worse",1,0.49455386
2019-08-06,19903100.0,51.869998931884766,52.7599983215332,51.61000061035156,52.27000045776367,50.59841537475586,KO,Anti-Gay Backlash Over Coke Ad ||| Understanding Coca-Cola’s Business Model And Performance Across Key Operating Markets ||| Stable Tone Prevails After Monday Rout As Disney Earnings Loom After Close,1,0.5038225
2019-08-07,17937000.0,52.27000045776367,53.38999938964844,51.77000045776367,53.18000030517578,51.47931671142578,KO,"Competition Comes for Monster Beverage ||| Dow Jones Today: Sliding Bond Yields Lift Dividend Stocks ||| Canopy Growth Stock Is a Buy Near $32 ||| Dow Movers: DIS, KO",1,0.49593872
2019-08-08,10799000.0,53.209999084472656,53.77999877929688,52.84999847412109,53.68999862670898,51.97300338745117,KO,Trimmed Costs Lift Coca-Cola Consolidated's Quarter ||| 4 Defensive Stocks to Weather Trade-War Volatility,0,0.5221967
2019-08-09,9260900.0,53.790000915527344,53.900001525878906,53.08000183105469,53.41999816894531,51.71163940429688,KO,Coca-Cola x KITH Collab 2019: 9 Things to Know About the Season 4 Collection,0,0.5115484
2019-08-12,4778600.0,53.27999877929688,53.43999862670898,52.9900016784668,53.20000076293945,51.498680114746094,KO,"3 Top Dividend Aristocrats to Buy Now ||| How to Invest in Value Stocks ||| Noteworthy ETF Outflows: IVW, KO, LLY, FIS ||| XLP, IBMO: Big ETF Inflows",1,0.5348677
2019-08-13,8581200.0,52.900001525878906,53.61000061035156,52.869998931884766,53.5,51.78908157348633,KO,Vanguard Dividend Growth Reopens. Enter at Will.,0,0.50513375
2019-08-14,17088900.0,53.34000015258789,53.970001220703125,52.970001220703125,52.9900016784668,51.29539489746094,KO,"Dow Jones Today: The Return of Unpleasantness ||| Wednesday's ETF with Unusual Volume: VDC ||| Dow Movers: GS, KO",1,0.5073222
2019-08-15,12393200.0,53.43000030517578,54.0,53.22999954223633,53.869998931884766,52.147247314453125,KO,"Consumer Sector Update for 08/15/2019: WMT, MCD, DIS, CVS, KO, BABA, JCP",1,0.4720004
2019-08-16,14288700.0,53.97999954223633,54.4900016784668,53.95000076293945,54.40999984741211,52.66997909545898,KO,"3 Big Stock Charts for Friday: Freeport-McMoRan, Microsoft and Coca-Cola ||| The Berkshire Hathaway Portfolio: All the Buffett Stocks Ranked ||| 3 Recent IPO Stock Pullbacks Worth Watching",1,0.5168536
2019-08-19,10936200.0,54.43999862670898,54.77999877929688,54.310001373291016,54.68999862670898,52.94102478027344,KO,"Determining The Potential Return For Your Covered Call Trades ||| 10 Mid-Cap Dividend Stocks to Buy Now ||| Only Ten Dow Components With Recent Insider Buying, KO is One of Them ||| This Popular Indicator Turned Bearish. What To Do Now...",0,0.4798513
2019-08-20,8176700.0,54.619998931884766,54.68000030517578,53.84000015258789,53.880001068115234,52.15692901611328,KO,This Powerful Tool Can Give You Instant Diversification ||| 8 Stocks With Unbelievable Dividend Growth,1,0.51713794
2019-08-21,10886500.0,54.25,54.40999984741211,53.84999847412109,54.09999847412109,52.36988830566406,KO,"Recession Fears Can't Stop This Megatrend. Here's How To Profit... ||| XLP, SNLN: Big ETF Outflows ||| Where Have All The Good Deals Gone?",1,0.47843894
2019-08-22,7467900.0,54.119998931884766,54.63999938964844,54.09999847412109,54.4900016784668,52.74742889404297,KO,"4 Defensive Mega-Cap Stocks to Buy Now ||| Why Aurora Cannabis May Have Made a Big Mistake By Not Partnering With a Beverage Company ||| IVV, KO, ADBE, ORCL: Large Inflows Detected at ETF ||| How Is Keurig Dr Pepper Making Money Post Its Merger With DPS? ||| Why We Shouldn't Panic About The Yield Curve...",0,0.52661425
2019-08-23,14160400.0,54.41999816894531,54.709999084472656,53.38999938964844,53.7400016784668,52.02140808105469,KO,"Why You Should Stop Using This Common Investing Tool Immediately ||| Noteworthy Friday Option Activity: ALRM, KO, UAL ||| 5 Tips for Making Money in Penny Stocks ||| How To Earn More Income Than You Ever Thought Possible...",1,0.5089842
2019-08-26,9226900.0,54.0,54.540000915527344,53.72999954223633,54.540000915527344,52.79582595825195,KO,How To Invest Like The Witch Of Wall Street ||| Coca-Cola Stock Is No ‘Zero’ in a Recession ||| Warren Buffett Generates $3.4 Billion in Dividend Income Annually From These 5 Stocks,1,0.48327336
2019-08-27,13537000.0,54.70000076293945,54.95000076293945,54.40999984741211,54.720001220703125,52.97006988525391,KO,3 Stocks That Could Hike Dividends In September ||| 7 Tech Industry Dividend Stocks for Growth and Income ||| It's Time To Buy This Out-Of-Favor Stock,1,0.48662102
2019-08-28,10046400.0,54.65999984741211,55.150001525878906,54.41999816894531,55.11000061035156,53.34759521484375,KO,KO Named A Top Socially Responsible Dividend Stock ||| A Recent IPO In The Market's Hottest Sector ||| Dow Jones Today: Glossing Over Some Things ||| I Still See Opportunity In This Market. Here's Why...,0,0.49304548
2019-08-29,9262800.0,55.2599983215332,55.34000015258789,54.59999847412109,55.04999923706055,53.289512634277344,KO,"Coca-Cola Stock Just Keeps Getting Better ||| The Coca-Cola Company is Bucking the Bearish Trend ||| 22 Stocks With Massive Insider Buying Activity ||| Dow Movers: KO, INTC ||| Stocks That Hit 52-Week Highs On Thursday",0,0.4829848
2019-08-30,8746700.0,55.15999984741211,55.220001220703125,54.810001373291016,55.040000915527344,53.27983474731445,KO,"The ""Win-Win"" Strategy Buffett Used To Make $7.5 Million Instantly ||| Noteworthy ETF Inflows: IWF, KO, COST, PYPL ||| 5 Artificial Intelligence Stocks to Consider",1,0.49364996
2019-09-03,12991400.0,54.97999954223633,55.33000183105469,54.869998931884766,55.29999923706055,53.53152084350586,KO,"Barron's Picks And Pans: Activision Blizzard, Best Buy, Coca-Cola, Microsoft And More ||| Morgan Stanley Met With Coca-Cola's CFO And Left Satisfied",1,0.51676035
2019-09-04,10718100.0,55.34999847412109,55.91999816894531,55.29999923706055,55.77000045776367,53.98648834228516,KO,"USMV, UAUG: Big ETF Inflows ||| Forget Coca-Cola: Here Are 2 Better Dividend Stocks ||| Stocks That Hit 52-Week Highs On Wednesday",0,0.4935707
2019-09-05,13677000.0,55.75,55.77000045776367,55.02999877929688,55.119998931884766,53.35727691650391,KO,"Dow Movers: KO, INTC ||| 4 Classic Defensive Dividend Stocks for Steady Returns ||| KO Crosses Above Average Analyst Target ||| Where Will PepsiCo Be in 5 Years? ||| Is It Time to Invest in the Coca-Cola Portfolio?     ||| 5 Companies Taking Big Steps To Reduce Virgin Plastic Waste",1,0.51734954
2019-09-06,9093500.0,55.43999862670898,55.43999862670898,54.7599983215332,55.22999954223633,53.4637565612793,KO,Aurora Cannabis Should Spend Latest Cash Infusion on Infusions of Its Own,0,0.50957036
2019-09-09,10814900.0,55.02999877929688,55.08000183105469,54.36000061035156,54.52000045776367,52.776458740234375,KO,These 5 Stocks Have Made Buffett $23 Billion in 2019 ||| Coca-Cola Denies Entering Chinese Liquor Market in Partnership with Liquor Supplier JiangXiaoBai,0,0.47259447
2019-09-10,12038200.0,54.22999954223633,54.43999862670898,53.84999847412109,54.400001525878906,52.66030502319336,KO,This Easy “Hack” Delivered 70% Gains in 9 Months (and is about to do it again),1,0.5280223
2019-09-11,9740400.0,54.290000915527344,54.79999923706055,53.970001220703125,54.77000045776367,53.01846694946289,KO,"Agree To Buy Coca-Cola At $38, Earn 1.9% Using Options ||| XLP, EWV: Big ETF Outflows ||| Ex-Dividend Reminder: Garmin, Coca-Cola and Altria Group ||| The Odd Reason the Stock Market Could Soar to New Highs",1,0.49621448
2019-09-12,12357900.0,55.09999847412109,55.310001373291016,54.97999954223633,55.11000061035156,53.34759521484375,KO,"Notable Thursday Option Activity: FB, LULU, KO ||| Why You Should Buy Pepsi Instead of Coca-Cola Stock ||| Canopy Growth Stock Needs to Be One of Your Main Cannabis Plays",0,0.48777434
2019-09-13,11486100.0,54.47999954223633,54.790000915527344,54.06999969482422,54.2599983215332,52.9088020324707,KO,"PepsiCo Offers Cashback Rewards ... for Eating More Junk Food ||| Friday’s Vital Data: Coca-Cola, Square and Intel",0,0.50081736
2019-09-16,11172000.0,54.09999847412109,54.34000015258789,53.630001068115234,53.959999084472656,52.61627197265625,KO,"Better Buy: Verizon Communications vs. Coca-Cola ||| Worried About a Recession? These 3 Stocks Can Help Protect Your Portfolio ||| Transplace Symposium Focuses On Future Of Carriers, Supply Chains And Technology",1,0.51445156
2019-09-17,11347400.0,54.09999847412109,54.70000076293945,53.959999084472656,54.2400016784668,52.88930130004883,KO,"Noteworthy ETF Inflows: ITOT, KO, PEP, WMT ||| Dow Movers: MMM, KO ||| The Secret to Growing Your Retirement Income 107% (with 69% upside) ||| 3 Big Stock Charts for Tuesday: Southwest Airlines, Visa and Coca-Cola",0,0.5029835
2019-09-18,9700400.0,54.20000076293945,54.290000915527344,53.81999969482422,54.22999954223633,52.87954711914063,KO,Dow Analyst Moves: KO ||| Why the Vaping Crisis Might Benefit CBD-infused New Age Beverages Stock,1,0.5113113
2019-09-19,7560300.0,54.22999954223633,54.59999847412109,54.130001068115234,54.52000045776367,53.16232299804688,KO,5 Utility Stocks for Conservative Investors ||| Where Will New Age Beverages Be in 5 Years? ||| 3 Reasons Starbucks' Growth Isn't Over,0,0.51597613
2019-09-23,6485300.0,53.90999984741211,54.36000061035156,53.880001068115234,54.13999938964844,52.79179000854492,KO,"Barron's Picks And Pans: Coca-Cola, McDonald's, Ford, Nike And More ||| Why HEXO Stock is Starting to Look Attractive at These Levels ||| This Day In Market History: Nintendo Is Founded",1,0.50401807
2019-09-25,10248400.0,54.43999862670898,54.47999954223633,54.0,54.16999816894531,52.82104110717773,KO,iShares Core S&P Total U.S. Stock Market ETF Experiences Big Inflow ||| iShares Core S&P Total U.S. Stock Market ETF Experiences Big Inflow,1,0.4777077
2019-09-26,10031200.0,54.470001220703125,54.58000183105469,54.130001068115234,54.38999938964844,53.03556442260742,KO,2 Dividend Stocks That Pay You Better Than Coca-Cola Does,0,0.49439636
2019-09-27,7939900.0,54.560001373291016,54.63999938964844,54.0,54.310001373291016,52.957557678222656,KO,"XLP, TMF: Big ETF Inflows ||| The New Revolution Of Cannabis Marketing: Passion And Early Market Targeting",1,0.5209263
2019-09-30,9808700.0,54.150001525878906,54.68000030517578,54.150001525878906,54.43999862670898,53.084320068359375,KO,The 5 Greatest Investments of Warren Buffett,1,0.5144705
2019-10-01,14261500.0,54.52999877929688,54.77999877929688,54.0099983215332,54.650001525878906,53.28908920288086,KO,Coca-Cola Plans To Launch Energy Drink In U.S. Next Year ||| Coca-Cola Says Its First Coke-Branded Energy Drink Will Launch In US In 2020 ||| Why It Might Be Time For This Obscure Geared ETF ||| Monster Beverage Shares Down 0.3%; Earlier Bloomberg Article Suggested 'Coke Targets U.S. Energy Drink Market in Challenge to Monster',0,0.48802245
2019-10-02,14343600.0,54.209999084472656,54.43999862670898,52.900001525878906,53.08000183105469,51.7581901550293,KO,How Does Coca-Cola Spend Its Money? ||| Coca-Cola Co shares are trading lower in sympathy with the overall market amid global recession concerns.,1,0.5089222
2019-10-03,13817500.0,53.5,53.97999954223633,52.81999969482422,53.84000015258789,52.49925994873047,KO,"ITOT, DIS, KO, CMCSA: Large Inflows Detected at ETF ||| 3 Big Stock Charts for Thursday: Coca-Cola, eBay and Lennar ||| Coca-Cola Option Alert: Nov 15 $50 Calls at the Ask: 2000 @ $4.05 vs 23522 OI; Earnings 10/18 Before Open Ref=$53.448",1,0.50364816
2019-10-04,9295400.0,54.0,54.540000915527344,53.88999938964844,54.540000915527344,53.18183135986328,KO,Pepsi Earnings Call Highlights: The Snack Food Market Is Fueling Growth,0,0.5296319
2019-10-07,5964900.0,54.33000183105469,54.36000061035156,53.77000045776367,53.869998931884766,52.52851104736328,KO,"Pepsi Earnings: Closing the Gap With Coca-Cola ||| Is Netflix a Buy Before the Next Earnings Release? ||| Consumer Sector Update for 10/07/2019: WMT, MCD, DIS, CVS, KO, NRZ, PEP, TSLA ||| 5 Great Blue-Chip Stocks to Buy ||| Uber's Next Chance ||| Your Cannabis Brand's Survival Depends On A Proper Supply Chain",0,0.4869641
2019-10-08,13301900.0,53.880001068115234,54.06999969482422,53.45000076293945,53.58000183105469,52.2457389831543,KO,"USMV, EFZ: Big ETF Inflows ||| Health Snacks And NCDs Could Drive PepsiCo’s Revenues Close To $69 Billion By 2020",1,0.52126205
2019-10-10,8942900.0,53.54999923706055,53.880001068115234,53.36000061035156,53.65999984741211,52.3237419128418,KO,Empty Miles And Tight Profit Margins: What Is LoadSmart Doing To Help?,0,0.49738413
2019-10-11,8981700.0,53.650001525878906,53.70000076293945,53.20000076293945,53.29999923706055,51.97270965576172,KO,"Dow Jones Today: A Partial, But Powerful Deal ||| Notable ETF Outflow Detected - ITOT, DIS, KO, CMCSA",0,0.49984938
2019-10-14,7306300.0,53.4900016784668,53.68000030517578,53.220001220703125,53.29999923706055,51.97270965576172,KO,"3 Things to Watch in the Stock Market This Week ||| These 3 Dividend Stocks Have 181 Years of Rising Payouts ||| How to Protect Yourself When a Covered Call Trade Is Losing Money ||| Dow Movers: DOW, NKE ||| Earnings, Econ Numbers And The Beige Book Pepper The Second Round of The WeTrader Competition",1,0.5161904
2019-10-15,9564300.0,53.43000030517578,53.68000030517578,53.27000045776367,53.5099983215332,52.17747497558594,KO,87% of Warren Buffett's Portfolio Is in These 3 Sectors ||| 7 Key Traits Of Buffett's Greatest Picks,0,0.47695124
2019-10-16,10454800.0,53.459999084472656,53.56999969482422,53.130001068115234,53.4900016784668,52.15797805786133,KO,"3 Numbers to Watch in Coca-Cola’s Earnings Report ||| Strong Q3 Earnings Will Support Richly Valued Coca-Cola Stock ||| Bank Of America Results Keep Financial Sector Flowing, With Netflix In Focus Later",1,0.5182438
2019-10-17,13190300.0,53.68999862670898,54.119998931884766,53.58000183105469,53.790000915527344,52.45050430297852,KO,"Daily Dividend Report: KO, JNJ, MAIN, SHW, PSXP ||| Notable Thursday Option Activity: ADSK, BMY, KO",1,0.49762064
2019-10-18,18122400.0,55.0,55.38999938964844,54.45000076293945,54.77999877929688,53.41585159301758,KO,"Consumer Sector Update for 10/18/2019: ADT,ACU,KO,GIL,GIL.TO ||| Consumer Sector Update for 10/18/2019: ACU,KO,GIL ||| Coca-Cola Co (KO) Q3 2019 Earnings Call Transcript ||| Stock Market News: Coke Is Still It; Losses Leave Schlumberger Unfazed ||| Dow Movers: JNJ, KO ||| Consumer Sector Update for 10/18/2019: GIL, KO, IHG, WMT, MCD, DIS, CVS ||| Daily Markets: Earnings Shine, China Continues to Slow, Brexit Deal Vote ||| Coca-Cola Q3 Profit Matches Estimates, Organic Revenues Up 5%; Updates Guidance ||| The Coca-Cola Company Q3 adjusted earnings Inline With Estimates ||| The Coca-Cola Q3 19 Earnings Conference Call At 8:30 AM ET ||| Mid-Afternoon Market Update: Dow Drops 200 Points; Gildan Activewear Shares Plummet ||| Mid-Day Market Update: Sensient Technologies Falls On Downbeat Q3 Results; Fluidigm Shares Gain ||| Mid-Morning Market Update: Markets Open Lower; Coca-Cola Sales Top Estimates ||| Coca-Cola, Schlumberger Earnings Help Boost Investor Morale Despite China Data ||| From Coca-Cola Q3 Earnings Conference Call: Sees 2 Point Headwind To Its Sales Growth ||| From Coca-Cola Q3 Earnings Conference Call: Performance In Water Category Has Not Been As Strong As Mgmt. Would Have Liked ||| 27 Stocks Moving in Friday's Pre-Market Session ||| Coca-Cola shares are trading higher after the company reported better-than-expected Q3 sales results. ||| A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Fed Speakers ||| Coca-Cola Trades Higher On Q3 Sales Beat ||| Coca-Cola Sees FY19 Organic Sales Growth At Least 5%, Operating Income Up 12-13%, Earnings Down 1% To Up 1%; Sees FY20 Sales Up 1-2%, Operating Income Growth 2-3% ||| 8 Stocks To Watch For October 18, 2019 ||| Earnings Scheduled For October 18, 2019 ||| Coca-Cola Q3 EPS $0.56, Inline, Sales $9.5B Beat $9.48B Estimate",0,0.45691723
2019-10-21,12778900.0,54.45000076293945,54.560001373291016,53.68000030517578,54.22999954223633,52.87954711914063,KO,"Coke Zero Sugar and Pricing Strength Are Driving Coca-Cola's Results ||| Big Growth Comes In Small Package For Coca-Cola ||| Coca-Cola Joins Pepsi In ""Dumping Sugar And Sweetening Earnings"" ||| BMO Capital Maintains Market Perform on Coca-Cola, Raises Price Target to $55",0,0.515796
2019-10-22,9533400.0,54.22999954223633,54.41999816894531,53.7400016784668,53.84999847412109,52.509010314941406,KO,Coca-Cola Dials Up the Cash ||| Netflix Concerns and Retail Woes ||| Return to Fundamentals to Succeed With Facebook Stock ||| Coca Cola Earnings: Another Modest Growth Upgrade,1,0.54305446
2019-10-23,8556600.0,54.060001373291016,54.65999984741211,54.0099983215332,54.63999938964844,53.27933883666992,KO,"Coca-Cola's Plan to Recruit New Generations of Consumers ||| UPDATE:UBS On Coca-Cola Notes Co's 'navigating aggressive US price increases, digesting a transformational deal (Costa), completing a global refranchising','demonstrating strong innovation capabilities while reinvigorating growth in high-margin sparkling' ||| UPDATE: UBS Upgrades Coca-Cola To Buy, Raises Target To $63 As Firm Believes 'a sustainable fundamental inflection will drive 3 years of above-algorithm earnings growth and cash flow generation' ||| UBS Upgrades Coca-Cola to Buy, Raises Price Target to $63",0,0.5059181
2019-10-25,9782400.0,54.54999923706055,54.560001373291016,53.66999816894531,53.75,52.411502838134766,KO,One Of The Best Ways To Profit From Volatility ||| The 4 Economic Moats That Create Big-Time Winners,0,0.49490586
2019-10-28,8866100.0,53.7400016784668,53.95000076293945,53.369998931884766,53.56999969482422,52.23598098754883,KO,"What Recession? Consumer Stocks Are Crushing It This Earnings Season ||| Maximize Your Gains In A Bear Market With This Income Strategy ||| 3 Big Stock Charts for Monday: Coca-Cola, L Brands, and General Mills ||| The Most Shocking Chart You'll Ever See",0,0.48618644
2019-10-29,7999700.0,53.38999938964844,53.65999984741211,53.2599983215332,53.40999984741211,52.0799674987793,KO,7 Dividend Stocks That Could Struggle to Continue Payout Hikes ||| The Opportunity (And Pitfalls) Of Cannabis Stocks...,1,0.4991854
2019-10-30,8620900.0,53.52000045776367,54.04999923706055,53.15999984741211,53.93999862670898,52.59676742553711,KO,This Overlooked Stock Could Help Solve The Vaping Crisis ||| You Won't Believe How Many Stocks Have Lost Money This Year...,1,0.52358747
2019-10-31,13981600.0,53.959999084472656,54.470001220703125,53.84999847412109,54.43000030517578,53.07456588745117,KO,2 Signs That the Cannabis Bubble Has Burst ||| This High-Yielder Is Entering The Streaming Wars. Time To Buy? ||| This Buffett Stock Just Invested in the Marijuana Industry ||| My Award-Winning Indicator Points To Another Rally. Here's Why...,0,0.48528862
2019-11-01,9889200.0,54.630001068115234,54.7400016784668,53.84999847412109,53.900001525878906,52.55776596069336,KO,"How To Evaluate Risk And Reward With Put Options ||| ITOT, WFC, KO, WMT: Large Inflows Detected at ETF ||| 3 Tips That Are Better Than ""Buy-And-Hope"" ||| Monster, Coca-Cola Shares Unaffected Amid Report '@NFL is dropping its ban on energy drink ads' -Reporter From SBJSBD",0,0.47922447
2019-11-04,17515100.0,53.959999084472656,54.0,52.970001220703125,53.13999938964844,51.816688537597656,KO,"Is Your Portfolio Prepared for Single-Use Plastic Bans? ||| 3 Dividend Stocks That Pay You Better Than Coca-Cola Does ||| How To Profit From The ""Fear Premium"" While Others Lose Money ||| 5 Stocks to Buy Heading to All-Time Highs ||| If I Had To Pick Only One Cannabis Stock...",0,0.48332632
2019-11-05,19283600.0,52.88999938964844,52.88999938964844,52.119998931884766,52.41999816894531,51.11462020874024,KO,"An Important Update On Big Blue's Turnaround ||| Notable Tuesday Option Activity: KR, KO, PYPL ||| 3 Stocks Buffett Has Owned for at Least 25 Years",1,0.5065936
2019-11-06,13288900.0,52.52999877929688,52.79999923706055,52.40999984741211,52.79999923706055,51.48515701293945,KO,"Aurora Cannabis Stock Demonstrates Promising Trading Opportunities ||| Wednesday’s Vital Data: Intel, Uber and Coca-Cola ||| 3 Big Stock Charts for Wednesday: PepsiCo, WestRock, and Intuit ||| How Buffett Used This Simple Strategy To Boost Returns ||| Today's Pickup: India Gains $755 Million In Additional Exports To The US Due To US-China Trade War",0,0.4959046
2019-11-07,11725500.0,52.880001068115234,53.0,51.959999084472656,52.290000915527344,50.98785781860352,KO,"7 Beverage Stocks to Stock Up On ||| Dow Movers: PG, CSCO",0,0.50021327
2019-11-08,7141800.0,52.459999084472656,52.59999847412109,52.09000015258789,52.209999084472656,50.90985107421875,KO,"Why Monster Beverage's Stock Jumped 8.6% Higher This Morning ||| Notable ETF Inflow Detected - SSO, BRK.B, WFC, KO",0,0.47811154
2019-11-12,12656900.0,51.90999984741211,51.90999984741211,51.58000183105469,51.709999084472656,50.42230224609375,KO,"Monster Beverage Isn't Losing Much Sleep Over Coca-Cola Energy ||| If You'd Invested $1,000 in Coca-Cola’s IPO, This Is How Much Money You'd Have Now",1,0.51583844
2019-11-13,12257900.0,52.18000030517578,52.45000076293945,51.959999084472656,52.40999984741211,51.1048698425293,KO,Analysts See 11% Gains Ahead For PBJ,1,0.53381324
2019-11-14,8660300.0,52.52999877929688,52.66999816894531,52.34999847412109,52.630001068115234,51.31939315795898,KO,Better Buy: General Electric vs. Coca-Cola ||| 10 Dividend Aristocrats Expected to Deliver Big Gains in 2020,1,0.5033492
2019-11-15,8982400.0,52.63999938964844,52.68000030517578,52.380001068115234,52.66999816894531,51.358394622802734,KO,"Friday's ETF with Unusual Volume: FXG ||| Dow Movers: DIS, NKE ||| 3 Ways to Prepare Your Portfolio for a Recession",1,0.5019418
2019-11-18,13782000.0,52.68000030517578,53.43999862670898,52.66999816894531,53.02999877929688,51.70942687988281,KO,Will Coca-Cola Raise Its Dividend in 2020? ||| Here's How Much Warren Buffett Has Made on Apple ||| Carnival Cruise Ditches Coca-Cola For PepsiCo,1,0.51394504
2019-11-19,12679500.0,53.150001525878906,53.310001373291016,52.869998931884766,53.08000183105469,51.7581901550293,KO,Here's How Much Warren Buffett Has Made on Coca-Cola,1,0.52686644
2019-11-20,11970300.0,53.09999847412109,53.400001525878906,53.0099983215332,53.220001220703125,51.89470291137695,KO,"Why Did Keurig Dr Pepper’s Profits Double In A Year? ||| Consumer Sector Update for 11/20/2019: WMT, MCD, DIS, CVS, KO, LOW, TGT, URBN",0,0.47739387
2019-11-21,7856100.0,53.11000061035156,53.34000015258789,52.77999877929688,52.959999084472656,51.64117431640625,KO,7 Tech Industry Dividend Stocks for Growth and Income,1,0.5564802
2019-11-22,9113300.0,52.959999084472656,53.18999862670898,52.75,53.02999877929688,51.70942687988281,KO,"Consumer Sector Update for 11/22/2019: WMT, MCD, DIS, CVS, KO, HIBB, JWN, WSM",1,0.4803465
2019-11-25,10963500.0,53.27999877929688,53.38999938964844,52.77000045776367,53.220001220703125,51.89470291137695,KO,"If You Invested $1,000 in Berkshire’s IPO, This Is How Much Money You'd Have Now ||| 5 Tricks Billionaires Use to Make Their Money Work for Them ||| Consumer Sector Update for 11/25/2019: WMT, MCD, DIS, CVS, KO, PDD, AMZN, TIF, TSLA ||| Is Coca-Cola Stock a Buy?",1,0.47332567
2019-11-26,13219800.0,53.310001373291016,53.93999862670898,53.220001220703125,53.900001525878906,52.55776596069336,KO,"Noteworthy Tuesday Option Activity: PRTA, KO, TSN ||| VOOG, BRK.B, BA, KO: ETF Inflow Alert ||| Consumer Sector Update for 11/26/2019: WMT, MCD, DIS, CVS, KO, DLTR, CAL, BBY ||| An In-Depth Breakdown of Warren Buffett's Portfolio",1,0.48895818
2019-11-27,9595200.0,53.93000030517578,54.09999847412109,53.59999847412109,53.95000076293945,52.60652160644531,KO,"Consumer Sector Update for 11/27/2019: WMT, MCD, DIS, CVS, KO, GES, CENT, BTI ||| Better Buy: IBM vs. Coca-Cola",0,0.48682085
2019-11-29,7222300.0,53.70000076293945,53.72999954223633,53.220001220703125,53.400001525878906,52.45916748046875,KO,"Consumer Sector Update for 11/29/2019: WMT, MCD, DIS, CVS, KO, BUD, TATT, MOGU ||| PreMarket Prep Recap: Muted Reaction To Trade Tensions, A Look At The Dividend Capture Strategy",1,0.48222375
2019-12-02,13173800.0,53.31999969482422,53.75,52.84999847412109,53.75,52.80299758911133,KO,A Less Risky ETF With Plenty Of Rewards ||| 3 Dividend Stocks That Pay You More Than PepsiCo ||| Best Stocks for Beginners: Making a Starter Portfolio,1,0.5168407
2019-12-03,14498300.0,53.709999084472656,53.84000015258789,53.400001525878906,53.79999923706055,52.85211563110352,KO,"3 Steps to 6% Dividends, 813% Gains (Bull or Bear) ||| 'Fast Money Halftime Report' Traders Advise Viewers On Twilio, GE And More",1,0.52891
2019-12-04,13624000.0,53.79999923706055,54.310001373291016,53.720001220703125,54.290000915527344,53.3334846496582,KO,Dow Analyst Moves: KO ||| iShares Edge MSCI Min Vol USA ETF Experiences Big Inflow,0,0.50023144
2019-12-05,14068100.0,54.209999084472656,54.290000915527344,53.83000183105469,54.18999862670898,53.23524475097656,KO,3 Warren Buffett Dividend Stocks You Can Buy Right Now ||| Starbucks Coffee and SBUX Stock Are Getting Back to the Basics,1,0.54392236
2019-12-06,7843500.0,54.310001373291016,54.5,54.16999816894531,54.41999816894531,53.46118927001953,KO,"Consumer Sector Update for 12/06/2019: WMT, MCD, DIS, CVS, KO, GCO, UNFI, ULTA, BIG ||| Consumer Sector Update for 12/06/2019: WMT, MCD, DIS, CVS, KO, GCO, ULTA, BIG",0,0.43803906
2019-12-09,13887200.0,54.29999923706055,54.5099983215332,54.02000045776367,54.06999969482422,53.11735916137695,KO,"Consumer Sector Update for 12/09/2019: WMT, MCD, DIS, CVS, KO, LOW, THO, SKX, CGC ||| Consumer Sector Update for 12/09/2019: WMT, MCD, DIS, CVS, KO, THO, TSCO, CGC, AMZN, FCAU ||| Coca-Cola On The Forefront Of Recycling Plastic",0,0.45010015
2019-12-11,8879100.0,53.93999862670898,54.150001525878906,53.65999984741211,53.95000076293945,52.999473571777344,KO,"Why 2020 Could Be ‘It’ for Aurora Stock Bulls ||| 3 Big Stock Charts for Wednesday: Groupon, Monster Energy, and F5 Networks",1,0.49131122
2019-12-12,11233300.0,54.0099983215332,54.45000076293945,53.93999862670898,54.13999938964844,53.186126708984375,KO,"Best ETFs for 2020: Consumer Staples Select Sector Fund (XLP) Is a Winner ||| Here's Why Amyris Rose as Much as 12.7% Today ||| Is the Dividend of Altria Stock High Enough to Offset Its Controversies? ||| NBEV Stock May Be Risky, but Its Situation Isn’t as Dire as You May Think ||| Coca-Cola a Top 25 Dividend Giant With 2.97% Yield (KO) ||| iShares Edge MSCI Min Vol USA ETF Experiences Big Inflow ||| Exercise Labels: The Next Frontier In Food Packaging? ||| Freight-Tracking Startup FourKites Focuses On Innovation, Global Expansion ||| Deutsche Bank Maintains Buy on Coca-Cola, Raises Price Target to $61",1,0.5007447
2019-12-13,13072200.0,53.93999862670898,54.54999923706055,53.84000015258789,54.41999816894531,53.46118927001953,KO,PepsiCo's New Coffee Drink Offers Twice As Much Caffeine,0,0.511282
2019-12-16,9538100.0,54.68999862670898,54.83000183105469,54.369998931884766,54.41999816894531,53.46118927001953,KO,"Adobe Sets Its Sights on a Bigger Target Market ||| Before Coke-Snorting Santa And An Ad Accused Of Weight-Shaming, Some Fails From Christmas Past ||| 2 Stocks You Can Keep Forever",0,0.4799236
2019-12-18,15132100.0,54.52999877929688,54.75,53.88999938964844,53.90999984741211,52.96017837524414,KO,"Can Coca-Cola Bridge Its Revenue Gap With PepsiCo? ||| 'Coca-Cola internal documents reveal efforts to sell to teens, despite obesity crisis' -Washington Post",1,0.5122194
2019-12-19,13385900.0,54.040000915527344,54.34000015258789,53.91999816894531,54.31999969482422,53.36295318603516,KO,"Time to Get Aggressive on Coca-Cola ||| Snapchat Brings On 2 Iconic Brands For AR Camera Feature ||| 'McDonald's, Coca-Cola Are the First Brand Partners for Snapchat Scan' -AdWeek",1,0.49429443
2019-12-20,23832800.0,54.93999862670898,55.20000076293945,54.470001220703125,54.970001220703125,54.00150680541992,KO,iShares Edge MSCI Min Vol USA ETF Experiences Big Inflow ||| PepsiCo Follows Coca-Cola Into the Hybrid Coffee Market,0,0.5190935
2019-12-23,9300800.0,55.0,55.2400016784668,54.84000015258789,54.90999984741211,53.94255828857422,KO,"Coca-Cola Prepares for Energy Drink Launch ||| Is PepsiCo Stock a Buy? ||| Can Monster Beverage Find the Energy to Grow Further? ||| How The Dow Jones Industrial Average Changed Over The Past Decade ||| As Bad as the Risk/Reward Looks, There Is an Argument for NBEV Stock ||| Banking on Pre-Earnings Strength in BAC ||| Coca-Cola Wants to Sell ""Soda as a Service"" ||| How Much Does PepsiCo Spend On Cost Of Sales And SG&A?",0,0.49727377
2019-12-26,6228500.0,54.91999816894531,55.02000045776367,54.790000915527344,55.02000045776367,54.05062484741211,KO,Why Coca-Cola's New Marketing Chief Can Make Sales Pop ||| Aurora Cannabis Shares Pullback From Session High Following Report Coca-Cola Does Not Have Plans To Enter CBD Market; Stock Still Up 1.5% For Session ||| Hearing Coca-Cola Has No Plans To Enter CBD Market,1,0.5031849
2019-12-27,6895500.0,55.0099983215332,55.45000076293945,55.0,55.34999847412109,54.37480926513672,KO,Stock Market Today: Tesla Preps for Model 3 Deliveries in China   ||| Monster Beverage Gained 900% This Decade: What's Next?,0,0.49535903
2019-12-30,6431700.0,55.18000030517578,55.38999938964844,55.060001373291016,55.27000045776367,54.29621887207031,KO,"12 Quotes That Will Make You Rethink Your Personal Finances ||| Here’s How Much Money Warren Buffett Has Made in GEICO ||| The Week In Cannabis: Aurora's Roller Coaster Ride, USDA's Hemp Moves, MJ's Dividend And More ||| The Consumer Staples Select Sector SPDR Fund Experiences Big Outflow ||| Three Dow Stocks To Buy For January ||| Is 2020 The Year Of THC Drinks? ||| Cannabis Countdown: Top 10 Marijuana Industry News Stories Of The Week",1,0.49227142
2019-12-31,7982600.0,55.20000076293945,55.380001068115234,54.97999954223633,55.34999847412109,54.37480926513672,KO,10 Best Consumer Staples Stocks to Buy for 2020,0,0.5391292
2020-01-02,11867700.0,55.31999969482422,55.43000030517578,54.7599983215332,54.9900016784668,54.02115249633789,KO,"Why 2020 Could be Another Big Year for Luckin Coffee Stock ||| Meet the 2020 Dogs of the Dow ||| Consumer Sector Update for 01/02/2020: WMT, MCD, DIS, CVS, KO, JMEI, AXE, FAMI ||| Is Coca-Cola Planning On Marketing A CBD Extract Version In Canada?",0,0.4900441
2020-01-03,11354500.0,54.31999969482422,54.9900016784668,54.09000015258789,54.68999862670898,53.72643661499024,KO,"Gold, Bonds, Crude All On The Rise After US Strike In Middle East Sparks Fears",0,0.49073583
2020-01-06,14698300.0,54.650001525878906,54.90999984741211,54.52000045776367,54.66999816894531,53.706787109375,KO,"Better Buy: Sprint vs. Coca-Cola ||| Is Coca-Cola Looking to Get Into Cannabis? ||| Consumer Sector Update for 01/06/2020: WMT, MCD, DIS, CVS, KO, NIO, CALM, CMC ||| 3 Big Stock Charts for Monday: Coca-Cola, The Trade Desk, and SAP",0,0.47174844
2020-01-07,9973900.0,54.45000076293945,54.59999847412109,54.150001525878906,54.25,53.294189453125,KO,"Noteworthy ETF Outflows: XLP, KO, PEP, WMT ||| 5 Dividend Growth Stocks With Upside To Analyst Targets ||| 3 Big Stock Charts for Tuesday: PepsiCo, Wells Fargo, and Helmerich & Payne ||| Coca-Cola Now Owns 100% Of Fairlife",1,0.52198374
2020-01-08,10676000.0,54.27000045776367,54.63999938964844,54.150001525878906,54.34999847412109,53.392425537109375,KO,Is Keurig Dr Pepper’s Stock Undervalued?,1,0.5250139
2020-01-09,15398000.0,55.0,55.400001525878906,54.84000015258789,55.34000015258789,54.36498260498047,KO,"Benzinga's Top Upgrades, Downgrades For January 9, 2020 ||| Credit Suisse Upgrades Coca-Cola to Outperform, Raises Price Target to $64",1,0.50275224
2020-01-10,13040100.0,55.47999954223633,55.93000030517578,55.45000076293945,55.52999877929688,54.5516357421875,KO,"Dow Jones Today: Stocks Pinched by Jobs Disappointment ||| Consumer Sector Update for 01/10/2020: WMT, MCD, DIS, CVS, KO, SPWH, RMBL, URBN ||| Stocks That Hit 52-Week Highs On Friday ||| Weaker Than Expected December Jobs Report Might Weigh, But Overall Growth Positive",1,0.48010516
2020-01-13,14302900.0,55.52999877929688,56.22999954223633,55.41999816894531,56.130001068115234,55.14106750488281,KO,Where to Invest $1 Million Right Now ||| How Important Is Europe & Sub-Saharan Africa For PepsiCo’s Growth?,0,0.5061204
2020-01-14,16345300.0,56.2400016784668,56.290000915527344,55.83000183105469,56.0,55.01335525512695,KO,"Consumer Sector Update for 01/14/2020: WMT, MCD, DIS, CVS, KO, BGFV, ZUMZ, ETH",1,0.4892781
2020-01-15,17735400.0,56.0,56.97999954223633,56.0,56.70000076293945,55.70102310180664,KO,"XLP, KO, PEP, WMT: ETF Outflow Alert ||| Stocks That Hit 52-Week Highs On Wednesday",1,0.51159346
2020-01-16,10234100.0,56.84999847412109,56.95000076293945,56.61000061035156,56.81999969482422,55.81890487670898,KO,The Best Large-Cap ETFs to Buy in 2020,1,0.5334107
2020-01-17,14264300.0,56.869998931884766,57.150001525878906,56.79999923706055,56.93999862670898,55.93679428100586,KO,3 Dividend Aristocrats to Buy and Hold Forever ||| Coca-Cola's Powerade Launches 2 New Products ||| Stocks That Hit 52-Week Highs On Friday,1,0.49854168
2020-01-21,11968900.0,56.84999847412109,57.25,56.56999969482422,57.16999816894531,56.162742614746094,KO,"Coca-Cola To Invest EUR 1 Bln In France ||| Morgan Stanley Maintains Overweight on Coca-Cola, Raises Price Target to $61",1,0.51037204
2020-01-22,12869600.0,57.25,57.63999938964844,57.18000030517578,57.61000061035156,56.59498977661133,KO,Coca-Cola CEO Says Consumers Will Never Drink The Same Product Forever ||| Stocks That Hit 52-Week Highs On Wednesday,1,0.5042819
2020-01-23,12858900.0,57.380001068115234,57.84999847412109,57.2400016784668,57.83000183105469,56.81111526489258,KO,Coca-Cola Says Its Customers Still Need Plastic Bottles ||| Top Dividend Stocks With Yields Over 4% ||| 3 Dividend Stocks That Pay Better Than Coca-Cola,0,0.51446515
2020-01-24,8594300.0,57.84999847412109,57.869998931884766,57.459999084472656,57.68000030517578,56.66375350952149,KO,Warren Buffett's 3 Biggest Stock Picks for 2020 ||| Stocks That Hit 52-Week Highs On Friday,0,0.48141268
2020-01-27,14359900.0,57.209999084472656,57.84999847412109,57.130001068115234,57.47999954223633,56.46727752685547,KO,"Better Buy: Procter & Gamble vs. Coca-Cola ||| 3 Dividend Stocks to Bankroll Your Retirement ||| How to Build a $100,000 Portfolio -- or an Even Bigger One ||| Going Viral: Stocks On Their Back As Virus Spreads Heading Into Key Earnings, Fed Week",0,0.4923189
2020-01-28,15240200.0,57.45000076293945,57.75,56.970001220703125,57.0099983215332,56.005558013916016,KO,Why Beyond Meat Stock Is Tumbling Today ||| Can Caffeinated Seltzer Do for Soda What Hard Seltzer Did for Beer?,0,0.48502877
2020-01-29,13163600.0,57.0,57.2599983215332,56.65999984741211,57.0099983215332,56.005558013916016,KO,Q4 Earnings Preview For Coca-Cola,1,0.54030377
2020-01-30,20225600.0,57.93000030517578,58.97999954223633,57.7599983215332,58.86000061035156,57.82296752929688,KO,"3 Trends Behind Coca-Cola's Surprisingly Strong Earnings Report ||| Coca-Cola Co (KO) Q4 2019 Earnings Call Transcript ||| Dow Jones Today: Stocks Show Immunity to Coronavirus Concerns ||| 4 Top Stock Trades for Friday: MSFT, MO, PYPL, KO ||| Coca-Cola Q4 Profit Matches Estimates; Sees 2020 Profit Below View ||| The Coca-Cola Company Q4 adjusted earnings Inline With Estimates ||| The Biggest Risk to Warren Buffett's Portfolio ||| The Coca-Cola Q4 19 Earnings Conference Call At 8:30 AM ET ||| The Coca-Cola Q4 19 Earnings Conference Call At 8:30 AM ET ||| 62 Crazy Super Bowl 54 Prop Bets You Have To See To Believe ||| Mid-Afternoon Market Update: Crude Oil Down Over 2%; Miragen Therapeutics Shares Climb ||| Mid-Day Market Update: Dow Falls 150 Points; Inovio Pharmaceuticals Shares Spike Higher ||| Stocks That Hit 52-Week Highs On Thursday ||| Mid-Morning Market Update: Markets Edge Lower; Coca-Cola Posts Upbeat Q4 Revenue ||| Coca-Cola shares are trading higher after the company reported better-than-expected Q4 sales results. ||| 7 Consumer Defensive Stocks Moving In Thursday's Pre-Market Session ||| Coca-Cola Reports Q4 Earnings Beat ||| Coca-Cola Sees FY20 Adj. EPS ~$2.25, Organic Sales Growth 5% Year Over Year ||| Coca-Cola Q4 Adj. EPS $0.44, Inline, Sales $9.1B Beat $8.85B Estimate ||| A Peek Into The Markets: US Stock Futures Tumble Ahead Of Earnings, GDP Data ||| Earnings Scheduled For January 30, 2020 ||| 14 Stocks To Watch For January 30, 2020",0,0.52798456
2020-01-31,17685200.0,58.970001220703125,59.08000183105469,58.150001525878906,58.400001525878906,57.37107467651367,KO,"Coca-Cola Is the Most Conservative Investment You Can Make ||| 13 Super Bowl 54 Commercials You Won't Want To Miss ||| UPDATE: Morgan Stanley Maintains Overweight On Coca-Cola, Raises Target To $65 Believes Co. 'offers a clearly superior LT growth outlook vs. CPG peers, with solid category growth, stronger KO pricing power, and favorable strategy tweaks' ||| Morgan Stanley Earlier Maintained Overweight on Coca-Cola, Raised Price Target to $65 ||| B of A Securities Maintains Buy on Coca-Cola, Raises Price Target to $65 ||| RBC Capital Maintains Outperform on Coca-Cola, Raises Price Target to $66 ||| Stocks That Hit 52-Week Highs On Friday ||| Deutsche Bank Maintains Buy on Coca-Cola, Raises Price Target to $64 ||| UBS Maintains Buy on Coca-Cola, Raises Price Target to $65 ||| Citigroup Maintains Neutral on Coca-Cola, Raises Price Target to $63 ||| Here's How Much Investing $100 In Coca-Cola Stock Back In 2010 Would Be Worth Today",1,0.52087843
2020-02-03,12336800.0,58.75,58.970001220703125,58.52000045776367,58.58000183105469,57.54790115356445,KO,"Subscription Services Are Here to Stay, and This Stock Started It ||| Coca-Cola Saves the Best for Last",1,0.50958014
2020-02-04,15417900.0,58.75,59.45000076293945,58.619998931884766,58.84000015258789,57.80331802368164,KO,"Notable ETF Inflow Detected - USMV, NEE, MCD, KO ||| Coca-Cola Taps Into Its Customer Insights to Fuel Strong Q4 Earnings ||| 7 Tech Industry Dividend Stocks for Growth and Income ||| Analysts: These 3 Dow Jones Stocks Look Like Solid Buys After Earnings ||| Coca-Cola Will Grind Higher To $65 ||| Stocks That Hit 52-Week Highs On Tuesday",1,0.4741485
2020-02-07,8757800.0,58.880001068115234,59.31999969482422,58.84999847412109,59.18999862670898,58.14715194702149,KO,"Consumer Sector Update for 02/07/2020: WMT, MCD, DIS, CVS, KO, SKX, MTW, EBAY ||| Coca-Cola Breaks Down a Record Quarter ||| Coca-Cola's Earnings: Outperforming Its Peers",1,0.48479098
2020-02-10,7984900.0,59.31999969482422,59.84000015258789,59.290000915527344,59.75,58.69728469848633,KO,PepsiCo Earnings: What to Watch ||| Stocks That Hit 52-Week Highs On Monday,0,0.5151505
2020-02-11,7431200.0,59.720001220703125,59.79999923706055,59.31999969482422,59.59000015258789,58.54010772705078,KO,Exxon Mobil Stock Could Be 2020’s Best Dog in Show ||| 3 Dividend Stocks That Are Perfect for Retirement ||| 2 Ways Buffett's Investing Strategy Has Changed Dramatically Since the Dot-Com Bubble,0,0.51321197
2020-02-12,9179100.0,59.47999954223633,59.77000045776367,59.31999969482422,59.40999984741211,58.363277435302734,KO,"Noteworthy ETF Inflows: USMV, NEM, KO, MCD",1,0.51270235
2020-02-13,8173200.0,59.380001068115234,59.84000015258789,59.209999084472656,59.61000061035156,58.55975341796875,KO,"Pepsi Earnings Show Strong Snack Demand ||| Pepsi Releases Solid Quarter Results During Its Biggest Month Of The Year ||| Judging By These Leveraged Funds, Consumers Are Still In The Economic Driver Seat",1,0.53474426
2020-02-14,9965500.0,59.630001068115234,60.06999969482422,59.619998931884766,59.95000076293945,58.89376449584961,KO,Kraft Heinz Is Still a Mess ||| Stocks That Hit 52-Week Highs On Friday,0,0.48236877
2020-02-18,10075700.0,59.810001373291016,59.93000030517578,59.45000076293945,59.52999877929688,58.48115921020508,KO,"2 Warren Buffett Stocks to Buy Right Now ||| Seltzer, Not Sam Adams, Will Drive Upside in Boston Beer Stock ||| 5 Reasons PepsiCo Is Still a ""Best in Breed"" Packaged Foods Stock ||| Here's How Long It Took Coca-Cola To Reach A $100B Market Cap",1,0.54160416
2020-02-19,6265700.0,59.5099983215332,60.0,59.470001220703125,59.77000045776367,58.71693420410156,KO,Pepsi Aims for Steady Growth in 2020 ||| Why Berkshire Hathaway Stock is Poised to Have a Good Year ||| NextGen Consortium Launches Reusable Cup Pilots In San Francisco ||| Better Buy: Berkshire Hathaway vs. Coca-Cola,0,0.5004886
2020-02-20,7597200.0,59.68000030517578,59.86000061035156,59.11000061035156,59.720001220703125,58.667816162109375,KO,"PepsiCo Breaks Down Its Best Year Since 2015 ||| Dow Analyst Moves: KO ||| Notable ETF Inflow Detected - USMV, NEM, NEE, KO ||| Coca-Cola Raises Quarterly Dividend From $0.40 To $0.41/Share",1,0.51491386
2020-02-21,10842400.0,59.5099983215332,60.130001068115234,59.43000030517578,60.130001068115234,59.07059097290039,KO,"Dow Jones Today: Flight to Safety Dings Stocks ||| Daily Dividend Report: RY,KO,PLD,WRB,ABBV ||| Why Coca-Cola Isn't Worried About the Coronavirus Impact ||| Coca-Cola Maintains FY20 Outlook; Provides COVID-19 Impact On Q1 - Quick Facts ||| Lululemon Trades Down, Coca-Cola Investors Stay Positive After Coronavirus Updates ||| Financial Sector Stocks Could Be In Focus Today As Treasury Yields Falter, But Deere Shines ||| Benzinga Pro's Top 5 Stocks To Watch For Fri., Feb. 21, 2020: PEP, SDGR, ZS, DPW, HPQ ||| UPDATE: Coca-Cola Sees 2-3 Point Impact to Unit Case Volume, 1-2 Point Impact To Organic Sales, $0.01-$0.02 Impact To EPS In Q1 Related To Coronavirus ||| Coca-Cola Reaffirms FY20 Guidance Amid Coronavirus Outbreak",0,0.49399182
2020-02-24,14415500.0,59.11000061035156,59.79999923706055,58.56999969482422,58.650001525878906,57.61666870117188,KO,"Could The Trade Desk Be a Millionaire-Maker Stock? ||| 5 Key Takeaways From Warren Buffett’s Shareholder Letter ||| Morgan Stanley Upgrades Keurig Dr Pepper On Improved Valuation ||| Warren Buffett Talks Succession Plans, Compares Acquisitions To Marriage In Annual Letter",0,0.48640576
2020-02-25,15915100.0,58.70000076293945,59.20000076293945,57.619998931884766,57.81999969482422,56.80128860473633,KO,How Cannabis MSOs Are Winning Over Customers In Evolving US Markets,0,0.519867
2020-02-26,15837800.0,57.97999954223633,58.470001220703125,57.47999954223633,57.59999847412109,56.58516693115234,KO,Coronavirus Could Mean Less Diet Coke on Store Shelves ||| Aurora Cannabis: Does This Signal a Long-Awaited Partnership Is Near?,0,0.49225673
2020-02-27,23750400.0,57.150001525878906,57.88999938964844,54.880001068115234,54.93000030517578,53.96220779418945,KO,"Coca-Cola Still Has Some Fizz Left ||| Consumer Sector Update for 02/27/2020: WMT, MCD, DIS, CVS, KO, BUD, ETSY, TPC ||| Coronavirus Is Not Necessarily Bad News For Everyone",0,0.46259978
2020-02-28,40891800.0,53.83000183105469,53.88999938964844,51.58000183105469,53.4900016784668,52.54758071899414,KO,"Dow Jones News: Consumer Giants Tumble; Cisco Down on Layoffs ||| Dow Movers: AAPL, MMM ||| Shares of several beverage companies are trading lower. Weakness appears market related as equities across sectors sell off on fears of the global coronavirus spread.",1,0.53909045
2020-03-02,25698600.0,53.93000030517578,55.959999084472656,53.70000076293945,55.91999816894531,54.93476486206055,KO,"If I Could Buy Only 1 Stock, This Would Be It ||| These 3 Stocks Are Warren Buffett's Biggest Winners ||| Stock Alert: Colgate-Palmolive, Coca-Cola, Pepsi Gain ||| The Coronavirus Outbreak's Impact On Global Stocks, Commodities, ETFs",1,0.50245345
2020-03-03,27099200.0,56.7599983215332,57.4900016784668,55.63999938964844,56.060001373291016,55.072303771972656,KO,"3 Stocks That Could Make You Rich ||| Dow Movers: JPM, UNH ||| Consumer Sector Update for 03/03/2020: WMT, MCD, DIS, CVS, KO, FOE, KSS, TPC",1,0.48077458
2020-03-04,20526100.0,56.40999984741211,59.0,56.40999984741211,58.91999816894531,57.88190460205078,KO,"Consumer Sector Update for 03/04/2020: WMT, MCD, DIS, CVS, KO, JWN, COST, ANF, JILL, JWN, URBN ||| Consumer Sector Update for 03/04/2020: WMT, MCD, DIS, CVS, KO, JWN, JILL, ANF",0,0.42739213
2020-03-05,17948500.0,57.79999923706055,58.16999816894531,56.18999862670898,56.7400016784668,55.74032211303711,KO,Here's How to Find the Best Dividend Stocks ||| Here's How Much Dividend Income Warren Buffett Will Receive in 2020,0,0.46505284
2020-03-09,27898300.0,52.04999923706055,53.58000183105469,51.47999954223633,51.86000061035156,50.94629669189453,KO,Apple Stock Is the Coca-Cola of the Tech Industry ||| Today Is a Great Day to Buy Coca-Cola Stock ||| Shares of several consumer goods companies are trading lower amid a selloff in US equities. The global coronavirus outbreak has hampered economic activity and negatively impacted multiple industries.,1,0.54631615
2020-03-10,27457400.0,53.220001220703125,53.79999923706055,51.16999816894531,53.65999984741211,52.71458435058594,KO,"Noteworthy ETF Outflows: OEF, KO, DIS, CVX",0,0.51890147
2020-03-11,22653900.0,52.34999847412109,52.650001525878906,51.13999938964844,52.209999084472656,51.290130615234375,KO,"Consumer Sector Update for 03/11/2020: WMT, MCD, DIS, CVS, KO, STNG, HEAR, PDD ||| Why Monster Beverage Stock Is Falling Today ||| Ex-Dividend Reminder: Johnson Controls International, Coca-Cola and Garmin ||| 3 Big Stock Charts for Wednesday: Microsoft, Visa, and China Mobile ||| Is Coca-Cola's Dividend Sustainable? ||| 3 Big Stock Charts for Wednesday: Microsoft, Visa, and China Mobile ||| Shares of several consumer goods and retail companies are trading lower as global markets continue to experience pressure amid the coronavirus spread, which has negatively impacted companies across sectors.",0,0.48299056
2020-03-12,31913100.0,48.540000915527344,49.93000030517578,46.68999862670898,47.15999984741211,46.32910537719727,KO,"PepsiCo Drops $3.85 Billion on Energy-Drink Maker ||| Warren Buffett's 4 Rules for Investing in a Bear Market ||| 25 Brands Line Up for Debut of Mobile-Only Streamer Quibi ||| Coronavirus Market Correction: Where to Invest $1,000 Right Now ||| As the Market Hammers Consumer Stocks, Here's Where to Invest $1,000 ||| Shares of several consumer defensive and consumer cyclical companies are trading lower as equities sell off amid continued global coronavirus concerns. The virus has caused global economic disruption and negatively impacted stocks across sectors.",1,0.5038581
2020-03-16,28682300.0,42.2400016784668,47.880001068115234,41.16999816894531,45.2599983215332,44.852516174316406,KO,"Could This 1 Big Problem Derail the Growth of Cannabis-Infused Beverages? ||| Why Warren Buffett Would Probably Hold These 3 Stocks During A Pandemic ||| 5 Stocks Mourning the Cancellation of March Madness ||| Shares of several consumer goods companies are trading lower amid the global coronavirus outbreak, which investors speculate may lead to softer consumer spending.",1,0.52636707
2020-03-17,32106700.0,45.880001068115234,47.5,45.369998931884766,47.18000030517578,46.75523376464844,KO,"7 of the Last Decade’s Fastest-Growing Dividend Stocks ||| Consumer Sector Update for 03/17/2020: WMT, MCD, DIS, CVS, KO, IDEX, AMZN, SBUX ||| Shares of several consumer goods and consumer staples companies are trading higher as markets rebound from Market's crash. Additionally, investors speculate the coronavirus outbreak may lead to bulk spending on several staples.",0,0.5129516
2020-03-18,35408300.0,44.7400016784668,45.150001525878906,41.59000015258789,44.84999847412109,44.44620895385742,KO,"Why Coca-Cola Company Stock Got Crushed Today ||| VTV, BAC, DIS, KO: Large Inflows Detected at ETF ||| 96 Stocks Moving In Wednesday's Mid-Day Session ||| Morgan Stanley Downgrades Coca-Cola And Monster Beverages ||| UPDATE: Morgan Stanley Downgrades Coca-Cola To Equal-Weight, Lowers Price Target To $52 Based On 'a weaker demand outlook post the COVID-19 situation' And Cites An Additional 4 Potential Risks: ||| Coca-Cola shares are trading lower as equities fall amid the global coronavirus outbreak. Morgan Stanley also reportedly downgraded the company's stock from Overweight to Equal-Weight and lowered its price target from $65 to $52. ||| Morgan Stanley Downgrades Coca-Cola From Overweight To Equal weight, Cuts PT From $65 To $52",0,0.4975007
2020-03-19,41956900.0,44.36000061035156,44.65999984741211,41.040000915527344,41.83000183105469,41.45340347290039,KO,"Thursday's ETF with Unusual Volume: KXI ||| Dow Movers: HD, WMT ||| Shares of several consumer goods companies are trading lower. The coronavirus outbreak has led to volatility in consumer spending, which has moved the sector both up and down in recent weeks.",0,0.530328
2020-03-20,51513500.0,41.95000076293945,42.06999969482422,37.5099983215332,38.29999923706055,37.95518112182617,KO,"Coca-Cola Expects It Won't Meet Fiscal 2020 Guidance ||| Dow Jones News: Apple's 5G iPhone on Track; Coca-Cola Pulls Guidance ||| Is Now a Good Time To Buy Stocks? ||| Better Buy: General Electric vs. Coca-Cola ||| 3 Stocks to Build Your Portfolio Around ||| Stocks That Hit 52-Week Lows On Friday ||| Shares of some beverage companies are trading lower. Consumer demand for staples and packaged food items has been volatile recently, contributing to volatility in stock movement. ||| UPDATE: Coca-Cola Says Impact From Coronavirus Could Be Material ||| UPDATE: Coca-Cola Says Recent Initiatives By Authorities To Limit Spread Of Coronavirus As Well As Recent Movement In Forex Rates, Will Have Negative Impact On FY Results; Says Does Not Expect To Achieve Prior Guidance ||| Coca-Cola 8-K Shows Recent Local Market Policies, Initiatives To Reduce Spread Of Coronavirus Have Significantly Increased, Including Direction To Refrain From Dining At Restaurants, Cancellation Of Major Sporting, Entertainment Events ||| Deutsche Bank Maintains Buy on Coca-Cola, Lowers Price Target to $53",0,0.49508968
2020-03-23,44978500.0,38.7599983215332,38.88999938964844,36.27000045776367,37.560001373291016,37.22184371948242,KO,"Coke, Disney Shareholders Anchoring a Renewed Movement Against Excessive CEO Pay ||| Validea James P. O'Shaughnessy Strategy Daily Upgrade Report - 3/21/2020 ||| Bulls And Bears Of The Week: Amazon, Boeing, Coca-Cola And More ||| How to Invest in a Historic Market Sell-Off ||| Better Buy: IBM vs. Coca-Cola ||| This Is One of the Safest Dividend Stocks You Can Buy Right Now ||| How to Invest in a Historic Market Selloff ||| 2 Stocks to Buy During the COVID-19 Crisis ||| UPDATE: JP Morgan Upgrades Coca-Cola to Overweight, Announces $44 Price Target As Firm Believes 'KO's deep transformation will allow faster top line, better margins, free cash flow conversion and returns in the long run.' ||| Stocks That Hit 52-Week Lows On Monday ||| JP Morgan Upgrades Coca-Cola to Overweight, Announces $44 Price Target",1,0.50604934
2020-03-24,49096200.0,41.220001220703125,41.400001525878906,38.83000183105469,39.45000076293945,39.09482955932617,KO,"Why Now Is the Perfect Time for New Investors to Get Into the Stock Market ||| Dow Jones Today: Stimulus Hopes Stoke Epic Dow Rally ||| Why Coca-Cola Stock Is Up (Only) 5% Today ||| Bear Market Investing: 3 Things to Do to Make Money ||| 3 Stocks to Stock Your Pantry as Coronavirus Escalates ||| 75 Stocks Moving In Tuesday's Mid-Day Session ||| Orange Juice Futures Jump As Much As 6% To 11-Month High ||| Shares of several consumer goods companies are trading higher amid market strength on hopes of a US economic stimulus agreement. The sector has been volatile recently amid consumer demand for household staples and cleaning products. ||| Coca-Cola shares are trading higher after HSBC upgraded the company's stock from Hold to Buy. ||| 26 Stocks Moving in Tuesday's Pre-Market Session ||| 2020 Summer Olympics Likely To Be Postponed Until 2021 Due To Global Pandemic ||| HSBC Upgrades Coca-Cola to Buy, Announces $45 Price Target",1,0.48383278
2020-03-25,42511700.0,40.630001068115234,43.45000076293945,39.90999984741211,41.61000061035156,41.235382080078125,KO,"3 Warren Buffett Stocks Worth Buying Now ||| Popeyes Sharing Netflix Login Data During Pandemic ||| Buy This Stock for Market-Trouncing Returns and Instant Diversification ||| DZ Bank Upgrades Coca-Cola to Buy, Announces $51 Price Target",1,0.5223366
2020-03-26,37821700.0,42.84000015258789,45.27000045776367,42.45000076293945,44.290000915527344,43.89125442504883,KO,"Selling Calls Against Coke as Stocks Push Higher ||| Consumer Sector Update for 03/26/2020: WMT, MCD, DIS, CVS, KO, SCVL, MCFT, HYRE ||| Why Coca-Cola Stock, Middleby, and Even Beyond Meat Stock Rose Wednesday ||| 7 Stock Picks That Analysts Are Actually Upgrading Now ||| Shares of several consumer goods companies are trading higher amid market strength following US Senate passage of an economic stimulus package. NOTE: Packaged food and discount store stocks have been volatile recently amid consumer demand for staples.",0,0.4733996
2020-03-27,23297900.0,43.65999984741211,44.02999877929688,42.400001525878906,42.810001373291016,42.42457962036133,KO,"3 Brand-Name Dividend Stocks to Buy and Never Sell ||| Shares of several consumer goods companies are trading lower as markets sell off following this week's strength. The sector has been on watch recently amid consumer demand for groceries, household items and other staples. ||| Argus Research Upgrades Coca-Cola to Buy, Announces $54 Price Target ||| Hearing Argus Upgrades Coca-Cola From Hold To Buy, Announces $54 Target",1,0.54074997
2020-03-30,23446000.0,43.040000915527344,45.560001373291016,43.040000915527344,45.0,44.5948600769043,KO,"5 Dividend Investing Tips That Could Earn You Thousands ||| Why Campbell Soup, Hershey, and Coca-Cola Stocks Popped 5% Today ||| iShares ESG MSCI USA ETF Experiences Big Inflow ||| Shares of several consumer-related companies are trading higher after President Trump extended coronavirus measures in an effort to better help sustain the outbreak.",0,0.52108115
2020-03-31,25373900.0,45.06999969482422,45.5099983215332,44.060001373291016,44.25,43.85161209106445,KO,"Morgan Stanley Maintains Equal-Weight on Coca-Cola, Raises Price Target to $46",0,0.49665037
2020-04-01,21936400.0,42.47999954223633,43.650001525878906,41.79999923706055,42.119998931884766,41.74078750610352,KO,"How Leaders Are Inspiring Confidence Amid Downturn ||| Goldman Sachs Reinstates Neutral on Coca-Cola, Announces $46 Price Target",1,0.49952048
2020-04-02,17621900.0,42.220001220703125,44.18999862670898,41.86000061035156,43.95000076293945,43.55431365966797,KO,Can Rates Go Any Lower? ||| Why Coca-Cola Stock Fell 17% in March ||| These 5 Stocks Have Cost Buffett $49 Billion in 6 Weeks ||| Coca-Cola CEO Reiterates Co. Has No Plans To Layoff Employees Amid Coronavirus Outbreak,0,0.48714292
2020-04-06,22850000.0,45.38999938964844,47.0099983215332,44.68999862670898,46.66999816894531,46.24982452392578,KO,"30 Top Stocks and Funds to Beat the COVID-19 Bear Market ||| This Dirt-Cheap Warren Buffett Stock Should Be Your Top Pick Right Now ||| Ty Cobb: The Greatest Pro Athlete Investor Of All Time? ||| 3 Top Value Stocks for Long-Term Investors ||| Shares of several beverage companies are trading higher amid overall market strength on hopes US coronavirus hotspots could soon reach their peak. Additionally, the virus has lead to high demand for packaged food and beverages.",0,0.5016755
2020-04-07,21279600.0,48.5,48.59999847412109,46.47999954223633,46.5099983215332,46.09126281738281,KO,"Food News Roundup: Guy Fieri Lends A Helping Hand, Expert Cautions Against Protectionist Measures, Coca-Cola Stock In Focus ||| 4 Consumer Defensive Stocks Moving In Tuesday's Pre-Market Session",1,0.5192218
2020-04-09,19167300.0,48.43999862670898,49.72999954223633,48.34999847412109,49.0,48.5588493347168,KO,"How to Create Stock Baskets ||| 10 Things You Didn't Know About Warren Buffett's Company, Berkshire Hathaway ||| Buffett's Dividend Yield on Cost for These 4 Stocks Is Incredibly High",0,0.4814241
2020-04-13,19586000.0,48.34999847412109,48.63999938964844,46.5,46.93000030517578,46.50748443603516,KO,Is PepsiCo Stock a Buy? ||| Is Ecolab Stock a Buy? ||| 2 Crazy-Cheap Buffett Stocks to Buy Now ||| How the OPEC+ Deal Could Impact the Market ||| Shares of several beverage companies are trading lower amid demand concerns caused by the coronavirus. The pandemic has caused a disruption in consumer spending.,1,0.50060034
2020-04-14,21801900.0,47.93999862670898,49.25,46.93000030517578,48.91999816894531,48.47956466674805,KO,"Strength of U.S. consumer staples stocks shows cracks as market recovers ||| 3 Dividend Stocks That Pay You More Than PepsiCo ||| 3 Reasons Buffett Is So Successful in Bear Markets ||| Shares of several beverage companies are trading higher as markets gain on positive coronavirus outlook. Optimism surrounding the virus has led to hopes of an upcoming return to economic activity, which would benefit the sector.",0,0.52140546
2020-04-15,12893200.0,47.709999084472656,48.400001525878906,47.40999984741211,47.61000061035156,47.18136215209961,KO,"IWB, MA, MRK, KO: Large Inflows Detected at ETF ||| 3 Top U.S. Stocks to Watch in April ||| Every Member Of Trump's 'Great American Economic Revival' Industry Groups ||| Shares of several beverage companies are trading lower as the coronavirus pandemic continues to take its toll on the economy. The pandemic has decreased economic activity and consumer spending.",0,0.5203775
2020-04-16,17606800.0,47.400001525878906,47.84999847412109,46.7599983215332,47.09999847412109,46.67595291137695,KO,This Stock Has Averaged a 20% Annual Return Since 1965 ||| This Stock Has Averaged a 20% Annual Return Since 1965 ||| S&P 500 Futures Up 3.2% After Hours; Many Other Stocks Moving Higher With Futures; Investors Reacting Favorably To White Phase Guidelines On Reopening Economy,1,0.49375382
2020-04-17,19844600.0,48.29999923706055,48.29999923706055,47.369998931884766,48.060001373291016,47.62731170654297,KO,"GRAPHIC-Cash is king as U.S. quarterly reporting season gains steam ||| GRAPHIC-Take Five: Euro zone, earnings, economy ||| Coca-Cola Earnings: What to Watch",0,0.48196498
2020-04-20,18957900.0,47.790000915527344,48.0,46.310001373291016,46.52999877929688,46.111083984375,KO,"Beer may lose its fizz as CO2 supplies go flat during pandemic ||| 2 Great Stocks You Can Buy on Sale ||| 3 Top Stocks You Can Buy on Sale ||| Indexes End Week Higher As White House Rolls Out State-By-State Coronavirus Strategy, Investors Digest First Round Of Earnings Reports ||| Wall St Week Ahead-In companies' earnings, words may matter more than numbers ||| 3 ETFs To Play For This Week's Earnings Onslaught ||| Put Selling And Winning Systems In Any Market: Options Advice From MOJO Day Trading",0,0.48092645
2020-04-21,26863700.0,45.880001068115234,46.900001525878906,44.2599983215332,45.380001068115234,44.971439361572266,KO,"Wall Street falls as U.S. crude collapse compounds pandemic woes ||| Wall Street falls as U.S. crude collapse worsens pandemic woes ||| Wall Street tumbles as oil crash stirs pandemic fears ||| Wall Street tumbles as oil crash adds to pandemic fears ||| 4 Top Stock Trades for Wednesday: CMG, LMT, NFLX, KO ||| Wall Street tumbles as oil crash adds to pandemic fears ||| Coca-Cola Beats on Q1 Revenue and Earnings Per Share, Stock Slumps Anyway ||| BUZZ-U.S. STOCKS ON THE MOVE-Energous, Hertz Global, PAVmed ||| Wall Street falls as U.S. crude crash adds to pandemic woes ||| Dow Jones News: IBM Pulls Guidance; Coca-Cola Sees Plunging Volumes ||| Coca-Cola sees significant hit to second-quarter sales from lockdowns ||| Coca-Cola Co (KO) Q1 2020 Earnings Call Transcript ||| BUZZ-U.S. STOCKS ON THE MOVE-Energous Corp, Schlumberger NV, IBM ||| 3 Dividend Stocks That Pay Better Than Coca-Cola ||| Coca-Cola Q1 Results Top Estimates ||| Coca-Cola sees 2nd quarter sales hit from coronavirus lockdown ||| U.S. stock futures slide as U.S. crude crashes below zero ||| The Coca-Cola Q1 20 Earnings Conference Call At 7:30 AM ET ||| The Coca-Cola Company Q1 adjusted earnings Beat Estimates ||| Consumer Sector Update for 04/21/2020: EDU, PM, KO, XLP, XLY ||| Wall Street set to slide as sub-zero U.S. crude adds to pandemic worries ||| Mid-Afternoon Market Update: Dow Slides 500 Points; Vaxart Shares Spike Higher ||| Coca-Cola CEO: Global Volumes 'Fell Off A Cliff' ||| UPDATE: CFRA On Coca-Cola Notes 'With its 3.5% dividend yield and high single-digit long-term EPS growth goal, we view KO as a stock capable of low double-digit total return potential and see little risk to KO's dividend' ||| UPDATE: CFRA Maintains Strong Buy On Coca-Cola, Lowers Target To $55 Notes 'KO remains one of our top picks, although disclosure of a 25% volume decline since April 1 proves that almost no company is immune from Covid-19 impacts' ||| Afternoon Market Stats in 5 Minutes ||| Mid-Day Market Update: TriState Capital Jumps Following Q1 Results; Cyclacel Pharmaceuticals Shares Plunge ||| Coca-Cola Faces Deteriorating Environment, But BofA Says Fundamentals Remain Solid ||| CFRA Maintains Strong Buy on Coca-Cola, Lowers Price Target to $55 ||| Mid-Morning Market Update: Markets Open Lower; Coca-Cola Tops Q1 Estimates ||| CocaCola, IBM Earnings Under Scrutiny As Both Multinationals Withdraw Guidance, Netflix Later ||| Coca-Cola CFO Says Does Not Forsee Any Significant M&A Activity This Year; Co Does Not Intend To Repurchase Shares Going Forward This Year ||| Coca-Cola CEO Says All Plants In China Are Operating, Employees Have Returned To Company Offices In Shanghai ||| Recap: Coca-Cola Q1 Earnings ||| Coca Cola Q1 EPS $0.51 Beats $0.44 Est; Revenue $8.6B Beats $8.28B Est ||| A Peek Into The Markets: US Stock Futures Fall Ahead Of Coca-Cola, Lockheed Martin Earnings ||| Earnings Scheduled For April 21, 2020 ||| 8 Stocks To Watch For April 21, 2020",1,0.48103514
2020-04-22,15815200.0,46.04999923706055,46.150001525878906,45.5,45.68000030517578,45.26873779296875,KO,"GRAPHIC-Cash is king as U.S. quarterly reporting season gains steam ||| Coca-Cola Sees 25% Volume Slump as On-the-Go Drink Occasions Plummet ||| Dow Jones News: Apple's iPhone SE Reportedly Selling Well; Coca-Cola Defended ||| BUZZ-U.S. STOCKS ON THE MOVE-SAExploration Holdings, Unit Corp, Expedia Group ||| 3 Big Stock Charts for Wednesday: Coca-Cola, Mastercard, and Merck ||| Citigroup Maintains Neutral on Coca-Cola, Lowers Price Target to $51 ||| Jefferies Maintains Hold on Coca-Cola, Lowers Price Target to $47 ||| UBS Maintains Buy on Coca-Cola, Lowers Price Target to $154 ||| RBC Capital Maintains Outperform on Coca-Cola, Lowers Price Target to $55",0,0.48673305
2020-04-23,17668200.0,45.95000076293945,46.09999847412109,44.970001220703125,45.06999969482422,44.66423034667969,KO,"Daily Dividend Report: KMI,LMT,KO,HUM,ADS ||| Why Coca-Cola Is Cutting Ad Spending ||| Coca-Cola can Handle the Coronavirus Storm ||| Why Coca-Cola Was Down",1,0.49524346
2020-04-24,15177600.0,45.5,45.75,45.119998931884766,45.43000030517578,45.02098846435547,KO,How to Invest Internationally ||| Coca-Cola Stock Loses Some Fizz: Is It Time to Buy?,1,0.49264765
2020-04-27,19175500.0,46.0,46.97999954223633,45.709999084472656,46.77999877929688,46.35883331298828,KO,"The 3 Best Dividend Stocks to Buy and Hold Forever ||| Despite the Coronavirus, Keurig Dr Pepper Reaffirms 2020 Guidance ||| Microsoft wins five-year deal with Coca-Cola to supply business software ||| Coca-Cola Company Partners With Microsoft To Standardize Business Operations",0,0.51867086
2020-04-28,17246700.0,47.900001525878906,48.0,46.56999969482422,46.7400016784668,46.31919479370117,KO,PepsiCo beats revenue estimates but scraps forecast over virus crisis ||| PepsiCo Makes Another Entry Into Energy Drinks ||| PepsiCo Still Plans to Deliver $7.5 Billion to Investors in 2020 ||| 3 of Warren Buffett's Top-Performing Stock Picks ||| Why Snap Needs to Evolve,1,0.47241896
2020-04-29,15780000.0,47.27000045776367,47.86000061035156,46.880001068115234,47.119998931884766,46.69577407836914,KO,"How Diversification Helps Businesses ||| 3 Dividend Stocks to Buy With Attractive Price Charts ||| Microsoft’s Earnings: 2 COVID-19 Questions That Need Answering ||| The Coronavirus Pandemic and its Impact on Corporate Earnings ||| The Coronavirus Pandemic and its Impact on Corporate Earnings ||| America First Investment Advisors, LLC Buys Visa Inc, Mastercard Inc, Brookfield Asset ... ||| First National Bank Of Omaha Buys UnitedHealth Group Inc, CSX Corp, Coca-Cola Co, Sells Cigna ...",0,0.50718474
2020-04-30,20795600.0,47.0,47.0,45.70000076293945,45.88999938964844,45.47684860229492,KO,"The Coronavirus Has Cost Buffett $1.1 Billion in Annual Dividend Income ||| Sell in May and Go Away: Should You in 2020? ||| HighMark Wealth Management LLC Buys iShares MSCI EAFE Value, SeaSpine Holdings Corp, Oxford ... ||| BancorpSouth Bank Buys Visa Inc, 'M Co, Walmart Inc, Sells Kinder Morgan Inc, Valero Energy ... ||| Zacks Earnings Trends Highlights: Ford, Delta Air, Starbucks, Boeing, Alphabet, Coca-Cola and Proctor & Gamble",0,0.4917395
2020-05-01,14290400.0,45.619998931884766,46.38999938964844,45.209999084472656,45.59999847412109,45.18945693969727,KO,"Video: Warren Buffett's Market Indicator Rises Above –'…% ||| Weatherly Asset Management L. P. Buys JPMorgan Ultra-Short Income, SPDR Gold Trust, DocuSign ... ||| FEMSA (FMX) Q1 Earnings Beat Estimates, Revenues Rise Y/Y",0,0.48711804
2020-05-04,22544200.0,45.31999969482422,45.47999954223633,44.59999847412109,45.13999938964844,44.73360061645508,KO,"Why Marijuana Legalization Won't Solve the Industry's Problems ||| Buffett’s Berkshire Hathaway Lost $50 Billion, Hit By Coronavirus Stock Sell-Off ||| Top Insider Buys Highlight for the Week of May – ||| Private Wealth Strategies, L.L.C. Buys Vanguard Intermediate-Term Bond, Alphabet Inc, New York ... ||| Forsta Ap-fonden Buys Microsoft Corp, Apple Inc, Facebook Inc, Sells SPDR Select Sector Fund - ... ||| Vigilare Wealth Management Buys iShares Edge MSCI Min Vol USA, Coca-Cola Co, Qualcomm Inc, ... ||| Payden & Rygel Buys International Business Machines Corp, Apple Inc, Comcast Corp, Sells ...",1,0.49282584
2020-05-05,13370500.0,45.36000061035156,46.09999847412109,45.150001525878906,45.400001525878906,44.99126052856445,KO,"Microsoft Taps Coca-Cola to Challenge Amazon, Salesforce, and Slack ||| Davy Asset Management Ltd Buys Cisco Systems Inc, Truist Financial Corp, The Scotts Miracle Gro ... ||| Inside the Q1 Earnings Strength of Staples ETFs and Q2 View ||| Beach Investment Management, LLC. Buys Xcel Energy Inc, UnitedHealth Group Inc, Stryker Corp, ...",0,0.49229357
2020-05-06,11892900.0,45.400001525878906,45.630001068115234,44.720001220703125,44.75,44.347110748291016,KO,"3 Refreshing Beverage Stocks to Buy Now ||| Warren Buffett’s Growing Cash Pile Is a Sign Panic Is Yet to Come ||| Dow Analyst Moves: KO ||| Cornerstone Wealth Group, LLC Buys Fidelity Total Bond, iShares Core U.S. ... ||| Yacktman Asset Management Trims Procter & Gamble, Oracle ||| Morgan Dempsey Capital Management Llc Buys HP Inc, United Parcel Service Inc, Enbridge Inc, ...",0,0.51886266
2020-05-07,16466000.0,45.150001525878906,45.2400016784668,44.5,44.59999847412109,44.19845962524414,KO,"Is Berkshire Hathaway Stock Still a Buy for the Next Decade? ||| Suncoast Equity Management Buys Abbott Laboratories, Intuit Inc, Alphabet Inc, Sells CBRE Group ... ||| Mark Sheptoff Financial Planning, Llc Buys Sanofi SA, Medtronic PLC, Coca-Cola Co, Sells ... ||| Premier Asset Managment LLC Buys Microsoft Corp, Citigroup Inc, DocuSign Inc, Sells NXP ... ||| Hamel Associates, Inc. Buys Chubb, The Home Depot Inc, Microsoft Corp, Sells Boeing Co, ... ||| ANTIPODES PARTNERS Ltd Buys Merck Inc, JD.com Inc, Amazon. ...",1,0.4940411
2020-05-08,13987800.0,45.08000183105469,46.220001220703125,44.880001068115234,46.11000061035156,45.69486618041992,KO,"Shares of several consumer goods companies are trading higher amid overall market strength. Better-than-expected US jobless numbers and easing lockdown restrictions in some states has led to hopes of a rebound in consumer spending. ||| Connable Office Inc Buys iShares —…+ Year Treasury Bond ETF, Merck Inc, Dominion Energy ... ||| Hilton Capital Management, LLC Buys Microsoft Corp, Johnson & Johnson, Colgate-Palmolive ... ||| South Street Advisors LLC Buys Microsoft Corp, MGM Growth Properties LLC, Coca-Cola Co, Sells ... ||| CapWealth Advisors, LLC Buys Gilead Sciences Inc, CenturyLink Inc, National Health Investors ... ||| The Yacktman Fund Cuts Samsung, PepsiCo ||| Drexel Morgan & Co. Buys AT&T Inc, International Business Machines Corp, JPMorgan ... ||| Mandatum Life Insurance Co Ltd Buys Facebook Inc, Alphabet Inc, Coca-Cola Co, Sells Caterpillar ... ||| Monster Beverage (MNST) Q1 Earnings Beat on Strong Top Line ||| Woodley Farra Manion Portfolio Management Inc Buys Stryker Corp, Motorola Solutions Inc, ... ||| On The Back Of Fed Backstop, Bond Issuance Picks Up Pace At Already-Levered US Corporations",0,0.518954
2020-05-11,10870000.0,45.68999862670898,46.11000061035156,45.52000045776367,45.540000915527344,45.130001068115234,KO,"Elon Musk Isn't Warren Buffett's Biggest Fan ||| 2 Stocks You Can Keep Forever ||| ESGU, KO, ACN, T: Large Outflows Detected at ETF ||| Live Oak Private Wealth LLC Buys Berkshire Hathaway Inc, The Walt Disney Co, Mastercard Inc, ... ||| Is Global Diversification Still Worth It? The Case For Investing Beyond The U.S. ||| Retirement Income Solutions, Inc Buys SPDR Russell –……… ETF, SPDR Select Sector Fund - ...",0,0.4853994
2020-05-12,13424400.0,45.59999847412109,45.84999847412109,44.79999923706055,44.81999969482422,44.416481018066406,KO,"Not Just Fun And Games: How Esports Could Offer Potential Investment Opportunities ||| Terril Brothers, Inc. Buys Verizon Communications Inc, Truist Financial Corp, International ... ||| Philadelphia Trust Co Buys Amazon.com Inc, Broadcom Inc, General Mills Inc, Sells Bank of ... ||| Diversified Portfolios, Inc. Buys Vanguard Total Bond Market ETF, Vanguard Russell –……… ...",0,0.48619273
2020-05-13,15854800.0,44.709999084472656,44.77999877929688,43.52000045776367,43.93999862670898,43.54440307617188,KO,"Validea James P. O'Shaughnessy Strategy Daily Upgrade Report - 5/13/2020 ||| 7 Tech Industry Dividend Stocks for Growth and Income ||| PepsiCo Is First Major Consumer Foods Name to Take a Big Dive Into DTC ||| Better Buy: McDonald's vs. Monster Beverage ||| AlphaCrest Capital Management LLC Buys AT&T Inc, Eli Lilly and Co, Apple Inc, Sells The ... ||| Capital Fund Management S.a. Buys Qualcomm Inc, Merck Inc, AbbVie Inc, Sells Procter & ... ||| Landscape Capital Management, L.l.c. Buys iShares Short Maturity Bond, PIMCO Enhanced Short ...",0,0.4861241
2020-05-14,18000800.0,43.380001068115234,44.060001373291016,43.22999954223633,43.70000076293945,43.30656433105469,KO,"How Lockdowns Are Impacting Automobile Makers ||| Franklin Street Capital Partners, LLC Buys Walmart Inc, The Kroger Co, Electronic Arts Inc, ... ||| Alliance Wealth Management Group Buys Schwab US Dividend Equity, Coca-Cola Co, iShares iBoxx $ ... ||| BSW Wealth Partners Buys WisdomTree U.S. SmallCap Fund, iShares Russell —………, iShares ... ||| Top 5 Buys of Jeremy Grantham's GMO in the –st Quarter ||| DPM Capital LLC Buys Sirius XM Holdings Inc, Coca-Cola Co, Loews Corp, Sells Synchrony ... ||| Gmo Llc Buys Coca-Cola Co, Quest Diagnostics Inc, iShares Core MSCI Emerging Markets, Sells ... ||| Coca-Cola Explores Non-Soda Opportunities",0,0.48326698
2020-05-15,31579400.0,43.959999084472656,44.68999862670898,43.20000076293945,43.2599983215332,42.87052536010742,KO,"Dow Movers: WBA, UNH ||| Anheuser-Busch Stock Makes a Solid Buy at Current Lows ||| Coca-Cola CFO Says Trough Will Come In Q2, Says Bullish Credit Suisse ||| Ethic Inc. Buys Microsoft Corp, Apple Inc, Healthpeak Properties Inc, Sells Discover Financial ... ||| Atlas Principals, LLC Buys Amazon.com Inc, PayPal Holdings Inc, Square Inc, Sells Berkshire ... ||| Voloridge Investment Management, Llc Buys Comcast Corp, PowerShares QQQ Trust Ser –, AT&T ... ||| APG All Pensions Group NV Buys MSA Safety Inc, Netflix Inc, Coca-Cola Co, Sells Chevron Corp, ... ||| Venturi Wealth Management, LLC Buys iShares Core MSCI Emerging Markets, iShares –-' Year ... ||| This Trio of Growth Stocks May Present Value Opportunities ||| Gyon Technologies Capital Management, LP Buys Berkshire Hathaway Inc, Coca-Cola Co, Novo ...",1,0.49658597
2020-05-18,26122300.0,44.81999969482422,45.38999938964844,44.130001068115234,44.970001220703125,44.56513214111328,KO,"Berkshire Exits Travelers, Boosts Stakes In United And Delta In Q1 ||| Who & What Are Dividend Kings? ||| Who And What Are Dividend Kings? ||| Q1 Scorecard and Research Reports for NVIDIA, Coca-Cola, PetroChina & Others ||| Guggenheim Raises PepsiCo To 'Best Idea' In Food And Beverage, Ups Target",0,0.51152223
2020-05-19,17839900.0,45.0099983215332,45.33000183105469,44.25,44.540000915527344,44.13900375366211,KO,"VTV, T, KO, AMGN: ETF Inflow Alert",1,0.5377577
2020-05-20,22295900.0,45.20000076293945,46.16999816894531,45.02000045776367,45.88999938964844,45.47684860229492,KO,"3 Dow Jones Stocks to Trade for the Technical Investor ||| Dow Jones Surges 400 Points as Coca-Cola Warns on Pandemic Aftermath, Intel's AMD Killer Falls Short ||| Better Buy: Beyond Meat vs. Keurig Dr Pepper ||| 4 Signs the Cannabis Industry Is Still Ultra-High-Risk ||| Coca-Cola shares are trading higher, potentially amid strength in overall market. Additionally, reopenings of some US restaurants and venues could be potential demand catalysts for the company's products. ||| Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)? ||| How Companies Use Brands To Build Competitive Advantage",0,0.5262858
2020-05-21,13193500.0,46.08000183105469,46.09000015258789,45.02999877929688,45.16999816894531,44.763328552246094,KO,Here's Why Warren Buffett's Berkshire Hathaway Has Lagged the S&P 500 (and Why It Could Have Been Worse) ||| 13 Dividend Stocks That Have Paid Investors for 100+ Years ||| Warren Buffett on the Advantage of Size ||| The Biggest Drops In The History Of The Dow Jones Industrial Average,0,0.46274737
2020-05-22,13008400.0,45.220001220703125,45.310001373291016,44.650001525878906,45.02999877929688,44.62458801269531,KO,"Warren Buffett's Top 5 Holdings as of the –st Quarter ||| Arcus Capital Partners, LLC Buys Coca-Cola Co, iShares Edge MSCI Min Vol Global, iShares Edge ... ||| Ethic Inc. Buys Healthpeak Properties Inc, Ecolab Inc, Procter & Gamble Co, Sells Discover ...",1,0.4855096
2020-05-26,22223100.0,46.91999816894531,46.93000030517578,45.93000030517578,46.09000015258789,45.675048828125,KO,"Where Will Coca-Cola Be in 1 Year? ||| 3 Dividend Stocks That Pay Better Than Coca-Cola ||| Better Buy: McDonald's vs. Coca Cola ||| Amazon Stock Is the Coca-Cola of Cloud Computing ||| 68% of Buffett's Portfolio Is in These 4 Stocks ||| Shares of several consumer staples are trading higher in sympathy with the overall market as equities rally on coronavirus vaccine hopes as well as a pickup in economic activity as some US states reopen businesses. A vaccine could bring a return to increased consumer spending. ||| Signature Wealth Management Group Buys Cisco Systems Inc, Coca-Cola Co, Leggett & Platt ... ||| Three Iconic Brands You Can Rely On Even In A Bear Market",1,0.5005629
2020-05-27,18447600.0,47.0,47.09000015258789,46.16999816894531,46.72999954223633,46.30928421020508,KO,3 Stocks Warren Buffett Would Love ||| Investing in Your 20s: 3 Stocks to Watch,1,0.48055205
2020-05-28,16230600.0,47.29999923706055,47.459999084472656,46.81999969482422,47.09000015258789,46.66604232788086,KO,"Better Buy: Starbucks vs. Coca-Cola ||| Tredje AP-fonden Buys Microsoft Corp, Amazon.com Inc, Apple Inc, Sells iShares U.S. ...",0,0.51146775
2020-05-29,51129900.0,46.68000030517578,47.18999862670898,46.13999938964844,46.68000030517578,46.25973510742188,KO,Learning from Warren Buffett's Decision to Buy Coca-Cola,1,0.5350709
2020-06-01,17010700.0,46.65999984741211,47.22999954223633,46.59000015258789,46.9900016784668,46.56694412231445,KO,Validea James P. O'Shaughnessy Strategy Daily Upgrade Report - 5/30/2020 ||| This Is Why Coca-Cola Stock Could Thrive in the ‘New Normal’ ||| Warren Buffett's Berkshire Hathaway Turns Up Stake in Liberty SiriusXM,0,0.48609188
2020-06-02,15255100.0,47.15999984741211,47.27999877929688,46.560001373291016,46.900001525878906,46.47775650024414,KO,3 International Stocks Whose Products You Will Soon Use ||| Warren Buffett Is a Legend … But He’s Wrong About This,1,0.50523835
2020-06-03,15508300.0,47.27000045776367,48.119998931884766,47.119998931884766,47.900001525878906,47.46875381469727,KO,Starbucks Is a Great Play on China Despite Global Drama ||| 3 Top Dividend Stocks for a Better Retirement ||| Warren Buffett's Berkshire Hathaway Turns Up Stake in Liberty SiriusXM,1,0.50504225
2020-06-08,19896700.0,49.540000915527344,49.970001220703125,49.470001220703125,49.84999847412109,49.40119552612305,KO,"Where Will Anheuser-Busch InBev Be in 5 Years? ||| Morgan Stanley Maintains Equal-Weight on Coca-Cola, Raises Price Target to $52",0,0.49491128
2020-06-10,15716600.0,49.15999984741211,49.27000045776367,48.56999969482422,48.619998931884766,48.18226623535156,KO,"Notable ETF Inflow Detected - IVE, JPM, C, KO ||| Ex-Dividend Reminder: Coca-Cola, Leggett & Platt and Tootsie Roll Industries",0,0.47833645
2020-06-11,26070400.0,47.810001373291016,47.91999816894531,45.459999084472656,45.540000915527344,45.130001068115234,KO,"Nestle explores sale of Pure Life as part of water business review ||| Shares of several companies in the broader consumer staples sector are trading lower as markets dip amid concerns of a second wave of the coronavirus. Virus concerns have clouded economic outlook and negatively impacted stocks across sectors, including staples",1,0.51429015
2020-06-12,21813400.0,46.209999084472656,46.25,45.0099983215332,45.59999847412109,45.59999847412109,KO,Validea James P. O'Shaughnessy Strategy Daily Upgrade Report - 6/12/2020,1,0.50549245
2020-06-15,15622300.0,44.56999969482422,46.45000076293945,44.470001220703125,46.29999923706055,46.29999923706055,KO,5 Top Dividend Kings to Buy and Hold Forever ||| 1 Thing Buffett Says You Should Do Before Investing Money Into Stocks,1,0.5383466
2020-06-17,12599500.0,46.77999877929688,47.060001373291016,46.43999862670898,46.58000183105469,46.58000183105469,KO,"IAU, UGE: Big ETF Inflows ||| 2 Stocks to Supplement Your Social Security Income",1,0.5239438
2020-06-18,9380800.0,46.29999923706055,47.040000915527344,46.06999969482422,46.9900016784668,46.9900016784668,KO,"3 Dow Jones Companies to Buy as Markets Get Volatile ||| 3 Reasons Clorox Stock Is a Buy Right Now ||| With the Economy Reopening, Is Now a Good Time to Buy Stocks?",0,0.49342027
2020-06-19,30464600.0,47.77000045776367,47.790000915527344,46.02000045776367,46.02000045776367,46.02000045776367,KO,"In Shades of Enron, Chesapeake Energy Is Another Victim of the Sports Stadium Naming Curse ||| Why Is Warren Buffett Getting Crushed by the Pandemic?",0,0.5086257
2020-06-22,20876200.0,46.02999877929688,46.150001525878906,45.380001068115234,45.7400016784668,45.7400016784668,KO,"5 Stocks That Turned $1,000 Into $1 Million (or More) ||| Uzbekistan to sell stake in Coca-Cola JV",0,0.5026989
2020-06-23,14675300.0,46.0,46.290000915527344,45.58000183105469,45.63999938964844,45.63999938964844,KO,5 American Stocks to Keep on Your Watch List ||| Nucor is the Coca-Cola of the Steel Industry ||| Better Buy: Costco vs. Coca Cola ||| 3 Dividend Stocks That Pay You Better Than Coca-Cola Does,0,0.5094596
2020-06-24,17631800.0,45.369998931884766,45.43999862670898,44.5,44.650001525878906,44.650001525878906,KO,Coca-Cola Is a Cash Flow Machine: Here's Why,1,0.48825315
2020-06-25,13829700.0,44.470001220703125,44.97999954223633,44.02999877929688,44.93000030517578,44.93000030517578,KO,8 Cash-Rich Stocks to Get You Through the Year and Beyond,0,0.5329903
2020-06-26,21955100.0,44.91999816894531,45.0099983215332,43.5099983215332,43.56999969482422,43.56999969482422,KO,iShares Global 100 ETF Experiences Big Inflow,1,0.5152083
2020-06-29,17603900.0,44.0,44.56999969482422,43.54999923706055,44.36000061035156,44.36000061035156,KO,"Big tobacco, big oil and Buffett join Fed's portfolio ||| Facebook Bows to Ad Boycotts and Will Block Certain Content ||| Why Alteryx Is Focusing on Large Companies to Fuel Its Growth ||| Technology Sector Update for 06/29/2020: FB, KO, DEO, UN, UL, SBUX, LEVI, NOK, WEX, XLK, SOXX ||| Meet the Stock That Turned $100 Into $2.7 Million",1,0.4848581
2020-06-30,23679800.0,44.25,44.83000183105469,44.040000915527344,44.68000030517578,44.68000030517578,KO,"Facebook agrees to audit its hate speech controls ||| Why Are Corporates Leaving Facebook, Twitter ||| 5 ESG Stocks to Buy for Conscientious Investment Gains ||| Facebook agrees to audit its hate speech controls ||| Microsoft Reportedly Cuts Facebook/Instagram Advertising ||| Better Buy: Berkshire Hathaway vs. JPMorgan Chase ||| 7 Investing Lessons You Can Learn From Warren Buffett",1,0.5010386
2020-07-01,14316500.0,44.93000030517578,45.52999877929688,44.709999084472656,44.81999969482422,44.81999969482422,KO,"3 Growth Stocks That Could Double ||| Coca-Cola Shuts Down Its Odwalla Juice Brand, Eliminates Refrigerated Trucking ||| Facebook frustrates advertisers as boycott over hate speech kicks off ||| Facebook frustrates advertisers as boycott over hate speech kicks off ||| COLUMN-One hundred years of certitude? FAANG-like century bonds clean up: Mike Dolan",1,0.5303979
2020-07-02,15108300.0,45.290000915527344,45.43000030517578,44.79999923706055,44.880001068115234,44.880001068115234,KO,"U.S. Supreme Court takes up Nestle, Cargill appeals over human rights claims ||| U.S. Supreme Court takes up Nestle, Cargill appeals over human rights claims",1,0.5043251
2020-07-06,15146000.0,45.13999938964844,45.27000045776367,44.61000061035156,45.22999954223633,40.635040283203125,KO,Why the Facebook Ad Boycott Could Be Good for Pinterest ||| Fed bond buying shows preference for liquid household names ||| 8 Stock Market Predictions for the Second Half of the Year ||| Why Coca-Cola Stock Has Fallen 19% So Far in 2020 ||| Will an Ad Boycott End Facebook’s 500% Rally Over the Past 8 Years?,0,0.5021332
2020-07-08,13851200.0,45.13999938964844,45.18000030517578,44.470001220703125,45.06999969482422,40.49129867553711,KO,"Dow Movers: AXP, AAPL",0,0.5134577
2020-07-09,16087100.0,45.04999923706055,45.04999923706055,43.83000183105469,43.90999984741211,39.44913482666016,KO,3 Top Cloud Computing Stocks to Buy Right Now,1,0.55075973
2020-07-10,15627800.0,43.880001068115234,45.25,43.86000061035156,45.150001525878906,40.56316757202149,KO,The 7 Best Dividend-Paying Stocks for Cautious Investors,1,0.5384589
2020-07-13,16705300.0,45.52999877929688,45.68000030517578,44.959999084472656,45.25,40.65300369262695,KO,"Pepsi Earnings: 3 Trends to Watch ||| As Advertisers Leave Facebook, Disney Could Benefit ||| 3 Things to Watch in the Stock Market This Week ||| PepsiCo’s Quaker Foods Business Notches a 55% Profit Spike ||| 1 Food Stock to Avoid No Matter What",1,0.5255318
2020-07-14,17080100.0,44.90999984741211,45.93999862670898,44.66999816894531,45.869998931884766,41.21001815795898,KO,PepsiCo's Snack Food Segment Saves the Day ||| Is Ecolab Stock a Buy? ||| Buffett Has Gained $108 Billion on These 5 Stocks,1,0.48518142
2020-07-15,23738000.0,46.29999923706055,47.18999862670898,46.20000076293945,46.400001525878906,41.686180114746094,KO,"Notable ETF Outflow Detected - XLP, PEP, KO, COST ||| What Pepsi’s Strong Second Quarter Could Mean for Coca-Cola’s Earnings ||| The Lurking Nightmare for Coke and Pepsi -- Should you Still Invest?",0,0.47963634
2020-07-16,13306100.0,46.2599983215332,46.68999862670898,45.93999862670898,46.150001525878906,41.46157836914063,KO,Why Pepsi Thinks It Can Keep Winning Market Share,1,0.53670704
2020-07-17,13899800.0,46.470001220703125,46.90999984741211,46.130001068115234,46.81999969482422,42.063507080078125,KO,"S&P 500 Up on Healthcare Stock Surge, Blackrock Earnings; Netflix Down on Earnings, Cruise Line, Airline, Oil Stocks Fall on Fears of Stalling Recovery ||| Dividend Aristocrat Coca-Cola Declares Its Latest Payout; Yield Is 3.5% ||| Daily Dividend Report: KO,PPG,TXN,ALL,APD ||| Better Buy: General Electric vs. Coca-Cola",0,0.4925443
2020-07-20,16633200.0,46.720001220703125,46.83000183105469,45.84999847412109,46.119998931884766,41.43461990356445,KO,"Better Buy: Amazon vs. Walmart ||| Is Monster Beverage Stock a Buy? ||| How to Pick a Stock Like Warren Buffett ||| 3 Things to Watch in the Stock Market This Week ||| Facebook Remains a Good Investment Despite the Drama ||| Pre-Market Earnings Report for July 21, 2020 : KO, PM, LMT, PLD, NVS, PCAR, SYF, CBSH, SBNY, CMA, NEOG, GPK ||| Dow Jones Lags as Microsoft Stock Surges, Coca-Cola Stock Sinks Ahead of Earnings",1,0.49955747
2020-07-21,25681500.0,47.52000045776367,47.9900016784668,46.93000030517578,47.20000076293945,42.404903411865234,KO,"BUZZ-U.S. STOCKS ON THE MOVE-Coca-Cola Co, Lockheed Martin, Acadia Pharma ||| Consumer Sector Update for 07/21/2020: NBEV,KO,TSLA ||| ANALYSIS-Want to make profits from coffee in China? It's actually a grind ||| S&P 500 News: Oil Stocks Surge on $2 Trillion EU Stimulus Deal, Will Tesla Join the Index? ||| Coca-Cola Looks to Optimize Efficiency by Axing “Zombie Brands” ||| 4 Top Stock Trades for Wednesday: KO, IBM, EBAY, UAL ||| S&P 500 closes slightly higher as stimulus hopes lift cyclical stocks ||| Consumer Sector Update for 07/21/2020: GES,NBEV,KO,TSLA ||| Coca-Cola (KO) Q2 2020 Earnings Call Transcript ||| Is Genius Brands Stock Finally a Smart Purchase? ||| S&P 500, Dow rise after positive earnings, stimulus bets ||| Wall Street gains as investors bet on stimulus ||| S&P 500, Dow rise on optimism over earnings reports, stimulus ||| Wall Street rises on upbeat earnings reports, stimulus hopes ||| Dow Jones Charges Higher After IBM and Coca-Cola Report Earnings ||| Consumer Sector Update for 07/21/2020: NBEV, PM, KO, XLP, XLY ||| Wall Street set to climb on upbeat earnings reports, stimulus hopes ||| Coca-Cola Q2 Adj. EPS Top Estimates, But Revenues Miss ||| Coca-Cola revenue tumbles as lockdowns hammer soda sales ||| Coca-Cola revenue falls about 29% as lockdowns crimp soda sales ||| The Coca-Cola Company Q2 adjusted earnings Beat Estimates ||| US STOCKS-Futures climb on IBM earnings report, stimulus hopes ||| Coca-Cola Sees Demand Improving After 32% Drop in Second-Quarter Earnings",1,0.49086276
2020-07-22,29831200.0,47.93000030517578,48.52000045776367,47.02999877929688,48.47999954223633,43.55486679077149,KO,"BUZZ-U.S. STOCKS ON THE MOVE-Biogen Inc, Teradyne Inc, Pfizer Inc ||| Coca-Cola’s Earnings Take a Historic Hit From Decreased Consumer Interactions ||| Britvic sales sink 16% on lockdown hit ||| Coca-Cola's COVID-19 Conundrum in 1 Handy Chart",0,0.4984681
2020-07-23,15935000.0,48.470001220703125,48.56999969482422,48.02999877929688,48.27999877929688,43.375186920166016,KO,"Coca-Cola Explains Why a Full Recovery Could Take Years ||| PREVIEW-U.S. ad market faces longer road to recovery as states' reopening efforts sputter ||| Broker Darlings of the Dow: Coca-Cola Ranks As a Top 15 Analyst Pick ||| Dow Analyst Moves: KO ||| Notable ETF Outflow Detected - IVE, KO, PEP, MDLZ ||| 3 Investing Lessons You Should Learn From Warren Buffett",1,0.50601673
2020-07-24,16196800.0,48.400001525878906,48.79999923706055,48.06999969482422,48.4900016784668,43.56385040283203,KO,Why Coca-Cola Needs a Strategy Change,0,0.5226449
2020-07-27,17346500.0,48.18000030517578,48.5099983215332,48.18000030517578,48.47999954223633,43.55486679077149,KO,"The Hidden Reason Why Companies Are Cutting Facebook Spending (It's Not Fake News) ||| After Hours Most Active for Jul 27, 2020 : BAC, SPPI, INTC, BABA, GE, MSFT, KO, MNK, SVC, SQQQ, JD, PFE ||| After Hours Most Active for Jul 27, 2020 : BAC, BABA, GE, SPPI, SVC, KO, INTC, BMY, CNQ, QQQ, AMTD, MSFT ||| 5 Undervalued Food and Beverage Stocks to Buy Right Now",0,0.47570738
2020-07-28,13872700.0,48.34000015258789,49.27999877929688,48.09999847412109,48.18000030517578,43.28533935546875,KO,The Current State of Natural Resource Companies ||| Why Intel Stock Went Down,0,0.50894195
2020-07-29,13758100.0,48.13999938964844,48.5,47.81999969482422,48.02000045776367,43.141597747802734,KO,Buffett's Latest Investment and Some Financial Sector Earnings,0,0.4957643
2020-07-30,17276500.0,47.66999816894531,48.22999954223633,47.20000076293945,47.68999862670898,42.845123291015625,KO,Coca-Cola Jumps Into the Popular Hard Seltzer Category ||| Choosing Between Renting and Buying a House ||| An Upbeat Boring Business ||| 4 Reasons You Shouldn't Invest Like Warren Buffett ||| Why Do Baby Boomers Love Coca-Cola Stock? ||| 3 Surprisingly Popular Robinhood Stocks,0,0.49573696
2020-07-31,14849200.0,47.43999862670898,47.77000045776367,46.72999954223633,47.2400016784668,42.44084167480469,KO,"SPYG, PEP, SPGI, KO: Large Outflows Detected at ETF ||| Coca-Cola To Offer Topo Chico Hard Seltzer",0,0.51006526
2020-08-03,14137500.0,47.13999938964844,47.36000061035156,46.22999954223633,46.29999923706055,41.59632873535156,KO,"Better Buy: IBM vs. Coca-Cola ||| 3 Safe Stocks to Hold Through the Next Market Crash ||| Is Constellation Brands the Coca-Cola of Adult Drinks? ||| Dow Movers: BA, MSFT",1,0.5050809
2020-08-04,11717200.0,46.290000915527344,46.86000061035156,46.220001220703125,46.68999862670898,41.94671630859375,KO,3 Fitness Stocks for a Fit Portfolio ||| Why Apple Did a 4-for-1 Stock Split ||| Stick With Plug Power for Long-Term Gains ||| Where to Look for Recession-Proof ETFs in 2020,1,0.5349631
2020-08-05,10498700.0,46.900001525878906,47.27000045776367,46.810001373291016,47.220001220703125,42.42287063598633,KO,"Equity Crowdfunding Versus Rewards Crowdfunding: 3 Pros, 3 Cons ||| The Facebook Ad Boycott Isn't Over",1,0.5320103
2020-08-06,10745000.0,46.65999984741211,47.52999877929688,46.59999847412109,47.47999954223633,42.65645217895508,KO,Refresh Your Portfolio with Income from Coca-Cola,1,0.54993874
2020-08-10,11888000.0,48.060001373291016,48.27999877929688,47.65999984741211,47.720001220703125,42.87207794189453,KO,"If You'd Invested $100 in Coca-Cola's IPO, This Is How Much Money You'd Have Now ||| The Man Behind Jack Daniel’s",1,0.50017965
2020-08-11,16531600.0,48.459999084472656,48.650001525878906,47.70000076293945,47.93000030517578,43.06074142456055,KO,"Mexico's new warning labels on junk food meet supersized opposition from U.S., EU ||| Why Value Investing Works ||| Noteworthy ETF Inflows: DGRO, CVX, KO, BAC",1,0.5062488
2020-08-12,9562200.0,48.29999923706055,48.68999862670898,48.119998931884766,48.43000030517578,43.50994110107422,KO,Is Coca-Cola Stock Recession-Proof?,0,0.5113248
2020-08-13,9882900.0,48.2599983215332,48.72999954223633,48.060001373291016,48.380001068115234,43.46502304077149,KO,"Structural Challenges Remain, But Not All Hope Is Lost for OrganiGram Stock",1,0.54023165
2020-08-14,10075800.0,48.34000015258789,48.68999862670898,48.02999877929688,48.45000076293945,43.52791595458984,KO,Buffett Bets the Farm on Bank of America,0,0.4846555
2020-08-17,9102400.0,48.31999969482422,48.75,48.20000076293945,48.209999084472656,43.312294006347656,KO,3 Ways to Plan for a Market Crash ||| Coca-Cola Expands Its Beverage Production in China With at Least 6 Facilities ||| Monday's ETF with Unusual Volume: FXG,1,0.52414715
2020-08-18,9829000.0,48.20000076293945,48.5,47.959999084472656,48.41999816894531,43.50095748901367,KO,Is Coca-Cola Stock a Buy?,0,0.5122264
2020-08-19,17371000.0,48.119998931884766,48.380001068115234,47.220001220703125,47.369998931884766,42.5576286315918,KO,"How I Invest My 401(K)--and How to ""Beat"" It ||| 3 Dividend Stocks That Pay You Better Than Coca-Cola Does",0,0.48362198
2020-08-20,11308700.0,47.27000045776367,47.59999847412109,47.09000015258789,47.34999847412109,42.53965759277344,KO,Consumer Goods Stocks Steam Ahead ||| MGM Resorts Adds IAC Executives to Board After $1 Billion Investment ||| 3 Blue Chip Stocks Robinhood Investors Love,0,0.48852336
2020-08-21,14734100.0,47.34000015258789,47.5,46.970001220703125,47.27999877929688,42.47677612304688,KO,20 Best Blue-Chip Stocks for 2020 and Beyond ||| 7 Safe Stocks to Buy That Can Shrug Off the Growing Volatility,1,0.52931005
2020-08-24,9257700.0,47.43000030517578,47.97999954223633,47.18000030517578,47.970001220703125,43.096675872802734,KO,What You Can Learn About Business From Taylor Swift,0,0.5113597
2020-08-25,7827800.0,48.0,48.04999923706055,47.650001525878906,47.90999984741211,43.04277038574219,KO,How to Find a Company's Value,1,0.5231469
2020-08-27,10931600.0,48.25,48.81999969482422,48.20000076293945,48.22999954223633,43.33026885986328,KO,3 Stocks to Buy Ahead of the Next Market Crash,1,0.5068323
2020-08-28,16420300.0,48.75,49.84999847412109,48.52999877929688,49.83000183105469,44.76771926879883,KO,"Coca-Cola to cut jobs in restructuring ||| Tech powers S&P 500 to record closing high, Dow now positive for the year ||| Wall St gains, S&P 500 on track for 6th straight record closing high ||| BUZZ-U.S. STOCKS ON THE MOVE-Nutanix Inc, iBio Inc, Panhandle Oil & Gas, Workday Inc ||| Tech stocks power S&P 500 for seventh session in a row ||| MGM Resorts to lay off 18,000 furloughed workers in US - WSJ ||| BUZZ-U.S. STOCKS ON THE MOVE-Enanta Pharmaceuticals, Hibbett Sports, Veeva Systems Inc ||| Tech stocks extend S&P 500's rally to seventh straight session ||| BUZZ-U.S. STOCKS ON THE MOVE-MGM Resorts, Afya Limited, Plantronics Inc ||| Tech stocks extend S&P 500's rally to seventh straight session ||| Coca-Cola Offering Voluntary Buyouts as Part of a Restructuring ||| BUZZ-U.S. STOCKS ON THE MOVE-Just Energy, Viking Therapeutics, Ulta Beauty, Carnival Corp ||| S&P 500 on pace for fifth straight record open ||| Tech powers S&P 500 to record closing high, Dow now positive for the year ||| Coca-Cola To Re-organize Operating Units Into 9 From Current 17; To Align Workforce - Quick Facts ||| Coca-Cola to cut jobs in restructuring",0,0.49216112
2020-08-31,18510800.0,49.79999923706055,50.06999969482422,49.34999847412109,49.52999877929688,44.498191833496094,KO,"Warren Buffett looks to Japan, takes 5% stakes in five trading companies ||| 3 Investing Tricks to Double Your Money",0,0.4961385
2020-09-02,26332600.0,49.36000061035156,51.36000061035156,49.36000061035156,51.18999862670898,45.98955535888672,KO,"Indexes Capture Another Set of Fresh Closing Highs ||| How Stock Splits Impact Investors ||| Dow Movers: AAPL, KO",0,0.4903741
2020-09-03,22289400.0,51.400001525878906,52.13999938964844,50.09999847412109,50.47999954223633,45.351688385009766,KO,"Britain's Pret A Manger turns to subscription drinks service to aid recovery ||| Better Buy: McDonald's vs. Coca-Cola ||| A Tale of 3 Dow Jones Stocks; 2 to Buy and 1 to Avoid ||| UK's Costa Coffee may cut 1,650 jobs as virus-hit forces restructuring",1,0.5051055
2020-09-04,21019500.0,50.93999862670898,51.470001220703125,50.27999877929688,51.040000915527344,45.854793548583984,KO,Twilio Will Likely Dip to $225 Before Reaching $300 ||| 3 Top Stocks to Buy in September,0,0.4876309
2020-09-08,17776700.0,50.93000030517578,51.040000915527344,49.36000061035156,49.810001373291016,44.74975204467773,KO,"3 Dividend Stocks That Pay You More Than Pepsi Does ||| No, Kim Kardashian's Stock Portfolio Isn't Better Than Warren Buffett's ||| Coca-Cola Presents Fresh Opportunity for Dividend Investors ||| 2 Top Robinhood Stocks Backed by Warren Buffett ||| 3 Top Food Stocks to Buy in September",1,0.5016549
2020-09-10,15439500.0,50.34999847412109,50.68000030517578,49.95000076293945,50.0,44.92045211791992,KO,The Coca-Cola To Participate In Barclays Global Consumer Staples Conference At 10:00 AM ET ||| Better Buy: Beyond Meat vs. Coca Cola,1,0.5354166
2020-09-14,10911700.0,50.970001220703125,51.22999954223633,50.56999969482422,50.709999084472656,45.927093505859375,KO,"Coca-Cola: The Bulls Will Outrun the Bears in the Long Run, Says Analyst",1,0.5327839
2020-09-17,13287100.0,50.220001220703125,50.630001068115234,49.93999862670898,50.54999923706055,45.78219223022461,KO,"Senator Warren blasts U.S. CEOs for 'empty' social promises ||| 6 Dividend Stocks To Buy For Stable Yield And Growth Potential ||| Will the Real PepsiCo Please Identify Itself? ||| FOCUS-Coca-Cola bottlers are feeling flat, even as U.S. grocery sales sparkle ||| 422 Stocks to Supplement Your Social Security Income",0,0.51241356
2020-09-18,23816600.0,50.75,51.15999984741211,50.209999084472656,50.45000076293945,45.69162368774414,KO,Lowe's Initiative for Small Businesses ||| Coca-Cola Stock Recovers Almost 40% But More Gains Are On The Way,0,0.509335
2020-09-21,17514800.0,49.75,50.02000045776367,48.61000061035156,49.09000015258789,44.459903717041016,KO,Beyond Meat Stock Is Serving up Tasty Upside Potential ||| Has The Rally Ended For PepsiCo Near $135?,1,0.50202686
2020-09-22,13034600.0,49.11000061035156,50.040000915527344,49.06999969482422,49.65999984741211,44.97614288330078,KO,Coca-Cola Is Poised for a 2021 Hard Seltzer Launch ||| Warren Buffett's Top 4 Dividend Stocks ||| 10 Stocks For Beginners To Buy Today For Profits Tomorrow,0,0.49904406
2020-09-23,17121200.0,49.72999954223633,49.91999816894531,48.16999816894531,48.209999084472656,43.662899017333984,KO,"After Hours Most Active for Sep 23, 2020 : SPI, KGC, AAPL, QQQ, TSLA, BAC, KO, MGP, GSX, SIRI, SQQQ, T ||| Keurig Dr Pepper To Rise 15%",1,0.5222354
2020-09-24,16788100.0,48.209999084472656,49.09999847412109,47.560001373291016,48.70000076293945,44.10668182373047,KO,Don't Go through a Second Market Crash Without This Stock in Your IRA ||| Better Buy: Verizon Communications vs. Coca-Cola,1,0.50231844
2020-09-25,12603400.0,48.20000076293945,48.7599983215332,47.97999954223633,48.720001220703125,44.12480545043945,KO,"7 Debt-Free Stocks to Buy For Peace of Mind In Volatile Markets ||| PepsiCo Earnings: What to Watch ||| Social media deal earns advertisers' 'likes', but not yet all their dollars",1,0.51047254
2020-09-28,11215700.0,49.310001373291016,49.709999084472656,49.13999938964844,49.27999877929688,44.631980895996094,KO,"We Ask Successful Investors: If You Could Only Own 3 Stocks, What Would They Be? ||| Forget Coca-Cola, Home Depot Is a Better Dividend Stock ||| 3 Top Stocks for Retirees ||| PepsiCo Wins Exclusive Canadian Distributorship for Evian Spring Water ||| 3 Stocks Warren Buffett Would Love ||| 3 Things to Watch in the Stock Market This Week",0,0.4995391
2020-09-29,12426600.0,49.38999938964844,49.560001373291016,48.90999984741211,48.91999816894531,44.30593490600586,KO,"Molson Coors Signs Deal With Coca-Cola To Distribute Topo Chico Hard Seltzer In U.S. ||| Molson Coors to launch Coca-Cola's first alcoholic beverage in the U.S. ||| After Hours Most Active for Sep 29, 2020 : MU, VICI, AAPL, JFIN, QQQ, SABR, BAC, KO, WMT, EQNR, VSLR, VIAC",1,0.48484018
2020-09-30,15755900.0,49.27000045776367,49.619998931884766,48.88999938964844,49.369998931884766,44.7134895324707,KO,Can Coca-Cola With Coffee Save the Fading Pop Star?,0,0.5273604
2020-10-05,10628700.0,49.43000030517578,49.54999923706055,49.119998931884766,49.380001068115234,44.7225456237793,KO,Worried About Another Market Crash? Buy These Stocks. ||| Could a Cannabis Investment Be on Coke's Radar? ||| A Costco Deep Dive ||| The Case for a Bullish October,0,0.46863335
2020-10-06,10077400.0,49.54999923706055,49.72999954223633,48.83000183105469,48.93999862670898,44.32404327392578,KO,Warren Buffett Doubles His Money on These Stocks Every 2 to 5 Years,1,0.50033224
2020-10-07,10135600.0,49.02000045776367,49.7599983215332,48.95000076293945,49.560001373291016,44.88556671142578,KO,"5 Tips for Making Money in Penny Stocks ||| Sachem Head takes $1.2 bln position in Elanco, stock price surges ||| Forget Coca-Cola, Starbucks Is a Better Dividend Stock ||| 5 Blue-chip Stocks to Buy on a Discount to Fortify Portfolios",1,0.50715387
2020-10-08,12143900.0,49.709999084472656,50.540000915527344,49.540000915527344,50.459999084472656,45.700679779052734,KO,Why Companies Are Increasingly Going Public Without an IPO ||| Pepsi Has a Shot at Another Big Sales Year,1,0.52891797
2020-10-09,11407800.0,50.66999816894531,51.22999954223633,50.59999847412109,50.810001373291016,46.017669677734375,KO,PepsiCo Will Quench Your Thirst: Stock To Hit $150,1,0.50554544
2020-10-12,11386500.0,50.84000015258789,51.52999877929688,50.83000183105469,51.09000015258789,46.27125549316406,KO,How to Find the Best Dividend Stocks ||| Where Will Facebook Be in 5 Years? ||| This Billionaire Investor Was Supposed to Save Aurora Cannabis. What Happened? ||| Wow! Buffett Has 78% of His Portfolio in These 5 Stocks ||| Coca-Cola Stock Outlook: Correction Followed By Rewards,0,0.47611785
2020-10-13,14365300.0,50.9900016784668,50.9900016784668,49.900001525878906,50.220001220703125,45.48332214355469,KO,"Investor Ubben warns more stocks vulnerable to social, environmental selling ||| Investor Ubben warns more stocks vulnerable to social, environmental selling ||| Despite Its Huge Run-Up, Hyliion Stock is Still a Long-Term Buy ||| 4 Reasons Warren Buffett Can't Stomach Bitcoin ||| These 15 Stocks Have Paid a Dividend for 125 (or More) Consecutive Years",0,0.46451885
2020-10-14,10582100.0,50.04999923706055,50.4900016784668,49.650001525878906,50.119998931884766,45.39274978637695,KO,"Rule Breaker Investing Over 15 Years ||| Moscow Exchange bets on retail investors, more listings ||| Moscow Exchange bets on retail investors, more listings",0,0.5094035
2020-10-15,9961700.0,49.400001525878906,50.130001068115234,49.29999923706055,49.9900016784668,45.27500915527344,KO,"3 Stocks I'll Hold Forever ||| Celsius Holdings Stock Is Up 600% In 7 Months, But The Rally Is Not Yet Over",1,0.49485147
2020-10-16,13569800.0,49.9900016784668,50.34999847412109,49.869998931884766,50.02999877929688,45.31122589111328,KO,Is Home Depot a Great Dividend Stock?,0,0.50599396
2020-10-19,9930400.0,50.02999877929688,50.47999954223633,49.459999084472656,49.619998931884766,44.93991088867188,KO,"Berkshire Hathaway Shows Resilience in the Corona Economy ||| 2 Stocks to Supplement Your Social Security Income ||| Coca-Cola Retiring Storied Tab, Other Products in Brand Cull ||| Coca-Cola Earnings: 3 Things to Watch",1,0.5117913
2020-10-20,10970700.0,49.88999938964844,50.619998931884766,49.790000915527344,50.25,45.5104866027832,KO,4 of the Safest Robinhood Stocks Investors Can Buy,0,0.532578
2020-10-21,12517400.0,49.959999084472656,50.43000030517578,49.77000045776367,49.9900016784668,45.27500915527344,KO,"3 Ways Dividend Aristocrats Can Enrich Your Retirement ||| Pre-Market Earnings Report for October 22, 2020 : KO, T, DHR, UNP, NOC, KMB, AEP, DOW, FCX, SIRI, LUV, WST ||| Better Buy: Disney vs. Coca-Cola ||| Berkshire Hathaway Stock Is Telling Investors Exactly What Buffett Wants ||| 3 Reasons to Invest in Dividend-Paying Stocks for Retirement",1,0.5011179
2020-10-22,20189200.0,51.16999816894531,51.20000076293945,50.380001068115234,50.68000030517578,45.89993667602539,KO,"BUZZ-U.S. STOCKS ON THE MOVE-MaxLinear Inc, Tesla, Moderna, AT&T ||| Coca-Cola Results Show a Tale of 2 Businesses ||| US STOCKS-Wall St dips in choppy trade as investors look for stimulus ||| US STOCKS-Futures slip ahead of jobless claims report ||| US STOCKS-Wall Street closes higher on U.S. fiscal stimulus bets ||| US STOCKS-Wall Street closes higher, trade choppy as U.S. stimulus talks eyed ||| Starbucks Is the New Coca-Cola of Consumer Stocks ||| US STOCKS-Wall Street rises as hopes rise for U.S. fiscal stimulus ||| US STOCKS-Wall St drops in choppy trade as investors look for stimulus ||| Here’s Why Proctor & Gamble Stock Analysts Yawned Over Its Big Q3 Beat ||| Coca-Cola revenue beats expectations as consumers venture out ||| BUZZ-U.S. STOCKS ON THE MOVE-Tesla, AT&T Inc, Helix Energy Solutions ||| The Coca-Cola Q3 20 Earnings Conference Call At 8:30 AM ET ||| BUZZ-U.S. STOCKS ON THE MOVE- Tesla, Align Technology Inc, Aptinyx ||| BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Moderna, Align Technology, Ideanomics Inc ||| The Coca-Cola Company Q3 adjusted earnings Beat Estimates ||| Coca-Cola Company Q3 Profit Beats Estimates; Organic Revenues Down 6% ||| US STOCKS-Futures slip as labor market recovery slows ||| Coca-Cola revenue beats as beverage demand rises from pandemic lows",0,0.48401758
2020-10-23,13491300.0,51.0,51.18000030517578,50.470001220703125,50.52000045776367,45.7550163269043,KO,"4 Top Stock Trades for Friday: TSLA, T, KO, LRCX ||| Moscow Exchange to expand number of foreign shares on offer to 40",0,0.54033697
2020-10-26,14696400.0,50.34000015258789,50.5099983215332,49.20000076293945,49.79999923706055,45.10293197631836,KO,3 Reasons You Shouldn't Invest Like Warren Buffett ||| Coca-Cola's European partner makes $6.6 bln play for Australia bottler ||| 10 Robinhood Stocks to Buy From the Top 100 ||| Coca-Cola Loses Ground to PepsiCo in Q3 ||| A Berkshire Hathaway Investment Manager Bought Dillard's Stock -- Why?,1,0.5420357
2020-10-27,13892100.0,49.810001373291016,50.290000915527344,49.54999923706055,49.900001525878906,45.19349670410156,KO,"After a Rough Year, Things Are Looking up for Coca-Cola Stock ||| Coca-Cola (KO) Q3 2020 Earnings Call Transcript ||| Warren Buffett's 11 Longest-Held Stocks ||| Coca-Cola Agrees to Sell Stake in Australian Bottler for $1.6 Billion as Part of Wider Buyout Deal",0,0.48174858
2020-10-28,19886200.0,49.0,49.150001525878906,47.77999877929688,47.959999084472656,43.43647003173828,KO,Coca-Cola Asks Investors to Stay Tuned,1,0.54080725
2020-10-29,15369900.0,47.72999954223633,48.47999954223633,47.29999923706055,48.02000045776367,43.490821838378906,KO,"After Hours Most Active for Oct 29, 2020 : ADAP, TWTR, QQQ, AAPL, ACWI, INTC, FB, TME, KO, WFC, ATUS, NIO ||| Facebook quarterly revenue beats estimates ||| American Express to invest $1 bln in diversity push ||| American Express to invest $1 bln in diversity push",1,0.5071069
2020-10-30,15804000.0,47.810001373291016,48.119998931884766,47.369998931884766,48.060001373291016,43.52705001831055,KO,3 Dividend Stocks That Pay You Better Than Coca-Cola Does ||| Coca-Cola: Helping the Environment by Using Plastic,1,0.52296096
2020-11-02,15156100.0,48.75,48.95000076293945,48.2400016784668,48.619998931884766,44.03422164916992,KO,"After Hours Most Active for Nov 2, 2020 : PINS, AAPL, KO, IQ, AMD, INTC, AIV, PPD, MSFT, TME, GE, NLY ||| Invest ‘Foundationally’ in Cannabis With Good Earth Organics ||| 5 Ways the Federal Government Is Harming the Cannabis Industry ||| 3 Dividend Stocks to Supplement Your Social Security",1,0.5031354
2020-11-03,15285100.0,49.220001220703125,49.959999084472656,49.0,49.34999847412109,44.69536972045898,KO,"After Hours Most Active for Nov 3, 2020 : QQQ, AAPL, SQQQ, NIO, INTC, AAL, TME, IQ, FHN, BMY, KO, GE ||| Get Paid While You Wait: 3 Top Dividend Stocks in the Food Industry ||| 3 Growth Stocks to Buy and Hold for the Next 50 Years",0,0.4993201
2020-11-05,12452400.0,49.7599983215332,50.209999084472656,49.34000015258789,49.43999862670898,44.7768783569336,KO,Can Impossible Foods Win the Cook-Off Against Beyond Meat?,1,0.52447844
2020-11-06,9294900.0,49.650001525878906,49.9900016784668,49.25,49.45000076293945,44.78594970703125,KO,"If You Invested $10,000 After Chipotle's IPO, This Is How Much Money You'd Have Now ||| Noteworthy ETF Inflows: QUAL, KO, MA, ITW",1,0.5084604
2020-11-09,33442000.0,52.5,53.2599983215332,52.06999969482422,52.56999969482422,47.61166763305664,KO,"Why Coca-Cola, Chefs' Warehouse, and Middleby Stocks All Popped on Today's Vaccine News",1,0.5012334
2020-11-10,29706700.0,52.56999969482422,54.27999877929688,52.45000076293945,53.97999954223633,48.88867568969727,KO,"After Hours Most Active for Nov 10, 2020 : TME, KGC, KO, F, CSCO, AAPL, QQQ, LUMN, BMRG, CMCSA, INTC, TCDA ||| 7 Dividend Stocks To Buy For Post-Election Volatility",0,0.479428
2020-11-11,17399900.0,53.93000030517578,54.29999923706055,53.33000183105469,53.58000183105469,48.526405334472656,KO,"Why Wayfair Stock Is Up ||| After Hours Most Active for Nov 11, 2020 : T, FCX, QQQ, ATUS, LYFT, INTC, KO, DISCA, MRO, AAL, XOM, KHC ||| Wednesday's ETF with Unusual Volume: KXI ||| For Market-Beating Investments, Look at Brand Value",0,0.45541778
2020-11-13,12447900.0,53.25,53.5,52.88999938964844,53.45000076293945,48.40866470336914,KO,3 Dividend Stocks That Pay You Better Than Coca-Cola Does,1,0.49852118
2020-11-16,14908200.0,54.5,54.619998931884766,53.27999877929688,53.84999847412109,48.77094268798828,KO,"Here's How to Boost Your Retirement Income With Zero Effort ||| After Hours Most Active for Nov 16, 2020 : V, MRO, COTY, ZNGA, BKD, SABR, KDP, MSFT, EGHT, KO, INTC, FB",0,0.48523864
2020-11-17,14248400.0,53.65999984741211,53.75,53.02999877929688,53.68000030517578,48.61697769165039,KO,3 Dividend Aristocrats That Could Make You Rich,0,0.5379951
2020-11-19,17189500.0,52.4900016784668,53.22999954223633,51.95000076293945,53.130001068115234,48.11885833740234,KO,Dow Jones Struggles as Coca-Cola Loses Tax Case; Walmart Stock Lifted After Target Earnings,0,0.49398613
2020-11-23,13191900.0,52.95000076293945,53.16999816894531,52.20000076293945,52.68000030517578,47.71129608154297,KO,Better Buy: General Electric vs. Coca-Cola ||| Better Buy: Starbucks vs. PepsiCo ||| Extent of Beyond Meat's Role in McDonald's McPlant Burger Questioned ||| Why Stocks of These Niche Electric Vehicle Players Are Soaring Today,1,0.51829267
2020-11-24,13827600.0,53.13999938964844,53.59000015258789,53.02000045776367,53.220001220703125,48.20036315917969,KO,"Notable ETF Inflow Detected - ITOT, TSLA, MA, KO",0,0.4948101
2020-11-25,10194800.0,53.06999969482422,53.27999877929688,52.790000915527344,52.93000030517578,47.93771362304688,KO,"Coca-Cola Moves Ahead With Big Strategic Reset ||| Vaccine or Not, Wall Street is Making a Big Mistake by Selling This Stock",0,0.4946275
2020-11-27,8499300.0,53.11000061035156,53.18999862670898,52.61000061035156,52.70000076293945,47.72940826416016,KO,"UK's Britvic posts income slump as virus curbs dent demand ||| Ex-Dividend Reminder: Cooper Tire & Rubber, Coca-Cola and La-Z-Boy ||| 17 Monthly Dividends That Pay $3,125 Per Month ||| 3 Stocks You Can Keep Forever ||| Is The Market Undervaluing PepsiCo Stock vs. Coca-Cola?",0,0.48652807
2020-11-30,43203600.0,52.09000015258789,52.18999862670898,51.08000183105469,51.59999847412109,47.099586486816406,KO,Investing in These 3 Stocks Now Could Make You a Millionaire Retiree,1,0.5278366
2020-12-02,14913100.0,51.900001525878906,52.130001068115234,51.63999938964844,52.11000061035156,47.56510162353516,KO,"XLP, KO, MDLZ, MO: Large Outflows Detected at ETF",1,0.52824044
2020-12-04,18122400.0,52.77999877929688,53.869998931884766,52.7599983215332,53.84999847412109,49.15334701538086,KO,Could Coca-Cola Be a Millionaire Maker Stock?,0,0.53348327
2020-12-07,16210900.0,53.7599983215332,53.77999877929688,52.70000076293945,52.9900016784668,48.36835479736328,KO,"3 Dividend Stocks That Pay You Better Than Coca-Cola Does ||| 6 Reasons Warren Buffett Is Such a Successful Investor ||| A $120 Investment in Coca-Cola's IPO Would Be Worth This Much Money Now ||| Forget Tesla, These 3 Stocks Are Better Buys Right Now ||| After Hours Most Active for Dec 7, 2020 : AAPL, BSX, KODK, T, PLTR, QQQ, WORK, MSFT, KO, INTC, SFIX, LI ||| India's Coffee Day gets new CEO a year after founder's death in apparent suicide",1,0.4788837
2020-12-08,12485800.0,52.93999862670898,53.47999954223633,52.790000915527344,53.18000030517578,48.541786193847656,KO,"As U.S. companies push to get workers vaccinated, states disagree on who's essential ||| As U.S. companies push to get workers vaccinated, states disagree on who's essential ||| 4 Dividend Investing Tips That Could Earn You Thousands",1,0.5226856
2020-12-09,11508400.0,53.369998931884766,53.59999847412109,53.0,53.33000183105469,48.678707122802734,KO,"3 Steps to 1,000% Returns, 6.6% Yields via Blue-Chip Stocks ||| INSIGHT-Ethiopia's war risks leaving manufacturing dreams in tatters",0,0.53096914
2020-12-10,12097300.0,53.400001525878906,53.5099983215332,52.97999954223633,53.04999923706055,48.42312240600586,KO,3 Popular Robinhood Stocks Dividend Investors Will Love,1,0.5588573
2020-12-11,10638100.0,52.79999923706055,53.540000915527344,52.77999877929688,53.34999847412109,48.69695281982422,KO,"Dow Movers: GS, DIS",0,0.52033365
2020-12-14,22292000.0,53.650001525878906,53.84000015258789,53.18000030517578,53.27000045776367,48.62393569946289,KO,This Is Jeff Bezos's Most Important Investing Lesson ||| Looking For The Top Consumer Stocks To Watch This Week? 1 Up More Than 400% Since April ||| 8 Retirement Stocks You Can Rely On,1,0.5152796
2020-12-15,16193700.0,53.790000915527344,54.220001220703125,53.59999847412109,53.84000015258789,49.14421844482422,KO,Love Dividends? Here Are 3 Stocks You Might Want to Buy ||| Can Coca-Cola Stock See Full Recovery To Pre-Covid Levels?,0,0.48412663
2020-12-16,15679600.0,53.59999847412109,53.79999923706055,52.93999862670898,53.060001373291016,48.4322509765625,KO,The Best Investors Did This 1 Thing in 2020,1,0.52914506
2020-12-17,12677300.0,53.29999923706055,53.709999084472656,53.150001525878906,53.27000045776367,48.62393569946289,KO,"Coca-Cola To Cut 2,200 Jobs Worldwide : Reports ||| Coca-Cola to cut 2,200 jobs globally, including 1,200 in U.S. ||| Coca-Cola to cut 2,200 jobs- WSJ ||| 7 Long-Term Stocks for Buffett-Like Investors",1,0.49444634
2020-12-18,35480100.0,53.08000183105469,53.84000015258789,52.619998931884766,53.7400016784668,49.05294036865234,KO,"Coca-Cola to Cut Around 2,200 Jobs ||| The 3 Best Warren Buffett Dividend Stocks to Buy Right Now ||| Uzbekistan invites bids for its stake in joint venture with Coca-Cola",0,0.5106497
2020-12-21,14926600.0,52.68000030517578,53.0,51.97999954223633,52.810001373291016,48.20405578613281,KO,"2 Stocks to Bankroll Your Retirement ||| Noteworthy ETF Outflows: QUAL, KO, NKE, HON ||| Dow Movers: INTC, NKE ||| 4 Keys to Sifting Stock Market News for Better Returns",0,0.48884332
2020-12-22,9689500.0,52.810001373291016,53.18000030517578,52.38999938964844,52.7599983215332,48.15841674804688,KO,4 Dividend Stocks to Help You Prepare for Retirement,1,0.5233834
2020-12-23,7040300.0,52.95000076293945,53.38999938964844,52.93999862670898,53.08000183105469,48.45050048828125,KO,Dow Analyst Moves: KO ||| 3 Fintech Stocks You Can Buy and Hold for the Next Decade ||| 5 Reasons to Invest in Dividend-Paying Stocks for Retirement,1,0.5040556
2020-12-28,9020500.0,53.84999847412109,54.43999862670898,53.72999954223633,54.15999984741211,49.43631362915039,KO,Introduce Investing to Teenagers With This Perfect Stock Sampler ||| 3 Dividend Stocks That Pay You More Than Pepsi Does,0,0.5023661
2020-12-29,8320600.0,54.45000076293945,54.4900016784668,54.02000045776367,54.130001068115234,49.408935546875,KO,"Noteworthy ETF Outflows: QUAL, KO, NKE, BKNG",1,0.5164624
2020-12-31,8495000.0,54.45000076293945,54.93000030517578,54.27000045776367,54.84000015258789,50.05700302124024,KO,How to Find the Best Dividend Stocks,0,0.5052828
2021-01-04,25611100.0,54.27000045776367,54.630001068115234,52.02999877929688,52.7599983215332,48.15841674804688,KO,"Got $3,000? Here Are 3 Stocks to Buy and Hold for the Long Term ||| 2 Top Consumer Staples Stocks to Buy In January ||| Bitcoin Bets Merited in 2021 Because Crypto Is Here to Stay ||| Why Coca-Cola Stock Got Crushed Today ||| Dow Jones Tumbles to Start 2021; Apple Called Top FAANG Stock; Coca-Cola Stock Downgraded",0,0.47146013
2021-01-05,20323800.0,52.33000183105469,52.619998931884766,52.02999877929688,52.18000030517578,47.62901306152344,KO,"Why Can't Aurora Cannabis Land a Deal? ||| Meet the 2021 Dogs of the Dow ||| Dow Movers: MRK, BA",0,0.48803058
2021-01-06,38724500.0,51.970001220703125,52.02000045776367,50.18999862670898,50.52000045776367,46.11377716064453,KO,"Dow Jones Rockets 500 Points After Georgia Elections; Financial Stocks Surge; Coca-Cola Stock Sinks ||| Dow Movers: KO, CAT ||| 3 Best Consumer Staples Stocks to Buy Now",0,0.47857764
2021-01-07,53225700.0,50.09000015258789,50.2599983215332,49.52000045776367,49.959999084472656,45.60262680053711,KO,"Dow Jones Soars Despite Riots; Walgreens Stock Surges on Strong Earnings; Coca-Cola Downgraded Again ||| The Dogs of the Dow Didn't Hunt in 2020, and 2021 Isn't Looking Much Better ||| Dow Movers: MMM, WBA ||| 3 Dividend Stocks That Pay You Better Than Coca-Cola Does",1,0.48642245
2021-01-08,29674000.0,50.02999877929688,51.130001068115234,49.84000015258789,51.08000183105469,46.624942779541016,KO,The Best Consumer Goods Stocks to Buy in 2021 ||| 3 Surefire Stocks to Buy If the Market Crashes,0,0.48569494
2021-01-11,19304400.0,50.619998931884766,50.86000061035156,49.95000076293945,50.20000076293945,45.82169723510742,KO,"9 Dow Stocks With the Most Upside Potential, According to Wall Street ||| Monday's ETF with Unusual Volume: HUSV ||| 3 Dividend Stocks to Supplement Your Social Security",0,0.50732434
2021-01-12,18538700.0,50.040000915527344,50.369998931884766,49.7599983215332,50.11000061035156,45.739540100097656,KO,7 Blue-Chip Stocks For A Steady-Eddie 2021,1,0.51689094
2021-01-13,18864100.0,49.97999954223633,50.36000061035156,49.95000076293945,50.15999984741211,45.78518295288086,KO,7 Dividend Stocks That Are Growing Their Payouts ||| Coca-Cola Stock Drops 7% In A Week – Patient Investors Will Benefit,0,0.50444424
2021-01-14,34303600.0,50.15999984741211,50.18000030517578,49.220001220703125,49.22999954223633,44.93629455566406,KO,"After Hours Most Active for Jan 14, 2021 : GE, WFC, KO, T, C, WMB ||| Consumer Sector Update for 01/14/2021: POSH,EXPR,PFSW,KO,MNST ||| Consumer Sector Update for 01/14/2021: KO,EXPR,PFSW ||| Better Buy: Beyond Meat vs. Coca-Cola",0,0.42145035
2021-01-15,24366800.0,49.15999984741211,49.18000030517578,48.52999877929688,48.70000076293945,44.452518463134766,KO,"Top Energy and Industrials Stocks for 2021 ||| Notable ETF Inflow Detected - IWV, TMO, KO, ABBV",0,0.4963943
2021-01-19,29114500.0,48.7400016784668,49.040000915527344,48.2400016784668,48.5099983215332,44.27908706665039,KO,"4 Stocks That Turned $10,000 Into $1.6 Million (or More) in the 21st Century ||| As Penny Stocks Make Massive Waves in the Market, Is Now the Time to Buy? ||| 3 Terrible Reasons To Sell Facebook Stock ||| 3 Investments That Could Drain Your Money, and Where to Invest Instead ||| 3 Stocks I'm Never Selling ||| 7 Stocks To Buy For Less-Stress Retirement Investments",1,0.49094853
2021-01-21,19702500.0,48.77999877929688,49.09000015258789,48.459999084472656,48.95000076293945,44.68070983886719,KO,3 Dividend Stocks That Pay You More Than PepsiCo Does ||| Here's How Much Dividend Income Warren Buffett Will Receive in 2021,0,0.49130052
2021-01-25,16604200.0,48.41999816894531,48.84000015258789,48.2400016784668,48.77999877929688,44.52553939819336,KO,"Rule Breaker Investing: 5 Stocks Rolled Up at Random ||| Notable ETF Inflow Detected - VT, NFLX, KO, T ||| 5 Biden-Friendly Warren Buffett Stocks to Load Up On ||| 3 Stocks for Beginning Investors",1,0.49545154
2021-01-26,12922600.0,48.90999984741211,49.400001525878906,48.61000061035156,49.290000915527344,44.99106597900391,KO,5 Great Retirement Stocks to Buy for Your Portfolio ||| Anheuser-Busch Punts on Budweiser Super Bowl Ads for First Time in 37 Years ||| Does Yeti Holdings Have Staying Power? ||| Warren Buffett's 3 Biggest Stock Picks for 2021,0,0.50237286
2021-01-27,21242400.0,48.88999938964844,49.31999969482422,48.22999954223633,48.52999877929688,44.29734802246094,KO,What's Happening With Netflix?,1,0.5113934
2021-01-28,17498900.0,48.68999862670898,49.5,48.61000061035156,49.150001525878906,44.8632698059082,KO,Here's Why Amazon Will Never Be a Dow Jones Industrials Stock,0,0.49108332
2021-01-29,18670300.0,49.02999877929688,49.119998931884766,48.11000061035156,48.150001525878906,43.95048904418945,KO,3 Dividend Stocks You Can Safely Hold for Decades ||| New to the Stock Market? 3 Investments You Can't Go Wrong With ||| Facebook to develop tools for advertisers to tackle harmful content,1,0.49871358
2021-02-01,12183600.0,48.27000045776367,48.68999862670898,48.18000030517578,48.47999954223633,44.25170516967773,KO,Don’t Overlook These 3 Dividend Kings ||| 7 Blue Chip Stocks to Help Prepare For Your Retirement ||| Is It Time to Buy the Dow Jones' 3 Worst-Performing January Stocks? ||| XL Stock Is Positioned Well to Climb Higher,1,0.49939582
2021-02-02,13319800.0,48.79999923706055,49.34999847412109,48.630001068115234,48.959999084472656,44.68984222412109,KO,"Even Before WallStreetBets, Shorting GameStop Didn't Make Sense",0,0.4751534
2021-02-03,12274100.0,48.95000076293945,49.09000015258789,48.66999816894531,48.77000045776367,44.516414642333984,KO,"ESGU, KO, MMM, LOW: ETF Inflow Alert ||| Why Coca-Cola Stock Lost 12% in January ||| What Kept Keurig Dr Pepper Stock Largely Immune From The Covid-19 Crisis?",1,0.5031238
2021-02-04,20597400.0,48.959999084472656,49.06999969482422,48.650001525878906,49.0099983215332,44.7354736328125,KO,"Laugh, but not too hard: New Super Bowl advertisers keep it light in pandemic ||| Laugh, but not too hard: New Super Bowl advertisers keep it light in pandemic",1,0.49094307
2021-02-05,12742000.0,49.5,49.77999877929688,49.27000045776367,49.650001525878906,45.31966400146485,KO,Coca-Cola's South African bottler to increase black ownership stake to 20% ||| PepsiCo Earnings: The Trends to Watch,1,0.5254999
2021-02-08,17833200.0,49.959999084472656,50.16999816894531,49.4900016784668,49.91999816894531,45.56610870361328,KO,Coca-Cola Earnings: What to Watch ||| 3 Dividend Stocks That Pay You More Than Pepsi Does ||| Worried About a 2021 Stock Market Crash? These 3 Stocks Have Staying Power ||| Better Buy: Nike vs. Coca Cola,0,0.508684
2021-02-09,14592900.0,49.84999847412109,50.02000045776367,49.630001068115234,49.70000076293945,45.36530303955078,KO,"Pre-Market Earnings Report for February 10, 2021 : KO, GM, CME, IQV, CDW, TEVA, IPG, BG, ARCC, EEFT, CCJ, PAG ||| Coca-Cola Just Launched 100% Recycled Plastic Bottles in North America ||| Coca-Cola turns to 100% recycled plastic bottles in U.S. ||| Coca-Cola Unveils Bottles Made From 100% Recycled Materials In U.S.",0,0.51298153
2021-02-10,22965400.0,50.40999984741211,50.58000183105469,49.52999877929688,49.59999847412109,45.27402114868164,KO,"4 Top Stock Trades for Thursday: APHA, AYRO, KO, RIDE ||| Coca-Cola (KO) Q4 2020 Earnings Call Transcript ||| Why Coca-Cola's (KO) Earnings Have Significance Far Beyond Coca-Cola ||| Consumer Sector Update for 02/10/2021: KO, BG, UA, XLP, XLY ||| Coca-Cola Q4 Profit Tops Estimates, Organic Revenue Down 3%; Reinstates Guidance ||| The Coca-Cola Company Q4 adjusted earnings Beat Estimates ||| The Coca-Cola Q4 20 Earnings Conference Call At 8:30 AM ET",1,0.5144187
2021-02-11,21928600.0,49.810001373291016,50.59000015258789,49.79999923706055,50.29999923706055,45.912967681884766,KO,"Noteworthy ETF Inflows: SPLG, BRK.B, TMO, KO ||| Better Buy: Starbucks vs. Keurig Dr Pepper ||| PepsiCo expects revenue to grow in 2021 as vaccines take effect",1,0.54870594
2021-02-12,13137100.0,50.56999969482422,50.84999847412109,50.38999938964844,50.68999862670898,46.26895523071289,KO,"In the Vast World of SPACs, XL Stock Could Be a Real Winner ||| The Stock Market's Laggards Will Bounce Back -- but When? ||| Hyliion’s New Battery Will Shake HYLN Stock From Its Bearish Slumber",0,0.48034665
2021-02-16,15093400.0,50.619998931884766,50.720001220703125,50.15999984741211,50.27000045776367,45.88558578491211,KO,"3 High-Yield Dividend Investing Tips That Could Earn You Thousands ||| Coca-Cola's European bottler sweetens $7.70 bln offer for Coca-Cola Amatil ||| 3 Reasons to Invest in Dividend-Paying Stocks for Retirement ||| Groceries, gowns and Coca-Cola: Jason Wu sets up shop at New York Fashion Week ||| Canopy Growth Still Holds the Same Potential ||| Can Coca-Cola Grow Again in 2021?",0,0.5505197
2021-02-17,12794300.0,50.0,50.4900016784668,49.88999938964844,50.130001068115234,45.7578010559082,KO,Coca-Cola Avoids an Earnings K.O. ||| 3 Big Questions PepsiCo Just Answered for Investors ||| PepsiCo Is Done Buying Back Its Stock ||| Coca-Cola Stock Undervalued At $50?,1,0.4984902
2021-02-18,12747100.0,50.15999984741211,50.84999847412109,50.02999877929688,50.77000045776367,46.34197998046875,KO,3 Dividend Stocks That Pay You Better Than Coca-Cola Does,0,0.49852118
2021-02-19,15968800.0,50.790000915527344,50.83000183105469,49.970001220703125,50.11000061035156,45.739540100097656,KO,"Coca-Cola Boosts Quarterly Dividend By 2.4%; Street Sees 12% Upside ||| Coca-Cola Looks to Take Control of Popular Sports Drink Company BodyArmor ||| ESGV, PG, CMCSA, KO: Large Inflows Detected at ETF",1,0.52244973
2021-02-22,14370900.0,49.84999847412109,50.880001068115234,49.66999816894531,50.630001068115234,46.21418762207031,KO,"A Look at GoodRx, Inari, and Amwell ||| 3 Dividend Stocks That Should Pay You the Rest of Your Life ||| Which of These Long-Held Warren Buffett Stocks Are on Their Way Out? ||| Foolish Stories With The Motley Fool's David Gardner ||| If the Market Crashes, I'll Be Glad I Own This Stock",0,0.47985914
2021-02-23,16222300.0,51.0,51.5099983215332,50.41999816894531,50.540000915527344,46.13204574584961,KO,CuriosityStream: What Investors Need to Know ||| 3 Top Stocks for Retirees,1,0.501074
2021-02-24,14442000.0,50.38999938964844,50.900001525878906,50.130001068115234,50.709999084472656,46.28720474243164,KO,What Investors Should Take Away From Coca-Cola's Q4 Report,0,0.52397245
2021-02-25,14211100.0,50.470001220703125,50.75,49.97999954223633,50.16999816894531,45.79430389404297,KO,5 Surefire Stocks If the Market Crashes ||| 3 Warren Buffett Stocks to Buy Right Now and Hold for a Decade ||| 3 Blue-Chip Stocks to Buy for Maximum Dividend Safety,0,0.5051869
2021-02-26,23638400.0,50.20000076293945,50.209999084472656,48.970001220703125,48.9900016784668,44.71721649169922,KO,"Tim Hortons China raises fresh cash, plans to add 200 shops in 2021",1,0.52463555
2021-03-01,13901200.0,49.43999862670898,50.43999862670898,49.400001525878906,49.900001525878906,45.54785537719727,KO,7 Safe Stocks You Can Hold Onto Forever ||| 3 Food and Beverage Stocks Likely to Grow in 2021,1,0.5082415
2021-03-02,11755100.0,49.84000015258789,50.560001373291016,49.70000076293945,50.09999847412109,45.73041534423828,KO,2 Buffett Stocks That Are Backed by Reasonable Catalysts ||| iShares MSCI ACWI ETF Experiences Big Inflow,0,0.4887477
2021-03-03,15410700.0,49.720001220703125,50.560001373291016,49.709999084472656,49.97999954223633,45.620880126953125,KO,"Got $3,000? Here Are 3 Stocks to Buy and Hold for the Long Term",0,0.47137612
2021-03-10,21331600.0,51.18000030517578,51.630001068115234,50.720001220703125,51.43999862670898,46.95354080200195,KO,"Dow Analyst Moves: KO ||| QUAL, KO, BKNG, JNJ: Large Outflows Detected at ETF ||| Dow Movers: UNH, WBA ||| Ex-Dividend Reminder: Coca-Cola, Garmin and Service Corp. International ||| Investors: Warren Buffett Warns This Asset Class Is a No-No ||| Forget Dividend Kings: This Is the Best Income Stock for Your Portfolio ||| How to Boost Your Retirement Income When Social Security Only Covers 40%",0,0.49030215
2021-03-11,17417700.0,51.40999984741211,51.43000030517578,50.810001373291016,50.880001068115234,46.4423828125,KO,"GE’s 8-for-1 Reverse Stock Split Shows CEO Culp’s Dow Jones Ambitions ||| Coca-Cola Company (KO) Ex-Dividend Date Scheduled for March 12, 2021",0,0.4521288
2021-03-12,17598600.0,50.59000015258789,50.68000030517578,50.20000076293945,50.36000061035156,46.350341796875,KO,What Google's Announcement Means for The Trade Desk and Magnite ||| 3 Dividend Stocks That Pay You Better Than Coca-Cola Does,1,0.5098392
2021-03-15,13411900.0,50.5,51.119998931884766,50.470001220703125,51.02999877929688,46.96699905395508,KO,3 Safe Stocks for Bear Market Defense,1,0.53410774
2021-03-16,14214200.0,51.20000076293945,51.52000045776367,51.040000915527344,51.220001220703125,47.14187240600586,KO,Marathon Digital Holdings Stock Is Excellent for Day Trading as Bitcoin Surges,1,0.5426535
2021-03-17,17502700.0,51.25,51.619998931884766,51.150001525878906,51.2400016784668,47.1602783203125,KO,Why Berkshire Hathaway Is a Retiree's Dream Stock ||| Here's Warren Buffett's Cost Basis for Berkshire Hathaway's 10 Largest Holdings,0,0.48639894
2021-03-18,18007300.0,51.060001373291016,51.18999862670898,50.4900016784668,50.56999969482422,46.54363632202149,KO,2 Dividend Giants to Buy Before Their Next Payout Hike,1,0.4978481
2021-03-19,67845700.0,50.459999084472656,51.08000183105469,50.16999816894531,50.810001373291016,46.76451873779297,KO,Copart Is a Totally Different Kind of Car Stock ||| iShares Core S&P 500 ETF Experiences Big Inflow,1,0.5059323
2021-03-22,17911400.0,50.31999969482422,51.08000183105469,50.31999969482422,51.0,46.93938827514648,KO,"FOCUS-In India, Reliance Retail's private labels revolution spooks global consumer goods makers",1,0.53466356
2021-03-23,16936700.0,50.9900016784668,51.650001525878906,50.83000183105469,51.38999938964844,47.29833221435547,KO,2 Top Dividend Stocks for a Better Retirement,1,0.5612382
2021-03-25,17091900.0,51.70000076293945,52.060001373291016,51.16999816894531,52.02000045776367,47.878177642822266,KO,3 Bargain Stocks You Can Buy Today,1,0.527472
2021-03-29,17514100.0,52.72999954223633,53.93999862670898,52.709999084472656,53.84999847412109,49.56246948242188,KO,"Write Your Own Stimulus Check Every Month With These Three Dividend-Paying Dow Stocks ||| Why Warren Buffett Would Love Nike Stock ||| ChargePoint Has the Right Product, But Timing Is the Question ||| IVV, KO, CRM, MRK: ETF Outflow Alert",0,0.50070006
2021-03-30,14871800.0,53.75,53.790000915527344,52.93000030517578,53.150001525878906,48.91820907592773,KO,"Georgia sued for third time over voting restrictions as Delta, Coke face boycott calls ||| Better Buy: McDonald's vs. PepsiCo",0,0.5020968
2021-03-31,15826500.0,53.02999877929688,53.16999816894531,52.5,52.709999084472656,48.51323699951172,KO,'Companies need to take a stand': Black executives urge fight on voting limits ||| Better Buy: General Electric vs. Coca-Cola ||| 71% of Warren Buffett's Portfolio Is in These 5 Stocks,0,0.47078717
2021-04-01,15834700.0,52.959999084472656,53.150001525878906,52.459999084472656,52.5099983215332,48.32915878295898,KO,Texas threatens to become next flash point on voting rules ||| Is It Too Late to Get in on This Millionaire-Maker Stock?,1,0.49650782
2021-04-05,16368700.0,52.34999847412109,53.220001220703125,52.290000915527344,52.810001373291016,48.60527801513672,KO,"ANALYSIS-Millennials and global consumers push U.S. companies to get political ||| How to Find the Best Dividend Stocks ||| 'Stay out of politics,' Republican leader McConnell tells U.S. CEOs, warns of 'consequences' ||| Is Coca-Cola a Great Dividend Stock?",1,0.49708477
2021-04-06,15614300.0,53.040000915527344,53.650001525878906,52.900001525878906,53.18999862670898,48.95501708984375,KO,"IVV, T, KO, CVX: ETF Inflow Alert ||| Baseball-Colorado to host MLB All-Star Game after Georgia voting law prompts pullout ||| Dow Movers: IBM, GS ||| This Surprising Projection Shows Why Big Tobacco Is Moving Into Cannabis ||| No Joke: Warren Buffett Is Yielding at Least 20% Annually on These 3 Stocks ||| 4 Top Consumer Stocks to Watch in April",1,0.5336081
2021-04-07,10062700.0,53.27999877929688,53.5,53.119998931884766,53.27999877929688,49.03785705566406,KO,7 Dividend Stocks With Unsustainable Yields,0,0.5161154
2021-04-08,9695600.0,53.16999816894531,53.380001068115234,52.970001220703125,53.119998931884766,48.890602111816406,KO,"Best Stocks To Buy Right Now? 4 Consumer Discretionary Stocks To Know ||| XLP, GOVZ: Big ETF Outflows ||| 82% of Warren Buffett's Portfolio Is in These 3 Sectors",1,0.46643838
2021-04-12,8565300.0,53.33000183105469,53.54999923706055,53.09999847412109,53.34999847412109,49.10227966308594,KO,"Corporate leaders plan new push on U.S. voting rights, will reconsider campaign donations ||| 3 Things to Watch in the Stock Market This Week ||| 5 Dividend Aristocrats Where Analysts See Capital Gains",0,0.489107
2021-04-13,11071700.0,53.040000915527344,53.290000915527344,52.810001373291016,53.09000015258789,48.86298751831055,KO,"Ford, GM among Michigan companies opposing Republican-backed voting limits",0,0.5255298
2021-04-14,9787600.0,52.97999954223633,53.18999862670898,52.650001525878906,53.08000183105469,48.85377502441406,KO,More than 100 companies sign letter opposing U.S. state voting restrictions ||| 5 Stocks to Teach You Rule Breaker Investing ||| 3 Things You'll Want to Know When Coca-Cola Reports Earnings ||| More than 100 companies sign letter opposing U.S. state voting restrictions,1,0.5121408
2021-04-15,13078100.0,53.130001068115234,53.65999984741211,53.119998931884766,53.33000183105469,49.08388137817383,KO,Coca-Cola Earnings: What to Watch ||| Is Berkshire Hathaway the Long-Term Stock for You?,1,0.5046023
2021-04-16,17974100.0,53.7400016784668,53.79999923706055,53.380001068115234,53.68000030517578,49.406005859375,KO,"5 Top Stock Trades for Monday: BA, MS, WMT, AA, KO ||| Pre-Market Earnings Report for April 19, 2021 : KO, PLD, MTB, ONB, BMRC, GNTY ||| iShares MSCI USA Quality Factor ETF Experiences Big Inflow ||| Coca-Cola Amatil votes in favour of European bottler's $7.68 bln takeover deal",1,0.54444355
2021-04-19,19352900.0,54.0,54.36000061035156,53.29999923706055,54.0,49.700531005859375,KO,"PepsiCo Starts 2021 Off Right ||| US STOCKS-Wall Street slips from all-time peaks, Tesla drops after fatal crash ||| US STOCKS-Wall Street slips off record highs, Tesla drops after fatal crash ||| Dow Movers: NKE, DIS ||| Coca-Cola Rises on Q1 Beats ||| US STOCKS-S&P 500, Dow slip from record highs; Coca-Cola rises on results ||| Coca-Cola (KO) Q1 2021 Earnings Call Transcript ||| US STOCKS-Wall Street slips from record levels; Tesla drops after fatal car crash ||| TREASURIES-Yields higher as traders look to Wednesday auction ||| The Coca-Cola Company Q1 adjusted earnings Beat Estimates ||| Consumer Sector Update for 04/19/2021: KO, MLHR, KNL, HOG, XLP, XLY ||| US STOCKS-S&P 500, Dow set to ease from record levels; Coca-Cola rises on results ||| Coca-Cola Q1 Profit Declines 19%, But Results Top Estimates ||| Coca-Cola revenue rises past estimates on easing pandemic curbs ||| Is Coca-Cola Stock A Good Option At $53? ||| US STOCKS-Futures dip after S&P 500, Dow hit record closing highs ||| Last Minute Thought: Buy or Sell Coca-Cola Before Earnings?",1,0.5030294
2021-04-20,14419200.0,53.84000015258789,54.59000015258789,53.810001373291016,54.16999816894531,49.85699081420898,KO,"Top Beverage Stocks To Watch After Coca-Cola Beat Earnings ||| Church leaders call for Home Depot boycott over Georgia voting curbs ||| Home Depot to face boycott over Georgia voting curbs ||| As Pepsi Prepares to Join the Dividend Kings, It’s a Better Buy than Coke ||| Warren Buffett Owns These 5 Dividend Aristocrats. Should You? ||| Here’s Why Keurig Dr Pepper Stock’s 80% Rally Is Not Surprising ||| Coca-Cola’s 1Q Results Beat Estimates Amid Uneven Global Economic Recovery",1,0.511177
2021-04-21,13866500.0,54.2400016784668,54.7400016784668,54.2400016784668,54.61000061035156,50.261962890625,KO,"Can Coca-Cola (NYSE:KO) Keep Up The Dividend Increases? ||| After Hours Most Active for Apr 21, 2021 : DISCK, IQ, VIAC, WFC, MRVL, V, CMCSA, KO, QQQ, NRZ, MRK, T ||| Daily Dividend Report: KO,DFS,SIRI,AEP,FCFS",0,0.46672577
2021-04-22,12558900.0,54.470001220703125,54.869998931884766,54.31999969482422,54.43999862670898,50.1054916381836,KO,Retail’s Surprisingly Big Month ||| Is Globant Stock a Buy? ||| Coca-Cola Hit a Big Milestone in March,1,0.51728326
2021-04-23,9020500.0,54.400001525878906,54.59000015258789,54.16999816894531,54.470001220703125,50.13311004638672,KO,Coca-Cola's Surprising Quarter ||| Is the S&P 500 All You Need to Retire a Millionaire?,0,0.49607694
2021-04-26,11684600.0,54.470001220703125,54.5099983215332,53.58000183105469,53.65999984741211,49.387603759765625,KO,"Rail shippers pick sides as CP, CN bid for Kansas City Southern ||| HDV, KO, MO, AVGO: ETF Inflow Alert ||| Warren Buffett Has Owned These Stocks Longer Than 112 Million Americans Have Been Alive",0,0.4794061
2021-04-27,9852400.0,53.560001373291016,53.70000076293945,53.31999969482422,53.58000183105469,49.31396865844727,KO,4 Consumer Discretionary Stocks To Watch Before May 2021 ||| Warren Buffett Generates Half of His Dividend Income From These 3 Stocks,1,0.50082564
2021-04-28,10868100.0,53.97999954223633,54.04999923706055,53.43999862670898,53.59000015258789,49.32316970825195,KO,Coca-Cola the latest global brand to 'Adopt a Park' in Brazil rainforest,1,0.53673184
2021-04-30,14912600.0,54.25,54.27000045776367,53.68999862670898,53.97999954223633,49.6821174621582,KO,3 Dividend Stocks That Pay You Better Than Coca-Cola Does ||| 3 Great Stocks for Low-Risk Investors ||| Dogecoin vs. Sundial Growers? How Warren Buffet Would Likely Weigh In ||| The Smartest Stocks to Buy With $500 Right Now,1,0.49899575
2021-05-03,10417900.0,54.27000045776367,54.79999923706055,54.15999984741211,54.47999954223633,50.14230346679688,KO,These 3 Under-the-Radar Stocks Are Great Buys Right Now ||| Don't Fall for This Silly Bear Argument on Skillz Stock ||| 3 Warren Buffett Stocks Perfect for Your Retirement Portfolio,0,0.47579584
2021-05-04,14151000.0,54.56999969482422,54.619998931884766,53.93999862670898,54.13999938964844,49.829376220703125,KO,Invesco PureBeta MSCI USA ETF Experiences Big Inflow ||| Warren Buffett Has Gained $158 Billion on These 4 Stocks ||| New Investor? Buy These 2 Rock-Solid Stalwarts for Safety and Dividends,0,0.48771212
2021-05-06,11572700.0,54.119998931884766,54.61000061035156,54.04999923706055,54.540000915527344,50.197532653808594,KO,3 Breakout Stocks Playing Defense While the Market Drops ||| 3 Stocks for a Reopening Boom,0,0.5090873
2021-05-10,15545800.0,54.880001068115234,55.5,54.83000183105469,54.90999984741211,50.5380744934082,KO,Is the Aluminum Shortage Hurting Monster Beverage? ||| Is The 40% Rally In PepsiCo Stock Justified?,0,0.5134742
2021-05-11,12986700.0,55.02999877929688,55.13999938964844,54.04999923706055,54.31999969482422,49.99505233764648,KO,"Worst-paying blue chip employers bolstered CEO pay in pandemic, report says ||| Global firms leave Myanmar office block with military ties ||| 7 Stocks to Start your Robinhood Portfolio With Just $2,000",0,0.48286125
2021-05-12,15836500.0,54.36000061035156,54.560001373291016,53.880001068115234,54.040000915527344,49.73735427856445,KO,"Getting Ready for the Weekend with Constellation Brands ||| Dow Hits $35,000, Crushing the Nasdaq. What Does That Mean for Retirees? ||| Inflation-Proof Stocks 2021: Where to Invest When Inflation Is High",1,0.49065617
2021-05-14,11725300.0,54.900001525878906,55.09999847412109,54.68999862670898,54.72999954223633,50.37241363525391,KO,Coca-Cola discontinues energy drink in N.America ||| iShares MSCI USA Quality Factor ETF Experiences Big Outflow ||| 3 Dividend Stocks That Pay You Better Than Coca-Cola Does,0,0.4950189
2021-05-18,13232500.0,54.38999938964844,54.560001373291016,54.09999847412109,54.34000015258789,50.01346206665039,KO,7 Blue-Chip Stocks Looking Better Than Ever,0,0.508045
2021-05-19,15126100.0,54.119998931884766,54.18000030517578,53.61000061035156,54.16999816894531,49.85699081420898,KO,These Are the Safest Dividend Stocks in the World,1,0.511705
2021-05-20,10948400.0,54.119998931884766,54.79999923706055,54.119998931884766,54.650001525878906,50.29877853393555,KO,Profit with Spreads While Amazon Snoozes ||| 3 Dividend Stocks Perfect for Retirees ||| Will Coca-Cola Stock Go Back To Its Pre-Covid Level?,0,0.48564634
2021-05-21,16033200.0,54.79999923706055,55.119998931884766,54.220001220703125,54.619998931884766,50.27116012573242,KO,Coca Cola in EU antitrust regulators' crosshairs,1,0.5369871
2021-05-24,10326100.0,54.630001068115234,54.93000030517578,54.4900016784668,54.79999923706055,50.43683242797852,KO,"What’s Next For Keurig Dr Pepper Stock After Its 20% Rally? ||| The Best Dividend Aristocrats to Buy With $500 Right Now ||| 3 High-Risk, High-Reward Stocks to Add to Your Watchlist ||| INSIGHT-Sea change: global freight sails out of the digital dark ages",0,0.4912186
2021-05-26,16064300.0,54.97999954223633,55.04999923706055,54.59000015258789,55.02999877929688,50.64852142333984,KO,"Better Buy: Beyond Meat vs. Coca Cola ||| Dow Analyst Moves: KO ||| The Honest Company: What Investors Need to Know ||| 3 Dividend Stocks That Pay You More Than Pepsi Does ||| ACWI, PG, XOM, KO: Large Inflows Detected at ETF ||| Better Buy: Starbucks vs. Coca-Cola",1,0.5140663
2021-05-27,59109600.0,55.209999084472656,55.56999969482422,54.77999877929688,55.4900016784668,51.0718994140625,KO,"After Hours Most Active for May 27, 2021 : CSCO, KO, GE, PG, LI, PFE, AAPL, XOM, WFC, TXN, INTC, HST ||| 7 Best Stocks for Upcoming Grads to Buy and Hold Forever",0,0.4513634
2021-05-28,17011600.0,55.34999847412109,55.709999084472656,55.20000076293945,55.290000915527344,50.887821197509766,KO,"Upstart Impresses, and Banks Get Creative Giving Credit",0,0.5010552
2021-06-01,13304000.0,55.34000015258789,55.650001525878906,55.09999847412109,55.27999877929688,50.87861251831055,KO,6 Top Dividend Stocks To Watch For Your Retirement Plan ||| Kraft Heinz's High Dividend Really Is Too Good to Be True,1,0.533504
2021-06-02,11328500.0,55.5,55.560001373291016,55.2599983215332,55.5,51.08110427856445,KO,"Coca-Cola To Become Global Implementation Partner For Ocean Cleanup's River Project ||| Coca-Cola, The Ocean Cleanup Partner For River Cleanup Project - Quick Facts",1,0.5196231
2021-06-03,17364300.0,55.18000030517578,55.7400016784668,55.09999847412109,55.63999938964844,51.20995330810547,KO,"Notable ETF Inflow Detected - XLP, PG, KO, WMT ||| Why Coca-Cola Could Gain Market Share as Global Economies Recover ||| Why Coca-Cola Is a Dividend Investor's Dream",1,0.4872172
2021-06-04,18935100.0,55.900001525878906,56.47999954223633,55.77999877929688,56.2400016784668,51.762184143066406,KO,"3 Attractive Dividends That Are Going Up in June ||| After Hours Most Active for Jun 4, 2021 : GE, KO, BAC, AAPL, AMC, LMNL, F, GFI, DBX, QQQ, INTC, IBKR ||| 3 Top Consumer Stocks To Watch In June 2021",0,0.5248848
2021-06-07,14010800.0,56.310001373291016,56.34000015258789,55.810001373291016,56.040000915527344,51.57810974121094,KO,"This Popular Stock Has Delivered a 26 Times Greater Return Than Dogecoin ||| After Hours Most Active for Jun 7, 2021 : PBR, IBN, CLOV, KO, SU, CSCO, TSM, AAPL, GLW, GILD, SESN, INTC ||| Worried About Inflation? Buy These 2 Forever Stocks Now",0,0.4862363
2021-06-08,10968300.0,56.25,56.25,55.54999923706055,55.650001525878906,51.21916580200195,KO,Here's 1 Popular Robinhood Stock That Could Be Even Riskier Than Dogecoin,0,0.492332
2021-06-10,12444400.0,55.90999984741211,56.119998931884766,55.7599983215332,55.90999984741211,51.45845413208008,KO,"After Hours Most Active for Jun 10, 2021 : NUAN, PFE, INTC, F, KDP, GE, QQQ, CSCO, T, SIRI, KO, CCL ||| U.S. senator slams Apple, Amazon, Nike, for enabling forced labor in China ||| Top Stocks To Buy Now? 5 Dividend Stocks To Watch",1,0.5279235
2021-06-11,11825800.0,55.9900016784668,56.209999084472656,55.65999984741211,56.15999984741211,51.68855285644531,KO,"XLP, FTXD: Big ETF Inflows ||| Noteworthy ETF Inflows: ESGU, PG, KO, NEE ||| Coca-Cola Company (KO) Ex-Dividend Date Scheduled for June 14, 2021",0,0.42577067
2021-06-14,9710800.0,55.68999862670898,55.709999084472656,55.20000076293945,55.54999923706055,51.51236343383789,KO,What’s Behind PepsiCo Stock’s 10% Rally In Three Months?,0,0.5139553
2021-06-15,11154200.0,55.77999877929688,55.790000915527344,55.18999862670898,55.40999984741211,51.382545471191406,KO,"Why Economic Reopenings Could Be a Headwind for PepsiCo ||| If You Like Dividends, You Should Love These 3 Stocks ||| Soccer-'Drink water!'-Ronaldo removes Coca-Cola bottles at Euro press conference",0,0.48626286
2021-06-16,15211700.0,55.43999862670898,55.459999084472656,54.63999938964844,54.66999816894531,50.69632339477539,KO,"Staples CEO Alexander Douglas to step down ||| Soccer-Ronaldo, Pogba snub sponsors at Euro 2020 ||| Can Coca-Cola Recover from Ronaldo’s Kick? ||| 5 Dividend Aristocrats Where Analysts See Capital Gains ||| These 10 Stocks Make Up 85% of Warren Buffett's Portfolio",1,0.48125985
2021-06-18,31445600.0,54.5099983215332,54.619998931884766,53.720001220703125,53.77000045776367,49.86174011230469,KO,Is Adidas the Best Fitness Stock to Buy Now?,1,0.5180462
2021-06-21,14404300.0,54.220001220703125,54.43000030517578,54.0,54.36000061035156,50.40885543823242,KO,7 Stocks to Watch If Climate Risk Disclosures Come to Pass ||| Which of These 2 Beverage Stocks Is Primed for Bigger Growth? ||| Maersk VC co-leads funding round in Egyptian start-up Trella,1,0.5166359
2021-06-22,13072800.0,54.34000015258789,54.84999847412109,54.2599983215332,54.560001373291016,50.59432220458984,KO,Tuesday’s Pre-Market: Here’s What You Need to Know Before the Market Opens ||| Coca-Cola to Double Spending with Minority-Owned Media Firms,0,0.5025872
2021-06-23,12339200.0,54.560001373291016,54.59999847412109,54.11000061035156,54.119998931884766,50.186302185058594,KO,"Dow Movers: MMM, CVX ||| Did Ronaldo Really Cost Coca-Cola (KO) $4 Billion?",1,0.50149477
2021-06-24,11488400.0,54.2599983215332,54.41999816894531,54.0,54.38999938964844,50.43667984008789,KO,"Dow Movers: WBA, AMGN ||| Warren Buffett Has Gained More Than 1,000% in These 6 Stocks",0,0.4737259
2021-06-25,18880300.0,54.2400016784668,54.470001220703125,54.0099983215332,54.31999969482422,50.37176132202149,KO,"Dow Movers: CRM, NKE",0,0.51967347
2021-06-28,10556900.0,54.25,54.369998931884766,54.0,54.2599983215332,50.31612396240234,KO,What’s Next For Coca-Cola Stock After Its 6% Rally? ||| Warren Buffett's 3 Favorite Robinhood Stocks ||| Coca-Cola HBC to acquire 30% stake in Italy's Caffè Vergnano,0,0.49998632
2021-06-29,12300900.0,54.130001068115234,54.34000015258789,53.720001220703125,53.86000061035156,49.945194244384766,KO,"ESGU, BAC, PG, KO: Large Inflows Detected at ETF",1,0.52594656
2021-06-30,14614200.0,53.79999923706055,54.18000030517578,53.75,54.11000061035156,50.17702865600586,KO,These Top-Dividend Stocks Have 140 Years of Payout Raises Between Them ||| Is Hershey Warren Buffett's Kind of Business? ||| Why Warren Buffett Would Love Airbnb Stock ||| 4 Stocks to Buy Before the Tokyo Summer Olympics,0,0.47913095
2021-07-01,13214700.0,54.34000015258789,54.47999954223633,53.86000061035156,53.959999084472656,50.03792953491211,KO,Will Movie Theaters Survive or Even Thrive in 2022 and Beyond?,1,0.53184056
2021-07-06,15278200.0,53.9900016784668,54.09000015258789,53.54999923706055,53.880001068115234,49.963748931884766,KO,PepsiCo's Shares Have Stayed Flat in 2021: Can Q2 Earnings Change That?,1,0.51768976
2021-07-07,14377700.0,53.720001220703125,54.380001068115234,53.720001220703125,54.31999969482422,50.37176132202149,KO,"Need To Know: The Coca-Cola Company (NYSE:KO) Insiders Have Been Selling Shares ||| After Hours Most Active for Jul 7, 2021 : AAPL, F, KO, CSCO, KHC, T, GE, BAC, GILD, KNL, MSFT, USIG ||| Noteworthy ETF Outflows: IWV, CMCSA, VZ, KO",0,0.46478045
2021-07-08,11943900.0,54.0099983215332,54.16999816894531,53.7400016784668,54.130001068115234,50.19557571411133,KO,PepsiCo Earnings: 3 Trends to Watch,1,0.5439223
2021-07-09,10847000.0,54.25,54.52000045776367,54.18000030517578,54.459999084472656,50.5015869140625,KO,"XLP, KLCD: Big ETF Outflows ||| Is PepsiCo Stock Fairly Valued?",1,0.51171815
2021-07-12,15107600.0,54.31999969482422,54.59999847412109,54.27000045776367,54.47999954223633,50.52013397216797,KO,"3 Things to Watch in the Stock Market This Week ||| After Hours Most Active for Jul 12, 2021 : EDU, IBN, XOM, PFE, KO, ITUB, AAPL, CSCO, MSFT, GILD, QQQ, IQ",1,0.4908654
2021-07-13,15170800.0,54.95000076293945,55.29999923706055,54.75,55.02000045776367,51.0208854675293,KO,"This Soaring Rivalry Should Be Good for Investors ||| Ethereum Classic May Be It Again ||| Dow Movers: BA, KO",1,0.50612646
2021-07-14,22002700.0,55.02000045776367,56.34999847412109,54.959999084472656,56.2599983215332,52.17075729370117,KO,3 Top Dividend Stocks to Buy in July,1,0.55765295
2021-07-15,15068200.0,56.2400016784668,56.470001220703125,55.90999984741211,56.43999862670898,52.337669372558594,KO,"Daily Dividend Report: PPG,WBA,KO,INTC,PSX ||| 3 Stocks That Turned $1,000 Into Over $300,000",0,0.4747665
2021-07-16,14860500.0,56.459999084472656,56.68000030517578,56.2599983215332,56.400001525878906,52.30058288574219,KO,Coca-Cola Earnings: What to Watch ||| Consumers Are Going Out Again: Why That's Good News for Coca-Cola's Q2 Earnings,0,0.5127284
2021-07-19,19527000.0,56.08000183105469,56.34999847412109,55.15999984741211,55.72999954223633,51.67927932739258,KO,"GLOBAL MARKETS-Asian shares hit 1-wk lows on renewed virus scare, inflation worry ||| GLOBAL MARKETS-Asian shares extend losses on renewed virus scare, inflation woes ||| 1 Dow Jones Stock That Could Double Your Money ||| GLOBAL MARKETS-Stocks on worst run in 18-months amid global COVID-19 surge ||| GLOBAL MARKETS-Investors flee stocks, pile into bonds as COVID-19 surges; oil plunges ||| After Hours Most Active for Jul 19, 2021 : KBWB, AAPL, CSCO, XOM, DBRG, PKW, INTC, PFE, CMCSA, KO, C, ABEV ||| GLOBAL MARKETS-COVID-19 surge sparks bond rally, stocks on worst run in 18 months ||| 4 Dividend Stocks To Watch With The Stock Market Down Today ||| GLOBAL MARKETS-COVID-19 surge sparks bond rally, stocks on worst run in 18 months ||| 5 Stocks with 50+ Years of Dividend Growth ||| GLOBAL MARKETS-Asian shares slip to 1-week lows on renewed virus scare, inflation worry ||| Noteworthy ETF Inflows: VOO, GOOGL, GOOG, KO",1,0.50017047
2021-07-20,16257900.0,55.72999954223633,56.33000183105469,55.52000045776367,55.83000183105469,51.77201461791992,KO,"Pre-Market Earnings Report for July 21, 2021 : JNJ, ASML, KO, VZ, ANTM, NDAQ, NVS, NTRS, RCI, STX, MKTX, MTB ||| Pre-Market Earnings Report for July 21, 2021 : JNJ, ASML, KO, VZ, ANTM, NDAQ, NVS, NTRS, RCI, STX, MKTX, MTB ||| Walmart Is a Bastion of Stability Amid the Volatility",1,0.47646317
2021-07-21,20918200.0,57.33000183105469,57.560001373291016,56.43000030517578,56.54999923706055,52.439674377441406,KO,"Coca-Cola raises full-year sales forecast ||| US STOCKS-Wall Street ends higher, powered by strong earnings, economic cheer ||| US STOCKS-Wall Street ends higher, powered by strong earnings, economic cheer ||| GLOBAL MARKETS-Investors turn to stocks as they shrug off COVID worries ||| US STOCKS-Wall Street extends rally on strong earnings, economic optimism ||| Coca-Cola (KO) Q2 2021 Earnings Call Transcript ||| Wall Street rises on earnings strength, recovery cheer ||| Dow Movers: AMGN, KO ||| GLOBAL MARKETS-Investors turn to stocks as shrug off COVID worries ||| US STOCKS-Wall Street rises on upbeat earnings, recovery optimism ||| 3 Takeaways From PepsiCo's Latest Earnings Call ||| Consumer Sector Update for 07/21/2021: KO, LAD, HOG, XLP, XLY ||| US STOCKS-Upbeat earnings, recovery optimism set S&P 500, Dow for higher open ||| US STOCKS-Upbeat earnings, recovery optimism lift Wall St futures ||| Coca-Cola raises revenue forecast as demand rebounds on reopening boost ||| These 2 Stock Giants Are Juicing the Market on Wednesday ||| Upbeat earnings, recovery optimism lift Wall Street at open",0,0.49585205
2021-07-28,9858000.0,56.9900016784668,57.15999984741211,56.630001068115234,56.7400016784668,52.61587142944336,KO,"Buy Coca-Cola Stock After Its Stellar Q2 Earnings ||| Banks, Tacos, and How Successful People See the World ||| U.S. lawmakers blast Coca-Cola, Visa and other sponsors of Beijing Olympics",1,0.5182512
2021-07-29,9599100.0,57.06999969482422,57.25,56.86000061035156,57.04999923706055,52.9033317565918,KO,"The 7 Best Warren Buffett Stocks to Buy in August and Hold for Years ||| After Hours Most Active for Jul 29, 2021 : PCG, GE, PINS, KO, EDU, ENB ||| 3 Earnings Results That Highlight the Reopening Trade Is Paying Off",0,0.4904754
2021-07-30,11727000.0,57.150001525878906,57.25,56.900001525878906,57.02999877929688,52.88478469848633,KO,"After Hours Most Active for Jul 30, 2021 : PBCT, IXUS, AAPL, IUSV, KO, SWN, CG, OPEN, PCG, GE, ENB, EOG ||| Getting In Cheap On The Coca-Cola Company (NYSE:KO) Is Unlikely ||| Coca-Cola's Earnings Call: 3 Big Takeaways",0,0.46445036
2021-08-02,9778000.0,57.20000076293945,57.2400016784668,56.709999084472656,56.880001068115234,52.74569320678711,KO,These 2 Dividend ETFs Are a Retiree's Best Friend,1,0.51237273
2021-08-03,8825500.0,57.0,57.0,56.75,56.91999816894531,52.78278350830078,KO,Don't Work During Retirement -- Collect Money From These 3 Dividend Aristocrats Instead,0,0.49148107
2021-08-05,9806800.0,56.43999862670898,56.59000015258789,56.290000915527344,56.5,52.393310546875,KO,2 Earnings Winners You Won't Want to Miss,1,0.55970705
2021-08-09,8859900.0,56.79999923706055,56.880001068115234,56.43000030517578,56.650001525878906,52.532413482666016,KO,3 Top Reopening Stocks to Buy Right Now ||| The Coca-Cola Company (NYSE:KO) Yields 3% With a Reasonable Upside,1,0.5301587
2021-08-10,10906900.0,56.84000015258789,57.16999816894531,56.65999984741211,56.79999923706055,52.671504974365234,KO,PepsiCo to launch Mountain Dew-branded alcoholic drinks in 2022,0,0.51855904
2021-08-12,6169200.0,56.72999954223633,56.97999954223633,56.72999954223633,56.84000015258789,52.70860290527344,KO,3 Dividend Investing Tips That Could Earn You Thousands ||| Is PepsiCo Stock Fairly Valued After Its 50% Recovery? ||| Bottler Coca Cola HBC sees lower margins after H1 profit surges ||| Bottler Coca Cola HBC sees lower margins after H1 profit surges,1,0.5299803
2021-08-13,7714200.0,56.810001373291016,57.29999923706055,56.77000045776367,57.22999954223633,53.07025146484375,KO,3 Top Value Stocks to Buy in August,1,0.5570354
2021-08-16,7972000.0,57.20000076293945,57.4900016784668,57.02999877929688,57.47999954223633,53.30208206176758,KO,China boycotts actor after photos of visit to Japan's Yasukuni Shrine ||| Don't Ignore The Fact That This Insider Just Sold Some Shares In The Coca-Cola Company (NYSE:KO),0,0.49744424
2021-08-18,13873700.0,57.18999862670898,57.22999954223633,56.41999816894531,56.5,52.393310546875,KO,"VTV, PG, INTC, KO: ETF Inflow Alert ||| XLP, FATT: Big ETF Outflows ||| Like Dividends? I Bet You'll Love These 3 Stocks",1,0.48504105
2021-08-19,9223700.0,56.060001373291016,56.97999954223633,55.95000076293945,56.86000061035156,52.727142333984375,KO,3 Hot Consumer Staples Stocks To Watch This Week,0,0.5546119
2021-08-20,10543600.0,56.84000015258789,57.02999877929688,56.58000183105469,56.63999938964844,52.523136138916016,KO,5 Dividend Aristocrats Where Analysts See Capital Gains,0,0.5003829
2021-08-23,8912800.0,56.66999816894531,56.75,56.380001068115234,56.43999862670898,52.337669372558594,KO,3 Hot Stocks to Buy in August ||| Here Are Warren Buffett's Biggest Stock Picks,0,0.4940536
2021-08-25,11270700.0,56.060001373291016,56.16999816894531,55.72999954223633,56.06999969482422,51.99456405639648,KO,This Tech Stock Continues to Tumble Despite Rising Revenue. Is It Time to Buy?,0,0.46946532
2021-08-26,10331500.0,55.95000076293945,55.97999954223633,55.5099983215332,55.540000915527344,51.50308227539063,KO,"XLP, FAUG: Big ETF Inflows",1,0.5244076
2021-08-30,10034700.0,55.68999862670898,56.20000076293945,55.63999938964844,56.18000030517578,52.0965690612793,KO,3 Food and Beverage Companies for Dividend Stock Fans,1,0.5645495
2021-08-31,14185700.0,56.15999984741211,56.52000045776367,56.0,56.310001373291016,52.21712112426758,KO,7 Consumer Goods Stocks To Buy if the Pandemic Worsens ||| Is Coca-Cola Stock A Good Investment At $56?,1,0.5012143
2021-09-01,9518900.0,56.380001068115234,56.79999923706055,56.27999877929688,56.68999862670898,52.56949996948242,KO,3 Investing Strategies to Grow Your Money Like Magic,1,0.55443007
2021-09-02,11653200.0,56.77000045776367,57.02999877929688,56.40999984741211,56.77000045776367,52.64369201660156,KO,EXCLUSIVE-Amazon to proactively remove more content that violates rules from cloud service -sources ||| EXCLUSIVE-Amazon to proactively remove more content that violates rules from cloud service -sources ||| 3 Flagging Dow Giants to Buy Today,0,0.49852002
2021-09-03,13220400.0,56.459999084472656,56.77000045776367,56.25,56.72999954223633,52.60659790039063,KO,"Pre-Market Most Active for Sep 3, 2021 : DIDI, DBX, VIPS, CLOV, KO, SQQQ, V, CSX, DIS, MSFT, EDU, LCID ||| 3 Ways You Can Beat Warren Buffett in the Stock Market ||| Slowbalization Should Not Damage The Coca-Cola Company's (NYSE:KO) High ROE",0,0.4684139
2021-09-07,20035300.0,56.59999847412109,56.68999862670898,55.5099983215332,55.66999816894531,51.62364196777344,KO,EXCLUSIVE-Amazon considers more proactive approach to determining what belongs on its cloud service,1,0.51567465
2021-09-08,12040100.0,55.61000061035156,56.47999954223633,55.61000061035156,56.41999816894531,52.319122314453125,KO,Best Stocks To Buy Now? 5 Retail Stocks To Know ||| Affirm Soars on Amazon Partnership ||| Warren Buffett Is Betting Big on This Stock -- Should You?,0,0.4654739
2021-09-09,12545400.0,56.18000030517578,56.41999816894531,55.79999923706055,55.86000061035156,51.7998275756836,KO,"Notable ETF Outflow Detected - ACWI, KO, ACN, NKE ||| Warren Buffett Has Made 2,200% on This Stock -- Is It a Buy?",0,0.46823844
2021-09-10,10573700.0,56.0099983215332,56.130001068115234,55.52000045776367,55.61000061035156,51.5680046081543,KO,"The Smartest Dividend Stocks to Buy With $400 Right Now ||| Ex-Dividend Reminder: Garmin, Altria Group and Coca-Cola ||| Warren Buffett Would Love These 3 Marijuana Stocks",1,0.4679789
2021-09-13,20274300.0,55.7400016784668,56.400001525878906,55.7400016784668,56.06999969482422,51.99456405639648,KO,"If You Like Dividends, You Should Love These 3 Stocks ||| Is This High-Yield Dividend Stock a Buy? ||| After Hours Most Active for Sep 13, 2021 : VOD, GSK, RIO, AAPL, VEON, KO, CCJ, TAL, LFST, VZ, GILD, KBWB ||| Coca-Cola Company (KO) Ex-Dividend Date Scheduled for September 14, 2021 ||| National Beverage Drinks Up Big Gains Despite Supply Chain Headwinds ||| Britain's Tesco joins refillable revolution with in-store trial ||| Britain's Tesco joins refillable revolution with in-store trial",0,0.4509008
2021-09-14,13918900.0,55.91999816894531,55.97999954223633,55.54999923706055,55.68999862670898,52.03193664550781,KO,"EXCLUSIVE-China's Miniso to double U.S. stores, add NY 'flagship' as pandemic slashes mall rents ||| EXCLUSIVE-Warburg Pincus-backed firm buys Odwalla brand from Coca-Cola ||| EXCLUSIVE-China's Miniso to double U.S. stores, add NY 'flagship' as pandemic slashes mall rents",1,0.50948906
2021-09-15,15746000.0,55.68000030517578,56.0,55.41999816894531,55.880001068115234,52.20945739746094,KO,"PepsiCo to reduce plastic use, launch plant-based snacks in green push ||| 3 Best Stocks to Buy When Consumer Confidence Falters ||| PepsiCo to slash plastic use in sustainability push ||| These 4 Stocks Are Netting Warren Buffett a Combined $3.1 Billion in Annual Dividend Income",0,0.49818692
2021-09-16,17430400.0,55.720001220703125,55.9900016784668,54.81999969482422,55.34999847412109,51.71426773071289,KO,Disney World's Worst Park Is Getting a Huge Makeover,0,0.48880488
2021-09-17,33370200.0,55.02000045776367,55.18999862670898,54.369998931884766,54.43999862670898,50.86404037475586,KO,"When Disaster Hits, Buy This Stock ||| Notable ETF Inflow Detected - VTI, KO, VZ, ABT ||| Smart Investors Are Watching This Trend Right Now",0,0.47704166
2021-09-20,27542500.0,54.11000061035156,54.400001525878906,53.72999954223633,54.060001373291016,50.50901794433594,KO,Warren Buffett Earns a 50% Annual Dividend On This Stock ||| 85% of Warren Buffett's Portfolio Is in These 3 Sectors,0,0.4789905
2021-09-21,16418200.0,54.38999938964844,54.81999969482422,53.93999862670898,54.04999923706055,50.49966430664063,KO,"After Hours Most Active for Sep 21, 2021 : KO, AAPL, SFIX, LPTX, BBD, CLOV, MO, MU, SQQQ, TTM, TEF, TAL ||| 3 Underrated Warren Buffett Stocks That Are Smart Buys Right Now",1,0.44071177
2021-09-22,12719700.0,54.5099983215332,54.560001373291016,54.060001373291016,54.130001068115234,50.57440948486328,KO,"Kroger, Woolworths to expand reusable packaging trials to stores",0,0.51594067
2021-09-23,13836200.0,54.2599983215332,54.619998931884766,54.0,54.040000915527344,50.490325927734375,KO,"7 Robinhood Stocks to Buy for Newbie Investors ||| Pre-Market Most Active for Sep 23, 2021 : AQN, SQQQ, EAR, KO, SLDB, ASX, AAPL, TQQQ, EDU, MRIN, SWN, AMC",0,0.49334875
2021-09-27,12429500.0,53.84999847412109,54.25,53.56999969482422,53.61000061035156,50.08856964111328,KO,"Investors in Coca-Cola (NYSE:KO) have made a favorable return of 50% over the past five years ||| Got $1,000? 3 Buffett Stocks to Buy and Hold Forever ||| IWF, NKE, ACN, KO: Large Outflows Detected at ETF",0,0.4955498
2021-09-28,19926100.0,53.459999084472656,53.459999084472656,52.43000030517578,52.63999938964844,49.18228149414063,KO,Hyzon Motors Stock Crashes on Scathing Short-Seller Report,1,0.52423835
2021-09-30,17672000.0,53.16999816894531,53.33000183105469,52.43000030517578,52.470001220703125,49.0234489440918,KO,My 3 Top Dividend Stocks for October,1,0.5351693
2021-10-04,18973400.0,53.060001373291016,53.52999877929688,52.400001525878906,52.9900016784668,49.50929641723633,KO,Here's Why PepsiCo Stock Is Still a Great Long-Term Bet ||| 3 Dividend Kings That Belong in Every Retirement Portfolio,1,0.5085707
2021-10-05,17173100.0,53.02000045776367,53.470001220703125,52.93000030517578,53.08000183105469,49.5933837890625,KO,Why Hyzon Motors Stock Surged Today ||| 3 Dividend Stocks You Can Buy and Hold Forever ||| Topo Chico Hard Seltzer To Roll Out Margarita Hard Seltzer Variety Pack In 2022 - Quick Facts,1,0.48966143
2021-10-06,21284500.0,52.77000045776367,53.77000045776367,52.5099983215332,53.709999084472656,50.18199920654297,KO,"After Hours Most Active for Oct 6, 2021 : ACWX, OLPX, BAC, CNQ, AAPL, VYGR, CSCO, NVDA, NCLH, KO, FTCH, USA ||| 3 Hot Stocks to Buy With $1,000 ||| Pre-Market Most Active for Oct 6, 2021 : VYGR, PLTR, BP, SQQQ, AZN, ACWX, QQQ, KO, TQQQ, SNII, TJX, X ||| How Does Keurig Dr Pepper Look Compared To Its Rivals?",1,0.47248307
2021-10-08,13786800.0,54.0,54.38999938964844,53.900001525878906,54.119998931884766,50.5650634765625,KO,"Along With Institutions, we are Optimistic About The Coca-Cola Company (NYSE:KO) ||| 2 Reasons PepsiCo's Q3 Earnings Were Good News for Coca-Cola",1,0.51563936
2021-10-11,12378500.0,54.209999084472656,54.38999938964844,54.0099983215332,54.22999954223633,50.66783905029297,KO,3 Top Stocks to Buy in October ||| 3 Top Warren Buffet Stocks to Buy in October ||| Should AMC Embrace Every Idea Its Investors Suggest?,0,0.50407225
2021-10-12,19474400.0,54.41999816894531,54.83000183105469,54.220001220703125,54.22999954223633,50.66783905029297,KO,"After Hours Most Active for Oct 12, 2021 : AAPL, GILD, X, QQQ, VZ, KMI, KO, CMCSA, PROG, SQQQ, BAC, BBD",1,0.4613671
2021-10-13,12143300.0,54.16999816894531,54.43000030517578,53.790000915527344,54.2400016784668,50.67718124389648,KO,3 Top Dividend Aristocrat Stocks for $55 or Less ||| Warren Buffett Is Yielding Between 20% and 52% Annually From These Stocks,1,0.54947984
2021-10-14,13704000.0,54.38999938964844,54.810001373291016,54.310001373291016,54.61000061035156,51.02288055419922,KO,How to Pick the Best Type of Stock for Your Portfolio ||| 3 Top Dividend Stocks for Retirees Wanting Consistent Income,0,0.49012893
2021-10-21,14388300.0,54.59999847412109,54.66999816894531,54.209999084472656,54.34999847412109,50.77995300292969,KO,"Top Dividend Stocks To Buy In 2021? 3 In Focus ||| VYM, KO, CVX, LLY: Large Inflows Detected at ETF ||| PepsiCo is Marching Toward Dividend King Designation ||| How Target Crushed the Market Over the Last Five Years ||| It's Time to Buy These Lagging Dividend Giants ||| End of October Packed with Tech Earnings, Data",1,0.49020523
2021-10-22,12828600.0,54.38999938964844,54.52999877929688,54.06999969482422,54.45000076293945,50.87338638305664,KO,3 Safe Stocks to Buy as the Economic Recovery Loses Momentum,0,0.50768167
2021-10-25,11855000.0,54.380001068115234,54.470001220703125,54.02000045776367,54.22999954223633,50.66783905029297,KO,Coca-Cola Earnings: What to Watch on Wednesday ||| Coca-Cola Earnings: What to Watch,1,0.5242074
2021-10-26,12086700.0,54.31999969482422,54.58000183105469,54.22999954223633,54.470001220703125,50.89207458496094,KO,"Pre-Market Earnings Report for October 27, 2021 : TMO, KO, MCD, BMY, BA, ADP, GM, CME, FISV, NSC, BSX, GD ||| Dow Analyst Moves: KO ||| These 10 Stocks Make Up 87% of Warren Buffett's Portfolio",1,0.46571618
2021-10-27,24019800.0,55.970001220703125,56.08000183105469,55.27000045776367,55.52000045776367,51.87310409545898,KO,"Coca-Cola lifts profit forecast on rising soda demand ||| Will These 3 Dow Stocks Spur New Market Records Wednesday? ||| Consumer Sector Update for 10/27/2021: KO, MCD, BG, XLP, XLY ||| Coca-Cola Q3 Earnings: Here's What Investors Should Know ||| GLOBAL MARKETS-Stocks run out of steam on regulation worries, higher yields ||| Coca-Cola Lifts FY21 Earnings, Revenue Growth View - Quick Facts ||| GLOBAL MARKETS-Stocks run out of steam on regulation worries, higher yields ||| GLOBAL MARKETS-Short-term yields leap with inflation, China tech drops ||| The Coca-Cola Company Q3 adjusted earnings Beat Estimates",1,0.5003704
2021-11-01,11651100.0,56.38999938964844,56.400001525878906,55.900001525878906,56.16999816894531,52.48040390014648,KO,"Should You Buy Coca-Cola Stock After Q3 Earnings? ||| Consumer Sector Update for 11/01/2021: GME,CNK,HZO,KO ||| SPYV, MDT, PM, KO: Large Inflows Detected at ETF ||| Coca-Cola: Do Potential Catalysts Justify Steep Valuation? ||| Coca-Cola Acquires Remaining 85% Of BODYARMOR For $5.6 Bln In Cash - Quick Facts ||| Coca-Cola to buy remaining stake in sports drink maker BodyArmor for $5.6 bln ||| Coca-Cola to buy controlling stake in sports drink maker BodyArmor for $5.6 bln ||| Consumer Sector Update for 11/01/2021: NIO, XPEV, KO, XLP, XLY",0,0.48234898
2021-11-02,11498900.0,56.470001220703125,56.5,55.970001220703125,56.09999847412109,52.41500473022461,KO,"7 Stocks to Set Your Sights on as the ‘Hyperinflation’ Debate Stirs Up ||| Top Stock Market News For Today November 2, 2021 ||| Coca-Cola Purchases Remaining Stake in BODYARMOR for $5.6B ||| Good Stocks To Buy Right Now? 4 Consumer Stocks In Focus ||| 3 Numbers You Don't Want to Miss From Coca-Cola's Earnings Report",1,0.4889478
2021-11-03,10788300.0,56.0,56.33000183105469,55.77999877929688,56.290000915527344,52.5925178527832,KO,Are Freshpet's High-Growth Days Over? ||| Bottler Coca Cola HBC third-quarter revenue tops estimates,1,0.52351916
2021-11-04,10820200.0,56.11000061035156,56.630001068115234,56.02999877929688,56.59999847412109,52.88216400146485,KO,"Microsoft's Ascension, Facebook's Metamorphosis",1,0.51793385
2021-11-05,12886700.0,56.84000015258789,57.15999984741211,56.59000015258789,56.84000015258789,53.10640335083008,KO,Why Coca-Cola is the Best Dividend Stock You Can Buy ||| 3 Robinhood Stocks With High Dividend Yields,0,0.48678443
2021-11-08,12828000.0,56.75,56.88999938964844,56.130001068115234,56.33000183105469,52.62989807128906,KO,Coca-Cola company names WPP as global marketing network partner,1,0.5463349
2021-11-10,8813600.0,56.540000915527344,56.91999816894531,56.290000915527344,56.720001220703125,52.994285583496094,KO,Coca-Cola's Largest Brand Acquisition Ever,1,0.529811
2021-11-11,7257700.0,56.83000183105469,56.880001068115234,56.56999969482422,56.7400016784668,53.01296615600586,KO,"Have $1,000? 2 Warren Buffett Stocks to Buy",0,0.47214288
2021-11-12,10162500.0,56.75,56.9900016784668,56.54999923706055,56.61000061035156,52.89151382446289,KO,"Inflation Isn’t a Trend-Killer… Yet ||| Pre-Market Most Active for Nov 12, 2021 : RLX, MQ, CG, PSFE, GILD, RIVN, MSFT, KO, DOCS, LCID, BEKE, JNJ",1,0.47607696
2021-11-15,10289200.0,56.52999877929688,56.68000030517578,56.27000045776367,56.619998931884766,52.90084838867188,KO,"Believe It or Not, These Stocks Pay You to Own Them ||| Buffett's Berkshire cuts U.S. drugmaker stakes, invests in drug royalty company ||| Don’t Make Any Major Portfolio Changes Until Mid-Week: Here’s Why",0,0.47459933
2021-11-17,13288700.0,56.040000915527344,56.04999923706055,55.650001525878906,55.90999984741211,52.237491607666016,KO,"Pre-Market Most Active for Nov 17, 2021 : LCID, PROG, GOEV, RIVN, WBA, KR, NRDY, EDU, GILD, KO, IONQ, DIS ||| 3 Best Dividend Stocks for Retirement",0,0.4634287
2021-11-18,15380100.0,55.83000183105469,55.93000030517578,55.13999938964844,55.40999984741211,51.77032852172852,KO,The Fizz is Flat in Coca-Cola ||| Britain's M&S to sell food in Costa Coffee stores,0,0.50497735
2021-11-19,15813700.0,55.43999862670898,55.4900016784668,54.900001525878906,55.130001068115234,51.50872802734375,KO,"7 Consumer Stocks to Buy as the Sector Heats Up ||| Noteworthy ETF Inflows: ESGU, DIS, NEE, KO ||| Ardagh Metal makes $200 million post-Brexit investment in N.Ireland",1,0.5324581
2021-11-22,16905600.0,55.09999847412109,56.02000045776367,55.08000183105469,55.470001220703125,51.82639694213867,KO,Monster Beverage: More Profit Pain Ahead ||| What Kind Of Shareholders Own The Coca-Cola Company (NYSE:KO)? ||| The Sectors to Focus on As the Holiday Season Kicks Off ||| WeWork and Oatly Report ||| Brazilian orange juice producer Cutrale suspends exports to the U.S. -report,1,0.52232784
2021-11-26,14754300.0,54.59000015258789,54.75,53.58000183105469,53.72999954223633,50.20068359375,KO,Four Days Left To Buy The Coca-Cola Company (NYSE:KO) Before The Ex-Dividend Date ||| This Popular Beverage Maker Took a Big Step Toward Larger Gains for Its Investors,1,0.5323728
2021-11-29,22712500.0,54.04999923706055,54.72999954223633,53.93000030517578,54.58000183105469,50.99485397338867,KO,"iShares Russell 1000 ETF Experiences Big Outflow ||| Coca-Cola Company (KO) Ex-Dividend Date Scheduled for November 30, 2021",0,0.47060657
2021-11-30,30485200.0,53.59999847412109,53.630001068115234,52.43999862670898,52.45000076293945,49.38478469848633,KO,4 Stocks Billionaires Are Buying Hand Over Fist,0,0.49523902
2021-12-01,18719600.0,52.97999954223633,53.52000045776367,52.27999877929688,52.29999923706055,49.24355316162109,KO,"FOCUS-Zero-sugar Oreos see weak China response despite healthy snacking trend ||| Is a Monster Merger Brewing? ||| Dow Jones Falls 462 Points on Omicron Fears, Salesforce.com 11% Drop ||| 2 Monster Growth Stocks to Buy Now and Hold ||| Coca-Cola: The Dividend Is Not Worth It",1,0.5174968
2021-12-03,21064400.0,53.33000183105469,53.61000061035156,52.97999954223633,53.540000915527344,50.41107940673828,KO,5 Best Dividend Stocks For Your Late 2021 List ||| REUTERS NEXT-Omicron may throw wrench in companies' plans to return to office,1,0.53264195
2021-12-06,26624100.0,54.310001373291016,55.25,54.13999938964844,54.90999984741211,51.701019287109375,KO,3 Incredible Value Stocks to Buy Before 2021 Is Over,1,0.5394414
2021-12-07,23832700.0,55.02000045776367,55.41999816894531,54.84999847412109,55.209999084472656,51.98348617553711,KO,"iShares Russell 1000 ETF Experiences Big Inflow ||| Pre-Market Most Active for Dec 7, 2021 : SQQQ, ABUS, INTC, TWTR, UBER, AAPL, KO, BABA, LCID, TQQQ, NIO, OWL ||| 7 Stocks to Watch as the Omicron Variant Becomes the Market’s New Wildcard",0,0.48356718
2021-12-09,13846400.0,54.75,55.130001068115234,54.59000015258789,54.86000061035156,51.6539421081543,KO,Shareholder objects to Activision CEO Kotick's renomination to Coca-Cola board ||| Shareholder objects to Activision CEO Kotick's renomination to Coca-Cola board,1,0.5168001
2021-12-10,23153600.0,55.25,56.31999969482422,55.06999969482422,56.27999877929688,52.99095916748047,KO,"After Hours Most Active for Dec 10, 2021 : FTXN, C, BZ, EDU, OCFT, DLTR, FTXR, JD, TAL, TCOM, KO, YMM ||| 2 Dividend Stocks That Will Pay You for Life",1,0.49351358
2021-12-13,31362800.0,56.97999954223633,57.93000030517578,56.959999084472656,57.7599983215332,54.38446044921875,KO,"Dow Movers: AXP, KO ||| Coca-Cola Recalls 3 Minute Maid Drinks Due To Foreign Matter ||| Monday's ETF with Unusual Volume: KXI",1,0.5106193
2021-12-14,24806600.0,57.400001525878906,58.16999816894531,57.400001525878906,57.79999923706055,54.422122955322266,KO,"7 of the Best Retirement Stocks to Buy Now for 2022 ||| With the Dow Up 16% for the Year, Is It Too Late to Buy? ||| 2 ‘Perfect 10’ Stocks with Strong Growth Potential",1,0.5253203
2021-12-15,24923800.0,57.93000030517578,58.25,57.650001525878906,58.060001373291016,54.666934967041016,KO,"Noteworthy ETF Inflows: DLN, ABBV, MRK, KO ||| 3 Consumer Staples Stocks to Buy for Safety ||| The Coca-Cola Company (NYSE:KO) Shares Could Be 27% Below Their Intrinsic Value Estimate",1,0.5102673
2021-12-17,51874400.0,58.4900016784668,58.91999816894531,57.70000076293945,57.72999954223633,54.35622024536133,KO,5 Top Dividend Kings to Buy and Hold Forever ||| How Has Warren Buffett's Stock Portfolio Performed in 2021?,0,0.5029786
2021-12-20,20879500.0,57.20000076293945,57.77999877929688,57.0,57.540000915527344,54.17731857299805,KO,"Successful Investors: What Would You Do in 2022 With a Blank Slate and $5,000?",1,0.50570047
2021-12-23,11027300.0,58.52000045776367,58.61000061035156,57.93999862670898,58.220001220703125,54.81758117675781,KO,iShares Core S&P Total U.S. Stock Market ETF Experiences Big Inflow ||| 3 Top Dividend Stocks to Buy Now,1,0.49564326
2021-12-27,9860000.0,58.0,58.68999862670898,58.0,58.650001525878906,55.22245407104492,KO,Coca-Cola Co Shares Close in on 52-Week High - Market Mover ||| 2 Robinhood Stocks to Buy Before the Year Ends ||| Best Dividend Stocks To Buy In 2022? 5 For Your Watchlist ||| Give the Gift of Investing With This Classic Stock Bundle,1,0.5116412
2021-12-28,8979900.0,58.400001525878906,58.93999862670898,58.29999923706055,58.880001068115234,55.43901062011719,KO,Is This Iconic Dividend Growth Stock a Buy for 2022?,1,0.53017837
2021-12-29,9996000.0,58.95000076293945,59.09999847412109,58.65999984741211,58.95000076293945,55.50491714477539,KO,"4 Ways To Grow $100,000 Into $1 Million for Retirement Savings ||| Invest Like Warren Buffett in 2022 and Buy These 3 Stocks for the Long Haul",0,0.5198252
2021-12-30,7703900.0,59.060001373291016,59.22999954223633,58.7599983215332,58.77999877929688,55.344852447509766,KO,Best Stocks for 2022: Deep Value Tech Stock POSaBIT Is A Can’t Miss Cannabis Play ||| 2 Stocks Under $100 You Can Buy and Hold Forever ||| 3 Dividend Kings to Buy for 2022,1,0.49213174
2021-12-31,10021300.0,58.75,59.34999847412109,58.70000076293945,59.209999084472656,55.74972152709961,KO,Coca-Cola: Another Company Succumbs to the Everything Bubble ||| Why Disney Is My Top Stock During Inflationary Periods,1,0.5226224
2022-01-03,20187300.0,58.81999969482422,59.310001373291016,58.380001068115234,59.29999923706055,55.83446502685547,KO,"3 Reopening Stocks to Counter Inflation ||| Where to Invest $100,000 in 2022 ||| 5 Cyclical Stocks To Watch In January 2022 ||| Pre-Market Most Active for Jan 3, 2022 : AFI, F, SQQQ, APLT, NIO, BMY, TSLA, KO, XERS, CPOP, AAPL, XOM ||| POSAF Stock: My No. 1 Moonshot Pick for 2022",1,0.53189063
2022-01-04,26141600.0,59.72999954223633,60.540000915527344,59.59000015258789,60.290000915527344,56.76660919189453,KO,Investors Met With Slowing Returns on Capital At Coca-Cola (NYSE:KO) ||| Meet the 2022 Dogs of the Dow,1,0.50123847
2022-01-05,22507300.0,60.09000015258789,61.20000076293945,60.04999923706055,60.790000915527344,57.23738479614258,KO,3 Dividend Giants to Pad Your Income in 2022 ||| The Coca-Cola Company (NYSE:KO) Remains a Linebacker in a Defensive Portfolio ||| This Beverage Giant Seems Better Placed Compared To PepsiCo,0,0.51441604
2022-01-06,17902300.0,60.470001220703125,61.119998931884766,60.43999862670898,60.470001220703125,56.93609237670898,KO,10 Warren Buffett Stocks That Belong on Your 2022 Watchlist ||| Coca-Cola Co Shares Near 52-Week High - Market Mover ||| Constellation Brands To Bring Coca-Cola's FRESCA Brand To The U.S. Next Year - Quick Facts,0,0.5140986
2022-01-07,12307900.0,60.27999877929688,60.720001220703125,60.060001373291016,60.33000183105469,56.80427932739258,KO,Tech Selloff Highlights Choppy First Week of 2022 ||| Constellation Brands Earnings: 3 Takeaways ||| Coca-Cola Collaborates with Constellation Brands to Launch FRESCA Mixed,1,0.53097314
2022-01-10,20954300.0,60.54999923706055,60.81999969482422,60.18000030517578,60.43000030517578,56.89842224121094,KO,"Coca-Cola Co Shares Close in on 52-Week High - Market Mover ||| Canopy Growth Continues to Weigh on Constellation Brands' Performance ||| Notable ETF Inflow Detected - ITOT, DIS, KO, UPS",1,0.5009859
2022-01-11,19369600.0,60.43000030517578,60.4900016784668,59.84000015258789,60.45000076293945,56.91726303100586,KO,Dow Analyst Moves: KO ||| Better Dividend Stock for 2022: Coca Cola or Home Depot?,1,0.499486
2022-01-12,15753800.0,60.52999877929688,60.68999862670898,60.18999862670898,60.540000915527344,57.00199890136719,KO,3 Warren Buffett-Approved Dividend Stocks to Buy ||| Coca-Cola Co Shares Approach 52-Week High - Market Mover ||| 2022 Market Prediction: Coca-Cola Outperforms PepsiCo ||| Meta Platforms Stock Has Become a Bargain,1,0.5444098
2022-01-13,14318000.0,60.540000915527344,61.040000915527344,60.38999938964844,60.900001525878906,57.34095764160156,KO,"After Hours Most Active for Jan 13, 2022 : AAPL, GGB, ATVI, PFE, QQQ, AMH, INFY, MSFT, KBWB, F, KO, BZ ||| Coca-Cola Co Shares Close in on 52-Week High - Market Mover ||| 7 Dividend Stocks You Can Depend on in 2022 and Beyond",1,0.5264551
2022-01-14,19729600.0,60.93999862670898,61.45000076293945,60.36000061035156,61.38999938964844,57.80232620239258,KO,ETF Strategies to Beat Inflation & Follow Warren Buffett ||| Monster Beverages (MNST) Enters Alcohol Space Via CANarchy Buyout,0,0.50425553
2022-01-18,21976700.0,61.060001373291016,61.18999862670898,60.45000076293945,60.900001525878906,57.34095764160156,KO,"Coca-Cola Co Shares Approach 52-Week High - Market Mover ||| Big brands call for global pact to cut plastic production ||| 3 Top Unstoppable Warren Buffett-Type Stocks to Buy in 2022 ||| 7 Defensive Stocks to Hide from the Market’s Slow Crash ||| Noteworthy ETF Inflows: VYM, VZ, ABBV, KO",1,0.50558007
2022-01-19,18654700.0,60.65999984741211,61.18000030517578,60.560001373291016,61.0,57.43511962890625,KO,"3 Dividend Stocks to Buy and Hold Forever ||| Got $3,000? 5 Buffett Stocks to Buy and Hold Forever ||| Coca-Cola Co Shares Approach 52-Week High - Market Mover ||| 5 Reasons to Invest in Dividend Stocks for Retirement ||| Do Options Traders Know Something About Coca-Cola (KO) Stock We Don't?",0,0.5013408
2022-01-20,23002400.0,61.0,61.43999862670898,60.720001220703125,60.75,57.19972610473633,KO,7 Dividend Stocks to Watch as Bond Yields Creep Higher ||| Thursday's ETF with Unusual Volume: PBJ,0,0.49075794
2022-01-21,26643200.0,61.08000183105469,61.29999923706055,60.400001525878906,60.45000076293945,56.91726303100586,KO,"The Future of Food, EVs in the Spotlight, and 3 Trends to Watch in 2022 ||| 7 Stocks to Buy for a Year Full of Volatility and Rate Hikes ||| The 10 Best Consumer Cyclical Stocks to Buy for 2022",0,0.48818672
2022-01-24,30185100.0,59.900001525878906,60.34999847412109,58.56999969482422,59.959999084472656,56.45588684082031,KO,"4 Index Funds I Predict Will Beat the Market in 2022 ||| The New York Times Co. + The Athletic. Will It Work? ||| Stocks to Watch, Cool Tech From CES, and What's Going on With the Nasdaq ||| Where Will Matterport Be in 3 Years?",0,0.4887255
2022-01-25,19027100.0,59.36000061035156,60.04999923706055,58.68999862670898,59.81999969482422,56.32407760620117,KO,"Molson Coors Inks Exclusive Deal With Coca-Cola To Launch Simply Spiked Lemonade - Quick Facts ||| Coca-Cola, Molson Coors to launch Simply-branded alcoholic drinks ||| Should You Be Adding Coca-Cola (NYSE:KO) To Your Watchlist Today? ||| 3 Reasons Metaverse Real Estate in Decentraland Is a Good Investment",0,0.49577665
2022-01-26,19190200.0,59.790000915527344,60.34999847412109,59.209999084472656,59.59999847412109,56.11692810058594,KO,"Coca-Cola (KO) Dips More Than Broader Markets: What You Should Know ||| DGRO, JNJ, MSFT, KO: Large Inflows Detected at ETF",1,0.51250535
2022-01-27,18893800.0,59.880001068115234,60.93000030517578,59.5,59.650001525878906,56.16401290893555,KO,Say Hello to 2022’s Dogs of the Dow: 10 Dividend Stocks to Watch ||| Thursday's ETF with Unusual Volume: PBJ ||| What Olympics? Advertisers lay low ahead of Beijing Winter Games,1,0.5005752
2022-01-28,19101500.0,59.38999938964844,60.88999938964844,58.93999862670898,60.84000015258789,57.28446578979492,KO,Start Your Investing Resolutions Off Right With This Classic Stock Bundle,1,0.5248361
2022-01-31,22045300.0,60.29999923706055,61.13999938964844,60.150001525878906,61.0099983215332,57.44453048706055,KO,Did Omicron's Rise Slow Coca-Cola's Rebound in Q4? ||| Nearing Retirement? These Stocks Are as Safe as They Come ||| Thank Bitcoin for Making This Stock So Cheap in 2022 ||| Coca-Cola Co Shares Near 52-Week High - Market Mover ||| How The Canopy Growth Acquisition Is Weighing on Constellation Brands,0,0.5088287
2022-02-01,20841700.0,60.90999984741211,61.13999938964844,60.15999984741211,60.560001373291016,57.02082824707031,KO,"It Pains Me To Say This, But Coca Cola Looks Stagnant ||| Coca-Cola (KO) Stock Sinks As Market Gains: What You Should Know ||| Is Keurig Dr Pepper A Better Pick Over This Food And Beverage Giant? ||| Plastics clampdown is key to climate change fight, EU environment chief says",1,0.5215507
2022-02-02,20225600.0,60.619998931884766,61.27000045776367,60.560001373291016,61.18000030517578,57.60459518432617,KO,Top Dividend Stocks To Watch This Week ||| 2 Top Buffett Stocks to Buy for the Long Haul,1,0.50901043
2022-02-03,19440500.0,60.93999862670898,61.77999877929688,60.59000015258789,61.61000061035156,58.00946807861328,KO,Analysts Estimate Coca-Cola (KO) to Report a Decline in Earnings: What to Look Out for,0,0.48198763
2022-02-04,17403700.0,61.4900016784668,61.68000030517578,60.56999969482422,60.959999084472656,57.3974494934082,KO,Wall St Week Ahead-Inflation data next focus for investors after bond yield spike,1,0.51734674
2022-02-07,17846400.0,61.380001068115234,61.720001220703125,60.86000061035156,61.59999847412109,58.00004959106445,KO,"Wall St Week Ahead-Inflation data next focus for investors after bond yield spike ||| Coca-Cola Earnings: What to Watch ||| 3 Things to Watch in the Stock Market This Week ||| Earnings Data Deluge ||| Quarterly Beats for Tyson (TSN), Onsemi (ON) and Hasbro (HAS) ||| Factors Likely to Influence Coca-Cola's (KO) Q4 Earnings ||| Dow Logs Muted Win Despite Volatile Trading ||| Top Research Reports for Bank of America, Coca-Cola & salesforce",1,0.49893317
2022-02-08,18771700.0,61.83000183105469,62.33000183105469,61.7400016784668,62.0,58.37667465209961,KO,"Why Coke (KO) is Poised to Beat Earnings Estimates Again ||| 7 Stocks That Will Win Whether It’s a Bull or Bear Market ||| The Zacks Analyst Blog Highlights Bank of America, The Coca-Cola Co, salesforce.com, Thermo Fisher Scientific and BlackRock",0,0.47795683
2022-02-09,23595600.0,62.16999816894531,62.31999969482422,60.900001525878906,61.040000915527344,57.472782135009766,KO,"Pre-Market Earnings Report for February 10, 2022 : KO, PEP, PM, LIN, AZN, DUK, MCO, GPN, DDOG, TU, TWTR, LH ||| Matterport Stock Is Still a Growth Story ||| Soft Drinks Stock Q4 Earnings Roster on Feb 10: KO, PEP & COCO ||| 3 Best Bear Market Stocks to Buy Now to Prepare for a Bumpy Ride Ahead",1,0.47513673
2022-02-10,23561500.0,60.36000061035156,62.29999923706055,60.20000076293945,61.380001068115234,57.79290771484375,KO,"Consumer Sector Update for 02/10/2022: DIS, KO, UL, XLP, XLY ||| Wall Street set to slide after hot CPI data ||| Coca-Cola (KO) Q4 2021 Earnings Call Transcript ||| Coca-Cola, criticized for plastic pollution, pledges 25% reusable packaging ||| Consumer Sector Update for 02/10/2022: IRBT, GOOS, GOOS.TO, KO, K ||| Consumer Sector Update for 02/10/2022: GOOS,GOOS.TO,KO,K ||| CPI for January Increased Higher Than Expectations ||| Coca-Cola (KO) Beats Q4 Earnings and Revenue Estimates ||| The Coca-Cola Company Q4 Profit Increases, beats estimates ||| Coca-Cola beats quarterly revenue estimates ||| The Coca-Cola Q4 21 Earnings Conference Call At 8:30 AM ET ||| These 4 Stocks Make Up Nearly 75% of Warren Buffett's Portfolio ||| Inflation Back on Front Burner: CPI +0.6% Not Cool ||| Inflation Back on Front Burner: CPI +0.6% Not Cool (revised)",0,0.49382567
2022-02-11,22781400.0,61.77000045776367,61.97999954223633,60.150001525878906,60.290000915527344,56.76660919189453,KO,"NFT marketplace shuts, citing 'rampant' fakes, plagiarism problem ||| 5 Numbers to See From Coca-Cola's Earnings Announcement ||| Company News for Feb 11, 2022",1,0.47841185
2022-02-14,23641300.0,60.15999984741211,60.790000915527344,59.27999877929688,60.68000030517578,57.133819580078125,KO,Best Stocks To Invest In 2022? 4 Consumer Staples Stocks To Watch ||| 3 Top Stocks to Buy for the Long Haul ||| Is Coca-Cola (NYSE:KO) A Risky Investment? ||| Coca-Cola's (NYSE:KO) 60th Consecutive Dividend Increase is on the Menu ||| Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)? ||| 3 Little-Known NFT Cryptos Coming on the Scene ||| Meta Platforms: Time to Buy the Dip? ||| These 6 Stocks Are Netting Warren Buffett a Combined $4.1 Billion in Annual Dividend Income,1,0.49755344
2022-02-15,13408700.0,60.959999084472656,61.77999877929688,60.630001068115234,60.90999984741211,57.35036849975586,KO,Mexican bottler Arca's quarterly net profit up 26.5% on high demand,0,0.51782686
2022-02-16,15484700.0,60.86000061035156,61.400001525878906,60.560001373291016,60.900001525878906,57.34095764160156,KO,Coca-Cola Delivered Double-Digit Revenue Growth in Q4: Price Increases Played a Major Role ||| 7 Passive Income Stocks To Buy Despite Rising Interest Rates,1,0.54148495
2022-02-17,21468700.0,60.54999923706055,62.27999877929688,60.40999984741211,62.119998931884766,58.48966217041016,KO,"Coca-Cola Unveils ""Space-Themed"" Flavor, Starlight For A Different Experience ||| Boston Beer (SAM) Q4 Earnings & Revenues Miss on Soft Trends ||| Watch for 4 Top Stock Holdings in Warren Buffett's Portfolio ||| 5 High ROE Stocks to Buy as Dovish Fed Stance Soothes Markets",1,0.5237779
2022-02-18,21975000.0,62.119998931884766,62.81999969482422,61.9900016784668,62.540000915527344,58.88511657714844,KO,"Is Archer Daniels Midland (ADM) Stock Outpacing Its Consumer Staples Peers This Year? ||| Daily Dividend Report: KO,MPW,NEE,AVB,ABT ||| Is Steris a Warren Buffett Stock? ||| INSIGHT-U.N. pact may restrict plastic production. Big Oil aims to stop it ||| Zacks.com featured highlights include: The Coca-Cola Co., Microchip Technology Inc., Qualcomm Inc., Whirlpool Corp. and D.R. Horton, Inc ||| Forget Disney -- Here Are 2 Better Dividend Stocks",0,0.47720844
2022-02-22,21731400.0,62.43000030517578,62.63999938964844,61.720001220703125,62.27999877929688,58.64030838012695,KO,"Looking To Invest Like Warren Buffett? Here Are His Top 5 Holdings Now ||| 4 Investing Strategies to Navigate the Stock Market Right Now ||| Should You Invest in the iShares U.S. Consumer Staples ETF (IYK)? ||| Top 5 Consumer Staples Stocks to Buy Amid Recent Meltdown ||| Want to Get Richer? 5 Best Stocks to Buy Now and Hold Forever ||| Coca-Cola HBC FY21 Profit Climbs, Lifts Dividend; Sees Growth In FY22 - Quick Facts ||| Bottler Coca-Cola HBC trounces profit estimate as demand soars ||| Bottler Coca-Cola HBC trounces profit estimates as demand soars",0,0.4809032
2022-02-23,19248500.0,62.2400016784668,62.33000183105469,61.34000015258789,61.59000015258789,57.99063873291016,KO,Coca-Cola (KO) Stock Moves -1.11%: What You Should Know ||| Invest in Virtual Real Estate With Move-in Ready Decentraland,0,0.4811566
2022-02-24,27207400.0,59.970001220703125,60.619998931884766,59.220001220703125,60.5099983215332,56.97374725341797,KO,"5 Top Consumer Staples Stocks To Watch As Russia Begins Ukraine Invasion ||| As Prices Drop, It’s a Great Time to Accumulate Ethereum Long Term ||| Companies shut Ukraine operations and brace for sanctions on Russia ||| Companies shut Ukraine operations and watch for sanctions as Russia attacks ||| 5 Monster Dividend Stocks Nearing Highs While the Nasdaq Plunges ||| Should You Invest in the Vanguard Consumer Staples ETF (VDC)?",1,0.5541474
2022-02-25,21487800.0,60.93999862670898,62.900001525878906,60.91999816894531,62.84999847412109,59.17699432373047,KO,"Are NFTs a Scam? Bulls Are Standing Strong Amid the Backlash ||| Monster Beverage (MNST) Q4 Earnings in Line, Sales Surpass ||| Which Is a Better Buy: Coca-Cola or Altria?",0,0.47898692
2022-02-28,25879100.0,61.650001525878906,62.34000015258789,61.40999984741211,62.2400016784668,58.6026496887207,KO,"7 Safe Stocks to Buy for March 2022 As Value Is Back in Force ||| ACWI, XOM, CVX, KO: ETF Inflow Alert ||| 7 Safe Defensive Stocks to Buy as Market Agitation Rises",0,0.48788306
2022-03-01,15871100.0,62.13999938964844,62.75,61.5099983215332,61.970001220703125,58.34843063354492,KO,"FEMSA (FMX) Misses on Q4 Earnings, Beats Revenues Estimates ||| Coca-Cola (KO) Stock Moves -0.43%: What You Should Know ||| 3 of My Favorite Dividend Stocks (and They're Not What You Think)",1,0.48403925
2022-03-02,17319100.0,62.22999954223633,62.880001068115234,61.77999877929688,62.43000030517578,58.781551361083984,KO,"After Hours Most Active for Mar 2, 2022 : SNOW, UBER, COTY, TLT, QQQ, PFE, AAPL, RTX, AMD, KO, FAST, CG ||| Which Companies Have Pricing Power? ||| 87% of Warren Buffett's Portfolio Is in These 3 Sectors",1,0.4739369
2022-03-03,21262800.0,62.61000061035156,63.02000045776367,62.290000915527344,62.470001220703125,58.81920623779297,KO,"Bottler Coca Cola HBC stops production in Kyiv, scraps annual forecasts",1,0.5288923
2022-03-04,17163000.0,61.459999084472656,62.59000015258789,61.20000076293945,62.56999969482422,58.91336441040039,KO,ANALYSIS-Big Oil's plastic boom threatens U.N.'s 'historic' pollution pact ||| Trying to Time the Market Doesn't Work ||| Are Options Traders Betting on a Big Move in The Coca-Cola Company (KO) Stock? ||| What Are the Best Stocks to Buy for Inflation? Here Are Our Top 10 Picks  ||| These 2 Dividend Kings Are Top Buffett Stocks. Are They Buys? ||| 5 High ROE Stocks to Buy as Geopolitical Crisis Hits Market ||| Warren Buffett's Secret to Netting a 54% Annual Yield on One of His Top Stocks,0,0.46932423
2022-03-07,29151400.0,62.0099983215332,62.06999969482422,60.720001220703125,61.08000183105469,57.510440826416016,KO,Bottle Up Strong Profit Potential with Coca-Cola Consolidated ||| Berkshire Hathaway reveals $5 bln Occidental stake as Icahn exits ||| Occidental rises after Berkshire Hathaway reveals $5 bln stake,0,0.49240574
2022-03-08,30242100.0,61.45000076293945,61.540000915527344,58.59000015258789,58.65999984741211,55.23186492919922,KO,"Russia's Economic Freeze-Out Advances ||| Coca-Cola, Starbucks And McDonald's Join Mass Exodus From Russia ||| 4 Top Dividend Stocks To Watch In March 2022 ||| Notable ETF Inflow Detected - ACWI, XOM, CVX, KO",1,0.50121576
2022-03-09,23022700.0,59.81999969482422,59.84000015258789,58.65999984741211,58.959999084472656,55.51433563232422,KO,"Coca-Cola (KO) Gains But Lags Market: What You Should Know ||| Makers of basic necessities face 'tradeoff' supplying Russia with cookies, soap ||| Ethical Dividend Investing (Invasions, Oil and More) ||| Pre-Market Most Active for Mar 9, 2022 : TQQQ, KO, SQQQ, CTVA, QQQ, NVDA, CSCO, AAPL, CCL, NINE, GOLD, F ||| Makers of basic necessities face 'tradeoff' supplying Russia with cookies, soap ||| 8 Strong Uptrend Stocks to Buy on the Next Dip ||| Ukraine's task is to hold off Russia for 7-10 days-senior official ||| Exodus draws Russian threat to nationalise foreign plants",0,0.47563964
2022-03-10,20887300.0,58.47999954223633,58.65999984741211,57.5,57.880001068115234,54.4974479675293,KO,"3 Restaurant Stocks to Buy as Equities Struggle Through Events ||| Coca Cola Consolidated Is a Buy Thanks to a Huge Free Cash Flow ||| How Big of a Risk Is Russian Divestment? ||| The 2 Best Stocks to Buy Now That the Market Is in Correction Territory ||| Warren Buffett Is Netting Between a 20% and 54% Yield Annually From These Stocks ||| Rio first big miner to cut Russia ties; Sony, Nintendo halt console sales",1,0.5054278
2022-03-11,19855600.0,57.959999084472656,58.84999847412109,57.86000061035156,57.91999816894531,54.53511047363281,KO,"Is Now the Time to Buy Coca-Cola Stock? ||| The Best Warren Buffett Stocks to Buy With $250 Right Now ||| How Does Your Portfolio Compare to Warren Buffett's? ||| Don't take Russia back to 1917, Russian metals king Potanin warns",1,0.4968954
2022-03-14,17799400.0,57.970001220703125,59.040000915527344,57.970001220703125,58.540000915527344,55.540809631347656,KO,"3 Best Dividend Stocks for Retirement ||| Why Peloton Isn't Going Anywhere Any Time Soon ||| 3 Strong Warren Buffett Stocks for a Volatile Market ||| What's Happening With Russian Oil and U.S. Gas Prices? ||| 4 Blue-Chip Stocks to Buy in March ||| Top Research Reports for Pfizer, Coca-Cola & Adobe ||| Here's Why it is Appropriate to Own Diageo (DEO) Stock Now ||| McCormick (MKC) Suspends Russian Operations Amid Conflict",1,0.5161725
2022-03-15,18607200.0,59.08000183105469,59.88999938964844,58.97999954223633,59.619998931884766,56.56547164916992,KO,My Top 2 Dividend Stocks to Buy Now ||| 3 Stocks To Buy That Should Score Big From March Madness 2022 ||| Warren Buffett Has Gained Over $182 Billion On These 4 Stocks ||| 11 Surprising Things About Warren Buffett and Berkshire Hathaway,0,0.46294296
2022-03-16,17347300.0,59.77999877929688,59.93999862670898,58.61000061035156,59.459999084472656,56.41366958618164,KO,"Notable ETF Inflow Detected - IVV, KO, PEP, CMCSA",1,0.50432664
2022-03-17,15586200.0,59.459999084472656,60.13999938964844,59.22999954223633,60.09000015258789,57.01139450073242,KO,Should You Invest in the Consumer Staples Select Sector SPDR ETF (XLP)? ||| Understanding Russian Oligarchs ||| Check Out This Dividend King You've Probably Never Heard Of,1,0.51045424
2022-03-18,30197800.0,60.29999923706055,60.29999923706055,59.709999084472656,60.09999847412109,57.020877838134766,KO,"Keurig (KDP) Looks Poised on Brand Strength Amid Supply Woes ||| Warren Buffett Has Made 1,725% to 2,985% Gains On These 3 Stocks",1,0.4868384
2022-03-21,17440100.0,60.5,61.09999847412109,60.25,60.58000183105469,57.47628784179688,KO,"5 Unexpected Sources of Retirement Income ||| After Hours Most Active for Mar 21, 2022 : BABA, INTC, AAPL, MDLZ, IBN, COTY, PFE, KO, USB, CMCSA, MSFT, QQQ ||| Want $2,860 in Passive Income? Invest $100,000 in These 3 Stocks ||| 3 Vanguard ETFs That Could Help You Retire a Millionaire",1,0.5468571
2022-03-22,17559500.0,60.93000030517578,60.95000076293945,60.060001373291016,60.79999923706055,57.68501663208008,KO,"After Hours Most Active for Mar 22, 2022 : PDBC, CVE, AAPL, KO, MSFT, MDLZ, GM, INTC, QQQ, PLTR, TSM, FSR ||| 5 Stocks With High ROE to Buy as Fed Aims to Tame Inflation",0,0.47614756
2022-03-24,13151300.0,60.63999938964844,61.02000045776367,60.459999084472656,60.97999954223633,57.85579681396485,KO,Be Careful Before You Lock and Load on Black Rifle Company ||| MOVES-Deutsche Bank appoints Ahlersmeyer to U.S. building products research unit - memo ||| 7 Recession-Resistant Stocks to Buy to Prepare for the Worst,1,0.49666113
2022-03-25,12259800.0,61.119998931884766,61.61000061035156,61.04999923706055,61.52999877929688,58.37761688232422,KO,Philip Morris (PM) Takes Bold Steps to Cut Operations in Russia ||| Occidental Petroleum Stock Looks Overheated After Doubling This Year ||| Caterpillar Inc: Current Conditions Point to Further Growth,1,0.54588354
2022-03-28,11485200.0,61.52999877929688,61.93999862670898,61.209999084472656,61.91999816894531,58.74763488769531,KO,"Coca-Cola Just Joined This Exclusive Group of Stocks ||| Pre-Market Most Active for Mar 28, 2022 : TLRY, TSLA, AAPL, SQQQ, NIO, TQQQ, XPEV, KO, NEE, DIDI, QQQ, BHP",1,0.47058678
2022-03-29,14720600.0,62.209999084472656,62.52999877929688,61.7400016784668,62.15999984741211,58.975341796875,KO,Dow Analyst Moves: KO ||| Broker Darlings of the Dow: Coca-Cola Ranks As a Top 15 Analyst Pick,1,0.5193067
2022-03-31,16822900.0,62.220001220703125,62.63999938964844,62.0,62.0,58.82353973388672,KO,"Coca-Cola (KO) Stock Moves -0.34%: What You Should Know ||| 7 Food Stocks to Buy as Shortages Impose Huge Pressures ||| Why These 3 Dividend Aristocrats Are Good Buys During a Bear Market ||| Dow Movers: WBA, AMGN",1,0.47050896
2022-04-04,11505800.0,62.59999847412109,62.790000915527344,61.720001220703125,62.540000915527344,59.33586883544922,KO,3 Reasons to Buy Dividend Aristocrats for Your Retirement Account ||| The Biggest Revolution Since the Computer Is Here — Synthetic Biology 🧫 ||| 3 Reasons Why Warren Buffett Is Beating the Stock Market in 2022 ||| 7 No-Brainer Stocks to Buy for April,0,0.51261675
2022-04-05,15721200.0,62.400001525878906,63.2400016784668,62.369998931884766,62.470001220703125,59.26945877075195,KO,3 Safe Long-Term Stocks to Ride Out the Volatility,1,0.5400112
2022-04-06,19267400.0,62.77000045776367,63.2599983215332,62.29999923706055,63.09999847412109,59.867183685302734,KO,"Coca-Cola Co Shares Close in on 52-Week High - Market Mover ||| SPLV, JNJ, HSY, KO: ETF Inflow Alert ||| Warren Buffett's Top Stocks",1,0.47694683
2022-04-07,13960800.0,63.130001068115234,63.66999816894531,62.709999084472656,63.43999862670898,60.18976211547852,KO,"3 Blue-Chip Stocks That Provide Defense ||| Top Research Reports for NVIDIA, Coca-Cola & Thermo Fisher ||| US STOCKS-Wall St eyes muted open as Fed, Ukraine worries linger ||| 8 Robinhood Stocks to Buy for April",1,0.51249963
2022-04-08,12703500.0,63.47999954223633,64.04000091552734,63.15999984741211,63.83000183105469,60.55978393554688,KO,"The Zacks Analyst Blog Highlights NVIDIA, The Coca-Cola,Thermo Fisher Scientific, Salesforce, and SAP ||| Growth Stocks Are Selling Off Again -- Here's How to Handle Stock Market Volatility ||| Starbucks: Howard Schultz’ End Game ||| Drinks firms spooked as India refuses to exempt some plastic straws from ban",0,0.47675714
2022-04-11,12720100.0,63.90999984741211,64.30000305175781,63.63999938964844,63.810001373291016,60.54080581665039,KO,4 Unstoppable Warren Buffett Dividend Stocks That are Passive Income Machines ||| 3 Top Stocks to Buy for the Long Haul ||| 3 Safe Warren Buffett Dividend Stocks to Buy This Spring ||| Best Dividend Stocks To Buy Today? 4 In Focus ||| Monday's ETF with Unusual Volume: PBJ ||| India's Amul dairy says bracing for sales disruption due to straws ban ||| Will Coca-Cola Stock See Higher Levels?,1,0.49327266
2022-04-13,11883000.0,64.44000244140625,64.87000274658203,64.2300033569336,64.7300033569336,61.413673400878906,KO,Coca-Cola Co Shares Climb 0.2% Past Previous 52-Week High - Market Mover ||| 2 Top Warren Buffett Stocks to Buy Right Now,1,0.50978833
2022-04-14,16388400.0,64.95999908447266,65.56999969482422,64.81999969482422,65.0199966430664,61.688812255859375,KO,"3 Defensive Stocks to Buy As They Climb to New Heights ||| Notable ETF Inflow Detected - SPLV, HSY, KO, JNJ ||| 2 Stocks Under $100 You Can Buy and Hold Forever",0,0.49602494
2022-04-18,11679400.0,64.7699966430664,65.18000030517578,64.18000030517578,64.44000244140625,61.13853454589844,KO,"Coca-Cola Co Shares Approach 52-Week High - Market Mover ||| A New Virtual Currency, Berkshire Hathaway's Stake in HP, and More",1,0.51202077
2022-04-19,11993800.0,64.5,65.25,64.44000244140625,65.06999969482422,61.73624801635742,KO,"Mexico's Coca-Cola FEMSA seals Campari distribution deal in Brazil ||| Coca-Cola: Are Its Dividend Growth Prospects Shrinking? ||| 7 Undervalued Stocks That Can Withstand High Inflation and a Recession ||| Here's How Boston Beer (SAM) is Placed Ahead of Q1 Earnings ||| Got $5,000? Buy and Hold These 3 Value Stocks for Years",1,0.50268465
2022-04-20,14827100.0,65.44000244140625,66.23999786376953,65.4000015258789,65.95999908447266,62.580657958984375,KO,3 Top Pot Stocks to Buy Right Now ||| Are You Missing Out on This Giant Company's 5% Dividend Raise? ||| Here's Why Coca-Cola (KO) Looks Poised for Q1 Earnings Beat ||| Should You Buy Coca-Cola (KO) Ahead of Earnings?,1,0.5495763
2022-04-21,15120400.0,65.9800033569336,67.0,65.72000122070312,66.20999908447266,62.81785202026367,KO,Coca-Cola (KO) Gains As Market Dips: What You Should Know ||| How to Value a Company With the Discounted Cash Flow Model ||| Coca-Cola Has Some Big Questions to Answer For Investors on Monday,0,0.48548275
2022-04-22,14902200.0,66.08000183105469,66.33999633789062,65.18000030517578,65.25,61.90702819824219,KO,"Coca-Cola vs. Pepsi, Which Is The Better Buy? ||| Wall St Week Ahead-Stakes are high as megacap companies highlight big earnings week ||| Pre-Market Earnings Report for April 25, 2022 : KO, ATVI, OTIS, LII, CBU, BOH, DORM, LKFN, WASH, HBT, BMRC ||| Previewing Tech Earnings After Netflix's Fiasco ||| Notable ETF Inflow Detected - SPLV, HSY, KO, SO ||| Starbucks Has Less International Exposure Than You May Think ||| Factors to Decide Archer Daniels' (ADM) Fate in Q1 Earnings",1,0.48894715
2022-04-25,25082000.0,67.0,67.19999694824219,64.77999877929688,65.94000244140625,62.56169128417969,KO,"This Warren Buffett Favorite Is Making Record Highs ||| Down More Than 23%, This Year's 2 Worst-Performing Dow Stocks Look Like Monster Buys Right Now ||| This Unstoppable Dividend Aristocrat Is 2022's Best-Performing Dow Stock (and It's Not Even Close) ||| 3 Best Buffett Stocks to Buy for the Long Haul ||| Wall St Week Ahead-Stakes are high as megacap companies highlight big earnings week ||| Big Week Ahead for Q1, Economic Data; KO Beats, ATVI Misses ||| Dow Movers: VZ, KO ||| Coca-Cola's (KO) Earnings & Revenues Surpass Q1 Estimates ||| Q1 Earnings Season in Full Swing ||| US STOCKS-Wall St slides on global slowdown fears ||| Coca-Cola (KO) Q1 2022 Earnings Call Transcript ||| SOFTS-Sugar, coffee and cocoa fall amid negative economic outlook ||| 4 Top Stock Trades for Tuesday: TSLA, Dogecoin, KO, PEP ||| Stock Market Today: Dow Jones, S&P 500 Opened In The Red; Twitter Takeover Reportedly In The Works ||| Coca-Cola Gains after Bubbly Earnings Report; What’s Next? ||| SOFTS-Raw sugar falls close to one-month low; cocoa and coffee also retreat ||| Coca-Cola exceeds revenue expectations on higher prices ||| Top Stock Market News For Today April 25, 2022 ||| The Coca-Cola Q1 22 Earnings Conference Call At 8:30 AM ET ||| The Coca-Cola Company Q1 Profit Increases, beats estimates ||| Consumer Sector Update for 04/25/2022: KO, DORM, WW, XLP, XLY ||| US STOCKS-Futures extend selloff after rough week ||| Coca-Cola Q1 Profit Increases 24%, Results Top Estimates ||| Coca-Cola (KO) Tops Q1 Earnings and Revenue Estimates ||| As Markets Keep Falling, These 2 Blue Chip Stocks Have Good News for Investors",0,0.46398145
2022-04-26,21982600.0,65.5199966430664,66.37000274658203,65.04000091552734,65.05000305175781,61.7172737121582,KO,"Should You Invest in the Vanguard Consumer Staples ETF (VDC)? ||| What Coca-Cola Can Tell Investors About Inflation ||| The Zacks Analyst Blog Highlights Amgen, Chevron, Coca-Cola, Visa and Merck ||| 3 Top Consumer Staples Stocks To Watch In The Stock Market Today ||| PepsiCo raises revenue forecast boosted by higher prices",1,0.51572543
2022-04-27,16971000.0,65.0,66.27999877929688,65.0,65.55999755859375,62.20114517211914,KO,Here's Why I'm Not Buying Costco Stock Just Yet ||| Outsmart Recession with These 4 Staple Stocks ||| Growth Stocks vs. Dividend Stocks ||| Should You Invest in the iShares U.S. Consumer Staples ETF (IYK)?,1,0.49762517
2022-04-28,22010600.0,64.66000366210938,66.27999877929688,64.5,66.19000244140625,62.79887008666992,KO,"Netflix, Tesla, Twitter. Investors Have a Lot to Talk About. ||| Daily Dividend Report: KO,XOM,CVX,BAC,CF,PFE ||| Sales and Profits Surge for This Buffett Favorite",0,0.4701239
2022-04-29,20137100.0,65.87000274658203,66.02999877929688,64.48999786376953,64.61000061035156,61.29981994628906,KO,"U.S. consumer sector braces for slowing demand as inflation bites ||| The Number From Coca-Cola That Brought Smiles to Investors' Faces ||| Stormy April Trading Closes on Low Note ||| Why PepsiCo Stock Is Poised for a Bull Run ||| How to Build a Dividend Portfolio With Grocery Stocks ||| Can Coca-Cola Sustain Its Recovery in 2022? ||| Reasons Why Investors Might Want to Avoid This Major Buffett Holding ||| The Real Reason Alphabet Stock Looks So Cheap ||| Believe It or Not, These Stocks Pay You to Own Them ||| 2 Consumer Goods Stocks to Consider for Your Smart Portfolio ||| 2 Shocking Dow Charts That Illustrate the Power of Long-Term Investing",0,0.49673837
2022-05-02,24970300.0,65.27999877929688,65.30999755859375,62.58000183105469,63.43999862670898,60.18976211547852,KO,Worried About Inflation? Here's What Warren Buffett Says Berkshire Hathaway Is Doing ||| Warren Buffett Talks Cash and More at Berkshire Hathaway's Annual Meeting ||| Coca-Cola Stock in 2022: What Investors Need to Know ||| It's Time to Take Another Look at This Dividend Giant ||| Warren Buffett Just Made an Even Bigger Bet on Oil Prices ||| Why PepsiCo Can Still Afford to Send Investors $8 Billion in 2022 ||| 7 Safe Stocks to Buy in May 2022,0,0.46992487
2022-05-03,21686300.0,63.720001220703125,63.93999862670898,62.66999816894531,63.08000183105469,59.84820556640625,KO,"Makers of Dawn dish soap, Heinz ketchup, Clorox boost defenses against store brand rivals ||| Why Alphabet Stock Fell 18% in April ||| UK-listed Fevertree's chairman to step down after nine years ||| EXCLUSIVE-Coca-Cola African bottler's $3 bln IPO delayed by Ukraine turmoil",1,0.5007448
2022-05-04,19780200.0,63.0,65.12000274658203,62.93999862670898,65.02999877929688,61.69829559326172,KO,6 Undervalued Consumer Brand Stocks Worth Buying Now Before a Recession Hits ||| 5 Top Consumer Staples Stocks To Watch Right Now,0,0.53100914
2022-05-05,20155200.0,64.69000244140625,65.02999877929688,64.01000213623047,64.51000213623047,61.20494079589844,KO,"AMC Is Betting on Gold, and Shareholders Should Be Furious",1,0.523785
2022-05-06,18984000.0,64.19999694824219,65.30999755859375,64.06999969482422,64.73999786376953,61.42316055297852,KO,3 Buffett Stocks That Are Screaming Buys in May ||| Looking for Passive Income? Buy This Dirt-Cheap Dividend Superstar ||| Why Coca-Cola Stock Trounced the Market in April ||| 3 of the Best Dividend Stocks to Buy in May ||| 73% of Warren Buffett's Portfolio Is Invested in These 5 Stocks,0,0.48566803
2022-05-09,20055300.0,64.47000122070312,65.36000061035156,64.04000091552734,64.61000061035156,61.29981994628906,KO,3 Reasons Why Cathie Wood Is an Excellent Stock Picker but Warren Buffett Is a Better Investor ||| Better Buffett Stock: Chevron vs. Apple ||| Where to Invest During Inflation? 3 Top Investments to Consider. ||| Why Trade Desk Stock Fell 15% in April,0,0.5256283
2022-05-10,21322200.0,64.5,65.31999969482422,63.84999847412109,64.01000213623047,60.730560302734375,KO,"Top Stock Trades for the Week of May 9, 2022 ||| 6 Stocks to Buy to Counter High Inflation That Will Do Well This Year ||| Should Principal U.S. MegaCap ETF (USMC) Be on Your Investing Radar? ||| Monster Beverage Has a Big Test Coming Up in Early September",1,0.49711657
2022-05-11,19648400.0,64.33000183105469,65.19999694824219,63.959999084472656,64.30999755859375,61.01518630981445,KO,4 Consumer Staples Stocks For Your May 2022 Watchlist ||| 3 Dow Stocks to Buy More of in May ||| 3 Top Mutual Funds to Invest in Right Now ||| ANALYSIS-Dollar's surge spurs currency hedging by U.S. companies ||| ANALYSIS-Dollar's surge spurs currency hedging by U.S. companies ||| Is Most-Watched Stock CocaCola Company The (KO) Worth Betting on Now?,1,0.54030794
2022-05-12,22574700.0,64.16000366210938,64.52999877929688,63.209999084472656,64.51000213623047,61.20494079589844,KO,Thursday's ETF with Unusual Volume: HUSV ||| Here's How Coca-Cola (KO) Stock is Poised Amid Cost Headwinds ||| Could Netflix Become the Next Buffett Stock? ||| Bottler Coca-Cola HBC mulls other options for Russian business ||| Bottler Coca-Cola HBC mulls other options for Russian business,1,0.51070243
2022-05-13,16167000.0,64.80999755859375,65.80000305175781,64.12000274658203,65.72000122070312,62.35295104980469,KO,Watch These 4 Soft Drink Stocks to Get an Insight on Industry Trends ||| These 5 Stocks Are Netting Warren Buffett $4.3 Billion in Annual Passive Income,1,0.5012133
2022-05-16,13223200.0,65.44000244140625,66.37999725341797,65.44000244140625,65.95999908447266,62.580657958984375,KO,"This Warren Buffett Stock Is Up Over 3,000% Since He First Bought It ||| EXCLUSIVE-India's Reliance to acquire dozens of brands in $6.5 bln consumer goods play-sources ||| The Top 5 Dow Stocks to Buy Now ||| EXCLUSIVE-India's Reliance to acquire dozens of brands in $6.5 bln consumer goods play-sources ||| Warren Buffett's Cost Basis on These 4 Stocks Is Shockingly Low ||| Brazil Coca-Cola bottler Solar Bebidas sees IPO resumption as soon as Q4 ||| Buffett's Berkshire buys Citigroup and several other stocks, slashes Verizon ||| Zacks Industry Outlook Highlights The Coca-Cola, PepsiCo, Keurig Dr Pepper, and Monster Beverage ||| 3 Stocks to Avoid This Week",0,0.4749868
2022-05-17,21300600.0,66.0999984741211,66.0999984741211,65.01000213623047,65.77999877929688,62.40987014770508,KO,"7 Warren Buffett Stocks to Buy After Berkshire’s Annual Meeting ||| 2 Warren Buffett Stocks That Provide Security During the Tech Sell-Off ||| Dow Movers: WMT, BA ||| 3 Top Retirement Stocks For Reliable Dividends ||| Got $5,000? 3 Stocks to Hold for the Next 20 Years",0,0.48325977
2022-05-18,31437300.0,65.41999816894531,65.5199966430664,60.959999084472656,61.20000076293945,58.06452560424805,KO,"Defensive Stocks Are Starting to Crack ||| Have $1,000? 2 Warren Buffett Stocks to Buy",0,0.47064745
2022-05-19,31493900.0,60.959999084472656,60.959999084472656,59.65999984741211,60.0,56.92600631713867,KO,ANALYSIS-Rare double whammy hits investors: steep slumps for both stocks and bonds,1,0.5175621
2022-05-20,29133800.0,60.4900016784668,61.2400016784668,59.65999984741211,60.97999954223633,57.85579681396485,KO,"SPLV, SO, JNJ, KO: ETF Inflow Alert ||| Coca-Cola vs. PepsiCo: Which Stock Looks More Promising Moving Forward? ||| Is Nuveen ESG LargeCap Value ETF (NULV) a Strong ETF Right Now? ||| 2 Dividend Kings That Will Pay You Handsomely",1,0.48115867
2022-05-23,19406900.0,61.650001525878906,63.09999847412109,61.59000015258789,62.86000061035156,59.63948059082031,KO,Is Dutch Bros the Next Starbucks? ||| My Favorite Safe Dividend King to Buy Now (and It's Not Even Close),1,0.5083511
2022-05-24,16154200.0,62.880001068115234,64.19000244140625,62.75,64.0199966430664,60.74003982543945,KO,This Is One of the Best Passive Income Buying Opportunities in Over 20 Years ||| Here Are Warren Buffett's 10 Best Dividend Stocks,1,0.48743197
2022-05-25,15360500.0,64.0,64.47000122070312,63.59999847412109,64.06999969482422,60.7874870300293,KO,Coke (KO) Down 1.6% Since Last Earnings Report: Can It Rebound? ||| Is Trending Stock CocaCola Company The (KO) a Buy Now? ||| Apple Can’t Lift the Market by Itself,1,0.49121225
2022-05-26,16159800.0,64.06999969482422,65.0999984741211,63.959999084472656,64.30000305175781,61.005706787109375,KO,Which Large-Cap Stock Could Generate Higher Returns? ||| ANALYSIS-Russia prepares to seize western firms looking to leave ||| ANALYSIS-Russia prepares to seize western firms looking to leave,1,0.50501513
2022-05-27,17709000.0,64.26000213623047,64.83000183105469,64.13999938964844,64.68000030517578,61.3662338256836,KO,"After Hours Most Active for May 27, 2022 : PINS, INFY, BABA, NLSN, KO, VALE",0,0.4816047
2022-05-31,43159000.0,64.08000183105469,64.31999969482422,63.04999923706055,63.380001068115234,60.1328353881836,KO,"2 Smart Pick-and-Shovel Plays on the Future of Tech Innovation ||| While Other Stocks Plunge, Coca-Cola Reaches Record Highs. What's Behind the Bull Run? ||| After Hours Most Active for May 31, 2022 : CSCO, MRO, T, BAC, KO, WBD, KMI, PFE, AGNC, AAPL, APA, CSX",0,0.49155948
2022-06-01,15408300.0,63.41999816894531,63.68000030517578,62.130001068115234,63.06999969482422,59.83872222900391,KO,"Coca-Cola (KO) Stock Moves -0.49%: What You Should Know ||| Notable ETF Inflow Detected - XLP, PG, KO, PEP ||| 7 Best Consumer Staples Stocks to Buy in June (That Pay Dividends!) ||| The Coca-Cola To Participate In Bernstein's Strategic Decisions Conference; Webcast At 8:00 AM ET",1,0.49158606
2022-06-02,14586000.0,63.18000030517578,63.7400016784668,62.11000061035156,63.72999954223633,60.46490859985352,KO,2 Consumer Goods Stocks with Perfect Smart Scores on TipRanks,0,0.51818657
2022-06-06,15112800.0,63.33000183105469,63.77000045776367,62.65999984741211,62.869998931884766,59.648963928222656,KO,"3 Dividend Stocks That Will Hold Up No Matter the Market Conditions ||| How Advertising's Massive Shift Affects Facebook, Snapchat, and Twitter ||| 2 Warren Buffett Stocks to Buy for Passive Income During the Tech Sell-Off ||| These 2 Stocks Are Warren Buffett's Favorite Dividend Aristocrats. Here's Why ||| 7 of the Safest Stocks to Buy Now ||| 91% of Warren Buffett's Portfolio Is in These 4 Sectors",1,0.47587547
2022-06-07,17886300.0,62.380001068115234,63.369998931884766,62.220001220703125,63.25,60.00949478149414,KO,"Coca-Cola (KO) Gains But Lags Market: What You Should Know ||| Pre-Market Most Active for Jun 7, 2022 : DIDI, SQQQ, C, TQQQ, AMZN, GM, AAPL, TGT, ET, KO, KHC, QQQ ||| This Vaccine Maker Is A Better Pick Over PepsiCo Stock",0,0.47484598
2022-06-08,10211500.0,62.9900016784668,63.209999084472656,62.560001373291016,62.88999938964844,59.66793823242188,KO,Warren Buffett Has Gained Over $171 Billion On These 4 Stocks,0,0.47836047
2022-06-09,13382200.0,62.869998931884766,63.34999847412109,61.77999877929688,61.79999923706055,58.633785247802734,KO,"3 Dividend Aristocrats Suited Perfectly for Income Investors ||| XLP, PG, KO, MDLZ: ETF Outflow Alert ||| Here is What to Know Beyond Why CocaCola Company The (KO) is a Trending Stock ||| India's Amul urges Modi to delay plastic straw ban, cites impact on dairy farmers -letter",0,0.50442386
2022-06-10,14967600.0,61.0099983215332,61.88999938964844,60.459999084472656,61.40999984741211,58.263763427734375,KO,"Top Stock Reports for Exxon Mobil, Coca-Cola & Thermo Fisher ||| Weed Economics 101 ||| 5 Starter Stocks to Generate Passive Income ||| 3 Dividend Stocks to Buy Now for 20 Years of Income Growth",0,0.5129036
2022-06-13,23064200.0,60.75,62.290000915527344,60.66999816894531,61.34000015258789,58.197357177734375,KO,"Forget Redbox, Here Are 2 Better Dividend Stocks ||| 7 Safe Stocks That Also Pay Dividends ||| Why the Dow Jones Industrial Average Has Avoided the Bear So Far ||| Coca-Cola (KO) Stock Moves -0.11%: What You Should Know ||| Monday Sector Leaders: Consumer Products, Healthcare ||| Monday's ETF Movers: IYK, ARKW ||| Dow Movers: BA, MMM ||| 7 Dividend Stocks to Watch for Stable Income ||| 3 Reasons Investors Should Not Follow Warren Buffett Into Coca-Cola Stock ||| The Zacks Analyst Blog Highlights Exxon Mobil, Coca-Cola, Thermo Fisher Scientific, The Progressive, and Dominion Energy ||| Is Principal U.S. MegaCap ETF (USMC) a Strong ETF Right Now?",0,0.46184522
2022-06-14,24620000.0,60.72999954223633,60.88999938964844,58.65999984741211,59.22999954223633,56.60146331787109,KO,"After Hours Most Active for Jun 14, 2022 : ITUB, AUY, PYPL, QQQ, KO, AVDX, MSFT, VALE, AAPL, CLVT, SABR, BAC ||| Consumer Sector Update for 06/14/2022: BF.A,BF.B,KO,KAVL,PM,EYE,SAVE,JBLU,ULCC ||| 3 Top Warren Buffett Stocks to Buy in a Bear Market ||| Top Food Stocks To Buy Right Now? 4 To Know ||| Dow Analyst Moves: KO ||| Brown-Forman (BF.B), Coca-Cola Tie-Up for Jack & Coke RTD ||| Coca-Cola delays IPO of African bottling unit ||| Coca-Cola Company To Delay Listing Of Coca-Cola Beverages Africa",1,0.473974
2022-06-15,19684700.0,60.0,60.63999938964844,58.970001220703125,59.66999816894531,57.021934509277344,KO,"6 Stocks That Will Be First to Rebound From the Coming Recession ||| 3 Recession-Resilient Stocks to Consider, According to Wells Fargo ||| 3 Underrated Warren Buffett Stocks That Are Smart Buys Right Now ||| Has Campbell Soup (CPB) Outpaced Other Consumer Staples Stocks This Year?",0,0.47828487
2022-06-16,15053800.0,58.63999938964844,59.52000045776367,58.25,59.06999969482422,56.44856643676758,KO,"Big Macs still sold in Russia despite McDonald's exit ||| Big Macs still on sale in Russia despite McDonald's exit ||| 4 Ways to Grow $100,000 Into $1 Million for Retirement Savings ||| 3 Winning Stocks to Buy No Matter What the Market Is Doing ||| Here's Why it is Apt to Own Molson Coors (TAP) Stock Now ||| You Won't Find a More Impressive Stock-Split Track Record Than This",1,0.52222526
2022-06-17,34781900.0,59.70000076293945,60.130001068115234,59.130001068115234,59.43000030517578,56.79258728027344,KO,"Calming Words for Investors in the Most Recent Bear Market ||| Notable ETF Inflow Detected - VV, PG, KO, PEP ||| 2 Warren Buffett Stocks to Buy and Hold Forever ||| Will Business Expansion Plans Aid FEMSA's (FMX) Stock Growth? ||| 3 Steady Stocks That Are Perfect for Riding Out Market Volatility",1,0.5259376
2022-06-21,17705000.0,59.4900016784668,60.880001068115234,59.0099983215332,60.70000076293945,58.0062255859375,KO,3 Top Stocks That Just Went on Sale ||| Down Between 12% and 91%: 3 Warren Buffett Stocks to Buy This Summer ||| Warren Buffett Just Bought Lots of Stocks -- Here's the One I'm Most Bullish on ||| Worried About the Tech Sell-Off? This Warren Buffett Stock Provides the Ultimate Protection ||| Coca-Cola (KO) Outpaces Stock Market Gains: What You Should Know ||| 3 Warren Buffett Stocks to Buy Hand Over Fist This Summer ||| Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)? ||| 3 Top Consumer Stocks For Your Watchlist Today ||| 6 High-Quality Stocks to Buy to Ride Out Any Recession ||| Coca-Cola CEO flags 'very painful' macroeconomic period ahead ||| EXCLUSIVE-Heir to McDonald's Russia craves success but Big Mac a 'big loss',1,0.5158347
2022-06-22,15207100.0,60.59999847412109,61.45000076293945,60.31999969482422,61.150001525878906,58.43626022338867,KO,Better Bear Market Buy: Coca-Cola vs. Altria ||| Better Buy: Dividend Stocks or Growth Stocks? ||| Economic Hurricane Ahead? 7 Profitable Places to Hide Your Money ||| This Dirt-Cheap Warren Buffett Stock Should Be Your Top Pick Right Now,1,0.488765
2022-06-23,17190900.0,61.29999923706055,61.90999984741211,61.22999954223633,61.880001068115234,59.13386154174805,KO,3 No-Brainer Warren Buffett Stocks to Buy Right Now for Lasting Wealth,1,0.546238
2022-06-24,18147100.0,62.11000061035156,63.060001373291016,62.11000061035156,63.040000915527344,60.24237823486328,KO,ANALYSIS -Swiss policy pivot signals exit for big stock and bond investor ||| Bet on 5 Stocks With High ROE to Trounce Recession Fears ||| These 9 Warren Buffett Stocks Are Higher During the Nasdaq Bear Market,0,0.47859675
2022-06-27,12142100.0,62.97999954223633,63.290000915527344,62.630001068115234,62.90999984741211,60.1181526184082,KO,"This Stock Has Nearly Tripled Its Dividend in 3 Years ||| These Warren Buffett Dividend Stocks Can Make You $10,000 in Passive Income ||| Warren Buffett's 10 Top Dividend Stocks to Buy Now ||| 7 Defensive Stocks to Buy for a Bear Market ||| 7 Defensive Stocks to Buy for a Bear Market ||| Coca-Cola (KO) Stock Moves -0.21%: What You Should Know ||| Zacks.com featured highlights include Louisiana-Pacific, Coca-Cola, Qualcomm, Matson and Dillard's ||| Notable ETF Outflow Detected - IVV, JPM, PG, KO ||| 5 Best Dividend Stocks to Buy Now ||| Should You Invest in the Vanguard Consumer Staples ETF (VDC)? ||| 4 Stocks Warren Buffett Has Owned for at Least 21 Years",0,0.48691982
2022-06-28,13150100.0,63.08000183105469,63.7599983215332,62.11000061035156,62.27999877929688,59.516109466552734,KO,New to Dividend Stocks? Start by Buying These 3 Ultra-Safe Picks,1,0.49069014
2022-06-29,11795500.0,62.540000915527344,63.11000061035156,62.43000030517578,62.72999954223633,59.946136474609375,KO,"Three Value Stocks to Consider For Your Bargain Hunting in 2022 ||| 9 Stocks to Survive a “Dead Cat Bounce” ||| With Coke and Pepsi out, Russian company says it's time for Cola Chernogolovka ||| 3 Best Bill Gates Stocks to Buy Now ||| Solid Demand & Innovation Aid Clorox (CLX) Amid Inflation Woes",1,0.49341258
2022-06-30,15514200.0,62.31999969482422,63.11000061035156,62.15999984741211,62.90999984741211,60.1181526184082,KO,Constellation Brands (STZ) Q1 Earnings & Sales Beat Estimates,1,0.5310979
2022-07-01,15143200.0,63.119998931884766,64.44999694824219,62.81999969482422,64.37999725341797,61.52291488647461,KO,"FOCUS-With a dash of spice, Reliance and Britain's Pret bet on India's changing tastes",0,0.50257546
2022-07-05,15921200.0,64.18000030517578,64.18000030517578,62.41999816894531,63.27999877929688,60.47172927856445,KO,"FOCUS-With a dash of spice, Reliance and Britain's Pret bet on India's changing tastes ||| 3 Investments That Can Help You Reach Financial Independence ||| Good Stocks To Buy Now? 5 Consumer Staples Stocks To Know ||| FMX vs. KO: Which Stock Is the Better Value Option? ||| CocaCola Company The (KO) Is a Trending Stock: Facts to Know Before Betting on It ||| 3 Stocks That Have Trounced the Market in 2022 ||| Coca-Cola (KO) Stock Sinks As Market Gains: What You Should Know ||| SPDR Portfolio S&P 500 Value ETF Experiences Big Outflow",1,0.4945656
2022-07-06,13450500.0,63.59999847412109,64.08999633789062,63.18999862670898,63.40999984741211,60.59596252441406,KO,Should Invesco S&P 500 Low Volatility ETF (SPLV) Be on Your Investing Radar? ||| FEMSA (FMX) to Buy Europe's Valora to Expand Retail Presence ||| Want to Retire Early? Buy and Hold These 2 Dividend Stocks for Decades ||| Beyond Crypto: This Is the Secret Sauce to Retiring a Millionaire ||| Should Schwab U.S. Dividend Equity ETF (SCHD) Be on Your Investing Radar?,0,0.48174036
2022-07-07,14828400.0,63.2599983215332,63.58000183105469,62.70000076293945,62.90999984741211,60.1181526184082,KO,Why Coca-Cola's Stock Popped as the Market Lost Its Fizz in 2022,1,0.5159445
2022-07-08,11311500.0,63.02999877929688,63.41999816894531,62.880001068115234,63.13999938964844,60.33794021606445,KO,Buy These 4 Blue-Chip Stocks to Strengthen Your Portfolio ||| 2 Stocks to Consider for Your Smart Portfolio,0,0.5064761
2022-07-11,12702100.0,62.9900016784668,63.459999084472656,62.59000015258789,62.93999862670898,60.146820068359375,KO,"3 Stocks That Are Great Long-Term Picks ||| Why Warren Buffett Loves Coca-Cola Stock ||| Coca-Cola (KO) Stock Moves -0.32%: What You Should Know ||| The Zacks Analyst Blog Highlights Coca-Cola, Home Depot, Merck and JPMorgan Chase ||| These 2 Stocks Could Triple Your Money Over the Next Decade",0,0.49167368
2022-07-12,14731100.0,63.0,63.45000076293945,62.470001220703125,62.66999816894531,59.88880157470703,KO,"Top Stock Reports for Coca-Cola, Merck & Toyota Motor ||| PepsiCo raises annual revenue forecast on resilient snacks, soda demand ||| Is ESG Investing a Good Approach? Perhaps, But There Are Pitfalls ||| What A Recession Would Mean For Coca-Cola Stock?",0,0.48671058
2022-07-13,13145300.0,62.33000183105469,63.0,61.97999954223633,62.380001068115234,59.61167144775391,KO,"Warren Buffett Has Bet $279 Billion on These 10 Stocks ||| Notable ETF Inflow Detected - IWF, NVDA, KO, PG ||| The Zacks Analyst Blog Highlights Coca-Cola, Merck, Toyota Motor, Enbridge, and Regeneron Pharmaceuticals",0,0.48220065
2022-07-14,14433000.0,61.33000183105469,62.25,61.29999923706055,62.18000030517578,59.42055130004883,KO,"Bear Market Blues? Buy PepsiCo Stock Now ||| These 3 Blue-Chip Stocks Are Great Shields for Volatility ||| Is Netflix Stock Undervalued? ||| Pre-Market Most Active for Jul 14, 2022 : TQQQ, SQQQ, TBPH, QQQ, ZI, GM, MOS, KO, GILD, KMI, MRO, JPM",1,0.48671073
2022-07-15,21968400.0,62.75,62.970001220703125,62.06999969482422,62.5,59.726348876953125,KO,"3 ‘Strong Buy’ Defensive Dividend Stocks for an Upcoming Recession ||| After Hours Most Active for Jul 15, 2022 : WY, MO, KO, ACGL, QQQ, VALE, AAPL, VTRS, PCAR, CTSH, PINS, PGR ||| This Warren Buffett Stock Is Recession-Proof and Generates Passive Income for Investors ||| Do PepsiCo's Results Make Coca-Cola Stock a Buy? ||| Zacks Investment Ideas feature highlights: Coca-Cola, Kroger and Johnson & Johnson",0,0.50885004
2022-07-18,10780800.0,62.52000045776367,62.560001373291016,61.5099983215332,61.650001525878906,58.9140739440918,KO,"Coca-Cola (KO) Dips More Than Broader Markets: What You Should Know ||| Is There Any Room For Growth In PepsiCo Stock? ||| HK's Swire Pacific buys Coca-Cola bottling ops in Vietnam, Cambodia ||| 4 Top Beverage Stocks To Watch After PepsiCos Strong Quarter",1,0.5163523
2022-07-19,10998200.0,62.09000015258789,62.650001525878906,61.93000030517578,62.52999877929688,59.75501251220703,KO,"If I Could Buy Only 1 Stock, This Would Be It ||| Analysts Estimate Coca-Cola (KO) to Report a Decline in Earnings: What to Look Out for ||| Former FDIC Chair Sheila Bair Helps Students Get Smarter About Debt ||| Johnson & Johnson profit outlook takes a knock from stronger dollar ||| Johnson & Johnson profit outlook takes a knock from stronger dollar",0,0.4743874
2022-07-20,11010500.0,62.400001525878906,62.58000183105469,61.150001525878906,61.5,58.77072143554688,KO,7 Best Beverage Stocks to Buy Now ||| Coca-Cola Q2 Preview: Can the Earnings Streak Continue? ||| Coca-Cola’s Stability is Something Investors Should Consider ||| 3 Most Undervalued Consumer Stocks to Buy Now ||| 5 Stocks Are Netting Warren Buffett a Combined $4.25 Billion in Annual Dividend Income ||| 3 Surefire Financials Stocks to Buy as You Near Retirement,0,0.4817207
2022-07-21,11959600.0,61.2599983215332,61.880001068115234,60.790000915527344,61.36000061035156,58.636940002441406,KO,"Daily Dividend Report: PPG,BAC,KMI,KO,SHW ||| All Eyes on Fed Meeting, FAANG Earnings ||| Is It Time to Buy Coca-Cola? 3 Things We Need to Find Out First ||| Coca-Cola Names CFO John Murphy To Additional Role Of President ||| Sales Are Surging for Coca-Cola -- Should You Buy Now?",1,0.5217578
2022-07-22,11644700.0,61.380001068115234,61.869998931884766,61.31999969482422,61.59000015258789,58.85673141479492,KO,Wall St Week Ahead-Strong dollar looms over U.S. earnings season ||| Market Predictions 2022: When Will Stocks Go Back Up? ||| What To Expect From Coca-Cola Stock Following Q2 Earnings? ||| GRAPHIC-Take Five: It's a Fed hot summer,1,0.49193192
2022-07-25,14941700.0,61.54999923706055,62.29999923706055,61.310001373291016,62.18999862670898,59.43009948730469,KO,"Younger Investors Should Like Dividend Stocks, Too ||| 3 Stocks the World's Greatest Investors Like the Most Right Now ||| Indices Swing Mostly Higher; Whirlpool (WHR) Mixed in Q2 ||| Pre-Market Earnings Report for July 26, 2022 : KO, MCD, RTX, UPS, MMM, GE, FISV, UBS, MCO, CNC, GM, ECL ||| 3 Dividend Kings Suited Perfectly for Income Investors ||| Factors Likely to Influence Coca-Cola (KO) in Q2 Earnings ||| US STOCKS-Futures edge higher at start of big week for earnings, Fed meet ||| What Warren Buffett Can Teach You From His Top 3 Holdings ||| 15 Stocks Warren Buffett Has Held for at Least 10 Years ||| GRAPHIC-Take Five: It's a Fed hot summer",1,0.4851027
2022-07-26,20118000.0,62.75,63.79999923706055,62.52999877929688,63.209999084472656,60.40483474731445,KO,"Indexes drop as Walmart profit warning spooks investors ||| GLOBAL MARKETS-Wall Street hit by Walmart wipeout, Gas woes knock Europe ||| Big Numbers for Home Prices, Q2 Earnings: GE, UPS, KO, MCD ||| US STOCKS-Wall Street falls as Walmart warning rattles retail stocks ||| Stock Market Today: Dow Jones, S&P 500 Drop; Walmart Falls On Lowered Profit Outlook; Microsoft & Alphabet Earnings On Deck ||| Dow Movers: WMT, MMM ||| US STOCKS-Wall Street falls as Walmart warning rattles retail sector ||| From burgers to bleach, stressed consumers buy cheap ||| US STOCKS-Indexes drop after Walmart profit warning; Nasdaq down 2% ||| Indexes end sharply lower as Walmart profit warning spooks investors ||| From burgers to bleach, stressed consumers buy cheap ||| Home Price Numbers Come In High ||| Coca-Cola (KO) Gains on Q2 Earnings & Revenue Beat, Hiked View ||| Top Stock Market News For Today July 26, 2022 ||| US STOCKS-Futures fall after Walmart warning spooks retail stocks ||| Zacks Investment Ideas feature highlights: Coca-Cola, Emerson Electric and AbbVie ||| Coca-Cola raises annual revenue forecast on sustained soda demand ||| The Coca-Cola Company Q2 Profit Decreases, but beats estimates ||| Coca-Cola Boost FY22 Organic Revenue Growth Outlook ||| GLOBAL MARKETS-Gas woes keep Europe subdued, Wall Street waits for Walmart wipeout ||| Coca-Cola (KO) Q2 Earnings and Revenues Top Estimates ||| 7 Warren Buffett Stocks to Buy on the Dip ||| Wall Street set to open lower as Walmart warning rattles retail stocks ||| The Coca-Cola Q2 22 Earnings Conference Call At 8:30 AM ET",0,0.47434863
2022-07-27,12142900.0,62.880001068115234,63.18999862670898,61.790000915527344,63.0099983215332,60.21371078491211,KO,"Food Stocks To Invest In 2022? 4 In Focus ||| Company News for Jul 27, 2022 ||| Tobacco group BAT takes $1.2 bln hit from Russian exit ||| Tobacco group BAT half-year profit shrinks",1,0.5088567
2022-07-28,10837000.0,62.91999816894531,64.25,62.88999938964844,64.05999755859375,61.21711730957031,KO,"7 Warren Buffett Stocks Trading at a Huge Discount Right Now ||| Thursday 7/28 Insider Buying Report: ADX, KO ||| Mexico's FEMSA net profit soars 69%, boosts expansion plans ||| Which Large-Cap Consumer Stock Could Yield Higher Returns? ||| Bear Market Investing: 3 Reasons to Buy Stocks Now",1,0.5234464
2022-07-29,13734200.0,63.709999084472656,64.29000091552734,63.630001068115234,64.16999816894531,61.32223129272461,KO,"Mexico declares drought in northern state of Nuevo Leon matter of 'national security' ||| ITOT, GOOG, PG, KO: ETF Outflow Alert ||| These 3 Stocks Are Rallying While the Rest of the Market Plunges ||| 6 Unexpected Sources of Retirement Income",1,0.4909746
2022-08-01,12831500.0,64.08999633789062,65.04000091552734,64.02999877929688,64.5199966430664,61.65669631958008,KO,Best Dividend Stocks To Buy In 2022? 3 In Focus ||| Have Insiders Sold The Coca-Cola Company (NYSE:KO) Shares Recently? ||| Here's What Makes This Dow Jones Stock So Safe ||| Is Coca-Cola Stock a Buy? ||| 3 Dividend Kings That Could Pay You for the Rest of Your Life ||| Warren Buffett Has 10% of Berkshire Hathaway's Portfolio in This Recession-Resistant Sector ||| Is Coca-Cola Stock a Buy After Q2 Earnings?,0,0.48744467
2022-08-02,15241900.0,64.58999633789062,64.5999984741211,63.43000030517578,63.63999938964844,60.81575393676758,KO,Why AMTD Idea Group Stock Skyrocketed Today ||| Best Dividend Stocks To Buy Now? 5 For Your List,1,0.49154302
2022-08-03,11317000.0,63.54999923706055,64.0999984741211,63.310001373291016,63.91999816894531,61.08332824707031,KO,"Is Most-Watched Stock CocaCola Company The (KO) Worth Betting on Now? ||| Better Buy: PayPal or Visa? ||| Warren Buffett's 3 Favorite Sectors to Invest His Money ||| EXCLUSIVE-Russian soft drinks maker targets 50% of market to fill gap left by Coke, Pepsi",0,0.4817962
2022-08-04,11795600.0,63.63999938964844,63.72999954223633,62.91999816894531,63.66999816894531,60.84441757202149,KO,Paging Peter Lynch: 3 Dividend Stocks to Buy This August ||| 5 Dividend Aristocrats Where Analysts See Capital Gains ||| Coca-Cola Stock Looks Unstoppable ||| Better Buy: Coca-Cola vs. PepsiCo,0,0.5152921
2022-08-08,9165200.0,63.5,63.810001373291016,62.75,62.970001220703125,60.17549133300781,KO,"Top Stocks To Buy Now? 4 Warren Buffett Stocks To Watch ||| 3 Warren Buffett Stocks to Buy Now ||| Notable ETF Inflow Detected - XLP, PG, KO, MDLZ ||| 2 Underrated Warren Buffett Stocks That Are Smart Buys Right Now ||| 3 Robinhood Stocks to Buy and Hold Forever ||| 7 Beaten-Down Dow Stocks to Buy Before They Rebound",1,0.46080977
2022-08-09,7910900.0,63.18000030517578,63.310001373291016,62.84999847412109,63.04999923706055,60.25193786621094,KO,"Pockets of Strength in Consumer Staples Stocks: KO, MO, PG Earnings ||| 7 Blue-Chip Stocks to Buy Now for Growth and Dividends",1,0.51182175
2022-08-10,8857300.0,63.630001068115234,63.790000915527344,63.09999847412109,63.650001525878906,60.825313568115234,KO,"Coca-Cola bottler to detail costs of exiting Russia ||| The Zacks Analyst Blog Highlights The Coca Cola, Altria Group and Procter & Gamble ||| 3 Warren Buffett Stocks to Buy Hand Over Fist in August",0,0.49939823
2022-08-11,8507800.0,63.68999862670898,63.9900016784668,63.08000183105469,63.220001220703125,60.41439437866211,KO,Coca-Cola HBC HY Profit Drops ||| Coca-Cola HBC flags one-time $195 mln hit from Russian operations ||| Coca-Cola HBC flags one-time $195 mln hit from Russian operations,1,0.50169826
2022-08-12,9489300.0,63.43000030517578,63.7599983215332,63.09000015258789,63.70000076293945,60.87309265136719,KO,Want to Retire Early? This Stock Could Help You Do That,1,0.528168
2022-08-15,9863300.0,63.63999938964844,64.69000244140625,63.56999969482422,64.5,61.63759231567383,KO,5 Ways to Prepare Your Portfolio for a Black Swan Event in 2022 ||| Why Tech Layoffs Aren't Panicking This Investor ||| Constellation Brands (STZ) Looks Prim on Brand Investments,1,0.53853035
2022-08-16,9569600.0,64.56999969482422,65.2300033569336,64.33000183105469,65.02999877929688,62.1440658569336,KO,"2 Top Dow Stocks to Buy on the Dip, and 1 to Brush Aside ||| Noteworthy ETF Outflows: VIG, KO, ABT, CMCSA ||| Is Trending Stock CocaCola Company The (KO) a Buy Now?",0,0.5011705
2022-08-17,8144000.0,64.83000183105469,65.22000122070312,64.76000213623047,64.87999725341797,62.0007209777832,KO,"7 Stocks That Are Still Hedge Fund Favorites ||| INSIGHT-Coca-Cola and McDonald's left Russia. Their brands stayed behind ||| The Zacks Analyst Blog Highlights Coca-Cola, Oracle, Morgan Stanley, Amgen and TotalEnergies ||| Elon Musk says he was joking about buying Manchester United",1,0.4881487
2022-08-18,6532000.0,64.95999908447266,65.3499984741211,64.70999908447266,65.22000122070312,62.32563781738281,KO,Keurig Dr Pepper in talks to buy Bang Energy drinks maker - Bloomberg ||| 4 Blue-Chip Stocks to Buy With Strong Earnings,0,0.51114464
2022-08-19,8921100.0,65.20999908447266,65.47000122070312,64.95999908447266,65.16999816894531,62.27785110473633,KO,"3 Top Stocks to Buy During a Sell-Off ||| Best Stocks To Invest In 2022? 3 Top Dividend Stocks To Watch ||| Want $7,800 in Passive Income? These 2 Monster Stocks Just Raised Their Dividends ||| Philippines mulls allowing drinks firms to directly import sugar in rare step ||| Is Coca-Cola (NYSE:KO) Using Too Much Debt? ||| 3 Dividend Aristocrat Stocks That Warren Buffett Likes the Most",0,0.5138432
2022-08-22,9087900.0,64.83999633789062,64.91999816894531,63.9900016784668,64.19999694824219,61.35089874267578,KO,News From Walmart and Other Members of Big Retail,1,0.53403497
2022-08-23,8443800.0,63.81999969482422,64.37000274658203,63.68000030517578,64.2699966430664,61.41779708862305,KO,7 Top-Rated Large-Cap Stocks to Buy and Hold,1,0.56367594
2022-08-24,6844700.0,64.23999786376953,64.58000183105469,64.05000305175781,64.36000061035156,61.50380325317383,KO,"3 Dividend Stocks That Are Passive Income Machines ||| Noteworthy ETF Inflows: DGRW, JNJ, KO, PG ||| 2 Top Dividend Stocks You Can Buy and Hold Forever ||| No Lie -- These Stocks Pay You to Own Them ||| 3 Warren Buffett Stocks to Hold Forever ||| Warren Buffett Just Did Something He Hasn't Done This Century",1,0.48719516
2022-08-25,7913900.0,64.36000061035156,64.70999908447266,63.900001525878906,64.66999816894531,61.800048828125,KO,4 of the Best Growth Stocks to Ride for the Rest of 2022,0,0.52996045
2022-08-26,10089500.0,64.7300033569336,64.80000305175781,62.97999954223633,63.11000061035156,60.30927658081055,KO,Coca-Cola bottler starts making 'Dobry Cola' in Russia ||| Coca-Cola bottler starts making 'Dobry Cola' in Russia,0,0.502861
2022-08-29,9115900.0,62.68999862670898,63.02999877929688,62.40999984741211,62.72999954223633,59.946136474609375,KO,Should You Invest in the Vanguard Consumer Staples ETF (VDC)? ||| Here is What to Know Beyond Why CocaCola Company The (KO) is a Trending Stock ||| What's Happening With PepsiCo Stock? ||| The 1 Number That's Imperative to Warren Buffett's Success,0,0.4752031
2022-08-30,8456800.0,62.90999984741211,62.90999984741211,61.9900016784668,62.150001525878906,59.39188003540039,KO,Best Stocks To Invest In Right Now? 3 Defensive Stocks To Know ||| Dow Analyst Moves: KO ||| 7 No-Brainer Dividend Stocks to Buy if You Have Money to Invest,0,0.47448698
2022-08-31,14633600.0,62.380001068115234,62.52999877929688,61.70000076293945,61.709999084472656,58.97140502929688,KO,"3 Consumer Staples Stocks For September 2022 ||| How I'd Invest $50,000 for Retirement, If I Had to Start From Scratch ||| Should You Invest in the iShares U.S. Consumer Staples ETF (IYK)? ||| 86% of Warren Buffett's Portfolio Is Invested in These 10 Stocks",1,0.543882
2022-09-01,14939700.0,61.58000183105469,62.040000915527344,61.290000915527344,62.0,59.248531341552734,KO,"Coca-Cola (KO) Outpaces Stock Market Gains: What You Should Know ||| Notable ETF Outflow Detected - QUAL, SPGI, JNJ, KO",0,0.4830326
2022-09-02,11809800.0,62.38999938964844,62.77000045776367,60.900001525878906,61.150001525878906,58.43626022338867,KO,"Dow Movers: MMM, CVX",1,0.5140736
2022-09-06,12181800.0,61.290000915527344,61.970001220703125,60.9900016784668,61.18000030517578,58.46492385864258,KO,Prediction: These Could Be the Best Growth Stocks in 2030 ||| 7 Dow Stocks With Superior Fundamentals,1,0.502611
2022-09-07,13290700.0,61.31999969482422,62.4900016784668,61.31999969482422,62.310001373291016,59.54478454589844,KO,Coca-Cola (KO) Outpaces Stock Market Gains: What You Should Know ||| 5 Soft Drink Stocks Poised for Growth on Favorable Industry Trends ||| 2 Winning Stocks to Buy No Matter What the Market Is Doing ||| Warren Buffett Has 74% of Berkshire Hathaway's Portfolio in Just 5 Stocks. Should You?,0,0.4793334
2022-09-08,17193500.0,62.08000183105469,62.29999923706055,61.34000015258789,62.119998931884766,59.36320877075195,KO,The 6 Best Food Stocks to Buy Now ||| 7 Bear Market Stocks to Buy and Hold Forever ||| Should We Be Delighted With The Coca-Cola Company's (NYSE:KO) ROE Of 39%? ||| Stock Market Sell-Off: Is Coca-Cola a Buy? ||| The Coca-Cola To Participate In Barclays Global Consumer Staples Conference At 10:30 AM ET ||| The Best Warren Buffett Stocks to Buy With $300 Right Now,1,0.51364017
2022-09-09,11855900.0,62.16999816894531,62.880001068115234,61.86000061035156,62.31999969482422,59.5543327331543,KO,"QUAL, SPGI, JNJ, KO: Large Outflows Detected at ETF ||| 2 Surprising Growth Stocks That Warren Buffett Owns ||| Pre-Market Most Active for Sep 9, 2022 : TQQQ, SQQQ, MOGU, VCIT, DMS, MRK, KO, BILI, TSLA, NIO, QQQ, HLN ||| Warren Buffett Generates 71% of His Dividend Income From These 5 Stocks ||| 2 Warren Buffett Stocks to Buy Hand Over Fist in September ||| 7 Dividend Stocks With Superior Fundamentals",1,0.49350002
2022-09-12,13026900.0,62.43000030517578,62.810001373291016,62.27000045776367,62.5,59.726348876953125,KO,Sitting on Cash? These 2 Dividend Stocks Are Great Buys. ||| 3 Undervalued S&P 500 Stocks to Buy Before Wall Street Catches On,0,0.4811173
2022-09-13,18532800.0,62.20000076293945,62.220001220703125,60.27999877929688,60.470001220703125,57.786434173583984,KO,"Colgate (CL) Cheers Investors With Dividend Amid Cost Woes ||| After Hours Most Active for Sep 13, 2022 : AAPL, INTC, SWN, KO, NVDA, IQ, CMCSA, CWK, AMZN, VALE, UBER, NEM ||| These 3 Low-Beta Stocks Are Great Shields Against Volatility ||| Investors Heavily Search CocaCola Company The (KO): Here is What You Need to Know ||| As Tech Stocks Drop, Consumer Staple Stocks PG and KO Tempt ||| Ex-Dividend Reminder: Dole, Coca-Cola and Advance Auto Parts",1,0.48211592
2022-09-14,12881600.0,60.63999938964844,61.08000183105469,60.43999862670898,60.790000915527344,58.09223175048828,KO,"Ready to Get Rich in the Stock Market? 5 Investments You Can't Go Wrong With ||| Coca-Cola (KO) Outpaces Stock Market Gains: What You Should Know ||| KO, WMT, or MDLZ: Which Defensive Stock is Best for a Recession? ||| FMX or KO: Which Is the Better Value Stock Right Now?",0,0.4698722
2022-09-16,20493500.0,59.65999984741211,59.79999923706055,59.11000061035156,59.540000915527344,57.312538146972656,KO,"Better Bear Market Buy: Coca-Cola vs. Procter & Gamble ||| Why National Beverage Stock Fell by 10% This Week ||| 3 Robinhood Stocks to Buy and Hold Forever ||| Top Stock Reports for Alphabet, JPMorgan & Coca-Cola ||| Here's Why Coca-Cola (KO) is a Strong Growth Stock",1,0.49816114
2022-09-19,12596200.0,59.38999938964844,60.09999847412109,59.22999954223633,59.9900016784668,57.745704650878906,KO,"What Are The Best Stocks To Invest In? 2 Consumer Staples Stocks To Know ||| VTI, KO, COST, ACN: Large Inflows Detected at ETF ||| The Zacks Analyst Blog Highlights Alphabet, JPMorgan Chase, Coca-Cola, Salesforce, and Linde ||| Should You Invest in the Consumer Staples Select Sector SPDR ETF (XLP)? ||| Is Nuveen ESG LargeCap Value ETF (NULV) a Strong ETF Right Now?",0,0.46369237
2022-09-20,11984600.0,59.68000030517578,60.02999877929688,59.31999969482422,59.900001525878906,57.6590690612793,KO,"Coca-Cola (KO) Stock Moves -0.15%: What You Should Know ||| KO, NEE, LW: These Stocks Could Hedge Your Bets against Rising Bond Yields ||| EXCLUSIVE-PepsiCo ends Pepsi, 7UP production in Russia months after promising halt over Ukraine",0,0.48774892
2022-09-21,14165300.0,60.13999938964844,60.70000076293945,59.38999938964844,59.400001525878906,57.177772521972656,KO,5 Best Stocks to Buy if You Have $100 to Spend ||| 2 Top Buffett Stocks To Buy and Hold for the Long Haul ||| Warren Buffett Is Sitting On $168 Billion In Unrealized Gains From These 4 Stocks,0,0.4861152
2022-09-22,11657600.0,59.54999923706055,59.72999954223633,59.20000076293945,59.2599983215332,57.04301071166992,KO,3 Dividend Stocks You Can Safely Hold for Decades,0,0.5424255
2022-09-23,14824000.0,58.959999084472656,59.09999847412109,58.0,58.59999847412109,56.4077033996582,KO,5 Reasons This Passive Income Stock Is No. 1 On My Buy List ||| India's Britannia names Domino's executive Rajneet Kohli as CEO ||| 3 No-Brainer Cryptocurrencies to Hold Forever,0,0.49697864
2022-09-26,18670100.0,58.4900016784668,58.56999969482422,57.68999862670898,57.869998931884766,55.70500946044922,KO,"What Stocks To Buy Today? 2 Top Dividend Stocks For Your List ||| 3 Consumer Staples Stocks to Consider Buying for Inflation Protection ||| Pre-Market Most Active for Sep 26, 2022 : TQQQ, SQQQ, LVTX, TSLA, QQQ, KO, AMC, XPEV, AAPL, NIO, F, ATCO",0,0.47541815
2022-09-27,23829300.0,58.08000183105469,58.369998931884766,56.310001373291016,56.380001068115234,54.270755767822266,KO,"How I'd Invest $20,000 Today if I Had to Start From Scratch",1,0.5287187
2022-09-28,21480100.0,56.65999984741211,57.25,55.90999984741211,56.97999954223633,54.84830474853516,KO,"EXCLUSIVE-Brands blast Twitter for ads next to child pornography accounts ||| 5 Little-Known Dividend Kings ||| The total return for Coca-Cola (NYSE:KO) investors has risen faster than earnings growth over the last five years ||| Is Coca-Cola Stock a Buy? ||| If You Invested $10,000 in This Warren Buffett Stock 10 Years Ago, Here's How Much You Would Have Today ||| Coca-Cola (KO) Gains But Lags Market: What You Should Know ||| EXCLUSIVE-Brands blast Twitter for ads next to child pornography accounts",0,0.5041967
2022-09-29,14570700.0,57.09000015258789,57.290000915527344,56.0,56.56999969482422,54.453643798828125,KO,Here's Why You Should Buy PepsiCo (PEP) Ahead of Q3 Earnings ||| Digital Investments & Premiumization to Aid AB InBev (BUD) ||| ProShares Ultra S&P500 Experiences Big Outflow ||| EXCLUSIVE-Brands blast Twitter for ads next to child pornography accounts,0,0.5001599
2022-09-30,16124600.0,56.869998931884766,57.130001068115234,56.0,56.02000045776367,53.924224853515625,KO,Dow Jones Bear Market: 2 Warren Buffett Stocks You Can Buy Today ||| 2 Perfect Index Funds to Buy in a Bear Market ||| 5 Dividend Growth Stocks to Beat Market Volatility,1,0.5052903
2022-10-03,16277600.0,56.36000061035156,56.84999847412109,56.060001373291016,56.650001525878906,54.53065872192383,KO,"Are Dividend Stocks Right for You? ||| Coca-Cola Stock: Buy Now or Wait? ||| Is This Warren Buffett Favorite a Buy? ||| Coca-Cola vs. PepsiCo: Which Stock Has More Fizz? ||| Stock Market Sell-Off: Is Unilever a Buy? ||| Why Warren Buffett Loves Coca-Cola Stock ||| Business Momentum & Diversification to Support FEMSA (FMX) ||| Zacks.com featured highlights include Coca-Cola, General Dynamics, AstraZeneca, Boise Cascade and Insperity",1,0.4774579
2022-10-04,18861400.0,56.95000076293945,57.810001373291016,56.459999084472656,56.77999877929688,54.655792236328125,KO,Coca-Cola (KO) Gains But Lags Market: What You Should Know ||| Why Warren Buffett Will Never Buy Bitcoin,0,0.47459003
2022-10-05,14324900.0,56.5,56.650001525878906,55.5099983215332,56.2400016784668,54.13599395751953,KO,Should Investors Follow Warren Buffett Into Coca-Cola Stock? ||| Know the Diageo (DEO) Stock In and Out Before Investing,0,0.48119834
2022-10-06,17192800.0,56.0,56.09999847412109,54.869998931884766,55.02999877929688,52.97126388549805,KO,Good Stocks To Buy Right Now? 3 Cyclical Stocks In Focus ||| Why Warren Buffett Loves Coca-Cola's Stock,0,0.47363892
2022-10-07,11479800.0,54.9900016784668,55.09000015258789,54.25,54.5099983215332,52.47071075439453,KO,"PepsiCo Earnings Preview: Should Investors be Thirsty for PEP Stock? ||| Down 14% in 6 Months, Is Coca-Cola a Buy? ||| 5 Dividend Growth Stocks With Upside To Analyst Targets ||| This Tech Giant Just Raised Its Dividend by 10%",0,0.49865824
2022-10-10,10239100.0,54.59999847412109,54.959999084472656,54.02000045776367,54.38999938964844,52.355201721191406,KO,"Got $1,000? 5 Buffett Stocks to Buy and Hold Forever. ||| Sugary Beverage Stocks: Are They Ethical to Invest In? ||| Stock Market Sell-Off: 5 Top Stocks to Buy Now ||| Still Room For Growth From PepsiCo's Q3? ||| Coca-Cola (KO) Stock Moves -0.22%: What You Should Know ||| Best Stocks To Invest In Right Now? 2 Warren Buffett Stocks To Watch ||| Will Coke (KO) Beat Estimates Again in Its Next Earnings Report?",1,0.4834742
2022-10-12,18377400.0,55.22999954223633,56.040000915527344,55.040000915527344,55.13999938964844,53.077144622802734,KO,"Why Coca-Cola Stock Is Down 8% This Year ||| Dow Movers: BA, KO ||| 2 Safe Stocks for Retirees to Buy Now ||| 2 Warren Buffett Stocks to Buy That Could Soar 80% and 91%, According to Wall Street ||| PepsiCo (PEP) Q3 Earnings and Revenues Surpass Estimates ||| 2 Stocks That Could Be Easy Wealth Builders ||| PepsiCo raises annual forecasts on higher prices for sodas and snacks",1,0.4890576
2022-10-13,16220700.0,54.47999954223633,56.08000183105469,54.2599983215332,55.869998931884766,53.77983093261719,KO,"After Hours Most Active for Oct 13, 2022 : OPEN, PCG, HBAN, EGY, GOOG, KO, OWL, QQQ, JBGS, GOOGL, RTO, TQQQ ||| Technology Sector Update for 10/13/2022: AMAT,TSM,LASE,KO,BKTI ||| Coca-Cola Looks Like a Screaming Buy Near Its 52-Week Low ||| Coca-Cola -- 1 Cause for Concern ||| This Hot Growth Stock Is Still a Buy After Enormous Gains",0,0.46831858
2022-10-14,15997900.0,56.290000915527344,56.470001220703125,54.93999862670898,54.97999954223633,52.92313003540039,KO,"What's Going On With PepsiCo Shares? ||| Down 33%, This Dividend King Could Be a Screaming Buy",1,0.5057475
2022-10-17,13721400.0,55.630001068115234,56.220001220703125,55.56999969482422,55.68999862670898,53.6065673828125,KO,How Warren Buffett Receives a Staggering 54% Yield From This Dividend Aristocrat ||| Warren Buffett Loves This Stock. Should You? ||| Got $1000? Here Are 3 Stocks to Buy,1,0.48469415
2022-10-18,11823100.0,56.310001373291016,56.77999877929688,56.09999847412109,56.43999862670898,54.32851028442383,KO,"Russian soft drinks maker to cut back investments, hiring over new sugar tax ||| Engine No. 1 held talks with Coca-Cola on new recycling initiatives - source ||| VTV, KO, PEP, ABBV: Large Inflows Detected at ETF ||| Top Stock Reports for Procter & Gamble, Coca-Cola & TotalEnergies ||| Engine No. 1 takes stake in Coca-Cola, pushes for better recycling- Semafor ||| 3 Facts About Polygon You Should Know ||| Analysts Estimate Coca-Cola (KO) to Report a Decline in Earnings: What to Look Out for",0,0.5036491
2022-10-19,10182300.0,56.310001373291016,56.540000915527344,55.72999954223633,55.959999084472656,53.86647033691406,KO,"The Zacks Analyst Blog Highlights Procter & Gamble, Coca-Cola, TotalEnergies, McDonald's, Prologis, and Petroleo Brasileiro S.A. - Petrobras",0,0.48055187
2022-10-20,16905100.0,55.77000045776367,55.91999816894531,54.959999084472656,55.08000183105469,53.01939010620117,KO,"Better Buy: Coca-Cola vs. Disney ||| 2 Growth Stocks You Can Buy Right Now With Less Than $100 ||| Why Is Everyone Talking About Coca-Cola Stock? ||| October Ends With Slew of Big Tech Earnings Reports on Tap ||| Keurig Dr Pepper, Inc (KDP) Reports Next Week: Wall Street Expects Earnings Growth",1,0.5109034
2022-10-21,15034100.0,55.0,56.11000061035156,54.9900016784668,55.959999084472656,53.86647033691406,KO,"Coca-Cola (KO) to Report Q3 Earnings: What's on the Cards? ||| 77% of Warren Buffett's $313 Billion Portfolio Is Invested in These 6 Stocks ||| Daily Dividend Report: KO, C, SLB, HCA, FIS",1,0.48234397
2022-10-24,17416700.0,56.63999938964844,57.72999954223633,56.56999969482422,57.56999969482422,55.416236877441406,KO,"Pre-Market Earnings Report for October 25, 2022 : KO, RTX, UPS, GE, MMM, ITW, SHW, GM, UBS, VLO, ADM, MCO ||| With 61% ownership of the shares, The Coca-Cola Company (NYSE:KO) is heavily dominated by institutional owners ||| Coca-Cola Q3 Preview: Can The Earnings Streak Continue? ||| US STOCKS-Wall St rises on hopes of less-aggressive Fed as business activity shrinks ||| Dow Movers: NKE, KO",1,0.49498057
2022-10-25,28829900.0,59.040000915527344,59.11000061035156,57.75,58.95000076293945,56.74460983276367,KO,"Poor report cards at U.S. companies fan recession fears ||| Coca-Cola Lifts FY22 Forecast - Update ||| Why Earnings from General Motors (GM) and Coca-Cola (KO) Have Changed the Overall Outlook for Stocks ||| US STOCKS-Wall St extends rally on signs of ebbing Fed rate hikes ||| US STOCKS-Wall St extends rally on signs of ebbing Fed rate hikes ||| Why Ethereum, Bitcoin, and Cardano Are Rocketing Higher Today ||| US STOCKS-Wall St notches third straight gain on signs of easing Fed rate hikes ||| US STOCKS-Nasdaq leads Wall St higher on hopes of less-hawkish Federal Reserve ||| US STOCKS-Nasdaq leads Wall Street higher as investors brace for megacap earnings ||| Coca-Cola (KO) Q3 2022 Earnings Call Transcript ||| US STOCKS-Nasdaq leads Wall Street higher as investors brace for megacap earnings ||| US STOCKS-Wall Street heads for muted open amid mixed earnings reports ||| Coke Offering Smaller Packaging as Inflation Changes Consumer Behavior ||| The Coca-Cola Company Q3 Profit Increases, beats estimates ||| Coca-Cola raises revenue, profit forecasts on boost from higher prices ||| Coca-Cola raises full-year revenue forecast ||| Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)? ||| The Coca-Cola Q3 22 Earnings Conference Call At 8:30 AM ET ||| GLOBAL MARKETS-Asia stocks struggle as Xi's leadership team spooks markets ||| Coca-Cola (KO) Q3 Earnings & Sales Beat Estimates, Stock Rises",1,0.4928518
2022-10-26,15831400.0,59.0099983215332,59.77999877929688,58.86000061035156,59.38999938964844,57.16815185546875,KO,"Company News for Oct 26, 2022 ||| Would Warren Buffett Buy Tilray Brands Stock?",1,0.49446377
2022-10-27,16026100.0,59.77000045776367,59.84000015258789,59.380001068115234,59.52999877929688,57.30291366577149,KO,"Top Analyst Reports for UnitedHealth, Johnson & Johnson, & Walmart ||| The Best Warren Buffett Stocks You Can Buy With Huge Passive Income Potential ||| Is Now the Right Time to Buy Coca-Cola Stock? ||| Warren Buffett Is Collecting 25% to 54% Yields on 3 Stocks: Here's His Secret",1,0.5209241
2022-10-28,12888900.0,59.56999969482422,60.90999984741211,59.470001220703125,60.7599983215332,58.48689270019531,KO,"Blue Chip Stocks To Invest In Right Now? 2 In Focus ||| IVE, MRK, KO, DIS: ETF Inflow Alert ||| The Zacks Analyst Blog Highlights UnitedHealth Group, Johnson & Johnson, Walmart, The Coca-Cola Company and NVIDIA ||| Looking for the Next Ethereum? 3 Cryptocurrencies to Buy Now ||| 3 Warren Buffett Stocks to Buy Hand Over Fist in November",0,0.48750302
2022-10-31,14016400.0,60.5099983215332,60.56999969482422,59.66999816894531,59.84999847412109,57.61093521118164,KO,"Top Dividend Stocks To Buy This Week? 2 To Know ||| Coca-Cola's Pricing Power Reinforces the Sustainability of Its Dividend ||| Company Report Roundup: Tesla, Tractor Supply, American Express, and More ||| Coke's Fizz, Weber's Proposed Deal, and Stock Market Superstitions",0,0.4897681
2022-11-01,10659500.0,60.02999877929688,60.290000915527344,59.369998931884766,59.63999938964844,57.40879821777344,KO,"Want $1,000 in Dividend Income Every Month? Invest $120,000 in This Stock ||| Oreo maker Mondelez lifts 2022 forecasts as snack demand holds up ||| Is Most-Watched Stock CocaCola Company The (KO) Worth Betting on Now? ||| This Dow Stock Can Help You Fight Off the Bear ||| 16 Words from Warren Buffett That May Answer Your Biggest Investing Question Right Now ||| What We Can Learn From This Warren Buffett Favorite About Investing When Inflation's High ||| Should You Invest in the iShares U.S. Consumer Staples ETF (IYK)?",0,0.49019948
2022-11-02,14549200.0,59.63999938964844,60.22999954223633,58.77000045776367,58.810001373291016,56.60984802246094,KO,"V, DIS, KO: Which is the Best “Strong Buy” Dow Jones Stock? ||| Should You Invest in the Vanguard Consumer Staples ETF (VDC)? ||| Is WisdomTree U.S. High Dividend ETF (DHS) a Strong ETF Right Now? ||| Big brands set to miss plastic sustainability targets ||| Better Buy: Coca-Cola vs. PepsiCo",0,0.4949008
2022-11-03,9194000.0,58.11000061035156,59.0,58.09999847412109,58.77999877929688,56.58097076416016,KO,Kellogg raises full-year revenue forecast on higher prices ||| Should WisdomTree U.S. High Dividend ETF (DHS) Be on Your Investing Radar?,1,0.50308585
2022-11-04,9725900.0,59.29999923706055,59.59000015258789,58.560001373291016,59.2599983215332,57.04301071166992,KO,Is This Warren Buffett-Owned Dividend King a Buy? ||| 3 Warren Buffett Investments That Crushed the Stock Market in 2022 ||| This Dividend King Sees an Inflation Crunch Into 2023,1,0.5005732
2022-11-07,8849700.0,59.2599983215332,59.77000045776367,59.2400016784668,59.4900016784668,57.26441192626953,KO,"Investors: Don't Fall Into Lurking Dividend Traps During Bear Markets ||| Thirsting for a Powerful Stock? Try Coca-Cola (KO) ||| 7 Consumer Stocks to Buy and Hold for Years ||| Noteworthy ETF Inflows: IVE, PG, MRK, KO ||| 3 Stocks You Can Keep Forever",1,0.4954187
2022-11-08,10081600.0,59.75,59.790000915527344,58.93999862670898,59.59999847412109,57.37029266357422,KO,"Better Buy: Coke or Pepsi ||| Got $3,000? 3 Growth Stocks To Double Up on Right Now ||| What Do Bitcoin and Coca-Cola Have in Common? ||| Bottler Coca-Cola HBC keeps its fizz on robust demand ||| Coca-Cola HBC Q3 Net Sales Revenue Up 26.9%; Upgrades 2022 Comparable EBIT Guidance",0,0.49069458
2022-11-09,10115200.0,59.59000015258789,59.63999938964844,58.75,58.77000045776367,56.57134246826172,KO,"At COP27, protesters within U.N. venue demand climate finance ||| The 4-Part Warren Buffett Approach You Can Use to Find Good Investments",1,0.51691467
2022-11-10,16804800.0,60.25,61.040000915527344,59.68000030517578,60.880001068115234,58.60240936279297,KO,7 No-Brainer Dividend Stocks to Buy for 2023 and Beyond ||| Q3 Earnings Season - Better Than Expected or Lackluster? ||| Worried About a Recession? Park Your Money In These 2 High-Yielding Dividend Stocks ||| Get Into This Growth Stock for 2023 and Beyond,1,0.51742333
2022-11-11,18972100.0,61.369998931884766,61.45000076293945,60.209999084472656,61.31999969482422,59.02594375610352,KO,"Friday's ETF with Unusual Volume: KXI ||| NFTs Are Coming to Instagram: Why Meta Is Bullish on These Cryptos, and You Should Be Too",0,0.47874027
2022-11-14,16361000.0,61.31999969482422,61.720001220703125,60.709999084472656,60.72999954223633,58.45801544189453,KO,The 7 Best Stocks for Retirement ||| The 7 Best Stocks to Buy This Week ||| Is Trending Stock CocaCola Company The (KO) a Buy Now?,0,0.4866352
2022-11-15,13295800.0,61.130001068115234,61.45000076293945,60.0,60.630001068115234,58.36176300048828,KO,"Dow Analyst Moves: KO ||| IVE, PG, MRK, KO: Large Outflows Detected at ETF ||| Where Will Coca-Cola Stock Be in 5 Years? ||| Warren Buffett Is Living Off These Five Stocks",0,0.4831453
2022-11-16,14199500.0,60.790000915527344,61.02999877929688,60.290000915527344,60.52000045776367,58.25587463378906,KO,"7 Recession-Resistant Stocks to Batten Down the Hatches ||| COP27: France, Spain latest to pledge halt to gasoline-driven vehicle sales",1,0.53766465
2022-11-17,11212600.0,60.18999862670898,60.7400016784668,60.130001068115234,60.709999084472656,58.43876266479492,KO,The Best Dividend Stocks to Buy Right Now Could Be Hiding in Plain Sight,1,0.49632302
2022-11-18,10415600.0,60.9900016784668,61.369998931884766,60.79999923706055,61.13999938964844,58.85268020629883,KO,FACTBOX-The newest fronts in climate-change-related legal battles,1,0.5207116
2022-11-21,15399400.0,61.40999984741211,62.209999084472656,61.20000076293945,62.08000183105469,59.75751495361328,KO,5 Signs You May Have a Recession-Proof Stock ||| 7 Juicy Dividends to Be Thankful For This Year ||| 5 Dividend Stocks to Build Your Portfolio Around in 2023 ||| 7 Must-Own Safe Havens as Market Selloff Accelerates ||| Is Nuveen ESG LargeCap Value ETF (NULV) a Strong ETF Right Now? ||| 89% of Warren Buffett's Portfolio Is Invested in These 12 Stocks,1,0.5135854
2022-11-22,12319600.0,62.470001220703125,62.5,62.04999923706055,62.34999847412109,60.01740646362305,KO,2 Soaring Stocks I'd Buy Now With No Hesitation ||| Coca-Cola (KO) Recently Broke Out Above the 200-Day Moving Average,1,0.51622754
2022-11-23,8990400.0,62.4900016784668,62.790000915527344,62.29999923706055,62.630001068115234,60.28693771362305,KO,"After Hours Most Active for Nov 23, 2022 : WE, CZR, ATUS, EFXT, QQQ, AMWL, AAPL, KO, MSFT, RSI, IMGO, AMZN ||| Do You Seek Reliable Passive Income? Trust this Low Beta Stock",1,0.4891152
2022-11-25,5165500.0,62.72999954223633,62.810001373291016,62.380001068115234,62.68999862670898,60.34469604492188,KO,"Why Is Coke (KO) Up 5.5% Since Last Earnings Report? ||| Here is What to Know Beyond Why CocaCola Company The (KO) is a Trending Stock ||| After Hours Most Active for Nov 25, 2022 : WE, AMZN, ISTB, KO, AAPL, CZR, CSX, TQQQ, VICI, BMY, ATUS, DELL ||| 3 Warren Buffett Quotes You Probably Haven't Heard that Will Inspire You to Buy More Stocks ||| Nike Is Going All In on Web3. Here's How Investors Can Benefit ||| 93% of Warren Buffett's Portfolio Is in These 4 Sectors ||| My Favorite Consumer Goods Stocks for 2023",1,0.4716235
2022-11-29,10969600.0,62.52000045776367,62.56999969482422,61.97999954223633,62.47999954223633,60.14254760742188,KO,"This Restaurant Is Likely A Better Pick Over Coca-Cola Stock ||| Top Stock Reports for Procter & Gamble, Coca-Cola & Progressive ||| Will FEMSA's (FMX) Digital Strategy Aid Growth Amid Cost Woes?",1,0.5165761
2022-11-30,30433900.0,62.0099983215332,63.68000030517578,61.75,63.61000061035156,61.66453170776367,KO,"The Zacks Analyst Blog Highlights Procter & Gamble, Coca-Cola, The Progressive, Zoetis and Palo Alto Networks",1,0.5164285
2022-12-01,12001400.0,63.61000061035156,64.11000061035156,63.43000030517578,63.790000915527344,61.83902740478516,KO,Why the Nasdaq Will Beat the Dow in 2023 ||| Is American Express Stock a Buy?,1,0.5051558
2022-12-02,13643500.0,63.61000061035156,64.5199966430664,63.400001525878906,64.3499984741211,62.38189697265625,KO,"Dow Movers: INTC, KO ||| Can This Classic Warren Buffett Advice Make You a Better Crypto Investor? ||| 2 of the Safest Dividend Stocks On Earth ||| Splunk Earnings Spark Software",0,0.4828188
2022-12-05,9185100.0,63.40999984741211,63.79999923706055,63.2599983215332,63.470001220703125,61.52881622314453,KO,"Got $5,000? 3 Top Dividend Stocks to Buy Right Now ||| 73% of Warren Buffett's Portfolio Is in These 5 Stocks as 2022 Winds Down ||| FTX Collapse: Lessons for Investors ||| 3 Top Dividend Stocks to Buy Now ||| Coca-Cola Stock (NYSE:KO): This Passive-Income Giant Still Has Fizz ||| Noteworthy ETF Outflows: ITOT, JNJ, KO, WFC ||| 3 Unstoppable Warren Buffett Dividend Stocks to Buy in December ||| Is There A Better Pick Over PepsiCo Stock?",0,0.4582913
2022-12-06,10099500.0,63.52000045776367,63.880001068115234,63.22999954223633,63.43999862670898,61.49972915649414,KO,3 Beverage Innovators to Caffeinate your Watchlist ||| 3 No-Brainer Buffett Stocks to Buy Before the End of 2022,1,0.54464257
2022-12-07,12307600.0,63.45000076293945,63.720001220703125,63.25,63.540000915527344,61.59667205810547,KO,Swedish self-driving truck start-up Einride raises more cash,1,0.5655701
2022-12-08,9946200.0,63.59999847412109,63.84999847412109,63.34999847412109,63.810001373291016,61.8584098815918,KO,2 Forever Stocks You Can Buy and Forget About ||| Investors Heavily Search CocaCola Company The (KO): Here is What You Need to Know ||| Coca-Cola vs. PepsiCo: Which Stock Has More Fizz? ||| Our 7 Top Consumer Stock Picks for 2023,0,0.48035255
2022-12-09,13914900.0,63.61000061035156,63.84000015258789,63.09000015258789,63.13999938964844,61.20890045166016,KO,"Wall Street Analysts Look Bullish on Coke (KO): Should You Buy? ||| This Top Buffett Stock Shows the Power of Long-Term Dividends ||| Zacks Industry Outlook Highlights Coca-Cola, PepsiCo, Coca-Cola FEMSA, Keurig Dr Pepper and Monster Beverage",1,0.48684248
2022-12-12,11647900.0,63.29999923706055,64.01000213623047,63.0099983215332,63.970001220703125,62.013519287109375,KO,Why Should You Invest in Blue Chip Stocks? ||| Our 3 Top Stock Picks for Beginners in 2023,1,0.48493004
2022-12-13,17521600.0,64.58999633789062,64.69999694824219,63.79999923706055,63.9900016784668,62.03290557861328,KO,"These 3 Recession-Tested Stocks are Strong Buys, According to Analysts ||| Insiders Bullish on Certain Holdings of XLP ||| QUAL, KO, MMC, LMT: ETF Outflow Alert ||| Reliable Passive Income: an Analysis on Dividend Kings",0,0.49343398
2022-12-15,12212300.0,63.59000015258789,63.88999938964844,62.4900016784668,63.11000061035156,61.1798210144043,KO,Our 3 Top Defensive Stock Picks for 2023,0,0.50150687
2022-12-16,33631500.0,62.75,63.13999938964844,62.33000183105469,62.75,60.83082962036133,KO,"Coca-Cola (KO) Stock Moves -0.57%: What You Should Know ||| After Hours Most Active for Dec 16, 2022 : AMZN, CSCO, CMCSA, SWN, BAC, VZ, AAPL, TSLA, FBIN, KO, META, XOM ||| Best Long-Term Stocks To Buy Today? 2 Consumer Stocks To Know ||| VettaFi Voices On: The Best New ETFs of 2022  ||| VettaFi Voices On: The Best New ETFs of 2022  ||| Meme Stocks That Are Actually Solid Long-Term Picks",1,0.46902025
2022-12-19,10919700.0,62.83000183105469,63.40999984741211,62.470001220703125,62.84000015258789,60.9180793762207,KO,"11.5% of Warren Buffett's Portfolio Is Invested in These 2 Consumer Staples Stocks ||| Unusual Options Activity in Apple, Home Depot and 8 Other Stocks ||| The Extremely Rare Warren Buffett Investing Strategy Not to Follow",0,0.4739033
2022-12-20,10286500.0,62.81999969482422,63.150001525878906,62.75,62.790000915527344,60.86960983276367,KO,"Got $1,000? 5 Buffett Stocks to Buy and Hold Forever",1,0.47292683
2022-12-21,10411300.0,63.06999969482422,64.05000305175781,63.06999969482422,63.79999923706055,61.84871673583984,KO,KO vs. PEP: Why Coca-Cola Stock Looks Tastier ||| CocaCola Company The (KO) Is a Trending Stock: Facts to Know Before Betting on It ||| 3 Cryptocurrencies to Buy in Any Bear Market ||| Top 15 Investing Tips for Beginners in 2023 and Beyond,0,0.48471877
2022-12-23,6463300.0,63.5,63.869998931884766,63.20000076293945,63.81999969482422,61.868106842041016,KO,3 Top Warren Buffett Stocks for 2023,1,0.5479623
2022-12-27,7320700.0,63.93000030517578,64.29000091552734,63.709999084472656,64.20999908447266,62.24617767333984,KO,2 Stocks Warren Buffett Should Buy in 2023 ||| Should You Invest in Coke (KO) Based on Bullish Wall Street Views? ||| 3 Top Value Stocks to Buy Right Now ||| These 6 Stocks Are Why Warren Buffett Beat the Market In 2022 ||| 2022: Winners & Losers ||| Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)? ||| 2 Best Buffett Stocks to Buy for the Long Haul,0,0.46522197
2022-12-28,7159400.0,64.45999908447266,64.6500015258789,63.4900016784668,63.56999969482422,61.62574768066406,KO,Coca-Cola (KO) Stock Moves -1%: What You Should Know ||| Our Predictions for the Top 7 Dividend Stocks for 2023,1,0.47115698
2022-12-29,7169300.0,63.79999923706055,64.1500015258789,63.70000076293945,63.95000076293945,61.99413299560547,KO,"DGRO, KO, MS, C: ETF Inflow Alert ||| 3 Dividend Growth Stocks That Have Increased Their Payouts for a Combined 188 Years ||| 1 Warren Buffett Stock I Wouldn't Touch With a 10-Foot Pole",0,0.47610843
2022-12-30,7650200.0,63.91999816894531,63.91999816894531,63.16999816894531,63.61000061035156,61.66453170776367,KO,73% of Warren Buffett's Portfolio Is Invested in These 5 Stocks,0,0.47670794
2012-01-03,17271400.0,37.880001068115234,38.560001373291016,37.810001373291016,38.29999923706055,29.06808280944824,MRK,Merck & Hits 52-Week High of $37.98 ||| Can Germany's Employers Turn Europe Around?,1,0.50524294
2012-01-04,13716300.0,38.25,38.34000015258789,37.900001525878906,38.34000015258789,29.09845352172852,MRK,AstraZeneca Remains Neutral - Analyst Blog ||| Will Alnylam's Prospective Obesity Drug Change the World Forever? ||| Bark At The Dow's Dogs With These ETFs,1,0.5079839
2012-01-05,20987600.0,38.13999938964844,39.0,38.040000915527344,38.7400016784668,29.40203094482422,MRK,Merck & Hits 52-Week High of $38.57,0,0.5046883
2012-01-06,16727700.0,38.75,38.75,38.43000030517578,38.470001220703125,29.19710922241211,MRK,Merck Says FDA Approves Isentress for Children in Ages 2 & Up -Bloomberg,0,0.5262833
2012-01-09,13906900.0,38.34000015258789,38.470001220703125,37.88999938964844,38.38999938964844,29.136388778686523,MRK,Trading Strategy: 2012 Dogs of the Dow ||| Merck Downgraded to “Hold” at Jefferies (MRK) ||| Jefferies Downgrades Merck & Company to Hold,1,0.50041384
2012-01-10,11366200.0,38.75,38.79999923706055,38.400001525878906,38.52000045776367,29.235063552856445,MRK,"Roche-Xenon Agree to Join Forces - Analyst Blog ||| 3 Health Care Stocks for Active Investors ||| Going Nuc-lear on Hepatitis C -- Is Idenix the Next Target? ||| Feuerstein: Merck for Idenix Pharma was Just a Prediction, Not a Rumor",0,0.48575523
2012-01-11,11945800.0,38.41999816894531,38.52000045776367,38.2400016784668,38.40999984741211,29.15157127380371,MRK,How to Trade Biotechs Based on the JP Morgan Health Care Conference,1,0.52464396
2012-01-13,9677400.0,38.45000076293945,38.5,38.02000045776367,38.31999969482422,29.08325958251953,MRK,Biosimilars: The Next Big Thing - Analyst Blog ||| UPS in New Markets - Analyst Blog,1,0.5273538
2012-01-18,14710600.0,38.650001525878906,38.95000076293945,38.63999938964844,38.869998931884766,29.500688552856445,MRK,"Benzinga's M&A Chatter for Wednesday January 18, 2012 ||| Positive Rumors Circulate About Vertex Pharmaceuticals ||| Hearing Wedbush Says Idenix Pharmaceuticals Takeover Target of Merck, Johnson & Johnson, Abbott Labs; $24/Share",1,0.5027433
2012-01-19,16546800.0,38.900001525878906,39.43000030517578,38.72999954223633,39.2599983215332,29.79667282104492,MRK,Gilead Clinches Pharmasset Buy - Analyst Blog ||| Merck & Hits 52-Week High of $39.01,0,0.4959483
2012-01-20,15333900.0,39.31999969482422,39.400001525878906,38.91999816894531,39.20000076293945,29.751144409179688,MRK,"The Zacks Analyst Blog Highlights: Gilead Sciences, Bristol-Myers Squibb, Inhibitex, Vertex Pharmaceuticals and Merck - Press Releases ||| Merck Announces Remicade Receives Positive Opinion From CHMP In Europe for Treatment of Ulcerative Colitis in Pediatric Patients ||| What's the Future Like For Health Care?",0,0.4893658
2012-01-23,13499900.0,38.959999084472656,39.09999847412109,38.68000030517578,38.77000045776367,29.424789428710938,MRK,Positive CHMP Rec for Merck's Remicade - Analyst Blog ||| Merck Receives Positive Mad Money/Jim Cramer Mention -CNBC,1,0.5212356
2012-01-24,13144700.0,38.970001220703125,39.209999084472656,38.650001525878906,38.77999877929688,29.4323844909668,MRK,"J&J Beats, 2012 Outlook Disappoints - Analyst Blog ||| UPDATE: ISI Group Initiates Buy, $45 on Merck",0,0.50433105
2012-01-25,14475200.0,38.56999969482422,38.790000915527344,38.2599983215332,38.68000030517578,29.356489181518555,MRK,"3 Drug Stocks for Active Investors ||| Benzinga's M&A Chatter for Wednesday January 25, 2012 ||| Merck Spokesperson Would Not Comment on Earlier Speculation of Idenix Pharmaceuticals Takeover ||| Idenix Pharmaceuticals Spokesperson Has No Comment on Earlier Merck Takeover Chatter ||| Idenix Pharmaceuticals Spiking Higher on Renewed Takeover Chatter; Merck Rumored Buyer ||| UPDATE: Merck: FDA Did Not Approve New Indication For Vytorin Because of Study Design ||| Merck Announces New FDA Approved Labeling For VYTORIN Includes Results From the Study of Heart and Renal Protection in Patients With Moderate to Severe Chronic Kidney Disease",1,0.54485893
2012-01-26,12388800.0,38.84000015258789,38.95000076293945,38.540000915527344,38.77999877929688,29.4323844909668,MRK,"Benzinga's M&A Chatter for Thursday January 26, 2012 ||| Seattle Genetics Spokesperson Would Not Comment on Earlier Merck Takeover Rumor",0,0.52359855
2012-01-30,12714300.0,38.380001068115234,38.900001525878906,38.27000045776367,38.88999938964844,29.515869140625,MRK,Earnings Expectations for the Week of January 30,0,0.47942594
2012-01-31,16477600.0,38.970001220703125,38.9900016784668,38.18999862670898,38.27000045776367,29.04532241821289,MRK,Merck Wins Patent Ruling Over Sandoz Version of Cancidas -Bloomberg,1,0.51942235
2012-02-02,20780700.0,38.93999862670898,38.970001220703125,38.0,38.43999862670898,29.174346923828125,MRK,"Merck Q4 Profit Beats Expectations, but Revenue Falls Short (MRK) ||| Opening View: DJIA Flat Ahead of Jobless Claims, Bernanke Speech ||| FDA Approves JANUMET XR for Type 2 Diabetes ||| UPDATE: Merck Swings To Q4 Profit ||| Merck's Earnings Are Up, But a Huge Drop may be Coming ||| Financial Breakfast: Morning News Summary for February 2, 2012 ||| Merck & Reports Q4 EPS $0.97 vs $0.95 Est; Revenues $12.30B vs $12.53B Est ||| Earnings Scheduled For February 2",0,0.4934047
2012-02-03,15010200.0,38.5,38.59000015258789,38.08000183105469,38.369998931884766,29.121206283569336,MRK,"The Zacks Analyst Blog Highlights: Cummins, Kellogg, Merck, Dow Chemical and International Paper - Press Releases ||| Candlesticks – Bears Appeared on Merck ||| From Earlier: Threshold Pharmaceuticals and Merck KGaA Announce Global Agreement to Co-Develop and Commercialize Phase 3 Hypoxia-Targeted Drug TH-302",1,0.52590877
2012-02-06,11032300.0,38.209999084472656,38.400001525878906,38.130001068115234,38.400001525878906,29.143983840942383,MRK,"Benzinga's M&A Chatter for Monday February 6, 2012 ||| Idenix Pharmaceuticals Spokesperson Has No Comment on Renewed Merck Takeover Chatter ||| UPDATE: Idenix Pharmaceuticals Spiking Higher on Renewed Takeover Chatter; Merck Rumored Buyer ||| Merck Confirms Plans to File NDA for Suvorexant in 2012",1,0.5290587
2012-02-07,12447400.0,38.27000045776367,38.77999877929688,38.25,38.630001068115234,29.31854057312012,MRK,Merck Analyst: Effectiveness of Vorapaxar Was Surprise; But Ability to Reach Market is Limited Due to Bleeding Risk ||| Merck Announces Top-Line Results of TRA-2P Study of Vorapaxar,0,0.48735705
2012-02-08,11333200.0,38.54999923706055,38.59999847412109,38.220001220703125,38.41999816894531,29.159160614013672,MRK,Higher Bleeding Haunts Merck Candidate - Analyst Blog,0,0.51336265
2012-02-10,10521100.0,37.93999862670898,38.0099983215332,37.77999877929688,37.90999984741211,28.77209854125977,MRK,Grandpa's 2012 ETF Portfolio,1,0.53416526
2012-02-13,11621600.0,38.09999847412109,38.2400016784668,37.97999954223633,38.11000061035156,28.92388153076172,MRK,"Label Update for Merck's Victrelis - Analyst Blog ||| FDA Approves ZIOPTAN, Merck's Once-Daily, Preservative-Free Ophthalmic Medication ||| UPDATE: Morgan Stanley Raises PT to $37 on Merck",1,0.5181934
2012-02-15,12184800.0,38.2599983215332,38.27999877929688,37.88999938964844,38.02000045776367,28.85557556152344,MRK,Merck Establishes Joint Venture with Supera Farma to Commercialize Innovative Pharmaceutical Products and Branded Generics in Brazil,1,0.5646967
2012-02-22,9833000.0,38.060001373291016,38.22999954223633,37.900001525878906,38.220001220703125,29.00736618041992,MRK,"J&J CEO to Step Down - Analyst Blog ||| Viva Vivus, But Not In ETFs (VVUS, IBB, PJP)",1,0.5090292
2012-02-23,10328200.0,38.09999847412109,38.52000045776367,38.09999847412109,38.5099983215332,29.227468490600582,MRK,"MannKind Narrows Loss - Analyst Blog ||| The Zacks Analyst Blog Highlights: Johnson & Johnson, Pfizer, Merck, Public Service Enterprise Group and Consolidated Edison - Press Releases ||| The Best Way to Profit From Stock Spin-Offs",0,0.47167403
2012-02-28,9461900.0,38.150001525878906,38.4900016784668,38.0,38.380001068115234,29.128807067871094,MRK,"The Rick Santorum ETF Portfolio (KOL, PBS, IYZ) ||| FDA Approves Important Safety Label Changes For The Class Of Cholesterol-Lowering Drugs Known As Statins -Reuters",0,0.50865716
2012-02-29,15240000.0,38.470001220703125,38.4900016784668,38.119998931884766,38.16999816894531,28.969417572021484,MRK,Bleak Outlook for Dendreon's Provenge - Analyst Blog,0,0.5120989
2012-03-05,18663100.0,38.0099983215332,38.52000045776367,37.9900016784668,38.45000076293945,29.181930541992188,MRK,Merck Says FDA Declines To Approve Its New Drug Application For Ezetimibe And Atorvastatin Tablets -Reuters ||| Merck's Investigational Allergy Immunotherapy Tablet Significantly Reduced the Combination of Ragweed Allergy Symptoms ||| Merck Says FDA Says Added Data Needed on Ezetimibe/Atorvastatin -Bloomberg,0,0.50700754
2012-03-06,18595300.0,37.97999954223633,38.380001068115234,37.29999923706055,37.43999862670898,28.41538429260254,MRK,Merck Provides Q1 Guidance Below Wall Street’s View (MRK) ||| Oncothyreon Analyst: Stimulax Continuation Was Expected; as Likely Outcome for Trial to be Completed Rather Than Stop Early for Positive Efficacy or Futility ||| Merck Down 2% After Reaffirming 2012 Guidance ||| Abbott and Merck Collaborate to Develop Companion Diagnostic Test for Investigational Cancer Therapy ||| Merck Issues Q1 Profit Forecast ||| UPDATE: Merck Confirms 2012 Full-Year Guidance ||| Merck Guides Q1 EPS $0.95-0.98 vs $1.01 Est; Confirms 2012 Guidance ||| Oncothyreon Falls 47% Pre-Market on Stimuvax Report ||| UPDATE: Merck Says Stimuvax Trial to Continue to Final Analysis; Says Final Result Expected in 2013,0,0.5023417
2012-03-07,16870000.0,37.33000183105469,37.43000030517578,36.90999984741211,37.310001373291016,28.316709518432617,MRK,"Company News for March 7, 2012 - Corporate Summary ||| Merck Gives Weak Q1 Outlook ||| From Earlier: Merck Announces Results from Investigational Studies with VICTRELIS Presented at the Conference on Retroviruses and Opportunistic Infections to Understand Potential Use in Patients Coinfected with Chronic Hepatitis C and HIV-1",1,0.53526115
2012-03-08,40922000.0,37.619998931884766,37.810001373291016,37.34999847412109,37.400001525878906,28.3850212097168,MRK,"Merck's 1Q Guidance Lags Expectations - Analyst Blog ||| Still Neutral on MannKind - Analyst Blog ||| After Hours Most Active for Mar 8, 2012 : AIG, MRK, MO, INTC, GMCR, KO, PFE, QQQ, GNW, BRCD, SIRI, ATML",1,0.49670792
2012-03-09,44521000.0,37.47999954223633,37.900001525878906,37.459999084472656,37.59999847412109,28.53681755065918,MRK,"Revenues Decline at Simcere Pharma - Analyst Blog ||| After Hours Most Active for Mar 9, 2012 : MRK, MO, KO, NYX, FTR, BP, VOD, QQQ, MSFT, INTC, ATML, ERIC",1,0.494935
2012-03-12,10873400.0,37.720001220703125,38.11000061035156,37.650001525878906,38.09999847412109,28.91630172729492,MRK,"Benzinga's M&A Chatter for Monday March 12, 2012 ||| Merck Repeats 2012 Forecast in Presentation Slides -Bloomberg ||| Merck Spokesperson Would Not Comment on Earlier Speculation of Idenix Pharmaceuticals Takeover Bid ||| Hearing Renewed Takeover Chatter in Idenix Pharmaceuticals, Merck Rumored Buyer ||| Positive Rumors Circulate About Idenix Pharmaceuticals",1,0.51752853
2012-03-15,12246000.0,38.150001525878906,38.25,37.95000076293945,38.060001373291016,29.207921981811523,MRK,"A Look At The New Russell High Yield ETF (HDIV, ABT, KFT)",0,0.5208992
2012-03-16,18555500.0,38.16999816894531,38.33000183105469,37.970001220703125,38.02999877929688,29.18487930297852,MRK,"ETF Showdown: Dividend Dilemma (HDV, HDIV, JNJ) ||| Briefing Information for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee",0,0.5030183
2012-03-20,13851000.0,37.650001525878906,37.91999816894531,37.619998931884766,37.7599983215332,28.977678298950195,MRK,Ariad Pharmaceuticals Falls 5% on FDA Panel Vote ||| FDA Panel Votes 13-1 Against Recommending Taltorvic As Maintenance Treatment For Soft-tissue And Bone Sarcoma -Reuters,0,0.5129492
2012-03-21,11497000.0,37.880001068115234,37.880001068115234,37.630001068115234,37.70000076293945,28.931644439697266,MRK,Panel Votes Against Merck-ARIAD Drug - Analyst Blog ||| UPDATE: Merck and ARIAD Pharmaceuticals Provide Update on FDA Advisory Committee Vote; Voted 13 To 1 Against The Use of Ridaforolimus,0,0.51304823
2012-03-22,12991500.0,37.540000915527344,37.93000030517578,37.52999877929688,37.59999847412109,28.85490608215332,MRK,Temodar Generic Cleared Down Under - Analyst Blog,1,0.5401807
2012-03-23,10766500.0,37.70000076293945,38.04999923706055,37.61000061035156,38.0099983215332,29.169544219970703,MRK,Positive Vote for Glaxo's Votrient - Analyst Blog,1,0.5382764
2012-03-26,12000700.0,38.2599983215332,38.70000076293945,38.150001525878906,38.65999984741211,29.66835594177246,MRK,Adding Merck's Vorapaxar to Standard of Care Significantly Reduced the Risk of Cardiovascular Events ||| Victrelis Available for Eligible Patients in British Columbia ||| Merck Reports C$35M Investment and Start of Merck Lumira Fund,1,0.52724075
2012-03-27,12689500.0,38.75,39.0,38.68000030517578,38.79999923706055,29.77580451965332,MRK,"Benzinga's M&A Chatter for Tuesday March 27, 2012 ||| Merck Spokesperson, Responding to Chatter of $26 Offer for Amarin, Says Company Policy is Not to Respond to Rumors Regarding Business Development Deals ||| Hearing Chatter Merck Making $26/Share Bid for Amarin",0,0.501222
2012-04-03,10948100.0,38.54999923706055,38.720001220703125,38.459999084472656,38.720001220703125,29.71441078186035,MRK,Merck ||| Codexis and Merck Develop Prototype Enzyme-Based Method for Production of Boceprevir,1,0.5247454
2012-04-04,15210800.0,38.59999847412109,38.95000076293945,38.5,38.900001525878906,29.8525390625,MRK,Decoding Wall St.: Express Scripts and Medco Merger is No Joke,0,0.4874812
2012-04-05,13880800.0,38.7599983215332,38.90999984741211,38.59000015258789,38.880001068115234,29.83719825744629,MRK,SNY Expands Animal Health Business - Analyst Blog,0,0.5219902
2012-04-11,10710600.0,38.61000061035156,38.70000076293945,38.400001525878906,38.47999954223633,29.530223846435547,MRK,"Smart Investors Need to Dump This ""Comeback Stock"" Before it's Too Late",0,0.49484354
2012-04-13,20858100.0,38.09000015258789,38.09999847412109,37.77000045776367,37.77999877929688,28.99304580688477,MRK,"After Hours Most Active for Apr 13, 2012 : JPM, T, PG, MRK, VZ, CTL, AAXJ, ATVI, QQQ, HAS, AERL, QCOM",1,0.47988
2012-04-16,13938100.0,37.880001068115234,38.060001373291016,37.880001068115234,37.95000076293945,29.123497009277344,MRK,"Option Alert: Endocyte Call Volume at 818% of Average on Merck Deal ||| Morning Market Movers ||| Benzinga's Top Pre-Market Gainers ||| Endocyte Rises 100% Pre-Market on Merck Deal ||| Financial Breakfast: Morning News Summary for April 16, 2012 ||| Endocyte Resumes Trading ||| PREVIEW: Endocyte to Resume Trading at 7:30am ||| Merck and Endocyte Enter Exclusive Worldwide Agreement to Develop and Commercialize Phase III Cancer Candidate Vintafolide",1,0.52408016
2012-04-17,11200400.0,38.11000061035156,38.540000915527344,37.9900016784668,38.5099983215332,29.55324935913086,MRK,"Company News for April 17, 2012 - Corporate Summary ||| Benzinga's Microcap Movers for Monday April 16, 2012 ||| Benzinga's Top Pre-Market Gainers",0,0.505827
2012-04-18,7665400.0,38.43999862670898,38.59999847412109,38.380001068115234,38.400001525878906,29.468839645385746,MRK,Merck Wins Another FOSAMAX State Court Trial,0,0.52924156
2012-04-19,10740800.0,38.54999923706055,38.619998931884766,38.15999984741211,38.36000061035156,29.438138961791992,MRK,Merck in Oncology Deal - Analyst Blog ||| S&P: Bullish On Pharma ETFs Long-Term ||| Merck Reports Phase III Study Results Evaluating Anaemia Management Strategies Used With VICTRELIS® (boceprevir) Combination Therapy,1,0.52405965
2012-04-23,10671300.0,38.54999923706055,38.560001373291016,38.20000076293945,38.27000045776367,29.369070053100582,MRK,"Earnings Expectations for the Week of April 23 (AAPL, XOM, UPS)",0,0.49123582
2012-04-24,12485400.0,38.34000015258789,38.43000030517578,38.16999816894531,38.27000045776367,29.369070053100582,MRK,Dow Takes a Triple-Digit Ride as the Street Chews On Apple,1,0.542192
2012-04-25,12840700.0,38.29999923706055,38.4900016784668,38.130001068115234,38.43000030517578,29.49186134338379,MRK,Earnings Preview: Merck - Analyst Blog,1,0.538252
2012-04-27,15514500.0,38.79999923706055,38.93999862670898,38.34000015258789,38.459999084472656,29.514890670776367,MRK,"Ahead of Wall Street - April 27, 2012 - Ahead of Wall Street ||| Merck Beats by a Penny; Affirms View - Analyst Blog ||| Merck’s Profit Beats, but Revenue Misses (MRK) ||| GDP Headline Weak, Stronger Underneath - Analyst Blog ||| Merck &amp; Reports Q1 EPS $0.99 vs $0.98 Est; Revenues $11.7B vs $11.82B Est ||| US Stock Futures Flat; GDP Data In Focus ||| Earnings Scheduled For April 27",1,0.50086194
2012-04-30,19808600.0,38.63999938964844,39.459999084472656,38.59000015258789,39.2400016784668,30.11346435546875,MRK,Best Health Care Investor Edward Owens Buys One New Health Care Stock in First Quarter ||| New Kids: Do These New ETFs Have The Right Stuff? ||| FDA Considering Letting Patients Purchase Drugs Without Prescriptions,1,0.51787746
2012-05-04,11932400.0,39.11000061035156,39.11000061035156,38.61000061035156,38.84000015258789,29.806489944458008,MRK,"Pfizer, Merck Pulled Into Expanded Congressional Investigation, Republicans Seeking Documents Over Obama Deal -Bloomberg",0,0.4653071
2012-05-07,11573700.0,38.5099983215332,38.810001373291016,38.5,38.540000915527344,29.57627868652344,MRK,J.P. Morgan Reiterates Overweight Rating for Merck ||| Goldman Sachs Reiterates Neutral Rating for Merck,1,0.5289724
2012-05-08,8762600.0,38.52000045776367,38.65999984741211,38.27999877929688,38.630001068115234,29.645336151123047,MRK,JP Morgan Reiterates “Overweight” Rating on Merck (MRK),0,0.49796832
2012-05-10,9452700.0,38.29999923706055,38.619998931884766,38.25,38.38999938964844,29.461151123046875,MRK,Simcere Misses on all Fronts - Analyst Blog,0,0.51178426
2012-05-11,12111400.0,38.20000076293945,38.34000015258789,37.95000076293945,38.02999877929688,29.18487930297852,MRK,The Shorts Report: 10 Mega-Caps With Increased Short Selling,1,0.5409577
2012-05-14,16272700.0,37.84999847412109,38.38999938964844,37.709999084472656,38.220001220703125,29.330699920654297,MRK,Greece Prompts a 125-Point Slide for Dow; JPM Still Not Forgotten,0,0.47296268
2012-05-15,10652700.0,38.08000183105469,38.20000076293945,37.58000183105469,37.7400016784668,28.962343215942383,MRK,"S&P Bullish On Biotech ETFs (FBT, IBB, XBI)",1,0.5022456
2012-05-18,18690600.0,38.20000076293945,38.209999084472656,37.630001068115234,37.81999969482422,29.023738861083984,MRK,"BMO Starts coverage on Merck with a “Market Perform” Rating (MRK) ||| BMO Capital Markets Initiates Coverage on Merck & at Market Perform, Announces PT of $43",0,0.5064563
2012-05-21,9300000.0,37.72999954223633,37.88999938964844,37.54999923706055,37.59999847412109,28.85490608215332,MRK,"Merck: FDA Approves New Labeling for ISENTRESS to Include 156-Week Data Demonstrating Long-Term Efficacy, Safety and Tolerability",0,0.5275819
2012-05-22,12327600.0,37.65999984741211,37.7400016784668,37.34999847412109,37.459999084472656,28.747467041015625,MRK,Health Care SPDR In Focus Ahead Of Obamacare Decision,0,0.5024464
2012-05-24,8651700.0,37.400001525878906,37.66999816894531,37.27999877929688,37.59999847412109,28.85490608215332,MRK,FDA Nod for Merck Drug Label Update - Analyst Blog,0,0.53581744
2012-05-25,6591600.0,37.56999969482422,37.75,37.369998931884766,37.54999923706055,28.81653594970703,MRK,"Amylin Shares Jump as Sanofi, Merck Sumbit Bids ||| Merck Spokesperson Would Not Comment on Reports of Bid for Amylin ||| Amylin Spokesperson Would Not Comment on Bloomberg Report of Bids from Merck and Sanofi ||| Amylin Said to Get First-Round Bids from Sanofi, Merck -Bloomberg ||| Government of Rwanda Introduces Merck's ROTATEQ",1,0.51351535
2012-05-29,8792400.0,37.68999862670898,37.75,37.43000030517578,37.59000015258789,28.84722137451172,MRK,"Benzinga's M&A Chatter for Friday May 25, 2012 ||| 5 Healthcare Stocks With The Highest Cash",0,0.4957507
2012-05-30,9668200.0,37.400001525878906,37.650001525878906,37.290000915527344,37.400001525878906,28.70140838623047,MRK,"Benzinga's M&A Chatter for Wednesday May 30, 2012",1,0.5080634
2012-05-31,13443100.0,37.61000061035156,37.869998931884766,37.25,37.58000183105469,28.839550018310547,MRK,15 Great Stocks with Great Yield ||| Merck CEO Says He Isn't Interested in Breaking Up the Company -Bloomberg,0,0.5000627
2012-06-01,13371600.0,37.18000030517578,37.4900016784668,37.02000045776367,37.18000030517578,28.5325870513916,MRK,Amylin Pharmaceuticals Spokesperson Declines Comment on Renewed Takeover Chatter ||| Hearing Renewed Takeover Chatter in Amylin Pharmaceuticals,1,0.51844746
2012-06-04,10915800.0,37.18000030517578,37.470001220703125,37.119998931884766,37.459999084472656,28.747467041015625,MRK,"Benzinga's M&A Chatter for Friday June 1, 2012 ||| The US Economy and the United Nations: Bold Strategies Needed - Tax Reform and Benefits Reform",1,0.52548784
2012-06-05,10560500.0,37.400001525878906,37.54999923706055,37.2599983215332,37.5,28.77816200256348,MRK,"Merck Sues Sandoz, Accord Healthcare on Proposed Emend Copy, Claims Infringement of Patents Expiring in 2015 and 2019 ||| Merck Gets Response Letter for Ridaforolimus, Says Added Clinical Trials Would Need to be Conducted; In Talks with EU Health Authorities -Bloomberg",1,0.49887744
2012-06-06,12613900.0,37.75,37.900001525878906,37.52999877929688,37.900001525878906,29.08512687683105,MRK,Merck's Drug Fails to Get FDA Nod - Analyst Blog,1,0.5363398
2012-06-07,53370900.0,38.06999969482422,38.470001220703125,38.0099983215332,38.33000183105469,29.41512107849121,MRK,Abbott Presents Data on Humira - Analyst Blog ||| Pfizer Plans to IPO Part of its Animal Health Segment,1,0.5231152
2012-06-08,50924300.0,38.47999954223633,38.54999923706055,38.25,38.459999084472656,29.514890670776367,MRK,"After Hours Most Active for Jun 8, 2012 : GE, MRK, MO, BAC, ZNGA, WFC, PBR, LINE, QQQ, MSFT, CG, NWS",1,0.48452905
2012-06-11,46814300.0,38.619998931884766,38.77000045776367,38.43999862670898,38.470001220703125,29.52256202697754,MRK,"Bristol-Myers Shares Positive Data - Analyst Blog ||| Positive Data on Sanofi's Lantus - Analyst Blog ||| After Hours Most Active for Jun 11, 2012 : MO, MRK, BAC, PM, QQQ, C, MRVL, SD, FITB, YHOO, QCOM, EA",1,0.4917534
2012-06-13,11566500.0,38.400001525878906,38.790000915527344,38.27000045776367,38.400001525878906,29.7908992767334,MRK,Merck Announces New Phase III Data Showed Merck's Investigational Insomnia Medicine Suvorexant Improved Patients' Ability to Fall Asleep and Stay Asleep,1,0.53150636
2012-06-14,12909600.0,38.52000045776367,38.93999862670898,38.34999847412109,38.790000915527344,30.09346580505371,MRK,"Perrigo in Neutral Lane - Analyst Blog ||| Believe In The Rally? Try These ETFs (HDV, IYZ, HYD) ||| Johnson & Johnson to Complete Synthes Acquisition",1,0.52136666
2012-06-15,16053000.0,39.02000045776367,39.09999847412109,38.869998931884766,38.93999862670898,30.209840774536133,MRK,US District Court Rules Against Merck in NASONEX Patent Lawsuit,0,0.51930904
2012-06-18,8254900.0,38.720001220703125,39.060001373291016,38.720001220703125,38.84999847412109,30.1400089263916,MRK,"Setback for Merck in Nasonex Lawsuit - Analyst Blog ||| Geisinger and Merck to Collaborate on Multi-year Effort to Improve Patient Adherence, Engagement and Care Delivery ||| From Earlier: U.S. District Court Rules Against Merck in NASONEX Patent Lawsuit",1,0.50034434
2012-06-20,11392200.0,39.16999816894531,39.380001068115234,39.0,39.209999084472656,30.4193058013916,MRK,Thermo Fisher's Focus On Emerging Markets And Profitability Sets The Stage For Growth ||| EMA Validates Gilead's Drug - Analyst Blog ||| Merck Statement on CDC Advisory Committee on Immunization Practices' Recommendation for Pneumococcal Vaccination in Immunocompromised Adults,1,0.5310857
2012-06-21,17334700.0,39.36000061035156,39.790000915527344,39.290000915527344,39.45000076293945,30.6054916381836,MRK,Dow Plunged 251 Points; Wall Street Overrun With Downbeat Data,1,0.5129945
2012-06-22,24147900.0,39.59999847412109,40.310001373291016,39.54999923706055,40.18000030517578,31.17183494567871,MRK,Stocks End Week of Woes on Upnote: Is a Bottom in Sight? ||| Merck Spikes to New 52-Week High on Heavy Volume; $40.18,0,0.4754501
2012-06-25,15348000.0,39.90999984741211,40.040000915527344,39.70000076293945,39.790000915527344,30.8692626953125,MRK,"Healthcare: This Week's Sector to Watch ||| Ahead of Obamacare Ruling, S&P Likes Health Care SPDR",1,0.5068404
2012-06-26,11439100.0,39.81999969482422,40.79999923706055,39.720001220703125,40.060001373291016,31.078725814819336,MRK,"Leveraged ETFs for the Obamacare Ruling ||| Benzinga's M&A Chatter for Tuesday June 26, 2012 ||| Spokesperson for Amylin Pharmaceuticals Won't Comment on Rumor of Bids from Pharma Companies ||| Amylin Pharmaceuticals Spiking to Highs on Earlier Bid Reports ||| Novartis, Sanofi, Merck, Bristol, AstraZeneca Weigh Amylin Final Bids; Amylin Expects Final Bids Starting End of the Week -Reuters",1,0.5198419
2012-06-27,13127500.0,40.08000183105469,40.75,39.970001220703125,40.52999877929688,31.4433536529541,MRK,A Peek Into The Market Before The Trading Starts ||| Merck and AstraZeneca Agree to Amend Partnership,1,0.52203435
2012-06-28,12562500.0,40.40999984741211,40.70000076293945,40.18999862670898,40.68000030517578,31.55974006652832,MRK,Gilead Seeks FDA Approval - Analyst Blog ||| Merck-AstraZeneca Amend Deal - Analyst Blog ||| Ultimate Stock Watch List for The Supreme Court's Health Care Ruling,1,0.53306913
2012-06-29,23675500.0,40.88999938964844,41.75,40.88999938964844,41.75,32.38984298706055,MRK,ALPS Unveils Dogs of the Dow ETF,1,0.5250003
2012-07-09,20219800.0,41.709999084472656,42.2599983215332,41.52999877929688,42.130001068115234,32.68464660644531,MRK,Equities Falter Ahead of Earnings Season; Are Expectations Too Low?,0,0.47907957
2012-07-10,16710400.0,42.18000030517578,42.209999084472656,41.2599983215332,41.369998931884766,32.09503936767578,MRK,"What Patent Cliff? Pharma ETFs Continue to Surge - ETF News And Commentary ||| Deutsche Bank Maintains Merck & at Buy, Raises PT from $43 to $47.25 ||| Dendreon, Pharmacyclics and Other Biotech Takeover Targets",0,0.4955875
2012-07-11,12362200.0,41.380001068115234,41.470001220703125,41.060001373291016,41.209999084472656,31.970916748046875,MRK,Study for Merck's Investigational Cat-K Inhibitor for Osteoporosis Meets Outcomes and Is Concluded Early ||| Merck Announces Collaboration to Improve Maternal Health through Expanded Access to Family Planning,1,0.5527492
2012-07-12,45955100.0,42.869998931884766,43.18000030517578,42.7599983215332,42.90999984741211,33.28977584838867,MRK,"Pre-Market Most Active for Jul 12, 2012 : SAP, SVU, MRK, BAC, ASML, SIRI, QQQ, GNOM, TLK, TOT, ORCL, INFY ||| ETF Trading Report: Emerging Market, Industrial ETFs In Focus - ETF News And Commentary ||| Pipeline Progresses at Nymox - Analyst Blog ||| Dow Battles Back from 112-Point Deficit, But the Losing Streak Drags On ||| Glaxo Reports Data on Diabetes Drug - Analyst Blog ||| Merck Hits 4-Year High Thursday on Positive Phase 3 Osteoporosis Drug Data -IBD ||| Thursday Market Movers ||| UPDATE: Citigroup Upgrades Merck; Raises PT ||| From Earlier: Update on Phase III Trial for Odanacatib, Merck's Investigational Cat-K Inhibitor for Osteoporosis ||| Benzinga's Top Pre-Market Gainers ||| Goldman Sachs Maintains Merck & Co. at Neutral, Raises PT from $41 to $45 ||| Benzinga's Top Upgrades ||| Citigroup Upgrades Merck & from Neutral to Buy, Raises PT from $34 to $50",1,0.4941644
2012-07-13,16968500.0,43.060001373291016,43.56999969482422,42.93000030517578,43.470001220703125,33.7242317199707,MRK,"Merck Still a “Buy” at UBS after New Osteoporosis Drug Proves Useful in Clinical Trial (MRK) ||| Low Volume, High Returns for These ETFs (BIB, FHC, DRW) ||| 5 Market-Based ETFs Your Broker Forgot to Mention (HDIV, OFF, PDP) ||| Social Media Outlook, Friday July 13 ||| Jefferies & Company Maintains Merck & Co. at Hold, Raises PT from $40 to $42",0,0.47470498
2012-07-17,20143800.0,43.290000915527344,44.369998931884766,43.15999984741211,44.18999862670898,34.282806396484375,MRK,"Currency Hits J&J, Outlook Down - Analyst Blog ||| Merck Says Court Approves Proposed Erisa Settlement ||| Popular Drug Manufacturing Stocks Among Hedge Funds",0,0.4955126
2012-07-18,16211100.0,43.93000030517578,44.11000061035156,43.68000030517578,43.93999862670898,34.08885192871094,MRK,"AZN to Restructure Operations - Analyst Blog ||| Kapito: 'We Like ATT, VZ, MRK, JNJ for Yields'' ||| Morgan Stanley Maintains Merck & Co. at Equal-weight, Raises PT from $37 to $43",0,0.49390745
2012-07-19,13990100.0,43.95000076293945,44.02999877929688,43.540000915527344,43.93999862670898,34.08885192871094,MRK,"Dow Scores Third Straight Win; Will Bulls Continue to Eat Up Earnings? ||| Alnylam In Talks On Cholesterol Drug Partnership, CEO Says, Has Completed Phase I Clinical Trial Of Drug",0,0.50591207
2012-07-23,14379100.0,43.220001220703125,43.43999862670898,43.060001373291016,43.27000045776367,33.56907272338867,MRK,"ISENTRESS in Combination Therapy Demonstrated Long-Term Efficacy, Safety and Tolerability in Previously Untreated Adult Patients with HIV-1 ||| 52-Week High Companies: LO, MRK, HSY, CL, AEP ||| From Earlier: Merck ISENTRESS in Combination Therapy Demonstrated Long-Term Efficacy, Safety and Tolerability in Previously Untreated Adult Patients with HIV-1 for up to 240 Weeks ||| Earnings Expectations for the Week of July 23",0,0.510496
2012-07-25,12231600.0,42.90999984741211,42.9900016784668,42.36000061035156,42.619998931884766,33.064788818359375,MRK,Earnings Preview: Merck & Co. - Analyst Blog,1,0.52557516
2012-07-26,16303300.0,43.04999923706055,43.75,42.97999954223633,43.33000183105469,33.615604400634766,MRK,Are Shorter Mortgages a Smart Move?,1,0.52659035
2012-07-27,29980900.0,43.75,45.16999816894531,43.459999084472656,45.09999847412109,34.98878860473633,MRK,"Merck Beats, Affirms View - Analyst Blog ||| Merck’s Q2 Earnings Fall on Charges; Adjusted Results Beat View (MRK) ||| After Hours Most Active for Jul 27, 2012 : GE, T, FCX, BMY, MRK, MO, SPLS, QQQ, SIRI, FB, INTC, CSCO ||| Dow, SPX Hurdle Above Critical Levels; Euro Zone News Trumps GDP ||| Merck on Call Says Expecting Multiple Generic Singulair Entrants on Day One ||| UPDATE: Merck Beats EPS Estimates by $0.03 and Beats Revenues Estimates While Reaffirming FY2012 Guidance ||| Merck Reports Q2 Vytorin Sales $445M vs $432.3M Est; Q2 Remicade Sales $518M vs $545M Est ||| Benzinga Market Primer, Friday July 27 ||| Merck says Suvorexant, Odanacatib Filings on Track ||| Merck & Reports Q2 EPS $1.05 vs $1.01 Est; Revenues $12.2B vs $12.15B Est ||| US Stock Futures Up; GDP Data In Focus ||| Earnings Scheduled For July 27 ||| Stocks To Watch For July 27",0,0.47938403
2012-07-30,12950300.0,44.63999938964844,44.93000030517578,44.33000183105469,44.47999954223633,34.50778579711914,MRK,"52- Week High Companies: CVX, GGP, DTE, COF, MRK ||| UBS Boosts Price Target for Merck; New Drug Trials Looking Good (MRK) ||| UBS Maintains Merck & at Buy, Raises PT from $45 to $50 ||| BMO Capital Markets Maitnains Merck & at Market Perform, Raises PT from $43 to $46 ||| Benzinga Market Primer, Monday July 30",0,0.4947493
2012-08-08,10791000.0,43.97999954223633,44.27000045776367,43.83000183105469,44.060001373291016,34.18194961547852,MRK,MannKind Reports Narrower 2Q Loss - Analyst Blog,1,0.53618145
2012-08-09,9987200.0,43.88999938964844,44.31999969482422,43.70000076293945,44.27999877929688,34.35262680053711,MRK,"Dr. Reddy's Expands Portfolio - Analyst Blog ||| Johnson & Johnson: A Buy And Core Holding For The Long Haul ||| Under The Hood: Tempting Technicals And a Dividend ||| Credit Suisse Maintains Merck & at Outperform, Lowers PT from $48 to $47",1,0.5135154
2012-08-13,8533700.0,44.58000183105469,44.61000061035156,44.25,44.41999816894531,34.46125030517578,MRK,"Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest Dividend Yield ||| Merck Still a “Hold” at Jefferies; Pipeline Risks Persist (MRK) ||| Simcere Misses 2Q Estimates - Analyst Blog ||| Jefferies & Company Maintains Merck & Co. at Hold, Raises PT from $42 to $44",0,0.506207
2012-08-14,6271700.0,44.5,44.63999938964844,44.27999877929688,44.40999984741211,34.45347595214844,MRK,"Ahead of Wall Street - August 14, 2012 - Ahead of Wall Street ||| Europe, Retail Gaining Traction? - Analyst Blog",0,0.4834056
2012-08-15,7450600.0,44.2599983215332,44.380001068115234,44.0,44.060001373291016,34.18194961547852,MRK,"U.S. Markets Close Mixed, But Technical Picture Remains Upbeat",0,0.49721336
2012-08-16,8395900.0,44.02000045776367,44.15999984741211,43.84999847412109,43.93999862670898,34.08885192871094,MRK,S&P Still Bullish on Health Care ETFs,0,0.5061933
2012-08-21,10764900.0,43.5,43.75,42.90999984741211,42.93999862670898,33.313045501708984,MRK,SPX Tags Four-Year Best Before Closing in the Red,0,0.50293976
2012-08-23,10049500.0,42.90999984741211,42.97999954223633,42.61000061035156,42.79999923706055,33.20442581176758,MRK,Allergan-Molecular Extend Contracts - Analyst Blog,1,0.51960343
2012-08-24,10161500.0,42.63999938964844,43.33000183105469,42.63999938964844,43.119998931884766,33.45270156860352,MRK,"Merck Downgraded to “Neutral” at Bank of America/Merrill Lynch; Valuation Call (MRK) ||| UPDATE: Bank of America Merrill Lynch Downgrades Merck to Neutral, Reiterates $45 PT ||| Bank of America Downgrades Merck & from Buy to Neutral, Announces PO of $45",0,0.48063296
2012-08-27,7750900.0,42.97999954223633,43.2400016784668,42.84000015258789,43.04999923706055,33.39839172363281,MRK,Merck Provides Update on Cardiovascular Development Programs,0,0.52753675
2012-08-29,7608100.0,42.95000076293945,43.2400016784668,42.68999862670898,43.060001373291016,33.40614318847656,MRK,Pfizer Could Acquire India's Stride Acrolab's Injectables Unit,1,0.49074244
2012-08-30,8553600.0,42.86000061035156,43.27000045776367,42.63999938964844,43.119998931884766,33.45270156860352,MRK,"Dow, SPX Test Round-Number Levels In Decidedly Down Day ||| Novartis Progresses with LCZ696 - Analyst Blog",0,0.5134077
2012-08-31,27582400.0,43.33000183105469,43.58000183105469,42.90999984741211,43.04999923706055,33.39839172363281,MRK,Stocks Extend Monthly Winning Streak as Bernanke Inspires the Bulls,1,0.53643566
2012-09-04,24591000.0,43.13999938964844,43.38999938964844,42.869998931884766,43.25,33.553550720214844,MRK,"JNJ Updates: Strikes Cancer Deal, Zytiga Gets FDA Priority Review Status",1,0.53279054
2012-09-05,8334800.0,43.38999938964844,43.52999877929688,43.08000183105469,43.43999862670898,33.70095443725586,MRK,Largest option buying in equities so far,1,0.5245229
2012-09-10,8995500.0,43.970001220703125,44.380001068115234,43.88999938964844,44.2599983215332,34.33711242675781,MRK,"Merck Announces New Phase III Data for Suvorexant, Says Patients Normal Sleep Patterns Return After Stopping Use",1,0.5287081
2012-09-12,8948500.0,44.34999847412109,44.56999969482422,44.310001373291016,44.52999877929688,34.54657745361328,MRK,Successful Achievement Of Milestones Is Driving InSite Vision's Stock ||| Dr. Reddy's Launches Generic Toprol - Analyst Blog,1,0.5374737
2012-09-13,11859900.0,44.08000183105469,44.709999084472656,44.0099983215332,44.65999984741211,34.977333068847656,MRK,Abbott-Astellas Collaborate - Analyst Blog ||| Simcere Pharmaceutical Group Announces Appointment of New Chief Executive Officer,0,0.52519
2012-09-14,16537400.0,44.54999923706055,44.54999923706055,43.43999862670898,43.619998931884766,34.162818908691406,MRK,Wall Street Continues to Climb on the Fed's Stimulus Promise ||| Amgen Bounces Back On Strong 2012 Performance,1,0.5237958
2012-09-17,11010400.0,43.47999954223633,44.0,43.47999954223633,44.0,34.46043014526367,MRK,New Data on Merck's Insomnia Drug - Analyst Blog ||| Vical and Bristol-Myers Ink Deal - Analyst Blog,1,0.531554
2012-09-18,7534000.0,43.7599983215332,44.13999938964844,43.68999862670898,44.08000183105469,34.523094177246094,MRK,Pfizer's Cancer Drug Inlyta Receives European Approval,1,0.5274908
2012-09-19,9818100.0,44.119998931884766,44.77999877929688,44.09000015258789,44.5099983215332,34.85985565185547,MRK,"Pfizer, Merck Set Up Chinese Joint Ventures for Generic Drugs -WantChinaTimes",1,0.47455567
2012-09-21,20254600.0,44.95000076293945,45.25,44.86000061035156,44.90999984741211,35.17312240600586,MRK,Dr. Reddy's Launches Generic Amoxil - Analyst Blog,1,0.53584355
2012-09-25,12805200.0,45.220001220703125,45.70000076293945,44.86000061035156,45.11000061035156,35.32976150512695,MRK,Phase III Data on Novartis' RLX030 - Analyst Blog ||| Another Approval for Amgen's Prolia - Analyst Blog ||| S&P Highlights Election ETFs,0,0.51518667
2012-09-26,12652800.0,45.11000061035156,45.369998931884766,45.0,45.0099983215332,35.25145721435547,MRK,"U.S., Global Markets Under Pressure as Greece, Euro-Debt in Focus ||| Mixed Results from Vertex Studies - Analyst Blog ||| Merck Returns Rights for Vernakalant to Cardiome",1,0.52047086
2012-09-27,9834300.0,45.06999969482422,45.43999862670898,45.0099983215332,45.22999954223633,35.42375183105469,MRK,"Parexel Gets Sales, Profit Bump From Big Pharma",0,0.5059344
2012-10-01,8553700.0,44.970001220703125,45.59000015258789,44.970001220703125,45.220001220703125,35.41592025756836,MRK,Generic Launch at Dr. Reddy's - Analyst Blog ||| Why Barron's Article on Opko Health is Myopic ||| Deutsche Bank Suspends Coverage on Merck & ||| Merck HPV Vaccine Shown to be Safe in a Kaiser Study,1,0.5234868
2012-10-02,7429500.0,45.43000030517578,45.59999847412109,45.09999847412109,45.470001220703125,35.61172103881836,MRK,Merck to Return Vernakalant Rights - Analyst Blog,1,0.5326302
2012-10-04,8953800.0,45.900001525878906,46.38999938964844,45.84999847412109,46.119998931884766,36.12080001831055,MRK,New Indication for Abbott's Humira - Analyst Blog,1,0.5318526
2012-10-08,7033700.0,46.16999816894531,46.459999084472656,45.790000915527344,46.34000015258789,36.29308319091797,MRK,MNKD Enrolls Patients for Afrezza - Analyst Blog ||| Delphi Genetics Grants Merck License for the Use of the StabyExpress System,0,0.5221306
2012-10-09,10030900.0,46.209999084472656,46.540000915527344,46.02999877929688,46.16999816894531,36.15995788574219,MRK,Part I: Must Know ETFs For Q3 Earnings ||| Merck to Move Global Headquarters Within New Jersey,0,0.5265786
2012-10-10,9475300.0,46.16999816894531,46.38999938964844,45.400001525878906,45.59999847412109,35.71354293823242,MRK,Encouraging Data on J&J Candidate - Analyst Blog,0,0.54319793
2012-10-11,7022600.0,45.88999938964844,45.91999816894531,45.34999847412109,45.45000076293945,35.5960578918457,MRK,Merck's MK-3102 Encourages - Analyst Blog,1,0.53222
2012-10-12,6844300.0,45.59999847412109,46.0,45.560001373291016,45.619998931884766,35.72919464111328,MRK,"Jefferies & Company Maintains Merck & at Hold, Raises PT from $44 to $47",1,0.5018
2012-10-15,10281300.0,45.7400016784668,46.630001068115234,45.68999862670898,46.59000015258789,36.488895416259766,MRK,"Merck BMD Data from a Phase II Study of Odanacatib Shows Significantly Increased Bone Mineral Density ||| Abbott Labs Eyes Russian Pharmaceutical Market ||| Barclays Maintains Merck & at Overweight, Raises PT from $46 to $50 ||| A Peek Into The Market Before The Trading Starts ||| AiCuris, Merck Enter Exclusive Worldwide License Agreement",1,0.50203323
2012-10-16,11954200.0,46.7400016784668,47.27000045776367,46.709999084472656,47.16999816894531,36.94313430786133,MRK,J&J Beats on Higher Revenues - Analyst Blog,1,0.53577316
2012-10-17,10132900.0,47.08000183105469,47.5,47.08000183105469,47.38999938964844,37.11544799804688,MRK,This Drug Market Could Expand 80-Fold by 2020,1,0.5442712
2012-10-18,10986100.0,47.290000915527344,48.0,47.27999877929688,47.959999084472656,37.56186676025391,MRK,"Pharmaceutical Stocks Are All-of-a-Sudden Hot Again: Read About Drugs and Dividends ||| Encouraging News for Perrigo - Analyst Blog ||| Theravance, Merck Ink Deal - Analyst Blog",0,0.49552262
2012-10-19,12976500.0,47.93999862670898,47.9900016784668,46.880001068115234,47.02999877929688,36.83350372314453,MRK,It's Time to Sell These 4 Surging Stocks,0,0.48777086
2012-10-22,14021400.0,46.810001373291016,47.02999877929688,46.18999862670898,46.47999954223633,36.40274810791016,MRK,Earnings Expectations for the Week of October 22,0,0.4845703
2012-10-23,12504200.0,46.18999862670898,46.52999877929688,45.869998931884766,45.88999938964844,35.94066619873047,MRK,Mann Group to Buy MNKD's Shares - Analyst Blog,0,0.52545506
2012-10-24,9639700.0,45.95000076293945,46.18999862670898,45.79999923706055,45.880001068115234,35.93282699584961,MRK,S&P Likes a Trio of Biotech ETFs,1,0.52051234
2012-10-25,10971500.0,46.09999847412109,46.34000015258789,46.0099983215332,46.29999923706055,36.26176834106445,MRK,"Pre-Market Earnings Report for October 26, 2012 : MRK, CMCSA, LYB, ERIC, CMCSK, VTR, AON, WY, MCO, EGO, DLR, COL ||| Earnings Preview: Merck & Co. - Analyst Blog",0,0.47506452
2012-10-26,11940500.0,45.790000915527344,46.77000045776367,45.790000915527344,46.150001525878906,36.144287109375,MRK,"Merck Reports Increased Profits; Misses on Revenue (MRK) ||| Merck Beats on EPS, Narrows View - Analyst Blog ||| Merck Begins Earnings Call ||| S&P Bullish on Select Dividend ETFs ||| Merck & Reports Q3 EPS $0.92 vs $0.92 Est; Revenues $11.49B vs $11.57B Est ||| Benzinga Market Primer, Friday, October 26 ||| US Stock Futures Down After Apple Earnings ||| Earnings Scheduled For October 26, 2012 ||| Stocks To Watch For October 26, 2012 ||| Stocks To Watch For October 26, 2012",0,0.5113836
2012-10-31,13535000.0,46.41999816894531,46.709999084472656,45.43999862670898,45.630001068115234,35.73701477050781,MRK,"Company News for October 29, 2012 - Corporate Summary ||| UPDATE: BMO Capital Markets Reiterates Market Perform Rating, Raises PT on Merck & Co. ||| BMO Capital Markets Maintains Merck & at Market Perform, Raises PT from $46 to $50 ||| Earnings Scorecard: J&J - Analyst Blog ||| Allergan Beats on EPS, Updates View - Analyst Blog ||| More Equal-Weight ETFs Your Broker Forgot to Mention ||| Loss at THRX Narrower Than Expected - Analyst Blog",1,0.49675405
2012-11-02,11050500.0,46.25,46.54999923706055,45.9900016784668,46.0,36.02681350708008,MRK,A Capital-Efficient Prescription for New Drugs: Raghuram “Ram” Selvaraju ||| MannKind Cuts 3Q Loss - Analyst Blog ||| Watson Pharma Starts New Era As Generic Drug Titan,0,0.51589185
2012-11-05,8981200.0,45.81999969482422,46.0,45.310001373291016,45.66999816894531,35.76835632324219,MRK,"Moves in Smaller Health Care Stocks (GMED, SEM, UAM, VRTX)",1,0.55243623
2012-11-07,24067900.0,45.54999923706055,45.66999816894531,44.18000030517578,44.459999084472656,34.82069396972656,MRK,Revenues Rise at Perrigo - Analyst Blog,0,0.53565025
2012-11-08,16329900.0,44.5099983215332,44.77000045776367,43.84000015258789,43.84000015258789,34.33512115478516,MRK,"After Hours Most Active for Nov 8, 2012 : PDLI, QQQ, AVP, ETP, PFE, GRPN, MRK, BAC, SD, NVDA, GILD, MSFT ||| Mylan To Wall Street: Forget Patent Cliff, We'll Grow ||| Futures Flat, Euro Falls Ahead of Central Banks",1,0.4740914
2012-11-09,13995200.0,43.68999862670898,44.31999969482422,43.619998931884766,44.04999923706055,34.49958801269531,MRK,FDA Accepts Merck's Sleep Drug NDA - Analyst Blog,0,0.5385567
2012-11-12,7329800.0,44.470001220703125,44.52000045776367,43.880001068115234,44.02000045776367,34.47609329223633,MRK,"Weekly Top Insider Sells: KSS, AMG, MRK, VRX, and AXP ||| Merck Upgraded to “Outperform” at BMO (MRK) ||| Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX) ||| UPDATE: BMO Capital Markets Upgrades Merck & Co. to Outperform, Reiterates $50 PT ||| BMO Capital Markets Upgrades Merck & from Market Perform to Outperform, Maintains PT at $50 ||| Merck Presents Early-Stage Interim Data for MK-3475 Study for Treatment of Advanced Melanoma",0,0.5033662
2012-11-14,14206900.0,43.70000076293945,43.900001525878906,42.90999984741211,43.04999923706055,33.716400146484375,MRK,Pipeline Progress at Novartis - Analyst Blog ||| These ETFs Offer Solid Yield in Uncertain Times,0,0.49703938
2012-11-16,16636500.0,42.84000015258789,43.22999954223633,42.36000061035156,43.06999969482422,33.73206329345703,MRK,S&P Reiterates Bullish View on Health Care ETFs,1,0.52378905
2012-11-19,9189700.0,43.31999969482422,43.400001525878906,43.09000015258789,43.34000015258789,33.94351959228516,MRK,Simcere 3Q Earnings Matches - Analyst Blog,1,0.53183264
2012-11-20,10905100.0,43.41999816894531,43.66999816894531,43.2400016784668,43.560001373291016,34.11582946777344,MRK,"MKM Upgrades Merck to a “Buy” (MRK) ||| After a Stellar Year, Can the Dogs of the Dow Outperform in 2013 as Well? ||| After a Stellar Year, Can the Dogs of the Dow Outperform in 2013 as Well? ||| Merck Receives FDA Orphan Status for Melanoma Treatment ||| MKM Partners Upgrades Merck & from Neutral to Buy, Raises PT from $47 to $51 ||| Benzinga's Top Upgrades",1,0.4997414
2012-11-21,7288000.0,43.79999923706055,43.93000030517578,43.630001068115234,43.88999938964844,34.37427520751953,MRK,Merck Updates: Outcome of Large Clinical Study On Tredaptive Soon ||| CHMP Positive on Sanofi's Lyxumia - Analyst Blog ||| Largest option buying in equities so far,1,0.511037
2012-11-27,8869200.0,44.02999877929688,44.18999862670898,43.84999847412109,43.880001068115234,34.36642837524414,MRK,Merck Increases Dividend to $0.43 from $0.42,1,0.5402182
2012-11-30,15017200.0,44.540000915527344,44.709999084472656,44.119998931884766,44.29999923706055,34.69539260864258,MRK,"Citigroup Initiates Coverage on Merck & Company, Inc. at Neutral, Announces $44.00 PT",1,0.5189118
2012-12-03,11620100.0,44.470001220703125,44.83000183105469,44.41999816894531,44.43999862670898,34.805030822753906,MRK,"Merck Files Debt Securities Shelf ||| Merck Begins Phase II/III Study of Investigational BACE Inhibitor, MK-8931",0,0.4957007
2012-12-10,9347500.0,44.459999084472656,44.83000183105469,44.41999816894531,44.47999954223633,34.836360931396484,MRK,"Barron's Recap (12/8/12): Ten Stock Picks for 2013 ||| Three More Defensive Stock Picks for 2013 (LLY, PFE, VTR)",1,0.5019992
2012-12-11,13583500.0,44.65999984741211,45.27999877929688,44.5,45.18999862670898,35.39241027832031,MRK,"Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for December 13, 2012 ||| Benzinga's Small Cap Movers for Tuesday December 11, 2012 ||| Benzinga's M&A Chatter for Tuesday December 11, 2012 ||| Warburg Pincus Said to Hire Goldman Sachs to Sell Bausch & Lomb, Seeking At Least $10B; Abbott, Glaxo, Merck, Sanofi Said to Be Contacted - Bloomberg ||| Cardiome Reaches Deal with Merck to Retire Debt/Close Line of Credit; Will Pay Merck $20M",1,0.484545
2012-12-13,13744400.0,44.93999862670898,44.93999862670898,43.900001525878906,43.95000076293945,34.75143814086914,MRK,"Market Close Report: NASDAQ Composite index closes at 2,992.16 down -21.65 points ||| Dow Takes a Breather, Drops 75 Points",0,0.49619165
2012-12-14,13186000.0,43.900001525878906,43.959999084472656,43.40999984741211,43.540000915527344,34.4272346496582,MRK,J&J Files NDA for Combo Diabetes Drug - Analyst Blog ||| An End to Drug Patent Woes? - Analyst Blog,1,0.5251226
2012-12-17,13280200.0,43.630001068115234,43.84000015258789,43.5099983215332,43.630001068115234,34.49840545654297,MRK,These 2 Dow Laggards Could Rebound in 2013 ||| Weekly Healthcare Note: Pfizer and JNJ ||| JNJ's Zytiga Inches Towards A Billion Dollar Sales As FDA Approves Expanded Use,1,0.54372305
2012-12-18,14081000.0,43.59000015258789,44.400001525878906,43.36000061035156,44.2400016784668,34.98073196411133,MRK,"Merck, GE Healthcare Announce Collaboration on Use of Imaging Biomarkers for Investigational BACE Inhibitor Program",0,0.51747197
2012-12-19,11693100.0,44.150001525878906,44.459999084472656,43.61000061035156,43.65999984741211,34.52212142944336,MRK,Merck Ties Up with GE Healthcare - Analyst Blog ||| Good News for AstraZeneca - Analyst Blog,0,0.51732004
2012-12-20,33648000.0,42.45000076293945,42.77999877929688,42.0,42.15999984741211,33.33606719970703,MRK,"Mid-Morning Market Update: Rite Aid Rallies, New York Stock Exchange Acquired by ICE ||| NVO Progresses with Pipeline - Analyst Blog ||| Market Close Report: NASDAQ Composite index closes at 3,050.39 up 6.03 points ||| Dow Ends Near Intraday Peak; Budget Drama Fails to Stall the Bulls ||| Goldman Sachs Maintains Neutral on Merck & Company, Inc., Lowers PT to $47.00 ||| Mid-Morning Market Update: Rite Aid Rallies, New York Stock Exchange Acquired by ICE ||| Merck Says HPS2-THRIVE Study of TREDAPTIVE Did Not Achieve Primary Endpoint",0,0.5038211
2012-12-26,7129500.0,41.45000076293945,41.58000183105469,41.220001220703125,41.34000015258789,32.687705993652344,MRK,"Merck's Tredaptive Fails in Study - Analyst Blog ||| Option Alert: Merck January 45 Call; Block Trade: 7,000 Contracts @$0.03; Currently $41.31",0,0.4780764
2012-12-28,11319400.0,41.0,41.16999816894531,40.630001068115234,40.63999938964844,32.13419723510742,MRK,"OPKO to Buy Brazilian Company - Analyst Blog ||| NVO's Ryzodeg Approved in Japan - Analyst Blog ||| Merck Sends Dear Doctor Letter Related to Tredaptive's Failed Study, Says Side Effects Include Muscle, Skin, Blood Damage",1,0.5053055
2013-01-02,15956900.0,41.86000061035156,41.869998931884766,40.93999862670898,41.34000015258789,32.687705993652344,MRK,"Merck Says FDA Acknowledged Resubmission of NDA for Ezetimibe, Atorvastatin Tablets",1,0.53639513
2013-01-03,23543400.0,41.88999938964844,42.43000030517578,41.11000061035156,42.33000183105469,33.47050476074219,MRK,"Abbott Labs Snapshot As AbbVie Begins Trading ||| Pfizer Secures Coveted FDA Approval For Eliquis ||| Market Close Report: NASDAQ trading volume joins the top ten ranking for the year. NASDAQ Composite Index closes at 3,100.57 ||| Stocks Retreat Amid Profit Taking, Surprising Fed Minutes ||| What Will Be the Top Dog in 2013? - Real Time Insight ||| Merck, Pfizer, Abbott, J&J, Sanofi Said to Show Interest in Bausch & Lomb Bid - Bloomberg",0,0.5004036
2013-01-07,11503600.0,42.040000915527344,42.18999862670898,41.84999847412109,42.119998931884766,33.304443359375,MRK,FDA Accepts Merck Combo Therapy NDA - Analyst Blog ||| 4 Health Care ETFs Your Broker Forgot to Mention ||| Merck Receives FDA Acceptance of Resubmission of NDA for Sugammadex Sodium Injection,1,0.5445718
2013-01-09,10073100.0,42.38999938964844,42.650001525878906,42.20000076293945,42.59000015258789,33.67607116699219,MRK,"Microbiotix, Merck Announce Licensing Pact for HCV NS5B",1,0.5261068
2013-01-10,12970500.0,42.869998931884766,43.150001525878906,42.75,42.77999877929688,33.82631301879883,MRK,Glaxo/THRX Seek European Approval - Analyst Blog ||| Pfizer Updates: Europe Approves Expanded Use Of Prevenar 13,1,0.5220014
2013-01-11,12140100.0,42.709999084472656,43.33000183105469,42.709999084472656,43.22999954223633,34.18213653564453,MRK,Three Stocks to Buy for Flu Season ||| Merck to Suspend Availability of TREDAPTIVE Worldwide,1,0.5088922
2013-01-14,11117100.0,43.310001373291016,43.560001373291016,43.04999923706055,43.34000015258789,34.26910400390625,MRK,"Weekly Healthcare Notes: Pfizer, Abbott Labs, Merck & JNJ ||| Merck to Stop Selling Tredaptive - Analyst Blog ||| Merck, Abbott And JNJ Show Interest In Bausch & Lomb",0,0.4570169
2013-01-15,11876600.0,43.380001068115234,43.540000915527344,42.810001373291016,42.869998931884766,33.89747619628906,MRK,Glaxo Seeks Albiglutide Approval - Analyst Blog,0,0.53783846
2013-01-16,11909500.0,42.88999938964844,43.040000915527344,42.5,42.540000915527344,33.63654708862305,MRK,"UPDATE: Jefferies & Company Reiterates Hold Rating, Lowers PT on Merck & Co. ||| Jefferies Maintains Hold on Merck & Company, Inc., Lowers PT to $47.00",1,0.48247772
2013-01-22,12232600.0,42.77000045776367,43.220001220703125,42.61000061035156,43.20000076293945,34.158409118652344,MRK,"J&J Beats on EPS but Guidance Lags - Analyst Blog ||| Weekly Healthcare Notes: Roche Holdings, Pfizer & JNJ",0,0.5018582
2013-01-24,12496300.0,42.95000076293945,43.209999084472656,42.93000030517578,43.0,34.00026321411133,MRK,"ETF Talk: Here Is to Your Healthcare ||| After Hours Most Active for Jan 24, 2013 : MSFT, QQQ, AMGN, NOK, SBUX, PFE, MRK, BAC, HIG, NWSA, KO, INTC",1,0.48342067
2013-01-25,13167300.0,43.119998931884766,43.459999084472656,42.720001220703125,43.459999084472656,34.363990783691406,MRK,"After Hours Most Active for Jan 25, 2013 : CTRP, SIRI, PPG, AAPL, QQQ, HAL, BAC, MRK, GGC, WNR, PDLI, NWSA ||| FDA Approves OXYTROL for Women",0,0.50159067
2013-01-28,11850000.0,43.34000015258789,43.5,42.93000030517578,42.93000030517578,33.94491195678711,MRK,Generic Launch at Dr. Reddy's - Analyst Blog ||| Merck's OAB Patch Gets FDA Nod - Analyst Blog,1,0.5415901
2013-01-30,12672600.0,43.65999984741211,43.77000045776367,43.459999084472656,43.5,34.3956184387207,MRK,Isis and Sanofi's Drug OK'd to Treat Inherited Cholesterol Disease,0,0.51408046
2013-01-31,14539400.0,43.43000030517578,43.63999938964844,43.25,43.25,34.197940826416016,MRK,"Pipeline Progress at Endocyte - Analyst Blog ||| Pre-Market Earnings Report for February 1, 2013 : XOM, CVX, MRK, LYB, NOV, BEN, AON, IR, MAT, BEAM, PRGO, BPO",0,0.47683668
2013-02-01,37688000.0,42.2400016784668,42.75,41.5099983215332,41.83000183105469,33.07513427734375,MRK,"Ahead of Wall Street - February 1, 2013 - Ahead of Wall Street ||| Merck Beats, Issues Outlook - Analyst Blog ||| Pre-Market Most Active for Feb 1, 2013 : NOK, DELL, BAC, QQQ, MRK, FB, RIMM, SAN, WU, VALE, ARMH, VVUS ||| Market Close Report: NASDAQ Composite index closes at 3,179.10 up 36.97 points ||| Dow Breaks 14,000 for First Time in Five Years ||| Hearing Merck Defded at Credit Suisse ||| Merck & Company, Inc. Reports Q4 EPS of $0.83 vs $0.81 Est; Revenue of $11.74B vs $11.54B Est ||| US Stock Futures Up; All Eyes On Payroll Data ||| Earnings Scheduled For February 1, 2013 ||| Stocks To Watch For February 1, 2013",0,0.45789143
2013-02-04,29409700.0,41.38999938964844,41.65999984741211,40.83000183105469,40.84999847412109,32.300254821777344,MRK,"After Hours Most Active for Feb 4, 2013 : BRCD, MSFT, EMC, ERIC, WU, QCOM, BAC, QQQ, YHOO, AA, MRK, ACMP ||| UPDATE: BMO Capital Markets Reiterates Outperform Rating, Lowers PT on Merck & Co. ||| UPDATE: Morgan Stanley Downgrades Merck to Underweight Ahead of Key March Trial ||| Leerink Swann Downgrades Merck & Company, Inc. to Market Perform ||| Morgan Stanley Downgrades Merck & Company, Inc. to Underweight, Removes $43.00 PT",1,0.49233943
2013-02-05,21307300.0,41.04999923706055,41.47999954223633,40.93000030517578,41.43000030517578,32.75886535644531,MRK,"Singulair Patent Loss Hits Merck's Earnings But International Growth Helps ||| Dow Reverses Course and Recoups Most of Its Losses ||| Merck Serono, Opexa Therapeutics Enter Option, License Agreement for Development of Tcelna",0,0.5075118
2013-02-06,17383800.0,41.34999847412109,41.45000076293945,40.97999954223633,41.09000015258789,32.49002456665039,MRK,The Market's Highest-Yielding Pharma Stocks ||| REV Your Engines: EnWave Corp. Ready To Capitalize On Groundbreaking Technology,0,0.50397104
2013-02-07,16174300.0,41.09999847412109,41.29999923706055,40.880001068115234,41.0,32.418853759765625,MRK,Largest option buying in equities so far ||| UPS Expands in Health Care Markets - Analyst Blog ||| Mylan Loses Appeals Court Bid to Invalidate Zetia Patents,1,0.50671905
2013-02-12,9996000.0,41.369998931884766,41.56999969482422,41.130001068115234,41.45000076293945,32.77466583251953,MRK,"4 BioPharma Catalyst Trades Offering Good Upside Potential ||| Cardiome Selects Quintiles - Analyst Blog ||| Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)",0,0.5072449
2013-02-13,15803300.0,41.41999816894531,41.4900016784668,41.0099983215332,41.150001525878906,32.5374641418457,MRK,Theravance Narrows Y/Y Loss - Analyst Blog ||| Merck Shares Down 0.6% Premarket Following Outlook Update ||| Merck Sees Q1 Adj.EPS $0.76-0.78 vs $0.86 Est ||| Merck Reaffirms Outlook,1,0.5058333
2013-02-14,16332800.0,41.040000915527344,41.220001220703125,40.83000183105469,41.18999862670898,32.569091796875,MRK,"Merck Resolves Securities Class-Action Suit Related to ENHANCE, to Record $493M Charge",1,0.5316103
2013-02-15,15579100.0,41.459999084472656,41.5,41.2400016784668,41.41999816894531,32.75094985961914,MRK,"BMO Capital Maintains Outperform on Merck & Company, Inc., Lowers PT to $47.00",1,0.4954981
2013-02-19,13306100.0,41.59999847412109,42.220001220703125,41.58000183105469,42.220001220703125,33.38351821899414,MRK,Roche Holdings: Revised $58 Price Estimate On Strong Pipeline ||| Weekly Healthcare Notes: Medtronic & Merck,1,0.51547456
2013-02-20,16800900.0,42.36000061035156,42.75,42.220001220703125,42.65999984741211,33.731422424316406,MRK,"Market Close Report: NASDAQ Composite index closes at 3,164.41 down -49.18 points ||| Housing Data, Fed Minutes Beat Dow Back Below 14,000",0,0.48378518
2013-02-22,15393900.0,42.58000183105469,43.27000045776367,42.52999877929688,42.970001220703125,33.97654342651367,MRK,UPS Expands Expedited Service - Analyst Blog,0,0.5303747
2013-02-25,19407300.0,43.310001373291016,43.45000076293945,42.5099983215332,42.52000045776367,33.62071990966797,MRK,"Weekly Healthcare Notes: Pfizer And Roche Holdings ||| UPDATE: Jefferies Reiterates Hold Rating, Lowers PT on Merck & Co. on IMPROVE-IT Overhang Removal ||| Jefferies Maintains Hold on Merck & Company, Inc., Lowers PT to $46.00",0,0.45282778
2013-02-26,13903100.0,42.75,42.79999923706055,42.09999847412109,42.41999816894531,33.54164505004883,MRK,Generic Segment at Mylan Boosted - Analyst Blog ||| Revenues Rise at Endocyte - Analyst Blog ||| Dendreon Reports Narrower Loss - Analyst Blog,1,0.5296493
2013-02-27,12917100.0,42.27000045776367,43.150001525878906,42.27000045776367,42.970001220703125,33.97654342651367,MRK,Still No Herbalife in 13F ETFs,0,0.5022384
2013-02-28,14211300.0,43.0099983215332,43.209999084472656,42.72999954223633,42.72999954223633,33.786773681640625,MRK,"If The Market Falls, Try These Low Beta ETFs",0,0.5108888
2013-03-04,14160200.0,42.91999816894531,43.34999847412109,42.7599983215332,43.34000015258789,34.26910400390625,MRK,"Data on Endocyte Candidate - Analyst Blog ||| An HIV Cure Is Great News For These Drug Manufacturers ||| Cardiome Ends Line of Credit Merck, to Buy Added $3M of Vernakalant IV Inventory ||| UPDATE: Bank of America Upgrades Merck to Buy; Pullback Creates Meaningful Upside Potential ||| Bank of America Upgrades Merck & Company, Inc. to Buy, Maintains $47.00 PO",0,0.5110712
2013-03-05,15118100.0,43.59999847412109,43.650001525878906,43.09999847412109,43.25,34.197940826416016,MRK,Dr. Reddy's Launches Generic Zometa - Analyst Blog ||| Death Crosses Over The Past Trading Week (50 SMA Crossed Below 200 SMA),1,0.52735204
2013-03-06,18417100.0,43.29999923706055,43.7400016784668,43.060001373291016,43.68000030517578,34.537940979003906,MRK,"3 Sector ETFs Outpacing Larger Rivals ||| From Merck Presentation for Cowen Healthcare Conference: Sees V503 for Cancer Endpoint Driven Trial Filing This Year, V212 Filing for HCT, V419 Pediatric Combo Vaccine Filing Next Year ||| Hedging The Dow At Its All-Time High",0,0.52417654
2013-03-07,13733600.0,43.81999969482422,43.93000030517578,43.09000015258789,43.27000045776367,34.2137565612793,MRK,"Merck Announces Appointment of Roger M. Perlmutter, M.D., Ph.D., As President of Merck Research Laboratories; Peter S. Kim, Ph.D., to Retire",0,0.4963245
2013-03-08,29273300.0,43.400001525878906,43.5,42.91999816894531,42.970001220703125,33.97654342651367,MRK,Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest Dividend Yield,1,0.522397
2013-03-11,38638100.0,42.95000076293945,43.66999816894531,42.869998931884766,43.65999984741211,34.52212142944336,MRK,"Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for March 13, 2013 ||| Glaxo Seeks EU Approval for Eperzan - Analyst Blog ||| J&J Seeks EU Nod for Combo Drug - Analyst Blog ||| Five Guru Approved Stocks for Jittery Investors ||| Death Crosses Over The Past Trading Week (50 SMA Cross Below 200 SMA)",1,0.505914
2013-03-12,56007500.0,45.41999816894531,45.41999816894531,44.880001068115234,45.040000915527344,35.61328887939453,MRK,"Pre-Market Most Active for Mar 12, 2013 : ZNGA, GLUU, BBRY, SNE, MRK, BCS, MT, GOV, BAC, ARMH, AAPL, AFFY ||| Market Close Report: NASDAQ Composite index closes at 3,242.32 down -10.55 points ||| Promising Data on Glaxo's HIV Drug - Analyst Blog ||| Weekly Healthcare Notes: Abbott Labs, Merck, Pfizer & JNJ ||| Unusual Options Alert: Merck & Co. Continues To Do Extremely Heavy Volume ||| Short Interest Swings in Biotech Stocks (AMGN, CELG, PCYC) ||| Lawyer Tells Jury in Merck Case Over Fosamax Co. Hid Product's Bone-Weakening Risks ||| Merck Issues Update on IMPROVE-IT Trial, Says DSMB Recommend Study to Continue",0,0.46425223
2013-03-13,17921200.0,44.540000915527344,44.72999954223633,44.47999954223633,44.59000015258789,35.597320556640625,MRK,"After Hours Most Active for Mar 13, 2013 : RF, QQQ, MFA, CSCO, QCOM, GNW, DF, BBRY, MET, MRK, ASNA, BRCM ||| Market Close Report: NASDAQ Composite index closes at 3,245.12 up 2.80 points ||| Simcere Gets Buyout Proposal - Analyst Blog ||| Johnson & Johnson: FDA Rejects Broader Use Of Anticlotting Drug Xarelto ||| The Top 20 African-American CEOs in Business Today ||| Bank of America Reiterates Buy Rating, $47 PT on Merck & Co. Following IMPROVE-IT Trial Review",0,0.4804902
2013-03-14,25893400.0,44.709999084472656,44.75,43.59999847412109,44.27000045776367,35.34187316894531,MRK,Merck Jumps As IMPROVE-IT Study Will Continue ||| Embrace These New ETFs ||| Embrace These New ETFs,0,0.49202627
2013-03-15,24331900.0,43.83000183105469,44.09000015258789,43.790000915527344,44.09000015258789,35.19816207885742,MRK,Reuters Reporting Merck Saying FDA Extended Review of Sugammadex,0,0.51903397
2013-03-18,12117700.0,43.77999877929688,43.93999862670898,43.56999969482422,43.630001068115234,34.830936431884766,MRK,Merck to Continue IMPROVE-IT - Analyst Blog ||| Cardiome Posts 4Q Profit - Analyst Blog ||| Golden Crosses Over The Past Trading Week (50 SMA Cross Above 200 SMA),1,0.50907916
2013-03-19,15504100.0,43.70000076293945,43.84000015258789,43.59999847412109,43.70000076293945,34.88682556152344,MRK,Data on Eli Lilly's Cialis - Analyst Blog ||| Merck-Luminex' Alzheimer's Collaboration - Analyst Blog,1,0.53232944
2013-03-21,11904600.0,44.02999877929688,44.18000030517578,43.7599983215332,43.790000915527344,34.958675384521484,MRK,Label Expansion for Roche's Pegasys - Analyst Blog,1,0.54822564
2013-03-25,13117100.0,43.95000076293945,44.0,43.5099983215332,43.68999862670898,34.878841400146484,MRK,"Bank of America Reiterates Buy Rating, $47 PT on Merck & Co. Ahead of Potential Approvals",1,0.51035583
2013-03-26,12112700.0,43.95000076293945,44.400001525878906,43.900001525878906,44.38999938964844,35.43767166137695,MRK,The Supreme Court is About to Stick it to Big Pharma ||| Risk On Rally? These ETFs Say No ||| EMA Investigating Pancreatic Risks with GLP-1 Diabetes Drugs,0,0.5030867
2013-03-27,10970900.0,44.130001068115234,44.25,43.90999984741211,44.09999847412109,35.206146240234375,MRK,"Stock Market News for March 27, 2013 - Market News ||| Merck Announces FDA Acceptance of Biologics License App for Investigational Grass Pollen Allergy Immunotherapy Tablet",1,0.5410131
2013-03-28,16641700.0,44.04999923706055,44.310001373291016,43.959999084472656,44.20000076293945,35.285980224609375,MRK,Good News for Simcere Pharma - Analyst Blog,1,0.5255921
2013-04-03,25872200.0,45.0,46.15999984741211,45.0,45.36000061035156,36.212039947509766,MRK,"Market Close Report: NASDAQ Composite index closes at 3,218.60 down -36.26 points ||| Jobs Data Sends Skittish Market Into the Red ||| Golden Crosses Over The Past Trading Week (50 SMA Cross Above 200 SMA)",0,0.48933417
2013-04-04,13967400.0,45.38999938964844,45.880001068115234,45.0099983215332,45.31999969482422,36.18010711669922,MRK,2 New Dividend ETFs to Consider,0,0.5159635
2013-04-08,10153500.0,45.09000015258789,45.47999954223633,44.959999084472656,45.47999954223633,36.30783462524414,MRK,"BMY Announces Management Changes - Analyst Blog ||| Golden Crosses Over The Past Trading Week (50 SMA Cross Above 200 SMA) CMG, LO, MRK, PRGO, SO, WMT, YUM ||| Cheap Does not Always Mean BUY",1,0.49777257
2013-04-09,10599300.0,45.72999954223633,45.93999862670898,45.34000015258789,45.5099983215332,36.331787109375,MRK,Merck Receives Positive Mad Money/Jim Cramer Mention -CNBC,1,0.52396184
2013-04-10,18735100.0,45.90999984741211,46.970001220703125,45.77999877929688,46.84000015258789,37.3935661315918,MRK,"Market Close Report: NASDAQ Composite index closes at 3,297.25 up 59.39 points ||| Stocks Unfazed by Early Fed Minutes; S&P Hits New All-Time Peak ||| Short Sellers Move Out of Amgen, Celgene, Pharmacyclics ||| UPDATE: Jefferies Raises PT on Merck & Co. on Positive Outlook ||| Merck Announces FDA Acceptance of NDA for NOXAFIL Investigational Tablet Formulation ||| Jefferies Maintains Hold on Merck & Company, Inc., Raises PT to $48.00",1,0.5077519
2013-04-11,17537900.0,46.68000030517578,47.5099983215332,46.68000030517578,47.209999084472656,37.68894958496094,MRK,"These Companies' Bets On R&D May Pay Off Big For Your Portfolio ||| ETF Showdown: A Pharma Fight ||| Court Says Merck Victory Upholding Vytorin Patents Will Stand, Says Mylan Can't Sell Copies of Vytorin, Zetia Before Apr. 2017",0,0.49552807
2013-04-12,10064400.0,46.66999816894531,47.130001068115234,46.650001525878906,47.11000061035156,37.609107971191406,MRK,"Benzinga Market Primer: Friday, April 12 ||| Merck Sees Odanacatib US, EU Filing in 2014 ||| Benzinga Market Primer: Friday, April 12",0,0.46650612
2013-04-17,11777200.0,46.720001220703125,46.90999984741211,46.40999984741211,46.7599983215332,37.32969665527344,MRK,"After Hours Most Active for Apr 17, 2013 : QQQ, BAC, EBAY, TSM, MS, MU, MDLZ, GLW, WFC, MRK, SNDK, CSCO",0,0.47315896
2013-04-19,12705300.0,46.86000061035156,47.4900016784668,46.65999984741211,47.4900016784668,37.9124870300293,MRK,"UPDATE: BMO Capital Markets Raises PT on Merck & Co. on 1Q13 Preview, Long-Term Outlook ||| BMO Capital Maintains Outperform on Merck & Company, Inc., Raises PT to $51.00",1,0.48981005
2013-04-22,14265400.0,47.45000076293945,47.970001220703125,47.18000030517578,47.91999816894531,38.25576019287109,MRK,"Merck In-Licenses from Xenon - Analyst Blog ||| After Hours Most Active for Apr 22, 2013 : PBR, NFLX, MTCN, QQQ, PBR/A, MRK, RAD, VOD, MSFT, MT, RFMD, TIBX ||| Merck & Co. Currently up $0.33 to $47.82; $0.17 Away from 52-Week and Multi-Year High",1,0.47870564
2013-04-23,17653500.0,47.95000076293945,48.70000076293945,47.93000030517578,48.630001068115234,38.82257843017578,MRK,Merck - BMY in HCV Deal - Analyst Blog,0,0.52220815
2013-04-25,15937100.0,47.95000076293945,48.0,47.27999877929688,47.34999847412109,37.80070495605469,MRK,"FDA Designation for Merck Candidate - Analyst Blog ||| Stocks to Watch for April 25, 2013",1,0.5011245
2013-04-26,10601600.0,47.27000045776367,48.06999969482422,47.11000061035156,47.869998931884766,38.21582794189453,MRK,"Weekly Preview: Focus Shifts from Earnings to Economy ||| Short Sellers Move into Celgene, Regeneron",0,0.49325705
2013-04-29,11375900.0,47.880001068115234,48.119998931884766,47.720001220703125,47.81999969482422,38.17592239379883,MRK,"Earnings Expectations for the Week of April 29 ||| A Look Ahead: This Week's ETFs to Watch ||| Healthcare ETF in Focus on Earnings Reports - ETF News And Commentary ||| Pfizer Likely to Report In Line Earnings - Analyst Blog ||| United Parcel to Buy CEMELOG - Analyst Blog ||| Merck Wins FOSAMAX Federal Bellwether Trial Involving Atypical Femur Fracture Claims ||| Market Wrap for Monday, April 29: Stocks Start Week With a Rally ||| Merck, Pfizer Announce Worldwide Collaboration Deal for Development, Commercialization of Ertugliflozin",0,0.49120522
2013-04-30,19744700.0,47.75,47.84000015258789,47.0,47.0,37.52130126953125,MRK,"Merck - Pfizer in Diabetes Deal - Analyst Blog ||| No News Becoming Bad News For Lexicon Pharmaceuticals ||| Pre-Market Earnings Report for May 1, 2013 : MRK, CMCSA, CVS, MA, TWX, AGN, AMT, EXC, VIAB, DVN, DLPH, CHK ||| Pfizer Tanks on Earnings, Unhealthy Guidance",0,0.47163004
2013-05-01,39740800.0,44.79999923706055,46.310001373291016,44.59999847412109,45.68999862670898,36.47549057006836,MRK,"Pre-Market Most Active for May 1, 2013 : SIRI, MRK, FB, CAJ, CHK, BAC, NTI, NOK, VOD, AAPL, BBRY, HIMX ||| Luminex Beats 1Q Earnings Est. - Analyst Blog ||| The Markets Now: Stocks Lower on Weak Economic Data; Fed Maintains Bond Purchase Pace ||| Earnings Trigger Volume Spike in Pharma ETF ||| May 1st Watchlist ||| Merck (CC): R&D Chief Calls Erosion on Singulair Sales 'Faster Than Expected,' Says Victrelis Sales Harmed in US, France, Germany ||| From Merck Conference Call: Q1 Results 'Not Indicative of the Future' ||| UPDATE: Merck Posts 8.3% Drop In Q1 Profit, Lowers Forecast ||| Merck Announces New $15B Buyback Plan ||| Merck & Company, Inc. Lowers FY2013 EPS Guidance from $3.60-3.70 to $3.45-3.55 vs $3.63 Est ||| Merck & Company, Inc. Reports Q1 EPS of $0.85 vs $0.79 Est; Revenue of $10.70B vs $11.09B Est ||| Merck Announces New $15B Share Repurchase Program",1,0.46645924
2013-05-02,14245600.0,45.900001525878906,46.0099983215332,45.4900016784668,45.72999954223633,36.507423400878906,MRK,"Are These The Biotech Stars Of Tomorrow? ||| Company News for May 2, 2013 - Corporate Summary",0,0.4835958
2013-05-03,12874600.0,46.25,46.380001068115234,45.459999084472656,45.66999816894531,36.45952224731445,MRK,"This May Be The Best Pharmaceutical Stock for Income Investors ||| After Hours Most Active for May 3, 2013 : NTAP, QQQ, PLD, S, PEG, EPD, MRK, AMX, BRCD, RFMD, AAPL, HERO ||| FDA Approves Merck's LIPTRUZET for Hyperlipidemia Treatment ||| UPDATE: Fitch Affirms Ratings on Merck; Outlook Lowered from Positive to Negative ||| Fitch Affirms ratings on Merck; Outlook Lowered from Positive to Negative",0,0.51469153
2013-05-06,14096300.0,45.5099983215332,46.0,44.970001220703125,44.97999954223633,35.90867614746094,MRK,"Netupitant Results Could Roil Tesaro In May ||| Market Close Report: NASDAQ Composite index closes at 3,392.97 up 14.34 points ||| S&P Tags Another New Record on a Light-News Day ||| Barron's Recap: Apple Tops the Barron's 500",1,0.49706748
2013-05-08,18308300.0,45.119998931884766,45.59999847412109,44.970001220703125,44.9900016784668,35.916656494140625,MRK,"After Hours Most Active for May 8, 2013 : MAC, QQQ, GRPN, MRK, GMCR, DDD, MU, COR, GRFS, ETP, CX, GT ||| In Danish Laboratories, Hope Looms Large for a Permanent HIV Cure ||| Merck Announces FDA Acceptance of Biologics License Application for Investigational Ragweed Pollen Sublingual Allergy Immunotherapy Tablet",1,0.5545442
2013-05-09,14175700.0,45.25,45.619998931884766,44.95000076293945,45.4900016784668,36.31583404541016,MRK,"Merck, Glaxo Reduce Prices 95% for HPV Vaccine in Poor Nations",1,0.5216998
2013-05-10,13923800.0,45.540000915527344,45.95000076293945,45.4900016784668,45.95000076293945,36.68305206298828,MRK,Simcere Beats 1Q Earnings & Revenue Estimate - Analyst Blog,1,0.5244222
2013-05-13,10246200.0,45.84000015258789,46.22999954223633,45.68000030517578,46.16999816894531,36.85868835449219,MRK,"Short Interest in Vertex Rises, in Celgene Falls",1,0.54471004
2013-05-14,13413900.0,46.119998931884766,46.77000045776367,46.0,46.650001525878906,37.24187088012695,MRK,"Health Care Is Hot, but Technology Offers Better Value ||| BSX and ABMD Highlight Increased Insider Buying in the Medical Technology Sector ||| Moody's Downgrades Merck's Guaranteed Senior Unsecured Rating from Aa3 to A1",1,0.49637073
2013-05-15,13197800.0,46.72999954223633,47.2599983215332,46.459999084472656,46.72999954223633,37.30574798583984,MRK,FDA Accepts Merck BLA - Analyst Blog ||| Merck Prices $6.5B Debt Offering,0,0.5192232
2013-05-20,16730000.0,45.959999084472656,46.02000045776367,45.09999847412109,45.209999084472656,36.0922966003418,MRK,"Market Close Report: NASDAQ Composite index closes at 3,496.43 down -2.54 points ||| ISI Suggesting the FDA Report on Merck Points to 'Some Risk' from Panel",1,0.51874286
2013-05-21,47020700.0,45.2400016784668,47.52999877929688,45.18999862670898,47.33000183105469,37.78474044799805,MRK,Merck to Take Initial Delivery of ~99.5M Shares ||| Merck Announces $5B Accelerated Buyback Plan,0,0.5004885
2013-05-22,42624900.0,47.59999847412109,48.29999923706055,46.4900016784668,46.709999084472656,37.28977966308594,MRK,"Merck Enters into Strategic Deal - Analyst Blog ||| Merck Issues Statement on FDA Advisory Committee Meeting Results for Suvorexant ||| FDA Panel Votes 8-7 Merck's Suvorexant Unsafe in Higher Doses ||| FDA Panel Votes 13-3 Merck's Suvorexant is Safe in Low Doses ||| FDA Panel Finds Merck Doesn't Need to Study 10mg Suvorexant ||| FDA Says Merck Insomnia Drug Helps Patients Stay Asleep -Bloomberg ||| FDA Panel Votes 12 Yes 4 No on Effectiveness of Merck Insomnia Drug ||| PreMarket Info Recap for May 22, 2013 ||| Merck FDA Advisory Committee Meeting for Insomnia Drug Suvorexant Begins at 8 AM ET",1,0.5098838
2013-05-23,22579600.0,46.459999084472656,47.43999862670898,46.41999816894531,47.33000183105469,37.78474044799805,MRK,Merck Issues Update on Phase III Trial for Preladenant,0,0.5104338
2013-05-24,15796000.0,47.04999923706055,47.15999984741211,46.59999847412109,47.15999984741211,37.64902877807617,MRK,Leon Cooperman's First Quarter Increases,1,0.53102994
2013-05-28,17663900.0,47.93999862670898,48.63999938964844,47.52000045776367,47.619998931884766,38.01625061035156,MRK,"Stock Upgrades: Can Merck Lead the Dow to Another Terrific Tuesday? ||| Mixed News on Merck's Pipeline - Analyst Blog ||| UPDATE: Jefferies Upgrades Merck to Buy, Raises PT Following SOTP Analysis ||| PreMarket Info Recap for May 28, 2013 ||| Jefferies Upgrades Merck & Company, Inc. to Buy, Raises PT to $54.00",0,0.4972064
2013-05-29,16051700.0,47.290000915527344,47.470001220703125,46.5099983215332,46.869998931884766,37.417510986328125,MRK,"Stock Upgrades: Athenahealth Is in Fine Fettle ||| SunTrust Robinson Humphrey Initiates Coverage on Merck & Company, Inc. at Neutral, Announces $47.00 PT ||| Short Interest in Vertex Rises, in Biogen Idec Falls",1,0.5348103
2013-05-30,15203500.0,47.02000045776367,47.38999938964844,46.7400016784668,47.06999969482422,37.57718276977539,MRK,"After Hours Most Active for May 30, 2013 : FCX, HPQ, MSFT, DPZ, MRK, PFE, PXP, INTC, SIRI, QQQ, VMED, INCY ||| Orphan Drug Status for Astellas' Candidate - Analyst Blog",0,0.48476237
2013-06-03,37982300.0,48.93000030517578,49.36000061035156,48.310001373291016,48.45000076293945,38.67886734008789,MRK,"Pre-Market Most Active for Jun 3, 2013 : BAC, QQQ, CLP, F, MRK, INTC, BCS, NBG, SIRI, AAPL, TSLA, INFI ||| Stock Market News for June 3, 2013 - Market News ||| Merck trade looks to make fast money ||| Data on Merck Candidate at ASCO - Analyst Blog ||| McDonald's and Four Others Named Dividend Growers Last Week ||| ISM Manufacturing Index Drops in May, Shows Contraction ||| Benzinga's Top Pre-Market Gainers",1,0.48044583
2013-06-04,37008600.0,48.20000076293945,50.15999984741211,48.16999816894531,49.43999862670898,39.46921157836914,MRK,"Stock Upgrades: Happy Headlines at USA Today Owner Gannett ||| Market Close Report: NASDAQ Composite index closes at 3,445.26 down -20.11 points ||| With Bond Yields So Low, Reluctant Investors Are Now Making the Move into These Stocks",0,0.49516368
2013-06-07,50431900.0,48.77000045776367,49.13999938964844,48.09999847412109,48.18999862670898,38.47129821777344,MRK,"UPDATE: Jefferies Raises PT on Merck & Co. Following Global Pharma Review ||| Jefferies Maintains Buy on Merck & Company, Inc., Raises PT to $56.00",1,0.49363348
2013-06-10,48557200.0,48.650001525878906,48.88999938964844,48.36000061035156,48.459999084472656,38.68685150146485,MRK,Warning: The Rebound May Be Over For Big Pharma ||| Merck Loses US Appeal of Apotex Patent Win Over Nasonex,0,0.50474924
2013-06-11,54150100.0,48.06999969482422,48.20000076293945,47.54999923706055,47.560001373291016,37.96836471557617,MRK,Merck's Shares Perk Up On Cancer Drug Clinical Trial Data ||| Pfizer Is Not Worried About Viagra Losing Its U.K. Patent This Month,0,0.50304747
2013-06-12,16853900.0,47.88999938964844,48.09999847412109,47.22999954223633,47.25,37.72088241577149,MRK,"Warning: This Might Be The Most Overvalued Sector In The Market ||| Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for June 13, 2013 ||| Short Interest Falls in Vertex, Rises in Biogen Idec (VRTX, BIIB) ||| FDA Says Considering New Study of Incretin Mimetic Diabetes Drug, Says May Need to Look for Cancer-Link Patterns",1,0.48717955
2013-06-14,13632300.0,47.77000045776367,48.52999877929688,47.5,47.95000076293945,38.63127899169922,MRK,"Luminex Collaborates with NMTC - Analyst Blog ||| The Biggest Companies That Don't Pay Dividends -- But May Be About To ||| Dow Jones Reporting Merck to Cut Jobs, Change Organizational Structure of R&D Unit",0,0.49947652
2013-06-17,12485200.0,48.33000183105469,48.54999923706055,47.560001373291016,47.79999923706055,38.51042175292969,MRK,"Mylan Being Sued by Pfizer, Merck, Want Blockage of Proposed Copy of Azasite",0,0.48560584
2013-06-18,11816800.0,47.880001068115234,48.04999923706055,47.65999984741211,47.75,38.47013473510742,MRK,"Largest option buying in equities so far ||| Market Close Report: NASDAQ Composite index closes at 3,482.18 up 30.05 points ||| Dow Busts Sixth Straight Triple-Digit Move, Adds 138 Points Ahead of Fed ||| Interesting Similarities Among 2013's Top-Performing ETFs",0,0.49181318
2013-06-19,17994200.0,47.709999084472656,48.16999816894531,47.45000076293945,47.58000183105469,38.33319091796875,MRK,Bond Yields Are Rising -- Do Your Stocks Measure Up?,0,0.49252236
2013-06-21,24287800.0,46.869998931884766,47.59999847412109,46.66999816894531,47.0,37.86590576171875,MRK,Label Updates for Lilly/Boehringer Diabetes Drugs - Analyst Blog,0,0.5228918
2013-06-24,18080700.0,46.470001220703125,46.86000061035156,46.060001373291016,46.40999984741211,37.39056015014648,MRK,"Data on Lilly's Dulaglutide at ADA - Analyst Blog ||| UPDATE: BMO Capital Markets Lowers PT on Merck Following New SGLT2 Data ||| BMO Capital Maintains Outperform on Merck & Company, Inc., Lowers PT to $52.00",0,0.48690873
2013-06-26,11435900.0,46.59999847412109,46.90999984741211,46.27999877929688,46.68999862670898,37.61614608764648,MRK,"Short Interest in Biogen Idec and Vertex Shrinks (BIIB, CELG, VRTX)",1,0.54089373
2013-06-27,11639800.0,47.02999877929688,47.36000061035156,46.869998931884766,47.27999877929688,38.09148025512695,MRK,"Aspen Pharmacare to Acquire Netherlands Plant, Portfolio of 11 Drug Brands from Merck for $1B -Reuters",0,0.51237804
2013-06-28,16339800.0,47.459999084472656,47.47999954223633,46.45000076293945,46.45000076293945,37.42279052734375,MRK,UPS Launches New Freight Solution - Analyst Blog,0,0.53287375
2013-07-01,13112200.0,46.2599983215332,46.84999847412109,46.220001220703125,46.31999969482422,37.31805419921875,MRK,"FDA Approves New U.S. Labeling for ISENTRESS® (raltegravir) to Include 240-Week Results from STARTMRK Study of ISENTRESS Containing Regimen in Previously Untreated HIV-1 Infected Adult Patients ||| Merck Receives Complete Response Letter for Suvorexant, Merck's Investigational Medicine for Insomnia; FDA Says Data Does Not Support Approval of Suvorexant 30mg and 40mg ||| Merck Receives CRL for Suvorexant",1,0.5351715
2013-07-02,11315900.0,46.09000015258789,46.72999954223633,46.02999877929688,46.54999923706055,37.50335311889648,MRK,"Good News for Hospira, Shares up - Analyst Blog ||| CRL for Merck's Suvorexant - Analyst Blog ||| Pfizer and Novartis Could Be Eyeing Onyx (PFE, NVS, ONXX)",0,0.4833467
2013-07-03,6874000.0,46.47999954223633,46.72999954223633,46.15999984741211,46.54999923706055,37.50335311889648,MRK,Setback for Achillion - Analyst Blog,1,0.5297964
2013-07-05,8103000.0,46.93000030517578,47.29999923706055,46.61000061035156,47.15999984741211,37.99480056762695,MRK,Financial Times Reporting That China Is Investigating 33 Foreign Pharmaceutical Companies For Pricing Irregularities ||| Will Earnings Growth Bottom in Q2? - Earnings Trends ||| Will Earnings Growth Bottom in Q2? - Earnings Trends ||| Will Earnings Growth Bottom in Q2? - Earnings Outlook ||| Will Earnings Growth Bottom in Q2? - Earnings Trends ||| Will Earnings Growth Bottom in Q2? - Earnings Trends ||| Will Earnings Growth Bottom in Q2? - Earnings Outlook ||| Will Earnings Growth Bottom in Q2? - Earnings Outlook,1,0.5110664
2013-07-10,7780700.0,47.619998931884766,48.18000030517578,47.59000015258789,47.959999084472656,38.63933563232422,MRK,Hospira Touches 52-week High - Analyst Blog,1,0.5409233
2013-07-11,11442000.0,48.43000030517578,48.5,48.130001068115234,48.310001373291016,38.92131042480469,MRK,"Short Interest Rises in Gilead Sciences, Onyx Pharmaceuticals (BIIB, GILD, ONXX)",1,0.5319904
2013-07-12,8855500.0,48.400001525878906,48.65999984741211,48.18999862670898,48.540000915527344,39.10660934448242,MRK,"Sanofi Pasteur Vaccine Suspended as Precautionionary Measury - WHO Citing Quality Problem ||| UPDATE: Jefferies Lowers PT on Merck on Challenges Ahead ||| Jefferies Maintains Buy on Merck & Company, Inc., Lowers PT to $54.00",0,0.4738805
2013-07-15,9654400.0,48.5099983215332,48.88999938964844,48.2599983215332,48.52000045776367,39.09049606323242,MRK,Health Care ETFs Looking Healthy Ahead of Earnings,0,0.48855057
2013-07-16,15273600.0,48.560001373291016,48.83000183105469,48.02999877929688,48.22999954223633,38.85685729980469,MRK,Merck in Talks with FDA to Identify Steps Needed for Review of Sugammadex Sodium Injection ||| Eli Lilly Tries Again with Alzheimer's Drug as the Race for a Cure Continues (LLY) ||| Life Technologies to Collaborate with Merck Serono for Companion Diagnostics Development and Commercialization,0,0.5315223
2013-07-18,17822000.0,48.02999877929688,48.130001068115234,47.34999847412109,47.400001525878906,38.18816375732422,MRK,"BMO Capital Downgrades Merck & Company, Inc. to Market Perform",1,0.52807736
2013-07-24,8941200.0,47.91999816894531,48.040000915527344,47.5099983215332,47.77000045776367,38.48625183105469,MRK,"Array Up on Positive Data - Analyst Blog ||| UPDATE: Merck Announces FDA Acceptance of New Drug Application for Vorapaxar, Investigational Anti-Thrombotic Medicine ||| Merck Announces FDA Acceptance of NDA for Vorapaxar",1,0.5147829
2013-07-26,9846200.0,48.04999923706055,48.4900016784668,47.77999877929688,48.4900016784668,39.06632614135742,MRK,"How Does Obamacare Work? 11 Questions, 11 Unbiased Answers ||| Weekly Preview: Earnings Season Continues, Fed In Focus, Economic Maelstrom Expected ||| Short Interest in Pharmacyclics Plunges (AMGN, ONXX, PCYC) ||| Merck Statement Regarding CHMP Review of Incretin-Based Therapies for Type 2 Diabetes, Including Sitagliptin",0,0.4813147
2013-07-29,10291600.0,48.27000045776367,48.790000915527344,48.150001525878906,48.34000015258789,38.94547653198242,MRK,Earnings Expectations for the Week of July 29 ||| Good News for BMY/AZN on Dapagliflozin - Analyst Blog ||| The Rally Stalls Out ||| Will Merck (MRK) Beat Earnings This Quarter? - Analyst Blog,0,0.49546358
2013-07-30,16778200.0,48.290000915527344,49.08000183105469,47.84000015258789,48.04999923706055,38.71183776855469,MRK,"Tentative Markets Ahead of Big Data - Ahead of Wall Street ||| July 30: An Important Week for Markets - Economic Highlights ||| Earnings Decline Again at Merck - Analyst Blog ||| SLIDESHOW: 8 Stocks to Benefit From a Repatriation Deal In Congress ||| Benzinga's PreMarket Info Recap for July 30, 2013: Potash Smash! ||| UPDATE: Merck Posts Drop In Q2 Profit ||| Merck & Company, Inc. Reports Q2 EPS of $0.84 vs $0.83 Est; Revenue of $11.0B vs $11.22B Est ||| Benzinga Market Primer: Wednesday, July 30: Futures Higher After Asia Turnaround",1,0.5130934
2013-07-31,21576400.0,48.5,48.72999954223633,47.970001220703125,48.16999816894531,38.80852508544922,MRK,"Earnings Beat at Hospira in 2Q, Sales In Line - Analyst Blog ||| Bionomics Signs Option and License Agreement With Merck ||| Benzinga Market Primer: Wednesday, July 31: Futures Higher Heading Into FOMC Decision",1,0.51474684
2013-08-02,8922200.0,48.43999862670898,48.540000915527344,48.18000030517578,48.540000915527344,39.10660934448242,MRK,"Wider-than-Expected Loss at Endocyte - Analyst Blog ||| S&P: Heaping Praise For Some Health Care ETFs ||| Three Soaring, But Overlooked Health Care ETFs",0,0.48622176
2013-08-05,6789100.0,48.38999938964844,48.65999984741211,48.06999969482422,48.52999877929688,39.09854888916016,MRK,"Hearing Unconfirmed Takeover Chatter in Inovio ||| Apple, Wal-Mart And Other Companies With Monster Share Buyback (AAPL, WMT)",0,0.5096155
2013-08-12,9935100.0,48.15999984741211,48.810001373291016,48.09000015258789,48.470001220703125,39.05020904541016,MRK,Irving Kahn Increases Four ||| Avanir Pharmaceuticals Announces Diabetes Co-Promotion Agreement with Merck,0,0.5391296
2013-08-13,7455100.0,48.52000045776367,48.84999847412109,48.08000183105469,48.43000030517578,39.01798629760742,MRK,"Teva & Perrigo Launch Generic Temodar - Analyst Blog ||| Mid-Morning Market Update: Markets Drop, Yum China Same-Store Sales Down 13% ||| Healthcare Stocks Edging Higher in Late Trade; Osiris More Than Doubles in Price After Diabetes Drug Success ||| Sector Update: Healthcare ||| Healthcare Stocks Gaining; GSK/Pfizer Joint Venture Picks Up FDA Nod For HIV Drug ||| Sector Update: Healthcare ||| Mid-Afternoon Market Update: Apple Rises Sharply On Icahn Stake, NASDAQ Pulled Upward ||| Mid-Day Market Update: US Stocks Edge Higher; Valspar Shares Decline On Downbeat Results ||| Mid-Morning Market Update: Markets Drop, Yum China Same-Store Sales Down 13% ||| Benzinga's Top Pre-Market Gainers",1,0.5333962
2013-08-14,8530900.0,48.54999923706055,48.7599983215332,48.40999984741211,48.56999969482422,39.13078689575195,MRK,"13F from Leon Cooperman's Omega Advisors Shows New Stakes in Thermo-Fisher, McKesson, Liquidated Stakes in Freeport-McMoRan, Facebook, Covidien, Raised Stakes in DISH, Citi, Lowered Stakes in Merck, AIG, Polycom",0,0.48496407
2013-08-15,11341500.0,48.27999877929688,48.36000061035156,47.84999847412109,47.970001220703125,38.64738082885742,MRK,Wider Loss at Achillion in Q2 - Analyst Blog ||| Prem Watsa's 4 Second Quarter Increases ||| Avanir and Merck Collaborate - Analyst Blog,0,0.53438187
2013-08-16,13200400.0,47.790000915527344,48.0,47.47999954223633,47.70000076293945,38.42986297607422,MRK,"Merck Shares Down ~0.75% Today, But Have Been Relatively Quiet/Rangebound All Day; Traders Seemed to Shrug at Earlier Report Co. to Temporarily Halt Zilmax Sales",0,0.49413842
2013-08-20,14095000.0,47.650001525878906,48.380001068115234,47.560001373291016,47.560001373291016,38.31707763671875,MRK,Merck Temporarily Suspends Zilmax Sales - Analyst Blog,0,0.5231767
2013-08-21,10800000.0,47.560001373291016,48.040000915527344,47.29999923706055,47.459999084472656,38.23649978637695,MRK,Still Bullish on Hospira - Analyst Blog,1,0.5115597
2013-08-23,9176300.0,47.97999954223633,47.97999954223633,47.45000076293945,47.72999954223633,38.45402526855469,MRK,Avanir Announces PBA Data Publication - Analyst Blog,0,0.5340012
2013-08-26,9220200.0,47.79999923706055,47.900001525878906,47.52999877929688,47.619998931884766,38.36540222167969,MRK,"Chicago Tribune Running Story 'Cargill to stop buying cows fed with questionable growth drug,' Related to Merck's Zillmax",0,0.50874746
2013-08-27,10842400.0,47.31999969482422,47.52000045776367,46.93000030517578,47.11000061035156,37.95452117919922,MRK,"Short Interest In Celgene, Onyx Continues To Shrink (CELG, ONXX, VRTX)",0,0.53713673
2013-08-28,9812200.0,46.77999877929688,47.400001525878906,46.470001220703125,47.09000015258789,37.93841552734375,MRK,Diamond Hill Capital Growing - Six Sells,1,0.5282517
2013-08-30,8326300.0,47.09000015258789,47.47999954223633,47.02000045776367,47.290000915527344,38.09952926635742,MRK,Plenty Of ETFs With Favorable Risk Traits,0,0.49844262
2013-09-04,11065200.0,47.130001068115234,47.880001068115234,47.11000061035156,47.68000030517578,38.41374969482422,MRK,Astellas and Merck Collaborate - Analyst Blog ||| Merck's Durham Site Receives US FDA License for Varicella Bulk,0,0.53001535
2013-09-05,7898200.0,47.790000915527344,47.790000915527344,47.2599983215332,47.5099983215332,38.27677917480469,MRK,Pipeline Progress at Tetraphase - Analyst Blog ||| X Factor: 5 Stocks Reaching Their Ex-Dividend Date on September 12,0,0.48130262
2013-09-06,26664900.0,47.56999969482422,47.81999969482422,47.060001373291016,47.4900016784668,38.26067733764648,MRK,FDA Licensure for Merck Facility - Analyst Blog,1,0.5407764
2013-09-09,29180200.0,47.59999847412109,47.84999847412109,47.47999954223633,47.7400016784668,38.46209335327149,MRK,USA TD Ameritrade's Investor Movement Index for Aug 5.16 vs 4.87 Prior ||| Merck Reports FDA Acceptance of NDA for Investigational Fertility Treatment,1,0.5394762
2013-09-10,30808600.0,47.86000061035156,48.400001525878906,47.86000061035156,47.97999954223633,38.65544509887695,MRK,Standard Review for MRK Fertility Drug - Analyst Blog,1,0.53633827
2013-09-11,13379100.0,48.02999877929688,48.5099983215332,47.959999084472656,48.13999938964844,38.78435134887695,MRK,"New CEO Named by Forest Labs - Analyst Blog ||| EC OKs Hospira's Inflectra, Shares up - Analyst Blog ||| Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for September 12, 2013 ||| Sector Update: Healthcare ||| US Stock Futures Flat; Apple Shares Drop In Pre-Market Trading ||| Merck, AstraZeneca Announce License Agreement for MK-1775",0,0.48204896
2013-09-12,9502400.0,47.79999923706055,47.97999954223633,47.650001525878906,47.84999847412109,38.89815139770508,MRK,"AstraZeneca, Merck Ink Licensing Deal - Analyst Blog ||| Watch Shares of Caterpillar, Deere, Devon, Merck, and Oracle to the Downside on a Bearish Article from Jim Cramer Tweeted Out by Carl Icahn",0,0.48321128
2013-09-16,9428200.0,48.25,48.45000076293945,48.09999847412109,48.18999862670898,39.17454147338867,MRK,"Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, CELG, PCYC)",0,0.508376
2013-09-19,9328000.0,48.470001220703125,48.4900016784668,48.09999847412109,48.2599983215332,39.2314453125,MRK,U.S. Patent Allowance for BioLineRx' BL-8020 - Analyst Blog ||| Write A Prescription For Health Care ETFs,0,0.5073704
2013-09-23,12605700.0,47.790000915527344,48.060001373291016,47.540000915527344,47.68000030517578,38.75996398925781,MRK,Merck Receives CRL for Investigational Medicine Sugammadex Sodium Injection,0,0.5179465
2013-09-24,13300600.0,47.630001068115234,48.220001220703125,47.52000045776367,47.52999877929688,38.63801193237305,MRK,Regulatory Setback for Merck - Analyst Blog,1,0.53713185
2013-09-25,11356300.0,47.66999816894531,47.9900016784668,47.41999816894531,47.66999816894531,38.751834869384766,MRK,Encouraging Data on Dapagliflozin - Analyst Blog,1,0.54278946
2013-09-26,10261100.0,47.77999877929688,48.0,47.5099983215332,47.68000030517578,38.75996398925781,MRK,Short-Term Bulls Take Over Merck Options Pits,1,0.54686403
2013-09-27,10510300.0,47.56999969482422,47.90999984741211,47.290000915527344,47.790000915527344,38.84938049316406,MRK,Health Care Stocks Gurus Investors Are Buying Ahead of Obamacare,0,0.49725136
2013-09-30,16244000.0,47.63999938964844,47.869998931884766,47.290000915527344,47.61000061035156,38.70305633544922,MRK,Setback for Achillion - Analyst Blog,1,0.5297964
2013-10-01,27339200.0,48.91999816894531,49.22999954223633,48.150001525878906,48.7400016784668,39.62165832519531,MRK,"US Futures Gain as Investors View Partial Government Shutdown as Temporary ||| US Futures Gain as Government Shutdown Seen Short-Lived; US PMI Short of Views ||| Sector Update: Healthcare ||| Sector Update: Healthcare Shares Higher Pre-Market; Lexicon Surges 21% on Glucose Inhibitor's Success ||| Pre-Market Most Active for Oct 1, 2013 : EDG, FB, ACTV, UN, ALU, LXRX, BAC, MRK, QQQ, ERIC, SIRI, MDLZ ||| Sector Update: Healthcare ||| Stocks Rise as Government Partially Shuts Down, Costing Economy $300 Million Per Day ||| Health Care and Biotech ETFs Brace for Obamacare ||| Top-line Data on Astellas' Isavuconazole - Analyst Blog ||| Healthcare Stocks Rising; Merck to Lay Off 8,500 Workers, Reports Positive Early Results for Lung Cancer Drug ||| Stocks Notch Daily Gains as Shutdown Becomes a Reality ||| Merck Shares Soar After Announcing More Job Cuts ||| Merck Says Interim Data for MK-3475 to be Presented at 15th World Conference on Lung Cancer ||| PreMarket Info Recap for October 1, 2013: Government Shutdown Gives Markets A Boost ||| Merck Says Will Close Summit Campus, Will Move Global HQ to Kenilworth ||| UPDATE: Merck Announces Global Initiative to Sharpen Commercial and R&D Focus; Cutting 8500 Jobs; Affirms FY Target ||| Merck Cutting 8,500 Jobs Related to Global Initiative to 'Sharpen Commercial, R&D Focus,' Sees Pretax Charge $2.5-3B, Reaffirms FY13 Outlook",0,0.49997
2013-10-02,13975300.0,48.45000076293945,48.54999923706055,48.119998931884766,48.369998931884766,39.32086944580078,MRK,Update on Tetraphase's Pipeline - Analyst Blog ||| Pharmaceutical Industry Expected To Collect Billions From Obamacare,0,0.5184207
2013-10-03,17900500.0,48.220001220703125,48.75,48.0,48.36000061035156,39.31273651123047,MRK,Update on Merck's Restructuring Efforts - Analyst Blog,0,0.52152556
2013-10-04,11570800.0,48.27000045776367,48.36000061035156,47.93999862670898,48.22999954223633,39.207069396972656,MRK,"Eli Lily to Cut Costs, Shares Down - Analyst Blog",0,0.51870465
2013-10-07,9195800.0,47.91999816894531,48.22999954223633,47.68000030517578,47.88999938964844,38.93067932128906,MRK,Merck Says Data Shows Cognigram as Sensitive Assessment,0,0.5113507
2013-10-08,14020700.0,47.84000015258789,48.150001525878906,47.63999938964844,47.75,38.81686782836914,MRK,"Credit Suisse Starts Pfizer, Bristol-Myers, AbbVie, Allergan at Outperform, Merck, Eli Lilly, Forest Labs at Neutral ||| FDA Postpones Advisory Committee Meeting for Grass Ait Tablet Due to US Government Shutdown",0,0.4846435
2013-10-09,15353400.0,47.68999862670898,47.81999969482422,47.13999938964844,47.27000045776367,38.42665863037109,MRK,"Fed Minutes, Yellen Appointment Help Halt Selling Pressure",1,0.5442855
2013-10-10,17262400.0,47.59999847412109,47.630001068115234,46.959999084472656,47.4900016784668,38.60551071166992,MRK,Johnson & Johnson Earnings Preview: Pharmaceutical Business Will Get Bigger,0,0.49850535
2013-10-11,10253500.0,47.41999816894531,47.4900016784668,47.150001525878906,47.290000915527344,38.44292449951172,MRK,"Short Sellers Move On Amgen, Vertex (AMGN, PCYC, VRTX) ||| Jefferies Downgrades Merck & Company, Inc. to Hold, Lowers PT to $50.00",0,0.48118496
2013-10-14,20674500.0,46.79999923706055,47.08000183105469,46.43999862670898,46.75,38.00394058227539,MRK,"Update on VIVUS' Qsymia - Analyst Blog ||| Can Johnson & Johnson (JNJ) Keep the Earnings Streak Alive? - Analyst Blog ||| Stocks Finish Higher Despite Budget Meeting Postponement ||| Merck, Endocyte Report Vintafolide-PLD Generaly Well Tolerated, Showed Median PFS of Five Months ||| UPDATE: Bernstein Downgrades Merck & Co. on Negative Outlook ||| Barclays Downgrades Merck & Company, Inc. to Equalweight ||| Benzinga's Top Downgrades ||| Bernstein Downgrades Merck & Company, Inc. to Market Perform, Lowers PT to $50.00",0,0.48593026
2013-10-15,14161000.0,46.52000045776367,46.83000183105469,46.41999816894531,46.56999969482422,37.85762405395508,MRK,Endocyte's Pipeline Encourages - Analyst Blog,1,0.52582484
2013-10-16,11102700.0,46.61000061035156,47.16999816894531,46.56999969482422,47.16999816894531,38.34536361694336,MRK,"Positive Data on REGN/Sanofi's Drug - Analyst Blog ||| Merck Confirms Development of Investigational Dosing ISENTRESS, Will Begin Phase III Trial Early 2014",0,0.50799924
2013-10-17,13878500.0,47.130001068115234,47.27999877929688,46.88999938964844,47.11000061035156,38.29658889770508,MRK,Johnson & Johnson Continues To Ride The Success Of Its Immunology & Oncology Drugs,0,0.51882625
2013-10-21,16678000.0,46.70000076293945,46.720001220703125,46.08000183105469,46.5099983215332,37.80884552001953,MRK,"Buy Big Pharma By All Means, But Spread the Risk",0,0.49933156
2013-10-22,15841500.0,46.310001373291016,46.720001220703125,46.13999938964844,46.470001220703125,37.77632522583008,MRK,Merck's MK-5172/MK-8742 Receives Breakthrough Therapy Designation from FDA,1,0.54152167
2013-10-23,9650700.0,46.59999847412109,46.720001220703125,46.47999954223633,46.560001373291016,37.8494987487793,MRK,"Earnings Beat from Eli Lilly Again - Analyst Blog ||| How Investors Can Play the ""Losers"" in Blue Chips",0,0.5102486
2013-10-24,11201100.0,46.79999923706055,46.86000061035156,46.18999862670898,46.220001220703125,37.57309341430664,MRK,"Merck Says Primary Endpoints Met for Investigational 9-Valent HPV Vaccine, Expecting to Submit BLA for V503 in 2013 ||| Merck Says Primary Endpoints Met for Investigational 9-Valent HPV Vaccine, Expecting to Submit BLA for V503 in 2013",1,0.48007342
2013-10-25,17894000.0,46.25,46.58000183105469,45.84999847412109,46.540000915527344,37.83323287963867,MRK,"Will Merck's (MRK) Earnings Streak End? - Analyst Blog ||| Pre-Market Earnings Report for October 28, 2013 : MRK, BIIB, L, ROP, CNA, EW, BWP, BKW, KEX, AHGP, AWI, TEN ||| Merck Earnings Preview: Competition From Generics & Currency Movements Will Continue To Plague Merck ||| Benzinga Weekly Preview: FOMC Meeting Closely Watched ||| Short Sellers Retreat From Biogen Idec, Move On Pharmacyclics (BIIB, BMRN, PCYC)",0,0.48433238
2013-10-28,27297600.0,45.56999969482422,45.81999969482422,45.209999084472656,45.34999847412109,36.8658561706543,MRK,"Earnings Expectations For The Week Of October 28: Apple, Facebook, GM and More ||| Mid-Day Market Update: Burger King Surges On Upbeat Earnings; Sohu Shares Dip ||| Stocks Slump on Merck Earnings, Homebuilders Hurt By Sluggish Housing Market ||| Mid-Morning Market Update: Markets Mixed; Merck Profit Beats Estimates ||| Stocks Futures Drift Lower Into Open; Waiting for Apple Results ||| Stock Futures Reverse Course on Disappointing Earnings From Merck ||| Pre-Market Most Active for Oct 28, 2013 : DNDN, PBR, ZGNX, SNTA, FB, NOK, NQ, DELL, MRK, QQQ, BAC, ALU ||| Closing Update: S&P Hits Another Record High Despite Indecisive Market ||| Stocks Hug Flatline Before Apple Earnings, Fed Meeting ||| Think Silver: Top Stocks Catering to Seniors ||| Mid-Afternoon Market Update: Markets Mixed as JC Penney Rises ||| Mid-Day Market Update: Burger King Surges On Upbeat Earnings; Sohu Shares Dip ||| Mid-Morning Market Update: Markets Mixed; Merck Profit Beats Estimates ||| Merck's Q3 Call Just Beginning ||| UPDATE: Merck Posts Upbeat Q3 Profit ||| Merck & Company, Inc. Narrows FY2013 EPS Guidance from $3.45-3.55 to $3.48-3.52 vs $3.47 Est ||| Merck & Company, Inc. Reports Q3 EPS of $0.92 vs $0.88 Est; Revenue of $11.03B vs $11.19B Est ||| #PreMarket Primer: Monday, October 28: All Eyes On Apple ||| Earnings Scheduled For October 28, 2013 ||| Stocks To Watch For October 28, 2013",1,0.49794596
2013-10-29,15890000.0,45.40999984741211,45.66999816894531,45.08000183105469,45.58000183105469,37.052833557128906,MRK,"Merck Continues To Disappoint As Weakness In Januvia's Sales & Japanese Market Adds To Its Woes ||| US Stock Futures Flat Ahead Of Fed ||| #PreMarket Primer: Tuesday, October 29: Fed Meeting Likely Uneventful ||| Merck Presents Interim Data from Phase 1B Study of MK-3475 at 15th World Conference on Lung Cancer",0,0.48547837
2013-10-30,9958500.0,45.75,45.7599983215332,45.11000061035156,45.2400016784668,36.77645111083984,MRK,Celldex: What's All The Excitement About?,0,0.4964594
2013-10-31,14994200.0,45.310001373291016,45.459999084472656,45.09000015258789,45.09000015258789,36.65449905395508,MRK,ETFs to Watch on Recent Microsoft Strength - ETF News And Commentary ||| Market Wrap for October 31: Fed Worries Pull Stocks Lower,1,0.49749812
2013-11-01,20893500.0,44.869998931884766,45.34999847412109,44.619998931884766,45.22999954223633,36.768314361572266,MRK,"AstraZeneca Misses on Both Earnings and Revs - Analyst Blog ||| BMO Capital Upgrades Merck & Company, Inc. to Outperform",1,0.53568906
2013-11-04,16177500.0,45.91999816894531,46.27000045776367,45.65999984741211,45.720001220703125,37.1666374206543,MRK,"Analysts Comment on Merck's Hep C Regiment Advances ||| Merck Says Investigational V503 Prevented 97% of Cervical, Vaginal, Vulvar Pre-Cancers Caused by Five Added HPV Types",0,0.5111336
2013-11-06,12361300.0,45.560001373291016,46.02000045776367,45.34000015258789,45.959999084472656,37.36173629760742,MRK,Narrower-than-Expected Loss at Endocyte - Analyst Blog ||| Job Cuts Higher in October; Pharmaceutical & Financial Sectors Took Biggest Hits,0,0.49126318
2013-11-08,17423800.0,45.93000030517578,46.869998931884766,45.86000061035156,46.79999923706055,38.04458236694336,MRK,"107-Year Old Irving Kahn Buys BP, BlackBerry, New York Community Bancorp, Sells SLM, Seaboard, ...",1,0.52255857
2013-11-11,7533400.0,46.90999984741211,47.150001525878906,46.880001068115234,47.0,38.207176208496094,MRK,Merck's MK-7243 Significantly Reduced Allergy Symptoms in Adults and Children in Pivotal Phase III Study,1,0.5467898
2013-11-12,13950600.0,46.95000076293945,47.630001068115234,46.79999923706055,47.59000015258789,38.686798095703125,MRK,Markets Drift South as Tapering Concerns Weigh on the Street,0,0.48446146
2013-11-18,7930100.0,48.040000915527344,48.2599983215332,47.77999877929688,48.0099983215332,39.02822113037109,MRK,"Paul Tudor Jones - High Impact Sells ||| Narrower-than-Expected Loss at Achillion, Shares Up - Analyst Blog ||| Investing in Companies Developing Promising Immunotherapy Drugs for Melanoma ||| Merck's NDA for Noxafil Wins FDA Priority Review",1,0.54701567
2013-11-19,8345300.0,48.04999923706055,48.16999816894531,47.650001525878906,48.06999969482422,39.07700347900391,MRK,"European Approval for Gilead's Vitekta - Analyst Blog ||| QIAGEN, Eli Lilly Expand Partnership - Analyst Blog",1,0.54166335
2013-11-22,13967900.0,48.4900016784668,49.040000915527344,48.43999862670898,48.93999862670898,39.78423690795898,MRK,Recent Cloud IPO Veeva Systems Scores In Health Biz ||| Merck Announces Position Opinion from CHMP on Update for Erbitux Metastatic Colorectal Cancer Labeling,1,0.52330184
2013-11-26,22939300.0,49.65999984741211,49.75,49.15999984741211,49.58000183105469,40.30450439453125,MRK,Merck Raises Quarterly Dividend to $0.44 from $0.43 ||| FDA Okays Merck's Noxafil DR Tablets,1,0.52199334
2013-11-29,6900000.0,49.790000915527344,49.95000076293945,49.47999954223633,49.83000183105469,40.50773239135742,MRK,Merck's Noxafil Tablets Approved by the FDA - Analyst Blog,1,0.54121786
2013-12-02,14829900.0,49.7400016784668,50.41999816894531,49.7400016784668,50.18000030517578,40.79225158691406,MRK,Healthcare Stocks Maintaining Small Gains; Galena Biopharma Up 11% After Positive 'Seeking Alpha' Article ||| Sector Update: Healthcare ||| Healthcare Stocks Holding Narrow Advance; Lannett Gaining on Upcoming Move to NYSE Big Board ||| Sector Update: Healthcare,0,0.48909655
2013-12-03,13604400.0,49.81999969482422,50.060001373291016,49.380001068115234,49.7599983215332,40.45082473754883,MRK,"Health Care Heartiest, Gold Funds All Red In November ||| After Hours Most Active for Dec 3, 2013 : QQQ, VIDI, JCP, MSFT, BAC, MRVL, IQNT, CSCO, PFE, WFC, ZTS, MRK ||| Bloomberg Reporting Merck, Eli Lilly Rumored to Be Interested in Novartis' Veterinary Unit",0,0.48683357
2013-12-04,11451600.0,49.59999847412109,49.650001525878906,48.81999969482422,49.310001373291016,40.08502578735352,MRK,Stocks Stumble Again as Wall Street Mulls Over Data,0,0.50187993
2013-12-09,9331500.0,49.380001068115234,49.84999847412109,49.20000076293945,49.560001373291016,40.28824234008789,MRK,Columbia Labs Needs A New Direction ||| Merck Agrees to settle Litigation over Jaw Injuries Caused by Fosamax -Reuters,0,0.50429
2013-12-10,10236400.0,49.27999877929688,49.54999923706055,49.09999847412109,49.43000030517578,40.18256759643555,MRK,Merck Says Data Monitoring Committee Recommending Continuation of Phase II/III EPOCH Study for MK-8931,0,0.49876687
2013-12-11,14504000.0,49.5099983215332,49.52999877929688,48.75,48.95000076293945,39.79236602783203,MRK,"Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for December 12, 2013 ||| After Hours Most Active for Dec 11, 2013 : WFC, MSFT, ERIC, JPM, CSCO, QQQ, S, FOXA, FITB, KBR, MRK, KEY",0,0.45630586
2013-12-12,11611700.0,48.56999969482422,48.77999877929688,48.02999877929688,48.31999969482422,39.636512756347656,MRK,"FDA Reviewing Merck's Bid for Grastek; Panel Recommends Approval of Grastek; ||| #PreMarket Primer: Thursday, December 12: US Budget Deal Gaining Momentum",1,0.51417196
2013-12-17,13900000.0,47.93000030517578,48.0,47.61000061035156,47.900001525878906,39.29199600219727,MRK,"After Hours Most Active for Dec 17, 2013 : MRK, NMIH, HCBK, PRGO, MRVL, LSI, SWFT, PFE, INTC, KMI, KFN, QQQ ||| Merck Says Vintafolide Has Won Orphan Drug Designation for Ovarian Cancer ||| EMA Says Will Discuss Extension of Indication for Merck's Noxafil, Isentress, Pfizer's Vfend, Amgen's Xgeva, Vertex Pharma's Kalydeco",1,0.52709204
2013-12-18,13549700.0,47.869998931884766,48.93000030517578,47.650001525878906,48.900001525878906,40.112281799316406,MRK,Sector Update: Healthcare Shares Flat Pre-Market; Merck Partners with GlaxoSmithKline ||| Sector Update: Healthcare ||| Merck Spikes Higher on Positive Jim Cramer/Mad Money Comments ||| Merck Collaborates with GlaxoSmithKline on MK-3475,0,0.49179205
2013-12-19,8762400.0,48.75,48.95000076293945,48.52999877929688,48.790000915527344,40.02204513549805,MRK,"Stock Market News for December 19, 2013 - Market News",1,0.50509405
2013-12-20,16805100.0,48.86000061035156,49.45000076293945,48.630001068115234,49.31999969482422,40.45680236816406,MRK,Here Is What Can Propel Merck,1,0.5481145
2013-12-23,8263900.0,49.43999862670898,49.70000076293945,49.25,49.36000061035156,40.48962020874024,MRK,Update on Sanofi/REGN's Alirocumab - Analyst Blog,1,0.5210349
2013-12-24,4252900.0,49.43000030517578,49.66999816894531,49.22999954223633,49.40999984741211,40.5306282043457,MRK,"TESARO Plunges on Study Results - Analyst Blog ||| After Hours Most Active for Dec 24, 2013 : S, QQQ, MS, MRK, GE, M, TEVA",1,0.5061421
2013-12-26,5069800.0,49.43999862670898,49.75,49.36000061035156,49.720001220703125,40.784912109375,MRK,ALK Reports FDA Panel Will Revie Ragweed Tablet ||| Merck Sues to Stop Generic NuvaRing,1,0.5263406
2013-12-27,4244300.0,49.77000045776367,49.900001525878906,49.52999877929688,49.790000915527344,40.84233856201172,MRK,"Healthcare Stocks Split Between Winners, Losers - Merck, Partner Sending Allergy Drug Before FDA Advisory Panel ||| Sector Update: Healthcare ||| WSJ Reporting Merck on 'Radically Reshaping R&D'",1,0.51971495
2013-12-30,6321900.0,49.7400016784668,49.93999862670898,49.33000183105469,49.93999862670898,40.96538162231445,MRK,Actavis' Women Health Biz Update - Analyst Blog,1,0.52411395
2013-12-31,8474900.0,49.7400016784668,50.08000183105469,49.52999877929688,50.04999923706055,41.05561065673828,MRK,"Merck & Co., Inc. (MRK): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report",0,0.48778254
2014-01-03,6435000.0,49.4900016784668,50.0,49.459999084472656,49.72999954223633,40.79312515258789,MRK,Positive Data on Amgen's Romosozumab - Analyst Blog,1,0.53914285
2014-01-06,9931400.0,49.810001373291016,50.13999938964844,49.5099983215332,49.7400016784668,40.80133056640625,MRK,Looking At China's Importance For Pfizer As The Diflucan's Imports Hit A Bump,1,0.5173935
2014-01-08,13695700.0,50.09999847412109,50.13999938964844,49.59999847412109,49.790000915527344,40.84233856201172,MRK,"AZN and Horizon Discovery Ink Deal - Analyst Blog ||| UPDATE: Novartis Could Swap Its Animal-Health, Human Vaccines Units for Merck's OTC Health-Products Unit ||| Bloomberg Reporting Novartis Said to Be in Talks with Merck on $5B Unit Swap ||| Merck Receives FDA Approval for Isentress for Pediatric",0,0.51053107
2014-01-09,9323900.0,49.81999969482422,50.0,49.34000015258789,49.52000045776367,40.62086486816406,MRK,Forest Labs Soars on Aptalis Deal - Analyst Blog,1,0.5254952
2014-01-10,8143100.0,49.83000183105469,50.06999969482422,49.5,49.880001068115234,40.91616821289063,MRK,Merck Gets FDA Approval For New Formulation Of Isentress As It Continues To Focus On Anti-Infectives,1,0.53269523
2014-01-13,37291300.0,50.900001525878906,53.43999862670898,50.790000915527344,53.119998931884766,43.57391357421875,MRK,"Bulls hang on with surge in Merck ||| Midday Update: Stocks Settling Into Narrow Range Prior to Earnings, December Retail Sales Reports This Week ||| Wall Street Loses Momentum As Stocks Flatline; Transports Firm On Cheap Fuel ||| Mid-Morning Market Update: Markets Open Lower; Lululemon Lowers Q4 Outlook ||| Pipeline Update at Alnylam - Analyst Blog ||| Dow Gives Up 179 Points Amid Tapering Remarks, Goldman Downgrade ||| Mid-Afternoon Market Update: Markets Dip Despite Large Amount of M&A ||| Closing Update: Stocks Turn Negative on Taper Uncertainty, Worries Over Retail Sales, Earnings ||| Benzinga's M&A Chatter for Monday January 13, 2014 ||| Market Wrap For January 13: Markets Showing Weakness Ahead Of Major Earning Releases ||| Mid-Afternoon Market Update: Markets Dip Despite Large Amount of M&A ||| Mid-Day Market Update: SodaStream Drops After Weak Outlook; Beam Shares Spike Higher ||| Mid-Morning Market Update: Markets Open Lower; Lululemon Lowers Q4 Outlook ||| Morning Market Movers ||| Merck Initiates Rolling Submission to FDA of US Biologics License Application for MK-3475 ||| Merck Begins Enrollment of BLA for MK-3475, Sees Completing Application in 1H'14 ||| Benzinga's Top #PreMarket Gainers",0,0.47345302
2014-01-14,21190700.0,52.52999877929688,53.09999847412109,52.16999816894531,53.0,43.47547912597656,MRK,"Merck Voluntarily Recalls All Lots of Liptruzet, Cites Packaging Defects",0,0.48615542
2014-01-15,10488000.0,52.650001525878906,52.900001525878906,52.34999847412109,52.52000045776367,43.08174133300781,MRK,Strategy Update from Merck - Analyst Blog ||| Merck Pleased with FDA Advisory Committee Recommendation for Approval of Vorapaxar ||| Market Wrap For January 15: Bulls Take Over As Economic Growth Remains Healthy ||| Bloomberg First Word Reporting Merck Has Won FDA Advisory Panel Support for Vorapaxar,0,0.5293983
2014-01-17,16758800.0,52.619998931884766,52.650001525878906,51.720001220703125,51.95000076293945,42.61417007446289,MRK,"After Hours Most Active for Jan 17, 2014 : AAL, AKS, ABMD, LLTC, QQQ, MRK, RF, FUL, GRT, TROW, TJX, MSFT ||| Johnson & Johnson To See Strong Growth In Drugs Sales",0,0.5125294
2014-01-22,10653600.0,51.77000045776367,51.97999954223633,51.27999877929688,51.34999847412109,42.12199020385742,MRK,Drugmaker Merck Tries To Jump-Start Slow Growth,1,0.51988006
2014-01-24,18261300.0,51.27000045776367,52.16999816894531,51.130001068115234,51.97999954223633,42.638771057128906,MRK,Amgen Reports Positive Evolocumab Data - Analyst Blog ||| Merck Shares Higher Following Bristol-Myers' Phase 3 Disappointment,1,0.5239866
2014-01-27,31002000.0,52.86000061035156,54.09999847412109,52.52999877929688,52.52999877929688,43.08993911743164,MRK,"Market Wrap For January 27: China Concerns, Declining Home Sales, Tomorrow's Fed Meeting and Obama's Speech Keep Markets Lower ||| Winter's Stock Knockdown May Give Way To A Spring Thaw ||| UPDATE: Merck Upgraded by Morgan Stanley on Oncology Optimism ||| Stocks Hitting 52-Week Highs ||| Benzinga's Top Upgrades ||| US Stock Futures Gain Ahead Of Home-Sales Data ||| Morgan Stanley Upgrades Merck & Company, Inc. to Overweight, Announces $60.00 PT",1,0.48744193
2014-01-29,19346100.0,52.70000076293945,52.84000015258789,51.77999877929688,52.209999084472656,42.827449798583984,MRK,Johnson & Johnson Is Going Strong,1,0.528425
2014-01-31,16290000.0,53.310001373291016,53.47999954223633,52.7599983215332,52.970001220703125,43.450870513916016,MRK,Market Wrap For January 31: Markets End January On Sour Note ||| Reuters Reporting Merck Consumer Health Unit Could Get $8-10B in Sale,0,0.5112073
2014-02-03,15488600.0,52.90999984741211,53.150001525878906,51.91999816894531,52.08000183105469,42.72080993652344,MRK,"Earnings Expectations For The Week Of February 3: GM, Twitter, Disney And More ||| Merck Receives Canadian Approval of Grastek ||| Earnings Expectations For The Week Of February 3: GM, Twitter, Disney And More",1,0.51378477
2014-02-04,18181900.0,52.59000015258789,53.52000045776367,52.400001525878906,53.5099983215332,43.893821716308594,MRK,"US Stocks Work Off Short-Term Oversold Conditions ||| Stocks Post Modest Recovery, While the VIX Takes a Plunge ||| Closing Update: Selling Subsides As Stocks Advance on Bargain Hunting, Upbeat Earnings ||| Stocks Snap Back, Helped by Dip Buying, Upbeat Earnings ||| Pre-Market Earnings Report for February 5, 2014 : MRK, TWX, ADP, AGN, CTSH, EL, HUM, MMP, CCE, RL, GRA, LVLT ||| Merck Rallies Back ||| SunTrust Robinson Humphrey Upgrades Merck & Company, Inc. to Buy",1,0.4862648
2014-02-05,24506300.0,54.27999877929688,55.20000076293945,53.13999938964844,53.52999877929688,43.91023254394531,MRK,"Merck Misses on Earnings by a Penny - Analyst Blog ||| Sector Update: Healthcare ||| Market Wrap For February 5: Markets Unsure Of Which Direction To Take ||| Merck Retreats From Highs ||| Top Trending Tickers On StockTwits For February 5 ||| Stocks Hitting 52-Week Highs ||| Benzinga's Top #PreMarket Gainers ||| UPDATE: Merck Posts Drop In Q4 Profit ||| Merck & Company, Inc. Sees FY2014 EPS $3.35-3.53 vs $3.47 Est; Sees Sales $42.40B-43.20B vs $43.54B Est ||| US Stock Futures Flat; All Eyes On ADP Report ||| Merck & Company, Inc. Reports Q4 Adjusted EPS of $0.88, Inline; Revenue of $11.32B vs $11.36B Est ||| Pfizer Confirms Collaboration with Merck on Innovative Anti-Cancer Combination Studies ||| Incyte Confirms Clinical Trial Collaboration with Merck to Evaluate Combination of Two Novel Immunotherapies ||| Merck Confirms Collaborations with Amgen, Incyte and Pfizer to Evaluate Novel Combination Anti-cancer Regimens with MK-3475 ||| Amgen,Merck Announce Collaboration to Evaluate Investigational Combination Treatment for Advanced Melanoma ||| Earnings Scheduled For February 5, 2014 ||| Stocks To Watch For February 5, 2014",1,0.4916664
2014-02-06,12244800.0,53.2599983215332,53.869998931884766,52.79999923706055,53.77000045776367,44.10710525512695,MRK,"USMV, MRK, LMT, ADP: ETF Inflow Alert ||| Bloomberg Reporting Merck Said to Agree to Pay $100M Related to NuvaRing Settlement ||| #PreMarket Primer: Thursday, February 6: Markets Taking A Breather After Twitter Earnings",1,0.49668768
2014-02-07,14497100.0,53.650001525878906,54.81999969482422,53.43999862670898,54.77000045776367,44.92739868164063,MRK,"Earnings Miss at AstraZeneca, Outlook Disappoints - Analyst Blog ||| Loss at Theravance Wider Than Expected - Analyst Blog ||| Actavis, Valeant, Jazz: New Roles For Specialty Pharma ||| Market Wrap For February 7: Jobs Report Not Great, But Not Too Bad ||| Bloomberg Reporting Merck Has Reached Agreement in Principle to Resolve Suits Related to NuvaRing",1,0.49027982
2014-02-10,10609600.0,54.290000915527344,55.0,54.220001220703125,54.88999938964844,45.02582550048828,MRK,"Vanguard Health Care Fund's Top Five ||| Three ETFs To Buy On The Pullback (PJP, SKYY, SPY) ||| Merck, Samsung Bioepis Announce Deal to Develop Insulin Glargine Candidate",1,0.5224162
2014-02-12,13629700.0,55.43999862670898,55.68999862670898,54.84999847412109,55.0,45.11607360839844,MRK,Marginal Earnings Beat at Hospira in Q4 - Analyst Blog ||| Merck Finds Resistance,1,0.5268456
2014-02-14,8681900.0,54.95000076293945,55.619998931884766,54.95000076293945,55.43999862670898,45.47697830200195,MRK,"IWB, BRK-B, MRK, KO: Large Outflows Detected at ETF",1,0.52127725
2014-02-20,10133100.0,55.11000061035156,56.0,55.02999877929688,55.810001373291016,45.7805061340332,MRK,"Agenus: Acquisition Of 4-Antibody Is A Transformational Move ||| HB Reporting (via Bloomberg) Merck is Still Interested in More Purchases in the Pharma Group ||| Merck Testing Multi-Year Highs ||| Merck Reports FDA Acceptance for Review of BLA for V503 ||| FDA Accepts for Review Merck's Biologics License Application for V503, Investigational 9-valent Human Papillomavirus Vaccine",1,0.5280217
2014-02-21,11666600.0,55.84999847412109,56.34000015258789,55.81999969482422,56.02999877929688,45.96097183227539,MRK,"USMV, IFSM: Big ETF Outflows ||| The Way Forward As Merck Continues To Face Pricing And Competitive Pressure",1,0.5106001
2014-02-24,11012500.0,55.869998931884766,56.91999816894531,55.869998931884766,56.18000030517578,46.08400344848633,MRK,"Interesting October Stock Options for MRK ||| Oncology, Streamlined R&D Will Help Pfizer Going Forward",0,0.49044204
2014-02-25,8514500.0,56.130001068115234,56.38999938964844,55.79999923706055,55.90999984741211,45.86251831054688,MRK,"Notable ETF Inflow Detected - IVW, QCOM, KO, MRK ||| Standard Review for Merck's V503 - Analyst Blog",1,0.5275517
2014-02-26,10139500.0,56.0,56.45000076293945,55.91999816894531,56.27000045776367,46.15782928466797,MRK,"Daily Dividend Report: MO, MRK, ESV, LINE, GCI ||| ARIAD's Q4 Loss Narrower-Than-Expected - Analyst Blog",1,0.51897615
2014-02-27,9055500.0,56.2400016784668,56.66999816894531,56.0,56.65999984741211,46.47774505615234,MRK,"Merck Becomes #21 Most Shorted Dow Stock, Replacing Microsoft",1,0.51885796
2014-02-28,11886600.0,56.72999954223633,57.459999084472656,56.650001525878906,56.9900016784668,46.74843978881836,MRK,"Overvaluing Liquidity: Invest For The Future, Not For Today ||| CHMP Issues Positive Opinion For Tablet Formulation Of Merck's NOXAFIL",0,0.5146296
2014-03-03,9821800.0,56.09999847412109,56.77000045776367,55.95000076293945,56.41999816894531,46.2808723449707,MRK,"One Put, One Call Option To Know About for Merck ||| GuruFocus Names Five Dividend Growers ||| The Top Five Dow Stocks In February",1,0.4995563
2014-03-04,10995900.0,57.040000915527344,57.38999938964844,56.90999984741211,57.060001373291016,46.80586624145508,MRK,"Merck Issues Results from Phase 2b Study of MK-8237, Says Secondary Efficacy Endpoints Average TNSS, DU Made Significant Dose, Time Dependent Reduction ||| Biotechs vs. Pharmaceuticals: What's the Difference?",0,0.47991985
2014-03-05,9042300.0,57.400001525878906,57.43999862670898,56.52000045776367,56.880001068115234,46.65821838378906,MRK,"Notable ETF Inflow Detected - IVW, QCOM, KO, MRK ||| Bull of the Day: Quintiles (Q) - Bull of the Day ||| Merck Announces MK-1439 Shows Antiviral Activity in Phase 2b Trial, Co. Planning to Initiate Phase 2 Development Program During 2H'14 ||| UPDATE: Merck Plans to Initiate Phase 3 Clinical Development Program In Second Half Of 2014 ||| Merck's Investigational HIV Therapy, Doravirine (MK-1439), Demonstrates Antiviral Activity in Phase 2B Study of Treatment-Naïve Adults",1,0.50608104
2014-03-06,10605700.0,57.060001373291016,57.650001525878906,57.0099983215332,57.2599983215332,46.96992492675781,MRK,Pipeline Progress at Bristol-Myers - Analyst Blog ||| Merck Trading Higher,1,0.5233399
2014-03-07,10634200.0,57.34999847412109,57.56999969482422,57.09999847412109,57.470001220703125,47.14217376708984,MRK,Top Owned Health Care Stocks of the Fourth Quarter,0,0.5188103
2014-03-10,7383200.0,57.43999862670898,57.619998931884766,57.0,57.31999969482422,47.019134521484375,MRK,"One Put, One Call Option To Know About for Merck & Co.",0,0.49947327
2014-03-12,9498300.0,56.38999938964844,56.93000030517578,56.2599983215332,56.810001373291016,46.60078048706055,MRK,"Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for March 13, 2014 ||| Merck Unchanged",0,0.4786031
2014-03-13,10120000.0,56.61000061035156,56.790000915527344,55.720001220703125,55.790000915527344,46.12130355834961,MRK,"Notable ETF Inflow Detected - IWB, BRK.B, MRK, KO",0,0.4985962
2014-03-14,12117800.0,55.52999877929688,56.02000045776367,55.27000045776367,55.70000076293945,46.046905517578125,MRK,Why Berkshire Owns $2.5 Billion of DVA Stock ||| UPDATE: FDA Approves Merck Noxafi Injection for IV Use ||| FDA Approves Merck Noxafi Injection for Intravenous Use,1,0.517635
2014-03-17,9509400.0,55.95000076293945,56.45000076293945,55.95000076293945,56.2599983215332,46.50984573364258,MRK,Ligand Pharma Announces $1M Milestone Payment Triggered Following FDA Approval of Merck's Noxafil,1,0.53652406
2014-03-19,10048400.0,56.68000030517578,56.90999984741211,55.63999938964844,55.9900016784668,46.28664779663086,MRK,"Dow Movers: MSFT, UNH",0,0.5067213
2014-03-21,23424900.0,56.5,56.59999847412109,54.619998931884766,54.65999984741211,45.1871452331543,MRK,"Midday Update: Wall Street Resumes Bull Trend, Shrugs off Yellen and Geo-Political Concerns ||| Notable ETF Inflow Detected - OEF, BRK.B, MRK, KO ||| Closing Update: Markets Drift Lower in Afternoon Swoon; Bullard Comments Reinforce Bearish Mood ||| Healthcare Stocks Mixed at Mid-Day; Endocyte Nearly Doubles In Price On Chemotherapy Test Results ||| Sector Update: Healthcare ||| Mid-Day Market Update: Nike Drops On Cautious Forecast; Endocyte Shares Spike Higher ||| ""Premarket Prep"" Technical Update - Merck Trading Lower After Higher Open ||| Mid-Morning Market Update: Markets Open Higher; Tiffany Posts Downbeat Earnings ||| Benzinga's Volume Movers ||| UPDATE: Endocyte Shares Rise 158% ||| UPDATE: Endocyte Shares Rise 91% on European CHMP Positive Opinions for VYNFINIT ||| PREVIEW: Endocyte to Resume Trading at 8:30AM ET ||| Benzinga's Top #PreMarket Gainers ||| Merck, Endocyte Announce European CHMP Positive Opinions for VYNFINIT, Companion Agents FOLCEPRI, NEOCEPRI",0,0.47979492
2014-03-24,15500800.0,54.86000061035156,54.86000061035156,53.56999969482422,53.77999877929688,44.45964813232422,MRK,"Johnson & Johnson's Sale Of K-Y Brand To Reckitt Benckiser Confirms Focus on Pharma ||| Reckitt Benckiser a Frontrunner for Merck's OTC Segment, Sanofi Rumored to Join Bidders, Final Bids Are Due Next Week - Bloomberg ||| Google Honors Activist Dorothy Height & Her Contributions",1,0.49551916
2014-03-25,14115700.0,53.880001068115234,55.47999954223633,53.810001373291016,55.18999862670898,45.62528991699219,MRK,"Tetraphase's Eravacycline Holds Promise - Analyst Blog ||| Dow Movers: WMT, CAT",1,0.50497377
2014-03-26,13073600.0,55.43000030517578,56.459999084472656,55.38999938964844,56.02000045776367,46.31145095825195,MRK,"Small-Caps Lead the Laggards as Intraday Volatility Continues ||| Recent Trials Could Help Pfizer Solidify Its Dominance In Pneumococcal Vaccine Market ||| Dow Movers: PG, MRK ||| Nanobio Announces Licensing Agreement With Unit of Merck for Use of its Nanoemulsion Adjuvant Technology ||| Nanobio Announces Licensing Agreement With Unit of Merck for Use of its Nanoemulsion Adjuvant Technology",0,0.51134545
2014-03-27,11123800.0,55.88999938964844,56.11000061035156,55.33000183105469,55.72999954223633,46.07170486450195,MRK,"Dow Movers: DIS, PG ||| Dow Analyst Moves: MRK ||| Merck Announces Appointment of Robert M. Davis as Chief Financial Officer; Succeeds Peter N. Kellogg, Who Has Served in the Role Since 2007 ||| Merck Names Robert Davis as CFO, Succeeding Peter Kellogg",1,0.4940439
2014-03-31,14181200.0,56.09000015258789,56.84000015258789,56.040000915527344,56.77000045776367,46.93146514892578,MRK,Interesting January 2016 Stock Options for MRK ||| iShares S&P 100 ETF Experiences Big Inflow ||| Endocyte Prices New Offering at $21 Per Share - Analyst Blog,0,0.5081458
2014-04-01,7715400.0,56.650001525878906,56.84000015258789,56.0099983215332,56.369998931884766,46.60077667236328,MRK,What If Merck Challenges Gilead Sciences In Hepatitis C Market?,1,0.5250843
2014-04-02,7060000.0,56.47999954223633,56.560001373291016,56.04999923706055,56.459999084472656,46.67518615722656,MRK,Why Ukraine's Gas Might Be the Most Profitable Gas in the World,0,0.48780912
2014-04-03,8313100.0,56.52999877929688,56.75,55.95000076293945,56.209999084472656,46.46851348876953,MRK,Stocks Pause Ahead of Big NFP Day,0,0.5093959
2014-04-04,10412800.0,56.61000061035156,56.720001220703125,56.09000015258789,56.119998931884766,46.39410781860352,MRK,Merck Shares Volatile This Afternoon; Reuters Earlier Reported Co. is Seeing Resistance from Beef Industry for Test of Zilmax on 200K+ Cattle,0,0.5020413
2014-04-07,11426300.0,55.369998931884766,56.15999984741211,55.02999877929688,55.18999862670898,45.62528991699219,MRK,Merck Presents Early Findings from MK-3475 Treatment at AARC 2014 ||| Amgen's Oncology Candidate Disappoints - Analyst Blog,0,0.52052176
2014-04-08,10766800.0,55.27999877929688,55.61000061035156,54.70000076293945,55.040000915527344,45.501277923583984,MRK,"EPO Upholds Alnylam's McSwiggen Patent - Analyst Blog ||| Update on Merck's MK-3475 - Analyst Blog ||| Biotechs Struggling To Find A Bottom ||| Express Scripts Reports Spending on Hepatitis C Medications in US to Rise 1,800% by 2016",1,0.5461819
2014-04-09,16108500.0,55.220001220703125,57.150001525878906,55.20000076293945,57.09999847412109,47.20426559448242,MRK,"Dow Movers: T, MRK ||| Stocks Soar After Fed Minutes; Dow Jumps 181 Points",0,0.50178725
2014-04-10,18018500.0,57.88999938964844,58.13999938964844,55.77999877929688,55.84999847412109,46.1708984375,MRK,"Noteworthy ETF Inflows: VTV, BRK.B, T, MRK ||| Bill Nygren Comments on Merck ||| Merck Up on Encouraging HCV Data - Analyst Blog ||| When It Comes To Drug Stocks, Do Not Always Buy The News ||| US Stock Futures Edge Lower Ahead Of Jobless Claims Data ||| Merck Announces Results from Studies Evaluating MK-5172 and MK-8742 Investigational Hepatitis C Treatments,",1,0.50101846
2014-04-11,13631700.0,55.54999923706055,56.59999847412109,55.29999923706055,55.91999816894531,46.22877502441406,MRK,"Dow 30 Stock Roundup: Pfizer Drug Trial Dents, P&G Ups Dividend - Analyst Blog ||| Top 40 Upcoming Earnings Releases ||| Google Honors Chemist Percy Julian & His Contributions ||| US Stock Futures Slip Ahead Of Consumer Sentiment Report ||| Phase 2 Trial of Merck's Investigational Chronic Hepatitis C Combination Therapy MK-5172/MK-8742 Demonstrates Antiviral Activity",0,0.49007973
2014-04-14,10787000.0,56.220001220703125,56.72999954223633,54.95000076293945,55.56999969482422,45.9394416809082,MRK,"Hard-to-Cure Patients May Benefit from Merck's HCV Drug - Analyst Blog ||| Roche's Competitive Advantage ||| Merck Announces FDA Has Approved Grastek Sublingual Tablet for Treatment of Grass Pollen-Induced Allergic Rhinitis ||| Market Wrap For April 14: Markets Surge on Positive Retail Data, Citi Earnings ||| Markets Falling? Get Your Defense Ready ||| No Legwork Mondays – Merck And Vioxx",1,0.49068302
2014-04-15,11142900.0,55.790000915527344,56.310001373291016,55.11000061035156,56.04999923706055,46.33624267578125,MRK,Sector Update: Healthcare Shares Higher Pre-Market; FDA Approves Merck's Grastek Tablet ||| Sector Update: Healthcares ||| Eli Lilly/ Boehringer Drug Under FDA Review - Analyst Blog ||| FDA Nod for Merck's Grastek - Analyst Blog,1,0.5369676
2014-04-17,11263700.0,56.45000076293945,57.0,56.27000045776367,56.470001220703125,46.68345642089844,MRK,FDA Clears Merck's Ragwitek,1,0.5329714
2014-04-21,6231000.0,56.560001373291016,57.29999923706055,56.400001525878906,57.25,47.32827758789063,MRK,The Top 21 African-American CEOs In Business,1,0.5362382
2014-04-23,7736100.0,57.75,57.77000045776367,57.08000183105469,57.5,47.53495407104492,MRK,"Noteworthy ETF Outflows: PJP, LLY, MRK, AMGN ||| #Premarket Technical Update -Merck Trading Lower ||| Bill Ackman Talks Partnership With Valeant For Allergan Deal",1,0.5069009
2014-04-24,6714800.0,57.31999969482422,57.81999969482422,56.84999847412109,57.52999877929688,47.55974960327149,MRK,"Market Wrap For April 24: Apple's Smashing Earnings Overshadowed By Ukraine Concerns ||| Fitch Affirms Merck's LT IDR at A+; Outlook Negative ||| Bank of America Maintains Buy on Merck & Company, Inc., Raises PT to $62.00",0,0.47995353
2014-04-25,6227700.0,57.52999877929688,57.68000030517578,57.02000045776367,57.2400016784668,47.32000732421875,MRK,Benzinga Weekly Preview: Earnings Season Continues As Biotech & Pharmaceutical Companies Report ||| 3 Ways To Profit From Merger Activity In The Pharmaceutical Sector,0,0.51794434
2014-04-28,16992200.0,57.61000061035156,57.84999847412109,56.47999954223633,56.68000030517578,46.857059478759766,MRK,"Reuters Reports Merck in Talks to Sell Consumer Health Unit to Bayer, Reckitt Benckiser for Approximately $14B, According to Sources ||| Benzinga's Weekend M&A Chatter ||| Earnings Expectations For The Week Of April 28: Big Oil, Big Pharma And More ||| After Hours Most Active for Apr 28, 2014 : MRK, SPLS, BAC, SIRI, RF, C, MSFT, ATLS, SCHW, INTC, CMCSA, CSCO ||| Will Merck (MRK) Disappoint This Earnings Season? - Analyst Blog ||| Pre-Market Earnings Report for April 29, 2014 : MRK, BMY, LYB, BP, ETN, S, VLO, ADM, CMI, FRX, HCA, PCAR ||| Market Wrap For April 28: Apple Hits New 52-Week Highs In a Volatile Start To the Trading Week ||| Reckitt Benckiser Confirms Talks With Merck Regarding Bid for Consumer Health Business, Bayer Also Rumored Bidder ||| Agenus Announces License Deal with Merck Related to Novel Checkpoint Antibody-Based Cancer Immunotherapies, Eligible for ~$100M in Milestone Payments",1,0.5086463
2014-04-29,13661500.0,57.5,58.86000061035156,57.27000045776367,58.720001220703125,48.54352188110352,MRK,"A Cloudy Earnings Picture - Ahead of Wall Street ||| Midday Update: Upbeat Earnings Take Center Stage as Markets Extend Gains ||| Stocks Grind Higher As Corporate Profits Encourage Investors ||| Dow Movers: PFE, MRK ||| Sector Update: Healthcare ||| Merck Tops Q1 Earnings Expectations, Affirms Outlook - Analyst Blog ||| US Futures Gain Amid Quarterly Results; Fed's Two-Day Policy Meeting Starts ||| Stocks Continue to Bounce Back; Dow Approaches New-High Territory ||| US Futures Gain as Quarterly Results Beat Views; Home Prices Gain as Expected ||| Market Wrap For April 29: Dow Approaches Record Highs Despite Ongoing Ukraine Tension and Upcoming Fed Meeting ||| Mid-Afternoon Market Update: Markets Show Strength as Prothena Shares Plummet ||| Bids for Merck Consumer-Health Unit Said to Be Over $14B, Bayer Looking to Weigh JV with Merck as Part of Offer - Bloomberg ||| #Premarket Technical Update -Merck Trading Higher ||| Mid-Day Market Update: Coach Slips After Q3 Results; Orbital Shares Spike Higher ||| Mid-Morning Market Update: Markets Rise; Merck Earnings Beat Street View ||| UPDATE: Merck Posts Upbeat Q1 Profit ||| #PreMarket Primer: Tuesday, April 29: US Steps Up Sanctions Against Russia ||| Merck & Company, Inc. Reports Q1 EPS of $0.88 vs $0.79 Est; Revenue of $10.30B vs $10.44B Est; Reaffirms Outlook",0,0.5023359
2014-04-30,13560400.0,58.5099983215332,59.0,58.02000045776367,58.560001373291016,48.4112434387207,MRK,"Hospira Beats on Earnings & Sales, View Maintained - Analyst Blog ||| #Premarket Prep Technical Update - Merck Trading Lower ||| Reckitt Benckiser Confirms it is No Longer in Talks with Merck Regarding Bid for Consumer Health Business ||| #PreMarket Primer: Wednesday, April 30: No BOJ Stimulus On The Horizon",1,0.50812167
2014-05-01,11724500.0,58.54999923706055,59.84000015258789,58.54999923706055,59.619998931884766,49.28754425048828,MRK,"Dow Movers: MCD, V ||| VV, XOM, JNJ, MRK: ETF Inflow Alert ||| Stocks End Mixed, as Traders Express Caution Ahead of Jobs Number ||| Healthcare Stocks Holding Small Gains; Merck Hits 52-Week High As Talks With Bayer Heat Up ||| Sector Update: Healthcare ||| Benzinga's M&A Chatter for Thursday May 1, 2014 ||| Bayer Could Be Preparing ~$14B Bid for Merck's Consumer Unit - Bloomberg",0,0.49793595
2014-05-02,12079300.0,59.470001220703125,59.52999877929688,57.93999862670898,58.220001220703125,48.13018035888672,MRK,"Dow 30 Stock Roundup: Microsoft, Merck, Exxon Beat, JNJ Ups Dividend - Analyst Blog ||| Blue Chips Snag Weekly Win Despite Losing Session ||| Market Wrap For May 2: Markets Slip On Ukraine Tensions Despite Positive Jobs Data ||| Sanofi, Merck Rumored to Each Weigh Sale of Mature-Drug Portfolios - Bloomberg ||| #Premarket Preo Technical Update - Merck Trading Lower ||| Endocyte to Resume Trading at 8:30 AM ET ||| Merck Endocyte Announce Independent DSMB Recommends Vintafolide PROCEED Phase 3 Trial Be Stopped for Futility Following Interim Analysis ||| Merck, Endocyte Report DSMB Has Recommended Vintafolide Trial Be Suspended, Cites Trial Not Showing Efficacy",1,0.5022363
2014-05-05,8135000.0,58.11000061035156,58.66999816894531,57.75,58.630001068115234,48.469120025634766,MRK,"ETF Outlook For The Week Of May 5, 2014 (NGE, XLU, USMV, JJN) ||| Will Pfizer's Q1 2014 Earnings Beat the Street on May 5, 2014? ||| ETF Outlook For The Week Of May 5, 2014 (NGE, XLU, USMV, JJN)",0,0.4555817
2014-05-06,13838300.0,58.75,58.77000045776367,57.040000915527344,57.11000061035156,47.21253967285156,MRK,"How Will Pfizer Treat These Healthcare ETFs? - ETF News And Commentary ||| Futures Defensive As Momentum Loses Steam; Merck Sells Consumer Business To Bayer ||| The Tech Sector Leads the Market Into the Red ||| Market Wrap For May 6: Dow Suffers Triple-Digit Point Loss, Nasdaq Underperforms Once Again ||| #Premarket Prep Technical Update - Merck Trading Sharply Lower ||| Fitch Says Merck Consumer Business Sale Improves Its Core Focus ||| Merck Says Global Cancer Sales Could Reach $120B by 2020 ||| Merck CEO Says Would be Interested in Acquiring Animal Health Brands with the Right Products at the Right Price -Reuters ||| Merck Says May Look to M&A For Biotech Expansion- Bloomberg ||| UPDATE: Merck Highlights Strategic Initiative ||| Merck Offers Details of Plans to File Odanacatib for Osteoporoisis in 2H, Will Continue to Explore Ways to Augment Animal Health Unit ||| Merck Announces FDA Acceptance for Review of MK-3475 ||| US Stock Futures Flat Ahead Of International Trade Data ||| Merck Announces Sale of Consumer Care Business to Bayer for $14.2B ||| Bayer to Buy Merck Consumer Care Ops for $14.2B",0,0.47647324
2014-05-07,22909900.0,56.18999862670898,56.84999847412109,55.52000045776367,55.84000015258789,46.16263961791992,MRK,Bayer to Purchase Merck's Consumer Division - Analyst Blog ||| Merck Banks On R&D Pipeline And Immunology Drugs As Pricing Pressure Grows ||| Market Wrap For May 7: Dow Banks Triple-Digit Point Gain While Nasdaq Closes Lower ||| #Premarket Technical Update - Merck Trading Lower ||| Merck Shares Tumble 2+% Following Morgan Stanley Downgrade,0,0.51475465
2014-05-08,14371400.0,55.54999923706055,55.7599983215332,54.720001220703125,54.83000183105469,45.32768249511719,MRK,"Dow Movers: CVX, T ||| After Hours Most Active for May 8, 2014 : LLY, BAC, QQQ, MSFT, ATML, RVT, MCP, SIRI, MRK, NEE^O, FB, OREX ||| Reversal of Fortune: Stocks Start Strong, Finish Weak ||| #Premarket Prep Technical Update - Merck Trading Lower Again ||| This Morning BMO Capital Downgraded Merck & Company to Market Perform, Lowered PT to $60.00 ||| Merck Announces Results Show Letermovir In CMV-Seropositive Allogeneic Human Blood Precursor Cell Recipients Met Study's Two Primary Efficacy Endpoints",1,0.47722793
2014-05-12,8085000.0,55.619998931884766,55.619998931884766,54.84999847412109,55.290000915527344,45.70795822143555,MRK,UPDATE: Merck Reports FDA Okay of Zontivity ||| Merck Reports FDA Okay o f Zontivity,1,0.52761066
2014-05-13,8959000.0,55.310001373291016,56.060001373291016,55.20000076293945,55.75,46.08823776245117,MRK,"US Stock Futures Up Ahead Of Retail Sales Report ||| Merck to Sell Ophthalmology Products in Japan, Key Markets in Europe and Asia Pacific to Santen for $600M Upfront Payment",1,0.53528655
2014-05-14,7797500.0,55.630001068115234,56.560001373291016,55.630001068115234,56.369998931884766,46.60077667236328,MRK,"Dow Movers: IBM, MRK ||| Merck Continues to Divest Ophthalmology Products - Analyst Blog ||| Dow Snaps Five-Day Winning Streak, S&P 500 Faces Resistance ||| Despite Disappointing Performance, Pfizer Pins Its Hope On These Drugs ||| Merck VP Schechter Sells 10,527 Shares @$55.91/Share -Form 4 ||| R&D Tax Credit Passed In The House, Faces Challenges Ahead ||| The 5 Most Overvalued Dow Stocks ||| New Data on Merck's Investigational Anti-PD1 Antibody, MK-3475 to be Presented at ASCO 2014",0,0.4828699
2014-05-16,9062000.0,55.65999984741211,56.2599983215332,55.65999984741211,55.869998931884766,46.187442779541016,MRK,"Chimerix Announces Has Regained Worldwide Rights to CMX157 from Merck, Says Co. Will No Longer Pursue Development",1,0.5353243
2014-05-19,7519300.0,55.7400016784668,56.369998931884766,55.619998931884766,56.34999847412109,46.58424377441406,MRK,"Merck, Endocyte Report Withrdrawal of Conditional Marketing Authorization for Vintafolide, Companion Imaging from EMA",0,0.49659944
2014-05-20,7855900.0,56.220001220703125,56.2599983215332,55.72999954223633,56.0,46.29490661621094,MRK,Merck Reports Animal Health Has Announced FDA Approval of BRAVECTO,1,0.53287286
2014-05-22,7178000.0,56.400001525878906,56.77999877929688,56.040000915527344,56.4900016784668,46.69999313354492,MRK,"Dow Movers: MRK, BA ||| Medtronic Earnings Drags Medical Device ETF Lower - ETF News And Commentary",1,0.51617736
2014-05-23,6053000.0,56.630001068115234,56.97999954223633,56.45000076293945,56.810001373291016,46.96452713012695,MRK,Celgene Gains Slightly on Management Changes - Analyst Blog ||| #Premarket Technical Update - Merck Trading Higher,0,0.49591482
2014-05-27,7301800.0,56.93000030517578,57.040000915527344,56.470001220703125,56.68999862670898,46.86532211303711,MRK,"Daily Dividend Report: MRK, OCR, TEX, SFL, EXR ||| Sector Update: Healthcare ||| Healthcare Stocks Locking in Gains Late; Merck Keeps Quarterly Dividend Unchanged at $0.44 Per Share ||| Notable ETF Outflow Detected - XLV, MRK, AMGN, BMY",0,0.484088
2014-05-29,8513700.0,56.90999984741211,57.790000915527344,56.59999847412109,57.70000076293945,47.70029067993164,MRK,"Dow Movers: CSCO, MRK ||| #Premarket Prep Technical Update - Merck Trading Higher",1,0.49811962
2014-05-30,11519000.0,57.52000045776367,58.27000045776367,57.52000045776367,57.86000061035156,47.83256149291992,MRK,"Weekly Market Wrap: May 30, 2014 ||| Merck Announces Generic Name for MK-3475, Pembrolizumab",1,0.53108203
2014-06-02,6425500.0,57.90999984741211,58.20000076293945,57.47999954223633,57.93000030517578,47.89043426513672,MRK,"Merck Presents Early Data for Pembrolizumab in Patients with PD-L1 Positive, Advanced Head and Neck Cancer at ASCO ||| Dow Movers: GS, CAT ||| One Put, One Call Option To Know About for Merck ||| ImmunoCellular Plans To Move ICT-107 Forward Into Phase III Trials Based On New Sub-Group Analysis Presented At ASCO ||| Merck Presents Positive Trial Results For Cancer Drug",0,0.5095457
2014-06-03,7078100.0,57.52000045776367,57.959999084472656,57.369998931884766,57.90999984741211,47.87389373779297,MRK,Dako and Merck Collaborate - Analyst Blog,1,0.5364153
2014-06-04,6875400.0,57.77999877929688,58.0099983215332,57.5099983215332,57.93000030517578,47.89043426513672,MRK,ASCO Meeting Day 4: Risks And Rewards Of Immunotherapy,1,0.53205067
2014-06-05,7640600.0,57.970001220703125,58.470001220703125,57.720001220703125,58.09999847412109,48.03096008300781,MRK,Vanguard Total Stock Market ETF Experiences Big Inflow ||| Merck Announces First Patient in Phase 3 Trial of ISENTRESS Enrolled ||| #Premarket Prep Technical Update - Merck Trading Higher,0,0.47838607
2014-06-06,6703200.0,58.20000076293945,58.2599983215332,57.68000030517578,57.84999847412109,47.82429504394531,MRK,"USMV, ENGN: Big ETF Outflows ||| #Premarket Prep Technical Update - Merck Trading Lower ||| Merck Announces Will Present New Clinical Data on JANUVIA at SSADA",1,0.51846594
2014-06-09,8082900.0,57.4900016784668,57.970001220703125,57.2400016784668,57.93999862670898,47.89869689941406,MRK,"Sector Update: Healthcare ||| Who is Buying Small Caps at P/E 84? - Real Time Insight ||| Sector Update: Mixed Pre-Market As Merck Snaps Up Idenix for $3.85 Bln ||| Sector Update: Healthcare Healthcare ||| Sector Update: Healthcare ||| Healthcare Stocks Extending Losses Late; Achillion Pharma Rallies After Upgrade, Rival's Buyout ||| Dow Movers: MRK, JPM ||| Healthcare Stocks Sinking Again; Growblox Sciences Jumping After Local Authorities OK Las Vegas-Area Dispensary ||| Benzinga's M&A Chatter for Monday June 9, 2014 ||| Market Wrap For June 9: Markets Higher On St. Louis Fed Comments, Low Volume ||| Mid-Afternoon Market Update; Icahn's 9% Stake In Family Dollar, Tyson Foods Wins Bid For Hillshire Brands ||| Are Gilead Shares Overreacting To Merck's Idenix Acquisition? ||| Mid-Day Market Update: Idenix Pharma Surges On Merck Buyout; Pilgrim's Pride Shares Slide ||| Benzinga's Volume Movers ||| Stocks Hitting 52-Week Highs ||| Mid-Morning Market Update: Markets Edge Higher; Tyson Wins Bidding Battle To Buy Hillshire Brands For $63/Share ||| Morning Market Movers ||| UPDATE: Merck Says Dual Therapy of MK-5172, MK-8742 Cures High 90's% of Patients In 12 Weeks; Triple Therapy Could Be More Effective, Faster ||| Hepatitis C Stocks Move After Idenix Rockets Up 235% ||| Merck Research Head Says Combination of Idenix Nucleotide Inhibitor IDX21437, Plus Leading Two Experimental Merck Drugs Could Produce Cures In 4-6 Weeks ||| Benzinga's Top #PreMarket Losers ||| Benzinga's Top #PreMarket Gainers ||| Achillion Pharmaceuticals Shares Rise 38% Premarket on News of Merck-Idenix Deal ||| Shares of Idenix Pharma Now Up 200+% to ~$22 ||| UPDATE: Merck Announces Will Purchase Idenix for $3.85Bn ||| Merck Announces Will Purchase Idenix for $24.50/Share",1,0.50362533
2014-06-10,7663700.0,57.91999816894531,58.5,57.91999816894531,58.4900016784668,48.3533821105957,MRK,"Protein therapeutics biotech Ambrx sets terms for $70 million IPO ||| After Stock Split, is Dow Membership Next for Apple Stock? - Stocks In The News ||| Two Biotech ETFs Surge on Idenix-Merck Deal - ETF News And Commentary ||| Idenix Skyrockets on Merck Acquisition Deal, Focus on HCV - Analyst Blog ||| ETF Outlook For Tuesday, June 10, 2014 (IAT, FXE, PBE, HYHG, IDIX, MRK)",1,0.51220745
2014-06-11,11696800.0,58.52000045776367,59.02999877929688,58.400001525878906,58.810001373291016,48.61792755126953,MRK,"Dow Movers: BA, MRK ||| Biotech ETFs Bounce Back After Three-Month Correction ||| Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for June 12, 2014 ||| Achillion Surges Two Days in a Row, HCV in Focus - Analyst Blog ||| Takeover Whispers Add To Achillion Pharmaceuticals' Momentum",0,0.48601046
2014-06-12,9563900.0,58.27999877929688,58.720001220703125,58.060001373291016,58.29999923706055,48.55961608886719,MRK,"UPDATE: Merck Research Head Says Company Aims to Capture Big Share of Hep C Market, Selling Best Drugs at Fair Cost ||| Merck Research Head Says Company Open to Big Acquisition for Biotech Products -Reuters ||| UPDATE: Bank Of America Reiterates On Merck & Co. On Higher Sales Estimates",0,0.50014436
2014-06-13,8398500.0,58.11000061035156,58.650001525878906,57.97999954223633,58.2400016784668,48.5096435546875,MRK,"Dow Analyst Moves: MRK ||| Noteworthy ETF Inflows: VTI, VZ, T, MRK",0,0.5000112
2014-06-16,7731500.0,58.060001373291016,58.380001068115234,57.72999954223633,58.06999969482422,48.3680419921875,MRK,AbbVie Gets Priority Review from FDA for HCV Treatment - Analyst Blog,0,0.5293771
2014-06-18,7837000.0,58.02999877929688,58.45000076293945,57.810001373291016,58.40999984741211,48.65124130249024,MRK,5-Star Biotech Stock Watch: Synta Pharmaceuticals,0,0.514548
2014-06-19,6011900.0,58.41999816894531,58.41999816894531,58.09999847412109,58.29999923706055,48.55961608886719,MRK,Why I Love The NASDAQ: The Exchange's Top 10 Performers Year To Date,1,0.506808
2014-06-20,14418000.0,58.61000061035156,59.27999877929688,58.43999862670898,58.91999816894531,49.07603454589844,MRK,"Dow Movers: WMT, XOM ||| Sector Update: Healthcare Shares Flat Pre-Market ||| Sector Update: Healthcare ||| Tetraphase Progresses with Eravacycline Late-Stage Study - Analyst Blog ||| Market Wrap For June 20: Yet Again, Dow And S&P 500 Indices Hit New Highs",0,0.47417045
2014-06-23,7054400.0,58.810001373291016,58.97999954223633,58.40999984741211,58.5,48.72620391845703,MRK,"Notable ETF Inflow Detected - VTI, VZ, T, MRK",0,0.5030687
2014-06-24,8158500.0,58.380001068115234,58.7599983215332,57.880001068115234,57.91999816894531,48.243106842041016,MRK,How Will Biotechnology ETFs Finish Out the Year? - ETF News And Commentary,1,0.5109567
2014-06-26,7238300.0,58.7599983215332,58.77000045776367,58.25,58.52999877929688,48.75118637084961,MRK,#Premarket Prep Technical Update - Merck Trading Lower,0,0.48470455
2014-06-27,17285700.0,58.369998931884766,58.52000045776367,57.47999954223633,57.52999877929688,47.91826248168945,MRK,Exclusive: Hepatitis C Stock Valuation With Enanta CEO Jay Luly,1,0.5387967
2014-06-30,8735000.0,57.61000061035156,58.20000076293945,57.52999877929688,57.84999847412109,48.18479919433594,MRK,"Dow Movers: BA, MRK ||| Interesting October Stock Options for MRK ||| Sector Update: Healthcare ||| Sector Update: Healthcare Shares Flat in Pre-Market Trade ||| Merck Announces Investigational Data From Phase 3 Emend ||| US Stock Futures Fall Ahead Of Home Sales Report ||| Merck's Investigational Anti-PD-1 Antibody, Pembrolizumab, Under Regulatory Review by EMA for Treatment of Advanced Melanoma",1,0.51188827
2014-07-01,8838000.0,57.70000076293945,58.63999938964844,57.47999954223633,58.5099983215332,48.73453140258789,MRK,"Vanguard Total Stock Market ETF Experiences Big Outflow ||| Will Merck's Anti-PD-1 Therapy be the First to Launch? - Analyst Blog ||| Bayer Could Keep Scholl's, Coppertone Brands from Merck - Reuters",1,0.5056635
2014-07-02,6941000.0,58.470001220703125,59.09999847412109,58.369998931884766,59.04999923706055,49.18430709838867,MRK,Agenus Up on Positive Prophage Data - Analyst Blog ||| Markets Little Changed Ahead Of 4th Of July Break ||| Barclays Downgrades Pharmaceutical Sector,1,0.5126979
2014-07-03,5220100.0,59.38999938964844,59.45000076293945,59.06999969482422,59.20000076293945,49.30924987792969,MRK,"Merck, Gilead Lead Race To Eradicate Hepatitis C ||| Exclusive: Enanta Pharmaceuticals CEO Jay Luly Discusses Hep C Pipeline",0,0.5078245
2014-07-07,9276200.0,58.90999984741211,59.650001525878906,58.4900016784668,58.52000045776367,48.74287033081055,MRK,Interesting January 2015 Stock Options for Merck ||| Markets Marginally Lower Ahead Of Earnings Season ||| #Premarket Prep Technical Update - Merck Trading Lower,0,0.4915003
2014-07-11,6106800.0,58.650001525878906,58.7400016784668,58.15999984741211,58.43999862670898,48.67621994018555,MRK,Bristol-Myers to Seek U.S. Approval for Immuno-Oncology Drug - Analyst Blog ||| Sector Update: Health Care Stocks Ending Mixed; Achillion Pharmaceutical Easing From M&A-Fueled Afternoon Rally ||| Sector Update: Health Care,0,0.4994845
2014-07-16,6805000.0,57.93999862670898,58.209999084472656,57.72999954223633,58.150001525878906,48.43467330932617,MRK,Roche Gets Priority Review for Avastin Label Expansion - Analyst Blog,0,0.52753407
2014-07-17,6649700.0,57.869998931884766,58.2400016784668,57.56999969482422,57.59999847412109,47.9765625,MRK,"Noteworthy ETF Inflows: VTI, T, IBM, MRK",1,0.51983863
2014-07-21,7095700.0,57.88999938964844,58.18999862670898,57.709999084472656,58.0,48.30973815917969,MRK,Idenix Pharma Shares Spiking Higher following SEC Filing Showing HSR Approval of Purchase by Merck,1,0.533147
2014-07-24,10064200.0,58.31999969482422,58.5,57.91999816894531,58.209999084472656,48.48465347290039,MRK,"Daily Dividend Report: INTC, MRK, V, BLK, AAL ||| Merck Announces Initiation of Phase 3 For Letermovir",0,0.5160076
2014-07-25,5525100.0,58.130001068115234,58.36000061035156,57.91999816894531,58.150001525878906,48.43467330932617,MRK,"Noteworthy ETF Inflows: XLV, MRK, GILD, CELG",0,0.51752186
2014-07-28,8600700.0,58.16999816894531,58.34000015258789,57.84999847412109,57.970001220703125,48.28475189208984,MRK,"Benzinga Weekly Preview: FOMC In Focus As Earnings Season Progresses ||| Earnings Expectations For The Week Of July 28: Exxon, Pfizer, Twitter And Much More ||| Will Merck & Co. (MRK) Surprise This Earnings Season? - Analyst Blog ||| Pre-Market Earnings Report for July 29, 2014 : PFE, MRK, UPS, BP, NEE, ETN, NOV, ITW, ECL, RAI, AET, GLW ||| Markets Little Changed Ahead Of The Federal Reserve's Policy Decision",1,0.49787185
2014-07-29,10328000.0,58.81999969482422,59.27999877929688,58.13999938964844,58.58000183105469,48.79284286499024,MRK,"US Futures Gain Amid Slew Of Corporate Earnings; S&P/Case Shiller Home Price Index Drops Unexpectedly ||| Merck (MRK) Tops Q2 Earnings Expectations on Cost Cuts - Analyst Blog ||| Q3 Estimates Beginning to Slip - Ahead of Wall Street ||| Midday Update: Sanctions Upset Upward Momentum; Stocks Giving Up Most of Consumer Confidence Gains ||| Pharmaceutical ETFs Are Health Care Sector Standouts ||| US Futures Gain In Line With World Markets Amid Upbeat Earnings, Ahead of FOMC Meeting ||| Closing Update: Stocks Turn Broad Lower Late After U.S., Europe Ratchet Up Pressure on Russia ||| Sector Update: Health-Care Shares Buoyant in Pre-Market Trade after Positive Q2 Results from Merck, Pfizer ||| Stocks Lower As Earnings Season Takes Back Seat To Geopolitical Uncertainties ||| Pharmaceutical ETFs Are Health Care Sector Standouts ||| Indices Remain Mixed; Merck Beats Expectations ||| Tuesday Morning Earnings Releases ||| #Premarket Prep Technical Update - Merck Trading Higher ||| Herbalife Falls On Downbeat Results; Windstream Shares Spike Higher ||| Markets Open Higher; Merck Posts Upbeat Profit ||| US Stock Futures Rise Ahead Of Earnings, Consumer Confidence Data ||| UPDATE: Merck Q2 Profit Beats Street View, Shares Rise ||| Merck & Company, Inc. Raises FY2014 EPS Guidance from $3.35-3.53 to $3.43-3.53 vs $3.48 Est, Reaffirms Sales Outlook ||| Merck & Company, Inc. Reports Q2 EPS of $0.85 vs $0.80 Est; Revenue of $10.93B vs $10.60B Est ||| Earnings Scheduled For July 29, 2014 ||| Stocks To Watch For July 29, 2014",0,0.49485275
2014-07-30,8051800.0,58.58000183105469,58.84999847412109,57.61000061035156,58.08000183105469,48.37637710571289,MRK,"Hospira Beats on Earnings and Sales in Q2, Boosts Guidance - Analyst Blog ||| Merck, J&J, Baxter Provide Healthy Dividend Stream ||| Pharma ETFs in Focus on String of Earnings Beat - ETF News And Commentary",0,0.528061
2014-07-31,10119000.0,57.7599983215332,58.06999969482422,56.720001220703125,56.7400016784668,47.26025390625,MRK,3 Reasons To Buy Merck For The Long Term,1,0.56563354
2014-08-04,8649500.0,56.95000076293945,57.27000045776367,56.36000061035156,57.060001373291016,47.52679443359375,MRK,"XLV, MRK, GILD, UNH: Large Outflows Detected at ETF ||| Glaxo, Sanofi Trend Up On Potential Deal For Established Brands",0,0.49206543
2014-08-05,9031200.0,56.720001220703125,56.970001220703125,55.81999969482422,56.02999877929688,46.66887664794922,MRK,Ukraine Tension Prominent As Dow Suffers Triple Digit Loss; S&P 500 & NASDAQ Also Lower ||| #Premarket Prep Technical Update - Merck Trading Sharply Lower ||| Merck Says on July 30 Was Advised by British Columbia Medical Beneficiary and Pharmaceutical Services Division of Delisting of Sitagliptin Products ||| Merck Successfully Completes Tender Offer to Acquire Idenix for $24.50/Share,0,0.47415254
2014-08-06,12275800.0,55.880001068115234,56.13999938964844,55.720001220703125,55.93000030517578,46.5855827331543,MRK,"Avanir's Q3 Loss in Line, Revenues Up on High Nuedexta Demand - Analyst Blog",0,0.52929705
2014-08-11,5499100.0,56.70000076293945,57.04999923706055,56.459999084472656,56.65999984741211,47.19361114501953,MRK,"Achillion Pharmaceuticals Up on Narrower-than-Expected Loss - Analyst Blog ||| 5 Things Merck & Co., Inc.'s Management Wants You to Know ||| Markets Marginally Higher On Light Volume And Encouraging Geopolitical Developments",1,0.51160765
2014-08-12,7090200.0,56.54999923706055,57.13999938964844,56.52000045776367,57.02999877929688,47.50179672241211,MRK,"Dow Movers: CVX, MRK",1,0.51862895
2014-08-13,10660700.0,57.38999938964844,57.88999938964844,57.15999984741211,57.84999847412109,48.18479919433594,MRK,"Notable ETF Outflow Detected - VTI, MRK, PM, CMCSA ||| Merck Issues Statement Related to Role of PNEUMOVAX 23 in Updated ACIP Recommendations ||| UPDATE: FDA Approves Belsomra Tablets for Use as Sleep Aid ||| FDA Approves Belsomra Tablets for Use as Sleep Aid ||| Medicare Spokesperson Tells CDC Vaccine Advisory Panel, Medicare Would Need to Change Current Policy to Cover Pfizer's Prevnar 13 for Elderly Previously Vaccinated With Merck's Pneumovax -Reuters",1,0.5338332
2014-08-14,7932300.0,58.04999923706055,58.790000915527344,58.0,58.77999877929688,48.95941925048828,MRK,Pfizer's Prevnar 13 Backed by U.S. Panel for Expanded Use - Analyst Blog,0,0.4860146
2014-08-18,9443900.0,58.79999923706055,58.869998931884766,58.34999847412109,58.41999816894531,48.65956878662109,MRK,"AstraZeneca's Asthma Drug in Focus, Phase III Study Initiated - Analyst Blog ||| Achillion Pharmaceuticals Soars on Mid-Stage HCV Study Data - Analyst Blog ||| Merck Is Banking On Pembrolizumab And Hepatitis C Pipeline",1,0.52418077
2014-08-19,7435000.0,58.84999847412109,58.95000076293945,58.34000015258789,58.90999984741211,49.06770706176758,MRK,"3 Reasons Merck & Co., Inc.'s Stock Could Rise",1,0.55744547
2014-08-20,7038400.0,58.68000030517578,59.56999969482422,58.52999877929688,59.47999954223633,49.542457580566406,MRK,Merck (MRK) Shares Cross 3% Yield Mark,0,0.5126425
2014-08-21,7646800.0,59.400001525878906,59.65999984741211,58.790000915527344,58.84999847412109,49.01773071289063,MRK,Achillion Attains 52-Week High on ACH-3102 Patent Protection - Analyst Blog,1,0.5428498
2014-08-22,5187600.0,59.040000915527344,59.36000061035156,58.900001525878906,59.16999816894531,49.284271240234375,MRK,"Dow Movers: GE, WMT",1,0.52077633
2014-08-25,5170800.0,59.34000015258789,59.869998931884766,59.2599983215332,59.72999954223633,49.75070190429688,MRK,"Close Update: Wall Street Resumes Rally Driving S&P 500 to 2000 ||| #Premarket Prep Technical Update - Merck Approaches $60.00 ||| US Stock Futures Rise Ahead Of Economic Data ||| US Regulators Have Approved Merck's Pembrolizumab Soon - Reuters ||| Advaxis, Merck to Collaborate on Investigational Combination of Two Novel Immunotherapy Candidates for Advanced Prostate Cancer",1,0.54624933
2014-08-26,9220600.0,59.66999816894531,60.400001525878906,59.65999984741211,60.20000076293945,50.142181396484375,MRK,"Sector Update: Health Care ||| Sector Update: Health Care Stocks Climbing in Late Trade; Merck Hits 11-Year High After Teaming Up With Pfizer on Cancer Treatment ||| Sector Update: Health Care ||| Cardiome Pharma Signs Agreement with Eurolab for Brinavess - Analyst Blog ||| Sector Update: Health-Care Shares Flat Pre-Market ||| S&P 500 Closes Above 2,000; Dow Hits New All-Time High As Markets Continue To Rally ||| Fast Money Halftime Report Final Trade From August 26 ||| Pfizer, Merck Report Collaboration on Study Evaluating Novel Anti-Cancer Combo Regimen",1,0.54227865
2014-08-27,6546700.0,60.400001525878906,60.58000183105469,60.11000061035156,60.27999877929688,50.20882034301758,MRK,"Markets Little Changed In Low Volume And Slow News Ahead Of Long Weekend ||| Biotech ETFs Hitting New Highs On Takeover News (FBT, PBE, ITMN) ||| Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers at Hold ||| UPDATE: Deutsche Bank Initiates Coverage On Merck ||| Deutsche Bank Initiates Coverage on Merck & Company, Inc. at Hold, Announces $63.00 PT",0,0.48764068
2014-08-28,5241000.0,59.88999938964844,60.22999954223633,59.84000015258789,60.0,49.9755859375,MRK,"3 Reasons Merck & Co., Inc.'s Stock Could Fall ||| Has Gilead Sciences, Inc.'s Star Drug Already Peaked?",1,0.53735983
2014-08-29,5715800.0,60.41999816894531,60.41999816894531,59.83000183105469,60.11000061035156,50.06721496582031,MRK,"IYH, PFE, MRK, UNH: ETF Inflow Alert",0,0.5221622
2014-09-02,6054500.0,59.72999954223633,60.09999847412109,59.66999816894531,59.790000915527344,49.80067443847656,MRK,"Regeneron/Sanofi Presents Encouraging Alirocumab Data - Analyst Blog ||| Is It Time to Buy Pfizer Inc.'s Stock? ||| Great Cholesterol Drug Data From Regeneron Pharmaceuticals Inc. and Sanofi SA, but Read the Fine Pri ||| This New Novartis AG Drug May Revolutionize Heart Failure Treatment",1,0.4867955
2014-09-03,9096200.0,60.119998931884766,60.86000061035156,60.060001373291016,60.47999954223633,50.37540435791016,MRK,"Dow Movers: MSFT, MRK",0,0.51769114
2014-09-04,10809000.0,60.56999969482422,61.0,59.91999816894531,60.08000183105469,50.0422248840332,MRK,"Merck & Co., Inc. Wins First Stage of the PD-1 Race ||| Is it Time to Buy Merck & Co., Inc.'s Stock? ||| 3 Reasons GlaxoSmithKline's Stock Could Fall ||| Merck Wins FDA Approval For Pembrolizumab In Melanoma ||| Merck & Co (MK-7655) Gets Fast Track Designation From FDA",1,0.52306753
2014-09-05,10744200.0,60.41999816894531,61.18000030517578,60.150001525878906,61.18000030517578,50.95845031738281,MRK,"Dow Movers: GS, WMT ||| Merck's Anti-PD-1 Drug Keytruda First to be Launched in US - Analyst Blog ||| Bristol-Myers Squibb Co In Patent Suit Vs. Merck & Co., Inc. Over Skin Cancer Drug ||| Shares of Bristol-Myers Edge Off Session Lows as Bloomberg Reporting Co. Has Filed Suit Against Merck Related to Patent for Immunotherapy Drugs",0,0.50714356
2014-09-08,8420400.0,61.220001220703125,61.33000183105469,60.83000183105469,61.04999923706055,50.85015106201172,MRK,"7 States Where Diabetes Prevalence Is the Highest ||| VTI, MRK, ORCL, CSCO: Large Inflows Detected at ETF ||| Bristol-Myers Sues Merck of Patent Infringement on Keytruda - Analyst Blog ||| Bristol-Myers Squibb Gets European Approval For HCV Drug Daklinza",0,0.4942761
2014-09-09,7443700.0,60.84000015258789,61.02999877929688,60.470001220703125,60.560001373291016,50.44203567504883,MRK,TESARO Seeks FDA Approval for NK-1 Receptor Rolapitant - Analyst Blog ||| Merck CEO Says Tax Inversion Deals Would Not Fit Corporate Strategy -Reuters,1,0.5457883
2014-09-10,9212800.0,60.66999816894531,60.869998931884766,60.34999847412109,60.7599983215332,50.608619689941406,MRK,"Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for September 11, 2014 ||| Ligand Inks 2nd Captisol Deal with CURx Pharmaceuticals - Analyst Blog ||| Is Merck & Co., Inc. A Leader In A Red Hot Market? ||| Option Alert: Merck Jan 15 $50 Call; 32,105 Traded vs 12,719 OI; Currently $60.78",0,0.48042223
2014-09-11,7785200.0,60.209999084472656,60.43999862670898,59.810001373291016,60.09999847412109,50.42403411865234,MRK,ETF Talk: Consider Investing in Dividend Dandies,0,0.5123759
2014-09-12,7021800.0,59.880001068115234,60.130001068115234,59.2599983215332,59.54999923706055,49.96257019042969,MRK,#Premarket Prep Technical Update - Merck Trading Lower,0,0.48470455
2014-09-15,7738900.0,59.650001525878906,59.9900016784668,59.5,59.52000045776367,49.937408447265625,MRK,Merck Announces Data from Pivotal Phase 3 Fracture Outcomes Study for Odanacatib; Expects to Submit NDA to FDA in 2015,1,0.5312908
2014-09-16,9045400.0,59.5099983215332,60.060001373291016,59.27999877929688,59.9900016784668,50.33174896240234,MRK,#Premarket Prep Technical Update - Merck Trading Higher,0,0.4870157
2014-09-17,10271200.0,59.52999877929688,60.0099983215332,59.27999877929688,59.880001068115234,50.23945617675781,MRK,"Dow Movers: MRK, DD ||| Merck Posts Positive Data on Osteoporosis Drug Odanacatib - Analyst Blog ||| Merck Reports Entered Into License Deal with Sun Pharma for Tildrakizumab ||| Merck Presents First Phase 3 Data In Japanese Patients for Omarigliptin, An Investigational Once-Weekly DPP-4 Inhibitor For Type 2 Diabetes ||| Sun Pharma and Merck Enter into Licensing Agreement for Tildrakizumab",1,0.5081395
2014-09-18,8004100.0,60.130001068115234,60.34000015258789,59.81999969482422,60.310001373291016,50.6002197265625,MRK,Merck Enters into Licensing Agreement with Sun Pharma - Analyst Blog,1,0.54573405
2014-09-19,14480700.0,60.75,60.88999938964844,60.4900016784668,60.4900016784668,50.751251220703125,MRK,"5 Things Gilead Sciences, Inc. Management Wants You to Know",1,0.5436647
2014-09-22,9320500.0,60.369998931884766,60.97999954223633,60.2599983215332,60.58000183105469,50.82675552368164,MRK,"Market Watchers Get a Breather - Ahead of Wall Street ||| Merck (MRK) Records the Largest Acquisition in Their History at $17 Billion - Stocks in the News ||| Citigroup Inc, Hertz Global Holdings, Inc. Highlight Fast Money Halftime Report Final Trade From September 22",0,0.45055515
2014-09-23,8012100.0,60.150001525878906,60.72999954223633,59.68999862670898,60.27999877929688,50.57505416870117,MRK,"Notable ETF Outflow Detected - HDV, T, MRK, PFE",1,0.50786865
2014-09-26,10786200.0,59.720001220703125,59.790000915527344,58.54999923706055,59.38999938964844,49.828346252441406,MRK,"Dow Movers: MRK, NKE ||| Fast Money Halftime Report Final Trade From September 26 - Merck & Co., Inc., NCR Corporation And BP plc",1,0.49523124
2014-09-29,8719200.0,59.02999877929688,59.720001220703125,58.810001373291016,59.40999984741211,49.84511947631836,MRK,"High Blood Pressure Is Most Prevalent in These 5 States ||| Sector Update: Health-Care Shares Sink in Pre-Market Trade ||| Sector Update: Health Care ||| Bristol-Myers' Opdivo Under Review in US, EU for Cancer Treatment - Analyst Blog ||| Why Endocyte, Inc. Stock Briefly Spiked Higher ||| Merck & Co., Inc. Stock Still Holding Its Position As A Big-Pharma Leader ||| Merck Presents Early Data on Investigational Use of KEYTRUDA in Patients with Advanced Bladder Cancer at ESMO 2014",0,0.4850617
2014-09-30,9247300.0,59.400001525878906,59.97999954223633,59.25,59.27999877929688,49.73605346679688,MRK,Big News for These 5 Stocks From ESMO,0,0.49425802
2014-10-01,9088900.0,59.09000015258789,59.220001220703125,58.5,58.709999084472656,49.25782775878906,MRK,"Noteworthy ETF Inflows: HDV, T, VZ, MRK",1,0.52019745
2014-10-02,8109800.0,58.77999877929688,59.060001373291016,58.290000915527344,58.84999847412109,49.37528610229492,MRK,"Ligand Earns Milestone Payment on EU Approval of Noxafil - Analyst Blog ||| Markets Little Changed Ahead Of Friday's Jobs Report ||| Guggenheim Securities Initiates Coverage on Merck & Company, Inc. at Neutral, Announces $65.00 PT",1,0.5214309
2014-10-03,8641800.0,59.16999816894531,60.09999847412109,59.16999816894531,59.900001525878906,50.2562370300293,MRK,"Dow Movers: XOM, DIS ||| #Premarket Prep Technical Update - Merck Trading Higher",0,0.49605933
2014-10-06,7114600.0,60.16999816894531,60.25,59.29999923706055,59.58000183105469,49.987754821777344,MRK,"There's a Powerful Case for Better Corporate Political Disclosure ||| Gilead Sciences, Inc. Got 2 Drugs Approved, and Didn't Bother to Tell Anyone ||| Lung Cancer Incidence Is the Highest in These 10 States ||| Better Dividend Stock: Merck & Co. Inc. or Bristol-Myers Squibb Co.? ||| Merck Prices $3.1B Debt Offering ||| 2 Mutual Funds Holding Hospital Stocks ||| Merck CommencesTender Offers for Eight Series of Notes ||| Merck Commences Public Debt Offering",0,0.47655255
2014-10-08,12318200.0,58.65999984741211,60.22999954223633,58.56999969482422,60.18000030517578,50.491153717041016,MRK,"Dow Movers: DD, MRK ||| Bristol-Myers Tells Gilead Sciences, Inc. ""You Win"" ||| Bristol Myers Squibb Getting Close To Lung Cancer Approval For Nivolumab ||| #Premarket Prep Technical Update - Merck Trading Sharply Higher",0,0.49670473
2014-10-09,8595800.0,60.0,60.5099983215332,59.11000061035156,59.209999084472656,49.67732238769531,MRK,iShares U.S. Healthcare ETF Experiences Big Inflow,0,0.49747205
2014-10-10,11285200.0,59.310001373291016,59.91999816894531,58.65999984741211,58.65999984741211,49.21586990356445,MRK,"Merck Becomes #21 Most Shorted Dow Stock, Replacing Chevron ||| Gilead Sciences Inc. Gets First Hepatitis C Cocktail Drug Approved",0,0.5072199
2014-10-13,14807700.0,58.54999923706055,58.54999923706055,55.97999954223633,56.13999938964844,47.1015853881836,MRK,"A Quick Look at Merck & Co. Inc.'s Drug Development Pipeline ||| Dow Movers: MRK, TRV ||| Markets Debut Week On Negative Note; S&P 500 Falls Through Key Level ||| #Premarket Prep Technical Update - Merck Trading Lower ||| Jefferies Maintains Hold on Merck & Company, Inc., Lowers PT to $60.00 ||| 5 Companies That Could Develop An Enterovirus Treatment",1,0.49634984
2014-10-14,10935800.0,56.56999969482422,56.95000076293945,55.72999954223633,56.33000183105469,47.2609977722168,MRK,Can Dividend Stock GlaxoSmithKline plc Bounce Back?,0,0.4982448
2014-10-15,18785800.0,55.369998931884766,55.869998931884766,54.290000915527344,54.72999954223633,45.9185905456543,MRK,Johnson & Johnson and Bristol-Myers Squibb’s New Collaboration Just the Tip of the Iceberg ||| Merck Announces Final Results of Tender Offers for Eight Series of Notes,0,0.49167183
2014-10-16,21856200.0,54.0099983215332,54.09000015258789,52.4900016784668,53.43000030517578,44.827884674072266,MRK,"Dow Movers: MRK, UNH ||| Will Actavis Win Competition For Allergan's Affection?",1,0.51790327
2014-10-17,19718100.0,53.84999847412109,54.630001068115234,53.52999877929688,54.02000045776367,45.32290649414063,MRK,"DLN, T, PFE, MRK: Large Inflows Detected at ETF",1,0.5311227
2014-10-20,12064100.0,54.220001220703125,54.27000045776367,53.91999816894531,54.04999923706055,45.34807205200195,MRK,Could This Game-Changing Drug Deliver $10 Billion in Sales Within Its First Year? ||| This Drug Could Outsell Medical Marijuana ||| Interesting April 2015 Stock Options for MRK ||| US FDA Accepts For Review A Biologics License Application For Merck And Sanofi Pasteur's Investigational Pediatric Hexavalent Vaccine,1,0.52412903
2014-10-21,17289900.0,54.56999969482422,55.27999877929688,54.31999969482422,55.130001068115234,46.25419616699219,MRK,Market Reaction To Johnson & Johnson's Earnings Is Justified ||| #Premarket Technical Update - Merck Trading Higher,1,0.51065964
2014-10-22,12901700.0,55.22999954223633,55.86000061035156,55.0,55.5099983215332,46.57301330566406,MRK,Gilead's Hep C Dream Drug Faces Demanding Investors ||| Drug ETFs Attractive Buys On Pullback,1,0.5232178
2014-10-23,11851100.0,56.2599983215332,57.06999969482422,56.18999862670898,56.630001068115234,47.51269912719727,MRK,Eli Lilly/Boehringer's Diabetes Drug Under FDA Review - Analyst Blog ||| Fast Money Picks For October 23,1,0.48821878
2014-10-24,8555400.0,56.79999923706055,57.65999984741211,56.630001068115234,57.61000061035156,48.33491897583008,MRK,"Bristol-Myers Squibb Co's Third-Quarter Earnings Beat the Street ||| Pre-Market Earnings Report for October 27, 2014 : MRK, BEN, STX, ROP, HUN, TEN, AWI, PDS, EXAS, STNG, EDR, SIR ||| Roche's Cancer Drug Sales Continue To Grow, May Face Competition In Medium Term ||| ETF Preview: Broad Market ETFs Decline in Line With Futures; Earnings in Focus ||| Fast Money Halftime Report Final Trade From October 24",0,0.47485158
2014-10-27,14418900.0,56.90999984741211,57.2400016784668,55.91999816894531,56.45000076293945,47.36167907714844,MRK,"Earnings Expectations For The Week Of October 27: Facebook, Exxon, Pfizer And Much More ||| Mid-Morning Market Update: Markets Down; Merck Posts Upbeat Earnings ||| Interesting December Stock Options for MRK ||| Mid-Day Market Update: Micron Gains On Buyback Announcement; Sarepta Shares Dip ||| DLN, T, PFE, MRK: Large Inflows Detected at ETF ||| Futures Defensive on German Business Confidence, Brazil's Election, Upcoming Data and FOMC ||| Merck & Co., Inc. Earnings: Patent Losses and Competition Weigh on Sales ||| Sector Update: Health-Care Shares Flat Before Opening Bell ||| Sector Update: Health Care ||| Mid-Afternoon Market Update: NQ Mobile Climbs On SEC Filing; Huntsman Shares Slide ||| In the news: Tesla's new lease, Merck earnings and more ||| Fast Money Traders Discuss Merck, Garmin And Sarepta Therapeutics ||| Markets Virtually Flat, Oil Continues To Decline Following Bearish Outlook ||| Merck Conference Call Highlights ||| Mid-Afternoon Market Update: NQ Mobile Climbs On SEC Filing; Huntsman Shares Slide ||| #Premarket Prep Technical Update - Merck Trading Lower ||| Mid-Day Market Update: Micron Gains On Buyback Announcement; Sarepta Shares Dip ||| Mid-Morning Market Update: Markets Down; Merck Posts Upbeat Earnings ||| #PreMarket Primer: Monday, October 27: ECB Stress Tests In-Line With Expectations ||| US Stock Futures Down Ahead Of Economic Data ||| UPDATE: Merck Q3 Earnings Top Street View ||| Merck & Company, Inc. Narrows FY2014 EPS Guidance from $3.43-3.53 to $3.46-3.50 vs $3.47 Est ||| Merck & Company, Inc. Reports Q3 EPS of $0.31 vs $0.88 Est; Revenue of $10.60B vs $10.68B Est ||| Merck Receives FDA Breakthrough Therapy Designation for KEYTRUDA in Advanced NSCLC ||| Earnings Scheduled For October 27, 2014 ||| Keep an Eye on These 7 Stocks for October 27, 2014",0,0.4887202
2014-10-28,23961200.0,56.59999847412109,56.59999847412109,54.09999847412109,55.84999847412109,46.85827255249024,MRK,"Sector Update: Health Stocks Generally Flat Pre-Bell ||| Sector Update: Health Care ||| #PreMarket Primer: Tuesday, October 28: CDC Warns That Involuntary Quarantines Could Discourage Progress On Ebola",1,0.5313554
2014-10-29,12492900.0,56.02000045776367,56.61000061035156,55.630001068115234,56.20000076293945,47.15193557739258,MRK,"Gilead Beats on Q3 Earnings, Sovaldi Sales Fall Sequentially - Analyst Blog",1,0.5333895
2014-10-30,12866600.0,55.709999084472656,57.38999938964844,55.70000076293945,57.310001373291016,48.08322143554688,MRK,5 Things GlaxoSmithKline plc Stock's Management Wants You to Know ||| Veeva Systems Flies High On Cloud For Life Sciences ||| Bristol-Myers Squibb Rises On Earnings Boost,1,0.5524036
2014-10-31,14066100.0,57.95000076293945,58.130001068115234,57.65999984741211,57.93999862670898,48.61178970336914,MRK,"Intel Moves Up In Market Cap Rank, Passing Merck",1,0.5536472
2014-11-03,10178900.0,57.95000076293945,58.93000030517578,57.56999969482422,58.91999816894531,49.43401718139648,MRK,"5 Staggering Statistics About the Fastest Growing Drug in the World ||| Noteworthy ETF Inflows: XLV, GILD, MRK, UNH ||| Bayer Q3 Earnings Grow Y/Y on New Product Sales, View Up - Analyst Blog ||| Merck Reports Data from 48-Week Phase 2B Study of Investigational HIV Therapy Doravirine in Treatment-Naive Patients; Phase 3 Clinical Trial Enrollment Scheduled to Begin by End of 2014",1,0.54259515
2014-11-04,11338400.0,58.869998931884766,59.709999084472656,58.869998931884766,59.369998931884766,49.81156539916992,MRK,"Dow Movers: CVX, MRK",1,0.51862895
2014-11-05,12678800.0,59.9900016784668,60.25,59.380001068115234,59.56999969482422,49.97936248779297,MRK,"Dow Movers: INTC, KO ||| After Hours Most Active for Nov 5, 2014 : F, MRK, LBRDK, AAPL, CBS, ORCL, KO, MO, QQQ, QCOM, WFM, TSLA ||| Merck Animal Health Provides Update on Zilmax Five-Step Plan; Announces Next Steps",0,0.49351197
2014-11-06,13362100.0,59.59999847412109,59.900001525878906,59.18999862670898,59.2599983215332,49.71928024291992,MRK,"US Stock Futures Edge Lower Ahead Of Earnings, Jobless Claims ||| BIND Therapeutics Announces Joint Research Agreement with Merck",1,0.5315085
2014-11-07,10613000.0,59.38999938964844,59.619998931884766,59.060001373291016,59.34000015258789,49.7863883972168,MRK,"After Hours Most Active for Nov 7, 2014 : F, GLW, MON, MRK, BTU, ORCL, SIRI, AAPL, MU, PPC, ARWR, ODP",0,0.47277328
2014-11-10,14598500.0,58.2400016784668,59.18999862670898,57.70000076293945,58.810001373291016,49.34172439575195,MRK,"Interim Data from C-SWIFT Study of Merck's Investigational Hepatitis C Treatment Grazoprevir/Elbasvir in Combination with a Nucleotide Inhibitor Presented at The Liver Meeting ||| Merck Reports Interim Data on Hepatitis C Virus Drug - Analyst Blog ||| Dow Movers: MRK, IBM ||| Merck Shares May Have Hit A Ceiling For The Most Recent Upside Move ||| Merck Has Said Taking No Impairment Charge Following Results of Cholesterol-Drug Study ||| RBC Sees Weak Merck Data As Positive For Gilead",1,0.51578975
2014-11-11,13303600.0,59.720001220703125,59.95000076293945,59.209999084472656,59.369998931884766,49.81156539916992,MRK,"Dow Movers: T, MRK ||| Notable ETF Inflow Detected - XLV, MRK, GILD, UNH ||| Gilead Sciences Inc. Breathes a Sigh of Relief -- Hepatitis C Patients, Not So Much ||| After Hours Most Active for Nov 11, 2014 : DG, MRK, ONNN, MU, ARCP, FOSL, LNCO, SPF, PBR, ISIS, BAC, LLY ||| How Will Johnson & Johnson's Ebola Investment Pay Off? ||| Merck Announces Results From Phase 2 Study Of Investigational Chronic Hepatitis C Treatment Grazoprevir/Elbasvir In Genotype 1 Infected Treatment-Naïve And Difficult-To-Cure Patients ||| Merck Offers Results of Phase 2 Study of Investigational Chronic Hep C Treatment Grazoprevir/Elbasvir; First Wave of Phase 3 Enrolled, Co. Will Submit NDA App in 2015",0,0.45659244
2014-11-12,6668800.0,59.27999877929688,59.54999923706055,59.09999847412109,59.310001373291016,49.76123428344727,MRK,"Bill Ackman's Latest Target: Zoetis Inc. ||| This Tiny Biotech Is Piggybacking on Gilead Sciences, Inc.'s Success ||| Pandering Your Wealth Away",1,0.51472574
2014-11-17,8571300.0,59.709999084472656,59.900001525878906,59.310001373291016,59.459999084472656,49.88708114624024,MRK,"Merck Announces Positive Study Investigating Use of KEYTRUDA Compared to Chemotherapy in Patients with Ipilimumab-Refractory Advanced Melanoma ||| Dow Movers: PFE, MRK ||| Merck Announces Its Vytorin Reduces Heart Disease Risk By 6.4% Over Statin Alone ||| Merck Announces That IMPROVE-IT Achieved Primary Endpoint; Data To Be Presented At American Heart Association Scientific Sessions Today ||| Pfizer Will Study Merck's PDL-1 in Combo with Pfizer Assets; to Start 20 Clinical Dev Programs with Merck, Six Registration Programs",1,0.53769165
2014-11-18,7663000.0,59.4900016784668,60.130001068115234,59.150001525878906,59.88999938964844,50.24783706665039,MRK,Merck IMPROVEs-IT Causing These Biotechs' Stock Prices to Improve Too ||| Do Merck's Recent Hepatits C Trial Results Weaken Its Position?,0,0.4886772
2014-11-20,6741100.0,59.209999084472656,59.400001525878906,58.86000061035156,59.380001068115234,49.81996154785156,MRK,"Dow Movers: MRK, MCD ||| Vanguard Value ETF Experiences Big Inflow ||| Regeneron & Sanofi Present Positive Data on PCSK9 Drug - Analyst Blog ||| Hearing Newlink, Merck Working on Producing Ebola Vaccine",1,0.52595174
2014-11-21,11260400.0,59.93999862670898,60.02000045776367,59.33000183105469,59.65999984741211,50.05487823486328,MRK,EMA Recommends Merck's Blood Clot Preventer Vorapaxar,0,0.4997044
2014-11-24,8488000.0,59.810001373291016,59.810001373291016,58.9900016784668,59.25,49.71088409423828,MRK,"11 Things You Need to Know About GMO Labeling ||| #Premarket Prep Technical Update - Merck Trading Lower ||| Merck Reports Submission to Japanese Pharma, Medical Devices Agency for Omarigliptin ||| Merck, NewLink Genetics Announce Licensing and Collaboration Agreement for Investigational Ebola Vaccine ||| Merck, NewLink Genetics Report Entering of Licensing, Collaboration Deal for Investigational Ebola Vaccine",1,0.53903276
2014-11-25,10328600.0,59.31999969482422,59.65999984741211,59.130001068115234,59.34000015258789,49.7863883972168,MRK,How to Make Money Day Trading ||| Merck Buys Rights to Ebola Vaccine Candidate from NewLink - Analyst Blog ||| Merck Announces Increased Quarterly Dividend From $0.44 To $0.45/share,1,0.5291916
2014-11-26,6280600.0,59.70000076293945,59.77000045776367,59.34999847412109,59.75,50.1303825378418,MRK,"Daily Dividend Report: MRK, CBS, ADI, BDC, FGP ||| Should Gilead Sciences, Inc. Pay a Dividend?",1,0.49573672
2014-11-28,6207400.0,59.70000076293945,60.869998931884766,59.70000076293945,60.400001525878906,50.67572784423828,MRK,Bristol-Myers Squibb's HCV Drug Daclatasvir Receives CRL - Analyst Blog ||| Glaxo's Ebola Candidate Well-Tolerated in Early U.S. Study - Analyst Blog,1,0.5389164
2014-12-01,8274100.0,60.400001525878906,61.31999969482422,60.27999877929688,60.52000045776367,50.77641677856445,MRK,"8-K from Gilead Sciences Shows UK Court Invalidated Idenix 489 Patent, Trials Will Be Held on Merck's Idenix Patents in Canada in Jan.",1,0.54330677
2014-12-02,6446000.0,60.630001068115234,60.97999954223633,60.27999877929688,60.77999877929688,50.99455261230469,MRK,"No Serious Side Effects Reported in Early Test of Experimental Ebola Vaccine Being Develped by Merck, NewLink -Reuters",0,0.48983297
2014-12-03,9730500.0,60.7599983215332,60.93000030517578,60.310001373291016,60.58000183105469,50.82675552368164,MRK,"5 Things Merck & Co., Inc.'s Management Wants You to Know",1,0.5443141
2014-12-04,7114600.0,60.5099983215332,61.380001068115234,60.5099983215332,60.91999816894531,51.11201858520508,MRK,"Markets Marginally Lower Ahead Of Friday's Jobs Report ||| Jefferies Maintains Hold on Merck & Company, Inc., Raises PT to $65.00",1,0.4940641
2014-12-05,11171800.0,61.02999877929688,61.77000045776367,60.81999969482422,61.4900016784668,51.59025192260742,MRK,"Gilead Sciences, Inc. Beats Another Threat ||| Merck in Talks to Acquire Cubist for ~$100/Share ||| Merck in Talks to Acquire Cubist Pharmaceuticals for More Than $7B; Could be Announced as Early as Next Week -NYT Dealbook",1,0.49246278
2014-12-08,11394700.0,61.16999816894531,62.20000076293945,60.97999954223633,61.880001068115234,51.91746520996094,MRK,"Merck Announces Anti-PD-1 Therapy, KEYTRUDA, Achieves Overall Response Rate of 66% in Classical Hodgkin Lymphoma Study ||| Benzinga's Weekend M&A Chatter ||| Time to Buy This Dip in Gilead Sciences, Inc. Stock? ||| Midday Update: Global Growth Worries Weigh on Equities; Oil Stocks Resume Slide as Crude Again Stumbles ||| Why Shares of Cubist Pharmaceuticals Inc Skyrocketed ||| Futures Lower As Global Growth Concerns Triggered Overseas ||| VTV, MRK, BMY, UNH: Large Outflows Detected at ETF ||| Health Care Sector Update for 12/08/2014: XLRN,CELG,CBST,MRK,ALR ||| Close Update: Stocks Turn Defensive as Energy Sector Slumps, Global Economy Wilts ||| Merck's New Oncology Product Positive in Early Study - Analyst Blog ||| Health Care Sector Update for 12/08/2014: BLRX,CBST,MRK,ALR ||| Why Cubist Pharmaceuticals Inc. Shares Soared in After-Hours Trading on Friday ||| Benzinga's M&A Chatter for Monday December 8, 2014 ||| 3 Biotech ETFs Rally On Merger News ||| Cubist Shares Fall Almost 5% After-Hours ||| Mid-Afternoon Market Update: Dow Slides Over 100 Points; Oil Futures Down 4% ||| Fitch Says Cubist Acquisition Will Strengthen Merck's Growth Opportunities, Particularly in Non-U.S./European Markets ||| Mid-Day Market Update: McDonald's Drops On Weak November Sales; Acceleron Pharma Shares Jump ||| Merck's CEO Doesn't Think That Valuations In The Biotech Industry Are 'Rich' ||| Mid-Morning Market Update: Markets Mixed; Merck To Buy Cubist Pharmaceuticals For $102/Share ||| Benzinga's Volume Movers ||| Stocks Hitting 52-Week Highs ||| Morning Market Movers ||| Pharmaceutical Stocks In Play Following Merck/Cubist Deal ||| Benzinga's Top #PreMarket Gainers ||| Advaxis Announces FDA Acceptance of Investigational NDA to Begin Clinical Trials of ADXS-PSA in Combo with Merck's KEYTRUDA(R) ||| Merck to Acquire Cubist Pharmaceuticals for $102/Share in Cash ||| UPDATE: Merck Says Cubist Deal Includes $1.1B In Net Debt ||| US Stock Futures Point To Lower Open Monday ||| Merck To Acquire Cubist Pharmaceuticals For $102 Per Share In Cash ||| Cubist Shares Bid 28% Higher Premarket on Rumor of Merck $100/Share Bid ||| Must Watch Stocks for December 8, 2014",0,0.49395302
2014-12-09,18778200.0,59.400001525878906,60.13999938964844,58.75,60.0099983215332,50.34852981567383,MRK,"Dow Movers: MRK, IBM ||| Cubist Shoots Up on $9.5 Billion Buyout Offer from Merck - Analyst Blog ||| Biotech ETFs in Focus on Cubist Takeover Deal - ETF News And Commentary ||| Zoetis Inc. Spikes Briefly On Remarks From Sanofi CEO ||| Mizuho Securities Downgrades Cubist Pharmaceuticals Post Acquisition Announcement ||| #Premarket Prep Technical Update - Merck Lower ||| Hospira, Inc. Ticks Up On Favorable Patent Ruling vs. Cubist Pharmaceuticals Inc ||| Merck & Co. Under Pressure Following Patent Ruling ||| Cellceutix Corp Shares Rise On Two Catalysts ||| Merck Issues Statement Regarding CUBICIN Patent Litigation; Reaffirms Transaction To Proceed As Planned",0,0.4921403
2014-12-10,13253700.0,60.119998931884766,60.52000045776367,59.70000076293945,59.97999954223633,50.32335662841797,MRK,"FDA Approves Gardasil 9 for Prevention of Certain Cancers Caused by 5 Additional Types of HPV ||| Data Investigating KEYTRUDA, Merck's Anti-PD-1 Therapy, In Patients With Advanced Triple-Negative Breast Cancer Presented At 2014 San Antonio Breast Cancer Symposium",0,0.5123568
2014-12-11,11314100.0,59.77999877929688,60.58000183105469,59.18999862670898,59.34000015258789,50.16272735595703,MRK,"Merck Reveals Data from Breast Cancer Study on Keytruda - Analyst Blog ||| Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines ||| These 4 Charts Highlight Twitter Sentiment For Today's Movers ||| Sky News Newsdesk Tweets: 'Reuters: Geneva University Hospital suspends trials of #Ebola vaccine one week early ""as a measure of precaution""' ||| Global Vaccines Alliance GAVI Said Thursday it was Committing up to $300M to Buy Ebola Vaccines -Reuters",0,0.49834672
2014-12-15,12175200.0,57.81999969482422,58.060001373291016,56.79999923706055,56.95000076293945,48.142364501953125,MRK,"It's Not the Zombie Apocalypse, but Killer Superbugs Could Be on the Way ||| Dow Movers: MRK, XOM",0,0.4894355
2014-12-16,11214000.0,56.970001220703125,58.290000915527344,56.77999877929688,56.79999923706055,48.01555633544922,MRK,Roche Submitted NDA for Melanoma Combination Drug - Analyst Blog ||| The 3 Most Exceptional CEOs of 2014 ||| Pfizer Moving Into Gene Therapy Is A Welcome Move ||| Quick Analysis Of Merck's Acquisition Of Cubist,1,0.50265545
2014-12-17,12663800.0,57.04999923706055,57.79999923706055,56.560001373291016,57.630001068115234,48.71719741821289,MRK,NewLink Genetics: Examining Likelihood Of Success In The Impress Trial,1,0.5513696
2014-12-18,13359400.0,58.59000015258789,58.97999954223633,58.09000015258789,58.97999954223633,49.85841369628906,MRK,"MRK Crosses Above Key Moving Average Level ||| Health Care Sector Update for 12/18/2014: ICPT, MRK, CPXX ||| Call buyers take a dose of Merck ||| NPS Pharmaceuticals and Shire Up on Takeover Rumors - Analyst Blog ||| After Hours Most Active for Dec 18, 2014 : ORCL, KMI, RAD, WMB, QQQ, FB, MRK, PFE, WFM, MSFT, BRCM, EBAY ||| Merck Reports Acquisition of OncoEthix for $110M Upfront Payment, Could Pay Added $265M in Milestone Payment",1,0.49960712
2014-12-19,17374200.0,59.25,59.900001525878906,59.0099983215332,59.58000183105469,50.36562728881836,MRK,"Merck Up on OncoEthix Acquisition Deal, Oncology in Focus - Analyst Blog ||| Bull of the Day: Seattle Genetics (SGEN) - Bull of the Day ||| Merck Begins Tender Offer To Acquire Cubist",0,0.49443597
2014-12-22,10010500.0,59.119998931884766,59.560001373291016,58.54999923706055,58.959999084472656,49.84150314331055,MRK,"Could the Next Generation of Diabetes Treatments Be Found in This Illegal Drug? ||| Exciting News: A Game-Changing Shingles Vaccine Could Be On Its Way ||| One Put, One Call Option To Know About for Merck & Co. ||| Dow Movers: CVX, INTC ||| Could Gilead Sciences, Inc. Be a Top Stock in 2015? ||| Cubist's Antibiotic Zerbaxa Wins FDA Nod for cUTI and cIAI - Analyst Blog ||| #Premarket Prep Technical Update - Merck Lower ||| NewLink Genetics Surges 3% Following Ebola Contract News ||| NewLink Genetics Announces Collaboration with Merck for Manufacture of Ebola Vaccine, Deal Supported by $30M Award",0,0.5100079
2014-12-23,14165400.0,58.68999862670898,59.0,57.02999877929688,57.209999084472656,48.36215591430664,MRK,"Dow Movers: MRK, DD ||| Bristol-Myers Oncology Drug Opdivo Receives FDA Approval - Analyst Blog ||| US Dept. of Health & Human Services Issues Release: 'HHS supports efforts to speed Ebola vaccine delivery' ||| Health Care And Biotech Sector Looking Sick ||| FTC Requests Public Comment on Merck & Co., Inc.'s Application to Approve Sale of Facilities",1,0.5407999
2014-12-24,5051000.0,57.290000915527344,57.86000061035156,57.25,57.459999084472656,48.573486328125,MRK,This Cancer Drug War Is Just Getting Started ||| Interesting MRK Put And Call Options For February 2015,1,0.49910071
2014-12-26,4672800.0,57.68000030517578,58.02000045776367,57.59000015258789,57.77999877929688,48.843997955322266,MRK,"Noteworthy ETF Outflows: VTV, MRK, WMT, BMY",0,0.5216871
2014-12-29,6003800.0,57.45000076293945,57.91999816894531,57.45000076293945,57.72999954223633,48.80173110961914,MRK,The Unfortunate Concern That Nearly Half of All Cancer Patients Face ||| Interesting March 2015 Stock Options for Merck ||| NewLink and Merck Get a $30M Contract for Ebola Candidate - Analyst Blog,0,0.5065686
2014-12-31,7483600.0,57.27000045776367,57.84999847412109,56.72999954223633,56.790000915527344,48.007110595703125,MRK,What Investors Should Be Watching In The Antibiotic Space ||| 19 Lesser-Known Biotech Stocks With Robust Drug Pipelines,1,0.5088413
2015-01-05,15961200.0,58.209999084472656,58.47999954223633,57.56999969482422,58.040000915527344,49.06378555297852,MRK,"Dow Movers: CAT, MRK ||| Bernstein Upgrades Merck to Outperform",1,0.5431932
2015-01-06,24287700.0,58.27999877929688,60.5,58.25,60.31999969482422,50.991172790527344,MRK,"Dow Movers: UTX, MRK ||| IVE, MRK, OXY, COST: Large Outflows Detected at ETF ||| The Year 2014 In Review: Everyone Is Looking At Merck's R&D Pipeline ||| The Year 2014 In Review: Pfizer Streamlined R&D And Pursued Oncology Market Amid Competition From Generics ||| FDA Has Approved Merck's Request to Supplement Pneumovax BLA, Will Add 2D Barcode on Label",1,0.494966
2015-01-07,18634500.0,60.43999862670898,61.619998931884766,60.36000061035156,61.61000061035156,52.081668853759766,MRK,CytRx Jumps on Positive Results from Brain Cancer Study - Analyst Blog,1,0.53999
2015-01-08,19121000.0,62.0,62.93999862670898,61.84999847412109,62.84999847412109,53.12989807128906,MRK,"Why Seattle Genetics, Inc. Stock Dove 12% in December",0,0.49749905
2015-01-09,12638700.0,62.810001373291016,63.130001068115234,62.16999816894531,62.560001373291016,52.88474655151367,MRK,Why Cubist Pharmaceuticals Inc. Stock Skyrocketed 33% in December,0,0.49642298
2015-01-12,11569000.0,63.09999847412109,63.5,62.09999847412109,62.29999923706055,52.66495895385742,MRK,"Can You Guess the Most Common Reason People Visit the Doctor? ||| 3 Ways Gilead Sciences, Inc. Could Still Be in Big Trouble ||| Dow Movers: CVX, MRK ||| Agenus Soars on Immuno-Oncology Agreement with Incyte - Analyst Blog ||| Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1 ||| Wall Street's Hall Of Fame (And Hall Of Shame): The Best And Worst Analyst Recommendations Of 2014",0,0.49049732
2015-01-13,10035200.0,62.90999984741211,63.619998931884766,61.72999954223633,62.18999862670898,52.57196807861328,MRK,What 2015 Will Bring For Bristol-Myers Squibb ||| Notes From The Street: 'FLASHBACK....Oil Going To $200/Barrel' ||| Merck and Eli Lilly Announce Agreement For Collaboration on Cancer Clinical Trial,1,0.51767457
2015-01-14,9858100.0,61.720001220703125,62.90999984741211,61.47999954223633,62.63999938964844,52.952369689941406,MRK,"Dow Movers: JPM, INTC ||| 7 Things Amgen Corporation's CEO Wants You to Know ||| Eli Lilly Inks Oncology Deals with Merck, Bristol-Myers - Analyst Blog ||| Practice Fusion Announces Positive Results of Population Health Vaccine Initiative",0,0.52579045
2015-01-15,9564600.0,62.790000915527344,62.9900016784668,61.83000183105469,61.880001068115234,52.30991363525391,MRK,"Agilent Arm/Cell Signaling Tie for Companion Diagnostics - Analyst Blog ||| IWD, INTC, MRK, C: ETF Outflow Alert ||| #Premarket Prep Technical Update - Merck Lower ||| Fast Money Halftime Report Final Trade From January 14",1,0.4869923
2015-01-16,11371200.0,61.86000061035156,63.15999984741211,61.52999877929688,63.02999877929688,53.28205871582031,MRK,"Barclays Issues 3 Upgrades, 1 Downgrade On Pharma Stocks ||| 'Merck Acquires OncoEthix' ||| Barclays Upgrades Merck to Equalweight",0,0.5041417
2015-01-20,13105900.0,62.709999084472656,63.29999923706055,61.880001068115234,62.61000061035156,52.92701721191406,MRK,Could This Common Medicine Cabinet Supplement Be the Key to Increased Survival for Some Cancer Patie ||| 3 Big Pharma Stocks With More Free Cash Flow Than Gilead Sciences Inc. ||| The 5 Best Dow Stocks So Far In 2015 ||| #Premarket Prep Technical Update - Merck Lower,0,0.46712416
2015-01-22,8494400.0,62.2599983215332,62.709999084472656,61.52999877929688,62.59000015258789,52.91011047363281,MRK,Celgene to Use Zymeworks' Azymetric Platform for New Drugs - Analyst Blog,0,0.51866776
2015-01-23,6229100.0,62.459999084472656,63.0,62.40999984741211,62.4900016784668,52.82556915283203,MRK,"XLV, JNJ, PFE, MRK: Large Outflows Detected at ETF ||| EMA Recommends Merck's Combination of Lamivudine/Raltegravir for Approval -Reuters",1,0.5238458
2015-01-26,6714600.0,62.58000183105469,62.97999954223633,62.119998931884766,62.81999969482422,53.10454559326172,MRK,"One Put, One Call Option To Know About for Merck & Co. ||| This Popular Beverage Could Be Responsible For a 20% Reduction in Melanoma Risk ||| Pfizer's Prevenar 13 Wins CHMP Backing for Expanded Use - Analyst Blog ||| Merck Reports CHMP Positive Opinion for Investigational Antibiotic SIVEXTRO",0,0.48869064
2015-01-27,7965100.0,62.880001068115234,63.02000045776367,62.130001068115234,62.560001373291016,52.88474655151367,MRK,Dow Analyst Moves: MRK ||| Fast Money Halftime Report Final Trade From January 27 ||| White House Budget To Support Biotech Rally,0,0.49703228
2015-01-29,9091300.0,61.540000915527344,62.150001525878906,60.7599983215332,62.09000015258789,52.487430572509766,MRK,#Premarket Prep Technical Update - Merck Lower,0,0.493771
2015-01-30,12086900.0,61.52999877929688,61.93000030517578,60.02999877929688,60.27999877929688,50.957366943359375,MRK,What Investors Are Watching For In Regulus Therapeutics' Next Data Release,1,0.534881
2015-02-02,9266700.0,60.5,60.93000030517578,59.77999877929688,60.880001068115234,51.46457290649414,MRK,"Earnings Expectations For The Week Of February 2: Disney, Exxon, GM And More ||| Will Merck's (MRK) Q4 Earnings be Hit by Patent Expiries? - Analyst Blog",1,0.51484746
2015-02-03,11477500.0,60.88999938964844,61.060001373291016,59.93999862670898,61.02000045776367,51.58292007446289,MRK,"Pre-Market Earnings Report for February 4, 2015 : MRK, GM, SO, ADP, CTSH, MPC, SE, HUM, BSX, LVLT, SEP, WHR ||| Why Esperion Therapeutics Inc. Shares Skyrocketed Today ||| Why Advaxis, Inc. Stock Cratered Today ||| Dow Movers: MRK, CAT ||| Irving Kahn Adds to Stakes in Three Companies in Q4 ||| Merck's Insomnia Medicine BELSOMRA® (suvorexant) C-IV, the First and Only Orexin Receptor Antagonist, Now Available in the United States",0,0.5073538
2015-02-04,19446700.0,59.970001220703125,60.0,58.34000015258789,59.04999923706055,49.9175910949707,MRK,"Futures Defensive as Oil Reverses Course, Job Data Disappoints ||| Merck (MRK) Beats on Q4 Earnings but Guidance Falls Short - Analyst Blog ||| Why Achillion Pharmaceuticals, Inc. Stock Is Crashing Today ||| Dow Movers: MRK, DIS ||| Health Care Sector Update for 02/04/2015: ACHN,MRK,GILD,ABBV,CTRV,PACB ||| Merck (MRK) Tops on Q4 Earnings & Revenues - Tale of the Tape ||| Earnings Reaction History: Merck & Co. Inc., 60.0% Follow-Through Indicator, 1.6% Sensitive ||| Merck & Co., Inc. Earnings: 1 Sentence That Changed Everything ||| UPDATE: Merck Posts Upbeat Q4 Earnings, Sales Decline ||| Merck Sees FY15 Adj. EPS $3.32-$3.47 Including Items, Sales $38.3B-$39.8B Including Items ||| Merck & Co Reports Q4 Adj. EPS $0.87 Vs Est $0.86, Sales $10.48B Vs Est $10.50B ||| Earning & Economic Calendar for Wednesday February 4, 2015 ||| Earnings Scheduled For February 4, 2015 ||| Keep an Eye on These 10 Stocks for February 4, 2015",1,0.49398413
2015-02-05,12660400.0,59.27000045776367,59.34999847412109,58.5099983215332,59.16999816894531,50.0190315246582,MRK,"Dow Movers: MRK, PFE ||| Company News for February 05, 2015 - Corporate Summary ||| Merck Prices $8B Debt Offering",0,0.49719924
2015-02-06,9864800.0,59.09999847412109,59.77000045776367,58.58000183105469,58.790000915527344,49.69779968261719,MRK,"Gabelli's Q4 Picks Include Acquisition Targets ||| After A Blockbuster 2014, What Will 2015 Hold For Pharmaceutical M&A? ||| Fast Money Halftime Report Final Trade From February 5",0,0.48290202
2015-02-09,10014100.0,58.650001525878906,59.0,57.93000030517578,58.33000183105469,49.30894470214844,MRK,"What's Bad For Gilead Sciences and Merck Is a Good Sign for Patients ||| 5 Things Merck & Co., Inc.'s Management Wants You to Know ||| These Common Medications May Put You At a Greater Risk of Developing Dementia ||| Why Shares of Achillion Pharmaceuticals, Inc. Soared",1,0.495055
2015-02-10,9539400.0,59.0,59.34000015258789,58.77000045776367,58.84999847412109,49.74851989746094,MRK,Don't Worry About Orexigen's Obesity Drug EU Approval,0,0.5018717
2015-02-12,7207700.0,59.0,59.11000061035156,58.59000015258789,58.880001068115234,49.77388381958008,MRK,Amgen's Skin Cancer Drug to Face FDA Advisory Panel - Analyst Blog,0,0.5281634
2015-02-13,7899300.0,58.900001525878906,58.93999862670898,58.61000061035156,58.810001373291016,49.71471786499024,MRK,PRIMECAP Management's New Positions,0,0.50792736
2015-02-17,10187300.0,58.7400016784668,58.970001220703125,58.70000076293945,58.790000915527344,49.69779968261719,MRK,"British Invasion: FDA May Release Genetically Modified Mosquitoes in Florida ||| Forget Traditional Chemotherapy! Could 3D Vaccines Eventually Cure Cancer? ||| Could This Be The Biggest Advance in Hepatitis C since Gilead Sciences' Sovaldi? ||| Hospira Launches Inflectra, Remicade Biosimilar, in Europe - Analyst Blog",1,0.5079781
2015-02-19,9836200.0,58.84999847412109,58.9900016784668,57.810001373291016,58.29999923706055,49.2835807800293,MRK,"XLV, PFE, MRK, GILD: Large Inflows Detected at ETF ||| NewLink Genetics Announces $20M Milestone Payment From MERCK",1,0.52323
2015-02-20,11604800.0,58.150001525878906,58.47999954223633,57.72999954223633,58.34999847412109,49.32585144042969,MRK,What's in Store for Endocyte (ECYT) this Earnings Season? - Analyst Blog,0,0.48303074
2015-02-23,8589900.0,58.38999938964844,58.66999816894531,58.16999816894531,58.29999923706055,49.2835807800293,MRK,"Agilent-ONO Companion Diagnostics Aim - Analyst Blog ||| Dow Movers: BA, UNH ||| Evercore ISI Technical Analysis: The 'Single Best Idea' ||| UPDATE: Merck to Make Upfront Payment NGM of $94M; Acquire 15% Stake in NGM for $106M ||| Merck, NGM Report Broad Strategic Deal to Discover, Develop, Commercialize Novel Biologic Therpeutics",1,0.5122334
2015-02-24,7714100.0,58.4900016784668,58.56999969482422,58.04999923706055,58.36000061035156,49.33430862426758,MRK,Merck Strikes Deal with NGM to Develop Novel Biologics - Analyst Blog ||| Merck Collaborates with Medicines Patent Pool to Expand Access to Pediatric Formulations of Raltegravir in Developing Countries,1,0.5401153
2015-02-25,8455200.0,58.459999084472656,58.970001220703125,58.060001373291016,58.4900016784668,49.44420623779297,MRK,The 3 Biggest Disappointments This Earnings Season ||| Heavy News Day For Several Biotech Stocks,1,0.51558024
2015-02-26,11489100.0,58.65999984741211,59.150001525878906,58.65999984741211,58.959999084472656,49.84150314331055,MRK,"Merck HPV Vaccine GARDASIL®9, Recommended by CDC's Advisory Committee on Immunization Practices for Females Aged 9-26 and Males Aged 9-21",0,0.5058115
2015-02-27,13059900.0,58.88999938964844,59.060001373291016,58.4900016784668,58.540000915527344,49.4864616394043,MRK,"Noteworthy ETF Inflows: IYH, MRK, GILD, AMGN ||| Bayer Q4 Net Income Down Y/Y, Provides 2015 Outlook - Analyst Blog",1,0.5222672
2015-03-02,9667200.0,58.540000915527344,58.88999938964844,58.27999877929688,58.58000183105469,49.52028274536133,MRK,Which Cancer Immunotherapy Will Be the Most Successful? ||| Billionaire George Soros Just Dumped These 3 Dividend Stocks ||| Fast Money Picks For March 2,0,0.478086
2015-03-04,13335200.0,58.40999984741211,58.650001525878906,57.68000030517578,57.880001068115234,48.92852783203125,MRK,"Geron's Q4 Loss Narrows Y/Y, Announces Restructuring Plan - Analyst Blog ||| Merck Announces Co. Eisai Enter Deal to Explore Novel Combo Regimens Anti-PD-1 Therapy with RTK Inhibitor, Microtubule Dynamics Inhibitor for Cancers",1,0.51500106
2015-03-05,11534100.0,58.09000015258789,58.27999877929688,57.79999923706055,57.97999954223633,49.013065338134766,MRK,"Pfizer's Prevenar Cleared in the EU for New Indication - Analyst Blog ||| WHO Reports Phase III Trial of Ebola Vaccine Being Developed by Merck, NewLink to Begin March 7",0,0.46886483
2015-03-06,11064700.0,57.84999847412109,57.869998931884766,56.720001220703125,56.84000015258789,48.04937744140625,MRK,Merck Inks Deal with Eisai for Cancer Combo Therapy - Analyst Blog,1,0.54761344
2015-03-09,8342000.0,56.84000015258789,57.369998931884766,56.29999923706055,57.2599983215332,48.4044189453125,MRK,"In Case You Missed It, This New Cancer Care Cost Study Is Extremely Disappointing ||| IYH, PFE, MRK, GILD: ETF Inflow Alert ||| Merck's Partnership With NGM Is A Bold Move",0,0.50598705
2015-03-10,13125000.0,56.95000076293945,57.18999862670898,56.4900016784668,56.58000183105469,47.829586029052734,MRK,Bristol-Myers Squibb's $1.6 Billion On New Drug Deals Is Well Spent ||| 8 Healthcare Names Cowen & Co Are Talking About,0,0.4923257
2015-03-11,15665300.0,57.4900016784668,57.4900016784668,55.970001220703125,56.060001373291016,47.39001083374024,MRK,"Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for March 12, 2015 ||| Health Care Sector Update for 03/11/2015: MRK, HTBX, ADXS ||| US Stock Futures Signal Higher Start On Wall Street ||| Merck Announces KEYTRUDA is First Medicine to be Made Available to Patients Through UK EAMS for Advanced Melanoma",1,0.48061323
2015-03-12,12954300.0,55.81999969482422,56.220001220703125,55.65999984741211,56.16999816894531,47.86723709106445,MRK,Measles Cases Could ~Double in W African Countries Due to Stain on Health Systems from Ebola Outbreak; Inability to Maintain Child Immunizations -Reuters,1,0.51561093
2015-03-13,13072900.0,56.02999877929688,56.43000030517578,55.63999938964844,56.20000076293945,47.89280700683594,MRK,Merck Provides Regulatory Update On Sugammadex Injection,1,0.54108346
2015-03-16,11520800.0,56.58000183105469,57.31999969482422,56.58000183105469,57.119998931884766,48.67681121826172,MRK,"One Put, One Call Option To Know About for Merck & Co. ||| Why Advaxis, Inc. Stock Ripped Higher Today ||| Merck's Sugammadex Faces Setback, FDA Delays Meeting - Analyst Blog ||| Merck Announced Results From Investigational IMPROVE-IT Study That Shows VYTORIN Reduced Total Cardiovascular Events By 9% Vs. SIMVASTATIN",0,0.5179545
2015-03-17,9999400.0,56.88999938964844,56.88999938964844,56.2400016784668,56.470001220703125,48.12288284301758,MRK,Merck Reports Encouraging Data from Cardiovascular Study - Analyst Blog,1,0.54716206
2015-03-18,14928500.0,56.38999938964844,57.970001220703125,56.209999084472656,57.650001525878906,49.12846755981445,MRK,Why I'm Not Giving Up on This Tiny Biotech Stock (Yet),1,0.47569034
2015-03-19,14455900.0,57.43000030517578,58.34000015258789,57.02999877929688,58.209999084472656,49.605690002441406,MRK,Option Alert: Merck Mar $57.5 Call; 4200 Contract Trade above Ask @$0.25; Now $57.60,1,0.4990097
2015-03-23,10658500.0,58.400001525878906,59.13999938964844,58.040000915527344,58.72999954223633,50.04883193969727,MRK,"3 Things You Need to Know About Achillion Pharmaceuticals Inc. ||| One Put, One Call Option To Know About for Merck & Co. ||| SunTrust Names Eli Lilly, Merck, Bristol-Myers as 'Favorite' Pharma Firms",0,0.5180996
2015-03-24,13065300.0,59.40999984741211,59.70000076293945,58.5099983215332,58.630001068115234,49.9636116027832,MRK,"Dow Movers: IBM, MRK ||| Merck Announces New $10B Share Repurchase Program ||| Merck's Pivotal KEYNOTE-006 Study in First-Line Treatment for Advanced Melanoma Met Co-Primary Endpoints, Will be Stopped Early",0,0.49491158
2015-03-25,14038400.0,59.5,59.709999084472656,58.18000030517578,58.2599983215332,49.64829635620117,MRK,"Dow Movers: MSFT, MRK ||| Wednesday's ETF with Unusual Volume: PPH ||| Key Catalysts Are Coming For Merck, Analyst Predicts",0,0.49985868
2015-03-26,10582900.0,58.040000915527344,58.20000076293945,57.40999984741211,57.59999847412109,49.08586502075195,MRK,Merck in $10B Buyback; Keytruda Tops Melanoma Study - Analyst Blog ||| Merck Announces Deal with American Diabetes Association for Education of Adults with Diabetes,1,0.50984484
2015-03-27,8523500.0,57.83000183105469,58.22999954223633,57.630001068115234,57.75,49.21369552612305,MRK,Is This Tiny Biotech Still a Buy at All-Time Highs? ||| Immune Design Starts Dosing Patients in CMB305 Study - Analyst Blog ||| EMA Recommends Approval of Merck's Gardasil 9 Vaccine,1,0.5380974
2015-03-30,8189000.0,58.25,58.540000915527344,58.150001525878906,58.34000015258789,49.71648025512695,MRK,"Out of 12 Big Pharma Stocks, This is the 1 You Can Confidently Hold for the Next 10 Years ||| Is Gilead Sciences Inc. About to Crater Before Our Very Eyes?",0,0.46768242
2015-03-31,10458700.0,58.18999862670898,58.310001373291016,57.47999954223633,57.47999954223633,48.98359680175781,MRK,"Why It's Not Too Late to Buy Agenus, Inc. Stock ||| The Single Worst Practice of the Drug Industry ||| Syndax and Merck to Partner on Immuno-Oncology Study Evaluating Entinostat in Combination with KEYTRUDA (pembrolizumab) in Lung Cancer and Melanoma",0,0.4988787
2015-04-01,12712200.0,57.2599983215332,57.31999969482422,56.220001220703125,56.86000061035156,48.45524597167969,MRK,"Dow Movers: BA, AXP ||| Merck Inks Deal with Syndax for Cancer Combo Therapy - Analyst Blog",1,0.5353347
2015-04-06,12649200.0,56.93000030517578,57.34000015258789,56.709999084472656,57.18000030517578,48.727935791015625,MRK,"10 Largest Companies by Market Cap in Pharmaceuticals ||| Disruptive Innovation Changing the Fight Against Cancer ||| Notable ETF Inflow Detected - XLV, MRK, GILD, UNH ||| BIND Extends Collaboration with Pfizer to Develop Accurins - Analyst Blog ||| Gilead Alert: What Deutsche Bank Is Saying ||| Merck Shares Teetering On The Brink Of A Further Downside Correction ||| Top 4 Large-Cap Stocks In The Drug Manufacturers Industry With The Highest ROE",1,0.5241021
2015-04-07,9278300.0,57.65999984741211,57.880001068115234,57.29999923706055,57.43000030517578,48.94099044799805,MRK,"Health Care Sector Update for 04/07/2015: CDTX, GLYC, MRK ||| Merck's Keytruda Is Ahead, But Bristol-Myers' Squibb's Opdivo Could Catch Up ||| Sector ETFs And Earnings ||| Arvinas in Strategic R&D Collaboration With Merck to Study Novel Protein Degradation Technology",0,0.46970767
2015-04-08,13559700.0,57.90999984741211,58.04999923706055,57.02000045776367,57.150001525878906,48.7023811340332,MRK,"Why Advaxis Inc. Shares Soared Today ||| Advaxis, Merck Report Initiation of Enrollment in Phase 1/2 Study of ADXS-PSA in Combo with Anti-PD-1 Therapy ||| Grazoprevir/Elbasvir, Merck's Investigational Chronic Hepatitis C Therapy, Granted FDA Breakthrough Therapy Designations; New Phase 2, 3 Data in Multiple HCV Patient Types Will Be Presented At The International Liver Congress TM 2015",1,0.50572777
2015-04-09,12006000.0,57.220001220703125,57.72999954223633,57.11000061035156,57.43000030517578,48.94099044799805,MRK,Merck's HCV Combo Drug Gets Two Breakthrough Status - Analyst Blog ||| The Biotech Stocks JMP Is Watching,0,0.5164404
2015-04-10,15507500.0,57.04999923706055,57.650001525878906,56.31999969482422,57.25,48.78759765625,MRK,"Dow Movers: MRK, GE ||| Biotech Investors: Nomura Says To Watch These Dates",0,0.4927798
2015-04-13,10480900.0,57.08000183105469,57.369998931884766,56.5,56.72999954223633,48.34445571899414,MRK,3 Best Dividend Stocks in Healthcare ||| AstraZeneca's Onglyza Briefing Documents Raise Concern - Analyst Blog,1,0.5347728
2015-04-14,14656200.0,56.93999862670898,57.9900016784668,56.61000061035156,57.7599983215332,49.222206115722656,MRK,"XLV, MRK, GILD, UNH: ETF Outflow Alert ||| Morgan Stanley's Major Pharma Q1 Preview ||| UPDATE: Phase III Trial of the Merck and NewLink Genetics Investigational Ebola Vaccine Initiated in Sierra Leone ||| Ebola vaccine trial begins in Sierra Leone",1,0.5223048
2015-04-15,12108800.0,58.06999969482422,58.95000076293945,58.06999969482422,58.45000076293945,49.81021881103516,MRK,"Dow Analyst Moves: MRK ||| Dow Movers: MCD, INTC ||| SunTrust's Latest Comments On Merck ||| Canine Flu Outbreak Reported in Chicago Area -Wall Street Journal",0,0.49492216
2015-04-16,6409400.0,58.209999084472656,58.38999938964844,57.7400016784668,57.84000015258789,49.29039001464844,MRK,AstraZeneca's Onglyza Label Needs Revision per FDA Panel - Analyst Blog,0,0.51909924
2015-04-17,11663400.0,57.34999847412109,57.36000061035156,56.56999969482422,56.880001068115234,48.4722900390625,MRK,It's A Big Weekend For Biotech,1,0.52770925
2015-04-20,9961400.0,57.5,58.0,57.38999938964844,57.61000061035156,49.09437942504883,MRK,"What Could Possibly Go Wrong With Gilead Sciences Inc. Stock? ||| 3 Drug Stocks Leading the Charge Against Infectious Diseases ||| Best Pure Play Investment in Cancer Drugs ||| Early Findings with Merck's Pembrolizumab in Patients with Advanced Pleural Mesothelioma Presented at AACR Annual Meeting ||| Merck Announces New Data on Treatment of Advanced NSCLC with Pembrolizumab Presented at AACR Annual Meeting, Published in NEJM ||| Early Findings with KEYTRUDA in Patients with Advanced Pleural Mesothelioma Presented at AACR Annual Meeting ||| Merck Submits sBLA to FDA for KEYTRUDA in Advanced Non-Small Cell Lung Cancer ||| Dow Movers: GE, IBM ||| Midday Update: Stocks Reversing Friday Sell-Off After China Trims Reserve Requirements, Raises Liquidity ||| Is Bristol-Myers Squibb. Co. About to Fall Apart? ||| Health Care Sector Update for 04/20/2015: TLOG,GENE,AMPE, MRK ||| Merck's Keytruda Tops Melanoma, Lung Cancer Studies - Analyst Blog ||| CAR-T Therapy Stocks Hit Hard Following AACR Data ||| Merck Will File ""Totality Of Data"" Regarding Hep C Drugs To FDA; Won't Limit FDA Filing To Breakthrough Status According To Phonecall With VP, Infectious Diseases Eliav Barr ||| Morning Market Gainers ||| Tetralogic Announces Co., Merck Will Collaborate Related to Evaluation of Birinapant In Combo With KEYTRUDA in Solid Tumors",1,0.52028507
2015-04-21,9255500.0,58.0099983215332,58.02999877929688,57.40999984741211,57.65999984741211,49.13698959350586,MRK,Bristol-Myers Announces Positive Data from Opdivo Study - Analyst Blog ||| Morgan Stanley Awaits This Merck Data,1,0.51221997
2015-04-22,7914600.0,57.560001373291016,57.88999938964844,57.31999969482422,57.68999862670898,49.16255187988281,MRK,"IHE, MRK, BMY, LLY: Large Inflows Detected at ETF ||| Goat Plague (PPR) Affecting Herds in Africa, Asia -Reuters ||| UPDATE: Organovo Shares Rise 15% Following Announcement of Deal With Merck ||| Organovo Announces Multi-Year Research Collaboration Agreement With Merck Sharp & Dohme Corp",0,0.5039228
2015-04-23,8342000.0,57.52000045776367,57.84999847412109,57.040000915527344,57.5099983215332,49.0091552734375,MRK,"FDA Sentinel Study Finds No Association Between Venous Thromboembolism, Gardasil Vaccination -Reuters ||| Merck Announces 99% of Patients in Phase 2/3 Study of Grazoprevir/Elbasvir Achieved Sustained Virologic Response",1,0.5445257
2015-04-24,7866500.0,57.84999847412109,58.18999862670898,57.5099983215332,57.59999847412109,49.08586502075195,MRK,Illumina's Earnings Set Positive Tone for Biotech ||| Merck Reports Encouraging Data on HCV Combo Candidate - Analyst Blog ||| The Parade of Weak Earnings Reports Continues - Earnings Preview ||| Morgan Stanley Alert: Gilead Investors Don't Have The Whole Story ||| Analyst: Biogen Will Miss On Tecfidera Sales; No Threat To Gilead's Harvoni ||| Merck's Pivotal Phase 3 C-EDGE Program Evaluating Grazoprevir/Elbasvir Shows High Sustained Virologic Responses Across Broad Range of Patients with Chronic Hepatitis C Virus Infection,0,0.4888971
2015-04-27,10599600.0,57.83000183105469,58.02999877929688,56.880001068115234,57.09999847412109,48.659767150878906,MRK,"Are Biosimilars the Next Big Thing in Biotech? ||| If You Live in This State, You May Lose the Choice Whether to Vaccinate Your Kids ||| Does Apple Hide More Cash Abroad Than Anyone? ||| U.S. Tech, Dollar & Health Care ETFs To Watch This Week ||| Apple & Other Earnings Expected To Dominate The Week Of April 27 ||| Pre-Market Earnings Report for April 28, 2015 : PFE, MRK, BMY, UPS, F, BP, AET, ECL, VLO, MHFI, GLW, TMUS ||| Will Merck's (MRK) Q1 Earnings be Hit by Generics & Currency? - Analyst Blog ||| Apple, Pfizer, Merck, Ford and UPS are part of Zacks Earnings Preview: - Press Releases ||| Merck Offers Results of Trial Evaluating CV Outcomes with Sitagliptin: Says Met Primary Endpoint ||| Merck Earnings: The Street And The Crowd Expect A Double-Digit Year-Over-Year Decline",1,0.50498253
2015-04-28,34731200.0,57.09999847412109,60.47999954223633,57.09999847412109,59.97999954223633,51.11405563354492,MRK,"Technology Sector Update for 04/28/2015: MRK,AEZS,IDXX ||| Dow Movers: AAPL, MRK ||| Merck (MRK) Beats on Q1 Earnings & Revenues, Ups View - Analyst Blog ||| Tumor profiling goes public: HTG Molecular Diagnostics sets terms for $50 million IPO ||| Midday Update: Stocks Rebound From Weak Consumer Confidence, Persian Gulf Incident ||| Earnings Reaction History: Merck & Co. Inc., 70.0% Follow-Through Indicator, 1.8% Sensitive ||| Close Update: Stocks Mixed As Early FOMC-Related Pressure Dissipates; Nasdaq Bends to Pressure on Apple ||| After Hours Most Active for Apr 28, 2015 : EIGI, TWTR, QQQ, GPRO, NOK, MSFT, CX, IBN, SAN, MRK, ICON, FTR ||| Pre-Market Most Active for Apr 28, 2015 : SIRI, AAPL, F, ERIC, VIV, COH, MRK, ERII, PBR, AMAT, GSK, QQQ ||| Morning Market Gainers ||| Bank Of America On Merck: 'MAGNIF-TECOS!' ||| Benzinga's Top #PreMarket Gainers ||| Merck Beats Q1 Estimates, Shares Rise ||| Merck Raises FY15 Adj. EPS Outlook from $3.32-$3.47 Previously to $3.35-$3.48 vs $3.37 Est., Affirms Sales Outlook ||| Merck Reports Q1 EPS $0.85 vs. Est. $0.74, Rev. $9.4B vs. Est. $8.99B ||| Earning & Economic Calendar for Thursday April 28, 2015 ||| Earnings Scheduled For April 28, 2015",0,0.5140109
2015-04-29,17192000.0,59.33000183105469,60.43000030517578,59.22999954223633,59.68000030517578,50.85840225219727,MRK,"Stock Market News for April 29, 2015 - Market News ||| Merck & Co., Inc. Earnings: 3 Big Surprises You Won't Read in the Headlines ||| What's Wall Street Been Saying About Gilead Lately?",0,0.4617873
2015-04-30,13012400.0,59.790000915527344,60.13999938964844,59.2400016784668,59.560001373291016,50.756141662597656,MRK,Vanguard Health Care ETF Experiences Big Inflow,1,0.52222335
2015-05-01,9357500.0,59.7599983215332,60.380001068115234,59.68000030517578,59.86000061035156,51.01179504394531,MRK,"Bayer (BAYRY) Q1 Net Income Down Y/Y, 2015 Outlook Up - Analyst Blog ||| Dow Movers: CVX, MRK ||| Hearing Unconfirmed Market Chatter of Potential Merck Bid for Lilly ||| Bank Of America Reviews Gilead Earnings",1,0.5053567
2015-05-04,9050400.0,60.13999938964844,60.95000076293945,60.02999877929688,60.63999938964844,51.6765022277832,MRK,"Dow Movers: BA, UTX",0,0.51687974
2015-05-05,12082100.0,60.31999969482422,60.70000076293945,60.060001373291016,60.4900016784668,51.548675537109375,MRK,"Credit Suisse: We Prefer Pfizer, Bristol Over Pharma Peers",0,0.47819114
2015-05-06,11570900.0,60.45000076293945,60.59000015258789,59.93000030517578,60.2599983215332,51.35266876220703,MRK,"Merck's Stock Price, Dividend Yield Beating S&P 500 ||| MRK Dividend Yield Pushes Past 3%",1,0.49287117
2015-05-08,10143400.0,61.0,61.380001068115234,60.70000076293945,60.7400016784668,51.76171875,MRK,"After Hours Most Active for May 8, 2015 : ESRX, VZ, MSFT, CMCSA, RIG, MAT, NVDA, PHH, NLSN, EMC, MRK, INTC",0,0.48512334
2015-05-11,9718900.0,60.65999984741211,60.68999862670898,59.84000015258789,60.0,51.131103515625,MRK,"One Put, One Call Option To Know About for Merck ||| IWB, MRK, GILD, V: Large Inflows Detected at ETF",0,0.48268697
2015-05-12,13191900.0,59.54999923706055,59.72999954223633,59.11000061035156,59.43999862670898,50.65388107299805,MRK,"GSK, NewLink Vaccine Trials May Not Produce Useful Efficacy Data as Ebola Disappears in W. Africa -Reuters",0,0.48759195
2015-05-14,7127300.0,59.470001220703125,59.88999938964844,59.04999923706055,59.77999877929688,50.9436149597168,MRK,How a Strong Dollar Affects Pharmaceutical Stocks,1,0.53255177
2015-05-15,7665700.0,59.93999862670898,60.22999954223633,59.810001373291016,60.22999954223633,51.32710266113281,MRK,Heron Therapeutics' HTX-019 Meeting with FDA Successful - Analyst Blog,0,0.5250429
2015-05-18,7190400.0,60.16999816894531,60.45000076293945,60.0099983215332,60.0099983215332,51.13962173461914,MRK,Big Pharma Stocks: Where to Invest Your Money Now,1,0.51461583
2015-05-22,8990400.0,60.06999969482422,60.06999969482422,59.34000015258789,59.380001068115234,50.60275650024414,MRK,"IVV, JNJ, MRK, KO: ETF Outflow Alert ||| Health Care Sector Update for 05/22/2015: SRPT, AMGN, MRK ||| Expert Explains How To Play Merck In 2 Charts ||| Merck Release Confirms CHMP Positive Recommendation for KEYTRUDA ||| EMA Gives Positive Opinion for Merck's Melanoma Drug Keytruda",0,0.48524517
2015-05-26,10857700.0,59.27999877929688,59.43999862670898,58.84999847412109,58.970001220703125,50.25334930419922,MRK,5 Reasons Your Health Insurance Premium Will Likely Rise in 2016 ||| Merck's (MRK) Keytruda a Step Closer to European Approval - Analyst Blog ||| Option Alert: Merck May 29 $60 Call; 6682 Contract Trade at Ask @$0.11; Now $59.10,1,0.5030484
2015-05-27,9726700.0,59.09000015258789,59.77999877929688,58.869998931884766,59.459999084472656,50.67092514038086,MRK,"Daily Dividend Report: MRK, DE, ESS, STR, DSW, MOV",1,0.502662
2015-05-28,9530100.0,59.45000076293945,59.84999847412109,59.380001068115234,59.70000076293945,50.875450134277344,MRK,Gilead's Sustainable Competitive Advantage ||| Merck Announces Has Submitted NDA for Grazoprevir/Elbasvir in US,1,0.53056234
2015-05-29,20015600.0,59.880001068115234,61.119998931884766,59.470001220703125,60.88999938964844,51.88954544067383,MRK,"Is A Big Acquisition Is Due For Pfizer? ||| Weekly Market Wrap: May 29, 2015 ||| Merck Shares Spike Higher Following Report on Study Evaluating DNA Mismatch Repair as Genetic Guide for Immunotherapy Treatment with KEYTRUDA ||| Merck Shares Spiking Higher on Durable Anti-Tumor Activity With KEYTRUDA ||| Initial Study Evaluating DNA Mismatch Repair as Genetic Guide for Immunotherapy Treatment with Merck's KEYTRUDA (pembrolizumab) Showcased at 2015 ASCO Annual Meeting and Published in the New England Journal of Medicine ||| Amgen, Merck Report Expansion of Collaboration to Support Studies of Talimogene Laherparepvec in Combo with KEYTRUDA in Patients with Head and Neck Cancer",0,0.47906503
2015-06-01,11807400.0,60.84999847412109,61.70000076293945,60.34000015258789,60.75,51.770240783691406,MRK,"TESARO, Merck to Collaborate on Combination Study of Niraparib, KEYTRUDA ||| A Stock Market Bubble In Healthcare Stocks? ||| Dow Movers: UNH, MRK ||| Merck Reports Acceptance of sBAL for KEYTRUDA in Advanced Non-Small Cell Lung Cancer, Priority Review Granted ||| Merck, Dynavax Partner On Investigating Combination Of Immuno-Oncology Therapies ||| Merck Announces New Data on Breadth of KEYTRUDA at ASCO: Anti-Tumor Activity Now Shown in 13 Different Tumor Types",0,0.5122486
2015-06-02,8993000.0,60.45000076293945,60.459999084472656,59.81999969482422,60.2400016784668,51.33563232421875,MRK,Merck's Keytruda under Priority Review for Lung Cancer - Analyst Blog,1,0.53012145
2015-06-03,8662400.0,60.65999984741211,60.880001068115234,60.2599983215332,60.38999938964844,51.46345901489258,MRK,Merck Announces Results from Investigational IMPROVE-IT Study of VYTORIN Published in NEJoM,0,0.51282465
2015-06-04,10830300.0,59.959999084472656,60.209999084472656,59.27000045776367,59.470001220703125,50.679447174072266,MRK,Agenus Gains after Merck Extends Immuno-Oncology Ties - Analyst Blog ||| ALK Announces Merck's North American Phase III Trial of House Dust Mite SLIT-Tablet Meets Primary Endpoint,0,0.4733072
2015-06-05,10881800.0,59.36000061035156,59.40999984741211,58.79999923706055,58.9900016784668,50.27040100097656,MRK,This Terrifying Cancer May Finally Be Treatable ||| 5 Stocks to Buy for June,0,0.50494874
2015-06-08,8047800.0,58.88999938964844,59.16999816894531,58.7599983215332,58.869998931884766,50.16813278198242,MRK,"The Highest Paid CEOs in Pharma ||| Is Gilead Sciences Inc.'s Moat Filling Up With Sand? ||| Problems With Obamacare That Could Prove Difficult to Fix ||| Ligand Pharmaceuticals Reports Type II Diabetes Drug Data - Analyst Blog ||| Benzinga's M&A Chatter for Monday June 8, 2015 ||| TECOS, Merck's Cardiovascular Safety Trial of JANUVIA, Met Primary Endpoint in Patients with Type 2 Diabetes ||| This Technology Could Disrupt U.S. Pharma Stocks, Credit Suisse Says ||| Option Alert: Celgene Jun $116 Call; 1000 Contract Trade above Ask @$1.14; Now $112.95 ||| UPDATE: Celgene Shares at High Following Early Rumored Bid from Merck ||| Hearing Unconfirmed Market Chatter of Potential Merck Bid for Celgene ||| Merck KGaA, Darmstadt, Germany, Illumina and Genea Create the Global Fertility Alliance for Excellence in Assisted Reproductive Treatment",0,0.5151871
2015-06-10,10223200.0,58.97999954223633,59.65999984741211,58.90999984741211,59.61000061035156,50.79875564575195,MRK,"DLN, KO, MRK, CSCO: Large Outflows Detected at ETF ||| Celgene and Lycera Collaborate, Acquisition Option Included - Analyst Blog ||| Merck, Samsung Bioepis Report Pivotal Phase 3 Studies for Investigational Biosimilars SB4, Enbrel (Etanercept), and SB2, Remicade (Infliximab), Met Primary Endpoints ||| US Stock Futures Signal Higher Start On Wall Street ||| Merck Publishes ALK's Data On Phase II House Dust Mite SLIT-Tablet In Leading Allergy Journal ||| TECOS, Merck's Cardiovascular Safety Trial of JANUVIA, Met Primary Endpoint in Patients with Type 2 Diabetes",0,0.5126402
2015-06-11,11640300.0,59.20000076293945,59.369998931884766,58.84000015258789,58.90999984741211,50.5840950012207,MRK,"Merck (MRK) Presents Multiple Biosimilar and Diabetes Data - Analyst Blog ||| Health Care Sector Update for 06/11/2015: DRNA,ALNY,MRK,PTBI,PBMD ||| Dow Movers: GE, BA",0,0.48458168
2015-06-15,10106500.0,57.59999847412109,57.63999938964844,57.02000045776367,57.119998931884766,49.04706573486328,MRK,"One Put, One Call Option To Know About for Merck & Co. ||| Is Medicare in Danger from Free Trade? ||| JMP Sees A 'Negative Market Tone' In Biotechnology",1,0.48996365
2015-06-16,6968900.0,57.2400016784668,57.72999954223633,56.880001068115234,57.709999084472656,49.55368423461914,MRK,"Benzinga's M&A Chatter for Tuesday June 16, 2015 ||| New Report: Abbvie Is Jefferies' Top Global Pharma Stock ||| Alkermes Declines Comment on Rumored Potential Bid from Merck ||| Alkermes Shares Off the Highs; Shares Moving Higher on Takeover Chatter, Upcoming Presentation of Data from Late-Stage CNS Portfolio ||| Hearing Merck Approached Dublin Based Alkermes With $12.4B Offer-Market Sources",1,0.51061183
2015-06-17,7917300.0,57.709999084472656,58.16999816894531,57.470001220703125,57.90999984741211,49.72541046142578,MRK,"Hearing Dept. of Justice Has Said Merck's Inspire Pharma to Pay $5.9M to Settle Civil Claims of Fraud ||| The Note Moving Pharma Giants Today ||| Organovo Has Upside To $6/Share, Cantor Fitzgerald Says ||| Piper Jaffray Initiates Coverage on Merck & Co at Neutral",1,0.49423566
2015-06-19,12613500.0,58.40999984741211,58.84000015258789,57.95000076293945,58.040000915527344,49.8370361328125,MRK,Why Bristol-Myers Squibb Co.'s Stock Could Sink,1,0.50776386
2015-06-22,8362500.0,58.790000915527344,59.20000076293945,58.43000030517578,58.83000183105469,50.51538848876953,MRK,"Barron's Recap: Airline Stocks Ready To Soar ||| Barron's Says Merck Shares Could Rise More than 20% to $70 ||| VHT, MRK, BMY, LLY: Large Inflows Detected at ETF ||| Where Can Mega-Drug Stock Gilead Sciences Go Now?",1,0.49971986
2015-06-25,9951200.0,58.25,58.59999847412109,57.720001220703125,57.900001525878906,49.716827392578125,MRK,Bayer Contraceptive Essure to Face FDA Panel on Complaints - Analyst Blog,1,0.5341411
2015-06-29,9601200.0,57.93000030517578,58.220001220703125,57.25,57.290000915527344,49.19304275512695,MRK,Interesting October Stock Options for MRK ||| Merck Announces Phase 3 Study of Single-Dose EMEND® (fosaprepitant dimeglumine) for Injection Regimen Met Primary Endpoint,0,0.5063977
2015-06-30,11847300.0,57.709999084472656,57.709999084472656,56.709999084472656,56.93000030517578,48.8839225769043,MRK,"Celldex's Rintega Phase III Study Recommended to Continue - Analyst Blog ||| Noteworthy ETF Inflows: VHT, PFE, MRK, UNH ||| Stock Market News for June 30, 2015 - Market News",1,0.4839036
2015-07-02,8518400.0,57.93999862670898,58.33000183105469,57.5,57.66999816894531,49.51933288574219,MRK,Exelixis-Roche's Skin Cancer Drug's FDA Review Delayed - Analyst Blog,0,0.51632744
2015-07-06,8054100.0,57.2400016784668,57.84000015258789,56.63999938964844,57.54999923706055,49.41628646850586,MRK,9 Top Sell Ideas From Oppenheimer's Technical Analysis Division,1,0.5485291
2015-07-07,9034300.0,57.75,58.09999847412109,57.18000030517578,57.9900016784668,49.79410934448242,MRK,"Allergan, Merck Enter Licensing Agreement to Obtain Exclusive Worldwide Rights to CGRP Migraine Development Program",0,0.52164096
2015-07-08,9111600.0,57.72999954223633,57.7400016784668,57.119998931884766,57.34999847412109,49.24456024169922,MRK,"Notable ETF Inflow Detected - VHT, PFE, MRK, UNH ||| Allergan Buys Rights to Merck's Migraine Drugs for $250M - Analyst Blog",1,0.5396421
2015-07-09,8677800.0,58.040000915527344,58.16999816894531,57.34999847412109,57.380001068115234,49.270320892333984,MRK,"Barclays Expects M&A In Specialty Pharma To Continue, Likes Valeant And Jazz",1,0.5279017
2015-07-10,8047400.0,58.06999969482422,58.25,57.58000183105469,57.95000076293945,49.75975799560547,MRK,Strong Dollar? Not So Good For Johnson & Johnson Earnings,0,0.48300484
2015-07-14,7235100.0,57.900001525878906,58.27999877929688,57.68000030517578,58.18999862670898,49.96583557128906,MRK,"J&J Beats on Q2 Earnings, Raises 2015 Earnings Outlook - Analyst Blog ||| Roche's Bladder Cancer Study Meets Primary Endpoint - Analyst Blog ||| Why We Are Ahead On Merck",1,0.511106
2015-07-16,5324700.0,58.5099983215332,58.869998931884766,58.34999847412109,58.81999969482422,50.506797790527344,MRK,Bullish Two Hundred Day Moving Average Cross - MRK,0,0.49243808
2015-07-20,5697200.0,58.959999084472656,59.20000076293945,58.86000061035156,59.0,50.66136932373047,MRK,"One Put, One Call Option To Know About for Merck & Co.",0,0.49947327
2015-07-21,6932800.0,58.9900016784668,59.02000045776367,58.650001525878906,58.66999816894531,50.37799835205078,MRK,Will Agenus (AGEN) Disappoint Investors this Earnings? - Analyst Blog,0,0.49163565
2015-07-22,8617800.0,58.5099983215332,59.02999877929688,58.0099983215332,58.130001068115234,49.91432189941406,MRK,"Daily Dividend Report: AAPL, MRK, JCI, ZTS, NTRS, FIS, MTB, AA, TXT ||| What's Coming For Large-Cap Pharma Stocks This Earnings Season? ||| European Commission Approves MSD's Anti-PD-1 Therapy, KEYTRUDA® (pembrolizumab), for Both First-line and Previously-treated Patients with Advanced Melanoma",0,0.48589376
2015-07-23,6441600.0,58.52999877929688,58.52999877929688,57.93999862670898,58.06999969482422,49.8628044128418,MRK,"Merck's Anti-PD-1 Therapy Melanoma Drug Gets EU Nod - Analyst Blog ||| MSD Reports European Medicines Agency Acceptance of Marketing Authorisation Application for Grazoprevir/Elbasvir, an Investigational Therapy for Treatment of Chronic Hepatitis C Infection ||| RaNA Therapeutics Announces $55 Million in Oversubscribed Series B Financing Led by Merck",0,0.5177694
2015-07-24,7847100.0,57.709999084472656,57.880001068115234,57.31999969482422,57.40999984741211,49.29608154296875,MRK,"Will Merck (MRK) Pull a Surprise this Earnings Season? - Analyst Blog ||| Weekly Market Wrap: July 24, 2015",0,0.4730344
2015-07-27,14887000.0,57.43000030517578,57.45000076293945,56.630001068115234,56.9900016784668,48.93544387817383,MRK,"Norfolk Southern, Roper Industries, Pfizer, Merck and IBM are part of Zacks Earnings Preview: - Press Releases ||| VHT, PFE, MRK, UNH: Large Inflows Detected at ETF ||| 4 Stocks to Fight the Virus on World Hepatitis Day - Analyst Blog ||| 3 Important Questions We Want Answered When Merck Reports Its Q2 Results ||| Dollar Plagues Pharma Earnings But Did Street Get It Right? ||| Merck Receives Positive CHMP Opinion for Investigational Antibiotic ZERBAXA",1,0.4979209
2015-07-28,16387100.0,56.52000045776367,57.63999938964844,55.83000183105469,57.52000045776367,49.39053726196289,MRK,"The Zacks Analyst Blog Highlights: Gilead Sciences, AbbVie, Merck, Achillion Pharmaceuticals and Express Scripts - Press Releases ||| Merck (MRK) Tops on Q2 Earnings & Revenues - Tale of the Tape ||| Earnings Reaction History: Merck & Co. Inc., 60.0% Follow-Through Indicator, 1.5% Sensitive ||| After Hours Most Active for Jul 28, 2015 : TWTR, SIG, JD, PRXL, ACWI, T, ABEV, MRK, BAC, GILD, UTIW, FB ||| Merck Q2 Profit Beats Estimates ||| UPDATE: Merck Sees FY15 Adj. EPS $3.45-$3.55 vs $3.45 Est. ||| Merck Narrows, Raises FY15 Adj. EPS Outlook ||| Merck Reports Q2 Adj. EPS $0.86 vs $0.81 Est., Sales $9.8B, Inline ||| Merck Boosts Immuno-Oncology Portfolio with Acquisition of cCAM Biotherapeutics ||| Merck Announces FDA Priority Review For NDA For Hepatits C Treatment ||| Earnings Scheduled For July 28, 2015 ||| 10 Stocks You Should Be Watching Today",1,0.48375157
2015-07-29,12876000.0,57.68999862670898,58.81999969482422,57.63999938964844,58.540000915527344,50.26637649536133,MRK,"How To YieldBoost Merck & Co. To 4.9% Using Options ||| Company News for July 29, 2015 - Corporate Summary ||| Why Merck is a Top Socially Responsible Dividend Stock (MRK)",0,0.4890592
2015-07-30,6989500.0,58.619998931884766,58.81999969482422,58.27999877929688,58.52000045776367,50.24920654296875,MRK,"Bayer (BAYRY) Q2 Revenues Up Y/Y, 2015 Guidance Revised - Analyst Blog",1,0.5301244
2015-07-31,8752500.0,59.0,59.33000183105469,58.70000076293945,58.959999084472656,50.62702178955078,MRK,5 Key Points You May Have Missed in Merck's Q2 Report ||| Merck Announces Global Collaboration Enabled Vaccine for Ebola Will Move from First-in-Human to Initial Phase 3 Results Within One Year ||| WHO Says Initial Results from Merck/Newlink VSV-EBOV Ebola Vaccine Look Promising -Reuters,1,0.5389208
2015-08-03,6807000.0,59.29999923706055,59.45000076293945,58.47999954223633,59.04999923706055,50.70429611206055,MRK,"Dow Movers: CVX, DIS ||| Codexis Reports CodeEvolver Technology Transfer, License Deal with Merck; Will Receive Up to $5M Upfront Payment, Eligibile for Up to $18M in Milestones",0,0.5177068
2015-08-04,6935800.0,59.43999862670898,59.470001220703125,58.369998931884766,58.70000076293945,50.403770446777344,MRK,"Big Pharma Tops Q1 Earnings & Revenue: ETFs in Focus - ETF News And Commentary ||| Health Care Sector Update for 08/04/2015: CDXS, MRK, IPCM, ELGX ||| Guinea, Sierra Leone Each Recorded Single Cases of Ebola in Past Week; WHO Says Risks Remain -Reuters ||| Morning Market Gainers",1,0.5338567
2015-08-05,5702600.0,59.08000183105469,59.27999877929688,58.77000045776367,59.09999847412109,50.74722671508789,MRK,Endocyte (ECYT) Posts Narrower-than-Expected Loss in Q2 - Analyst Blog,0,0.493065
2015-08-06,7019700.0,59.15999984741211,59.25,58.31999969482422,58.43000030517578,50.17191696166992,MRK,"Cellceutix: Empty Office, Unviable 'Science', Misleading Disclosures, 96% Downside",0,0.48564586
2015-08-07,9712400.0,58.34999847412109,58.45000076293945,57.66999816894531,57.970001220703125,49.77693939208984,MRK,"Better Dividend Stock: Bristol-Myers Squibb or Merck? ||| ALK's Partner, Torii Pharmaceutical, Reports Positive Phase II/III Trial Results for Japanese Cedar SLIT-tablet",1,0.51568705
2015-08-10,5052400.0,58.2599983215332,58.61000061035156,58.2599983215332,58.40999984741211,50.154747009277344,MRK,Market Got You Down? Don't Bail -- Get Defensive ||| Here's Which IT Stocks Benefit From Healthcare M&A,0,0.46760836
2015-08-11,7078300.0,57.93000030517578,58.18999862670898,57.560001373291016,57.7599983215332,49.59661865234375,MRK,"Sigma-Aldrich, Merck, Darmstadt, Germany, Report Antitrust Approval in Brazil for Planned Purchase",1,0.53242606
2015-08-12,7525300.0,57.27999877929688,58.27999877929688,57.119998931884766,58.2599983215332,50.02595138549805,MRK,5 Things Merck Wants You to Know,1,0.5576008
2015-08-13,10957200.0,58.54999923706055,59.45000076293945,58.5,58.97999954223633,50.64418411254883,MRK,"Immune Design's Q2 Loss Narrows Y/Y, Focus on Pipeline ||| Calls Of Note: Wall Street Research Moving The Market On Thursday ||| What Are Payors Saying About Managed Care Giants? ||| Good Data May Be Coming For Merck (And This Analyst Is Bullish) ||| Benzinga's Top Upgrades ||| US Stock Futures Rise Ahead of Jobless Claims, Retail Sales Data ||| BMO Capital Upgrades Merck & Co to Outperform, Raises PT to $70.00",1,0.49024093
2015-08-17,6113700.0,58.79999923706055,59.75,58.58000183105469,59.709999084472656,51.27101135253906,MRK,Did Merck and NewLink Genetics Just Cure Ebola? ||| Does J&J's Submission Of Supplemental New Drug Application For Olysio Warrant A Change In J&J's Valuation? ||| Roche's (RHHBY) Lung Cancer Drug Meets Primary Endpoint ||| Could Over-the-Counter Birth Control Boost Drug Makers?,0,0.5025567
2015-08-18,6797400.0,59.66999816894531,59.95000076293945,59.560001373291016,59.65999984741211,51.22808074951172,MRK,"Health Care Sector Update for 08/18/2015: TROV, LJPC, MRK ||| Something Big Is Happening With Big Pharma ||| FDA Accepts Supplemental Biologics License Application for KEYTRUDA, Merck's Anti-PD-1 Therapy, for First-Line Treatment of Advanced Melanoma, and Grants Priority Review",0,0.5045296
2015-08-19,7986300.0,59.31999969482422,60.06999969482422,59.18999862670898,59.65999984741211,51.22808074951172,MRK,Merck's Keytruda under FDA Review for First-Line Melanoma,0,0.51190805
2015-08-20,23694400.0,58.290000915527344,58.54999923706055,56.7400016784668,56.95000076293945,48.90109634399414,MRK,"Dow Movers: DIS, JNJ ||| New Skin Cancer Drugs Delayed (but Investors and Patients Needn't Worry) ||| These 2 Dividend Leaders Hold Up Well In Rocky Market ||| New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN and the TECOS Cardiovascular Safety Trial of JANUVIA Will Be Presented at the European Society of Cardiology Congress",0,0.4936443
2015-08-21,17632500.0,56.59000015258789,57.630001068115234,55.7599983215332,55.77000045776367,47.88786315917969,MRK,"Stock Market News for August 21, 2015 ||| Friday's ETF with Unusual Volume: PJP ||| Dow Movers: BA, MRK",0,0.4879686
2015-08-24,24838600.0,53.06999969482422,54.400001525878906,45.68999862670898,53.9900016784668,46.35944366455078,MRK,"Merck's Ebola Vaccine Won't Move The Needle ||| Noteworthy ETF Inflows: VHT, PFE, MRK, BMY ||| RSI Alert: Merck Now Oversold ||| Sierra Leone Released its Last Confirmed Ebola Patient from Hospital on Monday -Reuters",0,0.5060641
2015-08-27,16135600.0,55.27999877929688,55.400001525878906,53.63999938964844,54.95000076293945,47.18376159667969,MRK,5 Stocks That Led Dow to 3rd Biggest Gain ||| Eli Lilly's Diabetes Drug May Halt Heart Disease ||| Novo Nordisk to Start PIONEER Program on Semaglutide,1,0.52040595
2015-08-28,12797000.0,54.77999877929688,55.40999984741211,54.59000015258789,55.369998931884766,47.54439926147461,MRK,"The Zacks Analyst Blog Highlights: Merck & Co, Apple, Visa, Microsoft and Intel",0,0.5096379
2015-08-31,12917100.0,55.119998931884766,55.29999923706055,53.619998931884766,53.84999847412109,46.23923110961914,MRK,Did This Clinical Study Just Show Merck's Best-Selling Drug the Door? ||| Barron's Recap: What's Next?,0,0.49777475
2015-09-01,15747400.0,52.65999984741211,53.22999954223633,52.20000076293945,52.52999877929688,45.10578155517578,MRK,"VHT, MRK, BMY, LLY: Large Outflows Detected at ETF ||| Organovo CEO Keith Murphy: 'People Are Missing The Forest For The Trees' ||| It's Not Shopping, It's Market Research: Talking Investing Trends With TD Ameritrade's Nicole Sherrod ||| Hearing Buyside Volume Coming Into Staples, Drug, And Chemical Names ||| New Analyses from the IMPROVE-IT Study with VYTORIN (ezetimibe and simvastatin)",1,0.50685054
2015-09-02,13130800.0,53.16999816894531,53.27000045776367,52.34999847412109,52.97999954223633,45.492183685302734,MRK,"JNJ's Splenda Sale Shouldn't Be A Concern For Investors ||| Health Care Sector Update for 09/02/2015: MRK, GHDX, HZNP ||| Sierra Leone to Vaccinate 200 People Who Came in Contact With Latest Ebola Victim -Reuters ||| FDA Approves Pediatric Indication for EMEND® (aprepitant) Capsules in Combination with Other Antiemetic Agents",0,0.49201983
2015-09-03,12149100.0,53.27000045776367,53.54999923706055,52.59999847412109,52.650001525878906,45.20882797241211,MRK,Incyte & Hengrui to Develop Anti-PD-1 Monoclonal Antibody,0,0.51622766
2015-09-08,14961100.0,53.0099983215332,53.02000045776367,52.20000076293945,52.68999862670898,45.24317169189453,MRK,"Bad News Type 2 Diabetics: The FDA Is Out With Another Warning ||| It's Official, Merck Just Caved. Who's Next? ||| Merck, Samsung Bioepis Report Approval of BRENZYS, a Biosimilar of Enbrel, in Korea ||| MKM Partners Would Sell These Healthcare Stocks On Weaker Relative Trends",0,0.52118754
2015-09-09,11116700.0,53.209999084472656,53.33000183105469,51.810001373291016,51.93000030517578,44.590579986572266,MRK,Tetraphase's (TTPH) Antibiotic Fails in Phase III Study,1,0.5351166
2015-09-10,14065400.0,52.02000045776367,53.20000076293945,51.86000061035156,52.720001220703125,45.2689323425293,MRK,"Noteworthy ETF Outflows: XLV, JNJ, GILD, MRK ||| Dow Movers: WMT, MRK",0,0.4994057
2015-09-11,12090800.0,52.209999084472656,52.45000076293945,51.709999084472656,52.09000015258789,45.1130485534668,MRK,"Dow Movers: V, MCD",1,0.5188854
2015-09-14,8791400.0,52.119998931884766,52.72999954223633,51.9900016784668,52.34000015258789,45.32955551147461,MRK,"Big Pharma's 3 Most Perilous Pipelines ||| One Put, One Call Option To Know About for Merck & Co. ||| Dow Movers: MSFT, AAPL ||| Amgen And Biogen Lead Short Interest Surge In Biotechs",1,0.53104067
2015-09-15,11792200.0,52.77999877929688,53.88999938964844,52.66999816894531,53.54999923706055,46.37748336791992,MRK,Fighting Superbugs: 2 Stocks You Need to Know,1,0.53562516
2015-09-16,8681400.0,53.5099983215332,53.970001220703125,53.31999969482422,53.869998931884766,46.65462493896485,MRK,Dow Analyst Moves: MRK ||| Merck Offers Highlights for Commitment to Infectious Disease with 40 Presentations of Data at ICAAC/ICC '15,1,0.52787524
2015-09-17,22799900.0,53.84999847412109,54.5,53.02000045776367,53.959999084472656,46.73257827758789,MRK,"Dow Movers: VZ, MRK ||| Merck To Submit Applications To U.S. For Approval Of Ertugliflozin By End Of 2016 ||| Merck Provides Diabetes Portfolio Update and Underscores Comprehensive, Long-Term Commitment to Patients with Diabetes",0,0.49891376
2015-09-18,28997900.0,53.68000030517578,53.869998931884766,51.90999984741211,52.130001068115234,45.14768600463867,MRK,"Notable ETF Inflow Detected - XLV, JNJ, GILD, MRK ||| UPDATE: Merck Phase 2 Primary Efficacy Endpoint Was Similar Across Both Relebactam Groups Along With Placebo Group, All 95% Or Higher ||| Merck Offers Results from Phase 2 Study of Investigational Beta-Lactamase Inhibitor at ICAAC/ICC '15: Met Primary Endpoint ||| Eli Lilly's 'Home Run' Is Jardiance, Says Morgan Stanley",0,0.48968953
2015-09-21,17243300.0,52.43999862670898,52.43999862670898,50.68999862670898,50.97999954223633,44.1517219543457,MRK,"Merck's Bezlotoxumab Met Primary Endpoint in Phase 3 Studies ||| Merck Reports Encouraging Phase III Data on Bezlotoxumab ||| Interesting December Stock Options for MRK ||| Dow Movers: MRK, PFE ||| ANI Pharmaceuticals to Acquire Two NDAs from Merck for $75M ||| Data in Nine Difficult-to-Treat Cancers from Merck's KEYTRUDA Development Program to be Presented at European Cancer Congress 2015",0,0.49974477
2015-09-22,12795600.0,50.54999923706055,51.0,50.2599983215332,50.7400016784668,43.94386291503906,MRK,"Company News for September 22, 2015 ||| Eli Lilly Officially Puts Merck on Notice ||| Inovio Gets Grant for Ebola Drugs, Regeneron Inks Deal",1,0.51314753
2015-09-24,10508300.0,50.52999877929688,50.86000061035156,50.220001220703125,50.59000015258789,43.81395721435547,MRK,"Here's How Merck Plans to Protect Billions of Dollars in Sales ||| Will the FDA Approve All 3 of These Cancer Drugs in October? ||| Thursday's ETF with Unusual Volume: XPH ||| Merck and Pfizer Collaborate with Dako, an Agilent Technologies Company, on Development of Companion Diagnostic for Investigational anti-PD-L1 Antibody, Avelumab",0,0.49721512
2015-09-25,15322700.0,50.91999816894531,51.31999969482422,49.130001068115234,49.59999847412109,42.95655059814453,MRK,"Merck, Pfizer Reports FDA Orphan Drug Designation for Investigation Avelumab",0,0.5015195
2015-09-28,20150500.0,49.29999923706055,49.369998931884766,48.09000015258789,48.41999816894531,41.934608459472656,MRK,"Merck Presents New Findings Showing Anti-Tumor Activity of KEYTRUDA in Patients with Advanced NPC ||| Merck Announces New Data from KEYNOTE-028 Trial Evaluating KEYTRUDA Across Range of Cancer Types, Presented at 2015 ECC ||| Clinton Proposals Could Spell Trouble for These 3 Drugmakers ||| Monday's ETF with Unusual Volume: XPH ||| Roth Capital Upgrades ANI Pharmaceuticals To Buy On Valuation ||| Merck, Syndax Pharma Announce First Patients Dosed in Phase 1b/2 Trial of Entinostat, KEYTRUDA ||| Merck Reports Japan's PMDA Approved MARIZEV 25, 12.5mg Tablets",1,0.52233434
2015-09-29,12802900.0,48.58000183105469,49.29999923706055,48.20000076293945,48.650001525878906,42.1338005065918,MRK,Did Eli Lilly Just Get a Leg Up on Johnson & Johnson?,1,0.52178085
2015-09-30,12679100.0,49.400001525878906,49.540000915527344,48.84999847412109,49.38999938964844,42.77468490600586,MRK,iShares U.S. Pharmaceuticals ETF Experiences Big Outflow,0,0.5022158
2015-10-01,14408600.0,49.34999847412109,49.56999969482422,48.540000915527344,49.369998931884766,42.757362365722656,MRK,"Inovio Pharmaceuticals' Potentially Hollow Victory Buys it More Time ||| Merck, DNAtrix Report Phase 2 Immuno-Oncology Partnership in Patients with Aggressive Form of Brain Cancer",1,0.51189876
2015-10-02,24287900.0,48.790000915527344,50.150001525878906,48.34999847412109,50.13999938964844,43.42422866821289,MRK,Merck PR Confirms FDA Approves KEYTRUDA for the Treatment of Patients with Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 with Disease Progression On or After Platinum-Containing Chemotherapy ||| Bristol-Myers Spikes to High Following FDA Approval of Merck's Keytruda ||| FDA Approves Merck's Keytruda For Advanced Non-Small Cell Lung Cancer,1,0.53621876
2015-10-05,15881600.0,51.06999969482422,51.31999969482422,50.68999862670898,51.22999954223633,44.36823272705078,MRK,"Tweet This Hillary: Pros See Biotech ETFs As A Buy ||| Interesting January 2017 Stock Options for MRK ||| Merck's (MRK) Keytruda Gains FDA Nod for Label Expansion ||| Agilent Company Dako, Announces FDA Approval of New Companion Diagnostic for Lung Cancer",0,0.5225752
2015-10-06,16493500.0,51.38999938964844,51.38999938964844,49.31999969482422,49.79999923706055,43.12976837158203,MRK,Would an Ebola Vaccine Move Regeneron Pharmaceuticals' Bottom Line?,1,0.54772145
2015-10-07,14508200.0,50.459999084472656,51.119998931884766,49.77000045776367,50.95000076293945,44.125736236572266,MRK,"See Which Of The Latest 13F Filers Holds Merck & Co. ||| Guinea, Liberia, Sierra Leone See No New Cases for Week to October 4 -Reuters ||| Merck KGaA, Darmstadt, Germany, and Pfizer Announce Investigational Immunotherapy Avelumab Given FDA Fast Track Designation for Metastatic Merkel Cell Carcinoma",1,0.50470436
2015-10-08,12542000.0,50.65999984741211,51.18999862670898,50.13999938964844,51.02000045776367,44.18635559082031,MRK,"iShares Global Healthcare ETF Experiences Big Outflow ||| Dow Movers: AAPL, DD ||| Gilead Is About to Disappoint Investors -- but for All the Right Reasons ||| Merck KGaA/Pfizer's Avelumab Gets Fast Track Status ||| Ten People Quarantined Due to Possible Ebola Cases in Nigeria's Calabar City ||| Dynavax Reports Initiation of Immuno-Oncology Clinical Trial of SD-101 in Combo with Merck's KEYTRUDA",0,0.46716714
2015-10-09,10921400.0,50.9900016784668,51.5099983215332,50.68999862670898,50.95000076293945,44.125736236572266,MRK,"This Double-Whammy Sent Merck Shares Notably Lower in September ||| WHO Says Nigerian Suspected of Dying from Ebola, Did Not have the Virus -Reuters ||| KEYTRUDA® (pembrolizumab) Receives New Draft Recommendation from National Institute for Health and Care Excellence (NICE) in U.K. for First-Line Treatment for Advanced Melanoma",0,0.505736
2015-10-12,11653300.0,49.709999084472656,50.84999847412109,49.68999862670898,50.709999084472656,43.917877197265625,MRK,"Lung Cancer Treatment Gets Personal ||| How We'll Clean Up Riding This Historic M&A Wave ||| The Unsung Heroes of Cancer Immunotherapy ||| Bristol-Myers Cancer Drug Opdivo's Label Expanded in U.S. ||| Dow Movers: MRK, JNJ ||| Winners and Losers of Eli Lilly's CETP Drug Failure ||| Watching Volatility In Other Big Pharma Names Amid Eli Lilly Halt",0,0.49865818
2015-10-13,14905900.0,50.77999877929688,50.90999984741211,49.36000061035156,49.470001220703125,42.84395980834961,MRK,"Incyte, Merck Increase Clinical Collaboration to Include Phase 3 Study Investigating the Combination of Epacadostat with Keytrudaas First-line Treatment for Advanced Melanoma ||| Incyte and Merck Expand Clinical Collaboration to Include Phase 3 Study Investigating the Combination of Epacadostat with Keytruda® (pembrolizumab) as First-line Treatment for Advanced Melanoma",1,0.520099
2015-10-14,13731200.0,49.59000015258789,50.119998931884766,49.45000076293945,49.540000915527344,42.90458679199219,MRK,"Eli Lilly, Incyte's Baricitinib Scores in Phase III Study ||| 5 Stocks Searching for a Cancer Cure Right Now ||| Biotech ETFs Get More Refined With Debut Of Cancer Immunotherapy Fund ||| Nurse who Contracted Ebola in West Africa Now Critically Ill from Complications -BBC ||| Tianjin CanSino Biotechnology to Mass Produce Ebola Vaccine -Xinhua",1,0.5082043
2015-10-15,14037500.0,49.66999816894531,51.08000183105469,49.25,50.720001220703125,43.926544189453125,MRK,"The Zacks Analyst Blog Highlights: Juno Therapeutics, Kite Pharma, Merck, Bristol-Myers Squibb and Celldex Therapeutics",1,0.51149666
2015-10-16,11092500.0,51.29999923706055,51.720001220703125,51.08000183105469,51.47999954223633,44.58475112915039,MRK,"Dow Movers: CAT, GE ||| The Lazy Way to Invest in Cancer Immunotherapy ||| Ebola Outbreak: 3 Things We Needed to Learn ||| 5 Immunotherapy Stocks to Watch for Treating Cancer",0,0.5040398
2015-10-19,8441900.0,51.33000183105469,51.54999923706055,50.93000030517578,51.400001525878906,44.51546478271485,MRK,"AstraZeneca's Diabetes Drug Gets CRL; Expands Cancer Deal ||| Health Care Sector Update for 10/19/2015: GALT,MRK,DHRM,GNCA",0,0.48426896
2015-10-20,9944900.0,51.38999938964844,51.470001220703125,50.09999847412109,50.38999938964844,43.6407356262207,MRK,"IXJ, MRK, AGN, MDT: Large Outflows Detected at ETF ||| After Hours Most Active for Oct 20, 2015 : YHOO, GE, QQQ, MSFT, MRK, AAPL, GLNG, MS, STX, CMG, PFE, BAC",1,0.4990278
2015-10-22,18449600.0,50.81999969482422,52.560001373291016,50.29999923706055,52.0099983215332,45.04375457763672,MRK,"Merck Trading Higher Off Of Abbvie, Gilead FDA Comments, Up 3.62% On The Day At $52.42/Share",1,0.5090403
2015-10-23,15703500.0,52.34999847412109,53.25,52.13999938964844,52.880001068115234,45.79722595214844,MRK,"AbbVie Slumps, FDA Issues Warning Related to 2 HCV Drugs ||| Forget Merck's Headline Numbers and Focus on These Key Points Instead",1,0.5282972
2015-10-26,10975200.0,52.650001525878906,53.16999816894531,52.470001220703125,52.90999984741211,45.82321166992188,MRK,"ETF Update: An Unintended Focus On China A-Shares ||| Battle Royale: Merck & Co. vs. Pfizer ||| One Put, One Call Option To Know About for Merck & Co. ||| Pre-Market Earnings Report for October 27, 2015 : PFE, MRK, CMCSA, BMY, UPS, RAI, BABA, SPG, F, DD, TMUS, MMC ||| Will Agenus (AGEN) Disappoint Yet Again in Q3 Earnings? ||| Earnings Boom This Week: Big Pharma, E-Commerce Giant BABA And More ||| Fed Meeting A Mid-Week Bump In Flurry Of Earnings News ||| Merck's KEYTRUDA Shows Superior Overall Survival Compared to Chemotherapy in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer Whose Tumors Express PD-L1",1,0.48405004
2015-10-27,13956900.0,53.7599983215332,54.09999847412109,52.77999877929688,53.470001220703125,46.308204650878906,MRK,"Heavy Q3 Earnings Ahead of Fed Meeting ||| Dow Movers: CAT, PFE ||| U.S. Stock Futures Add to Losses on Bearish Durable Goods Orders ||| Merck (MRK) Tops on Q3 Earnings, Revenues Fall Short ||| Earnings Reaction History: Merck & Co. Inc., 60.0% Follow-Through Indicator, 1.5% Sensitive ||| These Three Pharma Giants Just Crushed Earnings ||| UPDATE: Merck Sees FY15 Sales $39.2B-$39.8B vs $39.67B Est. ||| Merck Sees FY EPS $3.55 to $3.60 vs $3.51 est ||| Merck Reports Q3 EPS $0.96 vs. Est. $0.92, Rev. $10.073B vs. Est. $10.08B ||| Earnings Scheduled For October 27, 2015",1,0.5257698
2015-10-28,14710000.0,53.9900016784668,55.13999938964844,53.54999923706055,55.09999847412109,47.71988296508789,MRK,"Wednesday's ETF with Unusual Volume: IHE ||| Gilead (GILD) Beats on Q3 Earnings, HCV Drugs Lose Shine",0,0.49910614
2015-10-29,8907300.0,54.959999084472656,55.63999938964844,54.470001220703125,54.869998931884766,47.52069854736328,MRK,"Another Strong Quarter for Gilead Sciences, Inc.",0,0.50590974
2015-10-30,11017400.0,54.790000915527344,55.27000045776367,54.65999984741211,54.65999984741211,47.338809967041016,MRK,"Bayer (BAYRY) Q3 Revenues Up Y/Y, 2015 View Adjusted",1,0.53496116
2015-11-02,10559100.0,54.68999862670898,55.33000183105469,54.40999984741211,55.11000061035156,47.72854232788086,MRK,"Gilead Sciences Is Shrugging Off Its Competitors ||| Et Tu, Bacon? WHO Just Dropped a Cancer Bombshell on Meat Lovers Worldwide ||| One Put, One Call Option To Know About for Merck & Co. ||| Which Dividends Would Be Safest If Drug Prices Were Slashed Tomorrow? ||| Merck Receives Breakthrough Therapy Designation from U.S.FDA for KEYTRUDA(R) (pembrolizumab) in Advanced Colorectal Cancer",0,0.48686287
2015-11-03,9216200.0,55.08000183105469,55.380001068115234,54.47999954223633,55.11000061035156,47.72854232788086,MRK,"How This Top Stock Mutual Fund Manager Seeks Growth ||| GSK, Merck to Study Immunotherapy Combination as Potential Cancer Treatment",1,0.5167823
2015-11-04,7749200.0,55.470001220703125,55.77000045776367,55.18000030517578,55.52999877929688,48.09229278564453,MRK,"Endocyte (ECYT) Posts Narrower-than-Expected Loss in Q3 ||| Notable ETF Inflow Detected - ACWI, MRK, C, CVX ||| Incyte Q3 Loss Narrower than Expected, Ups Jakafi Outlook ||| Merck, Pfizer Report Initiation of Phase III First-Line Trial of Avelumab",0,0.4704594
2015-11-05,9046800.0,55.459999084472656,55.68000030517578,54.68000030517578,55.04999923706055,47.67658615112305,MRK,Did the Immuno-Oncology Gap Between Bristol-Myers Squibb and Merck & Co. Just Grow? ||| Gilead's Sovaldi in Focus on Bradyarrhythmia Concerns ||| Merck Announces Samsung Bioepis Will Present New Biosimilars Data at the 2015 ACR/ARHP Annual Meeting,0,0.5006077
2015-11-06,10723000.0,54.790000915527344,54.880001068115234,54.0099983215332,54.61000061035156,47.29551315307617,MRK,Marijuana and Hepatitis C: What to Watch in 2016 ||| Why Incyte Corporation Shares Are Crashing Today ||| UPDATE: Merck Says 'We believe that BRIDION has the potential to offer anesthesia professionals an important new option to reverse neuromuscular blockade in the surgical setting' ||| Merck Issues Statement on FDA Panel Meeting for BRIDION ||| FDA Panel Votes 13-1 In Favor Of Merck Presenting Sufficient Data To Characterize Risk Of Hypersensitivity With Sugammadex -Reuters ||| Are You Investing Like A Millennial Or A Baby Boomer?,0,0.514684
2015-11-09,9140200.0,54.02999877929688,54.40999984741211,53.7400016784668,54.2400016784668,46.975074768066406,MRK,Which Of The Latest 13F Filers Holds Merck? ||| Incyte Down on Data from Epacadostat Combination Study ||| WHO Declares Sierra Leone Ebola-Free,1,0.5139255
2015-11-10,7462300.0,54.380001068115234,54.59999847412109,54.02000045776367,54.43000030517578,47.13962936401367,MRK,What's in Store for Immune (IMDZ) this Earnings Season?,0,0.4716914
2015-11-11,8544600.0,54.810001373291016,55.0,53.68000030517578,53.720001220703125,46.52472305297852,MRK,A Trio of Catalysts Lift Merck Higher in October ||| Patient in Brazil Being Tested for Ebola; 46 Year Old Man Came from Guniea -Reuters,0,0.4916009
2015-11-12,8577500.0,53.59000015258789,53.970001220703125,53.02999877929688,53.02999877929688,45.9271354675293,MRK,"Immune Design Starts Mid-Stage Soft Tissue Sarcoma Trial ||| Merck Issues Statement Regarding CUBICIN Patent Litigation; Says Reviewing Decision, Considering Next Steps",0,0.5031918
2015-11-13,11394500.0,53.459999084472656,53.720001220703125,52.900001525878906,53.02999877929688,45.9271354675293,MRK,"Immune Design Posts Narrower-Than-Expected Loss for Q3 ||| Richard Snow Invests in Familiar Names in 3rd Quarter ||| Dow Movers: CSCO, MRK ||| Hepatitis C Treatment in 2016: Will Gilead Sciences or AbbVie Win? ||| Gilead's (GILD) HCV Drug Harvoni's Label Expanded in U.S. ||| Hearing Unconfirmed Market Chatter of Potential Merck Bid for Celgene ||| Merck Issues Update on REVEAL Outcomes Sutdy",1,0.49728045
2015-11-16,6907800.0,52.18999862670898,53.810001373291016,52.130001068115234,53.70000076293945,46.50739669799805,MRK,"Exelixis, Inc. Earnings: Riding the Meteor ||| Vanguard Raises Stakes in Biogen, Mylan, Merck ||| Merck to Release Findings from Integrated Analysis of Six Phase 2 and 3 Clinical Trials Evaluating Investigational Elbasvir/Grazoprevir in Patients with Chronic Hepatitis C Genotype 1, 4 or 6 Infection and Compensated Cirrhosis at The Liver Meeting ||| Merck Announces Presentation of Phase 3 Results of Investigational Elbasvir/Grazoprevir in People with Chronic Hepatitis C Genotypes 1, 4 or 6 Infection Who Inject Drugs and Are on Opioid Agonist Therapy ||| Interesting January 2018 Stock Options for MRK ||| XLG, GE, HD, MRK: ETF Inflow Alert ||| 3 High-Yield Dividend Stocks You Don't Have to Babysit ||| Cambodia Reports Outbreak Of Highly Pathogenic H5N1 Bird Flu -Reuters",1,0.51365334
2015-11-17,7126600.0,53.709999084472656,54.29999923706055,53.290000915527344,53.709999084472656,46.516056060791016,MRK,Here's Why Advaxis' Stock Gained 11% in October ||| Why Novavax Inc Is Moving Higher Today,1,0.5207569
2015-11-18,10811400.0,53.86000061035156,54.31999969482422,53.70000076293945,54.22999954223633,46.96641159057617,MRK,"5 Things Merck & Co., Inc. Wants You to Know ||| Shares of Sigma Aldrich Halted, is Being Taken Out by Merck KGaA ||| Merck, Darmstadt, Pfizer Report FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma",1,0.55266935
2015-11-19,6839200.0,54.43999862670898,54.52999877929688,53.91999816894531,54.27999877929688,47.009708404541016,MRK,"Health Care Sector Update for 11/19/2015: LLY, MRK, ATHX, AMAG ||| US Stock Futures Edge Higher Ahead Of Jobless Claims Report ||| Lilly and Merck Expand Immuno-oncology Collaboration with Phase III Nonsquamous Non-Small Cell Lung Cancer Trial",0,0.47451004
2015-11-20,8933300.0,54.61000061035156,54.86000061035156,54.0,54.09999847412109,46.85381317138672,MRK,"Hearing Merck Planning to Expand Presence in African, Wants to More Than Double Sales in Africa by '20",0,0.5200053
2015-11-23,8688100.0,54.08000183105469,54.20000076293945,53.77999877929688,54.0099983215332,46.775875091552734,MRK,"Gilead Sciences Inc. Has Plenty of Room to Run in Hepatitis C ||| Merck Announces Initial Results for KEYTRUDA with Novel Immunotherapy Combinations from Three Investigational Studies Presented at the Society for Melanoma Research International Congress ||| Beyond Chemotherapy: 4 Unique Ways Drug Developers Are Fighting Back Against Cancer ||| Three New Ebola Cases Reported in Liberia; 153 Persons Under Observation -Reuters ||| Can Merck & Co. Take Down Gilead Sciences? ||| Health Care Sector Update for 11/23/2015: MRK, BXLT, AZN ||| After Hours Most Active for Nov 23, 2015 : GE, PFE, ESRX, WMB, AAPL, JPM, YHOO, TUMI, MRK, SCTY, PYPL, MSFT",0,0.51291364
2015-11-24,10507200.0,53.560001373291016,53.68000030517578,53.09999847412109,53.47999954223633,46.31686401367188,MRK,"Noteworthy ETF Outflows: IWB, GE, MRK, PEP ||| This Metric Implies That It Might Be Time to Buy Big Pharma Stocks ||| Bristol-Myers' Opdivo Label Now Includes Renal Cell Cancer ||| Merck Increases Qtr. Dividend From $0.45 To $0.46/Share ||| Benzinga's Top Initiations ||| Berenberg Initiates Coverage on Merck & Co at Buy ||| 15-Year Old Boy is First Ebola Fatality in Liberia Since Country was Declared Ebola Free in September -Reuters",1,0.49314725
2015-11-25,6078900.0,53.619998931884766,53.91999816894531,53.459999084472656,53.720001220703125,46.52472305297852,MRK,How Big Could This Drug Be for Opko Health? ||| Bristol-Myers' Opdivo Gets FDA Nod for Another Indication ||| MITICURE for house Dust Mite Allergic Rhinitis Now Available in Japan,1,0.51742786
2015-11-27,2981600.0,53.36000061035156,54.20000076293945,53.36000061035156,53.959999084472656,46.73257827758789,MRK,Merck KGaA-Pfizer's Avelumab May Get Orphan Status in EU,0,0.4879811
2015-11-30,13363200.0,54.040000915527344,54.11000061035156,53.0,53.0099983215332,45.90981674194336,MRK,"Bristol-Myers' Cancer Drug Opdivo Gets CRL from the FDA ||| Deere Announces Factory Workforce Adjustments, 220 Employees On Indefinite Leave Starting Feb 2016",1,0.51262134
2015-12-01,12996800.0,53.77000045776367,54.63999938964844,53.43999862670898,54.56999969482422,47.260868072509766,MRK,"The Path Is Clear for a New Immunotherapy Entrant ||| Barclays' Biopharmaceuticals Blueprint For 2016 ||| Barclays On Merck: Too Much Underlying Value To Ignore ||| Barclays Upgrades Merck & Co to Overweight, Raises PT to $66.00",0,0.49630344
2015-12-02,10099300.0,54.65999984741211,54.9900016784668,53.75,53.81999969482422,46.611328125,MRK,"Gilead's High-Priced HCV Drugs in Focus on Senate Report ||| Dow Movers: NKE, UNH ||| Dow Analyst Moves: MRK ||| 3 Global Infectious Diseases That May Soon Have Cures ||| Stock Market News for December 02, 2015",0,0.48488095
2015-12-03,13595100.0,54.06999969482422,54.09000015258789,52.2400016784668,52.59000015258789,45.54607391357422,MRK,"PowerShares Dynamic Pharmaceuticals Portfolio Experiences Big Inflow ||| Dow Movers: MRK, CVX ||| AbbVie's NDA for Once-Daily Viekira Pak Accepted by FDA",1,0.5149026
2015-12-04,13687000.0,52.869998931884766,53.68000030517578,52.83000183105469,53.63999938964844,46.45543670654297,MRK,"Bristol-Myers Squibb Finally Hits a Roadblock ||| Stock Market News for December 04, 2015 ||| After Hours Most Active for Dec 4, 2015 : F, MU, CSCO, AAPL, MYL, PFE, XOM, HPE, CMI, MRK, QQQ, CMCSA ||| Closing Update: Better-Than-Expected November Jobs Reports Ignites Big Rally for Stocks; S&P 500 Rises For Third Week in a Row ||| Health Care Sector Update for 12/04/2015: RLYP,MRK,GSK,SNY,KBIO,ZIOP ||| Merck Spokesperson Declines Comment on Speculation Related to Relypsa ||| EXCLUSIVE: Relypsa Being Evaluated By 3-4 Potential Acquirers; Sanofi Seen As 'Natural Buyer' ||| EXCLUSIVE: Wedbush's Liana Moussatos Tells Benzinga Sanofi 'is a natural buyer of Relypsa' ||| EXCLUSIVE: Source Tells Benzinga Merck Is Not Involved With Relypsa Bid; Calls To Merck Were Not Immediately Returned ||| Hearing Unconfirmed Marker Chatter of Potential Merck Bid for Relypsa ||| Amgen, Merck Report Cancer Immunotherapy Partnership For Patients With Non-Hodgkin Lymphoma",1,0.47582147
2015-12-07,8696000.0,54.02000045776367,54.22999954223633,53.18000030517578,53.68000030517578,46.49008560180664,MRK,"Second Cancer Incidence Rates Have Doubled, and a Catch-22 Has Emerged ||| Benzinga's Weekend M&A Chatter ||| One Put, One Call Option To Know About for Merck & Co. ||| The Zacks Analyst Blog Highlights: Wal-Mart Stores, Home Depot, Pfizer and Merck ||| Relypsa (RLYP) Catches Eye: Stock Adds 30.6% in Session ||| Amgen Seeks Kyprolis Label Expansion, Inks Deals with Merck ||| Merck Reports Samsung Bioepis Receives Approval of RENFLEXIS, a Biosimilar of Remicade, in Korea ||| Must Watch Stocks for Today",0,0.50648665
2015-12-08,7573200.0,53.56999969482422,54.400001525878906,53.220001220703125,53.470001220703125,46.308204650878906,MRK,Notable option activity in equities,0,0.5104075
2015-12-10,11451900.0,53.02000045776367,53.97999954223633,52.81999969482422,53.68999862670898,46.49873352050781,MRK,"Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for December 11, 2015 ||| 9 Healthcare Picks For 2016 ||| UPDATE: Merck Says Biothera Research Shows Imprime PGG Activates Key Immune Responses ||| Biothera Announces Clinical Study to Evaluate Combination Therapy of Imprime PGG ||| Eli Lilly and Merk Announces Expansion of Immuno Oncology Collaboration",0,0.48542574
2015-12-11,10397900.0,53.0,53.27999877929688,52.02000045776367,52.150001525878906,45.55531311035156,MRK,Balance Sheet Brawl: Merck & Co. Takes on Eli Lilly ||| Merck and Eli Lilly Expand Immuno-Oncology Collaboration,1,0.52262086
2015-12-14,11999200.0,52.150001525878906,52.36000061035156,51.650001525878906,52.20000076293945,45.59899139404297,MRK,"Meet the Miracle Cancer Drug That Cured Former President Jimmy Carter ||| Major Pharma Group Outlook In 2016: Fundamentals To Outweigh Political Headwinds ||| One Put, One Call Option To Know About for Merck & Co. ||| This May Be The Fastest-Growing Biotech Stock Next Year (Hint: It's Not Gilead Sciences) ||| Hearing FDA Panel Has Voted IMPROVE-IT Data for Merck's Zetia to Statin Therapy Does Not Support Claim of Reduced Risk of CV Events",1,0.53394806
2015-12-15,11585900.0,52.47999954223633,53.18999862670898,52.22999954223633,52.900001525878906,46.2104721069336,MRK,UPDATE: Merck Says Expanded Age Indication for GARDASIL 9 Includes 16-26 Age Range ||| Merck Announces FDA Approval for Expanded Age Indication for GARDASIL 9 in Males ||| FDA Approves Bridion To Reverse Effects Of Neuromuscular Blocking Drugs Used In Surgery ||| Fast Money Picks For December 15,1,0.5374909
2015-12-16,10014300.0,53.41999816894531,54.11000061035156,53.0,54.02000045776367,47.1888313293457,MRK,"Merck & Co. Inc's Best Drug in 2015 ||| Why Advaxis, Inc Shares are Skyrocketing Today ||| Dow Movers: XOM, MRK",0,0.48582804
2015-12-17,13517100.0,54.11000061035156,54.25,52.65999984741211,52.65999984741211,46.00082015991211,MRK,4 Top Dividend Plays To Help Cure Stock Price Blues,0,0.54226214
2015-12-18,21101800.0,52.150001525878906,52.31999969482422,51.61000061035156,51.63999938964844,45.10980224609375,MRK,"Merck Reports FDA Approval of Expanded Indication for KEYTRUDA for Treatment of Patients with Advanced Melanoma ||| Merck Reports EMA's CHMP Has Responded to MAA for elbasvir/grazoprevir (50mg/100mg), Application Will Now Be Reviewed on Standard Timetable ||| Codexis +7.1% Premarket @$4.50;, Co Announces Agreement Extension With Merck",1,0.5245196
2015-12-21,11636100.0,52.150001525878906,52.150001525878906,51.20000076293945,51.869998931884766,45.31071472167969,MRK,Credit Suisse Offers 2016 U.S. Large-Cap Pharma Outlook ||| Merck's KEYTRUDA Significantly Improves Survival Compared to Chemotherapy in Previously-Treated Patients with Non-Small Cell Lung Cancer Whose Tumors Express Any Level of PD-L1 ||| Merck CEO: Using Keytruda Could Extend Patient's Life By 13 Months On Average ||| ALK Sells European Veterinary Business to Fidelio Capital; Terms Not Disclosed,1,0.51502174
2015-12-22,13196900.0,52.0099983215332,52.22999954223633,51.27999877929688,52.09999847412109,45.51163864135742,MRK,"Dow Movers: MRK, CAT ||| Is Merck & Co. About to Derail Gilead Sciences? ||| Merck KGaA, Pfizer Report Advancement of Clinical Development Program with Two Added Phase III Trials of Avelumab",1,0.5129487
2015-12-23,7127400.0,52.380001068115234,53.220001220703125,52.36000061035156,52.97999954223633,46.28035354614258,MRK,Peering Through The Fog To Find The Best Sectors Into Year End,0,0.51497287
2015-12-24,2980100.0,52.790000915527344,53.130001068115234,52.61000061035156,52.84999847412109,46.16679763793945,MRK,Biotech Industry Could Offer Early Profit in 2016 ||| The Best Merck & Co. Inc. Headlines in 2015,0,0.49897417
2015-12-28,4836300.0,52.790000915527344,53.040000915527344,52.56999969482422,52.84000015258789,46.15805435180664,MRK,"Great News: This Government Agency Just Received a Big Raise ||| This Is the Most Effective Way to Treat Lung Cancer, Study Shows",1,0.5217208
2015-12-29,6608500.0,52.970001220703125,53.61000061035156,52.90999984741211,53.34000015258789,46.594825744628906,MRK,Pfizer Inc.'s Best Drug in 2015 ||| WHO Declares End of Ebola Virus Transmission in Republic of Guinea,0,0.46075264
2015-12-30,5560300.0,53.34000015258789,53.58000183105469,53.08000183105469,53.25,46.516212463378906,MRK,"Will Merck & Co. Inc. Raise Its Dividend in 2016? ||| After Hours Most Active for Dec 30, 2015 : QQQ, WMB, AAPL, HPE, SCTY, CMRX, GPOR, ETE, CPE, MSFT, TEL, MRK",0,0.48363674
2016-01-04,17174600.0,52.0099983215332,52.61000061035156,51.61000061035156,52.47999954223633,45.84358596801758,MRK,"One Put, One Call Option To Know About for Merck ||| Pfizer, Merck KGaA Report Syndax to Collab to Investigate Safety, Tolerability, Prelim. Efficacy of Avelumab, Entinostat in Advanced Ovarian Cancer",1,0.50850797
2016-01-05,11075500.0,52.790000915527344,53.470001220703125,52.66999816894531,53.150001525878906,46.42884826660156,MRK,"Gilead's (GILD) HCV Drug Gets Priority Review Status in U.S. ||| The Zacks Analyst Blog Highlights: Chevron, IBM, Exxon Mobil, Merck and Pfizer ||| Health Care Sector Update for 01/05/2016: ANIP, GALT, IMMU ||| Watch Stocks of Small-, Mid-Cap Cos. with Experimental Drugs as AP Reporting Merck CEO Frazier at Goldman Healthcare Conference Said Co. 'Raring to Go' on M&A Deals This Year ||| ANI Pharma Reports Closing of Deal to Purchase Two NDAs from Merck for $75M",0,0.4760401
2016-01-06,12465900.0,52.5099983215332,52.95000076293945,52.209999084472656,52.41999816894531,45.79117202758789,MRK,"ITOT, C, MRK, PEP: Large Inflows Detected at ETF ||| Why This Codexis Analyst Is Confident Stock Is Worth $6 ||| Washington University Initiates Clinical Study of Verastem's VS-6063 in Combination with Merck's Pembrolizumab and Gemcitabine in Pancreatic Cancer",0,0.50709254
2016-01-11,14367400.0,51.25,51.540000915527344,50.61000061035156,51.25,44.76911926269531,MRK,"5 Commonly Prescribed Drugs With Six-Digit Annual Price Tags ||| This Common Dietary Ingredient May Increase Breast Cancer and Lung Metastasis Risk ||| Why Medivation, Inc. Jumped 13% in December ||| One Put, One Call Option To Know About for Merck ||| Immune Design's Immunotherapy Drugs Get Orphan Status ||| Merck Acquires IOmet Pharma, Terms Not Disclosed",1,0.5413995
2016-01-12,11321000.0,51.5099983215332,52.06999969482422,50.97999954223633,51.7599983215332,45.214630126953125,MRK,3 Dividend ETFs to Buy Today ||| 3 Things You Absolutely Must Know About Merck ||| Fast Money Traders Share Their Biotech Picks,0,0.5039709
2016-01-13,16546600.0,51.90999984741211,52.060001373291016,50.58000183105469,50.65999984741211,44.25373077392578,MRK,7 Stocks to Buy in January ||| Incyte (INCY) Provides Update on Pipeline Candidates ||| WHO to Announce End of Ebola Outbreak on Thursday -AFP,1,0.50524
2016-01-14,13568500.0,50.66999816894531,52.11000061035156,50.59000015258789,51.79999923706055,45.24957656860352,MRK,Why Advaxis Gained 20% in 2015 ||| Sierra Leone Health Ministry Investigating Suspected Death from Ebola -Reuters,0,0.5032901
2016-01-15,15490400.0,50.5,51.29999923706055,50.09999847412109,51.13999938964844,44.673038482666016,MRK,"Bristol-Myers Squibb: A New Chapter, and the Beginning of Sustained Growth ||| iShares Core U.S. Value ETF Experiences Big Outflow ||| Write A Prescription For This Healthcare ETF ||| Merck Announces Resolution of Vioxx Class Action Lawsuit, Cash Payment ~$680M ||| UPDATE: Sierra Leone Ebola Victim Said to have Exposed 27 to Disease; Woman was Living in House With 22 People When She Became Ill -Reuters ||| UPDATE: Sierra Leone Health Ministry Confirms Death from Ebola -Reuters",1,0.49449962
2016-01-19,10929500.0,51.59999847412109,51.90999984741211,50.810001373291016,51.34000015258789,44.84773254394531,MRK,AbbVie's Management Just Made Some Pretty Bold Predictions,0,0.5056366
2016-01-20,15920400.0,50.290000915527344,51.02000045776367,49.29999923706055,50.54999923706055,44.15763473510742,MRK,"Incyte Reports Baricitinib NDA Filing for Rheumatoid Arthritis ||| Sierra Leone Confirms Second New Ebola Case in Less than a Week -Reuters ||| Credit Suisse Sets Outperform Rating, $125 Target On Gilead Story ||| Global Vaccine's Alliance Signs $5M Advance Order for Merck's Ebola Vaccine -Reuters",1,0.50847834
2016-01-22,10812800.0,51.43999862670898,51.7400016784668,50.95000076293945,51.34999847412109,44.8564682006836,MRK,10 Best Stocks to Buy for the Turnaround ||| Cleveland BioLabs Gets Orphan Status for Entolimod in EU,0,0.4942574
2016-01-25,9280500.0,51.34999847412109,51.43999862670898,50.7599983215332,50.91999816894531,44.48085403442383,MRK,"A 10-Year Cancer Survival Rate Study From Japan Yields Interesting Results ||| Midday Update: Stocks Turn South With Falling Oil Prices ||| One Put, One Call Option To Know About for Merck & Co. ||| iShares Russell 3000 ETF Experiences Big Outflow ||| Bristol-Myers' Opdivo/Yervoy Combination Expanded in U.S. ||| US Big Pharma: What To Watch For In Q4 Results ||| Affimed to Collaborate with Merck to Evaluate AFM13 in Combination with KEYTRUDA for Patients with Hodgkin Lymphoma",1,0.5071136
2016-01-26,9017500.0,51.04999923706055,51.59999847412109,50.7599983215332,51.45000076293945,44.94382858276367,MRK,A Billion-Dollar Drug? Maybe. But Lilly Will Have to Overcome This Roadblock First,0,0.49455252
2016-01-27,13119100.0,50.65999984741211,51.56999969482422,49.83000183105469,50.369998931884766,44.00039291381836,MRK,"See Which Of The Latest 13F Filers Holds Merck & Co. ||| Health Care Sector Update for 01/27/2016: JNJ, PFE, ABT, MRK, AMGN, NVS ||| MRK Named A Top Socially Responsible Dividend Stock ||| Affimed & Merck Ink Deal for AFM13-Keytruda Combination ||| Bank of America Downgrades Merck & Co to Neutral ||| Merck Reports FDA Acceptance of Biologics License Application for Bezlotoxumab ||| Merck Reports FDA Acceptance of BLA for Bezlotoxumab ||| ACARIZAX Receives Marketing Authorization in France",0,0.48255295
2016-01-28,18126900.0,50.33000183105469,50.540000915527344,48.97999954223633,49.20000076293945,42.97835922241211,MRK,"Johnson & Johnson's Newest Billion-Dollar Blockbuster ||| CDXS and LOGI are Aggressive Growth Stocks ||| Merck Receives FDA Approval of Hep C Drug ZEPATIER; To Cost $54,600/Patient for 12-Week Course ||| Adam Feurestein Reminds Twitter Followers 'Today Is Merck's HepC elbasvir/grazoprevir PDUFA' ||| Adam Feuerstein @adamfeuerstein Tweet: Reminder: Today is $MRK HepC elbasvir/grazoprevir PDUFA. Co. spox knows first and most important post-approval question is: What price? ||| Fast Money Picks For January 28 ||| Abbott to Sell ALK's House Dust Mite Sublingual Allergy Immunotherapy Tablet in SE Asia",1,0.4991995
2016-01-29,16922700.0,49.79999923706055,50.66999816894531,49.58000183105469,50.66999816894531,44.26247024536133,MRK,"Health Care Sector Update for 01/29/2016: JNJ, PFE, ABT, MRK, AMGN, ABBV ||| Merck's Hepatitis C Doublet Wins FDA Approval and Unveils Its Secret Weapon ||| Instant Analysis: Can Merck Make Waves In the Crowded Hepatitis C Space? ||| Why is Gilead (GILD) Stock Falling Today? ||| Instant Analysis: Gilead Sciences Inc.'s Longtime CEO Steps Down ||| Merck's HCV Drug Zepatier Gets FDA Nod; Sets Lower Price ||| Gilead Hits New 52-Week Low; Here Are Two Reasons Why ||| Merck Confirms FDA Approval Of Hep C Drug At A Cost Of $54,600 Per Patient ||| From Conf Call: Abbvie Says Merck's New Hep C Drug Will Crimp Viekira Pak Sales",1,0.50153685
2016-02-01,11431200.0,50.38999938964844,50.97999954223633,49.84000015258789,50.75,44.33235168457031,MRK,"Mixed Earnings Expectations For Merck And Pfizer ||| One Put, One Call Option To Know About for Merck & Co. ||| Will 2016 Be Merck & Co. Inc.'s Best Year Yet? ||| Will Merck (MRK) Keep the Earnings Streak Alive in Q4? ||| 3 Numbers That Matter When Merck Reports Its Fourth-Quarter Results ||| GW Pharmaceuticals (GWPH): What Awaits in Q1 Earnings? ||| Earnings: Pharma Tends to Top Street Estimate—Can PFE, MRK Repeat? ||| Stock Marquee is Crowded in Week Ahead: Oil, Earnings, Labor Data",0,0.4725308
2016-02-02,14899300.0,50.27000045776367,50.5099983215332,49.900001525878906,50.40999984741211,44.03533554077149,MRK,"Why We Backed Up Our Truck For Chimerix ||| Noteworthy ETF Inflows: IVE, MRK, BAC, INTC ||| Pre-Market Earnings Report for February 3, 2016 : MRK, CMCSA, MDLZ, GM, SO, ADP, ALXN, BDX, EXC, ETN, MPC, BEN ||| Why Gilead Sciences Shares Tumbled 18% in January ||| Can Perrigo (PRGO) Beat Q4 Earnings on Generic Sales? ||| Merck, Sanofi Exploring Potential End To Joint Venture In Europe ||| Sanofi, Merck Considering Ending JV to Sell Vaccines in Europe -Bloomberg",0,0.48052973
2016-02-03,19568600.0,49.619998931884766,50.11000061035156,48.58000183105469,50.04999923706055,43.72085952758789,MRK,"Merck Tops on Q4 Earnings, Revenue Outlook Falls Short ||| Earnings Reaction History: Merck & Co. Inc., 50.0% Follow-Through Indicator, 1.3% Sensitive ||| Gilead (GILD) Beats Q4 Earnings Estimates, Gives 2016 View ||| International Growth Propels Gilead Sciences Inc.'s Solid Q4 Results ||| Merck's (MRK) Q4 Earnings Beat Estimates ||| Health Care Sector Update for 02/03/2016: TRIL, MRK ||| Why Medivation, Inc. Shares Crashed 32% in January ||| Merck & Co., Inc. Falters After Q4 Report ||| Joe McCann: Here's How To Play Biotech Market In Earnings Season ||| Shares Of Merck Dip Lower Following Q4 Print ||| Merck Sees FY16 EPS $3.60-$3.75 vs. Est. $3.72, Rev. $38.7-$40.2B vs. Est. $40.25B ||| Merck Reports Q4 EPS $0.93 vs. Est. $0.91, Rev. $10.215B vs. Est. $10.35B ||| Merck Sees FY 2016 EPS $3.60 to $3.75 vs $3.72 est ||| Merck Sees FY 2016 Revenue $38.7B vs $40.2B est ||| Merck Q4 EPS $0.93 vs $0.91 est, Revenue $10.2B vs $10.4B est ||| Keep an Eye on These 10 Stocks for February 3, 2016 ||| Earnings Scheduled For February 3, 2016",0,0.5001636
2016-02-04,20609200.0,49.70000076293945,49.7400016784668,48.02999877929688,48.59000015258789,42.44549560546875,MRK,"Company News for February 04, 2016 ||| Health Care Sector Update for 02/04/2016: MRK, SGEN ||| 2 Numbers in Merck's 4th-Quarter Report That Have Investors Worried ||| How To Build A Defensive Portfolio ||| 25 Companies That Could Still Buy Back Mountains Of Stock ||| ImmunoGen, Merck Partner For Clincial Evaluation Of Mirvetuximab Soravtansine With Keytruda Combination For Ovarian Cancer Treatment",1,0.4931183
2016-02-05,16883000.0,48.59999847412109,49.720001220703125,48.27000045776367,49.380001068115234,43.13559722900391,MRK,"ImmunoGen/Merck Collaborate for Ovarian Cancer Study ||| Gilead Sciences 2016 Guidance: Sandbagging Wall Street Again? ||| Dow 30 Stock Roundup: Microsoft, Exxon Beat on Earnings, Chevron Incurs Loss ||| A Checkup On A Big Healthcare ETF",0,0.49385017
2016-02-08,13345100.0,48.93000030517578,49.33000183105469,47.970001220703125,48.83000183105469,42.6551513671875,MRK,Grading Gilead Sciences' Performance in 2015 ||| 1 Company Gilead Sciences Should Consider Buying Right Now ||| Last Week's Best Healthcare ETF ||| Waging War on the Greatest Cancer Myth of All ||| Is Gilead Sciences Finally Nearing a Bottom? ||| Bristol-Myers' Daklinza-Sovaldi Label Expanded by the FDA ||| How To Invest In An Aging World With The 'Live Long & Prosper' ETF,1,0.51557904
2016-02-09,10649100.0,48.68999862670898,49.56999969482422,48.400001525878906,49.15999984741211,42.94340896606445,MRK,Curing Hepatitis C: How Gilead Sciences Plans to Beat Merck ||| 1 Chart That's Bringing Big Smiles to America's Largest Companies ||| Pfizer Gets Back to Growth,1,0.4904781
2016-02-10,11036100.0,49.5099983215332,50.40999984741211,49.4900016784668,49.52999877929688,43.26661682128906,MRK,"Notable ETF Inflow Detected - IVE, BAC, MRK, UTX ||| Dow Movers: DIS, V ||| ALK Announces Merck Submits BLA to FDA for Investigational House Dust Mite SLIT-tablet",0,0.48944607
2016-02-11,11088400.0,48.810001373291016,49.38999938964844,48.5099983215332,48.84999847412109,42.6726188659668,MRK,"Ligand (LGND) Beats on Q4 Earnings, Raises 2016 Outlook",1,0.5224544
2016-02-12,13598300.0,48.97999954223633,49.11000061035156,48.27999877929688,49.02999877929688,42.82986068725586,MRK,Incyte (INCY) Beats on Q4 Earnings and Revenue Estimates ||| 5 Key Takeaways from Organovo Holdings Inc.'s Investor Conference,1,0.5087103
2016-02-16,11416200.0,49.400001525878906,49.9900016784668,49.2400016784668,49.77999877929688,43.48501205444336,MRK,Merck (MRK) Gets CRL for Zetia & Vytorin sNDA from FDA,1,0.5128149
2016-02-17,9323300.0,50.0,50.650001525878906,49.959999084472656,50.59999847412109,44.20131301879883,MRK,Bouncing Biotech? Here Are 3 Stocks to Buy,0,0.48398903
2016-02-18,9612900.0,50.59999847412109,50.9900016784668,50.25,50.31999969482422,43.95672225952149,MRK,"IVV, CMCSA, MRK, BAC: Large Outflows Detected at ETF",0,0.51956695
2016-02-19,8964200.0,50.25,50.400001525878906,49.869998931884766,50.119998931884766,43.782020568847656,MRK,"Pre-Market Most Active for Feb 19, 2016 : WMT, INTC, QCOM, YHOO, GMCR, MRK, CBX, BAC, TVIX, CSCO, GFI, AU ||| Dow Analyst Moves: MRK ||| Dow 30 Stock Roundup: Wal-Mart Disappoints, Apple Pay Debuts in China",1,0.48087716
2016-02-22,7770300.0,50.27999877929688,50.77999877929688,50.130001068115234,50.77000045776367,44.349830627441406,MRK,"A Look Back at 2 Successful Biotech Buyouts ||| Merck Reports Investigational One-Daily Formulation of ISENTRESS Met Primary, Secondary Endpoints in Pivotal Phase 3 Trial",0,0.50396377
2016-02-23,7899500.0,50.560001373291016,50.93999862670898,50.43000030517578,50.540000915527344,44.148902893066406,MRK,"Will Merck Encroach On Gilead's Harvoni Territory? ||| 8,383 Patients Contacted to Arrange Blood Test Following Possible Exposure to ex-NHS Worker with Hepatitis C -Sky News",1,0.5044142
2016-02-24,7572700.0,50.15999984741211,50.619998931884766,49.630001068115234,50.560001373291016,44.16637802124024,MRK,"Daily Dividend Report: DHR, ETN, CNK, CP, MRK, DE, CTL, TXT ||| AureoGen Announces Licensing Agreement with Merck",1,0.5253204
2016-02-29,12888700.0,50.52000045776367,50.83000183105469,50.150001525878906,50.209999084472656,43.86063003540039,MRK,"This Pancreatic Cancer Breakthrough Is Big News ||| Interesting May Stock Options for MRK ||| Dow Movers: MRK, V ||| Should This Data Worry Gilead Sciences Inc.'s Investors? ||| Watch Pharma Names Following FDA Issuance Of New Mandatory Clinical Study For Bayer's 'Essure', Requires Product Labeling, Including Box Warnings And Patient Decision Checklist ||| 3 Mega Biotechs Leerink Loves",1,0.5232598
2016-03-01,12105700.0,50.38999938964844,51.93999862670898,50.09000015258789,51.75,45.20589447021485,MRK,Merck's Management Just Clued Investors in to These 3 Critical Points,1,0.53817666
2016-03-02,11974100.0,51.630001068115234,52.43999862670898,51.52000045776367,52.27000045776367,45.66012954711914,MRK,"Dow Movers: NKE, INTC ||| Super Tuesday Recap: Wall Street’s Winners and Losers",0,0.49750876
2016-03-03,9808800.0,52.18000030517578,52.31999969482422,51.150001525878906,52.09999847412109,45.51163864135742,MRK,"UPDATE: Merck, Pfizer, and Verastem Combination Trial Of Avelumab and VS-6063 Expected To Begin In 2nd Half 2016 ||| Merck KGaA, Darmstadt, Germany, Pfizer and Verastem Report Combination Trial of Avelumab and VS-6063 in Ovarian Cancer",0,0.4498716
2016-03-04,9085800.0,51.84999847412109,52.290000915527344,51.5,52.08000183105469,45.49416732788086,MRK,Charles Brandes' Top Buys During the 4th Quarter ||| 5 Revenant Sectors Echo Leo's Oscar-Winning Performance,1,0.5393687
2016-03-07,7466300.0,51.84000015258789,52.93000030517578,51.75,52.63999938964844,45.983341217041016,MRK,Better Buy: Pfizer Inc. vs. Merck ||| 3 Blue-Chip Stocks Too Expensive to Consider Now ||| Gilead Vs. Merck: What To Know ||| FDA Accepts Supplemental Biologics License Application For Keytruda,0,0.48499143
2016-03-08,8269000.0,52.36000061035156,52.93000030517578,52.290000915527344,52.45000076293945,45.81737518310547,MRK,"What Awaits Immune Design (IMDZ) this Earnings Season? ||| Kiss Patent Protection Goodbye for These 3 Blockbuster Drugs in 2016 ||| Jimmy Carter Boosts Social Media Buzz For Merck's Blockbuster Drug ||| Sanofi Pasteur, Merck Report Intent to End Joint Vaccines Operations in Europe, Sanofi Pasteur MSD, to Pursue Their Own Distinct Growth Strategies",0,0.49256957
2016-03-09,9150600.0,52.58000183105469,52.88999938964844,52.09999847412109,52.36000061035156,45.73875045776367,MRK,"Is U.S. Demand for New Hepatitis C Drugs About to Explode? ||| Sanofi, Merck to Dissolve Joint Vaccines Venture in Europe",1,0.53413594
2016-03-10,12267500.0,52.68999862670898,53.2400016784668,52.43000030517578,53.040000915527344,46.332763671875,MRK,"Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for March 11, 2016 ||| The Stocks That Moved The S&P, Dow And Nasdaq Today",1,0.48431453
2016-03-11,15532400.0,53.02000045776367,53.459999084472656,52.77999877929688,53.20000076293945,46.87909698486328,MRK,"Immune Design Loss Wider than Expected, Pipeline in Focus",0,0.50218254
2016-03-14,6532900.0,53.150001525878906,53.31999969482422,52.84000015258789,53.08000183105469,46.77336502075195,MRK,Agenus Shares Spike Higher Following Mid-Day Upgrade To Buy From Maxim ||| Could Cancer Deaths Really Be Eliminated for People Under the Age of 80 by 2050? ||| Sanofi's New Products Will Fuel Sales,0,0.5027827
2016-03-17,9578400.0,51.93000030517578,51.970001220703125,51.33000183105469,51.52999877929688,45.40751647949219,MRK,Organovo Is A Company 3D Printing Human Tissue And Its CEO Is Excited About Creating Livers,1,0.5375105
2016-03-21,7647100.0,52.33000183105469,52.83000183105469,52.09999847412109,52.79999923706055,46.526634216308594,MRK,"You'll Never Guess Which Pharma Likely Owns 40% of 2016's New Blockbusters ||| 3 Large-Cap Stocks With the Highest Net Profit Margins ||| Why Advaxis, Inc. Shares Are Soaring 16% Today",1,0.5130633
2016-03-22,9302300.0,52.58000183105469,53.459999084472656,52.54999923706055,53.02999877929688,46.72930145263672,MRK,"Stock Market News for March 22, 2012",1,0.48735446
2016-03-23,9947500.0,53.59999847412109,53.59999847412109,52.84999847412109,53.08000183105469,46.77336502075195,MRK,"European Stocks Rebound as Traders Hunt for Bargains ||| This New Dividend ETF Has a 585% Upside ||| Dow Movers: NKE, MRK ||| Jury Rules Merck Patents Valid…Bad For Gilead? ||| Gilead -2.5% Premarket Following Verdict Tuesday Validating Merck's Hep C Patents",0,0.49020186
2016-03-24,7566200.0,52.790000915527344,53.34999847412109,52.59000015258789,53.06999969482422,46.76455307006836,MRK,"IVE, MRK, BAC, C: ETF Inflow Alert ||| Health Care Sector Update for 03/24/2016: NVIV, JNJ, PFE, ABT, MRK, AMGN ||| An Attempt to Value Valeant Just for Fun ||| Patent Expert: It's Not Over For Gilead, Still Has Strong Defense Against Merck",0,0.49203473
2016-03-28,6046800.0,53.119998931884766,53.290000915527344,52.650001525878906,52.83000183105469,46.55306625366211,MRK,"Patent Payoff? Merck's and Ionis Pharmaceuticals' Take Could Be Tiny ||| One Put, One Call Option To Know About for Merck & Co. ||| Gilead to Pay $200 Million to Merck for HCV Patent Dispute ||| Biopharma Names LLY, PFE, MRK, And More Popping Higher Following Reports China FDA To Investigate Improper Vaccine Trading ||| Data Shows Gilead's HCV Franchise Is Surviving New Competition",1,0.49607918
2016-03-31,8335000.0,53.08000183105469,53.47999954223633,52.7599983215332,52.90999984741211,46.62356185913086,MRK,"Dow Movers: BA, IBM",1,0.51110727
2016-04-04,10249600.0,53.90999984741211,54.630001068115234,53.75,54.400001525878906,47.9365234375,MRK,"Ebola Can Teach Investors an Important Lesson About Economic Viability ||| Patent Palooza: One Patent Battle in Hep C, And Another Patent Brawl Brewing On Capitol Hill ||| Interesting May Stock Options for MRK ||| Better Buy: Gilead Sciences Inc. vs. Biogen Inc. ||| The Stocks That Moved The S&P, Dow And Nasdaq Today ||| This Data Signals The End For Merck's Anacetrapib ||| Make A House Call With A Familiar Healthcare ETF",0,0.48029223
2016-04-05,9000800.0,54.09000015258789,54.720001220703125,53.9900016784668,54.2400016784668,47.795536041259766,MRK,"Trade of the Day: Nautilus, Inc. (NYSE:NLS) ||| Advaxis, Merck Combination Trial Evaluating ADXS-PSA Launches Third Dose-Escalation Cohort",1,0.50899124
2016-04-06,12480400.0,54.34999847412109,55.790000915527344,54.2599983215332,55.630001068115234,49.02037811279297,MRK,"Dow Movers: CAT, PFE ||| PPH May Be Home To Hedge Fund Hotels, But This ETF Can Endure ||| SocGen Picks New Favorites In Big Pharma ||| Societe Generale Initiates Coverage on Merck & Co at Buy ||| Merck Will Present New KEYTRUDA Data At AACR Meeting Apr. 16-20th ||| WHO Says Number of Adults with Diabetes has Quadrupled Since 1980 -AFP",0,0.5067801
2016-04-07,10536800.0,55.34000015258789,55.77999877929688,55.04999923706055,55.41999816894531,48.8353385925293,MRK,"European Equities Edge Lower as Oil Prices Pare Early Gains, Traders Await Minutes from ECB's March Meeting ||| How One Analyst Is Playing The Biotech Rebound This Week ||| BZ NOTE: Relypsa Has Been Mentioned In Rumors Over Past 7 Months In Possible M&A Talk With Sanofi, Merck, Astra Zeneca",0,0.5046483
2016-04-08,6987400.0,55.75,55.90999984741211,55.09999847412109,55.36000061035156,48.7824592590332,MRK,Edwards Lifesciences Corp: EW Stock Is at the Heart of Innovation,0,0.5168262
2016-04-11,7065600.0,55.369998931884766,55.7400016784668,54.97999954223633,55.04999923706055,48.50929641723633,MRK,"The Biggest Threat to Novavax Stock ||| Could This Biotech Company Be About to Soar Higher? ||| Notable ETF Inflow Detected - VYM, JPM, VZ, MRK",1,0.48832804
2016-04-12,5937000.0,54.970001220703125,55.75,54.93999862670898,55.34000015258789,48.76484298706055,MRK,"Health Care Sector Update for 04/12/2016: AMGN, MRK, ABT, PFE, JNJ, CLVS, CBRP ||| 3 Big Pharma Stocks to Buy, 3 to Avoid ||| Baird: Gilead Set For Q1 EPS Miss, But Hep C Trends Still Good Long Term ||| Notable Imbalances Before Tuesday's Open Led By Under Armour, Boeing, Caterpillar",1,0.50800294
2016-04-13,8444500.0,55.459999084472656,55.9900016784668,55.27000045776367,55.959999084472656,49.31117630004883,MRK,"Health Care Sector Update for 04/13/2016: OCLS, PSTI, AMGN, MRK, ABT, PFE, JNJ ||| Merck Says FDA Accepts Its sBLA For Keytruda And Grants Priority Review ||| FDA Accepts Supplemental Biologics License Application for Merck's KEYTRUDA in Recurrent or Metastatic Head and Neck Cancer, and Grants Priority Review ||| Merck Announces License Application for Investigational House Dust Mite SLIT-tablet Accepted for Review by FDA",1,0.52162796
2016-04-14,8356700.0,56.02000045776367,56.59999847412109,55.93999862670898,56.45000076293945,49.742950439453125,MRK,"Merck Offers Positive Data from Comparative Trial on Zepatier ||| Health Care Sector Update for 04/14/2016: AMGN, MRK, ABT, PFE, JNJ, ABBV, ENTA, SNTA ||| After-Hours Recap: Big Banks, Liquidity Services's DoD Deal, Haemonetics' CFO & More ||| Merck Kgaa Says Filed Answer in Response to Trademark Right Violation Claims Made By Merck ||| Merck's ZEPATIER Showed Superiority on Efficacy and Safety Endpoints vs Sofosbuvir Plus Peginterferon and Ribavirin Treatment Regimen in Phase 3 Trial",0,0.478568
2016-04-15,8434400.0,56.52999877929688,56.54999923706055,55.880001068115234,56.13999938964844,49.46978759765625,MRK,"Health Care Sector Update for 04/15/2016: AMGN, MRK, ABT, PFE, JNJ, VRX, MRNS ||| Jefferies Maintains Hold on Merck & Co, Raises PT to $54.00",1,0.47977015
2016-04-18,7794200.0,56.13999938964844,56.83000183105469,55.91999816894531,56.5099983215332,49.79583740234375,MRK,"The Race to Cure the Zika Virus is On, and This Company May Have the Best Solution ||| Merck Announces Results From Phase 3 Studies of ZEPATIER in Chronic Hep C Patient Populations at ILC ||| After Hours Most Active for Apr 18, 2016 : NFLX, HES, LSXMK, AAPL, BAC, MSFT, WFC, INTC, LSXMA, PFE, MRK, KR ||| Interesting May Stock Options for MRK ||| Health Care Sector Update for 04/18/2016: MDVN, BIIB, AMGN, MRK, ABT, PFE, JNJ ||| Merck Reports Received Breakthrough Therapy Designation from FDA for KEYTRUDA in cHL",1,0.49377617
2016-04-19,7644200.0,56.72999954223633,57.380001068115234,56.220001220703125,56.86000061035156,50.104251861572266,MRK,"16 Reasons to Buy Merck and Never Sell ||| Notable ETF Inflow Detected - VYM, JPM, VZ, MRK ||| Merck Animal Health To Acquire Rights To Whisper Veterinary Stethoscope System, Terms Not Disclosed ||| Merck Gives Statement On Blueprint Project Findings AT AACR, Encouraged By Findings And Eager To Support Greater Biomarker Testing Use",0,0.49603623
2016-04-20,8520900.0,57.150001525878906,57.400001525878906,56.43999862670898,56.58000183105469,49.857513427734375,MRK,"Health Care Sector Update for 04/20/2016: CARA, AMGN, MRK, ABT, PFE, JNJ, STJ",1,0.50221044
2016-04-22,7093500.0,56.68999862670898,57.02999877929688,56.5099983215332,56.7400016784668,49.99850463867188,MRK,See Which Of The Latest 13F Filers Holds Merck & Co.,0,0.49880907
2016-04-25,8280200.0,56.47999954223633,56.63999938964844,56.0,56.220001220703125,49.540283203125,MRK,"3 Things to Watch in Gilead Sciences, Inc.'s First-Quarter Results ||| 5 Stocks With Bigger Dividends Than Merck & Co. ||| The Top 10 S&P 500 Dividend Stocks to Buy Now ||| Pharma Names Under Pressure Amid Perrigo Warning",0,0.52389795
2016-04-27,6941400.0,56.060001373291016,56.619998931884766,56.060001373291016,56.310001373291016,49.619590759277344,MRK,"Noteworthy ETF Outflows: UPRO, JPM, MRK, IBM",0,0.5131558
2016-04-28,9094700.0,55.88999938964844,56.22999954223633,55.54999923706055,55.7400016784668,49.11731719970703,MRK,"9 Figures That Sum Up Gilead Sciences' First Quarter ||| AbbVie (ABBV) Beats on 1Q Earnings, Lowers View on Deal ||| 3 Healthcare Stocks Billionaires Love Right Now",0,0.50297046
2016-04-29,13228000.0,55.63999938964844,55.63999938964844,54.560001373291016,54.84000015258789,48.32423782348633,MRK,"Ligand Pharma Adds Tech, Grows On Partners' Success ||| Gilead Sciences, Inc. Reports Disappointing Q1 Harvoni Sales ||| Gilead (GILD) Lags Q1 Earnings & Revenues, '16 View Intact",1,0.50163263
2016-05-02,9678900.0,54.84999847412109,55.36000061035156,54.70000076293945,55.29999923706055,48.729583740234375,MRK,"Merck And Pfizer Earnings: Will They Beat Expectations Again? ||| One Put, One Call Option To Know About for Merck & Co. ||| Merck (MRK) Q1 Earnings: Can the Stock Pull a Surprise? ||| Earnings: Drug Makers Merck And Pfizer Report Q1 Results ||| The Market In 5 Minutes: May, She Will Stay",0,0.47664365
2016-05-03,7601200.0,55.13999938964844,55.45000076293945,54.84999847412109,55.08000183105469,48.53573226928711,MRK,"Drug Stocks Reporting Mid-Week: MRK, ABC, ENDP & More ||| Forget Bluebird Bio, Inc.: These 3 Stocks Are Better Buys ||| 5 Data Points Wall Street Is Anxiously Awaiting in Merck's Q1 Report ||| TheStreet's Adam Feuerstein Tweets '$MRK $BMY are not working with $NWBO on cancer immunotherapy combination clinical trials, per their respective spokespersons.'",0,0.46937746
2016-05-04,7706000.0,54.709999084472656,55.040000915527344,54.470001220703125,54.810001373291016,48.29780960083008,MRK,"The Zacks Analyst Blog Highlights: Zoetis, McKesson, Merck, Endo International and AmerisourceBergen ||| Pre-Market Earnings Report for May 5, 2016 : MRK, BABA, OXY, EOG, REGN, BDX, CNQ, K, APA, TU, ABC, MGA",0,0.4832946
2016-05-05,11225200.0,54.27999877929688,54.400001525878906,53.34000015258789,54.09000015258789,47.66335678100586,MRK,"7 Figures That Sum Up Merck & Co.'s First Quarter ||| Dow Analyst Moves: MRK ||| Midday Update: Stocks Higher With Oil, But Gains Tempered by Earnings, Jobless Claims ||| Merck (MRK) Raises Outlook Following Q1 Earnings Beat ||| US Stock Futures Cling to Gains as Weekly Jobless Claims Jump; Crude Oil Extends Advance ||| Merck's (MRK) Q1 Earnings Beat Estimates, Revenues Miss ||| US Equities Futures Edge Up Amid Oil Gains ||| Stocks Nudge Lower Near Closing Bell Amid Mixed Earnings ||| Earnings Reaction History: Merck & Co. Inc., 50.0% Follow-Through Indicator, 1.2% Sensitive ||| Close Update: Stocks End Mostly Lower Amid Mixed Earnings as Oil Pares Rally ||| Mid-Afternoon Market Update: U.S. Stocks Turn Lower; Zynga Shares Rise Following Earnings Beat ||| Merck Lower After Mixed Q1 Report ||| Mid-Day Market Update: Fitbit Slides On Weak Outlook; Atlas Air Worldwide Shares Shares Spike Higher ||| Mid-Morning Market Update: Markets Edge Higher; Merck Profit Beats Views ||| Merck Launch of Zepatier in EU May be Delayed Until Late 2016, Early 2017 as Regulator Inspects Record-Keeping of Third Party Manufacturer -Reuters ||| Merck's Q1 Adjusted Profit beats, But Revenue Miss, Narrows Adjusted EPS FY16 Forecast ||| Merck Sees FY 2016 EPS $3.65 to $3.77 vs $3.71 est ||| Merck Q1 EPS $0.89 vs $0.85 est, Revenue $9.3B vs $9.5B est ||| 12 Stocks To Watch For May 5, 2016 ||| Earnings Scheduled For May 5, 2016",0,0.5114194
2016-05-06,10526300.0,53.81999969482422,53.970001220703125,53.060001373291016,53.59999847412109,47.2315788269043,MRK,"Dow 30 Stock Roundup: Pfizer, Merck, Exxon Beat on Earnings, Chevron Posts Loss ||| Immune Design (IMDZ) Q1 Earnings: What Awaits the Stock? ||| What's M&A Like In The Biotech Sector Right Now?",1,0.48309502
2016-05-09,7975400.0,53.56999969482422,54.33000183105469,53.5099983215332,54.09999847412109,47.67216873168945,MRK,Close Update: Wall Street Posts Mixed Close as Oil Weighs on Dow and Health Boosts Nasdaq ||| Wall Street Heads for Mixed Close as Oil Weighs on Dow and Health Boosts Nasdaq,1,0.49839863
2016-05-10,6486200.0,54.470001220703125,54.72999954223633,54.38999938964844,54.68000030517578,48.18325424194336,MRK,U.S. Stocks Trade Flat at Start of Week,0,0.47606415
2016-05-11,6572900.0,54.70000076293945,54.790000915527344,54.2599983215332,54.310001373291016,47.85721969604492,MRK,Immune Design (IMDZ) Loss Narrower than Expected in Q1,0,0.5009041
2016-05-12,8244300.0,54.59000015258789,54.619998931884766,53.93000030517578,54.119998931884766,47.68978500366211,MRK,"Analysts Predict 14% Gains Ahead For The Holdings of SYE ||| Health Care Sector Update for 05/12/2016: JNJ, PFE, MRK, ABT, AMGN, AEGR ||| Berenberg Unimpressed With Pfizer, Initiates Coverage At Hold ||| Merck To Present Final Stage Data On Investigational Medicines Ertugliflozin And MK-1293",0,0.48979497
2016-05-16,6649100.0,53.77000045776367,54.77000045776367,53.59000015258789,54.650001525878906,48.156829833984375,MRK,Thinking About Buying Gold? Think Again ||| Merck To Present New And Updated Data On KEYTRUDA,0,0.48334616
2016-05-17,11794000.0,54.40999984741211,54.56999969482422,53.97999954223633,54.31999969482422,47.86603546142578,MRK,"IWD, JNJ, BAC, MRK: ETF Inflow Alert",1,0.53154415
2016-05-18,7391200.0,54.38999938964844,54.95000076293945,54.16999816894531,54.66999816894531,48.1744384765625,MRK,Can Pfizer Acquisition Of Anacore Be Justified?,0,0.480403
2016-05-19,8733900.0,54.15999984741211,54.97999954223633,54.08000183105469,54.58000183105469,48.09514617919922,MRK,Will These Game-Changing Cancer Treatments Hit the Market in 2016? ||| JPMorgan's Take On Big Pharma's New ASCO Abstracts,1,0.51970756
2016-05-23,5570300.0,55.0,55.22999954223633,54.77999877929688,54.91999816894531,48.39473724365234,MRK,The Top 10 S&P 500 Dividend Stocks to Buy Now ||| Chardan Initiates Asterias Biotherapeutics At Buy On Potential Cell Therapy Competitiveness,1,0.5329491
2016-05-24,6311200.0,55.22999954223633,55.88999938964844,55.18000030517578,55.59999847412109,48.99394607543945,MRK,"Daily Dividend Report: PCG, CBT, MRK, ALL, HRL, THG",1,0.5010763
2016-05-25,9592200.0,55.810001373291016,56.66999816894531,55.77000045776367,56.56999969482422,49.84870147705078,MRK,"Billionaires Are Bailing on Gilead Sciences -- Should You, Too?",0,0.49357724
2016-05-26,5720500.0,56.470001220703125,56.720001220703125,56.34000015258789,56.38999938964844,49.690086364746094,MRK,"Cancer Immunotherapies Take Center Stage in Pre-ASCO Abstract Releases ||| Celgene Rallies Of Possible Interest From Merck ||| Celgene Shares Spiking, Traders Passing Vague Comments Of Possible Interest From Merck",1,0.50513256
2016-05-27,7508800.0,56.5,56.84000015258789,56.22999954223633,56.47999954223633,49.76940155029297,MRK,"Dow Movers: CAT, NKE ||| Merck Gets Favorable Opinion From CHMP For Its ZEPATIER ||| Merck Receives Positive CHMP Opinion for ZEPATIER in the European Union",0,0.51674867
2016-05-31,9468500.0,56.4900016784668,56.720001220703125,56.08000183105469,56.2599983215332,49.57553863525391,MRK,"3 Dividend Growth Stocks to Buy in June ||| Gilead's (GILD) New HCV Drug Epclusa Wins CHMP Backing ||| Merck, AbbVie & Amgen Drugs a Step Closer to EU Approval",1,0.51893026
2016-06-01,6691000.0,56.20000076293945,56.52000045776367,55.95000076293945,56.33000183105469,49.63721084594727,MRK,40 Upgrades and Downgrades for this Week,1,0.54753584
2016-06-02,7295500.0,56.43999862670898,56.86000061035156,56.36000061035156,56.81999969482422,50.06899642944336,MRK,"Notable ETF Inflow Detected - ITOT, MRK, V, QCOM ||| Attention Merck Investors: It's Time to Start Worrying ||| 10 Potentially Game-Changing Cancer Immunotherapies You Should Be Following",0,0.48966962
2016-06-03,5436900.0,56.84000015258789,56.959999084472656,56.27999877929688,56.63999938964844,49.9103889465332,MRK,"Get Paid While You Wait: 3 Top Big Pharma Dividend Stocks ||| Ouch! Jobs Report Miss Sends Rate Hike Odds Down, Raises Questions",1,0.50881636
2016-06-06,6904000.0,56.65999984741211,57.369998931884766,56.650001525878906,57.16999816894531,50.37740707397461,MRK,"New Data Evaluating KEYTRUDA in Combination with Chemotherapy for First-Line Treatment of NSCLC Demonstrate Response Rates Ranging of 48%71%; Data to be Presented at #ASCO16 ||| New KEYTRUDA Data from KEYNOTE-010 and KEYNOTE-001 in Advanced NSCLC, Including Survival Data, to be Presented at #ASCO16 ||| Merck Announces New Data from Phase 2 Study Evaluating KEYTRUDA for the Treatment of Cancers Deficient in DNA Mismatch Repair Show Durable Responses Across a Range of Cancers at #ASCO16 ||| Lilly Announces Encouraging Data of Early-Phase Immuno-Oncology Studies of ALIMTA and CYRAMZA with Merck's KEYTRUDA in NSCLC Presented at #ASCO16 ||| Merck Announces New Data for KEYTRUDA in Combination with Talimogene Laherparepvec, Dabrafenib Plus Trametinib, or Low-Dose Ipilimumab in Advanced Melanoma Presented at #ASCO16 ||| Pfizer (PFE) Presents Data on Utomilumab for Solid Tumors ||| Merck (MRK) Reveals Data from Ongoing Studies on Keytruda ||| US Judge Rules Gilead Won't have to Pay $200M Jury Verdict to Merck in Hepatitis C Patent Dispute -Reuters ||| 4 Key Takeaways From ASCO ||| Merck, Pfizer Offers Results from Pivotal Avelumab Study ||| Merck Reports Response Rates from KEYNOTE-055 Show Nearly One in Five Patients Respond with KEYTRUDA",0,0.5032706
2016-06-07,6252400.0,57.20000076293945,57.43999862670898,56.91999816894531,57.0,50.22760772705078,MRK,"Dow Movers: GS, AAPL ||| Legal Dispute Puts Ionis Pharmaceuticals' Payday on Hold ||| Noteworthy Tuesday Option Activity: EOG, MHK, MRK ||| Merck Says Ruling Reversal in Gilead Case 'Doesn't Reflect the Facts,' Co. Will Appeal Ruling Overturn ||| Goldman Confident In Merck's Keytruda ||| FDA Staff Has Said Overall Clinical Results from Merck's Bezlotoxumab Trial Could Negatively Impact Cure Rate of Initial Episode of Infection with C. Difficile",1,0.50504446
2016-06-09,9227700.0,57.5099983215332,57.81999969482422,56.93000030517578,57.18000030517578,50.38622283935547,MRK,"Why Advaxis, Inc. Stock Rose 19.6% in May ||| UPDATE: Merck To Pay $500M Cash Upfront, Afferent Holders Eligible FOr Addition $750M Tied To 'clinical development and commercial milestones for multiple indications and candidates, including AF-219' ||| Merck To Acquire Afferent Pharmaceuticals ||| Hearing FDA Panel Has Said Merck Has Provided Substantial Evidence of Safety, Effectiveness of Bezlotoxumab ||| BZ NOTE: Relypsa Shares Still Up $0.20-$0.40 from Where Stock Was Trading Prior to Apparent Rumor Manipulation Ahead of Negative StreetSweeper Report (See Body of This Headline for More) ||| Hearing Merck May Be Interested In RLYP, Unconfirmed Takeover Chatter ||| Agenus Reports Lead Product Candidate Selection in its Collab with Merck, Received First Milestone Payment of $2M",0,0.49541402
2016-06-10,9531700.0,56.81999969482422,57.08000183105469,56.56999969482422,56.810001373291016,50.060184478759766,MRK,"Noteworthy ETF Inflows: ITOT, GOOGL, GOOG, MRK ||| Merck (MRK) to Acquire Afferent in Deal Worth Up To $1.25B",0,0.49624708
2016-06-13,6204800.0,56.18000030517578,56.68000030517578,56.09000015258789,56.11000061035156,49.84697341918945,MRK,"Merck, Pfizer Announce Two Pivotal Phase 3 Studies for Ertugliflozin Met Primary Endpoints, Showing Significant A1C Reductions in Patients with Type 2 Diabetes at the American Diabetes Association's 76th Scientific Sessions ||| Pfizer Reveals Final Phase III Data on Inotuzumab Ozogamicin ||| 5 Things Organovo Holdings, Inc. Management Wants You to Know ||| Tricking the Common Cold Into Destroying Cancer ||| Merck Reports MK-1293 Met Primary Endpoint in Two Phase 3 Studies ||| Has Cancer Research Become Cancerous? Same Cancer Strategy Targeted By 'Too Many Drugmakers,' Say Regulators",1,0.50590676
2016-06-14,8594200.0,55.77000045776367,56.310001373291016,55.619998931884766,56.25,49.97134399414063,MRK,Should Pfizer Buy This Beaten-Down Immuno-Oncology Company? ||| How The Parts Add Up: XLG Headed For $164 ||| Merck's Biosimilar Version of Lantus Tops Phase III Studies ||| Jefferies Shares Pharma Stock Catalyst Outlook,0,0.4658603
2016-06-16,22052200.0,56.9900016784668,57.66999816894531,56.130001068115234,57.5,51.08182144165039,MRK,"Why Merck & Co., Inc. (MRK), Shake Shack Inc (SHAK) and World Wrestling Entertainment, Inc. (WWE) Are 3 of Today’s Best Stocks ||| Dow Movers: BA, MRK ||| Merck & Co., Inc. Wins This Round of the Immunotherapy Lung-Cancer Battle ||| Cramer Talks About Merck's 'Fabulous News' And Why The Market Can't Rally ||| Merck Rallies Of Drug Trial Results ||| Merck Announces Keytruda Met Primary and Secondary Endpoint",0,0.45651034
2016-06-17,17484400.0,57.43000030517578,57.43000030517578,55.70000076293945,55.88999938964844,49.65152740478516,MRK,"Dow 30 Stock Roundup: Microsoft Acquires LinkedIn, Merck to Buy Afferent Pharmaceuticals ||| Dow Movers: AAPL, CAT ||| Close Update: U.S. Stocks Fall With Nasdaq, S&P 500 Posting Lowest Close Since Late May ||| 3 Reasons Gilead Sciences Is a Buy",1,0.4964729
2016-06-20,8698700.0,56.34000015258789,56.59999847412109,56.119998931884766,56.13999938964844,49.87362289428711,MRK,"3 Top Big Pharma Stocks to Buy Now ||| Noteworthy ETF Inflows: IWD, JNJ, CSCO, MRK ||| The Zacks Analyst Blog Highlights: Baker Hughes, LinkedIn, Microsoft, Apple and Merck ||| UPDATE: Merck Says Pivotal Phase 3 Studies for Relebacatam Ongoing in Treatment of Serious Bacterial Infections ||| Merck Offers Results of Phase 2 Study for Relebactam in Combo with Imipenem/Cilastatin",1,0.53189063
2016-06-22,12477500.0,56.13999938964844,57.27000045776367,56.09999847412109,57.040000915527344,50.67317199707031,MRK,The Top 10 S&P 500 Dividend Stocks to Buy Now,1,0.5302922
2016-06-23,6968400.0,57.47999954223633,57.68000030517578,57.11000061035156,57.68000030517578,51.24172592163086,MRK,Incyte Reports Epacadostat Combination Study Initiation,0,0.51077694
2016-06-24,17258600.0,56.040000915527344,57.06999969482422,55.77000045776367,55.880001068115234,49.64264297485352,MRK,Why Investors Are Paying a Premium for These 3 Drugmakers,0,0.50893533
2016-06-27,13093300.0,55.4900016784668,55.68000030517578,55.09999847412109,55.310001373291016,49.136260986328125,MRK,Can Gilead Sciences Rebound in the Second Half of 2016? ||| Regulus Therapeutics Inc. Clinical Hold: Should Investors Be Yellow-Bellied? ||| Why Agenus' Stock Has Stumbled in 2016 ||| Better Buy: Merck & Co. Inc. vs. AbbVie ||| Merck Gets CHMP Positive Opinion For KEYTRUDA For Advanced Non-Small Cell Lung Cancer Treatment ||| Merck Receives CHMP Positive Opinion for KEYTRUDA for the Treatment of Advanced Non-Small Cell Lung Cancer,1,0.49140066
2016-06-28,12760100.0,55.43999862670898,55.66999816894531,55.11000061035156,55.58000183105469,49.37613677978516,MRK,"Notable ETF Inflow Detected - IVE, MRK, WMT, SLB ||| The FDA Unsurprisingly Approves Gilead's New Hepatitis C Drug. Now What?",1,0.4907292
2016-06-29,9813800.0,56.13999938964844,57.13999938964844,55.97999954223633,57.04999923706055,50.68204879760742,MRK,"Merck, Moderna Therapeutics Report Strategic Collaboration Related to Advancement of Novel mRNA-Based Personalized Cancer Vaccines with KEYTRUDA",1,0.5263622
2016-06-30,9277700.0,57.150001525878906,57.68000030517578,56.90999984741211,57.61000061035156,51.17954254150391,MRK,"Eli Lilly Stock Up on FDA Advisory Panel Vote for Jardiance ||| Merck And Premier Join Hands To Prevent Fractures For Osteoporosis Patients ||| Merck, Premier Report Collaboration to Prevent Fractures for Osteoporosis Patients",1,0.51760113
2016-07-01,7868300.0,57.540000915527344,58.0,57.41999816894531,57.93999862670898,51.47271347045898,MRK,"Health Care Sector Update for 07/01/2016: MRK,ARRY,MSLI ||| Merck Animal Health Announces Agreement to Acquire Controlling Interest In Brazilian Animal Health Company Vallée S.A., Will Acquire 93% Of Shares For $400M",1,0.50417286
2016-07-05,7394100.0,57.77999877929688,58.16999816894531,57.77999877929688,58.0,51.52600860595703,MRK,"These 20 Recently Approved Cancer Drugs Essentially Have 1 Thing in Common ||| A Big Breakthrough for Ovarian Cancer Patients ||| The Big Loser After Gilead's Latest Approval May Not Be Who You Think (Hint: It's not AbbVie, Inc.) ||| Better Buy: Celgene Corporation vs. Merck ||| Merck to Acquire Brazilian Animal Health Company for $400M ||| How Gilead's New Hepatitis C Virus Combination Stacks Up to the Competition",1,0.49977863
2016-07-06,14327700.0,58.27000045776367,59.27000045776367,58.06999969482422,59.15999984741211,52.5565299987793,MRK,"IWD, JNJ, MRK, BAC: Large Outflows Detected at ETF ||| Close Update: U.S. Stocks Hold Gains as Oil Moves Higher ||| Merck, Pfizer Report Initiation of Phase III Trial to Evaluate Avelumab as First-Line Treatment for Ovarian Cancer",0,0.50675476
2016-07-07,9351900.0,58.88999938964844,59.02000045776367,58.290000915527344,58.77999877929688,52.21894454956055,MRK,"Dow Movers: VZ, INTC",1,0.5223943
2016-07-08,9479400.0,58.97999954223633,59.56999969482422,58.79999923706055,59.34999847412109,52.725318908691406,MRK,"Dow 30 Stock Roundup: Chevron, Exxon Mobil to Invest in Kazakh Oil Field, Disney to Buy Stake in MLB Advanced Media ||| Stock Fund Managers Seek Scarce Profits In Durable-Growth Stocks",0,0.4954825
2016-07-11,7336700.0,59.2599983215332,59.75,59.20000076293945,59.34000015258789,52.71643829345703,MRK,"One Put, One Call Option To Know About for Merck ||| Gilead's Pan-Genotypic HCV Drug Epclusa Gains EU Approval ||| 10 Stellar Dow Jones Stocks to Buy for Q3",1,0.51248044
2016-07-14,7345500.0,59.869998931884766,59.93000030517578,59.47999954223633,59.650001525878906,52.99182891845703,MRK,"Notable ETF Inflow Detected - IWD, JNJ, JPM, MRK",0,0.5045722
2016-07-15,8162700.0,59.79999923706055,59.93000030517578,59.25,59.630001068115234,52.97407150268555,MRK,Gilead's HCV Drug Epclusa Gets Regulatory Nod in Canada ||| Is Advaxis' Stock Now a Bargain?,0,0.5033275
2016-07-18,8769200.0,59.0,59.4900016784668,58.720001220703125,59.02000045776367,52.4321517944336,MRK,3 Primary Ways Researchers Are Combatting Cancer ||| BMO Analysts Say Merck's Fundamentals Don't Justify Its Valuations ||| Benzinga's Top Downgrades ||| BMO Capital Downgrades Merck & Co to Market Perform,0,0.52350765
2016-07-19,8881300.0,59.08000183105469,59.5,58.560001373291016,58.65999984741211,52.112335205078125,MRK,5 Big Pharma Stocks Struggling to Raise Their Dividends,1,0.53629446
2016-07-20,6476000.0,59.0,59.119998931884766,58.7599983215332,58.790000915527344,52.22782516479492,MRK,"Dow Analyst Moves: MRK ||| Benzinga's M&A Chatter for Wednesday July 20, 2016",0,0.49735144
2016-07-21,6047100.0,59.0,59.11000061035156,58.560001373291016,58.790000915527344,52.22782516479492,MRK,"Here's Why Myriad Genetics Is Down 26% in 2016 ||| These 5 Healthcare Stocks Have Huge Dividend Yields -- Are Any Worth Buying? ||| Sorry, You Can't Buy This Hot Biotech -- At Least Not Directly ||| Merck Animal Health Receives FDA Approval of BRAVECTO For Cats And Dogs, Topical Treatment for Fleas and Ticks Effective for up to 12 Weeks ||| Merck Provides Regulatory Update on Biologics Licensing Application for Investigational Agent Bezlotoxumab ||| The Market In 5 Minutes: Jam-Packed Day Of Earnings And Economic Data",1,0.5365957
2016-07-22,6269500.0,58.9900016784668,59.08000183105469,58.54999923706055,58.81999969482422,52.25447463989258,MRK,"T. Rowe Price Equity Income Fund Sells Apache, Johnson & Johnson in 2nd Quarter ||| IWD, MRK, CSCO, MDT: ETF Outflow Alert ||| Health Care Sector Update for 07/22/2016: ABAX, VRX, AMGN, MRK, ABT, PFE, JNJ ||| Merck Presents Data On Its Investigational Once-Daily Formulation Of ISENTRESS ||| Merck Reports Investigational Once-Daily Formulation of ISENTRESS Showed Non-Inferior Efficacy, Safety to Regimen Containing Approved Twice-Daily Formulation",0,0.4950738
2016-07-25,8037200.0,58.630001068115234,58.880001068115234,57.97999954223633,58.560001373291016,52.02350616455078,MRK,"In Case You Missed It, 5 New Lung Cancer Drugs Have Been Approved Since October ||| See Which Of The Latest 13F Filers Holds Merck & Co. ||| Agenus (AGEN): What's Ahead for the Stock in Q2 Earnings? ||| Merck Gets Breakthrough Therapy Status From FDA And PRIME Status From EMA For Investigational Ebola Zaire Vaccine ||| NewLink Genetics Announces Merck Receives Breakthrough Therapy Designation from FDA, PRIME Status from EMA for Investigational Ebola Zaire Vaccine ||| Merck Reports Received Breakthrough Therapy Designation from FDA, PRIME Status from EMA for V920 ||| Merck Receives Breakthrough Therapy Designation from FDA and PRIME Status from EMA for Investigational Ebola Zaire Vaccine",0,0.49326232
2016-07-26,7150800.0,58.70000076293945,58.810001373291016,58.13999938964844,58.36000061035156,51.845829010009766,MRK,Merck (MRK) Q2 Earnings: Will the Stock Pull a Surprise? ||| Harvoni Sales Declines Hurt Gilead Sciences Inc. in Q2,1,0.5000367
2016-07-27,7888800.0,58.38999938964844,58.720001220703125,57.93000030517578,58.59999847412109,52.05903244018555,MRK,Merck a Top Socially Responsible Dividend Stock With 3.1% Yield (MRK) ||| Can Keytruda Deliver Earnings Growth For Merck?,0,0.5006476
2016-07-28,7289700.0,58.52000045776367,58.59000015258789,58.11000061035156,58.43000030517578,51.90801239013672,MRK,"2 Large Cap Drug Stocks to Watch for Earnings: ABBV & MRK ||| Pre-Market Earnings Report for July 29, 2016 : XOM, CVX, MRK, ABBV, UPS, PSX, CI, LYB, AON, VTR, PEG, TYC",1,0.5144886
2016-07-29,8491200.0,59.0099983215332,59.20000076293945,58.27000045776367,58.65999984741211,52.112335205078125,MRK,"Merck (MRK) Updates Outlook Following Q2 Earnings Beat ||| Dow Movers: XOM, MRK ||| Merck (MRK) Beats on Q2 Earnings by a Penny ||| Weak GDP Data, Plunging Oil Renew Questions About Strength Of Economy ||| A Peek Into The Markets: U.S. Stock Futures Mostly Lower Ahead Of GDP Report ||| Investors Greet Merck Q2 Results As Key Launches Help Beat ||| Merck Reports EC Granted Marketing Authorization for Co.'s ZEPATIER for Treatment of Chronic Hep C Infection ||| Merck Narrows, Raises FY16 Adj. EPS Outlook from $3.60-$3.75 to $3.67-$3.77 vs $3.72 Est., Sales from $38.7B-$40.2B to $39.1B-$40.1B vs $39.5B Est. ||| Merck Reports Q2 Adj. EPS $0.93 vs $0.91 Est., Sales $9.844B vs $9.78B Est. ||| 12 Stocks You Should Be Watching Today ||| Earnings Scheduled For July 29, 2016",0,0.48295307
2016-08-01,8871200.0,58.83000183105469,59.0,58.5,58.65999984741211,52.112335205078125,MRK,"Company News for August 01, 2016 ||| What Awaits MNK & Other Drug Stocks this Earnings Season? ||| One Put, One Call Option To Know About for Merck & Co. ||| Merck's Q2 Good, But Not Good Enough, Says BMO",0,0.46762648
2016-08-02,6826300.0,58.68000030517578,58.72999954223633,58.25,58.33000183105469,51.81917953491211,MRK,"Revenue and Earnings Higher for Merck in the Second Quarter ||| Noteworthy ETF Inflows: IYH, MRK, MDT, ABT ||| Why Avon Products, Inc. (AVP), Biogen Inc (BIIB) and Sodastream International Ltd (SODA) Are 3 of Today’s Best Stocks ||| Biogen (BIIB) Stock Surges 8% on Takeover Rumors ||| Benzinga's M&A Chatter for Tuesday August 2, 2016 ||| 6 Stocks Moving In Tuesday's After-Hours Session ||| Merck Reports KEYTRUDA Has Received EC Approval for Patients with NSCLC Whose Tumors Express PD-L1 ||| Wall Street Journal Reports Biogen Drawing Interest From Merck, Allergan On Possibility Of Huge Deal",0,0.48779058
2016-08-03,9637300.0,58.16999816894531,58.29999923706055,57.18000030517578,57.650001525878906,51.21508407592773,MRK,"Pharma ETFs Soaring on Solid Q2 Earnings ||| Benzinga's M&A Chatter for Wednesday August 3, 2016 ||| Terms Of The Trade: Dogs Of The Dow Investing Strategy ||| Biogen Shares Down $3 Over Last Min Following Reuters Report Co. Not Soliciting Offers; Allergan, Merck Shares Relatively Quiet, Not Impacted ||| The Market In 5 Minutes: Downtrend Continues ||| Why Is Biogen Attractive? Credit Suisse Sees 12-24% Upside Takeout Potential",1,0.5020945
2016-08-04,5541400.0,57.7400016784668,58.22999954223633,57.7400016784668,57.84000015258789,51.38386917114258,MRK,"Better Buy: Merck & Co. Inc. vs. Eli Lilly ||| Stop Dreaming: Biogen Isn't for Sale ||| Dow Movers: HD, NKE ||| Immune Design (IMDZ): Stock to Disappoint on Q2 Earnings? ||| Celgene Shares Spiking, Traders Circulating Takeover Chatter By Merck",1,0.4999111
2016-08-05,72876000.0,57.84000015258789,64.0,57.84000015258789,63.86000061035156,56.73190689086914,MRK,"3 Big Stock Charts for Friday: Bristol-Myers Squibb Co (BMY), Merck & Co., Inc. (MRK) and Fitbit Inc (FIT) ||| Why Bristol-Myers Squibb Co (BMY), Liberty Interactive Corp (QVCA) and Royal Bank of Scotland Group PLC (RBS) and Are 3 of Today’s Worst Stocks ||| Shares in Bristol-Myers Squibb Co (BMY) and Merck & Co., Inc. (MRK) Need to Chill ||| S&P 500 Movers: BMY, MRK ||| BLS Reports Robust July Jobs: 255K, 4.9% Unemployment ||| Dow 30 Stock Roundup: Merck & Pfizer Earnings Impress; Exxon & Chevron Disappoint ||| Why EOG Resources Inc (EOG), Merck & Co., Inc. (MRK) and Rackspace Hosting, Inc. (RAX) Are 3 of Today’s Best Stocks ||| Close Update: Stocks Ride Jobs Report Wave With S&P 500 Set for Record High ||| Pre-Market Most Active for Aug 5, 2016 : VER, XIV, MRK, BMY, BAC, AZN, FEYE, NVO, ZNGA, DISH, TLT, QQQ ||| After Hours Most Active for Aug 5, 2016 : AAPL, BAC, MSFT, QQQ, GILD, FCX, NVDA, VZ, AAL, MRK, GM, PFE ||| Bristol-Myers Tanks, Buy These Two Large Cap Pharma Stocks Instead ||| BMO Capital Upgrades Merck & Co to Outperform, Raises PT to $72.00 ||| 25 Biggest Mid-Day Gainers For Friday ||| Benzinga's Volume Movers ||| Stocks Hitting 52-Week Highs ||| Option Alert: MRK Oct16 60.0 Puts Sweep: 594 @ ASK $1.71: 605 traded vs 1589 OI: $61.04 Ref ||| Bristol's Opdivo Misses Endpoint In Late-Stage Trial; Merck Rallies Sharply Amid Keytruda Potential ||| The Market In 5 Minutes: Blowout Jobs Report Pushes Markets Higher ||| UPDATE: Merck's KEYTRUDA is Viewed as Strongest Competitor to Bristol's Opdivo ||| Merck Spike in Price Likely Attributed to Negative Results on Bristol-Myers' Opdivo ||| Merck Shares Spiking ~$6 Over Last Min ||| Merck Reports Acceptance of FDA Filing for NDA for MK-1293",0,0.49062264
2016-08-08,25045900.0,62.65999984741211,63.02000045776367,61.95000076293945,62.86000061035156,55.843528747558594,MRK,"This Long-Term Cardiovascular Study Could Revolutionize the Treatment of Type 2 Diabetes ||| U.S. Market Indexes Higher After Positive Jobs Report ||| BMO Capital Upgrades Merck To Outperform, Bullish On Co ||| Midday Update: Rally Runs Out of Steam as Healthcare Sector Weighs ||| One Put, One Call Option To Know About for Merck & Co. ||| The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, Pfizer and Procter & Gamble ||| Results from Merck's Phase 3 Study Of Zepatier Hep C Treatment Published In Annals Of Internal Medicine ||| Technical Alert: Merck Surrenders Some Of Friday's Huge Gain ||| After Roaring To New Highs on Jobs Data, Market Faces Retail Sales, Job Openings ||| CheckMate Miss Is A Game Changer; Credit Suisse Downgrades Bristol, Upgrades Merck ||| 8 Biggest Price Target Changes For Monday ||| The Market in 5 Minutes: Can The Momentum Continue? ||| Benzinga's Top Upgrades ||| Citi Doesn't See Merck's Lung Cancer Success Lasting Long ||| FDA Approves Merck's KEYTRUDA® (pembrolizumab) for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Disease Progression on or After Platinum-Containing Chemotherapy ||| Credit Suisse Upgrades Merck & Co to Outperform, Raises PT to $73.00 ||| Watch These 5 Huge Put Purchases In Monday Trade",0,0.48997343
2016-08-09,12234400.0,62.86000061035156,63.13999938964844,62.43000030517578,62.4900016784668,55.514835357666016,MRK,"Dow Movers: MRK, GS ||| Stock Market News for August 09, 2016 ||| Bristol-Myers Squibb Co: The BMY Freefall Is Overdone ||| Gilead Sciences Inc. Stock in 3 Charts ||| Bernstein Says Merck's Lung Cancer Drug Will Lead The Market Near-Term, But Long-Term Market Share Harder To Predict",1,0.496442
2016-08-10,8835400.0,62.09000015258789,63.09999847412109,62.06999969482422,62.63999938964844,55.64809036254883,MRK,"Biogen Inc: BIIB Stock Is a Biotech Standout ||| Immune Design (IMDZ) Posts Wider-than-Expected Q2 Loss ||| Argus: Bristol-Myers Selloff Is Overdone, Reiterating $90 Target",1,0.49584454
2016-08-11,10365000.0,62.61000061035156,63.72999954223633,62.47999954223633,63.630001068115234,56.527587890625,MRK,"Notable ETF Outflow Detected - HDV, MRK, LMT, NEE ||| Biogen Cancels Out Of Citigroup Conference Following Weeks Of Rumors",0,0.49315554
2016-08-12,6244300.0,63.13999938964844,63.45000076293945,62.93000030517578,63.34999847412109,56.27883529663086,MRK,"U.S. Market Indexes Higher on Thursday with Positive Retail Reports ||| YieldBoost Merck & Co. From 2.9% To 4.7% Using Options ||| Top 3 Research Reports for August 12, 2016",0,0.4504009
2016-08-15,6650100.0,63.34999847412109,63.75,63.209999084472656,63.31999969482422,56.25218963623047,MRK,Bristol-Myers' Revolutionary Cancer Drug Suffers A Big Blow ||| Inovio Expands Enrollment in Ebola Vaccine Phase I Study,0,0.532579
2016-08-16,5680100.0,63.0,63.31999969482422,62.84000015258789,63.040000915527344,56.00344467163086,MRK,Mirror Image: Bristol-Myers Loss Is Merck's Potential Gain,1,0.5323253
2016-08-17,8271500.0,63.02999877929688,63.43000030517578,62.59999847412109,63.290000915527344,56.22553634643555,MRK,"Dow Movers: CSCO, PFE ||| UPDATE: Reuters Says Merck, Sanofi, Pfizer, Gilead, Celgene Have Each Submitted Expressions of Interest for Medivation",1,0.5256861
2016-08-18,6926600.0,63.08000183105469,63.63999938964844,63.08000183105469,63.630001068115234,56.527587890625,MRK,2 Cancer Therapy Stocks That Are Ridiculously Cheap Right Now ||| Why Did We Update Our Price Estimate For Bristol-Myers Squibb?,0,0.48881206
2016-08-19,8480000.0,63.18000030517578,63.43999862670898,62.869998931884766,63.36000061035156,56.287723541259766,MRK,"Noteworthy ETF Inflows: HDV, PFE, MRK, INTC",1,0.53139925
2016-08-22,6447200.0,63.25,63.63999938964844,63.08000183105469,63.54999923706055,56.45651626586914,MRK,"ETFs in Focus on Pfizer's Medivation Acquisition ||| Pfizer Acquires Medivation, Renews Biotech M&A Bets",1,0.5102505
2016-08-24,7482900.0,63.59999847412109,63.77999877929688,62.5099983215332,62.72999954223633,55.72804260253906,MRK,"Merck & Co., Inc. (MRK) Preps for a Healthy Breakout ||| The 2015 Flash Crash Was One Year Ago Today. Why Did It Happen? ||| Write A Prescription For More Pharma M&A With This ETF",0,0.49077347
2016-08-25,7947700.0,62.86000061035156,63.09999847412109,62.27000045776367,62.31999969482422,55.36381149291992,MRK,"Healthcare Drug Pricing a Factor for the Market on Wednesday ||| 3 Reasons Gilead Sciences Inc. Stock Could Fall ||| European Stocks Fall Before Yellen Speech Led by Mining Stocks, Drugmakers",1,0.49727392
2016-08-26,7793800.0,62.47999954223633,62.9900016784668,62.18000030517578,62.84999847412109,55.83465194702149,MRK,"After Hours Most Active for Aug 26, 2016 : LMT, BAC, CTSH, RAX, GLW, TLT, AAPL, MRK, SCVL, CCE, MSFT, QQQ",1,0.48998213
2016-08-31,8860500.0,63.08000183105469,63.119998931884766,62.41999816894531,62.790000915527344,55.781349182128906,MRK,"Dow Movers: DD, MRK ||| Shares Of Celgene Spiking Higher, Hearing Unconfirmed Rumors That Big Restructuring Under Way & Speculation Is That They Are Prepping Deal With Merck",1,0.51802987
2016-09-01,6544700.0,62.70000076293945,62.97999954223633,62.38999938964844,62.900001525878906,55.87907409667969,MRK,"Options Activity Shows Traders are Betting on a Recovery for This Health Care ETF ||| Noteworthy Thursday Option Activity: MRK, GPS, GILD",1,0.5124274
2016-09-02,7613200.0,62.59000015258789,63.27000045776367,62.59000015258789,62.97999954223633,55.95014190673828,MRK,"Merck Remains Stable Following Discontinuation Of Odanacatib Development Program ||| Merck Provides Update on Odanacatib Development Program, Will Discontinue Development and Not Seek Regulatory Approval For Its Use",1,0.5241609
2016-09-06,7930300.0,62.9900016784668,63.470001220703125,62.77000045776367,63.2400016784668,56.18112182617188,MRK,Is Biogen a Worthwhile Buyout Candidate? ||| Merck Stops Development of Odanacatib for Osteoporosis ||| Volatile September Likely After August Losses,0,0.50140065
2016-09-07,8668100.0,63.310001373291016,63.4900016784668,62.59999847412109,62.869998931884766,55.8524169921875,MRK,"CAR-T Isn't the Only Play in Immunotherapy Stocks ||| Slowing Economic Growth Has Stocks Trading Lower ||| Technical Alert: Merck Range-Bound For Third Day In A Row ||| UDPATE: Merck To Continue Distributing Product On Behalf of Aralez For 12 Months, Considerations Also Include Sales-Based Milestones And Graduated Royalties ||| Merck Gets FDA Priority Review and Breakthrough Therapy Designation for KEYTRUDA",1,0.5212276
2016-09-08,9186300.0,62.45000076293945,63.290000915527344,62.33000183105469,63.2400016784668,56.18112182617188,MRK,Better Buy: Biogen Inc. vs. Gilead Sciences ||| This Crushing Blow Sent Bristol-Myers Squibb Co. Down 23% in August ||| Another Election Year View On Healthcare ETFs,0,0.49108353
2016-09-09,12587500.0,62.68999862670898,62.709999084472656,62.31999969482422,62.4900016784668,55.514835357666016,MRK,"Dow 30 Stock Roundup: Apple Launches iPhone 7, 3M Buys Semfinder ||| The Biotech ETF With The Unusual Investment Strategy ||| Barclays Raises Target On Merck, Lowers Target On Bristol-Myers",1,0.5062909
2016-09-12,10629500.0,62.0,63.4900016784668,61.90999984741211,63.18999862670898,56.13670349121094,MRK,"How Risky Is Organovo Holdings, Inc.? ||| MRK January 2019 Options Begin Trading ||| Better Buy: Merck & Co., Inc. vs. Pfizer ||| Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for September 13, 2016 ||| Gilead Sciencs, Inc. a Takeover Target? It's Not as Crazy As It Sounds ||| Notable Monday Option Activity: CSTE, MRK, HLF",0,0.4323647
2016-09-13,10223400.0,62.369998931884766,62.77999877929688,61.369998931884766,61.810001373291016,55.31339645385742,MRK,"New GE, Catepillar & Sinopec Research Reports ||| Why Pfizer's Stock Is a Big Gamble Right Now ||| Billionaire Battleground: Is It Time to Buy or Sell Gilead Sciences? ||| Presidential Merck: 'Jimmy Carter' Oncology Drug Expected To Dominate, Hep C Drug Approved Across EU",0,0.489774
2016-09-14,10421800.0,61.91999816894531,62.34000015258789,61.29999923706055,61.34999847412109,54.90175247192383,MRK,Bayer AG (ADR) (BAYRY) Makes the Monsanto Deal Work ||| US Market Indexes Mixed With Increased Uncertainty,1,0.52053255
2016-09-15,8997800.0,61.2400016784668,62.61000061035156,61.119998931884766,62.380001068115234,55.82349395751953,MRK,"Noteworthy ETF Inflows: IWD, JPM, PFE, MRK ||| Seattle Genetics No Longer On Goldman Sachs' Sell List ||| UPDATE: Pfizer, Merck's VERTIS SITA2 Also Achieved 4 Secondary Endpoints ||| Merck, Pfizer Reports Ertugliflozin Met Primary Endpoint of A1C Reduction",0,0.496052
2016-09-19,11287700.0,62.540000915527344,62.540000915527344,61.31999969482422,61.33000183105469,54.88384628295898,MRK,"Sanofi SA (ADR) (SNY) Sues Merck & Co., Inc. (MRK) Over Multiple Patent Infringements ||| This Diabetes Breakthrough Is Great News or Terrible News, Depending on Your Perspective ||| Market Close Report: NASDAQ Composite index closes at 5,235.03 down -9.54 points ||| 9 Dividend Stocks for a Full Calendar of Safe Income",1,0.4988012
2016-09-20,9211600.0,61.900001525878906,62.40999984741211,61.68999862670898,61.93999862670898,55.42973327636719,MRK,"Theresa May Assures IBM, Amazon, Goldman Sachs About Brexit ||| How Safe Is Gilead Sciences Inc. and Its Dividend? ||| Sanofi Sues Merck Over Patent Infringement ||| Some Traders Attributing After-Hours Upside in Clovis to Janney Capital Analyst Comment During Bloomberg Interview There Are 'Many Suitors' for Co, Including Lilly, Roche, Merck ||| New 5-Year Contraceptive Coming To U.S. Adds To Long-Acting Reversible Contraceptives List ||| Citi Research Reevaluates Bristol-Myers, Lowers Price Target",1,0.5147385
2016-09-21,7219000.0,62.2599983215332,62.81999969482422,61.86000061035156,62.70000076293945,56.10985565185547,MRK,"BioLineRx Begins Trial on BL-8040/ Keytruda Combination ||| The Market In 5 Minutes: We're Waiting For You, Mrs. Yellen ||| Clovis Upgraded At Credit Suisse Following Acquisition Rumor",1,0.52270716
2016-09-26,6983800.0,62.52999877929688,62.58000183105469,61.880001068115234,62.150001525878906,55.6176643371582,MRK,"One Put, One Call Option To Know About for Merck & Co. ||| Can You Guess Which Big Pharma Has Raised Its Drug Prices 5 Times Since June 2014? ||| vTv Therapeutics Shares Initiated With Buy Rating, $13 Target",1,0.5105131
2016-09-27,7340800.0,62.310001373291016,62.70000076293945,61.83000183105469,62.56999969482422,55.9935188293457,MRK,Eli Lilly Stock Upgraded: What You Need to Know ||| Amgen/UCB's BLA for Osteoporosis Drug Accepted in the U.S.,1,0.5407773
2016-09-28,11795000.0,63.0,63.47999954223633,62.5,63.29999923706055,56.646785736083984,MRK,Merck Shares Indicated Up 1+% Premarket; Shares Could Be Higher Amid Positive Trial News from Incyte; Incyte Shares Up ~5% in Pre-Open,0,0.48872945
2016-09-29,10930000.0,63.02000045776367,63.02000045776367,61.560001373291016,61.90999984741211,55.40288543701172,MRK,"Dow Movers: MRK, CAT ||| Deutsche Bank's Losses Affecting the Market on Thursday",1,0.49553922
2016-09-30,13605300.0,61.88999938964844,62.72999954223633,61.86000061035156,62.40999984741211,55.85032653808594,MRK,"Exelixis, Inc. (EXEL) Crushed on CaboNivo Drug Trial Results",1,0.5004562
2016-10-04,7897400.0,62.47999954223633,62.95000076293945,61.93999862670898,62.459999084472656,55.89507675170898,MRK,Dow Analyst Moves: MRK ||| 5 FDA Decisions to Watch Out for in October 2016,1,0.51967734
2016-10-05,7871300.0,62.70000076293945,63.040000915527344,62.47999954223633,62.79999923706055,56.199337005615234,MRK,"Noteworthy ETF Outflows: IWD, MRK, INTC, CSCO ||| How Merck & Co., Inc. Ranks As a Top Analyst Pick (MRK) ||| FDA Issues Warning on Hepatitis C Drugs",0,0.49123377
2016-10-07,10775200.0,62.77000045776367,62.9900016784668,62.02999877929688,62.77000045776367,56.172489166259766,MRK,"Top Research Reports for Amazon, Celgene & Chubb ||| Merck Animal Health Announces USDA Approval of Innovative Canine Flu Bivalent Vaccine",1,0.53921175
2016-10-10,20345900.0,64.20999908447266,64.86000061035156,63.43999862670898,63.900001525878906,57.183719635009766,MRK,"Exclusive: Interview With DelMar Pharmaceutical CEO Jeffrey Bacha ||| New Data on the Combination of Lilly's ALIMTA and Merck's KEYTRUDA Show a Near-Doubling of Objective Response Rate Compared to Standard of Care Alone in First-Line Metastatic NSCLC Presented at ESMO 2016 ||| Merck Announces Two Major Studies to Be Presented at ESMO 2016 Demonstrate Potential of KEYTRUDA for the First-Line Treatment of Metastatic NSLCL in a Broad Range of Patients ||| Merck Announces KEYTRUDA Showed Continued Overall Survival Benefit Compared to Chemotherapy with Longer Follow-Up in Patients with Previously Treated Metastatic NSCLC in Data to Be Presented at ESMO 2016 ||| Merck Presents Longer-Term Follow-Up of Overall Survival Data for KEYTRUDA in Patients with Advanced Melanoma from KEYNOTE-002 at ESMO 2016 ||| Merck Announces New KEYTRUDA Data in Advanced Urothelial Cancer Demonstrate Overall Response Rate of 24 Percent in Cisplatin-Ineligible Patients ||| 3 Stocks to Watch Monday: Mylan NV (MYL), Bristol-Myers Squibb Co (BMY) and Comcast Corporation (CMCSA) ||| The Zacks Analyst Blog Highlights: Amazon, Celgene, Chubb, Delta and Merck ||| Why Bristol-Myers Squibb, Myriad Genetics, and Twilio Slumped Today ||| Dow Movers: WMT, XOM ||| CheckMate Again for Bristol-Myers Squibb Co. As Shares Dip 10% ||| The ESMO Conference Proves Its Ability To Move Stocks ||| Technical Alert: Merck Reaches Highest Level Since December 2001 ||| Bristol-Myers' Opdivo Vs. Merck's Keytruda In Front-Line Lung Treatment ||| SunTrust Cuts Target On Bristol-Myers As Opdivo Estimates Revised Lower",0,0.5002106
2016-10-11,13955400.0,63.52999877929688,63.54999923706055,61.75,61.93000030517578,55.420780181884766,MRK,"Company News for October 11, 2016 ||| Merck's New Products and Solid Pipeline As Growth Drivers ||| Market Close Report: NASDAQ Composite index closes at 5,246.79 down -81.88 points ||| Close Update: Wall Street Limps Into the Close on Alcoa's Lackluster Earnings, Sell-off in Oil ||| Technical Alert: Merck Surrenders Monday's Gains ||| Aetna and Merck Sign a Unique Value-Based Contract for Januvia and Janumet",0,0.4790436
2016-10-12,10121900.0,62.400001525878906,62.630001068115234,61.58000183105469,61.65999984741211,55.17915725708008,MRK,"Gilead Sciences, Inc. Is More Than an HCV Play (GILD)",1,0.49301785
2016-10-13,14541500.0,62.25,62.95000076293945,61.93999862670898,62.5099983215332,55.93981552124024,MRK,"3 Value Stocks Near 52-Week Lows Worth Buying ||| Dow Movers: GS, MRK ||| Market Close Report: NASDAQ Composite index closes at 5,213.33 down -25.69 points ||| 7 Biggest Price Target Changes For Thursday ||| Benzinga's Top Upgrades ||| A Peek Into The Markets: U.S. Stock Futures Tumble Ahead Of Jobless Claims Report ||| Bank of America Upgrades Merck & Company to Buy, Raises Price Target to $70.00",0,0.5269062
2016-10-14,12204200.0,62.720001220703125,62.86000061035156,62.130001068115234,62.13999938964844,55.60871124267578,MRK,"Top Research reports for Apple, Merck, BlackRock & Kraft Heinz",0,0.50295967
2016-10-17,13054600.0,62.04999923706055,62.04999923706055,60.79999923706055,61.52000045776367,55.05388259887695,MRK,"The Zacks Analyst Blog Highlights: Kraft Heinz's, Merck, BlackRock, Apple and Alibaba ||| The Zacks Analyst Blog Highlights: Mylan, Pfizer, Roche, Merck and Bristol-Myers ||| 7 Stocks to Buy That Will Grow by Double Digits",1,0.50354797
2016-10-18,9988000.0,61.900001525878906,62.619998931884766,61.83000183105469,62.09000015258789,55.56396484375,MRK,Analysts Forecast 10% Upside For IWX,0,0.52047616
2016-10-19,5582700.0,62.130001068115234,62.29999923706055,61.810001373291016,61.869998931884766,55.36708450317383,MRK,"Can Merck (MRK) Keep the Earnings Streak Alive in Q3? ||| Key Takeaways from JNJ's Q3 Call: Remicade, Pipeline, Acquisitions ||| Roche's Tecentriq Wins FDA Nod for Additional Indication ||| Fed Speakers And Beige Book, Bank Earnings, Rising Crude Take Center Stage ||| Roche Group, Competitor To Bristol-Myers And Merck, Has PDUFA DateFor Tecentriq Drug ||| Merck Announces Pivotal Phase 3 Study of Letermovir Met Primary Endpoint",1,0.5370701
2016-10-20,6323400.0,61.95000076293945,62.27000045776367,61.68999862670898,61.91999816894531,55.41183853149414,MRK,"Nothing Can Stop Merck & Co., Inc. (MRK) Stock Now ||| 7 Drug Stocks to Consider as Biosimilars Pick Up Pace ||| Merck's Antiviral Medicine Meets Endpoint in Phase III ||| Gilead Sciences: Is the Bar Set Low Enough for a Beat?",0,0.46491536
2016-10-21,7406700.0,61.54999923706055,61.900001525878906,61.02999877929688,61.20000076293945,54.76750946044922,MRK,"The Zacks Analyst Blog Highlights: Pfizer, Novartis AG, Amgen, Merck and Momenta Pharmaceuticals ||| Health Care Sector Update for 10/21/2016: MRK ||| The Top 10 S&P 500 Dividend Stocks to Buy Now ||| Merck Has An Upcoming PDUFA Date For Bezlotoxumab ||| Are The Drugs Working? Pharma Giants Eli Lilly And Merck To Update Investors On Cancer Treatments ||| Merck Has An Oct 23rd Pdufa Date For Bezlotoxumab; Drug Won FDA Advisory Panel Backing In June ||| Jim Cramer Gives His Opinion On Merck And Smith & Wesson ||| Merck Reports KEYNOTE-045 Studying KEYTRUDA in Advanced Bladder Cancer Meets Primary Endpoint, Stops Early",0,0.4721422
2016-10-24,9943000.0,61.400001525878906,61.47999954223633,60.63999938964844,60.75,54.36480712890625,MRK,"Interesting April 2017 Stock Options for MRK ||| Healthcare ETFs: Gain or Pain Ahead in Q3 Earnings? ||| Agenus (AGEN): What's Ahead for the Stock in Q3 Earnings? ||| Merck Gets FDA Approval for Investigational Drug Zinplava ||| What to Expect from Merck & Bristol-Myers' IO Drugs in Q3? ||| Drug Stocks Q3 Earnings Roster for Oct 25: MRK, LLY & More ||| Market Close Report: NASDAQ Composite index closes at 5,309.83 up 52.43 points ||| Pre-Market Earnings Report for October 25, 2016 : PG, MRK, MMM, LLY, UTX, LMT, DD, CAT, GM, MMC, BAX, S ||| What To Expect From Merck's Q3 Earnings? ||| Merck Reports FDA Approval Of KEYTRUDA ||| Big News Out Of Merck This Weekend",1,0.5313154
2016-10-25,15188500.0,60.27000045776367,62.18999862670898,59.54999923706055,61.95000076293945,55.43867874145508,MRK,"US Equities in the Red Amid Mixed Earnings, Slide in Consumer Confidence ||| 5 Healthcare Stocks to Buy Despite a Clinton Victory ||| Merck (MRK) Beats on Q3 Earnings & Revenues, Lifts View ||| Lilly (LLY) Misses on Q3 Earnings, Sales; Animal Health Hurts ||| Merck Keytruda Gets FDA Approval for First-Line Lung Cancer ||| Stock Futures Cautiously Higher Amid Earnings Deluge ||| Merck (MRK) Tops Q3 Earnings, Revenue Estimates ||| Better Buy: Merck & Co. Inc. vs. AbbVie Inc. ||| Merck & Co.'s Keytruda Is ""Off to The Races"" ||| Technical Alert: Merck Higher After Q3 Report ||| 6 Big Pharma Companies Left To Report September Quarterly Figures ||| Epic Earnings: Many US Companies Beating Expectations As Season Continues ||| The Market In 5 Minutes: UA, GM, P&G Earnings On The Street's Mind ||| A Peek Into The Markets: U.S. Stock Futures Rise; GM, Apple Earnings In Focus ||| Merck's Q3 Results, Guidance Look Strong ||| Merck Narrows and Raises Guidance; Sees FY EPS $3.71 to $3.78 vs $3.75 est, Revenue $39.7B to $40.2B vs $39.7B est ||| Merck Q3 EPS $1.07 vs $0.99 est, Revenue $10.54B vs $10.18B est ||| 12 Stocks You Should Be Watching Today ||| Earnings Scheduled For October 25, 2016",0,0.5111106
2016-10-26,9957800.0,61.7400016784668,61.84999847412109,60.54999923706055,60.869998931884766,54.47219467163086,MRK,"3 Key Questions for Gilead Sciences, Inc. in Q3 ||| Which Of The Latest 13F Filers Holds Merck & Co.? ||| Who Fared Better in Q3 Earnings Season: Merck or Eli Lilly?",1,0.5225081
2016-10-27,10350700.0,61.150001525878906,62.060001373291016,61.0,61.290000915527344,54.848052978515625,MRK,"Merck & Co.'s Patent Cliff In 2017 ||| Key Takeaways from Biogen's Q3 Call: Tecfidera, Pipeline, Biosimilars ||| Peek Into Drug Stocks' Earnings on Oct 28: ABBV & IMGN ||| Your Personal Healthcare Investment Plan",0,0.455585
2016-10-28,20358400.0,61.02000045776367,61.06999969482422,58.45000076293945,58.84000015258789,52.65555953979492,MRK,"Market Close Report: NASDAQ Composite index closes at 5,190.10 down -25.87 points ||| Stocks Positioned to End Mostly Lower as Wall Street Jolted by FBI Move on Clinton Emails ||| Can Keytruda Return Merck & Co. to Growth? ||| Dow 30 Stock Roundup: Apple's Earnings Disappoint, Boeing, Coca Cola, Microsoft Impress ||| Dow Movers: MRK, CVX ||| The Zacks Analyst Blog Highlights: Biogen, Merck, Eli Lilly, AbbVie and ImmunoGen",0,0.48970032
2016-10-31,14254800.0,59.09000015258789,59.150001525878906,58.369998931884766,58.720001220703125,52.54817581176758,MRK,"Could This Look-A-Like Drug Be Merck's Next Big Seller? ||| 3 Things AbbVie's Management Said While Its Stock Got Hammered ||| Will This Trend Cost Biotech Stock Investors Lots of Money? ||| 5 Dividend Stocks to Buy in November ||| Noteworthy ETF Outflows: IWD, WFC, MRK, INTC ||| One Put, One Call Option To Know About for Merck & Co.",1,0.5307663
2016-11-01,14347400.0,59.0,59.59000015258789,58.5099983215332,59.29999923706055,53.06721115112305,MRK,"Pfizer (PFE) Q3 Earnings Lag; Cuts View, Sheds Bococizumab ||| The Election Can't Come Soon Enough For Biotechs",0,0.45896763
2016-11-02,10724700.0,59.060001373291016,59.5099983215332,58.75,58.84000015258789,52.65555953979492,MRK,"2 Bullish Biotech Trades to Take Your Mind off the Election (BIIB CELG) ||| Gilead's Q3 Bombshell: No More Hepatitis C R&D ||| Merck Reports Publishing of New Research on Early Development of Verubecestat, Says 'Results of First Phase 3 Trial Anticipated in Late 2017'",0,0.49732384
2016-11-03,11323000.0,59.18000030517578,59.220001220703125,58.290000915527344,58.43000030517578,52.28865432739258,MRK,Pharma Industry Outlook - November 2016 ||| BZ NOTE Related to Traders Passing Around CNBC Story on New Cancer Drugs Possibly Damaging the Heart: NBC News via AP Published the Same Story ~7 p.m. EDT Wed. Evening ||| Traders Passing Around Recent CNBC Article on Cancer Treatments: 'New cancer drugs may damage the heart',1,0.4963677
2016-11-04,11318600.0,58.68999862670898,59.27000045776367,58.61000061035156,58.81999969482422,52.63766860961914,MRK,3 Reasons Why Organovo Holdings Inc. Should Rebound Big,1,0.5415503
2016-11-07,10478300.0,59.52000045776367,60.209999084472656,59.47999954223633,60.04999923706055,53.73838424682617,MRK,Interesting December Stock Options for MRK,1,0.517014
2016-11-08,7942100.0,59.81999969482422,60.77999877929688,59.52000045776367,60.5099983215332,54.1500358581543,MRK,iShares Russell 1000 Value ETF Experiences Big Inflow,1,0.5132242
2016-11-09,27851100.0,63.959999084472656,65.0,62.7599983215332,64.18000030517578,57.43429946899414,MRK,"Midday Update: Stocks Snap Back as Financial and Healthcare Sectors Rally ||| 6 Stocks to Profit from a Trump Presidency ||| Close Update: Stocks Rally as Wall Street Warms Up to Trump Presidency ||| Noteworthy Wednesday Option Activity: CNC, PNRA, MRK ||| Technical Alert: Merck Reaches $65 And Retreats ||| Stocks Hitting 52-Week Highs ||| Pharma Stocks Up Post Election: Ariad 16%, Infinity Up 13%, Allergan, Progenics, Endo 10%, Pfizer, Regeneron 8%, AbbVie 7%, Mylan, Medicines Co. 6%, Perrigo, Merck 5%, Bristol-Myers, Eli Lilly, Sanofi, Novartis 3.5% ||| Biotech Is Getting A Big Boost Following Clinton's Loss",1,0.49610263
2016-11-10,17862300.0,64.54000091552734,65.45999908447266,64.5199966430664,64.95999908447266,58.132320404052734,MRK,"Top Research Reports for Merck, DISH & Pioneer Natural ||| 3 Biotech Stocks You MUST Buy for Donald Trump’s Presidency ||| Merck & Co Inc (MRK) Chairman, President & CEO Kenneth C Frazier Sold $9. ... ||| American Assets Trust Inc (AAT) Chairman, CEO & President Ernest S Rady Bought $—. ... ||| The 7 Best Dividend Stocks to Buy for 2017 ||| 2 Big Medical Marijuana Stocks Riding High Post-Election",0,0.48959538
2016-11-11,14059700.0,64.08000183105469,64.51000213623047,63.58000183105469,63.95000076293945,57.228458404541016,MRK,"The Zacks Analyst Blog Highlights: Merck, DISH Network, Pioneer Natural Resources, Johnson Controls and Boston Properties ||| AstraZeneca (AZN) Beats on Q3 Earnings; Sales Slow Down ||| Why You Should (and Shouldn't) Buy Merck ||| Immune Design (IMDZ) Posts Lower-than-Expected Q3 Loss ||| Technical Alert - Merck Lower",0,0.4764039
2016-11-14,10124500.0,64.0,64.08999633789062,63.2400016784668,63.52999877929688,56.85262298583984,MRK,"Merck Announes KEYTRUDA Significantly Improves Overall Survival Compared to Chemotherapy in Previously Treated Patients with Advanced Bladder Cancer ||| Merck Presents New Findings for ZEPATIER in Patients with Chronic Hepatitis C at The Liver Meeting ||| Merck Announces Findings for Investigational Triple-Combination Chronic Hepatitis C Therapy Showing High Rates of Sustained Virologic Response in People with Genotypes 1, 2 or 3 Infection ||| Merck's Triple Combination HCV Therapy Positive in Phase III ||| Go for It, Pfizer -- Sell Your Consumer Healthcare Business ||| 6 Dow Stocks to Buy on Election Week Rally ||| Amgen Presents Osteoporosis Data; Parsabiv Approved in EU ||| Gilead Responds To CMS Blog Highlighting High Cost Of Harvoni: Most Payers Receive Substantial Discounts Off The List Price",1,0.540254
2016-11-15,7290400.0,63.68000030517578,63.72999954223633,63.08000183105469,63.650001525878906,56.96001052856445,MRK,Dynavax Technologies Shares Decimated -- Is There Any Hope for Heplisav? ||| Better Buy: Johnson & Johnson vs. Merck,0,0.504811
2016-11-16,10780200.0,63.70000076293945,63.95000076293945,62.45000076293945,62.630001068115234,56.047210693359375,MRK,"Noteworthy ETF Inflows: IYH, MRK, UNH, MDT ||| Health Care Sector Update for 11/16/2016: MRK ||| Is Immunotherapy the Next Hot Industry for Biotech Stock Investors? ||| Vetr Opts To Hold On Merck Despite Biotech Optimism",1,0.50091743
2016-11-17,8361300.0,62.5099983215332,62.790000915527344,62.119998931884766,62.70000076293945,56.10985565185547,MRK,"Health Care Sector Update for 11/17/2016: NWBO ||| Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for November 18, 2016 ||| Top Research Reports for 17th November, 2016 ||| The 10 Best Pharma Stocks Under President Donald Trump",0,0.45842406
2016-11-18,7696900.0,62.56999969482422,62.619998931884766,61.72999954223633,61.869998931884766,55.36708450317383,MRK,"The Zacks Analyst Blog Highlights: Home Depot, TOTAL, Pepsi, Merck, Target and Electronic Arts ||| 3 Big Drug Stocks That Billionaire Money Managers Dumped in Q3 ||| Market Close Report: NASDAQ Composite index closes at 5,321.51 down -12.46 points ||| Dow 30 Stock Roundup: Wal-Mart, Cisco, Home Depot Beat on Earnings, Disney Disappoints",1,0.51158386
2016-11-21,6836700.0,61.93999862670898,62.38999938964844,61.720001220703125,62.29999923706055,55.75189208984375,MRK,"Can Bristol-Myers Squibb's Dividend Even Survive? ||| 3 Dividend Stocks You Don't Have to Babysit ||| Stock Market News for November 21, 2016 ||| The 10 Best S&P 500 Blue-Chip Dividend Stocks to Buy Now",0,0.4752159
2016-11-22,9592200.0,62.5,62.650001525878906,61.209999084472656,61.70000076293945,55.21495056152344,MRK,"Merck Increases Qtr. Dividend From $0.46 To $0.47/Share ||| QuintilesIMS Forms New Collaboration with Bristol-Myers Squibb, Lilly, Merck KGaA, Darmstadt, Germany, and Pfizer to Generate Real World Insights On Usage of Anti-Cancer Therapies Across Europe",0,0.49787465
2016-11-23,9149000.0,60.33000183105469,61.70000076293945,59.81999969482422,61.63999938964844,55.1612663269043,MRK,"Dow Movers: MRK, CAT ||| After Hours Most Active for Nov 23, 2016 : T, PG, AAPL, SWFT, BAC, QQQ, CHK, MRK, MSFT, PYPL, TMUS, WYNN ||| AstraZeneca: FDA Lifts Hold on Head & Neck Cancer Trials ||| Daily Dividend Report: MRK, KRG, AXP, WMB, MTB ||| Top Research Reports for General Dynamics, DuPont, & Merck",1,0.46621895
2016-11-25,3501300.0,61.81999969482422,62.400001525878906,61.75,62.209999084472656,55.671348571777344,MRK,"Merck (MRK) Announces 2.2% Increase in Quarterly Dividend ||| Merck's New Drugs, Cost Management to Fuel Growth in 2017 ||| Better Buy: Celgene Corporation vs. Merck & Co.",0,0.5049378
2016-11-28,7449400.0,61.77999877929688,62.060001373291016,61.619998931884766,61.79999923706055,55.304443359375,MRK,"Merck to announce dividend increase ||| VYM, MRK, PM, MCD: Large Inflows Detected at ETF ||| J&J (JNJ) Confirms it Approached Actelion for Possible Deal ||| FDA Grants Priority Review to Merck's Supplemental Biologics License Application (sBLA) Seeking Approval for KEYTRUDA for New Indication in Microsatellite Instability-High Cancer",1,0.5231795
2016-11-29,10034900.0,61.95000076293945,62.459999084472656,61.91999816894531,62.18999862670898,55.6534538269043,MRK,8 Dividend Stocks Increasing Payouts — MRK BDX HRL LANC ROP SJI KRG YORW ||| Merck: Keytruda's Priority Review for New Cancer Indication,0,0.50669026
2016-11-30,12530700.0,62.310001373291016,62.31999969482422,60.9900016784668,61.18999862670898,54.75856399536133,MRK,Pfizer/Merck KGaA: Priority Review for Cancer Drug Avelumab ||| J&J (JNJ) Stands Tall in 2016: Reasons for Outperformance,0,0.45849565
2016-12-01,8398900.0,61.29999923706055,61.369998931884766,60.650001525878906,60.7599983215332,54.37375259399414,MRK,"Alexandria Real Estate, Merck Ink Long-Term Pharma Lease ||| 5 Top Performing S&P 500 Stocks of November ||| Pfizer's Herceptin Biosimilar Meets Primary Endpoint in Study ||| 3 Ways Organovo Holdings, Inc. Plans to Grow Exponentially for Years to Come ||| CNBC's Meg Tirrell Tweets: $MRK CEO: We are now at the equivalent stage in immunotherapy where we were w first effective treatments for HIV #ForbesHealth ||| Forbes Healthcare Summit Concludes Today; Presenters Include Express Scripts, Allergan, IBM, Bristol-Myers Squibb, Merck, Anthem, Eli Lilly, And Regeneron ||| FDA Grants Priority Review to Supplemental Biologics License Application for Merck's KEYTRUDA in Relapsed or Refractory Classical Hodgkin Lymphoma",1,0.50814444
2016-12-05,12985200.0,61.52000045776367,61.52999877929688,59.84000015258789,60.25,53.91736602783203,MRK,"One Put, One Call Option To Know About for Merck & Co ||| Merck Announces KEYTRUDA Treatment Results in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (cHL) Presented at ASH 2016 ||| Pressure Biosciences CEO On Biological Samples: It's All About How You Break Open A Cell ||| Merck Says Will Present Updated KEYTRUDA Findings at ASH: Data Showed KEYNOTE-013 Overall Response Rate of 41%, with 86% of Responses Ongoing at the Time of Analysis ||| Biothera, Merck Further Expand Research Collaboration to Include Phase 2 Clinical Trial in Head and Neck Cancer",1,0.5052567
2016-12-06,10659600.0,60.18000030517578,60.38999938964844,59.61000061035156,60.27999877929688,53.94420623779297,MRK,"Noteworthy ETF Inflows: XLV, MRK, AMGN, GILD ||| Merck KEYTRUDA Findings Show ORR Of 33.3% and 20% In Small Cell Lung Cancer and Malignant Pleural Mesothelioma Respectively In KEYNOTE-028",0,0.48393038
2016-12-07,14049600.0,59.70000076293945,60.060001373291016,58.619998931884766,60.060001373291016,53.7473258972168,MRK,"Top Research Reports for Cisco, Merck & MasterCard ||| Dow Movers: PFE, WMT ||| Close Update: Dow Closes At Another Record High as Trump-Rally Continues; Drug Makers Under Pressure ||| Global Blood Therapeutics: Short-Sellers Could Be In For A Ride ||| Why AstraZeneca plc Stock Slumped in November ||| Merck Canada Says Zostavax II Showed Vaccine Effectiveness Against Shingles In Observational Effectiveness Study ||| What If Trump Keeps Badmouthing Drug Pricing? ||| Technical Alert: Merck Lower ||| Pfizer, J&J, Other Big Pharma Names Dip Lower Just After the Open ||| Merck Announces KEYTRUDA Demonstrated Improved Health-Related Quality of Life vs Chemotherapy in First-Line Treatment of Patients with Metastatic NSCLC at WCLC 2016",1,0.50565165
2016-12-08,8586600.0,59.72999954223633,60.36000061035156,59.5,60.119998931884766,53.801025390625,MRK,2 Ways To Profit From Accelerated R&D Spending,1,0.5630897
2016-12-09,10516400.0,60.4900016784668,61.5099983215332,60.400001525878906,61.22999954223633,54.79436111450195,MRK,"Ex-Dividend Reminder: Merck, Solar Capital and Community Trust Bancorp ||| European Crohn's, Colitis Organisation Issues New Statement Support a Switch to Biosimilar from Reference Product in Inflammatory Bowel Disease",1,0.519604
2016-12-12,8246000.0,61.43999862670898,62.09999847412109,61.29999923706055,61.720001220703125,55.23286056518555,MRK,"The 3 Fastest-Growing Drug Classes Over the Next 5 Years ||| Should Big Pharma Be Worried About a Trump Trade War? ||| Big Alzheimer Flop Creates Buying Opportunity for Eli Lilly ||| 3 Big Advances In Cancer Treatment In 2016 ||| Regeneron Pharmaceuticals Inc (REGN) Stock Gains on Opthotech’s Loss ||| Value Battle: Pfizer Inc. (PFE) vs. Merck & Co., Inc. (MRK) ||| 10 Notable Stocks Trading Ex-Dividend Tuesday, December 13 ||| Merck Reports New KEYTRUDA Data In Combination With HALAVEN For Metastatic Triple-Negative Breast Cancer",1,0.52830184
2016-12-13,7842200.0,61.79999923706055,61.959999084472656,61.25,61.790000915527344,55.71981048583984,MRK,Merck (MRK) Offers Update on Keytruda-Halaven Combination ||| Lilly (LLY) Gets FDA Nod for Once-Daily Version of Synjardy,1,0.51190656
2016-12-14,11080700.0,61.84999847412109,62.7599983215332,61.59000015258789,61.79999923706055,55.728816986083984,MRK,"Better Buy: Pfizer Inc. vs. Merck ||| VYM, PG, CVX, MRK: ETF Inflow Alert ||| Dow Movers: BA, MRK",1,0.48150542
2016-12-15,8509400.0,62.0,62.63999938964844,61.84000015258789,62.369998931884766,56.242820739746094,MRK,3 Top Big Pharma Stocks to Buy Now ||| Big Pharma Face Off: Is Merck More Attractive than J&J? ||| How Risky Is Gilead Sciences Inc.? ||| Gilead To Pay Merck $2.54B In Hep. C Royalties,1,0.5586915
2016-12-16,17563700.0,62.65999984741211,63.02999877929688,62.04999923706055,62.43999862670898,56.30595016479492,MRK,"Is This Gilead Sciences' Biggest Mistake in 2016? ||| Gilead to Pay Merck $2.5B in HCV Patent Dispute, Stock Falls ||| Gilead Sciences' Year Officially Becomes Superbad ||| European Medicines Agency's CHMP Recommends Merck's KEYTRUDA For First-Line Treatment Of Patients With NSCLC",0,0.49966332
2016-12-19,11939000.0,61.79999923706055,62.27000045776367,60.869998931884766,61.13999938964844,55.1336669921875,MRK,"3 Biggest Risks for Incyte Corporation ||| The 12 Greatest Medical Breakthroughs of 2016 ||| Health Care Sector Update for 12/19/2016: BCLI, JNJ, PFE, ABT, MRK, AMGN ||| J&J Files sBLA for Plaque Psoriasis in Adolescent Patients ||| Upbeat Yellen, Tech Stocks Lift Dow Jones Industrial Average ||| Dow Movers: CAT, DIS ||| Merck Keytruda Gets CHMP Nod for First-Line Lung Cancer ||| Jefferies' 2017 Global Pharma Outlook ||| Jefferies' Huge Pharma Pair Trade: Bristol-Myers Upgraded To Buy, Merck Downgraded To Sell ||| Benzinga's Top Upgrades, Downgrades For December 19, 2016 ||| A Peek Into The Markets: U.S. Stock Futures Rise Ahead Of Yellen Speech ||| Merck Gets Approval for KEYTRUDA in Japan ||| Jefferies Downgrades Merck & Co to Underperform, Lowers Target to $48.00",0,0.52987695
2016-12-20,10377100.0,61.18999862670898,61.68000030517578,60.369998931884766,60.5,54.5565299987793,MRK,"Dow Movers: JNJ, CAT ||| Biogen Names Commercial Officer as New CEO, Shares Fall ||| Market Close Report: Historical high reached as NASDAQ Composite Index closes at 5,483.94. ||| Dow Jones Industrial Average Rally Falls Just Short of 20,000 ||| What Does Biogen's New CEO Mean For The Buyout Argument?",0,0.49717554
2016-12-21,12052200.0,60.59000015258789,60.810001373291016,59.34000015258789,59.43000030517578,53.59164810180664,MRK,"Dow Analyst Moves: MRK ||| Market Close Report: NASDAQ Composite index closes at 5,471.43 down -12.51 points ||| Dow Jones Industrial Average Takes a Breather as Bank, Drug Stocks Drag",1,0.50326693
2016-12-22,10100000.0,59.619998931884766,60.0,59.15999984741211,59.58000183105469,53.72692489624024,MRK,"The Dow Jones Industrial Average Still Eyeing 20,000 ||| Meet The New Dogs: 2017's Dogs Of The Dow Include Coca-Cola, Boeing",0,0.5053718
2016-12-23,7591500.0,59.77000045776367,59.86000061035156,59.25,59.560001373291016,53.70887756347656,MRK,"ITOT, HD, MRK, KO: Large Inflows Detected at ETF ||| Dow 30 Stock Roundup: Nike Beats, Coca-Cola to Buy AB InBev's Stake in CCBA ||| NewLink CFO: 'Ebola Vaccine Highly Unlikely To Drive Future Profit In Company' ||| Where Does Merck's Ebola Vaccine Breakthrough Leave Competitors? ||| Shares of NewLink Genetics Up 10%, Earlier Today, Traders Attributed Move To Partnership With Merck, Whose Ebola Vaccine Was Shown To Provide 100% Protection ||| 6 Worst Biotech Stocks Of 2016",1,0.51878494
2016-12-27,5815600.0,59.869998931884766,60.13999938964844,59.560001373291016,59.790000915527344,53.916290283203125,MRK,US Market Indexes Higher on Tuesday,0,0.4980521
2016-12-28,6174600.0,59.720001220703125,59.86000061035156,59.209999084472656,59.27000045776367,53.44737243652344,MRK,"Dow Movers: MRK, GS ||| Merck Gets A Strong Sell From Vetr Crowd ||| Technical Alert: Merck Lower",0,0.50719947
2016-12-29,6520100.0,59.290000915527344,59.59000015258789,58.97999954223633,59.040000915527344,53.239967346191406,MRK,Look Under The Hood: SYG Has 11% Upside ||| MRK Crosses Below Key Moving Average Level ||| Prima BioMed Announces First Clinical Data from Combination of IMP321 With Keytruda Show No Safety Concerns,0,0.4907485
2016-12-30,10772600.0,58.77999877929688,58.95000076293945,58.560001373291016,58.869998931884766,53.08665466308594,MRK,"Dow Movers: CAT, AXP ||| Health Care Sector Update for 12/30/2016: CO, JNJ, PFE, ABT, MRK, AMGN ||| Merck (MRK) Does Well in 2016: Reasons for Outperformance ||| Pharma Stock Roundup: Cempra Plunges to 52-Week Low, Shire Drug Label Expanded ||| UPDATE: Merck Says It Will Defend Itself Vigorously In Response To Government Notice; Given They Were Neither A Manufacturer Or A Marketer Of The Subject Drug ||| Merck Says NPPA Alleges Overcharging Of Price Of Polybion Syrup Formulation From Jan. 2006-June 2009",1,0.51722515
2017-01-03,11988700.0,59.150001525878906,60.380001068115234,59.04999923706055,60.150001525878906,54.24092483520508,MRK,3 Biggest Risks for Bristol-Myers Squibb in 2017 ||| US Market Indexes Start the New Year Higher ||| Close Update: Wall Street Starts 2017 on Stronger Note While Oil Curbs Gains ||| Wall Street Starts 2017 on Stronger Note While Oil Curbs Gains,0,0.49347615
2017-01-04,9411900.0,60.5,60.790000915527344,60.040000915527344,60.130001068115234,54.22288513183594,MRK,"Health Care Sector Update for 01/04/2017: NVLS, JNJ, PFE, ABT, MRK, AMGN ||| Shining A Spotlight On Ailing Health Care ETFs ||| Wednesday’s Vital Data: JPMorgan Chase & Co. (JPM), Verizon Communications Inc. (VZ) and Ford Motor Company (F) ||| Kite Pharma (KITE) to Move Cancer Candidate into Phase I ||| 4 Reasons Why Pfizer (PFE) Could be a Great Pick in 2017 ||| Bank of America Corp (BAC) Bulls Will Build Your Bank Account ||| Merck Acquires Biocontrol",0,0.44736826
2017-01-05,10096800.0,60.220001220703125,60.58000183105469,60.0,60.11000061035156,54.20484924316406,MRK,4 Dow Stocks Every Retiree Should Own ||| Lilly Jardiance Family Diabetes Drugs' Label to be Updated ||| Gilead Sciences Must Answer to Investors After a Disappointing 2016,1,0.5107576
2017-01-06,10238600.0,60.09000015258789,60.459999084472656,59.52999877929688,60.27000045776367,54.34912872314453,MRK,"The Best Thing About Glaxo's Next Vaccine (Hint: It's Not the Billion-Dollar Sales Estimate) ||| It Was CheckMate for Bristol-Myers Squibb Company in 2016 ||| 2 Big Reasons Merck & Co., Inc. Stock Surged 11% in 2016",1,0.54794335
2017-01-09,9734600.0,60.29999923706055,61.47999954223633,60.08000183105469,61.09999847412109,55.09759140014648,MRK,"5 Tough Questions for Bristol-Myers Squibb's CEO ||| Stock Research Reports for Wal-Mart, Exxon & Qualcomm ||| Market Close Report: Historical high reached as NASDAQ Composite Index closes at 5,531.82. ||| Oil Sinks Dow Jones Industrial Average as Nasdaq Scores Another High ||| Option Alert: Merck Jan 61.5 Calls Sweep: 745 @ ASK $0.64: 843 traded vs 562 OI: Earnings 2/2 Before Open $61.29 Ref ||| Exclusive: Ziopharm CEO Talks Partnerships, Balance Sheet And JPM Healthcare Conference Presentation ||| Incyte, Merck to Advance Clinical Development Program Investigating the Combination of Epacadostat with KEYTRUDA ||| The Year's Biggest Healthcare Conference Commences This Week; Here's What You Need To Know",0,0.50427425
2017-01-10,15302200.0,61.20000076293945,61.2400016784668,59.88999938964844,59.91999816894531,54.03351974487305,MRK,"Notable ETF Inflow Detected - VOO, BAC, PFE, MRK ||| Roche Gets Priority Review for Immunotherapy Drug Tecentriq ||| Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Breakup Gold ||| Incyte/Merck to Start More Epacadostat-Keytruda Studies ||| Incyte's Prospects Get Even Brighter With Merck Announcement ||| Kite Pharma Inks Deals for CAR T Cell Drug in Japan, China ||| Dow Jones Industrial Average Slumps Ahead of Trump; Nasdaq Keeps Tapping New Highs ||| Market Close Report: Historical high reached as NASDAQ Composite Index closes at 5,551.82. ||| Bristol-Myers Shares Down 2.2% After Hours as Merck Shares Trade Up ~2.5% Following News KEYTRUDA Accepted for Supplemental BLA ||| Merck Reports KEYTRUDA Has FDA PDUFA Date Of May 10, 2017 Under Accelerated Approval ||| Merck Receives FDA Acceptance Of Supplemental Biologics License Application for KEYTRUDA",1,0.50796056
2017-01-11,32711700.0,62.34000015258789,63.15999984741211,60.75,61.630001068115234,55.57552719116211,MRK,"3 Charts Every Bristol-Myers Squibb Shareholder Needs to See ||| 3 Stocks to Watch on Wednesday: Merck & Co., Inc. (MRK), United Continental Holdings Inc (UAL) and Parsley Energy Inc (PE) ||| Novo Nordisk (NVO) Fiasp Gets EU Nod for Diabetes in Adults ||| S&P 500 Movers: NEM, MRK ||| Dow Movers: UTX, MRK ||| Dow Jones Industrial Average Ends Choppy Session Higher After Trump ||| Close Update: Wall Street Settles Stronger as Stocks Shrug off Trump on Drugmakers ||| Notable Wednesday Option Activity: BIIB, MRK, AMGN ||| Market Close Report: Historical high reached as NASDAQ Composite Index closes at 5,563.65. ||| US Market Indexes Higher After Trump Press Conference ||| All The Markets Trump Moved During His Speech Today ||| Here's What Merck's Keytruda News Means For Bristol-Myers ||| 15 Biggest Mid-Day Gainers For Wednesday ||| 22 Stocks Moving In Wednesday's Pre-Market Session ||| Lilly and Merck Expand Immuno-Oncology Collaboration, Financial Terms Not Disclosed",1,0.53461796
2017-01-12,24885400.0,62.52999877929688,63.2400016784668,62.119998931884766,62.209999084472656,56.098541259765625,MRK,"2 Upgrades In 1 Day for Merck -- and 3 Things You Need to Know ||| Dow Movers: MSFT, MRK ||| Trump Attacks Biotech & Pharma: ETFs Bleed ||| Lilly, Merck Expand Tie-Up to Study Lartruvo-Keytruda Combo ||| Deja Vu for Drug Stocks as Trump Slams Drug Pricing Again ||| Favorable News On Keytruda Drives Piper Jaffray's Upgrade Of Merck ||| 8 Biggest Price Target Changes For Thursday ||| Benzinga's Top Upgrades, Downgrades For January 12, 2017 ||| Merck's Leadership Position In Immuno Oncology Is Improving ||| The Market In 5 Minutes: Jobless Claims Lower, Trump Conference Shakes Sectors ||| Guggenheim Upgrades Merck & Co to Buy, Announces $70.00 Target ||| Morgan Stanley Upgrades Merck & Co to Overweight, Raises Target to $71.00",1,0.5361671
2017-01-13,9969100.0,62.33000183105469,62.68000030517578,62.09999847412109,62.34000015258789,56.215782165527344,MRK,"Pharma Stock Roundup: Trump Targets Pharma Again, Merck Up on Keytruda News ||| Dow 30 Stock Roundup: American Express Buys InAuth, Visa Inks Deal with Wal-Mart",0,0.4895973
2017-01-18,8131700.0,61.380001068115234,61.77999877929688,61.08000183105469,61.16999816894531,55.16071701049805,MRK,"Noteworthy ETF Inflows: XLV, PFE, MRK, UNH ||| AstraZeneca Offers Update on Immuno-Oncology Program ||| Agenus, NCI Ink Deal to Evaluate Prophage-Keytruda Combo",0,0.5002522
2017-01-19,11397900.0,61.04999923706055,61.08000183105469,60.06999969482422,60.33000183105469,54.40324401855469,MRK,How Johnson & Johnson Beat Every Other Big Pharma Stock in 2016 ||| BioLineRx (BLRX) Starts Cancer Study on BL-8040+Keytruda,1,0.5066699
2017-01-20,25240300.0,62.400001525878906,62.91999816894531,62.150001525878906,62.52999877929688,56.38711166381836,MRK,"Why Bristol-Myers Squibb Co Stock Is Slipping Today ||| Incyte Has Insight Into Market With Potential Blockbuster Drugs ||| Dow Movers: GE, MRK ||| Bristol-Myers to Not Seek Accelerated Approval for Opdivo+Yervoy ||| Health Care Sector Update for 01/20/2017: MRK ||| Pre-Market Most Active for Jan 20, 2017 : BMY, SGYP, PG, GE, BAC, MRK, FTI, QQQ, TVIX, AFAM, CSX, VOD ||| Highland Capital Management, Llc Buys Oshkosh Corp, Goldman Sachs Group Inc, Envision ... ||| Market Close Report: NASDAQ Composite index closes at 5,555.33 up 15.25 points ||| Dow Jones Industrial Average Snaps Losing Streak as Trump Swears In ||| Why Merck & Co., Inc. (MRK) Stock Is Higher Today ||| UPDATE: Merck's Payment To Bristol-Myers Will Be Recorded In Its Q4 And FY16 Results, Excluded From Non-GAAP Results ||| Merck Announces Setlement With Bristol-Myers Resolving KEYTRUDA Patent Litigation, Will Pay $625M And Provide Royalties On KEYTRUDA In Any Market In Which It's Approved ||| Bristol-Myers Squibb Falls 10% After Opdivo Decision ||| Wall Street's M&A Chatter From January 19",0,0.4874753
2017-01-23,10201700.0,61.810001373291016,62.400001525878906,61.630001068115234,61.810001373291016,55.73783874511719,MRK,US Market Indexes Lower for the Week ||| 5 Drugs That Are Way Cheaper in Canada ||| Interesting January 2018 Stock Options for MRK ||| Can Q4 Earnings Revitalize Healthcare ETFs? ||| Prima Biomed Initiates Randomized Study for Breast Cancer ||| Bristol-Myers Settles Litigation with Merck for Keytruda ||| Incyte Has Insight Into Market With Potential Blockbuster Drugs,0,0.5203037
2017-01-24,10487500.0,61.59000015258789,61.68999862670898,60.72999954223633,61.209999084472656,55.19678497314453,MRK,Theravance's Infection Drug Vibativ Positive in TOUR Study ||| US Market Indexes Lower on Monday ||| J&J (JNJ) Q4 Earnings Top; Seeks Options for Diabetes Unit ||| Is It Finally OK to Buy Bristol-Myers Squibb? ||| Gilead Sciences Stock: What Could Go Wrong? ||| Bristol-Myers Squibb Earnings Preview: The Company Has To Reassure Investors,0,0.49790427
2017-01-25,14557000.0,61.31999969482422,61.380001068115234,60.7599983215332,61.08000183105469,55.07955551147461,MRK,"LaFleur & Godfrey LLC Buys Apache Corp, ResMed Inc, iShares TIPS Bond, Sells Walt Disney ... ||| Will Eli Lilly's (LLY) Earnings Surpass Estimates in Q4? ||| What Lies in Store for Pfizer (PFE) this Earnings Season? ||| Dow 10K's Hottest Stocks: Where Are They Now? ||| Which Pharma Players Dominate The Lung Cancer Space?",1,0.46078828
2017-01-26,12707500.0,61.02000045776367,61.36000061035156,60.540000915527344,61.20000076293945,55.18777084350586,MRK,Merck Shares Falling As Ketruda Brain Tumor Trial Put On Hold Due To Adverse Event ||| Merck's Keytruda Gains Momentum At The Expense Of Bristol-Myers,1,0.50807613
2017-01-27,6653200.0,61.380001068115234,61.9900016784668,61.29999923706055,61.75,55.68374252319336,MRK,"3 Companies Putting the Squeeze on Bristol-Myers Squibb ||| Merck (MRK): Stock to Gain on Likely Earnings Beat in Q4? ||| A CEO Who's Who Of Trump's Manufacturing Council ||| Andrew Left Furthers Comments Following ESRX Release Today, Points To Comment Made By Merck President Of U.S. Commercial To Highlight Thesis That Drug Co.'s Offer Incentives To PBM's To Stay On Preferred Drug Lists ||| WSJ Reporting Merck Raised List Prices By 9.6% Last Year",0,0.50365996
2017-01-30,7853600.0,61.52000045776367,61.709999084472656,60.93000030517578,61.43000030517578,55.39517211914063,MRK,"Interesting July Stock Options for MRK ||| News! News! News! Here's What's Happened in Healthcare Last Week ||| 3 Top Pharmaceutical Stocks to Buy in February ||| Key Takeaways from AbbVie's Q4 Call: Humira and the Pipeline ||| United Bank Buys Fortis, Sells ITC Holdings, Revance Therapeutics, T. Rowe Price Group ||| Taking A Clinical Road Less Traveled: Neurotrope Hopes To Succeed In Alzheimer's Where Competitors Fail ||| Mixing It Up: Markets Await Host Of Economic Data, Key Earnings, And Fed Meeting ||| The Market In 5 Minutes: Walgreens-Rite Aid, Personal Income And Trump's Executive Order ||| Can Merck And Pfizer Beat Low Expectations?",1,0.52491957
2017-01-31,9821100.0,61.060001373291016,62.2400016784668,60.91999816894531,61.9900016784668,55.9001579284668,MRK,"Dow Movers: NKE, PG ||| Pfizer (PFE) Q4 Earnings Lag, Sales Top; '17 Sales View Soft ||| Merck Makes Nice With Bristol-Myers Squibb ||| This Was, Unquestionably, the Most Disappointing Drug Launch of 2016 ||| Kahn Brothers Buys GlaxoSmithKline PLC, Sells Nam Tai Property ||| Merck Announces EU Approves KEYTRUDA For First-Line Pateitns",1,0.5126411
2017-02-01,11018800.0,62.060001373291016,62.27000045776367,61.560001373291016,62.09999847412109,55.99935150146485,MRK,"Drug Stocks to Report Q4 Earnings on Feb 2: MRK & AMGN ||| Drug Stocks Rally on Trump Meet with Pharma Bigwigs ||| Pre-Market Earnings Report for February 2, 2017 : MRK, PM, COP, CME, BDX, BCE, CI, MMC, BSX, ETN, IP, SIRI ||| Earnings: Facebook and Merck Scheduled to Open Their Books ||| Ringing up the iPhones: Strong Apple Results Put A Charge Into Markets",1,0.4901596
2017-02-02,18990200.0,62.63999938964844,64.20999908447266,62.52999877929688,64.18000030517578,57.87501907348633,MRK,"Close Update: Wall Street Unnerved by FOMC Statement, Political Tensions; Bracing for Jobs Report ||| Roche (RHHBY) Beats on Earnings in 2016, Misses on Sales ||| Dow Movers: BA, MRK ||| Agilent (A) Announces Expanded Use of Diagnostic Assay ||| Merck (MRK) Tops Q4 Earnings; Pharmaceutical Sales Down ||| Midday Update: Wall Street Struggles with FOMC Statement, Foreign Policy Tensions ||| Merck (MRK) Tops Q4 Earnings, Misses Sales Estimates ||| Earnings Reaction History: Merck & Co. Inc., 30.0% Follow-Through Indicator, 1.1% Sensitive ||| Market Close Report: NASDAQ trading volume joins the top ten ranking for the year. NASDAQ Composite Index closes at 5,636.20 ||| Dow Jones Industrial Average Slips Ahead of Jobs Report; S&P 500 Outperforms ||| Health Care Sector Update for 02/02/2017: MRK ||| Q4 2016 Real-Time Call Brief ||| The Market In 5 Minutes: Facebook Beats, Trump Tweets ||| Merck CEO Says Trump Focus On Patients Being Able To Afford Co-Pays Rather Than Overall Cost of Drugs ||| Merck Sees FY17 Adj. EPS $3.72-$3.87 vs $3.85 Est., Sales $38.6B-$40.1B vs $40B Est. ||| Merck Reports Q4 Adj. EPS $0.89, Inline, Sales $10.1B vs $10.22B Est.",1,0.5331063
2017-02-03,11650500.0,63.86000061035156,64.33000183105469,63.27000045776367,64.29000091552734,57.97420501708984,MRK,"Notable ETF Inflow Detected - XLV, PFE, MRK, UNH ||| Merck's Sneak Peek Into Its Drug Pricing May Not Be Enough to Satisfy Skeptics ||| Dow Movers: MRK, V ||| Bristol-Myers' Injectable Opdivo Gets FDA Approval for mUC ||| Dow 30 Stock Roundup: Apple, Intel, Exxon Beat; Merck, Pfizer, Chevron Miss on Revenues ||| FDA to Review Two of Merck's Supplemental Biologics License Applications",1,0.475361
2017-02-06,9158800.0,63.91999816894531,64.94999694824219,63.900001525878906,64.94000244140625,58.56035614013672,MRK,"Pfizer's New Biosimilar Is Off and Running ||| Q4 Earnings Faring Well for Pharma ETFs ||| The Zacks Analyst Blog Highlights: Apple, Exxon Mobil, Merck, Pfizer and Intel ||| Merck???s Keytruda Gets Priority Review for Bladder Cancer ||| Market Close Report: NASDAQ Composite index closes at 5,663.55 down -3.22 points ||| Dow Jones Industrial Average Dips On Continued Trump Concerns ||| Agilent (A) Announces Expanded Use of Diagnostic Assay (revised)",0,0.46477786
2017-02-07,8435300.0,64.76000213623047,64.93000030517578,64.05000305175781,64.19999694824219,57.893043518066406,MRK,"Drug Stock Q4 Earnings to Watch on Feb 8: AGN, GSK & More ||| Better Buy: Merck & Co. Inc. vs. GlaxoSmithKline",1,0.50813055
2017-02-08,5906800.0,63.900001525878906,64.4800033569336,63.83000183105469,64.31999969482422,58.00125503540039,MRK,Nasdaq Reaches a New High on Wednesday,1,0.5074682
2017-02-10,8531400.0,64.31999969482422,64.56999969482422,63.959999084472656,64.1500015258789,57.84796142578125,MRK,"Cypress Capital Management Llc Buys E.I. du Pont de Nemours, BB&T, Agrium, Sells SPDR ... ||| Here's Why M&A Has Tesaro's Stock Soaring 40% In 2017",1,0.5153345
2017-02-13,7151100.0,64.25,64.83000183105469,64.22000122070312,64.7699966430664,58.40705108642578,MRK,"SSO, BAC, PFE, MRK: Large Outflows Detected at ETF ||| The Zacks Analyst Blog Highlights: Coca-Cola, Walt Disney, Visa, Boeing and Merck",1,0.5186822
2017-02-14,10142700.0,64.63999938964844,65.72000122070312,64.43000030517578,65.66000366210938,59.20962905883789,MRK,"Merck Says APECS Study in People with Prodromal Alzheimer's Disease to Continue ||| Meg Tirrell Tweets: $MRK stops study of BACE inhibitor in mild to moderate Alzheimer's for lack of efficacy, prodromal study continues ||| Merck's Doravirine Meets Primary Efficacy Endpoint In Pivotal Phase 3 Trial",0,0.4975875
2017-02-15,17807300.0,64.9000015258789,65.87000274658203,64.8499984741211,65.16000366210938,58.75873947143555,MRK,"Merck (MRK) Halts Late Stage Alzheimer Study; Shares Slip ||| 3 Stocks to Watch on Wednesday: Berkshire Hathaway Inc. (BRK.B), Fossil Group Inc (FOSL) and Merck & Co., Inc. (MRK) ||| Dow Movers: MRK, PG ||| Wednesday's ETF with Unusual Volume: PPH ||| Roche's Herceptin And Perjeta Combination Trials Beg A Larger Question ||| Dow Jones Industrial Average, S&P, Nasdaq Nab Streak Not Seen Since '92 ||| Market Close Report: Historical high reached as NASDAQ Composite Index closes at 5,819.44. ||| Incyte's (INCY) Beats on Q4 Earnings, Provides 2017 Outlook ||| Merck Still Sees Path Forward For Failed Alzheimer's Drug ||| Merck, On Its Alzheimer's Drug Program, Tells Benzinga Too Early To Speculate What Verubecestat Trial Results Mean For Validity Of 'Amyloid Hypothesis', Hopes By Evaluating Drug In People W/Less Impairment Will Be Able To Slow Disease Progression ||| Deutsche Bank Casts Doubt On Pfizer's Rumored Takeover Approach To Bristol-Myers",1,0.4882073
2017-02-16,12346300.0,65.13999938964844,65.41000366210938,64.45999908447266,65.26000213623047,58.84891891479492,MRK,"What's Driving Lilly's (LLY) Shares after 2016 Decline? ||| Alzheimer's Market Suffers Yet Another Blow with Merck Drug Setback ||| Q4 Earnings Season Scorecard & Top Analyst Reports ||| After Merck Stops Study, What Remains Of The Alzheimer's Drug Pipeline?",1,0.49766356
2017-02-17,9048300.0,65.19999694824219,65.55999755859375,64.86000061035156,65.38999938964844,58.96614456176758,MRK,The Market In 5 Minutes,1,0.5408694
2017-02-21,7386100.0,64.9000015258789,65.77999877929688,64.9000015258789,65.4800033569336,59.047306060791016,MRK,"XLV, PFE, MRK, LLY: ETF Outflow Alert ||| The Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals International, Allergan, AstraZeneca and Johnson & Johnson ||| Better Buy: Pfizer Inc. vs. Merck & Co. Inc. ||| Can Carl Icahn Save Bristol Myers Squibb? ||| Icahn Takes Bristol-Myers Stake With M&A In Mind; Who Could Be The Acquirer? ||| Boeing, Pfizer And Others Band Together To Ask Congress For More Taxes",0,0.45667943
2017-02-22,8679600.0,65.5,65.75,65.08999633789062,65.29000091552734,58.875972747802734,MRK,Bristol Myers' Future Unsure as Carl Icahn Takes Stake,1,0.511074
2017-02-23,6855600.0,65.5199966430664,66.11000061035156,65.3499984741211,65.8499984741211,59.380950927734375,MRK,"Merck Says Will Record Intangible Asset Impairment Charge Related To MK-3682 Program, Previously Reported Q4 And FY Non-GAAP EPS Remain Unchanged ||| Breaking Down The Multiple Sclerosis 2017 Formularies: 'Stability Fares Well For The Market'",1,0.51879865
2017-02-24,8444300.0,65.6500015258789,66.16000366210938,65.62999725341797,66.16000366210938,59.66050720214844,MRK,Merck Reports First Phase 3 Trial of V212 Reduced Incidence of Confirmed Herpes Zoster Cases by ~64% in Immunocompromised Subjects ||| Merck Receives Positive CHMP Opinion For New Pergoveris Fertility Pen,0,0.5190761
2017-02-27,7133800.0,65.77999877929688,65.94000244140625,65.55999755859375,65.8499984741211,59.380950927734375,MRK,"Big Business Delivers Christmas Wish List To Trump, 10 Months Early ||| Billionaire Carl Icahn Is Reportedly Buying Bristol-Myers Squibb Stock -- Should You? ||| Merck Says Letermovir for Prevention of CMV)Infection in Bone Marrow Transplant Recipients is Highly Effective Through Week 24 Post-Transplant in Pivotal Phase 3 Study ||| Pharma Industry Outlook - February/March 2017",1,0.5295057
2017-03-01,10680700.0,66.06999969482422,66.80000305175781,65.88999938964844,66.20999908447266,59.70558547973633,MRK,"These 4 Stocks Have Dominated the Dow for the Past 10 Years ||| M&As, Pipeline Catalysts to Drive Pharma Sector ||| Merck's Odactra Approved For House Dust Mite Allergies",0,0.4873041
2017-03-02,8647700.0,66.37999725341797,66.58000183105469,66.0,66.08000183105469,59.58837127685547,MRK,"Noteworthy Thursday Option Activity: VMW, ZUMZ, MRK ||| Why Bermuda Could Be The Next Switzerland",1,0.52457607
2017-03-03,8316900.0,66.08000183105469,66.62000274658203,65.80999755859375,66.58000183105469,60.039249420166016,MRK,"Aduro (ADRO) Loss Wider than Expected, Sales Miss in Q4 ||| What's in Store for Immune Design (IMDZ) in Q4 Earnings?",0,0.4731796
2017-03-06,8687500.0,66.08000183105469,66.77999877929688,65.9000015258789,66.47000122070312,59.94004821777344,MRK,"Health Care Sector Update for 03/06/2017: MRK ||| 5 FDA Decisions to Watch Out for in Mar 2017 ||| Merck, Pfizer Report U.S. FDA and EMA Filing Acceptances of 3 Marketing Applications for Ertugliflozin-Containing Medicines For Adult Type 2 Diabetes Patients",0,0.5097193
2017-03-07,8328700.0,65.43000030517578,66.30999755859375,65.19000244140625,65.95999908447266,59.48014450073242,MRK,"Dow Analyst Moves: MRK ||| Dow Movers: MRK, WMT ||| Close Update: Wall Street Trades Lower as Energy and Healthcare Stocks Wilt ||| Trump's Tweet Hits Pharma Stocks, Promises Decreased Drug Prices ||| Stock Market Roundup, March 7: SNAP Falls Again, Drug Stocks Dip ||| Why Is Merck (MRK) Up 3.7% Since the Last Earnings Report? ||| 3 Drug Stocks Hit by Trump’s Call for Lower Prices",0,0.49726233
2017-03-08,8417600.0,65.95999908447266,66.12000274658203,65.2699966430664,65.80000305175781,59.33587265014648,MRK,"Retirees, Maximize Your Income From Dividends ||| Immune Design (IMDZ) Q4 Loss In Line; Sales Beat Estimates ||| Merck/Pfizer's Diabetes Drug Accepted for Review by FDA, EMA ||| Forget the Distractions: Bristol-Myers Squibb Is a Bargain ||| US Indexes Lower on Energy Stock Losses ||| Here's Your March PDUFA Date Preview ||| Everything We Know About Merck's Keytruda ||| REMINDER: Merck's PDUFA Date For Keytruda In Microsatellite Instability-High Cancer Today",1,0.4696714
2017-03-09,7735000.0,65.97000122070312,66.02999877929688,65.5199966430664,65.88999938964844,59.417022705078125,MRK,Incyte Corporation at the Cowen Healthcare Conference: 4 Things You'll Want to Know,0,0.5031212
2017-03-10,8823900.0,66.06999969482422,66.19999694824219,65.5,65.5999984741211,59.1555061340332,MRK,"Noteworthy ETF Inflows: DGRO, MRK, IBM, MMM ||| How Incyte Stock Became a Bull Market Star for Biotech Investors ||| Adam Feuerstein Talks Vulnerable Pharmaceuticals, Drug Pricing Under Trump ||| Feuerstein on Benzinga's PreMarket Prep Discussing Stocks Which Could Be Impacted by Drug Pricing Changes: Believes Worst Case Scenario Would Create Vulnerabilities for Drugs with High Levels of Competition",0,0.49508992
2017-03-13,14198600.0,65.23999786376953,65.29000091552734,64.01000213623047,64.1500015258789,58.265411376953125,MRK,"Dow Movers: INTC, CAT ||| Trefis Market Diagnosis: What Are Market Participants Thinking About Pfizer? ||| Interesting April Stock Options for MRK ||| Market Close Report: NASDAQ Composite index closes at 5,875.78 up 14.05 points ||| Repeat: Close Update: Stocks Mixed as Wall Street Braces for FOMC ||| Novo Nordisk's Diabetes Unit Strong; Generic Pressure Stays",1,0.51722383
2017-03-14,7892900.0,64.12999725341797,64.51000213623047,64.05000305175781,64.19999694824219,58.310829162597656,MRK,"Merck Says Submission Of Additional Data Is Considered Major Amendment to sBLA Under PDUFA; Thus, Extending Target Action Date By 3 Months To June 9th, 2017 ||| FDA Has Approved Merck's Keytruda For Intravenous Use In Hodgkin Lymphoma",1,0.53945714
2017-03-15,9025000.0,64.4000015258789,64.97000122070312,64.22000122070312,64.69999694824219,58.76495742797852,MRK,Merck's (MRK) Keytruda Gets FDA Nod for Lymphoma Indication ||| Celldex (CLDX) Shares Up as Q4 Loss Narrows; Sales Beat ||| Prima Biomed Completes Recruitment For Second Patient Cohort In Melanoma Trial,0,0.51870507
2017-03-16,9613200.0,64.56999969482422,64.79000091552734,63.9900016784668,64.18000030517578,58.29265975952149,MRK,"Roche Holding Ltd. (ADR) (RHHBY) Stock Is Weathering the Healthcare Storm ||| Close Update: Wall Street Posts Mostly Weaker Finish as Utilities, Health Care Lag ||| Wall Street Poised for Weaker Finish as Utilities, Health Care Lag ||| Valeant: It's Not a Game of Chess- Part I",0,0.47625026
2017-03-17,14449200.0,64.25,64.69999694824219,63.88999938964844,63.900001525878906,58.03834915161133,MRK,"Pharma Stock Roundup: AstraZeneca's Lynparza Impresses in Study, Merck Drug Label Expanded",1,0.5130975
2017-03-20,12971200.0,64.13999938964844,64.30000305175781,64.0,64.11000061035156,58.22908401489258,MRK,Why Biotech Stock Gilead (GILD) Could Be a Value Trap ||| Leerink Presents: Your 2017 Biopharma Catalyst Tracker,0,0.47997764
2017-03-21,10550700.0,64.31999969482422,64.61000061035156,63.619998931884766,63.90999984741211,58.04743194580078,MRK,"Health Care Sector Update for 03/21/2017: MRK ||| Notable ETF Inflow Detected - IWD, MRK, PM, INTC ||| The Zacks Analyst Blog Highlights: Merck, General Electric, MasterCard and NVIDIA",0,0.4623123
2017-03-23,9461000.0,63.36000061035156,63.81999969482422,63.18999862670898,63.27999877929688,57.47521209716797,MRK,Why Teva Pharmaceutical Industries Ltd (ADR) Stock Has Staying Power ||| Merck Closes Acquisition of Controlling Stake in Vallee S.A,0,0.50677824
2017-03-24,9136500.0,63.15999984741211,63.52999877929688,62.86000061035156,63.18000030517578,57.3843879699707,MRK,Pfizer's Immunotherapy for Skin Cancer Gets FDA Approval ||| European Medicines Agency's CHMP Recommends Approval of Merck's KEYTRUDA,1,0.50281394
2017-03-27,8015900.0,62.91999816894531,63.40999984741211,62.810001373291016,63.18999862670898,57.39347076416016,MRK,Interesting June 2018 Stock Options for MRK ||| Merck's Ketruda Gets Positive CHMP Opinion for Lymphoma,1,0.5156433
2017-03-28,10185000.0,63.20000076293945,63.400001525878906,62.880001068115234,63.34000015258789,57.52972030639648,MRK,Bristol-Myers (BMY) Opdivo Gets Positive CHMP Opinion,1,0.49709845
2017-03-29,8135300.0,63.66999816894531,64.11000061035156,63.459999084472656,63.63999938964844,57.80219650268555,MRK,"Notable ETF Outflow Detected - XLV, MRK, UNH, AMGN ||| Dow Movers: TRV, WMT ||| Tesaro Nets Surprise Early Approval",0,0.5033311
2017-03-30,5322000.0,63.5,63.68000030517578,63.31999969482422,63.45000076293945,57.6296272277832,MRK,Should Investors Worry About Bristol-Myers Squibb's Recent Setbacks?,1,0.5231011
2017-03-31,7614000.0,63.2599983215332,63.630001068115234,63.25,63.540000915527344,57.711368560791016,MRK,"UPDATE: Incyte, Merck Announce Clinical Program for Epacadostat, KEYTRUDA Includes 7 Registrational Trials Across 5 Tumor Types ||| Incyte, Merck Offer Added Details on Previously Announced Collab. Investigating Epacadostat, KEYTRUDA",0,0.47927335
2017-04-03,6643600.0,63.43000030517578,63.709999084472656,63.220001220703125,63.470001220703125,57.64779281616211,MRK,"5 Deadliest Diseases in the U.S. -- and the Top Drugs Potentially on the Way to Treat Them ||| Why Dynavax Technologies Corporation Stock Briefly Spiked Today ||| Kite Pharma Completes Filing for CAR-T Therapy with FDA ||| Bristol-Myers (BMY), Incyte to Advance Clinical Program ||| Benzinga Premarket Prep Host Dennis Dick Tweets: Notable opening imbalances: $PFE -243K, $MRK -93K, $BABA +115K, $KO +104K, $T +111K, $CAT -55K, $IBM -42K",1,0.5428052
2017-04-04,6345600.0,63.59000015258789,63.77000045776367,63.369998931884766,63.66999816894531,57.82944869995117,MRK,"Why NewLink Genetics Shares Fell 10.3% Today ||| Health Care Sector Update for 04/04/2017: BNTC,PRTK,NLNK,MRK ||| Health Care Sector Update for 04/04/2017: EDAP,PRTK,NLNK",0,0.45578152
2017-04-05,7713300.0,63.68999862670898,64.1500015258789,63.5099983215332,63.56999969482422,57.73862075805664,MRK,Agenus (AGEN) Sharpens Focus on Drug Development Programs ||| 5 Reasons to Invest in Eli Lilly (LLY) Stock Right Now ||| There Is Value To Be Had With The Right Healthcare ETFs,0,0.4906863
2017-04-06,7552600.0,63.47999954223633,63.970001220703125,63.18999862670898,63.2400016784668,57.43889236450195,MRK,"Notable ETF Outflow Detected - DGRO, MRK, AMGN, WMT ||| Bristol-Myers' (BMY) sBLA For Opdivo Accepted by the FDA",0,0.49876466
2017-04-07,7721100.0,63.27999877929688,63.33000183105469,62.95000076293945,63.130001068115234,57.33897399902344,MRK,"Pre-Market Imbalance Update: AmEx 89K Shares to Sell, Ford 71K Shares to Buy, Merck 40K to Buy, BofA 29K to Sell, Morgan Stanley 22K to Sell, Nike, GE 20K to Sell ||| Merck Reports Received CRL from FDA Related to TECOS Study with Sitagliptin",0,0.51250356
2017-04-10,7247700.0,63.27000045776367,63.33000183105469,62.52999877929688,62.54999923706055,56.81218719482422,MRK,"Barron's Picks And Pans: Gold, Energy, Dividends And More ||| The 3 Best HIV Drug Stocks to Buy in 2017 ||| Dow Movers: MRK, CAT ||| Market Close Report: NASDAQ Composite index closes at 5,880.93 up 3.12 points ||| Relative Strength Alert For Merck ||| Cardiovascular Players Could Be Eyeing Esperion",1,0.51626015
2017-04-11,6544800.0,62.4900016784668,62.7599983215332,62.18000030517578,62.58000183105469,56.83943557739258,MRK,"Dow Movers: CAT, MRK ||| Merck Stock History: The Drugmaker's Boom, Bust, and Bounce Back ||| Foundation Resource Management Inc Buys Johnson & Johnson, Sells SPDR S&P 500, Vectrus, ...",1,0.51054597
2017-04-12,9509200.0,62.369998931884766,63.209999084472656,62.27999877929688,63.04999923706055,57.26631546020508,MRK,"Inovio's Ebola Vaccine Positive in Expanded Phase I Study ||| This Survey's Bad News Could Be Good News for Inovio Pharmaceuticals, Inc. ||| Bristol-Myers (BMY) Collaborates with Apexigen for Opdivo ||| Healthcare Sector Earnings: Making A Comeback In Q1 2017?",0,0.50929934
2017-04-13,5932500.0,62.790000915527344,63.0,62.560001373291016,62.61000061035156,56.8666877746582,MRK,"The IDO-Inhibitor Race Is On to Improve Cancer Treatment ||| Dow 30 Stock Roundup: Microsoft Buys Cloud Tech Firm, Disney's ""Beauty and the Beast""",1,0.5202838
2017-04-17,5334200.0,62.709999084472656,62.84000015258789,62.38999938964844,62.79999923706055,57.03925323486328,MRK,"One Put, One Call Option To Know About for Merck ||| Zoetis (ZTS) Inks Agreement to Acquire Nexvet Biopharma",0,0.4862852
2017-04-18,7394500.0,62.459999084472656,62.459999084472656,61.9900016784668,62.27000045776367,56.55786895751953,MRK,"Roche's (RHHBY) Cancer Drug Gets FDA Nod for Label Expansion ||| J&J (JNJ) Q1 Earnings Beat Estimates, Pharma Sales Slow Down",1,0.5370611
2017-04-19,10349100.0,62.2599983215332,62.63999938964844,62.0,62.63999938964844,56.8939208984375,MRK,"Top Research Reports for Today: BRK.B, ORCL, MRK ||| Market Close Report: NASDAQ Composite index closes at 5,863.03 up 13.56 points ||| Is J&J's Pharma Sales Slowdown a Warning for Other Players? ||| Johnson & Johnson's Pharma Business To See Challenges In The Near Term ||| Exclusive: Leading Biosciences Execs Talk About How The Company Could Save Hospitals Millions Of Dollars Per Year",0,0.48479664
2017-04-20,8962300.0,62.65999984741211,62.75,62.25,62.54999923706055,56.81218719482422,MRK,"The Zacks Analyst Blog Highlights: Berkshire Hathaway, Oracle, Merck, Honeywell and Altria ||| What Would A $5.8 Billion NIH Cut Look Like? Devastation",0,0.48273697
2017-04-21,10498400.0,62.36000061035156,62.630001068115234,61.869998931884766,61.88999938964844,56.21272659301758,MRK,"Should Gilead Sciences Acquire NewLink Genetics? ||| Covenant Asset Management, LLC Buys Netflix, Citizens Financial Group, Regions Financial, Sells ... ||| 10 Reasons Merck Could Be the World's Most Perfect Stock ||| Merck Reports Study in US Veterans Affairs System Evaluating Use of ZEPATIER Showed High Sustained Virologic Response Rates in Patients with Chronic Hep C ||| Atara Bio Partners With Merck To Evaluate KEYTRUDA In Combination With ATA129 In NPC",1,0.5255361
2017-04-24,8846300.0,62.5,62.52000045776367,62.02000045776367,62.13999938964844,56.43979263305664,MRK,"Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1? ||| What's in Store for Agenus (AGEN) this Earnings Season? ||| 3 Key Factors to Look Out for in Biogen's Q1 Results ||| 3 IPOs to Watch For This Week ||| Big Tech Is Taking on Diabetes ||| Earnings: Caterpillar, Lockheed Martin, and Eli Lilly Report Tomorrow",1,0.50778234
2017-04-25,10691800.0,62.4900016784668,62.93000030517578,62.25,62.29999923706055,56.58512115478516,MRK,Tesaro Inc Bulls Need a Reality Check ||| Bristol-Myers (BMY) to Post Q1 Earnings: What's in Store? ||| Watching Volatility in Vaccine Names Here as Traders Circulating WSJ Article from Mon. Evening 'Vaunted Ebola Vaccine Faces Questions' ||| Mark Your Calendar For These Days In May To Play The Volatility Around FDA Decision Dates,1,0.50658107
2017-04-26,8859300.0,62.630001068115234,62.880001068115234,62.43000030517578,62.70000076293945,56.94842529296875,MRK,"What's in Store for Merck (MRK) this Earnings Season? ||| SSO, MRK, UNH, AMGN: Large Outflows Detected at ETF",0,0.5026347
2017-04-27,6603300.0,62.77999877929688,62.90999984741211,62.45000076293945,62.58000183105469,56.83943557739258,MRK,"Bristol-Myers (BMY) Beats on Q1 Earnings, Ups 2017 View ||| When Will ImmunoGen, Inc. Finally Start Making Money?",0,0.48550677
2017-04-28,9461700.0,62.58000183105469,62.650001525878906,62.13999938964844,62.33000183105469,56.61236190795898,MRK,"These 7 Drugmakers Relied on Price Hikes for 100% of Their Earnings Growth in 2016 ||| LaFleur & Godfrey LLC Buys Vulcan Materials Co, Copart, Apache, Sells AbbVie, Harman ... ||| Despite Worries, Bristol-Myers' Opdivo Keeps Racking Up Sales ||| Roche Earnings: Story Remains The Same, All Eyes On New Drugs",1,0.49257928
2017-05-01,10217100.0,62.25,62.5,62.09999847412109,62.380001068115234,56.65776824951172,MRK,"5 Big Drugmakers With Important Catalysts in May ||| One Put, One Call Option To Know About for Merck ||| Is Merck a Great Pick for Your Dividend Portfolio? ||| Drug Stocks Q1 Earnings Slated for May 2: MRK, PFE & GILD ||| 8 Stocks In Line For Dividend Hikes (JNJ, HAS, MS) ||| This Week's Most Spectacular Earnings Charts ||| What To Expect From Merck's Q1 Earnings ||| Pfizer Earnings Preview: What We Are Watching ||| Pre-Market Earnings Report for May 2, 2017 : PFE, MRK, MO, MA, CHTR, CVS, COP, EPD, SHPG, AET, BDX, EMR ||| Seattle Genetics, Inc. Earnings: Solid Quarter, but Investors Wait ||| Earnings Preview: Q1 Results From Pfizer, Merck, And Gilead Sciences This Week ||| Feuerstein On Neurotrope: The Study Failed And There Was Never 'A Lot Of Hope Here' ||| Looking For Action? Week Ahead Brings Heavy Load With Earnings, Data, Fed Meeting",1,0.5284595
2017-05-02,13022500.0,62.5099983215332,63.2400016784668,62.310001373291016,62.70000076293945,56.94842529296875,MRK,"5 Great Things About Merck & Co.'s Q1 Results ||| Merck (MRK) Beats on Q1 Earnings & Sales, Ups Annual View ||| Gilead Sciences Inc.'s Revenue and Earnings Continue to Fall on Declining HCV Sales ||| Earnings Reaction History: Merck & Co. Inc., 30.0% Follow-Through Indicator, 1.2% Sensitive ||| Pfizer (PFE) Q1 Earnings Beat, Sales Lag, 2017 View Intact ||| 3 Big Stock Charts for Tuesday: Coach Inc (COH), Merck & Co., Inc. (MRK) and Cummins Inc. (CMI) ||| Apple Earnings In Focus, But Fed Meeting, Auto Sales Also Could Grab Headlines ||| A Peek Into The Markets: U.S. Stock Futures Mostly Lower; Apple Earnings In Focus ||| Merck Raises FY 2017 Guidance , Sees FY 2017 EPS $3.76 to $3.88 vs $3.81 Est, Sales $39.1B to $40.3B vs $39.7B Est ||| Merck Q1 EPS $0.88 vs $0.83 Est, Sales $9.43B vs $9.25B Est ||| 12 Stocks To Watch For May 2, 2017 ||| Earnings Scheduled For May 2, 2017",1,0.5445137
2017-05-03,11429800.0,62.5,63.66999816894531,62.380001068115234,63.630001068115234,57.79312133789063,MRK,"Stock Market News for May 03, 2017 ||| Drug Stock Q1 Earnings Releases on May 4: ZTS, REGN & More ||| Market Close Report: NASDAQ Composite index closes at 6,072.55 down -22.82 points ||| Karpas Strategies Llc Buys Enbridge Inc, Apple Inc, National Fuel Gas Co, Sells Endurance ... ||| Ahead Of Merck's Keytruda PDUFA Date, Analyst Says Expect Approval",0,0.4773203
2017-05-04,8610000.0,63.66999816894531,63.88999938964844,63.220001220703125,63.380001068115234,57.56604766845703,MRK,"iShares Core Dividend Growth ETF Experiences Big Inflow ||| A Big, New Threat to Gilead Sciences Is Coming",1,0.50787026
2017-05-05,9346600.0,63.5,64.08999633789062,63.43000030517578,63.970001220703125,58.101932525634766,MRK,"Dow 30 Stock Roundup: Apple, Merck Beat; Pfizer Misses on Revenues ||| Merck vs. Pfizer: Which Stock Looks Better Post-Earnings? ||| Pre-Market Imbalance Update: IBM 110K Shares to Sell, Twitter 100K to Sell, Ford 63K Shares to Buy, Merck 62K to Sell, Disney 38K to Sell, P&G 20K to Sell ||| Merck Reports EC Approval of KEYTRUDA for Patients with Relapsed, Refractory Classical Hodgkin Lymphoma Who Who Failed Autologous Stem Cell Transplant and Brentuximab Vedotin (BV), or Who are Transplant-Ineligible and Have Failed BV",1,0.4918696
2017-05-08,11149500.0,63.90999984741211,64.51000213623047,63.83000183105469,64.01000213623047,58.13825988769531,MRK,"Near-Term Events Cast Shadow Of Uncertainty On Bristol-Myers ||| Interesting May Stock Options for MRK ||| Incyte (INCY) Q1 Loss Narrower than Expected, Revenues Beat ||| Array BioPharma Reports Strategic Partnership with Merck",0,0.49417314
2017-05-09,10222300.0,64.18000030517578,64.2699966430664,63.15999984741211,63.290000915527344,57.48430252075195,MRK,"Notable Tuesday Option Activity: COST, MRK, BR ||| UPDATE: Merck 10-Q Filing Shows Co. Eliminated ~545 Positions in Q1'17 Under Restructuring Program Activities ||| Merck 10-Q Just Out",1,0.48233095
2017-05-10,9631800.0,63.130001068115234,63.95000076293945,63.09000015258789,63.93999862670898,58.07467651367188,MRK,"Celldex (CLDX) Q1 Loss In Line, Revenues Beat, Shares Up ||| Top Ranked Income Stocks to Buy for May 10th ||| 3 Stocks That Could Double Your Investment ||| Top Research Reports for Activision Blizzard, Merck and Barclays ||| Health Care Sector Update for 05/10/2017: ARRY,MTBC,CXRX ||| Merck Press Release Confirms FDA Approval For KEYTRUDA ||| Andy Biotech Tweets: '$MRK FDA approves Keytruda chemo combo in 1L NSCLC' ||| Reminder: Merck Has Keytruda PDUFA Date Today ||| OncoSec Medical +21.5% Premarket @$1.30 Following Announcement of Clinical Collaboration with Merck to Evaluate Combination of ImmunoPulse IL-12 and KEYTRUDA ||| OncoSec Medical Reports Clinical Trial Collaboration, Supply Deal with Merck to Evaluate Combo of ImmunoPulse IL-12 and KEYTRUDA",1,0.5000036
2017-05-11,18515900.0,64.75,65.25,64.30999755859375,64.43000030517578,58.51972198486328,MRK,"Dow Movers: NKE, MRK ||| The Zacks Analyst Blog Highlights: Merck, Barclays, Activision Blizzard, Blackstone and Tyson Foods ||| Here's What The FDA Approval Of Keytruda Means For Merck, And For Bristol-Myers",0,0.49949425
2017-05-12,10342100.0,64.38999938964844,64.66999816894531,63.27000045776367,63.56999969482422,57.73862075805664,MRK,"Noteworthy ETF Inflows: XLV, MRK, UNH, AMGN ||| Dow Movers: GE, AAPL ||| Pharma Stock Roundup: Mylan, Teva Q1 Earnings, Roche Drug Misses in Pivotal Study ||| Ally Financial Inc. Buys ||| Sympathy Moves, Explained: Unsympathetic Earnings Season Continues As Nvidia, Advanced Micro Devices Diverge",0,0.47754252
2017-05-15,8311400.0,63.41999816894531,63.59999847412109,63.34000015258789,63.5099983215332,57.68412399291992,MRK,WHO Confirms Second Ebola Case in Congo -Reuters ||| AstraZeneca Imfinzi Positive in Phase III Lung Cancer Study,1,0.5234456
2017-05-17,7916900.0,63.790000915527344,63.790000915527344,62.880001068115234,63.0,57.22090530395508,MRK,"Vanguard Health Care ETF (VHT): A Healthy Long-Term Investment ||| 5 Reasons Why Merck (MRK) is a Good Stock to Buy Now ||| Syndax Pharmaceuticals Reports Study Results of Entinostat With Keytruda ||| Tweedy Browne Hooks Up Baidu in 1st Quarter ||| Incyte Issues Release Highlighting Co.'s IDO1 Enzyme Inhibitor in Combo with Merck's Anti-PD-1 Therapy is 'well-tolerated and demonstrates durable clinical responses across multiple solid tumors' ||| Merck's Glucophage SR Has Received Label Extension to Include Patients at High Risk of Type-2 Diabetes within UK ||| Aduro Biotech Reports Clinical Collaboration with Merck for Evaluation of CRS-207, KEYTRUDA Combo for Treatment of Mesothelioma",1,0.5125125
2017-05-18,11954500.0,62.90999984741211,64.5,62.90999984741211,63.88999938964844,58.02926254272461,MRK,"Immune Design (IMDZ) Posts Narrower-than-Expected Loss in Q1 ||| 4 Large-Cap Drug Stocks To Buy Post Q1 Earnings ||| Incyte (INCY) Announces Positive Data on Enzyme Inhibitor ||| The 3 Best Dow Jones Stocks to Buy ||| Merck Issues Release Confirming FDA Has Approved KEYTRUDA for Certain Patients with Locally Advanced or Metastatic Urothelial Carcinoma ||| FDA Has Granted Approval for Merck's Pembrolizumab for Treatment of Locally Advanced or Metastatic Urothelial Carcinoma ||| WHO Says Congo Ebola Cases Present High National, Low Global Risk -Reuters",0,0.4793105
2017-05-19,9293700.0,64.04000091552734,64.04000091552734,63.5,63.77999877929688,57.92935180664063,MRK,"Company News for May 19, 2017 ||| Pharma Stock Roundup: J&J's Pharma Pipeline Update, Shire's HAE Data & More ||| The Most Notable Abstracts Released Ahead Of ASCO 2017 ||| Merck Reports Received CHMP Opinion Recommending Approval of ISENTRESS 600 mg in EU",1,0.5064591
2017-05-22,6226500.0,63.70000076293945,64.44000244140625,63.56999969482422,64.04000091552734,58.165504455566406,MRK,"3 Top Animal-Health Companies to Buy in 2017 ||| Amgen Evenity Approval Derailed on Cardiovascular Side Effect ||| Merck's HIV Drug Gets Positive CHMP Opinion for Higher Dose ||| Novartis' (NVS) Lung Cancer Drug Gets Positive CHMP Opinion ||| Notable ETF Outflow Detected - SSO, MRK, MCD, AMGN ||| Merck vs. Sanofi: Which Stock is a Better Pick Post Q1 Earnings? ||| UPDATE: Merck Says Highest Dose of MK-7264 Evaluated Reduced Awake Cough Frequency by 37% from Baseline Relative to Placebo ||| Merck Reports Presentation of Phase 2 Results for MK-7264 for Treatment of Chronic Cough",1,0.55422467
2017-05-23,5734600.0,64.0,64.58999633789062,64.0,64.55000305175781,58.62872314453125,MRK,"Dow Analyst Moves: MRK ||| Merck Presents Phase II Data on Chronic Cough Candidate ||| Insider Buying: The Evidence ||| FDA Approves Pembrolizumab for Pancreatic Cancers with Mismatch Repair Deficiency ||| FDA Reports Approval for Merck's Solid Tumor with a Specific Genetic Feature Treatment ||| Zymeworks: Early But Compelling Data, Large Biopharma Partners And A Potential June Catalyst ||| Pre-Market Imbalance Update: Ford 397K Shares to Buy, GE 200K to Buy, Nike 57K to Buy, GM 32K to Buy, Alibaba 30K to Buy, Merck 25K Shares to Sell ||| Companies Holding Annual Meetings Today Include Waste Connections, Eastman Kodak, Alarm.com, Amyris, Achillion Pharma, GNC, Amazon, Nokia, Merck, Nvidia, Pinnacle Foods, Wendy's, & Xerox ||| Merck Gets Priority FDA Review for KYTRUDA sBLA",1,0.5458158
2017-05-24,6955400.0,64.7699966430664,65.19999694824219,64.54000091552734,64.93000030517578,58.97386169433594,MRK,"AstraZeneca's Bydureon Fails to Reduce Cardiovascular Risk ||| Merck's (MRK) Keytruda Gets FDA Nod for Solid Tumor Cancers ||| Daily Dividend Report: KRC, MRK, CME, BDX, MAA, PF",1,0.5059124
2017-05-25,7095900.0,64.95999908447266,65.12000274658203,64.66000366210938,65.04000091552734,59.07377243041992,MRK,"Dow Movers: MRK, CAT ||| Health Care Sector Update for 05/25/2017: ADAP ||| New Stock Research Reports for Merck, 3M and United Technologies ||| Merck Reports Exclusive Global License Deal with Teijin Pharma for Investigational Antibody Candidate Targeting Tau",0,0.5137295
2017-05-26,3685700.0,65.0,65.20999908447266,64.81999969482422,64.91999816894531,58.96478271484375,MRK,"UnitedHealth's (UNH) Business Unit Collaborates with Merck ||| Top Analyst Reports for Visa, GE, GlaxoSmithKline & Others ||| GlaxoSmithKline's New CEO Is Off to a Good Start ||| Pfizer's Epogen Biosimilar Gets Positive FDA Committee Vote ||| Pharma Stock Roundup: Label Expansion for Merck Drug, Aerie Up On Eye Data ||| The Zacks Analyst Blog Highlights: Merck, 3M, United Technologies, Ford Motor and Humana ||| Here's How the FDA Just Helped Trump Deliver on a Big Promise ||| Celldex's Immuno-Oncology Pipeline Continues to Impress ||| Reminder: Merck Has Isentress sNDA PDUFA Date Tomorrow May 27",0,0.45578775
2017-05-30,4885600.0,64.72000122070312,65.13999938964844,64.52999877929688,64.87999725341797,58.92844009399414,MRK,"Congo Approves Use of Merck Ebola Vaccine -DJ ||| DGRO, MRK, PEP, MCD: Large Inflows Detected at ETF ||| Tracking The Busy June PDUFA Calendar ||| A Peek Into The Markets: U.S. Stock Futures Down Ahead Of Economic Data ||| Merck Gets FDA Approval of ISENTRESS for the Treatment of HIV-1",1,0.5171081
2017-05-31,7788300.0,65.08000183105469,65.48999786376953,65.02999877929688,65.11000061035156,59.13734817504883,MRK,Merck's HIV Drug Isentress Gets FDA Approval for Higher Dose ||| Gilead Single Tablet Regiment for HIV Good in Phase III ||| 3 Top Dividend Stocks in Diabetes Treatment,1,0.5269801
2017-06-02,6298600.0,65.45999908447266,65.58000183105469,65.18000030517578,65.47000122070312,59.46433639526367,MRK,Aduro's Drug Gets Clearance by the FDA for Solid Tumors ||| Merck Gives Update on KEYTRUDA Effectiveness with Over 2 Years of Follow Up,0,0.5253487
2017-06-05,5968500.0,65.3499984741211,65.38999938964844,64.69999694824219,65.06999969482422,59.10102462768555,MRK,"Zoetis Just Hit an All-Time High: Here's Why the Stock Should Go Higher ||| Combination of Incyte's Epacadostat + Merck's KEYTRUDA Demonstrates Activity in Clinical Trial of Patients with Advanced Non-Small Cell Lung Cancer #ASCO17 ||| Merck Announces New Data Show Durability of Response for KEYTRUDA in Advanced Microsatellite Instability-High or Mismatch Repair Deficient Solid Tumors, Regardless of Tumor Type #ASCO17 ||| Merck Announces Presentation of New Monotherapy Data for KEYTRUDA in Heavily Pre-Treated Patients with Advanced Gastric Cancer#ASCO17 ||| Merck Announces KEYTRUDA Shows Continued Overall Survival Benefit Over Chemotherapy as Second-Line Treatment for Advanced Urothelial Carcinoma Patients Post-Platinum Failure #ASCO17 ||| Health Care Sector Update for 06/05/2017: JNJ, PFE, ABT, MRK, AMGN, CLSN, MBOT, LOXO ||| One Put, One Call Option To Know About for Merck ||| Dynavax Technologies Corporation (DVAX) Stock Earns a Double-Digit Lift ||| Why Dynavax Technologies Corporation Stock Soared Today ||| Incyte Announces Data on Enzyme Inhibitor with Keytruda ||| Top Ranked Income Stocks to Buy for June 5th ||| Bristol-Myers Presents Data on Immuno-Oncology Drug Opdivo ||| Why Array BioPharma Inc. Sank 13.5% in May ||| Merck (MRK) Up 2.3% Since Earnings Report: Can It Continue? ||| The Zacks Analyst Blog Highlights: General Electric, Walt Disney, Merck, Pfizer and Chevron ||| Health Care Sector Update for 06/05/2017: JNJ, PFE, ABT, MRK, AMGN, NLNK, RDUS, BPMC ||| Here's Why Loxo Oncology Soared as Much as 58.5% Today ||| Dynavax +21% Premarket @$7.15; Co on Friday Presented Updated Data for SD-101 in Combination with KEYTRUDA ||| Merck Gives Update on Phase 2 I-SPY 2 Trial",0,0.50113976
2017-06-06,7841800.0,65.0,65.04000091552734,64.45999908447266,64.66999816894531,58.73771667480469,MRK,Incyte Provides Updated Data on Cancer Combination Therapies ||| Merck's Cancer Drug Keytruda Positive in Clinical Studies ||| An Unprecedented FDA Approval Bodes Well for this Drug Stock,0,0.5208047
2017-06-07,7606600.0,64.5999984741211,64.6500015258789,64.0,64.05999755859375,58.18367385864258,MRK,"Health Care Sector Update for 06/07/2017: JNJ, PFE, ABT, MRK, AMGN, CALA, ALOG, CERS ||| Spring Bank Pharmaceuticals' Hepatitis B Results in Context",0,0.47217163
2017-06-08,18522000.0,64.05999755859375,64.25,62.83000183105469,63.20000076293945,57.40256118774414,MRK,"Health Care Select Sector SPDR Fund Experiences Big Outflow ||| Health Care Sector Update for 06/08/2017: JNJ, PRE, ABT, MRK, AMGN, CHRS, TVTY, AXN ||| Why Is NewLink Genetics Losing One-Third of Its Value Today? ||| Noteworthy Thursday Option Activity: TAP, JPM, MRK ||| Dow Movers: MRK, JPM ||| Organovo Holdings Still Not Back on Track",1,0.5256307
2017-06-09,10750400.0,63.20000076293945,64.44000244140625,63.13999938964844,64.38999938964844,58.4833984375,MRK,"Health Care Sector Update for 06/09/2017: JNJ, PFE, ABT, MRK, AMGN, ENZ, BNTC, SNSS ||| Ex-Dividend Reminder: Thermo Fisher Scientific, Conmed and Merck ||| Inovio's HPV Immunotherapy Moves to Phase III, Stock Rises ||| Inovio's HPV Immunotherapy Moves to Phase III, Stock Rises",0,0.46144727
2017-06-12,9400300.0,64.38999938964844,64.68000030517578,64.19999694824219,64.38999938964844,58.4833984375,MRK,"Zoetis Stock Is Sizzling Hot -- Here's What Could Make It Cool Down ||| Merck, Pfizer Announce that Investigational SGLT-2 Inhibitor Ertugliflozin Met Primary Endpoint in Two Phase 3 Studies at #2017ADA ||| Interesting June 2018 Stock Options for MRK ||| Merck Becomes #16 Most Shorted Dow Stock, Replacing United Technologies ||| Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for June 13, 2017 ||| Health Care Sector Update for 06/12/2017: JNJ, PFE, ABT, MRK, AMGN,CHRS, NVO, AZN ||| Merck's Diabetes Drug Meets Primary Endpoint in Key Studies ||| New Research Reports for Facebook, Wal-Mart & Merck ||| Merck Reports Update On Multiple Myeloma Studies KEYNOTE-183, 185 Of KEYTRUDA In Combo With Other Therapies: Has Accepted External Data Monitoring Committee Recommendation To Pause New Enrollment ||| Pre-Market Imbalance Update: Pfizer 74K Shares To Sell, Citi 61K To Sell, JP Morgan 35K Shares To Buy, Merck 33K To Buy",0,0.46072754
2017-06-13,12053000.0,63.72999954223633,63.84000015258789,63.02999877929688,63.27000045776367,57.88867950439453,MRK,"Health Care Sector Update for 06/13/2017: JNJ, PFE, ABT, MRK, AMGN, CHRS, IMNP ||| Merck: A Speed Bump For Keytruda? ||| J&J's Invokana Lowers Heart Issues, Raises Amputation Risk ||| Merck Stalls Enrolment in Two Myeloma Studies of Keytruda ||| Dow Movers: VZ, GS ||| 3 Stocks to Watch on Tuesday: Shopify Inc (US) (SHOP), Under Armour Inc (UAA) and Merck & Co., Inc. (MRK) ||| Gilead (GILD) Submits NDA for HIV Combination Therapy Regimen ||| Will Tesaro Be the Focus of the Next Biotech Bidding War? ||| Market Close Report: NASDAQ Composite index closes at 6,220.37 up 44.90 points ||| Michael Kors Holdings Ltd (KORS) Stock Can Deliver Low-Risk Profits ||| Merck Stalls Enrolment in Two Myeloma Studies of Keytruda ||| The Zacks Analyst Blog Highlights: Facebook, Wal-Mart, Merck, Kellogg and PACCAR",1,0.49845484
2017-06-14,10338600.0,63.02000045776367,63.63999938964844,63.02000045776367,63.369998931884766,57.98017883300781,MRK,"Health Care Sector Update for 06/14/2017: JNJ, PFE, ABT, MRK, AMGN, ALDX, NDRM, LOXO",0,0.46814424
2017-06-15,7866800.0,63.29999923706055,63.43999862670898,62.880001068115234,63.18999862670898,57.81547546386719,MRK,"Johnson & Johnson's Type 2 Diabetes Drug Is Stellar in Cardiovascular Trials, but Comes With a Catch ||| Health Care Sector Update for 06/15/2017: JNJ, PFE, ABT, MRK, AMGN, CRBP, LNTH ||| Is the Market Wrong About Bristol-Myers Squibb? ||| Merck Reports Expansion Of Distribution Deal With Public Health England",0,0.49201074
2017-06-16,14902000.0,63.2599983215332,63.709999084472656,62.68999862670898,62.970001220703125,57.614200592041016,MRK,"FDL, INTC, MRK, MO: Large Inflows Detected at ETF ||| Pharma Stock Roundup: J&J, Lilly Present Data, Merck Keytruda Study Enrolment Paused ||| Cerveau Technologies Reports FDA Accepted IND For MK-6240; BZ NOTE: Merck Is A Development Partner For The Candidate",1,0.5359413
2017-06-19,8426900.0,63.09000015258789,63.810001373291016,63.02000045776367,63.68000030517578,58.26380920410156,MRK,"3 Biotech Stocks That Could Become M&A Targets ||| 3 Stocks with Universal Display-like Return Potential ||| Merck Receives FDA Orphan Designation for Keytruda in Treatment of Esophageal Carcinoma ||| Bristol-Myers Opdivo Positive in Phase II Study CheckMate-205 ||| The Amount You Pay for Cancer Drugs May Double -- Here's Why ||| Health Care Sector Update for 06/19/2017: JNJ, PFE, ABT, MRK, AMGN, VRX, MACK, MDT ||| A Surprising Disappointment Derails NewLink Genetics -- What's Next? ||| Bristol-Myers Opdivo Positive in Phase II Study CheckMate-205",1,0.5415112
2017-06-20,10263000.0,63.68000030517578,64.95999908447266,63.58000183105469,64.52999877929688,59.04151153564453,MRK,"Dow Movers: CVX, MCD ||| Market Close Report: NASDAQ trading volume joins the top ten ranking for the year. NASDAQ Composite Index closes at 6,188.03 ||| Health Care Sector Update for 06/20/2017: JNJ, PFE, ABT, MRK, AMGN, NEOS, IMNP, GLPG ||| Merck Subsidiary Announces Collaboration With Serimmune",1,0.47391105
2017-06-21,11145000.0,64.55999755859375,65.5999984741211,64.55999755859375,65.45999908447266,59.89241409301758,MRK,"Small Cancer Biotech Space in Focus, 3 Stocks Up 100% & More ||| YieldBoost MRK From 2.9% To 4.9% Using Options ||| Ligand Gets Milestone Payment on Partner Drug FDA Approval ||| Dow Movers: INTC, NKE ||| Health Care Sector Update for 06/21/2017: JNJ, PFE, ABT, MRK, AMGN, RXII, PSTI, CARA ||| Ligand Gets Milestone Payment on Partner Drug FDA Approval ||| Small Cancer Biotech Space in Focus, 3 Stocks Up 100% & More ||| Leap Therapeutics Reports Collab With Merck For Evaluation Of KEYTRUDA In Combo With DKN-01 In Esophagogastric Cancer",1,0.52642244
2017-06-22,13441900.0,65.51000213623047,66.37000274658203,65.37999725341797,66.0199966430664,60.404781341552734,MRK,"Glaxo's (GSK) Shingles Candidate Phase III Data Positive ||| Market Close Report: NASDAQ Composite index closes at 6,236.69 up 2.74 points ||| Stocks to Fight Cancer: Why Immunotherapy Is a Gamechanger ||| The Long Case For Taro Pharmaceutical ||| Dow Movers: WMT, UNH ||| Merck's Keytruda on a Roll: Can it Retain the Momentum? ||| Why You Should Add Novo Nordisk Stock to Your Portfolio ||| Merck's Keytruda on a Roll: Can it Retain the Momentum? ||| Merck, Premier Report Expanded Collaboration To Address Chronic Care, Vaccination Rates",1,0.5161509
2017-06-23,14093500.0,66.04000091552734,66.38999938964844,65.83999633789062,66.16000366210938,60.53287887573242,MRK,"Health Care Sector Update for 06/23/2017: JNJ, PFE, ABT, MRK, AMGN, CARA, BLCM, NVS ||| Pharma Stock Roundup: NVS Scores with Positive Data, Shire ADHD Drug Gets FDA Nod ||| Pharma Stock Roundup: NVS Scores with Positive Data, Shire ADHD Drug Gets FDA Nod",0,0.5098932
2017-06-26,7576400.0,66.1500015258789,66.4000015258789,65.83000183105469,65.91999816894531,60.313289642333984,MRK,"The FDA Has Never Approved a Drug Like This in Its 111-Year History ||| VYM, CVX, MRK, INTC: Large Inflows Detected at ETF ||| Health Care Sector Update for 06/26/2017: JNJ, PFE, ABT, MRK, AMGN ||| The 3 Top Stocks for Your IRA in June ||| Better Buy: Merck & Co. Inc. vs. AbbVie Inc. ||| A Surprisingly Clean, Straightforward Approval Gives Portola Pharma Shares A Shot Of Upside",0,0.4957606
2017-06-27,8121600.0,66.2699966430664,66.2699966430664,65.54000091552734,65.54000091552734,59.96561050415039,MRK,"Wall Street Set to Open in Red Territory as Tech Sector Drags; Data, Fed Speeches Eyed ||| Bristol-Myers Reports Data on Immuno-Oncology Drug Empliciti ||| US Futures Sink into Red Territory as Tech Sector Drags; Data, Fed Speeches Eyed ||| AbbVie's HCV Combo Drug Gets Positive CHMP Opinion in EU ||| Pre-Market Most Active for Jun 27, 2017 : RAD, S, ALDR, BABA, QQQ, ARR, TMUS, MRK, CHK, AAPL, MU, TVIX ||| Ransomware Rears Its Head Again As 150 Countries Hit By New Virus ||| Hearing Merck Has Confirmed Co.'s Computer Network Was Compromised ||| Merck Announces REVEAL Met its Primary Endpoint, Says Will Consult With External Experts and Consider Whether to File NDA ||| Ablynx Achieves €2.5M Milestone Iin Immuno-oncology Collaboration With Merck",0,0.4798913
2017-06-28,6733300.0,65.76000213623047,65.9000015258789,65.13999938964844,65.16000366210938,59.61793899536133,MRK,Petya Ransomware Attack: List of Companies Hit in Latest Hack ||| Esperion's Combo Cholesterol Candidate Enters Phase III ||| Merck's CETP Inhibitor Reduces CV Risk in Phase III Study ||| Why Merck is a Top 25 Dividend Giant (MRK) ||| Russia In The Spotlight As Second Wave Of Ransomware Grips Globe ||| Esperion's Combo Cholesterol Candidate Enters Phase III ||| Merck's CETP Inhibitor Reduces CV Risk in Phase III Study,0,0.4891356
2017-06-29,8350300.0,65.01000213623047,65.08000183105469,64.08999633789062,64.33999633789062,58.86766815185547,MRK,"M&As, Rich Pipelines & Catalyst Rich 2017 to Drive Pharma Stocks ||| 3 Big Stock Charts for Thursday: Merck & Co., Inc. (MRK), Gilead Sciences, Inc. (GILD) and Valeant Pharmaceuticals Intl Inc (VRX) ||| Novartis Gets EC Nod for Lung Cancer Drug's Label Expansion ||| Risks To Consider As J&J's Stock Inches Up ||| Merck & Co. Inc.: The Bear Case from a Bull ||| Aduro Starts Phase II Combo Study with CRS-207 & Keytruda ||| Health Care Sector Update for 06/29/2017: JNJ, PFE, ABT, MRK, AMGN, VRX, SRPT, NVS ||| Aduro Biotech Initiates Phase 2 Clinical Trial Of CRS-207 In Combination With KEYTRUDA",0,0.48428863
2017-06-30,8360900.0,64.48999786376953,64.7300033569336,64.0,64.08999633789062,58.63893508911133,MRK,"Health Care Sector Update for 06/30/2017: JNJ, PFE, ABT, MRK, AMGN, SKLN, AMGN. CARA ||| Pharma Stock Roundup: Sanofi RA Drug Gets EU Nod, Merck CETP Inhibitor Surprises ||| Benzinga's Option Alert Recap From June 30",1,0.48956725
2017-07-03,4671400.0,63.84999847412109,64.62999725341797,63.84999847412109,64.2699966430664,58.80362319946289,MRK,"A New Class of Cancer Drugs Could Wipe Out Your Life Savings, Even if You're Enrolled in Medicare ||| 3 Top High-Yield Pharmaceutical Stocks to Buy Now ||| Health Care Sector Update for 07/03/2017: JNJ, PFE, ABT, MRK, AMGN, OPXA, PTCT. KND ||| Neville Rodie & Shaw Inc Buys Oracle Corp, Quanta Services Inc, Flowserve Corp, Sells ... ||| Watch These 5 Huge Put Purchases In Monday Trade",0,0.47622383
2017-07-05,6507800.0,64.47000122070312,64.80000305175781,63.91999816894531,64.16000366210938,58.70298767089844,MRK,"Incyte & Lilly's Olumiant Gets Marketing Approval in Japan ||| XLV, UNH, MRK, AMGN: Large Inflows Detected at ETF ||| Health Care Sector Update for 07/05/2017: JNJ, PFE, ABT, MRK, AMGN, MTBC, BGNE, EVHC ||| Merck Announces FDA Placed Clinical Hold On KEYNOTE-183, KEYNOTE-185 and KEYNOTE-023 Following Review Of Data By Data Monitoring Committee; FDA Has Determined Risk Of KEYTRUDA In Compination With Pomalidomide Of Lenalidomide Outweigh Potential Benefits ||| Healthcare Repeal Bad For GlaxoSmithKline, Other HIV Treatment Stocks",0,0.46973535
2017-07-06,11342700.0,63.77000045776367,63.90999984741211,62.9900016784668,63.09999847412109,57.7331428527832,MRK,"ProQR's Usher Syndrome Candidate Gets Orphan Drug Status ||| Merck Falls as FDA Puts Hold on 3 Keytruda Myeloma Studies ||| After Hours Most Active for Jul 6, 2017 : WY, PHM, OKE, MRK, QQQ, SRC, APC, TTWO, AAPL, ATVI, EXEL, CSCO ||| 4 Reasons Teva Pharmaceutical Industries Ltd. Gained 21% in June ||| Bristol-Myers' Opdivo Superior to Yervoy in Melanoma Study ||| Merck Falls As FDA Puts Hold On 3 Keytruda Myeloma Studies ||| Merck to Present New Data from Clinical Trials Evaluating ISENTRESS HD and Investigational HIV Therapies Doravirine and MK-8591 at IAS 2017",1,0.49734885
2017-07-07,7243400.0,63.209999084472656,63.34000015258789,62.810001373291016,63.15999984741211,57.788047790527344,MRK,"Bristol-Myers Gets FDA Nod for Orencia's Label Expansion ||| Pharma Stock Roundup: MRK's Keytruda MM Combo Studies on Clinical Hold, Bayer to Revise Outlook ||| Endo (ENDP) to Remove Opioid Pain Drug Opana ER from Market ||| MRK Makes Notable Cross Below Critical Moving Average",0,0.50618505
2017-07-10,6713800.0,63.38999938964844,63.400001525878906,62.61000061035156,62.83000183105469,57.48611068725586,MRK,Interesting August Stock Options for MRK ||| Cybersecurity Stocks Gain as Mondelez Loses Sales to Petya ||| These 5 Cancer Drugs Will Be the Biggest Winners 5 Years From Now ||| The Royalty-Amassing Strategy Of Royalty Pharma,0,0.50500107
2017-07-11,6877500.0,62.81999969482422,62.97999954223633,62.2400016784668,62.34000015258789,57.03778076171875,MRK,Sanofi to Buy Vaccine Biotech Protein Sciences for $650M ||| BioLineRx/Roche Scan BL-8040-Tecentriq for Pancreatic Cancer ||| 3 Dividend Stocks in Healthcare,1,0.5350007
2017-07-12,8216000.0,62.65999984741211,63.130001068115234,62.65999984741211,62.77999877929688,57.44035720825195,MRK,J&J (JNJ) to Commence Pharma Q2 Earnings Season: What's Up? ||| J&J To Commence Pharma Q2 Earnings Season: What's Up?,1,0.49005038
2017-07-13,6799200.0,62.790000915527344,62.9900016784668,62.27999877929688,62.88999938964844,57.54100036621094,MRK,"Lilly Settles Patent Litigation on Cialis with Generic Firms ||| Health Care Select Sector SPDR Fund Experiences Big Inflow ||| Dow Movers: MCD, WMT ||| The Zacks Analyst Blog Highlights: Merck, Eli Lilly, Celgene, Gilead Sciences and Shire ||| 5 Drug Stocks Well Poised to Beat Q2 Earnings Estimates ||| Shares of Eli Lilly, AstraZeneca, Merck, Gilead, Abbvie, Other Large Cap Biotech Spiking Higher",1,0.52115256
2017-07-14,6020900.0,62.93000030517578,63.400001525878906,62.86000061035156,63.060001373291016,57.6965446472168,MRK,"Pfizer Xeljanz Label Expansion Application Accepted by FDA ||| Top Research Reports for Facebook, Verizon & Merck ||| Gilead (GILD) Application for HIV Drug Validated in EU ||| AbbVie Inc (ABBV) Stock Isn’t Done Charting New Highs Yet",0,0.46363354
2017-07-17,7387300.0,63.150001525878906,63.310001373291016,62.52999877929688,62.61000061035156,57.28482437133789,MRK,"Gilead (GILD) Application for HIV Drug Validated in EU ||| Amgen (AMGN) Gets CRL for Osteoporosis Drug Evenity's BLA ||| The Zacks Analyst Blog Highlights: Facebook, Verizon, Merck, Pepsi and HCA Healthcare ||| 5 Pharma and Biotech Stocks Set for Big Q2 Earnings Wins ||| MRK Crosses Above 3% Yield Territory ||| 5 Biggest Price Target Changes For Monday",0,0.50586945
2017-07-18,6114900.0,62.5,62.630001068115234,62.27000045776367,62.40999984741211,57.10182571411133,MRK,"Ligand Signs Agreement with Amgen, Grants Rights to Captisol ||| Tealwood Asset Management Inc Buys Carnival Corp, Cypress Semiconductor Corp, Crown Castle ...",1,0.5292707
2017-07-19,5699100.0,62.5,62.83000183105469,62.43999862670898,62.619998931884766,57.2939682006836,MRK,"Health Care Sector Update for 07/19/2017: JNJ, PFE, ABT, MRK, AMGN, MDGS, GSK, INO",1,0.47128767
2017-07-20,6655100.0,62.90999984741211,63.2400016784668,62.86000061035156,62.93999862670898,57.58673858642578,MRK,"Oakbrook Investments Llc Buys Schlumberger, JPMorgan Chase, Visa Inc, Sells W.W. ... ||| Dow Movers: HD, NKE ||| Health Care Sector Update for 07/20/2017: JNJ, PFE, ABT, MRK, AMGN, BVXV, GSK, PFE ||| Hearing Merck Has Said Corning Will Make Initial $500M Investment Related To Modernization Of Pharmaceutical Glass Packaging ||| Trump Says Merck, Pfizer And Corning Announce That Glass Packaging Will Be Made In America ||| Merck Reports FDA Granted Tentative Approvaal For LUSDUNA Nexvue",0,0.46338382
2017-07-21,6906400.0,62.790000915527344,63.0,62.58000183105469,62.630001068115234,57.30311584472656,MRK,"What's in the Offing for Bristol-Myers (BMY) in Q2 Earnings? ||| XLV, UNH, MRK, AMGN: Large Outflows Detected at ETF ||| Health Care Sector Update for 07/21/2017: JNJ, PFE, ABT, MRK, AMGN, AEZS, BCLI, RH ||| Merck's Biosimilar Insulin Gets Tentative FDA Approval ||| Merck Reports EMA CHMP Recommended Approval For Co.'s KEYTRUDA For Treatment Of Certain Patients With Locally-Advanced Or Metastatic Urothelial Carcinoma ||| Merck and Pfizer's Avelumab Recommended for Approval by the EU Medicines Agency",0,0.4637497
2017-07-24,7783700.0,62.540000915527344,62.900001525878906,62.5,62.56999969482422,57.24821472167969,MRK,"Gilead Sciences, Inc. (GILD) Stock Is a 2-for-1 Deal ||| AMF Pensionsforsakring AB Buys Baker Hughes Inc, Sells Baker Hughes, a GE Co, Ball Corp ||| Is a Beat in Store for Agenus (AGEN) this Earnings Season? ||| Surprise in Store for Healthcare in Q2: Buy Top-Ranked ETFs ||| Corning Looks to Sustain Its Momentum ||| UPDATE: Merck Reports No Safety Signals Identified In Phase 3 KEYTRUDA Study ||| Merck Reports Update On Phase 3 KEYTRUDA Study, Did Not Meet Primary Endpoint ||| What You Need To Know About Dow Components Reporting This Week ||| Ahead Of Earnings: Why You Should Be Buying Merck And Selling Bristol-Myers ||| Merck Gives Results from ONCEMRK, A Study of ISENTRESS HD",0,0.4716979
2017-07-25,5955900.0,62.84999847412109,63.0,62.25,62.36000061035156,57.05607986450195,MRK,"Health Care Sector Update for 07/25/2017: JNJ, PFE, ABT, MRK, AMGN, NVAX, BIIB, LLY ||| Merck a Top Socially Responsible Dividend Stock With 3.0% Yield (MRK) ||| UPDATE: Merck Plans to Submit New Drug Applications with the U.S. FDA in Q4 2017 For Doravirine ||| Merck's Doravirine Meets Primary Efficacy Endpoint of Non-Inferiority to Efavirenz, Both in Combination with Other Antiretroviral Agents, in Pivotal Phase 3 Trial for Treatment of HIV-1 Infection",0,0.45446408
2017-07-26,9366700.0,62.310001373291016,62.34000015258789,61.720001220703125,61.79999923706055,56.54370880126953,MRK,"Biotech Stocks Jul27 Q2 Earnings Roster: BMY, CELG & ALXN ||| Key Takeaways from Lilly's (LLY) Q2 Call: Baricitinib, Cancer Pipeline ||| Corning Exceeds Expectations on Optical and Gorilla Glass Strength ||| Health Care Sector Update for 07/26/2017: JNJ, PFE, ABT, MRK, AMGN, TTPH, BMY, RETA ||| Ferguson Wellman Capital Management, Inc Buys Citigroup Inc, Bank of New York Mellon Corp, ...",1,0.53628135
2017-07-27,21846300.0,63.66999816894531,64.55000305175781,62.79999923706055,63.68999862670898,58.2729606628418,MRK,"Pharma Stocks to Watch for Earnings on Jul 28: ABBV, MRK ||| Mighty AstraZeneca Takes a Lickin' on Failed Mystic Trial ||| Pre-Market Most Active for Jul 27, 2017 : TWTR, AZN, FB, BTI, SIRI, BMY, CMCSA, MRK, NOK, SHOR, QQQ, TLT ||| Nasdaq Pivots Lower on Tech Sell-Off; Verizon Lifts Dow Jones Industrial Average ||| Friday's Earnings Reports To Watch: XOM, CVX, MRK, ABBV ||| Close Update: Nasdaq Roiled By Midday Sell-Off, Dow Keeps Upward Momentum ||| Pre-Market Earnings Report for July 28, 2017 : XOM, CVX, MRK, ABBV, TRP, LYB, HCN, BEN, WY, IMO, AAL, VTR ||| Noteworthy Thursday Option Activity: UNP, HIG, MRK ||| Did the Checkpoint Inhibitor Bubble Just Burst? ||| Merck Shares Up 3.3% After Announcing Oncology Collaboration With AstraZeneca ||| Why Is AstraZeneca Sinking Today? ||| Samsung, Amazon — Everyone Is Getting Into Pharmaceuticals ||| AstraZeneca, Merck Announce Strategic Oncology Collaboration; Merck to pay AstraZeneca up to $8.5B in Total Consideration",1,0.4947569
2017-07-28,13342100.0,63.810001373291016,64.36000061035156,63.220001220703125,64.11000061035156,58.65724182128906,MRK,"AbbVie Inc (ABBV) Q2 Beat Fueled by Best World’s Best-Selling Drug ||| AstraZeneca (AZN) Beats on Q2 Earnings, Falls on Failed Study ||| Q2 GDP In Focus ||| Roche's (RHHBY) Sales Grow Y/Y in 1H17 on New Drug Launches ||| Q2 GDP Lands at 2.6%, 1st Read ||| Roche Continues Steady Growth ||| Merck (MRK) Beats on Q2 Earnings and Sales, Keeps 2017 View ||| Merck (MRK) Q2 Earnings & Sales Top on Strong Keytruda Sales ||| Earnings Reaction History: Merck & Co. Inc., 20.0% Follow-Through Indicator, 1.2% Sensitive ||| Dow 30 Stock Roundup: Caterpillar, DuPont, MCD, P&G Beat ||| Health Care Sector Update for 07/28/2017: JNJ, PFE, ABT, MRK, AMGN, ABBV, NUVA ||| A Peek Into The Markets: U.S. Stock Futures Down; Amazon Earnings Miss Views ||| Merck Raises FY17 Sales Outlook From Feb. 2 Indication Of $38.6B-$40.1B To $39.4B-$40.4B vs $40.1B Est. ||| UPDATE: Merck Raises FY17 Adj. EPS Outlook From $3.72-$3.87 To $3.76-$3.88 vs $3.85 Est. ||| Merck Raises FY17 Adj. EPS Outlook ||| Merck Reports Q2 Adj. EPS $1.01 vs $0.87 Est., Sales $9.93B vs $9.75B Est. ||| 10 Stocks To Watch For July 28, 2017 ||| Earnings Scheduled For July 28, 2017",0,0.48941803
2017-07-31,11714900.0,64.25,64.30999755859375,63.5099983215332,63.880001068115234,58.44680404663086,MRK,"What's Next for AstraZeneca and Its Dividend? ||| Sanofi (SNY) Q2 Earnings In Line, Sales Lag,'17 View Raised ||| Noteworthy ETF Outflows: OEF, WFC, UNH, MRK ||| Drug Stocks Q2 Earnings Releases on Aug 1: PFE, AERI & INCY ||| Company News For July 31, 2017 ||| Dow Movers: MRK, BA ||| Merck To Collaborate With Generex Biotech For KEYTRUDA In Combination With AE37 Study",1,0.4972358
2017-08-01,6490900.0,64.04000091552734,64.2699966430664,63.77000045776367,63.91999816894531,58.4833984375,MRK,"Pfizer (PFE) Surpasses Q2 Earnings Estimates, Misses Sales ||| Merck's Keytruda Plays Catch-Up to Bristol-Myers' Opdivo ||| August PDUFA Dates: Biotech Investors Stay Tuned To A Month Of Plenty",0,0.4618843
2017-08-02,7034900.0,63.95000076293945,63.959999084472656,63.16999816894531,63.43999862670898,58.04421615600586,MRK,"Incyte (INCY) Q2 Loss Wider than Expected, Jakafi Strong ||| Health Care Sector Update for 08/02/2017: JNJ, PFE, ABT, MRK, AMGN, EYES, OCUL",1,0.48103917
2017-08-03,7018800.0,63.209999084472656,63.72999954223633,63.18000030517578,63.52000045776367,58.11741638183594,MRK,"Trillium Asset Management, Llc Buys Analog Devices Inc, Avangrid Inc, Nike Inc, Sells Panera ... ||| Immune Design (IMDZ) Posts Narrower-than-Expected Loss in Q2 ||| Health Care Sector Update for 08/03/2017: JNJ, PFE, ABT, MRK, AMGN, REGN, TEVA ||| Aduro (ADRO) Q2 Loss Narrower than Expected, Revenues Top ||| Close Update: Wall Street Retreats Before Jobs Report as Energy, Tech Slide ||| Exelixis (EXEL) Q2 Earnings, Sales Beat on Cabometyx Sales",0,0.464371
2017-08-04,5341000.0,63.630001068115234,63.68999862670898,62.93999862670898,63.09999847412109,57.7331428527832,MRK,Celgene vs. Gilead Sciences: Who Reported Better Earnings?,0,0.49812093
2017-08-07,6696800.0,62.95000076293945,63.09000015258789,62.65999984741211,62.84000015258789,57.49525451660156,MRK,"Q2 Earnings Fail to Impress Pharma ETF ||| Ar Asset Management Inc Buys Kinder Morgan Inc, Nike Inc, Public Storage, Sells Macy's Inc, ... ||| Merck Animal Health to Acquire Austrian Manufacturing Facility, Terms Not Disclosed",0,0.49412292
2017-08-08,7680100.0,62.540000915527344,62.720001220703125,62.20000076293945,62.31999969482422,57.01948165893555,MRK,"Dow Analyst Moves: MRK ||| Dow Movers: MRK, IBM ||| Horizon Pharma (HZNP) Q2 Earnings & Sales Top, Raises View ||| After Hours Most Active for Aug 8, 2017 : BAC, PFE, CMCSA, FIG, APO, DIS, INTC, QCOM, CSCO, MSFT, MRK, QQQ ||| Merck 10-Q Just Out ||| Nice Recommends Erbitux In Combination With Platinum-Based Chemotherapy For The Treatment Of Recurrent And/Or Metastatic Head And Neck Cancer In The Oral Cavity",1,0.48926976
2017-08-09,6552300.0,62.45000076293945,62.720001220703125,62.220001220703125,62.4900016784668,57.17502212524414,MRK,"Pfizer: Some Near Term Challenges May Mute Positive Triggers ||| Celldex (CLDX) Q2 Loss Narrows, Revenues Beat, Shares Up ||| Celldex Therapeutics, Inc. Finishes Second Quarter With Plenty of Cash and Clinical Momentum ||| Why BeiGene Soared 56.6% In July",0,0.44727197
2017-08-11,6051000.0,62.41999816894531,62.959999084472656,62.2599983215332,62.380001068115234,57.07437133789063,MRK,"3 Big Stock Charts for Friday: iShares Russell 2000 Index (ETF) (IWM), Goldman Sachs Group Inc (GS) and Merck & Co., Inc. (MRK) ||| Impax Laboratories (IPXL) Q2 Earnings Beat, Revenues Up Y/Y ||| Dow 30 Stock Roundup: Disney Ends Deal with Netflix, Dow & DuPont Set Merger Date ||| Validea Joel Greenblatt Strategy Daily Upgrade Report - 8/11/2017",1,0.5062736
2017-08-14,5507500.0,62.90999984741211,63.0,62.59000015258789,62.66999816894531,57.3397102355957,MRK,"Time to Buy General Electric Company (GE) Stock After Massive Decline? ||| Microsoft Corporation (MSFT) Stock Is Pushing the ‘Start’ Button ||| How to Pluck Apple Inc. (AAPL) Stock off the Money Tree ||| Trump Lashes Out at Merck & Co., Inc. (MRK), But Does It Matter? ||| Stocks Rebound, But Dow Jones Stays Below 22,000 ||| Can Markets Rise Through All the Question Marks? ||| Gilead (GILD) NDA for HIV Combo Regimen Gets Priority Review ||| Have the Markets Stagnated? ||| Merck Higher Despite Trump Bashing ||| Doug Kass Tweets: I am buying $MRK just on principle. @maddow @MSNBC @carlquintanilla @jimcramer @tomkeene @andrewrsorkin @BeckyQuick ||| Merck CEO Quits Manufacturing Council To Stand Against Violence; Trump Promptly Calls Him Out About Drug Pricing ||| Donald Trump Tweets: Now that Ken Frazier of Merck Pharma has resigned from President's Manufacturing Council,he will have more time to LOWER RIPOFF DRUG PRICES! ||| CNBC Now Tweets: JUST IN: Merck CEO resigns from Trump's manufacturing council amid fallout from the President's comments.",0,0.47792453
2017-08-15,6316000.0,62.72999954223633,63.02999877929688,62.4900016784668,62.5,57.18416976928711,MRK,"A Snapshot of the Retail Earnings ||| Can Ligand's Captisol Deals Boost Growth in the Long Run? ||| Retail Wraps: Q2 Earnings, Sales and Trump's Council ||| A Complete List of CEOs Who've Left Trump's Manufacturing Council, So Far ||| Cypress Capital Management Llc Buys iShares International Select Dividend, SPDR DJ STOXX 50 ... ||| Martin Shkreli Calls Merck CEO Ken Frazier 'Self-Indulgent,' 'Pathetic' ||| The Market In 5 Minutes",1,0.49135393
2017-08-16,6061200.0,62.43000030517578,62.93000030517578,62.33000183105469,62.70000076293945,57.36716079711914,MRK,"SSO, UNH, HD, MRK: Large Outflows Detected at ETF ||| A Complete List of CEOs Who Have Left Trump’s Manufacturing Council, So Far ||| Adalta Capital Management LLC Buys USG Corp, Obsidian Energy, STMicroelectronics NV, Sells ... ||| Bristol-Myers Opdivo Fails Kidney Cancer Trial CheckMate-214 ||| You Can't Quit, Because You're Fired! Trump Disbands Manufacturing Council, Policy Forum ||| Market Reaction To Bristol-Myers' Mixed Clinical Results: 'A Little Excessive'",0,0.49795765
2017-08-17,9150100.0,62.75,63.02000045776367,61.810001373291016,61.84000015258789,56.58030319213867,MRK,"Can Pfizer Bank on New Immunotherapy Bavencio for Growth? ||| Orbimed Advisors Llc Buys Cigna Corp, Clovis Oncology Inc, Gilead Sciences Inc, Sells Centene ... ||| AstraZeneca, Merck Issue Release Confirming Added, Broad Approval Of LYNPARZA In US For Ovarian Cancer",0,0.48001987
2017-08-18,8421700.0,61.77000045776367,61.81999969482422,61.15999984741211,61.4900016784668,56.26007461547852,MRK,AbbVie's HCV Combo Drug Mavyret Clinches Approval in Canada ||| Gilead (GILD) HCV Drug Vosevi Receives Approval in Canada ||| AstraZeneca/Merck's Lynparza Gets FDA Nod for Label Expansion,1,0.5330367
2017-08-21,7197200.0,61.47999954223633,62.040000915527344,61.43000030517578,61.970001220703125,56.69925308227539,MRK,"3 Stocks You Can Safely Own Until 2030 ||| The Implied Analyst 12-Month Target For VOOV ||| Health Care Sector Update for 08/21/2017: JNJ, PFE, ABT, MRK, AMGN, AZN, NVS, TNXP ||| Zoetis (ZTS) Poised to Grow on Companion Animal Portfolio",1,0.5019651
2017-08-22,5515200.0,61.970001220703125,62.5,61.91999816894531,62.41999816894531,57.1109733581543,MRK,"Large-Cap Stocks Gain on Monday ||| Orbimed Advisors Llc Buys Cigna Corp, Clovis Oncology Inc, Gilead Sciences Inc, Sells Centene ... ||| BioLineRx Moves a Regulatory Submission for BL-8040 Trial ||| Health Care Sector Update for 08/22/2017: JNJ, PFE, ABT, MRK, AMGN, MTBC, PFE, MDT",0,0.48856005
2017-08-23,6434900.0,62.25,62.59999847412109,62.150001525878906,62.150001525878906,56.86394882202149,MRK,"Health Care Sector Update for 08/23/2017: JNJ, PFE, ABT, MRK, AMGN, PRTK, NVAX, RARE",1,0.47325408
2017-08-24,7750100.0,62.25,62.90999984741211,62.18999862670898,62.709999084472656,57.376312255859375,MRK,"Can Sanofi (SNY) Sustain the Solid 1H Momentum in 2H17? ||| Noteworthy ETF Inflows: IVW, UNH, HD, MRK ||| 4 of the Highest-Growth Stocks in Biotech Today ||| Health Care Sector Update for 08/24/2017: JNJ, PFE, ABT, MRK, AMGN, CO, ENZY, MYL ||| Celldex Ends Phase II Enrollment for Breast Cancer Candidate ||| Playing The US Pharma Space: Buy Portola, Hold Corvus, Sell Teva",1,0.4795093
2017-08-25,5274900.0,62.869998931884766,63.290000915527344,62.77000045776367,62.93999862670898,57.58673858642578,MRK,"Biogen's Humira Biosimilar Imraldi Gets Approval in EU ||| Merck & Co Becomes #24 Most Shorted Dow Stock, Replacing Apple ||| Jon Najarian Sees Unusual Options Activity In Marathon Petroleum, Caesars And Merck",1,0.5183121
2017-08-28,7498200.0,63.11000061035156,63.459999084472656,62.97999954223633,63.31999969482422,57.93442535400391,MRK,Here Are the Big Pharma Stocks to Own Based on R&D Spending ||| Novo Nordisk's Victoza Gets FDA Nod for Label Expansion,0,0.51791406
2017-08-29,6564700.0,63.130001068115234,63.209999084472656,62.720001220703125,63.119998931884766,57.75143814086914,MRK,"Merck Announces Presentation of Results of REVEAL Outcomes Study of Anacetrapib, Investigational Medicine for Cardiovascular Disease",0,0.5096513
2017-08-30,5022500.0,63.13999938964844,63.16999816894531,62.900001525878906,63.119998931884766,57.75143814086914,MRK,"Merck's CETP Inhibitor Reduces Cardiovascular Risk by 9% ||| 5 Greatest Health-Care Stocks of All Time ||| Dow Ekes Out a Win; Harvey Sends Gasoline Futures Soaring ||| Health Care Sector Update for 08/30/2017: JNJ, PFE, ABT, MRK, AMGN, MDCO, OTIC ||| Born On The Battlefield: AcelRx Awaits FDA Ruling On Device That Delivers Potent Opioid To Wounded Soldiers",1,0.47757387
2017-08-31,12903000.0,63.34999847412109,63.91999816894531,62.95000076293945,63.86000061035156,58.428504943847656,MRK,"Health Care Sector Update for 08/31/2017: JNJ, PFE, MRK, ABT, AMGN, APRI, BVXV, AMGN ||| Top Stock Reports for Merck, Caterpillar & Intel ||| Health Care Sector Update for 08/31/2017: JNJ, PFE, ABT, MRK, AMGN, IPXL, INSY ||| Merck Shares Down 0.5% Over Last Few Mins., Remain Up ~0.1% For Session ||| Merck Shares Move To Session Lows, Up 0.4% For Session, As Traders Circulating FDA.gov Alert 'FDA Alerts Healthcare Professionals and Oncology Clinical Investigators about Two Clinical Trials on Hold Evaluating KEYTRUDA® in Patients w/ MM'",0,0.44328943
2017-09-01,6185100.0,63.790000915527344,64.0999984741211,63.59999847412109,63.83000183105469,58.40105438232422,MRK,"Notable ETF Outflow Detected - MGC, MRK, PEP, MDT ||| US Market Indexes End the Month Higher ||| The Zacks Analyst Blog Highlights: Merck, Caterpillar, Intel, Analog Devices and Best Buy ||| Health Care Sector Update for 09/01/2017: JNJ, PFE, ABT, MRK, AMGN, IOVA, APVO, PGNX ||| Pharma Stock Roundup: Novartis CAR-T Drug Gets FDA Nod, Lilly Gives Baricitinib Update ||| Incyte (INCY) Reports Positive Data on Epacadostat/Keytruda",0,0.46737862
2017-09-05,7236200.0,63.75,64.11000061035156,63.459999084472656,63.619998931884766,58.20890426635742,MRK,Key FDA Regulatory Events to Watch Out for in Sep 2017 ||| Merck's KEYTRUDA Approved by the European Commission for a Type of Bladder Cancer,1,0.52525604
2017-09-06,7148700.0,63.88999938964844,64.33000183105469,63.77000045776367,64.0,58.55659484863281,MRK,"Merck's (MRK) Keytruda Gets EU Approval for Bladder Cancer ||| Merck Announces Acquisition of Rigontec for EUR 115M Cash, May Make up to EUR 349M of Additional Payments ||| Eisai Signs Agreement with Merck to Expand Enrollment of Combination Study for Lenvima and Pembrolizumab in Endometrial Carcinoma",1,0.57165515
2017-09-07,6856400.0,64.08999633789062,64.41999816894531,63.790000915527344,64.31999969482422,58.84937286376953,MRK,"Merck (MRK) Opts for Buying German Immuno-Oncology Biotech ||| Health Care Sector Update for 09/07/2017: SGRY,NLNK,ALNY ||| Health Care Sector Update for 09/07/2017: EKSO, NLNK, ALNY ||| Wall Street's M&A Chatter From September 6: Cabelas, Merck-Rigontec, Altice-Charter, Amazon-Kohl's",0,0.4606885
2017-09-08,7365800.0,63.9900016784668,64.52999877929688,63.93999862670898,64.2699966430664,58.80362319946289,MRK,"Bristol-Myers' Opdivo Study Meets Early Success, Stock Up ||| Dow 30 Stock Roundup: UTX to Buy Rockwell Collins, Merck Secures EU Keytruda Approval ||| Health Care Sector Update for 09/08/2017: MRK ||| Bristol-Myers' (BMY) Opdivo's Myeloma Studies Put on Hold ||| Good News for Opdivo Shows Why You Shouldn't Give Up on Bristol-Myers Squibb Stock ||| Health Care Sector Update for 09/08/2017: NLNK, KURA, TNDM, MRK ||| Merck Reports KEYTRUDA Plus Pemetrexed, Carboplatin Showed Continued Benefit in Overall Response Rates and Progression-Free Survival Compared to Pem/Carbo Alone in Patients with First-Line Nonsquamous NSCLC ||| European Society for Medical Oncology(ESMO) 2017 Congress Begins Today, Day 1 Of 5 ||| Merck Reports Updated Data For KEYTRUDA In Patients With Advanced Gastric Cancer Across Treatment Settings",1,0.4836895
2017-09-11,10291600.0,64.94000244140625,65.30999755859375,64.68000030517578,65.12999725341797,59.590476989746094,MRK,"3 Biotech Stocks That Skyrocketed This Week: Can They Go Higher? ||| What Pharmaceuticals Spend On Lobbying To Influence Trump ||| Incyte, Merck Announce Positive Progression-Free Survival Data from ECHO-202 Trial of Epacadostat in Combination with KEYTRUDA in Patients with Advanced Melanoma at ESMO 2017 ||| Allergan's Patent Loophole Could Be a Huge Gift for Pfizer ||| AstraZeneca's Lung Cancer Study Data Promising, Shares Spike ||| Notable Monday Option Activity: MRK, ALB, V ||| Morgan Stanley Healthcare Conference Begins Today, Presenters Include: Veeva Systems, Quorum Health, Neurocrine Biosciences, Vertex Pharma, Merck, Ocular Therapeutix, Biogen, Gilead, and Bristol-Myers ||| Merck Reports Findings From Phase 3 Study OF KEYTRUDA vs Standard Of Care In Patients With Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma",1,0.5377822
2017-09-12,7354200.0,65.12000274658203,65.62000274658203,65.12000274658203,65.45999908447266,59.89241409301758,MRK,"Here's Why Advaxis, Inc. Stock Is Getting Pummeled Today ||| Ex-Dividend Reminder: Thermo Fisher Scientific, Conmed and Merck ||| Bristol-Myers Reports Positive Results from Melanoma Study ||| This Analyst Predicts Bullish Growth Outlook For Incyte",0,0.48471794
2017-09-13,5628700.0,65.36000061035156,65.55000305175781,65.30000305175781,65.44999694824219,59.883262634277344,MRK,"Nektar (NKTR) Starts PROPEL Combo Study for Cancer Candidate ||| Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for September 14, 2017",1,0.47371078
2017-09-14,9959100.0,64.98999786376953,66.16999816894531,64.91000366210938,66.12000274658203,60.93385696411133,MRK,"Biosimilar 2017 Progress Report: Stocks in Focus ||| Health Care Sector Update for 09/14/2017: JNJ, PFE, ABT, MRK, AMGN, EKSO, RARE, CRIS",1,0.48717076
2017-09-15,14685800.0,66.16999816894531,66.37999725341797,65.75,66.16000366210938,60.97071075439453,MRK,Oncology Space in Focus this Week on ESMO Presentations ||| Bristol-Myers (BMY) Collaborates With Halozyme for ENHANZE,0,0.49621192
2017-09-18,10543200.0,66.0199966430664,66.41000366210938,65.80999755859375,65.98999786376953,60.81404495239258,MRK,Which of These 5 Will Be the Best-Selling Drug Worldwide in 2020? ||| 10 Rock-Solid Reasons Johnson & Johnson's Near-Term Future Looks Bright ||| Buy Bristol-Myers Squibb Co (BMY) Stock With No Fear ||| The Top Cancer Immunotherapies Expected to Reach $1 Billion in Sales in 2017 ||| Roche's (RHHBY) Tecentriq Studies Put on Partial Hold by FDA,0,0.4895187
2017-09-19,7009300.0,66.0199966430664,66.16000366210938,65.68000030517578,65.94999694824219,60.77717590332031,MRK,iShares Russell 1000 Value ETF Experiences Big Inflow ||| Roche (RHHBY) Announces Positive Data on Leukemia Drug,0,0.52442163
2017-09-20,9450000.0,66.06999969482422,66.30999755859375,65.19000244140625,65.79000091552734,60.62973403930664,MRK,Pfizer and Johnson & Johnson's Brewing Brawl Gets Real,0,0.45441732
2017-09-21,5968700.0,65.8499984741211,65.93000030517578,65.5199966430664,65.5999984741211,60.45463180541992,MRK,"Pfizer Sues J&J, Accuses it of Preventing Inflectra Uptake ||| 3 Small-Cap Biotech Stocks to Buy This Fall ||| Merck and Pfizer Get European Commission Approval for Bavencio",0,0.47011513
2017-09-22,7465900.0,65.62999725341797,65.69999694824219,65.06999969482422,65.12999725341797,60.02149200439453,MRK,"Pfizer-Merck KGaA Skin Cancer Drug Bavencio Gets EU Approval ||| Dow 30 Stock Roundup: BA Wins $600M Air Force Contract, JPM Invests in Bill.com ||| Cancer Space Update: Mixed Week for Pfizer, Roche Falters ||| US Market Indexes Mostly Higher ||| Gilead's (GILD) Epclusa Receives Label Expansion in Canada ||| AstraZeneca Stock Upgraded: What You Need to Know ||| Agilent Technologies Receives FDA Approval For Use Of Dako PD-L1 For Treatment With Merck's KEYTRUDA In Gastric or Gastroesophageal Junction Cancer ||| REMINDER: Merck's KEYTRUDA In Gastric Or Gastroesophageal Cancer Indication Has PDUFA Date Today",1,0.4742206
2017-09-25,5573400.0,65.16000366210938,65.4000015258789,65.04000091552734,65.18000030517578,60.06757736206055,MRK,Cramer's Guide To Profit From Market Rotations ||| Merck's Keytruda Gets FDA Nod for Advanced Gastric Cancer ||| Bristol-Myers (BMY) Opdivo Gets Approval for Liver Cancer ||| Roche (RHHBY) Gets Approval for Label Expansion of Tecentriq,0,0.523872
2017-09-26,6976200.0,65.0999984741211,65.31999969482422,64.72000122070312,64.76000213623047,59.6805305480957,MRK,Top Stocks with Big Potential Catch-Up Moves ||| Axovant Sciences (AXON) Stock Crashed Over 70%: Here's Why ||| 3 Heart Disease Focused Stocks to Buy Ahead of World Heart Day,0,0.49620727
2017-09-27,6691900.0,64.68000030517578,64.75,64.31999969482422,64.56999969482422,59.50542068481445,MRK,"Agilent Boosts Market Share With FDA Nod to New Cancer Test ||| Impax Generic Division Progresses Well Amid Pricing Pressure ||| Zacks.com featured highlights include Merck, Haemonetics, LKQ, Eastman Chemical and Honeywell International ||| Zacks.com featured highlights include Merck, Haemonetics, LKQ, Eastman Chemical and Honeywell International",0,0.47624084
2017-09-28,7022800.0,64.2699966430664,64.66000366210938,64.16999816894531,64.29000091552734,59.24738311767578,MRK,"Sanofi Rides on Genzyme & Vaccines Unit, Diabetes Sales Weak ||| Agenus (AGEN) Remains Focused on Drug Development Programs ||| Gilead (GILD) Gets Approval for HCV Drug Sovaldi in China ||| Biotech Stocks To Watch And Pharma Industry News",0,0.5010935
2017-09-29,11449600.0,64.29000091552734,64.52999877929688,63.33000183105469,64.02999877929688,59.00777053833008,MRK,"1 Great Biotech Stock You Have Never Heard Of ||| Dow Movers: MRK, V ||| Friday's ETF with Unusual Volume: PWV ||| Merck To Offer New, Updated Data On KEYTRUDA At World Conference On Lung Cancer, No Further Details Given ||| Merck Reports Discontinuation Of MK-3682B, MK-3682C Development Programs",1,0.50834185
2017-10-02,6743400.0,64.20999908447266,64.68000030517578,63.88999938964844,64.55000305175781,59.48699569702149,MRK,"Health Care Sector Update for 10/02/2017: JNJ, PFE, ABT, MRK, AMGN, KTOV, MNKD, AEMD ||| AbbVie Patent Deal Staves Off Amgen Competition, But Others Lurk ||| Merck's Keytruda Continues To Roll With Another FDA Approval ||| One Put, One Call Option To Know About for Merck ||| Merck Drops Two HCV Combination Programs Amid Competition ||| Galena Biopharma Shares Up 10.6% Following Earlier SEC Filing Showing SELLAS Life Sciences Entered Collab., Supply Deal With Merck For Initiation Of Phase 1/2 Trial With Galinpepimut-S, KEYTRUDA",0,0.46752995
2017-10-03,6507100.0,64.55000305175781,64.58000183105469,63.77999877929688,64.37000274658203,59.32110977172852,MRK,"Johnson & Johnson Files sNDA for Label Expansion of Invokana ||| Seattle Genetics' Adcetris Gets Breakthrough Therapy Status ||| Health Care Sector Update for 10/03/2017: JNJ, PFE, ABT, MRK, AMGN, DMPI, RDHL, RIGL ||| Good News and Bad News for Gilead Sciences: Which Carries More Weight?",1,0.49825275
2017-10-05,9150000.0,64.41999816894531,64.80000305175781,64.33000183105469,64.5999984741211,59.53306198120117,MRK,"Health Care Sector Update for 10/05/2017: JNJ, PFE, ABT, MRK, AMGN, DXTR, NBIX, RIGL ||| 'Fear Index' Falls to Record Low Close; S&P Secures Longest Win Streak in 4 Years",0,0.46677268
2017-10-06,7488400.0,64.69999694824219,64.9000015258789,64.37000274658203,64.55000305175781,59.48699569702149,MRK,"Health Care Sector Update for 10/06/2017: JNJ, PFE, ABT, MRK, AMGN, KDMN ||| Everything Is Going Right for AbbVie: Is It the Best Biotech Stock to Buy Right Now? ||| Here's What's Has Happened in the HCV Space Lately ||| Heaps Of Healthy Health Care ETFs",0,0.4490137
2017-10-09,5451300.0,64.66999816894531,64.73999786376953,64.12000274658203,64.33000183105469,59.28424453735352,MRK,"These 5 Dow Stocks Are Near Buy Zones As Earnings Season Begins ||| The 1 Event That Sent NewLink Genetics Corporation Soaring 25% in September ||| Health Care Sector Back In Focus In Congress Ahead Of Q3 Earnings Result ||| Pre-Market Imbalance Update: GE Shares 198K To Buy, Macy's 75K To Buy, Pfizer 71K To Sell, Merck 56K To Buy, Citi 50K To Buy, P&G 40K To Buy, ExxonMobil 38K To Sell, Barrick Gold 30K To Buy, BofA 28K To Buy, Chevron 25K To Sell, JP Morgan 10K To Buy",1,0.5041368
2017-10-10,4921000.0,64.30999755859375,64.47000122070312,64.19000244140625,64.45999908447266,59.404052734375,MRK,"Health Care Sector Update for 10/10/2017: KALV,ROKA,LLY, MRK ||| Midday Update: Dow Comes Off Record High as Proctor & Gamble Weighs On Wall Street ||| Health Care Sector Update for 10/10/2017: JNJ, PFE, ABT, MRK, AMGN, ANAB, VICL, LLY ||| 5 Pharma & Biotech Stocks That Could Be Big Winners in Q3 Earnings ||| Small-Cap Biotech Rockets After Dow's Merck Buys 10% Stake ||| Close Update: Walmart and Boeing Fuel Dow's Record Close ||| Radnor Capital Management, LLC Buys iShares Core MSCI EAFE, Sells Micro Focus International PLC ||| 5 Pharma & Biotech Stocks That Could Be Big Winners in Q3 Earnings",0,0.45891505
2017-10-11,10101600.0,64.33999633789062,64.33999633789062,63.77999877929688,63.77999877929688,58.77738571166992,MRK,"Lgt Capital Partners Ltd. Buys Akamai Technologies Inc, Urban Outfitters Inc, Tupperware Brands ... ||| Seattle Genetics Begins Phase II Study of Cancer Candidate ||| Company News For Oct 11, 2017 ||| Ferguson Wellman Capital Management, Inc Buys Symantec Corp, Omnicom Group Inc, United Parcel ... ||| Dow's Merck Bails On Cholesterol Drug, Prodding Shares Down ||| This Drugmaker Hit A 4-Month High On Collaboration With Dow's Merck ||| UPDATE: Merck Says Co. Will Not Submit Apps For Regulatory Approval For Anacetrapib ||| Merck Offers Update On Anacetrapid Development Program",1,0.4974567
2017-10-12,6158500.0,63.790000915527344,63.97999954223633,63.560001373291016,63.83000183105469,58.823463439941406,MRK,"Tealwood Asset Management Inc Buys Digital Realty Trust Inc, Hanesbrands Inc, Innoviva Inc, ... ||| Seattle Genetics Inks Clinical Collaborations for Cancer Drug ||| 5 Game-Changing Cancer Drug Innovations Being Developed Right Now ||| Merck Will Not Seek Approval for CETP Inhibitor Anacetrapib",0,0.4971188
2017-10-13,7341400.0,63.95000076293945,64.16000366210938,63.380001068115234,63.38999938964844,58.41797637939453,MRK,"Pharma Stock Roundup: Pfizer Mulls Options for Consumer Healthcare, LLY's Pipeline Setback ||| Gilead Sciences, Inc. (GILD) Stock Is Primed After Kite Pharma Buy ||| Pharma Stock Roundup: Pfizer Mulls Options For Consumer Healthcare, Eli Lilly's Pipeline Setback ||| Bank Of America Sees NewLink Genetics As 'Undervalued'",0,0.45788023
2017-10-16,7449200.0,63.4900016784668,63.72999954223633,63.2599983215332,63.34000015258789,58.37189865112305,MRK,"Better Buy: AbbVie Inc. vs. Merck ||| Notable ETF Inflow Detected - IVV, GOOG, MRK, DWDP ||| Incyte Cancer Treatment Uses Patients' Immune System To Fight Disease ||| Loxo Oncology Fights Cancer With 'Tumor Agnostic' Approach ||| Merck Reports 9.9% Passive Stake in KalVista Pharmaceuticals -13G ||| Aeglea BioTherapeutics Announces Clinical Collaboration with Merck to Evaluate the Combination of Aeglea's AEB1102 (pegzilarginase) with Merck's KEYTRUDA (pembrolizumab) for the Treatment of Small Cell Lung Cancer",0,0.49542248
2017-10-17,7028500.0,63.209999084472656,63.310001373291016,62.880001068115234,63.220001220703125,58.26131820678711,MRK,"J&J (JNJ) Beats on Q3 Earnings, Actelion Buyout Drives Sales ||| Bristol-Myers Gets Priority Review for Opdivo Label Expansion",1,0.51019126
2017-10-18,7886900.0,64.08999633789062,64.11000061035156,63.40999984741211,63.5099983215332,58.528564453125,MRK,"Dow Leads Indexes Up, As IBM Stuns Street ||| Monarch Capital Management Inc Buys First Merchants Corp, ONEOK Inc, Sells Teva Pharmaceutical ... ||| Pricing Pressure, Competition Remain Headwinds for Pharma Stocks ||| 5 Blue-Chip Stocks That “Dow 23,000” Left in the Dust ||| Benzinga's Top Upgrades, Downgrades For October 18, 2017 ||| Boosted By Keytruda, Citi Upgrades Merck To Buy For The First Time Ever ||| Merck Reports FDA Accepted Regulatory Submission For LYNPARZA In Metastatic Breast Cancer, Grants Priority Review ||| UPDATE: Merck Highlights KEYTRUDA Data 'Showed Median Overall Survival of 30.0 Months for KEYTRUDA Group Compared to 14.2 Months for Chemotherapy Group' ||| Merck Reports KEYTRUDA More Than Doubled Median Overall Survival Compared to Chemotherapy After 2 Years of Follow Up in First-Line Treatment of Patients with Metastatic NSCLC with High Levels of PD-L1 ||| Citigroup Upgrades Merck & Co to Buy",1,0.47915018
2017-10-19,10071200.0,63.63999938964844,64.02999877929688,63.59000015258789,63.75,58.74974060058594,MRK,AstraZeneca's sNDA for Two Cancer Drugs Gets Priority Review ||| OncoSec Shares Spike 17% After New Data Defended ||| White House 'Shenanigans' Represent A Buying Opportunity: Cramer,1,0.50861937
2017-10-20,10304200.0,63.84999847412109,63.9900016784668,63.56999969482422,63.880001068115234,58.86954498291016,MRK,"Celgene Down on Discontinued Crohn's Disease Drug Study ||| Cancer Treatment Update: Second Gene Therapy Receives Approval ||| BioLineRx/Roche Scan BL-8040-Tecentriq for Gastric Cancer ||| Fierce Pharma Reports Merck Lays Off 1,800 U.S. Sales Reps To Overhaul Primary Care Marketing",0,0.49401563
2017-10-23,11582000.0,64.02999877929688,64.5199966430664,63.29999923706055,63.400001525878906,58.42719650268555,MRK,"A Preview Of Next Week's Blue-Chip Earnings ||| One Put, One Call Option To Know About for Merck ||| Is a Beat in Store for Bristol-Myers (BMY) in Q3 Earnings? ||| Health Care Sector Update for 10/23/2017: JNJ, PFE, ABT, MRK, AMGN, TIG, AZN ||| The Week Ahead: Earnings Season Starts In Earnest ||| 8 Firms To Debut On The Markets This Week ||| AstraZeneca, Merck Rapidly Advance LYNPARZA in Japan With a NDA To Japan's Pharmaceuticals and Medical Devices Agency",0,0.46190277
2017-10-24,10221100.0,63.310001373291016,63.310001373291016,62.369998931884766,63.11000061035156,58.15993881225586,MRK,"Dow Analyst Moves: MRK ||| IWD, MRK, WMT, AMGN: ETF Inflow Alert ||| Dow Movers: JNJ, CAT ||| Healthcare ETFs Set to Soar as Q3 Earnings Unfold ||| Will Merck (MRK) Keep the Earnings Streak Alive in Q3? ||| Merck (MRK) Shares Cross 3% Yield Mark ||| Healthcare ETFs Set To Soar As Q3 Earnings Unfold",0,0.47139758
2017-10-25,11016700.0,63.09999847412109,63.130001068115234,62.33000183105469,62.45000076293945,57.55170440673828,MRK,Is a Beat in Store for Agenus (AGEN) This Earnings Season? ||| Is a Beat Likely for Pfizer (PFE) This Earnings Season? ||| Merck Enters Oversold Territory (MRK) ||| 10 Healthcare Stocks to Buy for a Dividend Lifeline ||| Expect Bristol-Myers Squibb To Post Steady Growth In Q3 Led By Opdivio And Eliquis,0,0.4796435
2017-10-26,10744300.0,62.290000915527344,62.68999862670898,61.810001373291016,61.9900016784668,57.12778472900391,MRK,"Glaxo (GSK) Q3 Earnings Beat, Revenues In Line, Shares Down ||| Buy the Dip in Amgen, Inc. While Wall Street Fears It ||| Dow's Exxon Mobil, Chevron, Merck Earnings Lead Friday's Investing Action Plan ||| Celgene (CELG) Tops Q3 Earnings, Sales Miss, Updates View ||| Key Predictions for Q3 Earnings Reports of ABBV, MRK ||| Merck vs. Pfizer: Which is Better Ahead of Q3 Earnings? ||| Pre-Market Earnings Report for October 27, 2017 : XOM, CVX, MRK, ABBV, CL, SPG, PSX, SHPG, LYB, AON, WY, IMO",0,0.50873166
2017-10-27,29561300.0,60.54999923706055,60.54999923706055,57.81999969482422,58.2400016784668,53.67191696166992,MRK,"The Zacks Analyst Blog Highlights: Merck, Pfizer, Aetna and Electronic Arts ||| Despite Profit Beat, Merck Shares Fall Due to Impact of NotPetya Attack ||| Merck & Co., Inc. (MRK) Takes a Hit After Q3 Loss ||| Merck (MRK) Q3 Earnings Top, Sales Lag, Keytruda Stays Strong ||| Data and Earnings Deluge ||| Dow Movers: MRK, MSFT ||| Q3 GDP Hits 3.0%, Q3 Earnings Take Pre-Market Higher ||| Merck (MRK) Tops on Q3 Earnings, Ups View Despite Sales Miss ||| Dow Stock Merck, AbbVie Top Earnings Views, Light On Sales ||| Market Close Report: Historical high reached as NASDAQ Composite Index closes at 6,701.26. ||| Nasdaq Leaps 2.2% To Record High As Technology Darlings Rally ||| Notable Friday Option Activity: MRK, CTL, MU ||| Stocks Open Mixed As FANGs Soar, But Merck, Chevron Drag On Dow ||| Merck Announces It Has Withdawn KEYTRUDA European Application ||| A Peek Into The Markets: U.S. Stock Futures Climb After Amazon, Alphabet Results ||| Merck Raises FY17 Sales Guidance From $39.4B-$40.4B As Of Jul. 28 To $40B-$40.5B vs $40.3B Est. ||| Merck Raises FY17 Adj. EPS Outlook From $3.76-$3.88 As Of Jul. 28 To $3.91-$3.97 vs $3.87 Est. ||| Merck Reports Q3 Adj. EPS $1.11 vs $1.03 Est., Sales $10.3B vs $10.55B Est. ||| 12 Stocks To Watch For October 27, 2017 ||| Earnings Scheduled For October 27, 2017",0,0.48206213
2017-10-30,38989400.0,55.75,56.04999923706055,54.40999984741211,54.709999084472656,50.41879653930664,MRK,"3 Bright Spots in Merck's Q3 Results ||| Dow Movers: MRK, AAPL ||| One Put, One Call Option To Know About for Merck ||| What's in the Cards for PFE, INCY and ACOR in Q3 Earnings? ||| Stock Market News For Oct 30, 2017 ||| S&P 500 Movers: AMD, CHK ||| Tech Stocks Lead; FANG's Facebook, Apple Still In Buy Range ||| Pre-Market Most Active for Oct 30, 2017 : AAAP, DYN, IBN, CAA, M, AAPL, JCP, ERIC, MRK, FB, TVIX, QQQ ||| Market Close Report: NASDAQ Composite index closes at 6,698.96 down -2.30 points ||| Stocks Fall, Gold Gains as Political Uncertainty Ramps Up ||| U.S. Stocks Retreat as Profit-Taking Surfaces on Event Risk ||| Monday Sector Laggards: Healthcare, Services ||| Stocks Lower As Market Mulls Tax Cut, Sprint News ||| Dow's Merck Plunges To 17-Month Low On Growing Keytruda Worries ||| Close Update: Wall Street's Winning Streak Snapped by Drug Sector, Tax Reform ||| 35 Stocks Moving In Monday's Mid-Day Session ||| The Bull Thesis For Merck Is Evaporating ||| Analyst Grows Cautious On Merck's Keytruda After Company Withdraws European Application ||| 8 Technical Levels Highlighted On Monday's PreMarket Prep ||| 5 Biggest Price Target Changes For Monday ||| Benzinga's Top Upgrades, Downgrades For October 30, 2017 ||| Barclays Downgrades Merck & Co to Equal-Weight ||| 30 Stocks Moving In Monday's Pre-Market Session ||| SunTrust Robinson Humphrey Downgrades Merck & Co to Hold ||| Morgan Stanley Downgrades Merck & Co to Equal-Weight ||| 8 Stocks To Watch For October 30, 2017",1,0.53579974
2017-10-31,18429200.0,55.16999816894531,55.790000915527344,55.02999877929688,55.09000015258789,50.76899719238281,MRK,"Dow Movers: PFE, INTC ||| Stock Market News For Oct 31, 2017 ||| Benzinga's Top Upgrades, Downgrades For October 31, 2017 ||| The Market In 5 Minutes: A Halloween Scare For Under Armour, Qualcomm And Other Big Tech Names ||| A Peek Into The Markets: U.S. Stock Futures Rise Ahead Of Mastercard, Kellogg Earnings ||| Jefferies Upgrades Merck & Co to Hold ||| 40 Biggest Movers From Yesterday",1,0.49527377
2017-11-01,16418400.0,55.540000915527344,55.79999923706055,55.27999877929688,55.34000015258789,50.9993896484375,MRK,"Aduro (ADRO) Q3 Loss In Line With Estimates, Revenues Miss ||| IWD, MRK, WMT, AMGN: ETF Inflow Alert ||| Pfizer Inc. Stock Earnings Were a Snooze — But That’s Good",1,0.47826347
2017-11-02,12318500.0,55.47999954223633,55.56999969482422,55.040000915527344,55.369998931884766,51.02703094482422,MRK,"Boston Partners Buys DowDuPont Inc, Cummins Inc, KeyCorp, Sells Brunswick Corp, PPG Industries ... ||| Interesting MRK Put And Call Options For December 22nd ||| Sanofi (SNY) Q3 Earnings In Line, Sales Lag, Diabetes Weak ||| Pre-Market Imbalance Update: Alibaba 278K Shares To Buy, BofA 111K Shares To Sell, Merck 85K To Buy, GE 8.5K To Buy",1,0.5133955
2017-11-03,9810800.0,55.29999923706055,56.27999877929688,55.18999862670898,56.060001373291016,51.66291427612305,MRK,"Dow 30 Stock Roundup: Chevron, Exxon, Apple Earnings Impress ||| Apple's Earnings Help Stocks Gain on Friday ||| Indexes Trudge Higher; IBD 50 Outperforms Thanks To These 3 Names",0,0.4833654
2017-11-06,8718500.0,56.040000915527344,56.18000030517578,55.59999847412109,55.880001068115234,51.49702453613281,MRK,"Dow Movers: VZ, GE ||| Go Long Mylan N.V. After Earnings With Confidence ||| Pharma Stock Roundup: Pfizer, Teva's Q3 Earnings, Novartis Seeks New Indication for Kymriah ||| Kahn Brothers Buys VOXX International Corp, Patterson-UTI Energy Inc, AT&T Inc, Sells ... ||| Interesting March 2018 Stock Options for MRK ||| Pharma Stock Roundup: Pfizer, Teva, Novartis, And More",0,0.4962801
2017-11-07,14321100.0,55.880001068115234,56.18999862670898,55.380001068115234,55.59000015258789,51.22977828979492,MRK,"Horizon Pharma (HZNP) Tops Q3 Earnings & Sales, Ups View ||| After Hours Most Active for Nov 7, 2017 : SNAP, CMCSA, KW, MRK, SWN, INTC, F, AIG, CY, MAR, MU, MSFT",1,0.4942339
2017-11-08,15132900.0,55.5,56.720001220703125,55.459999084472656,56.58000183105469,52.14212417602539,MRK,"Nektar (NKTR) Q3 Earnings & Sales Surpass, Sales View Up ||| Here's Why Merck & Co., Inc. Tanked 14% in October ||| Dow Movers: AXP, MRK ||| Celldex (CLDX) Q3 Loss Narrows, Revenues Beat, Shares Up ||| Market Close Report: Historical high reached as NASDAQ Composite Index closes at 6,789.12. ||| Stocks Manage to Close Higher Ahead of Tax Bill Release ||| Indexes Quiet, Small Caps Recover; 4 Hot Stocks Gap Up In Price",0,0.49185607
2017-11-09,14140100.0,56.54999923706055,56.65999984741211,55.619998931884766,56.209999084472656,51.80113983154297,MRK,"Pharma ETFs Down Post Q3 Earnings ||| AstraZeneca (AZN) Misses Q3 Earnings, Tweaks 2017 EPS View ||| Sphera Funds Management Ltd. Buys Cellcom Israel, Allergan PLC, Teva Pharmaceutical Industries, ... ||| Pharma ETFs Down Post Q3 Earnings ||| Merck Reports Received FDA Approval For PREVYMIS For Prevention Of CMV Infection, Disease In Adult Allogeneic Stem Cell Transplant Patients",0,0.51468533
2017-11-10,16743900.0,56.290000915527344,56.290000915527344,55.150001525878906,55.47999954223633,51.12840270996094,MRK,"Top Research Reports for Merck, UPS & Caterpillar ||| Dow, S&P Snap 8-Week Winning Streak as U.S. Tax Reform Worries Weigh",0,0.50944275
2017-11-13,13488300.0,55.310001373291016,55.52000045776367,55.060001373291016,55.09999847412109,50.77820587158203,MRK,"It's Not Too Late to Buy Dynavax Stock After Its Hepatitis B Vaccine Approval ||| Interesting January 2020 Stock Options for MRK ||| Seattle Genetics' Adcetris Gets FDA Nod for Label Expansion ||| Syndax Says Entinostat, Keytruda Combination Continues to Support Immune Responsiveness in Cancer Trial ||| Nektar/Bristol-Myers' Combo Trial Positive in Phase I/II ||| This Biotech Just Neared A 17-Year High On Strong Cancer Regimen ||| Merck Receives a Positive CHMP Opinion for PREVYMIS in the European Union",0,0.50050104
2017-11-14,12705800.0,54.970001220703125,55.18000030517578,54.75,54.9900016784668,50.67683410644531,MRK,"Merck (MRK) Gets CHMP Nod for Infection Candidate Prevymis ||| After Hours Most Active for Nov 14, 2017 : BAC, INTC, DYN, WFC, TWX, AMAT, MRK, GE, ISBC, QQQ, PSCT, NWSA",0,0.4786731
2017-11-15,11727400.0,54.7599983215332,55.09999847412109,54.400001525878906,54.79999923706055,50.50173568725586,MRK,J&J Presents Positive New Data for Diabetes Drug Invokana ||| 13G Filing Shows Merck Reporting 6.5% Stake In Spero Therapeutics ||| Merck Revisits Low Of Move And Rebounds,1,0.5203804
2017-11-16,11996300.0,54.86000061035156,55.369998931884766,54.75,55.16999816894531,50.84271240234375,MRK,"Pharma Stock Roundup: FDA Nod for AstraZeneca Severe Asthma Drug, Bayer Signs Deal with Loxo ||| Cue Biopharma Reports Strategic Research Collab, License Deal With Merck; Terms Not Disclosed, However cue Will Receive Up-Front Payment, Co. Eligible To Earn Up To $374M Milestone Payments In Addition To Tiered Royalities",1,0.51677656
2017-11-17,9884100.0,55.0,55.43000030517578,54.75,55.20000076293945,50.87035751342773,MRK,"Noteworthy ETF Inflows: DGRO, MRK, WMT, AMGN ||| Opus Point Partners Management, LLC Buys Bioverativ Inc, ACADIA Pharmaceuticals Inc, United ... ||| Dow 30 Stock Roundup: GE Cuts Dividend, Wal-Mart, Home Depot Beat ||| Merck Will Miss a Promised Deadline for Filing an Ebola Vaccine License with the FDA, According to STAT News",0,0.47781014
2017-11-20,17178700.0,54.040000915527344,54.38999938964844,53.630001068115234,54.09999847412109,49.85663604736328,MRK,"10 Frightening Lung-Cancer Statistics and 3 Top Companies Looking to Do Something About It ||| Celldex (CLDX) Initiates Phase II Study on Cancer Candidate ||| Interesting July 2018 Stock Options for MRK ||| Why Roche Cancer Trial Is Kick In The Teeth For Dow Stock Merck ||| Dow Movers: MRK, CSCO ||| Roche: The Big Pipeline Payoff ||| Pre-Market Most Active for Nov 20, 2017 : MRVL, DCIX, CAVM, INTC, QQQ, SMFG, XNET, BABA, FCAU, SQ, MRK, GE ||| Market Close Report: NASDAQ Composite index closes at 6,790.71 up 7.92 points ||| Merck & Co., Inc. Stock’s Decline Is a Reason to Get In Now ||| Dow Kicks Off Short Week With Modest Gain ||| Close Update: Wall Street Starts Holiday-Shortened Week on Stronger Note as Telecoms Lead ||| Stocks Close Modestly Higher As Verizon Helps Prop Up The Dow ||| Health Care Sector Update for 11/20/2017: JNJ, PFE, ABT, MRK, AMGN, DBVT, EGLT, ACOR",1,0.5235363
2017-11-21,13711300.0,54.36000061035156,54.84999847412109,54.18000030517578,54.27000045776367,50.013309478759766,MRK,"Patent Expiry, Competition Will Continue To Weigh On Bristol-Myers Squibb's Virology Portfolio ||| TESARO (TSRO) Ovarian Cancer Drug Zejula Gets Approval in EU ||| Health Care Sector Update for 11/21/2017: JNJ, PFE, ABT, MRK, AMGN, ARDX, MDT, NVO ||| Is Merck & Co. Inc. a Buy?",1,0.47619003
2017-11-22,7376200.0,54.22999954223633,54.56999969482422,54.16999816894531,54.369998931884766,50.10546112060547,MRK,"The Outlook For Merck’s Anti-Infectives Drug Business ||| Health Care Sector Update for 11/22/2017: JNJ, PFE, ABT, MRK, AMGN, EXEL, PBMD, SSY ||| Validea Joel Greenblatt Strategy Daily Upgrade Report - 11/22/2017",0,0.47618347
2017-11-24,4341300.0,54.5,54.630001068115234,54.11000061035156,54.34999847412109,50.0870361328125,MRK,"52-Week Company Lows ||| Health Care Sector Update for 11/24/2017: JNJ, PFE, ABT, MRK, AMGN, TEVA, NKTR ||| 3 Companies Competing to Gain Lead in Ovarian Cancer Market ||| Adalta Capital Management LLC Buys USG Corp, Controladora Vuela Compania de Aviacion SAB de CV, ... ||| J&J & Glaxo's Jucala Approval Puts Spotlight on HIV Space ||| Nektar (NKTR) Stock Up More than 300% This Year: Here's Why ||| 5 Biggest Price Target Changes For Friday",1,0.4957524
2017-11-27,10100100.0,54.40999984741211,54.59999847412109,54.20000076293945,54.54999923706055,50.27134704589844,MRK,"5 Cancer Types With the Poorest Long-Term Outlook ||| Sphera Funds Management Ltd. Buys Cellcom Israel, Allergan PLC, Teva Pharmaceutical Industries, ... ||| One Put, One Call Option To Know About for Merck ||| SPDR Portfolio Total Stock Market ETF Experiences Big Inflow ||| Better Buy: Eli Lilly and Co. vs. Merck & Co., Inc.",1,0.53315437
2017-11-28,12830900.0,54.93000030517578,55.130001068115234,54.40999984741211,54.93000030517578,50.621543884277344,MRK,"Dow's Merck Announces $10 Billion Buyback, Increases Dividend ||| Daily Dividend Report: RGCO, CNMD, CASH, MRK ||| Here Are The Implications Of Merck Withdrawing Its Keytruda Application From EU ||| Merck Raises Qtr. Dividend From $0.47 To $0.48/Share ||| Merck Reports $10B Buyback Plan ||| Bank of America Reinstates Buy on Merck & Co, Announces $64.00 ||| Peregrine Pharmaceuticals, Ronin Trading and SW Investment Management Announce Settlement Agreement; Peregrine Board Reconstituted with Four New Independent Directors ||| UPDATE: Merck, Pfizer On JAVELIN Trial Of Avelumab, Say, 'Safety profile was consistent with that observed in previously reported studies of avelumab; no new safety signals were identified' ||| UPDATE: Merck, Pfizer Says Phase III JAVELIN Study Investigating Avelumab 'did not meet its pre-specified primary endpoint of superior overall survival compared to chemotherapy' ||| Merck, Pfizer Offer Update Related To Phase III JAVELIN Gastric 300 Study In Patients With Pre-Treated Advanced Gastric Cancer",1,0.49193498
2017-11-29,10477600.0,55.040000915527344,55.650001525878906,54.93000030517578,55.36000061035156,51.01781463623047,MRK,"Merck Announces $10 Billion Buyback, Hikes Dividend by 2.1% ||| Health Care Sector Update for 11/29/2017: JNJ, PFE, ABT, MRK, AMGN, KOOL, CAPR, RXII ||| Are These Two Drugs Going To Determine Bristol-Myers Squibb's Future?",0,0.46543875
2017-11-30,15400400.0,55.18999862670898,55.88999938964844,55.02999877929688,55.27000045776367,50.934871673583984,MRK,"Glaxo Stock Down So Far This Year: Is a Reversal in Store? ||| Asset Planning Services, Ltd. Buys Merck Inc, Vanguard Short-Term Corporate Bond ETF, Voya ...",1,0.5113747
2017-12-01,12092400.0,55.400001525878906,55.97999954223633,55.220001220703125,55.869998931884766,51.48781204223633,MRK,"Stock Indexes Drop, But Oil Stocks Rise; Vote Likely On Tax-Cut Bill ||| The 15 All-Time Best-Selling Prescription Drugs ||| Gilead & 3 Other Drug Stocks in Focus this World AIDS Day ||| Bristol-Myers' Opdivo's Lung Cancer Study Meets Early Success ||| Market Close Report: NASDAQ Composite index closes at 6,847.59 down -26.38 points ||| Dow, S&P Hold On To Weekly Wins Despite Flynn Bombshell ||| FDA Decisions In November: The Month In Review",1,0.51346046
2017-12-04,13440000.0,55.93000030517578,56.709999084472656,55.869998931884766,56.220001220703125,51.81036376953125,MRK,"Walt Disney Co Leads 5 Dividend Stocks Boosting Payouts ||| Notable Monday Option Activity: MRK, TOL, CAKE",0,0.5066245
2017-12-05,11837200.0,56.150001525878906,56.5099983215332,55.720001220703125,55.77000045776367,51.39565658569336,MRK,"Noteworthy ETF Outflows: IVW, GOOG, MRK, ACN ||| Building a Circle of Competency ||| Top Analyst Reports for Home Depot, Boeing & Merck",0,0.5035353
2017-12-06,20245900.0,54.43999862670898,55.93000030517578,54.18999862670898,54.34999847412109,50.0870361328125,MRK,"Market Close Report: NASDAQ Composite index closes at 6,776.38 up 14.17 points ||| Can Drug/Biotech M&A Rebound Next Year After Bleak 2017? ||| The Zacks Analyst Blog Highlights: Home Depot, Boeing, Merck, Allstate and Illumina ||| Merck Becomes Oversold ||| These 3 Stocks Just Raised Their Dividends ||| Merck Announces Publication Of Phase 3 PREVYMIS Study Results In NE Journal Of Medicine",1,0.50196284
2017-12-07,16460500.0,54.84999847412109,55.84000015258789,54.68000030517578,54.77000045776367,50.47409057617188,MRK,"52-Week Company Lows ||| Stocks Up Moderately; The Wild Cards In This Market ||| Dow Movers: JPM, MRK ||| NYSE, Nasdaq Open: Broadcom Climbs As This Biotech Stock Spikes ||| Why 2017 Was a Year to Forget for Merck & Co. Inc. ||| Roche's Cancer Drug Combo Effective For Some — But Shares Drop ||| Loncar Investment's Brad Loncar Tweets: Roche is trading slightly down in Europe and $MRK seems not to be doing anything in this early pre-market hour. IMpower150 basically in line with high expectations.",1,0.50740445
2017-12-11,9770200.0,56.34000015258789,56.63999938964844,55.560001373291016,56.34000015258789,51.92094802856445,MRK,"Health Care Sector Update for 12/11/2017: VSTM, MRK, IONS, GILD, IMGN, JUNO, CELG, REGN, BIVV ||| Apple Leads Nasdaq Stocks Up; Is This The Best Bitcoin ETF To Trade? ||| New Highs for S&P, Dow on Strong Jobs Report ||| Dow Movers: BA, DIS ||| 4 Drug/Biotech Stocks That Could Be Buyout Targets in 2018 ||| 3 Stocks In Focus As Biotech M&A Hopes For 2018 Rise ||| Merck Reports FDA Accepted sBLA, Assigned Priority Review For KEYTRUDA For Treatment Of Relapsed, Refractory PMBCL",1,0.4865014
2017-12-12,13792700.0,56.869998931884766,57.16999816894531,56.630001068115234,57.06999969482422,52.59368896484375,MRK,"US Market Indexes Higher on Monday ||| Ex-Dividend Reminder: Conmed, Merck and Gilead Sciences ||| Merck's Keytruda Gets FDA Priority Review for Rare Lymphoma",0,0.5212163
2017-12-13,13342500.0,56.93999862670898,57.369998931884766,56.650001525878906,56.90999984741211,52.44624328613281,MRK,"Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for December 14, 2017 ||| Will This Drug Kick-Start Regeneron Pharmaceuticals Shares? ||| Merck's Keytruda Gets FDA Priority Review For Rare Lymphoma ||| PreMarket Opening NYSE Imbalance Update: AT&T 168k Shares To Sell; Nike 54k Shares To Sell; Square 33k To Buy; Disney 41k To Buy; US Steel 53k Shares To Sell; Pfizer 50k Shares To Sell; Merck 28k Shares To Buy;",0,0.48676664
2017-12-14,10137300.0,56.400001525878906,56.7400016784668,55.959999084472656,56.0099983215332,52.05588912963867,MRK,"Noteworthy ETF Inflows: HDV, IBM, MRK, WMT ||| Market Close Report: NASDAQ Composite index closes at 6,856.53 down -19.27 points ||| UPDATE: Merck Says Progression Free Survival Did Not Show Statistical Significance In PD-L1 Positive Population ||| Merck Announces KEYTRUDA Did NOT Meet Primary Endpoint In Phase 3 KEYNOTE-061 Study ||| Merck Says PREVYMIS Expected To Be Available In Canada By Year-End",1,0.5337521
2017-12-15,22580700.0,56.22999954223633,56.369998931884766,55.75,56.2400016784668,52.26964569091797,MRK,"Merck's Keytruda Misses Primary End Point for Gastric Cancer ||| Bristol-Myers' Opdivo/Yervoy sBLA for RCC Accepted by FDA ||| Lightning Round: Jim Cramer Shares His Thoughts On T-Mobile, Electronic Arts, And More",0,0.49377817
2017-12-18,11595000.0,56.380001068115234,56.68999862670898,56.20000076293945,56.220001220703125,52.251068115234375,MRK,Better Buy: Johnson & Johnson vs. Merck,1,0.52121973
2017-12-19,9467100.0,56.220001220703125,56.619998931884766,56.0099983215332,56.22999954223633,52.26035690307617,MRK,Bristol-Myers Yervoy Gets Positive CHMP Opinion for Melanoma,0,0.49057236
2017-12-20,13135900.0,56.27999877929688,56.4900016784668,55.97999954223633,56.11000061035156,52.14883041381836,MRK,"Orbimed Advisors Llc Buys Clementia Pharmaceuticals Inc, Aetna Inc, Universal Health Services ... ||| 3 Biotech Pipeline Areas To Keep An Eye On In 2018",1,0.5038196
2017-12-21,9961800.0,56.08000183105469,56.79999923706055,56.08000183105469,56.59999847412109,52.6042366027832,MRK,Roche's Perjeta Gets FDA Nod for Post Surgery Breast Cancer ||| What's Happening in Advanced Renal Cell Carcinoma Space? ||| Merck Reports FDA Granted Breakthrough Therapy Designation For Avelumab In Combo With INLYTA In Advanced Renal Cell Carcinoma,0,0.5201051
2017-12-22,11346000.0,56.59999847412109,56.83000183105469,56.130001068115234,56.36000061035156,52.38118362426758,MRK,"How Big Is J&J's Phase 3 Drug Pipeline? ||| Why 2017 Was a Year to Remember for Corning Inc. ||| Dow 30 Stock Roundup: Nike Beats, Pfizer Hikes Dividend ||| Why is Nektar (NKTR) Stock Up More Than 350% This Year? ||| If I Could Only Buy 1 Healthcare Stock in January, It Would Be This One ||| FDA Approves Merck's SGLT2 Inhibitor STEGLATRO and Fixed-Dose Combination STEGLUJAN for Adults with Type 2 Diabetes",0,0.4845251
2017-12-26,4405300.0,56.4900016784668,56.59999847412109,56.27000045776367,56.34000015258789,52.36259078979492,MRK,"Merck's Diabetes Drugs Get FDA Nod as Adjunct Therapies ||| Why Oncology Accounts For 65% Of Bristol-Myers Squibb's Value ||| A Quick Look At Merck & Pfizer's New Diabetes Drug ||| Why Pfizer Inc. Stock Is One of the Few Safe Drug Stocks ||| Merck Shares Down 0.12%, Pfizer Shares Up 0.11%; Earlier Companies Together Announced FDA Approvla For Their Collaboration Treatment STEGLATRO, STEGLUJAN and SEGLUROMET ||| Merck's Diabetes Drugs Get FDA Nod As Adjunct Therapies",0,0.4600296
2017-12-27,5660300.0,56.38999938964844,56.630001068115234,56.2599983215332,56.34000015258789,52.36259078979492,MRK,Dow Ekes Out a Win in Low-Volume Session,1,0.5520538
2017-12-29,8436600.0,56.83000183105469,56.9900016784668,56.27000045776367,56.27000045776367,52.29753494262695,MRK,"Dow 30 Stock Roundup: UnitedHealth Arm to Buy Chile Company, FDA OKs Merck Diabetes Drugs ||| Last Original Blue Chip Leads The 5 Worst Dow Stocks Of 2017 ||| ImmunoGen (IMGN) Soars Above 200% This Year: Here's Why ||| How Large Is Merck's Phase 3 Drug Pipeline? ||| A Closer Look At Roche's Phase 3 Drug Pipeline ||| Roche's Purchase Of Ignyta: Drop In A Bucket But Strategically Aligned",0,0.49657723
2018-01-02,10073000.0,56.59000015258789,56.75,56.04999923706055,56.220001220703125,52.251068115234375,MRK,"Health Care Sector Update for 01/02/2018: JNJ, PFE, ABT, MRK, AMGN, SNGX, BTX, PLX, MASI, BGNE ||| 4 Reasons To Consider Adding Celldex To Your Portfolio ||| Merck's KEYTRUDA Approved in Japan for Use in the Treatment of Patients with Urothelial Carcinoma",0,0.47278038
2018-01-03,10582500.0,56.22999954223633,56.2599983215332,55.959999084472656,56.13999938964844,52.17671585083008,MRK,Can Merck Regain its Mojo in 2018 After an Unimpressive '17? ||| Merck's Keytruda Gets Approved for Bladder Cancer in Japan ||| Seattle Genetics' Adcetris sBLA Gets FDA Priority Review,1,0.51441735
2018-01-04,15030200.0,56.43999862670898,57.41999816894531,56.380001068115234,57.04999923706055,53.02246856689453,MRK,Healthcare Stocks: Year In Review; Your Growth Prescriptions For 2018 ||| How Will Pfizer's Oncology Segment Shape Up In The Coming Years?,0,0.4871725
2018-01-05,9499100.0,57.38999938964844,57.38999938964844,56.59000015258789,56.9900016784668,52.966705322265625,MRK,"Cancer Space Update: New Regulatory Status for 3 Major Drugs ||| The Slow Push Upward Continues for Johnson & Johnson Stock ||| Key Biosimilar Approvals in 2017: Progress Report ||| Dow 30 Stock Roundup: Apple Apologizes for iPhone Issue, Disney's The Last Jedi Crosses $1B Mark ||| DJIA's Move Above 25,000 Comes Less Than a Year After Reaching 20,000 Amid Quickening Milestone Pace ||| Why These 3 Biotech Stocks Could Outperform Their Peers In 2018 ||| Lower Jobs Growth in December, But Some Positive Signs For Economy",0,0.5078781
2018-01-08,11109300.0,57.209999084472656,57.25,56.5,56.65999984741211,52.65999984741211,MRK,"Health Care Sector Update for 01/08/2018: JNJ, PFE, ABT, MRK, AMGN, CELB, WMGI, MZOR, ABLX, FMI, LMNX, MDRX, UCB.BR ||| 1 Reason Dynavax Technologies Corporation Stock Soared in 2017 ||| Alzheimer's takes Another Hit as Pfizer Ends Research in this Area ||| Alzheimer's Takes Another Hit As Pfizer Ends Research In The Area ||| Merck's KEYTRUDA Improved Recurrence-Free Survival Compared to Placebo as Adjuvant Therapy in Patients with Stage 3 Resected High-Risk Melanoma ||| Merck Announces FDA Accepts NDA For Doravirine",1,0.46915033
2018-01-09,10631700.0,56.810001373291016,57.09999847412109,56.56999969482422,56.79999923706055,52.79011535644531,MRK,"After Irrational Fire Sale, It’s Time to Buy the Dip in Merck & Co., Inc. Stock ||| Dow Analyst Moves: MRK ||| Amgen Announces Acceptance of MAA for Evenity in Europe ||| Merck's (MRK) Keytruda Succeeds in High-Risk Melanoma Study ||| Health Care Sector Update for 01/09/2018: JNJ, PFE, ABT, MRK, AMGN, PSTI, AXSM, BSX, ILMN, GENE, GNMK, BHVN ||| Merck Announces Breakthrough Designation from the FDA for LENVIMA and KEYTRUDA as Combination Therapy for Renal Cell Carcinoma",1,0.5061491
2018-01-10,9062400.0,56.54999923706055,57.369998931884766,56.459999084472656,57.29999923706055,53.25481796264648,MRK,Novo Nordisk's Ozempic Gets Canadian Approval for Diabetes ||| Merck's Keytruda Combo Gets Breakthrough Therapy Status,1,0.5305154
2018-01-11,7106300.0,57.29999923706055,57.61000061035156,57.15999984741211,57.59999847412109,53.53364181518555,MRK,Key Takeaways from Pfizer & 3 Other Drug Stocks at Healthcare Conference ||| These 3 Dividend Giants Are Safer Than You Think ||| Miles White's Bold Moves Made Abbott Laboratories A Global Force ||| Big Pharma CEOs Speak About Impact of Tax Reform on M&A ||| A Strategy That Beat The S&P 500: Here Are Your 2018 'Dogs Of The Dow' ||| Key Takeaways From The J.P. Morgan Healthcare Conference,1,0.52011144
2018-01-12,12343100.0,57.95000076293945,58.810001373291016,57.88999938964844,58.65999984741211,54.51880645751953,MRK,"Merck a Top 25 Dividend Giant With 3.34% Yield (MRK) ||| Ligand (LGND) Inks Deal With Glenmark for OmniAb Platform ||| Merck's Keytruda on a Roll: Can it Retain the Spark in 2018? ||| FDA Approves AstraZeneca and Merck's Lynparza, For Breast Cancer With A Certain Inherited Genetic Mutation",1,0.510439
2018-01-16,48091300.0,61.75,63.77999877929688,61.25,62.06999969482422,57.688079833984375,MRK,"AstraZeneca's Lynparza Label Now Includes Breast Cancer ||| Dow Touches New Intraday High, Finishes Lower ||| Dow's Merck Does An About-Face, Releases Cancer Trial Results ||| Dow Rallies to 26,000 on Upbeat Earnings ||| The Dogs of the Dow: Investing Made Easy ||| S&P 500 Movers: UA, MRK ||| Dow Movers: GE, MRK ||| Will 2018 Be Agenus Inc.'s Best Year Yet? ||| Health Care Sector Update for 01/16/2018: JNJ, PFE, ABT, MRK, AMGN, BNTC, EIGR, AVXS ||| Stocks Reverse Early Gains as VIX Surges ||| With Social Media Use Set to Grow in 2018, Buy Twitter (TWTR) ||| Pre-Market Most Active for Jan 16, 2018 : GE, XNET, BAC, MRK, USLV, C, FB, NOK, MU, QQQ, ABX, REDU ||| Market Close Report: NASDAQ trading volume joins the top ten ranking for the year. NASDAQ Composite Index closes at 7,223.69 ||| Indexes Reverse Lower In Volatile Session; Bitcoin Slumps, Breakouts Fade ||| Health Care Sector Update for 01/16/2018: MRK,BNTC,EIGR,AVXS ||| Stocks Down, Energy Play Holds Firm; This Bitcoin ETF Finds 50-Day Support ||| Tuesday Sector Leaders: Healthcare, Financial ||| Stock Gains Vanish As Small Caps Reverse Lower ||| Notable Tuesday Option Activity: ALB, NVDA, MRK ||| Midday Update: Dow Pierces 26,000 on Upbeat Earnings ||| How Important Is Keytruda To Merck? ||| What Happened in the Stock Market Today ||| Watching Shares Of AstraZeneca and Merck As White House Doctor Says Pres. Trump Takes Crestor For Cholesterol and Propecia For Hair Loss ||| Early Keytruda Results Win Merck An Upgrade ||| Merck Shares Up 5.8% On Earlier News That Phase 3 KEYNOTE-189 Trial Met Dual Primary Endpoints Of Overall Survival And Progression-Free Survival ||| SunTrust Robinson Humphrey Upgrades Merck & Co to Buy",0,0.49500868
2018-01-17,21889900.0,62.290000915527344,62.59000015258789,61.88999938964844,62.02999877929688,57.65089797973633,MRK,Merck Strong on Confirmatory Phase III Lung Cancer Study ||| Merck (MRK) Jumps: Stock Rises 5.8%,0,0.5046152
2018-01-18,19905800.0,62.0,62.119998931884766,60.630001068115234,61.130001068115234,56.81443405151367,MRK,"Why This Biotech Stock Could Outperform Expectations In Lung Cancer ||| Merck & Co., Inc. Stock Could Still Soar Another 10% From Here ||| BioLineRx Cancer Drug Positive as Monotherapy in Phase IIa ||| J&J (JNJ) to Set Pharma Q4 Earnings in Motion: What's Up?",1,0.51225936
2018-01-19,12161900.0,61.47999954223633,61.47999954223633,60.63999938964844,61.27999877929688,56.95384216308594,MRK,"Merck & Co., Inc.’s Rally Could Burn Investors ||| Cancer Space Update: Label Expansions, Data Readouts in Focus ||| Will J&J's (JNJ) Pharma Segment Pull Up its Q4 Earnings? ||| Here's Why Nektar Stock Skyrocketed Almost 500% in a Year ||| Will Johnson & Johnson's Pharma Segment Pull Up Its Q4 Earnings? ||| Merck Reports First-Time Data For KEYTRUDA In Patients With Previously-Treated Advanced HCC: 'showed an overall response rate (ORR) of 16.3 percent (95% CI, 9.8-24.9) (n=17/104) with KEYTRUDA as monotherapy' ||| Merck Reports LYNPARZA For Treatment Of Advanced Ovarian Cancer Received Approval In Japan",0,0.47404963
2018-01-22,12247500.0,60.95000076293945,61.43999862670898,60.720001220703125,61.25,56.92596435546875,MRK,"Bristol-Myers (BMY) Reports Data from CheckMate-142 Study ||| Merck Reports Positive Phase III Liver Cancer Data on Keytruda ||| Healthcare ETFs to Watch As Q4 Earnings Unfold ||| Foreign Stock Roundup: Taiwan Semiconductor Beats, Shell Buys Stake in Silicon Ranch ||| Will These 4 Large-Cap Drug Stocks Be Big Winners This Earnings Season? ||| Noteworthy ETF Inflows: SPYV, MRK, DIS, PNC ||| Will These 4 Large-Cap Drug Stocks Be Big Winners This Earnings Season?",1,0.50439775
2018-01-23,11181500.0,61.02999877929688,62.130001068115234,60.869998931884766,61.70000076293945,57.344200134277344,MRK,"3 Large Cap Pharma Stocks to Beat Earnings This Quarter ||| Seattle Genetics' Adcetris Gets EU Nod for Label Expansion ||| The Zacks Analyst Blog Highlights: Alexion Pharmaceuticals, Celgene, AbbVie and Merck ||| Merck a Top Socially Responsible Dividend Stock With 3.1% Yield (MRK) ||| Should J&J Spin Off Its Consumer Business? ||| Biotech M&A Off To A Strong Start In 2018: More Deals To Follow?",0,0.53212494
2018-01-24,13482100.0,62.0099983215332,62.11000061035156,60.959999084472656,61.18000030517578,56.86090087890625,MRK,"Is a Beat in the Cards for AbbVie (ABBV) in Q4 Earnings? ||| The Zacks Analyst Blog Highlights: AbbVie, Merck & Co. and AstraZeneca",1,0.49278614
2018-01-25,9402300.0,61.29999923706055,61.380001068115234,60.95000076293945,61.29999923706055,56.97243118286133,MRK,Pfizer's Rituxan Biosimilar Meets Endpoint in Phase III ||| Will Pfizer (PFE) Surpass Estimates This Earnings Season?,1,0.47779185
2018-01-26,10553700.0,61.4900016784668,62.08000183105469,61.34000015258789,62.040000915527344,57.66019058227539,MRK,Seattle Genetics Adcetris Performs Well Despite Competition,0,0.5183086
2018-01-29,8776900.0,61.95000076293945,62.13999938964844,61.560001373291016,61.630001068115234,57.27913665771485,MRK,"Lilly (LLY) to Report Q4 Earnings: What's in the Cards? ||| The Week Ahead: Big Tech Earnings, Fed Rate Decision Likely To Dominate Headlines ||| PFE, LLY, MRK Write Up 'Scripts For Q4 ||| Fed, Earnings Are Meaty Filling Between Slices Of Job, Price Data",0,0.47817454
2018-01-30,13040700.0,60.790000915527344,61.25,60.43999862670898,60.650001525878906,56.36832427978516,MRK,"10 Retirement Stocks That You Should Already Own ||| Pfizer (PFE) Stock Falls Despite Q4 Earnings & Sales Beat ||| Notable ETF Inflow Detected - VT, DIS, RDS.A, MRK ||| After Hours Most Active for Jan 30, 2018 : ETP, MSFT, ETE, FE, EPD, MRK, T, CSCO, INTC, QQQ, GILD, FB ||| Can Merck (MRK) Deliver a Positive Surprise in Q4 Earnings? ||| Hang On: Rate Fears In Focus As Futures Point Lower After Monday's Big Losses",0,0.45370752
2018-01-31,14869000.0,60.77000045776367,60.79999923706055,58.900001525878906,59.25,55.06715393066406,MRK,"Will Bristol-Myers' (BMY) Q4 Earnings Exceed Expectations? ||| Dow Movers: MRK, BA ||| Dow Leads In Tight Finish; Video Gamers Clear Buy Points",1,0.5000111
2018-02-01,13368000.0,59.16999816894531,60.34000015258789,59.06999969482422,59.86000061035156,55.63409423828125,MRK,"Dow Movers: GE, MRK ||| Why Merck (MRK) Might Surprise This Earnings Season ||| Merck vs. Sanofii: Which Stock Is Better Pre-Q4 Earnings? ||| Pre-Market Earnings Report for February 2, 2018 : XOM, CVX, MRK, CHTR, PSX, LYB, AON, EL, ROP, WY, IMO, S ||| Jobs Data, Big Oil's Earnings To Drive Market: Investing Action Plan",0,0.46252668
2018-02-02,12264100.0,59.40999984741211,59.970001220703125,58.27999877929688,58.560001373291016,54.425872802734375,MRK,"Jobs Report Hits 200K, Unemployment 4.1%; Plus More Q4 Earnings ||| Here's What Pfizer's Saying About Its Future ||| Health Care Sector Update for 02/02/2018: JNJ, PFE, ABT, MRK, AMGN, OPGN, TGTX, AZN, MRK, TEVA ||| Merck (MRK) Beats on Q4 Earnings, Lags Sales, Guides for '18 ||| Job Data Upbeat, Tech Companies Post Modest Q4 Earnings ||| Merck Company Inc. (MRK) Q4 2017 Earnings Conference Call Transcript ||| Merck Sales Miss, But Earnings, 2018 Revenue Outlook Strong ||| Merck (MRK) Tops on Q4 Earnings, Misses Sales, Stock Up ||| Earnings Reaction History: Merck & Co. Inc., 36.4% Follow-Through Indicator, 1.7% Sensitive ||| Gilead's (GILD) HCV Segment to Decline Further in Q4 Earnings? ||| Health Care Sector Update for 02/02/2018: TGTX,OPGN,AZN,TEVA,MRK ||| Close Update: Wall Street Crushed By Earnings, Rising Bond Yields as Dow Plunges 660 Points ||| Merck Sees FY18 Adj. EPS $4.08-$4.23 vs $4.11 Est., Sales $41.2B-$42.7B vs $41.1B Est. ||| Merck Reports Q4 Adj. EPS $0.98 vs $0.94 Est., Sales $10.4B vs $10.49B Est. ||| 12 Stocks To Watch For February 2, 2018 ||| Earnings Scheduled For February 2, 2018",0,0.46318248
2018-02-05,19605700.0,58.27000045776367,58.95000076293945,55.81999969482422,56.400001525878906,52.41836166381836,MRK,"3 Headwinds in Q4 Earnings Results That Make Merck a Mediocre Stock ||| The Future of Merck & Co., Inc. Stock Is With Keytruda",0,0.5132661
2018-02-06,31006200.0,55.13999938964844,56.77000045776367,54.33000183105469,55.459999084472656,51.544715881347656,MRK,"Bristol-Myers' Opdivo/Yervoy Combo Positive in Cancer Study ||| Dow Movers: MRK, CVX ||| Either Analysts Got The Components Wrong or The Dow Headed 12% Higher ||| Leerink Swann Maintains Market Perform on Merck & Co, Lowers Price Target to $67.00",1,0.5063941
2018-02-07,13692500.0,55.16999816894531,56.709999084472656,55.09000015258789,55.880001068115234,51.93506240844727,MRK,"Pfizer Inc. Stock Hurt by Dwindling Revenue Growth Prospects ||| Seattle Genetics (SGEN) Q4 Earnings & Revenues Top Estimates ||| Sanofi (SNY) Q4 Earnings Lag on Weak Diabetes/Vaccines Sales ||| Gilead (GILD) Beats on Q4 Earnings, 2018 View Lacks Lustre",0,0.44141403
2018-02-08,20870000.0,56.040000915527344,56.459999084472656,54.709999084472656,54.72999954223633,50.86625671386719,MRK,Glaxo (GSK) Earnings and Revenues Surpass Estimates in Q4 ||| The Alzheimer's Drug Pipeline: High Failure Rates In Research On An Increasingly Common Disease,1,0.51448566
2018-02-09,18580500.0,55.150001525878906,55.40999984741211,53.36000061035156,54.869998931884766,50.99637222290039,MRK,"Solid Q4 Earnings Drive Pharma ETF Outlook ||| Top Analyst Reports for Merck, Goldman Sachs & Tesla",1,0.51921433
2018-02-12,12652200.0,55.34999847412109,55.88999938964844,54.959999084472656,55.43000030517578,51.51683044433594,MRK,"ImmunoGen (IMGN) Q4 Loss Wider Than Expected, Revenues Grow ||| The Zacks Analyst Blog Highlights: Merck, Goldman Sachs, Tesla, T-Mobile and Activision",0,0.48817533
2018-02-13,17039400.0,55.22999954223633,55.369998931884766,54.77000045776367,54.900001525878906,51.02425003051758,MRK,"Pfizer Announces FDA Acceptance of NDA for NSCLC Candidate ||| After Hours Most Active for Feb 13, 2018 : GE, MRK, HPQ, BAC, LC, EVTC ||| Merck Discontinues Alzheimer's MK-8931 Study, Unlikely That Positive Benefit/Risk Could Be Established ||| DZ Bank Upgrades Merck & Co to Buy",0,0.45310867
2018-02-14,11446700.0,54.310001373291016,55.09999847412109,54.220001220703125,54.900001525878906,51.02425003051758,MRK,"What To Expect From Roche In 2018 ||| Can ImmunoGen's Key Ovarian Cancer Candidate Drive Growth? ||| Merck (MRK) Halts Another Late Stage Study on Alzheimer's ||| Cramer Looks At The Dow's Biggest Losers ||| BMO Capital Maintains Outperform on Merck & Co, Lowers price target to $65.00 ||| Credit Suisse Maintains Outperform on Merck & Co, Lowers price target to $65.00",1,0.49770892
2018-02-15,10099900.0,55.43000030517578,55.9900016784668,54.83000183105469,55.9900016784668,52.03730010986328,MRK,"Notable ETF Inflow Detected - VTV, VZ, DWDP, MRK ||| Why Biogen May Seek A Merger In The Wake Of Alzheimer's Worries ||| Incyte (INCY) Beats on Q4 Revenues on Strong Jakafi Sales ||| 4 Dow Jones Heavyweights That Are Still on the Ropes ||| Merck Reports Co., AstraZeneca Won Orphan Drug Designation By FDA For Selumetinib For Treatment Of NF1 ||| AstraZeneca Says Selumetinib Granted Orphan Drug Designation by FDA for Neurofibromatosis Type 1",1,0.5215959
2018-02-16,11731300.0,55.970001220703125,56.9900016784668,55.91999816894531,56.290000915527344,52.31612014770508,MRK,"FDA Sets the Stage for Earlier-Stage Alzheimer's Treatments ||| How Much Is Roche's Phase 3 Drug Pipeline Worth? ||| Nektar, Bristol-Myers Tie-Up for Cancer Combos Drives Stock (Revised)",0,0.48359236
2018-02-20,13467000.0,56.119998931884766,56.13999938964844,54.95000076293945,54.97999954223633,51.09860610961914,MRK,"AstraZeneca's (AZN) Imfinzi Gets FDA Nod for Label Expansion ||| Can Bristol-Myers Squibb Squeeze $3.6 Billion From Its Nektar Therapeutics Deal? ||| How Are Roche's Revenues And Earnings Likely To Change Over The Next Five Years? ||| Gilead, Merck Quiet As Traders Circulate Reuters Article From Feb. 17th Titled 'Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict'",0,0.5076196
2018-02-21,10729900.0,55.02999877929688,55.43999862670898,54.54999923706055,54.54999923706055,50.69895553588867,MRK,"Eyes on the Fed as Stocks Point to Flat Opening ||| Health Care Sector Update for 02/21/2018: MRK, UTHR, MDCO, BHVN, BRKR, CELG, JUNO, CTLT ||| What's in Store for Agenus (AGEN) This Earnings Season? ||| Health Care Sector Update for 02/21/2018: UTHR,MRK ||| Merck to Acquire Viralytics for ~$394M",1,0.45761305
2018-02-22,10815800.0,54.59999847412109,55.06999969482422,54.41999816894531,54.56999969482422,50.717552185058594,MRK,Merck to Buy Australian Firm to Boost Immunotherapy Pipeline ||| How Much Has Roche Paid In Dividends Over The Last Five Years?,1,0.5149642
2018-02-23,9064100.0,54.81999969482422,55.0,54.56999969482422,54.869998931884766,50.99637222290039,MRK,"Dow 30 Stock Roundup: Walmart Disappoints, Coca-Cola Impresses ||| Pharma Stock Roundup: AZN's Imfinzi Gets 2nd FDA Nod, MRK to Buy Australian Firm ||| Pharma Stock Roundup: AstraZeneca, Merck, AbbVie And More ||| Merck, AstraZeneca Reports LYNPARZA Received Positive EU CHMP Opinion In Platinum-Sensitive Relapsed Ovarian Cancer",1,0.49329585
2018-02-26,12142200.0,55.0,56.18999862670898,55.0,56.060001373291016,52.10235977172852,MRK,"The Zacks Analyst Blog Highlights: Walmart, Chevron, ExxonMobil, Travelers and Merck ||| After Hours Most Active for Feb 26, 2018 : BAC, CTL, FIT, ORCL, PCG, MRK",0,0.4735534
2018-02-27,9288600.0,55.90999984741211,55.959999084472656,54.70000076293945,54.720001220703125,50.85695266723633,MRK,"Exelixis (EXEL) Q4 Earnings Meet Estimates, Revenues Beat ||| 10 Retirement Stocks That You Should Already Own ||| Exelixis (EXEL) Q4 Earnings Meet Estimates, Revenues Beat (revised) ||| 3 Top Pharma Stocks With Dividend Yields Over 3%",0,0.4857923
2018-02-28,11266800.0,55.060001373291016,55.16999816894531,54.209999084472656,54.220001220703125,50.39225769042969,MRK,5 Reasons Why Pfizer (PFE) Could be a Great Pick in 2018,0,0.4944489
2018-03-01,13023400.0,54.2599983215332,54.810001373291016,53.41999816894531,53.70000076293945,49.908966064453125,MRK,"Bayer (BAYRY) Q4 Earnings Beat Estimates, Sales Down Y/Y ||| Intangibles Hold the Key to Valeant Pharmaceuticals Intl Inc Stock",1,0.51449114
2018-03-02,8927200.0,53.47999954223633,54.43000030517578,53.119998931884766,54.36000061035156,50.52237319946289,MRK,"Nektar (NKTR) Q4 Loss Narrower Than Expected, Sales Soar Y/Y ||| Horizon Pharma (HZNP) Tops Q4 Earnings, Provides 2018 View",1,0.49756193
2018-03-05,13114100.0,54.2400016784668,54.709999084472656,54.08000183105469,54.400001525878906,50.559547424316406,MRK,Merck (MRK) Down 9.2% Since Earnings Report: Can It Rebound? ||| Merck (MRK) Down 9.2% Since Earnings Report: Can It Rebound? ||| 7 Biotech Stocks With Clinical Trial Outcomes In March,0,0.5012173
2018-03-06,9271900.0,54.4900016784668,54.709999084472656,53.81999969482422,54.29999923706055,50.466609954833984,MRK,AstraZeneca's Forxiga Label Expansion Filing Accepted in EU,1,0.52725756
2018-03-07,12230500.0,53.84000015258789,54.58000183105469,53.75,54.470001220703125,50.624610900878906,MRK,"Top Research Reports for Merck, McDonald's & Broadcom ||| Pharmaceutical Industry Outlook - March 2018 ||| Eisai, Merck Report Global Strategic Oncology Collaboration For LENVIMA, Will Jointly Develop, Commercialize ||| Height Casts 65% Odds That Congress Rolls Back Pharma Discounts",1,0.51202863
2018-03-08,7352100.0,54.52000045776367,54.81999969482422,54.36000061035156,54.7599983215332,50.894134521484375,MRK,"3 Dow Stocks You Had No Idea Were Testing Blockchain Technology ||| Zacks Industry Outlook Highlights: Sanofi, Celgene, Bioverativ, Juno and Merck ||| The Zacks Analyst Blog Highlights: Merck, McDonald's, Broadcom, Activision and Marvell ||| Merck to Pay $300M Upfront to Co-Develop Eisai's Cancer Drug",1,0.5149212
2018-03-09,8816800.0,55.02999877929688,55.18999862670898,54.70000076293945,55.13999938964844,51.24730682373047,MRK,"Zacks Industry Outlook Highlights: Sanofi, Celgene, Bioverativ, Juno and Merck ||| 'Pharma Bro' Martin Shkreli Gets 7 Years In Prison For Securities Fraud",1,0.5061406
2018-03-12,10752900.0,55.72999954223633,56.130001068115234,55.2400016784668,55.36000061035156,51.451778411865234,MRK,"Immutep Announces Clinical Trial Collaboration and Supply Agreement With Merck to Evaluate Combination of IMP321 with Keytruda ||| How Convenience Can Give Drugmakers a Competitive Edge ||| The Market In 5 Minutes: Coincheck, Gun Violence, Oil And More",1,0.51978165
2018-03-13,11710000.0,55.7400016784668,55.75,55.0,55.369998931884766,51.4610710144043,MRK,"AstraZeneca's Final Data From Key Lung Cancer Study Delayed ||| Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for March 14, 2018 ||| Health Care Sector Update for 03/13/2018: ABBV, BLCM, EPZM, MRK ||| Health Care Sector Update for 03/13/2018: ABBV,NBIX,EPZM,BLCM,MRK ||| Health Care Sector Update for 03/13/2018: EPZM,BLCM,MRK ||| Merck's Supplemental Biologics License Application for KEYTRUDA Granted Priority Review by the FDA for Treatment of Advanced Cervical Cancer",0,0.45289066
2018-03-14,11156700.0,55.27000045776367,55.43000030517578,54.310001373291016,54.79999923706055,51.37668991088867,MRK,"Merck's Keytruda Gets Priority Review for Cervical Cancer ||| Noteworthy Wednesday Option Activity: MRK, FEYE, ASIX",1,0.5087799
2018-03-15,10076600.0,54.95000076293945,55.72999954223633,54.88999938964844,55.25,51.79858016967773,MRK,"Notable ETF Inflow Detected - HDV, VZ, MRK, PEP ||| Jim Cramer Shares His Thoughts On Merck, Five Below And More",1,0.4922845
2018-03-16,21002500.0,55.18999862670898,55.84999847412109,55.08000183105469,55.66999816894531,52.19234848022461,MRK,"Pharma Stock Roundup: ABBV's Elagolix Meets Study Goal, MRK's Keytruda in Focus ||| Agenus (AGEN) Q4 Loss Wider Than Expected, Revenues Miss ||| Should Value Investors Pick Merck & Co. (MRK) Stock Now? ||| Dow 30 Stock Roundup: Boeing JV Wins $354M Satellite Contract, Merck's Keytruda Gets Priority Review",0,0.475415
2018-03-19,11824200.0,55.65999984741211,55.68000030517578,54.2400016784668,54.630001068115234,51.21731185913086,MRK,"Immune Design Poised on Progress of Pipeline Candidates ||| 10 Can’t-Miss Dividend Hikes Coming This April ||| Health Care Sector Update for 03/19/2018: CDTX,MDWD,GERN,REGN",1,0.4828194
2018-03-20,7780000.0,54.75,54.93999862670898,54.36000061035156,54.63999938964844,51.226680755615234,MRK,Roche Tecentriq Phase III Combo Study Meets Primary Endpoint ||| Checking In On The Healthcare Sector Ahead Of Q1 Earnings Season,1,0.5266721
2018-03-21,10009300.0,54.7599983215332,55.27999877929688,54.41999816894531,54.68999862670898,51.2735595703125,MRK,Seattle Genetics' Adcetris Gets FDA Nod for Label Expansion ||| European Stocks in the Red Amid Mixed Earnings Results,0,0.5173294
2018-03-22,12774800.0,54.2400016784668,54.97999954223633,54.02999877929688,54.119998931884766,50.73917388916016,MRK,Merck Gets European Committee Vote for Veterinary Product,0,0.52379376
2018-03-23,11840300.0,54.31999969482422,54.709999084472656,53.34000015258789,53.40999984741211,50.073524475097656,MRK,"Better Buy: Johnson & Johnson vs. Merck ||| Merck Announces Anticancer Agent Lenvima Approved for Additional Indication of Unresectable HCC in Japan,",1,0.5354785
2018-03-26,9970200.0,54.04999923706055,54.15999984741211,52.970001220703125,54.040000915527344,50.66416549682617,MRK,"Is Merck & Co. Inc. a Buy? ||| Dow Movers: GE, MSFT ||| Glaxo Drops Bid for Pfizer Unit, Shingrix Gains EU/Japan Nod ||| Merck, Eisai Get Japanese Nod for Lenvima Label Expansion ||| 3 Bear Trades on the Verge of Big-League Breakdowns ||| Roche's Tecentriq Combo Study Meets Co-Primary Endpoint ||| Stocks That Made New 52-Wk Lows Today Include: Charter Comms., Vornado Realty, Colgate-Palmolive, Merck, Hasbro, Ventas, Dentsply Sirona, Johnson Controls, Goodyear Tire, Clorox, GE, Kinder Morgan, Comcast, DISH Network, Stericycle and Patterson Cos. ||| The Week Ahead In Biotech: Earnings, PDUFA Dates And More",0,0.48803428
2018-03-27,16179900.0,53.9900016784668,54.560001373291016,53.470001220703125,53.75,50.39228439331055,MRK,Dow Analyst Moves: MRK ||| Roche Takes Aim at Bristol-Myers Squibb and Merck & Co. ||| Merck Reports Received Fast-Track Designation For Tepotinib In NSLCL In Japan,1,0.5132925
2018-03-28,12693500.0,54.04999923706055,55.34000015258789,54.02000045776367,55.09000015258789,51.648582458496094,MRK,"FDA Nods for Bristol-Myers' Colorectal Cancer Combo Therapy ||| Merck KGaA's Tepotinib Gets Fast Track Designation in Japan ||| Forget Merck: Novavax, Inc. Is a Better Vaccine Stock ||| Market Close Report: NASDAQ Composite index closes at 6,949.23 down -59.58 points ||| Close Update: Wall Street Slips Underwater as Tech Sector Weighs ||| Stocks Lower As Amazon Sinks Nasdaq ||| What Knocked ImmunoGen, Inc. Down 15% on Tuesday?",0,0.4893466
2018-03-29,9750500.0,55.36000061035156,55.40999984741211,54.470001220703125,54.470001220703125,51.06731033325195,MRK,"Dow 30 Stock Roundup: Apple's New iPad, Japanese Label Expansion for Merck/ Eisai's Lenvima",0,0.50588834
2018-04-02,13398000.0,54.400001525878906,54.650001525878906,52.959999084472656,53.27000045776367,49.9422721862793,MRK,"The Week Ahead In Biotech: PDUFA Dates, Clinical Trials And Conferences ||| Fast Pipeline Progress Pushes ImmunoGen Above 150% in a Year ||| Health Care Sector Update for 04/02/2018: MYGN,MNOV,RDUS ||| The Week Ahead: Switch's Lockup Expires, Spotify Debuts, And More ||| What's NeuVax? Wainwright Says Sellas' Cancer Vaccine Candidate Makes It A Buy",1,0.49278566
2018-04-03,9244600.0,53.34000015258789,54.150001525878906,52.83000183105469,54.09000015258789,50.71104431152344,MRK,"Aeglea Initiates Lung Cancer Combination Study With Keytruda ||| 4 Dow Titans That Could Slap the Mat ||| Stocks That Made New 52-Wk Lows Today Include: Incyte, Merck, Mallinckrodt, Celgene, Cerner, Willams Cos., AMD, Albemarle, Kinder Morgan, Western Union, Walgreens, Kraft Heinz, Nielsen, and Alliance Data Systems ||| Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates ||| REMINDER: Merck Has FDA PDUFA Date Today For Keytruda sBLA in Primary Mediastinal Large B-Cell Lymphoma ||| AstraZeneca, Merck Announces EMA Accepts Regulatory Submission for LYNPARZA in BRCA-Mutated HER2-Negative Metastatic Breast Cancer",1,0.49144724
2018-04-04,8902700.0,53.470001220703125,54.68999862670898,53.400001525878906,54.540000915527344,51.132938385009766,MRK,AstraZeneca's (AZN) Bydureon Gets FDA Nod for Expanded Use,0,0.5211446
2018-04-05,12475800.0,55.060001373291016,55.380001068115234,54.43999862670898,54.52999877929688,51.1235580444336,MRK,"Merck Spokesperson Tells Benzinga FDA Postponed PDUFA Date On sBLA For Keytruda In Mediastinal B-Cell Lymphoma To July 3rd After Co. Submitted Add'l Data; PDUFA Decision Was Originally Scheduled For April 3rd ||| Recro Pharma CEO Talks Non-Opioid Pain Management Opportunity, CDMO Business ||| Benzinga's Top Upgrades, Downgrades For April 5, 2018 ||| Barclays Upgrades Merck & Co to Overweight",0,0.49753124
2018-04-06,12500800.0,54.27999877929688,54.58000183105469,52.900001525878906,53.36000061035156,50.026641845703125,MRK,"Mid-Day Update: Stocks Sell-Off As New Tariffs Rattle Wall Street ||| Incyte Corporation Stock Plunges on Melanoma Drug Trial Failure ||| Health Care Sector Update for 04/06/2018: INCY, MRK, CDXS, MNKD, ACRS, CPHR ||| Incyte's Horrible News Derails a Promising Class of Cancer Drugs ||| Close Update: Wall Street Snaps Three-Day Winning Streak as Trade Woes Resurface ||| Health Care Sector Update for 04/06/2018: INCY,MRK,ACRS,CDXS,MNKD ||| Why Incyte and NewLink Genetics Crashed Today ||| Morning Movers: Are Tariffs a Game of Bluff? ||| Futures Lose Ground as Trade War Heats Up, Jobs Data Misses Mark ||| Incyte Falls 20% After Cancer Drug Fails Phase 3 Trial ||| UPDATE: Incyte Shares Down 20.5% After its Phase 3 ECGI-301/KEYNOT-252 Study With Merck Did Not Meet the Primary Endpoint ||| 'The first real test of the cancer immunotherapy combination thesis fails. $INCY $MRK' -Adam Feuerstein Tweet ||| Incyte and Merck Says Phase 3 ECHO-301/KEYNOTE-252 Study Did Not Meet The Primary Endpoint Of Improving Progression-Free Survival",1,0.48363903
2018-04-09,23237000.0,55.0,57.41999816894531,54.560001373291016,56.15999984741211,52.651737213134766,MRK,"We Did The Math USMV Can Go To $58 ||| Incyte's Epacadostat Fails in Melanoma Study, Shares Plunge ||| NewLink Shares Plunge After Incyte & Merck's Study Fails ||| US Stocks Rally as Tech Sector Logs Gains; Inflation Data in Focus ||| Dow Movers: PG, MRK ||| Health Care Sector Update for 04/09/2018: MRK, MNLO, APOP, IONS ||| Noteworthy Monday Option Activity: MRK, DDD, ISRG ||| Health Care Sector Update for 04/09/2018: AVXS,NVS,IONS,AZN,MRK,MNLO ||| Health Care Sector Update for 04/09/2018: IONS,AZN,MRK,MNLO ||| Why Alcoa, Merck, and Agios Pharmaceuticals Jumped Today ||| Market Close Report: NASDAQ Composite index closes at 6,950.34 up 35.23 points ||| Dow Backs Down from 440-Point Gain as Volatile Trading Continues ||| 31 Stocks Moving In Monday's Mid-Day Session ||| Cantor Fitzgerald Double Downgrades NewLink Genetics After Incyte's Disappointing Trial ||| 20 Stocks Moving In Monday's Pre-Market Session ||| A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street ||| Merck Reports its KEYTRUDA Monotherapey Met its Primary Endpoint in the Phase 3 KEYNOTE-042 Study",1,0.48473945
2018-04-10,12864400.0,56.68000030517578,56.790000915527344,56.040000915527344,56.4900016784668,52.96111679077149,MRK,vTv Therapeutics Crashes on Alzheimer's Drug Study Failure ||| 40 Biggest Movers From Yesterday,0,0.510424
2018-04-11,9013200.0,56.060001373291016,56.540000915527344,55.88999938964844,56.20000076293945,52.689239501953125,MRK,Pfizer's Kidney Cancer Drug Misses Endpoint in Phase III ||| Is Beaten-Down Incyte Corporation Stock a Buy Now? ||| PreMarket Prep Opening NYSE Imbalance Update: Pfizer 149k Shares To Buy: ExxonMobil 81k Shares To Buy; Merck 50k Shares To Buy; General Electric 114k Shares To Sell; Ford 42k Shares To Buy,1,0.47258982
2018-04-12,11938900.0,56.59999847412109,57.18999862670898,56.13999938964844,56.7400016784668,53.19550323486328,MRK,"Nektar Starts Phase I/II Combo for Advanced Solid Tumors ||| Dow Movers: PG, INTC ||| XLV, PFE, MRK, AMGN: ETF Inflow Alert",1,0.5140062
2018-04-13,10053700.0,57.08000183105469,57.33000183105469,56.63999938964844,57.16999816894531,53.59864044189453,MRK,"Is J&J's (JNJ) Pharma Segment Likely to Drive Q1 Earnings? ||| Pharma Stock Roundup: NVS to Buy AveXis, PFE & ABBV's Drugs Succeed in Phase III ||| The Week Ahead In Biotech: PDUFA Dates, IPOs And More ||| Mylan Shares Quiet Premarket; Co. Looking For Deal For Merck's Consumer Products Unit",1,0.5180968
2018-04-16,22545800.0,57.77000045776367,59.25,57.16999816894531,58.650001525878906,54.98618698120117,MRK,"Venture Capital Deals Of The Week: Tencent Led $3B Investment ||| Merck Announces KEYTRUDA Reduced Risk of Disease Recurrence or Death by More than 40% vs Placebo as Adjuvant Therapy in Resected, High-Risk Stage III Melanoma ||| Dow Movers: DIS, MRK ||| Merck's Keytruda Reduces Death Risk in Melanoma Patients ||| 5 Trades to Make First Thing Tomorrow Morning ||| What Happened in the Stock Market Today ||| U.S. Stocks Finish Higher With Healthcare, Earnings in Focus ||| Dynavax Reports Interim Data for SD-101 in Combination with KEYTRUDA, Results Showed 'Encouraging Response Rates' ||| UPDATE: Merck Says KEYTRUDA Combination Improved Overall Survival in Patients Regardless of PD-L1 Expression, Including Patients Who Tested Negative for PD-L1 ||| Merck's KEYTRUDAPlus Pemetrexed and Platinum Chemotherapy Reduced the Risk of Death by Half Compared with Chemotherapy Alone as First-Line Treatment for Advanced Nonsquamous NSCLC in Phase 3 KEYNOTE-189 Study ||| Merck Sunday Announced Updated Overall Survival Data for LYNPARZA® (olaparib) in gBRCA-Mutated HER2-Negative Metastatic Breast Cancer Presented at #AACR18",1,0.5121663
2018-04-17,15334400.0,59.84000015258789,59.959999084472656,58.959999084472656,59.27000045776367,55.56745147705078,MRK,"J&J (JNJ) Tops Q1 Earnings Estimates, Raises Sales Guidance ||| Bristol-Myers (BMY) Down as Merck NSCLC Study Fares Better ||| Merck (MRK) Shares Cross Above 200 DMA ||| Company News For Apr 17, 2018 ||| Merck's Keytruda Betters Survival in Lung Cancer Combo Study ||| 10 Retirement Stocks That You Should Already Own ||| Stocks Push Forward As Fears of War Diminish ||| One Up, One Down: Morgan Stanley Flips Merck, Bristol-Myers Ratings ||| Stock Market Gets Lift From Earnings As Geopolitical Fears Wane ||| Benzinga's Top Upgrades, Downgrades For April 17, 2018 ||| Merck Announces First Phase Three Studies for PCV-15 (V114) Its Investigational Pneumococcal Disease Vaccine ||| Morgan Stanley Upgrades Merck & Co to Overweight ||| Morgan Stanley Upgrades Merck to Overweight from Equal Weight; Raises PT to $68 from $63",0,0.46372363
2018-04-18,11240200.0,59.40999984741211,59.619998931884766,58.59000015258789,58.91999816894531,55.23931121826172,MRK,"Benzinga's Top Analyst Calls From April 18, 2018",0,0.5054104
2018-04-19,10535500.0,58.91999816894531,59.31999969482422,58.41999816894531,58.63999938964844,54.976810455322266,MRK,"Stock Market Seems Directionless, Volatility Low As Investors Await News",1,0.506422
2018-04-20,9646900.0,58.86000061035156,59.27000045776367,58.65999984741211,58.83000183105469,55.15494918823242,MRK,"What's in the Cards for Glaxo (GSK) This Earnings Season? ||| Lilly (LLY) to Report Q1 Earnings: What's in the Cards? ||| Dow Movers: AAPL, GE ||| J&J, Novartis' Q1 Earnings Impress: Will Others Follow Suit? ||| AstraZeneca Shares Are Looking Very Weak Right Now",1,0.49580932
2018-04-23,19816400.0,60.04999923706055,60.619998931884766,59.43000030517578,60.25,56.48623275756836,MRK,"Midday Update: Wall Street Keeping Cautious Eye on 10-Yr Treasury Yield ||| Q1 Earnings Surprise Well in Cards: Healthcare ETFs to Buy ||| Noteworthy ETF Inflows: SPTM, T, MRK, MA ||| Dow Movers: INTC, MRK ||| Market Close Report: NASDAQ Composite index closes at 7,128.60 down -17.53 points ||| Stocks Finish Lower as Treasury Yield Edges Near 3% ||| U.S. Stocks Waver Between Gains and Losses as Investors Watch Bond Yields, Earnings ||| Health Care Sector Update for 04/23/2018: DRNA,ALNY,HSIC,BHVN,AKRX,FMS ||| Merck Reports EMA Validated Type II Variation For Co.'s KEYTRUDA In Combo With Pemetrexed, Platinum Chemotherapy As First-Line Therapy In Metastatic Nonsquamous NSCLC ||| Keytruda Is Key To The Merck Thesis, Goldman Sachs Says In Upgrade ||| Benzinga's Top Upgrades, Downgrades For April 23, 2018 ||| Goldman Sachs Upgrades Merck & Co to Buy",0,0.49307454
2018-04-24,13334900.0,60.40999984741211,61.0,59.77000045776367,60.09000015258789,56.33623123168945,MRK,Get Paid While You Wait: 3 Top Dividend Stocks in Big Pharma ||| The Treasury Yield Is Trembling on the Edge of 3%,0,0.501318
2018-04-25,13413200.0,59.900001525878906,59.91999816894531,58.93000030517578,59.630001068115234,55.90497589111328,MRK,Will Pfizer's (PFE) Earnings Beat Estimates Again in Q1? ||| What's in the Cards for Merck (MRK) This Earnings Season? ||| Lessons to Learn From April's Biotech Blowups,0,0.48286906
2018-04-26,13500100.0,59.81999969482422,60.09000015258789,59.11000061035156,59.40999984741211,55.698707580566406,MRK,"Glaxo (GSK) Q1 Earnings Lag, Shingrix Vaccines Sales Solid ||| Merck vs. Pfizer: Which Stock is Better Before Q1 Earnings? ||| Earnings Preview: Oil Giants Chevron And ExxonMobil Report Friday Morning",1,0.48380277
2018-04-27,7666100.0,59.34000015258789,59.650001525878906,59.310001373291016,59.470001220703125,55.75495529174805,MRK,"Seattle Genetics (SGEN) Q1 Earnings Lag Estimates, Sales Top ||| Sanofi's (SNY) Earnings Beat Estimates in Q1, Sales Miss Mark ||| Is Bristol-Myers Squibb Stock a Buy After Its Mixed Q1 Results? ||| HIV Segment to Aid Gilead (GILD) Beat Q1 Earnings Estimates? ||| Upcoming Earnings: McDonald's Reports On Monday As It Continues On New Growth Plan ||| BMO Sees Balanced Risk-Reward In Bristol-Myers, Takes Neutral Position",0,0.50690925
2018-04-30,13101400.0,59.650001525878906,59.97999954223633,58.869998931884766,58.869998931884766,55.19244003295898,MRK,"The Week Ahead In Biotech: PDUFA Dates, Clinical Trials, Merck And Pfizer Earnings On Tap ||| Health Care Sector Update for 04/30/2018: AGN, STDY, UTHR, MOH, MRK ||| Will Agenus (AGEN) Disappoint Investors This Earnings Season? ||| Drug Stocks Q1 Earnings to Watch on May 1: PFE, MRK & More ||| Pre-Market Earnings Report for May 1, 2018 : PFE, MRK, AMT, AET, EMR, ECL, BP, MPC, HCA, ETN, JCI, FIS ||| Health Care Sector Update for 04/30/2018: STDY, UTHR, MRK, AGNCB ||| Gilead (GILD) 1st Quarter Earnings: What to Expect ||| Ramp Up In Opdivo And Eliquis Sales Bolsters Bristol-Myers Squibb's Q1 Earnings ||| Notable Monday Option Activity: NVDA, CLX, MRK ||| The Week Ahead: Tesla And Apple Earnings, Dropbox Quiet Period Expires, Fed Rate Decision And More ||| Upcoming Earnings: Tech Giant Apple Reports After Tuesday's Close ||| Pharmaceutical Earnings: Pfizer And Merck Are Slated To Report Tuesday Morning ||| Busy Week Begins With McDonald's Beating Estimates; Fed Meeting, Jobs Data Loom ||| Merck is Granted Priority Review of its sBLA for KEYTRUDA in Combination with Pemetrexed and Platinum Chemotherapy",0,0.47760135
2018-05-01,13126700.0,59.0,59.2400016784668,56.880001068115234,57.97999954223633,54.358036041259766,MRK,"Pfizer (PFE) Stock Falls on Q1 Sales Miss, Earnings Beat ||| Merck Company Inc. (MRK) Q1 2018 Earnings Conference Call Transcript ||| Amid Mixed News on Earnings, Merck & Co., Inc. (MRK) Stock Remains Steady ||| Merck (MRK) Beats on Q1 Earnings, Lags Sales, Raises Outlook ||| Jobs Week Shows New Wage Growth (and Lack Thereof) ||| Pfizer Inc. Stock Is Boring But Great for Your Portfolio’s Health ||| Incyte (INCY) Incurs Loss in Q1, Revenues Miss Estimates ||| ADP Job Data, Q1 Earnings In Focus ||| Dow Slides Before Apple Earnings; Dollar Gains Again ||| Health Care Sector Update for 05/01/2018: THC,AET,MRK,PFE ||| 3 Numbers That Should Grab Your Attention in Merck's Q1 Earnings ||| Health Care Sector Update for 05/01/2018: AET,MRK,PFE ||| Merck (MRK) Tops on Q1 Earnings, Misses Sales ||| Apple Results, Fed Decision, Jobs Report In Focus; Merck, Pfizer Reports Mixed ||| Benzinga Pro's 5 Stocks To Watch Today ||| Benzinga's Daily Biotech Pulse: Karyopharm's STORM Study, Inogen Rallies On Earnings ||| Merck Raises FY18 EPS Guidance From $4.08-$4.23 to $4.16-$4.28 vs $4.19 Est., Raises Sales From $41.2B-$42.7B to $41.8B-$43.0B vs $41.9B Est. ||| Merck Reports Q1 Adj. EPS $1.05 Beats $1.00 Est., Sales $10.04B Misses $10.10B Est. ||| 15 Stocks To Watch For May 1, 2018 ||| Earnings Scheduled For May 1, 2018",0,0.4409796
2018-05-02,10421600.0,57.68000030517578,58.0,57.02000045776367,57.29999923706055,53.72052001953125,MRK,"Stagnant Revenues Continue to Hamper the Growth of Pfizer Inc. ||| Company News for May 2, 2018 ||| Gilead (GILD) Q1 Earnings & Sales Miss Estimates on Weak HCV ||| Markets Await Confirmation of a June Rate Hike",1,0.5112247
2018-05-03,11321500.0,57.13999938964844,57.79999923706055,56.369998931884766,57.52999877929688,53.9361572265625,MRK,Exelixis (EXEL) Q1 Earnings & Sales Top on Cabometyx Strength ||| Moderna Snd Merck Expand mRNA Cancer Vaccines Collaboration ||| Merck Says Phase 3 KEYNOTE-407 Met A Pre-Specified Secondary Endpoint Related To Overall Response Rate In A Cohort Of Participants At An Interim Analysis,1,0.5135385
2018-05-04,8730900.0,57.119998931884766,57.90999984741211,56.83000183105469,57.75,54.14241027832031,MRK,"Aduro (ADRO) Q1 Loss Narrower Than Expected, Revenues Beat ||| Dow 30 Stock Roundup: AAPL, DWDP, CVX, MRK, MCD, PFE Beat on Earnings ||| Pharma Stock Roundup: Mixed Q1 for MRK, PFE, FDA Nod for Kymriah's 2nd Indication ||| Q1 Earnings Drag Pharma ETFs Down ||| Dow Movers: CAT, AAPL ||| PreMarket Prep Opening NYSE Imbalance Update: Alibaba 91k Shares To Sell; Merck 51k To Sell; Twitter 129k To Sell",0,0.4807294
2018-05-07,10032400.0,57.77000045776367,58.09999847412109,57.08000183105469,57.380001068115234,53.79552459716797,MRK,"Dow Posts Robust Daily Gains: 3 Top-Ranked Picks ||| Drug/Biotech Q1 Earnings Lineup on May 8: JAZZ, ARNA & More",0,0.49999937
2018-05-08,10257200.0,57.369998931884766,57.41999816894531,56.2599983215332,56.7599983215332,53.21425247192383,MRK,"7 Money-Making Stocks to Buy Now ||| Has Merck (MRK) Outpaced Other Medical Stocks This Year? ||| ImmunoGen Presses Forward ||| Agenus' (AGEN) Q1 Loss Wider than Expected, Shares Down ||| OncoSec Announces Clinical Collaboration with Merck to Evaluate Combination of ImmunoPulse IL-12 and KEYTRUDA for Triple Negative Breast Cancer ||| Jim Cramer Advises His Viewers On Prestige Brands, CVS Health And More ||| AstraZeneca and Merck Announce LYNPARZA Tablets Receive EU Approval for the Treatment of Platinum-Sensitive Relapsed Ovarian Cancer",1,0.5070507
2018-05-09,8286300.0,56.970001220703125,58.40999984741211,56.83000183105469,57.95000076293945,54.32991409301758,MRK,"VYM, VZ, MRK, AMGN: Large Inflows Detected at ETF ||| Johnson & Johnson Stock Looks Attractive on the Big Dip ||| Jim Cramer Gives His Opinion On Exxon Mobil, Pfizer And Cisco",1,0.485579
2018-05-10,8229100.0,58.130001068115234,58.72999954223633,57.93000030517578,58.060001373291016,54.43304061889648,MRK,"Horizon Pharma (HZNP) Q1 Earnings & Sales Miss, Shares Fall",1,0.51061493
2018-05-11,12733300.0,58.15999984741211,59.970001220703125,58.130001068115234,59.68999862670898,55.96122741699219,MRK,Merck vs. Pfizer: Which Stock Looks Better Post Q1 Earnings? ||| Trump Announces Plan to Reign In Drug Prices and Pharma Stocks Rally.,0,0.49658108
2018-05-14,9486700.0,59.77000045776367,60.08000183105469,59.43000030517578,59.68000030517578,55.951847076416016,MRK,"Is Agenus Inc. (AGEN) a Buy? ||| Better Buy: Pfizer Inc. (PFE) vs. Merck (MRK) ||| Will Trump's Surprise Drug Pricing Plan Boost Pharma Stocks? ||| Here's Why Aurinia Pharmaceuticals Inc. Is Surging Today ||| WHO Says 39 Cases Of Ebola Reported In Congo Outbreak So Far, Including 19 Deaths",0,0.46919057
2018-05-15,6821500.0,59.43999862670898,59.79999923706055,58.900001525878906,59.20000076293945,55.50182723999024,MRK,"Eli Lilly (LLY) to Buy AurKa Pharma, Expand Cancer Pipeline",1,0.5110019
2018-05-16,8531700.0,59.31999969482422,60.0099983215332,59.11000061035156,59.75,56.0174674987793,MRK,First Batch of Experimental Ebola Vaccine Arrives in Congo; Vaccinations Could Begin this Weekend,0,0.53839874
2018-05-17,7845800.0,59.540000915527344,59.77999877929688,58.880001068115234,59.06999969482422,55.37994766235352,MRK,"Investors Need to Adopt a Different Mindset for Big Pharma and Biotech Stocks ||| XLV, MRK, AMGN, GILD: ETF Inflow Alert ||| Roche Tecentriq Combo Achieves Longer Overall Survival Rate ||| The Zacks Analyst Blog Highlights: Home Depot, Merck, Raytheon, Eaton and Sun Life Financial ||| Syndax Pharmaceuticals Presents Updated Phase 2 Cancer-Drug Test Results ||| Amazon Roundup: Google Ads, Experience Centers, Alexa, Sears ||| WHO Says Will Convene Emergency Meeting On Fri. To Determine If Ebola Outbreak In Congo Is A Public Emergency Of Int'l. Concern ||| WHO Says Ebola Outbreak has Spread to DR Congo city",1,0.50730044
2018-05-18,9686300.0,58.959999084472656,59.459999084472656,57.4900016784668,59.13999938964844,55.44557571411133,MRK,"AstraZeneca's (AZN) Q1 Earnings & Sales Miss, Stock Down ||| Merck, Bristol Myers Shares Move On Alleged FDA Alert On Keytruda ||| WHO Official Says WHO Is Considering Using Mapp Biopharma's ZMapp Treatment For Ebola In Congo ||| Merck Shares Dip Lower, Bristol-Myers Squibb Shares Spike Higher Following FDA Alert On Issue Found In Trials Of Keytruda, Tecentriq ||| WHO Emergency Committee Says Ebola Outbreak In Congo Doesn't Yet Constitute A Public Health Emergency Of Intl. Concern ||| WHO Says Ebola Vaccinations In Congo Will Begin Sun. ||| WHO Raises Risk Assessment of Congo's Ebola Outbreak to 'Very High'",0,0.5265533
2018-05-21,8475400.0,59.18000030517578,59.31999969482422,58.38999938964844,58.56999969482422,54.91118240356445,MRK,"12 Dow 30 Companies With Above-Average Salaries ||| 4,000 Doses Of Ebola Vaccine Sent to Congolese City of Mbandaka on Saturday; Vaccination Campaign to Start Monday ||| Dow Movers: MRK, INTC ||| Market Close Report: NASDAQ Composite index closes at 7,394.04 up 39.70 points ||| Dow Tops 25K; Russell 2000 Hits Another High ||| Close Update: Wall Street Rallies on Cooling Trade War Rhetoric, M&A Cheer",0,0.5195005
2018-05-22,8928500.0,58.77999877929688,59.13999938964844,58.400001525878906,58.45000076293945,54.79868316650391,MRK,"Amgen's Label Expansion Application for Prolia Gets FDA Nod ||| Daily Dividend Report: MRK, HRL, CLX, ESS, KSS ||| Hearing A Suspected Ebola Case Is Being Treated At A Main Hospital In Congo's Capital City Kinshasa",1,0.520247
2018-05-23,9900400.0,58.45000076293945,59.4900016784668,58.43000030517578,59.16999816894531,55.47369766235352,MRK,7 S&P 500 Companies Doing Right for Employees ||| Merck's KEYTRUDA (pembrolizumab) Significantly Improved Overall Survival And Progression-Free Survival As First-Line Treatment For Squamous Non-Small Cell Lung Cancer (NSCLC) In Pivotal Phase 3 KEYNOTE-407 Trial,0,0.5359998
2018-05-24,6928800.0,59.25,59.40999984741211,58.810001373291016,59.130001068115234,55.43620300292969,MRK,Merck's Keytruda Shows Survival Benefit in Squamous NSCLC ||| 10 Top Health-Care Stocks That Never Break a Sweat,0,0.49201652
2018-05-25,6665400.0,59.13999938964844,59.459999084472656,58.84000015258789,59.09000015258789,55.39870071411133,MRK,"Eisai and Merck Announce Update on Lenvatinib sNDA Review ||| Benzinga's Daily Biotech Pulse: Biomarin Gets FDA Nod, Amarin Settles with Teva, Merck's Cancer Drug Review Extended ||| Eisai, Merck Provide Update on sNDA for Lenvatinib",0,0.5119758
2018-05-29,8805600.0,58.58000183105469,58.88999938964844,58.02999877929688,58.400001525878906,54.75180816650391,MRK,Roche's Tecentriq Study Meets Co-Primary Endpoints for NSCLC ||| 20 Cryptocurrencies to Bet the House On!,1,0.49599496
2018-05-30,11042000.0,58.650001525878906,59.79999923706055,58.52000045776367,59.720001220703125,55.98934173583984,MRK,"AstraZeneca (AZN) Stock on Growth Path This Year: Here's Why ||| Pfizer's Xalkori Gets Breakthrough Status for New Indications ||| Close Update: Wall Street Recovers After Selloff as Energy, Financial Stocks Surge ||| 30 Stocks Moving In Wednesday's Mid-Day Session ||| Mid-Morning Market Update: Markets Open Higher; Michael Kors Beats Q4 Estimates ||| Benzinga's Daily Biotech Pulse: Chinese Cheer For Gilead, Immutep Presents Positive Phase 1 Data, FDA Accepts Exelixis sNDA",0,0.50013345
2018-05-31,12200400.0,59.630001068115234,59.880001068115234,59.310001373291016,59.52999877929688,55.81120681762695,MRK,"Gilead & Galapagos Announce Positive Data on Filgotinib ||| Pfizer Inc. Stock Desperately Needs a Viagra-Like Boost ||| Merck, Premier Inc. Report Expansion Of Preventative, Chronic Disease Care Collaboration To Include New Effort Designed To Help Reduce Recurrence Of C. Diff ||| 41 Biggest Movers From Yesterday",1,0.51732826
2018-06-01,11027600.0,59.88999938964844,60.810001373291016,59.619998931884766,60.560001373291016,56.7768669128418,MRK,"Key FDA Events in June Investors Need to Watch Out For ||| Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates ||| EMA Says CHMP Has Recommended Restricting Use Of Merck's Keytruda, Tecentriq As First-Line Treatments For Urothelial Cancer",1,0.51139134
2018-06-04,19475700.0,61.54999923706055,62.52999877929688,61.18000030517578,62.02000045776367,58.14566421508789,MRK,"The Week Ahead In Biotech: ASCO Presentations Dominate The Headlines ||| Merck Announces KEYTRUDA Showed Overall Response Rate of Nearly 40 Percent as First-Line Therapy in Patients with Advanced Clear Cell RCC in Phase 2 KEYNOTE-427 Study at #ASCO2018 ||| Eisai, Merck Announce Data from Investigational Studies of LENVIMA and KEYTRUDA Combination Therapy in Four Different Tumor Types AT #asco2018 ||| Merck Announces KEYTRUDA Plus Chemotherapy Significantly Improved Overall Survival in First-Line Treatment of Metastatic Squamous NSCLC in Phase 3 KEYNOTE-407 Study ||| Merck Announces KEYTRUDA Monotherapy Significantly Improved Overall Survival in KEYNOTE-042 Study as First-Line Treatment for Locally Advanced or Metastatic NSCLC Patients Whose Tumors Expressed PD-L1 (TPS ≥1%) ||| 3 Stocks Raising Hopes in Troubled Large-Cap Pharma Industry ||| Close Update: Wall Street's Jobs Rally Rolls on as Nasdaq, Apple Hit Record High ||| Dow Movers: CSCO, MRK ||| Merck and Astrazeneca Pres Relase Announces LYNPARZA In Combo With Abiraterone Delayed Metastatic Prostate Cancer Disease Progression ||| Merck Gives an Update on its Pivotal Trial of JAVELIN into ASCO ||| Donald Trump Tweets: 'We had Repeal & Replace done (and the saving to our country of one trillion dollars) except for one person, but it is getting done anyway'...'less expensive plans will be announced this month. Drug prices coming down & Right to Try!' ||| Merck Says 'KEYTRUDA Showed Promising Anti-Tumor Activity in Patients with Advanced Small Cell Lung Cancer (SCLC) in Phase 2 KEYNOTE-158 Study' ||| Merck Announces New Analysis of Four-Year Data for KEYTRUDA from Phase 3 KEYNOTE-006 Study Showed 86 Percent of Patients Were Progression-Free 20 Months After Completing Two Years of KEYTRUDA ||| Five Additional Ebola Cases Detected by Congo Health Officials",0,0.5035691
2018-06-05,12498300.0,62.0,62.33000183105469,61.060001373291016,61.38999938964844,57.55502700805664,MRK,"Merck Presents Positive Melanoma Data on Keytruda at ASCO ||| Nektar (NKTR) and Bristol-Myers Present Data on Cancer Study ||| Bristol-Myers (BMY) Reports Data from CheckMate-214 Study ||| Market Close Report: Historical high reached as NASDAQ Composite Index closes at 7,637.86. ||| Roaring Nasdaq Nabs Record High, Overshadows Sluggish Dow ||| Benzinga's Daily Biotech Pulse: Mylan's Neulasta Biosimilar Approved, Portola's CEO To Retire, Regenxbio To Join S&P SmallCap Index",1,0.49869648
2018-06-06,7549800.0,61.5099983215332,61.93999862670898,61.220001220703125,61.93000030517578,58.06129455566406,MRK,ASCO Ends: Winners & Losers at the Key Cancer Research Event ||| Gilead Collaborates with Hookipa for HBV and HIV Therapies,1,0.5440923
2018-06-07,7548600.0,62.0,62.040000915527344,61.5099983215332,61.9900016784668,58.11753845214844,MRK,"Health Care Sector Update for 06/07/2018: MRK, ASND, PTI, IMGN, MDGL ||| Health Care Sector Update for 06/07/2018: AGN,IMGN,MRK,PTI,VRX,VRX.TO ||| Top Analyst Reports for Merck, Occidental Petroleum & Capital One Financial ||| Health Care Sector Update for 06/07/2018: IMGN,MRK,PTI,VRX,VRX.TO",1,0.4543603
2018-06-08,9678200.0,62.0099983215332,62.650001525878906,61.970001220703125,62.58000183105469,58.670684814453125,MRK,"The Zacks Analyst Blog Highlights: Merck, Occidental Petroleum, Capital One Financial, Kimberly-Clark and Allstate ||| Pharma Stock Roundup: Merck, Eli Lilly, AbbVie And More",0,0.4901649
2018-06-11,7197200.0,62.77000045776367,62.86000061035156,62.08000183105469,62.33000183105469,58.436302185058594,MRK,"Amgen's (AMGN) Prolia Gets Label Expansion Approval in Europe ||| AstraZeneca's Tagrisso Wins EU Nod for First-Line Lung Cancer ||| Mega Caps Are Soaring in June: 3 Top-Ranked Stocks on Sale ||| The Zacks Analyst Blog Highlights: Bristol Myers, Merck, Roche, Lilly and AbbVie",1,0.5237642
2018-06-12,7927700.0,62.369998931884766,62.61000061035156,62.0099983215332,62.43999862670898,58.53942108154297,MRK,"Noteworthy ETF Outflows: OEF, MRK, DWDP, BMY ||| Lilly & AstraZeneca Scrap Studies on Alzheimer's Candidate ||| Ex-Dividend Reminder: Merck, Rayonier and ARMOUR Residential REIT ||| Six Flags Entertainment, Thomson Reuters, Toyota Motor, China Petroleum & Chemical and Merck highlighted as Zacks Bull and Bear of the Day ||| Top Ranked Income Stocks to Buy for June 12th ||| Merck Press Release Confirms FDA Approval Of KEYTRUDA For Cervical Cancer ||| Merck Receives FDA Approval For KEYTRUDA in Advanced Cervical Cancer",1,0.48018956
2018-06-13,9421500.0,62.56999969482422,62.959999084472656,62.34999847412109,62.59000015258789,58.680057525634766,MRK,"Merck's (MRK) Keytruda Gets FDA Approval for Cervical Cancer ||| Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for June 14, 2018 ||| Health Care Sector Update for 06/13/2018: WMGI,FLKS,MRK,SNY ||| Health Care Sector Update for 06/13/2018: FLKS,MRK,SNY ||| Merck's KEYTRUDA Receives FDA Approval For Treatment of Primary Mediastinal Large B-Cell Lymphoma ||| FDA Grants Priority Review To Merck's Supplemental Biologics License Application (sBLA) For GARDASIL 9 In Women And Men Ages 27-45 For Prevention Of Certain HPV-Related Cancers And Diseases",0,0.4773669
2018-06-14,11954400.0,62.06999969482422,62.380001068115234,61.220001220703125,61.560001373291016,58.160438537597656,MRK,"Merck (MRK): Moving Average Crossover Alert ||| 3 Stocks Raising Hopes in Troubled Large-Cap Pharma Industry ||| Merck's Keytruda Gets FDA Nod for 2nd Lymphoma Indication ||| Benzinga's Daily Biotech Pulse: FDA Nods For Teligent And Keytruda, Sonoma's Q4 Miss, Sage Inks Deal With Japan's Shionogi",1,0.51883465
2018-06-15,16456600.0,61.59000015258789,62.09999847412109,61.220001220703125,62.02999877929688,58.60447692871094,MRK,"Dow 30 Stock Roundup: Caterpillar Raises Dividend, Merck's Keytruda Gets FDA Nod ||| 7 Perfect Dividend Stocks ||| Mid-Day Market Update: Dow Down Over 200 Points; Affimed Shares Plummet ||| Pharma Stock Roundup: LLY/AZN Alzheimer's Drug Fails, MRK's Keytruda Wins Approvals ||| Top Ranked Income Stocks to Buy for June 15th ||| Mid-Afternoon Market Update: Crude Oil Down Over 3%; Canada Goose Shares Gain Following Strong Q4 Results ||| 30 Stocks Moving In Friday's Mid-Day Session ||| Mid-Day Market Update: Dow Down Over 200 Points; Affimed Shares Plummet ||| Affimed Shares Slide On Updated Hodgkin Lymphoma Drug Combo Data ||| Benzinga's Daily Biotech Pulse: Hematology Conference In The Spotlight, Dr. Reddy To Launch Generic Opioid Addiction Drug",0,0.4997779
2018-06-18,9532700.0,61.34999847412109,61.36000061035156,60.59000015258789,60.9900016784668,57.62191390991211,MRK,"Bristol-Myers Posts Data on Empliciti, China Approves Opdivo ||| Monday's ETF with Unusual Volume: IXJ ||| 40 Biggest Movers From Friday",1,0.48953348
2018-06-19,10020600.0,60.650001525878906,61.310001373291016,60.630001068115234,61.02999877929688,57.65970230102539,MRK,Myriad Genetics Wins FDA SPMA Nod for BRACAnalysis CDx ||| ImmunoGen's Lead Candidate Gets Fast Track for Ovarian Cancer ||| Better Buy: Celgene Corporation vs. Merck ||| The Math Shows PPH Can Go To $66,1,0.5147201
2018-06-20,12172800.0,61.060001373291016,61.47999954223633,60.790000915527344,61.27999877929688,57.89589691162109,MRK,"IWD, WFC, PFE, MRK: Large Inflows Detected at ETF",0,0.5201216
2018-06-21,8908900.0,61.27000045776367,61.27000045776367,60.810001373291016,61.18000030517578,57.80141830444336,MRK,TESARO (TSRO) Stock Up on Rumors of Buyout Offer From Roche,1,0.51756996
2018-06-22,12295800.0,61.27999877929688,61.91999816894531,61.220001220703125,61.470001220703125,58.07540512084961,MRK,Merck (MRK) Stock Up So Far This Year on Keytruda Strength ||| Bristol-Myers' BLA for Opdivo Label Expansion Accepted by FDA,0,0.5089462
2018-06-25,10550800.0,61.40999984741211,61.619998931884766,60.63999938964844,61.08000183105469,57.70694351196289,MRK,Merck Presents New Data from Comparative Trials with Sitagliptin Clinical Trial Program with JANUVIA at #ADA2018 ||| Merck (MRK) Presents New Data from Januvia Diabetes Studies ||| Merck's Supplemental Biologics License Application for KEYTRUDA is Accepted by the FDA,0,0.50767475
2018-06-26,11996100.0,60.83000183105469,61.02000045776367,60.61000061035156,60.720001220703125,57.366825103759766,MRK,"Merck's Keytruda Under FDA Review for Advanced Melanoma ||| Gilead's (GILD) Biktarvy Gets EC Nod for HIV- 1 Infection ||| Better Buy: Exelixis, Inc. vs. Immunogen, Inc. ||| 3 Best Big Pharma Stocks of 2018 So Far ||| Incyte Downgraded As RBC Analyst Awaits More Revenue Visibility",0,0.5085189
2018-06-27,10447300.0,60.70000076293945,61.08000183105469,59.79999923706055,59.880001068115234,56.57320785522461,MRK,"AstraZeneca/Merck's Lynparza Betters Survival in Phase III ||| UPDATE: Merck Says Non-Inferiority Was Not Demonstrated For Second Primary Outcome Of Blood Loss Of Greater Than Equal To 1,000 ml Of Blood Loss ||| Merck Reports Study Results From Heat-Stable Formulation Of Carbetocin For Prevention Of Excessive Bleeding After Childbirth: Showed Clinical Non-Inferiority To Oxycontin For Primary Outcome Of Greater Than Equal To 500 ml Of Blood Loss ||| AstraZeneca Reports LYNPARZA Phase III Trial First-Line SOLO-1 Trial For Ovarian Cancer Met Primary Endpoint ||| Merck To Report Q2 Earnings On Fri., Jul. 27, 2018 Before Market Open ||| AstraZeneca, Merck Announce LYNPARZA S Met Primary Endpoint of Progression-Free Survival in Women with BRCA-Mutated Advanced Ovarian Cancer and Showed a Safety Profile Consistent with Previous Trials",1,0.51959056
2018-06-28,10201900.0,60.11000061035156,60.75,59.9900016784668,60.29999923706055,56.97001647949219,MRK,U.S. Supreme Court Agrees To Hear Merck Appeal Of Lower Court Ruling THat Revived Fosamax Warning Label Suits,1,0.5027182
2018-06-29,14271900.0,60.52999877929688,61.470001220703125,60.34999847412109,60.70000076293945,57.347923278808594,MRK,"XLV, UNH, MRK, ABBV: Large Outflows Detected at ETF ||| Will a Trade War With China Wreak Havoc in US Healthcare?",0,0.4923389
2018-07-02,9109100.0,60.54999923706055,60.560001373291016,59.91999816894531,60.459999084472656,57.12118148803711,MRK,"Gilead's (GILD) CAR T Therapy Gets Positive CHMP Opinion ||| Merck's Supplemental Biologics License for KEYTRUDA in Combination with Chemotherapy is Granted Priority Review by the FDA ||| AstraZeneca, Merck Announce LYNPARZA Approved in Japan for BRCA-Mutated Metastatic Breast Cancer",1,0.5271115
2018-07-03,4872700.0,60.7400016784668,61.29999923706055,60.54999923706055,60.709999084472656,57.35737609863281,MRK,"3 Reasons BeiGene Needs to Be on Your Radar ||| AstraZeneca's Two New Cancer Drugs Get Approval in Japan ||| Merck's Keytruda Gets Priority Review in Difficult Lung Cancer ||| The 5 Biggest Blockbuster Drugs of 2024, and the Companies Poised to Profit From Them",1,0.5313
2018-07-05,9081200.0,61.400001525878906,61.959999084472656,61.09000015258789,61.63999938964844,58.23601531982422,MRK,A Look At Biotech In 2018 And The Biggest Catalysts Coming Up In The Second Half Of The Year,1,0.49930543
2018-07-06,8151900.0,61.79999923706055,62.5099983215332,61.790000915527344,62.20000076293945,58.76509094238281,MRK,"Trade of the Day: Novocure Ltd (NVCR) ||| Dow 30 Stock Roundup: Bell-Boeing JV's Navy Deal Win, Merck Keytruda's Priority Review ||| Bristol-Myers' Sprycel Gets EC Approval for Label Expansion",0,0.5273341
2018-07-09,8325000.0,62.459999084472656,62.68999862670898,62.0,62.02000045776367,58.595027923583984,MRK,Health Care Select Sector SPDR Fund Experiences Big Inflow ||| Health Care Sector Outlook: Checking In Ahead Of Q2 Earnings Reports,1,0.51730084
2018-07-10,10750500.0,62.38999938964844,62.630001068115234,62.11000061035156,62.29999923706055,58.85956573486328,MRK,"Drug Pricing in Focus Again as Trump Tweet Slams Pfizer ||| Noteworthy Tuesday Option Activity: MRK, AVEO, TROX",0,0.50625575
2018-07-11,5778000.0,62.13999938964844,62.20000076293945,61.59000015258789,61.900001525878906,58.48165512084961,MRK,"Health Care Sector Update for 07/11/2018: MYGN,SCYX,PFE,ARQL ||| FDA Grants Merck Priority Review To Co.'s Supplemental Biologics License Application For Its KEYTRUDA Hepatocellular Carcinoma Therapy",1,0.50701594
2018-07-12,8038600.0,62.43999862670898,62.84000015258789,62.13999938964844,62.65999984741211,59.199684143066406,MRK,Pfizer (PFE) to Reorganize Business Into Three New Units ||| Bristol-Myers' Combo Drugs Get FDA Nod for Colorectal Cancer ||| Cue Biopharma Produces Immuno-STAT Biologic Candidate for Treatment of Autoimmune Disease Under Collaboration and License Agreement with Merck,1,0.46699283
2018-07-13,7352200.0,62.27000045776367,63.040000915527344,62.25,62.88999938964844,59.416988372802734,MRK,"Will J&J's (JNJ) Pharma Segment Strength Drive Q2 Earnings? ||| Pharma Stock Roundup: PFE to Split Into 3 Units, J&J to Pay $4.7B in Talc Lawsuit ||| Dow 30 Stock Roundup: Boeing Q2 Commercial Deliveries Up Y/Y, Pfizer to Reorganize ||| Why Merck is a Top 25 Dividend Giant (MRK) ||| Amgen Resubmits BLA to FDA for Osteoporosis Candidate Evenity",0,0.50326204
2018-07-16,4513300.0,62.93000030517578,62.95000076293945,62.33000183105469,62.59000015258789,59.13355255126953,MRK,Does the $4.7 Billion Talc Verdict Spell Trouble for J&J? ||| PreMarket Prep Opening NYSE Imbalance Update: ExxonMobil 55k Shares To Sell; Pfizer 50k To Sell; Merck 26k To Sell; Coca-Cola 54k To Sell; Johnson & Johnson 54k To Sell; Ford 103k To Sell; Kroger 90k To Sell,0,0.482096
2018-07-17,5049700.0,62.52999877929688,62.810001373291016,62.459999084472656,62.52999877929688,59.07686233520508,MRK,J&J's (JNJ) Q2 Earnings Beat on Higher Cancer Drug Sales,1,0.52308565
2018-07-19,7282100.0,62.7400016784668,62.93999862670898,62.25,62.5099983215332,59.05796813964844,MRK,"Roche's Tecentriq Met Primary Goal in First-Line NSCLC Study ||| Stocks Drop as Trump Talks Rate Hikes ||| UPDATE: Merck Says 'Going forward, we will continue to evaluate our portfolio of products to look for opportunities to further reduce costs for patients and the health care system' ||| UPDATE: Merck, Responding To Responsibility On Drug Pricing, Says 'We are also lowering our price on ZEPATIER by 60 percent and several other medicines by 10 percent to reduce out-of-pocket costs for patients across the country' ||| Merck Says 'We commit to not increase the average net price across our portfolio of products by more than inflation annually'",1,0.50737214
2018-07-20,6874700.0,62.060001373291016,62.540000915527344,62.0099983215332,62.52000045776367,59.067420959472656,MRK,Better Buy: Eli Lilly and Company vs. Merck & Co. ||| Eli Lilly Scores a Win in Diabetes ||| 10 Cancer-Fighting Health Care Stocks to Buy ||| Merck Announces Plans To Cut Drug Prices,1,0.5165127
2018-07-23,6933600.0,62.56999969482422,62.77999877929688,62.5099983215332,62.68999862670898,59.228023529052734,MRK,"Here's Why Big Pharma Loves This Plan to Lower Drug Prices ||| Healthcare ETFs to Buy on Solid Q2 Earnings Expectations ||| Will Strong HIV Sales Fuel Gilead (GILD) In Q2 Earnings? ||| Morgan Stanley: Newly Public Neon Therapeutics Has Outperformance Potential ||| Leap Therapeutics Announces Collaboration with Merck and Pfizer to Evaluate Combination of TRX518, Avelumab, and Chemotherapy in Advanced Solid Tumors",1,0.5142729
2018-07-24,9476200.0,62.900001525878906,63.43999862670898,62.81999969482422,63.41999816894531,59.91771697998047,MRK,"Merck (MRK) Q2 Earnings Coming Up: What's in the Cards? ||| Lilly (LLY) Tops Q2 Earnings, Chooses IPO Path for Elanco ||| Daily Dividend Report: BBT, EHC, HXL, MRK, EXC, AEP ||| Merck Announces Week 96 Data from Pivotal Phase 3 DRIVE-FORWARD Study of Its Investigational HIV Therapy Doravirine",1,0.48665595
2018-07-25,10518700.0,63.43000030517578,64.56999969482422,63.36000061035156,64.48999786376953,60.92863082885742,MRK,"Will Pfizer (PFE) Keep the Earnings Streak Alive in Q2? ||| Benzinga's Daily Biotech Pulse: Merck's Keytruda Found Effective, Nabriva To Acquire Zavante, FDA Denies Agile ||| Merck Reports Phase 3 KEYNOTE-048 Trial Investigating KEYTRUDA Met Primarry Endpoint Of Improving Overall SurvivalIn Head And Neck Squamous Cell Carcinoma Patients ||| Merck Announces KEYTRUDA Monotherapy Met a Primary Endpoint in the Phase 3 KEYNOTE-048 Trial, Significantly Improving OS as First-Line Therapy in Head and Neck Squamous Cell Carcinoma Patients Whose Tumors Expressed PD-L1",0,0.4735134
2018-07-26,11142400.0,64.61000061035156,65.19999694824219,63.9900016784668,64.01000213623047,60.475135803222656,MRK,"AstraZeneca's (AZN) Q2 Earnings and Sales Beat, Stock Up ||| ABBV, MRK Q2 Earnings on Jul 27: Here are the Key Predictions ||| 5 Must-See Earnings Charts to End the Week ||| Pre-Market Earnings Report for July 27, 2018 : XOM, CVX, MRK, ABBV, CL, PSX, AON, MCO, TWTR, IMO, WY, SYF ||| Merck Q2 Earnings Preview ||| Sutro Pharma Earlier Reported Merck Was Part Of $85.4M Series E Funding Round ||| Merck Reports KEYTRUDA Approved By China National Drug Admin.",0,0.49206176
2018-07-27,8411600.0,62.45000076293945,64.0199966430664,62.380001068115234,63.4900016784668,59.98384475708008,MRK,"Seattle Genetics (SGEN) Q2 Loss Narrows, Sales Top Estimates ||| Merck (MRK) Tops on Q2 Earnings & Sales, Stock Up ||| Earnings Reaction History: Merck & Co. Inc., 50.0% Follow-Through Indicator, 1.8% Sensitive ||| Intraday Update: Dow Slumps Despite Strong GDP ||| Benzinga Pro's 5 Stocks To Watch Today ||| Benzinga's Daily Biotech Pulse: Achaogen To Trim Workforce By 28%, Amgen's Beat-And-Raise Quarter ||| Endo Int'l. Reports Par Pharma Has Begun Shipping Authorized Generic Version Of Merck's INVANZ ||| Merck Narrows FY18 Sales Guidance From $41.8B-$43B To $42B-$42.8B vs $42.07B Estimate ||| Merck Raises FY18 Adj. EPS From $4.16-$4.28 To $4.22-$4.30 vs $4.23 Estimate ||| Merck & Co Q2 EPS $1.06 Beats $1.03 Estimate, Sales $10.465B Beat $10.29B Estimate ||| 12 Stocks To Watch For July 27, 2018 ||| Earnings Scheduled For July 27, 2018",1,0.48936665
2018-07-30,9665200.0,63.790000915527344,64.9000015258789,63.52999877929688,64.80999755859375,61.230953216552734,MRK,"Health Care Sector Update for 07/30/2018: MRK,SOHU, MNOV ||| Market Close Report: NASDAQ Composite index closes at 7,630 down -107.42 points ||| Visa Hits Dow; S&P, Nasdaq Walloped By Sinking Tech Stocks ||| Will Agenus (AGEN) Disappoint Investors This Earnings Season? ||| Health Care Sector Update for 07/30/2018: APLS,SOHU,MNOV,MRK ||| Health Care Sector Update for 07/30/2018: SOHU,MNOV,MRK ||| Benzinga Pro's 5 Stocks To Watch Today ||| BioLineRx Expands its Immuno-Oncology Collaboration in Pancreatic Cancer with Merck",1,0.46479964
2018-07-31,15443400.0,64.9000015258789,66.12000274658203,64.87999725341797,65.87000274658203,62.232418060302734,MRK,"3 Killer Stocks to Win the Biotech Game ||| Pfizer (PFE) Beats on Q2 Earnings & Sales, Ups Profit View ||| ImmunoGen's Investors Play the Waiting Game ||| Why Sanofi Stock Should Run Higher Despite Mixed Earnings ||| Incyte (INCY) Earnings Miss, Revenues Beat Estimates in Q2 ||| Benzinga Pro's 5 Stocks To Watch Today ||| A Peek Into The Markets: US Stock Futures Up Ahead Of Earnings, Economic Data ||| Eisai and Merck Announce FDA Grants Breakthrough Therapy Designation For LENVIMA In Combination With KEYTRUDA As Therapy For Previously Treated Patients With Advanced And/Or Metastatic Non-MSI-H/pMMR Endometrial Carcinoma ||| Eisai, Merck Announce FDA Breakthrough Therapy Designation for LENVIMA",0,0.49356854
2018-08-01,7585500.0,65.70999908447266,66.13999938964844,65.44999694824219,65.48999786376953,61.8734016418457,MRK,"WHO Chief Says That It Has Started Moving Staff, Supplies To The Area Of Democratic Republic Of Congo's New Ebola Outbreak ||| 4 Samples From Northeastern Democratic Rep. Of Congo Test Positive For Ebola Virus, 20 Deaths From Hemorrhagic Fever Recorded In Northeastern Congo",0,0.5119292
2018-08-02,6895400.0,65.30000305175781,65.43000030517578,64.87000274658203,65.22000122070312,61.61832046508789,MRK,"Immune Design (IMDZ) Posts Narrower-Than-Expected Loss in Q2 ||| Health Ministry Officials Say Ebola In Latest Congo Outbreak Is of the Zaire Strain Which Has Been Successfully Treated By A Vaccine In The Past ||| UPDATE: W.H.O. Says Depending On The Strain Of Ebola In Congo Outbreak, Merck Vaccine May Be 'An Option'",1,0.49105963
2018-08-03,6997200.0,65.19999694824219,66.0199966430664,64.97000122070312,65.93000030517578,62.28910827636719,MRK,"Aduro (ADRO) Q2 Loss Narrower Than Expected, Revenues Miss ||| Dow 30 Stock Roundup: Apple, DowDuPont, Caterpillar, Pfizer Earnings Impress ||| Merck Reports Co., AstraZeneca's Selumetinib Granted Orphan Designation In Europe For Neruofibromatosis Type 1",1,0.48420122
2018-08-06,8206300.0,66.08999633789062,66.4800033569336,65.69000244140625,66.22000122070312,62.563087463378906,MRK,"Congo Health Ministry Says Ebola Outbreak Likely to have Killed 33; Merck Vaccine Being Deployed to Control Spread of Outbreak ||| DGRO, KO, PEP, MRK: ETF Inflow Alert ||| 3 Healthcare Stocks to Buy for the Sector Rebound",1,0.5335459
2018-08-07,8083300.0,66.08999633789062,66.98999786376953,66.02999877929688,66.58000183105469,62.90321350097656,MRK,"Q2 Earnings Drive Pharma ETFs Higher ||| Stocks That Made New 52-Week Highs Earlier Today Include: SL Green Realty, Verisk Analytics, Medtronics, Pfizer, Conoco Phillips, Archer-Daniels, Eli Lilly, Merck, Phillips 66, Costco, Advance Auto Parts, Norfolk Southern, CSX, Zoetis, Apple, and Disney ||| Stocks Which Set New 52-Week High Yesterday, August 6th ||| The Daily Biotech Pulse: FDA Snub For Gemphire, Ligand Earnings, Insmed's Antibiotic Faces FDA Panel",1,0.48959643
2018-08-08,6509300.0,66.51000213623047,66.98999786376953,66.1500015258789,66.69000244140625,63.00713348388672,MRK,"Novo Nordisk (NVO) Beats Q2 Earnings and Sales Estimates ||| Stocks Which Set New 52-Week High Yesterday, August 7th ||| The Daily Biotech Pulse: FDA Panel Backs Insmed, Eidos' Maiden Earnings, Paratek Awaits Adcom Verdict",0,0.5056651
2018-08-09,7151800.0,66.87000274658203,66.87000274658203,65.80000305175781,66.0,62.35524368286133,MRK,"Endo (ENDP) Beats on Q2 Earnings & Sales, Raises Guidance ||| Perrigo (PRGO) Beats on Q2 Earnings, Cuts View, Shares Down ||| CDC Says There's No Recommendation To Avoid Travel To Democratic Republic Of The Congo Following Ebola Outbreaks ||| Perrigo Announces Rx-To-OTC Switch Licensing For Nasonex",1,0.52953285
2018-08-10,7439700.0,65.9000015258789,66.5,65.68000030517578,66.06999969482422,62.421363830566406,MRK,"Top Research Reports with Q2 Earnings Analysis: Merck, CVS Health, CME Group & More ||| Dow Movers: INTC, WMT",1,0.5067809
2018-08-13,9516800.0,66.12999725341797,66.88999938964844,66.06999969482422,66.72000122070312,63.03548431396485,MRK,"Turkey Crisis Pushes Stocks Into the Red ||| Market Close Report: NASDAQ Composite index closes at 7,819.71 down -19.40 points ||| Close Update: Wall Street Skids Into Close as Turkey Worries Strike Global Equities",0,0.4932093
2018-08-14,6596000.0,66.61000061035156,66.94999694824219,66.26000213623047,66.45999908447266,62.78984069824219,MRK,Here's Why Merck (MRK) Stock is Up Since Q2 Earnings Release,1,0.51029474
2018-08-15,10891100.0,66.7300033569336,67.56999969482422,66.47000122070312,67.37000274658203,63.64958953857422,MRK,"Dow Movers: CAT, MRK ||| Agenus (AGEN) Delivering Well on Its Pipeline Candidates ||| 5 Promising Vaccines in Development -- and the Stocks Poised to Profit From Them ||| Dow Drops Triple Digits; Energy Stocks Sink With Oil ||| Agenus Receives Milestone Payment From Merck Of $4M For Initiation Of Phase 1 Clinical Trial Of An Undisclosed Antibody Candidate Discovered By Agenus",1,0.4992005
2018-08-16,18490800.0,67.5999984741211,69.0,67.37000274658203,68.8499984741211,65.04785919189453,MRK,"IWD, MRK, PM, ORCL: Large Outflows Detected at ETF ||| Pain Therapeutics' Shares Rally on Alzheimer's Study Grant ||| Noteworthy Thursday Option Activity: HELE, EPC, MRK ||| Eisai And Merck Announce FDA Approval Of LENVIMA (lenvatinib) Capsules For First-line Treatment Of Unresectable Hepatocellular Carcinoma (HCC) ||| Stocks Which Set New 52-Week High Yesterday, August 15th ||| The Daily Biotech Pulse: No Anxiety For Biohaven, Strongbridge's About-Face, Bristol-Myers Squibb's FDA Wait",1,0.53455293
2018-08-17,7847100.0,68.77999877929688,69.23999786376953,68.69999694824219,69.05999755859375,65.24624633789062,MRK,"MRK Crosses Above Average Analyst Target ||| Merck, Eisai Get FDA Approval for Lenvima Label Expansion ||| 4 Mega-Cap Stocks to Buy As They’re Thrust Into the Spotlight ||| Stocks Which Set New 52-Week High Yesterday, August 16th ||| The Daily Biotech Pulse: Aveo Slips On Stock Offering, FDA Greenlights Generic EpiPen, Pfenex Exec Resigns ||| Eisai And Merck Announce FDA Approval Of LENVIMA",1,0.5079848
2018-08-20,10419300.0,69.0,70.22000122070312,68.93000030517578,70.16999816894531,66.29495239257812,MRK,Bristol-Myers' Opdivo Gets FDA Nod for Small Cell Lung Cancer ||| Close Update: Wall Street Extends Rally as S&P 500 Nears New Record High ||| FDA Approves Expanded Label for Merck's KEYTRUDA in Combination with Pemetrexed and Platinum Chemotherapy for First-Line Treatment,0,0.5327307
2018-08-21,9814600.0,70.20999908447266,70.25,69.08999633789062,69.16999816894531,65.35017395019531,MRK,"Is Merck & Co. a Buy? ||| Japan Nods to AstraZeneca's Tagrisso for First-Line NSCLC ||| NASDAQ Composite Index closes up 4.68 points for the week, rising for the 4th straight day ||| S&P Lands Record High; Dow Extends Win Streak ||| Incyte Has Quietly Risen 13 Percent In The Last Two Weeks, And That Uptrend Looks Like It Will Continue ||| Stocks Which Set New 52-Week High Tues., Aug. 21, 2018 ||| The Daily Biotech Pulse: Merck's Keytruda Secures Approval For Expanded Label, ProPhase Labs Q2 Loss Narrows ||| Rexahn Reports Clinical Collaboration With Merck For Evaluation Of RX-5902 In Combo With KEYTRUDA For Triple-Negative Breast Cancer",0,0.49363238
2018-08-22,5893300.0,69.18000030517578,69.4000015258789,68.8499984741211,69.04000091552734,65.22736358642578,MRK,"Horizon Pharma (HZNP) Boasts Robust Pipeline Amid Competition ||| Stocks Which Set New 52-Week High Yesterday, August 21st ||| The Daily Biotech Pulse: FDA Snub For Allergan, Myriad's Q4 Beat, Mallinckrodt's Stannsoporfin",0,0.4957441
2018-08-23,5540700.0,68.87000274658203,69.19000244140625,68.73999786376953,68.97000122070312,65.1612319946289,MRK,"Is Agenus Inc. Stock a Buy? ||| Morgan Stanley Maintains Overweight on Merck & Co, Raises Price Target to $74 ||| Eisai and Merck Announce European Commission Grants Marketing Authorization for LENVIMA",1,0.50889814
2018-08-24,4956200.0,69.0,69.25,68.7699966430664,69.04000091552734,65.22736358642578,MRK,"iShares Core S&P 500 ETF Experiences Big Inflow ||| Merck, Eisai Get EU Approval for Lenvima Label Expansion ||| Bristol-Myers (BMY) sBLA for Empliciti Gets Priority Review ||| 30 Stocks Moving In Friday's Pre-Market Session",0,0.48456356
2018-08-27,5083800.0,69.33999633789062,69.43000030517578,68.52999877929688,68.98999786376953,65.18011474609375,MRK,"Better Buy: AbbVie Inc. vs. Merck & Co., Inc. ||| BRZU, IDHQ: Big ETF Inflows ||| Novo Nordisk's Ozempic Lowers Risk of Cardiovascular Events",0,0.49775243
2018-08-28,5934400.0,68.8499984741211,68.87000274658203,68.37999725341797,68.62999725341797,64.8399887084961,MRK,"Dow Analyst Moves: MRK ||| Dow Movers: JNJ, DWDP ||| Esperion (ESPR) Combination Regimen Lowers Bad Cholesterol",1,0.49436802
2018-08-29,5489700.0,68.37999725341797,68.9000015258789,68.2699966430664,68.80999755859375,65.01005554199219,MRK,Up 246%: Is This Small-Cap Biotech Stock Still a Buy?,0,0.5078856
2018-08-30,4744600.0,68.66000366210938,68.94000244140625,68.3499984741211,68.54000091552734,64.75496673583984,MRK,"Better Buy: Johnson & Johnson vs. Merck ||| Merck Announces FDA Aproval of DELSTRIGO ||| The Daily Biotech Pulse: Verastem Gets New CFO, Mesoblast Earnings, Vertex's Precision Medicine Collaboration",1,0.5055405
2018-08-31,5743300.0,68.3499984741211,68.75,68.16000366210938,68.58999633789062,64.80220794677734,MRK,"Pharma Stock Roundup: Approval of NVS & ABBV Cancer Drugs, MRK's HIV Drug in Focus ||| 4 Large Cap Pharma Stocks in Focus on Robust Cancer Pipeline ||| Merck (MRK) Receives FDA Approval for Two HIV Medicines ||| The Daily Biotech Pulse: FDA Blessings for Merck's HIV Drug Combo, Veracyte's Test Gets Medicare Coverage",0,0.53339565
2018-09-04,5768300.0,68.37000274658203,68.41000366210938,67.93000030517578,67.94999694824219,64.19754791259766,MRK,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings ||| AstraZeneca Up This Year So Far on Favorable Pipeline Updates ||| Novo Nordisk's Ozempic Lowers Risk of Cardiovascular Events (revised) ||| Benzinga Pro's 5 Stocks To Watch Today ||| FDA Grants Priority Review to Merck's Supplemental Biologics License Application for KEYTRUDA, Application Based on Data from Phase 2 KEYNOTE-017 Trial",1,0.5097753
2018-09-05,6359100.0,67.94999694824219,68.69000244140625,67.91000366210938,68.62000274658203,64.83055877685547,MRK,"Invesco Dynamic Pharmaceuticals ETF Experiences Big Inflow ||| Merck's Keytruda Gets Priority Review for Rare Skin Cancer ||| The Daily Biotech Pulse: Biohaven In-Licenses Drug, Retrophin's Debt Offering, ProQR And Bluebird Report Positive Trial Results ||| Ebola-Related Stocks Unaffected Amid Earlier Report Officials In Congo Announced The First Ebola Case In A Major Eastern City, Butembo ||| Eisai And Merck Announce China National Medical Products Administration (NMPA) Approval Of LENVIMA For Treatment Of Unresectable Hepatocellular Carcinoma (HCC) ||| Eisai, Merck Announce China NMPA Approval of First Approval for LENVIMA for Treatment of Unresectable HCC",1,0.51007354
2018-09-06,9637400.0,68.97000122070312,69.54000091552734,68.81999969482422,69.37999725341797,65.548583984375,MRK,"Dow Movers: PFE, CSCO",1,0.5140179
2018-09-07,9515200.0,69.16000366210938,69.77999877929688,68.8499984741211,69.66999816894531,65.82257080078125,MRK,"Roche's Tecentriq sBLA Review For NSCLC Gets Extended by FDA ||| Health Care Has Been On Fire. Will The Uptrend Continue? ||| Barclays Maintains Overweight on Merck & Co, Raises Price Target to $75",0,0.50456935
2018-09-10,7267900.0,70.0,70.58999633789062,69.52999877929688,69.55999755859375,65.71864318847656,MRK,"The Week Ahead In Biotech: Conferences, Clinical Trial Results, Earnings And IPOs ||| Health Care Sector Update for 09/10/2018: ACAD,MRK,FOLD ||| Perrigo's OTC Version of Diarrhea Drug Imodium Gets FDA Nod ||| The Zacks Analyst Blog Highlights: Novartis, AstraZeneca, Merck, Pfizer and Johnson & Johnson ||| Health Care Sector Update for 09/10/2018: MYOK, ACAD, MRK, FOLD, LLY ||| A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street ||| Merck's KEYTRUDA in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of Patients with Metastatic Nonsquamous NSCLC Approved by the European Commission ||| European Commission Approves Merck's KEYTRUDA in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of Patients with Metastatic Nonsquamous NSCLC",0,0.5338893
2018-09-11,5815500.0,69.80000305175781,69.80000305175781,69.06999969482422,69.08000183105469,65.26515197753906,MRK,"Health Care Sector Update for 09/11/2018: ABC, IMV, MRK, MNK ||| Top Stock Reports for Merck, PepsiCo & 3M ||| 3 Small Biotech Stocks That Almost Doubled in Past Month ||| Merck's Keytruda Combo Gets Nod for Lung Cancer in Europe ||| Health Care Sector Update for 09/11/2018: XENE,ABC,IMV,IMV.TO,MRK,MNK ||| The Daily Biotech Pulse: Advaxis Posts Narrower Loss, Endocyte Announces $175M Offering, Leadership Transition At Insulet ||| A Peek Into The Markets: US Stock Futures Down Ahead Of Job Openings, Wholesale Inventories Data ||| IMV Inc. Announces Phase 2 Basket Trial With Merck To Evaluate DPX-Survivac In Combination With KEYTRUDA Across Five Solid Tumor Indications ||| Merck's ZERBAXA Met Primary Endpoints of Non-Inferiority Compared to Meropenem in Pivotal Phase 3 Study, Co. To Submit Supplemental New Drug App. In U.S. And EU",1,0.48312593
2018-09-12,6090000.0,69.4000015258789,70.0199966430664,69.12000274658203,69.86000061035156,66.0020751953125,MRK,"Immunotherapy for NSCLC: 4 Large-Cap Pharma Stocks in Focus ||| Pfizer's Drug Combo Betters Survival in Kidney Cancer Study ||| The Zacks Analyst Blog Highlights: Merck, PepsiCo, 3M, Broadcom and Phillips 66 ||| FDA Grants Priority Review to Merck's Application for KEYTRUDA Monotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Patients Whose Tumors Express PD-L1",1,0.5045439
2018-09-13,10258200.0,70.16000366210938,70.94000244140625,69.58000183105469,70.83000183105469,66.91850280761719,MRK,"Merck Gets Priority Review for Yet Another Keytruda sBLA ||| Midday Update: Wall Street Buoyed by Upbeat Inflation, Jobs Data ||| Noteworthy Thursday Option Activity: GOOGL, MRK, PI ||| PJP, PFE, MRK, LLY: ETF Outflow Alert ||| Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for September 14, 2018 ||| Stocks That Will Be Trading Ex Dividend For Fri., Sep. 14, 2018",0,0.4943129
2018-09-14,7436000.0,70.73999786376953,70.73999786376953,69.66000366210938,69.9800033569336,66.56655883789062,MRK,"Pharma Stock Roundup: AZN's Leukemia Drug Wins FDA Nod, MRK's Keytruda in Focus ||| AstraZeneca's Lumoxiti Gets FDA Nod for Hairy Cell Leukemia ||| Are Options Traders Betting on a Big Move in Merck (MRK) Stock? ||| Dow 30 Stock Roundup: Apple Unveils 3 New iPhones, Boeing Clinches $2.9B Deal ||| Stocks Which Set New 52-Week High Yesterday, September 13th ||| The Daily Biotech Pulse: FDA Nod For STAAR, Supernus Opens Wallet, Principia Biopharma To Debut",1,0.50068367
2018-09-17,6697300.0,69.8499984741211,70.45999908447266,69.6500015258789,70.41999816894531,66.9850845336914,MRK,"The Week Ahead In Biotech (Sept. 16-22): Conferences, PDUFA Dates, Clinical Trial Results And IPOs ||| Accenture and Merck Collaborate with Amazon Web Services to Launch a Research Platform to Drive Innovation in Drug Discovery and Scientific Research",0,0.52142334
2018-09-18,6800400.0,70.41000366210938,70.9000015258789,69.9000015258789,70.41999816894531,66.9850845336914,MRK,"Dow Movers: DIS, AAPL ||| Can Pfizer (PFE) Bank on Bavencio for Long-Term Growth? ||| Accenture, Merck & Amazon AWS Partner for Cloud Platform ||| Agenus Receives Milestone Payment of $5 Million from Incyte ||| Dow Surges; Tech, Healthcare Boost S&P and Nasdaq",0,0.52796453
2018-09-19,7944200.0,70.1500015258789,70.56999969482422,69.63999938964844,69.9800033569336,66.56655883789062,MRK,J&J Files NDA for Erdafitinib in Urothelial Cancer Indication,1,0.53724843
2018-09-20,6140700.0,70.3499984741211,70.83000183105469,70.05000305175781,70.77999877929688,67.3275375366211,MRK,"Merck or Pfizer: Which is the Better Large-Cap Pharma Stock? ||| Merck Reports Received Positive CHMP Opinion For ELSTRIGO, PIFELTRO In EU For Treatment Of HIV-1 Infection ||| Merck Or Pfizer: Which Is The Better Large-Cap Pharma Stock?",1,0.462232
2018-09-21,17033100.0,70.91000366210938,71.58000183105469,70.91000366210938,71.0999984741211,67.63192749023438,MRK,"How Do Drugs Compete Against Each Other? ||| Galectin's GR-MD-02 Positive in Phase Ib Study With Keytruda ||| Health Care Sector Update for 09/21/2018: CRSP,BGNE,XOMA,LLY,AGEN,INCY,MRK ||| Health Care Sector Update for 09/21/2018: BGNE,XOMA,AGEN,INCY,MRK ||| Democratic Republic Of Congo Confirms Ebola Case In Ituri Province Almost 200 KM Away From Closest Other Case And 50 KM From The Ugandan Border ||| The Daily Biotech Pulse: Exelixis Liver Cancer Drug On Track For European Approval, Medtronic Goes Shopping, Opiant Snags BARDA Funding ||| XOMA Reports Purchase Of Royalty Interest Position From Agenus On 7 Assets Being Developed By Merck, Incyte For $15M",0,0.48551428
2018-09-24,6438800.0,70.91999816894531,71.30000305175781,70.62999725341797,70.77999877929688,67.3275375366211,MRK,"Stocks Which Set New 52-Week High Friday, September 21 ||| OpGen Reports Partnership With New York State Dept. Of Health, Merck's ILUM Health Solutions To Detect Antimicrobial-Resistant Infections",0,0.508543
2018-09-25,6460400.0,70.8499984741211,71.37999725341797,70.5199966430664,70.6500015258789,67.20388793945312,MRK,"AstraZeneca's Imfinzi Gets EU Nod for Early-Stage Lung Cancer ||| Gilead (GILD) to Launch Generics for Leading HCV Treatments ||| Health Care Sector Update for 09/25/2018: SNDX,MRK,JAGX,TGTX",0,0.4822747
2018-09-26,6928400.0,70.93000030517578,71.1500015258789,70.18000030517578,70.33000183105469,66.89948272705078,MRK,"Top Analyst Reports for Amazon, Intel & Merck ||| Are You Looking for a High-Growth Dividend Stock? Merck (MRK) Could Be a Great Choice ||| Gilead Sciences' Latest Tactic? Go Generic ||| Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates ||| Merck Board Rescinds Mandatory CEO Retirement Policy; Current CEO Kenneth Frazier To Continue In Role Beyond December 2019",1,0.49302566
2018-09-27,6026200.0,70.33000183105469,71.18000030517578,70.08000183105469,70.72000122070312,67.27046203613281,MRK,"Big Pharma Players on Strong Footing Ahead of Q4: 4 Picks ||| The Zacks Analyst Blog Highlights: Amazon, Intel, Merck, Micron and Celgene",1,0.4940535
2018-10-01,7628500.0,71.06999969482422,71.88999938964844,70.61000061035156,71.52999877929688,68.04096221923828,MRK,Sanofi/Regeneron's Cemiplimab Wins FDA Nod for Skin Cancer,1,0.5151232
2018-10-02,10395600.0,71.97000122070312,72.16999816894531,71.08999633789062,71.75,68.25022888183594,MRK,"Pfizer's CEO Ian Read to Step Down Next Year, COO to Succeed ||| Did Bristol-Myers Squibb Make a Huge Mistake With Nektar? ||| Merck on Solid Footing This Year: Can it Sustain the Trend? ||| Stocks Which Set New 52-Week High Yesterday, October 1st ||| The Daily Biotech Pulse: TransEnterix's Positive Pre-Announcement, Merit Medical Opens Wallet, GW Pharma To Offer ADS Shares",0,0.45074737
2018-10-03,9577600.0,72.08999633789062,72.41999816894531,71.3499984741211,71.37000274658203,67.88876342773438,MRK,"Clovis' Rubraca Gets Breakthrough Therapy Status for mCRPC ||| Merck & Other Pharma Players Await FDA Decisions in October ||| Stocks Which Set New 52-Week High Yesterday, October 2nd ||| The Daily Biotech Pulse: Endologix's Q3 Sales, Obseva's Positive Trial Results, Kala To Offer Shares",0,0.4999471
2018-10-04,10340700.0,71.12000274658203,71.36000061035156,70.45999908447266,71.22000122070312,67.74607849121094,MRK,"Will Merck (MRK) Beat Estimates Again in Its Next Earnings Report? ||| 5 Reasons Why Investors Should Bet on Pfizer (PFE) Stock ||| BioLineRx Stock Up on Stake Increase in Lead Cancer Program ||| Stocks Which Set New 52-Week High Yesterday, October 3rd ||| The Daily Biotech Pulse: AtriCure's Guidance, Guardant Health And Kodiak To Debut ||| A Peek Into The Markets: US Stock Futures Drop Ahead Of Jobless Claims, Factory Orders Data ||| Merck Reports DELSTRIGO Phase 3 DRIVE-SHIFT Trial Met Primary Efficacy Endpoint",0,0.4994719
2018-10-05,7433500.0,71.2300033569336,71.69000244140625,70.58000183105469,71.02999877929688,67.56535339355469,MRK,"Pharma Stock Roundup: PFE to Get New CEO, LLY Presents Impressive Diabetes Data ||| Gilead Announces Positive Data From Ongoing Biktarvy Study ||| Bull of the Day: Roche (RHHBY) ||| Merck Reports Positive Efficacy Data from Phase III HIV Study ||| REMINDER: Merck Has FDA PDUFA Date Tomorrow October 6th For GARDASIL sBLA",1,0.53891903
2018-10-08,8854800.0,70.93000030517578,71.69999694824219,70.88999938964844,71.45999908447266,67.974365234375,MRK,5 Reasons Why Investors Should Bet on Merck (MRK) Stock,1,0.5322633
2018-10-09,7871300.0,71.45999908447266,72.66000366210938,70.97000122070312,72.33999633789062,68.81143951416016,MRK,Menlo Stock Plunges on Phase II Chronic Cough Study Failure,0,0.52460074
2018-10-10,12651900.0,72.4800033569336,72.88999938964844,70.38999938964844,70.44999694824219,67.01362609863281,MRK,"Stocks That Made New 52-Week Highs So Far Today Include: NextEra Energy, WEC Energy, Verizon, CMS Energy, Ameren, FirstEnergy, McCormick, AES, Merck, Public Service Enterprise, Express Scripts, and Public Service Enterprise ||| Stocks Which Set New 52-Week High Yesterday, October 9th ||| The Daily Biotech Pulse: Novartis Blood Disorder Drug Improves Patient Outcomes, Audentes To Offer Shares",0,0.47727934
2018-10-11,12874000.0,70.37000274658203,70.52999877929688,67.81999969482422,68.37000274658203,65.03509521484375,MRK,"J&J (JNJ) to Set the Ball Rolling for Pharma Q3 Earnings ||| Incyte's Jakafi Demand Strong, Label Expansion to Boost Sales ||| 3 Stock Charts for Thursday: Apple, Merck and Verizon ||| Credit Suisse Maintains Outperform on Merck & Co, Raises Price Target to $81 ||| Stocks Which Set New 52-Week High Yesterday, October 10th ||| The Daily Biotech Pulse: Clinical Hold Lifted Off Crispr's Gene-Edited Therapy, Endra To Offer Shares",1,0.50035214
2018-10-12,10161200.0,68.69999694824219,70.05999755859375,68.41999816894531,69.80999755859375,66.40484619140625,MRK,"Health Care Sector Update for 10/12/2018: APHB, TRVN, NVO, AMGN, MRK, ABT, PFE, JNJ ||| Noteworthy Friday Option Activity: SRG, AAL, MRK ||| 3 Large-Cap Pharma Stocks Performing Better Than Industry ||| Barclays Maintains Overweight on Merck & Co, Raises Price Target to $78 ||| The Daily Biotech Pulse: FDA Thumbs Down For Trevena, Corium To Go Private, Immune Design Discontinues Cancer Vaccine Program",0,0.50131243
2018-10-15,6580900.0,69.19000244140625,70.20999908447266,68.93000030517578,69.45999908447266,66.0719223022461,MRK,"4 Major Market Opportunities For The Cannabis Industry ||| Immune Design to Halt Cancer Vaccine Program, Shares Plunge ||| This is Why Merck (MRK) is a Great Dividend Stock ||| OncoSec Initiates KEYNOTE-890 Phase 2 Clinical Trial Of TAVO In Combination With Merck's KEYTRUDA For Treatment Of Late-Stage Triple Negative Breast Cancer",1,0.53949475
2018-10-16,10229000.0,69.8499984741211,71.30999755859375,69.75,71.22000122070312,67.74607849121094,MRK,"AstraZeneca's (AZN) Lynparza Gets Another Orphan Drug Status ||| Citigroup Maintains Buy on Merck & Co, Raises Price Target to $79 ||| U.S. FDA Grants Merck And AstraZeneca's LYNPARZA Orphan Drug Designation For Pancreatic Cancer ||| AstraZeneca, Merck Receive FDA Orphan Drug for Lynparza in Pancreatic Cancer",1,0.4983506
2018-10-17,9344500.0,71.08999633789062,71.94000244140625,70.80000305175781,71.81999969482422,68.31681060791016,MRK,"2 Big Pharmas Pleased With J&J's Third-Quarter Earnings Report ||| World Health Organization's Emergency Committee Has Said The Ebola Outbreak In Congo Is Not Yet A Health Emergency Of Int'l. Concern, Warns Situation Likely To Deteriorate Significantly Unless Response Is Intensified",1,0.54209834
2018-10-18,12226000.0,72.1500015258789,72.4000015258789,71.41999816894531,72.20999908447266,68.68778228759766,MRK,"Bio-Techne Partners Micropoint Bioscience, Expands in China ||| Novo Nordisk (NVO) Faces Pricing Pressure and Competition ||| Merck Says 'Pivotal Phase 3 KEYNOTE-426 Trial Met Both Primary Endpoints; Data to be Filed with Global Regulatory Authorities' ||| Merck Reports KEYTRUDA In Combo With Pfizer's Inlyta Improved Overall Survival, Progression-Free Survival As First-Line Therapy For Advanced, Metastatic Renal Cell Carcinoma",1,0.5189584
2018-10-19,14513400.0,72.30000305175781,72.66000366210938,71.94000244140625,72.3499984741211,68.82095336914062,MRK,"Agios Rides on Tibsovo Approval Amid Reliance on Celgene ||| Noteworthy ETF Outflows: OEF, MRK, SLB, USB ||| Top Stock Reports for UPS, Merck & BHP Billiton ||| Alkermes Boasts Strong Portfolio and Impressive Pipeline ||| Merck (MRK) Gains As Market Dips: What You Should Know ||| The Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Prices Offering, LogicBio To Debut",1,0.5187073
2018-10-22,11914300.0,72.97000122070312,73.48999786376953,71.8499984741211,72.56999969482422,69.03022766113281,MRK,"Merck Announces KEYTRUDA Showed a Complete Response Rate of Nearly 40% in Patients with High-Risk Non-Muscle Invasive Bladder Cancer Unresponsive to Standard of Care at ESMO 2018 ||| ImmunoGen Presents Encouraging Initial Data from FORWARD II Expansion Cohort Assessing Mirvetuximab Soravtansine in Combination with KEYTRUDA at ESMO 2018 ||| Dynavax Announces SD-101 in Combination with Merck's KEYTRUDA Continues to Show a 70% Overall Response Rate in Advanced Melanoma Patients According to Data Presented Today at ESMO 2018 ||| Merck Announces First Presentation of Early Data for Investigational STING Agonist (MK-1454) in Patients with Advanced Solid Tumors or Lymphomas at ESMO 2018 ||| The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results, Large-Cap Pharma Earnings And IPOs ||| AstraZeneca, Merck Announce Solo-1 Phase III Trial Demonstrates Lynparza Maintenance Therapy Cut the Risk of Disease Progression or Death by 70% in Patients with Newly-Diagnosed, Advanced BRCA-Mutated Ovarian Cancer at ESMO ||| Leap Therapeutics Presents Promising Esophagogastric Cancer Data at ESMO 2018 ||| Here's Why ImmunoGen Fell Today ||| BIIB, ALKS Q3 Earnings Due on Oct 23: What's in Store? ||| Why Dynavax Technologies Corporation Is Surging Today ||| Strong Earnings Enough Reason to Stay Long JNJ Stock ||| Why Aduro Biotech Crashed 29.5% Today ||| Why Tesaro, Inc. Is Tanking Today ||| Here's Why Clovis Oncology Dropped as Much as 21.2% Today ||| 11 Stocks That Moved From ESMO 2018 ||| Benzinga's Week Ahead: Can Tech Earnings Restore The Rally? Amazon, Google To Report ||| BMO Capital Maintains Outperform on Merck & Co, Raises Price Target to $82 ||| Merck Reports Presentation Of KEYTRUDA Showing Improved Overall Survival In Patients With Recurrent Or Metastatic Head And Neck Cancer; Results Being Presented At ESMO 2018 Congress ||| European Medicines Agency Adopts Positive Opinion for Merck's KEYTRUDA as Adjuvant Therapy in Melanoma ||| REMINDER: ESMO 2018 Event Continues Today, Clinical Updates Presented Today Include: CytomX Therapeutics, Mirati Therapeutics, Merck, NuCana, Protagonist Therapeutics, SELLAS Life Sciences, Epizyme, Kura Oncology, Intra-Cellular Therapies, and AVEO Pharma",0,0.51956075
2018-10-23,11561900.0,72.16000366210938,72.41999816894531,71.22000122070312,72.0999984741211,68.58314514160156,MRK,"Alkermes (ALKS) Exceeds Q3 Earnings Estimates, Raises Outlook ||| Bristol-Myers Declines, FDA Delays Review of Opdivo for NSCLC ||| Stocks Which Set New 52-Week High Yesterday, October 22nd ||| The Daily Biotech Pulse: Regulus Soars On Positive Pre-Clinical Data, Biogen Earnings, Proteostasis And Eiger to Offer Shares",0,0.4952716
2018-10-24,14645200.0,71.81999969482422,72.63999938964844,70.2300033569336,70.54000091552734,67.0992431640625,MRK,"Healthcare ETFs to Buy Ahead of Q3 Earnings ||| Drug Stocks' Earnings Due on Oct 25: MRK, BMY, GILD & CELG ||| Here's Why Tesaro Inc. Dropped 13.8% Today ||| Wednesday's ETF with Unusual Volume: XPH ||| Merck's Q3 Earnings Preview",0,0.4868208
2018-10-25,20566500.0,66.94000244140625,70.56999969482422,66.0999984741211,69.95999908447266,66.54752349853516,MRK,"Dow Movers: MRK, MSFT ||| Pfizer (PFE) to Report Q3 Earnings: What's in the Cards? ||| Merck (MRK) Beats on Q3 Earnings, Lags Sales, Ups EPS View ||| Daily Dividend Report: MRK, MMP, BAC, CMCSA, COST ||| Merck & Co Inc (MRK) Q3 2018 Earnings Conference Call Transcript ||| Earnings Data Deluge ||| Health Care Sector Update for 10/25/2018: ARPO,BMY,MRK,ELGX ||| Health Care Sector Update for 10/25/2018: CEMI, BMY, ELGX, JNJ, PFE, ABT, MRK, AMGN ||| Merck (MRK) Q3 Earnings Surpass Estimates ||| Snapping Back, But Can Rally Attempt Last? Strong Earnings Might Power Market ||| The Daily Biotech Pulse: AbbVie Takes Full Control Of Cystic Fibrosis Program, Amgen Slashes Cholesterol Drug Price ||| A Peek Into The Markets: US Stock Futures Rise Ahead Of Earnings, Economic Reports ||| Merck Raises Qtr. Dividend From $0.48 To $0.55/Share; Adds $10B To Buyback ||| UPDATE: Merck Raises FY18 Adj. EPS Guidance From $4.22-$4.30 As Of Jul. 27, 2018 To $4.30-$4.36 vs $4.29 Estimate ||| Merck Raises Guidance ||| Merck & Co Q3 EPS $1.19 Beats $1.14 Estimate, Sales $10.794B Miss $10.88B Estimate",1,0.49367338
2018-10-26,16950600.0,69.7699966430664,70.77999877929688,68.87999725341797,70.4000015258789,66.96607208251953,MRK,"Seattle Genetics (SGEN) Q3 Loss In Line, Sales Top Mark ||| 7 Stocks to Buy According to Five-Star Analysts ||| Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO ||| Dow 30 Stock Roundup: Boeing, Caterpillar, Intel, Microsoft Earnings Impress ||| Syndax Pharmaceuticals' Breast Cancer Treatment Fails to Reach Primary Endpoint; Shares Slide 18% To Record Low ||| BMO Capital Maintains Outperform on Merck & Co, Lowers Price Target to $80",1,0.4906495
2018-10-29,18839600.0,71.37000274658203,73.02999877929688,70.55000305175781,71.44999694824219,67.96484375,MRK,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results, Earnings And IPOs ||| SPDR Portfolio S&P 500 Growth ETF Experiences Big Outflow ||| Dow Movers: IBM, NKE ||| Merck (MRK) Gains As Market Dips: What You Should Know ||| Benzinga's Week Ahead: Can Facebook, Apple Earnings Rescue The Stock Market?",1,0.5103421
2018-10-30,18937000.0,71.69000244140625,72.95999908447266,71.5,72.87000274658203,69.31560516357422,MRK,"Pfizer (PFE) Beats on Q3 Earnings, Meets Sales, Narrows View ||| What's in Store for Verastem (VSTM) This Earnings Season? ||| Allergan (AGN) Beats on Q3 Earnings, Raises 2018 Guidance ||| Incyte (INCY) Misses on Q3 Earnings & Revenues, Updates View ||| 2 “Forever” Stocks to Grab on This Pullback (paying up to 7.7%) ||| Merck Reports FDA Approved KEYTRUDA In Combo With Carboplatin, Either Paclitaxel Or Nab-Paclitaxel For First-Line Treatment Of Patients With Metastatic Squamous Non-Small Cell Lung Cancer ||| Wild Times: Market Seems To Seek Solid Ground After Monday's Manic ||| The Daily Biotech Pulse: Pfizer And Allergan Earnings, CFO Departures At Acadia And Assertio ||| REMINDER: Merck Has PDUFA Date for KEYTRUDA+carboplatin-paclitaxel sBLA Today",1,0.45234007
2018-10-31,15863100.0,73.41000366210938,74.48999786376953,72.7699966430664,73.61000061035156,70.0195083618164,MRK,"Clovis (CLVS) Q3 Earnings & Sales Lag, Rubraca Disappoints ||| Sanofi's (SNY) Q3 Earnings and Sales Surpass Estimates ||| The Pharmaceuticals Industry Stock Outlook: A Steady Path Ahead ||| Citigroup Maintains Buy on Merck & Co, Raises Price Target to $84 ||| The Daily Biotech Pulse: KemPharm, FDA Nod For Merck, Clovis Q3 Miss, 3 Stocks To Debut",0,0.49519616
2018-11-01,13843500.0,73.80000305175781,74.04000091552734,72.66999816894531,73.12000274658203,69.55339813232422,MRK,"Novo Nordisk (NVO) Reports In-Line Q3 Earnings, Beats Sales ||| Zoetis (ZTS) Beats on Q3 Earnings & Sales, Updates '18 View ||| Stocks Which Set New 52-Week High Yesterday, October 31st ||| Citigroup Maintains Buy on Merck & Co, Raises Price Target to $84 ||| Attention Biotech Investors: Mark Your Calendar For These November PDUFA Dates ||| The Daily Biotech Pulse: AbbVie's Leukemia Drug Trial Meets Endpoint, Denali Strikes Collaboration Deal",0,0.4903787
2018-11-02,12898700.0,73.56999969482422,73.69999694824219,71.62000274658203,72.2699966430664,68.74486541748047,MRK,"Here's Why Exelixis Inc. Stock Is Surging Today ||| Dow Recovers More Than 900 Points in 3 Days: 5 Top Picks ||| Pharma Stock Roundup: PFE, AGN Q3 Earnings, LLY, NVS Collaboration Deals in Focus ||| Shire's (SHPG) Earnings, Revenues Miss Estimates in Q3 ||| AMAG Posts Wider-Than-Expected Q3 Loss, Beats on Revenues",1,0.5088926
2018-11-05,12330500.0,71.95999908447266,73.56999969482422,70.12000274658203,73.12000274658203,69.55339813232422,MRK,"The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs ||| ImmunoGen (IMGN) Beats on Earnings in Q3, Lowers Guidance ||| Endo (ENDP) to Report Q3 Earnings: What's in the Cards?",1,0.48006594
2018-11-06,10246100.0,72.94000244140625,73.80000305175781,72.75,73.30999755859375,69.734130859375,MRK,Democrats Hold Edge in House Battle: 5 Great Picks ||| Beaten-Down Pharma ETFs to Buy Post Q3 Results ||| What's in the Cards for Perrigo (PRGO) This Earnings Season?,1,0.48417118
2018-11-07,18670500.0,74.0999984741211,75.33000183105469,73.83999633789062,75.08000183105469,71.41780090332031,MRK,"Mallinckrodt (MNK) Beats on Q3 Earnings Estimates, Ups View ||| 7 Healthcare Stocks Soaring on Election Results ||| Merck Reports Early Phase 1 Data From MK-4280, MK-7684 Trial To Be Presented At SITC Meeting Nov. 9, 2018",1,0.4735588
2018-11-08,13010200.0,74.88999938964844,75.69000244140625,74.62000274658203,75.4800033569336,71.79827880859375,MRK,"Horizon Pharma (HZNP) Q3 Earnings & Sales Beat, Shares Rise ||| Immune Design (IMDZ) Posts Narrower-Than-Expected Loss in Q3 ||| AstraZeneca's (AZN) Q3 Earnings Beat, New Drugs Drive Sales ||| Perrigo (PRGO) Beats on Q3 Earnings, Cuts View, Shares Down ||| Democrats Hold Edge in House Battle: 5 Great Picks (Revised) ||| Merck (MRK) Gains As Market Dips: What You Should Know ||| Agenus (AGEN) Q3 Loss Wider Than Expected, Pipeline in Focus ||| Stocks Which Set New 52-Week High Yesterday, Wed., Nov. 7, 2018 ||| The Daily Biotech Pulse: Nantkwest Reports Positive Cancer Vaccine Trial Results, Sarepta Offering",0,0.50881463
2018-11-09,14656300.0,75.86000061035156,75.98999786376953,74.80000305175781,74.86000061035156,71.20853424072266,MRK,"Pharma Stock Roundup: LLY, AZN Report Q3 Earnings, PFE Gets FDA Nod for Cancer Drug ||| Endo (ENDP) Stock Declines Despite Q3 Earnings & Revenue Beat ||| Catalyst (CPRX) Reports Q3 Loss as Expected & Pipeline Update ||| Keryx's (KERX) Loss Narrower Than Expected in Q3, Sales Lag ||| FDA Approves Merck's KEYTRUDA For Patients With Hepatocellular Carcinoma (HCC) Who Have Been Previously Treated With Sorafenib ||| Stocks Which Set New 52-Week High Yesterday, Thurs., Nov. 8, 2018 ||| The Daily Biotech Pulse: SITC Presentations Pick Up Pace, Sandoz' Voluntary Recall",0,0.5082616
2018-11-12,14006700.0,75.12999725341797,75.2699966430664,74.02999877929688,74.69000244140625,71.04682159423828,MRK,"How Bristol-Myers Squibb Company Fell $18.8 Billion in October ||| Merck's (MRK) Keytruda Gets FDA Approval for Liver Cancer ||| Why Dynavax Technologies Corporation Fell 20.2% in October ||| October's biggest Losers And Most Surprising Winners ||| Merck Announces the FDA Has Accepted a Supplemental New Drug Application for LYNPARZA ||| AstraZeneca, Merck Announce FDA Accepts Regulatory Submission for Lynparza Maintenance Therapy in Newly-diagnosed, BRCA-mutated Advanced Ovarian Cancer and Grants Priority Review",0,0.506292
2018-11-13,15827700.0,75.22000122070312,75.2699966430664,74.01000213623047,74.61000061035156,70.97071838378906,MRK,Dow Analyst Moves: MRK ||| AstraZeneca's Lynparza Gets Priority Review in 1st Line Use ||| Merck Reports Commencement Of Rolling Submission Of Licensure Application For V920 To FDA ||| World Health Organization's Emergency Response Chief Says We Expect Democratic Republic Of Congo's Ebola Outbreak To Last At Least Another Six Months,0,0.49461788
2018-11-14,9481100.0,74.94999694824219,74.95999908447266,73.68000030517578,74.08999633789062,70.47607421875,MRK,"Tesaro, Clovis Rally on FDA Priority Review for Lynparza sNDA ||| Merck Starts Rolling BLA Submission for Ebola Vaccine V920 ||| Can These 2 Battered Biotech Stocks Recover? ||| Merck (MRK) Stock Moves -0.7%: What You Should Know ||| AbbVie's HCV Drug Mavyret Succeeds in Label Expansion Study ||| The Daily Biotech Pulse: Mallinckrodt Faces FDA Panel, Reshape's Earnings, Vapotherm To Debut ||| Merck Reports KEYTRUDA Significantly Improved Overall Survival Compared To Chemotherapy In Patients With Advanced Esophageal Or Esophagogastric Junction Carcnimoa Whose Tumors Express PD-L1",1,0.50454456
2018-11-15,11974400.0,73.5,74.87000274658203,73.12999725341797,74.83999633789062,71.18950653076172,MRK,"Merck's Keytruda Improves Survival in Esophageal Cancer Study ||| Mallinckrodt Gets FDA Committee Vote for Abuse-Deterrent Drug ||| NewLink Genetics Announces Merck Has Begun Rolling Submission Of Licensure Application For Ebola vaccine V920 To U.S. FDA; In 2014, Co. Entered Ito License Agreement With Merck To Develop, Manufacture And Commercialize Ebola Vaccine",1,0.5232729
2018-11-16,13725200.0,74.73999786376953,76.25,74.55000305175781,76.05999755859375,72.3499984741211,MRK,February 2019 Options Now Available For Merck ||| Seattle Genetics' Adcetris Gets Breakthrough Therapy Status ||| Bristol-Myers' Opdivo Receives Positive CHMP Opinion for RCC,1,0.50431687
2018-11-19,16422400.0,76.22000122070312,76.61000061035156,75.58999633789062,76.3499984741211,72.62584686279297,MRK,"Better Buy: Celgene Corporation vs. Merck & Co. ||| One Put, One Call Option To Know About for Merck & Co ||| AstraZeneca's Imfinzi Fails in Lung Cancer Study, Stock Down ||| Drug Pricing Resurfaces, Pfizer to Raise Cost of 41 Drugs ||| Health Care Sector Update for 11/19/2018: SNOA, GSK, PFE, MRK, ABT, AMGN, JNJ ||| 3 Steady Healthcare Stocks to Hold During a Downturn ||| Merck and Pfizer's Avelumab in Platinum-Resistant/Refractory Ovarian Cancer Did Not Meet Primary Endpoints",0,0.49994606
2018-11-20,13587800.0,76.01000213623047,76.36000061035156,74.6500015258789,74.77999877929688,71.13241577148438,MRK,"Pfizer's Bavencio Phase III Study for Ovarian Cancer Fails ||| Here's Why Tesaro Is On the Move Today ||| Stocks Which Set New 52-Week High Yesterday, Mon., Nov. 19, 2018 ||| The Daily Biotech Pulse: Denali's Positive Results, Novartis' Substance Abuse Therapy Launch, Medtronic Earnings",1,0.4755859
2018-11-21,9054500.0,74.91999816894531,75.06999969482422,74.18000030517578,74.79000091552734,71.1419448852539,MRK,"FDA Accepts Allergan's (AGN) sNDA for Anti-Infective Avycaz ||| Mylan Recalls Valsartan Lots, Gets FDA Warning for Facility ||| IntelGenx's NDA Resubmission for Rizaport Gets FDA Acceptance ||| TESARO Shares Rally on Rumors of Potential Acquisition Offer ||| Pfizer Stock Has Multiple Positive Catalysts ||| Shire-Takeda Deal Gets Phase I Conditional European Approval ||| Stocks Of Vaccination Providers Do Not React Following Update From Health Ministry Suggesting 13 New Cases Of Ebola Were Reported In Eastern Congo Wed. ||| October's Biggest Losers And Most Surprising Winners",0,0.54284644
2018-11-23,3521800.0,74.12999725341797,75.30000305175781,74.01000213623047,74.66999816894531,71.02779388427734,MRK,Bayer Hurts from Generic Competition & Pipeline Setbacks,1,0.5312237
2018-11-26,10884600.0,74.98999786376953,75.75,74.79000091552734,75.44000244140625,71.7602310180664,MRK,"The Week Ahead In Biotech: ASH 2018, PDUFA Dates, Clinical Trials And Earnings ||| 9 Policy Catalysts For Health Care Investors To Watch Before Year's End ||| Interesting January 2020 Stock Options for MRK ||| AMAG's Label Expansion of Lead Products Raises Share Price ||| Data Dive, Trade Talks And Powell: Busy Post-Holiday Week On The Way",1,0.5265901
2018-11-27,14623600.0,75.06999969482422,76.5199966430664,75.06999969482422,76.33999633789062,72.6163330078125,MRK,"Accenture Brings Open Partner Ecosystem for Drug Discovery ||| Merck (MRK) Outpaces Stock Market Gains: What You Should Know ||| Alnylam, Vir Begin Phase I/II Study on Hepatitis B Candidate ||| Bristol-Myers' Opdivo-Yervoy Combo Fails in Lung Cancer Trial ||| Dow Movers: UTX, VZ ||| Astrazeneca's Fasenra Gets Orphan Drug for Autoimmune Disease ||| The Daily Biotech Pulse: Abeona Fires CEO, Loxo Passes FDA Muster, Bristol-Myers Flunks Lung Cancer Trial",1,0.4890179
2018-11-28,12047400.0,76.80000305175781,77.36000061035156,76.2699966430664,77.2300033569336,73.46292114257812,MRK,Merck Receives European Commission Approval For DELSTRIGO As Part OF An HIV-1 Treatment Regimen,1,0.53718626
2018-11-29,10905700.0,77.19000244140625,78.4800033569336,77.11000061035156,77.91000366210938,74.10974884033203,MRK,"4 Big Pharma Stocks to Add to Your Portfolio in December ||| Merck (MRK) Receives Approval for 2 HIV Medicines in EU ||| Catalyst's Firdapse Receives FDA Approval for Rare Disease ||| Merck Is Up 40% In 2018: What's Driving The Rally? ||| Ebola Outbreak In Eastern Congo Now World's Second Largest Ever With 426 Cases ||| Merk shares rise after the European Commission approved Co's HIV treatments in Europe. ||| Stocks Which Set New 52-Week High Yesterday, Wed., Nov. 28, 2018 ||| The Daily Biotech Pulse: Twist In Protagonist Tale, Catalyst's Autoimmune Disorder Drug Approved",1,0.52096725
2018-11-30,21355600.0,77.83999633789062,79.48999786376953,77.72000122070312,79.33999633789062,75.4699935913086,MRK,"Key Pharma Players With HIV Focus Ahead of World Aids Day ||| Friday’s Vital Data: McDonald’s, Twitter and Merck ||| Dow 30 Stock Roundup: BA's $383M Modification Contract, MSFT's Army Contract ||| Novartis' Gilenya Approved in EU for Expanded Population ||| Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates ||| Stocks Which Set New 52-Week High Yesterday, Thurs., Nov. 29, 2018 ||| The Daily Biotech Pulse: EC Nod For Shire, Mirati Gets FDA Clearance For Cancer Drug Trials, PhaseBio's First Earnings",0,0.5140638
2018-12-03,12579300.0,79.5199966430664,79.58000183105469,78.27999877929688,79.22000122070312,75.3558578491211,MRK,"XLV, PFE, MRK, ABBV: ETF Inflow Alert ||| Shire's Takhzyro Gets European Nod for Hereditary Angioedema ||| Does Keytruda's Dominance Make Merck & Co. a Buy Now? ||| The Zacks Analyst Blog Highlights: General Motors, Boeing, Microsoft, Merck and UnitedHealth ||| Merck Reaches Analyst Target Price",0,0.48119214
2018-12-04,14773800.0,79.30000305175781,80.19000244140625,78.0999984741211,78.20999908447266,74.3951187133789,MRK,"3 Big Pharma Stocks Hitting 52-Week Highs -- Are They Buys? ||| Incyte (INCY) Announces Positive Data on Jakafi for GVHD ||| Ahead Of Mid-Week Pause, Investors Fret Over Trade Pact Details ||| Stocks Which Set New 52-Week High Yesterday, Mon., Dec. 3, 2018 ||| The Daily Biotech Pulse: ASH Presentations Take The Spotlight, Eiger Gets A New CFO",1,0.517064
2018-12-06,16535800.0,76.95999908447266,78.37000274658203,75.81999969482422,78.37000274658203,74.54731750488281,MRK,"AbbVie Halts Rova-T Phase III Second-Line Lung Cancer Study ||| The Daily Biotech Pulse: AbbVie Halts Lung Cancer Trial, Oncomed Merges With Mereo, Momenta Offering ||| Ra Pharma Reports Received Development Milestone Payment Under Deal With Merck; Says Is Eligible To Earn Up To $59M In Added Milestone Payments",0,0.52370316
2018-12-07,12622900.0,78.22000122070312,78.30000305175781,76.0999984741211,76.72000122070312,72.97779846191406,MRK,"Dow Movers: INTC, CVX ||| 7 Stocks to Buy to Survive a Bear Market ||| Mallinckrodt (MNK) to Separate Generics & Branded Businesses ||| Novartis Presents Additional Data on Breast Cancer Candidate ||| AstraZeneca's Imfinzi Fails in Head and Neck Cancer Study",1,0.51105
2018-12-10,15423300.0,77.44999694824219,77.77999877929688,75.86000061035156,77.41999816894531,73.64366149902344,MRK,"Roche's Tecentriq Gets FDA Approval for First-Line NSCLC ||| PFE Stock Has Broken Its Slump and Could Challenge Former Highs ||| After Hours Most Active for Dec 10, 2018 : V, MCHI, MRK, T, WEN, WFC, QQQ, TEVA, MGM, SIRI, AAPL, ODP ||| Merck Names Frank Clyburn Chief Commercial Officer, Michael Nally Chief Marketing Officer; BZ NOTE: These Positions Are Both New Roles For Merck ||| Merck Reports FDA Orphan Drug Designation For M7824 In Biliary Tract Cancer",0,0.5008459
2018-12-11,13232500.0,77.91999816894531,78.30999755859375,76.54000091552734,77.11000061035156,73.34877014160156,MRK,"Moderna Stock Ushers In the Next Wave of Biotech ||| Can Moderna Stock Recover From Its Initial Setback? ||| Gabelli Names Clovis As Top Pick, Calls The Biotech A Likely Takeout Candidate ||| Merck And Roche Enter Into Collaboration Agreement To Develop Companion Diagnostic Test To Identify Patients Eligible For PD-1 Therapy Based On The Status Of A Biomaker In Advanced Solid Tumors ||| The Daily Biotech Pulse: Management Change At Merck, Jazz Buyback, Arrowhead Earnings",1,0.5455974
2018-12-12,10705800.0,77.7699966430664,78.76000213623047,77.72000122070312,78.01000213623047,74.20487213134766,MRK,"Notable ETF Inflow Detected - IVE, C, WMT, MRK ||| Roche to Create Companion Diagnostic Test for Merck's Keytruda ||| Pfizer's (PFE) Shares Drop on Rating Downgrade by JP Morgan ||| Merck and Instituto Butantan Announce Collaboration Agreement To Develop Dengue Infections Vaccine; Instituto Butantan To Receive $26M Upfront And Is Eligible For Up To $75M In Milestones",1,0.47879952
2018-12-13,10756200.0,78.25,79.08000183105469,78.0,79.01000213623047,75.15608978271484,MRK,"J&J's Tremfya Beats Novartis' Cosentyx in Head-to-Head Study ||| Lilly Inks Deal With AC Immune for Potential Alzheimer's Drug ||| 5 Dow Stocks Stand Tall Despite Index's Loss of 2018 Gains ||| Mallinckrodt's Roxicodone Reformulation Gets CRL From FDA ||| Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for December 14, 2018",0,0.49627075
2018-12-14,13259900.0,77.83000183105469,78.02999877929688,76.2300033569336,76.4800033569336,73.25949096679688,MRK,"Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? ||| 5 Drug/Biotech Stocks With Promise to Sustain Bull Run in 2019 ||| Stocks Trading Ex Dividend For Fri., Dec. 14 2018 ||| A Peek Into The Markets: US Stock Futures Tumble Ahead Of Economic Reports ||| Merck Reports Purchase Of Antelliq Group For €2.1B In Cash, Assume €1.15B In Co. Debt",0,0.4832801
2018-12-17,15106700.0,75.97000122070312,76.88999938964844,74.86000061035156,75.2300033569336,72.06211853027344,MRK,Lilly (LLY) to Acquire Pain Candidate From Private Biotech ||| J&J Dips 10% as Reuters Says Company Knew of Asbestos in Talc ||| Better Buy: Eli Lilly and Company vs. Merck & Co. ||| Merck (MRK) Stock Moves -1.63%: What You Should Know ||| Merck to Acquire Europe's Antelliq Group for $2.4 Billion ||| Merck's KEYTRUDA as Adjuvant Therapy for Adults with Resected Stage III Melanoma Approved by the European Commission,0,0.48547223
2018-12-18,15423500.0,75.5999984741211,75.77999877929688,73.55999755859375,74.33000183105469,71.20001220703125,MRK,Merck's Keytruda Gets EU Nod as Adjuvant Therapy for Melanoma ||| Lilly's Taltz Outshines Humira in Psoriatic Arthritis Study ||| Bristol-Myers' Label Expansion of Sprycel Gets CHMP Nod ||| Evofem Shares Up as Birth Control Gel Succeeds in Phase III,0,0.50177985
2018-12-19,18860300.0,74.68000030517578,75.25,73.06999969482422,73.7699966430664,70.66358947753906,MRK,"FDA Approves Merck's KEYTRUDA For Treatment Of Recurrent Locally Advanced Or Metastatic Merkel Cell Carcinoma ||| AstraZeneca, Merck Report FDA Approval For LYNPARZA For First-Line Maintenance Therapy in BRCA-mutated Advanced Ovarian Cancer ||| Merck Announces FDA Approval Of LYNPARZA For Ovarian Cancer ||| Merck Receives FDA Approval For Pembrolizumab In Merkel Cell Carcinoma",0,0.52981865
2018-12-20,19390700.0,73.44999694824219,74.12999725341797,72.63999938964844,73.48999786376953,70.3953857421875,MRK,"AstraZeneca's (AZN) Lynparza Gets FDA Nod in 1st Line Setting ||| Merck's Keytruda Gets FDA Approval for Rare Skin Cancer ||| Bristol-Myers to Sell French Consumer Health Unit for $1.6B ||| Merck Extends PDUFA Date For Supplemental Biologics Licence For Keytruda By Three Months To April 11, 2019 ||| The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum ||| AstraZeneca, Merck Report LYNPARZA Met Primary Endpoint In Phase 3 SOLO-3 Trial For Treatment of Relapsed BRCA-Mutated Advanced Ovarian Cancer",0,0.5128146
2018-12-21,36183200.0,72.94999694824219,74.44999694824219,72.22000122070312,72.9000015258789,69.83023071289062,MRK,"Pfizer Xtandi Succeeds in Late-Stage Prostate Cancer Study ||| Pharma Stock Roundup: GSK, PFE Ink Consumer Health JV, JNJ Hit by Talc Allegations ||| Dow 30 Stock Roundup: Nike, Walgreens Boots Earnings Impress ||| 5 S&P 500 Stocks Stand Tall Despite Index's Loss of 2018 Gains ||| The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial",0,0.4750007
2018-12-24,11036100.0,72.52999877929688,72.9000015258789,70.88999938964844,71.1500015258789,68.1539306640625,MRK,"Better Buy: AbbVie vs. Merck ||| The Week Ahead In Biotech: Focus Shifts To Year-End Clinical Trial Results ||| Dow Movers: NKE, WMT ||| Pfizer/Merck KGaA End Bavencio Ovarian Cancer Phase III Study",1,0.50225335
2018-12-26,13429400.0,70.97000122070312,74.02999877929688,70.97000122070312,74.0,70.8839111328125,MRK,"Sanofi's paediatric hexavalent vaccine approved by U.S. FDA ||| Bristol-Myers Squibb Stock Is Coming Back Slow, but That’s Fine",1,0.49030223
2018-12-27,12955300.0,73.27999877929688,75.37999725341797,72.76000213623047,75.37999725341797,72.20580291748047,MRK,"Dow Movers: UTX, IBM ||| What Happened With Apple Stock in 2018, and What's Next ||| Sanofi Wins FDA Nod for Pediatric Hexavalent Combo Vaccine ||| Forget J&J, Buy These 3 Big Drug Stocks Instead in 2019",0,0.4858308
2018-12-28,12577000.0,75.87999725341797,76.58000183105469,74.83000183105469,75.37000274658203,72.19621276855469,MRK,"Top Analyst Reports for Merck, Abbott & Lockheed Martin ||| Merck (MRK) Stock Moves -0.01%: What You Should Know ||| BioXcel Surges on Fast Track Designation to Agitation Drug",1,0.5099486
2018-12-31,9243800.0,75.81999969482422,76.69999694824219,75.66000366210938,76.41000366210938,73.19242858886719,MRK,"The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials ||| What Happened in the Stock Market Today ||| The Zacks Analyst Blog Highlights: Merck, Abbott, Lockheed Martin, United Parcel Service and Bank of New York Mellon ||| Microsoft Stock Was the Dow's Top Tech Performer in 2018 ||| Attention Biotech Investors: Mark Your Calendar For These January PDUFA Dates",0,0.48862582
2019-01-02,14427600.0,75.29000091552734,75.98999786376953,74.5999984741211,75.58999633789062,72.40694427490234,MRK,The 3 Best Stocks in the Dow Jones in 2018 ||| Horizon Pharma (HZNP) Up 28% on Business Expansion Strategy,0,0.5155204
2019-01-03,13273500.0,75.55999755859375,75.97000122070312,73.8499984741211,74.04000091552734,70.92223358154297,MRK,"The Top Healthcare Stocks of 2018: Can They Continue in 2019? ||| Bristol-Myers' (BMY) Sprycel Gets FDA Nod for Label Expansion ||| Amunix Reports Licensing Deal With Merck For ProTIA Immune Activator Platform, No Terms Disclosed ||| Cocrystal Pharma Announces Exclusive Worldwide License And Collaboration Agreement With Merck To Develop Influenza A/B Agents; Cococrystal Will Receive Upfront Payment On An Undisclosed Amount, Is Eligible For Up To $156M In Milestones Plus Royalties ||| The Daily Biotech Pulse: Aevi's ADHD Drug Flunks Mid-Stage Trial, Bristol-Myers To Buy Celgene, Teva Settles With Amgen ||| Merck Reports KEYTRUDA Received 5 New Approvals In Japan, Including Advanced Non-Small Cell Lung Cancer, As Adjuvant Therapy for Melanoma, In Advanced Microsatellite Instability-High Tumors ||| Merck Reports Exercise Of Its Option For NGM Bio's NGM313 For Treatment Of NASH, Type 2 Diabetes ||| Merck Exercises Option for NGM Bio's Investigational Insulin Sensitizer NGM313 for Treatment of NASH and Type 2 Diabetes",1,0.50471044
2019-01-04,14077400.0,74.73999786376953,76.5,74.63999938964844,76.2699966430664,73.05831146240234,MRK,"Bristol-Myers Becomes a Cancer-Fighting Giant With Celgene Buyout ||| Pharma Stock Roundup: BMY to Buy CELG for $74B, MRK Gets Rights to NASH Candidate ||| Bristol-Myers to Acquire Leading Biotech Celgene for $74B ||| Pfizer Begins Pivotal Study on Alopecia Areata Candidate ||| Merck Buys NASH Candidate, Keytruda Wins 5 Approvals in Japan",0,0.49351197
2019-01-07,15071700.0,76.1500015258789,76.47000122070312,75.41000366210938,75.43000030517578,72.25370025634766,MRK,"Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? ||| Noteworthy ETF Outflows: XLV, MRK, ABT, AMGN ||| The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Merck, Pfizer and AbbVie ||| Merck (MRK) Stock Sinks As Market Gains: What You Should Know ||| 5 Top-Selling Drugs With Growth Potential In 2019",1,0.47750217
2019-01-08,11351800.0,75.87000274658203,76.20999908447266,75.29000091552734,75.98999786376953,72.79010772705078,MRK,Dogs of the Dow Win in 2018: Will ETFs See Success in 2019? ||| Is It Time to Sell Celgene Stock After the Bristol-Myers Squibb Offer?,0,0.49859798
2019-01-09,11370500.0,75.88999938964844,76.30999755859375,75.31999969482422,75.41000366210938,72.23454284667969,MRK,"Moderna (MRNA) Announces Pipeline Progress, Shares Rise ||| Novartis' Crizanlizumab Gets Breakthrough Therapy Status ||| Dow Posts Longest Winning Run Since November: 5 Top Picks ||| How 7 New Laws Affected Stocks In The Last Week",0,0.5103218
2019-01-10,18257700.0,75.68000030517578,75.68000030517578,73.47000122070312,74.4800033569336,71.34370422363281,MRK,Big Pharma CEOs Indicate More M&A Deals at JP Morgan Meeting,1,0.5153297
2019-01-11,9425600.0,74.69999694824219,74.94000244140625,74.1500015258789,74.9000015258789,71.74600219726562,MRK,"4 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2019 ||| Dow 30 Stock Roundup: Boeing Q4 Commercial Deliveries Up Y/Y, Merck Buys NASH Candidate ||| NASH Space in Focus in 2019 as Firms Look to Diversify ||| Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet ||| 5 Reasons Why Investors Should Buy Novo Nordisk (NVO) in 2019",0,0.5304877
2019-01-14,14951800.0,74.29000091552734,74.44000244140625,73.0999984741211,73.37000274658203,70.28044891357422,MRK,"Here's Why Merck & Co. Surged 35.8% in 2018 ||| Dow Closes Lower on China, Earnings Anxiety ||| What's in Store for Merck in 2019 After a Solid Run in '18? ||| Dow Movers: CAT, GS ||| Market Close Report: NASDAQ Composite index closes at 6,905.92 down -65.56 points ||| 5 Reasons Why Investors Should Buy Exelixis (EXEL) in 2019 ||| Merck Reports KEYTRUDA Reduced Risk Of Death By 31% Vs Chemotherapy In Previously-Treated Patients With Advanced Esophageal, Esophagogastric Junction Carcinoma Whose Tumors Expressed PD-L1",1,0.48181194
2019-01-15,12502000.0,73.0999984741211,74.88999938964844,73.0999984741211,74.5,71.36285400390625,MRK,"XLV, PFE, UNH, MRK: Large Inflows Detected at ETF ||| My 3 Favorite “Dogs of the Dow” for 2019 ||| 3 Big Stock Charts for Tuesday: Broadcom, Facebook and Merck ||| 3 of the Top Big Pharma Stocks to Buy Now ||| Bank Of America, JPMorgan, Merck, Stratasys: 'Fast Money' Picks For January 15",1,0.48363686
2019-01-17,16192100.0,74.30999755859375,75.7699966430664,74.30999755859375,75.5999984741211,72.4165267944336,MRK,"Why Bristol-Myers Squibb Stock Sank By 15.2% in 2018 ||| 3 Big Stock Charts for Thursday: Fiserv, Pfizer and PNC Financial Services Group ||| Pacira's Study on Exparel Label Expansion Meets Endpoints ||| Roche's sBLA for Tecentriq-Abraxane Combo Accepted by FDA",1,0.48743773
2019-01-18,14294600.0,76.13999938964844,76.33000183105469,75.47000122070312,75.87000274658203,72.67516326904297,MRK,Aerie's (AERI) Eye Care Candidate to Enter Clinical Studies,0,0.52345467
2019-01-22,10084700.0,75.56999969482422,76.19999694824219,75.36000061035156,75.83000183105469,72.63684844970703,MRK,"Top Analyst Reports for Bank of America, Merck & Netflix ||| J&J's (JNJ) Q4 Earnings Beat, 2019 Sales Forecast Soft ||| All Signals Are Positive for Buying Abbott Laboratories ||| Health Care Sector Update for 01/22/2019: TGTX, SRNE, JNJ, ABT, MRK, AMGN, PFE ||| Alnylam & Medison Partner to Market RNAi Products in Israel ||| The Zacks Analyst Blog Highlights: Bank of America, Merck, Netflix, IBM and The Bank of New York Mellon",0,0.4773472
2019-01-23,13711100.0,75.55000305175781,75.70999908447266,74.73999786376953,75.44000244140625,72.26326751708984,MRK,"MTUM, MRK, PFE, MA: ETF Outflow Alert ||| Dow Movers: MRK, IBM ||| Merck, Tencent Sign Deal On Intelligent Digital Healthcare Services In China ||| Benzinga's Top Upgrades, Downgrades For January 23, 2019 ||| BMO Capital Downgrades Merck & Co to Market Perform, Announces $80 Price Target",0,0.48871398
2019-01-24,20979600.0,75.16000366210938,75.16000366210938,72.37999725341797,73.16999816894531,70.08885192871094,MRK,"Healthcare ETFs in Focus Ahead of Q4 Earnings ||| Sanofi's (SNY) Influenza Vaccine Gets FDA Approval for Kids ||| Does Johnson & Johnson's Grim Outlook Spell Trouble for Big Pharma Stocks? ||| Market Close Report: NASDAQ Composite index closes at 7,073.46 up 47.69 points ||| Nasdaq Outperforms on Semiconductor Stock Strength ||| Bristol-Myers Squibb Withdraws Regulatory Application For Lung Cancer Combo Drug",0,0.50076187
2019-01-25,13410400.0,73.81999969482422,73.83999633789062,72.12000274658203,72.94999694824219,69.87812805175781,MRK,"Dow Movers: INTC, DWDP ||| Amgen/Allergan's Rituxan Biosimilar Meets Goal in Phase III ||| Pharma Stock Roundup: JNJ & BMY's Q4 Earnings, Study Failures at LLY & ABBV ||| 3 Big Stock Charts for Friday: Merck, Broadcom and Advanced Micro Devices ||| Merck (MRK) Stock Sinks As Market Gains: What You Should Know ||| Dow 30 Stock Roundup: UTX, TRV, PG, JNJ Earnings Impress, IBM Revenues Decline Y/Y",0,0.5070808
2019-01-28,12764000.0,72.5,73.06999969482422,72.05000305175781,72.91999816894531,69.84939575195312,MRK,"Is Bristol-Myers Squibb a Bargain Now? ||| Barron's On: The Cost Of Climate Change ||| The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings ||| The Zacks Analyst Blog Highlights: J&J, Bristol-Myers, Lilly, AbbVie and Merck ||| Merck (MRK) Q4 Earnings Coming Up: What's in the Cards? ||| 3 Big Stock Charts for Monday: Pfizer, MGM Resorts and Incyte ||| Evelo Biosciences Announces First Patient Does in Investigator-Sponsored Phase 2a Clinical Trial of EDP1503 in Combination with KEYTRUDA® in Patients with Metastatic Melanoma",1,0.48253992
2019-01-29,11418600.0,72.9000015258789,73.68000030517578,72.63999938964844,73.2300033569336,70.1463394165039,MRK,Dow Analyst Moves: MRK ||| Why Merck (MRK) Could Beat Earnings Estimates Again ||| How To Approach Q4 Earnings: The Technical Perspective,1,0.49708834
2019-01-30,13302700.0,73.45999908447266,73.80999755859375,73.0199966430664,73.37000274658203,70.28044891357422,MRK,"A Cure for Cancer Next Year? The Stock Market Says Don't Believe the Hype ||| Merck Receives FDA Breakthrough Therapy Designation For V114 - Quick Facts ||| Validea James P. O'Shaughnessy Strategy Daily Upgrade Report - 1/30/2019 ||| Daily Dividend Report: JNPR, AAPL, MRK, MCD, LUV",1,0.49798518
2019-01-31,16028300.0,73.1500015258789,74.81999969482422,73.11000061035156,74.43000030517578,71.29580688476562,MRK,"Merck's Pneumococcal Vaccine Gets Breakthrough Therapy Status ||| Eli Lilly (LLY) Q4 Earnings Coming Up: What's in the Cards? ||| What's in the Cards for Skyworks (SWKS) in Q1 Earnings? ||| Pre-Market Earnings Report for February 1, 2019 : XOM, CVX, MRK, HON, SPG, D, CI, ITW, AON, LYB, JCI, ROP ||| Merck's Q4 Earnings Preview",1,0.4978889
2019-02-01,15211600.0,75.97000122070312,77.48999786376953,75.33000183105469,76.44999694824219,73.23074340820312,MRK,"Merck News: MRK Stock Moves Higher on Q4 Earnings Beat ||| Dow Movers: WMT, MRK ||| Merck (MRK) Beats on Q4 Earnings & Sales as Keytruda Shines ||| Merck & Co. (MRK) Q4 2018 Earnings Conference Call Transcript ||| Merck (MRK) Tops on Q4 Earnings & Sales, Stock Up ||| Earnings Reaction History: Merck & Co. Inc., 45.5% Follow-Through Indicator, 1.7% Sensitive ||| Attention Biotech Investors: Mark Your Calendar For These February PDUFA Dates ||| Merck & Co shares are trading higher after the company reported inline Q4 EPS figures and beat sales estimates. ||| The Daily Biotech Pulse: Merck Earnings, Positive Relaunch Of Titan's Opioid Disorder Treatment Implant ||| Merck Sees FY19 Adj. EPS $4.57-$4.72 vs $4.69 Estimate, Sales $43.2B-$44.7B vs $44.54B Est. ||| Merck Q4 EPS $1.04, Inline, Sales $10.998B Beat $10.96B Estimate ||| 12 Stocks To Watch For February 1, 2019 ||| Earnings Scheduled For February 1, 2019",1,0.48352614
2019-02-04,11282600.0,75.94999694824219,76.88999938964844,75.68000030517578,76.87000274658203,73.63306427001953,MRK,"4 Things You Need to Know About Merck's Q4 Earnings Results ||| Barron's Picks And Pans: Corning, Merck, Microsoft And More ||| Stock Market News For Feb 4, 2019 ||| Why Merck (MRK) is a Great Dividend Stock Right Now ||| Merck Gets Positive CHMP Opinion For Keytruda In Combination With Chemotherapy ||| UPDATE: Financial Terms Of Codexis/Merck Deal Were Not Disclosed ||| Codexis Reports Secured Multi-Year Technology Upgrade Package For CodeEvolver Protein Engineering Platform License With Merck ||| Merck Announces the European Medicines Agency Gave a Positive Opinion on KEYTRUDA in Combination with Chemotherapy for First-Line Treatment of Adults with Metastatic Squamous Non-Small Cell Lung Cancer",1,0.52639717
2019-02-05,12362300.0,77.37999725341797,78.37999725341797,77.05999755859375,77.1500015258789,73.90127563476562,MRK,"Dow Movers: CVX, MRK ||| Merck's Keytruda Clinches CHMP Nod for Difficult Lung Cancer ||| Merck: FDA To Review Regulatory Filings By Company For Two Antibacterial Agents ||| Here's Why Codexis Gained as Much as 9.8% Today ||| Merck Says CEO Frazier Plans To Testify At Feb 26 Senate Drug Pricing Hearing ||| Codexis shares are trading higher after the company reported a multi-year agreement with Merck to perform technology upgrades. ||| The Daily Biotech Pulse: Gilead Earnings, Codexis Sings Pact With Merck, Eli Lilly Reports Positive Trial Results ||| FDA Accepts For Review New Drug Application For Merck's Investigational Combination Of Imipenem/Cilastatin And Relebactam; Acceps Supplemental NDA For ZERBAXA",1,0.5206218
2019-02-06,7992100.0,76.83999633789062,77.72000122070312,76.62999725341797,77.38999938964844,74.13116455078125,MRK,Winners & Losers from Trump's State of the Union Address ||| Drugmakers Offered C$9.6B in Price Cuts; Freeze of Drug Prices in Response to Proposed Crackdown by Canada Regulator,0,0.53060466
2019-02-07,9218900.0,76.94000244140625,77.12999725341797,76.11000061035156,76.81999969482422,73.58515930175781,MRK,"Bank Of America Reiterates Buy And $84 Target On Merck Due To 'Keytruda driven upside, undemanding valuation + optionality (animal health spin + OM expansion)'",1,0.5124337
2019-02-08,8842500.0,76.75,77.54000091552734,76.56999969482422,77.5199966430664,74.25567626953125,MRK,"IUSG, MRK, MA, NFLX: Large Outflows Detected at ETF ||| Dow Movers: UNH, MRK ||| Pharma Stock Roundup: Q4 Earnings at MRK, LLY, CHMP Nod for Several Drugs ||| Dow 30 Stock Roundup: Disney Earnings Impress, Pfizer's Cancer Drug Gets CHMP Nod ||| Incyte Down as FDA Extends Review Period of Jakafi for GVHD ||| Seattle Genetics (SGEN) Q4 Loss Widens, Revenues Top Mark",0,0.49947515
2019-02-11,13171700.0,77.80000305175781,77.83999633789062,76.20999908447266,76.70999908447266,73.47979736328125,MRK,"Third Point Dissolves Stakes in Netflix, Microsoft; Cuts Stake in PayPal, Merck, Visa, American Express, Baxter; Raises Stakes in Campbell Soup, Salesforce ||| The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials ||| ImmunoGen (IMGN) Beats on Earnings & Sales in Q4, Shares Up ||| Hemispherx Biopharma Announces Commencement Of A New 45 Subject Clinical Trial Combining Ampligen And Merck's Keytruda In The Treatment Of Recurrent Ovarian Cancer ||| Merck Granted FDA Priority Review for its Supplemental Biologics License Application for KEYTRUDA for the First-Line Treatment of Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma",1,0.4875316
2019-02-12,13049700.0,77.29000091552734,78.93000030517578,77.11000061035156,78.5199966430664,75.21357727050781,MRK,"Bristol-Myers' Sprycel Gets European Nod for Label Expansion ||| Dow Movers: PG, MRK ||| Merck's Keytruda Gets FDA Priority Review for Head/Neck Cancer ||| Aduro Initiates Dosing in Phase I Melanoma Study on ADU-S100 ||| Stock Market News For Feb 12, 2019 ||| Pfizer sBLA for Kidney Cancer Drug Combo Gets Priority Review",1,0.5086476
2019-02-13,10477200.0,78.55999755859375,79.16999816894531,78.44999694824219,79.0199966430664,75.6925277709961,MRK,"Top Research Reports for ExxonMobil, Merck & Danaher",0,0.5048375
2019-02-14,8184200.0,79.12999725341797,79.55000305175781,78.69000244140625,78.94000244140625,75.61588287353516,MRK,"The Zacks Analyst Blog Highlights: ExxonMobil, Merck, Danaher, Novartis and Expedia ||| AstraZeneca's (AZN) Q4 Earnings Beat, New Drugs Drive Sales ||| Merck Highlights 3 New Phase 3 Trials",1,0.50336003
2019-02-15,10387500.0,79.66000366210938,80.12999725341797,79.2699966430664,79.80999755859375,76.44924926757812,MRK,"Notable Friday Option Activity: MCD, MRK, WMT ||| Merck Reports FDA Granted Priority Review For Co.'s Supplemental Biologics License Application for KEYTRUDA Combo With Inlyta For First-Line Treatment for Advanced Renal Cell Carcinoma",0,0.50650346
2019-02-19,9211400.0,79.79000091552734,80.12999725341797,79.08000183105469,79.23999786376953,75.90325164794922,MRK,Merck Announces KEYTRUDA in Combination with Inlyta Reduced Risk of Death by Nearly Half Compared to Sunitinib as First-Line Treatment for Advanced RCC at ASCO GU 2019 ||| Merck Gets Priority Review for Keytruda Combo in Kidney Cancer ||| Merck's (MRK) Stock Up Almost 50% in a Year: Here's Why ||| Pfizer's Forgotten Cancer Pill Is About to Become Its Next Blockbuster ||| Merck Reports Phase 3 KEYNOTE-240 Trial Evaluating KEYTRUDA Did Not Meet Co-Primary Endpoints ||| Merck Says US Patent & Trademark Office Issued Formal Notice Allowing Co.'s Patent Application Directed To Its Proxy-CRISPR Technology ||| FDA Approves Merck's KEYTRUDA For Adjuvant Treatment Of Patients With Melanoma With Involvement Of Lymph Nodes Following Complete Resection,1,0.5073627
2019-02-20,8581600.0,79.0,79.54000091552734,78.80999755859375,79.43000030517578,76.08525848388672,MRK,"Why Merck (MRK) is a Top Dividend Stock for Your Portfolio ||| Intercept Reports Positive Top-Line Data for NASH, Shares Up ||| Noteworthy ETF Inflows: ITOT, HD, MRK, MA ||| The Daily Biotech Pulse: Teva Settles With FTC, Setback For Merck In Liver Cancer Trial, Sienna Biopharma Offering ||| FDA Grants Priority Review To Merck's Supplemental Biologics License Application For KEYTRUDA Monotherapy For Third-Line Treatment of Patients with Advanced Small Cell Lung Cancer",1,0.47887686
2019-02-21,7386100.0,79.18000030517578,80.02999877929688,79.1500015258789,79.83000183105469,76.46841430664062,MRK,"Mid-Day Update: Wall Street Spooked By Soft Housing Market, Manufacturing Data ||| Wall Street Stock Futures Surrender Overnight Gains as European Manufacturing Slows, China Sparks Trade War With Australia ||| Health Care Sector Update for 02/21/2019: JNJ, A, TFX, PFE, MRK, AMGN, ABT ||| Close Update: Stocks Slump as Dismal Economic Data Rekindles Slow Growth Fears ||| Merck Gets Priority Review for Keytruda in Third-Line SCLC ||| Mid-Afternoon Market Update: Dow Falls 150 Points; Delphi Technologies Shares Spike Higher ||| 50 Stocks Moving In Thursday's Mid-Day Session ||| Mid-Day Market Update: Immune Design Jumps Following Acquisition News; Carbon Black Shares Slide ||| Mid-Morning Market Update: Markets Open Lower; Domino's Pizza Misses Q4 Views ||| Merck To Buy Immune Design For $300M ||| 31 Stocks Moving In Thursday's Pre-Market Session ||| Merck To Acquire Immune Design At $5.85/Share In Cash, Or ~$300M",1,0.48423368
2019-02-22,7955600.0,79.7699966430664,80.86000061035156,79.7699966430664,80.7699966430664,77.36882781982422,MRK,"What's in the Cards for Perrigo (PRGO) This Earnings Season? ||| Pharma Stock Roundup: MRK Buys IMDZ, FDA Grants Priority Review to Some Candidates ||| Dow 30 Stock Roundup: WMT Earnings Beat, MRK's Keytruda sBLA Gets Priority Review ||| The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs ||| Cantor Fitzgerald Initiates Coverage On Merck & Co with Overweight Rating, Announces $95 Price Target ||| The Daily Biotech Pulse: BioMarin Slips On Earnings, TherapeuticsMD Posts In-Line Results, Orchard To Present Immunodeficiency Drug Data ||| 65 Biggest Movers From Yesterday",0,0.4904493
2019-02-25,9295100.0,80.86000061035156,80.98999786376953,79.98999786376953,80.37999725341797,76.99525451660156,MRK,"The Zacks Analyst Blog Highlights: Walmart, Pfizer, Eli Lilly, Merck and Microsoft ||| The Zacks Analyst Blog Highlights: Merck, Design, Roche and AbbVie ||| Pharma M&A Wave: Spark Therapeutics, Clementia Pharma Among The Rare Disease Biotechs Acquired",1,0.49054846
2019-02-26,8519000.0,80.5199966430664,81.0999984741211,80.0,80.73999786376953,77.340087890625,MRK,"5 Stock Charts Ripe for a Breakout ||| Sellas Reviews Strategic Options To Fund Clinical Development Programs ||| It Could Be Time For This Pharma ETF ||| The Daily Biotech Pulse: Immunomedics CEO Departs, Ultragenyx Offering, Karyopharm Awaits FDA Panel Vote ||| UPDATE: Merck, AstraZeneca Report Phase III POLO Trial Met Primary Endpoint ||| Merck, AstraZeneca Report LYNPARZA Reduced the Risk of Disease Progression or Death as 1st-Line Maintenance Treatment in Germline BRCA-Mutated Metastatic Pancreatic Cancer ||| AstraZeneca, Merck Announce Phase III POLO Trial Met its Primary Endpoint of Progression-free Survival",0,0.5301331
2019-02-27,7493300.0,80.54000091552734,81.29000091552734,80.43000030517578,80.62000274658203,77.22515106201172,MRK,"AstraZeneca/Merck's Lynparza Meets Endpoint in POLO Study ||| The Daily Biotech Pulse: FDA Panel Vote Sinks KaryoPharm, Refuse-To-file Letter For Adamis, Tandem Diabetes Earnings",1,0.49465916
2019-02-28,11057600.0,80.52999877929688,81.76000213623047,80.52999877929688,81.29000091552734,77.86693572998047,MRK,"Perrigo (PRGO) Q4 Earnings Miss, Sales Beat, Stock Down ||| iShares Russell 3000 ETF Experiences Big Outflow ||| The Daily Biotech Pulse: Bristol-Myers Squibb-Celgene Deal Faces Setback, Syneos Hit By SEC Probe, FDA Cheer For T2 Biosystems",1,0.48846036
2019-03-01,10137600.0,81.76000213623047,81.93000030517578,81.16999816894531,81.6500015258789,78.21177673339844,MRK,"Endo (ENDP) Q4 Earnings & Revenues Beat Estimates, Shares Up ||| Intercept (ICPT) Up on Q4 Revenue Beat, NASH Study in Focus ||| Esperion (ESPR) Reports Wider-Than-Expected Loss in Q4 ||| Merck Reports Positive CHMP Opinion For Use In Germline BRCA-Mutated HER2-Negative Advanced Breast Cancer",0,0.5005153
2019-03-04,8132400.0,82.02999877929688,82.12000274658203,80.52999877929688,81.37000274658203,77.94356536865234,MRK,"Immunogen Ovarian Cancer Drug Fails in Phase III, Stock Sinks ||| Merck Reaches Analyst Target Price ||| BioXcel Therapeutics Announces Merck and Pfizer Join its Clinical Collaboration with Nektar Therapeutics to Evaluate a Triple Therapy for Pancreatic Cancer ||| Merck Says the European Medicines Agency Adopts Positive Opinion for Merck's KEYTRUDA for Six-Week Dosing Schedule Across All Current Monotherapy Indications",1,0.5255493
2019-03-05,8299800.0,81.4800033569336,82.02999877929688,81.22000122070312,81.69999694824219,78.25965881347656,MRK,Merck Begins Tender Offer To Acquire Immune Design,0,0.51569754
2019-03-06,7793100.0,81.5999984741211,81.76000213623047,80.30000305175781,80.76000213623047,77.35924530029297,MRK,"Roche's (RHHBY) sNDA for Flu Candidate Accepted by the FDA ||| The Daily Biotech Pulse: Horizon Pharma Under DoJ Radar, FDA Greenlights J&J's Depression Drug, Endologix Reverse Split",0,0.5127123
2019-03-07,10425100.0,81.02999877929688,81.11000061035156,80.04000091552734,80.44999694824219,77.06229400634766,MRK,"Merck & Co Option Alert: Jun, 2020 $85 Calls at the Ask: 1000 @ $4.901 vs 113 OI; Earnings 4/30 Before Open [est] Ref=$80.62",0,0.47712314
2019-03-08,11179700.0,80.20999908447266,80.5999984741211,79.05000305175781,79.80000305175781,76.4396743774414,MRK,Roche's (RHHBY) Tecentriq Gets EC Nod for First-Line NSCLC,1,0.5098305
2019-03-11,8708600.0,80.36000061035156,81.02999877929688,80.06999969482422,80.87000274658203,77.46461486816406,MRK,"The Zacks Analyst Blog Highlights: J&J, Lilly, Pfizer, AstraZeneca and Merck's",1,0.49632692
2019-03-12,8837100.0,81.16999816894531,81.55999755859375,80.77999877929688,81.2300033569336,77.80945587158203,MRK,Pfizer's (PFE) Kidney Cancer Drug Combo Gets EMA's Validation ||| Why Merck (MRK) is a Great Dividend Stock Right Now,1,0.46026975
2019-03-13,7690600.0,81.61000061035156,82.01000213623047,81.19000244140625,81.5999984741211,78.16387939453125,MRK,"Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for March 14, 2019 ||| Notable Wednesday Option Activity: TSLA, MRK, GOOG ||| Lilly's Cyramza Successful in Phase III First-Line NSCLC Study",0,0.48767745
2019-03-14,8139700.0,81.30999755859375,81.76000213623047,80.93000030517578,81.48999786376953,78.58821105957031,MRK,"Thursday’s Vital Data: Aurora Cannabis, Roku and Merck ||| Merck Reports EC Approved KEYTRUDA In Combo With Chemo For First-Line Treatment Of Adults With Metastatic Squamous Non-Small Cell Lung Cancer",1,0.5097548
2019-03-15,16546800.0,81.5,81.91000366210938,80.80000305175781,81.56999969482422,78.66535186767578,MRK,"Merck's Keytruda Gets EU Approval for Difficult Lung Cancer ||| Pharma Stock Roundup: Regulatory Updates From MRK, PFE, J&J, AGN & Others ||| Is Celgene and Bristol-Myers a Match Made in Heaven or Doomed to Fail? ||| Enigma Biomedical Reports Exclusive License Deal With Merck For Global Development, Commercialization Of MK-6884, An Alzheimer's Treatment",0,0.49527812
2019-03-18,13700300.0,81.2699966430664,81.83000183105469,80.91999816894531,81.3499984741211,78.45319366455078,MRK,"The Zacks Analyst Blog Highlights: Pfizer, Roche, Merck, Allergan and J&J ||| After Hours Most Active for Mar 18, 2019 : ELAN, LLY, BAC, MRK, HPQ, WMB, QCOM, GILD, CMCSA, PEP, EBAY, ATVI ||| Top Research Reports for Merck, Adobe & Broadcom ||| Morgan Stanley Drops Bearish Exelixis Stance, Sees 'Limited Downside Risk'",1,0.46169132
2019-03-19,9756100.0,81.54000091552734,82.0,80.95999908447266,81.91000366210938,78.99325561523438,MRK,"The Zacks Analyst Blog Highlights: Merck, Adobe, Broadcom, AstraZeneca and Ross Stores ||| Roche's Tecentriq Gets FDA Approval for Difficult Lung Cancer ||| Dow Movers: MCD, GS ||| Why You Should Buy ABBV Stock for Income and Value ||| Merck (MRK) Gains As Market Dips: What You Should Know",1,0.50280637
2019-03-20,11349800.0,81.8499984741211,82.72000122070312,81.37999725341797,82.08000183105469,79.15721130371094,MRK,Glaxo Presents Encouraging Data on Endometrial Cancer Drug ||| Merck and NGM Bio Announce Extension Of Strategic Collaboration To 2022,1,0.52398056
2019-03-21,9039400.0,82.0999984741211,83.16999816894531,81.8499984741211,82.94999694824219,79.9962158203125,MRK,"Merck's Keytruda Picks Up Pace in Thriving Anti-PD-L1 Market ||| Bristol-Myers' Celgene Buyout Still Uncertain Amid Opposition ||| FedEx's Struggles May Be Less About Global Demand And More About 'NotPetya' ||| Watching Stocks With Alzheimer's Treatment Candidates: Merck, Roche, AbbVie, Neurotrope, AC Immune, Denali, INmune Bio, BioXcel Therapeutics, Intra-Cellular, Anavex, Pain Therapeutics, Grifols",0,0.49564216
2019-03-22,10151900.0,82.91000366210938,83.44999694824219,82.0199966430664,82.29000091552734,79.3597183227539,MRK,"The Daily Biotech Pulse: Immutep Gets US Patent, Conatus NASH Disappointment, Eisai Moves On After Aducanumab Setback",1,0.49565017
2019-03-25,7517800.0,82.06999969482422,82.75,81.91999816894531,82.3499984741211,79.41758728027344,MRK,"3 Cancer Treatment Stocks to Buy in March ||| The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs ||| 5 Dow Jones Stocks for the End of Mueller’s Investigation ||| Merck (MRK) Gains As Market Dips: What You Should Know ||| These Are Some Of The Best-Performing Leveraged ETFs Of The Year",1,0.5196938
2019-03-26,8819400.0,82.76000213623047,83.47000122070312,82.56999969482422,82.91999816894531,79.96729278564453,MRK,"3 Large-Cap Stocks Hitting 52-Week Highs: Are They Buys? ||| After Hours Most Active for Mar 26, 2019 : PKW, V, WP, KEY, CELG, CSCO, QQQ, ZNGA, FOE, MRK, HLT, AAPL ||| Merck Shares Unaffected As Traders Circulate Business Insider Interview From Mon. Highlighting CEO Hinted He Could Step Down",0,0.5035285
2019-03-27,9561800.0,82.91999816894531,83.05999755859375,81.80999755859375,82.29000091552734,79.3597183227539,MRK,"After Hours Most Active for Mar 27, 2019 : TAL, V, BILI, COTY, MRK, BZUN, IRBT, PFE, RXN, QQQ, MSFT, MCHI ||| The Daily Biotech Pulse: FDA Nod For Novartis, Jazz Positive Late-Stage Data For Sleep Disorder Drug, Genfit IPO",1,0.5093776
2019-03-28,6833300.0,82.79000091552734,82.9000015258789,82.18000030517578,82.62999725341797,79.68761444091797,MRK,One Key Strategy to Build Your Ultimate Retirement Portfolio,1,0.5231361
2019-03-29,9683200.0,83.0,83.30000305175781,82.70999908447266,83.16999816894531,80.20838165283203,MRK,"4 Upcoming IPOs to Watch That Aren’t Named Lyft ||| 4 Upcoming IPOs to Watch That Aren’t Named Lyft ||| Seattle Genetics, Astellas Report Positive Cancer Study Data ||| Congo Health Ministry Says Has Recorded 15 New Confirmed Cases Of Ebola ||| Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates",1,0.5485241
2019-04-01,8416300.0,83.7300033569336,83.8499984741211,82.94000244140625,83.30000305175781,80.3337631225586,MRK,"AstraZeneca: Selumetinib Gets US Breakthrough Therapy Designation ||| Why Advaxis Stock Skyrocketed 13.8% Today ||| Biotech News: Why Advaxis Stock Is Soaring Today ||| Syndax Pharmaceuticals Down 5.5% After Lead Candidate Entinostat Trial Shows 19% Objective Response Rate, 36% Clinical Benefit Rate ||| IWD, T, MRK, CMCSA: Large Inflows Detected at ETF ||| Syndax Pharmaceuticals Down 5.5% After Lead Candidate Entinostat Trial Shows 19% Objective Response Rate, 36% Clinical Benefit Rate ||| Merck Announces Post-hoc Analysis From KEYNOTE-189 Trial - Quick Facts ||| AstraZeneca's Selumetinib Gets Breakthrough Therapy Status ||| Health Care Sector Update for 04/01/2019: ZIOP, MNKD, UTHR, AZN, MRK, JNJ, PFE, ABT, AMGN ||| Biotech Winners, Losers In Q1 ||| Advaxis Shares Surge After Positive Clinical Trial Updates ||| AstraZeneca's Rare Pediatric Genetic Disorder Drug Granted Breakthrough Therapy Designation ||| Syndax Pharmaceuticals Highlights Presentation Of Updated Phase 2 Data From ENCORE 601 Trial Of Entinostat In Combination With KEYTRUDA At American Association For Cancer Research 2019 Annual Meeting ||| Advaxis Says its Phase 1/2 KEYNOTE-046 Study Prolonged Survival in Metastatic Castration-Resistant Prostate Cancer ||| Alkermes, Merck, Sage Therapeutics and Takeda Pharma Announce a Partnership to Qualify Biomarkers for Schizophrenia Drug Development ||| Merck's KEYTRUDA Approved in China for First-Line Treatment of Metastatic Nonsquamous Non-Small Cell Lung Cancer in Combination with Chemotherapy ||| Merck and AstraZeneca's Selumetinib is Granted Breakthrough Therapy Designation in Neurofibromatosis Type 1 ||| AstraZeneca, Merck Announce Selumetinib Granted US Breakthrough Therapy Designation in Neurofibromatosis Type 1",0,0.5326772
2019-04-02,5606000.0,83.45999908447266,83.72000122070312,82.9000015258789,83.20999908447266,80.24696350097656,MRK,"Study points to new antibody approach to tackling Ebola, other infections ||| Merck (MRK) Stock Moves -0.11%: What You Should Know ||| Merck Reports Successful Completion Of Cash Tender Offer For Immune Design ||| The Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial",0,0.51630896
2019-04-04,9787900.0,83.01000213623047,83.19999694824219,81.20999908447266,81.8499984741211,78.93538665771484,MRK,"Market Close Report: NASDAQ Composite index closes at 7,891.78 down -3.77 points ||| Dow Outperforms; S&P Extends Win Streak ||| Myriad Genetics, AstraZeneca, Merck Report Expansion Of Companion Diagnostic Partnership",0,0.5114503
2019-04-05,9851300.0,81.97000122070312,82.16000366210938,81.11000061035156,81.1500015258789,78.26031494140625,MRK,Exelixis (EXEL) Rallies 22.4% YTD: What to Expect Ahead? ||| Endo Unit Begins Shipping Generic Version Of Merck's PROVENTIL - Quick Facts,0,0.49833444
2019-04-08,10101400.0,80.95999908447266,81.26000213623047,80.3499984741211,80.94999694824219,78.06744384765625,MRK,"The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts ||| Merck (MRK) Stock Sinks As Market Gains: What You Should Know ||| After Hours Most Active for Apr 8, 2019 : AMH, FOLD, AABA, PFE, BILI, QQQ, URBN, BAC, EMB, MRK, SCHW, NEM",0,0.4821513
2019-04-09,10291300.0,80.56999969482422,80.9800033569336,80.26000213623047,80.80000305175781,77.92278289794922,MRK,"Here’s Where You Buy 3M Stock for Capital Gains ||| IWD, T, MRK, CMCSA: Large Inflows Detected at ETF ||| 10 Dow Jones Stocks Holding the Blue Chip Index Back ||| Here’s Where You Buy 3M Stock for Capital Gains ||| 10 Dow Jones Stocks Holding the Blue Chip Index Back",1,0.4881585
2019-04-10,6578500.0,80.86000061035156,81.31999969482422,80.6500015258789,80.81999969482422,77.94206237792969,MRK,"What the New York City Measles Emergency Means For Vaccine-Maker Merck ||| What the New York City Measles Emergency Means For Vaccine-Maker Merck ||| AstraZeneca, Merck Announce Lynparza Approved in EU for the treatment of Germline BRCA-mutated HER2-negative Advanced Breast Cancer",0,0.51882666
2019-04-11,9933700.0,80.93000030517578,80.93000030517578,79.38999938964844,79.83999633789062,76.99696350097656,MRK,"Risk-Tolerant Investors, Turn Your Eyes to Exelixis Stock ||| Merck Reports FDA Approval For Expanded Monotherapy Label For KEYTRUDA ||| NYC Mandates Measles Vaccinations; Merck Is The Exclusive Manufacturer ||| The Daily Biotech Pulse: NASH Cheer For Intercept, Gilead Layoffs, BioDelivery Licenses Constipation Drug",0,0.49174032
2019-04-12,9699200.0,80.01000213623047,80.44000244140625,79.30000305175781,79.43000030517578,76.60157012939453,MRK,"The Daily Biotech Pulse: Merck's Keytruda Clinches Another FDA Win, KemPharm Close To NDA Filing For ADHD Drug",0,0.51550305
2019-04-15,13189400.0,79.30999755859375,79.48999786376953,78.47000122070312,78.52999877929688,75.73361206054688,MRK,"Interesting MRK Put Options For May 31st ||| Merck (MRK) Dips More Than Broader Markets: What You Should Know ||| Merck is Oversold ||| Bristol-Myers' Shareholders Vote for Celgene Acquisition ||| Measles Cases Worldwide Rose Nearly Four-Fold In First Quarter Of 2019 To 112,163 Against Same Period Last Year, Provisional Data Shows",0,0.5236683
2019-04-16,11957300.0,79.2300033569336,79.29000091552734,77.41999816894531,77.55999755859375,74.79815673828125,MRK,"Dow Analyst Moves: MRK ||| Shares of several drug companies are trading lower. Weakness may be tied to uncertainty over healthcare policy going into the 2020 primaries and Washington's recent efforts to curb prescription drug prices. ||| The Daily Biotech Pulse: J&J Earnings, FDA Nod For Medicinova, Proteon To Explore Strategic Alternatives",0,0.5047213
2019-04-17,32615900.0,77.61000061035156,77.62000274658203,73.75,73.91999816894531,71.28778076171875,MRK,"Market Close Report: NASDAQ Composite index closes at 7,996.08 down -4.15 points ||| Noteworthy Wednesday Option Activity: MRK, MU, MLM ||| Stocks Close Lower as Healthcare Weighs Heavy ||| Close Update: Healthcare Sector Losses Drag Major Market Indexes Slightly Lower in Wednesday Trading ||| Correction: US Stocks Little Changed at Mid-Day as Earnings Fail to Trigger Broader Market Reaction ||| Noteworthy Wednesday Option Activity: MRK, MU, MLM ||| Close Update: Healthcare Sector Losses Drag Major Market Indexes Slightly Lower in Wednesday Trading ||| Major Market Indexes Little Changed in Late Wednesday Trading ||| Major Market Indexes Little Changed in Late Wednesday Trading ||| Shares of several drug companies are trading lower amid continued efforts from Washington to curb prescription drug prices. The overall healthcare sector has seen weakness recently due to uncertainty over the future of healthcare policy.",0,0.49103808
2019-04-18,31267600.0,73.4800033569336,74.05000305175781,72.2300033569336,73.19000244140625,70.58377075195312,MRK,Mid-Day Report: US Stocks Mixed as Health Care Sector Clouded by Political Rhetoric While US Retail Sales Jump Most in 18 Mths ||| Notable Two Hundred Day Moving Average Cross - MRK ||| Analysts Anticipate 10% Gains Ahead For DTN ||| MRK Dividend Yield Pushes Past 3% ||| Shares of several drug companies are trading lower amid continued efforts from Washington to curb prescription drug prices. The overall healthcare sector has seen weakness recently due to uncertainty over the future of healthcare policy.,1,0.5031646
2019-04-22,13882100.0,73.16000366210938,73.80999755859375,72.73999786376953,73.45999908447266,70.84415435791016,MRK,Merck: FDA Approves KEYTRUDA-Inlyta Combination - Quick Facts ||| Merck's KEYTRUDA in Combination with Inlyta Approved by the FDA as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma,1,0.5088596
2019-04-23,18398400.0,73.69999694824219,75.25,73.4000015258789,74.5999984741211,71.94355773925781,MRK,"Kidney-Cancer Market: Good for Patients, Hard for Investors ||| Why Is Bristol-Myers Near 52-Week Lows? ||| Shares of several healthcare stocks are trading higher in a potential rebound from last week's selloff. In an upgrade of HCA Healthcare, Raymond James analysts noted the selloff was 'based on legislation that has almost no chance of passing' ||| OncoSec Announces Triple Combination Immunotherapy Clinical Trial Of TAVO, Epacadostat And KEYTRUDA In Squamous Cell Head And Neck (SCCHN) Cancer",1,0.5226376
2019-04-24,12193800.0,74.7300033569336,75.11000061035156,73.9800033569336,74.7300033569336,72.06893157958984,MRK,Why Investors Should Buy the Dip in MRK Stock,1,0.50841916
2019-04-25,13353200.0,74.58000183105469,76.81999969482422,74.45999908447266,76.33999633789062,73.62159729003906,MRK,"iShares Edge MSCI USA Momentum Factor ETF Experiences Big Outflow ||| Pfizer Stock Has Positive and Negative Catalysts Going Into Results ||| Merck Offers Update On Phase 3 KEYNOTE-062 Trial Evaluating KEYTRUDA® as Monotherapy, In Combination with Chemotherapy for First-Line Treatment of Patients with Advanced Gastric or Gastroesophageal Junction Adenocarcinoma",1,0.5152451
2019-04-26,8481100.0,76.63999938964844,76.98999786376953,76.08999633789062,76.62999725341797,73.90127563476562,MRK,"The Daily Biotech Pulse: Mixed Results For Merck's Keytruda In Stomach Cancer; Roche's Spark-Buy Delayed, Teva Recalls Hypertension Drug",1,0.51117146
2019-04-29,7056600.0,76.58999633789062,77.18000030517578,76.4800033569336,76.77999877929688,74.04592895507812,MRK,"AstraZeneca: Lynparza Receives Positive CHMP Opinion For Expanded Indication ||| This Week, Market Eyes China Talks, Fed Meeting As Earnings Continue ||| AstraZeneca, Merck Announce Lynparza Receives Positive EU CHMP Opinion for 1st-line Maintenance Treatment of BRCA-mutated Advanced Ovarian Cancer",1,0.5026009
2019-04-30,10752900.0,77.55999755859375,78.9000015258789,76.0,78.70999908447266,75.9072036743164,MRK,"Merck & Co Inc (MRK) Q1 2019 Earnings Call Transcript ||| What You Need to Know About Merck's Great Q1 Earnings Results ||| Merck & Co Inc. Q1 adjusted earnings Beat Estimates ||| Alphabet Revenue Disappoints Ahead Of Apple Earnings After The Bell ||| Merck & Co shares are trading higher after the company reported better-than-expected Q1 EPS and sales and issued strong FY19 guidance. ||| The Daily Biotech Pulse: Earnings Deluge, G1 Therapeutics Positive FDA Meeting, Mustang Bio Offering ||| A Peek Into The Markets: US Stock Futures Mixed Ahead Of Earnings, Fed Meeting ||| Merck & Co. Sees FY19 Adj. EPS $4.67-$4.79 vs $4.67 Est., Sales $43.9B-$45.1B vs $44.42B Est. ||| Merck & Co Q1 Adj. EPS $1.22 Beats $1.06 Estimate, Sales $10.82B Beat $10.48B Estimate ||| 15 Stocks To Watch For April 30, 2019 ||| Earnings Scheduled For April 30, 2019",1,0.4851454
2019-05-01,14588400.0,78.69000244140625,79.7300033569336,78.43000030517578,78.72000122070312,75.91683959960938,MRK,"Profit from Earnings Volatility With This Biotech Stocks Pairs Trade ||| BMO Capital Maintains Market Perform on Merck & Company, Inc. Common Stock (new), Raises Price Target to $84 ||| Bank of America Maintains Buy on Merck & Company, Inc. Common Stock (new), Raises Price Target to $91",1,0.4769899
2019-05-02,11048800.0,78.61000061035156,79.83000183105469,78.61000061035156,79.5199966430664,76.68836212158203,MRK,"UBS Maintains Buy on Merck & Company, Inc. Common Stock (new), Raises Price Target to $88",1,0.48720258
2019-05-03,7578800.0,79.54000091552734,80.13999938964844,79.25,80.0,77.15127563476562,MRK,"VOO, VZ, T, MRK: Large Inflows Detected at ETF ||| Canopy Growth, Lockheed Martin, Merck And More: 'Fast Money Halftime Report' Picks For May 3",0,0.48538625
2019-05-06,9452800.0,78.52999877929688,79.79000091552734,78.30000305175781,79.4800033569336,76.64979553222656,MRK,Two Healthcare Stocks in the XLV Fund Stand Out,0,0.54475147
2019-05-07,10041400.0,78.88999938964844,79.29000091552734,77.41999816894531,77.9000015258789,75.12605285644531,MRK,Merck: Phase 3 Trial Of BELSOMRA C-IV Meets Primary Efficacy Endpoints ||| Merck's BELSOMRA C-IV Meets Primary Efficacy Endpoint In Phase 3 Trial For Treatment Of Insomnia In People With Mild-To-Moderate Alzheimer's Disease Dementia ||| Ebola Death Toll in Congo Rises to 979,1,0.5153494
2019-05-08,10083500.0,78.33000183105469,78.70999908447266,77.9000015258789,78.18000030517578,75.39607238769531,MRK,Merck Reports Results From Phase 2 Trial Of V114 In Infants: Met Primary Dndpoint,1,0.5174994
2019-05-10,8613700.0,78.08000183105469,78.33000183105469,76.80999755859375,78.19000244140625,75.40572357177734,MRK,Shares of several healthcare companies are trading lower in sympathy with the overall market. The S&P 500 is trading lower 1%,0,0.49741435
2019-05-14,7742200.0,77.62000274658203,78.08000183105469,77.36000061035156,77.41999816894531,74.66314697265625,MRK,"Notable ETF Inflow Detected - DGRO, WFC, MRK, WMT",1,0.5162805
2019-05-15,6950900.0,76.87000274658203,77.87999725341797,76.80000305175781,77.55000305175781,74.78851318359375,MRK,"13F From Loeb's Third Point Shows Liquidated Stake In Merck, Cut Stake In American Express ||| The Daily Biotech Pulse: FDA Greenlights Pfizer-Merck KGAa's Kidney Cancer Combo Treatment, Adcom Disappointment For Daiichi",1,0.49826625
2019-05-16,9456900.0,77.7699966430664,79.88999938964844,77.7300033569336,79.12999725341797,76.31224060058594,MRK,"5 ASCO Abstracts That Moved Stocks ||| Iovance Issues Cancer Trial Updates Ahead Of ASCO Meeting, Sending Stock Skyward ||| The Daily Biotech Pulse: FDA Nod For Roche, Trial Results For Agios, Iovance And MacroGenics ||| Intec Pharma Announces Research Collaboration Agreement With Merck",0,0.53921735
2019-05-20,7901900.0,78.36000061035156,79.2699966430664,78.25,78.87999725341797,76.07115173339844,MRK,"Merck's Keytruda Fails Late Stage Clinical Trial ||| UPDATE: Merck Says KEYTRUDA Trial Did Not Meet Primary Endpoint Of Superior Overall Survival ||| Merck Offers Update On Phase 3 KEYNOTE-19 Study Of KEYTRUDA in Previously-Treated Patients with Metastatic Triple-Negative Breast Cancer ||| Argus Questions Logic Behind Bristol-Myers' Proposed Celgene Buy, Steps To Sidelines",1,0.51447326
2019-05-21,10375700.0,79.08000183105469,79.7300033569336,78.52999877929688,79.5,76.66907501220703,MRK,"Merck To Acquire Peloton - Quick Facts ||| Merck To Buy Clinical-Stage Biopharma Peloton Therapeutics For More Than $1B ||| The Daily Biotech Pulse: Setback For Merck In Breast Cancer Study, Arrowhead to Join S&P SmallCap 600 Index, Ocular's Glaucoma Trial Fails ||| Merck To Purchase Peloton Therapeutics For $1.05B In Cash, Will Be Eligible To Receive Further $1.15B Based On Regulatory, Sales Milestones",1,0.50674
2019-05-22,12873900.0,79.3499984741211,81.1500015258789,79.30999755859375,80.9800033569336,78.09637451171875,MRK,Merck's Keytruda Vs. Bristol-Myers Squibb's Opdivo In Q1 And Beyond,1,0.50260824
2019-05-24,5793500.0,81.30000305175781,81.94000244140625,81.11000061035156,81.16999816894531,78.27960205078125,MRK,Biotech Stocks Facing FDA Decision In June 2019 ||| Here's Why Dynavax Technologies Is Tumbling,0,0.50236833
2019-05-28,13148600.0,81.37999725341797,81.94000244140625,80.2300033569336,80.26000213623047,77.40201568603516,MRK,"What Is Nektar Therapeutics' New Game Plan? ||| The Week Ahead In Biotech: ASCO Presentations In The Spotlight ||| 4 Drug and Health Stocks Pushing Higher   ||| Top 10 Most Overbought Stocks Via Benzinga Pro's Radar Tool For Tue., May 28, 2019 ||| Goldman Sachs Initiates Coverage On Merck & Co with Neutral Rating, Announces $85 Price Target",0,0.49132645
2019-05-29,10762300.0,80.12000274658203,80.37000274658203,78.75,79.36000061035156,76.5340576171875,MRK,"Daily Dividend Report: MRK, DE, CBS, NOV, DKS, VGR",1,0.50118
2019-05-30,7141000.0,79.55999755859375,79.81999969482422,79.19000244140625,79.68000030517578,76.84266662597656,MRK,11 Biotech Stocks to Put on Your Radar Soon,0,0.50923413
2019-05-31,6815600.0,79.33000183105469,79.91999816894531,78.80000305175781,79.20999908447266,76.389404296875,MRK,Veeva Stock Will Help You Ignore the Trade War Tensions ||| Drug and Healthcare Stocks to Keep Your Portfolio Healthy ||| Merck Reports KEYTRUDA Showed Improved Overall Survival as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma at Final Analysis of Pivotal Phase 3 KEYNOTE-048 Trial,1,0.50143063
2019-06-03,8795900.0,79.6500015258789,80.91999816894531,79.5199966430664,80.26000213623047,77.40201568603516,MRK,The Week Ahead In Biotech: ASCO Presentations Pick Up The Pace ||| Merck Announces Five-Year Survival Data for KEYTRUDA in Advanced Non-Small Cell Lung Cancer from First KEYNOTE Trial at #ASCO19 ||| What Happened in the Stock Market Today ||| Merck Reports LYNPARZA Phase 3 SOLO3 Trial Showed 72% Objective Response Rate in Patients with Platinum-Sensitive Relapsed Germline BRCA-mutated Advanced Ovarian Cancer Compared to 51% of Patients Receiving Chemotherapy ||| FDA Grants Approval Of Zerbaxa To Merck & Co Inc ||| Dynavax Highlights Presentation Of Results Showing 76% OVerall Response Rate In Advanced Melanoma Patients With SD-101 In Combination With KEYTRUDA ||| Merck Sat. Highlighted 5-Year Survival Data From KEYTRUDA In NSCLC As First Keynote Trial At ASCO,1,0.5105644
2019-06-04,8939700.0,80.75,81.33000183105469,80.11000061035156,81.08000183105469,78.19281768798828,MRK,"3 Drug Stocks That Could Win From Key FDA Approvals in June ||| Shares of several healthcare companies are trading higher with the overall US market. Recent comments out of China and Mexico has renewed trade optimism and lifted economic outlook. ||| 'I believe it is wrong to charge Americans astronomical prices for life-saving drugs developed with taxpayer dollars. You will not find me encouraging pharmaceutical companies to continue ripping off Americans like my Republican colleagues.' -Sen Sanders ||| The Daily Biotech Pulse: ASCO Presentations From Roche, Celgene & More, Edwards Recommends Rejection Of Mini-Tender Offer",1,0.5356093
2019-06-05,9372100.0,81.37999725341797,82.2699966430664,81.08000183105469,81.69000244140625,78.78108978271484,MRK,10 Jaw-Dropping Numbers About Cancer Drug Development -- and What They Mean for Investors,0,0.52519494
2019-06-06,10872100.0,82.16000366210938,82.44000244140625,81.43000030517578,81.44000244140625,78.53999328613281,MRK,Vanguard S&P 500 ETF Experiences Big Inflow,1,0.51746505
2019-06-07,8394500.0,81.81999969482422,82.87999725341797,81.81999969482422,82.45999908447266,79.52367401123047,MRK,Sanofi's Leadership Transition: What You Need To Know,1,0.49207565
2019-06-10,7191100.0,82.68000030517578,82.68000030517578,81.6500015258789,82.4800033569336,79.54296112060547,MRK,"The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts ||| Merck Strikes $773M Deal For Privately Held Tilos Therapeutics ||| A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street ||| Merck Reports Purchase Of Tilos Therapeutics For Total Potential Consideration OF $773M",1,0.5131275
2019-06-11,7432900.0,82.88999938964844,83.41000366210938,82.44999694824219,82.9800033569336,80.02516174316406,MRK,"Noteworthy Tuesday Option Activity: MRK, LMNR, SRPT ||| FDA Greenlights Merck's Blockbuster Drug Keytruda For First-Line Treatment Of Head, Neck Cancer ||| FDA Approves Two New Indications For Merck's KEYTRUDA",1,0.51032376
2019-06-12,10551300.0,83.13999938964844,84.2699966430664,83.13999938964844,83.70999908447266,80.72916412353516,MRK,"Ex-Dividend Reminder: DTE Energy, Merck and Iron Mountain ||| WHO Emergency Committee Meeting To Decide If Ebola Outbreak Constitutes An Int'l. Emergency Will Begin Jun. 14, 2019 ||| The Daily Biotech Pulse: Nuvectra Files For Expanded Label For Algovita SCS, Axovant Earnings, FDA Nod For Aratana",0,0.49982557
2019-06-13,9727100.0,84.05999755859375,84.18000030517578,82.52999877929688,82.9000015258789,79.947998046875,MRK,"IBM, Walmart, Merck Included In FDA Program To Test Blockchain Usage In US Drug Supply Chain ||| IBM, KPMG, Merck, Walmart Report Have Been Selected By FDA To Be Included In Blockchain Program In Support Of US Drug Supply Chain Security Act To Address Requirement To Identify, Track, Trace Medicines, Vaccines Distributed In US",0,0.5092389
2019-06-14,7624000.0,82.70999908447266,83.37000274658203,82.45999908447266,82.77999877929688,80.3654556274414,MRK,"From Earlier: 'Drug makers Amgen, Merck, Lilly and the Association of National Advertisers file suit to prevent the disclosure of drug prices in television ads.' ||| JP Morgan Maintains Overweight on Merck & Co, Raises Price Target to $93",1,0.49545544
2019-06-17,6132900.0,82.69999694824219,83.33000183105469,82.52999877929688,83.30000305175781,80.87029266357422,MRK,"5 Biggest Blockbuster Drugs of the Future ||| The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs ||| Notable ETF Inflow Detected - DGRO, VZ, ABBV, MRK ||| 'Measles cases in United States rise to 1,044- CNN",1,0.53225553
2019-06-18,10901800.0,83.2300033569336,84.66999816894531,83.2300033569336,84.48999786376953,82.02557373046875,MRK,"Merck Reports FDA Approved KEYTRUDA As Monotherapy for Patients with Metastatic Small Cell Lung Cancer (SCLC) with Disease Progression on or After Platinum-Based Chemotherapy and at Least One Other Prior Line of Therapy ||| AstraZeneca, Merck Report LYNPARZA Approved In EU For Use as First-Line Maintenance Therapy in Patients With BRCA-Mutated Advanced Ovarian Cancer ||| AstraZeneca, Merck Announce Lynparza Approved in the EU for 1st-line Maintenance Treatment Of BRCA-mutated Advanced Ovarian Cancer",1,0.5267399
2019-06-19,9375400.0,84.25,85.55999755859375,84.20999908447266,85.36000061035156,82.87020111083984,MRK,"Report: Merck Searching Internally For Next CEO ||| Merck Prepping For CEO Departure, Has Begun Internal Successor Hunt ||| The Daily Biotech Pulse: Positive Readouts From Adamas And Ironwood, Sesen Bio To Offer Shares, Stoke Therapeutics Debut ||| AstraZeneca,Merck Announce Lynparza Approved in Japan for 1st-line Maintenance Therapy in BRCA-mutated Advanced Ovarian Cancer",0,0.49251258
2019-06-20,11918400.0,85.9800033569336,86.5,84.31999969482422,84.5999984741211,82.13237762451172,MRK,"Merck CEO Frazier At Investor Day Says The Company Has Less Appetite For Big Deals Than Mid Or Small-Sized Deals; Says Most Big Pharma Deals Have Not Created The Value They Said They Were Going To Create ||| The Daily Biotech Pulse: DiaMedica Reports Positive Data For Chronic Kidney Disease Drug, Eloxx Offering, IPO Deluge ||| Merck Highlights 2019 Investor Day Presentation",0,0.5054161
2019-06-21,14345700.0,84.44000244140625,84.7699966430664,83.63999938964844,84.56999969482422,82.10324096679688,MRK,"Dow Jones Today: A Typical Summer Friday ||| Oh, By the Way, This Clinical Trial Didn't Work ||| Morgan Stanley Maintains Overweight on Merck & Co, Raises Price Target to $90 ||| The Daily Biotech Pulse: ContraVir's Volatile Ride Continues, Late-Stage Disappointment For Exelixis, Regeneron-Sanofi Breathe Easy",1,0.5038483
2019-06-24,7530000.0,84.97000122070312,86.02999877929688,84.73999786376953,85.51000213623047,83.01582336425781,MRK,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs ||| Noteworthy Monday Option Activity: DHI, PTCT, MRK",0,0.5056876
2019-06-25,8920700.0,85.55000305175781,86.26000213623047,84.80999755859375,85.23999786376953,82.75370788574219,MRK,"DGRO, VZ, ABBV, MRK: Large Inflows Detected at ETF ||| Intensity Therapeutics Announces Clinical Collaboration With Merck For A Phase 1/2 Clinical Trial To Evaluate Co'S Int230-6 In Combination With Keytruda For Multiple Solid Tumor Types",0,0.5162285
2019-06-26,12027100.0,85.18000030517578,85.19999694824219,83.08999633789062,83.54000091552734,81.1032943725586,MRK,"Dow Movers: MRK, INTC",1,0.52170855
2019-06-27,11184800.0,83.66999816894531,84.69000244140625,83.4000015258789,83.83000183105469,81.38483428955078,MRK,"The Daily Biotech Pulse: Verrica Rallies, Aclaris Flunked Hair Loss Study, 3 Biotechs To IPO",1,0.49884844
2019-06-28,44546600.0,83.97000122070312,84.45999908447266,82.9800033569336,83.8499984741211,81.40425109863281,MRK,Can Roche's #1 Therapeutic Area With $28 Billion In Revenue Grow Further?,1,0.5320568
2019-07-01,9812700.0,84.33000183105469,84.93000030517578,83.88999938964844,84.75,82.27799987792969,MRK,Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates,1,0.51209676
2019-07-02,9906100.0,84.45999908447266,85.51000213623047,84.0999984741211,85.51000213623047,83.01582336425781,MRK,"Dow Analyst Moves: MRK ||| Mizuho Initiates Coverage On Merck With Buy Rating, $97 Price Target",1,0.5257881
2019-07-03,6234000.0,86.05999755859375,87.06999969482422,85.98999786376953,86.9000015258789,84.36528778076172,MRK,"Vanguard Value ETF Experiences Big Inflow ||| 9 Health-Care Stocks for Your Portfolio ||| Benzinga's Top Upgrades, Downgrades For July 3, 2019 ||| Mizuho Initiates Coverage On Merck & Co with Buy Rating, Announces $97 Price Target",0,0.53108287
2019-07-05,8365800.0,86.68000030517578,86.80000305175781,85.48999786376953,85.5999984741211,83.10320281982422,MRK,"The Daily Biotech Pulse: FDA Approves Karyopharm's Blood Cancer Treatment, Grifols' Immunodeficiency Drug; ESMO, ISTH Conferences In The Spotlight",0,0.50842565
2019-07-08,13066100.0,85.01000213623047,85.5,83.5,84.04000091552734,81.58869934082031,MRK,"Johnson & Johnson: How Does Darzalex Compare To Other Multiple Myeloma Drugs? ||| MRK August 23rd Options Begin Trading ||| Are Natural Killer Cells the Next Big Thing in Immunotherapy? ||| Shares of several healthcare companies are trading lower after Trump on Friday said he was preparing an executive order declaring a 'favored nations clause' for drug prices, lowering the price that consumers will pay prescription drugs.",1,0.50719947
2019-07-09,8101900.0,84.23999786376953,85.20999908447266,84.08999633789062,84.86000061035156,82.38479614257812,MRK,"Dow Jones Today: Averting Catastrophe, but Nothing to Brag About ||| Dow Movers: MMM, MRK ||| Judge Rules Against Trump Proposal Forcing Pharma Companies To Disclose Drug Prices In Commercials ||| FDA Accepts Merck's Supplemental Biologics License Applications For KEYTRUDA Six-Week Dosing Schedule For Melanoma And Multiple Other Indications",0,0.5145021
2019-07-10,5721500.0,84.80000305175781,85.11000061035156,84.3499984741211,84.81999969482422,82.34595489501953,MRK,The 10 Biggest Healthcare Stocks ||| Merck To Present Results From Studies Evaluating Investigational Anti-HIV Agent MK-8591 At IAS 2019 On Jul. 21-24,0,0.48954636
2019-07-11,21131800.0,83.5,83.66999816894531,79.77999877929688,81.0,78.63736724853516,MRK,"Dow Jones Today: More Fed Fun, but Healthcare Weakness Caps Gains ||| Notable ETF Inflow Detected - SPYG, VZ, MRK, AVGO ||| Merck a Top 25 Dividend Giant With 2.59% Yield (MRK) ||| Shares of several drug manufacturing companies are trading lower. The Trump Administration earlier rolled back a proposal to eliminate rebates from government drug plans and commented on continued efforts to lower drug prices.",0,0.4898948
2019-07-12,18044500.0,80.8499984741211,80.9000015258789,78.62999725341797,79.7300033569336,77.4044189453125,MRK,"Friday’s Vital Data: Bed Bath & Beyond, CVS and Merck ||| Washington Worries Trigger Bearish Merck Options Trades ||| Novartis, Amgen Scrap Pivotal Study Of Alzheimer's Prevention Drug ||| Stock Market Eyes Records On Dovish Commentary From Federal Reserve ||| Shares of several drug manufacturing companies are trading lower, potentially on continued weakness after the Trump Administration on Thursday rolled back a proposal to eliminate rebates from government drug plans.",1,0.50720704
2019-07-15,10422300.0,80.5999984741211,81.2699966430664,80.12000274658203,80.95999908447266,78.59854125976562,MRK,"Better Buy: AbbVie vs. Merck ||| The Week Ahead In Biotech: Johnson & Johnson Kickstarts Big Pharma Earnings ||| Bulls & Bears Of The Week: Costco, DuPont, IBM, Merck And More ||| A Pairs Prescription for CVS Stock and Merck ||| Dow Movers: GS, MRK ||| World Health Organization Chief Says Ebola Case In Congolese City Of Goma Could Be A Gamechanger",1,0.5064012
2019-07-17,9397900.0,81.95999908447266,82.33999633789062,81.58000183105469,81.91999816894531,79.5305404663086,MRK,"WHO Emergency Committee Says It Recognises Shortage Of Supply Of Merck's Ebola Vaccine, Says Who Should Work With Member States And Manufacturers To 'Take All Measures' To Increase Supply ||| WHO Emergency Committee Chairman Says Ebola Is A Regional Emergency And In No Way A Global Threat ||| World Health Organization's Emergency Committee Says Congo's Ebola Outbreak Constitutes A Public Health Emergency Of International Concern ||| Merck's Novel Antibiotic For Abdominal, Urinary Tract Infections Receives FDA Nod ||| FDA Approves Merck's RECARBRIO For the Treatment of Adults with Complicated Urinary Tract And Complicated Intra-Abdominal Bacterial Infections Where Limited Or No Alternative Treatment Options Are Available",1,0.5150814
2019-07-19,11501700.0,82.69999694824219,82.81999969482422,81.1500015258789,81.38999938964844,79.01599884033203,MRK,"SPYG, PFE, VZ, MRK: Large Inflows Detected at ETF",0,0.520965
2019-07-22,6929100.0,81.68000030517578,81.81999969482422,81.05000305175781,81.20999908447266,78.84125518798828,MRK,The Week Ahead In Biotech: Pharma Earnings Pick Up Pace,1,0.52581966
2019-07-23,7080600.0,81.4800033569336,82.43000030517578,80.88999938964844,82.02999877929688,79.6373291015625,MRK,"How to Invest in Cancer-Fighting Stocks ||| Why Bristol-Myers Squibb Stock Is Stumbling Ahead of Earnings ||| Health Care Sector Update for 07/23/2019: JNJ, PFE, ABT, MRK, AMGN ||| Merck Reports Results From Phase 1 Study Of Investigational Nucleoside Reverse Transcriptase Translocation Inhibitor Presented At International AIDS Society Conference on HIV Science ||| Eisai's Cancer Drug Combo Gets Breakthrough Therapy Designation For Liver Cancer ||| The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation ||| Merck And Eisai Receive Third Breakthrough Therapy Designation From FDA For KEYTRUDA Plus LENVIMA Combination Treatment",0,0.4998082
2019-07-24,7366600.0,82.0,82.30999755859375,81.12000274658203,81.75,79.3655014038086,MRK,"Merck Highlights Presentation Of Phase 2b Results For Investigational HIV-1 Therapy Islatravir (MK-8591) At IAS 2019 ||| The Daily Biotech Pulse: Jounce Jumps On Licensing Deal, Regulus Hit With Partial Clinical Hold, Genomic Health Added to S&P SmallCap Index",0,0.49646822
2019-07-26,7289100.0,81.58000183105469,81.62999725341797,80.91000366210938,81.43000030517578,79.0548324584961,MRK,"Notable Earnings To Watch Next Week - LLY, AAPL, PG, MRK, PFE, CVX",1,0.5019333
2019-07-29,10614200.0,82.0999984741211,82.80000305175781,81.61000061035156,82.48999786376953,80.08391571044922,MRK,"10 Biggest Cancer-Fighting Stocks ||| The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate ||| Dow Movers: PFE, MRK ||| Merck: CHMP Supports KEYTRUDA Plus Inlyta To Treat Advanced Renal Cell Carcinoma ||| Merck Q2 Earnings Preview ||| Merck's Keytruda Gets A Double Dose Of Positive News ||| Merck's KEYTRUDA in Combination with Chemotherapy Met One of the Dual Primary Endpoints in Pivotal Phase 3 KEYNOTE-522 ||| Merck's KEYTRUDA in Combination with Inlyta as First-Line Treatment for Advanced Renal Cell Carcinoma Receives a Positive Opinion From the European Medicines Agency",1,0.54217255
2019-07-30,13632600.0,83.98999786376953,85.16999816894531,82.81999969482422,83.2699966430664,80.8411636352539,MRK,"Trade Tweets, Pfizer Drag On Dow ||| Merck Reports Fantastic Q2 Earnings Results: 4 Things You Need to Know ||| Notable Tuesday Option Activity: MRK, WAB, BLK ||| How Big Is Pfizer's Generic Drugs Business That It Plans To Merge With Mylan? ||| DGRO, VZ, PFE, MRK: Large Outflows Detected at ETF ||| Stock Market News: Proctor & Gamble, Merck Can't Buoy Benchmarks ||| Health Care Sector Update for 07/30/2019: FMS, MRK, LLY, JNJ, PFE, ABT, AMGN ||| Merck Lifts FY Adj. Profit View ||| Merck & Co Q2 19 Earnings Conference Call At 8:00 AM ET ||| Merck & Co Inc. Q2 adjusted earnings Beat Estimates ||| Apple On Today's Menu, With Starring Roles From China Talks, Fed Meeting ||| 33 Healthcare Stocks Moving In Today's Pre-Market Session ||| Merck & Co shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. The company also issued FY19 guidance above analyst estimates. ||| A Peek Into The Markets: US Stock Futures Down Ahead of Fed Meeting, Apple Earnings ||| Merck Reports Q2 Earnings Beat ||| The Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On Earnings ||| Merck & Co. Sees FY19 Adj. EPS $4.84-$4.94 vs $4.75 Est., Sees Sales $45.2B-$46.2B vs $44.74B Est. ||| Merck & Co Q2 Adj. EPS $1.3 Beats $1.16 Estimate, Sales $11.76B Beat $10.96B Estimate ||| 15 Stocks To Watch For July 30, 2019 ||| Earnings Scheduled For July 30, 2019",0,0.4797171
2019-07-31,11873500.0,82.9000015258789,84.6500015258789,82.83999633789062,82.98999786376953,80.56932830810547,MRK,SELLAS Advances Galinpepimut-S (GPS) In Combination With KEYTRUDA Program With Dosing Of First Patient In Phase 1/2 Basket Study ||| Merck Reports FDA Approved New Monotherapy Indication For KEYTRUDA: 'Recurrent Locally Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus in Patients Whose Tumors Express PD-L1 (CPS ≥10) With Disease Progression After One or More Prior Lines',1,0.5198804
2019-08-05,11341200.0,83.8499984741211,84.33999633789062,82.16000366210938,83.12000274658203,80.69554138183594,MRK,"Bulls And Bears Of The Week: Boeing, GM, Pfizer, Starbucks And More ||| The Week Ahead In Biotech: Focus On Earnings Deluge, Mid-Year Clinical Trial Readouts ||| These 5 Prescription Drugs Will Generate a Jaw-Dropping $62.3 Billion in 2024 ||| Universal Display and Merck Announce Research and Development Collaboration for OLED",1,0.49740192
2019-08-06,10520300.0,83.12000274658203,84.4800033569336,83.0999984741211,84.3499984741211,81.88965606689453,MRK,"Fear Around Bristol-Myers Squibb Stock is Starting to Fade ||| Merck 10-Q Out; Shows Co. Received Set Of Investigative Interrogatories From California Attorney General's Office On Apr. 15, 2019 Related To Conduct, Deal That Allegedly Affected, Delayed Competition To Lantus In Insulin Market ||| The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering",0,0.50672865
2019-08-07,10982500.0,84.20999908447266,84.69000244140625,82.80000305175781,84.25,81.7925796508789,MRK,"Codexis Rolls Into Second Half Armed with Cash ||| AstraZeneca, Merck Report Positive Phase III Trial Results Of Lynparza",1,0.5125485
2019-08-09,8557500.0,85.0999984741211,86.11000061035156,84.70999908447266,85.5199966430664,83.02552795410156,MRK,"The Health Care Select Sector SPDR Fund Experiences Big Inflow ||| Dow Movers: IBM, MRK ||| Health Care Sector Update for 08/09/2019: LVGO,MRK,AMRN,NVRO,NKTR",1,0.48968825
2019-08-12,7096000.0,85.2300033569336,85.93000030517578,84.5199966430664,85.7300033569336,83.22940826416016,MRK,Bristol-Myers Squibb Stock Has Upside — But Mind the Risks,1,0.47122258
2019-08-13,8028300.0,85.45999908447266,86.79000091552734,85.45999908447266,86.08000183105469,83.56919860839844,MRK,Shares of several healthcare companies are trading higher with the overall market after the U.S. announced it is excluding and delaying the additional 10% tariff on certain products.,0,0.5350738
2019-08-14,10888500.0,85.37000274658203,85.83999633789062,83.3499984741211,83.4000015258789,80.9673843383789,MRK,"See Which Of The Latest 13F Filers Holds Merck ||| The Daily Biotech Pulse: Regeneron's Bad Cholesterol Drug Aces Late-Stage Trial, Oncolytics Offering ||| AstraZeneca And Merck Announce LYNPARZA) Phase 3 PAOLA-1 Trial Met Primary Endpoint In Ovarian Cancer Patients ||| Lynparza Phase Iii Paola-1 Trial Met Primary Endpoint as 1st-line Maintenance Treatment With Bevacizumab for Advanced Ovarian Cancer ||| AstraZeneca, Merck Announce Lynparza Phase III PAOLA-1 Trial Met Primary Endpoint",1,0.4883503
2019-08-16,8736900.0,84.44999694824219,85.36000061035156,84.1500015258789,85.05999755859375,82.57894897460938,MRK,"What Has Led Bristol-Myers Squibb's Stock To Fall More Than 35% Over The Last 3 Years? ||| Shares of healthcare companies are trading higher as US markets rebound from recent weakness following a yield curve inversion, which caused recession fears. Trump also recently announced the US would delay China tariffs, renewing hopes of a trade deal. ||| Benzinga's Top Upgrades, Downgrades For August 16, 2019 ||| SVB Leerink Initiates Coverage On Merck & Co with Outperform Rating, Announces $103 Price Target",1,0.53012556
2019-08-19,7304600.0,85.58999633789062,86.52999877929688,85.44999694824219,86.19000244140625,83.67598724365234,MRK,"Notable ETF Inflow Detected - ITOT, AAPL, HD, MRK ||| Shares of several healthcare companies are trading higher as optimism increased for a resolution to the US-China trade war.",0,0.5347782
2019-08-21,6189000.0,86.29000091552734,87.25,86.12999725341797,86.91000366210938,84.37499237060547,MRK,"The Daily Biotech Pulse: Ra Pharma Earns Milestone, Aimmune Doses Patient In Egg Allergy Trial, Cara In-Licenses Platform",0,0.51515484
2019-08-22,6287000.0,86.75,87.19999694824219,86.25,86.72000122070312,84.19053649902344,MRK,"Jim Cramer Weighs In On Pfizer, Teva And More ||| Analysts Share Stocks To Buy On Fed Uncertainty ||| The Daily Biotech Pulse: ViiV's Long-Acting HIV Drug Meets Study Goal, Chinese Cheer For FibroGen, Retrophin Flunks Late-Stage Study",0,0.48985264
2019-08-26,5765100.0,85.37999725341797,85.9000015258789,85.08000183105469,85.87999725341797,83.3750228881836,MRK,"10 Biopharmaceutical Companies Trying To Cure Cancer ||| Bristol-Myers Squibb's Eliquis Has Added Over $1 Billion In Sales Each Year, But Can This Trend Continue?",0,0.5133948
2019-08-27,6228100.0,86.41999816894531,86.91999816894531,85.44999694824219,85.5199966430664,83.02552795410156,MRK,"Iovance Biotherapeutics: Buy the Dip? ||| Notable ETF Outflow Detected - XLV, MRK, PFE, ABT ||| How Much Will It Cost Johnson & Johnson To Settle Most of Its Lawsuits? ||| Why Jim Cramer's Negative Take on Pfizer Is Flat-Out Wrong",1,0.48433003
2019-08-28,5877800.0,85.26000213623047,86.56999969482422,85.04000091552734,86.4800033569336,83.95753479003906,MRK,Here's Why Lannett Stock Is Soaring Today ||| Here's How Rising Litigation Charges Are Impacting Johnson & Johnson’s Earnings ||| Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates,1,0.48899996
2019-08-29,6031500.0,87.06999969482422,87.3499984741211,86.18000030517578,86.72000122070312,84.19053649902344,MRK,Uganda Confirms Another Case Of Ebola - A 9-Year Old Girl Who Traveled Democratic Republic Of Congo ||| Stocks That Hit 52-Week Highs On Thursday,0,0.50606036
2019-08-30,6483900.0,87.12000274658203,87.22000122070312,86.16999816894531,86.47000122070312,83.94782257080078,MRK,"Xynomic Pharma ReportsInterim Data From Phase 1b Study Of Abexinostat Combined With Keytruda In Multiple Solid Tumors ||| Deaths from E. Congo Ebola Outbreak Top 2,000; Cases Top 3,000",1,0.50009835
2019-09-03,6389200.0,86.23999786376953,87.01000213623047,86.04000091552734,86.6500015258789,84.1225814819336,MRK,"Health Care Sector Update for 09/03/2019: CDTX, ENDP, MRK, ARDS, JNJ, PFE, ABT, MRK, AMGN ||| Dow Movers: BA, PFE ||| Can Roche's Blockbuster Drug Herceptin's Sales Grow?",0,0.48886737
2019-09-04,7507700.0,87.13999938964844,87.16999816894531,85.41999816894531,86.05000305175781,83.54008483886719,MRK,"Noteworthy ETF Outflows: XLV, MRK, UNH, PFE ||| Merck: European Commission Approves KEYTRUDA, Inlyta Combination To Treat RCC ||| Near an All-Time Low, Is Clovis Oncology a Buy? ||| Aduro Biotech Announces First Patient Dosed In Phase 2 Study Of ADU-S100 In Combination With KEYTRUDA For First-Line Treatment Of Recurrent Or Metastatic Head And Neck Squamous Cell Carcinoma ||| European Commission Approves Merck's KEYTRUDA In Combination With Inlyta As First-Line Treatment For Patients With Advanced Renal Cell Carcinoma",1,0.5020607
2019-09-05,7180300.0,86.63999938964844,86.66000366210938,85.5,86.0999984741211,83.588623046875,MRK,How Will Johnson & Johnson's Opioid Case Ruling Impact Big Pharma Stocks? ||| Is the FDA Out to Get This $2.9 Billion Diabetes Drug Class? ||| How Important Is Keytruda For Merck?,1,0.49237046
2019-09-06,6724900.0,86.54000091552734,86.93000030517578,86.30999755859375,86.56999969482422,84.04490661621094,MRK,"Dow Movers: DOW, MRK",0,0.51621276
2019-09-09,11489300.0,86.5,86.5199966430664,82.91999816894531,83.47000122070312,81.03533172607422,MRK,"Is Bristol-Myers Squibb a Buy? ||| Dow Movers: MRK, WBA ||| Merck & Co To Present At The Morgan Stanley Conference; Webcast At 10:30 AM ET ||| Merck & Co shares are trading lower. Not seeing any news to justify the price action. ||| Merck to Present Data From its Phase 3 Trial for KEYTRUDA as Neoadjuvant Therapy at the European Society for Medical Oncology",0,0.47745904
2019-09-10,17259000.0,82.38999938964844,82.38999938964844,78.8499984741211,81.69000244140625,79.3072509765625,MRK,"S&P 500 Movers: MKTX, NKTR ||| What To Make of Roche's Drugs With $21 Billion In Sales Nearing Patent Expiry? ||| Dow Movers: MRK, DOW ||| Shares of several drugmakers are trading lower on news of a drug pricing bill being developed by House Democrats. The proposed bill would set US drug prices based on prices in other wealthy countries.",1,0.50066334
2019-09-11,10116600.0,81.86000061035156,83.11000061035156,81.62000274658203,82.91999816894531,80.50137329101562,MRK,"FDA Approval of Roche Cancer Drug Confirms Beginning of New Oncology Era ||| Ex-Dividend Reminder: Atrion, Merck and First Citizens BancShares",1,0.52763546
2019-09-12,8031200.0,83.4800033569336,84.08000183105469,82.79000091552734,83.30999755859375,80.87999725341797,MRK,"Is Lannett Company a Turnaround Stock Worth Buying? ||| Noteworthy ETF Outflows: XLV, UNH, MRK, PFE ||| Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for September 13, 2019 ||| Oracle Reports Early In Surprise Move As Trump Surprises With Positive Trade Tweet",0,0.46729687
2019-09-16,5907700.0,82.44999694824219,82.44999694824219,81.69000244140625,82.02999877929688,80.16658020019531,MRK,"Worried About a Recession? These 3 Stocks Can Help Protect Your Portfolio ||| The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck ||| 3 Big Stock Charts for Monday: Merck, Facebook and Microsoft",1,0.48591208
2019-09-17,7037600.0,82.12999725341797,83.5,82.12999725341797,82.51000213623047,80.63568115234375,MRK,"Dow Analyst Moves: MRK ||| Merck: FDA Grants Priority Review For Investigational Ebola Vaccine ||| Merck Press Release Confirms FDA Approval Of KEYTRUDA Plus LENVIMA Combo Treatment For Patients With Certain Types Of Endometrial Carcinoma ||| FDA Says Granted Accelerated Approval To Lenvima In Combo With Keytruda For Treatment Of Patients With Advanced Endometrial Carcinoma ||| Merck Reports FDA Accepted Biologics License Application, Granted Priority Review For V920 For Ebola Zaire Virus",1,0.51876205
2019-09-18,6625700.0,82.66999816894531,83.27999877929688,82.37999725341797,83.0199966430664,81.13409423828125,MRK,"FDA Makes 1st Approval Under Project Orbis, KDMN On Watch, TBIO Down After-hrs ||| 10 Companies Making Their CEOs Rich ||| FDA, Canada, Australia Collaborate On Cancer Drugs Review ||| NewLink Genetics Rallies After Ebola Vaccine Granted Priority Review Status ||| The Daily Biotech Pulse: NewLink Genetics Rallies, Breakthrough Designation For Roche, IGM Biosciences Debuts ||| FDA Approves LENVIMA Plus KEYTRUDA Combination Treatment for Patients with Certain Types of Endometrial Carcinoma",1,0.54511815
2019-09-20,22548900.0,84.73999786376953,85.87000274658203,84.31999969482422,85.16000366210938,83.2254867553711,MRK,"Noteworthy Friday Option Activity: MRK, ABT, ARNA ||| FDA Approves Merck's SNDAs For PIFELTRO And DELSTRIGO - Quick Facts ||| Shares of several drug companies are trading higher after Senate Majority Leader McConnell suggested a new Democratic drug price reform proposal would be dead on arrival. ||| The Daily Biotech Pulse: FDA Approves Merck HIV Drugs, Five Prime CEO Quits, HTG Molecular Announces Secondary Offering ||| Merck's PIFELTRO And DELSTRIGO Receive FDA Approval For Use In Appropriate Adults Living With HIV-1 Who Are Virologically Suppressed",0,0.52526915
2019-09-23,8501500.0,84.91000366210938,85.22000122070312,84.33999633789062,84.36000061035156,82.44365692138672,MRK,2 Pharma Stocks You Should Buy Now ||| The Week Ahead In Biotech: Spotlight On ESMO Conference,0,0.5193263
2019-09-25,6957000.0,83.47000122070312,84.02999877929688,82.94999694824219,83.0999984741211,81.2122802734375,MRK,"Biotech Stock On The Radar: Anavex, A Neurology-Focused Precision Medicine Company",1,0.510561
2019-09-26,7733700.0,83.62000274658203,84.08999633789062,83.04000091552734,83.87999725341797,81.97455596923828,MRK,How Big Can This $8 Billion-Plus Diabetes Drug Class Get?,0,0.51542217
2019-09-27,7468600.0,83.87999725341797,83.98999786376953,82.58000183105469,82.91000366210938,81.02659606933594,MRK,Is GlaxoSmithKline a Buy?,1,0.509117
2019-09-30,9357800.0,83.20999908447266,85.0999984741211,83.20999908447266,84.18000030517578,82.26774597167969,MRK,"How Is Roche Doing In Crowded Multiple Sclerosis Drugs Market? ||| Merck's Leadership In HPV Vaccines Market ||| AstraZeneca , Merck Announced LYNPARZA Phase 3 PAOLA-1 Trial Significantly Increased Progression-Free Survival as First-Line Maintenance Treatment with Bevacizumab for Newly-Diagnosed Advanced Ovarian Cancer at ESMO 2019 ||| The Week Ahead In Biotech (Sept. 29-Oct. 5): Conference Presentations, IPOs Hit Top Gear ||| What Happened in the Stock Market Today ||| Why Immunomedics Stock Is Sinking Today ||| Here’s Why Seattle Genetics Stock Jumped Higher Today ||| Dow Movers: GS, MRK ||| Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates ||| Merck shares trading higher over the $82 level. The company announced its RESTORE-IMI study of RECARBRIO met its primary endpoint. Separately, the company and AstraZeneca highlighted new LYNPARZA data. ||| Movers And Shakers At ESMO 2019: Immunomedics, G1 Therapeutics, Seattle Genetics And More ||| Merck, AstraZeneca Highlight Data LYNPARZA More Than Doubled Median Radiographic Progression-Free Survival In BRCA1/2, ATM Metastatic Castration-Resistant Prostate Cancer ||| Merck's Pivotal RESTORE-IMI 2 Phase 3 Study of RECARBRIO Met its Primary Endpoint",0,0.5089944
2019-10-01,6727100.0,84.18000030517578,84.5999984741211,83.54000091552734,83.61000061035156,81.710693359375,MRK,"iShares Edge MSCI USA Momentum Factor ETF Experiences Big Outflow ||| Johnson & Johnson Can Overcome Its Legal Issues ||| 4 Healthcare Stocks to Buy Now ||| The Daily Biotech Pulse: Safety Scare For Anaptys' Psoriasis Drug, NewLink Genetics To Merge With Lumos, Insider Buy Props Up VBI Vaccines",0,0.5126339
2019-10-02,8361100.0,83.06999969482422,83.20999908447266,80.54000091552734,81.62000274658203,79.76589965820312,MRK,"Dow Movers: DOW, JNJ ||| Merck: FDA To Review Two Applications For DIFICID - Quick Facts ||| Winners and Losers of Europe’s Big Cancer Meeting ||| Shares of several healthcare companies are trading lower in sympathy with the overall market on continued fears of a recession amid a weak ADP jobs report. There is also uncertainty in the market over the upcoming U.S.-China meeting next week. ||| Merck's KEYTRUDA Now Approved as Monotherapy In China For First-Line Treatment Of Certain Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Whose Tumors Express PD-L1 ||| FDA Accepts Two Applications For Merck's DIFICID To Treat Children Aged Six Months Up To 18 years With Clostridium difficile Infections",1,0.52808523
2019-10-03,5524900.0,81.93000030517578,82.87999725341797,81.62999725341797,82.73999786376953,80.8604507446289,MRK,"Dow Movers: MMM, MRK ||| Biotech Stock On The Radar: FDA Verdict Ahead For Pfenex's Osteoporosis Biosimilar ||| What's Behind PDS Biotech's Rally? ||| PDS Biotech Reports Clinical Collaboration With Merck For Evaluation Of Combo Of PDS0101, Merck's KEYTRUDA",1,0.52209455
2019-10-07,4853200.0,85.02999877929688,85.11000061035156,83.94999694824219,84.38999938964844,82.47296905517578,MRK,"Here's Why Seattle Genetics Climbed 17.6% in September ||| 10 Great Biotech Stocks to Buy in Q4 ||| Health Care Sector Update for 10/07/2019: JNJ, ABT, PFE, MRK, AMGN, MREO, XENT, CAPR",0,0.48661166
2019-10-08,6122800.0,83.79000091552734,84.41000366210938,83.08000183105469,83.29000091552734,81.39795684814453,MRK,"Merck's $3 Billion Drug Jumped To 4x Growth Over Previous Year ||| How Does Bristol-Myers Squibb's Valuation Compare To Its Peers? ||| Goldman Recommends Selling Puma Biotech, Clovis Oncology; Cites Company-Specific, Competitive Risks ||| Shares of several healthcare companies are trading lower with the broader market after the US expanded its trade blacklist to include China's top AI firms. The US also will increase its tariffs on $250 billion worth of goods from 25% to 30% on Oct 15.",1,0.5140521
2019-10-09,4447400.0,84.16999816894531,84.48999786376953,83.52999877929688,84.18000030517578,82.26774597167969,MRK,"Notable ETF Outflow Detected - MTUM, MA, V, MRK",0,0.501595
2019-10-11,5944300.0,84.30000305175781,85.44000244140625,84.26000213623047,84.33999633789062,82.42410278320312,MRK,Shares of several healthcare companies are trading higher after President Trump made positive remarks on the U.S.-China trade talks as traders grew more optimistic over the possibility of a limited trade deal. Trump is scheduled to meet with Chinese Vice Premier Liu He at the White House today.,1,0.50412744
2019-10-14,5260700.0,84.37000274658203,85.11000061035156,84.29000091552734,84.69000244140625,82.76615905761719,MRK,"The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings ||| Johnson and Johnson Stock Still Significantly Undervalued",1,0.50540715
2019-10-15,4966700.0,84.9000015258789,85.0999984741211,84.58999633789062,85.04000091552734,83.10820770263672,MRK,"Better Buy: GlaxoSmithKline vs. Merck ||| 3 Dividend-Paying Pharma Stocks to Buy Now ||| The Daily Biotech Pulse: Reata Leaps On Positive Readout, Takeda Divests, FDA Nod For Akorn, J&J Earnings",0,0.5003541
2019-10-16,5425700.0,85.05999755859375,85.08999633789062,84.41999816894531,84.44999694824219,82.5316162109375,MRK,"Health Care Sector Update for 10/16/2019: TEVA, JNJ, PFE, ABT, MRK, AMGN, JNJ, MNK, ENDP, RYTM ||| Biotech Stock On The Radar: Assessing Mirati's Oncology Franchise With An Eye On Multiple Readouts",0,0.4968506
2019-10-17,6849700.0,84.41999816894531,84.6500015258789,83.73999786376953,83.80000305175781,81.89637756347656,MRK,"Bank of America Reinstates Neutral on Merck & Co, Announces $90 Price Target",1,0.52264845
2019-10-18,7522000.0,83.70999908447266,84.91000366210938,83.66000366210938,84.68000030517578,82.75637817382812,MRK,"WHO Says Ebola Concentrated In Congo Mining Area, Still An Emergency ||| Merck Reports Positive EU CHMP Opinion For 2 New Regimens Of KEYTRUDA As First-Line Treatment For Metastatic Or Unresectable Recurrent Head, Neck Squamous Cell Carcinoma ||| Merck Reports Received EU CHMP Positive Opinion For Investigational V920 Ebola Vaccine For Protection Against Ebola Virus",0,0.4998607
2019-10-21,5107000.0,84.97000122070312,85.05999755859375,84.08000183105469,84.5199966430664,82.60002136230469,MRK,See Which Of The Latest 13F Filers Holds Merck & Co ||| Here's How Johnson & Johnson's Oncology Drugs Portfolio Compares With That of Roche ||| NewLink Genetics Announces EU Regulatory Committee Recommendation For Conditional Marketing Authorization For Ebola Vaccine V920 ||| Exclusive: Plus Products Hires The Wonderful Company's Mackler As Chief Scientific Officer,0,0.5280422
2019-10-22,17775800.0,82.0,82.68000030517578,80.25,81.30000305175781,79.45316314697266,MRK,"Noteworthy Tuesday Option Activity: UTX, MRK, KMB ||| Jim Cramer Gives His Take On AMD, Merck And More ||| Merck & Co shares are trading lower on seemingly no company-specific news. The stock touched the $85 resistance level and traded lower. ||| The Daily Biotech Pulse: Biogen Alzheimer's Program Back On Track, Novartis Reports Strong Quarter, Takeda In-Licenses Autoimmune Disorder Drug ||| 8 Healthcare Stocks Moving In Tuesday's Pre-Market Session",1,0.51485276
2019-10-23,8122100.0,81.29000091552734,82.87000274658203,81.16000366210938,82.87000274658203,80.98751068115234,MRK,Is AnaptysBio a Buy? ||| Add Up The Pieces: DJD Could Be Worth $41 ||| 3 Cancer Treatment Stocks to Buy Right Now,0,0.49033576
2019-10-28,14845100.0,82.7300033569336,83.47000122070312,80.33999633789062,82.19999694824219,80.33271789550781,MRK,"5 Top Healthcare ETFs ||| The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings ||| More Earnings And A Fed Decision In Week Four Of The WeTrader Competition ||| Merck Shares Fall 2% Following Report AstraZeneca Trial Of Imfinzi, Imfinzi Plus Tremelimumab Delayed Disease Progression In Phase 3 Trial",1,0.54788333
2019-10-29,16575100.0,84.05000305175781,85.7699966430664,82.69999694824219,85.0999984741211,83.16683959960938,MRK,"Noteworthy Tuesday Option Activity: AWI, MIC, MRK ||| S&P Cools as Wall Street Looks to Fed Meeting ||| Dow Jones Today: Struggling at the Highs ||| Dow Jones News: Walmart Under Pressure From Amazon; Merck Trounces Analyst Estimates ||| Merck & Co Inc (MRK) Q3 2019 Earnings Call Transcript ||| Health Care Sector Update for 10/29/2019: PFE, MRK, MOR, GLPG, JNJ, ABT, AMGN ||| Daily Markets: Will the Fed Kill the Market Rally? ||| Merck Raises 2019 Non-GAAP EPS Guidance Range - Quick Facts ||| Merck & Co Q3 19 Earnings Conference Call At 8:00 AM ET ||| Merck & Co Inc. Q3 adjusted earnings Beat Estimates ||| Alphabet Misses On Earnings, But Drugmakers, Mastercard Beat Expectations ||| 28 Healthcare Stocks Moving In Tuesday's Pre-Market Session ||| Merck & Co Inc Sees Increased Pricing Pressure In 2020; Says Demand For Gardasil Continues To Outpace Supply ||| Pharma Earnings: Merck, Pfizer Trade Higher On Q3 Beats ||| The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study ||| Merck & Co shares are trading higher after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY19 EPS and sales guidance above analyst estimates. ||| Merck Sees FY19 Adj. EPS $5.12-$5.17 vs $4.92 Est., Sales $46.5B-$47.0B vs $45.98B Est. ||| Merck & Co Q3 Adj. EPS $1.51 Beats $1.24 Estimate, Sales $12.4B Beat $11.63B Estimate ||| 12 Stocks To Watch For October 29, 2019 ||| Earnings Scheduled For October 29, 2019",1,0.5144344
2019-10-30,9567600.0,85.0,86.48999786376953,84.31999969482422,86.22000122070312,84.26140594482422,MRK,"It's 9-7 For Withdrawal Of Makena, Roche-Spark Deal Delayed Again, MRK On Watch ||| Could Johnson & Johnson's Revenue Growth Stall? ||| US Appeals Court Upholds Lower Court Ruling That Tossed $2.54B Jury Verdict For Merck In Patent Case Against Gilead ||| Decision Day: Fed On Tap Later, Followed by Apple, Facebook After Close",1,0.5053364
2019-10-31,11850600.0,86.0999984741211,86.98999786376953,85.51000213623047,86.66000366210938,84.69141387939453,MRK,"What Should Investors Think of Biogen's Alzheimer's Drug Candidate? ||| Here’s Why Exelexis Sank Today ||| AstraZeneca's Stock Is on a Roll. Time to Buy? ||| 3 Big Stock Charts for Thursday: Merck, Anheuser-Busch InBev, and PPG Industries ||| Despite Key Patent Losses Roche Could Add $5 Billion In Sales Over The Next 3 Years",0,0.4899747
2019-11-01,8855900.0,87.06999969482422,87.23999786376953,84.79000091552734,84.94000244140625,83.01048278808594,MRK,3 Top Cannabis Stocks to Buy in November ||| WeTrader Competition: Round Four Wrap-up,0,0.5271282
2019-11-04,8537400.0,85.58999633789062,85.69999694824219,83.87999725341797,83.9000015258789,81.99410247802734,MRK,"The Week Ahead In Biotech: Smid-Cap Earnings Deluge, SITC Conference In The Spotlight ||| Should Merck Investors Worry About Bristol Myers' Lung Cancer Drug Results?",0,0.51509833
2019-11-05,9482800.0,83.66999816894531,83.75,82.7300033569336,82.91999816894531,81.03636169433594,MRK,Here's Why NextCure Stock Blew Through the Roof Today ||| BioLineRx Announces Data Showing BL-8040 In Combination With KEYTRUDA Shows Clinical Activity In Heavily Pretreated Metastatic Pancreatic Cancer Patients,1,0.5255524
2019-11-06,9289400.0,83.55999755859375,83.95999908447266,83.12999725341797,83.25,81.35887145996094,MRK,Buy These 2 Stocks to Access China's Huge Healthcare Market ||| AstraZeneca Named The Most Innovative Global Pharma Company,0,0.4935076
2019-11-07,8827600.0,83.2300033569336,83.98999786376953,82.66999816894531,82.87999725341797,80.99726867675781,MRK,Biotech Stock On The Radar: Alkermes At A Crossroads,1,0.49929968
2019-11-08,6348400.0,82.91000366210938,83.70999908447266,82.70999908447266,83.58999633789062,81.6911392211914,MRK,"The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut",0,0.5095713
2019-11-11,3554600.0,83.16000366210938,83.63999938964844,82.95999908447266,83.27999877929688,81.38819122314453,MRK,Merck Reports Its ERVEBO Granted Conditional Approval In EU ||| NextCure Shares Give Back Some Gains After Data Readout,1,0.5170035
2019-11-12,8222000.0,83.58000183105469,84.81999969482422,83.58000183105469,84.12000274658203,82.2091064453125,MRK,Roche's New Oncology Drugs To Add $5 Billion In Sales By 2021?,1,0.5109721
2019-11-13,6218400.0,84.55000305175781,85.11000061035156,84.11000061035156,84.81999969482422,82.89320373535156,MRK,"Noteworthy ETF Outflows: IYH, MRK, PFE, ABBV ||| Morgan Stanley Maintains Overweight on Merck & Co, Raises Price Target to $95 ||| The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher",0,0.49813786
2019-11-14,7548900.0,84.91999816894531,85.18000030517578,83.69999694824219,84.55000305175781,82.62934112548828,MRK,"AZN:FDA Accepts Regulatory Submission For Selumetinib In Neurofibromatosis Type1 ||| AstraZeneca, Merck Report FDA Acceptance Of Regulatory Submission For New Drug Application For Selumetinib In Neurofibromatosis Type 1, Priority Review Granted ||| AstraZeneca Announces FDA Accepts NDA for Selumetinib",1,0.52567804
2019-11-15,9232700.0,84.69000244140625,85.5999984741211,84.63999938964844,84.9000015258789,82.97138977050781,MRK,What's Bristol-Myers Squibb's Fair Stock Price Estimate Based On Expected 2019 Earnings? ||| Merck Reports Its Animal Health Unit Announced US Approval Of BRAVECTO PLUS,0,0.5313794
2019-11-18,10211600.0,84.66000366210938,84.81999969482422,83.8499984741211,84.12999725341797,82.2188720703125,MRK,Exelixis’ Stock Regains Its Mojo ||| Merck and Bayer's Investigational Drug Vericiguat Meets Primary Endpoint in Phase 3 Study of Patients with Worsening Chronic Heart Failure,1,0.5114588
2019-11-19,9247500.0,84.4000015258789,84.94999694824219,83.97000122070312,84.6500015258789,82.72706604003906,MRK,"Daily Dividend Report: MRK, BAX, GIS, PEG, GPC ||| Merck Raises Quarterly Dividend From $0.55 To $0.61/Share",1,0.5073794
2019-11-20,7786400.0,84.52999877929688,85.4800033569336,84.44999694824219,85.2699966430664,83.3329849243164,MRK,"Dow Movers: MMM, MRK ||| Health Care Sector Update for 11/20/2019: JNJ, PFE, ABT, MRK, AMGN, ALC, BCRX, CRSP ||| European Commission Approves Two New Regimens Of Merck's KEYTRUDA As First-Line Treatment For Metastatic Or Unresectable Recurrent Head And Neck Squamous Cell Carcinoma",1,0.51591057
2019-11-21,6866000.0,85.69999694824219,85.7699966430664,84.2699966430664,85.45999908447266,83.51866912841797,MRK,"January 2020 Options Now Available For Merck (MRK) ||| Dow Movers: MRK, XOM ||| Health Care Sector Update for 11/21/2019: JNJ, PFE, ABT, MRK, AMGN, HARP, ABBV, ENLV, NTGN",0,0.48148406
2019-11-22,7442900.0,85.6500015258789,86.36000061035156,85.31999969482422,85.44999694824219,83.5088882446289,MRK,"Dow Jones Today: Trade Progress Pushes Stocks, Healthcare Helps Dow ||| UPRO, INTC, CVX, MRK: ETF Outflow Alert ||| Pfizer's Xeljanz In the Crowded Rheumatoid Drugs Market ||| AstraZeneca CEO: Closing In On A Cancer Cure ||| Trump Says he Will Release a Plan to Let States Import Prescription Drugs Which are ""MUCH CHEAPER""",1,0.48378474
2019-11-25,8608100.0,86.04000091552734,86.58999633789062,85.33999633789062,85.69999694824219,83.75321197509766,MRK,"Is NextCure a Buy? ||| Health Care Sector Update for 11/25/2019: JNJ, PFE, ABT, MRK, AMGN, SRNE, MDCO, NVS, ZIOP",1,0.46701348
2019-11-26,18352500.0,86.0,87.44000244140625,85.91000366210938,87.33999633789062,85.35595703125,MRK,"Why Is Alkermes Stock Down 30% So Far This Year? ||| Why Is Alkermes Stock Down 30% So Far This Year? ||| Health Care Sector Update for 11/26/2019: JNJ, PFE, ABT, MRK, AMGN, CCXI, XFOR, SNOA ||| Merck Reports KEYTRUDA Now Approved In China For First-Line Treatment of Metastatic Squamous Non-Small Cell Lung Cancer in Combination with Chemotherapy",1,0.46542236
2019-11-27,5760800.0,87.4000015258789,87.87000274658203,86.98999786376953,87.61000061035156,85.61982727050781,MRK,"MRK January 2020 Options Begin Trading ||| Health Care Sector Update for 11/27/2019: JNJ, PFE, ABT, MRK, AMGN, ARAV, TNXP, VRCA ||| Stocks That Hit 52-Week Highs On Wednesday ||| The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen",0,0.48255178
2019-11-29,4656700.0,87.16999816894531,87.7699966430664,87.02999877929688,87.18000030517578,85.19960021972656,MRK,"Health Care Sector Update for 11/29/2019: JNJ, PFE, ABT, MRK, AMGN, CANF, REGN, AZN ||| National Business Daily Reports Drugmakers including Johnson & Johnson, Roche, Novartis and Merck have Agreed to Massively Cut the Prices of Some Drugs to Get Included in China's Medical Reimbursement List",0,0.53463125
2019-12-02,5341600.0,87.54000091552734,87.98999786376953,86.55000305175781,87.04000091552734,85.06278228759766,MRK,"What Percent Does Bristol-Myers Squibb Spend On R&D, 30%, 40%, Or 50%? ||| How Much Does Roche Spend On R&D: $5 Bil, $10 Bil, Or $20 Bil? ||| Here's Why Lexicon Pharmaceuticals Is Tumbling Today ||| Seattle Genetics, Astellas, Merck To Evaluate Enfortumab Vedotin Plus KEYTRUDA ||| Shares of several healthcare stocks are trading lower as US equities dip following escalating US-China tensions over Hong Kong. US Stocks further fell on worse-than-expected manufacturing data. ||| Stocks That Hit 52-Week Highs On Monday ||| Seattle Genetics Announces Collaboration with Merck to Evaluate its Enfortumab in Combination with KEYTRUDA ||| Merck's KEYTRUDA Granted Priority Review by the FDA for Patients with High-Risk, Non-Muscle Invasive Bladder Cancer",1,0.4739724
2019-12-03,7124200.0,86.68000030517578,87.47000122070312,86.5,87.37999725341797,85.39505004882812,MRK,"Notable ETF Inflow Detected - IWF, MRK, CSCO, ADBE ||| Dow Analyst Moves: MRK ||| Merck Isn't Too Reliant on Keytruda Yet, and That's Good News for Investors ||| Can Johnson & Johnson's Stelara Become Number 2 Drug In Crohn's Disease Market? ||| Is Clovis Oncology Really a Buyout Candidate? ||| The Daily Biotech Pulse: Astellas To Buy Audentes For $3B, Applied Genetics Chief Medical Officer Quits, Axsome Aces Midstage Trial",1,0.49258038
2019-12-04,6959700.0,87.52999877929688,88.7300033569336,87.18000030517578,88.66999816894531,86.65574645996094,MRK,Stocks That Hit 52-Week Highs On Wednesday,1,0.5148754
2019-12-05,7888800.0,88.7300033569336,88.79000091552734,87.97000122070312,88.75,86.73392486572266,MRK,"Why Has Alnylam's Stock Gained 25% In The Last Two Weeks ||| Why Has Alnylam's Stock Gained 25% In The Last Two Weeks ||| Stocks That Hit 52-Week Highs On Thursday ||| The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission ||| AstraZeneca, Merck Announce Lynparza Approved in China as a 1st-line Maintenance Therapy in BRCA-mutated Advanced Ovarian Cancer",1,0.4898709
2019-12-06,6914000.0,89.0,89.23999786376953,88.75,88.8499984741211,86.83165740966797,MRK,"Health Care Sector Update for 12/06/2019: JNJ, PFE, ABT, MRK, AMGN, CYAD, SAVA, CRIS ||| Health Care Sector Update for 12/06/2019: JNJ, PFE, ABT, MRK, AMGN, CYAD, ONCY, RCKT, SAVA ||| Stocks That Hit 52-Week Highs On Friday ||| The Daily Biotech Pulse: Cassava Gains On Alzheimer's Presentation, Bristol-Myers Hikes Dividend",0,0.4539157
2019-12-09,7685900.0,88.9000015258789,89.0,88.19999694824219,88.72000122070312,86.7046127319336,MRK,"The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling ||| Health Care Sector Update for 12/09/2019: JNJ, PFE, ABT, MRK, AMGN, PDLI, TGTX, TVTY, ARQL ||| Health Care Sector Update for 12/09/2019: JNJ, PFE, ABT, MRK, AMGN, ARQL, THOR, MBIO, XBIT ||| Why ArQule Shares Are Skyrocketing Today ||| Merck To Acquire ArQule For $20/share In Cash - Quick Facts ||| Daily Markets: Tariff Deadline, UK Election Driving Market Moves This Week ||| Mid-Afternoon Market Update: Dow Falls 90 Points; XBiotech Shares Spike Higher ||| PreMarket Prep Recap: Small Biotech Firms Looking Healthy, Street Fades Macy's Downgrade ||| 48 Stocks Moving In Monday's Mid-Day Session ||| Mid-Day Market Update: Synthorx Jumps Following Acquisition News; Biocept Shares Plunge ||| Mid-Morning Market Update: Markets Mixed; Merck To Acquire ArQule For $20/Share ||| KalVista Shares Sink On Failed Mid-Stage Study Of Diabetic Macular Edema Drug ||| Benzinga Pro's Top 5 Stocks To Watch For Mon., Dec. 9, 2019: MRK, PCG, M, DPLO, CHWY ||| 20 Stocks Moving In Monday's Pre-Market Session ||| ArQule To Be Acquired By Merck For $2.7B ||| A Peek Into The Markets: US Stock Futures Down; Crude Oil Falls 1% ||| ArQule to be Acquired by Merck for $20/Share Cash",1,0.48388103
2019-12-10,8266900.0,88.5999984741211,89.52999877929688,88.51000213623047,89.0999984741211,87.07598114013672,MRK,"What Do The Big Biotech Deals Mean for the Average Investor? ||| 2 Top Small-Cap Stocks to Buy in December ||| Stocks That Hit 52-Week Highs On Tuesday ||| The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares ||| 80 Biggest Movers From Yesterday",0,0.4635346
2019-12-11,6509300.0,89.13999938964844,89.48999786376953,88.8499984741211,88.9800033569336,86.95870971679688,MRK,"Ex-Dividend Reminder: Vistra Energy, Chesapeake Utilities and Merck ||| Noteworthy Wednesday Option Activity: MRK, IRBT, EAT ||| Can Johnson & Johnson's Imbruvica Sales Beat Roche's Rituxan In Chronic Lymphocytic Leukemia Market By 2021? ||| IHE, MRK, AGN, ZTS: ETF Outflow Alert ||| Health Care Sector Update for 12/11/2019: JNJ, PFE, ABT, MRK, AMGN, AQST, RCKT, MRNS ||| Cantor Fitzgerald Says Thinks ArQule May See Other Bidders But Thinks Merck Makes A 'Great Strategic Fit,' Says Thinks Merck's Proposed Acquisition Is 'Fair' ||| The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint",1,0.5207343
2019-12-12,6549500.0,89.04000091552734,89.95999908447266,88.91000366210938,89.56999969482422,87.5353012084961,MRK,Traders Circulating Materials From Merck's Keytruda Presentation At ESMO ||| Stocks That Hit 52-Week Highs On Thursday ||| Merck Highlights Exploratory Analysis Of KEYTRUDA Which Showed Improved Overall Survival As Monotherapy for the First-Line Treatment of Metastatic Non-Small Cell Lung Cancer Regardless of KRAS Mutational Status,0,0.5153677
2019-12-13,7225000.0,89.19999694824219,89.58999633789062,88.44000244140625,89.19000244140625,87.7616195678711,MRK,"Health Care Sector Update for 12/13/2019: TNDM,ONCS,SRPT,PFE,MRK ||| Health Care Sector Update for 12/13/2019: ONCS,SRPT,PFE,MRK ||| OncoSec Reports Interim Data From KEYNOTE-890 Study Evaluation TAVO In Combination With KEYTRUDA ||| The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer ||| EMA Reports Positive Opinion For Merck's Recarbrio By CHMP For Treatment Of Infections From Aerobic Gram-Negative Organisms In Adults",1,0.50656825
2019-12-16,9880900.0,89.6500015258789,90.0,89.18000030517578,89.29000091552734,87.86001586914062,MRK,"Better Buy: Eli Lilly vs. Merck ||| Is Codexis Stock a Buy? ||| Better Buy: AbbVie vs. Merck ||| The Week Ahead In Biotech: Avadel, Epizyme In Focus In A Quiet Week",0,0.49202064
2019-12-17,11155100.0,89.33000183105469,89.44999694824219,88.5199966430664,89.0199966430664,87.5943374633789,MRK,"AstraZeneca Says FDA Panel Backs Lynparza Use For Pancreatic Cancer ||| Merck Reports FDA's Oncologic Drugs AdCom Recommends KEYTRUDA For Treatment Of Certain Patients with High-Risk, Non-Muscle Invasive Bladder Cancer ||| The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO",1,0.50495064
2019-12-18,11047900.0,89.3499984741211,90.0,89.12999725341797,89.62000274658203,88.18473052978516,MRK,"Dow Jones Today: Stocks Took a Pre-Holiday Breather ||| Daily Markets: The Santa Claus Rally is in Full Swing ||| The Daily Biotech Pulse: Positive Adcom Verdict For Merck, Homology Medicine Slips On Mixed Gene Therapy Efficacy Data",1,0.49959376
2019-12-19,7254500.0,89.88999938964844,90.08999633789062,89.48999786376953,89.98999786376953,88.5488052368164,MRK,"Stocks That Hit 52-Week Highs On Thursday ||| The Daily Biotech Pulse: Seattle Genetics' Bladder Cancer Drug Gets FDA Nod, Paratek Wins Contract For Antibiotic",1,0.51088417
2019-12-20,17032100.0,91.45999908447266,92.63999938964844,90.83999633789062,91.58000183105467,90.11334228515624,MRK,"Health Care Sector Update for 12/20/2019: TXG,BIO,NLNK,MRK,ABEO ||| Dow Jones Today: Data Does It Again ||| Health Care Sector Update for 12/20/2019: GILD,TXG,BIO,NLNK,MRK,ABEO ||| FDA Grants Approval For Merck's Ebola Vaccine Ervebo - Quick Facts ||| How Big Is Roche's R&D Expense? ||| FDA Approves Ervebo Vaccine For Prevention Of Ebola Virus Disease ||| Stocks That Hit 52-Week Highs On Friday ||| NewLink Genetics Announces FDA Approval Of Ebola Vaccine V920 ||| The Daily Biotech Pulse: Axovant Surges On Gene Therapy Study Results, FDA Approves Merck's Ebola Vaccine, Abeona Announces Offering ||| Merck Reports FDA Approval For ERVEBO ||| Merck Reports KEYTRUDA Approved In Japan For 3 New First-Line Indications Across Advanced Renal Cell Carcinoma, Recurrent or Distant Metastatic Head and Neck Cancer ||| FDA Approves First Ebola Vaccine",1,0.45462087
2019-12-23,7534300.0,91.83000183105467,92.0199966430664,91.44000244140624,91.73999786376952,90.27078247070312,MRK,How The Dow Jones Industrial Average Changed Over The Past Decade ||| These Were the 10 Best Healthcare Stocks of 2019 ||| A Perspective On Biopharma's Record M&A Run In 2019,0,0.50734276
2019-12-24,2235900.0,91.63999938964844,91.7300033569336,91.06999969482422,91.44000244140624,89.9755859375,MRK,Johnson & Johnson's COGS On the Rise?,0,0.51005906
2019-12-26,2922400.0,91.5999984741211,91.72000122070312,91.06999969482422,91.33999633789062,89.87718200683594,MRK,Embattled TEVA Has Made Headlines for All of the Wrong Reasons,1,0.5084495
2019-12-27,3586800.0,91.68000030517578,91.6999969482422,91.2699966430664,91.5,90.03462219238281,MRK,Merck & Co Option Alert: Jun 19 $92.5 Calls Sweep (49) above Ask!: 4764 @ $4.107 vs 5293 OI; Earnings 1/31 Before Open [est] Ref=$91.46,0,0.46929282
2019-12-30,3752800.0,91.52999877929688,91.69000244140624,90.7300033569336,91.02999877929688,89.57215118408203,MRK,"Week Ahead In Biotech: PDUFA Date Ahead For Astra Zeneca, Merck's Lynparza, Pending Clinical Readouts In Focus ||| ARDS Turning Heads, AXSM's Momentum Continues, SVRA Abuzz, Jiankui Jailed ||| Dow Jones Today: A Rough Way to End 2019 ||| AstraZeneca: Lynparza Approved In US For Pancreatic Cancer - Quick Facts ||| How Much Revenue Does Roche's Pharmaceutical Business Generate From The United States? ||| How Does Johnson & Johnson's Revenue And Other Key Metrics Compare With That of Roche? ||| What's Fueling Merck's Stock Price Growth? ||| Merck-AstraZeneca's Lynparza Snags FDA Nod For Pancreatic Cancer ||| Merck's LYNPARZA Approved By FDA As First-Line Maintenance Treatment Of Germline BRCA-Mutated Metastatic Pancreatic Cancer ||| AstraZeneca Says FDA Approved Lynparza for Pancreatic Cancer",0,0.49451587
2019-12-31,4495000.0,90.91999816894533,90.98999786376952,90.44000244140624,90.9499969482422,89.49342346191406,MRK,"Dow Movers: MRK, IBM ||| Biotech Stocks Facing FDA Decision In January 2020",1,0.5021385
2020-01-02,7873500.0,91.08000183105467,92.13999938964844,90.37000274658205,92.04000091552734,90.56597900390624,MRK,"Attention Biotech Investors: Mark Your Calendar For These January PDUFA Dates ||| How Much Revenue Does Merck Generate From The United States? ||| 3 of the Best Healthcare Stocks to Buy in 2020 ||| Health Care Sector Update for 01/02/2020: JNJ, PFE, ABT, MRK, AMGN, IPHA, ONTX, AERI ||| Pros' Picks: The 13 Best Dividend Stocks for 2020 ||| Speaker Of The House Nancy Pelosi Says ""Enough is enough. @HouseDemocrats passed the bipartisan #LowerDrugCosts Now Act last year to stop Big Pharma from charging Americans more for our medicines than what they charge for the same drugs overseas.""",0,0.48239788
2020-01-03,5633300.0,90.68000030517578,92.06999969482422,90.51000213623048,91.25,89.78862762451172,MRK,"After Lackluster 2019, Pfizer Stock Could Rebound in 2020 ||| After Lackluster 2019, Pfizer Stock Could Rebound in 2020 ||| Better Buy: Illumina vs. Guardant Health",1,0.4624923
2020-01-06,7178400.0,91.2300033569336,91.73999786376952,90.98999786376952,91.63999938964844,90.17237854003906,MRK,"Why Biotech Stock ArQule Soared 108% in December ||| Is Johnson & Johnson Stock a Buy? ||| Health Care Sector Update for 01/06/2020: JNJ, PFE, ABT, MRK, AMGN, LIFE, LPTX, NOVN ||| Merck's Announces Phase 3 Of KEYNOTE-604 Study Did Not Meet Other Dual Primary Endpoint of Overall Survival; Results to be Presented at Upcoming Medical Meeting ||| Merck Buys Exclusive Global License from Taiho and Astex for its Small Molecule Inhibitor Candidates for $50M Upfront and Milestone Payments",0,0.4763531
2020-01-07,10622400.0,90.8000030517578,91.12000274658205,89.12000274658203,89.19999694824219,87.77145385742188,MRK,"Dow Drops as Oil Takes Breather ||| Noteworthy ETF Inflows: XLV, JNJ, UNH, MRK ||| Merck's Keytruda Misses an Important Lung Cancer Goal ||| Dow Movers: MRK, GS ||| The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck's Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering",0,0.47980243
2020-01-08,14504300.0,89.08999633789062,89.5,88.41000366210938,88.5999984741211,87.18106079101562,MRK,"MRK a Top 25 Dividend Giant With $25.04B Held By ETFs ||| FDA Nod For MRK, All Eyes On AGTC, ACTION Boosts APLT ||| Merck's Blockbuster Drug Wins Key New FDA Approval ||| The Risk of Cancer-Related Death Is Dropping Faster Than Ever ||| What Led To A 30% Jump In Roche's Stock In 2019? ||| What's Driving Johnson & Johnson's Stock Price Growth? ||| 3 Stocks to Buy That Will Hit New All-Time Highs in 2020 ||| Merck Reports FDA Approval Of KEYTRUDA For Patients BCG-Unresponsive, High-Risk, Non-Muscle Invasive Bladder Cancer With Carcinoma In Situ With or Without Papillary Tumors Who Are Ineligible for or Have Elected Not to Undergo Cystectomy ||| Merck Announces FDA Approves Pembrolizumab For BCG-Unresponsive, High-risk Non-muscle Invasive Bladder Cancer",1,0.5217405
2020-01-09,9269800.0,88.94999694824219,90.05000305175781,88.77999877929688,89.37999725341797,87.94857025146484,MRK,"Noteworthy Thursday Option Activity: HOLX, MRK, TJX ||| A Recent FDA Approval Will Be Huge in Moving Amarin Stock ||| The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, DBV Announces Positive Peanut Allergy Study Findings, Applied Genetic Soars On Trial Results",1,0.53033656
2020-01-10,5673000.0,89.72000122070312,90.11000061035156,89.44999694824219,89.52999877929688,88.0961685180664,MRK,"Health Care Sector Update for 01/10/2020: JNJ, PFE, ABT, MRK, AMGN, ACRS, MRNA, PTLA ||| 'California Gov. Gavin Newsom wants the state to become the first to create its own generic drug label, an attempt to create more competition and bring down prices.' -Axios, From Earlier",0,0.5079926
2020-01-13,9791500.0,89.5199966430664,89.62999725341797,89.0199966430664,89.51000213623047,88.07649993896484,MRK,"Dow Jones Today: Tech Lifts Stocks as Trade Deal Signing Nears ||| Health Care Sector Update for 01/13/2020: JNJ, PFE, ABT, MRK, AMGN, IOVA, OCX, NVTA ||| AZN : Lynparza-bevacizumab Granted Priority Review In US For Ovarian Cancer ||| AstraZeneca and Merck's Supplemental New Drug Application for LYNPARZA Granted Priority Review by the FDA",1,0.49274212
2020-01-14,8230600.0,89.2699966430664,89.93000030517578,88.87000274658203,89.93000030517578,88.4897689819336,MRK,"Health Care Sector Update for 01/14/2020: JNJ, PFE, ABT, MRK, AMGN, RTIX, TRXC, MREO ||| Just - Evotec Grants MSD Access To J.POD(R) Facility - Quick Facts",1,0.4707893
2020-01-15,9173700.0,90.0999984741211,91.61000061035156,90.08999633789062,91.54000091552734,90.07398223876952,MRK,Better Buy: Johnson & Johnson vs. Merck ||| Here's Why Clovis Oncology Rose as Much as 25.6% Today ||| The Health Care Select Sector SPDR Fund Experiences Big Inflow ||| Pfizer Stock Offers Good Value to Patient Investors,0,0.49537864
2020-01-16,6920300.0,91.86000061035156,92.05999755859376,91.0500030517578,91.18000030517578,89.7197494506836,MRK,"Beyond the Growing Dividend, Abbvie Stock Is a Good Buy Here ||| After FDA Approval, Amarin Stock Is Stuck in Worrisome Trading",0,0.5216393
2020-01-17,9667200.0,91.27999877929688,91.62999725341795,90.86000061035156,90.97000122070312,89.51311492919922,MRK,"Why Amarin Stock Is Poised for a Healthy 2020 ||| Cannabis Media Company The Fresh Toast Expands Again, Announces It's Now Cash Positive",0,0.49327835
2020-01-21,9563100.0,90.72000122070312,90.97000122070312,89.70999908447266,89.97000122070312,88.52912902832031,MRK,"Roche's $7 Billion Drug Sales At Risk? ||| AstraZeneca: FDA's ODD For Imfinzi, Tremelimumab; Priority Review For Lynparza ||| The Week Ahead In Biotech: Focus On Epizyme, Merck Ahead Of PDUFA Dates, J&J To Kickstart Big Pharma Earnings ||| Merck's Keytruda Could Face Direct Competition from New Chinese Drug ||| Merck a Top Socially Responsible Dividend Stock With 2.7% Yield (MRK) ||| FDA Accepts Regulatory Submission Of Supplemental New Drug Application For Merck's LYNPARZA In HRR-Mutated Metastatic Castration-Resistant Prostate Cancer And Grants Priority Review",0,0.5005182
2020-01-22,7443200.0,90.16999816894533,90.45999908447266,89.62000274658203,89.6500015258789,88.21424865722656,MRK,Procter & Gamble: Buy at the High?,0,0.48991293
2020-01-23,12593600.0,89.66000366210938,89.66000366210938,88.26000213623047,88.55999755859375,87.14170837402344,MRK,"Noteworthy ETF Inflows: VHT, UNH, MRK, CVS ||| Should Investors Be Worried About Merck's Keytruda? ||| Merck : Canada Oks KEYTRUDA As First-Line Treatment For Advanced RCC ||| UBS Maintains Buy on Merck & Co, Raises Price Target to $99",0,0.50481164
2020-01-24,14270000.0,88.62999725341797,88.83000183105469,85.58000183105469,85.9800033569336,84.60303497314453,MRK,"Roche's Tecentriq Fails to Help Patients in Muscle-Invasive Bladder Cancer Trial ||| Shares of several companies in the healthcare and pharmaceutical space are trading lower, not currently seeing sector-specific news. NOTE: The global spread of the Wuhan coronavirus has caused equities across to sell off. ||| The Daily Biotech Pulse: FDA Nod For Epizyme, Sonoma Explores Options For Dermatology Business, Roche's Cancer Drug Flunks Study",1,0.5303608
2020-01-27,10350700.0,85.0999984741211,86.51000213623047,84.70999908447266,86.0999984741211,84.72110748291016,MRK,"XLRN Soars, FDA Approves Triple Combo Pill For Type 2 Diabetes, MGEN On Watch ||| FDA Approves Merck's Dificid for Infections in Children ||| A Peek Into The Markets: US Stock Futures Down; Dow Futures Tumble Over 400 Points ||| Merck's DIFICID Receives FDA Approval to Treat Clostridioides in Children Aged Six Months and Older",1,0.51080006
2020-01-28,9061400.0,86.44000244140625,86.70999908447266,85.9000015258789,86.25,84.86869812011719,MRK,"Health Care Sector Update for 01/28/2020: XLRN, PHG, JNJ, ABT, MRK, PFE, AMGN ||| 3 Cancer Treatment Stocks to Buy Right Now ||| Biotech Stocks Facing FDA Decision In February 2020 ||| Turnaround Tuesday? Stocks Look To Bounce Back As Apple Earnings Loom Later",1,0.47202405
2020-01-29,8121400.0,86.5999984741211,88.16000366210938,86.43000030517578,87.23999786376953,85.84284210205078,MRK,"Is Merck Still a Strong Buy? ||| Daily Dividend Report: BLK, ALK, CMA, MRK, AAPL ||| February Market Outlook: Coronavirus, D.C. Proceedings, Earnings Season Could Mean Volatility",0,0.482994
2020-01-31,9180900.0,86.37999725341797,86.66999816894531,85.0,85.44000244140625,84.0716781616211,MRK,"Position Scrimmage: Coronavirus, End-Of-Month Profit Taking Influencing Markets",1,0.5063334
2020-02-03,9286100.0,86.04000091552734,88.22000122070312,86.04000091552734,87.33999633789062,85.94124603271484,MRK,"The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus ||| Merck's Insomnia Drug Approved for Alzheimer's Patients ||| iShares Russell 1000 Growth ETF Experiences Big Outflow ||| Attention Biotech Investors: Mark Your Calendar For These February PDUFA Dates ||| Merck & Co shares are trading higher after the company's RECARBRIO supplemental new drug application was accepted for FDA review. ||| Surprise, Surprise: Stocks Wearing Their Rally Hats Despite China Market Tanking ||| Merck's RECARBRIO Supplemental New Drug Application Accepted for FDA Review",1,0.49372625
2020-02-04,14400100.0,88.43000030517578,89.19999694824219,88.05999755859375,88.36000061035156,86.94490814208984,MRK,"Dow Jones Today: Coronavirus, Caucus Uncertainties and Stocks Don’t Care ||| Johnson & Johnson Stock Looks Like a Safe Place to Hide Out",0,0.49526623
2020-02-05,27948600.0,84.68000030517578,86.73999786376953,84.0,85.83000183105469,84.45543670654297,MRK,"Merck & Co Inc (MRK) Q4 2019 Earnings Call Transcript ||| Merck Announces a Big Planned Spinoff ||| Dow Jones Today: Stocks Continue Shrugging Off Virus Fears ||| Noteworthy Wednesday Option Activity: MRK, UAL, MA ||| 3 Up-and-Coming Drug Stocks to Buy Now ||| The 4 Most Important Things to Know About Merck's Q4 Earnings Results ||| Dow Movers: MRK, UNH ||| Merck & Co Q4 19 Earnings Conference Call At 8:00 AM ET ||| Merck Q4 Profit Tops; Plans Spin-off Of Women's Health, Biosimilar Businesses ||| Merck & Co Inc. Q4 adjusted earnings Beat Estimates ||| Merck To Spin Off Slow-Growing Women's Health, Legacy, Biosimilars Businesses: What You Need To Know ||| Earnings Bonanza: Results Keep Pouring In, With Investors Looking Over Merck, Disney ||| Merck & Co shares are trading lower after the company reported worse-than-expected Q4 sales results. ||| The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data ||| Merck Reports Mixed Q4 Earnings ||| Merck Sees FY20 Adj. EPS $5.62-$5.77 vs $5.61 Est., Sales $48.8B-$50.3B vs $49.53B Est. ||| Merck & Co Q4 Adj. EPS $1.16 Beats $1.15 Estimate, Sales $11.87B Miss $11.98B Estimate ||| Merck To Spin Off Products From Its Women's Health, Trusted Legacy Brands And Biosimilars Business Into New Independent Publicly-Traded Co.; Co. Says Transaction Enables It To Achieve $2.4$B n Operating Efficiencies By 2024 ||| 10 Stocks To Watch For February 5, 2020 ||| Earnings Scheduled For February 5, 2020",0,0.4956949
2020-02-06,15372300.0,86.0199966430664,86.2300033569336,85.26000213623047,85.68000030517578,84.30783081054688,MRK,"Merck’s Spinoff Plans Place a Big Bet on Cancer-Fighting Keytruda ||| 4 Dates Biotech Investors Should Circle in February ||| Is Merck's Decision to Slim Down a Buying Opportunity? ||| Twitter Up, Tesla Down: Strong User Numbers Help TWTR, But TSLA Selling Continues ||| UBS Maintains Buy on Merck & Co, Lowers Price Target to $96",0,0.50843644
2020-02-07,10896400.0,85.88999938964844,85.94000244140625,84.83000183105469,85.08000183105469,83.71744537353516,MRK,"Health Care Sector Update for 02/07/2020: JNJ, PFE, ABT, MRK, AMGN, ASRT, ZGNX, MYGN ||| 3 Canadian Biotechs to Consider Buying Today ||| The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns",1,0.47539753
2020-02-10,10105900.0,85.08000183105469,85.9800033569336,84.94000244140625,85.66000366210938,84.28815460205078,MRK,"Barron's Picks And Pans: GM, Kraft Heinz, Tesla, Under Armour And More ||| What Are Bristol-Myers Squibb's Top 3 Drugs? ||| The Week Ahead In Biotech: SMID-Cap Earnings In The Spotlight ||| KalVista Pharma Reports Option Deal Between Co., Merck Related To Intravitreal Diabetic Macular Edema Candidate KVD001, Future Oral DME Molecules Has Expired",0,0.48813742
2020-02-11,9783100.0,85.86000061035156,86.0,84.94999694824219,85.25,83.88471221923828,MRK,"Seattle Genetics, Astellas, and Merck Hit a Bladder Cancer Bullseye ||| The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology",0,0.49751
2020-02-12,18731800.0,85.04000091552734,85.2300033569336,82.9000015258789,83.25,81.91674041748047,MRK,Merck's Keytruda Helps Treat an Aggressive Form of Breast Cancer ||| Validea James P. O'Shaughnessy Strategy Daily Upgrade Report - 2/12/2020 ||| Merck Says Keytruda In Combination With Chemotherapy Met Primary Endpoint Of Progression-Free Survival As First-Line Treatment For Metastatic Triple-Negative Breast Cancer,0,0.5086809
2020-02-13,18500700.0,82.93000030517578,82.93000030517578,81.44999694824219,81.97000122070312,80.6572494506836,MRK,Merck’s Spinoff Promises Higher Dividends and Big Upside ||| Merck Becomes Oversold ||| Validea Joel Greenblatt Strategy Daily Upgrade Report - 2/13/2020,1,0.46681395
2020-02-14,8343000.0,82.2300033569336,82.80000305175781,81.66999816894531,82.6500015258789,81.32636260986328,MRK,"Merck's Ebola Vaccine Approved for Use in Four African Countries ||| Merck's Ebola Vaccine Approved for Use in Four African Countries ||| Ervebo Now Registered In Four African Countries, Within 90 Days Of Reference Country Approval And WHO Prequalification",0,0.52572805
2020-02-18,9558500.0,82.87999725341797,83.11000061035156,82.26000213623047,82.45999908447266,81.13939666748047,MRK,"The Week Ahead In Biotech: Baudax Bio, Merck, Esperion Await FDA Decisions ||| 3 Big Stock Charts for Tuesday: Merck, Nucor, and BorgWarner ||| 10% Upside For Roche's ADR?",0,0.50801
2020-02-19,11202500.0,83.08000183105469,83.11000061035156,81.56999969482422,82.0,80.686767578125,MRK,"Vanguard Value ETF Experiences Big Inflow ||| Is Merck & Co. Stock a Buy? ||| Jim Simons: The Investing Guru Bets on These 3 Healthcare Stocks ||| Health Care Sector Update for 02/19/2020: JNJ, PFE, ABT, MRK, AMGN, MREO, AMED, CTSO ||| FDA Rejects New Dosing for Merck's Cancer Drug Keytruda ||| Dow Analyst Moves: MRK ||| Elanco Signs Agreement with Merck Animal Health to Divest Worldwide Rights for Vecoxan ||| The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA ||| Merck Receives CRL from FDA for sBLAs for KEYTRUDA Six-Week Dosing Schedule",1,0.48329672
2020-02-20,10440200.0,82.22000122070312,82.83000183105469,81.72000122070312,82.48999786376953,81.16891479492188,MRK,"FDA Grants Priority Review to Roche's Lung Cancer Drug Tecentriq ||| Merck's Chief Digital Officer Leaves to Join Marriott ||| Merck's Chief Digital Officer Leaves to Join Marriott ||| Why Merck Has Had Underwhelming Start To 2020 ||| The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study",0,0.5158955
2020-02-24,13105100.0,80.61000061035156,82.58999633789062,80.56999969482422,81.33000183105469,80.02749633789062,MRK,"Is Merck a Better Buy After Announcing Spinoff? ||| Benzinga's Bulls And Bears Of The Week: Merck, Nike, Target And More ||| The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace ||| Here's Why Clovis Oncology Lost as Much as 11.8% Today ||| 3 Healthcare Stocks to Buy This Year ||| Dow Movers: UNH, VZ ||| What Drove Merck's Keytruda Shortfall In Q4",0,0.49418998
2020-02-25,12568400.0,81.52999877929688,81.94000244140625,79.8499984741211,80.2699966430664,78.98446655273438,MRK,"Agree To Purchase Merck & Co At $55, Earn 2.9% Using Options",0,0.5255867
2020-02-26,11393400.0,80.66000366210938,81.62999725341797,79.7699966430664,79.94000244140625,78.65975952148438,MRK,"What to Watch When Codexis Reports 2019 Operating Results ||| The Daily Biotech Pulse: Menlo Flunks Midstage Trial, GW Pharma's Earnings, COVID-19 Updates",0,0.49355206
2020-02-27,15012700.0,80.70999908447266,81.75,78.0,78.08000183105469,76.82955169677734,MRK,"DGRO, INTC, MRK, BMY: Large Inflows Detected at ETF ||| Dow Movers: DOW, MMM ||| Health Care Sector Update for 02/27/2020: JNJ, PFE, ABT, MRK, AMGN, TDOC, ORMP, LHCG ||| The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy",0,0.47752705
2020-02-28,27922000.0,76.68000030517578,77.48999786376953,74.18000030517578,76.55999755859375,75.3338851928711,MRK,"Coronavirus Disruptions in China Beginning to Affect U.S. Drug Supplies ||| Roche To Top $66 Billion In Sales By 2020, Led By Neuroscience ||| Shares of several healthcare companies are trading lower as the global coronavirus spread continues to cause equities across sectors to sell off amid worsened economic outlook.",1,0.54564315
2020-03-02,17977600.0,77.12999725341797,81.55000305175781,77.08000183105469,81.37000274658203,80.06685638427734,MRK,"3 High-Risk, High-Reward Stocks That Have Massive Upside Potential ||| Here's Why Clovis Oncology Has Upside Potential in 2020 ||| Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates ||| Merck shares are trading higher after the company's KEYNOTE-204 of KEYTRUDA met one of its primary endpoints of progression-free survival. ||| Merck Announces New Data from Broad HIV Program at CROI 2020 ||| A Peek Into The Markets: US Stock Futures Down Ahead Of Manufacturing Reports ||| Merck's Phase 3 KEYNOTE-204 Trial of KEYTRUDA Met One of its Primary Endpoints",0,0.49343288
2020-03-03,16597900.0,81.4000015258789,82.4000015258789,77.91000366210938,79.12999725341797,77.86272430419922,MRK,"Health Care Sector Update for 03/03/2020: JNJ, PFE, ABT, MRK, AMGN, KMPH, OMER, GNMK",1,0.4881398
2020-03-04,19297900.0,81.5,83.06999969482422,79.87999725341797,82.97000122070312,81.6412353515625,MRK,"Health Care Sector Update for 03/04/2020: JNJ, PFE, ABT, MRK, AMGN, MRNA, REPH, CNC, DRRX ||| Health Care Sector Update for 03/04/2020: JNJ, PFE, ABT, MRK, AMGN, DRRX, VVUS, VYGR ||| Better Coronavirus Stock: Moderna vs. Novavax ||| FDA Issues Warning On Merck's Singulair, Warns Of Mental Health Side Effects ||| Shares of several healthcare-related companies are trading higher after Joe Biden secured several key wins in Super Tuesday. Biden's more 'moderate' healthcare policies have been seen as more favorable for the sector.",0,0.4699271
2020-03-09,18075200.0,78.0,80.72000122070312,76.98999786376953,78.95999908447266,77.69544982910156,MRK,"Barron's Picks And Pans: Coronavirus Picks, Bonds, Safe Havens And More ||| 52 Healthcare Stocks Moving In Monday's Pre-Market Session",1,0.5190413
2020-03-10,16724700.0,80.4800033569336,82.18000030517578,77.5,82.0199966430664,80.7064437866211,MRK,CDC's Redfield Says Will Know By April If Ebola-Tied Drug Helps Coronavirus,0,0.5039811
2020-03-11,13620400.0,79.83000183105469,80.16000366210938,78.02999877929688,79.25,77.98080444335938,MRK,"Ex-Dividend Reminder: Merck, Simmons First National and Anthem ||| Shares of several healthcare companies are trading lower. Movement appears market related amid selloff in equities. The global coronavirus outbreak has caused volatility in global markets and impacted stocks across sectors.",0,0.5357279
2020-03-12,21626700.0,74.4000015258789,78.05999755859375,73.26000213623047,74.44999694824219,73.25767517089844,MRK,"CDC: Cancer Death Rates Are Declining ||| Dow Movers: BA, JNJ ||| The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO ||| Merck & Co shares are trading lower after the company announced its Phase 3 GY004 trial for Cediranib and LYNPARZA did not meet its primary endpoint. ||| WebMD Acquires Merck Subsidiary Staywell ||| AstraZeneca and Merck Announce Phase 3 GY004 for Cediranib and LYNPARZA in Platinum-Sensitive Relapsed Ovarian Cancer Did Not Meet the Primary Endpoint of Progression-Free Survival vs. Platinum-Based Chemotherapy",1,0.5108069
2020-03-13,24672800.0,76.22000122070312,77.2300033569336,72.26000213623047,76.75,76.14472961425781,MRK,"Intec Pharma Posts Q4 Net Loss Of $6.6M, Down By Nearly Half Year-Over-Year ||| Shares of several healthcare companies are trading higher as the market rebounds following Thursday's selloff. NOTE: Since the coronavirus outbreak the healthcare sector has been extremely volatile.",0,0.51522726
2020-03-16,19855300.0,70.7699966430664,76.08999633789062,67.12000274658203,69.91999816894531,69.36859130859375,MRK,"Barron's Picks And Pans: Roundtable Picks, Airline And Oil Stocks, And More ||| IWV, UNH, INTC, MRK: Large Inflows Detected at ETF ||| Shares of several healthcare companies are trading lower in sympathy with the overall market on continued downward momentum caused by the coronavirus. The virus has had a negative impact on the global economy.",1,0.512163
2020-03-17,23612400.0,71.6500015258789,76.06999969482422,71.37999725341797,74.4800033569336,73.89263916015625,MRK,"Merck Announces Positive Results for Its Investigational Chronic Cough Treatment ||| Health Care Sector Update for 03/17/2020: JNJ, PFE, ABT, MRK, AMGN, DBVT, AVRO, MRNA ||| Why Is Everyone Talking About Moderna? ||| Shares of several healthcare companies are trading higher, rebounding from Monday's crash. Stocks may also potentially be getting a boost from expectations of further stimulus proposals. ||| The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment ||| Merck Announces Top-Line Results From Phase 3 Trials Evaluating Gefapixant For Refractory Of Unexplained Chronic Cough; Gefapixant Demonstrated Statistically Significant Decrease In 24-Hour Coughs Per Hour Compared To Placebo At Week 12 And 24",0,0.4858007
2020-03-23,17533400.0,70.2699966430664,71.61000061035156,65.25,66.4000015258789,65.87635803222656,MRK,Merck Donates a Half a Million Masks to Support COVID-19 Emergency Response in New York City ||| Shares of several healthcare companies are trading lower amid market volatility. Sunday's fiscal stimulus bill failed a procedural senate vote while the Fed Monday morning announced further stimulus measures to support liquidity.,1,0.5140264
2020-03-24,18990400.0,68.98999786376953,69.75,67.19000244140625,69.05000305175781,68.50545501708984,MRK,"10 Biggest Price Target Changes For Tuesday ||| Argus Research Maintains Buy on Merck & Co, Lowers Price Target to $95 ||| The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test",0,0.53053474
2020-03-25,17472800.0,68.41000366210938,70.37999725341797,66.75,68.22000122070312,67.68199920654297,MRK,UPS Seeks To Accelerate Growth Of Drone-Delivery,1,0.552443
2020-03-26,17226000.0,68.13999938964844,74.18000030517578,68.0999984741211,73.52999877929688,72.95012664794922,MRK,"Health Care Sector Update for 03/26/2020: JNJ, PFE, ABT, MRK, AMGN, HTGM, RKDA, BIOC ||| Shares of several healthcare companies are trading higher following Senate passage of a $2 trillion economic stimulus package, which has lifted stocks across sectors.",0,0.51589394
2020-03-27,11896200.0,71.80000305175781,73.43000030517578,71.25,71.7300033569336,71.16432189941406,MRK,"Cramer Reveals Stock Favorites, Says Intuitive Surgical A 'Winner' ||| Shares of several healthcare companies are trading lower, selling off from this week's strength. While the US stimulus legislation has boosted economic optimism, demand concerns still exist amid the coronavirus outbreak.",1,0.5405701
2020-03-30,15079500.0,73.62000274658203,77.58999633789062,72.87999725341797,76.94999694824219,76.34315490722656,MRK,"Barron's Picks And Pans: Tech Picks, SoftBank, REITs, Tesla And More ||| Dow Jones Today: Healthcare Help, Hopes Worst May be Over Lift Stocks ||| Shares of several healthcare companies are trading higher as the market rebounds on extended measures to help curb the coronavirus. NOTE: The sector could also be trading higher due to increased demand for medical products amid the coronavirus outbreak.",0,0.5484631
2020-04-01,11131000.0,74.66000366210938,75.47000122070312,72.98999786376953,73.80000305175781,73.21800231933594,MRK,"RBC Capital Maintains Sector Perform on Merck & Co, Lowers Price Target to $89 ||| Shares of several healthcare companies are trading lower amid market weakness as growing coronavirus concerns in the US weigh on equities.",1,0.5391692
2020-04-02,12255100.0,75.9800033569336,77.12000274658203,74.02999877929688,76.87000274658203,76.26378631591797,MRK,"Pfizer, Merck, and Eli Lilly Will Pay Their Doctors to Get Back to Treating Patients During the COVID-19 Pandemic ||| Cannabis Opportunity In The Time Of The Coronavirus ||| Morgan Stanley Maintains Overweight on Merck & Co, Lowers Price Target to $89 ||| Merck Reports KEYTRUDA Significantly Improved Progression-Free Survival As First-Line Treatment For MSI-H, dMMR Colorectal Cancer",0,0.46581733
2020-04-06,13658500.0,78.33000183105469,80.8499984741211,77.9000015258789,80.30999755859375,79.67665100097656,MRK,Shares of several healthcare companies are trading higher as markets gain amid optimism that coronavirus cases in several US hotspots may be peaking. A sooner peak could mean a sooner return to economic activity.,0,0.5429876
2020-04-07,10169800.0,81.68000030517578,81.97000122070312,78.4000015258789,78.55999755859375,77.9404525756836,MRK,"Merck's Keytruda Receives Priority Review for a Key Indication ||| Merck Receives Priority Review From FDA For Second Application For KEYTRUDA Based On Biomarker, Regardless Of Tumor Type",1,0.5154465
2020-04-08,10956000.0,79.18000030517578,83.0,78.33999633789062,81.62000274658203,80.97632598876953,MRK,"FDA approves generic to commonly used inhaler as demand surges due to coronavirus ||| KPTI To Test XPOVIO In COVID-19, PTCT Will Have To Wait, SAGE Slashes Workforce ||| FDA Approves Generic Version Of Merck's Proventil HFA Metered-Dose Inhaler",1,0.51791817
2020-04-13,7353700.0,81.81999969482422,82.47000122070312,79.83000183105469,80.54000091552734,79.90484619140625,MRK,"Is AnaptysBio Stock a Buy? ||| FTCS's Holdings Imply 12% Gain Potential ||| AstraZeneca & Merck Announce FDA Approval Of KOSELUGO - Quick Facts ||| UBS Maintains Buy on Merck & Co, Lowers Price Target to $92 ||| AstraZeneca and Merck Announce Approval of KOSELUGO for Pediatric Patients Two Years and Older With Neurofibromatosis Type 1 and Symptomatic, Inoperable Plexiform Neurofibromas",1,0.5023407
2020-04-14,11598600.0,82.33000183105469,83.19999694824219,80.7300033569336,82.83999633789062,82.18669891357422,MRK,Stock Alert: Will Uptrend At Merck & Co. Continue? ||| AstraZeneca-Merck genetic disorder treatment wins FDA nod,0,0.532738
2020-04-15,10314000.0,81.2300033569336,82.95999908447266,80.55999755859375,82.06999969482422,81.42277526855469,MRK,"IWB, MA, MRK, KO: Large Inflows Detected at ETF ||| Every Member Of Trump's 'Great American Economic Revival' Industry Groups ||| The Daily Biotech Pulse: Applied DNA Ships Vaccine Constructs For Animal Testing, Herceptin Biosimilar Now Available In US ||| Merck Announces US Launch Of ONTRUZANT (trastuzumab-dttb), A Biosimilar Of Herceptin (trastuzumab)",1,0.5135618
2020-04-16,8726200.0,82.6500015258789,83.33000183105469,82.26000213623047,83.0,82.34544372558594,MRK,"Gilead's Encouraging Remdesivir Data: Rapid Reaction On The Stock ||| S&P 500 Futures Up 3.2% After Hours; Many Other Stocks Moving Higher With Futures; Investors Reacting Favorably To White Phase Guidelines On Reopening Economy ||| Next 45 Days Will Be 'Most Critical Period' For US, Says Alan Lancz Who Predicted 1987 and 2008 Crises",1,0.48750836
2020-04-17,14726300.0,83.94999694824219,84.16000366210938,82.44000244140625,83.45999908447266,82.80181121826172,MRK,"Whether or Not Gilead Sciences Produces a Successful COVID-19 Therapeutic, It's a Bargain",0,0.5078738
2020-04-20,11141000.0,82.81999969482422,84.12999725341797,80.76000213623047,83.0999984741211,82.44465637207031,MRK,"2 Biotechs Battling Against Kidney Cancer ||| Barron's Picks And Pans: Dropbox, Ford, Johnson & Johnson, Teladoc And More ||| Cue Biopharma Announces Clinical Trial Collaboration Agreement With Merck To Evaluate CUE-101 In Combination With KEYTRUDA As First-line Treatment For HPV+ Recurrent/Metastatic Head And Neck Cancer",0,0.5204929
2020-04-21,17057800.0,81.62000274658203,82.30000305175781,78.20999908447266,78.55999755859375,77.9404525756836,MRK,"Dow Jones Today: Stocks Are Already Acting Like a Recession Is Here ||| Dow Nosedives as Oil Collapse Continues ||| Better Coronavirus Stock: Abbott Labs vs. Moderna ||| Shares of several healthcare companies are trading lower with the overall market on continued downward momentum after oil prices fell to historic lows, partially stemming from weak demand caused by the coronavirus pandemic. ||| Merck Broadens Patient Support And Assistance Programs As Part Of Overall COVID-19 Relief Efforts",1,0.50369227
2020-04-22,11387300.0,79.19999694824219,80.6500015258789,78.83000183105469,79.9800033569336,79.3492660522461,MRK,"Stocks, Oil Rebound Higher ||| Artificial Intelligence and Drug Discovery: The Companies Leading The Way ||| Gilead Sciences Races to Manufacture Remdesivir, but Chemistry Has Speed Limits ||| 3 Big Stock Charts for Wednesday: Coca-Cola, Mastercard, and Merck",1,0.49291274
2020-04-23,7779100.0,80.19000244140625,81.87999725341797,80.16999816894531,80.87999725341797,80.24215698242188,MRK,"IWF, UNH, MA, MRK: Large Inflows Detected at ETF ||| Shares of several healthcare companies are trading higher. Movement appears market-related as equities gain amid a rebound in oil prices. ||| Merck Reports Resubmission Of Supplemental Biologics License Applications For KEYTRUDA 6-Week Dosing Schedule",1,0.51783794
2020-04-24,7334900.0,81.5999984741211,82.0999984741211,81.0199966430664,81.43000030517578,80.78782653808594,MRK,"Wall St Week Ahead-Spotlight falls on 'dividend aristocrats' after market tumult ||| AstraZeneca's Lynparza shows further promise in prostate cancer study ||| AZN : Lynparza Shows Overall Survival Benefit In Late-stage Trial On MCRPC ||| AstraZeneca's Lynparza meets secondary goal in prostate cancer study ||| AstraZeneca, Merck Announce Lynparza Demonstrated Overall Survival Benefit in Phase III PROfound Trial for BRCA1/2 or ATM-mutated Metastatic Castration-resistant Prostate Cancer",1,0.4991615
2020-04-27,12201100.0,81.2300033569336,84.66999816894531,80.83000183105469,83.9800033569336,83.31771850585938,MRK,"Better Buy: Moderna vs. Biocryst Pharmaceuticals ||| Wall St Week Ahead-Spotlight falls on 'dividend aristocrats' after market tumult ||| The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight ||| Biotech Stocks Facing FDA Decision In May 2020 ||| Positive Cancer Trial Results Offset a COVID-19 Flop for Regeneron and Sanofi ||| BUZZ-U.S. STOCKS ON THE MOVE-Regeneron, Zoom Video, U.S. oil companies, Apple, U.S. insurers ||| Positive Prostate Cancer Results for Lynparza Are Bad News for Clovis Oncology ||| Apple And Amazon Earnings, Fed Meeting Among Highlights In Busy Week Ahead ||| Merck and Institute for Systems Biology Collaborate to Define Molecular Mechanisms of SARS-CoV-2 Infection and Identify Potential Prognostic Biomarkers for Coronavirus ||| Lynparza Demonstrated Overall Survival Benefit in Phase III PROfound Trial for BRCA1/2 or ATM-mutated Metastatic Castration-resistant Prostate Cancer",0,0.5082905
2020-04-28,19345000.0,81.18000030517578,82.2300033569336,80.16999816894531,81.18000030517578,80.539794921875,MRK,"Dow Movers: MRK, BA ||| Wall Street down on flight from techs; move to value limits loss on Dow, S&P 500 ||| Merck Reports First-Quarter Results, Lowers Guidance ||| Wall Street down on flight from techs; move to value limits loss on Dow, S&P 500 ||| Merck & Co Inc (MRK) Q1 2020 Earnings Call Transcript ||| Fears of surge in coronavirus death toll weigh on S&P, Nasdaq ||| Why Merck's Q1 Update Disappointed Investors Despite Beating Wall Street Estimates ||| S&P 500, Dow gain on upbeat corporate earnings, reopening hopes ||| Merck & Co Inc. Q1 adjusted earnings Beat Estimates ||| S&P 500 gains modestly, warning of higher COVID-19 deaths curb recovery hopes ||| Merck Q1 Results Top Estimates; But Cuts 2020 Outlook ||| Merck profit beats, coronavirus uncertainty weighs on forecast ||| 3 Big Stock Charts for Tuesday: Johnson & Johnson, Merck, and Bristol-Myers Squibb ||| Merck profit rises, cuts 2020 forecast over COVID-19 uncertainty ||| Futures jump with focus on earnings, easing lockdowns ||| Merck & Co Q1 20 Earnings Conference Call At 8:00 AM ET ||| BUZZ-U.S. STOCKS ON THE MOVE-Imax Corp, 3M Co, Ford Motor ||| FDA Approves Merck's KEYTRUDA For Use At An Additional Recommended Dose Of 400 mg Every Six Weeks For All Approved Adult Indications ||| A CURE For The Common Earnings Play ||| Morning Market Stats in 5 Minutes ||| Earnings Feast: Bring a Plate With Healthcare and Caterpillar in Morning, GOOGL And AMD Later ||| Merck shares are trading lower after the company issued FY20 guidance below consensus estimates. ||| The Daily Biotech Pulse: Pfizer Earnings, Roche's Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine Update ||| Merck Sees FY20 EPS $5.17-$5.37 vs $5.56 Est., Sales $46.1B-$48.1B vs $48.72B Est. ||| Merck & Co Q1 Adj. EPS $1.500 Beats $1.340 Estimate, Sales $12.100B Beat $11.460B Estimate ||| Earnings Scheduled For April 28, 2020",0,0.4822809
2020-04-29,13060300.0,82.19000244140625,82.19000244140625,79.02999877929688,80.7699966430664,80.13302612304688,MRK,"BUZZ-U.S. STOCKS ON THE MOVE-Alphabet, Spotify, Blue Apron ||| U.S. FDA gives broader approval to GSK's Zejula for ovarian cancer ||| BUZZ-U.S. STOCKS ON THE MOVE-Liberty Oilfield, MRC Global, Capricor Therapeutics ||| BUZZ-U.S. STOCKS ON THE MOVE-Blue Apron, iRobot Corp, General Electric ||| How Diversification Helps Businesses ||| Guggenheim Maintains Buy on Merck & Co, Lowers Price Target to $93 ||| Barclays Maintains Overweight on Merck & Co, Lowers Price Target to $90 ||| Merck Analysts Focus On Fundamentals, Keytruda Strength Following Guidance Cut ||| The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda ||| SVB Leerink Maintains Outperform on Merck & Co, Lowers Price Target to $95",0,0.48473868
2020-04-30,11104000.0,79.81999969482422,80.4000015258789,79.13999938964844,79.33999633789062,78.71430206298828,MRK,"Pfizer aims for 10-20 mln doses of coronavirus vaccine by end-2020 for emergency use ||| Stock Alert: Merck Down More Than 1% ||| ServiceNow CEO Bill McDermott Says Company 'Hungry And Humble,' With $10B Ambitions",0,0.46968684
2020-05-01,9082600.0,78.86000061035156,78.86000061035156,76.93000030517578,77.66999816894531,77.0574722290039,MRK,"Noteworthy ETF Inflows: IWF, UNH, MA, MRK",0,0.52013105
2020-05-04,8444900.0,78.0199966430664,78.02999877929688,76.22000122070312,76.86000061035156,76.25386810302734,MRK,AstraZeneca Notches Win with Prostate Cancer Drug ||| Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates ||| The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,1,0.5041571
2020-05-05,7062400.0,77.25,78.80000305175781,76.7699966430664,78.01000213623047,77.3947982788086,MRK,Dow Analyst Moves: MRK ||| Validea Joel Greenblatt Strategy Daily Upgrade Report - 5/5/2020 ||| Why Shares Of Gene Therapy Company Genprex Are Surging Higher,0,0.53181225
2020-05-06,11846300.0,78.3499984741211,78.63999938964844,77.08000183105469,77.12000274658203,76.5118179321289,MRK,"BUZZ-U.S. STOCKS ON THE MOVE-GM, Axcella, Beyond Meat, SmileDirect ||| Ferring's therapy curbs recurrent superbug infection - study ||| Merck Announces RECARBRIO Demonstrated Noninferiority Compared To Piperacillin And Tazobactam In Primary And Key Secondary Endpoints",0,0.5124878
2020-05-07,12025200.0,77.0,77.12000274658203,75.43000030517578,75.5999984741211,75.00379943847656,MRK,"Dow Movers: MRK, TRV ||| From Gilead To AstraZeneca, Investors Should Watch These Biotech Giants Right Now ||| BUZZ-U.S. STOCKS ON THE MOVE-Lyft, Livongo Health, Tonix Pharma ||| BUZZ-U.S. STOCKS ON THE MOVE-Lyft, GM, Bristol Myers, Nvidia ||| Bristol Myers sees 2020 earnings holding despite coronavirus pandemic ||| Bristol Myers sees 2020 earnings holding despite coronavirus pandemic ||| Cigna's Express Scripts offers discounted drugs for U.S. newly unemployed",1,0.4837117
2020-05-08,8389000.0,76.5,76.95999908447266,75.97000122070312,76.4000015258789,75.79749298095703,MRK,5 Biopharmas Where BofA Would Put Its Money To Work,1,0.5404594
2020-05-11,10134800.0,76.02999877929688,78.06999969482422,75.91999816894531,77.91000366210938,77.29558563232422,MRK,"AbbVie Stock: Love It or Leave It? ||| Notable ETF Outflow Detected - IWF, UNH, MA, MRK ||| AstraZeneca: FDA Approves Lynparza In Treatment Of HRD-positive Ovarian Cancer ||| UPDATE: Cocrystal Says Collaboration With Merck For Discovery, Development Of Certain Proprietary Flu A/B Antiviral Agents Ongoing ||| AstraZeneca And Merck Announce LYNPARZA Approved In US As 1st-line Maintenance Treatment With bevacizumab For HRD-Positive Advanced Ovarian Cancer ||| AstraZeneca Announces Lynparza Approved in the U.S, as 1st-line Maintenance Treatment With Bevacizumab for HED-positive Advanced Ovarian Cancer",0,0.51243746
2020-05-13,10434300.0,76.66000366210938,78.80000305175781,76.58000183105469,77.88999938964844,77.27574157714844,MRK,"Wednesday Sector Leaders: Healthcare, Utilities ||| Exxon Mobil Faces New Climate Challenge From Shareholder ||| Merck Reports KEYTRUDA Plus Chemo Showed Statistically Significant Improvement In Progression-Free Survival vs Chemo In Certain Patients With Metastatic Triple-Negative Breast Cancer ||| Merck Reports KEYTRUDA Superior To Brentuximab Vedotin In Patients With Classical Hodgkin Lymphoma In Head-To-Head Phase 3 Trial ||| Merck Reports New Combo Data For KEYTRUDA Showed Benefit In Stage 3 Non-Small Cell Lung Cancer ||| Merck Reports Novel HIF-2a Inhibitor Showed Objective Response Rate Of Nearly 30% In Patients With von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma ||| AbbVie's Potential Is 'Underappreciated,' Says Morgan Stanley Analyst ||| The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter ||| Merck Animal Health to Acquire U.S. Rights to SENTINEL Brand of Combination Parasiticides for Companion Animals for ~$400M in Cash",1,0.50863177
2020-05-14,10885100.0,77.27999877929688,80.12999725341797,77.26000213623047,80.05000305175781,79.41870880126953,MRK,"Dow Jones Today: More Bleak Jobs Data Didn’t Ding Stocks ||| Dow Movers: BA, CSCO ||| Add Up The Pieces: QUAL Could Be Worth $100 ||| Merck Just Made a Gamble That Smart Investors Should Bet on Too",0,0.48385268
2020-05-15,8938200.0,80.11000061035156,80.55000305175781,78.83000183105469,79.77999877929688,79.15083312988281,MRK,Wall St Week Ahead-Investors prepare for more U.S. stock swings as states reopen ||| Clovis Oncology's Rubraca gets U.S. FDA approval for prostate cancer ||| U.S. FDA approves Bristol-Myers combo therapy for lung cancer ||| Wall St Week Ahead-Investors prepare for more U.S. stock swings as states reopen ||| Is Danaher Stock a Buy?,0,0.5296221
2020-05-18,11977700.0,81.0,81.0,79.2300033569336,79.72000122070312,79.09130859375,MRK,"Clovis Oncology Secures FDA Approval for Rubraca in Prostate Cancer ||| Could Veeva Systems Be a Millionaire-Maker Stock? ||| Wall Street Week Ahead-Investors prepare for more U.S. stock swings as states reopen ||| Roche's Tecentriq wins FDA approval as first-line therapy for some lung cancer forms ||| Dow Movers: PFE, DOW",0,0.51961637
2020-05-19,10106700.0,79.47000122070312,79.7300033569336,77.3499984741211,77.55000305175781,76.93842315673828,MRK,"Does Moderna Stock’s Rally Hold Up Under the Microscope? ||| Noteworthy ETF Inflows: VHT, UNH, MRK, PFE ||| AbbVie Is More Than Just a Portfolio of Drugs and Acquisitions ||| Telemedicine A COVID-19 Winner ||| Merck And UPMC Announces Infectious Disease Connect Has Combined Merck's ILÚM Health Solutions To 'Advance Precision Treatment of Infectious Diseases and Antimicrobial Stewardship '",0,0.4831097
2020-05-20,10522600.0,78.02999877929688,78.23999786376953,76.68000030517578,76.88999938964844,76.28363037109375,MRK,"Could This Cancer Drug Developer’s Stock Make You Filthy Rich? ||| FDA Approves New Prostate Cancer Treatment From AstraZeneca and Merck ||| Health Care Sector Update for 05/20/2020: SURF, MRK, RDY, MCK, XLV, IBB ||| Better Coronavirus Stock: Moderna vs. Sorrento Therapeutics ||| UK Stocks-Factors to watch on May 20 ||| AstraZeneca: Lynparza Approved In US For HRR Gene-mutated Prostate Cancer ||| AstraZeneca-Merck's Lynparza gets U.S. FDA nod for prostate cancer treatment ||| European shares unchanged amid doubts over COVID-19 vaccine ||| Mid-Afternoon Market Update: Crude Oil Up 5%; Surface Oncology Shares Spike Higher ||| Why Surface Oncology's Stock Is Surging Higher ||| Checkpoint Therapeutics CEO On Tapping Into A $25 Billion Cancer Treatment Market ||| The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test ||| AstraZeneca And Merck Announce LYNPARZA Approved By FDA For Treatment Of HRR Gene-Mutated Metastatic Castration-Resistant Prostate Cancer That Has Progressed Following Prior Treatment With Enzalutamide Or Abiraterone ||| AstraZeneca Says Lynparza Approved in the U.S. for Prostate Cancer",0,0.5076779
2020-05-21,8588100.0,76.76000213623047,77.02999877929688,76.2699966430664,76.55000305175781,75.9463119506836,MRK,"Validea Joel Greenblatt Strategy Daily Upgrade Report - 5/21/2020 ||| Mid-Afternoon Market Update: Dow Falls 50 Points; L Brands Shares Spike Higher ||| 51 Stocks Moving In Thursday's Mid-Day Session ||| Mid-Day Market Update: Crude Oil Rises Over 1%; Aurora Cannabis Shares Jump ||| Mid-Morning Market Update: Markets Mixed; Best Buy Tops Q1 Expectations ||| The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive",0,0.5274417
2020-05-22,6066300.0,76.16999816894531,76.66000366210938,76.06999969482422,76.37000274658203,75.76773071289062,MRK,"EXCLUSIVE-U.S. plans massive coronavirus vaccine testing effort to meet year-end deadline ||| US Health Official Says Vaccines From J&J, Sanofi, Merck May Be Added This Summer As They Complete Phase 1 Safety Studies ||| US Says Will Test Experimental Coronavirus Vaccines In 100,000+ People, Health Official Says Oxford Vaccine May Be Tested ""Side By Side"" With Moderna's Starting In July ||| 64 Biggest Movers From Yesterday",1,0.5307709
2020-05-26,18269100.0,78.26000213623047,78.5999984741211,76.91000366210938,77.26000213623047,76.65071105957031,MRK,"If You'd Invested $10,000 in Moderna's IPO, Here's How Much Money You'd Have Now ||| Better Buy: AbbVie vs. Merck ||| The Week Ahead In Biotech: ASCO Presentations In The Spotlight ||| S&P 500 rises on economic recovery and vaccine hopes, pulls back from highs ||| Why Avis Budget Group Popped 11% Tuesday ||| At Last, Merck Is Diving Into Coronavirus Vaccine and Antiviral Development ||| ARGX Soars On ADAPT Trial Data, MRK's Deals & Collaborations To Fight COVID-19, ALNY ON Watch ||| S&P 500 tops 3,000 on hopes of economic recovery, COVID-19 vaccine ||| S&P 500 rises on economic recovery and vaccine hopes, pulls back from highs ||| S&P 500 clears 3,000 barrier on economic recovery and vaccine hopes ||| Why Travel Stocks Were Soaring Today ||| S&P 500 clears 3,000 barrier on hopes of recovery, vaccine ||| Stock Market News: Why Shares of Cruise Companies Are Soaring as Moderna Plunges ||| BUZZ-U.S. STOCKS ON THE MOVE-Alliance Data Systems, Alibaba Group, Dexcom, Can Fite Biofarma, U.S. travel firms ||| S&P 500 futures surge on recovery, vaccine hopes ||| S&P 500 tops 3,000 pts on hopes of economic recovery, COVID-19 vaccine ||| Health Care Sector Update for 05/26/2020: ARGX, NVAX, MRK, XLV, IBB ||| Biotech Stocks Facing FDA Decision In June 2020 ||| Merck Inks Deals, Joins Coronavirus Vaccine Race ||| Wall St set to surge at open on recovery, vaccine hopes ||| Merck, Ridgeback Bio Collaborate To Develop Novel Antiviral Candidate EIDD-2801 ||| BUZZ-U.S. STOCKS ON THE MOVE-LATAM Airlines, Tuesday Morning, Novavax ||| Dow Jones Surges 600 Points as Merck Works on Vaccine, Restaurant Activity Picks Up ||| Merck To Buy Privately-held Themis - Quick Facts ||| Merck leaps into COVID-19 development fray with vaccine, drug deals ||| Merck CEO Can't Give A Timeline Or Date For COVID-19 Approval ||| Merck CEO Ken Frazier To Appear On CNBC ||| 'Merck chief casts doubt on coronavirus vaccine timeframe' -Financial Times ||| Merck's Coronavirus Plan Of Attack: 2 Partnerships, M&A Deal Aimed At Treatment, Vaccine Development ||| Benzinga Pro's Top 5 Stocks To Watch For Tues., May 26, 2020: NVAX, EWJ, SNY, SOXX, MRK ||| Merck To Acquire Vaccine Company Themis Bioscience; Also Announces Collaboration With IAVI For Coronavirus Vaccine And Collaboration With Ridgeback Bio For Coronavirus Antiviral Candidate",1,0.5074691
2020-05-27,12241400.0,77.0,77.63999938964844,76.0,77.55000305175781,76.93842315673828,MRK,Moderna rally loses steam over COVID-19 vaccine worries ||| The 8 Best Cash Cow Stocks to Buy for Stable Returns ||| iShares Russell Top 200 Growth ETF Experiences Big Inflow ||| Here's Why Arcus Biosciences Is Losing Ground Today ||| The Trip Aboard Carnival Cruises Stock Will Be Stormy,1,0.5200256
2020-05-28,12577200.0,78.5999984741211,80.29000091552734,78.51000213623047,79.04000091552734,78.41667175292969,MRK,"Pfizer ties up with glass maker Corning for vial supply ||| Dow Movers: CVX, BA ||| Pfizer ties up with glass maker Corning for vial supply ||| No preferential access to Themis' potential COVID-19 vaccine -CEO ||| No preferential access to Themis' potential COVID-19 vaccine -CEO ||| Merck's Keytruda (Pembrolizumab) Superior To Standard Of Care Chemotherapy In Patients With MSI-H Colorectal Cancer",1,0.4625876
2020-05-29,12900700.0,79.45999908447266,80.94000244140625,78.30999755859375,80.72000122070312,80.08342742919922,MRK,"Merck's Keytruda Better Than Chemotherapy for Certain Colon Cancers ||| J&J's Ebola vaccine wins EU regulatory panel backing ||| European agency panel recommends approval of J&J's Ebola vaccine ||| Earn Monthly Dividend Income By Investing in These 3 Stocks ||| Now’s the Time to Buy These 3 Stocks ||| Merck Yesterday Announced KEYTRUDA plus LENVIMA Combination Demonstrated Clinically Meaningful Tumor Response Rates in Unresectable Hepatocellular Carcinoma and Advanced Renal Cell Carcinoma ||| The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant ||| Cramer Shares His Thoughts On Teva, Oxford Industries And More",0,0.5131858
2020-06-01,5982100.0,80.18000030517578,80.45999908447266,79.12999725341797,79.55999755859375,78.93257141113281,MRK,"The Week That Was: MRK Enters COVID Space, GSK's 1Bln Dose Target, Roche, GILD Team Up For REMDACTA ||| The Week Ahead In Biotech: ASCO, Menlo And Merck FDA Decisions, IPOs In The Spotlight ||| Are Moderna’s Coronavirus Gains Over? ||| Vir Biotechnology Is Bucking The Biotech COVID-19 Trends, And Stands To Win ||| London stocks jump as retailers set to reopen from shutdown ||| London stocks jump as retailers reopen after coronavirus shutdown ||| AstraZeneca-Merck Lynparza gets EMA's positive recommendation ||| AstraZeneca-Merck Lynparza gets EMA's positive recommendation ||| Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates ||| 'New Ebola epidemic' in northwest DR Congo: health ministry' -AFP ||| Merck and AstraZeneca's LYNPARZA Receives a Positive Opinion from the European Medicines Agency ||| AstraZeneca Announces Lynparza Recommended for Approval in EU by CHMP for BRCA-mutated Metastatic Pancreatic Cancer ||| LYNPARZA® (olaparib) Receives Positive Opinion from EU CHMP for First-Line Maintenance ...",1,0.5028313
2020-06-02,10833000.0,79.54000091552734,80.86000061035156,78.83000183105469,80.83999633789062,80.20247650146484,MRK,Tuesday's ETF with Unusual Volume: IDHQ ||| Pharma Large And Mid-Caps Race Against COVID-19,1,0.50283664
2020-06-03,13049100.0,81.0,82.3499984741211,80.86000061035156,82.05999755859375,81.41285705566406,MRK,"Report: Trump Administration Picks 5 Coronavirus Vaccine Candidates to Support ||| Why Inovio Pharmaceuticals Stock Sank Today ||| Trump administration selects five coronavirus vaccine candidates as finalists - NYT ||| Trump Administration selects five coronavirus vaccine candidates as finalists - NYT ||| Vaccine group plans advance market agreement for COVID-19 vaccines ||| Is It Too Late to Jump In on Zentalis? ||| Revisiting The Coronavirus Vaccine Race: Updates On The 10 Candidates In Clinics ||| UPDATE: Five Companies Chosen For 'Vaccine Finalist' Are Moderna, Johnson & Johnson, Merck, Pfizer And AstraZeneca ||| Top Stock Reports for Alibaba, UnitedHealth & Merck",0,0.51195365
2020-06-04,8867300.0,81.2699966430664,82.16000366210938,80.83999633789062,81.55000305175781,80.9068832397461,MRK,"CYCN Awaits Sickle Cell Disease Data, TTPH Finalizes Its Suitor, ADMS Faces FDA In Feb ||| Merck (MRK) Shares Cross 3% Yield Mark ||| U.S. working with manufacturers to boost flu vaccine availability, top official says ||| Why Didn't Novavax Make Trump's Top 5 COVID-19 Vaccine List? ||| Could the Rush to a Vaccine Hurt Coronavirus Stocks? ||| Ex-FDA Chief On White House's Coronavirus Vaccine Shortlist: 'They Chose Very Novel Platforms' ||| The Daily Biotech Pulse: Positive Readout For Kezar, AstraZeneca Stitches Oncology Partnership, D-Day For Merck's Triple Combo Antibiotic",1,0.52892166
2020-06-05,9936400.0,82.11000061035156,83.12999725341797,81.48999786376953,82.26000213623047,81.61128234863281,MRK,"XLV, UNH, MRK, PFE: ETF Inflow Alert ||| FDA OKs Merck's Recarbrio For Hospital And Ventilator Associated Bacterial Pneumonia ||| The Daily Biotech Pulse: Adamas Rallies On FDA Acceptance, Oxford Immunotech Reportedly Gets $400M Bid ||| Merck Reports FDA Approved RECARBIO For Treatment Of Adults with Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia",1,0.51234585
2020-06-08,9500800.0,81.1500015258789,83.19999694824219,81.1500015258789,82.9000015258789,82.24623107910156,MRK,"AstraZeneca contacted Gilead over potential megamerger -Bloomberg News ||| The Week Ahead In Biotech: Viela FDA Decision, Hematology Conference Take Center Stage ||| Got $1,000? Buy These 4 Cancer Stocks ||| How Biotech Companies Are Valued",0,0.49789035
2020-06-09,8441000.0,83.19000244140625,83.51000213623047,82.12000274658203,82.26000213623047,81.61128234863281,MRK,Merck's bladder cancer late-stage study fails to meet main goals ||| Merck's bladder cancer late-stage study fails to meet main goals ||| Aggressive Investors Can Do Much Better Than Merck Stock ||| Merck Announces That The Phase 3 KEYNOTE-361 Trial Evaluating KEYTRUDA As Monotherapy And In Combination With Chemotherapy In Patients With Advanced Or Metastatic Urothelial Carcinoma,0,0.5113628
2020-06-10,8665000.0,82.44000244140625,82.77999877929688,80.98999786376953,81.7699966430664,81.12513732910156,MRK,"Ex-Dividend Reminder: Merck, CONMED and Atrion ||| Potential COVID-19 vaccine from China shows promise in animal tests ||| Johnson & Johnson To Start Coronavirus Vaccine Human Trials Ahead Of Schedule In July ||| The Daily Biotech Pulse: Keytruda Setback For Merck, Denali Pulls The Plug On Neurological Asset",0,0.48806784
2020-06-11,13648700.0,80.80999755859375,81.66000366210938,77.3499984741211,77.3499984741211,76.73999786376953,MRK,"Japan's PeptiDream to work with Merck in developing COVID-19 therapies ||| Shares of several healthcare companies are trading lower in sympathy with the overall market following an increase in coronavirus cases in some US states that have reopened, leading to concerns of a second wave of the virus.",0,0.5296394
2020-06-12,16218200.0,77.88999938964844,77.93000030517578,75.47000122070312,76.30000305175781,76.30000305175781,MRK,Avoid Merck Stock Until Shares Pull Back ||| Is Adaptimmune Therapeutics a Buy?,0,0.5064253
2020-06-15,16874200.0,74.91000366210938,75.37000274658203,73.56999969482422,74.0199966430664,74.0199966430664,MRK,"Could This Recent IPO Biotech Become the Next Moderna? ||| Got $1,000? You Might Want To Buy These 2 Coronavirus Stocks Now ||| Is Merck A Great Dividend Stock? ||| UK funds human trials of potential COVID-19 vaccine from Imperial ||| XLV, MRK, PFE, CVS: Large Outflows Detected at ETF",1,0.52927005
2020-06-16,20455200.0,75.37999725341797,77.41000366210938,74.83000183105469,76.97000122070312,76.97000122070312,MRK,U.S. appeals court rejects rule requiring drug prices in TV ads ||| Validea Joel Greenblatt Strategy Daily Upgrade Report - 6/16/2020 ||| U.S. narrows list of promising COVID-19 vaccine candidates to about 7 ||| UK funds human trials of potential COVID-19 vaccine from Imperial,0,0.5040524
2020-06-17,13341300.0,77.36000061035156,77.44999694824219,75.62999725341797,76.29000091552734,76.29000091552734,MRK,Merck Prices $4.5 Bln Public Debt Offering Of Senior Unsecured Notes - Quick Facts,0,0.4896561
2020-06-18,7395900.0,75.62999725341797,76.27999877929688,75.36000061035156,76.22000122070312,76.22000122070312,MRK,Better Buy: Pfizer vs. Merck,1,0.5013717
2020-06-19,16881100.0,77.12999725341797,77.9800033569336,75.80999755859375,77.9000015258789,77.9000015258789,MRK,3 Top Animal-Health Companies to Buy in June,0,0.56167376
2020-06-22,7131900.0,77.37000274658203,77.62999725341797,76.43000030517578,76.75,76.75,MRK,Merck: KEYTRUDA Approved For New Indication In China - Quick Facts,1,0.51749116
2020-06-23,10905200.0,77.5,78.62000274658203,76.88999938964844,77.12000274658203,77.12000274658203,MRK,Meet the Pharma Company That Just Had a Bigger IPO Than Moderna's,0,0.5138491
2020-06-24,7714600.0,76.7300033569336,76.88999938964844,75.44999694824219,75.87000274658203,75.87000274658203,MRK,"EXCLUSIVE-Vaccine alliance finds manufacturing capacity for 4 bln doses of coronavirus vaccines ||| Moderna Stock: Buy, Sell, or Hold?",1,0.50441253
2020-06-29,6899800.0,75.9000015258789,76.51000213623047,75.5199966430664,76.12000274658203,76.12000274658203,MRK,3 Biotech Stocks I’d Buy Right Now ||| Novo Nordisk Announces Approval Of Rybelsus In Japan For Treatment Of Type 2 Diabetes,1,0.517306
2020-06-30,9485500.0,76.75,77.66000366210938,76.19999694824219,77.33000183105469,77.33000183105469,MRK,Validea Joel Greenblatt Strategy Daily Upgrade Report - 6/30/2020 ||| FDA OKs Merck's Keytruda As First-line Treatment For Metastatic Colorectal Cancer,1,0.5118733
2020-07-01,9493100.0,77.43000030517578,78.94000244140625,77.12000274658203,78.12000274658203,78.12000274658203,MRK,"This Under-the-Radar Stock Is a Better Way to Bet on Coronavirus Vaccines ||| Noteworthy ETF Outflows: SPHQ, MRK, ORCL, LIN ||| Sigma-Aldrich, not Merck gave misleading info in deal review, EU says",1,0.4999695
2020-07-02,6513300.0,78.56999969482422,79.30999755859375,78.22000122070312,78.77999877929688,78.77999877929688,MRK,"Wall Street shifts bets to big pharma as COVID-19 vaccine race progresses ||| Keep an Eye on Royalty Pharma Stock, 2020’s Biggest IPO ||| Dow Movers: JNJ, DOW",0,0.49444968
2020-07-06,8058282.0,75.61068725585938,76.35496520996094,75.28626251220703,75.93511199951172,68.02391052246094,MRK,"These 3 Stocks Are Potential Buyout Targets ||| Is Dynavax Technologies Stock a Buy? ||| Why Bellus Health Stock Tanked 69.2% Today ||| Moderna Stock Has a Bright Future After the Coronavirus ||| Merck: New Analyses Show Additional Efficacy Data For Islatravir, Doravirine Combination ||| Royalty Pharma Stock Is Likely to Reach New Highs in the Coming Years ||| Ascentage, Merck To Evaluate APG-115 In Combination With KEYTRUDA In Advanced Solid Tumors",0,0.4902395
2020-07-07,6956414.0,75.38167572021484,76.03053283691406,74.9904556274414,75.114501953125,67.2887954711914,MRK,"ANALYSIS-'At war time speed', China leads COVID-19 vaccine race ||| Dogs of the Dow: Why 2020 Is Sending This Popular Strategy to the Doghouse ||| U.S. government awards Novavax $1.6 billion for coronavirus vaccine ||| CanSino's COVID-19 Vaccine Was Just Approved for Limited Use in China. Here's What Investors Should Know. ||| U.S. government awards Novavax $1.6 billion for coronavirus vaccine",0,0.51826215
2020-07-08,8211394.0,75.02862548828125,75.34351348876953,73.9312973022461,74.35114288330078,66.60497283935547,MRK,"Foghorn Therapeutics, Merck Enter Strategic Collaboration - Quick Facts ||| Why Merck is a Top 25 Dividend Giant (MRK) ||| FDA declines to approve Merck and Eisai's liver cancer combo therapy ||| UK Stocks-Factors to watch on July 8 ||| AstraZeneca-Merck's Lynparza wins EU approval for pancreatic cancer ||| AstraZeneca: Lynparza Gets EU Approval For BRCA-mutated Metastatic Pancreatic Cancer ||| AstraZeneca-Merck Lynparza wins EU approval for pancreatic cancer",0,0.50531507
2020-07-09,7966058.0,74.37023162841797,74.7614517211914,72.5572509765625,73.17748260498047,65.55358123779297,MRK,Coronavirus vaccine makers to testify before U.S. House committee ||| Coronavirus vaccine makers to testify before U.S. House committee ||| New $1 bln fund aims to steer antibiotic companies in tough market ||| New $1 bln fund aims to steer antibiotic companies in tough market ||| Prominent plaintiffs' firms sought government bailout to stay afloat,1,0.4905342
2020-07-10,5161400.0,73.23473358154297,73.8072509765625,72.90076446533203,73.21565246582031,65.58778381347656,MRK,"Botox, Keytruda Get FDA Approval For New Uses, BVXV Abuzz, First Droopy Eyelid Treatment Is Here",1,0.4950746
2020-07-13,8114245.0,73.47328186035156,74.98091888427734,73.21565246582031,73.8072509765625,66.11773681640625,MRK,Moderna and Other Coronavirus Vaccine Developers to Testify in Congress July 21,1,0.50290596
2020-07-14,8397100.0,73.9885482788086,75.0095443725586,73.8167953491211,74.66603088378906,66.88705444335938,MRK,"iBio Stock Is Worth the Gamble in the Covid-19 Vaccine Race ||| Dow Movers: MSFT, MCD",1,0.5061164
2020-07-15,7709717.0,75.61068725585938,76.3072509765625,75.22901153564453,75.80152893066406,67.90423583984375,MRK,"Health Care Sector Update for 07/15/2020: CANF, MRNA, NVCR, MRK, XLV, IBB ||| Better Coronavirus Vaccine Stock: BioNTech vs. Moderna",0,0.49154055
2020-07-16,5850774.0,76.1259536743164,76.15457916259766,75.14312744140625,75.76335906982422,67.87006378173828,MRK,FDA Accepts Merck's NDA For Vericiguat For Priority Review - Quick Facts,1,0.5020243
2020-07-17,8191378.0,76.0687026977539,76.57442474365234,75.67748260498047,76.21183013916016,68.27180480957031,MRK,"Analyst Sees 60% Upside for Nabriva (NBRV) Following Merck Deal ||| ACIU'S Alzheimer's Vaccine Study Chugs Along, LCI Up On Distribution Deal, TLSA Hits New High",0,0.4950949
2020-07-21,8967526.0,76.0687026977539,76.45037841796875,75.1812973022461,75.27671813964844,67.4341049194336,MRK,"Moderna, Merck say they will not limit price of coronavirus vaccines to company cost ||| Dow Analyst Moves: MRK ||| Coronavirus vaccine developers vow diversity in clinical trials ||| Merck a Top Socially Responsible Dividend Stock With 3.1% Yield (MRK)",0,0.5000311
2020-07-22,12362103.0,75.68701934814453,76.10687255859375,74.44656372070312,75.1717529296875,67.34009552001953,MRK,Why Was Novavax Awarded Almost $2 Billion in Free Money?,0,0.5160182
2020-07-23,11558916.0,75.52481079101562,75.57251739501953,73.95992279052734,74.48473358154297,66.72463989257812,MRK,ANALYSIS-U.S. sets global benchmark for COVID-19 vaccine price at around the cost of a flu shot ||| ANALYSIS-U.S. sets global benchmark for COVID-19 vaccine price at around the cost of a flu shot,0,0.48997882
2020-07-24,9068763.0,74.28434753417969,74.41793823242188,72.86259460449219,73.5687026977539,65.904052734375,MRK,U.S. drugmaker stocks fall ahead of Trump's pricing executive orders ||| U.S. healthcare stocks flat ahead of Trump's drug pricing executive orders,1,0.4978075
2020-07-27,10958307.0,72.9103012084961,75.51526641845703,72.81488800048828,75.31488800048828,67.46830749511719,MRK,PREVIEW-U.S. drugmaker earnings heat up this week with spotlight on vaccine news,1,0.5251749
2020-07-28,8494564.0,75.56298065185547,76.53626251220703,75.3530502319336,76.04007720947266,68.11793518066406,MRK,"Merck Declares Fresh Dividend; Yield Is 3.1% ||| Moderna pitches virus vaccine at around $50-$60 per course -FT ||| XLV, UNH, PFE, MRK: ETF Inflow Alert ||| 4 Reasons AstraZeneca Gave Daiichi Sankyo Another $1 Billion Upfront",0,0.5073437
2020-07-29,6398040.0,75.62023162841797,76.08778381347656,75.13359069824219,75.71565246582031,67.82732391357422,MRK,"Daily Dividend Report: MRK,GWW,WFC,EBAY,AFL",0,0.50473344
2020-07-30,7152600.0,75.1240463256836,75.64885711669922,74.07442474365234,75.37213897705078,67.51959228515625,MRK,"Pre-Market Earnings Report for July 31, 2020 : MRK, XOM, CVX, ABBV, CHTR, CAT, D, CL, ITW, AON, LHX, IDXX",1,0.47736877
2020-07-31,12291154.0,77.18511199951172,77.93893432617188,75.52481079101562,76.56488800048828,68.58807373046875,MRK,"Merck profit beats estimates on resilient Keytruda demand ||| Merck to Begin Pivotal COVID-19 Antiviral Studies in September ||| BUZZ-U.S. STOCKS ON THE MOVE-Electronic Arts, Spartan Energy, Phillips 66 ||| Merck's Q2 Sales Got Clobbered by COVID-19, but Still Beat Estimates ||| Dow Movers: CAT, AAPL ||| BUZZ-U.S. STOCKS ON THE MOVE-AbbVie, Xilinx, Pinterest, Expedia Group ||| BUZZ-U.S. STOCKS ON THE MOVE-Alphabet, Chevron, Applied DNA, Under Armour ||| BUZZ-U.S. STOCKS ON THE MOVE-Caterpillar, Under Armour, Merck & Co, L3Harris Tech ||| Merck Q2 Results Top Estimates; Boosts FY20 Outlook ||| Merck quarterly sales fall 7.6% as pandemic cuts doctor visits ||| Merck & Co Inc. Q2 adjusted earnings Beat Estimates ||| Merck & Co Q2 20 Earnings Conference Call At 8:00 AM ET ||| Health Care Sector Update for 07/31/2020: TLSA, BNTX, PFE, MRK, XLV, IBB",1,0.49024218
2020-08-03,10601463.0,78.38740539550781,79.96183013916016,78.11068725585938,78.7595443725586,70.5541000366211,MRK,"Merck & Co. (MRK) Q2 2020 Earnings Call Transcript ||| Merck (MRK) Shares Cross Above 200 DMA ||| BUZZ-U.S. STOCKS ON THE MOVE-Microsoft, Dynatrace, Carnival Corp, Atossa Therapeutics ||| BUZZ-U.S. STOCKS ON THE MOVE-Jernigan Capital, Keurig Dr Pepper, Spirit AeroSystems, Tyme Tech ||| BUZZ-U.S. STOCKS ON THE MOVE-Zovio, Tyson Foods, Mack-Cali Realty, Xerox ||| BUZZ-U.S. STOCKS ON THE MOVE-ADT Inc, Marathon Petroleum, Eli Lilly, VistaGen Therapeutics",0,0.47608775
2020-08-05,6492465.0,78.31106567382812,78.6927490234375,77.4332046508789,77.90076446533203,69.78477478027344,MRK,Merck Stock Remains a Dull Biotech Play Despite Earnings Success,0,0.51965857
2020-08-06,7256562.0,77.72901153564453,78.61640930175781,76.88931274414062,77.33778381347656,69.28044891357422,MRK,"5 Biotech Stocks That Offer Long-Term Growth and Value ||| IWF, MRK, ACN, LLY: Large Outflows Detected at ETF ||| Pfizer, Merck, and Others See a Slowdown in Vaccine Sales, but Anticipate an Autumn Rebound ||| Bristol Myers lifts annual profit view on hopes of pickup in patient visits ||| EARNINGS-Bristol Myers lifts annual profit view on hopes of pickup in patient visits to doctors",0,0.5209258
2020-08-07,6977584.0,77.0896987915039,77.30915832519531,76.364501953125,77.30915832519531,69.25479888916016,MRK,This Company is the Landlord of Life Sciences,0,0.528465
2020-08-12,7295652.0,77.64312744140625,79.11259460449219,77.614501953125,78.89312744140625,70.67376708984375,MRK,Top 5 Spenders in R&D in Biotech,1,0.5401582
2020-08-13,7455262.0,78.36832427978516,79.79962158203125,78.25381469726562,79.71373748779297,71.40886688232422,MRK,Corporate America worries WeChat ban could be bad for business- WSJ,0,0.49631312
2020-08-14,7390496.0,79.56106567382812,80.56298065185547,79.36068725585938,79.65648651123047,71.35758972167969,MRK,"Noteworthy ETF Outflows: IWF, TSLA, NFLX, MRK ||| 2 Forever Pharma Stocks to Buy Now",1,0.49899602
2020-08-17,8764319.0,80.41984558105469,81.27862548828125,80.16221618652344,80.87786102294922,72.45170593261719,MRK,Validea's Top Five Healthcare Stocks Based On John Neff - 8/16/2020,0,0.5095261
2020-08-19,6896050.0,80.68701934814453,81.78434753417969,80.68701934814453,81.135498046875,72.68251037597656,MRK,The Math Shows HDV Can Go To $93 ||| Merck : Phase 3 Study Of KEYTRUDA - Chemotherapy On Metastatic Esophageal Cancer Meets Main Goal,0,0.49879232
2020-08-20,6380434.0,80.91603088378906,81.40267181396484,80.52481079101562,81.135498046875,72.68251037597656,MRK,"April 2021 Options Now Available For Merck (MRK) ||| JNJ Acquires MNTA, FDA Strikes Down BMRN's Gene Therapy, BLRX's GENESIS On Track, TPTX On Watch",0,0.5005757
2020-08-24,7582280.0,81.2977066040039,81.55534362792969,80.61068725585938,81.50763702392578,73.01586151123047,MRK,Better Coronavirus Stock: CureVac vs. Moderna,1,0.5203377
2020-08-26,7844175.0,81.40267181396484,81.75572204589844,80.78244018554688,81.62213897705078,73.11845397949219,MRK,"Salesforce, Amgen, and Honeywell Are Being Added to the Dow Jones Index: Are They Buys?",1,0.47950128
2020-08-27,6464902.0,81.53626251220703,82.21373748779297,81.1832046508789,81.88931274414062,73.35780334472656,MRK,3 Growth Stocks for In-the-Know Investors,0,0.5535765
2020-08-28,6134049.0,81.94656372070312,81.94656372070312,81.02098846435547,81.72709655761719,73.21246337890625,MRK,"Dow Movers: TRV, WMT",0,0.52270937
2020-08-31,7929273.0,81.67938995361328,81.99427795410156,81.2404556274414,81.364501953125,72.88764190673828,MRK,"FOCUS-Scientists see downsides to top COVID-19 vaccines from Russia, China",0,0.517938
2020-09-02,11571597.0,80.61068725585938,83.21565246582031,80.4103012084961,82.94847106933594,74.30660247802734,MRK,"Merck To Present New Data From Oncology Development Program At ESMO Virtual Congress ||| In change of tack, EU leaves door open to COVID vaccines purchase through WHO",0,0.5140702
2020-09-03,12983672.0,83.67366027832031,83.77862548828125,81.04962158203125,81.57442474365234,73.07569122314453,MRK,Merck CEO sees human trials for COVID-19 vaccine candidate 'fairly soon' ||| Pfizer targets end of next month for COVID-19 vaccine update ||| Pfizer targets end of October for COVID-19 vaccine update ||| Should You Buy Merck Stock At $85?,0,0.49378017
2020-09-08,9095592.0,82.00381469726562,82.00381469726562,79.19847106933594,79.51335906982422,71.22937774658203,MRK,"U.S., European COVID vaccine developers make pledge to uphold testing rigour ||| AstraZeneca puts COVID-19 vaccine trial on hold over safety concern -Stat News ||| Merck: Gefapixant Significantly Reduced Cough Frequency Compared To Placebo In Two Phase 3 Trials",1,0.52960825
2020-09-09,8862307.0,79.9332046508789,81.88931274414062,79.8282470703125,80.99236297607422,72.5542984008789,MRK,"Merck Reports Positive Topline Results From Two Adult Studies Evaluating V114 ||| AstraZeneca pauses coronavirus vaccine trial, shares slip on rollout doubts ||| AstraZeneca pauses coronavirus vaccine trial, rollout doubts dent shares ||| Bristol Myers Squibb Valued At $75 Per Share",0,0.48801833
2020-09-11,7171254.0,80.0,80.99236297607422,79.9427490234375,80.61068725585938,72.2123794555664,MRK,"Senate Considers Bill to Block International Distribution of Coronavirus Vaccine ||| Merck starts recruitment for COVID-19 vaccine trial ||| Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for September 14, 2020",0,0.44533527
2020-09-14,8575994.0,80.34351348876953,81.2022933959961,79.89503479003906,80.30534362792969,72.46206665039062,MRK,"Merck (Finally) Starts a Clinical Trial of its Coronavirus Vaccine ||| BUZZ-U.S. STOCKS ON THE MOVE-Adobe Systems, DraftKings Inc, Newmont Corp, Photronics Inc ||| Merck Inks Multibillion-Dollar Deal With Seattle Genetics, Including Equity ||| Wall Street closes broadly higher on deal news, vaccine hopes ||| Wall Street closes broadly higher on deal news, vaccine hopes ||| Wall Street gains 1% on deal news, vaccine hopes ||| BUZZ-U.S. STOCKS ON THE MOVE-Vaxart Inc, GameStop Corp, Dynavax Technologies Corp, BioNTech SE ||| BUZZ-U.S. STOCKS ON THE MOVE-Town Sports International, Seattle Genetics, Mallinckrodt Plc, Scientific Games ||| Merck to buy $1 bln stake in Seattle Genetics, co-develop cancer therapy ||| Seattle Genetics, Merck Announce Two New Strategic Oncology Collaborations - Quick Facts ||| Wall Street climbs on mega mergers, vaccine hopes",1,0.53097224
2020-09-15,10826678.0,80.84923553466797,81.26908111572266,79.8187026977539,80.3530502319336,72.5051040649414,MRK,"Merck Could Be the Covid-19 Investment You’re Missing ||| With Its Vaccine Trail, Moderna Addresses Racial Disparity Head On ||| Better Buy: Veeva Systems vs. Hubspot ||| MRNS Catches Eye, SAVA Soars On Alzheimer's Study, ETNB Abuzz Over NASH Trial, GILD Snaps Up IMMU",1,0.5042023
2020-09-17,8090455.0,81.46946716308594,81.84160614013672,80.58206176757812,81.71755981445312,73.73634338378906,MRK,EXCLUSIVE-France won't buy vaccines through WHO's COVAX scheme - ministry source ||| Vaccinex In Clinical Collaboration Deal With Merck To Evaluate Pepinemab And KEYTRUDA ||| Better Coronavirus Stock: Moderna vs. Novavax,1,0.5037995
2020-09-18,12308446.0,81.65076446533203,82.34732818603516,81.04962158203125,81.87976837158203,73.88272094726562,MRK,AstraZeneca's Lynparza Delivers Progression-Free Survival of Over 4 Years in Advanced Ovarian Cancer ||| EXCLUSIVE-France won't buy vaccines through WHO's COVAX scheme - ministry source,0,0.49480346
2020-09-21,10445311.0,81.03053283691406,81.4312973022461,78.33015441894531,79.32251739501953,71.57523345947266,MRK,"Amgen drug shrinks tumors in lung cancer patients with KRAS gene mutation -study ||| 3 Top Biotech Picks for 2025 ||| AstraZeneca: Lynparza Recommended For Approval In EU For Prostate Cancer, Ovarian Cancer ||| AstraZeneca-Merck's Lynparza wins EU panel recommendation for cancer treatments ||| UK Stocks-Factors to watch on Sept 21 ||| AstraZeneca-Merck's Lynparza wins EU panel recommendation for cancer treatments",0,0.5049666
2020-09-28,6123674.0,79.38931274414062,79.86640930175781,78.77862548828125,78.96946716308594,71.25666046142578,MRK,Biotech Stocks Facing FDA Decision In October 2020 ||| Here's the Bigger Story About Moderna That You Might Be Missing,0,0.4885794
2020-09-29,6742413.0,78.89312744140625,79.34160614013672,77.95801544189453,78.14885711669922,70.51618957519531,MRK,Celyad Collaborates With Merck To Evaluate CYAD-101 With KEYTRUDA On Microsatellite Stable MCRC,1,0.53137726
2020-09-30,11593605.0,78.49236297607422,79.50381469726562,78.26335906982422,79.15076446533203,71.42024993896484,MRK,Validea Joel Greenblatt Strategy Daily Upgrade Report - 9/30/2020,0,0.5096844
2020-10-01,8410305.0,79.37023162841797,79.52290344238281,77.52862548828125,77.90076446533203,70.29232788085938,MRK,Gene Therapy Stocks Continue To Underperform. Are They Worth A Look?,0,0.4885265
2020-10-02,5255406.0,77.09923553466797,77.99618530273438,76.76526641845703,77.09923553466797,69.56909942626953,MRK,U.S. drugmaker Merck's research chief Roger Perlmutter to retire ||| This Late-to-the-Party Coronavirus Vaccine Maker Could Be the Biggest Winner Over the Long Run,1,0.5017303
2020-10-05,8807182.0,77.5095443725586,77.80534362792969,76.92748260498047,77.51908111572266,69.94792938232422,MRK,"Next Coronavirus Market Crash: Where to Invest $10,000 ||| Will Big Pharma Acquire Novavax?",0,0.5211797
2020-10-06,10273230.0,77.41412353515625,77.42366027832031,75.87786102294922,75.98282623291016,68.56172180175781,MRK,What's The Buzz About Roche's New Drugs?,1,0.51490444
2020-10-07,9845226.0,76.4217529296875,76.66984558105469,75.86832427978516,76.3740463256836,68.91474151611328,MRK,Tech: Palantir Technologies Deep Dive ||| Validea James P. O'Shaughnessy Strategy Daily Upgrade Report - 10/7/2020 ||| Why Seattle Genetics Stock Jumped 24% in September ||| Bristol Myers' Opdivo succeeds in late-stage lung cancer trial,1,0.51706165
2020-10-08,9217160.0,76.70801544189453,78.08206176757812,76.4885482788086,76.79389190673828,69.2935791015625,MRK,Merck Mid-stage HIV Study On Islatravir- Doravirine Shows Viral Suppression Maintained ||| Moderna Regains Rights To Respiratory Syncytial Virus Vaccine From Merck - Quick Facts ||| ANALYSIS-Investors eye discounted U.S. healthcare sector as Biden's lead in polls grows,0,0.5251915
2020-10-09,5956098.0,77.17557525634766,77.36640930175781,76.38359069824219,76.67938995361328,69.19023895263672,MRK,Why Precigen Stock Is Skyrocketing Today,0,0.479344
2020-10-12,8276370.0,76.82251739501953,77.02290344238281,76.25,76.67938995361328,69.19023895263672,MRK,7 Highly Rated Pharmaceutical Stocks for Q4 ||| Where Will Procter & Gamble Be in 5 Years?,1,0.5308714
2020-10-13,9125774.0,76.62213897705078,77.22328186035156,76.3740463256836,77.01335906982422,69.49159240722656,MRK,"As U.S. politics heats up, companies seek to avoid controversy",0,0.5168384
2020-10-15,9151974.0,76.14503479003906,76.27862548828125,75.1717529296875,75.43893432617188,68.0709457397461,MRK,7 Value Stocks To Buy in an Overvalued Market ||| Merck's KEYTRUDA Approved By Health Canada As First-line Treatment In Metastatic Recurrent HNSCC,1,0.5095247
2020-10-16,7903492.0,75.66793823242188,76.62213897705078,75.48664093017578,76.17366027832031,68.7339096069336,MRK,Forget Snowflake! 2 Hyper-Growth Stocks I'd Rather Buy ||| Teva Stock To See 40% Upside?,0,0.4953126
2020-10-19,8614455.0,76.45037841796875,76.80343627929688,74.74236297607422,75.0667953491211,67.73515319824219,MRK,"Why I Think Bristol Myers Squibb Is Too Cheap to Miss ||| U.S., Britain call out Russian hacking spree, cyberattacks against Olympics ||| France's Ose to enrol up to 400 for 'T-cell' coronavirus vaccine trials",0,0.51747096
2020-10-20,11144746.0,75.3530502319336,75.3530502319336,74.50381469726562,74.68511199951172,67.3907470703125,MRK,Merck Reports Positive Data From 2 Trials Of V114 Pneumococcal Conjugate Vaccine ||| France's Ose to enrol up to 400 for 'T-cell' coronavirus vaccine trials,0,0.5307829
2020-10-23,7309381.0,75.62976837158203,76.92748260498047,75.62976837158203,76.17366027832031,68.7339096069336,MRK,"Bristol Myers Squibb Stock Looks Attractive At $60 ||| As COVID-19 cases spike, pneumonia vaccine demand rockets and Europe runs low",0,0.5187876
2020-10-26,9122840.0,75.69656372070312,76.14503479003906,74.67557525634766,75.22901153564453,67.88153076171875,MRK,"Pre-Market Earnings Report for October 27, 2020 : PFE, MRK, LLY, MMM, CAT, SPGI, SHW, ECL, ROP, CNC, CMI, MSCI ||| Biotech Stocks Facing FDA Decision In November 2020",0,0.47802702
2020-10-27,12241374.0,75.31488800048828,76.55534362792969,74.41793823242188,74.41793823242188,67.14966583251953,MRK,"US STOCKS-S&P 500 flat after Monday's selloff as focus turns to corporate earnings ||| US STOCKS-S&P 500, Dow slip on earnings worries, stimulus uncertainty ||| US STOCKS-S&P 500, Dow slip on earnings worries, stimulus uncertainty ||| Dow Jones Doesn't Get Lift From Merck, Caterpillar, and 3M Earnings Beats ||| Merck quarterly profit rises nearly 55% as key drug sales rebound ||| Merck Updates FY20 Guidance; Q3 Profit Tops Estimates - Quick Facts ||| Merck raises annual profit outlook as Keytruda drives profit beat ||| US STOCKS-Wall St set to rise after Monday's selloff as earnings take center stage",0,0.48247007
2020-10-28,8989954.0,73.59732818603516,74.16984558105469,72.53816986083984,72.69084167480469,65.59124755859375,MRK,"BUZZ-U.S. STOCKS ON THE MOVE-Omnicom, Akerna, Mastercard, gold miners ||| BUZZ-U.S. STOCKS ON THE MOVE-Travel stocks, Bunge, AMD, Hess Corp ||| BUZZ-U.S. STOCKS ON THE MOVE-EQT, Fiverr, First Solar, oil stocks ||| BUZZ-U.S. STOCKS ON THE MOVE-Chefs' Warehouse, Chewy Inc, Polaris Inc ||| Validea Joel Greenblatt Strategy Daily Upgrade Report - 10/28/2020",0,0.46680525
2020-10-29,9314310.0,72.6812973022461,73.08206176757812,71.25,72.41412353515625,65.34156799316406,MRK,Sanofi raises outlook as specialty care and vaccines lift sales ||| Next crop of COVID-19 vaccine developers take more traditional route,0,0.5127769
2020-10-30,11096748.0,71.92748260498047,72.41412353515625,70.55343627929688,71.76526641845703,64.7560806274414,MRK,Why Seagen Shares Are Tumbling 12.5% Today,1,0.4927422
2020-11-04,14731422.0,76.27862548828125,79.09351348876953,75.8969497680664,76.92748260498047,69.41410827636719,MRK,"US STOCKS-S&P 500 futures rise as U.S. election suggests less regulatory risk ||| US STOCKS-Stocks jump as Wall Street thinks tight U.S. election means gridlock ||| US STOCKS-Stocks jump as Wall Street thinks tight U.S. election means gridlock ||| US STOCKS-Stocks rally as Wall St cheers potential gridlock ||| US STOCKS-Wall St soars as investors price in gridlock in Washington ||| Wall St seeks safety of Big Tech as election hangs in the balance ||| BUZZ-U.S. STOCKS ON THE MOVE-U.S. PE firms, defense stocks, Biogen, solar energy cos ||| BUZZ-U.S. STOCKS ON THE MOVE-Big tech, solar energy, health insurers, Corecivic ||| Wall St seeks safety of Big Tech bets as election hangs in the balance ||| 3 Big Advantages Novavax Has Over Moderna",0,0.49472862
2020-11-05,9277210.0,78.30152893066406,79.1030502319336,76.75572204589844,76.77481079101562,69.27635192871094,MRK,Is It Time to Buy These 3 Dow Jones Stocks? Analysts Weigh In ||| Merck Makes a $2.8 Billion Bet on an Experimental New Cancer Drug ||| An Investor’s Guide to U.S. Elections ||| Merck to buy cancer drug developer VelosBio for $2.75 bln ||| Merck to bolster cancer drug portfolio with VelosBio $2.75 bln deal ||| Pappas Capital's VelosBio To Be Acquired By Merck In $2.75 Bln Cash Deal,0,0.50641406
2020-11-06,6945515.0,75.81106567382812,77.42366027832031,75.81106567382812,76.67938995361328,69.19023895263672,MRK,"Pre-market Movers In Healthcare Sector: RGLS, ASMB, GBT, ONCT…",1,0.5172773
2020-11-09,11184046.0,80.8969497680664,81.26908111572266,76.66984558105469,76.81298065185547,69.310791015625,MRK,Every Stock Tells a Story ||| Merck Stock Poised For 25% Gains,1,0.5198123
2020-11-10,8593914.0,78.03434753417969,78.27290344238281,77.29962158203125,77.39503479003906,69.83600616455078,MRK,"Notable Tuesday Option Activity: ADI, AVGO, MRK",0,0.51104635
2020-11-11,5741678.0,78.12023162841797,78.12023162841797,76.89885711669922,77.34732818603516,69.79295349121094,MRK,Know Why You’re Buying (Or Not Buying) Palantir Technologies ||| Why Moderna Stock Vaulted Higher Today,0,0.49185318
2020-11-13,7694206.0,76.56488800048828,78.10114288330078,76.0687026977539,77.3759536743164,69.81877899169922,MRK,MRK February 2021 Options Begin Trading,0,0.52759886
2020-11-16,9503474.0,77.5095443725586,78.13931274414062,76.04962158203125,76.50763702392578,69.03529357910156,MRK,Why You Shouldn't Ignore Johnson & Johnson ||| 3 Top Growth Stocks to Buy on the Dip ||| 2 Biotech Stocks That Could Have Tripled Your Money This Year ||| Buffett's Berkshire invests in four big drugmakers ||| Supermarket chain Costco declares special dividend of $10 per share ||| Here Are the Stocks Warren Buffett Has Been Buying and Selling ||| Buffett's Berkshire invests in several big drugmakers ||| Warren Buffett Bought 4 Pharma Giants in Q3 ||| What’s Happening With Bristol Myers Squibb Stock? ||| Monday's ETF with Unusual Volume: DJD,1,0.49678823
2020-11-17,9509133.0,77.34732818603516,78.20610809326172,76.72709655761719,77.76717376708984,70.17179107666016,MRK,"Despite Buffett Bullishness, Stock Markets Are Falling ||| Dow Movers: WBA, MRK ||| US STOCKS-S&P 500, Dow drop from record levels as coronavirus cases spike ||| Buffett’s Berkshire Hathaway Buys New Stakes in Vaccine Makers, Cuts Banks",0,0.51458573
2020-11-18,8678174.0,77.70037841796875,78.21565246582031,76.55534362792969,76.57442474365234,69.09554290771484,MRK,Could Moderna Become the Biggest Vaccine Company in the World Within 4 Years? ||| Here's Exactly Why Warren Buffett Loaded Up on Big Pharma Stocks ||| ANALYSIS-Berkshire's bet a bright spot in gloomy year for Big Pharma stocks ||| ANALYSIS-Berkshire's bet a bright spot in gloomy year for Big Pharma stocks,1,0.48729548
2020-11-19,7037110.0,77.07061004638672,77.07061004638672,75.69656372070312,76.70801544189453,69.21607971191406,MRK,Sorrento CEO Henry Ji on How the Company Got Its Start ||| Covid-19 Treatment Approval To Drive Eli Lilly Stock Higher?,1,0.5066879
2020-11-20,8415440.0,76.78434753417969,77.10877990722656,76.0782470703125,76.76526641845703,69.26773834228516,MRK,"Dow Movers: BA, IBM ||| Warren Buffett Just Bought These Stocks",0,0.48305082
2020-11-23,9498548.0,76.91793823242188,77.4427490234375,75.74427795410156,76.6030502319336,69.1213607788086,MRK,"Better Coronavirus Stock: Moderna or Novavax? ||| Can the Moderna and BioNTech Bulls Keep Running? ||| With 2 Effective Coronavirus Vaccine Candidates, How Should Investors Proceed? ||| US STOCKS-Wall St set to rise as vaccine progress fuels recovery hopes ||| Add Up The Pieces: XLG Could Be Worth $297 ||| Merck To Buy OncoImmune; Submits Applications For 15-valent Pneumococcal Conjugate Vaccine ||| Better Buy: Gilead Sciences vs. Pfizer",0,0.5363106
2020-11-24,12790840.0,76.35496520996094,77.18511199951172,76.02098846435547,76.46946716308594,69.0008316040039,MRK,"QUAL, BKNG, ITW, MRK: Large Inflows Detected at ETF ||| AZN's COVID Shot 70% Effective On Average, ARQT Aces Scalp Psoriasis Study, BLRX' BLAST Fizzles",0,0.5091869
2020-11-25,6023590.0,76.46946716308594,76.77481079101562,75.9542007446289,76.39312744140625,68.93194580078125,MRK,"Noteworthy Wednesday Option Activity: MRK, ISRG, DOW",0,0.51641786
2020-11-27,5644528.0,76.62213897705078,76.98473358154297,75.91603088378906,76.2022933959961,68.75975036621094,MRK,"Why Moderna Is Less Risky Than You Think ||| 3 Cheap Stocks to Buy Before the Economy Makes a Full Recovery ||| Ten COVID-19 vaccines seen by mid-year, head of global pharma group says",1,0.4898691
2020-11-30,14501910.0,76.33587646484375,76.85114288330078,75.77290344238281,76.70801544189453,69.21607971191406,MRK,Where Will Pfizer Be in 5 Years?,1,0.48850235
2020-12-02,7165805.0,78.18701934814453,78.95037841796875,77.5667953491211,78.08206176757812,70.45591735839844,MRK,Merck Sells Direct Holding In Moderna - Quick Facts ||| Drugmaker Merck divests investment in Moderna ||| Should You Buy Bristol Myers Squibb Stock At $63? ||| Despite A 65% Rally AbbVie Stock Looks Like It Can Gain More,0,0.4973541
2020-12-03,7085109.0,78.18701934814453,78.21565246582031,77.11832427978516,77.71946716308594,70.12874603271484,MRK,85 Million & Climbing: Why Pets = Profits for These 6 Companies ||| Merck Just Sold Off Its Moderna Shares for a Huge Gain. Should You?,1,0.49377558
2020-12-04,8651554.0,77.42366027832031,78.20610809326172,77.39503479003906,78.18701934814453,70.5506362915039,MRK,Here's Why Pfizer Stock Looks Inviting At $39 Levels ||| What's Happening With Merck Stock? ||| 9 Best Stocks to Buy for the Santa Claus Rally ||| Should You Sell Your Moderna Stock Now?,1,0.47677374
2020-12-07,8829190.0,78.30152893066406,79.6469497680664,78.29198455810547,78.73091888427734,71.04141998291016,MRK,Here's Why Biotech Deals Are All the Rage Right Now,1,0.49954608
2020-12-08,8664969.0,78.52098846435547,79.90457916259766,78.49236297607422,79.37023162841797,71.61829376220703,MRK,Buy Pfizer Stock Or JNJ For Vaccine Run? ||| Should You Buy Amgen Stock At $225? ||| Covid Tests And New Drugs To Drive Roche's Stock Growth,1,0.48733672
2020-12-10,7349205.0,79.8282470703125,80.09542083740234,78.9312973022461,79.18893432617188,71.45469665527344,MRK,"USMV, TMUS, MRK, NEM: ETF Outflow Alert ||| Ex-Dividend Reminder: Merck, Owens & Minor and CONMED ||| The Only Warren Buffett Stock Worth Buying",0,0.4669005
2020-12-11,7979158.0,79.05534362792969,79.59923553466797,78.7404556274414,79.1603012084961,71.4288558959961,MRK,"Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for December 14, 2020 ||| Merck Reports Positive CHMP Opinion For KEYTRUDA - Quick Facts",0,0.46595764
2020-12-14,13139300.0,78.84542083740234,79.27481079101562,76.3740463256836,76.64122009277344,69.70193481445312,MRK,Why Did This Big Investor Sell Its Moderna Stock? ||| Where Will Moderna Be in 5 Years? ||| 3 Top Pharma Stocks to Buy Now ||| Here's Why Merck Made a Mistake by Selling Its Moderna Stake,1,0.47863668
2020-12-16,9487649.0,76.6030502319336,77.05152893066406,76.00190734863281,76.17366027832031,69.27670288085938,MRK,"4 Dividend Stocks That Will Refill Your Wallet After Holiday Spending ||| Health Care Sector Update for 12/16/2020: SCPS,AEMD,MRK,TLRY,APHA,TLRY.TO,APHA.TO,PEN ||| Health Care Sector Update for 12/16/2020: AEMD,MRK,TLRY,APHA,TLRY.TO,APHA.TO,PEN ||| What's Happening With Roche's Stock? ||| Merck : Keytruda Plus Lenvima Meets Primary Goal In Phase 3 Trial On Advanced Endometrial Cancer",0,0.48593545
2020-12-17,11710038.0,76.70801544189453,76.87023162841797,76.03053283691406,76.16412353515625,69.26802825927734,MRK,Merck Wins FDA Keytruda Priority Review For Gastrointestinal Cancer ||| Merck: FDA Grants Priority Review To SBLA For Keytruda Plus Chemotherapy,0,0.53348124
2020-12-21,11140764.0,75.19084167480469,75.69656372070312,74.17938995361328,75.65839385986328,68.80809020996094,MRK,3 Things to Expect From Berkshire Hathaway in 2021,1,0.5407303
2020-12-22,9052414.0,75.37213897705078,76.32633972167969,74.65648651123047,75.78244018554688,68.92090606689453,MRK,5 Rational Biotech Stocks to Buy ||| The 7 Worst Dow Jones Stocks of 2020 ||| Dow Analyst Moves: MRK ||| Vertex Pharmaceuticals Enters New Partnership With RNA Expert Skyhawk Therapeutics ||| iShares Core S&P U.S. Growth ETF Experiences Big Inflow,1,0.523671
2020-12-23,6056078.0,75.94465637207031,76.74618530273438,75.92557525634766,76.10687255859375,69.21595001220703,MRK,"US STOCKS-S&P, Dow rise as weekly jobless claims dip; Nasdaq retreats ||| US STOCKS-Wall Street ends higher as investors bet on recovery ||| US STOCKS-Wall Street gains on recovery bets ||| Why Pfizer Stock Deserves a Spot In Your Portfolio ||| Better Buy: Veeva Systems vs. Zendesk ||| Merck Signs Supply Agreement with U.S. Government for Experimental COVID Treatment; Deal Worth $356M ||| Merck signs $356 mln U.S. supply deal for its experimental COVID-19 treatment ||| Merck Collaborates With U.S. Government To Advance Investigational Biological Therapy For COVID-19 ||| US STOCKS-Nasdaq lags S&P, Dow as big tech weighs",1,0.4701465
2020-12-24,2957456.0,76.33587646484375,76.74618530273438,76.21183013916016,76.46946716308594,69.54572296142578,MRK,How The Pieces Add Up: CURE Targets $80,1,0.5025243
2020-12-28,4804242.0,76.95610809326172,77.42366027832031,76.45992279052734,76.76526641845703,69.81473541259766,MRK,"Pfizer's Pipeline Candidate That Could Be a Bigger Winner Than Its COVID Vaccine ||| Merck and AstraZeneca's Cancer Drug Wins 3 New Approvals in Japan ||| AstraZeneca, Merck’s Lynparza Wins Approval in Japan For Advanced Cancers ||| Health Care Sector Update for 12/28/2020: MYOV, PFE, AZN, MRK, TLC, VHT, IYH, IBB ||| AstraZeneca : Japan Approves Lynparza To Treat Three Types Of Advanced Cancer ||| As Vaccine Excitement Fades, Buy the Pullback in Pfizer",1,0.5169421
2020-12-29,5708037.0,77.09923553466797,77.8530502319336,77.06106567382812,77.69084167480469,70.65650939941406,MRK,"Notable Tuesday Option Activity: MDLZ, MRK, SWKS ||| As the Sun Sets on 2020, These 5 Stocks Are My Highest-Conviction Holdings",0,0.4719399
2020-12-30,5933357.0,77.91984558105469,77.98664093017578,76.85114288330078,76.89885711669922,69.93623352050781,MRK,Should Investors Be Watching These Top Biotech Stocks Next Week? 3 To Consider,1,0.48386654
2020-12-31,5511118.0,76.94656372070312,78.18701934814453,76.69847106933594,78.05343627929688,70.98628234863281,MRK,6 Cannabis Stocks to Buy as the U.S. Softens Its Stance ||| These Were the 5 Top Genetics Stocks of 2020,0,0.4944944
2021-01-05,10956526.0,76.97518920898438,77.6717529296875,76.25,77.385498046875,70.37882232666016,MRK,"Dow Movers: MRK, BA ||| Got $1,000? These 2 Top Stocks Can Make You Rich ||| Meet the 2021 Dogs of the Dow",1,0.4854069
2021-01-06,10521396.0,76.88931274414062,78.95037841796875,76.63167572021484,78.60687255859375,71.48961639404297,MRK,3 Big Potential Catalysts for Moderna in 2021,1,0.54441243
2021-01-07,10447931.0,78.76908111572266,80.50572204589844,78.31106567382812,80.1717529296875,72.91279602050781,MRK,"The Dogs of the Dow Didn't Hunt in 2020, and 2021 Isn't Looking Much Better ||| 2 Value Stocks to Buy With Your $600 Stimulus Check That Can Make You Rich ||| Merck Acquires AmpTec - Quick Facts",0,0.48223338
2021-01-08,9563105.0,80.50572204589844,80.50572204589844,78.76908111572266,79.22709655761719,72.05367279052734,MRK,"Notable ETF Inflow Detected - XLV, JNJ, PFE, MRK",1,0.50414205
2021-01-11,13488179.0,79.67557525634766,81.67938995361328,79.43701934814453,81.10687255859375,73.76325225830078,MRK,"9 Dow Stocks With the Most Upside Potential, According to Wall Street",0,0.5119926
2021-01-12,10128606.0,81.22137451171875,81.2404556274414,78.76908111572266,79.28434753417969,72.1057357788086,MRK,"Novartis, once wary of Chinese M&A, dives into BeiGene's cancer immunotherapy ||| Even In This Market, There Are Better Choices Than Pfizer Stock ||| 3 Coronavirus Stocks to Stay Miles Away From in 2021 ||| Novartis, once wary of Chinese M&A, dives into BeiGene's cancer immunotherapy ||| Merck : FDA Accepts For Priority Review BLA For Adult Invasive Pneumococcal Vaccine",0,0.49711144
2021-01-19,8467316.0,79.74236297607422,80.0572509765625,78.8740463256836,79.37976837158203,72.19253540039062,MRK,"VOO, ADBE, CRM, MRK: Large Outflows Detected at ETF ||| U.S. Supreme Court rebuffs Merck appeal in hepatitis C patent fight with Gilead",0,0.52310276
2021-01-20,11097901.0,79.43701934814453,79.72328186035156,78.50190734863281,78.6832046508789,71.55902862548828,MRK,The 7 Best Healthcare Stocks to Buy for 2021 ||| Merck : FDA Approves Soluble Guanylate Cyclase Stimulator Verquvo To Treat Heart Failure,0,0.52351743
2021-01-21,9043716.0,78.06298065185547,78.53053283691406,77.25190734863281,77.46183013916016,70.4482421875,MRK,"Dow Movers: CVX, TRV",0,0.5113088
2021-01-25,9957677.0,77.01335906982422,77.47137451171875,76.39312744140625,77.4332046508789,70.42221069335938,MRK,"Why Moderna's COVID Vaccine Is Just the Tip of the Iceberg ||| Drone company Wingcopter gets more firepower in vaccine delivery race ||| US STOCKS-Nasdaq rally cools as stimulus concerns resurface ||| Judge orders Merck documents on anti-baldness drug Propecia unsealed ||| Merck Gives Up on Coronavirus Vaccines ||| Japan stocks slip on vaccine worries, profit-taking ahead of earnings ||| US STOCKS-Stimulus jitters dent Wall St's early gains; Nasdaq hits record ||| TREASURIES-U.S. yields tumble, curve flattens on nagging virus worries ||| Merck ends COVID vaccine program, cites inferior immune responses ||| US STOCKS-Stimulus jitters dent Wall St's early gains; Nasdaq, S&P at records ||| Merck Stops Covid-19 Vaccine Program Due To Disappointing Data ||| Health Care Sector Update for 01/25/2021: AUPH, PHG, MRK, IBB, XLV ||| US STOCKS-Nasdaq scales new high ahead of big-tech earnings; cyclicals lag ||| US STOCKS-Nasdaq futures jump, hopes grow for stimulus ||| Merck To Discontinue Development Of SARS-CoV-2 Vaccine Candidates Based On Phase 1 Study Findings ||| TREASURIES-U.S. 10-year yield skids to three-week low on nagging virus woes",0,0.4970514
2021-01-26,7748283.0,77.4332046508789,77.4332046508789,76.45992279052734,76.57442474365234,69.64118194580078,MRK,"Should You Buy Johnson & Johnson Stock At $160? ||| Merck Presents Interim Data From Phase 2a Trial Of Treatment For Pre-exposure Prophylaxis ||| Merck: European Commission Approves KEYTRUDA For Treatment Of MSI-H Or DMMR Colorectal Cancer ||| Johnson & Johnson promises vaccine data ""soon"" ||| AZN Rejects Media Reports, MRK Quits COVID-19 Vaccine Work, MRNA Sets Eyes On New SARS-CoV-2 Strains ||| Japan shares end lower on vaccine delay, caution ahead of earnings season",0,0.5073072
2021-01-27,16230376.0,76.2022933959961,76.40267181396484,73.32061004638672,73.54007720947266,66.88158416748047,MRK,"Noteworthy ETF Inflows: XLV, JNJ, MRK, PFE ||| Relative Strength Alert For Merck ||| Daily Dividend Report: WFC,MRK,FTV,NSC,WMB",1,0.49737328
2021-01-28,12972039.0,73.54962158203125,74.91412353515625,73.54007720947266,74.35114288330078,67.61920166015625,MRK,Here's Why Amazon Will Never Be a Dow Jones Industrials Stock,0,0.49108332
2021-01-29,10671470.0,74.41793823242188,74.78053283691406,72.89122009277344,73.54007720947266,66.88158416748047,MRK,"Without a Vaccine, Is Merck Still a Hot COVID Stock?",1,0.52255017
2021-02-01,8224599.0,74.41793823242188,74.74236297607422,73.7977066040039,73.8167953491211,67.13323974609375,MRK,Merck Gets Positive EU CHMP Opinion For Expanded Approval Of Keytruda,1,0.534166
2021-02-03,10034810.0,74.08396911621094,74.57061004638672,73.61640930175781,73.77862548828125,67.0985336303711,MRK,"What To Expect From Bristol Myers Squibb's Q4? ||| Pre-Market Earnings Report for February 4, 2021 : MRK, BMY, PM, CI, BDX, APD, BAX, BCE, CMI, PH, ALXN, YUM ||| EXCLUSIVE-Merck anti-baldness drug Propecia has long trail of suicide reports, records show ||| 2 Growth Stocks for In-the-Know Investors",0,0.48592046
2021-02-04,18867563.0,73.44465637207031,73.48282623291016,72.08015441894531,72.5477066040039,65.97904205322266,MRK,"Dow Movers: MRK, AXP ||| Health Care Sector Update for 02/04/2021: MRK ||| Merck CEO Kenneth Frazier Stepping Down ||| What's Behind Merck's Disappointing Q4 Results? ||| Notable Thursday Option Activity: MCD, APD, MRK ||| Merck Issues FY21 Outlook; Elects Robert Davis As CEO ||| Merck CEO Kenneth Frazier to retire at the end of June ||| Merck's Kenneth Frazier to step down as CEO ||| 1 Major Problem for the Healthcare Industry ||| Can This Maverick Biotech Become the Frontrunner in the Fight Against Alzheimer's? ||| Merck Names Robert Davis CEO Effective July 1; Kenneth Frazier To Continue As Exe. Chairman",0,0.495904
2021-02-05,13901825.0,72.92938995361328,73.4542007446289,71.95610809326172,72.3282470703125,65.77946472167969,MRK,"Is Johnson & Johnson a Great Dividend Stock? ||| JNJ Single-shot COVID-19 Vaccine At FDA Altar, KPTI Expands Xpovio's Footprint, OTLK On Track ||| Merck & Co. (MRK) Q4 2020 Earnings Call Transcript",0,0.49328017
2021-02-08,16718534.0,72.3759536743164,72.70037841796875,71.2404556274414,71.6030502319336,65.11993408203125,MRK,3 Under-the-Radar Biotech Stocks to Buy After Dull Earnings Reactions,0,0.5196145
2021-02-09,13484616.0,71.6603012084961,71.72709655761719,70.9542007446289,71.6030502319336,65.11993408203125,MRK,Forget Gamestop! This Highly Shorted Stock Is a Strong Buy Now,0,0.49245003
2021-02-10,11721566.0,71.87023162841797,71.92748260498047,71.1259536743164,71.45992279052734,64.98975372314453,MRK,"Merck in talks with govts, other drugmakers to produce COVID-19 shots ||| Merck in talks to possibly produce COVID-19 shots - WSJ",0,0.49725053
2021-02-11,8780982.0,71.38359069824219,71.6603012084961,70.83015441894531,71.3167953491211,64.85958862304688,MRK,AC Immune's shares surge on early data from Alzheimer's vaccine,1,0.5342415
2021-02-12,6738116.0,71.2977066040039,71.66984558105469,71.1259536743164,71.56488800048828,65.08522033691406,MRK,The Stock Market's Laggards Will Bounce Back -- but When? ||| 8 Growing Dividend Payers (up to 8.2%) You Can Sit on for Decades ||| Here's Why Merck Is A Better Pick Over Johnson & Johnson Stock,0,0.48036
2021-02-17,13876463.0,71.04962158203125,72.57633972167969,70.96373748779297,72.08015441894531,65.55384063720703,MRK,"Nektar Collaborates With SFJ Pharma For Bempegaldesleukin In Head And Neck Cancer ||| Health Care Sector Update for 02/17/2021: VIR,GSK,NKTR,MRK,VRCA,KOD ||| Notable Wednesday Option Activity: VLO, MRK, PAYC ||| Here's What Caused Royalty Pharma's Mixed Results in Q4 ||| NKTR Teams Up With MRK, Pfizer Initiates Multiple Myeloma Trial, PCSA On Watch ||| 3 Dividend Stocks That Are Perfect for Retirement ||| 2 Top Stocks to Buy for a Post-Pandemic World ||| Stock Alert: Nektar Therapeutics Up 13% On Collaboration With Merck ||| AstraZeneca: IDMC Recommends Primary Analysis For OlympiA Phase III Trial",0,0.4846864
2021-02-18,10004627.0,71.82251739501953,72.40457916259766,71.6030502319336,71.95610809326172,65.44100952148438,MRK,October 15th Options Now Available For Merck (MRK) ||| Fund backed by 20 drugmakers raises $140 mln to save antibiotic pipeline ||| Here Are All 10 Stocks Warren Buffett Has Been Buying,0,0.48073027
2021-02-22,8612464.0,71.08778381347656,71.62213897705078,70.3530502319336,71.49809265136719,65.02445983886719,MRK,Did Merck Make a Mistake With a Key FDA Filing?,0,0.53269273
2021-02-24,9838834.0,71.3740463256836,71.82251739501953,70.98282623291016,71.15457916259766,64.71207427978516,MRK,There's More to Merck's New 'Bean Counter' CEO Than First Appears ||| How to Invest Like Warren Buffett in 2021,1,0.49904352
2021-02-25,10906955.0,70.81106567382812,71.56488800048828,70.68701934814453,71.2022933959961,64.75546264648438,MRK,"Health Care Sector Update for 02/25/2021: GBT,AGIO,PAND,MRK ||| Merck says FDA requires more data on its COVID-19 drug ||| Why Pandion Therapeutics Stock Blasted Sky-High on Thursday ||| Merck says FDA requires more data on its COVID-19 drug ||| Health Care Sector Update for 02/25/2021: MRNA,GBT,AGIO,PAND,MRK ||| Merck to buy drug developer Pandion Therapeutics for $1.85 bln ||| Merck to buy drug developer Pandion Therapeutics for $1.85 bln ||| Merck To Acquire Pandion Therapeutics - Quick Facts ||| PAND Stock: Why Pandion Therapeutics Shares Have Skyrocketed Today ||| Health Care Sector Update for 02/25/2021: PAND, MRK, MRNA, PGNY, XLV, IBB",0,0.49598587
2021-02-26,17644862.0,71.03053283691406,71.28816986083984,69.21755981445312,69.29389190673828,63.01984786987305,MRK,"Are These The Top Biotech Stocks To Buy In March? 4 Names To Consider ||| Buy This Blue Chip on the Dip ||| Nektar Posts Better-Than-Feared Quarterly Loss, Misses On Revenues ||| Merck Inks Deal To Buy Pandion Therapeutics For $1.85B; Shares Skyrocket",0,0.52115697
2021-03-01,12594864.0,69.85687255859375,70.02862548828125,68.8740463256836,69.06488800048828,62.81159210205078,MRK,Merck: FDA To Review NDA For Gefapixant - Quick Facts ||| Merck agrees $1 bln deal with Debiopharm for head and neck cancer drug,1,0.5236138
2021-03-02,16047290.0,69.50381469726562,70.1240463256836,69.08396911621094,69.51335906982422,63.21945190429688,MRK,Merck to help make Johnson & Johnson's vaccine - Washington Post ||| White House using Defense Production Act to equip Merck plants for J&J vaccine ||| Merck to help make Johnson & Johnson's vaccine - Washington Post ||| Where Will Pfizer Be in 1 Year?,1,0.47509316
2021-03-03,13939972.0,69.48473358154297,70.3530502319336,69.1030502319336,69.9427490234375,63.609962463378906,MRK,Why Moderna Stock Is Sinking Again Today ||| COVID-19 safety measures still essential even as U.S. boosts vaccine supply -White House ||| U.S. will invest $100 million to help J&J and Merck vaccine partnership ||| AstraZeneca Just Sold Its Moderna Stock: Should You?,0,0.5100074
2021-03-05,12241164.0,69.18893432617188,70.0477066040039,68.71183013916016,69.78053283691406,63.46242904663086,MRK,Why Pfizer Is Still a Top Stock for 2021 ||| Indian vaccine giant SII warns of supply hit from U.S. raw materials export ban,1,0.4760441
2021-03-08,15391347.0,70.96373748779297,72.09923553466797,70.03816986083984,70.77290344238281,64.36493682861328,MRK,"Merck says study shows COVID-19 drug causes quick reduction in virus ||| For fuboTV Stock, What's the Winning Edge? ||| Dow Analyst Moves: MRK ||| Are These The Top Health Care Stocks To Watch Right Now? ||| COVID SCIENCE-Vaccine response may be weaker in elderly; Merck drug shows promise in reducing virus level",0,0.4888308
2021-03-09,14189920.0,71.14503479003906,72.00381469726562,70.73473358154297,70.74427795410156,64.33891296386719,MRK,"Beyond COVID, Regeneron Is Betting Big on Oncology",1,0.51776934
2021-03-10,12827310.0,71.33587646484375,71.78434753417969,70.70610809326172,71.33587646484375,64.87693786621094,MRK,"Notable ETF Outflow Detected - XLV, PFE, MRK, MDT ||| Idorsia insomnia drug starts FDA review as founder Clozel's second act proceeds",0,0.516495
2021-03-11,13205324.0,71.45992279052734,71.90839385986328,71.17366027832031,71.21183013916016,64.76412200927734,MRK,"This Underperforming Biotech Is Ready to Beat the Market ||| Biden to urge vigilance and offer hope on anniversary of lockdown ||| Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for March 12, 2021 ||| U.S. curbs on raw material exports could dent new Quad alliance's vaccine push ||| Biden to urge vigilance and offer hope on anniversary of lockdown ||| EXPLAINER-Activists, drug groups in waiver war over COVID-19 shot patents",0,0.4651927
2021-03-12,11493940.0,70.63931274414062,71.45992279052734,70.60114288330078,71.1832046508789,65.306884765625,MRK,"Merck in talks for jumbo debt for spin-off ||| 4 Dow Stocks With 24% to 31% Upside, According to Wall Street ||| Here's Why Roche Looks Undervalued At $41",1,0.47480696
2021-03-15,17999295.0,72.04198455810547,73.05343627929688,71.64122009277344,72.7385482788086,66.73384094238281,MRK,"Was AstraZeneca Smart to Sell Its Moderna Shares? ||| Takeda, IDT to manufacture doses of Johnson & Johnson COVID-19 vaccine ||| EXCLUSIVE-Mexico focuses vaccine loan request on U.S. stockpile of AstraZeneca doses ||| Gilead, Merck collaborate to develop HIV treatment - WSJ ||| Gilead And Merck Agree To Joint Development Of Long-acting Treatments In HIV",1,0.49947008
2021-03-16,15697887.0,72.66221618652344,73.635498046875,72.65267181396484,73.29198455810547,67.24159240722656,MRK,Merck: FDA Grants Priority Review For NDA For Belzutifan - Quick Facts,1,0.51864105
2021-03-17,17533878.0,73.21565246582031,73.95037841796875,72.4904556274414,73.7595443725586,67.67054748535156,MRK,"Germany's Merck in fresh investment to make bioreactor gear in France ||| Merck Names Frank Clyburn President, Human Health - Quick Facts ||| Merck: European Commission Approves Expanded Indication For KEYTRUDA - Quick Facts ||| 4 Pharma Stocks That Could Be Losers With the $1.9 Trillion Stimulus Package",0,0.5062778
2021-03-18,14274179.0,73.72137451171875,74.60877990722656,73.67366027832031,73.73091888427734,67.64429473876953,MRK,There's Always Room for This Blue Chip in Your Portfolio,1,0.5261726
2021-03-19,58225203.0,73.71183013916016,74.66603088378906,72.53816986083984,73.95992279052734,67.85440063476562,MRK,iShares Core S&P 500 ETF Experiences Big Inflow ||| Teladoc (TDOC) Vs Clover Health (CLOV): Which Health Care Stock Is A Better Buy?,0,0.48706985
2021-03-22,11352879.0,72.3282470703125,74.42748260498047,72.08015441894531,73.95992279052734,67.85440063476562,MRK,"The 3 Most Fascinating Stocks to Buy Now ||| Health Care Sector Update for 03/22/2021: VCYT,MRK,DYAI,ACER,ODT ||| EU regulator advises against use of Merck's anti-parasite drug for COVID-19 ||| Is It Too Late to Buy Zymeworks Stock? ||| EU regulator warns against use of Merck's anti-parasite drug for COVID-19",0,0.49191684
2021-03-23,11651245.0,73.55915832519531,73.77862548828125,72.5477066040039,72.77671813964844,66.76885986328125,MRK,"Merck: FDA Approves KEYTRUDA With Chemotherapy For First-Line Treatment Of Esophageal, GEJ Carcinoma ||| Can Eli Lilly Stock Rebound After A 10% Drop Over Alzheimer's Drug?",0,0.5182616
2021-03-24,9135416.0,72.58587646484375,73.16793823242188,72.4332046508789,72.74809265136719,66.74259948730469,MRK,Fauci: AstraZeneca likely to release new statement on its COVID-19 vaccine ||| Fauci: AstraZeneca likely to release new statement on its COVID-19 vaccine ||| Merck names Caroline Litchfield as new CFO ||| Merck Names Caroline Litchfield CFO - Quick Facts,0,0.4980157
2021-03-25,10700918.0,72.91984558105469,73.10114288330078,71.86068725585938,72.58587646484375,66.59378051757812,MRK,How Gilead's and Merck's Surprise Partnership Will Shake Up the HIV Market,1,0.5385295
2021-03-29,11448562.0,73.77862548828125,74.9522933959961,73.635498046875,74.71373748779297,68.54597473144531,MRK,"Biotech Stocks Facing FDA Decision In April 2021 ||| IVV, KO, CRM, MRK: ETF Outflow Alert",0,0.50316
2021-03-30,10123366.0,74.42748260498047,74.50381469726562,73.27290344238281,73.43511199951172,67.3729019165039,MRK,Organon To Acquire Alydia Health For Up To $240 Mln ||| Merck: CHMP Adopts Positive Opinion For Updated Label Of KEYTRUDA To Include Data From KEYNOTE-361 ||| Could Merck's New Antiviral Be the Next Big COVID Treatment? ||| Here's Why Bristol Myers Squibb Stock Is Undervalued At $63,1,0.51560265
2021-03-31,13598219.0,73.5687026977539,74.13167572021484,73.12976837158203,73.55915832519531,67.48670196533203,MRK,'Companies need to take a stand': Black executives urge fight on voting limits ||| Should You Buy Bristol Myers Squibb Stock At $63?,0,0.49894434
2021-04-01,9121373.0,73.6259536743164,73.91221618652344,73.30152893066406,73.55915832519531,67.48670196533203,MRK,Merck Completes Acquisition Of Pandion - Quick Facts,0,0.521539
2021-04-05,9828144.0,73.96946716308594,74.34160614013672,73.26335906982422,73.47328186035156,67.40791320800781,MRK,The 7 Best Blue-Chip Stocks in the Dow Jones ||| This 2020 Biotech IPO Is Poised to Break Out in 2021 ||| 3 Dependable Dividend Stocks to Buy in April ||| The 3 Best Dow Stocks to Buy for the Second Quarter (and Beyond) ||| How the Infrastructure Bill Will Raise Taxes on 3 Big Pharma Stocks,0,0.50230074
2021-04-07,8970566.0,72.59542083740234,72.90076446533203,72.25190734863281,72.63359069824219,66.63755798339844,MRK,"ANALYSIS-White House, U.S. companies could agree on 25% tax rate, officials, business groups say",0,0.5085532
2021-04-08,12007984.0,72.59542083740234,72.90076446533203,71.83206176757812,72.03244018554688,66.08602142333984,MRK,"Why Immutep Limited Stock Popped Today ||| Notable ETF Inflow Detected - DGRO, VZ, JPM, MRK ||| May 28th Options Now Available For Merck (MRK) ||| Merck Says Phase 3 KEYNOTE-564 Trial Evaluating KEYTRUDA Met Primary Endpoint - Quick Facts ||| Is Gilead Sciences Stock a Buy?",1,0.48908734
2021-04-09,8177439.0,72.05152893066406,72.88167572021484,71.97518920898438,72.81488800048828,66.80387115478516,MRK,COVID SCIENCE-Moderna vaccine antibodies last at least 6 months; lung transplant can save some COVID-19 survivors,0,0.49498647
2021-04-12,9970672.0,72.87213897705078,73.09160614013672,72.5,72.72901153564453,66.72508239746094,MRK,"Corporate leaders plan new push on U.S. voting rights, will reconsider campaign donations",1,0.50962794
2021-04-13,8627346.0,72.4904556274414,73.24427795410156,72.39503479003906,72.92938995361328,66.90894317626953,MRK,"Interesting MRK Put And Call Options For November 19th ||| Why Amarin Stock Is Sinking Today ||| 2 Stocks That Are Perfect to Buy Now and Hold Until Retirement ||| 5 Value Stocks With 26% to 50% Upside, According to Wall Street",0,0.48959604
2021-04-14,8415545.0,72.80534362792969,73.27290344238281,72.53816986083984,72.90076446533203,66.88265991210938,MRK,Moderna discusses COVID-19 vaccine manufacturing with Nexus Pharmaceuticals -sources ||| More than 100 companies sign letter opposing U.S. state voting restrictions ||| Follow Warren Buffett Into These 3 Pharma Companies,1,0.51071
2021-04-15,14541734.0,72.5667953491211,73.78816986083984,72.5667953491211,73.14885711669922,67.11027526855469,MRK,"Merck, Ridgeback Biotherapeutics Update Covid Drug Development Program ||| Merck To Discontinue Development Of COVID-19 Drug 'MK-7110' ||| Merck plans large outpatient trial of COVID-19 pill, stops study in hospitalized patients ||| 3 Top Healthcare Stocks to Buy Right Now",1,0.5156019
2021-04-19,8536903.0,74.14122009277344,74.22709655761719,73.44465637207031,74.1030502319336,67.9857177734375,MRK,Covid-19 Antiviral Oral Drug Found Effective In Hamster Study ||| What's Next For Roche's Stock?,1,0.5114948
2021-04-20,11009345.0,74.12213897705078,75.51526641845703,74.12213897705078,74.97137451171875,68.78233337402344,MRK,Can Johnson & Johnson Stock Rise Post Q1 Results?,1,0.51697046
2021-04-21,11817248.0,75.31488800048828,75.84923553466797,75.0667953491211,75.60114288330078,69.36013793945312,MRK,"After Hours Most Active for Apr 21, 2021 : DISCK, IQ, VIAC, WFC, MRVL, V, CMCSA, KO, QQQ, NRZ, MRK, T",0,0.47368127
2021-04-22,13330560.0,75.38167572021484,75.43893432617188,74.00763702392578,74.38931274414062,68.24832916259766,MRK,Alibaba Stock Is Spring-Loaded After an Unimpressive Start to 2021,0,0.5127164
2021-04-26,7834219.0,74.29389190673828,74.34160614013672,73.7595443725586,73.97901153564453,67.87189483642578,MRK,"Down Nearly 50% From All-Time Highs, Is This Pharma Giant a Good Buy? ||| Merck Aims To Achieve Carbon Neutrality Across Operations By 2025 ||| 3 Top Blue-Chip Healthcare Stocks With Healthy Dividends ||| 7 Healthcare Stocks for a Reopening World",0,0.50699633
2021-04-27,9095802.0,73.8740463256836,74.37023162841797,73.6832046508789,73.8167953491211,67.72307586669922,MRK,"Merck To License COVID-19 Treatment Molnupiravir To Five Indian Generics Makers ||| Merck taps five Indian drugmakers to expand COVID-19 drug production ||| Merck taps 5 Indian drugmakers to expand COVID-19 drug production ||| This Pharma Giant Lost the Vaccine Race, But Its COVID-19 Journey May Not Be Over",0,0.50707984
2021-04-28,11628398.0,74.05534362792969,74.45610809326172,73.3396987915039,73.55915832519531,67.48670196533203,MRK,"Pre-Market Earnings Report for April 29, 2021 : MA, CMCSA, MRK, TMO, MCD, BMY, CAT, AMT, SPGI, MO, SO, NOC ||| iShares Core Dividend Growth ETF Experiences Big Inflow",0,0.48193523
2021-04-29,30602753.0,72.04198455810547,72.27098846435547,69.51335906982422,70.30534362792969,64.50150299072266,MRK,"Noteworthy Thursday Option Activity: BKNG, MRK, DISH ||| US STOCKS-Facebook lifts S&P 500 to record high ||| US STOCKS-S&P 500 near record high on Facebook boost, Nasdaq eases ||| What's Behind Merck's Q1 Earnings Miss ||| Why Merck Stock Dropped Today ||| Facebook fuels S&P 500 to record high close ||| US STOCKS-Facebook fuels S&P 500 to record high close ||| US STOCKS-Apple, Facebook set to boost Wall Street after strong earnings ||| US STOCKS-Apple, Facebook drive Nasdaq futures higher as earnings roll in ||| Merck & Co Q1 21 Earnings Conference Call At 8:00 AM ET ||| Merck Q1 Adj. Profit Declines ||| US STOCKS-S&P 500, Nasdaq hit record highs on tech earnings boost, upbeat data ||| Dow Movers: MRK, CVX ||| Health Care Sector Update for 04/29/2021: MRK, BMY, NVCR, XLV, IBB",1,0.48492876
2021-04-30,18052114.0,70.20992279052734,71.64122009277344,70.114501953125,71.08778381347656,65.21934509277344,MRK,"Dow Movers: V, MRK ||| Merck Reports Disappointing 1Q Results; Street Maintains A Strong Buy ||| The Math Shows FCTR Can Go To $37",1,0.49388704
2021-05-03,12543302.0,70.85877990722656,72.53816986083984,70.82061004638672,72.5,66.5149917602539,MRK,Better Buy for 2021: AbbVie or Merck? ||| 2 Top Stocks for 2021 and Beyond ||| Merck: Spinoff Organon Expected To Drive Sustainable Growth ||| Bristol Myers Squibb's Latest Data Could Help the Pharma Leapfrog Rival Merck ||| Congo declares end of Ebola outbreak that killed six,1,0.5135815
2021-05-04,10418587.0,72.59542083740234,72.96755981445312,72.07061004638672,72.5095443725586,66.52375030517578,MRK,German labs supplier Merck raises forecast on strong Q1 ||| Mind Medicine Stock Is Soaring After Its NASDAQ Debut. What's Next?,1,0.4868612
2021-05-05,16795143.0,72.614501953125,74.16984558105469,72.27098846435547,74.14122009277344,68.02072143554688,MRK,3 Value Stocks That'll Make You Richer in May (and Beyond),1,0.522449
2021-05-06,12871641.0,73.89312744140625,74.29389190673828,73.17748260498047,74.21755981445312,68.09075927734375,MRK,"Notable ETF Outflow Detected - PRF, CVS, GE, MRK ||| Dow Movers: WBA, GS ||| Fusion, Merck To Evaluate Fusion's Targeted Alpha Therapy In Combination With Merck's KEYTRUDA ||| 5 Brand-Name Stocks With 27% to 50% Upside, According to Wall Street",1,0.50224006
2021-05-10,10939758.0,75.20992279052734,75.55343627929688,74.58015441894531,74.5896987915039,68.43216705322266,MRK,Should You Buy Pfizer For 25% Gains?,0,0.48614907
2021-05-12,13379711.0,74.15076446533203,74.9332046508789,73.7595443725586,74.42748260498047,68.28336334228516,MRK,Germany's Merck sees boost from labs supplies earnings,1,0.549534
2021-05-13,10830451.0,74.32251739501953,75.37213897705078,74.08396911621094,75.08587646484375,68.88739776611328,MRK,"Interesting MRK Put And Call Options For July 2nd ||| Dow Movers: MRK, BA ||| Merck Says Phase 3 KEYNOTE-522 Trial Met Dual Primary Endpoint In Patients With Breast Cancer",0,0.5019579
2021-05-14,8273122.0,75.43893432617188,75.52481079101562,74.63740539550781,74.7042007446289,68.53721618652344,MRK,2 Top Healthcare Stocks for 2021 and Beyond,1,0.5387236
2021-05-17,12532508.0,75.0667953491211,76.49809265136719,74.9904556274414,76.21183013916016,69.92039489746094,MRK,"India's Cipla says supply of COVID-19 drug remdesivir catching up with demand ||| Could Surface Oncology Be a Millionaire-Maker Stock? ||| Dow Movers: HD, MRK ||| ProShares Ultra S&P500 Experiences Big Outflow",0,0.5020248
2021-05-18,7943106.0,75.70610809326172,76.14503479003906,75.27671813964844,75.74427795410156,69.49143981933594,MRK,"After a Blowout Quarter, Is AbbVie Stock a Buy? ||| Bristol Myers to pay up to $1.38 bln to develop, sell Agenus's cancer therapy",0,0.5145085
2021-05-19,9132796.0,75.31488800048828,75.76335906982422,74.37976837158203,75.72518920898438,69.47393035888672,MRK,Roche aims Tecentriq at early lung cancer after data shows benefit,1,0.54053986
2021-05-20,7345222.0,75.31488800048828,76.32633972167969,75.28626251220703,76.0114517211914,69.73655700683594,MRK,"Energy Sector Update for 05/20/2021: GLNG, RDS.A, RDS.B, TOT, MRK, XLE, USO, UNG ||| Merck Reports Positive Results From Two Trials Of V114 Phase 3 Pediatric Clinical Program ||| Roche aims Tecentriq at early lung cancer after data shows benefit",0,0.49679714
2021-05-21,10863987.0,76.26908111572266,76.6603012084961,75.45801544189453,75.55343627929688,69.31635284423828,MRK,INSIGHT-Inside the race to find a COVID-19 treatment pill ||| INSIGHT-Inside the race to find a COVID-19 treatment pill,0,0.49837434
2021-05-24,8737910.0,75.88740539550781,76.00190734863281,75.34351348876953,75.4103012084961,69.18502807617188,MRK,Best Health Care Stocks To Buy This Week? 4 To Know ||| Here's Why Everyone's Talking About Iovance Biotherapeutics ||| 3 of Warren Buffett's Biggest Losers of 2021 That Could Still Be Long-Term Winners,0,0.47677875
2021-06-01,15798914.0,72.57633972167969,72.65267181396484,71.59351348876953,71.73664093017578,65.81464385986328,MRK,"3 Dinosaurs That Are Stealth Tech Stocks ||| These Canadian Cannabis Producers May Benefit From an Israeli Medical Innovation ||| 7 Best Stocks To Buy To Hedge Against A Potential Downturn ||| Sanofi, Merck Announce Availability Of Six-in-one Pediatric Combination Vaccine Vaxelis In The U.S.",1,0.52854025
2021-06-02,11830453.0,71.86068725585938,72.60496520996094,71.82251739501953,72.39503479003906,66.41868591308594,MRK,Merck Spinoff Organon Will Do Well Over Time,1,0.51100844
2021-06-03,15974400.0,73.22000122070312,74.0,72.9000015258789,73.91000366210938,67.80860137939453,MRK,"Dow Movers: MRK, VZ ||| Health Care Sector Update for 06/03/2021: MRK, MESO, WVE, XLV, IBB ||| Merck Spins Off Organon ||| Amgen Stock Set To Rise After Lumakras Approval ||| AstraZeneca : Late-stage Trial Shows Lynparza Reduces Recurrence, Death In Breast Cancer Patients ||| S&P 500 Movers: MKTX, GM",1,0.5270686
2021-06-04,12728500.0,74.19999694824219,74.4800033569336,73.9000015258789,74.11000061035156,67.99208068847656,MRK,"Notable ETF Inflow Detected - PWV, ORCL, MRK, COF",0,0.5124047
2021-06-07,16794400.0,74.13999938964844,74.19999694824219,72.77999877929688,72.80000305175781,66.79021453857422,MRK,Merck Releases New Data From Late-stage Study Of Clear/Keynote-51,0,0.50568503
2021-06-08,13657700.0,72.94999694824219,73.16999816894531,72.08000183105469,72.4000015258789,66.42324829101562,MRK,"Health Care Sector Update for 06/08/2021: AVXL, VCNX, MRK, RFL, XLV, IBB",1,0.48612103
2021-06-09,12258700.0,73.0,74.30000305175781,72.94999694824219,74.04000091552734,67.92784881591797,MRK,"US STOCKS-U.S. stocks end lower ahead of inflation report ||| Wall Street reverses, closing lower ahead of inflation report ||| US STOCKS-S&P 500 teases record closing high as retail frenzy churns ||| Merck Cuts a Billion-Dollar COVID Deal ||| This New Product Is Central to mRNA Vaccines -- But Should You Buy the Stock? ||| Dow Movers: JPM, MRK ||| US STOCKS-Wall Street edges higher on tech gains, 'meme' stocks rally ||| US STOCKS-Wall Street set to inch higher, 'meme' stocks extend rally ||| Up 100% in a Year, Can This Animal Health Stock Keep Climbing? ||| U.S. to buy about 1.7 mln courses of Merck's COVID-19 treatment for $1.2 bln ||| Merck Inks Deal With U.S. Government To Supply 1.7 Mln Courses Of Molnupiravir - Quick Facts",1,0.48400953
2021-06-10,17236700.0,75.2300033569336,76.47000122070312,74.73999786376953,76.13999938964844,69.85449981689453,MRK,"Dow Movers: NKE, MRK ||| 3 Dividend Stocks Wall Street Thinks Will Soar 20% or More ||| Can The Rally Continue For Eli Lilly Stock After A 10% Rise On Increased Hopes For Its Alzheimer's Drug",1,0.5088764
2021-06-11,13928400.0,76.70999908447266,76.86000061035156,75.61000061035156,76.2699966430664,69.97376251220703,MRK,"Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for June 14, 2021",0,0.44956455
2021-06-14,7841400.0,75.73999786376953,75.80000305175781,74.87999725341797,75.44999694824219,69.81644439697266,MRK,Here's Why Wall Street Is Betting Against Clovis Oncology ||| 7 Dividend Stocks Offering Juicy Yields and Short-Squeeze Potential ||| What's Next For Alnylam Stock After The Recent 22% Rise?,1,0.49428183
2021-06-15,14185700.0,75.5,75.7699966430664,74.72000122070312,75.69999694824219,70.04778289794922,MRK,Hold Merck for Its Solid Dividend and Covid-19 Treatment Prospects ||| Bristol Myers Squibb Stock Remains Undervalued After Positive Data From Clinical Trials,1,0.52094495
2021-06-16,17576900.0,76.22000122070312,77.55000305175781,76.19000244140625,76.61000061035156,70.88984680175781,MRK,"Wednesday Sector Leaders: Financial, Healthcare ||| Dow Movers: DOW, MRK",1,0.5111302
2021-06-17,14233200.0,76.33999633789062,77.47000122070312,75.98999786376953,77.2300033569336,71.46354675292969,MRK,"Bristol-Myers, Eisai in up to $3.1 bln deal to develop cancer drug candidate ||| This Biopharma Giant May Have Just Found Its Ticket To Riches In the COVID-19 Market ||| Should You Buy This Cathie Wood Biotech Stock?",0,0.49856016
2021-06-21,10880800.0,76.88999938964844,77.29000091552734,76.55000305175781,76.75,71.01939392089844,MRK,Is Pfizer Stock A Better Bet Compared To Eli Lilly? ||| Does The Valuation Gap Between Merck Stock And Zoetis Make Sense? ||| Is There More Room For Growth In Roche Stock After A 12% Rise In A Month?,0,0.49942872
2021-06-23,9539100.0,75.8499984741211,76.26000213623047,75.55000305175781,75.58000183105469,69.93675231933594,MRK,Don’t Miss the Opportunity Presented by Organon Stock,1,0.5063802
2021-06-25,50285200.0,76.05999755859375,77.97000122070312,76.05000305175781,77.19999694824219,71.43577575683594,MRK,"After Hours Most Active for Jun 25, 2021 : F, PLTR, MRK, CLF, RIG, ETRN, AAPL, LPRO, SIRI, CZR, BLDR, RUN ||| Forget Dogecoin: These Dogs of the Dow Are More Likely to Make You Rich",0,0.49355364
2021-06-28,8796200.0,77.25,77.73999786376953,76.79000091552734,76.86000061035156,71.12118530273438,MRK,Aethlon Medical’s FDA Approval a Game Changer,1,0.5183745
2021-06-29,7696600.0,77.0,77.33000183105469,76.81999969482422,77.20999908447266,71.44505310058594,MRK,"Five Indian drugmakers to jointly start local trial of Merck & Co's COVID-19 drug ||| 3 Reasons to Buy BioNTech, And 1 Reason To Sell ||| Five Indian drugmakers to jointly start trial of Merck & Co's COVID-19 drug",1,0.52857435
2021-07-02,7668000.0,78.04000091552734,78.7699966430664,77.76000213623047,78.5999984741211,72.73126220703125,MRK,What's Next For Alnylam Stock After The Recent Positive Development For Intellia?,0,0.5246296
2021-07-07,8275100.0,78.41000366210938,78.61000061035156,78.12999725341797,78.55999755859375,72.69425201416016,MRK,"Health Care Sector Update for 07/07/2021: BHVN, ONCS, MRK, XBIT, XLV, IBB",0,0.48906007
2021-07-08,8400400.0,77.7699966430664,78.30000305175781,77.30999755859375,78.12000274658203,72.28710174560547,MRK,"3 Blue-Chip Stocks to Trade Right Now ||| Danger Lurks for These 2 High-Yield Dividend Stocks ||| The Coronavirus Pill Makes Merck a Solid Buy ||| DGRO, MRK, CSCO, BMY: ETF Inflow Alert",0,0.4986611
2021-07-09,6006500.0,78.41999816894531,78.69000244140625,77.94000244140625,77.98999786376953,72.16680908203125,MRK,India's Hetero says COVID-19 drug reduces hospitalisations in late-stage trial ||| Will Teva Stock Rebound After A 10% Fall In A Month? ||| After A 10% Rise In A Month Zoetis Stock May Continue To See Higher Levels,0,0.5179796
2021-07-12,11087900.0,77.55000305175781,78.43000030517578,77.38999938964844,77.55000305175781,71.75965118408203,MRK,"Should Investors Hold Out Hope for bluebird bio and Merck Spinoff Organon? ||| Health Care Sector Update for 07/12/2021: INMD,TPST,ALEC,MRK,NEPH,CVET ||| Health Care Sector Update for 07/12/2021: TPST,ALEC,MRK,NEPH,CVET",1,0.47267732
2021-07-19,9830600.0,77.80999755859375,78.33999633789062,76.1500015258789,77.05000305175781,71.29698944091797,MRK,"2 Top Pharma Stocks to Buy Right Now ||| Noteworthy ETF Inflows: VTV, T, WMT, MRK",0,0.53518546
2021-07-21,7429300.0,76.31999969482422,76.45999908447266,75.63999938964844,76.38999938964844,70.686279296875,MRK,What To Expect From Johnson & Johnson In Q2?,1,0.5042759
2021-07-22,8708900.0,76.5999984741211,76.79000091552734,76.08000183105469,76.52999877929688,70.81581115722656,MRK,3 Top Tech Stocks to Buy During a Recession,1,0.55686826
2021-07-26,5071800.0,77.45999908447266,77.61000061035156,76.95999908447266,77.23999786376953,71.47280883789062,MRK,"Dow Jones Breaks 35,100 With Apple, Visa, Microsoft Earnings Coming",1,0.5141408
2021-07-27,8136000.0,77.16999816894531,78.12999725341797,76.73999786376953,77.8499984741211,72.03726959228516,MRK,FDA Approves Merck's KEYTRUDA To Treat High-Risk Early-Stage Triple-Negative Breast Cancer ||| Merck : Phase 3 Trial On Metastatic Triple-Negative Breast Cancer Meets Primary Endpoint ||| U.S. FDA approves Merck's Keytruda combo for early breast cancer treatment ||| Biotech Stocks Facing FDA Decision In August 2021,1,0.52427286
2021-07-28,11037900.0,77.86000061035156,78.66999816894531,77.47000122070312,78.33000183105469,72.48141479492188,MRK,"Pre-Market Earnings Report for July 29, 2021 : MA, CMCSA, MRK, AZN, AMT, SNY, SPGI, MO, SO, NOC, KDP, TRP ||| Pre-Market Earnings Report for July 29, 2021 : MA, CMCSA, MRK, AZN, AMT, SNY, SPGI, MO, SO, NOC, KDP, TRP",0,0.4591856
2021-07-29,11583000.0,77.55000305175781,77.91999816894531,76.80999755859375,76.93000030517578,71.18595886230469,MRK,"Healthcare Stock Sell-Off Keeps the Dow Jones From Reaching Record Levels ||| Health Care Sector Update for 07/29/2021: BCEL,CFX,LH,MRK ||| Technology Sector Update for 07/29/2021: CFX, LH, MRK ||| Dow Movers: MRK, CVX ||| Health Care Sector Update for 07/29/2021: FUSN, AZN, MRK ||| Merck & Co Inc. Q2 adjusted earnings of $1.31 per share ||| Merck sales rise 22% as drug demand recovers after COVID-19 hit ||| Merck profit nearly halves on Organon spin off ||| Stock Market News For Today July 29, 2021 ||| Merck & Co Q2 21 Earnings Conference Call At 8:00 AM ET",0,0.4824161
2021-07-30,13004500.0,77.12000274658203,77.76000213623047,76.7699966430664,76.87000274658203,71.13041687011719,MRK,"Notable ETF Inflow Detected - DGRO, MRK, BMY, MMM ||| Merck & Co. (MRK) Q2 2021 Earnings Call Transcript",0,0.47844493
2021-08-02,9083400.0,76.93000030517578,77.26000213623047,76.13999938964844,76.18000030517578,70.49195098876953,MRK,Can Merck Beat Pfizer in This Multibillion-Dollar Vaccine Market?,1,0.5138163
2021-08-04,10893400.0,76.48999786376953,76.48999786376953,75.45999908447266,75.4800033569336,69.84422302246094,MRK,"This High-Risk, High-Reward Biotech Could Make COVID Less Deadly -- and Make Investors Money",1,0.52460945
2021-08-05,8701600.0,75.5199966430664,75.69000244140625,74.93000030517578,75.58999633789062,69.94599914550781,MRK,"Dow Movers: UNH, HD ||| Pfizer Stock Has Risen 11% In A Month But Will The Gains Continue?",0,0.49136323
2021-08-06,8670700.0,75.62000274658203,75.66000366210938,74.98999786376953,75.44000244140625,69.80720520019531,MRK,"Dow Movers: AMGN, JPM ||| Is It Time to Buy the Dow Jones' 3 Worst-Performing Stocks of 2021? ||| Here's Why Eli Lilly Stock May Continue To See Higher Levels",0,0.49370372
2021-08-09,7867000.0,75.8499984741211,76.22000122070312,75.0,75.31999969482422,69.69615936279297,MRK,"Here Are the Winners of Cowen's Big Pharma R&D Showdown ||| 3 Vaccine Stocks for the Next Decade ||| Noteworthy ETF Inflows: SUSL, TSLA, MRK, MCD ||| Dow Movers: BA, MRK",0,0.5045757
2021-08-10,11243100.0,75.1500015258789,75.36000061035156,74.81999969482422,75.19000244140625,69.57585906982422,MRK,Dow Analyst Moves: MRK ||| Merck: FDA To Review KEYTRUDA As Single Agent For Patients With MSI-H/dMMR Endometrial Carcinoma ||| Merck: FDA Grants Priority Review To SBLA For KEYTRUDA As Adjuvant Immunotherapy In RCC,1,0.51405346
2021-08-12,6077100.0,75.12000274658203,76.05999755859375,75.05999755859375,76.04000091552734,70.36241149902344,MRK,"Dow Movers: INTC, AAPL",1,0.51014906
2021-08-13,6810400.0,76.36000061035156,76.7699966430664,76.22000122070312,76.72000122070312,70.99163055419922,MRK,Merck initiates rolling submission to Health Canada for oral COVID-19 drug,1,0.5390493
2021-08-16,9368400.0,76.7300033569336,78.01000213623047,76.63999938964844,77.93000030517578,72.11128997802734,MRK,"Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen ||| Dow Movers: BA, AMGN",1,0.49580953
2021-08-17,10311600.0,77.9000015258789,79.05999755859375,77.83000183105469,78.83000183105469,72.94408416748047,MRK,"VTI, MRK, MCD, BA: ETF Inflow Alert",0,0.52959687
2021-08-18,7459100.0,78.87999725341797,79.06999969482422,77.75,77.79000091552734,71.98173522949219,MRK,Top Stocks Warren Buffett Just Bought ||| Werewolf Collaborates With Merck On WTX-124 In Combination With KEYTRUDA - Quick Facts,1,0.49010256
2021-08-20,6284200.0,78.52999877929688,79.19999694824219,78.22000122070312,78.68000030517578,72.8052978515625,MRK,Will The Gains Continue For Johnson & Johnson Stock After A 7% Rise In A Month?,0,0.52081823
2021-08-23,6492600.0,79.11000061035156,79.2300033569336,78.33999633789062,78.37999725341797,72.52767181396484,MRK,Could Veeva Systems Stock Help You Retire a Millionaire? ||| What This Label Expansion Means for Merck,0,0.5227589
2021-08-25,7045800.0,77.80999755859375,77.80999755859375,76.4000015258789,77.06999969482422,71.31549072265625,MRK,"Dow Movers: MRK, JPM ||| Merck: VAXNEUVANCE Meets Endpoints In Phase 3 Trial Evaluating Use In Infants ||| 3 Cathie Wood Stocks to Buy and Hold for Decades",0,0.5033509
2021-08-26,6640400.0,77.11000061035156,77.31999969482422,76.51000213623047,76.56999969482422,70.85284423828125,MRK,"Merck's Keytruda Gets Approvals For Recurrent Breast, Colorectal Cancer Treatments In Japan",0,0.52321744
2021-08-27,6010000.0,76.80999755859375,76.97000122070312,76.16999816894531,76.30000305175781,70.60298919677734,MRK,Could CureVac's Canceled Deal Spell Trouble for Other mRNA Cancer Vaccines? ||| The 3 Best Biotech Stocks to Buy Right Now,1,0.50744253
2021-08-31,10949500.0,76.79000091552734,77.0999984741211,76.02999877929688,76.29000091552734,70.5937271118164,MRK,"Dow Movers: NKE, WBA ||| 3 of the Dow's Worst-Performing Stocks Over the Trailing Year Are Now Screaming Buys ||| What's Happening With Merck Stock? ||| Will Alnylam Stock Continue To Make New Highs?",0,0.49934137
2021-09-01,9187200.0,76.22000122070312,76.80000305175781,75.83000183105469,76.18000030517578,70.49195098876953,MRK,"Pfizer, Merck launch new trials of oral COVID-19 drugs ||| Pfizer starts dosing patients in oral COVID-19 drug trial ||| Merck, Ridgeback Initiate Phase 3 MOVe-AHEAD Study Of Molnupiravir For COVID-19 - Quick Facts ||| Merck begins late-stage trial of experimental COVID-19 drug ||| Will Bristol Myers Squibb Stock Rebound After A 4% Fall Last Week?",1,0.4577338
2021-09-02,6559400.0,76.4800033569336,77.13999938964844,76.16999816894531,77.12000274658203,71.36175537109375,MRK,"One Merck & Co., Inc. (NYSE:MRK) insider reduced their stake by 40% in the previous year ||| Is Pfizer a Buy? ||| Will FibroGen Stock Rebound After Positive Roxadustat Data?",1,0.4987094
2021-09-07,13979500.0,76.58999633789062,76.87000274658203,75.16999816894531,75.9800033569336,70.30689239501953,MRK,"Illumina Partners With Merck To Develop Tests For Use In Identifying Specific Cancer Mutations ||| US STOCKS-S&P 500 ends down, Big Tech lifts Nasdaq to record ||| US STOCKS-Big Tech fuels Nasdaq record, S&P 500 dips ||| US STOCKS-Wall Street falls on worries over slowing economic recovery ||| Pre-Market Most Active for Sep 7, 2021 : ADAP, IRNT, MTL, MRK, IFRX, EDU, FATE, SQQQ, VEON, AAPL, DIDI, AMC ||| Merck: KEYTRUDA Regimen Approved In China For First-Line Treatment In Esophageal Cancer ||| US STOCKS-Wall Street falls on worries over slowing economic recovery",0,0.51037395
2021-09-08,8243000.0,75.97000122070312,75.97000122070312,74.80000305175781,75.36000061035156,69.73318481445312,MRK,"Dow Movers: MRK, DIS ||| Noteworthy ETF Inflows: CRBN, PFE, DHR, MRK ||| 3 Warren Buffett Stocks to Buy in September ||| Should You Buy AbbVie Stock After The Recent 7% Fall?",0,0.4926522
2021-09-09,14628700.0,75.19000244140625,75.19000244140625,73.5999984741211,73.81999969482422,68.30815887451172,MRK,"Validea Peter Lynch Strategy Daily Upgrade Report - 9/9/2021 ||| Dividend Investors: Don't Be Too Quick To Buy Merck & Co., Inc. (NYSE:MRK) For Its Upcoming Dividend ||| U.S. government to tackle Medicare drug payments to try to cut costs ||| Merck To Grow Group Sales Organically By More Than 6% Annually - Quick Facts ||| 3 Red-Hot Healthcare Stocks to Buy in September ||| Is It Time to Buy the Dow Jones' 3 Worst-Performing Stocks This Year? ||| Merck Investors Have Reason to Cheer This Label Expansion",0,0.4990398
2021-09-13,11245200.0,73.7699966430664,73.83000183105469,72.86000061035156,73.18000030517578,67.71593475341797,MRK,How Keytruda's Latest Approval in China Boosts Merck ||| 3 Smartest Big Pharma Stocks to Buy in September ||| 3 Dow Jones Stocks to Buy Hand Over Fist Right Now ||| Merck sees potential U.S. authorization for COVID-19 antiviral before year-end,0,0.49180043
2021-09-14,15202800.0,73.05000305175781,73.13999938964844,72.05999755859375,72.11000061035156,67.32382202148438,MRK,"After Hours Most Active for Sep 14, 2021 : ZNGA, INTC, AAPL, PCG, VIPS, GIS, JCS, UEPS, GOTU, BABA, MRK, CMCSA ||| 3 No-Brainer Warren Buffett Stocks to Buy Right Now",1,0.45701313
2021-09-15,12555900.0,72.08000183105469,73.1500015258789,71.87999725341797,72.80999755859375,67.97736358642578,MRK,2 Best Biotech Stocks to Buy in September ||| Will Roche Stock Rebound After A 3% Fall In A Week? ||| Is AbbVie's 4.9% Dividend Yield Safe? ||| 3 Dividend Stocks For Your Watchlist Right Now,0,0.5014479
2021-09-16,14818900.0,73.0199966430664,73.0199966430664,71.69000244140625,71.97000122070312,67.193115234375,MRK,"After Hours Most Active for Sep 16, 2021 : OPAD, BABA, PLTR, BAC, AAPL, CMCSA, MRK, CLOV, KR, KDMN, DLTR, ZNGA ||| ANALYSIS-China's biotech sector comes of age with big licensing deals, global ambitions ||| France's BIOCORP, Merck Sign Partnership To Develop Specific Version Of Mallya Device",0,0.497268
2021-09-17,43406600.0,71.19000244140625,72.0,70.88999938964844,71.68000030517578,66.92236328125,MRK,"VTV, CVX, MRK, WFC: ETF Inflow Alert ||| Merck Gets Positive CHMP Opinion For Keytruda Plus Chemotherapy For Triple-Negative Breast Cancer ||| Will Johnson & Johnson Stock Recover After A 4% Fall In A Week? ||| What's Next For Merck Stock After A 5% Fall In A Week?",1,0.48820364
2021-09-20,15989400.0,71.16000366210938,72.61000061035156,71.12000274658203,71.93000030517578,67.15577697753906,MRK,"Merck's Keytruda Plus Chemotherapy Reduces Risk Of Death By One-Third In Metastatic Cervical Cancer ||| Mirati drug combination shrinks tumors in 39% of colon cancer patients in study ||| Could Pfizer and Merck Be Big Winners With COVID Pills? ||| Dow Movers: CAT, MRK ||| How Moderna Stock Can Double From Here ||| Here's Why Pfizer Stock Can Rebound After Falling Nearly 15% From Its Peak Last Month",1,0.51731503
2021-09-21,11995900.0,72.4800033569336,72.68000030517578,71.7699966430664,71.97000122070312,67.193115234375,MRK,"Pre-Market Most Active for Sep 21, 2021 : SQQQ, APRE, MRK, F, CSCO, UBER, BMY, WBA, NWSA, SDC, AMC, NOK",1,0.48280513
2021-09-22,9028700.0,72.33000183105469,72.41000366210938,71.86000061035156,72.04000091552734,67.25847625732422,MRK,"Merck's (NYSE:MRK) Returns Offer Investors a Fundamental Baseline, but their Pipeline is Still Risky",1,0.49506548
2021-09-23,12813500.0,72.68000030517578,74.04000091552734,72.56999969482422,73.05000305175781,68.20143127441406,MRK,Should You Buy Merck Stock At $72?,1,0.5039209
2021-09-24,14714700.0,73.58999633789062,74.62999725341797,73.3499984741211,73.61000061035156,68.72425842285156,MRK,"Health Care Sector Update for 09/24/2021: VTVT, CAPR, AZN, MRK ||| Health Care Sector Update for 09/24/2021: VTVT, CAPR, AZN, MRK, XLV, IBB ||| AstraZeneca: Lynparza PROpel Phase III Trial In 1st-line MCRPC Meets Primary Endpoint",0,0.45867506
2021-09-27,8630600.0,73.51000213623047,74.2699966430664,73.33999633789062,73.36000061035156,68.49085998535156,MRK,Pfizer begins study of oral drug for prevention of COVID-19 ||| Merck: Phase 3 Trial With KEYTRUDA Meets Endpoint In Patients With Advanced Hepatocellular Carcinoma,0,0.483946
2021-09-28,11836200.0,73.55000305175781,73.81999969482422,72.66000366210938,73.31999969482422,68.45352172851562,MRK,"7 Biotech Stocks Entering the Golden Boom Phase ||| iShares MSCI USA Quality Factor ETF Experiences Big Outflow ||| GSK to develop longer-acting therapy for HIV with Japan's Shionogi ||| FOCUS-COVID-19 pill developers aim to top Merck, Pfizer efforts ||| Moderna CEO Predicts Pandemic Could End in 2022: Here's Why the Stock Could Plunge If He's Right",1,0.526968
2021-09-29,16054500.0,73.61000061035156,75.69999694824219,73.58000183105469,75.08999633789062,70.10602569580078,MRK,"COVID SCIENCE-Coronavirus can transform pancreas cell function; certain genes may protect an infected person's spouse ||| Wednesday Sector Leaders: Utilities, Healthcare ||| Merck says research shows its COVID-19 pill works against variants ||| Top Biotech Stocks To Watch In October 2021",1,0.49464363
2021-09-30,16248600.0,75.58000183105469,76.6500015258789,75.0999984741211,75.11000061035156,70.12470245361328,MRK,"Health Care Sector Update for 09/30/2021: ANGO, PRGO, OPRX, MRK ||| Merck KGaA, GSK end partnership on former cancer drug hopeful ||| Dow Movers: BA, MRK ||| Health Care Sector Update for 09/30/2021: PRGO, VIR, GSK, MRK, XLRN, XLV, IBB ||| Merck To Buy Acceleron Pharma For $11.5 Bln ||| Merck to buy Acceleron for about $11.5 bln in rare disease drugs push",1,0.44316164
2021-10-01,102497300.0,81.55999755859375,84.33999633789062,80.62999725341797,81.4000015258789,75.99722290039062,MRK,"Dow Movers: WBA, MRK ||| Why Pfizer, BioNTech, Novavax, and Vaxart Stocks Are Sinking Today ||| S&P 500 Movers: MRNA, MRK ||| Merck COVID-19 pill success slams Moderna shares, shakes up healthcare sector ||| Health Care Sector Update for 10/01/2021: MRK, ZOM, OMER, GH, NEO ||| COVID SCIENCE-Delta increases COVID-19 risks for pregnant women; Pfizer/BioNTech vaccine antibodies gone by 7 months for many ||| GLOBAL MARKETS-Stocks bounce but inflation fears persist ||| Wall Street rallies on first day of October, boosted by economic cheer ||| US STOCKS-Wall Street kicks off October with broad rally, boosted by economic cheer ||| Health Care Sector Update for 10/01/2021: MRK, ZOM, OMER ||| Why Moderna Stock Plunged Today ||| 4 Top Stock Trades for Monday: BTC, ETH, NVAX, MRNA ||| Merck Shouldn't Matter to the Nasdaq's Vaccine Stocks ||| Wall Street rises in choppy trade after Fitch warning ||| Merck News: The ‘Game-Changer’ Making MRK Stock the No. 1 Trending Ticker Today ||| Why Dynavax Technologies Stock Is Sliding Today ||| Merck's COVID-19 pill cuts risk of death, hospitalization by 50% in study ||| Novavax News: Why NVAX Stock Investors Have a Tough Pill to Swallow Today ||| Merck's COVID-19 pill cuts risk of death, hospitalization by 50% in study ||| BMRA Stock: The Big Walmart Deal That Has Biomerica Investors Smiling Today ||| Merck Reports Positive Data From Molnupiravir Phase 3 Trial In Mild Or Moderate COVID-19 Patients ||| Pre-Market Most Active for Oct 1, 2021 : MRK, SQQQ, AVIR, TQQQ, AAPL, QQQ, NIO, CCL, FIVN, AMC, PLTR, F ||| US STOCKS-Futures slip ahead of inflation, factory activity data ||| Wall Street set to open higher on bargain hunting, Merck boost ||| Why Merck Stock Is Heating Up Today ||| US STOCKS-S&P 500 turns flat after Fitch warning; Merck boosts Dow ||| GLOBAL MARKETS-Stocks under pressure as euro zone inflation hits 13-year high ||| Why Carnival, Royal Caribbean, and Norwegian Cruise Line Stocks All Just Jumped",1,0.47071734
2021-10-04,53553300.0,84.16999816894531,84.55999755859375,82.41999816894531,83.0999984741211,77.5843734741211,MRK,"Exactly How I'd Invest $5,000 if I Had to Start From Scratch Today ||| 2 Leading Healthcare Stocks to Buy in 2021 and Beyond ||| 2 Ridiculously Cheap Growth Stocks to Buy ||| GLOBAL MARKETS-Asian shares slip as Evergrande, inflation worries sap positive mood ||| 3 Stocks That Might Soar With Pills for COVID ||| Here Are the Leaders in the Race to Develop a COVID-19 Pill ||| US STOCKS-Nasdaq ends sharply lower; rising Treasury yields sink Big Tech ||| Wall Street slammed by rotation out of Big Tech ||| US STOCKS-Wall Street tumbles as rising Treasury yields sink Big Tech ||| US STOCKS-Nasdaq ends sharply lower; rising Treasury yields sink Big Tech ||| Australia to buy 300,000 doses of Merck's COVID-19 antiviral pill ||| Despite Game-Changing Treatment News, It’s Not Over for Novavax Yet ||| Why Amazon, Salesforce, Zoom, and Other Stay-at-Home Stocks Dropped Today ||| Australia to buy Merck's COVID-19 pill, Victoria cases hit record ||| Dow Movers: CRM, MRK ||| Why Moderna Stock Is Sliding Again Today ||| US STOCKS-Futures pressured by uptick in yields; Tesla up on record deliveries ||| US STOCKS-Nasdaq pressured by rising yields; Tesla, Merck limit declines ||| Is A Fall Imminent For Teva Stock After Its Recent Rally? ||| Thailand in talks with Merck for 200,000 courses of anti-COVID pills ||| Banks, chipmakers drag European stocks lower on growth worries ||| 2 Best Biotech Stocks to Buy In October ||| US STOCKS-Futures down on Evergrande troubles; Tesla rises after record deliveries ||| Stock Market News For Today October 4, 2021 ||| Thailand in talks with Merck for 200,000 courses of pill for COVID-19 treatment ||| India's Divi's Labs hits record high on Merck's positive trial data for COVID-19 drug",0,0.48971856
2021-10-05,28977800.0,82.77999877929688,83.38999938964844,81.30000305175781,81.5999984741211,76.18392944335938,MRK,With Acceleron Acquisition Merck Stock Is Likely To See A Multiple Revision ||| 3 Biotech Stocks That Surged in September ||| Merck’s Good News Doesn’t End the Bullish Story for Novavax ||| Could a New COVID Pill Crush Vaccine Sales? ||| Which COVID-19 Pill Stock Is the Best Buy? ||| Does the Sell-Off of BioNTech and Moderna Stocks Present a Buying Opportunity? ||| Tuesday's ETF with Unusual Volume: PFM ||| What's Happening With FibroGen Stock? ||| Here's Why Merck Stock May Continue To Rise ||| EMA to consider rolling review for Merck's molnupiravir in coming days,0,0.5350007
2021-10-06,17608000.0,81.5,81.68000030517578,80.1500015258789,80.66000366210938,75.30634307861328,MRK,"Why BioNTech Stock Sank Today ||| Why Investing in VXRT Stock is a Coin Flip ||| Latest Bad News Suggests Novavax Stock Might Be Cursed ||| Noteworthy ETF Outflows: DGRO, MRK, MMM, RTX ||| Is Good News Enough for You to Buy NGM on the Dip? ||| Merck May Beat Pfizer to the COVID Pill Market. Does It Matter? ||| Could Pfizer's COVID Pill Be Better Than Merck's? ||| S.Korea secures 20,000 courses of Merck's COVID-19 pill, says PM ||| Merck says deal signed with Singapore on COVID-19 antiviral pill",1,0.48813805
2021-10-07,14190500.0,81.54000091552734,82.66999816894531,81.02999877929688,81.94000244140625,76.50138092041016,MRK,"Malaysia buys 150,000 courses of Merck's COVID-19 pill ||| 4 Biotech To Watch As Pfizer Seeks FDA Approval For Child Vaccines ||| Europe approves Merck's plant to make J&J COVID-19 vaccine ||| If You Invested $1,500 in Novavax in Early 2020, This Is How Much You Would Have Today ||| Merck and Singapore sign deal on COVID-19 antiviral pill",0,0.506924
2021-10-08,12121100.0,81.66999816894531,81.80000305175781,80.52999877929688,80.62999725341797,75.2783203125,MRK,7 Defensive Stocks to Buy and Forget About In Times of Volatility ||| Is an Acquisition of Acceleron a Smart Move for Merck? ||| Once-Cinderella Novavax Stock Could Be Poisoned by Merck’s Covid Pill ||| Two Indian drugmakers seek to end Merck's molnupiravir trials for moderate COVID-19 ||| Merck drug less effective against moderate COVID -India regulatory source ||| Aurobindo Pharma to stop molnupiravir trial in moderate COVID-19 patients,0,0.49775538
2021-10-11,11279700.0,81.63999938964844,81.63999938964844,79.87000274658203,79.93000030517578,74.62478637695312,MRK,"3 Reasons to Buy Merck Stock Right Now ||| Why Pfizer Will Profit From Merck's Rival Pneumococcal Vaccine ||| Better Bet on COVID Pills: Merck or Pfizer? ||| Regeneron Could Have a Big Catalyst Coming in 2022 ||| Vaxart May Be a COVID Vaccine Game Changer -- but Is It Too Late? ||| 3 Top Warren Buffett Stocks to Buy in October ||| Merck Seeks Emergency Nod In US For Molnupiravir To Treat Mild-to-moderate COVID-19 ||| What's Hot in the Stock Market? ||| Novavax Stock Got Merck-ed, but Don’t Dump Your Shares Now ||| 4 Biotech Stocks To Watch As AstraZeneca Posts COVID Antibody Cocktail Breakthrough ||| 4 Key Things Investors Should Know About Pfizer's Experimental COVID-19 Pill ||| Cassava Sciences: Fine Trading Stock, Terrible Investment ||| Merck seeks first U.S. FDA authorization for COVID-19 tablet",0,0.50563514
2021-10-12,10945000.0,80.18000030517578,80.18000030517578,79.25,79.58999633789062,74.30734252929688,MRK,"3 COVID Stocks That Can Turn $1,000 Into $10,000 ||| Novavax Will Be Volatile Until the Company Delivers Answers ||| EU may consider deal on Merck's COVID pill after approval procedure begins -source ||| EU may consider deal on Merck's COVID pill after approval procedure begins - source ||| Blackstone, Hipgnosis partner to invest in music as online streaming booms ||| WHO says it awaits full data from Merck on antiviral pill ||| India's Everest Organics starts making ingredient for Merck's COVID-19 pill",0,0.5212812
2021-10-13,9462600.0,79.58999633789062,79.66000366210938,78.77999877929688,78.94999694824219,73.70983123779297,MRK,Can Carnival Stock Buck the Delta Variant and Gain Traction? ||| Novavax Stock Fortunes Are Still Awaiting the Magical Headline ||| Holocene Advisors says Merck's offer undervalues Acceleron ||| 2 Reasons to Buy Novavax Stock Now and 1 Reason to Skip It ||| 3 Biotech Stocks You Can Buy and Hold for the Next Decade,0,0.50064695
2021-10-14,14607900.0,78.97000122070312,79.66999816894531,77.9800033569336,78.33000183105469,73.13098907470703,MRK,"Merck's COVID-19 drug to be reviewed by U.S. FDA advisers- Bloomberg News ||| IWB, MRK, WFC, PM: Large Inflows Detected at ETF ||| Why Novavax Stock Is Absurdly Cheap Right Now",0,0.49198782
2021-10-15,12866800.0,78.19999694824219,79.05999755859375,77.9800033569336,78.33000183105469,73.13098907470703,MRK,"After Hours Most Active for Oct 15, 2021 : PCG, WISH, BABA, FCEL, AAPL, INFY, MSFT, QQQ, MRK, WMB, BGCP, DNA ||| COVID SCIENCE-Statins may slightly lower COVID-19 death risk; using a different vaccine as booster may offer more protection ||| Pre-Market Most Active for Oct 15, 2021 : SPCE, KOS, TIGR, FUTU, PROG, ATVI, SQQQ, BAC, TMC, NIO, MRK, GM ||| Merck, Eisai Receive Positive CHMP Opinions For Keytruda + Lenvima In Two Different Types Of Cancer",0,0.47183165
2021-10-18,13075500.0,78.73999786376953,78.73999786376953,77.11000061035156,77.1500015258789,72.02930450439453,MRK,3 COVID-19 Pill Stocks to Watch ||| Better COVID-19 Stock: Merck or Pfizer? ||| Merck COVID-19 pill sparks calls for access for lower income countries ||| 3 Stocks to Consider if the October Stock Market Sell-Off Worsens ||| Here's Why Warren Buffett Isn't Buying Many Stocks Right Now ||| 2 Best Biotech Stocks to Buy Right Now ||| 2 Bargain Stocks You Can Buy Today and Hold Forever,1,0.49816135
2021-10-19,15577100.0,78.7300033569336,79.5199966430664,78.11000061035156,79.48999786376953,74.2139892578125,MRK,"US STOCKS-Wall Street ends higher as investors bet on positive earnings season ||| Health Care Sector Update for 10/19/2021: JNJ,HRMY,AVIR,MRK,PFE,GRTX ||| US STOCKS-Wall Street rises as investors bet on positive earnings season ||| Wall Street rises as earnings whip up risk appetite ||| Why Atea Pharmaceuticals Is Imploding Today ||| EXCLUSIVE-WHO-led programme aims to buy antiviral COVID-19 pills for $10 -document ||| Wall Street rises as earnings whip up risk appetite ||| Will Johnson & Johnson Stock Rise After Q3 Results? ||| EXCLUSIVE-WHO-led programme aims to buy antiviral COVID-19 pills for $10 -document",1,0.47220695
2021-10-20,11465500.0,79.31999969482422,81.25,79.30999755859375,81.06999969482422,75.68912506103516,MRK,Britain secures COVID-19 antivirals from Merck and Pfizer ||| Gates Foundation to spend $120 mln to speed access to generics of Merck COVID-19 pill ||| Here's Why Moderna's Growth May Be Just Getting Started,1,0.49159813
2021-10-21,9893600.0,81.11000061035156,81.26000213623047,80.27999877929688,81.16999816894531,75.78248596191406,MRK,Merck Recalls About 22K Vials Of Antibiotic Injection Cubicin ||| 2 COVID Stocks I'd Consider Instead of Moderna ||| EU drug regulator to announce results of Moderna booster shot review next week ||| EU drug regulator to announce results of Moderna booster shot review next week,0,0.5035384
2021-10-22,7543600.0,81.1500015258789,81.4800033569336,80.87999725341797,81.1500015258789,75.76383209228516,MRK,"Novavax Is Set to Win on the Increasing Necessity of Booster Shots ||| How Many Merck & Co., Inc. (NYSE:MRK) Shares Do Institutions Own? ||| Here's Why Agenus Stock Is Getting Hammered Today ||| Noteworthy ETF Inflows: ITOT, WFC, MRK, MDT ||| EU Approves Merck's Keytruda Plus Chemotherapy To Treat Triple-Negative Breast Cancer",1,0.5056606
2021-10-25,9365900.0,81.02999877929688,81.72000122070312,79.94999694824219,81.66000366210938,76.23997497558594,MRK,"Can Merck's Antiviral for COVID Succeed Where Gilead's Failed? ||| Are Atea Pharmaceuticals, Agenus, Novavax, and Ocular Therapeutix Bad News Buy? ||| Xeris Biopharma In Collaboration With Merck On XeriJect; Stock Up 18% - Quick Facts ||| Health Care Sector Update for 10/25/2021: MMSI, KOD, EVAX, MRK ||| Novavax is Now a Riskier Play, but Still One to Keep Your Eye On ||| Merck : Positive Results From Phase 3 Trial Of Doravirine/Islatravir For HIV-1 Infection Treatment ||| Health Care Sector Update for 10/25/2021: ERYP, EVAX, MRK, INCR, XLV, IBB ||| Merck Announces Initiation Of Rolling Review By EMA For Molnupiravir For COVID-19 Treatment ||| EU regulator starts real-time review of Merck's COVID-19 pill",1,0.49969423
2021-10-26,9352500.0,81.9000015258789,82.36000061035156,81.70999908447266,82.25,76.79080963134766,MRK,3 Top COVID Stocks -- Are They Tricks or Treats?,0,0.5182946
2021-10-27,8465400.0,82.4800033569336,82.4800033569336,81.30000305175781,81.54000091552734,76.1279296875,MRK,"Pre-Market Earnings Report for October 28, 2021 : MA, CMCSA, MRK, LIN, SHOP, AMT, SNY, CAT, MO, MCO, ITW, NOC ||| Dow Analyst Moves: MRK ||| 2 Top Dividend Stocks That Can Safeguard Your Portfolio Against a Market Crash ||| Merck : Phase 2b Data Shows Islatravir - Doravirine Maintains Viral Suppression In HIV-1 Treatment ||| Merck signs pact to broaden generic manufacturing of COVID-19 pill ||| Merck To Share License For Oral COVID-19 Antiviral Medicine With Developing Countries ||| Merck signs pact to broaden generic manufacturing of COVID-19 pill ||| Pre-Market Earnings Report for October 28, 2021 : MA, CMCSA, MRK, LIN, SHOP, AMT, SNY, CAT, MO, MCO, ITW, NOC ||| Health Care Sector Update for 10/27/2021: PHAT,TAK,CRTX,ALKS,MRK",1,0.50829697
2021-10-28,28854700.0,83.37999725341797,86.86000061035156,83.16999816894531,86.55000305175781,80.8053970336914,MRK,"WHO, partners seek $23.4 bln for new COVID-19 war chest ||| US STOCKS-S&P, Nasdaq hit record closing highs on earnings bullishness ||| WHO, partners seek $23.4 bln for new COVID-19 war chest ||| US STOCKS-Nasdaq hits record high with Apple, Amazon results on deck ||| US STOCKS-Solid earnings lift mood on Wall Street ahead of Apple, Amazon results ||| US STOCKS-Nasdaq hits record high with Apple, Amazon results on deck ||| Merck & Co. (MRK) Q3 2021 Earnings Call Transcript ||| US STOCKS-S&P, Nasdaq hit record closing highs on earnings bullishness ||| Health Care Sector Update for 10/28/2021: RFL, MRK, TDOC, MOH ||| Merck & Co Inc. Q3 adjusted earnings Beat Estimates ||| Merck Q3 Results Top Estimates; Boosts FY21 Outlook - Quick Facts ||| Merck Greenlights Global Access to COVID-19 Oral Drug ||| Dow Movers: MSFT, MRK ||| US STOCKS-S&P, Nasdaq hit record closing highs on earnings bullishness ||| Merck profit jumps on strong vaccine, cancer drug sales ||| US STOCKS-Wall Street set to rise on positive earnings, Big Tech strength ||| Merck & Co Q3 21 Earnings Conference Call At 8:00 AM ET",1,0.48130974
2021-10-29,18678600.0,86.48999786376953,88.45999908447266,86.16999816894531,88.05000305175781,82.20584106445312,MRK,"Blue-Chip, Tech Stocks Headline Last Week of October ||| Why Xeris Pharmaceuticals Is Soaring 7% Higher Today ||| Novavax Just Caught a Big Break ||| Merck Rises 6% on Strong Q3 Results ||| How Atea's Clinical Flop Shakes Up the COVID-19 Pill Market ||| Oral COVID-19 Treatment Might Help Merck's (NYSE:MRK) Lagging Returns ||| What To Expect From Merck's Q3?",0,0.50973976
2021-11-01,10943900.0,88.05000305175781,88.62999725341797,87.29000091552734,87.83999633789062,82.00977325439453,MRK,"3 Biotech Stocks That Could Make You Richer ||| 2 Growth Stocks That Could Deliver 1,000% Returns ||| 3 Top Dividend Stocks to Buy in November ||| 2 Best Biotech Stocks to Buy in November ||| Novavax Stock Is a Buy for Long-Term Investors on Its Pipeline Alone",1,0.51761055
2021-11-02,14671400.0,88.2300033569336,90.41999816894533,87.4800033569336,89.0199966430664,83.1114501953125,MRK,"IWD, MRK, DHR, GS: ETF Inflow Alert ||| Here's How Much Extra Money Pfizer Will Make From Vaccines for Younger Kids This Year ||| What's Happening With Alnylam Stock?",0,0.48122004
2021-11-03,10883900.0,88.7699966430664,89.41999816894531,88.20999908447266,88.68000030517578,82.79401397705078,MRK,7 Best Stocks to Buy Now If You Have Faith in These Analyst Upgrades ||| 3 Explosive Biotech Stocks -- Could They Shoot Even Higher? ||| Is Pfizer Stock Set To See Higher Levels Post Q3 Results?,1,0.49196637
2021-11-04,19519800.0,90.37000274658205,91.4000015258789,89.2699966430664,90.54000091552734,84.53057098388672,MRK,"US STOCKS-Qualcomm, Big Tech lift S&P 500, Nasdaq to record highs ||| Big Tech, chipmakers power S&P 500, Nasdaq to record highs ||| Merck Receives Another Boost for Its Top-Selling Drug ||| Why AbCellera Biologics Stock Sank 21.6% in October ||| EU regulator reviewing data on AstraZeneca COVID-19 booster shots ||| Britain approves Merck's oral COVID-19 pill ||| 4 Health Care Stocks For Your November 2021 Watchlist ||| US STOCKS-Nasdaq eyes record open on earnings cheer ||| Britain approves Merck's oral COVID-19 pill in world first ||| Is There Any Hope for Atea Pharmaceuticals Stock? ||| Dow Movers: IBM, V",0,0.49473092
2021-11-05,37623900.0,82.29000091552734,84.0,81.3499984741211,81.61000061035156,76.19329071044922,MRK,"Friday Sector Laggards: Healthcare, Technology & Communications ||| Why BioNTech Stock Is Plunging Today ||| US STOCKS-Wall St extends record rally on strong jobs report, Pfizer COVID-19 pill cheer ||| Dow Jones Gains 300 Points on Jobs Report, Merck Shares Slammed on Pfizer's COVID Pill Results ||| US STOCKS-Wall St books records, weekly gains on strong jobs report, Pfizer COVID-19 pill cheer ||| Why Vir Biotechnology Stock Is Sliding Today ||| US STOCKS-S&P 500 books record on strong jobs report, Pfizer COVID-19 pill cheer ||| EXPLAINER-How does Merck's COVID-19 pill compare to Pfizer's? ||| S&P 500 Movers: MRNA, LYV ||| Dow Movers: MRK, BA ||| US STOCKS-Wall St extends record rally on strong jobs report, Pfizer COVID-19 pill cheer ||| US STOCKS-Wall St eyes record open on strong jobs report, Pfizer COVID-19 pill cheer ||| 3 COVID Pill Stocks That Might Be Game-Changers ||| Is It Too Late to Buy Pfizer Stock? ||| Pfizer says antiviral pill cuts risk of severe COVID-19 by 89% ||| The Novavax Rebound Is Just Warming Up ||| 2 Buffett Stocks That Look Like Great Buys in November ||| US STOCKS-S&P, Nasdaq futures scale new heights on earnings bullishness ||| Why Pfizer Gained $32 Billion in Market Capitalization Today ||| Pfizer says antiviral pill cuts risk of severe COVID-19 by 89%",1,0.49197197
2021-11-08,18655700.0,80.41000366210938,82.87999725341797,79.87999725341797,82.68000030517578,77.1922607421875,MRK,"Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move? ||| Indian shares fall as pharma stocks weigh; Pfizer Indian unit jumps ||| 4 Top Biotech Stocks To Watch This Week ||| Why BioNTech Stock Is Bouncing Back Today ||| Why Moderna Stock Faltered In October ||| Merck ahead of Pfizer in EU talks on COVID-19 pills -EU source ||| Are Vaccine Stocks A Buy On Earnings? ||| ANALYSIS-COVID-19 pills are coming, but no substitute for vaccines, disease experts say ||| Private banks, pharma weigh on India shares; Pfizer India unit jumps ||| Global COVID-19 cases hit 250 million, eastern Europe infections at record levels ||| 3 Best Biotech Stocks to Buy in November ||| Indonesia reviewing Merck COVID-19 pill, up to 1 mln doses targeted ||| What's Happening With Eli Lilly Stock? ||| Global COVID-19 cases hit 250 million, eastern Europe infections at record levels",1,0.52922827
2021-11-09,10512000.0,83.62000274658203,83.70999908447266,81.91000366210938,82.72000122070312,77.22960662841797,MRK,"IWD, MRK, CVX, VZ: Large Inflows Detected at ETF ||| Validea Peter Lynch Strategy Daily Upgrade Report - 11/9/2021 ||| Better COVID Stock: Merck vs. Pfizer ||| Merck And Ridgeback: U.S. Government To Buy 1.4 Mln Addl Courses Of Molnupiravir After FDA Approval ||| U.S. to buy 1.4 mln more courses of Merck's COVID-19 pill ||| 3 Dow Stocks That Are Screaming Buys in November ||| Should You Buy Pfizer Stock After the Fantastic COVID-19 Pill News? ||| Asian firm Beximco to sell generic version of Merck COVID-19 pill",1,0.48022953
2021-11-10,9855900.0,83.30999755859375,84.0199966430664,82.69999694824219,84.01000213623047,78.43397521972656,MRK,"Top Stock Market News For Today November 10, 2021 ||| Could Pfizer's COVID Pill Be Even Bigger Than Its Vaccine? ||| Japan to pay $1.2 billion for 1.6 mln courses of Merck's COVID-19 pill",1,0.49662971
2021-11-11,5761500.0,83.91999816894531,84.26000213623047,83.52999877929688,84.0199966430664,78.44332885742188,MRK,"Japan prepares beds, booster shots in COVID-19 lull before winter ||| Merck Initiates Phase 3 Study Of VERQUVO In Chronic Heart Failure And Reduced Ejection Fraction ||| 3 Vaccine Stocks With Big Opportunities Outside of COVID-19",0,0.48533288
2021-11-12,8206700.0,83.83999633789062,84.19999694824219,83.05000305175781,84.0,78.42465209960938,MRK,WHO to set guidelines on COVID-19 antiviral pills soon ||| Is Merck's Planned Acquisition of Acceleron in Trouble?,0,0.5150412
2021-11-15,7108200.0,84.1500015258789,84.18000030517578,83.4000015258789,83.69000244140625,78.1352310180664,MRK,"Better Buy: Bristol Myers Squibb vs. Merck ||| Pfizer: Bull vs. Bear ||| Buffett's Berkshire cuts U.S. drugmaker stakes, invests in drug royalty company ||| After rally in U.S. retailers, investors eye upcoming reports ||| India's Dr. Reddy's open to making Pfizer COVID pill after Merck deal ||| Buffett's Berkshire cuts stakes in U.S. drugmakers, invests in drug royalty company",1,0.49202737
2021-11-16,10565200.0,83.66999816894531,84.69000244140625,83.25,84.11000061035156,78.52735137939453,MRK,Pfizer files for U.S. authorization of promising COVID-19 antiviral pill ||| Pfizer files for U.S. authorization of COVID-19 pill ||| Pfizer to allow generic versions of its COVID pill in 95 countries ||| Pfizer to allow generic versions of its COVID-19 pill in 95 countries ||| Merck Is a Dividend Play Ready to Get Back in Gear,0,0.45465496
2021-11-17,10286300.0,84.37000274658203,84.66999816894531,82.58999633789062,82.5999984741211,77.11756896972656,MRK,"VONV, VZ, CVX, MRK: Large Inflows Detected at ETF ||| Will Investors Win With Johnson & Johnson's Planned Spinoff? Here's What History Shows ||| Will Johnson & Johnson Stock See Higher Levels After Its Split Announcement?",1,0.5172492
2021-11-18,9833600.0,82.30000305175781,83.13999938964844,82.0199966430664,83.05000305175781,77.53770446777344,MRK,"India allows export of 20 mln Novavax vaccine doses to Indonesia -document, source ||| EU assesses GSK-Vir COVID-19 antibody therapy for authorisation ||| The Biggest Problem With Moderna Has Nothing to Do With Its Recent Earnings Miss",0,0.53729
2021-11-19,17581100.0,82.37000274658203,82.75,80.62000274658203,80.69999694824219,75.34368133544922,MRK,"Will Pfizer's COVID Pill Crush the Hopes of Merck Investors? ||| EU regulator begins review of Pfizer's COVID-19 pill ||| Health Care Sector Update for 11/19/2021: LGVN, GRCL, MRK, XLV, IBB",1,0.48528698
2021-11-22,10880200.0,81.0,82.06999969482422,80.54000091552734,81.63999938964844,76.2212905883789,MRK,Why Regeneron's Results for Its COVID Antibody Therapy Won't Boost Sales Much ||| Is Merck Stock a Buy? ||| Merck's (NYSE:MRK) Balance Sheet Can Easily Handle Acquisitions like Acceleron Pharma (NASDAQ: XLRN) ||| Orally Administered Covid-19 Treatment Should Bolster Merck’s Value ||| 3 Falling-Star Stocks to Buy Into the Holidays ||| Covid Stand-out Pfizer’s Albert Bourla Gets My Vote for CEO of the Year ||| Will The Rally In Pfizer Stock Continue After A Large 21% Rise In A Month?,1,0.4915464
2021-11-23,12130800.0,81.48999786376953,83.58999633789062,81.33999633789062,82.80000305175781,77.3042984008789,MRK,EU to issue decision on Merck's COVID pill 'within weeks' ||| Why You Can't Afford Not to Buy Merck's Stock ||| 4 Reasons Pfizer Is Now the Ultimate COVID-19 Growth Stock ||| Will Investors Benefit From Johnson & Johnson's Breakup? ||| Thailand orders additional 30 mln doses of Pfizer-BioNTech vaccine ||| Merck Completes Acquisition of Acceleron Pharma,0,0.51008034
2021-11-24,8537000.0,82.80000305175781,82.9000015258789,81.95999908447266,82.27999877929688,76.81880950927734,MRK,Germany's government-to-be eyes backdated drug price cuts,0,0.5323752
2021-11-26,18022000.0,78.7300033569336,79.93000030517578,77.11000061035156,79.16000366210938,73.90589904785156,MRK,"Merck: Interim Analysis, Additional Analyses Support Efficacy Of Molnupiravir ||| Merck says COVID-19 pill cuts hospitalization, death risk by 30% ||| Merck says COVID-19 pill cuts hospitalization, death risk by 30% ||| Vietnam says Pfizer, MSD to grant its firms licenses to produce COVID-19 pills",0,0.49839932
2021-11-29,34192400.0,76.41999816894531,77.5,74.0,74.88999938964844,69.91930389404297,MRK,"EXPLAINER-How worried should we be about the Omicron variant? ||| Who Would Be the Best FDA Commissioner for Biotech Investors? ||| iShares Russell 1000 Value ETF Experiences Big Inflow ||| Why Merck Stock Is Slipping Today ||| US STOCKS-Wall Street rebounds after virus-related sell-off ||| US STOCKS-Wall Street rebounds after virus-related sell-off ||| US STOCKS-Tech rally lifts Wall Street from Omicron-driven rout ||| US STOCKS-Wall Street regains some ground after virus pullback ||| US STOCKS-Tech rally lifts Wall Street from Omicron-driven slump ||| Dow Movers: MRK, KD ||| Clearlake Capital bulks up software portfolio with Quest deal ||| Biotech Stocks Facing FDA Decision In December 2021 ||| S&P 500 Movers: MRK, MRNA ||| Health Care Sector Update for 11/29/2021: KRYS, NRXP, MRK, XLV, IBB",1,0.47087294
2021-11-30,30179900.0,74.75,75.02999877929688,73.83999633789062,74.91000366210938,69.93797302246094,MRK,4 Pharma Stocks Poised to Benefit from Omicron Variant Scare ||| U.S. FDA panel weighs Merck's COVID-19 antiviral drug ||| FDA To Decide On Merck's Covid-19 Pill ||| U.S. FDA panel to weigh Merck's COVID-19 antiviral drug ||| U.S. FDA advisers recommend authorization of Merck's COVID-19 pill ||| This Pharmaceuticals Stock Is A Better Pick Over Bristol Myers Squibb ||| AstraZeneca's Lynparza Granted Priority Review In U.S. For High-risk Early Breast Cancer,0,0.5258771
2021-12-01,21435900.0,75.52999877929688,76.91000366210938,74.38999938964844,74.44000244140625,69.49917602539062,MRK,"Belgium in talks to buy 10,000 doses of Merck's COVID-19 pill, health minister says ||| 2 Ridiculously Cheap Dividend Stocks To Buy for 2022 ||| Pfizer begins application for Canada's approval of COVID-19 pill ||| US STOCKS-Wall Street bounces back from Omicron, inflation jitters ||| Daily Dividend Report: MRK,VGR,RY,MKC,MA ||| FDA Panel Narrowly Recommends Use Of Merck's Covid-19 Pill ||| Is A Rise Imminent For Merck Stock After An 8% Fall In A Month? ||| US STOCKS-Wall Street set to rebound after rout spurred by inflation, Omicron ||| Top Stock Market News For Today December 1, 2021 ||| FDA Committee Votes in Favor of Merck’s COVID-19 Pill ||| 5 Biotech Stocks For Your December 2021 Watchlist ||| US STOCKS-Wall St bounces back after rout spurred by inflation, Omicron risks",0,0.4941273
2021-12-02,15345300.0,74.37999725341797,74.77999877929688,73.30000305175781,73.88999938964844,68.98567199707031,MRK,"3 Stocks to Buy for the New COVID Variant ||| Regeneron: Surfing on Covid, With More Under the Surface ||| REUTERS NEXT-NFTs next hit may be music industry, former manager for Elton John, Beyonce says ||| Dow Movers: AAPL, BA ||| What's Next For Merck Stock After FDA Advisors Back Its Covid-19 Pill?",0,0.49909928
2021-12-03,14508900.0,74.08999633789062,74.25,72.66000366210938,73.33999633789062,68.47218322753906,MRK,"Here's Why The New Coronavirus Variant Won't Harm Pfizer's Stock ||| Merck to supply up to 1 mln courses of COVID-19 pill to Canada ||| Merck to supply up to 1 mln courses of COVID-19 pill to Canada ||| Canada reports 12 cases of Omicron variant, says severe COVID trends could rise ||| Hot Stocks To Buy Right Now? 3 Health Care Stocks To Know",1,0.4924145
2021-12-06,13506800.0,73.30000305175781,73.8499984741211,72.80000305175781,73.41999816894531,68.546875,MRK,Will Adagio's COVID Antibody Therapy Be Too Late to the Party? ||| Merck (NYSE:MRK) Is Paying Out A Larger Dividend Than Last Year ||| Is A Rise Imminent For Bristol Myers Squibb Stock? ||| Omicron variant found in almost one-third of U.S. states ||| Merck Strikes Deal to Provide Molnupiravir to Canadian Government ||| Merck ties up with Thermo Fisher to make its COVID-19 pill in Canada ||| Why Vaccine Stocks Like BioNTech and Novavax Are Crashing Today ||| 7 Stocks to Buy to Give Your Portfolio a Booster Shot ||| FDA Approves Merck’s KEYTRUDA,0,0.49608642
2021-12-07,17635100.0,72.02999877929688,72.72000122070312,71.5,72.27999877929688,67.4825439453125,MRK,"US STOCKS-Wall Street closes higher with Nasdaq boosted by tech rally ||| US STOCKS-Wall Street closes higher with Nasdaq boosted by tech rally ||| US STOCKS-Wall Street rallies with Nasdaq up 3% as tech takes off ||| S&P 500 Movers: MRK, FTNT ||| Dow Movers: MRK, INTC ||| iShares Russell 1000 ETF Experiences Big Inflow ||| US STOCKS-Big Tech, chipmakers power Nasdaq as Omicron worries subside ||| Is Gilead Sciences Stock a Buy Now? ||| US STOCKS-Wall St set to open 1% higher as tech stocks roar back ||| MRK Named A Top Socially Responsible Dividend Stock",1,0.47330976
2021-12-08,14331400.0,72.54000091552734,73.41000366210938,72.08000183105469,73.20999908447266,68.35082244873047,MRK,Britain starts recruiting for real-world COVID antiviral trial,0,0.53199244
2021-12-09,11938000.0,73.44000244140625,73.55999755859375,72.69000244140625,72.86000061035156,68.0240478515625,MRK,MRK January 2022 Options Begin Trading,0,0.53057057
2021-12-10,11398800.0,73.12000274658203,73.2300033569336,72.25,72.62000274658203,67.79998016357422,MRK,"Why an FDA Panel Had Concerns About Merck's COVID-19 Pill ||| Ex-Dividend Reminder: UGI, New Jersey Resources and Merck ||| Is It Time to Buy the Dow's 3 Worst Performing Stocks This Year? ||| Why You Should Buy Moderna Stock at Every Dip",1,0.48746303
2021-12-13,17486100.0,72.37000274658203,73.44999694824219,71.97000122070312,73.41999816894531,68.546875,MRK,"U.S. crosses 50 million COVID-19 cases as Delta dominates amid Omicron emergence ||| Malaysia gives conditional approval for use of Ronapreve COVID-19 treatment ||| U.S. FDA puts Merck's HIV drug trials on hold ||| Notable Monday Option Activity: MRK, GPRE, AMD ||| Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for December 14, 2021 ||| 2 Top Biotech Stocks To Buy Right Now",1,0.5087426
2021-12-14,18949700.0,72.36000061035156,74.04000091552734,72.16000366210938,73.72000122070312,69.47992706298828,MRK,"Bristol Myers enters up to $920 mln deal with Immatics for cancer drug ||| 2 High-Yield Dividend Stocks That Can Safeguard Your Portfolio Against Inflation ||| Merck's HIV Trials Put On Clinical Hold, Vifor Gets A Suitor, VERU Scores FDA Nod... ||| Pfizer says COVID-19 pill near 90% effective in final analysis ||| Pfizer says COVID-19 pill near 90% effective in final analysis",1,0.5308409
2021-12-15,14263400.0,73.70999908447266,75.38999938964844,73.70999908447266,75.29000091552734,70.95964050292969,MRK,"Noteworthy ETF Inflows: DLN, ABBV, MRK, KO ||| Is It Time to Buy the 8 Worst-Performing Dividend Stocks of 2021?",1,0.4892624
2021-12-16,16601700.0,75.5,76.52999877929688,75.2699966430664,75.91000366210938,71.54397583007812,MRK,3 COVID Stocks That Will Pay You Rich Dividends in 2022 ||| 2 Dirt-Cheap Growth Stocks Trading Near Their 52-Week Lows ||| EU regulator okays COVID-19 treatments from GSK-Vir and Sobi ||| Denmark approves Merck's COVID-19 pill for at-risk patients,0,0.5316546
2021-12-17,28040600.0,76.55999755859375,77.73999786376953,75.5,75.69000244140625,71.33663177490234,MRK,"Dow Movers: GS, MRK ||| These 2 Dividend ETFs Are a Retiree's Best Friend ||| Merck: CHMP Adopts Positive Opinion For KEYTRUDA As Monotherapy For Adjuvant Treatment Of RCC ||| Is Merck's Dig at Pfizer's COVID-19 Pill Justified? ||| EU drug regulator won't rule on Merck COVID-19 pill before Christmas - source",1,0.49823418
2021-12-20,11818800.0,75.69999694824219,76.5,74.94999694824219,76.41000366210938,72.01522064208984,MRK,Will Eli Lilly Be a Top Pharma Stock Again in 2022? ||| Merck: Can COVID-19 Pill Be Key Catalyst?,0,0.50765926
2021-12-21,14947800.0,76.25,76.27999877929688,74.88999938964844,75.54000091552734,71.19525146484375,MRK,"Omicron's march revives urgent global calls for vaccinations ||| PRECIOUS-Gold holds tight range as higher yields counter Omicron fears ||| FOREX-Dollar out of favour as Omicron leaves currency markets unseasonably volatile ||| Best Defensive Stocks To Invest In Late 2021? 3 For Your List ||| U.S. FDA set to authorize Pfizer, Merck COVID-19 pills this week - Bloomberg News ||| U.S. FDA set to authorize Pfizer, Merck COVID-19 pills this week - Bloomberg News ||| Dow Movers: MRK, NKE ||| EU drug regulator: No link found between menstrual changes and COVID vaccines ||| EU drug regulator: No link found between menstrual changes and COVID vaccines",1,0.49476627
2021-12-22,9256000.0,75.44000244140625,76.55999755859375,75.12999725341797,76.16000366210938,71.77960968017578,MRK,"Pfizer oral COVID-19 pill gets U.S. authorization for at-home use ||| Pfizer oral COVID-19 pill gets U.S. authorization for at-home use ||| Wall St climbs on positive economic data, Omicron update ||| Wall Street set to drop as Omicron worries linger ||| France cancels order for Merck's COVID-19 antiviral drug ||| France cancels order for Merck's COVID-19 antiviral drug ||| US STOCKS-Futures little changed amid lingering Omicron worries ||| Merck, Ridgeback Say British Govt. Agrees To Procure Further 1.75 Mln Molnupiravir Pills ||| Buy Palantir Stock While the Analysts Remain Bearish ||| FOREX-Dollar finds its footing; Turkish lira holds its gains",0,0.44985843
2021-12-23,9894900.0,76.30000305175781,76.30000305175781,75.3499984741211,75.7300033569336,71.37432098388672,MRK,"FDA Gives Emergency Use Authorization For Merck's Molnupiravir, Second Covid-19 Pill To Get Approval ||| EMERGING MARKETS-Indonesian rupiah climbs, other Asian FX muted amid holiday lull ||| Australian shares wind down for Christmas on a positive note ||| GLOBAL MARKETS-U.S. stocks end at record high, oil prices rise as Omicron fears abate ||| Major Indexes Walk Into Christmas With 3 Straight Wins ||| S&P 500 hits record close as Omicron fears ebb ||| Wall Street climbs for third day as Omicron fears ebb ||| Health Care Sector Update for 12/23/2021: ABC,MRK,OCDX,LH,QDEL,INNV ||| Wall Street rises for third day as Omicron fears ease ||| S&P 500 inches closer to record high as Omicron fears ease ||| Why Moderna Stock Is Falling Again Today ||| MRK February 2022 Options Begin Trading ||| VHT, DHR, MRK, CVS: ETF Inflow Alert ||| U.S. FDA authorizes Merck's at-home antiviral COVID-19 pill ||| U.S. FDA authorizes Merck's at-home antiviral COVID-19 pill ||| Merck & Ridgeback to Supply Additional Courses of Molnupiravir to UK ||| Top 10 Blockbuster Drugs In 2021 ||| TREASURIES-Yields higher after progress on Omicron, rising stocks",1,0.5156982
2021-12-27,6334700.0,76.0,76.61000061035156,75.7699966430664,76.56999969482422,72.16603088378906,MRK,"Japan health panel approves Merck's oral COVID-19 treatment ||| Japan health panel approves Merck's oral COVID-19 treatment - NHK ||| FDA Grants Emergency Use Authorization to Merck’s COVID-19 Treatment ||| Merck & Ridgeback’s Molnupiravir Receives Special Emergency Approval in Japan ||| Some ""CEO of the Year"" Nominees for 2021 ||| India committee recommends EUA for Merck's COVID-19 pill, two other vaccines - report ||| S.Korea authorises emergency use of Pfizer's oral coronavirus treatment ||| Merck Gets First Approval in Japan for KEYTRUDA + LENVIMA",1,0.50382566
2021-12-28,5727100.0,76.68000030517578,77.13999938964844,76.20999908447266,76.80999755859375,72.3922119140625,MRK,"Best Health Care Stocks To Buy Now? 3 For Your 2022 Watchlist ||| Indian shares end higher on upbeat global cues; tech, auto stocks jump ||| India committee recommends emergency use authorisation for Merck's COVID-19 pill - report",1,0.5066945
2021-12-30,5859100.0,77.12000274658203,77.61000061035156,76.97000122070312,77.13999938964844,72.7032241821289,MRK,"Notable Thursday Option Activity: MBI, MRK, RUN ||| Consumer Sector Update for 12/30/2021: KR, DADA, WMT, PFE, MRK, XLP, XLY ||| India imposes stricter rules to prevent COVID-19 spread, leaders hold mass rallies",0,0.5243207
2022-01-03,9441200.0,76.58000183105469,76.94000244140625,75.3499984741211,76.87000274658203,72.44876098632812,MRK,"These 3 Stocks Just Hiked Their Dividends: Should You Buy Them? ||| Is Merck & Co. a Value Stock? ||| Genprex Receives FDA Fast Track Designation For REQORSA - Keytruda For NSCLC Treatment ||| Health Care Sector Update for 01/03/2022: APLT,IMMX,GNPX,MRK,AZN ||| Belgium agrees to buy 10,000 courses each of Pfizer, Merck COVID-19 pills ||| Belgium to buy 10,000 courses each of Pfizer and Merck COVID-19 pills ||| GNPX Stock: 5 Things to Know as Genprex Rockets Higher",1,0.48766738
2022-01-04,11981700.0,76.4000015258789,77.2699966430664,75.88999938964844,77.01000213623047,72.58071899414062,MRK,Top Stocks To Invest In 2022? 4 Health Care Stocks To Check Out ||| Pfizer to supply U.S. govt 10 mln more COVID-19 pill courses ||| Dr Reddy's to launch generic COVID-19 Merck drug at about 50 cents a pill ||| Meet the 2022 Dogs of the Dow ||| Japan's Kishida lays out new contigency plan against Omicron risk,1,0.51003724
2022-01-05,17447900.0,77.26000213623047,79.80999755859375,77.26000213623047,78.87999725341797,74.34314727783203,MRK,May 20th Options Now Available For Merck (MRK) ||| India says safety concerns restricting use of Merck COVID pill,0,0.5181458
2022-01-06,11359200.0,78.79000091552734,79.58000183105469,77.94999694824219,78.83000183105469,74.29602813720703,MRK,February 25th Options Now Available For Merck,1,0.52639
2022-01-07,15212000.0,78.86000061035156,80.52999877929688,78.45999908447266,80.30000305175781,75.68148040771484,MRK,"Canada warns provinces they need to do more to fight Omicron variant ||| Mexico grants emergency use approval for Merck's COVID-19 pill ||| ABSI Stock: 7 Things for Investors to Know About the Merck Deal That Has Absci Shares Flying Today ||| Health Care Sector Update for 01/07/2022: ABSI, MRK, EQRX, CYTK, RPRX, XLV, IBB ||| STMicro Gets a Boost, but This Tiny Biologics Stock's Seeing the Biggest Rise Friday Morning ||| Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday",1,0.5029881
2022-01-10,19636800.0,80.54000091552734,82.44999694824219,79.66999816894531,82.37000274658203,77.6324234008789,MRK,"Italy to receive 40,000 Merck antiviral drug doses next week - official ||| Merck expects COVID-19 pill molnupiravir to be effective against Omicron ||| Gilead Announces Clinical Trial Collaborations With Merck - Quick Facts ||| Merck (NYSE:MRK) stock performs better than its underlying earnings growth over last five years ||| Surprising Analyst 12-Month Target For MOTE ||| Idorsia's insomnia drug gets U.S. FDA approval",0,0.49848723
2022-01-11,11585100.0,82.41999816894531,82.55999755859375,80.6500015258789,81.66999816894531,76.9726791381836,MRK,"Dow Movers: IBM, DOW ||| What's Happening With Bristol Myers Squibb Stock?",0,0.48863897
2022-01-12,13057000.0,81.08000183105469,81.41999816894531,80.66999816894531,81.19999694824219,76.52971649169922,MRK,Dow Analyst Moves: MRK ||| Merck (MRK) Stock Sinks As Market Gains: What You Should Know ||| See How Merck Ranks Among Analysts' Top Dow 30 Picks ||| Why Agenus Stock Took Investors for a Wild Ride in 2021 ||| Here's A Better Pharmaceutical Pick Over Merck Stock ||| iShares Core S&P 500 ETF Experiences Big Outflow,1,0.47067833
2022-01-13,9678100.0,80.93000030517578,81.72000122070312,80.33000183105469,81.31999969482422,76.64281463623047,MRK,"Indonesia approves Merck's COVID-19 pill for emergency use ||| Pfizer says it applied for Japan gov't approval for oral COVID-19 drug ||| Interesting MRK Put And Call Options For March 4th ||| Dow Movers: MRK, BA ||| Stock Market News for Jan 13, 2022",1,0.51878715
2022-01-14,9478000.0,81.5999984741211,81.8499984741211,80.7699966430664,81.37999725341797,76.69935607910156,MRK,Pharma Stock Roundup: PFE's Research Deal With BEAM & Other Updates ||| Merck Snags Yet Another Indication for This Drug Combo,1,0.52165174
2022-01-18,14493100.0,81.0999984741211,82.16000366210938,80.80999755859375,81.54000091552734,76.85016632080078,MRK,"How Do Pfizer's and Merck's COVID Pills Work? ||| Canada study of Merck's COVID-19 oral treatment is moving more slowly - health minister ||| Canada approves Pfizer's COVID-19 oral antiviral treatment for adults ||| 4 Large-Cap Drugmaker Stocks to Watch Despite Omicron Woes ||| 2 Top Biotech Stocks to Buy and Hold for 10 Years ||| Is Bristol Myers Squibb Stock A Better Pick Over This Vaccine Company? ||| Will Moderna (MRNA) Continue to Ride on Vaccine Sales in 2022? ||| AstraZeneca (AZN) Enhertu sBLA Receives FDA Priority Tag ||| Merck signs supply deal with UNICEF for 3 mln courses of COVID-19 pill ||| Zacks Industry Outlook Highlights: Roche, Pfizer, AbbVie and Merck",0,0.4772427
2022-01-19,11448200.0,80.9800033569336,81.9800033569336,80.4800033569336,81.29000091552734,76.61454010009766,MRK,Palantir’s Long-Term Bull Case Looks Compelling ||| 3 Under-the-Radar COVID Stocks,0,0.5102678
2022-01-20,12069600.0,80.7300033569336,81.86000061035156,80.5199966430664,80.75,76.10560607910156,MRK,"Merck (MRK) Stock Moves -0.66%: What You Should Know ||| See Which Of The Latest 13F Filers Holds Merck ||| SPYV, MRK, WMT, MMM: Large Inflows Detected at ETF ||| Cheap version of Merck COVID pill to be made for poorer nations ||| Africa CDC says it plans to talk to Merck about COVID pill",0,0.47582993
2022-01-21,18461700.0,81.2699966430664,81.5199966430664,79.23999786376953,79.9800033569336,75.37989044189453,MRK,Friday's ETF with Unusual Volume: IYH,0,0.5118555
2022-01-24,17289000.0,79.7699966430664,80.11000061035156,76.6500015258789,78.83000183105469,74.29602813720703,MRK,"U.S. FDA limits use of Regeneron, Lilly COVID-19 antibody treatments ||| Advocacy group urges Pfizer to sell more COVID pills to developing countries ||| Gilead (GILD) Drug Gets FDA Nod for Non-Hospitalized COVID Patients ||| 3 No-Brainer Healthcare Stocks to Buy Right Now for Less than $150 ||| FDA Refuses To Approve Merck's 'gefapixant' To Treat Chronic Cough ||| EU regulator set to rule on Pfizer COVID pill by end-Jan, ahead of Merck ||| UK to begin testing Merck's COVID pill for hospitalised patients ||| U.S. FDA declines to approve Merck's cough treatment ||| Will Johnson & Johnson Stock Rise After Q4 Results?",1,0.5042766
2022-01-25,13662400.0,78.41999816894531,79.77999877929688,77.77999877929688,79.45999908447266,74.88980102539062,MRK,Merck's (MRK) Chronic Cough Drug Gets CRL From FDA ||| FDA Limits Use of Regeneron & Lilly's COVID Antibody Cocktails ||| These 4 Dow Stocks Are Screaming Buys in 2022,0,0.49063188
2022-01-26,13046600.0,79.38999938964844,80.33999633789062,78.7300033569336,79.13999938964844,74.58821105957031,MRK,"Early research suggests Merck cancer drug may target dormant HIV ||| 2 Stocks to Buy No Matter What Happens in 2022 ||| 2 Growth Stocks Down 21% to 39% That Could Soar, According to Wall Street ||| The Zacks Analyst Blog Highlights: Eli Lilly, Regeneron Pharmaceuticals, Pfizer and Merck ||| Merck (MRK) Dips More Than Broader Markets: What You Should Know ||| The Zacks Analyst Blog Highlights: Pfizer, Merck, Eli Lilly, Regeneron and Gilead ||| Is Invesco Dynamic Pharmaceuticals ETF (PJP) a Strong ETF Right Now?",1,0.50692064
2022-01-27,20187200.0,78.41999816894531,81.5999984741211,78.41999816894531,80.58000183105469,75.94537353515625,MRK,"Merck (MRK) Earnings Expected to Grow: Should You Buy? ||| EU drug regulator green lights Pfizer's COVID-19 pill ||| Gilead's (GILD) Magrolimab Studies Put on Hold by the FDA ||| EU Approves Merck's KEYTRUDA As Adjuvant Therapy For Renal Cell Carcinoma ||| Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? ||| As Omicron ebbs, England revives Plan A: living with COVID",1,0.5236023
2022-01-28,13915300.0,79.54000091552734,80.98999786376953,79.18000030517578,80.9000015258789,76.24696350097656,MRK,"Pfizer (PFE) Gets CHMP Recommendation for COVID Pill Paxlovid ||| Merck (MRK) Keytruda Gets EU Nod for Expanded Kidney Cancer Use ||| Britain to start rolling out Pfizer COVID pill next month ||| Merck's COVID-19 pill active against Omicron in lab studies ||| Merck's COVID-19 pill effective against Omicron in lab studies ||| Pharma Stock Roundup: J&J Q4 Earnings, FDA's Rejection of PFE, MRK Pipeline Drugs ||| Merck: Molnupiravir Shows Consistent Antiviral Activity Against Omicron In Multiple In Vitro Studies",1,0.45053652
2022-01-31,13035000.0,81.0199966430664,81.72000122070312,80.80000305175781,81.4800033569336,76.79362487792969,MRK,"3 Unstoppable Investments Everyone Needs in Their Portfolios ||| Are the Dow's Worst-Performing Stocks of 2021 Ready to Rebound in 2022? ||| INSIGHT-Merck's COVID pill is last choice for U.S. patients, global use varies ||| EXPLAINER-How does Merck's COVID-19 pill compare to Pfizer's?",1,0.5181515
2022-02-01,10803300.0,81.95999908447266,82.12000274658203,81.08000183105469,81.91999816894531,77.20830535888672,MRK,Will Merck (MRK) Succeed in Beating Q4 Earnings Expectations? ||| 2 Incredibly Cheap Value Stocks to Buy in February,1,0.5025069
2022-02-02,13988200.0,81.80000305175781,82.30000305175781,81.26000213623047,82.01000213623047,77.29313659667969,MRK,"Drug/Biotech Stocks Earnings on Feb 3: BIIB, LLY & MRK ||| Pre-Market Earnings Report for February 3, 2022 : LLY, MRK, HON, COP, CI, ITW, EL, BDX, ICE, BCE, PH, APTV ||| Avoid Novavax for Now, Until the Picture Clears Up ||| Is a Beat Likely for Pfizer (PFE) This Earnings Season? ||| Will Merck Stock Rise After Its Q4 Results? ||| AbbVie (ABBV) Tops Q4 Earnings Estimates ||| Gilead (GILD) Q4 Earnings Miss on Legal Settlement Charges",0,0.48685345
2022-02-03,19181400.0,81.6500015258789,81.80000305175781,78.4000015258789,79.01000213623047,74.46568298339844,MRK,"Price of COVID treatments from Pfizer, Merck, GSK align with patient benefits -report ||| Merck sees 2022 sales up nearly 20%, mostly on new COVID pill ||| Carnival’s Outlook Has Greatly Improved, But CCL Stock Remains Very Risky ||| Merck (MRK) Q4 Earnings & Sales Beat, COVID Drug Adds $952M ||| March 25th Options Now Available For Merck (MRK) ||| Top 4 Health Care Stocks To Watch In February 2022 ||| 3 Dividend Stocks That Can Make You Richer in February (and Beyond) ||| Merck Coughs Up a Failure With Its ""Pipeline in a Product"" ||| Merck sees 2022 sales up nearly 20%, mostly on molnupiravir ||| Merck & Co Q4 21 Earnings Conference Call At 8:00 AM ET ||| Merck Q4 Profit Beats Estimates ||| Merck (MRK) Q4 Earnings and Revenues Beat Estimates",0,0.49661577
2022-02-04,10716200.0,78.51000213623047,79.55000305175781,78.19999694824219,78.55999755859375,74.04156494140625,MRK,"5 Biotech Stocks to Buy to Benefit From Biden’s New Cancer Cabinet ||| Pharma Stock Roundup: MRK, LLY, ABBV Post Q4 Earnings, PFE Ends Vupanorsen Program ||| Merck & Co. (MRK) Q4 2021 Earnings Call Transcript",0,0.5121636
2022-02-07,23615300.0,78.79000091552734,78.91999816894531,77.44000244140625,77.58000183105469,73.11791229248047,MRK,"The Zacks Analyst Blog Highlights: AbbVie, Merck, Eli Lilly, Novartis and Pfizer ||| After Hours Most Active for Feb 7, 2022 : PLYA, VLDR, SQ, WFC, VTWO, BAC, T, AAPL, CHGG, SMFR, MRK, IMGN ||| Drug/Biotech Stock Q4 Earnings Due Feb 8: PFE, INCY & DCPH ||| iShares ESG MSCI USA Leaders ETF Experiences Big Inflow",0,0.472796
2022-02-08,17486500.0,77.0999984741211,77.33000183105469,75.81999969482422,76.91000366210938,72.48646545410156,MRK,4 Pharmaceutical Stocks To Watch In February 2022 ||| Merck (MRK) Shares Cross Below 200 DMA ||| Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)? ||| Should You Invest in the VanEck Pharmaceutical ETF (PPH)?,0,0.5340713
2022-02-09,15183100.0,77.16999816894531,77.33000183105469,76.41000366210938,76.52999877929688,72.12830352783203,MRK,"This 1 Number Could Supercharge Pfizer Stock by 40% or More ||| Validea Joel Greenblatt Strategy Daily Upgrade Report - 2/9/2022 ||| Pre-Market Most Active for Feb 9, 2022 : PTON, UBER, FB, PFE, TQQQ, SQQQ, SOFI, INTC, OXY, F, MRK, NIO",1,0.49439192
2022-02-10,12437600.0,76.36000061035156,76.7699966430664,75.93000030517578,76.55999755859375,72.15657806396484,MRK,"AstraZeneca (AZN) Q4 Earnings Beat, COVID Vaccine Drives Sales ||| Africa still talking to Merck, Pfizer about COVID pills -CDC",1,0.47439998
2022-02-11,9342300.0,76.4000015258789,77.9000015258789,76.16999816894531,76.63999938964844,72.23198699951172,MRK,China approves use of Pfizer's COVID drug Paxlovid ||| Palantir Technologies Stock Is Poised for a Strong Comeback,0,0.5304964
2022-02-14,9881100.0,76.62999725341797,76.69999694824219,75.11000061035156,76.47000122070312,72.07176208496094,MRK,Merck Japan says to accelerate imports of COVID-19 treatment ||| Lilly's (LLY) COVID-19 Drug Gets FDA Nod for Emergency Use ||| Does The Current Dip In Pfizer Stock Offer A Buying Opportunity?,1,0.49125028
2022-02-15,11425600.0,77.51000213623047,78.19000244140625,77.31999969482422,77.80999755859375,73.33468627929688,MRK,"U.S. Senate confirms Dr. Robert Califf to lead FDA for second time ||| XLV, ABBV, TMO, MRK: Large Inflows Detected at ETF ||| Should Invesco Defensive Equity ETF (DEF) Be on Your Investing Radar? ||| AstraZeneca: Lynparza Plus Abiraterone In Phase III Trial Show Positive Results In MCRPC Patients",0,0.48876682
2022-02-16,9981300.0,77.19999694824219,77.80000305175781,76.93000030517578,77.22000122070312,72.77863311767578,MRK,"7 Value Stocks Primed to Take Off in a Rising Rate Environment ||| Corcept's (CORT) Q4 Earnings Beat Estimates, Revenues Miss ||| Worried About Pfizer's Post-Pandemic Growth? These 14 Words from Pfizer's CEO Should Reassure You.",0,0.471766
2022-02-17,8889300.0,76.8499984741211,76.93000030517578,76.0,76.36000061035156,71.96809387207031,MRK,3 Dow Stocks To Avoid ||| October 21st Options Now Available For Merck (MRK) ||| Mirati (MRTX) Down on Longer Review Period for Adagrasib NDA ||| Is Invesco Defensive Equity ETF (DEF) a Strong ETF Right Now? ||| Alkermes' (ALKS) Q4 Earnings and Revenues Beat Estimates ||| Is Merck & Co. (MRK) Suitable for Value Investors Now? ||| S.Africa allows use of Merck COVID pill but government not buying,1,0.50208163
2022-02-18,8780500.0,76.31999969482422,76.86000061035156,75.88999938964844,76.37000274658203,71.9775161743164,MRK,"Top Research Reports for Merck, Shopify & Intercontinental Exchange ||| Exelixis (EXEL) Q4 Earnings & Revenues Beat, Cabometyx Strong",0,0.5019193
2022-02-22,9052500.0,76.45999908447266,76.86000061035156,75.61000061035156,75.94999694824219,71.58167266845703,MRK,"This Trend Is the Biggest Risk to Biotech Investors Right Now ||| S.Africa changes COVID vaccination rules to try to boost uptake ||| Is a Beat Likely for Moderna (MRNA) This Earnings Season? ||| The Zacks Analyst Blog Highlights Merck & Co, Shopify, Intercontinental Exchange, Barrick Gold Corp and NXP Semiconductors ||| Is Inflation a Threat for Pharma Stocks? ||| AstraZeneca (AZN) Enhertu Effective in HER2-Low Breast Cancer ||| Is Moderna the Next Gilead or the Next Regeneron?",0,0.50180495
2022-02-23,9659100.0,76.19000244140625,76.44000244140625,75.62000274658203,75.83999633789062,71.47801208496094,MRK,"Noteworthy ETF Outflows: XLV, TMO, MRK, LLY",0,0.5134112
2022-02-24,21135600.0,75.0999984741211,75.31999969482422,72.87999725341797,73.51000213623047,69.28202056884766,MRK,"Japan's Shionogi seeks approval for COVID-19 pill ||| Japan's Shionogi seeks approval for oral COVID-19 drug ||| Moderna (MRNA) Q4 Earnings Top, COVID-19 Vaccine Brings $7B ||| MRK April 8th Options Begin Trading",1,0.499904
2022-02-25,13665900.0,74.19999694824219,77.29000091552734,74.16999816894531,76.31999969482422,71.93038940429688,MRK,"Dow Movers: HD, MRK ||| Iovance (IOVA) Announces Wider-Than-Anticipated Q4 Loss",1,0.5168224
2022-02-28,14126100.0,75.83000183105469,76.76000213623047,74.77999877929688,76.58000183105469,72.1754379272461,MRK,3 Healthcare Stocks That Could Set You Up for Life ||| Here's Why Bristol Myers Squibb Stock Is A Better Pick Over This Pharmaceutical Bellwether ||| 7 Safe Defensive Stocks to Buy as Market Agitation Rises ||| Biotech Stocks Facing FDA Decision In March 2022,0,0.52359056
2022-03-01,9807300.0,76.5,77.76000213623047,75.94999694824219,76.33999633789062,71.94923400878906,MRK,"November 18th Options Now Available For Merck ||| Nektar (NKTR) Q4 Earnings Top, Three Bempeg Filings Due in 2022 ||| Mirati (MRTX) Q4 Earnings and Sales Fall Short of Estimates",1,0.500804
2022-03-02,9697500.0,76.30999755859375,77.22000122070312,76.05999755859375,76.66999816894531,72.26026916503906,MRK,WHO recommends Merck's COVID pill for high-risk patients ||| Pfizer to provide 10 mln courses of COVID pill to developing countries -the Global Fund,1,0.51559025
2022-03-03,8191100.0,76.7699966430664,77.54000091552734,76.41000366210938,77.1500015258789,72.71265411376953,MRK,"Genome, Merck To Evaluate GEN-001 - KEYTRUDA Combination In Phase 2 Trial In Biliary Tract Cancer ||| IVE, UNH, V, MRK: ETF Inflow Alert",1,0.5180317
2022-03-04,12216300.0,76.68000030517578,77.86000061035156,76.0199966430664,77.83000183105469,73.35356140136719,MRK,Merck (MRK) Gains As Market Dips: What You Should Know ||| WHO Recommends Merck (MRK) Oral Pill for Certain COVID Patients,0,0.50060344
2022-03-07,14008400.0,77.01000213623047,78.29000091552734,76.08000183105469,77.7300033569336,73.25930786132812,MRK,"Why You Should Buy and Hold This High-Yield Dividend Stock ||| FDA Nods to Bristol Myers' (BMY) Opdivo for Additional Indication ||| Merck (MRK) Outperforms Industry, What's in Store for 2022? ||| Here's Why Humira Maker Is A Better Bet Compared To Johnson & Johnson Stock",0,0.48529884
2022-03-08,10184100.0,77.25,78.08999633789062,76.55999755859375,76.94999694824219,72.52415466308594,MRK,Alpine (ALPN) Down on FDA Partial Clinical Hold on Cancer Study ||| Should You Invest in the Invesco Dynamic Pharmaceuticals ETF (PJP)? ||| Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? ||| What's Next For Pfizer Stock After A 10% Fall In A Month?,1,0.5150715
2022-03-09,9746000.0,77.62000274658203,78.22000122070312,77.05000305175781,77.79000091552734,73.31584167480469,MRK,4 Secular Growth Stocks To Watch In The Stock Market Today ||| Got $300? These 3 Stocks Could Be Bargain Buys for 2022 and Beyond ||| What's in Store for These 3 Big Pharma Outperformers in 2022?,1,0.48955363
2022-03-10,8972200.0,77.62999725341797,78.19999694824219,77.33000183105469,77.88999938964844,73.41008758544922,MRK,"Merck (MRK) Gains As Market Dips: What You Should Know ||| Philippines approves emergency use of Pfizer's COVID-19 drug Paxlovid ||| Top Stock Reports for Bank of America, Qualcomm & ConocoPhillips ||| April 29th Options Now Available For Merck (MRK) ||| Pfizer (PFE) Begins Pediatric Study on COVID Pill Paxlovid ||| 7 Drug Stocks to Consider After the Viatris Plunge ||| Africa CDC has MOU with Pfizer for supplies of COVID-19 pill ||| Is Invesco S&P 500 Equal Weight Health Care ETF (RYH) a Strong ETF Right Now?",1,0.49852812
2022-03-11,9424500.0,78.31999969482422,79.62999725341797,78.19999694824219,78.26000213623047,73.7588119506836,MRK,"U.S. FDA approves AstraZeneca-Merck's Lynparza to treat early-stage breast cancer ||| Noteworthy Friday Option Activity: DPZ, MRK, UPLD ||| Is Regeneron Stock a Buy Now? ||| iShares S&P 500 Value ETF Experiences Big Inflow ||| Mirati (MRTX) Focuses on Seeking Nod for KRAS Drug Adagrasib ||| ANALYSIS-Drugmakers look to help Ukrainians in drug trials after Russian invasion ||| Japan's Fujifilm to halt enrollment in Avigan trial for COVID-19 ||| Down 9% In A Month, Will Zoetis Stock Rebound?",0,0.50618476
2022-03-14,10085400.0,77.9000015258789,78.61000061035156,77.30999755859375,77.77999877929688,73.95849609375,MRK,Do Options Traders Know Something About Merck (MRK) Stock We Don't? ||| U.S. FDA declines to approve AstraZeneca treatment for chronic nasal condition,1,0.5039381
2022-03-15,11403000.0,77.68000030517578,79.01000213623047,77.4000015258789,78.63999938964844,74.7762451171875,MRK,"Imugene, Merck To Evaluate HER-Vaxx - KEYTRUDA Combination In Phase 2 Trial For Gastric Cancer ||| Nektar (NKTR) Plunges on Bempeg's Melanoma Study Failure ||| U.S., EU, India, S.Africa reach consensus on COVID vaccine IP waiver-sources ||| Illumina launches multiple-gene test to spot rare treatable cancers ||| Merck Stoping Phase 3 KEYLYNK-010 Trial Investigating KEYTRUDA In Combination With LYNPARZA",0,0.5147568
2022-03-16,10944000.0,78.95999908447266,79.11000061035156,77.6500015258789,78.12000274658203,74.28180694580078,MRK,"Merck (MRK) Stock Sinks As Market Gains: What You Should Know ||| Iovance (IOVA) to Start Clinical Studies for TIL Therapy ||| AbbVie (ABBV) Inks Deal to Develop COVID Antiviral Treatment ||| Merck (MRK) Stops Keytruda-Lynparza Combo Prostate Cancer Study ||| WTO chief welcomes COVID shot patent waiver plan, drugmakers balk ||| Merck to pause investments in Russia, will supply essential medicines ||| Drugmakers condemn plan for COVID vaccine patent waiver",1,0.48089427
2022-03-17,10279400.0,78.1500015258789,79.37000274658203,78.05999755859375,78.94000244140625,75.06150817871094,MRK,"Adagene (ADAG) Gets FDA Nod for Cancer Study on ADG126 Combo ||| AstraZeneca, Merck's Lynparza Cut Risk of Breast Cancer Death ||| Generic drugmakers sign on to make cheap version of Pfizer COVID pill ||| Here's Why Merck (MRK) is a Strong Value Stock ||| What's Next For Teva Pharmaceutical Stock After A 17% Fall In A Month? ||| GSK to supply essential medicines to Russia, halt clinical trials",1,0.50472414
2022-03-18,21064800.0,79.18000030517578,79.73999786376953,78.62999725341797,79.11000061035156,75.2231674194336,MRK,"3 Top Health Care Stocks To Watch Right Now ||| Dow Movers: TRV, MRK ||| Top Stock Market News For Today March 18, 2022",0,0.54600203
2022-03-21,10478300.0,79.66999816894531,80.44999694824219,78.91000366210938,79.05999755859375,75.17560577392578,MRK,"Bristol Myers' (BMY) Opdualag Wins FDA Nod for Melanoma ||| ESGU, HD, LLY, MRK: ETF Inflow Alert ||| 2 Top Biotech Stocks to Buy Right Now",1,0.50104797
2022-03-22,10016600.0,79.2699966430664,79.77999877929688,78.7699966430664,79.30000305175781,75.40382385253906,MRK,Merck (MRK) Gains But Lags Market: What You Should Know ||| Merck (MRK) Keytruda Gets Another FDA Nod in Endometrial Cancer ||| Pfizer to sell up to 4 mln courses of COVID pills to UNICEF this year ||| Roche Stock Has More Upside,1,0.518654
2022-03-23,8470400.0,79.30000305175781,80.58000183105469,79.2300033569336,79.7300033569336,75.81269836425781,MRK,"Dow Movers: CRM, CVX ||| AstraZeneca's preventative COVID shot set to win EU clearance this week-sources ||| Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio ||| Are Covid-19 Treatment Stocks A Buy As Global Infections Rise Again?",1,0.47848046
2022-03-24,7605000.0,80.04000091552734,80.66999816894531,79.72000122070312,80.41000366210938,76.45928955078125,MRK,"Pharma Stock Roundup: NVS, MRK Get FDA Nod, PFE Ulcerative Colitis Study Succeeds",1,0.5119627
2022-03-25,7125600.0,80.58999633789062,81.37999725341797,80.44999694824219,81.33999633789062,77.34358215332031,MRK,"AstraZeneca's (AZN) Imfinzi Misses Goal in Cervical Cancer Study ||| Bristol Myers (BMY) Gains 16% YTD: Will the Momentum Continue? ||| The Zacks Analyst Blog Highlights Novartis, Merck and Pfizer ||| Japan's Shionogi signs govt supply pact for pill to fight COVID",0,0.50031817
2022-03-28,7071900.0,81.37000274658203,81.66999816894531,80.7300033569336,81.20999908447266,77.219970703125,MRK,Merck (MRK) Stock Sinks As Market Gains: What You Should Know ||| Bristol (BMY) Label Expansion of Reblozyl Delayed by 3 Months ||| FDA Revises EUA of Glaxo (GSK) & Vir's (VIR) COVID Therapy ||| Biotech Stocks Facing FDA Decision In April 2022,1,0.4924017
2022-03-29,7398700.0,81.66000366210938,81.76000213623047,80.73999786376953,81.56999969482422,77.5622787475586,MRK,"Bristol Myers (BMY) Application for Opdivo With Chemo Validated ||| 2 Dirt Cheap Dividend Stocks to Buy Right Now ||| HDV, MRK, BMY, UPS: Large Inflows Detected at ETF ||| Here's How Investors Can Find Strong Medical Stocks with the Zacks ESP Screener ||| Is Invesco Dynamic Pharmaceuticals ETF (PJP) a Strong ETF Right Now?",1,0.4935711
2022-03-30,9326600.0,81.83999633789062,82.69999694824219,81.66999816894531,82.4000015258789,78.35150146484375,MRK,Dow Analyst Moves: MRK ||| 3 of the Best Value Stocks to Buy Heading Into April ||| 5 Charts That Show Why Bristol-Myers Squibb Is a No-Brainer Buy,0,0.4780005
2022-03-31,12466800.0,82.9000015258789,83.37999725341797,81.94000244140625,82.05000305175781,78.01870727539062,MRK,"3 Cash Cow Stocks to Buy for Stable Returns ||| Corcept (CORT) Posts OS Data from Phase II Ovarian Cancer Study ||| ANALYSIS-Cyber insurers face hefty Ukraine war-related claims, despite fine print ||| ANALYSIS-Cyber insurers face hefty Ukraine war-related claims, despite fine print ||| Will Pfizer Stock See Higher Levels After A 10% Rise In A Month?",1,0.5059648
2022-04-01,10086700.0,82.19000244140625,83.58000183105469,81.63999938964844,83.5199966430664,79.4164810180664,MRK,Merck: FDA Extends PDUFA Date Of SBLA For VAXNEUVANCE - Quick Facts ||| Stellar Sales Growth Trend Makes Alnylam Pharmaceuticals Stock A Wise Bet,0,0.500917
2022-04-04,9039600.0,83.5,83.88999938964844,82.7300033569336,83.48999786376953,79.38794708251953,MRK,"2 Drugmakers Set for Explosive Revenue This Decade ||| Pfizer made 6 mln courses of COVID pill, hitting Q1 target ||| Clovis (CLVS) Up 24% on Upbeat Data From Ovarian Cancer Study ||| Can Merck (MRK) Keep the Earnings Surprise Streak Alive? ||| Merck's (MRK) Pneumococcal Vaccine sBLA Faces FDA Delay",1,0.5129737
2022-04-05,12040900.0,83.66000366210938,85.43000030517578,83.51000213623047,83.72000122070312,79.60665130615234,MRK,"Merck (MRK) Gains As Market Dips: What You Should Know ||| Notable Tuesday Option Activity: MRK, ADI, ABBV ||| Bristol Myers (BMY) Gets EC Nod for Opdivo's Label Expansion ||| Why This 1 Value Stock Could Be a Great Addition to Your Portfolio ||| Top Stock Market News For Today April 5, 2022",1,0.48008615
2022-04-06,13924300.0,84.36000061035156,85.55999755859375,84.12000274658203,84.97000122070312,80.79524230957031,MRK,"Top Analyst Reports for Merck, CVS Health & American Tower ||| Iovance (IOVA) to Seek FDA Nod for Melanoma Therapy in August ||| Notable ETF Outflow Detected - HDV, MRK, BMY, UPS ||| Don’t Bet on New Highs for Novavax Stock",1,0.48657358
2022-04-07,13104300.0,85.75,87.11000061035156,84.95999908447266,86.80000305175781,82.53532409667969,MRK,"The Zacks Analyst Blog Highlights Merck, CVS Health, American Tower, QUALCOMM and Analog Devices",1,0.5119772
2022-04-08,11409300.0,86.63999938964844,87.83999633789062,86.26000213623047,87.68000030517578,83.3720932006836,MRK,"Pharma Stock Roundup: PFE to Buy RSV Drugmaker, FDA Updates for NVS, MRK and RHHBY ||| Iovance (IOVA) Stock Rallies 33% in a Month: Here's Why ||| Best Stocks To Buy Now? 3 Health Care Stocks For Your List ||| Here's Why a Drop in Moderna's Revenue Wouldn't Be Catastrophic ||| 3 Things About Pfizer That Smart Investors Know",0,0.48192886
2022-04-11,14381000.0,88.31999969482422,89.4800033569336,86.18000030517578,86.62999725341797,82.3736801147461,MRK,"Britain widens access to Pfizer's COVID antiviral drug through trial ||| Merck (MRK) Stock Moves -1.2%: What You Should Know ||| Best Dividend Stocks To Buy Today? 4 In Focus ||| Up 18% In A Month, Will Eli Lilly Stock Continue To See Higher Levels?",0,0.49911118
2022-04-12,12543000.0,86.0,86.55000305175781,85.22000122070312,85.62999725341797,81.42280578613281,MRK,"Bristol Myers' (BMY) Opdivo Data Positive for Neoadjuvant NSCLC ||| Dow Movers: MRK, CVX ||| Gilead (GILD) Magrolimab Studies' Partial Clinical Hold Removed ||| Will AbbVie Stock Continue To Make New Highs?",1,0.50456876
2022-04-13,12743800.0,85.80000305175781,86.23999786376953,84.83000183105469,86.12999725341797,81.89824676513672,MRK,"Merck Stock: COVID-19 Drug Should Boost 2022 Numbers ||| Noteworthy Wednesday Option Activity: MRK, FDX, CRM ||| Shionogi shares plunge 15% on pregnancy risk concern for COVID pill ||| 2 Unbelievable Clues That Biotech Revenue May Soon Rival Big Pharma",1,0.5357369
2022-04-14,22096100.0,86.12999725341797,87.51000213623047,85.41000366210938,86.91000366210938,82.63992309570312,MRK,"Nektar stops clinical trials for key cancer drug, shares tumble ||| See Which Of The Latest 13F Filers Holds Merck ||| Thursday's ETF with Unusual Volume: LGLV ||| Seagen (SGEN) Gets Nod From EU for Bladder Cancer Drug, Padcev ||| Anthem (ANTM) to Post Q1 Earnings: What's in the Offing? ||| Merck's 21-valent Pneumococcal Conjugate Vaccine Gets FDA Breakthrough Therapy Designation ||| 2 Unstoppable Green Flags for AbbVie",0,0.5120389
2022-04-18,7995100.0,86.41999816894531,87.44999694824219,85.68000030517578,86.06999969482422,81.8411865234375,MRK,3 Healthcare Stocks That Are Looking Even Healthier ||| Merck's (MRK) Pneumococcal Jab Gets FDA's Breakthrough Tag ||| J&J (JNJ) to Set the Tone for Pharma Sector's Q1 Earnings ||| Merck's Keytruda Scores Another Regulatory Nod In Canada,0,0.51094383
2022-04-19,8494700.0,85.97000122070312,86.08999633789062,85.12000274658203,85.79000091552734,81.57495880126953,MRK,Exelixis (EXEL) Outperforms Industry YTD: What Lies Ahead? ||| ANALYSIS-Demand for Pfizer's COVID pills lags around the world,1,0.5002235
2022-04-20,8719400.0,85.5199966430664,86.81999969482422,85.4800033569336,86.45999908447266,82.21202850341797,MRK,Merck (MRK) Gains As Market Dips: What You Should Know ||| 2 Healthcare Stocks That Could Make You Richer ||| AstraZeneca's (AZN) Enhertu sBLA Receives FDA Priority Tag,0,0.5110632
2022-04-21,8562400.0,86.41000366210938,87.2300033569336,85.38999938964844,86.2300033569336,81.99333953857422,MRK,Shionogi shares jump on report U.S. interested in buying COVID pill ||| WHO backs Pfizer's oral COVID therapy for high-risk patients ||| 3 High-Yielding Dividend Stocks You Can Buy and Forget,0,0.48605067
2022-04-22,7914000.0,85.86000061035156,86.13999938964844,84.5,84.58999633789062,80.43390655517578,MRK,2 Dividend Stocks to Buy and Hold Forever ||| Is a Beat Likely for Amgen (AMGN) This Earnings Season?,1,0.4927311
2022-04-25,10573400.0,84.58999633789062,85.80999755859375,83.52999877929688,85.44000244140625,81.24214172363281,MRK,"Down More Than 23%, This Year's 2 Worst-Performing Dow Stocks Look Like Monster Buys Right Now ||| This Unstoppable Dividend Aristocrat Is 2022's Best-Performing Dow Stock (and It's Not Even Close) ||| iShares Core Dividend Growth ETF Experiences Big Inflow ||| Where Will Vertex Pharmaceuticals Be in 5 Years? ||| These 3 Dow Stocks Are Set to Soar in 2022's Second Half and Beyond ||| 5 Blue-Chip Stocks Likely to Gain on Earnings Results This Week",0,0.47370428
2022-04-26,9009600.0,85.76000213623047,86.19999694824219,84.38999938964844,84.4800033569336,80.32931518554688,MRK,"U.S. to widen COVID antiviral pill distribution ||| Top Research Reports for Novo Nordisk, AMD & Netflix ||| Merck: A Dividend Growth Stock Worth Considering ||| Dow Movers: MMM, VZ ||| 7 Retirement Stocks to Buy to Sleep Soundly at Night ||| The Zacks Analyst Blog Highlights Amgen, Chevron, Coca-Cola, Visa and Merck ||| Will Merck (MRK) Beat Expectations This Earnings Season?",0,0.5155679
2022-04-27,10781300.0,84.30000305175781,85.12999725341797,83.5999984741211,84.41000366210938,80.26274871826172,MRK,"Pre-Market Earnings Report for April 28, 2022 : MA, LLY, MRK, TMO, CMCSA, MCD, LIN, SNY, CAT, MO, SO, NOC ||| Drug/Biotech Stocks Q1 Earnings Due on Apr 28: MRK, LLY & More ||| EU estimates up to 80% of population has had COVID ||| Why Earnings Season Could Be Great for Merck (MRK) ||| The Zacks Analyst Blog Highlights Novo Nordisk, Advanced Micro Devices, Netflix, Merck, and Marsh & McLennan ||| Merck Reports Earnings Tomorrow – What Can We Expect?",1,0.4815998
2022-04-28,21092300.0,85.75,89.37000274658203,85.0,88.58000183105469,84.2278823852539,MRK,"Alkermes (ALKS) Q1 Earnings Beat Estimates, Revenues Rise Y/Y ||| Merck & Co. (MRK) Q1 2022 Earnings Call Transcript ||| Notable Thursday Option Activity: OMCL, CHDN, MRK ||| COVID SCIENCE-Mental health issues in kids rose during pandemic; awareness and use of COVID treatments is low ||| Why Merck Crushed the Market Today ||| Merck profit tops expectations on demand for COVID pill, cancer drugs ||| Merck (MRK) Surpasses Q1 Earnings and Revenue Estimates ||| Merck Raises, Narrows Full-year Guidance ||| Could This FDA Approval Be a Boost for Merck? ||| Dow Movers: CAT, MRK",1,0.48613867
2022-04-29,15914200.0,88.66000366210938,90.01000213623047,88.08999633789062,88.69000244140625,84.33246612548828,MRK,"AstraZeneca (AZN) Q1 Earnings and Revenues Beat Estimates ||| Seagen's (SGEN) Q1 Earnings & Revenues Surpass Estimates ||| What This Regulatory News Could Mean for Merck ||| Pharma Stock Roundup: Q1 Earnings of LLY, MRK & NVS, FDA Updates for AZN & PFE ||| Company News for Apr 29, 2022",0,0.49183074
2022-05-02,12124900.0,88.72000122070312,88.83999633789062,86.62999725341797,87.6500015258789,83.34355926513672,MRK,Top Pharmaceutical Stocks To Watch In May 2022 ||| Is a Beat Likely for Moderna (MRNA) This Earnings Season? ||| 7 Safe Stocks to Buy in May 2022 ||| What To Expect From Bristol Myers Squibb Stock After Q1 Results? ||| What To Expect From Pfizer's Q1?,0,0.47811964
2022-05-03,8425600.0,86.98999786376953,88.23999786376953,86.43000030517578,87.0999984741211,82.82059478759766,MRK,Validea Joel Greenblatt Strategy Daily Upgrade Report - 5/3/2022,1,0.5034908
2022-05-04,10763500.0,86.56999969482422,88.7699966430664,86.36000061035156,88.5199966430664,84.17082214355469,MRK,"Moderna (MRNA) Beats on Q1 Earnings, to Start Two Late Studies",0,0.5190998
2022-05-05,9548300.0,88.41999816894531,88.66000366210938,87.02999877929688,88.01000213623047,83.68587493896484,MRK,"Mirati (MRTX) Q1 Loss Wider Than Expected, Sales Beat",1,0.5245332
2022-05-06,12227400.0,87.73999786376953,88.91999816894531,87.4800033569336,88.38999938964844,84.04720306396484,MRK,"Corcept's (CORT) Q1 Earnings & Revenues Fall Shy of Estimates ||| Iovance (IOVA) Q1 Earnings Beat, Lifileucel BLA on Track ||| Why Merck (MRK) is a Top Value Stock for the Long-Term",0,0.50405824
2022-05-10,12370800.0,88.12000274658203,89.29000091552734,87.2699966430664,87.80999755859375,83.49569702148438,MRK,"Health Care Sector Update for 05/10/2022: BHVN, PFE, EVAX, ITCI, MRK",1,0.4948719
2022-05-11,16338600.0,87.41999816894531,90.80999755859376,87.41999816894531,89.19000244140625,84.80789184570312,MRK,"Notable Wednesday Option Activity: CME, MCD, MRK ||| New class of cancer drugs down, not out, after Roche trial setback - analysts ||| Exelixis (EXEL) Q1 Earnings Beat, Revenues Miss Estimates ||| Pfizer's $11.6 bln Biohaven buy could spark more biotech deals ||| iShares Core High Dividend ETF Experiences Big Inflow ||| Blow to Roche's cancer immunotherapy prospects as 2nd trial fails",1,0.44800356
2022-05-12,14210200.0,89.8499984741211,90.8499984741211,88.36000061035156,90.83000183105467,86.3673324584961,MRK,Best Stocks To Buy Now In 2022? 4 Dividend Stocks For Your Watchlist ||| These High-Yield Dividend Stocks Are Growing at Blazing Speeds ||| Generic drugmakers to sell Pfizer's Paxlovid for $25 or less in low-income countries,0,0.4809035
2022-05-16,13999000.0,90.79000091552734,92.87000274658205,90.68000030517578,92.31999969482422,87.78411102294922,MRK,"Validea's Top Five Healthcare Stocks Based On Peter Lynch - 5/15/2022 ||| Dalio, Grantham, Simons, and Watsa All Hold Merck",1,0.51508534
2022-05-17,17582800.0,92.30999755859376,94.55999755859376,91.51000213623048,93.0,88.43070220947266,MRK,Merck (MRK) Shares Cross 3% Yield Mark ||| Bristol Myers (BMY) Phase III CheckMate -901 Study Disappoints ||| Merck Reaches Analyst Target Price,0,0.5044803
2022-05-18,12717600.0,92.55999755859376,93.16000366210938,91.7699966430664,92.0999984741211,87.57491302490234,MRK,Pfizer (PFE) Gets EUA for Use of Comirnaty Booster in Children,0,0.46536034
2022-05-19,11121600.0,91.25,92.61000061035156,90.87999725341795,92.08999633789062,87.56542205810547,MRK,4 Large Drug Stocks to Watch as the Industry Recovers ||| Merck (MRK) Outperforms Industry This Year So Far: Here's Why ||| 7 Dividend Stocks to Boost Your Retirement Savings ||| Here's Why Centene Stock Is A Better Bet Compared To This Pharmaceuticals Bellwether,1,0.5022452
2022-05-20,11757100.0,92.4499969482422,94.08000183105467,92.4499969482422,93.5500030517578,88.95368194580078,MRK,"Mirati (MRTX) Seeks EU Nod for Adagrasib to Treat Lung Cancer ||| Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck, and Glaxo",1,0.51697254
2022-05-23,9067000.0,93.58999633789062,94.91999816894533,93.4000015258789,93.83000183105467,89.21993255615234,MRK,7 Quality Dividend Stocks to Buy on the Dip ||| 2 Safe Stocks to Buy in a Bear Market ||| 7 Retirement Stocks to Buy for Any Market Conditions ||| Merck & Co Inc Shares Approach 52-Week High - Market Mover ||| Merck's (MRK) Keytruda Gets CHMP Nod for Expanded Melanoma Use ||| 4 Dow Stocks Billionaire Money Managers Bought Hand Over Fist in the First Quarter,1,0.5253319
2022-05-24,9021000.0,94.25,94.8000030517578,93.56999969482422,94.63999938964844,89.99012756347656,MRK,"DSI, PG, MRK, VZ: ETF Inflow Alert ||| Seagen (SGEN) Posts Positive Data from New Study on Tukysa ||| EU Approves Merck's Keytruda Combination For Early-stage Triple-negative Breast Cancer",0,0.51139134
2022-05-25,11177700.0,94.36000061035156,94.76000213623048,93.13999938964844,93.75,89.14385223388672,MRK,2 Top Biotech Stocks to Buy in May ||| 3 Unstoppable Investments Everyone Needs in Their Portfolio ||| Merck (MRK) Keytruda Gets EU Nod for Expanded Breast Cancer Use ||| 3 Dow Stocks That Are Crushing It in 2022: Are They Buys Now?,0,0.49997512
2022-05-26,17249500.0,94.23999786376952,94.25,91.0,92.30999755859376,87.77461242675781,MRK,"Mirati drug shrinks tumors in 44% of advanced lung cancer patients ||| Health Care Sector Update for 05/26/2022: CHNG,APYX,NVCR,MRK,EXAI ||| Health Care Sector Update for 05/26/2022: APYX,NVCR,MRK,EXAI ||| Best Health Care Stocks To Invest In 2022? 3 Names To Watch ||| Dow Movers: AAPL, NKE ||| Better Dividend Stock: Pfizer or Merck? ||| Why Did Warren Buffett Just Sell 1 of His Best Stocks of 2022?",1,0.4885073
2022-05-27,9802000.0,92.27999877929688,93.11000061035156,91.75,93.08000183105467,88.50678253173828,MRK,"Iovance (IOVA) Down After Announcing Data From Melanoma Study ||| Mirati (MRTX) Down 23% on Mixed Data From Lung Cancer Study ||| Why This Fast-Growing Dividend Stock Is a Buy ||| Exelixis (EXEL) Announces Results From Phase II HNSCC Study ||| Pharma Stock Roundup: EU Nod for AZN, JNJ & Others, PFE COVID Jab Effective in Kids",0,0.49062973
2022-05-31,22860800.0,91.91000366210938,92.62000274658205,90.87000274658205,92.02999877929688,87.50836944580078,MRK,"Bristol Myers' (BMY) Opdivo Combos Get FDA Nod for ESCC ||| Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick ||| Real Estate Trends for Investors to Watch ||| The Zacks Analyst Blog Highlights AstraZeneca, Merck, Roche, J&J, and Pfizer",0,0.49708584
2022-06-01,10492500.0,91.66999816894533,91.93000030517578,90.04000091552734,91.13999938964844,86.66210174560547,MRK,7 Stocks to Buy and Hold Forever in This Bear Market,0,0.50791436
2022-06-02,11066200.0,91.12999725341795,91.13999938964844,88.73999786376953,90.0,85.57810974121094,MRK,"Noteworthy ETF Outflows: MTUM, MRK, COP, LMT",0,0.5244383
2022-06-03,7051600.0,89.73999786376953,90.68000030517578,89.68000030517578,89.91000366210938,85.49252319335938,MRK,"Regeneron (REGN) to Buy Sanofi's Stake in Libtayo, Stock Down ||| Why Pfizer Needs a High-Growth Pipeline ||| The 3 Best Long-Term Stocks to Add to Your Q2 Buy List",0,0.48256046
2022-06-06,8336900.0,90.16999816894533,90.66000366210938,89.69000244140625,89.83999633789062,85.42597198486328,MRK,"Can the Best-Selling Drugs of 2021 Repeat Their Performance? ||| Bristol Myers (BMY) to Acquire Turning Point, Withdraws sBLA ||| Mirati drug helps some patients whose lung cancer spread to the brain -study",1,0.5063024
2022-06-07,10243300.0,90.1500015258789,90.81999969482422,89.58000183105469,90.4800033569336,86.0345230102539,MRK,Merck a Top Socially Responsible Dividend Stock With 3.1% Yield (MRK) ||| Is There More Room For Growth In Bristol Myers Squibb Stock?,0,0.49556282
2022-06-08,10266000.0,90.58000183105467,90.6500015258789,89.2699966430664,89.4800033569336,85.08364868164062,MRK,"Pre-Market Most Active for Jun 8, 2022 : RDBX, DIDI, TQQQ, NIO, SQQQ, NVAX, VZ, CCL, MRK, BABA, GILD, BILI",0,0.48738655
2022-06-09,7381100.0,89.25,89.79000091552734,87.91999816894531,88.0,83.6763687133789,MRK,Merck (MRK) Stock Moves -1.65%: What You Should Know ||| MRK July 29th Options Begin Trading,0,0.48546407
2022-06-10,8861600.0,87.16999816894531,88.04000091552734,86.70999908447266,87.18000030517578,82.89665222167969,MRK,"Ex-Dividend Reminder: Merck, Gilead Sciences and KBR ||| Merck a Top 25 Dividend Giant With 3.14% Yield (MRK)",0,0.49282846
2022-06-13,12016100.0,85.70999908447266,86.51000213623047,84.62999725341797,85.0,80.82376098632812,MRK,"2 Best Biotech Stocks to Buy Right Now ||| Noteworthy ETF Outflows: IVE, MRK, DIS, CMCSA ||| Bristol Myers (BMY) Up 20.4% YTD: Will the Momentum Continue? ||| Teladoc Can’t Rely On Hype To Attract Investors",0,0.51863706
2022-06-14,11226900.0,84.7699966430664,85.04000091552734,83.87000274658203,84.5,81.00591278076172,MRK,Merck Enters Oversold Territory ||| Merck (MRK) Keytruda Adjuvant Lung Cancer sBLA Accepted by FDA,1,0.5092352
2022-06-15,11357100.0,84.55999755859375,85.37000274658203,83.75,84.62999725341797,81.13053131103516,MRK,Merck (MRK) Gains But Lags Market: What You Should Know ||| Pfizer (PFE) COVID Pill Ineffective in Standard Risk Patients ||| Dow Analyst Moves: MRK ||| 7 Seriously Undervalued Dow Stocks to Buy Before Wall Street Catches On ||| Is There A Better Pick Over Merck Stock In Animal Health Space?,1,0.48053384
2022-06-16,12925200.0,83.7699966430664,85.19000244140625,83.05000305175781,84.88999938964844,81.3797836303711,MRK,September 16th Options Now Available For Merck (MRK),0,0.5086679
2022-06-17,32989100.0,84.63999938964844,85.76000213623047,83.38999938964844,84.62000274658203,81.1209487915039,MRK,"Health Care Sector Update for 06/17/2022: SRRK,SGEN,MRK,UNH,ADXN ||| Why Seagen Surged Today ||| Health Care Sector Update for 06/17/2022: SGEN,MRK,UNH,ADXN ||| Merck considering purchase of cancer drug maker Seagen - WSJ ||| These 2 Dividend ETFs Are a Retiree's Best Friend ||| Pharma Stock Roundup: FDA Panel Nod for PFE, MRNA Young Kids' COVID Jabs & More",1,0.45649707
2022-06-21,11778600.0,86.05000305175781,88.36000061035156,85.2699966430664,88.02999877929688,84.38993835449219,MRK,Seagen (SGEN) Stock Up on Rumors of Acquisition by Merck ||| Best Health Care Stocks To Buy Now? 3 To Watch ||| 3 Stocks That Drove the Dow's 641-Point Gain ||| Merck Presents Positive Results From Phase 1/2 Study Of Pneumococcal Conjugate Vaccine,1,0.5005142
2022-06-22,11935400.0,88.04000091552734,90.33999633789062,88.02999877929688,89.16000366210938,85.47322082519531,MRK,"Merck (MRK) Gains As Market Dips: What You Should Know ||| The Dow Lost Ground as Investors Piled into Recession-Proof Stocks ||| What Stocks To Invest In Today? 3 Pharmaceutical Stocks To Watch ||| Iovance (IOVA) Pipeline Aids Growth Amid Lack of Marketed Drugs ||| Dow Movers: DOW, MRK ||| FDA Approves Merck's Vaxneuvance For Prevention Of Invasive Pneumococcal Disease In Children",1,0.50028974
2022-06-23,14718400.0,90.0,92.1500015258789,89.55999755859375,92.0,88.1957778930664,MRK,"6 Dividend Income Stocks With Better Yields Than the S&P 500 ||| August 5th Options Now Available For Merck (MRK) ||| Dow Movers: BA, MRK ||| Merck's (MRK) Pneumococcal Vaccine Gets FDA Nod for Kids",1,0.5203394
2022-06-24,25248400.0,93.25,93.79000091552734,91.6999969482422,93.12999725341795,89.279052734375,MRK,"3 Dow Stocks to Buy for a Bear Market ||| Stock Market Today: Dow Jones, S&P 500 Rise; Zendesk Stock Jumps On Acquisition Deal ||| Pharma Stock Roundup: FDA OK's Expanded Use of ABBV, MRK, NVS Drugs, Other Updates ||| Ready to Get Rich in the Stock Market? 5 Investments You Can't Go Wrong With ||| Roche sceptical about investing more in 'guided-missile' ADC cancer drugs ||| Merck: EU Approves KEYTRUDA For Patients Above 12 Years In Stage IIB, IIC And III Melanoma ||| Top Stock Market News For Today June 24, 2022",1,0.51390225
2022-06-27,11949000.0,93.1999969482422,95.72000122070312,93.0500030517578,94.41000366210938,90.50613403320312,MRK,"4 Top Dividend Stocks To Watch Amid Recession Concerns ||| Still Think Tesla Is Expensive? This Stat Will Change Your Mind ||| Dow Movers: BA, MRK ||| Merck (MRK) Keytruda Gets Europe Nod for Expanded Melanoma Use ||| AstraZeneca : Lynparza Recommended For Approval In EU For High-risk Early Breast Cancer ||| Merck Reaches Analyst Target Price ||| Two AstraZeneca drugs get EU backing for treatment of some breast cancers ||| AstraZeneca gets EU backing for targeted breast cancer therapies",0,0.54471743
2022-06-28,13523300.0,94.11000061035156,94.33000183105467,91.47000122070312,91.88999938964844,88.09032440185547,MRK,"Sutro Biopharma (STRO) Up 50% on Cancer Treatment Collaboration ||| AstraZeneca (AZN) Drugs Get CHMP Recommendation for Breast Cancer ||| Dow Movers: NKE, BA",1,0.50062364
2022-06-29,8657100.0,92.30999755859376,92.9800033569336,91.88999938964844,92.51000213623048,88.68468475341797,MRK,"Merck (MRK) Gains As Market Dips: What You Should Know ||| Top Analyst Reports for Meta Platforms, Eli Lilly & Home Depot ||| 3 Reasons Why Merck (MRK) Is a Great Growth Stock ||| Seagen (SGEN) Up More Than 20% in Past 3 Months: Here's Why ||| This Acquisition Could Make Merck a Scorching-Hot Buy ||| Merck (MRK) is a Top-Ranked Value Stock: Should You Buy? ||| 4 Reasons Why Investors Should Buy Merck (MRK) Stock Now",0,0.500083
2022-06-30,18551400.0,91.6500015258789,92.9000015258789,90.91000366210938,91.16999816894533,87.40010833740234,MRK,"After Hours Most Active for Jun 30, 2022 : MU, TAL, AAPL, IUSV, MRK, QQQ, EQT, AMZN, GSK, MSFT, WFC, ZYME ||| Dow Movers: CRM, MRK ||| Pharma Stock Roundup: FDA Panel Backs Updated COVID Jabs, EU Nod for SNY, MRK Drugs ||| Should You Buy, Sell, Or Hold Pfizer Stock At $52?",1,0.49428394
2022-07-01,11413800.0,91.3000030517578,92.48999786376952,90.38999938964844,92.41999816894533,88.59841918945312,MRK,"Sanofi's (SNY) Studies on BTK Inhibitor Put on Hold by FDA ||| Pfizer (PFE) Seeks FDA Nod for Its Oral Antiviral COVID Pill ||| Has Merck & Co. (MRK) Outpaced Other Medical Stocks This Year? ||| The Zacks Analyst Blog Highlights Sanofi, Merck, Novartis, Pfizer and J&J ||| Should You Buy Johnson & Johnson Stock At $177?",1,0.4973768
2022-07-05,9574400.0,92.44000244140624,92.9499969482422,90.52999877929688,92.63999938964844,88.80931854248047,MRK,"Q3 Likely to Remain Volatile: Top 5 Picks to Stay Safe ||| Here's Why Investors Should Retain Charles River (CRL) Now ||| Should You Buy, Sell, Or Hold Roche Stock At $42? ||| ChemoCentryx's (CCXI) Tavneos Aids Growth, Overdependence a Woe ||| Corcept (CORT) Thrives on Korlym Amid Overdependence Concerns ||| AstraZeneca (AZN) to Buy TeneoTwo, Boost Hematology Pipeline ||| Exelixis (EXEL) Outperforms Industry in 1H22: What Lies Ahead? ||| 6 Recession-Proof Stocks to Buy as the Market Boom Ends ||| 6 Recession-Proof Stocks to Buy as the Market Boom Ends",1,0.5030574
2022-07-06,10455300.0,93.30999755859376,94.51000213623048,92.6999969482422,93.12999725341795,89.279052734375,MRK,"Merck in advanced talks to buy Seagen in nearly $40-billion deal - WSJ ||| Merck in advanced talks to buy Seagen in $40-billion deal - WSJ ||| Roche's (RHHBY) Lunsumio Application Gets Priority Review ||| Reasons Why You Should Invest in ResMed (RMD) Stock Now ||| Dow Movers: CVX, MRK ||| Tandem Diabetes (TNDM) New Launches Aid Growth Amid Cost Woes ||| Bruker (BRKR) International Growth Strong Amid Competition ||| China allows AstraZeneca's COVID preventive drug in southern city ||| China allows AstraZeneca's COVID preventive drug in southern city",0,0.50861186
2022-07-07,8140100.0,92.94000244140624,93.9499969482422,92.5500030517578,93.01000213623048,89.16403198242188,MRK,"Merck's Oncology Business Will Help It Crush the Bear Market ||| Merck (MRK) in Advanced Talks to Buy Seagen (SGEN) Per WSJ ||| Merck (MRK) Stock Sinks As Market Gains: What You Should Know ||| Is Most-Watched Stock Merck & Co., Inc. (MRK) Worth Betting on Now? ||| Bruker (BRKR) Debuts NMR Test for Research on Long COVID Risks ||| Health Care Sector Update for 07/07/2022: ANVS, VERU, MRK, SGEN, XLV, IBB ||| Merck Reportedly In Advanced Talks To Buy Seagen",0,0.48264018
2022-07-08,7161500.0,92.91000366210938,93.81999969482422,92.41000366210938,92.77999877929688,88.94351959228516,MRK,"LabCorp's (LH) Base Testing Volume Grows, Costs Rise ||| Here's Why You Should Retain Haemonetics (HAE) Stock For Now ||| Intercept (ICPT) Reports Positive Data From NASH Study on OCA ||| Buy These 4 Blue-Chip Stocks to Strengthen Your Portfolio",1,0.49080744
2022-07-11,9507700.0,92.87999725341795,94.77999877929688,92.83000183105467,94.3000030517578,90.40067291259766,MRK,"What's Driving AbbVie Stock Higher? ||| PFE, BNTX's COVID Jab Gets FDA's Full Nod for Adolescents ||| What Stocks To Buy Today? 5 Dividend Stocks To Watch In This Bear Market ||| Henry Schein's (HSIC) New Buyout Expands Its Switzerland Base ||| Quest Diagnostics (DGX), CDC Sign New COVID-19 Testing Deal ||| Dow Movers: BA, MRK ||| The Zacks Analyst Blog Highlights Coca-Cola, Home Depot, Merck and JPMorgan Chase",0,0.48365688
2022-07-12,7826500.0,93.77999877929688,94.23999786376952,93.13999938964844,93.5999984741211,89.7296142578125,MRK,"What's Happening With Merck Stock? ||| Top Stock Reports for Coca-Cola, Merck & Toyota Motor ||| Exelixis (EXEL) Cabometyx Combo Study Meets Primary Goal ||| Moderna (MRNA) Bivalent COVID Booster Effective Against BA.4/5 ||| Here's Why You Should Retain Walgreens Boots (WBA) For Now ||| Pliant Therapeutics (PLRX) Up on Positive Data From Lung Disease Study ||| Looking for Medical Stocks? The Zacks Rank Can Help You Find Winners",1,0.50796556
2022-07-13,6415600.0,93.58999633789062,94.36000061035156,93.0199966430664,93.7699966430664,89.89259338378906,MRK,"Quest Diagnostics (DGX) to Report Q2 Earnings: What's In Store? ||| Moderna (MRNA) Starts Early-Stage Nipah Virus Vaccine Study ||| Rhythm (RYTM) Surges on Upbeat Data on Lead Product Candidate ||| 6 Dow Stocks to Buy on the Dip ||| Merck (MRK) Gains As Market Dips: What You Should Know ||| Will Johnson & Johnson Stock See Higher Levels Post Q2? ||| CVS Health (CVS) Pharmacy Claims Volume Grows, Margin Woes Stay ||| Here's Why You Should Retain Thermo Fisher (TMO) Stock Now ||| 3 Drugmaker Stocks Worth Buying to Boost Your Portfolio Health ||| European shares slip ahead of U.S. inflation; investors focus on euro ||| Orion raises outlook after Merck deal on developing prostate cancer drug ||| European shares slip ahead of U.S. inflation; investors focus on euro ||| Catalyst (CPRX) Settles Patent Dispute Over Sole Marketed Drug ||| Orion raises outlook after Merck deal on developing prostate cancer drug ||| The Zacks Analyst Blog Highlights Coca-Cola, Merck, Toyota Motor, Enbridge, and Regeneron Pharmaceuticals ||| Merck, Orion In Deal To Develop Orion's Prostate Cancer Drug ODM-208",1,0.5095259
2022-07-14,6271000.0,92.5500030517578,94.05999755859376,92.05999755859376,93.87999725341795,89.998046875,MRK,Vaxcyte (PCVX) Completes Enrollment in Pneumococcal Disease Study ||| Here's Why Investors Should Retain Phibro (PAHC) For Now ||| LabCorp (LH) Debuts NfL Test for Neuronal Damage Diagnosis ||| Merck (MRK) Buys Rights to Mid-Stage Prostate Cancer Candidate ||| What's in Store for Abbott Laboratories (ABT) in Q2 Earnings?,1,0.4986986
2022-07-15,9731900.0,94.8499984741211,95.3499984741211,94.37000274658205,94.95999908447266,91.03339385986328,MRK,"This New Regulation Could Juice Pfizer Stock Even More ||| UnitedHealth Group (UNH) Q2 Earnings Beat, Hikes '22 EPS View ||| Noteworthy ETF Inflows: HDV, VZ, MRK, CSCO ||| Ultragenyx (RARE) Sells Portion of Royalty Interest for $500M ||| Pharma Stock Roundup: MRK Buys Cancer Drug Rights, SNY Dupixent Kids Study Succeeds ||| How Tax Loss Harvesting Works -- Turn Lemons Into Lemonade ||| Best Growth Stocks to Buy for July 15th ||| J&J (JNJ) to Begin Pharma Sector's Q2 Earnings With a Beat?",0,0.4644316
2022-07-18,8653700.0,94.9000015258789,95.0999984741211,91.91999816894533,92.33999633789062,88.52172088623047,MRK,What's Next For Roche Stock? ||| Align Technology (ALGN) to Post Q2 Earnings: What's in Store? ||| Moderna's (MRNA) COVID Jab Gets Nod For Kids in Canada ||| AbbVie (ABBV) Seeks EU Nod for Atogepant to Prevent Migraine ||| Will Biogen (BIIB) Succeed in Beating Q2 Earnings Estimates? ||| Merck and Block have been highlighted as Zacks Bull and Bear of the Day ||| Bull of the Day: Merck & Co. (MRK),1,0.48576722
2022-07-19,8233600.0,93.1500015258789,93.38999938964844,92.12000274658205,92.36000061035156,88.5408935546875,MRK,"J&J (JNJ) Beats on Q2 Earnings & Sales, Lowers 2022 Guidance ||| Here's Why You Should Retain Chemed (CHE) Stock For Now ||| What's in the Cards for HCA Healthcare's (HCA) Q2 Earnings? ||| What To Expect From Bristol Myers Squibb Stock After Q2 Results? ||| Company News for Jul 19, 2022 ||| GSK Completes Demerger of Consumer Healthcare Business ||| As COVID patent war rages on, pharma group seeks fairer future access",0,0.4974013
2022-07-20,11844000.0,92.36000061035156,92.43000030517578,89.22000122070312,89.6500015258789,85.94295501708984,MRK,"LabCorp (LH) to Offer New Test Report for Venom Allergy Testing ||| Abbott's (ABT) Q2 Earnings Top Estimates, '22 EPS View Up ||| US STOCKS-Nasdaq boosted by growth stocks after Netflix's upbeat forecast ||| AstraZeneca (AZN) Enhertu Receives EU Nod for Expanded Use ||| US STOCKS-Nasdaq boosted by growth stocks after Netflix's upbeat forecast ||| Pfizer (PFE), BioNTech Seek EU Nod for Omicron-Based COVID Jab ||| Merck: Phase 3 KEYNOTE-412 Trial With KEYTRUDA Fails To Meet Primary Endpoint ||| Is Trending Stock Merck & Co., Inc. (MRK) a Buy Now? ||| Shionogi sinks in Tokyo trade after panel again delays COVID pill approval ||| What's in the Offing for Infosys (INFY) This Earnings Season? ||| Merck's Keytruda fails head and neck cancer trial ||| US STOCKS-Wall Street set to open lower after strong gains",1,0.507963
2022-07-21,8197000.0,89.1500015258789,90.41000366210938,88.91000366210938,90.13999938964844,86.41268920898438,MRK,"What This FDA Delay Means for Novartis ||| 5 Cheap Healthcare Stocks in 2022 ||| Healthcare ETFs in Focus Ahead of Q2 Earnings ||| Tilray (TLRY) to Report Q4 Earnings: What's in the Cards? ||| 2 Pharma Stocks for a Recession ||| Is a Beat Likely for F5 Networks (FFIV) This Earnings Season? ||| I'm Buying These 3 Resilient Stocks During a Bear Market ||| Quest Diagnostics (DGX) Tops Q2 Earnings Estimates, Ups View",0,0.51407766
2022-07-22,6354500.0,90.11000061035156,90.4499969482422,89.45999908447266,90.11000061035156,86.38394165039062,MRK,"Market Predictions 2022: When Will Stocks Go Back Up? ||| Merck Q2 Preview: Double-Digit Earnings Growth in Store? ||| Liminal (LMNL) Ends Development of Lead Candidate, Stock Down ||| Zacks Value Investor Highlights: Merck, Maravai LifeSciences, Sensus Healthcare, PetIQ and AbbVie ||| 5 Hot ‘Mega Stocks’ Traded by U.S. Politicians",1,0.4985603
2022-07-25,6364500.0,90.1999969482422,90.7300033569336,89.75,90.52999877929688,86.78656768798828,MRK,"Should You Buy Pfizer Stock Ahead of Its Q2 Results? ||| Will Merck Stock Rise After Its Q2 Results? ||| Former Goldman banker, ex-FBI trainee charged with insider trading ||| Vanguard High Dividend Yield ETF Experiences Big Inflow ||| The Zacks Analyst Blog Highlights J&J, Novartis, GSK, Merck and AbbVie",1,0.46074358
2022-07-26,6414100.0,91.4000015258789,91.9499969482422,90.5999984741211,91.29000091552734,87.51514434814453,MRK,"Health Care Sector Update for 07/26/2022: IFRX, ISEE, SGEN, MRK, XLV, IBB ||| Astellas, Seagen Report Positive Topline Results For Padcev With Keytruda To Treat Urothelial Cancer",0,0.5089422
2022-07-27,6966300.0,90.5,91.37000274658205,90.01000213623047,91.2300033569336,87.45763397216797,MRK,"Pre-Market Earnings Report for July 28, 2022 : MA, PFE, MRK, TMO, CMCSA, LIN, SNY, HON, AMT, MO, SO, CP ||| 8 Dividend ETFs to Buy and Hold Forever ||| Pre-Market Earnings Report for July 28, 2022 : MA, PFE, MRK, TMO, CMCSA, LIN, SNY, HON, AMT, MO, SO, CP ||| The 3 Best Market Sectors for the Second Half of 2022 ||| Merck avoided billions in U.S. tax by offshoring Keytruda profits - senator ||| Daily Dividend Report: KHC,WMB,MRK,BDX,CTAS",0,0.4876006
2022-07-28,13909800.0,91.04000091552734,91.12999725341795,87.41999816894531,89.94000244140625,86.22095489501953,MRK,"Merck (MRK) Q2 Earnings & Revenues Top, COVID Drug Helps Sales ||| Alkermes' (ALKS) Earnings & Revenues Surpass Estimates in Q2 ||| Merck profit tops Wall Street view on strong Keytruda sales ||| These New Blockbusters Could Fill Bristol-Myers Squibb's Revenue Gap ||| Dow Movers: MRK, HON ||| US STOCKS-Wall St set to open lower after GDP data, Meta forecast ||| 7 Stocks to Buy on the Dip ||| Merck Updates FY22 Guidance ||| Merck quarterly profit tops Wall Street view on strong Keytruda sales ||| Should Invesco Dow Jones Industrial Average Dividend ETF (DJD) Be on Your Investing Radar?",0,0.50215036
2022-07-29,14938600.0,90.08000183105467,91.08000183105467,88.27999877929688,89.33999633789062,85.64576721191406,MRK,"Seagen's (SGEN) Earnings & Revenues Surpass Estimates in Q2 ||| Pharma Stock Roundup: MRK, PFE, SNY Q2 Earnings & Sales Beat, GSK Results Mixed ||| AstraZeneca (AZN) Beats on Q2 Earnings, Ups Sales Growth View",0,0.48485678
2022-08-01,7343300.0,89.33999633789062,90.0199966430664,88.3499984741211,88.52999877929688,84.86927032470703,MRK,"Looking for a Growth Stock? 3 Reasons Why Merck (MRK) is a Solid Choice ||| Merck (MRK) Upgraded to Buy: Here's What You Should Know ||| The Zacks Analyst Blog Highlights GSK, Merck, Pfizer, Sanofi and AstraZeneca",0,0.46507224
2022-08-02,7443000.0,89.05999755859375,89.58999633789062,87.55000305175781,87.61000061035156,83.98731231689453,MRK,"Henry Schein (HSIC) Q2 Earnings Top Estimates, '22 EPS View Up ||| What 1 Key COVID Drug's News Might Mean For Pfizer",1,0.47210485
2022-08-03,8187600.0,87.25,88.0199966430664,86.76000213623047,87.62000274658203,83.99688720703125,MRK,"Exact Sciences (EXAS) Q2 Earnings Top Estimates, Margins Down ||| Charles River (CRL) Q2 Earnings Top Estimates, 2022 View Cut ||| STERIS (STE) Q1 Earnings Match Estimates, EPS View Down ||| How The Pieces Add Up: HDV Headed For $114 ||| Merck : Phase 3 Trial Of Keytruda Combination In Liver Cancer Fails To Meet Main Goal ||| Medicare Drug Pricing Changes Could Be Coming: Time to Ditch Pharma Stocks?",0,0.49051723
2022-08-04,7993800.0,87.80999755859375,87.88999938964844,86.63999938964844,86.81999969482422,83.22997283935547,MRK,"Syneos Health (SYNH) Q2 Earnings Top Estimates, Cuts '22 View ||| Bruker (BRKR) Q2 Earnings Match Estimates, '22 Sales View Down ||| Mirati (MRTX) Q2 Loss Narrower Than Expected, Sales Beat ||| Tandem Diabetes (TNDM) Q2 Earnings Miss, Sales View Cut ||| What's Happening With AbbVie Stock?",1,0.4931195
2022-08-05,8801200.0,86.52999877929688,87.52999877929688,86.0199966430664,87.41000366210938,83.79558563232422,MRK,"3 Great Stocks to Buy in August for Safety and Long-Term Growth ||| Iovance (IOVA) Q2 Earnings Miss, Lifileucel BLA on Track ||| Corcept (CORT) Down on Q2 Earnings Miss, Revenues Rise Y/Y ||| Should You Buy Pfizer Stock After An Upbeat Q2?",1,0.507238
2022-08-08,8149400.0,87.30000305175781,88.77999877929688,86.91999816894531,88.48999786376953,84.83092498779297,MRK,"2 Healthcare Stocks You Can Buy and Hold for the Next Decade ||| NuVasive (NUVA) Q2 Earnings Miss Estimates, Revenues Beat ||| 5 High-Flying U.S. Corporate Giants to Buy Despite Volatility ||| Should You Buy Merck Stock After An Upbeat Q2? ||| These 3 Dow Stocks Are Set to Soar in 2022's Second Half and Beyond",1,0.5141634
2022-08-09,13215500.0,88.75,90.23999786376952,86.80999755859375,89.5199966430664,85.81832885742188,MRK,"FDA says found possible carcinogen in certain samples of Merck's Januvia ||| Noteworthy Tuesday Option Activity: TA, CELH, MRK ||| Insulet (PODD) Q2 Earnings Miss Estimates, '22 Sales View Up ||| FDA says found possible carcinogen in certain samples of Merck's Januvia ||| Q2 Earnings Scorecard and Analyst Reports for Roche, Adobe & McDonald's ||| The Zacks Analyst Blog Highlights Exxon Mobil, Merck & Co, Chevron, American Electric Power and The Southern ||| Why This 1 Value Stock Could Be a Great Addition to Your Portfolio",0,0.49652675
2022-08-10,8140200.0,90.02999877929688,90.12999725341795,88.19000244140625,89.19000244140625,85.50198364257812,MRK,"Omnicell (OMCL) Q2 Earnings Miss Estimates, Gross Margin Down ||| Exelixis (EXEL) Q2 Earnings Beat, Cabometyx Maintains Growth ||| Notable ETF Inflow Detected - DGRW, PM, MRK, MO ||| SmileDirectClub (SDC) Q2 Earnings Lag Estimates, Guidance Cut",0,0.49242333
2022-08-11,7396800.0,87.80999755859375,89.81999969482422,87.36000061035156,88.93000030517578,85.25272369384766,MRK,"Seagen's (SGEN) Cancer Drugs Aid Growth, Stiff Rivalry a Woe ||| Haemonetics (HAE) Q1 Earnings Beat Estimates, Margins Up ||| Dow Movers: JNJ, DIS ||| GSK, Sanofi and Haleon shares slump on Zantac litigation concerns ||| Roche Announces FDA Approval Of Label Expansion For VENTANA MMR RxDx Panel",1,0.50264215
2022-08-12,12317300.0,88.98999786376953,91.02999877929688,88.94999694824219,91.0199966430664,87.25630187988281,MRK,"ResMed (RMD) Q4 Earnings Beat Estimates, Gross Margin Up ||| Seagen loses arbitration against Daiichi Sankyo over drug technology ||| J&J (JNJ) to Stop Selling Talc-based Baby Powder From 2023 ||| STERIS (STE) Gains From Cantel Buyout, Supply Chain Issue Stays ||| 2 Top Biotech Stocks to Buy Right Now",0,0.5020103
2022-08-15,6339800.0,90.83000183105467,90.83999633789062,89.88999938964844,90.5999984741211,86.85367584228516,MRK,"Illumina (ILMN) Q2 Earnings Miss Estimates, Slashes '22 View ||| Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know ||| bluebird bio (BLUE) Focused on Pipeline Amid Marketed Drug Dearth ||| National Vision (EYE) Q2 Earnings Top Mark, Revenue View Cut ||| Should You Invest in the VanEck Pharmaceutical ETF (PPH)?",0,0.503272
2022-08-16,5661200.0,89.95999908447266,90.9000015258789,89.87000274658203,90.58999633789062,86.8440933227539,MRK,3 Top Stocks to Invest In Right Now ||| Here's Why You Should Retain Thermo Fisher (TMO) Stock Now ||| Why Moderna Stock Is Sliding Today ||| AstraZeneca's (AZN) Lynparza sNDA Gets FDA Priority Tag ||| Is Invesco Dow Jones Industrial Average Dividend ETF (DJD) a Strong ETF Right Now? ||| AstraZeneca: FDA Grants Priority Review To SNDA For Lynparza With Abiraterone For MCRPC,1,0.52314377
2022-08-17,6486000.0,90.33999633789062,91.88999938964844,90.3000030517578,91.04000091552734,87.27548217773438,MRK,"Notable Wednesday Option Activity: CROX, SPLK, MRK ||| Merck (MRK) Enters Into Circular RNA Collaboration With Orna ||| Quest Diagnostics' (DGX) Base Volume Revives, New Ruling Aids ||| What's Happening With Johnson & Johnson Stock",1,0.48826444
2022-08-18,6111600.0,91.5,91.83999633789062,90.52999877929688,91.4000015258789,87.62059020996094,MRK,"Noteworthy ETF Inflows: VTV, BRK.B, MRK, CSCO ||| What's in the Cards for Medtronic (MDT) in Q1 Earnings? ||| Zacks Market Edge Highlights: Merck, PepsiCo, Honeywell, Microsoft and PNC Financial",1,0.50191665
2022-08-19,8828700.0,91.5500030517578,93.0199966430664,91.52999877929688,92.08000183105467,88.27246856689453,MRK,"Dow Movers: CRM, MRK ||| Pharma Stock Roundup: End of SNY's Amcenestrant Development, FDA Updates for AZN, GSK ||| This Easy-to-Use Stock Strategy Is Crushing the Market",0,0.49417496
2022-08-22,6652100.0,91.80999755859376,92.22000122070312,91.01000213623048,91.16000366210938,87.39051818847656,MRK,3 Biopharmas on Buyout Watch,0,0.5292163
2022-08-23,5208800.0,90.87999725341795,90.98999786376952,89.72000122070312,90.1999969482422,86.47021484375,MRK,"Merck & Co Gets Fast Track Status For Investigational Anticoagulant Therapy MK-2060 ||| Medtronic (MDT) Q1 Earnings Beat Estimates, Margins Down ||| Is Alnylam Stock Poised For More Gains After A Stellar 50% Rise In A Month? ||| Should Invesco S&P Ultra Dividend Revenue ETF (RDIV) Be on Your Investing Radar? ||| Is First Trust Capital Strength ETF (FTCS) a Strong ETF Right Now? ||| Should Income Investors Buy This Dividend Stock?",0,0.5211369
2022-08-25,5884300.0,90.51000213623048,90.51000213623048,89.06999969482422,90.2699966430664,86.53732299804688,MRK,"Eli Lilly (LLY) Stock Up More Than 15% YTD: What Lies Ahead? ||| J&J (JNJ) Gets EU Nod for Multiple Myeloma Drug Tecvayli ||| AstraZeneca (AZN) Gets Japan Nod for Expanded Use of 3 Drugs ||| Phibro (PAHC) Q4 Earnings Miss Estimates, Sales Surpass ||| 1 Bear Market Blunder Investors Are Still Making ||| Do Warren Buffett's Recent Moves Spell Doom for This Group of Stocks? ||| AstraZeneca Reports Approval Of Tagrisso, Ultomiris & Lynparza In Japan",0,0.49925408
2022-08-26,5695300.0,90.27999877929688,90.73999786376952,89.08999633789062,89.26000213623047,85.569091796875,MRK,"Health Care Sector Update for 08/26/2022: SGN, MRK, MRNA, PFE, BNTX, ENTB ||| Iovance (IOVA) Starts Rolling BLA With FDA for Melanoma Therapy ||| Health Care Sector Update for 08/26/2022: PXMD,SGN,MRK,MRNA,PFE,BNTX,ENTB ||| Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It ||| Bristol Myers (BMY) Up 14.6% YTD: Will the Performance Continue? ||| Pharma Stock Roundup: NVS to Spin Off Sandoz; JNJ, MRK, ABBV's FDA Updates",0,0.46870148
2022-08-29,7850200.0,88.83000183105469,89.0,87.55999755859375,87.58999633789062,83.96813201904297,MRK,"The Zacks Analyst Blog Highlights Novartis, J&J, AbbVie, Merck and Pfizer",0,0.4848373
2022-08-30,6754000.0,87.47000122070312,87.56999969482422,86.58000183105469,86.87999725341797,83.28748321533203,MRK,"Relative Strength Alert For Merck ||| Notable ETF Inflow Detected - IVE, MRK, DIS, WMT",0,0.5105813
2022-08-31,11602000.0,87.04000091552734,87.12999725341797,85.16000366210938,85.36000061035156,81.8303451538086,MRK,"Down 6% In A Day, Will Bristol Myers Squibb Stock Rebound? ||| Why Guardant Health Crushed the Market Today ||| Dow Analyst Moves: MRK",1,0.5115085
2022-09-01,7528600.0,85.63999938964844,87.45999908447266,85.36000061035156,87.1500015258789,83.54634094238281,MRK,Is Humira Maker A Better Bet Over Merck Stock? ||| Why Ocugen Stock Topped the Market Today ||| India develops its first cervical cancer vaccine ||| Novartis taps Merck executive Marshall to replace Bradner as research head,0,0.50874126
2022-09-02,6997500.0,87.23999786376953,87.77999877929688,85.87999725341797,86.2300033569336,82.66438293457031,MRK,"3 Stocks to Buy in September as the Market Falls and Rates Rise ||| Merck (MRK) Stock Moves -1.06%: What You Should Know ||| After Hours Most Active for Sep 2, 2022 : NEOG, OPEN, IAS, QQQ, AAPL, BSX, MMM, MSFT, DXC, MRK, NEM, MO",1,0.49000984
2022-09-07,6121700.0,86.55999755859375,87.0,85.06999969482422,86.87000274658203,83.27791595458984,MRK,"Notable ETF Inflow Detected - IVE, UNH, MRK, DIS ||| Dow Movers: CVX, MCD ||| Should Schwab U.S. Dividend Equity ETF (SCHD) Be on Your Investing Radar? ||| Merck's Deal With Seagen May Have Fallen Through. Now What?",1,0.47944182
2022-09-08,8109200.0,86.5,87.44999694824219,86.12999725341797,87.41999816894531,83.80516815185547,MRK,"Should You Buy IDEXX Laboratories Stock At Around $350? ||| Merck (MRK) Gains But Lags Market: What You Should Know ||| Interesting MRK Put And Call Options For October 28th ||| Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know ||| What's Driving Amgen Stock Higher?",0,0.46859756
2022-09-09,7480100.0,87.58999633789062,88.16999816894531,87.2699966430664,87.33999633789062,83.72847747802734,MRK,"Why Shares of Shuttle Pharmaceuticals Jumped 160.4% This Week ||| AstraZeneca Says LYNPARZA Combination Shows Meaningful OS In Ovarian Cancer Across Phase III Trials ||| Pre-Market Most Active for Sep 9, 2022 : TQQQ, SQQQ, MOGU, VCIT, DMS, MRK, KO, BILI, TSLA, NIO, QQQ, HLN",1,0.503617
2022-09-12,6351500.0,88.12999725341797,89.16999816894531,87.81999969482422,88.16000366210938,84.51457214355469,MRK,"Is It Smart To Buy Merck & Co., Inc. (NYSE:MRK) Before It Goes Ex-Dividend? ||| Pick Either Johnson & Johnson Stock Or This Healthcare Company – Both Are Likely To Offer Similar Returns ||| Ex-Dividend Reminder: NorthWestern, Atrion and Merck ||| Seagen, Astellas, Merck: EV-103 Results Support Investigation Of Enfortumab Vedotin, Pembrolizumab ||| Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar?",0,0.46865094
2022-09-13,7650000.0,87.31999969482422,87.61000061035156,86.11000061035156,86.27999877929688,82.71231079101562,MRK,"The 7 Best Retirement Stocks to Buy Now ||| Merck: KEYTRUDA Approved In Canada For Adjuvant Treatment Of Patients With Stage IIB Or IIC Melanoma ||| Got $1,000? 3 Stocks to Buy and Hold Until Retirement ||| Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?",1,0.50261396
2022-09-14,9418700.0,87.0,87.63999938964844,86.37999725341797,86.94999694824219,84.02657318115234,MRK,"Merck (MRK) Outpaces Stock Market Gains: What You Should Know ||| Top Analyst Reports for Merck, Cisco & Morgan Stanley ||| Key Factors Driving Merck's (MRK) Outperformance This Year ||| Why This 1 Value Stock Could Be a Great Addition to Your Portfolio",0,0.47413555
2022-09-15,8006800.0,87.1500015258789,87.43000030517578,86.19999694824219,86.75,83.83331298828125,MRK,"Consumer group says drugmakers abuse U.S. patent system to keep prices high ||| Why This Monster Stock's Recent Blunders Might Not Matter ||| 2 Healthcare Stocks That Could Help Set You Up for Life ||| The Zacks Analyst Blog Highlights Merck, Cisco, Morgan Stanley, CME Group and Canadian Natural Resources",1,0.4893808
2022-09-16,14842500.0,86.5999984741211,87.87000274658203,86.4000015258789,87.72000122070312,84.77069854736328,MRK,"Bristol Myers' (BMY) Opdivo Meets Main Goal in Melanoma Study ||| Recession Warning Caps Off Volatile Week on Wall Street ||| 7 Undervalued Stock Picks to Beat the September Market Slump ||| Dow Movers: BA, MRK ||| Merck (MRK), Exxon (XOM): 2 “Strong Buy” Dividend Achievers You Can’t Ignore",0,0.48801154
2022-09-19,7748600.0,86.8499984741211,86.94000244140625,85.63999938964844,86.63999938964844,83.72699737548828,MRK,"Dow Movers: MRK, HD ||| Bristol Myers (BMY) Skin Cancer Drug Gets EC's Approval ||| The Zacks Analyst Blog Highlights AbbVie, Novartis, Merck and AstraZeneca",0,0.49447677
2022-09-20,5454800.0,86.06999969482422,86.44999694824219,85.58999633789062,86.0,83.1085205078125,MRK,"Merck (MRK) Stock Moves -0.74%: What You Should Know ||| Merck To Begin Phase 3 Program With Lower Dose Of Islatravir With Doravirine ||| Mohamed El-Erian Says Stagflation Is Coming; Here Are 2 ‘Strong Buy’ Dividend Stocks to Protect Your Portfolio ||| Merck to start studying lower dose of HIV drug after FDA hold ||| 3 Stocks That Could Rocket on Biden’s Cancer Moonshot ||| Merck to start new study of low-dose HIV drug after FDA's hold ||| Haleon rejects Zantac indemnification requests from GSK, Pfizer",0,0.48340333
2022-09-21,7190800.0,86.25,86.5,84.5199966430664,84.52999877929688,81.68794250488281,MRK,Merck (MRK) Resumes HIV Studies on Islatravir With Lower Dose,1,0.53291816
2022-09-22,12329700.0,84.55000305175781,88.1500015258789,84.55000305175781,87.51000213623047,84.5677490234375,MRK,"Evaxion (EVAX) Enrolls First Patient in Phase IIb Melanoma Study ||| Dow Movers: BA, CRM ||| Is Trending Stock Merck & Co., Inc. (MRK) a Buy Now? ||| Merck Animal Health To Buy Vence; Financial Terms Not Disclosed ||| U.S. District Court Rules In Favor Of Merck In Patent Infringement Suit Against Viatris ||| AstraZeneca Announces Approval Of Lynparza In China",0,0.48606002
2022-09-23,9038500.0,87.4000015258789,88.01000213623047,86.08999633789062,86.77999877929688,83.86229705810547,MRK,"Dow Movers: CVX, MRK ||| Merck's (MRK) Stock Up on Januvia Patent Win Against Viatris ||| My Take: 4 Strong Growth Stocks to Buy This Week ||| Pharma Stock Roundup: EU Nod to AZN & RHHBY Drugs, FDA Updates for LLY & MRK",0,0.5035939
2022-09-26,8841000.0,86.12000274658203,86.70999908447266,85.29000091552734,86.18000030517578,83.282470703125,MRK,"A Stock's Price ""Tells You Almost Nothing"" ||| Good Stocks To Buy Right Now? 4 Healthcare Stocks To Know ||| Dow Jones ETF Avoids Bear Market: 4 Stocks in Green",0,0.49213016
2022-09-27,6532100.0,86.81999969482422,87.62999725341797,85.66999816894531,85.83999633789062,82.95389556884766,MRK,Japan's Shionogi says COVID pill reaches endpoint in Phase III trial ||| Merck (MRK) Dips More Than Broader Markets: What You Should Know ||| Atea (AVIR) Dengue Candidate Gets Fast Track Designation ||| AstraZeneca : Japan Approves Koselugo For Rare Genetic Disease In Paediatric Patients,1,0.48460138
2022-09-28,6840000.0,86.98999786376953,87.25,86.19999694824219,86.77999877929688,83.86229705810547,MRK,Merck agrees to allow Sinopharm to sell molnupiravir COVID drug in China ||| Japan's Shionogi says COVID pill reaches Phase III milestone ||| Bear Market: 2 Safe Stocks to Buy Right Now ||| Should Invesco Dow Jones Industrial Average Dividend ETF (DJD) Be on Your Investing Radar?,0,0.49890178
2022-09-29,6601300.0,87.0,87.41999816894531,86.2300033569336,86.63999938964844,83.72699737548828,MRK,"November 11th Options Now Available For Merck (MRK) ||| Dow Movers: BA, MRK",0,0.4979268
2022-09-30,9035600.0,87.25,87.62000274658203,86.0999984741211,86.12000274658203,83.2244873046875,MRK,3 Undervalued Dow Stocks to Buy Before Wall Street Catches On ||| Biotech Stocks Facing FDA Decision In October 2022,1,0.52368516
2022-10-03,9186900.0,86.72000122070312,87.9000015258789,86.0199966430664,87.55000305175781,84.60640716552734,MRK,What This News Means for Merck ||| Merck (MRK) Gains But Lags Market: What You Should Know ||| SPDR S&P 500 ETF Trust Experiences Big Inflow ||| What's Happening With Roche (RHHBY) Stock?,1,0.49262667
2022-10-04,7373000.0,87.54000091552734,88.6500015258789,87.0,88.38999938964844,85.41816711425781,MRK,"Dow Movers: MRK, CRM",0,0.52005243
2022-10-05,6065700.0,88.58000183105469,88.77999877929688,88.0199966430664,88.38999938964844,85.41816711425781,MRK,See Which Of The Latest 13F Filers Holds Merck ||| Is Exelixis' (EXEL) Growth Story Likely to Continue? ||| Iovance (IOVA) Focuses on Seeking Nod for Melanoma Therapy,0,0.51123
2022-10-06,8055500.0,87.76000213623047,88.01000213623047,87.2300033569336,87.44000244140625,84.50010681152344,MRK,"ANALYSIS-Chip industry rethinks Taiwan risk after Pelosi visit but options limited ||| Why Guardant Health Topped the Market on Thursday ||| Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock",1,0.47411495
2022-10-07,8837400.0,87.87999725341797,88.30000305175781,87.12000274658203,87.5999984741211,84.65472412109375,MRK,"Dow Movers: INTC, CVX",1,0.5152797
2022-10-10,14485000.0,89.93000030517578,91.58999633789062,89.70999908447266,90.4800033569336,87.43789672851562,MRK,"3 Great Dividend Stocks to Buy in October ||| Merck & Co. Gains On Sotatercept's Positive Result In Phase 3 Trial ||| Health Care Sector Update for 10/10/2022: IMUX, MRK, GTHX, XLV, IBB ||| Stock Market News for Oct 10, 2022 ||| Merck's blood vessel disorder drug succeeds in late-stage study",1,0.51482123
2022-10-11,9743500.0,90.43000030517578,91.9800033569336,90.1999969482422,91.0500030517578,87.98873901367188,MRK,Merck Stock Is Likely A Better Pick Over Its Peer ||| Merck (MRK) Gains As Market Dips: What You Should Know ||| Best Stocks To Buy Right Now? 3 Dow Jones Stocks To Watch ||| Merck (MRK) Posts Positive Results From PAH Drug Study ||| We Ran A Stock Scan For Earnings Growth And Merck (NYSE:MRK) Passed With Ease,0,0.49677265
2022-10-12,8522200.0,91.25,91.72000122070312,90.37000274658205,90.41999816894533,87.37989807128906,MRK,"Health Care Sector Update for 10/12/2022: OMI,MRNA,MRK,BGNE,JNJ,NEOG ||| SPYV, MRK, WMT, DIS: Large Inflows Detected at ETF ||| Health Care Sector Update for 10/12/2022: MRNA,MRK,BGNE,JNJ,NEOG ||| Why Moderna Stock Is Bolting Higher Today ||| Here's Why Merck (MRK) is a Strong Value Stock ||| Corcept (CORT) Begins Phase II Study on Dazucorilant for ALS ||| Merck opts to jointly develop cancer vaccine with Moderna ||| 3 Dividend Stocks in Warren Buffett's Secret Portfolio Most Likely to Soar in Q4",1,0.47169966
2022-10-13,9382800.0,89.5,92.72000122070312,89.2699966430664,92.48999786376952,89.38031768798828,MRK,"Moderna (MRNA) Up After Merck Exercises Option for Cancer Jab ||| Pharma Stock Roundup: FDA Oks Omicron Jabs for Kids, MRK, MRNA Partner for Cancer Jab",0,0.512536
2022-10-14,9847600.0,92.2699966430664,93.36000061035156,91.73999786376952,92.18000030517578,89.08073425292969,MRK,"Why Shares of Keros Therapeutics Rose 10.2% This Week ||| Merck (MRK) Shares Cross 3% Yield Mark ||| The Zacks Analyst Blog Highlights Pfizer, BioNTech, Moderna, Merck and GSK",1,0.48726302
2022-10-17,12139700.0,92.83999633789062,94.37000274658205,92.4499969482422,94.12000274658205,90.95551300048828,MRK,Merck & Co Inc Shares Approach 52-Week High - Market Mover ||| Merck & Co Inc Shares Near 52-Week High - Market Mover,1,0.4945669
2022-10-18,9530400.0,94.41999816894533,95.31999969482422,94.0199966430664,94.61000061035156,91.42903137207033,MRK,"Notable Tuesday Option Activity: MRK, BIIB, SEDG ||| Will This News Send Moderna's Stock Soaring? ||| Is Invesco Dow Jones Industrial Average Dividend ETF (DJD) a Strong ETF Right Now? ||| What the Smartest Investors Know About Moderna Stock",0,0.4627194
2022-10-19,8546100.0,94.91000366210938,94.91000366210938,93.0999984741211,93.26000213623048,90.12442779541016,MRK,"Drugmaker Merck: placed under formal investigation in France over Levothyrox ||| Drugmaker Merck placed under formal investigation in France over thyroid drug ||| Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know ||| Merck (MRK) Dips More Than Broader Markets: What You Should Know",0,0.48137948
2022-10-20,7626000.0,93.1999969482422,93.4000015258789,92.36000061035156,92.94000244140624,89.815185546875,MRK,"Corcept (CORT) Thrives on Korlym, Overdependence a Concern ||| VONE, MRK, WMT, DIS: ETF Inflow Alert ||| Earnings Preview: Merck (MRK) Q3 Earnings Expected to Decline",1,0.4935509
2022-10-21,10297200.0,92.83999633789062,95.95999908447266,92.63999938964844,95.66999816894533,92.45338439941406,MRK,AbbVie (ABBV) Reports Next Week: Wall Street Expects Earnings Growth,1,0.5022006
2022-10-24,11414900.0,96.4499969482422,98.41999816894533,96.2699966430664,97.37000274658205,94.09624481201172,MRK,How Will Bristol Myers Squibb Stock Trend Post Q3 Results? ||| Merck: European Commission Approves Expanded Indication For VAXNEUVANCE,1,0.5155666
2022-10-25,8747900.0,96.86000061035156,98.29000091552734,96.3499984741211,97.70999908447266,94.4248046875,MRK,Merck to donate Ebola vaccine candidate for research program in Uganda ||| Spain antitrust watchdog fines Merck 39 mln euros in contraceptives case ||| Spain's antitrust watchdog fines Merck 39 mln euros in contraception case,1,0.51271516
2022-10-26,10374700.0,98.29000091552734,99.27999877929688,98.0,98.41000366210938,95.1012725830078,MRK,"Pre-Market Earnings Report for October 27, 2022 : MA, MRK, MCD, LIN, CMCSA, HON, SPGI, CAT, AMT, MO, NOC, SO ||| Drug/Biotech Stocks' Q3 Earnings on Oct 27: MRK, GILD & More ||| Merck's CEO to succeed Ken Frazier as chairman ||| Uganda steps up Ebola response as virus infects 109, kills 30 ||| Will Merck Stock Rise After Its Q3 Results? ||| Is Merck Moving Toward Another Blockbuster Drug Launch?",1,0.46758148
2022-10-27,12218400.0,99.83999633789062,101.5,99.5,99.73999786376952,96.38655853271484,MRK,"Merck & Co. (MRK) Q3 2022 Earnings Call Transcript ||| GLOBAL MARKETS-Wall Street mixed, European shares end nearly flat; British pound eases ||| US STOCKS-Dow jumps on earnings boost, Meta drags Nasdaq lower ||| Merck (MRK) Beats on Q3 Earnings & Revenues, Ups 2022 View ||| US STOCKS-Dow jumps on earnings boost; Meta weighs on Nasdaq ||| Health Care Sector Update for 10/27/2022: TDOC, MRK, TAK, XLV, IBB ||| Merck Boosts Outlook As Q3 Results Top Estimates ||| US STOCKS-Nasdaq futures fall as Meta plummets on dismal outlook ||| Merck (MRK) Q3 Earnings and Revenues Surpass Estimates ||| Merck lifts annual forecasts after sales, profit beat estimates ||| Merck third-quarter earnings climb, lifts full-year outlook",1,0.4645672
2022-10-28,11228000.0,100.23999786376952,101.13999938964844,98.5500030517578,100.7699966430664,97.38192749023438,MRK,"Moderna (MRNA) to Report Q3 Earnings: What's in the Cards? ||| Gilead (GILD) Q3 Earnings & Sales Top, Guidance Raised ||| Pharma Stock Roundup: NVS, MRK Report Q3 Earnings JNJ's Tecvayli Gets FDA Nod ||| Dow Movers: MRK, INTC ||| Seagen's (SGEN) Q3 Earnings Miss, Revenues Surpass Estimates ||| IVE, MRK, KO, DIS: ETF Inflow Alert",1,0.49458236
2022-10-31,11043800.0,99.9499969482422,101.36000061035156,99.30999755859376,101.1999969482422,97.79745483398438,MRK,Why Moderna Stock Soared Last Week ||| Merck (MRK) Upgraded to Buy: Here's Why,0,0.47646305
2022-11-01,11079300.0,100.6500015258789,101.06999969482422,98.9499969482422,99.76000213623048,96.40589141845705,MRK,"Lilly (LLY) Beats on Q3 Earnings & Sales, Lowers '22 View ||| 4 Blue-Chip Stocks to Buy as Dow Seals Record October Gains ||| Got $3,000? Here Are 3 Stocks to Buy and Hold for the Long Term",0,0.4917991
2022-11-02,9503500.0,99.6500015258789,101.02999877929688,98.9800033569336,99.4000015258789,96.0579833984375,MRK,"Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It ||| The Zacks Analyst Blog Highlights Caterpillar, JPMorgan Chase, Home Depot and Merck & Co ||| Esperion (ESPR) Q3 Earnings Beat Estimates, Revenues Miss ||| Exelixis (EXEL) Q3 Earnings & Sales Top, Cabometyx Aids Growth",0,0.4683541
2022-11-03,9912700.0,99.0,99.23999786376952,98.0,98.75,95.42984771728516,MRK,"Moderna's (MRNA) Lags on Q3 Earnings, Lowers '22 Sales Outlook",1,0.52621955
2022-11-04,8877600.0,99.0,99.37999725341795,97.95999908447266,99.1999969482422,95.86471557617188,MRK,"U.S. Supreme Court to hear Amgen bid to revive cholesterol drug patents ||| Iovance's (IOVA) Q3 Earnings Beat Estimates, Revenues Nil ||| Karuna Therapeutics (KRTX) Posts Wider-Than-Expected Q3 Loss ||| Corcept's (CORT) Q3 Earnings Beat Estimates, Revenues Miss",1,0.509492
2022-11-07,8644500.0,98.5,100.36000061035156,97.66999816894533,100.06999969482422,96.7054672241211,MRK,"After Hours Most Active for Nov 7, 2022 : ADT, LYFT, ENB, WBD, CMCSA, CSCO, MSFT, VZ, T, AAPL, MRK, NKE ||| Top Research Reports for Merck, ConocoPhillips & Adobe ||| AstraZeneca (AZN) to Report Q3 Earnings: What's in the Cards? ||| Are You a Value Investor? This 1 Stock Could Be the Perfect Pick",1,0.4798377
2022-11-08,8503900.0,100.06999969482422,101.97000122070312,99.52999877929688,101.5,98.08738708496094,MRK,"7 No-Brainer Retirement Stocks to Buy for 2023 and Beyond ||| Ligand (LGND) Beats on Q3 Earnings, Lags Sales, Ups '22 Outlook ||| Bayer's (BAYRY) Q3 Earnings Miss Estimates, Revenues Top ||| These 3 Dividend ETFs Are a Retiree's Best Friend ||| The Zacks Analyst Blog Highlights Merck, ConocoPhillips, Adobe, Intercontinental Exchange and Monster Beverage",1,0.5069596
2022-11-09,10602900.0,101.3000030517578,103.76000213623048,101.27999877929688,101.58999633789062,98.17435455322266,MRK,"Noteworthy Wednesday Option Activity: VLO, LSTR, MRK ||| Is Merck Too Dependent on Keytruda? ||| Mirati's (MRTX) Stock Rises on Q3 Earnings and Sales Beat",1,0.53375673
2022-11-10,9556000.0,102.6999969482422,102.80999755859376,100.5999984741211,101.88999938964844,98.46426391601562,MRK,"AstraZeneca's (AZN) Q3 Earnings Beat, EPS Growth View Up",0,0.5019336
2022-11-11,13342800.0,100.52999877929688,100.80999755859376,97.33000183105467,97.95999908447266,94.6664047241211,MRK,Wall Street Cheers Soft Inflation Data: 5 Growth Picks ||| Here is Why Growth Investors Should Buy Merck (MRK) Now ||| Are Investors Undervaluing Innoviva (INVA) Right Now?,1,0.4969986
2022-11-14,8958200.0,98.6999969482422,101.69000244140624,98.6999969482422,100.3499984741211,96.9760513305664,MRK,"Up 15% In A Month Will Bristol Myers Squibb Stock Continue To See Higher Levels? ||| AstraZeneca's (AZN) Imfinzi/Imjudo Combo Gets Another FDA Nod ||| Dow Movers: MSFT, MRK ||| The Zacks Analyst Blog Highlights Archer Daniels Midland, Charles River Associates, Murphy USA, Merck and New Fortress Energy ||| AstraZeneca: CHMP Recommends Approval Of Lynparza In Combination With Abiraterone, Prednisone",0,0.5043266
2022-11-15,7965900.0,100.4000015258789,100.73999786376952,98.70999908447266,99.5999984741211,96.25125885009766,MRK,"7 Value Stocks to Buy Before They Pop Off ||| IVE, PG, MRK, KO: Large Outflows Detected at ETF ||| Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know ||| Big pharma not doing enough to improve drug access - analysis ||| Is There More Room For Growth In IDEXX Laboratories Stock? ||| Britain's NICE recommends against NHS use of 5 COVID treatments as not cost-effective",1,0.47760344
2022-11-16,8757700.0,99.58000183105467,100.8000030517578,99.48999786376952,99.93000030517578,96.5701675415039,MRK,"Eli Lilly (LLY) Stock Up 26.7% YTD: What's in Store for 2023? ||| Dow Analyst Moves: MRK ||| Corcept (CORT) Up YTD on Robust Korlym Sales, Pipeline Advances",1,0.49205035
2022-11-17,8496800.0,100.41000366210938,102.3499984741211,100.2699966430664,102.30999755859376,98.87014770507812,MRK,Merck (MRK) Outpaces Industry YTD: What's in Store for 2023? ||| Novartis (NVS) Reportedly Looking to Sell Its Business Units ||| How Long Can This Top Stock Continue Defying the Bear Market?,1,0.4986766
2022-11-18,11626300.0,102.62999725341795,104.5999984741211,102.62999725341795,104.2300033569336,100.7255859375,MRK,"3 Bargain Stocks You Can Buy Today and Hold Forever ||| Notable Friday Option Activity: MRK, MRNA, AMAT ||| Sanofi's (SNY) Rare Anemia Drug Enjaymo Gets EU Approval ||| Pharma Stock Roundup: RHHBY's Alzheimer's Study Failure, EU Nod for SNY's Enjaymo",1,0.49277547
2022-11-21,8899300.0,105.0,105.87000274658205,104.2300033569336,105.61000061035156,102.05919647216795,MRK,"As Tesla Sinks to 2-Year Lows, This Nasdaq Stock Just Doubled ||| Japan's Shionogi shares jump after report of COVID drug gaining efficacy approval ||| Health Care Sector Update for 11/21/2022: FSTX,SHC,MRK,IMGO,SGRY ||| Iovance (IOVA) Extends Timeline for Rolling BLA of Melanoma Drug ||| Is Merck & Co. (MRK) Outperforming Other Medical Stocks This Year? ||| Drugmaker Merck to acquire Imago BioSciences for $1.35 bln ||| Merck To Acquire Imago BioSciences ||| Pfizer (PFE), BioNTech Provide New Data on BA.4/BA.5 Boosters ||| Health Care Sector Update for 11/21/2022: IMGO, MRK, SGRY, CYTK, XLV, IBB",1,0.49236667
2022-11-22,8295700.0,106.12999725341795,107.0999984741211,106.0500030517578,106.9000015258789,103.30582427978516,MRK,Imago Bio Shares Soar on Agreement to Selll to Merck for $1.35 Billion Cash ||| Encompass Health (EHC) Proposes 50-Bed Hospital in Florida ||| Imago (IMGO) Shares Surge 104% on Buyout Offer From Merck ||| Buy These 5 Corporate Giants Flying High in Disappointing 2022 ||| Merck's combination cancer therapy succeeds in late-stage study ||| Merck Reaches Analyst Target Price ||| Merck's combination cancer therapy succeeds in late-stage study ||| AbbVie (ABBV) BLA for Epcoritamab Gets FDA Priority Tag,0,0.5018678
2022-11-23,5749600.0,106.75,107.3000030517578,106.3000030517578,106.81999969482422,103.22852325439452,MRK,"Merck (MRK) Keytruda Advanced Gastric Cancer Study Meets Goal ||| OEF, PG, HD, MRK: ETF Outflow Alert ||| GSK to Withdraw Blenrep From U.S. Market on FDA Request ||| The Zacks Analyst Blog Highlights Archer-Daniels-Midland, McKesson, Marathon Petroleum, Exxon Mobil and Merck & Co",1,0.50683975
2022-11-25,3163700.0,106.55999755859376,107.5,106.55999755859376,107.5,103.8856430053711,MRK,"Novartis (NVS) Set to Advance Malaria Drug Into Phase III ||| Mirati's (MRTX) Stock Rallies 11% on Buyout Speculations ||| AbbVie's (ABBV) Skyrizi Gets EU Nod for Crohn's Disease ||| EU regulator warns of 'disappointing' vaccine booster uptake ||| 3 Biotech Stocks Smart Investors Should Be Buying Up Now ||| This Pharmaceutical Company Is A Better Pick Over Johnson & Johnson Stock ||| Pharma Stock Roundup: MRK to Buy IMGO, ABBV's Skyrizi Gets EU Nod for New Indication",1,0.5102793
2022-11-28,9524500.0,107.12999725341795,108.9000015258789,107.12999725341795,108.4499969482422,104.80370330810548,MRK,"Merck & Co Inc Shares Climb 0.9% Past Previous 52-Week High - Market Mover ||| Wall Street Loves These 4 “Strong Buy” Stocks Right Now ||| Notable Monday Option Activity: MRK, V, FDX ||| Factors That Make Elevance Health (ELV) a Lucrative Bet Now ||| Should Value Investors Buy Innoviva (INVA) Stock? ||| Merck & Co., Inc. (MRK) Hits Fresh High: Is There Still Room to Run? ||| 2 Biotech Stocks You Can Buy and Hold for the Next Decade",1,0.48916194
2022-11-29,9352400.0,108.0,109.05999755859376,107.5500030517578,108.83999633789062,105.18059539794922,MRK,"FOCUS-Rare success for Alzheimer's research unlocks hope for future therapies ||| 3 Dow Stocks to Take Seriously in 2023 ||| Is Most-Watched Stock Merck & Co., Inc. (MRK) Worth Betting on Now? ||| Should Invesco Dow Jones Industrial Average Dividend ETF (DJD) Be on Your Investing Radar? ||| FOCUS-Rare success for Alzheimer's research unlocks hope for future therapies",1,0.49698022
2022-11-30,20305800.0,108.6999969482422,110.33000183105467,107.62999725341795,110.12000274658205,106.41756439208984,MRK,3 Dow 30 Stocks To Buy Now According To Analysts ||| AstraZeneca (AZN) Boosts Cell Therapies With Neogene Deal,0,0.502873
2022-12-01,10110500.0,109.75,110.9800033569336,108.7699966430664,109.8000030517578,106.10831451416016,MRK,"Health Care Sector Update for 12/01/2022: CMPX,MRK,AZYO,NTLA,ONCY ||| 3 Reasons Growth Investors Will Love Merck (MRK) ||| Why Is Lilly (LLY) Up 4.5% Since Last Earnings Report? ||| PWV, MRK, UPS, PFE: ETF Inflow Alert ||| Merck (MRK) Is Considered a Good Investment by Brokers: Is That True? ||| 3 Stocks to Watch That Recently Announced Dividend Hikes",1,0.49473855
2022-12-02,6943600.0,109.0,110.08999633789062,108.70999908447266,110.04000091552734,106.34025573730467,MRK,Should Investors Consider These 3 Low-Beta Stocks? ||| FOCUS-Merck could keep its patent edge by shifting Keytruda cancer drug to a simple shot,0,0.49582678
2022-12-05,6961900.0,109.80999755859376,110.2300033569336,109.20999908447266,110.01000213623048,106.31126403808594,MRK,"What Bear Market? This Top-Performing Dow Stock Has Thrived in 2022. ||| GSK's Myelofibrosis Candidate MAA Gets Accepted in Europe ||| Mirati to focus adagrasib/Keytruda study in low PDL1 lung cancer patients ||| The Zacks Analyst Blog Highlights Caterpillar, Merck, UnitedHealth Group and Walmart ||| Merck a Top Socially Responsible Dividend Stock With 2.6% Yield (MRK)",0,0.5130113
2022-12-06,7458700.0,110.36000061035156,110.76000213623048,108.41999816894533,108.93000030517578,105.267578125,MRK,Merck & Co Inc Shares Approach 52-Week High - Market Mover ||| French drug agency says under investigation over thyroid drug ||| Pfizer (PFE) Seeks FDA Nod for Bivalent COVID Jab in Infants ||| Mirati to focus adagrasib/Keytruda study in low PDL1 lung cancer patients,1,0.5054152
2022-12-07,8270400.0,109.1500015258789,110.70999908447266,109.0,110.08999633789062,106.3885726928711,MRK,"Is Adicet Bio (ACET) Stock Outpacing Its Medical Peers This Year? ||| Why Shares of Mirati Therapeutics Fell Wednesday ||| 3 High-Yielding Stocks That Are Up 27%-Plus This Year ||| Notable Wednesday Option Activity: WMB, MRK, GATX ||| 4 Defensive Stocks to Prepare Your Portfolio for a Recession ||| GSK, Sanofi shares brighten as thousands of Zantac lawsuits are dismissed ||| Dow Movers: AAPL, MRK",1,0.49794263
2022-12-08,7354800.0,110.27999877929688,111.0199966430664,110.12000274658205,110.8499984741211,107.12300872802734,MRK,"Novartis' (NVS) PNH Candidate Achieves Study Objectives ||| Merck a Top 25 Dividend Giant With 2.65% Yield (MRK) ||| Uganda receives 1,200 doses of Ebola vaccine candidates for trials ||| Ebola vaccine candidates arrive in Uganda for trials",0,0.5187082
2022-12-09,9667800.0,110.9800033569336,111.37000274658205,108.75,108.77999877929688,105.12261199951172,MRK,"Merck (MRK) Dips More Than Broader Markets: What You Should Know ||| Notable ETF Inflow Detected - SPYV, PG, MRK, JPM ||| Merck (MRK) Is Up 2.36% in One Week: What You Should Know ||| Some bloodstream infection bacteria grew resistant to last-resort drugs in 2020 - WHO ||| Humana (HUM) Rises 23% in Past 6 Months: More Room to Run? ||| Early Q4 Earnings Results and Analyst Reports for Merck, Bristol-Myers & Deere",1,0.49659383
2022-12-12,10956600.0,107.93000030517578,109.0999984741211,107.31999969482422,108.97000122070312,105.30622863769533,MRK,"3 High-Flying Stocks in 2022 That Should Keep Soaring in 2023 ||| Merck & Co Inc Shares Approach 52-Week High - Market Mover ||| U.S. FDA approves Mirati's lung cancer drug ||| Clovis (CLVS) Files for Bankruptcy Amid Lack of Financial Aid ||| Ex-Dividend Reminder: Merck, KBR and Seacoast Banking Corp. of Florida ||| 3 Non-Energy S&P 500 Stocks With Enough Energy to Boost Returns ||| Merck Commences Tender Offer To Acquire Imago BioSciences",1,0.52966124
2022-12-13,15836900.0,111.26000213623048,111.26000213623048,109.0,110.91000366210938,107.18101501464844,MRK,"Why Moderna Stock Is Skyrocketing Today ||| US STOCKS-Wall St rises after CPI data but Fed concerns persist ||| US STOCKS-Wall St rises after CPI data but Fed concerns persist ||| Wall Street rises after cooler CPI data but off highs as Fed eyed ||| Why Moderna Stock Is Popping Over 20% Today ||| Health Care Sector Update for 12/13/2022: MRNA, MRK, BLCO, A, MRTX ||| Trending Today: 5 Stocks in the News ||| US STOCKS-Wall St gains as CPI data calms jitters over aggressive rate hikes ||| Is Trending Stock Merck & Co., Inc. (MRK) a Buy Now? ||| Moderna (MRNA) Stock Soars on Cancer Vaccine News ||| Health Care Sector Update for 12/13/2022: MRNA, MRK, MRTX, LLY, XLV, IBB ||| Moderna, Merck cancer vaccine combo cuts melanoma recurrence by 44% ||| Moderna, Merck's Phase 2b Trial Of MRNA-4157/V940 Combination In Melanoma Meets Primary Endpoint ||| Moderna, Merck vaccine combo cut melanoma recurrence by 44% - study ||| Shionogi says Japan government to buy 1 mln more COVID pill doses ||| 2 Nasdaq Stocks Taking Big Strides Forward",1,0.48190367
2022-12-14,10788300.0,110.5199966430664,112.16999816894533,110.04000091552734,111.5500030517578,108.5137176513672,MRK,"Moderna (MRNA) Up 20% on Upbeat Data From Cancer Jab Study ||| Dow Movers: BA, MRK ||| Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio ||| 4 Large Drug Stocks to Watch in a Booming Industry ||| Is Moderna Stock a Buy After Its Impressive Cancer Vaccine Results? ||| MORNING BID-Reserve judgment",0,0.49373358
2022-12-15,9871400.0,110.23999786376952,110.7699966430664,109.2300033569336,109.62999725341795,106.64595794677734,MRK,"Merck (MRK) Stock Moves -1.72%: What You Should Know ||| Company News for Dec 15, 2022 ||| 2 Dividend Stocks to Buy and Hold Through 2023 and Beyond ||| The Best ETF For Dividend Yield And Dividend Growth ||| Is Moderna a Good Stock to Buy Right Now? ||| Zacks Industry Outlook Highlights Johnson & Johnson, Novo Nordisk, Merck and AstraZeneca ||| AstraZeneca: FDA To Extend PDUFA Date Regarding SNDA For Lynparza With Abiraterone ||| What's Driving Growth For Amgen Stock?",0,0.48127073
2022-12-16,29465900.0,109.23999786376952,109.6999969482422,108.2699966430664,109.1999969482422,106.2276611328125,MRK,"FDA Delays Decision on AstraZeneca (AZN), Merck's Lynparza sNDA ||| Pharma Stock Roundup: LLY's 2023 View, MRK-MRNA Joint Cancer Vaccine Data & More ||| 4 Drug Stocks Up More Than 40% YTD With Room to Grow in 2023 ||| 2 Biotech Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague",1,0.5387135
2022-12-19,6949500.0,109.19000244140624,110.0999984741211,108.7699966430664,109.44000244140624,106.46114349365234,MRK,"Are These Multibillion-Dollar Vaccine Stocks Still a Buy? ||| Unusual Options Activity in Apple, Home Depot and 8 Other Stocks ||| Noteworthy ETF Inflows: IVE, PG, MRK, JPM ||| Is Pfizer Stock A Better Pick Over This Pharmaceuticals Bellwether?",1,0.50229925
2022-12-20,8022000.0,109.94000244140624,110.66000366210938,109.16000366210938,109.70999908447266,106.72380065917967,MRK,"2 Smartest Tech Stocks to Buy in 2022 and Beyond ||| Astellas: PADCEV, KEYTRUDA Granted Priority Review In Treatment Of Metastatic Urothelial Cancer ||| Is Invesco Dow Jones Industrial Average Dividend ETF (DJD) a Strong ETF Right Now?",1,0.5194798
2022-12-21,6640900.0,110.0999984741211,111.19000244140624,109.54000091552734,111.11000061035156,108.08568572998048,MRK,Merck (MRK) Gains But Lags Market: What You Should Know ||| 7 Perfect Presents to Gift Your 2023 Stock Portfolio  ||| Delta and Moderna Share Good News ||| Top 10 Dividend Growth Stocks and How to Choose Them ||| Could This Opportunity Make Moderna a Hot Buy Again? ||| AstraZeneca (AZN) Gets EU Nod to Expanded Use of 2 Cancer Drugs,1,0.4909841
2022-12-22,8373700.0,110.9000015258789,111.69000244140624,110.20999908447266,111.23999786376952,108.21214294433594,MRK,"Merck & Co Inc Shares Near 52-Week High - Market Mover ||| Mirati's (MRTX) Krazati Gets Breakthrough Therapy Tag for CRC ||| Merck, Kelun-Biotech Collaborate To Develop Seven Preclinical ADC For Treatment Of Cancer",1,0.5126908
2022-12-23,4547400.0,111.25,112.12999725341795,110.87000274658205,111.86000061035156,108.81527709960938,MRK,Merck (MRK) Inks Deal to Develop Antibodies for Treating Cancer,1,0.5231301
2022-12-27,5125800.0,112.41000366210938,112.58999633789062,111.52999877929688,112.12000274658205,109.06819915771484,MRK,"Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock ||| This Stock Just Soared by 20%: Should You Buy Now? ||| Merck (MRK) Gains As Market Dips: What You Should Know ||| XLV, PFE, ABBV, MRK: ETF Inflow Alert ||| Wall Street Analysts Think Merck (MRK) Is a Good Investment: Is It? ||| Biotech Stocks Facing FDA Decision In January 2023",0,0.47575054
2022-12-28,5107800.0,112.88999938964844,112.88999938964844,111.05999755859376,111.08000183105467,108.05650329589844,MRK,What's Driving Growth For Bristol Myers Squibb Stock?,0,0.50490004
2022-12-29,4467200.0,111.38999938964844,111.6999969482422,110.75,110.81999969482422,107.80357360839844,MRK,Want to Collect a Dividend Every Month Next Year? Buy These 3 High-Yielding Stocks,1,0.49627745
2022-12-30,5498600.0,111.2300033569336,111.41999816894533,110.12000274658205,110.9499969482422,107.93004608154295,MRK,"Have $2,000 to Invest? 2 Top Stocks That Could Go Parabolic ||| Dow Movers: DIS, MRK ||| Dow Jones Beats S&P 500 in 2022: 5 Hot Stocks ||| China Approves Merck's Covid-19 Drug For Emergency Use ||| China grants conditional approval for Merck's COVID treatment",0,0.4843635
2012-01-05,56354800.0,3.532500028610229,3.694999933242798,3.5174999237060547,3.677500009536743,3.3735368251800537,NVDA,"Benzinga's Top ETF Decliners, January 5th (GAZ, TVIX, SGG, SOXS) ||| Benzinga's Top ETF Gainers, January 5th (AGA, SOXL, FAS, XBI)",0,0.49390855
2012-01-11,48427200.0,3.587500095367432,3.619999885559082,3.532500028610229,3.547499895095825,3.254282236099243,NVDA,"Evercore Partners Maintains Underweight, $11 Price Target on NVIDIA ||| Nvidia: The Mobile Company",0,0.5087143
2012-01-17,62717600.0,3.484999895095825,3.484999895095825,3.375,3.380000114440918,3.100626945495605,NVDA,Keep The Semiconductors On The Radar,1,0.50900614
2012-01-24,73092000.0,3.627500057220459,3.75,3.625,3.734999895095825,3.4262843132019043,NVDA,"Benzinga's Top ETF Gainers, January 24th (EGPT, DRN, DBB, ZSL) ||| Should AMD Blame Itself for its Losses?",0,0.498421
2012-01-25,127415200.0,3.634999990463257,3.722500085830689,3.5299999713897705,3.712500095367432,3.4056432247161865,NVDA,"Apple Earnings: Outstanding Achievement in the Field of Excellence ||| FBR Capital Maintains Market Perform on NVIDIA After Guidance Cut ||| UPDATE: Jefferies Lowers Target to $16 on NVIDIA ||| UPDATE: Deutsche Bank Lowers PT to $14 on NVIDIA, Maintains Hold ||| From Earlier: NVIDIA Lowers Q4 Revenue Expectations to $950M vs 1.066B Prior",0,0.5234563
2012-02-06,27886800.0,3.934999942779541,3.940000057220459,3.890000104904175,3.924999952316284,3.600579738616944,NVDA,Top 4 Mid-Cap Stocks In The Semiconductor-Specialized Industry With The Highest Cash,1,0.51796013
2012-02-08,84761200.0,3.934999942779541,4.15500020980835,3.9149999618530273,4.077499866485596,3.7404744625091553,NVDA,"Benzinga's Top ETF Decliners, February 8th ||| Benzinga's Top ETF Gainers, February 8th ||| Rambus Up 12% After Signing Patent Agreement ||| Rambus Rises 14% Pre-Market on Patent License Agreement with NVIDIA ||| Rambus and NVIDIA Sign Patent License Agreement",0,0.51362944
2012-02-13,61066800.0,4.074999809265137,4.090000152587891,3.954999923706055,4.037499904632568,3.7037813663482666,NVDA,"Earnings Expectations for the Week of February 13 ||| UPDATE: FBR Upgrades Nvidia to Outperform ||| NVIDIA up 2% Pre-Market Following Analyst Upgrade ||| FBR Capital Markets Upgrades Nvidia from Market Perform to Outperform, Raises PT from $17 to $20 ||| FBR Capital Markets Upgrades Nvidia from Outperform to Market Perform, Raises PT from $17 to $20 ||| Benzinga's Top Upgrades",1,0.49548405
2012-02-15,111085600.0,4.097499847412109,4.224999904632568,4.03249979019165,4.042500019073486,3.7083685398101807,NVDA,Nvidia CEO Sees 50% Growth in Tegra Revenue This Year ||| Nvidia Says PC Market Will Face Headwinds; Full-Year Forecast No Longer Valid ||| Nvidia Guides Q1 Revenue $900-930M vs $940.40M Est ||| Nvidia Reports Q4 EPS $0.26 vs $0.19 Est; Revenues $953.20M vs $950.51M Est,1,0.5219615
2012-02-16,188858800.0,3.765000104904175,4.144999980926514,3.75,4.112500190734863,3.772582292556762,NVDA,"UPDATE: Bank of America Downgrades NVIDIA to Neutral ||| UPDATE: Bank of America Downgrades NVIDIA to Neutral ||| Evercore Partners Maintains Nvidia at Underweight, Raises PT from $11 to $12 ||| Bank of America Downgrades Nvidia from Buy to Neutral, Maintains PO at $16.5",0,0.4944788
2012-02-22,49243200.0,3.962500095367432,4.059999942779541,3.950000047683716,3.954999923706055,3.62809944152832,NVDA,"Evercore Partners Reiterates Underweight, $12 PT on NVIDIA",1,0.5022964
2012-03-07,44198400.0,3.700000047683716,3.7174999713897705,3.650000095367432,3.702500104904175,3.3964710235595703,NVDA,"SemiAccurate: TSMC Suddenly Halts 28nm Production; Potentially Negative for NVDA, QCOM, ALTR, XLNX",1,0.5112111
2012-03-13,55328800.0,3.662499904632568,3.7174999713897705,3.6449999809265137,3.697499990463257,3.391883850097656,NVDA,Apple Drops Nvidia Kepler From Large Numbers Of Laptops -Semi Accurate,0,0.50619656
2012-04-02,40777600.0,3.839999914169312,3.872499942779541,3.777499914169312,3.8324999809265137,3.515725612640381,NVDA,"Benzinga's M&A Chatter for Monday April 2, 2012 ||| Nvidia Spokesperson Declines Comment on Earlier Chatter of Intel Offer ||| Positive Rumors Circulate About Nvidia",0,0.50198257
2012-04-05,36942400.0,3.6675000190734863,3.712500095367432,3.6449999809265137,3.6575000286102295,3.3551900386810303,NVDA,"UPDATE: Cantor Fitzgerald Initiates NVIDIA with Buy, $20 PT ||| Cantor Fitzgerald Initiates Coverage on Nvidia at Buy, Announces PT of $20",0,0.49748096
2012-04-13,31132400.0,3.637500047683716,3.6575000286102295,3.5374999046325684,3.539999961853028,3.2474021911621094,NVDA,Four Stocks for Apple's Secret Project,0,0.53297436
2012-04-16,46346800.0,3.565000057220459,3.575000047683716,3.440000057220459,3.497499942779541,3.208415031433105,NVDA,Hearing Pacific Crest Negative on Nvidia,1,0.5235757
2012-04-24,73044000.0,3.317500114440918,3.345000028610229,3.1875,3.2049999237060547,2.940091609954834,NVDA,Nvidia to Make Special Announcement Saturday April 28 at 10:30pm EDT,1,0.50538874
2012-05-07,60444000.0,3.119999885559082,3.172499895095825,3.0924999713897705,3.117500066757202,2.859824180603028,NVDA,"Earnings Expectations for the Week of May 7 (DIS, M, CSCO)",0,0.48821574
2012-05-09,52060800.0,3.059999942779541,3.1524999141693115,3.0299999713897705,3.127500057220459,2.86899733543396,NVDA,"Stock Watch List for Thursday May 10, 2012 ||| Stock Watch List for Thursday May 10, 2012 ||| Stock Watch List for Thursday May 10, 2012",0,0.4409048
2012-05-11,143514000.0,3.362499952316284,3.4200000762939453,3.289999961853028,3.302500009536743,3.0295331478118896,NVDA,"Nvidia Jumps 7% After Q1 Results ||| NVIDIA Up 8.5% on Strong Q1 Earnings ||| Social Media Outlook for Friday May 11 (NVDA, INSP, JPM, CSCO) ||| UPDATE: Nvidia Posts Better-Than-Expected Q1 Revenue, Issues Upbeat Q2 Revenue Forecast ||| UPDATE: Nvidia Guides Q2 Rev $990M-$1.05B vs $976.2M Est ||| Nvidia Rises 7% Pre-Market on Earnings Beat ||| Nvidia Reports Q1 EPS $0.16 vs $0.10 Est; Revenues $924.9M vs $916.17M Est ||| Nvidia Reports Q1 EPS $0.16 vs $0.10 Est; Revenues $924.9M vs $916.17M Est ||| US Stock Futures Down; JPMorgan Shares Drop In Pre-Market Trading ||| Stocks To Watch For May 11 ||| Earnings Scheduled For May 11",0,0.4757932
2012-05-14,43747200.0,3.275000095367432,3.3324999809265137,3.2074999809265137,3.282500028610229,3.0111851692199707,NVDA,"New MacBook Pros Will Have Nvidia Graphics -The Verge ||| Salman Partners Maintains Nvidia at Buy, Lowers PT from $18.75 to $16.75 ||| NVIDIA and Intellectual Ventures Partner to Acquire Portfolio ||| UPDATE: Jefferies Cuts PT to $15 on NVIDIA Corporation; 28nm Capacity Constrainta ||| Jefferies & Company Maintains Nvidia at Hold, Lowers PT from $16 to $15 ||| Stocks To Watch For May 14",0,0.49697375
2012-05-15,59994000.0,3.282500028610229,3.3550000190734863,3.234999895095825,3.25,2.981372356414795,NVDA,"UPDATE: NVIDIA Introduces World's First Virtualized GPU, Accelerating Graphics for Cloud Computing ||| Nvidia Announces Graphics Chip for Cloud Computing",0,0.530832
2012-05-21,41626000.0,3.025000095367432,3.087500095367432,3.005000114440918,3.072499990463257,2.818543672561645,NVDA,MacBook Retina Displays to Raise Consumer Price by $300?,0,0.5185817
2012-05-25,39175200.0,3.025000095367432,3.125,3.025000095367432,3.0999999046325684,2.8437700271606445,NVDA,Today's Movers and Shakers,1,0.4995553
2012-05-29,31000000.0,3.150000095367432,3.200000047683716,3.137500047683716,3.180000066757202,2.917157888412476,NVDA,"Barron's Recap (5/26/12): The Top 50 Annuities, and Tech Firms Hoard Cash ||| Benzinga's M&A Chatter for Tuesday May 29, 2012 ||| Nvidia Spokesperson Would Not Comment on Note from Nomura Saying the Company is a Possible Takeover Target of Intel",0,0.50151604
2012-05-31,35819200.0,3.1424999237060547,3.1549999713897705,3.067500114440918,3.1075000762939453,2.8506503105163574,NVDA,"Benzinga's Initiation Summary for May 31, 2012 ||| UPDATE: Morgan Stanley Initiates Coverage on NVIDIA ||| Morgan Stanley Initiates Coverage on Nvidia at Equal-weight",0,0.51100504
2012-06-04,43285600.0,3.009999990463257,3.0274999141693115,2.907500028610229,2.932499885559082,2.6901137828826904,NVDA,Can Sony and LL Cool J Compete with Apple?,1,0.5286565
2012-06-07,52678000.0,3.1424999237060547,3.1600000858306885,2.970000028610229,2.9725000858306885,2.726808786392212,NVDA,"UPDATE: FBR Capital Markets Cuts PT to $18 on NVIDIA Corporation on Weakening PC Checks ||| FBR Capital Markets Lowers PT on NVIDIA from $20 to $18, Maintains Outperform",1,0.55203456
2012-06-11,83908000.0,3.127500057220459,3.182499885559082,3.057499885559082,3.065000057220459,2.811663627624512,NVDA,"Canaccord Says Nvidia Chip in New MacBook Lineup is Nice Win for Company, Demand Continues to Outstrip Supply for Nvidia Chips ||| Apple's Next-Gen MacBook Pro Might Change the World of Portable Computing ||| Apple's Next Macbook Pro Will Feature an Nvidia Graphics Card ||| Nvidia Spiking on Chip Inclusion in MacBook Pro ||| Apple: MacBook Pros Using A New Generation Nvidia GeForce GT 650m Graphics ||| New Nvidia Chip to Appear in New Apple Macbook Pro ||| UBS Upgrades Nvidia from Neutral to Buy, Maintains PT at $15.5 ||| Nvidia Spiking on Chatter of Apple Product Inclusion, Nvidia Spokesperson Says Only Apple Would be Able to Make that Announcement ||| Nvidia Spiking on Chatter of Apple Product Inclusion ||| New Mac Pros and MacBooks About to be Unveiled ||| Benzinga's Top Upgrades",1,0.49833733
2012-06-13,49427600.0,3.125,3.132499933242798,3.0299999713897705,3.0450000762939453,2.793316125869751,NVDA,"An Investor's Perspective on Apple's Announcements (Plus, What the Company Didn't Say)",0,0.51026124
2012-06-15,38528800.0,3.0299999713897705,3.075000047683716,3.002500057220459,3.072499990463257,2.818543672561645,NVDA,Chip Vendors Gearing Up For Next-generation iPhone -DigiTimes,1,0.5141845
2012-06-19,96047600.0,3.227499961853028,3.3575000762939453,3.212500095367432,3.309999942779541,3.036412477493286,NVDA,"Forget Apple: Microsoft's Surface Tablet Aimed at Dell, HP ||| NVIDIA up 7% After Microsoft Tablet Announcment ||| Top 4 Mid-Cap Stocks In The Semiconductor-Specialized Industry With The Highest EPS",1,0.50471383
2012-06-20,97272000.0,3.3424999713897705,3.424999952316284,3.322499990463257,3.362499952316284,3.084573984146118,NVDA,"Is NVIDIA's Tablet-Fueled Rally Sustainable? ||| Was Dell, HP Surprised or Angered by Microsoft's New Tablet?",0,0.5246824
2012-06-21,51637600.0,3.359999895095825,3.359999895095825,3.202500104904175,3.2100000381469727,2.944677829742432,NVDA,NVIDIA Powers Digital Dashboard in New Tesla Motors Electric Sedan,1,0.52246624
2012-06-25,49461600.0,3.252500057220459,3.262500047683716,3.134999990463257,3.1475000381469727,2.887343406677246,NVDA,"Benzinga's Upgrade Summary for June 25, 2012 ||| UPDATE: Canaccord Genuity Upgrades NVIDIA Corporation to Buy on 2012 Tablet Ramp-Up ||| Canaccord Upgrades Nvidia from Hold to Buy, Raises PT from $13 to $16",1,0.49459496
2012-06-27,50606400.0,3.184999942779541,3.307499885559082,3.184999942779541,3.2850000858306885,3.013479471206665,NVDA,"Did Google Humiliate Apple, Amazon and Microsoft with New Product Announcements? ||| UPDATE: Google's Tegra 3 Chipset is Manufactured by Nvidia ||| Is Google's Tablet a $200 iPad-Killer?",1,0.50029975
2012-06-28,54589600.0,3.255000114440918,3.3299999237060547,3.227499961853028,3.309999942779541,3.036412477493286,NVDA,Lazard Capital Initiates Coverage On Nvidia at Neutral,1,0.520465
2012-07-03,21928400.0,3.362499952316284,3.4574999809265137,3.359999895095825,3.450000047683716,3.1648406982421875,NVDA,"Google Nexus 7 iFixit Teardown Shows NVIDIA, NXP Semi, Broadcom, InvenSense Chips",0,0.5028365
2012-07-10,51202800.0,3.2699999809265137,3.367500066757202,3.180000066757202,3.2049999237060547,2.940091609954834,NVDA,"Raymond James Maintains Nvidia at Strong Buy, Lowers PT from $22 to $20 ||| Will AMD's Decline Create an Opportunity for NVIDIA?",0,0.5115091
2012-07-16,33446000.0,3.119999885559082,3.174999952316284,3.0899999141693115,3.150000095367432,2.889636993408203,NVDA,"Societe Generale Upgrades Qualcomm to Hold; What Chip Companies Could Benefit? ||| UPDATE: FBR Capital Markets Reiterates Outperform Rating, Lowers PT on Nvidia Corporation",0,0.5008006
2012-07-18,61600800.0,3.0850000381469727,3.309999942779541,3.069999933242798,3.265000104904175,2.9951324462890625,NVDA,Today's Top Winners in Mid-Cap Tech,1,0.5207911
2012-07-19,40303600.0,3.2874999046325684,3.3399999141693115,3.265000104904175,3.297499895095825,3.0249462127685547,NVDA,"Sony Launches iPod Touch Clone, Calls it a ""Walkman""",0,0.5248363
2012-07-31,38778800.0,3.3324999809265137,3.432499885559082,3.327500104904175,3.384999990463257,3.105213165283203,NVDA,Sony Developing a Microsoft Surface-Inspired Tablet,0,0.54493624
2012-08-07,40734000.0,3.5450000762939453,3.575000047683716,3.5174999237060547,3.5374999046325684,3.2451088428497314,NVDA,"FBR Capital Markets Maintains Nvidia at Outperform, Raises PT from $15 to $17",1,0.49464917
2012-08-08,51706400.0,3.5350000858306885,3.595000028610229,3.525000095367432,3.557499885559082,3.263455629348755,NVDA,AMD Gains on Rumored Acquisition by Samsung ||| AMD's Workstation Graphics Line Could Challenge Nvidia,1,0.5002971
2012-08-09,82230000.0,3.5625,3.684999942779541,3.557499885559082,3.677500009536743,3.3735368251800537,NVDA,"Nvidia Reports Q2 EPS $0.27 May Not Compare to $0.14 Est; Revenues $1.04B vs $1.01B Est ||| US Stock Futures Slightly Higher Ahead Of Economic Data ||| Earnings Scheduled For August 9, 2012",0,0.45007774
2012-08-10,127874400.0,3.775000095367432,3.805000066757202,3.607500076293945,3.6549999713897705,3.3528974056243896,NVDA,"Barclays Maintains Nvidia at Equal-weight, Raises PT from $15 to $16 ||| UPDATE: Wedbush Reiterates Outperform Rating, Raises PT on Nvidia Corporation ||| UBS Maintains Nvidia at Buy, Raises PT from $15.50 to $17.50 ||| Stifel Nicolaus Maintains Nvidia at Buy, Raises PT from $19 to $21 ||| FBR Capital Markets Maintains Nvidia at Outperform, Raises PT from $17 to $20 ||| Wedbush Securities Maintains Nvidia at Outperform, Raises PT from $18 to $20 ||| US Stock Futures Down After China Trade Data ||| Jefferies & Company Maintains Nvidia at Hold, Raises PT from $14 to $16 ||| Citigroup Maintains Nvidia at Hold, Raises PT from $14 to $15 ||| UPDATE: Nvidia Posts Better-Than-Expected Q2 Profit, Issues Upbeat Revenue Forecast ||| Stocks To Watch For August 10, 2012",1,0.48778328
2012-08-13,44724400.0,3.660000085830689,3.704999923706055,3.6449999809265137,3.702500104904175,3.3964710235595703,NVDA,Short Sellers Shy Away from Qualcomm and Texas Instruments ||| Barron's Recap (8/11/12): China's Top Brands,0,0.5040428
2012-08-15,59440400.0,3.660000085830689,3.690000057220459,3.602499961853028,3.619999885559082,3.320789098739624,NVDA,Will Microsoft Really Sell Surface for $199?,1,0.5158032
2012-08-21,34024800.0,3.674999952316284,3.697499990463257,3.615000009536743,3.652499914169312,3.350603103637696,NVDA,How to Trade a $200 Microsoft Surface Tablet,1,0.5289404
2012-08-27,34094400.0,3.6475000381469727,3.6575000286102295,3.5850000381469727,3.587500095367432,3.290976047515869,NVDA,Benzinga's Top Pre-Market Losers,0,0.5231748
2012-09-04,69445200.0,3.450000047683716,3.462500095367432,3.2874999046325684,3.319999933242798,3.0455856323242188,NVDA,Setups for the first week of September,1,0.5224346
2012-09-06,65729600.0,3.3550000190734863,3.5225000381469727,3.352499961853028,3.432499885559082,3.14878797531128,NVDA,"Amazon Ends Apple's Monopoly ||| Amazon Unveils $299 Kindle Fire HD, $499 with 4G LTE",0,0.51074123
2012-09-07,78106400.0,3.345000028610229,3.372499942779541,3.237499952316284,3.3499999046325684,3.073106288909912,NVDA,Intel Falls on Revised Guidance,0,0.5249337
2012-09-13,43383600.0,3.427500009536743,3.440000057220459,3.3550000190734863,3.4200000762939453,3.1373207569122314,NVDA,"Short Interest in Chip Makers on the Rise ||| NVIDIA Guides Q3 Revenue $1.15-1.25B vs $1.23B Est ||| UPDATE: NVIDIA Says Kepler, Tegra Driving Growth in 2H ||| UPDATE: NVIDIA Says Supply Situation Improving ||| NVIDIA Now Presenting at ThinkEquity ||| Citigroup Maintains Nvidia at Neutral, Lowers PT from $16.50 to $15.25",1,0.5041208
2012-09-25,48154400.0,3.4600000381469727,3.4749999046325684,3.3475000858306885,3.352499961853028,3.075399875640869,NVDA,Benzinga's Top Initiations,0,0.53323805
2012-09-26,43681200.0,3.3399999141693115,3.3424999713897705,3.255000114440918,3.2950000762939453,3.0226528644561768,NVDA,"Short Interest in Chip Makers on the Rise (AMD, BRCM, NVDA)",1,0.5332518
2012-09-28,48550800.0,3.305000066757202,3.382499933242798,3.262500047683716,3.3350000381469727,3.0593461990356445,NVDA,Brean Murray Initiates Coverage Nvidia at Hold,0,0.51813436
2012-10-01,50423600.0,3.3499999046325684,3.369999885559082,3.2674999237060547,3.2799999713897705,3.0088915824890137,NVDA,Former SAC Capital Analyst Horvath Pleads Guilty to Insider Trading,1,0.5053222
2012-10-05,48306800.0,3.414999961853028,3.450000047683716,3.3125,3.325000047683716,3.050173044204712,NVDA,Benzinga's Top Pre-Market Gainers,0,0.52491933
2012-10-10,32656800.0,3.2074999809265137,3.2225000858306885,3.1549999713897705,3.1675000190734863,2.905691146850586,NVDA,"Deutsche Bank Maintains Nvidia at Hold, Lowers PT from $15 to $14",1,0.48840252
2012-10-16,36769600.0,3.2249999046325684,3.299999952316284,3.194999933242798,3.289999961853028,3.01806640625,NVDA,Can Microsoft's $499 Surface Defeat Apple's iPad?,0,0.52683884
2012-10-19,70941200.0,3.1675000190734863,3.190000057220459,3.009999990463257,3.0274999141693115,2.777262687683105,NVDA,"UPDATE: FBR Capital Markets Downgrades NVIDIA to Market Perform on PC Weakness ||| FBR Capital Markets Downgrades Nvidia from Outperform to Market Perform, Lowers PT from $17.50 to $14",0,0.49860236
2012-10-23,57394800.0,2.9649999141693115,3.102499961853028,2.9574999809265137,3.0824999809265137,2.827716588973999,NVDA,"UPDATE: Apple New iMac Has Nvidia Graphics, Intel Quad-Core Ivy Bridge",0,0.52426136
2012-11-02,25670000.0,3.1700000762939453,3.174999952316284,3.102499961853028,3.122499942779541,2.864410638809204,NVDA,The Week Ahead: More Earnings and the U.S. Election,1,0.5356766
2012-11-05,44484000.0,3.115000009536743,3.2674999237060547,3.115000009536743,3.255000114440918,2.985958814620972,NVDA,"UPDATE: BMO Capital Markets Reiterates Market Perform Rating, Lowers PT on NVIDIA Corporation ||| BMO Capital Markets Maintains Nvidia at Market Perform, Lowers PT from $16 to $13",0,0.49951795
2012-11-06,35080400.0,3.262500047683716,3.262500047683716,3.197499990463257,3.252500057220459,2.983665943145752,NVDA,"UBS Maintains Nvidia at Buy, Lowers PT from $17.50 to $16.50",0,0.48863068
2012-11-07,32462000.0,3.227499961853028,3.247499942779541,3.137500047683716,3.1524999141693115,2.891931295394897,NVDA,"UPDATE: Wedbush Securities Reduces PT to $17 on Macro Uncertainties ||| Wedbush Securities Maintains Nvidia at Outperform, Lowers PT from $20 to $17",1,0.49520144
2012-11-08,83902400.0,3.1875,3.2699999809265137,3.1624999046325684,3.1700000762939453,2.9079835414886475,NVDA,"NVIDIA Sees Q4 Sales $1.025-1.175B vs $1.21B Est ||| NVIDIA Extends Buyback of $2.7B Through 2014, Initiates $0.075/Share Qtr. Dividend ||| Nvidia Reports Q3 EPS $0.39 vs $0.30 Est; Revenues $1.2B vs $1.19B Est ||| Futures Flat, Euro Falls Ahead of Central Banks ||| US Stock Futures Flat; ECB, Economic Data In Focus ||| Earnings Scheduled For November 8, 2012",0,0.47866195
2012-11-09,84628000.0,3.1875,3.2249999046325684,3.0374999046325684,3.047499895095825,2.7956089973449707,NVDA,"UPDATE: Nomura Cuts PT to $16 on NVIDIA on Weak Guidance ||| UPDATE: Jefferies & Company Reiterates Hold Rating, Lowers PT on NVIDIA Corporation ||| FBR Capital Markets Maintains Nvidia at Market Perform, Raises PT from $14 to $16 ||| Nomura Maintains Nvidia at Buy, Lowers PT from $18 to $16 ||| Jefferies & Company Maintains Nvidia at Hold, Raises PT from $16 to $14",0,0.52842623
2012-11-19,40409200.0,2.8975000381469727,2.934999942779541,2.862499952316284,2.924999952316284,2.683234930038452,NVDA,"Tablet Roundup: iPad Mini, Surface, Nexus 10 and More",0,0.5184897
2012-11-28,39833200.0,3.0274999141693115,3.0799999237060547,2.990000009536743,3.065000057220459,2.829803705215454,NVDA,One Semiconductor Stock That Could Benefit from Apple's Next iPad,0,0.5280986
2012-12-05,63302400.0,3.0,3.0199999809265137,2.947499990463257,2.990000009536743,2.7605578899383545,NVDA,"UPDATE: Oppenheimer Holdings Downgrades NVIDIA Corporation to Perform ||| Oppenheimer Downgrades NVIDIA Corporation to Perform, Removes $(aN) PT",1,0.4955015
2012-12-11,81672400.0,3.0999999046325684,3.202500104904175,3.0924999713897705,3.1624999046325684,2.919821262359619,NVDA,"Option Alert: Nvidia January 14 Call; Block Trade: 6,469 Contracts @$0.22; Currently $12.75",0,0.4919768
2012-12-12,39940400.0,3.172499895095825,3.190000057220459,3.117500066757202,3.130000114440918,2.889815092086792,NVDA,Wednesday December 12th Watchlist ||| NVIDIA Wins $20M DARPA Contract for High-Performance Embedded Processor Research,1,0.5190535
2012-12-14,33866000.0,3.1449999809265137,3.180000066757202,3.122499942779541,3.1475000381469727,2.9059712886810303,NVDA,Benzinga's Top Pre-Market Gainers,0,0.52491933
2012-12-17,44523200.0,3.140000104904175,3.157500028610229,3.087500095367432,3.134999990463257,2.8944315910339355,NVDA,6 stocks to watch in the week ahead,1,0.53307015
2012-12-19,45854400.0,3.1624999046325684,3.200000047683716,3.150000095367432,3.1624999046325684,2.919821262359619,NVDA,Wednesday December 19th watchlist,0,0.504909
2012-12-20,33433200.0,3.174999952316284,3.177500009536743,3.125,3.1600000858306885,2.917513370513916,NVDA,Top Stocks on my Watch List for Thursday December 20th,0,0.48273245
2012-12-26,19674000.0,3.055000066757202,3.1050000190734863,3.047499895095825,3.059999942779541,2.825186252593994,NVDA,Short Term Trading Ideas for Christmas Week,0,0.5319288
2012-12-28,22060000.0,3.012500047683716,3.072499990463257,3.007499933242798,3.025000095367432,2.792872428894043,NVDA,Another Executive Jumps Off AMD's Sinking Ship,1,0.52703553
2013-01-03,29888800.0,3.180000066757202,3.2174999713897705,3.1449999809265137,3.182499885559082,2.938286066055298,NVDA,"Stocks on my Watch List for Thursday, January 3",1,0.47899035
2013-01-07,61073200.0,3.2850000858306885,3.2950000762939453,3.1700000762939453,3.192500114440918,2.947518110275269,NVDA,Did NVIDIA Steal Apple's Retina Display? ||| The 5 Coolest Things You'll See at CES ||| Why is NVIDIA Building a Portable Game Machine? ||| 6 High Momentum Stocks to Watch next Week ||| Nvidia Announces Six Coud-Gaming Companies to Use GRID Platform,0,0.47883594
2013-01-09,69502000.0,3.1475000381469727,3.1624999046325684,3.032500028610229,3.052500009536743,2.8182621002197266,NVDA,Wednesday January 9th Watchlist,1,0.5051274
2013-01-23,42180800.0,3.0374999046325684,3.039999961853028,3.0,3.032500028610229,2.7997965812683105,NVDA,AMD is on Life Support While these Semiconductor Stocks Thrive,1,0.52107215
2013-01-28,42249200.0,3.117500066757202,3.172499895095825,3.109999895095825,3.1524999141693115,2.9105887413024902,NVDA,6 Stocks to Watch Out For Next Week,0,0.49484497
2013-01-29,38887200.0,3.140000104904175,3.1475000381469727,3.072499990463257,3.0850000381469727,2.8482682704925537,NVDA,Rumor: NVIDIA Building iPhone and iPad Competitors ||| Tuesday January 29th Watchlist,0,0.51690567
2013-02-01,28881600.0,3.0899999141693115,3.102499961853028,3.065000057220459,3.0924999713897705,2.8551933765411377,NVDA,Intel's New Strategy to Take on Apple's MacBook Air,0,0.520141
2013-02-06,53068800.0,3.0350000858306885,3.109999895095825,3.0174999237060547,3.0850000381469727,2.8482682704925537,NVDA,Wednesday February 6th Watchlist,0,0.50506866
2013-02-12,27780400.0,3.0999999046325684,3.1424999237060547,3.095000028610229,3.1075000762939453,2.8690414428710938,NVDA,"FBR Capital Maintains Market Perform on NVIDIA Corporation, Lowers PT to $14.00",0,0.5035735
2013-02-13,85639600.0,3.109999895095825,3.1675000190734863,3.0824999809265137,3.0924999713897705,2.8551933765411377,NVDA,"Nvidia Little Changed After Q4 Results ||| NVIDIA Corporation Sees Q1 Sales $940.0M +/- 2% vs $1.07B Est ||| NVIDIA Corporation Reports Q4 EPS of $0.35 vs $0.24 Est; Revenue of $1.11B vs $1.10B Est ||| Apple to Phase Out Standard, Retina-Free MacBook Pro ||| Short Interest in Chip Makers on the Rise (AMAT, ARM, NVDA) ||| US Stock Futures Higher Ahead Of Retail Sales Data ||| Earnings Scheduled For February 13, 2013",1,0.5063664
2013-02-14,88209600.0,3.049999952316284,3.184999942779541,3.012500047683716,3.182499885559082,2.938286066055298,NVDA,"Market Wrap for Thursday February 14: Stocks Close Near Unchanged ||| UPDATE: Stifel Nicolaus Cuts PT to $18 on NVIDIA Corporation on Raising OpEx, Product Transition ||| Needham Downgrades NVIDIA Corporation to Hold, Removes $17.00 PT ||| Stifel Nicolaus Maintains Buy on NVIDIA Corporation, Lowers PT to $18.00 ||| BMO Capital Maintains Market Perform on NVIDIA Corporation, Lowers PT to $12.00 ||| Nomura Maintains Buy on NVIDIA Corporation, Lowers PT to $15.00 ||| Deutsche Bank Maintains Hold on NVIDIA Corporation, Lowers PT to $13.00",0,0.5033345
2013-02-15,73386000.0,3.174999952316284,3.197499990463257,3.112499952316284,3.182499885559082,2.938286066055298,NVDA,Friday February 15th Watchlist,0,0.5086968
2013-02-21,58040800.0,3.0899999141693115,3.125,3.065000057220459,3.072499990463257,2.8367276191711426,NVDA,AMD Could Make Billions on Sony's PlayStation 4,1,0.5359307
2013-02-27,47698000.0,3.0924999713897705,3.172499895095825,3.0850000381469727,3.150000095367432,2.9261224269866943,NVDA,Wednesday February 27th watchlist,1,0.5043045
2013-03-04,35368000.0,3.1549999713897705,3.194999933242798,3.130000114440918,3.164999961853028,2.940056324005127,NVDA,"Short Interest in Chip Makers on the Rise (AMAT, ARM, QCOM) ||| 8 Stocks On Watch For Monday",1,0.522344
2013-03-06,34292800.0,3.220000028610229,3.25,3.182499885559082,3.197499990463257,2.9702470302581787,NVDA,"Unusual Option Action: 16,000 March $13.00 Nvidia Calls Trade Hands on Heavy Volume ||| Wednesday March 6th Watchlist",0,0.5014878
2013-03-07,31482400.0,3.2149999141693115,3.247499942779541,3.172499895095825,3.190000057220459,2.9632797241210938,NVDA,Top 4 Mid-Cap Stocks In The Semiconductor-Specialized Industry With The Highest ROE,1,0.5233688
2013-03-11,29974800.0,3.172499895095825,3.1875,3.1475000381469727,3.174999952316284,2.949345827102661,NVDA,"Benzinga's Top Pre-Market Losers ||| Susquehanna Downgrades NVIDIA Corporation to Negative, Announces $10.50 PT",1,0.5164746
2013-03-13,48584000.0,3.184999942779541,3.240000009536743,3.1549999713897705,3.184999942779541,2.9586355686187744,NVDA,"Wednesday March 13th Watchlist ||| Big Short Interest Swings in Chip Makers (AMAT, ARM, BRCM)",1,0.5049003
2013-03-14,38330400.0,3.2049999237060547,3.2149999141693115,3.1675000190734863,3.1875,2.960957765579224,NVDA,PlayStation 4 was Too Expensive for NVIDIA,0,0.5097466
2013-03-15,35577600.0,3.1875,3.1875,3.1475000381469727,3.1600000858306885,2.9354119300842285,NVDA,"Arm Holdings Workng on Plan to Help Second-Tier IC Designers Catch up with Qualcomm, Nvidia -DigiTimes",0,0.50017154
2013-03-18,29831200.0,3.140000104904175,3.1675000190734863,3.115000009536743,3.137500047683716,2.914510726928711,NVDA,"Tigress Financial's Ivan Feinseth Initiated Coverage on QUALCOMM with Strong Buy Rating, NVIDIA with Neutral Rating, Texas Instruments with Underperform",0,0.514974
2013-03-19,35548000.0,3.140000104904175,3.1549999713897705,3.095000028610229,3.117500066757202,2.8959314823150635,NVDA,"From NVIDIA Investor Session: CEO Says Windows RT Disappointing, Hasn't Sold Enough in Windows RT ||| UPDATE: Seeing Comments from NVIDIA's Huang, Says New Version of Tegra Mobile Processor Due Next Year ||| NVIDIA Shares Pushing to Session Lows Ahead of Investor Session on NVIDIA's Business with CEO Jen-Hsun Huang ||| Qualcomm to Replace NVIDIA for Google's Next-Gen Nexus 7",1,0.49472326
2013-03-25,36207600.0,3.137500047683716,3.140000104904175,3.0799999237060547,3.102499961853028,2.881998300552368,NVDA,Top 4 Mid-Cap Stocks In The Semiconductor-Specialized Industry With The Highest Cash,1,0.51796013
2013-03-26,23254000.0,3.109999895095825,3.127500057220459,3.0975000858306885,3.125,2.9028990268707275,NVDA,NVIDIA Shakes Up Sub-$200 Graphics Market With New GeForce GTX 650 Ti BOOST GPU,1,0.5061641
2013-04-01,44282800.0,3.200000047683716,3.200000047683716,3.0799999237060547,3.102499961853028,2.881998300552368,NVDA,"Big Short Interest Swings in Chip Makers (ARMH, MU, NVDA) ||| Here are a Few Setups to Watch Next Week",0,0.51020306
2013-04-03,35315600.0,3.065000057220459,3.0824999809265137,3.009999990463257,3.032500028610229,2.8169734477996826,NVDA,Google's New Nexus 7 Could Sell for $149,1,0.5093012
2013-04-10,38468800.0,3.1600000858306885,3.212500095367432,3.1524999141693115,3.2074999809265137,2.979535818099976,NVDA,Short Sellers Pile on ARM Holdings and Nvidia,0,0.49382257
2013-04-11,96922000.0,3.1624999046325684,3.212500095367432,3.075000047683716,3.192500114440918,2.9656014442443848,NVDA,"NVIDIA to Return $1B to Investors this FY, Says $100M in Stock to be Bought Back this Year -Bloomberg ||| NVIDIA to Increase Share Buyback, Will Add $750M by Q4 -Bloomberg ||| NVIDIA CEO Speaking at Annual Investor Day: Says Business Condtions Muted in 1H ||| Stocks to Watch for April 11, 2013",1,0.49729177
2013-04-16,46884400.0,3.234999895095825,3.262500047683716,3.2174999713897705,3.240000009536743,3.00972580909729,NVDA,SanDisk Earnings Preview: Solid First-Quarter Results Expected,0,0.52230006
2013-04-25,35322400.0,3.3575000762939453,3.375,3.327500104904175,3.367500066757202,3.128164052963257,NVDA,"Stocks to Watch for April 25, 2013",0,0.48697817
2013-04-26,32433200.0,3.362499952316284,3.367500066757202,3.3350000381469727,3.352499961853028,3.114229679107666,NVDA,"AMD, Texas Instruments See Short Interest Surge",1,0.51060784
2013-05-03,29386400.0,3.4749999046325684,3.492500066757202,3.4549999237060547,3.4674999713897705,3.221057415008545,NVDA,"The Week Ahead: Host of Earnings on Tap; Investors Watching Anadarko, Activision, and Whole Foods",0,0.5064138
2013-05-09,56680000.0,3.4124999046325684,3.492500066757202,3.407500028610229,3.477499961853028,3.230346441268921,NVDA,"NVIDIA Corporation Sees Q2 Sales $955.50-994.50 ||| NVIDIA Corporation Reports Q1 EPS of $0.18 vs $0.15 Est; Revenue of $954.70M vs $940.70M Est ||| Earnings Scheduled For May 9, 2013",1,0.5005879
2013-05-10,86113600.0,3.549999952316284,3.650000095367432,3.549999952316284,3.634999990463257,3.376651763916016,NVDA,"Short Sellers Retreat from Micron Technology, Other Semiconductor Stocks ||| Benzinga Market Primer: Friday, May 10 ||| Nvidia Beats Q1 Estimates; Provides Weak Guidance",0,0.49559715
2013-05-13,28981200.0,3.609999895095825,3.625,3.5450000762939453,3.559999942779541,3.3069822788238525,NVDA,Sony to Increase LCD TV Shipments by 19%,1,0.53923947
2013-05-14,45414000.0,3.602499961853028,3.642499923706055,3.567500114440918,3.612499952316284,3.355751276016236,NVDA,NVIDIA Begins Taking Orders for Shielf Portable-Gaming Device ||| Nvidia Partners up with Goldman to Repurchase $750 Million Worth of its Shares ||| NVIDIA Announces $750M Accelerated Buyback with Goldman Sachs,1,0.5069136
2013-05-22,48040400.0,3.744999885559082,3.744999885559082,3.5850000381469727,3.5999999046325684,3.36112642288208,NVDA,"IDC Report Shows Worldwide Semi Market Contracted 2.2% in 2012, Expecting 3.5% Growth This Year",1,0.52172333
2013-05-23,39388400.0,3.557499885559082,3.670000076293945,3.547499895095825,3.6575000286102295,3.414811849594116,NVDA,"UPDATE: Topeka Capital Markets Initiates NVIDIA Corporation at Hold ||| Topeka Capital Initiates Coverage on NVIDIA Corporation at Hold, Announces $15.00 PT",0,0.5120584
2013-05-28,27930000.0,3.662499904632568,3.672499895095825,3.5975000858306885,3.632499933242798,3.391470432281494,NVDA,"Broadcom, Nvidia See Upswings in Short Interest",0,0.511207
2013-06-04,36367600.0,3.634999990463257,3.700000047683716,3.595000028610229,3.617500066757202,3.377465009689331,NVDA,NVIDIA Shares Lower Despite WSJ Headline 'NVIDIA Open to Deals That Fit Into Businesses',0,0.50410014
2013-06-14,23601200.0,3.6050000190734863,3.609999895095825,3.5625,3.587500095367432,3.349456787109375,NVDA,"Short Sellers Less Keen on Applied Materials, Marvell Technology (AMAT, NVDA, MRVL)",1,0.51969856
2013-06-18,48677200.0,3.640000104904175,3.680000066757202,3.569999933242798,3.5999999046325684,3.36112642288208,NVDA,"NVIDIA Says Will Begin Licensing GPU Technology ||| Microsoft Said to Add Qualcomm as Supplier for Surface RT, Nvidia to Remain Supplier for Some Versions ||| One Simple Measure for Investing in a Volatile Market",1,0.49991724
2013-06-19,115958800.0,3.632499933242798,3.869999885559082,3.619999885559082,3.7100000381469727,3.463827610015869,NVDA,Microsoft's Next Tablet Could Include Qualcomm Chips,0,0.5337084
2013-06-26,57975200.0,3.595000028610229,3.5999999046325684,3.5199999809265137,3.5350000858306885,3.3004398345947266,NVDA,"UPDATE: NVIDIA Says the Mechanical Component Has Issues ||| Shares of NVIDIA Not Responding to Headlines Shipment of SHIELD Gaming Device Delayed til Next Month ||| Short Sellers Jump on ARM Holdings, Broadcom (AMAT, ARMH, BRCM)",0,0.49657437
2013-07-05,18468400.0,3.5425000190734863,3.567500114440918,3.5199999809265137,3.559999942779541,3.323780536651612,NVDA,"Can Microsoft's Surface 2 Save NVIDIA's Tegra 4? (MSFT, NVDA)",0,0.50469464
2013-07-11,23983200.0,3.627500057220459,3.662499904632568,3.619999885559082,3.6575000286102295,3.414811849594116,NVDA,"Short Sellers Jump on KLA-Tencor, Marvell Technology (ARMH, KLAC, MRVL)",1,0.51086086
2013-07-23,24679200.0,3.602499961853028,3.602499961853028,3.5350000858306885,3.552500009536743,3.31677770614624,NVDA,NVIDIA Appoints Former PepsiCo. Exec Dawn Hudson to Its Board of Directors,0,0.5126273
2013-07-24,28425200.0,3.5850000381469727,3.595000028610229,3.547499895095825,3.552500009536743,3.31677770614624,NVDA,"Will Google's $229 Nexus 7 Upgrade Dethrone Apple's iPad Mini? (AAPL, GOOG) ||| Google to Unveil Second-Generation Nexus 7 Today",1,0.5097092
2013-07-25,24332000.0,3.549999952316284,3.612499952316284,3.525000095367432,3.565000057220459,3.328449249267578,NVDA,"Short Sellers Continue to Pile on KLA-Tencor (AMAT, KLAC, TXN)",0,0.51094985
2013-07-31,27016000.0,3.5850000381469727,3.6449999809265137,3.5824999809265137,3.609999895095825,3.3704636096954346,NVDA,"Stocks to Watch for July 31, 2013 ||| Wells Fargo Downgrades NVIDIA Corporation to Market Perform",1,0.4829367
2013-08-01,27764800.0,3.622499942779541,3.6675000190734863,3.5799999237060547,3.660000085830689,3.4171457290649414,NVDA,"Option Alert: Nvidia January 16 Call; Block Trade: 7,795 Contracts @$0.59; Currently $14.49",1,0.49346635
2013-08-05,18518800.0,3.680000066757202,3.7200000286102295,3.660000085830689,3.7074999809265137,3.461493492126465,NVDA,Earnings Expectations For The Week Of August 5,0,0.47623456
2013-08-06,20660800.0,3.7100000381469727,3.7174999713897705,3.6449999809265137,3.652499914169312,3.4101433753967285,NVDA,"Google, IBM, NVIDIA, Mellanox Announce Development Group for IBM Chips, Consortium Will Build Server and Storage Technology ||| Tablet Shipments to Increase 17.7% on-Year in H2 2013 -DigiTImes",0,0.5035843
2013-08-07,24438000.0,3.632499933242798,3.6875,3.630000114440918,3.650000095367432,3.407809019088745,NVDA,Google's Second-Gen Nexus 7 May Be Limited To 3.5 Million Units (GOOG),1,0.49291706
2013-08-08,34569600.0,3.670000076293945,3.692500114440918,3.627500057220459,3.674999952316284,3.43114972114563,NVDA,"Nvidia Reports Lower Q2 Profit (NVDA) ||| NVIDIA Corporation Reports Q2 EPS of $0.23 vs $0.13 Est; Revenue of $977.20M ||| Earnings Scheduled For August 8, 2013",0,0.46129215
2013-08-09,90622400.0,3.5299999713897705,3.677500009536743,3.5274999141693115,3.622499942779541,3.382133722305298,NVDA,"Will Shield Stop Nvidia's Growth From Fading? ||| Benzinga's Top Pre-Market Losers ||| Nomura Maintains Buy on NVIDIA Corporation, Raises PT to $17.00",0,0.49371392
2013-08-12,25756800.0,3.4749999046325684,3.6449999809265137,3.2774999141693115,3.5924999713897705,3.3541245460510254,NVDA,"Amazon To Launch New Game Console Alongside PlayStation 4, Xbox One",1,0.5166382
2013-08-19,39343200.0,3.775000095367432,3.787499904632568,3.734999895095825,3.737499952316284,3.489503860473633,NVDA,"Will Apple, Dell And Hewlett-Packard Follow Lenovo And Build Notebooks In-House?",0,0.5253336
2013-08-21,26154000.0,3.714999914169312,3.762500047683716,3.704999923706055,3.7200000286102295,3.490676164627075,NVDA,Intel's Plan To Overtake Qualcomm's Snapdragon Platform ||| NVIDIA Shares Volatile as Co. Announces Gaming Alliance with Ubisoft for Fall Season,1,0.50282735
2013-08-22,12901600.0,3.7174999713897705,3.775000095367432,3.7174999713897705,3.740000009536743,3.509443759918213,NVDA,"NVIDIA, Ubisoft form Gaming Alliance",0,0.5120996
2013-08-27,27746400.0,3.712500095367432,3.737499952316284,3.6875,3.700000047683716,3.471908569335937,NVDA,"Short Sellers Gang Up On Marvell Technology (MRVL, QCOM, STM)",0,0.51963806
2013-09-09,24640800.0,3.75,3.7825000286102295,3.740000009536743,3.7825000286102295,3.549323320388794,NVDA,"Microsoft To Unveil New Surface Tablet September 23 (MSFT) ||| Nvidia Gets Orders for Microsoft's Surface RT, Asustek, Toshiba and Hewlett-Packard Tablets -DigiTImes",1,0.47277492
2013-09-12,30380800.0,3.9075000286102295,3.974999904632568,3.9075000286102295,3.924999952316284,3.683038234710693,NVDA,"Short Sellers Load Up On Applied Materials And Other Chip Stocks (AMAT, MU, NVDA)",1,0.5114206
2013-09-16,23141200.0,3.982500076293945,4.010000228881836,3.9375,3.952500104904175,3.708843231201172,NVDA,Microsoft 'Surface 2' Rumor Roundup ||| UPDATE: NVIDIA Appoints Colette Kress as Chief Financial Officer ||| NVIDIA Names Colette Kress as CFO,1,0.5051088
2013-09-27,15192000.0,3.887500047683716,3.920000076293945,3.872499942779541,3.8949999809265137,3.6548879146575928,NVDA,"Rising Short Interest For Broadcom And Other Semiconductor Stocks (BRCM, KLAC, MRVL) ||| Release of AMD Radeon R9 and R7 GPUs Expected to Pressure Nvidia to Offer Price Cuts -Digitimes",0,0.48031247
2013-10-09,27586000.0,3.890000104904175,3.892499923706055,3.785000085830689,3.805000066757202,3.570436477661133,NVDA,"Nvidia Cuts Prices, Will Release New Graphics Card -DigiTimes",1,0.50066906
2013-10-11,21370400.0,3.787499904632568,3.8350000381469727,3.775000095367432,3.815000057220459,3.579819440841675,NVDA,"UPDATE: Macquarie Downgraded Intel and NVIDIA Based on Thundering Cloud Computing ||| UPDATE: Macquarie Downgrades NVIDIA on Potential Impact of Cloud Computing ||| Applied Materials, Marvell Technology Face Rising Short Interest (AMAT, MRVL, STM) ||| Benzinga's Top Pre-Market Losers ||| Macquarie Downgrades NVIDIA Corporation to Underperform, Lowers PT to $14.00",1,0.5187127
2013-10-22,17945200.0,3.962500095367432,3.964999914169312,3.9075000286102295,3.942500114440918,3.699460506439209,NVDA,Apple Says New Mac Pro Desktop Has AMD Firepro Graphics ||| Shares of NVIDIA Not Yet Moving Following News of Intel Chip in New Macbook Pro,0,0.51505554
2013-10-28,39402400.0,3.805000066757202,3.822499990463257,3.75,3.802500009536743,3.5680906772613525,NVDA,"Short Sellers Pile On Applied Materials and STMicroelectronics (AMAT, MU, STM) ||| Nvidia Shield Can Now Download Games on Google Play Store",1,0.50358707
2013-11-07,55307600.0,3.712500095367432,3.722500085830689,3.630000114440918,3.637500047683716,3.413262367248535,NVDA,"NVIDIA Corporation Sees Q4 Sales $1.05B +/- 2% vs $1.05B Est; Reports Added $1B Buyback Plan ||| NVIDIA Corporation Reports Q3 EPS of $0.26 vs $0.20 Est; Revenue of $1.05B vs $1.05B Est ||| Earnings Scheduled For November 7, 2013",1,0.4923916
2013-11-08,73453200.0,3.75,3.902499914169312,3.734999895095825,3.890000104904175,3.650196075439453,NVDA,"Panasonic's New 4K Tablet Is 12X More Expensive Than Apple's iPad Air ||| FBR Capital Maintains Market Perform on NVIDIA Corporation, Raises PT to $15.00",1,0.49915227
2013-11-13,33279200.0,3.920000076293945,4.037499904632568,3.912499904632568,4.037499904632568,3.7886033058166495,NVDA,"Short Interest Rises In Marvell, Falls In Qualcomm (MRVL, QCOM, TXN)",1,0.52605045
2013-11-18,31694800.0,3.954999923706055,3.990000009536743,3.934999942779541,3.944999933242798,3.701806545257568,NVDA,"Mid-Morning Market Update: Markets Mixed; Tyson Posts Higher Profit ||| Benzinga's Top Downgrades ||| Benzinga's Top #PreMarket Losers ||| UPDATE: Morgan Stanley Downgrades NVIDIA On Projections Of Significant Headwinds ||| Morgan Stanley Downgrades NVIDIA Corporation to Underweight, Announces $13.00 PT",0,0.4964165
2013-11-19,20671600.0,3.9049999713897705,3.940000057220459,3.8550000190734863,3.859999895095825,3.6416618824005127,NVDA,Sony's $399 PlayStation 4 Costs $381 To Produce,0,0.5492202
2013-11-26,75317600.0,3.920000076293945,3.952500104904175,3.8949999809265137,3.910000085830689,3.6888349056243896,NVDA,"NVIDIA Reports Pricing of $1.3B of Convertible Senior Notes, Says Net Proceeds Will Be Used Primarily to Fund Capital Return",1,0.5207833
2013-12-02,37387200.0,3.884999990463257,3.964999914169312,3.877500057220459,3.9375,3.7147774696350098,NVDA,"IDC Expecting PC Shipments to Decline in Double Digit Percent Range During 2013, Cuts Global Shipments Outlook, from 9.7% to 10.1%",0,0.50074196
2013-12-03,29056000.0,3.9375,3.990000009536743,3.910000085830689,3.934999942779541,3.712419271469116,NVDA,IHS Says Expecting Semi Sales Up Almost 5% to Around $317.9B in '13,1,0.50530374
2013-12-11,41415600.0,3.8975000381469727,3.902499914169312,3.8450000286102295,3.8524999618530273,3.634585380554199,NVDA,"comScore Says US Online Holiday Sales to Date $31.5B, Sales from Desktops on Dec. 9th Up 10% to $1.4B",0,0.50869924
2013-12-18,42623200.0,3.785000085830689,3.837500095367432,3.737499952316284,3.829999923706055,3.613358736038208,NVDA,Intel Worried About Google's Plan to Make Server Processors,1,0.53146136
2014-01-09,29217200.0,4.027500152587891,4.034999847412109,3.924999952316284,3.9375,3.7147774696350098,NVDA,"Shares of NVIDIA Fall 4.2% Following Canaccord's Downgrade ||| Is NVIDIA's Tegra K1 On Par With PlayStation 4, Xbox One? ||| Canaccord Genuity Downgrades NVIDIA Corporation to Hold, Maintains $16.00 PT",0,0.49504092
2014-01-13,24333200.0,3.932499885559082,3.9574999809265137,3.8324999809265137,3.839999914169312,3.622793674468994,NVDA,"CES 2014 Review: Announcements, Products & Surprises",1,0.51045096
2014-01-14,24182800.0,3.859999895095825,3.9674999713897705,3.8424999713897705,3.9600000381469727,3.736006021499634,NVDA,"NVIDIA Names Cabrera General Counsel, Names Shannon as Chief Administrative Officer",1,0.5174146
2014-01-21,24607600.0,4.002500057220459,4.037499904632568,3.9700000286102295,4.012499809265137,3.785536050796509,NVDA,"Benzinga's Top Upgrades ||| UPDATE: Evercorp Upgrades NVIDIA ||| US Stock Futures Signal Higher Start On Wall Street ||| Evercore Partners Upgrades NVIDIA Corporation to Equal-weight, Announces $16.00 PT",0,0.510882
2014-02-03,43172800.0,3.952500104904175,3.9574999809265137,3.857500076293945,3.872499942779541,3.653454780578613,NVDA,"Susquehanna Upgrades NVIDIA Corporation to Neutral, Raises PT to $14.00",1,0.5069968
2014-02-10,32437200.0,3.962500095367432,4.03249979019165,3.9600000381469727,3.9800000190734863,3.754873991012573,NVDA,"Earnings Expectations For The Week Of February 10: AIG, Cisco, Deere, PepsiCo And More",1,0.50141174
2014-02-12,74452800.0,4.074999809265137,4.237500190734863,4.074999809265137,4.207499980926514,3.969505548477173,NVDA,"NVIDIA Corporation Sees Q1 Sales $1.05B +/- 2% vs $1.0B Est ||| NVIDIA Corporation Reports Q4 EPS of $0.32 vs $0.24 Est; Revenue of $1.14B vs $1.05B Est ||| Earnings Scheduled For February 12, 2014",1,0.49154517
2014-02-13,90283600.0,4.3125,4.364999771118164,4.237500190734863,4.340000152587891,4.094511032104492,NVDA,"NVIDIA Reports Strong EPS and Revenue ||| Morgan Stanley Sees Limited Upside for NVIDIA ||| Stocks Hitting 52-Week Highs ||| UPDATE: Evercore Group Upgrades NVIDIA on Progress in Growth Drivers ||| Benzinga's Top #PreMarket Gainers ||| Benzinga's Top Upgrades ||| B. Riley & Co. Upgrades NVIDIA Corporation to Buy, Raises PT to $21.00 ||| FBR Capital Maintains Market Perform on NVIDIA Corporation, Raises PT to $17.00 ||| Stifel Nicolaus Maintains Buy on NVIDIA Corporation, Raises PT to $19.00",1,0.5242173
2014-02-14,81753600.0,4.300000190734863,4.487500190734863,4.297500133514404,4.477499961853027,4.224232196807861,NVDA,"Form 8-K from NVIDIA Shows Accelerated Buyback Plan,Will Make Upfront Payment 4500M, Will Receive 20.6M Shares",0,0.50222826
2014-02-21,45105200.0,4.6875,4.747499942779541,4.630000114440918,4.659999847412109,4.396409034729004,NVDA,Stocks Hitting 52-Week Highs,1,0.5411546
2014-02-24,40311200.0,4.650000095367432,4.762499809265137,4.607500076293945,4.727499961853027,4.460092544555664,NVDA,"Option Alert: Nvidia Jun $20 Call; 10,000 Contract Trade Between Bid and Ask @$0.67; Currently $18.74",0,0.49044365
2014-03-19,36616800.0,4.59499979019165,4.727499961853027,4.582499980926514,4.639999866485596,4.397308349609375,NVDA,"Market Wrap For March 19: Yellen Hints of Higher Rates & Sooner Than Expected End To Taper ||| UPDATE: Stifel Reiterates on NVIDIA Ahead of 2014 Investor Day ||| Stifel Nicolaus Maintains Buy on NVIDIA Corporation, Raises PT to $21.00",1,0.5035807
2014-03-21,56611600.0,4.682499885559082,4.71999979019165,4.610000133514404,4.635000228881836,4.39256763458252,NVDA,"Market Wrap For March 21: Markets End Friday On A Negative Note, But Still Positive For The Week ||| CLSA Initiates Coverage on NVIDIA Corporation at Underperform, Announces $19.00 PT",0,0.4971616
2014-03-24,30609600.0,4.637499809265137,4.675000190734863,4.545000076293945,4.612500190734863,4.371245861053467,NVDA,NVIDIA Shares Volatile as FBR Issues Mid-Day Note Suggesting Co. Could Offer LT Goals for Returning Cash to Holders at Investor Day Tomorrow (Tuesday) ||| FBR Capital Markets Expects News About NVIDIA from Annual Investor Day,0,0.4866581
2014-03-25,30442400.0,4.662499904632568,4.667500019073486,4.577499866485596,4.612500190734863,4.371245861053467,NVDA,"GE Intelligent Platforms Announces Will Work with NVIDIA for Tegra K1-based, High Performance Embedded Computing Solution ||| Nvidia Announces Pascal Chip",0,0.52044326
2014-04-01,65627200.0,4.619999885559082,4.71750020980835,4.565000057220459,4.662499904632568,4.418632507324219,NVDA,"Morning Market Movers ||| Benzinga's Top Upgrades ||| JMP Securities Upgrades NVIDIA Corporation to Market Outperform, Announces $26.00 PT",0,0.5100769
2014-04-03,59954800.0,4.642499923706055,4.795000076293945,4.639999866485596,4.682499885559082,4.43758487701416,NVDA,"NVIDIA Shares Rally Amid Rumor of Greenlight Stake, Einhorn Spokesperson Declines Comment ||| UPDATE: Nvidia Spokesperson Says Company Does Not Comment on Who They Meet With ||| UPDATE: Einhorn Spokesperson Declines Comment on Rumor of Nvidia Meeting. Long Position ||| Hearing Unconfirmed Market Chatter of David Einhorn Long Position in Nvidia",0,0.4803653
2014-04-10,37274800.0,4.690000057220459,4.755000114440918,4.579999923706055,4.59499979019165,4.354660511016846,NVDA,ISI Initiates Coverage on Semi/Semi Equip. Stocks,0,0.50232476
2014-04-11,35311200.0,4.559999942779541,4.630000114440918,4.46999979019165,4.53000020980835,4.293061256408691,NVDA,"ISI Bullish on Semi-Conductors, Offers Top Picks",1,0.50695837
2014-05-06,41618800.0,4.702499866485596,4.742499828338623,4.550000190734863,4.5625,4.323860168457031,NVDA,"NVIDIA Announces Q1 2015 Results Early After 'Inadvertent' Internal Email ||| UPDATE: Nvidia to Provide Full Q1 Results, Outlook on Thursday as Initially Scheduled ||| NVIDIA Corporation Reports Q1 EPS of $0.29 vs $0.17 Est",1,0.49532157
2014-05-07,29390000.0,4.5625,4.605000019073486,4.517499923706055,4.567500114440918,4.328599452972412,NVDA,4 Compelling Trades Ahead Of Thursday's Earnings,1,0.5448702
2014-05-08,43272800.0,4.550000190734863,4.697500228881836,4.527500152587891,4.625,4.383091449737549,NVDA,NVIDIA Corporation Reports Q2 EPS of $0.29 vs $0.20 Est; Revenue of $1.10B vs $1.08B Est,0,0.5087732
2014-05-19,36007600.0,4.537499904632568,4.659999847412109,4.517499923706055,4.635000228881836,4.39256763458252,NVDA,"RBC Report: ""Cash is Becoming King, and Semis are Wearing the Crown"" ||| UPDATE: RBC Upgrades NVDA ||| RBC Capital Upgrades NVIDIA Corporation to Outperform, Raises PT to $26.00",0,0.4905046
2014-05-28,22467600.0,4.722499847412109,4.775000095367432,4.677499771118164,4.744999885559082,4.51752519607544,NVDA,Nvidia Shares Moving on Wednesday Report Being Circulated on 64-bit Nvidia Tegra ARM CPU in Google Nexus 8 Tablet,0,0.5066209
2014-06-09,24745600.0,4.752500057220459,4.807499885559082,4.71999979019165,4.762499809265137,4.534187316894531,NVDA,"Option Alert: Nvidia Jun $21 Call; 10,477 Contracts Traded vs 98 OI;; Currently $19.18",1,0.50109625
2014-06-19,47459200.0,4.807499885559082,4.832499980926514,4.75,4.784999847412109,4.555609703063965,NVDA,"Morning Market Losers ||| Benzinga's Top #PreMarket Losers ||| UPDATE: Bank Of America Downgrades NVIDIA ||| Benzinga's Top Downgrades ||| Bank of America Downgrades NVIDIA Corporation to Underperform, Maintains $19.00 PO",0,0.48712182
2014-06-23,41420000.0,4.670000076293945,4.679999828338623,4.614999771118164,4.677499771118164,4.453263759613037,NVDA,"Morning Market Losers ||| Benzinga's Top #PreMarket Losers ||| Benzinga's Top Downgrades ||| #PreMarket Primer: Monday, June 23: BNP Expected To Pay $9 Billion For Sanctions Violations ||| Pacific Crest Downgrades NVIDIA Corporation to Underperform",0,0.52699995
2014-07-17,32483200.0,4.78249979019165,4.875,4.78249979019165,4.824999809265137,4.593692302703857,NVDA,Top 4 Large-Cap Stocks In The Semiconductor-Specialized Industry With The Lowest PEG Ratio,0,0.51592577
2014-08-04,24172400.0,4.417500019073486,4.454999923706055,4.389999866485596,4.412499904632568,4.200965404510498,NVDA,Morgan Stanley: Nvidia's Gaming Growth Unsustainable ||| NVIDIA Renews Data Centre Partnership with NTT Communications,1,0.51075333
2014-08-07,40769600.0,4.447500228881836,4.487500190734863,4.335000038146973,4.364999771118164,4.155744552612305,NVDA,"NVIDIA Corporation Sees Q3 Sales $1.20B +/- 2% vs $1.16B Est ||| NVIDIA Corporation Reports Q2 EPS of $0.30 vs $0.20 Est; Revenue of $1.10B vs $1.10B Est ||| Earnings Scheduled For August 7, 2014",1,0.49165624
2014-08-08,89434800.0,4.554999828338623,4.775000095367432,4.554999828338623,4.75,4.522286415100098,NVDA,Markets Up As Russia Seeks To End Military Activity Near Ukraine ||| NVIDIA Q2 Earnings Analyst Roundup ||| Sotheby's Slips On Downbeat Earnings; NVIDIA Shares Surge ||| Markets Rise; Zynga Lowers 2014 Forecast ||| UPDATE: Morgan Stanley Reiterates On NVIDIA On Margin Upside From GPUs ||| FBR Capital Markets Is Surprised By Stronger 3Q14 GPU Shipments From NVIDIA ||| Morning Market Movers ||| Benzinga's Top Upgrades ||| Benzinga's Top #PreMarket Gainers ||| NVIDIA Higher Following Earnings ||| Needham Upgrades NVIDIA To Buy ||| Needham Upgrades NVIDIA Corporation to Buy,0,0.5042955
2014-08-11,34462400.0,4.755000114440918,4.775000095367432,4.712500095367432,4.724999904632568,4.498484611511231,NVDA,CNBC's Stock Pops & Drops From August 8,0,0.47256967
2014-08-26,26963600.0,4.789999961853027,4.872499942779541,4.772500038146973,4.862500190734863,4.649872779846191,NVDA,"VMware, NVIDIA, Google Report Collaboration for 'Graphics-Rich Applications Delivered on Enterprise Cloud Desktops' ||| UPDATE: Potentinal EU Investigation Comes Four Years After Nvidia's Icera Unit Filed Complaint Against Qualcomm ||| Reuters Reports EU Antitrust Regulators Considering Investigation Into Qualcomm, According to Sources",0,0.5132145
2014-10-02,28899600.0,4.559999942779541,4.582499980926514,4.442500114440918,4.547500133514404,4.348647594451904,NVDA,"Option Alert: Nvidia Oct 10 $18.5 Call; 1,000 Contract Trade at Ask @$0.11; Currently $17.83",1,0.49032766
2014-10-10,69137600.0,4.442500114440918,4.457499980926514,4.210000038146973,4.212500095367432,4.028295993804932,NVDA,Semiconductors Moving Lower Amid Microchip Lowered Guidance,0,0.5209144
2014-10-13,39762800.0,4.239999771118164,4.324999809265137,4.192500114440918,4.197500228881836,4.013951778411865,NVDA,NVIDIA Shares Tick Higher as JMP Adds to 'Best Ideas' List,1,0.51893723
2014-10-21,35109200.0,4.425000190734863,4.585000038146973,4.412499904632568,4.579999923706055,4.379725456237793,NVDA,"Benzinga's M&A Chatter for Tuesday October 21, 2014 ||| Intel Declines Comment on Chatter of Potential Bid for Nvidia ||| Hearing Unconfirmed Market Chatter of Potential Intel Bid for Nvidia",0,0.4933904
2014-11-03,30873200.0,4.997499942779541,5.014999866485596,4.942500114440918,4.96750020980835,4.750279426574707,NVDA,"CNBC's Stock Pops & Drops From November 3: GoPro, Gilead Sciences And More ||| Pacific Crest Upgrades NVIDIA Ahead Of Earnings ||| Pacific Crest Upgraded NVIDIA Corporation to Sector Perform ||| US Stock Futures Drop Ahead Of Economic Data ||| Pacific Crest Upgrades NVIDIA Corp To Sector Perform",1,0.48719138
2014-11-04,36019600.0,5.0,5.050000190734863,4.917500019073486,5.03249979019165,4.812438488006592,NVDA,Deutsche Bank Expects In-Line Revenues For NVIDIA,0,0.50584465
2014-11-06,39408800.0,5.042500019073486,5.0625,4.965000152587891,5.054999828338623,4.833954811096191,NVDA,"NVIDIA Corporation Reports Q3 EPS of $0.39 vs $0.29 Est; Revenue of $1.23B vs $1.20B Est ||| Option Alert: Nvidia Nov 14 $19 Call; 2,000 Contract Trade at Ask @$1.54; Currently $20.15 ||| Earning, Economic & IPO Calendar for Thursday November 6, 2014 ||| Earnings Scheduled For November 6, 2014 ||| Must Watch Stocks for November 6, 2014",0,0.49584168
2014-11-07,45080000.0,5.112500190734863,5.172500133514404,4.897500038146973,4.947500228881836,4.7311553955078125,NVDA,"UPDATE: Stifel Reiterates On NVIDIA As Strategy Is Playing Out In All Markets ||| NVIDIA Posts Record Revenue ||| Stifel Nicolaus Maintains Buy on NVIDIA Corporation, Raises PT to $24.50",1,0.4913715
2014-11-12,20458400.0,4.927499771118164,4.940000057220459,4.84499979019165,4.912499904632568,4.697686195373535,NVDA,"All Quiet On The Market Front: Dow, S&P 500, Nasdaq Virtually Flat",0,0.4964903
2014-11-19,24030000.0,5.025000095367432,5.039999961853027,4.949999809265137,5.002500057220459,4.803995132446289,NVDA,"UPDATE: In 10-Q Filing, Nvidia Reiterates Patent Infringement Complaint Filed by Samsung; Says has Not Yet Responded to Complaint",1,0.5206754
2014-11-21,19897600.0,5.130000114440918,5.137499809265137,5.070000171661377,5.112500190734863,4.909630298614502,NVDA,"If Qualcomm Can't Revolutionize Car Tech, Nobody Can",1,0.5023473
2014-12-08,22694400.0,5.260000228881836,5.3125,5.15749979019165,5.199999809265137,4.993658542633057,NVDA,"Notable Option Activity For December 8 ||| Option Alert: Nvidia Dec $21.5 Call; 1,349 Contract Trade at Ask @$0.26",0,0.48595795
2014-12-19,32552800.0,5.090000152587891,5.125,5.042500019073486,5.105000019073486,4.902429103851318,NVDA,"Bank Of America Analyst Sees Slower FY15 Growth For Semiconductor Group ||| UPDATE: Bank Of America Upgrades NVIDIA ||| Benzinga's Top Upgrades ||| #PreMarket Movers From December 19, 2014: NQ Mobile, BlackBerry, CarMax And More ||| Bank of America Upgrades NVIDIA To Neutral ||| Bank of America Upgrades NVIDIA to Neutral, Raises PT to $22.00",1,0.50851893
2014-12-23,10928000.0,5.235000133514404,5.260000228881836,5.15749979019165,5.162499904632568,4.957645893096924,NVDA,"KrebsOnSecurity's Brian Krebs Tweets: 'Heads up gamers: Nvidia discloses password breach. Change 'em, and if you used elsewhere (like email) change that http://ow.ly/GkZOi'",0,0.48897752
2015-01-05,19795200.0,5.03249979019165,5.047500133514404,4.925000190734863,4.947500228881836,4.751177310943604,NVDA,"S&P 500 Stocks With Most Active Options Today: CHRW, MUR, HAR, IP, NVDA",0,0.49776486
2015-01-06,19776400.0,4.954999923706055,4.960000038146973,4.792500019073486,4.797500133514404,4.607131004333496,NVDA,Will NVIDIA's Tegra X1 Dethrone The PlayStation 4 And Xbox One?,0,0.5268757
2015-01-09,20954000.0,4.982500076293945,5.022500038146973,4.914999961853027,4.985000133514404,4.787190914154053,NVDA,"Barclays: Connected Cars Take Center Stage At CES, 3 Themes Emerge",0,0.5161334
2015-01-23,12041600.0,5.167500019073486,5.1875,5.125,5.177499771118164,4.972051620483398,NVDA,Morgan Stanley Weighs In On Semiconductor Space,0,0.5257915
2015-01-29,23534000.0,4.829999923706055,4.972499847412109,4.807499885559082,4.945000171661377,4.748777866363525,NVDA,Option Alert: Nvidia Feb $20 Call; 8189 Contract Trade at Ask @$0.46; Now $19.48,0,0.49152917
2015-02-09,27394400.0,5.070000171661377,5.110000133514404,5.037499904632568,5.09499979019165,4.892824172973633,NVDA,"From Coca-Cola To Tesla, Here Are The 68 Most Important Earnings Expectations For The Week ||| Wedbush Previews NVIDIA's Q4 Results, Expects 'Solid' Beat",1,0.50473857
2015-02-11,32083200.0,5.25,5.25,5.167500019073486,5.202499866485596,4.996058940887451,NVDA,"After-Hours Movers Led By Zulily, Tripadvisor & Whole Foods ||| NVIDIA Sees Q1 Sales $1.16V +/- 2% vs $1.15B Est. ||| UPDATE: NVIDIA Shares Spike ~8% Following Earnings Release ||| NVIDIA Reports Q4 EPS $0.43 Vs Est $0.29, Sales $1.25B Vs Est $1.20B ||| Option Alert: NVDA Feb $19.5 Put; 10,000 Contracts On Ask @$0.24 ||| Earnings Scheduled For February 11, 2015 ||| 10 Must Watch Stocks for February 11, 2015",1,0.5347813
2015-02-12,67690400.0,5.5,5.625,5.46750020980835,5.574999809265137,5.35377836227417,NVDA,"Top Performing Industries For February 12, 2015 ||| NVIDIA Posts Strong Quarter Despite Weakness In Tegra ||| Stocks Hitting 52-Week Highs ||| 7 Risks Deutsche Bank Sees At NVIDIA ||| Morning Market Gainers ||| Morning-Movers Led By Orbitz, Tripadvisor & NVIDIA",1,0.5073833
2015-02-27,15749200.0,5.534999847412109,5.547500133514404,5.494999885559082,5.514999866485596,5.31655216217041,NVDA,Big Short Interest Swings In Semiconductor Stocks,1,0.50716376
2015-03-05,32305600.0,5.607500076293945,5.724999904632568,5.59250020980835,5.715000152587891,5.509355545043945,NVDA,Nvidia invites Tesla CEO Musk to Participate at GPU Technology Conference -DigiTimes,0,0.5093951
2015-03-10,52721200.0,5.677499771118164,5.787499904632568,5.667500019073486,5.75,5.543095111846924,NVDA,Stocks Hitting 52-Week Highs ||| Bank of America Upgrades NVIDIA to Buy,0,0.49476224
2015-03-12,40697200.0,5.664999961853027,5.707499980926514,5.559999942779541,5.667500019073486,5.463564395904541,NVDA,"Watch Intel Peers Following Reduced Outlook: AMD, NVIDIA, Micron, TI, Seagate, H-P",1,0.5003692
2015-03-16,23695600.0,5.71999979019165,5.777500152587891,5.682499885559082,5.742499828338623,5.5358662605285645,NVDA,Wedbush Securities Maintains Positive View On NVIDIA,1,0.49586543
2015-03-17,29990000.0,5.730000019073486,5.815000057220459,5.690000057220459,5.8125,5.603346347808838,NVDA,Option Alert: Nvidia Apr 2 $22 Call; 2070 Contract Trade at Ask @$1.22,0,0.4962593
2015-03-18,41384400.0,5.8125,5.84250020980835,5.664999961853027,5.71750020980835,5.511765480041504,NVDA,Why Is Wall Street Talking About Nvidia?,1,0.4931015
2015-03-19,31075600.0,5.737500190734863,5.824999809265137,5.695000171661377,5.804999828338623,5.596116542816162,NVDA,Canaccord Genuity Sees Solid Growth Potential For NVIDIA ||| CNBC's Stock Pops & Drops From March 18,1,0.48403215
2015-03-23,42601200.0,5.692500114440918,5.767499923706055,5.675000190734863,5.677499771118164,5.47320556640625,NVDA,"Why Goldman Is Downgrading Nvidia (And The Stock Is Down 2%) ||| Goldman Sachs Downgrades NVIDIA to Sell, Maintains $20.00 PT",0,0.47579238
2015-03-24,33048000.0,5.659999847412109,5.699999809265137,5.574999809265137,5.599999904632568,5.398492336273193,NVDA,Fast Money Traders Share Their Thoughts On NVIDIA And Micron Technology,0,0.50889826
2015-03-30,25325200.0,5.369999885559082,5.394999980926514,5.300000190734863,5.367499828338623,5.174358367919922,NVDA,BlackBerry Could Be An M&A Target For These 10 Companies,0,0.48887965
2015-04-01,33076800.0,5.252500057220459,5.269999980926514,5.162499904632568,5.252500057220459,5.063497543334961,NVDA,Bank Of America's 10 Most Explosive Stock Picks,1,0.5001913
2015-04-06,51586400.0,5.242499828338623,5.434999942779541,5.1875,5.417500019073486,5.222559928894043,NVDA,"NVIDIA Gets Favorable Ruling In Patent Dispute With Samsung, Qualcomm",1,0.5069624
2015-04-14,22027600.0,5.614999771118164,5.637499809265137,5.534999847412109,5.590000152587891,5.388853073120117,NVDA,"Intel Shares Up 3% Following Qtr. Results, Guidance; AMD, H-P, NVIDIA, Lam Research, KLA-Tencor Shares Also Seeing Volatility",1,0.4939181
2015-04-17,29363600.0,5.505000114440918,5.605000019073486,5.502500057220459,5.550000190734863,5.3502936363220215,NVDA,Option Alert: Nvidia Apr 24 $22.5 Call; 2853 Contract Trade at Ask @$0.23,0,0.4997375
2015-05-01,25696800.0,5.59499979019165,5.704999923706055,5.570000171661377,5.6875,5.482845783233643,NVDA,Wedbush Offers 4 Semiconductor Stocks To Watch Ahead Of Next Week's Earnings,0,0.51822543
2015-05-05,29292800.0,5.632500171661377,5.639999866485596,5.482500076293945,5.507500171661377,5.309320449829102,NVDA,NVIDIA Announces Will Wind Down Icera Modem Operations,1,0.51785266
2015-05-06,31648400.0,5.537499904632568,5.590000152587891,5.452499866485596,5.525000095367432,5.326192855834961,NVDA,Morgan Stanley Comments On Nividia Winding Down Icera,1,0.51278764
2015-05-07,53456400.0,5.502500057220459,5.639999866485596,5.485000133514404,5.622499942779541,5.420184135437012,NVDA,"NVIDIA Says Auto, Gaming, Hi-Pewrformance Computing Remains Health, Sees Very Soft Market For PC OEMS, Gaming Business Growing YoY In Q2 ||| NVIDIA Raises Qtr. Dividend from $0.085 to $0.0975/Share ||| NVIDIA Sees Q2 Sales $1.01B +/- 2% ||| Lukewarm Results Expected At NVIDIA Despite Strong Demand, Continued Gains ||| Must Watch Stocks for May 7, 2015 ||| Earning & Economic Calendar for Thursday May 7, 2015 ||| Earnings Scheduled For May 7, 2015",0,0.49112552
2015-05-08,114655200.0,5.252500057220459,5.460000038146973,5.122499942779541,5.207499980926514,5.020115852355957,NVDA,"Analysts: NVIDIA Still Tied To PC Demand ||| Morning Market Losers ||| NVIDIA'S Shareholder Returns Increased $800M, Wedbush Lowers PT ||| NVIDIA's July Revenue Guided 15% Lower, Adds To Morgan Stanley's Valuation Concerns ||| Benzinga's Top #PreMarket Losers ||| Roth Capital Downgrades NVIDIA to Neutral, Lowers PT to $22.00 ||| US Stock Futures Gain; All Eyes On Jobs Report ||| NVIDIA Beats Q1 EPS Expectations ||| NVIDIA Issues Weak Q2 Revenue Forecast ||| 7 Stocks You Should Be Watching Today",0,0.49921358
2015-05-11,54414400.0,5.135000228881836,5.210000038146973,5.09499979019165,5.15749979019165,4.971914768218994,NVDA,Nvidia Falls Short...And Wall Street Reacts,1,0.5021041
2015-05-14,29305200.0,5.252500057220459,5.349999904632568,5.239999771118164,5.322500228881836,5.130977153778076,NVDA,3 Semiconductor Stocks With Soaring Short Interest,1,0.5237437
2015-05-27,43233200.0,5.21750020980835,5.485000133514404,5.199999809265137,5.460000038146973,5.287894248962402,NVDA,Option Alert: Nvidia Jul $22 Call; 1111 Contract Trade at Ask @$0.40 ||| Nvidia Remains JMP's 'Best Idea'...Here's Why,1,0.47957817
2015-05-28,32765600.0,5.460000038146973,5.552499771118164,5.449999809265137,5.534999847412109,5.360529899597168,NVDA,Goldman Sachs Met With Semiconductor Giants; Here's What Happened,0,0.48665398
2015-06-04,32371200.0,5.392499923706055,5.539999961853027,5.392499923706055,5.522500038146973,5.348424911499023,NVDA,"FBR Downgrades Xilinx, Altera In Massive M&A Note",1,0.50787026
2015-06-10,52946000.0,5.400000095367432,5.434999942779541,5.337500095367432,5.367499828338623,5.198309421539307,NVDA,Benzinga's Top Downgrades ||| Nomura Downgrades NVIDIA To Neutral ||| Nomura Downgrades NVIDIA to Neutral,1,0.501265
2015-06-11,28305200.0,5.367499828338623,5.462500095367432,5.367499828338623,5.425000190734863,5.25399923324585,NVDA,NVDA Sells Proprietary Cross-Platform Portability Tech To TransGaming For $3.75M,0,0.5238393
2015-06-12,32372800.0,5.389999866485596,5.422500133514404,5.264999866485596,5.277500152587891,5.111147880554199,NVDA,"Wedbush Met With Nvidia's CFO; Here's What Happened ||| Wedbush On Nvidia: Impact Of Drop In General Purpose PC Has Minimal Impact, NVDA Focused On 'differentiated markets like gaming to drive growth'",0,0.5256533
2015-06-15,30654800.0,5.25,5.292500019073486,5.210000038146973,5.267499923706055,5.101462841033936,NVDA,Why Advanced Micro Devices And NVIDIA Are Worth Watching,1,0.49908403
2015-06-17,23354400.0,5.329999923706055,5.425000190734863,5.317500114440918,5.394999980926514,5.224944114685059,NVDA,Tigress Financial Upgrades NVIDIA to Buy,1,0.5157336
2015-06-22,51423600.0,5.477499961853027,5.507500171661377,5.362500190734863,5.445000171661377,5.273368835449219,NVDA,"Weekly Tech Highlights: Sony Beat Apple To The Punch, Twitter M&A Rumors And More",0,0.5135143
2015-06-29,39172400.0,5.125,5.177499771118164,5.022500038146973,5.03000020980835,4.871448993682861,NVDA,Morgan Stanley On 'What's Moving Semi Stocks',0,0.51043147
2015-07-02,14576400.0,5.097499847412109,5.137499809265137,5.072500228881836,5.105000019073486,4.944085597991943,NVDA,"IBM, NVIDIA and Mellanox Launch Design Center for Big Data and High Performance Computing ||| MediaTek Declines Comment on Rumor of Merger With Nvidia -DigiTimes",0,0.5065171
2015-07-07,59425200.0,5.012499809265137,5.03249979019165,4.789999961853027,4.947500228881836,4.791549682617188,NVDA,"Oppenheimer Likes Avago, Skyworks Solutions; Upgrades Marvell And Downgrades Broadcom",0,0.5048032
2015-07-10,21670800.0,4.914999961853027,4.982500076293945,4.902500152587891,4.9375,4.781865119934082,NVDA,Option Alert: Nvidia Jul $21 Call Sweep; 5024 Contracts at Ask @$0.13; Now $19.84,1,0.49277684
2015-07-17,22037200.0,5.03000020980835,5.034999847412109,4.952499866485596,5.017499923706055,4.859342098236084,NVDA,Needham Slashes Semiconductor Estimates On 'Muted' Second Half Recovery,0,0.53023666
2015-07-20,18841200.0,5.017499923706055,5.037499904632568,4.912499904632568,4.925000190734863,4.769758701324463,NVDA,TitleTec Partners with NIADA to Help Dealerships Tackle Out-Of-State Titling,1,0.549467
2015-07-29,23268000.0,4.922500133514404,5.03249979019165,4.902500152587891,4.992499828338623,4.835131168365479,NVDA,Cramer Versus Citron: The Ambarella Debate Rages On,1,0.5208695
2015-08-03,39713200.0,5.027500152587891,5.077499866485596,4.962500095367432,5.072500228881836,4.912610054016113,NVDA,"Benzinga's Top Upgrades ||| PC Market Be Damned, NVIDIA Stock Is A Buy ||| Trip Chowdhry Discusses Tesla's Auto-Pilot & Software Updates, Thinks NVIDIA & Mobileye Will Benefit ||| Macquarie Upgrades NVIDIA to Outperform ||| Global Equities' Trip Chowdhry Sees Tesla Rolling Out Advanced Auto-Pilot, Driver Assistance Software Update Before Aug. 22; Highlights NVIDIA, Mobileye as Cos. Benefiting",1,0.5363656
2015-08-06,65567600.0,5.132500171661377,5.170000076293945,5.027500152587891,5.112500190734863,4.951347827911377,NVDA,"NVIDIA Beats Q2 Views, Shares Jump ||| Thursday's After-Hours Movers Led By Zynga, Nvidia, Nuance And Monster Beverage ||| NVIDIA Sees Q3 Sales $1.18B +/- 2% ||| NVIDIA Reports Q2 Adj. EPS $0.34, GAAP EPS $0.05, Sales $1.153B vs $1.01B Est. ||| 10 Must Watch Stocks for Today ||| Earnings Scheduled For August 6, 2015",1,0.48205355
2015-08-07,140524800.0,5.614999771118164,5.84250020980835,5.46999979019165,5.744999885559082,5.563912868499756,NVDA,"Benzinga's Volume Movers ||| Morning Market Gainers ||| Benzinga's Top Upgrades ||| Benzinga's Top #PreMarket Gainers ||| Roth Capital Upgrades NVIDIA to Buy, Raises PT to $25.00 ||| Brean's Burton Commends NVIDIA on 'Executing in a Tough Environment,' But Sees Valuation as Full; Maintains Hold Rating Following Q2 Results ||| Morgan Stanley Maintains Underweight on NVIDIA, Raises PT to $21.00 ||| Morgan Stanley 'less negative' On NVIDIA, Says Valuation Is High And Gaming Growth Overstates Longer Terms Growth Possibilities ||| Wedbush's Van Hees on NVIDIA: 'Underestimation of Demand from PC Gamers Drove Big Upside to Top Line FQ2 Print & FQ3 Guide,' Reiterate Outperform, $24 Price Target ||| Brean Sees Yellow Flags At Nvidia, Cites Expected FCF Contraction Following Final Intel Royalty Pmt In Q1 2018, Notes Nvidia Litigation Efforts Against Samsung & Qualcomm To Secure Additional IP Revenue Streams ||| 7 Stocks You Should Be Watching Today",1,0.5047387
2015-08-10,66230400.0,5.704999923706055,5.987500190734863,5.670000076293945,5.945000171661377,5.757606506347656,NVDA,Fast Money Picks For August 10,0,0.47472498
2015-08-11,43500800.0,5.857500076293945,5.972499847412109,5.857500076293945,5.914999961853027,5.728552341461182,NVDA,20 Stocks With The Highest Exposure To China's Lagging Economy ||| Unusual Option Opportunity In Nvidia,1,0.5153928
2015-08-13,27688400.0,5.9375,5.949999809265137,5.864999771118164,5.880000114440918,5.6946563720703125,NVDA,Tigress Financial's Feinseth Reiterates Buy Rating on NVIDIA in Intraday Research Note; He's Convicted Co.'s 'premier position in the graphics chip space will continue to unlock shareholder value',1,0.51322323
2015-08-21,38266400.0,5.5,5.59250020980835,5.362500190734863,5.367499828338623,5.220181465148926,NVDA,"Not So Fast, Chip Investors: Sector Could Be 'Hit Hard,' Says Analyst",0,0.48723394
2015-08-24,68228400.0,5.067500114440918,5.457499980926514,5.0,5.177499771118164,5.035397529602051,NVDA,"Taiwan Semiconductor Gains Customers for 16nm FinFET Chips, Including Apple, AMD, Avago, Broadcom, Nvidia, Xilinx, Loses Qualcomm Mobile Chips -DigiTimes",0,0.4758913
2015-08-26,61497600.0,5.235000133514404,5.457499980926514,5.195000171661377,5.452499866485596,5.302848815917969,NVDA,"Watch Large Cap Semiconductor Stocks, These Names Up Around 4% And Higher As Of Mid Afternoon Trading",1,0.5148049
2015-08-27,46376400.0,5.510000228881836,5.659999847412109,5.477499961853027,5.65749979019165,5.502223491668701,NVDA,3 Semiconductor Stocks With Big Swings In Short Interest,1,0.5257742
2015-09-01,35340800.0,5.457499980926514,5.550000190734863,5.349999904632568,5.389999866485596,5.242063999176025,NVDA,"Semiconductors Struggling, These Names Down 2% Or More; Ambarella To Report After Market Closes, Down 6.24% On The Day",1,0.50020176
2015-09-17,26871200.0,5.875,5.927499771118164,5.815000057220459,5.827499866485596,5.667557716369629,NVDA,"Jefferies Upgrades NVIDIA On Virtual Reality 'Kicker' ||| Benzinga's Top Upgrades ||| US Stock Futures Edge Lower; All Eyes On Fed Decision ||| Jefferies Upgrades NVIDIA to Buy, Raises PT to $30.00",0,0.50167346
2015-09-23,16163200.0,5.727499961853027,5.784999847412109,5.704999923706055,5.75,5.592184066772461,NVDA,"Nvidia Might Be The Best Way To Play Virtual Realty That's 'Just Around The Corner' ||| Macquarie's Nag Says NVIDIA Remains the Firm's Top Growth Idea, Notes 'Graphics is a better market than you think, and VR is just around the corner'",1,0.48439407
2015-09-25,36969200.0,5.932499885559082,6.017499923706055,5.84499979019165,5.902500152587891,5.740498065948486,NVDA,Stocks Hitting 52-Week Highs,0,0.5411546
2015-09-28,39558400.0,5.902500152587891,5.940000057220459,5.787499904632568,5.824999809265137,5.665124893188477,NVDA,5 Semiconductor Stocks To Love (And 6 To Worry About),1,0.5354798
2015-09-30,55638000.0,5.982500076293945,6.170000076293945,5.947500228881836,6.162499904632568,5.993362903594971,NVDA,Stocks Hitting 52-Week Highs,0,0.5411546
2015-10-01,48929600.0,6.162499904632568,6.179999828338623,5.867499828338623,6.042500019073486,5.87665605545044,NVDA,Hear That? It's Tech Earnings Season Sneaking In,1,0.5134494
2015-10-05,48202400.0,6.239999771118164,6.432499885559082,6.207499980926514,6.355000019073486,6.180580139160156,NVDA,Stocks Hitting 52-Week Highs,1,0.5411546
2015-10-09,42324800.0,6.507500171661377,6.570000171661377,6.394999980926514,6.517499923706055,6.338620662689209,NVDA,Nvidia Shares Rebounding Off LOD Following Announcement Co. Lost First Round Of Patent Dispute With Samsung And Qualcomm,1,0.5125396
2015-10-12,22758800.0,6.525000095367432,6.625,6.477499961853027,6.587500095367432,6.406697750091553,NVDA,"UPDATE: Roth Capital Transfers Coverage on NVIDIA, Sets Neutral Rating, $26 Price Target ||| Roth Capital Initiates Coverage on NVIDIA at Neutral, Announces $26.00 PT",1,0.5158986
2015-10-14,61214800.0,6.607500076293945,6.947500228881836,6.599999904632568,6.840000152587891,6.652266979217529,NVDA,"Watch Other Semiconductor Stocks After Bloomberg Report, NVIDIA Shares Spiking To $27.52/Share ||| Stocks Hitting 52-Week Highs",1,0.5069874
2015-10-16,44839600.0,6.880000114440918,7.03000020980835,6.862500190734863,6.965000152587891,6.773836612701416,NVDA,The Street's Take On Advanced Micro Devices' Earnings Report ||| Hearing Unconfirmed Market Chatter of Intel Bid for Nvidia,0,0.5111868
2015-10-28,21703600.0,7.15500020980835,7.167500019073486,7.050000190734863,7.167500019073486,6.970778465270996,NVDA,Short Sellers Like These Three Top Semiconductor Stocks,0,0.49731162
2015-10-30,30116000.0,6.994999885559082,7.142499923706055,6.942500114440918,7.09250020980835,6.897837162017822,NVDA,"Benzinga's Top Upgrades ||| US Stock Futures Edge Higher Ahead Economic Data ||| Morgan Stanley Upgrades NVIDIA to Equal-weight, Raises PT to $28.00",1,0.5043584
2015-11-03,37676800.0,7.132500171661377,7.172500133514404,7.045000076293945,7.125,6.929444789886475,NVDA,"Nvidia Thesis 'Played Out,' Needham Cautions ||| Benzinga's Top Downgrades ||| Needham Downgrades NVIDIA to Hold",0,0.49936235
2015-11-04,44226400.0,7.105000019073486,7.15749979019165,6.974999904632568,7.007500171661377,6.8151702880859375,NVDA,NVIDIA Shares Falling,0,0.5146835
2015-11-05,47880000.0,7.042500019073486,7.0625,6.90749979019165,6.927499771118164,6.73736572265625,NVDA,"4 Stocks Moving In Thursday's After-Hours Session ||| UPDATE: NVIDIA Q4 Analyst Consensus Estimate for Sales $1.21B ||| NVIDIA Raises Qtr. Dividend from $0.0975 to $0.115/Share ||| NVIDIA Sees Q4 Rev. $1.27B-$1.326B vs $1.21B Est. ||| NVIDIA Reports Q3 EPS $0.46 vs. Est. $0.25, Rev. $1.305B vs. Est. $1.18B ||| Option Alert: $NVDA Dec $28 Call Sweep; 1774 Contracts @Ask @$1.51 ||| NVIDIA Shares Falling ||| Strategist Discusses Options And Volatility In Disney, NVIDIA And Weight Watchers Ahead Of Earnings ||| Must Watch Stocks for November 5, 2015 ||| Earnings Scheduled For November 5, 2015",1,0.52289593
2015-11-06,117227200.0,7.612500190734863,7.985000133514404,7.454999923706055,7.887499809265137,7.671016216278076,NVDA,"Wall Street Weighs In On Pricy NVIDIA After Stellar Earnings ||| Nvidia Sharply Higher After Q3 Beat ||| Top Performing Industries For November 6, 2015 ||| Stocks Hitting 52-Week Highs ||| Morning Market Gainers ||| MKM: It's Time To Buy Nvidia ||| Benzinga's Top Upgrades ||| UPDATE: MKM Upgrades NVIDIA, Calls 'Expensive,' But 'Worth It'; Sees Opportunities as 'Never Greater' ||| Benzinga's Top #PreMarket Gainers ||| MKM Partners Upgrades NVIDIA to Buy ||| 7 Stocks To Watch For November 6, 2015",0,0.4837674
2015-11-09,49256800.0,7.809999942779541,7.875,7.742499828338623,7.852499961853027,7.636978626251221,NVDA,These 11 Companies Are Betting On The Drone Revolution,0,0.5106964
2015-11-13,29294000.0,7.607500076293945,7.639999866485596,7.412499904632568,7.449999809265137,7.245524883270264,NVDA,Option Alert: $NVDA Nov 27 $13 Call Sweep; 1256 Contracts @Ask @$0.29; Ref $29.85,1,0.49345192
2015-11-16,34428000.0,7.547500133514404,7.605000019073486,7.487500190734863,7.599999904632568,7.391408443450928,NVDA,"Why Canaccord Is Buying Nvidia's Long-Term Picture ||| Benzinga's Top Upgrades ||| Canaccord Genuity Upgrades NVIDIA to Buy, Raises to $35.00",0,0.49757338
2015-11-30,32724400.0,7.855000019073486,7.965000152587891,7.847499847412109,7.929999828338623,7.741636753082275,NVDA,Option Alert: $NVDA Jan $32 Call Sweep; 1385 Contracts @Ask @$1.11,1,0.5026803
2015-12-09,37267600.0,8.387499809265137,8.4375,8.092499732971191,8.177499771118164,7.98325777053833,NVDA,Option Alert: NVDA Jan16 36.0 Calls Sweep: 959 @ ASK $0.48: 972 traded vs 2975 OI: $33.37 Ref,1,0.47665718
2015-12-14,27589200.0,8.130000114440918,8.1875,8.045000076293945,8.142499923706055,7.949090003967285,NVDA,FAA: Unregistered Drones Could Soon Mean Jail Time,1,0.50944984
2015-12-16,23635600.0,8.260000228881836,8.319999694824219,8.1875,8.292499542236328,8.095526695251465,NVDA,"MKM Partners Top Picks For 2016: ACE, CTXS, EA, FIVE, GOOGL, INFN, LB, MYCC, NVDA, TOL, VIAV",0,0.4948054
2015-12-17,25416000.0,8.305000305175781,8.390000343322754,8.162500381469727,8.167499542236328,7.973495483398437,NVDA,The Top 20 Wall Street Analysts Of 2015,0,0.5168543
2015-12-22,13001200.0,8.25,8.3149995803833,8.182499885559082,8.232500076293945,8.036953926086426,NVDA,"UPDATE: Argus Names Three Top Ideas for 'The Connected Car' Thesis: Sirius XM, Panasonic, SunnyOptical; Highlights Supply Chain Implications at NVIDIA, Qualcomm, Murata ||| UPDATE: Argus Sees 75+% of Autos Being LTE-Enabled by '20 ||| Argus Sees the Global Connected Car Market Reaching ~$150B, Telematics as $50B Market Opportunity by 2020",1,0.5158163
2015-12-24,5244800.0,8.239999771118164,8.3125,8.227499961853027,8.292499542236328,8.095526695251465,NVDA,"Shares Of Nvidia Slightly Higher Following Report Of Shortages, Higher Pricing ||| High-end Nvidia Graphics Card Pricing Up 15% Due to Shortages, Strong Demand -DigiTimes",0,0.48057982
2015-12-28,14202400.0,8.204999923706055,8.28499984741211,8.09000015258789,8.28499984741211,8.088202476501465,NVDA,"Option Alert: NVDA Fri 1/8 33.0 Calls (Wkly) Sweep: 700 @ ASK $0.80: 1205 traded vs 3130 OI: Earnings 2/10 $32.94 Ref ||| UPDATE: B. Riley on Semi Industry Into '16: 'Analysis Suggests Another Intense Year Of M&A In CY16' ||| UPDATE: B. Riley on Semi Industry Into '16: 'Bottoms-up tally (57 co's) suggests a double-digit CY16 FCF rebound' ||| B. Riley on Semi Industry Into '16: 'Ample fuel to build on CY15's record M&A (31+ deals), dividend pay-outs ($16.0B+), and buy-backs ($31.0B+)'",1,0.5011383
2015-12-29,20366000.0,8.289999961853027,8.444999694824219,8.267499923706055,8.420000076293945,8.21999740600586,NVDA,Option Alert: NVDA Jan16 33.5 Calls Sweep: 2519 @ ASK $1.23: 5952 traded vs 217 OI: Earnings 2/10 $33.71 Ref,0,0.47824875
2015-12-30,18034400.0,8.412500381469727,8.484999656677246,8.345000267028809,8.34749984741211,8.149216651916504,NVDA,Stocks Hitting 52-Week Highs,0,0.5411546
2016-01-05,49027200.0,8.244999885559082,8.359999656677246,8.125,8.22249984741211,8.027190208435059,NVDA,"Fast Money Halftime Report Traders Share Their Thoughts On NVIDIA, Microsoft, Walt Disney, GoPro And Fitbit ||| The Best Stock Ideas Of 2015",0,0.47765717
2016-01-06,44934400.0,8.087499618530273,8.125,7.789999961853027,7.882500171661377,7.695264339447021,NVDA,"Deutsche Bank Is Buying Mobileye On VW And GM Support, Expects Stock To Double ||| Fast Money Picks For January 6",0,0.48193944
2016-01-13,48167200.0,7.602499961853027,7.652500152587891,7.307499885559082,7.315000057220459,7.141243934631348,NVDA,Option Alert: NVDA Feb16 32.0 Calls Sweep: 2499 @ ASK $1.05: 2500 traded vs 2233 OI: Earnings 2/10 $30.40 Ref,0,0.47993663
2016-01-14,60023600.0,7.164999961853027,7.25,6.954999923706055,7.167500019073486,6.997249126434326,NVDA,"11 Different Ways To Play The Bear Market (From 11 Traders) ||| Barclays Downgrades Nvidia, Likes Skyworks, Cirrus And Others ||| Benzinga's Top Downgrades ||| Barclays Downgrades NVIDIA to Underweight, Raises PT to $25.00",0,0.5144391
2016-01-15,84145200.0,6.880000114440918,6.962500095367432,6.659999847412109,6.777500152587891,6.616512775421143,NVDA,Intel Starts Off Earnings Season For Chip-Maker Group With A Thud,1,0.5475317
2016-01-19,45714000.0,6.917500019073486,7.112500190734863,6.804999828338623,6.832499980926514,6.670206546783447,NVDA,Option Alert: NVDA Feb16 27.0 Puts Sweep: 612 @ ASK $1.46: 1131 traded vs 194 OI: Earnings 2/10 $27.35 Ref,1,0.47710776
2016-01-20,48118000.0,6.702499866485596,6.957499980926514,6.612500190734863,6.869999885559082,6.706814765930176,NVDA,"JMP Sees NVIDIA Slide From $33.44 2 Weeks Ago To Current Share Price Of $27.35 Ahead Of VR, AI, And Autonomous Driving",1,0.5128705
2016-01-21,48145600.0,6.945000171661377,7.057499885559082,6.802499771118164,6.949999809265137,6.784914970397949,NVDA,Nvidia Details New Partnership With Alibaba's Alicloud ||| EARLIER: Jefferies' Mark Lipacis on NVIDIA's Partnership with Alibaba: 'Big Data Partnership Highlights Cloud Opportunity'; Reiterate Buy ||| NVIDIA Announces Cloud Partnership with Alibaba's Alicloud,1,0.51117694
2016-01-22,25799600.0,7.082499980926514,7.159999847412109,7.067500114440918,7.112500190734863,6.9435553550720215,NVDA,NVIDIA's Deal With Alibaba Highlights Cloud Opportunity,0,0.51820534
2016-02-05,60042800.0,7.005000114440918,7.082499980926514,6.587500095367432,6.607500076293945,6.450550079345703,NVDA,David Bartosiak's NVIDIA Corporation Trade,0,0.5259241
2016-02-12,34081600.0,6.425000190734863,6.445000171661377,6.1875,6.432499885559082,6.279706001281738,NVDA,Option Alert: NVDA Jun16 21.0 Puts: 10000 @ ASK $1.20: 10k traded vs 126 OI: Earnings 2/17 After Close $25.52 Ref,1,0.4755459
2016-02-17,77146800.0,6.832499980926514,6.980000019073486,6.804999828338623,6.914999961853027,6.750745296478272,NVDA,"After-Hours Movers Led By NVIDIA, NetApp And Marriott ||| NVIDIA Sees Q4 Sales $1.26B +/- 2, CapEx $35M-$45M ||| NVIDIA Reports Q4 Non-GAAP $0.52, GAAP EPS $0.35 Vs Est $0.32, Sales $1.4B Vs Est $1.31B ||| Option Alert: NVDA Feb16 24.0 Puts Sweep: 516 @ ASK $0.22: 1612 traded vs 1977 OI: Earnings today After Close $27.53 Ref ||| Can NVIDIA Continue Its String Of Strong Earnings? Here's What To Expect ||| Option Alert: NVDA Feb16 28.5 Puts Sweep: 1046 @ ASK $1.70: 1054 traded vs 271 OI: Earnings today After Close $27.76 Ref ||| 10 Stocks To Watch For February 17, 2016 ||| Earnings Scheduled For February 17, 2016",1,0.4999109
2016-02-18,106866000.0,7.482500076293945,7.744999885559082,7.474999904632568,7.510000228881836,7.3316121101379395,NVDA,"NVIDIA Soars After Q4 Report ||| Top Performing Industries For February 18, 2016 ||| Benzinga's Volume Movers ||| 10 Stocks Moving In Thursday's Pre-Market Session ||| Brean Liked NVIDIA's Q4, But Remains On Sidelines ||| Macquarie Maintains Outperform On NVIDIA, Sees Graphics Processing As 'killer app' For Majority Of VR/AR Workloads ||| Brean Remains On NVIDIA Sidelines, Says Shares Trade Near Peak Earnings Multiple From Past 2 Years ||| 10 Stocks You Should Be Watching Today",1,0.5023957
2016-02-19,52562800.0,7.46999979019165,7.677499771118164,7.412499904632568,7.610000133514404,7.429237365722656,NVDA,Roth Capital Weighs in on Glu Mobile Inc. (GLUU) and NVIDIA Corporation (NVDA) Following a Game Release and Earnings,1,0.5059568
2016-02-24,33685200.0,7.867499828338623,7.96750020980835,7.650000095367432,7.954999923706055,7.766042709350586,NVDA,"AMD Share in GPU, PC Markets Could Hit Record Lows in Q1 -DigiTimes",1,0.51452005
2016-02-29,32334400.0,7.902500152587891,8.005000114440918,7.835000038146973,7.840000152587891,7.68165922164917,NVDA,These Insiders Were Making Moves Last Week,1,0.515359
2016-03-08,27494000.0,8.0024995803833,8.050000190734863,7.912499904632568,7.9375,7.777190685272217,NVDA,> Option Alert: NVDA Apr16 26.0 Puts Sweep: 1170 @ ASK $0.17: 3868 traded vs 729 OI: $31.89 Ref ||| Option Alert: NVDA Mar16 26.0 Puts Sweep: 1178 @ ASK $0.04: 1178 traded vs 2363 OI: $31.75 Ref,0,0.47450852
2016-03-14,19031200.0,8.017499923706055,8.107500076293945,7.980000019073486,8.074999809265137,7.911913871765137,NVDA,Option Alert: NVDA Apr16 32.0 Calls Sweep: 1274 @ ASK $1.46: 2373 traded vs 1404 OI: Earnings 5/5 $32.24 Ref ||| Option Alert: NVDA Apr16 33.0 Calls Sweep: 576 @ ASK $0.89: 3843 traded vs 502 OI: Earnings 5/5 $32.19 Ref,0,0.485803
2016-03-18,54551200.0,8.302499771118164,8.5625,8.25,8.452500343322754,8.281790733337402,NVDA,"Benzinga's Top Initiations ||| Argus Research Initiates Coverage on NVIDIA at Buy, Announces $39.00 PT",1,0.52841014
2016-03-21,33778000.0,8.3774995803833,8.479999542236328,8.287500381469727,8.477499961853027,8.306279182434082,NVDA,"15 Bullish Technical Charts MKM Analysts Are Watching ||| BoA Likes Avago, Intel And Others Semiconductor Giants After Meeting Asian Investors",0,0.50862944
2016-03-23,42900800.0,8.5,8.670000076293945,8.462499618530273,8.607500076293945,8.433659553527832,NVDA,"The Stocks That Moved The S&P, Dow And Nasdaq Today ||| UPDATE: Chowdhry Says 'For every 1 INTC Chip 7 NVDA Chips are deployed in Machine Learning Fabric' ||| Global Equities Trip Chowdhry Says Nvidia Business Extremely Strong ||| NVIDIA Corp. Enters Acclerated Buyback With Barclays Of $500M",1,0.50311416
2016-03-24,24495600.0,8.529999732971191,8.635000228881836,8.5024995803833,8.619999885559082,8.445905685424805,NVDA,"AMD, Nvidia Working to Meet Demand for VR Devices -DigiTimes",1,0.48827124
2016-03-29,26181200.0,8.670000076293945,8.867500305175781,8.649999618530273,8.84749984741211,8.66881275177002,NVDA,"This Derivatives Strategist Is Long NVIDIA Ahead Of Key Data Releases ||| MK M Partners Long NVDA Going Into Analyst Day, Semiconductor Analyst Maintains Buy ANd $135 PT, Says Core Gaming Business Is Strong ||| Jim Strugger's NVIDIA Trade",1,0.48686376
2016-04-04,39394000.0,9.112500190734863,9.15999984741211,8.914999961853027,8.949999809265137,8.769241333007812,NVDA,"Stocks Hitting 52-Week Highs ||| This Quant's Favorite Stock Picks Are Nvidia, Marvell, Amazon And Two Others ||| Jefferies Maintains Buy on NVIDIA, Raises PT to $42.00",0,0.4810647
2016-04-06,45337600.0,8.824999809265137,8.954999923706055,8.657500267028809,8.949999809265137,8.769241333007812,NVDA,10 Stocks Moving In Wednesday's Pre-Market Session ||| Stifel Nicolaus Downgrades NVIDIA to Neutral ||| Nvidia Suit Says was Forced to Shut Icera Unit Due Qualcomm's 'Unlawful Abuse of Dominance' -Bloomberg,0,0.49940503
2016-04-08,25593600.0,8.930000305175781,8.987500190734863,8.827500343322754,8.914999961853027,8.734950065612793,NVDA,New Research Shows Apple Working Heavily On Machine Learning Before WWDC 2016,1,0.54164517
2016-04-13,35071600.0,9.0,9.1875,9.0,9.1850004196167,8.999495506286621,NVDA,"Global Equities Trip Chowdhry Highlights Facebook & NVIDIA As Winners Of Facebook F8 Conference, Losers Are Old World Tech",1,0.49409562
2016-04-27,35239600.0,9.09749984741211,9.332500457763672,9.079999923706056,9.327500343322754,9.139114379882812,NVDA,"3 Put Spread Strategies For The Next Week: McDonald's, Johnson & Johnson And Nvidia",0,0.51022273
2016-05-02,25607600.0,8.967499732971191,9.05500030517578,8.925000190734863,9.0,8.818230628967285,NVDA,"NVIDIA, Samsung Agree to Settle All Outstanding IP Litigation, Terms Not Disclosed",0,0.4925104
2016-05-03,22402400.0,8.897500038146973,8.9350004196167,8.8149995803833,8.892499923706055,8.71290397644043,NVDA,These 3 Stocks Are Tied To Apple's Performance,0,0.5124275
2016-05-12,67054000.0,9.079999923706056,9.119999885559082,8.732500076293945,8.892499923706055,8.71290397644043,NVDA,"NVIDIA Q1'16 Earnings Conference Call: Full Transcript ||| NVIDIA Sees Q2 Sales $1.35B +/- 2% ||| NVIDIA Reports Q1 EPS $0.46 vs. Est. $0.32, Rev. $1.3B vs. Est. $1.26B ||| Option Alert: NVDA May16 32.5 Puts Sweep: 523 @ ASK $0.54: 841 traded vs 205 OI: Earnings today After Close $35.56 Ref ||| Earnings Scheduled For May 12, 2016 ||| 10 Stocks To Watch For May 12, 2016",1,0.49120107
2016-05-13,211025600.0,9.797499656677246,10.25,9.75,10.244999885559082,10.0380859375,NVDA,"Jefferies' Secular Trends Thesis In NVIDIA Just Starting, Remains A Top Pick ||| Mid-Afternoon Market Update: Dow Tumbles 1%; Nordstrom Shares Down Following Earnings Miss ||| Tesla Demand Drove NVIDIA's Q1 Beat, Q2 Outlook ||| NVIDIA Makes New All-Time High ||| 10 Biggest Mid-Day Market Gainers ||| Mid-Day Market Update: NVIDIA Gains On Earnings Beat; ConforMIS Shares Drop ||| Top Performing Industries For May 13, 2016 ||| Benzinga's Volume Movers ||| Mid-Morning Market Update: Markets Mixed; J C Penney Sales Miss Estimates ||| Stocks Hitting 52-Week Highs ||| NVIDIA Remains MKM's Top Pick ||| The Market In 5 Minutes: Friday The 13th ||| NVIDIA Just Hit It Out Of The Park...Again ||| Brean Adjusts NVIDIA's Fair Value Range To $35-$40 ||| Benzinga's Top Upgrades ||| 10 Stocks Moving In Friday's Pre-Market Session ||| Roth Upgrades NVIDIA To Buy, Encouraged By 'Deep Learning' Growth ||| Topeka Capital Upgrades NVIDIA to Buy ||| Roth Capital Upgrades NVIDIA to Buy, Raises PT to $40.00 ||| 7 Must Watch Stocks for Today",1,0.49443433
2016-05-16,97303200.0,10.167499542236328,10.699999809265137,10.135000228881836,10.547499656677246,10.334476470947266,NVDA,Option Alert: NVDA Fri 6/3 40.0 Calls (Wkly) Sweep: 500 @ ASK $2.90: 502 traded vs 538 OI: $42.60 Ref ||| Option Alert: NVDA Jun16 33.0 Puts Sweep: 2295 @ ASK $0.11: 2397 traded vs 3462 OI: $41.65 Ref ||| Stocks Hitting 52-Week Highs,1,0.4950762
2016-05-19,39888000.0,10.797499656677246,10.96500015258789,10.782500267028809,10.887499809265137,10.667610168457031,NVDA,"Invest Diva's Kiana Danial Likes Advanced Micro, Sees ~$9/Share On Lucrative VR Market Potential ||| Option Alert: NVDA Jun16 42.0 Calls Sweep: 682 @ ASK $2.36: 704 traded vs 12k OI: $43.50 Ref",1,0.48502335
2016-05-20,39108400.0,10.954999923706056,11.1274995803833,10.9375,11.082500457763672,10.858672142028809,NVDA,Stocks Hitting 52-Week Highs,1,0.5411546
2016-05-26,30996400.0,11.3125,11.494999885559082,11.279999732971191,11.412500381469728,11.21104335784912,NVDA,Option Alert: NVDA Jun16 45.5 Puts Sweep: 1174 @ ASK $1.24: 4447 traded vs 237 OI: $45.62 Ref,1,0.47248223
2016-06-02,32920800.0,11.765000343322754,11.885000228881836,11.649999618530272,11.78499984741211,11.5769681930542,NVDA,"Stocks Hitting 52-Week Highs ||| Benzinga's Top Initiations ||| The Market In 5 Minutes: Draghi, iPhones And Warriors ||| Nvidia Is A Buy With These Expanding Markets ||| Goldman Sachs Initiates Coverage on NVIDIA at Buy, Announces $54.00 PT",0,0.49776348
2016-06-03,46107600.0,11.670000076293944,11.6850004196167,11.414999961853027,11.619999885559082,11.41488265991211,NVDA,"You Can Hold NVIDIA Stock Now, Vetr Crowd Says",0,0.50096667
2016-06-13,47558800.0,11.5625,11.925000190734863,11.5625,11.697500228881836,11.491015434265137,NVDA,"Benzinga's Top Upgrades ||| Nomura Upgrades NVIDIA to Buy ||| Argus Removes 3 Names To Focus List: Kroger, NVidia, United Parcel Services, Valero",1,0.5027074
2016-06-14,29834400.0,11.670000076293944,11.774999618530272,11.539999961853027,11.720000267028809,11.513117790222168,NVDA,Nomura Comes Out Of Meeting With Nvidia CEO Convinced Stock Is Now A Buy,1,0.4995141
2016-06-15,30103600.0,11.817500114440918,11.942500114440918,11.6875,11.84000015258789,11.631000518798828,NVDA,Trip Chowdhry Shares Insights Into Apple's Machine Learning & Deep Learning Initiatives,1,0.5372595
2016-06-16,24645600.0,11.7524995803833,11.907500267028809,11.637499809265137,11.887499809265137,11.677660942077637,NVDA,Should NVIDIA Be Trading At A Premium To Its Peers?,0,0.5174226
2016-06-17,47100000.0,11.90250015258789,11.904999732971191,11.63249969482422,11.68000030517578,11.473821640014648,NVDA,Option Alert: NVDA Fri 6/24 47.0 Puts (Wkly) Sweep: 689 @ ASK $1.12: 3758 traded vs 136 OI: Earnings 8/4 $46.69 Ref ||| Option Alert: NVDA Fri 6/24 47.0 Puts (Wkly) Sweep: 749 @ ASK $0.95: 2346 traded vs 136 OI: Earnings 8/4 $46.92 Ref,1,0.47665218
2016-06-20,29376800.0,11.86750030517578,12.042499542236328,11.859999656677246,11.890000343322754,11.680116653442385,NVDA,Watch These 5 Huge Put Purchases In Monday Trade,0,0.5345744
2016-06-21,21250800.0,11.9399995803833,11.97249984741211,11.800000190734863,11.817500114440918,11.608894348144531,NVDA,"NVIDIA Says CAO David Shannon To Retire At End Of 2016 ||| Option Alert: NVDA Jul16 39.0 Puts Sweep: 1176 @ ASK $0.11: 2405 traded vs 705 OI: Earnings 8/4 $47.30 Ref ||| Machine Learning Conference Update: Amazon And NVIDIA Winning, IBM And Alphabet Losing",0,0.4974206
2016-06-27,44908800.0,11.337499618530272,11.425000190734863,11.142499923706056,11.3100004196167,11.110352516174316,NVDA,3 Companies Most Likely To Win When Virtual Reality Takes Over,1,0.54201055
2016-06-28,38192000.0,11.524999618530272,11.537500381469728,11.317500114440918,11.475000381469728,11.272440910339355,NVDA,Taiwan Semiconductor Could Blow Street Estimates Away,1,0.514939
2016-07-06,27310400.0,11.755000114440918,11.982500076293944,11.69499969482422,11.912500381469728,11.70221996307373,NVDA,Gaming Stocks Are A Playground For Traders,1,0.50755244
2016-07-08,48193200.0,12.352499961853027,12.772500038146973,12.30500030517578,12.712499618530272,12.488096237182615,NVDA,Option Alert: NVDA Jul16 50.0 Calls Sweep: 718 @ ASK $1.05: 1547 traded vs 2031 OI: Earnings 8/4 $50.41 Ref,1,0.47544006
2016-07-11,44877600.0,12.895000457763672,13.100000381469728,12.880000114440918,13.005000114440918,12.775434494018556,NVDA,The Best Performing Stocks Since May 2015,1,0.50588167
2016-07-15,42861600.0,13.15999984741211,13.234999656677246,12.960000038146973,13.175000190734863,12.942432403564451,NVDA,"Benzinga's Top Initiations ||| Benzinga's Top Downgrades ||| 12 Stocks Moving In Friday's Pre-Market Session ||| Wells Fargo Downgrades NVIDIA to Underperform ||| Mizuho Securities Initiates Coverage on NVIDIA at Buy, Announces $60.00 PT ||| Nvidia Downgraded to Underperform from Market Perform at Wells Fargo",1,0.52555215
2016-07-18,25299200.0,13.337499618530272,13.357500076293944,13.192500114440918,13.24250030517578,13.008742332458496,NVDA,"UPDATE: Goldman Sees Augmented Reality Market Value Of $59B in 2025, Sees Virtual Reality Market Value Of $36B ||| Goldman Raises 2025 Estimate For Expected Market Value Of Virtual Reality/Augmented Reality From $80B To $95B",1,0.5072475
2016-07-19,38265200.0,13.234999656677246,13.432499885559082,13.210000038146973,13.380000114440918,13.143814086914062,NVDA,"Disney, Time Warner Likely To Capitalize On Augmented Reality; Pokémon GO Prompts Other Game Proposals ||| Goldman Cautious on TXN & ADI, Favors Names W/ Structural & Content Growth Opportunity Such As NVDA, NXPI, AVGO, SWKS",1,0.4986331
2016-07-27,44667600.0,14.279999732971191,14.30500030517578,13.93000030517578,14.015000343322754,13.767605781555176,NVDA,"Xiaomi Takes On Another Tech Behemoth With 2 New Launches ||| Cramer Prefers CyberArk Over FireEye, Says NVIDIA Will Benefit From Pokemon Go",1,0.51726896
2016-08-04,27271200.0,14.114999771118164,14.3725004196167,14.087499618530272,14.307499885559082,14.054943084716797,NVDA,Option Alert: NVDA Oct16 55.0 Calls Sweep: 5001 @ Above Ask! $5.20: 5182 traded vs 885 OI: Earnings 8/11 After Close $56.97 Ref,1,0.47150868
2016-08-05,37158800.0,14.47249984741211,14.557499885559082,14.40250015258789,14.550000190734863,14.293160438537598,NVDA,Option Alert: NVDA Aug16 44.0 Puts Sweep: 3000 @ ASK $0.13: 5002 traded vs 3287 OI: Earnings 8/11 After Close $57.90 Ref ||| Watch These 7 Huge Call Purchases In Friday Trade,1,0.49813932
2016-08-08,30506400.0,14.75,14.78499984741211,14.529999732971191,14.6850004196167,14.42577838897705,NVDA,"Walt Disney, Alibaba On Deck For Earnings Announcements ||| 8 Biggest Price Target Changes For Monday ||| Jefferies Analysts Are Buyers Of NVIDIA Amid Sales Momentum, Probability Of Upside ||| Watch These 5 Huge Put Purchases In Monday Trade",1,0.50149477
2016-08-09,37234400.0,14.75749969482422,14.864999771118164,14.6850004196167,14.72249984741211,14.46261501312256,NVDA,Option Alert: NVDA Aug16 58.0 Puts Sweep: 2500 @ ASK $2.10: 2568 traded vs 212 OI: Earnings 8/11 After Close $59.06 Ref,0,0.47451833
2016-08-10,37574000.0,14.852499961853027,14.875,14.579999923706056,14.6274995803833,14.369293212890623,NVDA,4 Interesting Semiconductor Picks ||| Apple's $300 Billion Opportunity ||| Watch These 7 Huge Put Purchases In Wednesday Trade,1,0.5327064
2016-08-11,68106400.0,14.704999923706056,14.987500190734863,14.675000190734863,14.925000190734863,14.661540985107422,NVDA,"After-Hours Losers Aug. 11, 2016: ORIG Down %, XCOM 20%, RT 6.4%, PTX 4%, DDS 3.5%, NVDA 3% ||| Thursday's After-Hours Movers: 2 Stocks Spiking, 2 Stocks Tanking ||| Nvidia Beats Earnings And Revenue Estimates, Uplifting Forecasts ||| NVIDIA Sees Q3 Sales $1.68B +/- 2% vs $1.45B Est. ||| NVIDIA Reports Q2 Adj. EPS $0.53 vs $0.37 Est., Sales $1.43B vs $1.35B Est. ||| Option Alert: NVDA Jan17 40.0 Calls Sweep: 2000 @ ASK $20.98: 2036 traded vs 2081 OI: Earnings today After Close $59.83 Ref ||| Forgot The FANG Trade, This Stock Outperformed The Group ||| Can You Guess This Chart? ||| 10 Must Watch Stocks for Today ||| Earnings Scheduled For August 11, 2016",1,0.48927784
2016-08-12,142574400.0,15.475000381469728,15.845000267028809,15.157500267028809,15.760000228881836,15.48180103302002,NVDA,"18 Biggest Mid-Day Gainers For Friday ||| Jefferies Expects More Upside Surprises From NVIDIA Over The Next Year ||| Apple, Nvidia, Tesla: Trip Chowdhry's 3 Best Stock Ideas ||| Stocks Hitting 52-Week Highs ||| 10 Biggest Price Target Changes For Friday ||| Benzinga's Top Upgrades ||| Data Center Is The 'Most Exciting Aspect' Of NVIDIA's Story ||| 18 Stocks Moving In Friday's Pre-Market Session ||| NVidia Guides For A Significant Estimate Beat In Q3 ||| A Peek Into The Markets: U.S. Stock Futures Edge Higher Ahead Of J C Penney Earnings ||| RBC Capital Upgrades NVIDIA to Outperform ||| RBC Capital Upgrades NVIDIA to Outperform ||| 10 Stocks You Should Be Watching Today",0,0.5002039
2016-08-15,57330400.0,15.77750015258789,15.875,15.532500267028809,15.744999885559082,15.467068672180176,NVDA,More Room To Run For NVIDIA Shares,0,0.52811265
2016-08-18,33168400.0,15.265000343322754,15.550000190734863,15.204999923706056,15.524999618530272,15.250950813293455,NVDA,Tigress Financial Reiterates Buy Rating on NVIDIA,1,0.5001548
2016-08-19,29156000.0,15.517499923706056,15.682499885559082,15.449999809265137,15.5649995803833,15.290242195129396,NVDA,"Intel To Develop Autonomous Vehicle Solution To Compete Against Nvidia, Mobileye; CLSA Remains Unimpressed",1,0.5129759
2016-08-24,29844800.0,15.782500267028809,15.789999961853027,15.412500381469728,15.484999656677246,15.239688873291016,NVDA,6 Degrees Of Self-Driving Separation,0,0.5604412
2016-08-25,40603200.0,15.489999771118164,15.4975004196167,15.1899995803833,15.38249969482422,15.138813972473145,NVDA,Advanced Micro Devices Gets A Price Target Bump At Canaccord,1,0.514178
2016-09-01,42849200.0,15.34749984741211,15.845000267028809,15.335000038146973,15.787500381469728,15.537394523620604,NVDA,"Nvidia, Baidu to Collaborate on Artificial Intelligence, Self-Driving Car -Wall Street Journal",0,0.5056855
2016-09-06,30681200.0,15.6875,15.779999732971191,15.607500076293944,15.779999732971191,15.53001594543457,NVDA,"NVIDIA Corp. Files Mixed Shelf Offering, Terms Not Disclosed",0,0.4911263
2016-09-09,69776000.0,15.487500190734863,15.574999809265137,14.75,14.880000114440918,14.644271850585938,NVDA,Michigan Votes Unanimously To Remove Drivers From Autonomous Test Vehicles,1,0.5196839
2016-09-13,47176800.0,15.149999618530272,15.324999809265137,14.88249969482422,14.967499732971191,14.730384826660156,NVDA,Cramer's 11 Stocks To Buy During Fed-Fear Selloffs,1,0.50874054
2016-09-15,51521200.0,15.125,15.6899995803833,15.09000015258789,15.672499656677246,15.424220085144045,NVDA,"NVIDIA Will Win Machine Learning, Trip Chowdhry Argues",1,0.5144467
2016-09-16,90244400.0,15.727499961853027,15.8125,15.529999732971191,15.710000038146973,15.4611234664917,NVDA,"Delphi Automotive: The Less Heralded Autonomous Driving Play ||| Chip Stocks Mostly Soar As Intel Raises Q3 Guidance ||| Mobileye Is A $10 Stock That's 'Hyper-Inflated', Could Collapse In 6 Months: Chowdhry ||| Intel Shares Up 4% Following Raised Q3 Outlook; AMD Shares Up 3.8%, Micron Up 3.4%, NVIDIA Up 0.9%, Texas Instruments Up 0.8%",1,0.5109214
2016-09-20,33111200.0,16.100000381469727,16.100000381469727,15.6850004196167,15.772500038146973,15.52263355255127,NVDA,"Benzinga's Top Initiations ||| Susquehanna Initiates Coverage on NVIDIA at Neutral, Announces $66.00 PT ||| SunTrust Robinson Humphrey Initiates Coverage on NVIDIA at Neutral, Announces $59.00 PT",1,0.49939913
2016-09-22,30873200.0,16.309999465942383,16.360000610351562,16.162500381469727,16.2549991607666,15.997485160827637,NVDA,Jim Cramer Shares His Thoughts On Vonage And Intersil,0,0.51669884
2016-09-28,31978800.0,16.65999984741211,16.707500457763672,16.482500076293945,16.69499969482422,16.43051528930664,NVDA,NVIDIA to Work with TomTom On a Self Driving Car System,1,0.54057556
2016-09-29,33668400.0,16.667499542236328,16.90250015258789,16.512500762939453,16.850000381469727,16.583066940307617,NVDA,Technical Alert: Nvidia Corp Makes A New All Time High For Third Day In A Rpw,1,0.5320148
2016-10-04,28162400.0,17.137500762939453,17.424999237060547,16.947500228881836,17.075000762939453,16.80449867248535,NVDA,"25 Stocks Which Rallied Four Days, Then Sold Off Yesterday ||| Option Alert: NVDA Nov16 70.0 Puts Sweep: 1000 @ ASK $5.10: 2024 traded vs 927 OI: Earnings 11/3 $68.69 Ref",0,0.4763333
2016-10-05,30544000.0,17.219999313354492,17.395000457763672,17.0049991607666,17.0575008392334,16.78727149963379,NVDA,Watch These 5 Huge Put Purchases In Wednesday Trade,0,0.5367474
2016-10-06,36021200.0,16.852500915527344,16.957500457763672,16.565000534057617,16.834999084472656,16.56830406188965,NVDA,"Expect Pressure On Semi Stocks Amid Terminated KLA-Tencor/Lam Deal ||| Anadarko, NVIDIA, Royal Dutch Shell: Fast Money Picks For October 6 ||| Carter Worth Thinks That NVIDIA Is Too Expensive",0,0.48941013
2016-10-07,28626000.0,16.947500228881836,16.99250030517578,16.665000915527344,16.712499618530273,16.447744369506836,NVDA,6 Stocks Which Plummeted Three Days On Increasing Volume,1,0.5283504
2016-10-10,28787600.0,16.799999237060547,16.889999389648438,16.61750030517578,16.774999618530273,16.50925064086914,NVDA,Electrek Reports Tesla is about to increase its lead in semi-autonomous driving w/ 'Tesla Vision': computer vision based on NVIDIA's parallel computing,0,0.5200396
2016-10-13,39011600.0,16.412500381469727,16.450000762939453,15.925000190734863,16.337499618530273,16.07868003845215,NVDA,What Autopilot 2.0 Means For Mobileye,1,0.51301897
2016-10-17,19532800.0,16.4950008392334,16.649999618530273,16.3799991607666,16.40250015258789,16.14265251159668,NVDA,Advanced Micro Devices' Improved Near-Term Sales Trends Earn It An Oppenheimer Upgrade,1,0.54099387
2016-10-20,31208400.0,16.8125,16.987499237060547,16.575000762939453,16.9325008392334,16.664255142211914,NVDA,"Hearing Jefferies Positive On NVIDIA On Heels Of Nintendo Switch, Raises PT From $73 To $80 ||| Tesla And The Era Of Intelligent Transportation",0,0.5207226
2016-10-24,33983600.0,17.0,17.697500228881836,16.997499465942383,17.677499771118164,17.3974552154541,NVDA,Technical Alert: Nvidia Corp Attempts To Make New All-Time-High ||| Rambus Reports Licensing of DPA Countermeasures to NVIDIA,1,0.5111847
2016-10-25,39746000.0,17.647499084472656,18.075000762939453,17.5625,17.967500686645508,17.682857513427734,NVDA,"B. Riley Maintains Buy on NVIDIA Corporation - Common Stock, Raises to $85.00 ||| WSJ.D Live Conference Continues Today; Presenters Include AT&T & Time Warner, Nvidia, Facebook, Paypal, Yelp, And Trian Fund Management's Nelson Peltz",1,0.5044189
2016-10-27,38866400.0,18.177499771118164,18.21249961853028,17.59749984741211,17.670000076293945,17.390073776245117,NVDA,"Apple's New MacBook Specs Take On Top Competitors ||| Traders Passing Around Comment on NXP Semi Call: When Asked Why Do A Deal Now?, Exec Responded A Need for Automotive Driver Assist Processing, Machine Learning Capabilities; Seen as Positives for NVIDIA, Mobileye",0,0.49516952
2016-11-02,29584800.0,17.395000457763672,17.6299991607666,17.15999984741211,17.190000534057617,16.91767692565918,NVDA,"Benzinga's Top Initiations ||| Jim Cramer Gives His Opinion On Acushnet, Nvidia And Realty Income ||| Citigroup Initiates Coverage On NVIDIA Corporation - Common Stock at Buy, Announces $90.00",0,0.489233
2016-11-04,32878000.0,16.877500534057617,17.1825008392334,16.645000457763672,16.892499923706055,16.62489128112793,NVDA,"NVIDIA Shares Spike Over $67.50 Level, Now Over $68 as Traders Passing Around Unconfirmed Takeover Chatter ||| Jim Cramer Shares His Thoughts On Acacia Communications And Advanced Micro Devices",1,0.51490635
2016-11-07,48758000.0,17.387500762939453,17.93000030517578,17.375,17.8174991607666,17.535234451293945,NVDA,Big Tech Is Leading The Stock Market Higher Today ||| NVIDIA's Transformation Is Complete; Canaccord Lifts Price Target To $80 ||| M Science Out Negative On Nvidia ||| David Bartosiak's NVIDIA Trade,0,0.4806621
2016-11-10,86928000.0,17.872499465942383,17.875,16.690000534057617,16.9424991607666,16.674100875854492,NVDA,"NVIDIA Spikes On Record Quarterly Results, Strong Guidance And Dividend Raise ||| NVIDIA Raises Qtr. Dividend From $0.115 To $0.14/Share, Authorizes Additional $2B Buyback ||| NVIDIA Sees Q4 Sales $2.1B +/- 2% ||| NVIDIA Reports Q3 EPS $0.94 vs. Est. $0.57, Rev. $2B vs. Est. $1.69B ||| Big Tech Is Getting Crushed Today ||| 12 Stocks You Should Be Watching Today ||| Earnings Scheduled For November 10, 2016",1,0.5106834
2016-11-11,217534400.0,19.877500534057617,22.1924991607666,19.625,21.99250030517578,21.64409637451172,NVDA,"NVIDIA's Blowout Quarter Helps It Remain A Top Pick At Jefferies ||| Did NVIDIA's Ultra-Conservative Guidance Set It Up For Huge Beat? ||| Mid-Afternoon Market Update: Gold Futures Down 3.5%; PTC Therapeutics Shares Spike Higher ||| 12 Biggest Mid-Day Gainers For Friday ||| Trip Chowdhry's Top 4 Stock Picks ||| Mid-Day Market Update: Crude Oil Down Over 3%; NVIDIA Shares Jump On Earnings Beat ||| After NVIDIA's Solid Q3, Analyst Sees 18% Upside ||| NVIDIA Meets And Exceeds The Street's Great Expectations In Q3 ||| Top Performing Industries For November 11, 2016 ||| Benzinga's Volume Movers ||| The Technical Take: NVIDIA Makes New All-Time High After Q3 Beat ||| Barclays Issues A Rare Post-Earnings Upgrade On NVIDIA ||| Mid-Morning Market Update: Markets Mostly Lower; J C Penney Q3 Sales Miss Estimates ||| 7 Biggest Price Target Changes For Friday ||| NVIDIA Delivers Second Consecutive Spectacular Quarter ||| Benzinga's Top Upgrades ||| The Market In 5 Minutes: You Don't Really Care For Music, Do You? ||| 18 Stocks Moving In Friday's Pre-Market Session ||| NVIDIA's Blowout Quarter: 'Machine Learning Is Like A Quicksand' ||| A Peek Into The Markets: U.S. Stock Futures Down Ahead Of Consumer Sentiment Report ||| 7 Stocks To Watch For November 11, 2016 ||| Nvidia +12.5% Premarket @$76.30 on Solid Earnings Beat, Share Buyback, Dividend Raise ||| Barclays Upgrades NVIDIA Corporation - Common Stock to Equal-Weight, Raises to $72.00",0,0.52161187
2016-11-14,134879600.0,22.022499084472656,22.04750061035156,20.905000686645508,20.90999984741211,20.578746795654297,NVDA,"Nvidia's Big Win: Post-Earnings Sell-Side Sentiment ||| Vetr Crowd Downgrades NVIDIA After All-Time High ||| Worst Performing Industries For November 14, 2016 ||| Needham Upgrades NVIDIA Corporation - Common Stock to Buy ||| The Market In 5 Minutes: A Couple Of Pharma Stocks Move 70% In Opposite Directions ||| Can You Guess This Chart? ||| IBM, NVIDIA Collaborate on World's Fastest Deep Learning Enterprise Solution",1,0.49964094
2016-11-16,98798400.0,21.834999084472656,23.13999938964844,21.58749961853028,22.90749931335449,22.54459381103516,NVDA,Mid-Afternoon Market Update: StemCells Climbs On Asset Purchase Agreement; Endologix Shares Drop ||| Technical Alert: No Stopping Nvidia Corp ||| Mid-Day Market Update: Dow Falls 75 Points; Shipping Stocks Spike Higher ||| IC Insights Says Nvidia is Fastest Growing Semiconductor Co for 2016 -DigiTimes,1,0.4916113
2016-11-17,83298800.0,23.07749938964844,23.69750022888184,22.662500381469727,23.09749984741211,22.731590270996094,NVDA,"Intel Corporation, Mobileye May Be Star-Crossed Lovers, But Chowdhry Calls Veronian Tragedy",1,0.49986112
2016-11-18,57606000.0,23.09749984741211,23.582500457763672,22.950000762939453,23.34000015258789,22.970251083374023,NVDA,"Mobileye Stock Weakness Unwarranted, Wells Fargo Says Buy The Stock ||| NVIDIA's Stock Is On Quite The Run ||| 10 Stocks With Highest Close In Three Weeks",0,0.48412955
2016-11-22,33036800.0,23.325000762939453,23.434999465942383,23.09499931335449,23.412500381469727,23.041603088378903,NVDA,"Vetr Crowd Thinks AMD Is Running Hot ||| 7 Biggest Price Target Changes For Tuesday ||| MKM Partners Raising PT From $87 To $106 On NVIDIA, Says Thematic Attention Is Heating Up As Large Suppliers Crowding Into AI As An Investment Theme With Non-GPU Solutions",1,0.5153133
2016-11-28,27873600.0,23.467500686645508,23.684999465942383,23.39999961853028,23.52750015258789,23.1894474029541,NVDA,Technical Alert: Nvidia Corp Range Bound ||| Scott Bauer's NVIDIA Options Trade,0,0.5180388
2016-11-30,44050000.0,23.39999961853028,23.540000915527344,23.02499961853028,23.049999237060547,22.718807220458984,NVDA,"Intel, Nvidia to Announce New Platforms for CES 2017 -DigiTimes",0,0.50630295
2016-12-01,103552400.0,23.02499961853028,23.042499542236328,21.1924991607666,21.90999984741211,21.59518814086914,NVDA,NVIDIA's Crazy Run Begins To Slow Down ||| Technical Alert: Nvidia Corp Finally Has A Bad Day,1,0.49067795
2016-12-05,60228400.0,22.497499465942383,23.15250015258789,22.25,22.96999931335449,22.639955520629883,NVDA,"Chipmakers Trading High During Indian Conference ||| Chip Makers Trading Higher During India's GTCx Conference, NVIDIA up 2.04%",1,0.50681525
2016-12-06,49879600.0,23.052499771118164,23.4325008392334,22.89249992370605,23.34749984741211,23.01202964782715,NVDA,Option Alert: NVDA Fri 12/9 95.5 Calls (Wkly) Sweep: 2220 @ ASK $0.30: 3758 traded vs 292 OI: Earnings 2/15 After Close (est) $92.15 Ref,1,0.46604002
2016-12-07,48080400.0,23.209999084472656,23.825000762939453,23.02499961853028,23.76749992370605,23.425996780395508,NVDA,"Facebook, Google Make Glassdoor's List Of Top 50 Places To Work ||| Watch These 7 Huge Call Purchases In Wednesday Trade",0,0.50924
2016-12-08,38154400.0,23.79750061035156,24.155000686645508,23.262500762939453,23.3700008392334,23.034210205078125,NVDA,Technical Alert: Nvidia Corp Makes New All-Time-High And Retreats,0,0.51979643
2016-12-09,38231200.0,23.549999237060547,23.5674991607666,22.677499771118164,22.95499992370605,22.62517166137696,NVDA,"10 Stocks That Rallied Four Days, Then Sold Off Yesterday",0,0.5023253
2016-12-12,60133200.0,22.46249961853028,22.487499237060547,21.88500022888184,22.397499084472656,22.075681686401367,NVDA,"The Biggest Players In Augmented Reality ||| Technical Alert: Nvidia Corp Lower As Pacific Crest Urges Caution On The Rapid Price Increase ||| 3 Factors Pushing NVIDIA Shares Lower ||| Pacific Crest Out Cautious On NVIDIA, Warning Of Potential Excess Inventory In Desktop Graphics Card Market",1,0.50921655
2016-12-13,38779600.0,22.522499084472656,23.07250022888184,22.512500762939453,22.792499542236328,22.46500968933105,NVDA,"Why The NVIDIA Story Is Still In Its Early Innings Despite Recent Run ||| Loop Capital Initiates Coverage On NVIDIA at Buy, Announces $109.00 Target",1,0.49826777
2016-12-14,98398000.0,23.13500022888184,24.27750015258789,22.89249992370605,24.112499237060547,23.766036987304688,NVDA,"Watch NVIDIA Shares Here, Stock Up 5%; Benzinga Has Been Alerted to Traders Passing Concern on Possible Chip Recall ||| NVIDIA Is Up 190% In 2016: Here's Why You Should 'Jump On Board' For 2017 ||| Option Alert: NVDA Dec16 95.0 Puts: 2542 @ ASK $0.80: 3699 traded vs 678 OI: Earnings 2/15 After Close (est) $96.13 Ref ||| 15 Biggest Mid-Day Gainers For Wednesday ||| NVIDIA Continues With Yo-Yo Action ||| Advanced Micro Devices' Price Target Raised To 2007 Level At Canaccord ||| Benzinga's Top Upgrades, Downgrades For December 14, 2016 ||| The Market In 5 Minutes: All Eyes On The Fed ||| Evercore ISI Group Upgrades NVIDIA to Buy, Announces $120.00 Target",1,0.49063888
2016-12-15,74654800.0,24.225000381469727,24.98500061035156,24.14999961853028,24.677499771118164,24.322917938232425,NVDA,No Stopping NVIDIA ||| Stocks Hitting 52-Week Highs ||| Watch These 5 Huge Put Purchases In Thursday Trade,1,0.5054585
2016-12-19,74465600.0,24.924999237060547,25.612499237060547,24.75,25.40749931335449,25.04243278503418,NVDA,"Barron's Picks And Pans: Tech Infrastructure, Small Caps, DineEquity And More ||| Why These Stocks Skyrocketed On Friday's Quad Witch ||| Watch These 7 Huge Put Purchases In Monday Trade",1,0.49108088
2016-12-20,84805600.0,26.145000457763672,26.53249931335449,26.030000686645508,26.292499542236328,25.914714813232425,NVDA,"15 Biggest Mid-Day Gainers For Tuesday ||| 18 Stocks Moving In Tuesday's Pre-Market Session ||| Mizuho Maintains Buy on NVIDIA, Raises Target from $80 to $115.00",1,0.52931744
2016-12-22,71861200.0,26.70499992370605,27.217500686645508,26.63249969482422,26.77750015258789,26.392745971679688,NVDA,Looking Toward Nvidia's 2016 Boom To Pick The Next Big Tech Stock,1,0.5037164
2016-12-27,119427200.0,28.01499938964844,29.34000015258789,27.80500030517578,29.32999992370605,28.90857315063477,NVDA,Wall Street's Top Picks For 2017: All In One Place ||| Mid-Day Market Update: Crude Oil Up Over 1%; Endologix Shares Slide ||| Technical Alert: Nvidia Higher For Tenth Day In A Row ||| 6 Best Performing S&P 500 Stocks Of 2016,0,0.48377952
2016-12-28,229576400.0,29.89999961853028,29.982500076293945,27.17250061035156,27.3125,26.920061111450195,NVDA,"Left Says Short Nvidia for Past Few Days ||| Citron's Andrew Left on CNBC Says Likes Nvidia, But Market Got Ahead of Itself ||| Why NVIDIA's Recent Run Shouldn't Come As A Surprise ||| 23 Notable Presentations On The CES 2017 Schedule ||| Analyst: NVIDIA Is Overvalued, But Don't Sell Ahead Of CES ||| Should You Be Buying 2016 Market Leaders Or Laggards Heading Into 2017? ||| 10 Biggest Mid-Day Losers For Wednesday ||| NVIDIA's Pullback Might Not Last Very Long ||| Ways To Play The AI Theme At CES 2017 ||| Looking To Get Some Automotive Exposure Ahead Of CES 2017? Here Are 9 Stocks To Consider ||| Option Alert: Nvidia Dec 30th 120 Calls: 2540 @ ASK $0.20: 6976 traded vs 2145 OI: Earnings 2/15 After Close (est) $111.74 Ref ||| NVIDIA's 10-Day Win Streak Now In Danger ||| Is NVIDIA Going Back To $90? Citron Thinks So ||| NVIDIA Shares Down 4.7% ||| Citron's Andrew Left To Appear On CNBC At 5:25pm ET To Discuss NVIDIA ||| Citron Research @CitronResearch 1m Citron readers know we have long been fans of $NVDA,but now the mkt is disregarding headwinds. In 2017 we will see $NVDA head back to $90 ||| Technical Alert: Nvidia Corp Looks To Extend Ten Day Win Streak ||| CES 2017 Will Effectively Be A Car Show: A Look At Key Themes ||| 5 Biggest Price Target Changes For Wednesday ||| NVIDIA Has Significant Room For Further Gains ||| 15 Stocks Moving In Wednesday's Pre-Market Session ||| Nvidia +2.3% Premarket @$120",1,0.5089389
2016-12-29,217536800.0,26.225000381469727,27.872499465942383,25.700000762939453,27.857500076293945,27.45723342895508,NVDA,"Jim Strugger's Hedging Strategy In NVIDIA ||| Don't Be Surprised If NVIDIA Closes Higher Today ||| 12 Biggest Mid-Day Losers For Thursday ||| Tesla's Stock Under Selling Pressure ||| Mid-Day Market Update: Prima BioMed Climbs Following Positive IMP321 Data; Interpace Diagnostics Shares Slide ||| Mid-Morning Market Update: Markets Mostly Flat; Jobless Claims Drop To 265,000 ||| The Market In 5 Minutes: Jobless Claims Fall ||| 15 Stocks Moving In Thursday's Pre-Market Session ||| Nvidia -4% Premarket @$104.97",0,0.50055295
2016-12-30,121293200.0,27.83749961853028,27.979999542236328,26.575000762939453,26.684999465942383,26.30158233642578,NVDA,January Will Feature Some Of The Market's Most Influential Events ||| More Profit-Taking In NVIDIA After Recent Volatility ||| NVIDIA To 'Shine' With Smart Autos At CES ||| Nvidia +1.4% Premarket @$113.00,0,0.47133696
2017-01-03,150199600.0,26.100000381469727,26.592500686645508,24.84499931335449,25.502500534057617,25.13606834411621,NVDA,The Bear Cases For Wall Street's Darlings ||| A Sampling Of Citron's Most Influential Tweets ||| 9 Companies With Nvidia's Consistency In Delivering Upside To EPS Estimates ||| Technical Alert: Nvidia Corp Hovering Over Major Support,1,0.50250083
2017-01-04,119922000.0,25.850000381469727,26.375,25.38249969482422,26.09749984741211,25.72251510620117,NVDA,Why A Pullback Is Just What Nvidia Needed,0,0.49506155
2017-01-05,98429600.0,26.13249969482422,26.45499992370605,25.262500762939453,25.434999465942383,25.06953811645508,NVDA,"Execs Giving CES Keynote Speeches Could Create Volatility For Shareholders ||| Technical Alert: Nvidia Corp Lower ||| Nvidia At CES: 3 Big Announcements Leave Investors With 5 Major Questions ||| NVIDIA Shares Saw Overnight Action, Moved Higher Potentially On the Heels of Wed.'s CES Keynote by Jen-Hsun Huang; Shares Now Largely Unaffected; Watch for Volatility in Other CES Keynote Names ||| HERE, Nvidia Partner on AI technology for HD Mapping from Cloud to Car",1,0.50538296
2017-01-06,82285600.0,25.71249961853028,26.0625,25.299999237060547,25.77499961853028,25.4046573638916,NVDA,Citron's Andrew Left Currently Speaking on CNBC ||| 17 More Financial Twitter Names To Follow In 2017 ||| NVIDIA CEO's Keynote At CES Exceeded Expectations ||| Jim Cramer Gives His Opinion On Mobileye And Blackstone,1,0.5016915
2017-01-09,91624800.0,25.875,27.0,25.875,26.81999969482422,26.434642791748047,NVDA,Here Are The Brands Investors Were Buying And Selling In December ||| Investor Movement Index (IMX) for December 2016 ||| 7 Biggest Price Target Changes For Monday ||| Oppenheimer's Takeaways From Meeting With The NVIDIA CFO At CES ||| This Tech Analyst Loves Cybersecurity Stocks in 2017 ||| Nvidia And The Self-Driving Auto: Competition Is Good For Investors ||| KeyBanc Names CES Auto Winners,0,0.49938014
2017-01-10,88092000.0,26.95249938964844,27.29750061035156,26.40749931335449,26.61750030517578,26.23504638671875,NVDA,Nearly 200 S&P 500 Stocks Are Now In Correction Territory ||| Traders Passing Around The Information Article Published ~4 Hours Ago 'CES Proves Carmakers Still Confused About Autonomous'; Traders Mentioning NVIDIA,0,0.47460622
2017-01-11,52566400.0,26.5,26.549999237060547,26.037500381469727,26.290000915527344,25.912254333496094,NVDA,"If Lendingtree Continues To Deliver, A Major Short Squeeze Could Be On The Horizon ||| Option Alert: Nvidia Feb $110 Call; 3000 @Bid @$5.98 ||| Top 10 S&P Stocks Of The Obama Presidency ||| Shining Semiconductor ETFs",0,0.49431875
2017-01-13,45782000.0,25.89999961853028,26.25,25.76499938964844,25.857500076293945,25.48596572875977,NVDA,"In Honor Of Friday The 13th, Here Are Some Of The Unluckiest Trades Of 2016",0,0.49451733
2017-01-18,65442400.0,25.059999465942383,25.8075008392334,24.77750015258789,25.737499237060547,25.36768913269043,NVDA,Nvidia's Machine Learning Business Seems Very Strong,1,0.52208865
2017-01-19,64487200.0,25.76749992370605,26.614999771118164,25.7450008392334,26.290000915527344,25.912254333496094,NVDA,"CEO Huang Registers 125,002 Shares of NVIDIA -Form 144 ||| IBM Kicks Off The Big Tech Earnings Season",0,0.5198634
2017-01-23,36990400.0,25.950000762939453,26.475000381469727,25.924999237060547,26.272499084472656,25.895000457763672,NVDA,Todd Gordon Is Bullish On Netflix And NVIDIA,1,0.4920167
2017-01-24,42805200.0,26.375,26.895000457763672,26.225000381469727,26.832500457763672,26.44695472717285,NVDA,Old Tech Vs. New Tech: Which Will Be Better Investments For 2017?,1,0.49577072
2017-01-27,47199600.0,27.482500076293945,27.97249984741211,27.21249961853028,27.9424991607666,27.54100608825684,NVDA,Benzinga's Option Alert Recap From January 27 ||| Option Alert: Nvidia Feb 3 $109 Put Sweep; 2786 @Bid @$1.027; Ref=$111.61,0,0.4912745
2017-01-31,36275600.0,27.237499237060547,27.512500762939453,27.049999237060547,27.295000076293945,26.902814865112305,NVDA,"AMD Shares Down 3% Following Earnings, Guidance; NVIDIA Shares Down 1%",1,0.5043519
2017-02-03,37274400.0,28.862499237060547,28.975000381469727,28.475000381469727,28.59499931335449,28.18413352966309,NVDA,"Benzinga's Top Upgrades, Downgrades For February 3, 2017",1,0.5108948
2017-02-06,50676800.0,28.5,29.332500457763672,28.5,29.32749938964844,28.906110763549805,NVDA,"Barron's Picks And Pans: Chipotle, Snap, AMD And More ||| Advanced Micro Devices Continues To Rip On Potential Intel Deal ||| 7 Biggest Price Target Changes For Monday ||| Benzinga's Top Upgrades, Downgrades For February 6, 2017 ||| Roth Capital Downgrades NVIDIA To Neutral",1,0.51161873
2017-02-07,74622400.0,29.674999237060547,30.229999542236328,29.475000381469727,29.78249931335449,29.35457229614257,NVDA,"Apple, NVIDIA Near All Time-Highs As Microsoft Remains Under Pressure ||| Jim Cramer: NVIDIA Will Prove Its Worth ||| A NVIDIA Q4 Earnings Preview: Upside Should Come From EPS Growth ||| Pacific Crest Out Positive On NVIDIA Data Center Sales, Says Should Be Lifted Higher From Amazon and Google Orders",0,0.5096913
2017-02-08,44958000.0,29.600000381469727,29.82749938964844,29.09499931335449,29.65250015258789,29.226436614990234,NVDA,Q4 2017 Real-Time Call Brief ||| Arista Networks Pops to High of $96.50 on Volume ||| M Science Out Negative On Nvidia,0,0.4944144
2017-02-09,84256800.0,29.71500015258789,29.76499938964844,28.89999961853028,29.09499931335449,28.67694664001465,NVDA,"NVIDIA Beats Q4 Estimates, Sales Up 55% ||| Nvidia Sees FY18 Revenue $1.9B vs $1.88B ||| NVIDIA Reports Q4 Adj. EPS $1.13 May Not Compare to $0.83 Est., Sales $2.17B vs $2.11B ESt. ||| 2 Surprise Standouts From TD Ameritrade's January IMX ||| A Technical Look At NVIDIA ||| NVIDIA Option Activity Implies A 12.8% Move Post Earnings ||| A Peek Into The Markets: U.S. Stock Futures Rise; Twitter Sales Miss Views ||| 12 Stocks To Watch For February 9, 2017 ||| Earnings Scheduled For February 9, 2017",0,0.5021589
2017-02-10,165109200.0,29.982500076293945,30.174999237060547,28.14999961853028,28.405000686645508,27.99686050415039,NVDA,"Mid-Afternoon Market Update: Dow Gains Over 100 Points; Ubiquiti Networks Shares Drop On Downbeat Earnings ||| It's Hip To Be Square? Huey Lewis Suggests An Investing Strategy That's Nothing Fancy ||| Nvidia Remains One Of The Most Exciting Growth Stories In Tech ||| Mid-Day Market Update: Infinera Surges On Earnings Beat; ChannelAdvisor Shares Plunge ||| Jim Cramer Thinks Nvidia Remains A 'Frighteningly Positive Story' ||| The Positive And Negative Surprises In Nvidia's Q4 Conference Call ||| Pacific Crest OUt Negative on NVIDIA, Management Calling Around Talking Down Q2 Numbers Saying Gaming Unlikely To Grow QoQ, Saying Possibly Pause In Data Center Segment ||| Wild Ride In NVIDIA After Q4 Beat ||| Has Nvidia Reached Peak Market Share? ||| Mid-Morning Market Update: Markets Open Higher; NVIDIA Beats Q4 Views ||| The Market In 5 Minutes: Following Ruling Against Immigration Ban, Trump Says 'See You In Court' ||| 30 Stocks Moving In Friday's Pre-Market Session ||| A Peek Into The Markets: U.S. Stock Futures Rise; Crude Oil Up Over 1% ||| GM, Intel, NVIDIA, Viacom: Fast Money Picks For February 10 ||| Keep an Eye on These 10 Stocks for February 10, 2017",0,0.5131107
2017-02-13,118072400.0,28.34749984741211,28.4950008392334,27.049999237060547,27.09499931335449,26.705686569213867,NVDA,"Nvidia Has Beat The Street In Every Quarter Since 2011; How Do Rivals Measure Up? ||| Traders Attributing Recent Volatility In NVIDIA To Intel's Announcement of New FPGA For Industrial, Automotive Markets ||| The Consensus On NVIDIA Is Still Pretty Positive",1,0.47849107
2017-02-14,85063200.0,26.997499465942383,27.537500381469727,26.57250022888184,27.19499969482422,26.80425071716309,NVDA,"Paul Singer's Latest 13F Shows Big Changes In Apple, Western Digital ||| 5 Misguided Valentine's Day Gifts For Stock Traders",1,0.5063961
2017-02-16,64717600.0,27.34749984741211,27.36000061035156,26.415000915527344,26.8125,26.42724227905273,NVDA,Who's The Boss? It Could Be This New ETF,0,0.50365055
2017-02-22,43377200.0,27.854999542236328,27.950000762939453,27.497499465942383,27.690000534057617,27.32658195495605,NVDA,"NVIDIA Falls Following Nomura Downgrade, Analyst Concerned About Slowdown In Gaming ||| Nomura Downgrades NVIDIA to Reduce, Announces $90.00 Target",0,0.50661546
2017-02-23,159288800.0,26.375,26.59749984741211,24.920000076293945,25.122499465942383,24.79277610778809,NVDA,"Double Downgrade Sinks Nvidia's Stock ||| Nvidia: Know The Difference Between 'Highly Valued' And 'Overvalued' ||| As Nvidia Catches A Pair Of Downgrades, Attention Turns To AMD ||| 8 Biggest Price Target Changes For Thursday ||| Andrew Left on NVIDIA, Tells Benzinga 'as Good of a Company as NVIDIA is, the Underlying Business Couldn't Keep Up with the Stock Price' ||| Nvidia Shares Down 7.43% After Downgrades From BMO, Nomura; Tigress Analyst Ivan Feinseth Tells Benzinga Nvidia Shares Are 'Highly Valued' Not 'Overvalued,' Fundamentals Remain Strong ||| Nvidia Shares Are Overvalued At Current Levels ||| Benzinga's Top Upgrades, Downgrades For February 23, 2017 ||| The Hottest Stock Of 2016 No Longer A Buy For This Analyst ||| The Market In 5 Minutes ||| 22 Stocks Moving In Thursday's Pre-Market Session ||| Nomura Downgrades NVIDIA To Reduce, Lowers Price Target To $90 ||| A Peek Into The Markets: U.S. Stock Futures Edge Higher Ahead Of Economic Data ||| BMO Capital Downgrades NVIDIA to Underperform, Lowers Target to $85.00 ||| Applied Materials, L Brands, NVIDIA: Fast Money Picks For February 23",1,0.49828985
2017-02-24,102990400.0,24.26749992370605,25.5,23.924999237060547,25.364999771118164,25.032094955444336,NVDA,"Citron's Andrew Left Explains His Latest Trades ||| Nvidia, Advanced Micro Devices To Present At 2017 Game Developers Conference ||| Why Mobileye, Not Nvidia, Is Ripe For Short Sellers ||| UPDATE: Citron Report Says 'Do Not Listen to Citron. Just Follow the Insider Sales to Understand the Validity of the Trade!' ||| UPDATE: Citron's Andrew Left Issues New Note: Says Closing Short in NVIDIA, Transferring Short to Mobileye ||| Citron Research Tweets 'Updating our $NVDA call....switching focus to $MBLY Ridiculous comparison We expect $MBLY to trade short term $35. Insiders tell the story' ||| The Market In 5 Minutes",1,0.4854776
2017-02-27,71540000.0,25.549999237060547,26.2549991607666,25.38999938964844,26.102500915527344,25.759916305541992,NVDA,What's Next For Nvidia? ||| The Market In 5 Minutes ||| 2017 Game Developers Conference Begins Today; Advanced Micro Devices And Nvidia Attending,0,0.49987394
2017-02-28,62536000.0,26.200000762939453,26.299999237060547,25.19499969482422,25.3700008392334,25.037033081054688,NVDA,"2017 Game Developers Conference Continues Today, Day 2 Of 5",1,0.5000335
2017-03-01,50480400.0,25.94750022888184,26.092500686645508,25.27750015258789,25.69750022888184,25.360231399536133,NVDA,"GeForce Awakens: Nvidia Just Launched its Newest Graphics Card ||| Nomura Stands By Nvidia Downgrade, Recommends More Defensive Names ||| With The Mobile Industry Upgrading To 5G, Buy Cavium ||| 2017 Game Developers Conference Continues Today, Nintendo To Present ||| NVIDIA Announces Fastest Gaming GPU Ever",0,0.5205358
2017-03-02,75433200.0,25.5674991607666,25.709999084472656,24.72249984741211,24.75,24.42516326904297,NVDA,"Seeing Notable Block Trade In Nvidia; 1M Shares At $100.40 ||| Bank Of America: AMD, Cavium And Cypress Could All See 50% Upside ||| Game Developers Conference Continues Today, Day 4 Of 5",0,0.49804303
2017-03-03,86469200.0,24.64249992370605,24.6924991607666,24.05500030517578,24.607500076293945,24.2845401763916,NVDA,Game Developers Conference Concludes Today,0,0.5159986
2017-03-06,88356800.0,24.239999771118164,24.52499961853028,23.792499542236328,24.417499542236328,24.097028732299805,NVDA,Benzinga's Option Alert Recap From March 6 ||| NVIDIA Shares Spiking To High Of $97.71 ||| Option Alert: NVIDIA May $90 Puts at the Ask: Volume of 752 at $4.30 vs Open Interest of 734,1,0.5002449
2017-03-07,60340000.0,24.417499542236328,24.88249969482422,24.287500381469727,24.684999465942383,24.36102104187012,NVDA,9 Stocks That Retail Investors Loved in February ||| Can Nvidia Fend Off Competition From Intel And Advanced Micro Devices?,0,0.49719754
2017-03-09,47806000.0,24.477500915527344,24.862499237060547,24.350000381469727,24.63500022888184,24.311674118041992,NVDA,"NVIDIA Shares Spiking Higher, The Tech Report Announced Positive Review Of GTX 1080 TI Graphics Card",1,0.5251986
2017-03-10,49974000.0,24.90250015258789,25.022499084472656,24.59499931335449,24.780000686645508,24.45477294921875,NVDA,"Mobileye, NVIDIA, NXP Semi Shares Quiet Amid Report NIO Has Said Will Have Autonomous Electric Vehicles in US Market in 2020, Wants to Partner with Mobileye, NVIDIA, NXP",1,0.49661848
2017-03-13,77413600.0,24.88500022888184,25.5625,24.877500534057617,25.46249961853028,25.12831687927246,NVDA,"Citron's Andrew Left On CNBC Says It's Hard To Gauge Whether NVIDIA Is A Outlier, Says Co. Priced Perfectly Right Here ||| Gadfly's Ovide: Intel Is Spending Money 'Like It's 1999' ||| Intel Inherits Mobileye's Problems ||| Semiconductor Advisors Breaks Down The Intel-Mobileye Deal ||| Taiwan Semiconductor Manufacturing Receives Orders for HPC Chips from Nvidia, Qualcomm -DigiTimes",0,0.4929144
2017-03-14,52201600.0,25.592500686645508,25.6875,25.11750030517578,25.44499969482422,25.11104202270508,NVDA,Intel May Have Just 'Burned' $15 Billion On Mobileye,1,0.5177653
2017-03-15,61503600.0,25.5625,25.747499465942383,25.07999992370605,25.637500762939453,25.30101585388184,NVDA,Bosch Reports AI Self-Driving Computer with NVIDIA ||| Nividia to Supply Bosch with Chip for AI Computer for Car -DJ,1,0.5109461
2017-03-16,52310000.0,25.7450008392334,25.957500457763672,25.602500915527344,25.95249938964844,25.61188507080078,NVDA,"NVIDIA On Blog Post, Says It's Working With Truckmaker PACCAR On Self-Driving Tech ||| Loop Capital's ""Loop Around The Valley"" Semiconductor Conference Takes Place Today, Attendees Include Cypress Semiconductor, Broadcom, Nvidia, Cavium, & Maxim Integrated Products",1,0.49186108
2017-03-17,111968800.0,26.1299991607666,26.530000686645508,25.95249938964844,26.51749992370605,26.169469833374023,NVDA,M Science Negative on NVIDIA ||| Nvidia's Busy Week In Self-Driving Deals,1,0.5268055
2017-03-20,74856800.0,26.69499969482422,27.40250015258789,26.53249931335449,27.362499237060547,27.00337791442871,NVDA,"Benzinga's Option Alert Recap From March 20 ||| Option Alert: Nvidia Apr 28 101 Put; 4876 @Bid @$1.45; Ref=$109.01 ||| These Trends Bode Well For Nvidia, Microsoft",0,0.4980297
2017-03-21,91348400.0,27.1875,27.489999771118164,26.397499084472656,26.477500915527344,26.129995346069336,NVDA,Watch These 8 Huge Put Purchases In Tuesday Trade,1,0.53462493
2017-03-22,61676400.0,26.364999771118164,27.065000534057617,26.325000762939453,27.01749992370605,26.662904739379883,NVDA,Traders Circulating Unconfirmed Takeout Chatter On Nvidia,0,0.49408972
2017-03-23,53394000.0,26.9375,27.13999938964844,26.674999237060547,26.772499084472656,26.421125411987305,NVDA,"Weakening Demand Could Pitch AMD, Nvidia And Intel Into Price War ||| Digitimes Reporting Nvidia Dropping Prices On GPUs Due To Weak Demand ||| Pete Najarian And Guy Adami Share Their Thoughts On Nvidia And Alphabet",1,0.492107
2017-03-24,43950000.0,27.24250030517578,27.32250022888184,26.604999542236328,26.86750030517578,26.514869689941406,NVDA,The New Reality Of Video Games ||| Tencent Cloud To Use NVIDIA Tesla for AI Cloud Computing,1,0.51964676
2017-03-30,52553200.0,26.90749931335449,27.5,26.850000381469727,27.350000381469727,26.991039276123047,NVDA,Guy Adami And Pete Najarian Share Their Thoughts On Nvidia And Allergan,0,0.5098869
2017-03-31,44080800.0,27.252500534057617,27.47249984741211,27.100000381469727,27.232500076293945,26.875083923339844,NVDA,Macquarie Initiates Coverage On NVIDIA at Neutral,0,0.5323611
2017-04-03,44523200.0,27.237499237060547,27.412500381469727,26.854999542236328,27.09499931335449,26.739391326904297,NVDA,Tesla Rips Following Unit Figures Release; Morgan Stanley's Subsequent Commentary Focuses On Safety,0,0.51578486
2017-04-04,127128000.0,25.850000381469727,26.104999542236328,25.084999084472656,25.19499969482422,24.86432838439941,NVDA,"15 Biggest Mid-Day Losers For Tuesday ||| NVIDIA Sharply Lower After Downgrade ||| Benzinga's Top Upgrades, Downgrades For April 4, 2017 ||| The Market In 5 Minutes ||| 25 Stocks Moving In Tuesday's Pre-Market Session ||| Pacific Crest Downgrades NVIDIA To Underweight",0,0.5401658
2017-04-05,74704800.0,25.0049991607666,25.592500686645508,24.875,25.00749969482422,24.67928504943848,NVDA,"Citi Says Concerns Related To NVIDIA And Gaming Market Are 'Misleading' ||| Citi Defending NVIDIA, Says Sell Side Gaming Market Saturation Concerns On Stock Both Near-Term and Misleading",1,0.49396357
2017-04-06,63512000.0,25.059999465942383,25.3125,24.602500915527344,25.190000534057617,24.85939216613769,NVDA,"Goldman Starts Advanced Micro Devices At Sell, Sees 20% Downside ||| The Market In 5 Minutes",0,0.51781255
2017-04-07,42906800.0,25.2549991607666,25.4325008392334,24.93000030517578,25.082500457763672,24.75329971313477,NVDA,What One Analyst Thinks Will Get Nvidia's Stock Going Again,0,0.52362317
2017-04-10,75633200.0,25.09000015258789,25.15749931335449,24.39999961853028,24.4424991607666,24.121700286865234,NVDA,"Benzinga's Top Picks Of The Week: Disney, Netflix, BlackBerry And More ||| During A Bullish March, These Were The Stocks That Were Net Buys Among Retail Investors ||| Investor Movement Index (IMX) for March 2017 ||| Morgan Stanley Out Positive On NVIDIA, Says Concerns Revolving The Company's Core Gaming Business And Advises A Tactical Long Into May Analyst Day & Earnings ||| A Bearish Nvidia Options Trade",1,0.5161442
2017-04-12,41409200.0,24.530000686645508,24.674999237060547,24.27499961853028,24.32749938964844,24.008209228515625,NVDA,NVIDIA Shares Indicated ~$0.08 Higher Premarket; Goldman Late Tuesday Evening Reiterated a Conviction Buy Rating and $130 Price Target on Stock,0,0.49034244
2017-04-17,49729200.0,24.002500534057617,24.809999465942383,23.950000762939453,24.8075008392334,24.48191261291504,NVDA,Nvidia-Google Blog Beef: Here's What You Need To Know,1,0.49140975
2017-05-01,30773200.0,26.184999465942383,26.71249961853028,26.112499237060547,26.65999984741211,26.31009864807129,NVDA,Gearing Up For Nvidia's Q1 Earnings: A Technical Take,0,0.5303718
2017-05-02,62997200.0,26.387500762939453,26.39999961853028,25.63999938964844,25.8700008392334,25.530467987060547,NVDA,Semi Stocks Relatively Unaffected Amid Trader Circulation of Report Intel May Be Ramping 3D NAND Supply in China ||| Analyst On Advanced Micro Devices: 'Margins Not Ryzen' ||| Analyst Says Nvidia Is A Strong Play For The 'Post-Smartphone Era',1,0.50454926
2017-05-03,33690400.0,25.799999237060547,26.15999984741211,25.64999961853028,26.0625,25.720443725585938,NVDA,Earnings Preview: What Might Be Expected When FB Reports?,0,0.49931264
2017-05-08,36524000.0,26.084999084472656,26.100000381469727,25.57749938964844,25.6924991607666,25.35529899597168,NVDA,"Signs The Desktop GPU Market Is Oversaturated Keep Analyst Underweight On Nvidia ||| Earnings Preview: NVDA Reports First-Quarter Results Tomorrow ||| Sentiment Remains Soft On Nvidia ||| Benzinga's Bulls And Bears For The Past Week: Semiconductors And Warren Buffett ||| GPU Technology Conference Begins Today; Attendees Include Nvidia, Alibaba, Microsoft, Facebook, Baidu, Alphabet, Lockheed Martin, And Disney's Pixar",1,0.51420575
2017-05-09,84767200.0,25.75,26.232500076293945,25.665000915527344,25.73500061035156,25.39723777770996,NVDA,"Benzinga's Option Alert Recap From May 9 ||| Nvidia Soars After Big Q1 Beat ||| NVIDIA Shares Up ~10% At $113 Following Q1 Earnings Release ||| NVIDIA Sees Q2 Sales $1.95B +/- 2% vs $1.89B Est. ||| NVIDIA Reports Q1 Adj. EPS $0.85 vs $0.67 Est., Sales $1.94B vs $1.91B Est. ||| All The Ratings And Price Targets On Nvidia Ahead Of Q1 Earnings ||| Nvidia Higher Ahead Of Q1 Report ||| Option Alert: Nvidia May 12th 120 Calls: 5610 @ Above Ask! $0.27: 6681 traded vs 4201 OI: Earnings today After Close $103.97 Ref ||| GPU Technology Conference Continues Today, Day 2 Of 4 ||| 12 Stocks To Watch For May 9, 2017 ||| Earnings Scheduled For May 9, 2017",1,0.5096918
2017-05-10,212909600.0,28.57250022888184,30.45499992370605,28.5049991607666,30.32250022888184,29.924531936645508,NVDA,"Mid-Afternoon Market Update: Dow Falls 50 Points; Fossil Shares Slide After Disappointing Results ||| Bull & Bear Takeaways From Nvidia's Q1 Beat ||| 20 Biggest Mid-Day Gainers For Wednesday ||| Mid-Day Market Update: Crude Oil Down 3%; Proteon Therapeutics Shares Spike Higher ||| Analyst Not Budging On Bearish Nvidia Thesis ||| Nvidia Up 13% After Q1 Beat ||| Mid-Morning Market Update: Markets Open Lower; NVIDIA Beats Q1 Estimates ||| Nvidia Looks Like The Primary Beneficiary Of A Shift In The Computing Business Model ||| 5 Biggest Price Target Changes For Wednesday ||| 25 Stocks Moving In Wednesday's Pre-Market Session ||| GPU Technology Conference Continues Today, Day 3 Of 4 ||| A Peek Into The Markets: U.S. Stock Futures Signal Lower Start On Wall Street ||| 12 Stocks To Watch For May 10, 2017 ||| Watch These 8 Huge Call Purchases In Wednesday Trade",1,0.51346976
2017-05-11,193979200.0,30.012500762939453,32.60749816894531,29.977500915527344,31.625,31.209932327270508,NVDA,"Vetr Downgrades Nvidia After Big Earnings Beat ||| 6 Key Themes From Nvidia's Q1 ||| Deutsche Bank AutoTech Conference Takes Place Today; Attendees Include Ford, Intel, Delphi, Nvidia, ON Semiconductor, & Maxim Integrated Products ||| GPU Technology Conference Concludes Today ||| Taiwan Semiconductor Obtains 12nm Chip Orders from Nvidia Silicon Motion Technology -DigiTimes",1,0.49404314
2017-05-12,96262000.0,31.65749931335449,32.400001525878906,31.44499969482422,31.97249984741211,31.552867889404297,NVDA,"Sympathy Moves, Explained: Unsympathetic Earnings Season Continues As Nvidia, Advanced Micro Devices Diverge ||| 4 Big Takeaways From Nvidia's Sell-Side Meeting ||| 5 Biggest Price Target Changes For Friday",1,0.48633614
2017-05-15,108754000.0,32.38999938964844,33.602500915527344,32.345001220703125,33.57749938964844,33.13681411743164,NVDA,Private Label VR Enters The Wild West Of Virtual Reality Gaming ||| Here's What You Missed From Nvidia's Analyst Day,1,0.50246567
2017-05-16,112070000.0,34.095001220703125,34.36000061035156,33.34000015258789,34.20249938964844,33.753604888916016,NVDA,"Alphabet Soup, Revisited: 'FAANG,' Not 'FAANGSTN' ||| Marc Chaikin's Bullish Thesis On 3 Small-Cap Tech Stocks ||| Advanced Micro Devices Sharply Higher Amid Intel Chatter, Analyst Day ||| Intel Has Reportedly Ditched Nvidia For Advanced Micro Devices ||| Intel Has Reportedly Licensed AMD's Graphics Due To Nvidia Licensing Agreement Expiration, Neither Company Has Confirmed",0,0.508794
2017-05-17,127136800.0,33.525001525878906,33.71500015258789,31.887500762939453,31.93000030517578,31.51093864440918,NVDA,"A Few Key Takeaways From AMD's Biannual Analyst Meeting ||| The Market In 5 Minutes ||| AMD Downgraded, Analyst Thinks Intel Deal Is 'Unlikely'",1,0.4974602
2017-05-18,115603200.0,32.375,33.35749816894531,31.762500762939453,33.26750183105469,32.83087921142578,NVDA,A Sumptuous Semiconductor ETF ||| Nvidia Will Maintain 'Dominant Market Share' Thanks To New Volta Chip ||| 10 Industries That Could Be Impacted by Driverless Cars ||| The Sell-Side View On Advanced Micro Devices' Analyst Day ||| The Top 11 Analysts On TipRanks And What They Cover,1,0.510197
2017-05-19,101837200.0,34.25749969482422,34.55500030517578,33.80500030517578,34.0,33.589111328125,NVDA,"15 Biggest Mid-Day Gainers For Friday ||| Bernstein Starts Nvidia At Outperform, Long-Term Opportunity 'May Still Be Underestimated' ||| Benzinga's Top Upgrades, Downgrades For May 19, 2017 ||| Bernstein Initiates Coverage On NVIDIA with Outperform Rating, Announces $165.00 Price Target",1,0.5331184
2017-05-22,83660800.0,34.442501068115234,34.869998931884766,34.33250045776367,34.724998474121094,34.30533981323242,NVDA,Mike Khouw's NVIDIA Options Trade ||| Breaking Down The Reasons An Advanced Micro Devices Deal With Intel Not Likely To Happen ||| How The Top Institutional Investors Are Handling 2017's Most Popular Stocks ||| Benzinga's Bulls And Bears For The Past Week: Retail And Technology,0,0.51382357
2017-05-23,68124800.0,34.92499923706055,34.9474983215332,33.9275016784668,34.25749969482422,33.84348678588867,NVDA,"Companies Holding Annual Meetings Today Include Waste Connections, Eastman Kodak, Alarm.com, Amyris, Achillion Pharma, GNC, Amazon, Nokia, Merck, Nvidia, Pinnacle Foods, Wendy's, & Xerox",1,0.48261562
2017-05-24,81599600.0,35.2400016784668,35.26750183105469,34.52000045776367,34.64250183105469,34.22383117675781,NVDA,AMD CEO Puts Rumors To Rest: 'We're Not Looking At Enabling A Competitor To Compete With Our Products' ||| The Market In 5 Minutes ||| 25 Stocks Moving In Wednesday's Pre-Market Session ||| Nvidia Keeps Running After SoftBank Acquires 4% Stake ||| Nvidia +2.6% Premarket @$140.70 Following Report of $5B Softbank Stake ||| SoftBank Acquires $4B Stake in Nvidia -Bloomberg,0,0.49825507
2017-05-25,60822800.0,35.0,35.00749969482422,34.11000061035156,34.564998626708984,34.14726638793945,NVDA,A Look At Nvidia's Largest Shareholders And What Their Presence Means,1,0.5223705
2017-05-26,77914000.0,34.48249816894531,36.31999969482422,34.27750015258789,35.459999084472656,35.03145217895508,NVDA,NVIDIA Shares Spike to Session Highs Amid Report Softbank is Considering Boosting Stake in Co. 'Over Time',1,0.50154257
2017-06-01,50334000.0,36.247501373291016,36.25749969482422,35.630001068115234,36.09000015258789,35.653846740722656,NVDA,Citron's Andrew Left Makes A Bold Claim: BlackBerry Could Be The Next NVIDIA,0,0.5100872
2017-06-02,48745600.0,36.060001373291016,36.32500076293945,35.849998474121094,35.90999984741211,35.476016998291016,NVDA,Why Is Advanced Micro Devices Slashing Prices Of Ryzen 7 Chips? ||| Citron's Andrew Left Hits The Airwaves To Explain His Bullish BlackBerry Stance,1,0.49396828
2017-06-05,81737600.0,35.744998931884766,37.13249969482422,35.627498626708984,37.00249862670898,36.555320739746094,NVDA,"Benzinga's Bulls And Bears For The Past Week: McDonald's, Ford, BlackBerry And More ||| A Soaring Actively Managed Fund ||| UPDATE: AMD Shares Up 2%, NVIDIA Up 0.9%, Intel Up 0.2% Amid Fudzilla Report; BZ NOTE: Publication is Same Source Which Recently Reported Deal Which Failed to Materialize: Intel Dropped NVIDIA for AMD; Watch for Profit Taking in Semi Stocks ||| Semi Stocks Spike Higher Just After Open as Traders Circulating Fudzilla Report Suggesting Sources 'Very Confident' Order for Intel Chips Integrated with Radeon Graphics is from Apple ||| Nvidia Says on June 2 Entered into Agreement With Goldman Sachs to Terminate Remaining 11.5M Outstanding Warrants to Purchase Shares of Nvidia Common Stock -8-K",0,0.4921668
2017-06-06,75872800.0,36.95500183105469,37.42250061035156,36.70000076293945,36.834999084472656,36.38983917236328,NVDA,"BlackBerry Shares Recently Turn Positive, Now Up 0.7% for Session as Traders Circulating Rumor Co. Working Directly with NVIDIA for Integration Into Drive PX2, Diveworks",1,0.49610904
2017-06-08,116174400.0,38.3650016784668,40.0,37.9474983215332,39.98500061035156,39.50177001953125,NVDA,"Guide to Investing in Robotics Stocks: What's the Future in Automation? ||| After Two Quiet Days, The Nvidia Rally Continues ||| The Bull Case For Nvidia: $300 Per Share? ||| Zacks Market Edge Highlights: Blackberry, Snapchat, Facebook, NVIDIA and Tesla",0,0.5013803
2017-06-09,369292800.0,41.185001373291016,42.125,35.6875,37.400001525878906,36.94800567626953,NVDA,"Here's Why Tech Stocks Fell Today ||| Shorts Attack NVDA, TSLA and RLGT ||| Left Doubles Down On Nvidia Call: Don't Gamble, Stock Got Away Ahead Itself ||| Citron's Andrew Left Hammers Nvidia (NVDA), Shares Dip ||| NVIDIA Shares Continue Lower, At Session Lows With Rest Of Stock Market Despite RBC Raising Price Target On Stock From $150 To $175 In Mid-Day Note ||| Citron's Andrew Left, When Asked If He would Be A Buyer Of NVIDIA Shares At $130, Responds 'I'd Like To See The Next Quarter First...' ||| Andrew Left Currently On CNBC Discussing NVIDIA: Says Feels 'Market Overreacting A Bit,' Referring To Recent Upside In Stock ||| Why Bank Of America Says You Should Stay Bullish On Semi Stocks ||| Citron's Andrew Left: Move Your Money From Nvidia To Google ||| Scott Wapner Tweets: JUST IN: Citron's Andrew Left just threw shade on $NVDA (again). He'll join @HalftimeReport for a debate on the stock. Big pushback coming ||| Citron Research Issues Report 'NVIDIA To Trade Back To $130' On Website ||| Why Nvidia's Strategy Hints At A 'Fast-Rising' Stock Price ||| 20 Stocks Moving In Friday's Pre-Market Session",1,0.46580982
2017-06-12,169753200.0,36.470001220703125,37.92499923706055,35.52750015258789,37.49250030517578,37.03939437866211,NVDA,"Here's Why Apple (AAPL) Stock Is Falling Again Today ||| Tech Sector Set To Lead Stocks Lower Again ||| Intel, And Other Winners From Seasonal Strength In iPhones And Internet Of Things ||| Benzinga's Bulls And Bears For The Past Week: Apple, Best Buy, Tesla And More",1,0.4925625
2017-06-13,167250400.0,38.59999847412109,38.692501068115234,36.41249847412109,37.84999847412109,37.392578125,NVDA,"Despite A Hard Loss, Nvidia Is Still Winning ||| NVIDIA Shares Up 2.4% Premarket Despite No News; After Falling 10% On Friday Amid Tech Weakness And A Short Call From Citron's Andrew Left, Shares Rebounded Off $143 Level Monday ||| NVIDIA Partners with Activision and Bungie to Bring 'Destiny 2' to PC",1,0.54179764
2017-06-14,118464000.0,37.880001068115234,38.51499938964844,37.125,37.93000030517578,37.47161102294922,NVDA,"Is Nvidia Really A Casino Stock? ||| Goldman Lifts Earnings Estimates For Nvidia Due To Nintendo Switch Demand ||| Intel (INTC) Unveils Games & Announces Partnerships at E3 ||| Intel (INTC) Unveils Games & Announces Partnerships at E3 ||| 7 Biggest Price Target Changes For Wednesday ||| Your Guide To Trading The Autonomous Vehicle Theme ||| Loup Ventures' Gene Munster, In Benzinga Interview, Says He Likes Nvidia Among Chip-makers; Munster says 'I think it is going to be difficult to displace them,' Compares Co. To Intel In 1985 ||| Analyst Calls Out Nvidia's 'Astronomical' Valuation, Sees 42% Downside ||| Why Is NVIDIA (NVDA) Up 22.9% Since the Last Earnings Report?",1,0.50865096
2017-06-15,96382400.0,36.7400016784668,38.400001525878906,36.625,38.09249877929688,37.63214874267578,NVDA,Bull of the Day: Radiant Logistics (RLGT),0,0.51485217
2017-06-16,92496000.0,38.18999862670898,38.67499923706055,37.560001373291016,37.90499877929688,37.44690704345703,NVDA,"China-Focused Fund Manager Fang Zheng Makes Big Moves in Tesla; Nvidia; Alibaba ||| Raymond James Reinstates Outperform on NVIDIA, Announces $175.00 ||| Boeing, Mattel, Monsanto, Nvidia: Fast Money Picks For June 16",1,0.46477234
2017-06-19,77817600.0,38.352500915527344,39.38249969482422,38.31499862670898,39.33000183105469,38.85468673706055,NVDA,Assessing An Active Momentum ETF,0,0.5557974
2017-06-20,109544400.0,39.75749969482422,40.435001373291016,39.22999954223633,39.272499084472656,38.79788589477539,NVDA,"One Of Nvidia's Biggest Bears Has Changed His Mind ||| Despite Sustainability Concerns, Analyst Getting Positive On Nvidia And AMD Fundamentals ||| Benzinga's Top Upgrades, Downgrades For June 20, 2017 ||| The Market In 5 Minutes ||| A Peek Into The Markets: U.S. Stock Futures Edge Higher Ahead Of Fed Speakers ||| Pacific Crest Upgrades NVIDIA to Sector Weight",1,0.50030655
2017-06-21,68265200.0,39.5525016784668,39.90499877929688,38.92499923706055,39.86750030517578,39.38569641113281,NVDA,"Credit Suisse Previews Blackberry's Q1 Earnings ||| Seeing Interest In Chip Stocks Earlier Wednesday: AMD Shares Indicated Up 5.6% Premarket, NVIDIA Up 0.4%, Intel Shares Down 1.4%, TI Unch ||| Non-Horrible Bosses: Meet The Best CEOs Of 2017",0,0.4723179
2017-06-22,46913200.0,39.95000076293945,40.084999084472656,39.34999847412109,39.59249877929688,39.11400985717773,NVDA,"Hello, Mr. Chips: A Look At AMD's Wild Year",0,0.528315
2017-06-23,108858800.0,39.66999816894531,39.83000183105469,38.30500030517578,38.45750045776367,37.99273681640625,NVDA,NVIDIA vs. Texas Instruments: Which Stock is Better Now?,0,0.49503344
2017-06-26,106396000.0,38.790000915527344,39.150001525878906,37.08250045776367,38.03749847412109,37.57779693603516,NVDA,"'Dr Doom': Even If The Dow Goes To 100,000, It Will 'End Very Badly' For Investors ||| A Momentum ETF Tries To Keep Its Edge ||| The Week In Chip Stocks: AMD, Intel And More",0,0.49660683
2017-06-27,99949200.0,37.86000061035156,37.9474983215332,36.587501525878906,36.64500045776367,36.20213317871094,NVDA,"CNBC Now Tweets: BREAKING: Nvidia to launch graphics cards specifically designed for digital currency mining cnbc.com/id/104554373 ||| Nvidia-Volkswagen Relationship Deepens As Deluge Of Autonomous Car News Continues ||| Weakness in NVIDIA Being Attributed To T.Rowe Comments ON CNBC Calling The Stock Too Expensive ||| Volvo, Autoliv Team up with NVIDIA on Developing AI for Self-driving Cars",1,0.50987804
2017-06-28,99494800.0,37.33000183105469,37.98500061035156,36.4375,37.9375,37.47902297973633,NVDA,"Chips And Cryptocurrencies: A Match Made In Tech Heaven? ||| Autoliv & Volvo Partner With NVIDIA for Self-Driving Cars ||| Toshiba's Chips Are Past Their Sell-By Date, And Investors Are Buying American ||| Semi Stocks Moving Higher Wed. Morning, Potentially Amid Several News Items: Toshiba Suit Of Western Digital, Toshiba Missing Deadline For Sale Of Chip Unit; Cypress Semi Shares Up 3.9%, AMD Up 1.9%, NVIDIA Up 1.8%, Micron Up 1.1%",0,0.5046456
2017-07-05,82018800.0,35.474998474121094,36.05500030517578,35.282501220703125,35.76250076293945,35.33030700683594,NVDA,"How Have The Best And Worst Stocks Of 2016 Performed In 2017? ||| Baidu Is Partnering With Nvidia To 'Accelerate' Artificial Intelligence ||| NVIDIA, Baidu Report Partnership to Accelerate AI; Collaboration to Power AI in Cloud Data Centers, Self-Driving Cars and the Home ||| Baidu Announces Alliance with 50+ Partners, Including NVIDIA, Microsoft Cloud, to Accelerate the Adoption of Autonomous Driving",1,0.505901
2017-07-06,74628400.0,35.467498779296875,36.345001220703125,34.939998626708984,35.869998931884766,35.436500549316406,NVDA,AMD Has A Golden Opportunity To Gain CPU Share From Intel ||| Nvidia Shares Remain Under-Owned,1,0.5180792
2017-07-07,65497200.0,36.44499969482422,36.875,36.212501525878906,36.68999862670898,36.24659729003906,NVDA,"Alphabet, Avis, Nvidia: Fast Money Picks For July 7 ||| Todd Gordon's Bullish Nvidia Trade",1,0.50217927
2017-07-10,95849200.0,37.435001373291016,38.5,37.16999816894531,38.42499923706055,37.96062469482422,NVDA,"Nvidia Could Make Nearly $2 Billion In 2 Years From Toyota Self-Driving Car Deal ||| Semiconductors Are Leading To Another Tectonic Shift In Computing: Which Players Will Be Beneficiaries? ||| Nvidia, Baidu And AI ||| Chip Stocks On the Move: AMD, Nvidia, Xilinx, Rambus And More ||| Jefferies Maintains Buy Rating on Nvidia; Raises PT To $180 from $140",1,0.5002442
2017-07-11,75795600.0,38.462501525878906,39.04750061035156,38.03749847412109,38.970001220703125,38.49903869628906,NVDA,Semiconductor Companies Expected To Fuel Growth In Tech Sector Earnings This Quarter ||| AMD's RX Vega Vs. Nvidia's GTX1080: The Great Rivalry Heats Up,1,0.5108503
2017-07-12,114520800.0,39.57500076293945,40.75,39.13999938964844,40.62749862670898,40.136512756347656,NVDA,"Nvidia Has A Massive Market Opportunity; SunTrust Upgrades To Buy ||| Benzinga's Top Upgrades, Downgrades For July 12, 2017 ||| The Market In 5 Minutes ||| Encouraging Signs For Semiconductor ETFs ||| A Peek Into The Markets: U.S. Stock Futures Gain; Yellen Testimony In Focus ||| Jim Cramer Shares His Thoughts On Nvidia, Sirius XM, Chevron And TransUnion ||| SunTrust Robinson Humphrey Upgrades NVIDIA to Buy",0,0.522438
2017-07-13,136913200.0,40.75,41.57500076293945,39.6875,40.157501220703125,39.67218780517578,NVDA,Recapping The Semicon West Trade Show: Winners And Losers ||| Nvidia Higher For Seventh Day In A Row ||| Fast Money Traders Share Their Chip Picks,1,0.50142276
2017-07-17,93079200.0,41.58250045776367,41.875,40.4375,41.0625,40.566253662109375,NVDA,"Benzinga's Option Alert Recap From July 17 ||| The Most Bought And Sold Stocks Of The First Half Of 2017, According To TD Ameritrade Clients ||| NVIDIA Shares Down ~$1.10 Over Last Min. As Traders Circulating Concerning Report From 'Guru Of 3D' ||| Nvidia Option Alert: Fri $177.5 Calls Sweep (53) at the Bid: 1522 @ $0.538 vs 894 OI; Ref=$166.455",1,0.4985774
2017-07-18,77664000.0,40.44499969482422,41.63750076293945,40.32500076293945,41.4900016784668,40.98859024047852,NVDA,AMD Shares Volatile But Largely Unaffected As Traders Circulating Fudzilla Article Speculating 'The mid-range graphics card shortage...is probably at its end...'; BZ NOTE: Article Does Not Appear To Include Any New Information ||| Watch These 5 Huge Call Purchases In Tuesday Trade,0,0.4936173
2017-07-19,68704400.0,41.58250045776367,41.84999847412109,41.15250015258789,41.275001525878906,40.77618789672852,NVDA,"Analyst: Nvidia, Western Digital Only Buys In Semi Space Given Current Industry Dynamics",1,0.5175275
2017-07-20,69959600.0,41.48249816894531,41.87749862670898,40.977500915527344,41.875,41.368934631347656,NVDA,Maxim Integrated Stock Reports Earnings Tonight: 50 Percent 12 Month Upside,1,0.536422
2017-07-24,65252400.0,42.09749984741211,42.19499969482422,41.43000030517578,41.53749847412109,41.03550720214844,NVDA,"Cramer's Plea To New Investors: Don't Just Listen To Me, Do Your Homework",0,0.5084989
2017-07-25,49655600.0,41.30500030517578,41.48249816894531,40.89500045776367,41.337501525878906,40.837928771972656,NVDA,AMD Earnings Preview: A Look At What Might Be Expected For The Chipmakers' Q2 Results,1,0.51846546
2017-07-27,78285600.0,42.067501068115234,42.185001373291016,39.38999938964844,40.435001373291016,39.94633483886719,NVDA,Buckle Up: US House Panel Votes To Hasten Self-Driving Car Deployment ||| Reuters Tech News Tweets: JUST IN: House panel votes 54-0 to approve legislation to speed deployment of self-driving cars,1,0.52570164
2017-07-28,51334800.0,40.0724983215332,41.345001220703125,39.81999969482422,41.09749984741211,40.600833892822266,NVDA,Benzinga's Option Alert Recap From July 28 ||| Nvidia Option Alert: Jun 15 $135 Puts at the Bid: 600 @ $12.651 vs 12 OI; Ref=$163.1305,0,0.4819776
2017-07-31,55967200.0,41.23500061035156,41.59999847412109,40.15499877929688,40.62749862670898,40.136512756347656,NVDA,NVIDIA Shares Down 1% After Hours As Traders Circulate After-Hours Publication Of Seeking Alpha Article 'Nvidia: A Short Watch Is On' ||| GeForce Countered: AMD Launches RX Vega Gaming GPU ||| Watch These 3 Huge Put Purchases In Monday Trade,1,0.50118697
2017-08-03,44242000.0,41.09249877929688,41.657501220703125,40.91999816894531,41.619998931884766,41.11701583862305,NVDA,Are The Semiconductor Stocks Topping?,1,0.5122075
2017-08-07,71741200.0,42.09749984741211,43.09249877929688,42.0,43.087501525878906,42.566776275634766,NVDA,These Were The Most Bought And Sold Stocks In July ||| TD Ameritrade Investor Movement Index: Bullish Retail Investors Push IMX Above 7.0 For First Time ||| Last Week In The S&P 500: Russell Weakness Bleeds Into The High Caps,0,0.5038007
2017-08-08,75533600.0,43.47249984741211,43.63999938964844,42.1775016784668,42.57500076293945,42.06047058105469,NVDA,"Concern About AMD's Dependence On Crypto Data Mining? ||| Q2 Earnings: What's In Store For Nvidia Investors? ||| Nvidia Option Alert: Mar 16 $150 Puts at the Bid: 1000 @ $12.401 vs 129 OI; Ref=$170.6725 ||| Nvidia, Marriott, Verisign, Brazil: Fast Money Picks For August 8",1,0.4862963
2017-08-09,53078400.0,42.10749816894531,43.0525016784668,41.91749954223633,43.02750015258789,42.50749588012695,NVDA,Nvidia Reports Q2 Earnings On Thursday After Market Close ||| Watch These 7 Huge Put Purchases In Wednesday Trade ||| Nvidia Takes 3% Stake in China Self-driving Startup Tusimple,0,0.5107553
2017-08-10,132808800.0,43.040000915527344,43.165000915527344,41.08250045776367,41.185001373291016,40.687278747558594,NVDA,"Nvidia Posts Big Q2 Earnings Beat ||| Nvidia Sees Q3 Sales $2.35B vs $2.13B Est. ||| NVIDIA Reports Q2 EPS $1.01 vs $0.70 Est., Sales $2.23B vs $1.96B Est. ||| Andrew Left Shorts Nvidia Ahead Of Earnings Release ||| NVIDIA Shares Down Nearly $1 Over Last Few Mins. On Heavy Volume, Citron Research's Andrew Left Says He Shorted Stock Into This Afternoon's Earnings Report ||| How To Play Nvidia ||| Analysts Sentiment On Nvidia Ahead Of Q2 Earnings ||| An Easy-To-Use Cheat Sheet For Apple Suppliers ||| A Peek Into The Markets: U.S. Stock Futures Drop Ahead Of Macy's, Kohl's Earnings ||| 10 Stocks To Watch For August 10, 2017 ||| Earnings Scheduled For August 10, 2017",0,0.49363062
2017-08-11,149719600.0,39.28499984741211,39.75,38.227500915527344,38.9900016784668,38.51880645751953,NVDA,"18 Biggest Mid-Day Losers For Friday ||| Looking Beyond The Shiny Surface Of Nvidia's Big Q2 Beat ||| Cryptocurrency Mining Drives Nvidia's Q2 Outperformance; Is This An Entry? ||| 5 Biggest Price Target Changes For Friday ||| With Nvidia Down 13% This Week, Jefferies Says 'Buy On Weakness' ||| The Market In 5 Minutes ||| 22 Stocks Moving In Friday's Pre-Market Session ||| A Peek Into The Markets: U.S. Stock Futures Decline Ahead Of Consumer Price Report ||| 7 Stocks To Watch For August 11, 2017",1,0.5234713
2017-08-14,127902000.0,39.91749954223633,42.13750076293945,39.79999923706055,42.09999847412109,41.59120178222656,NVDA,"AMD Unveils New Radeon RX Vega GPUs ||| Traders Have Been All Over These Tech ETFs ||| This Is The Nvidia Pullback You've Been Waiting For ||| Analyst: Nvidia's Sell-Off Was Overdone, Time To Establish Or Add To A Position ||| 5 Biggest Price Target Changes For Monday",0,0.49081713
2017-08-15,76453200.0,42.15250015258789,42.41749954223633,41.397499084472656,41.744998931884766,41.24050521850586,NVDA,"Loop Capital 'Loop Around The Valley' Semiconductor Bus Tour Begins Today ||| Bank Of America, Citigroup, Micron, Nvidia: Fast Money Picks For August 15",0,0.46653724
2017-08-16,59663200.0,41.897499084472656,42.1349983215332,40.959999084472656,41.28749847412109,40.78852844238281,NVDA,"For AMD Ryzen Chips, Will Gains In Mindshare Lead To Market Share? ||| Loop Capital 'Loop Around The Valley' Semiconductor Bus Tour Concludes Today",0,0.5093474
2017-08-17,52544400.0,41.20249938964844,41.375,40.345001220703125,40.36750030517578,39.8796501159668,NVDA,"Chowdhry: Betting Against Nvidia Is 'Insane' And Stupid ||| Nvidia Now 3rd Largest IC Design Company, Behind Broadcom, Qualcomm -DigiTimes",1,0.5043247
2017-08-21,62367200.0,40.622501373291016,40.73749923706055,39.34249877929688,39.78749847412109,39.3066635131836,NVDA,"Cramer Finds A Way To Explain Stock Diversification With Fantasy Football ||| Nvidia, Intel Among Analyst Top Picks Following Semiconductor Conference ||| Cryptocurrency Mining: What It Is, How It Works And Who's Making Money Off It",1,0.49553043
2017-08-24,46970000.0,41.775001525878906,41.81999969482422,41.02999877929688,41.29750061035156,40.83433151245117,NVDA,"Autonomous Car, Smart Home Opportunities Keep This Analyst Bullish On Nvidia",0,0.49452814
2017-08-29,32409600.0,40.647499084472656,41.39500045776367,40.56499862670898,41.17499923706055,40.71319961547852,NVDA,NVIDIA Shares Quiet As Global Equities Trip Chowdhry Says They See Walmart Going 'Full Steam' With Deep Neural Networks And Will Be Creating Its Own NVDA GPU Clusters On Walmart Cloud OneOps ||| Credit Suisse Is 'Most Positive' On Micron Following Semiconductor Conference,1,0.5075022
2017-08-30,38440000.0,41.375,41.532501220703125,41.067501068115234,41.41999816894531,40.95545196533203,NVDA,There's A Late Summer Souring On Semiconductor ETFs,1,0.52944905
2017-08-31,61268400.0,41.625,42.400001525878906,41.54999923706055,42.36000061035156,41.88491821289063,NVDA,Benzinga's Option Alert Recap From August 31 ||| Steel Is For Real ||| Nvidia Option Alert: Nov 17 $145 Puts at the Ask: 1200 @ $3.65 vs 1188 OI; Ref=$168.69,1,0.48902765
2017-09-06,39767200.0,41.810001373291016,41.95000076293945,41.09999847412109,41.45249938964844,40.98759078979492,NVDA,Here's What Investors Were Buying And Selling In August ||| Nvidia Leader in AI Chip Market -DigiTimes,1,0.4957618
2017-09-11,56744400.0,41.3849983215332,42.35749816894531,41.33000183105469,42.25,41.77614212036133,NVDA,AMD And Nvidia: How Vulnerable Are They To Cryptocurrency Concerns?,1,0.49308386
2017-09-12,41148800.0,42.5,42.5,41.74250030517578,42.40250015258789,41.92692947387695,NVDA,"Intel, NVIDIA, AMD Shares Unaffected Following News Out Of Apple Product Unveil Event The New iPhone 8 Will Have, For The First Time, An Apple-Designed Graphic Processing Unit",1,0.50600874
2017-09-13,58096000.0,42.147499084472656,42.8849983215332,41.81999969482422,42.59249877929688,42.11480712890625,NVDA,Benzinga's Option Alert Recap From September 13 ||| Nvidia Option Alert: Mar 16 $130 Calls at the Ask: 10000 @ $45.951 vs 8 OI; Ref=$170.7783 ||| All The Stocks That Moved During Apple's Product Unveil Event,0,0.48695174
2017-09-14,51371200.0,42.1974983215332,43.13999938964844,41.95000076293945,42.34999847412109,41.87501907348633,NVDA,Watch These 8 Huge Call Purchases In Thursday Trade,1,0.5300376
2017-09-15,136479200.0,43.21500015258789,45.02750015258789,43.16249847412109,45.02750015258789,44.52250671386719,NVDA,All The Nvidia Launches Thus Far This Year ||| Benzinga's Option Alert Recap From September 15 ||| Mid-Afternoon Market Update: Dow Rises Over 50 Points; T2 Biosystems Shares Plummet ||| Mid-Day Market Update: Mirati Therapeutics Climbs Following Positive Sitravatinib Data; First Internet Bancorp Shares Slide ||| Nvidia Option Alert: Sep 29 $172.5 Puts at the Bid: 600 @ $2.0 vs 48 OI; Ref=$179.32 ||| 5 Biggest Price Target Changes For Friday ||| Nvidia Is 'Building The Industry Standard' For AI; Analyst Lifts Price Target To $250,1,0.5215111
2017-09-18,168446000.0,46.28499984741211,47.79999923706055,46.21500015258789,46.88750076293945,46.36164093017578,NVDA,"Vetr Crowd Downgrades Nvidia ||| Benzinga's Option Alert Recap From September 18 ||| Any Nice Chart Needs A Catalyst; Nvidia Has One ||| Nvidia Option Alert: Mar 16 $240 Calls at the Ask: 500 @ $7.1 vs 274 OI; Ref=$189. ||| Citron's Andrew Left, On CNBC, Says He's Not Currently Short NVIDIA ||| Nvidia Option Alert: Jan 19 $185 Puts Above Ask!: 500 @ $15.901 vs 101 OI; Ref=$187.8033 ||| All The Reasons Bank Of America Just Bumped Its Nvidia Price Target To $210 ||| 5 Biggest Price Target Changes For Monday ||| Watch These 4 Huge Put Purchases In Monday Trade",0,0.5082299
2017-09-19,87428000.0,46.37749862670898,47.462501525878906,46.15499877929688,46.837501525878906,46.31220245361328,NVDA,"AMD, Marvell Gain Semiconductor Share In Q3 ||| Fast Money Traders Share Their Picks In The Chip Space",0,0.51360846
2017-09-20,72492000.0,46.875,47.35499954223633,46.0525016784668,46.459999084472656,45.93893432617188,NVDA,"AMD Might Be Working With Tesla On An AI Chip ||| Benzinga's Option Alert Recap From September 20 ||| NVIDIA Shares Respond Lower, Down ~$1.20, Over Last Min. Following CNBC Report Tesla Working With AMD For Developing Of Its Own AI Chip For Self-Driving Cars ||| Nvidia Option Alert: Sep 29 $182.5 Puts Sweep (25) at the Ask: 549 @ $2.07 vs 513 OI; Ref=$186.461 ||| Analyst: Tesla's Self-Driving Technology Is 'Exaggerated'",0,0.51741946
2017-09-21,107560000.0,45.40999984741211,45.67499923706055,44.40250015258789,45.18999862670898,44.68317794799805,NVDA,"Mid-Day Market Update: Calgon Carbon Gains On Acquisition News; JAKKS Pacific Shares Drop ||| Tesla-AMD Partnership Likely A 'Modest' Negative For Nvidia, But Its Competitive Moat Still Substantial ||| What A Possible AMD-Tesla Deal Means For Nvidia ||| RBC Analyst Comments On Implications For NVIDIA From Possible AMD/Tesla Deal: Deal 'will unlikely result in a single source dynamic (where Tesla only works with AMD)'",0,0.5020439
2017-09-22,49123200.0,45.07500076293945,45.57749938964844,44.650001525878906,44.75,44.24810409545898,NVDA,AMD Sells Off As Tesla Rumor Cools Down; Analyst Calls Partnership 'Completely False',0,0.520318
2017-09-25,87458000.0,44.4375,44.45000076293945,42.540000915527344,42.75,42.27054214477539,NVDA,"When Bull Markets Die: What To Watch For, What Stocks Could Be The First To Get Hit ||| Nibbling At A Semiconductor ETF",1,0.4792168
2017-09-26,112562000.0,44.11249923706055,44.66999816894531,42.587501525878906,42.9900016784668,42.507843017578125,NVDA,"Tesla Spokesperson Tells Benzinga, 'Tesla's policy is to always decline to comment on speculation' Following Report Co. Shifting From NVIDIA To Intel For Infotainment Needs ||| Intel Shares Spiking Higher Amid Report Tesla Is Shifting From NVIDIA To Intel Related To Infotainment ||| Chinese OEMs Will Use Nvidia's HGX Reference Architecture For Data Centers ||| NVIDIA Shares Higher Following Announcement that Chinese OEMs Will Use NVIDIA HGX Reference Architecture for Data Centers",1,0.5109973
2017-09-27,71372000.0,43.90499877929688,44.067501068115234,43.1875,43.932498931884766,43.43977737426758,NVDA,Morgan Stanley Calls For 150% Upside In Ambarella,0,0.52041054
2017-09-28,43524400.0,44.005001068115234,44.04499816894531,43.43999862670898,43.91999816894531,43.42741775512695,NVDA,"AMD Vs. Cypress Vs. Cavium: Which Semi Has Biggest Potential Upside ||| A.I. Summit in San Francisco Concludes Today, Attendees Include Morgan Stanley, Johnson & Johnson, Bank of America, IBM, Nvidia, Microsoft, Amazon and Footlocker",1,0.49280837
2017-09-29,61909200.0,44.77000045776367,44.932498931884766,44.3125,44.692501068115234,44.19126129150391,NVDA,5 Biggest Price Target Changes For Friday,1,0.54672325
2017-10-02,50348000.0,45.20000076293945,45.494998931884766,44.25,44.75,44.24810409545898,NVDA,"5 Biggest Price Target Changes For Monday ||| Tech Tempts, But Valuations Look High",1,0.5303569
2017-10-03,39033200.0,44.8125,45.14500045776367,44.39500045776367,44.84249877929688,44.33956909179688,NVDA,"AMD, Nvidia Among Bank Of America's 9 Top Picks In A Q3 Strong For Semis",1,0.49858218
2017-10-05,43736400.0,45.46500015258789,45.5,44.88999938964844,45.192501068115234,44.685638427734375,NVDA,"Benzinga's Option Alert Recap From October 5 ||| Tech Stock Roundup: MSFT, NVDA, TSLA, INTC and More ||| 14% Upside Seen For Nvidia Shares On PC Gaming, Bitcoin Mining Strength ||| Nvidia Option Alert: Jun 15 $180 Puts at the Bid: 900 @ $22.851 vs 882 OI; Ref=$180.67 ||| Expect Nvidia, AMD To Ride Cryptocurrency Wave Into 2018",1,0.50889325
2017-10-09,56349200.0,45.6974983215332,46.682498931884766,45.50749969482422,46.34749984741211,45.82769012451172,NVDA,"Report: AMD Navi GPU Could Arrive By Next Year ||| Analysts More Positive On Nvidia, AMD Following Processor Conference ||| Are Options Traders Betting On A Big Move in NVIDIA?",1,0.507365
2017-10-10,97487600.0,47.85749816894531,48.23749923706055,46.81499862670898,47.23249816894531,46.702762603759766,NVDA,"Robotics Analyst: Nvidia's AI Developments Don't Change The Self-Driving Car Timeline ||| Loup Venture's Austin Bohlig Tells Benzinga While Nvidia Has Slight Advantange In GPU space, 'AMD has made great progress...much more competitive today' ||| Loup Ventures' Austin Bohlig Responds To Nvidia-DHL News, Tells Benzinga 'similar announcements made with strategics' Will Be Catalysts For NVDA, AMD Shares In Coming Years ||| 4 Semiconductor Stocks Fund Managers Are Buying Most ||| What AI And Autonomous Driving Mean For Nvidia Investors ||| The Market In 5 Minutes: Nvidia's Drive, Russia And Cryptos, And Carbon Emission Limits ||| American Airlines, Cypress Semi, Macy's, Nvidia: Fast Money Picks For October 10 ||| NVIDIA Issues Release Highlighting Deutsche Post DHL Group Has Selected Co.'s DRIVE PX For Autonomous Delivery Truck Fleet ||| NVIDIA Unveils World's First AI Computer Aimed At Making Robotaxis A Reality",1,0.5058288
2017-10-11,52950800.0,47.400001525878906,47.75,46.935001373291016,47.73500061035156,47.19963073730469,NVDA,"The Current Bull And Bear Case For Nvidia ||| The Market In 5 Minutes: Alibaba's Expansion, Uber's Warning",1,0.49796048
2017-10-12,52829200.0,47.77000045776367,48.272499084472656,47.48249816894531,47.75749969482422,47.22188568115234,NVDA,"Nvidia Shares Make New 52-Week High $192.96 ||| Nvidia Expands Lead In AI-Driven Vehicle Suppliers With New Products, New Partnerships ||| RBC Raises Price Target From $205 To $220, Says They Are Confident In Re-Acceleration In Data Center Spending, Sees Cont. Potential For EPS Upside Driven By DC and Gaming Both Near-Term And Long-Term ||| An ETF Levered To The Cryptocurrency Trade",1,0.5322491
2017-10-16,57664000.0,48.95000076293945,49.51250076293945,48.310001373291016,49.48249816894531,48.927528381347656,NVDA,Nvidia Seeing Strong Trends Heading Into Next Quarterly Print,0,0.5215361
2017-10-18,56731600.0,49.52750015258789,49.53499984741211,48.33000183105469,49.39500045776367,48.841007232666016,NVDA,Benzinga's Option Alert Recap From October 18 ||| Sizing Up Semiconductor ETFs For 2018 ||| Consumer Reports Withholds Recommendation From Microsoft's Surface Book 2 ||| Nvidia Option Alert: Nov 3 $177.5 Puts Sweep (33) at the Ask: 759 @ $0.73 vs 625 OI; Ref=$194.63,1,0.5075429
2017-10-19,57077200.0,48.61000061035156,49.5,48.11249923706055,49.45000076293945,48.89540481567383,NVDA,Benzinga's Option Alert Recap From October 19 ||| Nvidia Option Alert: Oct 27 $207.5 Calls Sweep (48) at the Bid: 1274 @ $0.443 vs 535 OI; Ref=$193.45,0,0.4780082
2017-10-20,45162000.0,49.622501373291016,49.897499084472656,49.1349983215332,49.22499847412109,48.67292404174805,NVDA,"Fast Money Traders Share Their Picks: Cisco, Nvidia And More",0,0.49981305
2017-10-23,42869600.0,49.44499969482422,49.712501525878906,48.95000076293945,49.15499877929688,48.60370635986328,NVDA,"A Benzinga HQ Exclusive: Ask Gene Munster Anything! ||| AMD, Microchip Tech Among Q3 Semiconductor Favorites At Jefferies ||| Why This Analyst Boosted His Price Target 28% On 'Franchise Pick' Nvidia ||| This AMD Bear Is No Less Bearish Ahead Of Q3 Earnings ||| 5 Biggest Price Target Changes For Monday",1,0.49804062
2017-10-24,40724400.0,49.247501373291016,49.6875,48.98500061035156,49.66999816894531,49.11293029785156,NVDA,"Robotics, AI Fund Thinks It's Found The 'New FAANG'",0,0.5048415
2017-10-25,82816000.0,49.27000045776367,49.80500030517578,47.79249954223633,48.415000915527344,47.87200927734375,NVDA,"SoftBank's Son Aims To Control 90% Of The Chip Market ||| NVIDIA Shares Down 2% Over Last Few Moments, Not Seeing Any News To Justify Price Action ||| Stifel: AMD's Q3 Wasn't As Bad As It Seems, But Not As Good As Hoped",1,0.49661237
2017-10-26,32274400.0,48.69499969482422,49.040000915527344,48.45249938964844,48.92250061035156,48.373817443847656,NVDA,"NVIDIA To Report Q3 Earnings On Thurs., Nov. 9 After Market Close ||| Tech Expert Sean Udall Predicts No Major Earnings Misses, Q4 Rotation ||| Nikkei Asian Review Reports NVIDIA CEO Huang Sees Fully Driverless Cars By 2021, But 'Has No Appetite For AI CHips For Mobile and Connected Devices' ||| The Market In 5 Minutes: Twitter Beats Estimates, WSJ Goes After Morningstar's Rating System ||| NVIDIA Announces Collaboration with Taiwan's Ministry of Science and Technology to Accelerate Taiwan AI Development",1,0.4876246
2017-10-27,57219200.0,49.45000076293945,50.46749877929688,49.1875,50.46500015258789,49.89901351928711,NVDA,"Apple, Nvidia, Western Digital: Fast Money Halftime Report Final Trades ||| Cramer Says The AMD Party Is Over, Calls Out Twitter Trolls",1,0.50932413
2017-10-30,50405600.0,50.46500015258789,51.522499084472656,50.30500030517578,50.959999084472656,50.388465881347656,NVDA,"Najarian Brothers See Unusual Options Activity In Melco, Pfizer, Nvidia and Abbvie",1,0.4975638
2017-10-31,41190800.0,51.282501220703125,51.97249984741211,51.22499847412109,51.70249938964844,51.12264251708984,NVDA,Apple-Qualcomm News Shakes These 7 Stocks,1,0.4823572
2017-11-06,38994400.0,51.79999923706055,52.494998931884766,51.67499923706055,52.407501220703125,51.81972503662109,NVDA,"The Week Ahead: Earnings Season Continues, Several IPOs, Notable Conferences On The Docket ||| An Intel Core Processor With Custom AMD Graphics Is Coming",1,0.50733155
2017-11-07,42770000.0,52.63750076293945,53.22499847412109,52.51499938964844,53.00749969482422,52.41300964355469,NVDA,No One Compares To Intel In Global Semiconductor Market Share ||| What's Powering This Robotics ETF ||| Does The AMD-Intel Chip Deal Really Matter For Nvidia?,0,0.50661254
2017-11-08,52298800.0,52.962501525878906,53.0,51.810001373291016,52.290000915527344,51.70354843139648,NVDA,"Expectations Mount For Nvidia; Analyst Raises Target To $190 Ahead Of Earnings ||| Nvidia Q3 Earnings Preview: A Tale Of Outstanding Fundamentals, Pricey Stock ||| Hearing Stifel Earlier Highlighted Negative Implications For NVIDIA Related To AMD Deal With Intel, AMD GPU Head Joining Intel; Said Intel Is Building A GPU, Parallel Processor To Compete Against NVIDIA ||| Deutsche Bank Maintains Hold on NVIDIA, Raises Price Target to $190.00",0,0.49117485
2017-11-09,97856400.0,51.317501068115234,51.58250045776367,50.09249877929688,51.33000183105469,50.75431442260742,NVDA,"From NVIDIA Q3 Earnings Conference Call: Pres, CEO Jen-Hsun Huang Says Over Longer-Term Crypto Is Small For Co., 'But Not 0.' Mgmt. Believes Crypto Will Be Around For Sometime, At Level 'Kind Of Like [Crypto Is] Today ||| 10 Stocks Moving In Thursday's After-Hours Session ||| Nvidia Raises Dividend From $0.14 To $0.15 ||| Nvidia Reports Big Q3 Earnings Beat, Record Sales ||| NVIDIA Sees Q4 Sales $2.65B +/- 2% vs $2.43B Est., Adj. Gross Margins ~60% +/- 50 Bps ||| NVIDIA Reports Q3 Adj. EPS $1.33 vs $0.94 Est., Sales $2.64B vs $2.36B Est. ||| Sizing Up The Sizzle In Semiconductor ETFs ||| Nvidia Lower Heading Into Q3 Report ||| Why Cryptocurrency Investors Should Pay Attention To Nvidia's Earnings ||| The Market In 5 Minutes: Adidas, Jobless Claims, And More ||| Here's What's Coming Up On PreMarket Prep For November 9 ||| A Peek Into The Markets: U.S. Stock Futures Down Ahead Of Earnings ||| 13 Stocks To Watch For November 9, 2017 ||| Earnings Scheduled For November 9, 2017",1,0.4677893
2017-11-10,125325600.0,53.27000045776367,54.66749954223633,52.907501220703125,54.03499984741211,53.428977966308594,NVDA,"What Wall Street Thinks Of Nvidia's Huge Quarter ||| 35 Stocks Moving In Friday's Mid-Day Session ||| Tap Nvidia's Growth Story With These Tech ETFs ||| Barclays Maintains Equal-Weight on NVIDIA, Raises Price Target to $225.00 ||| Nvidia's Q3 Success Dampens Fear Of Gaming Growth Slowdown ||| Bank of America Maintains Buy on NVIDIA, Raises Price Target to $251.00 ||| Game On: Intel Is Targeting Nvidia And AMD's Market Share ||| Nvidia Bears Still Exist: Wells Fargo Keeps Stock Rated Underperform ||| 5 Biggest Price Target Changes For Friday ||| BMO Capital Maintains Underperform on NVIDIA, Raises Price Target to $135.00 ||| 6 Technical Levels Discussed During Friday's PreMarket Prep ||| Nvidia Is 'En Fuego,' Analyst Lifts Target Price To $225 ||| Benzinga's Top Upgrades, Downgrades For November 10, 2017 ||| The Market In 5 Minutes: Nvidia, Roku, Star Wars, And More ||| Loop Capital Maintains Buy on NVIDIA, Raises Price Target to $235.00 ||| Morgan Stanley Maintains Equal-Weight on NVIDIA, Raises Price Target to $222.00 ||| 31 Stocks Moving In Friday's Pre-Market Session ||| Here's What's Coming Up On PreMarket Prep For November 10 ||| Nomura Upgrades NVIDIA to Neutral ||| A Peek Into The Markets: U.S. Stock Futures Decline Ahead Of J C Penney Earnings ||| 7 Stocks To Watch For November 10, 2017",0,0.48596713
2017-11-13,58237600.0,54.03499984741211,54.29249954223633,53.00249862670898,53.157501220703125,52.561317443847656,NVDA,"Retail Investors Keep Buying This Market ||| AMD Has More To Lose Than Nvidia Should Bitcoin Mining Hardware Sales Decline ||| Long-Time Nvidia Bear Upgrades Stock, Lifts Target To $200 ||| 5 Biggest Price Target Changes For Monday ||| Benzinga's Top Upgrades, Downgrades For November 13, 2017 ||| BMO Capital Upgrades NVIDIA to Market Perform ||| 44 Biggest Movers From Friday",1,0.5021128
2017-11-14,52929200.0,53.25,53.70000076293945,52.807498931884766,53.54499816894531,52.944461822509766,NVDA,"Nvidia Impresses At 2017 Supercomputing Conference, KeyBanc Says",0,0.52039015
2017-11-16,44176800.0,53.244998931884766,53.54999923706055,52.8125,52.90250015258789,52.309181213378906,NVDA,Todd Gordon's Nvidia Options Trade ||| Intercontinental Exchange Reports Launch Of NYSE FANG+ Index Futures Contract,0,0.5078214
2017-11-17,51566400.0,53.47999954223633,53.837501525878906,52.6875,52.84000015258789,52.24738311767578,NVDA,"There Could Be 18% Upside Left In Nvidia, Analyst Says ||| 8 Biggest Price Target Changes For Friday ||| Canaccord Genuity Maintains Buy on NVIDIA, Raises Price Target to $250.00",1,0.48203298
2017-11-21,39917600.0,53.92250061035156,54.130001068115234,53.59999847412109,54.01250076293945,53.4067268371582,NVDA,"For Nvidia, Gaming Trends Could Make 2018 Another Standout Year",0,0.53954184
2017-11-27,42289600.0,54.32749938964844,54.34000015258789,53.50249862670898,53.53499984741211,52.97136306762695,NVDA,Why Nvidia Will Play An 'Integral' Role In The Future Of Tech ||| Nuance Communications and NVIDIA to Partner to Advance Artificial Intelligence for Radiology ||| Watch GE and NVIDIA After the Companies Announced a Partnership to Accelerate Artificial Intelligence in Healthcare,0,0.5286911
2017-11-28,51275200.0,53.587501525878906,53.682498931884766,52.060001373291016,52.6775016784668,52.12288665771485,NVDA,"Nikkei Publishes 'Internet of things promises sustained chip market surge'; Not Seeing Any Chip Stocks Moving On Report ||| Analyst: Bitcoin Mining Will Mean Less For Semis In 2018, AMD Is More Exposed Than Nvidia ||| AMD Shares Down ~3.8% For Session Amid Comments From Mizuho Suggesting Cryptomining Will Be Less Meaningful For Co., NVIDIA In '18, John Peddie Research Highlighting AMD Is Losing Graphics Market Share Despite Vega",0,0.5201618
2017-11-29,139678800.0,52.50249862670898,52.52999877929688,47.807498931884766,49.10499954223633,48.588008880615234,NVDA,Traders See Signs Of Rotation Into Financials Amid Nasdaq's Worst Day In Months ||| NVIDIA Shares Not Reacting As Traders Circulate Rumor Softbank Purchased Stock,1,0.49047023
2017-11-30,82376800.0,49.79999923706055,50.66999816894531,49.16249847412109,50.1775016784668,49.649208068847656,NVDA,"Tech ETFs And Stocks Tumble: Time To Buy? ||| Nvidia Invests In Bay Area Artificial Intelligence Startup ||| NVIDIA, Wells Fargo Lead $40M Investment Round In A.I. Startup H20.ai, An Open-Source Deep Learning Platform For Predictive Maintenance, Security, Fraud, Auditing, Etc.",0,0.4957229
2017-12-01,81154800.0,49.82749938964844,50.032501220703125,48.11750030517578,49.41999816894531,48.89968490600586,NVDA,Seeing Notable Block Trade In NVIDIA Of 3.8M Shares At $197.65/Share,0,0.52551293
2017-12-04,124084400.0,50.01250076293945,50.07500076293945,46.125,46.665000915527344,46.17369079589844,NVDA,"Is It Time To Remove General Electric From The Dow 30? ||| Vetr Upgrades Nvidia ||| Seeing 2nd Notable Block Trade In NVIDIA In After Hours Session Of 3.3M Shares At $186.48/Share ||| Seeing Notable Block Trade In NVIDIA of 3.3M Shares At $186.66/Share ||| Back The Blockchain With This ETF ||| Semiconductor Stocks Are Under Heavy Selling Pressure ||| Seeing Continued Rotation/Profit-Taking In Year-to-Date Outperforming Semiconductor Stocks; AMD -5.36%, Nvidia -4.43%, Micron -3.36%, iShares Semi ETF SOXX -1.687%",1,0.5001886
2017-12-05,98148800.0,45.59999847412109,48.17499923706055,45.14500045776367,46.935001373291016,46.44084930419922,NVDA,"Rotation, Rotation, Rotation: Value Is The New Tech ||| VentureBeat Reports 'Nvidia launches Shield TV set-top box in China with remastered Nintendo titles' ||| Has Weakness In Semiconductor Stocks Made It Time To Buy? ||| Nvidia Shares Have Moved +4.1% Over Last 10 Minutes, Now Up 2.5% At $191.37",1,0.5062137
2017-12-07,54260000.0,47.9900016784668,48.400001525878906,47.52999877929688,47.997501373291016,47.49216842651367,NVDA,One Big Reason Why Tech Stocks Are Not In The 'Dot-Com Bubble',0,0.4845204
2017-12-08,46687600.0,48.50249862670898,48.69499969482422,47.78749847412109,47.872501373291016,47.36848068237305,NVDA,"UPDATE: Loup's Bohlig Tells Benzinga If Other OEMs Bring Development Of A.I. Chips For Autonomous In-House He Would Reconsider NVIDIA Thesis, But Most Will Likely 'Leave chip development to the experts.' ||| UPDATE: Loup Ventures' Bohlig Tells Benzinga Tesla Is Just One Potential Customer' For NVIDIA, Every Autonomous Car 'Will eventually need to integrate NVDA or similar competitor chips' ||| Loup Ventures' Austin Bohlig Tells Benzinga NVIDIA Likely Unhurt If Tesla Develops Its Own A.I. Chips, Says: 'Unless Tesla is going to be the only car sold in 10 years, I don't see this as a negative to the [NVIDIA] thesis.' ||| Tesla Developing Its Own AI Chip, Analyst Says Chipmakers Could Gain Manufacturing Contracts ||| UPDATE: Tigress' Feinseth Tells Benzinga He Believes Tesla Wants To Collaborate With NVIDIA or Skyworks Solutions, Says 'Tesla's not going to, in theory, buy a chip factory' ||| Tigress Financial's Ivan Feinseth Reacts To Report Tesla Designing Its Own A.I. Chip For Vehicles, Tells Benzinga He Believes If Tesla Is Designing Chip Will Likely 'Go to somebody like NVIDIA or Skyworks to work on actually making the chip.' ||| Tesla Shares Up Slightly Pre-Market Following Electrek Report Co. Working On Its Own A.I. Chip For Autonomous Vehicles, Potentially Impactful For Nvidia, Skyworks Solutions Among Others ||| NVIDIA Announces TITAN V, World's Most Powerful GPU for the PC",1,0.4911135
2017-12-11,37274800.0,48.01499938964844,48.69499969482422,47.85499954223633,48.665000915527344,48.15262985229492,NVDA,"How 3 College Students Turned $500K Into $2.6 Million In 4 Weeks ||| ICYMI: Digital Power Shares Sink On News, Unexpected Winners From A Tesla Report, And Will Bitcoin Go Boom Or Bust? ||| AI In Focus: 3 Pure-Play Stocks That Hold Promise",0,0.48921272
2017-12-12,45501600.0,48.22499847412109,48.459999084472656,47.47249984741211,47.709999084472656,47.20768356323242,NVDA,"Short Seller Claims 'If You Want Something Bitcoin-Related, Digital Power Isn't It' ||| What's Up With Nvidia? ||| UPDATE: Social Capital's Chamath Palihapitiya On CNBC Said NVIDIA Could Be A Short In Chip Space ||| Social Capital's Chamath Palihapitiya Currently On CNBC Discussing Chip Cos. Cautiously; Could Explain Move Lower In NVIDIA, AMD ||| UPDATE: NVIDIA Shares Down 1.2% In Pre-Market Trade; Not Yet Seeing Any News To Justify Move Lower ||| NVIDIA Shares Fall ~$3 In Pre-Market Action, Touch Low At $190.75",0,0.49154288
2017-12-13,55428000.0,48.125,48.13750076293945,46.470001220703125,46.54499816894531,46.0549430847168,NVDA,"NVIDIA Late Tuesday Announced Partnership With Japanese Construction Co. Komatsu ||| ICYMI: MoviePass' Unexpected New Partner, Venture Capitalist Makes A Pair Of Calls, Premarket Prep's Bitcoin Special",1,0.4974535
2017-12-15,67003600.0,47.0625,48.095001220703125,46.40499877929688,47.88999938964844,47.38578796386719,NVDA,"NVIDIA May Reportedly Offer Short-Term, Unsecured Commercial Paper Notes Of Up To $575M",1,0.4890696
2017-12-18,47770400.0,48.29999923706055,49.505001068115234,48.0,49.47499847412109,48.9541015625,NVDA,"Benzinga's Weekly Bulls & Bears: Bitcoin, Ford, Lululemon, Nike And More",0,0.51810706
2017-12-19,37310000.0,49.380001068115234,49.432498931884766,48.7400016784668,49.02750015258789,48.51130676269531,NVDA,"Watching Semi/Chip Stocks Following Micron Earnings Beat, Strong Q2 Guidance; Western Digital Shares Up 1%, Intel, AMD Up 0.5%, NVIDIA Up 0.4%",1,0.4980969
2017-12-21,30090400.0,49.23500061035156,49.48749923706055,48.88750076293945,48.97249984741211,48.45689392089844,NVDA,"Jim Cramer Advises His Viewers On Groupon, Buckle And More",0,0.5216026
2017-12-22,46627600.0,48.59999847412109,48.91249847412109,47.8125,48.817501068115234,48.30352783203125,NVDA,"12 Stocks Getting Crushed By Bitcoin's Rout ||| AMD Shares Down 4.5%, NVIDIA Shares Down Nearly 2%; Some Traders Attributing Weakness To Decline In Bitcoin/Other Cryptocurrencies",1,0.49672166
2017-12-26,35508000.0,48.25749969482422,49.4375,47.95500183105469,49.36000061035156,48.84031295776367,NVDA,"AMD, Fitbit Top List Of Robinhood Broker's 'Most Traded' Stocks Of The Year",0,0.49593863
2017-12-27,32948800.0,49.22499847412109,49.99250030517578,49.07749938964844,49.29249954223633,48.77352142333984,NVDA,"Melco Resorts, Nvidia, Tesla, SMH: 'Fast Money' Picks For December 27",1,0.474256
2017-12-28,24024800.0,49.532501220703125,49.845001220703125,49.28749847412109,49.34999847412109,48.83041763305664,NVDA,"Bitcoin, China, And AI Highlight Some Of The Year's Best ETFs ||| Chips On The Table: An Aggressive Semiconductor Idea ||| Stocks Which Moved Lower Last Time There Was Major Cryptocurrency News (Dec. 22), But Are Higher Pre-Market Thurs.: On Track Innovation Shares Up 2.5%, Seven Stars Cloud 1.4%, Social Reality 1%, AMD 0.5%, NVIDIA 0.3%",0,0.45587692
2018-01-02,35561600.0,48.94499969482422,49.875,48.625,49.837501525878906,49.31278991699219,NVDA,Our Most-Read Stories Of The Year ||| Taiwan Semiconductor Lands Short Lead-time HPC Chip Orders from China -DigiTimes,1,0.48713872
2018-01-03,91470400.0,51.025001525878906,53.42499923706055,50.9375,53.11750030517578,52.558250427246094,NVDA,"ICYMI: Intel's Issues Impact AMD, Nvidia A Favorite At BofA, Citron Calls Out Cannabis Company ||| Chip Stocks Volatile Hearing Amid Report Intel Offered Response To Report Of Security Research Findings ||| Nvidia, AMD Among Top Semis In 2018, According To Bank Of America ||| Intel's Potentially Major Security Flaw Boosting AMD, Other Chip Stocks",1,0.49512553
2018-01-04,58326800.0,53.93999862670898,54.51250076293945,53.17250061035156,53.397499084472656,52.83530807495117,NVDA,Analysts Weigh In On Intel's Security Issues ||| Cramer: AMD Needs To Take Advantage Of Intel's 'Messy' Security Issues,1,0.4972896
2018-01-05,58012400.0,53.54750061035156,54.227500915527344,52.77000045776367,53.84999847412109,53.28304672241211,NVDA,REMINDER: NVIDIA CEO To Present At CES Sunday Jan. 7th 11pm ET,1,0.510351
2018-01-08,88121600.0,55.09999847412109,56.25,54.64500045776367,55.5,54.91566848754883,NVDA,"Barron's Picks And Pans: FedEx, Intel, Caterpillar And More ||| New Year's Benzinga Bulls & Bears: Apple, Disney, Netflix And More ||| Foresight Autonomous Shares Up 18.96%; In Earlier 6-K Filing Presentation, Co. Reported Collaboration With Nvidia In Rail ||| The Market In 5 Minutes: Bitcoin ETFs, GoPro Downgrade, Nvidia Partners With Uber And Volkswagen ||| Nvidia To Partner With Volkswagen, Uber For Self-Driving Car Technology ||| NVIDIA Announces Big Format Gaming Displays at #CES2018 ||| NVIDIA, Aurora Announce Collaboration to Build Next-Generation Autonomous Vehicle Computer Platform at #CES2018 ||| Volkswagen, NVIDIA Announce Use of NVIDIA DRIVE IX with AI in Future Vehicle Lineup at #CES2018 ||| Uber Selects NVIDIA Technology for AI Computer System to Power Its Self-Driving Fleets; Announcement Made at CES#2018 ||| NVIDIA, ZF, Baidu Launch Industry's First AI Autonomous Vehicle Computer for China at#CES2018",0,0.5130045
2018-01-09,49700000.0,55.55500030517578,55.95500183105469,54.65999984741211,55.48500061035156,54.90082931518555,NVDA,"Investor Movement Index December Summary ||| Maxim Integrated Products Reports Collaboration With NVIDIA For Autonomous Driving, Safety Applications",1,0.5069365
2018-01-10,58266400.0,54.54999923706055,55.95500183105469,54.0,55.91999816894531,55.33124542236328,NVDA,Nvidia At CES: Oppenheimer's Major Takeaways,1,0.502075
2018-01-11,40603200.0,56.25,56.567501068115234,55.8025016784668,56.02000045776367,55.4301986694336,NVDA,"Auto Stock Roundup: Self-Driving Move Continues, Recalls Keep Hurting",0,0.51178783
2018-01-12,35991600.0,55.900001525878906,56.247501373291016,55.334999084472656,55.744998931884766,55.1580810546875,NVDA,"Here Are The 5 Most Bought And Sold Stocks Of TD Ameritrade Clients In 2017 ||| ICYMI: Snap Sinks, Bitcoin Trust Splits, Facebook's Facelift, Intel's 'Processor-Gate' ||| Bank Of America On AMD, Nvidia, And Intel's 'Processor-Gate' ||| TD Ameritrade Index Indicates Retail Investors Are At Their Most Bullish Point Yet",0,0.4896682
2018-01-16,70234800.0,56.01250076293945,56.87749862670898,54.17250061035156,55.02750015258789,54.44814682006836,NVDA,"AI Development In Automotive Is 'Full Steam Ahead,' Nvidia Exec Says In Detroit ||| 18 Stocks And ETFs To Watch In 2018 ||| Bernstein Surveys The Semis Space After 'Processor-Gate'",1,0.5135226
2018-01-17,53840800.0,55.17499923706055,56.27999877929688,54.22499847412109,56.18000030517578,55.58851623535156,NVDA,Nvidia Option Alert: Feb 16 $255 Calls at the Ask: 1350 @ $1.48 vs 282 OI; Earnings 2/8 After Close [est] Ref=$218.92,0,0.48419142
2018-01-19,60938000.0,57.022499084472656,57.772499084472656,56.75,57.52750015258789,56.92182159423828,NVDA,BofA: Nvidia Is The Beneficiary Of A Supercomputing 'Arms Race' ||| Nvidia Shares Rise 4.5% Premarket to $228.75 as Bank of America Raises PT to $275,1,0.4960523
2018-01-22,55094400.0,57.60749816894531,58.43999862670898,57.025001525878906,58.42250061035156,57.807395935058594,NVDA,"Benzinga's Weekly Bulls & Bears: Apple, Eli Lilly, GE, Nike And More ||| An Electric Vehicle ETF Revs Up",1,0.5235296
2018-01-23,47522800.0,58.962501525878906,59.95750045776367,58.775001525878906,59.727500915527344,59.09866714477539,NVDA,"ICYMI: Ransomware Hits Allscripts, Trump's Tariffs, New IPOs, And Ethereum ||| Ferocious FANGs: Leveraged ETNs For The Tech Sector Debut ||| Vetr Community Downgrades Nvidia ||| An ETF For Early Exposure To The Electric Car Market ||| Morgan Stanley Sees Ethereum's Strength Benefiting AMD, Nvidia ||| Morgan Stanley Raises Estimates On AMD, NVIDIA Amid Ethereum Strength, Says 'In Oct. we published an analysis suggesting Ethereum mining should slow, but a 200%+ increase in the currency value changes those economics materially'",0,0.50340265
2018-01-24,57997200.0,59.7599983215332,60.122501373291016,58.38750076293945,58.95000076293945,58.32935333251953,NVDA,"Chip Stocks Q4 Earnings: Intel Sets The Tone For AMD, Nvidia",1,0.50024843
2018-01-25,40988400.0,59.5,59.9375,58.9375,59.087501525878906,58.46540069580078,NVDA,NVIDIA To Report Q4 Results Feb. 8 After Hours Approximately 4:20pm ET ||| Off The Block: A Fast Start For A Blockchain ETF,1,0.5107599
2018-01-26,51635600.0,59.52999877929688,60.834999084472656,59.400001525878906,60.83250045776367,60.19202423095703,NVDA,A Third Blockchain ETF Debuts,1,0.535456
2018-01-29,45511600.0,60.685001373291016,62.02750015258789,60.15250015258789,61.712501525878906,61.06277084350586,NVDA,AMD Bear Admits Q4 Earnings Upside Is Likely On Cryptocurrency Strength ||| Aquantia Reports Will Deliver Multi-Gig Ethernet Capabilities On NVIDIA's DRIVE Autonomous Vehicle Platforms,0,0.52648395
2018-01-31,47857600.0,61.442501068115234,62.317501068115234,61.11249923706055,61.45000076293945,60.80302047729492,NVDA,"Samsung Enters The Cryptocurrency Mining Space, Announces First-Ever Stock Split ||| What AMD's Q4 Means For The Semi Space",0,0.51761454
2018-02-01,51922400.0,59.630001068115234,61.72499847412109,59.51499938964844,60.125,59.49197769165039,NVDA,"ICYMI: Nvidia, Qorvo, Bitcoin Breaks Down ||| Aquantia Shares Seeing Continued Upside From Monday's Announcement Co. Will Partner With NVIDIA On Autonomous Cars; Since News Of Partnership Stock Has Gained 26% ||| Earnings Preview: Reports From ExxonMobil And Chevron Wrap Up A Busy Week ||| Goldman Sachs Removes Nvidia From Conviction List, But Maintains Bullish Stance ||| NVIDIA Shares Down 1.6% Premarket; Goldman Removes Stock From 'Conviction Buy' List",0,0.50012165
2018-02-02,71846400.0,59.25,59.49250030517578,57.79249954223633,58.380001068115234,57.76534271240234,NVDA,"Citron Thinks Nvidia Shares Could Fall 15%, Calls It 'Great Company, Dangerous Stock' ||| Citron Tweets '$nvda shareholders can expect to see $200. Since Jan 1 $nvda has added over $30 bil in mkt cap (more than 2 $amd valuations). Great company dangerous stock' ||| The Companies Behind The Chips That Power Cryptocurrency Mining",0,0.4995997
2018-02-05,116520400.0,56.75,58.307498931884766,51.25,53.42499923706055,52.86251449584961,NVDA,"ICYMI: Super Bowl Commercials, Nvidia, Roku, And A Bitcoin Bull ||| Vetr Crowd Upgrades Nvidia To Buy ||| The Week Ahead: IPOs Ramp Up Just As Earnings Season Fades ||| Nvidia Partners With Continental On AI Self-Driving Cars ||| Amazon, Nvidia, And 3 Other Stocks In A Bullish Technical Trend ||| Disney Earnings Preview: Will Fox Deal Distract From Everything Else? ||| Continental, NVIDIA Report Partnership For Enabling Of Global Production Of AI For Self-Driving Cars ||| Continental, NVIDIA Partner to Enable Worldwide Production of AI Self-Driving Cars; Sees 2021 Market Introduction For Continental Autonomous Vehicle Systems",1,0.51713365
2018-02-06,111480000.0,51.09999847412109,56.42499923706055,51.0,56.39500045776367,55.801246643066406,NVDA,"'Busiest Trading Day Ever': Brokerages, Retail Clients React To Volatility",1,0.50774795
2018-02-07,80293200.0,57.39500045776367,58.74250030517578,56.67499923706055,57.20000076293945,56.59776306152344,NVDA,"Which Chipmaker Leads The Autonomous Driving Space? ||| Is Nvidia A Buy? Only If Shares Fall Further, Says Miller Tabak Analyst",0,0.51280063
2018-02-08,114400000.0,58.470001220703125,58.80500030517578,54.37749862670898,54.380001068115234,53.80747604370117,NVDA,"ICYMI: Nvidia, Snap, The VIX, And MoviePass ||| 8 Stocks Moving In Thursday's After-Hours Session ||| From NVIDIA Q4 Earnings Conference Call: CFO Colette Kress Says While Overall Contribution From Crypto Is Difficult To Quantify, Segment Was Higher As A Percentage Of Sales This Qtr. vs Last Qtr. ||| Nvidia Caps Record Year With Big Q4 Earnings Beat ||| NVIDIA Shares Up 5.3% Following Q4 Earnings Beat, Q1 Guidance ||| NVIDIA Sees Q1 Sales $2.9B Plus Or Minus 2% vs $2.47B Est. ||| NVIDIA Reports Q4 Adj. EPS $1.72 vs $1.16 Est., Sales $2.9B vs $2.68B Est. ||| Video: Does The Tech Selling Scare You Away From Buying NVIDIA stock? ||| ICYMI: Snap Earnings, VIX Instruments, AMD And Nvidia ||| Benzinga Pro's 6 Stocks To Watch Today ||| Nvidia Q4 Earnings Preview ||| 13 Stocks To Watch For February 8, 2018 ||| Earnings Scheduled For February 8, 2018",1,0.5134074
2018-02-09,167460400.0,59.5625,59.72249984741211,54.380001068115234,58.02000045776367,57.40913772583008,NVDA,"Wall Street Reacts To Nvidia's Blowout Q4 Quarter ||| Jim Cramer Tweets 'they couldn't crack the market at the 2:45 post.. good sign typically to 3:30...i would go buy some Nvidia $NVDA right now betting that the 2:45 checkpoint held' ||| Mid-Afternoon Market Update: Dow Falls Over 250 Points; Expedia Shares Tumble On Earnings Miss ||| Amended 13G Filing From Vanguard Shows 6.78% Stake In NVIDIA ||| 38 Stocks Moving In Friday's Mid-Day Session ||| Mid-Day Market Update: Crude Oil Down Over 2%; Mobileiron Shares Spike Higher ||| BMO Capital Maintains Market Perform on NVIDIA, Raises price target to $225.00 ||| B. Riley Maintains Buy on NVIDIA, Raises price target to $290.00 ||| 5 Tech Growth Stocks To Click With Investors Despite Selloff ||| Morgan Stanley Maintains Equal-Weight on NVIDIA, Raises price target to $258.00 ||| Mid-Morning Market Update: Markets Open Higher; NVIDIA Earnings Beat Estimates ||| Benzinga Pro's 6 Stocks To Watch Today ||| The Market In 5 Minutes: Budget Deal, MoviePass, Nvidia, And More ||| 5 Biggest Price Target Changes For Friday ||| Munster On Nvidia's Q4: 'Its Products Are A Foundational Part Of The Future Of Technology' ||| NVIDIA Shares Moving Lower Off The Open, Traders Attributing Move To Big Seller In Shares ||| Deutsche Bank Maintains Hold on NVIDIA, Raises price target to $230.00 ||| KeyBanc Has Valuation Concerns With Nvidia's Stock ||| Citigroup Maintains Buy on NVIDIA, Raises price target to $270.00 ||| 28 Stocks Moving In Friday's Pre-Market Session ||| A Peek Into The Markets: U.S. Stock Futures Mixed Ahead Of Wholesale Trade Report ||| 8 Stocks To Watch For February 9, 2018",0,0.47334146
2018-02-12,109317200.0,58.84000015258789,58.869998931884766,56.25749969482422,57.00749969482422,56.40729141235352,NVDA,"BofA: Three Semiconductor Picks In A Choppy Market ||| A Look at AMD's New Gaming APUs ||| Benzinga's Bulls & Bears Of The Week: Apple, Cisco, Lululemon, Nike, Wells Fargo And More ||| 44 Biggest Movers From Friday",1,0.50293386
2018-02-14,74498800.0,57.75,60.647499084472656,57.63750076293945,60.35499954223633,59.71956634521485,NVDA,"Form 4 Filing Late Tuesday Showed NVIDIA Director Perry Sold 17.307K Shares at $227.93 ||| Chip Stocks Lower Premarket: Micron Shares Down 1.6%, Western Digital Down 1.5%, AMD Down 0.9%, NVIDIA Down 0.6%; Traders Attributing Weakness To Nikkei Report 'Apple in talks for first order from a Chinese chipmaker'",1,0.47908542
2018-02-15,69890000.0,61.1974983215332,62.09249877929688,60.380001068115234,61.625,60.97618103027344,NVDA,Vetr Crowd Downgrades Nvidia To Hold,0,0.5155059
2018-02-16,63765600.0,61.34999847412109,62.5,60.86750030517578,60.959999084472656,60.31818008422852,NVDA,"Stocks That Made New 52-Wk Highs Earlier Include: Accenture, M&T Bank, PNC, Ansys, Lockheed Martin, Deere, Raytheon, Intuit, Comerica, Interpuclic, Northrop Grumman, VeriSign, Estee Lauder, Bristol-Myers, Red Hat, Nike, NVIDIA and Global Payments",1,0.4760047
2018-02-20,68624000.0,61.1875,62.96749877929688,61.150001525878906,62.27000045776367,61.6143913269043,NVDA,"Amplify ETFs CEO Breaks Down The Merits Of Blockchain Investing ||| Chip Stocks Higher Tues. Despite Seeing Some Notable Bearish Option Activity: NVIDIA Up 2%, AMD Up 1.6%, Micron Up 1.3% (See Body Of This Headline For Details On Option Activity ||| Stocks That Made New 52-Wk Highs Earlier Today Include: Moody's, Adobe, Cognizant, Zoetis, Salesforce, NVIDIA, Red Hat, CSRA, Intuit, Coty, Garmin, Global Payments, and Ansys",0,0.4870081
2018-02-22,53436400.0,60.682498931884766,61.407501220703125,59.875,60.53749847412109,59.93735885620117,NVDA,"ICYMI: Wayfair's Q4, Snapchat Gets Dissed, Cryptos And Semiconductors ||| How Long Will The Cryptocurrency GPU Boom Last?",1,0.5022826
2018-02-26,46931200.0,61.95000076293945,61.994998931884766,61.01499938964844,61.64500045776367,61.03388214111328,NVDA,"Cyclical Fears For Semis Are Rising, Says Deutsche Bank ||| Domo Arigato, Mr. Roboto: First Trust Launches AI, Robotics ETF",0,0.50115675
2018-02-27,45543600.0,61.375,62.227500915527344,61.282501220703125,61.51499938964844,60.90517044067383,NVDA,"Semi Execs Present Optimistic View At Morgan Stanley's TMT Conference ||| Citi Names Intel A Top Pick, Calls Stock 'The Micron Of 2018'",0,0.4968146
2018-03-06,63680800.0,59.775001525878906,60.73500061035156,59.34000015258789,60.540000915527344,59.93983840942383,NVDA,An Eventful February Took Its Toll On TD Ameritrade's Investor Index ||| Investor Movement Index February Summary,0,0.51445836
2018-03-08,41191200.0,60.73749923706055,60.73749923706055,59.84749984741211,60.29499816894531,59.69725799560547,NVDA,"ICYMI: Cigna And Express Scripts, AMD And Nvidia, Amazon And Wayfair ||| Nvidia Option Alert: May 18 $240 Puts at the Ask: 700 @ $17.301 vs 403 OI; Ref=$241.76 ||| 4 Semiconductor Stocks Grossly 'Underowned', According To Bank Of America",1,0.4875167
2018-03-12,60506000.0,61.75,63.25,61.66749954223633,62.43999862670898,61.82099151611328,NVDA,"Stocks That Made New 52-Wk Highs This Morning Include: Edward Lifesciences, Raymond James, NVIDIA, Goldman Sachs, Fastenal, Intercontinental Exchange, Xilinx, CBRE, Bank of America, Oracle, KeyCorp, Intuit, and IHS Markit",0,0.47016463
2018-03-13,61977200.0,62.872501373291016,63.625,61.5099983215332,61.9275016784668,61.31358337402344,NVDA,"AMD Investors Shrug Off Negative Headlines ||| NVIDIA Tells Benzinga It Declines To Comment On Earlier Digitimes Article Suggesting The Company Is Planning For A Slowdown In Demand For Cryptocurrency Mining Chips ||| Chip Stocks Largely Unaffected As Traders Circulate Earlier DigiTimes Article 'Nvidia wary of possible cryptocurrency demand drop': NVIDIA Shares Up 0.6%, AMD Up 0.5%, Intel Up 1.8% ||| Alibaba, Intel, Nvidia, US Steel: 'Fast Money' Picks For March 13 ||| Nvidia Said to be Taking Steps to Offset Drop in Cryptocurrency Mining Demand -DigiTimes",1,0.5011866
2018-03-14,50549600.0,62.36249923706055,62.63750076293945,61.55500030517578,62.185001373291016,61.56853485107422,NVDA,"Jim Cramer Advises His Viewers On Disney, AMD, RH And More",1,0.5290017
2018-03-19,71377200.0,62.04499816894531,62.337501525878906,59.25,60.25,59.652713775634766,NVDA,"ICYMI: Nvidia, Apple Supplier Sinks, AT&T In Court ||| B Riley FBR: Nvidia Remains Attractive For Growth Investors Ahead Of Analyst Day",1,0.5162517
2018-03-21,43868800.0,62.33000183105469,63.0,61.83250045776367,62.13999938964844,61.52398300170898,NVDA,Vetr Crowd Downgrades Nvidia ||| Esports Continue To Become More Mainstream And a Bigger Part Of The Gaming Industry ||| Vetr Crowd Upgrades Nvidia To Strong Buy,0,0.5130453
2018-03-23,73562000.0,60.59999847412109,60.625,58.130001068115234,58.24250030517578,57.66510772705078,NVDA,Vetr Crowd Upgrades Nvidia To Strong Buy,1,0.52543074
2018-03-26,61142400.0,59.5,61.13249969482422,58.97499847412109,61.119998931884766,60.51408767700195,NVDA,"Ethereum Mining Competition Turns Susquehanna Bearish On AMD ||| What To Expect From Nvidia's Analyst Day ||| NVIDIA Shares Up 2% Mon. Ahead Of Analyst Day On Tues.; BMO Sees 'very upbeat tone...particularly in light of the truly solid string of results the company has continued to deliver' ||| The Week Ahead: Apple Holds A Special Event, Roku's Lockup Expires And More",0,0.4798995
2018-03-27,140900000.0,61.9375,62.5,54.962501525878906,56.380001068115234,55.82107162475586,NVDA,"Marvell Announces Integration Of Ethernet Switch Into the NVIDIA DRIVE Autonomous Vehicle Platform ||| From NVIDIA's GPU Conference: CEO, Pres Jensen Hsun Huang Says Investment In Self-Driving Technology Will Rise Following Uber Fatality ||| From NVIDIA's GPU Conference In San Jose: Co. Unveiled Cloud Application Used To Simulate Self-Driving Vehicles ||| Nvidia To Halt AV Fleet Testing As Uber Investigates Fatal Crash ||| NVIDIA Press Release Highlights Series Of Important Advances To Deep Learning Computing Platform ||| 'Update: Nvidia tells CNBC that it is ""temporarily suspending the testing of [its] self-driving cars on public roads to learn from the Uber incident""'-CNBC Now Tweet ||| UPDATE: NVIDIA Will Suspend Self-Driving Auto Test On Public Roads 'To Learn From The Uber Incident,' Co.'s Global Fleet Of Manually-Driven Data Collection Autos Continue To Operate ||| NVIDIA Temporarily Suspends Self Driving Testing Across Globe Following Uber Fatality",0,0.5102235
2018-03-28,94590400.0,56.032501220703125,57.34749984741211,54.25,55.337501525878906,54.78891372680664,NVDA,"After Nvidia Analyst Day, Wall Street Talks AV Testing, Artificial Intelligence, GPUs ||| Tech Wreck Has Traders Getting Cozy With Bearish Chip ETF ||| Bank Of America's Key Takeaways From Nvidia's Investor Day ||| Benzinga Pro's Top 10 Most-Searched Tickers For Wed., Mar. 28, 2018 ||| After Tech Brings Misery Tuesday, Stronger GDP Reading Could Inject Optimism ||| Adobe, NVIDIA Report Partnership to Deliver New AI Services for Creativity and Digital Experiences",1,0.5053089
2018-04-02,92209200.0,57.185001373291016,58.66249847412109,54.375,55.26250076293945,54.71466064453125,NVDA,"Barron's Picks And Pans: Pot Stocks, Comcast, Bank Buybacks And More ||| Intel Falls On News Apple Will Shift Toward In-House Mac Chips ||| Are Cryptocurrency Woes Dragging AMD And Nvidia Shares Lower? ||| AMD, Nvidia Cut GPU Prices As Crypto Slump Saps Demand",1,0.48854464
2018-04-03,66743200.0,56.95000076293945,57.587501525878906,55.337501525878906,56.337501525878906,55.77899932861328,NVDA,"'Secretive Chinese bitcoin mining company just revealed a new chip that could hurt AMD, Nvidia' ||| Bank Of America Adds Nvidia To Top Stock List After Latest Gaming Checks ||| NVIDIA Shares Up 3.3% In Early Trading, Facebook Shares Flat-Slightly Higher; Earlier Bank of America Added NVDA To Us 1 List and Removed FB, Which Remains Buy-Rated",1,0.48748076
2018-04-04,78916800.0,53.75249862670898,56.665000915527344,53.5,56.560001373291016,55.99929428100586,NVDA,"Evercore: Nvidia Can 'Power Through' Bitmain Ethereum Mining Tailwinds ||| Evercore Out Positive On NVIDIA, Says Bitmain Release Of Ethereum-Mining ASIC Creates 'Tremendous Buying Opportunity' For The Company; Firm Reiterates Their Outperform Rating And $275 Price Target ||| Podcast: How To Control Your Emotions During Stock Market Madness ||| Analyst: Bitmain's New Ethereum Mining Chip Could Spell A Little Bit Of Trouble For AMD And Nvidia",0,0.5206276
2018-04-05,70124000.0,57.150001525878906,57.282501220703125,54.622501373291016,55.345001220703125,54.79633331298828,NVDA,"Citron Research @CitronResearch now Citron pressing $NVDA short expect sub $200 soon. Mkt starting to realize that ML/DL is narrowing and hyper-scale core customers experimenting with diff prop hardware solutions, Ether spreads are dead, Auto- unknown. N ||| UBS Initiates On Semis: Intel Is Golden, Micron Is A Sell, Nvidia, AMD And More ||| Benzinga's Top Upgrades, Downgrades For April 5, 2018 ||| UBS Initiates Coverage On NVIDIA with Neutral Rating, Announces $250.00 Price Target",0,0.4880693
2018-04-06,66298800.0,54.307498931884766,55.400001525878906,53.26750183105469,53.5625,53.03150177001953,NVDA,Watch Shares Of AMD As KitGuru Reports 'ASUS ROG may soon be Nvidia exclusive with AMD GPUs being bumped to new 'AREZ' brand',1,0.4995211
2018-04-09,49952400.0,54.20000076293945,55.49250030517578,53.650001525878906,53.852500915527344,53.31863021850586,NVDA,"Benzinga's Bulls & Bears Of The Week: Amazon, Fitbit, Mattel, Twitter And More ||| Confirming Morgan Stanley Upgrades NVIDIA to Overweight, Maintains Price Target At $258.00 ||| NVIDIA Shares Up ~2% After Hours, Hearing Morgan Stanley Has Upgraded From Equal-Weight To Overweight With a $258 Price Target",1,0.50031346
2018-04-10,76167600.0,56.18000030517578,57.25,55.602500915527344,56.977500915527344,56.41264343261719,NVDA,"Benzinga's Top Analyst Calls From April 10, 2018 ||| 25 Stocks Moving In Tuesday's Mid-Day Session ||| Benzinga's Top Upgrades, Downgrades For April 10, 2018 ||| Morgan Stanley Upgrades Nvidia As The Data Era Is Now 'Investable'",0,0.49873635
2018-04-11,46024400.0,56.82749938964844,57.244998931884766,56.22999954223633,56.560001373291016,55.99929428100586,NVDA,Forget Crypto: eSports Might Be Where It's At For Nvidia And AMD ||| 36 Biggest Movers From Yesterday,1,0.48747692
2018-04-13,50303600.0,59.29249954223633,59.37749862670898,57.38750076293945,57.875,57.30126190185547,NVDA,"'Citron accepting a challenge. @jimcramer has famously named his dog Nvidia. If $NVDA is trading over $230 in 12 months, Citron will donate $230k to the Humane Society...' ||| 'Morons buying $NVDA on higher crypto. They do ethereum and it is 5% max.. So sell it please. Get off my dog.'",0,0.5052757
2018-04-16,35079200.0,57.942501068115234,58.209999084472656,56.91999816894531,57.872501373291016,57.298789978027344,NVDA,"'Partners: Intel's Rumored Plans To Take On Nvidia, AMD With Discrete GPU Good For The Channel' ||| Elazar Warns Crypto-NVIDIA Shorts",1,0.5048927
2018-04-18,39136400.0,58.875,59.8125,58.192501068115234,59.09249877929688,58.50669097900391,NVDA,A Third Electric Vehicle ETF Charges Up,0,0.53767353
2018-04-19,47199600.0,57.9375,58.275001525878906,56.70000076293945,57.2599983215332,56.69235229492188,NVDA,"NVIDIA Sets Conference Call for First-Quarter Financial Results For May 10th After Market Close ||| Apple, Chips Stocks Falling Amid Taiwan Semiconductor's Weak Guidance ||| Semi Stocks Lower On Weak Q1 Report, Q2 Guidance From Taiwan Semi: NVIDIA Shares Down 2%, Micron Down 1.8%, AMD, Applied Materials Down 1.7%, Texas Instruments Down 1.3%, Xilinx Down 1% ||| CNBC Reports 'Apple, Nvidia shares fall after a key Asian chip partner gives weak guidance'; Taiwan Semiconductor Manufacturing Said Its Q2 Sales Guidance Is $7.8-$7.9B vs $8.8B Est.; Blames Weakness On Softening High-End Smartphone Demand, Crytpo Market",0,0.49149066
2018-04-20,38620000.0,57.17250061035156,58.025001525878906,56.86249923706055,57.1775016784668,56.61068344116211,NVDA,"Leverage Comes To The Robotics Trade ||| Though Their Stocks Have Cooled, The Semiconductor Industry Is As Hot As Ever",0,0.4943531
2018-04-23,42750800.0,57.35749816894531,57.875,55.70750045776367,55.970001220703125,55.415138244628906,NVDA,"Barron's Picks And Pans: General Electric, General Mills, MLPs And More ||| 4 Reasons Why 'Fortnite' Has Won Over Gamers ||| Who Profits From The Incredible Success Of 'Fortnite'? ||| 'Palihapitiya: $NVDA and $GOOG are the two big players in compute AI tech. Much of the value has been seen, but still interesting from this POV. #Sohn2018'- MarketWatch's Ryan Vlastelica Tweet",0,0.4891582
2018-04-25,58849200.0,55.0,55.39500045776367,52.57500076293945,54.165000915527344,53.6280403137207,NVDA,'Taiwan graphic card makers to see shipments plunge 40% in April',1,0.5240997
2018-04-26,37582400.0,55.79999923706055,56.38750076293945,55.13249969482422,56.30500030517578,55.746826171875,NVDA,Zacks: The Not-Good-Enough Earnings Season,1,0.5189808
2018-04-27,40084800.0,57.375,57.57500076293945,56.15499877929688,56.58250045776367,56.021575927734375,NVDA,Analysts Applaud Intel's Beat-And-Raise Q1 Earnings ||| Cramer Continues Warming Up To AMD After Listening To CEO ||| U.S. Government May Start Scrutinizing Informal Partnerships Between American and Chinese Companies in AI,0,0.52031267
2018-04-30,32784400.0,56.747501373291016,57.25,56.02999877929688,56.22499847412109,55.667606353759766,NVDA,Playmakers: The Investor Picks From CNBC's 2018 Stock Draft ||| 'Google brings Nvidia's Tesla V100 GPUs to its cloud',1,0.5094685
2018-05-01,25378800.0,56.14250183105469,56.8125,55.54999923706055,56.78499984741211,56.222049713134766,NVDA,Upcoming Earnings: Tesla To Report Q1 Results on Wednesday,0,0.5366629
2018-05-03,44314400.0,56.900001525878906,58.51250076293945,56.442501068115234,58.247501373291016,57.67007064819336,NVDA,"Upcoming Earnings: Alibaba Reports Before Market Open On Friday ||| Benzinga's Top Upgrades, Downgrades For May 3, 2018 ||| Barclays Upgrades Nvidia, Says AI Opportunity Is Too Big To Ignore ||| The Market In 5 Minutes: Tesla Earnings, Under Armour's Future, GM, Nvidia, Square And More ||| A Peek Into The Markets: US Stock Futures Gain Ahead Of Earnings, Economic Data ||| Barclays Upgrades NVIDIA to Overweight ||| Barclays Upgrades Nvidia to Overweight from Equal Weight; Raises PT to $280 from $265",1,0.5098677
2018-05-04,40066000.0,57.95750045776367,59.79750061035156,57.782501220703125,59.76499938964844,59.17251968383789,NVDA,"An ETF With A Futuristic View Of Transportation ||| Jobs Growth Stays A Little Slow in April As Unemployment Rate Falls ||| Morgan Stanley Previews Semi Earnings, Expects Strong Nvidia Results Despite Crypto Concerns",1,0.5005908
2018-05-07,68761600.0,60.8224983215332,62.747501373291016,60.72249984741211,62.16999816894531,61.55366516113281,NVDA,"Benzinga's Bulls & Bears Of The Week: Apple, Alibaba, Spotify, 3M And More ||| Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Mon., May 7 ||| The Week Ahead: Nvidia And Dropbox Earnings, April Retail Sales, Trump Drug Pricing Speech Expected",1,0.5084544
2018-05-08,50661600.0,62.17250061035156,62.62749862670898,61.6775016784668,62.59999847412109,61.97940444946289,NVDA,"NVIDIA Shares Largely Unaffected Following Citron Tweet 'Not a story of shorts vs $NVDA it is $NVDA vs $GOOG...Shorting into earnings.' ||| With Trump Iran Announcement In Focus, US Stock Futures Fall ||| 8 Biggest Price Target Changes For Tuesday ||| Deutsche Bank Maintains Hold on NVIDIA, Raises Price Target to $240 ||| Amgen, Halliburton, Nvidia, Gold: 'Fast Money' Picks For May 8",1,0.46815965
2018-05-09,59676000.0,62.8025016784668,63.96749877929688,62.52750015258789,63.94499969482422,63.31108856201172,NVDA,Upcoming Earnings: Nvidia Reports After Thursday's Close ||| 'NYTimes.com blames crypto miners for shortages of my chips but that is so yesterday's news. This quarter will show a big drop off in crypto sales. Everyone knows that. At least I thought they did. Nvidia',1,0.4790004
2018-05-10,99408000.0,64.4800033569336,65.125,64.30000305175781,65.03250122070312,64.3877944946289,NVDA,"NVIDIA CFO On Conf. Call Reportedly Says Supply Situation Is 'Now Easing' And GPU Channel Prices Normalizing ||| From NVIDIA Q1 Earnings Conference Call: CFO Says Co.'s Supply Situation Is 'Easing,' Channel Prices For GPUs Normalizing ||| Nvidia Blows Out Q1 Estimates, Raises Q2 Sales Guidance ||| UPDATE: NVIDIA Sees Q2 Adj. Gross Margins 63.5% +/- 50 Basis Points ||| NVIDIA Shares Initially Move Lower, Now Spiking Higher To $263.50 High, Now Down 0.6% ||| NVIDIA Sees Q2 Sales $3.1B vs $2.95B Est. ||| NVIDIA Q1 EPS $2.05 Beats $1.45 Estimate, Sales $3.21B Beat $2.89B Estimate ||| NVIDIA Shares At Intraday Highs 30 Mins. Ahead Of Q1 Earnings, Touch High At $260.00, Up 1.6% For Session ||| Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Thurs., May 10, 2018 ||| Cryptocurrency Mining Grew Faster Than Expected, Bernstein Says In Semiconductor Roundup ||| As Oil Fuels Equities Rally, Markets Eyeing Key Technical Levels ||| Benzinga Pro's 5 Stocks To Watch Today ||| 11 Stocks To Watch For May 10, 2018 ||| Earnings Scheduled For May 10, 2018",0,0.51467925
2018-05-11,121445600.0,63.19499969482422,64.94750213623047,62.6349983215332,63.63249969482422,63.00167846679688,NVDA,"UBS Maintains Neutral on NVIDIA, Raises Price Target to $266 ||| B. Riley FBR Maintains Buy on NVIDIA, Raises Price Target to $300 ||| Barclays Maintains Overweight on NVIDIA, Raises Price Target to $300 ||| Mid-Afternoon Market Update: MoSys Climbs Following Q1 Results; Obalon Therapeutics Shares Slide ||| Wall Street Reacts To Nvidia's Quarter ||| A BUZ-Worthy ETF ||| Mid-Day Market Update: Trade Desk Surges on Upbeat Earnings; Stellar Biotechnologies Shares Drop ||| Morgan Stanley Lifts Nvidia Price Target After Strong Q1 ||| Can Market Draw a Seven? DJIA Up Six Straight Days Amid Tech Rally ||| Mid-Morning Market Update: Markets Open Higher; NVIDIA Earnings Top Expectations ||| 5 Biggest Price Target Changes For Friday ||| KeyBanc's Takeaways From Nvidia's Q1 Report ||| A Peek Into The Markets: US Stock Futures Rise Ahead Of Import Prices, Consumer Sentiment Data ||| 6 Stocks To Watch For May 11, 2018",1,0.49773684
2018-05-14,52314000.0,64.01750183105469,64.62249755859375,63.59999847412109,63.84000015258789,63.20711898803711,NVDA,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Mon., May 14",0,0.47527552
2018-05-15,96352800.0,63.1974983215332,63.22499847412109,60.375,61.38999938964844,60.78141021728516,NVDA,13F From David Tepper's Appaloosa Shows New 150K Share Stake In NVIDIA,1,0.51076496
2018-05-16,55382800.0,61.0,62.130001068115234,60.62749862670898,61.50249862670898,60.89279174804688,NVDA,"Global X Launches AI, Big Data ETF ||| Q1 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolio",1,0.5237242
2018-05-17,51978400.0,61.52000045776367,62.875,61.35749816894531,61.9275016784668,61.31358337402344,NVDA,"Cowen Names 4 Top Semi Picks: AMD, Ambarella, Broadcom, Monolithic Power ||| Cowen & Co. Initiates Coverage On NVIDIA with Outperform Rating, Announces $325 Price Target ||| NVIDIA Shares Volatile After Hours, Hearing Cowen Initiated Coverage With Outperform Rating, $325 Price Target",0,0.49463278
2018-05-18,48371600.0,62.45249938964844,63.09249877929688,61.435001373291016,61.48500061035156,60.87548065185547,NVDA,Cowen Models 30% Upside In Nvidia,0,0.5045744
2018-05-21,64062400.0,62.470001220703125,62.50749969482422,60.122501373291016,61.060001373291016,60.45467758178711,NVDA,"Benzinga's Bulls & Bears Of The Week: Coca-Cola, Ford, JC Penney, Spotify And More ||| Benzinga Pro's Top 10 Most-Searched Tickers For Evening Of Mon., May 21, 2018",0,0.45932177
2018-05-22,51826400.0,61.19499969482422,61.45000076293945,60.0625,60.67499923706055,60.0734977722168,NVDA,"Nvdia, AMD May See 2018 Profits Fall as Crypto Mining Craze Fades",1,0.50200045
2018-05-30,39099600.0,62.48749923706055,63.334999084472656,62.23749923706055,63.247501373291016,62.65922546386719,NVDA,NVIDIA Introduces First Unified Computing Platform for Both AI and High Performance Computing,0,0.53344256
2018-05-31,49386800.0,62.92499923706055,63.79999923706055,62.817501068115234,63.04750061035156,62.461082458496094,NVDA,Encouraging Data For Electric Vehicle ETFs,1,0.54427254
2018-06-04,64202400.0,64.75,66.43499755859375,64.42500305175781,66.2125015258789,65.59664154052734,NVDA,"Stocks That Made New 52-Week Highs Today: Salesforce, Microchip, Fiserv, Edwards Lifesciences, Nike, Stryker, Align Tech, NVIDIA, Visa, IDEXX Labs, Ralph Lauren, Extra Space Storage, Kohl's, Macy's, Marathon Petroleum, Baxter, Expeditors Int'l & TransDigm ||| NVIDIA, Taiwan's MOST Announce Collaboration to Supercharge AI Efforts ||| NVIDIA Launches NVIDIA Isaac Platform to Power Next-gen Autonomous Machines",1,0.48084185
2018-06-06,37135600.0,65.35749816894531,66.31999969482422,65.19249725341797,66.2874984741211,65.67094421386719,NVDA,"BlueFin Research: Graphics Card Market For AMD, Nvidia Continues To Cool In Q2 ||| Three Industries Already Using Self-Driving Vehicles",0,0.5256531
2018-06-07,36944800.0,66.25,66.37000274658203,64.8125,65.7249984741211,65.11366271972656,NVDA,Form 4 Filing Late Wednesday Showed NVIDIA Director Brooke Seawell Sold a Total of 21.029K Shares at Avg. Prices Ranging From $264.63 TO $264.85,0,0.4835489
2018-06-12,31916000.0,65.42250061035156,65.76750183105469,64.91500091552734,65.6449966430664,65.034423828125,NVDA,BofA Highlights The Most 'Underowned' Semi Stocks,0,0.492489
2018-06-13,33820800.0,65.66000366210938,66.4175033569336,65.50749969482422,65.5999984741211,64.98983001708984,NVDA,A New Automation ETF For Traders Who Haven't Yet Been Replaced By Robots,1,0.5293162
2018-06-14,43001600.0,66.05500030517578,67.30000305175781,65.90499877929688,66.72750091552734,66.10684967041016,NVDA,"Stocks That Made New 52 Week Highs Today Include: Zoetis, Fortive, VeriSign, CF Industries, Ansys, Facebook, IDEXX, Fiserv, Global Payments, CA, Akamai, AES, NVIDIA, Align Tech, and Adobe ||| What The Latest Steam Gaming Data Means For AMD, Nvidia",0,0.47716102
2018-06-18,35626800.0,65.87000274658203,66.44999694824219,65.59500122070312,66.27249908447266,65.65608215332031,NVDA,S&P Dow Jones Indices Announces 'NVIDIA Set to Join S&P 100; FleetCor Technologies to Join S&P 500; Penn Virginia to Join S&P SmallCap 600',0,0.49328387
2018-06-19,59493200.0,65.2300033569336,65.91000366210938,63.755001068115234,65.0425033569336,64.43753051757812,NVDA,A Look Back At What's Happened To Each Sector Through The First Half Of 2018 (Part 1),1,0.4943223
2018-06-25,66581600.0,61.66249847412109,61.70000076293945,58.8849983215332,59.77999877929688,59.22397232055664,NVDA,Bank Of America Raises AMD Target On Market Share Optimism,1,0.5220743
2018-06-26,47888400.0,60.92499923706055,61.41249847412109,59.977500915527344,60.497501373291016,59.9348030090332,NVDA,"Trade Worries Still Weigh On Market A Day After Rout ||| FBN Securities Initiates Coverage On NVIDIA with Outperform Rating, Announces $300 Price Target ||| Benzinga's Top Upgrades, Downgrades For June 26, 2018 ||| Benchmark Initiates Coverage On NVIDIA with Buy Rating, Announces $280 Price Target",0,0.5191846
2018-06-27,45389200.0,60.9375,61.60749816894531,58.875,58.93000030517578,58.38187789916992,NVDA,Analyst Says Nvidia's Second-Half Outlook Is Promising,1,0.5202531
2018-06-28,33801200.0,58.83000183105469,60.334999084472656,58.75249862670898,60.21500015258789,59.65492630004883,NVDA,Trade Spat's A Boon For This Bearish Chip ETF,0,0.5202285
2018-07-02,35757200.0,58.522499084472656,60.59749984741211,58.31499862670898,60.560001373291016,59.9967155456543,NVDA,Tech Sector Earnings: What's Been Going on Ahead Of Q2 Reports? ||| NVIDIA Option Alert: Jul 20 $220 Puts Sweep (51) below Bid!: 1725 @ $2.601 vs 5202 OI; Earnings 8/9 After Close [est] Ref=$236.12,0,0.47671837
2018-07-05,30621600.0,59.76750183105469,60.73249816894531,59.375,60.682498931884766,60.11807632446289,NVDA,The Semiconductor Stocks That Fund Managers Love And Hate,1,0.5021257
2018-07-09,30388000.0,62.58250045776367,62.68000030517578,61.51750183105469,62.3125,61.73291397094727,NVDA,Forecasting Software: Nvidia Looks Primed For More Upside,1,0.50878555
2018-07-12,34550800.0,62.34000015258789,63.29249954223633,62.2400016784668,62.807498931884766,62.22331619262695,NVDA,NVIDIA Shares Trading Lower As Traders Circulate The Information Article Which Highlights Huawei's AI Push With 'Project Da Vinci' To Challenge NVIDIA's AI Chips,0,0.5132017
2018-07-13,24698800.0,62.994998931884766,62.994998931884766,61.90499877929688,62.33000183105469,61.7502555847168,NVDA,"Bluefin Research Talks Trade War Impact On Nvidia, AMD ||| NVIDIA Shares Fall Off The Open, Down 1.34% As Traders Circulate A Mixed Bluefin Note From July 12th; Bluefin Says That While Crypto Demand Is Weak And Graphics Card Sales Are Sluggish, They Believe Data Center Momentum Will Be A Near-Term Primary Driver",0,0.49083987
2018-07-17,36213600.0,61.5525016784668,63.57500076293945,61.29499816894531,63.42250061035156,62.83259582519531,NVDA,"Morgan Stanley: Nvidia 'The Cleanest Growth Story In Semis,' With New Products Ahead",0,0.50690925
2018-07-19,23575200.0,62.73500061035156,63.34749984741211,62.58250045776367,63.00749969482422,62.42144775390625,NVDA,"NVIDIA To Report Q2 Results August 16th At 4:20pm ET ||| European Union Antitrust Regulators Charge Qualcomm With New Violation In Case Related To NVIDIA Unit, ICERA",0,0.49745515
2018-07-20,22235200.0,62.98249816894531,63.375,62.61249923706055,62.72249984741211,62.139102935791016,NVDA,Opinion: Stock-Picking Is A Cult,0,0.5103434
2018-07-23,30158400.0,62.45500183105469,62.47249984741211,60.81999969482422,62.352500915527344,61.77254486083984,NVDA,"Benzinga's Bulls & Bears Of The Week: AbbVie, Netflix, Philip Morris, Wells Fargo And More ||| TechRadar Reports 'Nvidia GeForce GTX 1180 rumored again to release in August'",0,0.5083014
2018-07-26,32512400.0,62.76499938964844,64.0824966430664,62.595001220703125,63.709999084472656,63.1174201965332,NVDA,"Slew Of Semiconductor Earnings Could Elevate This ETF ||| Google Releases Its ASIC AI Infrastructure Called Edge TPU, Watch Shares of NVIDIA On This News",0,0.495874
2018-07-30,34034000.0,63.147499084472656,63.20750045776367,60.68000030517578,61.032501220703125,60.46482849121094,NVDA,"Barron's Picks And Pans: Amazon, Eli Lilly, Fiat Chrysler And More ||| Watching Self-Driving Fleet Players, Uber Partners For Self-Driving Truck Segment Amid Earlier Report Uber To Stop Development Of Self-Driving Trucks, Will Only Proceed With Cars",1,0.49801707
2018-07-31,28398800.0,60.9275016784668,61.970001220703125,60.53499984741211,61.21500015258789,60.645626068115234,NVDA,"Tesla Earnings: Model 3 Production Target Hit, What's Next?",1,0.4972701
2018-08-01,28355600.0,61.532501220703125,62.09000015258789,60.97249984741211,61.61750030517578,61.044376373291016,NVDA,Upcoming Earnings: MGM And Activision Blizzard Report Q2 Results On Thursday,1,0.534571
2018-08-02,26966800.0,60.897499084472656,62.69499969482422,60.3025016784668,62.65499877929688,62.07223129272461,NVDA,NVIDIA Shares Rebound 1.5% From Session Low At Open But Still Down ~0.7% For Session; CNBC Recently Published 'Elon Musk says Tesla A.I. chip project is 'finally coming to fruition'',1,0.50998944
2018-08-03,21428800.0,62.90250015258789,63.26499938964844,62.73249816894531,63.025001525878906,62.43879699707031,NVDA,"Semiconductor, Memory Related Stocks Appear Largely Unaffected Following Report China's Ministry Of Commerce Has Said Semiconductors Will Be One Group Targeted By New Proposed Tariffs On US",1,0.49277073
2018-08-08,26210000.0,64.25,65.05999755859375,63.897499084472656,64.6050033569336,64.00408935546875,NVDA,"Nvidia's Q2 Likely To Be 'Noisy,' But Goldman Sachs Remains Bullish",0,0.48691678
2018-08-10,25639600.0,63.28749847412109,64.0250015258789,63.17499923706055,63.6974983215332,63.10503768920898,NVDA,"Goldman's Chipmaker Pair Trade: Sell Intel, Not AMD",1,0.49993393
2018-08-13,37520800.0,63.78499984741211,65.25,63.76750183105469,64.02999877929688,63.43444061279297,NVDA,"The Week Ahead: Nvidia, Retailer Earnings In Focus",1,0.5177792
2018-08-14,46622000.0,65.09500122070312,65.5,64.25499725341797,65.35749816894531,64.74958801269531,NVDA,"Nvidia Shares Rise 0.8% After-Hours Following Wells Fargo Upgrade to Outperform ||| 13F From Soros Fund Shows Exited Stake In Fiat Chrysler, Exited Stake In NVIDIA; Reduced Stake In JP Morgan, Netflix; Raised Stake In Lululemon ||| What To Expect From Nvidia's Q2 Earnings",0,0.46843067
2018-08-15,59113600.0,65.56749725341797,65.91000366210938,63.97499847412109,64.7699966430664,64.16757202148438,NVDA,"Nvidia Gets Double Upgrade Ahead Of Earnings ||| Upcoming Earnings: Tech Giant Nvidia Unveils New GPUs Ahead Of Q2 Results ||| 13F From David Tepper's Appaloosa Late Tuesday Showed Exited Stake In Applied Materials, NVIDIA; New 219.272K Share Stake In NXP Semiconductors ||| Q2 13F Roundup: How Buffett, Einhorn, Loeb And Others Adjusted Their Portfolio ||| 10 Biggest Price Target Changes For Wednesday ||| Benzinga's Top Upgrades, Downgrades For August 15, 2018 ||| Wells Fargo Upgrades NVIDIA to Outperform, Raises Price Target to $315",0,0.47958237
2018-08-16,80126000.0,65.4749984741211,65.5,63.75249862670898,64.36000061035156,63.76137924194336,NVDA,"Elon Musk Tweet Replying to @StephenNellis @Tesla: Nvidia makes great hardware. High respect for Jensen & company. Our hardware needs were just unique & matched tightly to our software. ||| From NVIDIA's Q2 CFO Commentary, Co. Says It Previously Anticipated Crypto to Be 'Meaningful for the year, we are now projecting no contributions going forward.' ||| From NVIDIA's Q2 CFO Commentary, Co. Says GPU Sales Up 40% YoY, Down 4% Sequentially; Adds Co. Had Anticipated Crypto-product Sales Declining To ~$100M, But Actual Crypto Sales Were Only $18M ||| NVIDIA shares are trading down 5% after hours as weak Q3 sales guidance appears to offset Q2 earnings beat. ||| NVIDIA Sees Q3 Sales $3.185B-$3.315B vs $3.34B Est. ||| NVIDIA Q2 Adj. EPS $1.94 Beats $1.66 Estimate, Sales $3.12B Beat $3.11B Estimate ||| NVIDIA Q2 Earnings Due Out After The Close Today; Co. Historically Issues Its Report ~4:20pm ET ||| Benzinga Pro's 5 Stocks To Watch Today ||| Care Package: Walmart Results, China Trade Talks Might Help Lift Spirits ||| 10 Stocks To Watch For August 16, 2018 ||| Earnings Scheduled For August 16, 2018",0,0.49651358
2018-08-17,114318800.0,63.23500061035156,63.24250030517578,60.932498931884766,61.20500183105469,60.63572692871094,NVDA,"Podcast: 6 Charts Explain Why The Correction Has Started ||| 41 Stocks Moving In Friday's Mid-Day Session ||| Benzinga Pro's Top 10 Most-Searched Tickers For the Morning of Friday, Aug. 17th ||| Oppenheimer Upgrades Nvidia: 'We See Continued Outsized Growth' ||| 10 Biggest Price Target Changes For Friday ||| Headlights On Deere: Mixed Results As Company Cites Higher Costs ||| Benzinga's Top Upgrades, Downgrades For August 17, 2018 ||| Morgan Stanley Sees Buying Opportunity In Nvidia: 'Clarity Likely After Next Week's Product Launches' ||| 23 Stocks Moving In Friday's Pre-Market Session ||| Cisco, Macy's, Nvidia, TLT: 'Fast Money' Picks For August 17 ||| Oppenheimer Upgrades NVIDIA to Outperform ||| Stifel Nicolaus Maintains Hold on NVIDIA, Raises Price Target to $250 ||| A Peek Into The Markets: US Stock Futures Edge Lower Ahead Of Economic Data ||| 7 Stocks To Watch For August 17, 2018",1,0.49485224
2018-08-20,85438800.0,60.79499816894531,63.29999923706055,59.68000030517578,61.959999084472656,61.38370132446289,NVDA,"What Wall Street Thinks Of Nvidia's Q2 Earnings ||| Benzinga's Bulls & Bears Of The Week: Facebook, Netflix, Twitter, Walmart And More ||| Nvidia Unveils GeForce RTX Series: 'A New Golden Age Of Gaming' ||| NVIDIA shares are trading up 2.4% following company updates on RTX 2000 series gaming chips ||| From Gamescom 2018 Conference: NVIDIA Corp RTX 2000 Series Gaming Chips Will Range From $499 To $999 And Will Be Available Starting Sept. 20 ||| PR Confirms Gamescom News, NVIDIA RTX Platform Brings Real-Time Ray Tracing and AI to Barrage of Blockbuster Games ||| NVIDIA CEO Jensen Huang Giving Latest Updates From The Company's GeForce Pre-Gamescom Event, Live On YouTube ||| NVIDIA CEO At Gamescom Says Newest Gaming Chips Will Use AI To Improve Computer Graphics ||| REMINDER: NVIDIA Could Launch Its RTX 2080 Ti and RTX 2080 GPU as Early as Today ||| 50 Biggest Movers From Friday",1,0.5318154
2018-08-21,67398800.0,62.125,63.375,61.92499923706055,63.33000183105469,62.74095153808594,NVDA,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Tues., Aug. 21, 2018 ||| 'I have been a consistent backer of Nvidia. I understood there would be a short raid on it and i was right. No one has been as stalwart as i have been. Join the Club... '-Jim Cramer Tweets ||| Munster Sees 'Holy Grail' In Nvidia's New GPUs, While Stifel Takes Neutral Stance On Chipmaker ||| ' This is not a short talking- this is Ebay, Don't mess with Google.'-Citron Research Tweets (2/2) ||| 'Citron knows investors don't read full reports So here is the one takeaway to focus on why $NVDA going to $200. Customers are moving away from GPU to TPU as they find it faster and cheaper.'-Citron Research Tweets (1/2) ||| NVIDIA Shares Fall ~0.5% From Session High Following Tweet From Citron Research Suggesting Stock Is 'On Its Way To $200'; Shares Up 1.4% For Session ||| '$NVDA on its way to $200. With short interest at an all time low and datacenter facing major competition not even ray tracing can support these lofty levels' -Tweet From Citron ||| Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Tues., Aug. 21, 2018",1,0.4921532
2018-08-22,74985600.0,63.0,65.75499725341797,62.96500015258789,65.70500183105469,65.09386444091797,NVDA,NVIDIA Shares Unaffected After Hours As Citron's Andrew Left Is Currently On CNBC Discussing His Short Thesis In The Stock ||| Infographic: PC Gamers Prefer Nvidia GPUs ||| Netflix Vs. Amazon Vs. Nvidia: Picking A Tech Stock For The Long Haul,1,0.49608344
2018-08-23,72068400.0,65.31500244140625,67.37000274658203,65.17500305175781,66.70999908447266,66.08950805664062,NVDA,"Have You Tried The New Benzinga Pro Chat Beta Yet? We Often Discuss Hot Stocks And The Recent Breaking News Items Over The Last Few Mins.; Check It Out At https://pro.benzinga.com/popout/widget/chat/ ||| Rosenblatt Says AMD Now Has A Path To $30 Per Share ||| Fed On Center Stage As Jackson Hole Meeting Starts, With Powell Speech Friday",1,0.48684064
2018-08-24,53151200.0,66.79499816894531,68.20249938964844,66.75,68.05500030517578,67.4219970703125,NVDA,"The Hot Chips 2018 Conference: Morgan Stanley's Takeaways ||| Stocks Which Set New 52-Week High Yesterday, August 23rd",1,0.477972
2018-08-27,50577600.0,68.3550033569336,69.7249984741211,68.0374984741211,68.9749984741211,68.33345794677734,NVDA,"Benzinga's Bulls & Bears Of The Week: Alibaba, Apple, Nike, Tesla, Verizon And More ||| Stocks Which Set New 52-Week High Friday, August 24th",0,0.49477184
2018-08-29,42010800.0,68.4800033569336,69.875,68.2699966430664,69.62249755859375,69.01265716552734,NVDA,Solid Extra-Base Hit From GDP Breaks Up Otherwise Dull Week On Street,0,0.5122989
2018-08-30,34660800.0,69.30750274658203,70.43000030517578,69.08000183105469,69.45249938964844,68.84415435791016,NVDA,"Stocks That Made New 52-Week Highs Today Include: FLIR Systems, Textron, Darden Restaurants, United Continental, Intuitive Surgical, TJX, NetApp, Illumina, First Energy, NVIDIA, Microsoft, Visa, and Paypal ||| Stocks Which Set New 52-Week High Yesterday, August 29th",1,0.48182544
2018-08-31,30659200.0,69.25,70.30000305175781,69.1500015258789,70.16999816894531,69.55535888671875,NVDA,"Stocks Which Set New 52-Week High Yesterday, August 30th",1,0.5000733
2018-09-05,39315600.0,70.74749755859375,71.1050033569336,68.7874984741211,69.6050033569336,68.99531555175781,NVDA,"Watching NVIDIA Shares Amid Report Huawei Doing An AI Chip Deal With Microsoft In China ||| Stocks Which Set New 52-Week High Yesterday, September 4th",0,0.49685627
2018-09-10,22014000.0,68.19249725341797,68.98249816894531,67.75,68.68250274658203,68.0809097290039,NVDA,"BofA: Latest Steam Gaming Data Good News For Nvidia, AMD",0,0.50492567
2018-09-11,24311200.0,68.21499633789062,69.0999984741211,68.00499725341797,68.19999694824219,67.60260772705078,NVDA,AMD's Setup Gives Rosenblatt Securities Deja Vu ||| A Chip ETF Bleeds Cash; Some Of It May Be Going Here,0,0.48687926
2018-09-13,30553600.0,67.71499633789062,68.75,67.54000091552734,67.83499908447266,67.24081420898438,NVDA,NVIDIA Launches AI Data Center Platform,1,0.52708924
2018-09-14,38693600.0,68.74749755859375,69.7750015258789,68.375,69.10749816894531,68.50215911865234,NVDA,"NVIDIA Shares Indicated Up 1.4% Premarket On Light Volume (~11.5K Shares); Hearing Needham Raised Price Target On Stock To $350, Cited 'increased confidence NVDA will begin to take a larger share of the inference market...'",0,0.5299359
2018-09-20,43058400.0,66.76249694824219,67.19000244140625,66.0250015258789,66.56999969482422,65.98690032958984,NVDA,Still-Bullish Morgan Stanley Tamps Down Expectations For Nvidia's Turing GPUs,0,0.49417144
2018-09-24,29391200.0,65.55000305175781,66.45999908447266,64.66999816894531,66.42500305175781,65.84318542480469,NVDA,Bank Of America: Don't Sweat Mixed Nvidia Turing Reviews,1,0.51258713
2018-09-25,28038800.0,67.09249877929688,67.3550033569336,66.22750091552734,67.10250091552734,66.51473236083984,NVDA,"KeyBanc Starts Coverage On 10 Semiconductor Stocks, Downgrades Cypress Semi ||| Bank Of America Raises Nvidia Price Target To A Street High, Sees Upside In Multiple Segments ||| Benzinga's Top Upgrades, Downgrades For September 25, 2018 ||| KeyBanc Initiates Coverage On NVIDIA with Sector Weight Rating",0,0.49357054
2018-09-27,21442800.0,67.08499908447266,67.30000305175781,66.53250122070312,66.8499984741211,66.2644271850586,NVDA,'Cutting Edge' Collaborative Intelligence Startup Algo.ai Joins Nvidia Inception Accelerator,1,0.51460093
2018-09-28,70939600.0,68.18250274658203,70.4800033569336,67.9000015258789,70.25499725341797,69.63961029052734,NVDA,Intel Adding $1B To CapEx To Boost Production ||| Watching shares of AMD and NVIDIA after Intel announced it plans to add $1B to capex in order to boost production ||| NVIDIA Option Alert: Fri $275 Calls Sweep (60) near the Ask: 502 @ $2.938 vs 6346 OI; Earnings 11/8 After Close [est] Ref=$277.0 ||| NVIDIA Shares Up ~2% On ~16K Shares In Pre-Market Action; Hearing Evercore ISI Analyst Raised Price Target To $400,1,0.4992794
2018-10-01,62206000.0,71.04000091552734,73.01499938964844,70.6500015258789,72.33999633789062,71.70634460449219,NVDA,"Goldman Selective On Semis: Bullish On Nvidia, Xilinx, Bearish On Intel, Texas Instruments ||| Barclays Downgrades Intel, Says Chipmaker Faces 'Costly Battle' With AMD For Market Share",0,0.50575507
2018-10-02,38396400.0,72.0625,73.19000244140625,71.3949966430664,71.62000274658203,70.99266052246094,NVDA,"Stocks Which Set New 52-Week High Yesterday, October 1st",1,0.50062764
2018-10-03,32055200.0,72.33000183105469,72.40499877929688,70.63249969482422,71.68250274658203,71.05462646484375,NVDA,"Stocks Which Set New 52-Week High Yesterday, October 2nd ||| AMD's Stock Off To Rough October Start Following Best Quarter In Decades",0,0.49779898
2018-10-05,42663600.0,69.57250213623047,70.19999694824219,66.88500213623047,67.46499633789062,66.87406158447266,NVDA,Rambus Renews Patent License With NVIDIA ||| Rambus Wins Patent License Renewal With NVIDIA ||| Trading Journal: Look For Near-Term Weakness In Nvidia,0,0.4987113
2018-10-09,27350000.0,66.23500061035156,67.19000244140625,65.69999694824219,66.38500213623047,65.80351257324219,NVDA,Investor Movement Index September Summary,0,0.5007158
2018-10-10,68494000.0,65.31500244140625,65.77749633789062,61.400001525878906,61.42250061035156,60.88448333740234,NVDA,"Seeing downward movement in chip stocks, traders attributing move to earlier news Huawei unveiled new Ascend 910 and Ascend 310 AI chips aimed at data centers and smart devices; Nvidia down 4.3%, AMD down 6.1%, Qualcomm down 2.6%, Intel down 1.9%. ||| Volvo Selects AI-Based NVIDIA DRIVE Computer For Production Cars ||| IBM And NVIDIA Collaborate To Expand Open Source Machine Learning Tools For Data Scientists",0,0.49364662
2018-10-12,60823600.0,61.37749862670898,62.3849983215332,59.91249847412109,61.6349983215332,61.095123291015625,NVDA,"Shares of tech stocks moving higher as market rebounds from mid-week lows, strength could be related to rotation back into growth names; Netflix up 5.3%, NVIDIA up 5.8%, Salesforce Up 5.1%, PayPal Up 4.4%, Apple up 3.2%, VMWare up 3.0%.",0,0.4929027
2018-10-15,44976000.0,61.5,61.5,58.834999084472656,58.845001220703125,58.329566955566406,NVDA,NVIDIA Option Alert: Fri $235 Puts Sweep (38) below Bid!: 1649 @ $2.846 vs 3277 OI; Earnings 11/8 After Close [est] Ref=$243.9,1,0.4769615
2018-10-16,40871200.0,59.98249816894531,61.56999969482422,59.48500061035156,61.45750045776367,60.91917419433594,NVDA,Bank Earnings To The Rescue? Market Seeing Some Green After Strong Results,0,0.5151328
2018-10-18,52402000.0,61.46500015258789,61.852500915527344,59.272499084472656,59.88249969482422,59.35796356201172,NVDA,Goldman Sachs Adds Nvidia To 'Conviction Buy' List ||| Gamers Delight: A New E-Sports ETF Is Here ||| NVIDIA Shares Up 1.2% Premarket; Hearing Goldman Added Stock To Its 'Conviction Buy' List,0,0.48629344
2018-10-29,75801600.0,50.997501373291016,51.032501220703125,44.00249862670898,46.40499877929688,45.998531341552734,NVDA,NVIDIA Shares Down 1.3% Over Last Few Mins.; Not Seeing News To Justify Move Lower; Stock Down 5% Over Last Hour Since Price Broke Below Important Technical Level At $200; Stock Down 4.5% For Session,1,0.48600292
2018-10-30,80719200.0,46.63750076293945,50.84999847412109,46.40499877929688,50.75,50.30546569824219,NVDA,"NVIDIA shares are up 4.5% after analysts at JP Morgan upgraded the stock from 'Neutral' to 'Overweight'; Analysts said the company will continue to see outsized growth and clear leadership in data center/HPC and gaming over the next few years. ||| Stocks Which Set New 52-Week Low Yesterday, October 29th ||| Weakness In Nvidia's Gaming Segment Could Be A Passing Phase, JPMorgan Says In Upgrade ||| NVIDIA Shares Appear Unaffected; Traders Circulating Earlier Forbes Article 'Nvidia RTX 2080 Ti Cards Have A Serious Problem -- They Keep Dying' ||| Benzinga's Top Upgrades, Downgrades For October 30, 2018 ||| 30 Stocks Moving In Tuesday's Pre-Market Session ||| JP Morgan Upgrades NVIDIA to Overweight, Lowers Price Target to $255",1,0.49453908
2018-11-02,45296000.0,54.432498931884766,55.5,52.5525016784668,53.72999954223633,53.259368896484375,NVDA,"AMD's 'Next Horizon' Event: What You Need To Know ||| Tug-of-War: Solid Jobs Report, China Trade Talks Lift Market, But AAPL Disappoints",0,0.4984834
2018-11-07,48381200.0,53.4375,54.352500915527344,52.79499816894531,53.4474983215332,52.97933578491211,NVDA,"BlueFin Offers Q4 Update On PC Space: Oct. OEM Shipments Surprisingly Strong, Signaling A Strong Outlook For Dec. Qtr.; However, Uncertainty Surrounding Tariffs Creates Lack Of Clarity On Demand For Suppliers",0,0.49701595
2018-11-08,51135200.0,52.84999847412109,52.85749816894531,50.95750045776367,51.497501373291016,51.046417236328125,NVDA,"Morgan Stanley Maintains Overweight on NVIDIA, Lowers Price Target to $260 ||| Morgan Stanley's Bull Case For Nvidia Unchanged By Near-Term Concerns ||| NVIDIA shares are trading down 2.9% after analysts at Morgan Stanley lowered their price target on the stock; Analysts see headwinds in gaming and said they are de-risking their estimates going into earnings.",0,0.5026132
2018-11-09,41324000.0,50.59999847412109,52.33000183105469,50.2599983215332,51.41749954223633,50.96711349487305,NVDA,"Cold Start: Worries About Hawkish Fed, Rising Prices Seem To Weigh On Sentiment",0,0.50680625
2018-11-12,61711600.0,50.494998931884766,50.71749877929688,47.165000915527344,47.3849983215332,46.96993637084961,NVDA,"Goldman Sachs Reiterates Buy Rating And Conviction List Status For Nvidia Ahead Of Q3 Earnings; Analysts Say Near-Term Challenges Exist But Long-Term Secular Growth And Recommends Investors Use Recent Pullback To Buy The Stock ||| Citigroup Maintains Buy on NVIDIA, Lowers Price Target to $270",1,0.499944
2018-11-13,64471200.0,48.372501373291016,51.0525016784668,48.310001373291016,49.82749938964844,49.391056060791016,NVDA,"Nvidia shares trade up 5.4% after Susquehanna upgraded the stock from Neutral to Positive and FBR maintained shares at a Buy while lowering their price target to $240/share from $250/share. Nvidia reports Q3 results Thursday after the market closes. ||| Benzinga's Top Upgrades, Downgrades For November 13, 2018 ||| B. Riley FBR Maintains Buy on NVIDIA, Lowers Price Target to $240 ||| Susquehanna Upgrades NVIDIA to Positive",0,0.50411963
2018-11-14,52658000.0,51.57500076293945,51.720001220703125,48.20750045776367,49.29750061035156,48.86569213867188,NVDA,"Nvidia Q3 Earnings Preview: Analysts Forecast Data Center, Gaming, Automotive Performance ||| Upcoming Earnings: Tech Giant Nvidia To Report Q3 Results Tomorrow",1,0.52027416
2018-11-15,84070800.0,49.23749923706055,51.32500076293945,48.875,50.59749984741211,50.154296875,NVDA,"8 Stocks Moving In Thursday's After-Hours Session ||| NVIDIA shares down 18% following mixed Q3 reports, concerning Q4 sales guidance; AMD shares were down 6% in sympathy ||| NVIDIA 10-Q Discusses Crypto Mining Impact On Q3 Earnings ||| Nvidia Plummets Following Lower-Than-Expected Q4 Sales Guidance ||| NVIDIA Shares Down 16%; Other Chip Stocks Also Moving Lower In Sympathy: AMD Shares Down 6%, Micron Down 2.4%, Intel Down 1%, Texas Instruments Down 0.3% ||| NVIDIA Adds $7B To Buyback ||| NVIDIA Raises Quarterly Dividend From $0.15 To $0.16/Share ||| NVIDIA Sees Q4 Sales $2.7B +/- 2% vs $3.4B Estimate ||| NVIDIA Corporation Q3 Sales $3.181B Miss $3.24B Estimate ||| NVIDIA Corporation Q3 EPS $1.84 Beats $1.71 Estimate ||| NVIDIA To Report Q3 Earnings After The Closing Bell; Co. Historically Issues Its Report At 4:20 p.m. ET ||| Nvidia shares trade up 1.8% ahead of tonight's Q3 earnings; Analysts estimate EPS of $1.71 and revenues of $3.24 billion. ||| Big Box Bonanza: Walmart Beats Most Estimates, But Brexit Could Steal Attention ||| How Nvidia Historically Trades Following Earnings ||| Earnings Scheduled For November 15, 2018 ||| 10 Stocks To Watch For November 15, 2018",0,0.4938747
2018-11-16,196352000.0,40.83000183105469,42.665000915527344,40.40250015258789,41.10749816894531,40.74741744995117,NVDA,"Nvidia Gets Burned On Earnings: This Chart Shows More Pain Ahead ||| 48 Stocks Moving In Friday's Mid-Day Session ||| The Chips Are Down: Weak Forecasts Hurt Semiconductor Stocks ||| Mid-Day Market Update: Natural Grocers Climbs Following Strong Q4 Results; Chi-Med Shares Plummet ||| What To Do With Nvidia's Stock After 20% Fall? ||| Jefferies Maintains Buy on NVIDIA, Lowers Price Target to $246 ||| Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Fri., Nov. 16, 2018 ||| Raymond James Maintains Outperform on NVIDIA, Lowers Price Target to $250 ||| BMO Capital Maintains Market Perform on NVIDIA, Lowers Price Target to $175 ||| Nomura Maintains Neutral on NVIDIA, Lowers Price Target to $200 ||| Mid-Morning Market Update: Markets Mostly Higher; Viacom Beats Q4 Expectations ||| Wells Fargo Maintains Outperform on NVIDIA, Lowers Price Target to $235 ||| NVIDIA Option Alert: Fri $167.5 Calls Sweep (8) near the Ask: 618 @ $4.0 vs 9 OI; Ref=$170.2824 ||| Stocks Which Set New 52-Week Low Yesterday, Thurs., Nov. 16, 2018 ||| Barclays Maintains Overweight on NVIDIA, Lowers Price Target to $250 ||| Friday Follies: Brexit, Semiconductor, And Tariffs All Take Center Stage ||| Mizuho Maintains Buy on NVIDIA, Lowers Price Target to $245 ||| Citigroup Maintains Buy on NVIDIA, Lowers Price Target to $244 ||| 8 Biggest Price Target Changes For Friday ||| Deutsche Bank Maintains Hold on NVIDIA, Lowers Price Target to $190 ||| NVIDIA Option Alert: Jan 18 $240 Calls Sweep (3) near the Ask: 1100 @ $0.384 vs 7227 OI; Ref=$162.3001 ||| Benzinga's Top Upgrades, Downgrades For November 16, 2018 ||| NVIDIA shares down 18.1% following mixed Q3 reports, concerning Q4 sales guidance; AMD shares are down 6.9% in sympathy ||| 28 Stocks Moving In Friday's Pre-Market Session ||| Goldman Sachs Downgrades NVIDIA to Buy, Lowers Price Target to $200 ||| A Peek Into The Markets: US Stock Futures Fall, Dow Futures Down 100 Points ||| B. Riley FBR Downgrades NVIDIA to Neutral, Lowers Price Target to $190 ||| Loup Venture Publishes 'Nvidia: Despite Earnings Miss, Long-Term Story Still Intact' ||| 7 Stocks To Watch For November 16, 2018",0,0.52682436
2018-11-19,169782000.0,40.4474983215332,40.45500183105469,36.157501220703125,36.17499923706055,35.858131408691406,NVDA,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Mon., Nov. 19, 2018 ||| Several tech and tech-related stocks moving lower despite no company-specific news; Move may be linked to reports Apple cut iPhone production orders, as well as sell off in the overall market. ||| Stocks Which Set New 52-Week Lows Fri., Nov. 16, 2018 ||| 55 Biggest Movers From Friday",1,0.5048615
2018-11-20,169203200.0,33.51499938964844,38.56499862670898,33.32749938964844,37.27000045776367,36.943546295166016,NVDA,"This Leveraged ETF Rapidly Became One Of November's Best ||| Citron Turns Bullish On Nvidia, But Technicals Still Look Ugly ||| NVIDIA Option Alert: Mar 15 $175 Calls Sweep (2) near the midpoint: 600 @ $9.95 vs 566 OI; Ref=$147.11 ||| 'Citron buys $NVDA. This is the first time in 2 years stock offers an appealing risk-reward to investors. $NVDA still a player in AI and Data..will eat through inventory issue. We see $165 before we see 120...' -Citron Research Tweets ||| Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Tues., Nov. 20, 2018 ||| Exane BNP Paribas Downgrades NVIDIA to Underperform ||| Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 19, 2018",0,0.5031369
2018-11-21,102549600.0,38.65499877929688,38.82500076293945,35.90250015258789,36.1775016784668,35.86060333251953,NVDA,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Wed., Nov. 21, 2018 ||| Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018 ||| 20 Stocks Moving In Wednesday's Pre-Market Session ||| 'U.S. chipmaker Nvidia to provide AI platform for Chinese EV start-ups' -Earlier Reuters Report ||| NVIDIA Shares Up 3% Wed. Morning Following 3% Rebound Tues.; Stock Coming Off Its Fourth-Worst 2-Day Stretch, Had Fallen 28.5% Over Fri., Mon. Sessions",1,0.48979673
2018-11-26,81483200.0,37.47249984741211,38.36750030517578,36.63999938964844,38.26250076293945,37.92734909057617,NVDA,"KeyBanc Sees 'Significant Runway' For AMD In Cloud Data Processors ||| Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Mon., Nov. 26, 2018 ||| Benzinga's Top Upgrades, Downgrades For November 26, 2018 ||| Credit Suisse Initiates Coverage On NVIDIA with Outperform Rating, Announces $225 Price Target",1,0.49997017
2018-11-27,73806000.0,38.0,39.25249862670898,37.63750076293945,38.432498931884766,38.09585571289063,NVDA,"Watching Semiconductor Stocks, The VanEck Semi ETF Amid Circulation Of Comment From Citi Highlighting A Belief An 'Extreme' Component Of The Trump Admin.'s Crack Down On US Exports Could Include A Ban On The Sale Of US Semi Components To China",1,0.5095023
2018-11-28,80452400.0,39.619998931884766,40.06999969482422,38.282501220703125,40.01750183105469,39.66697692871094,NVDA,"Stocks That Will Be Trading Ex Dividend Thurs., Nov. 29, 2018",0,0.46181914
2018-11-29,54917200.0,40.0,40.375,39.03499984741211,39.34000015258789,39.034423828125,NVDA,"Nvidia And Epic Games Bartering On Fortnite Bundle, Variety Reports ||| Stocks Trading Ex Dividend For Thurs., Nov. 29, 2018",1,0.46370813
2018-11-30,72956400.0,39.4375,40.96500015258789,38.93000030517578,40.85749816894531,40.54014205932617,NVDA,Nvidia shares trading up 2.7% after IHS reported worldwide semiconductor revenue hit a record of $129.8B in Q3. ||| Heading South: G20 Meeting In Argentina Puts China Trade Squarely in Focus ||| IHS Reports Worldwide Semiconductor Revenue Hits Record $129.8B in Q3 2018,1,0.5257672
2018-12-03,89080400.0,43.150001525878906,43.66999816894531,41.834999084472656,42.5099983215332,42.17979431152344,NVDA,"Boeing, Lennar, Nvidia, Gold ETF: 'Fast Money' Picks For December 3",0,0.49258873
2018-12-04,81211200.0,42.060001373291016,42.11000061035156,39.125,39.27750015258789,38.97240829467773,NVDA,'AMD is readying graphics cards to take on Nvidia's GeForce RTX range' -Tech Radar,1,0.5042325
2018-12-11,67191200.0,38.88999938964844,38.97249984741211,36.25,37.04750061035156,36.75973510742188,NVDA,Hearing Softbank Considering Plan To Sell Stake In NVIDIA In 2019 ||| Downside In NVIDIA Shares Intensifies Over Last Few Mins. As $148 Level Breaks Down; Shares Down 4% For Session ||| Intel CPU Shortages May Impact Notebook ODM's in H1 2019,1,0.50250596
2018-12-12,65413600.0,37.10499954223633,38.19499969482422,36.20500183105469,37.22499847412109,36.93585968017578,NVDA,"Nvidia Bounces Back After News Of Potential SoftBank Sale ||| NVIDIA Option Alert: Dec 28 $172.5 Calls Sweep (3) near the Ask: 537 @ $0.49 vs 337 OI; Earnings 2/7 After Close [est] Ref=$150.265 ||| 10 Biggest Price Target Changes For Wednesday ||| RBC Capital Maintains Outperform on NVIDIA, Lowers Price Target from $260 to $230",0,0.47456548
2018-12-13,47138400.0,37.6974983215332,38.345001220703125,36.86000061035156,37.22249984741211,36.93338394165039,NVDA,"Citi Adds Nvidia, Marvell Technology To Holiday Shopping List ||| UPDATE: Citi On NVIDIA Being Added To 'Shopping List,' Cites 'Post Crypto Reset' ||| Citi Adds NVIDIA To Its 'Semis Christmas Shopping List' ||| SEMI Reports Semiconductor Equipment Sales to Rise to Record High in 2018",0,0.49329984
2018-12-18,56437200.0,36.337501525878906,37.58250045776367,36.0625,36.73500061035156,36.44965362548828,NVDA,"Micron Shares Down 7.6% Following Mixed Q1 Report, Concerning Outlook; Other Chip Stocks Trading Down In Sympathy: AMD Shares Down 1.7%, NVIDIA Down 1.5%, Intel Down 0.8%",0,0.48965052
2018-12-19,74536400.0,36.39500045776367,36.935001373291016,34.10749816894531,34.627498626708984,34.3585319519043,NVDA,"Intel, NVIDIA, and Advanced Micro Devices are trading lower in sympathy with Micron after the company issued concerning Q2 guidance and cut its DRAM bit output growth forecasts.",0,0.52861536
2018-12-20,74958800.0,34.54249954223633,35.45000076293945,33.17250061035156,33.775001525878906,33.51265335083008,NVDA,"Bank Of America Cuts AMD Target By 10%, Still Bullish In The Long Term",0,0.50539154
2018-12-27,63704400.0,32.747501373291016,33.095001220703125,31.295000076293945,32.79249954223633,32.53778839111328,NVDA,"Shares of chip stocks are trading lower after RBC analysts reportedly issued cautious commentary on NVIDIA, citing potential softness in the gaming sector. ||| UPDATE: RBC On NVIDIA, AMD: 'We have noticed ASPs for GPUs coming down in the secondary market (Newegg, Amazon.com, eBay). For this reason, we adjust our estimates slightly to reflect potential gaming softness' ||| RBC Capital Reiterates Outperform On NVIDIA, Lowers Price Target From $230 To $200",1,0.4817244
2018-12-31,46514000.0,33.849998474121094,34.1775016784668,33.064998626708984,33.375,33.11575698852539,NVDA,'Fortnite' Creator Turns $3B Profit In 2018: The Stocks That Benefit ||| NVIDIA Option Alert: Mar 15 $130 Calls at the Ask: 2250 @ $15.45 vs 374 OI; Earnings 2/7 After Close [est] Ref=$133.27,1,0.46714625
2019-01-02,50875200.0,32.65999984741211,34.619998931884766,32.51250076293945,34.05500030517578,33.79047393798828,NVDA,"Tech stocks shares are trading lower after Apple cut Q1 sales guidance drastically. ||| 'DRAM Market to See Lower Capital Expenditure and Moderated Bit Output in 2019 Due to Weak Demand, Says TrendForce' -DRAMeXchange Earlier Reported ||| Supply Chain Conservative About 2019 Mining Asic Outlook",0,0.48760554
2019-01-03,70555200.0,33.4474983215332,33.790000915527344,31.92250061035156,31.997499465942383,31.74896049499512,NVDA,Several Apple supplier shares are trading lower after Apple lowered Q1 sales expectations by 7.7%.,1,0.5269517
2019-01-07,70916000.0,34.625,36.22249984741211,34.10749816894531,35.849998474121094,35.571533203125,NVDA,"NVIDIA Introduces DRIVE AutoPilot Automated Driving System ||| NVIDIA shares are trading higher after the company announced a new gaming chip at CES 2019. ||| Jon Najarian Sees Big Options Activity In Johnson & Johnson, Nvidia",0,0.48558885
2019-01-08,78601600.0,36.67250061035156,36.69499969482422,34.224998474121094,34.95750045776367,34.68596649169922,NVDA,"Goldman Sachs Shares Semiconductor Stock Picks For A Challenging 2019 ||| 4 Tech Stocks That Are Showing Signs Of Life Right Now ||| Credit Suisse Sounds Alarm On Risks To Nvidia Estimates ||| Semiconductor stocks are trading lower after Goldman Sachs analysts announced they expect a 'challenging' 2019 for the space. ||| Goldman Expects '2019 to be another challenging year for Semis, particularly in 1H'; Firm Is 'least negative on Semi Cap Equipment as the stocks already seem to be pricing in a downturn'",1,0.49149996
2019-01-10,52315600.0,35.45000076293945,36.39500045776367,34.84000015258789,36.307498931884766,36.02547073364258,NVDA,Morgan Stanley's Key CES Takeaways For Semi Companies ||| Nvidia's Huang Dismisses Rival AMD's Latest Graphics Card As 'Underwhelming',1,0.5049626
2019-01-14,73016800.0,36.68000030517578,37.8650016784668,36.442501068115234,37.61000061035156,37.317867279052734,NVDA,"Benzinga's Bulls & Bears Of The Week: Delta Air, McDonald's, Netflix, Nokia, Tesla And More",0,0.5168578
2019-01-16,47010400.0,37.74250030517578,38.07500076293945,37.15499877929688,37.209999084472656,36.92096710205078,NVDA,"Tech Sector Earnings: Revenue Growth Widely Expected To Slow, Will Global Uncertainty Weigh?",1,0.511358
2019-01-17,49343600.0,36.87749862670898,38.33250045776367,36.602500915527344,37.93000030517578,37.635372161865234,NVDA,"JP Morgan Sees A 'Solid entry point for long-term investors - top pick remains AVGO, and we also favor NVDA, INTC, MXIM, MU, IPHI and MLNX' As Firm Sees 'value in semi stocks' And Thinks 'weak sentiment and estimate cuts are largely priced' IN",1,0.47990075
2019-01-18,65133600.0,38.432498931884766,39.494998931884766,37.91249847412109,39.23249816894531,38.9277572631836,NVDA,Shares of semiconductor stocks are trading higher potentially due to renewed optimism in US-China relations.,0,0.5388964
2019-01-22,66155200.0,38.9275016784668,39.04499816894531,36.88750076293945,37.192501068115234,36.90360641479492,NVDA,Chip and semiconductor stocks are trading lower; Dip may be related to ongoing concerns over China growth and trade talks.,1,0.5249286
2019-01-23,59102000.0,37.75,38.64500045776367,37.00749969482422,37.3224983215332,37.0325927734375,NVDA,"Big Chip Earnings Preview: Intel, AMD Set To Report Amid Changing Competitive Landscape, Cycle Risk ||| Motherboard Manufacturers to See Shipments plummet in Q1 2019",1,0.5220719
2019-01-24,70897200.0,38.17499923706055,39.63750076293945,38.12749862670898,39.459999084472656,39.15349960327149,NVDA,"Stocks in the semiconductor space are trading down following concerning earnings reports from Western Digital and Intel; Intel also issued weak guidance estimates. ||| 9 Stocks Moving In Thursday's After-Hours Session ||| Other Semi Stocks Fall Following Concerning Earnings From Intel, Western Digital: NVIDIA Shares Down 2.7%, AMD Down 2.5%, Seagate Down 2.4%, Micron Down 2.1%, ||| Semiconductor stocks are trading higher following strong earnings from multiple large companies in the space. ||| 35 Stocks Moving In Thursday's Pre-Market Session",1,0.5088241
2019-01-25,115457200.0,38.86000061035156,40.220001220703125,37.82500076293945,40.03749847412109,39.72649765014648,NVDA,NVIDIA shares are trading lower potentially on rumors that Jefferies removed the stock from their Franchise Pick List. ||| Hearing Jefferies Removes NVIDIA From Franchise Pick List; Unconfirmed ||| IC Insights Reports Semiconductor Unit Shipments Topped 1 Trillion In 2018,0,0.4983243
2019-01-28,251152800.0,34.13750076293945,35.40999984741211,32.75,34.502498626708984,34.23450469970703,NVDA,"Breaking Down The Incredible Rise Of Esports ||| 36 Stocks Moving In Monday's Mid-Day Session ||| Mid-Morning Market Update: Markets Open Lower; Caterpillar Profit Misses Expectations ||| Nvidia Cuts Q4 Sales Guidance, Chips Stocks Tumble ||| Shares of NVIDIA are trading lower after the company cut Q4 guidance, citing weaker sales in its gaming and datacenter platforms. ||| VanEck Vectors Semiconductor ETF Down 2.4% Following Q4 Sales, Gross Margin Guidance Cut From NVIDIA ||| NVIDIA Shares Down 9% Following Q4 Sales, Gross Margin Guidance Cut; AMD Shares Down 4.3%, Seagate Down 3.2%, Micron Down 2.5%, Intel, Western Digital Down 1.5%, Texas Instruments Down 1% ||| NVIDIA Guidance Cut Reflects 'Weaker Than Forecasted' Sales Of Its Gaming And Datacenter Platforms, ||| NVIDIA Cuts Q4 Gross Margin Guidance From ~62.5% To ~56.0% ||| NVIDIA Cuts Q4 Sales Guidance From $2.7B To $2.2B vs $2.7B Est.",0,0.50941455
2019-01-29,115393200.0,34.037498474121094,34.525001525878906,32.752498626708984,32.900001525878906,32.64445114135742,NVDA,"Analysts React To Nvidia's Guidance Cut ||| Apple Today, Powell Tomorrow: Busy Earnings And Fed Week Continues ||| Top 3 Price Prediction Bitcoin, Ripple, Ethereum: Suffers Amid NVidia And QuadrigaCX As Technical Levels Weigh ||| Nvidia shares are trading lower on continued weakness; Multiple analyst have downgraded the stock and cut price targets following the company's guidance cut. ||| UBS Turns Bullish On Nvidia After Guidance Cut, Sees Buying Opportunity ||| 8 Biggest Price Target Changes For Tuesday ||| Morgan Stanley Downgrades Nvidia, Faces 'More Significant Challenges' Than Expected ||| Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Tues., Jan. 29, 2019 ||| UPDATE: Needham Downgrades NVIDIA And Removes $225 Price Target As Firm Believes 'end demand will deteriorate further in its core markets, gaming (54% of sales) and datacenter (25%) driven by an ongoing deceleration in the Chinese economy' ||| Benzinga's Top Upgrades, Downgrades For January 29, 2019 ||| UPDATE: Morgan Stanley Downgrades NVIDIA As Firm Notes 'Missing the quarter this badly in gaming indicates more significant challenges than we had anticipated, given that this is still a channel fill quarter for midrange/high end' ||| UPDATE: UBS Upgrades NVIDIA As Firm Notes 'Important Q's remain unanswered, but we believe the ~20% miss to FQ4:19 (Jan '19) revenue and -15% stock move finally sets the stage for a new positive revision cycle starting this summer' ||| Needham Downgrades NVIDIA to Underperform ||| Morgan Stanley Downgrades NVIDIA to Equal-Weight, Lowers Price Target to $148 ||| UBS Upgrades NVIDIA to Buy, Lowers Price Target to $180 ||| 50 Biggest Movers From Yesterday ||| Morgan Stanley Downgrades Nvidia to Equal-Weight from Overweigth; Lowers Prices Target to $148 from $220",1,0.47397622
2019-01-30,97422800.0,33.66749954223633,34.49250030517578,32.8650016784668,34.34749984741211,34.08070373535156,NVDA,NVIDIA Option Alert: Fri $136 Calls Sweep (2) near the Ask: 500 @ $2.9 vs 1359 OI; Earnings 2/7 After Close [est] Ref=$136.9 ||| Analysts Weigh In On AMD Earnings Relief Rally ||| Chip and semiconductor stocks are trading higher following Apple and AMD earnings; Apple beat Q1 estimates and AMD reported Q4 margin improvement.,1,0.49489874
2019-01-31,84285200.0,34.314998626708984,36.29750061035156,34.095001220703125,35.9375,35.658355712890625,NVDA,"Cypress Semiconductor Corp shares are trading higher after the company beat Q4 earnings estimates; shares of other semiconductor stocks are trading slightly higher in sympathy. ||| Earnings, Volatility, Brexit Are Key Topics Heading Into February",1,0.4909933
2019-02-05,54242400.0,37.415000915527344,37.85749816894531,37.07500076293945,37.48749923706055,37.19630813598633,NVDA,AMD Falls As Major Shareholder Sells,1,0.5241886
2019-02-06,70246400.0,37.8224983215332,38.900001525878906,37.76750183105469,38.25,37.95289611816406,NVDA,Semiconductor and microchip stocks are trading higher after Microchip Technology reported strong earnings and Skyworks reported a $2 billion buyback.,0,0.51763606
2019-02-07,63712000.0,37.782501220703125,37.80500030517578,36.42250061035156,36.85499954223633,36.568729400634766,NVDA,Weak Eurozone Forecast Add To Concerns About Global Growth ||| Shares of several semiconductors are trading lower after NXP Semiconductors provided weak Q1 sales guidance.,1,0.5392559
2019-02-08,46160400.0,36.1775016784668,37.150001525878906,36.032501220703125,37.04249954223633,36.7547721862793,NVDA,"Hearing CalPERS Reduced Holdings In Apple, Amazon, Microsoft, Exxon Mobil, JP Morgan, Facebook And NVIDIA In Q4",0,0.5151545
2019-02-11,49518000.0,36.59749984741211,37.14500045776367,36.125,36.61249923706055,36.32811737060547,NVDA,"Bernstein Downgrades 'Hamstrung' Nvidia ||| Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Monday, February 11, 2019 ||| 10 Biggest Price Target Changes For Monday ||| Benzinga's Top Upgrades, Downgrades For February 11, 2019 ||| NVIDIA shares are trading lower after Bernstein downgraded the stock from outperform to market preform and lowered the price target from $250 to $175. ||| UPDATE: Bernstein Downgrades Nvidia As Firm Notes 'the latest cut appears much more fundamentally demand-driven, with the question of the ""true"" run-rate of the gaming business remaining up in the air for now' ||| Bernstein Downgrades NVIDIA to Market Perform, Lowers Price Target to $175",1,0.49420875
2019-02-14,82726400.0,38.209999084472656,38.91749954223633,37.775001525878906,38.63249969482422,38.33241653442383,NVDA,"7 Stocks Moving In Thursday's After-Hours Session ||| Nvidia Shares Spike Higher Following Q4 Earnings Beat ||| NVIDIA Q4 EPS $0.80 vs $0.75 Reuters Estimate, Sales $2.21B Beat $2.2B Reuters Estimate ||| Oppenheimer On Feb. 11 Previewed NVIDIA Earnings, Said Sees 'negative bias to Street Q1 sales/EPS,' Noted Q4 Guidance Cut Stemmed From 'lingering Pascal-crypto drag, though most of the incremental weakness came from DC and high-end Turing GPU demand' ||| NVIDIA To Report Q4 Earnings After The Closing Bell, Co. Historically Issues Its Report At 4:20 p.m. ET; Things To Watch Include Gaming And Datacenter Revenue, For Which The Company Previously Guidance ||| 11 Stocks To Watch For February 14, 2019 ||| Earnings Scheduled For February 14, 2019",1,0.5009164
2019-02-15,151674800.0,40.73749923706055,40.96749877929688,39.10499954223633,39.334999084472656,39.02946472167969,NVDA,"Nvidia Shares Up After Earnings, But A Weak Recovery Does Not Bode Well For The Chart ||| 52 Stocks Moving In Friday's Mid-Day Session ||| Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Fri., Feb. 15, 2019 ||| Analysts: Nvidia Needs A Big Second Half Of 2019 ||| Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Fri., Feb. 15, 2019 ||| 31 Stocks Moving In Friday's Pre-Market Session ||| NVIDIA shares are trading higher after the company said it expects 2020 revenue to be roughly the same as 2019 while analysts expected a revenue drop. ||| A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Economic Reports ||| UPDATE: Loup's Munster Sees NVIDIA Shares Being 'range bound in the coming months, as investors will likely trim revenue expectations' ||| Loup Ventures' Gene Munster On NVIDIA Results: 'While we are believers in the Nvidia story...we believe that there remains risk to FY20 guidance' ||| 10 Stocks To Watch For February 15, 2019",0,0.47939375
2019-02-19,55189200.0,39.227500915527344,39.97249984741211,39.03499984741211,39.15999984741211,38.85582733154297,NVDA,An Electric Outlook For The Esports ETF,1,0.5363368
2019-02-22,40174000.0,39.46500015258789,39.98749923706055,39.32749938964844,39.79750061035156,39.48837661743164,NVDA,"Why This Analyst Sees 25% Upside In NVIDIA ||| UPDATE: Atlantic Equities Initiates NVIDIA With Overweight And A $195 Target As Firm Believes 'the headwinds are transitory and growth should re-accelerate given underlying fundamentals, leaving the recent sell-off creating an attractive entry point' ||| Atlantic Equities Initiates Coverage On NVIDIA with Overweight Rating, Announces $195 Price Target",0,0.50271595
2019-02-25,65602000.0,40.63999938964844,41.31999969482422,39.584999084472656,39.67250061035156,39.36434173583984,NVDA,"Barron's Picks And Pans: Apple, Altria, Micron Technology, Nvidia And More ||| As Trade Optimism Grows, Markets Turn Green and Boeing, Caterpillar Among Leaders",0,0.4770668
2019-03-06,40352400.0,39.040000915527344,39.125,37.98500061035156,38.01250076293945,37.75611114501953,NVDA,Semiconductor Industry Association Reports 7.2% Decline in Global Chip Sales in January,0,0.5218825
2019-03-07,45010400.0,37.775001525878906,37.872501373291016,36.84999847412109,37.31499862670898,37.06331634521485,NVDA,'Global semiconductor market dips for first time in 30 months; Shrinking demand from data centers and China blamed for decline' -Nikkei Asian Review,1,0.5144463
2019-03-08,42241600.0,36.415000915527344,37.76750183105469,36.20000076293945,37.65999984741211,37.4059944152832,NVDA,Do You Love Cult Stocks?,1,0.5002203
2019-03-11,85972800.0,37.897499084472656,40.51499938964844,37.42250061035156,40.28499984741211,40.013282775878906,NVDA,"Nvidia Near Deal to Acquire Mellanox Technologies for $7B+ in Cash ||| The Early Reaction To Nvidia's Acquisition Of Mellanox ||| Mid-Afternoon Market Update: Crude Oil Up 1.2%; Yatra Online Shares Spike Higher ||| 40 Stocks Moving In Monday's Mid-Day Session ||| Mid-Day Market Update: NASDAQ Rises Over 100 Points; Axovant Sciences Shares Surge ||| NVIDIA shares are trading higher after the company announced it will acquire Mellanox Technologies for $6.9 billion. ||| Mid-Morning Market Update: Markets Mostly Higher; Nvidia To Buy Mellanox Technologies For $6.9B ||| From NVIDIA Call To Discuss Mellanox Purchase: CFO Says Mgmt. To Focus Rest Of Calendar Year To Close Deal, Notes Approval In US, China Still Needed ||| Nvidia To Buy Mellanox Technologies For $6.9B ||| A Peek Into The Markets: Boeing Leads Dow Futures Lower ||| Mellanox to be Acquired by NVIDIA for $125/Share Cash ||| 7 Stocks To Watch For March 11, 2019",1,0.4973386
2019-03-12,57957600.0,40.56499862670898,41.09749984741211,39.79750061035156,40.630001068115234,40.355953216552734,NVDA,"What's Next For Nvidia And Mellanox? ||| Starboard Value Comments Following News Of NVIDIA Offer To Mellanox, Says Has Sold Its Entire Position In Mellanox ||| Brexit Time Again: As Parliament Votes, U.S. Stocks Have Mixed Tone With Boeing Down ||| 50 Biggest Movers From Yesterday",1,0.48064426
2019-03-14,51938400.0,42.247501373291016,42.36750030517578,41.3125,41.38999938964844,41.11083221435547,NVDA,Pro: Nvidia's Stock At A Tipping Point ||| Global Barometer: Oracle Earnings Could Provide Insight On Economy ||| China Might Take Some Starch Out of U.S. Rally With More Weak Economic Data,1,0.5093224
2019-03-15,66148400.0,41.82500076293945,42.88249969482422,41.790000915527344,42.45249938964844,42.16616821289063,NVDA,Shares of several semiconductor companies are trading higher after Broadcom reported better-than-expected Q1 EPS and issued strong FY19 guidance.,0,0.5249333
2019-03-19,85497200.0,43.18999862670898,44.375,43.02000045776367,43.9275016784668,43.63121032714844,NVDA,"Samsung CEO Sees Intensified Competition in Chip Market Due to Oversupply ||| 45 Stocks Moving In Tuesday's Mid-Day Session ||| 45 Stocks Moving In Tuesday's Mid-Day Session ||| AMD Analyst Says Cloud Gaming A Good Opportunity, But Stock Is 'Ahead Of Itself' ||| ON Semiconductor Collaborates With NVIDIA On Cloud-Based Autonomous Vehicle Simulation ||| Analysts Dissect Nvidia's Product Announcements: 'Evolutionary Rather Than Game-Changing' ||| NVIDIA shares are trading higher after the company teamed up with Amazon Web Services IoT to bring AI to millions of connected devices. ||| NVIDIA Teams with Amazon Web Services to Bring AI to Millions of Connected Devices",0,0.5020483
2019-03-20,71914800.0,44.220001220703125,44.75749969482422,43.25,43.59999847412109,43.30592346191406,NVDA,"Sell-Side Largely Bullish On Nvidia, With Eye On Anticipated Second-Half Recovery ||| Fed And FedEx: While Fed Meeting Dominates News, Don't Forget Trade Situation ||| 70 Biggest Movers From Yesterday",1,0.49353248
2019-03-21,82431200.0,43.83250045776367,46.25,43.782501220703125,45.98500061035156,45.67484664916992,NVDA,Shares of several semiconductor stocks are trading higher after Micron reported better-than-expected Q2 EPS and revenue; the company's CEO also stated they expect NAND bit supply growth in FY20 to be below industry demand.,0,0.5381134
2019-03-22,74764400.0,45.709999084472656,46.20000076293945,44.23500061035156,44.375,44.07568740844727,NVDA,Shares of the overall market are trading lower after the yield curve inverted for the first time since 2007; some attribute this as a sign of the economy slowing. ||| The Place To Be With Israel ETFs ||| Light Goes From Green To Red As Weak European Data Puts Brakes On U.S. Rally,0,0.53557503
2019-03-26,70350800.0,44.872501373291016,45.4375,43.650001525878906,44.21749877929688,43.91926574707031,NVDA,"Nvidia Gets Boost From Bullish Piper Jaffray Initiation ||| Benzinga's Top Upgrades, Downgrades For March 26, 2019 ||| NVIDIA shares are trading higher after Piper Jaffray initiated coverage on the stock with an Overweight rating and announced a $200 price target. ||| Piper Jaffray Sees Opportunity For NVIDIA To Significantly Expand Margins ||| PiperJaffray Initiates Coverage On NVIDIA with Overweight Rating, Announces $200 Price Target",0,0.5134602
2019-04-01,48382400.0,45.81499862670898,45.875,45.09249877929688,45.56999969482422,45.262638092041016,NVDA,"NVIDIA's Director of Technical Marketing Tom 'TAP' Petersen Departs for Intel ||| Shares of several semiconductor stocks are trading higher following strong manufacturing data from China after a guidance warning by Infineon last week dragged the sector lower. Strength may also be related to news of a lower value-added tax in China and positive US manufacturing data. ||| Stifel Nicolas Analyst Kevin Cassidy, When Asked About News Impacting Semiconductor Sector, Tells Benzinga, 'I think it's the news of lower VAT and positive PMI data for March'",1,0.5147378
2019-04-03,78350400.0,46.25,47.75,46.20000076293945,47.15499877929688,46.836944580078125,NVDA,"UPDATE: Nomura Initiates NVIDIA With Neutral, $147 Target As Firm Believes Co's Current Valuation Factors In Co's 'impressive history of developing new markets for its products, and the computing accelerator and automotive' Market Opportunities ||| Nomura Initiates Coverage On Semi Stocks, Picks AMD And Intel As Winners ||| Shares of several semiconductor companies are trading higher after a report stating AMD sales will increase ""sharply"" in the second half of 2019 given a ramp up in CPU and GPU shipments for notebooks, motherboards, and servers. ||| Benzinga's Top Upgrades, Downgrades For April 3, 2019 ||| Nomura Initiates Coverage On NVIDIA with Neutral Rating, Announces $147 Price Target",0,0.51888233
2019-04-09,43997200.0,47.61000061035156,47.72249984741211,46.88999938964844,47.31499862670898,46.99586486816406,NVDA,Seeing weakness in the microchip and semiconductor space. Not currently seeing any news to justify price action.,1,0.5094193
2019-04-11,37460000.0,48.04999923706055,48.36750030517578,47.38750076293945,47.8849983215332,47.56201934814453,NVDA,Ad Revenue Another Big Catalyst For The Esports ETF,0,0.54179376
2019-04-12,47170800.0,48.275001525878906,48.31499862670898,47.415000915527344,47.50249862670898,47.18210220336914,NVDA,"DZ Bank Downgrades NVIDIA To Sell, Announces $170 Target",0,0.5158079
2019-04-17,35100400.0,47.40499877929688,47.6150016784668,46.59749984741211,46.8224983215332,46.506683349609375,NVDA,"Hot, Fresh Earnings On The Menu As Netflix, Morgan Stanley Results In Focus",0,0.50013226
2019-04-18,38098800.0,46.88999938964844,47.23249816894531,46.29499816894531,46.57500076293945,46.26085662841797,NVDA,"Jim Cramer Shares His Thoughts On AMD, Gilead, Nvidia And More",1,0.50178087
2019-04-22,27993600.0,46.337501525878906,47.275001525878906,46.02000045776367,47.11750030517578,46.79969787597656,NVDA,Another Electric Vehicle ETF Revs Up,1,0.5205161
2019-04-23,34685600.0,47.25,47.98249816894531,47.15250015258789,47.66749954223633,47.34598922729492,NVDA,Quarterhill's Wi-LAN Reports Polaris Innovations Subsidiary Granted Term License For Certain Patents Owned By Polaris To NVIDIA As Well As Options for NVIDIA To Renew Through Life Of Patents,1,0.50913507
2019-04-24,31820400.0,47.772499084472656,48.20249938964844,47.15999984741211,47.79249954223633,47.47014236450195,NVDA,Shares of several microchip and semiconductor stocks are trading higher after Texas Instruments and Silicon Laboratories reported strong quarterly results.,0,0.5286299
2019-04-25,49929600.0,47.38750076293945,47.61249923706055,45.92499923706055,46.727500915527344,46.412330627441406,NVDA,"AMD Shares Trading 1.7% Higher, NVIDIA Down 2.6%, Micron Down 2.4% Following Q1 Earnings And Q2 Guidance From Intel ||| Shares of several companies in the semiconductor and microchip sector are trading lower after Xilinx reported Q4 earnings. Xilinx reported weakness in the data center and TME end markets. ||| Seeing Weakness In Several Semiconductor And Microchip Stocks; Susquehanna Analyst Christopher Rolland Tells Benzinga The Sector Is Weak On The Back Of Xilinx Earnings. ||| Big Chip Q1 Earnings Preview: A Focus On Industry Downturn, Product Delays, Competitive Dynamics, New Tech ||| NVIDIA Option Alert: May 3 $187.5 Calls Sweep (3) near the Ask: 814 @ $3.951 vs 2432 OI; Earnings 5/9 After Close [est] Ref=$186.44",0,0.50149035
2019-04-26,86898800.0,45.1775016784668,45.22249984741211,43.32500076293945,44.522499084472656,44.222198486328125,NVDA,"Intel Guidance Disappoints, But Earnings Season Overall Has Surprised To Upside ||| Shares of several semiconductors and microchip stocks are trading lower in sympathy with Intel after it issued worse-than-expected Q2 and FY19 guidance.",1,0.5054142
2019-04-30,36292000.0,44.50749969482422,45.50749969482422,44.31499862670898,45.25,44.94479370117188,NVDA,"Shares of several semi/microchip companies are trading higher after Advanced Micro Devices reported better-than-expected Q1 EPS and sales results. ||| You're Entering the ""Show-Me State"" As Chip Firms Get Ready To Report",0,0.5106957
2019-05-01,35428000.0,45.77750015258789,46.20249938964844,45.1150016784668,45.11750030517578,44.81318664550781,NVDA,"Analysts Impressed With AMD's Execution, Pipeline Following Solid Q1 Results",1,0.5448144
2019-05-02,39468400.0,45.21500015258789,46.21749877929688,44.77999877929688,45.79750061035156,45.48860549926758,NVDA,"NVIDIA To Report Q1 Earnings On Thurs., May 16, 2019 After Market Close",0,0.4995224
2019-05-06,42217600.0,43.875,45.084999084472656,43.5,44.962501525878906,44.65923690795898,NVDA,"Boeing, Caterpillar, Chipmakers Retreat After Trump Threats To Raise China Tariffs ||| Shares of several multinational companies are trading lower following a tweet from President Trump which hinted at additional tariffs on China and China indicated it may back out of upcoming trade negotiations.",0,0.51489043
2019-05-07,55522000.0,44.47499847412109,44.47499847412109,42.79249954223633,43.27750015258789,42.985599517822266,NVDA,"Many stocks are trading lower amid continued uncertainty about the future of trade between the US and China, and concerns on U.S. sanctions on Iran and Venezuela.",1,0.5248638
2019-05-08,41916800.0,43.0,44.28749847412109,42.880001068115234,43.47999954223633,43.18673706054688,NVDA,Autonomous Driving Startup Drivent Comes Out Of Stealth Mode,0,0.5201596
2019-05-09,66024800.0,42.78499984741211,42.88249969482422,41.34999847412109,42.54750061035156,42.260528564453125,NVDA,"Shares of several semiconductor stocks are trading lower after Intel issued concerning guidance at an investor event on Wednesday; BMO also downgraded the company's stock from Outperform to Market Perform. ||| Key Day Shapes Up For Trade Talks But Earnings Also In Focus As Disney Results Gleaned ||| Red Hat Reports Expansion Of Alliance With NVIDIA To Accelerate, Scale AI/Machine Learning Workloads Across Hybrid Clouds, No Terms Disclosed",0,0.5275565
2019-05-10,56950000.0,42.23749923706055,42.897499084472656,41.0,42.20500183105469,41.92033004760742,NVDA,Shares of several technology companies are trading lower on continued uncertainty surrounding the future of trade relations between the US and China after the Trump Administration increased tariffs on $200 million of Chinese goods from 10% to 25%. ||| Tariff Troubles: Market Retreat Looks To Continue As U.S. Raises Levies On China Goods,0,0.5427195
2019-05-13,65691200.0,40.875,41.10749816894531,39.45249938964844,39.61249923706055,39.34531021118164,NVDA,"Morgan Stanley Earlier Maintained Equal-Weight on NVIDIA Corporation - Common Stock, Raised Price Target to $170 ||| Goldman Maintains Buy On Nvidia, Maintains $185 Target Ahead Of Co's Earnings 5/16 Post Close As Firm Remains Bullish Long-Term, But Expects 'Gaming to remain weak on channel adjustments while Datacenter likely to be impacted by near term customer pauses' ||| Trade War Heats Up As China Retaliates With Raised Tariffs Of Its Own ||| Shares of several technology companies are trading lower amid continued US-China trade concerns. Proposed tariffs between the two nations could raise input costs, while trade tensions could hurt tech companies with China exposure.",1,0.48872155
2019-05-14,52488000.0,40.01250076293945,40.8650016784668,39.622501373291016,40.5099983215332,40.23675155639648,NVDA,"Shares of several semiconductor and microchip companies are trading higher as US markets rebound on renewed optimism surrounding US-China trade talks. ||| Stifel Nicolaus Maintains Hold on NVIDIA Corporation - Common Stock, Lowers Price Target to $145",0,0.49331912
2019-05-15,50232000.0,39.95000076293945,40.26250076293945,39.352500915527344,39.89500045776367,39.62590408325195,NVDA,"Nvidia Q1 Earnings Preview: Data Center, Gaming Inventory In Focus Amid Fundamental Uncertainties ||| IDC Issues Press Release Highlighting Research Showing Forecast For Global Semi Sales To Be Down 7.2% In 2019",1,0.5374497
2019-05-16,78108800.0,39.84000015258789,40.477500915527344,39.41249847412109,40.04750061035156,39.77737808227539,NVDA,"From NVIDIA Q1 Earnings Conference Call: Sales To Gaming Unit $1.05B, Down 39% Year Over Year, Sales To Data Center Unit $634M, Down 10% YoY ||| 5 Stocks Moving In Thursday's After-Hours Session ||| Nvidia Trades Higher After Q1 Earnings Beat, CEO Says It's Back On Upward Trajectory ||| NVIDIA shares are trading higher after the company reported better-than-expected Q1 EPS and sales results; the company issued inline Q2 sales guidance. ||| NVIDIA Sees Q2 Adj. Gross Margins 59.5% +/- 50 Bps ||| NVIDIA Sees Q2 Sales $2.55B +/- 2% vs $2.54B Estimate ||| NVIDIA Q1 Adj. EPS $0.88 Beats $0.79 Estimate, Sales $2.22B Beat $2.2B Estimate ||| Shares of several semiconductor companies are trading lower after President Trump signed an executive order restricting companies deemed a national security threat from selling to the U.S. and threatened to blacklist Huawei Technologies. ||| 7 Stocks To Watch For May 16, 2019 ||| Earnings Scheduled For May 16, 2019",0,0.51274025
2019-05-17,102206800.0,39.625,40.9275016784668,38.73500061035156,39.13249969482422,38.86855316162109,NVDA,"A Look At Benzinga Pro's 10 Most-Searched Tickers For May 17, 2019 ||| Morgan Stanley On Nvidia Notes 'We're surprised at the magnitude of data center weakness, and continue to forecast a recovery'; Maintains Equal-weight, Maintains $170 Target ||| Nvidia Analysts Sold On Long-Term Story, But Cautious On Data Center Weakness, Competition ||| China Accuses U.S. Of ""Bullying Behavior,"" Helping Pressure Market Sentiment ||| Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Fri., May 17, 2019 ||| Summit Insights Group Downgrades NVIDIA Corporation - Common Stock to Hold ||| UBS Maintains Buy on NVIDIA Corporation - Common Stock, Lowers Price Target to $195 ||| A Peek Into The Markets: US Stock Futures Signal Lower Start On Wall Street ||| IDC Reports Worldwide Semiconductor Revenues to Decline 7.2% in 2019 ||| 5 Stocks To Watch For May 17, 2019",0,0.5034779
2019-05-20,57206400.0,38.13750076293945,38.692501068115234,37.6875,37.9375,37.68160629272461,NVDA,Chips Stocks Rattled As Companies Halt Supplying China's Huawei ||| Shares of many semiconductor companies are trading lower after Trump added China's Huawei to a trade blacklist.,1,0.5126222
2019-05-21,36184800.0,38.54999923706055,38.92499923706055,38.15999984741211,38.76499938964844,38.503536224365234,NVDA,NVIDIA Has Filed With China Regulator SAMR For Approval For Mellanox Deal ||| Shares of many Semiconductors stocks are trading higher after the US granted temporary relief for Huawei suppliers.,0,0.53340125
2019-05-23,59184400.0,37.42250061035156,37.42250061035156,36.227500915527344,36.83000183105469,36.58158874511719,NVDA,Shares of many semiconductor companies are trading lower on continued US-China tension after the Trump administration said it would add up to 5 more Chinese surveillance companies to the blacklist.,0,0.51435316
2019-05-28,42835600.0,36.46500015258789,36.79499816894531,35.8125,35.83250045776367,35.59081268310547,NVDA,Rosenblatt: AMD Will Be 'Much Bigger Player In High-End GPU Gaming',0,0.5230182
2019-05-29,55980000.0,35.352500915527344,35.70500183105469,34.73500061035156,35.084999084472656,34.848358154296875,NVDA,Shares of several technology companies are trading lower with the overall US market as US-China trade tensions continue to concern investors.,0,0.53265077
2019-05-30,39430000.0,35.07749938964844,35.4375,34.39250183105469,34.77750015258789,34.58235549926758,NVDA,FAANG's Out: Investing Gems In Today's Technology Landscape ||| Jim Cramer Tweets Building Stake in Nvidia in Charitable Trust,0,0.5123047
2019-05-31,38972000.0,34.28499984741211,34.962501525878906,33.84749984741211,33.8650016784668,33.67497634887695,NVDA,Many mega-cap stocks trading lower following a tweet from President Trump late Thursday the US will impose a 5 percent tariff on goods from Mexico.,0,0.5278356
2019-06-04,64183600.0,34.09000015258789,35.8025016784668,33.86750030517578,35.75,35.549407958984375,NVDA,Shares of several technology companies are trading higher after China's Commerce Ministry stated they are open to dialogue to resolve trade tensions; Mexico trade concerns also eased after Mexican officials said it could find common ground with the US.,0,0.54743683
2019-06-05,51161600.0,36.49250030517578,36.54750061035156,34.95500183105469,35.31999969482422,35.121803283691406,NVDA,"Shares of several technology companies are trading lower after Pivotal Software provided Q2 and FY20 sales guidance significantly below analyst estimates. ||| Boomerang Seems To Continue As Caterpillar, Nvidia, Apple Among Early Gainers ||| Nvidia to Adopt Samsung 7nm EUV Process in Next-gen GPU Production",1,0.50227976
2019-06-06,40814000.0,35.36249923706055,36.192501068115234,35.337501525878906,35.94499969482422,35.74331283569336,NVDA,"Morgan Stanley Upgrades AMD, Says 'Table Is Set Well' For 2020 ||| Barclays Maintains Overweight on NVIDIA, Lowers Price Target to $180",1,0.48686647
2019-06-10,40278000.0,36.93999862670898,37.79750061035156,36.93999862670898,37.10749816894531,36.89928436279297,NVDA,"Ready Trader One: Events, Stocks To Watch At E3 ||| Shares of several technology companies are trading higher after the U.S. and Mexico signed part of an immigration deal. If reached, Mexico would avoid previously announced tariffs; if not reached, President Trump stated tariffs would be reinstated.",1,0.51181
2019-06-11,38387200.0,37.709999084472656,38.09000015258789,37.290000915527344,37.6875,37.47603225708008,NVDA,"Analyst: AMD's New Graphics Cards Make 'Meaningful Improvement' But Cost More Than Expected ||| Shares of Shares of several semiconductor and technology companies are trading higher on continued trade optimism. The recent US-Mexico deal boosted confidence that the US could also strike a deal with China. ||| Super Micro Computer Reports Support for NVIDIA EGX Platform On Co.'s NGC-Ready Industry-Leading 1U, 2U GPU Servers, Edge Computing Servers",0,0.5143478
2019-06-12,35889200.0,37.25,37.3125,36.397499084472656,36.54999923706055,36.34490966796875,NVDA,Shares of several semiconductor stocks are trading lower after the FTC opposed Qualcomm's antitrust request.,1,0.5144563
2019-06-13,30808000.0,36.772499084472656,37.25,36.595001220703125,37.06499862670898,36.85702133178711,NVDA,"Oppenheimer Bullish On Nvidia, Cautious On AMD, Intel ||| As Oil Prices Jump, Energy Shares Help Fuel Market Rally",0,0.5166489
2019-06-14,39442800.0,36.12749862670898,36.372501373291016,35.709999084472656,36.15999984741211,35.95709228515625,NVDA,"Chip Stocks Fall In Sympathy With Broadcom After Q2 Sales Miss, Guidance Cut ||| Shares of several semiconductor companies are trading lower after weak quarterly results from Broadcom, citing ""broad-based"" demand weakness and the U.S. crackdown on Huawei.",1,0.52008396
2019-06-17,27604000.0,36.14250183105469,36.630001068115234,35.912498474121094,36.25749969482422,36.054046630859375,NVDA,Internet Trends Report: Why Immigration Is Critical To The US Tech Industry ||| Nvidia Announces Support For Arm CPUs: Why It Matters ||| NVIDIA Announces Support for Arm CPUs,1,0.5030406
2019-06-18,58192000.0,36.875,38.77750015258789,36.76499938964844,38.220001220703125,38.00555038452149,NVDA,"Cloud Looming? Oracle's Revenue Seen Down In Competitive Atmosphere ||| Nvidia To Partner With Volvo On Self-Driving Trucks ||| Shares of several semiconductor companies are trading higher after President Trump said he spoke with China's Xi and announced they will have an extended meeting at G20, renewing trade optimism. NOTE: Semis have major China exposure. ||| Volvo Group Partners With NVIDIA to Develop Advanced AI Platform for Autonomous Trucks",1,0.49255887
2019-06-20,35016800.0,39.192501068115234,39.33250045776367,38.380001068115234,38.525001525878906,38.3088264465332,NVDA,Shares of several technology companies are trading higher amid renewed hopes of a Federal Reserve rate cut this year and in sympathy with Oracle reporting strong Q4 earnings.,0,0.5298672
2019-06-24,28294800.0,38.15499877929688,38.462501525878906,37.68000030517578,38.165000915527344,37.95084762573242,NVDA,"As Anticipation Firms For Trump/Xi Meeting, Focus Is On Earnings, Iran Tensions",0,0.51041794
2019-06-26,58407200.0,39.15250015258789,40.43000030517578,39.022499084472656,39.81499862670898,39.59158706665039,NVDA,Shares of companies in the semiconductor space are trading higher after Micron reported strong Q3 earnings.,1,0.53718936
2019-06-27,44544000.0,40.6775016784668,41.0,40.31499862670898,40.807498931884766,40.57851028442383,NVDA,"NVIDIA shares are trading higher after Wedbush initiated coverage on the stock with an Outperform rating and announced a $184 price target. ||| Benzinga's Top Upgrades, Downgrades For June 27, 2019 ||| Wedbush Initiates Coverage On NVIDIA with Outperform Rating, Announces $184 Price Target",1,0.50422454
2019-07-01,70975600.0,43.14250183105469,43.48749923706055,41.165000915527344,41.54249954223633,41.30939865112305,NVDA,AMD-Nvidia Graphics Competition Heats Up ||| Shares of several hardware suppliers are trading higher after President Trump said he would ease the ban on US companies selling to Huawei. ||| Competition Between AMD and Nvidia in Graphics Card Market Expected to Heat Up in Early July,0,0.5001173
2019-07-02,40022800.0,41.375,41.587501525878906,40.42499923706055,40.557498931884766,40.32992172241211,NVDA,"With Jobs Report Ahead, Focus Turns To Economic Data, Auto Sales, Tesla Output",1,0.52873796
2019-07-05,39655200.0,40.09999847412109,40.14500045776367,39.41999816894531,40.057498931884766,39.83273315429688,NVDA,AMD Reportedly Slashes Prices On Graphics Card Ahead Of Launch,0,0.52488464
2019-07-08,32978800.0,39.45750045776367,39.647499084472656,39.0,39.3025016784668,39.08197021484375,NVDA,AMD's RX 5700 Graphics Cards Now Available: What You Need To Know,1,0.48508632
2019-07-09,34286000.0,38.87749862670898,39.61000061035156,38.75,39.32749938964844,39.1068229675293,NVDA,"Will Earnings Season Prompt a Resurr-tech-tion? ||| As Investors Await Fed Chair Testimony Wednesday, PepsiCo Delivers Strong Results ||| Kinahan Says Millennials Are Buying The Stocks They Know, Like Beyond Meat And Tesla",1,0.49119416
2019-07-11,68256000.0,40.75,41.97999954223633,40.375,41.56999969482422,41.33673858642578,NVDA,"Boutique Research Firm Upgrades Nvidia, Says AI, Ray Tracing Will Drive Demand For Chipmaker ||| NVIDIA shares are trading higher after Cascend upgraded the stock from Hold to Buy and announced a price target of $190 per share. ||| Cascend Upgrades NVIDIA to Buy, Announces $190 Price Target",1,0.5046178
2019-07-12,50639200.0,41.84999847412109,42.61750030517578,41.84999847412109,41.90250015258789,41.66737365722656,NVDA,"Shares of several semiconductor companies are trading higher amid positive trends in US-China trade negotiations, Trump loosening the Huawei ban and the Fed signaling a rate cut. Japan/Korea trade tensions could also drive up memory prices. ||| UPDATE: Cassidy Also Tells Benzinga 'Japan / Korea trade issues may drive up the prices of memory devices following a year of memory prices in free fall. Prices for memory increased w/w for the first time in over a year.' ||| Stifel Nicolaus Analyst Kevin Cassidy On Semiconductors Strength, Tells Benzinga 'The fed signaling lower interest rates and Trump loosening the ban on Huawei are both huge news for semiconductor companies.' ||| Tigress Financial Analyst Ivan Feinseth Comments On Semiconductors Strength, Tell Benzinga 'Positive trends in US-China trade negotiations is lifting all the chip stocks.'",0,0.51506925
2019-07-15,28984000.0,42.1150016784668,42.27750015258789,41.532501220703125,41.817501068115234,41.58284378051758,NVDA,"Barron's Picks And Pans: Dollar Tree, Expedia, Nvidia, Prudential And More",0,0.50677824
2019-07-16,34144400.0,41.66749954223633,42.04249954223633,41.209999084472656,41.77000045776367,41.53561401367188,NVDA,Rekor Systems Earlier Announced It Has Joined NVIDIA Metropolis Software Partner Program To Apply Deep Learning To Video Streams,1,0.5258869
2019-07-22,31594000.0,42.32500076293945,42.959999084472656,42.25,42.83000183105469,42.58967971801758,NVDA,"Shares of several semiconductor companies are trading higher after Kudlow and Mnuchin invited U.S. tech companies to discuss the Huawei ban; Goldman Sachs upgraded companies in the sector, believing excess inventory will be depleted more quickly.",1,0.5207699
2019-07-23,42817600.0,43.22499847412109,43.935001373291016,43.067501068115234,43.915000915527344,43.6685905456543,NVDA,Some Perspective On The Potent Esports ETF,1,0.5245466
2019-07-24,36623600.0,44.34999847412109,44.72249984741211,43.584999084472656,44.665000915527344,44.41439056396485,NVDA,Shares of several semiconductor companies are trading higher in sympathy with Texas Instruments and Teradyne after both companies reported positive Q2 EPS and sales results. Both companies also issued in-line Q3 guidance.,0,0.52147746
2019-07-25,39270000.0,44.247501373291016,44.375,43.11000061035156,43.345001220703125,43.101783752441406,NVDA,NVIDIA shares trading lower despite no company news. Note that shares of NVIDIA have rallied about 8% over the last 2 weeks and over 32% since the beginning of June.,1,0.5045179
2019-07-26,27416000.0,43.61750030517578,44.23749923706055,43.61750030517578,43.76750183105469,43.521915435791016,NVDA,Stock Wars: Intel Vs. AMD Vs. Nvidia ||| Semiconductor Equipment Billings Stay above $2B in June,0,0.50386107
2019-07-29,24816000.0,43.69499969482422,43.86750030517578,42.817501068115234,43.70500183105469,43.45976257324219,NVDA,Shares of several semiconductors companies are trading lower on seemingly no news. It could potentially be a sell-off following the sector experiencing continued growth over the course of the last two months.,1,0.52008235
2019-07-30,19777200.0,43.23749923706055,43.98500061035156,43.09249877929688,43.86249923706055,43.61637115478516,NVDA,China Fortunes Keep Chip Stocks On Wild Ride As Advanced Micro Reports,0,0.5086684
2019-07-31,35941600.0,43.54499816894531,43.55500030517578,41.755001068115234,42.18000030517578,41.94332504272461,NVDA,"AMD Drops On Mixed Quarter, Analysts Weigh In ||| Shares of several semiconductor companies are trading lower in sympathy with Advanced Micro Devices after the company issued Q3 sales guidance below analyst estimates. ||| Jim Cramer Gives His Opinion On Nvidia, Cisco And More ||| What To Watch In August: Retail Earnings, IPOs, Fed Moves",0,0.4873615
2019-08-01,42121200.0,42.28499984741211,43.19499969482422,40.70500183105469,41.22999954223633,40.99864196777344,NVDA,Analysts Weigh In On The Semiconductor ETF And NVIDIA ||| Shares of several semiconductor companies are trading higher on seemingly no sector-specific news. Strength may be due to a rebound following yesterday's sector-wide weakness after AMD issued weak Q3 sales guidance.,0,0.536004
2019-08-02,42834800.0,40.29750061035156,40.994998931884766,39.81999969482422,40.29750061035156,40.071380615234375,NVDA,26 Technology Stocks Moving In Today's Pre-Market Session,0,0.524156
2019-08-05,58915600.0,38.45000076293945,38.462501525878906,37.22499847412109,37.6974983215332,37.485965728759766,NVDA,Shares of several semiconductor companies are trading lower after President Trump announced additional tariffs on Chinese goods.,1,0.53036094
2019-08-08,30930000.0,39.0525016784668,39.57749938964844,38.47499847412109,39.56499862670898,39.34298706054688,NVDA,Shares of several semiconductors companies are trading higher on a potential rebound following a recent downturn the sector has experienced over the past few months amid growing trade tensions.,0,0.5340997
2019-08-09,34181600.0,39.15250015258789,39.1875,38.03749847412109,38.54499816894531,38.328704833984375,NVDA,"Shares of several semiconductor companies are trading lower after President Trump announced the U.S. is not doing any business with Huawei. Huawei is an important customer for many semiconductor companies. ||| Twists And Turns: This Week's Wild Ride Swings Through U.K., Italy, China",0,0.50925946
2019-08-12,27920000.0,38.02000045776367,38.54499816894531,37.64250183105469,37.86249923706055,37.650047302246094,NVDA,"Report: AMD Prepping For Launch Of 'Nvidia Killer' Graphics Card In Mid-2020 ||| Market Remains On Edge As Tensions Between U.S., China Continue",1,0.5297724
2019-08-13,35195600.0,37.84749984741211,39.47499847412109,37.45500183105469,39.01250076293945,38.79359817504883,NVDA,"Shares of several semiconductor companies are trading higher in sympathy with the overall market after the U.S. Trade Representative reported that some tariffs will be delayed to Dec 15 on some products including cell phones, monitors, and laptops.",0,0.52259487
2019-08-14,41988000.0,38.125,38.23749923706055,37.07749938964844,37.51750183105469,37.30698776245117,NVDA,"Nvidia Analysts Preview Q2 Earnings: A Challenging Near Term, But Out Years Hold Promise ||| Shares of several semiconductors companies are trading lower after the spread between the 2-year and 10-year yield curve inverted for the first time since 2007, potentially signaling an oncoming recession.",0,0.5256062
2019-08-15,47720000.0,37.70750045776367,37.907501220703125,36.84749984741211,37.192501068115234,36.98380661010742,NVDA,"5 Stocks Moving In Thursday's After-Hours Session ||| Nvidia Trades Higher On Q2 Earnings Beat ||| NVIDIA Sees Q3 Sales $2.842B-$2.958B vs $2.97B Estimate, Adj. Gross Margin ~62.5% ||| NVIDIA Q2 Adj. EPS $1.24 Beats $1.14 Estimate, Sales $2.58B Beat $2.55B Estimate ||| 10 Stocks To Watch For August 15, 2019 ||| Earnings Scheduled For August 15, 2019",1,0.5053036
2019-08-16,100796000.0,39.837501525878906,40.3849983215332,39.220001220703125,39.88999938964844,39.66616821289063,NVDA,"41 Stocks Moving In Friday's Mid-Day Session ||| A Look At Benzinga Pro's Most-Searched Tickers For August 16, 2019 ||| What Analysts Have To Say About Nvidia Following Earnings Beat ||| UPDATE: Raymond James Reiterates Outperform On NVIDIA, Reiterates $180 Target As Firm Thinks 'the pause in hyperscale spending this year (which affected all suppliers) provides a strong setup for next year' ||| Investors Seem More Optimistic As Trade, Bond Market Worries Ease ||| Mid-Morning Market Update: Markets Open Higher; Deere Earnings Miss Views ||| UPDATE: Morgan Stanley On NVIDIA Continues 'Bulls probably wanted more clarity on data center than we heard despite a return to q/q growth' ||| UPDATE: Morgan Stanley Maintains Equal-weight On NVIDIA, Raises Target To $180 As Firm Notes 'Headline is a sharp recovery in gross margins in the October quarter that drives up EPS, unexpectedly' ||| Top 10 Movers Via Benzinga Pro's Screener Tool For Morning of Friday., August 16, 2019 ||| Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Friday., August 16, 2019 ||| 10 Biggest Price Target Changes For Friday ||| 7 Technology Stocks Moving In Friday's Pre-Market Session ||| NVIDIA shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. ||| Morgan Stanley Maintains Equal-Weight on NVIDIA, Raises Price Target to $180 ||| 26 Stocks Moving in Friday's Pre-Market Session ||| A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street ||| 7 Stocks To Watch For August 16, 2019",1,0.5199477
2019-08-19,81511200.0,41.02999877929688,42.85499954223633,40.86750030517578,42.69499969482422,42.4554328918457,NVDA,"Bulls And Bears Of The Week: Apple, Cisco, Salesforce, Walmart And More ||| Shares of several semiconductors are trading higher on renewed hopes of a resolution to trade tensions between the US and China. ||| Busy Week Ahead With Fed Symposium And Retail Earnings Marching On With Target, Kohl's ||| 27 Technology Stocks Moving In Monday's Pre-Market Session ||| 60 Biggest Movers From Friday",0,0.49265948
2019-08-20,46318800.0,42.63999938964844,42.64500045776367,41.755001068115234,41.96749877929688,41.73201370239258,NVDA,"Nomura On Semiconductors: Analyst Eyes Data Center, PC Trends ||| Graphics Card Market to See Heated Competition between Nvidia, AMD, Intel in 2021",1,0.50582343
2019-08-21,42724400.0,42.63249969482422,43.36249923706055,42.415000915527344,42.807498931884766,42.56730270385742,NVDA,"Shares of several technology companies shares are trading higher in sympathy with the overall market. ||| NVIDIA shares are trading higher after Benchmark assumes the stock with a Buy rating and announced a $210 price target. ||| Benchmark Assumes NVIDIA at Buy, Announces $210 Price Target",1,0.48698056
2019-08-23,56805600.0,42.09999847412109,42.647499084472656,40.40999984741211,40.61000061035156,40.38212585449219,NVDA,Nvidia's Newest Competitor Is One Of Trump's Biggest Foes ||| China To Impose $75 Billion In Retaliatory Tariffs ||| Shares of several semiconductors companies are trading lower on escalated trade tensions after China announced it plans to impose a 5% to 10% tariff rate on $75 billion worth of U.S. goods.,1,0.51433426
2019-08-26,31820800.0,41.40250015258789,41.64500045776367,40.977500915527344,41.36249923706055,41.130409240722656,NVDA,"Shares of several semiconductor companies are trading higher amid easing trade tensions. President Trump said China is ready to come back to the negotiating table. ||| Week Starts With Trade Hopes Slightly Improved, But Caution Remains Watchword",0,0.48412573
2019-08-29,35797600.0,41.22499847412109,42.07500076293945,41.18999862670898,41.75,41.55682373046875,NVDA,Shares of several semiconductor companies are trading higher after China's Ministry of Commerce said the country is willing to work to resolve US trade tensions and does not want any further escalation. ||| 24 Technology Stocks Moving In Thursday's Pre-Market Session,1,0.49225888
2019-08-30,29061600.0,42.21500015258789,42.71500015258789,41.69499969482422,41.87749862670898,41.68374252319336,NVDA,AMD Desktop GPU Shipments Overtake Nvidia's For First Time In 5 Years,0,0.5149203
2019-09-03,29614000.0,41.14500045776367,41.477500915527344,40.8125,41.04249954223633,40.85260009765625,NVDA,"Shares of several semiconductor companies are trading lower as trade concerns continue to escalate following a new 15% tariff, which was added to $112 billion worth of Chinese goods on Sunday. ||| Trader Toolkit: Return Of The MACD ||| 27 Technology Stocks Moving In Tuesday's Pre-Market Session",1,0.51843196
2019-09-04,22772800.0,41.65250015258789,42.26499938964844,41.65250015258789,42.18999862670898,41.99478530883789,NVDA,Shares of many semiconductor companies are trading higher as Hong Kong tensions ease on the withdrawal of the extradition bill that has caused mass protesting. The protests are seen as a potential disruption to the global economy and U.S.-China trade talks. ||| These Are The Leveraged ETFs At Play When Trade War Worries Strike,1,0.50881875
2019-09-05,69567600.0,43.21749877929688,44.997501373291016,43.20000076293945,44.935001373291016,44.72710418701172,NVDA,Shares of many semiconductor companies are trading higher with the broader stock market after the Chinese Minister of Commerce said the U.S. and China are set to meet in Washington D.C in early October. ||| 14 Technology Stocks Moving In Thursday's Pre-Market Session ||| IHS Says Chip Sales Fell ~14% in H1 2019,0,0.49059382
2019-09-10,35281200.0,44.79499816894531,46.0625,44.6974983215332,45.79499816894531,45.58311080932617,NVDA,Game On: Nvidia Reportedly Working On Sub-$300 Graphics Card To Take On AMD,1,0.49513775
2019-09-11,36151200.0,45.942501068115234,46.567501068115234,45.650001525878906,46.08250045776367,45.86928939819336,NVDA,Shares of several semiconductor companies are trading higher after China released a tariff exemptions list for certain products from the U.S. Apple also released new iPhones which are expected to benefit several companies within the sector.,0,0.5382197
2019-09-16,23183200.0,44.72999954223633,45.400001525878906,44.625,45.0525016784668,44.844051361083984,NVDA,Examining The VanEck Esports ETF And Its 30% Surge This Year,1,0.5381442
2019-09-18,25815200.0,45.1974983215332,45.35499954223633,44.125,44.994998931884766,44.78681182861328,NVDA,"Jim Cramer Weighs In On Centene, Fastly And More",0,0.52867717
2019-09-19,24547600.0,45.05500030517578,45.2400016784668,44.12749862670898,44.23500061035156,44.03033065795898,NVDA,Report: AMD's Low-End Dominance Threatened As Nvidia Preps Budget Graphic Card Launch,0,0.5228085
2019-09-23,24971200.0,43.17499923706055,44.16749954223633,43.13750076293945,43.709999084472656,43.50775909423828,NVDA,"SunTrust Robinson Humphrey Maintains Buy on NVIDIA, Raises Price Target to $216",0,0.50787354
2019-09-24,31726800.0,44.025001525878906,44.3224983215332,42.775001525878906,43.13249969482422,42.93293762207031,NVDA,"'Fast Money Halftime Report' Traders Weigh In On Apple, Uber And More ||| Shares of companies in the semiconductor space are trading lower after Trump criticized China's trade policies in front of the UN. The sector has exposure to China and is sensitive to US-China trade relations.",1,0.5152181
2019-09-25,30843200.0,43.12749862670898,44.755001068115234,42.6775016784668,44.557498931884766,44.3513298034668,NVDA,NVIDIA shares are trading higher despite no company-specific news. The stock has rallied roughly 14% in the past 3 months.,0,0.5094691
2019-09-27,36205600.0,43.915000915527344,44.42499923706055,42.33000183105469,42.93999862670898,42.74131774902344,NVDA,"Shares of several semiconductor companies are trading lower following reports indicating the White House is considering setting limits on US flows to China, delisting Chinese company's from US stock exchanges. NOTE: Semiconductor companies are heavily impacted by U.S.-China trade war uncertainty, especially companies in business with Huawei.",1,0.5216628
2019-10-01,36600800.0,43.75,45.25,43.45249938964844,43.5,43.29872894287109,NVDA,"Shares of several semiconductor companies are trading higher on renewed U.S.-China trade optimisim. A U.S. Treasury spokeswoman said the White House ""is not contemplating blocking Chinese companies from listing shares on U.S. stock exchanges at this time.",0,0.51695
2019-10-02,29337200.0,43.27999877929688,43.400001525878906,42.532501220703125,43.2599983215332,43.05984115600586,NVDA,Shares of several semiconductor companies are trading lower in sympathy with the overall market on continued fears of a recession amid a weak ADP jobs report. There is also uncertainty in the market over the upcoming U.S.-China meeting next week.,1,0.51892745
2019-10-03,45058800.0,43.30500030517578,45.38999938964844,43.0,45.32749938964844,45.117767333984375,NVDA,Shares of many semiconductor companies are trading higher as investors are optimistic of a trade deal with China that could be reached after President Trump said a Chinese delegation is set to come to the U.S. next week for continued trade talks. ||| NVIDIA shares are trading higher despite no company-specific news. This could potentially be a rebound im sympathy with the overall market.,1,0.4837656
2019-10-07,48098400.0,46.14500045776367,47.084999084472656,46.057498931884766,46.08250045776367,45.86928939819336,NVDA,"Investors Sell FANG To Buy IPOs In September's IMX ||| Best And Worst Short Ideas Of The Week ||| AMD Unveils Budget Radeon Graphics Cards Aimed At Nvidia's Entry-Level Products ||| Investor Movement Index Summary: September 2019 ||| A Look At Benzinga Pro's Most-Searched Tickers For October 7, 2019 ||| Evercore ISI Group Maintains Outperform on NVIDIA, Raises Price Target to $225 ||| NVIDIA shares are trading higher after RBC Capital maintained an Outperform rating on the stock and raised the price target from $190 to $217. ||| Talking Trade: Back To The Table This Week, But Will Big Issues Be Addressed? ||| RBC Capital Maintains Outperform on NVIDIA, Raises Price Target to $217 ||| 17 Technology Stocks Moving In Monday's Pre-Market Session",0,0.5016438
2019-10-08,44443600.0,45.15999984741211,45.15999984741211,44.125,44.307498931884766,44.10249328613281,NVDA,"Shares of several semiconductor companies are trading lower as optimism around the upcoming U.S.-China trade talks waned. A report says China is toning down its expectations of the meeting. The U.S. expanded its trade blacklist, and scheduled an increase in tariffs on $250 billion worth of Chinese goods from 25% to 30% on Oct. 15, which will go into effect if no progress is made. ||| 20 Technology Stocks Moving In Tuesday's Pre-Market Session",1,0.5249844
2019-10-09,29241200.0,45.08000183105469,45.67499923706055,44.790000915527344,45.1775016784668,44.96847152709961,NVDA,"Option Traders Make Bullish Bets On Nvidia ||| Jim Cramer Shares His Thoughts On Roku, Gilead And More ||| Shares of several semiconductor companies are trading higher after multiple reports suggesting China is open to a partial trade deal surfaced. The reports renewed optimism in the upcoming U.S.-China trade talks. ||| 19 Technology Stocks Moving In Wednesday's Pre-Market Session",1,0.55487984
2019-10-10,30912400.0,45.15499877929688,46.27000045776367,45.102500915527344,45.75749969482422,45.5457878112793,NVDA,Shares of many semiconductors are trading higher on renewed trade optimism after the US was considering suspending tariff increase in exchange for a currency pact. President Trump's administration also plans to allow the sale of some supplies to Huawei.,1,0.5439283
2019-10-11,44640400.0,46.602500915527344,47.334999084472656,46.41249847412109,46.497501373291016,46.28236389160156,NVDA,Shares of several semiconductor companies are trading higher after President Trump made positive remarks on the U.S.-China trade talks. Trump is scheduled to meet with Chinese Vice Premier Liu He at the White House today.,1,0.5089523
2019-10-14,20004000.0,46.40999984741211,46.84249877929688,46.09749984741211,46.63249969482422,46.41674041748047,NVDA,"Chip Stocks Not Reacting As Traders Circulate Report From WCCF Tech 'Rumor: Intel To Skip 10nm For Desktop CPUs, Will Offer 7nm Desktop CPUs in 2022'",1,0.50330794
2019-10-15,66412400.0,47.540000915527344,49.8224983215332,47.400001525878906,49.09249877929688,48.86536407470703,NVDA,"UPDATE: Cascend Maintains Buy On NVIDIA, Raises Tgt To $220 Notes 'We see hyperscale AI development work continuing to grow off this summers' strong AI pus'; Believes 'this is a prime opportunity to take advantage of bad news already being in this name' ||| Cascend Maintains Buy on NVIDIA, Raises Price Target to $220 ||| Analyst: Nvidia Earnings Will Triple In The Next 5 Years ||| NVIDIA shares are trading higher after Bank of America maintained a Buy rating on the stock and raised the price target from $225 to $250. ||| 10 Biggest Price Target Changes For Tuesday ||| Bank of America Maintains Buy on NVIDIA, Raises Price Target to $250 ||| 10 Technology Stocks Moving In Tuesday's Pre-Market Session",0,0.5111597
2019-10-16,42894400.0,48.75,49.80500030517578,48.4375,48.5525016784668,48.32785034179688,NVDA,"Bank Of America Results Keep Financial Sector Flowing, With Netflix In Focus Later ||| Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Wednesday, October 16, 2019",1,0.48872325
2019-10-17,26343600.0,49.0,49.45249938964844,48.025001525878906,48.5724983215332,48.34775924682617,NVDA,9 Technology Stocks Moving In Thursday's Pre-Market Session,0,0.5164378
2019-10-21,26186800.0,48.2400016784668,49.13750076293945,48.04999923706055,49.00249862670898,48.77577590942383,NVDA,NVIDIA with Microsoft Announces Technology Collaboration for Era of Intelligent Edge ||| Shares of companies in the semiconductor space are trading higher amid US-China trade optimism. The sector has China exposure and has been highly affected by trade tensions this year.,0,0.52487224
2019-10-22,32872000.0,49.57500076293945,50.63249969482422,48.82500076293945,48.90250015258789,48.67623519897461,NVDA,"Analysts Like Nvidia's EGX Edge Supercomputing Platform, 5G Opportunity ||| Wells Fargo Earlier Maintained Outperform on NVIDIA, Raised Price Target to $220 ||| Ericsson and NVIDIA Collaborate to Accelerate Virtualized 5G Radio Access Networks With GPUs",0,0.5219118
2019-10-23,27991600.0,48.07749938964844,48.915000915527344,47.75749969482422,48.772499084472656,48.54683303833008,NVDA,NVIDIA shares are trading lower in sympathy with Texas Instruments after the company reported weak Q3 sales results and issued Q4 sales guidance below analyst estimates. ||| Semiconductor Equipment Billings Slip to 5-month Low,1,0.5139374
2019-10-24,23202000.0,49.1875,49.5525016784668,48.845001220703125,49.21500015258789,48.987281799316406,NVDA,"Shares of several semiconductors shares are trading higher in sympathy with Lam Research after the company reported better-than-expected Q1 EPS and sales results. The company had also issued Q2 EPS and sales above analyst estimates. ||| Big Chip Q3 Earnings Preview: Intel Could Win On Muted Expectations, AMD Makes Inroads",1,0.5029385
2019-10-25,42309200.0,50.025001525878906,51.345001220703125,49.9474983215332,51.1349983215332,50.898399353027344,NVDA,Nvidia shares are trading higher after RBC raised the price target of the stock from $217 to $251.,1,0.5082613
2019-10-28,33079200.0,51.57500076293945,52.22499847412109,51.27999877929688,51.6974983215332,51.45829772949219,NVDA,"Shares of several semiconductor companies are trading higher on progression in U.S.-China trade talks and positive sentiment from strong earnings reports. ||| Cramer Advises His Viewers On Del Taco, Tyson Foods And More ||| Another Bonanza Earnings Week As Apple Looms, With Fed, Payrolls Also On Weekly Agenda ||| NVDIA Announces a New Shield TV",0,0.5240286
2019-10-30,20596000.0,51.0,51.057498931884766,50.06499862670898,50.75,50.51519012451172,NVDA,"Analysts Upbeat On AMD's Product Roadmap, Execution ||| Video Game ETF Competition Gets Another Entrant With Global X's HERO",0,0.5163159
2019-10-31,20973200.0,50.540000915527344,50.75,49.45249938964844,50.255001068115234,50.02247619628906,NVDA,"NVIDIA To Report Q3 Earnings On Thurs., Nov. 14 After Market Close",1,0.51231915
2019-11-04,37671600.0,51.462501525878906,52.75,51.22999954223633,52.625,52.38151168823242,NVDA,"15 Stocks With A High Current Ratio ||| Earnings Thoughts Turn To Retail Later This Week, But Uber Starts Parade Today",0,0.4928652
2019-11-05,30086800.0,52.622501373291016,52.8849983215332,51.91999816894531,52.40250015258789,52.16004943847656,NVDA,"Ark Invest's Catherine Wood On Leveraging Disruption, Innovation To Grow Portfolios ||| NVIDIA Reports USPS Adopts Co. End-To-End AI Technology, No Terms Disclosed ||| Investor Movement Index Summary: October 2019",0,0.4741962
2019-11-07,28034000.0,52.77750015258789,52.92499923706055,51.6349983215332,52.084999084472656,51.84401321411133,NVDA,"3 Reasons Why Tesla Will Hit $6,000, According To Ark Invest's Catherine Wood ||| Analyst Warns Of Timing Issue With Nvidia's Datacenter Launch, But Remains Bullish ||| Shares of semiconductor companies are trading higher after Qualcomm reported better-than-expected Q4 results. ||| UPDATE: Raymond James Previews NVIDIA's Q3 Earnings (On Thurs., Nov. 14, 2019), Warns Of Uncertainty On Datacenter Launch Timing, Says Timing Could Impact Qtr. Results ||| Traders Circulating Word Of Cautious Sell-Side Comments On NVIDIA; Unconfirmed",0,0.5282547
2019-11-11,24343600.0,51.9375,52.27750015258789,51.06999969482422,52.04499816894531,51.804195404052734,NVDA,"UPDATE: Deutsche Bank Maintains Hold On NVIDIA, Raises Target To $190 Notes 'while we expect a solid print/guide that may deliver incremental upside to estimates, we believe much of this goodness is already reflected in the shares' ||| UPDATE: UBS Maintains Buy NVIDIA, Raises Target To $240 As Firm Notes 'Proof points are about to start playing out in': ||| After Slow Start, Week Might Gain Pace As Retail Sales, Inflation Data, Walmart Loom ||| Deutsche Bank Maintains Hold on NVIDIA, Raises Price Target to $190 ||| UBS Maintains Buy on NVIDIA, Raises Price Target to $240",1,0.5069275
2019-11-12,28350400.0,52.43000030517578,52.96500015258789,52.07749938964844,52.40250015258789,52.16004943847656,NVDA,"UPDATE: Cascend Maintains Buy On NVIDIA, Raises Target To $240 'on continued hyperscale AI development and fewer GPU price cuts (benefiting margins)' ||| Cascend Maintains Buy on NVIDIA, Raises Price Target to $240 ||| Oppenheimer Maintains Outperform on NVIDIA, Raises Price Target to $250 ||| 7 Technology Stocks Moving In Tuesday's Pre-Market Session",0,0.5044348
2019-11-13,30018800.0,52.087501525878906,52.3650016784668,51.47499847412109,52.14250183105469,51.9012451171875,NVDA,REX Shares Rolls Out A New ETN For FAANG Fans,1,0.5416029
2019-11-14,51808000.0,52.23249816894531,52.470001220703125,51.630001068115234,52.4474983215332,52.204837799072266,NVDA,"5 Stocks Moving In Thursday's After-Hours Session ||| Nvidia Posts Big Q3 Earnings Beat ||| NVIDIA Sees Q4 Sales $2.95B +/- 2% vs $3.06B Est. ||| NVIDIA Q3 Adj. EPS $1.78 Beats $1.58 Estimate, Sales $3.01B Beat $2.92B Estimate ||| NVIDIA Shares Unaffected As Traders Circulate Word From Jefferies Suggesting GPU-Card Maker In Contact With Firm Suggested Co. Stopped Shipping GPUs To It During Second Half Of Oct., Card Maker Sees H2'19 Unit Growth In 15-20% Range ||| Shoppers Rise To The Occasion As Walmart Reports Another Impressive Quarter ||| A Preview Of Nvidia's Q3 Earnings ||| Benzinga Pro's Top 5 Stocks To Watch For Thurs., Nov. 14, 2019: NVDA, SINA, DDS, TROV, AMRN ||| Earnings Scheduled For November 14, 2019 ||| 11 Stocks To Watch For November 14, 2019",0,0.5084738
2019-11-15,105362800.0,52.42499923706055,52.94499969482422,50.15999984741211,51.04750061035156,50.811309814453125,NVDA,"PreMarket Prep Recap: Breaking Down The Reaction To Walmart And Nvidia Earnings ||| Nvidia Impresses Analysts With Datacenter Resurgence, Expanding Margins ||| UPDATE: Morgan Stanley On NVIDIA Also Notes 'We have been surprised at the strength in the stock, and valuation leaves little room for error, but the company is back in growth mode' ||| UPDATE: Morgan Stanley Maintains Equal-Weight On NVIDIA, Raises Tgt To $217 Notes Co. 'showed upside to the qtr, but guided revs 4% below consensus/in line with our ests; data center grew in line with ests, vs. an expectation for some upside' ||| UPDATE: Raymond James Reiterates Outperform On NVIDIA, Raises Target To $240 Notes 'incremental strength appears to secular - coming from AI inferencing (driven by speech recognition), something bulls had been waiting on for several quarters' ||| UPDATE: Mizuho On NVIDIA Notes Co's 'strong position in gaming, DC growth, low inventories, and good GM positions it well for F21E(Jan)' ||| UPDATE: Mizuho On NVIDIA Notes 'Looking into JanQ, NVDA noted weakness from PCs and gaming offset by continued Data Center growth and strong GM driven by product mix' ||| UPDATE: Mizuho Maintains Buy On NVIDIA, Raises Target To $230 Notes 'The OctQ top line was driven by Gaming/Data Center strength from ray tracing RTX GPUs and Hyperscale/Cloud customers' ||| SunTrust Robinson Humphrey Maintains Buy on NVIDIA, Raises Price Target to $240 ||| UPDATE: Bank Of America On NVIDIA Notes 'In Q4, downside came from: (1) gaming – where seasonally declining notebooks and Nintendo consoles are larger/having a greater impact on segment growth (~$500mn combined sales); and (2) autos' ||| UPDATE: Bank Of America On NVIDIA Notes 'Overall, we raise FY20E/21E pf-EPS by 4%/1%, and take our PO to $275 from $250, based on 37x CY20E P/E ex-cash (vs. 34x prior) to reflect data center reacceleration' ||| UPDATE: Bank Of America Reiterates Buy On NVIDIA, Raises Target To $275 As Firm Believes Co.'is uniquely positioned to reaccelerate in existing markets while expanding into new markets (edge computing/5G, advanced autos, NLP)' ||| UPDATE: Citi Maintains Buy On NVIDIA, Raises Tgt To $245 Notes 'We like the stock setup on improving Y/Y comps next couple of quarters and believe NVDA offers the best programmable data center computing platform that can be scaled with high software moat' ||| NVIDIA shares are trading lower after the company issued Q4 sales guidance below analyst estimates. ||| Driving Higher: Market Keeps Hanging In, On Pace For Another Record-Setting Week ||| Benzinga's Top Upgrades, Downgrades For November 15, 2019 ||| JP Morgan Maintains Overweight on NVIDIA, Raises Price Target to $237 ||| Barclays Maintains Overweight on NVIDIA, Raises Price Target to $225 ||| Nomura Maintains Neutral on NVIDIA, Raises Price Target to $200 ||| 10 Biggest Price Target Changes For Friday ||| Morgan Stanley Maintains Equal-Weight on NVIDIA, Raises Price Target to $217 ||| Raymond James Reiterates Outperform on NVIDIA, Raises Price Target to $240 ||| Benchmark Maintains Buy on NVIDIA, Raises Price Target to $240 ||| Mizuho Maintains Buy on NVIDIA, Raises Price Target to $230 ||| Craig-Hallum Upgrades NVIDIA to Buy ||| A Peek Into The Markets: US Stock Futures Rise Ahead Of Economic Reports ||| New Street Downgrades NVIDIA to Neutral ||| Bank of America Maintains Buy on NVIDIA, Raises Price Target to $275 ||| Citi Maintains Buy on NVIDIA, Raises Price Target to $245 ||| Wells Fargo Maintains Outperform on NVIDIA, Raises Price Target to $240 ||| 6 Stocks To Watch For November 15, 2019",1,0.5013582
2019-11-18,57458800.0,50.97249984741211,53.337501525878906,50.942501068115234,53.06999969482422,52.82445526123047,NVDA,NVIDIA shares are trading higher. Hearing Citigroup raised the price target from $200 to $245. Also saw comments from a Credit Suisse analyst suggesting October graphics cards sales grew month-over-month. ||| NVIDIA Option Alert: Fri $197.5 Puts Sweep (2) near the Bid: 1000 @ $0.331 vs 1465 OI; Ref=$211.25 ||| More Records Shattered: Stocks Start Week At Record Highs With More Retail Earnings Next,0,0.48808613
2019-11-19,41456400.0,52.75749969482422,52.994998931884766,51.41249847412109,51.997501373291016,51.75691604614258,NVDA,5 Technology Stocks Moving In Tuesday's Pre-Market Session,1,0.5196516
2019-11-20,47258800.0,51.76750183105469,53.63750076293945,51.63999938964844,52.79499816894531,52.55072021484375,NVDA,"NVIDIA shares are trading higher. Analysts have reacted positively to Tuesday's investor Q&A session, including with regards to the company's 7nm Ampere development. ||| Nvidia Chips Are The 'Engine Of Artificial Intelligence,' CEO Tells Cramer",0,0.4834562
2019-11-21,28838800.0,52.75,53.310001373291016,52.32749938964844,52.54499816894531,52.30188751220703,NVDA,"Despite Tariff Fears, Market Shows Signs Of Resilience As Retail Earnings Continue",1,0.5546839
2019-11-25,50647600.0,54.0099983215332,55.352500915527344,53.880001068115234,55.3025016784668,55.0466194152832,NVDA,"Cascend Maintains Buy on NVIDIA, Raises Price Target to $250 ||| Stocks That Hit 52-Week Highs On Monday ||| Benzinga's Top Upgrades, Downgrades For November 25, 2019 ||| Nvidia Has One Of The Best Opportunities To Maintain High Multiple, Morgan Stanley Says In Upgrade ||| UPDATE: Morgan Stanley On NVIDIA Notes Co's 'ray tracing software support should generate more gamer enthusiasm in gaming products,and new data center workloads around conversational AI should lead to another leg of data center growth' ||| UPDATE: Morgan Stanley Upgrades NVIDIA To Overweight, Raises Target To $259 Notes 'We see 2020 as a return to solid growth in both key segments, gaming and hpc/cloud (datacenter), even in a tough semiconductor environment' ||| UPDATE: Morgan Stanley Upgrades NVIDIA To Overweight, Raises Target To $259 Notes 'We see 2020 as a return to solid growth in both key segments, gaming and hpc/cloud(datacenter), even in a tough semiconductor environment' ||| 12 Technology Stocks Moving In Monday's Pre-Market Session ||| NVIDIA shares are trading higher after Morgan Stanley upgraded the company's stock from Equal-Weight to Overweight and announced a $259 price target. ||| Morgan Stanley Upgrades NVIDIA to Overweight, Announces $259 Price Target",0,0.5295756
2019-11-26,38524400.0,55.125,55.17250061035156,54.185001373291016,54.25,53.99899291992188,NVDA,"Bank Of America Likes AMD, Nvidia Ahead Of 2020 Gaming Market Recovery ||| More Retail Results Pour In Ahead Of Holiday After Monday's Record-Setting Session",1,0.50654066
2019-11-27,21578400.0,54.66749954223633,55.01250076293945,54.29499816894531,54.560001373291016,54.347633361816406,NVDA,5 Technology Stocks Moving In Wednesday's Pre-Market Session,0,0.51877797
2019-11-29,14155600.0,54.25,54.53499984741211,53.94499969482422,54.185001373291016,53.97409057617188,NVDA,Decoding AMD's Breathtaking 2-Year Rally,0,0.53991175
2019-12-02,37203600.0,54.1150016784668,54.25,52.15999984741211,52.3125,52.10887145996094,NVDA,Shares of several technology and growth stocks are trading lower as US equities dip following escalating US-China tensions over Hong Kong. US stocks further fell on worse-than-expected manufacturing data.,0,0.51360065
2019-12-03,46523200.0,50.46749877929688,51.95500183105469,50.09249877929688,51.915000915527344,51.712921142578125,NVDA,"Gene Munster Talks Tesla's Energy Business, Apple's Trade War Risk And Facebook Libra ||| Shares of technology companies are trading lower on global macro concerns after Trump implied a US-China trade deal may not occur until 2020. ||| 9 Technology Stocks Moving In Tuesday's Pre-Market Session",1,0.50787306
2019-12-04,27342400.0,52.755001068115234,52.97999954223633,52.067501068115234,52.35499954223633,52.15121078491211,NVDA,"Shares of semiconductor companies are trading higher following positive US-China trade reports from earlier, offsetting the sector-wide effects of weak earnings and guidance from Marvell. ||| 10 Technology Stocks Moving In Wednesday's Pre-Market Session",0,0.50217533
2019-12-06,23223600.0,52.880001068115234,53.372501373291016,52.77999877929688,53.04249954223633,52.83604049682617,NVDA,"Cramer Gives His Opinion On Taiwan Semiconductor, Wendy's And More",0,0.5145369
2019-12-10,25638800.0,53.345001220703125,54.01499938964844,52.81499862670898,53.494998931884766,53.28677749633789,NVDA,Shares of several semiconductor companies are trading higher on news U.S. and Chinese trade negotiators are planning to delay the December 15 tariffs. ||| 8 Technology Stocks Moving In Tuesday's Pre-Market Session,1,0.5187048
2019-12-12,40434800.0,54.04499816894531,56.20000076293945,53.95500183105469,56.01750183105469,55.799461364746094,NVDA,Stocks That Hit 52-Week Highs On Thursday ||| Shares of semiconductor companies are trading higher after President Trump tweeted the US and China are 'getting very close to a big deal.',0,0.4769167
2019-12-13,45470400.0,56.04750061035156,57.244998931884766,55.45500183105469,55.997501373291016,55.77953338623047,NVDA,Stocks That Hit 52-Week Highs On Friday ||| Nvidia has Not Offered any Concessions to EU Related to $6.8B Mellanox Deal,1,0.49482447
2019-12-17,32119600.0,56.47499847412109,57.29999923706055,56.380001068115234,57.0724983215332,56.850341796875,NVDA,"PiperJaffray Maintains Overweight on NVIDIA, Raises Price Target to $250",1,0.50289094
2019-12-18,34354800.0,57.42250061035156,57.98500061035156,57.337501525878906,57.37749862670898,57.15415954589844,NVDA,EU Antitrust Regulators To Approve Without Conditions Nvidia's $6.8 Billion Bid For Mellanox Technologies ||| Stocks That Hit 52-Week Highs On Wednesday ||| Tencent Games Partners with NVIDIA to Launch START Cloud Gaming Service,1,0.51956844
2019-12-19,44536000.0,57.72499847412109,59.0,57.67499923706055,58.8650016784668,58.63587951660156,NVDA,"NVIDIA shares are trading higher in sympathy with Micron, which reported Q1 results and issued guidance late Wednesday, including sector-wide trend outlook. ||| Stocks That Hit 52-Week Highs On Thursday",1,0.4944174
2019-12-20,60304400.0,59.532501220703125,60.09749984741211,59.34000015258789,59.84249877929688,59.60956573486328,NVDA,"Stocks That Hit 52-Week Highs On Friday ||| Wells Fargo Names Nvidia As Top Semi Idea Into 2020, Lifts Price Target To $270 ||| UPDATE: Wells Fargo Maintains Overweight On NVIDIA, Raises Target To $270 Names Co. Firm's 'top Semi idea into 2020' Driven By Firm's Expectation 'of a meaningful reacceleration in data center growth through 2020' And Continued Strong Notebook Adoption ||| Wells Fargo Maintains Overweight on NVIDIA, Raises Price Target to $270 ||| 5 Technology Stocks Moving In Friday's Pre-Market Session",0,0.48380533
2019-12-23,35506000.0,60.130001068115234,60.45249938964844,59.59749984741211,59.70500183105469,59.47260665893555,NVDA,Stocks That Hit 52-Week Highs On Monday ||| 4 Technology Stocks Moving In Monday's Pre-Market Session,0,0.48654667
2019-12-26,18285200.0,59.68999862670898,60.08000183105469,59.5,59.79750061035156,59.56473922729492,NVDA,"PreMarket Prep Recap: Qiagen Pulls The Rug Out From Investors Banking On A Deal, Bad Data Equals Bad Price Action For Spectrum Pharmaceuticals",0,0.50555795
2019-12-30,25805600.0,58.997501373291016,59.04999923706055,57.76499938964844,58.08000183105469,57.85393142700195,NVDA,5 Best ETFs Of 2019 ||| Here's How Much Investing $100 In Nvidia Stock Back In 2010 Would Be Worth Today,1,0.53696704
2019-12-31,23100400.0,57.72499847412109,58.91999816894531,57.532501220703125,58.82500076293945,58.59602355957031,NVDA,"Benzinga Pro's Top 5 Stocks To Watch For Tues., Dec. 31, 2019: AMZN, WBAI, NVCN, NIO, NVDA ||| 8 Biggest Price Target Changes For Tuesday ||| Benchmark Maintains Buy on NVIDIA, Raises Price Target to $275",1,0.48291776
2020-01-02,23753600.0,59.6875,59.977500915527344,59.18000030517578,59.977500915527344,59.74404525756836,NVDA,24 Technology Stocks Moving In Thursday's Pre-Market Session,0,0.52097225
2020-01-03,20538400.0,58.775001525878906,59.45750045776367,58.525001525878906,59.01750183105469,58.78778076171875,NVDA,22 Technology Stocks Moving In Friday's Pre-Market Session,1,0.521555
2020-01-06,26263600.0,58.08000183105469,59.317501068115234,57.817501068115234,59.26499938964844,59.03432083129883,NVDA,12 Technology Stocks Moving In Monday's Pre-Market Session,1,0.5256858
2020-01-07,31485600.0,59.54999923706055,60.442501068115234,59.09749984741211,59.98249816894531,59.749019622802734,NVDA,"Sony, Nvidia, Uber Introduce Electric, Autonomous Auto Concepts At CES",1,0.5229681
2020-01-09,25511200.0,60.962501525878906,61.48249816894531,60.21500015258789,60.755001068115234,60.518516540527344,NVDA,Stocks That Hit 52-Week Highs On Thursday,1,0.5114542
2020-01-10,31629600.0,61.83250045776367,62.13750076293945,60.9375,61.08000183105469,60.84225463867188,NVDA,"UPDATE: B Of A Securities On Nvidia Notes 'In our 2020 playbook, we flag NVDA as our top large cap pick... due to its leading growth (15%+ sales/20%+ EPS CAGR, CY19-21E) at a still reasonable valuation (30x CY21 PE, 2-turns below 3-yr avg.) ||| Stocks That Hit 52-Week Highs On Friday ||| BofA Names Nvidia, Inphi Its Top Semiconductor Stock Picks For 2020 ||| B of A Securities Reiterates Buy on NVIDIA, Raises Price Target to $300 ||| Nvidia Added To Citi's Catalyst Watch; Expects Outperformance ||| 13 Technology Stocks Moving In Friday's Pre-Market Session",1,0.5041308
2020-01-13,31984000.0,61.915000915527344,63.247501373291016,61.6875,62.994998931884766,62.74979782104492,NVDA,"NVIDIA shares are trading higher after Needham upgraded the company's stock from Underperform to Hold. ||| Analysts Upbeat After Nvidia's CES Presentations: 'Must-Own Stock For Technology Investors' ||| Craig-Hallum Earlier Reiterated Buy on NVIDIA, Raised Price Target to $300 ||| UPDATE: Needham Upgrades NVIDIA To Hold 'following our positive meeting at CES'; 'we contend the shares are fully valued at 34x our F2021 earnings estimate (near multi-year high). Furthermore, we believe competition will accelerate in AI training in 2020' ||| UPDATE:Argus Reiterates Buy On NVIDIA, Raises Tgt To $300 Notes Co. Shined At CES As 'CES 2020 provided NVidia an opportunity to highlight rapid adoption of its ray tracing technology, which renders more realistic light and shadows in gaming applications' ||| Benzinga's Top Upgrades, Downgrades For January 13, 2020 ||| Nvidia Analyst Says Chipmaker Lacks Earnings Potential To Justify Lofty Valuation ||| 10 Biggest Price Target Changes For Monday ||| Argus Research Maintains Buy on NVIDIA, Raises Price Target to $300 ||| Needham Upgrades NVIDIA to Hold",0,0.49658775
2020-01-15,26310400.0,61.9474983215332,62.17250061035156,61.13249969482422,61.39250183105469,61.15353012084961,NVDA,"Piper Sandler Maintains Overweight on NVIDIA, Raises Price Target to $275 ||| Hearing Piper Sandler Out Positive On Semiconductors, Saying 2020 Appears To Be A Recovery Year For The Semiconductor Market; Unconfirmed",1,0.48704764
2020-01-16,28419200.0,61.93000030517578,62.29249954223633,61.69499969482422,62.23249816894531,61.99026870727539,NVDA,Another Bank Beats: Morgan Stanley Latest To Exceed Expectations On Strong Trading ||| 10 Technology Stocks Moving In Thursday's Pre-Market Session,1,0.5007557
2020-01-17,25379200.0,62.42499923706055,62.5,61.84249877929688,62.31999969482422,62.077423095703125,NVDA,"9 Takeaways From The JPMorgan Healthcare Conference ||| 'China Hasn't Started Remedy Talks On Mellanox/NVIDIA' - Deal Reporter ||| Record Run: Stocks Keep Rolling To New Highs as Housing Data, Earnings Look Solid",0,0.53969914
2020-01-21,21791600.0,61.95249938964844,62.3224983215332,61.64250183105469,61.98500061035156,61.74372482299805,NVDA,"Bulls And Bears Of The Week: IBM, Microsoft, Tesla And More ||| AMD Says 'Nvidia Killer' Graphics Card Is Set For Launch This Year",1,0.5007831
2020-01-23,24451600.0,62.93000030517578,63.29999923706055,62.03749847412109,63.21500015258789,62.96894073486328,NVDA,"Cramer: Tesla Is A Tech Company On Wheels, Unlike Ford And GM ||| UPDATE: UBS Maintains Buy on NVIDIA, Raises Price Target to $300 As Firm Sees 'a path to ~$10 EPS in FY21 (non-GAAP) on the back of a new 7nm product cycle in both data center + gaming.' Notes 2 Reasons: ||| UBS Maintains Buy on NVIDIA, Raises Price Target to $300",0,0.5052751
2020-01-24,37351200.0,64.375,64.875,62.07500076293945,62.619998931884766,62.376258850097656,NVDA,Stocks That Hit 52-Week Highs On Friday ||| 3 Chip ETFs To Buy On Intel's Stellar Forecast,0,0.48324627
2020-01-27,47053600.0,59.560001373291016,60.5625,58.057498931884766,60.04999923706055,59.81626129150391,NVDA,"15 Technology Stocks Moving In Monday's Pre-Market Session ||| Shares of several semiconductor companies are trading lower as concerns about the Wuhan coronavirus continue to grow, prompting travel bans in multiple Chinese cities. Reports say the death toll rose to 80 with more than 2,700 people now infected.",1,0.5215478
2020-01-28,31097600.0,60.712501525878906,62.317501068115234,60.1775016784668,61.99250030517578,61.75120544433594,NVDA,"Shares of several technology companies are trading higher, rebounding as fears of the coronavirus's impact on the economy settle. NOTE: Although the market rebounded, there are still concerns over the spread of the virus. ||| Turnaround Tuesday? Stocks Look To Bounce Back As Apple Earnings Loom Later",0,0.5088446
2020-01-30,29050400.0,60.40250015258789,61.587501525878906,59.84999847412109,61.45249938964844,61.21330261230469,NVDA,"7 Semiconductor Stocks To Buy On Coronavirus Weakness ||| Shares of several semiconductor companies are trading lower as markets sell off on coronavirus worries. The virus has caused global worries and disrupted activity in China, negatively impacting companies with China exposure. ||| 14 Technology Stocks Moving In Thursday's Pre-Market Session",0,0.50002575
2020-01-31,37042000.0,60.99250030517578,61.11249923706055,58.6875,59.10749816894531,58.87742614746094,NVDA,"Shares of several companies in the broader technology sector are trading lower amid global concerns driven by the coronavirus outbreak in China. The technology sector has strong China exposure and the virus has caused some economic disruption concerns in the country. ||| Position Scrimmage: Coronavirus, End-Of-Month Profit Taking Influencing Markets",1,0.5033532
2020-02-04,27154400.0,61.50749969482422,61.97499847412109,61.005001068115234,61.782501220703125,61.54201889038086,NVDA,"Nvidia GeForce Now Game Streaming Is Now Available ||| GameStop Shares Volatile Between $4.10-$4.20 Level; Pullback From $4.20 Level On Volume Following The Verge Report Of NVIDIA Streaming Game Service ||| 'Nvidia's GeForce Now is finally out of beta, challenges Google Stadia at $5 a month' -TheVerge; NVIDIA Shares Not Seeing Huge Reaction ||| Shares of technology companies are trading higher amid a continued rebound in equities following last week's selloff. Shares sold off last week amid coronavirus fears in China, as the sector has exposure to the country. ||| 14 Technology Stocks Moving In Tuesday's Pre-Market Session",1,0.48568276
2020-02-06,21828400.0,63.03499984741211,63.5625,62.220001220703125,63.5625,63.31509399414063,NVDA,Facebook At Key Inflection Point,0,0.51798844
2020-02-07,18975200.0,63.15999984741211,63.38249969482422,62.64250183105469,62.897499084472656,62.65268325805664,NVDA,"Job Market Heats Up In January, As Warmer Weather Might Have Helped Add Positions",1,0.5226399
2020-02-10,52960800.0,63.125,65.75,63.07500076293945,65.74250030517578,65.48658752441406,NVDA,"3 ETFs To Play For The Week Ahead: REITs, Chips And More ||| NVIDIA shares are trading higher after RBC Capital maintained an Outperform rating on the stock and raised its price target from $251 to $301. ||| Big Week Of Earnings Ahead Featuring Cisco, Nvidia, UnderArmour, Among Others ||| RBC Capital Maintains Outperform on NVIDIA, Raises Price Target to $301",1,0.51598936
2020-02-11,63855600.0,66.83000183105469,68.125,66.2074966430664,66.97250366210938,66.71182250976562,NVDA,"NVIDIA shares are trading higher after Oppenheimer maintained an Outperform rating and raised its price target from $250 to $300. Wells Fargo maintained an Overweight rating and raised its price target from $270 to $290. ||| Stocks That Hit 52-Week Highs On Tuesday ||| Under Armour Gets Torn Up As Earnings Disappoint, But Coronavirus Fears Retreat Slightly ||| Oppenheimer Maintains Outperform on NVIDIA, Raises Price Target to $300 ||| Wells Fargo Maintains Overweight on NVIDIA, Raises Price Target to $290",1,0.49852937
2020-02-12,37464400.0,67.50250244140625,68.19999694824219,67.11250305175781,68.13500213623047,67.86979675292969,NVDA,"2020 Mobile World Congress Cancelled Over Coronavirus Fears ||| Nvidia Analysts Raise Price Targets Ahead Of Q4 Print ||| Susquehanna Maintains Positive on NVIDIA, Raises Price Target to $310 ||| Wedbush Maintains Outperform on NVIDIA, Raises Price Target to $295",0,0.50774896
2020-02-13,52801600.0,67.55249786376953,68.37000274658203,67.27749633789062,67.69499969482422,67.43150329589844,NVDA,"NVIDIA shares are trading higher after the company reported better-than-expected Q4 EPS and sales results. ||| Nvidia Trades Higher After Big Q4 Earnings Beat ||| NVIDIA Corp Sees Q1 Of Fiscal 2021 Revenue Is Expected To Be $3B, Plus Or Minus 2 Percent vs $2.85B Est.; Co. Says While Ultimate Coronavirus Effect Is Difficult To Estimate, Reducing Revenue Outlook For Q1 By $100M To Account For Potential Impact ||| NVIDIA Q4 Adj. EPS $1.89 Beats $1.66 Estimate, Sales $3.105B Beat $2.96B Estimate ||| Coronavirus Fears Back On Big Earnings Day As Alibaba, PepsiCo, Nvidia All Report ||| SunTrust Robinson Humphrey Maintains Buy on NVIDIA, Raises Price Target to $314 ||| 10 Biggest Price Target Changes For Thursday ||| Nvidia's Q4 Earnings Outlook ||| Cascend Maintains Buy on NVIDIA, Raises Price Target to $300 ||| 12 Stocks To Watch For February 13, 2020 ||| Earnings Scheduled For February 13, 2020",1,0.5062222
2020-02-14,104192400.0,71.81500244140625,73.74250030517578,71.5,72.44750213623047,72.16549682617188,NVDA,"Mid-Afternoon Market Update: Dow Falls Over 100 Points; CarGurus Shares Slide ||| UPDATE: Raymond James Reiterates Outperform On Nvidia, Raises Target To $300 Notes 'Strong Upside Before the Product Cycle Has Even Gotten Started' ||| UPDATE: Rosenblatt On Nvidia Notes 'Although the market dynamics are different (more competition), from the missionary work Nvidia has done in AI training, we do believe the company's unambiguous leadership in GPU/GPU compute is intact' ||| UPDATE: Rosenblatt Maintains Buy On Nvidia, Raises Target To $315 Notes 'Solid beat and raise with a conservative guide (coronavirus impact of ~$100 million) that suggests consensus estimates move up driven by a strong data center recovery' ||| UPDATE: Morgan Stanley On Nvidia Notes 'That strong data center growth is particularly notable in that we see new products coming in the next quarter or two' ||| UPDATE: Morgan Stanley Maintains Overweight On Nvidia Raises Target To $304 Notes 'As we had hoped for when we upgraded the stock in November, the data center business has surged, growing 33% q/q in January, well above other cloud providers' ||| Nvidia Analysts Maintain Bullish Outlook Following Q4 Data Center, Gaming Strength ||| 50 Stocks Moving In Friday's Mid-Day Session ||| Mid-Day Market Update: ImmunoGen Surges On Upbeat Q4 Results; LivePerson Shares Plummet ||| Stocks That Hit 52-Week Highs On Friday ||| Mid-Morning Market Update: Markets Mostly Flat; NVIDIA Posts Upbeat Q4 Earnings ||| Travel Stocks May Stay In Focus As Coronavirus Fears Linger ||| Craig-Hallum Maintains Buy on NVIDIA, Raises Price Target to $325 ||| Cascend Maintains Buy on NVIDIA, Raises Price Target to $330 ||| Oppenheimer Maintains Outperform on NVIDIA, Raises Price Target to $350 ||| Morgan Stanley Maintains Overweight on NVIDIA, Raises Price Target to $304 ||| Industrials Ended 2019 On A Strong Note, But Are Some Segments In Better Shape Than Others? ||| Benzinga Pro's Top 5 Stocks To Watch For Fri., Feb. 14, 2020: TSLA, ROKU, CRON, YELP, AMD ||| 10 Biggest Price Target Changes For Friday ||| Wells Fargo Maintains Overweight on NVIDIA, Raises Price Target to $320 ||| Asia Markets Mixed As Coronavirus Cases Rise, Mobile World Congress Canceled ||| Raymond James Maintains Outperform on NVIDIA, Raises Price Target to $300 ||| Wedbush Maintains Outperform on NVIDIA, Raises Price Target to $311 ||| 5 Technology Stocks Moving In Friday's Pre-Market Session ||| Rosenblatt Maintains Buy on NVIDIA, Raises Price Target to $315 ||| UBS Maintains Buy on NVIDIA, Raises Price Target to $320 ||| 30 Stocks Moving in Friday's Pre-Market Session ||| NVIDIA shares are trading higher after the company reported better-than-expected Q4 EPS and sales results. ||| Citigroup Maintains Buy on NVIDIA, Raises Price Target to $315 ||| A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Economic Reports ||| 8 Stocks To Watch For February 14, 2020",1,0.500956
2020-02-18,62016400.0,71.41000366210938,74.32749938964844,71.21499633789062,74.14250183105469,73.85391235351562,NVDA,"NVIDIA Option Alert: Fri $300 Calls Sweep (78) near the Ask: 571 @ $2.637 vs 9131 OI; Ref=$296.25 ||| UPDATE: Argus On Nvidia Notes 'We believe that most technology investors should own NVDA in the age of deep learning, AI, and GPU-driven applications acceleration' ||| UPDATE: Argus Reiterates Buy On Nvidia, Raises Target To $340 Notes 'We recommend establishing or adding to positions in this preeminent vehicle for participation in the AI economy' ||| Susquehanna Upgrades Mellanox Technologies Ahead Of Chinese Decision On Nvidia Deal ||| Market Taking A Step Back: Walmart Misses On Earnings, Apple Lowers Sales Guidance ||| Argus Research Reiterates Buy on NVIDIA, Raises Price Target to $340 ||| 76 Biggest Movers From Friday",1,0.49741188
2020-02-19,69433200.0,75.37249755859375,78.85250091552734,75.37249755859375,78.67500305175781,78.36878204345703,NVDA,"Why AMD's Coronavirus Impact Could Be Worse Than Intel, Nvidia ||| 51 Stocks Moving In Wednesday's Mid-Day Session ||| Stocks That Hit 52-Week Highs On Wednesday ||| NVIDIA shares are trading higher after Bernstein upgraded the stock from Market Perform to Outperform and raised its price target from $300 to $360 per share. ||| Unfazed FAANGs: Pullback In Apple Didn't Carry Over To Other Big Tech Names ||| Autonomous Yard Trucking Startup Drives Out Of Stealth With $53M In Series A ||| 10 Biggest Price Target Changes For Wednesday ||| A Peek Into The Markets: US Stock Futures Up Ahead Of Economic Data, Fed Minutes ||| Bernstein Upgrades NVIDIA to Outperform, Raises Price Target to $360",0,0.5026728
2020-02-20,81005200.0,78.19249725341797,79.08000183105469,74.0875015258789,77.17500305175781,76.8746109008789,NVDA,Shares of several semiconductor companies are trading lower potentially on coronavirus fears. NOTE: The market had a sharp selloff. Not seeing any news to justify the bearish price action. ||| Stocks That Hit 52-Week Highs On Thursday ||| China Stimulus Doesn't Translate Into US Strength As Deere Prepares To Report Friday ||| 78 Biggest Movers From Yesterday,0,0.48402503
2020-02-21,76818000.0,76.04750061035156,76.30000305175781,72.66500091552734,73.51750183105469,73.23135375976562,NVDA,"Shares of several semiconductor companies are trading lower. Weakness potentially related to the ongoing conronavirus outbreak in China, which has hurt economic activity across sectors including the semi sector, which has China exposure.",0,0.51682454
2020-02-24,85691600.0,67.54750061035156,70.46749877929688,67.0,68.31999969482422,68.05406951904297,NVDA,"Rough Start To New Week As Apple, Chip Stocks, Travel And Leisure Sector Hit Hard By Virus ||| Shares of several semiconductor companies are trading lower amid continued spread of coronavirus including notable upticks in Iran and Italy. NOTE: The virus has raised fear of a global economic slowdown. ||| 25 Technology Stocks Moving In Monday's Pre-Market Session",0,0.5319012
2020-02-25,105549600.0,69.07499694824219,69.69750213623047,64.48999786376953,65.51249694824219,65.25750732421875,NVDA,"UPDATE: Nomura Downgrades NVIDIA to Reduce, Lowers Price Target to $230 As Firm Notes 'In our view, the risks to the global semiconductor industry posed by the COVID-19 outbreak have grown over the last few weeks.' ||| Earnings To The Rescue? HP, Macy's, Home Depot All Report Solid Results, Providing Lift ||| Shares of several semiconductor companies are trading higher as markets partially rebound from Monday's dip. NOTE: While some markets recover, coronavirus fears still persist globally. ||| Nomura Downgrades NVIDIA to Reduce, Lowers Price Target to $230",1,0.49206316
2020-02-26,74773200.0,65.51499938964844,68.86250305175781,65.5,66.9124984741211,66.65205383300781,NVDA,"Shares of several semiconductor companies are trading higher. Not seeing any news to justify the price action. ||| March Outlook: Political Season Starts To Sizzle, But Coronavirus Still Hogs Headlines ||| Shares of several semiconductor companies are trading higher. Strength potentially market related as equities begin to rebound from recent selloffs.",0,0.517625
2020-02-27,90641600.0,63.72499847412109,66.75,62.22249984741211,63.150001525878906,62.94182968139648,NVDA,"'AMD has sold more GPUs than Nvidia, according to this analyst report' -TechRadar ||| Department Of Correction: Both DJIA And SPX On Verge Of 10% Decline From Peaks ||| Shares of companies in the software, technology and semiconductor spaces are trading lower as continued coronavirus fears cause weakness across sectors.",1,0.5385969
2020-02-28,113325200.0,60.6150016784668,68.11499786376953,60.4474983215332,67.51750183105469,67.29491424560547,NVDA,"NVIDIA shares are trading higher despite broader market downturn. Mizuho analyst today noted that online gaming and ecommerce cloud remain strong amid the coronavirus outbreak, which the firm said is an advantage for NVIDIA.",1,0.50779605
2020-03-02,89074400.0,69.2249984741211,69.39749908447266,65.25,69.10749816894531,68.87967681884766,NVDA,What To Expect From AMD's Analyst Day ||| NVIDIA Says Will Shift Its GTC Chip Conference Scheduled For Mar. 22-26 To Only Online,0,0.497338
2020-03-03,65279200.0,69.6675033569336,70.26750183105469,65.61499786376953,66.47250366210938,66.25336456298828,NVDA,Shares of several technology companies are trading lower in sympathy with the overall market. The Fed cut rates to combat the coronavirus outbreak which caused an initial spike but then continued to trade lower. ||| 3 ETFs For Stocks With Positive Earnings Revisions ||| Spread of Coronavirus Beyond China to Impact 2020 Semiconductor Market,1,0.5208324
2020-03-04,59740800.0,67.55000305175781,71.22250366210938,66.80000305175781,71.12750244140625,70.89302062988281,NVDA,Shares of several technology companies are trading higher after Joe Biden took the delegate lead on Super Tuesday. Biden's more 'moderate' economic policies have been seen as more favorable for growth.,0,0.5558023
2020-03-05,54032800.0,69.125,70.80000305175781,67.875,68.32250213623047,68.0972671508789,NVDA,"Shares of several technology, semiconductor, and software companies are trading lower as global markets continue to experience volatility amid the coronavirus spread.",0,0.54842645
2020-03-06,51541200.0,66.5199966430664,67.09750366210938,64.5,66.51000213623047,66.2907485961914,NVDA,Shares of several technology companies are trading lower. Movement appears market related as markets continue to dip amid the global coronavirus outbreak. ||| 21 Technology Stocks Moving In Friday's Pre-Market Session,0,0.51251996
2020-03-09,61416000.0,59.97499847412109,64.8499984741211,59.54499816894531,61.36000061035156,61.15771865844727,NVDA,"Shares of several companies in the technology, software and semiconductor space are trading lower as equities crash amid coronavirus fears. The virus spread has disrupted economic activity across sectors and caused global macro uncertainty. ||| Here's How Much Investing $100 In Adobe Stock Back In 2010 Would Be Worth Today",1,0.49983618
2020-03-10,58064800.0,64.13500213623047,65.2699966430664,61.497501373291016,65.2699966430664,65.05482482910156,NVDA,Shares of several technology companies are trading higher as markets look to rebound from Monday's selloff. The technology sector has been highly impacted by the coronavirus due to its China exposure and sensitivity to economic conditions.,0,0.5358565
2020-03-11,49996400.0,63.8650016784668,64.1500015258789,60.64250183105469,61.61750030517578,61.41437530517578,NVDA,"Despite Volatility, FANG Continues to Prove Its Popularity ||| Shares of several companies in the technology, software and semiconductor space are trading lower as equities sell off amid coronavirus fears. The virus spread has disrupted economic activity across sectors and caused global macro uncertainty.",0,0.55200034
2020-03-12,81654000.0,56.3650016784668,59.02999877929688,53.95000076293945,54.07749938964844,53.899227142333984,NVDA,"Shares of several technology, software and semiconductor companies are trading lower as equities sell off amid continued global coronavirus concerns. The virus has caused global economic disruption and negatively impacted stocks across sectors.",1,0.53904605
2020-03-13,63483600.0,57.625,60.255001068115234,54.90250015258789,60.209999084472656,60.01150894165039,NVDA,"Shares of several technology, software and semiconductor companies are trading higher as equities rebound following Thursday's crash. The sector has been negatively impacted recently as the coronavirus outbreak has disrupted economic outlook globally.",0,0.5423438
2020-03-16,72697200.0,53.102500915527344,56.525001525878906,48.5,49.09999847412109,48.93812942504883,NVDA,Shares of several technology stocks are trading lower amid demand and supply chain disruption concerns driven by coronavirus. ||| Nvidia Urges Gamers To Use Their Gaming PCs To Fight Coronavirus,1,0.50799936
2020-03-17,83363200.0,50.227500915527344,55.21500015258789,47.75,54.317501068115234,54.138431549072266,NVDA,"All The Major Events Canceled By Coronavirus (Updated) ||| Shares of several technology, semiconductor, and software companies are trading higher, rebounding from Monday's crash. Stocks may also potentially be getting a boost from expectations of further stimulus proposals.",0,0.5272252
2020-03-18,87426800.0,50.025001525878906,52.48500061035156,45.16999816894531,50.70500183105469,50.53783798217773,NVDA,"Morgan Stanley Maintains Overweight on NVIDIA, Lowers Price Target to $268 ||| Shares of several technology, software and semiconductor companies are trading lower as equities sell off amid continued global coronavirus concerns. The virus has caused global economic disruption and negatively impacted stocks across sectors. ||| 11 Technology Stocks Moving In Wednesday's Pre-Market Session",1,0.49693707
2020-03-19,76551200.0,50.4900016784668,54.182498931884766,48.34749984741211,53.24250030517578,53.06698226928711,NVDA,"Esports, Gaming Thrive, Adapt As Nation Grapples With Pandemic ||| Shares of several technology companies are trading higher, rebounding from earlier weakness. Markets have been volatile amid the coronavirus outbreak, with central banks and governments around the world enacting stimulus measures. ||| Shares of several technology, software and semiconductor companies are trading lower amid continued global coronavirus concerns. The virus has caused global economic disruption and negatively impacted supply chains for many tech companies. UPDATE: Several stocks in the sector have since reversed.",0,0.49960348
2020-03-20,80463600.0,54.75,57.58000183105469,51.282501220703125,51.4375,51.2679328918457,NVDA,"Why BofA Says AMD, Nvidia Are High-Quality, High-Beta Stocks In A Volatile Market ||| Wells Fargo Maintains Overweight on NVIDIA, Lowers Price Target to $280 ||| Shares of several technology companies are trading higher. Market strength has been attributed to strong containment measures taken by California, rebound in oil, central bank actions and expectations of increased technology usage amid the virus outbreak.",1,0.5020404
2020-03-23,64387600.0,51.4275016784668,54.119998931884766,49.630001068115234,53.17250061035156,52.99721145629883,NVDA,"Shares of several technology, software, and semiconductor companies are trading higher as stocks move higher following Monday morning Fed stimulus action.",1,0.5371233
2020-03-24,110164400.0,57.25,63.165000915527344,57.01250076293945,62.29499816894531,62.08964157104492,NVDA,"Nvidia Analyst Says Pandemic Creates More Data Center Demand ||| 75 Stocks Moving In Tuesday's Mid-Day Session ||| UPDATE: Needham On NVIDIA Notes 'we believe the transition to AI, whether from hyperscalers, enterprise or verticals, will accelerate during this COVID-19 outbreak as the shift to private and public cloud will grow' ||| UPDATE: Needham Upgrades NVIDIA To Buy, Announces $270 Target Notes 'During this uncertain time, superior balance sheets remain supreme'; Firm Believes 'GPUs for medical applications will ramp in light of the COVID-19 pandemic' ||| RUMOR: Hearing Dealreporter Speculation China Has Reached A Deal For NVIDIA/Mellanox Deal ||| Rise In Semiconductor, Cloud Computing Stocks Could Set Tone For Broader Economy ||| Shares of several technology companies are trading higher amid market strength on hopes of a US economic stimulus package agreement. ||| NVIDIA shares are trading higher as equities gain amid hopes of a US stimulus agreement. Needham also upgraded the company's stock from Hold to Buy. ||| 26 Stocks Moving in Tuesday's Pre-Market Session ||| Needham Upgrades NVIDIA to Buy, Announces $270 Price Target",0,0.5272376
2020-03-25,79343200.0,63.45000076293945,65.45500183105469,60.915000915527344,61.40499877929688,61.20256423950195,NVDA,"Airline Shares Jump As Stimulus Agreement Offers Relief, While Nike Up On Earnings ||| 120 Biggest Movers From Yesterday",1,0.51553744
2020-03-26,69610800.0,63.48500061035156,65.55500030517578,62.5,64.30999755859375,64.09799194335938,NVDA,Shares of several semiconductor companies are trading higher following a strong Q2 earnings report from Micron.,0,0.5376074
2020-03-27,63882800.0,62.5,65.77999877929688,62.16999816894531,63.182498931884766,62.974212646484375,NVDA,"Mellanox Shares Volatile Over Last Few Mins. On Volume Spike; Hearing Capitol Forum Says Deal Approval 'In Trouble,' Recent Talks Failed To Address Objections",1,0.5063093
2020-03-30,60225200.0,63.84000015258789,66.48999786376953,63.397499084472656,66.39749908447266,66.1786117553711,NVDA,Shares of several technology companies are trading higher as equities continue to rise following last week's rebound amid US stimulus measures.,0,0.53950197
2020-03-31,94996000.0,66.80000305175781,68.8499984741211,64.4375,65.9000015258789,65.68274688720703,NVDA,"Option Traders Make Massive Multimillion Dollar Bets On Nvidia, Microsoft ||| NVIDIA shares are trading higher amid tech sector strength. Susquehanna analysts maintained a 'Positive' rating on the stock. ||| Susquehanna Maintains Positive on NVIDIA, Raises Price Target to $330",0,0.47347656
2020-04-01,65691200.0,63.91249847412109,65.38249969482422,60.31999969482422,60.76750183105469,60.567176818847656,NVDA,"Some Staples Stocks Bouncing Back After Sliding In Recent Rally As Caution Tightens Grip ||| Shares of several technology, semiconductor, and software companies are trading lower amid market weakness as macro concerns continue to grow as a result of the coronavirus pandemic. The White House said it expects a surge in cases over the next 2 weeks.",1,0.5341892
2020-04-03,66321200.0,63.4900016784668,63.907501220703125,59.59749984741211,60.977500915527344,60.7764778137207,NVDA,"Despite Near-Term Volatility, Nvidia Analyst Remains Bullish On Data Center Positioning, Gaming Dominance ||| Shares of several semiconductor and chip companies are trading lower amid overall equity weakness. Macro disruption as a result of the coronavirus pandemic has affected businesses across sectors.",1,0.5526685
2020-04-06,72788400.0,63.810001373291016,67.47000122070312,63.23249816894531,67.0999984741211,66.87879180908203,NVDA,Shares of several semiconductor and large technology stocks are trading higher with the broader market on optimism that coronavirus cases in several US hotspots appear to be reaching their peak.,0,0.5308961
2020-04-07,78452000.0,69.32499694824219,69.5625,64.32499694824219,64.75749969482422,64.54402160644531,NVDA,"Semiconductors Continue To Lead Rally Efforts, While Consumer Staples Keep Lagging ||| Shares of several technology, semiconductor, and software companies are trading higher amid optimism that coronavirus cases in Asia are potentially easing. Global slowing cases could raise hopes of a sooner return to spending and economic activity.",1,0.5603643
2020-04-08,54244400.0,65.85250091552734,66.98750305175781,65.1500015258789,66.73750305175781,66.5174789428711,NVDA,Shares of several technology companies are trading higher amid overall market strength on optimism that US coronavirus cases could soon leveling off. NOTE: Some names in the sector have potentially benefited from recent work-at-home trends.,0,0.5283313
2020-04-09,52556400.0,68.0,68.2300033569336,65.1050033569336,65.73750305175781,65.52079772949219,NVDA,Will FANG Lead The Market Rebound?,1,0.5261409
2020-04-14,53094800.0,68.75,71.33000183105469,68.47250366210938,70.98750305175781,70.75347900390625,NVDA,"Shares of several technology companies are trading higher as markets gain on positive coronavirus outlook. Optimism surrounding the virus has led to hopes of an upcoming return to economic activity, which would benefit the sector.",0,0.5450976
2020-04-15,36614800.0,69.30000305175781,71.0425033569336,68.84500122070312,70.20999908447266,69.9785385131836,NVDA,"Software Rises Above Semiconductors And Hardware As Tech Heads Into Earnings Season ||| Shares of several technology companies are trading lower as equities fall amid mixed earnings results from banks, a significant decline in the price of oil and worse than expected retail sales in March.",1,0.50730336
2020-04-16,74562000.0,71.7699966430664,74.75,71.63749694824219,73.67500305175781,73.43212890625,NVDA,"NVIDIA Says Mellanox Deal Closing Expected To Occur On Or About Apr. 27 ||| NVIDIA shares are trading higher after the company received Chinese approval for its acquisition of Mellanox. ||| Alibaba, Tesla Among Cramer's Stay-At-Home Stock Ideas ||| Cramer Shares His Thoughts On Yext, Workday And More ||| Hearing Mellanox Reportedly Receives China approval For NVIDIA Merger",0,0.50188893
2020-04-17,53912000.0,74.5,74.71499633789062,71.73500061035156,73.08000183105469,72.83906555175781,NVDA,"UBS Maintains Buy on NVIDIA, Raises Price Target to $330",0,0.502991
2020-04-20,44938800.0,71.80999755859375,73.375,71.31749725341797,71.76249694824219,71.52592468261719,NVDA,"Nvidia, Marvell, Monolithic Are Oppenheimer's Top Picks Ahead Of Semiconductor Earnings",0,0.4918638
2020-04-21,73516000.0,70.57749938964844,71.19249725341797,66.77749633789062,67.37750244140625,67.15538787841797,NVDA,Shares of several technology companies are trading lower amid overall market weakness following a collapse in oil prices. Oil has been negatively impacted by excess supply and low demand amid the coronavirus pandemic. ||| A Look Into NVIDIA's Price Over Earnings,1,0.48068297
2020-04-22,48335600.0,69.30750274658203,71.96749877929688,68.8499984741211,71.5374984741211,71.30168151855469,NVDA,"Shares of several semiconductor companies are trading higher, potentially in sympathy with Texas Instruments, which reported better-than-expected Q1 financial results.",0,0.5224785
2020-04-23,42416000.0,71.95999908447266,73.28500366210938,70.75,71.00250244140625,70.76844787597656,NVDA,"Shares of several semiconductor companies are trading higher. Strength potentially related to earnings from notable names in the space this week as well as overall market strength amid a rebound in oil. ||| Eli Lilly Kicks Off Earnings Day With A Beat And Investors Prepare For Intel After Close ||| Taiwan Semiconductor Seeing Ramp-up in Orders from AMD, Nvidia",1,0.5059638
2020-04-24,35232800.0,70.9000015258789,72.4175033569336,70.1500015258789,72.39749908447266,72.1588363647461,NVDA,"Nvidia Reportedly Eyeing 5nm Chips Even As Apple, AMD Ramp Up Orders",1,0.5045911
2020-04-27,47938800.0,73.74749755859375,75.875,73.5,74.2699966430664,74.02515411376953,NVDA,"'I've Been Dreaming About This,' Nvidia CEO Says After $7B Mellanox Acquisition Deal Finally Closed ||| Why Nvidia's Stock Is Trading Higher Today ||| NVIDIA shares are trading higher potentially on overall market strength as some states announced their plans to reopen in phases. The company also announced the completion of the acquisition of Mellanox. ||| A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street ||| NVIDIA Completes Acquisition of Mellanox",0,0.5247864
2020-04-28,44290400.0,75.75,76.05000305175781,72.78500366210938,72.83999633789062,72.5998764038086,NVDA,"Morgan Stanley Maintains Overweight on NVIDIA, Raises Price Target to $282",1,0.49879977
2020-04-29,37916000.0,74.19249725341797,75.1449966430664,73.4375,74.61499786376953,74.36902618408203,NVDA,"Shares of several technology companies are trading higher amid market strength following positive data from a study of Gilead's Remdesivir, which is being evaluated for coronavirus. A successful treatment could mean a sooner return to economic activity. NOTE: Some names may also be moving in sympathy following recent earnings from Google and some semiconductor companies. ||| May Market Outlook: No Spring Fling This Year As Dismal Data, Weak Earnings Seen Ahead",0,0.53297997
2020-04-30,37591600.0,74.07250213623047,74.61499786376953,72.93000030517578,73.06999969482422,72.82913970947266,NVDA,"NVIDIA To Report Q1 Earnings Thurs., May 21, 2020",0,0.47854614
2020-05-01,34209600.0,71.0875015258789,72.2249984741211,70.20999908447266,70.69499969482422,70.46195220947266,NVDA,Shares of several technology companies are trading lower on market weakness as investor uncertainty grows following quarterly earnings results from multiple companies. NOTE: This could potentially be a sell-off after the S&P 500 rallied 12.7% over the past month.,1,0.51986736
2020-05-04,31755600.0,70.22000122070312,72.95999908447266,70.22000122070312,72.82250213623047,72.5824203491211,NVDA,"Susquehanna Maintains Positive on NVIDIA, Raises Price Target to $355 ||| NVIDIA Shares Unaffected Following Report 'Nvidia Plans To Buy Cumulus Networks In Networking Software Play'",1,0.524302
2020-05-07,37373200.0,75.84500122070312,76.85250091552734,75.33000183105469,76.21749877929688,75.96622467041016,NVDA,"NVIDIA shares are trading higher after SunTrust analysts maintained a Buy rating on the stock and raised their price target from $294 to $327. The tech sector has been strong this week amid a rebound in economic sentiment. ||| SunTrust Robinson Humphrey Maintains Buy on NVIDIA, Raises Price Target to $327",1,0.4829726
2020-05-08,33921600.0,76.9375,78.1875,76.59750366210938,78.125,77.86744689941406,NVDA,Shares of several technology companies are trading higher amid market strength after US job loss figures came in better than expected. The sector has been strong recently as several companies reported strong earnings and benefited from online services.,1,0.5353951
2020-05-11,46906000.0,78.07499694824219,81.125,77.7874984741211,80.65499877929688,80.38910675048828,NVDA,"'Fast Money' Picks For May 11: EA, Nike, Nvidia ||| Why Nvidia Has A New Street-High Price Target ||| Stocks That Hit 52-Week Highs On Monday ||| 10 Biggest Price Target Changes For Monday ||| Needham Maintains Buy on NVIDIA, Raises Price Target to $360",0,0.48354524
2020-05-12,49306000.0,81.23500061035156,81.7249984741211,77.92749786376953,78.0250015258789,77.76778411865234,NVDA,"""Stay at Home"" Stocks Still Rule the Roost as Nvidia, Microsoft, Apple Start Week Firmly ||| 2 Options Strategies For Nvidia Ahead Of Earnings ||| Stocks That Hit 52-Week Highs On Tuesday ||| Not Just Fun And Games: How Esports Could Offer Potential Investment Opportunities",0,0.49117854
2020-05-13,62585200.0,79.17500305175781,80.78500366210938,75.94750213623047,77.80000305175781,77.54352569580078,NVDA,"Another Nvidia Analyst Boosts Price Target Ahead Of Q1 Report ||| Wedbush Maintains Outperform on NVIDIA, Raises Price Target to $340",1,0.4944598
2020-05-14,60231200.0,78.4175033569336,80.36000061035156,76.875,80.30500030517578,80.0402603149414,NVDA,"NVIDIA Datasheet Shows DGX A100 To Use Dual AMD Rome 7742 ||| Nvidia CEO Talks New Ampere-Based GPU, Advanced AI System In GTC 2020 Keynote ||| NVIDIA Highlights Expansion Of Its Clara Healthcare Platform With New Capabilities, Partnerships To Help Medical Community Track, Test, Treat Coronavirus",1,0.5267915
2020-05-15,98766000.0,78.89749908447266,85.00499725341797,78.73999786376953,84.90750122070312,84.6275863647461,NVDA,"Nvidia Analyst Says New, Ampere-Based Data Center GPU Makes Chipmaker 'Unassailable' ||| Quick Retreat: Impressive Thursday Turnaround Halted in Its Tracks Amid Fresh Trade Tiff ||| Raymond James Reiterates Outperform on NVIDIA, Raises Price Target to $330",1,0.50353056
2020-05-18,77446000.0,87.6050033569336,89.16500091552734,86.80500030517578,87.50250244140625,87.21404266357422,NVDA,"BMO Turns Bullish On Nvidia, Says It's Uniquely Positioned For Computing Shift ||| Walmart, Target And Home Depot Among Major Retailers Set To Report Earnings In Days Ahead ||| Stocks That Hit 52-Week Highs On Monday ||| Benzinga's Top Upgrades, Downgrades For May 18, 2020 ||| 10 Biggest Price Target Changes For Monday ||| NVIDIA shares are trading higher after BMO Capital upgraded the company's stock from Market Perform to Outperform and raised its price target from $285 to $425. ||| BMO Capital Upgrades NVIDIA to Outperform, Raises Price Target of $425",1,0.5017495
2020-05-19,71732000.0,87.90249633789062,90.875,87.62750244140625,88.05500030517578,87.76469421386719,NVDA,"Nvidia Investors Accuse Chipmaker Of Misrepresenting $1B In Crypto Revenue In Lawsuit ||| Stocks That Hit 52-Week Highs On Tuesday ||| Walmart Earnings Look Strong Across the Board, But Home Depot Down After Missing on EPS ||| NVIDIA shares are trading higher after Susquehanna and RBC Capital maintained their bullish ratings on the company's stock along with raising their price targets. ||| Susquehanna Maintains Positive on NVIDIA, Raises Price Target to $410 ||| RBC Capital Maintains Outperform on NVIDIA, Raises Price Target to $385",1,0.48368785
2020-05-20,58753600.0,89.91000366210938,90.43000030517578,88.88749694824219,89.69999694824219,89.404296875,NVDA,"Chop Chop: Strong Earnings Lift Markets After Tuesday Thud; FOMC Minutes Ahead ||| Benzinga Pro's Top 5 Stocks To Watch For Wednesday, May 20, 2020: BABA, SPOT, NVDA, SGBX, JD",0,0.4930142
2020-05-21,76106800.0,90.51499938964844,90.5250015258789,87.375,87.75250244140625,87.46322631835938,NVDA,"Nvidia Reports Q1 Earnings Beat ||| NVIDIA Sees Q2 Sales $3.65B +/- 2% vs $3.15B Estimate, Gross Margins 58.6-66% ||| NVIDIA Q1 Adj. EPS $1.800 Beats $1.680 Estimate, Sales $3.080B Beat $2.980B Estimate ||| Here's How Long It Took Nvidia To Reach A $100B Market Cap ||| Climate Change: Up And Down Pattern Continues As Week Advances And Powell Awaited ||| Credit Suisse Reinstates Outperform on NVIDIA, Announces $425 Price Target ||| A Peek Into The Markets: US Stock Futures Down Ahead Of Earnings, Jobless Claims Data ||| 8 Stocks To Watch For May 21, 2020 ||| Earnings Scheduled For May 21, 2020",1,0.4920976
2020-05-22,103876400.0,88.25250244140625,90.93000030517578,87.13249969482422,90.2624969482422,89.96493530273438,NVDA,"9 Nvidia Analysts On Q1 Beat, Ampere GPU: 'A Pure Play In Accelerated Computing' ||| Moderna, NVIDIA, Deere Form Bright Spots Amid Worries Over U.S.-China Relationship ||| Cascend Maintains Buy on NVIDIA, Raises Price Target to $380 ||| Piper Sandler Maintains Overweight on NVIDIA, Raises Price Target to $390 ||| UBS Maintains Buy on NVIDIA, Raises Price Target to $400 ||| NVIDIA shares are trading higher after the company reported better-than-expected Q1 EPS and sales results. ||| B of A Securities Reiterates Buy on NVIDIA, Raises Price Target to $420 ||| Deutsche Bank Maintains Hold on NVIDIA, Raises Price Target to $315 ||| Raymond James Reiterates Outperform on NVIDIA, Raises Price Target to $370 ||| Oppenheimer Maintains Outperform on NVIDIA, Raises Price Target to $400 ||| 10 Biggest Price Target Changes For Friday ||| Wedbush Maintains Outperform on NVIDIA, Raises Price Target to $420 ||| Mizuho Reiterates Buy on NVIDIA, Raises Price Target to $400 ||| Wells Fargo Maintains Overweight on NVIDIA, Raises Price Target to $430 ||| Nomura Instinet Maintains Reduce on NVIDIA, Raises Price Target to $260 ||| SunTrust Robinson Humphrey Maintains Buy on NVIDIA, Raises Price Target to $384 ||| Rosenblatt Maintains Buy on NVIDIA, Raises Price Target to $400 ||| Needham Maintains Buy on NVIDIA, Raises Price Target to $400 ||| A Peek Into The Markets: US Stock Futures Down Ahead Of Three-Day Weekend ||| 7 Stocks To Watch For May 22, 2020",0,0.5142221
2020-05-26,77078000.0,91.56749725341795,91.81749725341795,86.72000122070312,87.17749786376953,86.89012145996094,NVDA,"Bulls And Bears Of The Week: Carvana, Comcast, Walmart And More ||| Stocks That Hit 52-Week Highs On Tuesday ||| 3 Non-Semiconductor ETFs Benefiting From Nvidia Exposure ||| NVIDIA shares are trading higher after Morgan Stanley maintained its Overweight rating on the stock and raised its price target from $282 to $363 per share. ||| Morgan Stanley Maintains Overweight on NVIDIA, Raises Price Target to $363",0,0.49001217
2020-05-27,117589200.0,86.25,86.32749938964844,79.96749877929688,85.25250244140625,84.9714584350586,NVDA,"Chip Stocks Move Higher Following Strong Guidance Out Of Memory Manufacturer Micron: Intel Shares Up 0.1%, AMD Down 3.3%, NVIDIA Down 4% ||| Shares of several companies in the broader technology sector are trading lower despite market strength. Weakness potentially related to business reopenings and eased lockdown restrictions, as several names in the tech sector have benefited from work-from-home, home entertainment and e-commerce trends amid the pandemic.",0,0.50392
2020-05-28,73489600.0,84.12249755859375,87.6050033569336,83.7925033569336,84.87000274658203,84.59021759033203,NVDA,Synopsys' Silicon-Proven DesignWare DDR IP for High-Performance Cloud Computing Networking Chips Selected by NVIDIA,1,0.50974315
2020-06-01,38987600.0,88.3324966430664,88.40750122070312,86.8949966430664,88.0625,87.77218627929688,NVDA,Semiconductor Industry to Lobby for Billions to Boost U.S. Manufacturing,1,0.5235355
2020-06-02,39132000.0,87.9625015258789,88.37249755859375,86.58000183105469,88.25250244140625,87.9615707397461,NVDA,"Why BofA Recommends Buying GPU Plays AMD and Nvidia ||| Cramer Weighs In On Ciena, Harley-Davidson And More",0,0.49269325
2020-06-08,38773600.0,88.77249908447266,88.89749908447266,86.85749816894531,88.05000305175781,87.7998046875,NVDA,Afternoon Market Stats in 5 Minutes ||| Shares of some technology companies are trading lower despite market strength. The sector has performed well this year to date and appears to be giving back some gains following run up. ||| Morning Market Stats in 5 Minutes,1,0.5031445
2020-06-09,46848800.0,88.0,91.09750366210938,87.51249694824219,90.45999908447266,90.20293426513672,NVDA,Shares of several technology companies are trading higher despite market weakness. The sector recently experienced some welling and appears to be rebounding following dip.,1,0.5288294
2020-06-10,63218000.0,91.67749786376952,95.0,91.53500366210938,93.6675033569336,93.40131378173828,NVDA,Shares of several technology companies are trading higher on continued volatility despite market weakness. The sector sold off recently as other sectors gained amid US economic reopening and appears to be rebounding. ||| Afternoon Market Stats in 5 Minutes ||| Morning Market Stats in 5 Minutes,0,0.48557478
2021-08-17,20458500.0,196.8500061035156,197.6999969482422,192.6699981689453,194.5800018310547,194.25396728515625,NVDA,It’s Time to Double Down on Intel Stock,0,0.5248011
2021-08-18,28591300.0,195.0,196.33999633789065,190.0,190.3999938964844,190.0809631347656,NVDA,"Last Minute Thought: Buy or Sell Nvidia Before Earnings? ||| NVIDIA Corporation (NVDA) Q2 2022 Earnings Call Transcript ||| NVIDIA Corporation Q2 adjusted earnings Beat Estimates ||| Nvidia forecasts revenue above estimates on gaming, data center demand ||| MicroSectors™ Launches FANG & Innovation ETNs, ‘BULZ’ & ‘BERZ’ ||| QQQ, NVDA, CMCSA, NFLX: ETF Inflow Alert ||| Things to Know Before Nvidia Reports Earnings ||| Wall Street flat ahead of Fed minutes ||| Stock Market News For Today August 18, 2021 ||| Dow set to open lower on recovery fears as focus turns to Fed ||| Dow futures slip on recovery fears as focus turns to Fed ||| NVIDIA Q2 22 Earnings Conference Call At 5:00 PM ET ||| 1 Way to Invest in Cryptocurrency Without Actually Investing in Cryptocurrency ||| 3 Attractive Dividend Stocks Whose Dividends Could Double ||| Ride the Momentum of AMD Stock To Some Big Gains ||| Trading Strategies for Nvidia's (NVDA) Earnings",1,0.48884544
2021-08-19,76655500.0,194.94000244140625,204.9499969482422,187.6199951171875,197.97999572753903,197.64825439453125,NVDA,"Technology Sector Update for 08/19/2021: SNPS,NVDA,CSCO ||| Why These 2 Nasdaq Crypto Stocks Moved in Opposite Directions Thursday ||| Technology Sector Update for 08/19/2021: LITE,CSCO,NVDA,SPNS ||| US STOCKS-S&P 500 ends with slim gain as tech strength offsets cyclical woes ||| Stock Market Today: Dow Falls for Third Straight Day ||| Nikkei slides to 7-month low as Toyota drags peers, other cyclicals ||| Tesla unveils own chip for AI training computer Dojo ||| Musk says Tesla will launch prototype of humanoid robot next year ||| US STOCKS-S&P 500 slips as cyclical slide counters tech gains ||| Why Nvidia Stock Jumped Today ||| Nvidia Reported Strong Earnings -- but Investors Should Keep Their Eyes on a Few Yellow Flags ||| US STOCKS-S&P 500 rises as tech gains offset cyclical declines ||| Intel details mixed-source chip strategy and TSMC partnerships ||| Why TuSimple Stock Is Surging Today ||| Stock Market News For Today August 19, 2021 ||| Nvidia's Revenue Is Skyrocketing ||| Nvidia Stock Gets a New Street-High Price Target ||| GlobalFoundries IPO would give Arm a leg up ||| Nvidia Stock Pops on Earnings Beat and Better-Than-Expected Guidance ||| What Is Nvidia's Omniverse and Why Should You Pay Close Attention To It? ||| Best Artificial Intelligence Stocks To Buy Right Now? 5 To Watch",1,0.46826658
2021-08-20,67574100.0,199.9100036621093,208.6499938964844,199.3300018310547,208.1600036621093,207.81121826171875,NVDA,"Why Nvidia Stock Is Hopping Today ||| Why These 2 Tech Stock Giants Made Very Different Moves Friday ||| 3 Hypergrowth Stocks in Fallen Angel Industries ||| Stock Market Today: Stocks Snap Skid But Suffer Weekly Loss ||| 8 Semiconductor Stocks to Watch as Google Makes Its Own Chips ||| Nvidia's $40 bln deal for ARM likely set for lengthy review ||| US STOCKS-Wall St rebounds on tech support, but heads for weekly losses ||| Drastic Droughts Leave Bees Stricken, Crops to Suffer ||| Nvidia's $40 bln deal for ARM likely set for lengthy review ||| Nikkei falls to 8-month low as Toyota drags peers, materials makers ||| Nvidia vs. AMD -- the New Oil? Which Stock Should You Buy?",1,0.48632118
2021-08-23,57580700.0,209.7100067138672,219.97000122070312,209.5,219.5800018310547,219.21206665039065,NVDA,"NVIDIA Corporation (NASDAQ:NVDA) Looks Just Right ||| Why Nvidia Won't Be Taken Down With Crypto's Dive ||| 3 Stocks to Buy That Could Join the $1 Trillion Club ||| Monday Sector Leaders: Energy, Technology & Communications ||| Why Amazon, Nvidia, and Salesforce Stocks Popped Today ||| 4 Top Stock Trades for Tuesday: PFE, MRNA, NVDA, BABA ||| 4 Top Tech Stocks To Watch In The Stock Market This Week ||| Synopsys design software uses AI to make chips more power efficient ||| The Way to Play the Federal Investigation into Tesla ||| Nikkei rebounds from 8-month lows as bargain-hunters prop auto shares ||| This Is Why Microsoft and Nvidia Were Up on Friday",0,0.4900886
2021-08-24,29729900.0,217.52999877929688,219.58999633789065,215.3500061035156,217.92999267578125,217.56480407714844,NVDA,"U.S. near deal for Nvidia supercomputer as it waits for delayed Intel machine -sources ||| Cerebras Systems connects its huge chips to make AI more power-efficient ||| The CFC Ban Has Helped Drastically Reduce Global Warming ||| Best Growth Stocks To Buy Now? 4 Semiconductor Stocks For Your List ||| U.S. near deal for Nvidia supercomputer as it waits for delayed Intel machine -sources ||| Tuesday's ETF with Unusual Volume: SUSL ||| Why AMD and Nvidia Jumped on Monday ||| US STOCKS-Nasdaq futures at record high as tech stocks rise ||| Nvidia: Buy It for Gaming, Hold It for Data Centers ||| Why You Should Buy Nvidia Stock and Hold It Forever",1,0.5148704
2021-08-25,34770100.0,217.3699951171875,224.6999969482422,217.22000122070312,222.1300048828125,221.7577972412109,NVDA,"US STOCKS-Nasdaq scales new peak; Fed caution keeps S&P 500, Dow muted ||| Why Nvidia Stock Rose Today ||| S&P 500, Nasdaq notch all-time closing highs ahead of Jackson Hole ||| US STOCKS-Wall Street drifts toward record closing highs in risk-on session ||| Intel Is Positioning Itself to Make the Comeback of the Century ||| Financials, chipmakers push S&P 500, Nasdaq to new peaks ||| Is It Too Late to Buy Nvidia Stock? ||| After Street-Beating Sales Report, Nvidia Stock’s on the Path to $250 ||| Nvidia Is Too Far Ahead of Competitors AMD and Intel",0,0.48194858
2021-08-26,23794000.0,222.0,223.3999938964844,217.8999938964844,220.67999267578125,220.3102264404297,NVDA,"AMD Stock Is a ‘Cheaper’ Way to Play Semiconductor Success ||| New Investor? Here Are 3 Great Starter Stocks to Consider ||| Notable ETF Inflow Detected - XLK, NVDA, MA, INTC",1,0.49146357
2021-08-27,30472200.0,221.83999633789065,227.22000122070312,221.6699981689453,226.3600006103516,225.980697631836,NVDA,"EU set to launch formal probe into Nvidia's takeover of Arm - FT ||| Nvidia Delights ||| Some Insiders and Traders Behave as if NVIDIA (NASDAQ:NVDA) is Nearing a Peak ||| S&P 500, Nasdaq nab all-time closing highs as Powell soothes taper fears ||| US STOCKS-S&P 500, Nasdaq set for all-time closing highs as Powell sooths taper worries ||| US STOCKS-S&P 500, Nasdaq hit record closing highs as Powell calms taper fears ||| Ex-Dividend Reminder: Safety Insurance Group, Old Republic International and NVIDIA ||| FT: European Commission Intends To Investigate NVIDIA-Arm Deal ||| EU set to launch formal probe into Nvidia's takeover of Arm - FT ||| Peloton Stock Drops on Earnings Miss, Weak Outlook, and Federal Subpoenas ||| What You Should Know About Nvidia's New Supercomputer",1,0.48665133
2021-08-30,26258000.0,228.3000030517578,230.42999267578125,225.509994506836,226.8800048828125,226.49986267089844,NVDA,"Tesla's Musk signals concerns over Nvidia deal for UK chip maker -The Telegraph ||| Nvidia Is Gaining Graphics Card Market Share. What Does This Mean for AMD? ||| Is It Too Late to Buy Roblox Stock? ||| Why Nvidia's Future Still Looks Bright After 1,300% Returns Over the Past 5 Years ||| Will AMD Be Worth More Than Intel by 2025? ||| Why Nvidia Is a Top Growth Stock to Buy Right Now ||| 7 AI Stocks to Buy as Tesla Doubles Down on Automation ||| Top Stocks To Watch This Week? 4 Tech Stocks For Your List ||| Nvidia Stock Is Having a Great Year for Good Reasons ||| US STOCKS-S&P 500, Nasdaq hit record highs as taper fears calm",0,0.48572746
2021-08-31,25985000.0,226.9499969482422,226.9499969482422,221.1999969482422,223.8500061035156,223.51434326171875,NVDA,"Why Nvidia Stock Short-Circuited This Morning ||| How You Can Invest in the Metaverse ||| US STOCKS-S&P 500, Nasdaq slip on tech weakness, but set for monthly gains ||| Planning On Buying Nvidia Stock? Look At AMD Instead",1,0.4750888
2021-09-02,18783400.0,225.17999267578125,225.92999267578125,222.9499969482422,223.9600067138672,223.6241455078125,NVDA,These Earnings Winners Are Up Over 10% After Hours Thursday ||| 7 Semiconductor Stocks to Buy for an Ongoing Chip Shortage,1,0.52566034
2021-09-03,28053200.0,223.25,229.8600006103516,222.0,228.42999267578125,228.08746337890625,NVDA,"Why Nvidia Shares Beat the Market Today ||| Why PagerDuty Stock Popped Today ||| 3 Top Growth Stocks For Your September 2021 Watchlist ||| QQQ, NVDA, CMCSA, NFLX: Large Inflows Detected at ETF ||| 3 Ways You Can Beat Warren Buffett in the Stock Market ||| Nvidia Stock Will Keep Growing Even at These Prices",0,0.48841286
2021-09-07,19810700.0,228.3300018310547,228.9900054931641,225.22000122070312,226.6199951171875,226.2801513671875,NVDA,"3 Tech Hardware Stocks to Buy After Earnings ||| Why Nvidia Stock Jumped 15% in August ||| 3 5G Stocks to Buy in September ||| Nvidia Trounces AMD Once Again: Here's Why That's Great News for Nvidia Shareholders ||| Nvidia Stock Can Surge 58% From Here Based on Free Cash Flow ||| A Complete, Comprehensive Overview of Bitcoin ||| Tuesday's ETF with Unusual Volume: SUSL",0,0.49339244
2021-09-08,25443400.0,225.1300048828125,226.1000061035156,219.7700042724609,223.38999938964844,223.0550079345703,NVDA,"4 Top Stock Trades for Thursday: NVDA, BBIG, V, LULU ||| Why Nvidia Stock Slipped Wednesday ||| Nvidia seeks EU approval for Arm deal, decision due Oct. 13 ||| Nvidia seeks EU approval for Arm deal, EU decision due Oct. 13 ||| Market Direction Will Drive the Next Move For Nvidia Stock ||| 7 Top-Performing S&P 500 Stocks to Watch ||| 3 Surging Tech Stocks: Can They Go Higher?",0,0.53413415
2021-09-09,19685600.0,223.1199951171875,225.3800048828125,221.3099975585937,221.7700042724609,221.4374237060547,NVDA,"A Complete, Comprehensive Overview of Ethereum ||| Is This Going to Be Intel's Big Break? ||| Meet Nvidia's Next Big Catalyst",1,0.49527857
2021-09-10,24837600.0,223.47999572753903,226.259994506836,222.6999969482422,224.77999877929688,224.4429473876953,NVDA,7 Stocks To Buy To Bet on Underappreciated CEOs ||| Why NVIDIA Will Dominate the Data Center by 2030 ||| Nvidia Stock May Be Ripe for Profit-Taking Right Here,0,0.49692282
2021-09-13,29750000.0,226.83999633789065,229.63999938964844,218.5800018310547,221.5200042724609,221.18780517578125,NVDA,"4 Augmented Reality Stocks To Watch As Facebook Unveils Its First Smart Glasses ||| 3 Reasons to Buy Intel, and 1 Reason To Sell ||| 3 Red-Hot Tech Stocks to Buy Right Now ||| Why Nvidia Stock Dropped This Morning ||| Nvidia Is A Growth Stock You Must Not Take Lightly",1,0.51074326
2021-09-14,19975500.0,222.75,224.1000061035156,220.8600006103516,222.4199981689453,222.08645629882807,NVDA,"UK's Sunak says wave of foreign takeovers shows confidence in economy ||| The 7 Best Tech Stocks to Buy Heading Into Q4 ||| 3 Futuristic Stocks for a 5G, Cannabis, and Metaverse World ||| Micron Technology Stock Is Absolutely a Buy Now With These Massive Tailwinds",1,0.48564324
2021-09-15,16653800.0,223.08999633789065,223.6699981689453,219.6600036621093,223.4100036621093,223.07498168945312,NVDA,Top Stocks To Watch Today? 4 Autonomous Vehicle Stocks For Your Watchlist ||| 3 Large-Cap Tech Stocks to Sell ||| 2 Sizzling Hot Stocks to Buy Right Now ||| Nasdaq Yewno Global Artificial Intelligence and Big Data Index ||| 3 Top Tech Stocks to Buy Right Now ||| 2 Smart Growth Stocks to Buy Right Now ||| Bitcoin Has Another Volatile Week. Are These Crypto Stocks Better?,0,0.48566005
2021-09-16,15603300.0,221.8300018310547,222.7700042724609,219.2700042724609,222.4199981689453,222.08645629882807,NVDA,7 Stocks to Buy to Invest Like Jim Cramer,0,0.51398224
2021-09-17,29450300.0,223.0,223.2100067138672,218.3000030517578,219.0,218.6715850830078,NVDA,GameStop Stock Frenzy Shows What Happens When a Meme Hardens Into Belief,0,0.5196664
2021-09-20,34944000.0,211.4600067138672,214.3300018310547,206.6199951171875,211.1300048828125,210.8134002685547,NVDA,"3 Stocks to Add to Your Portfolio in a Market Pull-Back ||| How Has Nvidia Soared 70% This Year, But Still Costs Only $1? ||| Why Apple, Facebook, Amazon, and Other Tech Stocks Dropped Today ||| 5 Top Leisure Stocks To Watch Ahead Of October 2021 ||| History Teaches Us That Nvidia Stock Is Bound to Rally Again ||| TSLA, NVDA, AAPL, NIO: Why Is the Stock Market Down Today? ||| Stock Split Watch: Is Amazon Next? ||| Advanced Micro Devices Is a Buy as the Company Keeps Expanding Its Market Share",1,0.48603106
2021-09-21,20468800.0,214.1699981689453,214.25,209.5,212.4600067138672,212.1414031982422,NVDA,"Only Time Will Tell Whether Recent Plans Pay Off for Intel ||| Noteworthy ETF Inflows: QQQ, NVDA, NFLX, CMCSA ||| Here’s a Smart Way to Buy the Nvidia Stock Dip ||| Great Performers That Are Still Great Stocks ||| This Catalyst Could Give Nvidia Stock a Big Boost ||| SoFi Technologies Has a Future Worth Speculating On Here ||| 3 Top Artificial Intelligence Stocks to Buy in September",1,0.4711931
2021-09-22,26872600.0,213.6600036621093,219.6000061035156,211.9600067138672,219.4100036621093,219.0809936523437,NVDA,Is Nvidia Stock a Buy? ||| Why Nvidia Stock Just Popped ||| Hot Stocks To Buy Right Now? 4 Semiconductor Stocks To Know ||| 3 Top Artificial Intelligence Stocks to Buy Now ||| NVIDIA (NASDAQ:NVDA) Has A Rock Solid Balance Sheet,1,0.48256755
2021-09-23,24855500.0,221.3999938964844,225.3500061035156,218.8999938964844,224.82000732421875,224.4828643798828,NVDA,America’s Most Influential CEO Is Nvidia’s Jensen Huang ||| Nvidia’s (NASDAQ:NVDA) Road Ahead May be Bumpy as the Company Plays the Long Game with Metaverse Strategy ||| September Sell-Off: 2 Top Stocks to Buy Now,0,0.502569
2021-09-24,21765500.0,220.6999969482422,221.4900054931641,218.6100006103516,220.8099975585937,220.47889709472656,NVDA,"After Hours Most Active for Sep 24, 2021 : ZNGA, CXP, COTY, ATCO, BEKE, QQQ, MU, KBWB, BMY, NVDA, IGIB, MIC ||| Tech stocks, Nike drag Wall Street lower after two-day sharp rally ||| Why Nvidia Stock Dropped This Morning ||| The Best Stocks to Buy During the September Sell-Off",0,0.48432845
2021-09-27,24521500.0,217.1000061035156,217.9900054931641,213.25,216.6000061035156,216.2751922607422,NVDA,"Here's the Most Important Trend Investors Are Ignoring ||| Keep Buying AMD Stock as Charts Favor More Gains ||| Nvidia Stock Heats Up Again Amid Renewed Optimism in Semiconductor Space ||| Stock Market Today: Energy Leads, Tech Lags, As Interest Rates Keep Rising ||| Why Nvidia Investors Are Nervous Today ||| BUZZ-U.S. STOCKS ON THE MOVE-Beyond Meat, U.S. banks, U.S. insurers ||| 3 Reasons to Buy AMD Stock Over Nvidia ||| US STOCKS-Tech megacaps, chipmakers set to drag Nasdaq lower at open",0,0.47862136
2021-09-28,34306900.0,212.13999938964844,214.19000244140625,206.509994506836,206.9900054931641,206.6795959472656,NVDA,5 Top Semiconductor Stocks To Watch This Week ||| Nvidia Stock Is No Longer a Reasonable Bargain ||| Why Nvidia Stock Dropped Again Today ||| The 3 Best AI Stocks To Buy for Massive Upside Potential ||| 3 Growth Stocks That Expect to Boost Sales by at least 180% in the Next 5 Years,0,0.54323596
2021-09-29,21839400.0,209.3999938964844,210.1699981689453,204.6699981689453,205.1699981689453,204.86233520507807,NVDA,"NVDIA Has an Incredible Growth Runway Ahead of It ||| Expect Nvidia Stock to Hold Steady at Best in the Short Term ||| Will the Semiconductor Shortage Continue Into 2022? ||| 1 Overlooked Stock Offering Safety, Income, & Growth ||| 3 Stocks I'm Never Selling",1,0.4670767
2021-09-30,22100900.0,207.67999267578125,210.6600036621093,206.8800048828125,207.1600036621093,206.849349975586,NVDA,"Kiplinger ESG 20: Our Favorite Picks for ESG Investors ||| Why Nvidia Stock Just Popped ||| Nvidia Stock May See Some Resistence, But Its Broader Story Is Compelling",1,0.4919527
2021-10-01,24097800.0,207.5,208.58999633789065,202.02999877929688,207.4199981689453,207.10894775390625,NVDA,Cryptocurrency Clouds Hang Over Case To Buy Nvidia Stock Anytime Soon ||| 10 Metaverse Stocks for the Future of Technology ||| Investors Should Not Sell Palantir Stock ||| Top 3 High-Growth Stocks to Buy in October 2021 ||| Why Nvidia Investors Feel Nervous Today,0,0.46671054
2021-10-04,34563500.0,205.0399932861328,205.4199981689453,195.5500030517578,197.32000732421875,197.0241241455078,NVDA,Is Micron Technology Stock a Buy? ||| 3 Video Game Stocks You Can Buy and Hold for the Next Decade ||| Better Buy: Apple Stock or Every Nasdaq Stock? ||| 3 High-Growth Stocks That Could Be Worth $1 Trillion in 10 Years -- or Sooner ||| Nvidia Commands Respect on Wall Street ||| Why Nvidia Stock Keeps Dropping ||| Coding platform GitLab aims for nearly $9 bln valuation in U.S. IPO,1,0.50618184
2021-10-05,27928200.0,199.5,206.47999572753903,198.5399932861328,204.509994506836,204.20330810546875,NVDA,"Technology Sector Update for 10/05/2021: OUST, NVDA, VMW, CMTL ||| Technology Sector Update for 10/05/2021: SGMS,OUST,NVDA,VMW,CMTL ||| Stock Market Today: Tech Recovers in Broad-Market Bounce-Back ||| Here's My Favorite Artificial Intelligence Stock Now ||| EA Partnership News Powers the Long-Term Case for Nvidia Stock ||| Why Nvidia Stock Was Up Today",1,0.4883388
2021-10-06,29720200.0,201.1999969482422,207.1999969482422,200.8000030517578,207.0,206.6895904541016,NVDA,"4 Semiconductor Stocks to Watch After Monday's Dip ||| Nvidia Makes Early Concessions To Secure EU Approval For Chip Developer Acquisition ||| After Hours Most Active for Oct 6, 2021 : ACWX, OLPX, BAC, CNQ, AAPL, VYGR, CSCO, NVDA, NCLH, KO, FTCH, USA ||| Most Active Stocks Today? 4 Gaming Stocks To Watch ||| Nvidia offers EU concessions over $54 billion Arm deal ||| Nvidia Is Building the Future of Technology ||| Nvidia offers EU concessions over Arm buy ||| Is It Time to Play Defense in the Stock Market?",1,0.4937489
2021-10-07,25691900.0,210.9199981689453,213.22000122070312,209.72000122070312,210.75,210.43394470214844,NVDA,3 Stocks to Buy Where Wall Street Is Focused on Fear,0,0.5071095
2021-10-08,15125800.0,211.009994506836,212.0599975585937,207.75,208.3099975585937,207.99761962890625,NVDA,"Intel: A Cheap Defensive Cash Flow Machine ||| If You Invested $1,000 in AMD in 2014, This Is How Much You Would Have Today ||| Market Sell-Off: 2 Monster Growth Stocks to Buy at a Discount ||| 3 Unstoppable Stocks to Buy in October",0,0.49987933
2021-10-11,16338800.0,205.75,210.6300048828125,205.1100006103516,206.9499969482422,206.63967895507807,NVDA,What Is the Metaverse?,0,0.51758546
2021-10-12,16213400.0,208.27999877929688,210.57000732421875,205.27999877929688,206.7100067138672,206.4000396728516,NVDA,"EU to investigate Nvidia's $54 bln ARM bid after remedies fall short - sources ||| 2 ""Wide Moat"" Stocks That Can Help You Beat Inflation ||| Here's How Microsoft Is Using Artificial Intelligence ||| The Top Tech Stock to Buy in October ||| 2 Best Stocks to Invest in Virtual Reality ||| Coding platform GitLab raises IPO pricing range, eyes nearly $10 bln valuation ||| 3 Cryptocurrency Stocks I'd Buy in a Heartbeat Over Shiba Inu ||| EU to open probe into Nvidia's $54 billion bid for Arm - sources ||| 3 5G Stocks to Buy Right Now",1,0.4942609
2021-10-13,18065200.0,209.17999267578125,209.8999938964844,207.1300048828125,209.38999938964844,209.07598876953125,NVDA,"3 Strong Tier 1 Companies to Keep an Eye On ||| Got $1,000? Buy This Growth Stock Now ||| Internet Infrastructure Stocks To Watch",1,0.5377259
2021-10-14,24358900.0,212.8800048828125,217.5500030517578,211.22000122070312,217.4600067138672,217.13389587402344,NVDA,2 Chip Stocks Poised to Do Well Even as the Chip Shortage Rages On ||| Coding platform GitLab valued at $13.48 bln in strong market debut ||| Nvidia's Pending Arm Acquisition: What Investors Need to Know,1,0.4917296
2021-10-15,22699400.0,218.1000061035156,219.3099975585937,216.6199951171875,218.6199951171875,218.2921600341797,NVDA,"Why Nvidia Is So Much More Than Just a Semiconductor Stock ||| Will Nvidia Be a Trillion-Dollar Stock by 2025? ||| Noteworthy ETF Inflows: QQQ, TSLA, NVDA, PYPL ||| Buy Intel Stock While Shares Are Still a Bargain",1,0.4758593
2021-10-18,18949400.0,217.4900054931641,222.9100036621093,216.44000244140625,222.22000122070312,221.8867645263672,NVDA,"UK intervenes in bid by U.S. aviation firm Parker for Meggitt ||| US STOCKS-S&P, Nasdaq enjoy boost from big tech firms, Dow ends a hair lower ||| 8 Hot Stocks With the Potential to Join the Elite Trillion-Dollar Club by 2030  ||| Why NVIDIA Can Thrive Through a Downturn ||| 3 Top Stocks to Buy if There Is a Market Pullback ||| Current Valuation Levels and Prospects Make Intel Stock a Buy ||| Better Growth Stock: Nvidia or Teladoc Health? ||| Chip tech firm Arm plans to slash development time for connected devices",1,0.49096406
2021-10-19,16147300.0,222.759994506836,223.7899932861328,220.3699951171875,222.8999938964844,222.5657653808593,NVDA,"""9 Foolish Truths That I Hold to Be Self-Evident"" ||| What Type Of Shareholders Make Up NVIDIA Corporation's (NASDAQ:NVDA) Share Registry? ||| 4 Top Artificial Intelligence Stocks To Watch Right Now ||| With Bitcoin At $60K, Consider These Crypto Stocks",0,0.48263535
2021-10-20,14627600.0,223.0500030517578,224.3300018310547,219.82000732421875,221.02999877929688,220.6985626220703,NVDA,Intel Stock Is Gearing Up for a Serious Breakout Here,1,0.5290869
2021-10-21,18759000.0,220.97000122070312,227.1100006103516,220.8300018310547,226.9199981689453,226.57969665527344,NVDA,"Stock Market Today: The S&P Squeaks Out a Record Close ||| 3 Semiconductor Stocks to Buy on the Dips Going Into 2022 ||| Intel, SiFive end talks without deal - Bloomberg News ||| Why Nvidia Stock Just Jumped ||| Is Qualcomm Building a New Operating System for Cars? ||| CROX Stock: 9 Reasons Why Crocs Investors Are Kicking Up Their Heels Today ||| Could This Stock Join the Trillion-Dollar Market Cap Club? ||| NVDA Stock: 13 Things to Know About Nvidia’s Next-Gen Cloud Gaming Platform",1,0.48666662
2021-10-22,24938400.0,228.22999572753903,231.3000030517578,225.6100006103516,227.259994506836,226.919189453125,NVDA,"3 of the Best Stocks to Buy Now With $500 ||| Intel Might Be Down, But It's Certainly Not Out ||| 3 Long-Term Investments You'll Thank Yourself for Later",1,0.5157248
2021-10-25,23023500.0,229.72999572753903,233.5500030517578,227.6999969482422,231.6600036621093,231.3126373291016,NVDA,"These Stocks Are Shaping the Future of Technology ||| Noteworthy ETF Inflows: QQQ, TSLA, NVDA, PYPL ||| Top 5 Nancy Pelosi Stocks ||| Got $5,000? 2 Tech Stocks to Buy and Hold for the Long Term",1,0.47770557
2021-10-26,48589800.0,239.88999938964844,252.58999633789065,239.2400054931641,247.1699981689453,246.79934692382807,NVDA,"Wall Street closes at record but Facebook weighs ||| Why Nvidia Stock Jumped Today ||| Wall Street hits record but Facebook weighs ||| Technology Sector Update for 10/26/2021: CRWD,AMZN,NVDA,FB,CVLT,MSFT,GOOG,GOOGL ||| US STOCKS-Wall Street hits record but Facebook caps gains ||| S&P 500 hits record high on tech strength, earnings cheer ||| 3 Top Metaverse Stocks To Watch Right Now ||| S&P 500 hits record high on tech strength, earnings optimism ||| Nasdaq 100 Movers: PDD, NVDA ||| Why AMD's and Nvidia's Stock Prices Were Up Last Week ||| S&P 500 Movers: LMT, UPS ||| Is Nvidia’s New Gaming Service Worth $15 Billion in Extra Market Cap?",0,0.4715184
2021-10-27,24599000.0,244.7400054931641,250.8999938964844,242.82000732421875,244.509994506836,244.1433563232422,NVDA,"EU to investigate Nvidia's $54 bln ARM bid, says deal may harm competition ||| Setback for Nvidia's $54 bln ARM bid as EU regulators open probe ||| Microsoft (MSFT) and Alphabet (GOOGL) Earnings Show Why Big Tech is Still Your Best Bet ||| Intel launches new PC chips, says U.S. supercomputer will double expected speeds ||| Nvidia Is Doubling Down on a Massive Opportunity",1,0.4910707
2021-10-28,23420400.0,248.77999877929688,249.5,245.22999572753903,249.4100036621093,249.0359802246093,NVDA,10 Long-term Stocks to Buy for the Next 15 Years ||| 4 Top Semiconductor Stocks To Watch Before November 2021,1,0.5113279
2021-10-29,29250300.0,250.009994506836,257.0899963378906,250.0,255.6699981689453,255.2866058349609,NVDA,Buy Intel Before INTC Stock Rebounds Soon ||| Nvidia Stock Could Build On Stellar Weekly Returns,1,0.48974067
2021-11-01,26574000.0,256.489990234375,258.94000244140625,252.2700042724609,258.2699890136719,257.8826904296875,NVDA,Could This Megacap Company Get Even Bigger? ||| Top Stocks To Buy Now? 4 Tech Stocks To Watch ||| Hard-Hit Micron Stock Presents a Perfect Entry Opportunity ||| Who's building the metaverse?,1,0.4935472
2021-11-02,29411200.0,258.2200012207031,266.7799987792969,258.0,264.010009765625,263.61407470703125,NVDA,"Got $5,000? 3 Tech Stocks to Buy and Hold For the Long Term ||| 4 Top Stock Trades for Wednesday: NVDA, CHGG, Z, BX ||| NVIDIA (NASDAQ:NVDA) is Starting to Look Pricey if Forecasts don't begin to Rise ||| Why Nvidia Stock Surged 23% in October ||| 5 Metaverse Stocks To Watch In November 2021 ||| Why Nvidia Stock Popped Again Today ||| What's Next For AMD Stock After 20% Rise Last Month?",1,0.4675138
2021-11-03,23991000.0,266.70001220703125,267.8399963378906,262.3500061035156,265.9800109863281,265.58111572265625,NVDA,Why Shares of Super Micro Computer Raced 13% Higher This Morning ||| 3 Cloud Gaming Stocks to Buy for 2022 and Beyond ||| Why Advanced Micro Devices Stock Is a Buy After Earnings,1,0.49122232
2021-11-04,115363100.0,272.2900085449219,313.6499938964844,271.17999267578125,298.010009765625,297.5630798339844,NVDA,"Intel’s Rally Is a Ruse and Traders Should Fade It ||| Nvidia: Are Second-Hand GPU Sales Decoupling From Crypto? ||| US STOCKS-S&P 500, Nasdaq extend record streaks, with boost from chip, growth shares ||| Chip, growth shares lift S&P 500, Nasdaq to record highs ||| US STOCKS-Chip, growth stocks send S&P 500, Nasdaq to records as Dow lags ||| Nasdaq 100 Movers: MRNA, QCOM ||| Stock Market Today: Tech Helps Nasdaq, S&P 500 Extend Streaks ||| Why Nvidia Stock Rocketed Higher Today ||| Thursday's ETF Movers: SMH, BBH ||| Prediction: These Will Be the 10 Largest Stocks by 2035 ||| Big Tech, chipmakers power S&P 500, Nasdaq to record highs",0,0.48863807
2021-11-05,85126000.0,301.8699951171875,314.0,294.1000061035156,297.5199890136719,297.0738525390625,NVDA,"Why Nvidia Soared Over 10% on Thursday ||| Why Nvidia Shares Marched Higher Again This Week ||| Friday's ETF with Unusual Volume: PWB ||| FAANG is Dead. Long Live MANAMANA ||| 3 Explosive Stocks to Buy Right Now Without Any Hesitation ||| US STOCKS-S&P, Nasdaq futures scale new heights on earnings bullishness",1,0.4760987
2021-11-08,50310100.0,301.489990234375,311.0,299.07000732421875,308.0400085449219,307.5780334472656,NVDA,"3 Disruptive Stocks That Could Turn $200,000 Into $1 Million by 2030 ||| Better Buy: Nvidia vs. Advanced Micro Devices ||| Is This Hot IPO Worth Buying? ||| With Stocks at All-Time Highs, 3 Stocks to Buy Without Hesitation ||| Stock Market Today: New Week, New Highs for Stocks ||| Monday's ETF with Unusual Volume: PSI ||| US STOCKS-Dow hits record high as infrastructure bill lifts cyclicals ||| AMD lands Meta as customer, takes aim at Nvidia with new chips ||| AMD lands Meta as customer, takes aim at Nvidia with new supercomputing chips ||| Why Nvidia Stock Popped Again Today ||| SoftBank buyback may ease pain of quarterly loss ||| Got $3,000? Buy These 3 Stocks Riding Unstoppable Trends",0,0.49403918
2021-11-09,64674600.0,322.82000732421875,323.1000061035156,299.6400146484375,306.57000732421875,306.1103210449219,NVDA,"4 Trending Gaming Stocks To Watch In November 2021 ||| Technology Sector Update for 11/09/2021: SQSP,DDD,NEWR,LAZR,NVDA ||| Technology Sector Update for 11/09/2021: DDD,NEWR,LAZR,NVDA ||| INVZ Stock Rockets Higher on Nvidia News. 9 Things to Know. ||| LAZR Stock Alert: The Huge Partnership Sending Luminar Rocketing Higher Today ||| Invesco NASDAQ 100 ETF Experiences Big Inflow ||| Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ||| 7 Stocks to Buy That Could Be the Next Trillion-Dollar Company  ||| Nvidia launches new products to plug cars, factories into its Omniverse ||| Nvidia doubles down on software tools for crafting virtual worlds",0,0.49688223
2021-11-10,63620600.0,293.5599975585937,308.5,287.7799987792969,294.5899963378906,294.14825439453125,NVDA,"Stock Market Today: Persistent Inflation Gut-Punches Tech Stocks ||| Meet the Next FAANG ||| 3 Homebuilding Stocks That Are Breaking Out ||| Why Nvidia Stock Slumped Today ||| 3 Robinhood Stocks That Are Great Long-Term Picks ||| Nvidia Gets a New Street-High Price Target ||| Pre-Market Most Active for Nov 10, 2021 : SQQQ, PLTR, LCID, F, EVGO, IONQ, TSLA, NVDA, NIO, LAZR, IPOF, CPTK ||| Will Nvidia Be Worth More Than Apple by 2026? ||| Here's 1 Way You Can Experience the Metaverse Today",1,0.48009437
2021-11-11,33217200.0,304.67999267578125,305.8999938964844,297.7699890136719,303.8999938964844,303.4442443847656,NVDA,"Why Nvidia Stock Bounced Back Today ||| US STOCKS-S&P closes little changed as chips boost Nasdaq in subdued holiday trading ||| Private Investors Are Already Printing Metaverse Money ||| US STOCKS-S&P closes little changed as chips boost Nasdaq in muted holiday trading ||| Axie Infinity Price Predictions: How High Can the Metaverse Boom Take AXS Crypto? ||| US STOCKS-S&P 500, Nasdaq rise on chipmaker boost; Disney weighs on Dow ||| 3 WallStreetBets Stocks to Trade ||| Top 20 Metaverse Stocks and Cryptos to Buy Now ||| Advanced Micro Devices Is in a Strong Spot ||| 3 Ways to Invest in Cryptocurrency If You're a Risk-Averse Investor ||| 7 of the Best Stocks to Buy for Their Free Cash Flow",0,0.48059502
2021-11-12,41305400.0,300.1000061035156,306.79998779296875,296.29998779296875,303.8999938964844,303.4442443847656,NVDA,"Why Luminar Technologies Shares Are Jumping This Week ||| Wall St Week Ahead-Some worry U.S. stocks rally more 'Fear Of Missing Out' than fundamentals ||| Why Nvidia May Have a Reason to Fear AMD ||| Nasdaq 100 Movers: PTON, MU",0,0.4841006
2021-11-15,38490900.0,305.5199890136719,306.44000244140625,292.4700012207031,300.25,299.7997436523437,NVDA,"As Supply Chain Woes Plague Apple, When's the Best Time to Buy? ||| Nvidia Earnings: What to Watch on Wednesday ||| Wall St Week Ahead-Some worry U.S. stocks rally more 'Fear Of Missing Out' than fundamentals ||| 3 5G Stocks You Can Buy and Hold for the Next Decade ||| Weekly Preview: Earnings to Watch This Week (BABA, CSCO, NVDA, WMT) ||| 3 Things to Watch in the Stock Market This Week ||| 2 Dividend-Paying Tech Stocks to Buy in November ||| 3 Metaverse Stocks That Could Make You a Fortune ||| Stock Market Today: Boeing, Tesla Spice Up a Bland Market Session ||| Best Stocks To Buy? 4 Semiconductor Stocks For Your Watch List ||| Will Earnings Keep Nvidia's Stock Momentum Alive? ||| 3 Growth Stocks That Could Set You Up for Life",1,0.48564303
2021-11-16,26448400.0,297.5899963378906,303.8999938964844,297.0599975585937,302.0299987792969,301.5770874023437,NVDA,"Qualcomm, diversifying from mobiles, to supply chips for BMW self-driving cars ||| 2 ‘Perfect 10’ Stocks Worthy of Your Attention ||| Nvidia: Metaverse Turns its Hype Factor to 11 ||| UK Govt Begins Probe Into $40 Bln Nvidia-Arm Deal ||| Why This Nonsense-Named Basket of Stocks Could Pay Serious Dividends ||| Relentless Innovation Makes Nvidia Stock the Gift That Keeps On Giving ||| US STOCKS SNAPSHOT-Wall Street opens lower as Nvidia weighs ||| Nvidia Stock Before Earnings: Buy, Hold, or Sell? ||| Nvidia's New Multibillion-Dollar Opportunity Could Be a Huge Catalyst ||| US STOCKS-Wall Street rises on retail optimism around holiday season ||| Qualcomm, diversifying from mobile phones, to supply chips for BMW self-driving cars ||| What Facebook's Metaverse Means for Crypto",0,0.5008387
2021-11-17,42850800.0,304.17999267578125,305.0899963378906,288.0,292.6099853515625,292.17120361328125,NVDA,"4 Top Stock Trades for Thursday: NVDA, F, V, TJX ||| Nvidia forecasts upbeat revenue on data center chip demand ||| Wall Street ends lower as retailers stoke inflation fears ||| US STOCKS-Wall Street down as retailers stoke inflation fears ||| Stocks Fall as Tech Earnings Paint a Mixed Picture After Hours ||| Japanese shares dip as inflation worries hit global stocks ||| Stock Stories to Make You Smarter, Happier, and Richer ||| NVIDIA Corporation Q3 adjusted earnings Beat Estimates ||| US STOCKS-Rate hike jitters weigh on Wall Street; supply chain overshadows retail ||| Finding a Fee-Only Financial Planner ||| NVIDIA Q3 22 Earnings Conference Call At 5:00 PM ET ||| Top Stock Market News For Today November 17, 2021 ||| Nvidia (NVDA) Q3 Earnings: What to Expect ||| Why Nvidia Stock Dropped Ahead of Earnings ||| The Top 10 Meme Stocks on Reddit: Should You Buy, Sell or Hold? ||| What’s in the Cards for Nvidia’s Earnings Today? Top Analyst Weighs In ||| After-Hours Earnings Report for November 17, 2021 : NVDA, CSCO, CPRT, BBWI, ZTO, TTEK, SONO, SQM, KLIC, HI, HP, YY",1,0.5330183
2021-11-18,78171100.0,323.6700134277344,327.6000061035156,313.2099914550781,316.75,316.2750549316406,NVDA,"Dow Drops as S&P 500, Nasdaq Notch Record Closes ||| GLOBAL MARKETS-Asian shares down as Alibaba's slide reignites China worries ||| Why Nvidia Stock Surged to a New All-Time Today ||| US STOCKS-S&P, Nasdaq end at record peaks on strong earnings ||| Thursday's ETF Movers: SMH, PBW ||| Stock Market Today: New S&P, Nasdaq Highs Thanks to Apple, Nvidia ||| Nvidia's rally turbo charged by 'metaverse', valuation breaches $800 bln ||| Why Roblox Stock Broke to New Highs This Week ||| US STOCKS-S&P, Nasdaq rebound as strong earnings outweigh inflation fears ||| Technology Sector Update for 11/18/2021: NVDA,RAAS,CSCO ||| US STOCKS-S&P, Nasdaq tick higher as strong earnings outweigh inflation fears ||| CVS Store Closings: 6 Things for CVS Stock Investors to Know About Plan to Close 900 Locations ||| 3 Stocks to Buy From Catastrophic Price Action ||| US STOCKS-S&P, Nasdaq close at record highs on strong earnings ||| US STOCKS-S&P, Nasdaq rise on strong results from Nvidia, retailers ||| GLOBAL MARKETS-S&P 500, Nasdaq hit record closing highs; Turkey's lira plunges ||| Is Nvidia Stock the Easiest Buy of the Decade? ||| Pre-Market Most Active for Nov 18, 2021 : SEV, CLOV, LCID, DRNA, RAAS, PROG, M, BABA, NVDA, VIPS, IONQ, MT ||| S&P 500 Movers: ANET, NVDA ||| Technology Sector Update for 11/18/2021: RAAS, NVDA, YY, XLK, SOXX ||| Nasdaq 100 Movers: CSCO, NVDA ||| Nvidia Q3 Results Beat Estimates; Issues Guidance ||| Ford, GlobalFoundries say they will work together to boost chip supply ||| Top Stock Market News For Today November 18, 2021 ||| Nvidia Stock Jumps on Earnings Beat and Guidance That Sped by Expectations ||| Insider Selling Should Not Spook NVIDIA's (Nasdaq:NVDA) Shareholders ||| US STOCKS-Nasdaq futures boosted by tech demand, Nvidia earnings ||| Could Crypto Shape the Future of the Metaverse? ||| NVIDIA Corporation (NVDA) Q3 2021 Earnings Call Transcript",1,0.4817733
2021-11-19,53386700.0,322.42999267578125,330.8800048828125,319.04998779296875,329.8500061035156,329.3553771972656,NVDA,"Finding Calmer Waters Amidst Choppy Markets With RSP ||| Nvidia and Tech Companies Lifting Nasdaq ||| US STOCKS-Nasdaq ends atop 16,000 mark for the first time on tech strength ||| Stock Market Today: Nasdaq Sets New Highs in Polarized Session ||| The 30 Best Stocks of the Past 30 Years ||| US STOCKS-Nasdaq closes above 16,000 for the first time; Dow down again ||| Why's the Dow Down While the S&P and Nasdaq Hit Record Highs? ||| Friday's ETF with Unusual Volume: IUSG ||| US STOCKS-COVID fears weigh on Dow, S&P 500; Nasdaq hits record high ||| Why Nvidia Stock Climbed Today ||| 2 Top Video Game Stocks to Buy Right Now ||| Nvidia: Making Secular Growth Play with Omniverse ||| US STOCKS-Nasdaq set for record open as economic concerns drive tech gains ||| Data Center Growth Is Still the Top Reason to Buy Nvidia Stock Now ||| Why This Company Continues to Be My No. 1 Position ||| US STOCKS-Nasdaq futures at record high as economic concerns drive tech demand ||| 3 Metaverse Stocks That Could Set You Up for Life ||| Nikkei rises on chipmakers, energy boost; SoftBank drops ||| US STOCKS-Lockdown fears weigh on Dow, S&P 500; Nasdaq hits record high",0,0.5091672
2021-11-22,75433500.0,335.1700134277344,346.4700012207031,319.0,319.5599975585937,319.0807800292969,NVDA,"3 Reasons Broadcom Is a Great Dividend Stock ||| 3 Stocks for This Next Market Opportunity (and It's Not the Metaverse) ||| The Sectors to Focus on As the Holiday Season Kicks Off ||| For Investors, Nvidia Is a Gift That Keeps on Giving ||| Most Active Stocks Today? 4 Tech Stocks To Know ||| Nvidia: Fantastic Company, Valuation Warrants Caution ||| AMD Stock Just Gave Us the Best Trade of the Year. Now What?  ||| Nvidia vs. AMD: Which Semiconductor Stock to Pick? ||| Nvidia Stock: Bull vs. Bear ||| 4 Stocks That Can Turn $100,000 Into $500,000 by the Time You Retire ||| Nvidia Stock Is Set To Soar Higher as It Rides Blowout Quarterly Results",0,0.5188125
2021-11-23,53216300.0,315.3500061035156,323.6000061035156,308.79998779296875,317.4599914550781,316.98394775390625,NVDA,"Best Metaverse Stocks To Buy Now? 3 To Check Out ||| 7 Best Video Game Stocks to Buy for the Year End ||| My 5 Tips to Set Your Portfolio Up for the Long Haul ||| Nvidia: New Markets, Strong Growth, Too Expensive Now ||| Why Nvidia Stock Dipped on Tuesday",1,0.48509654
2021-11-24,43516200.0,314.6099853515625,328.54998779296875,309.2799987792969,326.739990234375,326.25,NVDA,"GLOBAL MARKETS-Wall Street ends higher; Treasury yields hold near highs after Fed minutes ||| US STOCKS-Wall Street ends higher; Nvidia surge offsets Nordstrom, Gap slide ||| US STOCKS-Wall Street mixed; Nordstrom and Gap tumble after results ||| Why Nvidia Stock Bounced Back Today ||| After Pullback From Q3 Earnings Surge, Nvidia Looks Tempting ||| Could This Be the Best Way To Invest In the Metaverse? ||| Here's Why Nvidia Stock Remains a Screaming Buy at Record Highs ||| Could Nvidia Really Bring in $40 Billion a Year in Sales From This One Software Product? ||| Is Nvidia Stock a Buy With the Metaverse on the Horizon?",0,0.46196973
2021-11-26,28306900.0,326.0,327.1000061035156,313.5,315.0299987792969,314.5575561523437,NVDA,"3 Innovative Stocks Shaping the Future of the Metaverse ||| Why Nvidia Stock Short-Circuited Today ||| 3 Unstoppable Investments Everyone Needs in Their Portfolio ||| Is It Too Late to Buy Nvidia Stock? ||| Nvidia Stock Is a Great Buy for Consistent, Long-Term Gains",1,0.5180636
2021-11-29,45496400.0,323.6600036621094,334.1199951171875,320.3599853515625,333.760009765625,333.259521484375,NVDA,"Up 150% This Year, Is Nvidia Stock a Smart Buy Now? ||| Better Semiconductor Stock: Nvidia or AMD ||| 2 Under-the-Radar Metaverse Stocks That Could Make You a Fortune ||| Best Semiconductor Stocks To Buy Now? 3 For Your List ||| Why Nvidia Stock Investors Cheered Today ||| Ex-Dividend Reminder: Vontier, NVIDIA and Qualcomm ||| Record number of U.S. firms change tack on political spending after Jan. 6 attack",0,0.49875325
2021-11-30,62206600.0,331.69000244140625,333.5299987792969,318.6400146484375,326.760009765625,326.2699890136719,NVDA,"Amazon's cloud unit launches new chips to take on Intel, Nvidia ||| Amazon offers new data tool to help carmakers prevent recalls, improve safety ||| Amazon's cloud unit launches new chips to take on Intel, Nvidia ||| What Is the Outlook for NVIDIA in 2022? ||| Why Nvidia Stock Tanked Today ||| Nvidia Steamrolls AMD as It Aggressively Pursues This Massive Market ||| Better Buy: Netflix Stock or Every Nasdaq Stock? ||| Does Nvidia Stock Still Have Upside Left? ||| NVIDIA Corporation (NVDA) Ex-Dividend Date Scheduled for December 01, 2021 ||| META ETF: 10 Things to Know About the Roundhill Ball Metaverse ETF",0,0.49289978
2021-12-01,48436800.0,332.19000244140625,332.8900146484375,313.79998779296875,314.3500061035156,313.9170227050781,NVDA,"Hewlett Packard Enterprise to supply U.S. green energy research supercomputer ||| Nvidia Goes Parabolic, Can It Soar Even Higher? ||| Don't Own These 10 Stocks? Then You're Probably Underperforming the Market ||| Everything You Need to Know About Nvidia's Business Mix in 1 Simple Chart",1,0.4707009
2021-12-02,47289000.0,312.1400146484375,324.7799987792969,310.25,321.260009765625,320.81756591796875,NVDA,"3 Hot Metaverse Stocks To Watch Right Now ||| Sportsman's Warehouse ends merger with Great Outdoors over FTC clearance concerns ||| 3 Stocks That Can Make You Richer in December ||| Buy and Hold Meta Platforms as Metaverse Growth Strategy Unfolds ||| Why Nvidia Stock Popped Today ||| 3 Top Stocks to Invest in the Metaverse ||| U.S. FTC sues to block Nvidia deal to buy Arm ||| Top 3 Stocks to Buy in December 2021 ||| SiFive speeds up computing chip designs as it staffs up ||| 3 Cryptomining Stocks to Profit From The Bitcoin Boom ||| US STOCKS-S&P 500, Dow climb on boost from financials, Boeing",0,0.51670074
2021-12-03,54432500.0,320.0,321.2900085449219,301.29998779296875,306.92999267578125,306.5072937011719,NVDA,"US STOCKS-Wall St ends lower on Omicron worries, Fed taper angst ||| NVDA Stock: 16 Things for Nvidia Investors to Know as FTC Fights Arm Mega Merger ||| Metaverse Stocks No One Is Talking About ||| Why Nvidia Stock Short-Circuited Today ||| US STOCKS-Nasdaq dives over 2% as tech stocks slide at end of volatile week ||| Crypto Executives to Get Congressional Scrutiny ||| TOMZ Stock: 7 Things to Know About Short-Squeeze Play TOMI Environmental as Shares Surge Today ||| Nvidia metaverse future bright even as Arm may slip from grasp ||| MRVL Stock Alert: 14 Reasons Why Marvell Technology Investors Are Feeling Marvelous Today ||| Here's Another Reason Why Nvidia Could Keep Growing at a Terrific Pace ||| 3 Unstoppable Stocks That Could Crush the Market Again in 2022 -- and Beyond ||| Nvidia and Arm Merger Deal Blocked By FTC on Competition Grounds ||| FTC To Block Nvidia-Arm Deal To Protect Critical Infrastructure Markets From Illegal Vertical Merger ||| GLOBAL MARKETS-Stocks stumble as bond traders turn to jobs data ||| Softbank Group shares slide 3% after Didi, Arm, Grab triple setback ||| Why Nvidia Stock Climbed 28% in November",0,0.47226107
2021-12-06,65893800.0,298.79998779296875,302.4100036621094,280.3800048828125,300.3699951171875,299.9562683105469,NVDA,"4 Top Semiconductor Stocks To Watch In December 2021 ||| Japanese shares fall on Omicron worries; SoftBank drags ||| SoftBank shares slide 9% as portfolio upside evaporates ||| US STOCKS-Dow leads Wall Street higher with 2% gain; cyclicals in vanguard ||| U.S. says Nvidia-Arm deal harms market for networking, self-driving car chips ||| Would Meta Platforms Buy Roblox? ||| US STOCKS-Wall Street regains some ground with help from easing virus fears ||| US STOCKS-Wall Street closes up as easing in virus fears aids rebound ||| 7 Best Gaming Stocks for You to Play Now ||| US STOCKS-Dow climbs over 1% on cyclical boost; Nvidia weighs on Nasdaq ||| US STOCKS-Dow, S&P 500 set to rebound on banks, energy boost ||| SPYG, TSLA, NVDA, ADBE: ETF Inflow Alert ||| US STOCKS-Dow bounces back on cyclical boost; Nvidia leads tech stocks lower ||| US STOCKS-Nasdaq set for lower open as Nvidia, Big Tech weigh ||| EU regulators pause investigation into Nvidia, ARM deal ||| 3 Stocks to Buy With a $30 Trillion Metaverse Market on the Way ||| Real Estate Investing & More ||| SoftBank drags Japan's Nikkei lower; hopes of milder Omicron impact cap losses",1,0.5144616
2021-12-07,59305300.0,309.57000732421875,324.489990234375,306.510009765625,324.2699890136719,323.8233642578125,NVDA,"After 130% Rally, What’s Next for Nvidia Stock? ||| New Troubles Hit Nvidia, No Need to Worry ||| Stock Market Today: Tech Takes the Reins as Stocks Soar Again ||| US STOCKS-Wall Street closes higher with Nasdaq boosted by tech rally ||| 7 Web3 Stocks to Buy if You’re Betting on a Blockchain-Based Internet ||| Better Buy for 2022: Crypto Crash or the Stock Market Sell-Off? ||| US STOCKS-Big Tech, chipmakers power Nasdaq as Omicron worries subside ||| US STOCKS-Wall Street closes higher with Nasdaq boosted by tech rally ||| 2 Top Metaverse Stocks Ready for a Bull Run ||| Why Nike Is a Better Metaverse Stock Than Roblox ||| US STOCKS-Wall St set to open 1% higher as tech stocks roar back ||| Can Sportsman's Warehouse Thrive Despite Its Merger Falling Through? ||| US STOCKS-Nasdaq futures jump as tech stocks bounce back ||| Intel shares surge on potential windfall from Mobileye listing ||| US STOCKS-Wall St set to open 1% higher as tech stocks roar back",0,0.48061135
2021-12-08,47555100.0,319.989990234375,322.8999938964844,314.2099914550781,318.260009765625,317.8216857910156,NVDA,Best Stocks To Invest In Right Now? 4 Tech For Your Watchlist ||| Cathie Wood's newest ARK ETF rises in first day of trading ||| US STOCKS-Wall Street mixed as Omicron worries cloud vaccine update ||| GameStop Plunges as Liquidity Squeeze Crushes Meme Assets ||| Why Nvidia Stock Slipped Lower Today ||| Public Companies Were Buzzing Over This Potential Trillion-Dollar Trend in Q3 ||| Is Nvidia Stock a Buy Now?,0,0.48543644
2021-12-09,48850700.0,317.3399963378906,322.04998779296875,304.2799987792969,304.8999938964844,304.4801025390625,NVDA,Will There Be More Than 1 Metaverse Winner? ||| U.S. chip subsidies will support design activities -U.S. Commerce official ||| The 15 Best Stocks to Buy for the Rest of 2022 ||| US STOCKS-Nasdaq leads Wall Street lower after sharp rally this week ||| US STOCKS-Wall Street pauses after sharp rally this week ||| US STOCKS-Wall Street set to take breather after sharp rally this week ||| Grading 7 Big 5G Stocks as 2022 Looms ||| 3 Top Stocks That Look Overvalued but Are Still No-Brainer Buys ||| Nvidia's Stock Price Seems Unstoppable ||| Applied Materials: First Stop In Solving the Chip Shortage ||| US STOCKS-Wall Street set to pause after sharp rally this week,0,0.48510066
2021-12-10,48882500.0,311.5,313.04998779296875,298.6099853515625,301.9800109863281,301.5640869140625,NVDA,"Why Ambarella Stock Jumped This Week ||| Nvidia Stock Still Has Plenty More Left in the Tank After Massive Climb ||| 5 Artificial Intelligence Stocks To Watch In December 2021 ||| Global tech show CES attracts 15,000 sign-ups since Omicron ||| 5 Tech Stocks That Should Be on Every Investor’s 2022 Buy List ||| Is Now a Good Time to Buy Nvidia? ||| Intel Stock Will Shine Again in 2022 ||| 2 Metaverse Stocks That Could Set You Up for Life ||| Will Nvidia Be a Trillion-Dollar Stock by Next Year? ||| AMD Stock: There May Be More Downside Ahead ||| US STOCKS-Wall Street rises as inflation data meets estimates",0,0.48514992
2021-12-13,59834400.0,302.489990234375,302.94000244140625,281.1600036621094,281.6099853515625,281.2221374511719,NVDA,3 Top Metaverse Stocks to Buy in December ||| What Does The Metaverse Mean For Non-Gamers? ||| 3 Reasons to Buy Qualcomm Stock Near Its All-Time High ||| Intel's first foray into the metaverse will be software to use others' chips ||| Why Nvidia Stock Keeps Dropping ||| Could Tesla Be the World's Most Valuable Company in 10 to 15 Years? ||| 2 Top Metaverse Stocks to Buy and Hold for the Next Decade ||| What New Metaverse ETFs Mean for Investors,1,0.50710803
2021-12-14,66703500.0,276.989990234375,286.7799987792969,272.5,283.3699951171875,282.979736328125,NVDA,"4 Top Stock Trades for Wednesday: AAPL, NVDA, UPST, NET ||| How to Trade Intel as it Tries to Bottom ||| 5 Metaverse Stocks To Watch In The Stock Market Today ||| These 3 Stocks Might Be Getting a Little Too Expensive",1,0.50061136
2021-12-15,69829700.0,284.0,305.0,278.3800048828125,304.5899963378906,304.1705322265625,NVDA,"Markets Get a Fed Bounce -- and These Mega-Stocks Were Big Winners ||| As Bitcoin Prices Crashed, Crypto Miners Hit Hard ||| Wall Street ends higher; Fed to end bond purchases in March ||| Wall Street ends higher; Fed to end bond purchases in March ||| Wall Street climbs; Fed says it will end bond purchases in March ||| Why Nvidia Stock Finally Popped Today ||| 3 Things About Nvidia That Smart Investors Know ||| 4 Growth Stocks to Buy and Hold Forever ||| Wall Street Wants You to Buy These 3 Chip Stocks for 2022 ||| Nvidia Stock Was Hot Before, But the Metaverse Should Light Things Up",0,0.4813996
2021-12-16,70736600.0,311.5199890136719,311.6000061035156,280.92999267578125,283.8699951171875,283.47906494140625,NVDA,US STOCKS-Nasdaq ends sharply lower as investors dump growth stocks ||| Nasdaq ends sharply lower as investors dump growth stocks ||| Best Stocks To Invest In Late 2021? 5 Top Growth Stocks To Watch Now ||| Why Nvidia Stock Dropped Again Today ||| Nasdaq ends sharply lower as investors dump growth stocks ||| Is Nvidia Still a Good Buy Going Into 2022? ||| Nasdaq tumbles as investors sell growth and buy value,0,0.47601023
2021-12-17,71375800.0,279.8500061035156,289.2200012207031,277.6000061035156,278.010009765625,277.62713623046875,NVDA,S&P 500 ends down after mostly negative week ||| Wall St Week Ahead-Narrowing market breadth may be worrying signal for stocks ||| Wall Street ends down after mostly negative week ||| 2 Metaverse Stocks That Could Make You Richer in 2022 ||| 7 Top Meme Stocks to Buy Before the Year End ||| Is the Semiconductor Shortage Almost Over? ||| US STOCKS-Indexes mixed as Wall Street heads for a weekly loss,0,0.48673347
2021-12-20,46184700.0,273.04998779296875,281.44000244140625,271.45001220703125,277.19000244140625,276.8082275390625,NVDA,"5 Growth Stocks to Buy Now for 2022 ||| Which Cybersecurity Stock Is the Smartest Buy for 2022? ||| Wall St Week Ahead-Narrowing market breadth may be worrying signal for stocks ||| Successful Investors: What Would You Do in 2022 With a Blank Slate and $5,000? ||| 5 Unstoppable Trends to Invest $5,000 In for 2022 ||| Why Nvidia Stock Dropped Again Today ||| NVDA Stock: Growth Justifies the Valuation ||| Nvidia Stock Surged on Analyst’s Cloud Computing Report, Then Sputtered Again ||| 2 Growth Stocks That Outperformed Tesla and Bitcoin in 2021 ||| Is Nvidia a Buy Despite Its High Valuation? ||| Are Strong Financial Prospects The Force That Is Driving The Momentum In NVIDIA Corporation's NASDAQ:NVDA) Stock? ||| Should You Buy the Adobe Stock Dip to Kick Off 2022?",1,0.5031723
2021-12-21,52438500.0,283.739990234375,291.20001220703125,274.010009765625,290.75,290.3495483398437,NVDA,"The Slump in Advanced Micro Devices Stock Is Only Temporary ||| Why Nvidia Stock Rebounded Today ||| Softbank’s Apollo landing does little to reassure ||| SoftBank finalizing $4 bln loan from Apollo-led group - WSJ ||| 7 Best-Looking Stock Charts Going Into Christmas ||| SoftBank to borrow $4 bln from Apollo-led group ||| Will Nvidia Stock Fly or Fall in 2022? ||| US STOCKS-Wall St set to rebound after sharp selloff as Nike, Micron lead gains ||| 7 of the Best ESG Stocks for 2022 to Buy Now That Will Remain Strong",1,0.48394808
2021-12-22,39518400.0,288.9100036621094,295.54998779296875,284.489990234375,294.0,293.5950927734375,NVDA,"Noteworthy ETF Inflows: RDVY, NVDA, HPQ, LPX ||| Tesla -- The World's Top High-Growth AI Stock ||| This Company Just Shared Great Insight Into the Semiconductor Market ||| Annual Event Sedan Reveal Shows Nio Stock Has 2x Potential Into 2022 ||| Despite Volatility, Crypto Finishing Strong for the Year ||| Which Metaverse Stocks To Buy In 2022? 5 For Your Watchlist",1,0.5009262
2021-12-23,34302200.0,297.54998779296875,300.5899963378906,294.3099975585937,296.3999938964844,295.99176025390625,NVDA,"ANALYSIS-After another stunning U.S. stock market year, investors wonder how much gas is left ||| My 3 Top-Performing Stocks of 2021, and Why I'm Still Buying for 2022 ||| Stock Split Watch: Is Amazon Next?",1,0.4827259
2021-12-27,40368600.0,296.6000061035156,310.8699951171875,296.3999938964844,309.45001220703125,309.0238037109375,NVDA,"NVIDIA Helps Open Door to the Metaverse; Street Upbeat ||| These 5 Stocks Moved the Market in 2021 ||| Got $3,000? These 3 Stocks Could Double Your Money by 2030 ||| Investing $500 Each Month Into These 2 ETFs Could Set Your Kids Up for Life ||| 3 Cathie Wood Charts That Show Why the Stock Market Feels Crazy Right Now ||| Investors Bet Big on Big Tech Heading Into Year-End ||| Why Nvidia Stock Popped Today ||| 2 Monster Metaverse Stocks to Buy and Hold For The Next Decade ||| Monday's ETF with Unusual Volume: SUSL ||| Advanced Micro Devices Is Strong But Caution Is Still Necessary",0,0.50198925
2021-12-28,42059100.0,313.1199951171875,313.29998779296875,300.1199951171875,303.2200012207031,302.8023376464844,NVDA,"Got $3,000? 2 Tech Stocks to Buy and Hold for the Long Term ||| US STOCKS-S&P 500 set to open at record high as rally sustains ||| 5 Reasons to Buy Texas Instruments, and 1 Reason to Sell ||| Best Growth Stocks To Buy For 2022? 5 Virtual Reality Stocks To Watch ||| With Bitcoin At $51,000, Check Out These Crypto Stocks ||| Why Nvidia Stock Dipped Today ||| How You Can Make More Money on the Metaverse Than Elon Musk Will ||| Pre-Market Most Active for Dec 28, 2021 : SQQQ, SPRB, BBIO, AAPL, TQQQ, NVDA, EDU, CCL, F, T, NIO, PLTR ||| Is Nvidia a Good Choice Now? ||| Pre-Market Most Active for Dec 28, 2021 : SQQQ, SPRB, BBIO, AAPL, TQQQ, NVDA, EDU, CCL, F, T, NIO, PLTR ||| My 3 Highest Conviction Growth Stocks to Buy Before 2022 ||| There’s a Bubble Brewing in Plain Sight. Here’s How to Play It.",0,0.47592655
2021-12-29,34313900.0,302.7300109863281,305.4800109863281,293.6600036621094,300.010009765625,299.5967712402344,NVDA,Stay on the Frontlines of Crypto Innovation With BLOK ||| ProShares Wants to Launch a Metaverse ETF. Here’s What You Should Know. ||| Why Nvidia Stock Stumbled Today ||| 7 Growth Stocks That Analysts Are Loving Right Now ,0,0.48731756
2021-12-30,30886400.0,298.2699890136719,304.57000732421875,295.3999938964844,295.8599853515625,295.45245361328125,NVDA,"How Blockchain Will Become a Driving Force on Wall Street ||| Predictions for the Stock Market in 2022 ||| Notable ETF Inflow Detected - IWV, TSLA, NVDA, UNH ||| Cloudflare Stock Is a Victim of Bearish Sentiment That Should Clear Soon ||| Not all merger boutiques will be equal in 2022 ||| This Growth Stock Could Be a Surprise Metaverse Pick in 2022 ||| AMD's $35 bln deal for Xilinx now expected to close in 2022 ||| Best Stocks for 2022: Can Nvidia Stock Double in Price Again?",0,0.47705102
2021-12-31,26653000.0,296.739990234375,300.29998779296875,293.3099975585937,294.1099853515625,293.70489501953125,NVDA,"The 25 Best-Performing Stocks of 2021 ||| Is a Big Tech Bear Market Coming in 2022? ||| 12 TOP Stocks to Buy Now in January 2022! (2022 High Growth) ||| As the Sun Sets on 2021, These 5 Stocks Are My Highest-Conviction Holdings",1,0.4732801
2022-01-03,39154700.0,298.1499938964844,307.1099853515625,297.8500061035156,301.2099914550781,300.79510498046875,NVDA,3 Red-Hot Growth Stocks to Buy in 2022 and Beyond ||| Investing in This ETF Right Now Could Make You a Millionaire Retiree ||| Nvidia: Beware the Steep Valuation Despite Favorable Prospects ||| AMD Could Jump Upward if China Gives Its Acquisition the Go Ahead ||| 7 of the Best Metaverse Stocks for 2022 to Buy Now ||| Good Stocks To Invest In Right Now? 4 Semiconductor Stocks To Check Out ||| CES 2022 Preview: The 9 Most Anticipated Reveals and Rumors ||| Why Nvidia Stock Started the New Year Strong ||| GLOBAL MARKETS-Wall Street shows confidence to start the new year ||| Wall Street climbs in upbeat start to 2022 ||| 3 Surefire Metaverse Stocks That Could Make You Richer in 2022 ||| US STOCKS-Wall Street climbs in upbeat start to 2022,0,0.5182032
2022-01-04,52715400.0,302.7699890136719,304.67999267578125,283.489990234375,292.8999938964844,292.4966125488281,NVDA,"Exactly How I'd Invest $5,000 If I Had to Start From Scratch Today ||| 3 “Strong Buy” Stocks for the Metaverse Revolution ||| Why AMD Stock Dropped More Than 5% Today ||| Intel launches graphics chips for gamers in effort to take on Nvidia ||| Nvidia Omniverse: 14 Things for NVDA Stock Investors to Know About the Metaverse Project ||| Why Nvidia Stock Dropped 4.5% Today ||| Chinese EV startups turn to Nvidia in the race to catch Tesla ||| 2 Unstoppable Stocks That Could Turn $100,000 Into $500,000 by 2030 ||| Nvidia embraces the metaverse with new software, marketplace deals ||| Nvidia Stock: Can Its Momentum Continue in 2022? ||| Why Matterport Stock Dove 36% in December ||| Better Metaverse Stock: Nvidia vs. Roblox ||| InMode Is Bringing a Paradigm Shift to Cosmetic Procedures ||| Could Marvell Technology Become the Next Nvidia? ||| Self-driving truck company TuSimple to use Nvidia chips for autonomous computing ||| 3 ‘Founder CEO’ Stocks to Buy as 2022 Gets Underway ||| Why This Semiconductor Stock's Price Jumped Monday",0,0.51239866
2022-01-05,49806400.0,289.489990234375,294.1600036621094,275.3299865722656,276.0400085449219,275.6597900390625,NVDA,"The U.S. Stock Market Just Did Something It May Never Do Again ||| Why Intel Popped, but AMD and Nvidia Dropped Today ||| Make a Move on Nvidia Stock While It Sits at November’s Levels ||| ANALYSIS-Some investors turn cautious on Big Tech as Fed hikes loom ||| Nvidia Impresses at the CES; Extends Partnership with TuSimple ||| US STOCKS-Futures subdued as tech stocks extend fall; Fed minutes awaited ||| My Favorite AMD Products Announced at CES 2022 ||| US STOCKS-Futures dip as tech stocks extend fall; Fed minutes eyed",1,0.47215778
2022-01-06,45418600.0,276.3999938964844,284.3800048828125,270.6499938964844,281.7799987792969,281.3919372558594,NVDA,General Motors taps three Qualcomm chips to power its Ultra Cruise feature ||| Why Nvidia Stock Bounced Back on Thursday ||| 7 Blockchain Stocks to Buy to Get In on the Crypto Action ||| 3 Large-Cap Tech Stocks to Sell ||| Tesla Briefly Led the Nasdaq to New Heights. Here's Why It Didn't Last,0,0.50942117
2022-01-07,40993900.0,281.4100036621094,284.2200012207031,270.57000732421875,272.4700012207031,272.0947265625,NVDA,"Wall Street mixed after soft jobs data; banks rally ||| Why Nvidia Stock Dropped Back Today ||| What Is the Metaverse (And How Can I Invest In It?) ||| Wall St Week Ahead-Hawkish Fed gives value stocks a second wind ||| Bank of America Pounds the Table on Nvidia Stock ||| 3 High-Yield Tech Stocks to Buy in January ||| Best Stocks To Buy Now? 5 Metaverse Stocks To Watch Today ||| FOCUS-At CES, tech alliances firm up in the self-driving car wars ||| Nvidia Teases a Monstrous Graphics Card ||| Intel Launches a Broadside at AMD and Nvidia as It Guns for a Turnaround",1,0.47289503
2022-01-10,59468100.0,265.8099975585937,274.69000244140625,256.44000244140625,274.0,273.6225891113281,NVDA,"Semiconductor Market Recap for the Week ||| Wall St Week Ahead-Hawkish Fed gives value stocks a second wind ||| 3 Things to Watch in the Stock Market This Week ||| 5 Unstoppable Metaverse Stocks to Buy in 2022 ||| Why CES 2022 was Bad News for Advanced Micro Devices ||| 4 Top Stock Trades for Tuesday: ROKU, TLRY, NVDA, INTC ||| Why TuSimple Stock Is Lower Today ||| FB, AMZN, NVDA, AAPL, COIN: Why Are Tech Stocks Down Today? ||| Investing in This ETF Right Now Could Make You a Millionaire Retiree ||| How to Beat the S&P 500 in 2022 ||| The Best Stocks to Invest $10,000 In Right Now ||| Top Metaverse Stocks to Watch: Nvidia & Matterport",1,0.49207792
2022-01-11,40408900.0,273.2300109863281,280.6499938964844,268.3900146484375,278.1700134277344,277.7868957519531,NVDA,"Prediction: These Will Be 3 of the Biggest Stocks by 2032 ||| 7 Semiconductor Stocks With the Most Upside in the New Year ||| Why This Stock Grew 7,000% in 10 Years ||| Nvidia Stock Is Worth the Premium on the Back of Solid Growth Drivers ||| Should You Buy Nvidia Stock in 2022? ||| Sweet Silicon: 5 Superb Semiconductor Stocks for 2022 and Beyond ||| AMD Stock Gives Investors Plenty of Ways to Play It ||| Why Nvidia Stock Just Popped ||| Will Investors See a Tech Sector Market Top in 2022?",1,0.50323015
2022-01-12,38341300.0,280.6700134277344,285.95001220703125,276.0799865722656,279.989990234375,279.6043395996094,NVDA,"3 Under-the-Radar Auto Technology Stocks to Watch in 2022 ||| PREVIEW-Investors ready for U.S. earnings as inflation worries run high ||| The Top 10 Best-Performing Stocks of 2021 ||| Best Metaverse Stocks To Buy Today? 4 For Your List ||| The Zacks Analyst Blog Highlights: Taiwan Semiconductor, Apple, Advanced Micro Devices and NVIDIA Corp",0,0.52474785
2022-01-13,54017100.0,283.7900085449219,284.79998779296875,264.9800109863281,265.75,265.3839416503906,NVDA,"Nvidia Could Surge Again This Year Based on Its Huge Free Cash Flow ||| Why Nvidia Stock Dropped Today ||| Nvidia: Multiple Reasons to Expect More Growth ||| Investment Opportunity Breakdown: Video Game Stocks ||| 7 Great Growth Stocks to Add to Your January Buy List ||| Nvidia Could Be the Stock of the Decade, so Make the Most of Its Pullback ||| Stock Market Today: Stocks Resume Slide on Busy News Day ||| 7 Amazing Companies to Watch in 2022 ||| Intel (INTC) to Power Turkey E-Commerce Platform for SMEs ||| US STOCKS-Futures gain after producer prices data eases rate hike fears ||| 4 Reasons to Invest in Nvidia's AI in 2022 ||| Hewlett Packard (HPE) to Streamline Brasfield & Gorrie's Network ||| PREVIEW-Investors ready for U.S. earnings as inflation worries run high ||| 2 Critical Factors Driving Nvidia's Success in Autonomous Driving",1,0.49925295
2022-01-14,39583200.0,263.0,271.9700012207031,262.1000061035156,269.4200134277344,269.0489196777344,NVDA,Why Nvidia Stock Blipped Higher Today ||| Block (SQ) to Boost Cryptocurrency Efforts With Latest Plans ||| 3 Popular ESG Indexes and How to Invest in Them ||| 3 Top Metaverse Stocks to Buy in January ||| Wall St Week Ahead-Earnings to test growth stocks after rocky start to year ||| Why Nvidia Stock Could Be Worth More Than Apple in a Decade ||| Estimating The Fair Value Of NVIDIA Corporation (NASDAQ:NVDA),0,0.4805412
2022-01-18,42427000.0,262.6000061035156,266.3800048828125,257.70001220703125,259.0299987792969,258.6732788085937,NVDA,"Should You Invest in the Metaverse or Is This an Overhyped Buzzword to Avoid? ||| 3 Top Artificial Intelligence Stocks to Buy in January ||| Wall St Week Ahead-Earnings to test growth stocks after rocky start to year ||| Could Nvidia Be a Great Stock to Buy in 2022? ||| 3 Stocks That Could Produce 10X Returns By 2037 ||| 3 Gaming Stocks To Watch For January 2022 ||| 7 Long-Term Stocks to Buy and Hold Until 2030 ||| How Will Rising Inflation and Interest Rates Affect Your Stock Portfolio? ||| 3 Stocks I'm Buying During a Tech Stock Correction ||| FOCUS-Cadence Design Systems aims to cash in on new custom-chip era ||| 3 Reasons Nvidia Stock Could Surge to $400 in 2022 ||| Tech Stocks Alert: Why TSLA, NVDA, FB, AMZN, UBER Stocks Are Down Today ||| Heavy Selling: Indexes Toward Correction Levels ||| 4 Semiconductor Stocks to Snap Up on Solid Sales Projection ||| FOCUS-Cadence Design Systems aims to cash in on new custom-chip era ||| Notable ETF Outflow Detected - SPY, FB, NVDA, DIS",0,0.47764605
2022-01-19,48831500.0,260.7900085449219,265.42999267578125,250.5200042724609,250.6699981689453,250.3247528076172,NVDA,"With Bitcoin At $43,000, Check Out These Crypto Stocks ||| Watch for a Buy Point in Advanced Micro Devices ||| Nvidia Stock Is an Investment in the Multi-Trillion Dollar Metaverse ||| US STOCKS-S&P 500, Dow up on earnings lift, Nasdaq off session low ||| 7 Stocks That Could Join Apple in the $3 Trillion-Dollar Club by 2030 ||| Hewlett Packard's (HPE) GreenLake Selected by J. J. Keller ||| Why Nvidia Stock Dropped Today ||| Unusual Options Activity in Marvell Technology (MRVL), NVIDIA (NVDA), and Bausch Health Companies (BHC) ||| The Metaverse Investment Playbook ||| My 3 Favorite Semiconductor ETFs to Buy in 2022 ||| Retail investors show signs of fatigue after last year's trading frenzy - report ||| The 2 Best Metaverse Stocks to Buy in 2022 and Beyond ||| The Zacks Analyst Blog Highlights: Microchip Technology, NVIDIA Corporation, Analog Devices and NXP Semiconductors ||| Expect Another Massive Year Ahead For AMD Stock ||| 7 Hyper-Growth Stocks That Could Melt Up in Q1",0,0.50740004
2022-01-20,43518100.0,253.0399932861328,255.7899932861328,240.77999877929688,241.5,241.1673583984375,NVDA,"Why Nvidia Stock Popped, Then Dropped, Today ||| Top Stock Reports for NVIDIA, Chevron & Accenture ||| 3 Reasons Why Decentraland Will Continue to Do Well in 2022 ||| 2 Top Tech Stocks Ready for a Bull Run ||| U.S. stock futures rise on earnings after Nasdaq enters correction territory ||| Why Nvidia Could Crush AMD Once Again in 2022 ||| Nvidia Stock Is a Buy on Every Dip as It Heads Toward a Trillion ||| Is It Too Late to Buy Taiwan Semiconductor Stock? ||| Is SPDR NYSE Technology ETF (XNTK) a Strong ETF Right Now? ||| Here Are the 3 Best Growth Stocks to Buy for 2022",0,0.48905286
2022-01-21,71895800.0,235.07000732421875,248.22999572753903,232.6300048828125,233.7400054931641,233.41807556152344,NVDA,"Why Nvidia Stock Fell on Friday ||| NVIDIA Enters Oversold Territory ||| 7 Beaten-Down Semiconductor Stocks for Your Bargain-Buy List ||| Chip Stocks: Why NVDA, AMAT, AMD and MU Are Moving Lower Today ||| 3 Growth Stocks That Are Screaming Buys in January ||| 3 Hot Stocks That Can Live Up to Their Lofty Valuations ||| The Zacks Analyst Blog Highlights: NVIDIA Corporation, Chevron Corporation, and Accenture plc ||| Best Semiconductor Stocks to Invest in for 2022 (Part 2 of 2)",0,0.47434396
2022-01-24,91398200.0,223.3000030517578,233.8000030517578,208.8800048828125,233.72000122070312,233.39810180664065,NVDA,"Could 1 of These Be the Next Trillion-Dollar Company? ||| Why Nvidia Is a Top Gaming Stock ||| Is iShares Semiconductor ETF (SOXX) a Strong ETF Right Now? ||| Is Taiwan Semiconductor the Most Important Company on Earth? ||| Nvidia (NVDA) Stock Sinks As Market Gains: What You Should Know ||| Investment Opportunity Breakdown: Semiconductor Stocks ||| Nvidia Stock’s Decline Is a Brief Window of Opportunity ||| Tech Stocks Alert: Why Are TSLA, MSFT, AAPL, NVDA, SNAP Plunging Again? ||| US STOCKS-Futures slide as Ukraine tensions weigh at start of crucial week ||| US STOCKS-Futures slide as Ukraine tensions dent mood at start of crucial week ||| Stocks to Watch, Cool Tech From CES, and What's Going on With the Nasdaq ||| Why Nvidia Stock Could Be One of 2022’s Best Bets ||| Where Will Matterport Be in 3 Years?",0,0.47335002
2022-01-25,66461600.0,225.4600067138672,229.42999267578125,220.0,223.2400054931641,222.9325408935547,NVDA,"Stock Market Today: Stocks End Down on Another Roller-Coaster Day ||| Defense deal crackdown is a bipartisan affair ||| NVDA Stock Price Predictions: Where Will Nvidia Go If It Abandons Arm? ||| Tech stocks drag Japan's Nikkei to 13-month low ahead of Fed decision ||| Texas Instruments (TXN) Q4 Earnings and Revenues Top Estimates ||| When Should You Buy the Dip in Nvidia? ||| HPE Offers Werder Bremen Edge-to-Cloud & Analytical Solutions ||| What Are the Three Most Quoted U.S. Stock Indexes? ||| 1 Semiconductor Growth Stock to Buy Right Now ||| Tuesday's ETF with Unusual Volume: DSI ||| Nvidia preparing to abandon acquisition of Arm - Bloomberg News ||| Is Invesco Dynamic Semiconductors ETF (PSI) a Strong ETF Right Now? ||| Why Nvidia Stock Dropped Again Today ||| 3 Not-So-Obvious Stocks for the ""New Space Race"" ||| 7 Best Technology Stocks to Buy After the Big Dip ||| Nvidia preparing to abandon acquisition of Arm - Bloomberg News",1,0.49806288
2022-01-26,75595900.0,232.3999938964844,240.57000732421875,223.0,227.72000122070312,227.4063720703125,NVDA,"Lessons from 7 Years of Stock Investing ||| Is Nvidia Stock a Buy Without ARM? ||| Why Now Might Be the Right Time to Buy Advanced Micro Devices Stock ||| As Crypto Crashes, It Will Take Nvidia Stock Down With It ||| Intel first-quarter earnings forecast miss Street view ||| Semiconductor Stocks: A Smart Bet for the Long Haul ||| Tech Is a Long-Term Bullish Sector: Recent Meltdown Temporary ||| Intel first-quarter revenue forecast ahead of expectations ||| US STOCKS-Wall St eyes strong open on Microsoft's outlook; Fed decision looms ||| Stock Market News for Jan 26, 2022 ||| Who's Afraid of the Hawkish Fed? Stocks to Buy On Sale ||| 2 Robinhood Stocks That Are Great Long-Term Picks ||| Meta Platforms (FB) to Launch World's Fastest AI Computer ||| F5 Networks' (FFIV) Q1 Earnings & Revenues Beat Estimates ||| As the Arm Acquisition Falters, NVIDIA's (NASDAQ:NVDA) Valuation Looks More Reasonable ||| Goodbye, Ethereum 2.0, We Hardly Knew Ye ||| Meta Platforms Is Bullish on Nvidia's Technology ||| U.S. House speaker Pelosi's stock trades attract growing following online ||| Prediction: These Will Be the 10 Largest Stocks by 2035 ||| Stock Market Crash: My 2022 Playbook ||| US STOCKS-Nasdaq futures jump 2% after Microsoft's strong forecast; Fed decision looms ||| Bull Of The Day: Taiwan Semi (TSM)",0,0.49443758
2022-01-27,57335300.0,235.67999267578125,239.9499969482422,216.75,219.44000244140625,219.1377716064453,NVDA,"7 High Growth Stocks to Buy Despite Rising Interest Rates ||| Noteworthy Thursday Option Activity: TGTX, NVDA, AMD ||| The Zacks Analyst Blog Highlights: NVIDIA Corp, Qualcomm, Broadcom, Advanced Micro Devices and Analog Devices ||| Why Nvidia Stock Dropped Again Today ||| 7 Metaverse Stocks That Future-Thinking Investors Need to Know About ||| The Fed, Interest Rates, and What This Team of Investors Is Watching ||| Zacks Market Edge Highlights: JPMorgan Chase, NVIDIA, PayPal and Block ||| 7 Top Stock Picks for Long-term Investors Looking for This Decade’s Winners ||| QUAL, NVDA, TGT, BX: Large Outflows Detected at ETF ||| How Investors Can Grab Better Returns for Computer and Technology Using the Zacks ESP Screener ||| Will Tesla's Dojo Supercomputer Disrupt AI in 2022? ||| Is Invesco S&P 500 Pure Growth ETF (RPG) a Strong ETF Right Now? ||| 7 High-Growth Stocks With High Margins for Your February Buy List ||| Better Metaverse Stock: Nvidia or Unity? ||| Hewlett Packard's (HPE) GreenLake Selected by CDW UK",1,0.5077324
2022-01-28,54377400.0,220.1199951171875,228.5800018310547,212.9600067138672,228.3999938964844,228.0854034423828,NVDA,"Better Chip Stock: ASML vs. Nvidia ||| Why Nvidia Stock Popped Today ||| Is It Finally Time to Buy Intel Stock? ||| Mercury (MRCY) Offers US & Allies RF Microelectronics Solutions ||| Nvidia Stock Is Crashing, and That's Great News for Growth Investors ||| SoftBank No.2 exit shows bad timing all round ||| Start Your Investing Resolutions Off Right With This Classic Stock Bundle",1,0.49619666
2022-01-31,56468000.0,231.82000732421875,245.08999633789065,230.5200042724609,244.8600006103516,244.52276611328125,NVDA,"Better Buy: Nvidia vs. AMD ||| Best Dividend Stocks To Buy Now? 3 For Your List ||| Why Taiwan Semiconductor Is Stepping Up Its Investments ||| My 2 Best Semiconductor Growth Stocks to Buy and Hold Forever ||| 3 Autonomous Driving Technologies Investors Must Know About in 2022 ||| How Earnings in Autonomous Technology May Shift by 2030 ||| 3 Unstoppable Investments Everyone Needs in Their Portfolios ||| 3 High-Growth Chip Stocks to Buy for 2022 and Beyond After the Market Sell-Off ||| Will Nvidia's Software Power Self-Driving Cars? ||| Here's How Nvidia Will Power Automotive Giants ||| Markets Close a Lousy Month on a Big Upswing ||| Could BBY Stock Be the Next Big Metaverse Bet? One Analyst Thinks So. ||| Why Nvidia Stock Popped 3.5% Today ||| If You Invested $10,000 in Nvidia in 1999, This Is How Much You Would Have Today ||| 3 Metaverse Stocks to Buy Now That Aren't Ridiculously Expensive",1,0.50429386
2022-02-01,51892500.0,251.0399932861328,251.4499969482422,238.8999938964844,246.3800048828125,246.0406494140625,NVDA,"AMD forecasts FY22 revenue above estimates ||| Buy The Chip Dip! ||| AMD forecasts annual revenue above estimates, shares surge ||| Grab These Top-Ranked Tech ETFs to Join the Latest Rebound Rally ||| Intel’s Government-Fueled Comeback ||| How to Handle Market Volatility and Manage Risk ||| 7 Best Robinhood Stocks to Buy on the Dip ||| What Crypto to Buy Now, and More Top Questions Answered ||| How to Value a Semiconductor Stock ||| Are These Semiconductor Stocks Shielded From Boom and Bust Cycles? ||| 4 Semiconductor Stocks Set to Top Estimates This Earnings Season ||| Why Nvidia and Meta Platforms are Partnering Up on Hardware",1,0.5169286
2022-02-02,54341900.0,257.94000244140625,258.1700134277344,245.52999877929688,252.4199981689453,252.0723419189453,NVDA,"Top 10 Stocks to Buy in February 2022 ||| 7 Web 3.0 Plays That Could Be the Best Plays You Ever Make ||| US STOCKS-Wall St set for fourth day of gains on Alphabet, AMD results ||| Intel Stock Is Now a Compelling Long-Term Investment ||| Wednesday's ETF with Unusual Volume: SUSL ||| US STOCKS-Wall St poised for fourth straight gain on Alphabet, AMD results ||| GRAPHIC-Alphabet stock split may trigger retail buying, Dow inclusion ||| US STOCKS-Tech earnings help Wall St to fourth straight gain ||| Can Nvidia (NVDA) Keep the Earnings Surprise Streak Alive? ||| 5 Top Stock Trades for Thursday: AMD, NVDA, FB, QCOM, ABBV ||| US STOCKS-Wall St posts 4th straight gain, Meta earnings rattle social media after hours ||| US STOCKS-Wall St posts 4th straight gain, Meta earnings rattle social media after hours ||| GRAPHIC-Alphabet latest megacap to split its stock, may trigger retail buying ||| US STOCKS-Nasdaq extends rally on Alphabet, AMD results ||| Why Nvidia Stock Fell 17% in January ||| 5 VR Stocks That Could Soar as Oculus Usage Grows ||| Chip designer mimicking brain, backed by Sam Altman, gets $25 mln funding ||| US STOCKS-Nasdaq futures rally as Alphabet, AMD jump after results ||| Alphabet inches closer to $2 trln market value after blowout results ||| 3 Stocks I Am Buying During This Tech Selloff ||| Is Nvidia's Stock the Safest Way to Invest in Automated Driving? ||| 5 Vital Resources for Stock Investors ||| Why Does Meta Platforms Need a Supercomputer? ||| US STOCKS-Nasdaq futures jump after Alphabet, AMD results ||| Alphabet inches closer to $2 trln market value after blowout results ||| US STOCKS-Nasdaq set to jump on Alphabet, AMD results boost",0,0.48463714
2022-02-03,41017800.0,244.5800018310547,250.7700042724609,237.8000030517578,239.47999572753903,239.1501617431641,NVDA,"Top Stock Reports for NVIDIA, UPS & Intuit ||| PREVIEW-Storm clouds gather at SoftBank Group as valuations slide ||| Best Stocks To Invest In Right Now? 3 Information Tech Stocks To Know ||| Why Nvidia Stock Dropped Again on Thursday ||| 7 Stocks to Buy as the Market Shakes Off Omicron Fears  ||| Arrow Electronics (ARW) Q4 Earnings & Revenues Beat Estimates ||| Check Point's (CHKP) Q4 Earnings and Revenues Beat Estimates ||| 4 Recent Signs That Nvidia Stock Remains on the Right Track ||| 3 Reasons Investors Should Take Intel Competition Seriously ||| Interesting NVDA Put And Call Options For March 25th",1,0.48191127
2022-02-04,35482900.0,239.72000122070312,246.3500061035156,236.32000732421875,243.19000244140625,242.85504150390625,NVDA,"Be Choosy In Tech Investing: ETFs to Buy/Sell ||| Wall St Week Ahead-Inflation data next focus for investors after bond yield spike ||| Why Nvidia Stock Popped on Friday ||| Look for Your Buy Point and Pounce on Nvidia Stock ||| XLK, NVDA, IBM, XLNX: ETF Outflow Alert ||| Notable Friday Option Activity: NVDA, OXY, EQIX ||| The Zacks Analyst Blog Highlights: NVIDIA Corp., United Parcel Service, Inc., and Intuit Inc ||| Earnings whiplash points to more volatility for U.S. markets ||| Fortinet (FTNT) Beats Q4 Earnings Estimates, Guides Strong",1,0.50596607
2022-02-07,37686800.0,243.72000122070312,251.82000732421875,242.0200042724609,247.27999877929688,246.9394073486328,NVDA,These 3 Stocks Could 10x Your Money by 2035 ||| Wall St Week Ahead-Inflation data next focus for investors after bond yield spike ||| 3 Unstoppable Stocks to Buy No Matter What Happens in 2022 ||| 3 Stocks to Buy if They Take a Dip ||| Nvidia (NVDA) Gains As Market Dips: What You Should Know ||| Nvidia Reportedly Abandons Acquisition Of Arm From SoftBank ||| Failed deals illuminate chip M&A red lines ||| US STOCKS-Wall Street ends lower as Meta Platforms weighs ||| SoftBank's sale of Arm to Nvidia collapses - FT ||| Wall Street mixed as Amazon gains and Meta weighs ||| Wall Street ends lower as Meta weighs ||| Will Top-Line Growth Benefit Motorola (MSI) Q4 Earnings? ||| 2 Hot Stocks to Buy and Hold Until You Retire ||| Why Nvidia Stock Popped Again on Monday,1,0.48985007
2022-02-08,41035900.0,243.58999633789065,252.3000030517578,239.8000030517578,251.0800018310547,250.7342071533203,NVDA,"ANALYSIS-SoftBank's choice of New York for Arm listing deals a blow to London ||| Why Micron Stock Is a Definite Buy on Weakness ||| What to Expect Ahead of CDW Corporation's (CDW) Q4 Earnings? ||| GLOBAL MARKETS-Wall Street rallies on tech boost, European shares end flat ||| Top Stocks To Invest In? 5 Autonomous Vehicle Stocks In Focus ||| Should You Invest in the Invesco Dynamic Semiconductors ETF (PSI)? ||| Why Nvidia Stock Dipped Today, Then Rebounded ||| Nvidia Is Still a Buy Despite the Failed Arm Acquisition ||| S&P 500, Nasdaq slip as Pfizer, megacap stocks drag ||| NVIDIA/ARM Deal Off, Peloton CEO Steps Down ||| Stock Market Today: Dow Jones, S&P 500 Mixed; Velodyne Skyrockets On Amazon Deal ||| 3 Best Web3 Stocks to Buy in February ||| GLOBAL MARKETS-Wall Street turns higher after groggy open, euro stalled by Lagarde ||| Will Higher Revenues Drive Arista's (ANET) Q4 Earnings? ||| Top Stock Market News For Today February 8, 2022 ||| SoftBank posts $251 million net profit in third quarter ||| ANALYSIS -Relief and challenges for chipmakers as Nvidia-Arm megadeal collapses ||| Arm IPO marks sober end to SoftBank chip party ||| Nvidia's Terrific Position in This Nascent Market Could Supercharge Its Growth ||| NVIDIA (NVDA) Calls Off Buyout of Softbank's Arm Per Reports ||| Nvidia Falls as Arm Deal Collapses, but This Nasdaq Stock Is Soaring Tuesday ||| Top 5 Semiconductor Stocks Pick to Tap Growing Industry Demand ||| Should First Trust Rising Dividend Achievers ETF (RDVY) Be on Your Investing Radar? ||| Nvidia Terminates Agreement To Buy Arm From SoftBank ||| SoftBank posts $251 million net profit in third quarter",1,0.49571946
2022-02-09,52428200.0,256.2200012207031,267.25,253.52999877929688,267.04998779296875,266.6821594238281,NVDA,"Nvidia Will Crush Its Fourth Quarter Earnings So Buy NVDA Stock ||| Nvidia (NVDA) Earnings Expected to Grow: Should You Buy? ||| GLOBAL MARKETS-Global stocks rise on strong earnings, tech sector strength ||| 4 Top Stock Trades for Thursday: S&P 500, NVDA, DIS, TWLO ||| Stock Market Today: Nasdaq Recovery Continues as Comms, Tech Rebound ||| US STOCKS-Wall Street ends sharply higher, lifted by Big Tech ||| US STOCKS-Wall Street ends sharply higher, lifted by Big Tech ||| 7 Top Growth Stocks to Add to Your Buy List Now ||| The Zacks Analyst Blog Highlights Advanced Micro Devices, QUALCOMM, Texas Instruments, NVIDIA and Analog Devices ||| Mandiant (MNDT) Stock Gains 3% on Lower-Than-Expected Q4 Loss ||| What's Next for Nvidia After a Failed Acquisition? ||| ANALYSIS-SoftBank's choice of New York for Arm listing deals a blow to London ||| Why Nvidia Stock Surged Higher on Wednesday ||| Can This Small-Cap Semiconductor Stock Be the Next 10x in Your Portfolio?",0,0.47526947
2022-02-10,51320000.0,259.95001220703125,269.25,256.0,258.239990234375,257.8843078613281,NVDA,Interesting NVDA Put And Call Options For April 1st ||| US STOCKS-Wall Street falls as hot inflation turns Fed official 'dramatically' hawkish ||| US STOCKS-Wall Street ends down sharply on fears of aggressive Fed rate hikes ||| Is Nvidia Stock a Buy Ahead of Earnings? This Is What You Need to Know ||| Akamai (AKAM) to Report Q4 Earnings: What's in the Cards? ||| 5 Tech Bigwigs to Buy Ahead of Earnings Results Next Week ||| SAIC Secures Space & Intelligence Contracts Worth $410M in Q4 ||| Tyler (TYL) Buys Outdoor Recreation Solution Firm US eDirect,0,0.49820662
2022-02-11,60547200.0,259.1600036621094,261.5199890136719,237.72999572753903,239.4900054931641,239.16015625,NVDA,"Intel launches blockchain chip to tap crypto boom ||| US STOCKS-Wall Street ends down sharply on fears of Ukraine conflict ||| Noteworthy Friday Option Activity: TWLO, SAGE, NVDA ||| US STOCKS-Wall Street drops on rate fears, Ukraine tension ||| 7 Tech Stocks Set for Strong Gains in February ||| 6 Stocks With Earnings Reports Next Week ||| NVIDIA (NVDA) Set to Report Q4 Earnings: What's in Store? ||| US STOCKS-Wall Street ends down sharply on fears of Ukraine conflict ||| Why Nvidia Stock Slipped Early Today ||| Nvidia Offers Offers Clarity in an Uncertain Economy ||| Nvidia: After the Arm Failure ||| Why This 1 Computer and Technology Stock Could Be a Great Addition to Your Portfolio ||| The Zacks Analyst Blog Highlights Arista Networks, Analog Devices, Applied Materials Inc, NVIDIA and Keysight Technologies",1,0.5081569
2022-02-14,44042400.0,239.33999633789065,248.75,237.5500030517578,242.6699981689453,242.33575439453125,NVDA,"Here Are Some Profitable Growth Stocks to Put on Your Radar ||| 3 Reasons Nvidia's $40 Billion Bid for Arm Holdings Failed ||| Should You Buy Alphabet Now or Wait Until After the Stock Split? ||| Why AMD and Nvidia Were Down on Friday ||| 2 Dividend-Paying Tech Stocks to Buy in February ||| Weekly Preview: Earnings to Watch (BABA, CSCO, NVDA, ROKU) ||| 3 Things to Watch in the Stock Market This Week ||| U.S. stocks slide as Russia-Ukraine tensions come to boil ||| US STOCKS-The S&P 500 closes lower as Russia-Ukraine tensions heat up ||| Nvidia Traders Should Prepare for Strong Quarterly Results ||| US STOCKS-Wall St mixed amid rate fears, slight easing in Ukraine tensions ||| The S&P 500 ends down as Russia-Ukraine tensions heat up ||| US STOCKS-The S&P 500 ends down as Russia-Ukraine tensions heat up ||| Goodbye, XLNX Stock! 7 Things to Know About the AMD-Xilinx Merger. ||| Lockheed deal flop is just antitrust amuse-bouche ||| Nvidia Earnings Are Coming; Here’s What Matters ||| What Nvidia Investors Should Expect This Week ||| We Did The Math SPMV Can Go To $45 ||| AMD closes biggest chip acquisition with $49.8 bln purchase of Xilinx ||| These Were The Ten Worst-Performing Mega-Cap Stocks In January 2022 ||| AMD closes record chip industry deal with about $50-bln purchase of Xilinx ||| Down 30% From Its High, Is Nvidia a Buy? ||| IWB, TSLA, NVDA, UNH: ETF Inflow Alert ||| Strong Graphic Chip Demand to Aid NVIDIA's (NVDA) Q4 Earnings",1,0.49210256
2022-02-15,69986900.0,249.4900054931641,265.45001220703125,247.83999633789065,264.95001220703125,264.5851135253906,NVDA,"Why Nvidia Stock Popped Ahead of Earnings ||| Markets Close at Pre-Market Highs; Airbnb Beats, RBLX & VIAC Miss ||| 4 Top Stock Trades for Wednesday: NVDA, SPCE, ABNB, ZTS ||| Stock Market Today: Stocks Sizzle on Russian Troop Withdrawal Reports ||| EXCLUSIVE-U.S. oil producer EP Energy seeks to save deal from regulator -sources ||| 4 Top Semiconductor Stocks To Watch Today ||| Tuesday Sector Leaders: Technology & Communications, Materials ||| How to Trade Nvidia Stock Ahead of Earnings ||| S&P 500 Technical Analysis, The Super Bowl Indicator & What's Ahead ||| The Arm Deal Didn’t Happen, But Don’t Sweat the Impact on Nvidia Stock ||| Nvidia ETFs in Focus Ahead of Q4 Earnings ||| US STOCKS-Wall St set to bounce on signs of easing Russia-Ukraine tensions ||| US STOCKS-Nasdaq futures jump 2% on signs of easing Russia-Ukraine tensions ||| Is Franklin LibertyQ U.S. Equity ETF (FLQL) a Strong ETF Right Now? ||| Buy Nvidia Stock: It’s America’s 7th-Largest Company  ||| The Zacks Analyst Blog Highlights: Nvidia, Walmart, Airbnb, Xilinx and STMicroelectronics ||| Nasdaq 100 Movers: XLNX, NVDA",1,0.47666326
2022-02-16,73267600.0,262.5899963378906,265.82000732421875,255.5200042724609,265.1099853515625,264.7448425292969,NVDA,"7 Best Stocks to Buy During an Interest-Rate Driven Market Crash ||| Mixed Trading Day on Fed Minutes, Ukraine; NVDA Beats, DASH Way Up ||| Nvidia (NVDA) Q4 Earnings and Revenues Surpass Estimates ||| NVIDIA Corporation Q4 Profit Increases, beats estimates ||| After Hours Most Active for Feb 16, 2022 : BABA, ZNGA, NVDA, DASH, PM, TWTR, LUMN, AAPL, V, CSCO, AMD, MSFT ||| Why Fiverr Stock Is Plummeting Today ||| Best Artificial Intelligence Stocks To Buy Now? 4 To Check Out ||| After-Hours Earnings Report for February 16, 2022 : NVDA, CSCO, AMAT, EQIX, PXD, AIG, SNPS, NTR, DASH, WCN, CPRT, ES ||| Wednesday's ETF with Unusual Volume: PWB ||| Why Nvidia Stock Dropped on Earnings Day ||| NVIDIA and 4 Other Must-See Earnings Charts ||| SoftBank mulls $8 bln margin loan as part of Arm IPO - Bloomberg News ||| What is the Metaverse and Should You Invest in It? ||| SoftBank considering $8 billion margin loan as part of Arm IPO - Bloomberg News ||| Jaguar Land Rover, Nvidia ally in vehicle software arms race ||| Nvidia (NVDA) Q4 Earnings: What to Expect ||| NVIDIA Q4 22 Earnings Conference Call At 5:30 PM ET ||| NVIDIA and 4 Other Must-See Earnings Charts",0,0.5075781
2022-02-17,81059500.0,256.29998779296875,257.8500061035156,241.6499938964844,245.07000732421875,244.73245239257807,NVDA,"2 Unstoppable Growth-Oriented ETFs To Hold for the Long Haul ||| NVIDIA (NVDA) Q4 Earnings Beat Estimates, Revenues Surge Y/Y ||| Rivian Stock News: Why Is RIVN Going Up Today? ||| Risk-off trade hits Wall St as Ukraine tensions heighten ||| Thursday Sector Laggards: Technology & Communications, Financial ||| Stocks slide as heightened Ukraine tensions weigh ||| Intel delays launch of standalone desktop graphics chips to Q2 ||| 8 Metaverse Stocks to Buy to Become a Virtual Millionaire ||| Why Nvidia Stock Dropped Today After Record Earnings ||| US STOCKS-Stocks slide as heightened Ukraine tensions weigh ||| Nvidia Stock Plunged Today -- Is It Time to Buy? ||| Nasdaq 100 Movers: NVDA, CSCO ||| Intel would participate in consortium to invest in Arm Ltd -Intel CEO ||| Nvidia Flexed Its Muscles Again, So Why Is It Down After Earnings? ||| US STOCKS-Futures slip on heightening Ukraine tensions ||| The Xilinx Deal Will Accelerate Growth in Advanced Micro Devices ||| Unusual Options Activity in Blue Owl Capital (OWL), Invesco Mortgage Capital (IVR), and NVIDIA (NVDA) ||| How Investors Should React to Nvidia's (NVDA) Earnings ||| Top Stock Market News For Today February 17, 2022 ||| Should Franklin LibertyQ U.S. Equity ETF (FLQL) Be on Your Investing Radar? ||| Nvidia (NVDA) Q4 2022 Earnings Call Transcript ||| Alcoa Corporation and First Solar highlighted as Zacks Bull and Bear of the Day ||| Pre-Market Most Active for Feb 17, 2022 : PLTR, MRIN, ERIC, TQQQ, SQQQ, NVDA, RBLX, QQQ, FSLY, WMT, CND, BKKT ||| Wall St set for sharp losses as Ukraine tensions mount ||| Nvidia ETFs to Tap on Upbeat Q4 Earnings",0,0.5340491
2022-02-18,76125500.0,246.67999267578125,249.8600006103516,231.0,236.4199981689453,236.09439086914065,NVDA,"Intel's new chip plans could turn rival AMD's fortunes- analysts ||| 3 Stocks To Tap The Semiconductor-General Industry Potential ||| 3 Discounted Microchip Stocks to Buy Now ||| The Zacks Analyst Blog Highlights: NVIDIA, Walmart, Dropbox, Shake Shack and Roku ||| Nvidia Isn't Just Playing Games Anymore ||| Want to Get Richer? 3 Top Stocks to Buy Now and Hold Forever",0,0.49900553
2022-02-22,63342200.0,230.3500061035156,240.63999938964844,230.0,233.8999938964844,233.57785034179688,NVDA,"6 Anti-Trust Laws That Smart Investors Should Be Watching ||| 3 Unstoppable Metaverse Stocks to Buy in 2022 ||| Aiming for a 100-Bagger? This Stock Has the Potential ||| 2 Metaverse Stocks to Buy Right Now ||| Can Nvidia (NVDA) Climb 29% to Reach the Level Wall Street Analysts Expect? ||| See Which Of The Latest 13F Filers Holds NVIDIA ||| 7 Momentum Stocks to Buy While the Market Corrects ||| What's in Store for Nova Measuring Instruments (NVMI) Q4 Earnings? ||| 2 Artificial Intelligence Stocks You Can Buy and Hold for the Next Decade ||| Ukraine and Inflation Fight the Market ||| Why Advanced Micro Devices Stock Just Popped ||| Perficient (PRFT) to Report Q4 Earnings: What's in Store? ||| Top Stock Reports for NVIDIA, Novartis & NextEra Energy ||| Pre-Market Most Active for Feb 22, 2022 : HMHC, CSX, GSK, TQQQ, SQQQ, MSFT, NVDA, M, RIO, DD, PLTR, UBS ||| Could This Drive Nvidia's Stock Price to New Levels? ||| 3 Top Stocks to Buy Right Away for Earnings Growth",0,0.51380855
2022-02-23,56651100.0,238.0200042724609,241.5500030517578,223.009994506836,223.8699951171875,223.5616607666016,NVDA,"3 Top Stocks That Just Went on Sale ||| 7 Semiconductor Stocks to Buy as Deals Shake Up the Industry ||| Why Nvidia Stock Popped, Then Dropped on Wednesday ||| The Zacks Analyst Blog Highlights NVIDIA, Novartis AG, NextEra Energy, The Goldman Sachs Group and Amgen ||| 2 Semiconductor Growth Stocks Powering the Metaverse ||| 2 Top Metaverse Stocks That Trillion-Dollar Asset Managers Are Buying ||| 2 Top Metaverse Stocks Ready for a Bull Run ||| Why Losing an ARM Won't Stop NVIDIA's Rise ||| Nvidia Stock: Bear vs. Bull",1,0.53177536
2022-02-24,73580100.0,210.1499938964844,238.0,208.8999938964844,237.47999572753903,237.1529235839844,NVDA,"Is Nvidia (NVDA) a Solid Growth Stock? 3 Reasons to Think "" Yes "" ||| Nvidia’s Momentum Is Not Going To Slow ||| 7 Stocks Making Major Metaverse Moves in 2022 ||| 7 Electric Vehicle Stocks With Strong Price Targets ||| New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point ||| Nvidia Stock Gets Disconnected From Reality ||| 1 Monster Opportunity in the Global Chip Shortage ||| Invest in Next-Gen Technologies With These 2 ETFs",1,0.4971561
2022-02-25,52886600.0,237.2100067138672,242.1699981689453,233.8099975585937,241.57000732421875,241.23727416992188,NVDA,"Wait for Intel’s Turnaround to Really Take Hold Before Buying ||| Chipmaker Nvidia investigating potential cyberattack - report ||| Chipmaker Nvidia investigating potential cyberattack - report ||| Nvidia (NVDA) Just Overtook the 200-Day Moving Average ||| If You Invested $1000 in Nvidia 10 Years Ago, This Is How Much You'd Have Now ||| Should You Invest in the Technology Select Sector SPDR ETF (XLK)? ||| $1 Trillion Metaverse Market on the Way: Here's Where 1 Big Bank Is Placing a Bet",1,0.49349853
2022-02-28,47731900.0,239.9199981689453,246.6499938964844,237.07000732421875,243.8500061035156,243.51416015625,NVDA,"This Monster Metaverse Stock With Analyst-Predicted 48% Upside Is a Screaming Buy ||| Exactly How I'd Invest $50,000 for Retirement, Starting From Scratch ||| 2 Top Semiconductor Stocks That Billionaires Can't Stop Buying ||| 1 Unstoppable Advantage Retail Investors Have Over Institutions ||| Nvidia Just Proved Why It Could Be a Big Winner in 2022 and Beyond ||| Why Nvidia Stock Should Remain on Investors’ Radars ||| BRK.A, BRK.B: 17 Key Takeaways From Warren Buffett’s Annual Letter 2022 ||| Ex-Dividend Reminder: Qualcomm, NVIDIA and Shutterstock ||| NVIDIA and Neurocrine Biosciences highlighted as Zacks Bull and Bear of the Day ||| Nvidia's Quarter Shows Why It's the Best Tech Stock to Beat Inflation ||| Bull of the Day: NVIDIA (NVDA)",0,0.5055518
2022-03-01,41205600.0,242.9100036621093,243.7700042724609,231.32000732421875,234.7700042724609,234.4466552734375,NVDA,"The Peloton-Chipotle Comparison ||| How to Get Better Returns by Ditching the Crowd ||| The Best Robinhood Stocks to Buy Now for March 2022 ||| Nvidia says employee, company information leaked online after cyber attack",1,0.5057992
2022-03-02,38964200.0,237.5599975585937,244.08999633789065,234.1499938964844,242.1999969482422,241.9076232910156,NVDA,"Why Nvidia Stock Popped Today ||| Cloud Gaming War Peps Up With Amazon's (AMZN) Luna Advances ||| A Deep Dive on PayPal ||| 3 Smartest Tech Stocks To Buy in 2022 and Beyond ||| 5 Unstoppable Trends to Invest $10,000 in Right Now ||| US STOCKS-Wall St rallies over 1% as Powell says rate hikes on track ||| 7 Top Mutual Funds to Buy to Keep Taxes Low ||| 2 No-Brainer Stocks I'd Buy Right Now Without Hesitation ||| Is This Bad News for Nvidia? ||| 10 Billion Reasons to Buy Intel Stock",0,0.4855602
2022-03-03,36509500.0,242.6199951171875,243.259994506836,234.69000244140625,237.13999938964844,236.85372924804688,NVDA,"US STOCKS-Wall Street mixed as growth stocks, Ukraine jitters weigh ||| US STOCKS-Growth stocks drag Wall St lower on inflation worries ||| Should You Worry About the Nvidia Hack Hurting NVDA Stock? ||| 4 Semiconductor Stocks With Huge Potential Not Named AMD or Nvidia ||| Why Now Could Be the Best Time to Buy Nvidia in Over a Year ||| 3 Supercharged Growth Stocks Billionaires Can't Stop Buying",0,0.47652644
2022-03-04,43141500.0,233.83999633789065,236.8000030517578,224.82000732421875,229.3600006103516,229.0831298828125,NVDA,"Wall St Week Ahead-Rate-hike fears abate but Ukraine muddies stock market outlook ||| Why Nvidia Lost More of Its Value Than the Broad Market Did on Friday ||| US STOCKS-Wall Street falls as Ukraine fears eclipse solid jobs data ||| US STOCKS-Wall Street drops as Ukraine worries eclipse strong jobs data ||| Noteworthy ETF Outflows: IVV, GOOG, NVDA, FB ||| Nvidia Stock Is a Buy Even After the Arm Deal Came Apart ||| Should Invesco Dynamic Large Cap Growth ETF (PWB) Be on Your Investing Radar?",0,0.46907172
2022-03-07,45082100.0,228.1699981689453,230.3300018310547,213.3000030517578,213.5200042724609,213.26223754882807,NVDA,"3 Robinhood Stocks That Are Great Long-Term Picks ||| Will Intel's Latest $5.4 Billion Acquisition Go Through? ||| 2 Nasdaq 100 Stocks to Buy Hand Over Fist in March ||| Wall St Week Ahead-Rate-hike fears abate but Ukraine muddies stock market outlook ||| Better Buy: Nvidia vs. Intel ||| Nvidia Is Crushing Records. So Why Is Its Stock Down? ||| 3 Stocks That Could Be Worth More Than Apple by 2035 ||| ANALYSIS-With war risk, unclear how much U.S. real-yield collapse will benefit stocks ||| Why Cybersecurity Stocks Are Soaring ||| Intel's Mobileye confidentially files for U.S. IPO ||| Buying These 3 Robinhood Stocks Could Be the Smartest Investing Move You Ever Make ||| 5 Dividend Growth Stocks for Safe and Consistent Income ||| Why Nvidia Stock Tanked Today ||| US STOCKS-Wall St tumbles on inflation jitters as oil prices surge",1,0.50292724
2022-03-08,55746700.0,213.08999633789065,223.72999572753903,206.5,215.13999938964844,214.8802947998047,NVDA,"Bear Of The Day: Wayfair (W) ||| Zacks.com featured highlights include J.B. Hunt Transport Services, Archer-Daniels-Midland, NVIDIA, Tractor Supply and AmerisourceBergen ||| 5 Stocks to Get Your Feet Wet in Emerging AI ||| 6 Semiconductor Stocks Worth Holding Long-Term ||| ETF Spotlight: International Women's Day Special ||| Why Micron (MU) May Be a Good Bet Amid Highly Volatile Market ||| 5 Semiconductor Growth Stocks to Buy Now and Hold ||| Bull Of The Day: NVIDIA (NVDA) ||| 1 Massive Reason Nvidia's Tearing Growth Will Continue ||| Why Nvidia, Micron, and AMD Stocks Popped Tuesday ||| Top Analyst Reports for Microsoft, Amazon & NVIDIA",1,0.52322596
2022-03-09,49274200.0,223.8699951171875,232.1999969482422,222.47000122070312,230.13999938964844,229.86219787597656,NVDA,"Technically Constructive: Higher Lows on Ukraine Talks ||| Stock Market Today: Tech Stocks Lead Relief Rally ||| Notable Wednesday Option Activity: NVDA, MRNA, STX ||| Why Nvidia Stock Is on Fire Today ||| The Zacks Analyst Blog Highlights Microsoft, Amazon.com, NVIDIA, AbbVie and HSBC Holdings ||| 2 Monster Growth Stocks Shaping the Future of Technology ||| 4 Stocks to Buy on Soaring Demand for Semiconductors ||| Should You Invest in the iShares Semiconductor ETF (SOXX)? ||| Should You Invest in the SPDR NYSE Technology ETF (XNTK)? ||| Bull of the Day: Advanced Micro Devices (AMD)",0,0.50167084
2022-03-10,42806600.0,225.3099975585937,227.8800048828125,218.82000732421875,226.5800018310547,226.3064727783203,NVDA,Advanced Micro Devices: The Snapback Rally Is On ||| Why Micron Technology Could Be the Nvidia of the 2020s ||| 5 Must-Buy Semiconductor Bigwigs at Attractive Valuation ||| GRAPHIC-Amazon latest megacap to join stock split squad ||| Expect Renewed Strength In AAPL Stock After the Year’s First Apple Event ||| US STOCKS-Wall St drops as inflation data cements rate hike bets ||| Will Nvidia Be a Trillion-Dollar Stock by 2025? ||| Amazon (AMZN) to Split Stock in 20 to Attract More Investors ||| Should You Buy the Dip In This Top Automotive Chip Company? ||| Peter Lynch: The Ultimate Guide to Stock Market Investing ||| Should You Buy Amazon Before Its Stock Split? ||| Should You Invest in the Fidelity MSCI Information Technology Index ETF (FTEC)? ||| 7 Web 3.0 Stocks to Buy for Their First-Mover Advantage,0,0.5320363
2022-03-11,36720900.0,230.22000122070312,231.4499969482422,220.4600067138672,221.0,220.73321533203125,NVDA,"Nvidia Stock Is a Buy After Its Recent Weakness ||| 2 Red-Hot Growth Stocks to Buy in 2022 and Beyond ||| Zacks Investment Ideas feature highlights: Apple, Advanced Micro Devices and Nvidia ||| Nordstrom and PayPal have been highlighted as Zacks Bull and Bear of the Day ||| This Semiconductor Market Will Boom by 2030",0,0.49790144
2022-03-14,38535400.0,218.69000244140625,222.6199951171875,211.58999633789065,213.3000030517578,213.04251098632807,NVDA,"Wall Street Loves These 3 Growth Stocks -- Should You? ||| 2 Dividend-Paying Tech Stocks to Buy in March ||| 3 Top Artificial Intelligence Stocks to Buy in March ||| Is Amazon Stock a Buy Now Before the 20-for-1 Stock Split? ||| Why Nvidia Stock Dropped Again Today ||| UK technology firm Arm plans to cut 12-15% of workforce ||| Noteworthy ETF Outflows: SOXX, NVDA, MRVL, MCHP ||| 5 of the Fastest-Growing Stocks on the Planet ||| Should You Invest in the VanEck Semiconductor ETF (SMH)? ||| Should Invesco S&P 500 Pure Growth ETF (RPG) Be on Your Investing Radar?",1,0.47711983
2022-03-15,49199600.0,215.17999267578125,230.3800048828125,213.22000122070312,229.72999572753903,229.45266723632807,NVDA,"Tuesday Sector Leaders: Technology & Communications, Services ||| Is Now the Time to Buy Nvidia Stock? ||| Should Investors Worry About Nvidia's Latest Hack? ||| Why AMD Stock Rocketed Higher Today ||| Why Nvidia Stock Rocketed Higher Today ||| Better Buy: Netflix vs. Nvidia ||| 7 Superstar Tech Stocks That May Outperform This Market Rout",1,0.51223046
2022-03-16,67142200.0,235.0,245.97000122070312,231.72000122070312,244.9600067138672,244.664306640625,NVDA,"These 2 Artificial Intelligence Stocks Are Set for Strong Growth, Says Truist ||| 7 Tech Stocks Hitching Their Wagon to Web 3.0 ||| 4 Top Stock Trades for Thursday: BABA, JD, AMD, NVDA ||| Noteworthy Wednesday Option Activity: LMAT, NVDA, CNMD ||| 4 Semiconductor Stocks For Your March 2022 List ||| The Best Stocks to Invest $1,000 in Right Now ||| AMD Expands Ryzen Portfolio With New Gaming Processor ||| Matterport Stock Is a Buy Right Here, Right Now ||| Stock Market Today: Dow Jones, S&P 500 Up Today; Chinese Tech Stocks Open Higher On China Reassurance ||| Stock Market News for Mar 16, 2022 ||| The Nasdaq's Soaring and Investors Are Watching These 2 Winning Stocks ||| 2 Best Metaverse Stocks to Buy in 2022 and Beyond",1,0.48715225
2022-03-17,47194100.0,241.1999969482422,248.4199981689453,239.0599975585937,247.6600036621093,247.3610382080078,NVDA,We Did The Math WGRO Can Go To $27 ||| The 10 Most Popular Recurring Investments of Retail Investors ||| Is Nvidia Stock a Buy Now?,1,0.49004602
2022-03-18,73071900.0,247.9900054931641,265.69000244140625,246.2400054931641,264.5299987792969,264.2106628417969,NVDA,"The Zacks Analyst Blog Highlights Apple, Marriott International, NVIDIA, Analog Devices, and Micron Technology ||| Friday's ETF with Unusual Volume: EFIV ||| S&P 500 Movers: FDX, MRNA ||| These 2 Nasdaq IPO Stocks in Full TGIF Mode ||| 3 Growth Stocks with the Best Chance of Bottoming ||| Why Nvidia Stock Moved Even Higher Today ||| Nvidia: All Eyes on Analyst Day ||| US STOCKS-Nasdaq, S&P rise on tech boost after Biden-Xi talks ||| Why Nvidia Stock Rocketed 18% Higher This Week ||| Why This 1 Computer and Technology Stock Could Be a Great Addition to Your Portfolio ||| The Metaverse Will Take Nvidia to a New All-Time High ||| 3 Metaverse Stocks to Buy Right Now ||| Nvidia Stock: Bear vs. Bull ||| 2 Smartest Tech Stocks To Buy in 2022 and Beyond ||| Why Is Nvidia (NVDA) Up 1.1% Since Last Earnings Report?",1,0.48688266
2022-03-21,59172700.0,265.07000732421875,271.5199890136719,259.6700134277344,267.3399963378906,267.0173034667969,NVDA,"Nvidia Is on an Acquisition Shopping Spree ||| 12 Tech Stocks to Buy Now ||| Better Buy: Meta Platforms vs. Nvidia ||| Just One More Reason to Be Bullish on Apple Stock ||| 4 Top Stock Trades for Tuesday: Nasdaq, SHOP, NVDA, NKE ||| How China’s New Money-Printing Scheme Will Affect the Market This Week ||| Top Analyst Reports for Amazon, NVIDIA & JPMorgan ||| How to Build a Stock Portfolio for Beginners -- Why I Bought SentinelOne ||| If You Invested $1000 in Nvidia 10 Years Ago, This Is How Much You'd Have Now ||| 3 Vanguard ETFs That Could Help You Retire a Millionaire",0,0.48380044
2022-03-22,54700700.0,267.2699890136719,272.3800048828125,260.7200012207031,265.239990234375,264.9198303222656,NVDA,"Nvidia unveils latest chips, technology to speed up AI computing ||| 2 Important Things Smart Investors Should Know About Micron ||| The Zacks Analyst Blog Highlights Amazon, NVIDIA and JPMorgan Chase",0,0.50362617
2022-03-23,50212000.0,261.260009765625,266.1199951171875,255.75,256.3399963378906,256.03057861328125,NVDA,"4 Top Stock Trades for Thursday: AAPL, GLD, AMD, AMC ||| Why Nvidia Stock Dropped Today ||| Nvidia CEO says interested in exploring chip manufacturing with Intel ||| 3 Tech Stocks to Buy as Their Trends Reverse Higher ||| Why Vicor Shares Powered Off Today ||| Nvidia: Primed to Win in the AI Space but Valuation Is Running Hot, Says Analyst ||| Will AMD Be a Trillion-Dollar Stock by 2030? ||| Is SPDR NYSE Technology ETF (XNTK) a Strong ETF Right Now? ||| Top Stock Market News For Today March 23, 2022 ||| Tech leads rebound in world stocks despite surging yields ||| Prediction: These Will Be the 10 Largest Stocks by 2035 ||| NVIDIA (NVDA) Starts Production of DRIVE Orin Platform",1,0.5382175
2022-03-24,87737900.0,261.6600036621094,283.20001220703125,259.07000732421875,281.5,281.1601867675781,NVDA,"US STOCKS-Wall St ends higher, led by Nasdaq, gains in chipmakers ||| Intel: Short-Term Pains, Long-Term Gains ||| Goldman Sachs poised to lead U.S. IPO of SoftBank's Arm -sources ||| US STOCKS-Wall St advances, led by Nasdaq, gains in chipmakers ||| Top Semiconductor Stocks To Watch Before April 2022 ||| 4 Top Stock Trades for Friday: Ethereum, Oil, NVDA, CGC ||| Stock Market Today: 53-Year-Low Jobless Claims Lift the Market ||| US STOCKS-Wall St resumes rally, led by Nasdaq as chipmakers soar ||| Thursday Sector Leaders: Technology & Communications, Materials ||| ""Chip Rally,"" NATO Results, Drive Market Indexes ||| Kiplinger ESG 20: ESG Stocks Not Immune From Downturn ||| Up 15% Over The Last Month, NVIDIA Stock Could Continue Rallying ||| Why Nvidia Stock Finally Popped Today ||| US STOCKS-Wall St rises as investors buy beaten-down chipmakers, tech stocks ||| Nvidia Announces 3 New Powerful AI Chips -- What Investors Need to Know ||| Is Most-Watched Stock NVIDIA Corporation (NVDA) Worth Betting on Now? ||| Nasdaq 100 Movers: PDD, INTC ||| 6 Blue-Chip Stocks That Will Survive Any Bubble Burst ||| May 6th Options Now Available For NVIDIA ||| British police say seven people arrested after Okta hack ||| Thursday's ETF Movers: SOXX, CQQQ ||| US STOCKS-Wall Street rises on tech boost; NATO summit in focus",0,0.47127414
2022-03-25,57901600.0,278.8599853515625,283.5799865722656,272.7099914550781,276.9200134277344,276.5857238769531,NVDA,"Interesting NVDA Put And Call Options For November 18th ||| 3 Semiconductor Stocks Heating Up ||| NVIDIA GTC Blows Your Mind, Every Time ||| US STOCKS-S&P 500 ends higher with financials as Treasury yields jump ||| Why Nvidia Stock Dropped on Friday ||| US STOCKS-Nasdaq leads Wall St lower as tech stocks lose ground ||| Meta (FB) Steps Forward in Metaverse With VNTANA Collaboration ||| US STOCKS-S&P 500 rises as financials gain with Treasury yields ||| Tech Sell-Off: 2 Top Stocks to Buy and Never Sell ||| Nvidia GTC 2022: Top 5 Keynote Announcements ||| Better Metaverse Stock: Nvidia vs. AMD ||| 3 Top AI Stocks Ready for a Bull Run ||| Nvidia Continues to Prove Why It's a Top Stock to Own ||| Alphabet Stock Price Will Continue to Rise in Run-up to GOOG Stock Split ||| Make Your Portfolio Smart(er) with These Top Stocks ||| Microsoft: Leveling Up to Become Netflix of Gaming",1,0.49265936
2022-03-28,42549400.0,277.5599975585937,282.5,272.0599975585937,282.19000244140625,281.84930419921875,NVDA,"More Competition for Nvidia and AMD as Intel Releases Its New Product ||| 3 Metaverse Stocks For Your Late March 2022 Watchlist ||| 2 Top Tech Stocks Ready for a Bull Run ||| Is It Too Late to Buy Nvidia Stock? ||| Why This Investor Is a Stock Market Optimist ||| Which Companies Are Investing in the Metaverse? 7 Stocks to Watch.  ||| 20 High-Volatility Stocks for the Market's Next Swing ||| The Best Metaverse Stocks to Consider Buying Now ||| Top Stock Picks for Week of March 28, 2022 ||| Nvidia Stock: Can Its Stellar Returns Continue? ||| 4 Stocks on My Radar This Week During This Tech Sell-Off ||| Is Invesco Dynamic Semiconductors ETF (PSI) a Strong ETF Right Now? ||| Is Nvidia's Autonomous-Car Project Just a Pipe Dream? ||| Hot Stocks To Buy Right Now? 3 Tech Stocks To Watch",1,0.4845058
2022-03-29,48898400.0,286.95001220703125,289.4599914550781,279.79998779296875,286.5599975585937,286.2140808105469,NVDA,"What Do Slowing GPU Demand Trends Spell for Nvidia Stock? Analyst Weighs In ||| Nvidia Is a Screaming Buy Following its Vibrant GTC Show ||| Why Nvidia Stock Jumped Today ||| Why Nvidia Is a Buy-and-Forget Stock ||| Tech News: Coinbase's Global Expansion, Shopee Ending Operations, and More ||| Earnings Growth & Price Strength Make Nvidia (NVDA) a Stock to Watch ||| 7 Sold-Off Semiconductor Stocks to Buy Before the Global Chip Shortage Ends ||| 7 Things Every Nio Investor Must Know ||| GRAPHIC-Tesla adds to wave of megacap stock splits ||| Why Nvidia Stock Is Ridiculously Expensive Again",0,0.4780425
2022-03-30,46348700.0,283.0400085449219,284.9599914550781,275.0299987792969,276.8999938964844,276.5657653808594,NVDA,Why Nvidia Stock Slumped Today ||| This Top Computer and Technology Stock is a #1 (Strong Buy): Why It Should Be on Your Radar ||| What Nvidia's Booming Growth Means for Intel ||| Why Nvidia's 2 Smallest Segments Are Its Most Exciting ||| Split Decision? Here's Why Amazon Stock Is a Buy ||| This Is One of the Highest-Conviction Stocks in my Portfolio ||| SK Hynix considering consortium to acquire chip designer Arm -CEO to Yonhap ||| Arm plans transfer of shares in China JV to speed up U.S. IPO - FT,0,0.4876227
2022-03-31,52344000.0,277.82000732421875,282.4800109863281,272.70001220703125,272.8599853515625,272.53057861328125,NVDA,"3 Unstoppable Investments Everyone Needs in Their Portfolio ||| Nvidia (NVDA) Stock Moves -1.46%: What You Should Know ||| NVDA May 13th Options Begin Trading ||| Notable Thursday Option Activity: NVDA, PVH, HD ||| 2 Explosive Growth Stocks to Buy in 2022 and Beyond ||| Micron Technology Stock Remains a Buy Amid Global Chip Shortage ||| QQQ, NVDA, FB, COST: ETF Inflow Alert",0,0.52746725
2022-04-01,51723500.0,273.75,274.9599914550781,262.6700134277344,267.1199951171875,266.7975769042969,NVDA,Why Nvidia Stock Dropped on Friday ||| Be Greedy When Experts Are Fearful of AMD Stock ||| Top 10 Stocks to Buy in April ||| Meme stock GameStop jumps on stock split plans ||| 3 Top Tech Stocks to Buy Right Now ||| Is iShares Semiconductor ETF (SOXX) a Strong ETF Right Now?,1,0.48322585
2022-04-04,39712000.0,267.2799987792969,275.5799865722656,266.1300048828125,273.6000061035156,273.26971435546875,NVDA,"Why Apple Is the Best Metaverse Stock ||| Why This ETF Is My Number One Recommendation for New Investors ||| Could This Be More Bad News for AMD and Other Semiconductor Companies? ||| Why Nvidia Investors Shouldn't Worry About Ethereum 2.0 ||| Why You Shouldn't Invest $135,000 in Bitcoin, Nvidia, and Tesla ||| My 3 Best Stock Split Growth Stocks to Buy Now and Hold Forever ||| Why Nvidia Should Raise Its Dividend ||| Is Trending Stock NVIDIA Corporation (NVDA) a Buy Now? ||| Nvidia’s Auto Software Opportunity Is Underappreciated, Says Wells Fargo ||| Why Nvidia Stock Popped on Monday ||| After Hours Most Active for Apr 4, 2022 : INTC, ATVI, MSFT, AAPL, NVDA, ONB ||| Metaverse ETFs Set for 'Exponential' Growth ||| 2 Cybersecurity Stocks You Can Buy and Hold for the Next Decade ||| Apple (AAPL) Now Rumored to Launch Foldable iPhone in 2025 ||| 3 Top Profitable Stocks to Buy Using Net Income Ratio ||| NVIDIA (NVDA) Gains 12% in March: Will the Momentum Continue? ||| My Top 3 Stocks to Buy During the Second Quarter ||| Bull of the Day: Advanced Micro Devices (AMD) ||| My Best Semiconductor Stock to Buy Now and Hold Forever",0,0.48471293
2022-04-05,43661500.0,272.5400085449219,273.19000244140625,258.20001220703125,259.3099975585937,258.9970092773437,NVDA,"It’s Time to Buy Nvidia Stock While It Remains Relatively Cheap ||| Why Nvidia, Skyworks, and Qualcomm Stocks Dropped on Tuesday ||| 4 Top Stock Trades for Wednesday: Dogecoin, NVDA, TLRY, NVAX ||| Top Stock Picks for Week of April 4, 2022 ||| Don’t Let TWLO Stock Become Your Problem ||| US STOCKS-Wall St falls on fears of hawkish Fed, fresh Russia sanctions ||| Market News and the Launch of The Motley Fool Foundation ||| Zacks.com featured highlights include MP Materials, NVIDIA, and LouisianaPacific ||| AMD Just Increased Its Solutions in Its Most Significant Market ||| AMD Acquires Pensando to Build Leading-Edge Data Center ||| Micron Is Set to Deliver Record Revenue in Fiscal 2022 ||| Down Almost 8% Last Month, What's Next For AMD Stock? ||| US STOCKS-Wall St retreats on worries about hawkish Fed, fresh Russia sanctions",0,0.49124458
2022-04-06,70383300.0,249.33999633789065,253.0,240.02999877929688,244.07000732421875,243.77536010742188,NVDA,"NVDA Makes Notable Cross Below Critical Moving Average ||| 4 Top-Ranked Semiconductor Stocks to Buy Amid Industry Growth ||| Why Nvidia Stock Is Falling Again Today ||| Nvidia: Trillion-Dollar Hopes Attainable, but Not So Soon ||| Why Semiconductor Stocks Got Clobbered Today ||| Is Now the Time to Nab Some NVDA Stock? Yes! Here’s Why. ||| Wednesday's ETF with Unusual Volume: SUSL ||| Pre-Market Most Active for Apr 6, 2022 : SQQQ, TQQQ, TLRY, TWTR, QQQ, DIDI, CL, NIO, NVDA, DHI, DELL, AAPL ||| AMD Acquires Pensando: Is It a Perfect Match? ||| Down on the Year, AMD Stock Remains a Best-in-Class Semiconductor Pick ||| Qualcomm's Autonomous Vehicle Segment Just Got a Big Boost ||| Vinco Ventures Stock May Still Be a $4.50 Meme Stock ||| Soaring Demand Continues to Drive Semiconductor Sales: 5 Picks ||| Stock Market News for Apr 6, 2022 ||| Warren Buffett's Top Stocks",0,0.48757654
2022-04-07,55799200.0,244.4100036621093,247.22000122070312,234.77999877929688,242.0800018310547,241.78778076171875,NVDA,"7 Beaten-Down Tech Stocks to Buy for the Long Term ||| Top Research Reports for NVIDIA, Coca-Cola & Thermo Fisher ||| Nvidia (NVDA) Stock Sinks As Market Gains: What You Should Know ||| Why AMD Shares Fell 11% Last Month ||| US STOCKS-Wall Street mixed, investors eye Fed and Ukraine ||| NVDA May 27th Options Begin Trading ||| Best Stocks for 2022: What’s Next For Nvidia Stock? ||| 5 Dividend Growth Stocks for Safe Income Amid Volatility ||| Better Metaverse Chip Stock: Nvidia vs. Qualcomm ||| Should Okta Shareholders Sell After the Recent Cyberattack?",0,0.53225255
2022-04-08,52478100.0,239.1699981689453,239.22999572753903,230.6199951171875,231.19000244140625,230.9109344482422,NVDA,"Stock Market Today: Tech Stocks Lag as Treasury Yields Keep Rising ||| Why Nvidia Stock Continued to Slump on Friday ||| Artificial Intelligence Is Here; 2 ‘Strong Buy’ Stocks That Stand to Benefit ||| US STOCKS-Dow gains, S&P 500 ends lower as market weighs Fed rate hikes ||| Nvidia seeks approval to double authorized shares to 8 bln ||| US STOCKS-Dow gains, S&P 500 slips as market weighs Fed rate hikes ||| US STOCKS-Dow gains, S&P 500 slips as market mulls Fed rate hikes ||| Dow, S&P 500 rise as banks jump ||| Zacks.com featured highlights include The Kroger, NVIDIA, Jones Lang LaSalle, Paychex and McKesson ||| Nvidia Believes This Is a $300 Billion Opportunity ||| Nasdaq, S&P 500 slide as higher yields hit growth stocks ||| US STOCKS-Wall St set for subdued open as yields rise again ||| 3 Unstoppable Stocks You Can Buy and Hold for the Next Decade (and Beyond) ||| Nvidia Stock Could Rise 45% ||| The Zacks Analyst Blog Highlights NVIDIA, The Coca-Cola,Thermo Fisher Scientific, Salesforce, and SAP",0,0.47884992
2022-04-11,57520700.0,222.13999938964844,223.1999969482422,216.6000061035156,219.1699981689453,218.90542602539065,NVDA,"300 Billion Reasons to Buy Nvidia Stock ||| 2 Tech Stocks You Can Buy and Hold for the Next Decade ||| These Opportunities Could Make Nvidia Stock Soar ||| 3 Creativity Software Stocks to Buy Right Now ||| 3 Unstoppable Growth Stocks to Buy for April (and Beyond) ||| 3 Powerful Stocks That Can Beat Inflation ||| Consumer Chip Demand Will Be Just Fine. Buy NVDA Stock on the Dip. ||| 3 Tech Stocks to Buy That Are About to Bounce ||| Nvidia Is Hurting as Ethereum Moves on From Crypto Mining ||| US STOCKS-Wall Street slides as jumping Treasury yields pummel growth stocks ||| US STOCKS-Wall Street stumbles as surging Treasury yields slam growth stocks ||| Stock Market Today: Stocks Start the Week With Sharp Losses ||| 4 Top Stock Trades for Tuesday: AMD, NVDA, PANW, COST ||| US STOCKS-S&P, Nasdaq slide 1% as surging yields hammer growth stocks ||| Why AMD Is Falling Today ||| Why Nvidia Stock Just Crashed ||| Metaverse Stocks To Buy Today? 4 For Your April Watchlist ||| Stock Market News for Apr 11, 2022 ||| 2 Top Growth Stocks to Buy Right Now ||| Qualcomm and the Great Tech Downgrade ||| Why Many Semiconductor Stocks Were Down Last Week ||| 3 Top Artificial Intelligence Stocks to Buy Right Now ||| US STOCKS-Nasdaq slides 1% as surging yields hit growth stocks ||| Nasdaq 100 Movers: NVDA, ROST",0,0.49995393
2022-04-12,66225800.0,225.3699951171875,227.25,212.82000732421875,215.0399932861328,214.7804107666016,NVDA,"Top Research Reports for Apple, Berkshire Hathaway & JPMorgan Chase ||| NVDA September 2023 Options Begin Trading ||| Meta (FB) Tests Tools to Sell Digital Assets in Virtual Reality ||| Pre-Market Most Active for Apr 12, 2022 : RLX, BDSX, AGLE, TQQQ, SQQQ, NVDA, T, QQQ, NIO, DB, DIDI, OXY ||| 1 Massive Green Flag for Nvidia's Future ||| Nvidia Stock Loses a Wall Street Supporter ||| 4 Top Stock Trades for Wednesday: WMT, SMH, DAL, ABBV",1,0.4912718
2022-04-13,51694300.0,217.27999877929688,225.0,214.5500030517578,222.02999877929688,221.761947631836,NVDA,"US STOCKS-Wall St ticks higher as recovery in growth stocks offsets mixed earnings ||| Should You Buy Alphabet Before the Stock Split? ||| Why Nvidia Stock Defied Crypto Worries Today ||| US STOCKS-Wall St rises as recovery in growth stocks offsets mixed earnings ||| What Makes Nvidia (NVDA) a New Strong Buy Stock ||| Broadcom (AVGO) Unveils World's First Wi-Fi Ecosystem Solutions ||| Stock Market News for Apr 13, 2022 ||| Intel's Smart Move Could Give Rivals a Run for Their Money ||| Nvidia Stock Falls on an Analyst Downgrade -- Is It Time to Buy? ||| 2 Semiconductor Stocks That Could Go Parabolic ||| Why Nvidia and Other Semiconductor Companies Keep Getting Downgraded ||| The Zacks Analyst Blog Highlights Apple, Berkshire Hathaway, JPMorgan Chase, NVIDIA, and Bank of America",0,0.5149479
2022-04-14,56909700.0,225.0500030517578,227.7700042724609,211.6300048828125,212.5800018310547,212.3233795166016,NVDA,"Short Week Turns Rocky as Inflation Woes Ramp Up ||| The Best (And Worst) Stocks for Rising Prices ||| The Curious Reason Nvidia Stock Slumped on Thursday ||| Goldman Sachs, Morgan Stanley to lead Intel's Mobileye IPO -sources ||| The NVIDIA and GameStop have been highlighted as Zacks Bull and Bear of the Day ||| Company News for Apr 14, 2022 ||| More Price Target Reductions Hit the Semiconductor Industry ||| Top 5 Chip Makers at Lucrative Valuation for a Solid Portfolio ||| Keep an Eye Out for Ampere Computing After It Files for IPO ||| Bull Of The Day: NVIDIA (NVDA) ||| These 2 High-Growth Stocks Could Power the Bull Market's Next Record Run ||| 2 Monster Growth Stocks to Buy and Hold Through any Recession",1,0.47475326
2022-04-18,52570100.0,212.0,220.8800048828125,210.7899932861328,217.8300018310547,217.56704711914065,NVDA,"2 Top Bargain Stocks Ready for Bull Runs ||| Best Semiconductor Stocks To Buy This Week? 3 To Know ||| 3 Stocks I Bought This Week ||| 2 Semiconductor Growth Stocks to Buy Now and Hold ||| Why Nvidia Stock Zigzagged on Monday ||| Noteworthy Monday Option Activity: TGT, JBHT, NVDA ||| Will Nvidia Stock Hold Key Support As It Nears 2022 Low? ||| 7 of the Top EV Stocks from the DRIV ETF ||| The Zacks Analyst Blog Highlights NVIDIA, Analog Devices, Broadcom, GLOBALFOUNDRIES, and Micron Technology ||| iShares S&P 500 Growth ETF Experiences Big Outflow ||| We Did The Math IVSG Can Go To $15 ||| Finally, Good News for Semiconductor Investors",1,0.5138871
2022-04-19,51278100.0,217.1999969482422,223.72999572753903,213.13999938964844,221.97999572753903,221.71202087402344,NVDA,"Here is What to Know Beyond Why NVIDIA Corporation (NVDA) is a Trending Stock ||| Nvidia Stock Dropped 11% In a Rough Week, Opening a Window of Opportunity for Investors ||| Nvidia (NVDA) Outpaces Stock Market Gains: What You Should Know ||| Why Nvidia Stock Was Climbing Again on Tuesday ||| 3 Reddit Stocks to Buy in April 2022 ||| These 3 Stocks Might Be Getting a Little Too Expensive ||| Why Valuation Isn't Everything When Purchasing a Stock ||| In shift to new era, Wave Computing adopts RISC-V chip architecture ||| I Can't Believe the Semiconductor Market Grew This Much",0,0.46870363
2022-04-20,46897400.0,225.1699981689453,226.6999969482422,212.0,214.82000732421875,214.5606842041016,NVDA,"AMD EPYC CPUs Help Mercedes-AMG F1 Team Win Pole Position ||| For Nvidia, It’s Looking Like 2021 All Over Again ||| Why Nvidia Stock Fell Again Today ||| 3 Charts Showing How Top Stocks Have Performed After a Split",0,0.49461547
2022-04-21,65620900.0,217.08999633789065,223.9199981689453,200.0,201.8300018310547,201.5863800048828,NVDA,"Elon Musk Wants to Buy Twitter. What's Going On? ||| Now Is the Time to Buy Nvidia Stock ||| With Chip Shortages Easing, Nvidia Could Be in for a Bull Run ||| Why Nvidia Stock Fell Hard Today ||| Beyond Stock Splits: 1 Growth Stock to Buy Now and Hold Forever ||| Looking for Investment Ideas? Check Out This List ||| 2 No-Brainer Growth Stocks to Buy While the Market Is Down",0,0.47766408
2022-04-22,62471300.0,203.02999877929688,204.8600006103516,195.0,195.1499938964844,194.91441345214844,NVDA,Price Targets Were Just Cut in These 2 Stocks -- Is It Time to Sell? ||| Will Nvidia Be a Trillion-Dollar Stock by 2025? ||| 3 Growth Stocks Wall Street Thinks Could Gain 60% or More,1,0.47395888
2022-04-25,64156600.0,192.0200042724609,199.4499969482422,190.9600067138672,199.0200042724609,198.77975463867188,NVDA,"Nvidia Stock Is Too Cheap to Ignore, But Should You Buy? ||| Shopify Follows FAANG With Its Own Stock Split. Time to Buy? ||| 3 Slam-Dunk Investing Lessons for Bull Markets and Bear Markets ||| This Will Become One of the 5 Most Valuable Companies in the World ||| This Emerging Opportunity Could Send Nvidia Stock Soaring ||| Nvidia (NVDA) Outpaces Stock Market Gains: What You Should Know ||| AMD Has Three Main Layers of Support According to This Chart ||| Noteworthy Monday Option Activity: SM, NVDA, ARCH ||| Why Nvidia Stock Dropped on Monday ||| First Week of December 16th Options Trading For NVIDIA ||| These 4 Semiconductor Stocks Are Looking Very Attractive Right Now ||| Could Micron Technology Become the Next Nvidia? ||| Better Semiconductor Stock: ASML or Nvidia ||| Should You Invest in the First Trust NASDAQ100Technology Sector ETF (QTEC)? ||| PREVIEW-Graphic chip price drop raises questions on whether end of shortage is in sight",0,0.48022208
2022-04-26,65314300.0,197.17999267578125,197.8800048828125,186.6999969482422,187.8800048828125,187.65321350097656,NVDA,"Why Nvidia Stock Tanked Another 4% Today ||| Wall Street's big slide makes retail investors wary to 'buy the dip' ||| Down 45% From Its Highs, This Is a Great Time to Buy Nvidia Stock ||| Is Nvidia Stock a Buy After Falling 40% From All-Time Highs? ||| Tech Sell-Off: 2 Beaten-Down Stocks That Could Set the Market on Fire ||| Don’t Worry That Falling Graphics Card Prices Will Hurt AMD Stock ||| Better Semiconductor Stock: Taiwan Semiconductor vs. Nvidia ||| Is First Trust NASDAQ100Technology Sector ETF (QTEC) a Strong ETF Right Now? ||| Chip startups using light instead of wires gaining speed and investments ||| Arm unveils new processor, systems to help speed up connected device development",0,0.4709339
2022-04-27,49946000.0,185.97999572753903,191.6699981689453,182.8999938964844,184.1499938964844,183.92770385742188,NVDA,"The Aggressive Investor Is Buying AMD Stock Ahead of Earnings ||| Best Stocks To Invest In? 5 Cyclical Stocks For Your List ||| Qualcomm forecasts upbeat revenue as diversification bet pays off ||| Qualcomm forecasts upbeat revenue as diversification bet pays off ||| Why Nvidia Stock Keeps Dropping ||| Should You Invest in the Technology Select Sector SPDR ETF (XLK)? ||| Take Advantage of the Current Rally in CrowdStrike ||| Microsoft and Alphabet Earnings Made Me More Bullish on This Specific Market ||| Nvidia Stock Has a Path to $250, But Bulls Must Act Fast ||| Is It Time to Buy Low on This Big Tech Stock? ||| 2 AI Growth Stocks With 101% to 339% Upside, According to Wall Street",1,0.49150333
2022-04-28,57032700.0,189.6699981689453,200.3699951171875,184.8999938964844,197.82000732421875,197.58120727539065,NVDA,"1 Growth Stock Down 65% to Buy Right Now ||| Intel (INTC) Q1 Earnings and Revenues Beat Estimates ||| Time to Buy Beaten Down Chip Stocks & ETFs? ||| Stock Market Today: Big Tech Carries Wall Street on Its Back ||| Have Microchip Stocks Declined Into an Attractive Buying Level? ||| US STOCKS-Wall St inches higher as Meta earnings offset GDP gloom ||| Is the S&P 500 All You Need to Retire a Millionaire? ||| US STOCKS-Nasdaq futures jump after strong Meta results; GDP data awaited ||| Ready to Get Rich in the Stock Market? 3 Investments You Can't Go Wrong With ||| Samsung Elec sees component shortages persisting in H2, solid server chip demand ||| US STOCKS-Wall St set for higher open as Meta earnings offset GDP gloom",0,0.5138868
2022-04-29,50043500.0,194.0200042724609,201.27999877929688,185.1699981689453,185.47000122070312,185.24612426757807,NVDA,Why Nvidia Stock Is Falling Today ||| 3 Reasons to Take Another Bite of Apple ||| Nvidia Is Down 37% in 2022: Is It Time to Buy? ||| Big Tech Are Falling Titans ||| $350 Price Target for Nvidia Stock Is Ambitious But Possible ||| Arm's path to IPO smoothened after its Chinese venture ousts CEO ||| FOCUS-Proposed China investment curb by U.S. sparks debate among chipmakers,1,0.4782929
2022-05-02,57204900.0,185.4100036621093,195.7400054931641,183.9100036621093,195.3300018310547,195.09420776367188,NVDA,"The Semiconductor Shortage Is Far From Over, According to Industry Executives ||| Is Texas Instruments Stock a Buy Now? ||| 3 Semiconductor Stocks to Buy for May 2022 ||| US STOCKS-Wall Street up before Fed meet as tech buying punctuates volatile trade ||| UK's Johnson joins final push to convince Arm to list in London -FT ||| There’s a New Rising Era for Advanced Micro Devices Stock ||| UK's Johnson joins final push to convince Arm to list in London -FT ||| Wall Street ends higher amid topsy-turvy trade before Fed meeting ||| US STOCKS-Wall Street drops as Fed focus takes hold, 10-yr Treasuries breach 3% ||| Why Nvidia Stock Is Jumping Higher Today ||| Gaming Stocks To Invest In Right Now? 5 Names To Know ||| US STOCKS-Wall Street falls in volatile trading as focus turns to Fed meet ||| US STOCKS-Wall Street inches higher as growth stocks rebound ||| NVDA: Still Expensive for the Risk ||| Buy Nvidia Stock As Semiconductor Companies Start to Recover",1,0.49414647
2022-05-03,47575100.0,194.0,198.25,191.3300018310547,196.0200042724609,195.7833709716797,NVDA,"Nvidia (NVDA) Gains But Lags Market: What You Should Know ||| 3 Mighty Mutual Funds to Buy for Q2 ||| Noteworthy Tuesday Option Activity: CC, RUN, NVDA ||| Which Stock Picks Could Profit from Rising Interest Rates? ||| Should You Invest in the Vanguard Information Technology ETF (VGT)? ||| The Ryder System and Carvana have been highlighted as Zacks Bull and Bear of the Day",1,0.48965132
2022-05-04,64885500.0,199.22999572753903,204.0,187.509994506836,203.33999633789065,203.09454345703125,NVDA,"AMD Crushes Earnings -- Is It a Buy Now? ||| Why Advanced Micro Devices Stock Fell 21.8% in April ||| Inflation Crisis and the Imploding Dollar: Panic of the Profiteers ||| The Stellar Cloud Business Update Bodes Incredibly Well for Nvidia ||| US STOCKS-Tech stocks drag Wall Street lower ahead of Fed decision ||| US STOCKS-Nasdaq, S&P 500 slide ahead of Fed decision ||| 3 Unbeatable Growth Stocks That Look Like Bargains Now ||| Is Nvidia Stock a Buy Ahead of Earnings? Morgan Stanley Weighs In ||| Is Micron Too Cheap to Ignore? ||| Is It Time to Buy the S&P 500's 3 Worst-Performing April Stocks? ||| Buy and Hold Intel Stock ||| Nvidia Stock May Be Worth Buying If It Has Bottomed Out ||| US STOCKS-Wall St eyes higher open on upbeat results ahead of Fed decision",0,0.50564086
2022-05-05,62633100.0,198.6699981689453,199.25,185.0,188.44000244140625,188.2125244140625,NVDA,"2 Semiconductor Stocks Worth the 2022 Risks ||| Negative Sentiment Kills Market Indices, Dow -1063 Points ||| 3 Reasons Investors Shouldn't Lose Sleep Over Microsoft's Pullback ||| Stock Market Today: Stocks Suffer Worst Losses of 2022 ||| Why Nvidia Stock Was Falling Today ||| IWF, GOOG, FB, NVDA: Large Inflows Detected at ETF ||| 2 Monster Growth Stocks to Buy Now and Hold Forever ||| Interesting NVDA Put And Call Options For June 24th",0,0.5077525
2022-05-06,63329700.0,187.3600006103516,195.1199951171875,179.89999389648438,186.75,186.52456665039065,NVDA,"AMD Stock Still Belongs on Investors’ Growth and Value Shopping Lists ||| AMD vs. Nvidia: Which Chip Giant Should Investors Buy? ||| Nvidia to pay $5.5 mln penalty for 'inadequate disclosures' about cryptomining -SEC ||| Zacks Investment Ideas feature highlights: Amazon, Microsoft, Alphabet, Nvidia and Meta Platforms ||| U.S. SEC charges Nvidia with 'inadequate disclosures' about impact of cryptomining ||| CF Industries and Amazon have been highlighted as Zacks Bull and Bear of the Day ||| 2 Reddit Stocks to Buy and Hold for Years",0,0.48614553
2022-05-09,64445500.0,180.33999633789065,182.5500030517578,168.27000427246094,169.5,169.29537963867188,NVDA,5 Stocks That Moved the Market in April ||| Nvidia Currently Has a Huge Lead on AMD ||| Nasdaq Bear Market: 1 Stock-Split Stock to Buy Now and Hold Forever ||| Graphic Packaging and Gap have been highlighted as Zacks Bull and Bear of the Day ||| PREVIEW-SoftBank seen posting bruising Vision Fund loss on tech sell-off ||| Why Nvidia Stock Fell Nearly 7% Today ||| Nvidia Stock Is a Buy on Weakness ||| 3 Companies Jumping on the Web 3.0 Train ||| PREVIEW-SoftBank seen posting bruising Vision Fund loss on tech sell-off ||| 2 Top Tech Stocks to Buy During a Recession,1,0.48810402
2022-05-10,76147400.0,176.88999938964844,181.97999572753903,170.25,175.9499969482422,175.73757934570312,NVDA,"Intel launches new AI chips, challenging Nvidia's market ||| Malcolm Ethridge From ""The Tech Money Podcast"" Provides Perspective for Investors ||| Crypto Mining Has Caused the SEC to Take Aim at Nvidia ||| Stock Market Today: Stocks Try to Find Their Legs Ahead of CPI Report ||| Nvidia Stock: New Growth Segments Secure Its Future ||| Why Nvidia Investors Are Bullish Today ||| Most Active Stocks To Buy Today? 4 Metaverse Stocks To Watch ||| Will Modest Top-Line Growth Buoy Motorola (MSI) Q1 Earnings? ||| Market Sell-Off: 4 Stocks With Attractive Growth and Valuations ||| Stock Market News for May 10, 2022 ||| Nvidia Faces a Crypto Wild Card ||| 3 of the Top Growth Stocks on Earth ||| Market Crash: Monster Growth Stocks to Buy Right Away",0,0.5106303
2022-05-11,67016700.0,173.47000122070312,177.52999877929688,165.67999267578125,166.3000030517578,166.09925842285156,NVDA,"More Delays Are Incoming for This Semiconductor Giant ||| NVIDIA Enters Oversold Territory (NVDA) ||| Why Nvidia Stock Dropped Again Wednesday ||| Notable Wednesday Option Activity: NVDA, VLO, SJM ||| 3 Stocks That Can Turn $10,000 Into $50,000 by 2025 ||| Stock Market Sell-Off: 3 Top Growth Stocks to Buy and Hold in May (and Beyond) ||| Bull of the Day: Cadence Design Systems (CDNS) ||| Tech Sell-Off: 2 Growth Stocks to Buy, and 1 to Sell",0,0.50385666
2022-05-12,70872800.0,162.19000244140625,167.8800048828125,155.6699981689453,161.75,161.5547332763672,NVDA,"Buying Power of Cardano vs. NVIDIA at New 52-Week Low ||| July 1st Options Now Available For NVIDIA ||| SoftBank's chip tech firm Arm posts record 2021 revenue ||| The Time is Coming to Buy Nvidia Stock, but It’s Not Now ||| Can Nvidia Stock Help Lead the Rebound in Tech Stocks? ||| US STOCKS-Wall Street falls on rate hike worries ||| Why Nvidia Stock Is Still Going Down ||| How to Invest in Web 3.0? 3 Stocks That Will Be the Long-Term Winner ||| My Top Value Stock to Buy in May (and It's Not Even Close) ||| US STOCKS-Futures signal more selling on Wall Street ||| Will Top-Line Growth Buoy Keysight's (KEYS) Q2 Earnings? ||| 3 Unstoppable Stocks That Could Soar 58% to 97%, According to Wall Street ||| SoftBank posts $13 bln FY net loss ||| US STOCKS-Wall Street set to extend declines on rate hike concerns",1,0.49832413
2022-05-13,67043700.0,167.8800048828125,179.27999877929688,165.92999267578125,177.05999755859375,176.8462677001953,NVDA,"1 Reason Why Nvidia Stock Is Rising Today ||| Stocks & ETFs for Summer Travel Surge ||| Talking About the Metaverse With Venture Capitalist and Author Matthew Ball ||| Stock Market Today: Stocks Paper Over Lousy Week With Wild Friday ||| Wall Street rallies as growth stocks rebound; Twitter slides ||| Notable ETF Inflow Detected - IWF, NVDA, DE, CAT ||| US STOCKS-Wall Street rallies as growth stocks rebound, Twitter slides ||| This Semiconductor Giant Just Reported Over 50% Growth ||| US STOCKS-Futures climb, Twitter slumps as Musk puts deal on hold ||| US STOCKS-Futures climb, Twitter slumps as Musk puts deal on hold ||| Validea Martin Zweig Strategy Daily Upgrade Report - 5/13/2022 ||| NVIDIA Corporation (NVDA) Is a Trending Stock: Facts to Know Before Betting on It",0,0.50990564
2022-05-16,52144600.0,175.08999633789062,177.8800048828125,171.05999755859375,172.63999938964844,172.43161010742188,NVDA,"The Good News and Bad News for Nvidia Investors ||| Don’t Let the SEC’s Crypto Fine Turn You Off Nvidia Stock ||| US STOCKS-Wall Street falls as growth stocks, glum China data weigh ||| Top Analyst Reports for NVIDIA, Home Depot, Pfizer & Others ||| US STOCKS-Wall Street falls as growth stocks, glum China data weigh ||| These 2 Semiconductor Giants Are Increasing Prices ||| US STOCKS-Wall St set for muted open after glum China data ||| Temasek hikes stake in e-commerce companies Amazon, Pinduoduo ||| The Nasdaq Is Down More Than 25% This Year. Time to Buy These 5 Top Stocks ||| Stock Market News for May 16, 2022",1,0.4927238
2022-05-17,58583000.0,180.7400054931641,183.7100067138672,176.33999633789062,181.7700042724609,181.5505828857422,NVDA,"Up 600% in 10 Years, Here's Why Apple Stock Is Still So Cheap ||| Why Nvidia Stock Shot Higher on Tuesday ||| Advanced Micro Devices Stock Offers More Than 36.50% Upside for Buyers ||| 3 Beaten Down Tech Stocks Trading at Attractive Buying Levels ||| It's Time to Welcome Nvidia (NVDA) as an Elite Wall Street Stock ||| 2 Top Metaverse Stocks Ready for a Bull Run ||| US STOCKS-Wall St climbs on gains in banks, strong retail sales data ||| Tech Market Sell-Off: 4 Stocks Down Big That Are Long-Term Holds ||| US STOCKS-Wall Street set to open higher as technology, growth stocks rebound ||| US STOCKS-Futures climb as technology and growth stocks rebound ||| $300 a Month in These 3 Stocks Could Make You a Millionaire by Retirement ||| The Zacks Analyst Blog Highlights NVIDIA, The Home Depot, Pfizer, The Walt Disney, and Salesforce ||| 7 Growth Stocks That Analysts Love Right Now",0,0.5170032
2022-05-18,54516100.0,177.0500030517578,181.17999267578125,168.63999938964844,169.3800048828125,169.175537109375,NVDA,"Notable Wednesday Option Activity: FIVE, AVYA, NVDA ||| US STOCKS-Wall Street ends sharply lower as Target and growth stocks sink ||| Micron Stock Has Substance At These Levels ||| Nvidia (NVDA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release ||| US STOCKS-Wall Street ends sharply lower as Target and growth stocks sink ||| Are Options Traders Betting on a Big Move in NVIDA (NVDA) Stock? ||| Why Nvidia Stock Was Down Today ||| Down 25%, Is It Safe to Invest in the Nasdaq Right Now? ||| US STOCKS-Wall Street tumbles as Target and growth stocks sink",1,0.48940507
2022-05-19,62131000.0,169.3699951171875,176.8699951171875,167.33999633789062,171.24000549316406,171.0332794189453,NVDA,Why Nvidia Stock Bounced Back Thursday ||| 5 Oversold Growth Stocks to Buy Now ||| Nvidia (NVDA) Gains As Market Dips: What You Should Know ||| US STOCKS-S&P 500 ends lower as Cisco and Apple sink ||| US STOCKS-Wall Street mixed as Cisco sinks and Nvidia recovers ||| 3 Reddit Stocks With Upcoming Catalysts to Watch  ||| Why AMD Investors Can Sleep Soundly ||| Add Up The Pieces: SMH Could Be Worth $318 ||| Is Nuveen ESG LargeCap Growth ETF (NULG) a Strong ETF Right Now? ||| What's the Best Big Tech Company to Buy in This Stock Market Downturn? ||| GLOBAL MARKETS-Shares slump as retailer warnings fuel stagflation fears,0,0.48296964
2022-05-20,73910500.0,173.32000732421875,174.10000610351562,157.5500030517578,166.94000244140625,166.73849487304688,NVDA,"US STOCKS-S&amp;P 500 on pace to confirm bear market, falls 20% from record close ||| US STOCKS-Wall Street ends mixed, Tesla falls ||| Yes, Nvidia Stock is Expensive — But Oppenheimer Says It’s Worth the Price ||| Why Nvidia Stock Cratered on Friday ||| Bull Of The Day: Core Scientific (CORZ) ||| Opinion: These Will Be the 3 Largest Stocks by 2030 ||| FOCUS-Computer chip giant ASML places big bets on a tiny future ||| Will Healthy Revenue Growth Buoy Splunk's (SPLK) Q1 Earnings?",1,0.48147583
2022-05-23,63988900.0,162.74000549316406,169.14999389648438,161.7899932861328,168.97999572753906,168.7760009765625,NVDA,"Supply Chain Snarls Sink Semiconductor Stock ||| Weekly Preview: Earnings to Watch This Week (BABA, NVDA, SPLK, ZM) ||| At its 52-week Lows, Nvidia Could Rebound ||| 3 Top AI Stocks Ready for Bull Runs ||| A Slew of Big Retailers to Report Q1 Results This Week ||| S&P 500, Dow rise as banks, Apple offer support ||| All Eyes Are on Nvidia’s May 25 Earnings Release, Given How Cheap NVDA Stock Is Now ||| 6 of the Most Undervalued Tech Stocks to Buy for June ||| Nvidia Q1 Preview: Another EPS Beat in Store? ||| iShares Russell 1000 Growth ETF Experiences Big Inflow ||| Nvidia: Why Investors Should Temper Expectations Ahead of Earnings ||| A Breather Before a Last Push on Q1 Earnings ||| Nvidia Earnings: What to Watch on Wednesday After the Market Close ||| Nvidia Earnings Preview: Get Ready for a Wild Ride ||| Best Buy Kicks Off Heavy Week of Retail Earnings ||| What's in the Offing for NVIDIA (NVDA) This Earnings Season? ||| Why Nvidia Stock Moved Lower on Monday ||| VMware (VMW) to Report Q1 Earnings: What's in the Cards? ||| S&P 500, Dow rise as banks, Apple offer support ||| Nvidia Stock Before Earnings: Buy or Sell?",0,0.4790446
2022-05-24,58855000.0,165.10000610351562,165.97000122070312,157.8000030517578,161.5399932861328,161.34500122070312,NVDA,"Why Micron, AMD, and Nvidia Stocks Retreated Today ||| 3 Metaverse Stocks to Buy Now ||| 7 Safe Stocks to Buy and Hold Onto Forever ||| June 2024 Options Now Available For NVIDIA ||| My 2 Best Growth Stocks to Buy and Hold Through Any Recession ||| Is a Surprise Coming for NVIDIA (NVDA) This Earnings Season?",1,0.46971887
2022-05-25,78113200.0,160.1999969482422,171.11000061035156,160.0,169.75,169.54505920410156,NVDA,"7 Undervalued Blue-Chip Stocks to Buy for June ||| Fed Minutes Firm Market; NVDA, WSM Beat, Head Separate Ways ||| Stock Market Today: Nasdaq Jumps as Fed Minutes Fail to Flame Fears ||| Nvidia Stock Sank in After-Hours Trading Today -- Here's Why the Stock Could Be a Solid Buy ||| 4 Top Stock Trades for Thursday: NVDA, DKS, GME, TOL ||| Nvidia (NVDA) Beats Q1 Earnings and Revenue Estimates ||| Nvidia forecasts second-quarter revenue below estimates, shares drop ||| Nvidia forecasts second-quarter revenue below estimates ||| NVIDIA Corporation Q1 Profit Decreases, but beats estimates ||| US STOCKS-Wall Street rallies as Fed minutes meet expectations ||| US STOCKS-Wall Street climbs after Fed minutes meet expectations ||| 3 Surefire Stocks to Buy in the Next Bear Market ||| After-Hours Earnings Report for May 25, 2022 : NVDA, SNOW, SPLK, UHAL, ZTO, WSM, CHNG, DXC, LU, NTNX, BOX, VSAT ||| With Nvidia Earnings on Tap, Be Smart with NVDA Stock ||| US STOCKS-Wall Street seesaws after Fed minutes release ||| Pre-Market Most Active for May 25, 2022 : TQQQ, SNAP, SQQQ, XOM, DKS, BSX, AAPL, QQQ, ELEV, NVDA, CCL, NIO ||| What's in Store for Nvidia ETFs in Q1 Earnings ||| US STOCKS-Wall Street rises on growth stocks ahead of Fed minutes ||| Nvidia (NVDA) Q1 Earnings: What to Expect ||| Where to Invest $5,000 for the Next 5 Years ||| What's Behind Nvidia Stock's 5x Rise Since Late 2018? ||| NVIDIA Q1 23 Earnings Conference Call At 5:00 PM ET",1,0.51686585
2022-05-26,99657500.0,160.36000061035156,180.9199981689453,160.22000122070312,178.50999450683594,178.29452514648438,NVDA,"Want $1 Million in Retirement? Invest $50,000 in These 3 Stocks and Wait a Decade ||| Nvidia Stock Is ‘Too Cheap to Ignore,’ Says Analyst ||| Is Nvidia a Buy or a Sell After Q1 Earnings? ||| Stock Market Today: Retail Roars Back, Markets Build Positive Momo ||| AMD Stock Is a Buy After Nvidia’s Earnings ||| Notable Thursday Option Activity: TSLA, COST, NVDA ||| Stock Market Today: Dow Jones, S&P 500 Surge; Broadcom To Acquire VMware For $61 Billion ||| Nvidia Sinks on Dismal Guidance: ETFs in Focus ||| Nvidia Stock Down After Earnings -- Is NVDA Stock a Buy Now? ||| Thursday's ETF with Unusual Volume: CRBN ||| Global firms warn of sluggish China demand due to lengthy COVID curbs ||| NVIDIA (NVDA) Q1 Earnings Beat, Stock Falls on Dim Q2 Guidance ||| US STOCKS-S&P, Dow futures edge higher ahead of GDP data; Nvidia slides ||| Top Stock Market News For Today May 26, 2022 ||| Oil stocks lift European shares as growth worries persist ||| 3 Ways to Sleep Easy in a Market Downturn ||| Nvidia (NVDA) Q1 2023 Earnings Call Transcript ||| Pre-Market Most Active for May 26, 2022 : BKSY, TQQQ, SQQQ, M, JOBY, NVDA, BABA, IQ, AAPL, NTNX, TJX, RTX ||| US STOCKS-Wall St set for higher open on earnings optimism",1,0.4760512
2022-05-27,73837900.0,181.8600006103516,188.8099975585937,181.0,188.1100006103516,187.8829345703125,NVDA,Better Buy: Nvidia Stock or Every Nasdaq Stock? ||| Do You Know Your Exposure to Mega Cap Stocks? ||| Why Nvidia Stock Jumped Another 3.5% Today ||| Stocks To Invest In Today? 4 Cyclical Stocks To Check Out ||| 2 Top Tech Stocks to Buy for the Long Haul ||| 5 Growth Stocks For Your June 2022 Watchlist ||| Why Doesn't Nvidia Want to Talk About Cryptocurrency Miners? ||| Everything I Liked and Hated About Nvidia's Earnings ||| Nvidia's Profit Has More Room to Run Thanks to This Technology,0,0.48621964
2022-05-31,66410000.0,189.8000030517578,192.0,183.5,186.72000122070312,186.4946136474609,NVDA,"7 Blue-Chip Stocks to Buy at an All-Time Low ||| Yes, the Crypto Crash Is Hurting Nvidia ||| New Google Partnership Is Good for AMD. Here’s 1 Thing Even Better ||| Is Invesco Dynamic Semiconductors ETF (PSI) a Strong ETF Right Now? ||| NVIDIA Corporation (NVDA) is Attracting Investor Attention: Here is What You Should Know ||| Top 2 Stocks from Expert Analyst Rick Schafer’s Coffers ||| 7 Great Growth Stocks That Could Double Your Investment ||| Why Nvidia Stock Stumbled on Tuesday ||| 3 Tech Stocks to Buy After Nvidia’s Earnings Report ||| How Artificial Intelligence Can Help Detect Wildfires ||| AMD Powers World's Fastest Supercomputer With Hewlett Packard ||| How Money Flow Impacted NVIDIA",0,0.50705343
2022-06-01,54451400.0,187.2400054931641,190.52999877929688,181.22000122070312,183.1999969482422,182.9788513183593,NVDA,"If You Invested $10,000 in Nvidia 10 Years Ago, This Is How Much You Would Have Today ||| Nvidia's Potential Is Massive as 2 New Data Center Types Emerge ||| 3 Stocks to Take Advantage of the Increased Spending in Data Centers ||| Is It Too Late to Buy Nvidia Stock?",1,0.48406163
2022-06-02,64865600.0,182.9199981689453,196.19000244140625,181.97999572753903,195.9199981689453,195.6835021972656,NVDA,"Down 48%, Is Nvidia Stock a Buy, Sell, or Hold? ||| US STOCKS-Wall Street rallies, lifted by Tesla and Nvidia ||| US STOCKS-Wall Street ends sharply higher, led by Tesla and Nvidia ||| The 10 Best High-Growth Stocks to Buy ||| Notable Thursday Option Activity: RH, AAPL, NVDA ||| US STOCKS-Growth stocks lead Wall St higher in choppy trade; eyes on jobs report ||| US STOCKS-Wall Street ends sharply higher, led by Tesla and Nvidia ||| Why You Might Regret Not Buying Nvidia on the Dip ||| 7 Massively Undervalued Stocks to Buy Before They Go Parabolic ||| Better Buy: Nvidia vs. AMD ||| 3 Cryptocurrency Stocks With Up to 439% Upside, According to Wall Street ||| Why Nvidia Stock Was Up More Than 5% This Morning ||| 1 Green Flag for Nvidia in 2022, and 1 Red Flag",0,0.4716487
2022-06-03,59877900.0,190.82000732421875,193.32000732421875,185.22000122070312,187.1999969482422,186.9739990234375,NVDA,"Separating Signal From Noise in the Metaverse ||| Stock Market News for June 3, 2022 ||| 3 Robinhood Stocks to Buy Right Now ||| 3 Best Semiconductor Stocks to Buy for June 2022 ||| Why Nvidia, Amazon, and Apple Stocks Slumped Friday ||| Nvidia Stock Looks Cheap After Recent Stellar Earnings",1,0.52039295
2022-06-06,42240600.0,191.38999938964844,193.3699951171875,185.63999938964844,187.8600006103516,187.6332244873047,NVDA,Author Christine Porath on the Importance of Respect ||| Is This Bad News for Nvidia? ||| GRAPHIC-Amazon stock split may draw retail traders in tough market ||| What Can Investors Learn from Nvidia’s Risk Factors?,1,0.49248317
2022-06-07,38891400.0,184.72000122070312,190.0,181.8800048828125,189.259994506836,189.0315093994141,NVDA,Rule Breaker Investing Mailbag: Dealing With the Market ||| Top Stocks to Buy Now -- 3 Semiconductor Stocks I'm Holding Long ||| Apple Announces M2 Chip: What Investors Need to Know ||| 3 Unstoppable Stocks to Buy Now and Never Sell ||| Should You Invest in Nvidia Right Now? ||| This Just Happened for the First Time in Nvidia's History ||| Which Metaverse Stock Could Augment Investors’ Returns? ||| GRAPHIC-Amazon stock split may draw retail traders in tough market,0,0.48908272
2022-06-08,36325200.0,187.9900054931641,191.8000030517578,185.3500061035156,186.47999572753903,186.29425048828125,NVDA,"These 2 Meme Stocks Have Legitimate Long-Term Upsides ||| Noteworthy ETF Inflows: SOXX, NVDA, KLAC, MCHP ||| Advanced Micro Devices Stock’s Overlooked Upside: The Metaverse ||| Agilent (A) to Provide Genomics Innovation Via New Tie-Ups ||| Nvidia Stock Still Looks Fairly Valued as It Shows Signs of Breaking Out",0,0.4925999
2022-06-09,39557400.0,184.8099975585937,189.3300018310547,180.4100036621093,180.47999572753903,180.3002319335937,NVDA,"Recession Recipe: Which Ingredients Spoil Consumer Confidence and Spending? ||| Nvidia’s 5nm Lovelace Chip Is Not the Right Reason to Worry About Nvidia Stock ||| US STOCKS-Wall Street set to open lower on inflation, rate hike angst ||| 3 Stocks That Could Be Worth More Than Meta by 2032",0,0.48014155
2022-06-10,46524800.0,176.0,176.97000122070312,168.69000244140625,169.74000549316406,169.5709228515625,NVDA,"AMD Unveils New Product Portfolio to Accelerate Growth ||| These 3 Tech Giants Have Made Big Acquisitions in 2022 ||| Notable Friday Option Activity: NVDA, ILMN, ALGN ||| Why Apple, Amazon, and Nvidia Plunged Today ||| Intel Investors Might Be Happy to Hear This ||| Is Most-Watched Stock NVIDIA Corporation (NVDA) Worth Betting on Now? ||| These Major Catalysts Make Nvidia Stock a Buy Right Now ||| Fortinet (FTNT) to Split Stock in 5 to Attract More Investors",0,0.49194404
2022-06-13,60415300.0,160.0,163.1199951171875,156.05999755859375,156.47000122070312,156.3141632080078,NVDA,"An American Supercomputer Just Shattered the Speed Record. What's That Mean? ||| Why Shares of Micron Technology, Nvidia, and AMD Fell Today ||| 7 Founder-Led Stocks to Buy and Hold Forever ||| Is It Too Late to Buy Intel Stock? ||| Should You Invest in the Invesco Dynamic Semiconductors ETF (PSI)? ||| The SEC’s Potential Thorn for Thematic ETFs ||| 1 Semiconductor Stock with 141% Upside, According to Wall Street",1,0.4981118
2022-06-14,46968000.0,157.30999755859375,160.66000366210938,154.1199951171875,158.36000061035156,158.2022705078125,NVDA,"Forget Inflation and Intel, With Data Center Strength Nvidia Is a Long-Term Buy ||| 3 Technology Stocks That Can Prosper During a Tech Downturn ||| Adobe revamps metaverse design tools for Apple's chips",1,0.49777237
2022-06-15,56393600.0,160.9499969482422,168.67999267578125,159.25999450683594,165.27000427246094,165.10537719726562,NVDA,One Low-Risk Way to Play a Potential Rally in Nvidia Stock ||| 7 Best Stocks to Buy if You Are All About ESG Investing ||| Is Nvidia Stock a Buy Now? ||| Bull of the Day: Cadence Design Systems (CDNS),0,0.49850535
2022-06-16,54574900.0,158.60000610351562,159.4199981689453,154.00999450683594,156.00999450683594,155.85459899902344,NVDA,"Why Nvidia, Advanced Micro Devices, Qualcomm Fell Today ||| Oppenheimer Pounds the Table on Nvidia Stock ||| VUG, GOOG, NVDA, SPGI: ETF Inflow Alert ||| Macroeconomic Headwinds to Hit Nvidia for $500 Million ||| Stock Market Today: Dow Jones, S&P 500 Tumble On Recession Concerns; Twitter Stock In Focus Ahead Of Meeting With Elon Musk",1,0.48575646
2022-06-17,63033400.0,156.47999572753906,159.9499969482422,153.27999877929688,158.8000030517578,158.64181518554688,NVDA,"Notable Friday Option Activity: DOCU, X, NVDA ||| Why AMD and Nvidia Were Down Big on Thursday ||| 4 Compelling Reasons Nvidia Is My Newest Stock Buy",1,0.48088744
2022-06-21,48308900.0,164.75,170.0800018310547,164.07000732421875,165.66000366210938,165.49501037597656,NVDA,"3 Top Metaverse Stocks Ready for a Bull Run ||| Top Stock Reports for Apple, NVIDIA & McDonald's ||| A Time to Reflect on the Juneteenth Holiday ||| 3 Stocks Affected by the Decline in Crypto ||| Wall Street Closes Worst Week In Two Years ||| Stock Market News for Jun 20, 2022 ||| 3 Growth Stocks to Buy Now Before the Recession Hits ||| Why Amazon, Nvidia, and Meta Platforms Are Climbing Higher Today ||| Is Trending Stock NVIDIA Corporation (NVDA) a Buy Now? ||| 2 Tech Stocks to Ride on the Booming Virtual Reality Market ||| Nvidia Stock: Wall Street Remains Bullish Despite the Sell-Off, Here’s Why ||| 3 Hard-Hit Stocks to Buy Now Before a Market Rally ||| Stock Market News for Jun 21, 2022",0,0.52916
2022-06-22,43713500.0,162.25999450683594,166.6199951171875,161.8000030517578,163.60000610351562,163.43707275390625,NVDA,4 Metaverse Stocks To Watch Right Now ||| Jump on the Metaverse Bandwagon With These 4 Tech Stocks ||| AMD Launches New Ryzen Series to Address Trending Markets ||| UK PM Johnson's spokesman: Not aware of plans to force ARM into London IPO ||| Is Nvidia Stock a Buy Now? ||| Bear Market 2022: Is There Anything Left to Invest In? ||| The Ultimate Growth Stocks to Buy With $100 Right Now,0,0.5091157
2022-06-23,46368000.0,165.19000244140625,165.85000610351562,158.52999877929688,162.25,162.08840942382812,NVDA,Nvidia (NVDA) Stock Sinks As Market Gains: What You Should Know ||| Advice for Gen Z & Millennial Investors On Bear Markets in Stocks & Crypto ||| 3 Must-Have Chip Stocks to Buy for Q3 ||| Driverless Taxis Are Here. How Should Investors Play It? ||| US STOCKS-Wall Street eyes higher open as tech-related stocks gain ||| Will Nvidia Be a Trillion-Dollar Stock by 2027?,1,0.46493992
2022-06-24,47215300.0,165.0,171.39999389648438,163.10000610351562,171.25999450683594,171.0894317626953,NVDA,"Nvidia Stock: Still Uncomfortably Expensive after 50% Haircut ||| 7 Top Metaverse Stocks with Massive Potential ||| Nvidia vs. AMD: Which Company Should Investors Focus On? ||| Top Cyclical Stocks To Buy Now? 3 In The News ||| Why Is Nvidia (NVDA) Down 9.1% Since Last Earnings Report? ||| SOXX, NVDA, INTC, NXPI: Large Outflows Detected at ETF ||| 2 Stocks Investors Should Buy to Capitalize on the Metaverse ||| Is Nvidia the Best Stock to Buy During This Bear Market?",0,0.49430633
2022-06-27,42796800.0,173.1199951171875,173.3000030517578,166.25999450683594,168.69000244140625,168.52198791503906,NVDA,"The S&P 500 Is Down 22% -- It's Time to Buy These 3 Ultra-Growth Stocks ||| 3 Stocks I Bought This Week ||| 7 Stocks to Own Until 2032 and Beyond ||| If You've Got $5,000, Buying These 5 Top Stocks Right Now Would Be a Genius Move ||| 3 Tips and Tricks That Have Helped My Investing Mindset ||| 3 Top Nasdaq Stocks That Are Set to Triple ||| Market Plunge: 2 Discounted Growth Stocks to Buy Before the Rebound ||| Notable Monday Option Activity: NVDA, RAPT, COST ||| Why Nvidia Stock Was Dropping on Monday ||| 1 Suffering Stock-Split Stock to Buy Now and Hold Forever ||| Microsoft (MSFT) Releases New Gaming Features on Edge Browser ||| Will Nvidia Be a Trillion-Dollar Stock by 2025? ||| 3 Dividend Stocks With 3%+ Yields to Buy on Sale Now ||| Should You Invest in the Technology Select Sector SPDR ETF (XLK)?",0,0.478886
2022-06-28,46114900.0,169.0,172.02000427246094,159.4499969482422,159.82000732421875,159.6608428955078,NVDA,"Why Nvidia Stock Fell More Than 4% Today ||| Like With its Main Rival, Investors Have Oversold Nvidia Stock ||| Alphabet's (GOOGL) Google Adds More Free Game Demos to Stadia ||| Have $300? These 2 Top Tech Stocks Are Screaming Buys Now ||| Markets Lose Impetus in Summer Trading Today ||| 7 Long-Term Growth Stocks That Wall Street Analysts Still Love ||| Adding $100 to These 7 Stocks Could Be a Genius Move Right Now",0,0.45892897
2022-06-29,48235200.0,158.13999938964844,158.1999969482422,151.6999969482422,155.4199981689453,155.26519775390625,NVDA,"Best Long-Term Stocks To Buy Now? 5 Semiconductor Stocks To Know ||| Why Advanced Micro Devices Fell Today ||| Why Nvidia Stock Slumped on Wednesday ||| Nvidia Is Still in Growth Mode and Could Be Nearing a Bottom ||| 2 Unstoppable Stocks to Buy and Forget ||| AMD's Versal AI Core Powers Real-Time AI Processing for Canon ||| Siemens and Nvidia collaborate to expand digital services ||| Nasdaq 100 Movers: AMD, DDOG ||| 2 Reasons to Buy Nvidia and 1 Reason to Sell ||| 2 Top Stocks That Pay You to Own Them",0,0.48577613
2022-06-30,68607000.0,153.61000061035156,155.6699981689453,148.6199951171875,151.58999633789062,151.4390106201172,NVDA,"Why Amazon, Apple, and Nvidia Are Falling Today ||| When in Doubt, Zoom Out; Bear Markets Are a Goldmine ||| When Should You Sell a Stock? ||| The College Investor: Road Maps To Flipping Debt Into Wealth Plans ||| 10 Warren Buffett Stocks to Buy for the Second Half of 2022 ||| The Curious Reason That Nvidia Stock Keeps Dropping ||| Want $1 Million In Retirement? Invest $300,000 In These 3 Stocks and Wait 10 Years ||| Why Wednesday Was Another Rough Day for AMD and Nvidia ||| Global smartphone, PC shipments to decline in 2022 on China slowdown - Gartner ||| Nvidia Looks Cheap But You Can Buy It Even Cheaper",0,0.48690194
2022-07-01,57761000.0,148.99000549316406,150.6300048828125,143.9199981689453,145.22999572753906,145.08535766601562,NVDA,Why Nvidia Stock Fell 15% This Week ||| Why Nvidia Stock Sank Today ||| This Is When You Can Be Aggressive in Buying AMD Stock ||| 5 Top Stocks to Buy in July ||| Ready to Get Rich With Stocks? You Can't Go Wrong With These 3 Investments ||| 1 Green Flag and 1 Red Flag for Nvidia ||| Better Augmented Reality Stock: Apple vs. Nvidia ||| Is First Trust NASDAQ100Technology Sector ETF (QTEC) a Strong ETF Right Now?,1,0.4699524
2022-07-05,65139700.0,141.75,149.7100067138672,140.5500030517578,149.63999938964844,149.49095153808594,NVDA,"The Real Reason Micron Is Sinking NVIDIA Stock ||| 2 Top AI Stocks Ready for a Bull Run ||| 3 Top Chip Stocks to Supplement Your Nvidia and AMD Position ||| Is Micron Technology Stock a Buy Now? ||| Here is What to Know Beyond Why NVIDIA Corporation (NVDA) is a Trending Stock ||| 2 Tech Stocks That Could Help Make You a Fortune ||| Notable ETF Outflow Detected - IVV, GOOG, JNJ, NVDA ||| 2 Explosive Growth Stocks to Buy in 2022 and Beyond ||| Here’s Why Nvidia’s Fortunes Are Changing at Such a Fast Pace ||| 1 Big Reason to Buy Nvidia Stock on the Dip",1,0.47589433
2022-07-06,52906600.0,150.10000610351562,153.19000244140625,147.88999938964844,151.3000030517578,151.14930725097656,NVDA,These 2 Tech Companies Have Made Significant Acquisitons in 2022 ||| Better Buy: Nvidia vs. Micron Technology ||| 2 Monster Growth Stocks That Could Lead a Market Rebound in the Second Half of 2022 ||| 2 Stocks I'm Buying in the Second Half of 2022 ||| Should You Invest in the Vanguard Information Technology ETF (VGT)?,1,0.48594713
2022-07-07,49290300.0,154.55999755859375,159.4499969482422,153.88999938964844,158.5800018310547,158.4220733642578,NVDA,"US STOCKS-Wall Street rises as traders temper bets on aggressive rate hikes ||| Why Nvidia and AMD Jumped Today ||| Top Stock Reports for NVIDIA, HSBC & 3M Company ||| Stock Market Today: S&P Surges to Fourth Gain in a Row ||| US STOCKS-Wall Street advances as traders' aggressive rate-hike fears ease ||| NVDA August 26th Options Begin Trading ||| US STOCKS-Wall Street rises as rate hike fears ebb ||| GameStop rises as stock split lures retail investors ||| Buy Nvidia Stock As It Keeps Falling ||| US STOCKS-Wall St eyes higher open as investors assess interest rate outlook",0,0.4966088
2022-07-08,46797200.0,154.3000030517578,160.3699951171875,153.88999938964844,158.3800048828125,158.22227478027344,NVDA,"Why NVIDIA Stock Got Beat by the Market Today ||| The Zacks Analyst Blog Highlights NVIDIA, HSBC Holdings, 3M, BP, and PNC Financial Services ||| Bear of the Day: Applied Materials (AMAT) ||| Top Metaverse Stocks To Watch In July 2022 ||| Why Intel Stock Will Rise Sharply From Here",0,0.47824904
2022-07-11,43732100.0,155.25999450683594,155.27000427246094,150.3800048828125,151.52000427246094,151.36907958984375,NVDA,2 Reddit Stocks to Buy and Hold for Years ||| Nvidia Investors Might Be Happy to Hear This ||| Where Will Warren Buffett Stock HP Be in 5 Years? ||| New to Investing? These 3 Stocks Are Great Buys ||| New Metaverse Angle Should Spur Investor Interest in Nvidia ||| Is Now the Time to Pull the Trigger on Nvidia Stock? This Analyst Says ‘Yes’ ||| Good News Is Bear News for Nvidia Stock,0,0.49777234
2022-07-12,45848300.0,152.67999267578125,154.30999755859375,148.77000427246094,150.82000732421875,150.66976928710938,NVDA,Market Sell-Off: 1 Nasdaq Stock Down 48% to Buy Hand-Over-Fist ||| 7 Tech Stocks Trading at a Terrific Discount Right Now ||| PREVIEW-Computer chips face toilet paper hoarding moment as shortage turns to glut ||| TSM Q2 Preview: Double-Digit Earnings Growth in Store? ||| US STOCKS-Recession worries keep futures under pressure ||| PREVIEW-Computer chips face toilet paper hoarding moment as shortage turns to glut ||| 7 Cheap Semiconductor Stocks to Buy Now,1,0.50446194
2022-07-13,52191800.0,145.89999389648438,153.75,144.64999389648438,151.63999938964844,151.48898315429688,NVDA,"After A Strong Week, Can Intel Stock Sustain Its Performance? ||| Google's cloud unit taps Arm-based chips, adding to Intel, AMD pressure ||| Why Apple, Okta, and Nvidia Stocks Tumbled Today ||| 2 Dividend-Paying Tech Stocks to Buy Right Now ||| This Is How the Crypto Decline Is Affecting Nvidia's Stock ||| Micron: The Good, The Bad, and The Ugly ||| What Do These Price Target Reductions Mean for AMD and Nvidia Investors? ||| Best Stocks for 2022: Nvidia Has What It Takes to Bounce Back ||| Where Will Nvidia Be in 10 Years?",1,0.5201227
2022-07-14,45623500.0,151.0800018310547,154.72999572753906,147.27999877929688,153.72000122070312,153.56690979003906,NVDA,"Should You Buy, Sell, or Hold Advanced Micro Devices Stock After the Plunge? ||| Chipmaker TSMC's shares jump after quarterly profit beats estimates ||| 5 Stocks to Outrun the Housing Market ||| Why Nvidia, Meta, and Amazon Stocks Are Falling Today ||| Should You Invest in the Fidelity MSCI Information Technology Index ETF (FTEC)? ||| Prediction: These Growth Stocks Will Be Worth $1 Trillion by 2030 ||| These Are the 2 Cheapest Stocks I Own -- but Not for Long ||| 5 Semiconductor Stocks to Look at After the CHIPS Act Passes",1,0.48673853
2022-07-15,38593500.0,156.58999633789062,157.82000732421875,154.4499969482422,157.6199951171875,157.46298217773438,NVDA,"Should You Buy GOOG on Monday After Its Big Split? ||| Why Nvidia, Meta Platforms, and Salesforce Stocks Rallied on Friday ||| 2 Growth Stocks That Could Beat the Market Over the Next 3 Years ||| 3 Vanguard ETFs That Could Help You Retire a Millionaire ||| Investors Heavily Search NVIDIA Corporation (NVDA): Here is What You Need to Know ||| Nvidia Stock Is a Buy Ahead of Its Q2 Earnings Report ||| Nvidia Does Some Future-Proofing and Expands Its Quantum Computing Development",1,0.4989371
2022-07-18,67051700.0,163.02000427246094,168.97000122070312,160.02000427246094,161.00999450683594,160.84963989257812,NVDA,"A Comprehensive Guide to Video-Gaming ETFs ||| US STOCKS-Easing rate-hike bets, bank earnings lift Wall Street ||| Chip designers warm to U.S. bill despite big benefits to Intel ||| Is the Options Market Predicting a Spike in NVIDIA (NVDA) Stock? ||| Why Nvidia Stock Popped Today ||| U.S. chip industry split over CHIPS act benefits to Intel -sources ||| Should You Invest in the VanEck Semiconductor ETF (SMH)?",1,0.5171839
2022-07-19,70236600.0,164.86000061035156,171.10000610351562,161.72000122070312,169.9199981689453,169.75074768066406,NVDA,Why Nvidia Stock Rallied on Tuesday ||| Is This an Unfair Advantage for Intel Stock?,1,0.47638646
2022-07-20,76053800.0,169.47000122070312,179.3300018310547,168.00999450683594,178.07000732421875,177.89263916015625,NVDA,"Why Nvidia Stock Rallied Another 3% Today ||| AMD Partners With Dell to Launch Alienware m17 R5 Gaming Laptop ||| Nancy Pelosi's Husband Is Buying Nvidia Stock -- Should You? ||| Bear Market Buys: Where to Invest $5,000 Right Now ||| 2 Stocks to Invest in Virtual Reality ||| Is Nuveen ESG LargeCap Growth ETF (NULG) a Strong ETF Right Now? ||| 3 Chip Stocks to Buy Ahead of Earnings ||| Bull vs. Bear: Royal Caribbean Cruises",1,0.49525103
2022-07-21,55704900.0,178.85000610351562,181.44000244140625,175.4499969482422,180.5,180.32020568847656,NVDA,"Interesting NVDA Put And Call Options For September 2nd ||| Notable ETF Inflow Detected - IVV, GOOG, JNJ, NVDA ||| Best Semiconductor Stocks To Buy Right Now? 5 To Watch ||| Jamie Dimon Tells It Like It Is as Earnings Season Kicks Off ||| The Best Stocks to Invest $50,000 in Right Now ||| Why AMD and Nvidia Stocks Are Jumping on Wednesday",0,0.4920652
2022-07-22,53667100.0,178.92999267578125,179.6699981689453,171.3699951171875,173.19000244140625,173.01751708984375,NVDA,Why Nvidia Fell More Than 4% on Friday ||| Why Nvidia Stock Was Up This Week ||| The 7 Best High-Yield Retirement Stocks for Your Nest Egg ||| Want to Invest in the Metaverse? 3 Promising Ways to Gain Exposure ||| 5 Hot ‘Mega Stocks’ Traded by U.S. Politicians,0,0.48294404
2022-07-25,48074800.0,170.19000244140625,171.24000549316406,166.49000549316406,170.24000549316406,170.07046508789062,NVDA,"Younger Investors Should Like Dividend Stocks, Too ||| 3 Dividend Growth Stocks to Buy Hand Over Fist ||| 3 Quantum Computing Stocks For Your Watchlist This Week ||| Nvidia Earnings: What to Watch on Aug. 24 ||| Stock Market Today: Stocks End Lower Ahead of Tech Earnings, Fed Meeting ||| US STOCKS-Dow rises at start of big earnings week, Big Tech pulls Nasdaq lower ||| Why Nvidia Stock Sank on Monday ||| 2 Growth Stocks That Could Turn $100,000 Into $1 Million by 2030",0,0.48783454
2022-07-26,39786500.0,168.88999938964844,169.19000244140625,164.77999877929688,165.3300018310547,165.1653289794922,NVDA,Texas Instruments (TXN) Q2 Earnings and Revenues Surpass Estimates ||| Intel Stock: 3 Things to Watch During Earnings,1,0.49430326
2022-07-27,56977600.0,170.32000732421875,179.36000061035156,169.1300048828125,177.89999389648438,177.72280883789062,NVDA,"3 Highly-Ranked Stocks With Stellar Projected Growth ||| Notable Wednesday Option Activity: PCVX, NVDA, UPWK ||| Semiconductor ETFs in Spotlight Ahead of Q2 Earnings ||| Pelosi's husband dumps Nvidia stock as House eyes chip bill ||| February 2023 Options Now Available For NVIDIA ||| Why Nvidia Stock Is Still a Buy as GPU Prices Tumble ||| How Bad Are Things for Nvidia Stock?",1,0.51843685
2022-07-28,47464600.0,179.75,181.3999938964844,174.39999389648438,179.83999633789062,179.66087341308594,NVDA,"Nvidia (NVDA) Gains But Lags Market: What You Should Know ||| What Is ESG Investing? Which Companies Are the Most Socially Responsible? ||| 3 Chip Stocks Up Double-Digits in July ||| House Speaker Nancy Pelosi Has Traded in These 4 Mega-Cap Companies ||| 3 Blue-Chip Stocks to Buy for a Bear Market ||| Zacks Investment Ideas feature highlights: Quanex, Taiwan Semiconductor, Kronos, Apple, Nvidia and Advanced Micro Devices",1,0.50326693
2022-07-29,43546000.0,178.1300048828125,182.44000244140625,176.9199981689453,181.6300048828125,181.44908142089844,NVDA,Good Stocks To Buy Right Now? 3 Growth Stocks For Your Watchlist ||| Single-Stock ETFs: What Investors Should Know ||| Can Single-Stock ETFs Help You Beat the Bear Market? ||| Intel's Earnings: What It Means for AMD and Nvidia Investors,1,0.48254323
2022-08-01,47646900.0,181.82000732421875,188.4600067138672,179.89999389648438,184.4100036621093,184.2263336181641,NVDA,"These Metaverse Stocks Are Best Positioned to Outperform ||| Why Meta Platforms, Amazon, and Nvidia Are Rising Today ||| Is iShares Semiconductor ETF (SOXX) a Strong ETF Right Now?",1,0.47073123
2022-08-02,48952700.0,181.22000122070312,189.3800048828125,180.9199981689453,185.259994506836,185.07546997070312,NVDA,Wall Street set to open lower as U.S.-China tensions grow ||| Is Nvidia Stock a Buy Now? ||| Chip stocks slip as Taiwan tensions mount ||| Can Nvidia Stock Get Out of This Slump? ||| Don't Want to Miss Out on the Metaverse? Buy This Stock Right Now ||| US STOCKS-Futures fall as U.S.-China tensions grow ||| Arista Networks Soars on Earnings Beat -- Is This Growth Stock a Buy? ||| 3 Humbled Nasdaq Stocks Ready to Bounce Back,1,0.48721024
2022-08-03,41814600.0,181.83999633789065,189.67999267578125,181.3699951171875,188.92999267578125,188.7418212890625,NVDA,Nvidia (NVDA) Outpaces Stock Market Gains: What You Should Know ||| Why AMD Shares Rose 23% in July ||| 5 Cyclical Stocks To Watch In August 2022 ||| AMD's Data Center Revenue Soars 83% -- Is the Stock a Buy Now? ||| Nvidia Stock Can Thrive Despite CHIPS Act Pressure,1,0.4797512
2022-08-04,40965200.0,188.4900054931641,192.7400054931641,187.6000061035156,192.1499938964844,191.95860290527344,NVDA,"Notable Thursday Option Activity: COST, NVDA, DUK ||| Intel and AMD Earnings Share Great Insight for Nvidia Investors ||| Should Nvidia Investors Be Worried About the Crypto Crash? ||| Proposed Crypto Regulation Bill will Ease Crypto Market Volatility ||| PREVIEW-Vision Fund slide points to more pain for SoftBank's Son ||| What Lies Ahead for Gold & Commodity ETFs",0,0.50257266
2022-08-05,38606800.0,188.1000061035156,192.2899932861328,186.6600036621093,189.88999938964844,189.7008514404297,NVDA,What Lies Ahead for Gold & Commodity ETFs ||| Is Invesco Dynamic Semiconductors ETF (PSI) a Strong ETF Right Now?,0,0.49058768
2022-08-08,98185900.0,175.02000427246094,182.38999938964844,172.4199981689453,177.92999267578125,177.75274658203125,NVDA,"Why Nvidia Stock Rose More Than 19% in July ||| The 7 Best Virtual Reality Stocks to Buy Now ||| Why GameStop Stock Is Gaining Today ||| AMD Partners With ECARX to Launch In-Vehicle Computing Platform ||| Nvidia Stock Drops on Weak Gaming Sales -- Is It Time to Sell This Growth Stock? ||| More money in the bank for insiders who divested US$163m worth of NVIDIA Corporation (NASDAQ:NVDA) shares last year ||| Technology Sector Update for 08/08/2022: NVDA,MNDY,TWLO,PLTR ||| GLOBAL MARKETS-Wall Street muted on mixed inflation messages ||| Take-Two forecasts weak annual sales as lack of major titles hits gaming industry ||| US STOCKS-Wall Street closes little changed on Fed policy fears ||| Wall St trades mixed on Fed tightening fears, Nvidia weighs ||| Which Stocks To Buy Now? 3 Tech Stocks To Know ||| Why GlobalFoundries Rocketed Higher Today, Again ||| Small-Caps Outperform, Most Indices Flat ||| US STOCKS-Wall St steady after selloff on jobs data, Nvidia weighs ||| NVIDIA Corporation (NVDA) is Attracting Investor Attention: Here is What You Should Know ||| Here Are 2 Safe Metaverse Stocks for Risk-Averse Investors ||| 5 Stocks I'll Almost Certainly Still Own in 2030 ||| Nvidia expects second-quarter revenue to drop on gaming weakness ||| Monday's ETF with Unusual Volume: NZUS ||| US STOCKS-Wall St set for higher open after selloff on jobs data ||| US STOCKS-Nasdaq rises over 1% as dip in yields supports megacaps ||| Nvidia expects second-quarter revenue to drop on gaming weakness ||| Nasdaq 100 Movers: NVDA, ZS ||| Why Nvidia Stock Slumped on Monday ||| Noteworthy ETF Inflows: XLK, NVDA, PYPL, ADP ||| Stock Market Today: Dow Jones, S&P 500 Rally; Nvidia Falls Following Revenue Warning ||| Is Nvidia a Buy or Sell Before Earnings?",0,0.49134827
2022-08-09,66826300.0,172.52000427246094,174.47000122070312,167.24000549316406,170.86000061035156,170.6898193359375,NVDA,"US STOCKS-Nasdaq slides 1% as chipmaker Micron's warning renews tech rout ||| Why Nvidia Stock Was Down on Tuesday ||| Nvidia Tumbles on Fiscal Q2 Revenue Warnings: ETFs in Focus ||| Stock Market Today: S&P, Nasdaq Extend Losing Streaks on Micron Demand Woes ||| US STOCKS-Nasdaq slides 1% as chipmaker Micron's warning rekindles tech rout ||| Best Stocks To Buy Today? 4 Semiconductor Stocks To Watch ||| SoftBank steps up asset sales from sinking portfolio ||| 3 Tech Stocks That Are Screaming Buys in August ||| SoftBank steps up asset sales from sinking portfolio ||| Chipmaker Micron forecasts negative free cash flow for first quarter ||| Nvidia Stock: 4 Things Investors Should Note From Preliminary Results ||| US STOCKS-Wall St set to open lower after chipmaker Micron's dour warning ||| US STOCKS-S&P 500, Nasdaq futures slip after chipmaker Micron's warning ||| Stock Market News for Aug 9, 2022",1,0.47984615
2022-08-10,59742200.0,176.97999572753906,181.17999267578125,173.1699981689453,180.97000122070312,180.78976440429688,NVDA,"The Curious Reason Nvidia Stock Popped Today ||| An Overview of the Gaming Industry and Ways to Invest in It ||| Did Micron Technology and Nvidia Break the Semiconductor Market? ||| Semiconductor ETFs Tumble: What Lies Ahead? ||| Gaming industry's fortunes fade as spending squeeze follows pandemic bump ||| Semiconductor Stock Plunge: Buy, Sell or Hold? ||| Stock Market News for Aug 10, 2022 ||| Nvidia: Despite Gaming Weakness, Risk-Reward Attractive Right Now, Says Top Analyst ||| Wednesday's ETF with Unusual Volume: ROBT",0,0.50165343
2022-08-11,50932700.0,181.3099975585937,187.07000732421875,178.75999450683594,179.4199981689453,179.2412872314453,NVDA,"Bull of the Day: Cadence Design Systems (CDNS) ||| Nvidia (NVDA) Dips More Than Broader Markets: What You Should Know ||| Notable Thursday Option Activity: Z, NVDA, TGH ||| A Detailed Guide to Cloud Computing ETFs ||| See Which Of The Latest 13F Filers Holds NVIDIA ||| China's SMIC posts quarterly revenue surge but warns of some panic in chip sector ||| 4 Index Funds to Retire a Millionaire Without Lifting a Finger ||| New Strong Sell Stocks for August 11th ||| Got $5,000? 2 Microchip Stocks You Need in Your Portfolio ||| Gaming industry's fortunes fade as spending squeeze follows pandemic bump ||| The Zacks Analyst Blog Highlights NVIDIA, Micron, Taiwan Semiconductor Company, Advanced Micro Devices and Texas Instruments",1,0.5082091
2022-08-12,47809400.0,181.6000061035156,187.17999267578125,179.52999877929688,187.08999633789065,186.90367126464844,NVDA,"3 Highly-Ranked Stocks With Stellar Growth Prospects ||| Market Rally Strengthens as Inflation Concerns Ease ||| Here’s Why the U.S. and China are Interested in Taiwan ||| US STOCKS-Futures up as easing price pressures set Wall St for weekly gains ||| Got $5,000? These Are 2 of the Best Growth Stocks to Buy Right Now ||| Nvidia Stock Is Down 48% -- Is It Time to Buy?",1,0.53483194
2022-08-15,45766600.0,187.009994506836,191.63999938964844,186.1300048828125,190.32000732421875,190.1304626464844,NVDA,"Shopify: Bull vs. Bear ||| 3 Semiconductor Stocks to Buy Now, Including Nvidia ||| 3 High-Growth Stocks That Could Be Worth $1 Trillion in 10 Years -- Or Sooner ||| Why Tech Layoffs Aren't Panicking This Investor ||| There Will Be Blood: Nvidia Edition ||| Should You Invest in the Invesco Dynamic Semiconductors ETF (PSI)?",0,0.49057183
2022-08-16,45124000.0,189.1999969482422,191.4199981689453,185.009994506836,188.7899932861328,188.6019592285156,NVDA,"VTI, JNJ, NVDA, PG: Large Inflows Detected at ETF ||| Why I Own Nvidia (NVDA) ||| 3 Top Cryptos to Buy Now ||| Genius Sports Limited (GENI) Reports Q2 Loss, Tops Revenue Estimates ||| These 3 Semiconductor Stocks Could Be Great Buys Right Now",0,0.50201935
2022-08-17,44679900.0,185.22999572753903,186.8800048828125,181.4499969482422,183.3500061035156,183.16737365722656,NVDA,"Nvidia Stock Could Crash -- Here's What You Should Do ||| Don’t Give Up on Nvidia (NVDA) Stock After Earnings Miss ||| 7 Stocks That Are Still Hedge Fund Favorites ||| US STOCKS-Wall St falls as growth stocks slide, Target weighs on retail shares ||| US STOCKS-Wall St drops as growth stocks slide, Target weighs on retail shares ||| Who Are the Leaders Shaping the Metaverse? ||| Inflation and Market News ||| Move Over Nvidia, This Tech Stock Is a Screaming Buy Right Now ||| Is Nvidia in Trouble? Or Is This a Buying Opportunity?",1,0.48191953
2022-08-18,41544700.0,183.009994506836,188.6499938964844,181.8300018310547,187.72999572753903,187.54299926757807,NVDA,"Top Stocks To Buy Now? 4 Semiconductor Stocks In Focus ||| US STOCKS-Wall St ends higher, Cisco Systems jumps after forecast ||| US STOCKS-Wall St ends higher, Cisco Systems jumps after forecast ||| US STOCKS-Wall St sheds early gains as investors assess Fed minutes ||| Got $5,000? Buy the Dip on This Mega-Tech Stock While It's Down 39% ||| Wall Street Continues to be Optimistic on Nvidia Stock; Here’s Why",0,0.48458084
2022-08-19,44158800.0,184.0599975585937,185.1999969482422,177.6999969482422,178.49000549316406,178.31222534179688,NVDA,"Notable Friday Option Activity: BA, MCK, NVDA ||| Nvidia Stock: Looking At The Big Picture ||| NVIDIA (NVDA) to Report Q2 Earnings: What's in the Cards? ||| 7 Tech Stocks Reporting Earnings the Week of August 22 ||| Exxon Mobil and Nvidia have been highlighted as Zacks Bull and Bear of the Day ||| Bear of the Day: Nvidia (NVDA)",0,0.48182943
2022-08-22,40959300.0,174.89999389648438,175.5800018310547,169.66000366210938,170.33999633789062,170.1703338623047,NVDA,"3 Hail Mary Plays to Bring Your Stock Portfolio Back From the Brink ||| 2 Monster Metaverse Stocks to Buy for the Long Haul ||| Weekly Preview: Earnings to Watch This Week 8-21-22 (CRM, NVDA, PTON, ZM) ||| NVDA Stock Price Prediction: The Case for Nvidia Hitting $300 ||| NVIDIA Q2 Preview: Can the Earnings Streak Stay Alive? ||| US STOCKS-Wall Street ends sharply lower on fears of aggressive Fed ||| US STOCKS-Wall Street ends sharply lower on fears of aggressive Fed ||| Pre-Markets in Red on Rate Hike Concerns ||| Eventful Week Ahead: Retail, Semis Report; Jackson Hole Later ||| Ethereum's ""Merge"" Is Having a Big Impact on NVIDIA Stock ||| US STOCKS-Wall Street tumbles on fears of aggressive Fed ||| Analysts Predict 17% Upside For MGK ||| It's an Interesting Week for the Semiconductor Market ||| 2 Top Growth Stocks to Buy Right Now and Hold for the Long Term ||| Warren Buffett's Secret Portfolio Bought 3 New Supercharged Growth Stocks ||| Monday's ETF with Unusual Volume: PSI",1,0.51764303
2022-08-23,36998600.0,169.88999938964844,174.64999389648438,169.6999969482422,171.80999755859375,171.63888549804688,NVDA,NVIDIA (NVDA) Q2 Earnings to Be Hurt by Weak Gaming Chip Demand ||| Why Things Are Looking Up for Nvidia Before Earnings ||| 3 Things About Nvidia That Smart Investors Know ||| US STOCKS-Nasdaq ticks up on hopes of less aggressive rate hikes after weak PMI data ||| Could Snowflake Become the Next Nvidia?,1,0.49303594
2022-08-24,52266100.0,170.1199951171875,174.05999755859375,168.9499969482422,172.22000122070312,172.0484619140625,NVDA,"Durable Goods Orders Remain Unchanged ||| Nvidia predicts third-quarter sales below expectations ||| Nvidia (NVDA) Q2 2023 Earnings Call Transcript ||| A Bottom Forming in Housing? Plus NVDA, CRM, SNOW Report Q2 ||| Nvidia (NVDA) Lags Q2 Earnings Estimates ||| Nvidia forecasts dull third-quarter sales on weak gaming demand ||| NVIDIA Corporation Q2 Income Retreats ||| Down 43%, Will Nvidia Become a Trillion-Dollar Stock? ||| Stock Market Today: Markets Edge Higher in Quiet Session ||| US STOCKS-Growth stocks lift Wall St, all eyes on Jackson Hole ||| This Week's 5 Hot Tech Earnings Charts ||| US STOCKS-Wall St set for subdued open as investors await Fed rate hike clues ||| 1 Little-Known Chip Stock Is a Top Buy Right Now ||| Nvidia (NVDA) Q2 2022 Earnings: What to Expect ||| NVIDIA Q2 23 Earnings Conference Call At 5:00 PM ET ||| After-Hours Earnings Report for August 24, 2022 : NVDA, CRM, SNOW, ADSK, SPLK, NTAP, WSM, BOX, VSCO, PSEC, GES, ZUO ||| Durable Goods Are Goldilocks; Pending Home Sales on Deck",1,0.4811183
2022-08-25,77069100.0,168.44000244140625,179.47000122070312,168.3300018310547,179.1300048828125,178.9515838623047,NVDA,"3 Metaverse Stocks with Multibagger Potential ||| Japan's Nikkei tracks tech-led Wall Street gains before Powell speech ||| US STOCKS-Wall Street ends sharply up, fueled by Nvidia and Amazon ||| US STOCKS-Nasdaq ends sharply up, fueled by Nvidia and Amazon ||| Investors Piling into NVIDIA, Chip Stocks Despite Weak Outlook ||| US STOCKS-Nasdaq rallies, fueled by Nvidia and Amazon ||| Wall St climbs as investors await Fed's signals from Jackson Hole ||| Nvidia's Earnings Were Disappointing, but Here Are 3 Reasons Why I'm Still Bullish ||| Was Cathie Wood Right to Dump Nvidia Stock Ahead of Weak Guidance? ||| Wall St rises as investors await Fed's signals from Jackson Hole ||| NVIDIA (NVDA) Tumbles on Weak Q2 Earnings, Dim Q3 Guidance ||| Nvidia Stock Falls 5% as Weak Gaming Outlook Torpedoes Guidance ||| US STOCKS-Wall St set to rise at open as investors focus on Jackson Hole meet ||| US STOCKS-Futures rise as investors await data, Jackson Hole ||| IWB, GOOG, NVDA, WFC: ETF Outflow Alert",0,0.50693464
2022-08-26,76912700.0,178.57000732421875,179.24000549316406,162.3699951171875,162.60000610351562,162.43804931640625,NVDA,"US STOCKS-Wall Street ends in a hole after Powell's Wyoming speech ||| The Top 10 Constituents of the Nasdaq-100 Index ||| US STOCKS-Wall Street ends well down as Powell's speech affirms hawkish rate stance ||| Why Nvidia, AMD, and Applied Materials Stocks Dropped Today ||| US STOCKS-Wall Street slumps as Powell's speech reinforces hawkish rate stance ||| NVIDIA (NVDA) Stock Showing Resilience After Missing Earnings Estimates ||| US STOCKS-Wall St falls after Powell warns of tight policy, slow growth ||| US STOCKS-Nasdaq, S&P 500 muted ahead of Powell's speech ||| Company News for Aug 26, 2022 ||| NVIDIA Forgot That Crypto Crashes Are Bad for Business ||| Is It a Good Time to Invest in Semiconductor Stocks? ||| Daily Markets: Investors Turn Attention to Powell’s Jackson Hole Speech ||| Is Nvidia Still a Good Stock to Buy? ||| US STOCKS-Wall St set to slip at open; all eyes on Powell's speech",0,0.46979368
2022-08-29,49613200.0,160.1999969482422,163.3800048828125,157.6699981689453,158.00999450683594,157.8526153564453,NVDA,"AMD vs. NVDA: Why AMD Stock Seems More Attractive ||| Analysts Are Bullish on These 3 “Strong-Buy” Tech Stocks ||| 3 Tech Stocks With More Potential Than Any Cryptocurrency ||| 1 Semiconductor Stock to Buy Right Now, Despite a Gaming Slowdown ||| Why Nvidia Didn't Really Have a Bad Quarter ||| Stock Market Today: Markets End Lower Again as Tech Stocks Drag ||| Estimating The Intrinsic Value Of NVIDIA Corporation (NASDAQ:NVDA) ||| Nvidia Stock: Surprising Data Center Sluggishness Keeps Morgan Stanley on the Sidelines ||| Should You Invest in the Technology Select Sector SPDR ETF (XLK)? ||| US STOCKS-Wall Street set to extend losses on rate worries ||| 1 Green Flag and 1 Red Flag for Nvidia After a Tough Earnings Report ||| Cathie Wood Drops Nvidia, Buys Zoom -- Should You?",0,0.480497
2022-08-30,53018100.0,159.60000610351562,160.38999938964844,151.82000732421875,154.67999267578125,154.52593994140625,NVDA,"US STOCKS-Wall Street falls as job openings data adds to rate hike jitters ||| How I'd Invest $20,000 Today If I Had to Start From Scratch ||| Why Nvidia Investors Were Nervous Tuesday Morning ||| US STOCKS-Wall Street falls as job openings data adds to rate hike jitters ||| Is Trending Stock NVIDIA Corporation (NVDA) a Buy Now? ||| 7 Hot Tech Stocks to Buy in September ||| 3 Quantum Computing Stocks to Buy for Next-Gen Energy ||| US STOCKS-Futures rebound after Jackson Hole shock, data eyed ||| AMD Expands Portfolio With Zen 4 Powered Ryzen 7000 Chip Series",0,0.4871839
2022-08-31,57371000.0,153.83999633789062,155.39999389648438,149.58999633789062,150.94000244140625,150.78965759277344,NVDA,"U.S. officials order Nvidia to halt sales of top AI chips to China ||| NVIDIA : U.S. Imposes New License Requirement For Future Export Of Some Chips To China, Russia ||| GLOBAL MARKETS-Asia stocks stagger into September as dollar spikes ||| Good Stocks To Buy Right Now? 4 Tech Stocks To Know ||| US STOCKS-Wall Street set for higher open as tech stocks rebound, oil drops ||| 22 Billion Reasons to Buy Nvidia Stock ||| The Silver Lining in Nvidia's Latest Announcement ||| April 2023 Options Now Available For NVIDIA",0,0.5252297
2022-09-01,117886500.0,142.08999633789062,143.8000030517578,132.6999969482422,139.3699951171875,139.23117065429688,NVDA,"With new AI chip rules, U.S. takes aim at a critical niche ||| MORNING BID-Financial conditions noose tightens ||| GLOBAL MARKETS-Stocks slide, dollar spikes as September starts stormy ||| Is Nvidia's Drop Signaling the Beginning of a New China-U.S. Trade War? ||| EXPLAINER-Biden's curbs on chips to China part of broader effort ||| With new China AI chip restrictions, U.S. takes aim at a critical niche ||| Stock Market Today: Nasdaq Falls for a Fifth Straight Day ||| GLOBAL MARKETS-Stocks slide, dollar soars as September starts stormy ||| S&P 500 snaps four-session losing streak with payrolls on deck ||| What's Going On With NVIDIA? ||| U.S. export ban on some advanced AI chips to hit almost all China tech majors - analysts ||| AMD Pensando DPUs Help VMware Reduce Operational Costs ||| US STOCKS-S&P 500 falls for fifth straight day on rate hike worry ||| Nvidia and AMD Fall After U.S. Bans Exports to China. Time to Buy These Chip Stocks? ||| Thursday Sector Laggards: Energy, Technology & Communications ||| Technology Sector Update for 09/01/2022: NTNX,MDB,GTLB,NVDA ||| US STOCKS-Wall Street slides for fifth straight day on rate hike jitters ||| Chip wreck: Nvidia sinks sector after U.S. restricts China sales ||| Why Nvidia Stock Cratered on Thursday ||| US STOCKS-Wall St set for a dull start to September on growing slowdown worries ||| 2 Stock-Split Stocks to Buy Hand Over Fist Amid the Market Sell-Off ||| US STOCKS-Wall Street slides for fifth straight day on rate hike jitters ||| Pre-Market Most Active for Sep 1, 2022 : TQQQ, SQQQ, NVDA, QQQ, AZN, JZ, TRQ, CCL, BHP, NIO, NOK, APE ||| This Is Why AMD and Nvidia Are Down Today ||| Stock Market News for Sep 1, 2022 ||| Nvidia Stock Drops as U.S. Restricts Sales of Data Center Chips to China ||| Is It Time to Buy the Dow Jones' 3 Worst Performing Stocks This Year? ||| Nasdaq 100 Movers: OKTA, CMCSA ||| U.S. allows Nvidia to export, transfer tech to develop flagship AI chip ||| NVDA October 14th Options Begin Trading ||| Best Undervalued Stocks To Buy Now? 3 Semiconductor Stocks To Watch ||| MORNING BID-Markets enter The Fall ||| US STOCKS-Futures begin September on dull note as slowdown worries escalate ||| NVIDIA (NVDA) Falls 7% as US Halts Top AI Chip Sales to China ||| 7 of Cathie Wood’s Favorite Stocks to Buy Now",0,0.51103836
2022-09-02,74315700.0,141.0,141.7100067138672,135.91000366210938,136.47000122070312,136.33407592773438,NVDA,"Bull of the Day: Taiwan Semiconductor (TSM) ||| New Futures Contract Empowers Investors to Gain or Hedge Exposure to Semiconductor Subsector ||| Why Nvidia Stock Is Plunging This Week ||| Noteworthy ETF Outflows: SPYG, GOOG, NVDA, TMO ||| Rate Hike Fears Crippling Wall Street ||| 2 High-Conviction Growth Stocks That Billionaires Are Buying Hand Over Fist ||| Nasdaq Bear Market: 2 Sensational Growth Stocks That Could Set You Up for Life ||| Stock Market News for Sep 2, 2022 ||| US STOCKS-Futures tick lower ahead of monthly jobs report ||| US STOCKS-Futures jump after August jobs report",0,0.49588016
2022-09-06,53575100.0,137.30999755859375,137.7899932861328,133.50999450683594,134.64999389648438,134.51589965820312,NVDA,"The Fed Chief Speaks; Wall Street Reacts ||| How Much Revenue Does Nvidia Get From China? It's Complicated ||| 1 Big Reason Why Nvidia's Second-Quarter Earnings Results Underwhelmed Investors ||| Top Stocks To Invest In Now? 3 Tech Stocks To Watch This Week ||| Is Nvidia Stock a Buy Now? ||| Worried About Nvidia? Buy This Tech Stock Right Now ||| PC Shipments Are Expected to Decline. Is This More Bad News for AMD, Nvidia, and Intel Stock? ||| Agilent (A) to Penetrate Chromatography Market Via New Tie-Up ||| China-focused hedge funds lower exposure as risks mount ||| Nvidia's China Ban: How Big a Hit Is It? ||| Nvidia (NASDAQ:NVDA) Stock: Is the Recent Correction an Opportunity for Investors? ||| Nvidia (NASDAQ:NVDA) Stock Could Still Ride Out Tough U.S. Govt Licensing Norms, Says Top Analyst ||| 7 Growth Stocks That Could 10X by 2027 ||| Why Nvidia Fell 16.9% in August ||| Better Buy: Nvidia vs. Snowflake ||| Notable Tuesday Option Activity: KMX, NVDA, ALGN ||| 2 Red Flags for Nvidia Stock in 2022 ||| Ex-Dividend Reminder: Bentley Systems, NVIDIA and Kontoor Brands ||| 3 Non-Buffett Tech Stocks That Would Match Warren Buffett's Philosophy ||| CHIPS Act Update Gives Bears the Upper Hand With Chip Stocks ||| 3 Dividend-Paying Tech Stocks To Buy in September ||| China-focused hedge funds lower exposure as risks mount ||| ANALYSIS-Banned U.S. AI chips in high demand at Chinese state institutes",1,0.48706388
2022-09-07,51265700.0,135.6300048828125,138.3800048828125,133.4600067138672,137.13999938964844,137.04412841796875,NVDA,"Which “Strong Buy” Semiconductor Stock Does Wall Street Love Most? ||| A Few Things Nvidia Investors Should Know ||| 7 Stocks to Buy on the Dip — or You’ll Be Kicking Yourself Later! ||| The Zacks Analyst Blog Highlights NVIDIA, Microsoft, Apple and Alphabet",1,0.5029026
2022-09-08,62487300.0,134.58999633789062,140.0800018310547,133.69000244140625,139.89999389648438,139.80218505859375,NVDA,"ANALYSIS-U.S. ban on Nvidia, AMD chips seen boosting Chinese rivals ||| 3 Reasons Why I Would Stay Away From Intel Stock ||| Should You Invest in the Vanguard Information Technology ETF (VGT)? ||| Better Semiconductor Stock: AMD vs. Nvidia",1,0.49655405
2022-09-09,48661200.0,141.57000732421875,144.74000549316406,141.25999450683594,143.8699951171875,143.7694091796875,NVDA,3 No-Brainer Tech Stocks to Buy if You Have Money to Invest ||| Why Nvidia and Semiconductor Stocks Keep Going Up ||| 4 Phenomenal Growth Stocks Billionaires Are Buying Hand Over Fist,1,0.5067765
2022-09-12,48415900.0,143.69000244140625,145.47000122070312,141.97999572753906,145.0500030517578,144.94857788085938,NVDA,"FAANG vs. MATANA: Looking Beyond the Glitzy Branding ||| Where Will Nvidia Be in 5 Years? ||| EXCLUSIVE-Biden to hit China with broader curbs on U.S. chip and tool exports -sources ||| Better Bear Market Buy: Nvidia vs. Intel ||| Here is What to Know Beyond Why NVIDIA Corporation (NVDA) is a Trending Stock ||| IWB, GOOG, XOM, NVDA: Large Inflows Detected at ETF ||| EXCLUSIVE-Biden to hit China with broader curbs on U.S. chip and tool exports -sources",0,0.5041376
2022-09-13,71495600.0,138.02000427246094,139.22000122070312,130.99000549316406,131.30999755859375,131.21820068359375,NVDA,"3 Best Metaverse Stocks to Buy Now ||| Notable Tuesday Option Activity: PUBM, MNTV, NVDA ||| Upset by high prices, GM's Cruise develops its own chips for self-driving cars ||| Markets Are Overdoing It a Bit ||| AMD Joins PyTorch Foundation to Accelerate AI Adoption ||| After Hours Most Active for Sep 13, 2022 : AAPL, INTC, SWN, KO, NVDA, IQ, CMCSA, CWK, AMZN, VALE, UBER, NEM ||| Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ||| Chip tech startup SiFive launches products aimed at automotive market ||| 2 Index Funds That Could Make You a Stock Market Millionaire ||| Prediction: 3 Growth Stocks That Could Be Worth $1 Trillion by 2030 ||| Why Nvidia, Amazon, and Apple Stocks All Slumped Tuesday Morning ||| Nvidia Stock Is Down 57% -- Should You Buy Right Now?",0,0.5247499
2022-09-14,58850700.0,132.5399932861328,132.89999389648438,129.1300048828125,131.27999877929688,131.18821716308594,NVDA,"7 Quantum Computing Stock Picks to Beat the September Market Slump ||| Wednesday's ETF with Unusual Volume: FCTR ||| Company News for Sep 14, 2022 ||| Silicon Valley startup SambaNova offers new AI system, triples previous system speed ||| Semiconductor Stocks Are Down Big -- Here Is My Next Move",0,0.51926005
2022-09-15,52362500.0,130.14999389648438,132.3300018310547,127.9000015258789,129.2899932861328,129.1995849609375,NVDA,"Move Over, Nvidia. These High-Growth Nasdaq Stocks Are Screaming Buys Right Now. ||| Is Nvidia Stock a Buy? ||| Why Nvidia Stock Got Trounced on Thursday ||| EXCLUSIVE-Biden to hit China with broader curbs on U.S. chip and tool exports -sources ||| All the Stocks I'm Selling in This Wild Market ||| Bear of the Day: NVIDIA (NVDA) ||| Should You Invest in the Fidelity MSCI Information Technology Index ETF (FTEC)? ||| Tech Sell-Off: 1 Nasdaq Stock Down 61% to Buy Before It Starts Soaring",1,0.49057594
2022-09-16,67075100.0,127.41999816894533,132.1199951171875,126.16999816894533,131.97999572753906,131.88772583007812,NVDA,"Here are 3 Oversold Tech Stocks with Solid Upside Potential ||| Why Nvidia Shares Rose on a Down Day ||| NVIDIA Corporation's (NASDAQ:NVDA) latest 7.6% decline adds to one-year losses, institutional investors may consider drastic measures ||| How to Read Financial Statements Series: Nvidia Stock Deep Dive ||| 2 Artificial-Intelligence Growth Stocks Shaping the Future of Technology ||| This Could Be Great News for AMD Investors but Bad News for Intel Stock ||| 3 Unstoppable Trends That Will Send These 3 Stocks Soaring",1,0.49289343
2022-09-19,56968500.0,130.1199951171875,134.6300048828125,130.10000610351562,133.82000732421875,133.72645568847656,NVDA,"Checking In on 10 Stock Picks ||| If You Haven't Done So Yet, It's Time to Buy Qualcomm Stock ||| These 2 Artificial Intelligence Stocks Are Set for Strong Growth, Say Analysts ||| Why Nvidia Attempted a Recovery Today ||| Nvidia Just Lost One of Its Oldest Partners ||| Uber says Lapsus$-linked hacker responsible for breach ||| US STOCKS-Wall Street set to fall on aggressive rate hike worries ||| US STOCKS-Futures fall on rate hike worries ||| How Much Will This Cost Nvidia Investors?",0,0.49735034
2022-09-20,52481800.0,132.14999389648438,134.8300018310547,130.57000732421875,131.75999450683594,131.66787719726562,NVDA,"Nvidia unveils new gaming chip with AI features, taps TSMC for manufacturing ||| US STOCKS-Wall Street drops 1% with focus on Fed ||| Check Out This Stock If You're Worried About Crypto and Chip Shortages ||| Intel Might Be Moving On From Its Gaming GPU Ambitions -- That Wouldn't Be a Bad Thing ||| US STOCKS-Wall Street set for lower open as focus turns to Fed ||| Is Nuveen ESG LargeCap Growth ETF (NULG) a Strong ETF Right Now?",1,0.5194023
2022-09-21,80767900.0,132.1300048828125,140.30999755859375,131.10000610351562,132.61000061035156,132.51727294921875,NVDA,"Nvidia CEO sees 'large space' for China sales despite U.S. restrictions ||| The Street Is Sleeping on Nvidia Stock, Says Top Analyst ||| Noteworthy Wednesday Option Activity: NVDA, MNTV, SMCI ||| Why Nvidia Stock Popped on Wednesday ||| Nvidia CEO sees 'large space' for China sales despite U.S. restrictions ||| US STOCKS-Wall Street rises ahead of likely hefty rate hike by Fed ||| Cheap Stocks To Buy Now? 2 Tech Stocks To Watch In 2022 ||| 2 Unstoppable Growth Stocks You Can Buy and Forget About ||| Nvidia Stock (NASDAQ:NVDA): High-End Graphics Cards Stir Up Excitement ||| NVIDIA (NVDA) Launches Ada Lovelace-Powered Gaming Chips ||| Should You Invest in the VanEck Semiconductor ETF (SMH)? ||| 7 Tech Stocks to Buy Now for Extraordinary Gains ||| 3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street ||| Cathie Wood Went Bargain Shopping: Here Are 3 Stocks She Bought Hand Over Fist Last Week",0,0.4904895
2022-09-22,75916200.0,130.6999969482422,131.49000549316406,124.27999877929688,125.61000061035156,125.52217864990234,NVDA,"US STOCKS-Wall Street ends down for third day as growth concerns weigh on tech ||| US STOCKS-Nasdaq, S&P end down for third day as growth concerns weigh on tech ||| US STOCKS-Wall Street drops as mounting growth concerns weigh on tech, financials ||| Best Stocks To Invest In Right Now? 3 Semiconductor Stocks To Know ||| AMD Expands Ryzen & Athlon Processor Portfolio for Laptops ||| 7 Meme Stocks to Buy During a Stock Market Crash ||| Stock Market Sell-Off: 2 Cathie Wood Stocks That Could Double in 5 Years",0,0.49211222
2022-09-23,66330900.0,124.1999969482422,126.11000061035156,122.56999969482422,125.16000366210938,125.07249450683594,NVDA,"My Take: 4 Strong Growth Stocks to Buy This Week ||| Why Nvidia Stock Fell on Friday (Hint: It Wasn't the Economy) ||| Nvidia (NVDA) Down 29.9% Since Last Earnings Report: Can It Rebound? ||| Stock Market News for Sep 23, 2022 ||| 1 Growth Stock Set to Soar 145% From Its 52-Week Low, According to Wall Street ||| 3 Supercharged Growth Stocks Down 62% to 94% That Billionaires Can't Stop Buying ||| Investors Heavily Search NVIDIA Corporation (NVDA): Here is What You Need to Know",0,0.49096853
2022-09-26,54734300.0,124.91000366210938,126.58999633789062,122.13999938964844,122.27999877929688,122.19450378417967,NVDA,"Why Is Everyone Talking About Nvidia? ||| 1 Beaten-Down Nasdaq Stock That Could Soar 55% to 146%, According to Wall Street ||| Missed Out on Nvidia? My Best Chip Stock to Buy and Hold ||| Is Nvidia Blunting Intuitive Surgical's Edge in Robotic Surgery? ||| Why Nvidia's New Lovelace Chip Is Bad News for Jay Powell ||| Implied Volatility Surging for NVIDIA (NVDA) Stock Options ||| The 3 Most Undervalued Quantum Computing Stocks to Buy Now",1,0.478737
2022-09-27,55385400.0,125.06999969482422,127.36000061035156,122.58000183105467,124.12999725341795,124.04320526123048,NVDA,"3 New Products That Have Me Excited for Nvidia's Future ||| US STOCKS-S&P 500 ends near two-year low as bear market deepens ||| US STOCKS-S&P 500 ends near two-year low as bear market deepens ||| Why Nvidia Stock Defied the Falling Market Tuesday Morning ||| 2 Monster Metaverse Stocks to Buy for the Long Haul ||| Is Nvidia's Stock Cheap Enough to Buy Yet? ||| This $300 Billion Market Could Bring Nvidia Stock Out of Its Slump ||| Bull of the Day: Cadence Design Systems (CDNS) ||| AMD Is My Top Tech Stock Buy Right Now ||| If You Had Invested $5,000 in Nvidia Stock at Its IPO, Here's How Much You'd Have Now",1,0.5106694
2022-09-28,54241400.0,124.0999984741211,128.22999572753906,123.54000091552734,127.36000061035156,127.27096557617188,NVDA,"Nvidia Stock Has Grown 2.5x In Less Than Five Years- Here's Why ||| Intel: Value Stock or Value Trap? ||| Why Nvidia, Meta Platforms, and Palantir Bounced Back Today ||| Hewlett Packard's (HPE) Cray Ex to Build KAUST's Shaheen III ||| AMD Expands Ryzen Portfolio for High-Growth Business Segments ||| US STOCKS-Dow, S&P 500 set to open higher on lower yields, Apple slides ||| US STOCKS-Futures fall as Apple drops production increase, falling yields limit losses ||| This Fast-Growing Tech Stock Pays a Solid Dividend, and No One Talks About It.",0,0.48906252
2022-09-29,53276300.0,124.4800033569336,125.0,119.45999908447266,122.1999969482422,122.11455535888672,NVDA,"Relative Strength Alert For NVIDIA ||| Review: U.S.-China tech fight leaves global losers ||| US STOCKS-Wall Street ends down sharply; investors fret over economy ||| US STOCKS-Wall Street skids as investors fret about U.S. economic downturn ||| Notable Thursday Option Activity: DIS, ADBE, NVDA ||| Noteworthy ETF Outflows: SPYG, NVDA, AMD, COST ||| 3 Hypergrowth Tech Stocks to Buy to Tap Into a Hidden Bull Market ||| Is Intel Trying to Outmatch Nvidia? ||| Could Intel Stock Help You Retire a Millionaire? ||| Dow Jones Bear Market: 2 Dividend Stocks That Haven't Been This Cheap in Years ||| November 11th Options Now Available For NVIDIA",0,0.49688148
2022-09-30,56563800.0,120.87000274658205,126.33000183105467,120.75,121.38999938964844,121.3051300048828,NVDA,"Nvidia (NVDA) Stock Moves -0.66%: What You Should Know ||| The Next Big Thing in Tech? 7 Quantum Computing Stocks to Bet On. ||| Trouble Mounts for Chipmakers, More Pain Ahead",1,0.47016466
2022-10-03,54747800.0,123.47000122070312,126.77999877929688,121.0500030517578,125.12000274658205,125.03252410888672,NVDA,"Best Semiconductor Stocks To Invest In 2022? 4 To Watch This Week ||| 3 High-Growth Stocks That Could Be Worth $1 Trillion in 10 Years – Or Sooner ||| Matterport Stock: Bear vs. Bull ||| Why Nvidia, Shopify, and Roku Stocks Popped on Monday ||| Meta launches AI software tools to ease switching between Nvidia, AMD chips ||| Facebook parent Meta launches AI software tools to help speed up work ||| 2 Incredible Growth Stocks That Turned $5,000 Into More Than $100,000 in 10 Years",1,0.48797014
2022-10-04,58418200.0,128.7899932861328,132.1999969482422,128.7899932861328,131.6699981689453,131.5779571533203,NVDA,Semiconductor Stocks Soar on Potential Chip Export Curbs on China ||| Is iShares Semiconductor ETF (SOXX) a Strong ETF Right Now? ||| Why Nvidia Stock Was Surging Today ||| Investors in NVIDIA (NASDAQ:NVDA) have made a strong return of 173% over the past three years ||| 3 Top Artificial Intelligence Stocks to Buy in October ||| US STOCKS-Growth stocks lift Nasdaq 3% as Treasury yields ease ||| US STOCKS-Wall St set to open higher as easing Treasury yields lift growth stocks ||| NVIDIA Corporation (NVDA) Is a Trending Stock: Facts to Know Before Betting on It ||| US STOCKS-Wall St futures jump as Treasury yields retreat ||| Is Intel the New Leader in Graphics Cards? ||| U.S. keeps losing antitrust court battles but few expect pullback,1,0.48570666
2022-10-05,50713100.0,129.11000061035156,133.2100067138672,126.20999908447266,132.08999633789062,131.99765014648438,NVDA,"US STOCKS-Wall St ends down as two-day rally fizzles on data, Fed message ||| US STOCKS-Wall St ends down as two-day rally fizzles on data, Fed message ||| Should You Sell Your FANGMAN Stocks? ||| US STOCKS-Wall St slides as Fed's hawkish talk snuffs two-day rally ||| US STOCKS-Wall St slides as rising Treasury yields snuff out stock rally ||| US STOCKS-Wall Street set to decline as rally in growth stocks falter ||| AMD Is Expected to See Strong Revenue Growth, but What About Nvidia? ||| US STOCKS-Megacap stocks lose ground as yields rise, economic data awaited ||| Is Invesco Dynamic Semiconductors ETF (PSI) a Strong ETF Right Now? ||| SoftBank makes no Arm investment proposal to Samsung-report",0,0.46518242
2022-10-06,64415700.0,132.1999969482422,136.55999755859375,131.02999877929688,131.3000030517578,131.20822143554688,NVDA,"The Curious Reason Why Nvidia Stock Gained Ground Thursday Morning ||| Nvidia (NVDA) Stock Moves -0.6%: What You Should Know ||| AMD sees lower Q3 revenue as PC market slump worse than expected ||| EU wants to know if Microsoft will block rivals after Activision deal ||| Why Advanced Micro Devices Shares Lost 25% Last Month ||| 1 Monster Opportunity in the Global Chip Shortage ||| This Could Be the Best Black Friday Ever! ||| Zacks Market Edge Highlights: ExxonMobil, Meta Platforms, UnitedHealth Group, Biogen and NVIDIA ||| US STOCKS-Futures fall as high oil prices stoke inflation worries; Tesla falls ||| US STOCKS-Wall Street drops amid inflation, rate hike worries",0,0.4942067
2022-10-07,67247800.0,125.0500030517578,126.6999969482422,120.22000122070312,120.76000213623048,120.67557525634766,NVDA,"US STOCKS-Wall Street slips as jobs growth boosts rate hike bets ||| Wall Street tumbles as jobs growth cements rate hike bets ||| Why Chip Stocks Were Falling Today ||| US STOCKS-Wall Street tumbles as jobs report cements harsh rate hike outlook ||| U.S. aims to hobble China's chip industry with sweeping new export rules ||| EXPLAINER-What is 'FDPR' and why is the U.S. using it to cripple China's tech sector? ||| Should Investors Stay Away from Top Chipmaker Stocks? ||| Chip stocks slide as Samsung, AMD expect steep fall in demand ||| AMD Misses Sales Estimates By a Mile -- Time to Sell the Stock? ||| US STOCKS-Nasdaq futures slip on AMD warning; jobs data awaited ||| Best destination for SoftBank’s Arm IPO is nowhere ||| US STOCKS-Wall St set to open lower as jobs growth boosts rate hike bets",0,0.50222045
2022-10-10,69869900.0,120.37000274658205,121.23999786376952,114.08000183105467,116.6999969482422,116.618408203125,NVDA,"Apple's CEO Bashes the Metaverse, and Nvidia's CEO Embraces It: What It Means for Investors ||| 3 Companies That Could Be Worth $1 Trillion by 2030 ||| Best Stock to Buy: Nvidia vs. Apple ||| US STOCKS-Nasdaq registers lowest close since July 2020; chips stocks fall ||| US STOCKS-Wall Street falls with tech shares; investors assess rate outlook ||| US STOCKS-Nasdaq falls as U.S. export controls on China weigh on chip stocks ||| AMD Preliminary Q3'22 Results Impact Share Price Negatively ||| Top Analyst Reports for NVIDIA, Pfizer & Citigroup ||| US STOCKS-Nasdaq falls as U.S. export controls on China weigh on chip stocks ||| US STOCKS-Nasdaq set to dip at open as chipmakers slip ||| Notable ETF Inflow Detected - IVV, AAPL, MSFT, NVDA",0,0.461472
2022-10-11,66748200.0,115.61000061035156,118.45999908447266,112.83000183105467,115.86000061035156,115.77899932861328,NVDA,"How Micron Sidestepped the Tech Wreck on Tuesday and Gained 4.5% ||| 3 of the Top-Growing Stocks on Earth ||| Why Qualcomm, Nvidia, and Other Semiconductor Stocks Were Down on Monday ||| Stock Market News for Oct 11, 2022 ||| The Zacks Analyst Blog Highlights NVIDIA, Pfizer, Citigroup, Humana, and Canadian Natural Resources ||| 3 Unstoppable Dividend Stocks That Could Soar 57% to 71%, According to Wall Street",0,0.4820393
2022-10-12,49259000.0,115.79000091552734,117.3499984741211,113.4499969482422,115.0,114.91959381103516,NVDA,"US STOCKS-Wall St struggles to stay higher on rate-hike worries; Fed minutes awaited ||| Understanding Earnings Calls Series: Nvidia Stock Analysis ||| Wednesday's ETF with Unusual Volume: SOXQ ||| Nvidia (NVDA) Dips More Than Broader Markets: What You Should Know ||| Microsoft (MSFT), Meta to Bring Teams, Office, Windows to VR ||| US STOCKS-S&P 500, Nasdaq rise after five-day selloff, rate-hike fears weigh ||| US STOCKS-Wall St futures rise with focus on inflation data, Fed minutes ||| US STOCKS-Wall St futures rise ahead of inflation data, Fed minutes ||| 3 Top Metaverse Stocks to Buy in October ||| US STOCKS-Wall St futures pare gains as inflation data cements rate hike bets ||| 3 Top Cloud Stocks to Buy in October ||| New Report Shows PC Shipments Down -- Here Are My Thoughts",1,0.48927343
2022-10-13,85010300.0,109.70999908447266,120.77999877929688,108.12999725341795,119.5999984741211,119.5163803100586,NVDA,"Is Nvidia Stock a Buy Now? ||| AMD Initiative to Address High-Growth Markets Aid Prospects ||| US STOCKS-Wall St falls as hot inflation data drives fears of big rate hike ||| US STOCKS-Futures tumble after hot inflation data ||| How Expensive Is Nvidia Stock Really? ||| The Zacks Analyst Blog Highlights NVIDIA, Alphabet, Apple, Snap and Autodesk ||| US STOCKS-Wall St futures edge higher ahead of inflation data ||| Why is there a Chip Shortage? The Semiconductor Supply Chain, Explained",0,0.4835678
2022-10-14,71343200.0,120.56999969482422,121.11000061035156,112.04000091552734,112.2699966430664,112.19149017333984,NVDA,"AI and the Future of Mobility: 3 Stocks to Consider ||| Notable Friday Option Activity: AZO, DPZ, NVDA ||| Is Nvidia Stock Cheap Enough to Buy? ||| US STOCKS-Futures rise after big banks kick off earnings season",1,0.5200412
2022-10-17,58077400.0,115.18000030517578,119.4800033569336,115.16999816894533,118.87999725341795,118.79688262939452,NVDA,"A Quick Update on Nvidia's Gaming and Automotive Market ||| An Investor's Look at Semiconductors ||| Taiwan touts $900 mln in new business from Silicon Valley meetings ||| 2 Stock-Split Stocks That Could Double Your Money ||| Have Insiders Sold NVIDIA Corporation (NASDAQ:NVDA) Shares Recently? ||| 5 Stocks That Turned a $10,000 Investment Into $1 Million ||| Why Nvidia Stock Is Rising Today ||| Here's Why Growth in Nvidia's Automotive Segment Is Not All Great News for Investors ||| NVIDIA Corporation (NVDA) is Attracting Investor Attention: Here is What You Should Know ||| 2 Once-in-a-Decade Buying Opportunities in a Nasdaq Bear Market",1,0.4993384
2022-10-18,65936200.0,123.44000244140624,124.91999816894533,116.18000030517578,119.66999816894533,119.5863265991211,NVDA,"Tech Sell-Off: These Nasdaq Stocks Could Drop Further, but One Looks Like a Screaming Buy ||| Nvidia (NVDA) Gains But Lags Market: What You Should Know ||| 3 Beaten-Down Tech Stocks Trading at a Discount ||| US STOCKS-Wall St up as Goldman results keep optimism alive, rising yields cap gains ||| See Which Of The Latest 13F Filers Holds NVIDIA ||| VTI, META, NVDA, PG: Large Inflows Detected at ETF ||| US STOCKS-Wall St climbs as Goldman winds up big bank earnings on upbeat note ||| US STOCKS-Wall St set to jump at open as Goldman, J&J results lift earnings mood ||| Oracle Cloud adding tens of thousands of Nvidia chips for AI ||| The Pelosis’ Trades: You Win Some, Lose Some! ||| US STOCKS-Futures firmly up as J&J results boost earnings optimism ||| Is AMD a Better Investment Than Nvidia Right Now? ||| Should You Invest in the Invesco Dynamic Semiconductors ETF (PSI)? ||| US STOCKS-Futures extend rally on earnings optimism ||| Why Microsoft Is Down 29% This Year",1,0.46195012
2022-10-19,52313100.0,118.79000091552734,123.5,118.33999633789062,120.51000213623048,120.4257583618164,NVDA,"Oracle (ORCL), NVIDIA Expanded Partnership Comes With AI Focus ||| What Do Nvidia, Meta Platforms, and Oracle Have in Common? ||| Why Nvidia Stock Was Up on a Down Day for the Market ||| Zacks Investment Ideas feature highlights: Nvidia, Adobe and Alphabet ||| 2 Semiconductor Stocks With 149% to 178% Upside, According to Wall Street ||| Nvidia Stock: Bear vs. Bull",1,0.494104
2022-10-20,65239800.0,121.12999725341795,127.69000244140624,121.0500030517578,121.94000244140624,121.85474395751952,NVDA,"Why Shopify, Nvidia, and Roku Stocks Rallied Early Thursday ||| Despite the Correction, Should You Bet on Semiconductor Stocks?",1,0.48037502
2022-10-21,60949400.0,120.9800033569336,124.9800033569336,118.87000274658205,124.66000366210938,124.57284545898438,NVDA,"Why Nvidia, AMD, ASML, and Other Semiconductor Stocks Were Up Thursday Morning ||| Notable Friday Option Activity: DIS, NVDA, ABNB ||| Burned by Tech Stocks? Try These 3 ETFs Instead ||| Why Nvidia Stock Rallied This Week ||| Here's Why the Competition Is Intense Between AMD and Intel",1,0.47256508
2022-10-24,51745700.0,125.08000183105467,127.0999984741211,120.63999938964844,125.98999786376952,125.9019012451172,NVDA,"Have You Lost $3,000 in the Stock Market This Year? Do This Before It's Too Late. ||| Down More Than 20% Last Month, Can AMD Stock Turn Things Around? ||| Can Netflix Crush Nvidia in This $40 Billion Market? ||| Nvidia (NVDA) Gains But Lags Market: What You Should Know",1,0.47879645
2022-10-25,50548200.0,126.94000244140624,133.0,126.63999938964844,132.61000061035156,132.51727294921875,NVDA,"Top 10 Wide-Moat Stocks to Buy Now ||| GRAPHIC-S&P 500 adds to mid-October rebound from bear market low ||| Will Lower Ad Revenues Hurt Meta Platforms (META) Q3 Earnings? ||| Stock Market News for Oct 25, 2022 ||| 1 Super Semiconductor Stock Down 64% to Buy Hand Over Fist ||| Why Nvidia, Shopify, and Roku Stocks Rallied Early Tuesday",0,0.50657684
2022-10-26,53295300.0,128.69000244140625,133.8800048828125,127.08000183105467,128.9600067138672,128.86984252929688,NVDA,2 Growth Stocks Down 60% From Their Highs That Could Be Future Steals ||| 2 Tech Stocks You Can Buy and Hold for the Next Decade,1,0.50255704
2022-10-27,58311300.0,136.3000030517578,138.3800048828125,131.22000122070312,131.75999450683594,131.66787719726562,NVDA,"Stock Market News for Oct 27, 2022 ||| Thursday's ETF with Unusual Volume: SUSL ||| Notable ETF Inflow Detected - SPY, NVDA, V, META ||| How Midterms Could Impact Your ETF Portfolio ||| Why Nvidia Stock Edged Higher Today ||| Where Will Intel Stock Be in 5 Years? ||| Is Meta Platforms Saving AMD and Nvidia Investors? ||| Better Growth Stock: Tesla vs. Nvidia ||| Tech rout widens as Meta sinks after results ||| Top Analyst Reports for UnitedHealth, Johnson & Johnson, & Walmart",1,0.47169614
2022-10-28,52104000.0,131.0399932861328,138.5,130.61000061035156,138.33999633789062,138.24327087402344,NVDA,"Long-Term Investment Options in Metaverse Stocks: 5 Companies That Could Prosper in the Age of Web3 ||| Is Most-Watched Stock NVIDIA Corporation (NVDA) Worth Betting on Now? ||| The Zacks Analyst Blog Highlights UnitedHealth Group, Johnson & Johnson, Walmart, The Coca-Cola Company and NVIDIA ||| Excited About Oracle Cloud? Not So Fast -- The Story Is Really About Nvidia ||| What Awaits Advanced Micro Devices (AMD) in Q3 Earnings? ||| Why Shares of Nvidia, AMD, and Skyworks Are Rallying Today",0,0.5021692
2022-10-31,48634100.0,137.77999877929688,138.3800048828125,132.97000122070312,134.97000122070312,134.87562561035156,NVDA,2 Growth Stocks on My Buy List ||| Breaking Down AMD Stock Ahead of Q3 Earnings ||| Why Nvidia Fell Today ||| Weak Client Segment Revenues to Hurt AMD Q3 Earnings Growth ||| Bull of the Day: AspenTech (AZPN),1,0.51005846
2022-11-01,43281700.0,138.11000061035156,139.25,135.19000244140625,135.42999267578125,135.33531188964844,NVDA,Why Lattice Semiconductor Stock Soared Today ||| Is Nvidia Stock (NASDAQ:NVDA) a Contrarian Buy? ||| Is Mobileye Stock a Buy Now? ||| What to Expect from Qualcomm Earnings and QCOM Stock ||| Nvidia (NVDA) Gains As Market Dips: What You Should Know,0,0.47379074
2022-11-02,67262800.0,138.5,142.10000610351562,132.11000061035156,132.19000244140625,132.0975799560547,NVDA,AMD shares rise as chip demand from data centers cushions PC slowdown ||| Surprise! It Isn't Just Meta Investing Heavily in the Metaverse. ||| AMD shares rise as chipmaker sees data center strength cushioning PC slowdown ||| Should You Invest in the Technology Select Sector SPDR ETF (XLK)? ||| Did Meta Platforms Just Give Nvidia a Big Shot in the Arm?,1,0.5004382
2022-11-03,50006500.0,130.42999267578125,137.80999755859375,129.55999755859375,134.2100067138672,134.1161651611328,NVDA,"What Are Retail Investors Buying And Selling This Week Amidst Q3 Earnings Season? ||| AI chip startup SiMa.ai launches auto business with former Bosch, Mercedes executive ||| Is Intel Stock a Buy Now?",1,0.50026697
2022-11-07,41006100.0,142.27999877929688,144.1199951171875,139.5399932861328,143.00999450683594,142.91000366210938,NVDA,Is Intel a Buying Opportunity Now? ||| Should AMD Investors Be Excited About This? ||| PREVIEW-SoftBank faces tech stock weakness at Q2 earnings ||| Is Meta Platforms Spending Too Much on Data Centers? ||| EXCLUSIVE-Nvidia offers new advanced chip for China that meets U.S. export controls ||| EXCLUSIVE-Nvidia offers new advanced chip for China that meets U.S. export controls ||| Nvidia (NVDA) Outpaces Stock Market Gains: What You Should Know ||| 3 Stocks Down 50% or More That Are Screaming Bear-Market Buys,1,0.52369684
2022-11-08,59529200.0,148.00999450683594,148.91000366210938,142.16000366210938,146.02000427246094,145.91790771484375,NVDA,"Nvidia Designs New Chip For China To Override U.S Ban ||| US STOCKS-Wall Street rises as investors eye midterm U.S. elections ||| Notable Tuesday Option Activity: NVDA, LMT, ALB ||| US STOCKS-Wall St climbs over 1% as midterm election begins; Amgen hits record high ||| Why Nvidia Stock Popped Tuesday Morning ||| Is Qualcomm Stock a Buy Now? ||| Should You Invest in the Vanguard Information Technology ETF (VGT)?",0,0.496592
2022-11-09,45441400.0,141.6199951171875,142.11000061035156,137.58999633789062,137.75999450683594,137.66368103027344,NVDA,AMD Unveils Sub-$1000 High-End Graphics Cards ||| Why Nvidia Stock Plunged Today ||| Analysts Estimate Nvidia (NVDA) to Report a Decline in Earnings: What to Look Out for,1,0.47671872
2022-11-10,70081900.0,148.0,157.72999572753906,145.47000122070312,157.5,157.389892578125,NVDA,"3 Semiconductor Stocks To Watch In The Stock Market Right Now ||| US STOCKS-Wall Street ends sharply higher on sign of cooling inflation ||| 7 No-Brainer Metaverse Stocks to Buy for 2023 and Beyond ||| AMD launches data center CPU 'Genoa', taps Google, Microsoft as customers ||| US STOCKS-Wall Street soars on sign of cooling inflation ||| Why Nvidia, Shopify, and Snowflake Stocks All Surged Early Thursday ||| 5 Cash-Rich Stocks to Buy to Resist the Fed ||| US STOCKS-Wall St soars as cooling inflation spurs bets of smaller rate hikes ||| 4 Solid Stocks to Watch on a Booming Metaverse Space ||| 3 Growth Stocks to Buy That Could Be Massive Long-Term Winners ||| 2 Once-in-a-Decade Buying Opportunities in a Nasdaq Bear Market ||| Bull of the Day: PACCAR (PCAR) ||| US STOCKS-Wall St set to open higher as inflation data spurs bets of smaller rate hikes",1,0.50963855
2022-11-11,65548700.0,158.07000732421875,163.88999938964844,154.82000732421875,163.27000427246094,163.1558380126953,NVDA,"Why Nvidia, AMD, Intel, and Other Semiconductor Stocks Jumped on Thursday ||| Previewing Retail Sector Earnings as Inventory Issues Linger ||| IWF, NVDA, V, MA: ETF Inflow Alert ||| Want to Get Richer? 3 Top Stocks to Buy Now and Hold Forever. ||| The Zacks Analyst Blog Highlights Apple, Snap, Autodesk and NVIDIA ||| Nvidia Devises a New Chip for China That Passes U.S. Export Controls ||| What's in the Cards for NVIDIA (NVDA) This Earnings Season?",0,0.46868068
2022-11-14,52785200.0,162.17999267578125,165.39999389648438,159.22000122070312,162.9499969482422,162.83607482910156,NVDA,"7 Game-Changing Tech Stocks to Buy to Retire a Millionaire ||| USA Chip Regulations and What They Mean for Semiconductor Investors ||| Evaluating NVIDIA (NVDA) Stock Down 50% Before Q3 Earnings ||| The Best Stocks to Buy With $500 Right Now ||| Big Retail Earnings Week Ahead ||| Quiet Ahead of Retail Q3, Sales & Housing Data ||| Walmart, Target, Nvidia, Cisco Systems and Applied Materials are part of Zacks Earnings Preview",1,0.49460393
2022-11-15,54587600.0,167.22000122070312,169.97999572753906,163.82000732421875,166.66000366210938,166.54348754882812,NVDA,"Markets Cool but Stay in the Green, Led by Chinese Stocks ||| Notable Tuesday Option Activity: NVDA, AVAV, LPX ||| NVIDIA and 4 Top Earnings Charts ||| Nvidia is under the microscope ahead of earnings; Here’s what to expect ||| Why Nvidia Stock Is Climbing Higher Today ||| Nvidia ETFs in Focus Ahead of Q3 Earnings ||| Arista Networks and Skechers have been highlighted as Zacks Bull and Bear of the Day ||| Surprise! Warren Buffett Just Bought a Semiconductor Stock",0,0.4780542
2022-11-16,64954700.0,161.6199951171875,163.6199951171875,158.72999572753906,159.10000610351562,158.98876953125,NVDA,"Why Nvidia Shares Fell Ahead of Earnings Today ||| Technology Sector Update for 11/16/2022: LYT,MU,HOLI,MSFT,NVDA ||| Nvidia (NVDA) Q3 2023 Earnings Call Transcript ||| Nvidia Stock Little Changed on Earnings Miss, Revenue Beat ||| 7 Meme Stocks That Are Actually Worth Betting On ||| Markets Slip This Hump Day; NVDA, CSCO Beat ||| Nvidia (NVDA) Q3 Earnings Lag Estimates ||| NVIDIA Corporation Q3 Profit Decreases, misses estimates ||| Nvidia forecasts fourth-quarter revenue below expectations ||| Technology Sector Update for 11/16/2022: MU,HOLI,MSFT,NVDA ||| US STOCKS-S&P 500, Nasdaq slip on Micron's supply cut, Target outlook ||| Semiconductor ETFs Surge on Warren Buffett's Stake Disclosure ||| Nvidia says it is working with Microsoft to build 'massive' cloud AI computer ||| Nvidia (NVDA) Q3 2023 Earnings: What to Expect ||| NVIDIA Q3 23 Earnings Conference Call AT 5:00 PM ET ||| US STOCKS-Futures tick higher as investors await retail sales data, earnings ||| After-Hours Earnings Report for November 16, 2022 : NVDA, CSCO, CPRT, BBWI, HP, GLBE, HI, KLIC, CPA, SONO, SBLK, EZPW ||| Should You Buy Taiwan Semiconductor-Heavy ETFs Now?",0,0.4744274
2022-11-17,71089400.0,157.14999389648438,162.66000366210938,155.35000610351562,156.77000427246094,156.660400390625,NVDA,"US STOCKS-Futures slip as investors assess mixed economic data ||| Analyzing NVIDIA (NVDA) Stock After Q3 Earnings ||| Are Tech Stocks Recovering? Here's What 2 Tech Titans Have to Say ||| Nvidia Misses Q3 Earnings, Shares Up: ETFs in Focus ||| Nvidia Earnings Were Boring, and That Might Be a Good Thing ||| Company News for Nov 17, 2022 ||| Pre-Market Most Active for Nov 17, 2022 : TQQQ, SQQQ, BABA, NIO, XPEV, M, QQQ, NVDA, TSLA, CCL, AMZN, F ||| Technology Sector Update for 11/17/2022: WB, NVDA, CSCO, XLK, SOXX ||| Pain or Gain Ahead of Semiconductor ETFs? ||| Did This 1 Segment Just Save Nvidia Investors? ||| 3 Stocks I'm Planning to Buy Very Soon ||| Should You Invest in the Fidelity MSCI Information Technology Index ETF (FTEC)? ||| Should You Invest in the iShares Semiconductor ETF (SOXX)? ||| NVIDIA (NVDA) Q3 Earnings Miss Estimates, Revenues Surpass ||| 2 Top Warren Buffett Stocks to Buy Now and Hold Forever",0,0.48470116
2022-11-18,49207200.0,159.66000366210938,160.02000427246094,151.1999969482422,154.08999633789062,153.98226928710938,NVDA,"Company News for Nov 18, 2022 ||| Best Undervalued Stocks To Buy Right Now? 2 Semiconductor Stocks To Watch ||| 10 Best Tech Stocks to Buy Now in November (High Conviction) ||| More Bullish News for Berkshire Hathaway's Semiconductor Stock",0,0.4872424
2022-11-21,40473900.0,151.47000122070312,154.77000427246094,150.8000030517578,153.1699981689453,153.0629119873047,NVDA,"Nvidia Scores a Huge Win -- Microsoft Will Be First Public Cloud to Adopt Its AI Stack ||| Noteworthy ETF Inflows: QQQ, NVDA, PEP, META ||| Here is What to Know Beyond Why NVIDIA Corporation (NVDA) is a Trending Stock ||| It's Not Just the U.S. Investing in Chips, and Investors Can Win Big Off the Trend",1,0.48042637
2022-11-22,47286600.0,153.27999877929688,160.5800018310547,151.22000122070312,160.3800048828125,160.2678680419922,NVDA,Is the Worst Over for Semiconductor Stocks & ETFs? ||| Meta Platforms (META) Developing Network Clocks for Metaverse ||| 3 Under-the-Radar Gaming Stocks You Can Buy and Hold for the Next Decade,1,0.4870087
2022-11-23,42724100.0,160.97999572753906,165.27000427246094,160.47999572753906,165.19000244140625,165.0745086669922,NVDA,"Is Nuveen ESG LargeCap Growth ETF (NULG) a Strong ETF Right Now? ||| Interesting NVDA Put And Call Options For January 2023 ||| Noteworthy Wednesday Option Activity: NVDA, ALB, MCD ||| A New Tailwind Emerges for Nvidia Stock -- Share Repurchases ||| Is Nvidia Stock a Buy Right Now?",0,0.50143975
2022-11-25,16793400.0,163.17999267578125,164.8699951171875,161.72000122070312,162.6999969482422,162.58624267578125,NVDA,"Here's Nvidia's Fastest-Growing Segment -- and It's Not Data Center or Gaming ||| 3 Tech Stocks You Can Count on in This Uncertain Market ||| Where to Invest $10,000 in a Bear Market ||| What's Going On With Nvidia Stock? ||| Should You Invest in the VanEck Semiconductor ETF (SMH)?",0,0.48864484
2022-11-28,30374100.0,160.25999450683594,163.57000732421875,157.25,158.27000427246094,158.1593475341797,NVDA,"2 Quantum Computing Stocks To Watch Right Now ||| Nvidia Stock Q&A With Wall Street Investors ||| The Smartest Stocks to Buy With $20 Right Now and Hold Forever ||| Nvidia (NASDAQ:NVDA): This Chip Stock is Down but Not Out ||| Better Semiconductor Stock: Mobileye vs. Nvidia ||| US STOCKS-Wall St futures slip on China COVID woes; Apple falls ||| US STOCKS-Wall Street drops, weighed down by Apple and China worries ||| US STOCKS-Wall Street drops, weighed down by Apple and China worries ||| Ex-Dividend Reminder: NVIDIA, Vontier and Shutterstock ||| US STOCKS-Apple, energy shares drag Wall St lower amid China COVID protests ||| US STOCKS-Wall St losses limited as Amazon gains on upbeat Cyber Monday ||| Will the Nasdaq or S&P 500 Have a Better 2023? ||| Nvidia Sees Better Times Ahead as 2023 Nears ||| Has AMD Replaced Nvidia as a Top Semiconductor Company?",0,0.4904589
2022-11-29,29838400.0,158.27000427246094,159.32000732421875,155.1999969482422,156.38999938964844,156.28065490722656,NVDA,"Time to Buy Beaten-Down Chip Stocks? ||| US STOCKS-S&P 500 ends down as Apple dips and traders eye Powell speech ||| Tuesday's ETF with Unusual Volume: SUSL ||| Nvidia Stock Looks Expensive but Might be Undervalued ||| Noteworthy ETF Inflows: SMH, TSM, NVDA, QCOM",1,0.4723311
2022-11-30,56529800.0,156.97000122070312,169.3000030517578,155.97000122070312,169.22999572753906,169.1549530029297,NVDA,"US STOCKS-Wall Street ends sharply higher after Powell comments ||| US STOCKS-Wall Street ends sharply higher after Powell comments ||| US STOCKS-Wall Street ends sharply higher after Powell comments ||| Noteworthy Wednesday Option Activity: AA, NVDA, RKT ||| Smart Investors Should Buy These 3 Stocks, Down Between 46% and 73%, Heading Into 2023 ||| US STOCKS-Wall Street rises after Powell eyes slower rate hikes ||| Report warns U.S. chip design market share to plunge without government support ||| US STOCKS-Wall Street rallies after Powell eyes slower rate hikes",1,0.4713189
2022-12-01,47097700.0,169.99000549316406,172.64999389648438,166.35000610351562,171.35000610351562,171.2740020751953,NVDA,"Amazon's New Chips Coming for NVIDIA ||| US STOCKS-Wall Street ends mixed; Salesforce selloff pressures Dow ||| How Artificial Intelligence Is Transforming Healthcare ||| Meta Platforms (META) Boosts Prospects With New VR Features ||| Time for Cloud ETFs Following Amazon's Recent Hiring Move? ||| January 2023 Options Now Available For NVIDIA ||| Is Amazon Going After Nvidia, Intel, and AMD Business? ||| TSMC plans to make more advanced chips in US on Apple's push - Bloomberg News",0,0.5123648
2022-12-02,37138900.0,166.58999633789062,169.3300018310547,164.4499969482422,168.75999450683594,168.68515014648438,NVDA,"Up 50% Since October, Is Nvidia Stock a Buy? ||| Nasdaq leads Wall St lower after robust November jobs data ||| My 3 Highest-Conviction Growth Stocks to Buy Before 2022 Ends ||| Why Nvidia, Alphabet, and Other Tech Stocks Slumped Friday ||| US STOCKS-Wall St futures slide after robust November jobs report ||| US STOCKS-Nasdaq leads Wall St lower after robust November jobs data ||| Investors Heavily Search NVIDIA Corporation (NVDA): Here is What You Need to Know ||| 3 Cheap Stocks to Buy Right Now",0,0.51332253
2022-12-05,35225500.0,166.7899932861328,169.9499969482422,164.72000122070312,166.10000610351562,166.02633666992188,NVDA,1 Thing You Need to Know Before You Buy Chip Stocks ||| Why Nvidia Stock Surged 25% in November ||| 2 Top Tech Stocks to Buy for the Long Haul ||| 5 Top Stocks for December ||| Two Outperforming Semiconductors You Haven't Heard Of ||| Are Options Traders Betting on a Big Move in NVIDIA (NVDA) Stock? ||| Is Invesco Dynamic Semiconductors ETF (PSI) a Strong ETF Right Now?,0,0.49278733
2022-12-06,35269400.0,165.3000030517578,165.72999572753906,158.19000244140625,159.8699951171875,159.79908752441406,NVDA,"3 Stocks to Buy Before 2023 That Can Set You Up for Life ||| TSMC expects $10 billion in annual revenue from Arizona fabs ||| 3 Reasons to Be Buying Nvidia Stock Hand Over Fist Right Now ||| Air Products Stock Could Be a Hidden Gem Among All the Chip Manufacturing Hype ||| Biden to visit Taiwan's TSMC chip plant in Arizona, hail supply chain fixes ||| Biden to visit Taiwan's TSMC chip plant in Arizona, hail supply chain fixes",1,0.48497823
2022-12-07,37238800.0,157.72000122070312,161.86000061035156,156.6699981689453,161.1999969482422,161.1284942626953,NVDA,Invesco QQQ Experiences Big Outflow ||| Better Buy: AMD vs. Nvidia ||| This Hot Growth Stock Is Still a Buy After Enormous Gains ||| US STOCKS-Futures fall on growing fears of recession ||| Is iShares Semiconductor ETF (SOXX) a Strong ETF Right Now? ||| 1 Monster Opportunity in the Global Chip Shortage ||| Apple To Use US-made Microchips From TSMC's New Arizona Factory,1,0.48230225
2022-12-08,51545600.0,162.72999572753906,171.7899932861328,159.58999633789062,171.69000244140625,171.6138458251953,NVDA,"Noteworthy Thursday Option Activity: GNRC, NVDA, NOW ||| Why Amazon, Nvidia, and Snowflake All Gained Ground Today ||| US STOCKS-S&P 500, Nasdaq snap losing streaks after jobless claims rise ||| US STOCKS-S&P 500 rebounds as investors take rate hike cues from jobless claims rise ||| 2 Top Index Funds Growth Stock Investors Can Buy With Confidence Before 2023 ||| US STOCKS-S&P 500 snaps losing streak on jobless claims rise ||| US STOCKS-S&P 500 rebounds on tech boost; weekly jobless claims rise ||| US STOCKS-S&P 500 rebounds on tech boost; weekly jobless claims rise ||| Oracle's (ORCL) Q2 Earnings Coming Up: What's in Store?",0,0.48304942
2022-12-09,46533800.0,171.60000610351562,175.8300018310547,169.75,170.00999450683594,169.93460083007812,NVDA,"4 Dividend Stocks to Hold Forever ||| 3 Growth Stocks That Could Be Huge Winners in the Next Decade and Beyond ||| Buffett's Buys; 3 Stocks Catching His Attention in 2022 ||| US STOCKS-Wall St slips as inflation data ignites rate hike worries ||| Taiwan Semiconductor's Arizona Fab Could Mean Big Wins for 2 Other Chip Stocks ||| US STOCKS-Wall St eyes lower open as inflation data stokes rate hike worries ||| 3 Top Artificial Intelligence Stocks to Buy in December ||| Company News for Dec 9, 2022",1,0.49290073
2022-12-12,45732800.0,170.3699951171875,175.3800048828125,167.97000122070312,175.35000610351562,175.27224731445312,NVDA,"3 Semiconductor Stocks To Check Out This Week ||| Why Nvidia Can Crush AMD Once Again In 2023 ||| Take the Zacks Approach to Beat the Market: NVIDIA, Boeing, Amgen in Focus ||| 2 Semiconductor Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague",1,0.48734143
2022-12-13,65658900.0,185.3099975585937,187.8999938964844,177.11000061035156,180.72000122070312,180.63986206054688,NVDA,"AMD Launches Its Best High-End Graphics Card in Years ||| Very Rare: 2 Leaders Near Long Term Buy Zone ||| Why Nvidia, Shopify, and The Trade Desk Stocks All Rallied on Tuesday ||| US STOCKS-Wall St surges as CPI data calms jitters over aggressive rate hikes ||| Our 3 Top Metaverse Stock Picks for 2023 ||| US STOCKS-Wall St set to surge at open as CPI data calms rate hike jitters ||| US STOCKS-Futures rise ahead of CPI report, Fed rate decision ||| 2 Semiconductor Stocks Down More Than 40% You'll Regret Not Buying on the Dip ||| NVIDIA Corporation (NVDA) Is a Trending Stock: Facts to Know Before Betting on It",0,0.49715137
2022-12-14,49688800.0,179.8699951171875,182.5200042724609,174.1999969482422,176.74000549316406,176.66162109375,NVDA,Brokers Suggest Investing in Nvidia (NVDA): Read This Before Placing a Bet ||| Meta Platforms (META) Launches Latest Family of Apps Features ||| Semiconductor Stock Showdown: Nvidia vs. TSMC,0,0.48217025
2022-12-15,47854200.0,171.4600067138672,173.1999969482422,167.0,169.52000427246094,169.44480895996094,NVDA,"Notable ETF Inflow Detected - QQQ, NVDA, GOOG, TSLA ||| Why Nvidia Stock Got Thumped on Thursday ||| ETF Market Outlook & Investing Strategies for 2023 ||| US STOCKS-Wall Street slumps as Fed heightens recession fears ||| US STOCKS-Wall Street tumbles as Fed sparks recession fears ||| US STOCKS-Wall Street falls sharply on angst over hawkish Fed ||| US STOCKS-Wall Street slides more than 1% on angst over hawkish Fed ||| US STOCKS-Wall Street set to open sharply lower on angst over hawkish Fed ||| Meta Platforms (META) Unveils New Features in WhatsApp Calling ||| Nasdaq Bear Market: 2 Top Growth Stocks to Buy in a Once-in-a-Decade Opportunity ||| Is Intel Stock a Buy Now? ||| Nvidia's CEO Just Gave Investors 1 Million Reasons to Sell or Buy",0,0.5238088
2022-12-16,47823200.0,168.63999938964844,170.41000366210938,164.10000610351562,165.7100067138672,165.6365203857422,NVDA,"3 Gaming Stocks to Buy Hand Over Fist Before 2022 Ends ||| U.S. Intensifies Crackdown on Chinese Firms, Blacklists Chipmaker YMTC ||| Crypto, the Metaverse, or the Stock Market: Which Is the Best Buy for 2023? ||| Nvidia (NVDA) Up 8.1% Since Last Earnings Report: Can It Continue? ||| Is Nvidia's Move Into Software a Good Idea?",0,0.49813855
2022-12-19,35403900.0,165.72000122070312,166.08999633789062,161.4499969482422,162.5399932861328,162.46791076660156,NVDA,"Cheap Stocks To Buy Now? 2 Tech Stocks To Know ||| 3 Stocks to Invest in Virtual Reality ||| Down 45%, This Trailblazing Semiconductor Stock Is a Must-Buy Before 2023 ||| 3 Cathie Wood Stocks That Could Deliver Bigger Gains Than the Market ||| AMD Thinks It Can Seriously Challenge Intel and Nvidia in 2023 ||| 2 Monster Metaverse Stocks to Buy for the Long Haul ||| Semiconductors: A Tale of Haves and Have-nots ||| Unusual Options Activity in Apple, Home Depot and 8 Other Stocks ||| What's the Better Investment: A Diversified AMD or an AI Software-Focused Nvidia? ||| 2 Top-Ranked Stocks to Buy From the Edge Computing Space in 2023",0,0.48080835
2022-12-20,40326000.0,160.63999938964844,163.10000610351562,158.52000427246094,160.85000610351562,160.77867126464844,NVDA,"The Zacks Analyst Blog Highlights Arista Networks, Cloudflare, Microsoft, Alphabet and NVIDIA ||| Intel Has a $39 Billion Graphics Opportunity ||| Will Nvidia Be a Trillion-Dollar Stock by 2030? ||| Should You Invest in the Invesco Dynamic Semiconductors ETF (PSI)?",1,0.50365263
2022-12-21,32502500.0,161.13999938964844,166.27000427246094,161.02000427246094,165.00999450683594,164.93679809570312,NVDA,NVIDIA (NVDA) vs. Taiwan Semiconductor (TSM): Which is the Better Investment for 2023? ||| Why Intel Stock Shot Higher on Wednesday ||| Intel splits graphic chips unit into two ||| Better Buy for 2023: Apple vs. Nvidia ||| Will Nvidia Stock Fly or Fall in 2023? ||| Buy These 3 Metaverse Stocks Before They Explode ||| Litecoin Gets a Second Wind Heading Into 2023,0,0.4821124
2022-12-22,56504500.0,160.94000244140625,161.3800048828125,148.82000732421875,153.38999938964844,153.32196044921875,NVDA,"US STOCKS-Wall Street slides as economic data fans rate hike worries ||| Thursday Sector Laggards: Energy, Technology & Communications ||| Why Did Nvidia, AMD, and Intel All Crash on Thursday? ||| US STOCKS-Nasdaq dives on Fed rate hike worries, rout in chipmakers ||| Is This the End for Intel Stock? Or a New Beginning? ||| US STOCKS-Wall St sees lower open as economic data renews rate hike worries ||| Better Stock to Buy for 2023: Nvidia Stock vs. AMD Stock ||| 2 Magnificent Semiconductor Stocks Down 46% and 51% to Buy Before the Next Bull Market",0,0.49431038
2022-12-23,34932600.0,151.9600067138672,153.38999938964844,148.8300018310547,152.05999755859375,151.9925537109375,NVDA,"Nvidia (NVDA) Stock Sinks As Market Gains: What You Should Know ||| Friday Sector Laggards: Healthcare, Technology & Communications ||| Stock Market News for Dec 23, 2022 ||| Did Micron Earnings Tank AMD and Nvidia Stock? ||| Nasdaq Bear Market: 1 Stunning Growth Stock to Buy Like There's No Tomorrow ||| 5 Stocks Billionaire Money Managers Want to Own in 2023 ||| Noteworthy Friday Option Activity: NVDA, DIS, NOW ||| 3 Nasdaq Stocks That Are Up 25% in 3 Months",0,0.48740867
2022-12-27,46490200.0,150.74000549316406,151.0,140.55999755859375,141.2100067138672,141.1473846435547,NVDA,"2 Semiconductor Stocks To Watch This Upcoming Week ||| Better Buy: Apple vs. Nvidia ||| How Much Longer Will the Semiconductor Industry Downturn Last? ||| These 2 Stocks Were Among the Biggest Losers of 2022 -- Could They Be Among the Biggest Winners in 2023? ||| 5 Ultra-Popular Stocks I'd Sell Right Now ||| Tuesday Sector Laggards: Technology & Communications, Healthcare ||| Is Taiwan Semiconductor Manufacturing Stock a Buy? ||| AMD Is Losing Ground to Intel in This Key Chip Market ||| ANALYSIS-Dealmakers grapple with unprecedented U.S. challenge to mergers ||| What the Latest Updates Mean for AMD and Nvidia Stock Investors ||| 2 Top Warren Buffett Stocks Down 54% and 55% to Buy Before the Next Bull Market ||| ANALYSIS-Dealmakers grapple with unprecedented U.S. challenge to mergers",0,0.48151484
2022-12-28,35106600.0,139.27000427246094,142.6199951171875,138.83999633789062,140.36000061035156,140.29774475097656,NVDA,"NVIDIA Corporation (NVDA) is Attracting Investor Attention: Here is What You Should Know ||| Down 48% in 2022, Is Nvidia Stock a Buy for 2023? ||| This Is How Nvidia Makes Billions in Sales Each Quarter ||| 5 Unstoppable Metaverse Stocks to Buy in 2023 ||| Down 52%; Should Investors Buy Nvidia (NASDAQ:NVDA) Stock?",1,0.48131666
2022-12-29,35492300.0,144.02000427246094,146.8300018310547,142.27000427246094,146.02999877929688,145.96524047851562,NVDA,TSMC starts volume production of most advanced chips in Taiwan ||| Top Analysts Cheer for These 5 Tech Stocks Heading Into 2023 ||| 3 Seriously Undervalued Semiconductor Stocks to Buy Now,1,0.500869
2022-12-30,31049000.0,143.33999633789062,146.2899932861328,142.3300018310547,146.13999938964844,146.07518005371094,NVDA,US STOCKS-Wall St set to end challenging year with steep drop ||| Nvidia (NVDA) Gains As Market Dips: What You Should Know ||| US STOCKS-Wall St ends 2022 with biggest annual drop since 2008 ||| US STOCKS-Wall St ends 2022 with biggest annual drop since 2008 ||| What Tech Investors Can Expect to See at CES 2023 ||| The Biggest Reason Nvidia Stock Is a Screaming Buy for 2023 ||| 3 Top Stocks Worth Buying for the Long Term in 2023 ||| This Large-Cap Semiconductor Stock Has Been Hot,0,0.4720882